<SEC-DOCUMENT>0001682852-21-000006.txt : 20210226
<SEC-HEADER>0001682852-21-000006.hdr.sgml : 20210226
<ACCEPTANCE-DATETIME>20210226163028
ACCESSION NUMBER:		0001682852-21-000006
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		216
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210226
DATE AS OF CHANGE:		20210226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moderna, Inc.
		CENTRAL INDEX KEY:			0001682852
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				813467528
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38753
		FILM NUMBER:		21689487

	BUSINESS ADDRESS:	
		STREET 1:		200 TECHNOLOGY SQUARE
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		6177146500

	MAIL ADDRESS:	
		STREET 1:		200 TECHNOLOGY SQUARE
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Moderna Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160822
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>mrna-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:587e37ef-2d85-4611-b0f5-79aaf037b83c,g:a4c5467e-e912-4919-957b-a5dc25d57b8f,d:ac7f3ce8465b4330a30f0fc9f4279c20--><html xmlns:mrna="http://www.modernatx.com/20201231" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mrna-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF80L2ZyYWc6NWFkYzEwNjVhNDQ5NDM5ODg3NzUzNDliYjc5Nzc4ZWEvdGFibGU6YWUxZTE0YTQ5YTljNGM2ODg5YzNkY2IyMGViZTZkZGEvdGFibGVyYW5nZTphZTFlMTRhNDlhOWM0YzY4ODljM2RjYjIwZWJlNmRkYV8xLTEtMS0xLTA_ace71dc9-0dd3-4092-ab0c-d6c8549bee39">false</ix:nonNumeric><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF80L2ZyYWc6NWFkYzEwNjVhNDQ5NDM5ODg3NzUzNDliYjc5Nzc4ZWEvdGFibGU6YWUxZTE0YTQ5YTljNGM2ODg5YzNkY2IyMGViZTZkZGEvdGFibGVyYW5nZTphZTFlMTRhNDlhOWM0YzY4ODljM2RjYjIwZWJlNmRkYV8zLTEtMS0xLTA_8586cc0c-5a7e-4eab-a2b7-d2dd9ee2a223">2020</ix:nonNumeric><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF80L2ZyYWc6NWFkYzEwNjVhNDQ5NDM5ODg3NzUzNDliYjc5Nzc4ZWEvdGFibGU6YWUxZTE0YTQ5YTljNGM2ODg5YzNkY2IyMGViZTZkZGEvdGFibGVyYW5nZTphZTFlMTRhNDlhOWM0YzY4ODljM2RjYjIwZWJlNmRkYV80LTEtMS0xLTA_96daa0f9-6f9d-4234-8661-bd5c6df459cc">FY</ix:nonNumeric><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF80L2ZyYWc6NWFkYzEwNjVhNDQ5NDM5ODg3NzUzNDliYjc5Nzc4ZWEvdGFibGU6YWUxZTE0YTQ5YTljNGM2ODg5YzNkY2IyMGViZTZkZGEvdGFibGVyYW5nZTphZTFlMTRhNDlhOWM0YzY4ODljM2RjYjIwZWJlNmRkYV82LTEtMS0xLTA_08a47628-5a5c-42eb-91ca-4b8598056a71">0001682852</ix:nonNumeric><ix:nonNumeric contextRef="i9d91300ccece4f0cb4993ca5f2e28e76_D20160101-20160131" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEzNTY2_b4c654c8-2a80-49cb-b78b-a61c53047d69">P12M</ix:nonNumeric><ix:nonNumeric contextRef="ifed27586ee884f47a07d016946f33a60_D20200101-20201231" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzkz_2d953b6a-57dd-4928-80b3-3c00ab223378">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ifed27586ee884f47a07d016946f33a60_D20200101-20201231" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzQ1_9c8cdcb6-3511-498b-8168-a066bbb63f69">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i9441d23013f14c83988a31bdbb559231_I20201231" format="ixt-sec:duryear" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNjA2L2ZyYWc6ZDlmMGU4YWE5NDhhNGQyYjhmNWViNGJjMGNkNWFmY2MvdGV4dHJlZ2lvbjpkOWYwZThhYTk0OGE0ZDJiOGY1ZWI0YmMwY2Q1YWZjY18xNTM5MzE2Mjc4ODkyOA_c5480414-ae84-4b35-a1ad-290fa518761a">8.25</ix:nonNumeric><ix:nonNumeric contextRef="i4d71f32e33e84216807274b731bdc696_I20201231" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNjA2L2ZyYWc6ZDlmMGU4YWE5NDhhNGQyYjhmNWViNGJjMGNkNWFmY2MvdGFibGU6Y2U0MTRlY2FhNjczNDM3YzlmZTY5ZTIxYmJiNjU2OTkvdGFibGVyYW5nZTpjZTQxNGVjYWE2NzM0MzdjOWZlNjllMjFiYmI2NTY5OV8wLTAtMS0xLTIxMDY4_c09b0f81-4818-449e-aad2-d3b142cfbbce"></ix:nonNumeric><ix:nonNumeric contextRef="i0f6399c8db0840dc9f38f108c60c920b_I20201231" format="ixt-sec:duryear" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNjA2L2ZyYWc6ZDlmMGU4YWE5NDhhNGQyYjhmNWViNGJjMGNkNWFmY2MvdGV4dHJlZ2lvbjpkOWYwZThhYTk0OGE0ZDJiOGY1ZWI0YmMwY2Q1YWZjY180OTQ3ODAyMzI1MTE4_08185581-ec1d-4614-94e5-758d7da14354">4.25</ix:nonNumeric><ix:nonNumeric contextRef="idfe0cd89ae6041918c135184fa183ddb_I20201231" format="ixt-sec:duryear" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNjA2L2ZyYWc6ZDlmMGU4YWE5NDhhNGQyYjhmNWViNGJjMGNkNWFmY2MvdGV4dHJlZ2lvbjpkOWYwZThhYTk0OGE0ZDJiOGY1ZWI0YmMwY2Q1YWZjY180OTQ3ODAyMzI1MTM0_9924a8f3-a56e-4fe8-bb00-77610482ef39">3.25</ix:nonNumeric><ix:nonNumeric contextRef="ib3f291fa3ef94d0986838b93d6b8a9b8_I20201231" format="ixt-sec:duryear" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNjA2L2ZyYWc6ZDlmMGU4YWE5NDhhNGQyYjhmNWViNGJjMGNkNWFmY2MvdGV4dHJlZ2lvbjpkOWYwZThhYTk0OGE0ZDJiOGY1ZWI0YmMwY2Q1YWZjY180OTQ3ODAyMzI1MTQ2_b29e0f18-3ee4-44f5-a8d9-21239ec0e022">1</ix:nonNumeric><ix:nonNumeric contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_509b73a1-344b-43fb-b968-8722c1c25a5e">us-gaap:OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_72c4555a-bb44-4abb-b6c7-1be6c51005ca">us-gaap:OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_2a800648-bfb3-4584-a0d1-7572b92f5809">us-gaap:OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_5ef609f9-9865-4708-ad5f-c12a24e8246f">us-gaap:OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNTk1L2ZyYWc6ZDFkZjA2M2EyNjEzNDMwMmFlMmJjODZjNTJhMjcyNWEvdGV4dHJlZ2lvbjpkMWRmMDYzYTI2MTM0MzAyYWUyYmM4NmM1MmEyNzI1YV80OTQ3ODAyMzI1MjE2_65276b38-96b3-4bdd-8d63-f5d1cd367a08">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNTk1L2ZyYWc6ZDFkZjA2M2EyNjEzNDMwMmFlMmJjODZjNTJhMjcyNWEvdGV4dHJlZ2lvbjpkMWRmMDYzYTI2MTM0MzAyYWUyYmM4NmM1MmEyNzI1YV80OTQ3ODAyMzI1MjE3_4f9b66d1-f583-457d-a7c6-b077d39e7b38">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i456564aebcd9408998fe415ad2b5746b_D20200101-20201231" format="ixt-sec:durmonth" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODEvZnJhZzphMTBiMDMwMTBkNDU0MDMxOTljNTVmMTZhYjBiM2Y5Yi90YWJsZTo5NmJiMDA4YTgwN2Y0YTZlOGQyNjVjMmM2N2MxZmIzNS90YWJsZXJhbmdlOjk2YmIwMDhhODA3ZjRhNmU4ZDI2NWMyYzY3YzFmYjM1XzItMS0xLTEtMA_c7576c9a-071d-41ce-bed3-173795a6d55d">36</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mrna-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ie96a43c24f044f688f10c58ea55f7047_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i71c171ceb13145969aa0a46d90bf882a_I20210216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1191369058cf41a6aec423e2a8b9ee92_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ia16dd0e2f0d2488eba0c73974791c3a4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i998364a642404015895ef6268a8bef44_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i234df8a6bf184a26bc8d6f61ec880f13_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3af31ae8238a40b6a097aa5017de8edd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67dc425fe1144699ae5760509f7e5da9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id76485547ab74bf79a9764e33c357192_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1bf0bccbb5d48e2b6b391bd4c6436d8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice56444d59b64b31a0940bfed6f9c48d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5db3bb48bb6499b83759eafea2dc91f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae26ac15cf594fc4a4c729775db551d1_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0f05a78cb4a45e0aae694728346c943_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67150ae834864a00a45a3aafe2462423_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d4e1054ad904b07b079bfcd6a3b0dfa_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i938ca78cd25647ac9350433b1e94b211_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i857b3ef318484e959ca8a3dddeb3a486_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i859a2b8a071243a4aab797a9e567cab2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia68cd3c2e44d470a8bb0dd6b86dfbcd9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i812ca2c8b582418791dd8a37f6934064_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67ede5f832064fd28db4be814bebe8c9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77c6c82735e645deaa5e5478b0a99aa6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2745e2110e849418080ca092c31fe61_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i014f1da45cd24ebfaccc119edf9098d7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie937c553bd26477b9acb13ff0d7ed4e0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib152449eaa214910b3c1ff9d8ebc950d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic468680da3a242bd8e509f8061d39e47_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e0a831810a84041aaa0ec3f4250a1ee_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2737f3bfa09d4954bbdecc2432f59275_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f1c28d9133c4d19994650191f44a618_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06ac627610d04fb3ad68a60243ee4351_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ad70ea4023a49e5923d1a79f4faf6fd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i413042b2017f4a90a355a0f54413c75f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbb1a345880141898c0782b97ae50bdd_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2425e3671ff2477f85a228531640c4e2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14c57127d88a41c5af194b5765483daa_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec0aa65fa9384232bb27dc252483b1ee_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20204b229a394d9ba8b28882826012db_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46a4ad30d8e44c75931d48376d7dd5a7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id01664a6e7894e8083439b3589eb02b8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife96d591748e4db1a06679e64f49ac18_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f826ec40d9a42d49d1f345df0664683_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2f2085b1dd5438ca46922e561f57fef_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ea8b1dba03d4c238442398f1dbc7fab_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfbf4e4b10ca4b88bc9d9e4de34dfec6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6276f01255674c1bb430a10fe7a5d756_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dd938ce77414d15a896664fd61440db_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52c971ec763a42d9b277341a14ec9c55_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93472a617e4d4f6f9147a6e05189a34e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81f30efddbba4bc19c03af8bc5c7eaf6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4c8e11b66a049928373daa1783da6a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87efeddd90154654bf0692ac7c3a035e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd928a22fd08462eafd4359a764e5cdf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e68e85a40d74b498b0bb46dec072277_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic97698562fbd485a80018d02cce80260_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id068aa2a6fcb49d59dfae933d3a4da27_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie66e5cf3847f4ccbb705424a971759bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29f3ebca75ec4b5b92053285ea842b9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee6a6d175624d8c9cfc907e7bb82743_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55d13e25166e42e0b68e9e232828cab2_D20200214-20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-14</xbrli:startDate><xbrli:endDate>2020-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6566041abeee45e59cb8ea4c0287e489_D20200521-20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-21</xbrli:startDate><xbrli:endDate>2020-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2137fd0894d40d79052cb2714afe3e4_I20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7205067242fc4eb0a524f10be89aa910_I20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-05-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="program"><xbrli:measure>mrna:program</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>mrna:segment</xbrli:measure></xbrli:unit><xbrli:context id="ie1dc78c134c44ed99d6c12dca67dd5b3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie35d35ef9a724996964e8f367d178412_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib024df048b7a4866887eea7ae4717c0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i6112e1e86f8340e6bab6155f0e0c14fe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:MerckMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i662ae8da17484626ac7417cac28e5c33_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:MerckMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ed2d47d1bf04e3aa23981e0213f4b17_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:MerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99de0fc656f94330bd58911cad710714_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01b7a2e27528463b8cd957d79fab92e6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28e4b001726a427395f0430b3d5fa7c3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3739e5568de9403ab6f1602f4947f2cf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58174bed8d7245f089be80163f527519_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:VertexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib97f41aa68a0406294fb319c1cc8c64f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:VertexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f19d573adc242b8b4b58f70beb853bb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:AstraZenecaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16562820b2134dc09272d9b7168eea9e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:USGovermentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i603a16907cb440afbec844ba69c28bce_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:EuropeanCommissionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d64ff60176946838aa93ccb8d36219f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:UnitedKingdomGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc33946b21844fddad6112c90f37042e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:SouthKoreaGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d723b3d7ee4498a8404a7814a0df9d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec2caba51ae04f34a09ef377a92c70a0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30999b30a90f434baeec1c4aabafdfc4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6025964d375a48f6b8048f71aa7069de_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ab4195256a147e9aca2014d6016eea5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic83f219ce3544b4fad28aa2afd18bf74_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89a7968116c24dfeb8928db01baf0eb1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:EquipmentAndLeasedFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0be93c00c40a4fb988eceb1c1a2692d9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:EquipmentAndLeasedFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6805eb08d3d64693bd8d92b3308b8e5a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:EquipmentAndLeasedFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0ea47aa0744431696869108e3c2ba80_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84920da0b3254bb3a9cda664635471b7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i388d1c703c504e9b9dab1f15168e6519_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9725be67d18a4c3bb82d57ad987d47ea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc74a29947d5452483558254ae2b1c81_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75fc0823bd854f9eba408cdefffe8ccf_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:DefenseAdvancedResearchProjectsAgencyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1df42e92dce49dfb7a34fa78d50f687_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:DefenseAdvancedResearchProjectsAgencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:ContractOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i013d6d10db654139a2efe361d808fc22_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i131a90691cbf4509abc1ae852ebc77cc_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb1114d7eef04248a3529921433f9c96_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91dd2c660e24460ab55f89af07de6dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1cec659c0ff4e069c4d60941677a150_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f900a7ac5af4c7da858cc85cc212124_D20160901-20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-09-01</xbrli:startDate><xbrli:endDate>2016-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contract_option"><xbrli:measure>mrna:contract_option</xbrli:measure></xbrli:unit><xbrli:context id="idba3a03acc0e45d5b9787c6de18eadbf_I20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2016-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie67f5391576f40369296654a31490551_I20160930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09c0c94594384d508f37a19a6c34c6a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:ContractOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1388a9527fb94a0a94fd4c620dc0bf17_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:InitialProjectMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:TheBillAndMelindaGatesFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d3ffcdb438747aa92be0aff3569a9ea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f1e8cedd3d64700b24c4e5f95a07fb2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2aac197e32f541178c0c0244356b6ee8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79e42df5da2b4678bbeea6e37c176ab0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:OtherGrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b76250e8e294bbdafee9c7d09ab09aa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:OtherGrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddc387885a1442e094e4ff923606bbf5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:OtherGrantRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5e6e85bd35c473b8a7fdfa429ebf3f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61596579e2804716ad9472fa52f24629_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaf02eddcdce45c9a3a94c51aaddfac8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb86376d0f446bb9527bead47b3f38f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfe5c56714774f52b2aa95484fa4c6cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CustomerDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i020daf53fdb84218b934041c4093d253_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:MerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie25766984ddb4900bc05c8dc1bcfe74d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:MerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57e78373a7b8469dbf68fb0f27cf0e87_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:MerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3c14a44a694301afc3fd745de06dfb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:AstraZenecaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib00cb507390f4481b30f9a19ccb9a5ac_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:AstraZenecaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16f428a3385e4f1ab1b775e48d93928f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:AstraZenecaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id39e130ad4a04ca288880a568ba61402_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:VertexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e9ebd18dd5147d1b84a636c49ed2357_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:VertexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ed1066cb22949e185aa0a6400e44041_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:VertexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4c1f58ac26245b49538b03723bb287b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e4582eea62043cc8c8a909446feda2a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab0e4014c3ae497f8257beaa2afdf2a3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc83b7e084b64944bd3c55a3664b6afa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e257e74e0c3417fa2d62c019e175efd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25d6ceefa0dd4987937b280087546df3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca78eb83d214ed796eefd75b65d5178_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="option"><xbrli:measure>mrna:option</xbrli:measure></xbrli:unit><xbrli:context id="i2866ce13b20c40499ee0ef2d3eb66afa_I20140331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae12a04f8a584ee1b88fb30da6f6e7c9_D20130301-20130331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-03-01</xbrli:startDate><xbrli:endDate>2013-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="milestone"><xbrli:measure>mrna:milestone</xbrli:measure></xbrli:unit><xbrli:context id="i3264926a036f49368bfd0a6e9404c012_I20140331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:DevelopmentMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0b34986f0674c9ea594d332b1f04fb7_I20140331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:RegulatoryMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id123e88b9869491798632873fce6c3a9_I20140331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:CommercialMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fae7e79285f4982b083cb9c1f4fbd5b_D20130301-20130331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2013-03-01</xbrli:startDate><xbrli:endDate>2013-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82bedeff4e8442618c0111343837f65b_D20160101-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id653faf9397c4b2abf5814a5f812a2dc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:VEGFAProductAZD8601Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ce35496660e4fd3bb2b5b20d645ce3b_D20160101-20160131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2016StrategicAllianceWithAstraZenecaIL12Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cbf12bb2be14e679beb021ee4ab6155_D20160101-20160131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2016StrategicAllianceWithAstraZenecaIL12Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d91300ccece4f0cb4993ca5f2e28e76_D20160101-20160131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2016StrategicAllianceWithAstraZenecaIL12Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68a34211294a4d41b7ae0a74e31673b3_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i458bfc4f6b6645b1ba08bf68c4e3c5f6_D20180601-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i839376eae85647209c7ffae9f8bb94d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2c30c2931b74241a4573d9b7e0a96f5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fce5c39376648a1885a52fda585e94e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:SublicenseReimbursementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i508d8e428eb4465394a0583607ec486d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:SublicenseReimbursementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a4f3ca9cebf43ce90d2496d447b9d8e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:ToxicityMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b49c52ea5674daf9ac712e3b8b21e47_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:ToxicityMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4df3ae247d504d6a89d97300985f10bc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:CompetitionMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic84bc8dd652f4aee96a5499bdf3e2474_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:CompetitionMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54988c4872c9499ca5902c5f6d9c7c25_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:EstimatedReimbursementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5ed97867924e718b4bd2e71e3b5a48_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:EstimatedReimbursementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i978a4c28e8214a16a5f021fa271e26f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac8e23e6e0694998b8904230abbb17b4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c28ae9af89f4befac5f089672e301ff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i018ccef08c534dd986a7e677e9da45b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:Combined2018AZAgreementPerformanceObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10f35a20934941e3b6fbe7ba24038ed1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:IL12PerformanceObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b8c03d227d64183b38b465e3aef9678_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:OncologyDevelopmentTargetPerformanceObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46fb7b59b5374455b1a475b17975fd25_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6304d23321e4e298da2bcf056211316_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9441d23013f14c83988a31bdbb559231_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d71f32e33e84216807274b731bdc696_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2028-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7507c06b17446d99769c50840782858_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aebca79df0b494194b5d4203b40878c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52cf8a74cf0b4054bf102b486d8851d3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96c0d1d3251a406d91ab4e10d74e2798_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:OptionExerciseFeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2b94ca2170140ac9a033fe7b05c864e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:OptionExerciseFeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb5a3ddf94f642219ac0a81b3fe95f50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c7086629714161b7f3158a965fcc28_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib86c1e0cb5a249f09dfbce827ef9dbc4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:SublicenseReimbursementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b95e1b3c41e4258bc74f50fafe6fb06_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:SublicenseReimbursementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadda166c80e447af92ff77e10772827a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd9e8d4a63f54baaba0b4b5ed1d455ff_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id54b6e3f162949438276b86a988013e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic177577240b14353b1e60187c3076a64_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3d6d1acafe2472e83a08aef3a25628d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:VariableConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f6399c8db0840dc9f38f108c60c920b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if79cc9521a4944dca9685e052deaf802_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i356a33ce286d48cca156527df59d429c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i563f38b3693b4356b6ea8f9fe73e7167_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdc3067fe5e145fe9f1452bcdebc7ceb_D20150101-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f08b25f930848c1a69931c8014c2742_D20150101-20150131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7359b975668474bab9835c2035fd8dd_D20160101-20160131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e4bfb91e3734bcbac49d735fb9839a4_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae641b44702e44228c65d680d89234fb_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a11405a9cb548088dc27731169c33c3_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56cc782d9cf240ab9de511487fe001b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaedcaef95a2f47b299253a6c24982262_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0212b2f2863143b0a038e34ad03323de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife317ed77f384b109eae0a11e402500a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b94988b255b492ab10c9199f363efe2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i018b2aab0ed44437b6b42610898fd072_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bfd65e4ca8b47f6a09d780605125913_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7561834c28344ed5a15e15ffa2d94708_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i316e60df5f6843bf9f30bdcae4453017_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia449e79cf2a44014b2511df73272f527_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckMay2019AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i392a2394213c44f893b9b592d6e59b88_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckMay2019AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51ff27e4a88e4237b3e19f6822bca430_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckMay2019AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46a1cdfdf44f41ceb9bb274d0f145355_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0395a7348b444ec48cc30fa685878865_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88da5e4006934b50a0e65f87903ba7d4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1acf7d5970e4063b3ec0293575fe05c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:SeparateAgreementsWithMerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i624e4ab60a804616a11ab12b4aaca0b7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:SeparateAgreementsWithMerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8350b0070d0a4021b617d51d1237f6e8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:SeparateAgreementsWithMerckMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16fd06682d81475283857811586f4079_D20160601-20160630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-06-01</xbrli:startDate><xbrli:endDate>2016-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3347a1fc6b94f67a83914d66ec9adbf_I20170630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0cd83a6a1924769a19a58e5f11bd212_I20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:PersonalizedMRNACancerVaccinesProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic50bf5d952c24703b46068d51770fec8_D20180401-20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d5048c0c1ab41668db8aa8a13a9f01d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia61f19b469e44cc391bbf2ed9db3b35b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ad30b16714046c3b761def5ad1ec930_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd817774a25a4b54a5e146a36338e853_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i791028eb61c741c0b0bcc8de949523e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ClinicalSupplyReimbursementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c48a89440e425d8cdcde9fe46e6f1d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ClinicalSupplyReimbursementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie979852e105e4bda87e75d94f1fc565c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie517b85a81b14dd1be0f4552d417c47e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3a8ffa0085e4794913a1deaa0b73f5d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ClinicalSupplyReimbursementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf670da31cdc46a09101eb0c8678cac6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:PCVPerformanceObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6260d9dece294c47adb143dbae8f22ba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:KRASPerformanceObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfe0cd89ae6041918c135184fa183ddb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i340827b3da36421394e5bd54e37ccfea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf3efea2a5d54653be9c2285642a667c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i950a1adc46aa45c28b3349f86c2a031e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i981f59fd40474c90ad61c969280172a6_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5499e80adfa6472b9e1528ab0f94b167_D20160701-20160731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="extension_period"><xbrli:measure>mrna:extension_period</xbrli:measure></xbrli:unit><xbrli:context id="i3f8781fcff4e440a97e13c637f9373b3_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:DevelopmentMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42f4b3b0fa0d4f57b37d2a96d63f003c_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:RegulatoryMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f178b19838f48b4914e2694d3057ea7_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:RegulatoryMilestonesSubsequentProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6a88a9c14d2404d970ffdfe239ee718_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8af61d149a74aa9bdde3e7ad4d3907f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb6bc087a0004b3e8507b5cc459cb4d5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ResearchAndDevelopmentFundingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id85fae767ef44643861725eb10c2ee6c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cfd6d8a963b437fba39ba94ab400b91_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15c73ffb7e51425da60d278c68eae95f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ResearchAndDevelopmentFundingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia11a3663e67e45c08dd00fe0f20b964b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd261966c1e44f1db6dc2b1efb265428_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ResearchAndDevelopmentFundingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie02f591019054030b611751b6c248c94_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifea86eb2da07419ea798ae719f81a8f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib894739b97434938997c5f99e78f77bd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d7dca1d4c4c4b9686df22df24888acf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5feaa13311494f2aad81d49c0f29adec_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e076d5d4a504530950dfa10765531a3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreement2019AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0acd16de5695440eb15012080a75bb86_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreement2019AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381c45f95fdc4c6cab91ea05c8184f74_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreement2019AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3f73020d7f8417cace85905171f5d06_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0d1ada6b97646e1811da4767837e43f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6a738901f794f2c95c70ed3d3ed65fc_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0798e7f1beab411290adc80b49b4a243_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreements1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e5b4776d84349f68d1f905844a0195b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreements1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie80373ee84ee409397695d20d023b830_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Vertex2020AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d3d81698c934b4a954d49e51245e401_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Vertex2020AgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdbe7e517bf742fb984721f52fab2d8d_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Vertex2020AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib95741ea249d4f97a45a3892a2351840_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Vertex2020AgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ab2427a6c084cf9af1c48d8c688b9d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifed27586ee884f47a07d016946f33a60_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8c83ee462da4e3dba463ddbc3ee245b_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d5a04ae7ee4c9facb541e95a628feb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8775b14ae8d42ba85896b375b513e87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ResearchAndDevelopmentFundingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6671830e11c43fa9c3834eab410c9a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7916b94daf6644a1ac5fd27053af9d56_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ChiesiAgreementTransactionPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i927d619ab07840569348f4a56e6f7fd9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:RemainingUnsatisfiedPerformanceObligationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i485a222ab1ab4c8aac1f1cbc39e1b10a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f291fa3ef94d0986838b93d6b8a9b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaa6defda34a4c4d932f1760b89de1bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99a06be594a943e1a989839f0ffb78dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0f3f6d0fe374c3bb4e9274841921099_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0721e19a82dc4039bc8fd234b6cb6467_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f82068d4e014cd3b0ee0ee048db1dfc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id80775b1abbd4c83a0c7b6a0f1187d02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6823e77a4aea4168b1bc6bd432b8c5f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39aad2a193424f66b1a29c5062031f07_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i996f146052f5425ab4c0c71f5c174fa6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef0d3913fd548d9aae035caa234d06f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i964440db25964be9b19c02aff5c46eef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2120d892fa64041a731353e8cb520f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7947068ef4b140cb8095b9ed2268d8ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f339cc94e424df7982cd710e1c8fbcf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie57495990d1840ab8a3259591e49318c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i571622ed8ff84fac92fa646c065d9071_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dee05d95adb41a4a76b2b9fe164e598_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76e8315a6df54be8bfc95f09f6f3034a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fcf3aa943004b48b99acf53c21041eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide75e7fae914434e8be15fac3dd2dfa1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie142da5d5a7142dfae28d3de3b0a7398_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6a6eab513bd479c8ee7b20cf6c72b5c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85f6292c70ae4905b5aa94e6b6388d63_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5deec5b143314f2491823db42ac2c318_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf5b8160d74845bcbadcdc11cae28b39_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8d8c21441bd4fc3927d70eb5b4e9cb0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e09bdef5a344ade862de02fe62cbd4f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5711c49fcbec48988da71f366d87842a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i595f9f5c7de04040938f423373395fd2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib098be9e25b24dd6963f1bce92ec3842_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8337e774481849ea898503604f8098ed_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c6c58de542642c998e43061db878c5d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56140fc5415b465091fac71874a1d04c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3679a9fffc96449eb191d1d92e564cb9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f97faca187a40e7932e5f1ed655d0e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33126ccd28674b319b0f542852efad14_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9134c7c3c5e41aaad7c846573608b98_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0cecee608c2404fb5cd0656311e9766_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia40c55509686422ea2a7aeb0800b0708_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94845de97f3740f29eb21f83595555aa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82ef8a8f960d4586b4b70315e91428ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i537052846af24b89bb148e79200f55b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ab59ae2ae3446928c5af56bfa301632_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1643b608a454ba48f175331a4403c94_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>mrna:security</xbrli:measure></xbrli:unit><xbrli:context id="i8b335d06520e4536aa8cb118383a9e23_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6ca9dac78c340bba06590609c9470cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f78c3ac89654cd9b1f1e7b8bc2a2df3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b7c40b209f7432bad8109c7ff3676d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8568db59e98348d5b7ca8485856bbd75_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d25a112fd9d498c8f8fea65aa96a2b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cf18fd57bb2482194f59b63056872c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c2ec2379a2440c98b39d472944fc58a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd8faf6c9e064166a193a079404e5f6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i415a12cbcecd4182b9b75a85618710ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f50ef9dcfe04ebd9ffd657cbf135f93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddd4aa81b7a24685aff1379ef5b70952_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d497d05b06c42e4ac9fccf950c4da8f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice8d50a6d09a405c9102e4f3dd28be53_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i435ec70bb8f44c8f98a7c85f98319563_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac8874c6a20b43398d1ddc844bbce921_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff0406894b54724bcaadabdc19dd9da_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2404bad267f4f3e822b71ad8835e7ce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a45bbb5f0fd487aa6bea47688234221_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93edb11d678e409e93fec11af2f7d699_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic32def168edf4442a4f6912414e3f4bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icac57ca879c546568a22b09873f17e85_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee48996722c54941b70a1cc762872f9f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48df454a47ab493e9a020ee1d9e830c1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7803fa02ca4547a9871f8bdeb3407587_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if68a771f3e9646a3af1d44b31f4770c5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4bbb095206742338a02ee9ddcc36c12_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04c7af5cb0944a609bc48c18ac1199c8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79bfa2998ec14f64b6ac249d9dba29fc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17d27b5a687e47f0b3b24ad613e488ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia68a26c9b80a46b89ff40f182120a6bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5b8e9cfd6ca448aa701acdac947ae5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee04f0bed89c49668441e99337b4c6e9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40944c7d8d6941028b74d51f0012965a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7f1f6b5edb444fd9d4b39047aec17fe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i029097fb98da493492487f2642eaca98_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9baf6f70a62949e58d3e834369eaf15d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7599583c04c4bb2b5065bb8e0fcccac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfa4e9080e444a89ba97d4bb414498ec_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7293e7dd6fe468bbf9ea8382a321117_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a3475829320460094cd0d1af2b0eb08_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i931a0fc9cb324f33bb8472be6674ba39_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:FinancingRightOfUseAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f4deb71bcf6418281042297367c1bea_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:FinancingRightOfUseAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9127d9980c58485bb596c9f9c0fe40f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ec608e56a914901a6ad79ac5be09f26_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc80cc31c16d4bb5b781ff93fa778e3d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a5ca8f57aed41fd9ba65d7a8eb8066c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82530c9d21864e758383518f41158ccf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee1f1d3a45314f5a8987999269779a3f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="campus"><xbrli:measure>mrna:campus</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="ibbcec80ae49c4b8286395ec88c10e2bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:CambridgeMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i620a2c29a9454e86abf8ee51f8558fe7_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:CambridgeMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:TwoHundredTechnologySquareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c54db761b0740ec8aba56ebf889d996_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:CambridgeMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:FiveHundredTechnologySquareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf6426583a4543de9fc96eca2bc03260_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b968f2e54364ba8ad58961ced8da02e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e728091fd7b4fddbe99aa3980407db5_I20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCNorthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i028772f3641244bba3f25ec35843b217_I20160831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:OfficeLaboratoryAndLightManufacturingSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i266a5c7f3c4d4becbe194489fb7a115a_I20160831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib99c6b4909974f38905c833f846083b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">mrna:EmbeddedLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i313b37fa8a694900aaf4a540ec5403b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:OfficeLaboratoryAndLightManufacturingSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f36d10d97c04db1b365a25391679774_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCSouthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3832eb52624b426797a221627ead873a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCNorthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1441021944924f86873ecc11207adf0d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:PersonalizedMRNACancerVaccinesProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2ffbac081c347a18476291631b1325f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:PersonalizedMRNACancerVaccinesProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62af6315d0994091a5ee85593def32e7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia470ee9b9d754ceeb6681190f52793c3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>mrna:claim</xbrli:measure></xbrli:unit><xbrli:context id="i3ea7b5505cee487fbf7be94bf6d55f95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i794421bf0a8e43a3a51997f49bc8dcb8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c7e100fa92b440a8d435619ce329b08_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">mrna:SupplyAndManufacturingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1170ecd035af4400a71afda6f522a17b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">mrna:ClinicalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b6cf5372b6e431587c7ba23a440fa6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">mrna:ClinicalOperationsAndSupportCommitmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61eb580f6c4e4674bede2f83be700c34_I20170626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:TherapeuticAndProphylacticProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c3c86543acc46e2b8b0c2c0de911ca5_I20170626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:DiagnosticProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e99c6608c7941008ec26bef45112da4_I20170626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia945c15292e84282b614fb94308ea684_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:SublicenseAgreementTermsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica4a9c0275b4439ab3a5bc61a47582f7_I20180228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8e4c8c0f7b04ed7b492b9f6c973bbd6_I20180507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-05-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if52ab1a643294862862c0ab9475e5fb5_I20181211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied8820941801441bbf695baf84bd4408_D20181211-20181211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-11</xbrli:startDate><xbrli:endDate>2018-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0015b9f558545eb8bbce9a072884272_I20181211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i817a91b1df304d8db9ad7e21b92c6d5e_I20181211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11303c4705d14f9e9722ef0609332f64_D20200214-20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mrna:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-14</xbrli:startDate><xbrli:endDate>2020-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d8ab51d966d48869f4a4a2010e84ff8_I20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mrna:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4562f74238f400d8605ac78ea70d681_D20200214-20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-14</xbrli:startDate><xbrli:endDate>2020-02-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafc11244cc12496099eda35772ccd636_D20200521-20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mrna:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-21</xbrli:startDate><xbrli:endDate>2020-05-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55700871828341ecbb850efa2faf67d5_I20200521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mrna:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c6d0348fa0f471c99e4a3d4fb593b39_I20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:StockOptionAndIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i262a8b76871743d192c168dbbc78eca7_D20181130-20181130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:StockOptionAndIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-30</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icac42209a69c4d4faecce8d9ec2c954c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:ServiceBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94e125ac24d548f7bcacf7258fb26f5e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:ServiceBasedAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>mrna:installment</xbrli:measure></xbrli:unit><xbrli:context id="i456564aebcd9408998fe415ad2b5746b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:ServiceBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94765e821a9d4db08f74e0976fc741a0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:StockOptionAndGrantPlan2016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifce35912e3be4df98cae3575af43d851_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28ea496c05f042ce8f74e96e04f6dc1c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:StockOptionAndIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a2b16bb22614c61b08450535a865c3a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4807ee8256114040874d647a3a407087_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf4921fe189a4bb3adbffaca20a7ba53_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4793fdc04065442a8c634bb5b8ed5276_I20181205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:EmployeeStockPurchasePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="offering"><xbrli:measure>mrna:offering</xbrli:measure></xbrli:unit><xbrli:context id="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:EmployeeStockPurchasePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-05</xbrli:startDate><xbrli:endDate>2018-12-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="purchase_period"><xbrli:measure>mrna:purchase_period</xbrli:measure></xbrli:unit><xbrli:context id="ieceb0f5d61c741e2ae79714848077fc6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:EmployeeStockPurchasePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic81d102f7ca14bd6bb17285971aa99df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:EmployeeStockPurchasePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f14ad75477c466dafbb2d98521f49c5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:EmployeeStockPurchasePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab7b67e811134bd584fb576d6e749803_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8ea87e5e7834335be8ba996294292fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc50b13e4114cdeb9dfbcfc004a74de_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iade5b4d11372466e90c1c179f3b5ac9f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38f16929f2a54250afa6263ffee43aa1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cadb2afe3df43fe8cacb9af45694889_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa289361628e459292558aa0cf78cd6b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:RestrictedStockAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id16aba6da7f64bd394030c96c373b2de_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:RestrictedStockAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea322dace75d448fad9eea135238af31_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:RestrictedStockAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d492fe3077f4edc95bfea38191dbe14_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b7796d6fc41467489873be3464c5281_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b394cfd73114e379da638593c59398d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i205ef00a043d47539d12683bf81d27bf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d40e479571a447ab799a9e823712900_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f343e6d4c4743d787e7ead6fa87139f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a3afd2d01d4284ab41f3b52d9d7bc3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie37236e25e6d4e2c8a87336c27d49324_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i249101ed25324c3c8d67aab92ad128da_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bb1304918df480cb950ea6c29a15615_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic351569ed65f40cab21d97c586306914_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85f3c831978247f8b69404de24b90b66_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c241daa0d5241ee9eed136d8c0fd4be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdad93679ee44415aefdf2bf5e771d19_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icee62dcd4e004b8681b4d520ee487a52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">mrna:FederalOrphanDrugMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f5c4be154334b0e874859f16c0dfa3c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:InvestmentCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51dd4a3f885044ac854c50b598512881_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i824d33d947634253bc2e12c49e671633_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e245ef509484130ac56ee0f5b6a622b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i240d1607bdb54d38918d10a2e1bc9173_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i707c59ec394d4425b93e15c1605fa977_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i224ecb912e2c48888f26b7e1cc4953dd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic87bc10f44de4145997be66dfd27f93c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie596a0c92b8647369ac2d14e1396ef36_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f5a8fda25cd4c74af63d87a7168e3ab_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69d8b71e26964171af7d0c08826cb641_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27c2ab469153406c91a205c6ac53f02f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14039f4ce16942f3a4976f3e56714742_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7733c373247646ffbbaca5983877f101_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id776b0bb1d8b431e96ac4e765df020ad_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibba4dc7e26f542198f1a60b6226271d0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="dose"><xbrli:measure>mrna:dose</xbrli:measure></xbrli:unit><xbrli:context id="i9ccdf2dca2df4aa3a9aece1c6399177d_D20210101-20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia03ce25e1fdb4153b6baf85bdb6588ef_I20210226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="numberofdose"><xbrli:measure>mrna:numberOfDose</xbrli:measure></xbrli:unit><xbrli:context id="i9483d986200a4cdfb7e88b336fd9711b_D20210218-20210218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001682852</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-18</xbrli:startDate><xbrli:endDate>2021-02-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:3.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:0.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:0.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="margin-bottom:6pt;margin-top:0.35pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:10.968%"><tr><td style="width:1.0%"></td><td style="width:56.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FORM</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6NmU5ZjIyMTAyNWQ0NDZkNmI2N2E4NmFkZjUyMWIyOTAvdGFibGVyYW5nZTo2ZTlmMjIxMDI1ZDQ0NmQ2YjY3YTg2YWRmNTIxYjI5MF8wLTEtMS0xLTE5NDgx_abfc3a0c-be4d-47d9-b948-39ddeb58b13e">10-K</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3.5pt;margin-top:1.55pt;padding-right:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTQy_575a7296-dd66-4aaa-862a-965cdf28de8c">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:0.7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTcz_6ae5696f-f10f-4e19-a286-d9cc7cb67e53"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTcz_a4936430-f0f6-471d-8773-850109d5a98f">December 31</ix:nonNumeric>, 2020</ix:nonNumeric></span></div><div style="margin-top:3.4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTQ0_be20ff9c-f8c0-49da-904d-7224a75f47f9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from _ to _ </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTg1_f38e1578-c01a-4372-a112-280eeab45fec">001-38753</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g1.jpg" alt="mrna-20201231_g1.jpg" style="height:48px;margin-bottom:5pt;vertical-align:text-bottom;width:212px"/></div><div style="margin-top:1.35pt;text-align:center"><span><br/></span></div><div style="margin-top:1.35pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTg3_68a6a506-d024-43c6-9cc1-31b78b587f5c">Moderna, Inc.</ix:nonNumeric></span></div><div style="margin-top:0.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="margin-bottom:6pt;margin-top:0.5pt;padding-right:15.75pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.831%"><tr><td style="width:1.0%"></td><td style="width:32.798%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.103%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8wLTAtMS0xLTEwMQ_1ceb0587-c528-4f4e-bd82-61a9bd8cc851">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8wLTItMS0xLTEwNA_281b9fca-48cf-4e72-a395-8e00f3a59a9f">81-3467528</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation or Organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8zLTAtMS0xLTMxOTUvdGV4dHJlZ2lvbjo0NzMyODRlMWJlZmY0NDAyODgwMzFjYzg5OTZlMTczNl80OTQ3ODAyMzI1MDYz_5ed87354-6278-4c42-93ce-11a5220e694b">200 Technology Square</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8zLTAtMS0xLTMxOTUvdGV4dHJlZ2lvbjo0NzMyODRlMWJlZmY0NDAyODgwMzFjYzg5OTZlMTczNl80OTQ3ODAyMzI1MDc2_c47226cc-de56-48e8-af44-7569a45a8816">Cambridge</ix:nonNumeric>, <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8zLTAtMS0xLTMxOTUvdGV4dHJlZ2lvbjo0NzMyODRlMWJlZmY0NDAyODgwMzFjYzg5OTZlMTczNl80OTQ3ODAyMzI1MDky_f1f932c5-1076-4047-b5f5-20c4f35b248e">Massachusetts</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8zLTItMS0xLTEwNg_74f8f363-916c-4aab-a76d-93cbed4d43de">02139</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3.1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTg5_05a54e83-ba63-4f25-a785-9d3815c122f9">617</ix:nonNumeric>) <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTkz_0223c42b-3a87-430b-9942-cea3d6c0fae3">714-6500</ix:nonNumeric></span></div><div style="margin-top:0.8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-top:0.8pt;text-align:center"><span><br/></span></div><div style="padding-left:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="padding-left:20.25pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:20.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:34.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6ODBhMzNhZjMwNWYzNGUzNGJlNzY3MmZmYmU3MjEzMDgvdGFibGVyYW5nZTo4MGEzM2FmMzA1ZjM0ZTM0YmU3NjcyZmZiZTcyMTMwOF8xLTAtMS0xLTExOA_201a9630-0227-42e5-a484-c0581db96ddf">Common stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6ODBhMzNhZjMwNWYzNGUzNGJlNzY3MmZmYmU3MjEzMDgvdGFibGVyYW5nZTo4MGEzM2FmMzA1ZjM0ZTM0YmU3NjcyZmZiZTcyMTMwOF8xLTEtMS0xLTExOA_bc60701c-f6e6-492d-a818-8d55421f031b">MRNA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6ODBhMzNhZjMwNWYzNGUzNGJlNzY3MmZmYmU3MjEzMDgvdGFibGVyYW5nZTo4MGEzM2FmMzA1ZjM0ZTM0YmU3NjcyZmZiZTcyMTMwOF8xLTItMS0xLTExOA_b6b34bc3-ddfb-4e27-b970-fda3ff372564">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:20.25pt"><span><br/></span></div><div style="padding-left:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">None</span></div><div style="margin-bottom:6pt;margin-top:1.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.      </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTk0_b69daacc-3c68-40d5-b279-bdb315e249ed">Yes</ix:nonNumeric>  &#9745;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="padding-left:20.25pt"><span><br/></span></div><div style="padding-left:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Yes  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTk1_6abae281-6f19-4031-85ef-a8eff95a4017">No</ix:nonNumeric>  &#9745;</span></div><div style="padding-left:20.25pt"><span><br/></span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTk2_6f84752b-8ec3-4344-919a-3b0dbb94fde7">Yes</ix:nonNumeric>  &#9745;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTk3_63d985cb-3763-48e2-9433-b32a058a94b1">Yes</ix:nonNumeric>  &#9745;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:1.2pt;padding-left:9pt;padding-right:33.75pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt;margin-top:0.05pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.366%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.369%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MTk3ZWY0OTBhZTE5NDY4ODk1ODJkMTBkMGVmOGI0YmMvdGFibGVyYW5nZToxOTdlZjQ5MGFlMTk0Njg4OTU4MmQxMGQwZWY4YjRiY18wLTAtMS0xLTUyMzkvdGV4dHJlZ2lvbjo5NjNmYmFlNDQ1MDk0MjY1YTU3NWJhNzZiY2FjYzBmYV80OTQ3ODAyMzI1MDQ5_96309af7-5c90-41b9-abfb-fea15d6dccea">Large accelerated filer</ix:nonNumeric> &#9745;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MTk3ZWY0OTBhZTE5NDY4ODk1ODJkMTBkMGVmOGI0YmMvdGFibGVyYW5nZToxOTdlZjQ5MGFlMTk0Njg4OTU4MmQxMGQwZWY4YjRiY18wLTYtMS0xLTUyMjgvdGV4dHJlZ2lvbjoxN2MzNGZmMzVhYWY0Nzk0OGE0ZTZiNWU2OWNiNmU3N180OTQ3ODAyMzI1MDI5_59c8514e-db07-464c-a9dd-3171567c851f">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MTk3ZWY0OTBhZTE5NDY4ODk1ODJkMTBkMGVmOGI0YmMvdGFibGVyYW5nZToxOTdlZjQ5MGFlMTk0Njg4OTU4MmQxMGQwZWY4YjRiY18xLTYtMS0xLTUyMzMvdGV4dHJlZ2lvbjpkMGM0YzA0YzEwZTk0ZDQ0YjMwNDQwZGYyMzg3Yjg0Ml80OTQ3ODAyMzI1MDI3_350a38a9-2384-4423-ab26-22dab21c86d8">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-top:0.5pt;padding-left:9pt;padding-right:33.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="padding-left:20.25pt"><span><br/></span></div><div style="padding-left:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Yes <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN182MDQ3MzEzOTU2MDkx_47c7f1ca-8fe8-4294-9618-ad8bb0164f50">&#9744;</ix:nonNumeric> No  &#9745;</span></div><div style="padding-left:20.25pt"><span><br/></span></div><div style="padding-left:20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. . </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Yes <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN180OTQ3ODAyMzI5NjUx_1f17d0f6-5558-4f9e-bc3a-befce24d86d8">&#9745;</ix:nonNumeric>   No  &#9744;</span></div><div style="padding-left:9pt"><span><br/></span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of June&#160;30, 2020, the aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="ie96a43c24f044f688f10c58ea55f7047_I20200630" decimals="-6" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN18yNDk2_b087c29c-65d1-4415-9d44-df47aef9a28d">25.25</ix:nonFraction> billion based on the closing sale price on that date of $64.21. Shares of common stock held by each executive officer and director and by each other person who may be deemed to be an affiliate of the Registrant have been excluded from this computation. The determination of affiliate status for this purpose is not necessarily a conclusive determination for other purposes.</span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span><br/></span></div><div style="margin-top:0.05pt;padding-left:9pt;padding-right:24.75pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of February 16, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i71c171ceb13145969aa0a46d90bf882a_I20210216" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN18yOTAy_43eb47fd-4cf9-4e72-a215-cd1fbbfef78f">399,769,582</ix:nonFraction> shares of the registrant&#8217;s common stock, par value $0.0001 per share, outstanding. </span></div><div style="margin-top:1.5pt;padding-left:9pt;padding-right:9pt;text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTk5_fa108de6-9fce-4776-a13b-7783e846cf5f" escape="true"><div style="margin-top:1.5pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:1.5pt;padding-left:9pt;padding-right:27pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s Definitive Proxy Statement relating to its 2021 Annual Meeting of Stockholders to be filed hereafter are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:1.5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1.5pt;padding-left:9pt;padding-right:27pt;text-indent:11.25pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.15pt"><span><br/></span></div><div style="padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">PART I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_16">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_70">101</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unresolved Staff Comments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_73">162</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Properties</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_76">162</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legal Proceedings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_79">162</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mine Safety Disclosures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_82">162</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.2pt;padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">PART II</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 5.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_88">163</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reserved</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_91">164</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_94">165</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosures about Market Risk</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_100">181</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial Statements and Supplementary Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_103">183</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_205">240</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_208">240</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_211">241</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.2pt;padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">PART III</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 10.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Directors, Executive Officers and Corporate Governance</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_217">243</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Executive Compensation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_220">243</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_223">243</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certain Relationships and Related Transactions, and Director Independence</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_226">243</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Principal Accountant Fees and Services</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_229">243</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.2pt;padding-left:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">PART IV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 15.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibits, Financial Statement Schedules</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_235">244</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Form 10-K Summary</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_238">247</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Signatures</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_241">248</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:0.1pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF THE MATERIAL RISKS ASSOCIATED WITH OUR BUSINESS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties that you should be aware of before making an investment decision, including those highlighted in the section entitled &#8220;Risk Factors.&#8221; These risks include, but are not limited to, the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">While we have received Emergency Use Authorization, or EUA, from the U.S. Food and Drug Administration and other provisional, interim or conditional authorizations from regulatory authorities outside the United States for our COVID-19 vaccine, we may encounter difficulties manufacturing. producing shipping or successfully commercializing the vaccine consistent with our existing or potential contractual obligations, including due to delays or difficulties experienced by our commercial partners;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We are devoting significant resources to the scale-up, manufacturing, development and commercialization of our COVID-19 vaccine, including for use by the U.S. government and other global governmental and commercial partners, and the distribution of our vaccine requires us to comply with additional regulatory requirements, including pharmacovigilance regimes that require us to monitor safety data and to identify, evaluate and potentially respond to adverse reactions to our COVID-19 vaccine;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The positive interim data from the ongoing clinical studies of our COVID-19 vaccine and the EUA granted by the FDA may not be predictive of the final results of the clinical trials, which is one of a number of factors that may delay or prevent us from receiving full regulatory approval of our vaccine;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our current COVID-19 vaccine (mRNA-1273) may prove ineffective at providing protection against infection by variant strains of the SARS-CoV-2 virus, and we may be unsuccessful in adapting our COVID-19 vaccine to effectively protect against variant strains of the SARS-CoV-2 virus;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our mRNA products, development candidates and investigational medicines are based on novel technologies and any development candidates and investigational medicines we develop may be complex and difficult to manufacture. We may encounter difficulties in manufacturing, product release, shelf life, testing, storage, supply chain management, or shipping for any of our medicines, including our COVID-19 vaccine. If we or any of our third-party manufacturers encounter such difficulties, our ability to supply commercial product or material for clinical trials could be delayed or stopped;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other companies or organizations may challenge our patent rights or may assert patent rights that prevent us from developing and commercializing our products&#8212;including our COVID-19 vaccine&#8212;or these rights may be subject to government action, including &#8220;march in rights&#8221; by the U.S. or foreign governments, which could harm our ability to commercialize our products or fully realize the financial benefits of those products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business may continue to be adversely affected by the ongoing coronavirus pandemic;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mRNA drugs have only been authorized for emergency use, or other provisional, interim or conditional use, for COVID-19, and there is no guarantee that any other mRNA drug will be granted an EUA or will be granted full approval in the future as a result of efforts by others or us. mRNA drug development has substantial clinical development and regulatory risks due to the novel nature of this new class of medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have incurred significant losses since our inception and we may incur significant losses again in the future;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Preclinical development is lengthy and uncertain, especially for a new class of medicines such as mRNA, and therefore our preclinical programs or development candidates may be delayed, terminated, or may never advance to the clinic, any of which may have a material adverse impact on our platform or our business;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Clinical development is lengthy and uncertain, especially with a new class of medicines such as mRNA medicines. Clinical trials of our investigational medicines may be delayed, including as a result of the COVID-19 pandemic or other pandemics in the future, and certain programs may never advance in the clinic or may be more costly to conduct than we anticipate, any of which could have a material adverse impact on our platform or our business;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mRNA medicines are a novel approach, and negative perception of the efficacy, safety, or tolerability of any investigational medicines that we develop could adversely affect our ability to conduct our business, advance our investigational medicines, or obtain regulatory approvals;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals, or if other regulatory requirements are introduced, we will not be able to commercialize, or will be delayed in commercializing, investigational medicines we may develop, and our ability to generate revenue will be materially impaired;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have in the past entered into, and in the future may enter into, strategic alliances with third parties for the development and commercialization of our products, development candidates and investigational medicines. If these strategic alliances are not successful, our business could be adversely affected;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have limited sales, distribution, and marketing experience, and have only recently invested significant financial and management resources to establish these capabilities as a result of our rapid development and commercialization of our COVID-19 vaccine. If we are unable to effectively establish such capabilities or enter into agreements with third parties to market and sell our future products, if approved, our ability to generate revenues may be adversely affected;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain of our customers for our COVID-19 vaccine prepay us for a portion of the product payment for the vaccine doses that they expect to receive from us, and under the terms of certain of our supply agreements, we may be required to refund some or all of those prepayments if a customer reduces its purchase commitment or if we fail to deliver the purchased volume;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will need to develop and expand our company, and we may encounter difficulties in managing this development and expansion, which could disrupt our operations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our internal computer systems and physical premises, or those of our strategic collaborators, other contractors, consultants or regulatory agencies with which we share sensitive data or information, may fail or suffer security breaches, which could result in a material disruption of our product development programs and our manufacturing operations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The price of our common stock has been volatile and fluctuates substantially, which could result in substantial losses for stockholders; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unfavorable U.S. or global economic conditions could adversely affect our business, financial condition, or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should consider carefully the risks and uncertainties described below, in the section entitled &#8220;Risk Factors&#8221; and the other information contained in this Annual Report on Form 10-K, including our consolidated financial statements and the related notes, before you decide whether to purchase our common stock. The risks described above are not the only risks that we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K, including the sections entitled &#8220;Business,&#8221; &#8220;Risk Factors,&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; contains express or implied forward-looking statements within the</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">meaning of the federal securities laws, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and are including this statement for purposes of complying with those safe harbor provisions. All statements other than statements of historical facts contained in this Annual Report are forward-looking statements. These forward-looking statements are based on our management&#8217;s belief and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements. Forward-looking statements in this Annual Report on Form 10-K include, but are not limited to, statements about:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our activities with respect to our COVID-19 vaccine, and our plans and expectations regarding future generations of our COVID-19 vaccine that we may develop in response to variants of the SARS-CoV-2 virus, ongoing clinical development, manufacturing and supply, pricing, commercialization, if approved, regulatory matters and third-party and governmental arrangements and potential arrangements;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, timing, progress, results, and cost of our research and development programs and our current and future preclinical studies and clinical trials, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work, the period during which the results of the trials will become available, and our research and development programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ultimate impact of the current coronavirus pandemic, or the COVID-19 pandemic, or any other health epidemic, on our business, manufacturing, clinical trials, research programs, supply chain, regulatory review, healthcare systems or the global economy as a whole;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks related to the direct or indirect impact of the COVID-19 pandemic or any future large-scale adverse health event, such as the scope and duration of the outbreak, government actions and restrictive measures implemented in response, material delays in diagnoses, initiation or continuation of treatment for diseases that may be addressed by our development candidates and investigational medicines, or in patient enrollment in clinical trials, potential clinical trials, regulatory review or supply chain disruptions, and other potential impacts to our business, the effectiveness or timeliness of steps taken by us to mitigate the impact of the pandemic, and our ability to execute business continuity plans to address disruptions caused by the COVID-19 pandemic or future large-scale adverse health event;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our anticipated next steps for our development candidates and investigational medicines that may be slowed down due to the impact of the COVID-19 pandemic, including our resources being significantly diverted towards our COVID-19 vaccine efforts, particularly if the federal government seeks to require us to divert such resources;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to identify research priorities and apply a risk-mitigated strategy to efficiently discover and develop development candidates and investigational medicines, including by applying learnings from one program to our other programs and from one modality to our other modalities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability and the potential to successfully manufacture our drug substances, delivery vehicles, development candidates, and investigational medicines for preclinical use, for clinical trials and on a larger scale for commercial use, if approved;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability and willingness of our third-party strategic collaborators to continue research and development activities relating to our development candidates and investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain funding for our operations necessary to complete further development and commercialization of our investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and maintain regulatory approval of our investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to commercialize our products, if approved;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the pricing and reimbursement of our investigational medicines, if approved;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the implementation of our business model, and strategic plans for our business, investigational medicines, and technology;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope of protection we are able to establish and maintain for intellectual property rights covering our investigational medicines and technology;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">estimates of our future expenses, revenues, capital requirements, and our needs for additional financing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential benefits of strategic collaboration agreements, our ability to enter into strategic collaborations or arrangements, and our ability to attract collaborators with development, regulatory, and commercialization expertise;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future agreements with third parties in connection with the commercialization of our investigational medicines, if approved;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the size and growth potential of the markets for our investigational medicines, and our ability to serve those markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial performance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate and degree of market acceptance of our investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory developments in the United States and foreign countries;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to produce our products or investigational medicines with advantages in turnaround times or manufacturing cost;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of competing therapies that are or may become available;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain key scientific or management personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of laws and regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments relating to our competitors and our industry; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other risks and uncertainties, including those listed under the caption &#8220;Risk Factors.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, forward-looking statements can be identified by terminology such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; or the negative of these terms or other comparable terminology. The risks set forth above are not exhaustive. Other sections of this report may include additional factors that could adversely affect our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time and it is not possible for management to predict all risk factors, nor can we assess the impact of all risk factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond our control and which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under the section entitled &#8220;Risk Factors&#8221; and elsewhere in this Annual Report on Form 10-K. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those expressed or implied by the forward-looking statements. No forward-looking statement is a guarantee of future performance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements in this Annual Report on Form 10-K represent our views as of the date of this Annual Report on Form 10-K. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should therefore not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K includes statistical and other industry and market data that we obtained from industry publications and research, surveys, and studies conducted by third parties. Industry publications and third-party research, surveys, and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. We have not independently verified the information contained in such sources.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE REGARDING COMPANY REFERENCES</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, the terms &#8220;Moderna,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; in this Annual Report on Form 10-K refer to Moderna, Inc. and its consolidated subsidiaries. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_16"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Business </span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_19"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THE mRNA OPPORTUNITY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">mRNA, the software of life</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Messenger RNA, or mRNA, transfers the information stored in our genes to the cellular machinery that makes all the proteins required for life. Our genes are stored as sequences of DNA which contain the instructions to make specific proteins. DNA serves as a hard drive, safely storing these instructions in the nucleus until they are needed by the cell.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">When a cell needs to produce a protein, the instructions to make that protein are copied from the DNA to mRNA, which serves as the template for protein production. Each mRNA molecule contains the instructions to produce a specific protein with a distinct function in the body. mRNA transmits those instructions to cellular machinery, called ribosomes, that make copies of the required protein.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">We see mRNA functioning as the &#8220;software of life.&#8221; Every cell uses mRNA to provide real time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. This was codified as the central dogma of molecular biology over 50 years ago, and is exemplified in the schematic below.</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:36pt"><img src="mrna-20201231_g2.jpg" alt="mrna-20201231_g2.jpg" style="height:292px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">mRNA is used to make every type of protein, including secreted, membrane, and intracellular proteins, in varying quantities over time, in different locations, and in various combinations. This is shown in the figure below.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><img src="mrna-20201231_g3.jpg" alt="mrna-20201231_g3.jpg" style="height:296px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our founding in 2010, we have been inspired by the belief that mRNA could be used to create a new class of medicines, with significant potential to improve the lives of patients. In 2020, mRNA technology emerged as a new class of medicine, with the potential to help treat the ongoing global pandemic. In the span of just over 11 months, we designed a vaccine against COVID-19 (mRNA-1273) using mRNA-based technology, conducted Phase 1, Phase 2 and Phase 3 clinical trials, which demonstrated that the vaccine was highly effective at preventing COVID-19, and obtained an Emergency Use Authorization (EUA) for the vaccine from the U.S. Food and Drug Administration on December 18, 2020, followed a few days later by an Interim Order from Health Canada authorizing the distribution of the vaccine in Canada. By December 31, 2020, we had delivered nearly 17 million doses of the Moderna COVID-19 Vaccine to the U.S. government, and several hundred thousand doses to the Canadian government to help fight the pandemic. As of December 31, 2020, we had committed orders for approximately 520 million doses of the vaccine to be delivered in 2021 to governments around the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success we experienced in 2020 builds on over 40 years of progress in the biotechnology industry. Our approach fundamentally differs from traditional approaches to medicine. Rather than introduce a protein or chemical to the body, we send tailored mRNA into cells to instruct them to produce specific proteins. We built Moderna on the guiding premise that if mRNA can be used as a medicine for one disease, it could work for many diseases. Instead of starting from scratch for each new vaccine or therapy, our mRNA approach leverages the technology and fundamental components that we have been researching and developing since our founding. By building off our prior research and learning, we believe we can improve how we discover, develop, and manufacture medicines.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our success in developing the Moderna COVID-19 Vaccine further underpins our belief that mRNA-based medicines have the potential to help patients in ways that could equal or exceed the impact of traditional approaches to medicine. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our strategic priorities </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our first priority for 2021 is to maximize the impact of our COVID-19 vaccine, both in terms of access and value creation of this product between now and the end of 2021. We are closely monitoring emerging variants of the SARS-CoV-2 virus as it continues to evolve and testing the performance of our vaccine against them. We are also studying potential booster shots, either of the existing vaccine or of a version that has been adjusted to address significant variants, as well as conducting further clinical trials in younger populations, with the hope of being able to provide the vaccine to adolescents aged 12 to 18 by fall 2021. Executing on this first priority will allow us to pursue our second priority, to accelerate vaccine development to advance our pipeline and bring new vaccines to market. In turn, this will make way for our third priority, to generate human proof-of-concept data in autoimmune diseases, cardiovascular diseases, oncology and rare diseases. And this will allow for our fourth priority, to continue to expand the use of mRNA technology to maximize the potential impact we can have on patients. We continue to believe that over time we will have a number of commercial products within our different modalities, which are described in more detail below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we announced the expansion of our pipeline of prophylactic vaccines with three new development programs: mRNA vaccine candidates against seasonal flu, human immunodeficiency virus (HIV) and the Nipah virus. We also announced our intent to expand our respiratory syncytial virus (RSV) vaccine program into older adults. We currently have 24 mRNA development programs in our portfolio, with 13 having entered the clinic.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February 15, 2021, we had received additional regulatory authorizations for use of our COVID-19 vaccine in Europe, the United Kingdom, Israel, Switzerland, Singapore and Qatar. We continue forging ahead with the rolling reviews of our COVID-19 vaccine that have already been initiated with several regulatory agencies across the globe and the WHO, which is important for obtaining regulatory authorization to distribute the vaccine in many middle- and low-income countries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The early investment we made in our manufacturing and digital capabilities prepared us to rapidly scale our production. At present, we believe we will be able to produce between 700 million and 1 billion doses of our COVID-19 vaccine in 2021. We are continuing to invest and add staff to make this production possible. We are also working on increasing our potential supply to up to 1.4 billion doses for 2022. Much of the production for the supply of the U.S. market will be completed at our Moderna Technology Center facility, or MTC South, in Norwood, Massachusetts, with additional production by Lonza Ltd. for the U.S. market. We have also partnered with Lonza to complete all production in Switzerland of our COVID-19 vaccine (generally referred to as COVID-19 Vaccine Moderna outside the U.S.) for markets other than the U.S. Fill-finish services for our COVID-19 vaccine are provided by Catalent Inc. in the U.S., and by ROVI and Recipharm outside the U.S. We have also partnered with other contract manufacturing organizations for the production of and fill-finish services for our COVID-19 vaccine, and expect that we will enter into additional collaborations as we scale production.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The structure of mRNA </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">Messenger RNA is a linear polymer comprising four monomers called nucleotides: adenosine (A), guanosine (G), cytosine (C), and uridine (U). Within the region of the molecule that codes for a protein, or the coding region, the sequence of these four nucleotides forms a language made up of three-letter words called codons. The first codon, or start codon (AUG), signals where the ribosome </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">should start protein synthesis. To know what protein to make, the ribosome then progresses along the mRNA one codon at a time, appending the appropriate amino acid to the growing protein. To end protein synthesis, three different codons (UAA, UAG, and UGA) serve as stop signals, telling the ribosome where to terminate protein synthesis. In total, there are 64 potential codons, but only 20 amino acids that are used to build proteins; therefore multiple codons can encode for the same amino acid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:113%">The process of protein production is called translation because the ribosome is reading in one language (a sequence of codons) and outputting in another language (a sequence of amino acids). As shown in the figure below, the coding region is analogous to a sentence in English. Much like a start codon, a capitalized word can indicate the start of a sentence. Codons within the coding region resemble groups of letters representing words. The end of the sentence is signaled by a period in English, or a stop codon for mRNA.</span></div><div style="margin-bottom:9pt;text-align:center"><img src="mrna-20201231_g4.jpg" alt="mrna-20201231_g4.jpg" style="height:296px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The intrinsic advantages of using mRNA as a medicine</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA possesses inherent characteristics that we believe provide it with a strong foundation as a new class of medicines. These characteristics include:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:10.5pt">mRNA is used by every cell to produce all proteins: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cells in the human body use mRNA to make all types of proteins, including secreted, membrane,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and intracellular proteins. mRNA is used by cells to vary the quantities of protein produced over time, in different locations, and in various combinations. Given the universal role of mRNA in protein production, we believe that mRNA medicines could have broad applicability across human disease.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:10.5pt">Making proteins inside one&#8217;s own cells mimics human biology: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Using a person&#8217;s own cells to produce protein therapeutics or vaccine antigens provides certain advantages over existing technologies such as recombinant proteins, which are manufactured using processes that are foreign to the human body. These advantages include the ability to:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">use multiple mRNAs to produce multiple proteins;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduce or eliminate immunogenicity;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create multi-protein complexes;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">produce therapeutic or vaccine proteins locally;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">harness native protein folding and glycosylation; and</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make proteins that are unstable outside the body.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:10.5pt">mRNA has a simple and flexible chemical structure: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Each mRNA molecule comprises four chemically similar nucleotides to encode proteins made</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">from up to 20 chemically different amino acids. To make the full diversity of possible proteins, only simple sequence changes are required in mRNA. A vast number of potential mRNA medicines can be developed, therefore, with only minor changes to the underlying chemical structure of the molecule or manufacturing processes, a significant advantage over small molecule or protein therapeutics.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:10.5pt">mRNA has classic pharmacologic features:</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The intrinsic properties of mRNA translate into attractive pharmacologic features,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">including:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each mRNA encodes for a specific protein and no other protein;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each mRNA molecule can produce many copies of a protein in the cell before being degraded;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing mRNA levels in a cell generally leads to increasing protein levels; and</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effects of mRNA in a cell can be transient and limits risk of irreversible changes to the cell&#8217;s DNA.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, mRNA possesses many of the attractive pharmacologic features of most modern medicines, including reproducible activity, predictable potency, and well-behaved dose dependency; and the ability to adjust dosing based on an individual patient&#8217;s needs, including stopping or lowering the dose, to seek to ensure safety and tolerability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">mRNA as a new class of medicines</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on these and other features, we have developed four core beliefs about the value drivers of mRNA as a new class of medicines:</span></div><div><span><br/></span></div><div style="padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">mRNA has the potential to create an unprecedented abundance and diversity of medicines. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although only two infectious disease vaccines using mRNA technology have been authorized to date for emergency use, or other provisional, interim or conditional use in response to the COVID-19 pandemic, we believe this success further demonstrates the potential for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA medicines to provide patients or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">healthy individuals with any therapeutic protein or vaccine, including those targeting intracellular and membrane proteins. This breadth of applicability has the potential to create an extraordinary number of new mRNA-based medicines that are currently beyond the reach of recombinant protein technology.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Advances in the development of our mRNA medicines can reduce risks across our portfolio. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA medicines share fundamental features that can</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be used to learn quickly across a portfolio. We believe that once safety and proof of protein production has been established in one program, the technology and biology risks of related programs that use similar mRNA technologies, delivery technologies, and manufacturing processes will decrease significantly. We believe that the progress of our COVID-19 vaccine has helped mitigate risk associated with our prophylactic vaccine modality.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">mRNA technology can accelerate discovery and development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The software-like features of mRNA enable rapid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in silico</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">design and the use of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">automated high-throughput synthesis processes that permit discovery to proceed in parallel rather than sequentially. We believe these mRNA features can also accelerate drug development by allowing the use of shared manufacturing processes and infrastructure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">The ability to leverage shared processes and infrastructure can drive significant capital efficiency over time. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the manufacturing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requirements of different mRNA medicines are dramatically more similar than traditional recombinant protein-based drugs across a similarly diverse pipeline. When manufacturing at commercial scale, we believe a portfolio of mRNA medicines will benefit from shared capital expenditures, resulting in lower program-specific capital needs and an advantageous variable cost profile.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the development of mRNA as a new class of medicines, as evidenced by the development of mRNA-based vaccines during 2020, represents a significant breakthrough for patients and our industry.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_22"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OUR STRATEGIC PRINCIPLES AND APPROACH TO MANAGING RISK</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy is designed to deliver on the full scope of the mRNA opportunity over the long-term. Reaching patients with mRNA medicines requires us to make complex choices, including: how much capital we devote to technology creation, drug discovery, drug development, commercial and global marketing and infrastructure; which programs we advance and how; whether we advance programs alone or with strategic collaborators; and which capabilities we build internally versus outsource.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To navigate these choices, we established five strategic principles that guide our approach to creating long-term value for patients and investors. No single strategic principle dominates our choices. Embedded in every decision we make is also our assessment of the most important risks inherent in our business. We believe these risks fall into four categories: technology, biology, execution, and financing.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To increase our chances of success, we often find it necessary to balance our near-to-mid-term risks against the strategic principles that guide our approach to long-term value creation.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our strategic principles</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">We seek to discover and develop a large pipeline in parallel.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is to address or prevent as many human diseases as our technology, talent,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">capital, and other resources permit. We do so as rapidly as we can, understanding both the urgency for patients and the need to be disciplined in our approach. We have a diverse pipeline of 24 development programs, with 13 of them having entered the clinic, many of which have the potential to be </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">first-in-class or best-in-class medicines. We have one commercial product, our COVID-19 vaccine, that is being distributed globally.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">We undertake sustained, long-term investment in technology creation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aim to improve the performance of mRNA medicines in our current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">modalities, and to unlock new modalities, through investments within basic and applied science. We are committed to remaining at the forefront of mRNA science.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">We focus on the pace and scale of our learning. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that time is a critical resource. We seek to accelerate our progress by solving numerous</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technical problems in parallel rather than in sequence. Our scientists pursue experiments based on how much we can learn from the results, not just the probability of a positive outcome. We believe negative information is valuable and we can learn from our setbacks. We make significant investments in digital assets and research infrastructure to accelerate the pace and scale of our learning.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">We integrate across the most critical parts of our value chain. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA is a complex multicomponent system and we believe it demands integration.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we must be directly engaged in research, drug discovery, drug development, process and analytical development, and manufacturing to accelerate our learning, reduce our risk, and protect our critical know-how. Where appropriate, we seek out strategic collaborators that can augment our capabilities or expand our capacity in specific therapeutic areas, while being careful to resist the fragmentation of our core technology.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">We forward invest in core enabling capabilities and infrastructure. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To execute across a broad pipeline, we need to invest at risk before we have all</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the answers. Our forward investments focus on areas where lead times are long and where early investments can reduce execution risk and accelerate future progress. We proactively invested in a dedicated manufacturing facility, Moderna Technology Center (MTC), in Norwood, MA, to support the anticipated growth of our pipeline, and this early investment greatly facilitated our ability to respond to the COVID-19 pandemic by allowing us to begin production of our vaccine even before we received regulatory authorization for its distribution.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our approach to managing risk</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the strategic principles that guide our approach to long-term value creation, we actively manage the risks inherent in our business. At present, these categories of risk include: technology, biology, execution, and financing. We summarize our approach to managing these risks below:</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Technology risk </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">encompasses the challenges of developing the product features of mRNA medicines, including delivery, controlling interactions with</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the immune system, optimizing therapeutic index, and manufacturing. We believe the best way to mitigate technology risk is to sustain long-term investments in our platform. In addition, we diversify our technology risk by compartmentalizing our pipeline into groups of programs with shared product features, which we call modalities. Lastly, we stage program development within a modality, leveraging the first program, whether successful or not, to generate insights that accelerate and reduce the risk of subsequent programs within the modality.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Biology risk </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">entails the risk unique to each program based on its mechanism of action and of clinical development in the target patient population. We</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">believe the best way to manage biology risk is to diversify it by pursuing multiple programs in parallel. In addition, within a modality we seek to initially pursue programs with well-understood biology. Lastly, we may seek strategic collaborators to share risk and upside in disease areas with high inherent biology risk, such as cancer and heart disease.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Execution risk </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">refers to the challenge of executing against the scale of our mission. We solve for this risk by seeking to hire the right people, the best</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">talent in the industry. We seek to foster a culture of execution with a focus on quick review cycles and high velocity decision-making. We make forward investments in infrastructure, including manufacturing. Lastly, we have created a digital backbone to track all aspects of our programs and anticipate challenges before they arise.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Financing risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> refers to our ability to access the capital required to fund the current breadth of our endeavor, as well as new opportunities. We manage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">this risk by attempting to maintain a strong balance sheet with several years of cash runway. As of December 31, 2020, we had cash, cash equivalents, and investments of $5.25 billion. This balance represents a significant increase in our liquidity over the prior year, driven primarily by customer deposits for the sale of our COVID-19 vaccine, as well as two equity offerings during the first half of the year (in February and May).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no single strategic principle nor single category of risk that dominates our decision-making, and universal rules do not exist across our portfolio. Our trade-offs generally involve balancing near-term risks and long-term value creation. Because development cycles are long, our choices are complex. We expect the weighting and types of risk we face will evolve as our business matures. We </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">believe that disciplined capital allocation across near- and long-term choices must be a core competency if we are to maximize the opportunity for patient impact and shareholder value creation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our progress</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success in developing a highly effective vaccine against COVID-19, going from sequence selection, conducting clinical trials and to receipt of regulatory authorization for emergency use, all in less than a year, provides a visible example of the promise of mRNA-based medicine. Our COVID-19 vaccine is currently authorized or conditionally approved in over 30 countries, and has already been used to vaccinate millions of patients to help combat the pandemic. We believe our success in developing this vaccine has positive implications beyond infectious disease vaccines and across our six modalities. We currently have 24 programs in development, and our pipeline spans five therapeutic areas: infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases. We remain on track to produce between 700 million and 1 billion doses of our COVID-19 vaccine in 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_28"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">OUR PLATFORM </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Overview of our platform</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our &#8220;platform&#8221; refers to our accumulated knowledge and capabilities in basic and applied sciences across mRNA, the delivery of mRNA to target tissues, and the manufacturing processes for making potential mRNA medicines. We invest in basic science to discover foundational mechanistic insights, and we invest in applied sciences to invent technology that harnesses those insights. We use our platform to identify and develop new mRNA medicines. When we identify a combination of platform technologies or programs across mRNA technologies, delivery technologies, and manufacturing processes that can enable shared product features across multiple potential mRNA medicines, we group those programs as a modality. The primary goal of our platform is to identify new modalities and to expand the utility of our existing modalities. We are committed to advancing the technological frontier of mRNA medicines over the long term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define success in our platform as achieving the following pharmacologic properties:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">predictable dose response;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reproducible pharmacology, including upon repeat dosing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">therapeutic potency, through achieving the intended pharmacologic activity in the target tissue;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safety and tolerability; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">scalability for development.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Achieving any of these pharmacologic properties requires many, often interdependent, technological solutions. We organize our efforts into three core scientific areas: mRNA, delivery, and manufacturing process as shown in the figure below:</span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g5.jpg" alt="mrna-20201231_g5.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pursue mRNA science to minimize undesirable activation of the immune system by mRNA, to maximize the mRNA potency of mRNA once inside target cells, and to extend pharmacology of our therapeutics. We pursue delivery science to protect mRNA from extracellular enzymes that would degrade it, to avoid counterproductive interactions of our delivery vehicles with the immune system, deliver mRNA to desired tissues, and facilitate mRNA transport across cell membranes to the translational machinery within cells. Finally, we have learned that the methods for producing mRNA and lipid nanoparticle, or LNP, delivery systems can have profound positive and negative effects on pharmacology. We pursue process science to optimize these features for our future medicines and to develop technical capabilities to scale our potential mRNA medicines for clinical development.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant expense to advance our platform technology and our intellectual property. This investment has underpinned the creation of all six of our existing modalities and helped us to establish fundamental intellectual property. We intend to sustain our investment in our platform in the future because we believe we can establish new modalities and continue to make meaningful improvements in the performance of our current modalities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our COVID-19 vaccine demonstrates the success of our current platform. Our current pipeline, which consists of 24 programs, depends on hundreds of small advances and 10 years of research and investment in our three core scientific areas. Examples of many </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">critical advances that we have made are described below. These advances demonstrate our significant progress to date, and exemplify our approach to tackling hundreds of smaller scientific problems and organizing them into technological solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our platform: mRNA science</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">An overview of mRNA biology</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Messenger RNA is a linear polymer comprised of four monomers called nucleotides: adenosine (A), guanosine (G), cytosine (C), and uridine (U). Within the region of the mRNA molecule that serves as instructions for protein synthesis, the coding region, the exact sequence of these four nucleotides forms a language made up of three-letter words called codons. One codon, the start codon (AUG), serves to signal where the ribosome should start protein synthesis. To know what protein to make, the ribosome then progresses along the mRNA one codon at a time, appending the appropriate amino acid to the growing protein chain. Because the ribosome is reading in one language (a sequence of codons) and outputting in another language (a sequence of amino acids), this process is called translation. Finally, three different codons (UAA, UAG, and UGA) can serve as stop signals, telling the ribosome where to terminate protein synthesis. The production of proteins from mRNA sequences is called translation and is used to make all human proteins. The production of mRNA from DNA is called transcription.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As shown in the figure below, the coding region in an mRNA molecule is analogous to a sentence in English. The start codon indicates the start of the protein, much like a capitalized word can indicate the start of a sentence. Codons within the coding region resemble groups of letters representing words. The end of the sentence is signaled by a period in English, or a stop codon for mRNA.</span></div><div style="text-align:center"><img src="mrna-20201231_g6.jpg" alt="mrna-20201231_g6.jpg" style="height:295px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In every cell, hundreds of thousands of mRNAs make hundreds of millions of proteins every day. A typical protein contains 200-600 amino acids; therefore a typical mRNA coding region ranges from 600-1,800 nucleotides.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the coding region, mRNAs contain four other key features: (1) the 5&#8217; untranslated region or 5&#8217;-UTR; (2) the 3&#8217; untranslated region or 3&#8217;-UTR; (3) the 5&#8217; cap; and (4) a 3&#8217; polyadenosine, or poly-A, tail. The sequence of nucleotides in the 5&#8217;-UTR influences how efficiently the ribosome initiates protein synthesis, whereas the sequence of nucleotides in the 3&#8217;-UTR contains information about which cell types should translate that mRNA and how long the mRNA should last. The 5&#8217; cap and 3&#8217; poly-A tail enhance ribosome engagement and protect the mRNA from attack by intracellular enzymes that digest mRNA from its ends. As a result of this biology, mRNA has several key features. First, mRNA is exquisitely specific. There is a one-to-one correspondence between an mRNA molecule and the protein dictated by the coding sequence. Second, the biological effects of mRNA are amplified. Because each mRNA copy can be translated thousands of times, we believe that in some cases, a small number of mRNA copies per cell may be sufficient to induce a pharmacologic effect. Finally, mRNA is impermanent. mRNAs produce proteins for a defined and biologically-regulated period of time without risk of changing genes or cell DNA. If dosing of mRNA stops, protein production will stop and the biological effects generally can be reversed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to invest in both applied and basic research, seeking to advance both the state of our technology and the state of the scientific community&#8217;s understanding of mRNA. Examples of advances in mRNA science that combine nucleotide chemistry, sequence engineering, and targeting elements are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mRNA chemistry: Modified nucleotides to mitigate immune system activation</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The innate immune system has evolved to protect cells from foreign RNA, such as viral RNA, by inducing inflammation and suppressing mRNA translation once detected. Many cells surveil their environment through sensors called toll-like-receptors, or TLRs. These include types that are activated by the presence of double-stranded RNA (TLR3) or uridine containing RNA fragments (TLR7, TLR8). Additionally, all cells have cytosolic double-stranded RNA, sensors, including retinoic acid inducible gene-I, or RIG-I that are sensitive to foreign RNA inside the cell.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The immune and cellular response to mRNA is complex, context specific, and often linked to the sensing of uridine. To minimize undesired immune responses to our potential mRNA medicines, our platform employs chemically-modified uridine nucleotides to minimize recognition by both immune cell sensors such as TLR3/7/8, and broadly-distributed cytosolic receptors such as RIG-I. mRNA produced using our synthesis technologies and containing unmodified uridine results in significant upregulation of secreted cytokines such as IP-10, which is indicative of local immune cell activation. Administration of monocyte-derived macrophages, or MDMs, with unmodified mRNA formulated in LNPs results in an increased ratio of IP-10 transcripts relative to a housekeeping gene. By substituting unmodified uridine with a modified uridine, we can substantially reduce immune cell activation in this assay. The control contains only transfection agent and no mRNA. In multiple preclinical experiments we have demonstrated reduced immune cell activation, including of B cells, lower immunoglobulin secretion, and lower cytokine expression when administering mRNA made with modified uridine versus unmodified uridine. To date, when deploying these technologies, we have yet to observe dose-limiting toxicity attributable to the mRNA encoding proteins from our drug substance even at the exaggerated doses in IND-enabling GLP toxicology programs. Importantly, in preclinical testing, our chemically-modified uridine has not significantly affected the ribosome&#8217;s ability to read and translate the mRNA sequence.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nucleotide chemistry of mRNA reduces immune activation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> (in monocyte-derived macrophages)</span></div><div style="text-align:center"><img src="mrna-20201231_g7.jpg" alt="mrna-20201231_g7.jpg" style="height:208px;margin-bottom:5pt;vertical-align:text-bottom;width:352px"/></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mRNA sequence engineering: Maximizing protein expression</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA exists transiently in the cytoplasm, during which time it can be translated into thousands of proteins before eventually being degraded. Our platform applies bioinformatic, biochemical, and biological screening capabilities, most of which have been invented internally that aim to optimize the amount of protein produced per mRNA. We have identified proprietary sequences for the 5&#8217;-UTR that have been observed to increase the likelihood that a ribosome bound to the 5&#8217;-end of the mRNA transcript will find the desired start codon and reliably initiate translation of the coding region.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We additionally design the nucleotide sequence of the coding region to maximize its successful translation into protein. As previously described, there are often multiple codons that encode for a specific amino acid. The amount of protein produced by an mRNA sequence is known to be partly determined by the codons it uses, with certain codons being more or less common in endogenous mRNAs. We have found that the amount of protein produced is also determined by the secondary structure of mRNA, or the propensity of mRNA to fold on itself, with more structured mRNAs producing more protein. We designed a set of sequences which independently varied codon usage and structure of the mRNA. As shown in the figure below, protein expression in the Alpha mouse liver 12, cell line is highest for sequences containing more commonly occurring codons and also more structured mRNA. Both codon usage and structure have an independent and additive effect on protein expression, shown as mean expression (solid line), as measured by fluorescence of the expressed protein, with 95% confidence interval in gray. The total expression area under the curve, or AUC, and standard error of the mean for AUC are shown for each quadrant, in relative fluorescence units per hour. By optimizing translation initiation and efficiency, we have further increased the average number of full-length desired proteins expressed per molecule mRNA. This permits us to reduce the mRNA doses required to achieve the same therapeutic benefit.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sequences with more structure and more common codons in mRNA maximize protein expression </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">in vitro</span></div><div style="text-align:center"><img src="mrna-20201231_g8.jpg" alt="mrna-20201231_g8.jpg" style="height:192px;margin-bottom:5pt;vertical-align:text-bottom;width:382px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeting elements: Enabling tissue-targeted translation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All nucleated cells in the body are capable of translating mRNA, resulting in pharmacologic activity in any cell in which mRNA is delivered and translated. To minimize or prevent potential off-target effects, our platform employs technologies that regulate mRNA translation in select cell types. Cells often contain short RNA sequences, called microRNAs or miRNAs, that bind to mRNA to regulate protein translation at the mRNA level. Different cell types have different concentrations of specific microRNAs, in effect giving cells a microRNA signature. microRNA binding directly to mRNA effectively silences or reduces mRNA translation and promotes mRNA degradation. We design microRNA binding sites into the 3&#8217;-UTR of our potential mRNA medicines so that if our mRNA is delivered to cells with such microRNAs, it will be minimally translated and rapidly degraded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example, we have demonstrated by intratumoral administration in an animal model that an mRNA encoding a cytotoxic protein and containing a microRNA binding site can be used to selectively kill cancer cells, while protecting systemic tissues such as liver cells. In a mouse model of cancer (Hep3b subcutaneous xenograft mouse), liver enzyme levels and immunohistochemistry, or IHC, of cleaved caspase-3, indicate production of an apoptosis-inducing protein encoded by mRNA in tumor cells but not healthy liver cells when the mRNA has multiple miR-122 target sites. This is denoted as 3x122ts in the figure below; miR-122 is more prevalent in non-cancerous liver cells, but absent in the cancerous liver cells. We published this work in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nucleic Acid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Therapeutics </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in 2018.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tissue-targeted translation of mRNA encoding a pro-apoptotic protein</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and microRNA binding sites in mouse study</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g9.jpg" alt="mrna-20201231_g9.jpg" style="height:243px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our platform: Delivery science</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We focus on the delivery of our mRNA molecules to specific tissues. Our mRNA can, in specific instances, such as our VEGF therapeutic, be delivered by direct injection to a tissue in a simple saline formulation without lipid nanoparticles, or LNPs, to locally produce small amounts of pharmacologically active protein. However, the blood and interstitial fluids in humans contain significant RNA degrading enzymes that rapidly degrade any extracellular mRNA and prevent broader distribution without LNPs. Additionally, cell membranes tend to act as a significant barrier to entry of large, negatively-charged molecules such as mRNA. We have therefore </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">invested heavily in delivery science and have developed LNP technologies, as well as alternative nanoparticle approaches to enable delivery of larger quantities of mRNA to target tissues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LNPs are generally composed of four components: an amino lipid, a phospholipid, cholesterol, and a pegylated-lipid, or PEG-lipid. Each component, as well as the overall composition, or mix of components, contributes to the properties of each LNP system. LNPs containing mRNA injected into the body rapidly bind proteins that can drive uptake of LNPs into cells. Once internalized in endosomes within cells, the LNPs are designed to escape the endosome and release their mRNA cargo into the cell cytoplasm, where the mRNA can be translated to make a protein and have the desired therapeutic effect. Any mRNA and LNP components that do not escape the endosome are typically delivered to lysosomes where they are degraded by the natural process of cellular digestion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of tools we developed by using our platform include proprietary LNP formulations that address the steps of mRNA delivery, including cell uptake, endosomal escape, and subsequent lipid metabolism, and for avoidance of counterproductive interactions with the immune system. Examples of delivery tools we have developed are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chemistry: Novel lipid chemistry to potentially improve safety and tolerability</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We initially used LNP formulations that were based on known lipid systems, which we refer to as &#8220;legacy LNPs.&#8221; A recognized limitation of these legacy LNPs is the potential for inflammatory reactions upon single and repeat administration that can impact tolerability and therapeutic index. Our later-developed, proprietary LNP systems are therefore designed to be highly tolerated and minimize any LNP vehicle-related toxicities with repeat administration </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The changes we made have included engineering amino lipids to avoid the immune system and to be rapidly biodegradable relative to prior lipids. Administered intravenously in non-human primates, at 0.2 mg/kg, our proprietary LNPs demonstrate rapid clearance of the lipid from plasma and organs such as peripheral lymphoid organs and the liver.</span></div><div><span><br/></span></div><div style="text-indent:117pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rapid clearance of lipid components of LNPs from plasma in non-human primate study</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(y-axis in log-scale)</span></div><div style="text-align:center"><img src="mrna-20201231_g10.jpg" alt="mrna-20201231_g10.jpg" style="height:226px;margin-bottom:5pt;vertical-align:text-bottom;width:516px"/></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even in the case of vaccines, where one might hypothesize that LNP-induced immune stimulation could potentially increase the effectiveness of the vaccine, we have demonstrated in preclinical studies that we can maintain the desired immune response to the vaccine while reducing undesired local immune reaction, or reactogenicity, to the LNP. The tolerability of our vaccine formulation has been demonstrated clinically and, to date, millions of individuals worldwide have received our vaccine against COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Composition: Proprietary LNPs enhance delivery efficiency</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform includes extensive in-house expertise in medicinal chemistry, which we have applied to design large libraries of novel lipids. Using these libraries in combination with our discovery biology capabilities, we have conducted high throughput screens for desired LNP properties and believe that we have made fundamental discoveries in preclinical studies about the relationships between structural motifs of lipids and LNP performance for protein expression. By screening for components and compositions that enhance the amount of mRNA delivered per cell and protein expression, we have demonstrated with intravenous administration up to a six-fold improvement in protein production over the prior state of the art for LNPs as shown in the figure below (n=3 rats, 95% CI shown).</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Enhanced protein production with our proprietary LNP in rat study</span></div><div style="text-align:center"><img src="mrna-20201231_g11.jpg" alt="mrna-20201231_g11.jpg" style="height:226px;margin-bottom:5pt;vertical-align:text-bottom;width:517px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Surface properties: Novel LNP design to avoid immune recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have designed our proprietary LNP systems for sustained pharmacology upon repeat dosing by eliminating or altering features that activate the immune system. These are based on insights into the surface properties of LNPs. Upon repeated dosing, surface features on traditional LNPs such as amino lipids, phospholipids, and PEG-lipids, can be recognized by the immune system, leading to rapid clearance from the bloodstream, a decrease in potency upon repeat dosing, and an increase in inflammation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our insights into these mechanisms, we have engineered our LNP systems to reduce or eliminate undesirable surface features. In preclinical studies in non-human primates for our systemic therapeutic development candidates that use our novel LNP systems, we have been able to repeat dose with negligible or undetectable loss in potency, liver damage, and immune system activation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our platform: Manufacturing process science</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest significantly in manufacturing process science to impart more potent features to our mRNA and LNPs, and to invent the technological capabilities necessary to manufacture our potential mRNA medicines at scales ranging from micrograms to kilograms, as well as achieve pharmaceutical properties such as solubility and shelf life. We view developing these goals of manufacturing and pharmaceutical properties as stage appropriate for each program. In some cases, this includes inventing novel analytical technologies that make it possible to connect analytical characterization of mRNA and LNPs to biological performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mRNA manufacturing process: Improving pharmacology</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform creates mRNA using a cell-free approach called </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transcription in which an RNA polymerase enzyme binds to and transcribes a DNA template, adding the nucleotides encoded by the DNA to the growing RNA strand. Following transcription, we employ proprietary purification techniques to ensure that our mRNA is free from undesired synthesis components and impurities that could activate the immune system in an indiscriminate manner. Applying our understanding of the basic science underlying each step in the manufacturing process, we have designed proprietary manufacturing processes to impart desirable pharmacologic features, for example increasing potency in a vaccine. Using a model antigen injected intramuscularly in mice at a 3 microgram (&#181;g) mRNA dose, the figure below shows the significant improvement in CD8 T cell response we have achieved through mRNA manufacturing process science and engineering as evidenced by Process B.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing process changes to tune immune response in mouse study</span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g12.jpg" alt="mrna-20201231_g12.jpg" style="height:193px;margin-bottom:5pt;vertical-align:text-bottom;width:276px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LNP manufacturing process: Improving pharmacology</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform technology includes synthetic processes to produce LNPs. Traditionally LNPs are assembled by dissolving the four molecular components, amino lipid, phospholipid, cholesterol, and PEG-lipid, in ethanol and then mixing this with mRNA in an aqueous buffer. The resulting mixture is then purified to isolate LNPs from impurities. Such impurities include molecular components that have not been incorporated into particles, un-encapsulated mRNA that could activate the immune system, and particles outside of the desired size range.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Going beyond optimization of traditional manufacturing processes, we have invested in understanding and measuring the various biochemical and physical interactions during LNP assembly and purification. We have additionally developed state-of-the-art analytical techniques necessary to characterize our LNPs and biological systems to analyze their </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> performance. With these insights, we have identified manufacturing process parameters that drive LNP performance, for example, the potency in a secreted therapeutic setting. These insights have allowed us to make significant improvements in the efficiency of our processing and the potency of our LNPs, as exemplified in the figure below. For example, expression of a secreted protein in our Relaxin program demonstrates an approximate eight-fold increase in AUC and approximate six-fold increase in maximum concentration for manufacturing process Y versus manufacturing process X in rats dosed intravenously with 0.5 mg/kg mRNA.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Manufacturing process changes to enhance relaxin protein production by mRNA in rat study</span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g13.jpg" alt="mrna-20201231_g13.jpg" style="height:196px;margin-bottom:5pt;vertical-align:text-bottom;width:493px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our platform progress to date </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have solved numerous interdependent problems related to the pharmacologic features of our potential mRNA medicines. These features are detailed and exemplified below. Please also see the section of this Annual Report on Form 10-K titled &#8220;Business&#8212;Program Descriptions&#8221; for recent clinical results for our investigational medicines, including our COVID-19 vaccine (mRNA-1273), CMV vaccine (mRNA-1647), hMPV/PIV3 vaccine (mRNA-1653), antibody against Chikungunya virus (mRNA-1944), and PCV (mRNA-4157) utilizing Moderna proprietary technology. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dose-dependent protein expression in the clinic</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have demonstrated in the clinic the ability to generate consistent dose dependent levels of protein (antibody) as well as the ability to safely repeat dose. Interim data from our Phase 1 study evaluating escalating doses of mRNA-1944 in the 0.6 mg/kg dose with steroid premedication cohort and two doses of 0.3 mg/kg (without steroid premedication) given one week apart demonstrated dose-dependent increases in levels of antibody against chikungunya. Safety and increased CHKV-IgG production in the two-dose regimen shows the platform&#8217;s ability for repeat dosing.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expression of antibody against Chikungunya virus in the Phase 1 study of mRNA-1944</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g14.jpg" alt="mrna-20201231_g14.jpg" style="height:282px;margin-bottom:5pt;vertical-align:text-bottom;width:573px"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g15.jpg" alt="mrna-20201231_g15.jpg" style="height:246px;margin-bottom:5pt;vertical-align:text-bottom;width:344px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reproducible pharmacology, including upon repeated dosing</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By combining advances in mRNA, delivery, and manufacturing process science, we have demonstrated in preclinical studies sustained and reproducible pharmacology. The figure below shows a recent example in a mouse model that recapitulates metabolic defects in propionic acidemia, or PA. In this rare disease, a defect in one or both of two different subunits (PCCA and PCCB) of the mitochondrial enzyme propionyl-CoA carboxylase results in accumulation of toxic metabolites such as 2-methylcitrate, or 2MC.In mice hypomorphic for the PCCA subunit, monthly intravenous, or IV, administration of mRNAs encoding PCCA and PCCB formulated in our proprietary LNP (mRNA-3927) resulted in a significant and sustained lowering of 2MC throughout the duration of the 6-month study compared to control (luciferase) mRNA (1 mg/kg, n=6/group). We are currently recruiting PA patients for our Phase 1 trial of mRNA-3927. As noted above, we have also seen success in repeat dosing of our antibody against Chikungunya virus.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plasma 2-methylcitrate levels with repeat dosing of PCCA+PCCB mRNA in PA mouse study</span></div><div style="text-align:center"><img src="mrna-20201231_g16.jpg" alt="mrna-20201231_g16.jpg" style="height:319px;margin-bottom:5pt;vertical-align:text-bottom;width:579px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Decreased immune activation upon repeat dosing in non-human primates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have observed decreased immune activation which enables repeat dosing in non-human primates, as shown in the figure below. The data below indicates serum concentration of human erythropoietin, or hEPO, with repeat dosing of mRNA encoding hEPO in our proprietary LNPs with weekly IV administration at 0.2 mg/kg in non-human primates. </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Repeat dosing with mRNA encoding for hEPO in our proprietary LNP in non-human primate study</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g17.jpg" alt="mrna-20201231_g17.jpg" style="height:217px;margin-bottom:5pt;vertical-align:text-bottom;width:519px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that by combining proprietary mRNA technologies, delivery technologies, and manufacturing process technologies we have significantly advanced the potential therapeutic index of our potential mRNA-based therapeutics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacologic activity in the target tissue and cell</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">While some of our modalities, such as systemic secreted therapeutics, can leverage many different cell types to make therapeutic proteins, others such as systemic intracellular therapeutics, may require delivery of our mRNA into specific tissues and cell types, for instance hepatocytes in certain liver metabolic diseases. Combining our proprietary mRNA, delivery, and manufacturing process technologies we have observed on-target pharmacologic activity in hepatocytes in non-human primates. The on-target potency of this approach contrasts with traditional delivery technologies. In the figure below, one of our proprietary LNPs with increased hepatocyte transfecting properties result in protein expression in liver hepatocytes in non-human primates as demonstrated with a reporter protein detected by immunohistochemistry at 6 hours after IV infusion at 2 mg/kg.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Protein expression in hepatocytes with a proprietary LNP in non-human primate study </span></div><div style="text-align:center"><img src="mrna-20201231_g18.jpg" alt="mrna-20201231_g18.jpg" style="height:285px;margin-bottom:5pt;vertical-align:text-bottom;width:616px"/></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Additionally, this LNP results in extended expression of a secreted reporter protein in non-human primates as compared to one of our other proprietary LNPs after IV delivery at 0.1mg/kg.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g19.jpg" alt="mrna-20201231_g19.jpg" style="height:194px;margin-bottom:5pt;vertical-align:text-bottom;width:422px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our platform&#8217;s future: Improving and expanding our modalities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to sustaining investment in our platform, both in basic science to elucidate new mechanistic insights, and in applied science to discover new technologies that harness these insights. Our platform investments have enabled six modalities to date, most of which have already led to multiple development candidates and investigational medicines in our pipeline. We believe that sustaining our investment in platform research and development will enable further improvements in the current modalities and will lead to the creation of new modalities, both of which will benefit our clinical pipeline in the years ahead.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CREATING MODALITIES WITH SHARED PRODUCT FEATURES</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our approach to developing modalities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Within our platform, we develop technologies that enable the development of mRNA medicines for diverse applications. When we identify technologies that we believe could enable a new group of potential mRNA medicines with shared product features, we call that group a &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">modality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.&#8221; While the programs within a modality may target diverse diseases, they share similar mRNA technologies, delivery technologies, and manufacturing processes to achieve shared product features. The programs within a modality will also generally share similar pharmacology profiles, including the desired dose response, the expected dosing regimen, the target tissue for protein expression, safety and tolerability goals, as well as pharmaceutical properties. Programs within a modality often have correlated technology risk, but because they pursue diverse diseases, they often have uncorrelated biology risk. We have created six modalities to date:</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prophylactic vaccines;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cancer vaccines;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intratumoral immuno-oncology;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">localized regenerative therapeutics;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">systemic secreted and cell surface therapeutics; and </span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">systemic intracellular therapeutics.</span></div><div style="padding-left:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">When entering into a new modality, our approach is consistent with our strategic principles and perspectives on risk management discussed previously. The tenets of our approach are summarized below.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We identify a first program (or programs) through which we seek to discover and develop solutions for any modality-specific technological challenges. We then leverage the learnings from this first program to the benefit of all subsequent programs in the modality.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">We seek to diversify biology risks within the modality by advancing multiple programs in parallel, against multiple diseases, following the first program.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">When we believe a strategic collaborator could significantly de-risk our early efforts in a new modality, we often seek a strategic collaborator to share the risks and benefits on a specific set of early programs.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">After experience with the first program (or programs) in a modality, we seek to rapidly expand our pipeline within that modality to take full advantage of the opportunity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Illustrating our approach: From our first modality to today</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We started with prophylactic vaccines as our first modality because we believed this modality faced lower technical hurdles, relative to other areas. Our early formulations of mRNA tended to stimulate the immune system, which would present a challenge to therapeutics but was a desired feature for vaccines. In addition, many potential prophylactic vaccine antigens are well-characterized, allowing us to reduce biology risk. Lastly, the dosing regimens for vaccines require as few as one or two administrations, and generally involve relatively low doses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For our first programs in this modality we chose our H10N8 and H7N9 pandemic influenza vaccines, each requiring expression of a single membrane protein.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We chose to pursue two programs in separate, but parallel, clinical trials to establish the flexibility of our platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When both programs met our goals for safety, tolerability, and pharmacology, we accelerated and expanded our vaccine pipeline to include multiple commercially meaningful and increasingly complex vaccines. These included a combination vaccine, designed to protect against two unrelated respiratory viruses, human metapneumovirus, or hMPV, and human parainfluenza 3, or PIV3, and a vaccine that combines six different mRNAs, our cytomegalovirus, or CMV, vaccine, to express a complex pentameric antigen. We also sought strategic alliances with the Defense Advanced Research Projects Agency (DARPA), the Biomedical Advanced Research Development Authority (BARDA) and Merck &amp; Co. (Merck), to allow us to rapidly expand our pipeline and complement our capabilities with their expertise. This early work in the prophylactic vaccines modality led to the ability to introduce our COVID-19 vaccine during 2020 in response to the ongoing pandemic.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over time, we have taken on more challenging applications and technological hurdles with each successive modality, but we have also tried to build upon our prior experiences to manage risk. For example, in our cancer vaccines modality, we are now applying our technology to elicit T cell responses to potentially recognize and eradicate cancer as a logical extension of our prophylactic vaccines modality. Having demonstrated local expression of protein in our vaccines, we expanded into local therapeutic applications. For example, in our intra-tumoral immuno-oncology modality, we are seeking to use local expression to drive anti-cancer T cell responses by transforming tumor microenvironments. We can also use local expression to drive regenerative processes as in our Vascular Endothelial Growth Factor A, or VEGF-A program. Most recently, we have expanded into two new modalities that use systemic delivery of mRNA to encode secreted and cell surface or intracellular proteins. We have moved multiple programs in these areas into development for the treatment of diseases as varied as rare genetic disorders, preventing viral infections, or treating heart failure.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expanding within our designated core modalities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020 we designated the prophylactic vaccines and systemic secreted and cell surface therapeutics modalities as &#8220;core modalities&#8221; following positive Phase 1 data from our CMV vaccine and chikungunya antibody program, respectively. We believed that this data reduced the risk of these modalities, and our strategy is to invest in additional development candidates within these modalities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 2020, we have nominated six new development candidates within our prophylactic vaccines modality, including our COVID-19 vaccine (which is now authorized for emergency use or conditionally approved in over 30 countries), as well as vaccine </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">candidates for seasonal flu, HIV, Nipah virus, and EBV. We also regained rights to develop an RSV vaccine for adults, following the conclusion of our collaboration with Merck in October 2020, which consolidated our global commercial rights to all development candidates within our prophylactic vaccines modality. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our systemic secreted and cell surface therapeutics modality, we announced two new development candidates in 2020: Interleukin-2, or IL-2, and programmed death-ligand-1, or PD-L1. In 2021, we also announced that we have regained the rights to our Relaxin program from AstraZeneca, and we are currently evaluating how to proceed with the program. Our exploratory modalities continue to be a critical part of advancing our strategy to maximize the application of our potential mRNA medicines.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">How modalities continue to build our pipeline</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe our portfolio of modalities&#8212;each with distinct technological and biological risk profiles&#8212;allows us to maximize long-term value for patients and investors. We see our six current modalities as six distinct multi-product pipelines that represent different risk profiles and benefit from common infrastructure and a shared platform technology. We believe the high technology correlation within a modality allows us to rapidly accelerate the expansion of the pipeline in that modality based on learnings from the initial programs. We believe the lower technology correlation between modalities allows us to compartmentalize the technology risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe our ongoing investments in our platform will lead to the identification of additional new modalities in the future, and will expand the diversity of our pipeline.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_2488"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">OUR PIPELINE</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Since we nominated our first program in late 2014, we and our strategic collaborators have advanced in parallel a diverse development pipeline which currently consists of 27 development candidates across our 24 programs, with 13 having entered the clinic and an additional development candidate subject to an open investigational new drug application (IND). Aspects of our pipeline have been supported through strategic alliances, including with AstraZeneca, Merck, and Vertex Pharmaceuticals, or Vertex, and government-sponsored organizations and private foundations focused on global health initiatives, including BARDA, DARPA, the National Institute of Allergy and Infectious Diseases (NIAID), the National Institutes of Health (NIH), the Coalition for Epidemic Preparedness Innovations (CEPI), and the Bill &amp; Melinda Gates Foundation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our selection process for advancing new development candidates reflects both program-specific considerations as well as portfolio-wide considerations. Program-specific criteria include, among other relevant factors, the severity of the unmet medical need, the biology risk of our chosen target or disease, the feasibility of clinical development, the costs of development, and the commercial opportunity. Portfolio-wide considerations include the ability to demonstrate technical success for our platform components within a modality, thereby increasing the probability of success and learnings for subsequent programs in the modality and in some cases in other modalities.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The breadth of biology addressable using mRNA technology is reflected in our current development pipeline of 24 programs. The diversity of proteins made from mRNA within our development pipeline is shown in the figure below.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g20.jpg" alt="mrna-20201231_g20.jpg" style="height:324px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:105%">The following chart shows our current pipeline of 24 development programs, grouped into modalities&#8212;first our two core modalities where we believe we have reduced the technology risk, followed by our four exploratory modalities in which we are continuing to investigate the clinical use of mRNA medicines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g21.jpg" alt="mrna-20201231_g21.jpg" style="height:324px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_34"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">PROPHYLACTIC VACCINES MODALITY</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designed our prophylactic vaccines modality to prevent or control infectious diseases. This modality includes our COVID-19 vaccine, which was first authorized by the U.S. FDA for emergency use in December 2020 for vaccination of adults age 18 and older against SARS-CoV-2. Our prophylactic vaccines modality currently includes ten development candidates in addition to our commercial COVID-19 vaccine, all of which are vaccines against viruses. The goal of any vaccine is to safely pre-expose the immune system to a small quantity of a protein from a pathogen, called an antigen, so that the immune system is prepared to fight the pathogen if exposed in the future, and prevent infection or disease.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prophylactic vaccines: Opportunity</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaccines to prevent infectious diseases are one of the great innovations of modern medicine. In the United States alone, the Centers for Disease Control and Prevention (CDC) estimates that childhood vaccinations given in the past two decades will in total prevent 322 million Americans from falling ill, 21 million hospitalizations, 732,000 deaths, $295 billion of direct costs, and $1.3 trillion in social costs. The commercial opportunity for vaccines is significant; the worldwide vaccine market in 2019 was $35 billion. More innovative vaccines have been able to achieve pricing per regimen generally ranging from 5 to 20 times that of seasonal flu vaccines.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Prophylactic vaccines: Product features</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe mRNA-based vaccines offer several advantages, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Ability to mimic many aspects of natural viral infections. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA enters cells and is used to produce viral antigen proteins from within the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cell that include natural, post-translational modifications. This mimics the process by which natural viral infections occur, where information from viral genomes is used to produce viral proteins from within a cell. This can potentially enhance the immune response, including improved B and T cell responses.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Multiplexing of mRNA for more compelling product profiles</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Multiple mRNAs encoding for multiple viral proteins can be included in a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">single vaccine, either permitting production of complex multimeric antigens that are much more difficult to achieve with traditional technologies, or producing antigens from multiple viruses at once. As an example, our CMV vaccine (mRNA-1647) contains six mRNAs, five of which encode five different proteins that combine to form a pentameric protein complex that is a potentially critical antigen for immune protection against CMV.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Rapid discovery and advancement of mRNA programs into the clinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Many viral antigens are known. However, with traditional vaccines,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the target pathogens or antigens have to be produced in dedicated cell-cultures and/or fermentation-based manufacturing production processes in order to initiate testing of potential vaccine constructs. Our ability to design our antigens </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in silico</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allows us to rapidly produce and test antigens in preclinical models, which can dramatically accelerate our vaccine selection. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Capital efficiency and speed from shared manufacturing processes and infrastructure. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Traditional vaccines require product-dedicated production processes, facilities, and operators. Our mRNA vaccines are produced in a manufacturing process that is sufficiently consistent across our pipeline to allow any one of our facilities the flexibility to produce any of our mRNA vaccines.</span></div><div style="padding-left:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Prophylactic vaccines: Vaccines against respiratory viruses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">COVID-19 vaccine (mRNA-1273) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moderna&#8217;s COVID-19 vaccine has already been administered in millions of patients and is authorized for use in more than 30 countries </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our COVID-19 vaccine (mRNA-1273) was designed, subject to Phase 1, Phase 2 and Phase 3 clinical trials, delivered clinical trial results, and received emergency use and other conditional authorizations in less than a year, and has been and continues to be a key tool in fighting the global SARS-CoV-2 pandemic. The vaccine is referred to as the Moderna COVID-19 Vaccine in the U.S. and Canadian markets, and is generally referred to as the COVID-19 Vaccine Moderna in other markets. Forward-looking references to our COVID-19 vaccine in this Annual Report on Form 10-K may include future modifications to mRNA-1273 or other development candidates that are designed to provide protection against variants of the SARS-CoV-2 virus. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We worked throughout 2020 to expand our manufacturing capacity and partnered with other companies to supplement that production, and currently anticipate that we will be able to produce between 700 million and 1 billion doses of our COVID-19 vaccine in 2021. Our COVID-19 vaccine is a two-dose course, meaning this production will be sufficient to vaccinate between 350 million and 500 million people against COVID-19 at the current 100 microgram (&#181;g) dose. As of December 31, 2020, we had committed orders for approximately 520 million doses of the COVID-19 vaccine to be delivered in 2021, for total contract consideration of $11.7 billion. We are conducting a Phase 2/3 study of mRNA-1273 in adolescents 12 to 17 years of age. Additional studies are planned to evaluate our COVID-19 vaccine in children younger than 12 years and immunocompromised populations. We are also conducting a field effectiveness trial in the United States to gather additional data in other populations, including older adults and individuals with co-morbidities that place them at increased risk for the complications of COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 25, 2021, we announced that the Company is developing a next-generation vaccine against COVID-19, mRNA-1283.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This vaccine candidate encodes for the portions of the SARS-CoV-2 spike protein that are critical for neutralization, specifically the Receptor Binding Domain (RBD) and N-terminal Domain (NTD). The encoded mRNA-1283 antigen is shorter than mRNA-1273, and is being developed as a potential refrigerator stable mRNA vaccine that we anticipate will facilitate easier distribution and administration by healthcare providers. mRNA-1283 is intended to be evaluated for use as a booster dose for previously vaccinated or infected individuals as well as in a primary series for seronegative individuals.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">COVID-19: Disease overview </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SARS-CoV-2 is the virus that causes COVID-19 disease, which has led to over 2.4 million global deaths</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Coronaviruses are a large family of viruses that can cause illness in animals or humans. In humans there are several known coronaviruses that cause respiratory infections. These coronaviruses range from the common cold to more severe diseases such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and COVID-19. SARS-CoV-2 is the novel coronavirus first identified in humans in December 2019 and is the cause of COVID-19. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 is the most severe global pandemic since the influenza pandemic of 1918. As of February 18, 2021, there have been over 110 million confirmed cases and over 2.4 million global deaths from COVID-19. The risk of mortality increases with age (estimated to be ~0.1% for individuals aged 0-19, ~6% for individuals over age 60). Risk of severe disease and mortality increase for persons with pre-existing diseases or comorbid conditions (e.g. cardiovascular disease, diabetes, chronic lung disease, obesity). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the pandemic has continued variants of the original SARS-CoV-2 virus first detected in Wuhan, China, have continued to evolve.  Certain of these variant strains of SARS-CoV-2 have already proven to lead to increased rates of transmission of the virus, and as the virus continues to evolve, future strains or those already in circulation could cause more severe forms of disease.  Some variant strains have also demonstrated resistance to existing vaccines and therapeutics for COVID-19.  Data from the primary efficacy analysis announced November 30, 2020 suggested that mRNA-1273&#8212;which was designed based upon the genetic sequence of the virus first detected in Wuhan, China&#8212;is 94.1% efficacious against symptomatic COVID-19 disease with a clinically-acceptable safety profile.  However, while the neutralization titers are comparable for most variant strains tested, including the B.1.1.7 strain first identified in the United Kingdom, there are data to suggest a 6.4-fold reduction in neutralization titers against the B.1.351 strain which was first identified in South Africa.  While the titers against B.1.351 remain higher than those found to be protective against viral challenge in animal models, we have nonetheless announced a proactive strategy to address variants of the virus.  We are continuing to collaborate with the NIH to study the evolution of the SARS-CoV-2 virus and the effectiveness of mRNA-1273 against new strains.  As one part of this strategy, we are testing additional boosters of mRNA-1273 to further increase protection against emerging strains. Additionally, we are advancing an emerging strain booster, referred to as mRNA-1273.351 (named for the B.1.351 strain) to assess protection against that strain. On February 24, 2021, doses of mRNA-1273.351 were shipped to the NIH for a Phase 1 clinical trial that will be led and funded by NIAID.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 vaccine (mRNA-1273): Product concept</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our vaccine is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from NIAID&#8217;s Vaccine Research Center</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Spike protein complex is necessary for membrane fusion and host cell infection and has been the target for the majority of vaccines against COVID-19. Our COVID-19 vaccine encodes a stabilized version of the SARS-CoV-2 full-length spike glycoprotein trimer, S-2P, which has been modified to include two proline substitutions at the top of the central helix in the S2 subunit (S-2P). </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><img src="mrna-20201231_g22.jpg" alt="mrna-20201231_g22.jpg" style="height:280px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">COVID-19 vaccine (mRNA-1273): Preclinical data</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mRNA-1273 led to protection against SARS-CoV-2 infection in the lungs and nose of non-human primates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2020, we announced the publication in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The New England Journal of Medicine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of data from a preclinical study of mRNA-1273, demonstrating that two doses of mRNA-1273 provided protection against lung inflammation following viral challenge with SARS-CoV-2 in non-human primates at both the 10 &#181;g and 100 &#181;g dose levels. In addition, both the 10 &#181;g and 100 &#181;g dose groups demonstrated protection against viral replication in the lungs, with the 100 &#181;g dose also protecting against viral replication in the nose of the animals. Of note, none of the eight animals in the 100 &#181;g group showed detectable viral replication in the nose compared to six out of eight in the placebo group on day 2. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 vaccine (mRNA-1273): Clinical data </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Phase 1 trial. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Phase 1 open-label study of mRNA-1273 is being conducted by the NIH. This study, which began on March 16, 2020, originally enrolled 45 healthy adult volunteers ages 18 to 55 years and is evaluating three dose cohorts (25 &#181;g, 100 &#181;g and 250 &#181;g). An additional seven cohorts were subsequently added in the Phase 1 study: a 50 &#181;g cohort in adults 18-55 (n=15), three cohorts of older adults (n=30, ages 56-70, 25 &#181;g, 50 &#181;g, and 100 &#181;g) and three cohorts of elderly adults (n=30, ages 71 and above, 25 &#181;g, 50 &#181;g, and 100 &#181;g).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 14, 2020, we announced the publication in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The New England Journal of Medicine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of an interim analysis of data from the original cohorts obtained through Day 57 in the Phase 1 study. This interim analysis demonstrated that mRNA-1273 induced binding antibodies to the full-length SARS-CoV-2 Spike protein (S) in all participants after the first vaccination, with all participants seroconverting by Day 15. Dose dependent increases in binding titers were seen across the three dose levels, and between prime and boost vaccinations within the dose cohorts. After two vaccinations, at Day 57, geometric mean titers exceeded those seen in convalescent sera obtained from 38 individuals with confirmed COVID-19 diagnosis. Of the 38 individuals in the convalescent sera group, 15% were classified as having severe symptoms (hospitalization requiring intensive care and/or ventilation), 22% had moderate symptoms and 63% had mild symptoms. Convalescent sera samples were tested using the same assays as the study samples. mRNA-1273 was generally well-tolerated, with no serious adverse events reported through Day 57. Adverse events were generally transient and mild to moderate in severity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evaluation of the durability of immune responses is ongoing, and participants will be followed for one year after the second vaccination, with scheduled blood collections throughout that period. On December 2, 2020, a letter to the editor was published in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New England Journal of Medicine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reporting that participants in the Phase 1 study of mRNA-1273 retained high levels of neutralizing antibodies through 119 days following first vaccination (90 days following second vaccination). The study was led by NIAID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Phase 1 older adult cohort. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 29, 2020, we announced the publication in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The New England Journal of Medicine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the second interim analysis of data from 40 healthy adult participants across two dose levels (25 &#181;g and 100 &#181;g) in two age cohorts (ages 56-70 and ages 71+), and reports results through Day 57 (1 month after the second dose). Both the 25 &#181;g and 100 &#181;g dose levels of mRNA-1273 were generally well-tolerated, with no serious adverse events reported through Day 57. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At both the 25 &#181;g and 100 &#181;g dose levels, after two vaccinations, mRNA-1273 induced dose-dependent binding antibody responses reaching the upper quartile of the distribution of convalescent sera. At Day 57 (1 month post-dose 2), geometric mean titers (GMT) exceeded the median of those seen in convalescent sera from 41 individuals with confirmed COVID-19 diagnosis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Phase 3 trial. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Phase 3 COVE trial for mRNA-1273 is a randomized, 1:1 placebo-controlled study testing the vaccine at the 100 &#181;g dose level in 30,000 participants in the U.S., ages 18 and older. The primary endpoint of the COVE study, which is ongoing, is the prevention of symptomatic COVID-19 disease. Key secondary endpoints include prevention of severe COVID-19 disease and prevention of infection by SARS-CoV-2. The Phase 3 COVE study was designed in collaboration with the FDA and NIH to evaluate vaccine efficacy in Americans at risk of severe COVID-19 disease and completed enrollment of more than 30,000 participants ages 18 and older in the U.S. on October 22, 2020, including those at high risk of severe complications of COVID-19 disease. In early September 2020, we announced that we were slowing enrollment in the trial to ensure representation of communities of color in the COVE study. Final enrollment in the study included more than 11,000 participants from communities of color, representing 37% of the study population.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 30, 2020, interim safety and primary efficacy results from the Phase 3 trial of mRNA-1273 were published in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The New England Journal of Medicine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. The primary endpoint of the Phase 3 COVE study was based on the analysis of COVID-19 cases confirmed and adjudicated starting two weeks following the second dose of vaccine. This final analysis was based on 196 cases, of which 185 cases of COVID-19 were observed in the placebo group versus 11 cases observed in the Moderna COVID-19 Vaccine group, corresponding to a 94% vaccine efficacy (95% CI 89.3-96.8%; p&lt;0.0001). This efficacy is highlighted in the chart below. The most common solicited adverse reactions (ARs) after the two-dose series was injection site pain (86.0%). Solicited systemic adverse events occurred more often in the Moderna COVID-19 vaccine group (54.9% and 79.4%) than in the placebo (42.2% and 36.5%) group after both the first dose and the second dose respectively and were most commonly headache, fatigue and myalgia. While the majority of these ARs were mild (grade 1) or moderate (grade 2), there was a higher occurrence of severe (grade 3) reactions in the Moderna COVID-19 Vaccine group after the first (2.9%) and second (15.8%) injections. The majority of local solicited ARs occurred within the first one to two days after injection and generally persisted for a median of one to two days. Safety data continues to accrue, and the study continues to be monitored by an independent Data Safety Monitoring Board (DSMB) appointed by the NIH. All participants in the COVE study will be monitored for two years after their second dose to assess long-term protection and safety. Additional data to be collected will include longer term safety follow-up, duration of protection against COVID-19, and efficacy against asymptomatic SARS-CoV-2 infection. All placebo recipients in the Phase 2 and Phase 3 trials have been offered our COVID-19 vaccine. As of February 15, 2020, over 80% of placebo recipients have received at least one dose of our COVID-19 vaccine.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g23.jpg" alt="mrna-20201231_g23.jpg" style="height:324px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also conducting a Phase 2/3 study of mRNA-1273 in adolescents 12 to less than 18 years of age and a Phase 2/3 pediatric study in children less than 12 years old is expected to begin in April 2021. Finally, to assess the ability of a third vaccination with mRNA-1273 to further boost antibody titers, participants in the active arms (100 and 50ug) of our Phase 2 adult study will be offered a 50ug booster dose. Additional studies are planned to evaluate mRNA-1273 in special risk groups, such as the immunocompromised. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 vaccine (mRNA-1273): Regulatory updates </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 18, 2020, the U.S. Food and Drug Administration authorized the emergency use of mRNA-1273, Moderna&#8217;s vaccine against COVID-19, in individuals 18 years of age or older. Our COVID-19 vaccine has also been authorized for emergency or conditional use by regulatory authorities in Canada, Israel, the United Kingdom, the European Union, Switzerland, Singapore and Qatar. Additional authorizations are currently under review in additional markets and by the World Health Organization (WHO).</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to submit a biologics license application, or BLA, to the FDA for approval of mRNA-1273, and to submit applications with other regulatory authorities for similar approvals, which will allow for the commercial sale and distribution of the vaccine after the pandemic subsides and conditions are no longer met for emergency or conditional use authorizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 vaccine (mRNA-1273): Commercial, manufacturing and supply updates </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we have signed supply agreements to deliver approximately 520 million doses of mRNA-1273 in 2021, for total contract consideration of $11.7 billion. We have confirmed the following supply agreements as of that date: United States: 200 million doses, with option for an additional 300 million doses; European Union: 160 million doses; Japan: 50 million doses; Canada: 40 million doses, with option for an additional 16 million doses; South Korea: 40 million doses; United Kingdom: 17 million doses; Switzerland: 7.5 million doses; Israel: 6 million doses. We also signed agreements with Qatar, Singapore, and other countries for which order amounts were not disclosed. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, and through the date of this Annual Report on Form 10-K, we have agreed to additional supply agreements, or received option exercises, for additional doses as follows: United States: 100 million doses, with an option remaining for 200 million doses; European Union:  150 million doses, with an option remaining for 150 million doses in 2022 (subject to final execution of the Purchase Agreement following the expiration of the opt out period for EU Member States); Canada: 4 million doses; Colombia: 10 million doses; and Taiwan: 5 million doses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our base case global production estimate is 700 million to 1 billion doses for 2021. We are continuing to invest and add staff as we meet production at the high end of this range. We are also working on increasing our potential supply to up to 1.4 billion doses for 2022 based upon the current 100 &#181;g dose. Much of the production for the supply of the U.S. market will be completed at our MTC facility in Norwood, Massachusetts, with additional production by Lonza Ltd. for the U.S. market. We have also partnered with Lonza to complete all production of mRNA-1273 for markets other than the U.S. in Switzerland. Fill-finish services for mRNA-1273 are provided by Catalent Inc. in the U.S., and by ROVI and Recipharm outside the U.S.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the conditions under which mRNA-1273 can be shipped and stored are a key feature of our vaccine as such conditions provide for greater flexibility in distributing the vaccine to markets where special handling may be a barrier to distribution. mRNA-1273 does not require dilution prior to use and remains stable at 2&#176; to 8&#176;C (36&#176; to 46&#176;F), the temperature of a standard home or medical refrigerator, for 30 days. mRNA-1273 remains stable at -20&#176; C (-4&#176;F) for up to six months, at refrigerated conditions for up to 30 days and at room temperature for up to 12 hours.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">hMPV/PIV3 vaccine (mRNA-1653)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are developing a combination vaccine to address two viruses that are leading causes of respiratory infection</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Human metapneumovirus, or hMPV, and human parainfluenza virus 3, or PIV3, are significant causes of respiratory tract infections in children. Despite the substantial impact hMPV and PIV3 have on human health, attention and research on these viruses have lagged relative to other respiratory infections, like respiratory syncytial virus (RSV). To date, no vaccine to prevent hMPV or PIV3 infections has been approved. Our platform allows us to combine mRNAs encoding antigens for the two pathogens in one combination vaccine, enabling a single vaccine that could protect against both respiratory infections. In our approach, we utilize mRNA sequences encoding for the membrane fusion (F) glycoproteins, or F proteins, for each of the viruses. We have generated safety, tolerability, and immunogenicity data from the Phase 1 trial for mRNA-1653 in the United States, which has been completed. Based on these data, we have a Phase 1b trial for mRNA-1653 ongoing in the United States in healthy adults and children aged 12-59 months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">hMPV/PIV3 vaccine (mRNA-1653): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">hMPV and PIV3 have a substantial impact on human health yet have lagged in research and attention relative to RSV</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no approved vaccine for hMPV although this RNA virus has been determined to be one of the more frequent causes of upper and lower respiratory tract infections. hMPV has been detected in 4% to 15% of patients with acute respiratory infections. hMPV causes disease primarily in young children but can also infect adults, the elderly, and immunocompromised individuals. Clinical signs of infection range from a mild upper respiratory tract infection to life-threatening severe bronchiolitis and pneumonia. hMPV was discovered in 2001 and identified as a leading cause of respiratory infection.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no approved vaccine for PIV3 although this RNA virus is recognized as an important cause of respiratory tract infections in children. Infections from parainfluenza virus, or PIV, account for up to 7% of acute respiratory infections among children younger than 5 years. Of the four PIV types identified, PIV3 most frequently results in infections and leads to the more serious lower respiratory tract infections compared to the other three PIV types. Though PIV3 related infections were identified in the past, awareness of their burden to patients and hospitals has risen over the past several years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awareness of hospitalizations due to hMPV or PIV3 infections have risen, and we believe that a single, combined vaccine intended for active immunization of infants against both hMPV and PIV3 would be valuable. Previous attempts at developing a vaccine have focused on only hMPV or PIV alone with no known attempts at a combination vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">hMPV/PIV3 vaccine (mRNA-1653): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our approach is to develop a combination vaccine for all infants </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA-1653 is a single investigational vaccine consisting of two distinct mRNA sequences that encode the membrane F proteins of hMPV and PIV3, co-formulated in our proprietary LNP.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g24.jpg" alt="mrna-20201231_g24.jpg" style="height:282px;margin-bottom:5pt;vertical-align:text-bottom;width:668px"/></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">hMPV/PIV3 vaccine (mRNA-1653): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our mRNA vaccine is immunogenic and protective in preclinical multiple species</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated multiple combinations for hMPV/PIV3 mRNA vaccines encoding full-length F proteins for hMPV and PIV3 viruses in mice, Sprague Dawley rats, cotton rats, and African green monkeys, each following intramuscular injection. These studies demonstrate that mRNA encoding for F proteins from these viruses induce robust hMPV and PIV3 neutralizing antibody titers in all species tested. Further, we have demonstrated that our hMPV and PIV3 mRNA combination vaccine does not lead to vaccine-enhanced respiratory disease (evaluated in cotton rats) and is protective against hMPV or PIV3 viral challenge (evaluated in cotton rats and African green monkeys).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">hMPV/PIV3 vaccine (mRNA-1653): Clinical data</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have generated safety, tolerability, and immunogenicity data from a Phase 1 trial in the U.S., which has been completed; based on the data, we have a Phase 1b trial in healthy adults and children aged 12-59 months ongoing in the U.S.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A first-in-human dose-ranging study, mRNA-1653-P101, in healthy adults (N = 124) was completed in January 2020. This study evaluated the safety, reactogenicity, and immunogenicity of a range of dose levels (25, 75, 150 or 300 &#181;g) administered on a 1-dose or 2-dose vaccination schedule (approximately 28 days apart) compared with a placebo control in healthy adult subjects (18 through 49 years of age) with a 13 month follow-up period. The mRNA-1653 vaccine was generally well-tolerated at all dose levels. There were no deaths or adverse events of special interest reported during the study. No subject was withdrawn from the study due to an unsolicited adverse event. Injection site pain was the most commonly reported solicited adverse event and the most common grade 3 adverse event. Neutralizing antibodies against hMPV and PIV3 were present at baseline in all subjects, consistent with prior exposure </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to both viruses. A single dose of mRNA-1653 boosted serum neutralization titers against hMPV and PIV3, and the magnitude of the boost was similar at all dose levels. The Month 1 to baseline geometric mean ratio (GMR) for the pooled mRNA-1653 treatment groups was approximately 6 for hMPV and 3 for PIV3. A second vaccination did not impact the magnitude of hMPV or PIV3 neutralization titers measured at Month 2. The hMPV neutralizing antibody titers remained above baseline at all dose levels through Month 13, and the PIV3 neutralizing antibody titers remained above baseline at all dose levels through Month 7.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are conducting a Phase 1b trial to evaluate mRNA-1653 in healthy adults and children aged 12-59 months. The Phase 1b trial is a randomized, observer-blinded, placebo-controlled, dose-ranging trial to evaluate the safety and immunogenicity of two dose levels of mRNA-1653 in healthy adults (18-49 years of age) and three dose levels in children (12-59 months of age) with serologic evidence of prior hMPV and PIV3 exposure. The adult cohort includes 24 adults randomized in the ratio 1:1:1 to receive two doses of 30 &#956;g of mRNA-1653, 150 &#956;g of mRNA-1653, or placebo two months apart. As of January 2021, the adult cohort has been completed and the pediatric portion is ongoing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RSV vaccine (mRNA-1345)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are developing an RSV vaccine for children and older adults. We intend to explore a combination vaccine with mRNA-1653, our hMPV/PIV3 vaccine, and/or other respiratory viruses to address a wide array of viral respiratory illness in these populations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Respiratory syncytial virus, or RSV, is one of the most common causes of respiratory disease in children under the age of five and also in older adults. The RSV vaccine (mRNA-1345) is our first RSV vaccine to enter the clinic with the same proprietary LNP as our COVID-19 vaccine. We previously had two different RSV candidates in partnership with Merck (mRNA-1777 and mRNA-1172) enter the clinic. mRNA-1345 was initially nominated as a pediatric vaccine for RSV. In October 2020, we announced that we regained the rights to adult RSV vaccines from Merck and will be moving mRNA-1345 into the adult population. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSV vaccine (mRNA-1345): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RSV is the leading cause of unaddressed severe lower respiratory tract disease and hospitalization in infants and young children worldwide and causes a substantial burden of illness in older adults</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSV causes upper and lower respiratory tract illness worldwide and is transmitted primarily via aerosolized droplets from an infected person, or via contamination of environmental surfaces with infectious secretions. Upper respiratory symptoms typically begin within several days of exposure. In healthy adults, the infection may remain confined to the upper respiratory tract. However, in those with compromised immune systems, such as premature infants, the elderly, or individuals with underlying respiratory disease, lower respiratory tract infections commonly occur and may manifest as wheezing, bronchiolitis, pneumonia, hospitalization or even death. Infections with RSV follow a seasonal pattern, occurring primarily in the Northern hemisphere between the months of November and April, and in the Southern hemisphere primarily between March and October.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSV is a common cause of respiratory tract illness in children, with most infected at least once by two years of age. In the United States, it is estimated that over two million children younger than five years of age receive medical attention and more than 86,000 are hospitalized due to RSV infection annually. Globally, it is estimated that RSV is responsible for over approximately 33 million episodes of acute lower-respiratory tract infection, 3.2 million hospitalizations and as many as 118,000 deaths per year in children younger than five years of age. RSV also causes a substantial burden of respiratory illness in older adults. RSV infection causes an estimated 177,00 hospitalizations and 14,000 deaths per year in adults aged &gt;65 years in the United States. To date, no effective vaccine to prevent RSV has been approved, and the only approved prophylactic treatment is the monoclonal antibody (mAb) palivizumab, marketed as SYNAGIS in the United States for the prevention of serious lower respiratory disease caused by RSV in pediatric patients at high risk for RSV infection</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSV vaccine (mRNA-1345): Product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prevent RSV disease in young children and older adults with an improved RSV antigen and our proprietary LNP formulation </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA-1345 encodes an engineered form of the RSV F proteins stabilized in the prefusion conformation and is formulated in our proprietary LNP. The F protein is present as a homotrimer on the surface of RSV. The prefusion conformation of the F protein interacts with a host cell membrane, and the conformational change from prefusion to postfusion drives virus fusion with a host cell. The majority of RSV-specific neutralizing antibodies in convalescent people are directed to epitopes present only on the prefusion conformation of the F protein. The prefusion state of the F protein elicits a superior neutralizing antibody response compared to the postfusion state in animal studies conducted by others. We believe that neutralizing antibodies elicited by mRNA-1345 may lead to an efficacious RSV vaccine.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSV vaccine (mRNA-1345): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have demonstrated that the RSV vaccine mRNA-1345 induces robust RSV neutralizing antibody titers in mice. For example, the left panel below shows the results of a study in which mice were immunized with different dose levels of mRNA-1345 intramuscularly on study days 1 and 21 and RSV neutralizing antibody titers were measured in serum collected on day 33. When compared to the results of a similar mouse study conducted with mRNA from mRNA-1777 formulated in the same proprietary LNP as mRNA-1345, mRNA-1345 was shown to be significantly more immunogenic. We have leveraged our body of non-clinical, clinical and CMC experience from our vaccine portfolio to expedite preclinical development of our RSV mRNA-1345 vaccine.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Serum neutralizing titers in mice for mRNA-1345 and for mRNA-1777 mRNA formulated in our same proprietary LNP</span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g25.jpg" alt="mrna-20201231_g25.jpg" style="height:384px;margin-bottom:5pt;vertical-align:text-bottom;width:672px"/></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials of a formalin-inactivated RSV vaccine conducted in the 1960s resulted in higher rates of severe RSV disease in vaccinated infants than in control infants, a finding referred to as vaccine enhanced respiratory disease (ERD). It is thought that nucleic acid-based vaccines, including mRNA, present a lower risk of ERD because of their biologic similarities with live virus. Given that the RSV vaccine mRNA-1345 is designed to enable intracellular production of prefusion F protein by a person&#8217;s own cells, we believe that it likely recapitulates the antigenic presentation and immune cell stimulation as seen with natural infection. Further, the mRNA-1777 RSV vaccine did not predispose for ERD in a cotton rat RSV model (Espeseth et al, npj Vaccines (2020)5:16). To provide further confirmation that the pediatric RSV vaccine mRNA-1345 does not present a risk for ERD, additional preclinical studies will be conducted prior to clinical development of mRNA-1345 in RSV seronegative children or infants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSV vaccine (mRNA-1345): Clinical plan </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are conducting a Phase 1 trial for mRNA-1345 in healthy younger adults, healthy older adults and RSV-seropositive children. The Phase 1 trial is a randomized, observer-blind, placebo-controlled, dose escalation study to evaluate the safety, reactogenicity and immunogenicity of three dose levels of mRNA-1345 in healthy younger adults aged 18 to 49 years and healthy older adults aged 65-79 years and two dose levels in RSV-seropositive children aged 12-59 months. As of January 2021, 3 of the 4 younger adult cohorts are fully enrolled, and we began enrollment for the older adult cohort in February 2021.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Seasonal influenza vaccine (mRNA-1010, mRNA-1020 and mRNA-1030)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Three development candidates will be assessed in a phase 1 study planned to start in 2021. Mouse immunization studies have shown strong immune responses against the vaccine antigens.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seasonal influenza viruses are estimated by the WHO to cause 3 to 5 million cases of severe illness and up to 650,000 deaths each year resulting in a severe challenge to public health. Currently licensed seasonal influenza virus vaccines rarely exceed 60% overall effectiveness and are poorly effective during years when the circulating viruses do not match the strains selected for the vaccine antigens. Particularly in older adults, the population most affected by severe influenza outcomes, vaccine effectiveness remains low. mRNA influenza vaccines could provide several benefits compared to current vaccines, including the ability to more quickly respond to strain changes, avoidance of mutations that may be acquired during vaccine production in eggs or cell culture and stronger immune responses and improved protection in older adults. We are planning to test three development candidates (mRNA-1010, mRNA-1020 and mRNA-1030) in a Phase 1 study starting in 2021, which will allow us to identify a candidate to take forward into pivotal efficacy studies. The vaccine will be administered as a single dose and will aim to elicit protection from all seasonal influenza viruses. In the future we also plan to evaluate the combination of a seasonal influenza vaccine with vaccines against other respiratory viruses with similar epidemiology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonal influenza vaccine (mRNA-1010, mRNA-1020 and mRNA-1030): Disease overview </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Influenza most substantially impacts young children and older adults, and current vaccines show low effectiveness</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Influenza epidemics occur each year and manifest in mild to severe forms. Common symptoms of influenza infection include fever, runny nose, sore throat, muscle pain and coughing. The symptoms onset generally occurs within two days after infection and in uncomplicated cases the disease is self-limiting and resolves within a week. However, influenza virus infection can lead to severe disease, especially in high risk groups (including older adults and individuals with comorbidities), and even death (290,000-650,000 respiratory deaths worldwide annually).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Influenza viruses follow a seasonal circulation pattern with increased cases during the winter months in the Northern and Southern hemispheres, respectively. Since influenza viruses continuously change through a process termed antigenic drift, the circulating viruses are actively monitored by a worldwide monitoring network coordinated by the WHO. Based on the observed circulation patterns and antigenic changes, an expert panel recommends influenza virus strains to be used for vaccine manufacturing twice a year (once for the Northern and once for the Southern hemisphere). Influenza A and influenza B viruses are the most relevant influenza viruses for human infection. Therefore, current recommendations include one influenza A H1N1 strain, one influenza A H3N2 strain and two influenza B strains (covering the B/Victoria and B/Yamagata lineages).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonal influenza vaccine (mRNA-1010, mRNA-1020 and mRNA-1030): Product concept </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prevent influenza virus infections by annual vaccination against circulating seasonal influenza viruses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investigational products will aim to elicit protective antibodies against circulating seasonal influenza viruses. Three products will be tested in the clinic in 2021 with the goal of selecting one product to move forward into pivotal studies. The final product is expected to be updated twice a year (for the Northern and Southern hemispheres, respectively) based on the recommendations by WHO and will include antigens of the four strains recommended for seasonal vaccines. An mRNA-based influenza vaccine has a number of potential advantages over vaccines produced using traditional manufacturing processes, such as avoiding mutations to proteins acquired by passage during egg- or cell-propagation of viruses, presentation of antigens in their natural conformation, better immunogenicity in older adults and more rapid manufacturing timelines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonal influenza vaccine (mRNA-1010, mRNA-1020 and mRNA-1030): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preclinical studies show that strong serum antibody responses against all antigens are elicited after a single administration of the mRNA vaccines in mice, even at low mRNA dose levels.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prophylactic vaccines: Vaccines requiring complex antigens and against highly prevalent infections</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CMV vaccine (mRNA-1647)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our CMV program targets congenital CMV infections to reduce or prevent birth defects</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congenital cytomegalovirus, or CMV, infection is the leading cause of birth defects in the United States. Despite several attempts, to date there is no vaccine approved to prevent congenital transmission of CMV. We believe that in addition to the glycoprotein B, or gB, protein antigen, a successful CMV vaccine would need to include the Pentamer, a 5-protein membrane-bound antigen complex required for epithelial, endothelial, and myeloid cell infection by the virus. A CMV vaccine containing the Pentamer as a recombinant protein or a replication defective virus is complex to make and scale. We used our platform to generate an mRNA vaccine designed to make the Pentamer in its natural membrane-bound conformation. This investigational medicine is designed to prevent or control CMV infection and includes five mRNAs encoding for the Pentamer, as well as one mRNA encoding for CMV gB that has previously demonstrated partial clinical efficacy. The Phase 1 and 2 trials for mRNA-1647 has generated safety and tolerability data, and demonstrated immunogenicity. Based on recent data from the 3-month interim analysis data from the Phase 2 trial, we have selected a dose and initiated planning for Phase 3 trials for mRNA-1647 in the United States, Canada, Europe, Australia, and Israel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CMV (mRNA-1647): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CMV is a major cause of birth defects with no approved vaccine</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Human CMV is a common human pathogen and member of the herpes virus family. Seropositivity, demonstrating prior exposure to virus, increases with age and is approximately 40-60% in women of child-bearing potential in the United States. However, general awareness of CMV is not high. Less than 10-20% of adults are aware of CMV and most healthy adults after initial (primary) CMV infection do not have symptoms. However, approximately 0.6-0.7% of newborns are congenitally infected by CMV annually in industrialized countries. Congenital CMV results from infected mothers transmitting the virus to their unborn child and it is the leading cause of birth defects, with approximately 25,000 newborns per year in the United States infected. Birth defects occur in approximately 20% of infected babies and include permanent neurodevelopmental disabilities, which can include hearing loss (often permanent), vision impairment, varying degrees of learning disability, decreased muscle strength and coordination, and even death. Some studies report approximately one-third of infants with severe congenital disease will die within the first year of life, and the survivors, their caregivers, and health systems bear significant long-term burdens.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is currently no available vaccine for CMV, and many previous attempts at developing a vaccine to reduce or prevent congenital transmission have been missing a key antigen, the Pentamer. We believe the Pentamer is critical for the infection of epithelial, endothelial, and myeloid cells by the virus. We believe the Pentamer was not included in certain prior recombinant protein vaccine attempts due to the complexity of producing it as a multi-unit antigen complex. Prior vaccine studies demonstrated insufficient efficacy against CMV infection and limited durability of immune response. A vaccine that leads to durable immunity in women of child-bearing age would address a critical unmet need in the prevention of congenital CMV infection.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CMV vaccine (mRNA-1647): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are developing a single vaccine with complex antigens to prevent or control infection</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to generate a multi-antigen vaccine enables us to combine a traditional target antigen (gB) with the Pentamer in order to specifically focus the immune system on these important antigens. We believe this gives us greater potential to produce neutralizing antibodies that can block CMV transmission from the mother to the fetus. Our approach to block transmission could either be:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">direct, by vaccinating adolescents or adults of child-bearing potential (female and male); or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">indirect, by vaccinating toddlers who could spread CMV to each other, their mothers, and their childcare workers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unlike a protein-based or live-attenuated vaccine, our mRNA instructs cells to specifically make predetermined antigens with a structure that mimics the one presented to the immune system by the virus, thus focusing the immune system on these important antigens.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA-1647 comprises six mRNAs that encode for these known hard-to-make CMV antigens in a proprietary LNP: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In CMV seropositive individuals, the majority of neutralizing antibodies target the Pentamer. The CMV Pentamer is made by five CMV glycoproteins that form a membrane-bound complex. The Pentamer is required for CMV entry into epithelial, endothelial, and myeloid cells. The mRNA-expressed Pentamer is displayed on the surface of the cell and stimulates the production of neutralizing antibodies that prevent the virus from entering the cells.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">gB is a trimeric CMV membrane glycoprotein that abundantly resides on the surface of the viral particles. Fusion between virus and host cells, and hence infection, requires gB. Antibodies to gB can prevent CMV infection. gB has been utilized in some earlier attempts at a CMV vaccine as the sole antigen which had resulted in partial efficacy but not at levels sufficient for approval.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">An illustration of our proposed approach for CMV is shown in the figure below.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g26.jpg" alt="mrna-20201231_g26.jpg" style="height:295px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CMV vaccine (mRNA-1647): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have published preclinical data for our CMV vaccine</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have demonstrated that the Pentamer and gB mRNAs can elicit potent and durable antibody titers against the antigens in mice and non-human primates, and have published these results in the journal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vaccine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2018. In one study, mice were immunized with the Pentamer and gB mRNAs encapsulated in our proprietary LNP. Serum samples were taken from the mice at specific timepoints post-vaccination. Post-vaccination neutralizing titers were measured by admixing serial dilutions of each sample with CMV virus, incubating the mixture in a human primary epithelial cell culture, and counting the number of infected cells. We used CytoGam, an approved product for prevention of CMV in transplant patients, as a control in our experiment. CytoGam is cytomegalovirus immune globulin from pooled plasma of CMV seropositive donors. The table below shows the neutralization antibody titers in epithelial cells for escalating vaccine doses in mice, demonstrating our ability to generate neutralizing antibodies. We also observed that at the highest dose, our mRNA vaccine generated a response more than 75-fold higher than CytoGam at estimated clinical levels. In addition, we have also observed that the Pentamer and gB mRNAs can elicit strong T cell responses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CMV vaccine (mRNA-1647): Clinical data</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have demonstrated tolerability and generated immunogenicity data in our Phase 1 and 2 trials. Based on interim Phase 2 data, we have initiated planning a Phase 3 trial of mRNA-1647 vaccine efficacy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Phase 1 12-Month Interim Analysis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We announced positive data from the 12-month interim analysis of the Phase 1 clinical trial of mRNA-1647, which has completed the final study visit of its last participant and is evaluating the safety and immunogenicity of mRNA-1647 in 181 healthy adult volunteers. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The clinical trial population includes those who are na&#239;ve to CMV infection (CMV-seronegative) and those who had previously been infected by CMV (CMV-seropositive). Participants were randomized to receive either placebo, or 30, 90, 180 or 300 &#181;g of mRNA-1647 on a dosing schedule of 0, 2 and 6 months. This 12-month planned interim analysis assessed immunogenicity of the first three dose levels (30, 90, and 180 &#181;g) at 12 months (six months after the third vaccination), and the highest dose level (300 &#181;g) at seven months (one month after the third vaccination). The analysis also assessed safety of the highest dose level at seven months. Neutralizing antibody titers (levels of circulating antibodies that block infection) were assessed in two assays utilizing epithelial cells and fibroblasts, which measure immune response to the pentamer and gB vaccine antigens, respectively. gB antigen-specific T cell responses after the second and third vaccinations were measured in a subset of CMV-seronegative participants in the 30, 90 and 180 &#181;g dose levels utilizing an ELISpot assay. Pentamer-specific T cell assays remain in development. Vaccine-induced neutralizing antibody responses in the CMV-seronegative group were compared to the baseline neutralizing antibody titers in the CMV-seropositive group, noting that prior maternal CMV infection is associated with an approximately 30-fold lower risk of congenital CMV infection compared to the risk in the setting of maternal primary CMV infection.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In CMV-seronegative participants at seven months (one month after the third vaccination) in the 30, 90 and 180 &#181;g dose levels:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A dose-related increase in neutralizing antibody titers was observed in both epithelial cell and fibroblast assays.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the third vaccination, neutralizing antibody titers against epithelial cell infection were greater than 10 times higher in the 90 and 180 &#181;g dose levels than CMV-seropositive baseline titers at the 90 and 180 &#181;g dose levels.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">After the third vaccination, neutralizing antibody titers against fibroblast infection were 1.3 to 1.4 times higher than CMV-seropositive baseline titers at the 90 and 180 &#181;g dose levels.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In CMV-seronegative participants at twelve months (six months after the third vaccination) in the 30, 90, and 180 &#181;g dose levels:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Neutralizing antibody titers remained at least 3.5-fold higher than the natural infection benchmark in epithelial cell assays. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Titers in fibroblast assays approximated that of the natural infection benchmark in the in the 90 &#956;g and 180 &#956;g treatment groups</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In CMV-seropositive participants at seven months (one month after the third vaccination) in the 30, 90 and 180 &#181;g dose levels:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A dose-related increase in neutralizing antibody titers was observed in both epithelial cell and fibroblast assays.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The third vaccination boosted neutralizing antibody titers against epithelial cell infection to levels of 22-fold to 40-fold over baseline titers in all dose levels.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The third vaccination boosted neutralizing antibody titers against fibroblast infection to levels of approximately 4-fold to 6-fold over baseline titers in all dose levels.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In CMV-seropositive participants at twelve months (six months after the third vaccination) in the 30, 90, and 180 &#181;g dose levels:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Neutralizing antibody titers were 14-fold to 31-fold over baseline titers in epithelial cell assays. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Titers in fibroblast assays were 6-fold to 8-fold over baseline titers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participants receiving 300 &#181;g of mRNA-1647 followed through seven months (one month after the third vaccination) continued to show consistent dose-dependent increases in neutralizing antibodies against epithelial cell infection and against fibroblast infection in both CMV-seronegative and CMV-seropositive groups. In CMV-seronegative participants at seven months, the neutralizing antibody titers in epithelial cell assays increased further to 17-fold higher than the natural infection benchmark, and neutralizing antibody titers in fibroblast assays increased further to 5-fold higher than natural infection benchmark. In CMV-seropositive participants at seven months, the neutralizing antibody titers in epithelial cell assays was 13.4-fold over baseline titers and against fibroblast infection was 7.1-fold over baseline titer. In a subset of CMV-seronegative participants in the 30, 90 and 180 &#181;g dose levels, gB antigen-specific T cell activation was observed at all dose levels after the second and third vaccinations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A safety analysis indicated that the vaccine was generally well-tolerated. There were no vaccine-related serious adverse events. Across all mRNA-1647 treatment groups, the most common solicited local adverse reaction, or AR, was injection site pain and the most common solicited systemic ARs were headache, fatigue, myalgia, arthralgia, and chills. Fever was reported in 0-55% of CMV-seronegative treatment groups and in 8-75% of CMV-seropositive treatment groups. In general, solicited systemic ARs occurred less frequently after the third vaccination compared to the second, and were more common in the CMV-seropositive treatment groups compared to the CMV-seronegative treatment groups. Grade 3 solicited ARs were more common in CMV-seropositive participants, and were fatigue (0-27% of a given dose cohort), chills (0-38% of a given dose cohort) and fever (0-33% of a given dose cohort). As reported in the previous interim analysis, there was a single Grade 4 AR of an isolated lab finding of elevated partial thromboplastin time, which was elevated at baseline (Grade 1) and self-resolved on the next lab test with no associated clinical findings. Safety and tolerability in participants receiving 300 &#181;g of mRNA-1647 was comparable to that observed at the 180 &#181;g dose level in CMV-seropositive participants and generally higher in 300 &#181;g dose level in CMV-seronegative participants.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the small sample size limits the conclusions that can be drawn from the data, the findings from this interim analysis build on an earlier interim analysis of safety and immunogenicity data through one month after the third vaccination in the 30, 90 and 180 &#181;g dose levels and one month after the second vaccination in the 300 &#181;g dose level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Phase 2 Part 1 3-Month Interim Analysis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Part 1 of the Phase 2 study, participants were randomized to receive either placebo, or 50, 100, or 150 &#181;g of mRNA-1647 on a dosing schedule of 0, 2, and 6 months. The planned 3-month interim analysis of safety and immunogenicity through 3 months (1 month after the second vaccination) in September 2020 informed the selection of the 100 &#181;g dose level for the Phase 3 pivotal efficacy study. In addition, we have initiated enrollment in Part 2 of the Phase 2 study, which is evaluating safety and immunogenicity of the 100 &#181;g dose level to expand the safety dataset in the target population planned for the Phase 3 study. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In CMV-seronegative participants at three months (one month after the second vaccination) in the 50, 100 and 150 &#181;g dose levels:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Neutralizing antibody titers against epithelial cell infection increased to at least 12-fold over the CMV-seropositive baseline titers after the second vaccination and were generally numerically similar in the 50, 100, and 150 &#956;g treatment groups.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Neutralizing antibody titers against fibroblast infection increased to titers equivalent to the CMV-seropositive baseline titers after the second vaccination and were generally numerically similar in the 50, 100, and 150 &#956;g treatment groups.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In CMV-seropositive participants at three months (one month after the second vaccination) in the 50, 100 and 150 &#181;g dose levels:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Neutralizing antibody titers against epithelial cell infection increased 12 to 51-fold over the CMV-seropositive baseline titers after the second vaccination.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Neutralizing antibody titers against fibroblast infection increased to levels at least 2-fold over CMV-seropositive baseline titers after the first and second vaccination. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Phase 2 Continuation and Phase 3 Planning</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our randomized, observer-blind, placebo-controlled, dose-confirmation Phase 2 study is investigating the safety and immunogenicity of mRNA-1647 in approximately 252 healthy CMV-seronegative and CMV-seropositive adult volunteers in Part 1 of the study, and an additional approximately 250 healthy CMV-seronegative and CMV-seropositive female volunteers in Part 2 of the study in the U.S. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are actively preparing for a global, randomized, observer-blind, placebo-controlled Phase 3 pivotal study to evaluate the efficacy of mRNA-1647 against primary CMV infection in females 16-40 years of age. We solicited and received Type C meeting feedback from the FDA on the preliminary design of the pivotal trial, requested an end-of-phase 2 (EoP2) meeting with FDA for mid-March 2021, and submitted our Phase 3 development plans to FDA in a briefing document. We believe this can be achieved with a trial with no more than 8,000 participants and study site selection and/or site feasibility has already begun across North America, Europe, Australia, and Israel. The pivotal Phase 3 trial design will be finalized after discussion with the FDA and other global health authorities. Additional adolescent bridging and concomitant vaccination trials are being planned. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Epstein-Barr Virus vaccine (mRNA-1189)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our EBV vaccine seeks to prevent the development of infectious mononucleosis and potentially prevent EBV infection.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Epstein-Barr virus, or EBV, a member of the herpesvirus family that includes CMV, infects approximately 90% of people by adulthood, with primary infection typically occurring during childhood and late adolescence (approximately 50% and 89% seropositivity, respectively) in the U.S. EBV is the major cause of infectious mononucleosis in the U.S., accounting for over 90% of the approximately 1-2 million cases of infectious mononucleosis in the U.S. each year. Infectious mononucleosis can debilitate patients for weeks to months and, in some cases, can lead to hospitalization and splenic rupture. EBV infection is associated with the development and progression of certain lymphoproliferative disorders, cancers, and autoimmune diseases. In particular, EBV infection and infectious mononucleosis are associated with increased risk of developing multiple sclerosis, an autoimmune disease of the central nervous system. There is no approved vaccine or effective treatment for EBV. Similar to CMV, EBV has lytic and latent stages in its lifecycle and contains on its surface (envelope) multiple glycoproteins and glycoprotein complexes (gp350, gH/gL, gH/gL/gp42 and gB) that mediate virus entry and infection in different cell types. EBV gp350 mediates attachment to B cells through binding to the complement receptor 2 (CR2), followed by binding of the viral gH/gL/gp42 complex to human leukocyte antigen (HLA) class II. Infection of epithelial cells instead requires binding of gH/gL to a different set of receptors. For both B cell and epithelial cell entry, binding of an EBV gH/gL complex to a cell-specific receptor leads to activation of gB, which in turn facilitates virus-cell-membrane fusion and infection. gH/gL and gB comprise the core viral-fusion machinery conserved across all herpesviruses.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to our CMV vaccine (mRNA-1647) product concept, we used our platform to generate an mRNA vaccine containing five mRNAs encoding for gp350, gB, gH, gL, and gp42, which are expressed in their native membrane-bound conformation for recognition by the immune system. We have observed preclinical immunogenicity in the form of high and durable levels of antigen-specific antibodies against both B cell and epithelial cell infection in mice and in non-human primates (NHPs). We intend to conduct a Phase 1 trial to test the safety and immunogenicity of the vaccine to understand its potential to prevent primary infection, and prevent infectious mononucleosis following EBV infection, in seronegative adults.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Epstein-Barr Virus: Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EBV is the major cause (approximately 90%) of infectious mononucleosis and has been associated with the development of a range of malignancies and autoimmune disorders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EBV is a common herpesvirus that is spread through bodily fluids, most commonly saliva, and is contracted primarily by young children and adolescents. Adolescents and young adults seroconvert at high rates, particularly in college-aged populations (approximately 10-25% per year) resulting a seroprevalence of approximately 90% by the age of 20. After primary infection, the virus establishes latency and persists in that state for life in most infected individuals. The virus can reactivate intermittently over time even in immunocompetent hosts. The virus usually infects resting B cells in the oropharynx or epithelial cells, which line the mucosal surfaces of the body and in turn infect B cells. B cells disseminate systemically and act as a reservoir for latent virus. Primary infection can cause infectious mononucleosis in 35% to 75% of instances, depending on age, and is characterized by symptoms requiring physician visits, including sore throat, lymph node swelling, fever, body aches and fatigue, often resulting in months of missed work and school for patients and caregivers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is currently no approved vaccine against EBV, but the potential of gp350 alone to reduce the rate of infectious mononucleosis has already been clinically demonstrated. An experimental vaccine, developed by others, consisting of adjuvanted recombinant gp350 protein led to a reduction in the incidence of infectious mononucleosis in 78% of the participants in a Phase 2 study of 181 healthy volunteers between the ages of 16-25. However, there was no significant difference between groups in protection against asymptomatic EBV infection. We believe that the addition of gH/gL and gB has the potential to provide protection against epithelial cell infection. We believe the immune response against gp350, gH/gL or gB has the potential to provide B cell protection, which may be further enhanced by the inclusion of gp42. By preventing infection in epithelial cells and B cells, this mRNA vaccine has the potential not only to significantly reduce the rate of infectious mononucleosis, but also to prevent EBV infection.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EBV infection is associated with increased risk of developing certain cancers and multiple sclerosis. In Western industrialized countries, EBV is implicated in the development of post-transplant lymphoproliferative disorder conditions as well as multiple cancers, including Hodgkin&#8217;s lymphoma. Additionally, in those seropositive for EBV, development of infectious mononucleosis is associated with a greater than 2-fold increased relative lifetime risk of developing multiple sclerosis. In East Asia, EBV is associated with 80-99% of nasopharyngeal carcinomas that arise. In Africa, EBV is implicated in the development of approximately 95% of cases of endemic Burkitt&#8217;s lymphoma. Together, approximately 1.5% of worldwide cancer deaths are attributable to EBV-associated malignancies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EBV vaccine (mRNA-1189): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are developing a vaccine with multiple antigens designed to prevent development of infectious mononucleosis and EBV infections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to our CMV vaccine (mRNA-1647) product concept, we believe that an effective EBV vaccine must generate an immune response to antigens that are required for viral entry in most of the susceptible cell types. We have thus designed our EBV vaccine, mRNA-1189, to elicit an immune response to EBV envelope glycoproteins gp350 as well as gB, gp42, and the gH/gL complex, which are required for infection of both epithelial and B cells. mRNA-1189 contains five mRNAs encoding the viral proteins gp350, gB, gp42, gH, and gL encapsulated in our proprietary LNPs. Proteins translated from our mRNA will be displayed on the cell surface in their native conformation, stimulating the production of neutralizing antibodies. By training the immune system to recognize and neutralize the machinery used to infect B and epithelial cells, we believe that our vaccine has the potential to prevent EBV primary infection and therefore the development of infectious mononucleosis. Further, in the long-run, should our EBV vaccine be approved, we may pursue post-marketing and population studies to potentially evaluate its impact on other EBV-associated diseases. Our EBV vaccine utilizes the same proprietary platform technology as our CMV vaccine (mRNA-1647), which was generally well-tolerated and demonstrated durable neutralizing antibody titers higher than those measured in CMV-seropositive patients following up to three doses of mRNA-1647 in our Phase 1 trial.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EBV vaccine (mRNA-1189): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have demonstrated the ability to induce antibodies against EBV antigens required for viral entry into B cells and epithelial cells.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Na&#239;ve Balb/c mice were given two doses of a vaccine against EBV antigens in combination approximately four weeks apart. Antibody titers against viral proteins involved in epithelial cell entry (gH/gL and gB) or B cell entry (gp350, gH/gL and gB) were measured in peripheral blood at day 57. Results shown here represent five animals per group and demonstrate high levels of antigen-specific immunoglobulin G (IgG) as compared to negative controls.</span></div><div style="margin-top:12pt;text-align:center"><img src="mrna-20201231_g27.jpg" alt="mrna-20201231_g27.jpg" style="height:348px;margin-bottom:5pt;vertical-align:text-bottom;width:470px"/></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EBV vaccine (mRNA-1189): Clinical plan</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are planning a Phase 1 clinical trial to test the safety and immunogenicity of mRNA-1189 in seronegative adults.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to conduct a Phase 1 trial to test the safety and immunogenicity of the vaccine to understand its potential to prevent primary infection, and prevent infectious mononucleosis following EBV infection, in seronegative adults.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROPHYLACTIC VACCINES: GLOBAL HEALTH PROGRAMS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global health portfolio for prophylactic vaccines seeks to leverage our mRNA technology to address epidemic and pandemic diseases. We are currently working with strategic collaborators such as BARDA, DARPA, NIH, the Bill and Melinda Gates Foundation and the International AIDS Vaccine Initiative (IAVI) to fund and support our programs within this area. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Zika vaccine (mRNA-1893)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In collaboration with BARDA, we have advanced a second generation Zika vaccine candidate to a Phase 1 clinical trial</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zika is an infectious disease caused by the Zika virus; infection during pregnancy has been linked to severe brain damage in infants with congenital infection and Guillain-Barr&#233; Syndrome in adults. To date, no vaccine to prevent Zika infection has been approved. In September 2016, we were awarded a contract with BARDA to be reimbursed up to approximately $125.0 million for the development of a Zika mRNA vaccine. Preclinical and clinical studies were carried out on an initial candidate, mRNA-1325. When a second-generation Zika vaccine, mRNA-1893, demonstrated better protection than mRNA-1325 in non-human primates at 1/20 of the dose, we decided to move forward with mRNA-1893 and discontinue development of mRNA-1325. mRNA-1893 is currently under evaluation in a Phase 1 trial in the United States. Enrollment and dosing are complete, and the interim analysis is available. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zika vaccine (mRNA-1893): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We faced a Zika epidemic in 2015 for which there were no vaccines or treatments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Zika virus is a single stranded RNA virus of the flaviviridae family. It was first isolated in a rhesus macaque in the Zika Forest, Uganda in 1947 and the first human case was documented in 1952. Seroepidemiology data suggest that it is endemic to regions of Africa and Asia where the Aedes mosquito vectors are found. Zika virus is predominantly spread by mosquitos from the Aedes genus, but it can also be transmitted congenitally, sexually, and through blood donation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zika infection is usually asymptomatic or mild in adults, leading to fever, rash, and conjunctivitis. However, infection of women during pregnancy can result in devastating microcephaly in newborns. Microcephaly is a birth defect characterized by an abnormally small head and brain, associated with lifelong neurodevelopmental delay, seizures, intellectual disability, balance problems, and dwarfism / short stature, resulting in significant disability and requiring lifelong support.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2007, a Zika infection outbreak progressed across the Pacific islands. An outbreak observed in Brazil in 2015 soon spread across the Americas. This led to the WHO declaring it a public health emergency of international concern in 2016. During the period, there were tens of thousands of cases of microcephaly and congenital Zika syndrome reported in infants and of resulting neurological sequelae such as Guillain-Barr&#233; syndrome reported in adults.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the number of cases has declined in the past couple of years, there is currently no treatment or vaccine available for the Zika virus to prevent and respond to potential future epidemics.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zika vaccine (mRNA-1893): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A more immunogenic second-generation vaccine was rapidly advanced to a Phase 1 clinical trial </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continued efforts at identifying different mRNA sequences with improved immunogenicity led to mRNA-1893, a sequence distinct from the first Zika vaccine candidate, mRNA-1325, that increases production of Zika viral-like particles (VLPs) and generates enhanced immunogenicity and protection in preclinical animal models compared with mRNA-1325, as depicted in the image below. </span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g28.jpg" alt="mrna-20201231_g28.jpg" style="height:295px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Zika vaccine (mRNA-1893): Clinical data</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are conducting a Phase 1 trial for mRNA-1893 in the United States. The results of the Phase 1 study support continued clinical development of mRNA-1893 and a Phase 2 study is planned for initiation in 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dosing has been completed in a Phase 1 randomized, observer-blind, placebo-controlled, dose-ranging study to evaluate the safety, tolerability, and immunogenicity of mRNA-1893 in healthy adults (18 to 49 years of age, inclusive) in endemic and non-endemic Zika regions. Key objectives of the study include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assessing the safety, tolerability, and reactogenicity of a 2&#8209;dose vaccination schedule of mRNA-1893 Zika vaccine, given 28 days apart, across a range of dose levels in flavivirus-seronegative and flavivirus-seropositive participants compared with placebo;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">Assessing the immunogenicity of a range of doses of mRNA-1893 Zika vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subjects were randomly assigned in a blinded fashion in an approximate 4:1 ratio to receive mRNA-1893 or placebo at one of four dose levels (10 &#181;g, 30 &#181;g, 100 &#181;g, and 250 &#181;g), with each subject receiving two vaccinations separated by 28 days. Twenty-five of the enrolled participants at each dose level were flavivirus seronegative and five were flavivirus seropositive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA-1893 was well tolerated at all dose levels, and safety and tolerability did not appear to be influenced by the serostatus of the participants at baseline. ZIKV-specific neutralizing antibodies were measured by Plaque Reduction Neutralization Test (PRNT50) and Microneutralization (MN). All dose levels of mRNA-1893 induced a strong neutralizing ZIKV-specific antibody response in baseline flavivirus seronegative participants. </span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> GMTs post-dose two were comparable to those in a small panel of Zika convalescent sera collected during the epidemic. In participants with pre-existing flavivirus antibodies, neutralizing antibody titers were boosted with a single dose of the vaccine as shown by the GMTs and the seroconversion rates. The participants will continue to be followed through 12 months to measure antibody persistence with time and to monitor safety.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">HIV vaccine program (mRNA-1644 &amp; mRNA-1574)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are advancing two development candidates against HIV &#8211; Phase 1 innovation is needed to accelerate human validation of novel strategies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA-1644, a collaboration with the IAVI and the Bill and Melinda Gates Foundation, is a novel strategy and approach to vaccination against human immunodeficiency virus (HIV) in humans designed to elicit broadly Neutralizing HIV-1 Antibodies (bNAbs). A Phase 1 study for mRNA-1644 will be the first trial in a series of human studies to iteratively test and improve HIV vaccine antigens that elicit bNAbs using a germline-targeting and immuno-focusing. A second trial, mRNA-1574, is being evaluated in collaboration with NIH and includes multiple native-like trimer antigens.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to begin Phase 1 clinical trials for both mRNA-1644 and mRNA-1574 in 2021. These programs have the potential to inform the future of the HIV vaccine field, and provide an opportunity for our mRNA technology to play a key role in accelerating the discovery of a protective HIV vaccine. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIV vaccine program (mRNA-1644 &amp; mRNA-1574): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIV is the virus responsible for acquired immunodeficiency syndrome (AIDS), a lifelong, progressive illness with no effective cure. Approximately 38 million people worldwide are currently living with HIV, with 1.2 million in the U.S. Approximately 2 million new infections of HIV are acquired worldwide every year and approximately 690,000 people die annually due to complications from HIV/AIDS. The primary routes of transmission are sexual intercourse and IV drug use, putting young adults at the highest risk of infection. From 2000 to 2015, a total of $562.6 billion globally was spent on care, treatment and prevention of HIV, representing a significant economic burden. There are no approved HIV vaccines and no effective cure. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Nipah vaccine (mRNA-1215)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are collaborating with the NIH-VRC for pandemic preparedness </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA-1215, our vaccine candidate against the Nipah virus (NiV), was co-developed along with the NIH-VRC. The Phase 1 clinical testing will be focused on pandemic preparedness. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nipah vaccine (mRNA-1215): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NiV is a zoonotic virus transmitted to humans from animals, contaminated food, or through direct human-to-human transmission and causes a range of illnesses including fatal encephalitis. Severe respiratory and neurologic complications from NiV have no treatment other than intensive supportive care. The case fatality rate among those infected is estimated at 40-75%. NiV outbreaks cause significant economic burden to impacted regions due to loss of human life and interventions to prevent further spread, such as the slaughter of infected animals. NiV has been identified as the cause of isolated outbreaks in India, Bangladesh, Malaysia, and Singapore since 2000 and is included on the WHO R&amp;D Blueprint list of epidemic threats needing urgent R&amp;D action. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">H7N9 influenza vaccine (mRNA-1851)</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">H7N9 investigational vaccine demonstrates the potential of our platform to respond to an influenza pandemic</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a proof of concept and as part of our earlier efforts to develop a vaccine against influenza, we developed vaccines for H10N8 and H7N9 avian influenza strains, where there is a quantitative correlate for protection in humans (hemagglutinin inhibition, or HAI, titer of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1:40). The results of the Phase 1 trial for H7N9 vaccine were reported by us in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vaccine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2019. The trial has met its objectives of assessing the safety and tolerability profile of mRNA-1851 versus placebo, including capturing solicited and unsolicited local and systemic adverse events. The Phase 1 trial for H7N9 vaccine has also demonstrated immunogenicity and we have observed 96% of the subjects demonstrating HAI titers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1:40 at day 43 (21 days post-second vaccination) for the 25 &#181;g dose where HAI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 1:40 is regarded as a quantitative measure for protection from influenza. We believe the data provides support to advance the program in clinical development if we choose to with additional government or other funding. However, we do not intend to progress the H7N9 vaccine through clinical development on our own.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SYSTEMIC SECRETED AND CELL SURFACE THERAPEUTICS MODALITY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designed our systemic secreted therapeutics modality to increase levels of desired secreted proteins in circulation or in contact with the extracellular environment, in order to achieve a therapeutic effect in one or more tissues or cell types. The goal of this modality is to provide secreted proteins, such as antibodies or enzyme replacement therapies across a wide range of diseases, such as heart failure, infectious diseases, and rare genetic diseases. This modality has benefited from our strategic alliances with AstraZeneca, DARPA, and the Bill and Melinda Gates Foundation. We have accumulated several innovations in technology, have gained process insights, and have built a set of preclinical and clinical experiences in our systemic secreted and cell surface therapeutics modality. Based on these, we believe this modality is core to our portfolio and we have expanded this portfolio with two new development candidates in a new autoimmune therapeutic area in 2020. Our systemic secreted and cell surface therapeutics modality has four development candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Systemic secreted and cell surface therapeutics: Opportunity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability to systemically deliver mRNA for a therapeutic effect would allow us to address a number of diseases of high unmet medical need. Systemically delivered, secreted and cell surface therapeutics address conditions often treated with recombinant proteins that are typically administered to the blood stream. These current therapies include, for example:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enzyme replacement therapies, or ERTs, for rare diseases;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Antibodies for membrane and extracellular soluble targets; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Circulating modulation factors for common and rare diseases such as growth factors and insulin.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Systemic secreted and cell surface therapeutics: Product features</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systemically delivered, secreted and cell surface therapeutics, we believe, would allow us to target areas of biology that cannot be addressed using recombinant proteins. Our potential advantages in these areas include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA can produce hard-to-make or complex secreted proteins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Some proteins, due to their folding requirements or complexity, are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">challenging to make using recombinant technologies, but can potentially be produced by human cells using administered mRNA.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA can produce membrane associated proteins. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In contrast to recombinant proteins, mRNA can lead to the production of membrane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">associated proteins on the cell surface, allowing the expression of native forms of signaling receptors or other cell surface complexes.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Native post-translational modifications are possible through intracellular protein production using mRNA. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA administered to a human</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cell uses natural secretory pathways inside the cell to make and process the encoded protein. The resulting post-translational modifications, such as glycosylation, are human. With recombinant proteins, these post-translational modifications are native to the non-human cells used for manufacture. These non-human post-translational modifications in recombinant proteins may lead to sub-optimal therapeutic outcomes, side effects, and increased immunogenicity.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA can sustain production of proteins, which can increase exposure to proteins with short half-lives. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA can lead to protein</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">production by cells that can last from hours to days depending on design. This feature could increase the levels of short half-life proteins for therapeutic benefit.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA allows for desirable pharmacology in rare genetic diseases currently addressed by enzyme replacement therapies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mRNA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology potentially permits several differentiated pharmacologic features for treating rare genetic diseases currently addressed by enzyme replacement therapies, including the ability to repeat dose as needed, lower immunogenicity of the replacement protein, the ability to adjust dose levels in real-time based on individual patient needs, and the ability to stop dosing. Gene therapies may also prove to be useful for treating rare genetic diseases; however, mRNA is not limited by pre-existing immunity that may exist for certain gene therapies using viral vectors, and does not localize to the nucleus or require persistent changes to cellular DNA to have the desired effect.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Our approach</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our systemic secreted and cell surface therapeutics modality comprises programs where mRNAs instruct various cells of the human body to secrete proteins for therapeutic effect. For systemic therapeutic programs that utilize cells in the liver, the liver is a highly productive tissue for secreted protein production. The human liver can make tens of grams of proteins per day, well above the amounts necessary for the pharmacologic effect for virtually all protein therapeutics. We have demonstrated that mRNA can make and secrete monoclonal antibodies and soluble modulating factors in non-human primates. These proteins made in non-human primates can exert their pharmacological activity by binding to targets with biological effect. Recombinant protein therapeutics, which focus on secreted proteins, generate over $200 billion in annual worldwide sales.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Antibody against Chikungunya virus (mRNA-1944)</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systemic mRNA administration to instruct cells to secrete antibodies, in this case for passive immunization to prevent Chikungunya infection</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are using this program to help understand how mRNA can be used to make complex secreted proteins in the human body and to address the potential health threat of Chikungunya virus, particularly for the military and others exposed to this virus. This program highlights a potentially important advancement of our platform and expansion of our modalities.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chikungunya is a serious health problem and is estimated to have caused at least 3 million cases during the 2005-2015 epidemic. There are no available vaccines or prophylactic treatments for this disease. This virus can cause severe and chronic arthritic-like conditions in up to 50% of infected people. This program offers a passive immunization approach using antibodies to prevent infection, to complement our vaccine approach. In this program, we utilize two mRNAs encoding for light chain and heavy chain of an antibody against the envelope glycoprotein E. We administered these mRNAs encapsulated in our proprietary LNPs intravenously to people to prevent infection by the Chikungunya virus. We are being financially supported for specific activities by DARPA. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antibody against Chikungunya virus (mRNA-1944): Disease overview</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Addressing a significant global health need</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chikungunya virus is a mosquito-borne alphavirus posing a significant public health problem in tropical and subtropical regions. While Chikungunya has been present in Africa for centuries, recent outbreaks and epidemics in new regions have arisen due to the expanding distribution of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aedes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mosquito in which it resides. A Chikungunya epidemic beginning in 2004 in Kenya spread to India and was exported to nearly all regions of the world and brought Chikungunya to the attention of the western world. As of April 2016, Chikungunya cases had been reported in 103 countries and territories around the world, including 46 countries and territories throughout the Americas.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chikungunya virus infection is characterized by an acute onset of fever, rash, myalgia, and sometimes debilitating polyarthralgia, giving the virus its name, which means &#8220;that which bends up&#8221; when translated from Makonde. While generally non-fatal, neurological sequelae such as Guillain-Barre syndrome and chronic arthritis have been recognized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chikungunya virus is an alphavirus of the Togaviridae family with a positive-strand RNA genome. The viral structural proteins are naturally expressed as a single polyprotein followed by subsequent cleavage by viral and cellular proteases into capsid (C) and envelope (E) glycoproteins E3, E2, 6k, and E1. The E proteins are major targets of protective neutralizing antibody responses that can be assessed in assays. In animal models, passive immunotherapy with convalescent sera from Chikungunya infected patients and human Chikungunya virus-specific neutralizing monoclonal antibodies that mainly recognize E2, have been shown to prevent CHKV infection, providing an approach for therapy. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are currently no effective therapies or approved vaccines to treat or prevent Chikungunya infection or disease, and effective mosquito control has proven challenging, even in higher income countries. Currently, infected individuals are treated with non-steroidal anti-inflammatory drugs to relieve some symptoms. Therefore, in addition to an effective prophylactic vaccine, we believe there is a need for systemic secreted antibody with the potential to provide passive immunity both prophylactically in susceptible populations and for treatment of active Chikungunya virus infections.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antibody against Chikungunya virus (mRNA-1944): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A systemically delivered mRNA instructing cells to secrete an antibody to glycoprotein E to neutralize Chikungunya</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The mRNA-1944 development candidate contains two mRNAs that encode the heavy and light chains of the Chikungunya antibody and utilizes our proprietary LNPs. The mRNA-1944 development candidate encodes a fully human IgG antibody isolated from B cells of a patient with a prior history of Chikungunya infection that targets the E2 protein. The systemic antibody against Chikungunya virus titers can be evaluated in clinical trials by enzyme-linked immunosorbent assay, or ELISA, to quantify the amount of expressed IgG. A neutralization assay can be used to ensure that the mRNA expressed antibody was properly folded and functional.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antibody against Chikungunya virus (mRNA-1944): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systemic mRNA administration results in antibody production and protection from Chikungunya infection in animals</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In preclinical studies, mRNA-1944 administered by infusion, elicited high levels of neutralizing antibodies in a dose-dependent manner that were protective against arthritis, musculoskeletal tissue infection and lethal challenge in mouse models. After treatment with 0.5 mg/kg of mRNA-1944, complete survival of mice was observed when challenged 24 hours post-prophylaxis with Chikungunya virus. In cynomolgus macaques following infusion of a single-dose of mRNA-1944 at 0.5 mg/kg, mean maximum concentrations of human Chikungunya antibodies (10.1-35.9 &#181;g/ml) were reached at 24 hours that exceeded the levels needed for protection in mice with a half-life of 23 day.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, mRNA-1944 was tested in rats and non-human primates in a repeat-dose study via IV infusion at up to 5 and 3 mg/kg, respectively. No dose-limiting toxicities related to mRNA-1944 were observed and all other observations were generally reversible.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antibody against Chikungunya virus (mRNA-1944): Clinical data</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Two-dose regimen of Chikungunya antibody demonstrates the platform&#8217;s ability for safe repeat doing</span></div><div><span><br/></span></div><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are conducting a Phase 1, randomized, placebo-controlled dose-escalation study of mRNA-1944 in healthy adults. The objective of this first-in-human study is to evaluate the safety and tolerability of escalating single doses of mRNA-1944 at 0.1 and 0.3 mg/kg, and 0.6 mg/kg with and without dexamethasone included in the premedication regimen with 8 subjects per cohort, and 2 weekly doses of 0.3 mg/kg administered via intravenous infusion. No further dose escalation beyond 0.6 mg/kg is planned. Other objectives are to determine the pharmacokinetics of all dose levels of mRNA-1944, to determine if the antibodies produced are sufficiently active to neutralize viral infection in assays and to determine the pharmacodynamics of anti-Chikungunya virus IgG levels. The safety monitoring committee, or SMC, reviews the safety data for the dose level and recommends escalation to the next dose level. </span></div><div><span><br/></span></div><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019 we announced that single doses of mRNA-1944 at 0.1, 0.3 and 0.6 mg/kg resulted in levels of antibody that exceeded those expected to be protective against chikungunya infection (&gt;1 &#956;g/mL), and the 0.3 mg/kg and 0.6 mg/kg doses were projected to maintain antibody levels above protective levels for at least 16 weeks as shown in the panel below. The average serum antibody level was quantified at various time points to demonstrate a half-life of 62 days. No significant adverse events were observed at the low and middle doses; infusion-related adverse events were observed at the high dose, which resolved spontaneously without treatment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we announced positive interim data from the Phase 1 study evaluating escalating doses of mRNA-1944 at 0.1, 0.3 and 0.6 mg/kg dose with and without steroid premedication and two doses of 0.3 mg/kg given one week apart. Administration of mRNA-1944 at all doses resulted in dose-dependent increases in levels of antibody against Chikungunya virus with a mean half-life of ~69 days. Post-single doses of 0.3 and 0.6 mg/kg therapeutically-relevant concentrations of antibody (&gt;1 &#181;g/mL) were observed for 16 weeks. Neutralizing antibodies were observed at all dose levels, indicating functional antibody production by mRNA-1944. Across doses of mRNA-1944, adverse effects were mild-to-moderate in severity and transient, and none were serious. The most common adverse events were headache, na</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">usea, myalgia, dizziness and chills.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Following a second dose of mRNA-1944 at the 0.3 mg/kg level, a 1.8-fold increase in the concentration of chikungunya virus was observed, with no worsening or exacerbation of side effects, and no significant accumulation of mRNA, LNP components or acute phase reactants. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Phase 1 trial is ongoing in follow-up period during 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phase 1 interim analysis with two-dose regimen</span></div><div style="text-align:center"><img src="mrna-20201231_g29.jpg" alt="mrna-20201231_g29.jpg" style="height:659px;margin-bottom:5pt;vertical-align:text-bottom;width:668px"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Relaxin (mRNA-0184): Summary </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have regained rights to develop relaxin from AstraZeneca and are evaluating the program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until December 2020, we collaborated with AstraZeneca on mRNA encoding for a relaxin protein designed for a long duration of action. Relaxin is a well-studied natural protein hormone that is known to have cardiovascular protective effects. Earlier attempts at developing relaxin as a protein therapeutic have not been successful. We believe that engineering the relaxin protein for a longer duration, utilizing repeat dosing, and pursuing an alternate indication might overcome the shortcomings of earlier attempts. We use mRNA encoding for an engineered relaxin protein designed for a longer duration of action. It is also designed to be produced by the body with human post-translational modifications.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we regained the rights to the relaxin program from AstraZeneca (previously AZD7970). We are currently evaluating our options for advancing the program. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Autoimmune Therapeutic Area (mRN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">A-6981 and mRNA-6231) Introduction </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our company strategy continues to be to invest in our platform technology and scalable infrastructure to pursue a pipeline of potential medicines that reflect the breadth of the mRNA opportunity. In January 2020, we announced the entry into a fifth therapeutic area, autoimmune diseases, building on the clinical validation of the systemic delivery of mRNA provided by the Phase 1 clinical proof of concept of the chikungunya antibody program. Autoimmune diseases are characterized by immune activation in response to antigens normally present in the body, reflecting a loss of tolerance. Within this therapeutic area, we are developing two potential medicines, mRNA-6981 and mRNA-6231, designed to engage peripheral tolerance pathways to dampen autoimmune activation and help restore immune homeostasis, thereby reducing autoimmune pathology. In this modality, mRNA is delivered systemically to create proteins that are either secreted or expressed on the cell surface.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our approach to the treatment of autoimmune diseases is to leverage mechanisms of peripheral tolerance to modulate the immune system&#8217;s reaction to self-antigens.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scientific and technical advances enable our expansion into new therapeutic areas, the latest of which is autoimmune disease. Autoimmune diseases are defined by pathology resulting from an adaptive immune response against an antigen or antigens normally present within the body. Pathology is present in a variety of organs across autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, psoriasis, type 1 diabetes, multiple sclerosis, autoimmune hepatitis and related disorders such as graft vs host disease. Autoimmune diseases affect millions of patients worldwide, many of whose disease is not well-controlled by existing treatment options, and represent billions of dollars in healthcare costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In healthy people, autoimmune reactions are prevented or controlled by mechanisms of tolerance. Lymphocytes (e.g., T and B cells) that are reactive against self-antigens are deleted during development, thus establishing central tolerance. Central tolerance is not completely protective, and so other mechanisms, collectively known as peripheral tolerance, act on any self-reactive lymphocytes that escape central tolerance to control potential autoimmune pathology. These mechanisms of peripheral tolerance include induction of a reversible state of cellular non-responsiveness in self-reactive cells called anergy, and expression of inhibitory receptors or cytokines by other cells, such as dendritic cells, macrophages, and regulatory T cells (Tregs). The immune system works constantly to maintain balance between a state of immune activation and immune tolerance, sometimes called homeostasis. We are developing two potential medicines we believe have the potential to engage peripheral tolerance mechanisms to dampen autoimmune activation and help restore immune homeostasis. PD-L1 (mRNA-6981) aims to induce the expression of this inhibitory receptor on myeloid cells, and IL-2 (mRNA-6231) aims to preferentially increase the number of Tregs.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PD-L1 (mRNA-6981)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PD-L1 is a co-inhibitory receptor that can induce anergy in programmed cell death protein 1 (PD-1)-expressing T cells.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Antigen presenting cells, such as dendritic cells, form stable cell-cell junctions with T and B cells, called immune synapses, to communicate in three ways: Signal 1 (antigen presentation and recognition), Signal 2 (co-stimulatory signals to activate the cell) and Signal 3 (cytokines, chemokines, and certain metabolites to activate, repress, or modulate the immune response). When immune synapses occur in the context of high levels of co-inhibition, such as high levels of PD-L1 expressed on antigen presenting cells, this may result in the induction of peripheral regulatory T cells, induction of a reversible non-responsive state called anergy, or death of autoreactive lymphocytes due to removal of critical survival signals. Given their role in adaptive immune responses and their involvement in autoimmune disorders, dendritic cells and other myeloid populations have become a target of recent immunotherapies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PD-L1/PD-1 pathway has a critical function in immune regulation and promotes development and function of Tregs. PD-L1 is a transmembrane protein expressed on antigen presenting cells, such as dendritic cells and macrophages, activated T cells, B cells, and monocytes as well as peripheral tissues. Its cognate receptor, PD-1, is a co-inhibitory transmembrane protein expressed on T cells, B cells, natural killer cells and thymocytes. Engagement of PD-1 to PD-L1 results in decreased IL-2 production and glucose metabolism, with continued engagement leading to induction of T cell anergy or conversion of na&#239;ve cells into peripheral regulatory T cells. Engagement of PD-L1 with PD-1 also inhibits T cell proliferation, cytotoxic activity and cytokine production, and suppresses the reactivation of previously activated T effector cells.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preclinical mouse models deficient in PD-1 spontaneously develop a variety of autoimmune diseases such as arthritis, myocarditis, lupus-like glomerulonephritis and type 1 diabetes, demonstrating the critical role of the PD-L1/PD-1 interaction in maintaining tolerance to self-antigens. Additionally, treatment of cancer patients with PD-1 or PD-L1 inhibitors sometimes results in immune-related adverse events, including the development of hepatitis, dermatitis and colitis, demonstrating the role of PD-1/PD-L1 in human autoimmune reactions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our PD-L1 therapy may augment PD-L1 expression on cell types similar to those that endogenously express it, and by reducing immune activation, potentially reduce the clinical manifestations of a variety of autoimmune diseases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PD-L1 (mRNA-6981): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We intend to induce expression of PD-L1 on myeloid cells to send a tolerizing signal to immune cells in their environment in order to treat autoimmune diseases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intent is to use our platform to influence myeloid cells, including dendritic cells, to provide additional co-inhibitory signals by augmenting endogenous expression of PD-L1. We believe that this tolerizing signal to lymphocytes may limit autoreactivity in the context of ongoing autoimmune pathology without severe and global suppression of the immune system. Given that our platform allows us to modify myeloid cells </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in situ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our approach to the creation of a tolerogenic environment may provide unique benefits in treating autoimmune diseases by seeking to restore immune homeostasis. We believe the platform technologies used have already been substantially validated in humans; mRNA-6981 employs the same delivery technology used in clinical trials for our chikungunya antibody therapeutic, mRNA-1944. Results with mRNA-1944 demonstrate predictable dose-dependent pharmacology that translated effectively from preclinical species into humans.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g30.jpg" alt="mrna-20201231_g30.jpg" style="height:268px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PD-L1 (mRNA-6981): Preclinical information</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have observed disease modification in a range of preclinical models.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have investigated the effect of mRNA-6981 in multiple disease models. In one example, we evaluated mRNA-6981 in a rat model of arthritis. Animals were given a single injection of chicken collagen type II in incomplete Freund&#8217;s adjuvant in order to induce chronic arthritis-like symptoms. mRNA-6981 was dosed subcutaneously at four times per week and compared to a negative PBS control and a positive control of daily high dose dexamethasone (Dex). Arthritis-like symptoms included paw swelling and joint rigidity, which were scored as a proxy for disease severity. Compared to animals treated with PBS, animals treated with PD-L1 mRNA presented with consistently less severe disease similar to animals treated daily with dexamethasone for at least three weeks.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collagen-Induced Arthritis model</span></div><div style="text-align:center"><img src="mrna-20201231_g31.jpg" alt="mrna-20201231_g31.jpg" style="height:324px;margin-bottom:5pt;vertical-align:text-bottom;width:397px"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have investigated mRNA-6981 in a range of other preclinical models of autoimmune and related diseases, including type 1 diabetes, colitis and graft-versus-host disease, and observed disease-modifying activity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PD-L1 (mRNA-6981): Clinical plan </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are planning a Phase 1 clinical trial for patients with type 1 autoimmune hepatitis (AIH).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AIH is an autoimmune condition involving inflammation in the liver, which over time can lead to cirrhosis and liver failure. Type 1 AIH is characterized by a specific autoantibody profile and afflicts more than 75,000 patients in the U.S. Type 1 AIH is typically treated with steroids and azathioprine but some patients either do not respond to these treatments or are unable to tolerate them and are therefore in need of alternatives. A specific role for PD-L1 therapy in treating type 1 AIH is supported by clinical observations in cancer patients receiving PD-1/PD-L1 checkpoint inhibitor treatment: a noted adverse event is the development of AIH, which responds to discontinuation of checkpoint inhibitor therapy and treatment with corticosteroids. Checkpoint inhibitor-induced AIH has an identical histological and clinical manifestation compared to non-drug induced type 1 AIH. We believe that mRNA-6981 may provide benefit to type 1 AIH patients by increasing PD-L1 expression and plan to pursue proof-of-concept in type 1 AIH as a first step to addressing a range of autoimmune indications. We are planning a clinical trial to evaluate the safety, tolerability, pharmacology, and duration of the effect of mRNA-6981 in type 1 AIH patients refractory or intolerant to the standard of care.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IL-2 Mutein (mRNA-6231) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IL-2 is a critical cytokine for Treg activation and expansion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cytokines are potent modulators of the immune system, directing function and homeostasis. IL-2 is critically important to T cell survival and function. IL-2 acts through a receptor complex that can be dimeric, IL-2R&#223; (CD122) plus the common &#947; chain (CD132), or trimeric, which is formed through the addition of IL-2R&#945; (CD25) to the dimeric form. The trimeric form has 10-fold to 100-fold greater affinity for IL-2. Under low or homeostatic IL-2 conditions, those cells which preferentially express the trimeric receptor, or IL-2R, such as Tregs and very recently activated effector T cells, are activated. Conversely, those cells that express the dimeric form, such as na&#239;ve or antigen-experienced cytotoxic T cells and natural killer cells (NK cells), are only activated by much higher concentrations of IL-2. Tregs play an obligate role in maintaining peripheral tolerance through the control of effector T cell responses, and several strategies are being developed to exploit IL-2 to treat autoimmune disease by selectively enhancing Treg function. These include recombinant protein forms of IL-2/mAb complexes, IL-2 Muteins and low-dose IL-2.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IL-2 Mutein (mRNA-6231): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We intend to utilize subcutaneous mRNA administration to produce a version of IL-2 that is potentially longer acting and more selective for the trimeric IL-2 receptor (IL-2R) in order to treat autoimmune diseases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IL-2-based therapeutics are being clinically evaluated for a wide range of immune-mediated disorders, including rheumatoid arthritis, systemic lupus erythematosus, graft versus host disease, inflammatory bowel diseases, and autoimmune hepatitis. We believe that our platform can be exploited to produce a modified IL-2 for the treatment of autoimmune conditions. Our modified IL-2 is engineered with mutations that selectively decrease binding to the dimeric IL-2 receptor present on CD4+ and CD8+ T effector cells and NK cells, and increase reliance upon CD25 of the trimeric IL-2 receptor complex to trigger the signaling cascade in regulatory T cells. Our modified IL-2 is also expressed as a fusion protein to extend its half-life in the serum. This will be the first demonstration of subcutaneous administration of the delivery technology that is also used in clinical trials for our chikungunya antibody therapeutic, mRNA-1944.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IL-2 Mutein (mRNA-6231): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have observed preferential expansion of Tregs in non-human primates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preclinical studies have been conducted using mouse homologs as well as cynomolgus monkeys. In one example, monkeys were dosed subcutaneously with a single dose of mRNA-6231 and T cells in the peripheral blood were monitored on days 1, 3, 5, 8, and 14. The percentage of Tregs (CD4+ T cells that were also FoxP3+) increased about 12-fold (average across N=4 animals) at their maximum (day 8 post-dosing). Conversely, the percentage of activated CD8+ conventional T cells (that co-express CD25) did not significantly increase over baseline at any time during the monitoring period, illustrating the preferential expansion of Tregs by the IL-2 Mutein.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g32.jpg" alt="mrna-20201231_g32.jpg" style="height:173px;margin-bottom:5pt;vertical-align:text-bottom;width:540px"/></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IL-2 Mutein (mRNA-6231): Clinical plan </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are planning a Phase 1 clinical trial in normal healthy volunteers to assess safety, tolerability, pharmacokinetics and pharmacodynamics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to conduct a Phase 1 dose escalation study of mRNA-6231 in adult healthy volunteers. The objectives of this study are to evaluate the safety and tolerability of mRNA-6231, to assess the pharmacodynamic response through Treg selective expansion, activation and duration, and to characterize the pharmacokinetic profile of mRNA-6231 in expressing IL-2 in the serum following subcutaneous administration.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CANCER VACCINES MODALITY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designed our cancer vaccines modality to treat or cure cancer by enhancing immune responses to tumor neoantigens, defined below. This modality has two programs currently for neoantigen vaccines, a personalized cancer vaccine, or PCV, program, and a vaccine against neoantigens related to a common oncogene called KRAS, both conducted in collaboration with Merck. The goal of a cancer vaccine is to safely expose the patient&#8217;s immune system to tumor related antigens, known as neoantigens, to enable the immune system to elicit a more effective antitumor response. Our cancer vaccines modality is focused on the use of mRNA to express neoantigens found in a particular tumor in order to elicit an immune response via T cells that recognize those neoantigens, and therefore the tumor. These neoantigens can either be unique to a patient, as in the case of our personalized cancer vaccine program, or can be related to a driver oncogene found across subsets of patients, as in the case of our KRAS vaccine program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More than 1.8 million new cancer cases and approximately 600,000 deaths due to cancer were predicted in the United States for 2020, according to the NIH. Despite the recent success of checkpoint inhibitors, the majority of patients with the most common types of epithelial cancer still do not benefit from checkpoint inhibitors, as many patients still have incomplete or no response to currently available therapies. In addition, treatment resistance is thought to arise from a number of mechanisms, principally the local immunosuppressive effects of cancer cells, which prevent either access to or recognition by T cells.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recent breakthroughs in cancer immunotherapy, such as checkpoint inhibitors and chimeric antigen receptor T cell therapies, have demonstrated that powerful antitumor responses can be achieved by activating antigen specific T cells. We believe one approach to improve the efficacy of checkpoint inhibitors is to develop vaccines that increase both the number and antitumor activity of a patient&#8217;s T cells that recognize tumor neoantigens. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cancer vaccines: Product features</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that mRNA technology is an attractive approach for cancer vaccines for many reasons, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA vaccines can deliver multiple neoantigens concatenated in a single mRNA molecule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We currently encode up to 34 neoantigens in one of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our personalized cancer vaccines (mRNA-4157), and four KRAS mutations in our KRAS vaccine (mRNA-5671). Given that a T cell response against a single antigen has the potential to eradicate cancer cells, we believe that delivering multiple neoantigens could increase the probability of a successful treatment outcome for a patient.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA encoding for neoantigens is translated and processed by patients&#8217; endogenous cellular mechanisms for presentation to the immune system</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neoantigen peptides are then potentially processed in multiple ways to give rise to different, smaller peptides for presentation by the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">immune system. We believe this endogenous antigen production and presentation has the potential to drive a more effective immune response.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA vaccines can be efficiently personalized. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shared features of mRNA, combined with our investments in automated manufacturing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology, enable us to manufacture individual cGMP batches of personalized cancer vaccines rapidly, in parallel. For example, we have demonstrated the ability to manufacture and release a &#8220;custom-designed&#8221; vaccine for an individual patient within 60 days of sequencing the patient&#8217;s tumor for the personalized cancer vaccine program (mRNA-4157).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Personalized Cancer Vaccines (PCV) (mRNA-4157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our personalized cancer vaccine, or PCV, is currently being evaluated in a Phase 1 and a Phase 2 study. The Phase 1 trial is assessing mRNA-4157 alone and in combination with KEYTRUDA&#174;. The Phase 2 trial is assessing the mRNA-4157 in combination with KEYTRUDA vs. KEYTRUDA alone. (KEYTRUDA is a registered trademark of Merck Sharp &amp; Dohme Corp.)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PCV (mRNA-4157): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As tumors grow they acquire mutations, some of which create new protein sequences, or neoantigens, that can be presented on HLA molecules in the tumor and recognized as non-self by T cells. These neoantigens can be shared, as in mRNA-5671, or are completely unique to an individual patient&#8217;s tumor. In addition to the neoantigens being unique and patient specific, the presentation of those neoantigens is also dependent on a patient&#8217;s specific HLA type. Identification of patient-specific HLA type and tumor neoantigens through next generation sequencing paired with our proprietary, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in silico</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> design of each patient&#8217;s mRNA </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vaccine and rapid manufacturing for a specific patient allows us to rapidly deliver a completely unique and personalized medicine to patients.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our personalized cancer vaccine program, mRNA-4157, consists of an mRNA that encodes up to 34 neoantigens, predicted to elicit both class I (CD8) and class II (CD4) responses, designed against each individual patient&#8217;s tumor mutations and specific to their HLA type. The neoantigens are encoded in a single mRNA sequence and formulated in our proprietary LNPs designed for intramuscular injection. The mRNA sequence is then manufactured using an automated workflow to enable a rapid turnaround time. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PCV (mRNA-4157): Clinical data</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Phase 1 trial is an open-label, multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with the checkpoint inhibitor, pembrolizumab (marketed in the United States as KEYTRUDA), in subjects with resected and unresected solid tumors. mRNA-4157 is administered on the first day of each 21-day cycle for a maximum of nine doses. mRNA-4157 is administered as monotherapy (Part A) or in combination with pembrolizumab (Parts, B, C, and D) in the United States. Studies have shown mRNA-4157 to be well tolerated at all dose levels. The majority of adverse events from mRNA-4157 have been low grade and reversible. Encouraging data emerging from an expansion arm in patients with head and neck cancer has recently caused us to increase the size of that cohort, which continues to recruit trial participants. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The randomized Phase 2 trial will assess whether post-operative adjuvant therapy with mRNA-4157 in combination with pembrolizumab, improves relapse-free survival compared to pembrolizumab alone.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">KRAS vaccine (mRNA-5671)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finding oncogenic driver mutations that encode targetable T cell epitopes has considerable therapeutic implications. Point mutations in the KRAS gene occur in about 22% of human cancers, such as colorectal, non-small cell lung and pancreatic cancers. It has been reported that KRAS-mutant neoantigens can be presented on certain human HLAs. We have designed an mRNA to generate and present KRAS neoantigens to the immune system from the four most common </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">KRAS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mutations. The Phase 1 trial is being conducted by Merck and is currently ongoing in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">KRAS vaccine (mRNA-5671): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Oncogenic driver mutations that encode targetable T cell neoantigens have considerable potential therapeutic implications: (1) driver mutations are subject to positive selection, as they confer survival advantages for the tumor, and (2) such neoantigens could be shared between patients, enabling an easier approach to developing and manufacturing such therapeutic or curative interventions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KRAS is a frequently mutated oncogene in epithelial cancers, primarily lung, colorectal cancer, or CRC, and pancreatic cancers. The four most prevalent KRAS mutations associated with these malignancies are G12D, G12V, G13D, and G12C, which constitute 80% to 90% of KRAS mutations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">KRAS vaccine (mRNA-5671): Clinical plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Merck is conducting an open-label, multi-center, dose-escalation and dose expansion Phase 1 study to evaluate the safety and tolerability of mRNA-5671 administered as an intramuscular injection both as a monotherapy and in combination with pembrolizumab. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">INTRATUMORAL IMMUNO-ONCOLOGY MODALITY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designed our intratumoral immuno-oncology modality to treat or cure cancer by transforming the tumor microenvironment to drive anti-cancer T cell responses against tumors. Our mRNA technology within this modality allows for the combination of multiple therapeutics that can be directly injected into a tumor with the goal of activating immune cells to kill cancer cells in the injected tumor as well as in distal tumors, known as the abscopal effect. Intratumoral administration allows for localized effect of these therapeutics that could be toxic if administered systemically. This exploratory modality has three development candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, more than 1.8 million new cancer cases and approximately 600,000 deaths due to cancer were predicted in the United States for 2020, according to the NIH. There have been several advances in the treatment of cancer through immune-mediated therapies in recent years. However, the outlook for many patients with advanced cancer remains poor, especially in tumors that have little immune system engagement and are sometimes termed immunologically &#8220;cold.&#8221; We aim to activate the tumor microenvironment with our mRNA therapeutic candidates, in conjunction with a checkpoint inhibitor, to activate the immune system against these otherwise immunologically cold tumors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intratumoral immuno-oncology: Our approach</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our approach to immuno-oncology using mRNA medicines could complement checkpoint inhibitors and has several advantages over recombinant protein-based drugs, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA focuses and limits exposure of immune stimulatory proteins. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the intrinsic properties of mRNA is its transient nature. This allows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for short exposure of the proteins encoded by the mRNA in the target tissue, thereby potentially enhancing tolerability.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA can produce membrane associated immune stimulatory proteins. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In contrast to recombinant proteins, mRNA administered to a tumor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">site can lead to the production of either secreted or membrane proteins, depending on the mRNA sequence.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Multiplexing of mRNA allows access to multiple immune stimulatory pathways</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ability to combine multiple mRNAs to express multiple</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proteins allows for activation of several immune pathways simultaneously. For example, OX40L/IL-23/IL-36&#947; (Triplet) (mRNA-2752) encodes for two secreted cytokines (IL-23 and IL-36&#947;) and one membrane protein (OX40L).</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA sequences can be engineered to reduce off-target effects. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA sequences can be designed to minimize translation in off-target tissues. For</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">immune-stimulatory proteins this can potentially prevent toxicities.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Local administration of mRNA can create a concentration gradient for encoded proteins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. mRNA administered intratumorally allows for the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">local production of encoded immune-stimulatory proteins, such as cytokines. The mRNA and encoded protein are expected to form a concentration gradient that decreases as a function of the distance from the tumor, thereby potentially lowering undesirable systemic effects and increasing immune-stimulatory effects close to the tumor.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OX40L (mRNA-2416)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been several recent advances in the treatment of cancer through activation of the immune system. However, many patients with advanced stages of cancer respond to few therapies and continue to face a poor outlook. Alternative strategies to activate an immunologic anti-tumor response, while at the same time reducing systemic toxicities, are required. To this end, we have developed an investigational mRNA therapeutic coding for wildtype OX40 ligand, or OX40L, protein, a membrane protein normally expressed on antigen presenting cells upon immune stimulation that augments an activated immune response. mRNA-2416 encodes for wild-type OX40L which is a membrane protein, a class of proteins that we believe cannot be manufactured for administration to tumor cells by recombinant technologies. mRNA-2416 is being developed for the treatment of solid tumors following local intratumoral injection. We are currently sponsoring a Phase 1/2 trial that is ongoing in the United States, which includes Phase 1 dose escalation cohorts of mRNA-2416 as monotherapy and in combination with durvalumab, followed by a Phase 2 expansion cohort in patients with advanced ovarian carcinoma in combination with durvalumab.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OX40L (mRNA-2416): Our product concept</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product consists of mRNA coding for the human sequence of OX40L formulated in our proprietary LNP. mRNA-2416 was designed to decrease the amount of protein that could be made in hepatocytes through incorporation of a microRNA binding site, thus potentially reducing off-target effects and resulting in better tolerability. Following intratumoral injection, a specific anti-tumor immune response is expected to be induced via proliferation and migration of T cell clones with specificity for the cancer that may also result in systemic anti-tumor responses. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OX40L (mRNA-2416): Clinical data</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Phase 1/2 trial for mRNA-2416 is an open-label, multicenter study of repeated intratumoral injections of mRNA-2416 as a monotherapy and in combination with durvalumab in patients with advanced relapsed/refractory solid tumor malignancies and lymphomas in the United States and Israel. The objectives of this Phase 1/2 study include evaluating safety and tolerability of mRNA-2416 administered intratumorally, and to define the maximum tolerated dose and recommended dose for expansion alone and in combination with durvalumab. Other endpoints include pharmacokinetic analyses as well as assessment of biomarkers of immunological response in tumor. The dose levels being tested in the monotherapy arm of the trial were 1 &#181;g, 2 &#181;g, 4 &#181;g, and 8 &#181;g. The monotherapy arm of the study has been completed and we are not planning an expansion cohort of mRNA-2416 as a monotherapy. We have completed a dose-finding cohort at 4 &#181;g mRNA-2416 given in combination with durvalumab (IMFINZI&#174;) and are currently enrolling a Phase 2 expansion cohort in ovarian cancer.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2021, 60 patients were dosed with mRNA-2416 (39 patients in monotherapy and 21 patients in combination with durvalumab). As of February 12, 2020, safety was reported on 39 patients treated with monotherapy mRNA-2416. mRNA-2416 has been tolerable at all dose levels with no dose-limiting toxicities reported and the majority of treatment related adverse events being grade 1 or 2. We have observed systemic injection related reactions in seven patients, all of which have been reversible. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the evaluable cases for patients dosed with mRNA-2416 as of November 13, 2019, 14 achieved a best overall response rate (BOR) of stable disease, of these patients 6 had stable disease for &#8805;14 weeks; 15 patients had progressive disease per RECIST 1.1. Clinical observations include a reduction in injected tumor size in two patients with ovarian cancer, one patient with breast cancer and one patient with pseudomyxoma peritonei.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OX40L/IL-23/IL-36</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#947;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (Triplet) (mRNA-2752): Clinical update</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite recent advances in immune-mediated therapies for cancer, the outlook for many patients with advanced cancer is poor. We are developing Triplet (mRNA-2752) and other programs to drive anti-cancer T cell responses by transforming cold tumor microenvironments into productive, &#8220;hotter&#8221; immune landscapes with local intratumoral therapies. Triplet (mRNA-2752) utilizes the intrinsic advantage of mRNA to multiplex and to produce membrane and secreted proteins with mRNA in a single investigational medicine. Triplet (mRNA-2752) includes three mRNAs encoding human OX40L, interleukin 23, or IL-23, and interleukin 36 gamma, or IL-36&#947;, that are encapsulated in our proprietary LNP and administered intratumorally. OX40L is a membrane protein, whereas IL-23 and IL-36&#947; are secreted cytokines. We believe our approach has the advantage of localized high concentration gradients of IL-23 and IL-36&#947; compared to recombinant proteins administered systemically or intratumorally. Additionally, the mRNA for OX40L encodes for the wild type membrane protein, which we believe recombinant protein technologies cannot enable. The combination of OX40L, IL-23, and IL-36&#947; has shown robust activity in preclinical cancer models and is synergistic with checkpoint inhibitors. In addition, this combination elicits an anti-tumor response on distal tumors (via the &#8220;abscopal effect&#8221;), as well as treated tumors in preclinical studies. A Phase 1 trial of Triplet (mRNA-2752) is ongoing.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OX40L/IL-23/IL-36&#947; (Triplet) (mRNA-2752): Our product concept</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing Triplet (mRNA-2752) for the treatment of advanced or metastatic solid tumor malignancies or lymphoma as a single agent or in combination with checkpoint inhibitors. Triplet (mRNA-2752) includes three mRNAs encoding OX40L, IL-23, and IL-36&#947;, encapsulated in our proprietary LNP. Triplet (mRNA-2752) is designed to make these proteins in cells of the local tumor environment or lymph node. Our approach potentially has the advantage of localized gradients of two important cytokines IL-23 and IL-36&#947;, rather than a systemic administration or intratumoral injection of cytokine proteins that would lead to quick diffusion away from the tumor. Additionally, the mRNA for OX40L encodes for the wild type membrane protein, which would be challenging to administer to either a tumor or systemically as a recombinant membrane protein capable of co-stimulation of T cells. mRNA for IL-23 produces a single-chain fusion protein of the IL-12B and IL-23A subunits, with a linker between the subunits. mRNA for IL-36&#947; produces a protein with introduced signal peptide to bypass a need for upstream processing for release and activity. In addition, all three mRNA were designed to decrease the amount of protein that could be made in hepatocytes through incorporation of microRNA binding sites, thus potentially reducing off-target effects and resulting in better tolerability. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OX40L/IL-23/IL-36&#947; (Triplet) (mRNA-2752): Clinical update</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an ongoing Phase 1 study that is designed as an open-label, multicenter study of intratumoral injections of Triplet (mRNA-2752) alone or in combination with durvalumab (anti-PD-L1) with sites in the United States and Israel. The objectives of this study include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assessment of safety and tolerability of Triplet (mRNA-2752) administered alone and in combination with durvalumab;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">define the maximum tolerated dose, or MTD, and recommended dose for expansion, or RDE, for intratumoral injections of Triplet (mRNA-2752) alone and in combination with durvalumab; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assessment of anti-tumor activity, protein expression in tumors, and pharmacokinetics, and exploratory endpoints that include assessment of immunological responses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The study consists of two arms: Arm A, Triplet monotherapy and Arm B, Triplet in combination with durvalumab. There are dose escalation and dose confirmation parts for each study arm followed by a dose expansions for Arm B. mRNA-2752 will be evaluated at 0.25, 0.5, 1, 2, 4, and 8 &#181;g. mRNA-2752 is administered once every two weeks for cycle 1, followed by once every four weeks for cycles 2 through 6. Durvalumab is administered every four weeks. Biopsy and blood samples to be collected pre- and post-treatment with mRNA in both dose escalation and dose expansion to assess protein expression and changes in tumor immune landscape.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2021, 44 patients have been dosed with mRNA-2752, including 19 patients in monotherapy and 25 patients in combination with durvalumab. Safety in this study was reported as of April 8, 2020, on 29 cases, including 17 patients treated with mRNA-2752 monotherapy and 12 patients in combination with durvalumab. Across dose levels tested, study treatment has been well tolerated with no dose-limiting toxicities, one patient with Grade 3 toxicity (at 4 &#181;g dose level) and no Grade 4/5 toxicities related to treatment. One partial response with an 81% decrease in target lesions has been observed in a squamous cell bladder cancer patient on the combination arm; stable disease has been observed in nine patients (five on mRNA-2752 monotherapy and four treated with durvalumab combination). Tumor shrinkage was observed in seven patients in injected and/or un-injected target lesions (three on monotherapy and four on combination). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 8, 2020, biomarker data from the first eight cohorts (monotherapy at dose levels between 0.25 &#181;g&#8211; 4 &#181;g; combination at 0.25 &#181;g and 0.5 &#181;g) demonstrated increased IL-23 and IL-36g protein expression, evidence of a pro-inflammatory effect of treatment including elevated interferon gamma, tumor necrosis factor alpha and PD-L1. Data consistent with demonstration of proof of mechanism. All post-treatment plasma cytokine levels evaluated were well below what has been suggested as clinically toxic levels for these cytokines in cytokine release syndromes. Significant increases in PD-L1 protein levels predominantly in immune cells in the tumor microenvironment were observed at days 2, 15 and 29 post-treatment demonstrating the sustained immunomodulatory effect of treatment. In the patient with the partial response, increased T cells, particularly of proliferating CD8+ cytotoxic T cells were observed post treatment.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IL-12 (MEDI1191)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another strategy for cancer patients with immunologically cold tumors is to transform the tumor microenvironment by introducing pro-inflammatory cytokines directly into tumors or draining lymph nodes. In collaboration with AstraZeneca, we are developing MEDI1191, which is an mRNA for IL-12 encapsulated in our proprietary LNP to be delivered intratumorally. Systemic administration of recombinant IL-12 protein was poorly tolerated in early clinical trials and exhibited generally low response rates. MEDI1191 can enhance the immune response by positively impacting both antigen presenting cells and T cells, and local, intratumoral expression of IL-12 can potentially improve tolerability compared to systemic protein treatments. AstraZeneca is conducting a Phase 1 clinical trial for MEDI1191, which is to be co-administered with a checkpoint inhibitor.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IL-12 (MEDI1191): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intratumoral delivery of IL-12 has been observed to be a feasible approach to overcome the toxicity associated with systemic IL-12 administration. For example, intratumoral delivery of an IL-12 containing DNA plasmid by injection followed by electroporation has shown promising activity in combination with pembrolizumab in patients with metastatic melanoma. Such an approach may be limited to accessible lesions amenable to electroporation. In contrast, it may be more feasible to inject our mRNA delivered by our proprietary LNP into both accessible and visceral tumors. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MEDI1191 is being developed for the treatment of advanced or metastatic solid tumors in combination with a checkpoint inhibitor. MEDI1191 consists of our proprietary LNP encapsulating an mRNA for human IL-12B (p40) and IL-12A (p35) subunits. The mRNA produces a single-chain fusion protein of the IL-12B and IL-12A subunits, with a linker between the subunits. The mRNA sequence has been engineered to enhance protein production and is designed to decrease the amount of protein that might be made in hepatocytes for better tolerability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IL-12 (MEDI1191): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have conducted several preclinical studies in which we observed activity with our approach</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preclinical studies were conducted with a mouse homolog of IL-12. In a tumor model that we have characterized as completely refractory to checkpoint therapy and associated with an immunosuppressive tumor microenvironment, treatment with IL-12 transformed the tumor microenvironment, with notable activation of natural killer and dendritic cells, and an increase in cytotoxic lymphocytes. In this checkpoint inhibitor refractory mouse model of cancer, a single dose of IL-12 mRNA yielded around 30% complete response rates as an mRNA monotherapy as shown in panel A below and was synergistically active with systemically administered anti-PD-L1 antibody, or &#945; PD-L1, demonstrating complete response rates of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&gt;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 70%, as shown in panel B of the figure below. The x-axis represents days after subcutaneous implantation of MC38-R tumor cells. Test articles were administered on Day 11 for mRNA treatments and on Days 11, 14, 18, and 21 for antibody treatments. All antibody treatments were administered at 20 mg/kg. There were 15 mice per group in this study. Survival curves were plotted by considering any reason a mouse was removed from study, including the predetermined tumor burden endpoint of 2,000 mm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as a survival event. NTC is a non-translating control mRNA. Synergy of locally administered IL-12 mRNA with systemic &#945; PD-L1 treatment was also observed on distal tumors that were not directly administered mRNA.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Panel A</span><span style="color:#ff0000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">                                                                   </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Panel B</span></div><div style="text-align:center"><img src="mrna-20201231_g33.jpg" alt="mrna-20201231_g33.jpg" style="height:324px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IL-12 (MEDI1191): Clinical plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are responsible for generating a preclinical data package to support the filing of an IND and clinical trial authorization (CTA) and clinical supply for early clinical development. AstraZeneca is leading the early clinical development. AstraZeneca is currently enrolling an open-label multicenter Phase 1 clinical trial of intratumoral injections of MEDI1191 alone and in combination with the checkpoint inhibitor, durvalumab. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">LOCALIZED REGENERATIVE THERAPEUTICS MODALITY</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We designed our localized regenerative therapeutics modality to develop mRNA medicines to address injured or diseased tissues. Our mRNA technology in this modality allows for the local production of proteins that provide a therapeutic benefit in the targeted tissue. The development of our program in this modality, AZD8601, for the local production of VEGF-A, is being led by our strategic collaborator, AstraZeneca. This program completed a Phase 1a/b clinical trial in which we observed both a dose-dependent protein production and a pharmacologic effect, as measured by changes in local blood flow in patients. We believe this data provides clinical proof of mechanism for our mRNA technology outside of the vaccine setting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Localized regenerative therapeutics: Opportunity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are multiple applications for tissue regeneration. With AstraZeneca, we have focused on ischemic heart failure for the first program. Coronary artery disease, the primary cause of ischemic heart failure, affects the arteries providing blood supply to the cardiac muscle. In 2015, coronary artery disease resulted in 366,000 deaths in the United States, and 8.9 million deaths globally.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Localized regenerative therapeutics: Product features</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our approach to localized regenerative therapeutics using mRNA has several advantages over alternative approaches, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA can be administered locally to produce the desired protein for an extended duration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Local exposure to the therapeutic protein encoded</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by our mRNA is sustained by the ongoing translation of the mRNA into protein, often from hours to days. This pharmacokinetic profile closely mimics the optimal tissue exposure profile for regenerative applications and cannot be achieved by injections of recombinant proteins that rapidly diffuse out of the tissue after injection.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Local administration of mRNA allows for focused activity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. mRNA administered to a specific tissue or organ should allow for local production of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the encoded protein, which could lead to lower levels of encoded protein in distant or systemic locations. This could help to prevent potential toxicity from production of the encoded protein outside of the targeted tissue.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA allows for dose-dependent and repeated production of the encoded protein</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. mRNA therapies should also allow for dose titration and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">repeat dosing. This provides several advantages over gene therapy. Gene therapy typically results in a permanent change to cellular DNA that may result in uncontrolled or constant production of the desired protein in local tissue or in distant sites, which could cause local or systemic side effects. Further, some gene therapy delivery vehicles are associated with immune responses that limit the ability to repeat dose, preventing dose titration.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">VEGF-A (AZD8601)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Addressing ischemic heart failure&#8212;VEGF-A as a localized therapeutic in collaboration with AstraZeneca</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Heart disease is the leading cause of death in the United States, accounting for one in every four deaths, and is often due to the inability of adults to regenerate heart tissue. Current approved therapies do not specifically address heart regeneration. Previous attempts at cardiac regeneration have included stem cell grafting and gene therapy, but have faced challenges with safety or efficacy. In collaboration with AstraZeneca, we are pioneering a unique approach to treating ischemic heart failure, a condition where the cardiac muscle does not get enough blood supply to perform its contractile function. Vascular Endothelial Growth Factor A, or VEGF-A, can promote cardiac tissue revascularization. The goal of this program is to promote recovery of cardiac function through partial tissue regeneration. The mRNA in this program is in a saline formulation without LNPs and is expected to act locally. Our strategic collaborator AstraZeneca has conducted a Phase 1a/b clinical study in diabetic patients in Europe. The study has met its primary objectives of describing safety and tolerability and secondary objectives of dose-dependent protein production and changes in blood flow. AstraZeneca has moved this program to a Phase 2a trial that is being conducted in Europe and is designed to test safety and tolerability of epicardial injections for patients undergoing coronary artery bypass grafting surgery.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VEGF-A (AZD8601): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">VEGF-A can promote blood vessel growth to potentially address ischemic heart failure</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several treatments are available for patients with ischemic heart failure. Current treatments include revascularization of the coronary arteries to relieve symptoms and improve cardiac function and therapies that reduce blood pressure or potentially help eliminate excess fluids in congested tissues, including: beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin II inhibitors, and aldosterone receptor blockers as diuretics. However, adult humans are unable to regenerate myocardium tissue following injury and the treatment options described above cannot compensate for this. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VEGF-A is a potent angiogenic factor that promotes growth of blood vessels. Preclinical data suggests that expression of this growth factor in the ischemic heart could increase blood flow and partially restore cardiac function.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VEGF-A (AZD8601): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Local delivery of VEGF-A mRNA to increase local concentration of VEGF-A protein while reducing systemic distribution of therapeutic VEGF-A protein</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VEGF-A protein acts as a powerful promoter of blood vessel growth. Systemic injection of VEGF-A protein increases VEGF-A exposure throughout the body, which can lead to side effects, but is very short-lived in circulation. Therefore, any therapy involving VEGF-A needs to be localized to elevate local protein concentration and drive revascularization while minimizing systemic side effects. AstraZeneca has opted to pursue the localized application of VEGF-A mRNA in a simple saline formulation in the heart muscle to elevate local protein concentration for longer periods due to increased local protein production. This potentially allows for an extended pharmacodynamic effect at the specific site of injection compared to systemic or local administration of a recombinant protein version of VEGF-A. Some of the early animal work for mRNA VEGF-A was published by our academic co-founder Dr. Kenneth Chien in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Biotechnology </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in 2013, showing improved cardiac function with increased survival with treatment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VEGF-A (AZD8601): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AstraZeneca has observed the activity of VEGF-A for ischemic heart failure in several preclinical animal models</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preclinical studies have been conducted at AstraZeneca in models of ischemic heart failure. In mouse, rat, and pig models of myocardial infarction, direct injection in the heart muscle (myocardium) of VEGF-A mRNA led to elevated cardiac VEGF-A protein levels and improved cardiac function. The data have been published by AstraZeneca in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Molecular Therapy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2018. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VEGF-A (AZD8601): Clinical data </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AstraZeneca has completed a Phase 1a/b trial in Germany; A Phase 2a trial is currently ongoing in Finland and Germany</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Phase1a/b clinical trial for the AZD8601 program has met its primary objectives of describing safety and tolerability and secondary objectives of protein production and changes in blood flow post AZD8601 administration. AstraZeneca has moved this program to a Phase 2a trial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Phase 1a/b study was a randomized, double-blind, placebo-controlled study in men with type 2 diabetes mellitus conducted in Europe. VEGF-A mRNA was administered by intradermal injection into the forearm skin in single ascending doses. The primary objective was to evaluate the safety and tolerability of the drug product into the forearm skin, with safety follow-up for six months.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The study was divided into Part A (single ascending-dose cohorts) and Part B (pharmacodynamic cohort). There were three treatment regimens in Part A. Regimens were either AZD8601 at site 1 and placebo at site 2, placebo at site 1 and AZD8601 at site 2, or placebo at both sites. Each regimen comprised six 50 &#181;L injections at one site and six 50 &#181;L injections at a second site on the forearm. In part B, the regimen comprised one 50 &#181;L intradermal injection of either AZD8601 or placebo at each of four sites on the forearm.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were 27 patients in Part A with 18 receiving AZD8601 in at least one site of the forearm and 9 patients receiving placebo. There were three dose cohorts in Part A, each with 9 patients. In the first cohort, AZD8601 dose was at 24 &#181;g per patient (4 &#181;g per injection). The AZD8601 dose was increased to 72 &#181;g and 360 &#181;g in the next two dose cohorts. There were 15 patients in Part B receiving AZD8601 in at least two sites on the forearm per patient. In Part B, each patient received 200 &#181;g of AZD8601 or placebo.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VEGF-A protein post injection of mRNA was produced at a high level, above the set expected threshold, as shown in the figure below. Expression was measured by skin microdialysis. At each sampling time, mean VEGF-A protein levels across all mRNA treated sites from patients across all cohorts were higher than that of placebo up to the 24-26 hour time point. Data are means with error bars showing standard error of the mean, or SEM. Asterisk indicates p-value &lt;0.05.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">VEGF-A protein levels in patients in Part A of the Phase 1a/b trial</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g34.jpg" alt="mrna-20201231_g34.jpg" style="height:284px;margin-bottom:5pt;vertical-align:text-bottom;width:350px"/></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The bioactivity of the VEGF-A protein post injection of mRNA was observed by an increase in blood flow at injection sites up to 7 days following a single injection, as shown in the figure below. Measurements were made using laser doppler imaging 7 and 14 days after administration (study part A, n = 27). Data shown are means with error bars showing SEM. Asterisk indicates p-value &lt;0.05.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">VEGF-A led to increase in blood flow at day 7 and day 14 in patients in the Phase 1a/b trial</span></div><div style="text-align:center"><img src="mrna-20201231_g35.jpg" alt="mrna-20201231_g35.jpg" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:344px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As shown above, administration of AZD8601 demonstrated protein production and changes in local blood flow in diabetic patients. Tolerability of our mRNA injected intradermally was demonstrated for all dose levels. The only causally treatment-related adverse events were mild injection-site reactions, occurring in 32 of 33 participants receiving VEGF-A mRNA across both parts of the study design. All adverse events of injection-site reaction were of mild intensity. No deaths, serious adverse events, or adverse events leading to discontinuation occurred. The program is currently in a Phase 2a clinical trial. It is a randomized, double-blind, placebo-controlled, multi-center, Phase 2a study to evaluate safety and tolerability of epicardial injections of AZD8601 during coronary artery bypass grafting surgery. Some of the outcomes to be monitored in the Phase 2a study include adverse and serious adverse events, electrocardiogram, or ECG, and LVEF. The study is being conducted in Europe. The study is intentionally designed to provide initial safety and tolerability data in about 24 coronary artery bypass patients.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SYSTEMIC INTRACELLULAR THERAPEUTICS MODALITY</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designed our systemic intracellular therapeutics modality to increase levels of intracellular proteins, using cells in the human body to produce proteins located in the cytosol or specific organelles of the cell to achieve a therapeutic effect in one or more tissues or cell types. The goal of this modality is to provide intracellular proteins, such as intracellular enzymes and organelle-specific proteins, as safe, tolerable, and efficacious therapies. Our initial focus within this exploratory modality is on rare genetic diseases. This modality currently has four programs: PA, MMA, PKU and GSD1a.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Systemic intracellular therapeutics: Opportunity</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systemically delivered, intracellular therapeutics focus on areas currently not addressable with recombinant proteins, which are typically administered systemically and cannot reach the inside of the cell. Objectives for potential new therapies in this area include, for example, increasing the levels of:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">intracellular pathway proteins;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">soluble organelle-specific proteins; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">organelle-specific membrane proteins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Systemic intracellular therapeutics: Product features</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systemically delivered, intracellular therapeutics, we believe, would allow us to target areas of biology that cannot be addressed using recombinant proteins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential advantages in these areas include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Using mRNA to encode for intracellular and organelle-specific proteins. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our modality permits the expression of intracellular proteins,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including those that must be directly translated and moved into organelles such as mitochondria. The ability of mRNA to produce protein inside of the cell enables production of these protein types that we believe are beyond the reach of recombinant proteins.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA can produce hard-to-make or complex proteins. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, some proteins, due to their folding requirements or complexity, are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">challenging to make using recombinant technologies, but can potentially be produced by human cells using administered mRNA.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Native post-translational modifications are possible through intracellular protein production using mRNA. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA administered to a human</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cell uses natural secretory pathways inside the cell to make and process the encoded protein. The resulting post-translational modifications, such as glycosylation, are human as opposed to recombinant proteins where these post-translational modifications are native to the non-human cells used for manufacture. These non-human post-translational modifications in recombinant proteins may lead to sub-optimal therapeutic outcomes, side effects and increased immunogenicity.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA can sustain production of proteins, which can increase exposure to proteins with short half-lives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. mRNA can lead to protein</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">production by cells that can last from hours to days depending on design. This feature could increase the levels of short half-life proteins for therapeutic benefit.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">mRNA allows for desirable pharmacology in complex metabolic diseases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mRNA technology potentially permits several differentiated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pharmacologic features for treating complex metabolic diseases, including the ability to repeat dose as needed, a rapid onset of action, the ability to adjust dose levels real-time based on individual patient needs, and the ability to stop dosing. Gene therapies may also prove to be useful for treating rare genetic diseases; however, mRNA is not limited by pre-existing immunity that may exist for certain gene therapies using viral vectors, and does not localize to the nucleus or require persistent changes to cellular DNA to have the desired effect.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Propionic acidemia (mRNA-3927)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We aim to produce an intracellular, mitochondrial enzyme complex to treat a pediatric metabolic disorder</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Propionic acidemia, or PA, is a rare, life-threatening, inherited metabolic disorder due to a defect in the mitochondrial enzyme propionyl-CoA carboxylase, or PCC. It primarily affects the pediatric population. There is no approved therapy for PA, including no approved enzyme replacement therapy, due to the complexity of the enzyme, which comprises six copies each of two different subunits (PCCA and PCCB), and its mitochondrial localization. The only effective treatment for severely affected individuals is liver transplant, aimed at increasing enzyme activity to reduce the occurrence of life-threatening acute metabolic crises. Our platform is uniquely positioned to potentially address this disease by enabling synthesis of this complex enzyme that is localized in the mitochondria of the cell. We are developing an IV-administered mRNA therapeutic comprising two different mRNAs encoding PCCA and PCCB in our proprietary LNP to replace the defective PCC enzyme with functional enzyme in liver and other cells. We have received Rare Pediatric Disease Designation and Orphan Drug Designation from the FDA and Orphan Drug Designation from the European Commission for the PA program. The FDA has also granted Fast Track designation to mRNA-3927. We plan to initiate a Phase 1/2 clinical trial in PA patients in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Propionic acidemia (mRNA-3927): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PA is an inherited metabolism disorder with significant morbidity and mortality and no approved therapy</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PA is a serious inborn error of metabolism disorder, closely related to MMA, with significant morbidity and mortality. There are approximately 325-2,000 PA patients in the United States based on estimated birth prevalence (0.2-1.2:100,000 newborns) and mortality rates. The vast majority of patients present with life-threatening metabolic crises during the first days or weeks of life, with mortality rates ranging from 13-53% during the neonatal period. Similar to MMA, the cardinal feature of the disorder is the occurrence of life-threatening acute metabolic decompensations that are more frequent in the first few years of life. Longer term sequelae include cardiac complications (cardiomyopathy, arrhythmias) and severe neurologic complications.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disorder is caused by a defect or deficiency in PCC, an enzyme that is one step upstream in the same metabolic pathway as the MUT enzyme that is deficient in MMA. PCC is a complex hetero-dodecamer enzyme composed of six alpha subunits (PCCA) and six beta subunits (PCCB). The disorder is autosomal recessive, with PA patients generally having loss-of-function mutations in either PCCA or PCCB (and in rare instances, mutations in both PCCA and PCCB). To date, over 100 mutations have been identified for both PCCA and PCCB genes and, similar to MMA, most of the mutations are private. Also similar to MMA, due to this enzyme deficiency resulting in a metabolic block, the disorder is biochemically characterized by the accumulation of toxic metabolites such as 3-hydroxypropionic acid and 2-methylcitrate, among others, and these metabolites may be used as biomarkers of disease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no approved therapy for PA to treat the underlying defect, including no enzyme replacement therapy, due to the complexity of PCC and mitochondrial localization. Carglumic acid (marketed as Carbaglu) is approved in the EU for the acute treatment of hyperammonemia due to various organic acidemias, including PA. Management of the disorder is otherwise limited to strict dietary restrictions and other supportive measures similar to MMA. Liver transplant is a radical yet effective treatment, with the aim of increasing PCC enzyme activity in liver for severely affected individuals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Propionic acidemia (mRNA-3927): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are utilizing the strength of our platform to produce a complex enzyme comprising two different proteins that localize to the mitochondria</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ability of our platform to encode for large, multimeric complexes such as PCC and enable production of intracellular, mitochondrial proteins makes mRNA especially suited to potentially address PA. We are developing an IV-administered combination mRNA approach, which contains two mRNAs, one for each of the subunits of PCC (PCCA and PCCB) encapsulated in our proprietary LNP. The intent is to potentially treat the entire PA population, regardless of whether an individual has a defect or deficiency in the PCC alpha or beta subunit. The mRNA sequences have been engineered to improve protein translation and encode enzymatically-active PCC with the proper subcellular localization in the mitochondria.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Propionic acidemia (mRNA-3927): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have demonstrated activity in a PA mouse model in a long-term repeat dose study</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A series of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pharmacology studies have been performed to demonstrate preclinical proof-of-concept for the combined PCCA and PCCB mRNA therapy. PCCA and PCCB mRNAs administered in PA patient fibroblasts (both PCCA and PCCB-deficient) showed production of active PCC enzyme with the proper subcellular localization in mitochondria at concentrations above wild-type levels. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> studies in PA (PCCA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">-/-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> [A138T]) mice have resulted in a dose-dependent increase in hepatic PCC activity with a concomitant decrease in disease biomarkers. Notably, a reduction in plasma ammonia levels was observed 3-4 weeks after a single IV administration (1 mg/kg) of PCCA and PCCB mRNA encapsulated in our proprietary LNP in PA mice (n=4-5/group). The data are shown in panel A of the figure below. Additionally, a 6-month repeat-dose study in PA mice showed decreased heart weight (normalized to body weight) in mice treated with monthly IV administration of PCCA and PCCB mRNA (1 mg/kg) compared to control mRNA (n=6/group). This is shown in panel B of the figure below. Data in both panels is presented as mean &#177; standard deviation.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reduction in plasma ammonia with PCCA+PCCB mRNA in PA mouse model study</span></div><div style="text-align:center"><img src="mrna-20201231_g36.jpg" alt="mrna-20201231_g36.jpg" style="height:316px;margin-bottom:5pt;vertical-align:text-bottom;width:374px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Panel (A)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Decrease in heart weight with PCCA+PCCB mRNA in 6 month repeat dose study in PA mouse model study</span></div><div style="text-align:center"><img src="mrna-20201231_g37.jpg" alt="mrna-20201231_g37.jpg" style="height:304px;margin-bottom:5pt;vertical-align:text-bottom;width:414px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Panel (B)</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the 6-month repeat dose study in PA mice, a significant and sustained lowering of additional disease biomarkers (e.g., 2-methylcitrate, or 2MC) was observed throughout the duration of the 6-month study. A comparison of 2-methylcitrate levels as a result of monthly IV administration of PCCA and PCCB mRNAs (0.5-1 mg/kg) compared to control mice injected with a control (luciferase) mRNA is shown in the figure below (n=6/group). Data are presented as mean &#177; standard deviation. The IND-enabling GLP toxicology program for PA (mRNA-3927) has been completed.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plasma 2-methylcitrate levels with repeat dosing of PCCA+PCCB </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">mRNA in PA mouse model study</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g38.jpg" alt="mrna-20201231_g38.jpg" style="height:290px;margin-bottom:5pt;vertical-align:text-bottom;width:538px"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Propionic acidemia (mRNA-3927): Clinical plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are conducting a global natural history study and are planning a Phase 1/2 clinical trial</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The clinical development plan for mRNA-3927 includes a global, natural history study in MMA and PA that was initiated in 2018 and a Phase 1/2 study in pediatric patients diagnosed with PA planned for early 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to conduct an open-label, multi-center, dose optimization Phase 1/2 study of multiple doses of mRNA-3927 in pediatric patients with PA in North America and Europe. The objectives of this study are to evaluate the safety and tolerability of mRNA-3927 administered via IV infusion, to assess the pharmacodynamic response from changes in plasma biomarkers, and to characterize the pharmacokinetic profile of mRNA-3927.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Methylmalonic acidemia (mRNA-3705)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Program aims to produce an intracellular, mitochondrial enzyme to treat a pediatric, genetic, metabolic disorder</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Isolated methylmalonic academia, or MMA, is a rare, life-threatening, inherited metabolic disorder that is primarily caused by a defect in the mitochondrial enzyme methylmalonyl-coenzyme A mutase, or MUT. It primarily affects the pediatric population. There is no approved therapy that addresses the underlying disorder, including no approved enzyme replacement therapy, due to the complexity of the protein and its mitochondrial localization. Liver or combined liver-kidney transplant is one option for severely affected individuals. Our platform may allow the cells in the human body to produce these and other complex mitochondrial enzymes. Therefore, we are developing an IV-administered mRNA encoding MUT in our proprietary LNP, in order to restore this deficient or defective mitochondrial enzyme in the liver and other cells. We have observed preclinical proof-of-concept in two different MMA mouse models, notably with a marked improvement in survival and reduction of biochemical abnormalities in a severe MMA mouse model. We recently ceased development of mRNA-3704 and will return to the clinic with the next generation formulation, mRNA-3705. To date, the new drug product mRNA-3705 has demonstrated greater potency and prolonged lowering of methylmalonic acid in mutase deficient mice when compared to mRNA-3704. mRNA-3705 has received </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rare Pediatric Disease Designation from the FDA. A Phase 1/2 clinical study with mRNA-3705 is in planning and will be initiated in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Methylmalonic acidemia (mRNA-3705): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MMA is a rare, life-threatening pediatric disorder with no approved therapies that address the underlying defect</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are an estimated 500-2,000 MMA MUT deficiency patients in the United States based on estimated birth prevalence (0.3-1.2:100,000 newborns) and mortality rates. Mortality is significant, with mortality rates of 50% for MMA patients with complete MUT deficiency (mut </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) (median age of death 2 years) and 40% for MMA patients with partial MUT deficiency (mut </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) (median age of death 4.5 years) reported in a large European study.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MMA mainly affects the pediatric population and usually presents in the first few days or weeks of life. The occurrence of acute metabolic decompensations is the hallmark of the disorder and decompensations are typically more frequent in the first few years of life. Each decompensation is life-threatening and often requires hospitalization and management at an intensive care unit. Surviving patients often suffer from numerous complications including chronic renal failure and neurologic complications such as movement disorders, developmental delays, and seizures. Consequently, the health-related quality of life for MMA patients and their families is significantly impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disorder is autosomal recessive and primarily caused by loss-of-function mutations in the gene encoding MUT, a mitochondrial enzyme that metabolizes certain proteins and fats, resulting in complete (mut </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or partial (mut </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) enzyme deficiency. There are currently no approved therapies that address the underlying defect for MMA. Carglumic acid (marketed as Carbaglu) is approved in the EU for the acute treatment of hyperammonemia due to various organic acidemias including MMA. Liver transplant and combined liver-kidney transplant have emerged as effective treatment options for severely affected individuals, resulting in substantial reductions in metabolic decompensations and circulating methylmalonic acid concentrations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Methylmalonic acidemia (mRNA-3705): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are utilizing our ability to produce a complex intracellular enzyme (MUT) that is localized to the mitochondria</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MUT is a complex intracellular enzyme that exists as a homodimer, and requires mitochondrial localization and engagement with its cofactor (a derivative of vitamin B</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) to be enzymatically active. mRNA has the capability to encode any type of protein, including a functional, intracellular protein that is trafficked to the proper subcellular localization within target cells.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing an mRNA encoding human MUT encapsulated in our proprietary LNPs for IV administration for the treatment of isolated MMA associated with MUT deficiency. The sequence has been engineered to improve protein translation. To function, the mRNA-encoded MUT protein is translocated to its site of action in the mitochondria.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Methylmalonic acidemia (mRNA-3705): Preclinical information</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">mRNA-3705 shows greater potency and more prolonged lowering of plasma methylmalonic acid compared to mRNA-3704 in animal studies.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously demonstrated, in a series of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pharmacology studies, that human MUT mRNA effectively directs the biosynthesis of active MUT protein with physiologically correct mitochondrial localization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and improves survival and corrects biochemical abnormalities in two different mouse models of MMA representing the spectrum of MUT deficiency (mut</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and mut</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), as published by us in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cell Reports</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2017 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EBioMedicine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2019. Technology and process improvements enabled the development of an updated drug product, mRNA-3705, which shows greater potency and better pharmacology compared to mRNA-3704. As shown in the figure below, mRNA-3705 produced approximately 3-times more MUT protein than mRNA-3704 in livers of rats 24 hours after a single intravenous injection.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">mRNA-3705mRNA-3705 produced higher levels of MUT protein in the livers of rats compared to mRNA-3704</span></div><div style="text-align:center"><img src="mrna-20201231_g39.jpg" alt="mrna-20201231_g39.jpg" style="height:233px;margin-bottom:5pt;vertical-align:text-bottom;width:467px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In MMA mice with partial MUT deficiency (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mut</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">-/-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;Tg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">INS-CBA-G715V</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, mut</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), mRNA-3705 showed greater potency and prolonged the reduction in plasma methylmalonic acid levels compared to mRNA-3704 in a 4-week study, as shown in the figure below. This data suggests that the minimal efficacious dose may be lower for mRNA-3705 than for mRNA-3704. </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">mRNA-3705 treatment produced a greater and more sustained reduction in plasma methylmalonic acid compared to mRNA-3704 in a 4-week study in mut</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> mice</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g40.jpg" alt="mrna-20201231_g40.jpg" style="height:325px;margin-bottom:5pt;vertical-align:text-bottom;width:591px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, mRNA-3705 treatment of a more severe MMA mouse model (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mut</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">-/-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;Tg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">INS-MCK-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">Mut</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, mut</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) improved survival, increased body weight, and produced a sustained reduction of plasma methylmalonic acid levels compared to PBS treatment in a 12-week study.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Methylmalonic acidemia (mRNA-3705): Clinical plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are conducting a global natural history study and a Phase 1/2 clinical trial in North America and Europe</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are conducting a global natural history study in methylmalonic acidemia, or MMA, and propionic acidemia, or PA, that was initiated in 2018. Our natural history study aims to identify and correlate clinical and biomarker endpoints for both MMA and PA. The natural history study is a global, multi-center, non-interventional study for patients with confirmed diagnosis of MMA due to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MUT deficiency or PA. Up to 60 MMA patients and up to 60 PA patients in the United States and Europe will be followed prospectively for 1-3 years. Enrollment in the study has been completed. Retrospective data are also being collected as available.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recently ceased development of mRNA-3704 and will return to the clinic with the next generation formulation, mRNA-3705. The new drug product mRNA-3705 has demonstrated greater potency and prolonged lowering of methylmalonic acid in mutase deficient mice when compared to mRNA-3704. An open-label, multi-center, dose finding Phase 1/2 study of mRNA-3705 in patients with isolated MMA due to MUT deficiency between 1 to 18 years of age is in planning and will enter clinic in 2021. The objectives of this study are to evaluate the safety, pharmacodynamics (as assessed by changes in plasma methylmalonic acid), and pharmacokinetic profile of mRNA-3705 in patients affected by MMA.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Phenylketonuria (PKU) (mRNA-3283)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our approach to Phenylketonuria with an mRNA encoding for an intracellular protein</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phenylketonuria, or PKU, is a rare inherited metabolic disease resulting from a deficiency in the metabolism of phenylalanine, or PHE, due to mutations within the enzyme phenylalanine hydroxylase, or PAH. The most effective treatment is a restrictive diet of low protein, which controls PHE intake. Approximately 20-56% of PKU patients respond to sapropterin dihydrochloride (marketed as Kuvan in the United States), a synthetic BH4 cofactor for PAH which improves PHE metabolism, but does not fully cure patients. In addition, in May 2018, Biomarin received approval for pegylated phenylalanine lyase, or PAL, marketed as Palynziq. Palynziq is a pegylated recombinant bacterial enzyme which metabolizes PHE in the blood. We believe the immune risk is, at least in part, driven by bacterial PAL. With our mRNA technology, cells in the human body can be instructed to produce functional PAH, decreasing PHE levels in the blood and restoring production of tyrosine. We are developing an intravenously administered mRNA which encodes for the PAH enzyme and is encapsulated in our proprietary LNP. We plan to conduct a Phase 1 clinical trial for mRNA-3283.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phenylketonuria (mRNA-3283): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">There are options to treat PKU which are not widely applicable, and efforts by other companies are likely to face hurdles</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PKU occurs in approximately 1:10,000-15,000 live births in the United States</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Based on current population estimates that would translate into approximately 21,000-32,000 PKU patients in the United States. Affected individuals have a deficiency in the enzyme PAH, resulting in a reduced or complete inability to metabolize the essential amino acid phenylalanine into tyrosine. Thus, PKU patients suffer from a phenylalanine intoxication and a subsequent deprivation of tyrosine, leading to severe mental disability if left untreated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PAH is expressed as a monomer, but functions as a tetramer and requires tetrahydrobiopterin (BH4) as a cofactor to complete the conversion of PHE to tyrosine, thereby maintaining adequate PHE:TYR ratios within circulation. To date, greater than 950 gene variants have been identified in the PAH gene, resulting in PKU.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnosis of PKU occurs primarily through newborn screening in available countries, followed by genetic confirmation. Newly diagnosed patients receive medical formulas containing protein with low PHE content to control blood PHE and provide adequate nutrition for growing infants. As patients age, they are tested for sensitivity to synthetic BH4 and may transition to Kuvan. Approximately 20% of patients respond favorably to Kuvan, which can aid in PHE control. Nonresponsive patients are treated mainly with restricted diet; however, adherence to the diet is challenging, resulting in poor compliance. When PHE levels are not adequately controlled, patients begin to show multiple signs of disease, including depression, anxiety, poor executive function, and attention deficit hyperactivity disorder, or ADHD. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One option for PKU patients may be treatment with gene therapy. We believe there are potential advantages for mRNA therapeutics for this disorder over gene therapy as described in the systemic intracellular therapeutics modality section.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phenylketonuria (mRNA-3283): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We intend to utilize the cells in the human body to produce PAH intracellularly</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe mRNA therapy is a viable therapeutic modality for PKU patients due to its ability to instruct cells in the human body to produce complex functional intracellular proteins such as PAH. Our program mRNA-3283 consists of an mRNA encoding human PAH encapsulated in our proprietary LNPs. The mRNA sequence is optimized for protein synthesis and contains a microRNA </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">binding site to reduce or potentially eliminate synthesis of protein outside of the target tissues. mRNA-3283 is designed to be administered intravenously to encode enzymatically-active PAH protein in liver to restore this deficient or defective enzyme.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phenylketonuria (mRNA-3283): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have demonstrated the ability to impact PHE levels by repeat dosing of our mRNA in preclinical studies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have conducted several </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pharmacology studies to demonstrate preclinical proof-of-concept for PAH therapy. A PKU mouse model demonstrated a significant reduction of blood PHE levels post dose as shown in the figure below. The study included IV administration of PAH mRNA every 7 days at 0.5 mg/kg in a PAH-/- mouse model. PHE level was measured using liquid chromatography with a combination of two mass analyzers (LC-MS/MS). The IND-enabling GLP toxicology program for PKU (mRNA-3283) is ongoing.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PHE reduction with repeat dosing of PAH mRNA in PKU mouse model study</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g41.jpg" alt="mrna-20201231_g41.jpg" style="height:278px;margin-bottom:5pt;vertical-align:text-bottom;width:534px"/></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Phenylketonuria (mRNA-3283): Clinical plan</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to conduct a Phase 1 open label clinical trial with single ascending dose to evaluate the safety, tolerability, and activity of our development candidate in patients.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Glycogen storage disease type 1a (GSD1a) (mRNA-3745)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our approach to glycogen storage disease type 1a using an mRNA encoding for intracellular human glucose 6-phosphatase</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Glycogen storage disease type 1a (GSD1a) is an inherited metabolic disease caused by the deficiency in the catalytic activity of glucose 6-phosphatase (G6Pase), which is encoded by the glucose 6-phosphatase gene (G6PC). The G6Pase enzyme is involved in the metabolic pathways of glycogenolysis and gluconeogenesis which allow the liver and kidney to release glucose into the blood. Those affected by GSD1a present with life-threatening hypoglycemia and a wide range of severe metabolic derangements and long-term complications such as hyperlipidemia, lactic acidemia, hepatomegaly, hepatocellular adenomas, and end-stage renal disease. The standard of care consists of strict diet control. Enzyme replacement therapy (ERT) is not an option for these patients due to challenges associated with delivering an enzyme inside the cell. Strict diet control via the frequent consumption of uncooked cornstarch is effective in improving hypoglycemia. However, the underlying pathologies continue and its efficacy in preventing the long-term metabolic complications has yet to be established. With our mRNA platform, cells in the liver may be instructed to produce functional G6Pase, with the goal of restoring the homeostasis of glycogenolysis and gluconeogenesis pathways and correcting the underlying pathologies. We are developing an intravenously administered mRNA which encodes for G6Pase and is encapsulated in our proprietary LNP. We have demonstrated activity in mouse models in the form of reduction in both liver and serum biomarkers and improvements in liver morphology. We plan to conduct a Phase 1 clinical trial for mRNA-3745.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Glycogen storage disease type 1a (mRNA-3745): Disease overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">There are no approved therapies for GSD1a that address the enzymatic deficiency</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GSD1a is an inherited metabolic disorder caused by a deficiency in the catalytic activity of G6Pase. G6Pase catalyzes the hydrolysis of glucose-6-phosphate to glucose and inorganic phosphate, the final step of glycogenolysis and gluconeogenesis that mainly takes place in liver and kidney. GSD1a patients suffer from severe fasting hypoglycemia, hepatomegaly, nephromegaly, lactic acidemia, hypertriglyceridemia, hyperuricemia, hypercholesterolemia, hepatic steatosis, and growth retardation. In addition, hepatocellular adenomas occur in 70% to 80% of GSD1a patients by their third decade of life and carries risk of transformation into hepatocellular carcinomas. Proteinuria has been observed in over half of patients above 25 years of age.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GSD1a occurs in approximately 1:100,000 live births in the United States and European Union but is more common in Ashkenazi Jews where the incidence is reported to be 1:20,000 live births. There are an estimated 2,500 people in the United States and over 4,000 people in the European Union with GSD1a. Although strict diet therapy, including frequent feeding with uncooked cornstarch, allows GSD1a patients to live into adulthood by preventing hypoglycemia, the underlying pathological processes remain uncorrected resulting in the development of many long-term complications including liver adenomas and hepatocellular carcinoma. While gene therapy is being investigated for treatment of GSD1a, we believe there are potential advantages for mRNA therapeutics for this disorder over gene therapy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Glycogen storage disease type 1a (mRNA-3745): Our product concept</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We intend to utilize the cells in the human body to produce G6Pase intracellularly</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our platform can address GSD1a with its ability to instruct cells in the human body to produce complex functional intracellular membrane proteins such as G6Pase. Our program, mRNA-3745, consists of an mRNA encoding for modified human G6Pase encapsulated in our proprietary LNPs. The human G6Pase sequence is modified for improved protein production and G6Pase activity. mRNA-3745 is designed to be administered intravenously and encodes G6Pase protein to restore this deficient or defective enzyme.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Glycogen storage disease type 1a (mRNA-3745): Preclinical information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We have demonstrated the ability to improve hypoglycemia and other metabolic abnormalities associated with GSD1a in a mouse model</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have conducted several in vitro and in vivo pharmacology studies to demonstrate preclinical proof-of-concept for GSD1a therapy. mRNA encoding for G6Pase introduced in human cells resulted in robust production of active G6Pase with subcellular localization into endoplasmic reticulum. We have examined the activity of mRNA encoding for human G6Pase in a liver-specific G6Pase -/- mouse model (G6PC.LKO). Like GSD1a patients, the G6PC.LKO mice are unable to produce endogenous glucose, leading to severe hypoglycemia during the fasting state.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a dose-response study performed in G6PC.LKO mice, we treated the mice with three different doses of 0.2, 0.5, and 1 mg/kg of G6Pase mRNA encapsulated in our proprietary LNP and examined fasting glucose, serum triglycerides, and liver enzymes (n=5-8). Of note, mice treated with G6Pase mRNA showed a dose-dependent improvement in fasting glycemia and a reduction in serum triglycerides, without a significant increase in liver enzymes (e.g. alanine transaminase - ALT). Fasting blood glucose and triglycerides are shown in the figure below. Each bar represents the mean &#177; standard deviation. Single and double asterisk denotes p &lt; 0.05 and p &lt; 0.0001, respectively, by one-way ANOVA, followed by Dunnett&#8217;s post-hoc test for multiple comparisons.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Serum biomarkers after single dose of G6Pase mRNA in G6PC.LKO mice</span></div><div style="text-align:center"><img src="mrna-20201231_g42.gif" alt="mrna-20201231_g42.gif" style="height:233px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the same study, a reduction in liver weight compared to the control-treated group was observed after 24 hours of administration of G6Pase encoded mRNA in LNP. The reduction in liver weight was associated with significant improvement in liver morphology presumably due to reduction in liver glucose 6-phosphate, glycogen, and triglycerides.</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reduction in liver weight 24 hours after IV administration of G6Pase mRNA in G6PC.LKO mice</span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g43.gif" alt="mrna-20201231_g43.gif" style="height:337px;margin-bottom:5pt;vertical-align:text-bottom;width:410px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, data for a 7-week repeat-dose study in G6PC.LKO mice receiving G6Pase mRNA in LNP at 0.25 mg/kg IV every other week have shown a pronounced improvement in fasting glycemia, in comparison with the G6PC.LKO mice receiving a control mRNA treatment as shown below (n=7-9).</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restoration of blood glucose above therapeutic threshold with repeat dosing of G6Pase mRNA in G6PC.LKO mice</span></div><div style="text-align:center"><img src="mrna-20201231_g44.gif" alt="mrna-20201231_g44.gif" style="height:299px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Glycogen storage disease type 1a (mRNA-3745): Clinical plan</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We are planning a Phase 1 clinical trial</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to conduct an open-label, dose escalation Phase 1 study of mRNA-3745 in adolescent and adult patients with GSD1a in the United States. The objectives of this study are to evaluate the safety and tolerability of mRNA-3745, to assess the pharmacodynamic response through changes in maintenance of euglycemia, and to characterize the pharmacokinetic profile of mRNA-3745.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_43"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MANUFACTURING (PRODUCT SUPPLY AND TECHNICAL DEVELOPMENT) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing plays a critical role in our value chain and our ability to develop a new class of medicines. Our manufacturing capabilities support our Research and Early Development Engines, in addition to our Late Stage Development and Commercial Engines. These capabilities have rapidly accelerated as a result of COVID-19 vaccine production.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within the Research Engine, manufacturing provides mRNA drug substance and drug product for platform research and therapeutic area drug discovery. For the Early Development Engine, we manufacture mRNA and drug product for IND-enabling GLP toxicology studies and initial human clinical studies. For the Late Stage Development Engine, we produce mRNA and drug product for phase 3 studies. In addition, within the Commercial Engine, we manufacture drug substance and drug product in collaboration with our contract manufacturing organizations, or CMOs, both in the U.S. and internationally. Our approach to date has been to proactively invest and build manufacturing capacity internally and externally with our network of strategic partners in anticipation of demand. This capacity planning was immediately leveraged and expanded during our COVID-19 vaccine ramp-up into a commercial product in response to the ongoing pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of our manufacturing operating model</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing activities focus on the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Commercial Production:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our manufacturing expertise includes state-of-the-art technologies for mRNA and drug product manufacturing, as well as quality control testing to attain a robust and consistent supply that matches target product profiles. Our manufacturing technology is built to scale-up and support industrialization of products for commercial approval.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Research and Development Support: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The product supply enables platform research and drug discovery in our therapeutic and vaccine areas, in addition to activities related to clinical studies of our investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given our expectations for significant ongoing pipeline expansion and the long lead time required to build manufacturing infrastructure, we built a dedicated in-house manufacturing facility in Norwood, MA, Moderna Technology Center (MTC). The campus is comprised of two distinct buildings (MTC South and MTC North). MTC South is approximately 200,000 square feet, with a production capacity of over 100 cGMP lots per year. MTC North is approximately 240,000 square feet, directly supporting improvement in our manufacturing capabilities. MTC supports our Research Engine supply, IND-enabling GLP toxicology study supplies, our Phase 1 and Phase 2 pipeline activities, later-stage clinical development activities (e.g., Phase 3 CMV vaccine clinical trials), as well as COVID-19 vaccine drug substance production.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MTC campus has been designed with a high level of automation and state-of-the-art digital integration to handle manufacturing execution, product testing and release, and regulatory filings. In addition, substantial manufacturing capabilities are realized via CMO relationships in the U.S. and abroad, providing drug substance and fill finish capacity for the COVID-19 vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing Technology Development </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support our broad pipeline of products, which span multiple therapeutic areas and routes of administration (e.g., intramuscular, intratumoral, and intravenous), there is close collaboration between our Platform Research and Technical Development teams to facilitate rapid and seamless clinical translation of scientific breakthroughs. This, in turn, enables us to develop potential vaccines and therapies to serve a widening patient population. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Technical Development encompasses the design and optimization of robust and consistent manufacturing processes, product characterization, fit-for-purpose formulations, and product presentations. For instance, our novel hardware platforms&#8217; automation and robotics, coupled with the flexibility of our in-house digital development systems, allows for thousands of experiments and process parameters across our projects, thus supporting our drug product pharmaceutical readiness. Moreover, our recent technical manufacturing advances have enabled internalization of new key capabilities, including DNA plasmids and small molecules. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In parallel, we have refined existing processes, resulting in increased manufacturing scale and more robust stability of our mRNA and drug product. These improvements allow us significant control over our supply chain, resulting in larger production yields and longer shelf life of our products. Furthermore, formulation development advancements have added new drug product images, including lyophilization, giving us a path from frozen to refrigerated storage conditions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our substantial investments in recent years in Technical Development enabled the breadth and depth of our pipeline, and laid the foundation to help meet the needs and requirements associated with late stage development and the commercialization of the COVID-19 vaccine.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supply of mRNA for the Research and Early Development Engines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supply for the Research Engine</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">High-throughput automation and custom engineered equipment allow us to produce and deliver high quality mRNA and formulated constructs in a short period of time: our proprietary platform is capable of producing up to 1,000 lots of mRNA sequences and formulations per month with a turnaround time of a few weeks from sequence to final product. The typical scale of mRNA manufactured by this team is 1&#8211;1,000 mg. Since 2014, we have produced over 27,000 batches of research-grade mRNA. This has been possible, in part, thanks to the ability of researchers in the Moderna ecosystem to order constructs through an integrated digital portal that tracks materials end-to-end in less than 45 days. In addition, multiple integrated algorithms that leverage artificial intelligence and machine learning optimize manufacturability, reduce failures, and increase quality of mRNA sequences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supply for the Early Development Engine</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Analogous to the Research Engine, we have established manufacturing capabilities that support the Early Development Engine in three key areas: GLP Tox, Clinical Studies, and Personalized Cancer Vaccines. We supply mRNA and formulated product to conduct IND-enabling GLP toxicology studies. In addition, human clinical studies rely on supply to meet required cGMP standards. This is achieved via internal manufacturing at MTC and external manufacturing at well-established contract manufacturing organizations (CMOs). We selected specialized CMOs to support a total of five programs in late 2015. We will continue to selectively partner with CMOs to complement our capacity and provide supply contingency where needed. Our MTC facility is also suited to enable rapid technology development and scale-up for future needs. Our manufacturing also produces cGMP Personalized Cancer Vaccines (PCVs). Due to the specialized nature of personalized medicine (i.e., where a batch is specifically designed and manufactured for a single patient), the manufacturing Personalized Vaccine Unit (PVU) has unique requirements. We digitally integrate patient-specific data from sequencing tumor samples to automatically design PCVs for patients. We have developed proprietary bioinformatics designed algorithms linked to an automated manufacturing process for rapid production of formulated mRNA, with a typical turnaround time of a few weeks. We have operationalized PCV manufacturing at the MTC campus to meet our Phase 1 and 2 pipeline supply needs by using single-use systems with fast &#8220;needle-to-needle&#8221; turnaround times. Unlike traditional process development, each PCV batch is manufactured for a single patient and thus scaled-out (in parallel) with extensive use of automation and robotics to account for the larger number of patients involved in later phases of development and commercialization. We have shown consistent quality in our production of over 160 patient batches, each with unique mRNA sequences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These capabilities have allowed us to build our broad pipeline of 24 development candidates, including the output required to supply related toxicological and human clinical studies. While the technology that underpins these 24 programs is the same, each program typically requires customization based on target product profiles. These custom features range from varying molecular architecture to different routes of administration, often requiring multivalent products. For example, our CMV vaccine (mRNA-1647) requires six different mRNA sequences to be manufactured for inclusion in an intramuscular mRNA medicine, whereas OX40L (mRNA-2416) requires a single mRNA sequence for inclusion in an intratumoral mRNA medicine. All programs, with the exception of PCV, require that we progressively scale up supply to meet clinical demand requirements across development phases, in addition to the necessary preparation for regulatory approval and commercial production, which demand larger batch sizes. In contrast, the PCV program seeks to develop a cancer vaccine that is designed and manufactured for a specific patient, thus increasing the number of unique batches. As we scale manufacturing output for each program, we plan to continuously improve yield, purity, and the pharmaceutical properties of our development candidates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supply for the Late-Stage Development and Commercialization Engines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we manufacture the COVID-19 vaccine, our development pipeline continues to advance to later-stage development and towards commercialization. Our platform approach allows us to continue to evolve our manufacturing suites and other capabilities at our MTC campus. Building expansions and enhancements have continued throughout scale-up of our COVID-19 vaccine manufacturing capabilities. The modular nature of the MTC suites permits us to manufacture multiple products in parallel. For instance, we can produce drug substance and drug product for our phase 3 CMV clinical trial while manufacturing COVID-19 drug substance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quality Unit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality is core to the way we operate. We seek to ensure quality at Moderna through a combination of a robust Quality Management System (QMS), our quality culture, and our people. In accordance with applicable regulations, we have established, documented, and implemented a QMS to assure continued compliance with the requirements therein. The QMS facilitates cGMP compliance by implementing practices that identify the various required processes, their application throughout the organization, and the sequence of interaction of these processes.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary mode of documenting these key practices is through policies, standard operating procedures (SOPs), forms, and other quality records, which include an overarching Quality Policy and Quality Manual. We have implemented measurement tools and metrics to monitor, measure, and analyze these practices to support cGMP operations, achieve planned results, and support continuous improvement. We monitor these quality metrics through formal governance processes, including Quality Management Review (QMR), to enable continuous improvement. We have also established an independent Quality Unit that fulfills quality assurance and quality control responsibilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Quality Unit grew into an international organization with the introduction of COVID-19 vaccine manufacturing. Quality drives our quality culture and ensures it is applied consistently and thoughtfully across the globe. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Quality Unit is ultimately accountable and responsible for quality, this is everyone&#8217;s responsibility. All cGMP personnel are empowered to ensure quality systems are appropriately maintained and executed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a culture that encourages transparency, accountability, and ownership of quality at all levels in the organization. As we scale the quality organization, we have focused on hiring the best talent with the required experience, training, and education. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supply Chain Unit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established an international supply chain to enable supply of the raw materials used to produce our mRNAs and the components of our formulations, securing supply for COVID-19 vaccine alongside clinical and preclinical demands. We have worked with our supply chain vendors to characterize critical raw materials and to understand their impact on the quality of mRNA drug substance and formulated drug product. We also assess the quality system and performance of our supply chain vendors and work with them to comply with regulatory requirements. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_46"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DIGITAL INFRASTRUCTURE </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that digital technologies, such as robotics, automation, artificial intelligence, or AI, and cloud computing, are critical to operationalize our strategy, accelerate our pace of learning and execute at scale. Since our inception, we have invested over $100 million in our digital technologies, robotics/automation, analytics, data science and AI. Given our growth, we expect we will invest more than an additional $100 million in digital over the next 5 years. Our approach to bring these digital technologies into our workflows and processes has involved the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">utilization of a consistent set of digital building blocks;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">application of digital technologies in multiple business processes; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">rapid iterations for maximum optimization.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have seen several benefits from our investments in digitization, most importantly through the depth of our platform technology and breadth of our pipeline. Other benefits include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Quality: Reduction in human errors by enabling automation, repeatability, and seamless integration;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Scalability: Growth in our pipeline to 24 programs;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Speed: Rapid manufacture of research-grade mRNA from the Research Engine; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost efficiencies: Digital infrastructure utilized across our platform, drug discovery, clinical development, and manufacturing to maximize efficiencies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our digital building blocks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize six building blocks for our digital infrastructure:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Cloud enablement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is a critical component of our digital infrastructure. We are at the forefront of mRNA technology. We generate complex data</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sets, and our scientists need computational power and agility to operate without being limited by traditional computing technology. Maintaining digital infrastructure in the cloud provides the benefits of lower costs by simplifying provisioning and administration, flexibility, scalability, ease of maintenance, disaster recovery, and information security.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Integration of business processes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enables us to streamline processes and bring data together in a consistent manner, avoiding caches of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information and manual intervention. This efficient flow of data between systems enables the automation of our business processes.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.15pt">Internet of things </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allows for smart interconnected devices that provide real-time synchronization of operations. The data from equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provides real-time guidance to our scientists and engineers and helps us in supply chain and manufacturing with compliance and traceability, including tracking material, controlling inventory and optimizing instrument usage.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Automation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allows us to scale our operations reliably and reproducibly. With the help of custom hardware solutions and state-of-the-art robotics,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we can continue to increase our operating efficiency, reduce errors, and improve our quality and compliance.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Advanced analytics </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enable us to draw insights from our data. We are constantly generating large data sets that can provide important insights if</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mined appropriately and regularly.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Artificial intelligence</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or AI, is enabling key breakthroughs in predictive modeling. It will allow us to improve our mRNA design algorithms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based on machine learning, and will provide us with critical insights into research, supply chain, manufacturing, and other processes.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital technologies to enable our Research Engine</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have deployed multiple digital technologies across our Research Engine to drive a rapid pace of learning, enable efficient workflows and business processes, and draw insights from vast amounts of data. Our aim is to provide our platform and discovery scientists with access to an environment that helps them through each step of their research cycle.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Drug Design Studio: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our proprietary in-house digital application suite contains a Sequence Designer module to tailor an entire mRNA, with ever-improving</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rule sets that contain our accumulated learning about mRNA design. Drug Design Studio utilizes cloud-based computational capacity to run various algorithms we have developed to design each mRNA sequence. The utility of cloud-based capacity allows us to provide flexible computational capacity on demand, allowing the Research Engine to power parallel intake and design of multiple mRNA sequences. Once a sequence is designed, it can be ordered digitally using an internal order form application within Drug Design Studio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacture of research grade mRNA: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once an order is optimized, the mRNA production process is triggered. We have developed proprietary interfaces</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that allow the manufacturing team to track production orders at every stage. We have automated several manufacturing steps using both off-the-shelf and custom automation. The equipment used in the manufacture of research-grade mRNA is integrated with the digital interfaces to capture, extract, and interpret the data generated at each step of the manufacturing process, building digital traceability on each mRNA order. We have also embedded real-time algorithms and analytics tools to allow for automated decision-making at some stages, accelerate the quality control workflows, and provide for continuous improvement of manufacturing processes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispatching and shipping mRNA: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we produce large quantities of research-grade mRNA, we require digital tools to track their shipment to our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">scientists and to external contract research organizations, or CROs, conducting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> studies. Our dispatching and shipping application automatically generates bar-coded labels, allowing for traceability of product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory and registry: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Material used in research and created in production, including mRNA, cell lines, chemicals, and reagents, is tracked in our Inventory</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">application. This application supports numerous workflow tools such as consumption, aliquoting, material transfer, and stock alerts. Critical material types are assigned unique registry identification by our Registry application.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Study design: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Using our Drug Design Studio, our scientists can design their</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">studies using our proprietary Study Design application. This application</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">captures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> study protocol design parameters, including dose amount, number of doses, frequency, samples, and assays for each sample. This application serves two purposes. It allows our scientists to maintain and track their </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> study designs and associated research grade mRNA. Our Study Design application also allows our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> pharmacology teams to track the various ongoing studies and leverage external CROs to manage the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> demand as needed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Experiment management: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have deployed Electronic Lab Notebooks for experiment management, allowing our scientists to streamline documentation of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their experiments and track it in a standardized, searchable repository. We have also integrated Electronic Lab Notebooks further with our other research tools to connect inventory, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> studies, and instrument data.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advanced analytics and AI to accelerate the pace of learning: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize AI to enable various parts of our platform and drug discovery. Examples include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Neural networks for protein engineering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: One way to optimize the efficacy of the proteins encoded by our mRNA is to engineer the sequence of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the protein itself. We use neural networks to analyze and model protein sequences. We train these models by inputting orthologous sequences from thousands of organisms, from which we can generate potential protein sequences optimized for specific attributes.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%;padding-left:14.15pt">Neural networks for mRNA engineering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">: The redundancy in the genetic code allows for a large number of mRNA sequences that encode the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">same protein. mRNA sequence may impact translation, thereby impacting the amount of protein produced in circulation. We are developing AI tools to predict mRNA sequences that can enhance protein expression.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:110%;padding-left:14.5pt">Automated Sanger sequencing analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">: Sanger sequencing is us used repeatedly to quality check, or QC, our DNA templates and final mRNA; while the data contain every nucleotide in a sequence, it is very complex to analyze. A fully automated data pipeline starts processing raw data the moment it is saved to the cloud by the sequencers. The pipeline spawns numerous AWS computer servers to run an analysis algorithm and then shuts the servers down, resulting in minimal costs. The results are viewable in a powerful, dynamic visualization tool. We have run over 3 million Sanger data files through this system. We have further improved our Sanger analysis with a convolutional neural network, or CNN, to better analyze the tail sections of mRNA as well. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital technologies to enable our Early Development Engine</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have deployed multiple digital technologies across our Early Development Engine to drive the rapid pace of advancement, in parallel, of our development candidates into the clinic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Digital systems for cGMP manufacture: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to having integrated systems connected with robotics to drive our manufacturing in a paperless</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">environment, and have designed and deployed automation to drive efficient manufacturing operations. We have also deployed digital tools within manufacturing process development that give us the ability to track, analyze, and rapidly deploy manufacturing process improvements. Additionally, we have implemented several digital systems across manufacturing process development, quality, supply chain, and operations, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enterprise Quality Management System, or QMS, to electronically manage deviations, investigation, and correction and preventive actions;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Laboratory Information Management System, or LIMS, to manage our analytical development data and automate our manufacturing quality control;</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">computerized maintenance management system to manage equipment maintenance and calibration; and</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">SAP/S4 Hana system for enterprise resource planning, or ERP, manufacturing execution system, and manufacturing control system to manage inventories, track raw material consumption, digitally integrate equipment with manufacturing recipes in batch records, and control automated equipment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Digital systems for clinical development and clinical operations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to track the timelines of various development candidates through the Early</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development Engine, we have created a set of integrated applications. Workflows include timelines for regulatory filings, planning for IND-enabling GLP toxicology studies, scheduling for cGMP manufacturing, and clinical operations management. Below is a summary of our applications:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our portfolio application is a digital interface that maintains and tracks the timelines across multiple workstreams for each of our development candidates.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The supply application manages the manufacturing schedule of IND-enabling GLP toxicology supplies and cGMP manufacture of clinical supplies to support our programs. This application helps us see how the manufacturing schedule changes over time, identifies supply/demand mismatches, and enables resource planning with real-time alerts should we have any issues.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The GLP toxicology application tracks the planned and ongoing IND-enabling GLP toxicology studies and allows us to manage timelines with our external vendors.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The regulatory application tracks timelines related to regulatory affairs including, pre-IND meetings, IND/CTA submission dates, and other planned regulatory interactions.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our clinical operations application allows us to track our ongoing trials by accessing clinical operations information in real-time from our CROs. It also has multiple tools and analytics to draw key insights, including, for example, enrollment by trial and enrollment by site to maintain our program timelines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Digital systems for PCV: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PCV program aims to design, manufacture, and deliver a drug product that includes an mRNA sequence encoding for each</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patient&#8217;s specific neoantigens. The personalized nature of the PCV program adds additional steps and complexity in the overall patient treatment process. We have addressed those additional steps and complexity by digitizing and automating steps within the process, as described below.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Each patient is provided a unique identifier. We track the entire workflow using a single integrated tracker based on this unique identifier. This is one of many ways we ensure that each patient receives the specific drug product lot manufactured for them.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We use neural networks to design the mRNA sequences for the PCV program. Our proprietary vaccine design algorithm selects the top twenty neoantigens to be used and determines their amino acid sequences to trigger the desired immune response.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We utilize Monte Carlo simulations of PCV supply/demand to manage our capacity. Since each drug product lot is personalized to a patient, there is a need to manage supply and demand to avoid bottlenecks at any stage of the workflow.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Digital systems for the Commercial Engine: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are building our commercial engine to establish medical affairs engagements with doctors, support our sales and marketing capabilities and deliver a world-class patient experience. In addition to a patient- and doctor-centric view, our commercial engine will strengthen our supply chain demand forecasting and our compliance. We are looking at building a robust serialization process for regulatory requirements as well as anti-counterfeiting technologies to ensure safe, efficacious medicines to patients.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital technologies to support our business processes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:106%">We have deployed several digital systems across finance, manufacturing, and human resources to automate our business processes and drive efficiencies. We have implemented the SAP S4/Hana system for ERP. We have implemented various cloud-based solutions to improve business processes and drive efficiencies. For example, we have implemented the Workday system for human resource planning and management and integrated various applications across payroll, 401k services, equity plan management and expense reporting. Our class-leading integration platform, Dell Boomi, allows us to have a highly interconnected environment, moving us from simple cloud-to-cloud integrations to an evolving use of the integration platform for master data management, systems account management, and ultimately for cost savings and improved user experience.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THIRD-PARTY STRATEGIC ALLIANCES </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategic alliances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To accelerate the discovery and advancement of potential mRNA medicines across therapeutic areas, we have entered into, and intend to seek other opportunities to form, alliances with a diverse group of strategic collaborators. We have forged productive strategic alliances with pharmaceutical and biotechnology companies, government agencies, academic laboratories, foundations and research institutes with therapeutic area expertise and resources in an effort to advance our discovery and development programs, while leveraging our platform and our Research and Early Development Engines.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One key principle of our approach to strategic alliances is to share the rewards and risks of developing a new mRNA modality, where we may have early research data and desire a strategic collaborator to join us in advancing early development candidates within such modality into the clinic. Representative relationships and associated programs include the following:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">AstraZeneca for the localized regenerative therapeutics modality, such as the VEGF-A program (AZD8601) currently in Phase 2a;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">AstraZeneca for the intratumoral immuno-oncology modality, such as the IL-12 program (MEDI1191) currently in Phase 1;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Merck for the cancer vaccines modality, such as the personalized cancer vaccine program (mRNA-4157) currently in Phase 2 using a workflow that enables a rapid turnaround time to bring personalized vaccines to patients, and the KRAS vaccine program (mRNA-5671) currently in Phase 1;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DARPA for the systemic secreted therapeutics modality, such as the antibody against Chikungunya virus program (mRNA-1944) currently in Phase 1; </span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Vertex for the lung delivery modality, such as the cystic fibrosis, or CF, and cystic fibrosis transmembrane conductance regulator, or CFTR program currently in research;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Vertex for gene editing, aimed at the discovery and development of LNPs and mRNAs for the delivery of gene-editing therapies for the treatment of CF; and</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Chiesi </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Farmaceutici S.P.A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the discovery and development of potential mRNA medicines for the treatment of pulmonary arterial hypertension.</span></div><div style="padding-left:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We view strategic alliances as important drivers for accelerating execution of our goal of rapidly developing mRNA medicines to treat patients across a wide range of medical and disease challenges. To maintain the integrity of our platform, the terms of our agreements with our strategic collaborators generally provide that our strategic collaborators receive rights to develop and commercialize potential mRNA medicines that we design and manufacture, as opposed to rights to use our platform to generate new mRNA, and that we generally own mRNA-related intellectual property arising from research activities performed under the strategic alliance. We plan to continue to identify potential strategic collaborators who can contribute meaningful resources and insights to our programs and allow us to more rapidly expand our impact to broader patient populations.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AstraZeneca (NASDAQ: AZN)&#8212;Strategic Alliances in Cardiovascular and Oncology</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have had three alliances with AstraZeneca, two of which are ongoing. Our first strategic alliance established in 2013 and amended and restated in 2018, was to discover, develop, and commercialize potential mRNA medicines for the treatment of cardiovascular and cardiometabolic diseases, as well as selected targets for cancer. The relationship with AstraZeneca was expanded in 2016 by entering into a new immuno-oncology strategic alliance which is now focused on the joint development of an mRNA investigational medicine to make the IL-12 protein. It was further expanded in 2017 by entering into a third strategic alliance focused on the joint development of a potential mRNA medicine to make the relaxin protein, following discovery and preclinical development of the relevant development candidate internally. This last strategic alliance related to relaxin was terminated in December 2020. Additionally, AstraZeneca made several equity investments in Moderna, totaling approximately $290.0 million through December 31, 2020, although AstraZeneca has disclosed it is no longer a Moderna shareholder as of that date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Agreements with AstraZeneca, amended and restated in 2018</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2013, we entered into an Option Agreement and a related Services and Collaboration Agreement with AstraZeneca, which were amended and restated in June 2018 (2018 A&amp;R Agreements). Under the 2018 A&amp;R Agreements, we granted AstraZeneca certain exclusive rights and licenses to research, develop and commercialize potential therapeutic mRNA medicines directed at certain targets for the treatment of cardiovascular and cardiometabolic diseases and cancer, and agreed to provide related services to AstraZeneca. The activities to be performed by the parties under the 2018 A&amp;R Agreements are limited to defined biological targets in the cardiovascular and cardiometabolic fields and one defined target in the cancer field.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the effective date of the original Option Agreement and Services and Collaboration Agreement in 2013, AstraZeneca made upfront cash payments to us totaling $240.0 million in exchange for the acquired options and our performance of certain research-related services, each as described above. AstraZeneca will pay us a $10.0 million option exercise payment with respect to each development candidate (and related back-up candidates) for which it exercises an option. We are also eligible to receive, on a product-by-product basis, up to $400.0 million in aggregate contingent option exercise payments upon the achievement of certain development, regulatory and commercial milestone events. Additionally, we are entitled to receive, on a product-by-product basis, earn-out payments on worldwide net sales of products ranging from a high-single digit percentage to 12%, subject to certain reductions, with an aggregate minimum floor. Through December 31, 2020, we have received from AstraZeneca an option exercise payment of $10.0 million and a clinical milestone payment of $30.0 million with respect to AstraZeneca&#8217;s VEGF-A product (AZD8601) that is currently being developed in a Phase 2a clinical trial in the cardiovascular and cardiometabolic fields. Additionally, through December 31, 2020, we have received $120.0 million from AstraZeneca under the 2018 A&amp;R Agreements for the achievement of specified technical milestones. Further detail on the terms of the 2018 A&amp;R Agreements, including the financial arrangements are included in Note 5 to our Financial Statements (&#8220;Collaboration Agreements&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Strategic Alliance with AstraZeneca&#8212;IL-12</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, we entered into a new Strategic Drug Development Collaboration and License Agreement (2016 AZ Agreement) with AstraZeneca to discover, develop and commercialize potential mRNA medicines for the treatment of a range of cancers.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the 2016 AZ Agreement, we and AstraZeneca have agreed to work together on an immuno-oncology program focused on the intratumoral delivery of a potential mRNA medicine to make the IL-12 protein. The 2016 AZ Agreement initially included research activities with respect to a second discovery program. During a limited period of time, each party had an opportunity to propose additional discovery programs to be conducted under the 2016 AZ Agreement. We are responsible for conducting and funding all discovery and preclinical development activities under the 2016 AZ Agreement in accordance with an agreed upon discovery program plan for the IL-12 program and any other discovery program the parties agree to conduct under the 2016 AZ Agreement. For the IL-12 program and any other discovery program the parties agree to conduct under the 2016 AZ Agreement, during a defined election period that commenced as of the effective date of the 2016 AZ Agreement (for the IL-12 program) and otherwise will commence on initiation of any such new discovery program, AstraZeneca may elect to participate in the clinical development of a development candidate arising under the 2016 AZ Agreement from such program. If AstraZeneca so elects (as it has for the IL-12 program), AstraZeneca will lead clinical development activities worldwide and we will be responsible for certain activities, including being solely responsible for manufacturing activities, all in accordance with an agreed upon development plan. AstraZeneca will be responsible for funding all Phase 1 clinical development activities (including costs associated with our manufacture of clinical materials in accordance with the development plan), and Phase 2 clinical development activities (including costs associated with our manufacture of clinical materials in accordance with the development plan) up to a defined dollar threshold. We and AstraZeneca will equally share the costs of Phase 2 clinical development activities in excess of such dollar threshold, all Phase 3 clinical development activities and certain other costs of late-stage clinical development activities, unless we elect not to participate in further development and commercialization activities and instead receive tiered royalties, as described below. Further detail on the terms of the 2016 AZ Agreement, including the financial arrangements are included in Note 5 to our Financial Statements (&#8220;Collaboration Agreements&#8221;).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">2017 Strategic Alliance with AstraZeneca&#8212;Relaxin </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, we entered a new Collaboration and License Agreement (2017 AZ License Agreement) under which AstraZeneca had the right to clinically develop and commercialize a development candidate, known as AZD7970, which is comprised of an mRNA construct for the relaxin protein designed by us and encapsulated in one of our proprietary LNPs. We discovered and performed preclinical development activities for AZD7970 prior to the initiation of the strategic alliance with AstraZeneca under the 2017 AZ License Agreement. On December 16, 2020, the 2017 AZ License Agreement was terminated by mutual agreement, and we received the right to further develop relaxin on our own without any further obligation to AstraZeneca.</span></div><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merck (NYSE: MRK)&#8212;Strategic Alliances in Infectious Diseases and Cancer Vaccines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a multi-faceted relationship with Merck Sharp &amp; Dohme Corp. (Merck) that includes distinct strategic alliances directed to the research, development, and commercialization of mRNA medicines for the prevention and treatment of viral infections and for the treatment of cancer. In connection with these alliances, Merck also made several equity investments in Moderna totaling approximately $182.0 million, although Merck has disclosed the sale of its direct equity interest. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2015 Strategic Alliance with Merck&#8212;Infectious Disease</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2015, we entered into a Master Collaboration and License Agreement with Merck (2015 Merck Agreement), to research, develop, and commercialize potential mRNA medicines for the prevention and treatment of infections by RSV. As a part of the May 2019 amendment of the 2015 Merck Agreement, we and Merck agreed to conclude the collaboration as it relates to development of potential mRNA medicines for other viruses, including mRNA-1278 for the prevention of varicella zoster virus (VZV) infection. Pursuant to the 2015 Merck Agreement, Merck was primarily responsible for research, development and commercialization activities and associated costs. We were responsible for designing and, at Merck's cost, manufacturing all mRNA constructs for preclinical and Phase 1 and Phase 2 clinical development purposes. On October 7, 2020, the 2015 Merck Agreement between us and Merck related to our collaboration on RSV was terminated by mutual agreement, and the right to pursue the continued development and commercialization of product candidates and products, including RSV, reverted to us. Further detail on the terms of the 2015 Merck Agreement, including the financial arrangements are included in Note 5 to our Financial Statements (&#8220;Collaboration Agreements&#8221;).</span></div><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Expansion of the Infectious Disease Strategic Alliance with Merck</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, we expanded our infectious disease strategic alliance with Merck. Specifically, we and Merck agreed to amend the original 2015 Merck Agreement to include the research, development, and commercialization of mRNA medicines for the prevention and treatment of infection by the VZV in place of one of the viruses initially included under the 2015 Merck Agreement. Under the terms of the amended 2015 Merck Agreement, we received an upfront payment of $10.0 million from Merck for the inclusion of the new program and we agreed with Merck to increase the tiered royalty rates ranging from the mid-single digits to low-teens for net sales of products directed to this virus. In 2020, Merck elected not to continue with this program, and it was terminated.</span></div><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Cancer Vaccine Strategic Alliance&#8212;Personalized mRNA Cancer Vaccines with Merck</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, we entered into a personalized mRNA cancer vaccines (PCV) Collaboration and License Agreement with Merck (PCV Agreement) to develop and commercialize PCVs for individual patients using our mRNA vaccine and formulation technology. Under the strategic alliance, we identify genetic mutations present in a particular patient&#8217;s tumor cells, synthesize mRNA for these mutations, encapsulate the mRNA in one of our proprietary LNPs and administer to each patient a unique mRNA cancer vaccine designed to specifically activate the patient&#8217;s immune system against her or his own cancer cells.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the PCV Agreement, we are responsible for designing and researching PCVs, providing manufacturing capacity and manufacturing PCVs, and conducting Phase 1 and Phase 2 clinical trials for PCVs, alone and in combination with KEYTRUDA (pembrolizumab), Merck&#8217;s anti-PD-1 therapy, all in accordance with an agreed upon development plan and budget. We received an upfront payment of $200.0 million from Merck, which we will use to fund the performance of our activities set forth in the agreed upon development plan and budget. In November 2017, we and Merck announced the achievement of a key milestone for the first-in-human dosing of a PCV (mRNA-4157) as a part of the alliance. Further detail on the terms of the PCV Agreement, including the financial arrangements are included in Note 5 to our Financial Statements (&#8220;Collaboration Agreements&#8221;).</span></div><div style="margin-top:13pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:20pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Expansion of the Cancer Vaccine Strategic Alliance with Merck&#8212;Shared Neoepitope Cancer Vaccines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, we and Merck agreed to expand our cancer vaccine strategic alliance to include the development and commercialization of our KRAS vaccine development candidate, mRNA-5671, and potentially other shared neoantigen mRNA cancer vaccines (SAVs). We preclinically developed mRNA-5671 prior to its inclusion in the cancer vaccine strategic alliance and it is comprised of a novel mRNA construct designed by us and encapsulated in one of our proprietary LNPs. The PCV Agreement was amended and restated to include the new SAV strategic alliance (PCV/SAV Agreement). Further detail on the terms of the PCV/SAV Agreement, including the financial arrangements are included in Note 5 to our Financial Statements (&#8220;Collaboration Agreements&#8221;).</span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vertex (Nasdaq: VRTX)&#8212;2016 Strategic Alliance in Cystic Fibrosis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In July 2016, we entered into a Strategic Collaboration and License Agreement (Vertex Agreement) with Vertex Pharmaceuticals Incorporated, and Vertex Pharmaceuticals (Europe) Limited (together, Vertex). The Vertex Agreement is aimed at the discovery and development of potential mRNA medicines for the treatment of cystic fibrosis (CF) by enabling cells in the lungs of people with CF to produce functional cystic fibrosis transmembrane conductance regulator (CFTR) proteins. Further detail on the terms of the Vertex Agreement, including the financial arrangements are included in Note 5 to our Financial Statements (&#8220;Collaboration Agreements&#8221;). </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vertex &#8212;2020 Strategic Alliance in Cystic Fibrosis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a new Strategic Collaboration and License Agreement with Vertex (Vertex 2020 Agreement). The Vertex 2020 Agreement is aimed at the discovery and development of potential medicines to treat CF by delivering gene-editing therapies to lung cells to facilitate production of functional CFTR proteins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The three-year research period of the Vertex 2020 Agreement will initially focus on the identification and optimization of novel LNPs and mRNAs that can deliver gene-editing therapies to cells in the lungs. Following the initial three-year period, Vertex is responsible for conducting development and commercialization activities for candidates and products that arise from the strategic alliance, including the costs associated with such activities. Vertex is also obligated to pay us for research services in connection with our performance of certain activities in accordance with a jointly agreed research plan. Subject to customary &#8220;back-up&#8221; supply rights granted to Vertex, under the agreement, we are the exclusive manufacturer of related mRNA and LNPs for preclinical, clinical, and commercialization purposes. Further detail on the terms of the Vertex 2020 Agreement, including the financial arrangements are included in Note 5 to our Financial Statements (&#8220;Collaboration Agreements&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chiesi&#8212;2020 Collaboration and License Agreement with Chiesi</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In September 2020, we entered into a Collaboration and License Agreement (Chiesi Agreement) with Chiesi Farmaceutici S.P.A. (Chiesi). The Chiesi Agreement is aimed at the discovery and development of potential mRNA medicines for the treatment of pulmonary arterial hypertension (PAH), a rare disease characterized by high blood pressure in the arteries of the lungs. Further detail on the terms of the Chiesi Agreement, including the financial arrangements are included in Note 5 to our Financial Statements (&#8220;Collaboration Agreements&#8221;).</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Strategic alliances with government organizations and foundations</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defense Advanced Research Projects Agency (DARPA)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2013, DARPA awarded Moderna up to approximately $24.6 million under Agreement No. W911NF-13-1-0417 to research and develop potential mRNA medicines as a part of DARPA&#8217;s Autonomous Diagnostics to Enable Prevention and Therapeutics, or ADEPT, program, which is focused on assisting with the development of technologies to rapidly identify and respond to threats posed by natural and engineered diseases and toxins. As of December 31, 2020, $19.7 million of the award amount has been funded. This award followed an initial award from DARPA of approximately $1.4 million given in March 2013 under Agreement No. W31P4Q-13-1-0007. The DARPA awards have been deployed primarily in support of our vaccine and antibody programs to protect against Chikungunya infection.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into an agreement with DARPA for an award of up to $56.4 million to fund development of a mobile manufacturing prototype leveraging our existing manufacturing technology that is capable of rapidly producing vaccines and therapeutics. As of September 30, 2020, the committed funding was $5.0 million, with an additional $51.4 million available under Agreement No. HR0011-20-9-0118 if DARPA exercises additional contract options.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biomedical Advanced Research and Development Authority (BARDA)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2016, we received an award of up to approximately $125.8 million under Agreement No. HHSO100201600029C from BARDA, a component of the Office of the Assistant Secretary for Preparedness and Response (ASPR), within the U.S. Department of Health and Human Services (HHS), to help fund our Zika vaccine program. Under the terms of the agreement with BARDA, an initial base award of approximately $8.2 million supported toxicology studies, a Phase 1 clinical trial, and associated manufacturing activities. Additionally, four contract options were awarded under the agreement with BARDA. Three out of four of these options have been exercised, bringing the total current award to approximately $117.3 million to support an additional Phase 1 study of an improved Zika vaccine candidate, Phase 2 and Phase 3 clinical studies, as well as large-scale manufacturing for the Zika vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we entered into an agreement with BARDA for an award of up to $483.3 million to accelerate development of mRNA-1273, our COVID-19 vaccine. In July 2020, we amended our agreement with BARDA to provide for an additional commitment of up to $471.6 million to support late-stage clinical development of mRNA-1273, including the execution of a 30,000 participant Phase 3 study in the U.S. The amendment increased the maximum award from BARDA from $483.3 million to $954.9 million. Under the terms of the agreement, BARDA will fund the advancement of mRNA-1273 to FDA licensure. All contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $444.3&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Bill &amp; Melinda Gates Foundation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, we entered a global health project framework agreement with the Bill &amp; Melinda Gates Foundation to advance mRNA-based development projects for various infectious diseases. The Bill &amp; Melinda Gates Foundation has committed up to $20.0 million in grant funding to support our initial project related to the evaluation of antibody combinations in a preclinical setting as well as the conduct of a first-in-human Phase 1 clinical trial of a potential mRNA medicine to help prevent human immunodeficiency virus, or HIV, infections. Follow-on projects which could bring total potential funding under the framework agreement up to $100.0 million (including the HIV antibody project) to support the development of additional mRNA-based projects for various infectious diseases can be proposed and approved until the sixth anniversary of the framework agreement, subject to the terms of the framework agreement, including our obligation to grant to the Bill &amp; Melinda Gates Foundation certain non-exclusive licenses.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_52"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our patent estate and approach, a strategic asset</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have considered the creation and building of our intellectual property, or IP, portfolio as a critical part of our mission. In a relatively short amount of time, we have built a significant patent estate that includes over 600 world-wide pending patent applications and over 270 issued or allowed U.S. and foreign patents covering key components of our proprietary platform technology, investigational medicines, and development candidates. The figure below shows our internally developed estate and indicates the number of patents approved since 2010.</span><img src="mrna-20201231_g45.jpg" alt="mrna-20201231_g45.jpg" style="height:269px;margin-bottom:5pt;vertical-align:text-bottom;width:720px"/></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly identify inventions and trade secrets as we surmount various challenges with our platform to create modalities. We seek to protect our proprietary position by, among other means, filing U.S. and certain foreign patent applications related to our platform, modality, and program inventions. Our company trade secrets and know-how are appropriately guarded to maintain our business </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">advantage. We also seek to identify and obtain third party licenses where useful to maintain our advantageous IP position in the mRNA medicines field.&#160;We seek to obtain and maintain, and intend to strategically enforce, patents in appropriate jurisdictions for our platform technologies, modalities, and programs.&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Protecting our platform, modality, and program investments: Building an expansive, multi-layered IP estate</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a substantial IP estate that includes numerous patents and patent applications related to the development and commercialization of mRNA vaccine and therapeutic development candidates, including related platform technologies. Our platform IP protects advances in mRNA design and engineering, proprietary LNP components, delivery systems, processes for the manufacture and purification of drug substances and products, and analytical methods. A significant portion of our platform IP estate further provides multi-layered protection for our modalities and programs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to our IP estate, our solely-owned patent portfolio consists of more than 145 issued or allowed U.S. patents or patent applications and more than 125 granted or allowed patents in jurisdictions outside of the U.S. covering certain of our proprietary platform technology, inventions, and improvements, and covering key aspects of our clinical and most advanced development candidates. Additional patent applications are also pending that, in many cases, are counterparts to the foregoing U.S. and foreign patents. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the patents and applications (if issued) in our portfolio have or will have expiry dates extending out to 2033 at the earliest and at least 2041-2042 for patents ultimately granting based on our more recently filed patent applications.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on trademarks, trade secrets, and know-how relating to our proprietary technology and programs, continuing innovation, and in-licensing opportunities to develop, strengthen, and maintain our proprietary position in the field of mRNA therapeutic and vaccine technologies. We additionally plan to rely on data exclusivity, market exclusivity, and patent term extensions when available, and plan to seek and rely on regulatory protection afforded through orphan drug designations. We also possess substantial proprietary know-how associated with related manufacturing processes and expertise.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IP protecting our platform</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a broad IP estate covering key aspects of our platform. This estate provides multiple layers of protection covering the making and use of the mRNA drug substance and delivery technologies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to our platform, we have a portfolio that includes approximately 100 issued or allowed U.S. patents or patent applications, and approximately 220 granted foreign patents and pending foreign patent applications covering platform innovations that are directly related to the design, formulation and manufacturing of mRNA medicines.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, these patents and patent applications include claims directed to:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mRNA chemistry imparting improved properties for vaccine and therapeutic uses;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">methods for mRNA sequence optimization to enhance the levels and fidelity of proteins expressed from our mRNA medicines;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">methods for identifying epitopes having superior suitability in cancer vaccine contexts;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engineering elements tailored to enhance stability and the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> performance of mRNA medicines;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">proprietary lipid nanoparticle, or LNP, delivery systems, including novel lipid components designed for optimal expression of both therapeutic and vaccine mRNAs, in particular, prophylactic infectious disease and cancer vaccine mRNAs, intratumoral immuno-oncology therapeutics, local regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics; and</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">innovative processes for the manufacture and analysis of mRNA drug substance and formulated drug product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IP protection for modalities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our IP estate provides protection for the multiple programs within our modalities both at the product-specific level and at various broader levels. For example, we have patent coverage for LNP-encapsulated mRNAs having specific chemical modification suited for vaccine and therapeutic mRNA use. Our estate also includes IP covering certain LNP-encapsulated mRNAs coding for infectious disease antigens for use in prophylactic vaccination. Our mRNA chemistry, formulation and manufacturing patent applications and related know-how and trade secrets may also provide us with additional IP protection relating to our development candidates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patent portfolio for our investigational medicines and development candidates features approximately 50 issued or scheduled-to-issue patents, with many additional pending applications in the U.S. and foreign jurisdictions directed to our development candidates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prophylactic vaccines</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For programs within our prophylactic vaccines modality, we typically pursue patent protection featuring composition of matter and method of use claims. Our global patent protection strategy may vary based on the unique geographic prevalence of various infectious diseases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have filed several patent applications covering our COVID-19 vaccine. Claims covering our COVID-19 vaccine compositions and methods of vaccinating subjects against SARS-CoV-2 infection with lipid nanoparticle-encapsulated mRNA encoding prefusion-stabilized Spike protein antigen are featured in a patent family that includes a pending PCT application, two pending U.S. patent applications, 7 pending U.S. provisional patent applications, and foreign patent applications filed in Argentina and Taiwan. Priority dates for these applications span a period from late January through late May 2020. The U.S. government has rights in certain of the foregoing patent applications. Issued U.S. Patent No. 10,702,600 includes claims to lipid nanoparticle-encapsulated mRNA encoding betacoronavirus spike protein. Claims to methods of using such compositions to elicit an immune response in subjects are featured an allowed and soon to be issued U.S. patent application featured. Corresponding vaccine composition and method of use claims are also featured in a pending European patent application. These patents and applications enjoy an October 2015 priority date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further coverage for our COVID-19 vaccine and many of our other prophylactic vaccines is found in a broad, infectious disease vaccine patent family featuring claims to lipid nanoparticle-encapsulated mRNAs encoding infectious disease antigens and methods using such compositions for vaccination. This patent family includes two issued U.S. patents, two pending U.S. patent applications and pending patent applications in Europe, Canada, Australia, Brazil, China, Hong Kong, India, Japan, Russia, and Singapore. Issued U.S. Patent Nos. 10,022,435 and 10,709,779 feature claims directed to methods of vaccinating subjects against infection with lipid nanoparticle-encapsulated mRNAs encoding infectious disease antigens. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patent coverage for our human CMV vaccine, which includes mRNAs encoding several surface glycoproteins of the CMV virus, can be found in pending applications in Australia, Canada, Europe and Japan. In the United States, our CMV vaccine is covered in a pending U.S. patent application and in issued U.S. Patent Nos. 10,064,935, 10,383,937 and 10,716,846. Three provisional patent applications and a pending PCT application feature claims to clinical formulations of our CMV vaccine and methods of use.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patent applications directed to our hMPV/PIV3 vaccine are pending in the United States, Europe and Hong Kong. Four U.S. patents have issued featuring hMPV/PIV3 vaccines with U.S. Patent No. 10,064,934 having claims covering LNP-encapsulated mRNA vaccines that encode the PIV3 and hMPV fusion proteins, U.S. Patent No. 10,272,150 having claims covering administration methods for these LNP-encapsulated mRNA vaccines, U.S. Patent No. 10,543,269 having claims covering vaccines that include HMPV-encoding mRNA formulated in LNPs, and U.S. Patent No. 10,702,599 having claims covering vaccines that include PIV3-encoding mRNA formulated in LNPs. A pending provisional patent application features claims to clinical aspects of our hMPV/PIV3 vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Zika mRNA vaccine is covered in a series of patent families directed to mosquito-borne viruses. These patent families include three issued U.S. Patents that cover our Zika vaccines, U.S. Patent Nos. 10,124,055, 10,449,244 and 10,653,767, several pending U.S. patent applications, one of which is recently allowed and soon to be issued as a U.S. patent, and several pending European and Hong Kong patent applications.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed patent applications in several jurisdictions covering RSV vaccines. At least two U.S. and two European patent applications are pending, as are applications in several African, Asian, European, Middle Eastern, South American, and other jurisdictions. Also pending is a provisional application featuring our pediatric RSV vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A pending provisional patent application includes claims covering our vaccine program for the prevention of human infection with seasonal influenza virus. The program also is protected by the broad, infectious disease vaccine patent family described above, in particular, issued U.S. Patent No. 9,872,900 having claims to HA-encoding mRNA vaccine compositions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of our earliest investigational medicines in the infectious disease pipeline, a vaccine containing mRNA encoding the H7 HA antigen for the prevention of infection with the influenza H7N9 avian influenza A virus is also protected by the broad, infectious disease vaccine patent family described above. In particular, issued U.S. Patent No. 9,872,900 includes claims to H7 mRNA vaccine compositions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pending patent applications in the United States, Australia, Canada, Europe, and Japan include claims covering our EBV vaccine and methods of use. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pending patent applications in the United States and Europe include claims covering our Nipah vaccine and methods of use.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cancer vaccines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Composition of matter and method claims also protect programs within our cancer vaccines modality. Proprietary methods around the making and therapeutic use of our PCVs and resulting vaccine compositions are described and claimed in four pending U.S. patent applications, a pending PCT application, four pending European patent applications, three pending patent applications in each of Australia, Canada, and Japan, and one or two pending patent applications in each of India, South Korea, New Zealand, Russia, Singapore and South Africa. These applications also relate to various vaccine design formats, in particular, polyepitopic vaccine formats, and methods of treating cancer with such personalized cancer vaccines. We also possess substantial know-how and trade secrets relating to the development and commercialization of our cancer vaccine programs, including related manufacturing process and technology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Likewise, our KRAS antigen cancer vaccine and methods of treating cancer featuring such vaccines are covered in issued U.S. Patent No. 10,881,730, which includes claims to lipid nanoparticle-encapsulated mRNA encoding mutant KRAS antigens, and in a pending U.S. patent application and pending applications in Australia, Canada, Europe, and Japan, as well as in several other European, South American, Asian and Middle Eastern jurisdictions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intratumoral immuno-oncology</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect programs within our intratumoral immuno-oncology modality, we have filed numerous patent applications featuring claims to mRNAs encoding immune-stimulatory proteins and methods of treating cancer using such compositions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three of our immuno-oncology programs are designed to be administered intratumorally to alter the tumor microenvironment in favor of mounting an immune response against tumors. Our OX40L mRNA program and our mRNA program that includes mRNAs that encode OX40L, IL-23 and IL-36&#947; are covered by eight issued U.S. patents, U.S. Patent Nos. 10,143,723, 10,172,808, 10,285,950, 10,322,090, 10,322,191, 10,379,767, 10,383,951 and 10,406,113, by several pending U.S. patent applications, two of which are allowed and soon to issue, and by several pending patent applications in foreign jurisdictions including European, Asian, South American and other jurisdictions. These applications feature claims to the mRNA therapeutics as compositions of matter, formulations that include such mRNAs and methods of reducing tumors and treating cancer featuring these development candidates. Similar claims cover our IL-12 development candidate which can be found in issued U.S. Patent No. 10,646,549, and in pending patent applications in the United States, Australia, Canada, China, Europe and Japan, as well as several other jurisdictions in Asia, South America and the Middle East.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Localized regenerative therapeutics</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our localized regenerative therapeutics modality is focused on regenerative therapeutics. Our sole program, VEGF-A, is being developed in collaboration with AstraZeneca and is covered by a pending U.S. patent application and by several national phase patent applications filed in South American, Asian and Middle Eastern jurisdictions. The VEGF patent applications are solely-owned by Moderna.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systemic intracellular therapeutics</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our systemic intracellular therapeutics modality, we have four programs featuring expression of intracellular enzymes for the treatment of rare diseases. For our rare disease programs, we generally pursue patent protection featuring composition of matter and method of use claims, for example, pharmaceutical composition and method of treatment claims. Our most advanced rare disease development candidate, MMA, is covered by a patent family that includes two issued U.S. Patents, U.S. Patent No. 10,406,112 and U.S. Patent No. 10,426,738, two pending U.S. patent applications, a pending PCT patent application, and foreign patent applications filed in Australia, Canada, Japan, Europe and the Middle East.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our PA development candidate, we have patent applications pending in the United States, Canada, Europe, and Japan which cover mRNA encoding the alpha and beta subunits of the enzyme propionyl-CoA carboxylase (PCCA and PCCB, respectively), for the treatment of PA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our PKU development candidate, we have a pending PCT and a pending provisional patent application covering mRNA encoding phenylalanine hydroxylase, or PAH, for the treatment of PKU.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our Glycogen Storage Disorder, Type 1a (GSD1a) development candidate, we have 2 pending PCT and 2 pending provisional patent applications covering mRNA encoding glucose 6-phosphatase (G6Pase) for the treatment of this disorder.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any U.S. and foreign patents that may issue from these four patent families would be expected to expire in 2036 for the earliest of the MMA patents and 2038-2041 for the remaining MMA, PA, PKU and GSD1a patents, excluding any patent term adjustments and any patent term extensions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described below, we have filed or intend to file patent applications on these and other aspects of our technology and development candidates, and as we continue the development of our intended products, we plan to identify additional means of obtaining patent protection that would potentially enhance commercial success, including protection for additional methods of use, formulation, or manufacture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Systemic secreted and cell-surface therapeutics</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our systemic secreted and cell-surface therapeutics modality features programs directed to expression of secreted or cell-surface proteins including antibodies, circulating modulation factors, secreted enzymes and transmembrane proteins. Our mRNA-encoded antibody against Chikungunya virus reported positive interim Phase 1 results in clinical trials and utilizes the same lipid nanoparticle (LNP) formulation being advanced for our MMA program and other rare disease programs. Patent protection for mRNA-encoded antibody against Chikungunya virus is being sought by way of a pending U.S. and European patent applications, in which we share joint ownership rights.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Relaxin development candidate is covered by several pending foreign patent applications outside the United States, for example, in several Asian, European, Middle Eastern, South American and other jurisdictions, and by a pending U.S. application and by issued U.S. Patent No. 10,730,924.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our PD-L1 and IL-2 development candidates are covered in three recently filed U.S. provisional patent applications.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademarks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our registered trademark portfolio currently contains at least 125 registered trademarks, consisting of at least 10 registrations in the United States and approximately 115 registrations in Australia, Canada, China, the EU, Japan, Singapore, Sweden, and under the Madrid Protocol. In addition, we have other pending trademark applications, consisting of trademark applications in the United States, Australia, Canada, China, the EU, Japan, Singapore, and under the Madrid Protocol.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-licensed intellectual property</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we develop and manufacture our potential mRNA medicines using our internally created mRNA technology platform, we also seek out and evaluate third party technologies and IP that may be complementary to our platform. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patent sublicense agreements with Cellscript and mRNA RiboTherapeutics</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustees of the University of Pennsylvania, or Penn, owns several issued U.S. patents, granted European patents and pending U.S. patent applications directed, in part, to nucleoside-modified mRNAs and their uses, or the Penn Modified mRNA Patents. mRNA RiboTherapeutics, Inc., or MRT, obtained an exclusive license to the Penn Modified mRNA Patents and granted its affiliate, Cellscript, LLC, or Cellscript, a sublicense to the Penn Modified mRNA Patents in certain fields of use.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2017, we entered into two sublicense agreements, one with Cellscript, and one with MRT, which agreements we collectively refer to as the Cellscript-MRT Agreements. Together, the Cellscript-MRT Agreements grant us a worldwide, sublicensable sublicense to the Penn Modified mRNA Patents to research, develop, make, and commercialize products covered by the Penn Modified mRNA Patents, or licensed products, for all</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> uses in humans and animals, including therapeutic, prophylactic, and diagnostic applications. The Cellscript-MRT Agreements are non-exclusive, although Cellscript and MRT are subject to certain time restrictions on granting additional sublicenses for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> in vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> uses in humans under the Penn Modified mRNA Patents.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid Cellscript and MRT aggregate sublicense grant fees of $28 million upon entering into the Cellscript-MRT Agreements, $25&#160;million in early 2018, and $22 million in early 2019. Cellscript and MRT are collectively eligible to receive, on a licensed product-by-licensed product basis, milestone payments totaling up to $0.5&#160;million upon the achievement of certain regulatory-based events for diagnostic products, and milestone payments totaling up to $1.5&#160;million upon the achievement of certain development and regulatory-based events for either therapeutic or prophylactic products, and up to $24&#160;million upon the achievement of certain commercial-based events for either therapeutic or prophylactic products. The Cellscript-MRT Agreements require us to pay royalties based on annual net sales of licensed products at rates in the low single digits for therapeutic, prophylactic, and diagnostic uses, and royalties based on annual net sales of licensed products sold for research uses at rates in the mid-single digits, subject to certain reductions, with an aggregate minimum floor. Following the first commercial sale of licensed products under a Cellscript-MRT Agreement, we are required to pay Cellscript or MRT, as applicable, minimum annual royalties ranging from $10,000&#8212;$400,000 depending on the use of such licensed product, with all such payments creditable against earned royalties on net sales.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cellscript-MRT Agreements will expire upon the expiration or abandonment of the last to expire or become abandoned of the Penn Modified mRNA Patents. Cellscript or MRT, as applicable, may terminate its respective Cellscript-MRT Agreement if we fail to make required payments or otherwise materially breach the applicable agreement, subject to specified notice and cure provisions. Cellscript or MRT, as applicable, may also terminate the applicable Cellscript-MRT Agreement upon written notice in the event of our bankruptcy or insolvency or if we challenge the validity or enforceability of the Penn Modified mRNA Patents. We have the right to terminate each Cellscript-MRT Agreement at will upon 60 days&#8217; prior notice to Cellscript or MRT, as applicable, provided that we cease all development and commercialization of licensed products upon such termination. If rights to MRT or Cellscript under the Penn Modified mRNA Patents are terminated (e.g., due to bankruptcy of MRT or Cellscript), the terminated party will assign its interest in the respective Cellscript-MRT Agreement to the licensor from which it received rights under the Penn Modified mRNA Patents and our rights will continue under the new licensor.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Formulation technology in-licenses</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our development candidates use internally developed formulation technology that we own. We do, however, have rights to use and exploit multiple issued and pending patents covering formulation technologies under licenses from other entities.&#160;If in the future we elect to use or to grant our strategic collaborators sublicenses to use these in-licensed formulation technologies, we or our strategic collaborators may be liable for milestone and royalty payment obligations arising from such use. We consider the commercial terms of these licenses and their provisions regarding diligence, insurance, indemnification and other similar matters, to be reasonable and customary for our industry.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have entered into material transfer agreements that have provided us with opportunities to evaluate third party delivery systems.</span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EMPLOYEES </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had approximately 1,300 full-time employees as of December 31, 2020, representing a 59% increase over our 830 full-time employees as of the end of the prior year. Of our total full-time employees as of December 31, 2020, nearly 600 joined us during the course of the year. This growth in our employee base has largely been as a result of developments related to our COVID-19 vaccine. We have undertaken significant hiring of employees to facilitate manufacturing of the vaccine, in addition to building out our commercial and regulatory organizations, as well as other functions, to support this roll-out. As part of this expansion, we have also increased our hiring outside the United States during 2020, and at year-end we had employees in Switzerland, the United Kingdom, Canada and Spain. Much of this hiring has been of talent with experience at other pharmaceutical companies as we seek to build out our commercial and regulatory capabilities, particularly at more senior levels of the company. We have also continued to hire talent to support our research and clinical capabilities across the rest of our pipeline, unrelated to our COVID-19 vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a highly competitive environment for human capital, particularly as we seek to attract and retain talent with experience in the biotechnology and pharmaceutical sectors. Our workforce is highly educated, and as of December 31, 2020, 51% of our employees hold Ph.D., M.D., J.D., or Master&#8217;s degrees. Among our employees, 46% are female and 54% are male. Among our leadership (which we define as employees at the vice president level and above), as of December 31, 2020, approximately 37% are female, an increase from 35% in the prior year. 35% of our U.S. employees identify as racially or ethnically diverse as of December 31, 2020, an increase from 32% in the prior year. In 2020, we expanded our emphasis on belonging, inclusion &amp; diversity, creating a Conscious Inclusion education series for senior leaders, conducting several internal seminars, panels, and discussions on inclusion, launching a new employee resource group in support of our Black and African American employees, and adding a full-time senior-level role focused on belonging, equity, inclusion and diversity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To help promote alignment between our employees and our shareholders, all employees participate in our equity programs through the receipt of new hire and annual equity grants, and the percentage of equity as a component of overall pay mix increases with seniority. We believe that in addition to incentivizing growth that leads to shareholder value, broad eligibility for our equity programs helps promote employee retention as these awards generally vest over a four-year period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, we undertook several initiatives to ensure the safety of our workforce and continuity of our operations. We created a Response Team that was responsible for implementing safety measures testing at our Cambridge and Norwood sites. This included regular COVID-19 testing, temperature and health screening as well as implementing digital tools to facilitate contact tracing and providing personal protective equipment (PPE). Throughout the pandemic, much of our workforce has worked remotely, wherever possible. We also implemented remote hiring and onboarding programs to facilitate significant hiring during 2020 in a remote work environment. In December 2020, following the receipt of an Emergency Use Authorization from the FDA for our COVID-19 vaccine, we made the vaccine available to our employees and adult members of their households to help ensure continuity of our operations due to the critical nature of our production of the vaccine.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our employees is represented by a labor union, and none of our employees has entered into a collective bargaining agreement with us, other than a small number of employees in Spain who are covered by collective bargaining agreements governing certain benefits. We consider our employee relations to be good.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our employees are highly engaged, and we and our employees have been recognized by surveys conducted by external groups. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Science</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> magazine ranked us as a top employer for each of the last six years. We measure employee engagement through a vendor-supplied engagement software, using validated external benchmarks to track quarter-over-quarter employee engagement factors.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our approach to attracting and retaining talent</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to ensuring that our employees find that their careers at Moderna are filled with purpose, growth and fulfillment. We believe that a career at Moderna provides opportunity for:</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Impact</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our people will have the opportunity to do work that is unparalleled in terms of its innovation and scope of impact on people&#8217;s lives.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For the intellectually curious, we provide incredible opportunities for growth. We invest in the development of our people as scientists and as leaders.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We are committed to the health and wellbeing of our employees and their families by providing family friendly benefits and opportunities to be healthy.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Inclusive environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We believe in the benefits of bringing together a diverse set of perspectives and backgrounds, and creating an environment where differences are celebrated and leveraged.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Compelling rewards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: To attract and retain the best talent, we provide competitive rewards that help to drive groundbreaking work and allow employees to share in the value we will create together, including through our equity programs.</span></div><div style="padding-left:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our approach to training our employees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a structured training curriculum for our employees called Moderna University and have a full-time team dedicated to developing the curriculum and conducting activities for Moderna University. The objective of Moderna University is for every employee to be deeply familiar with our core technology and able to learn about technologies that might further enable our science. In addition, Moderna University is also focused on creating strong leaders through management and leadership training. There are four core areas within Moderna University including:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Professional development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Includes on-site training programs for our employees including for example, leadership, tools to improve interpersonal communication, and project management.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Digital learning library</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We have built an online library of videos of a variety of scientific material that our employees can access flexibly. This content includes:</span></div><div style="padding-left:76.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">Presentations by external speakers to scientific seminars conducted in-house;</span></div><div style="padding-left:76.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">Scientific courses at external universities; and</span></div><div style="padding-left:76.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.46pt">Peer-to-peer video series in which in-house experts provide an introductory view of complex topics they tackle within their teams.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Learning management system</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We have deployed a digital system to track and administer training programs for each of our employees. Training content is developed digitally and offered to our employees.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">New hire orientation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: This program is designed to onboard all new employees. During this training program, new employees meet with the management team and senior functional leaders to learn about the Company and functional activities.</span></div><div style="padding-left:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To further develop and retain our workforce, we conduct periodic talent reviews that identify key talent within the organization. We use that data to inform specific development opportunities for key current and potential future leaders, and to support our periodic succession planning activities for key roles. These steps together ensure we have a robust understanding of our workforce and a talent pipeline to grow future leaders.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_58"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CORPORATE SOCIAL RESPONSIBILITY</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In pursuit of our mission to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients, we have scaled our operations, invested in research, and hired top-tier talent. As we continue to mature, we believe it is important to develop long-term programs that underscore our commitment to corporate social responsibility. Please refer to the &#8220;Citizenship&#8221; section of our website, which can be found at www.modernatx.com, for a description of some of the measures we have taken to support our commitment to corporate social responsibility.</span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_61"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">COMPETITION</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The biotechnology and pharmaceutical industries utilize rapidly advancing technologies and are characterized by intense competition. There is also a strong emphasis on intellectual property and proprietary products.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that mRNA as a medicine coupled with our capabilities across mRNA technology, drug discovery, development, and manufacturing provide us with a competitive advantage. However, we will continue to face competition from different sources including major pharmaceutical companies, biotechnology companies, academic institutions, government agencies, and public and private research institutions. For any products that we eventually commercialize, we will not only compete with existing therapies but also compete with new therapies that may become available in the future.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition in the market for our COVID-19 vaccine, particularly from established pharmaceutical companies with longer operating histories and significant experience in producing and marketing pharmaceutical products. Competition for the sale of our COVID-19 vaccine can be impacted by a number of factors, including: the efficacy of our vaccine in preventing COVID-19 (particularly in the prevention of severe cases of COVID-19); the ability of our vaccine, or future iterations of the vaccine, to protect effectively against variants of the SARS-CoV-2 virus; perceptions of the efficacy of our vaccine; concerns about potential side effects from the vaccine, its safety or tolerability; the novelty of mRNA-based technology; storage and handling conditions for our vaccine and the ease or difficulty with which it can be distributed; and the fact that our COVID-19 vaccine requires two doses, whereas certain competitors&#8217; vaccines may only require a single dose. The competitiveness of our COVID-19 vaccine in the future may also depend upon whether we are successful in efforts to combine this with other vaccines, like seasonal flu, and whether our competitors are successful in these efforts. Our competitive positioning may also be affected by the fact that we do not have as long a history of producing pharmaceutical products or existing commercial relationships compared to certain of our competitors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete in the segment of pharmaceutical and biotechnology industries. There are additional companies that are working on mRNA medicines, some of which have reached commercialization. Companies with mRNA programs include BioNTech (which has partnered with Pfizer for the production and commercialization of a COVID-19 vaccine) and CureVac (which also is developing a COVID-19 vaccine). Other competitors include eTheRNA Immunotherapies and Translate Bio and those with preclinical programs include Arcturus Therapeutics, Ethris, Genevant Sciences, Stemirna Therapeutics and GlaxoSmithKline. We also compete against other pharmaceutical companies in the market for COVID-19 vaccines that do not utilize mRNA-based technologies, including AstraZeneca and Johnson &amp; Johnson, among others.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_64"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GOVERNMENT REGULATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Government authorities in the United States at the federal, state and local level and in other countries regulate, among other things, the research, development, testing, manufacture, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, post-approval monitoring and reporting, marketing and export and import of drug and biological products, such as our investigational medicines and any future investigational medicines. Generally, before a new drug or biologic can be marketed, considerable data demonstrating its quality, safety and efficacy must be obtained, organized into a format specific for each regulatory authority, submitted for review and approved by the regulatory authority.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. drug and biological product development</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act, or FDCA, and its implementing regulations and biologics under the FDCA, the Public Health Service Act, or PHSA, and their implementing regulations. Both drugs and biologics also are subject to other federal, state and local statutes and regulations. The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state and local statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or following approval may subject an applicant to administrative or judicial sanctions. These sanctions could include, among other actions, the FDA&#8217;s refusal to approve pending applications, withdrawal of an approval, license revocation, a clinical hold, untitled or warning letters, voluntary or mandatory product recalls, market withdrawals, product seizures, total or partial </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement and civil or criminal penalties. Any agency or judicial enforcement action could have a material adverse effect on us.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investigational medicines and any future investigational medicines must be approved by the FDA through a biologics license application, or BLA, or new drug application, NDA process before they may be legally marketed in the United States. The process generally involves the following:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completion of extensive preclinical studies in accordance with applicable regulations, including studies conducted in accordance with GLP requirements;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to the FDA of an IND application, which must become effective before human clinical trials may begin;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approval by an institutional review board, or IRB, or independent ethics committee at each clinical trial site before each trial may be initiated;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance of adequate and well-controlled human clinical trials in accordance with applicable IND regulations, good clinical practice, or GCP, requirements and other clinical trial-related regulations to establish the safety and efficacy of the investigational product for each proposed indication;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">submission to the FDA of a BLA or an NDA;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a determination by the FDA within 60 days of its receipt of a BLA or an NDA to accept the filing for review;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">satisfactory completion of one or more FDA pre-approval inspections of the manufacturing facility or facilities where the biologic or drug will be produced to assess compliance with cGMP requirements to assure that the facilities, methods and controls are adequate to preserve the biologic or drug&#8217;s identity, strength, quality and purity;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential FDA audit of the clinical trial sites that generated the data in support of the BLA or NDA;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payment of user fees for FDA review of the BLA or NDA; and</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA review and approval of the BLA or NDA, including consideration of the views of any FDA advisory committee, prior to any commercial marketing or sale of the biologic or drug in the United States.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preclinical and clinical testing and approval process requires substantial time, effort and financial resources, and we cannot be certain that any approvals for our investigational medicines and any future investigational medicines will be granted on a timely basis, or at all.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preclinical studies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before testing any biological or drug candidate, including our product candidates, in humans, the product candidate must undergo rigorous preclinical testing. Preclinical studies include laboratory evaluation of product chemistry and formulation, as well as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and animal studies to assess the potential for adverse events and in some cases to establish a rationale for therapeutic use. The conduct of preclinical studies is subject to federal regulations and requirements, including GLP regulations for safety/toxicology studies. An IND sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data, any available clinical data or literature and plans for clinical studies, among other things, to the FDA as part of an IND. An IND is a request for authorization from the FDA to administer an investigational product to humans and must become effective before human clinical trials may begin. Some long-term preclinical testing may continue after the IND is submitted. An IND automatically becomes effective 30 days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to one or more proposed clinical trials and places the trial on clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. As a result, submission of an IND may not result in the FDA allowing clinical trials to commence.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical trials</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The clinical stage of development involves the administration of the investigational product to healthy volunteers or patients under the supervision of qualified investigators, generally physicians not employed by or under the trial sponsor&#8217;s control, in accordance with GCP requirements, which include the requirement that all patients provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria and the parameters to be used to monitor subject safety and assess efficacy. Each protocol, and any subsequent amendments to the protocol, must be submitted to the FDA as part of the IND. Furthermore, each clinical trial must be reviewed and approved by an IRB for each institution at which the clinical trial will be conducted to ensure that the risks to individuals participating in the clinical trials are minimized and are reasonable in relation to anticipated benefits. The IRB also approves the informed consent form that must be provided to each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed. There also are requirements governing the reporting of ongoing clinical trials and completed clinical trial results to public registries. Information about certain clinical trials, including clinical trial results, must be submitted within specific timeframes for publication on the www.clinicaltrials.gov website.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the submission of an IND to the FDA before initiation of a clinical trial in the United States, certain human clinical trials involving recombinant or synthetic nucleic acid molecules had historically been subject to review by the Recombinant DNA Advisory Committee, or RAC, of the National Institutes of Health, or NIH, Office of Biotechnology Activities, or the OBA, pursuant to the NIH </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guidelines for Research Involving Recombinant DNA Molecules, or NIH Guidelines. On August 17, 2018, the NIH issued a notice in the Federal Register and issued a public statement proposing changes to the oversight framework for gene therapy trials, including changes to the applicable NIH Guidelines to modify the roles and responsibilities of the RAC with respect to human clinical trials of gene therapy products, and requesting public comment on its proposed modifications. During the public comment period, which closed October 16, 2018, the NIH announced that it will no longer accept new human gene transfer protocols for review as a part of the protocol registration process or convene the RAC to review individual clinical protocols. In April 2019, NIH announced the updated guidelines, which reflect these proposed changes, and clarified that these trials will remain subject to the FDA&#8217;s oversight and other clinical trial regulations, and oversight at the local level will continue as set forth in the NIH Guidelines. Specifically, under the NIH Guidelines, supervision of human gene transfer trials includes evaluation and assessment by an institutional biosafety committee, or IBC, a local institutional committee that reviews and oversees research utilizing recombinant or synthetic nucleic acid molecules at that institution. The IBC assesses the safety of the research and identifies any potential risk to public health or the environment, and such review may result in some delay before initiation of a clinical trial. While the NIH Guidelines are not mandatory unless the research in question being conducted at or sponsored by institutions receiving NIH funding of recombinant or synthetic nucleic acid molecule research, many companies and other institutions not otherwise subject to the NIH Guidelines voluntarily follow them. </span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A sponsor who wishes to conduct a clinical trial outside of the United States may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. If a foreign clinical trial is not conducted under an IND, the sponsor may submit data from the clinical trial to the FDA in support of a BLA or NDA. The FDA will accept a well-designed and well-conducted foreign clinical study not conducted under an IND if the study was conducted in accordance with GCP requirements, and the FDA is able to validate the data through an onsite inspection if deemed necessary.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials generally are conducted in three sequential phases, known as Phase 1, Phase 2 and Phase 3, and may overlap.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 1 clinical trials generally involve a small number of healthy volunteers or disease-affected patients who are initially exposed to a single dose and then multiple doses of the product candidate. The primary purpose of these clinical trials is to assess the metabolism, pharmacologic action, side effect tolerability, and safety of the product candidate.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 2 clinical trials generally involve studies in disease-affected patients to evaluate proof of concept and/or determine the dosing regimen(s) for subsequent investigations. At the same time, safety and further pharmacokinetic and pharmacodynamic information is collected, possible adverse effects and safety risks are identified, and a preliminary evaluation of efficacy is conducted.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Phase 3 clinical trials generally involve a large number of patients at multiple sites and are designed to provide the data necessary to demonstrate the effectiveness of the product for its intended use, its safety in use and to establish the overall benefit/risk relationship of the product, and provide an adequate basis for product labeling.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FDA released a draft guidance entitled &#8220;Expansion Cohorts: Use in First-In-Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics,&#8221; which outlines how drug developers can utilize an adaptive trial design commonly referred to as a seamless trial design in early stages of oncology drug development, i.e., the first-in-human clinical trial, to compress the traditional three phases of trials into one continuous trial called an expansion cohort trial. Information to support the design of individual expansion cohorts are included in IND applications and assessed by FDA. Expansion cohort trials can potentially bring efficiency to drug development and reduce developmental costs and time.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Post-approval trials, sometimes referred to as Phase 4 clinical trials, may be conducted after initial marketing approval. These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication and are commonly intended to generate additional safety data regarding use of the product in a clinical setting. In certain instances, the FDA may mandate the performance of Phase 4 clinical trials as a condition of approval of a BLA or NDA.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Progress reports detailing the results of the clinical trials, among other information, must be submitted at least annually to the FDA and written IND safety reports must be submitted to the FDA and the investigators 15 calendar days after the trial sponsor determines the information qualifies for reporting for serious and unexpected suspected adverse events, findings from other studies or animal or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> testing that suggest a significant risk for human subjects and any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor also must notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction as soon as possible but in no case later than seven calendar days after the sponsor&#8217;s initial receipt of the information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase 1, Phase 2, Phase 3, and other types of clinical trials may not be completed successfully within any specified period, if at all. The FDA or the sponsor may suspend or terminate a clinical trial at any time on various grounds, including a finding that the patients are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#8217;s requirements or if the drug or biologic has been associated with unexpected serious harm to patients. Additionally, some clinical trials are overseen by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board or committee. This group provides </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">authorization for whether a trial may move forward at designated check points based on access to certain data from the trial. Concurrent with clinical trials, companies usually complete additional animal studies and also must develop additional information about the chemistry and physical characteristics of the drug or biologic as well as finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product and, among other things, companies must develop methods for testing the identity, strength, quality, and purity of the final product. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the investigational medicines do not undergo unacceptable deterioration over their shelf life.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FDA review process</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following completion of the clinical trials, data are analyzed to assess whether the investigational product is safe and effective for the proposed indicated use or uses. The results of preclinical studies and clinical trials are then submitted to the FDA as part of a BLA or NDA, along with proposed labeling, chemistry, and manufacturing information to ensure product quality and other relevant data. A BLA is a request for approval to market a biologic for one or more specified indications and must contain proof of the biologic&#8217;s safety, purity, and potency. An NDA for a new drug must contain proof of the drug&#8217;s safety and efficacy. The marketing application may include both negative and ambiguous results of preclinical studies and clinical trials, as well as positive findings. Data may come from company-sponsored clinical trials intended to test the safety and efficacy of a product&#8217;s use or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be sufficient in quality and quantity to establish the safety and efficacy of the investigational product to the satisfaction of the FDA. FDA approval of a BLA or NDA must be obtained before a biologic or drug may be marketed in the United States.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Prescription Drug User Fee Act, or PDUFA, as amended, each BLA or NDA must be accompanied by a user fee. The FDA adjusts the PDUFA user fees on an annual basis. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on BLAs or NDAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA reviews all submitted BLAs and NDAs before it accepts them for filing and may request additional information rather than accepting the BLA or NDA for filing. The FDA must make a decision on accepting a BLA or NDA for filing within 60 days of receipt, and such decision could include a refusal to file by the FDA. Once the submission is accepted for filing, the FDA begins an in-depth review of the BLA or NDA. Under the goals and policies agreed to by the FDA under PDUFA, the FDA has 10 months, from the filing date, in which to complete its initial review of an original BLA or NDA for a new molecular entity and respond to the applicant, and six months from the filing date of an original BLA or NDA designated for priority review. The FDA does not always meet its PDUFA goal dates for standard and priority BLAs and NDAs, and the review process is often extended by FDA requests for additional information or clarification.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before approving a BLA or NDA, the FDA will conduct a pre-approval inspection of the manufacturing facilities for the new product to determine whether they comply with cGMP requirements. The FDA will not approve the product unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA also may audit data from clinical trials to ensure compliance with GCP requirements. Additionally, the FDA may refer applications for novel products or products which present difficult questions of safety or efficacy to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation and a recommendation as to whether the application should be approved and under what conditions, if any. The FDA is not bound by recommendations of an advisory committee, but it considers such recommendations when making decisions on approval. The FDA likely will reanalyze the clinical trial data, which could result in extensive discussions between the FDA and the applicant during the review process. After the FDA evaluates a BLA or NDA, it will issue an approval letter or a Complete Response Letter. An approval letter authorizes commercial marketing of the biologic or drug with specific prescribing information for specific indications. A Complete Response Letter indicates that the review cycle of the application is complete, and the application will not be approved in its present form. A Complete Response Letter usually describes all of the specific deficiencies in the BLA or NDA identified by the FDA. The Complete Response Letter may require additional clinical data, additional pivotal Phase 3 clinical trial(s), and/or other significant and time-consuming requirements related to clinical trials, preclinical studies, or manufacturing. If a Complete Response Letter is issued, the applicant may either resubmit the BLA or NDA, addressing all of the deficiencies identified in the letter, or withdraw the application or request an opportunity for a hearing. Even if such data and information are submitted, the FDA may decide that the BLA or NDA does not satisfy the criteria for approval. Data obtained from clinical trials are not always conclusive and the FDA may interpret data differently than we interpret the same data.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Orphan drug designation</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biological product intended to treat a rare disease or condition, which is generally a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States and for which there is no reasonable expectation that the cost of developing and making the product available in the United States for this type of disease or condition will be recovered from sales of the product.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Orphan drug designation must be requested before submitting a BLA or NDA. After the FDA grants orphan drug designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation on its own does not convey any advantage in or shorten the duration of the regulatory review and approval process.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a product that has orphan designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to orphan drug exclusivity, which means that the FDA may not approve any other applications to market the same drug for the same indication for seven years from the date of such approval, except in limited circumstances, such as a showing of clinical superiority to the product with orphan exclusivity by means of greater effectiveness, greater safety, or providing a major contribution to patient care, or in instances of drug supply issues. Competitors, however, may receive approval of either a different product for the same indication or the same product for a different indication; in the latter case, because health care professionals are free to prescribe products for off-label uses, the competitor&#8217;s product could be used for the orphan indication despite our orphan exclusivity. Orphan drug exclusivity also could block the approval of one of our products for seven years if a competitor obtains approval before we do for the same drug and same indication, as defined by the FDA, for which we are seeking approval, or if our product is determined to be contained within the scope of the competitor&#8217;s product for the same indication or disease. If we pursue marketing approval for an indication broader than the orphan drug designation we have received, we may not be entitled to orphan drug exclusivity. Orphan drug status in the European Union, or EU, has similar, but not identical, requirements and benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expedited development and review programs</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has a fast track program that is intended to expedite or facilitate the process for reviewing new drugs and biologics that meet certain criteria. Specifically, new drugs and biologics are eligible for fast track designation if they are intended to treat a serious or life-threatening condition and preclinical or clinical data demonstrate the potential to address unmet medical needs for the condition. Fast track designation applies to both the product and the specific indication for which it is being studied. The sponsor can request the FDA to designate the product for fast track status any time before receiving BLA or NDA approval, but ideally no later than the pre-BLA or pre-NDA meeting. Any product submitted to the FDA for marketing, including under a fast track program, may be eligible for other types of FDA programs intended to expedite development and review, such as priority review and accelerated approval. Any product is eligible for priority review if it treats a serious or life-threatening condition and, if approved, would provide a significant improvement in safety and effectiveness compared to available therapies. The FDA will attempt to direct additional resources to the evaluation of an application for a new drug or biologic designated for priority review in an effort to facilitate the review.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A product may also be eligible for accelerated approval, if it treats a serious or life-threatening condition and generally provides a meaningful advantage over available therapies. In addition, it must demonstrate an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, or IMM, that is reasonably likely to predict an effect on IMM or other clinical benefit. As a condition of approval, the FDA may require that a sponsor of a drug or biologic receiving accelerated approval perform adequate and well-controlled post-marketing clinical trials. If the FDA concludes that a drug or biologic shown to be effective can be safely used only if distribution or use is restricted, it will require such post-marketing restrictions, as it deems necessary to assure safe use of the product. If the FDA determines that the conditions of approval are not being met, the FDA can withdraw its accelerated approval for such drug or biologic.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, a drug or biologic may be eligible for designation as a breakthrough therapy if the product is intended, alone or in combination with one or more other drugs or biologics, to treat a serious or life-threatening condition and preliminary clinical evidence indicates that the product may demonstrate substantial improvement over currently approved therapies on one or more clinically significant endpoints. The benefits of breakthrough therapy designation include the same benefits as fast track designation, plus intensive guidance from the FDA to ensure an efficient drug development program.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or the time period for FDA review or approval may not be shortened. Furthermore, fast track designation, priority review, accelerated approval, and breakthrough therapy designation do not change the standards for approval, but may expedite the development or approval process.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emergency Use Authorization (EUA)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Secretary of Health and Human Services may authorize unapproved medical products, including vaccines, to be marketed in the context of an actual or potential emergency that has been designated by the U.S. government. The COVID-19 pandemic has been designated as such a national emergency. After an emergency has been announced, the Secretary of Health and Human Services may authorize the issuance of and the FDA Commissioner may issue EUAs for the use of specific products based on criteria established by the FDCA, including that the product at issue may be effective in diagnosing, treating, or preventing serious or life-threatening diseases when there are no adequate, approved, and available alternatives. An EUA is subject to additional conditions and restrictions and is product-specific. An EUA terminates when the emergency determination underlying the EUA terminates. An EUA is not a long-term alternative to obtaining FDA approval, licensure, or clearance for a product. FDA may revoke an EUA for a variety of </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reasons, including where it is determined that the underlying health emergency no longer exists or warrants such authorization, so it is not possible to predict how long an EUA may remain in place.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pediatric information</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Pediatric Research Equity Act, as amended, a BLA or NDA or supplement to a BLA or NDA must contain data to assess the safety and efficacy of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for submission of pediatric data or full or partial waivers. A sponsor who is planning to submit a marketing application for a drug that includes a new active ingredient, new indication, new dosage form, new dosing regimen, or new route of administration must submit an initial Pediatric Study Plan, or PSP, within 60 days of an end-of-Phase 2 meeting or, if there is no such meeting, as early as practicable before the initiation of the Phase 3 or Phase 2/3 study. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints, and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach an agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials, and/or other clinical development programs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Post-marketing requirements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following approval of a new product, the manufacturer and the approved product are subject to continuing regulation by the FDA, including, among other things, monitoring and record-keeping activities, reporting of adverse experiences, complying with promotion and advertising requirements, which include restrictions on promoting products for unapproved uses or patient populations (known as &#8216;&#8216;off-label use&#8217;&#8217;), and limitations on industry-sponsored scientific and educational activities. Although physicians may prescribe legally available products for off-label uses, manufacturers may not market or promote such uses. Prescription drug and biologic promotional materials must be submitted to the FDA in conjunction with their first use. Further, if there are any modifications to the drug or biologic, including changes in indications, labeling or manufacturing processes or facilities, the applicant may be required to submit and obtain FDA approval of a new BLA or NDA or BLA or NDA supplement, which may require the development of additional data or preclinical studies and clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may also place other conditions on approvals including the requirement for a Risk Evaluation and Mitigation Strategy, or REMS, to assure the safe use of the product. If the FDA concludes a REMS is needed, the sponsor of the BLA or NDA must submit a proposed REMS. The FDA will not approve the BLA or NDA without an approved REMS, if required. A REMS could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries, and other risk minimization tools. Any of these limitations on approval or marketing could restrict the commercial promotion, distribution, prescription or dispensing of products. Newly discovered or developed safety or effectiveness data may require changes to a drug&#8217;s approved labeling, including the addition of new warnings and contraindications, and also may require the implementation of other risk management measures, including a REMS or the conduct of post-marketing studies to assess a newly discovered safety issue. Product approvals may be withdrawn for non-compliance with regulatory standards, or if problems occur following initial marketing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA regulations require that products be manufactured in specific approved facilities and in accordance with cGMP regulations. In addition to our own manufacturing facilities, we rely, and expect to continue to rely, on third parties for the production of certain clinical and commercial quantities of our products in accordance with cGMP regulations. We, and these manufacturers must comply with cGMP regulations that require, among other things, quality control and quality assurance, the maintenance of records and documentation, and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities involved in the manufacture and distribution of approved drugs or biologics are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP requirements and other laws. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance. The discovery of violative conditions, including failure to conform to cGMP regulations, could result in enforcement actions, and the discovery of problems with a product after approval may result in restrictions on a product, manufacturer, or holder of an approved BLA or NDA, including recall.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. patent term restoration and marketing exclusivity</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending upon the timing, duration, and specifics of FDA approval of our investigational medicines and any future investigational medicines, some of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term Restoration Act of 1984, commonly referred to as the Hatch Waxman Amendments. The Hatch Waxman Amendments permit restoration of the patent term of up to five years as compensation for patent term lost during product development and FDA regulatory review process. Patent term restoration, however, cannot extend the remaining term of a patent beyond a total of 14 years from the product&#8217;s approval date. The patent term restoration period is generally one half the time between the effective date of an IND and the submission date of a BLA or NDA, plus the time between the submission date of a BLA or NDA and the approval of that application, except that the review period is reduced by any time during which the applicant failed to exercise due diligence. Only one patent applicable to an approved drug is eligible for such an extension and the application for the extension must be submitted prior to the expiration of the patent. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, we may apply for restoration of patent term for our currently owned or licensed patents to add patent life beyond the current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant BLA or NDA.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing exclusivity provisions under the FDCA can also delay the submission or the approval of certain marketing applications. The FDCA provides three years of marketing exclusivity for an NDA, or supplement to an existing NDA, if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example for new indications, dosages, or strengths of an existing drug. This three-year exclusivity covers only the modification for which the drug received approval on the basis of the new clinical investigations and does not prohibit the FDA from approving abbreviated new drug applications, or ANDAs, for drugs containing the active agent for the original indication or condition of use. The FDCA also provides a five-year period of non-patent marketing exclusivity within the United States to the first applicant to obtain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the exclusivity period, the FDA may not accept for review an ANDA or a 505(b)(2) NDA submitted by another company for another drug based on the same active moiety, regardless of whether the drug is intended for the same indication as the original innovator drug or for another indication, where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be submitted after four years if it contains a certification of patent invalidity or non-infringement to one of the patents listed with the FDA by the innovator NDA holder. Three-year and five-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to all of the nonclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and efficacy.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An abbreviated approval pathway for biological products shown to be biosimilar to, or interchangeable with, an FDA-licensed reference biological product was created by the Biologics Price Competition and Innovation Act of 2009, or BPCI Act. This amendment to the PHSA, in part, attempts to minimize duplicative testing. Biosimilarity, which requires that the biological product be highly similar to the reference product notwithstanding minor differences in clinically inactive components and that there be no clinically meaningful differences between the product and the reference product in terms of safety, purity, and potency, can be shown through analytical studies, animal studies, and a clinical trial or trials. Interchangeability requires that a biological product be biosimilar to the reference product and that the product can be expected to produce the same clinical results as the reference product in any given patient and, for products administered multiple times to an individual, that the product and the reference product may be alternated or switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biological product without such alternation or switch.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reference biological product is granted 12 years of data exclusivity from the time of first licensure of the product and the FDA will not accept an application for a biosimilar or interchangeable product based on the reference biological product until four years after the date of first licensure of the reference product. &#8216;&#8216;First licensure&#8217;&#8217; typically means the initial date the particular product at issue was licensed in the United States. Date of first licensure does not include the date of licensure of (and a new period of exclusivity is not available for) a biological product if the licensure is for a supplement for the biological product or for a subsequent application by the same sponsor or manufacturer of the biological product (or licensor, predecessor in interest, or other related entity) for a change (not including a modification to the structure of the biological product) that results in a new indication, route of administration, dosing schedule, dosage form, delivery system, delivery device or strength, or for a modification to the structure of the biological product that does not result in a change in safety, purity, or potency.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pediatric exclusivity is another type of regulatory market exclusivity in the United States. Pediatric exclusivity, if granted, adds six months to existing regulatory exclusivity periods. This six month exclusivity may be granted based on the voluntary completion of a pediatric trial in accordance with an FDA issued &#8216;&#8216;Written Request&#8217;&#8217; for such a trial.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">European Union drug development</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU, our future products also may be subject to extensive regulatory requirements. As in the United States, medicinal products can be marketed only if a marketing authorization from the competent regulatory agencies has been obtained.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to the United States, the various phases of preclinical and clinical research in the European Union are subject to significant regulatory controls. Although the EU Clinical Trials Directive 2001/20/EC has sought to harmonize the EU clinical trials regulatory framework, setting out common rules for the control and authorization of clinical trials in the EU, the EU Member States have transposed and applied the provisions of the Directive differently. This has led to significant variations in the Member State regimes. Under the current regime, before a clinical trial can be initiated it must be approved in each of the EU countries where the trial is to be conducted by two distinct bodies: the National Competent Authority, or NCA, and one or more Ethics Committees, or ECs. Under the current regime all suspected unexpected serious adverse reactions to the investigated drug that occur during the clinical trial have to be reported to the NCA and ECs of the Member State where they occurred.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The EU clinical trials legislation currently is undergoing a transition process mainly aimed at harmonizing and streamlining clinical trial authorization, simplifying adverse event reporting procedures, improving the supervision of clinical trials, and increasing their transparency. In April 2014, the EU adopted a new Clinical Trials Regulation (EU) No 536/2014, which is set to replace the current Clinical Trials Directive 2001/20/EC. It is expected that the new Clinical Trials Regulation (EU) No 536/2014 will apply following confirmation of full functionality of the Clinical Trials Information System (CTIS), the centralized EU portal and database for clinical trials foreseen by the Regulation, through an independent audit, currently expected to occur in December 2021. It will overhaul the current system of approvals for clinical studies in the EU. Specifically, the new Regulation, which will be directly applicable in all Member States (and so does not require national implementing legislation in each Member State), aims at simplifying and streamlining the approval of clinical studies in the EU. For instance, the new Regulation provides for a streamlined application procedure via a single point and strictly defined deadlines for the assessment of clinical study applications.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pediatric investigation plan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An application for marketing authorization of a medicinal product for human use which is not yet authorized in the EU shall be considered valid only if it includes a Pediatric Investigational Plan, or PIP, according to Regulation (EC) No.&#160;1901/2006 unless a waiver applies (e.g., because the relevant disease or condition occurs only in adults). The PIP or the application for waiver shall be submitted with a request for agreement, except in duly justified cases, early during the product development phase and not later than upon completion of the human pharmacokinetic studies in healthy subjects. The end of Phase 1 pharmacokinetic studies can coincide with the initial tolerability studies, or the initiation of the adult Phase 2 studies (proof-of-concept studies); in any case, submission of the PIP cannot be after initiation of pivotal trials or confirmatory (Phase 3) trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pediatric Committee, a scientific committee established at the Community level, shall assess the content of any PIP, waivers, and deferrals for a medicinal product submitted to it in accordance with the regulation on medicinal products for pediatric use and formulate an opinion thereon.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">European drug review and approval</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Economic Area, or EEA, which is comprised of the 27 Member States of the EU and Norway, Iceland and Liechtenstein, medicinal products can only be commercialized after obtaining a Marketing Authorization, or MA. There are two types of marketing authorizations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Community MA is issued by the European Commission through the Centralized Procedure, based on the opinion of the Committee for Medicinal Products for Human Use, or CHMP, of the EMA, and is valid throughout the entire territory of the EEA. The Centralized Procedure is mandatory for certain types of products, such as biotechnology medicinal products, orphan medicinal products, advanced therapy medicines such as gene therapy, somatic cell therapy or tissue engineered medicines, and medicinal products containing a new active substance indicated for the treatment of HIV, AIDS, cancer, neurodegenerative disorders, diabetes, autoimmune, and other immune dysfunctions and viral diseases. For those products for which the use of the Centralized Procedure is not mandatory, applicants may elect to use the Centralized Procedure where either the product contains a new active substance not yet authorized in the EEA, or where the applicant can show that the product constitutes a significant therapeutic, scientific, or technical innovation or for which the Centralized Procedure is in the interest of patients at a European level.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">National Marketing Authorizations, which are issued by the competent authorities of the Member States of the EEA and only cover their respective territory, are available for products not falling within the mandatory scope of the Centralized Procedure. Where a product has already been authorized for marketing in a Member State of the EEA, this National Marketing Authorization can be recognized in another Member State through the Mutual Recognition Procedure. If the product has not received a National Marketing Authorization in any Member State at the time of application, it can be approved simultaneously in various Member States through the </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Decentralized Procedure. Under the Decentralized Procedure an identical dossier is submitted to the competent authorities of each of the Member States in which the marketing authorization is sought, one of which is selected by the applicant as the Reference Member State, or RMS. The competent authority of the RMS prepares a draft assessment report, a draft summary of the product characteristics, or SPC, and a draft of the labeling and package leaflet, which are sent to the other Member States (referred to as the Concerned Member States) for their approval. If the Concerned Member States raise no objections, based on a potential serious risk to public health, in relation to the assessment, SPC, labeling, or packaging proposed by the RMS, the product is subsequently granted a national marketing authorization in all the Member States (i.e., in the RMS and the Concerned Member States).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the above described procedures, before granting the marketing authorization, the EMA or the competent authorities of the Member States of the EEA make an assessment of the risk benefit balance of the product on the basis of scientific criteria concerning its quality, safety, and efficacy.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Now that the UK (which comprises Great Britain and Northern Ireland) has left the European Union, Great Britain will no longer be covered by centralized MAs (under the Northern Irish Protocol, centralized marketing authorizations will continue to be recognized in Northern Ireland). All medicinal products with a current centralized marketing authorization were automatically converted to Great Britain MAs on January 1, 2021. For a period of two years from January 1, 2021, the Medicines and Healthcare products Regulatory Agency, or MHRA, the UK medicines regulator, may rely on a decision taken by the European Commission on the approval of a new marketing authorization in the centralized procedure, in order to more quickly grant a new Great Britain MA. A separate application will, however, still be required.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">European exclusivity</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EEA, new innovative products authorized for marketing (i.e., reference products) qualify for eight years of data exclusivity and an additional two years of market exclusivity upon the grant of a marketing authorization. During the period of data exclusivity generic or biosimilar applicants may not reference the innovator&#8217;s preclinical or clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar marketing authorization for a period of eight years from the date on which the reference product was first authorized in the EEA. During the additional two-year period of market exclusivity, a generic or biosimilar marketing authorization application can be submitted, and the innovator&#8217;s data may be referenced, but no generic or biosimilar product can be marketed until the expiration of the market exclusivity period. The overall 10-year period will be extended to a maximum of 11 years if, during the first eight years of those 10 years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are determined to bring a significant clinical benefit in comparison with currently approved therapies. Even if an innovative medicinal product gains the prescribed period of data exclusivity, another company may market another version of the product if such company obtained a marketing authorization based on an application with a completely independent data package of pharmaceutical tests, preclinical tests and clinical trials.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">European orphan designation and exclusivity</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EEA, the EMA&#8217;s Committee for Orphan Medicinal Products grants orphan drug designation to promote the development of products that are intended for the diagnosis, prevention, or treatment of life threatening or chronically debilitating conditions affecting not more than five in 10,000 persons in the EU community, or where it is unlikely that the development of the medicine would generate sufficient return to justify the necessary investment in its development, and in each case for which no satisfactory method of diagnosis, prevention, or treatment has been authorized (or, if a method exists, the product would be a significant benefit to those affected).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EEA, orphan drug designation entitles a party to financial incentives such as reduction of fees or fee waivers and 10 years of market exclusivity is granted following medicinal product approval. This period may be reduced to six years if, at the end of the fifth year, it is established that the orphan drug designation criteria are no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market exclusivity. During the period of market exclusivity, marketing authorization may only be granted to a &#8220;similar medicinal product&#8221; for the same therapeutic indication if: (i) a second applicant can establish that its product, although similar to the authorized product, is safer, more effective or otherwise clinically superior; (ii) the marketing authorization holder for the authorized product consents to a second orphan medicinal product application; or (iii) the marketing authorization holder for the authorized product cannot supply enough orphan medicinal product. Orphan drug designation must be requested before submitting an application for marketing approval. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">European data collection</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collection and use of personal health data in the EU is governed by the provisions of the Data Protection Directive, and as of May 2018 the General Data Protection Regulation, or GDPR. This directive imposes several requirements relating to the consent of the individuals to whom the personal data relates, the information provided to the individuals, notification of data processing obligations to the competent national data protection authorities, and the security and confidentiality of the personal data. The Data Protection Directive and GDPR also impose strict rules on the transfer of personal data out of the EU to the United States. Failure to comply with the requirements of the Data Protection Directive, the GDPR, and the related national data protection laws of the EU Member States may result in fines and other administrative penalties. The GDPR introduces new data protection requirements in the EU and substantial fines for breaches of the data protection rules. The GDPR regulations may impose additional responsibility and liability in relation to personal data that we process and we may be required to put in place additional mechanisms ensuring compliance with the new data protection rules. This may be onerous and adversely affect our business, financial condition, results of operations, and prospects.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">European Union drug marketing</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Much like the Anti-Kickback Statute prohibition in the United States, the provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order, or use of medicinal products is also prohibited in the EU. Infringement of relevant EU laws could result in substantial fines and imprisonment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments may be made to physicians in limited circumstances, and in certain EU Member States such payments must be publicly disclosed. Moreover, agreements with physicians for the provision of services often must be the subject of prior notification and approval by the physician&#8217;s employer, his or her competent professional organization, and/or the regulatory authorities of the individual EU Member States. These requirements are provided in the national laws, industry codes, or professional codes of conduct, applicable in the EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines, or imprisonment.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Brexit and the Regulatory Framework in the United Kingdom </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 23, 2016, the electorate in the UK voted in favor of leaving the EU (commonly referred to as Brexit). Thereafter, on March 29, 2017, the country formally notified the EU of its intention to withdraw pursuant to Article 50 of the Lisbon Treaty. The UK formally left the EU on January 31, 2020. A transition period began on February 1, 2020, during which EU pharmaceutical law remained applicable to the UK, however this ended on December 31, 2020. Since the regulatory framework in the UK covering quality, safety and efficacy of pharmaceutical products, clinical trials, marketing authorization, commercial sales and distribution of pharmaceutical products is derived from EU Directives and Regulations, Brexit could materially impact the future regulatory regime which applies to products and the approval of product candidates in the UK, as UK legislation now has the potential to diverge from EU legislation. It remains to be seen how Brexit will impact regulatory requirements for product candidates and products in the UK in the long-term. The MHRA has recently published detailed guidance for industry and organizations to follow from January 1, 2021 now the transition period is over, which will be updated as the UK&#8217;s regulatory position on medicinal products evolves over time.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rest of the world regulation</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For other countries outside of the EU and the United States, such as countries in Eastern Europe, Latin America, Middle East, or Asia, the requirements governing the conduct of clinical trials, product licensing, pricing, and reimbursement vary from country to country. Additionally, the clinical trials must be conducted in accordance with GCP requirements and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions, or criminal prosecution.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other healthcare laws</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Healthcare providers, physicians, and third party payors, including governmental payors such as Medicare and Medicaid,will play a primary role in the recommendation and prescription of any products for which we obtain marketing approval. Our future arrangements with third party payors, healthcare providers, and physicians may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we market, sell, and distribute any drugs for which we obtain marketing approval. In the United States, these laws include, without limitation, state and federal anti-kickback, false claims, physician transparency, and patient data privacy and security laws and regulations, including but not limited to those described below.</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Anti-Kickback Statute, or AKS, makes it illegal for any person, including a prescription drug manufacturer (or a party acting on its behalf), to knowingly and willfully solicit, receive, offer, or pay any remuneration, directly or indirectly, in cash or in kind, that is intended to induce or reward referrals, including the purchase, recommendation, order or prescription of a particular drug or any other good or service, for which payment may be made under a federal healthcare program, such as Medicare or Medicaid. Violations of this law are punishable by up to five years in prison, criminal fines, administrative civil money penalties, and exclusion from participation in federal healthcare programs. In addition, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal False Claims Act imposes civil penalties, including through civil whistleblower or qui tam actions, against individuals or entities (including manufacturers) for, among other things, knowingly presenting, or causing to be presented, false or fraudulent claims for payment by a federal healthcare program or making a false statement or record material to payment of a false claim or avoiding, decreasing, or concealing an obligation to pay money to the federal government. The government may deem manufacturers to have &#8220;caused&#8221; the submission of false or fraudulent claims by, for example, providing inaccurate billing or coding information to customers or promoting a product off-label. Claims which include items or services resulting from a violation of the federal Anti-Kickback Statute are false or fraudulent claims for purposes of the False Claims Act. Our future marketing and activities relating to the reporting of wholesaler or estimated retail prices for our products, the reporting of prices used to calculate Medicaid rebate information, and other information affecting federal, state, and third-party reimbursement for our products, and the sale and marketing of our product and any future investigational medicines, are subject to scrutiny under this law.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health Insurance Portability and Accountability Act of 1996, or HIPAA, imposes criminal and civil liability for, among other things, knowingly and willfully executing a scheme, or attempting to execute a scheme, to defraud any healthcare benefit program, including private payors, or falsifying, concealing, or covering up a material fact or making any materially false statements in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their respective implementing regulations, impose, among other things, specified requirements on covered entities and their business associates relating to the privacy and security of individually identifiable health information, including mandatory contractual terms and required implementation of technical safeguards of such information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state Attorneys General new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Physician Payments Sunshine Act, enacted as part of the Patient Protection and Affordable Care Act, the (ACA), imposed new annual reporting requirements for certain manufacturers of drugs, devices, biologics, and medical supplies for which payment is available under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program, for certain payments and &#8220;transfers of value&#8221; provided to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Effective January 1, 2022, these reporting obligations will extend to include transfers of value made to certain non-physician providers such as physician assistants and nurse practitioners.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Analogous state and foreign fraud and abuse laws and regulations, such as state anti-kickback and false claims laws, which may be broader in scope and apply regardless of payor impose a variety of obligations on. Such laws are enforced by various state agencies and through private actions. Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant federal government compliance guidance, require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers, and restrict marketing practices or require disclosure of marketing expenditures. State and foreign laws also govern the privacy and security of health information in some circumstances. Such data privacy and security laws may differ from each other in significant ways and often are not pre-empted by HIPAA, thus complicating compliance efforts. For example, in California the California Consumer Protection Act (CCPA), which went into effect on January 1, 2020, establishes a new privacy framework for covered businesses by creating an expanded definition of personal information, establishing new data privacy rights for consumers in the State of California, imposing special rules on the </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">collection of consumer data from minors, and creating a new and potentially severe statutory damages framework for violations of the CCPA and for businesses that fail to implement reasonable security procedures and practices to prevent data breaches. Further, a new California privacy law, the California Privacy Rights Act (CPRA), was passed by California voters on November 3, 2020. The CPRA will create additional obligations with respect to processing and storing personal information that are scheduled to take effect on January 1, 2023 (with certain provisions having retroactive effect to January 1, 2022). While clinical trial data and information governed by HIPAA are currently exempt from the current versions of the CCPA and CPRA, other personal information may be applicable and possible changes to the CCPA and CPRA may broaden its scope.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions, and settlements in the healthcare industry. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes, regulations, or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other related governmental regulations that may apply to us, we may be subject to significant civil, criminal, and administrative penalties, damages, fines, imprisonment, disgorgement, exclusion of drugs from government funded healthcare programs, such as Medicare and Medicaid, reputational harm, additional oversight, and reporting obligations if we become subject to a corporate integrity agreement or similar settlement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of our operations. If any of the physicians or other healthcare providers or entities with whom we expect to do business is found to be not in compliance with applicable laws, they may be subject to similar actions, penalties, and sanctions. Ensuring business arrangements comply with applicable healthcare laws, as well as responding to possible investigations by government authorities, can be time- and resource-consuming and can divert a company&#8217;s attention from the business.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current and future healthcare reform legislation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of our investigational medicines, restrict or regulate post-approval activities, and affect our ability to profitably sell any investigational medicines for which we obtain marketing approval. The ACA, for example, contains provisions that subject biological products to potential competition by lower-cost biosimilars and may reduce the profitability of drug products through increased rebates for drugs reimbursed by Medicaid programs, extension of Medicaid rebates to Medicaid managed care plans, mandatory discounts for certain Medicare Part D beneficiaries and, annual fees based on pharmaceutical companies&#8217; share of sales to federal health care programs. We expect that current laws, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that we, or any strategic collaborators, may receive for any approved products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its enactment, there have been numerous judicial, administrative, executive, and legislative challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. For example, various portions of the ACA are currently undergoing legal and constitutional challenges in the United States Supreme Court, and the Trump Administration issued various Executive Orders that eliminated cost sharing subsidies and various provisions that would impose a fiscal burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices. Additionally, Congress has introduced several pieces of legislation aimed at significantly revising or repealing the ACA. It is unclear whether the ACA will be overturned, or further amended, particularly given the new administration. We cannot predict what effect further changes to the ACA would have on our business.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, other federal health reform measures have been proposed and adopted in the United States since the ACA was enacted:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. These changes included aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, which went into effect in April 2013 and will remain in effect through 2030 unless additional Congressional action is taken. Pursuant to the Coronavirus Aid, Relief, and Economic Security Act, also known as the CARES Act, as well as subsequent legislation, these reductions have been suspended from May 1, 2020 through March 31, 2021 due to the COVID-19 pandemic. Proposed legislation, if passed, would extend this suspension until the end of the pandemic.</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The American Taxpayer Relief Act of 2012, among other things, reduced Medicare payments to several providers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which have resulted in several recent Congressional inquiries and proposed bills designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. In addition, the federal government, state legislatures, and foreign governments have shown significant interest in implementing cost containment programs, including price-controls, restrictions on reimbursement, and requirements for substitution of generic products for branded prescription drugs to limit the growth of government paid health care costs. For example, the federal government has passed legislation requiring pharmaceutical manufacturers to provide rebates and discounts to certain entities and governmental payors to participate in federal healthcare programs. Additionally, the previous administration released a &#8220;Blueprint&#8221; to lower drug prices and reduce out of pocket costs of drugs that contains additional proposals to increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out of pocket costs of drug products paid by consumers. While any proposed measures will require authorization through additional legislation to become effective, Congress has indicated that it will continue to seek new legislative measures to control drug costs.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual states in the United States have also become increasingly aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation, from other countries and bulk purchasing.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Packaging and distribution in the United States</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our products are made available to authorized users of the Federal Supply Schedule of the General Services Administration additional laws and requirements apply. Products must meet applicable child-resistant packaging requirements under the U.S. Poison Prevention Packaging Act. Manufacturing, sales, promotion, and other activities also are potentially subject to federal and state consumer protection and unfair competition laws.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The distribution of pharmaceutical products is subject to additional requirements and regulations, including extensive record-keeping, licensing, storage, and security requirements intended to prevent the unauthorized sale of pharmaceutical products.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The failure to comply with any of these laws or regulatory requirements subjects firms to possible legal or regulatory action. Depending on the circumstances, failure to meet applicable regulatory requirements can result in criminal prosecution, fines or other penalties, injunctions, exclusion from federal healthcare programs, requests for recall, seizure of products, total or partial suspension of production, denial or withdrawal of product approvals, or refusal to allow a firm to enter into supply contracts, including government contracts. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. Prohibitions or restrictions on sales or withdrawal of future products marketed by us could materially affect our business in an adverse way.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in regulations, statutes, or the interpretation of existing regulations could impact our business in the future by requiring, for example: (i)&#160;changes to our manufacturing arrangements; (ii)&#160;additions or modifications to product labeling; (iii)&#160;the recall or discontinuation of our products; or (iv)&#160;additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other U.S. environmental, health, and safety laws and regulations</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to numerous environmental, health, and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment, and disposal of hazardous materials and wastes. From time to time and in the future, our operations may involve the use of hazardous and flammable materials, including chemicals and biological materials, and may also produce hazardous waste products. Even if we contract with third parties for the disposal of these materials and waste products, we cannot completely eliminate the risk of contamination or injury resulting from these materials. In the event of contamination or injury resulting from the use or disposal of our hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees, but this insurance may not provide adequate coverage against potential liabilities. However, we do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may incur substantial costs in order to comply with current or future environmental, health, and safety laws and regulations. Current or future environmental laws and regulations may impair our research, development or production efforts. In addition, failure to comply with these laws and regulations may result in substantial fines, penalties or other sanctions.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_67"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CORPORATE INFORMATION</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We were incorporated under the laws of the State of Delaware on July 22, 2016. We are the successor in interest to Moderna LLC, a limited liability company formed under the laws of the State of Delaware in 2013. Moderna LLC was the successor in interest to Moderna Therapeutics, Inc., a Delaware corporation incorporated in 2009 as Newco LS18, Inc. by Flagship Pioneering. In August 2018, we changed our name from Moderna Therapeutics, Inc. to Moderna, Inc. Our principal corporate office is located at 200 Technology Square, Cambridge, MA 02139, and our telephone number is (617) 714-6500. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">website, www.modernatx.com including the Investor Relations section, www.investors.modernatx.com; and corporate blog www.modernatx.com/moderna-blog; as well as our social media channels: Facebook, www.facebook.com/modernatx; Twitter, www.twitter.com/modernatx; and LinkedIn, www.linkedin.com/company/modernatx; contain a significant amount of information about us, including financial and other information for investors. We encourage investors to visit these websites and social media channels as information is frequently updated and new information is shared. The information on our website and that we disclose through social media channels is not incorporated by reference in this Annual Report on Form 10-K or in any other filings we make with the Securities and Exchange Commission, or SEC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make available on or through our website certain reports and amendments to those reports that we file with or furnish to the SEC in accordance with the Securities Exchange Act of 1934, as amended, or the Exchange Act. These include our Annual Reports on Form 10-K, our Quarterly Reports on Form 10-Q, and our Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. We make this information available on or through our website free of charge as soon as reasonably practicable after we electronically file the information with, or furnish it to, the SEC.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC also maintains a website that contains reports, proxy and information statements, and other information regarding us and other issuers that file electronically with the SEC. The SEC&#8217;s Internet website address is http://www.sec.gov.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_70"></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our common stock involves a high degree of risk. You should carefully consider the following risks and uncertainties, together with all other information in this Annual Report on Form 10-K, including our consolidated financial statements and related notes and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; before investing in our common stock. Any of the risk factors we describe below could adversely affect our business, financial condition or results of operations. The market price of our common stock could decline if one or more of these risks or uncertainties actually occur, causing you to lose all or part of your investment. Additional risks that we currently do not know about or that we currently believe to be immaterial may also impair our business. Certain statements in this Annual Report on Form 10-K are forward-looking statements. See the section of this Annual Report on Form 10-K titled &#8220;Special Note Regarding Forward-Looking Statements&#8221;.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to COVID-19 and our development of mRNA-1273, our vaccine against the SARS-CoV-2 virus</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">While we have received Emergency Use Authorization from the U.S. Food and Drug Administration and other provisional, interim or conditional authorizations from regulatory authorities outside the United States for our COVID-19 vaccine (mRNA-1273), we may encounter difficulties producing or successfully commercializing the vaccine consistent with our existing or potential contractual obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the global pandemic caused by SARS-CoV-2, we are pursuing the rapid manufacture and continued clinical testing of our COVID-19 vaccine (mRNA-1273). While we have received an Emergency Use Authorization (EUA), from the U.S. FDA and other authorizations for the distribution of our COVID-19 vaccine from regulatory authorities outside the United States (including Canada, the UK, the EU, Switzerland, Qatar, Israel and Singapore), we may encounter difficulties producing the vaccine on the timelines and in the quantities set forth in our existing supply agreements, and those potential difficulties could also prevent us from successfully signing or performing under future supply agreements for the COVID-19 vaccine. Our ability to commercialize an effective vaccine depends on the success of our manufacturing capability, both at our own manufacturing facility, and those of our manufacturing partners, which we rapidly scaled in response to the pandemic and in parallel with our development and clinical testing of our vaccine. We are also committing substantial financial resources and personnel to the development, manufacture and distribution of our COVID-19 vaccine, including to support the scale-up of manufacturing to enable our pandemic response, which may cause delays in or otherwise negatively impact our other development programs, despite uncertainties surrounding the longevity and extent of COVID-19 as a global health concern. Our business could be negatively impacted by our allocation of significant resources&#8212;including managerial and financial resources&#8212;to a global health threat against which our vaccine may not be fully effective, and may ultimately prove unsuccessful or unprofitable. Furthermore, notwithstanding our entry into supply agreements for the COVID-19 vaccine with the U.S. and foreign governments, there are no assurances that our vaccine will be approved for distribution and commercial use in all countries covered by such supply agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Although we have a dedicated manufacturing facility, we do not have sufficient manufacturing infrastructure to support a global roll-out of the COVID-19 vaccine on our own. For example, we have entered into a strategic collaboration with Lonza Ltd. to enable increased production of our COVID-19 vaccine. We have also entered into a collaboration with Catalent, Inc. for large-scale, commercial fill-finish manufacturing of our COVID-19 vaccine in the United States, and a collaboration with Laboratorios Farmac&#233;uticos Rovi, S.A., or ROVI, and Recipharm for large-scale, commercial fill-finish manufacturing of mRNA-1273, for supply to markets outside of the U.S. from ROVI&#8217;s facilities in Spain, and Recipharm&#8217;s facilities in France. We have engaged other collaborators, and may need to engage others in the future, including contract manufacturing organizations, government and non-government organizations, and other funding and manufacturing sources, to assist in meeting our capacity needs in support of our global roll-out. Prior to 2020, we have not previously ramped our organization for a commercial launch of any product, and doing so in a pandemic environment with an urgent, critical global need creates additional challenges such as distribution channels, intellectual property disputes or challenges, and the need to establish teams of people with the relevant skills worldwide. We may also face challenges with sourcing a sufficient amount of raw materials to support the demand for our COVID-19 vaccine. We may be unable to effectively create a supply chain for the vaccine that will adequately support demand as we are reliant on our third-party collaborators being able to fulfill demand. Any capacity issues or delays experienced by any of our third-party collaborators may result in us not being able to meet certain product volume or delivery timing obligations under our supply agreements for the COVID-19 vaccine. Furthermore, we will encounter significant additional capital requirements as we continue to expand our commercial launch efforts. While our collaboration with BARDA and revenue from customer contracts will help us meet these capital requirements, additional investment, whether from our own capital resources or through collaborations with others, will be necessary.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> We </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">cannot guarantee that any of these new challenges and requirements will be met in a timely manner or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, another party may ultimately be successful in producing a more efficacious vaccine or other treatment for COVID-19. In particular, given the widespread media attention on the current pandemic, there are efforts by public and private entities to develop a COVID-19 vaccine as fast as possible, including by AstraZeneca, GlaxoSmithKline/Sanofi, Johnson &amp; Johnson, Novavax and Pfizer/BioNTech. The Pfizer/BioNTech vaccine has also received an EUA in the United States and other territories (including the EU and UK), and other vaccines, including the AstraZeneca vaccine, have been authorized elsewhere.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those other entities may develop COVID-19 vaccines that, as compared to mRNA-1273 or any other COVID-19 vaccine that we may develop, are more effective, become the standard of care, have broader market acceptance, are safer or have fewer or less severe side effects, are more convenient, are developed at a lower cost, or may be more successfully commercialized. Many of these other organizations are much larger than we are and have access to larger pools of capital and broader manufacturing infrastructure. Larger pharmaceutical and biotechnology companies have extensive experience in clinical testing and obtaining regulatory approval for their products, and may have the resources to heavily invest to accelerate development and commercialization of their vaccine candidates. Our business could be materially and adversely affected if competitors develop and commercialize one or more COVID-19 vaccines before we can fully expand our commercialization capabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success or failure of other entities, or perceived success or failure, may adversely impact our ability to obtain any future funding for our COVID-19 vaccine commercialization effort. In addition, we may not be able to compete effectively if our product candidates do not satisfy government procurement requirements with respect to biodefense products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are devoting significant resources to the scale-up, development and commercialization of our COVID-19 vaccine, including for use by the U.S. government and other global governmental and commercial partners.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to work toward the large-scale technical development, manufacturing scale-up in several countries and larger scale deployment of our COVID-19 vaccine. The number of doses of this vaccine that we are able to produce and distribute is dependent on our ability, and the ability of our contract manufacturers, to successfully and rapidly scale up manufacturing capacity. To support the scale-up, we have expended and will need to continue to expend significant resources and capital. We may need to, or we may be required by the federal government to, divert resources and capital from our other programs. We may also seek and secure significant additional funding through contractual arrangements and collaborations with third parties. We may be unable to enter into such arrangements on favorable terms, or at all, which would adversely affect our ability to develop, manufacture and distribute the COVID-19 vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of this effort, we have a commitment from BARDA to fund up to $954.9 million to enable the initiation of and support the planning and execution of Phase 2 and Phase 3 clinical trials of mRNA-1273 under our own IND, as well as the scale-up of mRNA-1273 manufacture in 2020 to enable our pandemic response. To the extent our funding collaborators have discretion over the distribution of funding commitments, we may not ultimately receive the full amount of committed funds and could be exposed to urgent needs for additional funding to support our manufacturing activities. Our funding collaborators may also impose restrictions on or mandate input as to our conduct of clinical trials, manufacturing activities or distribution activities, which may cause delays in the event of disagreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into, and plan to continue entering into, supply agreements for the COVID-19 vaccine that include cash deposits from the purchasers. In the event we are unable to successfully obtain regulatory authorization or approval for the commercialization of the vaccine in the relevant jurisdictions, or we fail to meet certain product volume or delivery timing obligations under our supply agreements, we may be required to refund significant portions of the deposits, which could have a material and adverse effect on our financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have already incurred expenses in connection with the distribution of our COVID-19 vaccine, and these expenses could increase over time. Such expenses include the cost of implementing pharmacovigilance to collect, analyze and monitor safety data and to identify and evaluate adverse reactions to our COVID-19 vaccine as it is administered in jurisdictions around the globe.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, since we have received an EUA for the COVID-19 vaccine and have commenced commercialization activities, we have a widely used vaccine in circulation in the United States and other countries prior to our receipt of full marketing approval. This is also the case in other countries, such as the UK, where a form of emergency or conditional approval has been granted, but not a full marketing approval. Unexpected safety issues, including any that we have not yet observed in our Phase 1, 2 or 3 clinical trials for the COVID-19 vaccine, could lead to significant reputational damage for Moderna and our technology platform going forward and other issues, including delays in our other programs, the need for re-design of our clinical trials and the need for significant additional financial resources. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The positive efficacy and safety data from the ongoing clinical studies of our COVID-19 vaccine and the EUA granted by the FDA may not be predictive of the final results of the clinical trials, which is one of a number of factors that may delay or prevent us from receiving full regulatory approval of our vaccine. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The positive efficacy and safety data we have announced from the ongoing studies of our COVID-19 vaccine are based on analyses of those studies to date, and while the efficacy assessment is now considered final, efficacy, effectiveness, safety, and immunogenicity data continue to accumulate. Further results from the ongoing studies for mRNA-1273, as well as the experience of the millions of individuals who have been vaccinated with mRNA-1273, could show diminished immunogenicity, or protection, as compared to the </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">results released to date as efficacy and antibody persistence may wane over time. Additionally, we may observe new, more frequent or adverse events of greater severity in subjects participating in these ongoing clinical studies or among those individuals who have been vaccinated with mRNA-1273. In addition, the interpretation of the data from our clinical trials of mRNA-1273 by the FDA and other regulatory agencies may differ from our interpretation of such data and the FDA or other regulatory agencies may require that we conduct additional studies or analyses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assays being used to estimate the effectiveness of vaccine candidates being developed to prevent COVID-19 have only recently been developed and are continuing to evolve. Validation reports for these assays have been submitted for review to regulatory agencies. Results obtained in clinical studies of mRNA-1273 with subsequent versions of these assays may be less positive than the results we have obtained to date. Moreover, the samples of convalescent sera, or blood samples from people who have recovered from COVID-19, used to benchmark the level of antibodies produced by subjects receiving mRNA-1273 in clinical studies, have been taken from a small number of people and may not be representative of the antibody levels in a broader population of people who have recovered from COVID-19, particularly as variant strains have begun to emerge. The future results in clinical studies of mRNA-1273 may not be as positive when compared to the antibody levels in other samples of convalescent sera. Various preclinical animal studies of mRNA-1273 are ongoing, including preclinical studies in non-human primates. If safety data observed in these preclinical studies are inconsistent with safety data from clinical studies, we may be required to conduct additional studies of mRNA-1273. Any of these factors could delay or prevent us from receiving regulatory approval of mRNA-1273, including a biologics license application, or BLA, apart from the EUA by the FDA in the United States and related authorizations in other jurisdictions, and there can be no assurance that mRNA-1273 will be otherwise approved in a timely manner, if at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unsuccessful in adapting our COVID-19 vaccine (mRNA-1273) or developing future versions of our COVID-19 vaccine to protect against variants of the SARS-CoV-2 virus and a market for vaccines against these variants may not develop.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current COVID-19 vaccine (mRNA-1273) was developed based upon the genetic sequence of the SARS-CoV-2 virus that was first detected in Wuhan, China. As the pandemic has continued, the SARS-CoV-2 virus continues to evolve, and new strains of the virus or those that are already in circulation may prove more transmissible or cause more severe forms of COVID-19 disease than the predominant strains to date. There is a risk that mRNA-1273 will not be as effective in protecting against variant strains of the SARS-CoV-2 virus expressing variants of the spike protein, particularly strains with mutations in the receptor binding domain and N-terminal domain. Although we have shown comparable neutralization titers with the majority of variants that we have tested (including the B.1.1.7 strain, which was first detected in the United Kingdom), we did see a 6.4-fold reduction in neutralization titers in the B.1.351 strain (first detected in South Africa). The ultimate impact to protection against this variant remains unknown, but we are actively working to mitigate this risk by beginning non-clinical investigations into the immunogenicity of a modification to mRNA-1273, designed to reflect the mutations of the B.1.351 variant. However, these efforts may be unsuccessful, and failure to adapt our vaccine to this or other variants of the SARS-CoV-2 virus could lead to significant reputational harm, in addition to adversely affecting our financial results. It is also possible that we may expend significant resources adapting our COVID-19 vaccine to protect against variants of the SARS-CoV-2 virus, but that a market for this adapted vaccine does not develop or demand does not align with our projections or cost expenditures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The regulatory pathway for mRNA-1273 is continually evolving, and may result in unexpected or unforeseen challenges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, our COVID-19 vaccine has moved rapidly through the FDA regulatory review and EUA process, as well as the review and authorization process in a number of other jurisdictions, including the UK and EU. The speed at which all parties are acting to create and test many therapeutics and vaccines for COVID-19 is atypical, and evolving or changing plans or priorities within the FDA or the regulatory authorities in other jurisdictions, including changes based on new knowledge of COVID-19 and how the disease affects the human body, and new variants of the virus, may significantly affect the regulatory timeline for further authorizations or approvals for our COVID vaccine. We cannot anticipate or predict with certainty the timelines or regulatory processes that may be required for the authorization or approval of updated versions of our COVID-19 vaccine, or vaccines that may be developed to fight against variants of the SARS-CoV-2 virus. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has the authority to grant an EUA to allow unapproved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions when there are no adequate, approved, and available alternatives. Although we have been granted an EUA by the FDA for our COVID-19 vaccine (specifically mRNA-1273), the FDA may revoke an EUA where it is determined that the underlying health emergency no longer exists or warrants such authorization, and we cannot predict how long the EUA will remain in place. Such revocation could adversely impact our business in a variety of ways, including if mRNA-1273 is not yet approved by the FDA pursuant to a BLA, as we and our manufacturing partners have invested in the supply chain to provide mRNA-1273 under the EUA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, the European Medicines Agency (EMA) has granted a conditional marketing authorization for mRNA-1273. The EMA has the authority to grant a conditional marketing authorization in a public health emergency, on the basis of less comprehensive clinical data than normally required, but where the benefit of immediate availability of the product outweighs the risk inherent in the fact that </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional data are still required. A conditional marketing authorization is a formal marketing authorization of the vaccine and covers all batches produced for the EU, however we are obliged to provide certain additional information and data by specified timelines, as conditions of the authorization and the EMA can take regulatory action if we do not comply with such conditions. Conditional marketing authorizations are valid for one year and can be renewed annually, however there is a risk that the EMA may decide not to renew our conditional authorization. If new data emerges that shows the benefits of our vaccine do not continue to outweigh its risks, the EMA can suspend or revoke our authorization. Similar authorizations that we have received for mRNA-1273, including those in the UK and Canada, are temporary, emergency authorizations that could similarly be revoked if the conditions for granting the authorization no longer apply. Any such revocation of the temporary authorization to distribute mRNA-1273, without receiving final approval to distribute the vaccine, could adversely impact our ability to realize the full financial benefit of our existing or future supply agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to produce a successful vaccine and deliver it to customers may be curtailed by one or more government actions or interventions, which may be more likely during a global health crisis such as COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the significant global impact of the COVID-19 pandemic, it is possible that one or more government entities may take actions that directly or indirectly have the effect of diminishing some of our rights or opportunities with respect to our COVID-19 vaccine, limiting our economic prospects. In the U.S., the Defense Production Act of 1950, as amended (the &#8220;Defense Production Act&#8221;), gives the U.S. government rights and authorities that may directly or indirectly diminish our own rights or economic opportunities with respect to our COVID-19 vaccine. Our current and potential third-party service providers may be impacted by government entities potentially invoking the Defense Production Act or other potential restrictions to all or a portion of services they might otherwise offer. As of January 21, 2021, President Biden has stated his intent to use the Defense Production Act to maximize the manufacture of vaccine and vaccine supplies, and that this effort will prioritize supplies that could cause bottlenecks including glass vials, stoppers, syringes, needles and the fill and finish capacity to package vaccine into vials. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government entities imposing restrictions or limitations on our third-party service providers may require us to obtain alternative service sources for our COVID-19 vaccine or our vaccine candidates. If we are unable to timely enter into alternative arrangements, or if such alternative arrangements are not available on satisfactory terms, we will experience delays in the development or production of our COVID-19 vaccine and our vaccine candidates, increased expenses, and delays in distribution or commercialization of our COVID-19 vaccine, or, when and if approved, our vaccine candidates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our supply contracts with the U.S. government for our COVID-19 vaccine contain certain restrictions on our ability to export vaccine that is produced from our U.S.-dedicated supply chain to serve markets outside the U.S. prior to satisfying our delivery obligations to the U.S. government. Furthermore, governments have threatened to block or limit the export of COVID-19 vaccines manufactured in their territories in instances where the manufacturers have been delayed or have not fully satisfied their delivery obligations to those governments. Governments of the jurisdictions in which we or our contract manufacturing partners produce our COVID-19 vaccine may impose export restrictions, prohibiting us from delivering orders of our COVID-19 vaccine to customers in other jurisdictions. Such restrictions may also delay or prevent production of the vaccine. The imposition of export controls could severely and adversely impact our manufacturing activities, commercial activities and financial results. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, during a global health crisis, such as the COVID-19 pandemic, where the spread of a disease needs to be controlle</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d, closed or heavily regulated national borders will create challenges and potential delays in our development and production activities and may necessitate that we pursue strategies to develop and produce our vaccines and vaccine candidates within self-contained national or internationa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l borders, at potentially much greater expense and with longer timeframes for public distribution.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain aspects of our business may be adversely affected by the ongoing coronavirus pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic impacts our business and operating results will depend in part on future developments that are highly uncertain and cannot be accurately predicted, including new information that may emerge concerning COVID-19, including potential variants of SARS-CoV-2, and the actions taken to contain COVID-19 or treat its impact, among others. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">The spread of COVID-19 has resulted in the delay and interruption of certain of our business operations. Many of our clinical trials have been affected by the pandemic. Site initiation, participant recruitment and enrollment, participant dosing, distribution of clinical trial materials, study monitoring and data analysis may be paused or delayed (or continue to be paused or delayed) due to changes in hospital or university policies, federal, state or local regulations or restrictions, prioritization of hospital resources toward pandemic efforts, travel restrictions, concerns for patient safety in a pandemic environment, or other reasons related to the pandemic. More specifically, as previously disclosed, certain of our clinical trials have been adversely affected, resulting in paused enrollment or delayed site initiations. As COVID-19 continues to spread, some participants and clinical investigators may not be able to comply with clinical trial protocols. For example, quarantines or other travel limitations (whether voluntary or required) have been implemented in many countries, and may impede participant movement, affect sponsor access to study sites, or interrupt healthcare services, and we may be unable to conduct our clinical trials. Further, if the spread of the COVID-19 pandemic continues and our operations are adversely impacted, including due to facility access restrictions or from an outbreak in a facility, we risk manufacturing delays, or default and/or nonperformance under existing agreements. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Infections and deaths related to the pandemic have disrupted and may continue to disrupt the United States&#8217; healthcare and healthcare regulatory systems. Such disruptions could divert healthcare resources away from, or materially delay the review and/or approval by the FDA and other regulatory agencies with respect to, our clinical trials. Any elongation or de-prioritization of our clinical trials or delay in regulatory review resulting from such disruptions could materially affect the development and study of our development candidates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">We currently utilize third parties to, among other things, manufacture raw materials, components, parts, and consumables, perform quality testing and ship our products. For example, we rely on third-party manufacturers such as Lonza Ltd., Catalent Inc. and ROVI to enable larger scale manufacture and/or fill/finish capabilities for our mRNA vaccine (mRNA-1273) against the SARS-CoV-2 virus and others, such as McKesson, for shipping and distribution. We also manufacture our development candidates and investigational medicines and perform various services at our manufacturing facility. Certain of our third-party manufacturers and suppliers may pause their operations in response to the COVID-19 outbreak or otherwise encounter delays in providing their services. If either we or any third-party manufacturers or third parties in the supply chain for materials used in the production of our COVID-19 vaccine, development candidates or investigational medicines are adversely impacted by restrictions resulting from the COVID-19 outbreak, our supply chain may be disrupted, limiting our ability to manufacture our COVID-19 vaccine, as well as investigational medicines for our clinical trials, research and development operations and commercialization. In addition, delays and disruptions experienced by our strategic collaborators due to the COVID-19 outbreak could adversely impact the ability of such parties to fulfill their obligations, which could affect the clinical development or regulatory approvals of development candidates and investigational medicines under joint control.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19, which has caused a broad impact globally, including restrictions on travel and quarantine policies put into place by businesses and governments, may have a material economic effect on our business, including our ability to successfully commercialize our COVID-19 vaccine. Due to the pandemic, we may have difficulty meeting expectations with respect to commercial sales. While the potential economic impact brought by and the duration of the pandemic may be difficult to assess or predict, it has already caused, and may result in further, significant disruption of global financial markets, which may reduce our ability to access capital either at all or on favorable terms. In addition, a recession, depression or other sustained adverse market event resulting from the spread of COVID-19 could materially and adversely affect our business, prospects, operating results and financial condition, and the value of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of the current pandemic, or any other health epidemic, is highly uncertain and subject to change. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, our research programs, healthcare systems or the global economy as a whole. However, these effects could have a material impact on our operations, and we will continue to monitor the situation closely.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to our business and creating a new class of medicines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We attempt to distribute our technology, biology, execution, and financing risks across a wide variety of therapeutic areas, disease states, programs, and technologies. However, our assessment of, and approach to, risk may not be comprehensive or effectively avoid delays or failures in one or more of our programs or modalities. Failures in one or more of our programs or modalities could adversely impact other programs or modalities in our pipeline and have a material adverse impact on our business, results of operations, and ability to fund our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are creating a new class of medicines based on mRNA to improve the lives of patients. From the beginning, we designed our strategy and operations to realize the full potential value and impact of mRNA over a long time horizon across a broad array of human diseases. We have made investments in our platform, infrastructure, and clinical capabilities that have enabled us to establish a large pipeline of development candidates, of which many are in clinical trials or have an open IND. As our development candidates and investigational medicines progress, we or others may determine that: certain of our risk allocation decisions were incorrect or insufficient; we made platform level technology mistakes; individual programs or our mRNA science in general has technology or biology risks that were unknown or under-appreciated; our choices on how to develop our infrastructure to support our scale will result in an inability to manufacture our investigational medicines for clinical trials or otherwise impair our manufacturing; or we have allocated resources in such a way that large investments are not recovered and capital allocation is not subject to rapid re-direction. All of these risks may relate to our current and future programs sharing similar science (including mRNA science) and infrastructure, and in the event material decisions in any of these areas turn out to have been incorrect or under-optimized, we may experience a material adverse impact on our business and ability to fund our operations and we may never realize what we believe is the potential of mRNA.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">mRNA drugs have only been authorized for emergency, or other provisional or conditional use for COVID-19, and there is no guarantee that any other mRNA drug will be granted an EUA or will be granted full approval in the future as a result of efforts by others or us. mRNA drug development has substantial clinical development and regulatory risks due to the novel nature of this new class of medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the EUA and other similar authorizations for COVID-19 vaccines, no mRNA medicines have been granted EUA or have been granted full approval to date by the FDA or other regulatory agencies. Successful discovery and development of other mRNA medicines by us or our strategic collaborators is highly uncertain and depends on numerous factors, many of which are beyond our or their control. We have made and will continue to make a series of business decisions and take calculated risks to advance our development efforts and pipeline, including those related to mRNA technology, delivery technology, and manufacturing processes, which may be shown to be incorrect based on further work by us, our strategic collaborators, or others. Although we have received an EUA from the FDA for mRNA-1273, there may never be products in which mRNA is the primary active ingredient approved outside the context of authorization for emergency use. Our mRNA investigational medicines that appear promising in the early phases of development may fail to advance, experience delays in the clinic, experience clinical holds, or fail to reach the market for many reasons, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">discovery efforts at identifying potential mRNA medicines may not be successful;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">nonclinical or preclinical study results may show potential mRNA medicines to be less effective than desired or to have harmful or problematic side effects;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical trial results may show potential mRNA medicines to be less effective than expected (e.g., a clinical trial could fail to meet one or more endpoint(s)) or to have unacceptable side effects or toxicities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse effects in any one of our clinical programs or adverse effects relating to our mRNA, or our LNPs, may lead to delays in or termination of one or more of our programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the insufficient ability of our translational models to reduce risk or predict outcomes in humans, particularly given that each component of our investigational medicines and development candidates may have a dependent or independent effect on safety, tolerability, and efficacy, which may, among other things, be species-dependent;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing failures or insufficient supply of cGMP materials for clinical trials, or higher than expected cost could delay or set back clinical trials, or make mRNA-based medicines commercially unattractive;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our improvements in the manufacturing processes for this new class of medicines and potential medicines may not be sufficient to satisfy the clinical or commercial demand of our investigational medicines or regulatory requirements for clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes that we make to optimize our manufacturing, testing or formulating of cGMP materials could impact the safety, tolerability, and efficacy of our investigational medicines and development candidates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pricing or reimbursement issues or other factors that delay clinical trials or make any mRNA medicine uneconomical or noncompetitive with other therapies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to timely advance our programs or receive the necessary regulatory approvals or a delay in receiving such approvals, due to, among other reasons, slow or failure to complete enrollment in clinical trials, withdrawal by trial participants from trials, failure to achieve trial endpoints, additional time requirements for data analysis, data integrity issues, preparation of a BLA, or the equivalent application, discussions with the FDA or EMA, a regulatory request for additional nonclinical or clinical data, or safety formulation or manufacturing issues may lead to our inability to obtain sufficient funding; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the proprietary rights of others and their competing products and technologies that may prevent our mRNA medicines from being commercialized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, mRNA is considered a gene therapy product by the FDA. Unlike certain gene therapies that irreversibly alter cell DNA and could act as a source of side effects, mRNA-based medicines are designed to not irreversibly change cell DNA; however, side effects observed in gene therapy could negatively impact the perception of mRNA medicines despite the differences in mechanism. In addition, because no product in which mRNA is the primary active ingredient has been approved outside the context of authorization for emergency use, the regulatory pathway for approval is uncertain. The number and design of the clinical trials and preclinical studies required for the approval of these types of medicines have not been established, may be different from those required for gene therapy products, or may require safety testing like gene therapy products. Moreover, the length of time necessary to complete clinical trials and to submit an application for marketing approval for a final decision by a regulatory authority varies significantly from one pharmaceutical product to the next, and may be difficult to predict.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is highly dependent on the clinical advancement of our programs and modalities. Delay or failure to advance programs or modalities could adversely impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Using our platform, we are developing product features for medicines based on mRNA. Over time, our platform work led to commonalities, where a specific combination of mRNA technologies, delivery technologies, and manufacturing processes generated a set of product features shared by multiple programs. This is what we call a &#8220;modality.&#8221; We have historically utilized, and expect to continue to utilize, earlier programs in a modality to understand the technology risks within the modality, including manufacturing and pharmaceutical properties. Even if our earlier programs in a modality are successful in any phase of development any of such earlier programs may fail at a later phase of development, and other programs within the same modality may still fail at any phase of development including at phases where earlier programs in that modality were successful. This may be a result of technical challenges unique to that program or due to biology risk, which is unique to every program. As we progress our programs through clinical development, there may be new technical challenges that arise that cause an entire modality to fail.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we aim to segregate risk using modalities, there may be foreseen and unforeseen risks across modalities in whole or in part. These include, but are not limited to, mRNA, chemical modifications, and LNPs and their components. In addition, if any one or more of our clinical programs encounter safety, tolerability, or efficacy problems, developmental delays, regulatory issues, or other problems, our platform approach and business could be significantly harmed. We may believe that a particular modality has been de-risked but later determine that new and different risks exist with respect to such modality.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the biology risk across the majority of our pipeline represents targets and pathways not clinically validated by one or more approved drugs. While we believe we have made progress in seeking to reduce biology risk in certain settings, such as for vaccine targets for which we and others have shown the utility of neutralizing antibodies, the risk that the targets or pathways that we have selected may not be effective will continue to apply across the majority of our current and future programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">While we attempt to diversify our risks by developing one or more programs in each modality, there are risks that are unique to each modality and risks that are applicable across modalities. These risks may impair our ability to advance one or more of our programs in clinical development, obtain regulatory approval, or ultimately commercialize our programs, or cause us to experience significant delays in doing so, any of which may materially harm our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain features in our development candidates and investigational medicines, including those related to mRNA, chemical modifications, surface chemistries, LNPs, and their components, may result in foreseen and unforeseen risks that are active across some or all of our modalities. Any such portfolio spanning risks, whether known or unknown, if realized in any one of our programs would have a material and adverse effect on our other programs and on our business as a whole.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are specific additional risks to certain of our modalities and our programs as a whole. For example, prophylactic vaccines typically require clinical testing in thousands to tens of thousands of healthy volunteers to define an approvable benefit-risk profile. The need to show a high degree of safety and tolerability when dosing healthy individuals could result in rare and even spurious safety findings, negatively impacting a program prior to or after commercial launch. While we believe that certain safety, tolerability, and levels of immunogenicity we have observed in the clinical trials in our prophylactic vaccine programs are sufficient to initiate additional trials, there can be no assurance that we will observe acceptable safety or efficacy profiles in later-stage trials required for approval of these programs. For neoantigen cancer vaccines, to date, no molecular (non-cell-based) therapeutic protein vaccine has been shown to be effective against cancer and there are many clinical and manufacturing challenges to personalized medicines, including cell-based therapies and vaccines. These risks include: a rapid production turn-around time that is measured in weeks in order to supply patients in our clinical trials before further progression and mutation of their tumors, the significant costs incurred in making individualized vaccines, and potential lack of immune responses potentially due to the biology of the tumor or immune status of the patient. These and other risks apply to our PCV and other neoepitope investigational medicine programs. Additionally, there may be challenges in delivering an adequate quantity of active pharmaceutical ingredient (API) required to drive efficacy due to the limitation in volume of API that can be delivered to a specific location, like a tumor or injured tissue. Our therapies for local injections often require specialized skills for conducting a clinical trial that could delay trials or slow or impair commercialization of an approved investigational medicine due to the poor adoption of injected local therapeutics or intratumoral therapies. In addition, the uncertain translatability of target selection from preclinical animal models, including mouse and non-human primate models, to successful clinical trial results may be impossible, particularly for immuno-oncology and systemic therapies, and cancer vaccines. In general, several biological steps are required for delivery of mRNA to translate into therapeutically active medicines. These processing steps may differ between individuals or tissues, and this could lead to variable levels of therapeutic protein, variable activity, immunogenicity, or variable distribution to tissues for a therapeutic effect. Gene therapies and mRNA-based medicines may activate one or more immune responses against any and all components of the drug product (e.g., the mRNA or the delivery vehicle, such as an LNP) as well as against the encoded protein, giving rise to potential immune reaction related adverse events. Eliciting an immune response against the encoded protein may impede our ability to achieve a pharmacologic effect upon repeat administration or a side effect. These risks apply to all of our programs, including our systemic secreted therapeutics and systemic intracellular therapeutics modalities.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to our finances</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred significant losses since our inception and we may incur significant losses </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">again in the future</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred net losses in each year since our inception in 2009, including net losses of $747.1&#160;million, $514.0 million and $384.7 million for the years ended December 31, 2020, 2019 and 2018, respectively. As of December 31, 2020, we had an accumulated deficit of $2.24&#160;billion. Although we had entered into advance purchase agreements for the supply of our COVID-19 vaccine totaling $11.7 billion for deliveries scheduled for 2021 as of December 31, 2020, we may ultimately be unsuccessful in delivering under these agreements or those that we have subsequently enter into, and we may continue to recognize a loss in 2021 or in future years.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have devoted most of our financial resources to research and development, including our clinical and preclinical development activities and the development of our platform. To date, we have financed our operations primarily through the sale of equity securities and proceeds from strategic alliances and through grants from governmental and private organizations, and more recently through upfront payments from the supply agreements that have been invested into the manufacture, development and commercialization of our COVID-19 vaccine. The amount of our future net losses, if any, will depend upon whether we can successfully commercialize our COVID-19 vaccine and deliver on existing and future supply agreements, as well as the rate of our future expenditures. To the extent we are unsuccessful in commercializing our products (including our COVID-19 vaccine), our access to financing and liquidity will likely depend upon our ability to obtain funding through equity or debt financings, sales of assets, strategic alliances, or additional grants. Other than with respect to our COVID-19 vaccine, we have not commenced or completed pivotal clinical trials for any of our programs in clinical trials, which means that for most of our investigational medicines it may be several years, if ever, before we or our strategic collaborators have a product ready for commercialization. Even if we obtain regulatory approval to market an investigational medicine, our future revenues will depend upon the size of any markets in which our investigational medicines have received approval, and our ability to achieve sufficient market acceptance, reimbursement from third-party payors, and adequate market share in those markets. In addition, under certain of our supply agreements for the COVID-19 vaccine, we rely on our customers to pay us portions of the purchase price upon the achievement of certain regulatory or performance milestones. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that such milestones are never achieved, our customers could terminate their agreements with us, and we may not receive such regulatory or performance milestone payments. If we do not receive such milestone payments, our business may be materially harmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to incur significant expenses and could recognize significant operating losses in future periods. We anticipate that our expenses will increase substantially if and as we:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue or expand our research or development of our programs in preclinical development;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue or expand the scope of our mRNA clinical trials for our investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">initiate additional preclinical, clinical, or other studies for our development candidates and investigational medicines, including under our strategic alliance agreements;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue to invest in our platform to conduct research to identify novel mRNA technology improvements, including identifying novel methods of mRNA delivery, such as LNPs, that improve distribution and uptake of mRNA to specific tissues;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">change or add to internal manufacturing capacity or capability;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">change or add additional manufacturers or suppliers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">add additional infrastructure to our quality control and quality assurance groups to support our operations as we progress our investigational medicines toward commercialization;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract and retain skilled personnel, particularly in Cambridge and Norwood, Massachusetts, Basel, Switzerland, and in other global regions where we have established and may continue to establish operations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create additional infrastructure to support our operations as a public company and our product development and planned future commercialization efforts, including new sites in the United States and abroad;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek marketing approvals and reimbursement for our investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish a sales, marketing, and distribution infrastructure to commercialize any products for which we may obtain marketing approval;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek to identify and validate additional development candidates and investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquire or in-license other development candidates, investigational medicines, and technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make milestone or other payments under any in-license agreements;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain, protect, and expand our IP portfolio; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">experience any delays or encounter issues with any of the above.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a limited history of recognizing revenue from product sales and may not be able to achieve or maintain long-term sustainable profitability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to generate revenue and achieve profitability depends on our ability, alone or with strategic collaborators, to successfully complete the development of, and obtain the regulatory approvals necessary to commercialize our products and investigational medicines, including our commercialization of our COVID-19 vaccine. Our ability to recognize revenues from product sales depends heavily on our success in:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing and delivering supply of our COVID-19 vaccine (and any boosters developed in connection with variants, if any) in accordance with contractual terms;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">completing research, preclinical, and clinical development of our development candidates and investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seeking and obtaining U.S. and foreign marketing approvals for investigational medicines for which we complete clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developing a sustainable, stable, consistent, and transferable manufacturing process or processes for our development candidates and investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developing a sustainable, scalable, consistent, time sensitive, and transferable manufacturing process for our personalized cancer vaccine investigational medicine;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">furthering the development of our own manufacturing capabilities and manufacturing relationships with third parties in order to provide adequate (in amount and quality) products and services to support clinical development and the market demand for our investigational medicines, if approved;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining market acceptance of our investigational medicines as a treatment option;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">launching and commercializing investigational medicines for which we obtain marketing approval and reimbursement, either by collaborating with a strategic collaborator or, if launched independently, by establishing a sales force, marketing, and distribution infrastructure;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">addressing any competing technological and market developments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implementing additional internal systems and infrastructure;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negotiating favorable terms in any collaboration, licensing, or other arrangements into which we may enter;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintaining, defending, protecting, and expanding our portfolio of IP rights, including patents, trade secrets and know-how; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attracting, hiring, and retaining qualified personnel.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate incurring significant costs associated with the commercialization of our COVID-19 vaccine, and even if one or more of the other investigational medicines that we are developing is approved for commercial sale, we anticipate incurring significant costs associated the commercialization of any such approved investigational medicine. Our expenses could increase beyond expectations if we are required by the FDA, the EMA, or other regulatory agencies to perform clinical and other studies or make changes to our manufacturing or quality systems in addition to those that we currently anticipate. Even though we have begun to generate revenues from the sale of our COVID-19 vaccine, we may not be able to achieve or maintain long-term sustainable profitability and may need to obtain additional funding to continue operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our quarterly and annual operating results may fluctuate. As a result, we may fail to meet or exceed the expectations of research analysts or investors, which could cause our stock price to decline and negatively impact our financing or funding ability as well as negatively impact our ability to exist as a standalone company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial condition and operating results have varied in the past and will continue to fluctuate from quarter-to-quarter and year-to-year in the future due to a variety of factors, many of which are beyond our control. Factors relating to our business that may contribute to these fluctuations include the following, as well as other factors described elsewhere in this Annual Report on Form 10-K:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manufacture and deliver supply of our COVID-19 vaccine; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or failures in advancement of existing or future development candidates into the clinic or investigational medicines in clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the feasibility of developing, manufacturing, and commercializing our programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manage our growth;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcomes of research programs, clinical trials, or other product development or approval processes conducted by us and our strategic collaborators;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop or successfully commercialize mRNA medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our strategic collaborators to develop and successfully commercialize mRNA medicines or other products developed from our IP;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our relationships, and any associated exclusivity terms, with strategic collaborators;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our contractual or other obligations to provide resources to fund our development candidates and investigational medicines, and to provide resources to our strategic collaborators or to the strategic alliances themselves;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our operation in a net loss position </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the foreseeable future</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with the international aspects of our business including the conduct of clinical trials in multiple locations and potential commercialization in such locations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to consistently manufacture our development candidates and investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with committing financial resources and personnel to the commercialization of our COVID-19 vaccine, including to support a scale-up of manufacturing to enable a pandemic response;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to accurately report our financial results in a timely manner;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on, and the need to attract and retain, key management and other personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain, protect, and enforce our IP rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to prevent the theft or misappropriation of our IP, know-how, or technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advantages that our competitors and potential competitors may have in securing funding, obtaining the rights to critical IP or developing competing technologies or products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain additional capital that may be necessary to expand our business;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our strategic collaborators&#8217; ability to obtain additional capital that may be necessary to develop and commercialize products under our strategic alliance agreements;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business interruptions such as power outages, strikes, acts of terrorism, or natural disasters; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ultimate impact of the COVID-19 pandemic, or any other health epidemic, on our business, our clinical trials, our research programs, healthcare systems or the global economy as a whole. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the various factors mentioned herein, and others, the results of any of our prior quarterly or annual periods should not be relied upon as indications of our future operating performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial results may fluctuate significantly from quarter-to-quarter and year-to-year, such that a period-to-period comparison of our results of operations may not be a good indication of our future performance. In any particular quarter or quarters, our operating results could be below the expectations of securities analysts or investors, which could cause our stock price to decline. We do not control the timing of disclosure of any such milestones related to any of our programs that are managed by our strategic collaborators. Any disclosure by our strategic collaborators or competitors of data or other events that are perceived as negative, whether or not such data are related to other data that we or others release, may have a material adverse impact on our stock price or overall valuation. Our stock price may decline as a result of unexpected clinical trial results in one or more of our programs, including adverse safety events reported for any of our programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unsuccessful in commercializing our COVID-19 vaccine, we may need to seek and secure significant funding through financings or from other sources. Clinical data or trial execution that creates delays, setbacks, or failures in one or more of our programs or modalities or the entire pipeline could result in an impaired ability or inability to finance or fund the Company in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently advancing our pipeline of 24 development candidates with 13 having entered clinical studies. Discovering development candidates and developing investigational medicines is expensive, and we expect to continue to spend substantial amounts to (i) perform basic research, perform preclinical studies, and conduct clinical trials of our current and future programs, (ii) continue to develop and expand our platform and infrastructure and supply preclinical studies and clinical trials with appropriate grade materials (including cGMP materials), (iii) seek regulatory approvals for our investigational medicines, and (iv) launch and commercialize any products for which we receive regulatory approval, including building our own commercial sales, marketing, and distribution organization. Furthermore, our ongoing work on our COVID-19 vaccine, including the development of new formulations to respond to variants of the SARS-CoV-2 virus, will require significant additional investment during 2021 and beyond, some of which may not be reimbursed or otherwise paid for by our collaborators or through commercial sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had approximately $5.25&#160;billion in cash, cash equivalents, and investments. We expect that our existing cash, cash equivalents, and investments will be sufficient to fund our current operations through at least the next twelve months. However, our operating plan may change as a result of many factors currently unknown to us, including with respect to our development, manufacturing and commercialization of our COVID-19 vaccine, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings, structured financings, government or other third-party funding, sales of assets, marketing and distribution arrangements, other collaborations and licensing arrangements, or a combination of these approaches. In any event, we will require additional capital to obtain regulatory approval for, and to commercialize, our investigational medicines. Even if we believe we have sufficient funds for our current or future operating plans, we may seek additional capital if market conditions are favorable or if we have specific strategic considerations. Our spending will vary based on new and ongoing development and corporate activities. Because the length of time and activities associated with discovery of development candidates and development of our investigational medicines are highly uncertain, we are unable to estimate the actual funds we will require for </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development, marketing, and commercialization activities. Our future funding requirements, both near and long term, will depend on many factors, including, but not limited to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, progress, timing, costs, and results of preclinical or nonclinical studies and clinical trials for our development candidates and investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the results of research and our other platform activities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the clinical development plans we establish for our investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms of any agreements with our current or future strategic collaborators;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number and characteristics of development candidates and investigational medicines that we develop or may in-license;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcome, timing, and cost of meeting regulatory requirements established by the FDA, the EMA, and other comparable foreign regulatory authorities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of filing, prosecuting, defending, and enforcing our patent claims and other IP rights, including patent infringement actions brought by third parties against us regarding our investigational medicines or actions by us challenging the patent or IP rights of others;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of competing technological and market developments, including other products that may compete with one or more of our development candidates or investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of completion and further expansion of clinical and commercial scale manufacturing activities sufficient to support all of our current and future programs, whether in-house or outsourced; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of establishing sales, marketing, and distribution capabilities for any investigational medicines for which we may receive marketing approval and reimbursement in regions where we choose to commercialize our medicines on our own.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We expect to recognize significant revenue in 2021 upon the delivery of our COVID-19 vaccine pursuant to our supply agreements; however, at this time we cannot predict whether we will continue to recognize significant revenue in future years based solely on sales of our COVID-19 vaccine. Until we can generate sufficient product or royalty revenue to fully finance our operations and long-term strategic plan, which we may never do, we expect to finance our future cash needs through a combination of product sales, public or private equity or debt offerings, structured financings, debt financings, collaborations, strategic alliances, sales of assets, licensing arrangements, and other marketing or distribution arrangements. Any fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our investigational medicines. In addition, we cannot guarantee that future financing will be available in sufficient amounts, at the right time, on favorable terms, or at all. Negative clinical trial data or setbacks, or perceived setbacks, in our programs or with respect to our technology could impair our ability to raise additional financing on favorable terms, or at all. If our commercialization of our COVID-19 vaccine is unsuccessful, there can be no assurance that we will have the funds necessary to meet our existing payment obligations to third parties, or be able to raise such funds when needed, on terms acceptable to us, or at all. Moreover, the terms of any financing may adversely affect the holdings or the rights of our stockholders and the issuance of additional securities, whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our shares to decline. If we raise additional funds through public or private equity offerings, the terms of these securities may include liquidation or other preferences that may adversely affect our stockholders&#8217; rights.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, to the extent that we raise additional capital through the sale of common stock or securities convertible or exchangeable into common stock, your ownership interest will be diluted. If we raise additional capital through debt financings, we would be subject to fixed payment obligations and may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, or declaring dividends. If we raise additional capital through marketing and distribution arrangements, sales of assets or other collaborations, strategic alliances, or licensing arrangements with third parties, we may have to relinquish certain valuable rights to our development candidates and investigational medicines, technologies, future revenue streams, or research programs. We also could be required to seek strategic collaborators for one or more of our current or future investigational medicines at an earlier stage than otherwise would be desirable or relinquish our rights to development candidates, investigational medicines, or IP that we otherwise would seek to develop or commercialize ourselves. If we are unable to raise additional capital in sufficient amounts, at the right time, on favorable terms, or at all, we may have to significantly delay, scale back, or discontinue the development or commercialization of one or more of our products or investigational medicines, or one or more of our other research and development initiatives. Any of the above events could significantly harm our business, prospects, financial condition, and results of operations, cause the price of our common stock to decline, and negatively impact our ability to fund operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The investment of our cash, cash equivalents, and investments is subject to risks which may cause losses and affect the liquidity of these investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had approximately $5.25&#160;billion in cash, cash equivalents, and investments. These investments are subject to general credit, liquidity, market, and interest rate risks. We may realize losses in the fair value of these investments, which would have a negative effect on our consolidated financial statements. In addition, should our investments cease paying or reduce the amount of interest paid to us, our interest income would suffer. The market risks associated with our investment portfolio may have an adverse effect on our results of operations, liquidity, and financial condition.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The amount of and our ability to use net operating losses and research and development credits to offset future taxable income may be subject to certain limitations and uncertainty.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had federal and state net operating loss carryforwards of $2.26 billion and $1.70 billion, respectively, a portion of which, if unused, will begin to expire in 2030 and 2032, respectively. As of December 31, 2020, we also had federal and state research and development tax credit carryforwards of $73.3 million and $26.1 million, respectively, which, if unused, begin to expire in 2030 and 2029, respectively. We expect to utilize all of these net operating loss and tax credit carryforwards to offset our future income tax liabilities in the taxable year ending December 31, 2021. Federal net operating losses generated in taxable years beginning after December 31, 2017 generally may not be carried back to prior taxable years, and while such federal net operating losses generated in taxable years beginning after December 31, 2017 will not be subject to expiration, the deduction for such net operating loss in any taxable year will be limited to 80% of our taxable income in such year, where taxable income is determined without regard to the net operating loss deduction itself. However, the Coronavirus Aid, Relief and Economic Security Act repeals the 80% limitation on the utilization of such federal net operating losses for taxable years beginning after December 31, 2017 and beginning before January 1, 2021 and allows for federal net operating losses generated in taxable years beginning after December 31, 2017 and before January 1, 2021 to be carried back to each of the five taxable years preceding the taxable year in which the loss arises. This change in law temporarily allowing for the carryback of federal net operating losses is not expected to produce any material benefit for the issuer. In general, under Sections 382 and 383 of the Internal Revenue Code, a corporation that undergoes an &#8220;ownership change&#8221; is subject to limitations on its ability to utilize its pre-change net operating losses, or NOLs or tax credits, or credits (including federal research and development tax credits), to offset future taxable income or taxes. For these purposes, an ownership change generally occurs where the aggregate stock ownership of one or more stockholders or groups of stockholders who owns at least 5% of a corporation&#8217;s stock increases its ownership by more than 50 percentage points over its lowest ownership percentage within a specified testing period. As of December 31, 2020, none of our NOLs or credits will expire due to Sections 382 and 383. However, future changes in our stock ownership, many of which are outside of our control, could result in an ownership change under Sections 382 and 383 of the Internal Revenue Code and limit our ability to utilize our NOLs and credits. Our NOLs or credits may also be impaired under state law. Accordingly, we may not be able to utilize a material portion of our NOLs or credits if we undergo an ownership change prior to the utilization of all of such NOLs or credits. In addition, the rules regarding timing of revenue and expense recognition for tax purposes in connection with various transactions we have undertaken are complex and uncertain in various respects and could be subject to challenge by taxing authorities. In the event any such challenge is sustained, our remaining net operating losses could be materially reduced and/or we could be determined to be a material cash taxpayer for one or more years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to the research, development, regulatory review, and approval of our existing and future pipeline</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preclinical development is lengthy and uncertain, especially for a new class of medicines such as mRNA, and therefore our preclinical programs or development candidates may be delayed, terminated, or may never advance to the clinic, any of which may have a material adverse impact on our platform or our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Much of our pipeline is in preclinical development, and these programs could be delayed or not advance into the clinic. Before we can initiate clinical trials for a development candidate, we must complete extensive preclinical studies, including IND-enabling good laboratory practice (GLP), toxicology testing, that support our planned INDs in the United States, or similar applications in other jurisdictions. We must also complete extensive work on Chemistry, Manufacturing, and Controls (CMC) activities (including yield, purity and stability data) to be included in the IND submission. CMC activities for a new class of medicines such as mRNA require extensive manufacturing processes and analytical development, which is uncertain and lengthy. For instance, batch failures as we scale up our manufacturing have occurred and may continue to occur. In addition, we have in the past and may in the future have difficulty identifying appropriate buffers and storage conditions to enable sufficient shelf life of batches of our preclinical or clinical development candidates. If we are required to produce new batches of our development candidates due to insufficient shelf life, it may delay the commencement or completion of preclinical studies or clinical trials of such development candidates. For example, we cannot be certain of the timely completion or outcome of our preclinical testing and studies and cannot predict if the FDA or other regulatory authorities will accept the results of our preclinical testing or our proposed clinical programs or if the outcome of our preclinical testing, studies, and CMC activities will ultimately support the further development of our programs. As a result, we cannot be sure that we will be able to submit INDs or similar applications for our preclinical programs on the timelines we expect, if at all, and we cannot be sure that submission of INDs or similar applications will result in the FDA or other regulatory authorities allowing clinical trials to begin.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical development is lengthy and uncertain, especially with a new class of medicines such as mRNA medicines. Clinical trials of our investigational medicines may be delayed, including as a result of the COVID-19 pandemic or other pandemics in the future, and certain programs may never advance in the clinic or may be more costly to conduct than we anticipate, any of which could have a material adverse impact on our platform or our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical testing is expensive and complex and can take many years to complete, and its outcome is inherently uncertain. We may not be able to initiate, may experience delays in, or may have to discontinue clinical trials for our investigational medicines. We and our strategic collaborators also may experience numerous unforeseen events during, or as a result of, any clinical trials that we or our strategic collaborators conduct that could delay or prevent us or our strategic collaborators from successfully developing our investigational medicines, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA, other regulators, Institutional Review Boards (IRBs), or ethics committees may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site for any number of reasons, including concerns regarding safety and aspects of the clinical trial design;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may experience delays in reaching, or fail to reach, agreement on favorable terms with prospective trial sites and prospective contract research organizations (CROs), the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we have in the past and intend to continue to optimize our manufacturing processes, including through changes to the scale and site of manufacturing, which may lead to potentially significant changes in our clinical trial designs, requiring additional cost and time, and, as a consequence, lead to a delay in plans for progressing one or more investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcome of our preclinical studies and our early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be unable to establish clinical endpoints that applicable regulatory authorities would consider clinically meaningful;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in an effort to optimize product features, we have in the past and may continue to make changes to our investigational medicines after we commence clinical trials of an investigational medicine, which may require us to repeat earlier stages of clinical testing or delay later stage testing of the investigational medicine;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical trials of any investigational medicines may fail to show safety or efficacy, or produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional nonclinical studies or clinical trials, or we may decide to abandon product development programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differences in trial design between early-stage clinical trials and later-stage clinical trials make it difficult to extrapolate the results of earlier clinical trials to later clinical trials;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preclinical and clinical data are often susceptible to varying interpretations and analyses, and many investigational medicines believed to have performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our investigational medicines may have undesirable side effects, such as the immunogenicity of the LNPs or their components, the immunogenicity of the protein made by the mRNA, or degradation products, any of which could lead to serious adverse events, or other effects. One or more of such effects or events could cause regulators to impose a clinical hold on the applicable trial, or cause us or our IRBs or ethics committees to suspend or terminate the trial of that investigational medicine or any other of our investigational medicines for which a clinical trial may be ongoing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of trial participants required for clinical trials of any investigational medicines may be larger than we anticipate, identification of trial participants for such trials may be limited, enrollment in these clinical trials may be slower than we anticipate due to perceived adverse effects, competitive trials, size of the patient population, or other reasons, or participants may withdraw from clinical trials or fail to return for post-treatment follow-up at a higher rate than we anticipate;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all, or may deviate from the clinical trial protocol or withdraw from the trial, which may require that we add new clinical trial sites;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators may elect to impose a clinical hold, or we or our investigators, IRBs, or ethics committees may elect to suspend or terminate clinical research or trials for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable benefit risk ratio;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of preclinical or nonclinical testing and studies and clinical trials of any investigational medicines may be greater than we anticipate;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the supply or quality of our investigational medicines or other materials necessary to conduct clinical trials may be insufficient or inadequate;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safety and efficacy concerns regarding one or more of our investigational medicines will be considered by us and by the FDA and other global regulators as we pursue clinical trials of new investigational medicines, develop effective informed consent documentation and work with IRBs and scientific review committees (SRCs);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safety or efficacy concerns regarding our investigational medicines may result from any safety or efficacy concerns arising from nonclinical or clinical testing of other therapies targeting a similar disease state or other therapies, such as gene therapy, that are perceived as similar to ours; and</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA or other regulatory authorities may require us to submit additional data such as long-term toxicology studies, or impose other requirements before permitting us to initiate a clinical trial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could also encounter delays if a clinical trial is suspended or terminated by us, the FDA or other regulatory authorities, ethics committees, or the IRBs of the institutions in which such trials are being conducted, or if such trial is recommended for suspension or termination by the data safety monitoring board for such trial. We have in the past been, and may in the future be, delayed in gaining clearance from the FDA or other regulators to initiate clinical trials through the imposition of a clinical hold in order to address comments from such regulators on our clinical trial design or other elements of our clinical trials. The clinical trials of other companies working on mRNA medicines have been put on clinical hold by the FDA. A suspension or termination may be imposed due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues, or adverse side effects, including those experienced by other investigational medicines in the same class as our investigational medicines, failure to demonstrate a benefit, or adequate benefit risk ratio, from using an investigational medicine, failure to establish or achieve clinically meaningful trial endpoints, changes in governmental regulations or administrative actions, or lack of adequate funding to continue the clinical trial. Many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our investigational medicines. We must also complete extensive CMC activities that require extensive manufacturing processes and analytical development, which is uncertain and lengthy. For instance, batch failures as we scale up our manufacturing have occurred and may continue to occur. In addition, we have in the past and may in the future have difficulty identifying appropriate buffers and storage conditions to enable sufficient shelf life of batches of our clinical development candidates or investigational medicines. If we are required to produce new batches of our development candidates or investigational medicines due to insufficient shelf life, it may delay the commencement or completion of clinical trials of such development candidates or investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the FDA has indicated that prior to commencing later-stage clinical trials for our programs we will need to develop assays to measure and predict the potency of a given dose of our investigational medicines. Any delay in developing assays that are acceptable to the FDA or other regulators could delay the start of future clinical trials. Further, the FDA or other regulatory authorities may disagree with our clinical trial design and our interpretation of data for our clinical trials. Additionally, we have conducted and may conduct in the future clinical trials that utilize an &#8220;open-label&#8221; trial design. An &#8220;open-label&#8221; clinical trial is one where both the patient and investigator know whether the patient is receiving the investigational product candidate or either an existing approved drug or placebo. The results from an open-label trial may not be predictive of future clinical trial results when studied in a controlled environment with a placebo or active control. Further, the FDA or other regulators may change the requirements for approval even after they have reviewed and commented on the design for our clinical trials. Significant preclinical or nonclinical testing and studies or clinical trial delays for our investigational medicines also could allow our competitors to bring products to market before we do, potentially impairing our ability to successfully commercialize our investigational medicines and harming our business and results of operations. Any delays in the development of our investigational medicines may harm our business, financial condition, and prospects significantly.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience delays in identifying and enrolling participants in our clinical trials which would delay the progress of our investigational medicines and result in increased expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on enrollment of participants in our clinical trials for our investigational medicines. We may find it difficult to enroll trial participants in our clinical trials, which could delay or prevent clinical trials of our investigational medicines. Identifying and qualifying trial participants to participate in clinical trials of our investigational medicines is critical to our success. The timing of our clinical trials depends on the speed at which we can recruit trial participants to participate in testing our investigational medicines. Delays in enrollment may result in increased costs or may affect the timing or outcome of the planned clinical trials, which could prevent completion of these trials and adversely affect our ability to advance the development of our investigational medicines. If trial participants are unwilling to participate in our trials because of negative publicity from adverse events in our trials or other trials of similar products, or those related to specific therapeutic area, or for other reasons, including competitive clinical trials for similar patient populations, the timeline for recruiting trial participants, conducting studies, and obtaining regulatory approval of potential products may be delayed. These delays could result in increased costs, delays in advancing our product development, delays in testing the effectiveness of our product, or termination of the clinical trials altogether.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to identify, recruit, and enroll a sufficient number of trial participants, or those with required or desired characteristics to achieve diversity in a trial to complete our clinical trials in a timely manner. In addition, as we did in our Phase 3 clinical study of mRNA-1273 in September 2020, we may slow enrollment in a trial to focus on achieving greater diversity in the subject population. Patient and subject enrollment is affected by factors including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">severity of the disease under investigation; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complexity and design of the study protocol; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">size of the patient population; </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">eligibility criteria for the study in question, including age-based eligibility criteria limiting subject enrollment to adolescent or pediatric populations; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">proximity and availability of clinical study sites for prospective trial participants; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of competing therapies and clinical trials, including between our own clinical trials; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">efforts to facilitate timely enrollment in clinical trials; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patient referral practices of physicians; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to monitor trial participants adequately during and after treatment; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to recruit clinical trial investigators with the appropriate competencies and experience; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinicians&#8217; and trial participants&#8217; perceptions as to the potential advantages and side effects of the investigational medicine being studied in relation to other available therapies, including any new drugs or treatments that may be approved for the indications we are investigating; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the need, in the case of our personalized cancer vaccine, to wait for the manufacture of the personalized drug product; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain and maintain participant informed consent. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our clinical trials will compete with other clinical trials for investigational medicines that are in the same therapeutic areas as our investigational medicines, and this competition will reduce the number and types of trial participants available to us, because some trial participants who might have opted to enroll in our trials may instead opt to enroll in a trial being conducted by a third party. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of trial participants who are available for our clinical trials at such clinical trial sites. Moreover, because in some cases our investigational medicines represent a departure from more traditional methods for disease treatment and prevention, potential trial participants and their doctors may be inclined to use conventional therapies or other new therapies rather than enroll trial participants in any future clinical trial involving mRNA investigational medicines. Additionally, if new investigational medicines, such as gene editing therapies, show encouraging results, potential trial participants and their doctors may be inclined to enroll trial participants in clinical trials using those investigational medicines. If such new investigational medicines show discouraging results or other adverse safety indications, potential trial participants and their doctors may be less inclined to enroll trial participants in our clinical trials. We also have entered into strategic alliances under which our strategic collaborators control the development of certain of our investigational medicines, which may provide us limited or no ability to influence the enrollment rate of our clinical trials. Even if we are able to enroll trial participants, there is no guarantee that they will ultimately be dosed as part of, or complete, a clinical trial. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">mRNA medicines are a novel approach, and negative perception of the efficacy, safety, or tolerability of any investigational medicines that we develop could adversely affect our ability to conduct our business, advance our investigational medicines, or obtain regulatory approvals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the EUA and other similar authorizations for COVID-19 vaccines, including ours, no mRNA medicines have been granted EUA or have been approved to date by the FDA or any other regulatory agency. Adverse events in clinical trials of our investigational medicines or in clinical trials of others developing similar products and the resulting publicity, as well as any other adverse events in the field of mRNA medicine, or other products that are perceived to be similar to mRNA medicines, such as those related to gene therapy or gene editing, could result in a decrease in the perceived benefit of one or more of our programs, increased regulatory scrutiny, decreased confidence by patients and clinical trial collaborators in our investigational medicines, and less demand for any product that we may develop. Our large pipeline of development candidates and investigational medicines could result in a greater quantity of reportable adverse events, including suspected unexpected serious adverse reactions, other reportable negative clinical outcomes, manufacturing reportable events or material clinical events that could lead to clinical delay or hold by the FDA or applicable regulatory authority or other clinical delays, any of which could negatively impact the perception of one or more of our programs, as well as our business as a whole. In addition, responses by U.S., state, or foreign governments to negative public perception may result in new legislation or regulations that could limit our ability to develop any investigational medicines or commercialize any approved products, obtain or maintain regulatory approval, or otherwise achieve profitability. More restrictive statutory regimes, government regulations, or negative public opinion would have an adverse effect on our business, financial condition, results of operations, and prospects and may delay or impair the development of our investigational medicines and commercialization of any approved products or demand for any products we may develop.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we are developing some of our development candidates or investigational medicines for the treatment of diseases in which there is little clinical experience and, in some cases, using new endpoints or methodologies, the FDA or other regulatory authorities may not consider the endpoints of our clinical trials to provide clinically meaningful results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no pharmacologic therapies approved to treat the underlying causes of many diseases that we currently attempt to address or may address in the future. For instance, for both MMA and PA, few clinical trials have been attempted. In addition, there has been limited clinical trial experience for the development of pharmaceuticals to treat these rare diseases in general, and we are not aware of a registrational trial that led to approval of a drug to treat these diseases. There have been some historical trials with other agents to address organic acidemias which may have utilized clinical endpoints that are less applicable to our efforts with our MMA and PA </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">programs that address the underlying defect. As a result, the design and conduct of clinical trials of investigational medicines for the treatment of these disorders and other disorders may take longer, be more costly, or be less effective as part of the novelty of development in these diseases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the FDA does find our success criteria to be sufficiently validated and clinically meaningful, we may not achieve the pre-specified endpoint to a degree of statistical significance in any pivotal or other clinical trials we or our strategic collaborators may conduct for our programs. Further, even if we do achieve the pre-specified criteria, our trials may produce results that are unpredictable or inconsistent with the results of the more traditional efficacy endpoints in the trial. The FDA also could give overriding weight to other efficacy endpoints over a primary endpoint, even if we achieve statistically significant results on that endpoint, if we do not do so on our secondary efficacy endpoints. The FDA also weighs the benefits of a product against its risks and the FDA may view the efficacy results in the context of safety as not being supportive of licensure. Other regulatory authorities in Europe and other countries may make similar findings with respect to these endpoints.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our investigational medicines are classified as gene therapies by the FDA and the EMA, and the FDA has indicated that our investigational medicines will be reviewed within its Center for Biologics Evaluation and Research (CBER). Even though our mRNA investigational medicines are designed to have a different mechanism of action from gene therapies, the association of our investigational medicines with gene therapies could result in increased regulatory burdens, impair the reputation of our investigational medicines, or negatively impact our platform or our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been few approvals of gene therapy products in the United States or foreign jurisdictions, and there have been well-reported significant adverse events associated with their testing and use. Gene therapy products have the effect of introducing new DNA and potentially irreversibly changing the DNA in a cell. By contrast, mRNA is highly unlikely to localize to the nucleus, integrate into the DNA, or otherwise make any permanent changes to cell DNA. Consequently, we expect that our investigational medicines will have a different potential side effect profile from gene therapies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory requirements governing gene and cell therapy products have evolved and may continue to change in the future, and the implications for mRNA-based therapies are unknown. For example, the FDA has established the Office of Tissues and Advanced Therapies within CBER to consolidate the review of gene therapy and related products, and convenes the Cellular, Tissue and Gene Therapies Advisory Committee to advise CBER on its review. In the European Union, mRNA has been characterized as a gene therapy medicinal product, which falls within a broader category known as Advanced Therapy Medicinal Products, or ATMPs, which are subject to additional regulatory requirements. In certain countries, mRNA therapies have not yet been classified or any such classification is not known to us; specifically, in Japan, the Pharmaceuticals and Medical Devices Agency has not taken a position on the regulatory classification. Notwithstanding the differences between our mRNA investigational medicines and gene therapies, the classification of some of our mRNA investigational medicines as gene therapies in the United States, the European Union, and potentially other countries could adversely impact our ability to develop our investigational medicines, and could negatively impact our platform and our business. For instance, a clinical hold on gene therapy products across the field due to risks associated with altering cell DNA irreversibly may apply to our mRNA investigational medicines irrespective of the mechanistic differences between gene therapies and mRNA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse events reported with respect to gene therapies or genome editing therapies could adversely impact one or more of our programs. Although our mRNA development candidates and investigational medicines are designed not to make any permanent changes to cell DNA, regulatory agencies or others could believe that adverse effects of gene therapies products caused by introducing new DNA and irreversibly changing the DNA in a cell could also be a risk for our mRNA investigational therapies, and as a result may delay one or more of our trials or impose additional testing for long-term side effects. Any new requirements and guidelines promulgated by regulatory review agencies may have a negative effect on our business by lengthening the regulatory review process, requiring us to perform additional or larger studies, or increasing our development costs, any of which could lead to changes in regulatory positions and interpretations, delay or prevent advancement or approval and commercialization of our investigational medicines, or lead to significant post-approval studies, limitations, or restrictions. As we advance our investigational medicines, we will be required to consult with these regulatory agencies and advisory committees and comply with applicable requirements and guidelines. If we fail to do so, we may be required to delay or discontinue development of some or all of our investigational medicines.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A breakthrough therapy designation or fast track designation by the FDA for a drug may not lead to a faster development or regulatory review or approval process, and it would not increase the likelihood that the drug will receive marketing approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek a breakthrough therapy designation for one or more of our investigational medicines. A breakthrough therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For drugs that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Drugs designated as breakthrough therapies by the FDA are also eligible for priority review if supported by clinical data at the time of the submission of the BLA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designation as a breakthrough therapy is at the discretion of the FDA. Accordingly, even if we believe that one of our investigational medicines meets the criteria for designation as a breakthrough therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a breakthrough therapy designation for a drug may not result in a faster development process, review, or approval compared to drugs considered for approval under conventional FDA procedures and it would not assure ultimate approval by the FDA. Even if we are successful in obtaining accelerated approval in the United States or under comparable pathways in other jurisdictions, we may face requirements and limitations that will adversely affect our prospects. For example, we may be approved only for a very limited indication, we may not successfully complete required post-approval trials, such trials may not confirm the clinical benefit of our drug, or approval of the drug may be withdrawn. In addition, even if one or more of our investigational medicines qualify as breakthrough therapies, the FDA may later decide that the investigational medicine no longer meets the conditions for qualification or it may decide that the time period for FDA review or approval will not be shortened.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received Fast Track Designation for some of our investigational medicines and may seek Fast Track Designation for others. If a therapy is intended for the treatment of a serious or life-threatening condition and the therapy demonstrates the potential to address significant unmet medical needs for this condition, the drug sponsor may apply for Fast Track Designation. The FDA has broad discretion whether or not to grant this designation, and even if we believe a particular investigational medicine is eligible for this designation, we cannot assure you that the FDA would decide to grant it. Even if we do receive Fast Track Designation, we may not experience a faster development process, review, or approval compared to conventional FDA procedures. The FDA may withdraw Fast Track Designation if it believes that the designation is no longer supported by data from our clinical development program. Fast Track Designation alone does not guarantee qualification for the FDA&#8217;s priority review procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may fail to obtain and maintain orphan drug designations from the FDA or EMA for our future investigational medicines, as applicable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy includes filing for orphan drug designation where available for our investigational medicines, and we have received orphan drug designation from both the FDA and the European Commission for PA (mRNA-3927) and our prior MMA candidate (mRNA-3704). Under the Orphan Drug Act, the FDA may grant orphan drug designation to a drug or biologic intended to treat a rare disease or condition, which is defined as one occurring in a patient population of fewer than 200,000 in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug or biologic will be recovered from sales in the United States. In the United States, orphan drug designation entitles a party to financial incentives, such as opportunities for grant funding toward clinical trial costs, tax advantages, and user-fee waivers. However, orphan drug designation neither shortens the development time or regulatory review time of a drug, nor gives the drug any advantage in the regulatory review or approval process. If a product that has orphan drug designation subsequently receives the first FDA approval for the disease for which it has such designation, the product is entitled to orphan drug exclusivity, which means that the FDA may not approve any other applications, including a full new drug application or NDA, or biologics license application, or BLA, to market the same drug or biologic for the same indication for seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity or where the original manufacturer is unable to assure sufficient product quantity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, exclusive marketing rights in the United States may be limited if we seek approval for an indication broader than the orphan-designated indication or may be lost if the FDA later determines that the request for designation was materially defective. Further, even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different drugs with different active moieties may receive and be approved for the same condition, and only the first applicant to receive approval will receive the benefits of marketing exclusivity. Even after an orphan-designated product is approved, the FDA can subsequently approve a later drug with the same active moiety for the same condition if the FDA concludes that the later drug is clinically superior if it is shown to be safer, more effective, or makes a major contribution to patient care. In addition, while we may seek additional orphan drug designation for our investigational medicines, we may never receive such further designations.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The criteria for designating an &#8220;orphan medicinal product&#8221; in the European Economic Area (consisting of Member States of the European Union, plus Iceland, Liechtenstein and Norway, or the EEA) are similar in principle to those in the United States. Under Article 3 of Regulation (EC) 141/2000, a medicinal product may be designated as orphan if it meets the following criteria: (i) it is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition; and (ii) either the prevalence of such condition must not be more than five in 10,000 persons in the EEA when the application is made; or without the benefits derived from orphan status, it must be unlikely that the marketing of the medicine would generate sufficient return in the EEA to justify the investment needed for its development; and (iii) there exists no satisfactory method of diagnosis, prevention or treatment of such condition, or if such a method exists, the product will be of significant benefit to those affected by the condition. Orphan medicinal products are eligible for financial incentives such as reduction of fees or fee waivers made available by the EEA and its Member States to support research into, and the development and availability of, orphan drugs, however orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process. If products with an orphan designation obtain a marketing authorization, they can receive ten years of market exclusivity, during which time no &#8220;similar medicinal product&#8221; for the same indication may be placed on the market. A &#8220;similar medicinal product&#8221; is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication. Market exclusivity may, however, be reduced to six years if, at the end of the fifth year, it is established that the product no longer meets the criteria for orphan designation, for example, if the product is sufficiently profitable not to justify maintenance of market exclusivity. Orphan medicine marketing exclusivity may also be revoked in certain cases, such as if it is established that a similar medicinal product is safer, more effective or otherwise clinically superior or if not enough orphan medicinal product can be supplied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our investigational medicines may face competition from biosimilars approved through an abbreviated regulatory pathway.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 or ACA, includes a subtitle called the Biologics Price Competition and Innovation Act of 2009 (the BPCIA), which created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-approved reference biological product. Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first approved by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first approved. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a BLA for the competing product containing the sponsor&#8217;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity, and potency of the other company&#8217;s product. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that any of our investigational medicines approved as a biological product under a BLA should qualify for the 12-year period of exclusivity. However, there is a risk that this exclusivity could be shortened due to Congressional action or otherwise, or that the FDA will not consider our investigational medicines to be reference products for competing products, potentially creating the opportunity for generic competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. Moreover, the extent to which a biosimilar, once approved, will be substituted for any one of our reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any clinical trials of our oncology-related products that we conduct with a seamless trial design may not be acceptable to regulatory authorities in the form submitted, or at all, which may delay our clinical development and limit or change the type of information we may gather from our clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may pursue a development program for our oncology-related products that relies upon a seamless trial design, which presents additional risks compared to traditional three-phase development programs. A seamless trial design can be achieved through a first-in-human (FIH) multiple expansion cohort trial, which has a single protocol with an initial dose-escalation phase and also contains three or more additional patient cohorts with cohort-specific objectives. FIH multiple expansion cohort trials are intended to expedite development by seamlessly proceeding from initial determination of a potential effective dose to individual cohorts that have trial objectives typical of Phase 2 trials. Challenges and risks associated with such seamless trial designs include challenges in the timely dissemination of new safety information to investigators, IRBs, and regulators, exposing a large number of patients across cohorts to potentially suboptimal or toxic doses of an investigational drug, exposing more patients than is needed to achieve the cohort&#8217;s objectives, and missed interpretations of preliminary trial results and unplanned analyses which can lead to delays in clinical development. Regulatory authorities may find our seamless trial designs unacceptable based on these and other risks of utilizing such designs.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals, we will not be able to commercialize, or will be delayed in commercializing, investigational medicines we may develop, and our ability to generate revenue will be materially impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we complete the necessary preclinical studies and clinical trials, the marketing approval process is expensive, time-consuming, and uncertain, and may prevent us from obtaining approvals for the commercialization of any development candidates and investigational medicines we may develop. Any mRNA medicine we may develop and the activities associated with its development and commercialization, including design, testing, manufacture, record-keeping, labeling, storage, approval, advertising, promotion, sale, and distribution, are subject to comprehensive regulation by the FDA and by comparable global health authorities. To obtain the requisite regulatory approvals to commercialize any of our investigational medicines, we and our strategic collaborators must demonstrate through extensive preclinical studies and clinical trials that our products are safe, pure, and potent or effective in humans, including the target population. Successful completion of clinical trials is a prerequisite to submitting a BLA to the FDA, a marketing authorization application (MAA) to the EMA, and similar marketing applications to comparable global regulatory authorities, for each investigational medicine and, consequently, the ultimate approval and commercial marketing of any investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to obtain marketing approval for an investigational medicine will prevent us from commercializing the investigational medicine in a given jurisdiction. We have not received approval to market any investigational medicines from regulatory authorities in any jurisdiction, and it is possible that none of our investigational medicines or any investigational medicines we may seek to develop in the future will ever obtain regulatory approval. We have limited experience in filing and supporting the applications necessary to gain marketing approvals and may need to rely on third-party CROs or regulatory consultants to assist us in this process. To our knowledge, there is no current precedent for an mRNA-based medicine such as the types we are developing being approved for sale by the FDA or any other global regulatory agency. Although we expect to submit BLAs for our mRNA-based investigational medicines in the United States, other jurisdictions may consider our mRNA-based investigational medicines to be new drugs, not biologics, and require different marketing applications. Securing regulatory approval requires the submission of extensive preclinical and clinical data and supporting information to the various regulatory authorities for each therapeutic indication to establish the investigational medicine&#8217;s safety and efficacy. Securing regulatory approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the relevant regulatory authority. Any investigational medicines we develop may not be effective, may be only moderately effective, or may prove to have undesirable or unintended side effects, toxicities, or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of obtaining marketing approvals, both in the United States and abroad, is expensive, may take many years if additional clinical trials are required, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity, and novelty of the investigational medicines involved. Changes in marketing approval policies during the development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may cause delays in the approval or rejection of an application. The FDA and comparable authorities in other countries have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional preclinical, clinical, or other studies. In addition, varying interpretations of the data obtained from preclinical and clinical testing could delay, limit, or prevent marketing approval of an investigational medicine. Any marketing approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments that render the approved product not commercially viable. Additional delays or non-approval may result if an FDA Advisory Committee or other regulatory authority recommends non-approval or restrictions on approval. In addition, we may experience delays or rejections based upon additional government regulation from future legislation or administrative action, or changes in regulatory agency policy during the period of product development, clinical trials, and the review process.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory agencies also may approve an mRNA medicine for fewer or more limited indications than requested or may grant approval subject to the performance of post-marketing studies. In addition, regulatory agencies may not approve the labeling claims that are necessary or desirable for the successful commercialization of our investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and other regulatory agencies review the CMC section of regulatory filings. Any aspects found unsatisfactory by regulatory agencies may result in delays in clinical trials and commercialization. In addition, the regulatory agencies conduct pre-approval inspections at the time of a BLA. Any findings by regulatory agencies and failure to comply with requirements may lead to delay in approval and failure to commercialize the potential mRNA investigational medicine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we experience delays in obtaining approval or if we fail to obtain approval of any investigational medicines we may develop, the commercial prospects for those investigational medicines will be harmed, and our ability to generate revenues will be materially impaired.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may never obtain EMA or other foreign regulatory body approval for any of our investigational medicines, and even if we do, we may never be able to commercialize any of our investigational medicines in any other jurisdiction, which would limit our ability to realize their full market potential.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, our COVID-19 vaccine (mRNA-1273) is our only product that has obtained an EUA from the FDA in the United States and similar authorizations in other jurisdictions. Approval of an investigational medicine by the FDA, if obtained, does not ensure approval by regulatory authorities in other countries or jurisdictions. In order to eventually market any of our investigational medicines in any particular foreign jurisdiction, we must establish and comply with numerous and varying regulatory requirements on a jurisdiction-by-jurisdiction basis regarding safety and efficacy. In addition, clinical trials conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not guarantee regulatory approval in any other country. Approval processes vary among countries and can involve additional product testing and validation and additional administrative review periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seeking foreign regulatory approval could result in difficulties and costs for us and require additional preclinical studies or clinical trials which could be costly and time consuming. Regulatory requirements can vary widely from country-to-country and could delay or prevent the introduction of our products in those countries. The foreign regulatory approval process involves all of the risks associated with FDA approval. We do not have any investigational medicines approved for sale in any jurisdiction, including international markets, and we do not have experience in obtaining regulatory approval in international markets. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, or if regulatory approvals in international markets are delayed, our target market will be reduced and our ability to realize the full market potential of our products will be unrealized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our planned clinical trials or those of our strategic collaborators may reveal significant adverse events not seen in our preclinical or nonclinical studies and may result in a safety profile that could delay or terminate clinical trials, or delay or prevent regulatory approval or market acceptance of any of our investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is typically an extremely high rate of attrition for product candidates across categories of medicines proceeding through clinical trials. These product candidates may fail to show the desired safety and efficacy profile in later stages of clinical trials despite having progressed through nonclinical studies and initial clinical trials. A number of companies in the biopharmaceutical industry have suffered significant setbacks in later-stage clinical trials due to lack of efficacy or unacceptable safety profiles, notwithstanding promising results in earlier trials. Most investigational medicines that commence clinical trials are never approved as products and there can be no assurance that any of our current or future clinical trials will ultimately be successful or support further clinical development of any of our investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our investigational medicines are developed or intended to be co-administered with other developmental therapies or approved medicines. For example, our PCV investigational medicine (mRNA-4157) and our KRAS investigational medicine (mRNA-5671) in collaboration with Merck may be co-administered with Merck&#8217;s anti-PD-1 therapy, pembrolizumab. Our IL-12 investigational medicine (MEDI1191) in collaboration with AstraZeneca is being developed to be co-administered with checkpoint inhibitors (e.g., anti-PD-L1, anti-CTLA4). These combinations may have additional side effects. The uncertainty resulting from the use of our investigational medicines in combination with other therapies may make it difficult to accurately predict side effects in future clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our development candidates and investigational medicines are developed or intended for adolescent and/or pediatric patients under the age of eighteen, including our hMPV/PIV3 vaccine (mRNA-1653), pediatric RSV vaccine (mRNA-1345), PA development candidate (mRNA-3927) and MMA development candidate (mRNA-3705). The first pediatric subjects in the Phase 1b age de-escalation clinical trial of mRNA-1653 have been enrolled and dosed. During the COVID-19 related pause, the Safety Monitoring Committee reviewed a preliminary data set on these small initial group of pediatric patients and recommended continuation of the study with no modification in the planned trial execution. Our PA development candidate (mRNA-3927) for which we are conducting a first-in-human Phase 1/2 trial in patients between one and eighteen years of age has resumed study start up activities. If participants are enrolled in the trial and successfully dosed, they will be the first of our rare disease investigational medicines from our systemic intracellular therapeutics modality dosed in humans. The uncertainty resulting from the first dosing of young, human subjects with an investigational medicine makes it difficult to accurately predict if significant adverse events or other side effects will be observed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our investigational medicines are formulated and administered in an LNP which, when administered, may lead to systemic side effects related to the components of the LNP, some of which may not have been previously tested in humans. While we have continued to optimize our LNPs, there can be no assurance that our LNPs will not have undesired effects. Our LNPs could contribute, in whole or in part, to one or more of the following: immune reactions, infusion reactions, complement reactions, opsonization reactions, antibody reactions, or reactions to PEG. Certain aspects of our investigational medicines may induce immune reactions from either the mRNA or the lipid as well as adverse reactions within liver pathways or degradation of the mRNA or the LNP, any of which could lead to significant adverse events in one or more of our clinical trials. Many of these types of side effects have been seen for </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">previously developed LNPs. There may be resulting uncertainty as to the underlying cause of any such adverse event, which would make it difficult to accurately predict side effects in future clinical trials and would result in significant delays in our programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If significant adverse events or other side effects are observed in any of our current or future clinical trials, we may have difficulty recruiting trial participants to any of our clinical trials, trial participants may withdraw from trials, or we may be required to abandon the trials or our development efforts of one or more development candidates or investigational medicines altogether. We, the FDA or other applicable regulatory authorities, or an IRB, may impose a clinical hold or suspend or terminate clinical trials of an investigational medicine at any time for various reasons, including a belief that participants in such trials are being exposed to unacceptable health risks or adverse side effects. Some potential therapeutics developed in the biotechnology industry that initially showed therapeutic promise in early-stage trials have later been found to cause side effects that prevented their further development. Even if the side effects do not preclude the drug from obtaining or maintaining marketing approval, unfavorable benefit risk ratio may inhibit market acceptance of the approved product due to its tolerability versus other therapies. Any of these developments could materially harm our business, financial condition, and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we obtain regulatory approval for an investigational medicine, and even though we have obtained an EUA for our COVID-19 vaccine, our products will remain subject to regulatory scrutiny.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we obtain regulatory approval in a jurisdiction,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the applicable regulatory authority may still impose significant restrictions on the indicated uses or marketing of our product, or impose ongoing requirements for potentially costly post-approval studies or post-market surveillance. For example, the holder of an approved BLA is obligated to monitor and report adverse events and any failure of a product to meet the specifications in the BLA. The holder of an approved BLA must also submit new or supplemental applications and obtain FDA approval for certain changes to the approved product, product labeling, or manufacturing process. Advertising and promotional materials must comply with FDA rules and are subject to FDA review, in addition to other potentially applicable federal and state laws.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with applicable regulatory requirements following approval of any of our investigational medicines, a regulatory agency may:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issue a warning letter asserting that we are in violation of the law; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek an injunction or impose civil or criminal penalties or monetary fines; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or withdraw regulatory approval or revoke a license; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend any ongoing clinical trials; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refuse to approve a pending BLA or supplements to a BLA submitted by us; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seize product; or </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refuse to allow us to enter into supply contracts, including government contracts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. The occurrence of any event or penalty described above may inhibit our ability to commercialize any approved products and generate revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our investigational medicines cause undesirable side effects, it could delay or prevent their regulatory approval, limit the commercial potential, or result in significant negative consequences following any potential marketing approval. Investigational medicines we may develop may be associated with an adverse immune response or other serious adverse events, undesirable side effects, or unexpected characteristics. In addition to serious adverse events or side effects caused by any of our investigational medicines, the administration process or related procedures also can cause undesirable side effects. If any such events occur, the clinical trials of any of our investigational medicines could be suspended or terminated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If in the future we are unable to demonstrate that such adverse events were caused by factors other than our investigational medicine, the FDA, the EMA, or other regulatory authorities could order us to cease further development of, or deny approval of, any of our investigational medicines for any or all targeted indications. Even if we are able to demonstrate that all future serious adverse events are not product-related, such occurrences could affect patient recruitment or the ability of enrolled trial participants to complete the trial. Moreover, if we elect, or are required, to delay, suspend, or terminate any clinical trial of any of our investigational medicines, the commercial prospects of such investigational medicines may be harmed and our ability to generate product revenues from any of these investigational medicines may be delayed or eliminated. Any of these occurrences may harm our ability to identify and develop investigational medicines, and may harm our business, financial condition, result of operations, and prospects significantly.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if we successfully obtain regulatory approval for an investigational medicine, the FDA or other regulatory authority could require us to adopt a Risk Evaluation and Mitigation Strategy to ensure that the benefits of treatment with such investigational medicine outweigh the risks for each potential patient, which may include, among other things, a medication guide outlining the risks of the product for distribution to patients, a communication plan to health care practitioners, extensive patient monitoring, or </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">distribution systems and processes that are highly controlled, restrictive, and more costly than what is typical for the industry. Furthermore, if we or others later identify undesirable side effects caused by any product that we develop, several potentially significant negative consequences could result, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may suspend or withdraw approvals or revoke licenses of such product; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory authorities may require additional warnings on the label; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be required to change the way a product is administered or conduct additional clinical trials; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could be sued and held liable for harm caused to patients and their children; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reputation may suffer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these events could prevent us from achieving or maintaining market acceptance of any products we may identify and develop and could have a material adverse impact on our business, financial condition, results of operations, and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are successful in gaining approval for any of our investigational medicines, we will continue to face significant regulatory oversight of the manufacturing and distribution of our products. Product manufacturers and their facilities are subject to payment of user fees and continual review and periodic inspections by the FDA and other regulatory authorities for compliance with cGMP and adherence to commitments made in the BLA. If we or a regulatory agency discovers previously unknown problems with a product such as adverse events of unanticipated severity or frequency, or problems with the facility where the product is manufactured, a regulatory agency may impose restrictions relative to that product or the manufacturing facility, including requiring recall or withdrawal of the product from the market or suspension of manufacturing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even though mRNA-1273 has been granted an EUA, mRNA-1273 will remain the subject of regulatory scrutiny. For example, the EUA issued by the FDA contains numerous conditions of authorization, including the requirement to conduct post-authorization observational studies to evaluate the association between mRNA-1273 and a pre-specified list of adverse events of special interest, along with deaths and hospitalizations, and severe COVID-19. We or others could identify previously unknown side effects, or known side effects could be observed as being more frequent or severe than in clinical studies or earlier post-marketing periods, in which case:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of mRNA-1273 may be more modest than originally anticipated;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA and other regulatory agencies may revoke an EUA or other authorizations for mRNA-1273;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may decide, or be required, to conduct recalls or send field alerts to physicians, pharmacists and hospitals;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additional nonclinical or clinical studies, changes in labeling, or changes to manufacturing processes, specifications and/or facilities may be required; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government investigations or lawsuits, including class action suits, may be brought against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, should we be unable to follow the conditions of authorization included in the EUA, the FDA may revoke EUA for mRNA-1273. Any of the above occurrences could reduce or prevent sales of mRNA-1273, increase our expenses and impair our ability to successfully commercialize mRNA-1273.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to the manufacturing of our commercial products, development candidates, investigational medicines and our future pipeline</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our mRNA products, development candidates and investigational medicines are based on novel technologies and any development candidates and investigational medicines we develop may be complex and difficult to manufacture. We may encounter difficulties in manufacturing, product release, shelf life, testing, storage, supply chain management, or shipping for any of our medicines, including our COVID-19 vaccine. If we or any of our third-party manufacturers encounter such difficulties, our ability to supply commercial product or material for clinical trials or any approved product could be delayed or stopped.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing processes for our commercial products, development candidates and investigational medicines are novel and complex. Other than vaccines for active immunization to prevent COVID-19 caused by SARS-CoV-2, including our COVID-19 vaccine, that have received EUAs from the FDA or similar authorizations by authorities in other jurisdictions, there are no mRNA medicines commercialized to date or manufactured at such scale. Due to the novel nature of this technology and our limited experience at larger scale production, we may encounter difficulties in manufacturing, product release, shelf life, testing, storage, supply chain management, or shipping. These difficulties could be due to any number of reasons including, but not limited to, complexities of producing batches at larger scale, equipment failure, choice and quality of raw materials and excipients, analytical testing technology, and product instability. In an effort to optimize product features, we have in the past and may in the future make changes to our development candidates or investigational medicines in their manufacturing and stability formulation and conditions. This has in the past and may in the future result in our having to resupply batches for preclinical or clinical activities when there is insufficient product stability during storage and insufficient supply. Insufficient stability or shelf life of our development candidates </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and investigational medicines could materially delay our or our strategic collaborators&#8217; ability to continue the clinical trial for that development candidate or investigational medicine or require us to begin a new clinical trial with a newly formulated drug product, due to the need to manufacture additional preclinical or clinical supply.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our rate of innovation is high, which has resulted in and will continue to cause a high degree of technology change that can negatively impact product comparability during and after clinical development. Furthermore, technology changes may drive the need for changes in, modification to, or the sourcing of new manufacturing infrastructure or may adversely affect third-party relationships.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process to generate mRNA medicines encapsulated in LNPs is complex and, if not developed and manufactured under well-controlled conditions, can adversely impact pharmacological activity. Furthermore, prior to our recent scale-up for our COVID-19 vaccine, we had not manufactured mRNA medicines at commercial scale. We may encounter difficulties in continuing to scale up our manufacturing process, thereby potentially impacting clinical and commercial supply.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are scaling up our batch size to accommodate the clinical supply requirements of some of our programs. However, in many cases, we may have to utilize multiple batches of drug substance and drug product to meet the clinical supply requirement of a single clinical trial. Failure in our ability to scale up batch size or failure in any batch may lead to a substantial delay in our clinical trials or in the commercialization of any approved product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue developing new manufacturing processes for our drug substance and drug product, the changes we implement to manufacturing process may in turn impact specification and stability of the drug product. Changes in our manufacturing processes may lead to failure of batches and this could lead to a substantial delay in delivery of commercial product or conduct of our clinical trials. Our mRNA investigational medicines may prove to have a stability profile that leads to a lower than desired shelf life of the final approved mRNA medicine. This poses risk in supply requirements, wasted stock, and higher cost of goods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent on a number of equipment providers who are also implementing novel technology. Further, we have developed our own custom manufacturing equipment for certain of our medicines. If such equipment malfunctions or we encounter unexpected performance issues, we could encounter delays or interruptions to clinical and commercial supply. Due to the number of different programs, we may have cross contamination of investigational medicines inside of our factories, CROs, suppliers, or in the clinic that affect the integrity of our investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we scale the manufacturing output for commercial production and particular programs, we plan to continuously improve yield, purity, and the pharmaceutical properties of our commercial products, development candidates and investigational medicines from IND-enabling studies through commercial launch, including shelf life stability, and solubility properties of drug product and drug substance. Because of continuous improvement in manufacturing processes, we may switch processes for a particular program during development. However, after the change in process, more time is required for pharmaceutical property testing, such as 6 or 12 month stability testing. That may require resupplying clinical material or making additional cGMP batches to keep up with clinical trial demand before such pharmaceutical property testing is completed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are utilizing a number of raw materials and excipients that have a single source of supply, are new to the pharmaceutical industry, and are being employed in a novel manner. Some of these raw materials and excipients have not been scaled to a level to support commercial supply and could experience unexpected manufacturing or testing failures, or supply shortages. Such issues with raw materials and excipients could cause delays or interruptions to clinical and commercial supply of our investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a number of analytical assays, and may have to establish several more, to assess the quality of our mRNA investigational medicines. We may identify gaps in our analytical testing strategy that might prevent release of product or could require product withdrawal or recall. For example, we may discover new impurities that have an impact on product safety, efficacy, or stability. This may lead to an inability to release mRNA investigational medicines until the manufacturing or testing process is rectified.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and product intermediates are extremely temperature sensitive, and we may learn that any or all of our investigational medicines are less stable than desired. We may also find that transportation conditions negatively impact product quality. This may require changes to the formulation or manufacturing process for one or more of our investigational medicines and result in delays or interruptions to clinical or commercial supply. In addition, the cost associated with such transportation services and the limited pool of vendors may also add additional risks of supply disruptions.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As our drug development pipeline increases and matures, the increased demand for clinical and commercial supplies from our facilities and third parties may impact our ability to operate. We will require increased capacity across our entire supply chain. Furthermore, we rely on many service providers, including those that provide manufacturing or testing services, all of whom have inherent risks in their operations that may adversely impact our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Completion of our clinical trials and commercialization of our vaccine candidates require access to, or development of, facilities to manufacture our vaccine candidates at sufficient yields and at commercial-scale. We have limited experience manufacturing any of our vaccine candidates in the volumes that are necessary to support large-scale clinical trials or commercial sales. Efforts to establish these capabilities may not meet initial expectations as to scheduling, scale-up, reproducibility, yield, purity, cost, potency or quality. In addition, other companies, many with substantial resources, compete with us for access to the materials needed to manufacture our vaccines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently utilize, and expect to continue to utilize, third parties to, among other things, manufacture raw materials, components, parts, and consumables, and to perform quality testing. If the field of mRNA and other nucleic acid medicines continues to expand, we may encounter increasing competition for these materials and services. Demand for third-party manufacturing or testing facilities may grow at a faster rate than their existing capacity, which could disrupt our ability to find and retain third-party manufacturers capable of producing sufficient quantities of such raw materials, components, parts, and consumables required to manufacture our mRNA investigational medicines. The use of service providers and suppliers could expose us to risks, including, but not limited to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">termination or non-renewal of supply and service agreements with third parties in a manner or at a time that is costly or damaging to us;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions to the operations of these suppliers and service providers caused by conditions unrelated to our business or operations, including the bankruptcy of the supplier or service provider; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inspections of third-party facilities by regulatory authorities that could have a negative outcome and result in delays to or termination of their ability to supply our requirements.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on thir</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d-party manufacturers may adversely affect our operations or result in unforeseen delays or other problems beyond our control. Because of contractual restraints and the limited number of third-party manufacturers with the expertise, required regulatory approvals and facilities to manufacture our bulk vaccines on a commercial scale, replacement of a manufacturer may be expensive and time-consuming and may cause interruptions in the production of our vaccine. A third-party manufacturer may also encounter difficulties in production. These problems may include:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties with production costs, scale up and yields;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of raw materials and supplies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quality control and assurance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">shortages of qualified personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with strictly enforced federal, state and foreign regulations that vary in each country where products might be sold; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of capital funding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, any delay or interruption could have a material adverse effect on our business, financial condition, or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The illegal distribution and sale by third parties of counterfeit versions of mRNA products, stolen products, or alternative third-party distribution and sale of mRNA products could have a negative impact on our financial performance or reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties could illegally distribute and sell counterfeit versions of mRNA products, especially on online marketplaces, which do not meet the rigorous manufacturing and testing standards under cGMP. Counterfeit products are frequently unsafe or ineffective, and may even be life-threatening. Counterfeit medicines may contain harmful substances or the wrong dose. However, to distributors and users, counterfeit products may be visually indistinguishable from the authentic version.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reports of adverse reactions to counterfeit products, increased levels of counterfeiting, or unsafe mRNA products could materially affect patient confidence in our mRNA products. It is possible that adverse events caused by unsafe counterfeit or other non-mRNA products will mistakenly be attributed to our mRNA products. In addition, thefts of inventory at warehouses, plants or while in-transit, which are not properly stored and which are sold through unauthorized channels could adversely impact patient safety, our reputation, and our business. Public loss of confidence in the integrity in mRNA products as a result of counterfeiting, theft, or improper manufacturing processes could have a material adverse effect on our business, results of operations, and financial condition.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to regulatory and operational risks associated with the physical and digital infrastructure at both our internal manufacturing facilities and at those of our external service providers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, we completed construction of a new manufacturing facility, Moderna Technology Center, or MTC, in Norwood, Massachusetts that, among other things, is intended for cGMP manufacture of drug substance and drug product. While the design of the facility is based on current standards for biotechnology facilities and it has been visited by the FDA, it has not been subject to formal review, inspection or pre-approved by any regulatory agency, such as the FDA. We only recently began producing drug product and drug substance at the MTC for commercial use. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have designed the MTC to incorporate a significant level of automation of equipment with integration of several digital systems to improve efficiency of operations. We have attempted to achieve a high level of digitization for a clinical and commercial manufacturing facility relative to industry standards. While this is meant to improve operational efficiency, this may pose additional risk of process equipment malfunction and even overall manufacturing system failure or shutdown due to internal or external factors including, but not limited to, design issues, system compatibility, or potential cybersecurity breaches. Our facilities or those of our contract manufacturers may also be subject to intentional attacks or acts of sabotage, whether by outside actors, contractors or employees. These disruptions may lead to delay in supply or shutdown of our facility or facilities. Any disruption in our manufacturing capabilities at the MTC, or those of our contract manufacturers, could cause delays in our production capacity for our drug substances or drug products, impose additional costs, or may require us to identify, qualify, and establish an alternative manufacturing site, the occurrence of which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we expand our development and commercial capacity, we may establish additional manufacturing capabilities inside the MTC footprint or expand to other locations or geographies, which may lead to regulatory delays or prove costly. If we fail to select the correct location, complete the construction in an efficient manner, recruit the required personnel, and generally manage our growth effectively, the development and production of commercial products or our investigational medicines could be delayed or curtailed. Additional investments may be needed if changes in our manufacturing process lead to required changes in the MTC&#8217;s infrastructure.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There are risks inherent in pharmaceutical manufacturing operations that could affect our ability and the ability of our third-party manufacturers or contract manufacturing organizations to meet our delivery requirements or provide adequate amounts of material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The convergence of process and analytical technology, raw materials, consumables, equipment, physical infrastructure, including a clean room environment, and air handling and other utilities, results in complex procedures and systems that have to work effectively to manufacture our investigational medicines. Failure or process defects in any of the interrelated systems at either our manufacturing facilities or those of our third-party providers, could adversely impact our ability to manufacture and supply our COVID-19 vaccine or our investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products and investigational medicines are inherently sensitive to shipping and storage conditions, which, in some cases, requires cold-chain logistics and could subject our investigational medicines to risk of loss or damage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our COVID-19 vaccine and our investigational medicines are sensitive to temperature, storage, and handling conditions. Loss in investigational medicines could occur if the product or product intermediates are not stored or handled properly. Shelf life for our products and investigational medicines may vary by product and is not fully quantified and is expected to be variable, and it is possible that our investigational medicines could be lost due to expiration prior to use. Cold-chain logistics are required for certain of our investigational medicines, as well as for our COVID-19 vaccine. If we or third-party distributors do not effectively maintain effective cold-chain supply logistics, then we may experience an unusual number of returned or out of date products and critical batches of products may be rendered unusable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to effectively maintain cold-chain supply logistics, by us or third parties, has in the past and could in the future lead to additional manufacturing costs and delays in our ability to supply required quantities for clinical trials, commercial sale, or otherwise.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We are subject to significant regulatory oversight with respect to manufacturing our COVID-19 vaccine and our mRNA investigational medicines. Our manufacturing facilities or the manufacturing facilities of our third-party manufacturers or suppliers may not meet regulatory requirements. Failure to meet cGMP requirements set forth in regulations promulgated by the FDA, EMA, and other global health authorities could result in significant delays in any approval of and costs of our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing of vaccines and therapeutics for clinical trials or commercial sale is subject to extensive regulation. Components of a finished product approved for commercial use or used in clinical trials must be manufactured in accordance with cGMP requirements. These regulations govern manufacturing processes and procedures, including record keeping, and the implementation and operation of quality systems to control and assure the quality of products and materials used in clinical trials. Poor control of the cGMP production processes can lead to product quality failures that can impact our ability to supply product, resulting in cost overruns and delays to clinical timelines, which could be extensive. Such production process issues include but are not limited to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">critical deviations in the manufacturing process;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">facility and equipment failures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contamination of the product due to an ineffective quality control strategy;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">facility contamination as assessed by the facility and utility environmental monitoring program;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ineffective process, equipment, or analytical change management, resulting in failed lot release criteria;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">raw material failures due to ineffective supplier qualification or regulatory compliance issues at critical suppliers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ineffective product stability;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failed lot release or facility and utility quality control testing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ineffective corrective actions or preventative actions taken to correct or avoid critical deviations due to our developing understanding of the manufacturing process as we scale; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failed or defective components or consumables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must supply all necessary documentation in support of a BLA or other marketing authorization application on a timely basis and must adhere to the FDA&#8217;s, EMA&#8217;s, and other countries&#8217; cGMP requirements which are enforced, in the case of the FDA, in part through its facilities inspection program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory authorities typically require representative manufacturing site inspections to assess adequate compliance with cGMP and manufacturing controls as described in the filing. If either we or one of our third-party manufacturing sites fails to provide sufficient quality assurance or control, the product approval to commercialize may not be granted. Inspections by regulatory authorities may occur at any time during the development or commercialization phase of products. The inspections may be product specific or facility specific for broader cGMP inspections or as a follow up to market or development issues that the regulatory agency may identify. Deficient inspection outcomes may influence the ability of our third-party manufacturers or suppliers to fulfill their supply obligations, impacting or delaying supply or delaying programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing process for our COVID-19 vaccine, and for any other products that we may develop, is subject to the FDA and foreign regulatory authority approval process, and we may need to contract with manufacturers who we believe can meet applicable FDA and foreign regulatory authority requirements on an ongoing basis. If we or our third-party manufacturers are unable to reliably produce products or investigational medicines to specifications acceptable to the FDA or other regulatory authorities, we or our strategic collaborators may not obtain or maintain the approvals we or they need to commercialize such products. Even if we or our strategic collaborators obtain regulatory approval for any of our mRNA medicines, and even though we have received an EUA for our COVID-19 vaccine, there is no assurance that either we or our contract manufacturing organizations will be able to manufacture the approved medicine to specifications acceptable to the FDA or other regulatory authorities, to produce it in sufficient quantities to meet the requirements for the potential launch of the product, or to meet potential future demand. Any of these challenges could delay completion of clinical trials, require bridging clinical trials or the repetition of one or more clinical trials, increase clinical trial costs, delay approval of our investigational medicines, impair commercialization efforts, or increase our cost of goods. The occurrence of any of the foregoing could have an adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may not have direct control over the ability of our contract manufacturers to maintain adequate quality control, quality assurance, and qualified personnel. Furthermore, all of our contract manufacturers are engaged with other companies to supply or manufacture materials or products for such companies, which exposes our contract manufacturers to regulatory risks for the production of such materials and products. As a result, failure to meet the regulatory requirements for the production of those materials and products may generally affect the regulatory status of our contract manufacturers&#8217; facility. In addition, to the extent that we rely on foreign contract manufacturers, including for our COVID-19 vaccine, we are or will be subject to additional risks, including the need to comply with import and export regulations. Our failure, or the failure of our third-party manufacturers or other strategic collaborators, to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocation, seizures or recalls of investigational medicines or products, operating restrictions, and criminal prosecutions, any of which could significantly and adversely affect supplies of our products and investigational medicines (including those of our strategic collaborators) and our overall business operations. Our </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">potential future dependence upon others for the manufacture of our investigational medicines and raw materials may adversely affect our future profit margins and our ability to commercialize any products that receive regulatory approval on a timely and competitive basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, the EMA, and other foreign regulatory authorities may require us to submit product samples of any lot of any approved product together with the protocols showing the results of applicable tests at any time. Under some circumstances, the FDA, the EMA, or other foreign regulatory authorities may require that we do not distribute a lot or lots until the relevant agency authorizes such release. Deviations in the manufacturing process, including those affecting quality attributes and stability, may result in unacceptable changes in the product that could result in lot failures or product recalls. Our third-party contract manufacturers have, in the past, experienced lot failures and some may have experienced product recalls. Lot failures have in the past caused, and lot failures or product recalls in the future with respect to product produced by either our own facilities or those of our third-party manufacturers could cause, us and our strategic collaborators to delay clinical trials or product launches, which could be costly to us and otherwise harm our business, financial condition, results of operations, and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also may encounter problems hiring and retaining the experienced scientific, quality-control, and manufacturing personnel needed to operate our manufacturing processes and operations, which could result in delays in production or difficulties in maintaining compliance with applicable regulatory requirements. While we will train and qualify all personnel around the appropriate handling of our products and materials, we may not be able to control for or ultimately detect intentional sabotage or negligence by any employee or contractor.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks specific to certain investigational medicines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our personalized cancer vaccine, or PCV, investigational medicine is uniquely manufactured for each patient using a novel, complex manufacturing process and we may encounter difficulties in production.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We custom design and manufacture PCVs that are unique and tailored specifically for each patient. Manufacturing unique lots of PCVs is susceptible to product loss or failure due to issues with:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">logistics associated with the collection of a patient&#8217;s tumor, blood, or other tissue sample;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">shipping such samples to a facility for genetic sequencing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">next generation sequencing of the tumor mRNA;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identification of appropriate tumor-specific mutations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the use of a software program, including proprietary and open source components, which is hosted in the cloud and a part of our investigational medicine, to assist with the design of the patient-specific mRNA, which software must be maintained and secured;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effective design of the patient-specific mRNA that encodes for the required neoantigens;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">batch specific manufacturing failures or issues that arise due to the uniqueness of each patient-specific batch that may not have been foreseen;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quality control testing failures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected failures of batches placed on stability;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">shortages or quality control issues with single-use assemblies, consumables, or critical parts sourced from third-party vendors that must be changed out for each patient-specific batch;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant costs associated with individualized manufacturing that may adversely affect our ability to continue development;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful and timely manufacture and release of the patient-specific batch;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">shipment issues encountered during transport of the batch to the patient site of care; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to define a consistent safety profile at a given dose when each participant receives a unique vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built and installed custom manufacturing equipment for PCV that has been incorporated into a personalized vaccine unit in the MTC. This unit is currently operational and we are producing batches of PCV from the MTC. This equipment may not function as designed, which may lead to deviations in the drug product being produced. This can lead to increased batch failure and the inability to supply patients enrolled in the clinical trial. If our clinical development plans are expanded, due to the custom nature of the equipment and single-use assemblies, we may not be able to supply this expanded need reliably without significant investments. In addition, there will be considerable time to scale up our facilities or build new facilities before we can begin to meet any commercial demand if our PCV product is approved. This expansion or addition of new facilities could also lead to product comparability issues which can further delay introduction of new capacity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our PCVs are manufactured for each individual patient, we will be required to maintain a chain of identity with respect to each patient&#8217;s tissue sample, sequence data derived from such tissue sample, results of analysis of such patient&#8217;s genomic analysis, and the custom manufactured product for each patient. Maintaining such a chain of identity is difficult and complex, and failure to do so has in the past and may in the future result in product mix up, adverse patient outcomes, loss of product, or regulatory action including </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">withdrawal of any approved products from the market. Further, as our PCV investigational medicine is developed through early-stage clinical trials to later-stage clinical trials towards approval and commercialization, we expect that multiple aspects of the complicated collection, analysis, manufacture, and delivery process will be modified in an effort to optimize processes and results. These changes may not achieve the intended objectives, and any of these changes could cause our PCVs to perform differently than we expect, potentially affecting the results of clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to our reliance on third parties</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have in the past entered into, and in the future may enter into, strategic alliances with third parties for the development and commercialization of our products, development candidates and investigational medicines. If these strategic alliances are not successful, our business could be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited resources to conduct clinical operations and we are in the process of establishing infrastructure for sales, marketing, and distribution. Accordingly, we have entered into strategic alliances under which our strategic collaborators have provided, and may in the future provide, funding and other resources for developing, manufacturing and commercializing our investigational medicines. We expect to enter into additional strategic alliances to access additional funding, capabilities, and expertise in the future. Our existing strategic alliances, and any future strategic alliances we enter into, may pose a number of risks, including the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may not perform their obligations as expected;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the clinical trials conducted as part of such strategic alliance may not be successful;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may not pursue development and commercialization of any investigational medicines that achieve regulatory approval or may elect not to continue or renew development or commercialization of programs based on clinical trial results, changes in the strategic collaborators&#8217; focus or available funding, or external factors, such as an acquisition, that divert resources or create competing priorities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may delay clinical trials, provide insufficient funding for clinical trials, stop a clinical trial, abandon an investigational medicine, repeat or conduct new clinical trials, or require a new formulation of an investigational medicine for clinical testing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our products or investigational medicines if the strategic collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">products or investigational medicines developed in strategic alliances with us may be viewed by our strategic collaborators as competitive with their own investigational medicines or products, which may cause strategic collaborators to cease to devote resources to the development or commercialization of our investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a strategic collaborator with marketing and distribution rights to one or more of our products or investigational medicines that achieve regulatory approval may not commit sufficient resources to the marketing and distribution of any such product;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disagreements with strategic collaborators, including disagreements over proprietary rights, contract interpretation, or the preferred course of development of any investigational medicines, may cause delays or termination of the research, development, or commercialization of such investigational medicines, may lead to additional responsibilities for us with respect to such investigational medicines, or may result in litigation or arbitration, any of which would be time-consuming and expensive;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may not properly maintain or defend our IP rights or may use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our IP or proprietary information or expose us to potential litigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes may arise with respect to the ownership of IP developed pursuant to our strategic alliances;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may infringe the IP rights of third parties, which may expose us to litigation and potential liability;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic alliances may be materially amended, or terminated for the convenience of the strategic collaborator and, if materially amended, or terminated, the development of our investigational medicines may be delayed, and we could be required to raise additional capital to pursue further development or commercialization of the applicable investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future relationships may require us to incur non-recurring and other charges, increase our near- and long-term expenditures, issue securities that dilute our existing stockholders, or disrupt our management and business;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could face significant competition in seeking appropriate strategic collaborators and the negotiation process is time-consuming and complex; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our international operations through any future collaborations, acquisitions, or joint ventures may expose us to certain operating, legal, and other risks not encountered in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our strategic alliances do not result in the successful development and commercialization of programs, or if one of our strategic collaborators materially amends, or terminates its agreement with us, we may not receive any future research funding or milestone, earn-out, royalty, or other contingent payments under the strategic alliances. If we do not receive the funding we expect under these agreements, our development of investigational medicines could be delayed and we may need additional resources to develop our </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investigational medicines. In addition, in general our strategic collaborators have the right to terminate their agreements with us for convenience. A strategic collaborator has in the past terminated its agreement with us. If one of our strategic collaborators terminates its agreement with us, we may find it more difficult to attract new strategic collaborators and the perception of us in the business and financial communities could be adversely affected. All of the risks relating to product development, regulatory approval, and commercialization described in this Annual Report on Form 10-K apply to the activities of our strategic collaborators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our strategic collaborators control aspects of our clinical trials, regulatory activities, and other aspects of our strategic alliances, which could result in delays and other obstacles in the development and commercialization of our proposed products and materially harm our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For some programs, we depend on strategic collaborators to design and conduct clinical trials for our investigational medicines. As a result, we may not control the manner or time schedule in which these clinical trials are conducted, which may negatively impact our business operations. In addition, if any of our strategic collaborators withdraws support for one or more of our programs or proposed products or otherwise impairs their development, our business could be negatively affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may seek to establish additional strategic alliances and, if we are not able to establish them on commercially reasonable terms, we may have to alter our development and commercialization plans. Certain of our strategic alliance agreements may restrict our ability to develop certain products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our development programs and the potential commercialization of our development candidates and investigational medicines will require substantial additional cash to fund expenses. For some of our investigational medicines, we may decide to collaborate with pharmaceutical and biotechnology companies for the development and potential commercialization of those investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition in seeking appropriate strategic collaborators. Whether we reach a definitive agreement for any additional strategic alliances will depend, among other things, upon our assessment of the strategic collaborator&#8217;s resources and expertise, the terms and conditions of the proposed strategic alliance, and the proposed strategic collaborator&#8217;s evaluation of a number of factors. Those factors may include the design or results of clinical trials, the likelihood of approval by the FDA or similar regulatory authorities outside the United States, the potential market for the subject investigational medicine, the costs and complexities of manufacturing and delivering such investigational medicine to trial participants, the potential of competing drugs, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge, and industry and market conditions generally. The strategic collaborator may also consider alternative investigational medicines or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us for our investigational medicine. The terms of any additional strategic alliances or other arrangements that we may establish may not be favorable to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also restricted under our existing strategic alliance agreements from entering into certain future agreements on certain terms with potential strategic collaborators to pursue other targets on our own. These restrictions on working with targets, polypeptides, routes of administration, and fields could limit our ability to enter into strategic collaborations with future strategic collaborators or to pursue certain potentially valuable development candidates or investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to negotiate additional strategic alliances on a timely basis, on favorable terms, or at all. Strategic alliances are complex and time-consuming to negotiate and document. If we are unable to negotiate and enter into new strategic alliances, we may have to curtail the development of the investigational medicine for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on favorable terms or at all. If we do not have sufficient funds, we may not be able to further develop our investigational medicines or bring them to market and generate product revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on single-source suppliers for some of the components and materials used in, and the processes required to develop, our products, development candidates and investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently depend on single-source suppliers for some of the components and materials used in, and manufacturing processes required to develop and commercialize, our products, development candidates and investigational medicines. We cannot ensure that these suppliers or service providers will remain in business, have sufficient capacity or supply to meet our needs, or that they will not be purchased by one of our competitors or another company that is not interested in continuing to work with us. Our use of single-source suppliers of raw materials, components, key processes, and finished goods exposes us to several risks, including disruptions in supply, price increases, or late deliveries. There are, in general, relatively few alternative sources of supply for substitute components. These vendors may be unable or unwilling to meet our future demands for our clinical trials or commercial sale. Establishing additional or replacement suppliers for these components, materials, and processes could take a substantial amount of time and it may </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be difficult to establish replacement suppliers who meet regulatory requirements. Any disruption in supply from any single-source supplier or service provider could lead to supply delays or interruptions which would damage our business, financial condition, results of operations, and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we have to switch to a replacement supplier, the manufacture and delivery of our products, development candidates or investigational medicines could be interrupted for an extended period, which could adversely affect our business. Establishing additional or replacement suppliers for any of the components or processes used in our products or investigational medicines, if required, may not be accomplished quickly. If we are able to find a replacement supplier, the replacement supplier would need to be qualified and may require additional regulatory authority approval, which could result in further delay. While we seek to maintain adequate inventory of the single-source components and materials used in our products, any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand for our investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as part of the FDA&#8217;s approval of our investigational medicines, we will also require FDA review of the individual components of our process, which include the manufacturing processes and facilities of our single-source suppliers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on these suppliers, service providers, and manufacturers subjects us to a number of risks that could harm our reputation, business, and financial condition, including, among other things:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays to the development timelines for our development candidates or investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interruption of supply resulting from modifications to or discontinuation of a supplier&#8217;s operations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in product shipments resulting from uncorrected defects, reliability issues, or a supplier&#8217;s variation in a component;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a lack of long-term supply arrangements for key components with our suppliers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inability to obtain adequate supply in a timely manner, or to obtain adequate supply on commercially reasonable terms;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty and cost associated with locating and qualifying alternative suppliers for our components in a timely manner;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">production delays related to the evaluation and testing of components from alternative suppliers, and corresponding regulatory qualifications;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delay in delivery due to our suppliers&#8217; prioritizing other customer orders over ours;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage to our reputation caused by defective components produced by our suppliers; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuation in delivery by our suppliers due to changes in demand from us or their other customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of these risks materialize, costs could significantly increase and our ability to meet demand for our products could be impacted.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on and expect to continue to rely on third parties to conduct aspects of our research, preclinical studies, protocol development, and clinical trials for our development candidates or investigational medicines. If these third parties do not perform satisfactorily, comply with regulatory requirements, or meet expected deadlines, we may not be able to obtain regulatory approval for or commercialize our investigational medicines and our business could be substantially harmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely and expect to continue to rely on third parties, such as CROs, clinical data management organizations, medical institutions, and clinical investigators, to conduct our clinical trials. We currently rely and expect to continue to rely on third parties to conduct certain research and preclinical testing activities. In some cases, these third parties may terminate their engagements with us. If we need to enter into alternative arrangements, it would delay our discovery or product development activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on these third parties for research and development activities will reduce our control over these activities but will not relieve us of our regulatory or contractual responsibilities. We will be responsible for ensuring that each of our preclinical studies and clinical trials is conducted in accordance with the applicable protocol, legal and regulatory requirements, and scientific standards. For example, we will remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA requires us to comply with regulations, commonly referred to as GCPs for conducting, recording, and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity, and confidentiality of trial participants are protected. We also are required to register ongoing clinical trials and post the results of completed clinical trials on a government-sponsored database, ClinicalTrials.gov, within certain timeframes. Failure to do so can result in fines, adverse publicity, and civil and criminal sanctions. For any violations of laws and regulations during the conduct of our preclinical studies and clinical trials, we could be subject to warning letters or enforcement action that may include civil penalties up to and including criminal prosecution.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our CROs will be required to comply with regulations, including GCPs, for conducting, monitoring, recording, and reporting the results of preclinical studies and clinical trials to ensure that the data and results are scientifically credible and accurate and that the trial participants are adequately informed, among other things, of the potential risks of participating in clinical trials. We also are responsible for ensuring that the rights of our clinical trial participants are protected. These regulations are enforced by the FDA, the Competent Authorities of the Member States of the European Economic Area, and comparable foreign regulatory authorities for any </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investigational medicines in clinical development. The FDA enforces GCP regulations through periodic inspections of clinical trial sponsors, principal investigators, and trial sites. If we or our CROs fail to comply with applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that, upon inspection, the FDA will determine that any of our future clinical trials will comply with GCPs. In addition, our clinical trials must be conducted with investigational medicines produced in accordance with the requirements in cGMP regulations. Our failure or the failure of our CROs to comply with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process and could also subject us to enforcement action.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we intend to design the clinical trials for certain of our investigational medicines, our strategic collaborators will design the clinical trials that they are managing (in some cases, with our input) and in the case of clinical trials controlled by us, we expect that CROs will conduct all of the clinical trials. As a result, many important aspects of our development programs, including their conduct and timing, will be outside of our direct control. Our reliance on third parties to conduct future preclinical studies and clinical trials will also result in less direct control over the management of data developed through preclinical studies and clinical trials than would be the case if we were relying entirely upon our own staff. Communicating with outside parties can also potentially lead to mistakes as well as difficulties in coordinating activities. Outside parties may:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">have staffing difficulties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fail to comply with contractual obligations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">experience regulatory compliance issues;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">undergo changes in priorities or become financially distressed;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">form relationships with other entities, some of which may be our competitors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">have human errors; or</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be subject to cyber-attacks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These factors may materially adversely affect the willingness or ability of third parties to conduct our preclinical studies and clinical trials and may subject us to unexpected cost increases that are beyond our control. If the CROs do not perform preclinical studies and clinical trials in a satisfactory manner, breach their obligations to us or fail to comply with regulatory requirements, the development, regulatory approval, and commercialization of our investigational medicines may be delayed, we may not be able to obtain regulatory approval and commercialize our investigational medicines, or our development programs may be materially and irreversibly harmed. If we are unable to rely on preclinical and clinical data collected by our CROs, we could be required to repeat, extend the duration of, or increase the size of any clinical trials we conduct and this could significantly delay commercialization and require significantly greater expenditures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also expect to rely on other third parties to transport, store, and distribute the required materials for our clinical trials and for our manufacturing processes. In the past certain of our third-party vendors have mishandled our materials, resulting in loss of full or partial lots of material. Any further performance failure on the part of these third parties could result in damaged products and could delay clinical development or marketing approval of any investigational medicines we may develop or commercialization of our medicines, if approved, producing additional losses and depriving us of potential product revenue, causing us to default on our contractual commitments, result in losses that are not covered by insurance, and damage our reputation and overall perception of our products in the marketplace.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to our intellectual property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other companies or organizations may challenge our patent rights or may assert patent rights that prevent us from developing and commercializing our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mRNA medicines are a relatively new scientific field, the continued development and potential use of which has resulted in many different patents and patent applications from organizations and individuals seeking to obtain IP protection in the field. We have obtained grants and issuances of patents on mRNA medicines and our delivery technology. The issued patents and pending patent applications in the United States and in key markets around the world that we own, claim many different methods, compositions, and processes relating to the discovery, development, manufacture, and commercialization of mRNA medicines and our delivery technology, including LNPs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the field of mRNA therapeutics and vaccines is maturing, patent applications are being processed by national patent offices around the world. There is uncertainty about which patents will issue, and, if they do, as to when, to whom, and with what claims. It is likely that there will be significant litigation and other proceedings, such as interference, reexamination, and opposition proceedings, as well as</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and post-grant review proceedings introduced by provisions of the America Invents Act, which became available to third-party challengers on September 16, 2012, in various patent offices relating to patent rights in the mRNA field. An opposition has been filed against one of our European platform patents covering uridine-modified mRNAs and we expect that further oppositions will </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be filed in the European Patent Office (EPO) and elsewhere relating to patents and patent applications in our portfolio. In many cases, the possibility of appeal exists for either us or our opponents, and it may be years before final, unappealable rulings are made with respect to these patents in certain jurisdictions. The timing and outcome of these and other proceedings is uncertain and may adversely affect our business if we are not successful in defending the patentability and scope of our pending and issued patent claims. We cannot be certain that such patent will survive or that the claims will remain in the current form. In addition, third parties may attempt to invalidate our IP rights. Even if our rights are not directly challenged, disputes could lead to the weakening of our IP rights. Our defense against any attempt by third parties to circumvent or invalidate our IP rights could be costly to us, could require significant time and attention of our management, and could have a material adverse impact on our business and our ability to successfully compete in the field of mRNA therapeutics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are many issued and pending third-party patents that claim aspects of oligonucleotide delivery technologies that we may need for our mRNA therapeutic and vaccine candidates or marketed products, including our COVID-19 vaccine, if approved. There are also many issued third-party patents that claim targeting genes or portions of genes that may be relevant for mRNA medicines we wish to develop. For example, there may be issued and pending patent applications that may be asserted against us in a court proceeding or otherwise based upon the asserting party&#8217;s belief that we may need such patents for our mRNA therapeutic candidates. Thus, it is possible that one or more organizations will hold patent rights to which we may need a license, or hold patent rights which could be asserted against us. If those organizations refuse to grant us a license to such patent rights on reasonable terms or a court rules that we need such patent rights that have been asserted against us and we are not able to obtain a license on reasonable terms, we may be unable to perform research and development or other activities or market products, including our COVID-19 vaccine, covered by such patents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we become involved in patent litigation or other proceedings related to a determination of rights, we could incur substantial costs and expenses, substantial liability for damages, or be required to stop our product development and commercialization efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends in part on our avoiding infringement of the patents and proprietary rights of third parties. There is a substantial amount of litigation, both within and outside the United States, involving patent and other IP rights in the biotechnology and pharmaceutical industries, including patent infringement lawsuits, interferences, oppositions,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> ex parte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reexaminations, post-grant review, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review proceedings before the U.S. Patent and Trademark Office (USPTO) and corresponding foreign patent offices. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are pursuing development candidates. In certain instances, we have instituted and may in the future institute</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review proceedings against issued U.S. patents and opposition proceedings against European patents owned by third parties in the field of mRNA medicines. We have a number of these proceedings ongoing against third-party patents related to RNA vaccinations and mRNA delivery. If we are unsuccessful in invalidating certain of the third-party patents that we are currently challenging, those third parties may attempt to assert those patents against us should certain of our investigational medicines obtain regulatory approval. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our development candidates may be subject to claims of infringement of the patent rights of third parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may assert that we are employing their proprietary technology without authorization. There may be third-party patents or patent applications with claims to materials, formulations, methods of manufacture, or methods for treatment related to the use or manufacture of our investigational medicines. Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that our investigational medicines may infringe. In addition, third parties may obtain patents in the future and claim that our technologies infringe upon these patents. If any third-party patents were held by a court of competent jurisdiction to cover the manufacturing process of any of our investigational medicines, any molecules formed during the manufacturing process, or any final product itself, the holders of any such patents may obtain injunctive or other equitable relief, which could effectively block our ability to commercialize such investigational medicine unless we obtained a license under the applicable patents, or until such patents expire. Similarly, if any third-party patents were held by a court of competent jurisdiction to cover aspects of our formulations, processes for manufacture, or methods of use, including combination therapy, the holders of any such patents may be able to block our ability to develop and commercialize the applicable investigational medicine unless we obtained a license or until such patent expires. In either case, such a license may not be available on commercially reasonable terms or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Defense of infringement and other claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#8217; fees for willful infringement, pay royalties, redesign our infringing products, or obtain one or more licenses from third parties, which may not be made available on commercially favorable terms, if at all, or may require substantial time and expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, such licenses are likely to be non-exclusive and, therefore, our competitors may have access to the same technology licensed to us. If we fail to obtain a required license and are unable to design around a patent, we may be unable to effectively market some of our technology and products, which could limit our ability to generate revenues or achieve profitability and possibly prevent </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">us from generating revenue sufficient to sustain our operations. Moreover, we expect that a number of our collaborations will provide that royalties payable to us for licenses to our IP may be offset by amounts paid by our collaborators to third parties who have competing or superior IP positions in the relevant fields, which could result in significant reductions in our revenues from products developed through collaborations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in connection with certain license and strategic alliance agreements, we have agreed to indemnify certain third parties for certain costs incurred in connection with litigation relating to IP rights or the subject matter of the agreements. The cost to us of any litigation or other proceeding relating to IP rights, even if resolved in our favor, could be substantial, and litigation would divert our management&#8217;s efforts. Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. Uncertainties resulting from the initiation and continuation of any litigation could delay our research, development and commercialization efforts and limit our ability to continue our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in obtaining or maintaining necessary IP rights to product components and manufacturing processes for our development pipeline.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Presently we have rights to certain IP, through licenses from third parties and under patents that we own, to develop our development candidates and investigational medicines. Because our pipeline may involve additional development candidates that could require the use of proprietary rights held by third parties, the growth of our business could depend in part on our ability to acquire, in-license, or use these proprietary rights. In addition, our development candidates and investigational medicines may require specific formulations to work effectively and efficiently and these rights may be held by others. We may be unable to acquire or in-license any compositions, methods of use, processes, or other third-party IP rights from third parties that we identify. The licensing and acquisition of third-party IP rights is a competitive area, and a number of more established companies are also pursuing strategies to license or acquire third-party IP rights that we may consider attractive. These established companies may have a competitive advantage over us due to their size, cash resources, and greater clinical development and commercialization capabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, we sometimes collaborate with U.S. and foreign academic institutions to accelerate our preclinical research or development under written agreements with these institutions. Typically, these institutions provide us with an option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the collaboration. Regardless of such right of first negotiation for IP, we may be unable to negotiate a license within the specified time frame or under terms that are acceptable to us. If we are unable to do so, the institution may offer the IP rights to other parties, potentially blocking our ability to pursue our program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party IP rights on terms that would allow us to make an appropriate return on our investment. If we are unable to successfully obtain rights to required third-party IP rights, our business, financial condition, and prospects for growth could suffer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to obtain and enforce patent protection for our discoveries, our ability to effectively compete using our development candidates will be harmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends, in part, on our ability to protect proprietary methods and technologies that we develop under the patent and other IP laws of the United States and other countries, so that we can prevent others from unlawfully using our inventions and proprietary information. However, we may not hold proprietary rights to some patents required for us to develop, manufacture, and commercialize our proposed products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because certain U.S. patent applications are confidential until the patents issue, such as applications filed prior to November 29, 2000, or applications filed after such date which will not be filed in foreign countries, third parties may have filed patent applications for technology covered by our pending patent applications without our being aware of those applications, and our patent applications may not have priority over those applications. In addition, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in our patents or pending patent applications, or that we were the first to file for patent protection of such inventions, including our COVID-19 vaccine. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For this and other reasons, we may be unable to secure desired patent rights, thereby losing exclusivity. Further, we may be required to obtain licenses under third-party patents to market our proposed products or conduct our research and development or other activities. If licenses are not available to us on favorable terms, we may not be able to market the affected products or conduct the desired activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategy depends on our ability to rapidly identify and seek patent protection for our discoveries. In addition, we may rely on third-party strategic collaborators to file patent applications relating to proprietary technology that we develop jointly as a part of certain strategic alliances. The process of obtaining patent protection is expensive and time-consuming. If our present or future strategic collaborators fail to file and prosecute all necessary and desirable patent applications at a reasonable cost and in a timely </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manner, our business may be adversely affected. Despite our efforts and the efforts of our strategic collaborators to protect our proprietary rights, unauthorized parties may be able to obtain and use information that we regard as proprietary. While issued patents are presumed valid, this does not guarantee that the patent will survive a validity challenge or be held enforceable. Any patents we have obtained, or obtain in the future, may be challenged, invalidated, adjudged unenforceable, or circumvented by parties attempting to design around our IP. Moreover, third parties or the USPTO may commence interference proceedings involving our patents or patent applications. Any challenge to, finding of unenforceability or invalidation, or circumvention of, our patents or patent applications, would be costly, would require significant time and attention of our management, could reduce or eliminate royalty payments to us from third-party licensors, and could have a material adverse impact on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pending patent applications may not result in issued patents. The patent position of pharmaceutical or biotechnology companies, including ours, is generally uncertain and involves complex legal and factual considerations. The standards that the USPTO and its foreign counterparts use to grant patents are not always applied predictably or uniformly and can change. Similarly, the ultimate degree of protection that will be afforded to biotechnology inventions, including ours, in the United States and foreign countries, remains uncertain and is dependent upon the scope of the protection decided upon by patent offices, courts, and lawmakers. Moreover, there are periodic discussions in the U.S. Congress and in international jurisdictions about modifying various aspects of patent law. For example, the America Invents Act, which took effect in March 2013, included a number of changes to the patent laws of the United States. If any of the enacted changes prevent us from adequately protecting our discoveries, including our ability to pursue infringers of our patents to obtain injunctive relieve or for substantial damages, our business could be adversely affected. One major provision of the America Invents Act changed U.S. patent practice from a first-to-invent to a first-to-file system. If we fail to file an invention before a competitor files on the same invention, we no longer have the ability to provide proof that we were in possession of the invention prior to the competitor&#8217;s filing date, and thus would not be able to obtain patent protection for our invention. There is also no uniform, worldwide policy regarding the subject matter and scope of claims granted or allowable in pharmaceutical or biotechnology patents. In certain countries, for example, methods for the medical treatment of humans are not patentable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, we do not know the degree of future protection for our proprietary rights or the breadth of claims that will be allowed in any patents issued to us or to others. We also rely to a certain extent on trade secrets, know-how, and technology, which are not protected by patents, to maintain our competitive position. If any trade secret, know-how, or other technology not protected by a patent were to be disclosed to or independently developed by a competitor, our business and financial condition could be materially adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to obtain and maintain all available regulatory exclusivities and broad patent scope and to maximize patent term restoration or extension on patents covering our products may lead to loss of exclusivity and early biosimilar entry resulting in a loss of market share and/or revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may choose not to enforce our intellectual property rights in certain circumstances or for certain periods of time. For example, in October 2020 we announced that while the COVID-19 pandemic continues, we will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic. We also noted that to eliminate any perceived intellectual property barriers to vaccine development during the pandemic period, upon request we are also willing to license our intellectual property for COVID-19 vaccines to others for the post pandemic period. However, we may never enter into such licenses of our intellectual property for the post-pandemic period, and our business may be otherwise adversely impacted by our decision not to enforce this intellectual property during the pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We license patent rights from third-party owners. If such owners do not properly or successfully obtain, maintain, or enforce the patents underlying such licenses, our competitive position and business prospects may be harmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party to licenses that give us rights to third-party IP that is necessary or useful for our business. In particular, we have obtained licenses from Cellscript, LLC and its affiliates to patent rights covering modified mRNA chemistries and from certain other parties for IP useful in our formulation efforts. We may enter into additional licenses to third-party IP in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success will depend in part on the ability of our licensors to obtain, maintain, and enforce patent protection for our licensed IP. Our licensors may not successfully prosecute the patent applications we license. Even if patents issue in respect of these patent applications, our licensors may fail to maintain these patents, may determine not to pursue litigation against other companies that are infringing these patents, or may pursue such litigation less aggressively than we would. Without protection for the IP we license, other companies might be able to offer substantially identical products for sale, which could adversely affect our competitive business position and harm our business prospects. In addition, we sublicense our rights under various third-party licenses to our strategic collaborators. Any impairment of these sublicensed rights could result in reduced revenues under our strategic alliance agreements or result in termination of an agreement by one or more of our strategic collaborators.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with our obligations in the agreements under which we license IP rights from third parties or otherwise experience disruptions to our business relationships with our licensors, we could lose license rights that are important to our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Licensing of IP is important to our business and involves complex legal, business, and scientific issues and is complicated by the rapid pace of scientific discovery in our industry. We are a party to certain IP license agreements that are important to our business and expect to enter into additional license agreements in the future. Our existing license agreements impose, and we expect that future license agreements will impose, various diligence, milestone payment, royalty, and other obligations on us. If we fail to comply with our obligations under these agreements, or we are subject to a bankruptcy, the licensor may have the right to terminate the license, in which event we would not be able to market products covered by the license.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, patent prosecution of our licensed technology is controlled solely by the licensor. If our licensors fail to obtain and maintain patent or other protection for the proprietary IP we license from them, we could lose our rights to the IP and our competitors could market competing products using the IP. In certain cases, we control the prosecution of patents resulting from licensed technology. In the event we breach any of our obligations related to such prosecution, we may incur significant liability to our strategic collaborators. Disputes may arise regarding IP subject to a licensing agreement, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope of rights granted under the license agreement and other interpretation-related issues; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which our technology and processes that are not subject to the licensing agreement infringe on IP of the licensor; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sublicensing of patent and other rights under our collaborative development relationships; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our diligence obligations under the license agreement and what activities satisfy those diligence obligations; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ownership of inventions and know-how resulting from the joint creation or use of IP by our licensors and us and our strategic collaborators; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the priority of invention of patented technology. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If disputes over IP that we have licensed prevent or impair our ability to maintain our current licensing arrangements on favorable terms, we may be unable to successfully develop and commercialize the affected development candidates or investigational medicines. We are generally also subject to all of the same risks with respect to protection of IP that we license, as we are for IP that we own, which are described below. If we or our licensors fail to adequately protect this IP, our ability to commercialize products could suffer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to patent protection, we rely heavily upon know-how and trade secret protection, as well as non-disclosure agreements and invention assignment agreements with our employees, consultants, and third parties, to protect our confidential and proprietary information, especially where we do not believe patent protection is appropriate or obtainable. In addition to contractual measures, we try to protect the confidential nature of our proprietary information using physical and technological security measures. Such measures may not, for example, in the case of misappropriation of a trade secret by an employee or third party with authorized access, provide adequate protection for our proprietary information. Our security measures may not prevent an employee or consultant from misappropriating our trade secrets and providing them to a competitor, and recourse we take against such misconduct may not provide an adequate remedy to protect our interests fully. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive, and time-consuming, and the outcome is unpredictable. In addition, trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. If any of our confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated, or if any such information was independently developed by a competitor, our competitive position could be harmed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain former employees have obtained employment with companies or academic institutions that could be considered competitive with us and are operating their business in areas that are similar to ours, including in their business model, product discovery efforts, mRNA-based product development, or formulation technology such as our LNPs. This competition may be limited by contractual provisions which may or may not be enforceable by us in the Commonwealth of Massachusetts or other jurisdictions. In addition, we may not be aware of such competitive employment arrangements until after our trade secrets have been disclosed to potentially competitive companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ individuals who were previously employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants, and independent contractors do not use the proprietary information or know-how of others in their work for us, from time to time we are subject to claims that we, or our employees, consultants, or independent contractors, have inadvertently or otherwise used or disclosed IP, including trade secrets or </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other proprietary information, of any of our employees&#8217; former employers or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable IP rights or personnel, which could adversely impact our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims challenging the inventorship or ownership of our patents and other IP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to claims that former employees, collaborators, or other third parties have an ownership interest in our patents or other IP. Ownership disputes may arise, for example, from conflicting obligations of consultants or others who are involved in developing our development candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or ownership. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable IP rights, such as exclusive ownership of, or right to use, valuable IP. Such an outcome could have a material adverse impact on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment, and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that defects of form in the preparation or filing of our patents or patent applications may exist, or may arise in the future, for example with respect to proper priority claims, inventorship, claim scope, or requests for patent term adjustments. If we fail to establish, maintain or protect such patents and other intellectual property rights, such rights may be reduced or eliminated. If there are material defects in the form, preparation, prosecution, or enforcement of our patents or patent applications, such patents may be invalid and/or unenforceable, and such applications may never result in valid, enforceable patents. Any of these outcomes could impair our ability to prevent competition from third parties, which may have an adverse impact on our business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodic maintenance fees, renewal fees, annuity fees, and various other governmental fees on patents or applications will be due to be paid to the USPTO and various governmental patent agencies outside of the United States in several stages over the lifetime of the patents or applications. We have systems in place to remind us to pay these fees, and we employ an outside firm and rely on our outside counsel to pay these fees due to non-U.S. patent agencies. The USPTO and various non-U.S. governmental patent agencies require compliance with a number of procedural, documentary, fee payment, and other similar provisions during the patent application process. We employ reputable law firms and other professionals to help us comply, and in many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. However, there are situations in which non-compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors might be able to enter the market and this circumstance could have a material adverse impact on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issued patents covering our development candidates and investigational medicines could be found invalid or unenforceable if challenged in court.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we or one of our strategic collaborators initiated legal proceedings against a third party to enforce a patent covering one of our development candidates or investigational medicines, the defendant could counterclaim that the patent covering our development candidate or investigational medicine is invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including patent eligible subject matter, lack of novelty, obviousness, or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include reexamination, post-grant review, and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings). Such proceedings could result in revocation of or amendment to our patents in such a way that they no longer cover our development candidates or investigational medicines. The outcome following legal assertions of invalidity and unenforceability is unpredictable. With respect to the validity question, for example, there may be invalidating prior art that we and the patent examiner were unaware of during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we would lose at least part of the patent protection for our development candidates and investigational medicines. Such a loss of patent protection could have a material adverse impact on our business.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in U.S. patent and regulatory law could impair our ability to protect our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is the case with other biotechnology companies, our success is heavily dependent on IP, particularly patents. Obtaining and enforcing patents in the biotechnology industry involve both technological and legal complexity, and therefore obtaining and enforcing biotechnology patents is costly, time-consuming and inherently uncertain. In addition, the United States has enacted and is implementing wide-ranging patent reform legislation. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. Furthermore, depending on the Supreme Court&#8217;s review of the ACA, or legislation to repeal or amend the ACA, the twelve years of regulatory exclusivity currently provided to certain biologic products in the United States may be reduced or eliminated, as further discussed above under the risk factor entitled &#8220;Our investigational medicines may face competition from biosimilars approved through an abbreviated regulatory pathway.&#8221; Any such reduction or elimination could impair the length of exclusivity against biosimilar products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to protect our IP rights throughout the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filing, prosecuting, and defending patents on development candidates and investigational medicines in all countries throughout the world would be prohibitively expensive, and our IP rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect IP rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with our products and our patents or other IP rights may not be effective or sufficient to prevent them from competing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many companies have encountered significant problems in protecting and defending IP rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other IP protection, particularly those relating to biotechnology products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our IP rights around the world may be inadequate to obtain a significant commercial advantage from the IP that we develop or license.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. As a result, in response to the COVID-19 pandemic, it is possible that certain countries may take steps to facilitate compulsory licenses that permit the distribution of a COVID-19 vaccine in those countries. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of the relevant patent rights. If we or any of our licensors is forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired, and our business, financial condition, results of operations, and prospects may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our reliance on government funding and collaboration from governmental and quasi-governmental entities for certain of our programs adds uncertainty to our research and development efforts with respect to those programs and may impose requirements that increase the costs of development, commercialization and production of any programs developed under those government-funded programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development of each of our Zika vaccine (mRNA-1893), our antibody against Chikungunya virus (mRNA-1944), and our Chikungunya vaccine (mRNA-1388), are currently being funded through subcontracts with funding from either BARDA or DARPA. Our COVID-19 vaccine is being developed in collaboration with NIAID. BARDA has agreed to fund the advancement of our COVID-19 vaccine to FDA licensure. Contracts and grants funded by the U.S. government and its agencies, including our agreements funded by BARDA and DARPA and our collaboration with NIAID, include provisions that reflect the government&#8217;s substantial rights and remedies, many of which are not typically found in commercial contracts, including powers of the government to:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">terminate agreements, in whole or in part, for any reason or no reason; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduce or modify the government&#8217;s obligations under such agreements without the consent of the other party; </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">claim rights, including IP rights, in products and data developed under such agreements; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">audit contract-related costs and fees, including allocated indirect costs; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend the contractor or grantee from receiving new contracts pending resolution of alleged violations of procurement laws or regulations; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose U.S. manufacturing requirements for products that embody inventions conceived or first reduced to practice under such agreements; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or debar the contractor or grantee from doing future business with the government; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">control and potentially prohibit the export of products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pursue criminal or civil remedies under the False Claims Act, False Statements Act, and similar remedy provisions specific to government agreements; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit the government&#8217;s financial liability to amounts appropriated by the U.S. Congress on a fiscal-year basis, thereby leaving some uncertainty about the future availability of funding for a program even after it has been funded for an initial period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not have the right to prohibit the U.S. government from using certain technologies developed by us, and we may not be able to prohibit third-party companies, including our competitors, from using those technologies in providing products and services to the U.S. government. The U.S. government generally takes the position that it has the right to royalty-free use of technologies that are developed under U.S. government contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, government contracts and grants, and subcontracts and subawards awarded in the performance of those contracts and grants, normally contain additional requirements that may increase our costs of doing business, reduce our profits, and expose us to liability for failure to comply with these terms and conditions. These requirements include, for example:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specialized accounting systems unique to government contracts and grants; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mandatory financial audits and potential liability for price adjustments or recoupment of government funds after such funds have been spent; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public disclosures of certain contract and grant information, which may enable competitors to gain insights into our research program; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mandatory socioeconomic compliance requirements, including labor standards, non-discrimination, and affirmative action programs, and environmental compliance requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, under these agreements we are subject to the obligations to and the rights of the U.S. government set forth in the Bayh-Dole Act of 1980 (Bayh-Dole Act). As a result, the U.S. government may have rights in certain inventions developed under these government-funded programs, including a non-exclusive, non-transferable, irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right to require us to grant exclusive, partially exclusive, or nonexclusive licenses to any of these inventions to a third party if it determines that: (i) adequate steps have not been taken to commercialize the invention; (ii) government action is necessary to meet public health or safety needs; or (iii) government action is necessary to meet requirements for public use under federal regulations, also referred to as &#8220;march-in rights.&#8221; While the U.S. government has sparingly used, and to our knowledge never successfully exercised, such march-in rights, any exercise of the march-in rights by the U.S. government could harm our competitive position, business, financial condition, results of operations, and prospects. If the U.S. government exercises such march-in rights, we may receive compensation that is deemed reasonable by the U.S. government in its sole discretion, which may be less than what we might be able to obtain in the open market. Intellectual property generated under a government funded program is also subject to certain reporting requirements, compliance with which may require us to expend substantial resources.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the U.S. government requires that any products embodying any invention generated through the use of U.S. government funding be manufactured substantially in the United States. The manufacturing preference requirement can be waived if the owner of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States or that under the circumstances domestic manufacture is not commercially feasible. This preference for U.S. manufacturers may limit our ability to contract with non-U.S. manufacturers for products covered by such intellectual property.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an organization, we are relatively new to government contracting and new to the regulatory compliance obligations that such contracting entails. If we fail to maintain compliance with those obligations, we may be subject to potential liability and to termination of our contracts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a U.S. government contractor, we are subject to financial audits and other reviews by the U.S. government of our costs and performance on their contracts, as well as our accounting and general business practices related to these contracts. Based on the results of its audits, the government may adjust our contract-related costs and fees, including allocated indirect costs. Although adjustments arising from government audits and reviews have not had a material adverse impact on our financial condition or results of operations in the past, we cannot assure you that future audits and reviews will not have those effects.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Coalition for Epidemic Preparedness Innovations is a global organization that has publicly stated its intent to work with multiple global organizations on potential vaccines and therapies targeting the novel coronavirus, including other companies working on mRNA based approaches. There is a possibility that our confidential information may become exposed to others during this process, including the details and timing of our vaccine efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to the commercialization of our pipeline</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have limited sales, distribution, and marketing experience, and have only recently invested significant financial and management resources to establish these capabilities as a result of our rapid development and commercialization of our COVID-19 vaccine. If we are unable to effectively establish such capabilities or enter into agreements with third parties to market and sell our products or to help ensure compliance with local regulatory requirements, our ability to generate revenues may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our COVID-19 vaccine (mRNA-1273) represents the first product that we have commercialized for sales, distribution and marketing. To enable the successful commercialization of this vaccine and other products that may result from our development programs, we are investing in the development of sales, marketing, distribution, managerial and other non-technical capabilities in the United States, Europe, and other regions, both on our own and with others. We may enter into strategic alliances with other entities to utilize their mature marketing and distribution capabilities, but we may be unable to enter into marketing agreements on favorable terms, if at all. To the extent that we rely on third parties to commercialize our approved products, if any, w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e will receive lower revenues th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an if we commercialized these products ourselves. In addition, we may have little or no control over the sales efforts of third parties involved in our commercialization efforts. If our future strategic collaborators do not commit sufficient resources to commercialize our future products, if any, and we are unable to develop the necessary marketing capabilities on our own, we may be unable to generate sufficient product revenue to sustain our business. We are and will be competing with many companies that currently have extensive and well-funded marketing and sales operations. In the event that we develop our own marketing or sales force, we will also have to compete with such companies to recruit, hire, train and retain marketing and sales personnel. Without a significant internal team or the support of a third party to perform marketing and sales functions, we may be unable to compete successfully against these more established companies.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commercialization and distribution of our COVID-19 vaccine also subjects us to pharmacovigilance obligations under various regulatory regimes in the jurisdictions in which our vaccine is distributed. Under these regulations, we are generally required to collect, process, analyze and monitor safety data and to identify and evaluate adverse reactions to our COVID-19 vaccine as it is administered in those jurisdictions. We partner with third party organizations to assist us in collecting and processing this safety data as it is reported from healthcare providers, recipients of our vaccine and others. To the extent that we or the third parties with whom we contract to conduct these pharmacovigilance activities are unable to comply with relevant regulations, including with respect to the timely processing of safety data, we may be subject to sanctions, increased costs, reputational harm, or our authorizations to distribute the COVID-19 vaccine in the relevant jurisdictions may be revoked or curtailed. There are a limited number of third-party service providers who are qualified and capable of providing pharmacovigilance services on a global basis, and our inability to identify or contract with qualified service providers may impede our commercial activities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are and will be competing with many companies that currently have extensive and well-funded marketing, sales and pharmacovigilance operations. In the event that we develop our own marketing or sales force, we will also have to compete with such companies to recruit, hire, train and retain marketing and sales personnel. We have and will continue to incur expenses associated with hiring third-party contractors to assist in conducting local pharmacovigilance services. Without a significant internal team or the support of a third party to perform these functions, we may be unable to compete successfully against these more established companies.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of our customers for our COVID-19 vaccine prepay us for a portion of the product payment for the vaccine doses that they expect to receive from us, and under the terms of certain of our supply agreements, we may be required to refund some or all of those prepayments if a customer reduces its purchase commitment or if we fail to deliver the purchased volume.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our customers for our COVID-19 vaccine prepay us for a portion of the product payment for the vaccine doses that they expect to receive from us. In some cases, this prepayment can be substantial. We are generally not required by our contracts to retain these prepayments in cash or otherwise and we have generally used these prepayments to make capital expenditures and fund the manufacturing scale-up and commercialization of our vaccine. Under certain supply agreements with customers for our COVID-19 vaccine, if we fail to deliver a portion or all of the committed number of doses by a certain date, a customer may reduce the volume of vaccine doses that it commits to purchase or the contract may be terminated. Upon termination by the customer, we would generally be required to refund a portion of that customer&#8217;s prepayment. We may not have the cash or other available resources to satisfy that repayment obligation. Even if we are able to satisfy the repayment obligation from available resources, we may need to seek additional sources of capital to fund our operations, which funding may not be available when needed or on acceptable terms. In either of those circumstances, our business, financial condition, results of operations, and reputation could be materially and adversely affected. Furthermore, in the future, customers may elect not to prepay us for our services in which case we would have to find other sources of funding for our capital expenditures and operations, which may not be available when needed or on acceptable terms.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The pharmaceutical market is intensely competitive. If we are unable to compete effectively with existing products, new treatment methods, and new technologies, we may be unable to commercialize successfully any products that we develop.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pharmaceutical market is intensely competitive and rapidly changing. Many large pharmaceutical and biotechnology companies, academic institutions, governmental agencies, and other public and private research organizations are pursuing the development of novel products for the same diseases that we are targeting or expect to target. Many of our competitors have:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater financial, technical, and human resources than we have at every stage of the discovery, development, manufacture, and commercialization of products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">more extensive experience in preclinical testing, conducting clinical trials, obtaining regulatory approvals, and in manufacturing, marketing, and selling products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investigational medicines that are based on previously tested or accepted technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">products that have been approved or are in late stages of development; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborative arrangements in our target markets with leading companies and research institutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will face intense competition from products that have already been approved and accepted by the medical community for the treatment of the conditions for which we may develop products. For example, we announced in September 2020 that we plan to develop a vaccine for the seasonal flu. Although we believe there is an unmet need for a highly effective seasonal flu vaccine, this is a well-developed market and we may not be successful in either developing a successful product or achieving a market share for our product that justifies our investment. We also expect to face competition from new products that enter the market. There are a number of products currently under development, which may become commercially available in the future, for the treatment of conditions for which we are trying, or may in the future try, to develop products. These products may be more effective, safer, less expensive, or marketed and sold more effectively, than any products we develop. While we believe that our COVID-19 vaccine has and will continue to have a competitive profile, it is possible it will not compete favorably with these products and product candidates, or others, and as a result, we may not achieve commercial success. Moreover, positive data and/or the commercial success of competitive products could negatively impact our stock price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate competing with the largest pharmaceutical companies in the world, many of which are all currently conducting research in the fields of infectious diseases, immuno-oncology, rare genetic diseases, and cancer vaccines. Some of these companies have greater financial and human resources than we currently have. In addition to these large pharmaceutical companies, we may directly compete with fully-integrated biopharmaceutical companies and other immunotherapy-focused oncology companies, as well as a number of companies focused on mRNA medicines or shared tumor antigen and neoantigen therapeutics, some of which have entered into collaboration and funding agreements with larger pharmaceutical or biotechnology companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we successfully develop investigational medicines, and obtain approval for them, we will face competition based on many different factors, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the safety and effectiveness of our products relative to alternative therapies, if any;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ease with which our products can be administered and the extent to which patients accept relatively new routes of administration;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and scope of regulatory approvals for these products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability and cost of manufacturing, marketing, and sales capabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the price of any approved mRNA medicine;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reimbursement coverage; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patent position.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors may develop or commercialize products with significant advantages over any products we develop based on any of the factors listed above or on other factors. In addition, our competitors may develop strategic alliances with or receive funding from larger pharmaceutical or biotechnology companies, providing them with an advantage over us. Our competitors may therefore be more successful in commercializing their products than we are, which could adversely affect our competitive position and business. Competitive products may make any products we develop obsolete or noncompetitive before we can recover the expenses of developing and commercializing our products, if approved.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The commercial success of any current or future investigational medicine, if approved, will depend upon the degree of market acceptance by physicians, patients, third-party payors, and others in the medical community.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ethical, social, and legal concerns about genetic research could result in additional regulations restricting or prohibiting the products and processes we may use. Even with the requisite approvals, the commercial success of our products will depend in part on the medical community, patients, and third-party or governmental payors accepting mRNA medicines in general, and our products in particular, as medically useful, cost-effective, and safe. Any product that we bring to the market may not gain market acceptance by physicians, trial participants, patients, third-party payors, and others in the medical community. If these products do not achieve an adequate level of acceptance, we may not generate significant product revenue and may not become profitable. The degree of market acceptance of our investigational medicines, if approved for commercial sale, will depend on a number of factors, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential efficacy and potential advantages over alternative treatments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to offer our products, if approved, at competitive prices;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prevalence and severity of any side effects, including any limitations or warnings contained in a product&#8217;s approved labeling;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prevalence and severity of any side effects resulting from checkpoint inhibitors or other products or therapies with which our products are co-administered;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">relative convenience and ease of administration;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any restrictions on the use of our products, if approved, together with other medications;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the strength of marketing and distribution support and timing of market introduction of competitive products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">publicity concerning our products or competing products and treatments; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sufficient third-party insurance coverage or reimbursement, and patients&#8217; willingness to pay out-of-pocket in the absence of third-party coverage or adequate reimbursement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if a potential product displays a favorable efficacy and safety profile in preclinical studies and clinical trials, market acceptance of the product will not be known until after it is launched. Our efforts to educate the medical community and third-party payors on the benefits of the products may require significant resources and may never be successful. Our efforts to educate the marketplace may require more resources than are required by the conventional technologies marketed by our competitors due to the complexity and uniqueness of our programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are successful in obtaining marketing approval for any product, commercial success of any approved products will also depend in large part on the availability of coverage and adequate reimbursement from third-party payors, including government payors such as the Medicare and Medicaid programs, and entry into managed care organizations, which may be affected by existing and future healthcare reform measures designed to reduce the cost of healthcare. Third-party payors could require us to conduct additional studies, including post-marketing studies related to the cost effectiveness of a product, to qualify for reimbursement, which could be costly and divert our resources. If government and other healthcare payors do not provide adequate coverage and reimbursement levels for any of our products once approved, whether due to healthcare reform legislation or otherwise, market acceptance and commercial success would be reduced.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if any of our products are approved for marketing, we or a strategic collaborator will be subject to significant regulatory obligations regarding the submission of safety and other post-marketing information and reports for such product, and will need to continue to comply (or ensure that our third-party providers comply) with cGMP and current GCPs for any clinical trials that we or a strategic collaborator conduct post-approval. In addition, there is always the risk that we or a strategic collaborator or regulatory authority might identify previously unknown problems with a product post-approval, such as adverse events of unanticipated severity or frequency. Compliance with these requirements is costly, and any such failure to comply or other issues with our investigational medicines identified post-approval could have a material adverse impact on our business, financial condition, and results of operations.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will need to obtain FDA approval of any proposed product names, and any failure or delay associated with such approval may adversely impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any name we intend to use for our proposed products will require approval from the FDA regardless of whether we have secured a trademark registration from the USPTO. The FDA typically conducts a review of proposed product names, including an evaluation of potential for confusion with other product names. The FDA may object to any product name we submit if it believes the name inappropriately implies medical claims. If the FDA objects to any of our proposed product names, we may be required to adopt an alternative name for our proposed products. If we adopt an alternative name, we would lose the benefit of any existing trademark applications for such developmental candidate and may be required to expend significant additional resources in an effort to identify a suitable product name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. We may be unable to build a successful brand identity for a new trademark in a timely manner or at all, which would limit our ability to commercialize our products, if approved. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We market our products outside of the United States, and we are subject to the risks of doing business outside of the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we market our COVID-19 vaccine, and we plan to market any other products, if approved, outside of the United States, our business is subject to risks associated with doing business outside of the United States, including an increase in our expenses, diversion of our management&#8217;s attention from the acquisition or development of investigational medicines, or forgoing profitable licensing opportunities in these geographies. We are not permitted to market or promote any of our developmental candidates or investigational medicines before we receive regulatory approval from the applicable regulatory authority in that foreign market, and we may never receive such regulatory approval for any of our developmental candidates or investigational medicines. To obtain separate regulatory approval in many other countries we must comply with numerous and varying regulatory requirements of such countries regarding safety and efficacy and governing, among other things, clinical trials, manufacturing, commercial sales, pricing and distribution of our developmental candidates and investigational medicines, and we cannot predict success in these jurisdictions. We are rapidly expanding our global operations and third-party arrangements to support the worldwide manufacture and distribution of our COVID-19 vaccine, which is a complex task that we are undertaking on an accelerated timeline. Accordingly, our business and financial results may be adversely affected due to a variety of factors associated with our expanding global business, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">efforts to develop an international commercial sales, marketing, and supply chain and distribution organization, including efforts to mitigate longer accounts receivable collection times, longer lead times for shipping, and potential language barriers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our customers&#8217; ability to obtain reimbursement for our products in foreign markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to directly control commercial activities because we are relying on third parties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">different medical practices and customs in foreign countries affecting acceptance in the marketplace;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in a specific country&#8217;s or region&#8217;s political and cultural climate or economic condition, including as a result of the COVID-19 pandemic;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased legal and compliance burden associated with establishing, maintaining and operating legal entities in foreign countries;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the burden of complying with complex and changing foreign regulatory, tax, accounting and legal requirements, including the European General Data Protection Regulation 2016/679, or GDPR; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the interpretation of contractual provisions governed by foreign laws in the event of a contract dispute, and the difficulty of effective enforcement of contractual provisions in local jurisdictions, and the existence of potentially relevant third-party IP rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inadequate IP protection in foreign countries, and the existence of potentially relevant third-party IP rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trade-protection measures including trade restrictions, import or export licensing requirements such as Export Administration Regulations promulgated by the U.S. Department of Commerce and fines, penalties, or suspension or revocation of export privileges, the imposition of government controls, and changes in tariffs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effects of applicable foreign tax structures and potentially adverse tax consequences; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant adverse changes in foreign currency exchange rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to FDA and related regulatory requirements in the United States and abroad, we are subject to extensive additional federal, state and foreign anti-bribery regulations, which include the U.S. Foreign Corrupt Practices Act (FCPA), the U.K. Bribery Act, and similar laws in other countries outside of the United States. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FCPA prohibits any U.S. individual or business from paying, offering, authorizing payment or offering anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with the FCPA is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign officials. Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions. Various laws, regulations and executive orders also restrict the use and dissemination outside the United States, or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. As we expand our presence outside the United States, it will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and product candidates outside the United States, which could limit our growth potential and increase our development costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are developing and implementing a corporate compliance program based on what we believe are current best practices in the pharmaceutical industry for companies similar to ours, but we cannot guarantee that we, our employees, our consultants, or our third-party contractors are or will be in compliance with all federal, state, and foreign regulations regarding bribery and corruption. Moreover, our strategic collaborators and third-party contractors located outside the United States may have inadequate compliance programs or may fail to respect the laws and guidance of the territories in which they operate. The failure to comply with laws governing international business practices may result in substantial civil and criminal penalties and suspension or debarment from government contracting. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#8217;s accounting provisions. Even if we are not determined to have violated these laws, government investigations into these issues typically require the expenditure of significant resources and generate negative publicity, which could also have an adverse effect on our business, financial condition, and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The insurance coverage and reimbursement status of newly-approved products, particularly in a new class of medicines, is uncertain. Failure to obtain or maintain adequate coverage and reimbursement for new or current products could limit our ability to market those products and decrease our ability to generate revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford expensive treatments such as the medicines that we hope to develop and sell. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors is critical to new product acceptance. In addition, because our personalized cancer vaccine and intratumoral immuno-oncology investigational medicines represent new approaches to the treatment of cancer, we cannot accurately estimate how these products would be priced, whether reimbursement could be obtained, or any potential revenue. Sales of our investigational medicines will depend substantially, both domestically and abroad, on the extent to which the costs of our investigational medicines will be paid by health maintenance, managed care, pharmacy benefit, and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers, and other third-party payors. If reimbursement is not available, or is available only to limited levels, we may not be able to successfully commercialize our investigational medicines. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment in any of our products. In the U.S., we may establish various programs to help patients afford our products, which may include patient assistance programs and co-pay coupon programs for eligible patients.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is significant uncertainty related to the insurance coverage and reimbursement of newly approved products, including genetic medicines and coverage may be more limited than the purposes for which the medicine is approved by the FDA or comparable foreign regulatory authorities. Third-party payors decide which medications they will pay for and establish reimbursement levels. In the United States, the principal decisions about reimbursement for new medicines are typically made by the Centers for Medicare &amp; Medicaid Services (CMS), an agency within the U.S. Department of Health and Human Services (HHS), as CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare. Private payors tend to follow CMS to a substantial degree. It is difficult to predict what CMS will decide with respect to reimbursement for novel products such as ours. Factors payors consider in determining reimbursement are based on whether the product is:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a covered benefit under its health plan;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safe, effective and medically necessary;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appropriate for the specific patient;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cost-effective; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">neither experimental nor investigational.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, no uniform policy for coverage and reimbursement for products exists among third-party payors. Therefore, coverage and reimbursement for our products can differ significantly from payor to payor. The process for determining whether a payor will provide coverage for a product may be separate from the process for setting the reimbursement rate that the payor will pay for the product. One payor&#8217;s determination to provide coverage for a product does not assure that other payors will also provide coverage and reimbursement for the product. Third-party payors may also limit coverage to specific products on an approved list, or </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">formulary, which might not include all of the FDA-approved products for a particular indication. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors. Many third-party payors are also increasingly requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. Furthermore, many pharmaceutical manufacturers must calculate and report certain price reporting metrics to the government, such as average sales price (ASP), and best price. Penalties may apply in some cases when such metrics are not submitted accurately and timely. We cannot be sure that coverage and reimbursement will be available for, or accurately estimate the potential revenue from, our product candidates or assure that coverage and reimbursement will be available for any product that we may develop.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A decision by a third-party payor not to cover or not to separately reimburse for our medical products or therapies using our products could reduce physician utilization of our products once approved. Assuming there is coverage for our product candidates, or therapies using our product candidates by a third-party payor, the resulting reimbursement payment rates may not be adequate or may require co-payments that patients find unacceptably high. We cannot be sure that coverage and reimbursement in the United States will be available for our current or future product candidates, or for any procedures using such product candidates, and any reimbursement that may become available may not be adequate or may be decreased or eliminated in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Coverage and reimbursement of our COVID-19 vaccine, which was recently granted EUA, may be subject to unique regulatory policies. Under the ACA preventive care mandate, non-grandfathered group health plans and health insurance coverage offered in the individual or group market typically have at least one year before it must provide first-dollar coverage for a newly issued preventive care requirement or guideline. However, pursuant to the CARES Act, non-grandfathered group health plans and health insurance coverage offered in the individual or group market must cover any qualifying coronavirus preventive service 15 business days after the United States Preventive Services Task Force, or Advisory Committee on Immunization Practices (ACIP) designates such service as preventive. On December 19, 2020, ACIP voted 11&#8211;0 in favor of the interim recommendation for use of the Moderna COVID-19 vaccine. Currently, third party payors do not offer coverage or reimbursement for the vaccine. However, third-party reimbursement for providers administering our COVID-19 vaccine may affect market acceptance of the product. Currently, the CARES Act and its implementing regulations state (i) providers that participate in the CDC COVID-19 Vaccination Program must administer a COVID-19 immunization regardless of an individual&#8217;s ability to pay or health insurance coverage status, (ii) providers may not seek any reimbursement, including through balance billing, from an immunization recipient, (iii) that coverage is required, without cost-sharing, for the administration of the immunization even if a third party, such as the federal government, pays for the cost of the immunization, and that (iv) private health insurance plans must cover COVID-19 immunizations and their administration even when provided by out-of-network providers for the duration of the public health emergency for COVID-19.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no guarantee payors will provide coverage and reimbursement for our COVID-19 vaccine during or after the termination of the public health emergency, nor can we guarantee that even if coverage is provided, the approved reimbursement amount will be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment. The FDA may revoke EUA of mRNA-1273 or may not approve the BLA, if submitted. Under the CARES Act and an accompanying interim final rule, Medicare beneficiaries are expected to have coverage for COVID-19 vaccines through Medicare Part B with no cost sharing. Coverage is further expected to apply whether the vaccine receives FDA authorization through an EUA or is licensed under a BLA and will likely extend to employer-sponsored and individual health plans subject to the ACA&#8217;s preventive services standards. The outcome of current and future clinical trials, as well as the market demand for COVID-19 vaccines may impact patient eligibility and current and future coverage determinations. It is unclear whether the FDA will approve the administration of our COVID-19 vaccine for patients under eighteen years of age or if the vaccine will be required to be administered once (i.e. one-time, double dose), annually, or if future booster shots will be required. We cannot predict continued prevalence of COVID-19, whether herd immunity will be achieved which would affect the need for future administration of the vaccine, or whether mRNA-1273 will be effective against future mutations or variants of the SARS-CoV-2 virus. Such factors may impact if mRNA-1273 shall be reimbursable under Medicare Part D rather than Part B and if mRNA-1273 will be excluded from participating in certain federal entitlement programs such as the Vaccines for Children Program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursement agencies in Europe may be more conservative than CMS. For example, a number of cancer drugs have been approved for reimbursement in the United States and have not been approved for reimbursement in certain European countries. Outside the United States, certain countries, including a number of member states of the European Union, set prices and reimbursement for pharmaceutical products, or medicinal products, as they are commonly referred to in the European Union, with limited participation from the marketing authorization holders. We cannot be sure that such prices and reimbursement will be acceptable to us or our strategic collaborators. If the regulatory authorities in these foreign jurisdictions set prices or reimbursement levels that are not commercially attractive for us or our strategic collaborators, our revenues from sales by us or our strategic collaborators, and the potential profitability of our drug products, in those countries would be negatively affected. An increasing number of countries are taking initiatives to attempt to reduce large budget deficits by focusing cost-cutting efforts on pharmaceuticals for their state-run healthcare systems. These international price control efforts have impacted all regions of the world, but have been most drastic in the European Union. Additionally, some countries require approval of the sale price of a product before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. As a result, we might obtain </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">marketing approval for a product in a particular country, but then may experience delays in the reimbursement approval of our product or be subject to price regulations that would delay our commercial launch of the product, possibly for lengthy time periods, which could negatively impact the revenues we are able to generate from the sale of the product in that particular country.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, CMS may develop new payment and delivery models, such as bundled payment models. Recently, there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their products, resulting in several recent U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. For example, at the federal level, the U.S. government&#8217;s budget proposal for fiscal year 2021 includes a $135 billion allowance to support legislative proposals seeking to reduce drug prices, increase competition, lower out-of-pocket drug costs for patients, and increase patient access to lower-cost generic and biosimilar drugs. On March 10, 2020, the U.S. government sent &#8220;principles&#8221; for drug pricing to Congress, calling for legislation that would, among other things, cap Medicare Part D beneficiary out-of-pocket pharmacy expenses, provide an option to cap Medicare Part D beneficiary monthly out-of-pocket expenses, and place limits on pharmaceutical price increases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the U.S. government previously released a &#8220;Blueprint&#8221; to reduce the cost of drugs. This Blueprint contains certain measures that the HHS is already working to implement. For example, in May 2019, CMS issued a final rule that amends the Medicare Advantage and Medicare Part D prescription drug benefit regulations to reduce out of pocket costs for plan enrollees and allow Medicare plans to negotiate lower rates for certain drugs. Among other things, the final rule now allows Medicare Advantage plans the option to use step therapy, a type of pre-authorization, for Part B drugs beginning January 1, 2020. This final rule codified CMS&#8217;s policy change that was effective January 1, 2019. In addition, there have been several changes to the 340B drug pricing program, which imposes ceilings on prices that drug manufacturers can charge for medications sold to certain health care facilities. Some of these changes are undergoing legal challenges, and their status is currently in question. It is unclear how these developments could affect covered hospitals who might purchase our future products and affect the rates we may charge such facilities for our approved products in the future, if any. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 24, 2020 and September 13, 2020, former President Trump signed a series of Executive Orders aimed at lowering drug prices and at implementing several of the administration's proposals. In response, the FDA released a final rule on September 24, 2020, which went into effect on November 30, 2020, creating a process for states to build and submit to the FDA importation plans for drugs from Canada. Further, on November 20, 2020 CMS issued an Interim Final Rule implementing the Most Favored Nation, or MFN Model under which Medicare Part B reimbursement rates will be calculated for certain drugs and biologicals based on the lowest price drug manufacturers receive in Organization for Economic Cooperation and Development countries with a similar gross domestic product per capita. The MFN Model regulations mandate participation by identified Part B providers and was intended to apply in all U.S. states and territories for a seven-year period beginning January 1, 2021, and ending December 31, 2027. However, on December 28, 2020, a judge in the U.S. District Court for the Northern District of California granted a preliminary injunction prohibiting CMS from implementing the MFN Model. Additionally, on November 20, 2020, HHS finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers. Pursuant to an order entered by the U.S. District Court for the District of Columbia, the portion of the rule eliminating safe harbor protection for certain rebates related to the sale or purchase of a pharmaceutical product from a manufacturer to a plan sponsor under Medicare Part D has been delayed to January 1, 2023. Implementation of the this change and new safe harbors for point-of-sale reductions in price for prescription pharmaceutical products and pharmacy benefit manager service fees are currently under review by the Biden administration and may be amended or repealed. Although a number of these, and other proposed measures will require authorization through additional legislation to become effective, and the Biden administration may reverse or otherwise change these measures, Congress has indicated that it will continue to seek new legislative measures to control drug costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the state level, legislatures are increasingly passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, or restrictions on certain product access, and marketing cost disclosure and transparency measures, which, in some cases, are designed to encourage importation from other countries and bulk purchasing. Legally mandated price controls on payment amounts by third-party payors or other restrictions on coverage or access could harm our business, results of operations, financial condition and prospects. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. This could reduce the ultimate demand for our product candidates that we successfully commercialize or put pressure on our product pricing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to experience pricing pressures in connection with the sale of any of our investigational medicines, due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pressure on healthcare costs in general, particularly prescription drugs and surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent federal legislation and actions by federal, state and local governments may permit reimportation of drugs from foreign countries into the United States, including foreign countries where the drugs are sold at lower prices than in the United States, which could materially adversely affect our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may face competition in the United States for our development candidates and investigational medicines, if approved, from therapies sourced from foreign countries that have placed price controls on pharmaceutical products. In the United States, the Medicare Modernization Act contains provisions that call for the promulgation of regulations that expand pharmacists&#8217; and wholesalers&#8217; ability to import cheaper versions of an approved drug and competing products from Canada, where there are government price controls. Further, the Medicare Modernization Act provides that these changes to U.S. importation laws will not take effect unless and until the Secretary of HHS certifies that the changes will pose no additional risk to the public&#8217;s health and safety and will result in a significant reduction in the cost of products to consumers. On September 23, 2020, the Secretary of HHS made such certification to Congress, and on October 1, 2020, the FDA published a final rule that allows for the importation of certain prescription drugs from Canada. Under the final rule, States and Indian Tribes, and in certain future circumstances pharmacists and wholesalers, may submit importation program proposals to the FDA for review and authorization. Since the issuance of the final rule, several industry groups have filed federal lawsuits challenging multiple aspects of the final rule, and authorities in Canada have passed rules designed to safeguard the Canadian drug supply from shortages. On September 25, 2020, CMS stated drugs imported by States under this rule will not be eligible for federal rebates under Section 1927 of the Social Security Act and manufacturers would not report these drugs for &#8220;best price&#8221; or Average Manufacturer Price purposes. Since these drugs are not considered covered outpatient drugs, CMS further stated it will not publish a National Average Drug Acquisition Cost for these drugs. Separately, the FDA also issued a final guidance document outlining a pathway for manufacturers to obtain an additional National Drug Code (NDC) for an FDA-approved drug that was originally intended to be marketed in a foreign country and that was authorized for sale in that foreign country. Since the issuance of the final rule, on November 23, 2020, several industry groups filed federal lawsuits in the U.S. District Court for the District of Columbia, requesting injunctive relief to prevent certification from the Secretary of HHS from taking effect and challenging multiple aspects of the final rule. This litigation has not progressed. If implemented, drug importation may materially and adversely affect the price we receive for any of our products and product candidates. The market implications of these rules and guidance are unknown at this time. For example, proponents of drug reimportation may attempt to pass legislation that would directly allow reimportation under certain circumstances. Legislation or regulations allowing the reimportation of drugs, if enacted, could decrease the price we receive for any products that we may develop and adversely affect our future revenues and prospects for profitability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare legislative reform discourse and potential or enacted measures may have a material adverse impact on our business and results of operations and legislative or political discussions surrounding the desire for and implementation of pricing reforms may adversely impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare costs. For example, in March 2010, the ACA was passed, which substantially changes the way health care is financed by both governmental and private insurers, and significantly impacts the U.S. pharmaceutical industry. The ACA, among other things, increased the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extended the rebate program to individuals enrolled in Medicaid managed care organizations, established annual fees and taxes on manufacturers of certain branded prescription drugs, and promoted a new Medicare Part D coverage gap discount program. Considerable uncertainty remains regarding the implementation and impact of the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its enactment, there have been numerous judicial, administrative, executive, and legislative challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. Various portions of the ACA are currently undergoing legal and constitutional challenges in the United States Supreme Court; the Trump Administration issued various Executive Orders that eliminated cost sharing subsidies and various provisions that would impose a fiscal burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals or medical devices; and Congress has introduced several pieces of legislation aimed at significantly revising or repealing the ACA. The United States Supreme Court is expected to rule on a legal challenge to the constitutionality of the ACA in early 2021. The implementation of the ACA is ongoing, the law appears likely to continue the downward pressure on pharmaceutical pricing, especially under the Medicare program, and may also increase our regulatory burdens and operating costs. Litigation and legislation related to the ACA are likely to continue, with unpredictable and uncertain results. It is unclear whether the ACA will be overturned, repealed, replaced, or further amended. We cannot predict what affect further changes to the ACA would have on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. The Budget Control Act of 2011, among other things, created measures for spending reductions by the U.S. Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several government programs. This </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes aggregate reductions of Medicare payments to providers up to 2% per fiscal year. These reductions will remain in effect through 2030 unless additional Congressional action is taken. However, pursuant to the CARES Act and subsequent legislation, these Medicare sequester reductions will be suspended from May 1, 2020 through March 31, 2021 due to the COVID-19 pandemic. Proposed legislation, if passed, would extend this suspension until the end of the COVID-19 pandemic. On January 2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers, including hospitals and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. Additionally, the Bipartisan Budget Act of 2018, among other things, amended the ACA, effective January 1, 2019, by increasing the point-of-sale discount (from 50% under the ACA to 70%) that is owed by pharmaceutical manufacturers who participate in Medicare Part D and closing the coverage gap in most Medicare drug plans, commonly referred to as the &#8220;donut hole&#8221;.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout the COVID-19 pandemic, there has been public concern over the availability and accessibility of critical medical products, and the CARES Act enhances FDA&#8217;s existing authority with respect to drug shortage measures. Under the CARES Act, we must have in place a risk management plan that identifies and evaluates the risks to the supply of approved drugs for certain serious diseases or conditions for each establishment where the drug or API is manufactured. The risk management plan will be subject to FDA review during an inspection. If we experience shortages in the supply of our marketed products, our results could be materially impacted.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical products. We cannot be sure whether additional legislative changes will be enacted, or whether FDA regulations, guidance, or interpretations will be changed, or what the impact of such changes on the marketing approvals, if any, of our development candidates, may be. In addition, increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing conditions and other requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The delivery of healthcare in the European Union, including the establishment and operation of health services and the pricing and reimbursement of medicines, is almost exclusively a matter for national, rather than EU, law and policy. National governments and health service providers have different priorities and approaches to the delivery of health care and the pricing and reimbursement of products in that context. In general, however, the healthcare budgetary constraints in most EU member states have resulted in restrictions on the pricing and reimbursement of medicines by relevant health service providers. Coupled with ever-increasing EU and national regulatory burdens on those wishing to develop and market products, this could prevent or delay marketing approval of our investigational medicines, restrict or regulate post-approval activities, and affect our ability to commercialize any products for which we obtain marketing approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that additional foreign, state, and federal healthcare reform measures or proposals will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our investigational medicines or additional pricing pressures. In the event that the pricing structures for healthcare products, such as the investigational medicines we are developing, change materially and limit payments for such investigational medicines, our business will be adversely impacted as our products may no longer be commercially viable based on their expected net present value, we may have invested significant resources in products that cannot be commercially developed, or we may determine that assets that have reached an early phase of development cannot or will not be taken into further development, notwithstanding their clinical viability. In addition, development assets or clinical programs that are part of our strategic alliances may no longer be deemed commercially viable to pursue based on our strategic collaborators&#8217; assessments of the impact of any proposed, announced, or legislated pricing reforms.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict what healthcare reform initiatives may be adopted in the future. Further federal, state, and foreign legislative and regulatory developments are likely, and we expect ongoing initiatives to increase pressure on drug pricing. Such reforms could have an adverse effect on anticipated revenues from investigational medicines that we may successfully develop and for which we may obtain regulatory approval, and may affect our overall financial condition and ability to develop investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Due to the novel nature of our technology, we face uncertainty related to pricing and reimbursement for these investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Target patient populations for certain of our investigational medicines, such as those for rare genetic diseases, may be relatively small, and certain of our investigational medicines, like PCV, require customization on an individual scale. As a result, the pricing and reimbursement of our investigational medicines, if approved, must be adequate to support commercial infrastructure. If we are unable to obtain adequate levels of reimbursement, our ability to successfully market and sell our investigational medicines will be adversely affected. The manner and level at which reimbursement is provided for services related to our investigational medicines (e.g., for administration of our product to patients) is also important. Inadequate reimbursement for such services may lead to physician resistance and adversely affect our ability to market or sell our products.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, third-party payor coverage for our COVID-19 vaccine is not currently available and there is no guarantee payors will provide coverage for the vaccine during or after the termination of the public health emergency. We cannot guarantee that even if coverage is provided, the approved reimbursement amount will be high enough to allow us to establish or maintain pricing sufficient to realize a sufficient return on our investment. While coverage will most likely be provided under Medicare Part B, it is unclear whether such coverage may be re-designated to Part B and it is further unclear to what extent other payors, including certain federal entitlement programs, such as the Vaccines for Children Program, will provide coverage for the product. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the market opportunities for our development candidates or investigational medicines are smaller than we believe they are, our revenue may be adversely affected and our business may suffer. Because the target patient populations for some of our programs are difficult to ascertain or small, we must be able to successfully identify clinical trial participants and achieve a significant market share to maintain profitability and growth.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An important area of focus of our research and product development activities is the development of treatments for severe rare genetic diseases. Our projections of both the number of people who have these diseases, as well as the subset of people with these diseases who have the potential to benefit from treatment with our programs are based on estimates. These estimates have been derived from a variety of sources, including scientific literature, surveys of clinics, patient foundations, or market research, and may prove to be incorrect. Further, new studies may change the estimated incidence or prevalence of these diseases. The number of clinical trial participants or patients in the United States, Europe, and elsewhere may turn out to be lower than expected, potential clinical trial participants or patients may not be otherwise amenable to treatment with our products, or new clinical trial participants or patients may become increasingly difficult to identify or gain access to, all of which would adversely affect our results of operations and our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market opportunities of some of our programs may be limited to those patients who are ineligible for or have failed prior treatments and for which the market opportunities may be small.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA often approves new therapies initially only for use by patients with relapsed or refractory advanced disease. We expect to initially seek approval of our PCV and intratumoral immuno-oncology investigational medicines in this context. Subsequently, for those products that prove to be sufficiently beneficial, if any, we would expect to seek approval in earlier lines of treatment and potentially as a first line therapy but there is no guarantee that our investigational medicines, even if approved, would be approved for earlier lines of therapy, and, prior to any such approvals, we may have to conduct additional clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our projections of both the number of people who have the cancers we may be targeting, as well as the subset of people with these cancers in a position to receive second or third line therapy, and who have the potential to benefit from treatment with our investigational medicines, are based on our beliefs and estimates. These estimates have been derived from a variety of sources, including scientific literature, surveys of clinics, patient foundations, or market research, and may prove to be incorrect. Further, new studies may change the estimated incidence or prevalence of these cancers. The number of trial participants may turn out to be lower than expected. Additionally, the potentially addressable patient population for our investigational medicines may be limited or may not be amenable to treatment with our investigational medicines. Even if we obtain significant market share for our products, if approved, because the potential target populations are small, we may never achieve profitability without obtaining regulatory approval for additional indications.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to our business and operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will need to develop and expand our company, and we may encounter difficulties in managing this development and expansion, which could disrupt our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had approximately 1,300 full-time employees and, in connection with the growth and advancement of our pipeline and operating as a public company, we expect to increase the number of employees and the scope of our operations. To manage our anticipated development and expansion, including expansion outside of the United States, we must continue to implement and improve our managerial, operational, and financial systems, expand our facilities, and continue to recruit and train additional qualified personnel. Also, our management may need to divert a disproportionate amount of its attention away from its day-to-day activities and devote a substantial amount of time to managing these development activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a growing biotechnology company, we are actively pursuing development candidates and investigational medicines in many therapeutic areas and across a wide range of diseases. Successfully developing products for and fully understanding the regulatory and manufacturing pathways to all of these therapeutic areas and disease states requires a significant depth of talent, resources, and corporate processes in order to allow simultaneous execution across multiple areas. Due to our limited resources and early stage of growth, we may not be able to effectively manage this simultaneous execution and the expansion of our operations or recruit and train additional qualified personnel. This may result in weaknesses in our infrastructure, give rise to operational mistakes, loss of business </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opportunities, loss of employees, and reduced productivity among remaining employees. The physical expansion of our operations may lead to significant costs and may divert financial resources from other projects, such as the development of our investigational medicines. If our management is unable to effectively manage our expected development and expansion, our expenses may increase more than expected, our ability to generate or increase our revenue could be reduced, and we may not be able to implement our business strategy. Our future financial performance and our ability to commercialize our COVID-19 vaccine or our other investigational medicines, if approved, and compete effectively will depend, in part, on our ability to effectively manage the future development and expansion of our company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future success depends on our ability to retain key employees, consultants, and advisors and to attract, retain, and motivate qualified personnel. We may not be able to retain employees or executives who have vested stock options.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to compete in the highly competitive biotechnology and pharmaceutical industries depends upon our ability to attract and retain highly qualified managerial, scientific, and medical personnel. We are highly dependent upon members of our management and scientific teams. Each of our executive officers and all of our employees, including key scientists and clinicians, are employed &#8220;at will,&#8221; meaning we or each officer or employee may terminate the employment relationship at any time. The loss of any of these persons&#8217; services may adversely impact the achievement of our research, development, financing, and commercialization objectives. We currently do not have &#8220;key person&#8221; insurance on any of our employees. Many of our key employees, including members of our executive team, have been with us for a long period of time, and have valuable, fully vested stock options or other long-term equity incentives. We may not be able to retain these employees due to the competitive environment in the biotechnology industry, particularly in Cambridge, Massachusetts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we rely on consultants, contractors, and advisors, including scientific and clinical advisors, to assist us in formulating our research and development, regulatory approval, manufacturing and commercialization strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. The loss of the services of one or more of our current employees or advisors might impede the achievement of our research, development, regulatory approval, manufacturing and commercialization objectives. In addition, we have flexibly grown our workforce through the use of contractors and part time workers. We may not be able to retain the services of such personnel which might result in delays in the operation of our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recruiting and retaining other qualified employees, consultants, and advisors for our business, including scientific and technical personnel, also will be critical to our success. Competition for skilled personnel, including in mRNA and LNP research, clinical operations, regulatory affairs, therapeutic area management, and manufacturing, is intense and the turnover rate can be high. We may not be able to attract and retain personnel on favorable terms given the competition among numerous pharmaceutical and biotechnology companies and academic institutions for individuals with similar skill sets. In addition, adverse publicity, failure to succeed in preclinical or clinical trials or applications for marketing approval may make it more challenging to recruit and retain qualified personnel. Furthermore, we may not be successful commercializing our first product and as a result, we may be unable to attract and retain highly qualified sales and marketing professionals to support our COVID-19 vaccine and our future products, if approved. The inability to recruit, or loss of services of certain executives, key employees, consultants, or advisors, may impede the progress of our research, development and global commercialization objectives and have a material adverse impact on our business, financial condition, results of operations, and prospects.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our internal computer systems and physical premises, or those of our strategic collaborators, other contractors, consultants, or regulatory agencies with which we share sensitive data or information may fail or suffer security breaches, which could result in a material disruption of our product development programs and our manufacturing operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our internal computer systems and those of our current and any future strategic collaborators, vendors, contractors, consultants or regulatory authorities with whom we share sensitive data or information are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, cybersecurity threats, war, and telecommunication and electrical failures. We have experienced, and may experience in the future, cyber-attacks on our information technology systems by threat actors of all types (including but not limited to nation states, organized crime, other criminal enterprises, individual actors and/or advanced persistent threat groups). In addition, we may experience intrusions on our physical premises by any of these threat actors. If any such cyber-attack or physical intrusion were to cause interruptions in our operations, such as a material disruption of our development programs or our manufacturing operations, whether due to a loss of our trade secrets or other proprietary information, it would have a material and adverse effect on us. For example, the loss of clinical trial data from one or more ongoing or completed or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. In addition, because of our approach to running multiple clinical trials in parallel, any breach of our computer systems or physical premises may result in a loss of data or compromised data integrity across many of our programs in many stages of development. Any such breach, loss, or compromise of clinical trial participant personal data may also subject us to civil fines and penalties, or claims for damages either under the GDPR and relevant member state law in the EU, other foreign laws, and the federal Health Insurance </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portability and Accountability Act of 1996 (HIPAA), and other relevant state and federal privacy laws in the United States including the California Consumer Privacy Act (the CCPA). On May 13, 2020, the Federal Bureau of Investigation (FBI) and Cybersecurity and Infrastructure Security Agency (CISA), announced that the FBI was investigating the targeting and compromise of U.S. organizations conducting COVID-19-related research by People&#8217;s Republic of China, or PRC-affiliated cyber actors. Furthermore, on July 16, 2020, the National Security Agency and other U.S. and foreign agencies released a joint cybersecurity advisory regarding the Russian Intelligence Services&#8217; targeting of COVID-19 research and vaccine development. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, including but not limited to information related to our rapid manufacture of mRNA-1273, we could incur liability, our competitive and reputational position could be harmed, and the further development and commercialization of our investigational medicines could be delayed. The CCPA is of particular concern since it provides for a private right of actions for certain breaches of personal information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may use our financial and human resources to pursue a particular research program or investigational medicine and fail to capitalize on programs or investigational medicines that may be more profitable or for which there is a greater likelihood of success.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we have limited resources, we must choose to pursue and fund the development of selected research programs or investigational medicines and may forego or delay pursuit of opportunities with other programs or investigational medicines that could later prove to have greater commercial potential. Our resource allocation decisions, or our contractual commitments to provide resources to our strategic collaborators under strategic alliance agreements, may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs for investigational medicines may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular investigational medicine, we may relinquish valuable rights to that investigational medicine through a strategic alliance, licensing, or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such investigational medicine, or we may allocate internal resources to an investigational medicine in a therapeutic area in which it would have been more advantageous to enter into a strategic alliance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not successful in discovering, developing, and commercializing additional products beyond our current portfolio, our ability to expand our business and achieve our strategic objectives would be impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although a substantial amount of our efforts will focus on the commercialization of our COVID-19 vaccine and the clinical trials and potential approval of our investigational medicines, a key element of our strategy is to discover, develop, and potentially commercialize additional products beyond our current portfolio to treat various conditions and in a variety of therapeutic areas. We intend to do so by investing in our own drug discovery efforts, exploring potential strategic alliances for the development of new products, and in-licensing technologies. Identifying new investigational medicines requires substantial technical, financial, and human resources, whether or not any investigational medicines are ultimately identified. Even if we identify investigational medicines that initially show promise, we may fail to successfully develop and commercialize such products for many reasons, including the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the research methodology used may not be successful in identifying potential investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitors may develop alternatives that render our investigational medicines obsolete;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investigational medicines we develop may nevertheless be covered by third parties&#8217; patents or other exclusive rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an investigational medicine may, on further study, be shown to have harmful side effects or other characteristics that indicate it is unlikely to be effective or otherwise does not meet applicable regulatory criteria;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an investigational medicine may not be capable of being produced in commercial quantities at an acceptable cost, or at all; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an approved product may not be accepted as safe and effective by patients, the medical community or third-party payors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unsuccessful in identifying and developing additional products, our potential for growth may be impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product liability lawsuits against us could cause us to incur substantial liabilities and could limit commercialization of any product or investigational medicine that we may develop, such as our COVID-19 vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face an inherent risk of product liability exposure related to the development, testing, manufacturing and marketing of our COVID-19 vaccine and our other current or future investigational medicines in clinical trials. Product liability claims and related cross-claims and claims for indemnification may be brought against us by patients, healthcare providers or others using, prescribing, selling or otherwise coming into contact with our COVID-19 vaccine or other investigational medicines. For example, we may be sued if the COVID-19 vaccine or any other investigational medicine allegedly causes injury or is found to be otherwise unsuitable during clinical trials, manufacturing, or, if approved, marketing, sale or commercial use. If we cannot successfully defend ourselves against claims that our medicines caused injuries, we could incur substantial liabilities.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased demand for any investigational medicine that we may develop;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of revenue;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial monetary awards to patients, healthy volunteers, or their family members;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payments to indemnify clinical trial sites and other clinical trial partners;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant time and costs to defend the related litigation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of clinical trial participants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of regulatory or marketing approval in a territory; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to commercialize any investigational medicine(s) that we may develop; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injury to our reputation and significant negative media attention.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the risks undertaken by all persons who participate in clinical trials or who receive our COVID-19 vaccine, and the information on risks provided to study investigators and patients participating in our clinical trials or receiving our COVID-19 vaccine, it is possible that product liability claims will be asserted against us relating to the worsening of a patient&#8217;s condition, injury or death alleged to have been caused by one of our products or investigational medicines or our COVID-19 vaccine. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, including as a result of interactions with alcohol or other drugs, knowledge of risks, negligence, strict liability and a breach of warranties. Claims could also be asserted under state consumer protection acts. Such claims might not be fully covered by product liability insurance. If we succeed in marketing products, including our COVID-19 vaccine, product liability claims could result in an FDA investigation of the safety and effectiveness of our products, our manufacturing processes and facilities or our marketing programs, and potentially a recall of our products or more serious enforcement action, limitations on the approved indications for which they may be used, suspension or withdrawal of approvals or license revocation. Regardless of the merits or eventual outcome, liability claims may also result in decreased demand for our products, injury to our reputation, costs to defend the related litigation, a diversion of management&#8217;s time and our resources, substantial monetary awards to trial participants or patients and a decline in our stock price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed to liabilities that are unique to developing and commercializing an mRNA vaccine in the context of an ongoing global pandemic. Although the U.S. government and certain foreign governments have contractually agreed to indemnify us or make statutory immunity available to us, such indemnification or statutory immunity may not be available to cover potential claims or liabilities resulting from the research, development, manufacture, distribution or commercialization of our COVID-19 vaccine. Substantial claims arising from the vaccine outside the scope of or in excess of U.S. government or foreign government indemnity or statutory immunity could harm our financial condition and operating results. Moreover, any adverse event or injury for which we are liable, even if fully covered under an indemnity or immunity, could negatively affect our reputation, thereby making it more difficult for us to compete effectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carry product liability insurance which we believe to be sufficient in light of our current commercial and clinical programs; however, we may not be able to maintain insurance coverage at a reasonable cost or in sufficient amounts to protect us against losses due to liability. If and when we obtain marketing approval for investigational medicines, we intend to expand our insurance coverage to include the sale of commercial products; however, we may be unable to obtain product liability insurance on commercially reasonable terms or in adequate amounts. On occasion, large judgments have been awarded in individual, mass tort and class action lawsuits based on drugs or medical treatments that had unanticipated adverse effects. A successful product liability claim or series of claims brought against us could cause our stock price to decline and, if judgments exceed our insurance coverage, could adversely affect our results of operations and business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the costs of maintaining adequate insurance coverage increase significantly in the future, our operating results could be materially adversely affected. Likewise, if insurance coverage should become unavailable to us or become economically impractical, we would be required to operate our business without indemnity from commercial insurance providers. Additionally, even if we maintain insurance coverage for a type of liability, a particular claim may not be covered if it is subject to a coverage exclusion or we do not otherwise meet the conditions for coverage. If we operate our business without insurance, or with inadequate insurance, we could be responsible for paying claims or judgments against us, which could adversely affect our results of operations or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject, directly or indirectly, to federal and state healthcare fraud and abuse laws, false claims laws, information privacy and security laws. If we are unable to comply, or have not fully complied, with such laws, we could face substantial penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we obtain FDA approval for any of our investigational medicines and begin commercializing those products in the United States, our operations will be directly, or indirectly through our prescribers, customers, and purchasers, subject to various federal and state fraud and abuse laws and regulations, including, without limitation, the federal Health Care Program Anti-Kickback Statute, the federal civil and criminal False Claims Act, and Physician Payments Sunshine Act and regulations. These laws will impact, among other things, our proposed sales, marketing, and educational programs. In addition, we may be subject to patient privacy laws enacted </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by both the federal government and the states in which we conduct our business. The laws that will affect our operations include, but are not limited to the following:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and willfully soliciting, receiving, offering, or paying any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the for the purchase, order or recommendation or arranging of, any good, leasing, or furnishing of an item or service reimbursable under a federal healthcare program, such as the Medicare and Medicaid programs. The government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act or federal civil money penalties statute. This statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand, and prescribers, purchasers, and formulary managers on the other. Although there are several statutory exceptions and regulatory safe harbors protecting certain common activities from prosecution, they are drawn narrowly, and practices that involve remuneration intended to induce prescribing, purchasing or recommending may be subject to scrutiny if they do not qualify for an exception or safe harbor. The ACA amends the intent requirement of the federal Anti-Kickback Statute to provide that a person or entity no longer needs to have actual knowledge of this statute or specific intent to violate it.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal civil and criminal false claims laws and civil monetary penalty laws, including the federal False Claims Act, prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment or approval from Medicare, Medicaid, or other government payors that are false or fraudulent. In addition, the government may assert that a claim including items or services resulting from a violation of the Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal False Claims Act or federal civil money penalties statute. Manufacturers can be held liable under the False Claims Act even when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims. Companies that submit claims directly to payors may also be liable under the False Claims Act for the direct submission of such claims. The False Claims Act also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of the federal government alleging violations of the False Claims Act and to share in any monetary recovery. The ACA provides, and recent government cases against pharmaceutical and medical device manufacturers support, the view that federal Anti-Kickback Statute violations and certain marketing practices, including off-label promotion, may implicate the False Claims Act. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The anti-inducement law prohibits, among other things, the offering or giving of remuneration, which includes, without limitation, any transfer of items or services for free or for less than fair market value (with limited exceptions), to a Medicare or Medicaid beneficiary that the person knows or should know is likely to influence the beneficiary&#8217;s selection of a particular supplier of items or services reimbursable by a federal or state governmental program.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA and its implementing regulations, which create new federal criminal statutes that prohibit a person from knowingly and willfully executing, or attempting to execute, a scheme or making false or fraudulent statements to defraud any healthcare benefit program, regardless of the payor (e.g., public or private), or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity can be found guilty of violating HIPAA without actual knowledge of the statute or specific intent to violate it. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their implementing regulations, imposes certain requirements relating to the privacy, security, and transmission of individually identifiable health information without appropriate authorization by entities subject to the rule, such as health plans, health care clearinghouses, and health care providers as well as their respective &#8220;business associates,&#8221; those independent contractors or agents of covered entities that create, receive, maintain, transmit or obtain protected health information in connection with providing a service on behalf of a covered entity. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The U.S. Federal Food, Drug and Cosmetic Act, which prohibits, among other things, the adulteration or misbranding of drugs, biologics, and medical devices. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal transparency laws, including the federal Physician Payment Sunshine Act, which require disclosure of payments and other transfers of value provided by manufacturers of drugs, devices, biologicals and medical supplies to physicians (currently defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, and ownership and investment interests held by physicians and other healthcare providers and their immediate family members and applicable group purchasing organizations. Effective January 1, 2022, these reporting obligations will extend to include transfers of value made to certain non-physician providers such as physician assistants and nurse practitioners.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">State, local and fo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reign law and their regulatory equivalents of each of the above federal laws, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving healthcare items or services </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reimbursed by any third-party payor, including private insurers and may be broader in scope than their federal equivalents; state and foreign laws that require biopharmaceutical companies to comply with the biopharmaceutical industry&#8217;s voluntary compliance guidelines and other relevant compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers, marketing expenditures, or drug pricing and state laws governing the privacy and security of health information in certain circumstances are also applicable to us and many of them differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts in certain circumstances. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on November 20, 2020, HHS finalized a regulation that, among other things, removed safe harbor protection for price reductions from pharmaceutical manufacturers and created new safe harbor for certain fixed fees. Pursuant to an order entered by the U.S. District Court for the District of Columbia, the portion of the rule eliminating safe harbor protection for certain rebates related to the sale or purchase of a pharmaceutical product from a manufacturer to a plan sponsor under Medicare Part D has been delayed to January 1, 2023. Implementation of the this change and new safe harbors for point-of-sale reductions in price for prescription pharmaceutical products and pharmacy benefit manager service fees are currently under review by the Biden administration and may be amended or repealed. It is not clear at this time what effect, if any, these and other changes to the Anti-Kickback Safe Harbors, will have on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Ensuring business arrangements comply with applicable healthcare laws, as well as responding to possible investigations by government authorities, can be time- and resource-consuming and can divert a company&#8217;s attention from the business. If our operations are found to be in violation of any of the laws described above or any other government regulations that apply to us, we may be subject to significant sanctions, including civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, reputational harm, exclusion from participation in federal and state funded healthcare programs, contractual damages and the curtailment or restricting of our operations, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws. Further, if any of the physicians or other healthcare providers or entities with whom we expect to do business are found to be not in compliance with applicable laws, they may be subject to similar penalties. Any action for violation of these laws, even if successfully defended, could cause a biopharmaceutical manufacturer to incur significant legal expenses and divert management&#8217;s attention from the operation of the business. In addition, the approval and commercialization of any product candidate we develop outside the United States will also likely subject us to foreign equivalents of the healthcare laws mentioned above, among other foreign laws. All of these could harm our ability to operate our business and our financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order or use of medicinal products is prohibited in the European Union and the UK. The provision of benefits or advantages to induce or reward improper performance generally is also governed by the national anti-bribery laws of EU Member States, and the UK Bribery Act 2010 in the UK. Infringement of these laws could result in substantial fines and imprisonment. EU Directive 2001/83/EC, which is the EU Directive governing medicinal products for human use, provides that, where medicinal products are being promoted to persons qualified to prescribe or supply them, no gifts, pecuniary advantages or benefits in kind may be supplied, offered or promised to such persons unless they are inexpensive and relevant to the practice of medicine or pharmacy. This provision has been transposed into the Human Medicines Regulations 2012 and so remains applicable in the UK despite its departure from the EU. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments made to physicians in certain European Union Member States must be publicly disclosed. Moreover, agreements with physicians often must be the subject of prior notification and approval by the physician&#8217;s employer, his or her competent professional organization, or the regulatory authorities of the individual European Union Member States. These requirements are provided in the national laws, industry codes, or professional codes of conduct, applicable in the EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines, or imprisonment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collection and use of personally identifiable data, including health data and medical data (personal data) in the European Union is regulated by the GDPR, which became effective on May 25, 2018. The GDPR applies to personal data processed in connection with clinical trial activities in EU Member States. The GDPR imposes strict requirements on controllers and processors of personal data, including special protections for &#8220;sensitive information&#8221; which includes health and genetic information of data subjects residing in the EU. The GDPR grants individuals the opportunity to object to the processing of their personal data, allows them to exercise certain data subject requests, including to request deletion of personal data in certain circumstances, and provides the individual with an express right to seek legal recourse in the event the individual believes his or her rights have been violated. Further, the GDPR imposes strict rules on the transfer of personal data out of the European Union to the United States or other regions that have not been deemed to offer &#8220;adequate&#8221; privacy protections. Failure to comply with the requirements of the GDPR may result in monetary penalties of up to &#8364;20 million or 4% of annual worldwide revenue, whichever is higher. In addition to risking such fines for any failure </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to comply with the GDPR, we may require substantial costs in connection with our efforts to put in place additional mechanisms ensuring compliance with European data protection requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the U.K.&#8217;s decision to leave the EU, often referred to as Brexit, has created uncertainty in data protection issues involving the U.K. For example, pursuant to a post-Brexit trade deal between the U.K. and the EU, transfers of personal information from the European Economic Area to the U.K. are not considered restricted transfers under the GDPR for a period of up to six months from January 1, 2021. However, unless the European Commission makes an adequacy finding with respect to the U.K. before the end of that period, the U.K. will be considered a &#8220;third country&#8221; under the GDPR and transfers of European personal information to the U.K. will require an adequacy mechanism to render such transfers lawful under the GDPR. Additionally, although the U.K. enacted a Data Protection Act in May 2018 that is designed to be consistent with the GDPR, uncertainty remains regarding how data transfers to and from the U.K. will be regulated notwithstanding Brexit. The full effects of Brexit are uncertain and will remain so until the U.K. and EU reach a definitive resolution with regards to outstanding trade and legal matters. Given these possibilities and others we may not anticipate, as well as the lack of comparable precedent, the full extent to which our business, results of operations, and financial condition could be adversely affected by Brexit is uncertain.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is significant uncertainty related to the manner in which data protection authorities will seek to enforce compliance with GDPR. For example, it is not clear if the authorities will conduct random audits of companies doing business in the EU, or if the authorities will wait for complaints to be filed by individuals who claim their rights have been violated. Enforcement uncertainty and the costs associated with ensuring GDPR compliance may be onerous and adversely affect our business, financial condition, results of operations, and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We or the third parties upon whom we depend may be adversely affected by natural disasters, health epidemics or other business interruptions such as cybersecurity attacks and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natural disasters or health epidemics could severely disrupt our operations, and have a material adverse impact on our business, results of operations, financial condition, and prospects. If a natural disaster, power outage, cybersecurity attack, health epidemic or other event occurred that prevented us from using all or a significant portion of our headquarters, damaged critical infrastructure, such as our manufacturing facilities or those of our third-party contract manufacturers, limited our ability to access or use our digital information systems or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible for us to continue our business for a substantial period of time. The disaster recovery and business continuity plans we have in place currently are limited and are unlikely to prove adequate in the event of a serious disaster or similar event. Cybersecurity liability insurance is difficult to obtain and may not cover any damages we would sustain based on any breach of our computer security protocols or other cybersecurity attack. We may incur substantial expenses as a result of the limited nature of our disaster recovery and business continuity plans, which could have a material adverse impact on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our products become subject to a product recall it could harm our reputation, business, and financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and similar foreign governmental authorities have the authority to require the recall of certain commercialized products. In the case of the FDA, the authority to require a recall of a biologic product must be based on an FDA finding that a batch, lot of other quantity of the biologic product presents an imminent or substantial hazard to the public health. In addition, foreign governmental bodies have the authority to require the recall of any investigational medicine in the event of material deficiencies or defects in design or manufacture. Manufacturers may, under their own initiative, recall a product if any material deficiency in a product is found. A government-mandated or voluntary recall by us or our strategic collaborators could occur as a result of manufacturing errors, design or labeling defects or other deficiencies and issues. Recalls of any of our investigational medicines would divert managerial and financial resources and have an adverse effect on our financial condition and results of operations. A recall announcement could harm our reputation with customers and negatively affect our sales, if any.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we engage in future acquisitions, joint ventures, or strategic collaborations, this may increase our capital requirements, dilute our stockholders, cause us to incur debt or assume contingent liabilities, and subject us to other risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may evaluate various acquisitions and collaborations, including licensing or acquiring complementary products, IP rights, technologies, or businesses. Any potential acquisition, joint venture, or collaboration may entail numerous risks, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased operating expenses and cash requirements; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the assumption of additional indebtedness or contingent liabilities; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assimilation of operations, IP, and products of an acquired company, including difficulties associated with integrating new personnel; </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the diversion of our management&#8217;s attention from our existing product programs and initiatives in pursuing such a strategic merger or acquisition; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">retention of key employees, the loss of key personnel, and uncertainties in our ability to maintain key business relationships; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing products or investigational medicines and regulatory approvals; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to generate revenue from acquired technology or products sufficient to meet our objectives in undertaking the acquisition or even to offset the associated acquisition and maintenance costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we undertake acquisitions, we may utilize our cash, issue dilutive securities, assume or incur debt obligations, incur large one-time expenses, and acquire intangible assets that could result in significant future amortization expense.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, we may not be able to locate suitable acquisition or strategic collaboration opportunities and this inability could impair our ability to grow or obtain access to technology or products that may be important to the development of our business.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks related to ownership of our common stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of our common stock has been volatile and fluctuates substantially, which could result in substantial losses for stockholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock price has been, and in the future, may be, subject to substantial volatility. From December 7, 2018, our first day of trading on the Nasdaq Global Select Market, through December 31, 2020, our stock has traded within a range of a high price of $178.50</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and a low price of $11.54 per share. In addition, since we began our development efforts with respect to our COVID-19 vaccine in early 2020, our stock has experienced pronounced and extended periods of volatility. As a result of the volatility in our stock price, our stockholders could incur substantial losses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Public statements by us, government agencies, the media, competing vaccine developers, financial analysts, or others relating to the coronavirus outbreak (including regarding our and others&#8217; efforts to develop a coronavirus vaccine) have in the past resulted, and may in the future result, in significant fluctuations in our stock price. Given the global focus on the coronavirus pandemic, information in the public arena on this topic, whether or not accurate, has had and will likely continue to have an outsized impact (positive or negative) on our stock price. Information related to our clinical trials, manufacturing, regulatory and commercialization efforts with respect to our COVID-19 vaccine, or information regarding such efforts by competitors with respect to their vaccines and potential vaccines, or the evolution of the pandemic, may meaningfully impact our stock price. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock market in general, and the market for biopharmaceutical companies in particular, has experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, you may not be able to sell your common stock at or above your initial purchase price. The market price for our common stock may be influenced by many factors, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of our COVID-19 vaccine sales;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">results of clinical trials of our investigational medicines or those of our competitors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of competitive products or technologies;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commencement or termination of strategic alliances;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory or legal developments in the United States and other countries;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning patent applications, issued patents, or other proprietary rights;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the recruitment or departure of key personnel;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product revenue;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of expenses related to any of our products, investigational medicines or clinical development programs;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the results of our efforts to discover, develop, acquire, or in-license additional investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated changes in estimates as to financial results, development timelines, or recommendations by securities analysts;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variations in our financial results or those of companies that are perceived to be similar to us;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the structure of healthcare payment systems;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions in the pharmaceutical and biotechnology sectors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic, industry, and market conditions; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the numerous programs in our pipeline, the development of which could each generate news or significant adverse events that could impact financial results or recommendations by securities analysts; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public announcements by us or our strategic collaborators regarding the progress of our development candidates or investigational medicines or similar public announcements by our competitors.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our quarterly or annual results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. Furthermore, any quarterly or annual fluctuations in our results may, in turn, cause the price of our stock to fluctuate substantially. We believe that period-to-period comparisons of our results are not necessarily meaningful and should not be relied upon as an indication of our future performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock price is likely to continue to be volatile and subject to significant price and volume fluctuations in response to market and other factors, including the other factors discussed in our filings incorporated by reference herein or in future periodic reports; variations in our quarterly operating results from our expectations or those of securities analysts or investors; downward revisions in securities analysts&#8217; estimates; and announcement by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, following periods of volatility in the market price of a company&#8217;s securities, securities class-action litigation often has been instituted against that company. Such litigation, if instituted against us, could cause us to incur substantial costs to defend such claims and divert management&#8217;s attention and resources, which could seriously harm our business, financial condition, and results of operations, and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have broad discretion in the use of our cash, cash equivalents, and investments, and may not use them effectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management will have broad discretion in the application of our cash, cash equivalents, and investments, and could spend the proceeds in ways that do not improve our results of operations or enhance the value of our common stock. Furthermore, our operating expenses have significantly increased due to development and manufacturing activities for our COVID-19 vaccine program, and we may not deploy our expanded capital base effectively. The failure by our management to apply these funds effectively could result in financial losses that could have a material adverse impact on our business, cause the price of our common stock to decline, and delay the development of our investigational medicines. Pending their use, we may invest our cash, cash equivalents, and investments in a manner that does not produce income or that loses value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are in the early stages of developing our policies and practices regarding pre-approval access and any policy we develop and implement may result in a negative perception of our Company and have a material adverse impact on our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we advance our pipeline, patients and their physicians have sought access to our investigational medicines outside of sponsored clinical trials and prior to regulatory approval. While we will continue to review and respond to these early access requests, at this stage in our development of a new class of medicines, we are not providing access to our investigational medicines outside of the clinical trial setting. As our development programs progress further, we will continue our dialogue with patients and their families, advocacy leaders, physicians, and others on this and other topics. We will post our pre-approval access policies in accordance with regulatory guidelines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of a substantial number of shares of our common stock by our existing stockholders in the public market could cause our stock price to fall.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our common stock in the public market could occur at any time, subject to certain restrictions described below. These sales, or the perception in the market that holders of a large number of shares intend to sell shares, could reduce the market price of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of up to 61.1 million shares of our common stock are entitled to rights with respect to the registration of their shares under the Securities Act. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by affiliates, as defined in Rule 144 under the Securities Act. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the number of shares of our common stock reserved for issuance under our 2018 Stock Option and Incentive Plan automatically increased on January 1, 2020 and will automatically increase each January 1 thereafter by 4% of the number of shares of common stock outstanding on the immediately preceding December 31 or such lesser number of shares determined by our compensation committee. Our Compensation Committee elected not to increase the number of shares reserved for issuance under our 2018 Stock Plan on January 1, 2021. If our Compensation Committee elects to increase the number of shares available for future grant each year, our stockholders may experience additional dilution.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain of our employees, executive officers, and directors have entered or may enter into Rule 10b5-1 trading plans providing for sales of shares of our common stock from time to time. Under a Rule 10b5-1 trading plan, a broker executes trades pursuant to parameters established by the employee, director, or officer when entering into the plan, without further direction from the employee, officer, or director. A Rule 10b5-1 trading plan may be amended or terminated in some circumstances. Our employees, executive officers, and directors also may buy or sell additional shares outside of a Rule 10b5-1 trading plan when they are not in </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">possession of material, nonpublic information. To the extent that sales or other distributions of Moderna stock by our executive officers or directors are reported publicly, whether or not conducted under a 10b5-1 plan, such sales or distributions could lead to a decline in our stock price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Raising additional capital may cause dilution to our existing stockholders, restrict our operations, or require us to relinquish rights to our technologies or development candidates or investigational medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek additional capital through a combination of public and private equity offerings, debt financings, strategic alliances, and licensing arrangements. To the extent that we raise additional capital through the sale of equity or debt securities, your ownership interest will be diluted and the terms may include liquidation that adversely affect your rights as a stockholder. The incurrence of indebtedness would result in increased fixed payment obligations and could involve restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire or license IP rights, and other operating restrictions that could adversely impact our ability to conduct our business. If we raise additional funds through collaborations and alliances and licensing arrangements with third parties or through asset sales, we may have to relinquish valuable rights to our technologies or development candidates or investigational medicines, or grant licenses on terms unfavorable to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our principal stockholders and management own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers, directors, five percent stockholders, and their affiliates beneficially own approximately 21.1</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our outstanding common stock, as of February 16, 2021. Therefore, these stockholders will have the ability to influence us through their ownership positions. For example, these stockholders, acting together, may be able to exert significant influence over matters such as elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may believe are in your best interest as one of our stockholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in our amended and restated certificate of incorporation and by-laws, as well as provisions of Delaware law, could make it more difficult for a third party to acquire us or increase the cost of acquiring us, even if doing so would benefit our stockholders or remove our current management.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation, by-laws, and Delaware law contain provisions that may have the effect of delaying or preventing a change in control of us or changes in our management. Our amended and restated certificate of incorporation and amended and restated by-laws include provisions that:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize &#8220;blank check&#8221; preferred stock, which could be issued by our board of directors without stockholder approval and may contain voting, liquidation, dividend, and other rights superior to our common stock;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create a classified board of directors whose members serve staggered three-year terms;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specify that special meetings of our stockholders can be called only by our board of directors, the chairperson of our board of directors, our chief executive officer, or our president;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibit stockholder action by written consent;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that our directors may be removed only for cause;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specify that no stockholder is permitted to cumulate votes at any election of directors;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expressly authorize our board of directors to modify, alter, or repeal our amended and restated by-laws; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require supermajority votes of the holders of our common stock to amend specified provisions of our amended and restated certificate of incorporation and amended and restated by-laws.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of our amended and restated certificate of incorporation or amended and restated by-laws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our common stock.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any, will be your sole source of gain.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently intend to declare or pay cash dividends on our capital stock. We currently intend to retain all of our future earnings, if any, to finance the growth and development of our business. In addition, the terms of any future debt agreements may preclude us from paying dividends. As a result, capital appreciation, if any, of our common stock will be your sole source of gain </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the foreseeable future</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our amended and restated by-laws designate the Court of Chancery of the State of Delaware or the United States District Court for the District of Massachusetts as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our amended and restated by-laws, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware is the sole and exclusive forum for state law claims for (1) any derivative action or proceeding brought on our behalf, (2) any action asserting a claim of or based on a breach of a fiduciary duty owed by any of our current or former directors, officers, or other employees to us or our stockholders, (3) any action asserting a claim against us or any of our current or former directors, officers, employees, or stockholders arising pursuant to any provision of the Delaware General Corporation Law or our amended and restated by-laws, or (4) any action asserting a claim governed by the internal affairs doctrine (the Delaware Forum Provision). The Delaware Forum Provision will not apply to any causes of action arising under the Securities Act, or the Exchange Act. Our amended and restated by-laws further provide that the United States District Court for the District of Massachusetts is the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act (the Federal Forum Provision). We have chosen the United States District Court for the District of Massachusetts as the exclusive forum for such causes of action because our principal executive offices are located in Cambridge, Massachusetts. In addition, our amended and restated by-laws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our common stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize that the Delaware Forum Provision and the Federal Forum Provision may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware or the Commonwealth of Massachusetts, as applicable. Additionally, the forum selection clauses in our amended and restated by-laws may limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees, which may discourage the filing of lawsuits against us and our directors, officers, and employees, even though an action, if successful, might benefit our stockholders. While the Delaware Supreme Court ruled in March 2020 that federal forum selection provisions purporting to require claims under the Securities Act be brought in federal court are &#8220;facially valid&#8221; under Delaware law, there is uncertainty as to whether other courts will enforce our Federal Forum Provision. The Federal Forum Provision may also impose additional litigation costs on stockholders who assert that the provision is unenforceable or invalid, and if the Federal Forum Provision is found to be unenforceable, we may incur additional costs in resolving such matters. The Court of Chancery of the State of Delaware and the United States District Court for the District of Massachusetts may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General risk factors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unfavorable U.S. or global economic conditions could adversely affect our business, financial condition, or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations could be adversely affected by general conditions in the global economy and financial markets, including by the current COVID-19 pandemic, or any other health epidemic. The most recent global financial crisis caused extreme volatility and disruptions in the capital and credit markets. A severe or prolonged economic downturn, such as the most recent global financial crisis, could result in a variety of risks to our business, including weakened demand for our investigational medicines and our ability to raise additional capital when needed on favorable terms, if at all. A weak or declining economy could strain our suppliers, possibly resulting in supply disruption, or cause delays in payments for our services by third-party payors or our collaborators. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business and operations in the UK and EU may be negatively impacted by the United Kingdom&#8217;s withdrawal from the EU. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 23, 2016, the UK held a referendum in which a majority of voters approved an exit from the EU, or Brexit. After nearly three years of negotiation and political and economic uncertainty, the UK&#8217;s withdrawal from the EU became effective on January 31, 2020. There was a transitional period, during which EU laws, including pharmaceutical laws, continued to apply in the UK, however this </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended on December 31, 2020. The UK and EU have signed a EU-UK Trade and Cooperation Agreement, which became provisionally applicable on January 1, 2021 and will become formally applicable once ratified by both the UK and the EU. This agreement provides details on how some aspects of the UK and EU&#8217;s relationship regarding medicinal products will operate, particularly in relation to Good Manufacturing Practice, however there are still many uncertainties. The long-term effects of Brexit will depend in part on how the EU-UK Trade and Cooperation Agreement, and any future agreements signed by the UK and the EU, take effect in practice. Such a withdrawal from the EU is unprecedented, and it is unclear how the restrictions on the UK&#8217;s access to the European single market for goods, capital, services and labor within the EU and the wider commercial, legal and regulatory environment, could impact our current and future operations and clinical activities in the UK. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that, now the transition period has expired, Brexit could lead to legal uncertainty and potentially divergent national laws and regulations as the UK determines which EU laws to replicate or replace, including those related to the regulation of medicinal products. Any of these effects of Brexit, and others we cannot anticipate, could negatively impact our business and results of operations in the UK.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The uncertainty concerning the UK&#8217;s legal, political and economic relationship with the EU following Brexit may also be a source of instability in the international markets, create significant currency fluctuations, and/or otherwise adversely affect trading agreements or similar cross-border co-operation arrangements (whether economic, tax, fiscal, legal, regulatory or otherwise).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, principal investigators, and consultants may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk of fraud or other misconduct by our employees, principal investigators, and consultants. Misconduct by these parties could include intentional failures to comply with FDA regulations or the regulations applicable in the EU and other jurisdictions; provide accurate information to the FDA, the EMA, and other regulatory authorities; comply with healthcare fraud and abuse laws and regulations in the United States and abroad; or report financial information or data accurately or disclose unauthorized activities to us. Such misconduct also could involve the improper use of information obtained in the course of clinical trials or interactions with the FDA or other regulatory authorities, which could result in regulatory sanctions and cause serious harm to our reputation. Sales, marketing, and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing, and other abusive practices. These laws and regulations restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs, and other business arrangements. We have adopted a code of conduct applicable to all of our employees, but it is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from government investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, financial condition, results of operations, and prospects, including the imposition of significant fines or other sanctions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee litigation and unfavorable publicity could negatively affect our future business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our employees may, from time to time, bring lawsuits against us regarding injury, creating a hostile work place, discrimination, wage and hour disputes, sexual harassment, or other employment issues. In recent years there has been an increase in the number of discrimination and harassment claims generally. Coupled with the expansion of social media platforms and similar devices that allow individuals access to a broad audience, these claims have had a significant negative impact on some businesses. Certain companies that have faced employment- or harassment-related lawsuits have had to terminate management or other key personnel, and have suffered reputational harm that has negatively impacted their business. If we were to face any employment-related claims, our business could be negatively affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with environmental, health, and safety laws and regulations, we could become subject to fines or penalties or incur costs that could harm our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to numerous environmental, health, and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment, and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals and biological materials. Our operations also may produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We will not be able to eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from any use by us of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines and penalties for failure to comply with such laws and regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we maintain workers&#8217; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological or hazardous materials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may incur substantial costs in order to comply with current or future environmental, health, and safety laws and regulations. These current or future laws and regulations may impair our research, development, or production efforts. Our failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax law could adversely affect our business and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to evolving and complex tax laws in the jurisdictions in which it operates. The rules dealing with U.S. federal, state, and local and non-U.S. income taxation are constantly under review by persons involved in the legislative process and by tax authorities. Changes to tax laws (which changes may have retroactive application) could adversely affect us or holders of our common stock. In recent years, many such changes have been made and changes are likely to continue to occur in the future. Future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations. We urge investors to consult with their legal and tax advisers regarding the implications of potential changes in tax laws on an investment in our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the estimates we make, or the assumptions on which we rely, in preparing our consolidated financial statements prove inaccurate, our actual results may vary from those reflected in our projections and accruals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of our assets, liabilities, revenues, and expenses, the amounts of charges accrued by us and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. We cannot assure you, however, that our estimates, or the assumptions underlying them, will be correct.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The increasing use of social media platforms presents new risks and challenges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Social media is increasingly being used to communicate about our research, development candidates, investigational medicines, and the diseases our development candidates and investigational medicines are being developed to treat. Social media practices in the biopharmaceutical industry continue to evolve and regulations relating to such use are not always clear. This evolution creates uncertainty and risk of noncompliance with regulations applicable to our business, resulting in potential regulatory actions against us. For example, subjects may use social media channels to comment on their experience in an ongoing blinded clinical trial or to report an alleged adverse event. When such disclosures occur, there is a risk that we fail to monitor and comply with applicable adverse event reporting obligations or we may not be able to defend our business or the public&#8217;s legitimate interests in the face of the political and market pressures generated by social media due to restrictions on what we may say about our development candidates and investigational medicines. There is also a risk of inappropriate disclosure of sensitive information or negative or inaccurate posts or comments about us on any social networking website. If any of these events were to occur or we otherwise fail to comply with applicable regulations, we could incur liability, face regulatory actions, or incur other harm to our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred and will continue to incur increased costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives. We are subject to financial reporting and other requirements for which our accounting and other management systems and resources may not be adequately prepared.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we incur significant legal, accounting, and other expenses that we did not incur as a private company. In addition, the federal securities laws, including the Sarbanes-Oxley Act of 2002 and rules subsequently implemented by the SEC and Nasdaq have imposed various requirements on public companies, including requirements to file annual, quarterly, and event driven reports with respect to our business and financial condition, and to establish and maintain effective disclosure and financial controls and corporate governance practices. Our management and other personnel devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations increase our legal and financial compliance costs and make some activities more time consuming and costly. For example, these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance. We may not be able to produce reliable financial statements or file these financial statements as part of a periodic report in a timely manner with the SEC or comply with the Nasdaq listing requirements. In addition, we could make errors in our financial statements that could require us to restate our financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404, we are required to furnish a report by our management on our internal control over financial reporting, including an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. However, while we were an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act, our auditors were not required to formally attest to the effectiveness of our internal control over financial reporting. As of the end of our fiscal year ended December 31, 2019, we qualified as a &#8220;large accelerated filer&#8221; as defined in the </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">160</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities Exchange Act of 1934, as amended, or the Exchange Act and, as a result, ceased to qualify as an emerging growth company. Accordingly, commencing with our Annual Report on Form 10-K for the year ended December 31, 2019, we were required to have our auditors formally attest to the effectiveness of our internal control over financial reporting pursuant to Section 404. Our compliance with Section 404 necessitates that we incur substantial accounting expense and expend significant management efforts. We will continue to dedicate internal resources, potentially engage outside consultants, and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented, and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude within the prescribed timeframe that our internal control over financial reporting is effective as required by Section 404. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_73"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B - Unresolved Staff Comments</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_76"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Properties</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two campuses in Massachusetts. We occupy a campus in Technology Square near the Kendall Square area in Cambridge, MA with a mix of offices and research laboratory space totaling approximately 175,000 square feet. Kendall Square is the location of our corporate headquarters, platform, drug discovery, manufacturing process development, and clinical development. Our facilities in Kendall Square are leased with the majority of the space being leased through 2029, with the option to extend.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a manufacturing facility in Norwood, MA, Moderna Technology Center (MTC). The campus is comprised of two buildings (MTC South and MTC North). MTC South is approximately 200,000 square feet, with a production capacity of over 100 cGMP lots per year. MTC North is approximately 240,000 square feet and provides lab and office space, directly supporting improvement in our manufacturing capabilities. MTC South is leased through 2032 and we have the option to extend it for two ten-year terms. MTC North is leased into early 2031 and we have the option to extend it for up to four additional five-year terms. </span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_79"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Legal Proceedings</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently a party to any material legal proceedings.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_82"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_88"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market for Our Common Stock</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock began trading on the Nasdaq Global Select Market under the symbol &#8220;MRNA&#8221; on December 7, 2018. Prior to that time, there was no public market for our common stock. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Performance Graph</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following performance graph shall not be deemed &#8220;soliciting material&#8221; or to be &#8220;filed&#8221; with the Securities and Exchange Commission for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any filing of Moderna, Inc. under the Securities Act or the Exchange Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph shows a comparison from December 7, 2018, the date on which our common stock first began trading on the Nasdaq Global Select Market, through December 31, 2020 of the cumulative total return for our common stock, the Nasdaq Composite Total Return Index and the Nasdaq Biotechnology Index, each of which assumes an initial investment of $100 and reinvestment of all dividends. Such returns are based on historical results and are not intended to suggest future performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparisons shown in the graph below are based upon historical data. We caution that the stock price performance shown in the graph below is not necessarily indicative of, nor is it intended to forecast, the potential future performance of our common stock. </span></div><div><span><br/></span></div><div style="text-align:center"><img src="mrna-20201231_g46.jpg" alt="mrna-20201231_g46.jpg" style="height:401px;margin-bottom:5pt;vertical-align:text-bottom;width:596px"/></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholders</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had approximately 74 stockholders of record as of February 16, 2021; however, because many of our outstanding shares are held in accounts with brokers and other institutions, we believe we have more beneficial owners. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our common stock and do not expect to pay dividends on our common stock for the foreseeable future. Instead, we anticipate that all of our earnings in the foreseeable future will be used for the operation and growth of our business. Any future determination to pay dividends will be made at the discretion of our board of directors and will depend on various factors, including applicable laws, our results of operations, financial condition, future prospects, then applicable contractual restrictions and any other factors deemed relevant by our board of directors. Investors should not purchase our common stock with the expectation of receiving cash dividends.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">Securities Authorized for Issuance Under Equity Compensation Plans</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about our equity compensation plans in Item 12 of Part III of this Annual Report on Form 10-K is incorporated herein by reference.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">Recent Sales of Unregistered Securities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_91"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Reserved</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_94"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Annual Report on Form 10-K. Some of the information contained in this discussion and analysis or set forth elsewhere in this Annual Report on Form 10-K, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in &#8220;Part I, Item 1A - Risk Factors&#8221; section of this Annual Report on Form 10-K, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines to improve the lives of patients. mRNA medicines are designed to direct the body&#8217;s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Our platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing us the capability to pursue in parallel a robust pipeline of new development candidates.&#160;We are developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune diseases and cardiovascular diseases, independently and with our strategic collaborators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our platform, we develop technologies that enable the development of mRNA medicines for diverse applications. When we identify technologies that we believe could enable a new group of potential mRNA medicines with shared product features, we call that group a &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">modality.&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the programs within a modality may target diverse diseases, they share similar mRNA technologies, delivery technologies, and manufacturing processes to achieve shared product features. The programs within a modality will also generally share similar pharmacology profiles, including the desired dose response, the expected dosing regimen, the target tissue for protein expression, safety and tolerability goals, and pharmaceutical properties. Programs within a modality often have correlated technology risk, but because they pursue diverse diseases they often have uncorrelated biology risk. We have created six modalities to date:</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">prophylactic vaccines;</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">systemic secreted and cell surface therapeutics;</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">cancer vaccines;</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">intratumoral immuno-oncology;</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">localized regenerative therapeutics; and</span></div><div style="padding-left:40.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">systemic intracellular therapeutics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have designated our prophylactic vaccines and systemic secreted and cell surface therapeutics modalities as our &#8220;core modalities&#8221;. In these core modalities, our strategy is to invest in additional development candidates using our accumulated innovations in technology, our process insights and our preclinical and clinical experience. Our exploratory modalities continue to be a critical part of advancing our strategy to maximize the application of our potential mRNA medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Business Highlights </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We brought five new development candidates forward in 2020: a COVID-19 vaccine (mRNA-1273); interleukin-2 (IL-2); programmed death-ligand 1 (PD-L1); a pediatric Respiratory Syncytial Virus (RSV) vaccine; and an Epstein-Barr Virus (EBV) vaccine, as part of our mission to use our technology to advance global public health. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the global coronavirus pandemic, we are pursuing the rapid development and manufacture of our mRNA-1273 vaccine, for the treatment of SARS-CoV-2, the novel strain of coronavirus that causes COVID-19, in collaboration with the Vaccine Research Center and Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases, or NIAID, part of the National Institutes of Health, or NIH. The progress of mRNA-1273 during 2020 has resulted in the need for us to devote significant resources toward the development and manufacture of this product. Significant capital investment is necessary for ongoing clinical development, manufacturing and distribution of the COVID-19 vaccine at a scale necessary to meet demand in a global pandemic environment. This capital investment includes the ongoing clinical development for updated versions of the COVID-19 vaccine that may provide continued protection against variants of the SARS-CoV-2 virus. BARDA has committed to fund up to $954.9 million to accelerate the clinical development and manufacturing process scale-up of our COVID-19 vaccine. Under the terms of the agreement, BARDA will fund the advancement of mRNA-1273 to FDA licensure and the scale-up of manufacturing processes. The agreement does not contemplate any product stockpiling.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">164</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February and May 2020, we completed two separate public equity offerings, resulting in aggregate net proceeds of $1.85 billion, net of underwriting discounts, commissions and offering expenses. This additional funding has enabled us to substantially expand our manufacturing network, purchase the required capital equipment, hire appropriate global staff and secure the raw materials and other consumables to manufacture substantial doses of our COVID-19 vaccine.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and an Interim Order from Health Canada authorizing our COVID-19 vaccine for use in the U.S. and Canada.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2021, we have received additional provisional, interim or conditional approvals for the use and distribution of our COVID-19 vaccine from regulatory authorities in the European Union, the United Kingdom, Switzerland, Qatar, Israel and Singapore</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, we entered into a supply agreement with the U.S. Government (the U.S. Supply Agreement) for the supply of 100 million doses of our COVID-19 vaccine. The agreement was subsequently amended in December 2020, in connection with the U.S. Government's exercise of an option for an additional 100 million doses, bringing the total to 200 million doses of our COVID-19 vaccine for a total consideration of up to $3.19 billion. The total consideration includes approximately $300.0 million of incentive payments which we earned as a result of securing an Emergency Use Authorization (EUA) before January 31, 2021. As a result of our satisfying the requirements for this incentive payment, the total price for the supply of the first 100 million doses, inclusive of the $300.0 million incentive, is $1.53 billion. We will receive such incentive payments as product is delivered to and accepted by the U.S. Government. Pursuant to the U.S. Supply Agreement, the U.S. Government made a $601.4 million upfront payment to us which represents approximately 50% of the fixed price per dose that we are entitled to receive for the committed first 100 million doses. We will receive the remainder of the fixed price per dose upon delivery and acceptance of contracted doses to the U.S. Government. We are required to secure, manage and maintain storage for any contracted doses of mRNA-1273 based on the specific requirements of the contract and deliver the product to designated government facilities. We will be reimbursed for such services at a negotiated price. Subsequent to December 31, 2020, the U.S. Government exercised a second option to purchase 100 million doses on February 11, 2021, bringing its total order to 300 million doses, with a remaining option for 200 million doses. The price for each option is fixed at a price of $1.65 billion per 100 million doses. The U.S. Supply Agreement contains terms and conditions that are customary for U.S. Government agreements of this nature, including provisions giving the U.S. Government the right to terminate the agreement if the applicable Contracting Officer determines that a termination is in the U.S. Government&#8217;s interest. Following any such termination, we and the U.S. Government may agree upon the amount to be paid or remaining to be paid to us because of the termination. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have entered into supply agreements with several other governmental agencies outside the United States for the supply of our COVID-19 vaccine. The agreements are generally subject to receipt of authorization or approval for the use and distribution of the vaccine from the relevant regulatory authority in each jurisdiction. Under these agreements, we are entitled to upfront deposits for our COVID-19 vaccine supply, initially recorded as deferred revenue. As of December 31, 2020, we had approximately $3.80 billion in deferred revenue in connection with the supply agreements with the U.S. Government and other governmental agencies, which will be recognized as revenue when revenue recognition criteria have been met. Between the granting of the EUA by the FDA on December 18, 2020 and the end of 2020, we delivered 12.8 million doses of our COVID-19 vaccine and recognized product sales of $199.9 million. In addition, we delivered 4.0 million doses of our COVID-19 vaccine to the U.S. government under the BARDA agreement through December 31, 2020, for a total of nearly 17 million doses delivered to the U.S. government and Canada between receipt of our EUA authorization and the end of the year and satisfying the criteria for revenue recognition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on our strategic priorities for 2021, please see &#8220;Business&#8212;The mRNA Opportunity&#8212;Our strategic priorities,&#8221; above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The early investment we made in our manufacturing and digital capabilities prepared us to rapidly scale our production to accommodate between 700 million doses and 1 billion doses of our COVID-19 vaccine in 2021. We are continuing to invest and add staff to build up to potentially 1 billion doses for 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have a diverse development pipeline, and the broad potential applications of mRNA medicines have led us to raise significant capital and adopt a long-term approach to capital allocation that balances near-term risks and long-term value creation. As of December 31, 2020, we had cash, cash equivalents and investments of approximately $5.25&#160;billion, of which $82.1 million was related to product sales and $2.84 billion was related to customer deposits for the future supply of our COVID-19 vaccine. We use this capital to fund operations and investing activities for technology creation, drug discovery and clinical development programs, infrastructure and capabilities to enable our research engine and early development engine (which includes our Moderna Technology Center), our digital infrastructure, creation of our portfolio of intellectual property, acquisition of key raw materials and supplies to support our commercial production quantities, development of a commercial team, expansion into global markets and administrative support.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have incurred significant operating losses. Our net losses were $747.1&#160;million, $514.0&#160;million and $384.7&#160;million for the years ended December 31, 2020, 2019 and 2018, respectively. As of December 31, 2020, our accumulated deficit was $2.24&#160;billion. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the foreseeable future</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we may continue to incur significant expenses in connection with our ongoing activities, including as we:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue our platform research and drug discovery and development efforts;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conduct clinical trials for our investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacture our COVID-19 vaccine;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacture clinical trial materials and develop large-scale manufacturing capabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek regulatory approval for our investigational medicines;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain, expand, and protect our intellectual property;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hire additional personnel to support our program development effort to obtain regulatory approval and secure additional facilities for operations; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">build up our commercial operations and organization; and </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue to operate as a public company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we seek to obtain regulatory approval for and commercialize further of our investigational medicines, we expect to incur significant commercialization expenses, which include establishing a sales, marketing, manufacturing, and distribution infrastructure globally. As a result, we may need substantial additional funding to support our continued operations and pursue our growth strategy in addition to our product sales. If we fail to become profitable or are unable to sustain profitability on a continuing basis, we may be required to finance our operations through a combination of public or private equity offerings, structured financings and debt financings, government funding arrangements, strategic alliances and marketing, manufacturing, distribution, and licensing arrangements. We may not be able to raise additional funds or enter into such other agreements on favorable terms, or at all. If we fail to raise capital or enter into such agreements as, and when, needed, we may have to significantly delay, scale back, or discontinue the development and commercialization of one or more of our programs. Because of the numerous risks and uncertainties associated with pharmaceutical development, we are unable to predict the timing or amount of expenses or when or if we will be able to achieve or maintain profitability. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic impacted certain of our business operations. For instance, we are experiencing disruptions in the conduct of certain of our clinical trials, including our ability to initiate and complete our clinical trials within the originally anticipated timelines. Site initiation, participant recruitment and enrollment, participant dosing, distribution of clinical trial materials, study monitoring and data analysis may or continue to be paused or delayed. While to date we have not experienced significant disruptions in our supply chain and distribution, an extended duration of this pandemic could result in such disruptions in the future. </span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_97"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Operations Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue for each period presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:47.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began to record product sales for our COVID-19 vaccine subsequent to its authorization for emergency use by the FDA and Health Canada in December 2020. For the year ended December 31, 2020, we recognized $199.9&#160;million of product sales from sales of our COVID-19 vaccine. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than product sales, our revenue has been primarily derived from government-sponsored and private organizations including BARDA, DARPA and the Gates Foundation and from strategic alliances with AstraZeneca, Merck and Vertex to discover, develop, and commercialize potential mRNA medicines.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes collaboration revenue for the periods presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total grant revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,905&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,556&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grant revenue from BARDA increased significantly in 2020, as a result of an award to accelerate development of our COVID-19 vaccine. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes collaboration revenue for the periods presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:47.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total collaboration revenue</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,618&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,036&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,512&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our product sales to significantly increase in 2021. As of December 31, 2020, we had signed supply agreements of approximately $11.65 billion for the future supply of our COVID-19 vaccine and had deferred revenue of $3.80&#160;billion associated with customer deposits received or billable under these agreements. Additional supply agreements have been agreed upon since December 31, 2020, and others are under discussion for 2021 and 2022 deliveries. In addition, we expect to continue to receive funding from our contract with BARDA. As of December 31, 2020, the remaining available funding net of revenue earned was $444.3&#160;million. To the extent that existing or potential future products generate revenue, our revenue may vary due to many uncertainties in the independent development of our mRNA medicines and pursuant to our strategic alliances and other factors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to incur significant expenses as we continue our research and development and commercialization efforts. We expect our programs to mature and advance to later stage clinical development, and we expect expenses to increase as we seek regulatory approvals for our investigational medicines and commercialize any approved mRNA medicines. If we fail to become profitable or are unable to sustain profitability on a continuing basis, we may incur losses in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of Sales includes raw materials, personnel and facility and other costs associated with manufacturing our commercial product. These costs include production materials, production costs at our manufacturing facilities, third-party manufacturing costs, and final formulation and packaging costs. Cost of Sales also includes shipping costs and royalties payable to third parties based on sales of our products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nature of our business and primary focus of our activities generate a significant amount of research and development costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses represent costs incurred by us for the following:</span></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">cost to develop our platform;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">discovery efforts leading to development candidates;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">preclinical, nonclinical, and clinical development costs for our programs;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">costs related to pre-launch inventory;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">cost to develop our manufacturing technology and infrastructure; and</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">digital infrastructure costs.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs above comprise the following categories:</span></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">personnel-related expenses, including salaries, benefits, and stock-based compensation expense;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">expenses incurred under agreements with third parties, such as consultants, investigative sites, contract research organizations, or CROs, that conduct our preclinical studies and clinical trials, and in-licensing arrangements;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">expenses associated with developing manufacturing capabilities and acquiring materials for preclinical studies, clinical trials and pre-launch inventory, including both internal manufacturing and third-party contract manufacturing organizations, or CMOs;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">expenses incurred for the procurement of materials, laboratory supplies, and non-capital equipment used in the research and development process; and</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">facilities, depreciation, and amortization, and other direct and allocated expenses incurred as a result of research and development activities.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our employee and infrastructure resources for the advancement of our platform, and for discovering and developing programs. Due to the number of ongoing programs and our ability to use resources across several projects, indirect or shared operating costs incurred for our research and development programs are generally not recorded or maintained on a program- or modality-specific basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects our research and development expenses, including direct program specific expenses summarized by modality and indirect or shared operating costs summarized under other research and development expenses during the years ended December 31, 2020, 2019 and 2018 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:60.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Program expenses by modality:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prophylactic vaccines</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">707,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancer vaccines</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intratumoral immuno-oncology</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systemic secreted and cell surface therapeutics</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Localized regenerative therapeutics</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systemic intracellular therapeutics</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total program-specific expenses by modality</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767,834&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other research and development expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discovery programs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,601&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,376&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Platform research</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technical development and unallocated manufacturing expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shared discovery and development expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expenses</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370,339&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,309&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454,082&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Includes a total of 21 development candidates at each of December 31, 2020, 2019 and 2018. Program-specific expenses include external costs and allocated manufacturing costs of pre-launch inventory, mRNA supply and consumables, and are reflected as of the beginning of the period in which the program was internally advanced to development or removed if development was ceased.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">Relates to an in-licensing agreement entered into in June 2017 with Cellscript, LLC to sublicense certain patent rights.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8220;modality&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> refers to a group of programs with common product features and the associated combination of enabling mRNA technologies, delivery technologies, and manufacturing processes. The program-specific expenses by modality summarized in the table above include expenses we directly attribute to our programs, which consist primarily of external costs, such as fees paid to outside consultants, central laboratories, investigative sites, and CROs in connection with our preclinical studies and clinical trials, CMOs, and allocated manufacturing costs of pre-launch inventory, mRNA supply and consumables. Costs to acquire and manufacture pre-launch inventory, mRNA supply for preclinical studies and clinical trials are recognized and included in unallocated manufacturing expenses when incurred, and subsequently allocated to program-specific manufacturing costs after completion of the program-specific production. The timing of allocating manufacturing costs to the specific program varies depending on the program </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development and production schedule. We generally do not allocate personnel-related costs, including stock-based compensation, costs associated with our general platform research, technical development, and other shared costs on a program-specific basis. These costs were therefore excluded from the summary of program-specific expenses by modality. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discovery program expenses are costs associated with research activities for our programs in the preclinical discovery stage, and primarily consist of external costs for CROs and lab services, and allocated manufacturing cost of preclinical mRNA supply and consumables.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Platform research expenses are mainly costs to develop technical advances in mRNA science, delivery science, and manufacturing process design. These costs include personnel-related costs, computer equipment, facilities, preclinical mRNA supply and consumables, and other administrative costs to support our platform research. Technology development and unallocated manufacturing expenses are primarily related to non-program-specific manufacturing process development and manufacturing costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shared discovery and development expenses are research and development costs such as personnel-related costs and other costs, which are not otherwise included in development programs, discovery programs, platform research, technical development and unallocated manufacturing expenses, stock-based compensation, and other expenses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The largest component of our total operating expenses has historically been our investment in research and development activities, including development of our platform, mRNA technologies, and manufacturing technologies. We expense research and development costs as incurred and cannot reasonably estimate the nature, timing, and estimated costs required to complete the development of the development candidates and investigational medicines we are currently developing or may develop in the future. There are numerous risks and uncertainties associated with the research and development of such development candidates and investigational medicines, including, but not limited to:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">scope, progress, and expense of developing ongoing and future development candidates and investigational medicines;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">entry in and completion of related preclinical studies;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enrollment in and completion of subsequent clinical trials;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safety and efficacy of investigational medicines resulting from these clinical trials;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in laws or regulations relevant to the investigational medicines in development;</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">receipt of the required regulatory approvals; and</span></div><div style="padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commercialization, including establishing manufacturing and marketing capabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to progress mRNA-1273 through the development process toward a Biologics License Application approval and indication expansion of mRNA-1273 during the current pandemic, we expect to continue to incur significant additional expenses. At this time, the magnitude of these potential expenditures is not known. In connection with the BARDA agreement to accelerate development of mRNA-1273, significant grant revenue and expenses are expected in 2021. BARDA's funding is expected to offset those expenses that are covered under the BARDA agreement, subject to our obtaining reimbursement from BARDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in expectations or outcomes of any of the known or unknown risks and uncertainties may materially impact our expected research and development expenditures. Continued research and development is central to the ongoing activities of our business. Investigational medicines in later stages of clinical development, such as our CMV vaccine (mRNA-1647) and our COVID-19 vaccine, generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. We expect our research and development costs to continue to increase in the foreseeable future as our investigational medicines progress through the development phases and identify and develop additional programs. There are numerous factors associated with the successful commercialization of any of our investigational medicines, including future trial design and various regulatory requirements, many of which cannot be determined with accuracy at this time due to the early stage of development of our investigational medicines. Moreover, future commercial and regulatory factors beyond our control will impact our clinical development programs and plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We started to incur sales and marketing expenses in the fourth quarter of 2020 to prepare for commercial operations in connection with the sale of our COVID-19 vaccine. Selling, general and administrative expenses consist primarily of personnel-related costs, including stock-based compensation, for executives, finance, legal, human resources, business development and other administrative and operational functions, professional fees, accounting and legal services, information technology and facility-related costs, and expenses associated with obtaining and maintaining intellectual property, or IP. These costs relate to the operation of the business, unrelated to the research and development function, or any individual program. Selling, general and administrative expenses, including IP-related expenses, totaled $188.3 million, $109.6 million and $94.3 million for the years ended December 31, 2020, 2019 and 2018, respectively. IP-related expenses, including our internal personnel-related costs, were $13.5 million, $13.4&#160;million and $11.9&#160;million, for the years ended December 31, 2020, 2019 and 2018, respectively.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate selling, general and administrative expenses will increase as we continue to expand the number of programs in development and prepare for the establishment of commercial activities both within and outside the United States. We have already incurred additional expenses related to building out a regulatory, sales and marketing team to support the sale, marketing and distribution of our COVID-19 vaccine. If we obtain regulatory approval for any of our investigational medicines, and do not enter into one or more third-party commercialization collaboration and manufacturing arrangements, we will incur significant additional expenses related to building out these functions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a broad IP portfolio covering our development and commercialization of mRNA vaccine and therapeutic programs, including those related to mRNA design, formulation, and manufacturing platform technologies. We regularly file patent applications to protect innovations arising from our research and development. We also hold trademarks and trademark applications in the United States and foreign jurisdictions. Costs to secure and defend our IP are expensed as incurred, and are classified as selling, general and administrative expenses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists of interest generated from our investments in cash and cash equivalents, money market funds, and high-quality fixed income securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other expense, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net consists of interest expense, gains (losses) from the sale of investments in marketable securities, and other income and expense unrelated to our core operations. Interest expense is primarily derived from our finance leases related to our Moderna Technology Center manufacturing facility, or MTC South, and Moderna Technology Center North, or MTC North.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting policies and significant judgments and estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make judgments and estimates that affect the reported amounts of assets, liabilities, revenues, and expenses and the disclosure of contingent assets and liabilities in our consolidated financial statements. We base our estimates on historical experience, known trends and events, and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. On an ongoing basis, we evaluate our judgments and estimates in light of changes in circumstances, facts, and experience. The effects of material revisions in estimates, if any, are reflected in the consolidated financial statements prospectively from the date of change in estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our significant accounting policies are described in more detail in the notes to our consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K, we believe the following accounting policies used in the preparation of our </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements require the most significant judgments and estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue recognition</span></div><div><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Product Sales </span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales are associated with our COVID-19 vaccine supply agreements with the U.S. Government and international government agencies. These agreements generally do not provide provisions for various forms of variable consideration, such as discounts, rebates or returns. We recognize revenue from product sales, using the five-step model under ASC 606, based on the fixed price per dose according to the contracts when control of the product transfers to the customer and customer acceptance has occurred, unless such acceptance provisions are deemed perfunctory. </span></div><div style="padding-right:9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaboration Revenue </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our alliances with strategic collaborators typically contain multiple elements, including research and other licenses, options to obtain development and commercialization rights, research and development services, obligations to develop and manufacture preclinical and clinical material, and options to obtain additional research and development services and preclinical and clinical material. Such arrangements provide for various types of payments to us, including upfront fees, funding of research and development services and preclinical and clinical material, technical, development, regulatory, and commercial milestone payments, licensing fees, option exercise fees, and royalty and earnout payments on product sales. Such payments are often not commensurate with the timing of revenue recognition and therefore result in deferral of revenue recognition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We analyze our collaboration arrangements to assess whether they are within the scope of Accounting Standards Codification ASC Topic 808,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 808), to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards that are dependent on the commercial success of such activities.&#160;If we conclude that some or all aspects of the arrangement are within the scope of ASC 808 and do not represent a transaction with a customer, we recognize our allocation of the shared costs incurred with respect to the jointly conducted activities as a component of the related expense in the period incurred. If we conclude that some or all aspects of the arrangement represent a transaction with a customer, we account for those aspects of the arrangement within the scope of ASC 606 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Revenue from Contracts with Customers)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the appropriate amount of revenue to be recognized for arrangements that we determine are within the scope of ASC 606, we perform the following steps: (i) identify the contract(s) with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) each performance obligation is satisfied. ASC 606 requires significant judgment and estimates and results in changes to, but not limited to: (i) the determination of the transaction price, including estimates of variable consideration, (ii) the allocation of the transaction price, including the determination of estimated selling price, and (iii) the pattern of recognition, including the application of proportional performance as a measure of progress on service-related promises and application of point-in-time recognition for supply-related promises.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is generally comprised of an upfront payment due at contract inception and variable consideration in the form of payments for our services and materials and milestone payments due upon the achievement of specified events. Other payments the Company could be entitled to include tiered royalties earned when customers recognize net sales of licensed products.&#160;We consider the existence of any significant financing component within our arrangements and have determined that a significant financing component does not exist in our arrangements as substantive business purposes exist to support the payment structure other than to provide a significant benefit of financing. We measure the transaction price based on the amount of consideration to which we expect to be entitled in exchange for transferring the promised goods and/or services to the customer. We utilize either the expected value method or the most likely amount method to estimate the amount of variable consideration, depending on which method is expected to better predict the amount of consideration to which we will be entitled. Amounts of variable consideration are included in the transaction price to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.&#160;With respect to arrangements that include payments for a development or regulatory milestone payment, we evaluate whether the associated event is considered probable of achievement and estimate the amount to be included in the transaction price using the most likely amount method. Milestone payments that are not within our control or the licensee, such as those dependent upon receipt of regulatory approval, are not considered to be probable of achievement until the triggering event occurs. At the end of each reporting period, we re-evaluate the probability of achievement of each milestone and any related constraint, and if necessary, adjust our estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment. For arrangements that include sales-based royalties, including milestone payments based upon the achievement of a certain level of product sales, wherein the license is deemed to be the sole or predominant item to which the payments relate, we recognize revenue upon the later of: (i) when the related sales occur or (ii) when the performance obligation to which some or all of the payment has been allocated has been satisfied (or partially satisfied). Consideration that would be received for optional goods and/or services is excluded from the transaction price at contract inception.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allocate the transaction price to each performance obligation based on a relative standalone selling price basis. We develop assumptions that require judgment to determine the standalone selling price for each performance obligation in consideration of applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated research and development costs. However, in certain instances, we allocate variable consideration entirely to one or more performance obligation if the terms of the variable consideration relate to the satisfaction of the respective performance obligation and the amount allocated is consistent with the amount we would expect to receive for the satisfaction of the respective performance obligation.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue based on the amount of the transaction price that is allocated to each respective performance obligation when or as the performance obligation is satisfied by transferring a promised good or service to the customer. For performance obligations that are satisfied at a point in time, we recognize revenue when control of the goods and/or services is transferred to the customer. For performance obligations that are satisfied over time, we recognize revenue by measuring the progress toward complete satisfaction of the performance obligation using a single method of measuring progress which depicts the performance in transferring control of the associated goods and/or services to the customer. We generally use input methods to measure the progress toward the complete satisfaction of performance obligations satisfied over time. With respect to arrangements containing a license to our intellectual property that is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from amounts allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, we utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. Significant management judgment is required in determining the level of effort required under an arrangement and the period over which we are expected to complete our performance obligations under an arrangement. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prelaunch Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to an initial regulatory approval for our investigational medicines, we expense costs relating to raw materials and production of inventory as research and development expense in our consolidated statements of operations, in the period incurred. When we believe regulatory approval and subsequent commercialization of our investigational medicines is probable, and we also expect future economic benefit from the sales of the investigational medicines to be realized, we will then capitalize the costs of production as inventory. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the authorization of distribution and use of our COVID-19 vaccine under an EUA in December 2020, we began to capitalize inventory costs associated with our COVID-19 vaccine, as it was determined that inventory costs incurred subsequent to the EUA had a probable future economic benefit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the process of preparing our financial statements, we are required to estimate our accrued research and development expenses, a significant portion of which are clinical study expenses conducted by third-party service providers. This process involves reviewing open contracts and purchase orders, communicating with our personnel to identify services that have been performed on our behalf, and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of the actual cost. The majority of our service providers invoice us in arrears for services performed or when contractual milestones are met. Examples of estimated accrued research and development expenses include fees paid to:</span></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">CROs to conduct our clinical trials;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">investigative sites in connection with clinical trials;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">vendors for laboratory services, supplies, and distribution of materials in connection with clinical trials; and</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">vendors in connection with preclinical development activities.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our expenses related to clinical trials on our estimates of the services received and efforts expended pursuant to contracts with CROs that conduct and manage clinical trials on our behalf. The financial terms of these contracts are subject to negotiation, vary from contract to contract and may result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the expense. Payments under some of these contracts depend on factors such as the successful enrollment of subjects and the completion of clinical trial milestones. In accruing service fees, we estimate the time period over which services will be performed and the level of effort to be expended in each period and adjust accordingly.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make estimates of our research and development accrued expenses as of each balance sheet date in our financial statements based on facts and circumstances known to us at that time. We recognize costs for certain development activities based on an evaluation of the progress to completion of specific tasks using information and data provided to us by our vendors and our clinical sites, such as number of sites activated, number of patient enrollments and visits, and patient duration. We determine accrual estimates through financial models that take into account discussions with applicable personnel and service providers as to the progress or state of completion of trials. We periodically confirm the accuracy of these estimates with the service providers and make adjustments, if necessary. Upon settlement, these costs may differ materially from the amounts accrued in our consolidated financial statements. Our historical accrual estimates have not been materially different from our actual costs. However, due to the nature of estimates, we </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cannot provide assurance that we will not make changes to our estimates in the future as we become aware of additional information about the status or conduct of our research activities and clinical trials.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issue stock-based awards to employees and non-employees, generally in the form of stock options and restricted stock units. We measure and recognize compensation expense for our stock-based awards granted to our employees and non-employee directors based on the estimated grant date fair value in accordance with&#160;ASC 718,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock-based awards are subject to either service or performance-based vesting conditions. We recognize compensation expense related to awards to employees and non-employee directors with service-based vesting on a straight-line basis based on the grant date fair value over the requisite service period, which is generally the vesting period. Compensation expense related to awards to employees and non-employee directors with performance-based vesting conditions is recognized based on the grant date fair value over the requisite service period using an accelerated attribution method to the extent the achievement of the performance condition is probable. We made an accounting policy election to recognize forfeitures of stock-based awards as they occur. We classify stock-based compensation expense in our consolidated statements of operations in the same manner in which the award recipient&#8217;s salary and related costs are classified or in which the award recipient&#8217;s service payments are classified.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of restricted stock and restricted stock units, based on the fair value of our common stock. We estimate the fair value of our stock options using the Black-Scholes option pricing model, which requires inputs of subjective assumptions, including: (i)&#160;the expected volatility of our stock; (ii)&#160;the expected term of the award; (iii)&#160;the risk-free interest rate; (iv)&#160;expected dividends; and (v)&#160;the fair value of common stock. Due to the lack of company specific historical and implied volatility data, we based our estimate of expected volatility on the estimate and expected volatilities of a guideline group of publicly traded companies. For these analyses, we select companies with comparable characteristics to ours including enterprise value, risk profiles, and with historical share price information sufficient to meet the expected life of the stock-based awards. We compute the historical volatility data using the daily closing prices for the selected companies&#8217; shares during the equivalent period of the calculated expected term of our stock-based awards. We will continue to apply this process until a sufficient amount of historical information regarding the volatility of our own stock price becomes available. We estimate the expected term of our stock options granted to employees and non-employee directors using the simplified method, whereby, the expected term equals the average of the vesting term and the original contractual term of the option. We utilize this method as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. For stock options granted to non-employees, we utilize the contractual term of the option as the basis for the expected term assumption. For the determination of the risk-free interest rates we utilize the U.S. Treasury yield curve for instruments in effect at the time of measurement with a term commensurate with the expected term assumption. The expected dividend yield is assumed to be zero as we have never paid dividends and do not have current plans to pay any dividends on our common stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes based on an asset and liability approach. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. We determine our deferred tax assets and liabilities based on differences between financial reporting and tax bases of assets and liabilities, which are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Realization of our deferred tax assets is dependent upon the generation of future taxable income, the amount and timing of which are uncertain. Valuation allowances are provided, if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of December 31, 2020, we continued to maintain a full valuation allowance against all of our deferred tax assets based on management&#8217;s evaluation of all available evidence, including our history of incurring significant losses from operations. We will continue to monitor the realizability of our deferred tax assets as we may generate profits in 2021 if we are able to fulfill our obligations under the supply agreements for our COVID-19 vaccine. We</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> may release all or a portion of the valuation allowance in the near-term; however, the release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, our level of profitability, revenue growth, clinical program progression and expectations regarding future profitability. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may become subject to income tax audits and adjustments by local tax authorities. The nature of uncertain tax positions is subject to significant judgment by management and subject to change, which may be substantial. We develop our assessment of uncertain tax positions, and the associated cumulative probabilities, using internal expertise and assistance from third-party experts. As additional information becomes available, estimates are revised and refined. Differences between estimates and final settlement may occur resulting in additional tax expense. We record reserves for potential tax payments to various tax authorities related to uncertain tax positions. These reserves are based on a determination of whether and how much of a tax benefit taken by us in our tax filings or positions is more likely than not to be realized following resolution of any potential contingencies present related to the tax benefit. Potential interest and penalties associated with such uncertain tax positions is recorded as a component of income tax expense. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently issued accounting pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reviewed all recently issued standards and have determined that such standards will not have a material impact on our financial statements or do not otherwise apply to our operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our consolidated statements of operations for each period presented (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change 2020 vs. 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,905&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Expenses:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874,030&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566,539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605,929&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960,610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763,144)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(545,720)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217,424)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,815)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,084)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744,513)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,716)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229,797)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(467)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747,064)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,021)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,043)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change 2019 vs. 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(383)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,476)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,209&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,068&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,859)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Expenses:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605,929&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,334&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,595&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(545,720)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413,266)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132,454)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before (benefit from) provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,716)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384,408)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,308)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Benefit from) provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,021)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,021)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384,734)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,287)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased by $743.2 million, or 1,234% in 2020, due to increases in grant revenue, product sales and collaboration revenue. Grant revenue increased by $516.7 million, or 4,245% in 2020, mainly due to an increase in revenue from BARDA related to our COVID-19 vaccine development in 2020. Product revenue was $199.9 million in 2020 from sales of our COVID-19 vaccine </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">174</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subsequent to the authorization by the FDA and Health Canada for emergency use in December 2020. Collaboration revenue increased by $26.6 million, or 55% in 2020, primarily due to&#160;increased revenue from AstraZeneca and Vertex attributable to a change in estimated costs for our future performance obligations under the collaboration agreement with AstraZeneca and an increase in reimbursable costs under the collaboration agreement with Vertex, partially offset by a decrease in revenue from Merck. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue decreased by $74.9 million, or 55% in 2019, primarily due to decrease in collaboration revenue. Collaboration revenue decreased by $74.5 million, or 61% in 2019, mainly due to decreased revenue across all our strategic alliances, particularly AstraZeneca and Merck, largely driven by our adoption of ASC 606 and the completion of the initial four-year research period under the 2016 Merck Agreement. Grant revenue remained relatively flat in 2019. There was a decrease in revenue from DARPA as the research and development activities under the DARPA awards were substantially concluded at the end of 2018, offset by increases in revenue from the Gates Foundation and BARDA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began capitalizing our COVID-19 vaccine inventory costs in December 2020, in connection with an Emergency Use Authorization from the FDA and an Interim Order from Health Canada for use of our COVID-19 vaccine, and based upon our expectation that these costs would be recoverable through commercialization of mRNA-1273. Prior to the capitalization of our COVID-19 vaccine inventory costs, such costs were recorded as research and development expenses in the period incurred. We expensed $242.0 million of pre-launch inventory costs in 2020. Our cost of sales were $7.9 million, or 4.0% of our product sales, in 2020, comprised of third-party royalties of $6.9 million and shipping and handling costs of $1.0 million as the associated inventory costs were expensed previously. If inventory sold during 2020 was valued at cost, our cost of sales for 2020 would have been $62.4 million, or 31.2% of our product sales. At December 31, 2020, we had $187.5 million of zero-cost COVID-19 vaccine inventory that we expect to sell prior to March 31, 2021. We expect our cost of sales as a percentage of our product sales will increase, reflecting the full cost of manufacturing, subsequent to the utilization of our zero-cost mRNA-1273 inventory. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased by $874.0 million, or 176% in 2020. The increase was primarily attributable to an increase&#160;in clinical trial expenses of&#160;$321.2 million, an increase in manufacturing expenses of $301.7 million, an&#160;increase&#160;in personnel related costs of&#160;$105.2 million, an increase&#160;in technology and facility related expenses of&#160;$74.2 million, and an&#160;increase in consulting and outside services of&#160;$60.7 million. The increase in 2020 was largely attributable to mRNA-1273 clinical development and pre-launch inventory buildup prior to the authorization from the FDA. The increase in personnel related costs was primarily driven by an increase in the number of employees supporting our mRNA-1273 development activities as well as other research and development programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased by $42.2 million, or 9% in 2019. The increase was primarily attributable to an increase in personnel related costs of $37.4 million, an increase in clinical trial and manufacturing costs of $16.9 million, and an increase in stock-based compensation of $10.6 million. The increases were partially offset by a decrease in in-licensing costs of $22.0 million related to in-licensing agreements executed in 2017 with Cellscript, LLC and its affiliate mRNA RiboTherapeutics, Inc. (Cellscript) to sublicense certain patent rights, and a decrease in lab supplies and materials of $8.2 million. The increases in personnel related costs and stock-based compensation were largely driven by an increase in the number of employees supporting our research and development programs. The in-licensing costs decreased in 2019 as the sublicense grant fees were fully recognized at the end of 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that research and development expenses will increase as we continue to progress mRNA-1273 through the development process toward a BLA approval and indication expansion during the current pandemic, and continue to develop our pipeline and advance our product candidates into later-stage development. In addition, we also expect to incur significant costs related to the development of new generations of our COVID-19 vaccine designed to address new variants of the virus.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased by $78.6 million, or 72% in 2020. The increase was mainly due to an increase in personnel related costs of $30.9 million, an increase in consulting and outside services of $26.9 million, and an increase in legal and other licensing expenses of $14.2 million. The increases in personnel costs and consulting and outside services were primarily attributable to increased headcount and mRNA-1273 vaccine candidate commercialization-related activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased by $15.4 million, or 16% in 2019. The increase was primarily due to an increase in insurance costs of $5.2 million, an increase in consulting and outside services of $4.9 million, an increase in information technology and facility-related costs of $4.0 million and an increase in personnel related costs of $2.5 million. The increases in insurance costs, </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">175</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consulting and outside services and personnel related costs were primarily driven by an increase in the number of employees and costs in support of being a publicly traded company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that selling, general and administrative expenses will increase in 2021 as compared to 2020 as we continue to expand the number of programs and our business operations, and continue to build out our global commercial, regulatory, sales and marketing infrastructure to support the commercialization of our COVID-19 vaccine.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income generated from our investments in marketable securities decreased by&#160;$13.8 million, or&#160;36%, in 2020, mainly attributable to an overall lower interest rate. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income generated from our investments in marketable securities increased by $11.5 million, or 43%, in 2019, mainly driven by a higher weighted average balance of cash and investments, primarily from the net proceeds of our IPO. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other (expense) income, net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarizes other (expense) income, net for each period presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:58.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years&#160;Ended&#160;December&#160;31,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change 2020 vs. 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,886)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,084)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,526)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,442&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:58.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.357%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years&#160;Ended&#160;December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change 2019 vs. 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,096)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,516)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other (expense) income, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,526)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,361)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net decreased by $1.4 million, or 19% in 2020. The decrease was primarily due to an increase in foreign currency gains and a reclassification of other income in 2020, offset by a higher interest expense driven by a new finance lease commenced in 2020 for a laboratory and office space, Moderna Technology Center North (MTC North). Please refer to Note 11 to our consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other expense, net increased by $9.4 million in 2019. The increase was mainly attributable to a one-time $7.0 million cash receipt in 2018 as consideration for the waiver of a third party's previously negotiated commitment, and higher interest expense in 2019 of $3.5 million related to our financing lease liabilities. We started recording the interest expense in July 2018 upon the completion of our Moderna Technology Center manufacturing facility, or MTC South. Please refer to Note 11 to our consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provision for (benefit from) income taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was a tax provision of $2.5 million in 2020, primarily related to foreign income taxes. There were no significant income tax benefits or provisions in 2019 and 2018.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have historically funded our operations primarily from the sale of equity instruments and from proceeds from certain strategic alliance arrangements and grant agreements. During 2020, we entered into supply agreements with the U.S. Government and several governmental agencies outside the United States for the supply of mRNA-1273, our COVID-19 vaccine, and received upfront deposits of $2.92 billion, of which $82.1 million was recognized as product sales. In addition, we raised $1.85 billion in total through two public equity offerings in 2020. As of December 31, 2020, we had cash, cash equivalents and investments of $5.25&#160;billion. Cash, cash equivalents and investments are invested in accordance with our investment policy, primarily with a view to liquidity and capital preservation. Investments, consisting primarily of government and corporate debt securities are stated at fair value. As of December 31, 2020, we had current and non-current investments of approximately $1.98 billion and $0.64 billion, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began construction of our MTC South facility, in the second half of 2016 and completed construction in 2019. In the second quarter of 2019, we entered into an additional lease for office and laboratory space nearby for our MTC North facility and construction on this facility began in 2019, and is continuing. Our capital expenditures related to our MTC facilities were $46.6 million, $3.9 million and $86.5 million for the years ended December 31, 2020, 2019 and 2018, respectively. Cash disbursements related to our MTC facilities were $41.7 million, $14.6 million and $94.5 million for the years ended December 31, 2020, 2019 and 2018, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 30, 2018 and February 15, 2018, we issued Series G preferred stock for total gross proceeds of $560.0&#160;million. On May 7, 2018, we issued Series H preferred stock for gross proceeds of $125.0&#160;million of which $13.0 million was determined to be a premium and recorded to deferred revenue as part of the Merck PCV/SAV agreement executed contemporaneously with our Series H redeemable convertible preferred stock issuance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2018, we closed our IPO, whereby we sold 26,275,993 shares of common stock at a price of $23.00 per share. The shares began trading on the NASDAQ Global Select Market on December 7, 2018. The aggregate net proceeds received by us from the IPO were $563.0 million, net of underwriting discounts, commissions and offering expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, we completed a public equity offering of 30,263,158 shares of common stock, including exercise of the underwriters' option over-allotment option, at a price of $19.00 per share. The aggregate net proceeds from the offering were $549.5 million, net of underwriting discounts, commissions and offering expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed a public equity offering of 17,600,000 shares of common stock, at a price of $76.00 per share. The aggregate net proceeds from the offering were $1.30 billion, net of underwriting discounts, commission and offering expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have used and intend to use the net proceeds from these equity offerings: (i) to fund working capital needs (raw materials, labor and capital equipment purchases) related to the manufacturing of mRNA-1273 for distribution in the United States and outside the United States, assuming necessary regulatory approvals are obtained and the remainder, if any, (ii) to fund clinical development and drug discovery in existing and new therapeutic areas, (iii) to fund further development of our mRNA technology platform and the creation of new modalities, or (iv) to fund working capital and other general corporate purposes.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-indent:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash flow</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the primary sources and uses of cash for each period presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026,971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(458,968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330,865)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,671,928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,945)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(373,094)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,226,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,388,236&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(422,792)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522,883&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We derive cash flows from operations primarily from cash collected from customer deposits related to our COVID-19 vaccine supply agreements as well as certain government-sponsored and private organizations and strategic alliances. Our cash flows from operating activities are significantly affected by our use of cash for operating expenses and working capital to support the business. Prior to 2020, we have historically experienced negative cash flows from operating activities as we have invested in our mRNA technologies, development pipeline, digital infrastructure, manufacturing technology, and infrastructure.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities in 2020 was $2.03 billion and consisted of net loss of $747.1 million less non-cash adjustments of $197.0 million, plus a net change in assets and liabilities of $2.58 billion. Non-cash items primarily included stock-based compensation of $93.0 million, leased assets expensed of $62.3 million, depreciation and amortization of $31.3 million, and amortization of investment premiums and discounts of $10.2 million. The net change in assets and liabilities was primarily due to an increase in deferred revenue of $3.84 billion, an increase in accrued liabilities of $388.4 million, an increase in accounts payable of $11.9 million, and an increase in operating lease liabilities of $11.8 million, partially offset by an increase in accounts receivable of $1.39 billion, an increase in prepaid expenses and other assets of $241.0 million, an increase of inventory of $46.5 million, and an increase in operating lease right-of-use assets of $10.5 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities in 2019 was $459.0 million and consisted of net loss of $514.0 million less non-cash adjustments of $108.7 million, plus a net change in assets and liabilities of $53.7 million. Non-cash items primarily included stock-based compensation of $81.1 million, depreciation and amortization of $31.0 million, and amortization of investment premiums and discounts of $3.7 million. The net change in assets and liabilities was primarily due to a decrease in deferred revenue of $44.1 million, a decrease in accounts payable of $24.0 million, a decrease in other liabilities of $6.2 million, an increase in right-of-use assets, operating leases of $5.7 million and an decrease in accrued liabilities of $3.4 million, partially offset by an increase in operating lease liabilities, non-current of $12.6 million, a decrease in prepaid expenses and other assets of $9.8 million and a decrease in accounts receivable of $6.7 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities in 2018 was $330.9 million and consisted of net loss of $384.7 million less non-cash adjustments of $96.5 million, plus a net change in assets and liabilities of $42.6 million. Non-cash items primarily included stock-based compensation of $72.6 million and depreciation and amortization of $24.9 million. The net change in assets and liabilities was primarily due to a decrease in deferred revenue of $65.3 million, and an increase in prepaid expenses and other assets of $5.3 million, partially offset by an increase in accounts payable of $15.0 million and an increase in accrued liabilities of $8.8 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary investing activities consist of purchases, sales, and maturities of our investments and capital expenditures for manufacturing, laboratory, computer equipment, and software.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities in 2020 was $1.67 billion, which included purchases of marketable securities of $2.96 billion and purchases of property and equipment of $67.4 million, partially offset by proceeds from maturities of marketable securities of $1.14 billion and proceeds from sales of marketable securities of $214.7 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities in 2019 was $14.9 million, which included purchases of marketable securities of $1.15 billion and purchases of property and equipment of $31.6 million, partially offset by proceeds from maturities of marketable securities of $993.2 million and proceeds from sales of marketable securities of $168.7 million.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">178</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities in 2018 was $373.1 million, which included purchases of marketable securities of $1.23 billion and purchases of property and equipment of $105.8 million, partially offset by proceeds from maturities of marketable securities of $783.4 million and proceeds from sales of marketable securities of $177.0 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated cash from financing activities of $2.03 billion in 2020, primarily from net proceeds from equity offerings of $1.85 billion, net proceeds from the issuance of common stock through our equity plans of $179.6 million, and proceeds from the purchase of common stock under our employee stock purchase plan of $7.0 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated cash from financing activities of $51.1 million in 2019, primarily from net proceeds from the issuance of common stock under our equity plans of $47.3 million, and net proceeds from the purchase of common stock from our employee stock purchase plan of $2.9 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated cash from financing activities of&#160;$1.23 billion&#160;in 2018, primarily from net proceeds from the issuance of redeemable convertible preferred stock of&#160;$661.1 million&#160;and net proceeds from the issuance of common stock of&#160;$563.0 million&#160;in connection with our IPO. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operation and funding requirements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have incurred significant losses and negative cash flows from operations due to our significant research and development expenses. We have an accumulated deficit of $2.24 billion and $1.50 billion as of December 31, 2020 and 2019, respectively. We expect our expenses to increase in connection with our ongoing activities, particularly as we continue research and development of our development candidates and clinical activities for our investigational medicines. We also expect our expenses to increase associated with manufacturing costs, including our arrangements with our international supply and manufacturing partners. Our ongoing work on mRNA-1273 will require significant cash outflows during 2021, most of which may not be reimbursed or otherwise paid for by our partners or collaborators. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash, cash equivalents, and investments as of December 31, 2020, will be sufficient to enable us to fund our projected operations through at least the next 12 months from the issuance of our financial statements. We are subject to all the risks related to the development and commercialization of novel medicines, and we may encounter unforeseen expenses, difficulties, complications, delays, and other unknown factors including expenses related to the ongoing coronavirus pandemic, which may adversely affect our business. Our forecast of the period of time through which our financial resources will be adequate to support our operations is a forward-looking statement and involves risks and uncertainties, and actual results could vary as a result of a number of factors. We have based this estimate on assumptions that may prove to be wrong, and we could utilize our available capital resources sooner than we currently expect. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to become profitable or are unable to sustain profitability on a continuing basis, we may be required to finance future cash needs through a combination of public or private equity offerings, structured financings and debt financings, government funding arrangements, potential future strategic alliances from which we receive upfront fees, milestone payments, and other forms of consideration, and marketing, manufacturing, distribution and licensing arrangements. If we are required to finance future cash needs, additional capital may not be available on reasonable terms, if at all. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back, or discontinue the development or commercialization of one or more of our investigational medicines, or slow down or cease work on one or more of our programs. If we raise additional funds through the issuance of additional equity or debt securities, it could result in dilution to our existing stockholders or increased fixed payment obligations, and any such securities may have rights senior to those of our common stock. If we incur indebtedness, we could become subject to covenants that would restrict our operations and potentially impair our competitiveness, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. If we raise funds through strategic alliances or marketing, distribution, or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs, or investigational medicines or grant licenses on terms that may not be favorable to us. Any of these events could significantly harm our business, financial condition, and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off balance sheet arrangements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we did not have any off-balance sheet arrangements, as defined in Item&#160;303(a)(4)(ii) of Regulation S-K.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual obligations and commitments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contractual obligations as of December 31, 2020 and the effects that such obligations are expected to have on our liquidity and cash flows in future periods (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.764%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments Due by Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Less&#160;than&#160;1</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">year</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1&#160;-&#160;3&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3&#160;-&#160;5&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">More&#160;than&#160;5</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,921&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,599&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contractual cash obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373,531&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,678&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,585&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,658&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The amounts in the table include a total payment of $338.9 million associated with our MTC South and MTC North leases for the optional lease extension periods. For accounting purpose, a lease term is the non-cancelable period of the lease and includes options to extend or terminate the lease when it is reasonably certain that an option will be exercised. Please refer to Note 11 to our consolidated financial statements. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt">The amounts represent non-cancelable fixed payment obligations related to purchases of raw materials, contract manufacturing services, clinical services and other goods or services in the normal course of business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our strategic collaboration agreements, we are committed to perform certain research, development, and manufacturing activities. As part of our personalized mRNA cancer vaccines, or PCV, collaboration and license agreement with Merck, we are committed to perform certain research, development, and manufacturing activities related to PCV products through an initial Phase 2 clinical trial up to a budgeted amount of $243.0 million as of December&#160;31, 2020. Please refer to Note 5 to the consolidated financial statements. The expenses we expect to incur as part of our commitments under the PCV and other collaboration agreements were not included in the above table as we are not able to determine the timing and amounts of such expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreements with certain vendors for various services, including services related to clinical operations and support and contract manufacturing, which we are not contractually able to terminate for convenience. Certain agreements provide for termination rights subject to termination fees or wind down costs. Under such agreements, we are contractually obligated to make certain payments to vendors, mainly to reimburse them for their unrecoverable outlays incurred prior to cancellation. The exact amounts of such obligations are dependent on the timing of termination, and the exact terms of the relevant agreement and cannot be reasonably estimated. At December 31, 2020, we had cancelable open purchase orders of $896.9 million in total under such agreements for our clinical operations and support and contract manufacturing. These amounts represent only our estimate of those items for which we had a contractual commitment to pay at December 31, 2020, assuming we would not cancel these agreements. The actual amounts we pay in the future to the vendors under such agreements may differ from the cancelable open purchase order amounts of $896.9 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the above obligations, we enter into a variety of agreements and financial commitments in the normal course of business. The terms generally allow us the option to cancel, reschedule, and adjust our requirements based on our business needs, prior to the delivery of goods or performance of services. It is not possible to predict the maximum potential amount of future payments under these agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement.</span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_100"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary exposure to market risk relates to changes in interest rates. As of December 31, 2020 and 2019, we had cash, cash equivalents, restricted cash, and investments in marketable securities of $5.25&#160;billion and $1.26 billion, respectively. Our investment portfolio comprises money market funds and marketable debt securities (including U.S. Treasury securities, debt securities of U.S. government agencies and corporate entities, and commercial paper), which are classified as available-for-sale securities. Our primary investment objectives are the preservation of capital and the maintenance of liquidity, and our investment policy defines allowable investments based on quality of the institutions and financial instruments designed to have very low risk exposure. We generally hold investments in marketable debt securities to maturity to limit our exposure to interest rate risk. Our exposure to interest rate sensitivity is affected by changes in the general level of U.S. interest rates. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">180</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketable securities are subject to interest rate risk and will fall in value if market interest rates increase. Due to the short-term maturities and low risk profiles of our investments, we do not anticipate a significant exposure to interest rate risk. If market interest rates were to increase immediately and uniformly by one percentage point from levels at December 31, 2020 and 2019, the net fair value of our interest sensitive marketable securities would not experience a material change in fair market value.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue generating activities and operations have been primarily denominated in U.S. dollars. As we expand internationally our results of operations and cash flows will become increasingly subject to fluctuations due to changes in foreign currency exchange rates. To help manage the exposure to foreign currency exchange rate fluctuations, we have implemented a balance sheet hedging program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Hedging Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use foreign currency forward contracts to mitigate foreign currency exchange risk associated with foreign currency-denominated monetary assets and liabilities. Notwithstanding our efforts to mitigate some foreign currency exchange risks, there can be no assurance that our hedging activities will adequately protect us against the risks associated with foreign currency fluctuations. We believe the counterparties to our foreign currency forward contracts are creditworthy multinational commercial banks. While we believe the risk of counterparty nonperformance is not material, a sustained decline in the financial stability of financial institutions as a result of disruption in the financial markets could affect our ability to secure creditworthy counterparties for our foreign currency hedging programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December 31, 2020, a hypothetical adverse movement of 10 percent in foreign currency exchange rates compared to the U.S. dollars across all maturities would have resulted in potential declines in the fair value on our foreign currency forward contracts used in balance sheet hedging of approximately $36.5 million. We expect that any increase or decrease in the fair value of the portfolio would be substantially offset by increases or decreases in the underlying exposures being hedged. We did not have any foreign currency hedge activities prior to 2020. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">181</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_103"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Financial Statements and Supplementary Data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_106">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_106">184</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_109">Consolidated Balance Sheets as of December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_109">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_109"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_109">19</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_109">186</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_115">Consolidated Statements of Operations for the years ended December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_115">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_115">, 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_115">9</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_115"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_115">18</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_115">187</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_118">Consolidated Statements of Comprehensive Loss for the years ended December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_118">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_118">, 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_118">9</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_118"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_118">8</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_118">188</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_124">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_124"> for the years ended December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_124">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_124">, 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_124">9</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_124"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_124">18</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_124">189</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_130">Consolidated Statements of Cash Flows for the years ended December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_130">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_130">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_130">19</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_130"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_130">18</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_130">191</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_133">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iac7f3ce8465b4330a30f0fc9f4279c20_133">192</a></span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">182</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_106"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of Moderna, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Moderna, Inc. (the Company) as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive loss, redeemable convertible preferred stock and stockholders&#8217; equity, and cash flows for each of the three years in the period ended December 31, 2020, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with U.S. generally accepted accounting principles.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 26, 2021 expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">183</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:12.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.188%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Collaboration Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 2 to the consolidated financial statements, the Company recognizes revenue under Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers (ASC 606). The Company recognized $74.6 million in collaboration revenue for the year ended December 31, 2020.<br/><br/>The Company recognizes revenue based on the amount of the transaction price that is allocated to each respective performance obligation when or as the performance obligation is satisfied by transferring a promised good or service to the customer. In determining the total revenue to be recognized under the proportional performance models, the Company develops assumptions that require judgment to determine the total expected effort for each performance obligation, including both internal and external estimated research and development costs. For performance obligations that are satisfied at a point in time, the Company recognizes revenue when control of the goods and/or services is transferred to the customer. For performance obligations that are satisfied over time, the Company recognizes revenue by measuring the progress toward complete satisfaction of the performance obligation using a single method of measuring progress which depicts the performance in transferring control of the associated goods and/or services to the customer. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition.<br/><br/>Auditing the Company&#8217;s proportional performance models is especially challenging because the assessment of progress required a high degree of audit judgment due to the subjectivity, including estimating the remaining research and development costs necessary to satisfy a performance obligation. The recognition of revenue pursuant to collaboration arrangements is subject to these estimates and judgments developed by management, as the underlying proportional performance models are sensitive to changes in the assumptions, including the Company&#8217;s estimate in determining the remaining level of effort required under an arrangement.<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the collaboration revenue recognition process. This included testing controls over the review of management's significant judgments and estimates related to the inputs to the proportional performance model including (i) an estimate of the total and remaining pre-clinical and clinical activities, (ii) an estimate of the total and remaining amount of clinical material to be delivered and (iii) an estimate of the total and remaining costs to<br/>be incurred related to each performance obligation.  <br/><br/>To evaluate the Company&#8217;s proportional performance models utilized for the Company&#8217;s ongoing recognition of revenue for its collaborative arrangements, our audit procedures included, among others, reading the agreements and all related schedules, and testing the accuracy and completeness of the underlying data used in evaluating the estimates and significant judgments, described above. To assess the reasonableness of the Company&#8217;s significant estimates and judgments, we corroborated management estimates and judgments through a review of the agreements and evaluated the accuracy of the prior period estimates and judgments as a potential source of corroborating or contradictory evidence. We also discussed the judgments with the Company&#8217;s research and development personnel that oversee the collaboration arrangements. <br/></span></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2014.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 26, 2021</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_109"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share data)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzQtMS0xLTEtMA_53fe8601-3784-4f7b-92e3-06475ea2c6cb">2,623,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzQtMy0xLTEtMA_063b9451-2c38-4671-8ffb-45de71b248b2">235,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzUtMS0xLTEtMA_ca2b882a-94a3-49c5-ac59-3b34cb7021f1">1,983,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzUtMy0xLTEtMA_ad66ec20-db1f-421e-8d5e-25fbae6adcb8">867,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzYtMS0xLTEtMA_fb5d37d0-f4fd-4770-ba26-a6e11c2ed401">1,390,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzYtMy0xLTEtMA_1881cfa5-4251-4922-b22a-652e65ed578d">5,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzctMS0xLTEtMjkzOQ_c51a0e31-cb21-4236-849a-768f746aa0bc">46,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 7pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzctMy0xLTEtMjkzOQ_b63894d9-f51e-4ae3-a5ac-5a3254228895">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzgtMS0xLTEtMA_feeb65e3-26cf-4654-8665-193bdfe7f9fc">252,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzgtMy0xLTEtMA_48fdd5f2-148f-4ac2-b4e4-5a1b24d33442">19,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzktMS0xLTEtMA_c1ce5813-c2c0-4955-b754-382de263dbce">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzktMy0xLTEtMA_90770317-e633-4130-8040-dd6b0e6c9a43">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEwLTEtMS0xLTA_ea1390e6-0501-496a-baef-1a9fe5e930c7">6,297,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEwLTMtMS0xLTA_98661ed8-10f7-44ee-87fe-708df0f84d8e">1,128,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments, non-current</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzExLTEtMS0xLTA_f364144b-5db2-4b53-b6fe-80442b75695b">638,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzExLTMtMS0xLTA_b1cb1da6-6f1f-45bd-8fb9-a86fe9f02e3f">159,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEyLTEtMS0xLTA_18a044a3-67a5-4827-a60e-85f76db06d15">296,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEyLTMtMS0xLTA_8a82e4fa-5a0c-4dc3-a10a-12ddc2305f6f">201,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, operating leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEzLTEtMS0xLTA_8746cbc5-8be6-432f-aef6-d7e5760e162c">90,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEzLTMtMS0xLTIyNzk_06e7f7ef-f6d1-460b-83ce-5253480b0773">86,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, non-current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE0LTEtMS0xLTA_ef80a292-5626-4e66-bb98-4e8cb447d7d3">11,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE0LTMtMS0xLTA_ce771501-f638-454f-a372-38dbecd3373b">10,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE1LTEtMS0xLTA_6b91a7ff-bb45-4865-8a33-3c9df03c4552">1,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE1LTMtMS0xLTA_37ff6295-9ea9-41b6-9332-c432b04a6e56">1,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE2LTEtMS0xLTA_1749810a-3b33-496b-bbe2-c33c0f78ec1c">7,336,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE2LTMtMS0xLTA_0c211d79-d418-4875-98e9-bbd68102dec3">1,589,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE5LTEtMS0xLTA_8ad75991-910c-4ff7-a7fb-140d2739d986">18,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE5LTMtMS0xLTA_a57c99b2-0784-4f90-b018-44b8079cfef8">7,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIwLTEtMS0xLTA_8f3c0f8d-e992-4945-a477-cc5af8d3bcbe">469,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIwLTMtMS0xLTA_68ec129b-0491-44be-bab8-9af6066db0f9">67,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIxLTEtMS0xLTA_6268c799-d962-4166-8e2f-dc2eb70f69e3">3,867,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIxLTMtMS0xLTA_e4e2fbbe-4aac-4ddc-899e-0f0a6301a002">63,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIyLTEtMS0xLTA_c242bd2a-4e72-4d4f-8ede-9466bdcdda3a">33,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIyLTMtMS0xLTA_6b8a7e00-3d9a-46d9-891a-000db21e8141">5,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIzLTEtMS0xLTA_f89d5e73-945d-41be-b562-1827805c6629">4,388,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIzLTMtMS0xLTA_8ca39616-2546-4ec3-a151-e4538e80e379">143,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI0LTEtMS0xLTA_bf59ae66-04e0-415f-a865-077921f62b63">177,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI0LTMtMS0xLTA_d4ac7c7b-cd83-40e3-b9dd-7f7a274836c4">138,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI1LTEtMS0xLTA_4f9c1bf0-6218-4c0e-907d-993b08615c3f">97,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI1LTMtMS0xLTIyODQ_7a55b6f3-5b25-440d-952f-a00414b97fb3">93,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities, non-current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI2LTEtMS0xLTA_9913bc6c-bc2c-48af-b10b-eeaa51445d2c">109,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI2LTMtMS0xLTIyODQ_7fa60bf5-e3b9-4003-bad2-fae41cf9b780">38,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI5LTEtMS0xLTA_188de67f-7e9a-408d-a683-08f239a56b8b">1,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI5LTMtMS0xLTA_13c0e4ae-3af6-4acd-801c-62c533006d96">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMwLTEtMS0xLTA_cf683f7b-726c-4a1a-a722-edfcda557518">4,775,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMwLTMtMS0xLTA_d1f71252-1912-4968-a04a-f892c44e0971">414,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 12)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMxLTEtMS0xLTA_93ee2cc2-9621-44ce-b3b5-cb1e8a85bfef"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMxLTMtMS0xLTA_b05c09a0-e3b1-4a28-afe8-cf98b0593454"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTYz_838a585f-8699-4e90-8733-76c9ec31bb91"><ix:nonFraction unitRef="usdPerShare" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTYz_9ef8bbe7-0412-4ab2-aac1-fc1204cd8dc8">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTc3_1abf0b0f-7cc2-439d-a466-63cf394f63ae"><ix:nonFraction unitRef="shares" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTc3_f5c6995c-a452-48f9-9dad-14d0a323a020">162,000,000</ix:nonFraction></ix:nonFraction> shares authorized at December 31, 2020</span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;and 2019; <ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTgx_0847ff0a-4c31-4109-9d55-58ed9fdca1a1"><ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTgx_35f33b83-2a81-4c90-bf57-bdfa8efc43da"><ix:nonFraction unitRef="shares" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTgx_69643a54-6487-4a0f-b4dd-cd00f22f715e"><ix:nonFraction unitRef="shares" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTgx_dbe057fc-2da7-47b1-8d40-f8c6197b7456">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding at December 31, 2020 and 2019</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTEtMS0xLTA_1407e577-f19f-4fe4-b115-697118ec4a91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTMtMS0xLTA_16f592a2-31c8-41d4-93ff-7c837eb735b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1MjI4_626ffb61-8e4e-42ca-8ccf-1dc82383ef6d"><ix:nonFraction unitRef="usdPerShare" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1MjI4_ff1dad1c-6809-451e-a925-657b721fce64">0.0001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1MjY2_9efe9bf1-2a5f-49d5-8e65-98abcfd9b78b"><ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1MjY2_c38eca7d-d4d5-486c-803a-e1bca42d2bb9">1,600,000,000</ix:nonFraction></ix:nonFraction> shares authorized as of December&#160;31, 2020 and 2019; <ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1Mjgw_27e55e28-8577-4975-b73a-f3c908197057"><ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1Mjgw_f4a2c7b0-d166-4398-8756-d4de1114f53e">398,787,678</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1Mjk0_08465d40-4224-44c4-940f-7114bdec0a36"><ix:nonFraction unitRef="shares" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1Mjk0_4cbcb8ea-b4de-4f86-9c6e-82069ec9eca1">336,536,985</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2020 and 2019, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTEtMS0xLTA_6de41199-345d-448a-81e0-914a5e68aaa5">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTMtMS0xLTA_296d3000-7d30-4c15-b19a-3d996f3bce35">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM1LTEtMS0xLTA_cfe60448-d14a-43c2-a408-0462a0b607d6">4,801,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM1LTMtMS0xLTA_405db83d-8575-484c-9bf7-d1fba1cdf2a0">2,669,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM2LTEtMS0xLTA_e08ac13b-542c-4585-9841-c1cad889ac66">3,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM2LTMtMS0xLTA_7a69eb89-c492-40f4-b3e3-0cace673749b">1,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM3LTEtMS0xLTA_2e3d06e7-6a12-49d6-b5cd-94ee0572bd8c">2,243,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM3LTMtMS0xLTA_948003eb-241a-4d66-89e5-08c69aa82b06">1,496,454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM4LTEtMS0xLTA_c76b3fd8-925e-4c21-a5ce-19764ab30387">2,561,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM4LTMtMS0xLTA_eb871c5c-8344-4413-bcbb-12283b67cd69">1,174,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM5LTEtMS0xLTA_1a1a049b-fb00-40b1-8847-980708888d38">7,336,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM5LTMtMS0xLTA_c084cc0c-68c5-474e-813f-1c44266d4142">1,589,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">185</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_115"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share data)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia16dd0e2f0d2488eba0c73974791c3a4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtMS0xLTEtMTE5NQ_8c4387bd-becf-4ae5-883c-2ba062170562">528,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998364a642404015895ef6268a8bef44_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtMy0xLTEtMTE5NQ_de5d6b86-d695-431c-9407-2761e0b021cd">12,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234df8a6bf184a26bc8d6f61ec880f13_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtNS0xLTEtMTE5NQ_4fccc242-4444-44d7-a8fc-18cc940ae3cf">12,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af31ae8238a40b6a097aa5017de8edd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzUtMS0xLTEtNjI4Mw_16e2c989-94ed-41b7-93b4-05ee55eb4606">199,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67dc425fe1144699ae5760509f7e5da9_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzUtMy0xLTEtNjI4Mw_886f1d77-5e6e-4149-ad71-356ef2fa37b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id76485547ab74bf79a9764e33c357192_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzUtNS0xLTEtNjI4Mw_fdd5a645-0cd7-4b16-b540-d4bc8f495596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bf0bccbb5d48e2b6b391bd4c6436d8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtMS0xLTEtMA_2307ea56-85b9-469f-9c2b-e868b3fa4128">74,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice56444d59b64b31a0940bfed6f9c48d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtMy0xLTEtMA_c421250a-c4e6-45f7-a6df-91e2ac81e028">48,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5db3bb48bb6499b83759eafea2dc91f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtNS0xLTEtMA_5250b731-93f0-4827-9d27-28719995da3b">122,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:47.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzYtMS0xLTEtMA_ab4c452a-48b7-4591-958a-5d14a8d61ccf">803,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzYtMy0xLTEtMA_8606dcbe-4bc3-4ea5-aa01-53496005670b">60,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzYtNS0xLTEtMA_4081b8f3-3021-4944-ba4a-278a6785876a">135,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtMS0xLTEtNjI3Mg_67f0cfbc-39b4-4cdf-9cfb-121ad1676293">7,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtMy0xLTEtNjgxNA_9da2dd30-c6c0-427c-89a6-ac20569a6e8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtNS0xLTEtNjgxNg_80a92df2-1e2d-4220-b1db-7689b6fd1611">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtMS0xLTEtMA_6cea3d74-3ae9-402a-ba28-cf462510bdab">1,370,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtMy0xLTEtMA_4d99a28e-e952-442f-b8ec-b245a0c2260b">496,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtNS0xLTEtMA_80b88320-eaea-45c5-aeca-ada6d62c4c3e">454,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzktMS0xLTEtMA_5474b33c-0887-4f43-b825-7eb4e6952ec0">188,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzktMy0xLTEtMA_654f7ed3-6b99-4385-a388-b75b96f01b6a">109,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzktNS0xLTEtMA_a4553b74-6e87-4ee1-bc9b-a2d3f59d393c">94,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:47.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEwLTEtMS0xLTA_a88bafd6-8736-48db-8362-a7eaa73d966b">1,566,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEwLTMtMS0xLTA_1eee4039-75d9-44e9-a565-c28269c7ced7">605,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEwLTUtMS0xLTA_1465efe8-a894-40b4-928a-50ca04f1a935">548,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzExLTEtMS0xLTA_a63c1bcd-7df9-4b86-9eed-fa51a791c4f8">763,144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzExLTMtMS0xLTA_0c6c0336-6122-4e74-bc08-418dad3f9854">545,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzExLTUtMS0xLTA_ba67afcd-aee0-4ff6-8950-b3d16e1c0cbb">413,266</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEyLTEtMS0xLTA_3e21b4f6-0b46-4ffc-8394-77437e2ab039">24,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEyLTMtMS0xLTA_e1a8e8c3-e7a2-40e8-8141-d8fa40526e4b">38,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEyLTUtMS0xLTA_9cc52e5c-c6c4-4509-9a55-6a3e9617d54a">27,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEzLTEtMS0xLTA_b90d047a-9b71-4425-8dab-30637f72a090">6,084</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEzLTMtMS0xLTA_ad29cfda-f527-49fb-89b5-9456db53f920">7,526</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEzLTUtMS0xLTA_68c50dce-166b-47b3-9179-4bc95f8ac793">1,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE0LTEtMS0xLTA_c7f69baf-3767-458a-a032-c06584cb30dc">744,513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE0LTMtMS0xLTA_9bef7aa2-0d71-4f7a-9441-653fbfed513c">514,716</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE0LTUtMS0xLTA_64b97b7c-b588-46c5-b484-329999568942">384,408</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE1LTEtMS0xLTA_ea62a1fd-c988-4b89-839d-d3d1013ae27e">2,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE1LTMtMS0xLTA_de6c7a88-12be-4e96-b4a3-8a85299ce769">695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE1LTUtMS0xLTA_9fea19a5-3632-4266-bb68-cb7203017445">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE2LTEtMS0xLTA_77bdcb84-af4f-4c74-9842-959de5cd21d1">747,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE2LTMtMS0xLTA_60309c7d-2658-4fd8-8b87-7f6c4cfaa2ca">514,021</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE2LTUtMS0xLTA_a76b68d2-acde-4e46-83d4-0913fbd9117e">384,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net loss to net loss attributable to common stockholders:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium paid on repurchase of preferred stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockRedemptionPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE4LTEtMS0xLTA_c69084bf-80c1-41af-a8e0-82c60ca184a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockRedemptionPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE4LTMtMS0xLTA_c1b08d25-1f53-47d1-ba0f-dd5e47632672">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockRedemptionPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE4LTUtMS0xLTA_3b06624c-3486-4ad5-bf10-ad821be5d5f8">4,127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative preferred stock dividends</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RedeemablePreferredStockDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE5LTEtMS0xLTA_e50d0619-c769-4e26-895f-72c93adbeac4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RedeemablePreferredStockDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE5LTMtMS0xLTA_d74a12cd-8a84-4040-ad9b-0ce80c22a277">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemablePreferredStockDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE5LTUtMS0xLTA_ed97c3a1-729c-4bfc-96d8-83758cf69509">12,996</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIwLTEtMS0xLTA_59ce2ec2-4487-448f-9d13-97dd0fa7f88d">747,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIwLTMtMS0xLTA_aa672010-e20e-451f-a68a-f890d0838705">514,021</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIwLTUtMS0xLTA_12e640ec-2cb1-43b9-ad5d-58c7daf45da8">401,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIxLTEtMS0xLTA_91fc91f5-2b96-4514-ba14-98e4faeb2127">1.96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIxLTMtMS0xLTA_ffd161f8-b675-4007-8134-9d7d544c3a41">1.55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIxLTUtMS0xLTA_21f1004a-8602-40b2-b36a-6eaedd834562">4.95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIyLTEtMS0xLTA_e51a3f45-d537-47a9-aa9f-1a9def243fb5">381,333,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIyLTMtMS0xLTA_8bc3d790-b796-4df9-a0bd-afb05b3feaf9">330,802,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIyLTUtMS0xLTA_bc40bf9a-bb18-4d30-b3e8-88bb39ac46de">81,114,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_118"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.027%"><tr><td style="width:1.0%"></td><td style="width:61.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.120%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzItMS0xLTEtMA_400b6572-ec01-40b4-9aa3-80cff372893e">747,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzItMy0xLTEtMA_9cc86b8e-e907-40ec-a305-c1becc7bb2f2">514,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzItNS0xLTEtMA_23a62cd2-857c-4cd8-b41c-a5e5ca0dfcb3">384,734</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on available-for-sale debt securities, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtMC0xLTEtMC90ZXh0cmVnaW9uOjBlNzVlMDNmNjIyNjRiZjNiMGJjZjkxZGI0YzVmNWNmXzQ5NDc4MDIzMjUyMDU_8ff094b8-8351-4bef-a041-64c1a162a60d">0</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtMC0xLTEtMC90ZXh0cmVnaW9uOjBlNzVlMDNmNjIyNjRiZjNiMGJjZjkxZGI0YzVmNWNmXzQ5NDc4MDIzMjUyNTk_e9a9ae18-477d-4ad2-b678-6f3c212e89e1">1,148</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtMC0xLTEtMC90ZXh0cmVnaW9uOjBlNzVlMDNmNjIyNjRiZjNiMGJjZjkxZGI0YzVmNWNmXzQ5NDc4MDIzMjUyNjQ_4fef82b4-cf82-4127-8a6e-7832884878a2">0</ix:nonFraction>, for the years ended December 31, 2020, 2019 and 2018, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtMS0xLTEtMA_89b62ee7-1bab-4ac3-8932-d9f86f537f3e">2,501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtMy0xLTEtMA_fe3ac4c2-3c12-40c5-84f3-8edf4814d65d">3,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtNS0xLTEtMA_22bb50c9-a290-419d-a7ac-7f40ff4a0f9f">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts recognized for net realized gain included in net loss</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzUtMS0xLTEtMA_c24fac26-5ca0-4b96-b4ce-a75b49424ca8">1,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzUtMy0xLTEtMA_fa9843bb-c592-4b0a-a7fc-8e97924ce0d5">323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzUtNS0xLTEtMA_67b084fc-f08a-4089-b511-cf3c520698c2">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss) </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzYtMS0xLTEtMA_3c37a758-1fcd-4d60-986d-42ad67741e73">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzYtMy0xLTEtMA_402836e4-ce5a-4587-ae9e-6e89f3f01b22">3,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzYtNS0xLTEtMA_36eac1ad-149a-45ce-a0c3-ee5ced8abdd7">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzctMS0xLTEtMA_c16cb75d-d6c0-419b-ac5c-81f077a8c4d4">745,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzctMy0xLTEtMA_cae33287-5962-4564-84fc-dab60ec89889">510,897</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzctNS0xLTEtMA_775a253a-25c8-4b3d-8a61-fbc4f0ae76a4">384,897</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">187</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_124"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except unit and share data)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.687%"><tr><td style="width:1.0%"></td><td style="width:42.891%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.635%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.907%"></td><td style="width:0.1%"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Redeemable&#160;Convertible</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Preferred Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Paid-In</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Comprehensive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Loss</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Deficit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December&#160;31, 2017</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae26ac15cf594fc4a4c729775db551d1_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItMi0xLTEtMA_99b00008-da7d-43e0-b283-8d92e0764c4a">448,686,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae26ac15cf594fc4a4c729775db551d1_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItNC0xLTEtMA_827cb49c-6835-47a8-9e1b-dec1ab2eaee8">1,176,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia0f05a78cb4a45e0aae694728346c943_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItNy0xLTEtMA_90bdefc5-b150-45df-90c6-43b5239ba425">65,206,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0f05a78cb4a45e0aae694728346c943_I20171231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItOS0xLTEtMA_e8ccc0de-cfd2-4790-9496-578ce8a1e1e3">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67150ae834864a00a45a3aafe2462423_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItMTEtMS0xLTA_4f488f45-63f6-469f-aa8b-cfe17b71dcc6">71,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d4e1054ad904b07b079bfcd6a3b0dfa_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItMTMtMS0xLTA_6f8773bb-3fa5-4ed6-b43e-0692c5f31502">1,157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i938ca78cd25647ac9350433b1e94b211_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItMTUtMS0xLTA_56ebd553-6170-4c26-a852-41027119e427">621,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i857b3ef318484e959ca8a3dddeb3a486_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItMTctMS0xLTA_70ac5e3d-53ca-4657-a6b2-25255844675b">551,365</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vesting of restricted common stock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzMtNy0xLTEtMA_e294b4b5-2f1d-4502-a736-f0ce726c85c8">856,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of Series G redeemable convertible preferred stock, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i859a2b8a071243a4aab797a9e567cab2_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjAwODgxYzM3YmNiMDQ5ZTdiYmIwN2MzNTM4OGRlN2VhXzQ5NDc4MDIzMjUwOTc_c3239ac1-3b55-48b6-89d8-7cd609daddcf">10,517</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia68cd3c2e44d470a8bb0dd6b86dfbcd9_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="mrna:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzQtMi0xLTEtMA_c895931a-805f-41f3-bd68-ae6970eaa0c1">55,666,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia68cd3c2e44d470a8bb0dd6b86dfbcd9_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzQtNC0xLTEtMA_81eb14f7-ddcb-446e-bb25-da5b67453a11">549,413</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i812ca2c8b582418791dd8a37f6934064_D20180101-20181231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzQtMTEtMS0xLTA_ee53e5cf-5ebb-4477-ad2c-fab411ca49dd">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i859a2b8a071243a4aab797a9e567cab2_D20180101-20181231" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzQtMTctMS0xLTA_3084838f-b338-45e2-9f33-21a1951c6bed">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of Series H redeemable convertible preferred stock, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i67ede5f832064fd28db4be814bebe8c9_D20180101-20181231" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjA5NWE5MjkwODcxZDQzOTFhOTkxYjI4Mjk3NTlhMDg1XzQ5NDc4MDIzMjUwOTE_8f9eeb39-7920-4345-a712-fb9f6eef8c79">474</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i77c6c82735e645deaa5e5478b0a99aa6_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="mrna:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzUtMi0xLTEtMA_b9570912-5470-44e1-82fc-e6b98638d7ce">5,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77c6c82735e645deaa5e5478b0a99aa6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzUtNC0xLTEtMA_459e12cf-8576-4d8a-9e0a-c80c64873e23">111,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of Series D redeemable convertible preferred stock</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia2745e2110e849418080ca092c31fe61_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="mrna:TemporaryEquityStockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzYtMi0xLTEtMA_4fee3e70-1bff-48ce-bfc5-febbb90039aa">269,180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2745e2110e849418080ca092c31fe61_D20180101-20181231" decimals="-3" name="mrna:TemporaryEquityStockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzYtNC0xLTEtMA_435069c8-053c-466a-a4f5-29d39d64eeca">704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i014f1da45cd24ebfaccc119edf9098d7_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:TemporaryEquityStockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzYtMTEtMS0xLTA_6586cdc4-0995-411d-86c1-76804121ab38">2,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie937c553bd26477b9acb13ff0d7ed4e0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:TemporaryEquityStockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzYtMTctMS0xLTA_40a0d418-f650-4241-95c0-bfe97cbf2b09">2,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of Series E redeemable convertible preferred stock</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib152449eaa214910b3c1ff9d8ebc950d_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="mrna:TemporaryEquityStockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzctMi0xLTEtMA_75c849c5-ac7e-4a7c-a44e-b74e927034bf">544,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib152449eaa214910b3c1ff9d8ebc950d_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:TemporaryEquityStockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzctNC0xLTEtMA_2fad5843-b047-459f-b6af-8af8e8dbec92">3,355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic468680da3a242bd8e509f8061d39e47_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:TemporaryEquityStockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzctMTEtMS0xLTA_ffcd2058-9bad-4a76-b14c-2b25556d11f9">2,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e0a831810a84041aaa0ec3f4250a1ee_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:TemporaryEquityStockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzctMTctMS0xLTA_df5404a7-893f-4d23-9135-3122987d76e5">2,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-2.25pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercise of options to purchase common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzgtNy0xLTEtMA_707d4e0b-1a13-4792-a559-30ebdc395204">446,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2737f3bfa09d4954bbdecc2432f59275_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzgtMTEtMS0xLTA_4dd4d400-d727-466c-ac62-2737d63714b4">1,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzgtMTctMS0xLTA_ce73f758-c4da-415d-9933-19237e0354ab">1,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;Conversion of redeemable convertible preferred stock into common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5f1c28d9133c4d19994650191f44a618_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="mrna:ReclassificationsOfTemporaryToPermanentEquityShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktMi0xLTEtMA_3a188602-3e12-4ac4-b7b4-fb20054464cb">508,539,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f1c28d9133c4d19994650191f44a618_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktNC0xLTEtMA_11e62259-cfbf-45d8-8622-1705afc95dd9">1,833,561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="mrna:ReclassificationsOfTemporaryToPermanentEquityShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktNy0xLTEtMA_4a54884f-5def-4be6-88d5-4f397a71add9">236,012,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231" decimals="-3" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktOS0xLTEtMA_ebcbefb1-c50f-4bec-91a6-37cf523aa948">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2737f3bfa09d4954bbdecc2432f59275_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktMTEtMS0xLTA_d8b15a12-861a-4f22-9e10-7c887d4c4bd1">1,833,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktMTctMS0xLTA_b3cc1235-ccbd-4246-8d23-af1250c0c285">1,833,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;Proceeds of initial public offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjozN2Q4M2Y3MWNjMWQ0MTYwYjNkOGYwNWQ1Y2M3ZTIzNl80OTQ3ODAyMzI1MDcy_b819c120-0996-4cd4-9e98-ab373bc1d92d">41,322</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEwLTctMS0xLTA_ebe9e6c4-1a72-42ac-bb7c-ea1d97131a54">26,275,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEwLTktMS0xLTA_438feae4-9f06-4987-afd5-6cd853275daa">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2737f3bfa09d4954bbdecc2432f59275_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEwLTExLTEtMS0w_85a1a29c-40f0-438f-a3b3-18a815a5ff2c">563,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEwLTE3LTEtMS0w_4dc402c0-65a3-40f1-833f-a3446d060679">563,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2737f3bfa09d4954bbdecc2432f59275_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzExLTExLTEtMS0w_1d0447a6-9c06-4cf0-8ed4-914da0246099">72,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzExLTE3LTEtMS0w_4f052400-314a-4a71-88c3-148229e26663">72,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-2.25pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06ac627610d04fb3ad68a60243ee4351_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEyLTEzLTEtMS0w_bc8d5db1-17d7-4d2d-9e79-985d4f0a5015">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEyLTE3LTEtMS0w_cd615ada-bc58-420a-b287-c7b44df062b1">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ad70ea4023a49e5923d1a79f4faf6fd_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEzLTE1LTEtMS0w_358077ed-8953-4138-b93a-66eba8daa3c6">384,734</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEzLTE3LTEtMS0w_8e0efcaf-6119-4aa3-9d05-7fd37a1748dd">384,734</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December&#160;31, 2018</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i413042b2017f4a90a355a0f54413c75f_I20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTItMS0xLTA_1b723fd2-e5e3-4ab9-9c0c-8492463cb65f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i413042b2017f4a90a355a0f54413c75f_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTQtMS0xLTA_2924d50b-6f39-4780-8632-c05529784554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbb1a345880141898c0782b97ae50bdd_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTctMS0xLTA_4c42829f-4812-475a-8d33-9f61adaabb19">328,798,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb1a345880141898c0782b97ae50bdd_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTktMS0xLTA_e7731dce-ba07-4642-8d87-38a739837fbd">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2425e3671ff2477f85a228531640c4e2_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTExLTEtMS0w_18049926-b7ee-491a-8ca2-48bf917e883c">2,538,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14c57127d88a41c5af194b5765483daa_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTEzLTEtMS0w_0e2ace5e-27dd-4709-a544-0276f41f4493">1,320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec0aa65fa9384232bb27dc252483b1ee_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTE1LTEtMS0w_8f0a6c32-be12-450a-b80f-b052e3e249a6">1,006,627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20204b229a394d9ba8b28882826012db_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTE3LTEtMS0w_f3d28014-5fcf-4546-b183-643e78353b29">1,530,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.687%"><tr><td style="width:1.0%"></td><td style="width:43.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.906%"></td><td style="width:0.1%"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Redeemable&#160;Convertible</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Preferred Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Paid-In</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Comprehensive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Gain (Loss)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Deficit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December&#160;31, 2018</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i413042b2017f4a90a355a0f54413c75f_I20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItMi0xLTEtMA_387d3f15-493d-4a29-964d-6739e48b45cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i413042b2017f4a90a355a0f54413c75f_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItNC0xLTEtMA_4898e1f6-f80d-4e4d-bba8-f06487f470b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbb1a345880141898c0782b97ae50bdd_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItNy0xLTEtMA_1369e879-8f4c-4807-93dd-7d8fcd5351da">328,798,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbb1a345880141898c0782b97ae50bdd_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItOS0xLTEtMA_384991d2-5823-47b8-a0d5-ba08b55d97db">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2425e3671ff2477f85a228531640c4e2_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItMTEtMS0xLTA_d757253a-9cd5-4c60-9f8e-6829be70a224">2,538,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14c57127d88a41c5af194b5765483daa_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItMTMtMS0xLTA_2456a841-7711-47ab-9b75-4b9456a5eaba">1,320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec0aa65fa9384232bb27dc252483b1ee_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItMTUtMS0xLTA_4cb8eb4e-3abf-4733-907a-bf536992551e">1,006,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20204b229a394d9ba8b28882826012db_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItMTctMS0xLTA_b0e0e75c-91a4-4480-a66f-4de54b41d9a5">1,530,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vesting of restricted common stock and restricted stock units</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46a4ad30d8e44c75931d48376d7dd5a7_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzMtNy0xLTEtMA_7e949928-4aff-4746-a94a-5ab05adc3144">621,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-2.25pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercise of options to purchase common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46a4ad30d8e44c75931d48376d7dd5a7_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzQtNy0xLTEtMA_fc7ff13c-0e03-4096-b5f3-9d3b4b6ef7cd">6,945,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a4ad30d8e44c75931d48376d7dd5a7_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzQtOS0xLTEtMA_fe2b7a21-5226-4314-bc4a-ae1de02d545b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01664a6e7894e8083439b3589eb02b8_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzQtMTEtMS0xLTA_5123b824-1970-471e-9999-f289aa5316fe">47,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzQtMTctMS0xLTA_215f5649-1e66-4218-bedb-52a9bc464dd4">47,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of common stock under employee stock purchase plan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46a4ad30d8e44c75931d48376d7dd5a7_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzUtNy0xLTEtMA_f8a5a052-7cc7-4dc2-86e6-4c777b633886">171,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01664a6e7894e8083439b3589eb02b8_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzUtMTEtMS0xLTA_e06f7c39-74a4-4c41-abae-ee360f096899">2,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzUtMTctMS0xLTA_04398cbf-42fe-48b3-a91c-fbec0e116dda">2,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transition adjustment from adoption of ASC 606 (Note 2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife96d591748e4db1a06679e64f49ac18_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzYtMTUtMS0xLTA_2b024963-2e4f-452d-bdd1-5fff586bfe0a">27,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f826ec40d9a42d49d1f345df0664683_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzYtMTctMS0xLTA_83ed27d0-ee4c-4762-9d09-4afa9392a07e">27,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Transition adjustment from adoption of ASC 842 (Note 2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2f2085b1dd5438ca46922e561f57fef_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzctMTUtMS0xLTA_02e17c65-908a-4f66-a33e-a42f959fbc5d">3,790</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ea8b1dba03d4c238442398f1dbc7fab_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzctMTctMS0xLTA_b88d4c12-6390-4d22-81e6-047066a07784">3,790</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01664a6e7894e8083439b3589eb02b8_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzgtMTEtMS0xLTA_63c377eb-a9b5-4606-a90d-2c2200ac0ddd">81,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzgtMTctMS0xLTA_70bd6cb9-ae22-4c88-9fef-a796e930fef8">81,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-2.25pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbf4e4b10ca4b88bc9d9e4de34dfec6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzktMTMtMS0xLTA_e82bb47c-3967-4b66-8cf7-4a56452b6aad">3,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzktMTctMS0xLTA_f459e26f-e612-48a6-a177-022878f4d695">3,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6276f01255674c1bb430a10fe7a5d756_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzEwLTE1LTEtMS0w_084f9af9-af46-44a4-b408-7d124fffef72">514,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzEwLTE3LTEtMS0w_8eda2ae7-9bd0-4e8a-9d36-229a04caf771">514,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December&#160;31, 2019</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5dd938ce77414d15a896664fd61440db_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTItMS0xLTA_14c679f7-b51e-43d5-8244-aaaf91cb7228">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd938ce77414d15a896664fd61440db_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTQtMS0xLTA_66890c10-7ea3-4439-aff3-7b081e3f0f15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52c971ec763a42d9b277341a14ec9c55_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTctMS0xLTA_74fb4dfe-bb67-494a-ac44-c9ed916cfe81">336,536,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52c971ec763a42d9b277341a14ec9c55_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTktMS0xLTA_4c42f7f0-7e12-4781-9a95-c4f670e6dbb6">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93472a617e4d4f6f9147a6e05189a34e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTExLTEtMS0w_cd3bec95-046c-4956-bba1-9268e934516d">2,669,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f30efddbba4bc19c03af8bc5c7eaf6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTEzLTEtMS0w_55112b75-2dde-478a-98f4-10dc5be49611">1,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c8e11b66a049928373daa1783da6a5_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTE1LTEtMS0w_f37e650a-9baa-4948-94d1-5a401dcbf91c">1,496,454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTE3LTEtMS0w_e8048ad2-ba3e-4023-a032-6193637b8b7e">1,174,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">188</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.687%"><tr><td style="width:1.0%"></td><td style="width:43.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.319%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.906%"></td><td style="width:0.1%"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Redeemable&#160;Convertible</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Preferred Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Paid-In</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Comprehensive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Gain (Loss)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Deficit</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-2.25pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December&#160;31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5dd938ce77414d15a896664fd61440db_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItMi0xLTEtMTI1OA_eda446bd-b108-4fed-aa4e-9586051f20a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd938ce77414d15a896664fd61440db_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItNC0xLTEtMTI1OA_a81c82a5-3c5f-4d05-a665-88542c7af731">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52c971ec763a42d9b277341a14ec9c55_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItNy0xLTEtMTI2Mg_7da3b3f5-51be-49cb-8687-ab7e8e824de6">336,536,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52c971ec763a42d9b277341a14ec9c55_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItOS0xLTEtMTI2Mg_51869c19-c64a-4d07-9409-c96a5c40d074">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93472a617e4d4f6f9147a6e05189a34e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItMTEtMS0xLTEyNjI_e887cfc1-e1a3-44a2-8301-59ce3d98e20b">2,669,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f30efddbba4bc19c03af8bc5c7eaf6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItMTMtMS0xLTEyNjY_6fb0fae1-2103-4ff9-af00-b42d41c22464">1,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4c8e11b66a049928373daa1783da6a5_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItMTUtMS0xLTEyNjY_a3f7cf8f-db14-4eef-97d7-0a7cdb68c9e5">1,496,454</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItMTctMS0xLTEyNjY_bc303d00-de0c-44f3-ace6-fb84fed40cf3">1,174,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds of public offerings, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzMtMC0xLTEtNTE4MC90ZXh0cmVnaW9uOmQ2ZTA3NTM0ZDFmNDRhNmZhYzBlYjg2YTZhOWYwNWJiXzQ5NDc4MDIzMjUwNjg_0e26ec4f-c63f-4891-ae32-0bcfcd65cbd5">2,120</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzMtNy0xLTEtMTI2Mg_f9e0c345-6a58-4fa1-8001-37f6a55840ba">47,863,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzMtOS0xLTEtMTI2Mg_0a1c49d2-4684-44bc-8c78-5907f00ba1e1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87efeddd90154654bf0692ac7c3a035e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzMtMTEtMS0xLTEyNjI_02f2c914-c5f5-445a-851b-8d5ad3b86eab">1,852,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzMtMTctMS0xLTEyNjY_7c5ff33b-17d9-4243-b110-aec767c28423">1,852,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vesting of restricted common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzQtNy0xLTEtMTI2Mg_69069c3d-c695-426e-9f91-ff73f88c8dd2">247,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercise of options to purchase common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzUtNy0xLTEtMTI2Mg_2228bded-135e-420f-b010-ca0f08de6ac9">13,888,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzUtOS0xLTEtMTI2Mg_eca6cef7-5128-41a8-a100-ba227e832a32">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87efeddd90154654bf0692ac7c3a035e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzUtMTEtMS0xLTEyNjI_c4d4bc0b-d984-455f-bfb7-428648bdfa94">179,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzUtMTctMS0xLTEyNjY_4b79d72c-635c-41ff-ad70-abf917c76661">179,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of common stock under employee stock option purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzYtNy0xLTEtMTI2Mg_35297af5-beab-4c68-bf54-207a3d3c8cc5">251,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87efeddd90154654bf0692ac7c3a035e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzYtMTEtMS0xLTEyNjI_cf1c1839-26da-4098-b537-68cf9217a77d">7,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzYtMTctMS0xLTEyNjY_a56079f9-7150-4345-8b99-0c35897c761a">7,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87efeddd90154654bf0692ac7c3a035e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzctMTEtMS0xLTEyNjI_359d3e4c-0964-4755-9fef-2236670ac857">93,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzctMTctMS0xLTEyNjY_550d761c-d51b-4b50-8094-09b1287d0bff">93,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd928a22fd08462eafd4359a764e5cdf_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzgtMTMtMS0xLTEyNjY_ad8b1333-89b6-4fe4-b319-e1b304445b35">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzgtMTctMS0xLTEyNjY_e9dd75c9-58e3-4197-abf7-ec7c90569222">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e68e85a40d74b498b0bb46dec072277_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzktMTUtMS0xLTEyNjY_deddb0b6-0bbb-4962-8f6c-d290d318adf6">747,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzktMTctMS0xLTEyNjY_676fb7c6-8306-4ae6-a90b-0823244842c0">747,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-2.25pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic97698562fbd485a80018d02cce80260_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTItMS0xLTMyMjc_23714fab-e7c4-42e6-872e-12ab5bca16de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97698562fbd485a80018d02cce80260_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTQtMS0xLTMyMjU_58404688-847c-4cae-9c34-1d6cfa52e9b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id068aa2a6fcb49d59dfae933d3a4da27_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTctMS0xLTMyMjI_6d6f3a2a-a138-4b15-8dce-560830138cb5">398,787,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id068aa2a6fcb49d59dfae933d3a4da27_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTktMS0xLTMyMjA_1066181c-56e7-424a-95c5-bbee7401c1c7">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie66e5cf3847f4ccbb705424a971759bc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTExLTEtMS0zMjE3_776555d0-d814-480a-ac84-16dbf3b91e94">4,801,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29f3ebca75ec4b5b92053285ea842b9c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTEzLTEtMS0zMjE2_32ace6d3-8f0f-4ad7-baca-bba5c5f0c175">3,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ee6a6d175624d8c9cfc907e7bb82743_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTE1LTEtMS0zMjE0_fd6779cd-348f-4639-9784-f8e30a67990a">2,243,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTE3LTEtMS0zMjEy_923b83df-bf7d-47d1-bfd5-2db466ef5d98">2,561,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">189</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_130"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.512%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Years&#160;Ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMtMS0xLTEtMA_9fced919-e253-41a1-95f7-d0d9e6183028">747,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMtMy0xLTEtMA_4199136e-81bc-4dd5-947e-f52ee3736366">514,021</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMtNS0xLTEtMA_d40a47c9-00c4-440c-8f1f-1646ab339498">384,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzUtMS0xLTEtMA_7bae01a2-a4d9-4587-ba68-f653a0e9d2d4">93,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzUtMy0xLTEtMA_c10a0b7f-ec0e-4ed5-beda-dd014352edc9">81,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzUtNS0xLTEtMA_663c9404-dbe5-42ac-a313-17ad825cd158">72,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzYtMS0xLTEtMA_d14b29bc-833a-423d-8232-02f0cafd5b8c">31,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzYtMy0xLTEtMA_eb275401-c1aa-4657-ac0b-feab2d0e7ab1">31,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzYtNS0xLTEtMA_34228047-6853-4903-ba29-8f0b1d1001ed">24,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Leased assets expensed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctMS0xLTEtNzA4Ng_bcba2e81-2b45-4157-b3de-fa99aea49057">62,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctMy0xLTEtMTA2NjU_b3830b9c-4f6b-45df-8158-93dcf22e2317">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctNS0xLTEtMTA2Njc_837e09f8-752c-4cdb-a6a3-6c3e666ecbee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization/accretion of investments</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctMS0xLTEtMA_2491f657-7cc8-4e98-bd30-4b1154b54ff7">10,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctMy0xLTEtMA_ba97a090-4301-4b52-abd2-5b242cd39cbb">3,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctNS0xLTEtMA_db9283fa-e5cd-4bdf-9111-233b6371348c">1,866</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzgtMS0xLTEtMA_19d4a9af-d237-4cdb-aaf6-3d42d4aab1d1">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzgtMy0xLTEtMA_c86c7499-0f95-4b92-8112-1b27c6d60a68">316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzgtNS0xLTEtMA_363b100a-e6ee-4928-a760-e73fdf045adb">891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEwLTEtMS0xLTA_8520f3a5-f875-4368-a3d0-4041c4e25a63">1,385,191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEwLTMtMS0xLTA_429979aa-e769-4060-802b-d68e84a9e598">7,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEwLTUtMS0xLTA_cda17040-ab18-4631-aab0-6afc0ae891da">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 46pt;text-align:left;text-indent:-27pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEzLTEtMS0xLTcwOTQ_b980c570-20df-4b4f-919b-5690e48962cf">46,527</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEyLTMtMS0xLTEwNjY5_ca1d1ed3-88d4-42c8-bdf8-83a5dfa3e04c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEyLTUtMS0xLTEwNjcx_1591f89d-3ca6-45bf-b6d0-640eb3720f86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEyLTEtMS0xLTA_4fe68e69-4724-447e-b2a5-6b2adbabf1ce">241,041</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEyLTMtMS0xLTA_bb25e827-d521-41a2-abd8-1432b6e4efa8">9,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEyLTUtMS0xLTA_d6adb1d2-3887-4091-9fc5-1240e6063a5b">5,289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Right-of-use assets, operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:RightOfUseAssetOperatingLeases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEzLTEtMS0xLTA_36b5d21c-b211-412f-a0c9-2bee5801b3ae">10,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:RightOfUseAssetOperatingLeases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEzLTMtMS0xLTA_ee5189c2-d545-4f29-ae5c-69ade4d516a4">5,664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="mrna:RightOfUseAssetOperatingLeases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEzLTUtMS0xLTA_8aef66b6-8629-487c-b8aa-8c4ec8872ad1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE0LTEtMS0xLTA_22670753-617e-46dd-8b10-b57d0bb1cf20">11,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE0LTMtMS0xLTA_9f267732-71b5-45af-ad0c-87d71c6aa37c">23,964</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE0LTUtMS0xLTA_94f8c805-d2f0-4266-bb35-778f2041f31e">15,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE1LTEtMS0xLTA_c8d9c65b-ae6d-4150-8594-ed06eff3430b">388,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE1LTMtMS0xLTA_f66a0e50-3547-4c80-b345-f752cebc3ff8">3,362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE1LTUtMS0xLTA_e27b4ffe-e97a-4422-9aad-e498eacdda1d">8,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE2LTEtMS0xLTA_efd035a9-24a4-4e80-b8c3-240c91d39b94">3,842,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE2LTMtMS0xLTA_fe6acf14-f2a7-4133-8852-ae13624042e7">44,119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE2LTUtMS0xLTA_5949a673-04c5-4c7c-b77c-e437029f178f">65,260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred lease obligation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="mrna:IncreaseDecreaseInDeferredRentCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE3LTEtMS0xLTA_b05f6ec1-2932-4db2-88bf-b08bb1178eef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="mrna:IncreaseDecreaseInDeferredRentCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE3LTMtMS0xLTA_d7e22cc9-81a8-4d4e-a5ec-d50084e25e63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:IncreaseDecreaseInDeferredRentCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE3LTUtMS0xLTA_ba30bedf-62f3-4332-bc67-0c8b962bde04">2,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE4LTEtMS0xLTA_813d383c-bb54-4732-ac36-c33b1ea9638c">11,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE4LTMtMS0xLTA_776a6f19-d399-4ede-b095-8c39fe74c879">12,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="mrna:OperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE4LTUtMS0xLTA_3bc0f3ad-184f-48f4-817c-b21325f60410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE5LTEtMS0xLTA_5c358080-181b-4956-a8c6-21177aa8bdd9">5,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE5LTMtMS0xLTA_2eb5c217-f939-4bad-9940-a63233d07037">6,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE5LTUtMS0xLTA_5c07416e-54ac-4f39-b71e-6cf7b36c057d">910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIwLTEtMS0xLTA_fe22d444-9b9c-4e91-a859-49a33e6b67b7">2,026,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIwLTMtMS0xLTA_16886916-be3b-4f9d-8894-776589798cdb">458,968</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIwLTUtMS0xLTA_c8b253c9-dade-4817-8c68-f03f496cd1c0">330,865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIyLTEtMS0xLTA_10135f5d-a4f1-4da8-be37-aba8f23a1197">2,956,295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIyLTMtMS0xLTA_eb1ea61c-c4d0-412c-b4f2-eeb96e6345f3">1,145,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIyLTUtMS0xLTA_559e0845-c139-4b8e-b9cc-34f7f1c2ff48">1,227,709</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from maturities of marketable securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIzLTEtMS0xLTA_d16124fc-190e-4f0f-a8c8-cb0d8e236444">1,137,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIzLTMtMS0xLTA_c228622d-de6c-4e05-b520-43ac77b93cb3">993,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIzLTUtMS0xLTA_12ddf956-1b1b-4e7c-86be-54be365d368c">783,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sales of marketable securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI0LTEtMS0xLTA_367fe69f-4fd4-47a2-84be-94d5956acae0">214,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI0LTMtMS0xLTA_68a61d06-94d7-4b7a-a0e4-79a845cb8d23">168,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI0LTUtMS0xLTA_48daff39-d2f3-4118-994a-fdacf26edc8a">177,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI1LTEtMS0xLTA_f4db957f-bb4e-4dd5-8703-495add146252">67,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI1LTMtMS0xLTA_b82cb143-984a-4597-a40d-d888ba0c0bc6">31,554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI1LTUtMS0xLTA_2e431783-1220-4e3f-8207-664568a8df62">105,766</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI2LTEtMS0xLTA_abbccc1e-65fd-4c63-baf1-237f6495cde5">1,671,928</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI2LTMtMS0xLTA_9c7f854c-ded8-44bb-bd57-63a8f45a5e94">14,945</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI2LTUtMS0xLTA_a1888073-401b-41ce-bb96-c7202fbbad4c">373,094</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI4LTEtMS0xLTA_82f27c2e-fd77-442f-b2c1-caf4cff9f30e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI4LTMtMS0xLTA_ccce2062-3637-4fbb-8d0f-3b19adae833f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI4LTUtMS0xLTA_a0e3e864-640c-43a8-8d5f-ba27f0d7cc19">661,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from offerings of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI5LTEtMS0xLTA_08d13a07-b6e5-46a3-9a43-eae366071692">1,852,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI5LTMtMS0xLTA_8e6b4259-774f-435b-9291-2ca63580aec3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI5LTUtMS0xLTA_fc66f5c3-46ec-4686-83ab-03a4a9305a83">563,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchases of redeemable convertible preferred stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMwLTEtMS0xLTA_69e0d3f0-0160-4de0-9769-722d3540a13b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMwLTMtMS0xLTA_c8da560b-6d85-4ec0-9394-7ced8d3d84c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMwLTUtMS0xLTA_93b7484f-7757-449f-b629-df4a315a4d64">8,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock under equity plans</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMyLTEtMS0xLTA_3185d22a-ad53-48ec-beed-4e3d278dd1ed">179,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMyLTMtMS0xLTA_9fa0aee8-8211-489f-8533-266efbf59cf7">47,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMyLTUtMS0xLTA_a8c0e64e-80a9-4274-b106-e63ec4770d60">1,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from purchase of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMzLTEtMS0xLTA_4de82dee-fe88-4ffb-84ea-173079632735">7,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMzLTMtMS0xLTA_e6a83d74-b258-4239-ad27-286db9a4f688">2,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMzLTUtMS0xLTA_579da897-bec3-4465-a4c2-c8cd8999d9f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Charges to financing lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="mrna:ChargesToFinancingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM0LTEtMS0xLTA_1da23b5c-b479-48a6-ae25-7615e11e54a1">6,215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" name="mrna:ChargesToFinancingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM0LTMtMS0xLTA_a5d0a8ad-0e16-4d0f-8991-4a489d9e98f8">971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="mrna:ChargesToFinancingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM0LTUtMS0xLTA_03c07454-0cc6-4b97-981f-8a4e94a5f609">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reimbursement of assets under financing lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="mrna:ReimbursementOfAssetsFromLeaseFinancingObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM1LTEtMS0xLTA_9fbbac99-b0cd-4683-9141-75bef6f294e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="mrna:ReimbursementOfAssetsFromLeaseFinancingObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM1LTMtMS0xLTA_378924db-9fa4-484c-ad13-fdd9932852d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:ReimbursementOfAssetsFromLeaseFinancingObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM1LTUtMS0xLTA_0cd7760d-bd5e-4de4-8343-c995e34d384c">11,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments on financing lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="mrna:PaymentsForLeaseFinancingObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM2LTEtMS0xLTA_cb1cbec2-8d3d-4cd1-b304-dbe378995d9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="mrna:PaymentsForLeaseFinancingObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM2LTMtMS0xLTA_440bac19-945e-4c65-ae98-5523a9670029">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:PaymentsForLeaseFinancingObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM2LTUtMS0xLTA_05abe876-92fe-464d-9309-40407d616bea">2,175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM3LTEtMS0xLTA_8f4a66cb-67dc-41b2-afc4-4d8df58d53f8">2,033,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM3LTMtMS0xLTA_ea7e0dfd-a9fa-4853-b9b1-f09d7bed3934">51,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM3LTUtMS0xLTA_8c3d6063-0331-42ba-a11a-e84026be8b86">1,226,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM4LTEtMS0xLTA_e92a6175-2d4a-4cf4-aa26-d2a424608834">2,388,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM4LTMtMS0xLTA_8c55016d-b4ea-49e8-8740-98088077dfc3">422,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM4LTUtMS0xLTA_4c8e0f47-0567-412d-8337-2664d1b58c8b">522,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of year</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM5LTEtMS0xLTA_4f12d6d8-fc17-457b-bff9-d10aee8ae198">247,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20204b229a394d9ba8b28882826012db_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM5LTMtMS0xLTA_2fb949aa-b129-41e6-a04d-ae839fa8c863">670,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i857b3ef318484e959ca8a3dddeb3a486_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM5LTUtMS0xLTA_9ddaf37a-418e-4b13-9f77-e95d8ce4c3f5">147,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, end of year</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQwLTEtMS0xLTA_5f1b0795-fa17-4052-b5e7-5c601d51a740">2,635,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQwLTMtMS0xLTA_c41640ad-acac-4379-9def-8718b7c41d6e">247,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20204b229a394d9ba8b28882826012db_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQwLTUtMS0xLTA_29204ecc-6d64-4eaa-8070-645c9beb2ef7">670,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental cash flow information</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQyLTEtMS0xLTA_0a63be42-164b-45fb-a88a-c694c256d280">572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQyLTMtMS0xLTA_37f81e3c-3ba9-49e3-b4a3-fbc3ac6cc415">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQyLTUtMS0xLTA_4d546c98-ae5a-4af4-b329-f26f4ebd1f7e">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQzLTEtMS0xLTA_2454e999-743a-43f9-ad20-4e94b6e9cbf8">8,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQzLTMtMS0xLTA_3605ccdc-c80c-4f28-ac9c-b7e0ccef8501">5,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQzLTUtMS0xLTA_2522514a-7cda-4e28-b5c6-74119b80964e">2,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-cash investing and financing activities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance costs included in accounts payable and accrued liabilities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="mrna:StockIssuanceCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ1LTEtMS0xLTA_0adcbcc5-bf83-4acc-a47f-0c3e2a45484e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="mrna:StockIssuanceCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ1LTMtMS0xLTA_8c363df8-4564-4a81-becf-4c881b61bd43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:StockIssuanceCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ1LTUtMS0xLTA_246830ba-5f4d-48f3-9d75-8b4639e2dd0f">2,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment included in accounts payable and accrued liabilities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ2LTEtMS0xLTA_b5f304ba-7bb6-4f5f-8927-9cc02e72eae7">17,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ2LTMtMS0xLTA_dbad3c3b-970c-4e18-b2ae-5d0f360f50f9">4,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ2LTUtMS0xLTA_11f17ab1-d088-4a9f-9048-80046b6fa06f">12,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Leasehold improvements included in prepaid and other current assets</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="mrna:LeaseholdImprovementsIncurredButNotYetReimbursed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ3LTEtMS0xLTA_4ce6e6f5-0a09-4a2b-99ea-6ca6fbfa324a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="mrna:LeaseholdImprovementsIncurredButNotYetReimbursed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ3LTMtMS0xLTA_bae3f196-9a59-4ca7-9450-58f4c84473dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:LeaseholdImprovementsIncurredButNotYetReimbursed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ3LTUtMS0xLTA_93a2cde4-de93-43bc-8046-3cd6352c920c">10,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease financing obligation </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="mrna:LeaseFinancingObligationsIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ4LTEtMS0xLTA_2c27417b-62f7-4aea-ba4b-07a988615508">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="mrna:LeaseFinancingObligationsIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ4LTMtMS0xLTA_2e18212c-2cdc-42fd-afa7-c78c3e64df44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="mrna:LeaseFinancingObligationsIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ4LTUtMS0xLTA_2518ef19-2a6a-40d8-a9d7-ce9b1a23e4e7">10,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_133"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MODERNA, INC.</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_136"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzM3NTY_33735080-3de5-4fe0-a2f1-3b7aac2b189c" continuedAt="ia9eab91fb4db4802bb7a22282b980739" escape="true">Organization and Description of Business</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia9eab91fb4db4802bb7a22282b980739"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moderna, Inc. (collectively, with its consolidated subsidiaries, any of Moderna, we, us, or the Company) was incorporated in Delaware on July&#160;22, 2016. We are the successor in interest to Moderna LLC, a limited liability company formed under the laws of the State of Delaware in 2013. Our principal executive office is located at 200 Technology Square, Cambridge,&#160;MA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biotechnology company creating a new generation of transformative medicines based on messenger RNA (mRNA), to improve the lives of patients. mRNA medicines are designed to direct the body&#8217;s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Our platform builds on continuous advances in basic and applied mRNA science, delivery technology, and manufacturing, providing us the capability to pursue in parallel a robust pipeline of new development candidates.&#160;We are developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with our strategic collaborators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and an Interim Order from Health Canada authorizing the Moderna COVID-19 vaccine (also referred to as mRNA-1273) in the U.S. and Canada.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have incurred significant net losses, which were $<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzEwODI_2fedcd5d-6da1-4e6d-b38d-da4403002c5d">747.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzEwODY_5898d99f-04de-4037-ba32-128126f6a2c1">514.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzEwOTQ_6ab79c2e-fa94-43ce-86fd-7766c2254e9f">384.7</ix:nonFraction> million for the years ended December 31, 2020, 2019 and 2018, respectively. On February 14, 2020 and May 21, 2020, we sold <ix:nonFraction unitRef="shares" contextRef="i55d13e25166e42e0b68e9e232828cab2_D20200214-20200214" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAxNTU_94041882-64d8-46a5-987a-bf36825be273">30,263,158</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6566041abeee45e59cb8ea4c0287e489_D20200521-20200521" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAxNjc_4a88818c-373d-4372-9397-624128fa5055">17,600,000</ix:nonFraction> shares of common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="id2137fd0894d40d79052cb2714afe3e4_I20200214" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAxNzk_bf03e4e1-1f77-43ba-b14c-102eaae83fa0">19.00</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i7205067242fc4eb0a524f10be89aa910_I20200521" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAxODc_5167ded2-5554-4122-b48c-7a84acc50d89">76.00</ix:nonFraction> per share through public equity offerings, with aggregate net proceeds from the offering of $<ix:nonFraction unitRef="usd" contextRef="i55d13e25166e42e0b68e9e232828cab2_D20200214-20200214" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAxOTU_31932363-f7e8-4630-9199-bc76f08312d9">549.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6566041abeee45e59cb8ea4c0287e489_D20200521-20200521" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAyMTE_60cd7e8d-803e-47a2-9bf6-e79d0c31c621">1.30</ix:nonFraction>&#160;billion, respectively, net of underwriting discounts, commissions and offering expenses. As of December 31, 2020, we had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-7" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzEzOTM_aafac71e-142a-41fe-9f4d-caad676848af">2.24</ix:nonFraction> billion. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had <ix:nonFraction unitRef="program" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" name="mrna:NumberOfDevelopmentProgram" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzQ5NDc4MDIzNTY1ODc_2daf2603-50c4-442a-af1f-c6cf075f4d40">21</ix:nonFraction> mRNA development programs in our portfolio with 13 having entered the clinic. We expect to continue to incur significant expenses for the foreseeable future. If we seek to obtain regulatory approval for any of our investigational medicines, we expect to incur significant commercialization expenses. In addition, we anticipate that our expenses will increase significantly in connection with our development and commercializing our mRNA-1273 vaccine and ongoing activities to support our platform research, drug discovery and clinical development, including development of any new generations of vaccines against variants of SARS-CoV-2, infrastructure and Research Engine and Early Development Engine (which includes our Moderna Technology Center), digital infrastructure, creation of a portfolio of intellectual property, and administrative support. We may finance our future cash needs that exceed our operating costs through a combination of public or private equity offerings, structured financings and debt financings, government funding arrangements, strategic alliances and marketing, manufacturing, distribution and licensing arrangements. We may be unable to raise additional funds or enter into such other agreements on favorable terms, or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash, cash equivalents, and investments as of&#160;December 31, 2020&#160;will be sufficient to enable us to fund our projected operations through at least the next 12&#160;months from the issuance of our financial statements. We are subject to numerous risks and uncertainties associated with pharmaceutical development and commercialization, and we are unable to predict the timing or amount of expenses or when or if we will be able to achieve or maintain profitability. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce our operations.</span></div></ix:continuation><div><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_139"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzIz_7e7b2a19-6420-4ddb-9845-c8298663d3a8" continuedAt="if4a57658ccc6473ba76d2fe176fe8d86" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if4a57658ccc6473ba76d2fe176fe8d86" continuedAt="id1ba64d18804455ea3f9f328991272e3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjcz_be356195-438b-4a30-be33-02b05bc3ac13" continuedAt="i01bbf15bddf74adbbf00e0e9fc6abf25" escape="true">Our consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP). Any reference in these notes to applicable guidance is meant to refer to the authoritative accounting principles generally accepted in the United States as found in the Accounting Standard Codification (ASC) and Accounting Standards Updates (ASU) of the&#160;Financial Accounting Standards Board (FASB).</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">191</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="id1ba64d18804455ea3f9f328991272e3" continuedAt="i9b09f09d60ff4ad4a5a53bcf4069e5ad"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i01bbf15bddf74adbbf00e0e9fc6abf25">The consolidated financial statements include the Company and its subsidiaries.</ix:continuation> <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjYx_7760fdde-01d4-4deb-9ec6-9bd4b07b4dae" escape="true">All intercompany transactions and balances have been eliminated in consolidation.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjY0_295303f8-060a-44bc-b352-9920b8b377e9" escape="true">We have made estimates and judgments affecting the amounts reported in our consolidated financial statements and the accompanying notes. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, research and development expenses, income tax provisions, stock-based compensation, leases, derivative financial instruments, inventory, and useful lives of long-lived assets. We base our estimates on historical experience and various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The actual results that we experience may differ materially from our estimates. Significant estimates relied upon in preparing these financial statements include, among others, those related to fair value of equity awards, revenue recognition, research and development expenses, leases, fair value of financial instruments, useful lives of property and equipment, income taxes, and our valuation allowance on our deferred tax assets.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjg1_a9da7040-f0ce-4df1-bb6d-727570a6b083" escape="true">We have determined that our chief executive officer is the chief operating decision maker (CODM). The CODM reviews financial information presented on a consolidated basis. Resource allocation decisions are made by the CODM based on consolidated results. There are no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels or components below the consolidated unit level. As such, we have concluded that we operate as <ix:nonFraction unitRef="segment" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzIzMzM_33c1901f-773d-444d-90f8-e99c4c291da3">one</ix:nonFraction> segment.</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzI0_ebf7c6ee-4f18-4fe0-ada3-b8b770825c82" continuedAt="ib74fb7e1da714bc6983466de862b03bc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019, we adopted ASC 606&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) using the modified retrospective transition method applied to those contracts which were not completed as of January 1, 2019. We recognized the cumulative effect of the adoption as an adjustment to the opening balance of accumulated deficit in the current period consolidated balance sheet. Results for reporting periods beginning after January 1, 2019 are presented under ASC 606, while prior period amounts have not been adjusted and continue to be reported in accordance with our historic accounting (ASC 605). ASC 606 applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the appropriate amount of revenue to be recognized for arrangements that we determine are within the scope of ASC 606, we perform the following five steps (the five-step model): (i) identify the contract(s) with our customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when or as each performance obligation is satisfied. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is primarily generated through grants from government-sponsored and private organizations, product sales and collaboration arrangements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Grant Revenue</span></div><div style="padding-right:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have contracts with Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS); the U.S. government&#8217;s Defense Advanced Research Projects Agency (DARPA); the Bill &amp; Melinda Gates Foundation (Gates Foundation) and other government-sponsored and private organizations for research and development related activities that provide for payments for reimbursed costs, which may include overhead and general and administrative costs as well as a related profit margin. We recognize revenue from these contracts as we perform services under these arrangements when the funding is committed. Associated expenses are recognized when incurred as research and development expense. Revenues and related expenses are presented gross in the consolidated statements of operations as we have determined we are the primary obligor under the arrangements relative to the research and development services we perform as lead technical expert.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Collaboration Revenue</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for a contract with a customer that is within the scope of ASC 606 using the five-step model. We account for a contract with a customer that is within the scope of ASC 606 when all of the following criteria are met: (i) the arrangement has been approved by the parties and the parties are committed to perform their respective obligations; (ii) each party&#8217;s rights regarding the </span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">192</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i9b09f09d60ff4ad4a5a53bcf4069e5ad" continuedAt="ibb888f943be147b580e5fc76c91d5932"><ix:continuation id="ib74fb7e1da714bc6983466de862b03bc" continuedAt="i1ee39c47f23b41bda0ebf31e705b4b45"><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goods and/or services to be transferred can be identified; (iii) the payment terms for the goods and/or services to be transferred can be identified; (iv) the arrangement has commercial substance; and (v) collection of substantially all of the consideration to which we will be entitled in exchange for the goods and/or services that will be transferred to the customer is probable. We also determine the term of the contract based on the period in which we and our customer have present and enforceable rights and obligations for purposes of identifying the performance obligations and determining the transaction price.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate contracts that contain multiple promises to determine which promises are distinct. Promises are considered to be distinct and therefore, accounted for as separate performance obligations, provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer and (ii) the promise to transfer the good or service to the customer is separately identifiable from other promises in the contract.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual goods or services (or bundles of goods and/or services) that meet both criteria for being distinct are accounted for as separate performance obligations. Promises that are not distinct at contract inception are combined and accounted for as a single performance obligation. Options to acquire additional goods and/or services are evaluated to determine if such option provides a material right to the customer that it would not have received without entering into the contract. If so, the option is accounted for as a separate performance obligation. If not, the option is considered a marketing offer which would be accounted for as a separate contract upon the customer&#8217;s election.</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is generally comprised of an upfront payment due at contract inception and variable consideration in the form of payments for our services and materials and milestone payments due upon the achievement of specified events. Other payments the Company could be entitled to include tiered royalties earned when customers recognize net sales of licensed products.&#160;We measure the transaction price based on the amount of consideration to which we expect to be entitled in exchange for transferring the promised goods and/or services to the customer. We utilize either the expected value method or the most likely amount method to estimate the amount of variable consideration, depending on which method is expected to better predict the amount of consideration to which we will be entitled. Amounts of variable consideration are included in the transaction price to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to arrangements that include payments for a development or regulatory milestone payment, we evaluate whether the associated event is considered probable of achievement and estimate the amount to be included in the transaction price using the most likely amount method. Milestone payments that are not within our control or the licensee, such as those dependent upon receipt of regulatory approval, are not considered to be probable of achievement until the triggering event occurs. At the end of each reporting period, we re-evaluate the probability of achievement of each milestone and any related constraint, and if necessary, adjust our estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment. For arrangements that include sales-based royalties, including milestone payments based upon the achievement of a certain level of product sales, wherein the license is deemed to be the sole or predominant item to which the payments relate, we recognize revenue upon the later of: (i) when the related sales occur or (ii) when the performance obligation to which some or all of the payment has been allocated has been satisfied (or partially satisfied). Consideration that would be received for optional goods and/or services is excluded from the transaction price at contract inception. </span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allocate the transaction price to each performance obligation based on a relative standalone selling price basis. We develop assumptions that require judgment to determine the standalone selling price for each performance obligation in consideration of applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated research and development costs. However, in certain instances, we allocate variable consideration entirely to one or more performance obligation if the terms of the variable consideration relate to the satisfaction of the respective performance obligation and the amount allocated is consistent with the amount we would expect to receive for the satisfaction of the respective performance obligation.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue based on the amount of the transaction price that is allocated to each respective performance obligation when or as the performance obligation is satisfied by transferring a promised good or service to the customer. For performance obligations that are satisfied at a point in time, we recognize revenue when control of the goods and/or services is transferred to the customer. For performance obligations that are satisfied over time, we recognize revenue by measuring the progress toward complete satisfaction of the performance obligation using a single method of measuring progress which depicts the performance in transferring control of the associated goods and/or services to the customer. We generally use input methods to measure the progress toward the complete satisfaction of performance obligations satisfied over time. With respect to arrangements containing a license to our intellectual property that is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from amounts allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, we utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. Significant management judgment is required in </span></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">193</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="ibb888f943be147b580e5fc76c91d5932" continuedAt="i3dcff8bad0424eb8a912d6289ec01c87"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1ee39c47f23b41bda0ebf31e705b4b45">determining the level of effort required under an arrangement and the period over which we are expected to complete our performance obligations under an arrangement. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment.</ix:continuation></span></div><div><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Product Sales </span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales are associated with our COVID-19 vaccine supply agreements with the U.S. Government and international government agencies. These agreements generally do not provide provisions for various forms of variable consideration, such as discounts, rebates or returns. We recognize revenue from product sales, using the five-step model under ASC 606, based on the fixed price per dose according to the contracts when control of the product transfers to the customer and customer acceptance has occurred, unless such acceptance provisions are deemed perfunctory. </span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjgw_c8101d9b-05d9-4e8d-8b20-c7bd38286ed5" escape="true">We consider all highly liquid investments with an original maturity of 90&#160;days or less from the date of purchase to be cash equivalents.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjgx_11f9b0e4-8332-46d0-b621-d766eb2e0729" escape="true">Restricted cash is composed of amounts held on deposit related to our lease arrangements. The funds are maintained in money market accounts and are recorded at fair value. We classify our restricted cash as either current or non-current based on the terms of the underlying lease arrangement.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash shown in the Consolidated Statements of Cash Flows</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzEwNDQ1MzYwNjczNzI3_07e301d8-766f-432c-8b12-051fa91b94c8" escape="true"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzEwNDQ1MzYwNjczNzI3_39db6d09-5365-4bf5-8ffb-290371b66b1d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzItMi0xLTEtNzk1MQ_514cf3a2-f62f-4ba4-acf7-32115fcf82af">2,623,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzItNC0xLTEtNzk1MQ_7ebe46cf-75be-42b2-9e2e-b2f28761802c">235,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzMtMi0xLTEtNzk1MQ_d11d9686-ef55-4ca3-96a5-769bb566134d">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzMtNC0xLTEtNzk1MQ_9339a6ec-2a3f-4efa-8c28-3cd683c42e0c">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, non-current </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzQtMi0xLTEtNzk1MQ_a8ba823b-c07c-4a22-b718-087f537f0a0f">11,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzQtNC0xLTEtNzk1MQ_54e2509b-50bc-4f7f-80b7-bda3808e49e4">10,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash shown in the consolidated<br/>    statements of cash flows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzUtMi0xLTEtMTA2ODA_d254a136-3374-41a2-bc69-2efdb2ec5d3a">2,635,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzUtNC0xLTEtMTA2ODI_d5ce5836-ab31-4283-80c5-6b752174ba2f">247,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzA5_1ef41553-b2f3-4df5-901e-cebc9ba349a1" continuedAt="i2cda501bc1824ed887848d986715ff7e" escape="true">We invest our excess cash balances in marketable debt securities. We classify our investments in marketable debt securities as available-for-sale. We report available-for-sale investments at fair value at each balance sheet date, and include any unrealized holding gains and losses (the adjustment to fair value) in accumulated other comprehensive gain (loss), a component of stockholders&#8217; equity. Realized gains and losses are determined using the specific-identification method, and are included in other (expense) income, net in our consolidated statements of operations. We classify our available-for-sale marketable securities as current or non-current based on each instrument&#8217;s underlying effective maturity date and for which we have the intent and ability to hold the investment for a period of greater than <ix:nonNumeric contextRef="ie1dc78c134c44ed99d6c12dca67dd5b3_D20200101-20201231" format="ixt-sec:durmonth" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE4OTE1_241ac262-d24d-4ffa-9171-3743d3b0761c">12</ix:nonNumeric> months. Marketable securities with maturities of less than <ix:nonNumeric contextRef="ie35d35ef9a724996964e8f367d178412_I20201231" format="ixt-sec:durmonth" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE4OTc3_4c1ce54f-b6b4-451d-b969-03b3c353396d">12</ix:nonNumeric>&#160;months are classified as current and are included in investments in the consolidated balance sheets. Marketable securities with maturities greater than <ix:nonNumeric contextRef="ib024df048b7a4866887eea7ae4717c0f_I20201231" format="ixt-sec:durmonth" name="us-gaap:DebtSecuritiesAvailableForSaleTerm" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE5MTMy_378b31ea-218c-4be4-9aa2-9719fdbaa426">12</ix:nonNumeric>&#160;months for which we have the intent and ability to hold the investment for greater than <ix:nonNumeric contextRef="ie1dc78c134c44ed99d6c12dca67dd5b3_D20200101-20201231" format="ixt-sec:durmonth" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE5MjIz_3804f95b-4e3c-4add-9680-a9ac6dbc482a">12</ix:nonNumeric> months are classified as non-current and are included in investments, non-current in the consolidated balance sheets.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2cda501bc1824ed887848d986715ff7e">We evaluate securities for impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and our intent and ability to hold the investment to allow for an anticipated recovery in fair value. A credit-related impairment is recognized as an allowance on the balance sheet with a corresponding adjustment to earnings. Any impairment that is not credit- related is recognized in other comprehensive (loss) income, net of applicable taxes.</ix:continuation> </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><ix:continuation id="i3dcff8bad0424eb8a912d6289ec01c87" continuedAt="i571da6e32b2c44feb3fe11e91cd911fe"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjg4_0915b706-a2de-4b92-acba-84aabda69812" escape="true">We have accounts receivable amounts due from our product sales and related vaccine supply agreements and our grant agreements. We also have accounts receivable amounts due from strategic collaborators as a result of manufacturing and research and development services provided under collaboration arrangements, or milestones achieved, but not yet paid. Amounts payable to us are recorded as accounts receivable when our right to consideration is unconditional. To estimate the allowance for doubtful accounts, we make judgments about the creditworthiness of our customers based on ongoing credit evaluation and historical experience.</ix:nonNumeric> There was <ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE5OTgw_9ca38582-7471-4ffc-acb6-1df6ba6272ad"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE5OTgw_cce69047-f928-4a5d-a512-624ec805bd04">no</ix:nonFraction></ix:nonFraction> allowance for doubtful accounts at December 31, 2020, and 2019. There was <ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzIwMDQw_204167f3-4943-4778-81f3-1e1e68cd6747"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzIwMDQw_5cce395f-1868-461c-99ad-aaa1340ddc55"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzIwMDQw_a13b0573-7576-4312-a59f-93f8a1b88f94">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> bad debt expense for the years ended December 31, 2020, 2019 or 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzA0_b770ccdc-5fb1-41bf-b135-66d1dada60ba" escape="true">Financial instruments that subject us to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, marketable securities, and accounts receivable. Our investment portfolio comprises money market funds, marketable debt securities, including U.S. Treasury securities, debt securities of U.S. government agencies and corporate entities and commercial paper. Our cash management and investment policy limits investment instruments to investment-grade securities with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations. Bank accounts in the United States are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. Our primary operating accounts significantly exceed the FDIC limits.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:MajorCustomersPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzA1_55fed40b-67e9-45dd-82f1-f31e1b821b13" escape="true">Our accounts receivable are generally unsecured and are from customers in different countries. We generated revenue from grants made by government-sponsored and private organizations, product sales to the U.S. Government and international government agencies, and to a lesser extent, strategic alliances in 2020. Historically, we generated revenue primarily from strategic alliances.</ix:nonNumeric> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjk3_d3cf8238-5111-4cf9-9368-0b1b3cbdb726" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our revenue to date has been generated from the following entities that accounted for more than 10% of total revenue and accounts receivable for the periods presented:</span></div><div style="padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:50.153%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage&#160;of&#160;Revenue</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years&#160;Ended&#160;December&#160;31,</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage&#160;of&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accounts&#160;Receivable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6112e1e86f8340e6bab6155f0e0c14fe_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzItMy0xLTEtMA_551a4325-e443-4e6f-a7dd-1400ebde9b84">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i662ae8da17484626ac7417cac28e5c33_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzItNS0xLTEtMA_c0e4bf6d-f14b-4937-b156-065698e62e80">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ed2d47d1bf04e3aa23981e0213f4b17_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzItOS0xLTEtMA_5ab5a32f-eb1c-4fe8-8216-055b06377cfe">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i99de0fc656f94330bd58911cad710714_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzMtMS0xLTEtMA_2d383cde-1a99-400e-ba5f-3d616d882787">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01b7a2e27528463b8cd957d79fab92e6_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzMtMy0xLTEtMA_06e7bf47-a6b4-4925-af5e-75f2f2a6e936">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i28e4b001726a427395f0430b3d5fa7c3_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzMtNy0xLTEtMA_0348abee-2fe0-484a-8441-7e1b254b2f4d">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3739e5568de9403ab6f1602f4947f2cf_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzMtOS0xLTEtMA_7068c07a-465a-4150-8871-9150086fb508">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i58174bed8d7245f089be80163f527519_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzQtMy0xLTEtMA_ba688c60-3bc5-4c13-972e-d511dc56c8e2">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib97f41aa68a0406294fb319c1cc8c64f_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzQtOS0xLTEtMA_84027cdf-a4c2-4bd8-ad38-e55365fe03b1">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f19d573adc242b8b4b58f70beb853bb_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzUtNS0xLTEtMA_7c2c15ee-af5a-45ba-b3eb-710924b20fb7">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government (excluding BARDA)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i16562820b2134dc09272d9b7168eea9e_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzYtMS0xLTEtMTE1Mjk_b93c6506-55ab-4f51-8391-a052b72276d4">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Commission</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i603a16907cb440afbec844ba69c28bce_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzctNy0xLTEtMTE1Mzg_cae620f2-6e83-4195-8bca-10bfeca67766">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom Government</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1d64ff60176946838aa93ccb8d36219f_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzgtNy0xLTEtMTY1OTM_cd853178-c22d-4207-ae43-5a6848e102ef">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea Government</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc33946b21844fddad6112c90f37042e_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzgtNy0xLTEtMTY1NjM_707c0c0b-19a2-4296-85cc-f45c2c1db1ba">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">* - Represents an amount of less than 10%</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">195</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><ix:continuation id="i571da6e32b2c44feb3fe11e91cd911fe" continuedAt="i0e609c4079d94017bf2fa20c4aef49da"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc1ODY_0922137b-4d51-4c69-b49c-ad2e590f1551" escape="true">We record all derivatives on our consolidated balance sheets at fair value. The accounting for changes in the fair value of a derivative depends on whether the derivative has been designated and qualifies for hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. We may enter into derivative contracts that are intended to economically hedge certain risk, even though hedge accounting does not apply or we elect not to apply hedge accounting. Foreign currency gains or losses associated with derivatives that are not designated as hedging instruments for accounting purposes are recorded within other (expense) income, net, in our consolidated statements of operations.</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjk4_b94e7fb3-7aeb-413f-a2ea-9c15893ecc04" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as risks inherent in valuation techniques, transfer restrictions and credit risk. FASB ASC Topic&#160;820,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC&#160;820), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and our assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from our independent sources. Unobservable inputs are inputs that reflect our assumptions about the inputs that market participants would use in pricing the asset or liability, and are developed based on the best information available in the circumstances. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used to value the assets and liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level&#160;2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; or</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e.,&#160;supported by little or no market activity).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash equivalents and marketable securities are reported at fair value determined using Level&#160;1 and Level&#160;2 inputs (Note&#160;6). The fair value of our foreign currency forward contracts is calculated using Level 2 inputs, which include currency spot rates, forward rates, interest rate curve and credit or non-performance risk (Note 7). We do not have any non-financial assets or liabilities that should be recognized or disclosed at fair value on a recurring basis at December 31, 2020, 2019 and 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and 2019, we maintain letters of credit of $<ix:nonFraction unitRef="usd" contextRef="i2d723b3d7ee4498a8404a7814a0df9d8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzMyOTg1MzUxNDIyODU_7d9582d4-5f0c-46a2-b6b9-c40a226b2b82">12.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iec2caba51ae04f34a09ef377a92c70a0_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzI0MjY4_e7738d5e-8b14-48fc-9313-6cb645c6fa4a">11.8</ix:nonFraction> million, respectively, related to our lease arrangements, which are secured by money market accounts in accordance with certain of our lease agreements. The amounts are recorded at fair value using Level 1 inputs and included as restricted cash in our consolidated balance sheets.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc1ODg_2fb2a03d-6a92-439c-8c1a-b0090d067482" continuedAt="ifd9b64bb20994f28a5f13b57c32b0d35" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is recorded at the lower of cost or net realizable value, with cost determined on a first-in, first-out (FIFO) basis. We periodically review the composition of inventory in order to identify excess, obsolete, slow-moving or otherwise unsaleable items. If unsaleable items are observed and there are no alternate uses for the inventory, we will record a write-down to net realizable value in the period that the decline in value is first recognized through a charge to cost of sales. The determination of whether inventory costs will be realizable requires estimates by management. If actual market conditions are less favorable than projected by management, additional write-downs of inventory may be required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to an initial regulatory approval for our investigational medicines, we expense costs relating to raw materials and production of inventory as research and development expense in our consolidated statements of operations, in the period incurred. When we believe regulatory approval and subsequent commercialization of our investigational medicines is probable, and we also expect future </span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">196</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i0e609c4079d94017bf2fa20c4aef49da" continuedAt="i87e28f813e7f42e2870b564c5c1043a5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifd9b64bb20994f28a5f13b57c32b0d35" continuedAt="i5a9641744069468fb3bb1524b098b269">economic benefit from the sales of the investigational medicines to be realized, we will then capitalize the costs of production as inventory. </ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5a9641744069468fb3bb1524b098b269">Upon the authorization of distribution and use of our COVID-19 vaccine under an EUA in December 2020, we began to capitalize inventory costs associated with our COVID-19 vaccine, as it was determined that inventory costs incurred subsequent to the EUA had a probable future economic benefit.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction in Progress</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjgy_b1b38dad-bfd0-4e39-b1b4-b24b04449459" continuedAt="i81c87040b37e4d508f6c3973872f5a0e" escape="true">Construction in progress includes direct costs related to the construction of various property and equipment, including leasehold improvements, and is stated at original cost. Construction in progress includes costs incurred under construction contracts including project management services, engineering services, design services and development, construction services and other construction-related fees and services. Such costs are not depreciated until the asset is completed and placed into service. Once the asset is placed into service, these capitalized costs will be allocated to certain property and equipment categories and will be depreciated over the estimated useful life of the underlying assets. </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div><span><br/></span></div><ix:continuation id="i81c87040b37e4d508f6c3973872f5a0e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjc4_62dc8b62-5faf-4542-920e-4bc94ecc6092" continuedAt="i303bfe0a21e64d0c8f38528ad1aaf3c0" escape="true">The estimated useful lives of property and equipment are described below:</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="i303bfe0a21e64d0c8f38528ad1aaf3c0" continuedAt="i977343811e2d4e4ea8f6d9bcd473963c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.552%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Useful&#160;Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i30999b30a90f434baeec1c4aabafdfc4_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2YjRiMDI4OWQ0YWI0OTVmYTg4ZDdjMDk5ZjMxMzJjZi90YWJsZXJhbmdlOjZiNGIwMjg5ZDRhYjQ5NWZhODhkN2MwOTlmMzEzMmNmXzEtMi0xLTEtMA_ef07cce0-7874-4b57-8d1a-d7ea3485f733">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lesser&#160;of&#160;estimated&#160;useful&#160;life&#160;of&#160;improvement</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or&#160;remaining life of related lease</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6025964d375a48f6b8048f71aa7069de_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2YjRiMDI4OWQ0YWI0OTVmYTg4ZDdjMDk5ZjMxMzJjZi90YWJsZXJhbmdlOjZiNGIwMjg5ZDRhYjQ5NWZhODhkN2MwOTlmMzEzMmNmXzMtMi0xLTEtMA_0371cbd0-477f-41af-afaa-5083f3b66e1d">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ab4195256a147e9aca2014d6016eea5_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2YjRiMDI4OWQ0YWI0OTVmYTg4ZDdjMDk5ZjMxMzJjZi90YWJsZXJhbmdlOjZiNGIwMjg5ZDRhYjQ5NWZhODhkN2MwOTlmMzEzMmNmXzQtMi0xLTEtMTA2ODU_3f38df3b-0245-493c-832c-8dc3a3751b2f">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic83f219ce3544b4fad28aa2afd18bf74_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2YjRiMDI4OWQ0YWI0OTVmYTg4ZDdjMDk5ZjMxMzJjZi90YWJsZXJhbmdlOjZiNGIwMjg5ZDRhYjQ5NWZhODhkN2MwOTlmMzEzMmNmXzQtMi0xLTEtMA_1ffa2cd4-efd7-46b5-9efb-a40ce98ddd39">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset, financing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease term</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for maintenance and repairs are charged to expense as incurred. Upon retirement or sale, the cost of the assets disposed of, and the related accumulated depreciation, are removed from the accounts, and any resulting gain or loss is recorded to other (expense) income, net.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjcy_7e548fdf-18a5-4fcd-9bb6-dbf507ed47f0" escape="true">We evaluate our long-lived assets, which consist of property and equipment, to determine if facts and circumstances indicate that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess the recoverability of the long-lived assets by comparing the projected future undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. If such review indicates that such cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair values based on the expected discounted future cash flows attributable to the assets or based on appraisals.</ix:nonNumeric> For the year ended December 31, 2020, we incurred $<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzEwNDQ1MzYwNzIyODE1_6fead72c-1a6b-4d04-bed5-6df835c1eb66">1.6</ix:nonFraction>&#160;million of impairment expenses. We did <ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzI2Njcw_0ec45ade-4ae2-442a-892f-eb84a1dd9859"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzI2Njcw_9799924b-7cce-42a5-a139-8ec43922a9fe">no</ix:nonFraction></ix:nonFraction>t record any impairment expenses for the years ended December 31,2019 and 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzE1_6a40b4ad-d432-469d-b415-23222dcc10de" continuedAt="i5121d7bdca304d82a02d11d85d12512e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASC 842 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) on January 1, 2019 on a modified retrospective basis under which we recognized and measured leases existing at, or entered into after, the beginning of the period of adoption. We elected the optional transition approach of not adjusting our comparative period financial statements for the impacts of adoption. Therefore, we recognized the effects of applying ASC 842 as a cumulative-effect adjustment to accumulated deficit as of January 1, 2019, the effective date of this standard. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases are classified at their commencement date, which is defined as the date on which the lessor makes the underlying asset available for use by the lessee, as either operating or finance leases based on the economic substance of the agreement. We recognize lease right-of-use assets and related liabilities in our consolidated balance sheets for both operating and finance leases. Lease liabilities are measured at the lease commencement date as the present value of the future lease payments using the interest rate implicit in the </span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">197</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i87e28f813e7f42e2870b564c5c1043a5" continuedAt="if3d646741d3a408d8a26752498bdbcfe"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5121d7bdca304d82a02d11d85d12512e" continuedAt="i07146b9a0eb3411a90847f9738cafed5">lease. If the rate implicit is not readily determinable, we will utilize our incremental borrowing rate as of the lease commencement date. Lease right-of-use assets are measured as the lease liability plus initial direct costs and prepaid lease payments less lease incentives. The lease term is the non-cancelable period of the lease and includes options to extend or terminate the lease when it is reasonably certain that an option will be exercised. </ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i07146b9a0eb3411a90847f9738cafed5">We recognize operating lease cost in operating expense in our consolidated statements of operations, inclusive of rent escalation provisions and rent holidays, on a straight-line basis over the respective lease term. For our finance leases, we recognize depreciation expense associated with the leased asset acquired and recognize interest expense related to the portion of the financing in our consolidated statements of operations. Additionally, we recognize tenant improvement allowances as a reduction to rent expense on a straight-line basis over the respective lease term.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc1ODk_a2a14f1d-bcbd-4429-aaa0-ca55d9da45a5" escape="true">Cost of sales includes cost of raw materials, production, transportation, freight and indirect overhead costs associated with our product revenue during the period and third-party royalties on net sales of our product. Cost of sales also includes adjustments for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjg2_07733877-c748-4ee6-9702-fade07bccb97" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred in performing research and development activities, including salaries and benefits, facilities costs, overhead costs, prelaunch inventory costs, contract services, and other outside costs. The value of goods and services received from contract research organizations and contract manufacturing organizations in the reporting period are estimated based on the level of services performed, and progress in the period in cases when we have not received an invoice from the supplier. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment or facilities that are acquired or constructed for research and development activities and that have alternative future uses, in research and development projects or otherwise, should be capitalized and depreciated as tangible assets. However, the costs of equipment or facilities that are acquired or constructed and intangibles that are purchased from others for a particular research and development project and that have no alternative future uses and therefore no separate economic values are considered research and development costs and are expensed when incurred. Certain equipment and leased facilities purchased for our COVID-19 vaccine program prior to the EUA from the FDA were deemed to have no alternative use. The related acquisition costs of such equipment and lease facilities of $<ix:nonFraction unitRef="usd" contextRef="i89a7968116c24dfeb8928db01baf0eb1_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzM4NDgyOTA5NjM0MzY_1ae44026-0454-4b3b-b40f-f3040d75a3ee">109.6</ix:nonFraction>&#160;million were charged to research and development expense for the year ended December 31, 2020. We did <ix:nonFraction unitRef="usd" contextRef="i0be93c00c40a4fb988eceb1c1a2692d9_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc1OTA_a22f8320-a3eb-442c-ba8b-f7c965641354"><ix:nonFraction unitRef="usd" contextRef="i6805eb08d3d64693bd8d92b3308b8e5a_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc1OTA_cc4878ad-f21b-40f8-a400-ee98acf16873">no</ix:nonFraction></ix:nonFraction>t recognize such expense for the years ended December 31, 2019 or 2018.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patent Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="mrna:PatentCostsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzA3_3b57408f-14fe-448b-b584-75fa56ea64e8" escape="true">Costs to secure, defend and maintain patents are expensed as incurred, and are classified as selling, general and administrative expenses due to the uncertainty of future benefits.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">198</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="if3d646741d3a408d8a26752498bdbcfe" continuedAt="i09e93de6be30496a9917d89c4564f351"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjYz_95998690-76c9-4e5f-b643-0acee0d2fb56" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issue stock-based awards to employees and non-employees, generally in the form of stock options and restricted stock units (RSUs). We account for our stock-based compensation awards in accordance with ASC 718,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Most of our stock-based awards have been made to employees. We measure compensation cost for equity awards at their grant-date fair value and recognize compensation expense over the requisite service period, which is generally the vesting period, on a straight-line basis. The grant date fair value of stock options is estimated using the Black-Scholes option pricing model, which requires management to make assumptions with respect to the fair value of our common stock on the grant date, including the expected term of the award, the expected volatility of our stock, calculated based on a period of time generally commensurate with the expected term of the award, risk-free interest rates and expected dividend yields of our stock. Historically, for periods prior to our IPO, the fair value of the shares of common stock and common units underlying our stock-based awards were determined on each grant date by our board of directors based on valuation estimates from management considering our most recently available independent third-party valuation of our common stock. Our board of directors also assessed and considered, with input from management, additional objective and subjective factors that we believed were relevant and which may have changed from the date of the most recent valuation through the grant date. The grant date fair value of RSUs is estimated based on the fair value of our underlying common stock. For performance-based stock awards, we recognize stock-based compensation expense over the requisite service period using the accelerated attribution method when achievement is probable. We classify stock-based compensation expense in our consolidated statement of operations in the same manner in which the award recipient&#8217;s salary and related costs are classified or in which the award recipient&#8217;s service payments are classified.</span></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc2MDQ_4f45c5fa-8b31-4bd4-810f-969d1fcc36e5" escape="true">We use an asset and liability approach to account for income taxes. We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. These differences are measured using the enacted statutory tax rates that are expected to be in effect for the years in which differences are expected to reverse. Valuation allowances are provided when the expected realization of deferred tax assets does not meet a &#8220;more likely than not&#8221; criterion. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss. We recognize tax benefits from uncertain tax positions if we believe the position is more likely than not to be sustained on examination by the taxing authorities based on the technical merits of the position. We make adjustments to these reserves when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. The provision for income taxes includes the effects of any reserves for tax positions that are not more likely than not to be sustained, as well as the related net interest and penalties.</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss per Share Attributable to Common Stockholders</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzI2_c72be0eb-d842-401a-92da-cbe72119f66d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period, without consideration for common stock equivalents. Upon the closing of our IPO, all outstanding shares of our redeemable convertible preferred stock were converted into common stock. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate diluted net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding after giving consideration to the dilutive effect of restricted common stock and stock options that are outstanding during the period. We have generated a net loss in all periods presented, therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjkz_20ca9909-a887-4155-b19b-729a5523b1eb" escape="true">Comprehensive loss includes net loss and other comprehensive income (loss) for the period. Other comprehensive income (loss) mainly consists of unrealized gains and losses on our investments. Total comprehensive income (loss) for all periods presented have been disclosed in the consolidated statements of comprehensive loss.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">199</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i09e93de6be30496a9917d89c4564f351"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzIx_8893231a-b6b7-4bdf-ab2f-3b262875ce35" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive gain (loss) for the years ended December 31, 2020 and 2019 are as follows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized&#160;Gain on Available-for-Sale Debt Securities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0ea47aa0744431696869108e3c2ba80_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2NDc1ZDhkMzRiOTA0ZjFlYmEwMzczMDlmMjI3ZDM4Ny90YWJsZXJhbmdlOjY0NzVkOGQzNGI5MDRmMWViYTAzNzMwOWYyMjdkMzg3XzEtMS0xLTEtMA_170f4a62-adb0-4df5-be2b-09dfff1bf7a5">1,320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84920da0b3254bb3a9cda664635471b7_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2NDc1ZDhkMzRiOTA0ZjFlYmEwMzczMDlmMjI3ZDM4Ny90YWJsZXJhbmdlOjY0NzVkOGQzNGI5MDRmMWViYTAzNzMwOWYyMjdkMzg3XzItMS0xLTEtMA_862b3cdc-d8dc-4634-b517-38de434a8b1e">3,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive gain, balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i388d1c703c504e9b9dab1f15168e6519_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2NDc1ZDhkMzRiOTA0ZjFlYmEwMzczMDlmMjI3ZDM4Ny90YWJsZXJhbmdlOjY0NzVkOGQzNGI5MDRmMWViYTAzNzMwOWYyMjdkMzg3XzMtMS0xLTEtMA_ae2f6198-75bf-4afe-8ebf-6ab39ce17818">1,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9725be67d18a4c3bb82d57ad987d47ea_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2NDc1ZDhkMzRiOTA0ZjFlYmEwMzczMDlmMjI3ZDM4Ny90YWJsZXJhbmdlOjY0NzVkOGQzNGI5MDRmMWViYTAzNzMwOWYyMjdkMzg3XzQtMS0xLTEtMA_39dbba89-04eb-4771-b5e1-fa4e2a954922">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive gain, balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc74a29947d5452483558254ae2b1c81_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2NDc1ZDhkMzRiOTA0ZjFlYmEwMzczMDlmMjI3ZDM4Ny90YWJsZXJhbmdlOjY0NzVkOGQzNGI5MDRmMWViYTAzNzMwOWYyMjdkMzg3XzUtMS0xLTEtMA_e0bc8f7f-63f6-4276-abfe-3d6d7c632b78">3,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjY4_0e968637-88e4-4ea5-a423-898dbf0f2c96" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard changes how companies account for credit losses for most financial assets and certain other instruments. For trade receivables, loans and held-to-maturity debt securities, companies will be required to recognize an allowance for credit losses rather than reducing the carrying value of the asset. The amendments in this standard should be applied on a modified retrospective basis to all periods presented. We adopted this standard in the first quarter of 2020. Based on the composition of our investment portfolio and investment policy, the adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Topic 350): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard requires capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). We adopted this standard in the first quarter of 2020 using the prospective method. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard removes certain exceptions for investments, intra-period allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. We early adopted this standard in the second quarter of 2020. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial statements and disclosures.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">200</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_151"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzMzMTA_beffe83f-b78f-4407-9ca1-09344f0b472d" continuedAt="ic30ec607d16c4706b161232c1f78f4be" escape="true">Grant Revenue</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic30ec607d16c4706b161232c1f78f4be" continuedAt="icd2257f855cc40ee96c2c38b47627179"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into an agreement with the Defense Advanced Research Projects Agency (DARPA) for an award of up to $<ix:nonFraction unitRef="usd" contextRef="i75fc0823bd854f9eba408cdefffe8ccf_D20200901-20200930" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsMaximumAward" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkxNzU_80c7f035-2edd-4162-8530-7fe1948511e1">56.4</ix:nonFraction>&#160;million to fund development of a mobile manufacturing prototype leveraging our existing manufacturing technology that is capable of rapidly producing vaccines and therapeutics. As of December 31, 2020, the committed funding, net of revenue earned was $<ix:nonFraction unitRef="usd" contextRef="ie1df42e92dce49dfb7a34fa78d50f687_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsCurrentFundingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzEwNDQ1MzYwNDgyNjI3_05a2babe-7098-4d3a-940b-013aabbb3f0d">4.6</ix:nonFraction>&#160;million, with an additional $<ix:nonFraction unitRef="usd" contextRef="ie1df42e92dce49dfb7a34fa78d50f687_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsRemainingFundingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyMDQ_30cbd343-d2cd-4bfa-805f-da8322b761d5">51.4</ix:nonFraction>&#160;million available if DARPA exercises additional contract options.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we entered into an agreement with BARDA for an award of up to $<ix:nonFraction unitRef="usd" contextRef="i013d6d10db654139a2efe361d808fc22_D20200401-20200430" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsMaximumAward" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyMTk_f4a89c52-0e81-4772-9014-9dd6d22cbd64">483.3</ix:nonFraction>&#160;million to accelerate development of mRNA-1273, our vaccine candidate against COVID-19. In July 2020, we amended our agreement with BARDA to provide for an additional commitment of up to $<ix:nonFraction unitRef="usd" contextRef="i131a90691cbf4509abc1ae852ebc77cc_I20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherCommitment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyMzU_71b649cd-6561-4e1c-8426-9392e25820b9">471.6</ix:nonFraction>&#160;million to support late-stage clinical development of mRNA-1273, including the execution of a 30,000 participant Phase 3 study in the U.S. The amendment increased the maximum award from BARDA from $<ix:nonFraction unitRef="usd" contextRef="ieb1114d7eef04248a3529921433f9c96_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsMaximumAward" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyNTE_b697a912-8444-41a6-b548-a30307404a06">483.3</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="ie91dd2c660e24460ab55f89af07de6dd_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsMaximumAward" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyNjc_7bb8065a-fc63-4753-8001-70a420fb4659">954.9</ix:nonFraction>&#160;million. Under the terms of the agreement, BARDA will fund the advancement of mRNA-1273 to FDA licensure. All contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $<ix:nonFraction unitRef="usd" contextRef="ic1cec659c0ff4e069c4d60941677a150_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsCurrentFundingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyODM_ac240a34-fbd1-46dc-97a6-6c8a3e56283d">444.3</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2016, we received an award of up to $<ix:nonFraction unitRef="usd" contextRef="i8f900a7ac5af4c7da858cc85cc212124_D20160901-20160930" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsMaximumAward" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyOTk_f3fd9cb9-8110-4909-af1f-fb27c24de2c0">125.8</ix:nonFraction>&#160;million from BARDA, to help fund our Zika vaccine program. <ix:nonFraction unitRef="contract_option" contextRef="idba3a03acc0e45d5b9787c6de18eadbf_I20160930" decimals="INF" format="ixt-sec:numwordsen" name="mrna:RevenueFromGrantsNumberOfContractOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkzNDU_6ada89a9-8cef-4420-937f-eea21f7f2a27">Three</ix:nonFraction> of the <ix:nonFraction unitRef="contract_option" contextRef="ie67f5391576f40369296654a31490551_I20160930" decimals="INF" format="ixt-sec:numwordsen" name="mrna:RevenueFromGrantsNumberOfContractOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkzNTg_2d508405-dc03-4ba3-b353-07e42dd4c439">four</ix:nonFraction> contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $<ix:nonFraction unitRef="usd" contextRef="i09c0c94594384d508f37a19a6c34c6a0_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsCurrentFundingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkzMTc_bc902f8f-12a1-4cc5-9f45-11ba9696b3b6">70.8</ix:nonFraction>&#160;million, with an additional $<ix:nonFraction unitRef="usd" contextRef="i09c0c94594384d508f37a19a6c34c6a0_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsRemainingFundingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkzMzI_3866fb55-d809-449c-8f75-8e88097a98ea">8.4</ix:nonFraction>&#160;million available if the final contract option is exercised.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, we entered a global health project framework agreement with the Gates Foundation to advance mRNA-based development projects for various infectious diseases, including human immunodeficiency virus (HIV). As of December 31, 2020, the available funding net of revenue earned was $<ix:nonFraction unitRef="usd" contextRef="i1388a9527fb94a0a94fd4c620dc0bf17_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:RevenueFromGrantsRemainingFundingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkxNDU_5fba7297-93da-4443-bcbd-590a848536e8">11.4</ix:nonFraction>&#160;million, with up to an additional $<ix:nonFraction unitRef="usd" contextRef="i1388a9527fb94a0a94fd4c620dc0bf17_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkxNjA_a2243056-0190-458d-a52a-bf4f2de891e8">80.0</ix:nonFraction>&#160;million available if additional follow-on projects are approved. </span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkxNDM_ec83aab5-f3b3-4493-ac87-b920edb86fc0" continuedAt="iba6e63be6e504d08b098db2a341d93b0" escape="true"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following tables summarize grant revenue and deferred grant revenue for and as of the periods presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3ffcdb438747aa92be0aff3569a9ea_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzItMy0xLTEtMTA3Mg_4678fba5-15f1-4607-899b-b8cde91985f0">521,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f1e8cedd3d64700b24c4e5f95a07fb2_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzItNS0xLTEtMTA3Mg_35ddbc63-edce-4853-9c0c-acd1b085e903">7,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2aac197e32f541178c0c0244356b6ee8_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzItNy0xLTEtMTA3Mg_1f9cd674-e523-434b-a60f-39a4758523b3">6,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79e42df5da2b4678bbeea6e37c176ab0_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzMtMy0xLTEtMTA3Mg_173fac1f-36f3-42b9-9da4-c37e02646eff">7,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b76250e8e294bbdafee9c7d09ab09aa_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzMtNS0xLTEtMTA3Mg_b993f54d-1c3c-4f2d-88aa-c3b1216d20e4">4,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddc387885a1442e094e4ff923606bbf5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzMtNy0xLTEtMTA3Mg_0ba71151-8e5d-43eb-bf33-e78e1f447b16">5,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total grant revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia16dd0e2f0d2488eba0c73974791c3a4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzQtMS0xLTEtMzMwMA_fae0b0b3-86e0-4d22-b9cc-d608f35e8ac5">528,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998364a642404015895ef6268a8bef44_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzQtMy0xLTEtMzMwMg_ec59b749-0580-47d9-9312-0398ef80a072">12,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234df8a6bf184a26bc8d6f61ec880f13_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzQtNS0xLTEtMzMwNA_eb1f4e01-e8e7-4964-80e8-2ed15d1732f1">12,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e6e85bd35c473b8a7fdfa429ebf3f0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo3NmE2N2Q5ZmI5ZmI0Njg3YjQxN2M5NjhmNDdiN2NmOS90YWJsZXJhbmdlOjc2YTY3ZDlmYjlmYjQ2ODdiNDE3Yzk2OGY0N2I3Y2Y5XzItMy0xLTEtMTA3Mg_ff12dca9-5964-4c21-950e-1be2812dae57">5,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61596579e2804716ad9472fa52f24629_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo3NmE2N2Q5ZmI5ZmI0Njg3YjQxN2M5NjhmNDdiN2NmOS90YWJsZXJhbmdlOjc2YTY3ZDlmYjlmYjQ2ODdiNDE3Yzk2OGY0N2I3Y2Y5XzItNS0xLTEtMTA3Mg_85940617-9bd6-4977-b2dd-f0b4686665bb">2,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_2373"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:continuation id="icd2257f855cc40ee96c2c38b47627179" continuedAt="ifed90a2f1b0540ceb2539bdfe33f1bdf">Product Sales</ix:continuation></span></div><div><span><br/></span></div><ix:continuation id="ifed90a2f1b0540ceb2539bdfe33f1bdf" continuedAt="i64229eef64d342698922435a7fdaca16"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we began selling our COVID-19 vaccine to the U.S. Government and international government agencies. Under the supply agreements with these government agencies, we received or billed for upfront deposits for our future vaccine supply, which are initially recorded as deferred revenue. We recognize revenue based on the fixed price per dose when control of the product has transferred and customer acceptance has occurred, unless such acceptance provisions are deemed perfunctory. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMzczL2ZyYWc6YjcwMjJlZDZjNmIyNGEzZWExZjgzYzEyNGFmNzMxOWEvdGV4dHJlZ2lvbjpiNzAyMmVkNmM2YjI0YTNlYTFmODNjMTI0YWY3MzE5YV8xMDQ0NTM2MDQ5MDY3NQ_7f69a51b-9389-4480-8c78-975edad80d28" continuedAt="ia50069fcef434de39554cc5a548f9de9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales by customer geographic location was as follows (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaf02eddcdce45c9a3a94c51aaddfac8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMzczL2ZyYWc6YjcwMjJlZDZjNmIyNGEzZWExZjgzYzEyNGFmNzMxOWEvdGFibGU6MjQxNzA4ZDhmN2M2NDkyYjkwZWIzNzRiNDE1NzVjNWYvdGFibGVyYW5nZToyNDE3MDhkOGY3YzY0OTJiOTBlYjM3NGI0MTU3NWM1Zl8xLTItMS0xLTEwNjky_d3d41066-2d0d-4c11-a296-9b84429e3f0b">193,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb86376d0f446bb9527bead47b3f38f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMzczL2ZyYWc6YjcwMjJlZDZjNmIyNGEzZWExZjgzYzEyNGFmNzMxOWEvdGFibGU6MjQxNzA4ZDhmN2M2NDkyYjkwZWIzNzRiNDE1NzVjNWYvdGFibGVyYW5nZToyNDE3MDhkOGY3YzY0OTJiOTBlYjM3NGI0MTU3NWM1Zl8yLTItMS0xLTEwNjky_417f599b-0c93-44b3-86e8-e15b47892c7b">6,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af31ae8238a40b6a097aa5017de8edd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMzczL2ZyYWc6YjcwMjJlZDZjNmIyNGEzZWExZjgzYzEyNGFmNzMxOWEvdGFibGU6MjQxNzA4ZDhmN2M2NDkyYjkwZWIzNzRiNDE1NzVjNWYvdGFibGVyYW5nZToyNDE3MDhkOGY3YzY0OTJiOTBlYjM3NGI0MTU3NWM1Zl8zLTItMS0xLTEwNjky_e087ee98-b8ea-4074-ad4c-d716927825f7">199,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no product sales in 2019 and 2018. We had one commercial product, our COVID-19 vaccine, authorized for use as of December 31, 2020. </span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">201</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i64229eef64d342698922435a7fdaca16" continuedAt="i0dfbed98c2844c31b9da2519e6c5fa00">As of December 31, 2020, we had deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="idfe5c56714774f52b2aa95484fa4c6cb_I20201231" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMzczL2ZyYWc6YjcwMjJlZDZjNmIyNGEzZWExZjgzYzEyNGFmNzMxOWEvdGV4dHJlZ2lvbjpiNzAyMmVkNmM2YjI0YTNlYTFmODNjMTI0YWY3MzE5YV8xMDQ0NTM2MDQ4OTUyMw_5b7fe099-8b87-4f98-85e4-b94db6ccf65a">3.80</ix:nonFraction>&#160;billion related to customer deposits, classified as current deferred revenue in our consolidated balance sheet. Timing of product manufacturing, delivery and receipt of marketing approval will determine the period in which revenue is recognized.</ix:continuation></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_145"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzkwMTk1_6091c6e6-bcce-46f6-b16a-2094b9790463" continuedAt="i400a07b892074c4ba3b457cc0393daa1" escape="true">Collaboration Agreements</ix:nonNumeric></span></div><ix:continuation id="i400a07b892074c4ba3b457cc0393daa1" continuedAt="i4d92f68ffc5c4be1838b9f7acd36bba6"><ix:continuation id="iba6e63be6e504d08b098db2a341d93b0" continuedAt="if854173d836c4e5f9be149f068263e14"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total consolidated net revenue from our strategic collaborators for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collaboration Revenue by Strategic Collaborator:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i020daf53fdb84218b934041c4093d253_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzItMi0xLTEtMA_7ab054a5-4d80-4084-b9e3-79605041459e">26,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie25766984ddb4900bc05c8dc1bcfe74d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzItNC0xLTEtMA_ca779c48-b912-44b5-8ede-a3ba67ed5119">36,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57e78373a7b8469dbf68fb0f27cf0e87_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzItNi0xLTEtMA_8353f87d-5a3e-49e5-9635-dfddd05f865f">66,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd3c14a44a694301afc3fd745de06dfb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzMtMi0xLTEtMA_49a51cdf-4445-4a35-9823-9aba51c4aff2">32,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib00cb507390f4481b30f9a19ccb9a5ac_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzMtNC0xLTEtMA_bc2aec20-7d75-4c88-8479-4a32d27bdd6f">5,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f428a3385e4f1ab1b775e48d93928f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzMtNi0xLTEtMA_73d49104-4cd2-4bc3-ba27-3dd7e44291b4">45,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id39e130ad4a04ca288880a568ba61402_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzQtMi0xLTEtMA_ebacb0ed-5c06-4f4f-a037-2dbf27452888">15,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e9ebd18dd5147d1b84a636c49ed2357_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzQtNC0xLTEtMA_0ad3bd15-2799-43ee-ae98-c35cedd2b175">6,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed1066cb22949e185aa0a6400e44041_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzQtNi0xLTEtMA_beb597ea-a720-49c5-857a-23f3f42cc27b">10,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4c1f58ac26245b49538b03723bb287b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtMi0xLTEtODE3OA_7335fcb4-47ec-428e-92e6-97f320be8590">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e4582eea62043cc8c8a909446feda2a_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtNC0xLTEtODE3OA_5d9a7349-9aac-46f5-af17-abcccf1ce1ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab0e4014c3ae497f8257beaa2afdf2a3_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtNi0xLTEtODE3OA_a8c4b8d8-c90b-4c30-8092-ae047dd04188">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtMi0xLTEtMA_db262eeb-b254-40b3-b945-a655cd355085">74,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc83b7e084b64944bd3c55a3664b6afa_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtNC0xLTEtMA_a5366948-2ab9-4f8e-9820-9133200a2d54">48,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e257e74e0c3417fa2d62c019e175efd_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtNi0xLTEtMA_8f1f5872-3d61-475a-9038-55521226f5d7">122,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under ASC 605</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzkwMTk3_9a43e5c8-a43a-4614-942f-215aa38286d1" continuedAt="i86becb687e6c47debb9cacbf6a0b4739" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the balances of our receivables and contract liabilities related to our strategic collaboration agreements during the year ended December&#160;31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d6ceefa0dd4987937b280087546df3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzItMi0xLTEtMA_edeabf26-6a25-4026-b347-2931ec0eb665">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:ContractWithCustomerAssetIncreaseDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzItNC0xLTEtMA_23417dd6-e349-4371-a7d8-d154af1cc1c1">120,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="mrna:ContractWithCustomerAssetDecreaseDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzItNi0xLTEtMA_744e4241-f5f4-4fbc-a8fe-7f3ef603381f">117,249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca78eb83d214ed796eefd75b65d5178_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzItOC0xLTEtMA_ad6a97b1-7820-4016-9b08-e019d6aad0a9">5,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d6ceefa0dd4987937b280087546df3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzQtMi0xLTEtMA_4a0b84e1-5b16-4f46-a414-9319446a1a87">199,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:ContractWithCustomerLiabilityIncreaseDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzQtNC0xLTEtMA_f3672ccc-5c62-4277-9fb6-d038daa1ac8c">121,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="mrna:ContractWithCustomerLiabilityDecreaseDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzQtNi0xLTEtMA_fb8b2422-17dc-4b01-8e12-f6e64833cd9d">81,228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca78eb83d214ed796eefd75b65d5178_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzQtOC0xLTEtMA_2f222400-7295-4055-a2dc-9e96f74c5230">240,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, we recognized the following revenue as a result of the change in the contract liability balances related to our collaboration agreements (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:65.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.338%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue recognized in the period from:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended <br/>December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in contract liabilities at the beginning of the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTphOTA0Nzc1NWYwZTY0NzhmYmRiYjRhM2U1YmRiMWVlZC90YWJsZXJhbmdlOmE5MDQ3NzU1ZjBlNjQ3OGZiZGJiNGEzZTViZGIxZWVkXzEtMy0xLTEtMA_64bbf1c2-5b20-478b-8132-92d484b1c4f4">72,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance obligations satisfied (or partially satisfied) in previous reporting periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTphOTA0Nzc1NWYwZTY0NzhmYmRiYjRhM2U1YmRiMWVlZC90YWJsZXJhbmdlOmE5MDQ3NzU1ZjBlNjQ3OGZiZGJiNGEzZTViZGIxZWVkXzItMy0xLTEtMTMzMg_2fdbc17e-48cb-4be3-a6f7-be0eab21e1c2">8,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">______________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We first allocate revenue to the individual contract liability balance outstanding at the beginning of the period until the revenue exceeds that balance. If additional consideration is received on those contracts in subsequent periods, we assume all revenue recognized in the reporting period first applies to the beginning contract liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Related to changes in estimated costs for our future performance obligations and estimated variable considerations.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the aggregated amount of the transaction price allocated to performance obligations under our collaboration agreements that are unsatisfied or partially unsatisfied was $<ix:nonFraction unitRef="usd" contextRef="i0ca78eb83d214ed796eefd75b65d5178_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExMDY_d13246de-8b18-48d9-bbe5-5b8404089eb0">327.7</ix:nonFraction> million. </span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i4d92f68ffc5c4be1838b9f7acd36bba6" continuedAt="ic118dbc5855147958aee259b424ae5bb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AstraZeneca &#8211; Strategic Alliances in Cardiovascular and Oncology</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Option Agreement and Services and Collaboration Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2013, we entered into an Option Agreement, the AZ Option Agreement, and a related Services and Collaboration Agreement, the AZ Services Agreement, with AstraZeneca, which were amended and restated in June 2018. We refer to these agreements in the forms that existed prior to the 2018 amendment and restatement as the 2013 AZ Agreements. Under the 2013 AZ Agreements, we granted AstraZeneca certain exclusive rights and licenses, and options to obtain exclusive rights to develop and commercialize potential therapeutic mRNA medicines directed at certain targets for the treatment of cardiovascular and cardiometabolic diseases and cancer, and agreed to provide related services to AstraZeneca. Pursuant to the 2013 AZ Agreements, AstraZeneca was responsible for all research, development and commercialization activities, while we provided specified research and manufacturing services during a research and evaluation period, as described below, to further AstraZeneca&#8217;s activities pursuant to an agreed upon services plan. Under the 2013 AZ Agreements, AstraZeneca could have requested we provide additional services, at AstraZeneca&#8217;s expense. Subject to customary &#8220;back-up&#8221; supply rights granted to AstraZeneca, we exclusively manufactured (or had manufactured) mRNA for all research, development and commercialization purposes under the 2013 AZ Agreements until, on a product-by-product basis, the expiration of the time period for which we are entitled to receive earn-out payments with respect to such product pursuant to the 2013 AZ Agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the effective date of the 2013 AZ Agreements, AstraZeneca acquired <ix:nonFraction unitRef="option" contextRef="i2866ce13b20c40499ee0ef2d3eb66afa_I20140331" decimals="INF" format="ixt-sec:numwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzI4NzQ_956d9525-c802-41e8-a8ca-c8053b375ff2">forty</ix:nonFraction> options that it may exercise to obtain exclusive rights to clinically develop and commercialize identified development candidates (and related back-up candidates) directed to specified targets that arise during the research and evaluation period. During the research and evaluation period for research candidates under the 2013 AZ Agreements, AstraZeneca could have elected to designate a limited number of research candidates as development candidates in order to continue preclinical development on such development candidates (and related back-up candidates). From such pool of development candidates designated by AstraZeneca, during a specified option exercise period, AstraZeneca could have then exercised one of its options to obtain exclusive rights to clinically develop and commercialize an identified development candidate (and related back-up candidates). If AstraZeneca did not exercise one of its options to acquire exclusive rights to clinically develop and commercialize a particular development candidate during the defined option exercise period for such development candidate, AstraZeneca&#8217;s rights to exercise an option and other rights granted under the 2013 AZ Agreements with respect to such development candidate (and related back-up candidates) would terminate, all rights to exploit such development candidate (and related back-up candidates) would be returned to us and all data and results generated by AstraZeneca with respect to such development candidate (and related back-up candidates) would be either assigned or licensed to us. Upon the earlier of termination of the 2013 AZ Agreements for any reason and a specified anniversary of the effective date of the 2013 AZ Agreements, all exercised options, and the right to exercise any and all options if not previously exercised by AstraZeneca, would automatically terminate. On a target-by-target basis, we and AstraZeneca agreed to certain defined exclusivity obligations under the 2013 AZ Agreements with respect to the research, development and commercialization of mRNA medicines for such target.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the effective date of the 2013 AZ Agreements, AstraZeneca made upfront cash payments to us totaling $<ix:nonFraction unitRef="usd" contextRef="iae12a04f8a584ee1b88fb30da6f6e7c9_D20130301-20130331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzUwNjc_1843ed7a-c4fc-4617-ad56-6e0a851ce55e">240.0</ix:nonFraction> million. Under the 2013 AZ Agreements, we were entitled to receive payments that are not related to any specific program of up to $<ix:nonFraction unitRef="usd" contextRef="i2866ce13b20c40499ee0ef2d3eb66afa_I20140331" decimals="INF" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzUxOTI_fdff8de1-0bfd-4fac-ac62-1da0a3416a6b">180.0</ix:nonFraction> million in the aggregate for the achievement of <ix:nonFraction unitRef="milestone" contextRef="i2866ce13b20c40499ee0ef2d3eb66afa_I20140331" decimals="INF" format="ixt-sec:numwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzUyMzU_6ec3460c-54c8-461b-a0a9-ffa21b586980">three</ix:nonFraction> technical milestones relating to toxicity, delivery, and competition criteria. We achieved the toxicity and competition milestones in the year ended December&#160;31, 2015. The delivery milestone has expired. Under the 2013 AZ Agreements, AstraZeneca was obligated to pay us a $<ix:nonFraction unitRef="usd" contextRef="iae12a04f8a584ee1b88fb30da6f6e7c9_D20130301-20130331" decimals="-5" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzU1MTA_7484c988-4fca-459d-be32-5646fa4eb395">10.0</ix:nonFraction> million option exercise fee with respect to each development candidate (and related back-up candidates) for which it exercised an option. In addition, upon AstraZeneca&#8217;s exercise of each option, we were eligible to receive certain payments contingent upon the achievement of specified clinical, regulatory, and commercial events. For any product candidate optioned by AstraZeneca, we were eligible to receive, per product candidate, up to $<ix:nonFraction unitRef="usd" contextRef="i3264926a036f49368bfd0a6e9404c012_I20140331" decimals="INF" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzU5NDQ_7f8614a9-f59c-4b60-a422-2c7002b156a5">100.0</ix:nonFraction> million in payments for achievement of development milestones, up to $<ix:nonFraction unitRef="usd" contextRef="ic0b34986f0674c9ea594d332b1f04fb7_I20140331" decimals="INF" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzYwMDg_d90bc314-d534-404c-9c0b-7647c7a330cb">100.0</ix:nonFraction> million payments for achievement of regulatory milestones, and up to $<ix:nonFraction unitRef="usd" contextRef="id123e88b9869491798632873fce6c3a9_I20140331" decimals="INF" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzYwNzI_42637bfb-47ca-469a-ae5f-02b5005f67a6">200.0</ix:nonFraction> million payments for achievement of commercial milestones. Additionally, under the 2013 AZ Agreements, we were entitled to receive, on a product-by-product basis, earn-out payments on worldwide net sales of products ranging from a high-single digit percentage to <ix:nonFraction unitRef="number" contextRef="i4fae7e79285f4982b083cb9c1f4fbd5b_D20130301-20130331" decimals="INF" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzYzMzA_f60034c6-c68f-4540-906f-3a202a3d3d47">12</ix:nonFraction>%, subject to certain reductions, with an aggregate minimum floor.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received from AstraZeneca under the 2013 AZ Agreements an option exercise payment of $<ix:nonFraction unitRef="usd" contextRef="i82bedeff4e8442618c0111343837f65b_D20160101-20161231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzY0ODY_0cd35816-53d4-4de4-b95c-2b315692b14a">10.0</ix:nonFraction> million (the 2016 VEGF Exercise) in the year ended December&#160;31, 2016, and a clinical milestone payment of $<ix:nonFraction unitRef="usd" contextRef="id653faf9397c4b2abf5814a5f812a2dc_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzY1ODc_ee5c02c5-b6b0-4408-b92c-59140204cbe3">30.0</ix:nonFraction> million with respect to AstraZeneca&#8217;s VEGF-A product (AZD8601) during the year ended December&#160;31, 2018, that is currently being developed in a Phase&#160;2 clinical trial. Unless earlier terminated, the 2013 AZ Agreements would have continued until the expiration of AstraZeneca&#8217;s earn-out and contingent option exercise payment obligations for optioned product candidates. Either party had the right to terminate the 2013 AZ Agreements upon the other party&#8217;s material breach, either in its entirety or in certain circumstances, with respect to relevant candidates, subject to a defined materiality threshold and specified notice and cure provisions. If AstraZeneca had the right to terminate the 2013 AZ Agreements for our material breach, then AstraZeneca could have elected, in lieu of terminating the 2013 AZ Agreements, in their entirety or with respect to such candidates, to have the 2013 AZ Agreements remain in effect, subject to reductions in certain payments we were eligible to receive and certain adjustments to AstraZeneca&#8217;s obligations under the 2013 AZ Agreements. AstraZeneca had the right to terminate the 2013 AZ Agreements in full, without cause, upon <ix:nonNumeric contextRef="iae12a04f8a584ee1b88fb30da6f6e7c9_D20130301-20130331" format="ixt-sec:durday" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc3NDk_5bbb4d21-f54d-4d3f-8267-131a69bdab37">90</ix:nonNumeric>-days&#8217; prior notice to us.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">203</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><ix:continuation id="ic118dbc5855147958aee259b424ae5bb" continuedAt="i45155d9cd97f4496b86544d0837d1ae0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Strategic Alliance with AstraZeneca</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IL-12</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, we entered into a new Strategic Drug Development Collaboration and License Agreement, which we refer to as the 2016 AZ Agreement, with AstraZeneca to discover, develop and commercialize potential mRNA medicines for the treatment of a range of cancers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the 2016 AZ Agreement, we and AstraZeneca have agreed to work together on an immuno-oncology program focused on the intratumoral delivery of a potential mRNA medicine to make the IL-12 protein.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 AZ Agreement initially included research activities with respect to a second discovery program. During a limited period of time, each party had an opportunity to propose additional discovery programs to be conducted under the 2016 AZ Agreement. We are responsible for conducting and funding all discovery and preclinical development activities under the 2016 AZ Agreement in accordance with an agreed upon discovery program plan for the IL-12 program and any other discovery program the parties agree to conduct under the 2016 AZ Agreement. For the IL-12 program and any other discovery program the parties agree to conduct under the 2016 AZ Agreement, during a defined election period that commenced as of the effective date of the 2016 AZ Agreement (for the IL-12 program) and otherwise will commence on initiation of any such new discovery program, AstraZeneca may elect to participate in the clinical development of a development candidate arising under the 2016 AZ Agreement from such program. If AstraZeneca so elects (as it has for the IL-12 program), AstraZeneca will lead clinical development activities worldwide and we will be responsible for certain activities, including being solely responsible for manufacturing activities, all in accordance with an agreed upon development plan. AstraZeneca will be responsible for funding all Phase&#160;1 clinical development activities (including costs associated with our manufacture of clinical materials in accordance with the development plan), and Phase&#160;2 clinical development activities (including costs associated with our manufacture of clinical materials in accordance with the development plan) up to a defined dollar threshold. We and AstraZeneca will equally share the costs of Phase&#160;2 clinical development activities in excess of such dollar threshold, all Phase 3 clinical development activities and certain other costs of late-stage clinical development activities, unless we elect not to participate in further development and commercialization activities and instead receive tiered royalties, as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and AstraZeneca will co-commercialize products in the U.S. in accordance with an agreed upon commercialization plan and budget, and on a product-by-product basis will equally share the U.S. profits or losses arising from such commercialization. Notwithstanding, on a product-by-product basis, prior to a specified stage of development of a given product, we have the right to elect not to participate in the further development and commercialization activities for such product. If we make such election, instead of participating in the U.S. profits and losses share with respect to such product, we are obligated to discuss future financial terms with AstraZeneca. If we are unable to agree on future financial terms within a short, defined period of time, we are entitled to receive tiered royalties at default rates set forth in the 2016 AZ Agreement, ranging from percentages in the mid-single digits to <ix:nonFraction unitRef="number" contextRef="i0ce35496660e4fd3bb2b5b20d645ce3b_D20160101-20160131" decimals="2" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExMzA2_f5aed0a1-739a-41f5-8f29-8da57c40d927">20</ix:nonFraction>% on worldwide net sales of products, subject to certain reductions with an aggregate minimum floor. AstraZeneca has sole and exclusive responsibility for all ex-U.S. commercialization efforts. Unless we have elected to not to participate in further development (in which case royalties on ex-U.S. net sales will be at the default rates as described above, unless otherwise agreed by the parties), we are entitled to tiered royalties at rates ranging from <ix:nonFraction unitRef="number" contextRef="i2cbf12bb2be14e679beb021ee4ab6155_D20160101-20160131" decimals="INF" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNzYz_d592b8c3-3eda-49c8-b069-209f717791e7">10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i0ce35496660e4fd3bb2b5b20d645ce3b_D20160101-20160131" decimals="INF" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNzY5_c5b90297-8700-4de3-9b10-7b43b4a30198">30</ix:nonFraction>% on ex-U.S. net sales of the products, subject to certain reductions with an aggregate minimum floor. Subject to customary &#8220;back-up&#8221; supply rights granted to AstraZeneca, we exclusively manufacture (or have manufactured) products for all development and commercialization purposes. We and AstraZeneca have agreed to certain defined exclusivity obligations with each other under the 2016 AZ Agreement with respect to the development and commercialization of mRNA medicines for IL-12. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, our strategic alliance under the 2016 AZ Agreement will continue on a product-by-product basis (i)&#160;until both parties cease developing and commercializing such product without the intention to resume, if we have not elected our right not to participate in further development and commercialization of such product or (ii)&#160;on a country-by-country basis, until the end of the applicable royalty term for such product in such country, if we have elected our right not to participate in further development and commercialization of such product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Either party may terminate the 2016 AZ Agreement upon the other party&#8217;s material breach, subject to specified notice and cure provisions. Each party may also terminate the 2016 AZ Agreement in the event the other party challenges such party&#8217;s patent rights, subject to certain defined exceptions. AstraZeneca has the right to terminate the 2016 AZ Agreement in full or with respect to any program for scientific, technical, regulatory or commercial reasons at any time upon <ix:nonNumeric contextRef="i9d91300ccece4f0cb4993ca5f2e28e76_D20160101-20160131" format="ixt-sec:durday" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEzMjk4_20042bfa-3102-4436-b669-c952ba492f9e">90</ix:nonNumeric> days&#8217; prior written notice to us. On a product-by-product basis, we have the right to terminate the 2016 AZ Agreement in certain cases if AstraZeneca has suspended or is no longer proceeding with the development or commercialization of such product for a period of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEzNTY2_b4c654c8-2a80-49cb-b78b-a61c53047d69">twelve</span> consecutive months, subject to specified exceptions, including tolling for events outside of AstraZeneca&#8217;s control. On a product-by-product basis, if the 2016 AZ Agreement is terminated with respect to a given product, AstraZeneca&#8217;s rights in such product will terminate and, to the extent we terminated for AstraZeneca&#8217;s breach, patent challenge or cessation of development or AstraZeneca terminated in its discretion, AstraZeneca will grant us reversion licenses and take certain other actions so as to enable us to continue developing and commercializing such product in the oncology field.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">204</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i45155d9cd97f4496b86544d0837d1ae0" continuedAt="i5fb4da97836146bbbe2c820eae544b83"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we continue developing and commercializing a given product following termination of the 2016 AZ Agreement by AstraZeneca in its discretion with respect to such product, AstraZeneca is entitled to receive a mid-single digit royalty on our worldwide net sales of such product and a high-single digit percentage of the amounts received by us from a third party in consideration of a license to such third party to exploit such product, in each case, until AstraZeneca recovers an amount equal to specified development costs incurred by AstraZeneca under the 2016 AZ Agreement with respect to such product prior to such termination. Such percentages increase by a low to mid-single digit amount to the extent such termination occurs after such product achieves a specified stage of development.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Agreements with AstraZeneca, amended and restated in 2018 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, we entered into an Amended and Restated Option Agreement and a related Amended and Restated Services and collaboration Agreement with AstraZeneca, or the 2018 A&amp;R Agreements, which amended and restated the 2013 AZ Agreements. Under the 2018 A&amp;R Agreements, we granted AstraZeneca certain exclusive rights and licenses to research, develop and commercialize potential therapeutic mRNA medicines directed at certain targets for the treatment of cardiovascular and cardiometabolic diseases and cancer, and agreed to provide related services to AstraZeneca. The activities to be performed by the parties under the 2018 A&amp;R Agreements are limited to defined biological targets in the cardiovascular and cardiometabolic fields and one defined target in the cancer field.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the 2018 A&amp;R Agreements, AstraZeneca is responsible for all research, development and commercialization activities and associated costs, while we provide specified research and manufacturing services during a research and evaluation period, as described below, to further AstraZeneca&#8217;s activities conducted pursuant to an agreed upon services plan. During this research and evaluation period, these research services, and manufacturing services in excess of a specified threshold, are provided at AstraZeneca&#8217;s expense, and manufacturing services below the specified threshold are provided at no additional expense to AstraZeneca. AstraZeneca may request we provide additional research and manufacturing services, at AstraZeneca&#8217;s expense, following the end of the research and evaluation period. Subject to customary &#8220;back-up&#8221; supply rights granted to AstraZeneca, we exclusively manufacture (or have manufactured) mRNA for all research, development and commercialization purposes under the 2018 A&amp;R Agreements until, on a product-by-product basis, the expiration of the time period for which we are entitled to receive earn-out payments with respect to such product pursuant to the 2018 A&amp;R Agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the effective date of the 2013 AZ Agreements, and as further reflected in the 2018 A&amp;R Agreements, AstraZeneca acquired </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="option" contextRef="i68a34211294a4d41b7ae0a74e31673b3_I20190630" decimals="INF" format="ixt-sec:numwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzI0NDg5_3ef050b2-1a5b-476e-b2b1-00a6c1929c93">forty</ix:nonFraction> options that it may exercise to obtain exclusive rights to clinically develop and commercialize identified development candidates (and related back-up candidates) directed to specified targets that arise during the research and evaluation period. During the research and evaluation period for research candidates, AstraZeneca may elect to designate a limited number of research candidates as development candidates in order to continue preclinical development on such development candidates (and related back-up candidates). From such pool of development candidates designated by AstraZeneca, during a specified option exercise period, AstraZeneca may then exercise one of its options to obtain exclusive rights to clinically develop and commercialize an identified development candidate (and related back-up candidates) in certain fields. If AstraZeneca does not exercise one of its options to acquire exclusive rights to clinically develop and commercialize a particular development candidate during the defined option exercise period for such development candidate, AstraZeneca&#8217;s rights to exercise an option and other rights granted under the 2018 A&amp;R Agreements with respect to such development candidate (and related back-up candidates) will terminate, all rights to exploit such development candidate (and related back-up candidates) will be returned to us and all data and results generated by AstraZeneca with respect to such development candidate (and related back-up candidates) will be either assigned or licensed to us. Upon the earlier of termination of the 2018 A&amp;R Agreements for any reason and a specified anniversary of the effective date of the 2013 AZ Agreements, all unexercised options, and the right to exercise any and all options if not previously exercised by AstraZeneca, will automatically terminate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a target-by-target basis, we and AstraZeneca have agreed to certain defined exclusivity obligations under the 2018 A&amp;R Agreements with respect to the research, development and commercialization of mRNA medicines for such target in certain fields. In addition, we and AstraZeneca have agreed to certain defined exclusivity obligations with respect to the research, development and commercialization of mRNA medicines coding for the same polypeptide as any development candidate being developed under the 2018 A&amp;R Agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the 2018 A&amp;R Agreements will continue until the expiration of AstraZeneca&#8217;s earn-out and contingent option exercise payment obligations for optioned product candidates. Either party may terminate the 2018 A&amp;R Agreements upon the other party&#8217;s material breach, either in its entirety or in certain circumstances, with respect to relevant candidates, subject to a defined materiality threshold and specified notice and cure provisions. If AstraZeneca has the right to terminate the 2018 A&amp;R Agreements for our material breach, then AstraZeneca may elect, in lieu of terminating the 2018 A&amp;R Agreements, in their entirety or with respect to such candidates, to have the 2018 A&amp;R Agreements remain in effect, subject to reductions in certain payments we are eligible to receive and certain adjustments to AstraZeneca&#8217;s obligations under the 2018 A&amp;R Agreements. AstraZeneca may terminate the 2018 A&amp;R Agreements in full, without cause, upon <ix:nonNumeric contextRef="i458bfc4f6b6645b1ba08bf68c4e3c5f6_D20180601-20180630" format="ixt-sec:durday" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzI3ODEy_4d090cbd-07fb-4942-af5d-f0c4334194c5">90</ix:nonNumeric> days&#8217; prior notice to us.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">205</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i5fb4da97836146bbbe2c820eae544b83" continuedAt="i4cefe4043c9f477a81437e9cffead524"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Combined 2018 AZ Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2013 Agreements, as amended by the 2018 A&amp;R Agreements, and the 2016 AZ Agreement, referred to as the Combined 2018 AZ Agreements, are treated as a single agreement for accounting purposes as these agreements were negotiated in contemplation of each other. The Combined 2018 AZ Agreements represent a transaction with a customer and therefore is accounted for in accordance with ASC 606. We identified the following performance obligations in the Combined 2018 AZ Agreements: (i) a combined performance obligation that includes a research license, research and development pool services, and manufacturing obligations related to the 2013 AZ Agreements, as amended by the 2018 A&amp;R Agreements, collectively referred to as the Combined 2018 AZ Agreement Performance Obligation, (ii) preclinical development services for IL-12, (iii) preclinical development services for an oncology development target, (iv) a combined performance obligation for a development and commercialization license and manufacturing obligations for IL-12, and (v) a material right to receive development and commercialization rights and manufacturing services for an oncology development target.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We concluded that the research license is not distinct from the research and development pool services or the manufacturing obligations related to the 2018 A&amp;R Agreements, as AstraZeneca cannot fully exploit the value of the research license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Any supply requested by AstraZeneca in excess of the minimum quantities specified in the agreement are considered customer options and treated as separate contracts for accounting purposes. Further, we concluded that AstraZeneca cannot exploit the value of the development and commercialization license for IL-12 without receipt of supply as the development and commercialization license does not convey to AstraZeneca the right to manufacture and therefore combined the development and commercialization license and the manufacturing obligations for IL-12 into one performance obligation.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjIwMDI_84b96845-7444-48af-a8ec-45441bc0d8ec" continuedAt="i4236569674884f6383751331261d6d5b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Combined 2018 AZ Agreements:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i839376eae85647209c7ffae9f8bb94d6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzQtMi0xLTEtMTM4Mg_e7c6ec00-d2b1-476c-82f4-946ec343c20d">240,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2c30c2931b74241a4573d9b7e0a96f5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzQtNC0xLTEtMTM4Mg_fddf8bab-d0f6-4ee8-a47a-576f37334205">240,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublicense reimbursement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fce5c39376648a1885a52fda585e94e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzUtMi0xLTEtMTM4Mg_31054b81-e94b-4eec-8b81-ed9de68ed2fe">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i508d8e428eb4465394a0583607ec486d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzUtNC0xLTEtMTM4Mg_a10fdcea-632d-4da9-9a31-dfe93f89ed03">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Toxicity milestone payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a4f3ca9cebf43ce90d2496d447b9d8e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzYtMi0xLTEtMTM4Mg_d2688b12-4c0e-49ac-a24e-966f132e3786">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b49c52ea5674daf9ac712e3b8b21e47_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzYtNC0xLTEtMTM4Mg_50258ae2-592b-42e8-9d26-1a107cf9b48e">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Competition milestone payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4df3ae247d504d6a89d97300985f10bc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzctMi0xLTEtMTM4Mg_ff6277e1-24da-431f-a4a3-6b95d9e626cc">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84bc8dd652f4aee96a5499bdf3e2474_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzctNC0xLTEtMTM4Mg_6c10155d-c8a0-41ca-a538-fe80b407a7eb">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated reimbursement for IL-12 manufacturing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54988c4872c9499ca5902c5f6d9c7c25_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzgtMi0xLTEtMTM4Mg_8665dc81-a7c0-476b-9514-6d9bfcaa0768">35,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b5ed97867924e718b4bd2e71e3b5a48_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzgtNC0xLTEtMTM4Mg_1e7b5ce8-dfe2-4b97-8896-b6b026e6c150">40,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i978a4c28e8214a16a5f021fa271e26f7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzktMi0xLTEtMzU5MQ_b702013e-d8cf-42e4-8877-feded3d8bea4">396,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac8e23e6e0694998b8904230abbb17b4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzktNC0xLTEtMzU5Mw_662e5daa-0fc0-45de-95c7-90367f73020d">401,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the most likely amount method to determine the amount of reimbursement for IL-12 manufacturing obligations to be received. We determined that any sales-based royalties related to IL-12 will be recognized when the related sales occur as they were determined to relate predominately to the license granted and therefore have been excluded from the transaction price. In addition, we are eligible to receive future milestones and royalties on future commercial sales for optioned product candidates under the 2018 A&amp;R Agreements and future royalties under the 2016 Agreement; however, these amounts are not considered variable consideration under the Combined 2018 Agreements as we are only eligible to receive such amounts if AstraZeneca exercises its options (including certain options that are deemed to be material rights). We have concluded that the exercise of an optioned product candidate represents a separate transaction under ASC 606. We re-evaluate the transaction price at the end of each reporting period. There was</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a $<ix:nonFraction unitRef="usd" contextRef="i2c28ae9af89f4befac5f089672e301ff_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjE5ODk_8a4ad107-1044-4074-aee7-7a076d46d24d">5.0</ix:nonFraction>&#160;million d</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ecrease to the transaction price during the year ended December 31, 2020, resulting from a change in estimate of variable consideration.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was allocated to the performance obligations based on the relative estimated standalone selling prices of each performance obligation. We developed the estimated standalone selling price for the licenses included in the Combined 2018 AZ Agreement Performance Obligation and the combined performance obligation for a development and commercialization license and manufacturing obligations for IL-12 primarily based on the probability-weighted present value of expected future cash flows associated with each license related to each specific program. In developing such estimate, we also considered applicable market conditions and relevant entity-specific factors, including those factors contemplated in negotiating the agreement, probability of success and the time needed to commercialize a product candidate pursuant to the associated license. We developed the estimated standalone selling price for the services and/or manufacturing and supply included in each of the performance obligation, as applicable, primarily based on the nature of the services to be performed and/or goods to be manufactured and estimates of the </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">206</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i4cefe4043c9f477a81437e9cffead524" continuedAt="ie8e9a6feeb574f058e940eea9d175beb"><div style="padding-right:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">associated costs, adjusted for a reasonable profit margin that would be expected to be realized under similar contracts. The estimated standalone selling price of the material right to receive development and commercialization rights and manufacturing services for an oncology development target was developed by estimating the amount of discount that AstraZeneca would receive when exercising the option and adjusting such amount by the likelihood that the option will be exercised.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjIwMjA_1237366e-ac4b-42cf-bc79-a6866cf53ed5" continuedAt="i839a584dcfa54bcdb6aa795b5c86e5a9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Combined 2018 AZ Agreements:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined 2018 AZ Agreement performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i018ccef08c534dd986a7e677e9da45b2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzQtMi0xLTEtMTQxOA_649c59dc-96bc-451e-b12e-c926fd6158ff">293,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical development service - IL-12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f35a20934941e3b6fbe7ba24038ed1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzUtMi0xLTEtMTQxOA_c366b099-c24a-4766-8d46-de275ede430e">8,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical development service - oncology development target</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b8c03d227d64183b38b465e3aef9678_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzYtMi0xLTEtMTQxOA_1407aa1e-fdba-4e02-92fe-ae5b8ee3ee49">8,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and commercialization license and manufacturing obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46fb7b59b5374455b1a475b17975fd25_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzctMi0xLTEtMTQxOA_563db2d3-d8a6-4e81-80eb-51f7670702f1">85,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Material right to receive development and commercialization rights</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6304d23321e4e298da2bcf056211316_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzgtMi0xLTEtMTQxOA_21f48021-54f6-4cd1-9e51-50857791ed03">1,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i978a4c28e8214a16a5f021fa271e26f7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzktMi0xLTEtNDExMw_6004aad8-58cc-4848-9c57-2f4bfc62c65c">396,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzEwLTItMS0xLTE0Mjk_05a22894-fc5a-4746-bc1e-414673d13fc7">87,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i9441d23013f14c83988a31bdbb559231_I20201231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzA0MDM1_d6c5b40a-951b-4f9f-8099-baf26292ecf5">77.5</ix:nonFraction> million of the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through December 31, 2029 and $<ix:nonFraction unitRef="usd" contextRef="i4d71f32e33e84216807274b731bdc696_I20201231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzA0MDQx_8fcfe63a-4c01-4234-80c9-c670e88b80b8">9.7</ix:nonFraction> million is expected to be recognized as revenue at the earlier of expiration or modification of the Combined 2018 AZ Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure proportional performance over time using an input method based on cost incurred relative to the total estimated costs for the Combined 2018 AZ Agreement Performance Obligation and the preclinical development services for IL-12 and the other oncology target performance obligations. We recognize revenue related to the amounts allocated to the combined performance obligation for a development and commercialization license and manufacturing obligations for IL-12 based on the point in time upon which control of supply is transferred to AstraZeneca for each delivery of the associated supply.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue for the Combined 2018 AZ Agreement Performance Obligation by determining the proportion of effort incurred as a percentage of total effort we expect to expend.&#160;This ratio is applied to the transaction price allocated to this combined performance obligation. We also estimate the development plan, including expected demand from AstraZeneca, and the associated costs for this combined performance obligation, as we will satisfy this combined performance obligation as the manufacturing services are performed.&#160;Management has applied significant judgment in the process of developing our budget estimates. Any changes to these estimates will be recognized in the period in which they change as a cumulative catch up.</span></div><div><span><br/></span></div><ix:continuation id="if854173d836c4e5f9be149f068263e14" continuedAt="i1558f9c4a60749039f3fbabd2da3a57b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined AZ Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7507c06b17446d99769c50840782858_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4OGZlNDI1ZDkxMmI0ZjE3YTI4NWY5NGQ1MjEyODRkOC90YWJsZXJhbmdlOjg4ZmU0MjVkOTEyYjRmMTdhMjg1Zjk0ZDUyMTI4NGQ4XzItMi0xLTEtMTUwMA_1cd26efb-5f2a-44c7-83a9-8faa3c68bdff">18,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aebca79df0b494194b5d4203b40878c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4OGZlNDI1ZDkxMmI0ZjE3YTI4NWY5NGQ1MjEyODRkOC90YWJsZXJhbmdlOjg4ZmU0MjVkOTEyYjRmMTdhMjg1Zjk0ZDUyMTI4NGQ4XzItNC0xLTEtMTUwMA_eefa6584-b80e-4081-8d21-834f17115f33">4,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52cf8a74cf0b4054bf102b486d8851d3_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4OGZlNDI1ZDkxMmI0ZjE3YTI4NWY5NGQ1MjEyODRkOC90YWJsZXJhbmdlOjg4ZmU0MjVkOTEyYjRmMTdhMjg1Zjk0ZDUyMTI4NGQ4XzItNi0xLTEtMTUwMA_f0e3ac72-89d5-4ffd-a194-069d2bad4446">45,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue recognized for the year ended December 31, 2020 includes the amortization of deferred revenue due to the satisfaction of our performance obligation during the period, including a cumulative catch-up adjustment of $<ix:nonFraction unitRef="usd" contextRef="ib7507c06b17446d99769c50840782858_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjIzODk_c1d033a8-9e02-42e2-9bd9-42fd0e569fa9">12.5</ix:nonFraction>&#160;million due to changes in estimated costs for our future performance obligations. </span></div><div><span><br/></span></div><ix:continuation id="i86becb687e6c47debb9cacbf6a0b4739" continuedAt="ib88d94ff65a24255b60080db5af35ee5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined AZ Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i978a4c28e8214a16a5f021fa271e26f7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo3OTIwYTY5ZWM0NTc0MGQ1YmVkYzQyNmViZjQ3NGUyYS90YWJsZXJhbmdlOjc5MjBhNjllYzQ1NzQwZDViZWRjNDI2ZWJmNDc0ZTJhXzItMi0xLTEtMTY3MQ_660a84f8-e906-4c09-bdd5-ad18b2748d60">57,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac8e23e6e0694998b8904230abbb17b4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo3OTIwYTY5ZWM0NTc0MGQ1YmVkYzQyNmViZjQ3NGUyYS90YWJsZXJhbmdlOjc5MjBhNjllYzQ1NzQwZDViZWRjNDI2ZWJmNDc0ZTJhXzItNC0xLTEtMTY3MQ_f762728e-70b1-4f86-8b02-2cddd1884cfc">73,669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="ie8e9a6feeb574f058e940eea9d175beb" continuedAt="i816f90783e61420cb681681d639dcd82"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 VEGF Exercise</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We concluded that the 2016 VEGF Exercise should be treated as a separate transaction for accounting purposes, represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. We identified one performance obligation in this arrangement which is comprised of the exclusive license to develop and commercialize VEGF and the manufacturing of clinical supply. We concluded that the VEGF license is not distinct from the manufacturing obligations because AstraZeneca cannot fully exploit the value of the license without receipt of such supply. This is due to limitations inherent in the licenses conveyed wherein AstraZeneca does not have the contractual right to manufacture during the term of the agreement.</span></div><div><span><br/></span></div><ix:continuation id="i4236569674884f6383751331261d6d5b" continuedAt="iacddb1e9706f40a7a343bea723eb38b0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2016 VEGF Exercise:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option exercise fee </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96c0d1d3251a406d91ab4e10d74e2798_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzQtMi0xLTEtMTY5NA_a6af67df-9e94-42a8-a04a-467a90e74a20">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2b94ca2170140ac9a033fe7b05c864e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzQtNC0xLTEtMTY5NA_11616a8b-940f-459b-8672-dc36604b3ae6">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milestone payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5a3ddf94f642219ac0a81b3fe95f50_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzUtMi0xLTEtMTY5NA_0edb29af-d553-4fb6-b3e8-6d5945a75e85">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15c7086629714161b7f3158a965fcc28_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzUtNC0xLTEtMTY5NA_5b3d3425-139a-4c9d-a4c3-464d322a4121">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublicense reimbursement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib86c1e0cb5a249f09dfbce827ef9dbc4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzYtMi0xLTEtMTY5NA_96dbc6d8-7291-443e-8a64-3fbb024f0563">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b95e1b3c41e4258bc74f50fafe6fb06_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzYtNC0xLTEtMTY5NA_abd686bd-cde6-434a-9dae-8214d47512fc">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated reimbursement for clinical supply</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadda166c80e447af92ff77e10772827a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzctMi0xLTEtMTY5NA_bba9d1be-45b3-4737-95ca-b3d4770451e4">18,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd9e8d4a63f54baaba0b4b5ed1d455ff_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzctNC0xLTEtMTY5NA_f33ba12b-edb0-472f-8e64-ccb9baf44d80">15,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54b6e3f162949438276b86a988013e1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzgtMi0xLTEtNDA4Ng_8993b944-c124-4e5f-b0f1-ac06f7ce1e01">60,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic177577240b14353b1e60187c3076a64_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzgtNC0xLTEtNDA4OA_6e8186d9-f307-4131-9968-d59edf9f3a87">57,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are eligible to receive future milestones and royalties on future commercial sales under this arrangement. We utilize the most likely amount method to estimate any development and regulatory milestone payments to be received and the amount of estimated reimbursement for clinical supply. As of December 31, 2020, there were no milestones that had not been achieved included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or AstraZeneca&#8217;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any commercial milestones and sales-based royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted and therefore have also been excluded from the transaction price. We re-evaluate the transaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur. When a milestone payment is included in the transaction price in the future, it is recognized as revenue based on the relative completion of the underlying performance obligation. There was a $<ix:nonFraction unitRef="usd" contextRef="ic3d6d1acafe2472e83a08aef3a25628d_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI0MDg_5ec27eb0-05cd-4876-9b1d-ff0ae0d2a717">2.4</ix:nonFraction>&#160;million increase to the transaction price during the year ended December 31, 2020, resulting from a change in estimate of variable consideration.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><ix:continuation id="i839a584dcfa54bcdb6aa795b5c86e5a9" continuedAt="i210c4ee55a55461d993fee83bd22764e"><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total transaction price allocated to the single performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.790%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise combined performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54b6e3f162949438276b86a988013e1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZDlmNzI2MDFlYTQ0ZjdkYWQ1MzQwNjUyMTI3Yjc2Yy90YWJsZXJhbmdlOmJkOWY3MjYwMWVhNDRmN2RhZDUzNDA2NTIxMjdiNzZjXzQtMi0xLTEtNDA3MQ_3f5a80a2-8dd1-4431-a68f-3de5bc5b0202">60,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6399c8db0840dc9f38f108c60c920b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZDlmNzI2MDFlYTQ0ZjdkYWQ1MzQwNjUyMTI3Yjc2Yy90YWJsZXJhbmdlOmJkOWY3MjYwMWVhNDRmN2RhZDUzNDA2NTIxMjdiNzZjXzUtMi0xLTEtNDA3MQ_6067f759-6a46-4930-9ca2-5dd3e3d982ff">41,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through December 31, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue related to the amount of the transaction price allocated to the VEGF Exercise performance obligation based on the point in time upon which control of supply is transferred to AstraZeneca for each delivery of the associated supply.</span></div><div><span><br/></span></div><ix:continuation id="ib88d94ff65a24255b60080db5af35ee5" continuedAt="i6e6f7764f6b74fef96fd0705c859d77c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if79cc9521a4944dca9685e052deaf802_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YzMzMzU0OTA0NjI0YzM1YWNhYzRiNmJmZWQ2NDY1Ni90YWJsZXJhbmdlOjRjMzMzNTQ5MDQ2MjRjMzVhY2FjNGI2YmZlZDY0NjU2XzItMi0xLTEtMTc0Ng_c39816ea-9979-44a3-8f4b-97b522839e26">14,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i356a33ce286d48cca156527df59d429c_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YzMzMzU0OTA0NjI0YzM1YWNhYzRiNmJmZWQ2NDY1Ni90YWJsZXJhbmdlOjRjMzMzNTQ5MDQ2MjRjMzVhY2FjNGI2YmZlZDY0NjU2XzItNC0xLTEtMTc0Ng_ce575aca-7fbe-44b3-ba29-280178216db8">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563f38b3693b4356b6ea8f9fe73e7167_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YzMzMzU0OTA0NjI0YzM1YWNhYzRiNmJmZWQ2NDY1Ni90YWJsZXJhbmdlOjRjMzMzNTQ5MDQ2MjRjMzVhY2FjNGI2YmZlZDY0NjU2XzItNi0xLTEtMTc0Ng_14c2f818-13f1-47a6-97a3-9f81c2b35e64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">208</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i816f90783e61420cb681681d639dcd82" continuedAt="ic43144b25e624d768ba67256d2ba094b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue recognized for the year ended December 31, 2020 includes the amortization of deferred revenue due to the satisfaction of our performance obligation during the period, offset by a cumulative catch-up adjustment of $<ix:nonFraction unitRef="usd" contextRef="if79cc9521a4944dca9685e052deaf802_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODI5MzA3_f1b3fe59-dce1-4c6b-8673-716fb4c0b71c">0.4</ix:nonFraction>&#160;million due to changes in estimated costs for our future performance obligations. </span></div><div><span><br/></span></div><ix:continuation id="i6e6f7764f6b74fef96fd0705c859d77c" continuedAt="iaf6cc7dd92764413a98ac6a24c3ac063"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54b6e3f162949438276b86a988013e1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGU5MTg2N2VlN2Y0OGU2YmI0YzU3OWM4ZTAwZWUyMC90YWJsZXJhbmdlOjk0ZTkxODY3ZWU3ZjQ4ZTZiYjRjNTc5YzhlMDBlZTIwXzItMi0xLTEtODU0Mw_91364192-d38f-4268-8e88-c9aa9c54b6d1">29,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic177577240b14353b1e60187c3076a64_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGU5MTg2N2VlN2Y0OGU2YmI0YzU3OWM4ZTAwZWUyMC90YWJsZXJhbmdlOjk0ZTkxODY3ZWU3ZjQ4ZTZiYjRjNTc5YzhlMDBlZTIwXzItNC0xLTEtODU0Mw_f4db2f4e-6531-498a-b111-25e3839bac87">41,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merck &#8211; Strategic Alliances in Infectious Diseases and Cancer Vaccines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2015 Strategic Alliance with Merck&#160;&#8211; Infectious Disease</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2015, we entered into a Master Collaboration and License Agreement with Merck, which was amended in January 2016, June 2016, and May 2019, and which we refer to, as amended, as the 2015 Merck Agreement. Pursuant to the 2015 Merck Agreement, we and Merck agreed to research, develop, and commercialize potential mRNA medicines for the prevention of infections by RSV. The 2015 Merck Agreement was terminated on October 7, 2020, by mutual agreement, and the right to pursue the continued development and commercialization of product candidates and products, including RSV, reverted to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a part of the May 2019 amendment of the 2015 Merck Agreement, we and Merck agreed to conclude the collaboration as it relates to development of potential mRNA medicines for other viruses, including mRNA-1278 for the prevention of varicella zoster virus (VZV) infection. Pursuant to the 2015 Merck Agreement, Merck was primarily responsible for research, development, and commercialization activities and associated costs of such research and commercialization. We were responsible for designing and, at Merck's cost, manufacturing all mRNA constructs for preclinical and Phase 1 and Phase 2 clinical development purposes, and we were responsible for certain costs associated with the conduct of a Phase 1 clinical trial for a RSV vaccine product candidate (mRNA-1172). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and Merck agreed to certain defined exclusivity obligations during the term of the 2015 Merck Agreement with respect to mRNA investigational medicines against RSV. As part of the May 2019 amendment of the 2015 Merck Agreement, we and Merck agreed to certain exceptions to the existing exclusivity obligations, pursuant to which we will no longer be restricted from researching, developing, and commercializing an mRNA investigational medicine for the prevention of a specific set of respiratory infections, including RSV, for the pediatric population.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the 2015 Merck Agreement, we received a $<ix:nonFraction unitRef="usd" contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ1NjQy_c8b2040f-5963-4f58-b630-75a5bd6ce0c3">50.0</ix:nonFraction> million upfront payment. We were eligible to receive, on a product-by-product basis, additional milestone payments upon the achievement of certain development, regulatory, and commercial milestone events, as well as royalties on Merck&#8217;s net sales of products at rates ranging from the mid-single digits to low teens, subject to certain reductions, with an aggregate minimum floor. During the term of the agreement, we received from Merck a clinical milestone payment of $<ix:nonFraction unitRef="usd" contextRef="ibdc3067fe5e145fe9f1452bcdebc7ceb_D20150101-20190531" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ1OTIx_548b8784-0d0f-4365-a8c0-170d6af4ea60">5.0</ix:nonFraction> million with respect to the initiation of a Phase&#160;1 clinical trial for a Merck RSV vaccine product candidate. Concurrent with entering into the 2015 Merck Agreement, Merck made a $<ix:nonFraction unitRef="usd" contextRef="i6f08b25f930848c1a69931c8014c2742_D20150101-20150131" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ2NTQ2_b270c62f-2706-4700-b336-5a576ce349b7">50.0</ix:nonFraction> million equity investment in us, and concurrent with amending the 2015 Merck Agreement in January 2016, we received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="ic7359b975668474bab9835c2035fd8dd_D20160101-20160131" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ2Njc5_d2e4c274-0634-4198-b29b-526a61652036">10.0</ix:nonFraction> million from Merck.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that all aspects of amended 2015 Merck Agreement represent a transaction with a customer and therefore the amended 2015 Merck Agreement is accounted for in accordance with ASC 606. The <ix:nonNumeric contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjE_c2fb8168-0516-41a5-b60c-eb108094661c">four-year</ix:nonNumeric> research period was complete as of December 31, 2018 and we recognized the total transaction price of $<ix:nonFraction unitRef="usd" contextRef="i3e4bfb91e3734bcbac49d735fb9839a4_I20190101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI0NTQ_afbc39cd-7290-40dc-958a-638fcf5bc197">65.0</ix:nonFraction>&#160;million (the $<ix:nonFraction unitRef="usd" contextRef="iae641b44702e44228c65d680d89234fb_I20190101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI0Mzk_194553ea-54d3-490b-b577-b2e694673c80">60.0</ix:nonFraction>&#160;million in aggregate upfront payments and a $<ix:nonFraction unitRef="usd" contextRef="i4a11405a9cb548088dc27731169c33c3_I20190101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI0Njk_0329c444-351d-4782-9764-8d7adf71d7e9">5.0</ix:nonFraction>&#160;million payment pertaining to achievement of a development milestone) in full as we concluded there were no unsatisfied performance obligations pertaining to the amended 2015 Merck Agreement. Additionally, we concluded the following customer options were marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement: (i) research services during the <ix:nonNumeric contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjI_66276b0b-1e37-4a3b-8589-0958faa6c306">three-year</ix:nonNumeric> period following the initial <ix:nonNumeric contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjM_d8370a83-42f3-4040-9599-2df15436836e">four-year</ix:nonNumeric> research period during which Merck could continue to preclinically and clinically develop product candidates and (ii) clinical mRNA supply for Phase 1 and Phase 2 and/or non-cGMP mRNA supply beyond the initial <ix:nonNumeric contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NjM2_aed26c8a-5a16-483e-a634-2af72a164c2a">four-year</ix:nonNumeric> research period. Therefore, such options would be accounted for as a separate contract if exercised by the customer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After completion of the initial <ix:nonNumeric contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjQ_d8658c26-2cf9-4ab3-95fb-faefc3e0bbe4">four-year</ix:nonNumeric> research period, and as part of the May 2019 amendment of the 2015 Merck Agreement, Merck elected to establish a new RSV vaccine product candidate and elected to conduct a Phase 1 clinical trial. We are responsible for </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">209</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="ic43144b25e624d768ba67256d2ba094b" continuedAt="i9dadeb323bbe487ab1c39999ed1c59bd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain costs associated with the conduct of the Phase 1 clinical trial. We determined that our obligation under the May 2019 amendment to reimburse Merck for certain costs associated with the RSV vaccine Phase 1 clinical trial represents consideration payable to a customer and is accounted for as a reduction of the transaction price. The consideration amount is determined based on the most likely method and recorded as contra-revenue as costs are incurred. The one-time payment upon election by Merck to continue developing RSV is fully constrained as it is contingent upon completion of the RSV Phase 1 clinical trial and upon decisions to be made by Merck to continue development thereafter.</span></div><div><span><br/></span></div><ix:continuation id="iacddb1e9706f40a7a343bea723eb38b0" continuedAt="i3efeba6addf54c06bc1a7819a8eef1a1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2015 Merck Agreement:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56cc782d9cf240ab9de511487fe001b7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzQtMi0xLTEtMTc3Nw_c04b0890-b99b-468c-88f0-387a513283ed">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaedcaef95a2f47b299253a6c24982262_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzQtNC0xLTEtMTc3Nw_74844d21-337e-4fad-a4f1-4211013eef4d">60,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0212b2f2863143b0a038e34ad03323de_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzUtMi0xLTEtMTc3Nw_3475474d-94e2-48bc-a053-55e85cbde80e">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife317ed77f384b109eae0a11e402500a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzUtNC0xLTEtMTc3Nw_9e75d53a-d9d6-4b9a-875f-39df09831241">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction of reimbursements paid to Merck</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b94988b255b492ab10c9199f363efe2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzYtMi0xLTEtMTc3Nw_5cc9a41c-0bbb-4f58-96a0-b3419e666728">12,353</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i018b2aab0ed44437b6b42610898fd072_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzYtNC0xLTEtMTc3Nw_c3f1d5ba-20d8-463f-8d99-f70d9ada4e11">5,265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bfd65e4ca8b47f6a09d780605125913_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzctMi0xLTEtMzk2NA_f7871077-5d41-4833-9c07-74d6117a4268">52,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7561834c28344ed5a15e15ffa2d94708_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzctNC0xLTEtMzk2NQ_7af43339-2b0a-412d-b056-b3f61d5c57cf">59,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the most likely amount method to estimate any development and regulatory milestone payments to be received. As of December 31, 2020, there were no milestones that had not been achieved included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Merck&#8217;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We re-evaluate the transaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur. For the year ended December 31, 2020, there was a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwNjc2NzA2_289944ea-eb5c-485b-985f-c4eff941ee9b">7.1</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> deduction to the transaction price related to reimbursements paid to Merck for RSV vaccine Phase I clinical trial costs.</span></div><div><span><br/></span></div><ix:continuation id="i210c4ee55a55461d993fee83bd22764e" continuedAt="i3afa633eb5154bf2b25603648ffc70f0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total transaction price allocated to the combined performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Merck Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bfd65e4ca8b47f6a09d780605125913_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTphMDQwOTQzNjhiZGU0ZjU4YWQ4N2RmNGQzY2Y0YWY4My90YWJsZXJhbmdlOmEwNDA5NDM2OGJkZTRmNThhZDg3ZGY0ZDNjZjRhZjgzXzMtMi0xLTEtMTc5NA_ed5f0055-5934-4382-b123-5e420e928dd7">52,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316e60df5f6843bf9f30bdcae4453017_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTphMDQwOTQzNjhiZGU0ZjU4YWQ4N2RmNGQzY2Y0YWY4My90YWJsZXJhbmdlOmEwNDA5NDM2OGJkZTRmNThhZDg3ZGY0ZDNjZjRhZjgzXzQtMi0xLTEtMTc5NA_1ba5903c-4ad9-48b9-8285-97be78e46763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="i1558f9c4a60749039f3fbabd2da3a57b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue and contra-revenue recognized for the periods presented (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contra-revenue under the May 2019 Amendment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia449e79cf2a44014b2511df73272f527_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzItMi0xLTEtMTg1MA_8f0b8449-92a4-4c62-8447-56387bbaa4fb">7,088</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i392a2394213c44f893b9b592d6e59b88_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzItNC0xLTEtMTg1MA_b54d69f1-6813-4972-89e9-bfbab6ae0f5b">5,265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51ff27e4a88e4237b3e19f6822bca430_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzItNi0xLTEtMTg1MA_11d1a472-0dd7-4201-a47c-bf95e18843d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue under the 2015 Merck Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a1cdfdf44f41ceb9bb274d0f145355_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzMtMi0xLTEtMTg1MA_01f8299e-beed-46b6-9235-dc7c08b89bbc">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0395a7348b444ec48cc30fa685878865_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzMtNC0xLTEtMTg1MA_2eff19b1-3c0b-4253-9b3e-7a98bc7015bf">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88da5e4006934b50a0e65f87903ba7d4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzMtNi0xLTEtMTg1MA_ce1fb200-769f-4a9b-923e-2a5efee5c62d">24,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contra-revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1acf7d5970e4063b3ec0293575fe05c_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzQtMi0xLTEtMzk0Nw_dc25485a-ff57-45e4-b34d-b2c661f319c7">7,026</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i624e4ab60a804616a11ab12b4aaca0b7_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzQtNC0xLTEtMzk0OA_0ca49bf8-c649-40a0-9caf-535bd01a2b6c">4,773</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8350b0070d0a4021b617d51d1237f6e8_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzQtNi0xLTEtMzk1MQ_eb866872-2f7a-4ce4-a1ca-3e5485f2ad75">24,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contra-revenue recognized was related to consideration payable to Merck under the May 2019 Amendment of the 2015 Merck Agreement. Collaboration revenue recognized was pursuant to separate agreements with Merck related to the exercise of customer options to purchase clinical mRNA supply to further develop a product candidate after the initial <ix:nonNumeric contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NTY4_4d5cea9d-714b-4e47-b955-e91300676060">four-year</ix:nonNumeric> research period. Clinical mRNA supply was recognized as collaboration revenue at a point in time upon which control of supply was transferred to Merck for each delivery of the associated supply. We had no deferred revenue as of December 31, 2020 or December 31, 2019 from the amended 2015 Merck Agreement as all performance obligations under the amended 2015 Merck Agreement were completed as of December 31, 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2020, the 2015 Master Collaboration and License Agreement between us and Merck related to our collaboration on RSV was terminated by mutual agreement. Merck will complete the Phase 1 study and transition the program to Moderna. The termination did not have an impact to our consolidated financial statements as of and for the year ended December 31, 2020.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i9dadeb323bbe487ab1c39999ed1c59bd" continuedAt="i510f7d81bc034fccac994425606b706e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Cancer Vaccine Strategic Alliance-Personalized mRNA Cancer Vaccines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, we entered into a personalized mRNA cancer vaccines (PCV) Collaboration and License Agreement with Merck, which we refer to as the PCV Agreement, to develop and commercialize PCVs for individual patients using our mRNA vaccine and formulation technology. Under the strategic alliance, we identify genetic mutations present in a particular patient&#8217;s tumor cells, synthesize mRNA for these mutations, encapsulate the mRNA in one of our proprietary LNPs and administer to each patient a unique mRNA cancer vaccine designed to specifically activate the patient&#8217;s immune system against her or his own cancer cells.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the PCV Agreement, we are responsible for designing and researching PCVs, providing manufacturing capacity and manufacturing PCVs, and conducting Phase&#160;1 and Phase&#160;2 clinical trials for PCVs, alone and in combination with KEYTRUDA (pembrolizumab), Merck&#8217;s anti-PD-1 therapy, all in accordance with an agreed upon development plan and budget and under the oversight of a committee comprised of equal representatives of each party. The parties have entered into a clinical quality agreement with respect to Moderna&#8217;s manufacture and supply activities. We received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i16fd06682d81475283857811586f4079_D20160601-20160630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzU1MjY4_8bbeb91e-5256-45b3-990b-490921537b22">200.0</ix:nonFraction> million from Merck. In November 2017, we and Merck announced the achievement of a key milestone for the first-in-human dosing of a PCV (mRNA-4157) as a part of the alliance. The Phase&#160;1 open-label, dose escalation, multicenter clinical trial in the United States (KEYNOTE-603) is designed to assess the safety, tolerability and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with KEYTRUDA, in subjects with unresectable solid tumors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the expiration of a defined period of time following our completion of Phase 1 and Phase 2 clinical trials for PCVs under the PCV Agreement and delivery of an associated data package to Merck, Merck has the right to elect to participate in future development and commercialization of PCVs by making a $<ix:nonFraction unitRef="usd" contextRef="ie3347a1fc6b94f67a83914d66ec9adbf_I20170630" decimals="-5" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzU2MDUw_369034bd-7dc2-4e7b-b027-fba6f1d97f65">250.0</ix:nonFraction> million participation payment to us. If Merck exercises its election and pays the participation payment, then the parties will equally co-fund subsequent clinical development of PCVs, with Merck primarily responsible for conducting clinical development activities under a jointly agreed development plan and budget. Each party may also conduct additional clinical trials for PCVs that are not included in the jointly agreed development plan and budget, in which case the non-conducting party will reimburse the conducting party for half of the total costs for such trials, plus interest, from its share of future profits resulting from sales of such PCVs, if any. Merck will lead worldwide commercialization of PCVs, subject to Moderna&#8217;s option to co-promote PCVs in the United States, and the parties will equally share the profits or losses arising from worldwide commercialization. Until a PCV becomes profitable, we may elect to defer payment of our share of the commercialization and related manufacturing costs and instead reimburse Merck for such costs, plus interest, from our share of future profits resulting from sales of such PCV, if any. Subject to customary &#8220;back-up&#8221; supply rights granted to Merck, we will manufacture (or have manufactured) PCVs for preclinical and clinical purposes. Manufacture of PCVs for commercial purposes will be determined by the parties in accordance with the terms of the PCV Agreement. Under the PCV Agreement, we grant certain licenses to Merck to perform its collaboration activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Merck does not exercise its right to participate in future development and commercialization of PCVs, then Moderna will retain the exclusive right to develop and commercialize PCVs developed during the strategic alliance, subject to Merck&#8217;s rights to receive a percentage in the high teens to the low 20s, subject to reductions of our net profits on sales of such PCVs. During a limited period following such non-exercise, Merck has the right to perform clinical studies of such PCVs in combination with KEYTRUDA, for which we agree to use reasonable efforts to supply such PCVs. During such limited period, we also have the right to perform clinical studies of PCVs in combination with KEYTRUDA, for which Merck agrees to use reasonable efforts to supply KEYTRUDA. In addition, following its non-exercise, Merck is also entitled to receive a percentage in the high teens to the low 20s, subject to reductions, of our net profits on sales of certain PCVs first developed by us following such non-exercise and reaching a specified development stage within a defined period of time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and Merck have agreed to certain defined, limited exclusivity obligations with respect to the development and commercialization of PCVs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Expansion of the Cancer Vaccine Strategic Alliance-Shared Neoepitope Cancer Vaccines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, we and Merck agreed to expand our cancer vaccine strategic alliance to include the development and commercialization of our KRAS vaccine development candidate, mRNA-5671 or V941, and potentially other shared neoantigen mRNA cancer vaccines (SAVs). We preclinically developed mRNA-5671 prior to its inclusion in the cancer vaccine strategic alliance and it is comprised of a novel mRNA construct designed by us and encapsulated in one of our proprietary LNPs. The PCV Agreement was amended and restated to include the new SAV strategic alliance (PCV/SAV Agreement).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted Merck certain licenses and we and Merck have agreed to certain exclusivity obligations with respect to SAVs and particular SAV programs, which obligations are subject to termination or expiration upon certain triggering events. Under the PCV/SAV Agreement, Merck will be responsible for conducting Phase 1 and Phase 2 clinical trials for mRNA-5671 and for all costs associated with such activities, in accordance with a jointly agreed development plan and budget, and we will be responsible for manufacturing and supplying all mRNA-5671 required to conduct such trials and for all costs and expenses associated with such </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">211</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i510f7d81bc034fccac994425606b706e" continuedAt="i523d979a93404ea09c3cc2c57d3bc4aa"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacture and supply. Under the PCV/SAV Agreement, our budgeted commitment for PCV increased to $<ix:nonFraction unitRef="usd" contextRef="ia0cd83a6a1924769a19a58e5f11bd212_I20180430" decimals="-5" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzYwMjEw_0ee629f9-029d-4946-8870-737499c12a93">243.0</ix:nonFraction> million. Until the expiration of a defined period of time following the completion of Phase 1 and Phase 2 clinical trials for mRNA-5671 under the PCV/SAV Agreement and our delivery of an associated data package to Merck, Merck has the right to elect to participate in future development and commercialization of mRNA-5671 by making a participation payment to us. If Merck exercises its participation rights, then the parties will equally co-fund subsequent clinical development of mRNA-5671, with Merck primarily responsible for conducting clinical development activities under a jointly agreed development plan and budget. If Merck declines to participate in future development and commercialization activities following the initial Phase 1 and Phase 2 clinical trials for mRNA-5671, then we will retain the rights to develop and commercialize mRNA-5671. If Merck elects to participate in future development and commercialization of mRNA-5671, Merck may also conduct additional clinical trials for mRNA-5671 that are not included in the jointly agreed development plan and budget, in which case we will reimburse Merck for half of the total development costs for such clinical trials, plus interest, from our share of future profits resulting from sales of mRNA-5671, if any. If Merck does conduct additional clinical trials for mRNA-5671, we will be responsible for manufacturing and supplying all mRNA-5671 required to conduct such trials. Merck will lead worldwide commercialization of mRNA-5671, subject to our option to co-promote mRNA-5671 in the United States, and the parties will equally share the operating profits or losses arising from worldwide commercialization. Until mRNA-5671 becomes profitable, we may elect to defer payment of our share of the commercialization and related manufacturing costs and instead reimburse Merck for such costs, plus interest, from our share of future profits resulting from sales of mRNA-5671, if any. Subject to &#8220;back-up&#8221; supply rights granted to Merck, we will manufacture (or have manufactured) mRNA-5671 and other SAVs for preclinical and clinical purposes. After Merck exercises its right to participate in future development and commercialization of mRNA-5671 and other SAVs, we will grant the applicable development and commercialization licenses and the parties are obligated to discuss responsibility for future manufacturing, giving consideration to applicable criteria.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the PCV/SAV Agreement, for a defined period of time, either party may propose that the parties conduct additional programs for the research and development of SAVs directed to different shared neoantigens. If the parties agree to conduct any such programs, then we will be responsible for conducting and funding preclinical discovery and research activities for such SAVs, and otherwise the programs would be conducted on substantially the same terms as mRNA-5671 program. If we or Merck propose a new SAV program and the other party does not agree to conduct such program, then the PCV/SAV Agreement includes provisions allowing the proposing party to proceed with such development, at the proposing party&#8217;s expense. If Merck is the proposing party, we will be responsible for manufacturing and supplying material for such program at Merck&#8217;s expense. In such case, the non-proposing party will have the right to opt-in to such SAV program any time before the proposing party commits to performing Good Laboratory Practice (GLP)-toxicity studies. Until the expiration of a defined period of time following our completion of Phase&#160;1 and Phase&#160;2 clinical trials for any SAV program mutually agreed by the parties under the PCV/SAV Agreement and our delivery of an associated data package to Merck, Merck has the right to elect to participate in future development and commercialization of such SAV by making a participation payment to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the PCV/SAV Agreement will continue on a program-by-program basis until Merck terminates its participation in such program. Following any such termination, we will retain the exclusive right to develop and commercialize PCVs or SAVs developed as a part of such program, subject to restrictions and certain limited rights retained by Merck.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the amendment of the PCV Agreement to include the development and commercialization of mRNA-5671 and potentially other SAVs, Merck made a contemporaneous equity investment in our Series H redeemable convertible preferred stock, resulting in gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ic50bf5d952c24703b46068d51770fec8_D20180401-20180430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzY0NzMw_41095f84-c64f-4c12-810b-3510776459c4">125.0</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ic50bf5d952c24703b46068d51770fec8_D20180401-20180430" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RedemptionPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzY0NzQz_20cbd55e-57a7-4103-bfb8-90cdeb46310b">13.0</ix:nonFraction> million was determined to be a premium and recorded to deferred revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div style="padding-left:2.25pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that the PCV/SAV Agreement should be accounted for separately from the amended 2015 Merck Agreement, as the agreements were not negotiated in contemplation of one another and the elements within each of the agreements are not closely interrelated or interdependent on each other. The PCV/SAV Agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. </span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the following performance obligations in the PCV/SAV Agreement: (i) a research license and research and development services, including manufacturing and supply of PCVs, during the proof of concept (POC) term for the PCV program, referred to as the PCV Performance Obligation, and (ii) research license and manufacturing and supply of mRNA-5671 during the POC term for the KRAS program, referred to as the KRAS Performance Obligation. We concluded that the research license is not distinct from the research and development services, including manufacturing and supply of PCVs, during the POC term for the PCV program, as Merck cannot fully exploit the value of the license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Therefore, the research license has been combined with the research and development services, including manufacturing and supply of PCVs, during the POC term for the PCV program, into a single performance obligation. Similarly, we concluded that the research license is not distinct from the manufacturing and supply of mRNA-5671 during the POC term for the KRAS program, as Merck cannot fully </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i523d979a93404ea09c3cc2c57d3bc4aa" continuedAt="i157c0a679c1746cb956e648220fbb1f5"><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exploit the value of the license without receipt of such supply which must be provided by us. This is due to limitations inherent in the licenses conveyed wherein Merck does not have the contractual right to manufacture during the POC term. Therefore, the research license has been combined with the manufacturing and supply of mRNA-5671, during the POC term for the KRAS program, into a single performance obligation. Conversely, we concluded that the PCV Performance Obligation and the KRAS Performance Obligation are distinct from each other because Merck can fully exploit the value of each program for its intended purpose without the promises associated with the other program. Additionally, we concluded the following customer options are marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement: (i) Merck participation election license related to future joint development and commercialization on a program-by-program basis, (ii) manufacturing and supply in support of certain SAV programs and/or the PCV program upon Merck election to not participate in future development and commercialization of that program and (iii) research and development services associated with certain SAV programs. Therefore, such options will be accounted for as a separate contract upon the customer&#8217;s election.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><ix:continuation id="i3efeba6addf54c06bc1a7819a8eef1a1" continuedAt="i810d646d173941e083ec8098962e6242"><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-right:6.75pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">PCV/SAV Agreement:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d5048c0c1ab41668db8aa8a13a9f01d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzQtMi0xLTEtMjAyNQ_91370295-c755-4ece-a3c1-4eaf1a386ffb">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia61f19b469e44cc391bbf2ed9db3b35b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzQtNC0xLTEtMjAyNQ_e0f8daca-5bfa-41cc-8da9-aa3522d0a1e0">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium associated with the contemporaneous sale of Series H redeemable convertible preferred stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ad30b16714046c3b761def5ad1ec930_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzUtMi0xLTEtMjAyNQ_ca471b58-194d-4f08-b3f5-b76e3b99a97f">13,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd817774a25a4b54a5e146a36338e853_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzUtNC0xLTEtMjAyNQ_3afd543d-d892-4b5d-85c3-1ecb9166b6d8">13,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursement for clinical supply</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i791028eb61c741c0b0bcc8de949523e3_I20201231" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzYtMi0xLTEtMjAyNQ_b22650de-359e-46c5-933b-ef6f7c854c71">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1c48a89440e425d8cdcde9fe46e6f1d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzYtNC0xLTEtMjAyNQ_e2d9575c-521f-482f-a029-92289866a8a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie979852e105e4bda87e75d94f1fc565c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzctMi0xLTEtMzkyNQ_a39e1b0a-dd4d-4bea-8443-adad8b00ce7f">213,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie517b85a81b14dd1be0f4552d417c47e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzctNC0xLTEtMzkyNw_ae32db7d-fbd4-416e-9036-57758a2fd446">213,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We re-evaluate the transaction price at the end of each reporting period. During the year ended December 31, 2020, there was a $<ix:nonFraction unitRef="usd" contextRef="id3a8ffa0085e4794913a1deaa0b73f5d_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODI5MzIx_ed4ca9d2-e033-4c87-9736-804fd502de2f">0.3</ix:nonFraction>&#160;million increase to the transaction price from a reimbursement for clinical supply.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was allocated to the performance obligations based on the relative estimated standalone selling price of each performance obligation. We developed the estimated standalone selling price for the license included in each of the PCV Performance Obligation and the KRAS Performance Obligation primarily based on the probability-weighted present value of expected future cash flows associated with each license related to each specific program. In developing such estimate, we also considered applicable market conditions and relevant entity-specific factors, including those factors contemplated in negotiating the agreement, probability of success and the time needed to commercialize a product candidate pursuant to the associated license. We developed the estimated standalone selling price for the services and/or manufacturing and supply included in each of the PCV Performance Obligation and the KRAS Performance Obligation, as applicable, primarily based on the nature of the services to be performed and/or goods to be manufactured and estimates of the associated cost, adjusted for a reasonable profit margin that would be expected to be realized under similar contracts.</span></div><div style="padding-right:11.25pt"><span><br/></span></div><ix:continuation id="i3afa633eb5154bf2b25603648ffc70f0" continuedAt="ic9b037e0fe4146a883b9d61e99a6329e"><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-right:6.75pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">PCV/SAV Agreement:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf670da31cdc46a09101eb0c8678cac6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2MjdkNDk0NWFlNzY0NGI2OWQwZGM2OTE2YWQ1ZjA1Ny90YWJsZXJhbmdlOjYyN2Q0OTQ1YWU3NjQ0YjY5ZDBkYzY5MTZhZDVmMDU3XzQtMi0xLTEtODY1Nw_74091da3-35ad-46c8-bb85-9e61244b78ab">206,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KRAS performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6260d9dece294c47adb143dbae8f22ba_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2MjdkNDk0NWFlNzY0NGI2OWQwZGM2OTE2YWQ1ZjA1Ny90YWJsZXJhbmdlOjYyN2Q0OTQ1YWU3NjQ0YjY5ZDBkYzY5MTZhZDVmMDU3XzUtMi0xLTEtODY1Nw_821c597a-69ad-4b27-b14a-a0e9320f6429">7,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie979852e105e4bda87e75d94f1fc565c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2MjdkNDk0NWFlNzY0NGI2OWQwZGM2OTE2YWQ1ZjA1Ny90YWJsZXJhbmdlOjYyN2Q0OTQ1YWU3NjQ0YjY5ZDBkYzY5MTZhZDVmMDU3XzQtMi0xLTEtMTA3Nzg_dd87d5c7-0227-4ae7-875c-9c191c9698be">213,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfe0cd89ae6041918c135184fa183ddb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2MjdkNDk0NWFlNzY0NGI2OWQwZGM2OTE2YWQ1ZjA1Ny90YWJsZXJhbmdlOjYyN2Q0OTQ1YWU3NjQ0YjY5ZDBkYzY5MTZhZDVmMDU3XzctMi0xLTEtODY3NA_22a04fa5-7960-487b-9b25-345c6954e3cf">51,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through December 31, 2024.</span></div></ix:continuation><div style="padding-right:6.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">213</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i157c0a679c1746cb956e648220fbb1f5" continuedAt="i091b77e0e99944d985e0c65a17cb2ae3"><div style="padding-right:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will recognize revenue related to amounts allocated to the PCV Performance Obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of research and development efforts. We recognize revenue related to the amounts allocated to the KRAS Performance Obligation based on the point in time upon which control of supply is transferred to Merck for each delivery of the associated supply. </span></div><div style="padding-right:11.25pt"><span><br/></span></div><ix:continuation id="iaf6cc7dd92764413a98ac6a24c3ac063" continuedAt="i16839f8a19444be5897c4d1077a1eaf0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV/SAV Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i340827b3da36421394e5bd54e37ccfea_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZToxYjRjODY1ZTczMDg0MjNhYmMxMzgwNjZjMzRjMmVmYi90YWJsZXJhbmdlOjFiNGM4NjVlNzMwODQyM2FiYzEzODA2NmMzNGMyZWZiXzItMi0xLTEtMjA3MA_4df8f58e-036c-45a3-9da0-033e3f3036bf">33,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3efea2a5d54653be9c2285642a667c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZToxYjRjODY1ZTczMDg0MjNhYmMxMzgwNjZjMzRjMmVmYi90YWJsZXJhbmdlOjFiNGM4NjVlNzMwODQyM2FiYzEzODA2NmMzNGMyZWZiXzItNC0xLTEtMjA3MA_fc949897-160b-42f3-a422-b0cb70634c2f">41,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950a1adc46aa45c28b3349f86c2a031e_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZToxYjRjODY1ZTczMDg0MjNhYmMxMzgwNjZjMzRjMmVmYi90YWJsZXJhbmdlOjFiNGM4NjVlNzMwODQyM2FiYzEzODA2NmMzNGMyZWZiXzItNi0xLTEtMjA3MA_49a2a81f-3e23-46ba-bf2d-c2455391305a">41,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue recognized during the year ended December 31, 2020 includes the amortization of deferred revenue due to the satisfaction of our performance during the period, offset by a cumulative catch-up adjustment of $<ix:nonFraction unitRef="usd" contextRef="i981f59fd40474c90ad61c969280172a6_D20201001-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NjIz_47038f29-e987-41f7-a2dc-25f4e4291328"><ix:nonFraction unitRef="usd" contextRef="i340827b3da36421394e5bd54e37ccfea_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NjIz_bdbcc70b-a674-44fa-b712-d64b32b72198">3.5</ix:nonFraction></ix:nonFraction>&#160;million due to changes in estimated costs for our future performance obligations. </span></div><div><span><br/></span></div><ix:continuation id="i16839f8a19444be5897c4d1077a1eaf0" continuedAt="i2c06973e8e194df5b2dd2d687737de5c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue, which is classified as current or non-current in the condensed consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV/SAV Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie979852e105e4bda87e75d94f1fc565c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2OWIzOTRiOWU1Y2U0OTg5OWI4OTQ3MTAyMzIzYjg0MS90YWJsZXJhbmdlOjY5YjM5NGI5ZTVjZTQ5ODk5Yjg5NDcxMDIzMjNiODQxXzItMi0xLTEtMjA5MA_9c0c3c17-4ff1-404d-a808-2d6419262432">51,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie517b85a81b14dd1be0f4552d417c47e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2OWIzOTRiOWU1Y2U0OTg5OWI4OTQ3MTAyMzIzYjg0MS90YWJsZXJhbmdlOjY5YjM5NGI5ZTVjZTQ5ODk5Yjg5NDcxMDIzMjNiODQxXzItNC0xLTEtMjA5MA_43aa88fa-2be2-4e1f-bdc0-7db09686668e">83,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="padding-right:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vertex &#8211; 2016 Strategic Alliance in Cystic Fibrosis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In July 2016, we entered into a Strategic Collaboration and License Agreement, with Vertex Pharmaceuticals Incorporated, and Vertex Pharmaceuticals (Europe) Limited, together, Vertex, which we refer to as the Vertex Agreement. The Vertex Agreement, which was amended in July 2019, which we refer to as the 2019 Vertex Amendment, is aimed at the discovery and development of potential mRNA medicines for the treatment of cystic fibrosis (CF) by enabling cells in the lungs of people with CF to produce functional cystic fibrosis transmembrane conductance regulator (CFTR) proteins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Vertex Agreement, we lead discovery efforts during an initial research period that currently extends until March 2020, leveraging our Platform technology and mRNA delivery expertise along with Vertex&#8217;s scientific experience in CF biology and the functional understanding of CFTR. Vertex is responsible for conducting development and commercialization activities for candidates and products that arise from the strategic alliance, including the costs associated with such activities. Subject to customary &#8220;back-up&#8221; supply rights granted to Vertex, we exclusively manufacture (or have manufactured) mRNA for preclinical, clinical and commercialization purposes. The parties established a joint steering committee to oversee and coordinate activities under the Vertex Agreement. We and Vertex have granted each other certain licenses under the Vertex Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Vertex Agreement, we received a $<ix:nonFraction unitRef="usd" contextRef="i5499e80adfa6472b9e1528ab0f94b167_D20160701-20160731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc0NTA2_bf3a7bf6-bb53-4aed-9d9d-35f040cf88b5">20.0</ix:nonFraction> million upfront payment from Vertex. In July 2019, Vertex elected to extend the initial research period by <ix:nonNumeric contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc0NjA4_565919ee-e085-43ec-be7d-350362fefe57">six months</ix:nonNumeric> by making a $<ix:nonFraction unitRef="usd" contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc0NjIz_43eca0a6-1329-43ec-b497-9ce5844fda75">2.0</ix:nonFraction> million payment to us pursuant to the 2019 Vertex Amendment. In March 2020, based on the promising preclinical data generated to date, Vertex extended the conduct of the initial Research Plan through the First Extended Research Term (an additional <ix:nonNumeric contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjU_e4d23f87-1155-4239-92fb-678c87f468a0">18-month</ix:nonNumeric> term) by making an additional payment to us. Vertex has rights to further extend the research period for <ix:nonFraction unitRef="extension_period" contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731" decimals="INF" format="ixt-sec:numwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc0ODcw_1e767283-bed8-4a0e-a8e5-fec3a96b050e">two</ix:nonFraction> additional <ix:nonNumeric contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjY_f64cf570-ee60-44c2-a8ae-b9801add2f59">one-year</ix:nonNumeric> periods by making an additional payment to us for each <ix:nonNumeric contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3Njc_efa65cf7-19eb-43d0-9642-883ec47dc577">one-year</ix:nonNumeric> extension. We are eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="i3f8781fcff4e440a97e13c637f9373b3_I20190731" decimals="INF" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc0OTk5_e5d2fafa-d7bb-4952-858b-9bfe0f353e3a">55.0</ix:nonFraction> million in payments for achievement of development milestones, up to $<ix:nonFraction unitRef="usd" contextRef="i42f4b3b0fa0d4f57b37d2a96d63f003c_I20190731" decimals="INF" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc1MDYz_b9089f18-80b8-47cd-9e8c-1d6f21217db0">220.0</ix:nonFraction> million in payments for achievement of regulatory milestones and potentially could receive an additional $<ix:nonFraction unitRef="usd" contextRef="i7f178b19838f48b4914e2694d3057ea7_I20190731" decimals="INF" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc1MTYz_e92a81ae-152e-4013-adcc-f7e808be483f">3.0</ix:nonFraction> million milestone payment for achievement of a regulatory milestone for second and each subsequent product under the Vertex Agreement. Vertex will also pay us tiered royalties at rates ranging from the low- to high-teens on worldwide net sales of products arising from the strategic alliance, subject to certain reductions, with an aggregate minimum floor. In connection with the strategic alliance, Vertex also made a $<ix:nonFraction unitRef="usd" contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc1NTc3_86c91804-a1a1-41e4-829a-506f30661da1">20.0</ix:nonFraction> million equity investment in us. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Vertex Agreement, we and Vertex have agreed to certain defined exclusivity obligations under the Vertex Agreement with respect to the development and commercialization of certain mRNA medicines. Unless earlier terminated, the Vertex Agreement will continue until the expiration of all royalty terms. Vertex may terminate the Vertex Agreement for convenience upon <ix:nonNumeric contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731" format="ixt-sec:durday" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc1OTkx_65d12140-40da-49a6-bb13-9b75b1046f18">90</ix:nonNumeric>&#160;days&#8217; prior written notice, except if termination relates to a product in a country where Vertex has received marketing approval, which, in such case, Vertex must provide <ix:nonNumeric contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731" format="ixt-sec:durday" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc2MTY1_b9f7d584-2da8-4d70-85ba-505de47ef7a3">180</ix:nonNumeric> days&#8217; prior written notice. Either party may terminate the Vertex Agreement upon the other party&#8217;s material breach, subject to specified notice and cure provisions. Each party may also terminate the Vertex Agreement in </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">214</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i091b77e0e99944d985e0c65a17cb2ae3" continuedAt="i1b8d17d451684577888301b21f48fac6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the event that the other party challenges the validity or enforceability of such party&#8217;s patent rights, subject to certain exceptions, or if the other party becomes insolvent.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div style="padding-right:2.25pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total transaction price for the Vertex Agreement was determined to be $<ix:nonFraction unitRef="usd" contextRef="ic6a88a9c14d2404d970ffdfe239ee718_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NTcw_17810874-4669-4fe6-a0a5-6c46404c3f9a">24.4</ix:nonFraction>&#160;million, comprised of the $<ix:nonFraction unitRef="usd" contextRef="if8af61d149a74aa9bdde3e7ad4d3907f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NTg1_ca7419ea-6ccb-4486-a79f-bfe8c993df39">20.0</ix:nonFraction>&#160;million upfront payment and $<ix:nonFraction unitRef="usd" contextRef="ieb6bc087a0004b3e8507b5cc459cb4d5_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NjAw_0b9484d5-e997-4a89-9595-ad91d672c668">4.4</ix:nonFraction>&#160;million in research and development funding related to the research and development services and supply of non-cGMP mRNA. As of December 31, 2019, all performance obligations under the Vertex Agreement were completed. The 2019 Vertex Amendment represents a contract modification and is accounted for as a separate contract. As of December 31, 2020, all performance obligations under the 2019 Vertex Amendment were completed and the total transaction price of $<ix:nonFraction unitRef="usd" contextRef="id85fae767ef44643861725eb10c2ee6c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI3NTQ_e4950413-3159-4b39-8b57-2ad2e336da5a">4.5</ix:nonFraction>&#160;million, comprised of the $<ix:nonFraction unitRef="usd" contextRef="i9cfd6d8a963b437fba39ba94ab400b91_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI3MzU_31be2ac4-9df0-42f2-a396-a2ea2d96f46b">2.0</ix:nonFraction>&#160;million upfront payment and $<ix:nonFraction unitRef="usd" contextRef="i15c73ffb7e51425da60d278c68eae95f_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI3MTY_543d6188-324f-4b4f-a496-1db1ed9f0af2">2.5</ix:nonFraction>&#160;million in research and development funding related to the research and development services and supply of non-cGMP mRNA, was fully recognized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Extended Research Term represents a contract modification and is accounted for as a separate contract. Pursuant to the 2019 Vertex Amendment, we identified one performance obligation comprised of: (i) a research, development and commercialization license and (ii) research and development services, including manufacturing and supply of non-cGMP mRNA, during the 18-month First Extended Research Term. We concluded that the license is not distinct from the research and development services, including manufacturing and supply of non-cGMP mRNA. Additionally, we concluded that the following customer options are marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement: (i) Vertex&#8217;s rights to extend the extended initial research period and (ii) clinical mRNA supply and/or non-cGMP mRNA supply beyond the extended initial research period. Therefore, such options will be accounted for as a separate contract upon the customer&#8217;s election.</span></div><div><span><br/></span></div><ix:continuation id="i810d646d173941e083ec8098962e6242" continuedAt="i12c322cc6ec24d9494429785cd988e47"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the First Extended Research Term at December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:84.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Vertex Agreement - First Extended Research Term:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia11a3663e67e45c08dd00fe0f20b964b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZDZjNTBlNzA2ZjA0YmQ2OTQ0OGJjYzBlOWJlNzgxNS90YWJsZXJhbmdlOmJkNmM1MGU3MDZmMDRiZDY5NDQ4YmNjMGU5YmU3ODE1XzQtMi0xLTEtMjEzNQ_1f175c1c-ba49-420a-849b-3c2946184040">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd261966c1e44f1db6dc2b1efb265428_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZDZjNTBlNzA2ZjA0YmQ2OTQ0OGJjYzBlOWJlNzgxNS90YWJsZXJhbmdlOmJkNmM1MGU3MDZmMDRiZDY5NDQ4YmNjMGU5YmU3ODE1XzUtMi0xLTEtMjEzNQ_05b5c605-f976-41ce-9bc1-d5a6f8017640">39,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02f591019054030b611751b6c248c94_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZDZjNTBlNzA2ZjA0YmQ2OTQ0OGJjYzBlOWJlNzgxNS90YWJsZXJhbmdlOmJkNmM1MGU3MDZmMDRiZDY5NDQ4YmNjMGU5YmU3ODE1XzUtMi0xLTEtMzkwMg_d16bdb98-f531-42ed-a6e7-03708a6550e4">43,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the most likely amount method to determine the amount of research and development funding to be received. As of December 31, 2020, there were no milestones included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Vertex&#8217;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any sales-based royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted and therefore have also been excluded from the transaction price. We re-evaluate the tra</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nsaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur. There was a $<ix:nonFraction unitRef="usd" contextRef="id85fae767ef44643861725eb10c2ee6c_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI2OTY_5f02e464-a8e4-4b69-bb43-91218cb45595">8.6</ix:nonFraction>&#160;million increas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e to the transaction price during the year ended December 31, 2020, resulting from a change in the estimate of variable consideration.</span></div><div><span><br/></span></div><ix:continuation id="ic9b037e0fe4146a883b9d61e99a6329e" continuedAt="i8c195b0c1cb448edbb8ac738b70dfa2f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total transaction price allocated to the single performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.790%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Extended Research Term transaction price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02f591019054030b611751b6c248c94_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1OTI2MmQ5MDkxZmM0ZDUxYWMwOTcyODdiODMyNjU5Yy90YWJsZXJhbmdlOjU5MjYyZDkwOTFmYzRkNTFhYzA5NzI4N2I4MzI2NTljXzMtMi0xLTEtMjE3MQ_aae15ead-4247-4fae-864a-9e718ffa05d4">43,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea86eb2da07419ea798ae719f81a8f9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1OTI2MmQ5MDkxZmM0ZDUxYWMwOTcyODdiODMyNjU5Yy90YWJsZXJhbmdlOjU5MjYyZDkwOTFmYzRkNTFhYzA5NzI4N2I4MzI2NTljXzQtMi0xLTEtMjE3MQ_c46bb53e-141b-464a-a65d-1e2654ac1ad3">30,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 the aggregate amount of transaction price allocated to the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through the fourth quarter of 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue related to amounts allocated to the single performance obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of the research and development efforts.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">215</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i1b8d17d451684577888301b21f48fac6" continuedAt="i5947ada21ae14d5b8c635b15f3487813"><ix:continuation id="i2c06973e8e194df5b2dd2d687737de5c" continuedAt="ica69e03f11ee4f9897e3552470a6b2ad"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex First Extended Research Term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib894739b97434938997c5f99e78f77bd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzItMi0xLTEtMjE5NA_a0b0cc53-dd3d-4df7-8423-1192770ee2da">13,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d7dca1d4c4c4b9686df22df24888acf_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzItNC0xLTEtMjE5NA_24acbf7a-fcaf-46a8-a081-06e3fb5364d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5feaa13311494f2aad81d49c0f29adec_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzItNi0xLTEtMjE5NA_d2185e55-b02b-4525-9efd-e4f337a6c369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex Agreement/2019 Amendment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e076d5d4a504530950dfa10765531a3_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzMtMi0xLTEtMjE5NA_c77eb519-7469-4c5e-a631-80047c5754c4">2,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0acd16de5695440eb15012080a75bb86_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzMtNC0xLTEtMjE5NA_31e3ebd9-a17f-40dc-9dda-d8b5a0050656">6,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381c45f95fdc4c6cab91ea05c8184f74_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzMtNi0xLTEtMjE5NA_fdeebdee-2f37-4f4c-8e41-de624c72e983">10,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f73020d7f8417cace85905171f5d06_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzQtMi0xLTEtMjE5NA_548f084e-5e7a-4e15-bb2d-1c3b0930c683">15,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0d1ada6b97646e1811da4767837e43f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzQtNC0xLTEtMjE5NA_a535ba3d-f44f-490a-bc10-3f928799c068">6,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6a738901f794f2c95c70ed3d3ed65fc_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzQtNi0xLTEtMjE5NA_a5828eb6-df57-4472-bc8b-d737cf16dadc">10,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue recognized during the year ended December 31, 2020, includes the amortization of the deferred revenue due to the satisfaction of our performance during the period, offset by a cumulative catch-up adjustment of $0.2&#160;million due to changes in estimated costs for our future performance obligations. </span></div><div><span><br/></span></div><ix:continuation id="ica69e03f11ee4f9897e3552470a6b2ad" continuedAt="i49ebc6a6864b4de3bd68aa43fae78dbd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue, classified as current and non-current in the condensed consolidated balance sheets based on the term of the research period for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex Agreement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0798e7f1beab411290adc80b49b4a243_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZToyM2VhZTEzYjAwZWE0ZTJiODc5NTA1N2Y0MDczZmEwYS90YWJsZXJhbmdlOjIzZWFlMTNiMDBlYTRlMmI4Nzk1MDU3ZjQwNzNmYTBhXzItMi0xLTEtMjIzOA_1bede6fd-18f7-47cd-9f8c-4716b9b712e9">2,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5b4776d84349f68d1f905844a0195b_I20191231" decimals="-3" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZToyM2VhZTEzYjAwZWE0ZTJiODc5NTA1N2Y0MDczZmEwYS90YWJsZXJhbmdlOjIzZWFlMTNiMDBlYTRlMmI4Nzk1MDU3ZjQwNzNmYTBhXzItNC0xLTEtMjIzOA_6ff8a8e9-c4ef-4c2f-b013-9ebbed3567a2">793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">____________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance as of December 31, 2019 represents deferred revenue related to the Vertex 2019 Amendment</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vertex &#8212;2020 Strategic Alliance in Cystic Fibrosis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a new Strategic Collaboration and License Agreement with Vertex (Vertex 2020 Agreement). The Vertex 2020 Agreement is aimed at the discovery and development of potential medicines to treat CF by delivering gene-editing therapies to lung cells to facilitate production of functional CFTR proteins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The <ix:nonNumeric contextRef="ie80373ee84ee409397695d20d023b830_D20201201-20201231" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3Njg_89f9cb28-f3c8-4163-ad54-283343b895b7">three-year</ix:nonNumeric> research period of the Vertex 2020 Agreement will initially focus on the identification and optimization of novel LNPs and mRNAs that can deliver gene-editing therapies to cells in the lungs. Following the initial <ix:nonNumeric contextRef="ie80373ee84ee409397695d20d023b830_D20201201-20201231" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3Njk_44209c4f-33c0-4f58-80aa-b19e2d3ebd11">three-year</ix:nonNumeric> period, Vertex is responsible for conducting development and commercialization activities for candidates and products that arise from the strategic alliance, including the costs associated with such activities. Vertex is also obligated to pay us for research services in connection with our performance of certain activities in accordance with a jointly agreed research plan. Subject to customary &#8220;back-up&#8221; supply rights granted to Vertex, under the agreement, we are the exclusive manufacturer of related mRNA and LNPs for preclinical, clinical, and commercialization purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Vertex 2020 Agreement, we received a $<ix:nonFraction unitRef="usd" contextRef="i1d3d81698c934b4a954d49e51245e401_D20201201-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI1ODk_51aa1381-082f-4786-8dc7-ae4d04e75a06">75.0</ix:nonFraction>&#160;million upfront payment from Vertex. We are eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="icdbe7e517bf742fb984721f52fab2d8d_D20201201-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI2MTE_39368654-6954-4aff-9ecf-c05d57fb5519">380.0</ix:nonFraction>&#160;million in milestone payments upon the achievement of certain development, regulatory, and commercial milestone events with respect to any products that result from the strategic alliance, and Vertex will also pay us a tiered percentage of its gross profits derived from worldwide net sales of products arising from the strategic alliance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Vertex 2020 Agreement, we and Vertex have agreed to certain defined exclusivity obligations with respect to the development and commercialization of certain mRNA medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the Vertex 2020 Agreement will continue until the expiration of all payment obligations. Vertex may terminate the Vertex 2020 Agreement for convenience upon <ix:nonNumeric contextRef="ie80373ee84ee409397695d20d023b830_D20201201-20201231" format="ixt-sec:durday" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzODM0_334b82aa-11b9-4060-be38-ffac387a2ef3">90</ix:nonNumeric> days&#8217; prior written notice, except if termination relates to a product in a country where Vertex has received marketing approval; in such case, Vertex must provide <ix:nonNumeric contextRef="ie80373ee84ee409397695d20d023b830_D20201201-20201231" format="ixt-sec:durday" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzODQy_85e3878c-bd78-408d-b452-3d7a784b9ad1">180</ix:nonNumeric> days&#8217; prior written notice. Either party may terminate the Vertex 2020 Agreement upon the other party&#8217;s material breach, subject to specified notice and cure provisions. Each party may also terminate the Vertex 2020 Agreement in the event that the other party challenges the validity or enforceability of such party&#8217;s patent rights, subject to certain exceptions, or if the other party becomes insolvent.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that all aspects of the 2020 Vertex Agreement represent a transaction with a customer and therefore should be accounted for in accordance with ASC 606. We also determined that the 2020 Vertex Agreement should be accounted for separately from other Vertex Agreements as the agreements contemplate research on separate research candidates. We identified one performance obligation comprised of: (i) a research, development and commercialization license; and (ii) research and development </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">216</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i5947ada21ae14d5b8c635b15f3487813" continuedAt="i852ceda6ed034dbbbec90b5c5232ff4b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services, including manufacturing and supply of non-cGMP mRNA, performed as part of the Initial Research Plan and the Additional Research Plan (collectively, the research period). We concluded that the license is not distinct from the research and development services, including manufacturing and supply of non-cGMP mRNA used in the performance of the research services, as Vertex cannot fully exploit the value of the license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Therefore, the license has been combined with the research and development services, including manufacturing and supply of non-cGMP supply, into a single performance obligation. Additionally, we concluded the provision of clinical mRNA supply and/or non-cGMP mRNA supply provided to Vertex at their option represents a customer option and is considered a marketing offer as such options did not provide any discounts or other rights that would be considered a material right in the arrangement. Such options will be accounted for as a separate contract upon the customer&#8217;s election.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total transaction price was determined to be $<ix:nonFraction unitRef="usd" contextRef="ie80373ee84ee409397695d20d023b830_D20201201-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI2MzM_21668900-10ad-4d63-a12e-2128a68a29ca">75.0</ix:nonFraction>&#160;million, comprised of the upfront payment. We utilize the most likely amount method to determine the amount of research and development funding to be received associated with the Additional Research Plan. Our funding estimate is based on our experience bringing research candidates to the point of nomination by our collaboration partners, including our experience with Vertex under separate transactions. We have fully constrained such amounts and will not include any expected funding in the transaction price until the scope of such services have been agreed to amongst the parties. We also utilize the most likely amount method to estimate any development and regulatory milestone payments to be received. Further, there were no milestones included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Vertex&#8217;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any sales-based royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted, and therefore have also been excluded from the transaction price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the 2020 Vertex Agreement, the total transaction price was allocated entirely to a single performance obligation. We recognize revenue related to amounts allocated to the single performance obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of the research and development efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, we did not recognize any revenue associated with the 2020 Vertex Agreement. As of December 31, 2020, the aggregate amount of the transaction price allocated to the remaining performance obligations that are unsatisfied is $<ix:nonFraction unitRef="usd" contextRef="ib95741ea249d4f97a45a3892a2351840_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI2NTQ_f743bd3c-17da-42fa-9e2d-3625c49e5352">75.0</ix:nonFraction>&#160;million, which is expected to be recognized as revenue through the third quarter of 2023. We had deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="ib95741ea249d4f97a45a3892a2351840_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI2NzU_8c3f9e64-e1a0-4b41-a329-3f682acc6b64">75.0</ix:nonFraction>&#160;million as of December 31, 2020, which is classified as current and non-current in the consolidated balance sheets based on the term of the research period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Chiesi&#8212;2020 Collaboration and License Agreement with Chiesi</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a Collaboration and License Agreement with Chiesi Farmaceutici S.P.A. (Chiesi), which we refer to as the Chiesi Agreement. The Chiesi Agreement is aimed at the discovery and development of potential mRNA medicines for the treatment of Pulmonary Arterial Hypertension (PAH), a rare disease characterized by high blood pressure in the arteries of the lungs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Chiesi Agreement, we lead discovery efforts during a <ix:nonNumeric contextRef="i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NzA_4b1601aa-a191-45a3-a068-6a151fedd0a0">four-year</ix:nonNumeric> research period, leveraging our Platform technology and mRNA delivery expertise along with Chiesi&#8217;s scientific experience in PAH biology. Chiesi is responsible for conducting development and commercialization activities for candidates and products that arise from the collaboration, including the costs associated with such activities. Chiesi is also obligated to pay us for our performance of research activities during the research period in accordance with a jointly agreed research plan. Under the agreement, we are the exclusive manufacturer of related candidates and products for preclinical, clinical, and commercialization purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Chiesi Agreement, we are entitled to receive a $<ix:nonFraction unitRef="usd" contextRef="i2ab2427a6c084cf9af1c48d8c688b9d4_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI1Njg_5e119333-1d37-4131-bdbb-8cfa0734c293">25.0</ix:nonFraction>&#160;million upfront payment from Chiesi. Chiesi has the right to extend the initial <ix:nonNumeric contextRef="i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NzE_f2dd76eb-6320-439c-af69-0e411d41c7e4">four-year</ix:nonNumeric> research period by <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzkz_2d953b6a-57dd-4928-80b3-3c00ab223378">one</span> additional year by making an additional payment to us. We are eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="id8c83ee462da4e3dba463ddbc3ee245b_D20201201-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI1NDI_db034bcd-f0f4-4057-b2a0-0562cb8592d6">405.0</ix:nonFraction>&#160;million in aggregate milestone payments upon the achievement of certain development, regulatory and commercial milestone events, and Chiesi will also pay us tiered double-digit royalties on worldwide net sales of products arising from the collaboration, subject to certain reductions, with an aggregate minimum floor.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Chiesi Agreement, we and Chiesi have agreed to certain defined exclusivity with respect to the development and commercialization of certain mRNA medicines.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">217</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i852ceda6ed034dbbbec90b5c5232ff4b" continuedAt="i6ca583d0d5e645e7bacb709cee11d9f4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that all aspects of the Chiesi Agreement represent a transaction with a customer and therefore should be accounted for in accordance with ASC 606. We identified the following performance obligations in the Chiesi Agreement: (i) a research license and research and development services, including manufacturing and supply during the research period; (ii) a material right for the first product development and commercialization license; and (iii) a material right for the second product development and commercialization license. We concluded that the license is not distinct from the research and development services, including manufacturing and supply of non-cGMP mRNA, during the <ix:nonNumeric contextRef="i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NzI_f7996d7a-816c-4505-aa79-c432052c3c97">four-year</ix:nonNumeric> research period, as Chiesi cannot fully exploit the value of the license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Therefore, the license has been combined with the research and development services, including manufacturing and supply of non-cGMP supply, into a single performance obligation. Additionally, we concluded the provision of clinical mRNA supply and/or non-cGMP mRNA supply beyond the <ix:nonNumeric contextRef="i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231" format="ixt-sec:durwordsen" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NzM_104ed389-1b4e-4a73-add8-9d7919c1e0eb">four-year</ix:nonNumeric> research period and the right to extend the research period for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzQ1_9c8cdcb6-3511-498b-8168-a066bbb63f69">one</span> additional year represent customer options and are considered marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement. Such options will be accounted for as a separate contract upon the customer's election.</span></div><div><span><br/></span></div><ix:continuation id="i12c322cc6ec24d9494429785cd988e47"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:84.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chiesi Agreement:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d5a04ae7ee4c9facb541e95a628feb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0ZjFmOGUzZTFlNWE0ZDBiOGRlM2FjNGMwZmMyZWY0Ni90YWJsZXJhbmdlOjRmMWY4ZTNlMWU1YTRkMGI4ZGUzYWM0YzBmYzJlZjQ2XzMtMi0xLTEtMjI3MA_0cba4751-fd4d-4b59-b9ad-5b09a1a6b95c">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8775b14ae8d42ba85896b375b513e87_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0ZjFmOGUzZTFlNWE0ZDBiOGRlM2FjNGMwZmMyZWY0Ni90YWJsZXJhbmdlOjRmMWY4ZTNlMWU1YTRkMGI4ZGUzYWM0YzBmYzJlZjQ2XzQtMi0xLTEtMjI3MA_84071ce4-9da0-418b-b9c8-fb1086ff05e6">17,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6671830e11c43fa9c3834eab410c9a4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0ZjFmOGUzZTFlNWE0ZDBiOGRlM2FjNGMwZmMyZWY0Ni90YWJsZXJhbmdlOjRmMWY4ZTNlMWU1YTRkMGI4ZGUzYWM0YzBmYzJlZjQ2XzUtMi0xLTEtMjI3MA_7e95efe8-746d-4df6-87c6-16ed5f050571">42,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the most likely amount method to determine the amount of research and development funding to be received associated with the research period. We also utilize the most likely amount method to estimate any development and regulatory milestone payments to be received. Further, there were no milestones included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Chiesi&#8217;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any sales-based commercial milestone payments and royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted and therefore have also been excluded from the transaction price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was allocated to the performance obligations based on the relative estimated standalone selling prices of each performance obligation. We developed the estimated standalone selling price for the services and manufacturing and supply included in the performance obligation, as applicable, primarily based on the nature of the services to be performed and the goods to be manufactured and estimates of the associated costs, adjusted for a reasonable profit margin that would be expected to be realized under similar contracts. We developed the estimated standalone selling prices for the licenses included in the associated performance obligations based on an analysis of our other transactions with collaboration partners and third party comparable transactions. In developing such estimates, we also considered applicable market conditions and relevant entity-specific factors, including those factors contemplated in negotiating the agreement, probability of success and the time needed to commercialize a product candidate pursuant to the associated license. The estimated standalone selling price of the material rights to receive development and commercialization rights was developed by estimating the amount of discount that Chiesi would receive when exercising the option and adjusting such amount by the likelihood that the option will be exercised.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i6ca583d0d5e645e7bacb709cee11d9f4"><ix:continuation id="i8c195b0c1cb448edbb8ac738b70dfa2f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.789%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chiesi Agreement transaction price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7916b94daf6644a1ac5fd27053af9d56_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2YjdhZmZlZjA0ZmY0MGI4Yjc0MGRjYWM2NWNiYzhjMi90YWJsZXJhbmdlOjZiN2FmZmVmMDRmZjQwYjhiNzQwZGNhYzY1Y2JjOGMyXzQtMi0xLTEtMzE3NQ_ff291e43-e205-41d9-92dd-c2eefb25299e">42,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i927d619ab07840569348f4a56e6f7fd9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2YjdhZmZlZjA0ZmY0MGI4Yjc0MGRjYWM2NWNiYzhjMi90YWJsZXJhbmdlOjZiN2FmZmVmMDRmZjQwYjhiNzQwZGNhYzY1Y2JjOGMyXzUtMi0xLTEtMzE3NQ_295e348c-3cf6-4b54-81c4-0d05686191c7">42,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue related to amounts allocated to the combined research license and research and development services performance obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of the research and development efforts. We will recognize revenue associated with the material rights as revenue at the earlier of the exercise or expiry of the material rights.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, we recognized collaboration revenue of $<ix:nonFraction unitRef="usd" contextRef="ifed27586ee884f47a07d016946f33a60_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDc5MzQ_d7f44cb9-7889-497a-8308-92aed4a639b7">0.2</ix:nonFraction>&#160;million from the Chiesi Agreement. We did not recognize any revenue associated with the Chiesi Agreement for the years ended December 31, 2019 and 2018. As of December 31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i485a222ab1ab4c8aac1f1cbc39e1b10a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzE5_ac3d8442-9054-446e-a60c-c75ab417eaa5">17.3</ix:nonFraction>&#160;million of the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through the third quarter of 2024 and $<ix:nonFraction unitRef="usd" contextRef="ifed27586ee884f47a07d016946f33a60_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzA0_eae56eaf-a75f-45d2-b4b1-3c098bd402c2">25.0</ix:nonFraction>&#160;million is expected to be recognized as revenue at the earlier of the exercise or expiry of the material rights.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="ie6671830e11c43fa9c3834eab410c9a4_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNjg3_f86349fe-f25a-4910-954b-890c5a1195b1">25.0</ix:nonFraction>&#160;million as of December 31, 2020, classified as non-current in the consolidated balance sheets based on the term of the research period.</span></div></ix:continuation><div><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">219</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_157"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzIwOTA_a183301c-a3a7-4e49-bbac-f74a6305efbb" continuedAt="i673ad6a6da9f40c38a78b6414d98f51d" escape="true">Financial Instruments and Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i673ad6a6da9f40c38a78b6414d98f51d" continuedAt="i27df3fb56b814de98a4a70c5917d9df1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents and Investments</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzIwODY_654374a6-7c69-4d71-becb-1edd6e4a920d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our cash and available-for-sale securities by significant investment category at December 31, 2020 and 2019 (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.212%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa6defda34a4c4d932f1760b89de1bd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItMi0xLTEtMA_9c2ccff6-5ad4-4e48-ae9c-eb686a19ac0c">2,623,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa6defda34a4c4d932f1760b89de1bd_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItNC0xLTEtMA_d3f73ab4-f39c-497d-8e52-402679e31a1e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa6defda34a4c4d932f1760b89de1bd_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItNi0xLTEtMA_30fd2567-1347-414d-b03a-9423b0bb2d24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa6defda34a4c4d932f1760b89de1bd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItOC0xLTEtMA_bd4c3b74-50e6-4560-8108-338a2d59df62">2,623,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99a06be594a943e1a989839f0ffb78dc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItMTAtMS0xLTA_88176d8b-10b5-46fe-9c3f-6f73ede25940">2,623,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f3f6d0fe374c3bb4e9274841921099_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItMTItMS0xLTA_a5356cfa-d25b-40af-801d-fcf9ad80888d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0721e19a82dc4039bc8fd234b6cb6467_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItMTQtMS0xLTA_c27e863b-53b4-4d17-a311-96a8a7a42bf0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f82068d4e014cd3b0ee0ee048db1dfc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtMi0xLTEtMA_08f2329b-56bb-44a5-9335-86f8c3653338">238,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f82068d4e014cd3b0ee0ee048db1dfc_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtNC0xLTEtMA_8a81d7a3-0945-4711-8312-30e7efe0ec12">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f82068d4e014cd3b0ee0ee048db1dfc_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtNi0xLTEtMA_272a0be6-0245-477f-b402-ad241d8cfc2d">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f82068d4e014cd3b0ee0ee048db1dfc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtOC0xLTEtMA_b70328a6-7dcb-4a30-bcd5-6ff5a87b30af">238,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80775b1abbd4c83a0c7b6a0f1187d02_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtMTAtMS0xLTA_4496d609-dfdd-4533-a3d9-e478e78cf963">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6823e77a4aea4168b1bc6bd432b8c5f0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtMTItMS0xLTA_cb53a085-788d-4a80-9ce2-b3dbf3d3218f">215,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39aad2a193424f66b1a29c5062031f07_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtMTQtMS0xLTA_353cb18b-a155-43fa-89a1-475e6cfb70c0">23,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996f146052f5425ab4c0c71f5c174fa6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtMi0xLTEtMA_9103ecef-4b2b-44a2-9290-8839e6e1b4b4">491,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996f146052f5425ab4c0c71f5c174fa6_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtNC0xLTEtMA_0d8cc42f-9226-4824-86ef-33a987d2bd4b">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996f146052f5425ab4c0c71f5c174fa6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtNi0xLTEtMA_7e5e6831-478f-4a8f-953b-2b20b35a6921">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i996f146052f5425ab4c0c71f5c174fa6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtOC0xLTEtMA_16bfec90-1987-4a09-97ef-7ae750400193">491,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icef0d3913fd548d9aae035caa234d06f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtMTAtMS0xLTA_80594f38-1ef7-43ff-af26-6786295f62a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i964440db25964be9b19c02aff5c46eef_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtMTItMS0xLTA_944f887b-d5f4-4a15-82ab-6ea55abbb505">491,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2120d892fa64041a731353e8cb520f7_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtMTQtMS0xLTA_28b42ad8-820f-40d5-be49-f902fc2f1fc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7947068ef4b140cb8095b9ed2268d8ce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctMi0xLTEtMA_bdded2b1-52ce-4c70-8840-43bf64ce22f3">1,888,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7947068ef4b140cb8095b9ed2268d8ce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctNC0xLTEtMA_830fd43d-5ccb-4d88-951c-645e6e2c5ec0">4,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7947068ef4b140cb8095b9ed2268d8ce_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctNi0xLTEtMA_f8b3cdbf-3df1-40c0-ade6-77c6b96e8262">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7947068ef4b140cb8095b9ed2268d8ce_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctOC0xLTEtMA_d0e2a395-50b2-4d52-9037-cf44bf937512">1,892,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f339cc94e424df7982cd710e1c8fbcf_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctMTAtMS0xLTA_0581670e-4a83-42cb-8c2d-f24e5d17ad34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie57495990d1840ab8a3259591e49318c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctMTItMS0xLTA_dddec197-3ce0-45bb-ac19-715d6a8ab81c">1,276,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571622ed8ff84fac92fa646c065d9071_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctMTQtMS0xLTA_c6584270-85de-4602-91e7-5f8e01f5ba90">615,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dee05d95adb41a4a76b2b9fe164e598_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtMi0xLTEtMA_f208d757-6428-47c8-9fdf-279b8f2a2f56">5,242,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dee05d95adb41a4a76b2b9fe164e598_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtNC0xLTEtMA_003445e5-a62e-4416-82c0-ed09b6e8a722">4,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dee05d95adb41a4a76b2b9fe164e598_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtNi0xLTEtMA_f6079761-ffa9-4cee-b0aa-4ecceb033bd3">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dee05d95adb41a4a76b2b9fe164e598_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtOC0xLTEtMA_c3e9b819-bcf6-4058-924c-84001822b483">5,246,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76e8315a6df54be8bfc95f09f6f3034a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtMTAtMS0xLTA_b6982acf-dc57-48a8-a18f-de89245e0810">2,623,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fcf3aa943004b48b99acf53c21041eb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtMTItMS0xLTA_75c49b9e-f262-4867-ab97-174566fa6dad">1,983,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide75e7fae914434e8be15fac3dd2dfa1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtMTQtMS0xLTA_8fd0f721-d8c1-431b-8f8e-9f0d9281447e">638,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:17pt"><td colspan="45" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie142da5d5a7142dfae28d3de3b0a7398_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTItMS0xLTA_5e6a3269-286f-4e27-9692-8cb03a0c8693">225,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie142da5d5a7142dfae28d3de3b0a7398_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTQtMS0xLTA_7b75857f-8472-4c1e-ab60-bf312778a204">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie142da5d5a7142dfae28d3de3b0a7398_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTYtMS0xLTA_7ac19ad0-81e6-4b7c-a123-da7b5cc443b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie142da5d5a7142dfae28d3de3b0a7398_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTgtMS0xLTA_800c3775-5c24-4db0-a757-8ec06eee3288">225,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6a6eab513bd479c8ee7b20cf6c72b5c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTEwLTEtMS0w_10586f73-09d9-4425-8f0e-3be91cb99897">225,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f6292c70ae4905b5aa94e6b6388d63_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTEyLTEtMS0w_19e20d0c-ba13-460b-9e7b-3f3d79aaf6e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5deec5b143314f2491823db42ac2c318_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTE0LTEtMS0w_75e9bd7b-44e6-4aea-9ef5-0e7402de561d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf5b8160d74845bcbadcdc11cae28b39_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTItMS0xLTA_30269281-ab7d-41cd-b420-ed08c1e1eda3">82,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf5b8160d74845bcbadcdc11cae28b39_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTQtMS0xLTA_9ce30fe5-5f4e-4f78-abaa-7e95e612279d">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf5b8160d74845bcbadcdc11cae28b39_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTYtMS0xLTA_de5d62f9-8a90-4558-b513-8949a75ea430">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf5b8160d74845bcbadcdc11cae28b39_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTgtMS0xLTA_d57141db-b797-4ce0-95e9-2a9dfe46e0b4">82,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8d8c21441bd4fc3927d70eb5b4e9cb0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTEwLTEtMS0w_40f0a7c2-259a-4080-8b48-dc146faa0e95">10,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e09bdef5a344ade862de02fe62cbd4f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTEyLTEtMS0w_892b7c03-ebe7-4590-b8d5-c518bbe9f94c">69,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5711c49fcbec48988da71f366d87842a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTE0LTEtMS0w_9f482063-0917-4035-87fa-dbb22d04cd35">2,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i595f9f5c7de04040938f423373395fd2_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTItMS0xLTA_ef2e430a-ff25-4357-9e93-784819b25439">117,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i595f9f5c7de04040938f423373395fd2_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTQtMS0xLTA_8c8a6b68-351d-4be1-aa33-c73c9d76acda">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i595f9f5c7de04040938f423373395fd2_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTYtMS0xLTA_4891d88b-5e96-4570-93dc-252c8e605de2">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i595f9f5c7de04040938f423373395fd2_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTgtMS0xLTA_de4d5733-da8d-4af1-b4a0-66b2aa877a85">118,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib098be9e25b24dd6963f1bce92ec3842_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTEwLTEtMS0w_8b704c98-e8e9-40f6-abea-d4b471107d41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8337e774481849ea898503604f8098ed_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTEyLTEtMS0w_9d7305a2-1258-4a8c-b61a-baba1e426094">110,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c6c58de542642c998e43061db878c5d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTE0LTEtMS0w_236ecfc2-f526-4249-83f5-13bc14aaee9c">7,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56140fc5415b465091fac71874a1d04c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTItMS0xLTA_e5cc6ee1-ed12-4cfa-8de8-be625a0aa388">834,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56140fc5415b465091fac71874a1d04c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTQtMS0xLTA_aedead34-7dd0-4fec-81d2-770779666904">2,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56140fc5415b465091fac71874a1d04c_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTYtMS0xLTA_edb5a0e8-0bcf-4b7b-988f-abcf73d78dda">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56140fc5415b465091fac71874a1d04c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTgtMS0xLTA_673f8537-fc64-4763-bece-d92c03f715db">836,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3679a9fffc96449eb191d1d92e564cb9_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTEwLTEtMS0w_89562705-e01a-4dbb-8c73-a734871caedb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f97faca187a40e7932e5f1ed655d0e4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTEyLTEtMS0w_0adb536a-48a5-42a0-bdd1-1e4ddf1de332">687,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33126ccd28674b319b0f542852efad14_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTE0LTEtMS0w_b21c2a24-966c-476d-80fd-768c40fc48be">149,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9134c7c3c5e41aaad7c846573608b98_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTItMS0xLTA_6269556e-8519-4c36-a4ac-2b9272c963f1">1,259,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9134c7c3c5e41aaad7c846573608b98_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTQtMS0xLTA_b8bcf194-a4f6-4107-bc53-6d720e441985">3,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9134c7c3c5e41aaad7c846573608b98_I20191231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTYtMS0xLTA_90146b22-391c-4f90-aafc-a8696c26d560">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9134c7c3c5e41aaad7c846573608b98_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTgtMS0xLTA_019cf1f3-945a-4dba-a3f3-01fcc5b56ae5">1,262,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0cecee608c2404fb5cd0656311e9766_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTEwLTEtMS0w_e665bfe4-279e-4ac7-b85d-8632635aa7af">235,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia40c55509686422ea2a7aeb0800b0708_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTEyLTEtMS0w_539bf146-3962-4789-9c85-4c3851578ad6">867,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94845de97f3740f29eb21f83595555aa_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTE0LTEtMS0w_b432db56-c2de-474a-9f7c-9acc9e8e5dc1">159,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzIwODg_516a989c-2346-43b4-9f76-e5b4eab51ee8" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and estimated fair value of marketable securities, by contractual maturity at December 31, 2020 and 2019 are as follows (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzItMi0xLTEtMA_e2f8e44d-1ed0-45f6-b00c-f951028ef0f1">1,980,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzItNC0xLTEtMA_6c3b4fe3-e0a9-4e3e-90c8-e6834188dd7c">1,983,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzMtMi0xLTEtMA_ed3df0eb-3cf3-4a23-a07f-39189c52b799">637,382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzMtNC0xLTEtMA_049a4b24-c1bd-41d3-80a6-344543029c78">638,848</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzQtMi0xLTEtMA_bfc82607-b6db-4e83-a3e7-3fbd74f79e69">2,618,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzQtNC0xLTEtMA_909fc592-7133-45be-b23c-91c8274ec9b2">2,622,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzctMi0xLTEtMA_8c41e95e-e9a5-4b19-8198-ffd232e14bf0">864,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzctNC0xLTEtMA_4a41786c-8177-4586-9710-4d65bf5855ef">867,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzgtMi0xLTEtMA_ef055ba2-0126-4186-a03e-ee41ff65ded2">159,148</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzgtNC0xLTEtMA_d3f53e89-72f6-472d-8e20-5cac17ce602b">159,987</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzktMi0xLTEtMA_200e53c0-a954-4ecf-b3f0-ea697fab0e4a">1,024,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzktNC0xLTEtMA_679700b8-1a08-4d6c-9332-653803ec6606">1,027,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">220</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="i27df3fb56b814de98a4a70c5917d9df1" continuedAt="i3ed776f5c08e4e4fa1206a77a24509b7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with our investment policy, we place investments in investment grade securities with high credit quality issuers, and generally limit the amount of credit exposure to any one issuer. We evaluate securities for impairment at the end of each reporting period. We did <ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEzMTk0MTM5NTM5NjM2_330a07db-7072-401c-a194-0ea74ec43132"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEzMTk0MTM5NTM5NjM2_a9da6f44-a7a7-4ceb-92f3-c7cfd4baf9b6"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEzMTk0MTM5NTM5NjM2_e3e1fe3e-e27f-4fdc-9d5d-a6d4b90c8ad1">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t record any impairment charges related to our available-for-sale securities during the&#160;years ended December 31, 2020, 2019 and 2018. We did not recognize any credit losses related allowance to available-for-sale securities as of the years ended December 31, 2020 and 2019. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzk4OTU2MDQ2NTM1OTY_b9ac8da1-84d3-4094-854d-d0d1bc119906" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amount of gross unrealized losses and the estimated fair value for our available-for-sale securities in an unrealized loss position by length of time the securities have been in an unrealized loss position at December 31, 2020 and 2019 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtMi0xLTEtMjM1OQ_6323ae6a-bcf4-407a-bb2f-c0b855356bce">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtNC0xLTEtMjM1OQ_a98f27b4-f333-4062-b9fb-368076a6bc9f">81,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtNi0xLTEtMjM1OQ_08ea2607-4765-4d25-975a-c4332a588303">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtOC0xLTEtMjM1OQ_427b3fe2-9c11-4126-aecb-cd80e53901e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtMTAtMS0xLTIzNTk_9aa7d831-15a1-4fbc-85ff-0065e8977e19">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtMTItMS0xLTIzNTk_0bb273c5-822c-4547-b5c8-cb051dcaddf2">81,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i537052846af24b89bb148e79200f55b7_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtMi0xLTEtMjM1OQ_49899342-ffa1-408b-9c70-01d6add89a74">148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537052846af24b89bb148e79200f55b7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtNC0xLTEtMjM1OQ_7d582ed1-a723-49bb-aa20-58faca508966">507,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537052846af24b89bb148e79200f55b7_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtNi0xLTEtMjM1OQ_e85a72c2-9456-47be-94c1-7131af8e0df0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537052846af24b89bb148e79200f55b7_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtOC0xLTEtMjM1OQ_c17256fb-ec02-4c44-b5f2-0143d6458e57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i537052846af24b89bb148e79200f55b7_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtMTAtMS0xLTIzNTk_593fcdc4-8322-442b-b2f9-fe9a8b16c7ce">148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537052846af24b89bb148e79200f55b7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtMTItMS0xLTIzNTk_c3883dd6-c771-42f0-8372-def6e0df5e3e">507,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtMi0xLTEtMjM1OQ_5fdd8c38-5e6d-4a6e-ad76-033ef56f4186">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtNC0xLTEtMjM1OQ_4afff8f2-9cdd-4331-8176-0805f84d588c">588,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtNi0xLTEtMjM1OQ_fcd25fc8-af39-47d5-81f3-c135922b5eaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtOC0xLTEtMjM1OQ_89a6d35b-5641-475d-bca9-d02eaf644bca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtMTAtMS0xLTIzNTk_eae80cb8-c2a9-44ef-af63-d3d21d61f658">152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtMTItMS0xLTIzNTk_be4ae244-c497-4e03-b4aa-11803e0747b9">588,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2019:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktMi0xLTEtMjM1OQ_5122b18a-d933-4eca-bac2-5538756af07a">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktNC0xLTEtMjM1OQ_2d1b206f-8989-4fab-86b4-d046f7ac4566">12,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktNi0xLTEtMjM1OQ_c5d8c05b-ef3f-4814-b4d3-1b949ac85ac8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktOC0xLTEtMjM1OQ_58dda3ed-f7be-4b5e-a0de-2c876d79b5a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktMTAtMS0xLTIzNTk_873a2967-6164-4967-847b-2419c6adc409">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktMTItMS0xLTIzNTk_bfb9e516-7025-4744-a0c3-d80f20527007">12,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTItMS0xLTIzNTk_96d08c5c-99ad-4646-b641-c553f06bf6b0">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTQtMS0xLTIzNTk_0a2bd481-30fd-449c-8b5d-53de82f5ea08">9,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTYtMS0xLTIzNTk_bfbcca71-0ca1-4260-8025-266741157921">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTgtMS0xLTIzNTk_1fc0cc9e-6cf5-430b-8133-6e0ca3292197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTEwLTEtMS0yMzU5_4890a2b9-7fe2-4cc3-a1f7-66991a6b14fe">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTEyLTEtMS0yMzU5_d63927b6-587a-4840-a6af-91fb0ed2e4e1">9,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1643b608a454ba48f175331a4403c94_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTItMS0xLTIzNTk_52e7b08f-21b9-4a6d-9829-7ca130f24dad">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1643b608a454ba48f175331a4403c94_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTQtMS0xLTIzNTk_33b6d11f-15b4-46e0-bceb-a1b2a4553cf9">62,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1643b608a454ba48f175331a4403c94_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTYtMS0xLTIzNTk_d680608e-21aa-4c7b-9c07-203d24418d2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1643b608a454ba48f175331a4403c94_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTgtMS0xLTIzNTk_81f65b28-0b36-486e-910a-400ed78ebf2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1643b608a454ba48f175331a4403c94_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTEwLTEtMS0yMzU5_e9ec6d2d-36f5-4aad-8bd3-68153a1e47be">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1643b608a454ba48f175331a4403c94_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTEyLTEtMS0yMzU5_f812c66d-e6db-4d64-b4bb-5c1b8adf2b67">62,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTItMS0xLTIzNTk_f57b0c33-bb35-44ea-a9f4-4773dd88d684">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTQtMS0xLTIzNTk_6cd02045-561f-4dbc-98a0-3083786acc01">85,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTYtMS0xLTIzNTk_f8659439-72e7-43a7-81e6-82712e863bc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTgtMS0xLTIzNTk_c78d97ca-38c7-4a5d-b1e6-9debd62d90f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTEwLTEtMS0yMzU5_b2d6187f-9d48-400e-ab9f-84435c1e3b79">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTEyLTEtMS0yMzU5_739a333c-4f31-47f5-a215-206421cd2252">85,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 and 2019, we held <ix:nonFraction unitRef="security" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEwNDQ1MzYwNDc1OTI3_a8443014-6b8b-4c46-8725-9b4f842d08b4">108</ix:nonFraction> and <ix:nonFraction unitRef="security" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEwNDQ1MzYwNDc1OTMy_3e6aa3d1-00a1-40b8-856c-c7aeda3545e5">19</ix:nonFraction> individual available-for-sale securities, respectively, out of our total investment portfolio that were in a continuous unrealized loss position for less than 12 months. We neither intend to sell these investments nor conclude that we are more-likely-than-not that we will have to sell them before recovery of their carrying values. We also believe that we will be able to collect both principal and interest amounts due to us at maturity.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEwNDQ1MzYwNDc5MTc5_bd258927-17d5-4177-a0c7-a5fe7a8e05e2" continuedAt="i76028ab2f7a548dba84cccc3c5877d3c" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our financial assets measured at fair value on a recurring basis as of December 31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement Using</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b335d06520e4536aa8cb118383a9e23_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzMtMi0xLTEtMTg3NDM_93e6638f-d69b-4211-acf4-de280ce704cc">620,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6ca9dac78c340bba06590609c9470cc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzMtNC0xLTEtMTg3MTc_dbe602f4-2d7e-4dc5-80bc-b8f769552ba6">620,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f78c3ac89654cd9b1f1e7b8bc2a2df3_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzMtNi0xLTEtMTg3MTc_de0b1f67-70ef-45a9-bf76-65e23d479fb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b7c40b209f7432bad8109c7ff3676d5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzQtMi0xLTEtMTg3MTc_c4624e4f-2f67-49e0-96ec-bab401a05f7d">238,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8568db59e98348d5b7ca8485856bbd75_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzQtNC0xLTEtMTg3MTc_ae80c54b-2bfd-4f62-ac2f-c9e7057ae2a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d25a112fd9d498c8f8fea65aa96a2b1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzQtNi0xLTEtMTg3MTc_5e16e26e-344a-49f3-b5c8-071a3aafb140">238,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf18fd57bb2482194f59b63056872c4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzUtMi0xLTEtMTg3MTc_7b6bb1bf-6bc5-4931-a794-26865e593ff8">491,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c2ec2379a2440c98b39d472944fc58a_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzUtNC0xLTEtMTg3MTc_e4bdb57c-7bae-4394-85f1-aed712ec11e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd8faf6c9e064166a193a079404e5f6c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzUtNi0xLTEtMTg3MTc_5fab24d3-bc64-480b-a4df-1616ec5ef87d">491,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i415a12cbcecd4182b9b75a85618710ff_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzYtMi0xLTEtMTg3MTc_e29def4a-b0fa-40e5-92fb-ee1c14d27abd">1,892,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f50ef9dcfe04ebd9ffd657cbf135f93_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzYtNC0xLTEtMTg3MTc_fba5e711-b433-40e6-b29f-22bad5d20c2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddd4aa81b7a24685aff1379ef5b70952_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzYtNi0xLTEtMTg3MTc_a77d7685-16bb-477e-bc53-31a42ffe5633">1,892,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (Note 7)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d497d05b06c42e4ac9fccf950c4da8f_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzctMi0xLTEtMTg3MTc_6597f886-7dd0-4535-bb24-b1ce01e3b9e5">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice8d50a6d09a405c9102e4f3dd28be53_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzctNC0xLTEtMTg3MTc_816876c5-2213-4da3-807e-392c6f826895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i435ec70bb8f44c8f98a7c85f98319563_I20201231" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzctNi0xLTEtMTg3MTc_b9012653-7a35-4ab0-8cdc-b1d0d3765e61">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d497d05b06c42e4ac9fccf950c4da8f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzgtMi0xLTEtMTg3ODI_4e238b82-3482-40b6-8dab-845c0cb05546">3,243,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice8d50a6d09a405c9102e4f3dd28be53_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzgtNC0xLTEtMTg3ODQ_7f744117-0325-4080-84b1-80702a040294">620,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i435ec70bb8f44c8f98a7c85f98319563_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzgtNi0xLTEtMTg3ODY_f61b1db4-0bde-4be2-b265-bb866d2ed37d">2,622,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">221</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span><br/></span></div><ix:continuation id="i3ed776f5c08e4e4fa1206a77a24509b7"><div><ix:continuation id="i76028ab2f7a548dba84cccc3c5877d3c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement Using</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac8874c6a20b43398d1ddc844bbce921_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzQtMi0xLTEtMTg3MjQ_464fb4f2-64f0-425b-8b97-dc70be67ae52">82,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff0406894b54724bcaadabdc19dd9da_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzQtNC0xLTEtMTg3MjQ_abb38f19-402a-4f95-856c-2f592e2089a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2404bad267f4f3e822b71ad8835e7ce_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzQtNi0xLTEtMTg3MjQ_31954a4d-d487-42e6-bf34-1136055c5406"><ix:nonFraction unitRef="usd" contextRef="id2404bad267f4f3e822b71ad8835e7ce_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzQtNi0xLTEtMTg3MjQ_61779437-bd17-44b6-bf3d-668fa5fc44a0">82,101</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a45bbb5f0fd487aa6bea47688234221_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzUtMi0xLTEtMTg3MjQ_2c234e80-c947-4f96-80a2-9b87e5788773">118,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93edb11d678e409e93fec11af2f7d699_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzUtNC0xLTEtMTg3MjQ_772a355d-523d-45ad-ba9f-41f70612180f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic32def168edf4442a4f6912414e3f4bb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzUtNi0xLTEtMTg3MjQ_278e9fad-9d5a-4458-902e-ead37c235941"><ix:nonFraction unitRef="usd" contextRef="ic32def168edf4442a4f6912414e3f4bb_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzUtNi0xLTEtMTg3MjQ_69c9fc1c-ad9b-4e8a-97e4-22931199bbe1">118,149</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icac57ca879c546568a22b09873f17e85_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtMi0xLTEtMTg3MjQ_73d575b5-c7e5-40b6-a365-aa9306335a5e">836,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee48996722c54941b70a1cc762872f9f_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNC0xLTEtMTg3MjQ_1e2fa255-af71-4958-b576-c524ff169e29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48df454a47ab493e9a020ee1d9e830c1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNi0xLTEtMTg3MjQ_79ed05de-551e-4055-bb1f-a2aa3db9f297"><ix:nonFraction unitRef="usd" contextRef="i48df454a47ab493e9a020ee1d9e830c1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNi0xLTEtMTg3MjQ_c3269ed8-b1c3-45a3-be6e-5c4b01b220ca">836,863</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7803fa02ca4547a9871f8bdeb3407587_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtMi0xLTEtMTg3ODg_38cd0fe6-35ae-4360-89d4-bf45efb107ec">1,037,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if68a771f3e9646a3af1d44b31f4770c5_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNC0xLTEtMTg3OTA_358468d9-5038-4c49-a459-f8eb9c14100a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bbb095206742338a02ee9ddcc36c12_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNi0xLTEtMTg3OTI_505e1662-0449-47ec-9f33-ee960a8c681c"><ix:nonFraction unitRef="usd" contextRef="id4bbb095206742338a02ee9ddcc36c12_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNi0xLTEtMTg3OTI_de7b359d-4630-4cb9-9319-d5b3efa9b7dd">1,037,113</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2020 and 2019, we did not have any financial liabilities measured at fair value on a recurring basis and did not have non-financial assets or liabilities measured at fair value on a recurring basis.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">222</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_2407"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGV4dHJlZ2lvbjoxMmMzYmJmYjk4NDg0ZmQ5YmI2Yzg5OWFlMGEyYWI4Zl8xMDQ0NTM2MDQ3MjI2OQ_c338a57c-2289-4d95-b12a-3d2221e96e4e" continuedAt="iea322a95ab634b90b037fa59855ab2c1" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iea322a95ab634b90b037fa59855ab2c1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We transact business in various foreign currencies and have international sales and expenses denominated in foreign currencies. Therefore, we are exposed to certain risks arising from both our business operations and economic conditions. Our risk management strategy includes the use of derivative financial instruments to hedge foreign currency exchange rate fluctuations on monetary assets or liabilities denominated in foreign currencies. We do not enter into derivative financial contracts for speculative or trading purposes. We do not believe that we are exposed to more than a nominal amount of credit risk in our foreign currency hedges, as counterparties are large, global and well-capitalized financial institutions. We classify cash flows from our derivative transactions as cash flows from operating activities in our consolidated statements of cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency forward contracts, primarily accounts receivable, are not designated for hedge accounting treatment. Therefore, these forward contracts are accounted for as derivatives whereby the fair value of the contracts are reported as other current assets or other current liabilities on our consolidated balance sheets, and gains and losses resulting from changes in the fair value are recorded as a component of other (expense) income, net, in our consolidated statements of operations. The gains and losses on these foreign currency forward contracts generally offset the gains and losses in the underlying foreign currency denominated assets and liabilities, which are also recorded to other (expense) income, net, in our consolidated statements of operations. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGV4dHJlZ2lvbjoxMmMzYmJmYjk4NDg0ZmQ5YmI2Yzg5OWFlMGEyYWI4Zl8xMDQ0NTM2MDQ3MjI3MA_b54f9a37-20e2-46d1-b5f2-00e1d5b39c24" continuedAt="i0a435818139e48fa9232a8560605e990" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross notional amount and fair value for foreign currency derivatives that are not designated as hedging instruments are accounted for as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04c7af5cb0944a609bc48c18ac1199c8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV80LTItMS0xLTY4NDg_a39fa198-47e1-4e45-8e8d-738538537b97">368,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04c7af5cb0944a609bc48c18ac1199c8_I20201231" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV80LTQtMS0xLTY4NTI_e033634b-dfdd-4c8e-9d4c-a730f4923df7">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04c7af5cb0944a609bc48c18ac1199c8_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV80LTYtMS0xLTY4NTY_fe3b40d4-cbba-4fc9-9bb5-8ce68750edb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79bfa2998ec14f64b6ac249d9dba29fc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV81LTItMS0xLTY4NTA_37a14af6-c8dc-4596-a6ef-770e78a9d2f3">368,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79bfa2998ec14f64b6ac249d9dba29fc_I20201231" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV81LTQtMS0xLTY4NTQ_f9401422-aba2-448b-a07e-36908c5fe198">293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79bfa2998ec14f64b6ac249d9dba29fc_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV81LTYtMS0xLTY4NTg_4f2d5ed9-39b8-4451-8842-278e87c13421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">_________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As presented in the consolidated balance sheet within other current assets.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We did not have any derivative instruments as of December 31, 2019. </span></div><div><span><br/></span></div><ix:continuation id="i0a435818139e48fa9232a8560605e990"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The effect of foreign currency forward contracts not designated as hedging instruments in our consolidated statements of operations for the year ended December 31, 2020 was as follows (in thousand):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:56.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Statement of Operations Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended<br/> December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d27b5a687e47f0b3b24ad613e488ba_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6NjhhYzcwZWU5MGNhNDJkYzk3NzY0NDg5NzMyZGQ1YzYvdGFibGVyYW5nZTo2OGFjNzBlZTkwY2E0MmRjOTc3NjQ0ODk3MzJkZDVjNl8zLTQtMS0xLTY4NjA_fed8dbd9-ff7a-421b-8eab-d1e818d861c2">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia68a26c9b80a46b89ff40f182120a6bb_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6NjhhYzcwZWU5MGNhNDJkYzk3NzY0NDg5NzMyZGQ1YzYvdGFibGVyYW5nZTo2OGFjNzBlZTkwY2E0MmRjOTc3NjQ0ODk3MzJkZDVjNl80LTQtMS0xLTY4NjI_b073b0a2-3762-42f6-9792-13c68fe4b609">293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no hedging activities for the years ended December 31, 2019 and 2018.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_2432"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGV4dHJlZ2lvbjo0NDQ0ZDE4NWQwOTA0ZGZiODQyYWY5ZGQ3ZTllMGRlYl8xMDQ0NTM2MDQ2NDUzMA_22a6c0f9-0f12-4551-8ee2-4f8287c43940" continuedAt="i179551384061499e9c6cc8b6b3d6d1b9" escape="true">Inventory</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i179551384061499e9c6cc8b6b3d6d1b9" continuedAt="i45068f6b65084aa5a321d2f2be5105e0"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGV4dHJlZ2lvbjo0NDQ0ZDE4NWQwOTA0ZGZiODQyYWY5ZGQ3ZTllMGRlYl8xMDQ0NTM2MDQ2NDUzMQ_ae7431ac-8455-428b-b66f-a2652473fc7e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of December 31, 2020 consists of the following (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:60.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGFibGU6Yzg0OTI2ODk0ZDMwNDgyNjkwZjFkMWFmYmIzZWZkZmIvdGFibGVyYW5nZTpjODQ5MjY4OTRkMzA0ODI2OTBmMWQxYWZiYjNlZmRmYl8yLTItMS0xLTYxNzc_eb0b06e0-aaca-42aa-9741-8215f617b1b0">36,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGFibGU6Yzg0OTI2ODk0ZDMwNDgyNjkwZjFkMWFmYmIzZWZkZmIvdGFibGVyYW5nZTpjODQ5MjY4OTRkMzA0ODI2OTBmMWQxYWZiYjNlZmRmYl8zLTItMS0xLTYxNzc_1b29245d-4576-4487-b1f4-9f30485e18b5">9,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGFibGU6Yzg0OTI2ODk0ZDMwNDgyNjkwZjFkMWFmYmIzZWZkZmIvdGFibGVyYW5nZTpjODQ5MjY4OTRkMzA0ODI2OTBmMWQxYWZiYjNlZmRmYl80LTItMS0xLTYxNzc_d631d37f-9ba5-427f-bc39-b4c0745eb1b4">1,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGFibGU6Yzg0OTI2ODk0ZDMwNDgyNjkwZjFkMWFmYmIzZWZkZmIvdGFibGVyYW5nZTpjODQ5MjY4OTRkMzA0ODI2OTBmMWQxYWZiYjNlZmRmYl81LTItMS0xLTY4NjQ_edc5e85a-eded-403f-8d52-4eb5e06b6357">46,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i45068f6b65084aa5a321d2f2be5105e0">We did <ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:InventoryNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGV4dHJlZ2lvbjo0NDQ0ZDE4NWQwOTA0ZGZiODQyYWY5ZGQ3ZTllMGRlYl80OTQ3ODAyMzI2MDE1_a773a4f0-6323-4cd8-86cd-4bf861684b9e">no</ix:nonFraction>t have any inventory at December 31, 2019.</ix:continuation> </span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_2426"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGV4dHJlZ2lvbjo1YTYzMDM2MDE5MjE0OGJkYjNjMWZhYTBjYWYyOWY2ZF8xMDQ0NTM2MDQ2NDE2OQ_6f89cf58-6c43-4170-b1bf-867e5ef89c12" continuedAt="i74a575d4b25c4c76bc920ad5016671f2" escape="true">Property and Equipment</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i74a575d4b25c4c76bc920ad5016671f2"><ix:continuation id="i977343811e2d4e4ea8f6d9bcd473963c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5b8e9cfd6ca448aa701acdac947ae5c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8yLTItMS0xLTYxNjA_be00a7c8-a11a-40d8-b7ed-1897bbfa9638">120,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee04f0bed89c49668441e99337b4c6e9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8yLTQtMS0xLTYxNjA_30af7de5-0e7d-4713-8755-11517548ee12">108,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40944c7d8d6941028b74d51f0012965a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8zLTItMS0xLTYxNjA_cdddfabd-00c9-4af6-afc8-f93b1231e670">179,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7f1f6b5edb444fd9d4b39047aec17fe_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8zLTQtMS0xLTYxNjA_b0edc006-1de8-471b-a14c-90cd549c346b">152,426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i029097fb98da493492487f2642eaca98_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl80LTItMS0xLTYxNjA_8375bb5b-3b27-4764-a189-b6f921771653">4,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9baf6f70a62949e58d3e834369eaf15d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl80LTQtMS0xLTYxNjA_05cd9d11-e3bf-4aad-9c3f-bb35f7d1ea9b">3,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7599583c04c4bb2b5065bb8e0fcccac_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl81LTItMS0xLTYxNjA_24809d47-cd4a-4897-b2f7-7d808c2804e5">13,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa4e9080e444a89ba97d4bb414498ec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl81LTQtMS0xLTYxNjA_3e745ac1-cb99-4138-aac8-a2bf32fddbb1">11,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7293e7dd6fe468bbf9ea8382a321117_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl82LTItMS0xLTYxNjA_3e409457-6816-4a5f-96a7-5a784fe88c9c">7,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a3475829320460094cd0d1af2b0eb08_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl82LTQtMS0xLTYxNjA_0931439d-f33f-47c4-852e-3b08e519c85b">7,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, financing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i931a0fc9cb324f33bb8472be6674ba39_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl83LTItMS0xLTYxNjA_425a1115-53dc-4613-9150-24cfed1d906b">56,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f4deb71bcf6418281042297367c1bea_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl83LTQtMS0xLTYxNjA_17e80ea7-56d1-4e70-8da8-21340215dc20">9,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9127d9980c58485bb596c9f9c0fe40f2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl84LTItMS0xLTYxNjA_80fb9128-c273-491b-b9be-2adc33d43a8c">34,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ec608e56a914901a6ad79ac5be09f26_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl84LTQtMS0xLTYxNjA_4f2b1644-0665-4f04-8da2-a1a50a163143">3,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl85LTItMS0xLTY4NzU_dccb6d12-d194-4dcf-bfb4-c24ad4e695fb">416,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl85LTQtMS0xLTY4Nzc_d28d3ea4-f502-4ca2-9d14-866618f30c29">296,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8xMC0yLTEtMS02MTYw_02fb9f4a-576b-44fb-9b8b-68f82b26b3a4">119,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8xMC00LTEtMS02MTYw_59e6c8a6-3a14-4e68-90f4-42aca464f743">94,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8xMS0yLTEtMS02ODc5_40648ac3-21e2-453e-aeca-50989deee0eb">296,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8xMS00LTEtMS02ODgx_a380ee91-6808-43d8-bf5d-5cc0bf9d1899">201,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense for the&#160;years ended December 31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGV4dHJlZ2lvbjo1YTYzMDM2MDE5MjE0OGJkYjNjMWZhYTBjYWYyOWY2ZF8zODQ4MjkwNjk3NDUz_23ad95ee-8074-422a-850d-16a1de4be986">31.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGV4dHJlZ2lvbjo1YTYzMDM2MDE5MjE0OGJkYjNjMWZhYTBjYWYyOWY2ZF8zODQ4MjkwNjk3NDU4_1d91610a-3769-412e-a436-fbd471f1f89b">31.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGV4dHJlZ2lvbjo1YTYzMDM2MDE5MjE0OGJkYjNjMWZhYTBjYWYyOWY2ZF8zODQ4MjkwNjk3NDYz_e61d05da-d82e-4a2d-9693-1e0200ed6238">24.9</ix:nonFraction> million, respectively.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_160"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. Other <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90ZXh0cmVnaW9uOjNmOTM1ZDRkY2JjZjQzZmQ4OTU3ZmIwNTQyNzQ3ODlhXzczMA_dece174a-c029-4f7c-9853-400e2729056c" continuedAt="i615e48d1d29a4f718595c922ea8ebccd" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i615e48d1d29a4f718595c922ea8ebccd" continuedAt="i85172d84e0894ab28cbf0508d37eaa9e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90ZXh0cmVnaW9uOjNmOTM1ZDRkY2JjZjQzZmQ4OTU3ZmIwNTQyNzQ3ODlhXzczMg_8d6b1429-7e21-4a01-b47c-621de92ee6a3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Down payments to manufacturing vendors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OtherPrepaidExpenseManufacturing" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzItMi0xLTEtMjQwMQ_005233d6-cef9-45ba-8a4e-8dbd17ca61cb">216,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="mrna:OtherPrepaidExpenseManufacturing" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzItNC0xLTEtMjQwMQ_8ee87423-5b9f-414a-9a8e-d63be4410781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzItMi0xLTEtMA_cf0cb9fe-4d5f-4f18-8dcd-1f55a1e8b06f">15,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzItNC0xLTEtMA_a54c672f-2b07-4d4a-aab4-b5bdd8e22c47">8,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant incentives receivables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:TenantIncentivesReceivablesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzMtMi0xLTEtMA_64bcd7ec-ff14-4a0c-b5f4-0d5fefb19deb">10,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:TenantIncentivesReceivablesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzMtNC0xLTEtMA_59c30384-aa2e-41f2-9d7f-a59e844f8e75">4,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable on marketable securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzQtMi0xLTEtMA_87dbf73c-fc36-4447-aeca-b127a873e537">9,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzQtNC0xLTEtMA_950f1096-3c86-442f-a416-15fab7762499">6,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzUtMi0xLTEtMA_bc09e13f-60a0-4365-9a88-9edcc62915a3">252,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzUtNC0xLTEtMA_da4a3766-05f3-428a-a7f1-65f7c0c174ea">19,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="i85172d84e0894ab28cbf0508d37eaa9e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Liabilities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90ZXh0cmVnaW9uOjNmOTM1ZDRkY2JjZjQzZmQ4OTU3ZmIwNTQyNzQ3ODlhXzcyOA_949b79db-a3ce-43e1-94d2-23bcf8db48c1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"><tr><td style="width:1.0%"></td><td style="width:73.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:AccruedClinicalTrials" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzItMi0xLTEtMjQ0MA_0dc8d839-4714-4877-9a92-c1066594543f">97,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:AccruedClinicalTrials" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzItNC0xLTEtMjQ0MA_9b5071db-1071-4be5-99d4-454cb341bece">6,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation-related</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzMtMi0xLTEtMjQ0MA_881d8c59-d7d6-4903-973e-a7f777e53b50">95,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzMtNC0xLTEtMjQ0MA_1a8558fa-d0c6-4a35-9acd-cda75707b31c">27,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:RawMaterialsAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtMi0xLTEtMTcyNDU_26ec9741-3157-48b8-a31f-e07dc4b1efcc">78,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="mrna:RawMaterialsAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtNC0xLTEtMTcyNDU_477faae9-037e-439d-b261-a9af367ed353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:AccruedManufacturing" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtMi0xLTEtMTcyNTU_64e24b2c-6391-42a5-90bb-d6dd24321a97">53,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:AccruedManufacturing" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtNC0xLTEtMTcyNTU_38251f21-ad18-48f6-9816-adfc2d2a6010">5,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:AccruedDevelopmentOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtMi0xLTEtMTcyMzI_f59ce74e-b0ab-4c12-a14a-7de882a71aba">29,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:AccruedDevelopmentOperation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtNC0xLTEtMTcyMzI_7a9b8ea5-9cb1-40d2-ba2a-4ecefc898d3d">2,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:AccruedPropertyAndEquipmentCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtMi0xLTEtMjQ0MA_04423e9d-bafe-4cc2-b0dc-7417f3a260d5">17,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:AccruedPropertyAndEquipmentCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtNC0xLTEtMjQ0MA_ec9a9d0b-a323-45ec-b1bf-c44fc9da0a78">4,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:Commercial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtMi0xLTEtMTEyNDE_166c2a3d-3a3f-47a4-ac41-28f509b3cc05">6,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="mrna:Commercial" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtNC0xLTEtMTEyNDE_b2d40fff-d210-46f0-9395-60b73f0c1784">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external goods and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:AccruedExternalGoodsAndServicesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtMi0xLTEtMjQ0MA_1712c240-94a6-4424-b5c0-6b6af4163903">91,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:AccruedExternalGoodsAndServicesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtNC0xLTEtMjQ0MA_3d1f7a6e-ac54-4451-8cba-8f126cca26eb">21,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzYtMi0xLTEtMA_f315268d-56ce-4644-adbb-7d859665fb72">469,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzYtNC0xLTEtMA_d6e70960-3b32-4323-94a6-3b9696e966e0">67,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Current Liabilities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90ZXh0cmVnaW9uOjNmOTM1ZDRkY2JjZjQzZmQ4OTU3ZmIwNTQyNzQ3ODlhXzQ5NDc4MDIzMzAzNjU_dba961cd-f005-45c0-bf9c-102081e728e2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"><tr><td style="width:1.0%"></td><td style="width:73.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities - financing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzItMi0xLTEtNjc3OA_6de914dd-7658-4f33-9fd0-a96b293a2008">24,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzItNC0xLTEtNjc3OA_e1a3513a-c82e-4e7f-b5b6-211b71dc5f5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities - operating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzMtMi0xLTEtNjc3OA_a8253707-096a-40a7-b189-caa837563e04">5,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzMtNC0xLTEtNjc3OA_444722dd-70f2-421f-88aa-8957a02e216c">3,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzQtMi0xLTEtNjc3OA_d03d1d3d-e40e-40af-88bf-ce94a68f9b4f">3,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzQtNC0xLTEtNjc3OA_051698a2-2a02-40e9-82f6-a6078ffdcbf8">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzUtMi0xLTEtNjkzMg_66589b30-ab83-4125-9941-b0841a8c8b43">33,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzUtNC0xLTEtNjkzNA_82c40834-85f2-40c8-918d-aa63f7df7dcc">5,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:continuation id="i49ebc6a6864b4de3bd68aa43fae78dbd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activities in deferred revenue during the year ended December&#160;31, 2020 (in thousands): </span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc80cc31c16d4bb5b781ff93fa778e3d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzItMi0xLTEtMTI1NzU_3fd49392-440e-455c-bcde-2b0ff1cb7b94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af31ae8238a40b6a097aa5017de8edd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzItNC0xLTEtMTI1NzU_dad31536-37fc-4f2e-8dc2-97ef84b19e8b">3,881,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3af31ae8238a40b6a097aa5017de8edd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzItNi0xLTEtMTI1NzU_ae16cd40-6152-49c5-9495-58f558f94d6f">82,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a5ca8f57aed41fd9ba65d7a8eb8066c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzItOC0xLTEtMTQ0ODQ_25cbeea2-9f05-4bec-a889-96699f626ca4">3,799,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61596579e2804716ad9472fa52f24629_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtMi0xLTEtMTcyNzM_99b18eb6-46e9-41c3-8e49-de2f4b27217d">2,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia16dd0e2f0d2488eba0c73974791c3a4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtNC0xLTEtMTcyNzM_1621a114-d389-4c8a-bb64-4ab8d174253f">6,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia16dd0e2f0d2488eba0c73974791c3a4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtNi0xLTEtMTcyNzM_2dac9ed5-d947-40bf-bc0b-697d899275bd">4,291</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e6e85bd35c473b8a7fdfa429ebf3f0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtOC0xLTEtMTcyNzM_f3e4f0fc-7dac-4baa-9b85-9da95202cdd7">5,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82530c9d21864e758383518f41158ccf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtMi0xLTEtMTI1NzU_bf7b2a53-e729-4026-8db2-03056c93ed06">199,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bf0bccbb5d48e2b6b391bd4c6436d8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtNC0xLTEtMTI1NzU_1328be04-07e7-41e0-8030-4fcdc5b2d6a2">121,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1bf0bccbb5d48e2b6b391bd4c6436d8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtNi0xLTEtMTI1NzU_3d615944-9e0e-433a-828c-22a494d5a483">81,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee1f1d3a45314f5a8987999269779a3f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtOC0xLTEtMTQ0ODQ_65f7e7ef-01fb-4986-94aa-3f82890fbe50">240,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzQtMi0xLTEtMTQ0Nzg_a04f790f-b718-4421-ac05-5e62adcd1b1b">202,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzQtNC0xLTEtMTQ0ODA_b7689082-826d-43c3-b645-276178c1d780">4,009,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzQtNi0xLTEtMTQ0ODI_c0f0697d-10e3-4a7f-b589-4d57df385fd8">167,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzQtOC0xLTEtMTQ0ODQ_69833246-0adc-4501-976c-eda77d436385">4,044,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_163"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTY3_cb47788c-ef9f-4fe6-af53-565f9196ad8e" continuedAt="i2282567d151f42479b37009b400b56b5" escape="true"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTY4_0bd534ec-e25f-42b9-85bd-d1469a52158f" continuedAt="ide374b46c44843cdaecc93271e968ebd" escape="true">Leases </ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2282567d151f42479b37009b400b56b5" continuedAt="i00631d0dfa294c5795e4f38362a1abbd"><ix:continuation id="ide374b46c44843cdaecc93271e968ebd" continuedAt="ifec115b38378463bafd6cf95886806ac">We have entered into various long-term non-cancelable lease arrangements for our facilities and equipment expiring at various times through 2032. Certain of these arrangements have free rent periods or escalating rent payment provisions, which we recognize lease cost under such arrangements on a straight-line basis over the life of the leases. We have <ix:nonFraction unitRef="campus" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="mrna:OperatingLeaseNumberOfProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzM3MA_b18c396d-82ad-4333-a0e3-8df3b4cd1854">two</ix:nonFraction> campuses in Massachusetts, our Cambridge facility and our Moderna Technology Center (MTC), located in Norwood. </ix:continuation></ix:continuation></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">225</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i00631d0dfa294c5795e4f38362a1abbd" continuedAt="ifb3043554fff428391c5d12a08125b76"><ix:continuation id="ifec115b38378463bafd6cf95886806ac" continuedAt="i87ff128860cf41d2bcd8888e645e9622"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cambridge facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We occupy a multi-floor building at Technology Square in Cambridge, Massachusetts with a mix of offices and research laboratory space totaling approximately <ix:nonFraction unitRef="sqft" contextRef="ibbcec80ae49c4b8286395ec88c10e2bf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AreaOfRealEstateProperty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzY3MA_700494df-0b75-4ee0-9fd9-773f1821b27b">175,000</ix:nonFraction> square feet. Our Cambridge facility leases have expiry ranges from 2020 to 2029.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we entered into an amendment to our lease agreements to consolidate our Technology Square space in Cambridge, Massachusetts. This included entering into a forward-starting lease agreement starting in January 2020 to acquire approximately <ix:nonFraction unitRef="sqft" contextRef="i620a2c29a9454e86abf8ee51f8558fe7_I20190831" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AreaOfRealEstateProperty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2Xzk5Nw_264af2fc-8aee-4a7b-8c65-f44dd0957272">50,000</ix:nonFraction> square feet of additional space at 200 Technology Square. In addition, our current 200 Technology Square lease has been extended for <ix:nonNumeric contextRef="i620a2c29a9454e86abf8ee51f8558fe7_I20190831" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEzMTk0MTM5NTQ2MDEy_33f8770e-44bd-4427-b0f6-1ae941e0ee71">two years</ix:nonNumeric> to 2029. As part of the lease amendment, we completely exited our leased space of approximately <ix:nonFraction unitRef="sqft" contextRef="i9c54db761b0740ec8aba56ebf889d996_I20190831" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AreaOfRealEstateProperty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEyMTU_798c3e56-1883-46fc-ae69-c4d39d932e4c">60,000</ix:nonFraction> square feet at 500 Technology Square by May 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record operating lease cost for each of our operating leases on a straight-line basis from lease commencement date through the end of the lease term. Operating lease cost is recorded in operating expenses in our consolidated statements of operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finance Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moderna Technology Center North (MTC North) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we entered into a new lease agreement for office and laboratory space of approximately <ix:nonFraction unitRef="sqft" contextRef="idf6426583a4543de9fc96eca2bc03260_I20190228" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AreaOfRealEstateProperty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzM3MjM_3ac25506-f816-4b3e-be68-0b898fe7f8be">200,000</ix:nonFraction> square feet, MTC North, located in Norwood, Massachusetts. The lease commenced in the second quarter of 2019 and had an initial expiration date of 2031. We have the option to extend the lease for up to <ix:nonFraction unitRef="extension_period" contextRef="idf6426583a4543de9fc96eca2bc03260_I20190228" decimals="INF" format="ixt-sec:numwordsen" name="mrna:LesseeOperatingLeaseNumberOfExtensionPeriods" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzM5MTc_a44255ab-87c6-4eaf-bbf3-c0c9d4fbc3bc">four</ix:nonFraction> additional <ix:nonNumeric contextRef="idf6426583a4543de9fc96eca2bc03260_I20190228" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNTg3OTQ_e0d2324c-48de-4b56-b92f-cf9b94773335">five-year</ix:nonNumeric> terms. Contemporaneously, we entered into an agreement to sublease approximately <ix:nonFraction unitRef="number" contextRef="idf6426583a4543de9fc96eca2bc03260_I20190228" decimals="2" format="ixt:numdotdecimal" name="mrna:LesseeOperatingLeasePercentageSubleased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQwMjA_0438d632-aad7-4798-9e74-376379af7955">64</ix:nonFraction> percent of the leased space to a third party. In May 2020, we entered into an amendment to the lease whereby we exercised an option available in the original lease to receive a tenant improvement allowance in the amount of $<ix:nonFraction unitRef="usd" contextRef="i7b968f2e54364ba8ad58961ced8da02e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TenantImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNjMyMzM_86ed1bea-ccc8-489b-8987-45ba6f23e2d1">22.2</ix:nonFraction>&#160;million to be paid back over the term of the lease with interest and extend the term of the lease to 2035. In May 2020, we also amended our MTC North sublease agreement. As the result of that amendment, effective June 1, 2020, we obtained an additional, approximately <ix:nonFraction unitRef="sqft" contextRef="i6e728091fd7b4fddbe99aa3980407db5_I20200601" decimals="-3" format="ixt:numdotdecimal" name="mrna:AreaOfRealEstatePropertyAdditionalSpace" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNTg3OTY_d4c2abda-1d41-482b-82a5-0dad4b75ecbc">28,000</ix:nonFraction> square feet, or <ix:nonFraction unitRef="number" contextRef="i6e728091fd7b4fddbe99aa3980407db5_I20200601" decimals="2" format="ixt:numdotdecimal" name="mrna:LesseeOperatingLeasePercentageSubleased" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNTg4MDM_caae21e0-e6c8-4750-b372-c3507190c174">12</ix:nonFraction> percent of the leased space in MTC North and the remainder of the space in July 2020 when the sublease expired. The lease modifications to MTC North in the second quarter of 2020 resulted in a change in lease classification, from operating to finance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moderna Technology Center manufacturing facility (MTC South) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August&#160;2016, we entered into a lease agreement for approximately&#160;<ix:nonFraction unitRef="sqft" contextRef="i028772f3641244bba3f25ec35843b217_I20160831" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AreaOfRealEstateProperty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzUxMzM_e4e1601b-711e-4208-898b-efb9051ddbb7">200,000</ix:nonFraction>&#160;square feet of office, laboratory, and light manufacturing space, MTC South, in Norwood, Massachusetts. The lease will expire in September&#160;2032. We have the option to extend the term for&#160;<ix:nonFraction unitRef="extension_period" contextRef="i266a5c7f3c4d4becbe194489fb7a115a_I20160831" decimals="INF" format="ixt-sec:numwordsen" name="mrna:LesseeOperatingLeaseNumberOfExtensionPeriods" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzU1OTg_3e87cda2-a623-4992-81dc-7637df7d2597">two</ix:nonFraction>&#160;extension periods of&#160;<ix:nonNumeric contextRef="i266a5c7f3c4d4becbe194489fb7a115a_I20160831" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzU2MjI_938d5de3-16f2-443f-8643-3b9d2543df3a">ten years</ix:nonNumeric>&#160;each at market-based rents. The base rent is subject to increases over the term of the lease. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Embedded Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into multiple contract manufacturing service agreements with third parties which contain embedded leases within the scope of ASC 842. As of December 31, 2020, we had lease liabilities of $<ix:nonFraction unitRef="usd" contextRef="ib99c6b4909974f38905c833f846083b4_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEwNDQ1MzYwNTAyMDk4_8406b635-bc0f-4c0c-9e33-61ec622a23ac">24.3</ix:nonFraction>&#160;million related to the embedded leases. Certain embedded leases dedicated to our COVID-19 vaccine program prior to the EUA from the FDA were deemed to have no alternative use. The related right-of-use assets of $<ix:nonFraction unitRef="usd" contextRef="ib99c6b4909974f38905c833f846083b4_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEwNDQ1MzYwNTAyMDgz_75dd217f-6447-4ac3-b58f-82ed519abdd7">62.3</ix:nonFraction>&#160;million were charged to research and development expense for the year ended December 31, 2020.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">226</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="ifb3043554fff428391c5d12a08125b76" continuedAt="i0477422c160e47999051f477b41fa281"><ix:continuation id="i87ff128860cf41d2bcd8888e645e9622" continuedAt="i953c93745d004a45a063d531188629f3"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="mrna:CurrentAssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTcw_6b05ed45-a859-40b0-997c-77f098295ab5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating and financing lease right-of-use assets and lease liabilities as of December 31, 2020 and 2019 were as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, operating, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzMtMi0xLTEtMA_5c1c9e6f-0f38-4ac2-82f2-5adfa1d18e9b">90,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzMtNC0xLTEtMA_f9bf1eab-143e-4b7a-88d7-a745d09fc685">86,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, financing, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzQtMi0xLTEtMA_6d8d962e-bf6e-40a3-b584-be6cbdd1b586">55,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzQtNC0xLTEtMA_3bc2db7b-5c2f-4e45-80bc-590b5cb86873">9,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OperatingAndFinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzUtMi0xLTEtMA_c65b466f-a059-42e6-b5f2-32d65c7dcc96">145,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OperatingAndFinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzUtNC0xLTEtMA_8ea12e46-0db6-434c-93b4-e4fb4f99c819">95,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_509b73a1-344b-43fb-b968-8722c1c25a5e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_72c4555a-bb44-4abb-b6c7-1be6c51005ca"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMi0xLTEtMA_a61eabfb-e1b6-4000-8241-ff7c95dd0c3f">5,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktNC0xLTEtMA_3ef636b2-bfb6-4eda-99b3-b9a030ead566">3,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_2a800648-bfb3-4584-a0d1-7572b92f5809"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_5ef609f9-9865-4708-ad5f-c12a24e8246f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTItMS0xLTA_82ba12a2-7f5d-4c96-8c58-7bc25f1f6ea5">24,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTQtMS0xLTA_44a86d75-e7e6-4221-b172-90d571ac9727">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current lease liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OperatingAndFinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzExLTItMS0xLTE1NDgw_5035623d-c618-49ac-94fd-64a0b8a292f1">30,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OperatingAndFinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzExLTQtMS0xLTE1NDgy_046fbe35-2bfa-4f53-896d-3b8642d542d2">3,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEzLTItMS0xLTA_533d7aae-ffeb-4938-a02c-0461b46b3819">97,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEzLTQtMS0xLTA_efa79e73-a657-4706-b4b9-340f25982f76">93,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE0LTItMS0xLTA_f0b3d557-849b-42bc-ba4c-127ae2b2feed">109,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE0LTQtMS0xLTA_7215f4ef-14f7-4a13-bf82-7c918e092c98">38,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OperatingAndFinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE1LTItMS0xLTA_0f7f4cb5-c15d-41cb-b43e-a2bec46b3cba">207,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OperatingAndFinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE1LTQtMS0xLTA_239801a4-c11d-47ae-b19e-e7ae61711fa5">132,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OperatingAndFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE2LTItMS0xLTA_6e40f201-0f52-45cd-a7f4-4610cda82723">237,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:OperatingAndFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE2LTQtMS0xLTA_9fb89f1b-cc58-4bda-8c4a-1bd8dc64849d">135,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are real estate related assets, which include land, office and laboratory spaces.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net of accumulated depreciation. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are&#160;real estate assets related to the MTC North and MTC South leases. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in property and equipment in the consolidated balance sheets, net of accumulated depreciation.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in other current liabilities in the consolidated balance sheets.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTY0_ad0898c0-43aa-409c-a89b-5a02a5b3e27a" continuedAt="i90bef30fde604d5e935d9b04d7b93571" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the lease costs for the year ended December 31, 2020 and 2019 were as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"><tr><td style="width:1.0%"></td><td style="width:72.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.120%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzItMi0xLTEtMjQ4MA_626f6fc7-337f-4a16-a4f1-3e57251a1669">16,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzItMi0xLTEtMA_5e96fc28-f729-4bae-8383-7d221a7d0a76">17,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of right-of-use assets, financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzQtMi0xLTEtMjQ4MA_6d2a57eb-e0a2-4a45-bc87-30abe33ddef5">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzQtMi0xLTEtMA_7e16ba76-6578-4090-a340-ac1c77d5a5ac">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense for financing lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzUtMi0xLTEtMjQ4MA_1beacd86-cfa4-42c5-89dd-b60649091fbc">9,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzUtMi0xLTEtMA_5fcca09e-642b-4301-b906-3b9859558ac0">6,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financing lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzYtMi0xLTEtMzU3MQ_1cd8b4a3-816a-4f10-bc3e-aa8f71c51088">10,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzYtMi0xLTEtMA_eaa0a2c1-fa99-4479-acf5-e99089a1fc79">6,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzctMi0xLTEtODQxNw_9a24d42d-89dd-49c1-a141-e72ee0713368">13,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzctNC0xLTEtODQxNw_4e4c1958-2f3b-4bd9-aa9b-bd739e3e92f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzgtMi0xLTEtMjQ4NA_ab7348d0-7ccb-489c-89bd-4108277b9088">5,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzgtMi0xLTEtMA_352d7f33-883b-45c3-9ac4-85045c3dca41">4,399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total rent expense&#160;for the&#160;year ended&#160;December&#160;31, 2018 was&#160;$<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEwMjA1_9b788a28-5d04-4723-beae-50b0a0d20daa">19.1</ix:nonFraction> million.&#160;</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i0477422c160e47999051f477b41fa281" continuedAt="i40463fe9e4864947afc82bb76ef5e941"><ix:continuation id="i953c93745d004a45a063d531188629f3" continuedAt="idcc138a003ca4bfe839c0594dd8dc1b3"><ix:continuation id="i90bef30fde604d5e935d9b04d7b93571"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information relating to our leases for the year ended December 31, 2020 and 2019 was as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used in operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzMtMi0xLTEtMjUzNg_73676464-157c-48eb-8c67-ea23b468b5f5">15,089</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzMtMi0xLTEtMA_cf400bb9-6b54-4359-afa8-8a007a77bb8d">16,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used in financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzQtMi0xLTEtMjUzNg_6a85c943-2b4a-493b-8b1e-fee3a124b174">8,523</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzQtMi0xLTEtMA_74fad7d6-a65a-4813-b2d1-ea32fca2f1c2">5,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Financing cash flows used in financing leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzUtMi0xLTEtODI0Nw_91d91485-6641-4826-ba09-cf0a78ac4b83">7,519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzUtMi0xLTEtMA_9e4b20fe-35c0-48d4-9686-2b4ace0cf6c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease non-cash items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets reduced through lease modifications and reassessments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzgtMi0xLTEtMjU0Mg_8b3ee6dd-b90a-4b79-942c-89f0f19b51b5">6,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzgtMi0xLTEtMA_1937cb2c-6cf1-450d-a260-7db83829f15a">2,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzktMi0xLTEtMjU0Mg_98531766-b5e5-4937-91ce-a5d42e94c6ea">17,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzktMi0xLTEtMA_f9c2e688-e3f4-4941-a2d8-8bfcbae833b8">34,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease non-cash items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained through lease modifications and reassessments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzEyLTItMS0xLTI1NDY_58221b5f-adc1-40ea-acf8-d7bd183325de">46,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzEyLTQtMS0xLTI1NDY_484008e8-2bfc-406a-9a30-c65853ceaed5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge to financing lease obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:LesseeFinanceLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzEzLTItMS0xLTI1NDY_f105ea7e-fba6-47ec-b583-ab660bc6884d">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" name="mrna:LesseeFinanceLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzEzLTQtMS0xLTI1NDY_2d783926-967d-423f-8e4b-b67ee2418748">971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease terms and discount rates as of December 31, 2020 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjY2E5YWVlZjczMDc0YWRhODM0NTY4ZmYxY2RkMjJhZi90YWJsZXJhbmdlOmNjYTlhZWVmNzMwNzRhZGE4MzQ1NjhmZjFjZGQyMmFmXzMtMi0xLTEtMA_d753dfca-a757-4207-8cc1-4ed23e45ba70">11</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjY2E5YWVlZjczMDc0YWRhODM0NTY4ZmYxY2RkMjJhZi90YWJsZXJhbmdlOmNjYTlhZWVmNzMwNzRhZGE4MzQ1NjhmZjFjZGQyMmFmXzQtMi0xLTEtMA_a505a73d-f1b3-4e42-b823-d100c842a6bf">25</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjY2E5YWVlZjczMDc0YWRhODM0NTY4ZmYxY2RkMjJhZi90YWJsZXJhbmdlOmNjYTlhZWVmNzMwNzRhZGE4MzQ1NjhmZjFjZGQyMmFmXzYtMi0xLTEtMA_40041360-0661-400d-9dc8-8768322bd24f">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjY2E5YWVlZjczMDc0YWRhODM0NTY4ZmYxY2RkMjJhZi90YWJsZXJhbmdlOmNjYTlhZWVmNzMwNzRhZGE4MzQ1NjhmZjFjZGQyMmFmXzctMi0xLTEtMA_5870ef51-cef3-4a2a-ac41-9b8603edd01d">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTY1_034da700-d1df-4eaf-8042-ba0e025f5d5d" continuedAt="i5b5d0c759f394a62ba8e9672731313e8" escape="true"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTY2_7dd585a8-107b-4ea2-b073-25fdc22d11dc" continuedAt="i72caa21ab71f47b9834c9cdd42e210b2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable lease agreements as of&#160;December&#160;31, 2020, were as follows (in&#160;thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzEtMi0xLTEtMA_f794c413-7111-43c6-aef0-d4ad83652c90">15,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzEtNC0xLTEtMA_651bac77-367d-48cd-8c5a-96ec2c9a78a0">36,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzItMi0xLTEtMA_5e0e5e06-76ea-4459-af55-d4724659d83f">15,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzItNC0xLTEtMA_106cc30b-3025-40b0-b681-7a1c0a6c497b">11,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzMtMi0xLTEtMA_7184ff25-b2c8-4b34-8baa-3eed7b1cca52">16,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzMtNC0xLTEtMA_28bd2b38-fe15-4891-9c35-05e32b6f7ed3">12,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzQtMi0xLTEtMA_4421f709-f147-4f4f-8726-84bc75336d1d">16,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzQtNC0xLTEtMA_9b9905bb-e4cc-4442-aaa1-a5e07ceb7f2b">12,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzUtMi0xLTEtMA_c4b26d4e-2690-4501-bfb8-60fd06aa3bbe">16,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzUtNC0xLTEtMA_8f7fa129-38d8-400e-8948-ce2fa8b9d2be">12,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzYtMi0xLTEtMA_6df6bc1b-0fd2-42b8-a76f-0dbe80084878">93,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzYtNC0xLTEtMA_76ea7346-03e4-41c8-976d-bf98cb1246f5">428,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzctMi0xLTEtMA_b6a28262-a913-439e-b013-f67b1f33d7fa">173,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzctNC0xLTEtMA_6f5ad7dd-8a64-4d9c-abe7-dad8ab33aa8f">513,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amounts representing interest or imputed interest </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzgtMi0xLTEtMA_857c469b-7d77-4609-83c5-3193c75a68d1">70,354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzgtNC0xLTEtMA_5b556780-b6eb-40c9-84ff-5fc53c9041ab">379,110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzktMi0xLTEtMA_e4a1e01c-b982-4504-a4ce-a6814ec4ff12">103,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzktNC0xLTEtMA_f3465c22-4cac-4db7-8912-28aec44782fc">134,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Include the optional extensions in the MTC North and MTC South lease terms which represent a total of $<ix:nonFraction unitRef="usd" contextRef="i313b37fa8a694900aaf4a540ec5403b2_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEwNjk1_14584fd2-47e5-495f-89cd-368fc7b94f3e">338.9</ix:nonFraction> million un-discounted future lease payments. </span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"><ix:continuation id="i40463fe9e4864947afc82bb76ef5e941" continuedAt="i55582e5f25cf46d4b9452afc72f67911"><ix:continuation id="idcc138a003ca4bfe839c0594dd8dc1b3" continuedAt="id090773849d440178be064892800fa15"><ix:continuation id="i5b5d0c759f394a62ba8e9672731313e8" continuedAt="i4fd7db6983f4445d9127c65b83337cc9"><ix:continuation id="i72caa21ab71f47b9834c9cdd42e210b2" continuedAt="i2a21d07900664e3488702a7cb6351231">(2)  </ix:continuation></ix:continuation></ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i55582e5f25cf46d4b9452afc72f67911"><ix:continuation id="id090773849d440178be064892800fa15"><ix:continuation id="i4fd7db6983f4445d9127c65b83337cc9"><ix:continuation id="i2a21d07900664e3488702a7cb6351231">MTC South interest is based on an imputed interest rate of <ix:nonFraction unitRef="number" contextRef="i6f36d10d97c04db1b365a25391679774_D20200101-20201231" decimals="3" name="mrna:LeasesImputedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNTg3NzE_31257760-b7e7-4896-82ff-11c61328670e">17.2</ix:nonFraction>%. MTC North interest is based upon an incremental borrowing rate of <ix:nonFraction unitRef="number" contextRef="i3832eb52624b426797a221627ead873a_D20200101-20201231" decimals="3" name="mrna:LeasesIncrementalBorrowingRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNTg3Nzg_4286be83-cde4-4121-8496-902a95b940ab">8.2</ix:nonFraction>%.</ix:continuation></ix:continuation></ix:continuation></ix:continuation>&#160;</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">228</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_166"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzQ4MDg_46a0c4b7-fafb-4a47-97cb-d46203db1fc5" continuedAt="i8dc502d5eed84c60bae8f889f60581fa" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8dc502d5eed84c60bae8f889f60581fa" continuedAt="iafae2b517cf64f309087ec28aab8b7c9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Collaborations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our strategic collaboration agreements, we are committed to perform certain research, development, and manufacturing activities. As part of our PCV Agreement and PCV/SAV Agreement with Merck, we are committed to perform certain research, development and manufacturing activities related to PCV products through an initial Phase 2 clinical trial up to a budgeted amount of $<ix:nonFraction unitRef="usd" contextRef="i1441021944924f86873ecc11207adf0d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzQ0MQ_f0e72f52-1254-472b-a4bb-29219b661094"><ix:nonFraction unitRef="usd" contextRef="ib2ffbac081c347a18476291631b1325f_I20191231" decimals="-5" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzQ0MQ_ff7691b1-914f-4d51-a54b-3055125b1c93">243.0</ix:nonFraction></ix:nonFraction> million as of December 31, 2020 and 2019 (Note 5).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently a party to any material legal proceedings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted under Delaware law, we indemnify our officers, directors, and employees for certain events, occurrences while the officer, or director is, or was, serving at our request in such capacity. The term of the indemnification is for the officer&#8217;s or director&#8217;s lifetime.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have standard indemnification arrangements in our leases for laboratory and office space that require us to indemnify the landlord against any liability for injury, loss, accident, or damage from any claims, actions, proceedings, or costs resulting from certain acts, breaches, violations, or non-performance under our leases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into indemnification provisions under our agreements with counterparties in the ordinary course of business, typically with business partners, contractors, clinical sites and customers. Under these provisions, we generally indemnify and hold harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of our activities. These indemnification provisions generally survive termination of the underlying agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is unlimited.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through December 31, 2020 and 2019, we had <ix:nonFraction unitRef="usd" contextRef="i62af6315d0994091a5ee85593def32e7_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyLossInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEyMTQ_0d19de70-2fed-4c34-ab80-a691d38d6e8d"><ix:nonFraction unitRef="usd" contextRef="ia470ee9b9d754ceeb6681190f52793c3_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyLossInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEyMTQ_107b1449-fe6d-48fe-b51e-af533a7c14f1">no</ix:nonFraction></ix:nonFraction>t experienced any losses related to these indemnification obligations, and <ix:nonFraction unitRef="claim" contextRef="i3ea7b5505cee487fbf7be94bf6d55f95_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEyOTE_31ce6b42-5c69-4ee2-a1f8-73daa59059a0"><ix:nonFraction unitRef="claim" contextRef="i794421bf0a8e43a3a51997f49bc8dcb8_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEyOTE_412715bb-7f28-4626-828f-b61955153dc0">no</ix:nonFraction></ix:nonFraction> material claims were outstanding. We do not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and <ix:nonFraction unitRef="usd" contextRef="i794421bf0a8e43a3a51997f49bc8dcb8_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzE0OTg_6ffdc872-6a26-4f5a-880b-26411c4edef0"><ix:nonFraction unitRef="usd" contextRef="i3ea7b5505cee487fbf7be94bf6d55f95_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzE0OTg_b909c474-2bed-403a-a664-ad41a16dde5d">no</ix:nonFraction></ix:nonFraction> related reserves were established.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments and Purchase Orders</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we entered into a 10-year strategic collaboration agreement with Lonza Ltd. to enable larger scale manufacture for our COVID-19 vaccine and additional Moderna products in the future. This agreement was reflected in the Global Long Term Agreement entered into between Moderna and Lonza on September 4, 2020. Under the terms of the agreement, we established dedicated manufacturing suites at Lonza&#8217;s facilities in the United States and Switzerland for the manufacture of mRNA-1273 at both sites. Certain arrangements under this strategic collaboration agreement are within the scope of lease accounting (see Note 11). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into agreements in the normal course of business with vendors and contract manufacturing organizations (CMOs) for raw materials and manufacturing services and with vendors for preclinical research studies, clinical trials and other goods or services. As of December 31, 2020, we had </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i4c7e100fa92b440a8d435619ce329b08_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNjIw_48c4b288-eb51-4a19-9962-e050d1b3c1aa">659.5</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of non-cancelable purchase commitments related to raw materials and manufacturing agreements, including the Lonza agreement, which are expected to be paid through 2021. As of December 31, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="i1170ecd035af4400a71afda6f522a17b_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEzNzQzODk1Mzc2NjEx_d681ed66-eb48-4a5f-b375-512b548ecd05">27.0</ix:nonFraction>&#160;million of non-cancelable purchase commitments for clinical services and other goods and services which are expected to be paid through 2024. These amounts represent our minimum contractual obligations, including termination fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to purchase commitments, we have agreements with third parties for various services, including services related to clinical operations and support and contract manufacturing, for which we are not contractually able to terminate for convenience and avoid any and all future obligations to the vendors. Certain agreements provide for termination rights subject to termination fees or wind down costs. Under such agreements, we are contractually obligated to make certain payments to vendors, mainly, to reimburse them for their unrecoverable outlays incurred prior to cancellation. At December 31, 2020, we had cancelable open purchase orders of $<ix:nonFraction unitRef="usd" contextRef="i2b6cf5372b6e431587c7ba23a440fa6a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzIzNDg_01e74371-e50a-4f83-96a5-66b4ed691a71">896.9</ix:nonFraction> million in total under such agreements for our significant clinical operations and support and contract manufacturing. These amounts represent only our estimate of those items for which we had a contractual commitment to pay at December 31, 2020, assuming we would not cancel these agreements. The actual amounts we pay in the future to the vendors under such agreements may differ from the purchase order amounts.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><ix:continuation id="iafae2b517cf64f309087ec28aab8b7c9" continuedAt="i5a89227e50734eb8abcf40f98c05a998"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licenses to Patented Technology</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;26, 2017, we entered into sublicense agreements with Cellscript, LLC and its affiliate, mRNA RiboTherapeutics, Inc. to sublicense certain patent rights. Pursuant to each agreement, we are required to pay certain license fees, annual maintenance fees, minimum royalties on future net sales and milestone payments contingent on achievement of certain development, regulatory and commercial milestones for specified products, on a product-by-product basis. The development and regulatory milestone payments, up to $<ix:nonFraction unitRef="usd" contextRef="i61eb580f6c4e4674bede2f83be700c34_I20170626" decimals="-5" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNDY4_c6d83b0e-1883-42fe-a97c-88a0d38826b3">1.5</ix:nonFraction>&#160;million for therapeutic and prophylactic products and up to $<ix:nonFraction unitRef="usd" contextRef="i0c3c86543acc46e2b8b0c2c0de911ca5_I20170626" decimals="-5" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNDgz_f2de267d-1c5a-452d-82c1-97b765027ca7">0.5</ix:nonFraction> million for diagnostic products will be recognized as a cost of the asset acquired upon resolution of the associated contingency and will be capitalized or expensed depending on the nature of the associated asset as of the date of recognition. Conversely, commercial milestone payments, up to $<ix:nonFraction unitRef="usd" contextRef="i7e99c6608c7941008ec26bef45112da4_I20170626" decimals="-5" format="ixt:numdotdecimal" name="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNDg3_8eceab4f-5f4b-4735-a504-7692eee900f4">24.0</ix:nonFraction> million, and royalties based on annual net sales of licensed products for therapeutic and prophylactic products will be accounted for as additional expense of the related product sales in the period in which the corresponding sales occur. In connection with these sublicense agreements, we recognized sublicense grant fees of $<ix:nonFraction unitRef="usd" contextRef="ia945c15292e84282b614fb94308ea684_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNDkw_6d30b50a-280e-45b2-8192-4b0ffa4e315c">22.0</ix:nonFraction>&#160;million in 2018 and have no further obligation for additional sublicense grant fees. We recognized $<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNTA1_5d12c637-e2d3-4e21-8810-dc3b0c4b6a26">6.9</ix:nonFraction>&#160;million of royalties associated with our product sales in 2020.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5a89227e50734eb8abcf40f98c05a998">Additionally, we have other in-license agreements with third parties which require us to make future development, regulatory and commercial milestone payments for specified products associated with the agreements. The achievement of these milestones was not deemed probable as of December 31, 2020.</ix:continuation> </span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_172"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzE0NjY1_b25637e5-dbe4-4d9b-8f3d-c0187f9c7668" continuedAt="i3ed84759fd6a49f893900a32e1ede177" escape="true">Redeemable Convertible Preferred Stock and Common Stock</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3ed84759fd6a49f893900a32e1ede177"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;28, 2018 and May&#160;7,&#160;2018, the Board of Directors approved an amendment to our Certificate of Incorporation resulting in a total of <ix:nonFraction unitRef="shares" contextRef="ica4a9c0275b4439ab3a5bc61a47582f7_I20180228" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzIwNw_d46f8b64-db05-473a-abee-8fc9331f6d79">775,000,000</ix:nonFraction> shares of common stock and a total of <ix:nonFraction unitRef="shares" contextRef="ic8e4c8c0f7b04ed7b492b9f6c973bbd6_I20180507" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzI0OA_dc891fdb-5065-4ebb-9b0e-0c5a0cd915be">509,352,795</ix:nonFraction> shares of redeemable convertible preferred stock being authorized, respectively. Upon completion of our IPO, our authorized capital stock consists of <ix:nonFraction unitRef="shares" contextRef="if52ab1a643294862862c0ab9475e5fb5_I20181211" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzQwMQ_f18b40e9-5dcc-455f-8fca-90d6c6a4c37d">1,600,000,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="if52ab1a643294862862c0ab9475e5fb5_I20181211" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzQzOA_fb6e0e00-fecd-4511-b1c4-62a514cab3f7">0.0001</ix:nonFraction> per share, and <ix:nonFraction unitRef="shares" contextRef="if52ab1a643294862862c0ab9475e5fb5_I20181211" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzQ1Ng_e19feffd-0e9a-4bc3-85fe-df9b6e0ec738">162,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="if52ab1a643294862862c0ab9475e5fb5_I20181211" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzQ5Ng_54cd8d63-f4cb-443f-9755-0f1bad59ebd5">0.0001</ix:nonFraction> per share, all of which shares of preferred stock are undesignated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2018, we completed our IPO, whereby we sold <ix:nonFraction unitRef="shares" contextRef="ied8820941801441bbf695baf84bd4408_D20181211-20181211" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzYyNw_10340c6d-edbb-4bb6-acf4-87c993cbbc37">26,275,993</ix:nonFraction> shares of common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib0015b9f558545eb8bbce9a072884272_I20181211" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzY2Nw_1dd38974-9341-45cf-81b6-37a0b56f6ab2">23.00</ix:nonFraction> per share. The aggregate net proceeds received by us from the IPO were $<ix:nonFraction unitRef="usd" contextRef="ied8820941801441bbf695baf84bd4408_D20181211-20181211" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzkzNDU4NDg4OTM3Mjk_b7b35f50-0bb1-47c0-96f4-2ec81843825c">563.0</ix:nonFraction>&#160;million, net of underwriting discounts and commissions of $<ix:nonFraction unitRef="usd" contextRef="ied8820941801441bbf695baf84bd4408_D20181211-20181211" decimals="-5" format="ixt:numdotdecimal" name="mrna:PaymentsOfUnderwritingDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzc5NA_7cdfc18a-5752-42c2-b5c7-11634f8391cc">33.2</ix:nonFraction> million and offering expenses of $<ix:nonFraction unitRef="usd" contextRef="ied8820941801441bbf695baf84bd4408_D20181211-20181211" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzgyMg_3e2adb67-4c67-41f6-b76e-9b63b64c123b">8.1</ix:nonFraction> million payable by us. Upon the closing of the IPO, all of the outstanding shares of our redeemable convertible preferred stock were converted into <ix:nonFraction unitRef="shares" contextRef="i817a91b1df304d8db9ad7e21b92c6d5e_I20181211" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzk2NQ_b06c82bb-1903-4636-896c-72aaf5739eab">236,012,913</ix:nonFraction> shares of the common stock. As of December&#160;31, 2020 and 2019, we did <ix:nonFraction unitRef="shares" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwMzc_39e16fe9-d910-4766-a95e-49a5434d3548"><ix:nonFraction unitRef="shares" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwMzc_543d21b7-23f0-4321-98e9-5b2188265b47"><ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwMzc_58849a64-2a35-46b1-a01f-c8e068bd79e6"><ix:nonFraction unitRef="shares" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwMzc_68ccfc08-8869-46f3-ba0f-ff8ffe29c5f0"><ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwMzc_79cd806d-b62b-4eb7-bd20-04007c39b4b5">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t have any convertible preferred stock issued or outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, we sold <ix:nonFraction unitRef="shares" contextRef="i11303c4705d14f9e9722ef0609332f64_D20200214-20200214" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzA0_d39d651c-0798-4772-87ff-92eff3e19496">26,315,790</ix:nonFraction> shares of common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8d8ab51d966d48869f4a4a2010e84ff8_I20200214" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzE2_d1cdd5ad-0aa5-442e-a266-c6c577d8ba27">19.00</ix:nonFraction> per share through a public equity offering. The aggregate net proceeds from the offering were $<ix:nonFraction unitRef="usd" contextRef="i11303c4705d14f9e9722ef0609332f64_D20200214-20200214" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzI0_67d1002b-5773-4508-ac59-bb01450afd15">477.7</ix:nonFraction>&#160;million, net of underwriting discounts, commissions and offering expenses. In addition, the underwriters exercised their options to purchase an additional <ix:nonFraction unitRef="shares" contextRef="if4562f74238f400d8605ac78ea70d681_D20200214-20200214" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzQw_ce3c203a-933b-4061-9c48-c228de10aba4">3,947,368</ix:nonFraction> shares of common stock at the public offering price less underwriting discounts, resulting in additional net proceeds of $<ix:nonFraction unitRef="usd" contextRef="if4562f74238f400d8605ac78ea70d681_D20200214-20200214" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzUx_1cdfcaca-04d8-4485-bbf6-d350f4785644">71.8</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2020, we sold <ix:nonFraction unitRef="shares" contextRef="iafc11244cc12496099eda35772ccd636_D20200521-20200521" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzY2_9a38f24a-0ec7-4df7-b4fb-998755886a0d">17,600,000</ix:nonFraction> shares of common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i55700871828341ecbb850efa2faf67d5_I20200521" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzc4_f3d69477-2292-438d-a25c-a18f7fbcd63e">76.00</ix:nonFraction> per share through a public equity offering. The aggregate net proceeds from the offering were $<ix:nonFraction unitRef="usd" contextRef="iafc11244cc12496099eda35772ccd636_D20200521-20200521" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzg2_012891b8-e103-4443-90cf-67c2ed3bafa5">1.30</ix:nonFraction>&#160;billion, net of underwriting discounts, commissions and offering expenses.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_178"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5OTQ_5f997cdb-ce5b-40d1-8136-ddb409f4f359" continuedAt="i38a13f5a4e2e4bf9bd6ae62d078784d8" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i38a13f5a4e2e4bf9bd6ae62d078784d8" continuedAt="i025c881008d447b892643ba6758dd79d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2013, we adopted the 2013 Equity Incentive Plan (the 2013 Incentive Plan) and the 2013 Unit Option and Grant Plan (the 2013 Option Plan), which provided for the grant of incentive units, non-qualified unit options, and restricted and unrestricted unit awards to our employees, officers, directors, advisors, and outside consultants. Historically, we also granted restricted stock to founders, officers, directors, and advisors outside any of the Plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August&#160;2016, we adopted the 2016 Stock Option and Grant Plan (the 2016 Equity Plan), which replaced the 2013 Option Plan and the 2013 Incentive Plan. The 2016 Equity Plan and provided for the grant of incentive stock options, non-qualified stock options, restricted stock, unrestricted stock, and restricted stock units to our employees, officers, directors, consultants, and other key persons.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the IPO, we adopted the 2018 Stock Option and Incentive Plan (the 2018 Equity Plan) in November 2018. The 2018 Equity Plan became effective on the date immediately prior to the effective date of the IPO and replaced our 2016 Plan. The 2018 Equity Plan provides flexibility to our compensation committee to use various equity-based incentive awards as compensation tools to motivate our workforce. We have initially reserved <ix:nonFraction unitRef="shares" contextRef="i6c6d0348fa0f471c99e4a3d4fb593b39_I20181130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzEzNTI_3645c2e9-7c8c-4ab5-a901-4823fe21d5de">13,000,000</ix:nonFraction> shares of our common stock for the issuance of awards under the 2018 Equity Plan. The 2018 Equity Plan provides that the number of shares reserved and available for issuance under the plan will </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">230</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="i025c881008d447b892643ba6758dd79d" continuedAt="i18aaad9311694a059a80fe4fcd249710"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">automatically increase each January 1, beginning on January 1, 2019, by <ix:nonFraction unitRef="number" contextRef="i262a8b76871743d192c168dbbc78eca7_D20181130-20181130" decimals="INF" name="mrna:ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzE2MjE_fafc54c3-b6bb-434e-90bb-5090e3e84e74">4</ix:nonFraction>% of the outstanding number of shares of our common stock on the immediately preceding December 31, or such lesser number of shares as determined by the Compensation and Talent Committee of our Board of Directors. The shares of common stock underlying any awards that are forfeited, canceled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting, satisfied without any issuance of stock, expire or are otherwise terminated (other than by exercise) under the 2018 Equity Plan and the 2016 Plan will be added back to the shares of common stock available for issuance under the 2018 Equity Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms and conditions of stock-based awards are defined at the sole discretion of our Board of Directors. We issue service-based awards, vesting over a defined period of service, and performance-based awards, vesting upon achievement of defined conditions. Service based awards generally vest over a <ix:nonNumeric contextRef="icac42209a69c4d4faecce8d9ec2c954c_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ5NDc4MDIzMzI2MTc_4f08f68e-6ee3-4931-93b9-cb819b8b17f1">four-year</ix:nonNumeric> period, with the first <ix:nonFraction unitRef="number" contextRef="i94e125ac24d548f7bcacf7258fb26f5e_D20200101-20201231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzI1OTQ_37279288-9da3-4b05-938f-81cfcfe48f15">25</ix:nonFraction>% of such awards vesting following <ix:nonNumeric contextRef="i94e125ac24d548f7bcacf7258fb26f5e_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzI2MzA_e969417b-9893-4739-8538-b1cabad6870b">twelve months</ix:nonNumeric> of continued employment or service. The remaining awards vests in <ix:nonFraction unitRef="installment" contextRef="i456564aebcd9408998fe415ad2b5746b_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzI2OTk_8607e46c-ef48-45a4-9b4c-f934aaf5a964">twelve</ix:nonFraction> quarterly installments over the following twelve quarters. Stock options granted under the 2016 Equity Plan expire <ix:nonNumeric contextRef="i94765e821a9d4db08f74e0976fc741a0_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzI4MTc_1d5db3ae-3068-42d7-8af5-a4f503e50fc5">ten years</ix:nonNumeric> from the date of grant and the exercise price must be at least equal to the fair market value of common stock on the grant date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;December 31, 2020, we had a total of&#160;<ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzI5Nzc_1f330a0c-cd19-4d7b-a44b-6bba6e39a1bb">64.2</ix:nonFraction> million shares reserved for future issuance under our Equity Plans, of which <ix:nonFraction unitRef="shares" contextRef="ifce35912e3be4df98cae3575af43d851_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzMwNDk_3001fdd6-2f3d-4b4e-be92-125fc7a0fe17">36.3</ix:nonFraction> million shares were reserved for equity awards previously granted, and&#160;<ix:nonFraction unitRef="shares" contextRef="i28ea496c05f042ce8f74e96e04f6dc1c_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzMxMTU_0544e75f-2dfd-43d3-a8d3-bac78c476db9">27.9</ix:nonFraction> million shares were available for future grants under the 2018 Equity Plan. No additional awards will be granted under the 2016 Equity Plan as it was replaced by the 2018 Equity Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted options generally through the 2018 Equity Plan and 2016 Equity Plan. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5OTE_f2e0cb49-9a63-4bda-9a13-b0fa31c78343" continuedAt="id4ccc8bf8b1c4f28b8d31fe6edfb540c" escape="true">The following table summarizes our option activity as of December 31, 2020 and 2019:</ix:nonNumeric></span></div><ix:continuation id="id4ccc8bf8b1c4f28b8d31fe6edfb540c"><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price per</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Share</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value per</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Share</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Term</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in&#160;thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzEtMi0xLTEtMA_4d9df535-e9a7-4fec-b7ee-10a10cbcd356">45,536,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzEtNC0xLTEtMA_8d4e3468-9d9a-4fe0-9f3a-39f471222e16">13.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="2" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzEtNi0xLTEtMA_7040a493-5ad3-4bc5-9212-099d18fac90d">7.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzEtOC0xLTEtMA_4262b27f-4338-414e-8e80-a4fa368a7fff">7.2</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzEtMTAtMS0xLTA_fb6f762b-19a9-4ddf-b907-b49ac4fb6931">286,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzItMi0xLTEtMA_b39b38ae-c8a4-4aed-a9ea-144b60b50f0d">5,036,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzItNC0xLTEtMA_d2cab064-1b22-4531-8873-9923ff4055e7">36.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzItNi0xLTEtMA_a0b485e2-c752-4509-b889-7c71e5774155">19.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzMtMi0xLTEtMA_6a87a1f9-38db-40b4-906b-5dc6992e3351">13,888,434</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzMtNC0xLTEtMA_43d054e9-0ced-4da1-8452-02eb00d6ca8e">12.93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="2" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzMtNi0xLTEtMA_1ac04223-3351-4475-a3c2-6b70bb6cb835">6.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/forfeited</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzQtMi0xLTEtMA_83d2e070-8e6b-41f9-bd99-9000b7f2558e">2,627,468</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzQtNC0xLTEtMA_50210f68-7c9a-446a-8a58-cceee92dbb68">18.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="2" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzQtNi0xLTEtMA_cd8de44d-ad67-4496-8e52-46f01fbc0137">10.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzUtMi0xLTEtMA_4200bf7a-a3cc-42a9-9e39-d59ea78aa55c">34,057,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzUtNC0xLTEtMA_617d4dfb-b5a1-40eb-82d0-7120211a5da7">17.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="2" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzUtNi0xLTEtMA_e5090bc3-5703-4bfd-a53c-7f7194ac137a">9.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzUtOC0xLTEtMA_37824f9c-1541-4ea1-8f8b-0d7edd88032d">6.7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzUtMTAtMS0xLTA_4adb5f90-6b3d-4c67-9d66-aba120d43e3e">2,976,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzYtMi0xLTEtMA_7693b4d7-70b7-40ef-b8ba-97eea2165d26">17,461,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzYtNC0xLTEtMA_2651c160-d6ac-4fb8-a2f7-33cd81af2890">10.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="2" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzYtNi0xLTEtMA_59f64481-59bd-4cc4-b10d-48c7690e1c54">5.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzYtOC0xLTEtMA_4d4ce69a-c4af-463e-b14d-e1fc61c33c4d">5.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzYtMTAtMS0xLTA_2eee50a7-5ea7-43f9-b7d0-694ed2d10aa0">1,632,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzctMi0xLTEtMA_accd1682-0c68-43f2-ac9f-4b0893dfb159">16,596,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzctNC0xLTEtMA_e05b6976-c1a0-44fd-86cd-3db89fa87b28">23.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="2" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzctNi0xLTEtMA_97f4248b-ce11-4b08-b2a6-d48efc9052f1">12.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzctOC0xLTEtMA_1a50c3ae-5926-47e5-b823-c9f8557bad39">8.2</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzctMTAtMS0xLTA_2dd42034-7dfb-4d26-b51f-95e4980de5fc">1,343,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of common stock for those options in the money as of December 31, 2020.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options exercised was $<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzM3MjQ_82f8d90e-698a-4748-be01-211cc89d3fa7">785.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzM3Mjg_8a1ec3b6-3810-4f6f-8822-6866728f3e50">75.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzM3NDU_adc75559-84e3-4423-9fc7-e07bbc24d9f1">5.3</ix:nonFraction> million for the&#160;years ended December 31, 2020, 2019 and 2018, respectively. The aggregate intrinsic value represents the difference between the exercise price and the selling price received by option holders upon the exercise of stock options during the period. The total consideration recorded as a result of stock option exercises&#160;was approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzM4ODY_9d9f1e7d-927a-4929-a0da-ab5d06289b83">179.6</ix:nonFraction> million&#160;for&#160;the year ended December 31, 2020.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">231</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><ix:continuation id="i18aaad9311694a059a80fe4fcd249710" continuedAt="iaa6b7a2f41c6458fb338bffb5dc9fbf4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Common Stock Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted restricted stock unit awards generally through the 2018 Equity Plan. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5OTc_c145ce1b-e779-4c75-b8f8-17f9bf954902" continuedAt="i4c197627eb55448595adb6ebb628fa83" escape="true">The following table summarizes our restricted stock unit activity during the year ended December 31, 2020:</ix:nonNumeric></span></div><div><ix:continuation id="i4c197627eb55448595adb6ebb628fa83"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:72.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.834%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">per Unit</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, non-vested at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a2b16bb22614c61b08450535a865c3a_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzEtMS0xLTEtMA_eb4c83e8-25c6-478e-b33b-e34fea468836">1,177,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3a2b16bb22614c61b08450535a865c3a_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzEtMy0xLTEtMA_241c7933-5b69-438d-83c2-afe295030d1e">19.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzItMS0xLTEtMA_443cd623-ac71-4742-9c0d-04aec89db9d3">1,478,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzItMy0xLTEtMA_ca70a4d1-36f4-49d5-a9f2-e7972d49e6ac">37.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzMtMS0xLTEtMA_d0408c5d-6db0-4dd2-89e3-677a2c4fe535">247,349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzMtMy0xLTEtMA_6e64ec67-711d-404a-8514-3d1d510b5ae0">20.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzQtMS0xLTEtMA_63a37881-6e54-40c4-8eb5-7e051d54b7e8">215,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzQtMy0xLTEtMA_19a2a7a4-86aa-46ea-a08a-985d0876f945">23.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, non-vested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibf4921fe189a4bb3adbffaca20a7ba53_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzYtMS0xLTEtMA_2a2dbc3a-2bd6-4297-90b5-19aa4a9f61d3">2,192,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibf4921fe189a4bb3adbffaca20a7ba53_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzYtMy0xLTEtMA_8b22bf25-2a13-4681-8e33-20e3023397cf">30.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of restricted stock units vested during the years ended December 31, 2020, 2019 and 2018, were $<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestrictedStockExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzMyOTg1MzQ4OTQyNDg_664a14c8-d403-4784-a03c-f1771a37e6b3">5.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestrictedStockExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzMyOTg1MzQ4OTQyNjc_98393c04-b1d8-435e-850c-4575ad70fe6d">5.5</ix:nonFraction> million, and <ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:RestrictedStockExpense" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzEwNDQ1MzYwNDc0ODU3_82957cff-b3e2-4bcd-b4af-06c79a1aa438">zero</ix:nonFraction>, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Employee Stock Purchase Plan</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we adopted the 2018 Employee Stock Purchase Plan (the ESPP), which became effective on December 5, 2018. The ESPP initially reserves and authorizes the issuance of up to a total of <ix:nonFraction unitRef="shares" contextRef="i4793fdc04065442a8c634bb5b8ed5276_I20181205" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ2NzI_bb24c45c-be15-4911-847d-b8f6639b5e6f">810,000</ix:nonFraction>&#160;shares of common stock to participating employees. We will make <ix:nonFraction unitRef="offering" contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205" decimals="INF" format="ixt-sec:numwordsen" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ5NDc4MDIzMzY3MDU_292039ae-2662-44ae-83bf-9404a5fa621f">one</ix:nonFraction> or more offerings, consisting of <ix:nonFraction unitRef="purchase_period" contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205" decimals="INF" format="ixt-sec:numwordsen" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ5NDc4MDIzMzY3MTM_8a98578d-43d9-454e-a5a2-42fb88d06f12">one</ix:nonFraction> or more purchase periods, each year to our employees to purchase shares under the ESPP. Offerings will usually begin every <ix:nonNumeric contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205" format="ixt-sec:durwordsen" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ5MDM_3831730e-16bd-48a4-a6da-c19c08fa7935">six months</ix:nonNumeric> and will continue for <ix:nonNumeric contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205" format="ixt-sec:durwordsen" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ5NDc4MDIzMzI2MTg_5ac0e71d-3979-4227-a289-abf2ac6658a4">six-month</ix:nonNumeric> periods, referred to as offering periods. The purchase price at which shares are sold under the ESPP will be equal to <ix:nonFraction unitRef="number" contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzUwNTU_ec0438cb-4c7a-4027-b83a-6445e3c7085d">85</ix:nonFraction>% of the lower of the fair market value of the shares on the first business day of the offering period or the last business day of the purchase period. Employees are generally eligible to participate through payroll deductions of between <ix:nonFraction unitRef="number" contextRef="i4793fdc04065442a8c634bb5b8ed5276_I20181205" decimals="INF" name="mrna:ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzUyOTQ_0393b4d7-7ada-428d-826d-ce6adbbc1b31">1</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i4793fdc04065442a8c634bb5b8ed5276_I20181205" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzUzMDA_76e60c88-d8d7-4aa2-b0b3-badf3a0c64be">50</ix:nonFraction>% of their compensation and may not purchase more than <ix:nonFraction unitRef="shares" contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzUzNTY_39a91177-97dc-4fcf-9ca0-4ddf412ccb0c">3,000</ix:nonFraction> shares of common stock during each purchase period or&#160;$<ix:nonFraction unitRef="usd" contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205" decimals="-3" format="ixt:numdotdecimal" name="mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzU0MTM_1539cffc-9a00-461c-900d-1fb196fcf5be">25,000</ix:nonFraction>&#160;worth of shares of common stock in any calendar year.&#160;We began our first ESPP offering on June 1, 2019. There were <ix:nonFraction unitRef="shares" contextRef="ieceb0f5d61c741e2ae79714848077fc6_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzU1MzE_d7e82b6e-b5b9-487d-97d0-cdaa22274b7a">251,752</ix:nonFraction> shares of common stock sold at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic81d102f7ca14bd6bb17285971aa99df_I20201231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzU1ODU_fba830c5-b623-4371-9294-6b89d380b404">27.97</ix:nonFraction> per share under the ESPP during the year ended December&#160;31, 2020. As of&#160;December&#160;31, 2020,&#160;<ix:nonFraction unitRef="shares" contextRef="i0f14ad75477c466dafbb2d98521f49c5_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzM4NDgyOTA3MDUwNTY_d6c9b5cd-43d1-4246-bd60-5c8a0aab48e5">3.6</ix:nonFraction>&#160;million&#160;shares were available for future issuance under the ESPP.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">232</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><ix:continuation id="iaa6b7a2f41c6458fb338bffb5dc9fbf4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation and Stock-Based Compensation Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation for options granted under our Equity Plans and share purchases under our ESPP is determined using the Black-Scholes option pricing model. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5OTM_4da55583-eb47-4f06-a693-63d6b261aacc" continuedAt="i9283946d635a4b138afe437d49bd6cbc" escape="true">The weighted-average assumptions used to estimate the fair value of options granted and ESPP for the&#160;years ended December 31, 2020, 2019 and 2018 are as follows:</ix:nonNumeric></span></div><ix:continuation id="i9283946d635a4b138afe437d49bd6cbc" continuedAt="iaafc9cfcc51646589767b12b0ef0e23f"><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.986%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years&#160;Ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Risk-free interest rate</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzQtMi0xLTEtMA_57e4bfb2-6e29-4268-97df-10e1177b8a61">0.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzQtNC0xLTEtMA_978b528a-79fd-4702-91f8-394d7486f651">2.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab7b67e811134bd584fb576d6e749803_D20180101-20181231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzQtNi0xLTEtMA_e1d0b392-757d-42dd-a90b-4af9a63a4f3a">2.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Expected term</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzUtMi0xLTEtMA_88b2f55e-6e72-44b3-acc8-ab90b5454f3b">6.11</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzUtNC0xLTEtMA_b4dda0ea-40c3-4b5d-b51d-ca5fdbb3d1d2">6.07</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iab7b67e811134bd584fb576d6e749803_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzUtNi0xLTEtMA_622af53c-e729-4ef2-a8f3-d57d5a18f724">6.27</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Expected volatility</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzYtMi0xLTEtMA_1dab62bf-a4a3-4ea4-861f-b83567498b53">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzYtNC0xLTEtMA_e58cb766-5411-44f7-be79-608162d3101b">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab7b67e811134bd584fb576d6e749803_D20180101-20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzYtNi0xLTEtMA_4af8c2ab-2f14-462b-b14d-47d227e61bcb">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Expected dividends</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzctMi0xLTEtMA_75ed099a-6446-4a95-ad91-0177601b45e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzctNC0xLTEtMA_c4d3d8c4-4ad7-4857-a7c4-6db7ba70b054">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iab7b67e811134bd584fb576d6e749803_D20180101-20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzctNi0xLTEtMA_d03c1aed-9ec2-4a29-ac9e-f60a0ca310dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Weighted average fair value per share</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic8ea87e5e7834335be8ba996294292fd_I20201231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzgtMi0xLTEtMA_a05b6e7f-dbc0-456f-ae76-fc2421c06c6c">19.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5bc50b13e4114cdeb9dfbcfc004a74de_I20191231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzgtNC0xLTEtMA_4a30a1ae-0c04-4a29-9d93-fb085536f835">11.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iade5b4d11372466e90c1c179f3b5ac9f_I20181231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzgtNi0xLTEtMA_69574702-0110-4e76-b5db-fae395f084a9">9.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzExLTItMS0xLTA_6e9966a1-2609-4cbc-b46e-5ecfb1a593d3">0.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzExLTQtMS0xLTA_d05f608a-012d-4cf7-97de-7fa74acfd793">1.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzEyLTItMS0xLTA_599a0f06-fa72-412c-b51d-0b63fd9bdd36">0.50</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzEyLTQtMS0xLTA_c35553d0-7b11-4d84-bf4a-a8bda65bb0a5">0.50</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzEzLTItMS0xLTA_e9472737-aaa2-440f-a3e6-bf9edf1dff02">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzEzLTQtMS0xLTA_36989425-ae05-4640-864f-3c55d3dc5627">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzE0LTItMS0xLTA_0b73c9dc-69da-4210-8dc2-4bef60cd7c04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzE0LTQtMS0xLTA_86c5e530-82b5-4462-a88e-ee4d6d0f7edc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value per share</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i38f16929f2a54250afa6263ffee43aa1_I20201231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzE1LTItMS0xLTA_fc3afd12-0ed8-44d9-afac-5bd314109551">32.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7cadb2afe3df43fe8cacb9af45694889_I20191231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzE1LTQtMS0xLTA_ca0ae332-30cf-48f8-937d-12526479b4ca">5.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaafc9cfcc51646589767b12b0ef0e23f">* - Not applicable</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5OTk_efdfd0ce-63d4-462d-a4d3-320496341a89" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components and classification of stock-based compensation expense for the&#160;years ended December 31, 2020, 2019 and 2018 as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years&#160;Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzItMS0xLTEtMA_d7f7e397-38fb-4a98-9a25-590c70c231ce">77,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzItMy0xLTEtMA_aff02389-75ad-45cc-8852-a4a2130f658b">74,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab7b67e811134bd584fb576d6e749803_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzItNS0xLTEtMA_4aed66c3-f735-4239-8398-79d72ed6c6fa">63,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted common stock and units</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa289361628e459292558aa0cf78cd6b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzMtMS0xLTEtMA_cb371020-3730-4c69-b592-cb36be6f19f8">12,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id16aba6da7f64bd394030c96c373b2de_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzMtMy0xLTEtMA_5813aa1d-f1fb-4098-89a8-5d8374b2577b">5,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea322dace75d448fad9eea135238af31_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzMtNS0xLTEtMA_715a10dc-0638-4f60-9ca9-f0ae435d4107">9,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzQtMS0xLTEtMA_1c7fb9fb-b01a-4447-b2b4-3d5451b9e111">2,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzQtMy0xLTEtMA_2a3c69d4-3ed7-46e3-8b3c-f6cc401419d0">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d492fe3077f4edc95bfea38191dbe14_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzQtNS0xLTEtMA_9f93b91d-46ee-478b-abfd-147357a54889">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzUtMS0xLTEtMA_1049b6f5-0375-42a2-99fd-4bba4f9fe50e">93,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzUtMy0xLTEtMA_fd8c7f2f-2915-4d86-aba1-1dd3976138c3">81,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzUtNS0xLTEtMA_3000e862-e684-4042-a2cf-38b1c85a6cdb">72,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b7796d6fc41467489873be3464c5281_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzYtMS0xLTEtMA_1585ed21-c09e-4edc-bb4e-62d07500fd90">56,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b394cfd73114e379da638593c59398d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzYtMy0xLTEtMA_4c5de71e-300a-4276-921d-8728f4c7b472">48,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i205ef00a043d47539d12683bf81d27bf_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzYtNS0xLTEtMA_cb66bf99-3473-4534-990e-ec097ba220f1">37,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d40e479571a447ab799a9e823712900_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzctMS0xLTEtMA_69d109b7-9763-4db9-a58f-63fed9c52659">36,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f343e6d4c4743d787e7ead6fa87139f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzctMy0xLTEtMA_3441d4dc-fb5d-4b47-a9e1-97f96173e26d">32,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a3afd2d01d4284ab41f3b52d9d7bc3_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzctNS0xLTEtMA_0f47ff7b-b37f-4d65-a9db-5daf5b2d9583">34,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzgtMS0xLTEtMA_3d5837d7-237e-4e10-8871-f6db8733688e">93,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzgtMy0xLTEtMA_d6ca70cb-2ebd-45aa-8f2c-fc92cc1c52c0">81,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzgtNS0xLTEtMA_25cbda97-5de0-485f-bccd-8a2901667761">72,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, we recognized stock-based compensation expense of $<ix:nonFraction unitRef="usd" contextRef="ie37236e25e6d4e2c8a87336c27d49324_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQzOTgwNDY1MjIwODQ_2d77c3fd-c852-42c4-a92b-1da42c410868">9.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i249101ed25324c3c8d67aab92ad128da_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY0MTQ_e578048e-1ca1-4215-9e9d-87e96c5a812c">9.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8bb1304918df480cb950ea6c29a15615_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY0MjE_4cc0f66d-dbea-40f6-936a-2e93a4ed03ba">10.6</ix:nonFraction> million, respectively, related to performance-based awards, including awards with vesting or commencement contingent upon the IPO, for which achievement of such performance-based condition was deemed probable. Stock-based compensation expenses related to non-employee awards were immaterial for the years ended December 31, 2020, 2019 and 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there were $<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY3NjM_ab201763-3770-4193-bcae-7b87ca71587d">226.8</ix:nonFraction> million of total unrecognized compensation cost related to non-vested stock-based compensation with respect to options and restricted stock granted. That cost is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5ODA_12dba3b6-c253-4f9b-88ea-90da58a3b1f6">2.9</ix:nonNumeric> years at December 31, 2020.</span></div></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">233</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_184"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzU1NQ_bd1e6b22-bcbd-42cc-bfdc-e442f9e2a509" continuedAt="id9d7413882e941809c8f73f9f5acc8d6" escape="true">Employee Benefit Plan</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id9d7413882e941809c8f73f9f5acc8d6">We provide a retirement savings option to our eligible U.S. employees through the Moderna, Inc. 401(k)&#160;Plan (the 401(k) Plan), subject to certain limitations. As allowed under Section&#160;401(k) of the Internal Revenue Code, the 401(k) Plan allows tax deferred salary deductions for eligible employees. We match <ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzMzOQ_8dddf746-40e5-4156-8468-59640ce272e5">50</ix:nonFraction>% up to the first <ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzM1OA_2ffcff76-0ce7-4e34-b0e1-8bb9ccfd4f30">6</ix:nonFraction>% contributed by a participant. All matching contributions are immediately vested. Total matching contributions to the 401(k) Plan were $<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzQ5NQ_dd4394c6-fd45-464f-bc60-3dbbe25bff86">5.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzQ5OQ_6a14d943-8fdc-4692-9dda-7f536ac231c6">4.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzUwMw_d91d64c3-b355-42ac-8ca8-31cc93f4a6e9">2.1</ix:nonFraction> million for the&#160;years ended December 31, 2020, 2019 and 2018, respectively.</ix:continuation></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_187"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0MjY_7b5332f2-8a6a-469a-852a-4248be27871b" continuedAt="ic277d10f20684168ade875b3ebe1f2f4" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic277d10f20684168ade875b3ebe1f2f4" continuedAt="i8e14b5dd77be47a3a5e6fe25e5fff969"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0MTk_15e3de63-d7a5-4d8a-94be-ea1c26ebea39" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before provision for (benefit from) income taxes for the years ended December 31, 2020, 2019 and 2018 consist of the following (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:67.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzItMS0xLTEtMA_c275d93c-e24e-4229-91a5-822e64296d9a">745,445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzItMy0xLTEtMA_b0412b53-5850-4075-a08d-11ae76d25327">508,595</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzItNS0xLTEtMA_5c36947d-b229-47e3-b9b1-c215881ffc8b">380,473</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzMtMS0xLTEtMA_aef5648e-5420-4524-9b69-cc05e58180a2">932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzMtMy0xLTEtMA_7fbf65da-a41a-462f-89fb-10041f3f6c64">6,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzMtNS0xLTEtMA_edc41d70-686f-4de9-a051-b66c1b24c19a">3,935</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzQtMS0xLTEtMA_26450336-6f92-4a66-981a-fd4f1dfda8bf">744,513</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzQtMy0xLTEtMA_22d302ab-a438-43d3-83f1-cf2ef2702fc0">514,716</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzQtNS0xLTEtMA_67ee3c07-fc1a-4de1-94c6-f8a2ee62f22b">384,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:3pt"><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0Mjc_227c8753-84a1-4b25-af88-f1665cb27c42" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for (benefit from) income taxes for the years ended December 31, 2020, 2019 and 2018 consist of the following components (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:67.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzMtMS0xLTEtMA_752912b2-c815-4560-a2b4-05f61e8e7592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzMtMy0xLTEtMA_9c370d77-e05d-4207-8365-0198c93fff62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzMtNS0xLTEtMA_65e83596-5e97-4953-8a40-fa648ccec72f">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzQtMS0xLTEtMA_5157b2b2-c961-4d94-a946-8556a48362ae">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzQtMy0xLTEtMA_9f60fd9b-a958-48ca-8927-eea935a8a427">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzQtNS0xLTEtMA_5cfe8b32-5682-4d0c-9755-1c17c91c3245">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtMS0xLTEtMTQwNjg_e2c0c329-b6e7-48e6-83c3-7d38a7362e76">2,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtMy0xLTEtMTQwNjg_85b3a6f4-4f0a-45ac-a967-e79fad109919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtNS0xLTEtMTQwNjg_f34e017e-2cab-4932-b782-67da6421e8f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtMS0xLTEtMA_fa979e2f-d195-451d-81cf-01dfe3d67081">2,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtMy0xLTEtMA_025f0c7c-1eed-4ddd-9063-4fe9d5c0595a">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtNS0xLTEtMA_320c08ed-ad26-4b3a-9c7f-fa21f014eba0">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzctMS0xLTEtMA_45da105c-cc12-44c1-83aa-e87a526ab247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzctMy0xLTEtMA_4ab02904-7828-4f0c-8af5-031ae418b0de">1,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzctNS0xLTEtMA_320ea633-da91-48e9-93a2-26c06d5cff80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzgtMS0xLTEtMA_21295c57-3dab-4141-ab73-7884c2204199">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzgtMy0xLTEtMA_9aa991b9-3de3-4bc6-8977-d8fbdc3c26f2">1,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzgtNS0xLTEtMA_983d126b-259e-4ea9-8dc9-b560aba6501d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzktMS0xLTEtMA_1fd59bdb-c090-454a-ad3c-4358a9ca8382">2,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzktMy0xLTEtMA_3421e31c-e97b-4f5a-a9d6-baf8ad459161">695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzktNS0xLTEtMA_da6dac03-e855-488b-a1c5-1475dacb5caf">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0MjI_159698d4-2ac3-4867-be13-7bcc93aec27f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the U.S. statutory income tax rate to our effective tax rate for the years ended December 31, 2020, 2019 and 2018 are as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:67.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.067%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effected at statutory rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzItMS0xLTEtMA_dc169738-5d60-4711-81bf-61b4cd906b93">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzItMy0xLTEtMA_b2cf62a7-8877-4355-a77c-c9c40d630799">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzItNS0xLTEtMA_9e578dd7-4f94-41f0-8502-fc586c8b3a6d">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes, net of federal benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzMtMS0xLTEtMA_bbe64f5b-0ecf-41d2-a80c-6de5b0f8d68b">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzMtMy0xLTEtMA_fb170e71-2dd3-4f18-b569-c1e2ad695b75">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzMtNS0xLTEtMA_97eba8b1-7b1c-496c-89e7-be4c22af3224">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzQtMS0xLTEtMA_51ca0238-88a3-4894-8196-c6372ab4d40a">0.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzQtMy0xLTEtMA_38028cdb-b121-4d9e-a2ec-c5a129d16f4a">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzQtNS0xLTEtMA_183617fd-ea65-43c0-a4ee-2387f134555f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzUtMS0xLTEtMA_c2e2b279-820c-45f8-8269-40e179d23f54">47.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzUtMy0xLTEtMA_f00aa521-58fe-4674-8db8-3826c5940d97">33.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzUtNS0xLTEtMA_364535e0-b02a-454f-be7d-bd12c03f4ba4">28.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research and development credits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzYtMS0xLTEtMA_647d0d55-6e2a-444a-baba-4af915d5f57c">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzYtMy0xLTEtMA_dbe93efc-3393-4e04-8fc3-b7905bb7f111">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzYtNS0xLTEtMA_c764f62c-6445-4fd9-8f41-ffa39b2224d1">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzctMS0xLTEtMA_c37ec45f-4481-4e87-922f-1a3647003dcf">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzctMy0xLTEtMA_14fefeea-6e3e-4b30-a7e4-a8f36ab4c325">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzctNS0xLTEtMA_966735e5-17f6-424a-a7db-1ea7963f4130">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation windfall</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktMS0xLTEtMTM1MTA_24c931d0-85c7-4cfe-9618-cea53191ac65">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktMy0xLTEtMTM1MTA_0a317843-5ecb-43f0-b350-4ff4f27a0ce2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="3" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktNS0xLTEtMTM1MTA_c1a980c0-977d-4507-b00f-5c47d51ac641">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktMS0xLTEtMA_daac7b6e-97b3-4ec2-b44d-077cd4e12810">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktMy0xLTEtMA_a1677257-b4a3-48d9-8db0-32a923880eb9">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktNS0xLTEtMA_2843e908-d524-4153-84f8-3f3f5497bc82">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzEwLTEtMS0xLTA_3857946d-3423-40b9-b5a1-0d647863c3a3">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzEwLTMtMS0xLTA_867d6198-8340-4db5-b783-5497f091558b">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzEwLTUtMS0xLTA_ac2e7957-77b8-4703-868a-6a41c5dafb72">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">234</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-top:3pt"><span><br/></span></div><ix:continuation id="i8e14b5dd77be47a3a5e6fe25e5fff969" continuedAt="i30dd5ddedee746a6aa64140006723088"><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0MTc_7151a503-28d4-4477-b511-173f2febb5d7" escape="true"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of our deferred tax assets and tax liabilities as of December 31, 2020 and 2019 are as follows (in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:77.898%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carry-forwards</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzMtMS0xLTEtMA_554bccaf-dd74-4d65-8d7d-d25a482708b8">587,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzMtMy0xLTEtMA_6bbf198d-651a-4f4f-89ac-e16f75a4785b">268,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzQtMS0xLTEtMA_b0ed7622-c72b-4a71-ae50-e9f6695d0ee7">33,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzQtMy0xLTEtMA_74dc740a-f073-47c5-8526-bd6e9b832c61">43,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized licenses, research and development and start-up costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzUtMS0xLTEtMA_bffb0a8d-a9d1-4d54-9c4c-0787a2a06b8a">13,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzUtMy0xLTEtMA_2e0f4c6c-5a91-44c0-89a0-07c9c58690e0">19,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carry-forwards</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzYtMS0xLTEtMA_9b45c06d-06ad-46ed-991c-5697af107b39">99,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzYtMy0xLTEtMA_c17d53cd-380d-4466-b2be-2b5850f34728">77,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzctMS0xLTEtMA_e4fdfd68-2b97-4273-9e6a-31e5b50079fe">26,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzctMy0xLTEtMA_3a189483-2706-4bc3-83ed-ba07d0e896d3">7,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzgtMS0xLTEtMA_d08033ba-65ef-4f86-8a66-0ecdff7f83f9">29,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzgtMy0xLTEtMA_e496fa18-c1f3-4e88-9408-b3780a27d7eb">53,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxAssetsOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzktMS0xLTEtMA_2600c713-9796-4dbb-b9e5-a54e458b8d32">22,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxAssetsOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzktMy0xLTEtMA_dc746f0b-e26c-4c7a-b0c9-8ad4cb011830">26,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease financing obligation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxAssetsFinancingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEwLTEtMS0xLTA_7aff939e-520e-4847-9fed-6ad6a842fd98">23,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxAssetsFinancingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEwLTMtMS0xLTA_f36ea7f3-f1db-44ff-8aa0-db9326022648">10,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzExLTEtMS0xLTE1NjA2_7e72c1c9-58ff-48d7-8c39-2bf451fd9fa3">38,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="mrna:DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzExLTMtMS0xLTE1NjA4_d7a6b811-dee2-48d9-b413-159b4a93ba71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzExLTEtMS0xLTA_15658ca2-34eb-4832-84df-2b34c593045c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzExLTMtMS0xLTA_fd6a1789-594a-4bdd-8985-1933435b0806">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEyLTEtMS0xLTA_bd7daa03-0721-4d23-8a78-e83f22a3b238">874,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEyLTMtMS0xLTA_8898dfcd-a74e-4d3a-89a2-1c510024b08a">507,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEzLTEtMS0xLTA_ecb2b8fb-c2d4-427d-8f63-8cd218898777">823,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEzLTMtMS0xLTA_c6a0e8ee-5e13-48d4-ab2d-a284d6b3bb00">470,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets, net of valuation allowance</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE0LTEtMS0xLTA_f5363523-1caf-4d5f-ae6e-ac2b9d2493e2">50,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE0LTMtMS0xLTA_c8a64348-b749-4e7d-ae1b-c0ef0676c884">36,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing right-of-use assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE2LTEtMS0xLTA_1ab31903-e862-4db4-81a1-8f2ec483a35e">11,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE2LTMtMS0xLTA_6cde1fe7-5292-4ea4-bed5-9086bf797f9b">2,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE3LTEtMS0xLTA_b9609ed7-80c7-4f45-85cc-d43461f63326">20,349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="mrna:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE3LTMtMS0xLTA_7a422a10-b65c-4cc0-9fa0-51359240a142">24,944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE4LTEtMS0xLTA_3b62d28c-c7d7-44c9-93db-9c31e9423536">18,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE4LTMtMS0xLTA_9f4c1468-e477-4c3a-8c09-c348c9118094">8,959</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzIwLTEtMS0xLTE1ODg5_34af7659-4cdb-4527-87f5-c4db364296b1">513</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzIwLTMtMS0xLTE1ODg5_384f0f45-eed2-4ded-903c-5b2e015e835e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE5LTEtMS0xLTA_359cb9a0-fe81-4a68-be5f-1f5ed490f262">50,677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE5LTMtMS0xLTA_7b1bddb3-430b-48a3-a7ff-fbadd6a04b47">36,515</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzIwLTEtMS0xLTA_256bff4f-8df3-461c-9aac-ca1f9e69baf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzIwLTMtMS0xLTA_33338235-8b68-4b65-ac94-04414c321d53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated the positive and negative evidence bearing upon the realization of our deferred tax assets, including our history of significant losses in every year since our inception and in accordance with the applicable accounting standards, have fully reserved the net deferred tax asset. We concluded that realization of our net deferred tax assets is not more-likely-than-not to be realized as of December 31, 2020. The valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzkzNg_e8750d34-a0c3-4da3-a083-231681d63a67">352.7</ix:nonFraction> million in the year ended December 31, 2020, primarily due to the increase in net operating loss carry-forwards, research and development tax credits and capitalized inventory.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a periodic basis, we reassess the valuation allowance on our deferred income tax assets, weighing positive and negative evidence to assess the recoverability of the deferred tax assets. In 2020, we reassessed the valuation allowance and considered negative evidence, including our cumulative losses over the three years ended December 31, 2020, and positive evidence, including our recent EUA for our COVID-19 vaccine. After assessing both the negative and positive evidence, we concluded that we should maintain the valuation allowance on our net operating losses and our other deferred tax assets as of December 31, 2020. The release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, our level of profitability, revenue growth, clinical program progression and expectations regarding future profitability. Our total deferred tax asset balance subject to the valuation allowance was approximately $<ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzM4NDgyOTA3MTMwODg_3b5f1ab9-2d6c-4137-ac24-024a7b696022">874.1</ix:nonFraction>&#160;million at December 31, 2020. We will continue to monitor the need for a full or partial valuation allowance each quarter in 2021 and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, we had approximately $<ix:nonFraction unitRef="usd" contextRef="ic351569ed65f40cab21d97c586306914_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzExMjU_983d0c7c-6f40-4ff0-afd4-4e882e305c23">2.26</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i85f3c831978247f8b69404de24b90b66_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzExMzI_ce8313e7-db06-464a-ac84-ee3891ca1c48">1.70</ix:nonFraction> billion of federal and state net operating loss carry-forwards, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="ic351569ed65f40cab21d97c586306914_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:OperatingLossCarryforwardsSubjectToExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzEyMTQ_20bf27d8-c4e7-4d63-a9df-b1a85d8d138e">380.1</ix:nonFraction> million of federal and $<ix:nonFraction unitRef="usd" contextRef="i85f3c831978247f8b69404de24b90b66_I20201231" decimals="-5" format="ixt:numdotdecimal" name="mrna:OperatingLossCarryforwardsSubjectToExpiration" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzEyMzI_16c6826d-eb18-42ce-9e32-c1c380e657ae">1.70</ix:nonFraction> billion of state loss carry-forwards begin to expire in 2030. Additionally, $<ix:nonFraction unitRef="usd" contextRef="ic351569ed65f40cab21d97c586306914_I20201231" decimals="-7" format="ixt:numdotdecimal" name="mrna:OperatingLossCarryforwardsNotSubjectToExpiration" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzEzMDM_faeef821-033f-4165-b83d-1aac95465a89">1.88</ix:nonFraction> billion of federal net operating loss carry-forward will carry forward indefinitely. At December 31, 2020 we also had federal and state research and development credit carry-forwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i5c241daa0d5241ee9eed136d8c0fd4be_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzE0ODM_b123d205-2ef9-4a02-9ab5-ba9befaab518">73.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifdad93679ee44415aefdf2bf5e771d19_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzE0OTA_33978e9b-7958-4273-a242-527eac5f9cae">26.1</ix:nonFraction> million, which begin to expire in 2030 and 2032, respectively. At December 31, 2020, we also had federal orphan drug and state investment tax credit carry-forwards of approximately $<ix:nonFraction unitRef="usd" contextRef="icee62dcd4e004b8681b4d520ee487a52_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzE2NDc_1c62b069-36df-4a99-b20f-4b97d6489628">2.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1f5c4be154334b0e874859f16c0dfa3c_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzE2NTQ_0ed19675-9cbd-4187-8dd4-09a4f160b731">3.9</ix:nonFraction> million which begin to expire in 2039 and 2021, respectively.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">235</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><ix:continuation id="i30dd5ddedee746a6aa64140006723088"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Coronavirus Aid, Relief and Economic Security Act (the CARES Act) was signed into law. The CARES Act includes provisions relating to several aspects of corporate income taxes. We do not currently expect the CARES Act to have a significant impact on our provision for income taxes; however, we will continue to monitor the provisions of the CARES Act in relation to its operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the net operating loss (NOL) and tax credit carry-forwards may be subject to a substantial annual limitation due to ownership change limitations that have occurred previously, or that could occur in the future, as provided by Section&#160;382 of the Internal Revenue Code of 1986, as amended, or Section&#160;382, as well as similar state provisions and other provisions of the Internal Revenue Code. Ownership changes may limit the amount of NOLs and tax credit carry-forwards that can be utilized annually to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section&#160;382, results from transactions that increase the ownership of 5% shareholders in the stock of a corporation by more than 50% in the aggregate over a three-year period. We may experience ownership changes in the future as a result of subsequent shifts in our stock ownership, some of which may be outside our control.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file U.S. federal income tax returns and income tax returns in various state, local and foreign jurisdictions. All tax years since the date of our incorporation remain open to examination by the major taxing jurisdictions (state and federal) to which we are subject, as carry-forward attributes generated in years past may still be adjusted upon examination by the Internal Revenue Service (IRS) or other authorities if they have or will be used in a future period. We are not currently under examination by the IRS, or any other jurisdictions, for any tax year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize, in our financial statements, the effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0MjQ_fa926e71-a738-4d51-b168-2eaccd4de78c" continuedAt="i17d0a4751f754f81ae233b88e564be86" escape="true">A reconciliation of the beginning and ending amounts of unrecognized tax benefits during the years ended December 31, 2020 and 2019 are as follows (in&#160;thousands):</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="i17d0a4751f754f81ae233b88e564be86"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20204b229a394d9ba8b28882826012db_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzAtMS0xLTEtMA_7d51f82b-4083-4ad6-b1bd-aaf7f33710e4">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to prior positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzEtMS0xLTEtMA_430cb06f-2457-4553-aa86-61aeb499367d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year tax position</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzItMS0xLTEtMA_37c68bf7-828b-440b-b955-6944b0d579b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzMtMS0xLTEtMA_0b4210c7-4f73-4b2f-ba87-5827f95c5841">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to prior positions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzQtMS0xLTEtMA_a6d23e58-fb61-4dbd-8aed-4c45db1767bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzUtMS0xLTEtMA_f8ecae22-dd5f-4028-aec5-a2cc530bcee5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzYtMS0xLTEtMA_4f515982-e497-4bfa-99b2-97930abcea95">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized tax benefits may change during the next twelve months for items that arise in the ordinary course of business. We do not anticipate a material change to our unrecognized tax benefits over the next twelve months that would have an adverse effect on our consolidated operating results. We recognize interest and penalties, if applicable, related to uncertain tax positions as a component of income tax expense.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">236</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_190"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90ZXh0cmVnaW9uOmMxNWVjZThlMTNmYzQ5NWM4NWQ3YzcxNWY2MGU3ODFkXzU1NQ_88ab30f8-75d4-4d46-8a4e-d7d0c38744f2" continuedAt="iee3cbae4c6434303aaffcee667a297f2" escape="true">Net Loss per Share </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iee3cbae4c6434303aaffcee667a297f2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss per Share Attributable to Common Stockholders</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90ZXh0cmVnaW9uOmMxNWVjZThlMTNmYzQ5NWM4NWQ3YzcxNWY2MGU3ODFkXzU1MQ_75ee2403-5cb7-4e54-b084-725f7ad9d924" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2020, 2019 and 2018 are calculated as follows (in thousands, except share and per share data):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:61.208%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzMtMS0xLTEtMA_16a439e5-93b0-4ae9-a3f8-50cddbadd462">747,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzMtMy0xLTEtMA_bcd652f1-546c-4437-86e4-2b8f6f5889e3">514,021</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzMtNS0xLTEtMA_48a8343d-4b19-4d8c-abf7-6b99c0ca71c7">384,734</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium paid on repurchase of redeemable convertible preferred stock</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockRedemptionPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzQtMS0xLTEtMA_268cbb91-4d41-4190-9845-05b696b37afa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockRedemptionPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzQtMy0xLTEtMA_b4958660-761a-4194-a71c-cdfc8c073b73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockRedemptionPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzQtNS0xLTEtMjU2Mg_b044366c-7518-490a-9e99-5c4e38b2dae2">4,127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative dividends on redeemable convertible preferred stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RedeemablePreferredStockDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzUtMS0xLTEtMA_9975d903-eebe-45d9-bd59-a1b937bd42a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RedeemablePreferredStockDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzUtMy0xLTEtMA_5ff6764f-867b-4280-869f-7edbacc65b5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RedeemablePreferredStockDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzUtNS0xLTEtMA_cce22af2-a8fa-42fe-9d81-d7864eeafc95">12,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzYtMS0xLTEtMA_552694ba-d4de-465e-be32-fbf581f1371c">747,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzYtMy0xLTEtMA_be1481b4-47ec-4cfe-bb21-565da08c2ea6">514,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzYtNS0xLTEtMA_620c02af-7db0-4522-b999-7c9080e53121">401,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzgtMS0xLTEtMA_e51a3f45-d537-47a9-aa9f-1a9def243fb5">381,333,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzgtMy0xLTEtMA_aa56836b-068f-44f6-b17a-7aaffad264fc">330,802,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzgtNS0xLTEtMA_8bb4757d-ab32-4555-8422-c11b635151b9">81,114,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzktMS0xLTEtMA_0143f436-e1ab-458c-9c2c-fa1268771a6a">1.96</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzktMy0xLTEtMA_a4ded046-703a-4025-acf0-0a7dd358b7f7">1.55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzktNS0xLTEtMA_d6b68405-9e87-4c91-b75c-fad44edb7725">4.95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90ZXh0cmVnaW9uOmMxNWVjZThlMTNmYzQ5NWM4NWQ3YzcxNWY2MGU3ODFkXzU1Mw_59abd2ba-e247-4080-843b-6c55d763cb96" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents, presented based on amounts outstanding as of December 31, 2020, 2019 and 2018 were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because their inclusion would have been anti-dilutive:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i51dd4a3f885044ac854c50b598512881_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzMtMS0xLTEtMA_d9be035e-3813-41e7-b507-971a97b301f3">34,057,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i824d33d947634253bc2e12c49e671633_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzMtMy0xLTEtMA_3324bcb3-f856-43ac-a4b7-1fc775546b90">45,536,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e245ef509484130ac56ee0f5b6a622b_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzMtNS0xLTEtMA_8b1cbb8d-9de2-4a8d-b18f-459b99a8491a">50,821,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i240d1607bdb54d38918d10a2e1bc9173_D20200101-20201231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzQtMS0xLTEtMA_71427258-bbc8-4317-b392-41069ce1a82e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i707c59ec394d4425b93e15c1605fa977_D20190101-20191231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzQtMy0xLTEtMA_331fab28-d3a1-410d-af83-648d175c2cbf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i224ecb912e2c48888f26b7e1cc4953dd_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzQtNS0xLTEtMA_d40347e3-6b7c-46f0-abc9-8afd1b392d4f">198,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted common stock units</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic87bc10f44de4145997be66dfd27f93c_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzUtMS0xLTEtMA_2f340b36-4ca3-498a-9bf4-8b239a6aff43">2,192,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie596a0c92b8647369ac2d14e1396ef36_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzUtMy0xLTEtMA_c89d2575-271c-4095-a000-91815219db6b">1,177,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f5a8fda25cd4c74af63d87a7168e3ab_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzUtNS0xLTEtMA_768d0828-8198-4b03-90b7-c3bb2402575f">458,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzYtMS0xLTEtMA_42985c07-0937-42bb-b66d-260baa1c376e">36,250,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzYtMy0xLTEtMA_9399ba72-7bf0-48c9-bf65-e7a80ff61f05">46,714,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzYtNS0xLTEtMA_4015f71d-8ab1-4179-a309-684af65b4775">51,478,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_2452"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. <ix:continuation id="i0dfbed98c2844c31b9da2519e6c5fa00" continuedAt="i5468811597a44005969199b90bc949a4">Geographic Information </ix:continuation></span></div><div><span><br/></span></div><ix:continuation id="i5468811597a44005969199b90bc949a4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in <ix:nonFraction unitRef="segment" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGV4dHJlZ2lvbjpkZGI5ZTY4OWI1MzY0YjI4YjRjYWNiYTExOGU0MzYyMl80OTQ3ODAyMzMwOTEx_7c35690c-a066-40a5-b36d-f32b6582de9b">one</ix:nonFraction> reporting segment that primarily focuses on the discovery, development and commercialization of mRNA medicines. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.</span></div><div><span><br/></span></div><ix:continuation id="ia50069fcef434de39554cc5a548f9de9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue by geographic area of our customers and collaboration partners was as follows (in thousands): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69d8b71e26964171af7d0c08826cb641_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8xLTItMS0xLTY5OTM_c754d1e4-ca8f-48c6-b161-0803e0812bf2">764,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c2ab469153406c91a205c6ac53f02f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8xLTQtMS0xLTY5OTU_9fef4c75-5159-4469-ae31-2d8ce78558f6">54,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14039f4ce16942f3a4976f3e56714742_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8xLTYtMS0xLTY5OTc_96f51e12-b2fb-47c9-b291-1d254890c2c1">89,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7733c373247646ffbbaca5983877f101_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8yLTItMS0xLTY5OTk_85d858fb-e132-49eb-8480-e815c2bbf0d5">38,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id776b0bb1d8b431e96ac4e765df020ad_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8yLTQtMS0xLTcwMDE_90c5f7dc-56b5-4eef-b412-e39a0f7b7587">5,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibba4dc7e26f542198f1a60b6226271d0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8yLTYtMS0xLTcwMDM_7eac52f9-2599-4cdc-a5d1-f56806fee3e7">45,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8zLTItMS0xLTcwMDU_8f91aba1-740f-4d6e-8fde-5d2e5ba31e70">803,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8zLTQtMS0xLTcwMDc_6973aea5-5bf9-4184-99e1-eb98be0dae6a">60,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8zLTYtMS0xLTcwMDk_223ed062-10c1-4e07-bb26-0c869a262297">135,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our property and equipment, including financing right-of-use asset, were principally located within the United States as of December 31, 2020 and 2019.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_202"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMDIvZnJhZzo2YTYwMjhlZTA2ZDM0OThiOWQ1MzI4MGRmNmU2ZDk3OS90ZXh0cmVnaW9uOjZhNjAyOGVlMDZkMzQ5OGI5ZDUzMjgwZGY2ZTZkOTc5XzUwNQ_88c36aec-be85-452e-97bd-f3bcf01ae1d1" continuedAt="i9ce49f2713474eeeb97258a28d3b8d28" escape="true">Subsequent Events </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9ce49f2713474eeeb97258a28d3b8d28"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December 31, 2020, we have entered into several supply agreements with customers to provide our COVID-19 vaccine, up to <ix:nonFraction unitRef="dose" contextRef="i9ccdf2dca2df4aa3a9aece1c6399177d_D20210101-20210226" decimals="-5" format="ixt:numdotdecimal" name="mrna:NumberOfDosesOfVaccineCandidate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMDIvZnJhZzo2YTYwMjhlZTA2ZDM0OThiOWQ1MzI4MGRmNmU2ZDk3OS90ZXh0cmVnaW9uOjZhNjAyOGVlMDZkMzQ5OGI5ZDUzMjgwZGY2ZTZkOTc5XzQ5NDc4MDIzMzAxMjA_e6173906-9c09-4b68-baf2-6d9b8cfec9a0">125.1</ix:nonFraction>&#160;million doses, and have received upfront deposits of $<ix:nonFraction unitRef="usd" contextRef="ia03ce25e1fdb4153b6baf85bdb6588ef_I20210226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SignificantSupplyCommitmentRemainingMinimumAmountCommitted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMDIvZnJhZzo2YTYwMjhlZTA2ZDM0OThiOWQ1MzI4MGRmNmU2ZDk3OS90ZXh0cmVnaW9uOjZhNjAyOGVlMDZkMzQ5OGI5ZDUzMjgwZGY2ZTZkOTc5XzQ5NDc4MDIzMzAxMDQ_ff7f8306-485e-48d6-a330-49f4f9789b0e">125.4</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, b</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ased on the initial confirmed volume, subject to modifications. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 18, 2021, the European Commission advised us that we had successfully tendered for the provision of <ix:nonFraction unitRef="numberofdose" contextRef="i9483d986200a4cdfb7e88b336fd9711b_D20210218-20210218" decimals="INF" format="ixt:numdotdecimal" name="mrna:NumberOfVaccineDoses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMDIvZnJhZzo2YTYwMjhlZTA2ZDM0OThiOWQ1MzI4MGRmNmU2ZDk3OS90ZXh0cmVnaW9uOjZhNjAyOGVlMDZkMzQ5OGI5ZDUzMjgwZGY2ZTZkOTc5XzQ5NDc4MDIzMzIzNTY_4325f3bf-bd51-4994-8353-5b94e52e0d9a">150</ix:nonFraction>&#160;million doses of our COVID-19 vaccine in 2021. This tender is subject to execution of the Purchase Agreement, which is expected shortly following an opt out period for individual Member States that expired on February 25, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December 31, 2020, we have entered into additional binding purchase commitments with third-party contractual manufacturing organizations for our COVID-19 vaccine under existing agreements. We are currently committed to minimum non-cancelable purchase obligations of $<ix:nonFraction unitRef="usd" contextRef="ia03ce25e1fdb4153b6baf85bdb6588ef_I20210226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMDIvZnJhZzo2YTYwMjhlZTA2ZDM0OThiOWQ1MzI4MGRmNmU2ZDk3OS90ZXh0cmVnaW9uOjZhNjAyOGVlMDZkMzQ5OGI5ZDUzMjgwZGY2ZTZkOTc5XzQ5NDc4MDIzMzAxMzU_ae9ac578-375e-4d2d-bd84-de8decf344af">314.8</ix:nonFraction>&#160;million related to these agreements, which are expected to be paid through 2021.</span></div></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">238</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_205"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_208"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A. Controls and Procedures </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of&#160;December 31, 2020. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of&#160;December 31, 2020, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as such term is defined in Exchange Act Rule 13a-15(f) to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Management assessed our internal control over financial reporting as of&#160;December&#160;31, 2020. Management based its assessment on criteria established in&#160;Internal Control - Integrated Framework&#160;issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework).&#160;Based on that evaluation, our management concluded that our internal control over financial reporting was effective as of&#160;December&#160;31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of our internal control over financial reporting as of&#160;December&#160;31, 2020&#160;has been audited by Ernst &amp; Young LLP, an independent registered public accounting firm, as stated in their report included in this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Controls over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2020, we implemented certain internal controls in connection with our inventory capitalization, product sales and derivative financial instruments. There were no other changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended December 31, 2020, which have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inherent Limitations on the Effectiveness of Controls</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Executive Officer and Chief Financial Officer, believe that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by the collusion of two or more people or by a management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">239</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of Moderna, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Moderna, Inc.&#8217;s internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Moderna, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on the COSO criteria.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2020 and December 31, 2019, the related consolidated statements of operations, comprehensive loss, redeemable convertible preferred stock and stockholders&#8217; equity, and cash flows for each of the three years in the period ended December 31, 2020, and the related notes and our report dated February 26, 2021 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 26, 2021</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_211"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">240</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B. Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in a Current Report on Form 8-K filed with the SEC on March 30, 2020 (the &#8220;March 30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 8-K&#8221;), on March 29, 2020, the Company&#8217;s Chief Medical Officer, Tal Zaks, and the Company entered into an Executive Retention Agreement (the &#8220;Zaks Retention Agreement&#8221;), setting forth the terms of Dr. Zaks&#8217; continued service as the Company&#8217;s Chief Medical Officer through at least September 30, 2021 (the &#8220;Retention Date&#8221;). Details of the Zaks Retention Agreement are included on the March 30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 8-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2021, the Company entered into an Amended and Restated Executive Retention Agreement (the &#8220;Amended Zaks Retention Agreement&#8221;), which modified the original Zaks Retention Agreement. Under the Amended Zaks Retention Agreement, in addition to the benefits already conferred under the original agreement, if a successor Chief Medical Officer is appointed by the Company prior to September 30, 2021, Dr. Zaks will continue to serve as a Special Advisor to our CEO through that date, and as additional consideration, a pro rata share of Dr. Zaks&#8217; 2020 restricted stock unit equity grant, equivalent to 11,449 shares, which otherwise would not have vested until February 2022 will vest as of the Retention Date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above summary is not complete and is qualified in its entirety by the Amended Zaks Retention Agreement, a copy of which is attached hereto as Exhibit 10.17 and is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">241</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_214"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_217"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated herein by reference to the information that will be contained in our proxy statement related to the 2021 Annual Meeting of Stockholders, which we intend to file with the Securities and Exchange Commission within 120 days of the end of our fiscal year pursuant to General Instruction G(3) of Form 10-K.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_220"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. Executive Compensation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated herein by reference to the information that will be contained in our proxy statement related to the 2021 Annual Meeting of Stockholders, which we intend to file with the Securities and Exchange Commission within 120 days of the end of our fiscal year pursuant to General Instruction G(3) of Form 10-K.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_223"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated herein by reference to the information that will be contained in our proxy statement related to the 2021 Annual Meeting of Stockholders, which we intend to file with the Securities and Exchange Commission within 120 days of the end of our fiscal year pursuant to General Instruction G(3) of Form 10-K.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_226"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. Certain Relationships and Related Transactions, and Director Independence</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated herein by reference to the information that will be contained in our proxy statement related to the 2021 Annual Meeting of Stockholders, which we intend to file with the Securities and Exchange Commission within 120 days of the end of our fiscal year pursuant to General Instruction G(3) of Form 10-K.</span></div><div><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_229"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14. Principal Accounting Fees and Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated herein by reference to the information that will be contained in our proxy statement related to the 2021 Annual Meeting of Stockholders, which we intend to file with the Securities and Exchange Commission within 120 days of the end of our fiscal year pursuant to General Instruction G(3) of Form 10-K.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_232"></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">242</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_235"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15. Exhibits, Financial Statement Schedules</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Index</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518349938/d677222dex31.htm">Amended and Restated Certificate of Incorporation of the Registrant. (3)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518349938/d677222dex32.htm">Amended and Restated&#160;By-laws of the Registrant. (3)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex41.htm">Specimen Common Stock Certificate. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex42.htm">Second Amended and Restated Investors&#8217; Rights Agreement by and among the Registrant and certain of its stockholders, dated May&#160;7, 2018. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit4312312020.htm">Description of Capital Stock</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex101.htm">2016 Stock Option and Grant Plan, as amended, and forms of award agreements thereunder. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex102.htm">2018 Stock Option and Incentive Plan and forms of award agreements thereunder. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex103.htm">Form of Indemnification Agreement between the Registrant and each of its directors. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex104.htm">Master Collaboration and License Agreement, by and between Moderna Therapeutics, Inc. and Merck Sharp &amp; Dohme Corp., dated as of January&#160;12, 2015, as amended by Amendment No.&#160;1 dated as of January 8, 2016, Amendment No.&#160;2 dated as of June&#160;28, 2016, Amendment No.&#160;3 dated as of June&#160;28, 2016 and Amendment No.&#160; 4 dated as of June&#160;28, 2016. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex105.htm">Amended and Restated mRNA Cancer Vaccine Collaboration and License Agreement, by and between ModernaTX, Inc. and Merck Sharp &amp; Dohme Corp., dated as of April&#160;17, 2018. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex106.htm">Amended and Restated Option Agreement by and between ModernaTX, Inc. and AstraZeneca AB, dated as of June&#160;15, 2018. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex107.htm">Amended and Restated Services and Collaboration Agreement by and between ModernaTX, Inc. and AstraZeneca AB, dated as of June&#160;15, 2018. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex108.htm">Patent Sublicense Agreement, by and among ModernaTX, Inc. and Cellscript, LLC and mRNA RiboTherapeutics, Inc. (solely with respect to certain provisions), dated as of June&#160;26, 2017. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Lease Agreement, by and between Moderna Therapeutics, Inc. and ARE-Tech Square, LLC, dated as of May 26, 2016, as amended by Amendment No. 1 dated as of August 31, 2016, Amendment No. 2 dated as of December 31, 2016,<br/>Amendment No. 3 dated as of April 24, 2017, Amendment No. 4 dated as of April 13, 2018. (1)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000168285219000036/a101fifthamendmentto200tec.htm">Fifth Amendment to Lease Agreement, by and between ModernaTX, Inc. and ARE-Tech Square, LLC, dated as of August 28, 2019. (4)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex1010.htm">Net Lease by and between Moderna Therapeutics, Inc. and Campanelli-TriGate Norwood Upland, LLC, dated as of August&#160;29, 2016, as amended by Amendment No.&#160;1 dated as of April&#160;10, 2017 and Amendment No.&#160;2 dated as of March&#160;16, 2018. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex1011.htm">Amended and Restated Executive Severance Plan and Form of Participation Letter, as amended on November&#160;4, 2018. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex1015.htm">Letter Agreement by and between the Company and St&#233;phane Bancel, dated as of June&#160; 13, 2018, as amended by Amendment No. 1 dated as of November&#160;4, 2018. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex1016.htm">Letter Agreement by and between the Company and Stephen Hoge, dated as of October&#160;17, 2017. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Retention and Separation Agreement by and between the Company and Lorence Kim, dated as of May 5, 2020. (7)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offer Letter by and between the Company and David W. Meline, dated as of June 3, 2020. (8)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17#*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1017moderna.htm">Amended and Restated Executive Retention Agreement by and between the Company and Tal Zaks, dated as of February 23, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex1017.htm">Senior Executive Cash Incentive Bonus Plan. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000168285219000023/exhibit101amendedandrestat.htm">Non-Employee Director Compensation Policy. (5)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex1019.htm">Form of Indemnification Agreement between the Registrant and each of its officers. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473dex1020.htm">2018 Employee Stock Purchase Plan. (1)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518335714/d611137dex1021.htm">Form of Non-Plan Restricted Stock Award Agreement. (2)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1682852/000119312518335714/d611137dex1022.htm">Form of Non-Plan Non-Qualified Stock Option Agreement. (2)</a></span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1682852/000168285220000023/exhibit101.htm">Agreement No. HHSO100201600029C, by and between the Company and the Biomedical Advanced Research and Development Authority, dated as of April 16, 2020, as amended on May 24, 2020, June 16, 2020, July 25, 2020, August 31, 2020 and September 15, 2020. (6)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global Long Term Agreement, by and among ModernaTX Inc., Lonza Sales Ltd., and Lonza Ltd., dated September 4, 2020. (6)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Award Contract No. W911QY20C0100, by and between Moderna US Inc. and the Army Contracting Command of the U.S. Department of Defense, dated August 9, 2020, as amended September 8, 2020, and September 11, 2020. (6)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1027supplycontrac.htm">Amendment No. P00003 to Award Contract No. W911QY20C0100, by and between Moderna US Inc. and the Army Contracting Command of the U.S. Department of Defense, dated December 11, 2020.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit21subsidiaries1.htm">Subsidiaries of the Registrant.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2312020consentforincorpra.htm">Consent of Ernst&#160;&amp; Young LLP, Independent Registered Public Accounting Firm.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31112312020.htm">Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31212312020.htm">Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32112312020.htm">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32212312020.htm">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Labels Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Link Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">244</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:2.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential treatment has been granted by the Securities and Exchange Commission as to certain portions.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">#</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates a management contract or any compensatory plan, contract or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+<br/><br/><br/><br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The certifications furnished in Exhibit 32.1 and 32.2 hereto are deemed to accompany this Annual Report on Form 10-K and will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the Registrant specifically incorporates it by reference.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to the Registration Statement on Form S-1 (File No. 333-228300) filed with the Securities and Exchange Commission on November 9, 2018.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to the Registration Statement on Form S-1 (File No. 333-228300) filed with the Securities and Exchange Commission on November 28, 2018.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to the Current Report on Form 8-K (File No. 001-38753) filed with the Securities and Exchange Commission on December 14, 2018.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to the Quarterly Report on Form 10-Q (File No. 001-38753) filed with the Securities and Exchange Commission on November 6, 2019. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Incorporated by reference to the Current Report on Form 8-K (File No. 001-38753) filed with the Securities and Exchange Commission on May 7, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Incorporated by reference to the Quarterly Report on Form 10-Q (File No. 001-38753) filed with the Securities and Exchange Commission on August 6, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incorporated by reference to the Quarterly Report on Form 10-Q (File No. 001-38753) filed with the Securities and Exchange Commission on May 9, 2019.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Incorporated by reference to the Quarterly Report on Form 10-Q (File No. 001-38753) filed with the Securities and Exchange Commission on October 30, 2020. </span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">245</span></div></div></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_238"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. Form 10-K Summary</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">246</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="margin-bottom:9pt"><span><br/></span></div><div id="iac7f3ce8465b4330a30f0fc9f4279c20_241"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MODERNA, INC.</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ St&#233;phane Bancel</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St&#233;phane Bancel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">247</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY AND SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each individual whose signature appears below hereby constitutes and appoints each of St&#233;phane Bancel and David Meline and as such person&#8217;s true and lawful&#160;attorney-in-fact&#160;and agent with full power of substitution and resubstitution, for such person in such person&#8217;s name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission granting unto each said&#160;attorney-in-fact&#160;and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that any said&#160;attorney-in-fact&#160;and agent, or any substitute or substitutes of any of them, may lawfully do or cause to be done by virtue hereof.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.666%"><tr><td style="width:1.0%"></td><td style="width:36.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.331%"></td><td style="width:0.1%"></td></tr><tr style="height:39pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ St&#233;phane Bancel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:26pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St&#233;phane Bancel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David Meline</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:35pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David Meline</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Noubar B. Afeyan, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman and Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noubar B. Afeyan, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stephen Berenson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen Berenson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sandra Horning, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandra Horning M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Robert Langer, Sc.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert Langer, Sc.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Francois Nader, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Francois Nader M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Paul Sagan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paul Sagan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Elizabeth Tallett</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elizabeth Tallett</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">248</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>exhibit4312312020.htm
<DESCRIPTION>EX-4.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7c6ae151961749c3912d8e258e6e8c5e_1"></div><div style="min-height:43pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">EXHIBIT 4.3</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">DESCRIPTION OF CAPITAL STOCK</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following description of the capital stock of Moderna, Inc. (&#8220;us,&#8221; &#8220;our,&#8221; &#8220;we&#8221; or the &#8220;Company&#8221;) is a summary of the rights of our common stock and certain provisions of our amended and restated certificate of incorporation and our amended and restated bylaws currently in effect. This summary does not purport to be complete and is qualified in its entirety by the provisions of our amended and restated certificate of incorporation, as amended, and amended and restated bylaws, each previously filed with the Securities and Exchange Commission and incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit 4.3 is a part, as well as to the applicable provisions of the Delaware General Corporation Law (the &#8220;DGCL&#8221;). We encourage you to read our certificate of incorporation, bylaws and the applicable portions of the DGCL carefully.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Authorized Capital Stock</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our authorized capital stock consists of 1,600,000,000 shares of common stock, par value $0.0001 per share, and 162,000,000 shares of preferred stock, par value $0.0001 per share, all of which shares of preferred stock are undesignated.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Common Stock</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of the stockholders. The holders of our common stock do not have any cumulative voting rights. Holders of our common stock are entitled to receive ratably any dividends declared by our board of directors out of funds legally available for that purpose, subject to any preferential dividend rights of any outstanding preferred stock. Our common stock has no preemptive rights, conversion rights or other subscription rights or redemption or sinking fund provisions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in all assets remaining after payment of all debts and other liabilities and any liquidation preference of any outstanding preferred stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Preferred Stock</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our board of directors has the authority, without further action by our stockholders, to issue up to 162,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of common stock. The issuance of our preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our Company or other corporate action. No shares of preferred stock are outstanding, and we have no present plan to issue any shares of preferred stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Anti-Takeover Effects of Our Certificate of Incorporation and Bylaws and Delaware Law</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our certificate of incorporation and bylaws include a number of provisions that may have the effect of delaying, deferring or preventing another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other </font></div><div style="height:43pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:43pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">unilateral takeover proposals to negotiate with our board of directors rather than pursue&#160;non-negotiated&#160;takeover attempts. These provisions include the items described below.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Board composition and filling vacancies</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our certificate of incorporation provides for the division of our board of directors into three classes serving staggered three-year terms, with one class being elected each year. Our certificate of incorporation also provides that directors may be removed only for cause and then only by the affirmative vote of the holders of 66</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:1.12pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">% or more of the shares then entitled to vote at an election of directors. Furthermore, any vacancy on our board of directors, however occurring, including a vacancy resulting from an increase in the size of our board, may only be filled by the affirmative vote of a majority of our directors then in office even if less than a quorum. The classification of directors, together with the limitations on removal of directors and treatment of vacancies, has the effect of making it more difficult for stockholders to change the composition of our board of directors.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">No written consent of stockholders</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our certificate of incorporation provides that all stockholder actions are required to be taken by a vote of the stockholders at an annual or special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder actions and would prevent the amendment of our bylaws or removal of directors by our stockholders without holding a meeting of stockholders.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Meetings of stockholders</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our certificate of incorporation and bylaws provide that only a majority of the members of our board of directors then in office may call special meetings of stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders. Our bylaws limit the business that may be conducted at an annual meeting of stockholders to those matters properly brought before the meeting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Advance notice requirements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our bylaws establish advance notice procedures with regard to stockholder proposals relating to the nomination of candidates for election as directors or new business to be brought before meetings of our stockholders. These procedures provide that notice of stockholder proposals must be timely given in writing to our corporate secretary prior to the meeting at which the action is to be taken. Generally, to be timely, notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the annual meeting for the preceding year. Our bylaws specify the requirements as to form and content of all stockholders&#8217; notices. These requirements may preclude stockholders from bringing matters before the stockholders at an annual or special meeting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Amendment to certificate of incorporation and bylaws</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Any amendment of our certificate of incorporation must first be approved by a majority of our board of directors, and if required by law or our certificate of incorporation, must thereafter be approved by a majority of the outstanding shares entitled to vote on the amendment and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of the provisions relating to stockholder action, board composition, and limitation of liability must be approved by not less than&#160;two-thirds&#160;of the outstanding shares entitled to vote on the amendment, and not less than&#160;two-thirds&#160;of the outstanding shares of each class entitled to vote thereon as a class. Our bylaws may be amended by the affirmative vote of a majority of the directors then in office, subject to any limitations set forth in the bylaws&#59; and may also be amended by the affirmative vote of a majority of the outstanding shares entitled to vote on the amendment, voting together as a single class, except that the amendment of the provisions relating to notice of stockholder business and nominations and special meetings must be approved by not less than&#160;two-thirds&#160;of the outstanding shares entitled to vote on the amendment, and not less than&#160;two-thirds&#160;of the outstanding shares of each class entitled to vote thereon as a class, or, if our board of directors </font></div><div style="height:43pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:43pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">recommends that the stockholders approve the amendment, by the affirmative vote of the majority of the outstanding shares entitled to vote on the amendment, in each case voting together as a single class.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Undesignated preferred stock</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our certificate of incorporation provides for 162,000,000 authorized shares of preferred stock. The existence of authorized but unissued shares of preferred stock may enable our board of directors to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best interests of our stockholders, our board of directors could cause shares of preferred stock to be issued without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our certificate of incorporation grants our board of directors broad power to establish the rights and preferences of authorized and unissued shares of preferred stock. The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The issuance may also adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or preventing a change in control of us.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Section 203 of the Delaware General Corporation Law</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">We are subject to the provisions of Section 203 of the Delaware General Corporation Law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. Under Section 203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions&#58;</font></div><div><font><br></font></div><div style="padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">before the stockholder became interested, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder&#59;</font></div><div style="padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances, but not the outstanding voting stock owned by the interested stockholder&#59; or</font></div><div style="padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">at or after the time the stockholder became interested, the business combination was approved by our board of directors and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Section 203 defines a business combination to include&#58;</font></div><div><font><br></font></div><div style="padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">any merger or consolidation involving the corporation and the interested stockholder&#59;</font></div><div style="padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">any sale, transfer, lease, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation&#59;</font></div><div style="padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder&#59;</font></div><div style="padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">subject to exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder&#59; and</font></div><div style="padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges, or other financial benefits provided by or through the corporation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person.</font></div><div style="height:43pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:43pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Nasdaq Global Select Market Listing</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Our common stock is listed on the Nasdaq Global Select Market under the trading symbol &#8220;MRNA.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Transfer Agent and Registrar</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The transfer agent and registrar for our common stock is Computershare Trust Company, N.A.</font></div><div><font><br></font></div><div style="height:43pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>3
<FILENAME>exhibit1017moderna.htm
<DESCRIPTION>EX-10.17
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie4428959eb5d457f8c18df94679475fc_1"></div><div style="min-height:31pt;width:100%"><div><img alt="image_01a.jpg" src="image_01a.jpg" style="height:14px;margin-bottom:5pt;vertical-align:text-bottom;width:337px"></div><div><font><br></font></div></div><div style="margin-top:4pt;padding-right:5.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.17</font></div><div><font><br></font></div><div style="margin-top:7.45pt;padding-left:124.5pt;padding-right:124.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDED AND RESTATED EXECUTIVE RETENTION AGREEMENT</font></div><div><font><br></font></div><div style="margin-top:8.85pt;padding-left:5pt;padding-right:5.95pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Amended and Restated Executive Retention Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is entered into effective as of February 23, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) between Tal Zaks, M.D. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and Moderna, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,&#8221; together with Executive, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-right:6.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Executive currently serves as the Company&#8217;s Chief Medical Officer&#59; </font></div><div style="padding-right:6.15pt;text-align:right"><font><br></font></div><div style="padding-right:6.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Executive and the Company entered into an Executive Retention Agreement effective as of March 27, 2020 and now wish to amend and restate such agreement&#59; and </font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Board of Directors wishes to enter into this Agreement with the Executive to set forth the terms of the Executive&#8217;s continued services to the Company through September 30, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Retention Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt;padding-right:6.05pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOW, THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:77pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.05pt;text-decoration:underline">Retention Period&#59; Duties.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5pt;padding-right:5.95pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt;text-decoration:underline">Term and Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement shall be effective from the Effective Date through the Retention Date or the last day of Executive&#8217;s employment, if different, as set forth herein (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Retention Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). The Executive shall continue to serve as the Company&#8217;s Chief Medical Officer during the Retention Period&#59; provided, however that if the Company appoints a new Chief Medical Officer at any time during the Retention Period the Executive shall serve for the remainder of the Retention Period in the role of Special Advisor to the Company&#8217;s Chief Executive Officer (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). Nothing in this Agreement changes the &#8220;at will&#8221; nature of the Executive&#8217;s employment with the Company. If Executive&#8217;s employment is terminated without Cause prior to the Retention Date, the Company will place him on a paid Garden Leave from the date of termination through the Retention Date, during which time the Executive will be paid his full Base Salary, continue to participate in all Company group benefits and continue to vest in all equity awards through the Retention Date.&#160; The payment and benefits due to Executive during the Garden Leave period shall be in addition to, and in not in lieu of, the payments and benefits due to Executive under Sections 3(a) and (b) and Section 4 of this Agreement.</font></div><div style="padding-left:76.95pt;padding-right:5.95pt;text-align:right"><font><br></font></div><div style="padding-left:5pt;padding-right:5.95pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt;text-decoration:underline">Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Retention Period, the Executive shall continue to report to the Company&#8217;s CEO and shall have the duties and responsibilities as set out by the CEO and the Company&#8217;s Board of Directors&#59; as set forth above in Section 1.a.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:6pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt;text-decoration:underline">Work Location and Travel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive&#8217;s place of work during the Retention Period shall continue to be in Cambridge, Massachusetts, with such business travel as the CEO and the Executive shall mutually agree.</font></div><div style="padding-left:5pt;text-align:justify;text-indent:71.95pt"><font><br></font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:7%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:31pt;width:100%"><div><img alt="image_01a.jpg" src="image_01a.jpg" style="height:14px;margin-bottom:5pt;vertical-align:text-bottom;width:337px"></div><div><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:6pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt;text-decoration:underline">Public Announcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company and the Executive will agree on a communication plan regarding the CMO transition plan, which communication is expected to take place on or around February 25, 2021.</font></div><div style="margin-top:10.9pt;padding-left:77pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.05pt;text-decoration:underline">Compensation During the Retention Period.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt;text-decoration:underline">Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Retention Period, the Executive&#8217;s base salary shall continue to be $552,000 (to be adjusted to $571,000 in March pursuant to the approved executive compensation adjustments) as set by the CEO and approved by the Company&#8217;s Compensation and Talent Committee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), payable semi-monthly in accordance with the Company&#8217;s normal payroll practices, subject to tax withholding under applicable law. The Executive&#8217;s salary will continue to be subject to periodic review and adjustments at the discretion of the CEO and the Compensation Committee.</font></div><div style="margin-top:4.5pt;padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt;text-decoration:underline">Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive shall receive an annual incentive bonus under the Company&#8217;s Senior Executive Cash Incentive Bonus Plan, with   respect to fiscal year 2020, as has been already determined and approved by the Company&#8217;s Compensation Committee.  The 2020 bonus will be paid at the time that bonuses for the executive team of the Company are paid.  The Executive will not be entitled to a bonus for 2021 other than as provided in Section 3 hereof.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5pt;padding-right:5.95pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive shall be entitled to receive reimbursement for all reasonable business expenses incurred by him during the Retention Period in performing services hereunder, in accordance with the policies and procedures then in effect and established by the Company.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:5.65pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt;text-decoration:underline">Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Retention Period, the Executive shall continue to be eligible to participate in or receive benefits under the Company&#8217;s retirement, health, welfare and fringe benefit plans for employees in effect from time to time, subject to the terms and conditions of such plans.</font></div><div style="margin-top:10.9pt;padding-left:5pt;padding-right:6pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt;text-decoration:underline">Vacations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Retention Period, the Executive shall be entitled to vacation in accordance with the Company&#8217;s vacation policy, as in effect from time to time.</font></div><div style="margin-top:10.95pt;padding-left:41pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:9.05pt;text-decoration:underline">Severance and Retention Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Retention Period, the Executive will continue to participate in the Company&#8217;s Amended and Restated Executive Severance Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Severance Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and shall be entitled to any benefits and payments thereunder in the event of a Qualified Termination Event (as defined in the Severance Plan) subject to the terms and conditions of the Severance Plan, provided that any change to the Executive&#8217;s duties set forth herein shall not constitute Good Reason for purposes of the Severance Plan.  For avoidance of doubt, the parties agree that following completion of employment, the Executive will receive the benefits and payments pursuant to the Severance Plan following the execution of the Separation Agreement and Release as defined below.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt;text-decoration:underline">Retention Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Provided that the Executive remains continuously employed by the Company pursuant to the terms of this Agreement through the Retention Date, or in the event that the Executive&#8217;s employment is terminated by the Company without Cause (as defined in the Severance Plan) prior to the Retention Date, the Company shall pay the Executive a one-time cash bonus of $1,000,000 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Retention Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), subject to tax withholding under </font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:7%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:31pt;width:100%"><div><img alt="image_01a.jpg" src="image_01a.jpg" style="height:14px;margin-bottom:5pt;vertical-align:text-bottom;width:337px"></div><div><font><br></font></div></div><div style="padding-left:5pt;padding-right:5.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">applicable law, in a single lump sum within sixty (60) days of the Retention Date or earlier termination without Cause. In the event that the Retention Bonus is payable as a result of a termination of the Executive&#8217;s employment by the Company without Cause, payment of the Retention Bonus shall be subject to the Executive&#8217;s execution of the Separation Agreement and Release (as defined in the Severance Plan) and the Separation Agreement and Release becoming irrevocable, all within the time period set forth in the Separation Agreement and Release but in no  event more than sixty (60) days after the date of termination.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:77pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.05pt;text-decoration:underline">Company Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt;text-decoration:underline">Treatment of Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All outstanding equity awards held by or granted to the Executive under the Moderna Therapeutics, Inc. 2016 Stock Option and Grant Plan (as amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2016 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) or the Moderna, Inc. 2018 Stock Option and Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2018 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and together with the 2016 Plan, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) as of the Effective Date shall continue to be governed by the terms and conditions of the Plans and the applicable award agreements, other than as set forth herein.</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt;text-decoration:underline">Post-Termination Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Upon the Executive&#8217;s termination of employment on the Retention Date or earlier, upon agreement of the parties, for any reason other than for Cause, and subject to the Executive&#8217;s execution and non-revocation of the Separation Agreement and Release, any options to purchase the Company&#8217;s common stock granted to the Executive under the Plans, to the extent vested, exercisable and outstanding immediately prior to such termination, shall remain exercisable for two years following the date of such termination (but in no event later than the original expiration date applicable to such option). If the Executive resigns for any reason prior to the Retention Date, the exercise period applicable to any stock options shall be governed in accordance with their terms and shall not be extended as set forth herein.</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt;text-decoration:underline">Pro-Rata Vesting of RSU granted on February 28, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.    Notwithstanding the terms of the Restricted Stock Unit Award Agreement between the Company and the Executive dated as of February 28, 2020 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2020 RSU</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), upon the termination of employment on the Retention Date and following the execution of the Separation Agreement and Release, the 2020 RSU will accelerate as to a total of 11,449 shares, which shares will vest effective as of the Retention Date and become fully owned by the Executive and any restrictions on such 11,449 shares shall lapse as to those shares as set forth in the 2020 RSU.  If the Executive resigns for any reason prior to the Retention Date, the terms of this Section 4.c. shall not be applicable and the 2020 RSU will be governed by its original terms and no shares thereunder shall accelerate.</font></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt;text-decoration:underline">Restrictive Covenants&#59; Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Executive&#8217;s obligations set forth in the Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement by and between the Executive and the Company, dated as of February 20, 2015, shall be referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Restrictive Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and are incorporated herein by reference and shall survive the termination or expiration of this Agreement. In consideration of the benefits received under this Agreement, the Executive hereby reconfirms his obligations under the Restrictive Covenants in all respects.</font></div><div style="margin-top:10.95pt;padding-left:77pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27.05pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:7%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:31pt;width:100%"><div><img alt="image_01a.jpg" src="image_01a.jpg" style="height:14px;margin-bottom:5pt;vertical-align:text-bottom;width:337px"></div><div><font><br></font></div></div><div style="margin-top:10.95pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt">Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive&#8217;s separation from service within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Executive becomes entitled to under this Agreement on account of the Executive&#8217;s separation from service would be considered deferred compensation otherwise subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A) six months and one day after the Executive&#8217;s separation from service, or (B) the Executive&#8217;s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt">All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of in-</font></div><div style="margin-top:4.5pt;padding-left:5pt;padding-right:5.85pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses). Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5pt;padding-right:5.95pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt">To the extent that any payment or benefit described in this Agreement constitutes &#8220;non-qualified deferred compensation&#8221; under Section 409A of the Code, and to the extent that such payment or benefit is payable upon the Executive&#8217;s termination of employment, then such payments or benefits shall be payable only upon the Executive&#8217;s &#8220;separation from service.&#8221; The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section 1.409A-1(h).</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt">The parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in such a manner so that all payments hereunder comply with, or are exempt from, Section 409A of the Code. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). The parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with, or be exempt from, Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.9pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.73pt">The Company makes no representation or warranty and shall have no liability to the Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or the conditions of, such Section.</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:7%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:31pt;width:100%"><div><img alt="image_01a.jpg" src="image_01a.jpg" style="height:14px;margin-bottom:5pt;vertical-align:text-bottom;width:337px"></div><div><font><br></font></div></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement constitutes the entire agreement between Executive and the Company concerning Executive&#8217;s relationship with the Company, and supersedes and replaces any and all prior agreements and understandings between the Parties concerning Executive&#8217;s relationship with the Company, including that certain Offer Letter by and between the Company and the Executive, dated as of February 15, 2017&#59; provided that, for the avoidance of doubt, the Restrictive Covenants and each of the award agreements applicable to the Executive&#8217;s outstanding equity awards shall continue to survive.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:6.05pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All payments made by the Company to the Executive under this Agreement shall be net of any tax or other amounts required to be withheld by the Company under applicable law.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:6pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.05pt;text-decoration:underline">Enforceability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.05pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The provisions of Section 5 this Agreement shall survive the termination of this Agreement and&#47;or the termination of the Executive&#8217;s employment to the extent necessary to effectuate the terms contained herein.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.05pt;text-decoration:underline">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.75pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.05pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to the Executive at the last address the Executive has filed in writing with the Company or, in the case of the Company, at its main offices, attention of the Board.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:6.15pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.05pt;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement may be amended or modified only by a written instrument signed by the Executive and by a duly authorized representative of the Company.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.8pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.05pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This is a Massachusetts contract and shall be construed under and be governed in all respects by the laws of the Commonwealth of Massachusetts, without giving effect to the conflict of laws principles of such Commonwealth. With respect to any disputes concerning federal law, such disputes shall be determined in accordance with the law as it would be interpreted and applied by the United States Court of Appeals for the First Circuit.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.85pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:16.05pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original&#59; but such counterparts shall together constitute one and the same document.</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:7%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:31pt;width:100%"><div><img alt="image_01a.jpg" src="image_01a.jpg" style="height:14px;margin-bottom:5pt;vertical-align:text-bottom;width:337px"></div><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Remainder of page left intentionally blank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:7%">6</font></div><div><font><br></font></div></div></div><div id="ie4428959eb5d457f8c18df94679475fc_4"></div><hr style="page-break-after:always"><div style="min-height:31pt;width:100%"><div><img alt="image_01a.jpg" src="image_01a.jpg" style="height:14px;margin-bottom:5pt;vertical-align:text-bottom;width:337px"></div><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:5pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Parties, intending to be legally bound, have executed this Agreement effective as of the Effective Date.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:8.15pt;padding-left:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">MODERNA, INC.</font></div><div style="margin-top:10.65pt;padding-left:41pt;padding-right:267.1pt;text-indent:-36pt"><font><br></font></div><div style="margin-top:10.65pt;padding-left:41pt;padding-right:267.1pt;text-indent:-36pt"><font><br></font></div><div style="margin-top:10.65pt;padding-left:41pt;padding-right:267.1pt;text-indent:-36pt"><font><br></font></div><div style="margin-top:10.65pt;padding-left:41pt;padding-right:267.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> &#47;s&#47; St</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#233;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">phane Bancel&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Name&#58; St&#233;phane Bancel</font></div><div style="padding-left:41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58; Chief Executive Officer</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="text-indent:5pt"><font><br></font></div><div style="text-indent:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE</font></div><div style="text-indent:5pt"><font><br></font></div><div style="margin-top:10.65pt;padding-left:41pt;padding-right:267.1pt;text-indent:-36pt"><font><br></font></div><div style="margin-top:10.65pt;padding-left:41pt;padding-right:267.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> &#47;s&#47; Tal Zaks&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Name&#58; Tal Zaks, M.D., PhD</font></div><div><font><br></font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:7%">7</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.27
<SEQUENCE>4
<FILENAME>exhibit1027supplycontrac.htm
<DESCRIPTION>EX-10.27
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>exhibit1027supplycontrac</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- exhibit1027supplycontrac001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 1 of 31  1. CONTRACT ID CODE PAGE OF PAGES  1 31  2. AMENDMENT/MODIFICATION NO.  P00003  3. EFFECTIVE DATE  11-Dec-2020  4. REQUISITION/PURCHASE REQ. NO.  SEE SCHEDULE  5. PROJECT NO.(If applicable)  6. ISSUED BY CODE W911QY 7. ADMINISTERED BY (If other than item 6) CODE S2206A  W6QK ACC-APG NATICK DIVISION  BLDG 1 GENERAL GREENE AVENUE  NATICK MA 01760-5011   DEFENSE CONTRACT MANAGEMENT AGENCY  DCMA BOSTON495 SUMMER STREET BOSTON MA 02210-2138      8. NAME AND ADDRESS OF CONTRACTOR (No., Street, County, State and Zip Code)  MODERNA US, INC.  [***]  200 TECHNOLOGY SQ  CAMBRIDGE MA 02139-3578    9A. AMENDMENT OF SOLICITATION NO.    9B. DATED (SEE ITEM 11)  X  10A. MOD. OF CONTRACT/ORDER NO.  W911QY20C0100  X  10B. DATED (SEE ITEM 13)  09-Aug-2020  CODE 8PTM0 FACILITY CODE  11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS  The above numbered solicitation is amended as set forth in Item 14.  The hour and date specified for receipt of Offer  is extended, is not extended.  Offer must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended by one of the following methods:  (a) By completing Items 8 and 15, and returning copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;  or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE  DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN  REJECTION OF YOUR OFFER.  If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter  makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.  12. ACCOUNTING AND APPROPRIATION DATA (If required)  13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.  IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.   A. THIS CHANGE ORDER IS ISSUED PURSUANT TO:  (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE  MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.   B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as  changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(B).  XC. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:  See Block 14 Continuation Page   D. OTHER (Specify type of modification and authority)  E. IMPORTANT:  Contractor is not X is required to sign this document and return __1__ copies to the issuing office.  14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject  matter where feasible.)  Modification Control Number:   dsoto21610  See Block 14 Continuation Page      Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.  15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)  [***]  TEL: [***] EMAIL:  [***]  15B. CONTRACTOR/OFFEROR 15C. DATE SIGNED 16B. UNITED STATES OF AMERICA  BY  16C. DATE SIGNED  11 Dec 2020  (Signature of person authorized to sign) (Signature of Contracting Officer)  EXCEPTION TO SF 30  APPROVED BY OIRM 11-84  30-105-04 STANDARD FORM 30 (REV. 10-83)  Prescribed by GSA  FAR (48 CFR) 53.243      </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 2 of 31  SECTION SF 30 BLOCK 14 CONTINUATION PAGE  SECTION SF 30 - BLOCK 14 CONTINUATION PAGE  The following have been added by full text:  OBLIGATION AMOUNT:  $1,966,598,000  a. The purpose of this modification (P00003) is to:  - Update Moderna TX to Moderna US per contract modification W911QY-20-C-0100-P00001 (Authority H.14  Novation Clause)  - Add and fund new CLINs for acceleration efforts on the base (0001AE $8,408,000) and option 1 (1001  $8,190,000) (Authority FAR 43.103(a))  - Apply incremental funding to CLINs 0003AA, 0003AB, 0003AC, and 0003AD for a total of $300,000,000  (Authority DFARS 252.232-7007)  - Exercise and fund Option 1 CLINs 1001AA, 1001AB, 1001AC for a total of $1,650,000,000 (Authority FAR  52.217-7)  - Change inspection and acceptance terms for SARS-CoV2 mRNA-1273 Vaccine CLIN No&#8217;s 0001AC, 0001AD,  1001AA, 1001AB, 1001AC, 2001AA, 2001AB, 2001AC, 3001AA, 3001AB, 3001AC, 4001AA, 4001AB, and  4001AC (0001AE and 1001AE will remain at Destination) from Destination to Origin (Authority FAR 52.243-1)  - Add delivery locations (Authority FAR 52.243-1)  - Update Inspect by DODAAC and update the Contracting Officer (Authority FAR 43.103(b))  - Update the Performance Based Payment Milestone Billing Plan (Attachment 0008, dated 4 December 2020)  and update the associated table in Section G accordingly (Authority FAR 52.232-16)  - Update H.1 Key Personnel and add H.15 Acceleration Production Credit (Authority FAR 43.103(a)(3), Mutual  Agreement of the Parties)  b. This modification was requested by the program office to meet the Government&#8217;s mission requirements.  c. The total contract value has increased by $1,666,598,000 from $1,525,000,000 to $3,191,598,000, the total  funded amount has increased by $1,966,598,000 from $1,225,000,000 to $3,191,598,000.  The following have been deleted:  SECTION A - SOLICITATION/CONTRACT FORM  The total cost of this contract was increased by $1,666,598,000.00 from $1,525,000,000.00 to  $3,191,598,000.00.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 3 of 31  SECTION B - SUPPLIES OR SERVICES AND PRICES  Global Changes  CLIN 0001 -- CLIN 4002  The manufacturer organization has changed from  MODERNATX, INC.  200 TECHNOLOGY SQ  CAMBRIDGE MA 02139-3578  to  MODERNA US, INC.  200 TECHNOLOGY SQ  CAMBRIDGE MA 02139-3578  SUBCLIN 0003AA  The project Operation Warp Speed has been added.  SUBCLIN 0003AB  The project Operation Warp Speed has been added.  SUBCLIN 0003AC  The project Operation Warp Speed has been added.  SUBCLIN 0003AD  The project Operation Warp Speed has been added.  CLIN 1001  The option status has changed from Option to Option Exercised.  SUBCLIN 1001AA  The option status has changed from Option to Option Exercised.  SUBCLIN 1001AB        The option status has changed from Option to Option Exercised.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 4 of 31  SUBCLIN 1001AC  The option status has changed from Option to Option Exercised.  SUBCLIN 1001AE is added as follows:  ITEM NO SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT  0001AE  [***] [***] [***] [***]   Acceleration Efforts  FFP  a. [***]     b.  This subCLIN shall be invoiced in full at the completion of all deliveries on the base  period.  FOB:  Destination  [***]  PROJECT:  Operation Warp Speed  PSC CD:  6505         NET AMT [***]   ACRN AC  CIN:  GFEBS0011584850 00001     [***]    SUBCLIN 1001AD is added as follows:     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 5 of 31  ITEM NO SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT  1001AD  1 Lot [***] [***]  EXERCISED  OPTION  Acceleration Efforts  FFP        a.  [***].    b.  This subCLIN shall be invoiced in full at the completion of all deliveries on the  option period.  FOB:  Destination  [***]  PROJECT:  Operation Warp Speed  PSC CD:  6505        NET AMT [***]   ACRN AC  CIN: GFEBS001158485000009     [***]    SECTION E - INSPECTION AND ACCEPTANCE  The Acceptance/Inspection Schedule for SUBCLIN 0001AC has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:     INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The Acceptance/Inspection Schedule for SUBCLIN 0001AD has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:     INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The following Acceptance/Inspection Schedule was added for SUBCLIN 0001AE:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  The Acceptance/Inspection Schedule for SUBCLIN 1001AA has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The Acceptance/Inspection Schedule for SUBCLIN 1001AB has been changed from  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 6 of 31  The Acceptance/Inspection Schedule for SUBCLIN 1001AC has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The following Acceptance/Inspection Schedule was added for SUBCLIN 1001AD:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  The Acceptance/Inspection Schedule for SUBCLIN 2001AA has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The Acceptance/Inspection Schedule for SUBCLIN 2001AB has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The Acceptance/Inspection Schedule for SUBCLIN 2001AC has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 7 of 31  The Acceptance/Inspection Schedule for SUBCLIN 3001AA has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The Acceptance/Inspection Schedule for SUBCLIN 3001AB has been changed from  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The Acceptance/Inspection Schedule for SUBCLIN 3001AC has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The Acceptance/Inspection Schedule for SUBCLIN 4001AA has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The Acceptance/Inspection Schedule for SUBCLIN 4001AB has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government  The Acceptance/Inspection Schedule for SUBCLIN 4001AC has been changed from:  INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Destination Government Destination Government  To:      INSPECT AT INSPECT BY ACCEPT AT ACCEPT BY  Origin Government Origin Government     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 8 of 31  The following have been modified:  E1. Inspection:  Vaccine CLINs:  Quality inspection of Filled Drug Product (FDP) shall occur when the Contractor performs release testing to confirm  that products complies with Contractor&#8217;s release specifications and criteria.  Contractor will submit the Certificate of  Analysis for quality inspection of all drug product lots in BARDA Data Infrastructure (BDI) system.  Initial  Inspection under this contract will be performed at the Contractor&#8217;s facility, or the subcontractor facility, by the  BARDA Contracting Officer Technical Representative (COTR).  The Government shall inspect each shipment of product delivered to it hereunder for visible damage and quantity  within [***] of final delivery.  In the event Contractor supplies any product to the Government and it is established  that such Product was damaged or does not include the required quantities at the time of final delivery, the  Government shall promptly notify Contractor in writing within [***].  A BDI extract of the inspection  documentation shall also be submitted in Wide Area Workflow (WAWF) as supporting documentation for invoice  submittals.  Storage CLIN:  In the event the USG requires storage of the FDP to a Vendor Managed Inventory (VMI) location, quantity  inspection shall be conducted by submission of shipping or other documentation into WAWF confirming quantity to  VMI location.  Physical inspection of the FDP shall be conducted upon receipt of product to USG CDC location.  Data CLIN:  Inspection of all reports and Contract Data Requirement List (CDRL) under this contract will be performed at  Destination by duly authorized representative of the Government.  Initial quality inspection of Filled Drug Product (FDP) shall occur when the Contractor performs release testing to  confirm that products complies with Contractor&#8217;s release specifications and criteria.  Contractor will submit in  WAWF to the Contracting Officer or the duly authorized representative of the Government with a Certificate of  Analysis for quality inspection of all deliverables.  Initial Inspection under this contract will be performed at the  Contractor&#8217;s facility, or the subcontractor facility, by the BARDA Contracting Officer Technical Representative  (COTR).  Final inspection of product shall occur when the Government inspects each shipment of product delivered to it  hereunder for visible damage and quantity within [***] of such delivery.  In the event Contractor supplies any  product to the Government and it is established that such Product was damaged or does not include the required  quantities at the time of delivery, the Government shall promptly notify Contractor in writing within [***].  Final  inspection shall be conducted at the CDC location identified as destination.  In the event the USG requires storage of the FDP to a Vendor Managed Inventory (VMI) location, final quantity  inspection shall be conducted by submission into WAWF of shipping or other documentation confirming quantity to  VMI location.  Final physical inspection of the FDP shall be conducted upon receipt of product to USG location.  Inspection of all reports and Contract Data Requirement List (CDRL) under this contract will be performed at  Destination by duly authorized representative of the Government.  E.2 Acceptance     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 9 of 31  a. Acceptance at origin shall occur at the contractor or subcontractor facility.  Acceptance at destination shall  occur at a government designated CDC location.  Regardless of where acceptance occurs, the contractor is  responsible for final delivery of Filled Drug Product (FDP) to a government designated CDC location.  b. Acceptance of vaccines under this agreement will be performed by the COTR in the BDI system, which  constitutes government acceptance at origin.  Documentation of acceptance shall be submitted in accordance with  WAWF instructions.  b. Acceptance under this agreement will be performed by Army Contracting Command Aberdeen Proving Ground  (ACC-APG) Natick Contracting Division (NCD) Contracting Officer.  c. Acceptance of storage services under VMI CLIN No. 0002 shall occur upon satisfactory physical and quantity  inspection of FDP upon delivery at USG designated CDC location.  Acceptance of Data CLIN No. 0004 shall occur  in WAWF by the KO.  c. Acceptance of services under VMI SubCLINs ( List CLINS) shall occur upon satisfactory physical and quantity  inspection of FDP upon delivery at USG designated CDC location.  d. The parties acknowledge that acceptance may depend on the compliance with the Contractor&#8217;s product  specifications.  The KO and COR may prior to acceptance consult with FDA under its authority under Public Law  115-92 to determine whether the material to be delivered meets the Contractor&#8217;s product specifications.  To this end,  Contractor agrees to provide a letter to FDA authorizing the Government to engage in dialog with FDA about the  ultimate compliance of this product with the Contractor&#8217;s product specifications prior to acceptance.  BARDA/COR  will accept product according to the approved Product Acceptance Procedure.  SECTION F - DELIVERIES OR PERFORMANCE  The following Delivery Schedule item for SUBCLIN 0001AA has been changed from:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]  FOB:  Origin (Shipping Point)    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]      FOB:  Origin (Shipping Point)  [***]    The following Delivery Schedule item for SUBCLIN 0001AB has been changed from:  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 10 of 31   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC /  CAGE   [***] [***] N/A  FOB:  Origin (Shipping Point)    To:        DELIVERY DATE QUANTITY SHIP TO ADDRESS  DODAAC /  CAGE   [***] [***] [***]  FOB:  Origin (Shipping Point)  [***]    The following Delivery Schedule item for SUBCLIN 0001AC has been changed from   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC /  CAGE   [***] [***] N/A  FOB:  Destination    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC /  CAGE   [***] [***] [***]  FOB:  Destination  [***]    The following Delivery Schedule item for SUBCLIN 0001AD has been changed from:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC /  CAGE   [***] [***] N/A  FOB:  Destination    To:         </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 11 of 31   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]  FOB:  Destination  [***]  The following Delivery Schedule for SUBCLIN 0001AE has been added:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]  FOB:  Destination  [***]  The following Delivery Schedule item for SUBCLIN 1001AA has been changed from:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] N/A  FOB:  Destination    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]  FOB:  Destination  [***]  The following Delivery Schedule item for SUBCLIN 1001AB has been changed from:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 12 of 31    [***] [***] N/A  FOB:  Destination    To:        DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]  FOB:  Destination  [***]  The following Delivery Schedule item for SUBCLIN 1001AC has been changed from:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] N/A  FOB:  Destination    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]  FOB:  Destination  [***]  The following Delivery Schedule for SUBCLIN 1001AD has been added:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC /  CAGE   [***] [***] [***]  FOB:  Destination  [***]     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 13 of 31    The following Delivery Schedule item for SUBCLIN 2001AA has been changed from:     DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] N/A  FOB:  Destination    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE  [***] [***] [***]  FOB:  Destination  [***]  The following Delivery Schedule item for SUBCLIN 2001AB has been changed from:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE    [***] [***] N/A  FOB:  Destination    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]  FOB:  Destination  [***]  The following Delivery Schedule item for SUBCLIN 2001AC has been changed from:    To: DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC /  CAGE   [***] [***] [***]  FOB:  Destination       </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 14 of 31  To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]  FOB:  Destination  [***]  The following Delivery Schedule item for SUBCLIN 3001AA has been changed from:    DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]  FOB:  Destination    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]  FOB:  Destination  [***]  The following Delivery Schedule item for SUBCLIN 3001AB has been changed from:    DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] N/A  FOB:  Destination    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac015.jpg" title="slide15" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 15 of 31   [***] [***] [***]    FOB:  Destination  [***]    The following Delivery Schedule item for SUBCLIN 3001AC has been changed from:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] N/A  FOB:  Destination    To       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]    FOB:  Destination  [***]      The following Delivery Schedule item for SUBCLIN 4001AA has been changed from   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] N/A  FOB:  Destination    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]    FOB:  Destination  [***]     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac016.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac016.jpg" title="slide16" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 16 of 31  The following Delivery Schedule item for SUBCLIN 4001AB has been changed from:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] N/A    FOB:  Destination    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]    FOB:  Destination  [***]  The following Delivery Schedule item for SUBCLIN 4001AC has been changed from:   DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] N/A    FOB:  Destination    To:       DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE   [***] [***] [***]    FOB:  Destination  [***]      The following have been modified:  F.1 The contractor shall ship mRNA-1273 vaccines to the designated locations listed below.  locations [***] in  the United States.  The contractor shall be responsible for secure shipment of all vaccine product whether acceptance  is conducted at origin or destination.  Delivery Locations:     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac017.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac017.jpg" title="slide17" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 17 of 31  Location 1  [***]  Location 2  [***]    SECTION G - CONTRACT ADMINISTRATION DATA  Accounting and Appropriation  Summary for the Payment Office  As a result of this modification, the total funded amount for this document was increased by [***]  SUBCLIN 0001AE:  Funding on SUBCLIN 0001AE is initiated as follows:  ACRN:  AC  CIN:  GFEBS001158485000001  Acctng Data:  0212021202220400000665654255 S.0074658.5.33 6100.9000021001  Increase:  [***]  Total:  [***]  Cost Code:  A5XAH  SUBCLIN 0003AA:  AB:  0212020202120400000664643255 S.0074658.5.6.1 6100.9000021001 A5XAH (CIN  GFEBS001158485000002) was increased by [***]  The contract ACRN AB has been added.     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac018.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac018.jpg" title="slide18" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 18 of 31  The CIN GFEBS001158485000002 has been added.  The Cost Code A5XAH has been added.  SUBCLIN 0003AB:  AB:  0212020202120400000664643255 S.0074658.5.6.1 6100.9000021001 A5XAH (CIN  GFEBS001158485000003) was increased by [***]  The contract ACRN AB has been added.  The CIN GFEBS001158485000003 has been added.  The Cost Code A5XAH has been added.  SUBCLIN 0003AC:  AB:  0212020202120400000664643255 S.0074658.5.6.1 6100.9000021001 A5XAH (CIN  GFEBS001158485000004) was increased by [***]  The contract ACRN AB has been added.  The CIN GFEBS001158485000004 has been added.  The Cost Code A5XAH has been added.  SUBCLIN 0003AD:  AB:  0212020202120400000664643255 S.0074658.5.6.1 6100.9000021001 A5XAH (CIN  GFEBS001158485000005) was increased by [***]  The contract ACRN AB has been added.  The CIN GFEBS001158485000005 has been added.  The Cost Code A5XAH has been added.  SUBCLIN 1001AA:  AC:  0212021202220400000665654255 S.0074658.5.33 6100.9000021001 A5XAH (CIN  GFEBS001158485000006) was increased by [***]  The contract ACRN AC has been added.  The CIN GFEBS001158485000006 has been added.  The Cost Code A5XAH has been added.  SUBCLIN 1001AB:  AD:  0212021202220400000665654255 S.0074658.5.33.1 6100.9000021001 A5XAH (CIN  GFEBS001158485000007) was increased by [***]  The contract ACRN AD has been added.  The CIN GFEBS001158485000007 has been added.  The Cost Code A5XAH has been added.  SUBCLIN 1001AC:  AE:  0212021202220400000665654255 S.0074658.5.33.2 6100.9000021001 A5XAH (CIN  GFEBS001158485000008) was increased by [***]  The contract ACRN AE has been added.  The CIN GFEBS001158485000008 has been added.  The Cost Code A5XAH has been added.  SUBCLIN 1001AD:  Funding on SUBCLIN 1001AD is initiated as follows:  ACRN:  AC  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac019.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac019.jpg" title="slide19" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 19 of 31  CIN:  GFEBS001158485000009  Acctng Data:  0212021202220400000665654255 S.0074658.5.33 6100.9000021001  Increase:  [***]  Total:  [***]  Cost Code:  A5XAH  The following have been modified:  In no event shall any understanding or agreement, contract modification, change order, or other matter in deviation  from the terms of this contract between the Contractor and a person other than the Contracting Officer be effective  or binding upon the Government.  All such actions must be formalized by a proper contractual document executed  by the Contracting Officer.  Procuring Contracting Officer:  [***]  Bldg. 1, General Greene Avenue  Natick, MA 01760-5011  Contract Specialist:  [***]  Bldg. 1, General Greene Avenue  Natick, MA 01760-5011  [***]  Biologist/Project Officer  200 C Street, SW  Washington, DC 20201  [***]  Moderna US, Inc.  200 Technology SQ.  Cambridge, MA 02139-3578  Moderna US, Inc.  200 Technology SQ.  Cambridge, MA 02139-3578  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac020.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac020.jpg" title="slide20" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 20 of 31  Notification of revision or changes to names or email addresses will be provided by official correspondence from the  PCO/ACO or office of the PCO/ACO in lieu of a contract modification.  This does not apply to any such revisions  or changes in the event this contract includes a key personnel clause.  Performance-based payments (PBP) are authorized under this contract in accordance with FAR 52.232-32.  The  contractor shall bill for the PBP upon achievement of the completion criteria identified in Attachment 0007,  Performance-based Payment Milestone Table.  Upon achievement of the completion criteria, the contractor shall bill  for the PBP for the base and each option IAW the following schedule:  0001AA BASE $ 94,861,200  0001AB BASE $ 139,129,760  0001AC BASE $ 189,322,400  0001AD BASE $ 208,694,640    $ 632,008,000       [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]   [***] [***]       [***] [***] [***] [***]  [***] [***] [***] [***]  [***] [***] [***] [***]    [***] [***]    Delivery Invoicing: PBPs are a type of contract financing and are recouped by the Government through deductions  of payments otherwise due to the contractor for the partial or complete delivery of contract items.  The deductions  are made by applying a liquidation rate to the price of delivered contract items.  Attachment 0008, Performance- based Payment Milestone Billing Plan, identifies the contractor invoicing schedule for liquidation.  The contractor  shall submit all invoices IAW Attachment 0008 dated 4 December 2020.  252.232- 7006 WIDE AREA WORKFLOW PAYMENT INSTRUCTIONS (DEC 2018)  (a) Definitions.  As used in this clause&#8212;  &#8220;Department of Defense Activity Address Code (DoDAAC)&#8221; is a six position code that uniquely identifies a unit,  activity, or organization.  &#8220;Document type&#8221; means the type of payment request or receiving report available for creation in Wide Area  WorkFlow (WAWF).  &#8220;Local processing office (LPO)&#8221; is the office responsible for payment certification when payment certification is  done external to the entitlement system.  &#8220;Payment request&#8221; and &#8220;receiving report&#8221; are defined in the clause at 252.232-7003, Electronic Submission of  Payment Requests and Receiving Reports.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac021.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac021.jpg" title="slide21" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 21 of 31  (b) Electronic invoicing.  The WAWF system provides the method to electronically process vendor payment  requests and receiving reports, as authorized by Defense Federal Acquisition Regulation Supplement (DFARS)  252.2327003, Electronic Submission of Payment Requests and Receiving Reports.  (c) WAWF access.  To access WAWF, the Contractor shall&#8212;  (1) Have a designated electronic business point of contact in the System for Award Management at  https://www.sam.gov; and  (2) Be registered to use WAWF at https://wawf.eb.mil/ following the step-by-step procedures for self-registration  available at this web site.  (d) WAWF training.  The Contractor should follow the training instructions of the WAWF Web-Based Training  Course and use the Practice Training Site before submitting payment requests through WAWF.  Both can be  accessed by selecting the &#8220;Web Based Training&#8221; link on the WAWF home page at https://wawf.eb.mil/.  (e) WAWF methods of document submission.  Document submissions may be via web entry, Electronic Data  Interchange, or File Transfer Protocol.  (f) WAWF payment instructions.  The Contractor shall use the following information when submitting payment  requests and receiving reports in WAWF for this contract or task or delivery order:  (1) Document type.  The Contractor shall submit payment requests using the following document type(s):  COMBO  (ii) For fixed price line items&#8212;  (A) That require shipment of a deliverable, submit the invoice and receiving report specified by the Contracting  Officer.  Invoice and receiving report document type  (B) For services that do not require shipment of a deliverable, submit either the Invoice 2in1, which meets the  requirements for the invoice and receiving report, or the applicable invoice and receiving report, as specified by the  Contracting Officer.  N/A  (iii) For customary progress payments based on costs incurred, submit a progress payment request.  (iv) For performance based payments, submit a performance based payment request.  (v) For commercial item financing, submit a commercial item financing request.  (2) Fast Pay requests are only permitted when Federal Acquisition Regulation (FAR) 52.213-1 is included in the  contract.  (3) Document routing.  The Contractor shall use the information in the Routing Data Table below only to fill in  applicable fields in WAWF when creating payment requests and receiving reports in the system.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac022.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac022.jpg" title="slide22" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 22 of 31  Routing Data Table  Field Name in WAWF Data to be entered in WAWF  Pay Official DoDAAC HQ0337  Issue By DoDAAC W911QY  Admin DoDAAC S2206A  Inspect By DoDAAC W56XNH  Acceptor W911QY  Ship To TDB    (4) Payment request.  The Contractor shall ensure a payment request includes documentation appropriate to the  type of payment request in accordance with the payment clause, contract financing clause, or Federal Acquisition  Regulation 52.216-7, Allowable Cost and Payment, as applicable.  (5) Receiving report.  The Contractor shall ensure a receiving report meets the requirements of DFARS Appendix  F.  (g) WAWF point of contact.  (1) The Contractor may obtain clarification regarding invoicing in WAWF from the following contracting activity&#8217;s  WAWF point of contact.  [***]  (2) Contact the WAWF helpdesk at [***], if assistance is needed.  (End of clause)  FOR REFERENCE:  https://www.acq.osd.mil/dpap/dars/pgi/pgi_htm/current/PGI204_71.htm#payment_instructions  SECTION H - SPECIAL CONTRACT REQUIREMENTS  The following have been modified:  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac023.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac023.jpg" title="slide23" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 23 of 31  Any key personnel specified in this contract are considered to be essential to work performance.  At least thirty (30)  calendar days prior to the Contractor voluntarily diverting any of the specified individuals to other programs or  contracts the Contractor shall notify the Contracting Officer and shall submit a justification for the diversion or  replacement and a request to replace the individual.  The request must identify the proposed replacement and  provide an explanation of how the replacement&#8217;s skills, experience, and credentials meet or exceed the requirements  of the contract (including, when applicable, Human Subjects Testing requirements).  If the employee of the  Contractor is terminated for cause or separates from the Contractor voluntarily with less than thirty (30) calendar- day notice, the Contractor shall provide the maximum notice practicable under the circumstances.  The Contractor  shall not divert, replace, or announce any such change to key personnel without the written consent of the  Contracting Officer.  The contract will be modified to add or delete key personnel as necessary to reflect the  agreement of the parties.  The following individuals are determined to be key personnel  Name Title  [***] [***]  [***] [***]  [***] [***]  [***] [***]  [***] [***]  [***] [***]  [***] [***]    The Contractor agrees to assign to the contract those persons whose resumes/CVs were submitted with the proposal  who are necessary to fill the requirements of the contract.  No substitutions shall be made except in accordance with  this clause.  All requests for substitution must provide a detailed explanation of the circumstance necessitating the proposed  substitution, a complete resume for the proposed substitute and any other information requested by the contracting  officer to approve or disapprove the proposed substitution.  All proposed substitutes must have qualifications that  are equal to or higher than the qualifications of the person to be replaced.  The contracting officer or authorized  representative will evaluate such requests and promptly notify the contractor of his approval or disapproval thereof.  Performance under this contract may require the Contractor to access non-public data and information proprietary to  a Government agency, another Government Contractor or of such nature that its dissemination or use other than as  specified in the work statement would be adverse to the interests of the Government or others.  Neither the  Contractor, nor Contractor personnel, shall divulge nor release data nor information developed or obtained under  performance of this contract, except authorized by Government personnel or upon written approval of the CO which  the KO will provide in accordance with OWS or other Government policies and/or guidance.  The Contractor shall  not use, disclose, or reproduce proprietary data that bears a restrictive legend, other than as specified in this contract,  or any information at all regarding this agency.  The Contractor shall comply with all applicable Government requirements for protection of non-public information.   Unauthorized disclosure of nonpublic information is prohibited by the Government&#8217;s rules.  Unauthorized disclosure  may result in termination of the contract, replacement of a Contractor employee, or other appropriate redress.   Neither the Contractor nor the Contractor&#8217;s employees shall disclose or cause to be disseminated, any information  concerning the operations of the activity, which could result in, or increase the likelihood of, the possibility of a  breach of the activity&#8217;s security or interrupt the continuity of its operations.  No information related to data obtained under this contract shall be released or publicized without the prior written  consent of the COR, whose approval shall not be unreasonably withheld, conditioned, or delayed, provided that no  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac024.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac024.jpg" title="slide24" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 24 of 31  such consent is required to comply with any law, rule, regulation, court ruling or similar order; for submission to any  government entity&#8217; for submission to any securities exchange on which the Contractor&#8217;s (or its parent corporation&#8217;s)  securities may be listed for trading; or to third parties relating to securing, seeking, establishing or maintaining  regulatory or other legal approvals or compliance, financing and capital raising activities, or mergers, acquisitions,  or other business transactions.  The exceptions identified in this paragraph apply to all disclosures under this Section  H.3 except to the extent that a disclosure is otherwise prohibited by law.  The contractor shall not release any reports, manuscripts, press releases, or abstracts about the work being performed  under this contract without written notice in advance to the Government.  (a) Unless otherwise specified in this contract, the contractor may publish the results of its work under this contract.   The contractor shall promptly send a copy of each submission to the COR for security review prior to submission.   The contractor shall also inform the COR when the abstract article or other publication is published, and furnish a  copy of it as finally published.  (b) Unless authorized in writing by the CO, the contractor shall not display the DoD logo including Operating  Division or Staff Division logos on any publications.  (c) The contractor shall not reference the products(s) or services(s) awarded under this contract in commercial  advertising, as defined in FAR 31.205-1, in any manner which states or implies DoD approval or endorsement of the  product(s) or service(s) provided.  (d) The contractor shall include this clause, including this section (d) in all subcontracts where the subcontractor  may propose publishing the results of its work under the subcontract.  The contractor shall acknowledge the support  of the Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response,  Biomedical Advanced Research and Development Authority whenever publicizing the work under this contract in  any media by including an acknowledgement substantially as follows:  &#8220;This project has been funded in whole or in part with Federal funds from the Office of the Assistant Secretary for  Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract Number  W911QY-20-C-0100.&#8221;  a. Confidential information, as used in this article, means non-public information or data of a personal nature  about an individual, or proprietary information or data submitted by or pertaining to an institution or organization.  b. The Contracting Officer and the Contractor may, by mutual consent, identify elsewhere in this contract specific  information and/or categories of information which the Government will furnish to the Contractor or that the  Contractor is expected to generate which is confidential.  Similarly, the Contracting Officer and the Contractor may,  by mutual consent, identify such confidential information from time to time during the performance of the contract.   Failure to agree will be settled pursuant to the &#8220;Disputes&#8221; clause.  c. If it is established elsewhere in this contract that information to be utilized under this contract, or a portion  thereof, is subject to the Privacy Act, the Contractor will follow the rules and procedures of disclosure set forth in  the Privacy Act of 1974, 5 U.S.C. 552a, and implementing regulations and policies, with respect to systems of  records determined to be subject to the Privacy Act.  d. Confidential information, as defined in paragraph (a) of this article, shall not be disclosed without the prior  written consent of the individual, institution, or organization.  (e) Whenever the Contractor is uncertain with regard to the proper handling of material under the contract, or if the  material in question is subject to the Privacy Act or is confidential information subject to the provisions of this  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac025.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac025.jpg" title="slide25" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 25 of 31  article, the Contractor shall obtain a written determination from the Contracting Officer prior to any release,  disclosure, dissemination, or publication.  (f) Contracting Officer Determinations will reflect the result of internal coordination with appropriate program and  legal officials.  (g) The provisions of paragraph (d) of this article shall not apply to conflicting or overlapping provisions in other  Federal, State or local laws.  This contract involves supply of a product that requires FDA pre-market approval or clearance before commercial  authorization.  Contractor is seeking FDA authorization or clearance for the commercialization of mRNA-1273,  Moderna vaccine for SARS-CoV-2 Coronavirus (the &#8220;Technology&#8221;).  The Contractor is the Sponsor of the  Regulatory Application (an investigational new drug application (IND), investigational device exemption (IDE),  emergency use authorization (EUA), new drug application (NDA), biologics license application (BLA), premarket  approval application (PMA), or 510(k) pre-market notification filing (510(k)) or another regulatory filing submitted  to FDA) for the technology.  As the Sponsor of the Regulatory Application to FDA (as the terms &#8220;sponsor&#8221; and  &#8220;applicant&#8221; are defined or used in at 21 CFR &sect;&sect;3.2(c), 312.5, 600.3(t), 812.2(b), 812 Subpart C, or 814.20), the  Contractor has certain standing before the FDA that entitles it to exclusive communications related to the Regulatory  Application.  Accordingly, the Contractor and the Government agree to the following:  a. DoD Medical Product Priority.  PL 115-92 allows the DoD to request, and FDA to provide, assistance to  expedite development of products to diagnose, treat, or prevent serious or life-threatening diseases or conditions  facing American military personnel.  The contractor recognizes that only the DoD can utilize PL 115-92.  As such,  the contractor will work proactively with the Government to leverage this law to its maximum potential under this  contract.  The contractor shall submit Public Law 115-92 Sponsor Authorization Letter that will be delivered to the  designated OWS POC(s) within [***]of award.  b. [***]  Performance Based Payments (PBPs) have been authorized as a method of financing under this contract.  In the  event the Moderna&#8217;s mRNA-1273 COVID Vaccine is unsuccessful in its bid to obtain EUA or FDA approval, the  Government may issue a Termination for Convenience (T4C) in whole or in part, on this contract.  Upon notice of a  T4C, the contractor shall submit a termination settlement proposal, IAW FAR 52.249-2, Termination for  Convenience of the Government (Fixed-Price).  In accordance with the Public Readiness and Emergency Preparedness Act (&#8220;PREP Act&#8221;), Pub. L. No. 109-148,  Division C, Section 2, as amended (codified at 42 U.S.C. &sect; 247d-6d and 42 U.S.C. &sect; 247d-6e), as well as the  Secretary of HHS&#8217;s Declaration Under the Public Readiness and Emergency Preparedness Act for Medical  Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020, effective Feb. 4, 2020), and amended on  April 15, 2020, 85 Fed. Reg. 21012 (together, the &#8220;Prep Act Declaration&#8221;):  (i) This Agreement is being entered into for purposes of facilitating the manufacture, testing, development,  distribution, administration, and use of &#8220;Covered Countermeasures&#8221; for responding to the COVID-19 public health  emergency, in accordance with Section VI of the PREP Act Declaration;  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac026.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac026.jpg" title="slide26" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 26 of 31  (ii) Contractor&#8217;s performance of this Agreement falls within the scope of the &#8220;Recommended Activities&#8221; for  responding to the COVID-19 public health emergency, to the extent it is in accordance with Section III of the PREP  Act Declaration; and  (iii) Contractor is a &#8220;Covered Person&#8221; to the extent it is a person defined in Section V of the PREP Act  Declaration.  Therefore, in accordance with Sections IV and VII of the PREP Act Declaration as well as the PREP Act (42 U.S.C.  &sect; 247d-6d), the Department of Defense contracting via assisted acquisition on behalf of the HHS, expressly  acknowledges and agrees that the HHS Declaration cited above, specifically its language providing immunity from  suit and liability is applicable to this acquisition as long as Contractors activities fall within the terms and conditions  of the PREP Act and the PREP Act Declaration.  The Government may not use, or authorize the use of, any products or materials provided under this contract, unless  such use occurs in the United States (or a U.S. territory where U.S. law applies such as embassies, military and  NATO installations) and is protected from liability under a declaration issued under the PREP Act, or a successor  COVID-19 PREP Act Declaration of equal or greater scope.  Any use where the application of the PREP Act is in  question will be discussed with Moderna prior to use and, if the parties disagree on such use, the dispute will be  resolved according to the &#8220;Disputes Clause&#8221; (52.233-1)  The items and technology covered by this Contract are being developed for both civil and military applications.    [***]  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac027.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac027.jpg" title="slide27" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 27 of 31  1. In recognition of the Government&#8217;s significant funding for the development and manufacturing of the product in  this contract and the Government&#8217;s need to provide sufficient quantities of a COVID-19 vaccine to protect the  United States population, the Government shall have the remedy described in this section to ensure sufficient supply  of the product to meet the needs of the public health or national security.  This remedy is not available to the  Government unless and until both of the following conditions ((a) and (b)) are met:  a. Moderna gives written notice, required to be submitted to the Government no later than [***], of:  i. any formal management decision to terminate manufacturing of this product vaccine prior to delivery of any  doses to USG under this contract, including all exercised options, other than as a result of clinical failure, or serious  technical or safety reasons or;  ii. any formal management decision to discontinue sale of this product vaccine to the Government prior to delivery  of any doses to USG under this contract, including all exercised options, other than as a result of clinical failure, or  serious technical or safety reasons; or  iii. any filing that anticipates Federal bankruptcy protection; and  b. Moderna has submitted an Emergency Use Authorization application under &sect;564 of the FD&amp;C Act or a  biologics license application provisions of &sect;351(a) of the Public Health Service Act (PHSA).  2. If both conditions listed in section 1 occur, Moderna, upon the request of the Government, shall provide the  following items necessary for the Government to pursue manufacturing of this product vaccine with a third party for  exclusive sale to the U.S. Government:  a. a writing evidencing a non-exclusive, nontransferable, irrevocable (except for cause), royalty-free paid-up  license to practice or have practiced for or on behalf of the U.S. Government any Moderna Background Patent,  Copyright, other Moderna Intellectual Property, Moderna Know-How, Moderna Technical Data rights necessary to  manufacture doses of the mRNA-1273 vaccine;  b. necessary FDA regulatory filings or authorizations owned or controlled by Moderna related to this product  vaccine and any confirmatory instrument pertaining thereto; and  c. any outstanding Deliverables contemplated or materials purchased under this contract.  3. This remedy will remain available until the end of the contract.    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac028.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac028.jpg" title="slide28" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 28 of 31  During the course of performance under this contract, the Government may require storage of the filled drug product  (FDP) before delivery to the final government location.  In these circumstances, the Government will accept FDP at  the contractor facility (Origin).  The contractor; however, shall continue to be responsible for secure delivery of the  vaccine to its final destination as identified on this contract.  [***].  The Parties acknowledge that background intellectual property and technical data assertions have been made and  evaluated by the parties.  The parties agree that, should additional information relevant to these assertions become  available, the parties will reevaluate said assertions as necessary in the future.  Upon Moderna, US, Inc.&#8217;s registration in the System for Award Management, the Government will, at the  Contractor&#8217;s request, complete a novation of this Contract to recognize Moderna US, Inc. as a counterparty instead  of Moderna TX, Inc.  This novation will be completed through a modification executed by the Government that  identifies Moderna US, Inc.  as the contracting party for all purposes as if it had originally executed the Contract.  [***]     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac029.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac029.jpg" title="slide29" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 29 of 31        SECTION I - CONTRACT CLAUSES  The following have been modified:  252.232- 7007 LIMITATION OF GOVERNMENT&#8217;S OBLIGATION (APR 2014)  (a) Contract line item 0003 is incrementally funded.  For this item, the sum of $300,000,000.00 of the total price is  presently available for payment and allotted to this contract.  An allotment schedule is set forth in paragraph (j) of  this clause.  (b) For items(s) identified in paragraph (a) of this clause, the Contractor agrees to perform up to the point at which  the total amount payable by the Government, including reimbursement in the event of termination of those item(s)  for the Government&#8217;s convenience, approximates the total amount currently allotted to the contract.  The Contractor  is not authorized to continue work on those item(s) beyond that point.  The Government will not be obligated in any  event to reimburse the Contractor in excess of the amount allotted to the contract for those item(s) regardless of  anything to the contrary in the clause entitled &#8220;TERMINATION FOR THE CONVENIENCE OF THE  GOVERNMENT.&#8221; As used in this clause, the total amount payable by the Government in the event of termination  of applicable contract line item(s) for convenience includes costs, profit and estimated termination settlement costs  for those item(s).  (c) Notwithstanding the dates specified in the allotment schedule in paragraph (j) of this clause, the Contractor will  notify the Contracting Officer in writing at least ninety days prior to the date when, in the Contractor&#8217;s best  judgment, the work will reach the point at which the total amount payable by the Government, including any cost for  termination for convenience, will approximate 85 percent of the total amount then allotted to the contract for  performance of the applicable item(s).  The notification will state (1) the estimated date when that point will be  reached and (2) an estimate of additional funding, if any, needed to continue performance of applicable line items up  to the next scheduled date for allotment of funds identified in paragraph (j) of this clause, or to a mutually agreed  upon substitute date.  The notification will also advise the Contracting Officer of the estimated amount of additional  funds that will be required for the timely performance of the item(s) funded pursuant to this clause, for subsequent  period as may be specified in the allotment schedule in paragraph (j) of this clause, or otherwise agreed to by the  parties.  If after such notification additional funds are not allotted by the date identified in the Contractor&#8217;s  notification, or by an agreed substitute date, the Contracting Officer will terminate any item(s) for which additional  funds have not been allotted, pursuant to the clause of this contract entitled &#8220;TERMINATION FOR THE  CONVENIENCE OF THE GOVERNMENT&#8221;.   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac030.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac030.jpg" title="slide30" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 30 of 31    (d) When additional funds are allotted for continued performance of the contract line item(s) identified in paragraph  (a) of this clause, the parties will agree as to the period of contract performance which will be covered by the funds.   The provisions of paragraph (b) through (d) of this clause will apply in like manner to the additional allotted funds  and agreed substitute date, and the contract will be modified accordingly.  (e) If, solely by reason of failure of the Government to allot additional funds, by the dates indicated below, in  amounts sufficient for timely performance of the contract line item(s) identified in paragraph (a) of this clause, the  Contractor incurs additional costs or is delayed in the performance of the work under this contract and if additional  funds are allotted, an equitable adjustment will be made in the price or prices (including appropriate target, billing,  and ceiling prices where applicable) of the item(s), or in the time of delivery, or both.  Failure to agree to any such  equitable adjustment hereunder will be a dispute concerning a question of fact within the meaning of the clause  entitled &#8220;disputes.&#8221;  (f) The Government may at any time prior to termination allot additional funds for the performance of the contract  line item(s) identified in paragraph (a) of this clause.  (g) The termination provisions of this clause do not limit the rights of the Government under the clause entitled  &#8220;DEFAULT.&#8221; The provisions of this clause are limited to work and allotment of funds for the contract line item(s)  set forth in paragraph (a) of this clause.  This clause no longer applies once the contract if fully funded except with  regard to the rights or obligations of the parties concerning equitable adjustments negotiated under paragraphs (d) or  (e) of this clause.  (h) Nothing in this clause affects the right of the Government to this contract pursuant to the clause of this contract  entitled &#8220;TERMINATION FOR CONVENIENCE OF THE GOVERNMENT.&#8221;  (i) Nothing in this clause shall be construed as authorization of voluntary services whose acceptance is otherwise  prohibited under 31 U.S.C. 1342.  (j) The parties contemplate that the Government will allot funds to this contract in accordance with the following  schedule:  On execution of contract $0.00   Modification P00003 dated 11 Dec 2020 - $300,000,000  (End of clause)  SECTION J - LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACHMENTS  The following have been modified:  Document Type Description Page # Date  Exhibit A CDRLs 15 18 July 2020  Attachment 0001 Supply Chain Resiliency Plan for CDRL A010 3 23 July 2020  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- exhibit1027supplycontrac031.jpg -->
<DIV style="padding-top:2em;">
<IMG src="exhibit1027supplycontrac031.jpg" title="slide31" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">W911QY20C0100 (dsoto21610)  Page 31 of 31  Attachment 0002 Security Plan 7 23 July 2020  Attachment 0003 Dose Tracking Template Draft Moderna Excel 15 July 2020  Attachment 0004 Data Rights 3 7 August 2020  Attachment 0005 [***] 2 7 August 2020  Attachment 0006 ModernaTx, Inc. Background Intellectual Property 3 6 August 2020  Attachment 0007 Performance Base Payment Milestone Schedule 2 7 August 2020  Attachment 0008 Performance Base Payment Milestone Billing Plan 17 4 December 2020  Attachment 0009 HRPAS Moderna Letter 1 3 September 2020    (End of Summary of Changes)    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>5
<FILENAME>exhibit21subsidiaries1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4becc4ca8b964a31b7a49092dce6b403_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;21.1</font></div><div><font><br></font></div></div><div style="margin-top:24pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SUBSIDIARIES</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.856%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction&#160;of&#160;Incorporation</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ModernaTX, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brizo Ltd.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderna Biotech Securities, Inc. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Massachusetts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderna Biotech UK Limited</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderna US, Inc. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderna Services, Inc. </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderna France</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderna Switzerland GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderna Biotech Spain, S.L.U.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderna Biopharma Canada Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderna Italy S.r.l.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderna Germany GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>a2312020consentforincorpra.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i05530eaf0fdb48318736e2d53f3696f7_1"></div><div style="min-height:43pt;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Exhibit 23.1</font></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="margin-bottom:10pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">Registration Statement (Form S-8 No. 333-228718) pertaining to the Moderna Therapeutics, Inc. 2016 Stock Option and Grant Plan and the Moderna, Inc. 2018 Employee Stock Purchase Plan,</font></div><div style="margin-bottom:10pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">Registration Statement (Form S-8 No. 333-230245) pertaining to the Moderna, Inc. 2018 Stock Option and Incentive Plan,</font></div><div style="margin-bottom:10pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">Registration Statement (Form S-3 No. 333-236348) of Moderna, Inc., </font></div><div style="margin-bottom:10pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">Registration Statement (Form S-8 No. 333-236713) pertaining to the Moderna, Inc. 2018 Stock Option and Incentive Plan and the Moderna, Inc. 2018 Employee Stock Purchase Plan, and</font></div><div style="margin-bottom:10pt;margin-top:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">Registration Statement (Form S-3 No. 333-238467) of Moderna, Inc&#59;</font></div><div style="margin-bottom:10pt;margin-top:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of our reports dated February 26, 2021, with respect to the consolidated financial statements of Moderna, Inc. and the effectiveness of internal control over financial reporting of Moderna, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2020.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#47;s&#47; Ernst&#160;&#38; Young LLP</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Boston, Massachusetts</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">February 26, 2021 </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:43pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>exhibit31112312020.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i05844c29bf1d4948bec43996c5352faa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EX-31.1 Section 302 Certification of CEO</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO RULES 13a-14(a)&#160;AND 15d-14(a)&#160;UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="margin-bottom:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, St&#233;phane Bancel, certify that&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form&#160;10-K of Moderna,&#160;Inc.&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s)&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.397%"><tr><td style="width:1.0%"></td><td style="width:23.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.741%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.630%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; February 26, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#47;s&#47; St&#233;phane Bancel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St&#233;phane Bancel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>exhibit31212312020.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia0f8a122b8874b9abc4b68c3041fc9b5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EX-31.2 Section 302 Certification of CFO</font></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO RULES 13a-14(a)&#160;AND 15d-14(a)&#160;UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David W. Meline, certify that&#58;</font></div><div style="margin-bottom:9pt;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form&#160;10-K of Moderna,&#160;Inc.&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s)&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:9pt;padding-left:63pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:24.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br>Date&#58; February 26, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#47;s&#47; David W. Meline</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David W. Meline</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Financial Officer)</font></div></td></tr></table></div><div style="margin-bottom:9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>exhibit32112312020.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6b57aea97229405197831f1f2b4ee865_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, St&#233;phane Bancel, Chief Executive Officer of Moderna,&#160;Inc. (Company), do hereby certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.971%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Annual Report on Form&#160;10-K of the Company for the year ended&#160;December&#160;31, 2020&#160;(Annual Report) fully complies with the requirements of Section&#160;13(a)&#160;or 15(d) of the Securities Exchange Act of 1934&#59; and</font></td></tr></table></div><div style="margin-bottom:9pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:4.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.939%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.414%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br><br>Date&#58; February 26, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#47;s&#47; St&#233;phane Bancel</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">St&#233;phane Bancel</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>exhibit32212312020.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i46187108eaec429b867c9b712be27d24_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:9pt;text-align:center"><font><br></font></div><div style="margin-bottom:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David W. Meline, Chief Financial Officer of Moderna,&#160;Inc. (Company), do hereby certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge&#58;</font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.971%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Annual Report on Form&#160;10-K of the Company for the year ended&#160;December&#160;31, 2020&#160;(Annual Report) fully complies with the requirements of Section&#160;13(a)&#160;or 15(d) of the Securities Exchange Act of 1934&#59; and</font></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:4.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.781%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.702%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br><br>Date&#58; February 26, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; David W. Meline</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David W. Meline</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>mrna-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:587e37ef-2d85-4611-b0f5-79aaf037b83c,g:a4c5467e-e912-4919-957b-a5dc25d57b8f-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mrna="http://www.modernatx.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.modernatx.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mrna-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mrna-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mrna-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mrna-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.modernatx.com/role/Cover">
        <link:definition>000010001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>100010002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>100020003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>100030004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>100040005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical">
        <link:definition>100050006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY" roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY">
        <link:definition>100060007 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical" roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical">
        <link:definition>100070008 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>100080009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandDescriptionofBusiness" roleURI="http://www.modernatx.com/role/OrganizationandDescriptionofBusiness">
        <link:definition>210011001 - Disclosure - Organization and Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandDescriptionofBusinessDetails" roleURI="http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails">
        <link:definition>240024001 - Disclosure - Organization and Description of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>210031002 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails" roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails">
        <link:definition>240064002 - Disclosure - Summary of Significant Accounting Policies - Accounting Policies Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>240074003 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails">
        <link:definition>240084004 - Disclosure - Summary of Significant Accounting Policies - Significant Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails" roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails">
        <link:definition>240094005 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment and Software Capitalization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails" roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails">
        <link:definition>240104006 - Disclosure - Summary of Significant Accounting Policies - Components of Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GrantRevenue" roleURI="http://www.modernatx.com/role/GrantRevenue">
        <link:definition>210111003 - Disclosure - Grant Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GrantRevenueTables" roleURI="http://www.modernatx.com/role/GrantRevenueTables">
        <link:definition>230123002 - Disclosure - Grant Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GrantRevenueDetails" roleURI="http://www.modernatx.com/role/GrantRevenueDetails">
        <link:definition>240134007 - Disclosure - Grant Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductSales" roleURI="http://www.modernatx.com/role/ProductSales">
        <link:definition>210141004 - Disclosure - Product Sales</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductSalesTables" roleURI="http://www.modernatx.com/role/ProductSalesTables">
        <link:definition>230153003 - Disclosure - Product Sales (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductSalesDetails" roleURI="http://www.modernatx.com/role/ProductSalesDetails">
        <link:definition>240164008 - Disclosure - Product Sales (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreements" roleURI="http://www.modernatx.com/role/CollaborationAgreements">
        <link:definition>210171005 - Disclosure - Collaboration Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsTables" roleURI="http://www.modernatx.com/role/CollaborationAgreementsTables">
        <link:definition>230183004 - Disclosure - Collaboration Agreements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails">
        <link:definition>240194009 - Disclosure - Collaboration Agreements - Summary of Total Consolidated Net Revenues from Strategic Collaborators (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails">
        <link:definition>240204010 - Disclosure - Collaboration Agreements - Changes in Balances of Receivables and Contract Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationRevenueRemainingPerformanceObligationDetails" roleURI="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails">
        <link:definition>240214011 - Disclosure - Collaboration Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationRevenueRemainingPerformanceObligationDetails_1" roleURI="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails_1">
        <link:definition>240214011 - Disclosure - Collaboration Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails">
        <link:definition>240224012 - Disclosure - Collaboration Agreements - AstraZeneca - Strategic Alliances in Cardiovascular and Oncology (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails">
        <link:definition>240234013 - Disclosure - Collaboration Agreements - Composition of the Total Transaction Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails">
        <link:definition>240244014 - Disclosure - Collaboration Agreements - Total Transaction Price to the Identified Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsRevenueRecognizedDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails">
        <link:definition>240254015 - Disclosure - Collaboration Agreements - Revenue Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsRevenueRecognizedDetails_1" roleURI="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails_1">
        <link:definition>240254015 - Disclosure - Collaboration Agreements - Revenue Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails">
        <link:definition>240264016 - Disclosure - Collaboration Agreements - Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsVEGFTotalTransactionPriceDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails">
        <link:definition>240274017 - Disclosure - Collaboration Agreements - VEGF Total Transaction Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails">
        <link:definition>240284018 - Disclosure - Collaboration Agreements - Total Transaction Price Allocated to the Single Identified Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1" roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1">
        <link:definition>240284018 - Disclosure - Collaboration Agreements - Total Transaction Price Allocated to the Single Identified Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsVEGFRevenueRecognizedDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails">
        <link:definition>240294019 - Disclosure - Collaboration Agreements - VEGF Revenue Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails">
        <link:definition>240304020 - Disclosure - Collaboration Agreements - VEGF Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails">
        <link:definition>240314021 - Disclosure - Collaboration Agreements - Merck &#8211; Strategic Alliances in Infectious Diseases and Cancer Vaccines (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails">
        <link:definition>240324022 - Disclosure - Collaboration Agreements - MERCK Composition of the Total Transaction Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails">
        <link:definition>240334023 - Disclosure - Collaboration Agreements - MERCK Total Transaction Price to the Identified Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1">
        <link:definition>240334023 - Disclosure - Collaboration Agreements - MERCK Total Transaction Price to the Identified Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails">
        <link:definition>240344024 - Disclosure - Collaboration Agreements - MERCK Revenue and Contra-Revenue Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails">
        <link:definition>240354025 - Disclosure - Collaboration Agreements - PCV/SAV Composition of the Total Transaction Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails">
        <link:definition>240364026 - Disclosure - Collaboration Agreements - PCV/SAV Total Transaction Price to the Identified Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1">
        <link:definition>240364026 - Disclosure - Collaboration Agreements - PCV/SAV Total Transaction Price to the Identified Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsPCVSAVRevenueRecognizedDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails">
        <link:definition>240374027 - Disclosure - Collaboration Agreements - PCV/SAV Revenue Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails">
        <link:definition>240384028 - Disclosure - Collaboration Agreements - PCV/SAV Balances of Deferred Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails">
        <link:definition>240394029 - Disclosure - Collaboration Agreements - Vertex &#8211; 2016 Strategic Alliance in Cystic Fibrosis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails">
        <link:definition>240404030 - Disclosure - Collaboration Agreements - VERTEX Composition of the Total Transaction Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails">
        <link:definition>240414031 - Disclosure - Collaboration Agreements - VERTEX Total Transaction Price to the Identified Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1">
        <link:definition>240414031 - Disclosure - Collaboration Agreements - VERTEX Total Transaction Price to the Identified Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsVERTEXRevenueRecognizedDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails">
        <link:definition>240424032 - Disclosure - Collaboration Agreements - VERTEX Revenue Recognized (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails">
        <link:definition>240434033 - Disclosure - Collaboration Agreements - VERTEX Balances of Deferred Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails">
        <link:definition>240444034 - Disclosure - Collaboration Agreements - Vertex 2020 Strategic Alliance in Cystic Fibrosis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails">
        <link:definition>240454035 - Disclosure - Collaboration Agreements - Chiesi Agreement Composition of the Total Transaction Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1" roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1">
        <link:definition>240454035 - Disclosure - Collaboration Agreements - Chiesi Agreement Composition of the Total Transaction Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails">
        <link:definition>240464036 - Disclosure - Collaboration Agreements - Chiesi Agreement Total Transaction Price to the Identified Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurements" roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements">
        <link:definition>210471006 - Disclosure - Financial Instruments and Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsTables" roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables">
        <link:definition>230483005 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails" roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails">
        <link:definition>240494037 - Disclosure - Financial Instruments and Fair Value Measurements - Summary of Cash and Available-for-Sale Securities by Significant Investment Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails" roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails">
        <link:definition>240504038 - Disclosure - Financial Instruments and Fair Value Measurements - Amortized Cost and Estimated Fair Value of Marketable Securities, by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails" roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails">
        <link:definition>240514039 - Disclosure - Financial Instruments and Fair Value Measurements - Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsNarrativeDetails" roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails">
        <link:definition>240524040 - Disclosure - Financial Instruments and Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails" roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails">
        <link:definition>240534041 - Disclosure - Financial Instruments and Fair Value Measurements - Financial Assets Measured At Fair Value On a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://www.modernatx.com/role/DerivativeFinancialInstruments">
        <link:definition>210541007 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://www.modernatx.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>230553006 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsBalanceSheetHedgesDetails" roleURI="http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails">
        <link:definition>240564042 - Disclosure - Derivative Financial Instruments - Balance Sheet Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://www.modernatx.com/role/Inventory">
        <link:definition>210571008 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://www.modernatx.com/role/InventoryTables">
        <link:definition>230583007 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryDetails" roleURI="http://www.modernatx.com/role/InventoryDetails">
        <link:definition>240594043 - Disclosure - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.modernatx.com/role/PropertyandEquipment">
        <link:definition>210601009 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.modernatx.com/role/PropertyandEquipmentTables">
        <link:definition>230613008 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetails" roleURI="http://www.modernatx.com/role/PropertyandEquipmentDetails">
        <link:definition>240624044 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetComponents" roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponents">
        <link:definition>210631010 - Disclosure - Other Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetComponentsTables" roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsTables">
        <link:definition>230643009 - Disclosure - Other Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>240654045 - Disclosure - Other Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetComponentsAccruedLiabilitiesDetails" roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails">
        <link:definition>240664046 - Disclosure - Other Balance Sheet Components - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails" roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails">
        <link:definition>240674047 - Disclosure - Other Balance Sheet Components - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetComponentsDeferredRevenueDetails" roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails">
        <link:definition>240684048 - Disclosure - Other Balance Sheet Components - Deferred Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.modernatx.com/role/Leases">
        <link:definition>210691011 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.modernatx.com/role/LeasesTables">
        <link:definition>230703010 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.modernatx.com/role/LeasesNarrativeDetails">
        <link:definition>240714049 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesBalanceSheetInformationDetails" roleURI="http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails">
        <link:definition>240724050 - Disclosure - Leases - Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostsDetails" roleURI="http://www.modernatx.com/role/LeasesLeaseCostsDetails">
        <link:definition>240734051 - Disclosure - Leases - Lease Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMinimumLeasePaymentsDetails" roleURI="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails">
        <link:definition>240744052 - Disclosure - Leases - Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMinimumLeasePaymentsDetails_1" roleURI="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1">
        <link:definition>240744052 - Disclosure - Leases - Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.modernatx.com/role/CommitmentsandContingencies">
        <link:definition>210751012 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesStrategicCollaborationsDetails" roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails">
        <link:definition>240764053 - Disclosure - Commitments and Contingencies - Strategic Collaborations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesIndemnificationObligationsDetails" roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails">
        <link:definition>240774054 - Disclosure - Commitments and Contingencies - Indemnification Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails" roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails">
        <link:definition>240784055 - Disclosure - Commitments and Contingencies - Purchase Commitments and Purchase Orders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLicensestoPatentedTechnologyDetails" roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails">
        <link:definition>240794056 - Disclosure - Commitments and Contingencies - Licenses to Patented Technology (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockandCommonStock" roleURI="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock">
        <link:definition>210801013 - Disclosure - Redeemable Convertible Preferred Stock and Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails" roleURI="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails">
        <link:definition>240814057 - Disclosure - Redeemable Convertible Preferred Stock and Common Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.modernatx.com/role/StockBasedCompensation">
        <link:definition>210821014 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.modernatx.com/role/StockBasedCompensationTables">
        <link:definition>230833011 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>240844058 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationOptionsActivityDetails" roleURI="http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails">
        <link:definition>240854059 - Disclosure - Stock-Based Compensation - Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails" roleURI="http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails">
        <link:definition>240864060 - Disclosure - Stock-Based Compensation - Restricted Common Stock and Common Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails" roleURI="http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails">
        <link:definition>240874061 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockBasedCompensationExpenseDetails" roleURI="http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails">
        <link:definition>240884062 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlan" roleURI="http://www.modernatx.com/role/EmployeeBenefitPlan">
        <link:definition>210891015 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanDetails" roleURI="http://www.modernatx.com/role/EmployeeBenefitPlanDetails">
        <link:definition>240904063 - Disclosure - Employee Benefit Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.modernatx.com/role/IncomeTaxes">
        <link:definition>210911016 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.modernatx.com/role/IncomeTaxesTables">
        <link:definition>230923012 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails" roleURI="http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails">
        <link:definition>240934064 - Disclosure - Income Taxes - Loss Before Provision For (Benefit From) Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" roleURI="http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails">
        <link:definition>240944065 - Disclosure - Income Taxes - Provision For (Benefit From) Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails" roleURI="http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails">
        <link:definition>240954066 - Disclosure - Income Taxes - Reconciliation of U.S. Statutory Income Tax Rate to Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails" roleURI="http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails">
        <link:definition>240964067 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets and Tax Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.modernatx.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240974068 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails" roleURI="http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails">
        <link:definition>240984069 - Disclosure - Income Taxes - Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShare" roleURI="http://www.modernatx.com/role/NetLossperShare">
        <link:definition>210991017 - Disclosure - Net Loss per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareTables" roleURI="http://www.modernatx.com/role/NetLossperShareTables">
        <link:definition>231003013 - Disclosure - Net Loss per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails" roleURI="http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails">
        <link:definition>241014070 - Disclosure - Net Loss per Share - Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails" roleURI="http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails">
        <link:definition>241024071 - Disclosure - Net Loss per Share - Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicInformation" roleURI="http://www.modernatx.com/role/GeographicInformation">
        <link:definition>211031018 - Disclosure - Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicInformationTables" roleURI="http://www.modernatx.com/role/GeographicInformationTables">
        <link:definition>231043014 - Disclosure - Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeographicInformationDetails" roleURI="http://www.modernatx.com/role/GeographicInformationDetails">
        <link:definition>241054072 - Disclosure - Geographic Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvent" roleURI="http://www.modernatx.com/role/SubsequentEvent">
        <link:definition>211061019 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.modernatx.com/role/SubsequentEventsDetails">
        <link:definition>241074073 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mrna_OperatingLeaseLiabilities" abstract="false" name="OperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_StockOptionAndIncentivePlan2018Member" abstract="true" name="StockOptionAndIncentivePlan2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_IL12PerformanceObligationMember" abstract="true" name="IL12PerformanceObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_CommercialMilestonesMember" abstract="true" name="CommercialMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_USGovermentMember" abstract="true" name="USGovermentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_FinancingRightOfUseAssetMember" abstract="true" name="FinancingRightOfUseAssetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts" abstract="false" name="DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember" abstract="true" name="A2013OptionAgreementAndServicesAndCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_FiveHundredTechnologySquareMember" abstract="true" name="FiveHundredTechnologySquareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_UpfrontPaymentMember" abstract="true" name="UpfrontPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_PaymentsForLeaseFinancingObligation" abstract="false" name="PaymentsForLeaseFinancingObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_OtherGrantRevenueMember" abstract="true" name="OtherGrantRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_SouthKoreaGovernmentMember" abstract="true" name="SouthKoreaGovernmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_EuropeanCommissionMember" abstract="true" name="EuropeanCommissionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod" abstract="false" name="ContractWithCustomerLiabilityIncreaseDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_OperatingLossCarryforwardsSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_EstimatedReimbursementMember" abstract="true" name="EstimatedReimbursementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_MilestonePaymentsMember" abstract="true" name="MilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mrna_TemporaryEquityStockRepurchasedDuringPeriodValue" abstract="false" name="TemporaryEquityStockRepurchasedDuringPeriodValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember" abstract="true" name="DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_DevelopmentMilestonesMember" abstract="true" name="DevelopmentMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_LeasesIncrementalBorrowingRate" abstract="false" name="LeasesIncrementalBorrowingRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mrna_ChangeInContractWithCustomerLiabilityLineItems" abstract="true" name="ChangeInContractWithCustomerLiabilityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember" abstract="true" name="CollaborationArrangementIncludingArrangementsWithAffiliateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_NumberOfVaccineDoses" abstract="false" name="NumberOfVaccineDoses" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mrna_LeaseFinancingObligationsIncurred" abstract="false" name="LeaseFinancingObligationsIncurred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_MerckAgreement2015Member" abstract="true" name="MerckAgreement2015Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityNonCurrentRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mrna_MerckMay2019AgreementMember" abstract="true" name="MerckMay2019AgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_RevenueFromGrantsRemainingFundingCapacity" abstract="false" name="RevenueFromGrantsRemainingFundingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_PCVSAVAgreementMember" abstract="true" name="PCVSAVAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ClinicalServicesMember" abstract="true" name="ClinicalServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_RevenueFromGrantsCurrentFundingCapacity" abstract="false" name="RevenueFromGrantsCurrentFundingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_RegulatoryMilestonesSubsequentProductsMember" abstract="true" name="RegulatoryMilestonesSubsequentProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_OfficeLaboratoryAndLightManufacturingSpaceMember" abstract="true" name="OfficeLaboratoryAndLightManufacturingSpaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mrna_CurrentMarketableSecuritiesMember" abstract="true" name="CurrentMarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_Commercial" abstract="false" name="Commercial" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_UpfrontPaymentResearchAndDevelopmentMember" abstract="true" name="UpfrontPaymentResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ContractWithCustomerAssetDecreaseDuringPeriod" abstract="false" name="ContractWithCustomerAssetDecreaseDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_LesseeFinanceLeaseExpense" abstract="false" name="LesseeFinanceLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_RemainingUnsatisfiedPerformanceObligationMember" abstract="true" name="RemainingUnsatisfiedPerformanceObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset" abstract="false" name="DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_OtherPrepaidExpenseManufacturing" abstract="false" name="OtherPrepaidExpenseManufacturing" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_OperatingLeaseNumberOfProperties" abstract="false" name="OperatingLeaseNumberOfProperties" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_OperatingAndFinanceLeaseLiabilityNoncurrent" abstract="false" name="OperatingAndFinanceLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_Combined2018AZAgreementPerformanceObligationMember" abstract="true" name="Combined2018AZAgreementPerformanceObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_PersonalizedMRNACancerVaccinesProductsMember" abstract="true" name="PersonalizedMRNACancerVaccinesProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_VEGFAProductAZD8601Member" abstract="true" name="VEGFAProductAZD8601Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_StockOptionAndGrantPlan2016Member" abstract="true" name="StockOptionAndGrantPlan2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_PerformanceObligationDomain" abstract="true" name="PerformanceObligationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_CambridgeMassachusettsMember" abstract="true" name="CambridgeMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_OptionExerciseFeeMember" abstract="true" name="OptionExerciseFeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mrna_SeparateAgreementsWithMerckMember" abstract="true" name="SeparateAgreementsWithMerckMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ReclassificationsOfTemporaryToPermanentEquityShares" abstract="false" name="ReclassificationsOfTemporaryToPermanentEquityShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityCurrentRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mrna_PaymentsOfUnderwritingDiscounts" abstract="false" name="PaymentsOfUnderwritingDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_AstraZenecaMember" abstract="true" name="AstraZenecaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod" abstract="false" name="ContractWithCustomerLiabilityDecreaseDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_RevenueFromGrantsNumberOfContractOptions" abstract="false" name="RevenueFromGrantsNumberOfContractOptions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_CustomerDepositsMember" abstract="true" name="CustomerDepositsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember" abstract="true" name="CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_AccruedDevelopmentOperation" abstract="false" name="AccruedDevelopmentOperation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mrna_CompetitionMilestonesMember" abstract="true" name="CompetitionMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain" abstract="true" name="ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_TenantIncentivesReceivablesCurrent" abstract="false" name="TenantIncentivesReceivablesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ReimbursementOfAssetsFromLeaseFinancingObligation" abstract="false" name="ReimbursementOfAssetsFromLeaseFinancingObligation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_LesseeOperatingLeasePercentageSubleased" abstract="false" name="LesseeOperatingLeasePercentageSubleased" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ChiesiAgreementMember" abstract="true" name="ChiesiAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_OperatingLossCarryforwardsNotSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsNotSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mrna_DiagnosticProductsMember" abstract="true" name="DiagnosticProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentFundingMember" abstract="true" name="ResearchAndDevelopmentFundingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_EmployeeStockPurchasePlan2018Member" abstract="true" name="EmployeeStockPurchasePlan2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mrna_VertexAgreementsMember" abstract="true" name="VertexAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mrna_EmbeddedLeasesMember" abstract="true" name="EmbeddedLeasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_Vertex2020AgreementMember" abstract="true" name="Vertex2020AgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_RestrictedStockAndRestrictedStockUnitsRSUMember" abstract="true" name="RestrictedStockAndRestrictedStockUnitsRSUMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_PCVPerformanceObligationMember" abstract="true" name="PCVPerformanceObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_PublicEquityOfferingMember" abstract="true" name="PublicEquityOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_MTCNorthMember" abstract="true" name="MTCNorthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_CollaborationArrangementMember" abstract="true" name="CollaborationArrangementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_NoncurrentMarketableSecuritiesMember" abstract="true" name="NoncurrentMarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_AreaOfRealEstatePropertyAdditionalSpace" abstract="false" name="AreaOfRealEstatePropertyAdditionalSpace" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:areaItemType"/>
  <xs:element id="mrna_FederalOrphanDrugMember" abstract="true" name="FederalOrphanDrugMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_NumberOfDevelopmentProgram" abstract="false" name="NumberOfDevelopmentProgram" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_ToxicityMilestonesMember" abstract="true" name="ToxicityMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_RevenueFromGrantsMaximumAward" abstract="false" name="RevenueFromGrantsMaximumAward" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_DeferredTaxAssetsFinancingLeaseLiability" abstract="false" name="DeferredTaxAssetsFinancingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod" abstract="false" name="ContractWithCustomerLiabilityDeductionsDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember" abstract="true" name="AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mrna_ChargesToFinancingLeaseLiabilities" abstract="false" name="ChargesToFinancingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_OperatingAndFinanceLeaseLiabilityCurrent" abstract="false" name="OperatingAndFinanceLeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" abstract="true" name="BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_AccruedManufacturing" abstract="false" name="AccruedManufacturing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_TemporaryEquityStockRepurchasedDuringPeriodShares" abstract="false" name="TemporaryEquityStockRepurchasedDuringPeriodShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mrna_VertexAgreement2019AgreementMember" abstract="true" name="VertexAgreement2019AgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_SupplyAndManufacturingAgreementsMember" abstract="true" name="SupplyAndManufacturingAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember" abstract="true" name="UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_SublicenseAgreementTermsMember" abstract="true" name="SublicenseAgreementTermsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_VEGFExercise2016Member" abstract="true" name="VEGFExercise2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_LeasesImputedInterestRate" abstract="false" name="LeasesImputedInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_LesseeOperatingLeaseNumberOfExtensionPeriods" abstract="false" name="LesseeOperatingLeaseNumberOfExtensionPeriods" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_LeaseholdImprovementsIncurredButNotYetReimbursed" abstract="false" name="LeaseholdImprovementsIncurredButNotYetReimbursed" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_UnitedKingdomGovernmentMember" abstract="true" name="UnitedKingdomGovernmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_DeferredTaxAssetsOperatingLeaseLiability" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_OncologyDevelopmentTargetPerformanceObligationMember" abstract="true" name="OncologyDevelopmentTargetPerformanceObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember" abstract="true" name="PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts" abstract="false" name="DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_AccruedPropertyAndEquipmentCurrent" abstract="false" name="AccruedPropertyAndEquipmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_OperatingAndFinanceLeaseLiability" abstract="false" name="OperatingAndFinanceLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_AccruedExternalGoodsAndServicesCurrent" abstract="false" name="AccruedExternalGoodsAndServicesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_PerformanceObligationAxis" abstract="true" name="PerformanceObligationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="mrna_RegulatoryMilestonesMember" abstract="true" name="RegulatoryMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_ClinicalSupplyReimbursementMember" abstract="true" name="ClinicalSupplyReimbursementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward" abstract="true" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mrna_PatentCostsPolicyPolicyTextBlock" abstract="false" name="PatentCostsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mrna_DefenseAdvancedResearchProjectsAgencyMember" abstract="true" name="DefenseAdvancedResearchProjectsAgencyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_AdditionalNumberOfVaccineDoses" abstract="false" name="AdditionalNumberOfVaccineDoses" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_RightOfUseAssetOperatingLeases" abstract="false" name="RightOfUseAssetOperatingLeases" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ServiceBasedAwardsMember" abstract="true" name="ServiceBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ContractOptionsMember" abstract="true" name="ContractOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_IncreaseDecreaseInDeferredRentCredit" abstract="false" name="IncreaseDecreaseInDeferredRentCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ChangeInContractwithCustomerAssetRollForward" abstract="true" name="ChangeInContractwithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mrna_ClinicalOperationsAndSupportCommitmentMember" abstract="true" name="ClinicalOperationsAndSupportCommitmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_EquipmentAndLeasedFacilitiesMember" abstract="true" name="EquipmentAndLeasedFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ChangeInContractWithCustomerLiabilityTable" abstract="true" name="ChangeInContractWithCustomerLiabilityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mrna_MerckMember" abstract="true" name="MerckMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_A2016StrategicAllianceWithAstraZenecaIL12Member" abstract="true" name="A2016StrategicAllianceWithAstraZenecaIL12Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ChiesiAgreementTransactionPriceMember" abstract="true" name="ChiesiAgreementTransactionPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_NorwoodMassachusettsMember" abstract="true" name="NorwoodMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_TherapeuticAndProphylacticProductsMember" abstract="true" name="TherapeuticAndProphylacticProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_SublicenseReimbursementMember" abstract="true" name="SublicenseReimbursementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_VariableConsiderationMember" abstract="true" name="VariableConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ProductSalesMember" abstract="true" name="ProductSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_VertexFirstMember" abstract="true" name="VertexFirstMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis" abstract="true" name="ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mrna_RevenueFromGrantsNumberOfContractOptionsExercised" abstract="false" name="RevenueFromGrantsNumberOfContractOptionsExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mrna_StockIssuanceCostsIncurredButNotYetPaid" abstract="false" name="StockIssuanceCostsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mrna_OperatingAndFinanceLeaseRightOfUseAsset" abstract="false" name="OperatingAndFinanceLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments" abstract="false" name="RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="CurrentAssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="mrna_MTCSouthMember" abstract="true" name="MTCSouthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_TheBillAndMelindaGatesFoundationMember" abstract="true" name="TheBillAndMelindaGatesFoundationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ContractWithCustomerAssetIncreaseDuringPeriod" abstract="false" name="ContractWithCustomerAssetIncreaseDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_TwoHundredTechnologySquareMember" abstract="true" name="TwoHundredTechnologySquareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member" abstract="true" name="DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_NumberOfDosesOfVaccineCandidate" abstract="false" name="NumberOfDosesOfVaccineCandidate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mrna_VertexAgreements1Member" abstract="true" name="VertexAgreements1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember" abstract="true" name="StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_InitialProjectMember" abstract="true" name="InitialProjectMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember" abstract="true" name="USGovernmentAgenciesAndCorporateDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_VertexMember" abstract="true" name="VertexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_KRASPerformanceObligationMember" abstract="true" name="KRASPerformanceObligationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_RawMaterialsAccountsPayable" abstract="false" name="RawMaterialsAccountsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_AccruedClinicalTrials" abstract="false" name="AccruedClinicalTrials" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mrna_Combined2018AZAgreementsMember" abstract="true" name="Combined2018AZAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>mrna-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:587e37ef-2d85-4611-b0f5-79aaf037b83c,g:a4c5467e-e912-4919-957b-a5dc25d57b8f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.modernatx.com/role/Cover" xlink:type="simple" xlink:href="mrna-20201231.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee908c97-5f1c-4650-9346-70c4b29c14a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6e5e8de7-a301-4979-90df-13095789719a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee908c97-5f1c-4650-9346-70c4b29c14a3" xlink:to="loc_us-gaap_StockholdersEquity_6e5e8de7-a301-4979-90df-13095789719a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_eaa08449-984e-4d3a-a3f9-ebdad0229088" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee908c97-5f1c-4650-9346-70c4b29c14a3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_eaa08449-984e-4d3a-a3f9-ebdad0229088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fed5bd68-6da1-413f-86e5-6b6edf6740cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee908c97-5f1c-4650-9346-70c4b29c14a3" xlink:to="loc_us-gaap_Liabilities_fed5bd68-6da1-413f-86e5-6b6edf6740cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_34829e11-eab3-4d8c-9751-4c1721577d91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9801a871-0533-4b2c-83d1-a8312cd2dcd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34829e11-eab3-4d8c-9751-4c1721577d91" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9801a871-0533-4b2c-83d1-a8312cd2dcd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fe111d73-512b-4751-81c9-db5ed34a3636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34829e11-eab3-4d8c-9751-4c1721577d91" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fe111d73-512b-4751-81c9-db5ed34a3636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6cf166de-4ad2-40ce-8d9a-7a632bb0b15d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34829e11-eab3-4d8c-9751-4c1721577d91" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6cf166de-4ad2-40ce-8d9a-7a632bb0b15d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3d22aabd-d340-4bf2-bf23-6182411aad6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34829e11-eab3-4d8c-9751-4c1721577d91" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3d22aabd-d340-4bf2-bf23-6182411aad6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_49a38832-e2fa-467b-a143-f8e188963f70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34829e11-eab3-4d8c-9751-4c1721577d91" xlink:to="loc_us-gaap_RestrictedCashCurrent_49a38832-e2fa-467b-a143-f8e188963f70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_82bb260b-d23c-4fec-99aa-22a0a6f510bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_34829e11-eab3-4d8c-9751-4c1721577d91" xlink:to="loc_us-gaap_InventoryNet_82bb260b-d23c-4fec-99aa-22a0a6f510bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_067e82e2-2459-4df0-88ba-096315d1a369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_220e6df7-a8c9-4f84-9f2b-620b9e61c255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_067e82e2-2459-4df0-88ba-096315d1a369" xlink:to="loc_us-gaap_LiabilitiesCurrent_220e6df7-a8c9-4f84-9f2b-620b9e61c255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_803edaa4-c764-4add-a4ee-da8ed76b8e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_067e82e2-2459-4df0-88ba-096315d1a369" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_803edaa4-c764-4add-a4ee-da8ed76b8e37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c2333765-5231-49a4-8a30-3f9ce8e937fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_067e82e2-2459-4df0-88ba-096315d1a369" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c2333765-5231-49a4-8a30-3f9ce8e937fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c9b08659-7517-4f9c-9664-2bb1559e582a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_067e82e2-2459-4df0-88ba-096315d1a369" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_c9b08659-7517-4f9c-9664-2bb1559e582a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c7217d91-99a2-4dc4-905a-d18815b7c988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_067e82e2-2459-4df0-88ba-096315d1a369" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c7217d91-99a2-4dc4-905a-d18815b7c988" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_12755344-f620-4ea8-ae11-fdbcdf961ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_957c55da-166f-4f42-b88e-217d8debe842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_12755344-f620-4ea8-ae11-fdbcdf961ff5" xlink:to="loc_us-gaap_CommonStockValue_957c55da-166f-4f42-b88e-217d8debe842" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_679b64d1-0b4a-44e5-a53f-d153fe7fc440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_12755344-f620-4ea8-ae11-fdbcdf961ff5" xlink:to="loc_us-gaap_AdditionalPaidInCapital_679b64d1-0b4a-44e5-a53f-d153fe7fc440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9fcb7209-7a54-403a-9be2-b53570dd36c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_12755344-f620-4ea8-ae11-fdbcdf961ff5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9fcb7209-7a54-403a-9be2-b53570dd36c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9f7fefb6-fbaf-4a42-b92b-09176a343de3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_12755344-f620-4ea8-ae11-fdbcdf961ff5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9f7fefb6-fbaf-4a42-b92b-09176a343de3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_06dc85eb-f577-44a6-bf3c-7b5d9d45a9e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_12755344-f620-4ea8-ae11-fdbcdf961ff5" xlink:to="loc_us-gaap_PreferredStockValue_06dc85eb-f577-44a6-bf3c-7b5d9d45a9e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_74c4361e-b46e-4366-b740-394705050dc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8b048aeb-73f4-4961-968b-41e29025b84e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c4361e-b46e-4366-b740-394705050dc6" xlink:to="loc_us-gaap_AssetsCurrent_8b048aeb-73f4-4961-968b-41e29025b84e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_87ff2636-0174-49ff-99a5-211600747315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c4361e-b46e-4366-b740-394705050dc6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_87ff2636-0174-49ff-99a5-211600747315" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7ee7d7e8-2f8d-41bb-9c77-eff642af5222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c4361e-b46e-4366-b740-394705050dc6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7ee7d7e8-2f8d-41bb-9c77-eff642af5222" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_2dcb103a-0c89-4f27-8893-63a310e16df4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c4361e-b46e-4366-b740-394705050dc6" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_2dcb103a-0c89-4f27-8893-63a310e16df4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5e9a1863-16a0-46c2-a071-cd1427e1ed77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c4361e-b46e-4366-b740-394705050dc6" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5e9a1863-16a0-46c2-a071-cd1427e1ed77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_17bf7c25-82c3-4b4f-9fae-8b085ecfd7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_74c4361e-b46e-4366-b740-394705050dc6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_17bf7c25-82c3-4b4f-9fae-8b085ecfd7b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a7a62d09-afa4-40ff-811c-cd03fc44c8f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_61b3ae5c-dcdf-4dca-9ae2-79f6c02c0808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a7a62d09-afa4-40ff-811c-cd03fc44c8f1" xlink:to="loc_us-gaap_AccountsPayableCurrent_61b3ae5c-dcdf-4dca-9ae2-79f6c02c0808" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_4f95bbf6-5a80-4f8a-b26b-12b2225a0551" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a7a62d09-afa4-40ff-811c-cd03fc44c8f1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_4f95bbf6-5a80-4f8a-b26b-12b2225a0551" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7aa984aa-f2e4-4455-aa6d-9d5a200a83b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a7a62d09-afa4-40ff-811c-cd03fc44c8f1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7aa984aa-f2e4-4455-aa6d-9d5a200a83b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_e7212525-db52-4163-b977-866ca9fcfdfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a7a62d09-afa4-40ff-811c-cd03fc44c8f1" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_e7212525-db52-4163-b977-866ca9fcfdfd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b16a9815-a17d-4c12-848a-66d0d49a45c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_24c4d95e-100c-47e6-a440-b82a89cfe19e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b16a9815-a17d-4c12-848a-66d0d49a45c4" xlink:to="loc_us-gaap_Revenues_24c4d95e-100c-47e6-a440-b82a89cfe19e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f4e7d2a0-f533-4b79-84e5-60a4cac85c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b16a9815-a17d-4c12-848a-66d0d49a45c4" xlink:to="loc_us-gaap_CostsAndExpenses_f4e7d2a0-f533-4b79-84e5-60a4cac85c86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d66546a3-20c8-42bf-9be1-7c748f9fccff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8271322a-8bd7-4644-9c9b-6ba2db13cb93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d66546a3-20c8-42bf-9be1-7c748f9fccff" xlink:to="loc_us-gaap_OperatingIncomeLoss_8271322a-8bd7-4644-9c9b-6ba2db13cb93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_168a9b2f-a716-4230-85bf-0711dd72d83a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d66546a3-20c8-42bf-9be1-7c748f9fccff" xlink:to="loc_us-gaap_InvestmentIncomeInterest_168a9b2f-a716-4230-85bf-0711dd72d83a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_eef4e868-7533-40a2-a498-bfd618b25cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d66546a3-20c8-42bf-9be1-7c748f9fccff" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_eef4e868-7533-40a2-a498-bfd618b25cb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e116bf25-8aed-45f9-972d-97b3ae655d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_422e42d7-d007-4fe1-bb66-e8ea40fe050c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e116bf25-8aed-45f9-972d-97b3ae655d1b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_422e42d7-d007-4fe1-bb66-e8ea40fe050c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_24152495-dd9b-4e6f-906a-1df7777e77b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e116bf25-8aed-45f9-972d-97b3ae655d1b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_24152495-dd9b-4e6f-906a-1df7777e77b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_c7000526-4363-414d-a245-9961b8cde8ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_e116bf25-8aed-45f9-972d-97b3ae655d1b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_c7000526-4363-414d-a245-9961b8cde8ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cdc8ec5c-491a-4e27-b142-0077e7cba3cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5a8fe943-7fbe-45f8-b75b-561eafb84bd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_cdc8ec5c-491a-4e27-b142-0077e7cba3cd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5a8fe943-7fbe-45f8-b75b-561eafb84bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_65d426f5-c85c-4ac5-9a78-16b6de52e830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_cdc8ec5c-491a-4e27-b142-0077e7cba3cd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_65d426f5-c85c-4ac5-9a78-16b6de52e830" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c4065a55-64e0-432c-8cff-09df745bb561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_48f9737e-ae93-4010-8aad-45621c311594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c4065a55-64e0-432c-8cff-09df745bb561" xlink:to="loc_us-gaap_NetIncomeLoss_48f9737e-ae93-4010-8aad-45621c311594" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockRedemptionPremium_62863c76-cb03-48ae-a7a5-4d220a1722f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockRedemptionPremium"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c4065a55-64e0-432c-8cff-09df745bb561" xlink:to="loc_us-gaap_PreferredStockRedemptionPremium_62863c76-cb03-48ae-a7a5-4d220a1722f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockDividends_dfad832a-f4f9-4f75-9b54-c06fb2c0e913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c4065a55-64e0-432c-8cff-09df745bb561" xlink:to="loc_us-gaap_RedeemablePreferredStockDividends_dfad832a-f4f9-4f75-9b54-c06fb2c0e913" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_9566a5c7-097f-430f-b263-2aead7cc9f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_febda7cd-9648-4dd2-9052-a8d5d6584eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_9566a5c7-097f-430f-b263-2aead7cc9f5b" xlink:to="loc_us-gaap_NetIncomeLoss_febda7cd-9648-4dd2-9052-a8d5d6584eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c693a59a-48c2-4569-84ca-5c33e1c49c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_9566a5c7-097f-430f-b263-2aead7cc9f5b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c693a59a-48c2-4569-84ca-5c33e1c49c7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_03e7e571-80eb-4a82-95d4-25e3144b3ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3fcb5924-82d9-4576-853c-a7735d0ddb2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_03e7e571-80eb-4a82-95d4-25e3144b3ea5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3fcb5924-82d9-4576-853c-a7735d0ddb2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_38178f77-14bc-41fe-917b-2dd015c5c0e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_03e7e571-80eb-4a82-95d4-25e3144b3ea5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_38178f77-14bc-41fe-917b-2dd015c5c0e2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75d3d296-9a85-4110-8f70-0765424789a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_e607d73b-e938-4892-9c60-549c73f61e66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75d3d296-9a85-4110-8f70-0765424789a1" xlink:to="loc_us-gaap_ProceedsFromStockPlans_e607d73b-e938-4892-9c60-549c73f61e66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChargesToFinancingLeaseLiabilities_f8b0bc66-ea6e-41b0-8ddb-d229df62ee3b" xlink:href="mrna-20201231.xsd#mrna_ChargesToFinancingLeaseLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75d3d296-9a85-4110-8f70-0765424789a1" xlink:to="loc_mrna_ChargesToFinancingLeaseLiabilities_f8b0bc66-ea6e-41b0-8ddb-d229df62ee3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation_4f4b6df2-683a-4a4e-a66e-a28c8d1addda" xlink:href="mrna-20201231.xsd#mrna_ReimbursementOfAssetsFromLeaseFinancingObligation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75d3d296-9a85-4110-8f70-0765424789a1" xlink:to="loc_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation_4f4b6df2-683a-4a4e-a66e-a28c8d1addda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PaymentsForLeaseFinancingObligation_27b2355e-34a4-4e78-b6da-a894b16d0255" xlink:href="mrna-20201231.xsd#mrna_PaymentsForLeaseFinancingObligation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75d3d296-9a85-4110-8f70-0765424789a1" xlink:to="loc_mrna_PaymentsForLeaseFinancingObligation_27b2355e-34a4-4e78-b6da-a894b16d0255" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_0fa6aaa2-bcd9-4f0c-bdb4-05438818908f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75d3d296-9a85-4110-8f70-0765424789a1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_0fa6aaa2-bcd9-4f0c-bdb4-05438818908f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock_f5b55ea6-735d-4165-abb6-0bd6d11916e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75d3d296-9a85-4110-8f70-0765424789a1" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock_f5b55ea6-735d-4165-abb6-0bd6d11916e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans_5253e549-f726-4eca-89e5-5352a3595c63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75d3d296-9a85-4110-8f70-0765424789a1" xlink:to="loc_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans_5253e549-f726-4eca-89e5-5352a3595c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_86864c9c-ebf1-45f1-825e-4186708731b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75d3d296-9a85-4110-8f70-0765424789a1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_86864c9c-ebf1-45f1-825e-4186708731b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_45df4093-adc9-4399-a784-8bcb9f0170ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_45df4093-adc9-4399-a784-8bcb9f0170ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_4f6a1ea8-34fc-4089-81b8-d9562ba6a16d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_4f6a1ea8-34fc-4089-81b8-d9562ba6a16d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_62e96fa8-7dbd-40d9-a2cf-ad813ea1f51c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_NetIncomeLoss_62e96fa8-7dbd-40d9-a2cf-ad813ea1f51c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RightOfUseAssetOperatingLeases_263e4954-e3c4-452b-b8cf-577171cc6b2f" xlink:href="mrna-20201231.xsd#mrna_RightOfUseAssetOperatingLeases"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_mrna_RightOfUseAssetOperatingLeases_263e4954-e3c4-452b-b8cf-577171cc6b2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_34aaf6fd-b107-4923-9e84-ccc78eb0a4a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_34aaf6fd-b107-4923-9e84-ccc78eb0a4a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_IncreaseDecreaseInDeferredRentCredit_c7a5849f-0fd4-4080-9031-514bb382c7b2" xlink:href="mrna-20201231.xsd#mrna_IncreaseDecreaseInDeferredRentCredit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_mrna_IncreaseDecreaseInDeferredRentCredit_c7a5849f-0fd4-4080-9031-514bb382c7b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7ac1cc57-2c5c-4625-a39c-e25613798e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7ac1cc57-2c5c-4625-a39c-e25613798e6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2a283abd-7dfc-468f-8a7e-4fc57b8ab9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_ShareBasedCompensation_2a283abd-7dfc-468f-8a7e-4fc57b8ab9e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_da338130-d9a7-4b04-9c95-c9e2c2087cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_da338130-d9a7-4b04-9c95-c9e2c2087cb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_c0ee6444-8121-4486-a151-042470a2f787" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_c0ee6444-8121-4486-a151-042470a2f787" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLeaseLiabilities_b74f8264-83d2-43bc-acbf-8621d775c842" xlink:href="mrna-20201231.xsd#mrna_OperatingLeaseLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_mrna_OperatingLeaseLiabilities_b74f8264-83d2-43bc-acbf-8621d775c842" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fc3a256f-7f1f-449b-a5ed-ca26d7452c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fc3a256f-7f1f-449b-a5ed-ca26d7452c1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d461c92e-60c1-4a5d-9cc3-3e0ec40e8943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d461c92e-60c1-4a5d-9cc3-3e0ec40e8943" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_25370061-d843-4df6-964d-665178a523dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_25370061-d843-4df6-964d-665178a523dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_722b1b7a-76b8-4b85-bbd6-c1a63a965c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_722b1b7a-76b8-4b85-bbd6-c1a63a965c7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_98031aee-06d0-4191-b3c9-32fd4690e0be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c16c083d-a242-473b-b3cc-cf83aa0b34df" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_98031aee-06d0-4191-b3c9-32fd4690e0be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_607a40fa-5843-4132-8842-21aaf0bba77c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_00ecc048-6655-4809-93e1-39221c7048a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_607a40fa-5843-4132-8842-21aaf0bba77c" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_00ecc048-6655-4809-93e1-39221c7048a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2a108cf6-9a2d-4802-b9fc-66a1ff551807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_607a40fa-5843-4132-8842-21aaf0bba77c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2a108cf6-9a2d-4802-b9fc-66a1ff551807" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_b0279649-dbba-4e45-8e8d-8edd46d6f853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_607a40fa-5843-4132-8842-21aaf0bba77c" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_b0279649-dbba-4e45-8e8d-8edd46d6f853" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_da50dbed-37c7-429c-8fb4-41787731edf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_607a40fa-5843-4132-8842-21aaf0bba77c" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_da50dbed-37c7-429c-8fb4-41787731edf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ccd8ac6-dba7-4e7f-9b1a-8fee79c6bbda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dfe4aadc-e4c4-413b-be34-4925e275ac22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ccd8ac6-dba7-4e7f-9b1a-8fee79c6bbda" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dfe4aadc-e4c4-413b-be34-4925e275ac22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e2d40ea4-bdff-42a9-8f83-c81c3ac66e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ccd8ac6-dba7-4e7f-9b1a-8fee79c6bbda" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e2d40ea4-bdff-42a9-8f83-c81c3ac66e30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b31359b3-22ab-4c97-88eb-21a96d3f99b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ccd8ac6-dba7-4e7f-9b1a-8fee79c6bbda" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b31359b3-22ab-4c97-88eb-21a96d3f99b9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OrganizationandDescriptionofBusiness" xlink:type="simple" xlink:href="mrna-20201231.xsd#OrganizationandDescriptionofBusiness"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/OrganizationandDescriptionofBusiness" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OrganizationandDescriptionofBusinessDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a28e578a-1b92-4441-99e2-9b67c940a681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_86cbf4a1-35d4-4009-a205-60f9a54821b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a28e578a-1b92-4441-99e2-9b67c940a681" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_86cbf4a1-35d4-4009-a205-60f9a54821b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_35b1dc40-f361-4780-9544-208ee20b7acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a28e578a-1b92-4441-99e2-9b67c940a681" xlink:to="loc_us-gaap_RestrictedCashCurrent_35b1dc40-f361-4780-9544-208ee20b7acf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_e9bedfa8-0fae-420e-9fd8-97822acdc7e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a28e578a-1b92-4441-99e2-9b67c940a681" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_e9bedfa8-0fae-420e-9fd8-97822acdc7e0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/GrantRevenue" xlink:type="simple" xlink:href="mrna-20201231.xsd#GrantRevenue"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/GrantRevenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/GrantRevenueTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#GrantRevenueTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/GrantRevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/GrantRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#GrantRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/GrantRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/ProductSales" xlink:type="simple" xlink:href="mrna-20201231.xsd#ProductSales"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/ProductSales" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/ProductSalesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#ProductSalesTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/ProductSalesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/ProductSalesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#ProductSalesDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/ProductSalesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreements" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreements"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationRevenueRemainingPerformanceObligationDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationRevenueRemainingPerformanceObligationDetails_1"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsRevenueRecognizedDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsRevenueRecognizedDetails_1"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVEGFTotalTransactionPriceDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVEGFRevenueRecognizedDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVRevenueRecognizedDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXRevenueRecognizedDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7e89c5d8-b5ae-43ec-93ca-28e52dfe630b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_513bf9ac-103c-483a-a360-b99e2420a94a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7e89c5d8-b5ae-43ec-93ca-28e52dfe630b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_513bf9ac-103c-483a-a360-b99e2420a94a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ca29fa26-aa97-4dd9-b263-9a4a91f558a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7e89c5d8-b5ae-43ec-93ca-28e52dfe630b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ca29fa26-aa97-4dd9-b263-9a4a91f558a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d62f3779-df09-47ed-abf9-03c36e2e1ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7e89c5d8-b5ae-43ec-93ca-28e52dfe630b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d62f3779-df09-47ed-abf9-03c36e2e1ccd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_48d1cd59-6e8e-4d2d-b7e3-6b281f3e5218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_cb91dd85-e812-49b2-9903-2c8442a49d40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_48d1cd59-6e8e-4d2d-b7e3-6b281f3e5218" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_cb91dd85-e812-49b2-9903-2c8442a49d40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_2a7608b0-d14e-46ed-ad17-b06eaf864b54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_48d1cd59-6e8e-4d2d-b7e3-6b281f3e5218" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_2a7608b0-d14e-46ed-ad17-b06eaf864b54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d03c478c-3262-4cff-b8e8-dcb881701245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_7d26aee9-3e1d-48f7-8ddd-c92335d4bede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d03c478c-3262-4cff-b8e8-dcb881701245" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_7d26aee9-3e1d-48f7-8ddd-c92335d4bede" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_adc52f7e-e550-4d57-9349-1cbd39ae2f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d03c478c-3262-4cff-b8e8-dcb881701245" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_adc52f7e-e550-4d57-9349-1cbd39ae2f86" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_30c8454e-43ba-4850-9c5c-aa2cea9e80a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d724eb87-38f8-40d1-ab9c-7247742ec262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_30c8454e-43ba-4850-9c5c-aa2cea9e80a4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_d724eb87-38f8-40d1-ab9c-7247742ec262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_e1c01452-ee53-4b97-87e3-3a8068f7aa29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_30c8454e-43ba-4850-9c5c-aa2cea9e80a4" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_e1c01452-ee53-4b97-87e3-3a8068f7aa29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_34fcd627-b3d6-4ee6-9b91-69e4992f67e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_3cace28a-bf99-477d-b949-8e1e4a0af818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_34fcd627-b3d6-4ee6-9b91-69e4992f67e1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_3cace28a-bf99-477d-b949-8e1e4a0af818" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_501353eb-18f4-4b93-bce4-d1aec741f84a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_34fcd627-b3d6-4ee6-9b91-69e4992f67e1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_501353eb-18f4-4b93-bce4-d1aec741f84a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_da791a4a-30b3-47ea-b3e8-3b45f0afe530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3f9e0f34-6e27-44c1-b87a-eaed48839483" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_da791a4a-30b3-47ea-b3e8-3b45f0afe530" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3f9e0f34-6e27-44c1-b87a-eaed48839483" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_b57784fa-bf3d-4a77-a2cb-25658fa9449a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_da791a4a-30b3-47ea-b3e8-3b45f0afe530" xlink:to="loc_us-gaap_DerivativeAssets_b57784fa-bf3d-4a77-a2cb-25658fa9449a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="mrna-20201231.xsd#DerivativeFinancialInstruments"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/DerivativeFinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/Inventory" xlink:type="simple" xlink:href="mrna-20201231.xsd#Inventory"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/Inventory" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/InventoryTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#InventoryTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/InventoryTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/InventoryDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#InventoryDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8e498cd1-b4c5-4b50-95d3-ed7afe77f221" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_42a1d158-d904-44a0-a8d6-4c77a467d9ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8e498cd1-b4c5-4b50-95d3-ed7afe77f221" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_42a1d158-d904-44a0-a8d6-4c77a467d9ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8ca31374-8307-406f-8533-1acd01f95c65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8e498cd1-b4c5-4b50-95d3-ed7afe77f221" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8ca31374-8307-406f-8533-1acd01f95c65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1520927d-c32b-48fa-9ee8-1cc5a7fe2664" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_8e498cd1-b4c5-4b50-95d3-ed7afe77f221" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_1520927d-c32b-48fa-9ee8-1cc5a7fe2664" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="mrna-20201231.xsd#PropertyandEquipment"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/PropertyandEquipment" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#PropertyandEquipmentTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/PropertyandEquipmentTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#PropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_52b9dad2-eed7-40c2-b2ed-3f99fdb38bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_bbd9263d-fc5a-4cee-93b6-a4834aad7e2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_52b9dad2-eed7-40c2-b2ed-3f99fdb38bed" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_bbd9263d-fc5a-4cee-93b6-a4834aad7e2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_6a184a20-ae09-4f2d-90b0-ac0c206ea3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_52b9dad2-eed7-40c2-b2ed-3f99fdb38bed" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_6a184a20-ae09-4f2d-90b0-ac0c206ea3ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponents" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponents"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponents" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_466e6270-f646-4cb7-bfe5-5572839f949b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_177b6f94-a257-4916-91e5-d18b835817be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_466e6270-f646-4cb7-bfe5-5572839f949b" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_177b6f94-a257-4916-91e5-d18b835817be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent_30a58bc8-1de1-4d66-a6f5-2e25d003d94b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_466e6270-f646-4cb7-bfe5-5572839f949b" xlink:to="loc_us-gaap_InterestReceivableCurrent_30a58bc8-1de1-4d66-a6f5-2e25d003d94b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TenantIncentivesReceivablesCurrent_4bead0bb-83de-43d3-8343-636e6c3cf2aa" xlink:href="mrna-20201231.xsd#mrna_TenantIncentivesReceivablesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_466e6270-f646-4cb7-bfe5-5572839f949b" xlink:to="loc_mrna_TenantIncentivesReceivablesCurrent_4bead0bb-83de-43d3-8343-636e6c3cf2aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OtherPrepaidExpenseManufacturing_8e35afbd-3d68-403b-a6d8-52a2b3dbf7b8" xlink:href="mrna-20201231.xsd#mrna_OtherPrepaidExpenseManufacturing"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_466e6270-f646-4cb7-bfe5-5572839f949b" xlink:to="loc_mrna_OtherPrepaidExpenseManufacturing_8e35afbd-3d68-403b-a6d8-52a2b3dbf7b8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f4a2570c-81fa-4a3d-be84-83744911ac85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Commercial_1b94561c-3753-4b05-a5b7-bcdef2b0e637" xlink:href="mrna-20201231.xsd#mrna_Commercial"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f4a2570c-81fa-4a3d-be84-83744911ac85" xlink:to="loc_mrna_Commercial_1b94561c-3753-4b05-a5b7-bcdef2b0e637" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedDevelopmentOperation_8fe3344b-7ead-42b0-9fbc-e9848e9cea77" xlink:href="mrna-20201231.xsd#mrna_AccruedDevelopmentOperation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f4a2570c-81fa-4a3d-be84-83744911ac85" xlink:to="loc_mrna_AccruedDevelopmentOperation_8fe3344b-7ead-42b0-9fbc-e9848e9cea77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_997fd849-c6e4-4c10-afe2-f9ca3c0d8bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f4a2570c-81fa-4a3d-be84-83744911ac85" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_997fd849-c6e4-4c10-afe2-f9ca3c0d8bfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedExternalGoodsAndServicesCurrent_67d0a13f-168b-4781-a843-078cf031525f" xlink:href="mrna-20201231.xsd#mrna_AccruedExternalGoodsAndServicesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f4a2570c-81fa-4a3d-be84-83744911ac85" xlink:to="loc_mrna_AccruedExternalGoodsAndServicesCurrent_67d0a13f-168b-4781-a843-078cf031525f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedManufacturing_232ac454-9cbd-416e-8c5d-c0673b48f6c4" xlink:href="mrna-20201231.xsd#mrna_AccruedManufacturing"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f4a2570c-81fa-4a3d-be84-83744911ac85" xlink:to="loc_mrna_AccruedManufacturing_232ac454-9cbd-416e-8c5d-c0673b48f6c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedClinicalTrials_62c98dda-3301-4aeb-a964-d0ea933cbbd4" xlink:href="mrna-20201231.xsd#mrna_AccruedClinicalTrials"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f4a2570c-81fa-4a3d-be84-83744911ac85" xlink:to="loc_mrna_AccruedClinicalTrials_62c98dda-3301-4aeb-a964-d0ea933cbbd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedPropertyAndEquipmentCurrent_39ad4e0a-27e1-4132-9265-b9ba70d544e4" xlink:href="mrna-20201231.xsd#mrna_AccruedPropertyAndEquipmentCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f4a2570c-81fa-4a3d-be84-83744911ac85" xlink:to="loc_mrna_AccruedPropertyAndEquipmentCurrent_39ad4e0a-27e1-4132-9265-b9ba70d544e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RawMaterialsAccountsPayable_722bec5a-0ba9-4530-bbc9-9e1a73e82fe7" xlink:href="mrna-20201231.xsd#mrna_RawMaterialsAccountsPayable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f4a2570c-81fa-4a3d-be84-83744911ac85" xlink:to="loc_mrna_RawMaterialsAccountsPayable_722bec5a-0ba9-4530-bbc9-9e1a73e82fe7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d214c5ed-c2ab-4d49-bca5-44a34b1deeac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_9e8b8f86-1f2e-444a-addd-a1a7fd72c9d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_d214c5ed-c2ab-4d49-bca5-44a34b1deeac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_9e8b8f86-1f2e-444a-addd-a1a7fd72c9d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_351477c7-f115-42a8-b2e2-2a7bd4ae75ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_d214c5ed-c2ab-4d49-bca5-44a34b1deeac" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_351477c7-f115-42a8-b2e2-2a7bd4ae75ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a336e3b0-aea0-4370-a001-f8afea8eb70d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_d214c5ed-c2ab-4d49-bca5-44a34b1deeac" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a336e3b0-aea0-4370-a001-f8afea8eb70d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsDeferredRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/Leases" xlink:type="simple" xlink:href="mrna-20201231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseRightOfUseAsset_474b4955-7041-42f8-8970-05517e69fca9" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3c1c215a-2f09-4307-b72c-6ea529e2d38d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mrna_OperatingAndFinanceLeaseRightOfUseAsset_474b4955-7041-42f8-8970-05517e69fca9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3c1c215a-2f09-4307-b72c-6ea529e2d38d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_61c8ff63-11e6-4f14-8bd1-c4aec6395e81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mrna_OperatingAndFinanceLeaseRightOfUseAsset_474b4955-7041-42f8-8970-05517e69fca9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_61c8ff63-11e6-4f14-8bd1-c4aec6395e81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseLiabilityCurrent_dc43aefa-b987-4a7d-9cc1-b1dbe33ddd25" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f1b801e2-6201-4ab8-955d-d760e8834e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mrna_OperatingAndFinanceLeaseLiabilityCurrent_dc43aefa-b987-4a7d-9cc1-b1dbe33ddd25" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f1b801e2-6201-4ab8-955d-d760e8834e5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e45aefbd-51de-46d6-a246-34953c047294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mrna_OperatingAndFinanceLeaseLiabilityCurrent_dc43aefa-b987-4a7d-9cc1-b1dbe33ddd25" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e45aefbd-51de-46d6-a246-34953c047294" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseLiability_0b09ee2a-57da-4dfe-a0ee-ee9021c2f2f3" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_02d3821a-748f-47f0-bf98-db488a8cc4c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mrna_OperatingAndFinanceLeaseLiability_0b09ee2a-57da-4dfe-a0ee-ee9021c2f2f3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_02d3821a-748f-47f0-bf98-db488a8cc4c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent_cef3e97c-29c2-4f84-a308-cbfc26c5dcbe" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mrna_OperatingAndFinanceLeaseLiability_0b09ee2a-57da-4dfe-a0ee-ee9021c2f2f3" xlink:to="loc_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent_cef3e97c-29c2-4f84-a308-cbfc26c5dcbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent_9200c890-382d-4f3e-a607-e89a3b4fa222" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f079cc9f-3d02-4634-9e9c-2caa0a732984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent_9200c890-382d-4f3e-a607-e89a3b4fa222" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f079cc9f-3d02-4634-9e9c-2caa0a732984" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8ab5006d-2cfe-450f-b303-1ca2b967e364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent_9200c890-382d-4f3e-a607-e89a3b4fa222" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8ab5006d-2cfe-450f-b303-1ca2b967e364" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesLeaseCostsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/LeasesLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FinanceLeaseCost_fdb687da-50bc-42aa-affe-091ca84a2dd6" xlink:href="mrna-20201231.xsd#mrna_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_ed795703-9801-405a-86a6-71340eabcf66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mrna_FinanceLeaseCost_fdb687da-50bc-42aa-affe-091ca84a2dd6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_ed795703-9801-405a-86a6-71340eabcf66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_970d1fcf-3d67-4470-bb87-a25f3aa81a39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mrna_FinanceLeaseCost_fdb687da-50bc-42aa-affe-091ca84a2dd6" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_970d1fcf-3d67-4470-bb87-a25f3aa81a39" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f56af9b1-3fbe-4c4f-9118-925e4386740a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_accbeb43-5e95-4526-b759-42deb61718c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f56af9b1-3fbe-4c4f-9118-925e4386740a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_accbeb43-5e95-4526-b759-42deb61718c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e8776013-5289-4ce3-8d78-07b7bb6ab442" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f56af9b1-3fbe-4c4f-9118-925e4386740a" xlink:to="loc_us-gaap_OperatingLeaseLiability_e8776013-5289-4ce3-8d78-07b7bb6ab442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_517d3105-e1df-4528-8b01-f734b9e02835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_20e1acf2-858a-4d66-af8f-e983ffaab2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_517d3105-e1df-4528-8b01-f734b9e02835" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_20e1acf2-858a-4d66-af8f-e983ffaab2fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_e1aa53c2-eb3a-4d6f-ae90-7b23af27a048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_517d3105-e1df-4528-8b01-f734b9e02835" xlink:to="loc_us-gaap_FinanceLeaseLiability_e1aa53c2-eb3a-4d6f-ae90-7b23af27a048" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d0b7edb-0e4c-4819-af9f-a1987d10bf75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_38a94529-b2c1-422d-9b31-bbb535e72e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d0b7edb-0e4c-4819-af9f-a1987d10bf75" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_38a94529-b2c1-422d-9b31-bbb535e72e37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_03d2ce52-74e3-4627-ac0a-8eb0c47300d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d0b7edb-0e4c-4819-af9f-a1987d10bf75" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_03d2ce52-74e3-4627-ac0a-8eb0c47300d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_ca1f8c2b-9c58-4d94-b88a-a6478933896c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d0b7edb-0e4c-4819-af9f-a1987d10bf75" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_ca1f8c2b-9c58-4d94-b88a-a6478933896c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5c4576e4-b740-452b-9957-6bc527aa7090" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d0b7edb-0e4c-4819-af9f-a1987d10bf75" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5c4576e4-b740-452b-9957-6bc527aa7090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_cbb52f58-9ad5-48d2-b463-7d500e3b8e94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d0b7edb-0e4c-4819-af9f-a1987d10bf75" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_cbb52f58-9ad5-48d2-b463-7d500e3b8e94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_75221cfa-be9d-4fef-9dbb-f18049323a0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_5d0b7edb-0e4c-4819-af9f-a1987d10bf75" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_75221cfa-be9d-4fef-9dbb-f18049323a0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2f719570-1e99-4a6b-9b06-64644edd4537" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f6dbbba0-3ae5-4a1e-8dce-9843ee145ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2f719570-1e99-4a6b-9b06-64644edd4537" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f6dbbba0-3ae5-4a1e-8dce-9843ee145ee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_18a1f54f-3800-40e9-885b-1a2c40d21682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2f719570-1e99-4a6b-9b06-64644edd4537" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_18a1f54f-3800-40e9-885b-1a2c40d21682" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f89b9cff-0d77-4593-afb5-343d98a3fab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2f719570-1e99-4a6b-9b06-64644edd4537" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f89b9cff-0d77-4593-afb5-343d98a3fab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f92bd82a-2a18-466d-a5ef-311db9004c9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2f719570-1e99-4a6b-9b06-64644edd4537" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f92bd82a-2a18-466d-a5ef-311db9004c9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_449c2d0a-db47-47d0-8359-ef30aa008973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2f719570-1e99-4a6b-9b06-64644edd4537" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_449c2d0a-db47-47d0-8359-ef30aa008973" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_280bc3eb-6361-43eb-bc06-c781f90aa257" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2f719570-1e99-4a6b-9b06-64644edd4537" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_280bc3eb-6361-43eb-bc06-c781f90aa257" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesStrategicCollaborationsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesIndemnificationObligationsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesLicensestoPatentedTechnologyDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock" xlink:type="simple" xlink:href="mrna-20201231.xsd#RedeemableConvertiblePreferredStockandCommonStock"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationOptionsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/EmployeeBenefitPlan" xlink:type="simple" xlink:href="mrna-20201231.xsd#EmployeeBenefitPlan"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/EmployeeBenefitPlan" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/EmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#EmployeeBenefitPlanDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/EmployeeBenefitPlanDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d37cac27-4958-4c64-8c89-139cc8b5f304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_76d7b9c0-0449-4d5f-8547-8b6a949e59a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d37cac27-4958-4c64-8c89-139cc8b5f304" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_76d7b9c0-0449-4d5f-8547-8b6a949e59a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_82397aed-26d7-4e23-92c0-3ed34985f1dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d37cac27-4958-4c64-8c89-139cc8b5f304" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_82397aed-26d7-4e23-92c0-3ed34985f1dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c0af4763-96fb-476e-b031-aa8d7ddfd65f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_71a05273-d0a8-4599-a4dd-b0cdb84906a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_c0af4763-96fb-476e-b031-aa8d7ddfd65f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_71a05273-d0a8-4599-a4dd-b0cdb84906a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_89cfa3c0-b196-4c7c-9629-fd6d3d6a4d7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3676c06f-4627-42cd-b558-478478642e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_89cfa3c0-b196-4c7c-9629-fd6d3d6a4d7b" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3676c06f-4627-42cd-b558-478478642e8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_727f7ca5-7139-4d83-ae8d-36e454b013be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_89cfa3c0-b196-4c7c-9629-fd6d3d6a4d7b" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_727f7ca5-7139-4d83-ae8d-36e454b013be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ab5e8b5b-3858-4ea2-a6a5-171fa2f30211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_89cfa3c0-b196-4c7c-9629-fd6d3d6a4d7b" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ab5e8b5b-3858-4ea2-a6a5-171fa2f30211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a9ee6e02-abd9-44b7-8b14-65b15511a2cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_341dedab-6b5d-44f3-9cbb-916c17c134fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a9ee6e02-abd9-44b7-8b14-65b15511a2cc" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_341dedab-6b5d-44f3-9cbb-916c17c134fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4c5a1e20-b3a4-436f-b1d1-cdab358b867c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a9ee6e02-abd9-44b7-8b14-65b15511a2cc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4c5a1e20-b3a4-436f-b1d1-cdab358b867c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_15a47445-b57a-4691-af31-874cacec0a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_bdae026e-7898-4f34-aecf-78da026bfd3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_15a47445-b57a-4691-af31-874cacec0a5e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_bdae026e-7898-4f34-aecf-78da026bfd3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_11237e2e-c59a-411b-a440-ca1ab87f4c02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_15a47445-b57a-4691-af31-874cacec0a5e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_11237e2e-c59a-411b-a440-ca1ab87f4c02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_be455790-9e39-4ec7-b695-365b3c9eeda1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_15a47445-b57a-4691-af31-874cacec0a5e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_be455790-9e39-4ec7-b695-365b3c9eeda1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_57ff8942-1f8f-4ed1-ba15-b6b623d8e08f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_15a47445-b57a-4691-af31-874cacec0a5e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_57ff8942-1f8f-4ed1-ba15-b6b623d8e08f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_77fb4db9-a36f-4001-9aa9-f019d37fb4cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_15a47445-b57a-4691-af31-874cacec0a5e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_77fb4db9-a36f-4001-9aa9-f019d37fb4cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f848b2c1-8532-41cb-8fe3-b6a4ecd7a8d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_15a47445-b57a-4691-af31-874cacec0a5e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_f848b2c1-8532-41cb-8fe3-b6a4ecd7a8d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_5243f439-887c-462f-9652-718e7a22ebb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_15a47445-b57a-4691-af31-874cacec0a5e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_5243f439-887c-462f-9652-718e7a22ebb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_fb7de52a-0697-474b-8353-29a7a0f295ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_15a47445-b57a-4691-af31-874cacec0a5e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_fb7de52a-0697-474b-8353-29a7a0f295ea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_26c0d4dc-9555-4643-840b-286831655985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4d682d6d-c16f-4077-a135-581b8f0d24f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_26c0d4dc-9555-4643-840b-286831655985" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_4d682d6d-c16f-4077-a135-581b8f0d24f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_79823000-d349-4a4a-869e-d9af21612ea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_26c0d4dc-9555-4643-840b-286831655985" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_79823000-d349-4a4a-869e-d9af21612ea8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_f2708cba-5627-4b42-b19b-1c3c31e8651c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_01e6fafd-2557-4e8e-858f-9db5d0c2ccf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_f2708cba-5627-4b42-b19b-1c3c31e8651c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_01e6fafd-2557-4e8e-858f-9db5d0c2ccf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5a784c27-4a92-4ce6-95de-9922c97ab63d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_f2708cba-5627-4b42-b19b-1c3c31e8651c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5a784c27-4a92-4ce6-95de-9922c97ab63d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c277ee2f-8b7b-4454-a086-b2cfafe8bfb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0286fb5f-3f90-4a8c-bc10-f5c664023110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_c277ee2f-8b7b-4454-a086-b2cfafe8bfb5" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0286fb5f-3f90-4a8c-bc10-f5c664023110" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset_2db36aa3-a7c4-4c1b-bf09-92197f23d71a" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_c277ee2f-8b7b-4454-a086-b2cfafe8bfb5" xlink:to="loc_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset_2db36aa3-a7c4-4c1b-bf09-92197f23d71a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_990915a1-d0c7-4451-a208-793266b7adb9" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_c277ee2f-8b7b-4454-a086-b2cfafe8bfb5" xlink:to="loc_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_990915a1-d0c7-4451-a208-793266b7adb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_fb4c1810-223c-4432-a248-76efae5c6e74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_70f44d58-4aee-4211-a900-3170f1ead8d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_fb4c1810-223c-4432-a248-76efae5c6e74" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_70f44d58-4aee-4211-a900-3170f1ead8d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_12789fac-0c41-48d3-9091-dd30c84b1a65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_fb4c1810-223c-4432-a248-76efae5c6e74" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_12789fac-0c41-48d3-9091-dd30c84b1a65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts_0f30b995-ef68-45c8-834f-af3d15c70d6b" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_fb4c1810-223c-4432-a248-76efae5c6e74" xlink:to="loc_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts_0f30b995-ef68-45c8-834f-af3d15c70d6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_d9bbff8d-6c82-454b-b3a6-bb1e09a2e0f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_fb4c1810-223c-4432-a248-76efae5c6e74" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_d9bbff8d-6c82-454b-b3a6-bb1e09a2e0f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_78ee22c4-7082-42e5-b7d5-46670af4efc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_fb4c1810-223c-4432-a248-76efae5c6e74" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_78ee22c4-7082-42e5-b7d5-46670af4efc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_2f4533e1-b221-4efc-b646-2e6d29d727bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_fb4c1810-223c-4432-a248-76efae5c6e74" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_2f4533e1-b221-4efc-b646-2e6d29d727bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_54aec26e-d9dd-4c73-8230-d7f0306890fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_fb4c1810-223c-4432-a248-76efae5c6e74" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_54aec26e-d9dd-4c73-8230-d7f0306890fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsOperatingLeaseLiability_814fbc1f-a173-431d-aa79-520bb061fd7a" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_fb4c1810-223c-4432-a248-76efae5c6e74" xlink:to="loc_mrna_DeferredTaxAssetsOperatingLeaseLiability_814fbc1f-a173-431d-aa79-520bb061fd7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsFinancingLeaseLiability_e19422a2-1ef4-4f9f-84d6-afb25b36506a" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsFinancingLeaseLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_fb4c1810-223c-4432-a248-76efae5c6e74" xlink:to="loc_mrna_DeferredTaxAssetsFinancingLeaseLiability_e19422a2-1ef4-4f9f-84d6-afb25b36506a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShare" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShare"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/NetLossperShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShareTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShareTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/NetLossperShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/GeographicInformation" xlink:type="simple" xlink:href="mrna-20201231.xsd#GeographicInformation"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/GeographicInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/GeographicInformationTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#GeographicInformationTables"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/GeographicInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/GeographicInformationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#GeographicInformationDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/GeographicInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="mrna-20201231.xsd#SubsequentEvent"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/SubsequentEvent" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SubsequentEventsDetails"/>
  <link:calculationLink xlink:role="http://www.modernatx.com/role/SubsequentEventsDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>mrna-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:587e37ef-2d85-4611-b0f5-79aaf037b83c,g:a4c5467e-e912-4919-957b-a5dc25d57b8f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/Cover" xlink:type="simple" xlink:href="mrna-20201231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/Cover" xlink:type="extended" id="id869aab487ef42108805ab715fc15a4c_Cover"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="ia5f8848b737145329cb53cb2c0f61c0f_CONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i9a992d34ab4648cb94c37b01f6286410_CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i983d1e26177c44749b19da4de0bc4b37_CONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_44531a82-e843-42f9-bf76-02341e9d2062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_RevenuesAbstract_44531a82-e843-42f9-bf76-02341e9d2062" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_35872149-de02-4a00-9015-480ed5017e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_44531a82-e843-42f9-bf76-02341e9d2062" xlink:to="loc_us-gaap_Revenues_35872149-de02-4a00-9015-480ed5017e33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d777e2e5-14d1-4154-9400-0ad239064ed8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d777e2e5-14d1-4154-9400-0ad239064ed8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2026d311-152e-4ac4-acae-4c9151cbc9f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2026d311-152e-4ac4-acae-4c9151cbc9f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9f5bdff3-8a4c-4841-9571-f54130db1ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9f5bdff3-8a4c-4841-9571-f54130db1ad6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5b522978-0826-4ab8-aa6a-d2dafd0cc57d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:to="loc_us-gaap_CostsAndExpenses_5b522978-0826-4ab8-aa6a-d2dafd0cc57d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c10f9082-6445-41ac-bebf-b3d9c2818f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_OperatingIncomeLoss_c10f9082-6445-41ac-bebf-b3d9c2818f24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_52bfbc48-a033-42b8-a5c9-6be1889811e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_InvestmentIncomeInterest_52bfbc48-a033-42b8-a5c9-6be1889811e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_33c06645-52f0-4124-bfba-c36150fb3354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_33c06645-52f0-4124-bfba-c36150fb3354" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_01005e4b-cdfb-4e37-b26b-4229cea7dfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_01005e4b-cdfb-4e37-b26b-4229cea7dfeb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d1d6d816-b312-4235-bf8a-8733bba68696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d1d6d816-b312-4235-bf8a-8733bba68696" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_41c05de8-e324-4214-bcb3-dfcee77e6cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_NetIncomeLoss_41c05de8-e324-4214-bcb3-dfcee77e6cb9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_57b7b0be-9207-464e-b24f-89ff8f67e8cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_57b7b0be-9207-464e-b24f-89ff8f67e8cc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockRedemptionPremium_84923864-c45e-4b43-9aff-03bad0614406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockRedemptionPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_57b7b0be-9207-464e-b24f-89ff8f67e8cc" xlink:to="loc_us-gaap_PreferredStockRedemptionPremium_84923864-c45e-4b43-9aff-03bad0614406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockDividends_2b838c91-6a1a-48bf-82f5-dd7a5c328e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_57b7b0be-9207-464e-b24f-89ff8f67e8cc" xlink:to="loc_us-gaap_RedeemablePreferredStockDividends_2b838c91-6a1a-48bf-82f5-dd7a5c328e99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4e233f7e-7e3d-4a5c-bea4-7d3820730eb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4e233f7e-7e3d-4a5c-bea4-7d3820730eb3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_dbca39a2-90a4-49fc-8545-031a6bbdc9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_dbca39a2-90a4-49fc-8545-031a6bbdc9b2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_b603d5e2-b905-4ccb-8d42-0425c67ff56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_b603d5e2-b905-4ccb-8d42-0425c67ff56e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c82373d7-bee2-463a-88a1-c5ef415146b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_StatementTable_c82373d7-bee2-463a-88a1-c5ef415146b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_46da70d2-82b6-4215-a746-f1675dfa99ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c82373d7-bee2-463a-88a1-c5ef415146b2" xlink:to="loc_srt_ProductOrServiceAxis_46da70d2-82b6-4215-a746-f1675dfa99ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_46da70d2-82b6-4215-a746-f1675dfa99ee_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_46da70d2-82b6-4215-a746-f1675dfa99ee" xlink:to="loc_srt_ProductsAndServicesDomain_46da70d2-82b6-4215-a746-f1675dfa99ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_949fd2ef-ea2a-4257-b138-30bd6d314485" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_46da70d2-82b6-4215-a746-f1675dfa99ee" xlink:to="loc_srt_ProductsAndServicesDomain_949fd2ef-ea2a-4257-b138-30bd6d314485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_4865a67d-0ca5-48f5-a7e1-d3fc6df4ecf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_949fd2ef-ea2a-4257-b138-30bd6d314485" xlink:to="loc_us-gaap_GrantMember_4865a67d-0ca5-48f5-a7e1-d3fc6df4ecf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ProductSalesMember_86500364-cdc9-4091-89cd-efa796bb8f11" xlink:href="mrna-20201231.xsd#mrna_ProductSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_949fd2ef-ea2a-4257-b138-30bd6d314485" xlink:to="loc_mrna_ProductSalesMember_86500364-cdc9-4091-89cd-efa796bb8f11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_f1203602-b15f-4c57-97f6-e50c54721dd8" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_949fd2ef-ea2a-4257-b138-30bd6d314485" xlink:to="loc_mrna_CollaborationArrangementMember_f1203602-b15f-4c57-97f6-e50c54721dd8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended" id="i44f7ba33a7bd441faff42652c1b0f065_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" xlink:type="extended" id="i0959c3f1bfe249d599ed5a9694f4baed_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY" xlink:type="extended" id="i85e85f3576104c98a41160d2e50530b9_CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0770a070-50d1-4675-9a57-4c341f62ae0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0770a070-50d1-4675-9a57-4c341f62ae0b" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_5aeedcda-e10a-4467-9ec0-19989d59a360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_5aeedcda-e10a-4467-9ec0-19989d59a360" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a4c33d94-01da-4d1b-a8a3-907c0074bb7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a4c33d94-01da-4d1b-a8a3-907c0074bb7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_c15d428c-2966-42c8-b2f6-ef4916f557ac" xlink:href="mrna-20201231.xsd#mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_c15d428c-2966-42c8-b2f6-ef4916f557ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_c0e2e089-4f84-4e96-b7a6-93836ab0a7a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_c0e2e089-4f84-4e96-b7a6-93836ab0a7a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares_0da7fe7c-9827-47d7-8219-57a9a304c5d1" xlink:href="mrna-20201231.xsd#mrna_TemporaryEquityStockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares_0da7fe7c-9827-47d7-8219-57a9a304c5d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue_dfaadf39-2795-4ed4-9433-e9193d99f239" xlink:href="mrna-20201231.xsd#mrna_TemporaryEquityStockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue_dfaadf39-2795-4ed4-9433-e9193d99f239" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_dfad6aca-1055-40da-b0aa-5e1a72db5508" xlink:href="mrna-20201231.xsd#mrna_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_dfad6aca-1055-40da-b0aa-5e1a72db5508" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_12863e91-b47b-4377-832a-e2206fa82536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_12863e91-b47b-4377-832a-e2206fa82536" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_a576a8c5-d15d-4599-8764-e12bfce3fdee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_961aa497-873c-46d6-8c48-5ecd14b48fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0770a070-50d1-4675-9a57-4c341f62ae0b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_7abf119c-154b-40e6-a370-c36b6380f3b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_SharesOutstanding_7abf119c-154b-40e6-a370-c36b6380f3b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b6940e2d-61d3-4947-9974-d02e3026aebe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockholdersEquity_b6940e2d-61d3-4947-9974-d02e3026aebe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_fbd8df22-6ea9-40f8-a2a4-5ccc5b679841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_fbd8df22-6ea9-40f8-a2a4-5ccc5b679841" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b734f145-7f85-4c49-938c-4022046e8d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b734f145-7f85-4c49-938c-4022046e8d65" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0925c3d5-7191-4e7d-b790-397d30b77779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0925c3d5-7191-4e7d-b790-397d30b77779" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2bac59d6-5831-4148-bd99-7f0c3d36be28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2bac59d6-5831-4148-bd99-7f0c3d36be28" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_69159b4c-4943-45c5-aa35-cb537b70fedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_69159b4c-4943-45c5-aa35-cb537b70fedf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_4b974ee1-4cf4-41ab-91e2-2c2bed6b8d6e" xlink:href="mrna-20201231.xsd#mrna_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_b20d4ef8-344f-4441-94c5-09ecf81cb60a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_dd48e244-95cd-4d52-bfb4-a2024f6225e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_dd48e244-95cd-4d52-bfb4-a2024f6225e1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1e49aada-fae5-4bfb-8dfa-f09653d4bd57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1e49aada-fae5-4bfb-8dfa-f09653d4bd57" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bb3afb5a-c56b-4d6c-9269-dc3eb3d090cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bb3afb5a-c56b-4d6c-9269-dc3eb3d090cf" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_79ddbc49-b52a-49b8-bec4-23851e92a1c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_79ddbc49-b52a-49b8-bec4-23851e92a1c1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2214729-3f80-440b-b8fc-646f114375fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_NetIncomeLoss_c2214729-3f80-440b-b8fc-646f114375fd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4c5e5449-286a-46bd-9d67-7bd95a31bb73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_065f85c4-dc38-490e-a0f8-341aabaaea88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0770a070-50d1-4675-9a57-4c341f62ae0b" xlink:to="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_325ac5cd-51ca-4e4a-a4e8-071c48b7358b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_325ac5cd-51ca-4e4a-a4e8-071c48b7358b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_325ac5cd-51ca-4e4a-a4e8-071c48b7358b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_325ac5cd-51ca-4e4a-a4e8-071c48b7358b" xlink:to="loc_us-gaap_TypeOfAdoptionMember_325ac5cd-51ca-4e4a-a4e8-071c48b7358b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3f0899b2-ffab-493d-a112-0fd7326297ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_325ac5cd-51ca-4e4a-a4e8-071c48b7358b" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3f0899b2-ffab-493d-a112-0fd7326297ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_1a3909e3-df5c-4b2f-9700-8d18c2c1852d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3f0899b2-ffab-493d-a112-0fd7326297ac" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_1a3909e3-df5c-4b2f-9700-8d18c2c1852d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_8d5f8945-2d93-41dc-a1be-300677c0acbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3f0899b2-ffab-493d-a112-0fd7326297ac" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_8d5f8945-2d93-41dc-a1be-300677c0acbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_abac770f-7d23-4058-ae62-33c6890afacc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_abac770f-7d23-4058-ae62-33c6890afacc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_abac770f-7d23-4058-ae62-33c6890afacc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abac770f-7d23-4058-ae62-33c6890afacc" xlink:to="loc_us-gaap_EquityComponentDomain_abac770f-7d23-4058-ae62-33c6890afacc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abac770f-7d23-4058-ae62-33c6890afacc" xlink:to="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_a9328de8-b851-453c-a22a-de0a9413ad62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:to="loc_us-gaap_PreferredStockMember_a9328de8-b851-453c-a22a-de0a9413ad62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ea823062-17c8-465b-b99d-fd5a7c2a1971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:to="loc_us-gaap_CommonStockMember_ea823062-17c8-465b-b99d-fd5a7c2a1971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ede96309-4034-45c6-8ff3-43f938756a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ede96309-4034-45c6-8ff3-43f938756a49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_261f5801-1b36-4fca-8d5e-9d4e9b6e275f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_261f5801-1b36-4fca-8d5e-9d4e9b6e275f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_dc4dc5f3-c599-48d9-8e99-536414080add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:to="loc_us-gaap_RetainedEarningsMember_dc4dc5f3-c599-48d9-8e99-536414080add" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3507f754-9725-4dbc-ba88-0defea92c5a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3507f754-9725-4dbc-ba88-0defea92c5a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3507f754-9725-4dbc-ba88-0defea92c5a6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3507f754-9725-4dbc-ba88-0defea92c5a6" xlink:to="loc_us-gaap_ClassOfStockDomain_3507f754-9725-4dbc-ba88-0defea92c5a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3507f754-9725-4dbc-ba88-0defea92c5a6" xlink:to="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesGPreferredStockMember_520bfe22-80a4-477b-a120-b9e40010de31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesGPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:to="loc_us-gaap_SeriesGPreferredStockMember_520bfe22-80a4-477b-a120-b9e40010de31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesHPreferredStockMember_dcf18e22-fc6e-49e8-b036-b8e4c4484ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesHPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:to="loc_us-gaap_SeriesHPreferredStockMember_dcf18e22-fc6e-49e8-b036-b8e4c4484ea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_512fce0d-8bff-44fa-8016-c956c7e87ba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_512fce0d-8bff-44fa-8016-c956c7e87ba3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_f93da79f-4abe-49e7-b860-10f1f5604943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_f93da79f-4abe-49e7-b860-10f1f5604943" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8a509ea1-cc6b-4c61-8a39-9b1f629296de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8a509ea1-cc6b-4c61-8a39-9b1f629296de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a509ea1-cc6b-4c61-8a39-9b1f629296de_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8a509ea1-cc6b-4c61-8a39-9b1f629296de" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8a509ea1-cc6b-4c61-8a39-9b1f629296de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b0a040d5-fe71-437c-b0ce-758e7c018c4e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8a509ea1-cc6b-4c61-8a39-9b1f629296de" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b0a040d5-fe71-437c-b0ce-758e7c018c4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_19d35076-7e3d-4829-9b76-46568eaef055" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b0a040d5-fe71-437c-b0ce-758e7c018c4e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_19d35076-7e3d-4829-9b76-46568eaef055" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended" id="i54b35f103525463b8cb69483661cb696_CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b38bb9c5-56dd-4bc6-8264-b81920c105b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_fef89a2f-abfa-494c-8956-52d15b272184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b38bb9c5-56dd-4bc6-8264-b81920c105b5" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_fef89a2f-abfa-494c-8956-52d15b272184" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_854f92fd-31d3-47a0-a064-7074ca14b366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b38bb9c5-56dd-4bc6-8264-b81920c105b5" xlink:to="loc_us-gaap_StatementTable_854f92fd-31d3-47a0-a064-7074ca14b366" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4fa6d8c8-38fa-458c-ad62-d919cf8c37c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_854f92fd-31d3-47a0-a064-7074ca14b366" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4fa6d8c8-38fa-458c-ad62-d919cf8c37c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4fa6d8c8-38fa-458c-ad62-d919cf8c37c4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4fa6d8c8-38fa-458c-ad62-d919cf8c37c4" xlink:to="loc_us-gaap_ClassOfStockDomain_4fa6d8c8-38fa-458c-ad62-d919cf8c37c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8aa59fae-d5cc-4f86-aad6-f4776d0d9a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4fa6d8c8-38fa-458c-ad62-d919cf8c37c4" xlink:to="loc_us-gaap_ClassOfStockDomain_8aa59fae-d5cc-4f86-aad6-f4776d0d9a41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesGPreferredStockMember_6da6aa28-078c-4826-8d30-f75b21ed04b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesGPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8aa59fae-d5cc-4f86-aad6-f4776d0d9a41" xlink:to="loc_us-gaap_SeriesGPreferredStockMember_6da6aa28-078c-4826-8d30-f75b21ed04b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesHPreferredStockMember_8b320966-434c-4037-b19e-259363d8378a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesHPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8aa59fae-d5cc-4f86-aad6-f4776d0d9a41" xlink:to="loc_us-gaap_SeriesHPreferredStockMember_8b320966-434c-4037-b19e-259363d8378a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i02d8e760f0b1417ba066ab71e99098a7_CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/OrganizationandDescriptionofBusiness" xlink:type="simple" xlink:href="mrna-20201231.xsd#OrganizationandDescriptionofBusiness"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/OrganizationandDescriptionofBusiness" xlink:type="extended" id="iaaf8292b6e1745d6bc3850a19ec221b7_OrganizationandDescriptionofBusiness"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OrganizationandDescriptionofBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="extended" id="i4c6c0848c8aa46559e1a85913cbaad4d_OrganizationandDescriptionofBusinessDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="ib15784d542f84883b681d2ad41b66506_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i67674c2290d24b9cba2c129b3a70bd5c_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="i6879fe56b4dc42d5a07d58606594ceb8_SummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i84b69f63ca724ee2a25dd7bac316b8a1_SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_3b35a67d-2f06-45b4-870a-d2cd3db6f5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_DebtInstrumentTerm_3b35a67d-2f06-45b4-870a-d2cd3db6f5a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_5908d1a8-dbd7-4dfa-ab2a-ffbd39e9f2a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_5908d1a8-dbd7-4dfa-ab2a-ffbd39e9f2a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_0469bdbe-8202-4071-bcfd-86d98d6c23c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_0469bdbe-8202-4071-bcfd-86d98d6c23c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_78c170c7-8d20-4e3c-b1e2-81eeb5c1db21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_AssetImpairmentCharges_78c170c7-8d20-4e3c-b1e2-81eeb5c1db21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_94326a92-792f-4ab6-b427-80a76191f8aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_94326a92-792f-4ab6-b427-80a76191f8aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_76ec4ef3-62b6-4cfd-95dd-3fc92dce78fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_76ec4ef3-62b6-4cfd-95dd-3fc92dce78fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76ec4ef3-62b6-4cfd-95dd-3fc92dce78fb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_76ec4ef3-62b6-4cfd-95dd-3fc92dce78fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_76ec4ef3-62b6-4cfd-95dd-3fc92dce78fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e9a06d60-4557-4f75-a6a0-ed5fb0143136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_76ec4ef3-62b6-4cfd-95dd-3fc92dce78fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e9a06d60-4557-4f75-a6a0-ed5fb0143136" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_527df401-a6e1-45ce-9a1f-9922e9893b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e9a06d60-4557-4f75-a6a0-ed5fb0143136" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_527df401-a6e1-45ce-9a1f-9922e9893b27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a19d0f10-bd52-43c1-a22f-95a9a086ed5a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:to="loc_srt_RangeAxis_a19d0f10-bd52-43c1-a22f-95a9a086ed5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a19d0f10-bd52-43c1-a22f-95a9a086ed5a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a19d0f10-bd52-43c1-a22f-95a9a086ed5a" xlink:to="loc_srt_RangeMember_a19d0f10-bd52-43c1-a22f-95a9a086ed5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_152dbbe7-f517-45f6-ba5c-d36cee21c9f7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a19d0f10-bd52-43c1-a22f-95a9a086ed5a" xlink:to="loc_srt_RangeMember_152dbbe7-f517-45f6-ba5c-d36cee21c9f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_54bbf982-b56e-4b6c-9f7f-3f257e16bfb6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_152dbbe7-f517-45f6-ba5c-d36cee21c9f7" xlink:to="loc_srt_MinimumMember_54bbf982-b56e-4b6c-9f7f-3f257e16bfb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b7ec644f-803b-4aef-ae4f-14e2a946bfd3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_152dbbe7-f517-45f6-ba5c-d36cee21c9f7" xlink:to="loc_srt_MaximumMember_b7ec644f-803b-4aef-ae4f-14e2a946bfd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2f42a27c-d244-4207-9ec9-0990305959c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2f42a27c-d244-4207-9ec9-0990305959c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_2f42a27c-d244-4207-9ec9-0990305959c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2f42a27c-d244-4207-9ec9-0990305959c7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_2f42a27c-d244-4207-9ec9-0990305959c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_55a04c9c-815e-4b97-b74f-32c161fd4338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2f42a27c-d244-4207-9ec9-0990305959c7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_55a04c9c-815e-4b97-b74f-32c161fd4338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_081f5709-d623-42fd-9b6e-3f862f5c3040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_55a04c9c-815e-4b97-b74f-32c161fd4338" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_081f5709-d623-42fd-9b6e-3f862f5c3040" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b412de-c7e4-4bfa-8135-baaedbd5043e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b412de-c7e4-4bfa-8135-baaedbd5043e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e3b412de-c7e4-4bfa-8135-baaedbd5043e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b412de-c7e4-4bfa-8135-baaedbd5043e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e3b412de-c7e4-4bfa-8135-baaedbd5043e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357fbb75-7ebf-4c87-992b-8af49d3874e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b412de-c7e4-4bfa-8135-baaedbd5043e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357fbb75-7ebf-4c87-992b-8af49d3874e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EquipmentAndLeasedFacilitiesMember_42e5c573-8368-4b31-beb2-266f21501f5c" xlink:href="mrna-20201231.xsd#mrna_EquipmentAndLeasedFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357fbb75-7ebf-4c87-992b-8af49d3874e7" xlink:to="loc_mrna_EquipmentAndLeasedFacilitiesMember_42e5c573-8368-4b31-beb2-266f21501f5c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended" id="i033e39fb046f4010a394cfe5b26e4915_SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" xlink:type="extended" id="i6d972f6732c143d89e2a00e44633eaa0_SummaryofSignificantAccountingPoliciesSignificantCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c1f82c1a-ffe3-4a7c-8333-18ea5f26ec87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ac6ffa65-0d66-43b8-b035-4caa48551e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c1f82c1a-ffe3-4a7c-8333-18ea5f26ec87" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ac6ffa65-0d66-43b8-b035-4caa48551e5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c1f82c1a-ffe3-4a7c-8333-18ea5f26ec87" xlink:to="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78e1d679-df3c-41cd-9d24-25e5515d13db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78e1d679-df3c-41cd-9d24-25e5515d13db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_78e1d679-df3c-41cd-9d24-25e5515d13db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78e1d679-df3c-41cd-9d24-25e5515d13db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_78e1d679-df3c-41cd-9d24-25e5515d13db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5f8dc405-59ac-4480-968e-4d6054f2cfdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78e1d679-df3c-41cd-9d24-25e5515d13db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5f8dc405-59ac-4480-968e-4d6054f2cfdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_e79fdfef-2791-4a32-bfd0-e9fba1bb778f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5f8dc405-59ac-4480-968e-4d6054f2cfdb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_e79fdfef-2791-4a32-bfd0-e9fba1bb778f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_36f540cf-4ea9-41e0-842c-c9b8e5edfb40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5f8dc405-59ac-4480-968e-4d6054f2cfdb" xlink:to="loc_us-gaap_AccountsReceivableMember_36f540cf-4ea9-41e0-842c-c9b8e5edfb40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6728f997-b6d0-474b-abf2-71568f6ac0ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6728f997-b6d0-474b-abf2-71568f6ac0ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6728f997-b6d0-474b-abf2-71568f6ac0ed_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6728f997-b6d0-474b-abf2-71568f6ac0ed" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6728f997-b6d0-474b-abf2-71568f6ac0ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_684022b3-b1d1-4cc0-8145-577bc082e45f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6728f997-b6d0-474b-abf2-71568f6ac0ed" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_684022b3-b1d1-4cc0-8145-577bc082e45f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1c665043-c6eb-4a3c-bd3d-05977820b617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_684022b3-b1d1-4cc0-8145-577bc082e45f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1c665043-c6eb-4a3c-bd3d-05977820b617" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_942741ed-04bc-4ffe-8a37-2e906c36f508" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:to="loc_srt_MajorCustomersAxis_942741ed-04bc-4ffe-8a37-2e906c36f508" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_942741ed-04bc-4ffe-8a37-2e906c36f508_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_942741ed-04bc-4ffe-8a37-2e906c36f508" xlink:to="loc_srt_NameOfMajorCustomerDomain_942741ed-04bc-4ffe-8a37-2e906c36f508_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_942741ed-04bc-4ffe-8a37-2e906c36f508" xlink:to="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckMember_06596963-9817-4c5d-bfe6-dde8519c40d9" xlink:href="mrna-20201231.xsd#mrna_MerckMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_MerckMember_06596963-9817-4c5d-bfe6-dde8519c40d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_fadf8117-0e6c-4552-ac34-b3346b03e011" xlink:href="mrna-20201231.xsd#mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_fadf8117-0e6c-4552-ac34-b3346b03e011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexMember_9e4e8b24-a2af-4807-80e7-90f08d3836a8" xlink:href="mrna-20201231.xsd#mrna_VertexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_VertexMember_9e4e8b24-a2af-4807-80e7-90f08d3836a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AstraZenecaMember_d3da1f22-375f-4a8a-8737-f2bb308effa7" xlink:href="mrna-20201231.xsd#mrna_AstraZenecaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_AstraZenecaMember_d3da1f22-375f-4a8a-8737-f2bb308effa7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_USGovermentMember_208de73d-6c85-4c71-a2bf-603bc4c4f3a4" xlink:href="mrna-20201231.xsd#mrna_USGovermentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_USGovermentMember_208de73d-6c85-4c71-a2bf-603bc4c4f3a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EuropeanCommissionMember_e7706c56-00cb-4f23-a071-60cc628a771e" xlink:href="mrna-20201231.xsd#mrna_EuropeanCommissionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_EuropeanCommissionMember_e7706c56-00cb-4f23-a071-60cc628a771e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UnitedKingdomGovernmentMember_cf5a9a98-3b2d-4d14-83b3-a682a395fdb6" xlink:href="mrna-20201231.xsd#mrna_UnitedKingdomGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_UnitedKingdomGovernmentMember_cf5a9a98-3b2d-4d14-83b3-a682a395fdb6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SouthKoreaGovernmentMember_6a0cbd22-c1d5-44e2-96bb-170c40343c90" xlink:href="mrna-20201231.xsd#mrna_SouthKoreaGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_SouthKoreaGovernmentMember_6a0cbd22-c1d5-44e2-96bb-170c40343c90" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails" xlink:type="extended" id="i8590674e682f49a1b19c5afd0993384d_SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7afe4c80-534a-4a83-bf72-e997f82a9981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9106098b-942f-4354-a05e-8b90af8baecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7afe4c80-534a-4a83-bf72-e997f82a9981" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9106098b-942f-4354-a05e-8b90af8baecf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c9f483db-d4f9-46a3-ab47-d5fb899d71ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7afe4c80-534a-4a83-bf72-e997f82a9981" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c9f483db-d4f9-46a3-ab47-d5fb899d71ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30efa7ee-b344-4941-a0a3-ec88c6a2b390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c9f483db-d4f9-46a3-ab47-d5fb899d71ee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30efa7ee-b344-4941-a0a3-ec88c6a2b390" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30efa7ee-b344-4941-a0a3-ec88c6a2b390_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30efa7ee-b344-4941-a0a3-ec88c6a2b390" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_30efa7ee-b344-4941-a0a3-ec88c6a2b390_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30efa7ee-b344-4941-a0a3-ec88c6a2b390" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_411d6842-d603-4eee-9f0c-5bb8bfaf4c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:to="loc_us-gaap_EquipmentMember_411d6842-d603-4eee-9f0c-5bb8bfaf4c7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_5a250d7a-1d3e-4d7c-b24a-cde58c7f0808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:to="loc_us-gaap_ComputerEquipmentMember_5a250d7a-1d3e-4d7c-b24a-cde58c7f0808" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_6899f426-9f35-46f1-a514-a8efa736ec4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_6899f426-9f35-46f1-a514-a8efa736ec4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_3527884b-072b-4654-8ddd-653ebd6379f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOtherTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_3527884b-072b-4654-8ddd-653ebd6379f4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="i3c3e590fe4cd463cbabd5163f0082b2c_SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_599b965c-fd83-4652-9f5f-7486e626d043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4dab7827-dfeb-486b-b1ae-685d940d1a1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_599b965c-fd83-4652-9f5f-7486e626d043" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4dab7827-dfeb-486b-b1ae-685d940d1a1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_04227241-b221-4dfb-aba1-03f6d4c5808e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4dab7827-dfeb-486b-b1ae-685d940d1a1e" xlink:to="loc_us-gaap_StockholdersEquity_04227241-b221-4dfb-aba1-03f6d4c5808e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c98e5035-da73-4136-9c98-c2568faf12be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4dab7827-dfeb-486b-b1ae-685d940d1a1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c98e5035-da73-4136-9c98-c2568faf12be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8055afb2-1d11-4776-9567-157c869264f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_56776959-6870-474b-aa97-c2e4e0cd3517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_599b965c-fd83-4652-9f5f-7486e626d043" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_56776959-6870-474b-aa97-c2e4e0cd3517" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e1e86715-2b41-4321-955f-cb9e8f3e8988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_56776959-6870-474b-aa97-c2e4e0cd3517" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e1e86715-2b41-4321-955f-cb9e8f3e8988" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e1e86715-2b41-4321-955f-cb9e8f3e8988_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e1e86715-2b41-4321-955f-cb9e8f3e8988" xlink:to="loc_us-gaap_EquityComponentDomain_e1e86715-2b41-4321-955f-cb9e8f3e8988_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_74a53070-e327-4b22-ba51-fa17d93d799b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e1e86715-2b41-4321-955f-cb9e8f3e8988" xlink:to="loc_us-gaap_EquityComponentDomain_74a53070-e327-4b22-ba51-fa17d93d799b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a5309982-6832-441a-bf24-060982b5cdfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_74a53070-e327-4b22-ba51-fa17d93d799b" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a5309982-6832-441a-bf24-060982b5cdfd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/GrantRevenue" xlink:type="simple" xlink:href="mrna-20201231.xsd#GrantRevenue"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/GrantRevenue" xlink:type="extended" id="i5f7d926777c14a398e16269d3f745029_GrantRevenue"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/GrantRevenueTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#GrantRevenueTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/GrantRevenueTables" xlink:type="extended" id="i458cfa9dbd7d44e79f9f592540be3324_GrantRevenueTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/GrantRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#GrantRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/GrantRevenueDetails" xlink:type="extended" id="i6e3ec39ebb2a46cba8eef223b5f3824a_GrantRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsMaximumAward_95cab80a-f871-4f34-ae4a-353fb345cef4" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsMaximumAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_mrna_RevenueFromGrantsMaximumAward_95cab80a-f871-4f34-ae4a-353fb345cef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsRemainingFundingCapacity_9d3e10f1-660d-4420-b417-170fb5c2db2b" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsRemainingFundingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_mrna_RevenueFromGrantsRemainingFundingCapacity_9d3e10f1-660d-4420-b417-170fb5c2db2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_2936da3b-c7b4-403d-87c6-22e639e25219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_us-gaap_OtherCommitment_2936da3b-c7b4-403d-87c6-22e639e25219" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsCurrentFundingCapacity_352262f5-ac5c-456b-8509-c01fe4985016" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsCurrentFundingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_mrna_RevenueFromGrantsCurrentFundingCapacity_352262f5-ac5c-456b-8509-c01fe4985016" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsNumberOfContractOptions_40a0bcf4-b1c5-433a-97d8-e54cddb2aa74" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsNumberOfContractOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_mrna_RevenueFromGrantsNumberOfContractOptions_40a0bcf4-b1c5-433a-97d8-e54cddb2aa74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsNumberOfContractOptionsExercised_e120aea8-3566-4ed8-b7b4-a5d0fe1e381a" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsNumberOfContractOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_mrna_RevenueFromGrantsNumberOfContractOptionsExercised_e120aea8-3566-4ed8-b7b4-a5d0fe1e381a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e2a9a4fb-c744-428b-83eb-ea4c6ab7d4e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_us-gaap_Revenues_e2a9a4fb-c744-428b-83eb-ea4c6ab7d4e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9df543b2-2c0c-4c89-ad4b-e007dc758a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9df543b2-2c0c-4c89-ad4b-e007dc758a3c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_f7801227-3a4d-4c6d-bc21-4c83bae07974" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:to="loc_srt_MajorCustomersAxis_f7801227-3a4d-4c6d-bc21-4c83bae07974" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f7801227-3a4d-4c6d-bc21-4c83bae07974_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_f7801227-3a4d-4c6d-bc21-4c83bae07974" xlink:to="loc_srt_NameOfMajorCustomerDomain_f7801227-3a4d-4c6d-bc21-4c83bae07974_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_f7801227-3a4d-4c6d-bc21-4c83bae07974" xlink:to="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_179b392f-5ca1-46a0-9844-b4ac3e74dacb" xlink:href="mrna-20201231.xsd#mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:to="loc_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_179b392f-5ca1-46a0-9844-b4ac3e74dacb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DefenseAdvancedResearchProjectsAgencyMember_686e536f-b946-4984-8e83-e4ab9972c8bd" xlink:href="mrna-20201231.xsd#mrna_DefenseAdvancedResearchProjectsAgencyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:to="loc_mrna_DefenseAdvancedResearchProjectsAgencyMember_686e536f-b946-4984-8e83-e4ab9972c8bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TheBillAndMelindaGatesFoundationMember_b181de48-0561-43e8-9181-0d4609ce875a" xlink:href="mrna-20201231.xsd#mrna_TheBillAndMelindaGatesFoundationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:to="loc_mrna_TheBillAndMelindaGatesFoundationMember_b181de48-0561-43e8-9181-0d4609ce875a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OtherGrantRevenueMember_d4d93d66-7bdc-4ac3-975f-07425250bf8d" xlink:href="mrna-20201231.xsd#mrna_OtherGrantRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:to="loc_mrna_OtherGrantRevenueMember_d4d93d66-7bdc-4ac3-975f-07425250bf8d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_942facdc-d0ed-40f3-b5b9-4ef980bfa695" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:to="loc_srt_ProductOrServiceAxis_942facdc-d0ed-40f3-b5b9-4ef980bfa695" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_942facdc-d0ed-40f3-b5b9-4ef980bfa695_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_942facdc-d0ed-40f3-b5b9-4ef980bfa695" xlink:to="loc_srt_ProductsAndServicesDomain_942facdc-d0ed-40f3-b5b9-4ef980bfa695_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_097bb9b0-0944-4f69-a3f9-98e5b233f691" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_942facdc-d0ed-40f3-b5b9-4ef980bfa695" xlink:to="loc_srt_ProductsAndServicesDomain_097bb9b0-0944-4f69-a3f9-98e5b233f691" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_03bb4342-2255-448f-825a-3b68f32c6028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_097bb9b0-0944-4f69-a3f9-98e5b233f691" xlink:to="loc_us-gaap_GrantMember_03bb4342-2255-448f-825a-3b68f32c6028" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_1052b8cb-a862-4eb4-8cee-a302b4d22dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_1052b8cb-a862-4eb4-8cee-a302b4d22dd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_1052b8cb-a862-4eb4-8cee-a302b4d22dd1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_1052b8cb-a862-4eb4-8cee-a302b4d22dd1" xlink:to="loc_us-gaap_ProjectMember_1052b8cb-a862-4eb4-8cee-a302b4d22dd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_9d8b69aa-e4ff-4b85-93ed-cea84364d10b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_1052b8cb-a862-4eb4-8cee-a302b4d22dd1" xlink:to="loc_us-gaap_ProjectMember_9d8b69aa-e4ff-4b85-93ed-cea84364d10b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractOptionsMember_fd6aea06-6b11-4516-bc9b-f6fc1919b140" xlink:href="mrna-20201231.xsd#mrna_ContractOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_9d8b69aa-e4ff-4b85-93ed-cea84364d10b" xlink:to="loc_mrna_ContractOptionsMember_fd6aea06-6b11-4516-bc9b-f6fc1919b140" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_InitialProjectMember_33c9f9f1-000d-4db9-8c78-d2ae574243a9" xlink:href="mrna-20201231.xsd#mrna_InitialProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_9d8b69aa-e4ff-4b85-93ed-cea84364d10b" xlink:to="loc_mrna_InitialProjectMember_33c9f9f1-000d-4db9-8c78-d2ae574243a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fb32502b-fb10-4f4b-9cc0-07680d5ceafc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:to="loc_srt_RangeAxis_fb32502b-fb10-4f4b-9cc0-07680d5ceafc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fb32502b-fb10-4f4b-9cc0-07680d5ceafc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fb32502b-fb10-4f4b-9cc0-07680d5ceafc" xlink:to="loc_srt_RangeMember_fb32502b-fb10-4f4b-9cc0-07680d5ceafc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57d9922c-059b-4fe8-942b-2abf17f0ba19" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fb32502b-fb10-4f4b-9cc0-07680d5ceafc" xlink:to="loc_srt_RangeMember_57d9922c-059b-4fe8-942b-2abf17f0ba19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_07fd02fd-7a49-43c6-bbfe-52b89509433b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_57d9922c-059b-4fe8-942b-2abf17f0ba19" xlink:to="loc_srt_MinimumMember_07fd02fd-7a49-43c6-bbfe-52b89509433b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e901c6ca-8570-4210-b957-227c929ba936" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_57d9922c-059b-4fe8-942b-2abf17f0ba19" xlink:to="loc_srt_MaximumMember_e901c6ca-8570-4210-b957-227c929ba936" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/ProductSales" xlink:type="simple" xlink:href="mrna-20201231.xsd#ProductSales"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/ProductSales" xlink:type="extended" id="i245c73a97bb142d99da7684ad59b3dc2_ProductSales"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/ProductSalesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#ProductSalesTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/ProductSalesTables" xlink:type="extended" id="i911dfe0ceafa4a4396ca0cda25d55ceb_ProductSalesTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/ProductSalesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#ProductSalesDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/ProductSalesDetails" xlink:type="extended" id="i43bdc1cc5ec04a0eb8742e4e0434139b_ProductSalesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c73acc7a-d36c-457a-9cae-1f95be4b25c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6f22ff37-8b25-47bd-bec4-5d645fa9f970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c73acc7a-d36c-457a-9cae-1f95be4b25c4" xlink:to="loc_us-gaap_Revenues_6f22ff37-8b25-47bd-bec4-5d645fa9f970" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1316eaff-e959-489f-8aac-f9d99df033dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c73acc7a-d36c-457a-9cae-1f95be4b25c4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1316eaff-e959-489f-8aac-f9d99df033dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_350a25cd-18dd-4589-91a5-48b447c72e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c73acc7a-d36c-457a-9cae-1f95be4b25c4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_350a25cd-18dd-4589-91a5-48b447c72e1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e5535602-f07a-4092-a441-7f688a87a6d6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_350a25cd-18dd-4589-91a5-48b447c72e1c" xlink:to="loc_srt_StatementGeographicalAxis_e5535602-f07a-4092-a441-7f688a87a6d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e5535602-f07a-4092-a441-7f688a87a6d6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e5535602-f07a-4092-a441-7f688a87a6d6" xlink:to="loc_srt_SegmentGeographicalDomain_e5535602-f07a-4092-a441-7f688a87a6d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0e438ac8-f14e-4d38-838f-7d24f75760f4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e5535602-f07a-4092-a441-7f688a87a6d6" xlink:to="loc_srt_SegmentGeographicalDomain_0e438ac8-f14e-4d38-838f-7d24f75760f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b9003b63-3a9a-4f9b-83f4-05e7505609a1" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e438ac8-f14e-4d38-838f-7d24f75760f4" xlink:to="loc_country_US_b9003b63-3a9a-4f9b-83f4-05e7505609a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_25960037-9602-4927-b405-67346504c87a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0e438ac8-f14e-4d38-838f-7d24f75760f4" xlink:to="loc_us-gaap_NonUsMember_25960037-9602-4927-b405-67346504c87a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c95b1724-58d2-43cf-b233-675efc06eed8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_350a25cd-18dd-4589-91a5-48b447c72e1c" xlink:to="loc_srt_ProductOrServiceAxis_c95b1724-58d2-43cf-b233-675efc06eed8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c95b1724-58d2-43cf-b233-675efc06eed8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c95b1724-58d2-43cf-b233-675efc06eed8" xlink:to="loc_srt_ProductsAndServicesDomain_c95b1724-58d2-43cf-b233-675efc06eed8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ae49037e-9463-43c7-9bf5-4cc6efd18ce6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c95b1724-58d2-43cf-b233-675efc06eed8" xlink:to="loc_srt_ProductsAndServicesDomain_ae49037e-9463-43c7-9bf5-4cc6efd18ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ProductSalesMember_cddfff9e-9032-47e6-b205-38a14e34d00d" xlink:href="mrna-20201231.xsd#mrna_ProductSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ae49037e-9463-43c7-9bf5-4cc6efd18ce6" xlink:to="loc_mrna_ProductSalesMember_cddfff9e-9032-47e6-b205-38a14e34d00d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CustomerDepositsMember_cb749936-e4e6-4d26-b47e-ddef69f5443b" xlink:href="mrna-20201231.xsd#mrna_CustomerDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ae49037e-9463-43c7-9bf5-4cc6efd18ce6" xlink:to="loc_mrna_CustomerDepositsMember_cb749936-e4e6-4d26-b47e-ddef69f5443b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreements" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreements"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreements" xlink:type="extended" id="ia016bcd1f2454feaa12c3573eca4b29e_CollaborationAgreements"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTables" xlink:type="extended" id="ia12083b11af54552b662289e47c68439_CollaborationAgreementsTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails" xlink:type="extended" id="if8b112b483614266ba49228673eb169f_CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b73460c-f46d-44d9-b95d-36dd71e62944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_553f563a-c962-4e08-b429-cc2d52e47277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b73460c-f46d-44d9-b95d-36dd71e62944" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_553f563a-c962-4e08-b429-cc2d52e47277" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b73460c-f46d-44d9-b95d-36dd71e62944" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7812d680-7e31-4c6d-bad7-f8f746c3019c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:to="loc_srt_ProductOrServiceAxis_7812d680-7e31-4c6d-bad7-f8f746c3019c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7812d680-7e31-4c6d-bad7-f8f746c3019c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_7812d680-7e31-4c6d-bad7-f8f746c3019c" xlink:to="loc_srt_ProductsAndServicesDomain_7812d680-7e31-4c6d-bad7-f8f746c3019c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4eeb7d09-fb08-4fea-903d-7f331a85c751" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_7812d680-7e31-4c6d-bad7-f8f746c3019c" xlink:to="loc_srt_ProductsAndServicesDomain_4eeb7d09-fb08-4fea-903d-7f331a85c751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_1222580d-702c-49a6-8e6a-976fb12bd874" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4eeb7d09-fb08-4fea-903d-7f331a85c751" xlink:to="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_1222580d-702c-49a6-8e6a-976fb12bd874" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_096cbd44-fe16-45ee-bcdf-fd22b512fd70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:to="loc_srt_CounterpartyNameAxis_096cbd44-fe16-45ee-bcdf-fd22b512fd70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_096cbd44-fe16-45ee-bcdf-fd22b512fd70_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_096cbd44-fe16-45ee-bcdf-fd22b512fd70" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_096cbd44-fe16-45ee-bcdf-fd22b512fd70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_096cbd44-fe16-45ee-bcdf-fd22b512fd70" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckMember_a75034ca-e8a2-4a1d-8f66-a1a879576ef2" xlink:href="mrna-20201231.xsd#mrna_MerckMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:to="loc_mrna_MerckMember_a75034ca-e8a2-4a1d-8f66-a1a879576ef2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AstraZenecaMember_1e361fb4-c2b0-4f2e-92fb-970771e870d4" xlink:href="mrna-20201231.xsd#mrna_AstraZenecaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:to="loc_mrna_AstraZenecaMember_1e361fb4-c2b0-4f2e-92fb-970771e870d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexMember_451bee3f-9a0c-4fff-b137-6b10d32852fc" xlink:href="mrna-20201231.xsd#mrna_VertexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:to="loc_mrna_VertexMember_451bee3f-9a0c-4fff-b137-6b10d32852fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OtherMember_c02b2da2-373a-4e52-a563-1fec1a0b9fe1" xlink:href="mrna-20201231.xsd#mrna_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:to="loc_mrna_OtherMember_c02b2da2-373a-4e52-a563-1fec1a0b9fe1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_0ffb9b2f-9ebd-48f4-b9ca-0eeb155382a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_0ffb9b2f-9ebd-48f4-b9ca-0eeb155382a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_0ffb9b2f-9ebd-48f4-b9ca-0eeb155382a6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_0ffb9b2f-9ebd-48f4-b9ca-0eeb155382a6" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_0ffb9b2f-9ebd-48f4-b9ca-0eeb155382a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_0fc54cb4-d15b-4724-af5e-016601ee93df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_0ffb9b2f-9ebd-48f4-b9ca-0eeb155382a6" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_0fc54cb4-d15b-4724-af5e-016601ee93df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member_69660f88-e1cb-47e7-9779-78a940f1eec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_0fc54cb4-d15b-4724-af5e-016601ee93df" xlink:to="loc_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member_69660f88-e1cb-47e7-9779-78a940f1eec0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails" xlink:type="extended" id="iec2d02966bc64bb6845eab8170654539_CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractwithCustomerAssetRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_51ed5633-54d3-44e4-9972-1a2d025890e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_51ed5633-54d3-44e4-9972-1a2d025890e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerAssetIncreaseDuringPeriod_9bd673d2-62e5-464f-8437-835d68b551ad" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerAssetIncreaseDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:to="loc_mrna_ContractWithCustomerAssetIncreaseDuringPeriod_9bd673d2-62e5-464f-8437-835d68b551ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerAssetDecreaseDuringPeriod_6865d114-166c-4592-a6e0-54b67e532a77" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerAssetDecreaseDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:to="loc_mrna_ContractWithCustomerAssetDecreaseDuringPeriod_6865d114-166c-4592-a6e0-54b67e532a77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_a696da43-cccd-497e-8153-1f0d2fbe611b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_bb0f38f8-5c03-4aff-82fc-21d63a85068f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:to="loc_us-gaap_ContractWithCustomerLiability_bb0f38f8-5c03-4aff-82fc-21d63a85068f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod_20a573d0-0fac-4777-94ed-67a60e221eab" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:to="loc_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod_20a573d0-0fac-4777-94ed-67a60e221eab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod_8ea65fd5-ff3c-43fe-b4b4-b674f7c42d0f" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:to="loc_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod_8ea65fd5-ff3c-43fe-b4b4-b674f7c42d0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e79dedea-cb55-4e21-9686-8b756a353374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_64223038-ef2c-471c-85ef-f71d24452b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_64223038-ef2c-471c-85ef-f71d24452b18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_2a14ebdd-b26e-442a-a01d-fa7933b299d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_2a14ebdd-b26e-442a-a01d-fa7933b299d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5a89c882-89b4-41c2-bee5-b23cfcd9f156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5a89c882-89b4-41c2-bee5-b23cfcd9f156" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_692104ff-ff03-4e1d-be15-856ee7af257d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_692104ff-ff03-4e1d-be15-856ee7af257d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d85e722b-9c5c-495b-bf92-7d5d89e743d7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_692104ff-ff03-4e1d-be15-856ee7af257d" xlink:to="loc_srt_ProductOrServiceAxis_d85e722b-9c5c-495b-bf92-7d5d89e743d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d85e722b-9c5c-495b-bf92-7d5d89e743d7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d85e722b-9c5c-495b-bf92-7d5d89e743d7" xlink:to="loc_srt_ProductsAndServicesDomain_d85e722b-9c5c-495b-bf92-7d5d89e743d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a147f547-b754-41d4-9756-5298e7d482c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d85e722b-9c5c-495b-bf92-7d5d89e743d7" xlink:to="loc_srt_ProductsAndServicesDomain_a147f547-b754-41d4-9756-5298e7d482c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_2967e03c-f432-49b7-bc59-f3dbfd444104" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a147f547-b754-41d4-9756-5298e7d482c1" xlink:to="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_2967e03c-f432-49b7-bc59-f3dbfd444104" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationRevenueRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails" xlink:type="extended" id="ibe17ebd7f15a449d879ad8aedf42fb6c_CollaborationRevenueRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_1ab6568e-a1ba-4ecc-b339-7a33ce68c589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_1ab6568e-a1ba-4ecc-b339-7a33ce68c589" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_71e6b1b6-731a-45f0-9875-f9d64e859892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_71e6b1b6-731a-45f0-9875-f9d64e859892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fbed7522-d5cd-4232-bcb8-0bc49f9170a2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fbed7522-d5cd-4232-bcb8-0bc49f9170a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_1228be16-5a58-48cd-b447-a0b661ec4050" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_Combined2018AZAgreementsMember_1228be16-5a58-48cd-b447-a0b661ec4050" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_c469aedf-4be8-4b6f-8ddd-e1daf59e6830" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_VEGFExercise2016Member_c469aedf-4be8-4b6f-8ddd-e1daf59e6830" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_c9b25891-efe6-4919-b26c-f572ef45bc7a" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_PCVSAVAgreementMember_c9b25891-efe6-4919-b26c-f572ef45bc7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_7db4260d-7d2a-4c08-9b3f-75e17738684b" xlink:href="mrna-20201231.xsd#mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_7db4260d-7d2a-4c08-9b3f-75e17738684b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:to="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_243b4f48-6798-4add-8867-90627a15c1c9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:to="loc_srt_ProductsAndServicesDomain_243b4f48-6798-4add-8867-90627a15c1c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_14bf82ad-1e02-40f4-8d70-e020f4c6a47f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:to="loc_srt_ProductsAndServicesDomain_14bf82ad-1e02-40f4-8d70-e020f4c6a47f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_16c6bb4f-b8a1-45d0-9f59-c1511c3d36ff" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_14bf82ad-1e02-40f4-8d70-e020f4c6a47f" xlink:to="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_16c6bb4f-b8a1-45d0-9f59-c1511c3d36ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_083e0c8f-40e6-4585-babf-2c75365fbdd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_083e0c8f-40e6-4585-babf-2c75365fbdd5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationRevenueRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended" id="i7e818976ef8f487d8550f7bdab0f9316_CollaborationRevenueRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_1ab6568e-a1ba-4ecc-b339-7a33ce68c589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_1ab6568e-a1ba-4ecc-b339-7a33ce68c589" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_71e6b1b6-731a-45f0-9875-f9d64e859892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_71e6b1b6-731a-45f0-9875-f9d64e859892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fbed7522-d5cd-4232-bcb8-0bc49f9170a2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fbed7522-d5cd-4232-bcb8-0bc49f9170a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_1228be16-5a58-48cd-b447-a0b661ec4050" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_Combined2018AZAgreementsMember_1228be16-5a58-48cd-b447-a0b661ec4050" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_c469aedf-4be8-4b6f-8ddd-e1daf59e6830" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_VEGFExercise2016Member_c469aedf-4be8-4b6f-8ddd-e1daf59e6830" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_c9b25891-efe6-4919-b26c-f572ef45bc7a" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_PCVSAVAgreementMember_c9b25891-efe6-4919-b26c-f572ef45bc7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_7db4260d-7d2a-4c08-9b3f-75e17738684b" xlink:href="mrna-20201231.xsd#mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_7db4260d-7d2a-4c08-9b3f-75e17738684b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:to="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_243b4f48-6798-4add-8867-90627a15c1c9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:to="loc_srt_ProductsAndServicesDomain_243b4f48-6798-4add-8867-90627a15c1c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_14bf82ad-1e02-40f4-8d70-e020f4c6a47f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:to="loc_srt_ProductsAndServicesDomain_14bf82ad-1e02-40f4-8d70-e020f4c6a47f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_16c6bb4f-b8a1-45d0-9f59-c1511c3d36ff" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_14bf82ad-1e02-40f4-8d70-e020f4c6a47f" xlink:to="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_16c6bb4f-b8a1-45d0-9f59-c1511c3d36ff" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails" xlink:type="extended" id="ib9681bffb948494583f4b5ff290e2c82_CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions_6acd36c6-cf02-4920-83ac-f085e0488f44" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions_6acd36c6-cf02-4920-83ac-f085e0488f44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_3445f511-0aa6-41ae-88eb-105777b86940" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_3445f511-0aa6-41ae-88eb-105777b86940" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones_8ccb1a44-0f72-4a5a-807e-256822ecf698" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones_8ccb1a44-0f72-4a5a-807e-256822ecf698" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee_e790c5d5-7bdc-4ac2-a554-02f831271f48" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee_e790c5d5-7bdc-4ac2-a554-02f831271f48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent_8c3023b4-47d4-406f-b264-4d9e16251596" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent_8c3023b4-47d4-406f-b264-4d9e16251596" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_5a5378fb-0860-484c-bd84-467c11d919a8" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_5a5378fb-0860-484c-bd84-467c11d919a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent_48f50980-5f28-40c8-af15-f5ba18c18e51" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent_48f50980-5f28-40c8-af15-f5ba18c18e51" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent_42350dda-073b-4e8c-93b5-c7bb274a2ca6" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent_42350dda-073b-4e8c-93b5-c7bb274a2ca6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod_92ae9982-efb0-4e80-b369-ee6d6a3d8ee5" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod_92ae9982-efb0-4e80-b369-ee6d6a3d8ee5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_979476a4-27c3-4d23-b97c-8d3d8dd746bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_979476a4-27c3-4d23-b97c-8d3d8dd746bf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_63c10670-d3d5-499a-86e3-51103971febb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_63c10670-d3d5-499a-86e3-51103971febb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationAxis_36197310-94d2-4a12-81e2-f709dd791813" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_mrna_PerformanceObligationAxis_36197310-94d2-4a12-81e2-f709dd791813" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_36197310-94d2-4a12-81e2-f709dd791813_default" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mrna_PerformanceObligationAxis_36197310-94d2-4a12-81e2-f709dd791813" xlink:to="loc_mrna_PerformanceObligationDomain_36197310-94d2-4a12-81e2-f709dd791813_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mrna_PerformanceObligationAxis_36197310-94d2-4a12-81e2-f709dd791813" xlink:to="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementPerformanceObligationMember_629bb9da-1d32-4cb0-8529-549976e67d0a" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:to="loc_mrna_Combined2018AZAgreementPerformanceObligationMember_629bb9da-1d32-4cb0-8529-549976e67d0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_IL12PerformanceObligationMember_df04b245-5b6a-417f-86d0-1657059b164f" xlink:href="mrna-20201231.xsd#mrna_IL12PerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:to="loc_mrna_IL12PerformanceObligationMember_df04b245-5b6a-417f-86d0-1657059b164f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OncologyDevelopmentTargetPerformanceObligationMember_58d7b964-499b-4f4a-95d4-c39ede84b9dd" xlink:href="mrna-20201231.xsd#mrna_OncologyDevelopmentTargetPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:to="loc_mrna_OncologyDevelopmentTargetPerformanceObligationMember_58d7b964-499b-4f4a-95d4-c39ede84b9dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_2a795b27-eedb-4b9a-9fad-38121baefca9" xlink:href="mrna-20201231.xsd#mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:to="loc_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_2a795b27-eedb-4b9a-9fad-38121baefca9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_a762b08b-eaa9-45fd-8afb-9afc357be373" xlink:href="mrna-20201231.xsd#mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:to="loc_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_a762b08b-eaa9-45fd-8afb-9afc357be373" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1652d90f-781e-4a80-bb21-454436548380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1652d90f-781e-4a80-bb21-454436548380" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1652d90f-781e-4a80-bb21-454436548380_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1652d90f-781e-4a80-bb21-454436548380" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1652d90f-781e-4a80-bb21-454436548380_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1652d90f-781e-4a80-bb21-454436548380" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VariableConsiderationMember_d5a940bf-e4a5-46bb-8662-0c7a3d45b890" xlink:href="mrna-20201231.xsd#mrna_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:to="loc_mrna_VariableConsiderationMember_d5a940bf-e4a5-46bb-8662-0c7a3d45b890" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EstimatedReimbursementMember_3109343d-aa41-4fcb-92aa-6371b2cac95b" xlink:href="mrna-20201231.xsd#mrna_EstimatedReimbursementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:to="loc_mrna_EstimatedReimbursementMember_3109343d-aa41-4fcb-92aa-6371b2cac95b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MilestonePaymentsMember_fec3cd43-2516-439b-b34b-e870ae1cf330" xlink:href="mrna-20201231.xsd#mrna_MilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:to="loc_mrna_MilestonePaymentsMember_fec3cd43-2516-439b-b34b-e870ae1cf330" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OptionExerciseFeeMember_48f00cd4-83b2-4ac7-b868-d6bd5bf446ef" xlink:href="mrna-20201231.xsd#mrna_OptionExerciseFeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:to="loc_mrna_OptionExerciseFeeMember_48f00cd4-83b2-4ac7-b868-d6bd5bf446ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4ef8949d-57d3-4941-8dd3-9a22711f6f9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4ef8949d-57d3-4941-8dd3-9a22711f6f9e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4ef8949d-57d3-4941-8dd3-9a22711f6f9e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4ef8949d-57d3-4941-8dd3-9a22711f6f9e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4ef8949d-57d3-4941-8dd3-9a22711f6f9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4ef8949d-57d3-4941-8dd3-9a22711f6f9e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_111abd47-8c11-4116-ab59-e075252a7b64" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:to="loc_mrna_Combined2018AZAgreementsMember_111abd47-8c11-4116-ab59-e075252a7b64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember_b198ebcf-55a8-4061-ac1c-1397a0b3ee75" xlink:href="mrna-20201231.xsd#mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:to="loc_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember_b198ebcf-55a8-4061-ac1c-1397a0b3ee75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_4b8851fc-ac6e-48af-ad42-d1b0e52a2255" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:to="loc_mrna_VEGFExercise2016Member_4b8851fc-ac6e-48af-ad42-d1b0e52a2255" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member_24e3d46b-d5dd-405a-8d02-529c86d2d841" xlink:href="mrna-20201231.xsd#mrna_A2016StrategicAllianceWithAstraZenecaIL12Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:to="loc_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member_24e3d46b-d5dd-405a-8d02-529c86d2d841" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember_a280c9dc-9d7e-4360-b378-8c276ec25242" xlink:href="mrna-20201231.xsd#mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:to="loc_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember_a280c9dc-9d7e-4360-b378-8c276ec25242" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_13a95736-feef-41b8-ac8a-d744fd57de9e" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_13a95736-feef-41b8-ac8a-d744fd57de9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_13a95736-feef-41b8-ac8a-d744fd57de9e_default" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_13a95736-feef-41b8-ac8a-d744fd57de9e" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_13a95736-feef-41b8-ac8a-d744fd57de9e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_a18a2798-95c6-49db-9c46-cf85a32d8840" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_13a95736-feef-41b8-ac8a-d744fd57de9e" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_a18a2798-95c6-49db-9c46-cf85a32d8840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentMilestonesMember_613c1189-339a-4f1b-b759-3751de4043c4" xlink:href="mrna-20201231.xsd#mrna_DevelopmentMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_a18a2798-95c6-49db-9c46-cf85a32d8840" xlink:to="loc_mrna_DevelopmentMilestonesMember_613c1189-339a-4f1b-b759-3751de4043c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RegulatoryMilestonesMember_90cd38cd-e4a1-409f-84ce-7156e55d9a6f" xlink:href="mrna-20201231.xsd#mrna_RegulatoryMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_a18a2798-95c6-49db-9c46-cf85a32d8840" xlink:to="loc_mrna_RegulatoryMilestonesMember_90cd38cd-e4a1-409f-84ce-7156e55d9a6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CommercialMilestonesMember_b34cfabf-1fc6-435b-bcdc-79482ccbeb9a" xlink:href="mrna-20201231.xsd#mrna_CommercialMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_a18a2798-95c6-49db-9c46-cf85a32d8840" xlink:to="loc_mrna_CommercialMilestonesMember_b34cfabf-1fc6-435b-bcdc-79482ccbeb9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1e4f0558-68fa-4f55-8872-32618e66609f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_srt_RangeAxis_1e4f0558-68fa-4f55-8872-32618e66609f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1e4f0558-68fa-4f55-8872-32618e66609f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1e4f0558-68fa-4f55-8872-32618e66609f" xlink:to="loc_srt_RangeMember_1e4f0558-68fa-4f55-8872-32618e66609f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_178ab795-e72e-4825-89d4-3cc99858d6df" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1e4f0558-68fa-4f55-8872-32618e66609f" xlink:to="loc_srt_RangeMember_178ab795-e72e-4825-89d4-3cc99858d6df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c4a15272-a5ab-4aed-8879-d1063daef074" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_178ab795-e72e-4825-89d4-3cc99858d6df" xlink:to="loc_srt_MinimumMember_c4a15272-a5ab-4aed-8879-d1063daef074" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cf05fcf3-0912-4018-a98f-c30734f920bd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_178ab795-e72e-4825-89d4-3cc99858d6df" xlink:to="loc_srt_MaximumMember_cf05fcf3-0912-4018-a98f-c30734f920bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_27728527-4612-467d-913a-d1448390991f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_27728527-4612-467d-913a-d1448390991f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_27728527-4612-467d-913a-d1448390991f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_27728527-4612-467d-913a-d1448390991f" xlink:to="loc_us-gaap_ProjectMember_27728527-4612-467d-913a-d1448390991f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_a6ca038e-81a2-4f35-80fd-68c6c5c647c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_27728527-4612-467d-913a-d1448390991f" xlink:to="loc_us-gaap_ProjectMember_a6ca038e-81a2-4f35-80fd-68c6c5c647c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFAProductAZD8601Member_8c83ef1a-092a-49e4-b876-dfb59055abdd" xlink:href="mrna-20201231.xsd#mrna_VEGFAProductAZD8601Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_a6ca038e-81a2-4f35-80fd-68c6c5c647c7" xlink:to="loc_mrna_VEGFAProductAZD8601Member_8c83ef1a-092a-49e4-b876-dfb59055abdd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails" xlink:type="extended" id="ide760f0d70164ae287e1442edb4a3e9b_CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_c4e6ce00-d119-4cc1-9ebb-ad406bb29549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_cd38541a-ae18-4670-aec8-2d8c6df5c09b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_c4e6ce00-d119-4cc1-9ebb-ad406bb29549" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_cd38541a-ae18-4670-aec8-2d8c6df5c09b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_c4e6ce00-d119-4cc1-9ebb-ad406bb29549" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c854afb6-5549-48c8-9402-40dfd5d1d398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c854afb6-5549-48c8-9402-40dfd5d1d398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c854afb6-5549-48c8-9402-40dfd5d1d398_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c854afb6-5549-48c8-9402-40dfd5d1d398" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c854afb6-5549-48c8-9402-40dfd5d1d398_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_daf9fbe8-a38a-4643-b7a8-983b49baa3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c854afb6-5549-48c8-9402-40dfd5d1d398" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_daf9fbe8-a38a-4643-b7a8-983b49baa3e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_209a6928-398e-46e1-ae9d-27900d2d4d5e" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_daf9fbe8-a38a-4643-b7a8-983b49baa3e7" xlink:to="loc_mrna_Combined2018AZAgreementsMember_209a6928-398e-46e1-ae9d-27900d2d4d5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_0aa04baa-783e-4ee3-b878-0c4b163087b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_0aa04baa-783e-4ee3-b878-0c4b163087b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_0aa04baa-783e-4ee3-b878-0c4b163087b1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_0aa04baa-783e-4ee3-b878-0c4b163087b1" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_0aa04baa-783e-4ee3-b878-0c4b163087b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_0aa04baa-783e-4ee3-b878-0c4b163087b1" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_c853dc2d-ef5e-4d6d-b310-260c4ffb46e9" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:to="loc_mrna_UpfrontPaymentMember_c853dc2d-ef5e-4d6d-b310-260c4ffb46e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SublicenseReimbursementMember_def7602d-bb7f-482c-8f8a-6889acf056d3" xlink:href="mrna-20201231.xsd#mrna_SublicenseReimbursementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:to="loc_mrna_SublicenseReimbursementMember_def7602d-bb7f-482c-8f8a-6889acf056d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MilestonePaymentsMember_6644bab7-a2cf-4bb3-b325-f8e5a0fee58f" xlink:href="mrna-20201231.xsd#mrna_MilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:to="loc_mrna_MilestonePaymentsMember_6644bab7-a2cf-4bb3-b325-f8e5a0fee58f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EstimatedReimbursementMember_90e739cb-306b-4e1f-847d-b870098086c3" xlink:href="mrna-20201231.xsd#mrna_EstimatedReimbursementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:to="loc_mrna_EstimatedReimbursementMember_90e739cb-306b-4e1f-847d-b870098086c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_d67f5846-015b-4026-a86b-8bbb06f19a68" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_d67f5846-015b-4026-a86b-8bbb06f19a68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_d67f5846-015b-4026-a86b-8bbb06f19a68_default" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_d67f5846-015b-4026-a86b-8bbb06f19a68" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_d67f5846-015b-4026-a86b-8bbb06f19a68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_c70e2d8e-0aca-40e7-a305-6c973cccdd9c" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_d67f5846-015b-4026-a86b-8bbb06f19a68" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_c70e2d8e-0aca-40e7-a305-6c973cccdd9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ToxicityMilestonesMember_c740d866-25ba-4e26-b805-39a711ba4101" xlink:href="mrna-20201231.xsd#mrna_ToxicityMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_c70e2d8e-0aca-40e7-a305-6c973cccdd9c" xlink:to="loc_mrna_ToxicityMilestonesMember_c740d866-25ba-4e26-b805-39a711ba4101" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CompetitionMilestonesMember_806abd8e-c236-4d04-a6af-5b4d53f6d299" xlink:href="mrna-20201231.xsd#mrna_CompetitionMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_c70e2d8e-0aca-40e7-a305-6c973cccdd9c" xlink:to="loc_mrna_CompetitionMilestonesMember_806abd8e-c236-4d04-a6af-5b4d53f6d299" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended" id="i66e0510bec1c42709a0288306467956f_CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1b6b86ea-c624-428e-9581-af93c56115ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d984a84a-94ae-43c5-93d4-2c461315bc59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1b6b86ea-c624-428e-9581-af93c56115ae" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d984a84a-94ae-43c5-93d4-2c461315bc59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6c18855a-1c48-415e-b674-446a7e406de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1b6b86ea-c624-428e-9581-af93c56115ae" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6c18855a-1c48-415e-b674-446a7e406de5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationAxis_add138ef-c36b-4f5d-b7b0-db5e978b8222" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6c18855a-1c48-415e-b674-446a7e406de5" xlink:to="loc_mrna_PerformanceObligationAxis_add138ef-c36b-4f5d-b7b0-db5e978b8222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_add138ef-c36b-4f5d-b7b0-db5e978b8222_default" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mrna_PerformanceObligationAxis_add138ef-c36b-4f5d-b7b0-db5e978b8222" xlink:to="loc_mrna_PerformanceObligationDomain_add138ef-c36b-4f5d-b7b0-db5e978b8222_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mrna_PerformanceObligationAxis_add138ef-c36b-4f5d-b7b0-db5e978b8222" xlink:to="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementPerformanceObligationMember_d0de1897-c50e-4052-8a29-6654dcbef86b" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:to="loc_mrna_Combined2018AZAgreementPerformanceObligationMember_d0de1897-c50e-4052-8a29-6654dcbef86b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_IL12PerformanceObligationMember_920d17f6-3561-46ae-a272-26cd018a822e" xlink:href="mrna-20201231.xsd#mrna_IL12PerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:to="loc_mrna_IL12PerformanceObligationMember_920d17f6-3561-46ae-a272-26cd018a822e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OncologyDevelopmentTargetPerformanceObligationMember_13d7f990-bbdd-495c-822a-4bb8c034f445" xlink:href="mrna-20201231.xsd#mrna_OncologyDevelopmentTargetPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:to="loc_mrna_OncologyDevelopmentTargetPerformanceObligationMember_13d7f990-bbdd-495c-822a-4bb8c034f445" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_54a7e85a-c249-4a51-ac24-498e51cbeab4" xlink:href="mrna-20201231.xsd#mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:to="loc_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_54a7e85a-c249-4a51-ac24-498e51cbeab4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_9244363e-14cc-470c-b5e5-2379ffe86cd2" xlink:href="mrna-20201231.xsd#mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:to="loc_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_9244363e-14cc-470c-b5e5-2379ffe86cd2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2eb02959-6c8b-4cd7-8e2a-098f9865eda0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6c18855a-1c48-415e-b674-446a7e406de5" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2eb02959-6c8b-4cd7-8e2a-098f9865eda0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2eb02959-6c8b-4cd7-8e2a-098f9865eda0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2eb02959-6c8b-4cd7-8e2a-098f9865eda0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_2eb02959-6c8b-4cd7-8e2a-098f9865eda0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_404e026e-3331-4463-abc8-773edfa28fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2eb02959-6c8b-4cd7-8e2a-098f9865eda0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_404e026e-3331-4463-abc8-773edfa28fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_bccf3bb2-5d2b-4585-9ad5-213e5b661c08" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_404e026e-3331-4463-abc8-773edfa28fba" xlink:to="loc_mrna_Combined2018AZAgreementsMember_bccf3bb2-5d2b-4585-9ad5-213e5b661c08" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsRevenueRecognizedDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails" xlink:type="extended" id="i67ee502ce00140639a0b774e20a2f7b8_CollaborationAgreementsRevenueRecognizedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_297dee68-7c0d-48d7-9c9a-f993657ca610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_297dee68-7c0d-48d7-9c9a-f993657ca610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_d5a9688b-c26d-4091-b34d-128e00fba2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_d5a9688b-c26d-4091-b34d-128e00fba2c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:to="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0a0b0501-ba88-4485-a767-b89e1b9fe6d3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:to="loc_srt_ProductsAndServicesDomain_0a0b0501-ba88-4485-a767-b89e1b9fe6d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_27f2f2a5-a3e2-43f5-b3f8-345f77ad1b30" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:to="loc_srt_ProductsAndServicesDomain_27f2f2a5-a3e2-43f5-b3f8-345f77ad1b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_29491e27-67dc-49af-b6bd-75a32eda3514" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_27f2f2a5-a3e2-43f5-b3f8-345f77ad1b30" xlink:to="loc_mrna_CollaborationArrangementMember_29491e27-67dc-49af-b6bd-75a32eda3514" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a216429-d9f2-42f1-936d-6b9ed0bfaccc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a216429-d9f2-42f1-936d-6b9ed0bfaccc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_815b384a-0c65-488b-9d8a-995695b00504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_815b384a-0c65-488b-9d8a-995695b00504" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_4c8d5664-107e-4831-b1dd-108f877b9c69" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_815b384a-0c65-488b-9d8a-995695b00504" xlink:to="loc_mrna_Combined2018AZAgreementsMember_4c8d5664-107e-4831-b1dd-108f877b9c69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b05b349d-064b-4bea-9b4a-1f6c3ebed39b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b05b349d-064b-4bea-9b4a-1f6c3ebed39b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsRevenueRecognizedDetails_1"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails_1" xlink:type="extended" id="i5df94cb79aab4b4abcc38ba0544fc400_CollaborationAgreementsRevenueRecognizedDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_297dee68-7c0d-48d7-9c9a-f993657ca610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_297dee68-7c0d-48d7-9c9a-f993657ca610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_d5a9688b-c26d-4091-b34d-128e00fba2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_d5a9688b-c26d-4091-b34d-128e00fba2c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:to="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0a0b0501-ba88-4485-a767-b89e1b9fe6d3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:to="loc_srt_ProductsAndServicesDomain_0a0b0501-ba88-4485-a767-b89e1b9fe6d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_27f2f2a5-a3e2-43f5-b3f8-345f77ad1b30" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:to="loc_srt_ProductsAndServicesDomain_27f2f2a5-a3e2-43f5-b3f8-345f77ad1b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_29491e27-67dc-49af-b6bd-75a32eda3514" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_27f2f2a5-a3e2-43f5-b3f8-345f77ad1b30" xlink:to="loc_mrna_CollaborationArrangementMember_29491e27-67dc-49af-b6bd-75a32eda3514" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a216429-d9f2-42f1-936d-6b9ed0bfaccc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a216429-d9f2-42f1-936d-6b9ed0bfaccc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_815b384a-0c65-488b-9d8a-995695b00504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_815b384a-0c65-488b-9d8a-995695b00504" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_4c8d5664-107e-4831-b1dd-108f877b9c69" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_815b384a-0c65-488b-9d8a-995695b00504" xlink:to="loc_mrna_Combined2018AZAgreementsMember_4c8d5664-107e-4831-b1dd-108f877b9c69" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails" xlink:type="extended" id="i0fe2be9d5ff04a5e9ed203cba602dbf6_CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5a637337-56cf-4284-a44e-85904e520fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_82e43e96-6dab-47d4-8933-695c510d0b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5a637337-56cf-4284-a44e-85904e520fa9" xlink:to="loc_us-gaap_ContractWithCustomerLiability_82e43e96-6dab-47d4-8933-695c510d0b28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ca972c68-e890-4e6e-a362-b132dcc91bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5a637337-56cf-4284-a44e-85904e520fa9" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ca972c68-e890-4e6e-a362-b132dcc91bd1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_29ddfd02-c6fe-4478-b110-93501752755e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ca972c68-e890-4e6e-a362-b132dcc91bd1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_29ddfd02-c6fe-4478-b110-93501752755e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_29ddfd02-c6fe-4478-b110-93501752755e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_29ddfd02-c6fe-4478-b110-93501752755e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_29ddfd02-c6fe-4478-b110-93501752755e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4f58f84c-27c8-4d84-8e0e-6f0e47442239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_29ddfd02-c6fe-4478-b110-93501752755e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4f58f84c-27c8-4d84-8e0e-6f0e47442239" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_12405371-cefa-4556-ab6d-4122ce43e64e" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4f58f84c-27c8-4d84-8e0e-6f0e47442239" xlink:to="loc_mrna_Combined2018AZAgreementsMember_12405371-cefa-4556-ab6d-4122ce43e64e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVEGFTotalTransactionPriceDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails" xlink:type="extended" id="ife89ec1e88f141358c3e276e7bb3363c_CollaborationAgreementsVEGFTotalTransactionPriceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1b02f9e6-237d-4383-be51-6eccc7d157f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_75e9224b-ff7e-4a29-9727-557fd3239b6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1b02f9e6-237d-4383-be51-6eccc7d157f3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_75e9224b-ff7e-4a29-9727-557fd3239b6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5fe7869d-4337-4f58-8818-5d4d62a1ead0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1b02f9e6-237d-4383-be51-6eccc7d157f3" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5fe7869d-4337-4f58-8818-5d4d62a1ead0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_be7c1ed2-74e0-4706-b63e-72e761b5e398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5fe7869d-4337-4f58-8818-5d4d62a1ead0" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_be7c1ed2-74e0-4706-b63e-72e761b5e398" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_be7c1ed2-74e0-4706-b63e-72e761b5e398_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_be7c1ed2-74e0-4706-b63e-72e761b5e398" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_be7c1ed2-74e0-4706-b63e-72e761b5e398_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_be7c1ed2-74e0-4706-b63e-72e761b5e398" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OptionExerciseFeeMember_4ac2a9cc-2bf6-4c57-9bd0-8853d2ff59d7" xlink:href="mrna-20201231.xsd#mrna_OptionExerciseFeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:to="loc_mrna_OptionExerciseFeeMember_4ac2a9cc-2bf6-4c57-9bd0-8853d2ff59d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MilestonePaymentsMember_c001a1de-6278-490e-9887-e2643ed4a36b" xlink:href="mrna-20201231.xsd#mrna_MilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:to="loc_mrna_MilestonePaymentsMember_c001a1de-6278-490e-9887-e2643ed4a36b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SublicenseReimbursementMember_2b4c00d5-98ad-4b7a-877b-48ed6bf44cb2" xlink:href="mrna-20201231.xsd#mrna_SublicenseReimbursementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:to="loc_mrna_SublicenseReimbursementMember_2b4c00d5-98ad-4b7a-877b-48ed6bf44cb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VariableConsiderationMember_a1854d01-9b32-4511-870e-7ea24cf1bd0a" xlink:href="mrna-20201231.xsd#mrna_VariableConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:to="loc_mrna_VariableConsiderationMember_a1854d01-9b32-4511-870e-7ea24cf1bd0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_752fff75-aabc-448e-838a-81b8be643507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5fe7869d-4337-4f58-8818-5d4d62a1ead0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_752fff75-aabc-448e-838a-81b8be643507" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_752fff75-aabc-448e-838a-81b8be643507_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_752fff75-aabc-448e-838a-81b8be643507" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_752fff75-aabc-448e-838a-81b8be643507_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8ce011f2-bf66-458f-a2d8-374eb965f585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_752fff75-aabc-448e-838a-81b8be643507" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8ce011f2-bf66-458f-a2d8-374eb965f585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_53332c21-3be8-4ac4-a5ec-4e60ab724983" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8ce011f2-bf66-458f-a2d8-374eb965f585" xlink:to="loc_mrna_VEGFExercise2016Member_53332c21-3be8-4ac4-a5ec-4e60ab724983" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails" xlink:type="extended" id="ia395651dc36d4afca91f0c7bd504b4b8_CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0d45c47b-cd6e-46c4-839c-bb611ea1379c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ffa4cbe2-6d51-4088-8903-3cdc41ee0bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0d45c47b-cd6e-46c4-839c-bb611ea1379c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ffa4cbe2-6d51-4088-8903-3cdc41ee0bd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0d45c47b-cd6e-46c4-839c-bb611ea1379c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0028db23-835f-45c7-aed5-e0ce41990bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0028db23-835f-45c7-aed5-e0ce41990bd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_3d0b526e-7a40-411e-916d-2adc27a654a2" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0028db23-835f-45c7-aed5-e0ce41990bd8" xlink:to="loc_mrna_VEGFExercise2016Member_3d0b526e-7a40-411e-916d-2adc27a654a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7ec7c19a-0e12-4071-a63f-cade4aea0301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7ec7c19a-0e12-4071-a63f-cade4aea0301" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1" xlink:type="extended" id="i03e06a51d9674368861c17d3b9eaffd7_CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0d45c47b-cd6e-46c4-839c-bb611ea1379c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ffa4cbe2-6d51-4088-8903-3cdc41ee0bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0d45c47b-cd6e-46c4-839c-bb611ea1379c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ffa4cbe2-6d51-4088-8903-3cdc41ee0bd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0d45c47b-cd6e-46c4-839c-bb611ea1379c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0028db23-835f-45c7-aed5-e0ce41990bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0028db23-835f-45c7-aed5-e0ce41990bd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_3d0b526e-7a40-411e-916d-2adc27a654a2" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0028db23-835f-45c7-aed5-e0ce41990bd8" xlink:to="loc_mrna_VEGFExercise2016Member_3d0b526e-7a40-411e-916d-2adc27a654a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVEGFRevenueRecognizedDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails" xlink:type="extended" id="i76d06314f42f42bc9b788822f67a2b39_CollaborationAgreementsVEGFRevenueRecognizedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_243de378-3ca2-4b94-abe2-c8261322160c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5aec0078-d3b1-471d-83c5-76290c497a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_243de378-3ca2-4b94-abe2-c8261322160c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5aec0078-d3b1-471d-83c5-76290c497a4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_77ea420d-e3a6-4564-8593-9e3077a5ce0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_243de378-3ca2-4b94-abe2-c8261322160c" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_77ea420d-e3a6-4564-8593-9e3077a5ce0e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_37ccc629-87b8-44e2-8b29-3d25978b2c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_77ea420d-e3a6-4564-8593-9e3077a5ce0e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_37ccc629-87b8-44e2-8b29-3d25978b2c6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_37ccc629-87b8-44e2-8b29-3d25978b2c6b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_37ccc629-87b8-44e2-8b29-3d25978b2c6b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_37ccc629-87b8-44e2-8b29-3d25978b2c6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_091ebec7-80be-4df5-8ed3-8322e90645e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_37ccc629-87b8-44e2-8b29-3d25978b2c6b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_091ebec7-80be-4df5-8ed3-8322e90645e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_d34c4eda-77f0-4444-8f93-fbcd23f567af" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_091ebec7-80be-4df5-8ed3-8322e90645e1" xlink:to="loc_mrna_VEGFExercise2016Member_d34c4eda-77f0-4444-8f93-fbcd23f567af" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails" xlink:type="extended" id="i18a124acce174e5ea5c308f3339375a0_CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_455135dc-22c6-47c0-aaf9-e8b6c60742ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7d71707c-1614-4434-bde1-1192707db58f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_455135dc-22c6-47c0-aaf9-e8b6c60742ac" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7d71707c-1614-4434-bde1-1192707db58f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d80254ea-4cdb-4cb5-9c21-72b7b8e34799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_455135dc-22c6-47c0-aaf9-e8b6c60742ac" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d80254ea-4cdb-4cb5-9c21-72b7b8e34799" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_bce665a3-030e-412e-9f9e-2fdd5605d73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d80254ea-4cdb-4cb5-9c21-72b7b8e34799" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_bce665a3-030e-412e-9f9e-2fdd5605d73d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bce665a3-030e-412e-9f9e-2fdd5605d73d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_bce665a3-030e-412e-9f9e-2fdd5605d73d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bce665a3-030e-412e-9f9e-2fdd5605d73d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9d10cb81-e44f-4239-b17d-99af5f934a3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_bce665a3-030e-412e-9f9e-2fdd5605d73d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9d10cb81-e44f-4239-b17d-99af5f934a3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_4aa503a3-76d3-46bd-8fa7-c9d6a96e0e60" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9d10cb81-e44f-4239-b17d-99af5f934a3b" xlink:to="loc_mrna_VEGFExercise2016Member_4aa503a3-76d3-46bd-8fa7-c9d6a96e0e60" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails" xlink:type="extended" id="if8b59774aa454929a8aeba16a4a0ad3c_CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d2ba59d3-9f2d-4dec-8b73-cb73d5834b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d2ba59d3-9f2d-4dec-8b73-cb73d5834b4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8414aa38-0a8a-4644-9f83-bda1a52919c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8414aa38-0a8a-4644-9f83-bda1a52919c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_93ba953f-27a2-4b42-8109-2beb44ad163d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_93ba953f-27a2-4b42-8109-2beb44ad163d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_942646b7-1cd4-4bf5-9667-cc61062ebcbc" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_942646b7-1cd4-4bf5-9667-cc61062ebcbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_a7303435-c864-4206-ac65-80483a3170c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_a7303435-c864-4206-ac65-80483a3170c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod_34c5bc3a-198a-451f-8308-e61cff735617" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod_34c5bc3a-198a-451f-8308-e61cff735617" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_aa4e5fa7-69e3-4140-b4e2-072ffe2fcdc7" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_aa4e5fa7-69e3-4140-b4e2-072ffe2fcdc7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_e1a7eddb-2a72-45c0-8f8b-43fd740ccb42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_e1a7eddb-2a72-45c0-8f8b-43fd740ccb42" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4844cbd8-ff9b-4fea-b02d-ef43783e0bbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4844cbd8-ff9b-4fea-b02d-ef43783e0bbc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedemptionPremium_2ea8f312-f3d6-49d6-ad65-73dddb38adc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedemptionPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_RedemptionPremium_2ea8f312-f3d6-49d6-ad65-73dddb38adc7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c22edf48-0cd6-4892-a5c3-3f2dfd8b2ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c22edf48-0cd6-4892-a5c3-3f2dfd8b2ffd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_5cc47961-f74c-4e0c-8583-84bfaf3b3801" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_5cc47961-f74c-4e0c-8583-84bfaf3b3801" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationAxis_b8ce8b10-1e49-4f95-9014-a608ee0357e6" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_mrna_PerformanceObligationAxis_b8ce8b10-1e49-4f95-9014-a608ee0357e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_b8ce8b10-1e49-4f95-9014-a608ee0357e6_default" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mrna_PerformanceObligationAxis_b8ce8b10-1e49-4f95-9014-a608ee0357e6" xlink:to="loc_mrna_PerformanceObligationDomain_b8ce8b10-1e49-4f95-9014-a608ee0357e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_a0918541-40ff-4f3c-8160-40786ab066e1" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mrna_PerformanceObligationAxis_b8ce8b10-1e49-4f95-9014-a608ee0357e6" xlink:to="loc_mrna_PerformanceObligationDomain_a0918541-40ff-4f3c-8160-40786ab066e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVPerformanceObligationMember_af84b34e-90c5-4484-8567-98d93d1c1895" xlink:href="mrna-20201231.xsd#mrna_PCVPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_a0918541-40ff-4f3c-8160-40786ab066e1" xlink:to="loc_mrna_PCVPerformanceObligationMember_af84b34e-90c5-4484-8567-98d93d1c1895" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_KRASPerformanceObligationMember_0e406a47-a207-48f9-8e36-d5d51527b1ee" xlink:href="mrna-20201231.xsd#mrna_KRASPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_a0918541-40ff-4f3c-8160-40786ab066e1" xlink:to="loc_mrna_KRASPerformanceObligationMember_0e406a47-a207-48f9-8e36-d5d51527b1ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_ccef675a-9012-4883-bca8-5fcc0f39d889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_ccef675a-9012-4883-bca8-5fcc0f39d889" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ccef675a-9012-4883-bca8-5fcc0f39d889_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_ccef675a-9012-4883-bca8-5fcc0f39d889" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ccef675a-9012-4883-bca8-5fcc0f39d889_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_ccef675a-9012-4883-bca8-5fcc0f39d889" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_f0ca9f39-7116-42c1-a5bc-c5183351b748" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:to="loc_mrna_UpfrontPaymentMember_f0ca9f39-7116-42c1-a5bc-c5183351b748" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MilestonePaymentsMember_fa175e0d-7c3e-434f-acc5-9ede61c400e1" xlink:href="mrna-20201231.xsd#mrna_MilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:to="loc_mrna_MilestonePaymentsMember_fa175e0d-7c3e-434f-acc5-9ede61c400e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_a899dbc9-c469-4df7-96fa-24a7fb2b897f" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:to="loc_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_a899dbc9-c469-4df7-96fa-24a7fb2b897f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentResearchAndDevelopmentMember_7d648f3f-f123-4da7-9778-3f9d4ad343d6" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:to="loc_mrna_UpfrontPaymentResearchAndDevelopmentMember_7d648f3f-f123-4da7-9778-3f9d4ad343d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a5edca27-991b-4cd8-bc3b-63b4a7f13ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a5edca27-991b-4cd8-bc3b-63b4a7f13ed1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_a5edca27-991b-4cd8-bc3b-63b4a7f13ed1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a5edca27-991b-4cd8-bc3b-63b4a7f13ed1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_a5edca27-991b-4cd8-bc3b-63b4a7f13ed1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a5edca27-991b-4cd8-bc3b-63b4a7f13ed1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckAgreement2015Member_c2e5e240-e982-473b-9153-d97793b5cb4d" xlink:href="mrna-20201231.xsd#mrna_MerckAgreement2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:to="loc_mrna_MerckAgreement2015Member_c2e5e240-e982-473b-9153-d97793b5cb4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SeparateAgreementsWithMerckMember_7f3dd890-669c-448c-ba5e-10f4b95c25e6" xlink:href="mrna-20201231.xsd#mrna_SeparateAgreementsWithMerckMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:to="loc_mrna_SeparateAgreementsWithMerckMember_7f3dd890-669c-448c-ba5e-10f4b95c25e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_39831a29-c1fd-41de-84b0-25604fa37390" xlink:href="mrna-20201231.xsd#mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:to="loc_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_39831a29-c1fd-41de-84b0-25604fa37390" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_c7373be0-6072-45a7-9a4e-a72a5e91f8d9" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:to="loc_mrna_PCVSAVAgreementMember_c7373be0-6072-45a7-9a4e-a72a5e91f8d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_c3926df9-f944-41b7-ad45-bb00121cd81f" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_c3926df9-f944-41b7-ad45-bb00121cd81f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_c3926df9-f944-41b7-ad45-bb00121cd81f_default" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_c3926df9-f944-41b7-ad45-bb00121cd81f" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_c3926df9-f944-41b7-ad45-bb00121cd81f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_e7926d9f-427b-4e46-b833-77753360b920" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_c3926df9-f944-41b7-ad45-bb00121cd81f" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_e7926d9f-427b-4e46-b833-77753360b920" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentMilestonesMember_6e7653c2-6766-4e99-9866-b2ff5b54e129" xlink:href="mrna-20201231.xsd#mrna_DevelopmentMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_e7926d9f-427b-4e46-b833-77753360b920" xlink:to="loc_mrna_DevelopmentMilestonesMember_6e7653c2-6766-4e99-9866-b2ff5b54e129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RegulatoryMilestonesMember_c3e7d241-9d33-4f75-a046-2e518348678c" xlink:href="mrna-20201231.xsd#mrna_RegulatoryMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_e7926d9f-427b-4e46-b833-77753360b920" xlink:to="loc_mrna_RegulatoryMilestonesMember_c3e7d241-9d33-4f75-a046-2e518348678c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CommercialMilestonesMember_dfbad693-5e2e-4ee0-b842-1bceea42aa2b" xlink:href="mrna-20201231.xsd#mrna_CommercialMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_e7926d9f-427b-4e46-b833-77753360b920" xlink:to="loc_mrna_CommercialMilestonesMember_dfbad693-5e2e-4ee0-b842-1bceea42aa2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_38031192-0e03-428f-b7e0-61ece1886090" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_srt_ProductOrServiceAxis_38031192-0e03-428f-b7e0-61ece1886090" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_38031192-0e03-428f-b7e0-61ece1886090_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_38031192-0e03-428f-b7e0-61ece1886090" xlink:to="loc_srt_ProductsAndServicesDomain_38031192-0e03-428f-b7e0-61ece1886090_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_63fcb235-8184-4f0c-bf5a-13b576dc0d1c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_38031192-0e03-428f-b7e0-61ece1886090" xlink:to="loc_srt_ProductsAndServicesDomain_63fcb235-8184-4f0c-bf5a-13b576dc0d1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_806cfdcb-6a03-4998-a9c7-f81307288dfa" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_63fcb235-8184-4f0c-bf5a-13b576dc0d1c" xlink:to="loc_mrna_CollaborationArrangementMember_806cfdcb-6a03-4998-a9c7-f81307288dfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_465e5164-f2d8-4d34-8fd8-5d2868ffe3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_465e5164-f2d8-4d34-8fd8-5d2868ffe3fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_465e5164-f2d8-4d34-8fd8-5d2868ffe3fd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_465e5164-f2d8-4d34-8fd8-5d2868ffe3fd" xlink:to="loc_us-gaap_ProjectMember_465e5164-f2d8-4d34-8fd8-5d2868ffe3fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_259f9e30-b976-4ba6-bf29-663f25250de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_465e5164-f2d8-4d34-8fd8-5d2868ffe3fd" xlink:to="loc_us-gaap_ProjectMember_259f9e30-b976-4ba6-bf29-663f25250de5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PersonalizedMRNACancerVaccinesProductsMember_8c87e95a-1fb8-4055-a637-643a6fd40686" xlink:href="mrna-20201231.xsd#mrna_PersonalizedMRNACancerVaccinesProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_259f9e30-b976-4ba6-bf29-663f25250de5" xlink:to="loc_mrna_PersonalizedMRNACancerVaccinesProductsMember_8c87e95a-1fb8-4055-a637-643a6fd40686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_09a036c5-a4b6-478c-a35b-b8abbff3539c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_us-gaap_StatementClassOfStockAxis_09a036c5-a4b6-478c-a35b-b8abbff3539c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_09a036c5-a4b6-478c-a35b-b8abbff3539c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_09a036c5-a4b6-478c-a35b-b8abbff3539c" xlink:to="loc_us-gaap_ClassOfStockDomain_09a036c5-a4b6-478c-a35b-b8abbff3539c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_648d5a75-327a-4d49-9ef2-e57a92dc89f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_09a036c5-a4b6-478c-a35b-b8abbff3539c" xlink:to="loc_us-gaap_ClassOfStockDomain_648d5a75-327a-4d49-9ef2-e57a92dc89f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesHPreferredStockMember_c51d4e70-c3ae-40b4-be3d-0fa71a00294d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesHPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_648d5a75-327a-4d49-9ef2-e57a92dc89f3" xlink:to="loc_us-gaap_SeriesHPreferredStockMember_c51d4e70-c3ae-40b4-be3d-0fa71a00294d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails" xlink:type="extended" id="i031bdd3fb94245eda349c98644c7a23a_CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1bf3cd83-3638-4355-8844-430940014a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_97105583-7f9e-4b22-bdcd-9d0926360357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1bf3cd83-3638-4355-8844-430940014a8c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_97105583-7f9e-4b22-bdcd-9d0926360357" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_dbc86417-0350-4a7d-9932-4e57f0f033a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1bf3cd83-3638-4355-8844-430940014a8c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_dbc86417-0350-4a7d-9932-4e57f0f033a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_992ae02a-f5f6-46fb-93f3-69f08bfa0b33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1bf3cd83-3638-4355-8844-430940014a8c" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_992ae02a-f5f6-46fb-93f3-69f08bfa0b33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4abdebab-6279-40ba-bb43-b0d1067be0c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_992ae02a-f5f6-46fb-93f3-69f08bfa0b33" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4abdebab-6279-40ba-bb43-b0d1067be0c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4abdebab-6279-40ba-bb43-b0d1067be0c6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4abdebab-6279-40ba-bb43-b0d1067be0c6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4abdebab-6279-40ba-bb43-b0d1067be0c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_af1ea10a-8fc0-4bb1-98eb-335b7e4374c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4abdebab-6279-40ba-bb43-b0d1067be0c6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_af1ea10a-8fc0-4bb1-98eb-335b7e4374c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckAgreement2015Member_b6b2e926-fd92-49c9-b36a-6464aa244c11" xlink:href="mrna-20201231.xsd#mrna_MerckAgreement2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_af1ea10a-8fc0-4bb1-98eb-335b7e4374c9" xlink:to="loc_mrna_MerckAgreement2015Member_b6b2e926-fd92-49c9-b36a-6464aa244c11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_49d04995-ab05-4a3b-96c5-533647044cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_992ae02a-f5f6-46fb-93f3-69f08bfa0b33" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_49d04995-ab05-4a3b-96c5-533647044cea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_49d04995-ab05-4a3b-96c5-533647044cea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_49d04995-ab05-4a3b-96c5-533647044cea" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_49d04995-ab05-4a3b-96c5-533647044cea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7d87c46f-e29e-408d-9885-dbb66f0ba2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_49d04995-ab05-4a3b-96c5-533647044cea" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7d87c46f-e29e-408d-9885-dbb66f0ba2d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_21d4e746-c0fd-4284-9dc6-6053bc9c2cef" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7d87c46f-e29e-408d-9885-dbb66f0ba2d7" xlink:to="loc_mrna_UpfrontPaymentMember_21d4e746-c0fd-4284-9dc6-6053bc9c2cef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentResearchAndDevelopmentMember_780591be-35b0-478c-b666-a8b0b6c39fe8" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7d87c46f-e29e-408d-9885-dbb66f0ba2d7" xlink:to="loc_mrna_UpfrontPaymentResearchAndDevelopmentMember_780591be-35b0-478c-b666-a8b0b6c39fe8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended" id="i895dd3139dbd4869a361656272c157b3_CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_42760de0-4476-4085-8ab6-92610fa65601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_75bf0fea-6856-4ecc-91ee-8c4241c54133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_42760de0-4476-4085-8ab6-92610fa65601" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_75bf0fea-6856-4ecc-91ee-8c4241c54133" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_42760de0-4476-4085-8ab6-92610fa65601" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ce356526-a6b6-465f-960d-09146ece063b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ce356526-a6b6-465f-960d-09146ece063b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f033979-7322-47cc-ac90-2d518d8f0c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f033979-7322-47cc-ac90-2d518d8f0c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckAgreement2015Member_694a6634-1f46-4386-94dd-4f1c5c1dbd4c" xlink:href="mrna-20201231.xsd#mrna_MerckAgreement2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f033979-7322-47cc-ac90-2d518d8f0c71" xlink:to="loc_mrna_MerckAgreement2015Member_694a6634-1f46-4386-94dd-4f1c5c1dbd4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_70a34813-71f3-43b8-826e-c9b6186b5dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_70a34813-71f3-43b8-826e-c9b6186b5dbf" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="extended" id="i5b9cefbdd2e54666a88f2af3c685bf43_CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_42760de0-4476-4085-8ab6-92610fa65601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_75bf0fea-6856-4ecc-91ee-8c4241c54133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_42760de0-4476-4085-8ab6-92610fa65601" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_75bf0fea-6856-4ecc-91ee-8c4241c54133" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_42760de0-4476-4085-8ab6-92610fa65601" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ce356526-a6b6-465f-960d-09146ece063b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ce356526-a6b6-465f-960d-09146ece063b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f033979-7322-47cc-ac90-2d518d8f0c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f033979-7322-47cc-ac90-2d518d8f0c71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckAgreement2015Member_694a6634-1f46-4386-94dd-4f1c5c1dbd4c" xlink:href="mrna-20201231.xsd#mrna_MerckAgreement2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f033979-7322-47cc-ac90-2d518d8f0c71" xlink:to="loc_mrna_MerckAgreement2015Member_694a6634-1f46-4386-94dd-4f1c5c1dbd4c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails" xlink:type="extended" id="i5afe0c980a8e4304b096cd46e36ab7a1_CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f6ceae1f-0964-4fa3-8c61-6cc1cc1e8bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8661953c-1dbe-4bbd-abda-248bc46175db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f6ceae1f-0964-4fa3-8c61-6cc1cc1e8bc1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8661953c-1dbe-4bbd-abda-248bc46175db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ce88b4d6-8d14-4422-a905-f760f684dd60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f6ceae1f-0964-4fa3-8c61-6cc1cc1e8bc1" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ce88b4d6-8d14-4422-a905-f760f684dd60" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6b446b42-d410-41ac-847f-512db98db9d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ce88b4d6-8d14-4422-a905-f760f684dd60" xlink:to="loc_srt_ProductOrServiceAxis_6b446b42-d410-41ac-847f-512db98db9d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6b446b42-d410-41ac-847f-512db98db9d3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6b446b42-d410-41ac-847f-512db98db9d3" xlink:to="loc_srt_ProductsAndServicesDomain_6b446b42-d410-41ac-847f-512db98db9d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_292e476b-0e30-44c9-b145-a040157c76f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6b446b42-d410-41ac-847f-512db98db9d3" xlink:to="loc_srt_ProductsAndServicesDomain_292e476b-0e30-44c9-b145-a040157c76f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_95c10415-39e0-4c62-8c22-fe33e51b2673" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_292e476b-0e30-44c9-b145-a040157c76f0" xlink:to="loc_mrna_CollaborationArrangementMember_95c10415-39e0-4c62-8c22-fe33e51b2673" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_8cdb301a-1da6-4481-8ab8-5ca91a14dff6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ce88b4d6-8d14-4422-a905-f760f684dd60" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_8cdb301a-1da6-4481-8ab8-5ca91a14dff6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdb301a-1da6-4481-8ab8-5ca91a14dff6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_8cdb301a-1da6-4481-8ab8-5ca91a14dff6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdb301a-1da6-4481-8ab8-5ca91a14dff6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_86f6db2c-54a9-4cae-ba76-9389a36dd933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_8cdb301a-1da6-4481-8ab8-5ca91a14dff6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_86f6db2c-54a9-4cae-ba76-9389a36dd933" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckMay2019AgreementMember_763a981c-63d9-4ff4-8470-047342fac53b" xlink:href="mrna-20201231.xsd#mrna_MerckMay2019AgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_86f6db2c-54a9-4cae-ba76-9389a36dd933" xlink:to="loc_mrna_MerckMay2019AgreementMember_763a981c-63d9-4ff4-8470-047342fac53b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckAgreement2015Member_66d0f342-8742-4943-a0bf-bad2d2a8640f" xlink:href="mrna-20201231.xsd#mrna_MerckAgreement2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_86f6db2c-54a9-4cae-ba76-9389a36dd933" xlink:to="loc_mrna_MerckAgreement2015Member_66d0f342-8742-4943-a0bf-bad2d2a8640f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SeparateAgreementsWithMerckMember_b02c7b07-7d6b-4a10-aa12-29726c96ec27" xlink:href="mrna-20201231.xsd#mrna_SeparateAgreementsWithMerckMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_86f6db2c-54a9-4cae-ba76-9389a36dd933" xlink:to="loc_mrna_SeparateAgreementsWithMerckMember_b02c7b07-7d6b-4a10-aa12-29726c96ec27" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails" xlink:type="extended" id="i58c18df9db3645dabb9e174c03e4ef9c_CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d677d1aa-6a0a-432d-bd73-e2caa4aad6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_2772d90a-e7c6-4a6c-b6e9-8a75d49bb14a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d677d1aa-6a0a-432d-bd73-e2caa4aad6e6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_2772d90a-e7c6-4a6c-b6e9-8a75d49bb14a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d75c1e0c-6059-4980-8195-24d0b3b1e9c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d677d1aa-6a0a-432d-bd73-e2caa4aad6e6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d75c1e0c-6059-4980-8195-24d0b3b1e9c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_23645aba-fd2c-4701-84bf-628cb7398989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d75c1e0c-6059-4980-8195-24d0b3b1e9c4" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_23645aba-fd2c-4701-84bf-628cb7398989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_23645aba-fd2c-4701-84bf-628cb7398989_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_23645aba-fd2c-4701-84bf-628cb7398989" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_23645aba-fd2c-4701-84bf-628cb7398989_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fc9d8654-bc13-4e94-a016-8ff923877199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_23645aba-fd2c-4701-84bf-628cb7398989" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fc9d8654-bc13-4e94-a016-8ff923877199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_9e184509-6930-4d70-add7-ac7a23328ea7" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fc9d8654-bc13-4e94-a016-8ff923877199" xlink:to="loc_mrna_PCVSAVAgreementMember_9e184509-6930-4d70-add7-ac7a23328ea7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8e583666-1c4d-4161-8296-14fc0adb7c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d75c1e0c-6059-4980-8195-24d0b3b1e9c4" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8e583666-1c4d-4161-8296-14fc0adb7c41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_8e583666-1c4d-4161-8296-14fc0adb7c41_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8e583666-1c4d-4161-8296-14fc0adb7c41" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_8e583666-1c4d-4161-8296-14fc0adb7c41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e525fb14-6e1f-4bf7-8a8e-cca00bc41e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8e583666-1c4d-4161-8296-14fc0adb7c41" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e525fb14-6e1f-4bf7-8a8e-cca00bc41e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_f8198288-fb5a-4f0b-a711-a9ec322008ca" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e525fb14-6e1f-4bf7-8a8e-cca00bc41e53" xlink:to="loc_mrna_UpfrontPaymentMember_f8198288-fb5a-4f0b-a711-a9ec322008ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_98e129c8-301d-43ef-9ce7-632348846d6c" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e525fb14-6e1f-4bf7-8a8e-cca00bc41e53" xlink:to="loc_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_98e129c8-301d-43ef-9ce7-632348846d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalSupplyReimbursementMember_19358b22-2817-4aa7-b8e4-3dc1acf92e98" xlink:href="mrna-20201231.xsd#mrna_ClinicalSupplyReimbursementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e525fb14-6e1f-4bf7-8a8e-cca00bc41e53" xlink:to="loc_mrna_ClinicalSupplyReimbursementMember_19358b22-2817-4aa7-b8e4-3dc1acf92e98" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended" id="i648d62179c684927b780a569e28d0a89_CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7b755d8e-a806-41a0-ac69-5a46772f5e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7b755d8e-a806-41a0-ac69-5a46772f5e19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_ce3022a2-f8c7-4e62-be56-9a5e4e34813c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_ce3022a2-f8c7-4e62-be56-9a5e4e34813c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0d4cd46f-c399-47a8-95b5-f8a08f054b36_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0d4cd46f-c399-47a8-95b5-f8a08f054b36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c2088955-c0e2-498f-9f0c-d024213e8110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c2088955-c0e2-498f-9f0c-d024213e8110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_bf2a6229-1771-4ace-8964-2ea63d227620" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c2088955-c0e2-498f-9f0c-d024213e8110" xlink:to="loc_mrna_PCVSAVAgreementMember_bf2a6229-1771-4ace-8964-2ea63d227620" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_568c88ed-8f7f-4391-b687-f4c67498d2b2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_568c88ed-8f7f-4391-b687-f4c67498d2b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVPerformanceObligationMember_0376f77a-b7d5-4c9c-9116-56ad32fbd2a1" xlink:href="mrna-20201231.xsd#mrna_PCVPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:to="loc_mrna_PCVPerformanceObligationMember_0376f77a-b7d5-4c9c-9116-56ad32fbd2a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_KRASPerformanceObligationMember_dc5cbebb-362b-4916-9ff1-2e1def85c8e1" xlink:href="mrna-20201231.xsd#mrna_KRASPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:to="loc_mrna_KRASPerformanceObligationMember_dc5cbebb-362b-4916-9ff1-2e1def85c8e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalSupplyReimbursementMember_1d3dc9b7-d3d7-43a5-9e6a-a72004209b27" xlink:href="mrna-20201231.xsd#mrna_ClinicalSupplyReimbursementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:to="loc_mrna_ClinicalSupplyReimbursementMember_1d3dc9b7-d3d7-43a5-9e6a-a72004209b27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_ec5486f8-6a5f-4440-8c76-184fc8940da8_default" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:to="loc_mrna_PerformanceObligationDomain_ec5486f8-6a5f-4440-8c76-184fc8940da8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:to="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVPerformanceObligationMember_8d272ef3-65c2-47d8-a1e2-e7b70c94e647" xlink:href="mrna-20201231.xsd#mrna_PCVPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:to="loc_mrna_PCVPerformanceObligationMember_8d272ef3-65c2-47d8-a1e2-e7b70c94e647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_KRASPerformanceObligationMember_1c520075-27db-49a0-85b4-f88f94b910a6" xlink:href="mrna-20201231.xsd#mrna_KRASPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:to="loc_mrna_KRASPerformanceObligationMember_1c520075-27db-49a0-85b4-f88f94b910a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8e197653-29fd-4376-addb-20c9d6fea0f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8e197653-29fd-4376-addb-20c9d6fea0f8" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="extended" id="ie0f920105bdf46dfb72c4f9b63606d05_CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7b755d8e-a806-41a0-ac69-5a46772f5e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7b755d8e-a806-41a0-ac69-5a46772f5e19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_ce3022a2-f8c7-4e62-be56-9a5e4e34813c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_ce3022a2-f8c7-4e62-be56-9a5e4e34813c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0d4cd46f-c399-47a8-95b5-f8a08f054b36_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0d4cd46f-c399-47a8-95b5-f8a08f054b36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c2088955-c0e2-498f-9f0c-d024213e8110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c2088955-c0e2-498f-9f0c-d024213e8110" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_bf2a6229-1771-4ace-8964-2ea63d227620" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c2088955-c0e2-498f-9f0c-d024213e8110" xlink:to="loc_mrna_PCVSAVAgreementMember_bf2a6229-1771-4ace-8964-2ea63d227620" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_568c88ed-8f7f-4391-b687-f4c67498d2b2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_568c88ed-8f7f-4391-b687-f4c67498d2b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVPerformanceObligationMember_0376f77a-b7d5-4c9c-9116-56ad32fbd2a1" xlink:href="mrna-20201231.xsd#mrna_PCVPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:to="loc_mrna_PCVPerformanceObligationMember_0376f77a-b7d5-4c9c-9116-56ad32fbd2a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_KRASPerformanceObligationMember_dc5cbebb-362b-4916-9ff1-2e1def85c8e1" xlink:href="mrna-20201231.xsd#mrna_KRASPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:to="loc_mrna_KRASPerformanceObligationMember_dc5cbebb-362b-4916-9ff1-2e1def85c8e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalSupplyReimbursementMember_1d3dc9b7-d3d7-43a5-9e6a-a72004209b27" xlink:href="mrna-20201231.xsd#mrna_ClinicalSupplyReimbursementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:to="loc_mrna_ClinicalSupplyReimbursementMember_1d3dc9b7-d3d7-43a5-9e6a-a72004209b27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_ec5486f8-6a5f-4440-8c76-184fc8940da8_default" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:to="loc_mrna_PerformanceObligationDomain_ec5486f8-6a5f-4440-8c76-184fc8940da8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:to="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVPerformanceObligationMember_8d272ef3-65c2-47d8-a1e2-e7b70c94e647" xlink:href="mrna-20201231.xsd#mrna_PCVPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:to="loc_mrna_PCVPerformanceObligationMember_8d272ef3-65c2-47d8-a1e2-e7b70c94e647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_KRASPerformanceObligationMember_1c520075-27db-49a0-85b4-f88f94b910a6" xlink:href="mrna-20201231.xsd#mrna_KRASPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:to="loc_mrna_KRASPerformanceObligationMember_1c520075-27db-49a0-85b4-f88f94b910a6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVRevenueRecognizedDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails" xlink:type="extended" id="i0d36c448cd89402f88e6d577d8828f71_CollaborationAgreementsPCVSAVRevenueRecognizedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f26c2df9-157d-40a1-a594-1758ac0def6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61538431-a947-4530-a5ae-8982789d9695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f26c2df9-157d-40a1-a594-1758ac0def6f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61538431-a947-4530-a5ae-8982789d9695" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3fd98f7-16c1-406a-b33e-38d5ab2e6c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f26c2df9-157d-40a1-a594-1758ac0def6f" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3fd98f7-16c1-406a-b33e-38d5ab2e6c6d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_56ccb764-3a6e-4670-bdd3-7c843aa9c555" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3fd98f7-16c1-406a-b33e-38d5ab2e6c6d" xlink:to="loc_srt_ProductOrServiceAxis_56ccb764-3a6e-4670-bdd3-7c843aa9c555" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_56ccb764-3a6e-4670-bdd3-7c843aa9c555_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_56ccb764-3a6e-4670-bdd3-7c843aa9c555" xlink:to="loc_srt_ProductsAndServicesDomain_56ccb764-3a6e-4670-bdd3-7c843aa9c555_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_289ca828-50ff-432f-9bf4-52ba5cced70e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_56ccb764-3a6e-4670-bdd3-7c843aa9c555" xlink:to="loc_srt_ProductsAndServicesDomain_289ca828-50ff-432f-9bf4-52ba5cced70e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_9ef7018f-7d59-4959-b2d7-024add3d9a23" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_289ca828-50ff-432f-9bf4-52ba5cced70e" xlink:to="loc_mrna_CollaborationArrangementMember_9ef7018f-7d59-4959-b2d7-024add3d9a23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_3da119c4-5448-4c8f-a3e2-be3a5703a44d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3fd98f7-16c1-406a-b33e-38d5ab2e6c6d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_3da119c4-5448-4c8f-a3e2-be3a5703a44d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3da119c4-5448-4c8f-a3e2-be3a5703a44d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_3da119c4-5448-4c8f-a3e2-be3a5703a44d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3da119c4-5448-4c8f-a3e2-be3a5703a44d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_a58f9bc6-6e3a-4239-a1ec-4adb5d1567ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_3da119c4-5448-4c8f-a3e2-be3a5703a44d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_a58f9bc6-6e3a-4239-a1ec-4adb5d1567ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_f79af18a-0768-401b-8da2-ab0b7f10f483" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_a58f9bc6-6e3a-4239-a1ec-4adb5d1567ea" xlink:to="loc_mrna_PCVSAVAgreementMember_f79af18a-0768-401b-8da2-ab0b7f10f483" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails" xlink:type="extended" id="i19e0fd54f2e24ab9a23a0afcb42c387a_CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d8b5c89a-0d6e-47d0-95bf-ba4171009f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_8219f59c-7dc4-4f39-9ca7-f776fd9dbb08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d8b5c89a-0d6e-47d0-95bf-ba4171009f59" xlink:to="loc_us-gaap_ContractWithCustomerLiability_8219f59c-7dc4-4f39-9ca7-f776fd9dbb08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_19d38aaa-a257-4b79-b37a-ca69ada17541" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d8b5c89a-0d6e-47d0-95bf-ba4171009f59" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_19d38aaa-a257-4b79-b37a-ca69ada17541" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98565203-d7b3-49d2-9895-72afbc4eff2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_19d38aaa-a257-4b79-b37a-ca69ada17541" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98565203-d7b3-49d2-9895-72afbc4eff2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_98565203-d7b3-49d2-9895-72afbc4eff2a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98565203-d7b3-49d2-9895-72afbc4eff2a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_98565203-d7b3-49d2-9895-72afbc4eff2a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7e946df8-d1e9-4f7d-868a-11829602c094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98565203-d7b3-49d2-9895-72afbc4eff2a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7e946df8-d1e9-4f7d-868a-11829602c094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_ea747874-b462-4969-918e-07ab2a403ebb" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7e946df8-d1e9-4f7d-868a-11829602c094" xlink:to="loc_mrna_PCVSAVAgreementMember_ea747874-b462-4969-918e-07ab2a403ebb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails" xlink:type="extended" id="i2e5cc3a02ab94461a75c7e0ee41399ab_CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_69c6fcaa-856b-4c44-9a37-337edff5714d" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_69c6fcaa-856b-4c44-9a37-337edff5714d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac68e0d3-6699-4cee-979c-a9d9df3ea44e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac68e0d3-6699-4cee-979c-a9d9df3ea44e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod_12281c99-9222-4ac6-8273-b62e122668be" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod_12281c99-9222-4ac6-8273-b62e122668be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods_3053541a-0443-4080-ad5f-eb2346643ac1" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods_3053541a-0443-4080-ad5f-eb2346643ac1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_e1c7edcc-9e07-4cc0-ba86-51877eeaf4ee" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_e1c7edcc-9e07-4cc0-ba86-51877eeaf4ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_50b2c7e5-ec1b-4eac-964f-8a799731b11f" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_50b2c7e5-ec1b-4eac-964f-8a799731b11f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_f469cfbb-b421-47fd-ad17-4a00dd1ad6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_f469cfbb-b421-47fd-ad17-4a00dd1ad6ba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_6c6955d9-3a63-4614-8a8b-e8d740e01d7a" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_6c6955d9-3a63-4614-8a8b-e8d740e01d7a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_33850dce-b171-42ad-ba62-ddaad7369f5b" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_33850dce-b171-42ad-ba62-ddaad7369f5b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_58cc3dae-68e0-40ab-9b59-60f6b0d72e69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_58cc3dae-68e0-40ab-9b59-60f6b0d72e69" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_95a21967-7d18-4440-89e3-6195eeee707d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_95a21967-7d18-4440-89e3-6195eeee707d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_4cec7e56-fce6-4e45-bb70-ea0bed7dabe8" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_4cec7e56-fce6-4e45-bb70-ea0bed7dabe8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d168af41-111f-49d4-9c2f-8bb3cebf45d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d168af41-111f-49d4-9c2f-8bb3cebf45d6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a001fc3e-e36c-45d3-a32f-9e037073a37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a001fc3e-e36c-45d3-a32f-9e037073a37a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_e85dfd43-86f3-474c-b639-8ee13efde087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_e85dfd43-86f3-474c-b639-8ee13efde087" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c611250f-a182-40de-979a-f07a515518a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c611250f-a182-40de-979a-f07a515518a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c611250f-a182-40de-979a-f07a515518a5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c611250f-a182-40de-979a-f07a515518a5" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c611250f-a182-40de-979a-f07a515518a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_1326194d-0a0e-445e-a5a3-dec1c95e1d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c611250f-a182-40de-979a-f07a515518a5" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_1326194d-0a0e-445e-a5a3-dec1c95e1d74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_b5aaef98-2cd0-419f-804f-f12ff9c129ad" xlink:href="mrna-20201231.xsd#mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_1326194d-0a0e-445e-a5a3-dec1c95e1d74" xlink:to="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_b5aaef98-2cd0-419f-804f-f12ff9c129ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8be6922e-778b-48b2-babc-01e7ac6c7c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8be6922e-778b-48b2-babc-01e7ac6c7c58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_8be6922e-778b-48b2-babc-01e7ac6c7c58_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8be6922e-778b-48b2-babc-01e7ac6c7c58" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_8be6922e-778b-48b2-babc-01e7ac6c7c58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1752581d-1718-4c16-ad27-38a4ae5e2df4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8be6922e-778b-48b2-babc-01e7ac6c7c58" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1752581d-1718-4c16-ad27-38a4ae5e2df4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_7e577199-1d88-42f8-9d81-9905aa146f4a" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1752581d-1718-4c16-ad27-38a4ae5e2df4" xlink:to="loc_mrna_UpfrontPaymentMember_7e577199-1d88-42f8-9d81-9905aa146f4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentFundingMember_f0a5345d-33cd-47f9-8391-4f3cac7495ab" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentFundingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1752581d-1718-4c16-ad27-38a4ae5e2df4" xlink:to="loc_mrna_ResearchAndDevelopmentFundingMember_f0a5345d-33cd-47f9-8391-4f3cac7495ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_12de247c-44e2-421e-af3b-025dd865d0b3" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_12de247c-44e2-421e-af3b-025dd865d0b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_12de247c-44e2-421e-af3b-025dd865d0b3_default" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_12de247c-44e2-421e-af3b-025dd865d0b3" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_12de247c-44e2-421e-af3b-025dd865d0b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_0cc59668-88f2-40f9-8981-b70539c826c7" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_12de247c-44e2-421e-af3b-025dd865d0b3" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_0cc59668-88f2-40f9-8981-b70539c826c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentMilestonesMember_64778a61-383e-456f-bb47-c529a35c619b" xlink:href="mrna-20201231.xsd#mrna_DevelopmentMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_0cc59668-88f2-40f9-8981-b70539c826c7" xlink:to="loc_mrna_DevelopmentMilestonesMember_64778a61-383e-456f-bb47-c529a35c619b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RegulatoryMilestonesMember_9b304dba-32a9-4c73-af07-68448b95edab" xlink:href="mrna-20201231.xsd#mrna_RegulatoryMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_0cc59668-88f2-40f9-8981-b70539c826c7" xlink:to="loc_mrna_RegulatoryMilestonesMember_9b304dba-32a9-4c73-af07-68448b95edab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RegulatoryMilestonesSubsequentProductsMember_a98dae33-e6de-43d6-84a9-c596b4122602" xlink:href="mrna-20201231.xsd#mrna_RegulatoryMilestonesSubsequentProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_0cc59668-88f2-40f9-8981-b70539c826c7" xlink:to="loc_mrna_RegulatoryMilestonesSubsequentProductsMember_a98dae33-e6de-43d6-84a9-c596b4122602" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails" xlink:type="extended" id="i91f9835d54ac47a984a4fa48c4025b24_CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e96e7d41-615f-4fe1-9dc1-473a7f97f5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_2839ee29-1d6c-474c-9ef8-00a442d58a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e96e7d41-615f-4fe1-9dc1-473a7f97f5cc" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_2839ee29-1d6c-474c-9ef8-00a442d58a51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1a132248-3cb0-4c58-9662-b7d3a693ba91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e96e7d41-615f-4fe1-9dc1-473a7f97f5cc" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1a132248-3cb0-4c58-9662-b7d3a693ba91" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0b149664-1e59-450b-b41d-81cec2e68e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1a132248-3cb0-4c58-9662-b7d3a693ba91" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0b149664-1e59-450b-b41d-81cec2e68e8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0b149664-1e59-450b-b41d-81cec2e68e8c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0b149664-1e59-450b-b41d-81cec2e68e8c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0b149664-1e59-450b-b41d-81cec2e68e8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bbe8ec48-b5ee-432b-bca5-4d4ca32bb016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0b149664-1e59-450b-b41d-81cec2e68e8c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bbe8ec48-b5ee-432b-bca5-4d4ca32bb016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexFirstMember_55eff99a-06d5-4e62-8466-1ec531226cfd" xlink:href="mrna-20201231.xsd#mrna_VertexFirstMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bbe8ec48-b5ee-432b-bca5-4d4ca32bb016" xlink:to="loc_mrna_VertexFirstMember_55eff99a-06d5-4e62-8466-1ec531226cfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_57b522c6-4cfa-477a-9402-939738fbc071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1a132248-3cb0-4c58-9662-b7d3a693ba91" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_57b522c6-4cfa-477a-9402-939738fbc071" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_57b522c6-4cfa-477a-9402-939738fbc071_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_57b522c6-4cfa-477a-9402-939738fbc071" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_57b522c6-4cfa-477a-9402-939738fbc071_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_40bc0337-fb87-405e-9720-3b28af7dff1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_57b522c6-4cfa-477a-9402-939738fbc071" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_40bc0337-fb87-405e-9720-3b28af7dff1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_e17f69dd-9e6b-41ac-981a-42348557bc40" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_40bc0337-fb87-405e-9720-3b28af7dff1e" xlink:to="loc_mrna_UpfrontPaymentMember_e17f69dd-9e6b-41ac-981a-42348557bc40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentFundingMember_3a251b0d-f4f0-450e-98a2-30f047345b6d" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentFundingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_40bc0337-fb87-405e-9720-3b28af7dff1e" xlink:to="loc_mrna_ResearchAndDevelopmentFundingMember_3a251b0d-f4f0-450e-98a2-30f047345b6d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended" id="ie0c8d2b688604e17814acc0b458cc60c_CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2f90f567-f226-4caf-805b-b115c212eb22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d3fccaa3-8220-4a36-83fc-5b0a36c2a57c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2f90f567-f226-4caf-805b-b115c212eb22" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d3fccaa3-8220-4a36-83fc-5b0a36c2a57c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2f90f567-f226-4caf-805b-b115c212eb22" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_d0c5e9be-6943-4991-8b95-e8b8d33db6ed_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_d0c5e9be-6943-4991-8b95-e8b8d33db6ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f670b1c7-f67c-4f89-b344-f1618bbdce6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f670b1c7-f67c-4f89-b344-f1618bbdce6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexFirstMember_46d78e19-4303-4c56-ab44-31886e99a1bb" xlink:href="mrna-20201231.xsd#mrna_VertexFirstMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f670b1c7-f67c-4f89-b344-f1618bbdce6b" xlink:to="loc_mrna_VertexFirstMember_46d78e19-4303-4c56-ab44-31886e99a1bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_e7d66a6c-9b06-4628-b6a2-619ba49f56b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_e7d66a6c-9b06-4628-b6a2-619ba49f56b2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="extended" id="i0b39799e74564ccf81d015a3b06e8adb_CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2f90f567-f226-4caf-805b-b115c212eb22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d3fccaa3-8220-4a36-83fc-5b0a36c2a57c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2f90f567-f226-4caf-805b-b115c212eb22" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d3fccaa3-8220-4a36-83fc-5b0a36c2a57c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2f90f567-f226-4caf-805b-b115c212eb22" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_d0c5e9be-6943-4991-8b95-e8b8d33db6ed_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_d0c5e9be-6943-4991-8b95-e8b8d33db6ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f670b1c7-f67c-4f89-b344-f1618bbdce6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f670b1c7-f67c-4f89-b344-f1618bbdce6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexFirstMember_46d78e19-4303-4c56-ab44-31886e99a1bb" xlink:href="mrna-20201231.xsd#mrna_VertexFirstMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f670b1c7-f67c-4f89-b344-f1618bbdce6b" xlink:to="loc_mrna_VertexFirstMember_46d78e19-4303-4c56-ab44-31886e99a1bb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXRevenueRecognizedDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails" xlink:type="extended" id="i0cd2d4fb9f474c0794a87f3cd791a90f_CollaborationAgreementsVERTEXRevenueRecognizedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e337b307-3bce-44c5-85fa-f199f6653f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b6e6b598-adc3-45da-8300-4678b8dee1e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e337b307-3bce-44c5-85fa-f199f6653f22" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b6e6b598-adc3-45da-8300-4678b8dee1e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_17116ed3-ad3c-41d2-bffe-7f9079d3ecec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e337b307-3bce-44c5-85fa-f199f6653f22" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_17116ed3-ad3c-41d2-bffe-7f9079d3ecec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a9420e3b-31bd-48a8-8829-6a50021a67e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_17116ed3-ad3c-41d2-bffe-7f9079d3ecec" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a9420e3b-31bd-48a8-8829-6a50021a67e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_a9420e3b-31bd-48a8-8829-6a50021a67e2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a9420e3b-31bd-48a8-8829-6a50021a67e2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_a9420e3b-31bd-48a8-8829-6a50021a67e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c99c877e-0434-4103-8bde-fcd0104dba45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a9420e3b-31bd-48a8-8829-6a50021a67e2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c99c877e-0434-4103-8bde-fcd0104dba45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexFirstMember_61be810d-ec46-4b43-92b3-0830e20b7a24" xlink:href="mrna-20201231.xsd#mrna_VertexFirstMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c99c877e-0434-4103-8bde-fcd0104dba45" xlink:to="loc_mrna_VertexFirstMember_61be810d-ec46-4b43-92b3-0830e20b7a24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreement2019AgreementMember_ca86a67c-805f-46b1-a16e-7dca937b545e" xlink:href="mrna-20201231.xsd#mrna_VertexAgreement2019AgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c99c877e-0434-4103-8bde-fcd0104dba45" xlink:to="loc_mrna_VertexAgreement2019AgreementMember_ca86a67c-805f-46b1-a16e-7dca937b545e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreementsMember_fa48d860-5d5f-4903-bbb1-7ec69bcd25e1" xlink:href="mrna-20201231.xsd#mrna_VertexAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c99c877e-0434-4103-8bde-fcd0104dba45" xlink:to="loc_mrna_VertexAgreementsMember_fa48d860-5d5f-4903-bbb1-7ec69bcd25e1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails" xlink:type="extended" id="i90144604ebd0442cb1b08a149903b667_CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_260f2c44-d9fd-487d-a1e3-8a4398e3c122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_ec832fd5-e27f-4c89-a14d-6e20dde2039b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_260f2c44-d9fd-487d-a1e3-8a4398e3c122" xlink:to="loc_us-gaap_ContractWithCustomerLiability_ec832fd5-e27f-4c89-a14d-6e20dde2039b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3cb7f23-6e36-4bf9-a340-0889d99089d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_260f2c44-d9fd-487d-a1e3-8a4398e3c122" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3cb7f23-6e36-4bf9-a340-0889d99089d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e2d758d0-aebc-482b-8bc1-e32766ac0e1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3cb7f23-6e36-4bf9-a340-0889d99089d8" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e2d758d0-aebc-482b-8bc1-e32766ac0e1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e2d758d0-aebc-482b-8bc1-e32766ac0e1d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e2d758d0-aebc-482b-8bc1-e32766ac0e1d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e2d758d0-aebc-482b-8bc1-e32766ac0e1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e20f5937-5021-43d4-aa67-30df4f64e283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e2d758d0-aebc-482b-8bc1-e32766ac0e1d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e20f5937-5021-43d4-aa67-30df4f64e283" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreementsMember_4834147e-0cfe-4291-929a-25489e6a27b7" xlink:href="mrna-20201231.xsd#mrna_VertexAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e20f5937-5021-43d4-aa67-30df4f64e283" xlink:to="loc_mrna_VertexAgreementsMember_4834147e-0cfe-4291-929a-25489e6a27b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreements1Member_62990329-13ef-4013-b8d7-3a6415660b6d" xlink:href="mrna-20201231.xsd#mrna_VertexAgreements1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e20f5937-5021-43d4-aa67-30df4f64e283" xlink:to="loc_mrna_VertexAgreements1Member_62990329-13ef-4013-b8d7-3a6415660b6d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails" xlink:type="extended" id="i6b0c8a253051436ab3a79ccc62a39f22_CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_93599db5-eb86-421b-8845-c6c23b0c34bc" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_93599db5-eb86-421b-8845-c6c23b0c34bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1416b8b4-ab72-4359-a557-7457f52bf601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1416b8b4-ab72-4359-a557-7457f52bf601" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_bc69f821-0a21-4c18-86a0-84a65c8478f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_bc69f821-0a21-4c18-86a0-84a65c8478f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_008339cc-1684-4dd3-bfa8-aa2619e75963" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_008339cc-1684-4dd3-bfa8-aa2619e75963" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_601cbd9f-5f07-4233-baab-74bb950ce2d8" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_601cbd9f-5f07-4233-baab-74bb950ce2d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_473a49d8-7a9b-4a27-8a17-05b07695e84f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_473a49d8-7a9b-4a27-8a17-05b07695e84f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ba7ac0a3-7c7d-4bd7-a02f-84590f3e95ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ba7ac0a3-7c7d-4bd7-a02f-84590f3e95ba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_324e0771-5a20-4ae9-ac25-d0f96daa288e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_324e0771-5a20-4ae9-ac25-d0f96daa288e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e643f169-bbec-4b29-83e0-e716661fa0ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_324e0771-5a20-4ae9-ac25-d0f96daa288e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e643f169-bbec-4b29-83e0-e716661fa0ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e643f169-bbec-4b29-83e0-e716661fa0ca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e643f169-bbec-4b29-83e0-e716661fa0ca" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e643f169-bbec-4b29-83e0-e716661fa0ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_858cbefb-e2a8-4655-b0c8-3aa4416db565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e643f169-bbec-4b29-83e0-e716661fa0ca" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_858cbefb-e2a8-4655-b0c8-3aa4416db565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Vertex2020AgreementMember_02500b2d-2ac2-46f8-95e0-52d7f7c3fc46" xlink:href="mrna-20201231.xsd#mrna_Vertex2020AgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_858cbefb-e2a8-4655-b0c8-3aa4416db565" xlink:to="loc_mrna_Vertex2020AgreementMember_02500b2d-2ac2-46f8-95e0-52d7f7c3fc46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_f85bab6e-03bf-462e-bb21-02e7c36180d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_324e0771-5a20-4ae9-ac25-d0f96daa288e" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_f85bab6e-03bf-462e-bb21-02e7c36180d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_f85bab6e-03bf-462e-bb21-02e7c36180d0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_f85bab6e-03bf-462e-bb21-02e7c36180d0" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_f85bab6e-03bf-462e-bb21-02e7c36180d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_49469b60-2c9f-4482-95f3-07f2bd71bc0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_f85bab6e-03bf-462e-bb21-02e7c36180d0" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_49469b60-2c9f-4482-95f3-07f2bd71bc0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_8ce02b1a-61e9-42c8-8e03-655fe41ce7ee" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_49469b60-2c9f-4482-95f3-07f2bd71bc0a" xlink:to="loc_mrna_UpfrontPaymentMember_8ce02b1a-61e9-42c8-8e03-655fe41ce7ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_749a18f8-c083-486f-946b-d17a3f763cec" xlink:href="mrna-20201231.xsd#mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_49469b60-2c9f-4482-95f3-07f2bd71bc0a" xlink:to="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_749a18f8-c083-486f-946b-d17a3f763cec" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails" xlink:type="extended" id="i8ebff3bfb1d64c99a0b865f2d52870c6_CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_4ffaf04c-e312-4381-846c-8c86a1a81fbf" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_4ffaf04c-e312-4381-846c-8c86a1a81fbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4d79a62b-9dc1-41af-bcd1-f0785be01076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4d79a62b-9dc1-41af-bcd1-f0785be01076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_6dd3d2b5-f19d-4911-b06f-0dc9c18e7792" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_6dd3d2b5-f19d-4911-b06f-0dc9c18e7792" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_d37b7311-35a6-487f-8564-adfca3a3b230" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_d37b7311-35a6-487f-8564-adfca3a3b230" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_94cbf9d1-0fcc-4ee9-97ac-837ab5e1a24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_94cbf9d1-0fcc-4ee9-97ac-837ab5e1a24b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e64f9dbf-0558-4938-baaa-ef07c4c53981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e64f9dbf-0558-4938-baaa-ef07c4c53981" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ff21c4f6-6747-457c-8136-a467cbef1249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ff21c4f6-6747-457c-8136-a467cbef1249" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fa363300-d72a-46e0-a0f1-ab8f3c526a07_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fa363300-d72a-46e0-a0f1-ab8f3c526a07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdafc82-f9a4-4d69-8f11-41738391fa50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdafc82-f9a4-4d69-8f11-41738391fa50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChiesiAgreementMember_23af5b8c-c460-4c6f-98c6-8dc457827482" xlink:href="mrna-20201231.xsd#mrna_ChiesiAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdafc82-f9a4-4d69-8f11-41738391fa50" xlink:to="loc_mrna_ChiesiAgreementMember_23af5b8c-c460-4c6f-98c6-8dc457827482" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_80643447-ed80-4d54-99ca-0bf33aec3e68_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_80643447-ed80-4d54-99ca-0bf33aec3e68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_e84afb96-0c96-414b-bb01-db96a118f014" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:to="loc_mrna_UpfrontPaymentMember_e84afb96-0c96-414b-bb01-db96a118f014" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_7df209b1-bd01-4f20-b637-ac8203105ad5" xlink:href="mrna-20201231.xsd#mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:to="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_7df209b1-bd01-4f20-b637-ac8203105ad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_cac684bd-3e80-4c5c-a55b-88741a9f229c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_cac684bd-3e80-4c5c-a55b-88741a9f229c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1" xlink:type="extended" id="i832e0ca308c742589fa5e598b2df4ecf_CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_4ffaf04c-e312-4381-846c-8c86a1a81fbf" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_4ffaf04c-e312-4381-846c-8c86a1a81fbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4d79a62b-9dc1-41af-bcd1-f0785be01076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4d79a62b-9dc1-41af-bcd1-f0785be01076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_6dd3d2b5-f19d-4911-b06f-0dc9c18e7792" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_6dd3d2b5-f19d-4911-b06f-0dc9c18e7792" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_d37b7311-35a6-487f-8564-adfca3a3b230" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_d37b7311-35a6-487f-8564-adfca3a3b230" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_94cbf9d1-0fcc-4ee9-97ac-837ab5e1a24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_94cbf9d1-0fcc-4ee9-97ac-837ab5e1a24b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e64f9dbf-0558-4938-baaa-ef07c4c53981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e64f9dbf-0558-4938-baaa-ef07c4c53981" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ff21c4f6-6747-457c-8136-a467cbef1249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ff21c4f6-6747-457c-8136-a467cbef1249" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fa363300-d72a-46e0-a0f1-ab8f3c526a07_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fa363300-d72a-46e0-a0f1-ab8f3c526a07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdafc82-f9a4-4d69-8f11-41738391fa50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdafc82-f9a4-4d69-8f11-41738391fa50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChiesiAgreementMember_23af5b8c-c460-4c6f-98c6-8dc457827482" xlink:href="mrna-20201231.xsd#mrna_ChiesiAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdafc82-f9a4-4d69-8f11-41738391fa50" xlink:to="loc_mrna_ChiesiAgreementMember_23af5b8c-c460-4c6f-98c6-8dc457827482" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_80643447-ed80-4d54-99ca-0bf33aec3e68_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_80643447-ed80-4d54-99ca-0bf33aec3e68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_e84afb96-0c96-414b-bb01-db96a118f014" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:to="loc_mrna_UpfrontPaymentMember_e84afb96-0c96-414b-bb01-db96a118f014" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_7df209b1-bd01-4f20-b637-ac8203105ad5" xlink:href="mrna-20201231.xsd#mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:to="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_7df209b1-bd01-4f20-b637-ac8203105ad5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended" id="icdbf432bc01b4b77bf6111a0eabf3492_CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_70cbaaa8-219e-42be-9007-60869a493972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_50645e4f-7153-4bdc-b92a-4b8a7e527e6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_70cbaaa8-219e-42be-9007-60869a493972" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_50645e4f-7153-4bdc-b92a-4b8a7e527e6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_79cce3b9-7cc7-468a-8b62-e12eee42fef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_70cbaaa8-219e-42be-9007-60869a493972" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_79cce3b9-7cc7-468a-8b62-e12eee42fef9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ae7cb6f6-0a27-417a-bef6-62f37350133f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_79cce3b9-7cc7-468a-8b62-e12eee42fef9" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ae7cb6f6-0a27-417a-bef6-62f37350133f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ae7cb6f6-0a27-417a-bef6-62f37350133f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ae7cb6f6-0a27-417a-bef6-62f37350133f" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_ae7cb6f6-0a27-417a-bef6-62f37350133f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f160e34-3a89-4d87-ba41-1581a27580d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ae7cb6f6-0a27-417a-bef6-62f37350133f" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f160e34-3a89-4d87-ba41-1581a27580d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChiesiAgreementMember_3f389a60-696e-4e5f-bd1a-51db999dab81" xlink:href="mrna-20201231.xsd#mrna_ChiesiAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f160e34-3a89-4d87-ba41-1581a27580d1" xlink:to="loc_mrna_ChiesiAgreementMember_3f389a60-696e-4e5f-bd1a-51db999dab81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_580fadce-ea96-4e21-9f2e-1a1737af0b42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_79cce3b9-7cc7-468a-8b62-e12eee42fef9" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_580fadce-ea96-4e21-9f2e-1a1737af0b42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_580fadce-ea96-4e21-9f2e-1a1737af0b42_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_580fadce-ea96-4e21-9f2e-1a1737af0b42" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_580fadce-ea96-4e21-9f2e-1a1737af0b42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_580fadce-ea96-4e21-9f2e-1a1737af0b42" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_25786189-8d4a-4aa4-8a6b-b11f9fc9fd0c" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:to="loc_mrna_UpfrontPaymentMember_25786189-8d4a-4aa4-8a6b-b11f9fc9fd0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentFundingMember_f33a805b-f4c6-4d57-860d-ae161e7b69c2" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentFundingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:to="loc_mrna_ResearchAndDevelopmentFundingMember_f33a805b-f4c6-4d57-860d-ae161e7b69c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChiesiAgreementTransactionPriceMember_130b056c-67ff-4760-8619-75697500a33d" xlink:href="mrna-20201231.xsd#mrna_ChiesiAgreementTransactionPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:to="loc_mrna_ChiesiAgreementTransactionPriceMember_130b056c-67ff-4760-8619-75697500a33d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RemainingUnsatisfiedPerformanceObligationMember_8c4efbe9-0d5e-437d-a352-5f4a0f8a1d17" xlink:href="mrna-20201231.xsd#mrna_RemainingUnsatisfiedPerformanceObligationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:to="loc_mrna_RemainingUnsatisfiedPerformanceObligationMember_8c4efbe9-0d5e-437d-a352-5f4a0f8a1d17" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="extended" id="i9a4b33d9101a40b5a110230b66c63145_FinancialInstrumentsandFairValueMeasurements"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="extended" id="ifbe1c6366c644b6e8d7ce085735fe8ca_FinancialInstrumentsandFairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails" xlink:type="extended" id="i710a643ce8c64d109f1865a3e43f5374_FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e2d20b82-6c56-40b4-9aec-f1e358982c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e2d20b82-6c56-40b4-9aec-f1e358982c55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5ed869ab-caa8-4753-9c39-981619365648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5ed869ab-caa8-4753-9c39-981619365648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_219ae3a2-f785-4bf1-b7ec-079eaf7f1a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_219ae3a2-f785-4bf1-b7ec-079eaf7f1a02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6bd99594-30ce-45e0-bacb-63b6b67a00a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6bd99594-30ce-45e0-bacb-63b6b67a00a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_89c3f65e-97d8-4d16-8a52-fac6dd525b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_89c3f65e-97d8-4d16-8a52-fac6dd525b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89c3f65e-97d8-4d16-8a52-fac6dd525b47_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_89c3f65e-97d8-4d16-8a52-fac6dd525b47" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_89c3f65e-97d8-4d16-8a52-fac6dd525b47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_89c3f65e-97d8-4d16-8a52-fac6dd525b47" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_fe17820d-2fcb-4c42-b75c-aa34db8051fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_fe17820d-2fcb-4c42-b75c-aa34db8051fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_be82f7ba-ef33-4b14-9f85-4c88a99a193a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:to="loc_us-gaap_CertificatesOfDepositMember_be82f7ba-ef33-4b14-9f85-4c88a99a193a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_73138a8c-59e5-4a34-b389-02ca7c1d3e2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_73138a8c-59e5-4a34-b389-02ca7c1d3e2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_36a7e0e6-99da-434e-9839-76d316a0fde9" xlink:href="mrna-20201231.xsd#mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:to="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_36a7e0e6-99da-434e-9839-76d316a0fde9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21da6dfb-ffd1-4018-8e8f-382e0ca04d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21da6dfb-ffd1-4018-8e8f-382e0ca04d05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21da6dfb-ffd1-4018-8e8f-382e0ca04d05_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21da6dfb-ffd1-4018-8e8f-382e0ca04d05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21da6dfb-ffd1-4018-8e8f-382e0ca04d05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c575f866-6ba8-4322-ba46-71f9f2927d09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21da6dfb-ffd1-4018-8e8f-382e0ca04d05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c575f866-6ba8-4322-ba46-71f9f2927d09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_61e9becd-e2ed-4e5e-a12b-5301959baa11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c575f866-6ba8-4322-ba46-71f9f2927d09" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_61e9becd-e2ed-4e5e-a12b-5301959baa11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e680e86b-7d19-46bc-a7eb-72815a5c5ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c575f866-6ba8-4322-ba46-71f9f2927d09" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e680e86b-7d19-46bc-a7eb-72815a5c5ff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0270bc7c-fe8b-4325-b35e-be31d13ff7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0270bc7c-fe8b-4325-b35e-be31d13ff7c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0270bc7c-fe8b-4325-b35e-be31d13ff7c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0270bc7c-fe8b-4325-b35e-be31d13ff7c9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0270bc7c-fe8b-4325-b35e-be31d13ff7c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b33d1a89-9d9c-4bd9-b30a-57dc2e1be7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0270bc7c-fe8b-4325-b35e-be31d13ff7c9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b33d1a89-9d9c-4bd9-b30a-57dc2e1be7e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_47ae6e05-612f-4c76-a64b-1e19e7f541bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b33d1a89-9d9c-4bd9-b30a-57dc2e1be7e8" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_47ae6e05-612f-4c76-a64b-1e19e7f541bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CurrentMarketableSecuritiesMember_9aef32dc-aece-4cf7-83a4-fc5611a47324" xlink:href="mrna-20201231.xsd#mrna_CurrentMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b33d1a89-9d9c-4bd9-b30a-57dc2e1be7e8" xlink:to="loc_mrna_CurrentMarketableSecuritiesMember_9aef32dc-aece-4cf7-83a4-fc5611a47324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NoncurrentMarketableSecuritiesMember_56d11299-d898-4a26-a740-a8f950b41e38" xlink:href="mrna-20201231.xsd#mrna_NoncurrentMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b33d1a89-9d9c-4bd9-b30a-57dc2e1be7e8" xlink:to="loc_mrna_NoncurrentMarketableSecuritiesMember_56d11299-d898-4a26-a740-a8f950b41e38" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails" xlink:type="extended" id="ibfb11ccec68441aea05a04b6009b04d8_FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails" xlink:type="extended" id="i78906ab492c041658f1503e1cea29290_FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_4f8c36bd-34cf-4af1-aec1-dd6532dcd9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_4f8c36bd-34cf-4af1-aec1-dd6532dcd9fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_005bffc8-99b3-4c84-95ae-e7ef649c9122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_005bffc8-99b3-4c84-95ae-e7ef649c9122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_61e40c93-3925-4108-897b-2f0683bab593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_61e40c93-3925-4108-897b-2f0683bab593" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_82152cb6-d41e-4298-8f0a-6926343cd87a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_82152cb6-d41e-4298-8f0a-6926343cd87a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2250d29f-3777-4ad3-b477-1dcf64b663e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2250d29f-3777-4ad3-b477-1dcf64b663e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e4b93a62-6997-43e3-845b-b5b27a90d5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e4b93a62-6997-43e3-845b-b5b27a90d5d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e5215d98-687b-44ce-882f-16aa3192f90e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e5215d98-687b-44ce-882f-16aa3192f90e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2a0a1a5e-93c8-401a-8481-53637266497b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e5215d98-687b-44ce-882f-16aa3192f90e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2a0a1a5e-93c8-401a-8481-53637266497b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a0a1a5e-93c8-401a-8481-53637266497b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2a0a1a5e-93c8-401a-8481-53637266497b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2a0a1a5e-93c8-401a-8481-53637266497b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c783f1b9-b3ef-4b74-9bba-38e4ef6e990c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2a0a1a5e-93c8-401a-8481-53637266497b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c783f1b9-b3ef-4b74-9bba-38e4ef6e990c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_69feaf81-adfe-488b-8f7c-8470c14780c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c783f1b9-b3ef-4b74-9bba-38e4ef6e990c" xlink:to="loc_us-gaap_CertificatesOfDepositMember_69feaf81-adfe-488b-8f7c-8470c14780c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_5280ff5a-53db-482d-a6c9-24f2e38445c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c783f1b9-b3ef-4b74-9bba-38e4ef6e990c" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_5280ff5a-53db-482d-a6c9-24f2e38445c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_8509249e-13af-48c4-9dc1-c6e5d54798b9" xlink:href="mrna-20201231.xsd#mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c783f1b9-b3ef-4b74-9bba-38e4ef6e990c" xlink:to="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_8509249e-13af-48c4-9dc1-c6e5d54798b9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i5ec334651f514ca68a9ae55f2d9870a9_FinancialInstrumentsandFairValueMeasurementsNarrativeDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails" xlink:type="extended" id="if45a9f2a0c8b455a8002a75713d5c74d_FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ce83f96a-134f-4965-b38e-e520ee07cb58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a69ab99d-ee95-4c6d-96f0-3ae4d7a7d3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ce83f96a-134f-4965-b38e-e520ee07cb58" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a69ab99d-ee95-4c6d-96f0-3ae4d7a7d3ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_dbb1d06d-e119-4467-b3d0-bdfab1c83f8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ce83f96a-134f-4965-b38e-e520ee07cb58" xlink:to="loc_us-gaap_DerivativeAssets_dbb1d06d-e119-4467-b3d0-bdfab1c83f8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_39322b30-bb94-4100-93ec-b7d559d88459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ce83f96a-134f-4965-b38e-e520ee07cb58" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_39322b30-bb94-4100-93ec-b7d559d88459" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ce83f96a-134f-4965-b38e-e520ee07cb58" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7964a98d-c436-4054-8cd8-8134be366a7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7964a98d-c436-4054-8cd8-8134be366a7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7964a98d-c436-4054-8cd8-8134be366a7c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7964a98d-c436-4054-8cd8-8134be366a7c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7964a98d-c436-4054-8cd8-8134be366a7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_581fcda8-9af8-4026-bd10-65095498c89d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7964a98d-c436-4054-8cd8-8134be366a7c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_581fcda8-9af8-4026-bd10-65095498c89d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_89742ad9-eb4d-4692-8e0c-805457a07a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_581fcda8-9af8-4026-bd10-65095498c89d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_89742ad9-eb4d-4692-8e0c-805457a07a8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3c514eaa-3d04-4652-8b0c-5b43a5e12ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3c514eaa-3d04-4652-8b0c-5b43a5e12ad3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3c514eaa-3d04-4652-8b0c-5b43a5e12ad3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3c514eaa-3d04-4652-8b0c-5b43a5e12ad3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3c514eaa-3d04-4652-8b0c-5b43a5e12ad3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3c514eaa-3d04-4652-8b0c-5b43a5e12ad3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_30a207b7-02de-451e-8f97-49cd196c4bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:to="loc_us-gaap_MoneyMarketFundsMember_30a207b7-02de-451e-8f97-49cd196c4bf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_89450c83-0448-4159-aaef-e13382703950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:to="loc_us-gaap_CertificatesOfDepositMember_89450c83-0448-4159-aaef-e13382703950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_248e5335-1b46-4645-b0c2-7af1affb4ecb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_248e5335-1b46-4645-b0c2-7af1affb4ecb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_9d9c750b-f685-4437-9aa5-60073e28dde1" xlink:href="mrna-20201231.xsd#mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:to="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_9d9c750b-f685-4437-9aa5-60073e28dde1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f8d4ecd0-e5b9-4dd3-933c-9ac70407216e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f8d4ecd0-e5b9-4dd3-933c-9ac70407216e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8d4ecd0-e5b9-4dd3-933c-9ac70407216e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f8d4ecd0-e5b9-4dd3-933c-9ac70407216e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f8d4ecd0-e5b9-4dd3-933c-9ac70407216e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5da4e27b-26b9-4e63-b7b5-90a81a9254e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f8d4ecd0-e5b9-4dd3-933c-9ac70407216e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5da4e27b-26b9-4e63-b7b5-90a81a9254e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fc741424-aa5a-4606-9696-c6f3c2990515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5da4e27b-26b9-4e63-b7b5-90a81a9254e8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fc741424-aa5a-4606-9696-c6f3c2990515" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1f52cc8a-cb8e-4b6d-ac03-fcaa35760aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5da4e27b-26b9-4e63-b7b5-90a81a9254e8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1f52cc8a-cb8e-4b6d-ac03-fcaa35760aa1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="mrna-20201231.xsd#DerivativeFinancialInstruments"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/DerivativeFinancialInstruments" xlink:type="extended" id="i73f30d5ad34441e4bd3c1a73728e16f1_DerivativeFinancialInstruments"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended" id="i9744a5b76cac4ac3b20fed5891debb8f_DerivativeFinancialInstrumentsTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails" xlink:type="extended" id="ib27f190064534906997763f074c434b7_DerivativeFinancialInstrumentsBalanceSheetHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ae9be3fc-c350-4d33-b0d7-d8d77c9f90b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ae9be3fc-c350-4d33-b0d7-d8d77c9f90b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_3495f292-81ba-4c3a-af19-d512e8f41af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_3495f292-81ba-4c3a-af19-d512e8f41af6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_4f8c2f4e-2de9-4506-a9ab-52af166e1c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_4f8c2f4e-2de9-4506-a9ab-52af166e1c49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_b30e0ae7-1b74-486e-8205-4857b07a841b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_b30e0ae7-1b74-486e-8205-4857b07a841b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9c9f26a7-8b91-440d-8caa-b855d0c07743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9c9f26a7-8b91-440d-8caa-b855d0c07743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9c9f26a7-8b91-440d-8caa-b855d0c07743_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9c9f26a7-8b91-440d-8caa-b855d0c07743" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9c9f26a7-8b91-440d-8caa-b855d0c07743_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4cc9c1e5-5f22-4c82-88de-6b683f5aeaa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9c9f26a7-8b91-440d-8caa-b855d0c07743" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4cc9c1e5-5f22-4c82-88de-6b683f5aeaa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1a1164c2-1bb5-4c7f-93fd-5d4f6d86e1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4cc9c1e5-5f22-4c82-88de-6b683f5aeaa6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1a1164c2-1bb5-4c7f-93fd-5d4f6d86e1e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_25704cb9-dc86-4d1d-96c4-a6cc5e6d9643" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_25704cb9-dc86-4d1d-96c4-a6cc5e6d9643" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_25704cb9-dc86-4d1d-96c4-a6cc5e6d9643_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_25704cb9-dc86-4d1d-96c4-a6cc5e6d9643" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_25704cb9-dc86-4d1d-96c4-a6cc5e6d9643_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_134dbe88-77e4-4873-bb4d-0d9e87f8d77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_25704cb9-dc86-4d1d-96c4-a6cc5e6d9643" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_134dbe88-77e4-4873-bb4d-0d9e87f8d77e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_eb103ad3-58d9-44bb-bf62-e80ea250922f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_134dbe88-77e4-4873-bb4d-0d9e87f8d77e" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_eb103ad3-58d9-44bb-bf62-e80ea250922f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ffec2803-a217-48f2-8b13-5e95795d4db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:to="loc_us-gaap_HedgingDesignationAxis_ffec2803-a217-48f2-8b13-5e95795d4db1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ffec2803-a217-48f2-8b13-5e95795d4db1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_ffec2803-a217-48f2-8b13-5e95795d4db1" xlink:to="loc_us-gaap_HedgingDesignationDomain_ffec2803-a217-48f2-8b13-5e95795d4db1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_966dbb02-0b3b-4b43-9b2f-cd51346c22da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_ffec2803-a217-48f2-8b13-5e95795d4db1" xlink:to="loc_us-gaap_HedgingDesignationDomain_966dbb02-0b3b-4b43-9b2f-cd51346c22da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_bb0bbb1a-3c3b-4720-8c85-800ab3559f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_966dbb02-0b3b-4b43-9b2f-cd51346c22da" xlink:to="loc_us-gaap_NondesignatedMember_bb0bbb1a-3c3b-4720-8c85-800ab3559f1e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/Inventory" xlink:type="simple" xlink:href="mrna-20201231.xsd#Inventory"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/Inventory" xlink:type="extended" id="ic17457b7fb9a439082a9303d3b8e14fc_Inventory"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/InventoryTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#InventoryTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/InventoryTables" xlink:type="extended" id="ied34905432444882ad3314fe48daf911_InventoryTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/InventoryDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#InventoryDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/InventoryDetails" xlink:type="extended" id="ib7f2e2b37e254707b1e1f09aac77729f_InventoryDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="mrna-20201231.xsd#PropertyandEquipment"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/PropertyandEquipment" xlink:type="extended" id="i1ca1a96093974a009f8c826cdfa4aac1_PropertyandEquipment"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#PropertyandEquipmentTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/PropertyandEquipmentTables" xlink:type="extended" id="id0b41a8fbe4f4d5192c4dfb2be4e5fc5_PropertyandEquipmentTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#PropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/PropertyandEquipmentDetails" xlink:type="extended" id="ic5341076f98c4d0f96042b419418fc2b_PropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_afbce671-fbe4-424e-add4-26f79472e052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_afbce671-fbe4-424e-add4-26f79472e052" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5f9d01ea-20d6-4256-9588-dab7215eccfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5f9d01ea-20d6-4256-9588-dab7215eccfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_36a46252-56ea-4131-b639-ec43519da6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_36a46252-56ea-4131-b639-ec43519da6d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0fbec848-9c10-408d-b7d3-0987d5796a72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0fbec848-9c10-408d-b7d3-0987d5796a72" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_668f9dab-123c-4db0-8052-f93bd82495c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_668f9dab-123c-4db0-8052-f93bd82495c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3c05098-dd1c-462f-8627-e53db1f8dfd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_668f9dab-123c-4db0-8052-f93bd82495c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3c05098-dd1c-462f-8627-e53db1f8dfd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a3c05098-dd1c-462f-8627-e53db1f8dfd3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3c05098-dd1c-462f-8627-e53db1f8dfd3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a3c05098-dd1c-462f-8627-e53db1f8dfd3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3c05098-dd1c-462f-8627-e53db1f8dfd3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_b98bf5a3-2c77-469d-9cb1-e5982331c3d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_EquipmentMember_b98bf5a3-2c77-469d-9cb1-e5982331c3d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3a609a53-59a6-40a6-bdc5-1e07e1656ce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3a609a53-59a6-40a6-bdc5-1e07e1656ce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_a8b9eab9-8f72-4a1a-b04e-4b7235bf6eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOtherTypesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_a8b9eab9-8f72-4a1a-b04e-4b7235bf6eeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_56c543d1-f4a2-48ff-a02d-38e513b5728c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_ComputerEquipmentMember_56c543d1-f4a2-48ff-a02d-38e513b5728c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_f8e465c3-2830-4d45-934b-e5f4d2708524" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_f8e465c3-2830-4d45-934b-e5f4d2708524" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FinancingRightOfUseAssetMember_e280ced9-ea8b-40b9-b4d3-3c6a10f75dad" xlink:href="mrna-20201231.xsd#mrna_FinancingRightOfUseAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_mrna_FinancingRightOfUseAssetMember_e280ced9-ea8b-40b9-b4d3-3c6a10f75dad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_563f49a4-b854-4738-98c2-eeee8cfc0fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_ConstructionInProgressMember_563f49a4-b854-4738-98c2-eeee8cfc0fa8" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponents" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponents"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponents" xlink:type="extended" id="iddbb52da2f794edab6be6ef2e9d8a4ee_OtherBalanceSheetComponents"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsTables" xlink:type="extended" id="i0faeab86863f4c599406ca1ccc4231a5_OtherBalanceSheetComponentsTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended" id="icfc0b603aa3d418ab27880322d5cb982_OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsAccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="extended" id="i2a87817ec15e459291c5bf3ab98e31b2_OtherBalanceSheetComponentsAccruedLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="extended" id="i8b9ba1f29ddf47bfa8de29cf4275fd29_OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsDeferredRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails" xlink:type="extended" id="if4748458e106440597fa6c849bd3fe85_OtherBalanceSheetComponentsDeferredRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityLineItems_3de3e557-4d33-4d8e-a113-9704ce426520" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityLineItems_3de3e557-4d33-4d8e-a113-9704ce426520" xlink:to="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_12b1c800-1609-43b9-9ca3-27d4764da869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:to="loc_us-gaap_ContractWithCustomerLiability_12b1c800-1609-43b9-9ca3-27d4764da869" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_6425b586-4cd6-4629-ad08-d32ff7cca9d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_6425b586-4cd6-4629-ad08-d32ff7cca9d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod_5e4fcdab-e30f-48c2-87f9-1edd84cbeb31" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:to="loc_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod_5e4fcdab-e30f-48c2-87f9-1edd84cbeb31" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_caabd233-4091-4964-8f20-a957c4351610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityTable_fb95e7fa-9dc3-4a09-8f94-1e209666a56e" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityLineItems_3de3e557-4d33-4d8e-a113-9704ce426520" xlink:to="loc_mrna_ChangeInContractWithCustomerLiabilityTable_fb95e7fa-9dc3-4a09-8f94-1e209666a56e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_41ecfe15-a927-454c-9449-2faa70a2da80" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityTable_fb95e7fa-9dc3-4a09-8f94-1e209666a56e" xlink:to="loc_srt_ProductOrServiceAxis_41ecfe15-a927-454c-9449-2faa70a2da80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_41ecfe15-a927-454c-9449-2faa70a2da80_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_41ecfe15-a927-454c-9449-2faa70a2da80" xlink:to="loc_srt_ProductsAndServicesDomain_41ecfe15-a927-454c-9449-2faa70a2da80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_66cea332-3bbe-4c84-8d0b-0c0996fdcf55" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_41ecfe15-a927-454c-9449-2faa70a2da80" xlink:to="loc_srt_ProductsAndServicesDomain_66cea332-3bbe-4c84-8d0b-0c0996fdcf55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ProductSalesMember_66b74c27-3ee5-4c2b-b073-dfe75d691988" xlink:href="mrna-20201231.xsd#mrna_ProductSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_66cea332-3bbe-4c84-8d0b-0c0996fdcf55" xlink:to="loc_mrna_ProductSalesMember_66b74c27-3ee5-4c2b-b073-dfe75d691988" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_4eccba6b-e21e-4cac-a545-75e60142b01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_66cea332-3bbe-4c84-8d0b-0c0996fdcf55" xlink:to="loc_us-gaap_GrantMember_4eccba6b-e21e-4cac-a545-75e60142b01f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_85897a8a-c09d-4bce-a122-3457578bb22b" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_66cea332-3bbe-4c84-8d0b-0c0996fdcf55" xlink:to="loc_mrna_CollaborationArrangementMember_85897a8a-c09d-4bce-a122-3457578bb22b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/Leases" xlink:type="simple" xlink:href="mrna-20201231.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/Leases" xlink:type="extended" id="i86076aed7d384baa8a4d959cccacfae2_Leases"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/LeasesTables" xlink:type="extended" id="ifab5ae04d0bd44dfa233f6c5ba80469f_LeasesTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i9e9aa0596ba44f7bbec83244df220aff_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLeaseNumberOfProperties_4287fc9d-f93c-4313-ad1b-4530ef80cdfe" xlink:href="mrna-20201231.xsd#mrna_OperatingLeaseNumberOfProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_OperatingLeaseNumberOfProperties_4287fc9d-f93c-4313-ad1b-4530ef80cdfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_11ae7e8a-12b2-4a16-acdc-3cc4227fb3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_11ae7e8a-12b2-4a16-acdc-3cc4227fb3ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_fcb98f9a-ea9d-46db-b749-30604048766a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_fcb98f9a-ea9d-46db-b749-30604048766a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods_21440d93-e496-42a0-95be-b33e06ccc093" xlink:href="mrna-20201231.xsd#mrna_LesseeOperatingLeaseNumberOfExtensionPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods_21440d93-e496-42a0-95be-b33e06ccc093" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LesseeOperatingLeasePercentageSubleased_b35b2284-6fd8-4469-8aea-1845690e7dbc" xlink:href="mrna-20201231.xsd#mrna_LesseeOperatingLeasePercentageSubleased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_LesseeOperatingLeasePercentageSubleased_b35b2284-6fd8-4469-8aea-1845690e7dbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements_1e097cf4-4602-4455-a249-7d12a516743e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TenantImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_TenantImprovements_1e097cf4-4602-4455-a249-7d12a516743e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AreaOfRealEstatePropertyAdditionalSpace_9c89f378-5c71-463c-bb54-b326312f22f3" xlink:href="mrna-20201231.xsd#mrna_AreaOfRealEstatePropertyAdditionalSpace"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_AreaOfRealEstatePropertyAdditionalSpace_9c89f378-5c71-463c-bb54-b326312f22f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_00b57a5f-3322-4b19-bb27-ff812b3306a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_OperatingLeaseLiability_00b57a5f-3322-4b19-bb27-ff812b3306a9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_11efccea-2d31-4cd7-99ea-0c051de531f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_11efccea-2d31-4cd7-99ea-0c051de531f5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_472c2c96-c52d-40ed-a4f8-1d65b78dfbd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_472c2c96-c52d-40ed-a4f8-1d65b78dfbd2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0c49fd13-4370-4f1b-a11d-60a7c13aded7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0c49fd13-4370-4f1b-a11d-60a7c13aded7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e4508be0-e358-4e82-8dd0-05bc281f7ad7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e4508be0-e358-4e82-8dd0-05bc281f7ad7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LeasesImputedInterestRate_50a39c42-899b-44ce-9daa-e13c953cc7d2" xlink:href="mrna-20201231.xsd#mrna_LeasesImputedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_LeasesImputedInterestRate_50a39c42-899b-44ce-9daa-e13c953cc7d2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LeasesIncrementalBorrowingRate_3abcec5c-1553-4229-9a55-417d3068c91f" xlink:href="mrna-20201231.xsd#mrna_LeasesIncrementalBorrowingRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_LeasesIncrementalBorrowingRate_3abcec5c-1553-4229-9a55-417d3068c91f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_520f9a8d-d680-40ba-937a-f5019e2d8d88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:to="loc_srt_StatementGeographicalAxis_520f9a8d-d680-40ba-937a-f5019e2d8d88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_520f9a8d-d680-40ba-937a-f5019e2d8d88_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_520f9a8d-d680-40ba-937a-f5019e2d8d88" xlink:to="loc_srt_SegmentGeographicalDomain_520f9a8d-d680-40ba-937a-f5019e2d8d88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cbb7d63d-f2ad-4452-8c50-c0c47da38bf6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_520f9a8d-d680-40ba-937a-f5019e2d8d88" xlink:to="loc_srt_SegmentGeographicalDomain_cbb7d63d-f2ad-4452-8c50-c0c47da38bf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CambridgeMassachusettsMember_c9590e94-7ade-4b82-983c-8c73c366f4dc" xlink:href="mrna-20201231.xsd#mrna_CambridgeMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cbb7d63d-f2ad-4452-8c50-c0c47da38bf6" xlink:to="loc_mrna_CambridgeMassachusettsMember_c9590e94-7ade-4b82-983c-8c73c366f4dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NorwoodMassachusettsMember_b0fe5f63-027e-47b9-a203-05afb9c6a632" xlink:href="mrna-20201231.xsd#mrna_NorwoodMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_cbb7d63d-f2ad-4452-8c50-c0c47da38bf6" xlink:to="loc_mrna_NorwoodMassachusettsMember_b0fe5f63-027e-47b9-a203-05afb9c6a632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_79be82c0-4498-4ea5-ad2d-f3c24ec738a7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_79be82c0-4498-4ea5-ad2d-f3c24ec738a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_79be82c0-4498-4ea5-ad2d-f3c24ec738a7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_79be82c0-4498-4ea5-ad2d-f3c24ec738a7" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_79be82c0-4498-4ea5-ad2d-f3c24ec738a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_79be82c0-4498-4ea5-ad2d-f3c24ec738a7" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TwoHundredTechnologySquareMember_721adce1-98bb-4c53-8f23-bd90f0c5736d" xlink:href="mrna-20201231.xsd#mrna_TwoHundredTechnologySquareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:to="loc_mrna_TwoHundredTechnologySquareMember_721adce1-98bb-4c53-8f23-bd90f0c5736d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FiveHundredTechnologySquareMember_0a435fee-282a-4754-a571-13033bafbd4f" xlink:href="mrna-20201231.xsd#mrna_FiveHundredTechnologySquareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:to="loc_mrna_FiveHundredTechnologySquareMember_0a435fee-282a-4754-a571-13033bafbd4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember_c913bb8b-2db8-42ee-a8a4-58d41bfcd67a" xlink:href="mrna-20201231.xsd#mrna_OfficeLaboratoryAndLightManufacturingSpaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:to="loc_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember_c913bb8b-2db8-42ee-a8a4-58d41bfcd67a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MTCNorthMember_bb030d0b-81a4-48ea-a161-53b0c0c79725" xlink:href="mrna-20201231.xsd#mrna_MTCNorthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:to="loc_mrna_MTCNorthMember_bb030d0b-81a4-48ea-a161-53b0c0c79725" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MTCSouthMember_121ce135-17e5-4fac-82b4-47b3f16e9282" xlink:href="mrna-20201231.xsd#mrna_MTCSouthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:to="loc_mrna_MTCSouthMember_121ce135-17e5-4fac-82b4-47b3f16e9282" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_d0b0292b-23a7-4df0-990a-ee46135459ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:to="loc_us-gaap_LeaseContractualTermAxis_d0b0292b-23a7-4df0-990a-ee46135459ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_d0b0292b-23a7-4df0-990a-ee46135459ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_d0b0292b-23a7-4df0-990a-ee46135459ee" xlink:to="loc_us-gaap_LeaseContractualTermDomain_d0b0292b-23a7-4df0-990a-ee46135459ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_96270f93-4f34-4be5-91ef-126a46e86034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_d0b0292b-23a7-4df0-990a-ee46135459ee" xlink:to="loc_us-gaap_LeaseContractualTermDomain_96270f93-4f34-4be5-91ef-126a46e86034" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EmbeddedLeasesMember_b19c5e50-19d5-47f1-a04b-ff37b68e120b" xlink:href="mrna-20201231.xsd#mrna_EmbeddedLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_96270f93-4f34-4be5-91ef-126a46e86034" xlink:to="loc_mrna_EmbeddedLeasesMember_b19c5e50-19d5-47f1-a04b-ff37b68e120b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails" xlink:type="extended" id="id3f6bb7ad2754227a614284be7e22505_LeasesBalanceSheetInformationDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesLeaseCostsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesLeaseCostsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/LeasesLeaseCostsDetails" xlink:type="extended" id="if05552a1be6a43e1b68eeb4c93c7a54e_LeasesLeaseCostsDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesMinimumLeasePaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails" xlink:type="extended" id="i495c396aadfb41bb8972a358d713c158_LeasesMinimumLeasePaymentsDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingencies" xlink:type="extended" id="i4bb16daab74746c2a076cc8c121ae6a7_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesStrategicCollaborationsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails" xlink:type="extended" id="ibcfcce569dfa47ed811ca98e6790df68_CommitmentsandContingenciesStrategicCollaborationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5e20031b-f6ec-4375-a85d-031faa7f6da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_5839bcb3-5cdd-46e3-8236-7769e46ff07e" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5e20031b-f6ec-4375-a85d-031faa7f6da3" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_5839bcb3-5cdd-46e3-8236-7769e46ff07e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_563c1040-bf54-4849-b6c3-4ff53d3d61ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5e20031b-f6ec-4375-a85d-031faa7f6da3" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_563c1040-bf54-4849-b6c3-4ff53d3d61ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_47833705-f972-4cd2-9542-d2e58d27d12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_563c1040-bf54-4849-b6c3-4ff53d3d61ba" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_47833705-f972-4cd2-9542-d2e58d27d12a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_47833705-f972-4cd2-9542-d2e58d27d12a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_47833705-f972-4cd2-9542-d2e58d27d12a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_47833705-f972-4cd2-9542-d2e58d27d12a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4540696-d690-4129-8846-a293d68a0cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_47833705-f972-4cd2-9542-d2e58d27d12a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4540696-d690-4129-8846-a293d68a0cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_f3b4034c-35c3-4c01-a594-656ec3cfacf6" xlink:href="mrna-20201231.xsd#mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4540696-d690-4129-8846-a293d68a0cab" xlink:to="loc_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_f3b4034c-35c3-4c01-a594-656ec3cfacf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_47f6e65d-27f8-4b72-b102-0d25faf57984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_563c1040-bf54-4849-b6c3-4ff53d3d61ba" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_47f6e65d-27f8-4b72-b102-0d25faf57984" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_47f6e65d-27f8-4b72-b102-0d25faf57984_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_47f6e65d-27f8-4b72-b102-0d25faf57984" xlink:to="loc_us-gaap_ProjectMember_47f6e65d-27f8-4b72-b102-0d25faf57984_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_aa444ef5-0cc3-4332-9507-1c1d4dac77ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_47f6e65d-27f8-4b72-b102-0d25faf57984" xlink:to="loc_us-gaap_ProjectMember_aa444ef5-0cc3-4332-9507-1c1d4dac77ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PersonalizedMRNACancerVaccinesProductsMember_56ef8459-f8f9-455a-98dd-e58c4e5e934c" xlink:href="mrna-20201231.xsd#mrna_PersonalizedMRNACancerVaccinesProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_aa444ef5-0cc3-4332-9507-1c1d4dac77ff" xlink:to="loc_mrna_PersonalizedMRNACancerVaccinesProductsMember_56ef8459-f8f9-455a-98dd-e58c4e5e934c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesIndemnificationObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails" xlink:type="extended" id="ie0364fec435d4b979bc4def28cbfacc2_CommitmentsandContingenciesIndemnificationObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a2fa60a9-434d-4e81-9a52-4bb669006c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_1da72f42-48ba-4f87-80c1-d5bfbaf5c154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2fa60a9-434d-4e81-9a52-4bb669006c34" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_1da72f42-48ba-4f87-80c1-d5bfbaf5c154" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_fa0bb83a-ced8-4c25-994e-4c4a13d57ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2fa60a9-434d-4e81-9a52-4bb669006c34" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_fa0bb83a-ced8-4c25-994e-4c4a13d57ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_acdf754b-f9c4-4a7e-820e-bb50e251c95a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2fa60a9-434d-4e81-9a52-4bb669006c34" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_acdf754b-f9c4-4a7e-820e-bb50e251c95a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_20dcec50-c61d-46ef-ba5b-55400c311c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2fa60a9-434d-4e81-9a52-4bb669006c34" xlink:to="loc_us-gaap_LossContingenciesTable_20dcec50-c61d-46ef-ba5b-55400c311c91" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_722f3643-be4d-450a-86a3-1bdc6e3b514e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_20dcec50-c61d-46ef-ba5b-55400c311c91" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_722f3643-be4d-450a-86a3-1bdc6e3b514e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_722f3643-be4d-450a-86a3-1bdc6e3b514e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_722f3643-be4d-450a-86a3-1bdc6e3b514e" xlink:to="loc_us-gaap_LossContingencyNatureDomain_722f3643-be4d-450a-86a3-1bdc6e3b514e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_138e2285-6598-42d9-925c-54838843c0da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_722f3643-be4d-450a-86a3-1bdc6e3b514e" xlink:to="loc_us-gaap_LossContingencyNatureDomain_138e2285-6598-42d9-925c-54838843c0da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_7d91670f-7eda-45a1-a12d-fdfa2ba5ddb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_138e2285-6598-42d9-925c-54838843c0da" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_7d91670f-7eda-45a1-a12d-fdfa2ba5ddb8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails" xlink:type="extended" id="if8c586c245df48e3af33c0cf75f245d3_CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_f67f6a4b-d6b8-4144-8f2f-0f8bb2c6a113" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_a5761ab9-97ea-42f4-97c0-c80bfe4f8717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_f67f6a4b-d6b8-4144-8f2f-0f8bb2c6a113" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_a5761ab9-97ea-42f4-97c0-c80bfe4f8717" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_e1edddad-1237-47cf-8106-01490ed55d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_f67f6a4b-d6b8-4144-8f2f-0f8bb2c6a113" xlink:to="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_e1edddad-1237-47cf-8106-01490ed55d87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_3daacb10-6f0b-417a-b80c-706074b30ac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_e1edddad-1237-47cf-8106-01490ed55d87" xlink:to="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_3daacb10-6f0b-417a-b80c-706074b30ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_3daacb10-6f0b-417a-b80c-706074b30ac9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_3daacb10-6f0b-417a-b80c-706074b30ac9" xlink:to="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_3daacb10-6f0b-417a-b80c-706074b30ac9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_7e12f301-4ae5-478b-9a88-de09bcb61a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_3daacb10-6f0b-417a-b80c-706074b30ac9" xlink:to="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_7e12f301-4ae5-478b-9a88-de09bcb61a4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SupplyAndManufacturingAgreementsMember_27fccf72-fe3c-4891-b8ce-76024bc71a77" xlink:href="mrna-20201231.xsd#mrna_SupplyAndManufacturingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_7e12f301-4ae5-478b-9a88-de09bcb61a4f" xlink:to="loc_mrna_SupplyAndManufacturingAgreementsMember_27fccf72-fe3c-4891-b8ce-76024bc71a77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalServicesMember_93b229a5-ca69-4bf9-b300-9a1d9c4678f7" xlink:href="mrna-20201231.xsd#mrna_ClinicalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_7e12f301-4ae5-478b-9a88-de09bcb61a4f" xlink:to="loc_mrna_ClinicalServicesMember_93b229a5-ca69-4bf9-b300-9a1d9c4678f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalOperationsAndSupportCommitmentMember_07282ff0-cf50-4a9a-8494-5042b8dbb4a4" xlink:href="mrna-20201231.xsd#mrna_ClinicalOperationsAndSupportCommitmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_7e12f301-4ae5-478b-9a88-de09bcb61a4f" xlink:to="loc_mrna_ClinicalOperationsAndSupportCommitmentMember_07282ff0-cf50-4a9a-8494-5042b8dbb4a4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesLicensestoPatentedTechnologyDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails" xlink:type="extended" id="i39e1d43ac2844154be5f537a0c9351ee_CommitmentsandContingenciesLicensestoPatentedTechnologyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount_5c059c9f-8a05-4b57-8550-8d89b057b9c5" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount_5c059c9f-8a05-4b57-8550-8d89b057b9c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount_f0326f39-f521-48d4-b1d5-e87a9fcc8218" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount_f0326f39-f521-48d4-b1d5-e87a9fcc8218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross_d0e98aca-5585-4d49-96b9-baf664072dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross_d0e98aca-5585-4d49-96b9-baf664072dc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_22b7b932-2464-4a6f-abec-cb8e5135c78f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_22b7b932-2464-4a6f-abec-cb8e5135c78f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a8e6a201-bf47-4a43-9a2d-2f7c319bb9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a8e6a201-bf47-4a43-9a2d-2f7c319bb9cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_037158a2-8341-4875-88cc-197ea28c1512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a8e6a201-bf47-4a43-9a2d-2f7c319bb9cc" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_037158a2-8341-4875-88cc-197ea28c1512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_037158a2-8341-4875-88cc-197ea28c1512_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_037158a2-8341-4875-88cc-197ea28c1512" xlink:to="loc_us-gaap_ProjectMember_037158a2-8341-4875-88cc-197ea28c1512_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_3285eb66-f037-401e-8a6b-303778e0c341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_037158a2-8341-4875-88cc-197ea28c1512" xlink:to="loc_us-gaap_ProjectMember_3285eb66-f037-401e-8a6b-303778e0c341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TherapeuticAndProphylacticProductsMember_3f01dd18-bc7d-4021-8b84-7e4f7d035f4c" xlink:href="mrna-20201231.xsd#mrna_TherapeuticAndProphylacticProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_3285eb66-f037-401e-8a6b-303778e0c341" xlink:to="loc_mrna_TherapeuticAndProphylacticProductsMember_3f01dd18-bc7d-4021-8b84-7e4f7d035f4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DiagnosticProductsMember_8676dcbd-3315-426f-b596-3b90a4c3b5db" xlink:href="mrna-20201231.xsd#mrna_DiagnosticProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_3285eb66-f037-401e-8a6b-303778e0c341" xlink:to="loc_mrna_DiagnosticProductsMember_8676dcbd-3315-426f-b596-3b90a4c3b5db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9acab9f-fff7-4947-ad59-ef3d6fcd33fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a8e6a201-bf47-4a43-9a2d-2f7c319bb9cc" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9acab9f-fff7-4947-ad59-ef3d6fcd33fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c9acab9f-fff7-4947-ad59-ef3d6fcd33fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9acab9f-fff7-4947-ad59-ef3d6fcd33fa" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c9acab9f-fff7-4947-ad59-ef3d6fcd33fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb99cac-21e4-4283-99fe-e2e54f308e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9acab9f-fff7-4947-ad59-ef3d6fcd33fa" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb99cac-21e4-4283-99fe-e2e54f308e89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SublicenseAgreementTermsMember_d289ce90-b298-4b33-b95f-a9ce3cb0299b" xlink:href="mrna-20201231.xsd#mrna_SublicenseAgreementTermsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb99cac-21e4-4283-99fe-e2e54f308e89" xlink:to="loc_mrna_SublicenseAgreementTermsMember_d289ce90-b298-4b33-b95f-a9ce3cb0299b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock" xlink:type="simple" xlink:href="mrna-20201231.xsd#RedeemableConvertiblePreferredStockandCommonStock"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock" xlink:type="extended" id="ib91e4b0918c54ad498899a86b2dfb6d2_RedeemableConvertiblePreferredStockandCommonStock"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails" xlink:type="extended" id="ibbd29c90c9ca46c5b12b7011b0c69ad5_RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8d0b3be6-8811-41d3-a42a-0f89a8e80f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8d0b3be6-8811-41d3-a42a-0f89a8e80f5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_e2ee5b7f-ba6e-4115-b87f-f2503abe1473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_e2ee5b7f-ba6e-4115-b87f-f2503abe1473" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1a233eb7-21cc-4db5-b590-c1116eaa28e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1a233eb7-21cc-4db5-b590-c1116eaa28e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7a7eea3e-b012-4382-a2fa-d688a3951cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7a7eea3e-b012-4382-a2fa-d688a3951cec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f9282064-9268-46a3-b1bd-f1358f2e7999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f9282064-9268-46a3-b1bd-f1358f2e7999" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a514768e-b25f-4b8a-abd9-2d4aa4a3619f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a514768e-b25f-4b8a-abd9-2d4aa4a3619f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_b72a9797-dcf4-48fb-8ba2-d0b5e4836cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_b72a9797-dcf4-48fb-8ba2-d0b5e4836cb5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PaymentsOfUnderwritingDiscounts_c59b6f85-235a-4939-bf4c-9fabb38f9ce5" xlink:href="mrna-20201231.xsd#mrna_PaymentsOfUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_mrna_PaymentsOfUnderwritingDiscounts_c59b6f85-235a-4939-bf4c-9fabb38f9ce5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_359f4cdd-2402-494f-9094-0e8d1b64cb94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_359f4cdd-2402-494f-9094-0e8d1b64cb94" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_7acbbfa7-c808-4256-a7b1-e8a3638e5d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_7acbbfa7-c808-4256-a7b1-e8a3638e5d00" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_d139654f-5f08-4dc2-a6fe-41a7a867f457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_d139654f-5f08-4dc2-a6fe-41a7a867f457" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_924b4e90-0177-47ef-be8c-34fe99196151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_924b4e90-0177-47ef-be8c-34fe99196151" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8d665703-579b-4b92-b5fc-b9016172d9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8d665703-579b-4b92-b5fc-b9016172d9d1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_98e9840d-8464-4d5a-8597-4e383ecce789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_98e9840d-8464-4d5a-8597-4e383ecce789" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e568579a-14f7-4ff2-95ff-b6ad94be9f7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_98e9840d-8464-4d5a-8597-4e383ecce789" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e568579a-14f7-4ff2-95ff-b6ad94be9f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e568579a-14f7-4ff2-95ff-b6ad94be9f7b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e568579a-14f7-4ff2-95ff-b6ad94be9f7b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e568579a-14f7-4ff2-95ff-b6ad94be9f7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6d216f1a-aec5-4cd8-bf7b-157b231c4a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e568579a-14f7-4ff2-95ff-b6ad94be9f7b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6d216f1a-aec5-4cd8-bf7b-157b231c4a80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_4d063539-d040-414b-b0aa-a09f8fbb7bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6d216f1a-aec5-4cd8-bf7b-157b231c4a80" xlink:to="loc_us-gaap_IPOMember_4d063539-d040-414b-b0aa-a09f8fbb7bde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PublicEquityOfferingMember_6f182c02-9b73-49b7-8dab-1826f880f51b" xlink:href="mrna-20201231.xsd#mrna_PublicEquityOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6d216f1a-aec5-4cd8-bf7b-157b231c4a80" xlink:to="loc_mrna_PublicEquityOfferingMember_6f182c02-9b73-49b7-8dab-1826f880f51b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_4054e4a1-9213-4b58-8e37-2bd4e35d2b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6d216f1a-aec5-4cd8-bf7b-157b231c4a80" xlink:to="loc_us-gaap_OverAllotmentOptionMember_4054e4a1-9213-4b58-8e37-2bd4e35d2b13" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_717165e6-173c-48fd-a858-c8029a2ae4da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_98e9840d-8464-4d5a-8597-4e383ecce789" xlink:to="loc_us-gaap_StatementClassOfStockAxis_717165e6-173c-48fd-a858-c8029a2ae4da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_717165e6-173c-48fd-a858-c8029a2ae4da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_717165e6-173c-48fd-a858-c8029a2ae4da" xlink:to="loc_us-gaap_ClassOfStockDomain_717165e6-173c-48fd-a858-c8029a2ae4da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f58a9061-81f2-4735-9ca0-9ace1221ab01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_717165e6-173c-48fd-a858-c8029a2ae4da" xlink:to="loc_us-gaap_ClassOfStockDomain_f58a9061-81f2-4735-9ca0-9ace1221ab01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b552b152-dc2c-46db-ae0a-7bf2070e22de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f58a9061-81f2-4735-9ca0-9ace1221ab01" xlink:to="loc_us-gaap_CommonStockMember_b552b152-dc2c-46db-ae0a-7bf2070e22de" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/StockBasedCompensation" xlink:type="extended" id="i3b8e7baf65fc49c995637abc0b5e894f_StockBasedCompensation"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationTables" xlink:type="extended" id="i2631b1a42812400081beeba811055e3b_StockBasedCompensationTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended" id="i785cc17030f845fbbd77d6f0d95b61e2_StockBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e59e62b0-d14e-433f-bd2b-efa423199d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e59e62b0-d14e-433f-bd2b-efa423199d6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized_da71e9cb-9611-4f32-9574-2f9a9ee223c8" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized_da71e9cb-9611-4f32-9574-2f9a9ee223c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a1d0b41b-8e05-4c06-a5bd-64c5f75fe471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a1d0b41b-8e05-4c06-a5bd-64c5f75fe471" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f92f24d1-b4a6-4132-b0e2-bdcd7fe714d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f92f24d1-b4a6-4132-b0e2-bdcd7fe714d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments_4e2081f6-617b-4ac0-8c6a-0af2c113c38b" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments_4e2081f6-617b-4ac0-8c6a-0af2c113c38b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40cf2122-3ec7-4b4f-b8a1-bb28ad24b553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40cf2122-3ec7-4b4f-b8a1-bb28ad24b553" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9026cdba-9e01-45e0-80bb-f13d57ab2eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9026cdba-9e01-45e0-80bb-f13d57ab2eff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2b9ef3e6-fd9f-426a-b5ab-16b40f794007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2b9ef3e6-fd9f-426a-b5ab-16b40f794007" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_8adb94a1-6d17-4ebf-8903-f15da636bdee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_8adb94a1-6d17-4ebf-8903-f15da636bdee" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_8b821511-23c9-439b-898f-c19030559a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_RestrictedStockExpense_8b821511-23c9-439b-898f-c19030559a99" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod_9895a368-8e17-4a11-9785-9ec9049fd46b" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod_9895a368-8e17-4a11-9785-9ec9049fd46b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_c753cc5b-3d43-419c-a1d2-f65beda54583" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_c753cc5b-3d43-419c-a1d2-f65beda54583" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_26ac5a4b-04f4-4011-ad96-ef33f54fea17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_26ac5a4b-04f4-4011-ad96-ef33f54fea17" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate_fc581e9e-7b7a-4aab-b686-d9be4f1d9034" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate_fc581e9e-7b7a-4aab-b686-d9be4f1d9034" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_75dee7b9-5dc7-41fb-ab5c-80d67e466e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_75dee7b9-5dc7-41fb-ab5c-80d67e466e06" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_2c207623-8d97-46c6-938e-7a47b3fa58ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_2c207623-8d97-46c6-938e-7a47b3fa58ed" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_74931f49-e172-400f-a077-cee3fabc1f00" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_74931f49-e172-400f-a077-cee3fabc1f00" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0889f4a7-6b35-4f0b-8b55-0e9e7d7c72c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0889f4a7-6b35-4f0b-8b55-0e9e7d7c72c6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_9c2da066-cfd7-4321-a841-cbc0d9739b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_SharePrice_9c2da066-cfd7-4321-a841-cbc0d9739b3c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f2d2b831-45ed-4c7a-8f9e-cf390931f341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f2d2b831-45ed-4c7a-8f9e-cf390931f341" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f96f2f6a-e4f9-4f0b-afc3-34c25fc34e2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f96f2f6a-e4f9-4f0b-afc3-34c25fc34e2d" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3efac41b-0f51-4e2d-8a3c-9a096c8bbb2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3efac41b-0f51-4e2d-8a3c-9a096c8bbb2b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2a702aef-bb16-428e-b6ee-1f05d09627bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2a702aef-bb16-428e-b6ee-1f05d09627bb" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_5f383d39-068a-4934-ac05-4389580933d9" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_5f383d39-068a-4934-ac05-4389580933d9" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_a9884b8d-f58f-462f-9893-5374fa860111" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_a9884b8d-f58f-462f-9893-5374fa860111" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_16033c05-0d51-4903-be63-4a2b7be2804e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:to="loc_us-gaap_PlanNameAxis_16033c05-0d51-4903-be63-4a2b7be2804e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_16033c05-0d51-4903-be63-4a2b7be2804e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_16033c05-0d51-4903-be63-4a2b7be2804e" xlink:to="loc_us-gaap_PlanNameDomain_16033c05-0d51-4903-be63-4a2b7be2804e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_46c5d506-186f-4c0a-98da-fc0496bbb658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_16033c05-0d51-4903-be63-4a2b7be2804e" xlink:to="loc_us-gaap_PlanNameDomain_46c5d506-186f-4c0a-98da-fc0496bbb658" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StockOptionAndIncentivePlan2018Member_f8cbb66a-1ca0-4f6e-b0c0-8739b2de550d" xlink:href="mrna-20201231.xsd#mrna_StockOptionAndIncentivePlan2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_46c5d506-186f-4c0a-98da-fc0496bbb658" xlink:to="loc_mrna_StockOptionAndIncentivePlan2018Member_f8cbb66a-1ca0-4f6e-b0c0-8739b2de550d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StockOptionAndGrantPlan2016Member_2cf8dec5-3a03-4e47-97b9-1ff7e66190d9" xlink:href="mrna-20201231.xsd#mrna_StockOptionAndGrantPlan2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_46c5d506-186f-4c0a-98da-fc0496bbb658" xlink:to="loc_mrna_StockOptionAndGrantPlan2016Member_2cf8dec5-3a03-4e47-97b9-1ff7e66190d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EmployeeStockPurchasePlan2018Member_606843fc-950b-4558-bc73-c99797075649" xlink:href="mrna-20201231.xsd#mrna_EmployeeStockPurchasePlan2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_46c5d506-186f-4c0a-98da-fc0496bbb658" xlink:to="loc_mrna_EmployeeStockPurchasePlan2018Member_606843fc-950b-4558-bc73-c99797075649" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8b5c7841-f066-4cdf-af7c-a62e82398202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:to="loc_us-gaap_AwardTypeAxis_8b5c7841-f066-4cdf-af7c-a62e82398202" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b5c7841-f066-4cdf-af7c-a62e82398202_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8b5c7841-f066-4cdf-af7c-a62e82398202" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8b5c7841-f066-4cdf-af7c-a62e82398202_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8b5c7841-f066-4cdf-af7c-a62e82398202" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ServiceBasedAwardsMember_2ee3fd39-9ddc-4286-919d-41d4ed135169" xlink:href="mrna-20201231.xsd#mrna_ServiceBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:to="loc_mrna_ServiceBasedAwardsMember_2ee3fd39-9ddc-4286-919d-41d4ed135169" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_febadd08-3acb-4f26-885b-68a61ea2657f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_febadd08-3acb-4f26-885b-68a61ea2657f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_989d872e-b289-4b11-bfff-3d60ed5bf5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:to="loc_us-gaap_EmployeeStockMember_989d872e-b289-4b11-bfff-3d60ed5bf5f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c7fbe6de-1cdc-4450-a9bf-86ce75310438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:to="loc_us-gaap_PerformanceSharesMember_c7fbe6de-1cdc-4450-a9bf-86ce75310438" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_f69520d3-e8ad-4456-a80e-2b6321e2df32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:to="loc_us-gaap_VestingAxis_f69520d3-e8ad-4456-a80e-2b6321e2df32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_f69520d3-e8ad-4456-a80e-2b6321e2df32_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_f69520d3-e8ad-4456-a80e-2b6321e2df32" xlink:to="loc_us-gaap_VestingDomain_f69520d3-e8ad-4456-a80e-2b6321e2df32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_da1fa6f0-33ab-4a50-a99d-6455ed5f26b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_f69520d3-e8ad-4456-a80e-2b6321e2df32" xlink:to="loc_us-gaap_VestingDomain_da1fa6f0-33ab-4a50-a99d-6455ed5f26b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_73f9d3bd-270e-4944-a9f5-8ed034115e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_da1fa6f0-33ab-4a50-a99d-6455ed5f26b7" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_73f9d3bd-270e-4944-a9f5-8ed034115e9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c1a3d868-4cea-4af1-8ba5-a4af6dab5530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_da1fa6f0-33ab-4a50-a99d-6455ed5f26b7" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c1a3d868-4cea-4af1-8ba5-a4af6dab5530" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails" xlink:type="extended" id="iadc00c85d32e42d081b45286bc5ae855_StockBasedCompensationOptionsActivityDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails" xlink:type="extended" id="i0ba43613ff95421a8305fd273168d52e_StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9ebc0ddf-fc5d-40dc-957c-c37c23c28053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9ebc0ddf-fc5d-40dc-957c-c37c23c28053" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7e45144d-2508-4e8b-af03-17bb33790989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7e45144d-2508-4e8b-af03-17bb33790989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_072cd153-0d04-4826-ae74-8358fa897bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_072cd153-0d04-4826-ae74-8358fa897bb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_92933273-3c6e-40eb-89fe-789ed0dd462f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_92933273-3c6e-40eb-89fe-789ed0dd462f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6a82e035-2ecc-4716-80a0-635f27108c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6a82e035-2ecc-4716-80a0-635f27108c1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b45e3803-49e7-4d0e-95f0-c351aee455df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9ebc0ddf-fc5d-40dc-957c-c37c23c28053" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_77f75308-d1a8-4478-ab03-766e40083e5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_77f75308-d1a8-4478-ab03-766e40083e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_80d25fca-c339-475b-8813-abadbe9cd42d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_80d25fca-c339-475b-8813-abadbe9cd42d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c0425920-d657-4f42-aac2-356333d4c58d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c0425920-d657-4f42-aac2-356333d4c58d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fd6ca1c4-e418-460e-861b-a4d855a2e504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fd6ca1c4-e418-460e-861b-a4d855a2e504" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_65050dd3-e395-4301-841c-0093ab815110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a5152aa8-6db7-4d98-abc4-c8e4d1cd5aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9ebc0ddf-fc5d-40dc-957c-c37c23c28053" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a5152aa8-6db7-4d98-abc4-c8e4d1cd5aaa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_de2a340d-5ae1-4dad-80c0-f641b9efe1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a5152aa8-6db7-4d98-abc4-c8e4d1cd5aaa" xlink:to="loc_us-gaap_AwardTypeAxis_de2a340d-5ae1-4dad-80c0-f641b9efe1a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_de2a340d-5ae1-4dad-80c0-f641b9efe1a0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_de2a340d-5ae1-4dad-80c0-f641b9efe1a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_de2a340d-5ae1-4dad-80c0-f641b9efe1a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e50e4abe-467c-4902-9d22-95cfe6cb60d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_de2a340d-5ae1-4dad-80c0-f641b9efe1a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e50e4abe-467c-4902-9d22-95cfe6cb60d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1211235f-1e1a-4ace-a35b-51d1b3d34f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e50e4abe-467c-4902-9d22-95cfe6cb60d9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1211235f-1e1a-4ace-a35b-51d1b3d34f5c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails" xlink:type="extended" id="i9d841d5f576c4d809752a9e90a78393b_StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0e5b733f-68cb-4192-87e9-2f7b6577d59e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0e5b733f-68cb-4192-87e9-2f7b6577d59e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ea803ded-e98e-419b-a146-c3f8117c27df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ea803ded-e98e-419b-a146-c3f8117c27df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_751c198f-cc27-4f7c-ae12-9e6c23febedd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_751c198f-cc27-4f7c-ae12-9e6c23febedd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_82a56160-2c5c-4653-841a-858aa7adfede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_82a56160-2c5c-4653-841a-858aa7adfede" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_4d1a8ae2-efaf-41fc-97b9-617da5a505d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_SharePrice_4d1a8ae2-efaf-41fc-97b9-617da5a505d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cfba536-bd5f-462d-b334-c33db54d8a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cfba536-bd5f-462d-b334-c33db54d8a97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cd530501-1f7d-4932-8216-c5a3cd5efae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cfba536-bd5f-462d-b334-c33db54d8a97" xlink:to="loc_us-gaap_AwardTypeAxis_cd530501-1f7d-4932-8216-c5a3cd5efae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd530501-1f7d-4932-8216-c5a3cd5efae5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_cd530501-1f7d-4932-8216-c5a3cd5efae5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd530501-1f7d-4932-8216-c5a3cd5efae5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1443bc29-8adc-47b7-afd8-57148085a3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_cd530501-1f7d-4932-8216-c5a3cd5efae5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1443bc29-8adc-47b7-afd8-57148085a3dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e2a67f9d-72f9-4a1e-96bd-15c71c50e49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1443bc29-8adc-47b7-afd8-57148085a3dd" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e2a67f9d-72f9-4a1e-96bd-15c71c50e49c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_80d18424-6fba-4839-8323-235d59f341fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1443bc29-8adc-47b7-afd8-57148085a3dd" xlink:to="loc_us-gaap_EmployeeStockMember_80d18424-6fba-4839-8323-235d59f341fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd683b11-3b5e-4afe-a18a-827901d25c43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cfba536-bd5f-462d-b334-c33db54d8a97" xlink:to="loc_srt_RangeAxis_dd683b11-3b5e-4afe-a18a-827901d25c43" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd683b11-3b5e-4afe-a18a-827901d25c43_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd683b11-3b5e-4afe-a18a-827901d25c43" xlink:to="loc_srt_RangeMember_dd683b11-3b5e-4afe-a18a-827901d25c43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b3a1b01a-948d-4ac9-87c9-9193ea0324be" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd683b11-3b5e-4afe-a18a-827901d25c43" xlink:to="loc_srt_RangeMember_b3a1b01a-948d-4ac9-87c9-9193ea0324be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_9d38bac4-a899-49ed-b44d-30f4993afb5d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b3a1b01a-948d-4ac9-87c9-9193ea0324be" xlink:to="loc_srt_WeightedAverageMember_9d38bac4-a899-49ed-b44d-30f4993afb5d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended" id="i2539e93223eb4181ae6eecfd770e2c42_StockBasedCompensationStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdc03bac-3a71-49f6-9da0-261d1cd7abf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4ab3f16a-8f5f-4bf9-ab45-8443e67c1bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdc03bac-3a71-49f6-9da0-261d1cd7abf8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4ab3f16a-8f5f-4bf9-ab45-8443e67c1bd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3dd80219-4539-49c7-b76f-02cc660f009f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdc03bac-3a71-49f6-9da0-261d1cd7abf8" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3dd80219-4539-49c7-b76f-02cc660f009f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d140218b-7a6f-410d-b075-5fd9071231ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3dd80219-4539-49c7-b76f-02cc660f009f" xlink:to="loc_us-gaap_AwardTypeAxis_d140218b-7a6f-410d-b075-5fd9071231ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d140218b-7a6f-410d-b075-5fd9071231ec_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d140218b-7a6f-410d-b075-5fd9071231ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d140218b-7a6f-410d-b075-5fd9071231ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c2a4701-5f38-450f-8816-4bd1a15d9dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d140218b-7a6f-410d-b075-5fd9071231ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c2a4701-5f38-450f-8816-4bd1a15d9dfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ee14120e-92af-434e-a122-5fef0479a156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c2a4701-5f38-450f-8816-4bd1a15d9dfa" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ee14120e-92af-434e-a122-5fef0479a156" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember_acbbc0f5-5424-4c1b-9e45-f7affde6b944" xlink:href="mrna-20201231.xsd#mrna_RestrictedStockAndRestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c2a4701-5f38-450f-8816-4bd1a15d9dfa" xlink:to="loc_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember_acbbc0f5-5424-4c1b-9e45-f7affde6b944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a2e1c949-2be2-4fc3-9f44-418ee2ebd954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c2a4701-5f38-450f-8816-4bd1a15d9dfa" xlink:to="loc_us-gaap_EmployeeStockMember_a2e1c949-2be2-4fc3-9f44-418ee2ebd954" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_08dfae45-47cd-48fe-85a2-9ba0f249e1c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3dd80219-4539-49c7-b76f-02cc660f009f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_08dfae45-47cd-48fe-85a2-9ba0f249e1c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_08dfae45-47cd-48fe-85a2-9ba0f249e1c0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_08dfae45-47cd-48fe-85a2-9ba0f249e1c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_08dfae45-47cd-48fe-85a2-9ba0f249e1c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_99e59679-3098-46d4-a49b-9bea58d74c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_08dfae45-47cd-48fe-85a2-9ba0f249e1c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_99e59679-3098-46d4-a49b-9bea58d74c13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a07d90eb-1a0c-4558-90a3-895b893c7023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_99e59679-3098-46d4-a49b-9bea58d74c13" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a07d90eb-1a0c-4558-90a3-895b893c7023" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5f92b296-ee87-47af-af23-171f1d26b2ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_99e59679-3098-46d4-a49b-9bea58d74c13" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5f92b296-ee87-47af-af23-171f1d26b2ae" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/EmployeeBenefitPlan" xlink:type="simple" xlink:href="mrna-20201231.xsd#EmployeeBenefitPlan"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/EmployeeBenefitPlan" xlink:type="extended" id="i9ca7bc0f37cf4297a478bd99e3fab7bf_EmployeeBenefitPlan"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/EmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#EmployeeBenefitPlanDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/EmployeeBenefitPlanDetails" xlink:type="extended" id="i1ed62cdb8dc5488b835d06e877814442_EmployeeBenefitPlanDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/IncomeTaxes" xlink:type="extended" id="i82adb89ce34d4f77b940503adb085bd6_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/IncomeTaxesTables" xlink:type="extended" id="i757b9d198355417383a5715ffa86781e_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails" xlink:type="extended" id="i441deee8f2604154858fb4875e86d0a6_IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" xlink:type="extended" id="i7b8b2edc3c494d3096e2844c5c8d141e_IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails" xlink:type="extended" id="i536f0e4d09d64d6d968ee5bcc3a87087_IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails" xlink:type="extended" id="i6fa36e4b3c7a4efea85433b4ad773c5a_IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="ie117fdeff8974ca7a54d38ac151e5042_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0612bec1-cfca-48f0-88b6-b72982a33634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0612bec1-cfca-48f0-88b6-b72982a33634" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_14638329-ca03-4ca3-a228-3b594f48436c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_14638329-ca03-4ca3-a228-3b594f48436c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_07ee6c10-efd8-44e5-936e-a97de7deb886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_07ee6c10-efd8-44e5-936e-a97de7deb886" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLossCarryforwardsSubjectToExpiration_81740551-9a95-4288-98c9-69511153bd40" xlink:href="mrna-20201231.xsd#mrna_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_mrna_OperatingLossCarryforwardsSubjectToExpiration_81740551-9a95-4288-98c9-69511153bd40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLossCarryforwardsNotSubjectToExpiration_bd5d8a33-b2d0-4f6a-b33b-edbedff67ca6" xlink:href="mrna-20201231.xsd#mrna_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_mrna_OperatingLossCarryforwardsNotSubjectToExpiration_bd5d8a33-b2d0-4f6a-b33b-edbedff67ca6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_29b7a948-4586-4c77-b101-aed3bfa0d6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_29b7a948-4586-4c77-b101-aed3bfa0d6ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_a09af1eb-dedc-4594-861e-91c7fa2b0206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_a09af1eb-dedc-4594-861e-91c7fa2b0206" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_c7478415-5703-4675-b1f6-5f19ead6f883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a09af1eb-dedc-4594-861e-91c7fa2b0206" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_c7478415-5703-4675-b1f6-5f19ead6f883" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_c7478415-5703-4675-b1f6-5f19ead6f883_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c7478415-5703-4675-b1f6-5f19ead6f883" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_c7478415-5703-4675-b1f6-5f19ead6f883_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f0afddc5-1c5d-40d7-9f65-b93cd7740197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c7478415-5703-4675-b1f6-5f19ead6f883" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f0afddc5-1c5d-40d7-9f65-b93cd7740197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_26257cd7-8ff0-4a95-84e0-997c4c37d3e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f0afddc5-1c5d-40d7-9f65-b93cd7740197" xlink:to="loc_us-gaap_DomesticCountryMember_26257cd7-8ff0-4a95-84e0-997c4c37d3e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_29d7a8c9-5e7f-4b1f-bd58-27df14cb981c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f0afddc5-1c5d-40d7-9f65-b93cd7740197" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_29d7a8c9-5e7f-4b1f-bd58-27df14cb981c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_8c919324-9aaa-434e-88b0-2d6c00412ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a09af1eb-dedc-4594-861e-91c7fa2b0206" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_8c919324-9aaa-434e-88b0-2d6c00412ef3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_8c919324-9aaa-434e-88b0-2d6c00412ef3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8c919324-9aaa-434e-88b0-2d6c00412ef3" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_8c919324-9aaa-434e-88b0-2d6c00412ef3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_dab7a8d1-1606-44a9-9b61-ea8b4f039909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8c919324-9aaa-434e-88b0-2d6c00412ef3" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_dab7a8d1-1606-44a9-9b61-ea8b4f039909" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_c2daccb8-d8a5-47c2-9b9c-8ce2f3a363b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_dab7a8d1-1606-44a9-9b61-ea8b4f039909" xlink:to="loc_us-gaap_ResearchMember_c2daccb8-d8a5-47c2-9b9c-8ce2f3a363b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FederalOrphanDrugMember_3610fcf9-450f-419a-acbd-19c6e58dacf7" xlink:href="mrna-20201231.xsd#mrna_FederalOrphanDrugMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_dab7a8d1-1606-44a9-9b61-ea8b4f039909" xlink:to="loc_mrna_FederalOrphanDrugMember_3610fcf9-450f-419a-acbd-19c6e58dacf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCreditMember_51625e28-5e72-4cb6-9204-ccb5ae33b0bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_dab7a8d1-1606-44a9-9b61-ea8b4f039909" xlink:to="loc_us-gaap_InvestmentCreditMember_51625e28-5e72-4cb6-9204-ccb5ae33b0bb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended" id="ia8e7cf0bf5c847ee8c5a3cad90cf2f0b_IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShare" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShare"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/NetLossperShare" xlink:type="extended" id="i48b3f87536a34567947e63813c774d92_NetLossperShare"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShareTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShareTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/NetLossperShareTables" xlink:type="extended" id="ie0d4c6c2ed344ccd966765d860f9544a_NetLossperShareTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails" xlink:type="extended" id="ic25d9b63fc4c4dbf965bcafab9943be3_NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails" xlink:type="extended" id="i340037f6af344603997394186c353cf3_NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ca40557-283a-4617-b8a0-e1768c056272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e6fe655d-e223-4891-a08a-2d26a79532ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ca40557-283a-4617-b8a0-e1768c056272" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e6fe655d-e223-4891-a08a-2d26a79532ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_25618528-a6df-43f5-b08f-3cafb5f03310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ca40557-283a-4617-b8a0-e1768c056272" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_25618528-a6df-43f5-b08f-3cafb5f03310" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a33107f4-c191-46fb-892b-a73e8a8089d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_25618528-a6df-43f5-b08f-3cafb5f03310" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a33107f4-c191-46fb-892b-a73e8a8089d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a33107f4-c191-46fb-892b-a73e8a8089d4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a33107f4-c191-46fb-892b-a73e8a8089d4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a33107f4-c191-46fb-892b-a73e8a8089d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_195eda4b-7170-42a7-838f-e48f907ac31e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a33107f4-c191-46fb-892b-a73e8a8089d4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_195eda4b-7170-42a7-838f-e48f907ac31e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9c5c13a1-325c-4ee5-bbc9-45175552ed1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_195eda4b-7170-42a7-838f-e48f907ac31e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9c5c13a1-325c-4ee5-bbc9-45175552ed1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fd363e64-7414-4f00-be82-67c19263ddc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_195eda4b-7170-42a7-838f-e48f907ac31e" xlink:to="loc_us-gaap_RestrictedStockMember_fd363e64-7414-4f00-be82-67c19263ddc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1487968e-9a5c-4df0-b934-bc212d222373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_195eda4b-7170-42a7-838f-e48f907ac31e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1487968e-9a5c-4df0-b934-bc212d222373" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/GeographicInformation" xlink:type="simple" xlink:href="mrna-20201231.xsd#GeographicInformation"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/GeographicInformation" xlink:type="extended" id="i5577f5f35cf649b8b1dff1fad0977b16_GeographicInformation"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/GeographicInformationTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#GeographicInformationTables"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/GeographicInformationTables" xlink:type="extended" id="i5ba92778eda14d5284b32d838eb625e1_GeographicInformationTables"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/GeographicInformationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#GeographicInformationDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/GeographicInformationDetails" xlink:type="extended" id="icf476bbef6b64412a73168f13d86b281_GeographicInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5447aeb3-2a4e-4e92-83d6-411459e3d298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ca14fdc9-3425-4dbd-816b-5b65adf04b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5447aeb3-2a4e-4e92-83d6-411459e3d298" xlink:to="loc_us-gaap_Revenues_ca14fdc9-3425-4dbd-816b-5b65adf04b53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2d4c8884-4be2-434f-9f3c-f8f7fb1d917a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5447aeb3-2a4e-4e92-83d6-411459e3d298" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2d4c8884-4be2-434f-9f3c-f8f7fb1d917a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_227eb161-62fd-4f9e-85a3-833ef0e637db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2d4c8884-4be2-434f-9f3c-f8f7fb1d917a" xlink:to="loc_srt_StatementGeographicalAxis_227eb161-62fd-4f9e-85a3-833ef0e637db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_227eb161-62fd-4f9e-85a3-833ef0e637db_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_227eb161-62fd-4f9e-85a3-833ef0e637db" xlink:to="loc_srt_SegmentGeographicalDomain_227eb161-62fd-4f9e-85a3-833ef0e637db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5358cab4-7514-49f8-87fd-3e5eddcb2944" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_227eb161-62fd-4f9e-85a3-833ef0e637db" xlink:to="loc_srt_SegmentGeographicalDomain_5358cab4-7514-49f8-87fd-3e5eddcb2944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_52e7aa38-1224-47e2-85fd-9a3aa559b3ac" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5358cab4-7514-49f8-87fd-3e5eddcb2944" xlink:to="loc_country_US_52e7aa38-1224-47e2-85fd-9a3aa559b3ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_31aee2a0-7923-4cd9-b547-5f21bde80705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5358cab4-7514-49f8-87fd-3e5eddcb2944" xlink:to="loc_us-gaap_NonUsMember_31aee2a0-7923-4cd9-b547-5f21bde80705" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="mrna-20201231.xsd#SubsequentEvent"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/SubsequentEvent" xlink:type="extended" id="i9b751dedd1954baab0b87e9d1814d3b6_SubsequentEvent"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.modernatx.com/role/SubsequentEventsDetails" xlink:type="extended" id="i43ab68013a85477cbeab7a7e0c70436c_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NumberOfDosesOfVaccineCandidate_97208bcc-7c5c-4eb0-b780-691679751e79" xlink:href="mrna-20201231.xsd#mrna_NumberOfDosesOfVaccineCandidate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_mrna_NumberOfDosesOfVaccineCandidate_97208bcc-7c5c-4eb0-b780-691679751e79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_27d54e8f-3aba-40dd-951c-61c85cee7d33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_27d54e8f-3aba-40dd-951c-61c85cee7d33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NumberOfVaccineDoses_e8b08e14-9a74-4a0d-9433-0f28c9ff3368" xlink:href="mrna-20201231.xsd#mrna_NumberOfVaccineDoses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_mrna_NumberOfVaccineDoses_e8b08e14-9a74-4a0d-9433-0f28c9ff3368" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AdditionalNumberOfVaccineDoses_2c20dc65-fa28-4345-98b6-7d233320d033" xlink:href="mrna-20201231.xsd#mrna_AdditionalNumberOfVaccineDoses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_mrna_AdditionalNumberOfVaccineDoses_2c20dc65-fa28-4345-98b6-7d233320d033" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_3ea3d39a-48cb-4454-8490-2cca99899bf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_3ea3d39a-48cb-4454-8490-2cca99899bf2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_e416af66-75d7-4cee-b1c9-50ea75f0bd14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_us-gaap_SubsequentEventTable_e416af66-75d7-4cee-b1c9-50ea75f0bd14" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2c2bc859-66f4-4fff-a2a9-9a572b5c8014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_e416af66-75d7-4cee-b1c9-50ea75f0bd14" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2c2bc859-66f4-4fff-a2a9-9a572b5c8014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2c2bc859-66f4-4fff-a2a9-9a572b5c8014_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2c2bc859-66f4-4fff-a2a9-9a572b5c8014" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2c2bc859-66f4-4fff-a2a9-9a572b5c8014_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4e5096c4-fdc1-4066-bb3f-8deb6dacbec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2c2bc859-66f4-4fff-a2a9-9a572b5c8014" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4e5096c4-fdc1-4066-bb3f-8deb6dacbec1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_81d56aa6-a288-4535-87a4-38fbb1105b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4e5096c4-fdc1-4066-bb3f-8deb6dacbec1" xlink:to="loc_us-gaap_SubsequentEventMember_81d56aa6-a288-4535-87a4-38fbb1105b28" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>mrna-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:587e37ef-2d85-4611-b0f5-79aaf037b83c,g:a4c5467e-e912-4919-957b-a5dc25d57b8f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_46055fab-acb0-4443-a4e7-c50bb2fcced6_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of office space (in sqft)</link:label>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_label_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of Real Estate Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b3c5a692-87ad-4b37-9cc2-ec7459f19a9c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ClinicalServicesMember_0e69f7d6-2ab9-42cb-9790-ac4d82570a2f_terseLabel_en-US" xlink:label="lab_mrna_ClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical services</link:label>
    <link:label id="lab_mrna_ClinicalServicesMember_label_en-US" xlink:label="lab_mrna_ClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Services [Member]</link:label>
    <link:label id="lab_mrna_ClinicalServicesMember_documentation_en-US" xlink:label="lab_mrna_ClinicalServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalServicesMember" xlink:href="mrna-20201231.xsd#mrna_ClinicalServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ClinicalServicesMember" xlink:to="lab_mrna_ClinicalServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_33314ccb-b55c-4880-a7dc-8aa5eeb8c348_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_VertexMember_5d0532b1-d845-4826-aa77-82af77bca110_terseLabel_en-US" xlink:label="lab_mrna_VertexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex</link:label>
    <link:label id="lab_mrna_VertexMember_label_en-US" xlink:label="lab_mrna_VertexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex [Member]</link:label>
    <link:label id="lab_mrna_VertexMember_documentation_en-US" xlink:label="lab_mrna_VertexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexMember" xlink:href="mrna-20201231.xsd#mrna_VertexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_VertexMember" xlink:to="lab_mrna_VertexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_PersonalizedMRNACancerVaccinesProductsMember_f1a11a8f-ff73-43a0-a9ab-21385f9b73be_terseLabel_en-US" xlink:label="lab_mrna_PersonalizedMRNACancerVaccinesProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PCV products</link:label>
    <link:label id="lab_mrna_PersonalizedMRNACancerVaccinesProductsMember_label_en-US" xlink:label="lab_mrna_PersonalizedMRNACancerVaccinesProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personalized MRNA Cancer Vaccines Products [Member]</link:label>
    <link:label id="lab_mrna_PersonalizedMRNACancerVaccinesProductsMember_documentation_en-US" xlink:label="lab_mrna_PersonalizedMRNACancerVaccinesProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personalized MRNA Cancer Vaccines Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PersonalizedMRNACancerVaccinesProductsMember" xlink:href="mrna-20201231.xsd#mrna_PersonalizedMRNACancerVaccinesProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_PersonalizedMRNACancerVaccinesProductsMember" xlink:to="lab_mrna_PersonalizedMRNACancerVaccinesProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_905cc300-1fe8-424f-b779-aa58920a2f4e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_StockOptionAndIncentivePlan2018Member_eb742fe7-1c3f-4b12-be89-3da55dd3bf62_terseLabel_en-US" xlink:label="lab_mrna_StockOptionAndIncentivePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Equity Plan</link:label>
    <link:label id="lab_mrna_StockOptionAndIncentivePlan2018Member_label_en-US" xlink:label="lab_mrna_StockOptionAndIncentivePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Incentive Plan 2018 [Member]</link:label>
    <link:label id="lab_mrna_StockOptionAndIncentivePlan2018Member_documentation_en-US" xlink:label="lab_mrna_StockOptionAndIncentivePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Incentive Plan 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StockOptionAndIncentivePlan2018Member" xlink:href="mrna-20201231.xsd#mrna_StockOptionAndIncentivePlan2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_StockOptionAndIncentivePlan2018Member" xlink:to="lab_mrna_StockOptionAndIncentivePlan2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_61e54af0-801e-467c-884c-cf8a00dacdc9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_EmployeeStockPurchasePlan2018Member_dc04057d-f9d5-4c2a-9001-368bcf175c56_terseLabel_en-US" xlink:label="lab_mrna_EmployeeStockPurchasePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_mrna_EmployeeStockPurchasePlan2018Member_label_en-US" xlink:label="lab_mrna_EmployeeStockPurchasePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan 2018 [Member]</link:label>
    <link:label id="lab_mrna_EmployeeStockPurchasePlan2018Member_documentation_en-US" xlink:label="lab_mrna_EmployeeStockPurchasePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EmployeeStockPurchasePlan2018Member" xlink:href="mrna-20201231.xsd#mrna_EmployeeStockPurchasePlan2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_EmployeeStockPurchasePlan2018Member" xlink:to="lab_mrna_EmployeeStockPurchasePlan2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_04620400-5cc1-46d7-9880-0b1da817723d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance obligations satisfied (or partially satisfied) in previous reporting periods</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_83b9cbc2-2d91-4fe9-8315-a4ff1c5be215_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_290caef2-ffe9-4079-acb8-8c4dd080afca_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a0631c4b-c8bc-4c70-b2e0-266b4c7e811e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_2eb3e9cf-8e5f-4fc8-a928-e1fde2bfa883_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets, financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_a99adaa9-b794-4a61-884c-afb18b14eb09_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable&#160;Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_fd042aa2-f0c2-4a47-bdc0-2d620ae9bdc5_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OtherMember_67b14348-8f78-43dd-aa19-68098eeac683_terseLabel_en-US" xlink:label="lab_mrna_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mrna_OtherMember_label_en-US" xlink:label="lab_mrna_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_mrna_OtherMember_documentation_en-US" xlink:label="lab_mrna_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OtherMember" xlink:href="mrna-20201231.xsd#mrna_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OtherMember" xlink:to="lab_mrna_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_LeaseFinancingObligationsIncurred_201bcf04-2784-40f9-817f-e1bc5bef88e7_terseLabel_en-US" xlink:label="lab_mrna_LeaseFinancingObligationsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease financing obligation</link:label>
    <link:label id="lab_mrna_LeaseFinancingObligationsIncurred_label_en-US" xlink:label="lab_mrna_LeaseFinancingObligationsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Financing Obligations Incurred</link:label>
    <link:label id="lab_mrna_LeaseFinancingObligationsIncurred_documentation_en-US" xlink:label="lab_mrna_LeaseFinancingObligationsIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Financing Obligations Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LeaseFinancingObligationsIncurred" xlink:href="mrna-20201231.xsd#mrna_LeaseFinancingObligationsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_LeaseFinancingObligationsIncurred" xlink:to="lab_mrna_LeaseFinancingObligationsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_83906ad8-5810-4f0d-81d8-9683946b741d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_0b4eff20-fcf5-4b39-96f1-1221037c6173_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_19234ec5-d8f6-4a7d-8fd0-d39cf47ad0bc_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-based awards</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e1e0b424-407e-4117-8550-42588b848920_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9174a2d7-82ca-4abe-ae90-4b19ba5f07a7_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_83475314-7f27-48a6-8764-e128f7e8e7a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, non-vested at beginning of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6bd3ec6d-2752-4ffe-b9d4-2030988d9541_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, non-vested at end of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod_20ab77b2-27af-44ae-b48e-f0e353243cdb_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Suspension period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Product Suspension Period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Product Suspension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_NoncurrentMarketableSecuritiesMember_36d38092-2a4b-4c00-b7bb-e93dda9c02ce_terseLabel_en-US" xlink:label="lab_mrna_NoncurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- Current Marketable Securities</link:label>
    <link:label id="lab_mrna_NoncurrentMarketableSecuritiesMember_label_en-US" xlink:label="lab_mrna_NoncurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent Marketable Securities [Member]</link:label>
    <link:label id="lab_mrna_NoncurrentMarketableSecuritiesMember_documentation_en-US" xlink:label="lab_mrna_NoncurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent Marketable Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NoncurrentMarketableSecuritiesMember" xlink:href="mrna-20201231.xsd#mrna_NoncurrentMarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_NoncurrentMarketableSecuritiesMember" xlink:to="lab_mrna_NoncurrentMarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_29bc3676-4306-4991-955f-c9155eb8e417_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_d61fb88f-e17b-471a-a784-4e0d00ef5e5f_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_a20bc295-9d67-45ed-a93b-cf6ee3e2b593_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ea34e836-d4dc-49b2-9d71-376954f604cf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_c3b1289a-82eb-42f7-bc0b-26290b9a2f4c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_ee8ffc52-c0d7-4d9e-bbe9-b1bd464621c1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_VariableConsiderationMember_392fbb57-e49d-4dfc-85ca-899df1623cd4_terseLabel_en-US" xlink:label="lab_mrna_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated reimbursement for clinical supply</link:label>
    <link:label id="lab_mrna_VariableConsiderationMember_label_en-US" xlink:label="lab_mrna_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration [Member]</link:label>
    <link:label id="lab_mrna_VariableConsiderationMember_documentation_en-US" xlink:label="lab_mrna_VariableConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Consideration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VariableConsiderationMember" xlink:href="mrna-20201231.xsd#mrna_VariableConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_VariableConsiderationMember" xlink:to="lab_mrna_VariableConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_cb706d6c-4c27-4d2d-bfac-080404fabce1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock under equity plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_49f37782-7c1a-4c2b-8231-82b46e169a64_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows used in operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_713b6020-2afe-402d-a1dc-f1b74cec50bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Activity</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_3c2a703b-30cb-4880-afe3-06be37e32322_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4cee5211-9608-4e21-840b-bfc852d60583_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ClinicalSupplyReimbursementMember_08a48c50-db02-448b-b47e-1af8ae383494_terseLabel_en-US" xlink:label="lab_mrna_ClinicalSupplyReimbursementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursement for clinical supply</link:label>
    <link:label id="lab_mrna_ClinicalSupplyReimbursementMember_label_en-US" xlink:label="lab_mrna_ClinicalSupplyReimbursementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Supply Reimbursement [Member]</link:label>
    <link:label id="lab_mrna_ClinicalSupplyReimbursementMember_documentation_en-US" xlink:label="lab_mrna_ClinicalSupplyReimbursementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Supply Reimbursement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalSupplyReimbursementMember" xlink:href="mrna-20201231.xsd#mrna_ClinicalSupplyReimbursementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ClinicalSupplyReimbursementMember" xlink:to="lab_mrna_ClinicalSupplyReimbursementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a37d3c9c-ad04-45b1-adf7-0321dd2d8515_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e7e42cc8-176d-46f6-a14b-24ca6fa835ef_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_633bf33e-83f1-42b1-b2db-398585b867a6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2ff8315f-5978-4f0e-9549-07bbb7bf5f95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1258605b-f48d-4373-9efa-c4d6ff09bb16_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost related to non-vested stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_66b3cdc4-a891-4cdb-8073-3484ea54624a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_2fd3cbcc-d20c-48eb-975b-e61f9a085b13_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_bce39434-35fb-4e4e-9d09-a72b44262622_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum shares to be purchased during purchase period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8b59ea07-d2b6-409f-a111-c15bf814e926_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_7eef2475-217f-416d-83d4-66992a2f094b_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carry-forwards</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_778a72bb-b444-45de-9786-ea6a0e80a4f9_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_cae95f16-22d2-41eb-8d17-8b3bad9eff98_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_2f835b8b-0528-4bf1-8d2f-c8ea7892845a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value; 162,000,000 shares authorized at December 31, 2020 and 2019; 0 shares issued or outstanding at December 31, 2020 and 2019</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_AstraZenecaMember_2201a9d9-a6fa-4fcb-9268-6e16294ca5de_terseLabel_en-US" xlink:label="lab_mrna_AstraZenecaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AstraZeneca</link:label>
    <link:label id="lab_mrna_AstraZenecaMember_label_en-US" xlink:label="lab_mrna_AstraZenecaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AstraZeneca [Member]</link:label>
    <link:label id="lab_mrna_AstraZenecaMember_documentation_en-US" xlink:label="lab_mrna_AstraZenecaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AstraZeneca [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AstraZenecaMember" xlink:href="mrna-20201231.xsd#mrna_AstraZenecaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_AstraZenecaMember" xlink:to="lab_mrna_AstraZenecaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8978a3e2-5f46-4940-a007-8a1eab8c4022_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_InitialProjectMember_85a915f7-506d-492b-bc2b-8a915975465b_terseLabel_en-US" xlink:label="lab_mrna_InitialProjectMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial project</link:label>
    <link:label id="lab_mrna_InitialProjectMember_label_en-US" xlink:label="lab_mrna_InitialProjectMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Project [Member]</link:label>
    <link:label id="lab_mrna_InitialProjectMember_documentation_en-US" xlink:label="lab_mrna_InitialProjectMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Project [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_InitialProjectMember" xlink:href="mrna-20201231.xsd#mrna_InitialProjectMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_InitialProjectMember" xlink:to="lab_mrna_InitialProjectMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_57500875-d740-4f07-b992-b302d776e275_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_180bb7d6-c26c-4419-bfed-47a446a67718_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_1a6dde9f-1f7b-4322-9609-701b391ed51a_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows used in financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_MTCSouthMember_71f758db-3075-41f1-9944-45bec52493a6_terseLabel_en-US" xlink:label="lab_mrna_MTCSouthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MTC South</link:label>
    <link:label id="lab_mrna_MTCSouthMember_label_en-US" xlink:label="lab_mrna_MTCSouthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MTC South [Member]</link:label>
    <link:label id="lab_mrna_MTCSouthMember_documentation_en-US" xlink:label="lab_mrna_MTCSouthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MTC South</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MTCSouthMember" xlink:href="mrna-20201231.xsd#mrna_MTCSouthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_MTCSouthMember" xlink:to="lab_mrna_MTCSouthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_78a6f114-7668-40f7-89c5-87e98c9bbc17_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in progress</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_8ca38696-7515-4c38-ba2e-05b00f55f54b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_77dafb44-f883-4829-b811-09b43dd9a14e_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_a3c735c4-0751-44e8-bb6e-c7ae74499170_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RegulatoryMilestonesMember_14c23c9a-34bc-4cc1-9140-003118855daa_terseLabel_en-US" xlink:label="lab_mrna_RegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Milestones</link:label>
    <link:label id="lab_mrna_RegulatoryMilestonesMember_label_en-US" xlink:label="lab_mrna_RegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Milestones [Member]</link:label>
    <link:label id="lab_mrna_RegulatoryMilestonesMember_documentation_en-US" xlink:label="lab_mrna_RegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Milestones [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RegulatoryMilestonesMember" xlink:href="mrna-20201231.xsd#mrna_RegulatoryMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RegulatoryMilestonesMember" xlink:to="lab_mrna_RegulatoryMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_81f028cd-d438-434f-a788-66c26d0b0f47_periodStartLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (usd per share)</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_b6e67804-2242-43c5-94d4-b8836f9c7ae9_periodEndLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (usd per share)</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_c246b528-c8d0-47ca-835f-f225f33b22f0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_67302475-d29f-49cb-a1b1-b3d0009f8434_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_828850c0-f577-421d-961c-ab450db42a70_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_23ed2bfb-2c9f-4d07-8970-6ddea1b24a78_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_93610e08-2a42-4dd3-a43d-19cdb6925c51_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_7be78c17-3384-4e2c-b1d4-10ca00db4c45_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_ce9f3055-cf48-4bb1-ab26-74719f84a16b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_CambridgeMassachusettsMember_c7dc91b9-59fa-4fcb-8eca-1c4745f37154_terseLabel_en-US" xlink:label="lab_mrna_CambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cambridge Leases</link:label>
    <link:label id="lab_mrna_CambridgeMassachusettsMember_label_en-US" xlink:label="lab_mrna_CambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cambridge, Massachusetts [Member]</link:label>
    <link:label id="lab_mrna_CambridgeMassachusettsMember_documentation_en-US" xlink:label="lab_mrna_CambridgeMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cambridge, Massachusetts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CambridgeMassachusettsMember" xlink:href="mrna-20201231.xsd#mrna_CambridgeMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_CambridgeMassachusettsMember" xlink:to="lab_mrna_CambridgeMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares_ccb25190-3ce9-4cc1-9345-caac0052edd5_negatedLabel_en-US" xlink:label="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of redeemable convertible preferred stock (in shares)</link:label>
    <link:label id="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Repurchased During Period, Shares</link:label>
    <link:label id="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares_documentation_en-US" xlink:label="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:href="mrna-20201231.xsd#mrna_TemporaryEquityStockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:to="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5513eec4-2381-4596-899e-3866ff5d5940_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_fefa1a53-d958-41ff-abd8-f62634c9e073_terseLabel_en-US" xlink:label="lab_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and commercialization license and manufacturing obligation</link:label>
    <link:label id="lab_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_label_en-US" xlink:label="lab_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development And Commercialization License And Manufacturing Obligations For IL12 [Member]</link:label>
    <link:label id="lab_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_documentation_en-US" xlink:label="lab_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development And Commercialization License And Manufacturing Obligations For IL12 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member" xlink:href="mrna-20201231.xsd#mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member" xlink:to="lab_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d1341cf2-494f-496d-8e20-b7c648e19129_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent_1a77f8bd-5599-4631-8740-2bd90cf42d8b_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tiered royalties at default rate</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Royalty Payment, Default Percent</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Royalty Payment, Default Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_acd8d129-1d7d-42fa-a793-d5a6e0c95e03_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7ac785b9-d176-43f2-b5fc-f7e9985591d2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_3d0897e0-c678-4b25-9215-a0f339d3ce6d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation windfall</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0b37780b-b48c-4d11-a5c0-50cfe25f86d6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_c93cdd60-e2c1-4503-b1d2-9c58e98ed55d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities maturity term</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_49ebccf7-5f3a-4335-a2e7-d24475cb59c8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_03170f24-989f-43af-b98e-af40a0fc0ab9_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_67bd427d-7d55-43e3-a9a1-d03608d7dad1_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research extension period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Research Extension Period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Research Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_0479ea83-8edf-42ec-9ab9-f7a14ce4df5b_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d7fd91c5-bb95-4c94-b829-fd0baa95dd78_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_62526e3f-c097-4ac5-9ff6-7d7aff3dc68e_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_e1302641-1b7e-4bf3-9d50-eeda6ef46733_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant Date Fair Value per Share, Exercisable (usd per share)</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_7c9b7b70-e841-47b4-982a-9c6984ee7ddd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_325a235a-d9be-4e28-8071-2a69f993d5df_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3466ccb-df2e-4c58-b156-89987d75314c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_669e96cf-ebed-432c-b0a9-286f4c1164e8_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_61a67daa-1c45-4576-bc6e-92cfb5dfa2c2_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_6a666d69-7d0a-4ff8-b77f-0b304fe8175d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7425ba75-cafc-4d31-8934-15eb2eebf691_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate number of shares authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_PCVSAVAgreementMember_3af9f8e1-f58c-44ce-9b9a-f85c5f32ab1d_terseLabel_en-US" xlink:label="lab_mrna_PCVSAVAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PCVSAV Agreement</link:label>
    <link:label id="lab_mrna_PCVSAVAgreementMember_label_en-US" xlink:label="lab_mrna_PCVSAVAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PCVSAV Agreement [Member]</link:label>
    <link:label id="lab_mrna_PCVSAVAgreementMember_documentation_en-US" xlink:label="lab_mrna_PCVSAVAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PCVSAV Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_PCVSAVAgreementMember" xlink:to="lab_mrna_PCVSAVAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_036d1698-321c-4c98-a910-318bcf2a96fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_a42eff0a-ab21-4b30-9ee6-ee95c535aaec_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual commitment to pay</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Remaining Minimum Amount Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:to="lab_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_8a9af8f7-0280-4284-8c31-1a7a570b7db1_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply commitment</link:label>
    <link:label id="lab_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_label_en-US" xlink:label="lab_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Commitment, Remaining Minimum Amount Committed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted" xlink:to="lab_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_bc204b10-0f33-4a96-8fa6-6743a49dd15d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_EquipmentAndLeasedFacilitiesMember_64193f11-a042-4fd8-a7eb-7642b87f600c_terseLabel_en-US" xlink:label="lab_mrna_EquipmentAndLeasedFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment and Leased Facilities</link:label>
    <link:label id="lab_mrna_EquipmentAndLeasedFacilitiesMember_label_en-US" xlink:label="lab_mrna_EquipmentAndLeasedFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment And Leased Facilities [Member]</link:label>
    <link:label id="lab_mrna_EquipmentAndLeasedFacilitiesMember_documentation_en-US" xlink:label="lab_mrna_EquipmentAndLeasedFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment And Leased Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EquipmentAndLeasedFacilitiesMember" xlink:href="mrna-20201231.xsd#mrna_EquipmentAndLeasedFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_EquipmentAndLeasedFacilitiesMember" xlink:to="lab_mrna_EquipmentAndLeasedFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_2ddde8cb-f244-4c35-98d4-8441ee72f8a0_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_e5668d2a-98fd-4f3f-9dc1-ea2e1d13805c_terseLabel_en-US" xlink:label="lab_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of redeemable convertible preferred stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:href="mrna-20201231.xsd#mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6609f6c3-09a0-47a8-b00d-3f2a1e5bb807_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_03b12d43-b9b1-4f6f-a43f-a4f6959a2544_terseLabel_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liabilities:</link:label>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_label_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract with Customer Liability, NonCurrent [Roll Forward]</link:label>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_documentation_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract with Customer Liability, NonCurrent [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward" xlink:to="lab_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_d31c84ea-fb4c-4bae-84b1-9d0e5740c2ea_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses, 12 months or more</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_154bb0e2-11b6-4d39-ba71-60d630f621bc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a3d93ce5-907f-4a81-a811-4a6f6e13751e_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_40321d56-fac4-49fc-88a0-d6298e82c42a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_b96643bc-531d-44ec-81e0-ea5475ddda3b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_d1f08d08-7a9c-4238-b994-1868addd0ccc_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination period upon marketing approval</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_732ed6d9-7dd8-4e9b-b962-9ee62148d399_verboseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written notice period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Marketing Approval, Termination Period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Marketing Approval, Termination Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_17c3bd21-1669-45fb-aa78-0175a5d0f511_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod_98a36ceb-0c20-4e9a-b74d-98a94e50dd77_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment received, research extension period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Payment Received, Research Extension Period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Payment Received, Research Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1596b93d-456a-4756-9eed-4fdd742d309a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_7e20efaf-0eea-43db-9ba4-8e9771cf746e_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_5ea0430b-9a3d-4b5a-9498-64c6262efd46_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_aed48195-fcda-4135-916e-6167cc93c379_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_7a27af3e-b97c-4453-986f-b74cba7e67c3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_cd0b7ec4-f30f-4979-9b83-4c7b6eb9ac73_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_791802e7-d8bc-4861-9aed-2d1885d0cc9d_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e4647a3f-ff9b-43b0-b778-f345e173f85d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_7a4bc004-5237-45ad-9d49-e0af43139823_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_ee26f896-5b5c-4ae7-8789-cc90270c5b15_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_e58f72d3-fa85-4b5c-abe5-d9ef38ebc7c5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_98605104-b846-4ebb-bbbc-a63701c20a54_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_496a43e4-5d48-4d8b-9cbd-871dfd55a10b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_8a7aefa4-1d5e-4955-950e-aad09ddba059_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_14c8a27d-21cb-486c-9468-7f77e8cc7856_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_f91db1d5-a57d-4fc6-9bae-16114e8bed98_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_412361df-3a9a-492a-a81c-768f30c5ebb8_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_479348f2-98be-4780-9301-76bd444303dc_terseLabel_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Customers</link:label>
    <link:label id="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major Customers, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:to="lab_us-gaap_MajorCustomersPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue_84ffedc8-4fd7-42e7-94a6-399c816cfd4a_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested And Expected To Vest, Outstanding, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested And Expected To Vest, Outstanding, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember_3721204f-87da-4111-ba06-e476edefcd7c_terseLabel_en-US" xlink:label="lab_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 AZ Agreements</link:label>
    <link:label id="lab_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember_label_en-US" xlink:label="lab_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Option Agreement And Services And Collaboration Agreement [Member]</link:label>
    <link:label id="lab_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember_documentation_en-US" xlink:label="lab_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2013 Option Agreement And Services And Collaboration Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember" xlink:href="mrna-20201231.xsd#mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember" xlink:to="lab_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a02fe1df-962a-4f8f-8195-d2ea90f1bb10_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, non-vested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7e9bb2a7-f03d-4e62-bcd6-9727e6445cf3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding, non-vested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_AdditionalNumberOfVaccineDoses_4af0ea81-4648-44e2-bb62-96f8a05458dd_terseLabel_en-US" xlink:label="lab_mrna_AdditionalNumberOfVaccineDoses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of doses</link:label>
    <link:label id="lab_mrna_AdditionalNumberOfVaccineDoses_label_en-US" xlink:label="lab_mrna_AdditionalNumberOfVaccineDoses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Number Of Vaccine Doses</link:label>
    <link:label id="lab_mrna_AdditionalNumberOfVaccineDoses_documentation_en-US" xlink:label="lab_mrna_AdditionalNumberOfVaccineDoses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Number Of Vaccine Doses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AdditionalNumberOfVaccineDoses" xlink:href="mrna-20201231.xsd#mrna_AdditionalNumberOfVaccineDoses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_AdditionalNumberOfVaccineDoses" xlink:to="lab_mrna_AdditionalNumberOfVaccineDoses" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityLineItems_277c548d-e5f8-4686-b9ff-c523954bd41f_terseLabel_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Line Items]</link:label>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityLineItems_label_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract With Customer Liability [Line Items]</link:label>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityLineItems_documentation_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract With Customer Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityLineItems" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityLineItems" xlink:to="lab_mrna_ChangeInContractWithCustomerLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis_62d70831-9f1e-446e-9907-475ae4fcd8be_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:to="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_44848394-a665-4d70-8ffc-560bcd277705_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_4575fdf8-887c-4c9d-a2dd-be46adf0d1d9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_873cff0b-f987-4ea6-a48c-77f735edb03e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e1cd5f56-59d5-437f-beed-9dd000429fb8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_67491dd5-a8f6-4b27-8e3c-28a98bc798eb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ChangeInContractwithCustomerAssetRollForward_aa09ce51-6fc7-4db8-9a92-7d1fdf1dbd01_terseLabel_en-US" xlink:label="lab_mrna_ChangeInContractwithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Assets:</link:label>
    <link:label id="lab_mrna_ChangeInContractwithCustomerAssetRollForward_label_en-US" xlink:label="lab_mrna_ChangeInContractwithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract with Customer Asset [Roll Forward]</link:label>
    <link:label id="lab_mrna_ChangeInContractwithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_mrna_ChangeInContractwithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract with Customer Asset [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractwithCustomerAssetRollForward" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractwithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ChangeInContractwithCustomerAssetRollForward" xlink:to="lab_mrna_ChangeInContractwithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset_f71e08bf-fb02-4452-85d2-1fbec0468fb9_negatedTerseLabel_en-US" xlink:label="lab_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing right-of-use assets</link:label>
    <link:label id="lab_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Finance Lease Right Of Use Asset</link:label>
    <link:label id="lab_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Finance Lease Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset" xlink:to="lab_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b7f0732e-bdbd-42d7-8360-6b0a7f7e59f9_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OptionExerciseFeeMember_fc3749e4-0705-47b7-b535-8c84d3a96b7f_terseLabel_en-US" xlink:label="lab_mrna_OptionExerciseFeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option exercise fee</link:label>
    <link:label id="lab_mrna_OptionExerciseFeeMember_label_en-US" xlink:label="lab_mrna_OptionExerciseFeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Exercise Fee [Member]</link:label>
    <link:label id="lab_mrna_OptionExerciseFeeMember_documentation_en-US" xlink:label="lab_mrna_OptionExerciseFeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Exercise Fee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OptionExerciseFeeMember" xlink:href="mrna-20201231.xsd#mrna_OptionExerciseFeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OptionExerciseFeeMember" xlink:to="lab_mrna_OptionExerciseFeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_4d27a144-3752-4580-a7a6-f5e78dd04fb1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization/accretion of investments</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net, Amortization of Discount and Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:to="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d54c4522-815f-4f10-b060-4c3228870d83_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_06c51544-f48f-4e6e-a2db-bd9918e35c6b_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts representing interest or imputed interest, operating lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5dc12d33-eb5d-4a81-8734-d0f2daf66e5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amounts representing interest or imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6c5a320f-d9ee-4f50-becb-38a01fb7f803_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_8316d082-d1d2-47e0-9fdf-b6b8c2aacb11_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses, Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_FinancingRightOfUseAssetMember_58db6153-5e20-4538-a4a5-c58f1c197e2d_terseLabel_en-US" xlink:label="lab_mrna_FinancingRightOfUseAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset, financing</link:label>
    <link:label id="lab_mrna_FinancingRightOfUseAssetMember_label_en-US" xlink:label="lab_mrna_FinancingRightOfUseAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing, Right-Of-Use Asset [Member]</link:label>
    <link:label id="lab_mrna_FinancingRightOfUseAssetMember_documentation_en-US" xlink:label="lab_mrna_FinancingRightOfUseAssetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing, Right-Of-Use Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FinancingRightOfUseAssetMember" xlink:href="mrna-20201231.xsd#mrna_FinancingRightOfUseAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_FinancingRightOfUseAssetMember" xlink:to="lab_mrna_FinancingRightOfUseAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2d8c5db6-8cd4-4590-84dc-23ba69e1c7ca_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_45bbd0b4-8fe0-44a6-9f92-7e1804268a4e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_68fadd53-9318-4ac9-9962-ec2239d217d7_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_0ac8f5a4-b7fd-43b4-b539-5dc7fabd2549_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_AccruedExternalGoodsAndServicesCurrent_81a0fe1e-66b1-4bbc-bd40-c04e0cb947df_terseLabel_en-US" xlink:label="lab_mrna_AccruedExternalGoodsAndServicesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other external goods and services</link:label>
    <link:label id="lab_mrna_AccruedExternalGoodsAndServicesCurrent_label_en-US" xlink:label="lab_mrna_AccruedExternalGoodsAndServicesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued External Goods And Services, Current</link:label>
    <link:label id="lab_mrna_AccruedExternalGoodsAndServicesCurrent_documentation_en-US" xlink:label="lab_mrna_AccruedExternalGoodsAndServicesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued External Goods And Services, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedExternalGoodsAndServicesCurrent" xlink:href="mrna-20201231.xsd#mrna_AccruedExternalGoodsAndServicesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_AccruedExternalGoodsAndServicesCurrent" xlink:to="lab_mrna_AccruedExternalGoodsAndServicesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_58ed7972-1610-4b66-99de-989422e37453_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreements</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0a53e9b8-2a3e-4a53-9236-616cf01d6f23_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbf60b0d-a9de-41e0-95de-ffa075e3ad01_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares/Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments_42d3b89f-ea7f-4770-ac3c-018959509eaf_terseLabel_en-US" xlink:label="lab_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets reduced through lease modifications and reassessments</link:label>
    <link:label id="lab_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments_label_en-US" xlink:label="lab_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Assets Reduced Through Lease Modifications And Reassessments</link:label>
    <link:label id="lab_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments_documentation_en-US" xlink:label="lab_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Assets Reduced Through Lease Modifications And Reassessments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments" xlink:href="mrna-20201231.xsd#mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments" xlink:to="lab_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_900f0c1d-9943-445f-81af-fcdcc2e02ac8_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_be55d822-e46c-45f4-b110-ab70b245bd5d_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Domain]</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:to="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1eb567e1-4724-4ba1-8384-f1478779011c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_1b44802f-db8d-42b0-b755-094042b6488d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense for financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_NorwoodMassachusettsMember_862d4ab4-eb33-4a7f-acfe-f632a4ab21e2_terseLabel_en-US" xlink:label="lab_mrna_NorwoodMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwood Leases</link:label>
    <link:label id="lab_mrna_NorwoodMassachusettsMember_label_en-US" xlink:label="lab_mrna_NorwoodMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwood, Massachusetts [Member]</link:label>
    <link:label id="lab_mrna_NorwoodMassachusettsMember_documentation_en-US" xlink:label="lab_mrna_NorwoodMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Norwood, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NorwoodMassachusettsMember" xlink:href="mrna-20201231.xsd#mrna_NorwoodMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_NorwoodMassachusettsMember" xlink:to="lab_mrna_NorwoodMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_db4c0dfc-b7b9-4489-a0f9-37f28558e6d6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_VertexAgreement2019AgreementMember_30cda43a-8bc1-4429-a47e-8a5423b3b667_terseLabel_en-US" xlink:label="lab_mrna_VertexAgreement2019AgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex Agreement/2019 Amendment</link:label>
    <link:label id="lab_mrna_VertexAgreement2019AgreementMember_label_en-US" xlink:label="lab_mrna_VertexAgreement2019AgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex Agreement2019 Agreement [Member]</link:label>
    <link:label id="lab_mrna_VertexAgreement2019AgreementMember_documentation_en-US" xlink:label="lab_mrna_VertexAgreement2019AgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex Agreement2019 Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreement2019AgreementMember" xlink:href="mrna-20201231.xsd#mrna_VertexAgreement2019AgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_VertexAgreement2019AgreementMember" xlink:to="lab_mrna_VertexAgreement2019AgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7a340ff0-6af4-44ba-8899-b1d622d06595_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_77e54b50-03e5-4927-a14a-72fa075380ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_76340a89-1e84-42e7-a818-a94e992c00df_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Milestone [Domain]</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Milestone [Domain]</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Research And Development Arrangement, Contract To Perform For Others, Milestone [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_PerformanceObligationAxis_012d4766-7e21-41b7-ac8f-8665797b61eb_terseLabel_en-US" xlink:label="lab_mrna_PerformanceObligationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Obligation [Axis]</link:label>
    <link:label id="lab_mrna_PerformanceObligationAxis_label_en-US" xlink:label="lab_mrna_PerformanceObligationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Obligation [Axis]</link:label>
    <link:label id="lab_mrna_PerformanceObligationAxis_documentation_en-US" xlink:label="lab_mrna_PerformanceObligationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Obligation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationAxis" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_PerformanceObligationAxis" xlink:to="lab_mrna_PerformanceObligationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_1acff298-da8a-4392-85f0-49ced1d58aa5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_55ea7bd7-53a6-4c52-a0da-8e71340b7113_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ac5a3315-e419-4131-a713-55e2ceedfd4c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_78061f53-046f-4be1-89f5-5d89b4121b30_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7453507e-e321-43d9-96ef-e3a5f12f192c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_18198a51-a01a-4475-b629-ce7846abf4e3_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_dac95e02-5950-40ae-9f2f-b1b2e49d0a71_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_08d89f14-7c06-4ca4-81f3-076f13b982b4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration for options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_6cc94462-1d50-4030-9c32-a0c075395e81_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c78df0a3-7769-41a8-a584-d7e181721f76_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_VEGFAProductAZD8601Member_975cec62-495c-4552-b43c-2469e9bbd715_terseLabel_en-US" xlink:label="lab_mrna_VEGFAProductAZD8601Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VEGF-A product (AZD8601)</link:label>
    <link:label id="lab_mrna_VEGFAProductAZD8601Member_label_en-US" xlink:label="lab_mrna_VEGFAProductAZD8601Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VEGF-A Product (AZD8601) [Member]</link:label>
    <link:label id="lab_mrna_VEGFAProductAZD8601Member_documentation_en-US" xlink:label="lab_mrna_VEGFAProductAZD8601Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VEGF-A Product (AZD8601) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFAProductAZD8601Member" xlink:href="mrna-20201231.xsd#mrna_VEGFAProductAZD8601Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_VEGFAProductAZD8601Member" xlink:to="lab_mrna_VEGFAProductAZD8601Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OtherPrepaidExpenseManufacturing_b40b3da0-5f3e-4385-bfab-26ebc3e26a85_terseLabel_en-US" xlink:label="lab_mrna_OtherPrepaidExpenseManufacturing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Down payments to manufacturing vendors</link:label>
    <link:label id="lab_mrna_OtherPrepaidExpenseManufacturing_label_en-US" xlink:label="lab_mrna_OtherPrepaidExpenseManufacturing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Manufacturing</link:label>
    <link:label id="lab_mrna_OtherPrepaidExpenseManufacturing_documentation_en-US" xlink:label="lab_mrna_OtherPrepaidExpenseManufacturing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Manufacturing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OtherPrepaidExpenseManufacturing" xlink:href="mrna-20201231.xsd#mrna_OtherPrepaidExpenseManufacturing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OtherPrepaidExpenseManufacturing" xlink:to="lab_mrna_OtherPrepaidExpenseManufacturing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_46eb3eef-b21e-4372-9c44-50025c8f8a3e_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_aa23c88a-7a1c-4435-ac59-7d204f49c45d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_37f980e2-66e1-43d9-adc5-000ba09e1038_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_6af40724-b3a6-47ef-b4fd-3e408d58241b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost and Estimated Fair Value of Marketable Securities, by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6d3df5b2-0a10-4116-b167-2b3c2e75cfab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_3179a41f-5b7a-474b-a3b4-04f3401f4deb_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_9469b961-fc52-47b3-a9b1-77cee9677e2d_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue_89a44b27-c86c-4fad-86d0-cb1df8cad87a_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (usd per share)</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_3cebb457-06fe-4586-aa04-ce8d0e4b882d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_63846e91-57ea-4552-bdb7-e62964515b4d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_25448520-ce34-47b2-8951-25f99cff5265_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_3837fabf-4488-44fc-808c-21d55823d631_negatedLabel_en-US" xlink:label="lab_mrna_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock into common stock (in shares)</link:label>
    <link:label id="lab_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_d9aa0660-472a-474e-b698-b70f651ca8ec_netLabel_en-US" xlink:label="lab_mrna_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock into common stock (in shares)</link:label>
    <link:label id="lab_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_label_en-US" xlink:label="lab_mrna_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications Of Temporary To Permanent Equity, Shares</link:label>
    <link:label id="lab_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_documentation_en-US" xlink:label="lab_mrna_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications Of Temporary To Permanent Equity, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:href="mrna-20201231.xsd#mrna_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:to="lab_mrna_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_StockOptionAndGrantPlan2016Member_b9773e91-6fb3-4b87-bfc2-8d9d62dc1628_terseLabel_en-US" xlink:label="lab_mrna_StockOptionAndGrantPlan2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Equity Plan</link:label>
    <link:label id="lab_mrna_StockOptionAndGrantPlan2016Member_label_en-US" xlink:label="lab_mrna_StockOptionAndGrantPlan2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Grant Plan 2016 [Member]</link:label>
    <link:label id="lab_mrna_StockOptionAndGrantPlan2016Member_documentation_en-US" xlink:label="lab_mrna_StockOptionAndGrantPlan2016Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Grant Plan 2016 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StockOptionAndGrantPlan2016Member" xlink:href="mrna-20201231.xsd#mrna_StockOptionAndGrantPlan2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_StockOptionAndGrantPlan2016Member" xlink:to="lab_mrna_StockOptionAndGrantPlan2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_2086dbbd-46a4-4ee8-a3b8-14589c593be5_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial research period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Research Period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Research Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_698d90b4-4c8c-4efe-aa61-b8ef58199800_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net loss to net loss attributable to common stockholders:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_6c184971-1f63-4d36-b06c-0cc411c03439_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_ce805976-2423-4a04-b212-cd3ecf4d86c7_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49857ab5-9a8c-46ca-bde1-583eca81d537_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_SublicenseReimbursementMember_3af546ec-e7cd-4126-b701-3fc7d2f0364b_terseLabel_en-US" xlink:label="lab_mrna_SublicenseReimbursementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublicense reimbursement</link:label>
    <link:label id="lab_mrna_SublicenseReimbursementMember_label_en-US" xlink:label="lab_mrna_SublicenseReimbursementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublicense Reimbursement [Member]</link:label>
    <link:label id="lab_mrna_SublicenseReimbursementMember_documentation_en-US" xlink:label="lab_mrna_SublicenseReimbursementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublicense Reimbursement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SublicenseReimbursementMember" xlink:href="mrna-20201231.xsd#mrna_SublicenseReimbursementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_SublicenseReimbursementMember" xlink:to="lab_mrna_SublicenseReimbursementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_2d4d9b84-5eb9-4d56-acdd-7f1a185726a4_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserves established</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_b9c62c4e-83ca-4b60-8195-290969ad1110_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value, Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ce665e48-3c71-4e40-a545-ff26647921a2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share available for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_da8e0573-6ef1-42fb-81b3-53e63590b61b_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock converted into common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d746e2f3-8418-45c7-8547-e47ec95b7a36_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_67633ade-9b8d-49ce-9ab2-e1d61cc20ac6_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_90fbf116-f976-4bc8-86eb-87ecc66b68c5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_5e711127-690b-4352-aa5e-d2ffe8ca7fa3_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_6d3dfd2c-f052-47d7-9597-04e0614e3f1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_SouthKoreaGovernmentMember_aa62429e-4cfd-43f8-8bc1-2fb67ff890b0_terseLabel_en-US" xlink:label="lab_mrna_SouthKoreaGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Korea Government</link:label>
    <link:label id="lab_mrna_SouthKoreaGovernmentMember_label_en-US" xlink:label="lab_mrna_SouthKoreaGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Korea Government [Member]</link:label>
    <link:label id="lab_mrna_SouthKoreaGovernmentMember_documentation_en-US" xlink:label="lab_mrna_SouthKoreaGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Korea Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SouthKoreaGovernmentMember" xlink:href="mrna-20201231.xsd#mrna_SouthKoreaGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_SouthKoreaGovernmentMember" xlink:to="lab_mrna_SouthKoreaGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_b18d7a81-8f1d-4f27-a5d0-112fbc9f24fc_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research extension period elected</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Research Extension Period Elected</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Research Extension Period Elected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_a94dd270-d808-4d50-8f7a-f8d419461a6d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RevenueFromGrantsCurrentFundingCapacity_f7b4cd1d-d32d-4c28-8376-25ab46383b1e_terseLabel_en-US" xlink:label="lab_mrna_RevenueFromGrantsCurrentFundingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount committed for funding</link:label>
    <link:label id="lab_mrna_RevenueFromGrantsCurrentFundingCapacity_label_en-US" xlink:label="lab_mrna_RevenueFromGrantsCurrentFundingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Grants, Current Funding Capacity</link:label>
    <link:label id="lab_mrna_RevenueFromGrantsCurrentFundingCapacity_documentation_en-US" xlink:label="lab_mrna_RevenueFromGrantsCurrentFundingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Grants, Current Funding Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsCurrentFundingCapacity" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsCurrentFundingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RevenueFromGrantsCurrentFundingCapacity" xlink:to="lab_mrna_RevenueFromGrantsCurrentFundingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_6e9b2ff1-b363-4704-9832-ce05badfd380_terseLabel_en-US" xlink:label="lab_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BARDA</link:label>
    <link:label id="lab_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_label_en-US" xlink:label="lab_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biomedical Advanced Research And Development Authority [Member]</link:label>
    <link:label id="lab_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_documentation_en-US" xlink:label="lab_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biomedical Advanced Research And Development Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:href="mrna-20201231.xsd#mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:to="lab_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_3f081c80-700c-421b-b4c0-a5126d2a46cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Foreign Currency Derivatives</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_b8148e85-4ea6-4c3f-af72-dd2be658f9cf_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated&#160;Useful&#160;Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TenantImprovements_ca0dc9bb-8dd1-4ded-9149-3122f6d906e2_terseLabel_en-US" xlink:label="lab_us-gaap_TenantImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant improvements</link:label>
    <link:label id="lab_us-gaap_TenantImprovements_label_en-US" xlink:label="lab_us-gaap_TenantImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TenantImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TenantImprovements" xlink:to="lab_us-gaap_TenantImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_f2192041-33ef-4523-ae89-c745022dd978_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_b0414efe-8a04-4972-94cd-d64524625fe5_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_06d11b7f-49d8-49ac-961b-0284bc1d94c9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_TherapeuticAndProphylacticProductsMember_0ba05b68-6f87-4fbc-a932-4171479a05f4_terseLabel_en-US" xlink:label="lab_mrna_TherapeuticAndProphylacticProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Therapeutic and prophylactic products</link:label>
    <link:label id="lab_mrna_TherapeuticAndProphylacticProductsMember_label_en-US" xlink:label="lab_mrna_TherapeuticAndProphylacticProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Therapeutic And Prophylactic Products [Member]</link:label>
    <link:label id="lab_mrna_TherapeuticAndProphylacticProductsMember_documentation_en-US" xlink:label="lab_mrna_TherapeuticAndProphylacticProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Therapeutic And Prophylactic Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TherapeuticAndProphylacticProductsMember" xlink:href="mrna-20201231.xsd#mrna_TherapeuticAndProphylacticProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_TherapeuticAndProphylacticProductsMember" xlink:to="lab_mrna_TherapeuticAndProphylacticProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_52f0562f-611b-4ae2-9780-08a9ddd880ad_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6d38fa20-0780-4e2b-b157-181bfb6c08da_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AFS</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_d72a5788-9fd9-4b96-99ac-68c9489cd265_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from equity investment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_7603298a-6b4c-42fd-9a62-d71ab28f988e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted common stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_9384d5c6-30f6-40b5-8da8-ffa0b28eb1bd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b5dc6c69-f13d-4224-aeb5-4ea659e68513_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_85ba6748-142e-46ce-b686-8ef3409d6e68_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency forward contracts</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_6a4d797b-31bb-4917-8635-ca26a9f3ccfc_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities - operating</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_e29c7ace-f69b-4303-a1a9-581ae04fca70_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DefenseAdvancedResearchProjectsAgencyMember_73d1ea08-f152-43be-9f05-6b34e4c5441d_terseLabel_en-US" xlink:label="lab_mrna_DefenseAdvancedResearchProjectsAgencyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DARPA</link:label>
    <link:label id="lab_mrna_DefenseAdvancedResearchProjectsAgencyMember_label_en-US" xlink:label="lab_mrna_DefenseAdvancedResearchProjectsAgencyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defense Advanced Research Projects Agency [Member]</link:label>
    <link:label id="lab_mrna_DefenseAdvancedResearchProjectsAgencyMember_documentation_en-US" xlink:label="lab_mrna_DefenseAdvancedResearchProjectsAgencyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defense Advanced Research Projects Agency [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DefenseAdvancedResearchProjectsAgencyMember" xlink:href="mrna-20201231.xsd#mrna_DefenseAdvancedResearchProjectsAgencyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DefenseAdvancedResearchProjectsAgencyMember" xlink:to="lab_mrna_DefenseAdvancedResearchProjectsAgencyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_FiveHundredTechnologySquareMember_573df753-5e5d-432e-9d92-94790320446d_terseLabel_en-US" xlink:label="lab_mrna_FiveHundredTechnologySquareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">500&#160;Technology Square</link:label>
    <link:label id="lab_mrna_FiveHundredTechnologySquareMember_label_en-US" xlink:label="lab_mrna_FiveHundredTechnologySquareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Hundred&#160;Technology Square [Member]</link:label>
    <link:label id="lab_mrna_FiveHundredTechnologySquareMember_documentation_en-US" xlink:label="lab_mrna_FiveHundredTechnologySquareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Hundred&#160;Technology Square [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FiveHundredTechnologySquareMember" xlink:href="mrna-20201231.xsd#mrna_FiveHundredTechnologySquareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_FiveHundredTechnologySquareMember" xlink:to="lab_mrna_FiveHundredTechnologySquareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_92011c85-7d9a-42a4-bf51-10e4540b987f_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained through lease modifications and reassessments</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RevenueFromGrantsRemainingFundingCapacity_3530673f-16bb-4bda-940d-990c05d9935d_terseLabel_en-US" xlink:label="lab_mrna_RevenueFromGrantsRemainingFundingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available funding</link:label>
    <link:label id="lab_mrna_RevenueFromGrantsRemainingFundingCapacity_label_en-US" xlink:label="lab_mrna_RevenueFromGrantsRemainingFundingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Grants, Remaining Funding Capacity</link:label>
    <link:label id="lab_mrna_RevenueFromGrantsRemainingFundingCapacity_documentation_en-US" xlink:label="lab_mrna_RevenueFromGrantsRemainingFundingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Grants, Remaining Funding Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsRemainingFundingCapacity" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsRemainingFundingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RevenueFromGrantsRemainingFundingCapacity" xlink:to="lab_mrna_RevenueFromGrantsRemainingFundingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_14b9a0d6-f304-4390-8e07-a01c28839d9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled/forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_16fefa78-eac0-4720-bdf0-60066aeb54c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_a90897c5-5456-41ef-88b9-2a11abaaff7f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of match</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_da011622-2298-43e2-b056-1923baaa67ff_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_a6e3cf03-3ba8-4bfb-871e-9a1b6e31ca77_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_4c1b19d6-c193-48f7-9c24-baee13dd8c6c_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c397df3f-d74d-47fa-90c7-7b564b0fecf7_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_4841a869-f013-4e73-9a1b-57d9e8263656_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_8d285155-da74-4320-a8e9-7a3b6bee61b1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_0d468064-0062-48de-995c-c228fee2eceb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b2a7cb4b-9efb-4e41-a07b-fe1467682456_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_e0b6fc1b-2b68-4116-8bd1-15e512f7f098_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment expenses</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseLiability_4840cbdf-44f1-48b6-9a04-f2c7ea1eedd5_totalLabel_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseLiability_label_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability</link:label>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseLiability_documentation_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseLiability" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OperatingAndFinanceLeaseLiability" xlink:to="lab_mrna_OperatingAndFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9565d6f9-2719-4a51-bd3b-443192714fea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_dc4af596-6626-45d7-a4f4-fe693361cc34_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e40d24f4-3787-45e9-b254-a452d7fe2dc4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts representing interest or imputed interest, finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_9f41ebfa-c540-4232-a559-896e4997db0b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amounts representing interest or imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d52a97b2-ad6b-4e0b-9a41-65159504beb1_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods_61eb3f3b-4dad-4218-960e-ba4e4011b3a4_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of extension periods</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Number Of Extension Periods</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Number Of Extension Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OtherGrantRevenueMember_53261fca-f33c-436d-bfbf-7505292b3c41_terseLabel_en-US" xlink:label="lab_mrna_OtherGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Grant Revenue</link:label>
    <link:label id="lab_mrna_OtherGrantRevenueMember_label_en-US" xlink:label="lab_mrna_OtherGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Grant Revenue [Member]</link:label>
    <link:label id="lab_mrna_OtherGrantRevenueMember_documentation_en-US" xlink:label="lab_mrna_OtherGrantRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Grant Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OtherGrantRevenueMember" xlink:href="mrna-20201231.xsd#mrna_OtherGrantRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OtherGrantRevenueMember" xlink:to="lab_mrna_OtherGrantRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_6f86fde3-d776-4ef2-a484-aa279ab5c6ef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_6379841f-c34c-44fb-80c1-82d35011dbbd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_5d0e5d34-a72a-4bcd-9967-5570e332271e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, non-current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4e627d1d-1954-4ddf-a0ae-1064d04a59cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_d3a33947-5756-469f-9cb6-1ad3102fa3ae_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_402a3181-2b73-4feb-bcc2-a3be3e203624_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_0edfeaef-ddaa-4ba3-94d0-2f6386883392_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a70f07b1-0b71-4728-a875-3c161d19cac5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_fe3dc19b-5fa4-4b48-b434-dc2357f43973_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets, net of valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_bfee167d-d358-4ace-9241-c596064e1b03_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price at which shares are sold, percent</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_c23639e8-865d-4c32-87f7-edb6c98d01d4_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Milestone [Axis]</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Milestone [Axis]</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Milestone [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_1b93d930-60e2-4d23-8d03-2515a74bb28b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesHPreferredStockMember_0ac5975a-9482-4265-b0f5-7aae721382d3_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesHPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series&#160;H Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesHPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesHPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series H Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesHPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesHPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesHPreferredStockMember" xlink:to="lab_us-gaap_SeriesHPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_5471e2bb-ec8d-4d31-a019-923610f0f497_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_91a8410e-7404-4833-8cef-f3b748230e62_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_879e0487-a8fc-450c-af8b-5b19bfd2b337_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_MTCNorthMember_3a6bc6b3-8ff0-4b8b-b340-4d46bcc78e73_terseLabel_en-US" xlink:label="lab_mrna_MTCNorthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MTC North [Member]</link:label>
    <link:label id="lab_mrna_MTCNorthMember_label_en-US" xlink:label="lab_mrna_MTCNorthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MTC North [Member]</link:label>
    <link:label id="lab_mrna_MTCNorthMember_documentation_en-US" xlink:label="lab_mrna_MTCNorthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MTC North</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MTCNorthMember" xlink:href="mrna-20201231.xsd#mrna_MTCNorthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_MTCNorthMember" xlink:to="lab_mrna_MTCNorthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember_2a75ffde-f7cb-416f-8bfe-836a18b6e533_terseLabel_en-US" xlink:label="lab_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 A&amp;R Agreements</link:label>
    <link:label id="lab_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember_label_en-US" xlink:label="lab_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended And Restated Option Agreement Related Amended And Restated Services And Collaboration Agreement With AstraZeneca [Member]</link:label>
    <link:label id="lab_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember_documentation_en-US" xlink:label="lab_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended And Restated Option Agreement Related Amended And Restated Services And Collaboration Agreement With AstraZeneca [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember" xlink:href="mrna-20201231.xsd#mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember" xlink:to="lab_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_98f9d516-0934-4d49-b80f-a2d10abad7c9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_31b75e76-dc15-48e5-b2cf-28cc3424feb7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carry-forwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_VertexAgreements1Member_e0483e9a-134e-461c-a971-804318b3284a_terseLabel_en-US" xlink:label="lab_mrna_VertexAgreements1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex Agreements 1</link:label>
    <link:label id="lab_mrna_VertexAgreements1Member_label_en-US" xlink:label="lab_mrna_VertexAgreements1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex Agreements 1 [Member]</link:label>
    <link:label id="lab_mrna_VertexAgreements1Member_documentation_en-US" xlink:label="lab_mrna_VertexAgreements1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex Agreements 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreements1Member" xlink:href="mrna-20201231.xsd#mrna_VertexAgreements1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_VertexAgreements1Member" xlink:to="lab_mrna_VertexAgreements1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_675e3a5e-d422-4e78-9356-69490985d0fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled/forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RawMaterialsAccountsPayable_cebc88e2-4f36-4add-807e-eab201cf292a_terseLabel_en-US" xlink:label="lab_mrna_RawMaterialsAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_mrna_RawMaterialsAccountsPayable_label_en-US" xlink:label="lab_mrna_RawMaterialsAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw Materials, Accounts Payable</link:label>
    <link:label id="lab_mrna_RawMaterialsAccountsPayable_documentation_en-US" xlink:label="lab_mrna_RawMaterialsAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw Materials, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RawMaterialsAccountsPayable" xlink:href="mrna-20201231.xsd#mrna_RawMaterialsAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RawMaterialsAccountsPayable" xlink:to="lab_mrna_RawMaterialsAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_2dc04ea9-8012-45c2-9ab0-2d9f0e57c069_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_583d15a7-3ce6-43c0-94be-584fb140f0c9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f53e9e77-ccaa-4e27-8f30-92ffd1469e0d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_66e492c1-a64f-4465-9fd2-195ea7018ef2_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e6db7365-adc7-4f81-8cce-862a937d075f_verboseLabel_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_label_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract with Customer Liability, Current [Roll Forward]</link:label>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_documentation_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract with Customer Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward" xlink:to="lab_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_VertexAgreementsMember_496feb71-54fc-49ee-a02f-3ab6456824dc_terseLabel_en-US" xlink:label="lab_mrna_VertexAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex Agreements</link:label>
    <link:label id="lab_mrna_VertexAgreementsMember_label_en-US" xlink:label="lab_mrna_VertexAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex Agreements [Member]</link:label>
    <link:label id="lab_mrna_VertexAgreementsMember_documentation_en-US" xlink:label="lab_mrna_VertexAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreementsMember" xlink:href="mrna-20201231.xsd#mrna_VertexAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_VertexAgreementsMember" xlink:to="lab_mrna_VertexAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_13312d2d-356d-4835-b036-d8ba8015614c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2e56acda-1edc-4473-9358-72e93fdcd38b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_da7ce690-bcaf-45ea-84d8-4927fd3ad83c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_8e8a7a26-f589-45d5-a819-cf8e8a2a177a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount_74e0bcb6-1d48-482f-834e-81abb608a0f3_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial milestone payments</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Commercial Milestones, Maximum Amount</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Commercial Milestones, Maximum Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ToxicityMilestonesMember_e389d7a6-cda2-4218-9c36-b07d8e73967c_terseLabel_en-US" xlink:label="lab_mrna_ToxicityMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toxicity milestone payment</link:label>
    <link:label id="lab_mrna_ToxicityMilestonesMember_label_en-US" xlink:label="lab_mrna_ToxicityMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toxicity Milestones [Member]</link:label>
    <link:label id="lab_mrna_ToxicityMilestonesMember_documentation_en-US" xlink:label="lab_mrna_ToxicityMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Toxicity Milestones [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ToxicityMilestonesMember" xlink:href="mrna-20201231.xsd#mrna_ToxicityMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ToxicityMilestonesMember" xlink:to="lab_mrna_ToxicityMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_fe444cbf-bea4-4788-834a-26514aea3b15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_da56d71a-7b27-40bc-ac6f-96daed05e322_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3d606879-485f-4457-bbf5-fef038442677_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled/forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_NumberOfVaccineDoses_0ef14a7f-8a43-4ac9-8ea5-af41ae23b271_terseLabel_en-US" xlink:label="lab_mrna_NumberOfVaccineDoses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of vaccine doses</link:label>
    <link:label id="lab_mrna_NumberOfVaccineDoses_label_en-US" xlink:label="lab_mrna_NumberOfVaccineDoses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Vaccine Doses</link:label>
    <link:label id="lab_mrna_NumberOfVaccineDoses_documentation_en-US" xlink:label="lab_mrna_NumberOfVaccineDoses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Vaccine Doses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NumberOfVaccineDoses" xlink:href="mrna-20201231.xsd#mrna_NumberOfVaccineDoses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_NumberOfVaccineDoses" xlink:to="lab_mrna_NumberOfVaccineDoses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_93d5b0dd-b4a0-40eb-ad45-bb456b03922a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b91b108a-bb6c-4edc-8a2d-e8ab4bfedbf8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_dc9d33ae-79c8-4468-af09-5fd1e025b6ca_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_51310cb0-0b08-4d31-a0ff-9fcbf1373851_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_18398170-d7bd-439f-bea8-3e3ffbbe2b76_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_9cfb6f0c-c26d-45e5-a55c-3fd29b94846e_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_6f7f179c-2fda-4c3f-8361-e46eb4a169a1_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_e09da002-11ea-4966-94cc-6424a85ca1e9_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_529f8946-254e-47e0-8e05-bb7192ca930b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.0001; 1,600,000,000 shares authorized as of December&#160;31, 2020 and 2019; 398,787,678 and 336,536,985 shares issued and outstanding as of December&#160;31, 2020 and 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_7c06a19c-8274-4709-811f-f67b2ae141e4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OperatingLeaseLiabilities_d6ecc158-7997-4967-a591-188572c2cc76_terseLabel_en-US" xlink:label="lab_mrna_OperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_mrna_OperatingLeaseLiabilities_label_en-US" xlink:label="lab_mrna_OperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liabilities</link:label>
    <link:label id="lab_mrna_OperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_mrna_OperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLeaseLiabilities" xlink:href="mrna-20201231.xsd#mrna_OperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OperatingLeaseLiabilities" xlink:to="lab_mrna_OperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_a395b279-98b6-41f4-9f82-23975b3f2640_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ed6e652c-9a1c-4a25-afbe-271ce2d02dd5_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_66bb0957-9202-4c71-b2d6-40fe31890e82_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per share (usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee_9732feb3-fb0e-4b1e-b4b5-454a2b8bfed1_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option exercise fee</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Option Exercise Fee</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Option Exercise Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_c1972981-13f2-4a9a-91f6-19fe06b7ed6a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_312bf242-3aab-47cd-abde-738505c0a3bc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_CustomerDepositsMember_475449e9-3c24-4159-a40d-59dcbf25eccd_terseLabel_en-US" xlink:label="lab_mrna_CustomerDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer deposits</link:label>
    <link:label id="lab_mrna_CustomerDepositsMember_label_en-US" xlink:label="lab_mrna_CustomerDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Deposits [Member]</link:label>
    <link:label id="lab_mrna_CustomerDepositsMember_documentation_en-US" xlink:label="lab_mrna_CustomerDepositsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CustomerDepositsMember" xlink:href="mrna-20201231.xsd#mrna_CustomerDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_CustomerDepositsMember" xlink:to="lab_mrna_CustomerDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ed065703-dbdc-4928-b13f-5f4612e76b3a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b172b09f-9be8-4707-9e40-60bc1d48e53c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_21fb0381-88e3-4733-a457-de88280040b6_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_1ed0a7d8-7a4d-4f05-97c0-7f81eba63562_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_SeparateAgreementsWithMerckMember_ac87bdf6-6034-40fe-b1a9-096c11b89d8b_terseLabel_en-US" xlink:label="lab_mrna_SeparateAgreementsWithMerckMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate agreements with Merck</link:label>
    <link:label id="lab_mrna_SeparateAgreementsWithMerckMember_label_en-US" xlink:label="lab_mrna_SeparateAgreementsWithMerckMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Agreements With Merck [Member]</link:label>
    <link:label id="lab_mrna_SeparateAgreementsWithMerckMember_documentation_en-US" xlink:label="lab_mrna_SeparateAgreementsWithMerckMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Agreements With Merck [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SeparateAgreementsWithMerckMember" xlink:href="mrna-20201231.xsd#mrna_SeparateAgreementsWithMerckMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_SeparateAgreementsWithMerckMember" xlink:to="lab_mrna_SeparateAgreementsWithMerckMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_dc9477b1-f8dd-4661-8f47-44e2e43b3d20_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3350526a-be66-40b0-8e31-e3db0bf38f94_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_d4752b96-53fa-4010-bafe-608951c65794_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain_a4b8ed30-5a61-47f3-b70b-5396fa39be97_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:to="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesDPreferredStockMember_ae032ccc-6086-4590-b11a-7f71af90a832_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesDPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series&#160;D Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesDPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesDPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesDPreferredStockMember" xlink:to="lab_us-gaap_SeriesDPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_f3a68d5e-530e-4df6-9593-5d3eaedc5906_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Axis]</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:to="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_39e1a539-b8fd-40f9-b0a2-4ef9dcbfa2fd_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_bd821d85-5adc-4545-9114-923414f4bdfd_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e414cea6-b658-40a1-9ced-90eb9b35aa9d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d066a77e-b54c-4a39-a44c-31628a9ae3d9_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c72c47b3-e210-47f8-8564-e0aeb75dec84_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_LeasesIncrementalBorrowingRate_fe0042ff-b957-4b94-9853-cebeb08d3b55_terseLabel_en-US" xlink:label="lab_mrna_LeasesIncrementalBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental borrowing rate</link:label>
    <link:label id="lab_mrna_LeasesIncrementalBorrowingRate_label_en-US" xlink:label="lab_mrna_LeasesIncrementalBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Incremental Borrowing Rate</link:label>
    <link:label id="lab_mrna_LeasesIncrementalBorrowingRate_documentation_en-US" xlink:label="lab_mrna_LeasesIncrementalBorrowingRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Incremental Borrowing Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LeasesIncrementalBorrowingRate" xlink:href="mrna-20201231.xsd#mrna_LeasesIncrementalBorrowingRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_LeasesIncrementalBorrowingRate" xlink:to="lab_mrna_LeasesIncrementalBorrowingRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_AccruedManufacturing_8a94ee48-17b7-43f0-b494-608df7c92935_terseLabel_en-US" xlink:label="lab_mrna_AccruedManufacturing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing</link:label>
    <link:label id="lab_mrna_AccruedManufacturing_label_en-US" xlink:label="lab_mrna_AccruedManufacturing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Manufacturing</link:label>
    <link:label id="lab_mrna_AccruedManufacturing_documentation_en-US" xlink:label="lab_mrna_AccruedManufacturing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Manufacturing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedManufacturing" xlink:href="mrna-20201231.xsd#mrna_AccruedManufacturing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_AccruedManufacturing" xlink:to="lab_mrna_AccruedManufacturing" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_64ae293d-f09d-476c-8f4f-958ebd4ec399_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_fbf78cb5-9981-4238-9fd8-2e41238d4f45_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation-related</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_fca1a120-6261-449b-a214-853d3b0c58e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_83760a54-ef79-48fd-85c1-6e36f87061e2_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Common Stock Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_4f9298c5-4dd9-4f15-94da-ddd2174d9ec2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted common stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_1f377611-b5b6-4d0d-8a51-b3f67ad04e81_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum percentage of compensation through payroll deductions</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_f6347be4-c0e3-4906-8292-2b46f5c58caf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_e91b4da7-61a8-496e-9b93-be436623dedc_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_1adc3fcb-de39-4c17-998f-0fa38ce031b1_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_59eb5e40-cbad-463c-857b-a3002ece547b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short term lease costs</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_98825bac-1701-4ffb-beb1-eb06279dcdb9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockRedemptionPremium_8c572bcc-ee33-47dc-9d8d-41fece049ad4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockRedemptionPremium" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium paid on repurchase of preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockRedemptionPremium_label_en-US" xlink:label="lab_us-gaap_PreferredStockRedemptionPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock Redemption Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockRedemptionPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockRedemptionPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockRedemptionPremium" xlink:to="lab_us-gaap_PreferredStockRedemptionPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_c0a9904d-b3f8-49a7-8b6c-6869d2d26831_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_086e0dcb-4cb4-44ef-8ee0-1a5c34c92601_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a4a9d9bf-5f38-48c1-8594-28a20defe44f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_f9fac599-e1d1-415f-9281-5e6d0d5ba057_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_9694ebbc-a80e-48bd-b228-cada2906a921_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RightOfUseAssetOperatingLeases_bd9dc8ad-1cc0-48ca-b13c-251f9d70308a_negatedTerseLabel_en-US" xlink:label="lab_mrna_RightOfUseAssetOperatingLeases" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets, operating leases</link:label>
    <link:label id="lab_mrna_RightOfUseAssetOperatingLeases_label_en-US" xlink:label="lab_mrna_RightOfUseAssetOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Operating Leases</link:label>
    <link:label id="lab_mrna_RightOfUseAssetOperatingLeases_documentation_en-US" xlink:label="lab_mrna_RightOfUseAssetOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RightOfUseAssetOperatingLeases" xlink:href="mrna-20201231.xsd#mrna_RightOfUseAssetOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RightOfUseAssetOperatingLeases" xlink:to="lab_mrna_RightOfUseAssetOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_8be89fe2-c377-4f00-931f-9d75ff825cfc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_3f2c8cb0-0e7d-4f53-a308-3acda2eba8e4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent_37a87540-2458-4705-965e-8d94430bd348_totalLabel_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-current lease liabilities</link:label>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent" xlink:to="lab_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward_af8d4737-1e53-48ab-a8f4-b46d5f437564_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value per Share</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value [Roll Forward]</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_78d4359b-13a1-4402-bed2-beec3069ca78_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_CommercialMilestonesMember_2b493fa8-d9e5-4e2f-86d3-0f27ef9cbfdf_terseLabel_en-US" xlink:label="lab_mrna_CommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Milestones</link:label>
    <link:label id="lab_mrna_CommercialMilestonesMember_label_en-US" xlink:label="lab_mrna_CommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Milestones [Member]</link:label>
    <link:label id="lab_mrna_CommercialMilestonesMember_documentation_en-US" xlink:label="lab_mrna_CommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Milestones [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CommercialMilestonesMember" xlink:href="mrna-20201231.xsd#mrna_CommercialMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_CommercialMilestonesMember" xlink:to="lab_mrna_CommercialMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod_f0a70e65-94ca-41aa-8298-55e69e6886e3_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering period</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Consecutive Offering Period</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Consecutive Offering Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0e467f45-c63d-4d7f-9786-72263a4862ce_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_0968c1e7-9502-4619-90bb-8a949d450f89_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e2fa17a3-8414-4a7b-875e-d422b5fa71a4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_1fd7427f-a6a7-40d2-9b6a-e25add91563c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_87407182-5bc3-41e9-a112-fbb431a0e2c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Components of Deferred Tax Assets and Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a6873ba9-717b-4aae-b6dc-7df8e6f874ed_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_6bee9e80-8b5d-42a9-a5ea-efd308ee39d9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f6823943-ca11-4f6a-8f17-36b1ce476a71_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_38c18ca7-5d30-444f-b640-2e39e3c57e31_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod_00f6e9f4-1c71-4a59-85a2-f869b1fe8939_terseLabel_en-US" xlink:label="lab_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod_label_en-US" xlink:label="lab_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Decrease During Period</link:label>
    <link:label id="lab_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod_documentation_en-US" xlink:label="lab_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Decrease During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod" xlink:to="lab_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_9e680bbb-5c92-419d-ac5b-ceceb521ef76_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_818da4e7-6e7d-4c4c-9c0e-1b1bddea2372_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internally developed software</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_403d989b-4d41-4c1a-b842-bf7616088b4e_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DeferredTaxAssetsFinancingLeaseLiability_39dcbbee-4df9-4ac9-aaf1-891dcbe623e1_terseLabel_en-US" xlink:label="lab_mrna_DeferredTaxAssetsFinancingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease financing obligation</link:label>
    <link:label id="lab_mrna_DeferredTaxAssetsFinancingLeaseLiability_label_en-US" xlink:label="lab_mrna_DeferredTaxAssetsFinancingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Financing Lease, Liability</link:label>
    <link:label id="lab_mrna_DeferredTaxAssetsFinancingLeaseLiability_documentation_en-US" xlink:label="lab_mrna_DeferredTaxAssetsFinancingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Financing Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsFinancingLeaseLiability" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsFinancingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DeferredTaxAssetsFinancingLeaseLiability" xlink:to="lab_mrna_DeferredTaxAssetsFinancingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_15241d6f-8f95-4e54-8919-9dc28cd00e30_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Termination Period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Termination Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_253126bf-0fd3-4d2b-bc75-089ec7b2957f_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible items</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_9679b167-caba-4177-b8e4-b433be18b642_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_7da48ce8-8342-4e93-8612-7a2c1c3800ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_8152d698-8edf-4088-bdb0-63de78f7fa28_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_06770897-a6f6-44a6-ae13-04d8ce99d857_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_2a93fd31-60a8-48c5-9e40-033c48376d7d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign tax rate differential</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_2bba738d-9d11-4aca-965e-9ed1795dab4f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_1846c5db-6a37-46e8-83d9-c0cf36fd22ad_terseLabel_en-US" xlink:label="lab_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PCV Agreement</link:label>
    <link:label id="lab_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_label_en-US" xlink:label="lab_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personalized MRNA Cancer Vaccines (PCV) Collaboration And License Agreement With Merck Sharp&#160;And Dohme Corp [Member]</link:label>
    <link:label id="lab_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_documentation_en-US" xlink:label="lab_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personalized MRNA Cancer Vaccines (PCV) Collaboration And License Agreement With Merck Sharp&#160;And Dohme Corp [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember" xlink:href="mrna-20201231.xsd#mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember" xlink:to="lab_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_0e0623d2-49d6-4b33-8233-8a58c7a05e33_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total matching contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_78d86891-6949-4c83-8262-26223a6fd7d9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, discount rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_fb86789c-5d1e-4f88-a054-d91d31fffbb5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_f3372b41-53c9-44ee-8794-ad5b68e3bf80_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ProductSalesMember_5c87b059-9b74-4bcb-af0b-f60da054f004_terseLabel_en-US" xlink:label="lab_mrna_ProductSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales</link:label>
    <link:label id="lab_mrna_ProductSalesMember_label_en-US" xlink:label="lab_mrna_ProductSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Sales [Member]</link:label>
    <link:label id="lab_mrna_ProductSalesMember_documentation_en-US" xlink:label="lab_mrna_ProductSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ProductSalesMember" xlink:href="mrna-20201231.xsd#mrna_ProductSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ProductSalesMember" xlink:to="lab_mrna_ProductSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans_b6b79704-d122-4d78-bfc7-ccc47e2983c0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from purchase of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Repayment of Loans by Employee Stock Ownership Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans" xlink:to="lab_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_9fb46e38-9f69-4cd8-ad64-384a809f2afc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_c3fe90d5-8347-4149-bfcb-efafd4f294da_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_MerckMember_6c8f3c8c-62b2-4f8e-8955-5d8757a18073_terseLabel_en-US" xlink:label="lab_mrna_MerckMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck</link:label>
    <link:label id="lab_mrna_MerckMember_label_en-US" xlink:label="lab_mrna_MerckMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck [Member]</link:label>
    <link:label id="lab_mrna_MerckMember_documentation_en-US" xlink:label="lab_mrna_MerckMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckMember" xlink:href="mrna-20201231.xsd#mrna_MerckMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_MerckMember" xlink:to="lab_mrna_MerckMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ca34d57e-d97f-4487-b9e2-7a5e944cbfbc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options to purchase common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a2ca7af3-2fc3-4b4f-809a-209192dd3398_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2cfa950f-c464-4baf-85c0-9ffe648bbf63_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_VertexFirstMember_b39e340c-49c7-415b-9b74-0325ac90ef81_terseLabel_en-US" xlink:label="lab_mrna_VertexFirstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex First Extended Research Term</link:label>
    <link:label id="lab_mrna_VertexFirstMember_label_en-US" xlink:label="lab_mrna_VertexFirstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex First [Member]</link:label>
    <link:label id="lab_mrna_VertexFirstMember_documentation_en-US" xlink:label="lab_mrna_VertexFirstMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex First</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexFirstMember" xlink:href="mrna-20201231.xsd#mrna_VertexFirstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_VertexFirstMember" xlink:to="lab_mrna_VertexFirstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross_3235c521-adee-4d5c-998d-e7355b0520f5_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses associated with license agreements</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_0ddf5677-6e69-4126-96f1-6de618781d2f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_46b1d0aa-f0d0-45a2-8d64-4a6fd41a5205_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_f0aee5fd-a169-45a4-8fe2-3a4c9be16486_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_53884ec7-6e52-44cc-ac2d-71005762bf59_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_259c2ea0-6d9e-41d5-831b-96a7dc373b91_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of AFS securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_MerckAgreement2015Member_920c47fd-7fdc-40cd-9587-ac39b8baa94a_verboseLabel_en-US" xlink:label="lab_mrna_MerckAgreement2015Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck agreement 2015</link:label>
    <link:label id="lab_mrna_MerckAgreement2015Member_ab0c1cab-c06a-4343-a9cb-1e72d6e11212_terseLabel_en-US" xlink:label="lab_mrna_MerckAgreement2015Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration revenue under the 2015 Merck Agreement</link:label>
    <link:label id="lab_mrna_MerckAgreement2015Member_label_en-US" xlink:label="lab_mrna_MerckAgreement2015Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck Agreement 2015 [Member]</link:label>
    <link:label id="lab_mrna_MerckAgreement2015Member_documentation_en-US" xlink:label="lab_mrna_MerckAgreement2015Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck Agreement 2015 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckAgreement2015Member" xlink:href="mrna-20201231.xsd#mrna_MerckAgreement2015Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_MerckAgreement2015Member" xlink:to="lab_mrna_MerckAgreement2015Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_24ad9206-a38e-4d84-9e45-99d2347783a8_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a473a679-2417-41a7-a9b7-c5333fc45b2d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_13778103-9a41-4e3e-9c6b-67b448ccadbf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_9914b763-ce62-4532-84ad-197c6de7f361_terseLabel_en-US" xlink:label="lab_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex Agreement</link:label>
    <link:label id="lab_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_label_en-US" xlink:label="lab_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Collaboration And License Agreement, With Vertex Pharmaceuticals Incorporated, And Vertex Pharmaceuticals (Europe) Limited [Member]</link:label>
    <link:label id="lab_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_documentation_en-US" xlink:label="lab_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Collaboration And License Agreement, With Vertex Pharmaceuticals Incorporated, And Vertex Pharmaceuticals (Europe) Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember" xlink:href="mrna-20201231.xsd#mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember" xlink:to="lab_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b57dbf55-653f-4e58-9f8c-3ce3c474cd3f_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Description of Business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_f48234be-da5c-4e01-bc5f-4f8d098e8bc7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_9bbb88f9-1b85-43c4-8011-9ea5cf640f37_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_8233a17e-35f7-4ab3-9b5e-630ad97c0fd7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OncologyDevelopmentTargetPerformanceObligationMember_55b393ee-0cb7-4091-ba0f-de6535fffaf9_terseLabel_en-US" xlink:label="lab_mrna_OncologyDevelopmentTargetPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preclinical development service - oncology development target</link:label>
    <link:label id="lab_mrna_OncologyDevelopmentTargetPerformanceObligationMember_label_en-US" xlink:label="lab_mrna_OncologyDevelopmentTargetPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology Development Target Performance Obligation [Member]</link:label>
    <link:label id="lab_mrna_OncologyDevelopmentTargetPerformanceObligationMember_documentation_en-US" xlink:label="lab_mrna_OncologyDevelopmentTargetPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology Development Target Performance Obligation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OncologyDevelopmentTargetPerformanceObligationMember" xlink:href="mrna-20201231.xsd#mrna_OncologyDevelopmentTargetPerformanceObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OncologyDevelopmentTargetPerformanceObligationMember" xlink:to="lab_mrna_OncologyDevelopmentTargetPerformanceObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_18bbb375-4677-4a2a-a42c-b60d7652236c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_e2d4c7d8-748d-4616-9e76-0f313233aa09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Common Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_ca7140e7-a43e-4bde-bc11-6ad2594ac84d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_cb811b08-ca7c-4205-9f0f-997eef588d06_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_0a64c629-6d4c-4e9c-8f0d-37efd6078755_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_4a99ddd5-f00b-431f-ac45-77300bb935cc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_ab52826e-9ef1-412f-8c40-d876f22cb6e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ChargesToFinancingLeaseLiabilities_7bc2f390-29f6-4085-a1bd-406e09d3c6ee_terseLabel_en-US" xlink:label="lab_mrna_ChargesToFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges to financing lease liabilities</link:label>
    <link:label id="lab_mrna_ChargesToFinancingLeaseLiabilities_label_en-US" xlink:label="lab_mrna_ChargesToFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges To Financing Lease Liabilities</link:label>
    <link:label id="lab_mrna_ChargesToFinancingLeaseLiabilities_documentation_en-US" xlink:label="lab_mrna_ChargesToFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges To Financing Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChargesToFinancingLeaseLiabilities" xlink:href="mrna-20201231.xsd#mrna_ChargesToFinancingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ChargesToFinancingLeaseLiabilities" xlink:to="lab_mrna_ChargesToFinancingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_23276717-9382-4372-be98-fec7a36f3def_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b538eda5-aab8-41bf-924c-2365dda2a622_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_1d257af7-04ec-4f55-8184-488a60d9dfa3_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_EmbeddedLeasesMember_ab684413-2b57-4123-82d7-20b2043fc940_terseLabel_en-US" xlink:label="lab_mrna_EmbeddedLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Leases</link:label>
    <link:label id="lab_mrna_EmbeddedLeasesMember_label_en-US" xlink:label="lab_mrna_EmbeddedLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Leases [Member]</link:label>
    <link:label id="lab_mrna_EmbeddedLeasesMember_documentation_en-US" xlink:label="lab_mrna_EmbeddedLeasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EmbeddedLeasesMember" xlink:href="mrna-20201231.xsd#mrna_EmbeddedLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_EmbeddedLeasesMember" xlink:to="lab_mrna_EmbeddedLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_134311d0-22d9-4a09-ab50-af197bcf6b47_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses related to indemnification obligations</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_17a68017-cc79-461d-9e51-67344641e72e_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_f8886004-af20-4475-ae50-2731f1dea2cd_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_407fe5c1-4d79-44b6-94cf-015e5fca6f12_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_SublicenseAgreementTermsMember_6048ce6f-b4a0-47ea-ae30-8f3a152cae8a_terseLabel_en-US" xlink:label="lab_mrna_SublicenseAgreementTermsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublicense agreement</link:label>
    <link:label id="lab_mrna_SublicenseAgreementTermsMember_label_en-US" xlink:label="lab_mrna_SublicenseAgreementTermsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublicense Agreement Terms [Member]</link:label>
    <link:label id="lab_mrna_SublicenseAgreementTermsMember_documentation_en-US" xlink:label="lab_mrna_SublicenseAgreementTermsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublicense Agreement Terms [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SublicenseAgreementTermsMember" xlink:href="mrna-20201231.xsd#mrna_SublicenseAgreementTermsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_SublicenseAgreementTermsMember" xlink:to="lab_mrna_SublicenseAgreementTermsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_44aa151e-e539-487e-8be9-3c8a1be7d76c_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ab141260-7c12-4a18-8892-129551accd11_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_a2a1edfe-deaa-4e98-b665-e95f0e1a1555_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c0ac9891-001b-4c7a-ac51-9f6410aa6fda_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_9b3a54fa-90ec-4453-91fa-3dc007b16ad3_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_9d1da4b0-9723-45ce-aaeb-c77210ff69e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ChiesiAgreementTransactionPriceMember_3a675694-08bd-474d-b728-f778bdb6c7da_terseLabel_en-US" xlink:label="lab_mrna_ChiesiAgreementTransactionPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chiesi Agreement transaction price</link:label>
    <link:label id="lab_mrna_ChiesiAgreementTransactionPriceMember_label_en-US" xlink:label="lab_mrna_ChiesiAgreementTransactionPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chiesi Agreement Transaction Price [Member]</link:label>
    <link:label id="lab_mrna_ChiesiAgreementTransactionPriceMember_documentation_en-US" xlink:label="lab_mrna_ChiesiAgreementTransactionPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chiesi Agreement Transaction Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChiesiAgreementTransactionPriceMember" xlink:href="mrna-20201231.xsd#mrna_ChiesiAgreementTransactionPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ChiesiAgreementTransactionPriceMember" xlink:to="lab_mrna_ChiesiAgreementTransactionPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member_63a80997-e950-4929-a27b-10ddb159b815_terseLabel_en-US" xlink:label="lab_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 AZ Agreement</link:label>
    <link:label id="lab_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member_label_en-US" xlink:label="lab_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Strategic Alliance With AstraZeneca &#8211; IL12 [Member]</link:label>
    <link:label id="lab_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member_documentation_en-US" xlink:label="lab_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Strategic Alliance With AstraZeneca &#8211; IL12 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member" xlink:href="mrna-20201231.xsd#mrna_A2016StrategicAllianceWithAstraZenecaIL12Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member" xlink:to="lab_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_9f46eb9b-6974-4c1c-ac4b-e96fa7a2fe78_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_f1fc6e25-cf3c-4605-914f-6167c2c6a3ec_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_5cbf46ad-b141-4670-827d-223cc9e8c775_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Total Transaction Price to the Identified Performance Obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_03b54646-517d-4dc5-9bfb-051e6cd8c3ba_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Table]</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:to="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_e9da852b-250d-4156-9d06-381d0af3765e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b84b9e16-2116-4e04-9109-a900768f3992_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod_e19e5b61-bca3-4eaa-aa4c-57374ad24af7_terseLabel_en-US" xlink:label="lab_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod_label_en-US" xlink:label="lab_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Increase During Period</link:label>
    <link:label id="lab_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod_documentation_en-US" xlink:label="lab_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Increase During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod" xlink:to="lab_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_438dd76e-13fd-4f27-b34a-b9a4c461bb79_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_6f772401-485e-4f8e-858b-410c26e5e1b2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b3d3f892-df3e-449a-9cd5-26e833410730_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_efdc00a9-a69a-4e66-9978-460a42dd1c7f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_94293ef1-7a10-406c-8921-2b117b0a5e00_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_c6d61642-dc5d-4738-b571-a7511d200647_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_712dfe29-5ad3-439a-8ed4-bbd586f22287_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_d79ab058-e820-43cb-9e48-b2fba8b31b3c_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_b70397c4-237f-430c-bd1d-f63f24108891_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase to the transaction price</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_64ad80b9-f4eb-4b23-b709-356ad8073b41_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease to the transaction price</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0c8fd4bd-4e51-4102-9cfa-9f10206aa364_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_766b3b6b-b8f4-4f4b-a629-f2f35e358de2_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b5ab3905-11df-4a12-9fc7-72128ad6d77a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7f3331bb-c5f4-49be-87c7-19196ff25244_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments_19981966-2b63-4605-afae-3db925d4ccec_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of installments</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period, Number Of Installments</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period, Number Of Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RevenueFromGrantsNumberOfContractOptionsExercised_4b6574e7-ae0f-4b15-b60b-c43c8ec35038_terseLabel_en-US" xlink:label="lab_mrna_RevenueFromGrantsNumberOfContractOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of contract options exercised</link:label>
    <link:label id="lab_mrna_RevenueFromGrantsNumberOfContractOptionsExercised_label_en-US" xlink:label="lab_mrna_RevenueFromGrantsNumberOfContractOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Grants, Number Of Contract Options Exercised</link:label>
    <link:label id="lab_mrna_RevenueFromGrantsNumberOfContractOptionsExercised_documentation_en-US" xlink:label="lab_mrna_RevenueFromGrantsNumberOfContractOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Grants, Number Of Contract Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsNumberOfContractOptionsExercised" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsNumberOfContractOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RevenueFromGrantsNumberOfContractOptionsExercised" xlink:to="lab_mrna_RevenueFromGrantsNumberOfContractOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_4c7e1f9a-fffd-473a-8fb6-8ea88bd711bb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_CurrentMarketableSecuritiesMember_c86744b7-516a-4207-8d08-be0e063ebae4_terseLabel_en-US" xlink:label="lab_mrna_CurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Marketable Securities</link:label>
    <link:label id="lab_mrna_CurrentMarketableSecuritiesMember_label_en-US" xlink:label="lab_mrna_CurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Marketable Securities [Member]</link:label>
    <link:label id="lab_mrna_CurrentMarketableSecuritiesMember_documentation_en-US" xlink:label="lab_mrna_CurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Marketable Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CurrentMarketableSecuritiesMember" xlink:href="mrna-20201231.xsd#mrna_CurrentMarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_CurrentMarketableSecuritiesMember" xlink:to="lab_mrna_CurrentMarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_d18fb4c3-9bc2-4965-af88-858ce4048327_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_aa83e82c-da37-4529-96c2-8d72f7d651a1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e883d68e-8675-4a87-9640-7795249358b1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_749e17ea-77a4-49b1-a0f4-19b210f724f6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_7c754d84-0e55-4433-ad6d-7bac06d4c8f8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_bad42e08-2da0-46da-966e-6d4b36375da9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_cc9299f6-fa09-4639-be0c-a6d3c5fa0550_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment, Excluding Long-term Commitment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:to="lab_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_944e3083-385c-4f10-b9bf-5262e358bd11_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_97f0851f-20bd-4117-880e-f35c43cfc693_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_33eb1b80-c003-4645-833b-b58523ffbac0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Composition of the Total Transaction</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Transactions Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:to="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_4f79af16-e0bd-463e-b4bb-9e068d44fd53_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Balances of Receivables and Contract Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0930e4c6-93dc-4ba6-93d1-ba74dc84139e_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member_024a5c24-626a-4773-9319-863c0b6ba887_terseLabel_en-US" xlink:label="lab_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance without adoption of ASC 605</link:label>
    <link:label id="lab_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member_label_en-US" xlink:label="lab_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Calculated under Revenue Guidance in Effect before Topic 606 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member" xlink:to="lab_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_63809f07-8ba1-472c-8740-c1bd1f6260c5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_dfbab20d-39d0-4ea1-ae2e-96e4fa944b0e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_a1e915fb-a505-4e99-8d68-f313592fd665_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent contributed by participant</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_375a0cb1-63cd-4bb4-b2d7-d4eaa5034444_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, non-current</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_bebe3d4f-315e-4fa9-8558-7af21114dfe9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Following twelve quarters</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_5d8f1ea5-d017-4e3a-bedb-aaa36db38c29_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_711f3cd2-057c-4a3f-86f5-f8d478ad36e4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e68c3a89-4ce7-4b53-9025-e84ac8e5cf4b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2e2abd6b-6781-4b70-99c2-9e277f724ce1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_751553f2-fe0d-49d5-9de1-2aa702aabf69_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_3de4e93f-f159-41d2-8bdf-8f8378e28a0c_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_75685177-ca0a-4921-85fd-940f80b3f837_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_fdb83eea-391a-436b-8eb1-da6b8d5b6505_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5c0b8abd-3ef9-4045-a5cc-befdddcd7a15_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets, operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_339f1bc2-c75b-487e-9653-055089202140_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets, operating, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_ecf44ffb-fd85-4709-8345-37fd61075ed2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c976a68d-e105-4c7c-998f-1a0b7d36703c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentFundingMember_7344a018-cbc2-4398-98af-dc70eed7bbed_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentFundingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentFundingMember_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentFundingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Funding [Member]</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentFundingMember_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentFundingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Funding [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentFundingMember" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentFundingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentFundingMember" xlink:to="lab_mrna_ResearchAndDevelopmentFundingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_TwoHundredTechnologySquareMember_ffd4e5e2-11f8-47d0-908f-99444748d869_terseLabel_en-US" xlink:label="lab_mrna_TwoHundredTechnologySquareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">200&#160;Technology Square</link:label>
    <link:label id="lab_mrna_TwoHundredTechnologySquareMember_label_en-US" xlink:label="lab_mrna_TwoHundredTechnologySquareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Hundred&#160;Technology Square [Member]</link:label>
    <link:label id="lab_mrna_TwoHundredTechnologySquareMember_documentation_en-US" xlink:label="lab_mrna_TwoHundredTechnologySquareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Hundred&#160;Technology Square</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TwoHundredTechnologySquareMember" xlink:href="mrna-20201231.xsd#mrna_TwoHundredTechnologySquareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_TwoHundredTechnologySquareMember" xlink:to="lab_mrna_TwoHundredTechnologySquareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_eb48b25b-2b1f-4733-be22-e35c5aa137e1_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_ea4a3836-bcd0-4ff5-9e4c-996fda6569fd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_7bffb630-31a6-46f0-b21f-6edc03c3d635_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_867f6534-d4be-4435-95a7-300bd2b5e7d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Options, Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_PaymentsForLeaseFinancingObligation_68da4287-73af-4f27-af37-ce1b2e702824_negatedTerseLabel_en-US" xlink:label="lab_mrna_PaymentsForLeaseFinancingObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on financing lease obligation</link:label>
    <link:label id="lab_mrna_PaymentsForLeaseFinancingObligation_label_en-US" xlink:label="lab_mrna_PaymentsForLeaseFinancingObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Lease Financing Obligation</link:label>
    <link:label id="lab_mrna_PaymentsForLeaseFinancingObligation_documentation_en-US" xlink:label="lab_mrna_PaymentsForLeaseFinancingObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Lease Financing Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PaymentsForLeaseFinancingObligation" xlink:href="mrna-20201231.xsd#mrna_PaymentsForLeaseFinancingObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_PaymentsForLeaseFinancingObligation" xlink:to="lab_mrna_PaymentsForLeaseFinancingObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c6247b58-5885-4ae6-993d-9b37f7955179_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_926bc11d-3972-4b44-aac0-627a16ac7231_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total collaboration revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a947237c-caf8-4b20-896d-c6131501358e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contract with customer, excluding assessed tax</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ContractWithCustomerAssetIncreaseDuringPeriod_67edd421-ba42-4035-b05c-11d7509bb275_terseLabel_en-US" xlink:label="lab_mrna_ContractWithCustomerAssetIncreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_mrna_ContractWithCustomerAssetIncreaseDuringPeriod_label_en-US" xlink:label="lab_mrna_ContractWithCustomerAssetIncreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Asset Increase During Period</link:label>
    <link:label id="lab_mrna_ContractWithCustomerAssetIncreaseDuringPeriod_documentation_en-US" xlink:label="lab_mrna_ContractWithCustomerAssetIncreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Asset Increase During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerAssetIncreaseDuringPeriod" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerAssetIncreaseDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ContractWithCustomerAssetIncreaseDuringPeriod" xlink:to="lab_mrna_ContractWithCustomerAssetIncreaseDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_2f920c52-e283-4d8f-9e6e-f09bc0bc17a4_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value per share (usd per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts_8c3baa5f-1d85-4cfb-8edc-05e1bf1c6a99_terseLabel_en-US" xlink:label="lab_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized licenses, research and development and start-up costs</link:label>
    <link:label id="lab_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts_label_en-US" xlink:label="lab_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Capitalized Licenses, Research And Development, And Start-Up Costs</link:label>
    <link:label id="lab_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts_documentation_en-US" xlink:label="lab_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Capitalized Licenses, Research And Development, And Start-Up Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts" xlink:to="lab_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_bcb4fcfd-17eb-44e5-9b12-79accbd4cae3_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c29971c9-51cc-4f62-8a98-8ac7e64cec3c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_d0adc8a0-3345-43ce-873d-c7529d62547a_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock_724bde99-92ae-487b-8c51-2849c32c6c6e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of redeemable convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_795d02a2-f1f1-4873-9331-582e544888be_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_CollaborationArrangementMember_81cd0be5-2f1e-4e86-9d13-778d32edcd8c_terseLabel_en-US" xlink:label="lab_mrna_CollaborationArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration revenue</link:label>
    <link:label id="lab_mrna_CollaborationArrangementMember_label_en-US" xlink:label="lab_mrna_CollaborationArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement [Member]</link:label>
    <link:label id="lab_mrna_CollaborationArrangementMember_documentation_en-US" xlink:label="lab_mrna_CollaborationArrangementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_CollaborationArrangementMember" xlink:to="lab_mrna_CollaborationArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_795014ca-e353-435e-bac7-b40f2404932f_negatedLabel_en-US" xlink:label="lab_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating right-of-use assets</link:label>
    <link:label id="lab_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease Right Of Use Asset</link:label>
    <link:label id="lab_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:to="lab_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_0635bcfc-67ea-46d6-8af6-4eb207a7c746_terseLabel_en-US" xlink:label="lab_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities of U.S. government agencies and corporate entities</link:label>
    <link:label id="lab_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies And Corporate Debt Securities [Member]</link:label>
    <link:label id="lab_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_documentation_en-US" xlink:label="lab_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies And Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember" xlink:href="mrna-20201231.xsd#mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember" xlink:to="lab_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_a28fc2d7-a10b-4f1c-99de-28c5a75746b7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_e43e27af-604c-49cb-8b6c-47984f559568_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_FinanceLeaseCost_b634b301-a2b3-410e-b9e2-1a73c18f3522_totalLabel_en-US" xlink:label="lab_mrna_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total financing lease costs</link:label>
    <link:label id="lab_mrna_FinanceLeaseCost_label_en-US" xlink:label="lab_mrna_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_mrna_FinanceLeaseCost_documentation_en-US" xlink:label="lab_mrna_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FinanceLeaseCost" xlink:href="mrna-20201231.xsd#mrna_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_FinanceLeaseCost" xlink:to="lab_mrna_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_78d8d5a2-e71d-4054-82cb-e8b24b868005_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders, basic and diluted (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a180afc2-c2fd-4ec8-af8a-544255bf0983_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesEPreferredStockMember_9ac2b22c-717e-4a1a-a4ff-f31e1b218a9a_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesEPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series&#160;E Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesEPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesEPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesEPreferredStockMember" xlink:to="lab_us-gaap_SeriesEPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_596269f5-65c6-430a-89fc-a6d220ccd1eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_9db2c011-16d3-4b88-9f74-52fbf12029ea_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Term, Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_89e43c4b-0ac4-49c4-a9ac-5bec73996310_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from offerings of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_2b5b3906-fd2f-4ead-8f7a-9bee0f436775_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from public offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8015afd5-a168-4bf2-ac5c-4bc8e1bbca95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and Diluted Net Loss per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentCreditMember_5f06eb9d-2419-40fe-8b6d-56d47ba8fbdd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment tax credit</link:label>
    <link:label id="lab_us-gaap_InvestmentCreditMember_label_en-US" xlink:label="lab_us-gaap_InvestmentCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentCreditMember" xlink:to="lab_us-gaap_InvestmentCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_AccruedPropertyAndEquipmentCurrent_b000a50a-4714-41b8-bddf-c8cb9338b49e_terseLabel_en-US" xlink:label="lab_mrna_AccruedPropertyAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_mrna_AccruedPropertyAndEquipmentCurrent_label_en-US" xlink:label="lab_mrna_AccruedPropertyAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Property And Equipment, Current</link:label>
    <link:label id="lab_mrna_AccruedPropertyAndEquipmentCurrent_documentation_en-US" xlink:label="lab_mrna_AccruedPropertyAndEquipmentCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Property And Equipment, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedPropertyAndEquipmentCurrent" xlink:href="mrna-20201231.xsd#mrna_AccruedPropertyAndEquipmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_AccruedPropertyAndEquipmentCurrent" xlink:to="lab_mrna_AccruedPropertyAndEquipmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_37251580-6100-44c8-aeae-e1d138b9ae57_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_938acb44-604e-4700-99aa-43b1668cdadf_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_TheBillAndMelindaGatesFoundationMember_98824050-7403-4946-869a-28ffc55d1ad1_terseLabel_en-US" xlink:label="lab_mrna_TheBillAndMelindaGatesFoundationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Bill&#160;&amp; Melinda Gates Foundation</link:label>
    <link:label id="lab_mrna_TheBillAndMelindaGatesFoundationMember_label_en-US" xlink:label="lab_mrna_TheBillAndMelindaGatesFoundationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Bill&#160;And Melinda Gates Foundation [Member]</link:label>
    <link:label id="lab_mrna_TheBillAndMelindaGatesFoundationMember_documentation_en-US" xlink:label="lab_mrna_TheBillAndMelindaGatesFoundationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Bill&#160;And Melinda Gates Foundation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TheBillAndMelindaGatesFoundationMember" xlink:href="mrna-20201231.xsd#mrna_TheBillAndMelindaGatesFoundationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_TheBillAndMelindaGatesFoundationMember" xlink:to="lab_mrna_TheBillAndMelindaGatesFoundationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_467db468-6ad9-4c02-b795-84e5704d6c97_terseLabel_en-US" xlink:label="lab_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material right to receive development and commercialization rights</link:label>
    <link:label id="lab_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_label_en-US" xlink:label="lab_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development And Commercialization Rights And Manufacturing Services For An Oncology Development Target [Member]</link:label>
    <link:label id="lab_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_documentation_en-US" xlink:label="lab_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development And Commercialization Rights And Manufacturing Services For An Oncology Development Target [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember" xlink:href="mrna-20201231.xsd#mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember" xlink:to="lab_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_92cb082c-9ae1-4e36-ab03-ec46d4f8244c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_fe28334a-1d1c-451b-a993-ba4454121fe2_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_f083589a-77e5-4515-a33e-0f29405be960_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_UnitedKingdomGovernmentMember_8e8c97a8-79e0-4460-a62c-086246b34015_terseLabel_en-US" xlink:label="lab_mrna_UnitedKingdomGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom Government</link:label>
    <link:label id="lab_mrna_UnitedKingdomGovernmentMember_label_en-US" xlink:label="lab_mrna_UnitedKingdomGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom Government [Member]</link:label>
    <link:label id="lab_mrna_UnitedKingdomGovernmentMember_documentation_en-US" xlink:label="lab_mrna_UnitedKingdomGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United Kingdom Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UnitedKingdomGovernmentMember" xlink:href="mrna-20201231.xsd#mrna_UnitedKingdomGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_UnitedKingdomGovernmentMember" xlink:to="lab_mrna_UnitedKingdomGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f7facf1e-54c9-4db8-a6f4-dfeb4b733920_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_1e69ee63-5eef-4b2a-8d86-8fda77e3bbd6_terseLabel_en-US" xlink:label="lab_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium associated with the contemporaneous sale of Series H redeemable convertible preferred stock</link:label>
    <link:label id="lab_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_label_en-US" xlink:label="lab_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payment, Premium Associated With Contemporaneous Sale Of Preferred Stock [Member]</link:label>
    <link:label id="lab_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_documentation_en-US" xlink:label="lab_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payment, Premium Associated With Contemporaneous Sale Of Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember" xlink:to="lab_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3eb0befb-5257-4f79-ac63-00ff598d5004_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_297930ab-4aa8-48e8-bca6-4ecc048a9260_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_4b9eceae-a654-4941-8e1c-5669fc3fa0bf_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f0eca612-a36f-452d-8dfb-b4d1b9f68379_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_59016f24-0306-49cb-a8c5-737f030cf906_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_71e4a893-3dd5-490f-a142-8188dedb5ab9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_CompetitionMilestonesMember_ae11defc-fa99-4182-801c-31061e0293bd_terseLabel_en-US" xlink:label="lab_mrna_CompetitionMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Competition milestone payment</link:label>
    <link:label id="lab_mrna_CompetitionMilestonesMember_label_en-US" xlink:label="lab_mrna_CompetitionMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Competition Milestones [Member]</link:label>
    <link:label id="lab_mrna_CompetitionMilestonesMember_documentation_en-US" xlink:label="lab_mrna_CompetitionMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Competition Milestones [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CompetitionMilestonesMember" xlink:href="mrna-20201231.xsd#mrna_CompetitionMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_CompetitionMilestonesMember" xlink:to="lab_mrna_CompetitionMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_30ca49ee-5512-4fb3-a81d-7a576184b75a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_42f43f14-2481-4b44-9303-dbedf21426e9_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized_768b4862-9540-4485-b0fe-07d17f1f4f90_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual percentage increase of shares reserved and available for issuance</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Annual Percentage Of Additional Shares Authorized</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Annual Percentage Of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized" xlink:to="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_USGovermentMember_db56fdef-32f8-4239-8de9-3e11b3265155_terseLabel_en-US" xlink:label="lab_mrna_USGovermentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Government (excluding BARDA)</link:label>
    <link:label id="lab_mrna_USGovermentMember_label_en-US" xlink:label="lab_mrna_USGovermentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Goverment [Member]</link:label>
    <link:label id="lab_mrna_USGovermentMember_documentation_en-US" xlink:label="lab_mrna_USGovermentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Goverment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_USGovermentMember" xlink:href="mrna-20201231.xsd#mrna_USGovermentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_USGovermentMember" xlink:to="lab_mrna_USGovermentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ContractWithCustomerAssetDecreaseDuringPeriod_14550ce9-5a3c-4165-ab46-3273f79fa7a6_terseLabel_en-US" xlink:label="lab_mrna_ContractWithCustomerAssetDecreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_mrna_ContractWithCustomerAssetDecreaseDuringPeriod_label_en-US" xlink:label="lab_mrna_ContractWithCustomerAssetDecreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Asset Decrease During Period</link:label>
    <link:label id="lab_mrna_ContractWithCustomerAssetDecreaseDuringPeriod_documentation_en-US" xlink:label="lab_mrna_ContractWithCustomerAssetDecreaseDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Asset Decrease During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerAssetDecreaseDuringPeriod" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerAssetDecreaseDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ContractWithCustomerAssetDecreaseDuringPeriod" xlink:to="lab_mrna_ContractWithCustomerAssetDecreaseDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_9acfcb2d-20fa-4c52-8945-f1d986184372_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_00decc7b-6b76-4407-8764-17d8bab01d36_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_4ee87ea9-3a51-411b-aa27-4c9eb1271dc8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_d4b014ab-9c4c-41ba-bb8a-4e3230a046b2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds of initial public offering, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_4aa8b369-f33d-4fdd-a73a-7b022804ad92_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows used in financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_c4897e95-c68e-403f-992c-faac5b3c477d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_562a20ad-a4ad-4a8c-b3c0-9fe4dad0f271_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_7b73fa00-0dd2-4e1f-811c-1104f648a955_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1e1a50a9-9962-4408-9059-bde0f3195784_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_7980a07e-3373-454c-9c52-d1b5f6c0906d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges related to marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_LeasesImputedInterestRate_d8be3c1c-57a3-4238-aa9b-5bb85ed49299_terseLabel_en-US" xlink:label="lab_mrna_LeasesImputedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imputed interest rate</link:label>
    <link:label id="lab_mrna_LeasesImputedInterestRate_label_en-US" xlink:label="lab_mrna_LeasesImputedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Imputed Interest Rate</link:label>
    <link:label id="lab_mrna_LeasesImputedInterestRate_documentation_en-US" xlink:label="lab_mrna_LeasesImputedInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Imputed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LeasesImputedInterestRate" xlink:href="mrna-20201231.xsd#mrna_LeasesImputedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_LeasesImputedInterestRate" xlink:to="lab_mrna_LeasesImputedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9fd9b7bf-fbb5-4992-b9a4-32802a120b90_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on available-for-sale debt securities, net of tax of $0, $1,148 and $0, for the years ended December 31, 2020, 2019 and 2018, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_54708da7-e686-4339-a7f0-0805df310abb_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_4581a7a9-3f1c-4c6d-b75d-109785e65006_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on available-for-sale debt securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_a4b4a032-4dc9-4074-bc7d-2e5fde786567_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_18e5b4bf-6c8c-4925-b35c-9dc644bfdc02_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_9487a6de-36ab-434b-9f79-7e539163be43_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions_dbe0649f-51bb-4e07-8a2f-f1ec76937562_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options to develop candidates</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Number Of Options</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Number Of Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchMember_392f2450-ee49-4e35-8fb6-41bf2d998cd2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchMember_label_en-US" xlink:label="lab_us-gaap_ResearchMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Tax Credit Carryforward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchMember" xlink:to="lab_us-gaap_ResearchMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_2ab8f266-5bb1-4027-bdf7-79b9584bc318_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate net proceeds from the offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_695ddb29-b18a-4959-8860-58034ec31f3b_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_7fbd7f8b-1877-44f9-bfcf-66374d7eca59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision For (Benefit From) Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_b031a188-f3c8-4d1a-8a39-0ad0e6f6dd83_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ClinicalOperationsAndSupportCommitmentMember_61d16f73-3dc0-4f52-9d02-7464270fdb85_terseLabel_en-US" xlink:label="lab_mrna_ClinicalOperationsAndSupportCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical operations and support commitments</link:label>
    <link:label id="lab_mrna_ClinicalOperationsAndSupportCommitmentMember_label_en-US" xlink:label="lab_mrna_ClinicalOperationsAndSupportCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Operations And Support Commitment [Member]</link:label>
    <link:label id="lab_mrna_ClinicalOperationsAndSupportCommitmentMember_documentation_en-US" xlink:label="lab_mrna_ClinicalOperationsAndSupportCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical Operations And Support Commitment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalOperationsAndSupportCommitmentMember" xlink:href="mrna-20201231.xsd#mrna_ClinicalOperationsAndSupportCommitmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ClinicalOperationsAndSupportCommitmentMember" xlink:to="lab_mrna_ClinicalOperationsAndSupportCommitmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_PatentCostsPolicyPolicyTextBlock_cc1f5983-5a95-440a-acc9-51705a8a4a56_terseLabel_en-US" xlink:label="lab_mrna_PatentCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent Costs</link:label>
    <link:label id="lab_mrna_PatentCostsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_mrna_PatentCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent Costs, Policy [Policy Text Block]</link:label>
    <link:label id="lab_mrna_PatentCostsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_mrna_PatentCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PatentCostsPolicyPolicyTextBlock" xlink:href="mrna-20201231.xsd#mrna_PatentCostsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_PatentCostsPolicyPolicyTextBlock" xlink:to="lab_mrna_PatentCostsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_e0c4c93c-dd41-47b3-8abe-e29e4fb4166f_terseLabel_en-US" xlink:label="lab_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Revenue by Strategic Collaborator</link:label>
    <link:label id="lab_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_label_en-US" xlink:label="lab_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement Including Arrangements With Affiliate [Member]</link:label>
    <link:label id="lab_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_documentation_en-US" xlink:label="lab_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement Including Arrangements With Affiliate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember" xlink:to="lab_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_cbbf2a41-4f1a-468d-871b-465b66131627_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period of cost expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_da090b87-7691-439c-a75f-6c46e92ffbb5_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_2cef7f1b-88c8-4ec7-8042-49dc709ccbee_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c7aade5a-6bac-41f9-9620-a3ee70a458c8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts included in contract liabilities at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_233267d0-277e-4e30-94ea-6c8a0c3dade5_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2f231894-0589-4925-91cf-7a95c39b036d_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f266c259-11ec-4634-8dfc-9816f48f038b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_af9ba7ab-c974-4e44-a251-607c45f2928a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_8be8d62a-b0d7-4f34-9bc1-16c7a4b93c8e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_Vertex2020AgreementMember_23343423-d50e-4c1f-bc43-49419f7ac8fa_terseLabel_en-US" xlink:label="lab_mrna_Vertex2020AgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex 2020 Agreement</link:label>
    <link:label id="lab_mrna_Vertex2020AgreementMember_label_en-US" xlink:label="lab_mrna_Vertex2020AgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex 2020 Agreement [Member]</link:label>
    <link:label id="lab_mrna_Vertex2020AgreementMember_documentation_en-US" xlink:label="lab_mrna_Vertex2020AgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vertex 2020 Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Vertex2020AgreementMember" xlink:href="mrna-20201231.xsd#mrna_Vertex2020AgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_Vertex2020AgreementMember" xlink:to="lab_mrna_Vertex2020AgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesGPreferredStockMember_24c1cc9d-59d1-457f-98e0-c04d9397f067_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesGPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series&#160;G Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesGPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesGPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series G Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesGPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesGPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesGPreferredStockMember" xlink:to="lab_us-gaap_SeriesGPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_96974559-ed25-42b9-92d7-52d67bea4dd5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_5a2b559d-da0a-415e-9cfd-75e0da8a3236_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_359b61d3-0678-49ec-ac1d-dccf868ff985_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_54f8557b-982e-4c06-a6d7-1bbb399e80a1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_827a6945-68df-4c2c-80a5-0549fa60f766_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_62d39825-26fe-489d-8658-f8616a14046c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_6c0bcbb7-acee-4e57-a473-12eb7e3362e6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_57faee99-5368-436d-9324-7c8d1f3443c8_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_607f4378-cba4-423b-9e4f-4e1fad9e3952_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_46a57eee-dcff-4801-ae08-f4ebe13c98b1_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_32c5ae0e-004b-4b40-8f84-0f508884773f_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_ad746c4e-14d0-4b73-8c4b-7b42f929a4a8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_065b978f-fed7-4bbe-af2c-6737a16bb9af_terseLabel_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:label id="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_label_en-US" xlink:label="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Application Period Cumulative Effect Transition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:to="lab_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_FederalOrphanDrugMember_5ea99a43-6eb9-4421-b86a-1f87060fde71_terseLabel_en-US" xlink:label="lab_mrna_FederalOrphanDrugMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Orphan Drug</link:label>
    <link:label id="lab_mrna_FederalOrphanDrugMember_label_en-US" xlink:label="lab_mrna_FederalOrphanDrugMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Orphan Drug [Member]</link:label>
    <link:label id="lab_mrna_FederalOrphanDrugMember_documentation_en-US" xlink:label="lab_mrna_FederalOrphanDrugMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Orphan Drug [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FederalOrphanDrugMember" xlink:href="mrna-20201231.xsd#mrna_FederalOrphanDrugMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_FederalOrphanDrugMember" xlink:to="lab_mrna_FederalOrphanDrugMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_23fa8f0c-b03c-4431-8bef-1f479a528229_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2566ff5b-d67a-4212-ba2a-2950b0bb647e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones_a425d482-b0b2-41ef-8b51-2565aca7d9e2_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of milestones</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Number Of Milestones</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Number Of Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_5763af57-15ec-4147-9c6d-2045bbdeb13e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Cash and Available-for-Sale Securities by Significant Investment Category</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_986ec310-0d9b-4623-8247-74e9244f6551_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal research and development credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_2bdb1b61-07b0-494b-99c3-cae2a85cb4eb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_36bc37b0-2d7b-4743-b491-6cd6392751c8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue_7244be07-5c52-4604-ac2f-c93bd4b7759f_negatedLabel_en-US" xlink:label="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of redeemable convertible preferred stock</link:label>
    <link:label id="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Repurchased During Period, Value</link:label>
    <link:label id="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue_documentation_en-US" xlink:label="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:href="mrna-20201231.xsd#mrna_TemporaryEquityStockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:to="lab_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_EstimatedReimbursementMember_00a7644e-2de3-4ea4-a4ab-ea938a68fc54_terseLabel_en-US" xlink:label="lab_mrna_EstimatedReimbursementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Reimbursement</link:label>
    <link:label id="lab_mrna_EstimatedReimbursementMember_label_en-US" xlink:label="lab_mrna_EstimatedReimbursementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Reimbursement [Member]</link:label>
    <link:label id="lab_mrna_EstimatedReimbursementMember_documentation_en-US" xlink:label="lab_mrna_EstimatedReimbursementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Reimbursement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EstimatedReimbursementMember" xlink:href="mrna-20201231.xsd#mrna_EstimatedReimbursementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_EstimatedReimbursementMember" xlink:to="lab_mrna_EstimatedReimbursementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_PaymentsOfUnderwritingDiscounts_7f14f1b3-4a83-4550-b2e0-39a9687d04d6_terseLabel_en-US" xlink:label="lab_mrna_PaymentsOfUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underwriting discounts</link:label>
    <link:label id="lab_mrna_PaymentsOfUnderwritingDiscounts_label_en-US" xlink:label="lab_mrna_PaymentsOfUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Of Underwriting Discounts</link:label>
    <link:label id="lab_mrna_PaymentsOfUnderwritingDiscounts_documentation_en-US" xlink:label="lab_mrna_PaymentsOfUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Of Underwriting Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PaymentsOfUnderwritingDiscounts" xlink:href="mrna-20201231.xsd#mrna_PaymentsOfUnderwritingDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_PaymentsOfUnderwritingDiscounts" xlink:to="lab_mrna_PaymentsOfUnderwritingDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_Combined2018AZAgreementPerformanceObligationMember_03e838c0-fb6e-4cc8-9de6-82fb1787c35c_terseLabel_en-US" xlink:label="lab_mrna_Combined2018AZAgreementPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined 2018 AZ Agreement performance obligation</link:label>
    <link:label id="lab_mrna_Combined2018AZAgreementPerformanceObligationMember_label_en-US" xlink:label="lab_mrna_Combined2018AZAgreementPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined 2018 AZ Agreement Performance Obligation [Member]</link:label>
    <link:label id="lab_mrna_Combined2018AZAgreementPerformanceObligationMember_documentation_en-US" xlink:label="lab_mrna_Combined2018AZAgreementPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined 2018 AZ Agreement Performance Obligation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementPerformanceObligationMember" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementPerformanceObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_Combined2018AZAgreementPerformanceObligationMember" xlink:to="lab_mrna_Combined2018AZAgreementPerformanceObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_a594b5bc-bc18-4359-bd05-918276e54859_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e597b5fe-9490-49fb-bfc7-ff2a87b03173_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_aae8009f-1310-4484-a1ec-91260fd89c8c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividends</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_44611d2c-6616-479f-b510-96d77b8b491c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets expensed</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Leased Assets, Net, Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" xlink:to="lab_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_51eecad8-0577-4121-8e1b-c9e823ce4250_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_6ba998e5-60d4-4f86-a3f5-79085a06144c_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_10a0d001-3a83-4f0c-b5ae-c7cf7111d25a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of U.S. Statutory Income Tax Rate to Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4d3b8190-4b3d-4aa1-924d-c93cc72d945d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_0a660918-32bc-4b51-b9d1-fb827984b946_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b1fd2ba4-b65f-4591-9480-1880951d9746_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_748213f3-1e26-491c-a2e9-87dbba1f03ec_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock_b6dc0e33-b588-4cb6-8af4-783e21e25807_terseLabel_en-US" xlink:label="lab_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Lease Liabilities</link:label>
    <link:label id="lab_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="mrna-20201231.xsd#mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_030781c8-9ba1-4d77-92e6-5d9942f0cb10_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockDividends_6f16b60f-4a4e-4e4a-8d49-8c161e0d2fa0_negatedLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative preferred stock dividends</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockDividends_895e1762-92eb-4f8e-96c2-2c4351fc0f4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative dividends on redeemable convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockDividends_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockDividends" xlink:to="lab_us-gaap_RedeemablePreferredStockDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_ed6d2132-39f7-45d7-8788-db67b213d63e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_d8adfd28-e4c6-4e1f-ac98-0fe78db37981_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_AreaOfRealEstatePropertyAdditionalSpace_6adfb97c-b313-45bd-9ed6-5dc6c3f7f41b_terseLabel_en-US" xlink:label="lab_mrna_AreaOfRealEstatePropertyAdditionalSpace" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional space (in sqft)</link:label>
    <link:label id="lab_mrna_AreaOfRealEstatePropertyAdditionalSpace_label_en-US" xlink:label="lab_mrna_AreaOfRealEstatePropertyAdditionalSpace" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area Of Real Estate Property, Additional Space</link:label>
    <link:label id="lab_mrna_AreaOfRealEstatePropertyAdditionalSpace_documentation_en-US" xlink:label="lab_mrna_AreaOfRealEstatePropertyAdditionalSpace" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area Of Real Estate Property, Additional Space</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AreaOfRealEstatePropertyAdditionalSpace" xlink:href="mrna-20201231.xsd#mrna_AreaOfRealEstatePropertyAdditionalSpace"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_AreaOfRealEstatePropertyAdditionalSpace" xlink:to="lab_mrna_AreaOfRealEstatePropertyAdditionalSpace" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_56912468-32e1-44e9-a944-e02f85419aaa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_MerckMay2019AgreementMember_586f677d-487b-4630-9a93-54ac5e8c5fc5_terseLabel_en-US" xlink:label="lab_mrna_MerckMay2019AgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contra-revenue under the May 2019 Amendment</link:label>
    <link:label id="lab_mrna_MerckMay2019AgreementMember_label_en-US" xlink:label="lab_mrna_MerckMay2019AgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck May2019 Agreement [Member]</link:label>
    <link:label id="lab_mrna_MerckMay2019AgreementMember_documentation_en-US" xlink:label="lab_mrna_MerckMay2019AgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merck May2019 Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckMay2019AgreementMember" xlink:href="mrna-20201231.xsd#mrna_MerckMay2019AgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_MerckMay2019AgreementMember" xlink:to="lab_mrna_MerckMay2019AgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_7d5f8bef-7e66-4b7a-bbe8-140f7bf45656_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Consecutive Offering Period</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Consecutive Offering Period</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Consecutive Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_844ef93c-2a64-428f-b783-ca82bf12c0a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Before Provision For (Benefit From) Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_StockIssuanceCostsIncurredButNotYetPaid_6af8ec17-9ef5-483f-9bfe-89efb96498fc_terseLabel_en-US" xlink:label="lab_mrna_StockIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_mrna_StockIssuanceCostsIncurredButNotYetPaid_label_en-US" xlink:label="lab_mrna_StockIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Incurred But Not Yet Paid</link:label>
    <link:label id="lab_mrna_StockIssuanceCostsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_mrna_StockIssuanceCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Costs Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StockIssuanceCostsIncurredButNotYetPaid" xlink:href="mrna-20201231.xsd#mrna_StockIssuanceCostsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_StockIssuanceCostsIncurredButNotYetPaid" xlink:to="lab_mrna_StockIssuanceCostsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_PublicEquityOfferingMember_389fedfd-2b68-4bcf-a06f-bb4f119a867f_terseLabel_en-US" xlink:label="lab_mrna_PublicEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Equity Offering</link:label>
    <link:label id="lab_mrna_PublicEquityOfferingMember_label_en-US" xlink:label="lab_mrna_PublicEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Equity Offering [Member]</link:label>
    <link:label id="lab_mrna_PublicEquityOfferingMember_documentation_en-US" xlink:label="lab_mrna_PublicEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Equity Offering [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PublicEquityOfferingMember" xlink:href="mrna-20201231.xsd#mrna_PublicEquityOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_PublicEquityOfferingMember" xlink:to="lab_mrna_PublicEquityOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseRightOfUseAsset_5a0ec87c-0166-4991-8f3f-2ae4d51412b9_totalLabel_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseRightOfUseAsset" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OperatingAndFinanceLeaseRightOfUseAsset" xlink:to="lab_mrna_OperatingAndFinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_b5216ab1-149d-4ad3-8e89-bdba0a7e71be_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_4825cc46-bff8-4182-9fde-3253b5f6387f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_b408ddc0-ce4a-4a32-aa1b-8bfcfeb7dee5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_bb87c615-91ae-403c-a15e-d90b0e769fbb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1878a234-304c-4404-bbd9-81363124e915_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts recognized for net realized gain included in net loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_ee927c61-4296-4fd7-a14b-6a2ddc77f34b_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a2c26541-0295-4057-bdad-e35198ec38f3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember_afb58105-587b-4abb-8a15-f520b7b69c90_terseLabel_en-US" xlink:label="lab_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted common stock and units</link:label>
    <link:label id="lab_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Restricted Stock Units (RSU) [Member]</link:label>
    <link:label id="lab_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember_documentation_en-US" xlink:label="lab_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember" xlink:href="mrna-20201231.xsd#mrna_RestrictedStockAndRestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember" xlink:to="lab_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_6b21d555-4b01-4b4d-8c14-abc3b7d237d1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims outstanding</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount_3e701791-6935-4789-9364-2c330c8eab0c_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and regulatory milestone payments</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Development And Regulatory Milestones, Maximum Amount</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Development And Regulatory Milestones, Maximum Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_24dfbc27-6d45-4139-bb33-639329860470_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_a7125f57-a0ec-41e1-adf1-9402255e0d10_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3016a4aa-c8d5-4e66-a256-1cd1c35f7404_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_4f8b474a-f546-4882-ab0b-00a44b8013a2_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_8646443d-e8dd-4fa7-bdbe-b17bc30aae38_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b9f6bf3d-a291-447d-837c-40ace7d8222c_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockExpense_c17e946f-1df8-464c-a7a5-ce3be0983983_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock unit</link:label>
    <link:label id="lab_us-gaap_RestrictedStockExpense_label_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock or Unit Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockExpense" xlink:to="lab_us-gaap_RestrictedStockExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_6b3df14d-4527-4f39-ba6c-152fde14e9f6_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_80eca307-8380-459f-8532-cd1fa80cfd37_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_edd5b048-de0f-4ca7-b979-4ea0cc0b3d28_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_28cbb3cf-fe4c-4512-ac02-76b65efcbea1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_c6aa955d-99a0-4739-83d8-ea1ade69d0e0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ed9168fc-a2a3-4b6d-8b9c-4bedb23d214d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ea55521d-45ad-4199-b051-439027d72256_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock and Common Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseLiabilityCurrent_50002e1c-36a6-4198-b88a-bd7b19877284_totalLabel_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Current</link:label>
    <link:label id="lab_mrna_OperatingAndFinanceLeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_mrna_OperatingAndFinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseLiabilityCurrent" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OperatingAndFinanceLeaseLiabilityCurrent" xlink:to="lab_mrna_OperatingAndFinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_8fe41f98-1ef8-4051-854f-5a9c6e2e7b8f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_02f75eb2-813b-4ec5-b88d-6cf70d419917_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_e624aea5-cf2d-4731-9109-53ce735d470e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod_a1be1c82-b696-4878-bdcf-c67cc9c2c2c8_negatedTerseLabel_en-US" xlink:label="lab_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod_label_en-US" xlink:label="lab_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Deductions During Period</link:label>
    <link:label id="lab_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod_documentation_en-US" xlink:label="lab_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Deductions During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod" xlink:to="lab_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_568d5dcb-1e14-4cc5-a2fc-4f5f5334b1eb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ServiceBasedAwardsMember_6f78a6e7-e2a2-4db3-be37-92a6527facb3_terseLabel_en-US" xlink:label="lab_mrna_ServiceBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service-based awards</link:label>
    <link:label id="lab_mrna_ServiceBasedAwardsMember_label_en-US" xlink:label="lab_mrna_ServiceBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service-Based Awards [Member]</link:label>
    <link:label id="lab_mrna_ServiceBasedAwardsMember_documentation_en-US" xlink:label="lab_mrna_ServiceBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service-Based Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ServiceBasedAwardsMember" xlink:href="mrna-20201231.xsd#mrna_ServiceBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ServiceBasedAwardsMember" xlink:to="lab_mrna_ServiceBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_da98c163-33b4-4119-97ab-04129813f0c0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_63781c87-8a01-4ba4-9a56-f87c93b20c95_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrantMember_03157fcd-67b1-4ca3-b81c-7b48645570e3_terseLabel_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant revenue</link:label>
    <link:label id="lab_us-gaap_GrantMember_label_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrantMember" xlink:to="lab_us-gaap_GrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_AccruedDevelopmentOperation_e70d2d6c-9ecf-4ba3-ba5d-d770705f735f_terseLabel_en-US" xlink:label="lab_mrna_AccruedDevelopmentOperation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development operations</link:label>
    <link:label id="lab_mrna_AccruedDevelopmentOperation_label_en-US" xlink:label="lab_mrna_AccruedDevelopmentOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Development Operation</link:label>
    <link:label id="lab_mrna_AccruedDevelopmentOperation_documentation_en-US" xlink:label="lab_mrna_AccruedDevelopmentOperation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Development Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedDevelopmentOperation" xlink:href="mrna-20201231.xsd#mrna_AccruedDevelopmentOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_AccruedDevelopmentOperation" xlink:to="lab_mrna_AccruedDevelopmentOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_758d6713-faa5-4788-a05c-cb84a59a79cc_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of redeemable convertible preferred stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_dc79a61f-1b36-4153-919a-4de804005587_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOtherTypesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures and other</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOtherTypesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Other Types [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOtherTypesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOtherTypesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_3e7b36cc-ea31-44f5-96ff-c62cca8df505_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Period</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Period</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation_dc4ca069-3292-4251-9508-694cc5c3d634_terseLabel_en-US" xlink:label="lab_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursement of assets under financing lease obligation</link:label>
    <link:label id="lab_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation_label_en-US" xlink:label="lab_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursement Of Assets From Lease Financing Obligation</link:label>
    <link:label id="lab_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation_documentation_en-US" xlink:label="lab_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursement Of Assets From Lease Financing Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation" xlink:href="mrna-20201231.xsd#mrna_ReimbursementOfAssetsFromLeaseFinancingObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation" xlink:to="lab_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_c93385cb-7d78-4ad3-b234-59cf4eac676a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_b9f7b1ca-e7e8-4f7b-8f9c-bdddfc6b500d_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_b40ce3f3-38ab-48c1-b6bf-998b763fa3cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_082e9b05-c019-49b5-aa40-ad78c6b03c51_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_a48a225a-6e3b-47ad-8692-4bc313776f73_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_40fbe955-9e7e-49bb-90b2-1e03a08e5e1b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_07ddb813-1a17-46df-b264-fd88fbf85ce3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_06018006-aec4-4349-a178-93f3f5af32e9_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RevenueFromGrantsNumberOfContractOptions_df3b9838-e387-4567-8d6f-bae6906eb787_terseLabel_en-US" xlink:label="lab_mrna_RevenueFromGrantsNumberOfContractOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of contract options</link:label>
    <link:label id="lab_mrna_RevenueFromGrantsNumberOfContractOptions_label_en-US" xlink:label="lab_mrna_RevenueFromGrantsNumberOfContractOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Grants, Number Of Contract Options</link:label>
    <link:label id="lab_mrna_RevenueFromGrantsNumberOfContractOptions_documentation_en-US" xlink:label="lab_mrna_RevenueFromGrantsNumberOfContractOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Grants, Number Of Contract Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsNumberOfContractOptions" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsNumberOfContractOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RevenueFromGrantsNumberOfContractOptions" xlink:to="lab_mrna_RevenueFromGrantsNumberOfContractOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_UpfrontPaymentResearchAndDevelopmentMember_1c102f83-8257-4a8f-b2cf-129b2772ff30_terseLabel_en-US" xlink:label="lab_mrna_UpfrontPaymentResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payment, Research And Development</link:label>
    <link:label id="lab_mrna_UpfrontPaymentResearchAndDevelopmentMember_label_en-US" xlink:label="lab_mrna_UpfrontPaymentResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payment, Research And Development [Member]</link:label>
    <link:label id="lab_mrna_UpfrontPaymentResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_mrna_UpfrontPaymentResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payment, Research And Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentResearchAndDevelopmentMember" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_UpfrontPaymentResearchAndDevelopmentMember" xlink:to="lab_mrna_UpfrontPaymentResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4b0bd9e0-a09b-4f8a-bfa1-f597b784fd48_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_f2ecedee-3398-4ce8-b5c1-a80988629b74_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_6da33451-018f-4407-8e35-2f05096cbfe0_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_PerformanceObligationDomain_d2c85fa6-34b3-41cf-b8d0-8332402f3e26_terseLabel_en-US" xlink:label="lab_mrna_PerformanceObligationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Obligation [Domain]</link:label>
    <link:label id="lab_mrna_PerformanceObligationDomain_label_en-US" xlink:label="lab_mrna_PerformanceObligationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Obligation [Domain]</link:label>
    <link:label id="lab_mrna_PerformanceObligationDomain_documentation_en-US" xlink:label="lab_mrna_PerformanceObligationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Performance Obligation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_PerformanceObligationDomain" xlink:to="lab_mrna_PerformanceObligationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a97ef07b-d579-417c-80cc-f6463beccf0f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value, 12 months or more</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_ac52bf8a-e0d2-4330-ac02-d024d8295dce_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_364a747e-3d21-436a-9bc9-84d36a0862ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_8c8db83b-5bb0-47d7-8c51-0138d14928cc_terseLabel_en-US" xlink:label="lab_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Development Regulatory And Commercial Milestone Events</link:label>
    <link:label id="lab_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_label_en-US" xlink:label="lab_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Development Regulatory And Commercial Milestone Events [Member]</link:label>
    <link:label id="lab_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_documentation_en-US" xlink:label="lab_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Development Regulatory And Commercial Milestone Events</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember" xlink:href="mrna-20201231.xsd#mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember" xlink:to="lab_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_43cb42c9-9e7b-4ec3-8060-1188e5472bea_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_5abbaca0-89cc-4851-8cb0-572eba0285af_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_940b7982-077a-40d8-ad9b-1d1c710d122d_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_MilestonePaymentsMember_e8a3c7ce-26a4-49e5-bec8-241f04bb1878_terseLabel_en-US" xlink:label="lab_mrna_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payment</link:label>
    <link:label id="lab_mrna_MilestonePaymentsMember_label_en-US" xlink:label="lab_mrna_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments [Member]</link:label>
    <link:label id="lab_mrna_MilestonePaymentsMember_documentation_en-US" xlink:label="lab_mrna_MilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MilestonePaymentsMember" xlink:href="mrna-20201231.xsd#mrna_MilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_MilestonePaymentsMember" xlink:to="lab_mrna_MilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent_639494ec-211c-41b5-812d-c739ff8e0f59_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out payments</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Earnout Payment, Percent</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Earnout Payment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_ac92cb72-08dc-44d3-8118-cd8c79182dd1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_2ff913cb-dd0c-4b8b-b851-8656d4416ac0_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_39c46786-2c2d-445e-8991-8bb5041c394a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_e2ec797d-a27a-42d9-a5d7-400d4df70c2b_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_Commercial_dfbeccd8-8762-4f54-92b7-e807b6306fa9_terseLabel_en-US" xlink:label="lab_mrna_Commercial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial</link:label>
    <link:label id="lab_mrna_Commercial_label_en-US" xlink:label="lab_mrna_Commercial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial</link:label>
    <link:label id="lab_mrna_Commercial_documentation_en-US" xlink:label="lab_mrna_Commercial" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Commercial" xlink:href="mrna-20201231.xsd#mrna_Commercial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_Commercial" xlink:to="lab_mrna_Commercial" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_LesseeFinanceLeaseExpense_65e4d4b7-6aff-457c-a0c6-65a81dea6606_terseLabel_en-US" xlink:label="lab_mrna_LesseeFinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge to financing lease obligation</link:label>
    <link:label id="lab_mrna_LesseeFinanceLeaseExpense_label_en-US" xlink:label="lab_mrna_LesseeFinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Expense</link:label>
    <link:label id="lab_mrna_LesseeFinanceLeaseExpense_documentation_en-US" xlink:label="lab_mrna_LesseeFinanceLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LesseeFinanceLeaseExpense" xlink:href="mrna-20201231.xsd#mrna_LesseeFinanceLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_LesseeFinanceLeaseExpense" xlink:to="lab_mrna_LesseeFinanceLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_12a1ccc6-7ac5-4154-a5e4-358beaf77763_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_cc7fccfe-dc95-4bdc-b970-22668ec127af_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_34fe65cf-2789-4ad1-97db-5d9a95e29e6e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_95de9972-3dd1-4115-ba64-790f7d873215_terseLabel_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnifications</link:label>
    <link:label id="lab_us-gaap_IndemnificationGuaranteeMember_label_en-US" xlink:label="lab_us-gaap_IndemnificationGuaranteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndemnificationGuaranteeMember" xlink:to="lab_us-gaap_IndemnificationGuaranteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod_ed94ad55-501b-4b77-9077-1fd30749b915_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Performance Period</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_d5e85c11-401c-4027-813f-83072c6f1ca4_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation costs</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b27ab091-aade-4363-98fd-aa431c4b5580_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d7fb9d40-fcaa-49cb-927f-3703b3888193_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized&#160;Gain on Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_53a4a08b-9813-4192-af51-980c0886b2e7_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1ec723bf-d3cf-4e0a-aa7f-08c523e43741_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7b7f2759-624e-45b6-8443-0674c35dc5b3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_fc97c82a-3324-41ae-904a-33dd8feb9a08_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum value of shares to be purchased during purchase period</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Maximum Employee Subscription Amount</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Maximum Employee Subscription Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_a72bdad2-87ae-4fce-b0d9-0296deede778_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent_1723bf0e-3ab9-42bb-b9fa-42c992e250a1_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tiered royalties</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Royalty Payment, Percent</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Royalty Payment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_42b272ca-1991-4b3f-8b9e-6911e7fe5fcc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_a367cdf1-d19e-4102-be19-2993f84b7f2a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_IL12PerformanceObligationMember_7e2986c5-ec16-4395-9d7f-6fa77b4737ae_terseLabel_en-US" xlink:label="lab_mrna_IL12PerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preclinical development service - IL-12</link:label>
    <link:label id="lab_mrna_IL12PerformanceObligationMember_label_en-US" xlink:label="lab_mrna_IL12PerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IL12 Performance Obligation [Member]</link:label>
    <link:label id="lab_mrna_IL12PerformanceObligationMember_documentation_en-US" xlink:label="lab_mrna_IL12PerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IL12 Performance Obligation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_IL12PerformanceObligationMember" xlink:href="mrna-20201231.xsd#mrna_IL12PerformanceObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_IL12PerformanceObligationMember" xlink:to="lab_mrna_IL12PerformanceObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_92ab6097-ce2a-4df7-9a4a-dbf42df5e8de_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_7cae211c-cc5e-4b5b-a21e-b6647b8ade77_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate_3bb76ccc-5e38-413d-95c5-db150250c3e8_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum percentage of compensation through payroll deductions</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Minimum Employee Subscription Rate</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Minimum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:to="lab_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_52f1da9b-7960-428c-9e32-b8ba8f8427b6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_NumberOfDevelopmentProgram_e916b888-4a44-40b0-9894-ce3dc5aa5395_terseLabel_en-US" xlink:label="lab_mrna_NumberOfDevelopmentProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development programs</link:label>
    <link:label id="lab_mrna_NumberOfDevelopmentProgram_label_en-US" xlink:label="lab_mrna_NumberOfDevelopmentProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Development Program</link:label>
    <link:label id="lab_mrna_NumberOfDevelopmentProgram_documentation_en-US" xlink:label="lab_mrna_NumberOfDevelopmentProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Development Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NumberOfDevelopmentProgram" xlink:href="mrna-20201231.xsd#mrna_NumberOfDevelopmentProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_NumberOfDevelopmentProgram" xlink:to="lab_mrna_NumberOfDevelopmentProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_58a8a5a4-5d74-41c5-bd3b-9e5701a61bff_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_LesseeOperatingLeasePercentageSubleased_87c01f4a-96de-4299-b608-54917fc46d5c_terseLabel_en-US" xlink:label="lab_mrna_LesseeOperatingLeasePercentageSubleased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage subleased</link:label>
    <link:label id="lab_mrna_LesseeOperatingLeasePercentageSubleased_label_en-US" xlink:label="lab_mrna_LesseeOperatingLeasePercentageSubleased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Percentage Subleased</link:label>
    <link:label id="lab_mrna_LesseeOperatingLeasePercentageSubleased_documentation_en-US" xlink:label="lab_mrna_LesseeOperatingLeasePercentageSubleased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Percentage Subleased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LesseeOperatingLeasePercentageSubleased" xlink:href="mrna-20201231.xsd#mrna_LesseeOperatingLeasePercentageSubleased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_LesseeOperatingLeasePercentageSubleased" xlink:to="lab_mrna_LesseeOperatingLeasePercentageSubleased" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RegulatoryMilestonesSubsequentProductsMember_ad5ae747-3f05-4d5b-9bd2-27c1a75d910b_terseLabel_en-US" xlink:label="lab_mrna_RegulatoryMilestonesSubsequentProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Milestones, Subsequent Products</link:label>
    <link:label id="lab_mrna_RegulatoryMilestonesSubsequentProductsMember_label_en-US" xlink:label="lab_mrna_RegulatoryMilestonesSubsequentProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Milestones, Subsequent Products [Member]</link:label>
    <link:label id="lab_mrna_RegulatoryMilestonesSubsequentProductsMember_documentation_en-US" xlink:label="lab_mrna_RegulatoryMilestonesSubsequentProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Milestones, Subsequent Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RegulatoryMilestonesSubsequentProductsMember" xlink:href="mrna-20201231.xsd#mrna_RegulatoryMilestonesSubsequentProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RegulatoryMilestonesSubsequentProductsMember" xlink:to="lab_mrna_RegulatoryMilestonesSubsequentProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_736b732b-b34c-4993-b8cc-72d78992523a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember_9e2c4661-830a-4a1b-ad34-6d1f9a6aa0c0_terseLabel_en-US" xlink:label="lab_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office, laboratory, and light manufacturing space</link:label>
    <link:label id="lab_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember_label_en-US" xlink:label="lab_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office, Laboratory, And Light Manufacturing Space [Member]</link:label>
    <link:label id="lab_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember_documentation_en-US" xlink:label="lab_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office, Laboratory, And Light Manufacturing Space [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember" xlink:href="mrna-20201231.xsd#mrna_OfficeLaboratoryAndLightManufacturingSpaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember" xlink:to="lab_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProjectMember_99d50639-0cf1-410e-9b88-1c3b0a33fdb6_terseLabel_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Domain]</link:label>
    <link:label id="lab_us-gaap_ProjectMember_label_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProjectMember" xlink:to="lab_us-gaap_ProjectMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_bb983e65-8f45-4e6b-9a6f-71b8339f8843_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DiagnosticProductsMember_f056d8f1-1136-4f00-a5c3-2a15c5fbd8f0_terseLabel_en-US" xlink:label="lab_mrna_DiagnosticProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic products</link:label>
    <link:label id="lab_mrna_DiagnosticProductsMember_label_en-US" xlink:label="lab_mrna_DiagnosticProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Products [Member]</link:label>
    <link:label id="lab_mrna_DiagnosticProductsMember_documentation_en-US" xlink:label="lab_mrna_DiagnosticProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DiagnosticProductsMember" xlink:href="mrna-20201231.xsd#mrna_DiagnosticProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DiagnosticProductsMember" xlink:to="lab_mrna_DiagnosticProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f6fe7e12-7c03-4bb3-9f63-33e4317a1fe2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_5299fa2d-5656-450e-bed6-ea9bb4af2111_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_bba1e8dc-497e-4548-a66a-0a8e46372e5a_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering expenses</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_f70d2232-04a9-48bc-85f2-39741ff6cc90_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_df6d532a-07bc-4f3e-a57a-8639f267c660_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_5ec6389e-03ce-4794-b28d-585b811e4afe_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_c166e03e-df1a-4423-8de9-e0b42b838c4e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_d421db15-33f3-4598-9ecd-b774b5efdb0f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201409Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2014-09 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201409Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201409Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d0d2d52b-4bf0-4504-8531-d6a4d1630974_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive gain</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_6f992b17-0cba-431b-a350-10c95cffceba_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_bb738af9-555e-4fdf-992b-395fd10d3240_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities that Accounted for More than 10% of Total Revenue and Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_3cf1bd13-a9c3-4836-97f8-42a3fc701843_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_76958f79-ec29-48e5-ac26-d6c403fda639_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d5b67cf0-d81e-4b16-821f-8e42a362da1c_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_10497740-b3c0-47a7-b8c7-3f7b19f057ac_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods_3828074c-a1ca-4848-bad2-57293c526a3c_terseLabel_en-US" xlink:label="lab_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of extension periods</link:label>
    <link:label id="lab_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods_label_en-US" xlink:label="lab_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Extension Periods</link:label>
    <link:label id="lab_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods_documentation_en-US" xlink:label="lab_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Number Of Extension Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods" xlink:href="mrna-20201231.xsd#mrna_LesseeOperatingLeaseNumberOfExtensionPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods" xlink:to="lab_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_5e9e4f85-80b0-4e75-b35c-f9aaccf37387_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, remaining lease term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_92e19984-c699-4c75-9fc1-c0fd0a3028d0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase due to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_KRASPerformanceObligationMember_b86f7b26-b6a8-4f09-9cb4-4ac49af37202_terseLabel_en-US" xlink:label="lab_mrna_KRASPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KRAS Performance Obligation</link:label>
    <link:label id="lab_mrna_KRASPerformanceObligationMember_label_en-US" xlink:label="lab_mrna_KRASPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KRAS Performance Obligation [Member]</link:label>
    <link:label id="lab_mrna_KRASPerformanceObligationMember_documentation_en-US" xlink:label="lab_mrna_KRASPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KRAS Performance Obligation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_KRASPerformanceObligationMember" xlink:href="mrna-20201231.xsd#mrna_KRASPerformanceObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_KRASPerformanceObligationMember" xlink:to="lab_mrna_KRASPerformanceObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_558e8edb-3e8d-4802-9eb8-a2e526b3c353_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_NumberOfDosesOfVaccineCandidate_097d39e1-b1aa-46ee-b615-6131ea11f511_terseLabel_en-US" xlink:label="lab_mrna_NumberOfDosesOfVaccineCandidate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of doses of vaccine candidate</link:label>
    <link:label id="lab_mrna_NumberOfDosesOfVaccineCandidate_label_en-US" xlink:label="lab_mrna_NumberOfDosesOfVaccineCandidate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Doses Of Vaccine Candidate</link:label>
    <link:label id="lab_mrna_NumberOfDosesOfVaccineCandidate_documentation_en-US" xlink:label="lab_mrna_NumberOfDosesOfVaccineCandidate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Doses Of Vaccine Candidate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NumberOfDosesOfVaccineCandidate" xlink:href="mrna-20201231.xsd#mrna_NumberOfDosesOfVaccineCandidate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_NumberOfDosesOfVaccineCandidate" xlink:to="lab_mrna_NumberOfDosesOfVaccineCandidate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9c415f1d-bd20-4db5-a511-645de58f5003_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_97c2ef2a-2fbc-4bcc-be11-5789ff763df8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0282e493-c3be-4789-8ab4-5ee92f51957f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_26632cb1-a311-42b4-bdb4-6cd239cac84e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_9d193f5a-b33d-45ce-8b6a-f4c38949075c_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_0b64e9f1-7961-4171-bd8b-4636b1695cd7_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating losses</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_10efc9c3-1343-4e32-bb3e-0a7c948d7704_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_c0c50e37-649c-46b8-8712-37d4770664a0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ChiesiAgreementMember_51ce4e1d-b4bc-4190-bbae-61801ee08faf_terseLabel_en-US" xlink:label="lab_mrna_ChiesiAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chiesi agreement</link:label>
    <link:label id="lab_mrna_ChiesiAgreementMember_label_en-US" xlink:label="lab_mrna_ChiesiAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chiesi Agreement [Member]</link:label>
    <link:label id="lab_mrna_ChiesiAgreementMember_documentation_en-US" xlink:label="lab_mrna_ChiesiAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chiesi Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChiesiAgreementMember" xlink:href="mrna-20201231.xsd#mrna_ChiesiAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ChiesiAgreementMember" xlink:to="lab_mrna_ChiesiAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_aef30e74-ebcf-4ab3-bd14-01e49a7d9008_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_93ac638c-f22b-4893-8972-798a217729ec_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_EuropeanCommissionMember_37be6a47-1688-4775-b0ea-65b9bd496b41_terseLabel_en-US" xlink:label="lab_mrna_EuropeanCommissionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Commission</link:label>
    <link:label id="lab_mrna_EuropeanCommissionMember_label_en-US" xlink:label="lab_mrna_EuropeanCommissionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Commission [Member]</link:label>
    <link:label id="lab_mrna_EuropeanCommissionMember_documentation_en-US" xlink:label="lab_mrna_EuropeanCommissionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EuropeanCommissionMember" xlink:href="mrna-20201231.xsd#mrna_EuropeanCommissionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_EuropeanCommissionMember" xlink:to="lab_mrna_EuropeanCommissionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_b82b685a-4965-493a-a47c-bfb989b62671_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_VEGFExercise2016Member_d75e452c-d70f-4036-aff5-249046895de4_terseLabel_en-US" xlink:label="lab_mrna_VEGFExercise2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VEGF Exercise 2016</link:label>
    <link:label id="lab_mrna_VEGFExercise2016Member_label_en-US" xlink:label="lab_mrna_VEGFExercise2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VEGF Exercise 2016 [Member]</link:label>
    <link:label id="lab_mrna_VEGFExercise2016Member_documentation_en-US" xlink:label="lab_mrna_VEGFExercise2016Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VEGF Exercise 2016 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_VEGFExercise2016Member" xlink:to="lab_mrna_VEGFExercise2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e4be0830-b87d-4136-9564-74f7b95ab086_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_798f3ad5-dce1-4ac4-b604-c7560366fe38_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carry-forwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_70b138ee-ebaf-408f-b853-b85e7517b2fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_96dfa5fa-a910-466c-9bcb-ea44606fa690_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase period</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_75b8fcab-b370-402b-90ea-10b8f68a904e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_f23b0732-2279-4efb-b680-ec2b8a9a90df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OperatingLossCarryforwardsSubjectToExpiration_fc833cbb-19c8-4327-9b77-90d2ee0f1680_terseLabel_en-US" xlink:label="lab_mrna_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses that begin to expire in 2030</link:label>
    <link:label id="lab_mrna_OperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_mrna_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:label id="lab_mrna_OperatingLossCarryforwardsSubjectToExpiration_documentation_en-US" xlink:label="lab_mrna_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLossCarryforwardsSubjectToExpiration" xlink:href="mrna-20201231.xsd#mrna_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_mrna_OperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_d65a875f-54cc-43cf-88ec-d1a9bf5e895d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedemptionPremium_36ef8607-5ba9-4e5e-afee-dbe34d913ea9_terseLabel_en-US" xlink:label="lab_us-gaap_RedemptionPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium recorded to deferred revenue</link:label>
    <link:label id="lab_us-gaap_RedemptionPremium_label_en-US" xlink:label="lab_us-gaap_RedemptionPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedemptionPremium" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedemptionPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedemptionPremium" xlink:to="lab_us-gaap_RedemptionPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_8d003bd3-7c1c-4d3a-9461-401bc7654240_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_792c6645-9a80-452a-8fd0-7f9712655269_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityTable_45e29dda-7539-4d7a-83de-569f68fc38bd_terseLabel_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract With Customer Liability [Table]</link:label>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityTable_label_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability [Table]</link:label>
    <link:label id="lab_mrna_ChangeInContractWithCustomerLiabilityTable_documentation_en-US" xlink:label="lab_mrna_ChangeInContractWithCustomerLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Contract With Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityTable" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityTable" xlink:to="lab_mrna_ChangeInContractWithCustomerLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e137d252-9bd6-4a2b-a73b-f970e42c2f33_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of common stock under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_b6fc8311-ba7e-479a-a73b-f57bb8352b2c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_277dc034-a313-42b7-ab8b-5fa8e2f07f70_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_aa929d3d-3891-41af-9139-cf7d1dc03636_terseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated arrangement consideration</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_70c2cb3a-0cf7-4eaf-b8a8-05a9ffdb4120_verboseLabel_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Budgeted amount</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_label_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Maximum Amount</link:label>
    <link:label id="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_documentation_en-US" xlink:label="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Maximum Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" xlink:to="lab_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_IncreaseDecreaseInDeferredRentCredit_612875f4-9dd7-467a-9eeb-a99b5ad65416_terseLabel_en-US" xlink:label="lab_mrna_IncreaseDecreaseInDeferredRentCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred lease obligation</link:label>
    <link:label id="lab_mrna_IncreaseDecreaseInDeferredRentCredit_label_en-US" xlink:label="lab_mrna_IncreaseDecreaseInDeferredRentCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Deferred Rent Credit</link:label>
    <link:label id="lab_mrna_IncreaseDecreaseInDeferredRentCredit_documentation_en-US" xlink:label="lab_mrna_IncreaseDecreaseInDeferredRentCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Deferred Rent Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_IncreaseDecreaseInDeferredRentCredit" xlink:href="mrna-20201231.xsd#mrna_IncreaseDecreaseInDeferredRentCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_IncreaseDecreaseInDeferredRentCredit" xlink:to="lab_mrna_IncreaseDecreaseInDeferredRentCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_916b6b2e-7e73-4772-a4e0-9a700634ddb7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Useful Lives of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_b3fff6f9-1bd7-4ddf-82b3-3507e70e106a_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_7dc22a44-d53e-4555-b3d0-f1c33c993152_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6eef97a2-496e-4c6c-a73c-1e2ccc07fe75_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds of initial public offering, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_355f41ad-890d-4031-8a7e-ccd275522061_verboseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock into common stock</link:label>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_48a69dca-2c52-4ea5-9b4e-67ad9dc5f720_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock into common stock</link:label>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_label_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of Temporary to Permanent Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:to="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_8ad4933f-5db0-475f-b4c6-78015cc89467_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed_2d119344-1236-459c-84c5-caa96c9545b6_terseLabel_en-US" xlink:label="lab_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements included in prepaid and other current assets</link:label>
    <link:label id="lab_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed_label_en-US" xlink:label="lab_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements Incurred But Not Yet Reimbursed</link:label>
    <link:label id="lab_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed_documentation_en-US" xlink:label="lab_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements Incurred But Not Yet Reimbursed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed" xlink:href="mrna-20201231.xsd#mrna_LeaseholdImprovementsIncurredButNotYetReimbursed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed" xlink:to="lab_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_63789bfe-743d-435d-a0b8-aeb5a23e6f95_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_84713424-e222-463d-b4ce-7f782d7934ac_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_dad2ea50-6e72-4f8e-a64b-c822db6b5090_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_abf42256-33b1-4f28-acf7-d4a35d5ad444_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivableCurrent_4647c299-fed5-4b6b-aab5-0f5dbef23b10_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable on marketable securities</link:label>
    <link:label id="lab_us-gaap_InterestReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivableCurrent" xlink:to="lab_us-gaap_InterestReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_7cc90cf7-3517-479b-8b05-7c0dca9664c0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets, financing, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9a927160-5d5b-4645-8e71-f5dfc0dcdca1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2d1abe9a-dae7-4ee9-974f-a610713540e8_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ae3637ee-c1f5-4898-b4e6-2972c4ee2d65_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_582719c9-366e-4e8c-aa24-7b58adf99739_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled/forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_UpfrontPaymentMember_c614a413-66d3-4661-8efe-e17f650a0f8f_terseLabel_en-US" xlink:label="lab_mrna_UpfrontPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payment</link:label>
    <link:label id="lab_mrna_UpfrontPaymentMember_label_en-US" xlink:label="lab_mrna_UpfrontPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payment [Member]</link:label>
    <link:label id="lab_mrna_UpfrontPaymentMember_documentation_en-US" xlink:label="lab_mrna_UpfrontPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_UpfrontPaymentMember" xlink:to="lab_mrna_UpfrontPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_55a687f1-49a6-4185-9dbf-45744635c2ef_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_de99ec5f-0307-45e9-a3fe-c9cd38b5a528_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_1059d9fb-e52a-430d-940f-0936627b32ca_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_91f0f55c-d80d-4ed3-be67-33273d46db99_terseLabel_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled/forfeited (usd per share)</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_3c22c6eb-25ef-4193-b345-e5dc387898cc_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OperatingLeaseNumberOfProperties_6e6e35e4-580d-468f-9681-aa16210ef4d7_terseLabel_en-US" xlink:label="lab_mrna_OperatingLeaseNumberOfProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of campuses</link:label>
    <link:label id="lab_mrna_OperatingLeaseNumberOfProperties_label_en-US" xlink:label="lab_mrna_OperatingLeaseNumberOfProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Number Of Properties</link:label>
    <link:label id="lab_mrna_OperatingLeaseNumberOfProperties_documentation_en-US" xlink:label="lab_mrna_OperatingLeaseNumberOfProperties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Number Of Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLeaseNumberOfProperties" xlink:href="mrna-20201231.xsd#mrna_OperatingLeaseNumberOfProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OperatingLeaseNumberOfProperties" xlink:to="lab_mrna_OperatingLeaseNumberOfProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_74c450fe-e025-47fb-adc6-8c0ebb8275ce_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_e575c9a2-15a9-4629-bda3-bf4526eba2a5_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_c266db05-2161-4800-99fa-aca1884111ae_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_631840d7-6187-49f8-8288-81d1c19a3394_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_cf35de3e-88dc-49cc-9e09-b576bea45083_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_818f60b9-fb74-426b-acfb-dea1837e4753_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Redeemable Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8aa76de4-4ac7-4b14-8f33-7defb17859c1_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_278a3102-b938-47e0-8fad-1cb9b64c96e8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_cb9f39f0-dcfb-4b53-ab88-813b163732e4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_2757f8d3-4723-4aeb-87bc-7f553940ba59_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RevenueFromGrantsMaximumAward_8c25afc7-6f19-4d25-9e13-3709b36d68f6_terseLabel_en-US" xlink:label="lab_mrna_RevenueFromGrantsMaximumAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award amount</link:label>
    <link:label id="lab_mrna_RevenueFromGrantsMaximumAward_label_en-US" xlink:label="lab_mrna_RevenueFromGrantsMaximumAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Grants, Maximum Award</link:label>
    <link:label id="lab_mrna_RevenueFromGrantsMaximumAward_documentation_en-US" xlink:label="lab_mrna_RevenueFromGrantsMaximumAward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Grants, Maximum Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsMaximumAward" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsMaximumAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RevenueFromGrantsMaximumAward" xlink:to="lab_mrna_RevenueFromGrantsMaximumAward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1d6e8a72-8da6-4f59-bbc4-e54bf198ba0f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e3c7efde-d5a2-44f2-a3e8-98005f46248a_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e5e489de-4059-4d2e-9aff-2cefdeaa6895_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DeferredTaxAssetsOperatingLeaseLiability_4eac1dd5-3d35-4047-b860-0471a5fd4e9a_terseLabel_en-US" xlink:label="lab_mrna_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_mrna_DeferredTaxAssetsOperatingLeaseLiability_label_en-US" xlink:label="lab_mrna_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:label id="lab_mrna_DeferredTaxAssetsOperatingLeaseLiability_documentation_en-US" xlink:label="lab_mrna_DeferredTaxAssetsOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsOperatingLeaseLiability" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DeferredTaxAssetsOperatingLeaseLiability" xlink:to="lab_mrna_DeferredTaxAssetsOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_82ee6553-e95a-4673-b280-7546a7528eac_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress and Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_81dab5bf-2947-44f4-9259-5192673a5253_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_PCVPerformanceObligationMember_e5356acd-4e66-4a24-b4ee-1d8e2a7177ce_terseLabel_en-US" xlink:label="lab_mrna_PCVPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PCV Performance Obligation</link:label>
    <link:label id="lab_mrna_PCVPerformanceObligationMember_label_en-US" xlink:label="lab_mrna_PCVPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PCV Performance Obligation [Member]</link:label>
    <link:label id="lab_mrna_PCVPerformanceObligationMember_documentation_en-US" xlink:label="lab_mrna_PCVPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PCV Performance Obligation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVPerformanceObligationMember" xlink:href="mrna-20201231.xsd#mrna_PCVPerformanceObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_PCVPerformanceObligationMember" xlink:to="lab_mrna_PCVPerformanceObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_2f7d40d2-6b6f-469e-ac29-7660a2f340b7_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities - financing</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_5f2089f9-8d4d-4378-b27f-358decbb0ca1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d3ea633e-dd2a-4fb3-b73b-0be94a12fe03_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_4ddaae70-c9e6-48c1-9c8d-fcc7bf7359ed_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_e003f504-a4f8-4deb-a499-025992d716ba_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_d4ad7fb6-2835-407a-a7ce-299144b75c5f_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_37f340d2-5b97-4959-8ed7-8686de0c1c85_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_fd3ab4a3-2e70-4f84-a101-2fe0e338e447_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twelve months of continued employment or service</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_498c2d72-d255-4a29-9ca5-06fcbafa8da9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of options exercised (less than for the year ended December 31, 2017)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_625c1541-4514-4727-aa6d-5e3be6db530b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease due to prior positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_RemainingUnsatisfiedPerformanceObligationMember_b6d93f46-40ce-4767-abb0-6f7ec8ed9bd0_terseLabel_en-US" xlink:label="lab_mrna_RemainingUnsatisfiedPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining unsatisfied performance obligation</link:label>
    <link:label id="lab_mrna_RemainingUnsatisfiedPerformanceObligationMember_label_en-US" xlink:label="lab_mrna_RemainingUnsatisfiedPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Unsatisfied Performance Obligation [Member]</link:label>
    <link:label id="lab_mrna_RemainingUnsatisfiedPerformanceObligationMember_documentation_en-US" xlink:label="lab_mrna_RemainingUnsatisfiedPerformanceObligationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining Unsatisfied Performance Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RemainingUnsatisfiedPerformanceObligationMember" xlink:href="mrna-20201231.xsd#mrna_RemainingUnsatisfiedPerformanceObligationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_RemainingUnsatisfiedPerformanceObligationMember" xlink:to="lab_mrna_RemainingUnsatisfiedPerformanceObligationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_2c2bc3bf-14b2-498d-88c5-0fd4c1a8a1f9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_711dbd1e-27b3-4c3d-893a-aee1d7ce5bdf_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_b57f5224-7c33-4365-9d1b-17e1d99191d6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_c1c34979-1a64-4443-b666-b9d27ba223c9_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_591c9c1d-058a-4a29-8f82-8fa30623c91d_netLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_485e2c0c-5335-44b1-8096-0a48d2012efd_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Axis]</link:label>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Project [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_281475ec-7f5c-49e3-a058-f96457578d3f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9331fc58-012c-476a-8493-f3b30ffd2b57_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DevelopmentMilestonesMember_9e04a7bf-7443-4ade-a736-3d895c6ba36a_terseLabel_en-US" xlink:label="lab_mrna_DevelopmentMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Milestones</link:label>
    <link:label id="lab_mrna_DevelopmentMilestonesMember_label_en-US" xlink:label="lab_mrna_DevelopmentMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Milestones [Member]</link:label>
    <link:label id="lab_mrna_DevelopmentMilestonesMember_documentation_en-US" xlink:label="lab_mrna_DevelopmentMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Milestones [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentMilestonesMember" xlink:href="mrna-20201231.xsd#mrna_DevelopmentMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DevelopmentMilestonesMember" xlink:to="lab_mrna_DevelopmentMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_2e1e8486-8259-4688-96ed-e3c8813318fa_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_09db86b0-7254-4905-a08b-6868bc1cf0fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date per Share/Unit</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_9ea7bfe6-4213-4f40-b2db-bfbcd150988f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_AccruedClinicalTrials_d8626bc1-82e1-417e-8bd5-12683b986c4a_terseLabel_en-US" xlink:label="lab_mrna_AccruedClinicalTrials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Clinical trials</link:label>
    <link:label id="lab_mrna_AccruedClinicalTrials_label_en-US" xlink:label="lab_mrna_AccruedClinicalTrials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Clinical Trials</link:label>
    <link:label id="lab_mrna_AccruedClinicalTrials_documentation_en-US" xlink:label="lab_mrna_AccruedClinicalTrials" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Clinical Trials</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedClinicalTrials" xlink:href="mrna-20201231.xsd#mrna_AccruedClinicalTrials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_AccruedClinicalTrials" xlink:to="lab_mrna_AccruedClinicalTrials" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_SupplyAndManufacturingAgreementsMember_b62cdec6-1920-478e-95c9-c5d1ec8afcf2_terseLabel_en-US" xlink:label="lab_mrna_SupplyAndManufacturingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply and manufacturing agreements</link:label>
    <link:label id="lab_mrna_SupplyAndManufacturingAgreementsMember_label_en-US" xlink:label="lab_mrna_SupplyAndManufacturingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply And Manufacturing Agreements [Member]</link:label>
    <link:label id="lab_mrna_SupplyAndManufacturingAgreementsMember_documentation_en-US" xlink:label="lab_mrna_SupplyAndManufacturingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply And Manufacturing Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SupplyAndManufacturingAgreementsMember" xlink:href="mrna-20201231.xsd#mrna_SupplyAndManufacturingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_SupplyAndManufacturingAgreementsMember" xlink:to="lab_mrna_SupplyAndManufacturingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_4f112796-c1e7-4553-8b6c-834a69a548bd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_afa2cdf7-43e6-477e-aaa8-91012537bf36_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_Combined2018AZAgreementsMember_fa5203ba-1d85-47b6-9bb9-118e9ec42640_terseLabel_en-US" xlink:label="lab_mrna_Combined2018AZAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined 2018 AZ Agreements</link:label>
    <link:label id="lab_mrna_Combined2018AZAgreementsMember_label_en-US" xlink:label="lab_mrna_Combined2018AZAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined 2018 AZ Agreements [Member]</link:label>
    <link:label id="lab_mrna_Combined2018AZAgreementsMember_documentation_en-US" xlink:label="lab_mrna_Combined2018AZAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined 2018 AZ Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_Combined2018AZAgreementsMember" xlink:to="lab_mrna_Combined2018AZAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_8b5a55d0-bc0d-4fbe-ab05-f23fa0334606_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_TenantIncentivesReceivablesCurrent_81663fac-2731-4e2d-b4db-1d77cb7b4361_terseLabel_en-US" xlink:label="lab_mrna_TenantIncentivesReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant incentives receivables</link:label>
    <link:label id="lab_mrna_TenantIncentivesReceivablesCurrent_label_en-US" xlink:label="lab_mrna_TenantIncentivesReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant Incentives Receivables, Current</link:label>
    <link:label id="lab_mrna_TenantIncentivesReceivablesCurrent_documentation_en-US" xlink:label="lab_mrna_TenantIncentivesReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant Incentives Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TenantIncentivesReceivablesCurrent" xlink:href="mrna-20201231.xsd#mrna_TenantIncentivesReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_TenantIncentivesReceivablesCurrent" xlink:to="lab_mrna_TenantIncentivesReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_57432d21-af0f-4a14-82b2-b1dbb5424f11_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_99912516-3855-4835-a470-f5b4f97b0a7d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_823da96b-02e4-4882-b263-fd8638967492_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding and Exercisable</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_ContractOptionsMember_f5acdde4-e1be-4667-ae0f-be112aeef545_terseLabel_en-US" xlink:label="lab_mrna_ContractOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract options</link:label>
    <link:label id="lab_mrna_ContractOptionsMember_label_en-US" xlink:label="lab_mrna_ContractOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Options [Member]</link:label>
    <link:label id="lab_mrna_ContractOptionsMember_documentation_en-US" xlink:label="lab_mrna_ContractOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractOptionsMember" xlink:href="mrna-20201231.xsd#mrna_ContractOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_ContractOptionsMember" xlink:to="lab_mrna_ContractOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_262cdafc-151f-4ea6-b70a-e1d383a2b113_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Term, Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cf5f0a3-76ed-4aa8-ae9e-954f84dad234_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts_c2063181-3000-4cfa-ba61-8780457e7cfc_terseLabel_en-US" xlink:label="lab_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized inventory</link:label>
    <link:label id="lab_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts_label_en-US" xlink:label="lab_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Expense, Capitalized Inventory Costs</link:label>
    <link:label id="lab_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts_documentation_en-US" xlink:label="lab_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Expense, Capitalized Inventory Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts" xlink:to="lab_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c92faef3-4395-4e34-a630-ba11793cf281_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price per Share, Exercisable (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f0646461-fb16-42ad-86a4-3bbd82b5bedb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_8b22e980-0b35-499a-b510-7f8f4c40ec5a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_4abc34af-127b-4b89-9d0d-93051089f116_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_7f527ac7-3186-4ece-8fe9-80bed9e7d6c2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_239bfbdb-0416-4a02-93d6-57d9a7caac47_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effected at statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_fab95429-7618-4fd9-b648-108a7da5b004_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price per Share (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f34e4f69-9ec5-40d6-a658-0a7e9fea6135_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Standards/Recently Issued Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mrna_OperatingLossCarryforwardsNotSubjectToExpiration_9cb2ee4f-d284-4c4c-99ce-3d0d1cfaba57_terseLabel_en-US" xlink:label="lab_mrna_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses that will carry-forward indefinitely</link:label>
    <link:label id="lab_mrna_OperatingLossCarryforwardsNotSubjectToExpiration_label_en-US" xlink:label="lab_mrna_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:label id="lab_mrna_OperatingLossCarryforwardsNotSubjectToExpiration_documentation_en-US" xlink:label="lab_mrna_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Not Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:href="mrna-20201231.xsd#mrna_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mrna_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="lab_mrna_OperatingLossCarryforwardsNotSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_c73bd4d0-d62a-4cfc-aa99-949ad701c045_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>mrna-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:587e37ef-2d85-4611-b0f5-79aaf037b83c,g:a4c5467e-e912-4919-957b-a5dc25d57b8f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.modernatx.com/role/Cover" xlink:type="simple" xlink:href="mrna-20201231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_eefe848d-325b-458a-a8b3-63518feca6a4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_DocumentType_eefe848d-325b-458a-a8b3-63518feca6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_df10ebe0-c638-4884-879c-bba012659258" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_DocumentAnnualReport_df10ebe0-c638-4884-879c-bba012659258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_686a7280-9bc7-4e85-a934-347140994e7e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_DocumentPeriodEndDate_686a7280-9bc7-4e85-a934-347140994e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e3888c0c-9585-4f83-83ff-3e1e79dc4122" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_DocumentTransitionReport_e3888c0c-9585-4f83-83ff-3e1e79dc4122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_54974366-12f1-4060-b1a8-996bd7d7c9ef" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityFileNumber_54974366-12f1-4060-b1a8-996bd7d7c9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_94088696-3d13-4b4b-8234-388d633dfea9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityRegistrantName_94088696-3d13-4b4b-8234-388d633dfea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d3215bf6-c402-4488-bb7c-72f50f409a52" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d3215bf6-c402-4488-bb7c-72f50f409a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a6d52007-e248-4a54-8dea-ea58d3fcfa90" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityTaxIdentificationNumber_a6d52007-e248-4a54-8dea-ea58d3fcfa90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c6231d56-69fc-4fb8-ace3-9c92449957e8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityAddressAddressLine1_c6231d56-69fc-4fb8-ace3-9c92449957e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c7afd2a5-75f9-40a6-9dca-4340d19f6a74" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityAddressCityOrTown_c7afd2a5-75f9-40a6-9dca-4340d19f6a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f603267c-2507-4a3b-a654-543d427965ba" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityAddressStateOrProvince_f603267c-2507-4a3b-a654-543d427965ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_194c030e-0610-4773-8309-f9f1aa0ffb13" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityAddressPostalZipCode_194c030e-0610-4773-8309-f9f1aa0ffb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ca3252c9-8259-4fc9-969c-bbaaeacb80c7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_CityAreaCode_ca3252c9-8259-4fc9-969c-bbaaeacb80c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_74f4cce8-c7ea-424a-9929-96a598cd98fc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_LocalPhoneNumber_74f4cce8-c7ea-424a-9929-96a598cd98fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c68dcc48-c1fa-4c8b-b7b9-224dc4bff0eb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_Security12bTitle_c68dcc48-c1fa-4c8b-b7b9-224dc4bff0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_52dcc792-c7c9-492c-b0fc-7e0e2422123e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_TradingSymbol_52dcc792-c7c9-492c-b0fc-7e0e2422123e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2d2ace18-219a-4382-b763-40e978023c1d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_SecurityExchangeName_2d2ace18-219a-4382-b763-40e978023c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_2f54d2f6-6bdc-4d41-b5e6-6a94a01111f6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_2f54d2f6-6bdc-4d41-b5e6-6a94a01111f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_cff69cd6-6aff-46bc-b05b-9d445da44421" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityVoluntaryFilers_cff69cd6-6aff-46bc-b05b-9d445da44421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c982fd76-d726-4609-8b94-f9bba8639469" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityCurrentReportingStatus_c982fd76-d726-4609-8b94-f9bba8639469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ff238dda-e82e-47f6-badc-71610562d30b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityInteractiveDataCurrent_ff238dda-e82e-47f6-badc-71610562d30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d81ee959-84a1-4b93-acf9-da6d8e37285d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityFilerCategory_d81ee959-84a1-4b93-acf9-da6d8e37285d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_073dc52f-a2d2-42dc-b388-124558e87eb3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntitySmallBusiness_073dc52f-a2d2-42dc-b388-124558e87eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_084e9f3c-2f67-40be-b9cd-64a90df4a76d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityEmergingGrowthCompany_084e9f3c-2f67-40be-b9cd-64a90df4a76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_0c3b0997-2312-4eec-a989-a72d088de8ff" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityShellCompany_0c3b0997-2312-4eec-a989-a72d088de8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_ced5ea7e-4a12-4e56-87a9-bd5a1bdc958e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityPublicFloat_ced5ea7e-4a12-4e56-87a9-bd5a1bdc958e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_683b0f5a-3f5d-4e52-acb7-1e9286d51040" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_683b0f5a-3f5d-4e52-acb7-1e9286d51040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_6cb7671f-7c8a-424e-84f5-5f15e886d251" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_6cb7671f-7c8a-424e-84f5-5f15e886d251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_3d64f15d-5db8-4a21-9f0d-c465e6d6ab23" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_AmendmentFlag_3d64f15d-5db8-4a21-9f0d-c465e6d6ab23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a94f20b2-b32b-4c67-83f6-c22cf38d15ea" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_DocumentFiscalYearFocus_a94f20b2-b32b-4c67-83f6-c22cf38d15ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_47c3af65-5b9f-46ed-81b4-6afcd631eaa0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_47c3af65-5b9f-46ed-81b4-6afcd631eaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f9e20231-5850-419e-be70-5f3cff936e28" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_EntityCentralIndexKey_f9e20231-5850-419e-be70-5f3cff936e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4049e0fb-81c9-4712-80fc-64ced38b9a5d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_CurrentFiscalYearEndDate_4049e0fb-81c9-4712-80fc-64ced38b9a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_904c967b-0bbd-40c2-9898-d54b66d1e4d4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_985f3265-2b20-49f3-8976-446ade1ad10d" xlink:to="loc_dei_IcfrAuditorAttestationFlag_904c967b-0bbd-40c2-9898-d54b66d1e4d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_82699c42-025e-4747-8448-9bd7c33f8f37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_022af93b-76ba-49f4-b3f6-a7304db5b37b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_82699c42-025e-4747-8448-9bd7c33f8f37" xlink:to="loc_us-gaap_AssetsAbstract_022af93b-76ba-49f4-b3f6-a7304db5b37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ec01f763-ca5c-41e4-910a-e9af3accccf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_022af93b-76ba-49f4-b3f6-a7304db5b37b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ec01f763-ca5c-41e4-910a-e9af3accccf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9911fa62-f20d-4af8-86d2-4dee21083777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ec01f763-ca5c-41e4-910a-e9af3accccf7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9911fa62-f20d-4af8-86d2-4dee21083777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b0c8ecf5-5a65-4c65-a62f-f2a7d061d9aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ec01f763-ca5c-41e4-910a-e9af3accccf7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b0c8ecf5-5a65-4c65-a62f-f2a7d061d9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_03c7fef7-f77a-452c-b8e1-169c7680b064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ec01f763-ca5c-41e4-910a-e9af3accccf7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_03c7fef7-f77a-452c-b8e1-169c7680b064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cbca9728-f526-426c-8a36-4842515f1e1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ec01f763-ca5c-41e4-910a-e9af3accccf7" xlink:to="loc_us-gaap_InventoryNet_cbca9728-f526-426c-8a36-4842515f1e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ec55f7be-db53-4fe0-9407-17e272f04c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ec01f763-ca5c-41e4-910a-e9af3accccf7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ec55f7be-db53-4fe0-9407-17e272f04c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_f11162b0-7ea0-4e4e-81c5-2efaf8adf940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ec01f763-ca5c-41e4-910a-e9af3accccf7" xlink:to="loc_us-gaap_RestrictedCashCurrent_f11162b0-7ea0-4e4e-81c5-2efaf8adf940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b70863f2-6158-4472-9a3f-2f789b568311" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ec01f763-ca5c-41e4-910a-e9af3accccf7" xlink:to="loc_us-gaap_AssetsCurrent_b70863f2-6158-4472-9a3f-2f789b568311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_ee698764-87d8-4752-92ac-10f9221688af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_022af93b-76ba-49f4-b3f6-a7304db5b37b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_ee698764-87d8-4752-92ac-10f9221688af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_57d1b977-bdcb-454c-9ca0-806f95d878db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_022af93b-76ba-49f4-b3f6-a7304db5b37b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_57d1b977-bdcb-454c-9ca0-806f95d878db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_81509ed0-f20a-497c-9fa3-30fed3ab2e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_022af93b-76ba-49f4-b3f6-a7304db5b37b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_81509ed0-f20a-497c-9fa3-30fed3ab2e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_d527cdaa-4cc3-484b-a86a-23add3d9a8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_022af93b-76ba-49f4-b3f6-a7304db5b37b" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_d527cdaa-4cc3-484b-a86a-23add3d9a8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_cd706449-1e46-4796-a098-1675ac0e5b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_022af93b-76ba-49f4-b3f6-a7304db5b37b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_cd706449-1e46-4796-a098-1675ac0e5b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_92af9a62-1095-48aa-94c6-4df2062a6253" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_022af93b-76ba-49f4-b3f6-a7304db5b37b" xlink:to="loc_us-gaap_Assets_92af9a62-1095-48aa-94c6-4df2062a6253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_82699c42-025e-4747-8448-9bd7c33f8f37" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6af8608c-f15f-43d0-abdf-72a931394749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6af8608c-f15f-43d0-abdf-72a931394749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_696d3865-98e0-4452-8609-0b51b26693ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6af8608c-f15f-43d0-abdf-72a931394749" xlink:to="loc_us-gaap_AccountsPayableCurrent_696d3865-98e0-4452-8609-0b51b26693ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b5c51d27-dcb0-4585-ab24-1c946a07a99c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6af8608c-f15f-43d0-abdf-72a931394749" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_b5c51d27-dcb0-4585-ab24-1c946a07a99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d0e7dce1-4093-4eee-862c-205b8790fdc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6af8608c-f15f-43d0-abdf-72a931394749" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d0e7dce1-4093-4eee-862c-205b8790fdc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_dcfdedb2-5134-411d-a8f2-f3f65238a6bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6af8608c-f15f-43d0-abdf-72a931394749" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_dcfdedb2-5134-411d-a8f2-f3f65238a6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ec15d7c9-211e-4cc0-8a06-0ad87b90fd4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6af8608c-f15f-43d0-abdf-72a931394749" xlink:to="loc_us-gaap_LiabilitiesCurrent_ec15d7c9-211e-4cc0-8a06-0ad87b90fd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6327627d-ec3b-4218-b41d-97c3b246802c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6327627d-ec3b-4218-b41d-97c3b246802c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5bc7994e-526a-45c2-b106-def7d720cb83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5bc7994e-526a-45c2-b106-def7d720cb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_19b236f8-a6f4-4467-bd24-389f6d01dee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_19b236f8-a6f4-4467-bd24-389f6d01dee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_08c423eb-ee85-40d5-9753-c541e2c2962b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_08c423eb-ee85-40d5-9753-c541e2c2962b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_959b717c-5d23-4dba-a24c-9f4e4bc7bce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:to="loc_us-gaap_Liabilities_959b717c-5d23-4dba-a24c-9f4e4bc7bce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_13cf60ad-cdf9-44ac-8b32-99f597a7aca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_13cf60ad-cdf9-44ac-8b32-99f597a7aca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_fec07476-35bf-43af-88e6-f20dd98f43de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:to="loc_us-gaap_StockholdersEquityAbstract_fec07476-35bf-43af-88e6-f20dd98f43de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_44318c0e-e1c7-4a9b-8f4a-3cc505c4240c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fec07476-35bf-43af-88e6-f20dd98f43de" xlink:to="loc_us-gaap_PreferredStockValue_44318c0e-e1c7-4a9b-8f4a-3cc505c4240c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0f09528e-af32-45a8-af6f-8e0de1a994f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fec07476-35bf-43af-88e6-f20dd98f43de" xlink:to="loc_us-gaap_CommonStockValue_0f09528e-af32-45a8-af6f-8e0de1a994f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_525e6efe-0c42-489f-b02d-d320242025c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fec07476-35bf-43af-88e6-f20dd98f43de" xlink:to="loc_us-gaap_AdditionalPaidInCapital_525e6efe-0c42-489f-b02d-d320242025c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8f604be9-233e-4257-bd99-11addc85c53d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fec07476-35bf-43af-88e6-f20dd98f43de" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8f604be9-233e-4257-bd99-11addc85c53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2fddc598-8da4-4215-a248-443da21062c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fec07476-35bf-43af-88e6-f20dd98f43de" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2fddc598-8da4-4215-a248-443da21062c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2f53251f-316c-4f23-9e7a-14822742deb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fec07476-35bf-43af-88e6-f20dd98f43de" xlink:to="loc_us-gaap_StockholdersEquity_2f53251f-316c-4f23-9e7a-14822742deb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d5358fb8-9bc3-4e0a-8e96-fdfe827cf5e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0af9bd07-5e76-41ac-a013-fe7e48b7afa0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d5358fb8-9bc3-4e0a-8e96-fdfe827cf5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e59e7ee7-df34-4d57-bd42-4b6b54153f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1c01e4d1-a9ed-41b4-a772-82e886190283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e59e7ee7-df34-4d57-bd42-4b6b54153f9b" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1c01e4d1-a9ed-41b4-a772-82e886190283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_09c001a2-4d06-452c-9677-c1e7999e81dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e59e7ee7-df34-4d57-bd42-4b6b54153f9b" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_09c001a2-4d06-452c-9677-c1e7999e81dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_b5fcbf57-8d60-485a-93f7-442b3bf8f1e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e59e7ee7-df34-4d57-bd42-4b6b54153f9b" xlink:to="loc_us-gaap_PreferredStockSharesIssued_b5fcbf57-8d60-485a-93f7-442b3bf8f1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_d28c39e8-7c1d-4252-b294-ce271950460f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e59e7ee7-df34-4d57-bd42-4b6b54153f9b" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_d28c39e8-7c1d-4252-b294-ce271950460f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_70fa7425-d1b5-49ba-bcdf-689361d67392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e59e7ee7-df34-4d57-bd42-4b6b54153f9b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_70fa7425-d1b5-49ba-bcdf-689361d67392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_96dd5478-71a6-4795-9428-14a10b0ff83d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e59e7ee7-df34-4d57-bd42-4b6b54153f9b" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_96dd5478-71a6-4795-9428-14a10b0ff83d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_808ba7d1-938f-4017-9fb2-dbc67c5e91e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e59e7ee7-df34-4d57-bd42-4b6b54153f9b" xlink:to="loc_us-gaap_CommonStockSharesIssued_808ba7d1-938f-4017-9fb2-dbc67c5e91e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1962a966-7256-4ea0-9f53-68607858b77b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e59e7ee7-df34-4d57-bd42-4b6b54153f9b" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1962a966-7256-4ea0-9f53-68607858b77b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_09922eff-2692-465d-b2b9-903f2b1710b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c82373d7-bee2-463a-88a1-c5ef415146b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_09922eff-2692-465d-b2b9-903f2b1710b8" xlink:to="loc_us-gaap_StatementTable_c82373d7-bee2-463a-88a1-c5ef415146b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_46da70d2-82b6-4215-a746-f1675dfa99ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c82373d7-bee2-463a-88a1-c5ef415146b2" xlink:to="loc_srt_ProductOrServiceAxis_46da70d2-82b6-4215-a746-f1675dfa99ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_949fd2ef-ea2a-4257-b138-30bd6d314485" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_46da70d2-82b6-4215-a746-f1675dfa99ee" xlink:to="loc_srt_ProductsAndServicesDomain_949fd2ef-ea2a-4257-b138-30bd6d314485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_4865a67d-0ca5-48f5-a7e1-d3fc6df4ecf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_949fd2ef-ea2a-4257-b138-30bd6d314485" xlink:to="loc_us-gaap_GrantMember_4865a67d-0ca5-48f5-a7e1-d3fc6df4ecf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ProductSalesMember_86500364-cdc9-4091-89cd-efa796bb8f11" xlink:href="mrna-20201231.xsd#mrna_ProductSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_949fd2ef-ea2a-4257-b138-30bd6d314485" xlink:to="loc_mrna_ProductSalesMember_86500364-cdc9-4091-89cd-efa796bb8f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_f1203602-b15f-4c57-97f6-e50c54721dd8" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_949fd2ef-ea2a-4257-b138-30bd6d314485" xlink:to="loc_mrna_CollaborationArrangementMember_f1203602-b15f-4c57-97f6-e50c54721dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c82373d7-bee2-463a-88a1-c5ef415146b2" xlink:to="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_44531a82-e843-42f9-bf76-02341e9d2062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_RevenuesAbstract_44531a82-e843-42f9-bf76-02341e9d2062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_35872149-de02-4a00-9015-480ed5017e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_44531a82-e843-42f9-bf76-02341e9d2062" xlink:to="loc_us-gaap_Revenues_35872149-de02-4a00-9015-480ed5017e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d777e2e5-14d1-4154-9400-0ad239064ed8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d777e2e5-14d1-4154-9400-0ad239064ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2026d311-152e-4ac4-acae-4c9151cbc9f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2026d311-152e-4ac4-acae-4c9151cbc9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9f5bdff3-8a4c-4841-9571-f54130db1ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9f5bdff3-8a4c-4841-9571-f54130db1ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5b522978-0826-4ab8-aa6a-d2dafd0cc57d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5d8bf6ce-385b-4cdf-895f-6b64a3d17eac" xlink:to="loc_us-gaap_CostsAndExpenses_5b522978-0826-4ab8-aa6a-d2dafd0cc57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c10f9082-6445-41ac-bebf-b3d9c2818f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_OperatingIncomeLoss_c10f9082-6445-41ac-bebf-b3d9c2818f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_52bfbc48-a033-42b8-a5c9-6be1889811e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_InvestmentIncomeInterest_52bfbc48-a033-42b8-a5c9-6be1889811e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_33c06645-52f0-4124-bfba-c36150fb3354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_33c06645-52f0-4124-bfba-c36150fb3354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_01005e4b-cdfb-4e37-b26b-4229cea7dfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_01005e4b-cdfb-4e37-b26b-4229cea7dfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d1d6d816-b312-4235-bf8a-8733bba68696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d1d6d816-b312-4235-bf8a-8733bba68696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_41c05de8-e324-4214-bcb3-dfcee77e6cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_NetIncomeLoss_41c05de8-e324-4214-bcb3-dfcee77e6cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_57b7b0be-9207-464e-b24f-89ff8f67e8cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_57b7b0be-9207-464e-b24f-89ff8f67e8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockRedemptionPremium_84923864-c45e-4b43-9aff-03bad0614406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockRedemptionPremium"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_57b7b0be-9207-464e-b24f-89ff8f67e8cc" xlink:to="loc_us-gaap_PreferredStockRedemptionPremium_84923864-c45e-4b43-9aff-03bad0614406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockDividends_2b838c91-6a1a-48bf-82f5-dd7a5c328e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockDividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_57b7b0be-9207-464e-b24f-89ff8f67e8cc" xlink:to="loc_us-gaap_RedeemablePreferredStockDividends_2b838c91-6a1a-48bf-82f5-dd7a5c328e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4e233f7e-7e3d-4a5c-bea4-7d3820730eb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_4e233f7e-7e3d-4a5c-bea4-7d3820730eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_dbca39a2-90a4-49fc-8545-031a6bbdc9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_dbca39a2-90a4-49fc-8545-031a6bbdc9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_b603d5e2-b905-4ccb-8d42-0425c67ff56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_a7b840b5-ad78-404f-97fd-992d74bb6dd5" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_b603d5e2-b905-4ccb-8d42-0425c67ff56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a6c2c066-6e2e-4a46-b4c6-d73e7c168e27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_eca78c3c-bcf8-461d-9faf-846843216610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a6c2c066-6e2e-4a46-b4c6-d73e7c168e27" xlink:to="loc_us-gaap_NetIncomeLoss_eca78c3c-bcf8-461d-9faf-846843216610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d4e789e-0d17-46b8-a298-e9a4dcd7dc75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a6c2c066-6e2e-4a46-b4c6-d73e7c168e27" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d4e789e-0d17-46b8-a298-e9a4dcd7dc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_b2198e26-6ef1-4392-9e3c-bfa1a77e6740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d4e789e-0d17-46b8-a298-e9a4dcd7dc75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_b2198e26-6ef1-4392-9e3c-bfa1a77e6740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_a4e39cdf-d64a-448e-bdf8-c8ff9af9870f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d4e789e-0d17-46b8-a298-e9a4dcd7dc75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_a4e39cdf-d64a-448e-bdf8-c8ff9af9870f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f2232459-f3cd-420c-89f1-21b8d54f2013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_7d4e789e-0d17-46b8-a298-e9a4dcd7dc75" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f2232459-f3cd-420c-89f1-21b8d54f2013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b00d22d-31df-4ad6-8bfb-da3712745ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a6c2c066-6e2e-4a46-b4c6-d73e7c168e27" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b00d22d-31df-4ad6-8bfb-da3712745ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_79fef38f-5645-41b3-bb97-ffe6aa0ef3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2c317628-80db-4f84-9cf7-be14e7846847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_79fef38f-5645-41b3-bb97-ffe6aa0ef3fd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2c317628-80db-4f84-9cf7-be14e7846847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2a67856e-a814-43f0-abcd-5da554172502" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2a67856e-a814-43f0-abcd-5da554172502" xlink:to="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_325ac5cd-51ca-4e4a-a4e8-071c48b7358b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_325ac5cd-51ca-4e4a-a4e8-071c48b7358b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_3f0899b2-ffab-493d-a112-0fd7326297ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_325ac5cd-51ca-4e4a-a4e8-071c48b7358b" xlink:to="loc_us-gaap_TypeOfAdoptionMember_3f0899b2-ffab-493d-a112-0fd7326297ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201409Member_1a3909e3-df5c-4b2f-9700-8d18c2c1852d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201409Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3f0899b2-ffab-493d-a112-0fd7326297ac" xlink:to="loc_us-gaap_AccountingStandardsUpdate201409Member_1a3909e3-df5c-4b2f-9700-8d18c2c1852d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_8d5f8945-2d93-41dc-a1be-300677c0acbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_3f0899b2-ffab-493d-a112-0fd7326297ac" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_8d5f8945-2d93-41dc-a1be-300677c0acbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_abac770f-7d23-4058-ae62-33c6890afacc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_abac770f-7d23-4058-ae62-33c6890afacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_abac770f-7d23-4058-ae62-33c6890afacc" xlink:to="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_a9328de8-b851-453c-a22a-de0a9413ad62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:to="loc_us-gaap_PreferredStockMember_a9328de8-b851-453c-a22a-de0a9413ad62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ea823062-17c8-465b-b99d-fd5a7c2a1971" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:to="loc_us-gaap_CommonStockMember_ea823062-17c8-465b-b99d-fd5a7c2a1971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ede96309-4034-45c6-8ff3-43f938756a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ede96309-4034-45c6-8ff3-43f938756a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_261f5801-1b36-4fca-8d5e-9d4e9b6e275f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_261f5801-1b36-4fca-8d5e-9d4e9b6e275f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_dc4dc5f3-c599-48d9-8e99-536414080add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_1f9303ee-857b-46da-8379-95acfcbc2247" xlink:to="loc_us-gaap_RetainedEarningsMember_dc4dc5f3-c599-48d9-8e99-536414080add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3507f754-9725-4dbc-ba88-0defea92c5a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3507f754-9725-4dbc-ba88-0defea92c5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3507f754-9725-4dbc-ba88-0defea92c5a6" xlink:to="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesGPreferredStockMember_520bfe22-80a4-477b-a120-b9e40010de31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesGPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:to="loc_us-gaap_SeriesGPreferredStockMember_520bfe22-80a4-477b-a120-b9e40010de31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesHPreferredStockMember_dcf18e22-fc6e-49e8-b036-b8e4c4484ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesHPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:to="loc_us-gaap_SeriesHPreferredStockMember_dcf18e22-fc6e-49e8-b036-b8e4c4484ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_512fce0d-8bff-44fa-8016-c956c7e87ba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_512fce0d-8bff-44fa-8016-c956c7e87ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_f93da79f-4abe-49e7-b860-10f1f5604943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cb60f971-1f2b-445e-9b43-0acea0de6dd3" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_f93da79f-4abe-49e7-b860-10f1f5604943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8a509ea1-cc6b-4c61-8a39-9b1f629296de" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8a509ea1-cc6b-4c61-8a39-9b1f629296de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b0a040d5-fe71-437c-b0ce-758e7c018c4e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8a509ea1-cc6b-4c61-8a39-9b1f629296de" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b0a040d5-fe71-437c-b0ce-758e7c018c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_19d35076-7e3d-4829-9b76-46568eaef055" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b0a040d5-fe71-437c-b0ce-758e7c018c4e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_19d35076-7e3d-4829-9b76-46568eaef055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0770a070-50d1-4675-9a57-4c341f62ae0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f281e88f-cead-47be-9d61-31b444eee3f6" xlink:to="loc_us-gaap_StatementLineItems_0770a070-50d1-4675-9a57-4c341f62ae0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0770a070-50d1-4675-9a57-4c341f62ae0b" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_5aeedcda-e10a-4467-9ec0-19989d59a360" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_5aeedcda-e10a-4467-9ec0-19989d59a360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a4c33d94-01da-4d1b-a8a3-907c0074bb7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a4c33d94-01da-4d1b-a8a3-907c0074bb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_c15d428c-2966-42c8-b2f6-ef4916f557ac" xlink:href="mrna-20201231.xsd#mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_c15d428c-2966-42c8-b2f6-ef4916f557ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_c0e2e089-4f84-4e96-b7a6-93836ab0a7a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_c0e2e089-4f84-4e96-b7a6-93836ab0a7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares_0da7fe7c-9827-47d7-8219-57a9a304c5d1" xlink:href="mrna-20201231.xsd#mrna_TemporaryEquityStockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares_0da7fe7c-9827-47d7-8219-57a9a304c5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue_dfaadf39-2795-4ed4-9433-e9193d99f239" xlink:href="mrna-20201231.xsd#mrna_TemporaryEquityStockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue_dfaadf39-2795-4ed4-9433-e9193d99f239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_dfad6aca-1055-40da-b0aa-5e1a72db5508" xlink:href="mrna-20201231.xsd#mrna_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_dfad6aca-1055-40da-b0aa-5e1a72db5508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_12863e91-b47b-4377-832a-e2206fa82536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_12863e91-b47b-4377-832a-e2206fa82536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_a576a8c5-d15d-4599-8764-e12bfce3fdee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_a576a8c5-d15d-4599-8764-e12bfce3fdee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_961aa497-873c-46d6-8c48-5ecd14b48fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_c50bcd56-70e5-4913-b820-508a957b11b9" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_961aa497-873c-46d6-8c48-5ecd14b48fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0770a070-50d1-4675-9a57-4c341f62ae0b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_7abf119c-154b-40e6-a370-c36b6380f3b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_SharesOutstanding_7abf119c-154b-40e6-a370-c36b6380f3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b6940e2d-61d3-4947-9974-d02e3026aebe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockholdersEquity_b6940e2d-61d3-4947-9974-d02e3026aebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_fbd8df22-6ea9-40f8-a2a4-5ccc5b679841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_fbd8df22-6ea9-40f8-a2a4-5ccc5b679841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b734f145-7f85-4c49-938c-4022046e8d65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b734f145-7f85-4c49-938c-4022046e8d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0925c3d5-7191-4e7d-b790-397d30b77779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0925c3d5-7191-4e7d-b790-397d30b77779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2bac59d6-5831-4148-bd99-7f0c3d36be28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2bac59d6-5831-4148-bd99-7f0c3d36be28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_69159b4c-4943-45c5-aa35-cb537b70fedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_69159b4c-4943-45c5-aa35-cb537b70fedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_4b974ee1-4cf4-41ab-91e2-2c2bed6b8d6e" xlink:href="mrna-20201231.xsd#mrna_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_mrna_ReclassificationsOfTemporaryToPermanentEquityShares_4b974ee1-4cf4-41ab-91e2-2c2bed6b8d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_b20d4ef8-344f-4441-94c5-09ecf81cb60a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_b20d4ef8-344f-4441-94c5-09ecf81cb60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_dd48e244-95cd-4d52-bfb4-a2024f6225e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_dd48e244-95cd-4d52-bfb4-a2024f6225e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1e49aada-fae5-4bfb-8dfa-f09653d4bd57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_1e49aada-fae5-4bfb-8dfa-f09653d4bd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bb3afb5a-c56b-4d6c-9269-dc3eb3d090cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_bb3afb5a-c56b-4d6c-9269-dc3eb3d090cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_79ddbc49-b52a-49b8-bec4-23851e92a1c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_79ddbc49-b52a-49b8-bec4-23851e92a1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2214729-3f80-440b-b8fc-646f114375fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_NetIncomeLoss_c2214729-3f80-440b-b8fc-646f114375fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4c5e5449-286a-46bd-9d67-7bd95a31bb73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_SharesOutstanding_4c5e5449-286a-46bd-9d67-7bd95a31bb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_065f85c4-dc38-490e-a0f8-341aabaaea88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e2494cda-493c-41a3-a17a-8a74904ad2d4" xlink:to="loc_us-gaap_StockholdersEquity_065f85c4-dc38-490e-a0f8-341aabaaea88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c1adcbc2-3fbc-426f-b6c3-44542f009543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_854f92fd-31d3-47a0-a064-7074ca14b366" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c1adcbc2-3fbc-426f-b6c3-44542f009543" xlink:to="loc_us-gaap_StatementTable_854f92fd-31d3-47a0-a064-7074ca14b366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4fa6d8c8-38fa-458c-ad62-d919cf8c37c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_854f92fd-31d3-47a0-a064-7074ca14b366" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4fa6d8c8-38fa-458c-ad62-d919cf8c37c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8aa59fae-d5cc-4f86-aad6-f4776d0d9a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4fa6d8c8-38fa-458c-ad62-d919cf8c37c4" xlink:to="loc_us-gaap_ClassOfStockDomain_8aa59fae-d5cc-4f86-aad6-f4776d0d9a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesGPreferredStockMember_6da6aa28-078c-4826-8d30-f75b21ed04b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesGPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8aa59fae-d5cc-4f86-aad6-f4776d0d9a41" xlink:to="loc_us-gaap_SeriesGPreferredStockMember_6da6aa28-078c-4826-8d30-f75b21ed04b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesHPreferredStockMember_8b320966-434c-4037-b19e-259363d8378a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesHPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8aa59fae-d5cc-4f86-aad6-f4776d0d9a41" xlink:to="loc_us-gaap_SeriesHPreferredStockMember_8b320966-434c-4037-b19e-259363d8378a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b38bb9c5-56dd-4bc6-8264-b81920c105b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_854f92fd-31d3-47a0-a064-7074ca14b366" xlink:to="loc_us-gaap_StatementLineItems_b38bb9c5-56dd-4bc6-8264-b81920c105b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_fef89a2f-abfa-494c-8956-52d15b272184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b38bb9c5-56dd-4bc6-8264-b81920c105b5" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_fef89a2f-abfa-494c-8956-52d15b272184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mrna-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_271ed279-f5a6-4a6a-953d-75d617931ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4768442c-2038-4853-a3d7-602eb688d148" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_271ed279-f5a6-4a6a-953d-75d617931ff8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4768442c-2038-4853-a3d7-602eb688d148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3997bc8a-2b79-410e-b3bb-f103d9ce362d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4768442c-2038-4853-a3d7-602eb688d148" xlink:to="loc_us-gaap_NetIncomeLoss_3997bc8a-2b79-410e-b3bb-f103d9ce362d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0eb27f09-558f-4c72-a5a1-af6145509b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4768442c-2038-4853-a3d7-602eb688d148" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0eb27f09-558f-4c72-a5a1-af6145509b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c3bf28a7-7e4a-4e86-9ed7-2617c0b5b678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0eb27f09-558f-4c72-a5a1-af6145509b8c" xlink:to="loc_us-gaap_ShareBasedCompensation_c3bf28a7-7e4a-4e86-9ed7-2617c0b5b678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2899bdaf-6528-4c04-8cd2-fde6895cda59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0eb27f09-558f-4c72-a5a1-af6145509b8c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2899bdaf-6528-4c04-8cd2-fde6895cda59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_e964e901-84e2-4422-be8c-f9115f25bee6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0eb27f09-558f-4c72-a5a1-af6145509b8c" xlink:to="loc_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases_e964e901-84e2-4422-be8c-f9115f25bee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_372104a6-bb1b-4f76-a809-d0a29bbc2005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0eb27f09-558f-4c72-a5a1-af6145509b8c" xlink:to="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_372104a6-bb1b-4f76-a809-d0a29bbc2005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_3261050b-f41c-4174-8519-89baa2af925c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0eb27f09-558f-4c72-a5a1-af6145509b8c" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_3261050b-f41c-4174-8519-89baa2af925c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0eb27f09-558f-4c72-a5a1-af6145509b8c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_aa0b9cef-2cee-4333-9967-292c3ae7625b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_aa0b9cef-2cee-4333-9967-292c3ae7625b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b0fa5dfb-1b60-4c69-8395-9e82a21e085f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b0fa5dfb-1b60-4c69-8395-9e82a21e085f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_54ddfd10-b686-4fce-82c5-1f213d9a0780" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_54ddfd10-b686-4fce-82c5-1f213d9a0780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RightOfUseAssetOperatingLeases_454e0c17-a163-43e7-853c-cd7ff31b6b8f" xlink:href="mrna-20201231.xsd#mrna_RightOfUseAssetOperatingLeases"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:to="loc_mrna_RightOfUseAssetOperatingLeases_454e0c17-a163-43e7-853c-cd7ff31b6b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0922a5d2-4a30-4085-adde-e3974e71f0cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0922a5d2-4a30-4085-adde-e3974e71f0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_898003d9-3c27-4af8-9b92-79b10690bc12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_898003d9-3c27-4af8-9b92-79b10690bc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_087976d9-908d-4357-9921-e95d2394965a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_087976d9-908d-4357-9921-e95d2394965a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_IncreaseDecreaseInDeferredRentCredit_b872f2df-903c-4c36-8c0f-c39355cafb6b" xlink:href="mrna-20201231.xsd#mrna_IncreaseDecreaseInDeferredRentCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:to="loc_mrna_IncreaseDecreaseInDeferredRentCredit_b872f2df-903c-4c36-8c0f-c39355cafb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLeaseLiabilities_85969bc6-08de-4a11-80af-9f27d7ea59be" xlink:href="mrna-20201231.xsd#mrna_OperatingLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:to="loc_mrna_OperatingLeaseLiabilities_85969bc6-08de-4a11-80af-9f27d7ea59be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1f1c3787-3cf8-481a-965d-56251d05c59f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11a63cb1-4ddd-45bd-bfc9-96b7c358ae8b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1f1c3787-3cf8-481a-965d-56251d05c59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4219133-fd73-4226-9840-9dd2adcd06ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_4768442c-2038-4853-a3d7-602eb688d148" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4219133-fd73-4226-9840-9dd2adcd06ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7706783e-eccb-489f-adf1-155d061ccbb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_271ed279-f5a6-4a6a-953d-75d617931ff8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7706783e-eccb-489f-adf1-155d061ccbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_477a228f-4aaf-4382-a037-5a2192c34dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7706783e-eccb-489f-adf1-155d061ccbb5" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_477a228f-4aaf-4382-a037-5a2192c34dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_f270fbae-dc72-4b00-b414-cd3bccdad4e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7706783e-eccb-489f-adf1-155d061ccbb5" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_f270fbae-dc72-4b00-b414-cd3bccdad4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_5816dd02-a8be-4598-92b7-98da8dff2f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7706783e-eccb-489f-adf1-155d061ccbb5" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_5816dd02-a8be-4598-92b7-98da8dff2f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_10a1cd7d-b851-4c86-9d96-88c77a5efc08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7706783e-eccb-489f-adf1-155d061ccbb5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_10a1cd7d-b851-4c86-9d96-88c77a5efc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35f41210-a434-466d-9a5b-548487fee990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7706783e-eccb-489f-adf1-155d061ccbb5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_35f41210-a434-466d-9a5b-548487fee990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_271ed279-f5a6-4a6a-953d-75d617931ff8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_30179431-31df-46d5-a7cc-0801d9a39ee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_30179431-31df-46d5-a7cc-0801d9a39ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_92d5b333-a2f5-4a0c-bf21-4ba874b05b40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_92d5b333-a2f5-4a0c-bf21-4ba874b05b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock_ef7bbf21-69a6-4f35-b983-7e7a3edce56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock_ef7bbf21-69a6-4f35-b983-7e7a3edce56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_77a7c0ee-0920-4957-8159-70b46adc194f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:to="loc_us-gaap_ProceedsFromStockPlans_77a7c0ee-0920-4957-8159-70b46adc194f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans_3daa1e11-ffbb-46ee-bf6f-8c2f74f77097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:to="loc_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans_3daa1e11-ffbb-46ee-bf6f-8c2f74f77097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChargesToFinancingLeaseLiabilities_71cc482c-399e-451c-a51e-7464faef3e4a" xlink:href="mrna-20201231.xsd#mrna_ChargesToFinancingLeaseLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:to="loc_mrna_ChargesToFinancingLeaseLiabilities_71cc482c-399e-451c-a51e-7464faef3e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation_f78e488f-d4d8-4b44-aa7a-0e8b7f4caaec" xlink:href="mrna-20201231.xsd#mrna_ReimbursementOfAssetsFromLeaseFinancingObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:to="loc_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation_f78e488f-d4d8-4b44-aa7a-0e8b7f4caaec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PaymentsForLeaseFinancingObligation_f5f619b7-2f61-4e3a-850c-67a2507a1650" xlink:href="mrna-20201231.xsd#mrna_PaymentsForLeaseFinancingObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:to="loc_mrna_PaymentsForLeaseFinancingObligation_f5f619b7-2f61-4e3a-850c-67a2507a1650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eed17cf6-108b-426b-9805-9c6093f9004f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7fc3caee-7a23-4b4f-b3af-a145c4124e3c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_eed17cf6-108b-426b-9805-9c6093f9004f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b525cd83-94e2-457c-b84e-ed3a744fa356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_271ed279-f5a6-4a6a-953d-75d617931ff8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b525cd83-94e2-457c-b84e-ed3a744fa356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_95047153-8cfc-4da8-81b2-580a9c57faa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_271ed279-f5a6-4a6a-953d-75d617931ff8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_95047153-8cfc-4da8-81b2-580a9c57faa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_02c7567a-1a11-4d50-80f8-f5c74fa3cea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_271ed279-f5a6-4a6a-953d-75d617931ff8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_02c7567a-1a11-4d50-80f8-f5c74fa3cea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_8190c6fe-cc89-4b51-9cf4-463691deac5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_271ed279-f5a6-4a6a-953d-75d617931ff8" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_8190c6fe-cc89-4b51-9cf4-463691deac5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_c6462d90-63f8-4869-aac8-94da652f52ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8190c6fe-cc89-4b51-9cf4-463691deac5c" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_c6462d90-63f8-4869-aac8-94da652f52ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_ed7a81e5-cab0-4093-9f85-0367cd35dc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8190c6fe-cc89-4b51-9cf4-463691deac5c" xlink:to="loc_us-gaap_InterestPaidNet_ed7a81e5-cab0-4093-9f85-0367cd35dc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0f8075b6-bb86-408b-b1bf-c6bc211c7085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_271ed279-f5a6-4a6a-953d-75d617931ff8" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0f8075b6-bb86-408b-b1bf-c6bc211c7085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StockIssuanceCostsIncurredButNotYetPaid_0a7dfc6f-0371-47f6-a42a-b699d4469243" xlink:href="mrna-20201231.xsd#mrna_StockIssuanceCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0f8075b6-bb86-408b-b1bf-c6bc211c7085" xlink:to="loc_mrna_StockIssuanceCostsIncurredButNotYetPaid_0a7dfc6f-0371-47f6-a42a-b699d4469243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_facbcaa1-12c5-4a21-a89e-e277738bacd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0f8075b6-bb86-408b-b1bf-c6bc211c7085" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_facbcaa1-12c5-4a21-a89e-e277738bacd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed_425b0a49-435d-47e7-a16c-56ae95fa3c82" xlink:href="mrna-20201231.xsd#mrna_LeaseholdImprovementsIncurredButNotYetReimbursed"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0f8075b6-bb86-408b-b1bf-c6bc211c7085" xlink:to="loc_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed_425b0a49-435d-47e7-a16c-56ae95fa3c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LeaseFinancingObligationsIncurred_ea292aa9-6418-4775-ae65-0b2f8627b460" xlink:href="mrna-20201231.xsd#mrna_LeaseFinancingObligationsIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_0f8075b6-bb86-408b-b1bf-c6bc211c7085" xlink:to="loc_mrna_LeaseFinancingObligationsIncurred_ea292aa9-6418-4775-ae65-0b2f8627b460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OrganizationandDescriptionofBusiness" xlink:type="simple" xlink:href="mrna-20201231.xsd#OrganizationandDescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/OrganizationandDescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9d0e667e-c119-4527-b889-057109bf881c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2d7008ba-c292-4e51-b4d2-a6d2d6a2ca53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9d0e667e-c119-4527-b889-057109bf881c" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_2d7008ba-c292-4e51-b4d2-a6d2d6a2ca53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OrganizationandDescriptionofBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6bc995e-eaf2-4f84-8469-8f3243997714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e0f478e0-8ecf-473d-80f3-418d21deb2a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6bc995e-eaf2-4f84-8469-8f3243997714" xlink:to="loc_us-gaap_NetIncomeLoss_e0f478e0-8ecf-473d-80f3-418d21deb2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3955d22d-218b-4aae-9163-fc9a89ae7051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6bc995e-eaf2-4f84-8469-8f3243997714" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_3955d22d-218b-4aae-9163-fc9a89ae7051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_131a1121-03be-471c-ab60-54982e2545bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6bc995e-eaf2-4f84-8469-8f3243997714" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_131a1121-03be-471c-ab60-54982e2545bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6309775d-3fe0-44a2-be17-350b64749634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6bc995e-eaf2-4f84-8469-8f3243997714" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6309775d-3fe0-44a2-be17-350b64749634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0c9afd07-ea8b-4bcf-8f11-e1452962044d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6bc995e-eaf2-4f84-8469-8f3243997714" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0c9afd07-ea8b-4bcf-8f11-e1452962044d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NumberOfDevelopmentProgram_86155817-1cd1-4511-a422-62120ae8f720" xlink:href="mrna-20201231.xsd#mrna_NumberOfDevelopmentProgram"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6bc995e-eaf2-4f84-8469-8f3243997714" xlink:to="loc_mrna_NumberOfDevelopmentProgram_86155817-1cd1-4511-a422-62120ae8f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bfdfb12e-ce16-4a10-ac52-12364608ad44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a3f00064-aa1d-4ed0-ba6e-a55a35665ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bfdfb12e-ce16-4a10-ac52-12364608ad44" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_a3f00064-aa1d-4ed0-ba6e-a55a35665ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3ed5e638-9aca-4921-8b89-29ce3d4cbb7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3ed5e638-9aca-4921-8b89-29ce3d4cbb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_e7667846-1bd5-40ee-8897-08113e8a6163" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_e7667846-1bd5-40ee-8897-08113e8a6163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_9a1cef73-2d94-4aab-a329-2e76f01323d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_UseOfEstimates_9a1cef73-2d94-4aab-a329-2e76f01323d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_6c35dc51-6f84-4dc4-b994-2999dc96823b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_6c35dc51-6f84-4dc4-b994-2999dc96823b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0fe475a8-1fd9-4ab0-8ff0-e136f9c19d53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0fe475a8-1fd9-4ab0-8ff0-e136f9c19d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_53925519-07e8-49e4-8dc0-f4b832e1ee22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_53925519-07e8-49e4-8dc0-f4b832e1ee22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_c27cb5a7-3835-4be4-a1bd-8e17aa85c206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_c27cb5a7-3835-4be4-a1bd-8e17aa85c206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_86276d38-0b79-4b87-a200-ed936afd46be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_86276d38-0b79-4b87-a200-ed936afd46be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_5a6d6156-42e6-48f8-a8d4-9200c3b42233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_5a6d6156-42e6-48f8-a8d4-9200c3b42233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_c9c9a6c0-05f9-445e-9de4-f205910c1218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_c9c9a6c0-05f9-445e-9de4-f205910c1218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_a33c6318-805e-4062-9f20-4c33852b7f23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MajorCustomersPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_MajorCustomersPolicyPolicyTextBlock_a33c6318-805e-4062-9f20-4c33852b7f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_4d4f421c-e603-4889-ae6c-20626c8fb291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_4d4f421c-e603-4889-ae6c-20626c8fb291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_7ecf1931-a541-450e-b1fa-a84e5064dfc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_7ecf1931-a541-450e-b1fa-a84e5064dfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_aff156c2-bc29-4ce3-852e-3526d287a0c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_aff156c2-bc29-4ce3-852e-3526d287a0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_885129a6-c9fc-46b3-84d6-3729d4dc171c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_885129a6-c9fc-46b3-84d6-3729d4dc171c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_06060934-0c2c-4004-8b22-ae851a6f4084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_06060934-0c2c-4004-8b22-ae851a6f4084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_62aba95c-027c-435d-a00d-a11b19b7e188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_62aba95c-027c-435d-a00d-a11b19b7e188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_e97abfba-9f64-41bf-8da8-751814bac6db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_e97abfba-9f64-41bf-8da8-751814bac6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_a607238f-52cd-43fc-b6af-fcf7c5ee62ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_a607238f-52cd-43fc-b6af-fcf7c5ee62ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PatentCostsPolicyPolicyTextBlock_9ea33582-2801-4212-90e7-ab99bd185491" xlink:href="mrna-20201231.xsd#mrna_PatentCostsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_mrna_PatentCostsPolicyPolicyTextBlock_9ea33582-2801-4212-90e7-ab99bd185491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d46633cd-e0f0-43ef-955d-e1d539c6b3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d46633cd-e0f0-43ef-955d-e1d539c6b3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_9c8bc803-1593-4c29-b8d5-395859ebe749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_9c8bc803-1593-4c29-b8d5-395859ebe749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_b7e4875c-d6b7-41da-bbf9-909ed70ee795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_b7e4875c-d6b7-41da-bbf9-909ed70ee795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_b4871194-5141-40e3-8954-89070cbd5de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_b4871194-5141-40e3-8954-89070cbd5de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0a4af452-3588-4d82-9e0a-8c513a157cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_84cc0b34-3cc4-408c-ac26-dcc16db07efe" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0a4af452-3588-4d82-9e0a-8c513a157cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2c5b9b22-8753-48ec-8fd6-a0dc88f57b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_7778d17e-3c0d-44cf-a860-2ba2db0b9ed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2c5b9b22-8753-48ec-8fd6-a0dc88f57b89" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_7778d17e-3c0d-44cf-a860-2ba2db0b9ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_dbd6b0b8-6bb9-4c08-bfa5-e0eebfd8c597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2c5b9b22-8753-48ec-8fd6-a0dc88f57b89" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_dbd6b0b8-6bb9-4c08-bfa5-e0eebfd8c597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_bfb3c8c1-4a38-43e0-a768-1e6f7f01012d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2c5b9b22-8753-48ec-8fd6-a0dc88f57b89" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_bfb3c8c1-4a38-43e0-a768-1e6f7f01012d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ea2d7b81-f817-45ed-9a38-b078fdf4e7ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2c5b9b22-8753-48ec-8fd6-a0dc88f57b89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ea2d7b81-f817-45ed-9a38-b078fdf4e7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1afbc86f-646d-49ef-8e5a-656464a1506d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2c5b9b22-8753-48ec-8fd6-a0dc88f57b89" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1afbc86f-646d-49ef-8e5a-656464a1506d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_50671e75-0555-40b6-9389-39d38a9d13b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_b1507dea-f724-41c6-9c20-27dba23996f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50671e75-0555-40b6-9389-39d38a9d13b0" xlink:to="loc_us-gaap_NumberOfOperatingSegments_b1507dea-f724-41c6-9c20-27dba23996f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6d4db738-0c9f-4e6f-bfe9-d765abbb55e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50671e75-0555-40b6-9389-39d38a9d13b0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6d4db738-0c9f-4e6f-bfe9-d765abbb55e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9743343b-a752-4466-9800-da8bf71f33f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50671e75-0555-40b6-9389-39d38a9d13b0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9743343b-a752-4466-9800-da8bf71f33f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_50671e75-0555-40b6-9389-39d38a9d13b0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_76ec4ef3-62b6-4cfd-95dd-3fc92dce78fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_76ec4ef3-62b6-4cfd-95dd-3fc92dce78fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e9a06d60-4557-4f75-a6a0-ed5fb0143136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_76ec4ef3-62b6-4cfd-95dd-3fc92dce78fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e9a06d60-4557-4f75-a6a0-ed5fb0143136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_527df401-a6e1-45ce-9a1f-9922e9893b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e9a06d60-4557-4f75-a6a0-ed5fb0143136" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_527df401-a6e1-45ce-9a1f-9922e9893b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a19d0f10-bd52-43c1-a22f-95a9a086ed5a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:to="loc_srt_RangeAxis_a19d0f10-bd52-43c1-a22f-95a9a086ed5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_152dbbe7-f517-45f6-ba5c-d36cee21c9f7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a19d0f10-bd52-43c1-a22f-95a9a086ed5a" xlink:to="loc_srt_RangeMember_152dbbe7-f517-45f6-ba5c-d36cee21c9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_54bbf982-b56e-4b6c-9f7f-3f257e16bfb6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_152dbbe7-f517-45f6-ba5c-d36cee21c9f7" xlink:to="loc_srt_MinimumMember_54bbf982-b56e-4b6c-9f7f-3f257e16bfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b7ec644f-803b-4aef-ae4f-14e2a946bfd3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_152dbbe7-f517-45f6-ba5c-d36cee21c9f7" xlink:to="loc_srt_MaximumMember_b7ec644f-803b-4aef-ae4f-14e2a946bfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2f42a27c-d244-4207-9ec9-0990305959c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2f42a27c-d244-4207-9ec9-0990305959c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_55a04c9c-815e-4b97-b74f-32c161fd4338" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_2f42a27c-d244-4207-9ec9-0990305959c7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_55a04c9c-815e-4b97-b74f-32c161fd4338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_081f5709-d623-42fd-9b6e-3f862f5c3040" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_55a04c9c-815e-4b97-b74f-32c161fd4338" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_081f5709-d623-42fd-9b6e-3f862f5c3040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b412de-c7e4-4bfa-8135-baaedbd5043e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b412de-c7e4-4bfa-8135-baaedbd5043e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357fbb75-7ebf-4c87-992b-8af49d3874e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e3b412de-c7e4-4bfa-8135-baaedbd5043e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357fbb75-7ebf-4c87-992b-8af49d3874e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EquipmentAndLeasedFacilitiesMember_42e5c573-8368-4b31-beb2-266f21501f5c" xlink:href="mrna-20201231.xsd#mrna_EquipmentAndLeasedFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_357fbb75-7ebf-4c87-992b-8af49d3874e7" xlink:to="loc_mrna_EquipmentAndLeasedFacilitiesMember_42e5c573-8368-4b31-beb2-266f21501f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8926b7fe-dd81-43b0-96e0-fd29ebec5e89" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_3b35a67d-2f06-45b4-870a-d2cd3db6f5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_DebtInstrumentTerm_3b35a67d-2f06-45b4-870a-d2cd3db6f5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_5908d1a8-dbd7-4dfa-ab2a-ffbd39e9f2a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTerm_5908d1a8-dbd7-4dfa-ab2a-ffbd39e9f2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_0469bdbe-8202-4071-bcfd-86d98d6c23c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_0469bdbe-8202-4071-bcfd-86d98d6c23c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_78c170c7-8d20-4e3c-b1e2-81eeb5c1db21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_AssetImpairmentCharges_78c170c7-8d20-4e3c-b1e2-81eeb5c1db21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_94326a92-792f-4ab6-b427-80a76191f8aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9f874f2d-6ef2-4c79-b36b-bc05febe6135" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_94326a92-792f-4ab6-b427-80a76191f8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b0feb248-015a-4eb1-9303-b19bb8465f6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_56953075-d8e3-4c82-9330-0b905792a100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0feb248-015a-4eb1-9303-b19bb8465f6c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_56953075-d8e3-4c82-9330-0b905792a100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_c8d68ddd-3742-470c-bef6-a8e1b4140a84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0feb248-015a-4eb1-9303-b19bb8465f6c" xlink:to="loc_us-gaap_RestrictedCashCurrent_c8d68ddd-3742-470c-bef6-a8e1b4140a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_f61eaea0-57c4-4ff3-b3d8-19341a7500eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0feb248-015a-4eb1-9303-b19bb8465f6c" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_f61eaea0-57c4-4ff3-b3d8-19341a7500eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_180b1b03-0210-45a0-b4c0-8950c628e744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b0feb248-015a-4eb1-9303-b19bb8465f6c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_180b1b03-0210-45a0-b4c0-8950c628e744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_579a8b9c-66f6-46d0-8a64-3b9d4ceabf4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_579a8b9c-66f6-46d0-8a64-3b9d4ceabf4c" xlink:to="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78e1d679-df3c-41cd-9d24-25e5515d13db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78e1d679-df3c-41cd-9d24-25e5515d13db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5f8dc405-59ac-4480-968e-4d6054f2cfdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78e1d679-df3c-41cd-9d24-25e5515d13db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5f8dc405-59ac-4480-968e-4d6054f2cfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_e79fdfef-2791-4a32-bfd0-e9fba1bb778f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5f8dc405-59ac-4480-968e-4d6054f2cfdb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_e79fdfef-2791-4a32-bfd0-e9fba1bb778f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_36f540cf-4ea9-41e0-842c-c9b8e5edfb40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5f8dc405-59ac-4480-968e-4d6054f2cfdb" xlink:to="loc_us-gaap_AccountsReceivableMember_36f540cf-4ea9-41e0-842c-c9b8e5edfb40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6728f997-b6d0-474b-abf2-71568f6ac0ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6728f997-b6d0-474b-abf2-71568f6ac0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_684022b3-b1d1-4cc0-8145-577bc082e45f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6728f997-b6d0-474b-abf2-71568f6ac0ed" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_684022b3-b1d1-4cc0-8145-577bc082e45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1c665043-c6eb-4a3c-bd3d-05977820b617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_684022b3-b1d1-4cc0-8145-577bc082e45f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1c665043-c6eb-4a3c-bd3d-05977820b617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_942741ed-04bc-4ffe-8a37-2e906c36f508" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:to="loc_srt_MajorCustomersAxis_942741ed-04bc-4ffe-8a37-2e906c36f508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_942741ed-04bc-4ffe-8a37-2e906c36f508" xlink:to="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckMember_06596963-9817-4c5d-bfe6-dde8519c40d9" xlink:href="mrna-20201231.xsd#mrna_MerckMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_MerckMember_06596963-9817-4c5d-bfe6-dde8519c40d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_fadf8117-0e6c-4552-ac34-b3346b03e011" xlink:href="mrna-20201231.xsd#mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_fadf8117-0e6c-4552-ac34-b3346b03e011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexMember_9e4e8b24-a2af-4807-80e7-90f08d3836a8" xlink:href="mrna-20201231.xsd#mrna_VertexMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_VertexMember_9e4e8b24-a2af-4807-80e7-90f08d3836a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AstraZenecaMember_d3da1f22-375f-4a8a-8737-f2bb308effa7" xlink:href="mrna-20201231.xsd#mrna_AstraZenecaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_AstraZenecaMember_d3da1f22-375f-4a8a-8737-f2bb308effa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_USGovermentMember_208de73d-6c85-4c71-a2bf-603bc4c4f3a4" xlink:href="mrna-20201231.xsd#mrna_USGovermentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_USGovermentMember_208de73d-6c85-4c71-a2bf-603bc4c4f3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EuropeanCommissionMember_e7706c56-00cb-4f23-a071-60cc628a771e" xlink:href="mrna-20201231.xsd#mrna_EuropeanCommissionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_EuropeanCommissionMember_e7706c56-00cb-4f23-a071-60cc628a771e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UnitedKingdomGovernmentMember_cf5a9a98-3b2d-4d14-83b3-a682a395fdb6" xlink:href="mrna-20201231.xsd#mrna_UnitedKingdomGovernmentMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_UnitedKingdomGovernmentMember_cf5a9a98-3b2d-4d14-83b3-a682a395fdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SouthKoreaGovernmentMember_6a0cbd22-c1d5-44e2-96bb-170c40343c90" xlink:href="mrna-20201231.xsd#mrna_SouthKoreaGovernmentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5d20bd5f-d40e-4084-af2e-4e5dfab0f867" xlink:to="loc_mrna_SouthKoreaGovernmentMember_6a0cbd22-c1d5-44e2-96bb-170c40343c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c1f82c1a-ffe3-4a7c-8333-18ea5f26ec87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_e4e92647-ab18-4a28-82ac-3a5a75657869" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_c1f82c1a-ffe3-4a7c-8333-18ea5f26ec87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ac6ffa65-0d66-43b8-b035-4caa48551e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c1f82c1a-ffe3-4a7c-8333-18ea5f26ec87" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ac6ffa65-0d66-43b8-b035-4caa48551e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0668c1d3-b333-4ef9-b313-4bdd582f4be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c9f483db-d4f9-46a3-ab47-d5fb899d71ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0668c1d3-b333-4ef9-b313-4bdd582f4be8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c9f483db-d4f9-46a3-ab47-d5fb899d71ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30efa7ee-b344-4941-a0a3-ec88c6a2b390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c9f483db-d4f9-46a3-ab47-d5fb899d71ee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30efa7ee-b344-4941-a0a3-ec88c6a2b390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_30efa7ee-b344-4941-a0a3-ec88c6a2b390" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_411d6842-d603-4eee-9f0c-5bb8bfaf4c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:to="loc_us-gaap_EquipmentMember_411d6842-d603-4eee-9f0c-5bb8bfaf4c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_5a250d7a-1d3e-4d7c-b24a-cde58c7f0808" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:to="loc_us-gaap_ComputerEquipmentMember_5a250d7a-1d3e-4d7c-b24a-cde58c7f0808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_6899f426-9f35-46f1-a514-a8efa736ec4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_6899f426-9f35-46f1-a514-a8efa736ec4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_3527884b-072b-4654-8ddd-653ebd6379f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOtherTypesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0c9f2c7b-a966-4aba-8624-ff7f161de6b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_3527884b-072b-4654-8ddd-653ebd6379f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7afe4c80-534a-4a83-bf72-e997f82a9981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c9f483db-d4f9-46a3-ab47-d5fb899d71ee" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7afe4c80-534a-4a83-bf72-e997f82a9981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9106098b-942f-4354-a05e-8b90af8baecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7afe4c80-534a-4a83-bf72-e997f82a9981" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_9106098b-942f-4354-a05e-8b90af8baecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e13dff2a-e1a3-4f9a-875a-d113d51ca84a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_56776959-6870-474b-aa97-c2e4e0cd3517" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e13dff2a-e1a3-4f9a-875a-d113d51ca84a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_56776959-6870-474b-aa97-c2e4e0cd3517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e1e86715-2b41-4321-955f-cb9e8f3e8988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_56776959-6870-474b-aa97-c2e4e0cd3517" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e1e86715-2b41-4321-955f-cb9e8f3e8988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_74a53070-e327-4b22-ba51-fa17d93d799b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e1e86715-2b41-4321-955f-cb9e8f3e8988" xlink:to="loc_us-gaap_EquityComponentDomain_74a53070-e327-4b22-ba51-fa17d93d799b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a5309982-6832-441a-bf24-060982b5cdfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_74a53070-e327-4b22-ba51-fa17d93d799b" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_a5309982-6832-441a-bf24-060982b5cdfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_599b965c-fd83-4652-9f5f-7486e626d043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_56776959-6870-474b-aa97-c2e4e0cd3517" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_599b965c-fd83-4652-9f5f-7486e626d043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4dab7827-dfeb-486b-b1ae-685d940d1a1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_599b965c-fd83-4652-9f5f-7486e626d043" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4dab7827-dfeb-486b-b1ae-685d940d1a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_04227241-b221-4dfb-aba1-03f6d4c5808e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4dab7827-dfeb-486b-b1ae-685d940d1a1e" xlink:to="loc_us-gaap_StockholdersEquity_04227241-b221-4dfb-aba1-03f6d4c5808e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c98e5035-da73-4136-9c98-c2568faf12be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4dab7827-dfeb-486b-b1ae-685d940d1a1e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c98e5035-da73-4136-9c98-c2568faf12be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8055afb2-1d11-4776-9567-157c869264f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_4dab7827-dfeb-486b-b1ae-685d940d1a1e" xlink:to="loc_us-gaap_StockholdersEquity_8055afb2-1d11-4776-9567-157c869264f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/GrantRevenue" xlink:type="simple" xlink:href="mrna-20201231.xsd#GrantRevenue"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/GrantRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3f418013-0536-456d-b81b-7d05dacb7937" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_3e04d15b-d4a2-4292-8e01-eecc87ef488a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3f418013-0536-456d-b81b-7d05dacb7937" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_3e04d15b-d4a2-4292-8e01-eecc87ef488a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/GrantRevenueTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#GrantRevenueTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/GrantRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a4b773f5-bb35-4d45-8387-ac1c5c4b341d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6737efa2-74f4-4ecf-94dd-9d142a4934ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a4b773f5-bb35-4d45-8387-ac1c5c4b341d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_6737efa2-74f4-4ecf-94dd-9d142a4934ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/GrantRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#GrantRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/GrantRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f6efcaa9-66f0-4051-b067-1e997eead01c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f6efcaa9-66f0-4051-b067-1e997eead01c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_f7801227-3a4d-4c6d-bc21-4c83bae07974" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:to="loc_srt_MajorCustomersAxis_f7801227-3a4d-4c6d-bc21-4c83bae07974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_f7801227-3a4d-4c6d-bc21-4c83bae07974" xlink:to="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_179b392f-5ca1-46a0-9844-b4ac3e74dacb" xlink:href="mrna-20201231.xsd#mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:to="loc_mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember_179b392f-5ca1-46a0-9844-b4ac3e74dacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DefenseAdvancedResearchProjectsAgencyMember_686e536f-b946-4984-8e83-e4ab9972c8bd" xlink:href="mrna-20201231.xsd#mrna_DefenseAdvancedResearchProjectsAgencyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:to="loc_mrna_DefenseAdvancedResearchProjectsAgencyMember_686e536f-b946-4984-8e83-e4ab9972c8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TheBillAndMelindaGatesFoundationMember_b181de48-0561-43e8-9181-0d4609ce875a" xlink:href="mrna-20201231.xsd#mrna_TheBillAndMelindaGatesFoundationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:to="loc_mrna_TheBillAndMelindaGatesFoundationMember_b181de48-0561-43e8-9181-0d4609ce875a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OtherGrantRevenueMember_d4d93d66-7bdc-4ac3-975f-07425250bf8d" xlink:href="mrna-20201231.xsd#mrna_OtherGrantRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_cc5ed699-0e50-4b66-885a-1e926e14b76f" xlink:to="loc_mrna_OtherGrantRevenueMember_d4d93d66-7bdc-4ac3-975f-07425250bf8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_942facdc-d0ed-40f3-b5b9-4ef980bfa695" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:to="loc_srt_ProductOrServiceAxis_942facdc-d0ed-40f3-b5b9-4ef980bfa695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_097bb9b0-0944-4f69-a3f9-98e5b233f691" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_942facdc-d0ed-40f3-b5b9-4ef980bfa695" xlink:to="loc_srt_ProductsAndServicesDomain_097bb9b0-0944-4f69-a3f9-98e5b233f691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_03bb4342-2255-448f-825a-3b68f32c6028" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_097bb9b0-0944-4f69-a3f9-98e5b233f691" xlink:to="loc_us-gaap_GrantMember_03bb4342-2255-448f-825a-3b68f32c6028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_1052b8cb-a862-4eb4-8cee-a302b4d22dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_1052b8cb-a862-4eb4-8cee-a302b4d22dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_9d8b69aa-e4ff-4b85-93ed-cea84364d10b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_1052b8cb-a862-4eb4-8cee-a302b4d22dd1" xlink:to="loc_us-gaap_ProjectMember_9d8b69aa-e4ff-4b85-93ed-cea84364d10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractOptionsMember_fd6aea06-6b11-4516-bc9b-f6fc1919b140" xlink:href="mrna-20201231.xsd#mrna_ContractOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_9d8b69aa-e4ff-4b85-93ed-cea84364d10b" xlink:to="loc_mrna_ContractOptionsMember_fd6aea06-6b11-4516-bc9b-f6fc1919b140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_InitialProjectMember_33c9f9f1-000d-4db9-8c78-d2ae574243a9" xlink:href="mrna-20201231.xsd#mrna_InitialProjectMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_9d8b69aa-e4ff-4b85-93ed-cea84364d10b" xlink:to="loc_mrna_InitialProjectMember_33c9f9f1-000d-4db9-8c78-d2ae574243a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fb32502b-fb10-4f4b-9cc0-07680d5ceafc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:to="loc_srt_RangeAxis_fb32502b-fb10-4f4b-9cc0-07680d5ceafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57d9922c-059b-4fe8-942b-2abf17f0ba19" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fb32502b-fb10-4f4b-9cc0-07680d5ceafc" xlink:to="loc_srt_RangeMember_57d9922c-059b-4fe8-942b-2abf17f0ba19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_07fd02fd-7a49-43c6-bbfe-52b89509433b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_57d9922c-059b-4fe8-942b-2abf17f0ba19" xlink:to="loc_srt_MinimumMember_07fd02fd-7a49-43c6-bbfe-52b89509433b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e901c6ca-8570-4210-b957-227c929ba936" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_57d9922c-059b-4fe8-942b-2abf17f0ba19" xlink:to="loc_srt_MaximumMember_e901c6ca-8570-4210-b957-227c929ba936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7bb6a43d-164f-43b4-b752-e07f89bdb0c6" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsMaximumAward_95cab80a-f871-4f34-ae4a-353fb345cef4" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsMaximumAward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_mrna_RevenueFromGrantsMaximumAward_95cab80a-f871-4f34-ae4a-353fb345cef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsRemainingFundingCapacity_9d3e10f1-660d-4420-b417-170fb5c2db2b" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsRemainingFundingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_mrna_RevenueFromGrantsRemainingFundingCapacity_9d3e10f1-660d-4420-b417-170fb5c2db2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_2936da3b-c7b4-403d-87c6-22e639e25219" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_us-gaap_OtherCommitment_2936da3b-c7b4-403d-87c6-22e639e25219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsCurrentFundingCapacity_352262f5-ac5c-456b-8509-c01fe4985016" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsCurrentFundingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_mrna_RevenueFromGrantsCurrentFundingCapacity_352262f5-ac5c-456b-8509-c01fe4985016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsNumberOfContractOptions_40a0bcf4-b1c5-433a-97d8-e54cddb2aa74" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsNumberOfContractOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_mrna_RevenueFromGrantsNumberOfContractOptions_40a0bcf4-b1c5-433a-97d8-e54cddb2aa74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RevenueFromGrantsNumberOfContractOptionsExercised_e120aea8-3566-4ed8-b7b4-a5d0fe1e381a" xlink:href="mrna-20201231.xsd#mrna_RevenueFromGrantsNumberOfContractOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_mrna_RevenueFromGrantsNumberOfContractOptionsExercised_e120aea8-3566-4ed8-b7b4-a5d0fe1e381a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e2a9a4fb-c744-428b-83eb-ea4c6ab7d4e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_us-gaap_Revenues_e2a9a4fb-c744-428b-83eb-ea4c6ab7d4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_9df543b2-2c0c-4c89-ad4b-e007dc758a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_97501307-67e7-4268-b5a4-0474b0ff8442" xlink:to="loc_us-gaap_ContractWithCustomerLiability_9df543b2-2c0c-4c89-ad4b-e007dc758a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/ProductSales" xlink:type="simple" xlink:href="mrna-20201231.xsd#ProductSales"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/ProductSales" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8d85765e-ce76-4e9e-b261-c96fcf896b1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_da87f310-9f3b-46eb-aff9-bd4c453d2bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8d85765e-ce76-4e9e-b261-c96fcf896b1e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_da87f310-9f3b-46eb-aff9-bd4c453d2bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/ProductSalesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#ProductSalesTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/ProductSalesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2e95ad36-3c7d-4255-8d65-b9c0b6e5e594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_5c98aead-90a0-4723-bd10-fb05baaddb7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2e95ad36-3c7d-4255-8d65-b9c0b6e5e594" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_5c98aead-90a0-4723-bd10-fb05baaddb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/ProductSalesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#ProductSalesDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/ProductSalesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_33ff2d1e-421d-40b8-af12-dddd4bb63547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_350a25cd-18dd-4589-91a5-48b447c72e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_33ff2d1e-421d-40b8-af12-dddd4bb63547" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_350a25cd-18dd-4589-91a5-48b447c72e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e5535602-f07a-4092-a441-7f688a87a6d6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_350a25cd-18dd-4589-91a5-48b447c72e1c" xlink:to="loc_srt_StatementGeographicalAxis_e5535602-f07a-4092-a441-7f688a87a6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0e438ac8-f14e-4d38-838f-7d24f75760f4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e5535602-f07a-4092-a441-7f688a87a6d6" xlink:to="loc_srt_SegmentGeographicalDomain_0e438ac8-f14e-4d38-838f-7d24f75760f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b9003b63-3a9a-4f9b-83f4-05e7505609a1" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e438ac8-f14e-4d38-838f-7d24f75760f4" xlink:to="loc_country_US_b9003b63-3a9a-4f9b-83f4-05e7505609a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_25960037-9602-4927-b405-67346504c87a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0e438ac8-f14e-4d38-838f-7d24f75760f4" xlink:to="loc_us-gaap_NonUsMember_25960037-9602-4927-b405-67346504c87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c95b1724-58d2-43cf-b233-675efc06eed8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_350a25cd-18dd-4589-91a5-48b447c72e1c" xlink:to="loc_srt_ProductOrServiceAxis_c95b1724-58d2-43cf-b233-675efc06eed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ae49037e-9463-43c7-9bf5-4cc6efd18ce6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c95b1724-58d2-43cf-b233-675efc06eed8" xlink:to="loc_srt_ProductsAndServicesDomain_ae49037e-9463-43c7-9bf5-4cc6efd18ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ProductSalesMember_cddfff9e-9032-47e6-b205-38a14e34d00d" xlink:href="mrna-20201231.xsd#mrna_ProductSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ae49037e-9463-43c7-9bf5-4cc6efd18ce6" xlink:to="loc_mrna_ProductSalesMember_cddfff9e-9032-47e6-b205-38a14e34d00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CustomerDepositsMember_cb749936-e4e6-4d26-b47e-ddef69f5443b" xlink:href="mrna-20201231.xsd#mrna_CustomerDepositsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ae49037e-9463-43c7-9bf5-4cc6efd18ce6" xlink:to="loc_mrna_CustomerDepositsMember_cb749936-e4e6-4d26-b47e-ddef69f5443b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c73acc7a-d36c-457a-9cae-1f95be4b25c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_350a25cd-18dd-4589-91a5-48b447c72e1c" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c73acc7a-d36c-457a-9cae-1f95be4b25c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6f22ff37-8b25-47bd-bec4-5d645fa9f970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c73acc7a-d36c-457a-9cae-1f95be4b25c4" xlink:to="loc_us-gaap_Revenues_6f22ff37-8b25-47bd-bec4-5d645fa9f970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1316eaff-e959-489f-8aac-f9d99df033dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c73acc7a-d36c-457a-9cae-1f95be4b25c4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1316eaff-e959-489f-8aac-f9d99df033dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreements" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreements"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_efe9c8bd-b351-4fdb-8d2e-e15fa8cde3da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_f627e7c2-d001-40dd-aadc-f87133429ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_efe9c8bd-b351-4fdb-8d2e-e15fa8cde3da" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_f627e7c2-d001-40dd-aadc-f87133429ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_42c6b318-64d2-4ddf-807b-8dc0948d3143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_b40d17bc-2fe4-4969-a11b-fbd02765f8c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_42c6b318-64d2-4ddf-807b-8dc0948d3143" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_b40d17bc-2fe4-4969-a11b-fbd02765f8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0f4d9381-3698-4816-8bed-173dfaafe7d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_42c6b318-64d2-4ddf-807b-8dc0948d3143" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_0f4d9381-3698-4816-8bed-173dfaafe7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_e9debb13-8d62-48a2-bb3f-7c5882a73946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_42c6b318-64d2-4ddf-807b-8dc0948d3143" xlink:to="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_e9debb13-8d62-48a2-bb3f-7c5882a73946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_1b8f3ace-5d0f-437f-b005-09c3ebf7f56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_42c6b318-64d2-4ddf-807b-8dc0948d3143" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_1b8f3ace-5d0f-437f-b005-09c3ebf7f56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_297f583c-4a6f-4621-a2f8-7c1abb28c5fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_297f583c-4a6f-4621-a2f8-7c1abb28c5fc" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7812d680-7e31-4c6d-bad7-f8f746c3019c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:to="loc_srt_ProductOrServiceAxis_7812d680-7e31-4c6d-bad7-f8f746c3019c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4eeb7d09-fb08-4fea-903d-7f331a85c751" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7812d680-7e31-4c6d-bad7-f8f746c3019c" xlink:to="loc_srt_ProductsAndServicesDomain_4eeb7d09-fb08-4fea-903d-7f331a85c751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_1222580d-702c-49a6-8e6a-976fb12bd874" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4eeb7d09-fb08-4fea-903d-7f331a85c751" xlink:to="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_1222580d-702c-49a6-8e6a-976fb12bd874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_096cbd44-fe16-45ee-bcdf-fd22b512fd70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:to="loc_srt_CounterpartyNameAxis_096cbd44-fe16-45ee-bcdf-fd22b512fd70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_096cbd44-fe16-45ee-bcdf-fd22b512fd70" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckMember_a75034ca-e8a2-4a1d-8f66-a1a879576ef2" xlink:href="mrna-20201231.xsd#mrna_MerckMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:to="loc_mrna_MerckMember_a75034ca-e8a2-4a1d-8f66-a1a879576ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AstraZenecaMember_1e361fb4-c2b0-4f2e-92fb-970771e870d4" xlink:href="mrna-20201231.xsd#mrna_AstraZenecaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:to="loc_mrna_AstraZenecaMember_1e361fb4-c2b0-4f2e-92fb-970771e870d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexMember_451bee3f-9a0c-4fff-b137-6b10d32852fc" xlink:href="mrna-20201231.xsd#mrna_VertexMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:to="loc_mrna_VertexMember_451bee3f-9a0c-4fff-b137-6b10d32852fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OtherMember_c02b2da2-373a-4e52-a563-1fec1a0b9fe1" xlink:href="mrna-20201231.xsd#mrna_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9803690c-0e56-4f07-9848-0e50524ed2ff" xlink:to="loc_mrna_OtherMember_c02b2da2-373a-4e52-a563-1fec1a0b9fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_0ffb9b2f-9ebd-48f4-b9ca-0eeb155382a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_0ffb9b2f-9ebd-48f4-b9ca-0eeb155382a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_0fc54cb4-d15b-4724-af5e-016601ee93df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_0ffb9b2f-9ebd-48f4-b9ca-0eeb155382a6" xlink:to="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_0fc54cb4-d15b-4724-af5e-016601ee93df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member_69660f88-e1cb-47e7-9779-78a940f1eec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain_0fc54cb4-d15b-4724-af5e-016601ee93df" xlink:to="loc_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member_69660f88-e1cb-47e7-9779-78a940f1eec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b73460c-f46d-44d9-b95d-36dd71e62944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_d741cb80-d0ba-4d99-943a-aa15188deb1f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b73460c-f46d-44d9-b95d-36dd71e62944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_553f563a-c962-4e08-b429-cc2d52e47277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b73460c-f46d-44d9-b95d-36dd71e62944" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_553f563a-c962-4e08-b429-cc2d52e47277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_c36e7dc3-da7c-4abc-b1ec-3d69e4c44f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_692104ff-ff03-4e1d-be15-856ee7af257d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_c36e7dc3-da7c-4abc-b1ec-3d69e4c44f77" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_692104ff-ff03-4e1d-be15-856ee7af257d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d85e722b-9c5c-495b-bf92-7d5d89e743d7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_692104ff-ff03-4e1d-be15-856ee7af257d" xlink:to="loc_srt_ProductOrServiceAxis_d85e722b-9c5c-495b-bf92-7d5d89e743d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a147f547-b754-41d4-9756-5298e7d482c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d85e722b-9c5c-495b-bf92-7d5d89e743d7" xlink:to="loc_srt_ProductsAndServicesDomain_a147f547-b754-41d4-9756-5298e7d482c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_2967e03c-f432-49b7-bc59-f3dbfd444104" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a147f547-b754-41d4-9756-5298e7d482c1" xlink:to="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_2967e03c-f432-49b7-bc59-f3dbfd444104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_692104ff-ff03-4e1d-be15-856ee7af257d" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractwithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_51ed5633-54d3-44e4-9972-1a2d025890e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_51ed5633-54d3-44e4-9972-1a2d025890e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerAssetIncreaseDuringPeriod_9bd673d2-62e5-464f-8437-835d68b551ad" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerAssetIncreaseDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:to="loc_mrna_ContractWithCustomerAssetIncreaseDuringPeriod_9bd673d2-62e5-464f-8437-835d68b551ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerAssetDecreaseDuringPeriod_6865d114-166c-4592-a6e0-54b67e532a77" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerAssetDecreaseDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:to="loc_mrna_ContractWithCustomerAssetDecreaseDuringPeriod_6865d114-166c-4592-a6e0-54b67e532a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_a696da43-cccd-497e-8153-1f0d2fbe611b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractwithCustomerAssetRollForward_543e722d-4edc-4e17-93c3-1985b014e8b0" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_a696da43-cccd-497e-8153-1f0d2fbe611b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_bb0f38f8-5c03-4aff-82fc-21d63a85068f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:to="loc_us-gaap_ContractWithCustomerLiability_bb0f38f8-5c03-4aff-82fc-21d63a85068f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod_20a573d0-0fac-4777-94ed-67a60e221eab" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:to="loc_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod_20a573d0-0fac-4777-94ed-67a60e221eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod_8ea65fd5-ff3c-43fe-b4b4-b674f7c42d0f" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:to="loc_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod_8ea65fd5-ff3c-43fe-b4b4-b674f7c42d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_e79dedea-cb55-4e21-9686-8b756a353374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward_165971af-cae3-4919-b981-d01a1b064669" xlink:to="loc_us-gaap_ContractWithCustomerLiability_e79dedea-cb55-4e21-9686-8b756a353374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_64223038-ef2c-471c-85ef-f71d24452b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_64223038-ef2c-471c-85ef-f71d24452b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_2a14ebdd-b26e-442a-a01d-fa7933b299d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_2a14ebdd-b26e-442a-a01d-fa7933b299d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_5a89c882-89b4-41c2-bee5-b23cfcd9f156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_0020e159-84f2-4519-83e3-9c2af98ecb65" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_5a89c882-89b4-41c2-bee5-b23cfcd9f156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationRevenueRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_3bb22cd0-6de1-454d-bdd7-f7621eb9267d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_3bb22cd0-6de1-454d-bdd7-f7621eb9267d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fbed7522-d5cd-4232-bcb8-0bc49f9170a2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_1228be16-5a58-48cd-b447-a0b661ec4050" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_Combined2018AZAgreementsMember_1228be16-5a58-48cd-b447-a0b661ec4050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_c469aedf-4be8-4b6f-8ddd-e1daf59e6830" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_VEGFExercise2016Member_c469aedf-4be8-4b6f-8ddd-e1daf59e6830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_c9b25891-efe6-4919-b26c-f572ef45bc7a" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_PCVSAVAgreementMember_c9b25891-efe6-4919-b26c-f572ef45bc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_7db4260d-7d2a-4c08-9b3f-75e17738684b" xlink:href="mrna-20201231.xsd#mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7a19c69a-7cf0-4433-bad7-3ae2124c806c" xlink:to="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_7db4260d-7d2a-4c08-9b3f-75e17738684b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:to="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_14bf82ad-1e02-40f4-8d70-e020f4c6a47f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_243b4f48-6798-4add-8867-90627a15c1c9" xlink:to="loc_srt_ProductsAndServicesDomain_14bf82ad-1e02-40f4-8d70-e020f4c6a47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_16c6bb4f-b8a1-45d0-9f59-c1511c3d36ff" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_14bf82ad-1e02-40f4-8d70-e020f4c6a47f" xlink:to="loc_mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember_16c6bb4f-b8a1-45d0-9f59-c1511c3d36ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_083e0c8f-40e6-4585-babf-2c75365fbdd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_083e0c8f-40e6-4585-babf-2c75365fbdd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_3a3b3637-5ec3-4e55-92b1-052f5f9ff9d7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_1ab6568e-a1ba-4ecc-b339-7a33ce68c589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_1ab6568e-a1ba-4ecc-b339-7a33ce68c589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_71e6b1b6-731a-45f0-9875-f9d64e859892" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_312bbc4b-35b5-4b2e-bc92-ee5ce4e12ae7" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_71e6b1b6-731a-45f0-9875-f9d64e859892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationRevenueRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_3278d01b-db7a-4c3b-98e3-f059c0edb1a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_3278d01b-db7a-4c3b-98e3-f059c0edb1a4" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationAxis_36197310-94d2-4a12-81e2-f709dd791813" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_mrna_PerformanceObligationAxis_36197310-94d2-4a12-81e2-f709dd791813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationAxis_36197310-94d2-4a12-81e2-f709dd791813" xlink:to="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementPerformanceObligationMember_629bb9da-1d32-4cb0-8529-549976e67d0a" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementPerformanceObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:to="loc_mrna_Combined2018AZAgreementPerformanceObligationMember_629bb9da-1d32-4cb0-8529-549976e67d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_IL12PerformanceObligationMember_df04b245-5b6a-417f-86d0-1657059b164f" xlink:href="mrna-20201231.xsd#mrna_IL12PerformanceObligationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:to="loc_mrna_IL12PerformanceObligationMember_df04b245-5b6a-417f-86d0-1657059b164f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OncologyDevelopmentTargetPerformanceObligationMember_58d7b964-499b-4f4a-95d4-c39ede84b9dd" xlink:href="mrna-20201231.xsd#mrna_OncologyDevelopmentTargetPerformanceObligationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:to="loc_mrna_OncologyDevelopmentTargetPerformanceObligationMember_58d7b964-499b-4f4a-95d4-c39ede84b9dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_2a795b27-eedb-4b9a-9fad-38121baefca9" xlink:href="mrna-20201231.xsd#mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:to="loc_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_2a795b27-eedb-4b9a-9fad-38121baefca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_a762b08b-eaa9-45fd-8afb-9afc357be373" xlink:href="mrna-20201231.xsd#mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_d295f602-13bf-4d03-91ea-2b1df9984c58" xlink:to="loc_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_a762b08b-eaa9-45fd-8afb-9afc357be373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1652d90f-781e-4a80-bb21-454436548380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1652d90f-781e-4a80-bb21-454436548380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1652d90f-781e-4a80-bb21-454436548380" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VariableConsiderationMember_d5a940bf-e4a5-46bb-8662-0c7a3d45b890" xlink:href="mrna-20201231.xsd#mrna_VariableConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:to="loc_mrna_VariableConsiderationMember_d5a940bf-e4a5-46bb-8662-0c7a3d45b890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EstimatedReimbursementMember_3109343d-aa41-4fcb-92aa-6371b2cac95b" xlink:href="mrna-20201231.xsd#mrna_EstimatedReimbursementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:to="loc_mrna_EstimatedReimbursementMember_3109343d-aa41-4fcb-92aa-6371b2cac95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MilestonePaymentsMember_fec3cd43-2516-439b-b34b-e870ae1cf330" xlink:href="mrna-20201231.xsd#mrna_MilestonePaymentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:to="loc_mrna_MilestonePaymentsMember_fec3cd43-2516-439b-b34b-e870ae1cf330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OptionExerciseFeeMember_48f00cd4-83b2-4ac7-b868-d6bd5bf446ef" xlink:href="mrna-20201231.xsd#mrna_OptionExerciseFeeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_a02ea291-67ad-4910-a9db-654a421727b5" xlink:to="loc_mrna_OptionExerciseFeeMember_48f00cd4-83b2-4ac7-b868-d6bd5bf446ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4ef8949d-57d3-4941-8dd3-9a22711f6f9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4ef8949d-57d3-4941-8dd3-9a22711f6f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4ef8949d-57d3-4941-8dd3-9a22711f6f9e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_111abd47-8c11-4116-ab59-e075252a7b64" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:to="loc_mrna_Combined2018AZAgreementsMember_111abd47-8c11-4116-ab59-e075252a7b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember_b198ebcf-55a8-4061-ac1c-1397a0b3ee75" xlink:href="mrna-20201231.xsd#mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:to="loc_mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember_b198ebcf-55a8-4061-ac1c-1397a0b3ee75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_4b8851fc-ac6e-48af-ad42-d1b0e52a2255" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:to="loc_mrna_VEGFExercise2016Member_4b8851fc-ac6e-48af-ad42-d1b0e52a2255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member_24e3d46b-d5dd-405a-8d02-529c86d2d841" xlink:href="mrna-20201231.xsd#mrna_A2016StrategicAllianceWithAstraZenecaIL12Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:to="loc_mrna_A2016StrategicAllianceWithAstraZenecaIL12Member_24e3d46b-d5dd-405a-8d02-529c86d2d841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember_a280c9dc-9d7e-4360-b378-8c276ec25242" xlink:href="mrna-20201231.xsd#mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7fd227bc-c206-4bdc-b783-d97ac02745ce" xlink:to="loc_mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember_a280c9dc-9d7e-4360-b378-8c276ec25242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_13a95736-feef-41b8-ac8a-d744fd57de9e" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_13a95736-feef-41b8-ac8a-d744fd57de9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_a18a2798-95c6-49db-9c46-cf85a32d8840" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_13a95736-feef-41b8-ac8a-d744fd57de9e" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_a18a2798-95c6-49db-9c46-cf85a32d8840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentMilestonesMember_613c1189-339a-4f1b-b759-3751de4043c4" xlink:href="mrna-20201231.xsd#mrna_DevelopmentMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_a18a2798-95c6-49db-9c46-cf85a32d8840" xlink:to="loc_mrna_DevelopmentMilestonesMember_613c1189-339a-4f1b-b759-3751de4043c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RegulatoryMilestonesMember_90cd38cd-e4a1-409f-84ce-7156e55d9a6f" xlink:href="mrna-20201231.xsd#mrna_RegulatoryMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_a18a2798-95c6-49db-9c46-cf85a32d8840" xlink:to="loc_mrna_RegulatoryMilestonesMember_90cd38cd-e4a1-409f-84ce-7156e55d9a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CommercialMilestonesMember_b34cfabf-1fc6-435b-bcdc-79482ccbeb9a" xlink:href="mrna-20201231.xsd#mrna_CommercialMilestonesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_a18a2798-95c6-49db-9c46-cf85a32d8840" xlink:to="loc_mrna_CommercialMilestonesMember_b34cfabf-1fc6-435b-bcdc-79482ccbeb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1e4f0558-68fa-4f55-8872-32618e66609f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_srt_RangeAxis_1e4f0558-68fa-4f55-8872-32618e66609f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_178ab795-e72e-4825-89d4-3cc99858d6df" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1e4f0558-68fa-4f55-8872-32618e66609f" xlink:to="loc_srt_RangeMember_178ab795-e72e-4825-89d4-3cc99858d6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c4a15272-a5ab-4aed-8879-d1063daef074" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_178ab795-e72e-4825-89d4-3cc99858d6df" xlink:to="loc_srt_MinimumMember_c4a15272-a5ab-4aed-8879-d1063daef074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cf05fcf3-0912-4018-a98f-c30734f920bd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_178ab795-e72e-4825-89d4-3cc99858d6df" xlink:to="loc_srt_MaximumMember_cf05fcf3-0912-4018-a98f-c30734f920bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_27728527-4612-467d-913a-d1448390991f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_27728527-4612-467d-913a-d1448390991f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_a6ca038e-81a2-4f35-80fd-68c6c5c647c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_27728527-4612-467d-913a-d1448390991f" xlink:to="loc_us-gaap_ProjectMember_a6ca038e-81a2-4f35-80fd-68c6c5c647c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFAProductAZD8601Member_8c83ef1a-092a-49e4-b876-dfb59055abdd" xlink:href="mrna-20201231.xsd#mrna_VEGFAProductAZD8601Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_a6ca038e-81a2-4f35-80fd-68c6c5c647c7" xlink:to="loc_mrna_VEGFAProductAZD8601Member_8c83ef1a-092a-49e4-b876-dfb59055abdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_6f1ac442-6df9-4205-8a73-690e836b207b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions_6acd36c6-cf02-4920-83ac-f085e0488f44" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions_6acd36c6-cf02-4920-83ac-f085e0488f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_3445f511-0aa6-41ae-88eb-105777b86940" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_3445f511-0aa6-41ae-88eb-105777b86940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones_8ccb1a44-0f72-4a5a-807e-256822ecf698" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones_8ccb1a44-0f72-4a5a-807e-256822ecf698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee_e790c5d5-7bdc-4ac2-a554-02f831271f48" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee_e790c5d5-7bdc-4ac2-a554-02f831271f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent_8c3023b4-47d4-406f-b264-4d9e16251596" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent_8c3023b4-47d4-406f-b264-4d9e16251596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_5a5378fb-0860-484c-bd84-467c11d919a8" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_5a5378fb-0860-484c-bd84-467c11d919a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent_48f50980-5f28-40c8-af15-f5ba18c18e51" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent_48f50980-5f28-40c8-af15-f5ba18c18e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent_42350dda-073b-4e8c-93b5-c7bb274a2ca6" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent_42350dda-073b-4e8c-93b5-c7bb274a2ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod_92ae9982-efb0-4e80-b369-ee6d6a3d8ee5" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod_92ae9982-efb0-4e80-b369-ee6d6a3d8ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_979476a4-27c3-4d23-b97c-8d3d8dd746bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_979476a4-27c3-4d23-b97c-8d3d8dd746bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_63c10670-d3d5-499a-86e3-51103971febb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_23b0f4b8-2a88-4647-b466-ede1d840ce77" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_63c10670-d3d5-499a-86e3-51103971febb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_a8f1fce5-829e-4004-9486-a6a66dcbb472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_a8f1fce5-829e-4004-9486-a6a66dcbb472" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c854afb6-5549-48c8-9402-40dfd5d1d398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c854afb6-5549-48c8-9402-40dfd5d1d398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_daf9fbe8-a38a-4643-b7a8-983b49baa3e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c854afb6-5549-48c8-9402-40dfd5d1d398" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_daf9fbe8-a38a-4643-b7a8-983b49baa3e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_209a6928-398e-46e1-ae9d-27900d2d4d5e" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_daf9fbe8-a38a-4643-b7a8-983b49baa3e7" xlink:to="loc_mrna_Combined2018AZAgreementsMember_209a6928-398e-46e1-ae9d-27900d2d4d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_0aa04baa-783e-4ee3-b878-0c4b163087b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_0aa04baa-783e-4ee3-b878-0c4b163087b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_0aa04baa-783e-4ee3-b878-0c4b163087b1" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_c853dc2d-ef5e-4d6d-b310-260c4ffb46e9" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:to="loc_mrna_UpfrontPaymentMember_c853dc2d-ef5e-4d6d-b310-260c4ffb46e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SublicenseReimbursementMember_def7602d-bb7f-482c-8f8a-6889acf056d3" xlink:href="mrna-20201231.xsd#mrna_SublicenseReimbursementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:to="loc_mrna_SublicenseReimbursementMember_def7602d-bb7f-482c-8f8a-6889acf056d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MilestonePaymentsMember_6644bab7-a2cf-4bb3-b325-f8e5a0fee58f" xlink:href="mrna-20201231.xsd#mrna_MilestonePaymentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:to="loc_mrna_MilestonePaymentsMember_6644bab7-a2cf-4bb3-b325-f8e5a0fee58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EstimatedReimbursementMember_90e739cb-306b-4e1f-847d-b870098086c3" xlink:href="mrna-20201231.xsd#mrna_EstimatedReimbursementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_b94a0ea6-6c3a-493a-a2ec-f20b56616662" xlink:to="loc_mrna_EstimatedReimbursementMember_90e739cb-306b-4e1f-847d-b870098086c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_d67f5846-015b-4026-a86b-8bbb06f19a68" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_d67f5846-015b-4026-a86b-8bbb06f19a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_c70e2d8e-0aca-40e7-a305-6c973cccdd9c" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_d67f5846-015b-4026-a86b-8bbb06f19a68" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_c70e2d8e-0aca-40e7-a305-6c973cccdd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ToxicityMilestonesMember_c740d866-25ba-4e26-b805-39a711ba4101" xlink:href="mrna-20201231.xsd#mrna_ToxicityMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_c70e2d8e-0aca-40e7-a305-6c973cccdd9c" xlink:to="loc_mrna_ToxicityMilestonesMember_c740d866-25ba-4e26-b805-39a711ba4101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CompetitionMilestonesMember_806abd8e-c236-4d04-a6af-5b4d53f6d299" xlink:href="mrna-20201231.xsd#mrna_CompetitionMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_c70e2d8e-0aca-40e7-a305-6c973cccdd9c" xlink:to="loc_mrna_CompetitionMilestonesMember_806abd8e-c236-4d04-a6af-5b4d53f6d299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_c4e6ce00-d119-4cc1-9ebb-ad406bb29549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_bf524ee4-6ee2-49b6-9063-699eb142b958" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_c4e6ce00-d119-4cc1-9ebb-ad406bb29549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_cd38541a-ae18-4670-aec8-2d8c6df5c09b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_c4e6ce00-d119-4cc1-9ebb-ad406bb29549" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_cd38541a-ae18-4670-aec8-2d8c6df5c09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_4ee8f66d-7af4-49b9-953e-d073f3ed6369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6c18855a-1c48-415e-b674-446a7e406de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_4ee8f66d-7af4-49b9-953e-d073f3ed6369" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6c18855a-1c48-415e-b674-446a7e406de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationAxis_add138ef-c36b-4f5d-b7b0-db5e978b8222" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6c18855a-1c48-415e-b674-446a7e406de5" xlink:to="loc_mrna_PerformanceObligationAxis_add138ef-c36b-4f5d-b7b0-db5e978b8222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationAxis_add138ef-c36b-4f5d-b7b0-db5e978b8222" xlink:to="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementPerformanceObligationMember_d0de1897-c50e-4052-8a29-6654dcbef86b" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementPerformanceObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:to="loc_mrna_Combined2018AZAgreementPerformanceObligationMember_d0de1897-c50e-4052-8a29-6654dcbef86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_IL12PerformanceObligationMember_920d17f6-3561-46ae-a272-26cd018a822e" xlink:href="mrna-20201231.xsd#mrna_IL12PerformanceObligationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:to="loc_mrna_IL12PerformanceObligationMember_920d17f6-3561-46ae-a272-26cd018a822e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OncologyDevelopmentTargetPerformanceObligationMember_13d7f990-bbdd-495c-822a-4bb8c034f445" xlink:href="mrna-20201231.xsd#mrna_OncologyDevelopmentTargetPerformanceObligationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:to="loc_mrna_OncologyDevelopmentTargetPerformanceObligationMember_13d7f990-bbdd-495c-822a-4bb8c034f445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_54a7e85a-c249-4a51-ac24-498e51cbeab4" xlink:href="mrna-20201231.xsd#mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:to="loc_mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member_54a7e85a-c249-4a51-ac24-498e51cbeab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_9244363e-14cc-470c-b5e5-2379ffe86cd2" xlink:href="mrna-20201231.xsd#mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_440c88da-e74f-44d1-b380-fbcc65130490" xlink:to="loc_mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember_9244363e-14cc-470c-b5e5-2379ffe86cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2eb02959-6c8b-4cd7-8e2a-098f9865eda0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6c18855a-1c48-415e-b674-446a7e406de5" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2eb02959-6c8b-4cd7-8e2a-098f9865eda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_404e026e-3331-4463-abc8-773edfa28fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_2eb02959-6c8b-4cd7-8e2a-098f9865eda0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_404e026e-3331-4463-abc8-773edfa28fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_bccf3bb2-5d2b-4585-9ad5-213e5b661c08" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_404e026e-3331-4463-abc8-773edfa28fba" xlink:to="loc_mrna_Combined2018AZAgreementsMember_bccf3bb2-5d2b-4585-9ad5-213e5b661c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1b6b86ea-c624-428e-9581-af93c56115ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6c18855a-1c48-415e-b674-446a7e406de5" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1b6b86ea-c624-428e-9581-af93c56115ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d984a84a-94ae-43c5-93d4-2c461315bc59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1b6b86ea-c624-428e-9581-af93c56115ae" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d984a84a-94ae-43c5-93d4-2c461315bc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsRevenueRecognizedDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_34139181-c202-4024-9c92-a5c6bb0525eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_34139181-c202-4024-9c92-a5c6bb0525eb" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:to="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_27f2f2a5-a3e2-43f5-b3f8-345f77ad1b30" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0a0b0501-ba88-4485-a767-b89e1b9fe6d3" xlink:to="loc_srt_ProductsAndServicesDomain_27f2f2a5-a3e2-43f5-b3f8-345f77ad1b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_29491e27-67dc-49af-b6bd-75a32eda3514" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_27f2f2a5-a3e2-43f5-b3f8-345f77ad1b30" xlink:to="loc_mrna_CollaborationArrangementMember_29491e27-67dc-49af-b6bd-75a32eda3514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_815b384a-0c65-488b-9d8a-995695b00504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7a216429-d9f2-42f1-936d-6b9ed0bfaccc" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_815b384a-0c65-488b-9d8a-995695b00504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_4c8d5664-107e-4831-b1dd-108f877b9c69" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_815b384a-0c65-488b-9d8a-995695b00504" xlink:to="loc_mrna_Combined2018AZAgreementsMember_4c8d5664-107e-4831-b1dd-108f877b9c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b05b349d-064b-4bea-9b4a-1f6c3ebed39b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_b05b349d-064b-4bea-9b4a-1f6c3ebed39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8302e2ac-b844-4a34-8d99-10858bc1257c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_297dee68-7c0d-48d7-9c9a-f993657ca610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_297dee68-7c0d-48d7-9c9a-f993657ca610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_d5a9688b-c26d-4091-b34d-128e00fba2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_171736fa-b45d-4d4a-a809-68b1f51f333d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_d5a9688b-c26d-4091-b34d-128e00fba2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsRevenueRecognizedDetails_1"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_e0c1e869-a888-4e1a-9755-5825d734d24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ca972c68-e890-4e6e-a362-b132dcc91bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_e0c1e869-a888-4e1a-9755-5825d734d24c" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ca972c68-e890-4e6e-a362-b132dcc91bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_29ddfd02-c6fe-4478-b110-93501752755e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ca972c68-e890-4e6e-a362-b132dcc91bd1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_29ddfd02-c6fe-4478-b110-93501752755e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4f58f84c-27c8-4d84-8e0e-6f0e47442239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_29ddfd02-c6fe-4478-b110-93501752755e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4f58f84c-27c8-4d84-8e0e-6f0e47442239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Combined2018AZAgreementsMember_12405371-cefa-4556-ab6d-4122ce43e64e" xlink:href="mrna-20201231.xsd#mrna_Combined2018AZAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4f58f84c-27c8-4d84-8e0e-6f0e47442239" xlink:to="loc_mrna_Combined2018AZAgreementsMember_12405371-cefa-4556-ab6d-4122ce43e64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5a637337-56cf-4284-a44e-85904e520fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ca972c68-e890-4e6e-a362-b132dcc91bd1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5a637337-56cf-4284-a44e-85904e520fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_82e43e96-6dab-47d4-8933-695c510d0b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5a637337-56cf-4284-a44e-85904e520fa9" xlink:to="loc_us-gaap_ContractWithCustomerLiability_82e43e96-6dab-47d4-8933-695c510d0b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVEGFTotalTransactionPriceDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_e7a80bc4-4dc4-432e-9964-ffb89a3d82ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5fe7869d-4337-4f58-8818-5d4d62a1ead0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_e7a80bc4-4dc4-432e-9964-ffb89a3d82ae" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5fe7869d-4337-4f58-8818-5d4d62a1ead0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_be7c1ed2-74e0-4706-b63e-72e761b5e398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5fe7869d-4337-4f58-8818-5d4d62a1ead0" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_be7c1ed2-74e0-4706-b63e-72e761b5e398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_be7c1ed2-74e0-4706-b63e-72e761b5e398" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OptionExerciseFeeMember_4ac2a9cc-2bf6-4c57-9bd0-8853d2ff59d7" xlink:href="mrna-20201231.xsd#mrna_OptionExerciseFeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:to="loc_mrna_OptionExerciseFeeMember_4ac2a9cc-2bf6-4c57-9bd0-8853d2ff59d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MilestonePaymentsMember_c001a1de-6278-490e-9887-e2643ed4a36b" xlink:href="mrna-20201231.xsd#mrna_MilestonePaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:to="loc_mrna_MilestonePaymentsMember_c001a1de-6278-490e-9887-e2643ed4a36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SublicenseReimbursementMember_2b4c00d5-98ad-4b7a-877b-48ed6bf44cb2" xlink:href="mrna-20201231.xsd#mrna_SublicenseReimbursementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:to="loc_mrna_SublicenseReimbursementMember_2b4c00d5-98ad-4b7a-877b-48ed6bf44cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VariableConsiderationMember_a1854d01-9b32-4511-870e-7ea24cf1bd0a" xlink:href="mrna-20201231.xsd#mrna_VariableConsiderationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_cb9daf88-c698-4eb2-b1f2-83e9da79bd2f" xlink:to="loc_mrna_VariableConsiderationMember_a1854d01-9b32-4511-870e-7ea24cf1bd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_752fff75-aabc-448e-838a-81b8be643507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5fe7869d-4337-4f58-8818-5d4d62a1ead0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_752fff75-aabc-448e-838a-81b8be643507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8ce011f2-bf66-458f-a2d8-374eb965f585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_752fff75-aabc-448e-838a-81b8be643507" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8ce011f2-bf66-458f-a2d8-374eb965f585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_53332c21-3be8-4ac4-a5ec-4e60ab724983" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8ce011f2-bf66-458f-a2d8-374eb965f585" xlink:to="loc_mrna_VEGFExercise2016Member_53332c21-3be8-4ac4-a5ec-4e60ab724983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1b02f9e6-237d-4383-be51-6eccc7d157f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5fe7869d-4337-4f58-8818-5d4d62a1ead0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1b02f9e6-237d-4383-be51-6eccc7d157f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_75e9224b-ff7e-4a29-9727-557fd3239b6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1b02f9e6-237d-4383-be51-6eccc7d157f3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_75e9224b-ff7e-4a29-9727-557fd3239b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_6f7841c1-3e8a-4e55-bf5a-b4cb1c2dc0b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_6f7841c1-3e8a-4e55-bf5a-b4cb1c2dc0b9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0028db23-835f-45c7-aed5-e0ce41990bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_b8d9bcd7-7d2a-4ff9-a0b0-c1ae69696615" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0028db23-835f-45c7-aed5-e0ce41990bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_3d0b526e-7a40-411e-916d-2adc27a654a2" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_0028db23-835f-45c7-aed5-e0ce41990bd8" xlink:to="loc_mrna_VEGFExercise2016Member_3d0b526e-7a40-411e-916d-2adc27a654a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7ec7c19a-0e12-4071-a63f-cade4aea0301" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_7ec7c19a-0e12-4071-a63f-cade4aea0301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0d45c47b-cd6e-46c4-839c-bb611ea1379c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_ee7bc6e7-a772-4f12-9dfb-07609d95cb38" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0d45c47b-cd6e-46c4-839c-bb611ea1379c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_ffa4cbe2-6d51-4088-8903-3cdc41ee0bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_0d45c47b-cd6e-46c4-839c-bb611ea1379c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_ffa4cbe2-6d51-4088-8903-3cdc41ee0bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVEGFRevenueRecognizedDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_5c59fd96-09de-4c7b-8785-704216c8360e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_77ea420d-e3a6-4564-8593-9e3077a5ce0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_5c59fd96-09de-4c7b-8785-704216c8360e" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_77ea420d-e3a6-4564-8593-9e3077a5ce0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_37ccc629-87b8-44e2-8b29-3d25978b2c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_77ea420d-e3a6-4564-8593-9e3077a5ce0e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_37ccc629-87b8-44e2-8b29-3d25978b2c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_091ebec7-80be-4df5-8ed3-8322e90645e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_37ccc629-87b8-44e2-8b29-3d25978b2c6b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_091ebec7-80be-4df5-8ed3-8322e90645e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_d34c4eda-77f0-4444-8f93-fbcd23f567af" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_091ebec7-80be-4df5-8ed3-8322e90645e1" xlink:to="loc_mrna_VEGFExercise2016Member_d34c4eda-77f0-4444-8f93-fbcd23f567af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_243de378-3ca2-4b94-abe2-c8261322160c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_77ea420d-e3a6-4564-8593-9e3077a5ce0e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_243de378-3ca2-4b94-abe2-c8261322160c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5aec0078-d3b1-471d-83c5-76290c497a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_243de378-3ca2-4b94-abe2-c8261322160c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5aec0078-d3b1-471d-83c5-76290c497a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_545e6b46-9ebc-49b4-8ea3-cf4d7eda33d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d80254ea-4cdb-4cb5-9c21-72b7b8e34799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_545e6b46-9ebc-49b4-8ea3-cf4d7eda33d6" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d80254ea-4cdb-4cb5-9c21-72b7b8e34799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_bce665a3-030e-412e-9f9e-2fdd5605d73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d80254ea-4cdb-4cb5-9c21-72b7b8e34799" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_bce665a3-030e-412e-9f9e-2fdd5605d73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9d10cb81-e44f-4239-b17d-99af5f934a3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_bce665a3-030e-412e-9f9e-2fdd5605d73d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9d10cb81-e44f-4239-b17d-99af5f934a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VEGFExercise2016Member_4aa503a3-76d3-46bd-8fa7-c9d6a96e0e60" xlink:href="mrna-20201231.xsd#mrna_VEGFExercise2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_9d10cb81-e44f-4239-b17d-99af5f934a3b" xlink:to="loc_mrna_VEGFExercise2016Member_4aa503a3-76d3-46bd-8fa7-c9d6a96e0e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_455135dc-22c6-47c0-aaf9-e8b6c60742ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d80254ea-4cdb-4cb5-9c21-72b7b8e34799" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_455135dc-22c6-47c0-aaf9-e8b6c60742ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_7d71707c-1614-4434-bde1-1192707db58f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_455135dc-22c6-47c0-aaf9-e8b6c60742ac" xlink:to="loc_us-gaap_ContractWithCustomerLiability_7d71707c-1614-4434-bde1-1192707db58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_91fc0434-68e8-4d25-a4ec-245629d0b720" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_91fc0434-68e8-4d25-a4ec-245629d0b720" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationAxis_b8ce8b10-1e49-4f95-9014-a608ee0357e6" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_mrna_PerformanceObligationAxis_b8ce8b10-1e49-4f95-9014-a608ee0357e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_a0918541-40ff-4f3c-8160-40786ab066e1" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationAxis_b8ce8b10-1e49-4f95-9014-a608ee0357e6" xlink:to="loc_mrna_PerformanceObligationDomain_a0918541-40ff-4f3c-8160-40786ab066e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVPerformanceObligationMember_af84b34e-90c5-4484-8567-98d93d1c1895" xlink:href="mrna-20201231.xsd#mrna_PCVPerformanceObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_a0918541-40ff-4f3c-8160-40786ab066e1" xlink:to="loc_mrna_PCVPerformanceObligationMember_af84b34e-90c5-4484-8567-98d93d1c1895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_KRASPerformanceObligationMember_0e406a47-a207-48f9-8e36-d5d51527b1ee" xlink:href="mrna-20201231.xsd#mrna_KRASPerformanceObligationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_a0918541-40ff-4f3c-8160-40786ab066e1" xlink:to="loc_mrna_KRASPerformanceObligationMember_0e406a47-a207-48f9-8e36-d5d51527b1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_ccef675a-9012-4883-bca8-5fcc0f39d889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_ccef675a-9012-4883-bca8-5fcc0f39d889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_ccef675a-9012-4883-bca8-5fcc0f39d889" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_f0ca9f39-7116-42c1-a5bc-c5183351b748" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:to="loc_mrna_UpfrontPaymentMember_f0ca9f39-7116-42c1-a5bc-c5183351b748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MilestonePaymentsMember_fa175e0d-7c3e-434f-acc5-9ede61c400e1" xlink:href="mrna-20201231.xsd#mrna_MilestonePaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:to="loc_mrna_MilestonePaymentsMember_fa175e0d-7c3e-434f-acc5-9ede61c400e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_a899dbc9-c469-4df7-96fa-24a7fb2b897f" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:to="loc_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_a899dbc9-c469-4df7-96fa-24a7fb2b897f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentResearchAndDevelopmentMember_7d648f3f-f123-4da7-9778-3f9d4ad343d6" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentResearchAndDevelopmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_4f1fc9b7-16df-4e79-8444-a251884ec200" xlink:to="loc_mrna_UpfrontPaymentResearchAndDevelopmentMember_7d648f3f-f123-4da7-9778-3f9d4ad343d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a5edca27-991b-4cd8-bc3b-63b4a7f13ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a5edca27-991b-4cd8-bc3b-63b4a7f13ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a5edca27-991b-4cd8-bc3b-63b4a7f13ed1" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckAgreement2015Member_c2e5e240-e982-473b-9153-d97793b5cb4d" xlink:href="mrna-20201231.xsd#mrna_MerckAgreement2015Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:to="loc_mrna_MerckAgreement2015Member_c2e5e240-e982-473b-9153-d97793b5cb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SeparateAgreementsWithMerckMember_7f3dd890-669c-448c-ba5e-10f4b95c25e6" xlink:href="mrna-20201231.xsd#mrna_SeparateAgreementsWithMerckMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:to="loc_mrna_SeparateAgreementsWithMerckMember_7f3dd890-669c-448c-ba5e-10f4b95c25e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_39831a29-c1fd-41de-84b0-25604fa37390" xlink:href="mrna-20201231.xsd#mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:to="loc_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_39831a29-c1fd-41de-84b0-25604fa37390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_c7373be0-6072-45a7-9a4e-a72a5e91f8d9" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4a0c130-91b1-4565-bf3d-0e99cd6f7074" xlink:to="loc_mrna_PCVSAVAgreementMember_c7373be0-6072-45a7-9a4e-a72a5e91f8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_c3926df9-f944-41b7-ad45-bb00121cd81f" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_c3926df9-f944-41b7-ad45-bb00121cd81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_e7926d9f-427b-4e46-b833-77753360b920" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_c3926df9-f944-41b7-ad45-bb00121cd81f" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_e7926d9f-427b-4e46-b833-77753360b920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentMilestonesMember_6e7653c2-6766-4e99-9866-b2ff5b54e129" xlink:href="mrna-20201231.xsd#mrna_DevelopmentMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_e7926d9f-427b-4e46-b833-77753360b920" xlink:to="loc_mrna_DevelopmentMilestonesMember_6e7653c2-6766-4e99-9866-b2ff5b54e129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RegulatoryMilestonesMember_c3e7d241-9d33-4f75-a046-2e518348678c" xlink:href="mrna-20201231.xsd#mrna_RegulatoryMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_e7926d9f-427b-4e46-b833-77753360b920" xlink:to="loc_mrna_RegulatoryMilestonesMember_c3e7d241-9d33-4f75-a046-2e518348678c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CommercialMilestonesMember_dfbad693-5e2e-4ee0-b842-1bceea42aa2b" xlink:href="mrna-20201231.xsd#mrna_CommercialMilestonesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_e7926d9f-427b-4e46-b833-77753360b920" xlink:to="loc_mrna_CommercialMilestonesMember_dfbad693-5e2e-4ee0-b842-1bceea42aa2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_38031192-0e03-428f-b7e0-61ece1886090" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_srt_ProductOrServiceAxis_38031192-0e03-428f-b7e0-61ece1886090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_63fcb235-8184-4f0c-bf5a-13b576dc0d1c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_38031192-0e03-428f-b7e0-61ece1886090" xlink:to="loc_srt_ProductsAndServicesDomain_63fcb235-8184-4f0c-bf5a-13b576dc0d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_806cfdcb-6a03-4998-a9c7-f81307288dfa" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_63fcb235-8184-4f0c-bf5a-13b576dc0d1c" xlink:to="loc_mrna_CollaborationArrangementMember_806cfdcb-6a03-4998-a9c7-f81307288dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_465e5164-f2d8-4d34-8fd8-5d2868ffe3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_465e5164-f2d8-4d34-8fd8-5d2868ffe3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_259f9e30-b976-4ba6-bf29-663f25250de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_465e5164-f2d8-4d34-8fd8-5d2868ffe3fd" xlink:to="loc_us-gaap_ProjectMember_259f9e30-b976-4ba6-bf29-663f25250de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PersonalizedMRNACancerVaccinesProductsMember_8c87e95a-1fb8-4055-a637-643a6fd40686" xlink:href="mrna-20201231.xsd#mrna_PersonalizedMRNACancerVaccinesProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_259f9e30-b976-4ba6-bf29-663f25250de5" xlink:to="loc_mrna_PersonalizedMRNACancerVaccinesProductsMember_8c87e95a-1fb8-4055-a637-643a6fd40686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_09a036c5-a4b6-478c-a35b-b8abbff3539c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_us-gaap_StatementClassOfStockAxis_09a036c5-a4b6-478c-a35b-b8abbff3539c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_648d5a75-327a-4d49-9ef2-e57a92dc89f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_09a036c5-a4b6-478c-a35b-b8abbff3539c" xlink:to="loc_us-gaap_ClassOfStockDomain_648d5a75-327a-4d49-9ef2-e57a92dc89f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesHPreferredStockMember_c51d4e70-c3ae-40b4-be3d-0fa71a00294d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesHPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_648d5a75-327a-4d49-9ef2-e57a92dc89f3" xlink:to="loc_us-gaap_SeriesHPreferredStockMember_c51d4e70-c3ae-40b4-be3d-0fa71a00294d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_c81ccf35-10dd-4c4e-9e16-5f82a9bc3f62" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d2ba59d3-9f2d-4dec-8b73-cb73d5834b4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d2ba59d3-9f2d-4dec-8b73-cb73d5834b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8414aa38-0a8a-4644-9f83-bda1a52919c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8414aa38-0a8a-4644-9f83-bda1a52919c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_93ba953f-27a2-4b42-8109-2beb44ad163d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_93ba953f-27a2-4b42-8109-2beb44ad163d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_942646b7-1cd4-4bf5-9667-cc61062ebcbc" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_942646b7-1cd4-4bf5-9667-cc61062ebcbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_a7303435-c864-4206-ac65-80483a3170c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_a7303435-c864-4206-ac65-80483a3170c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod_34c5bc3a-198a-451f-8308-e61cff735617" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod_34c5bc3a-198a-451f-8308-e61cff735617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_aa4e5fa7-69e3-4140-b4e2-072ffe2fcdc7" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_aa4e5fa7-69e3-4140-b4e2-072ffe2fcdc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_e1a7eddb-2a72-45c0-8f8b-43fd740ccb42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_e1a7eddb-2a72-45c0-8f8b-43fd740ccb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4844cbd8-ff9b-4fea-b02d-ef43783e0bbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_4844cbd8-ff9b-4fea-b02d-ef43783e0bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedemptionPremium_2ea8f312-f3d6-49d6-ad65-73dddb38adc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedemptionPremium"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_RedemptionPremium_2ea8f312-f3d6-49d6-ad65-73dddb38adc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c22edf48-0cd6-4892-a5c3-3f2dfd8b2ffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c22edf48-0cd6-4892-a5c3-3f2dfd8b2ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_5cc47961-f74c-4e0c-8583-84bfaf3b3801" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d064e14b-c920-43b7-a707-bd50d2556d34" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_5cc47961-f74c-4e0c-8583-84bfaf3b3801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_a32f2547-f954-4a52-8abb-29f46e631e30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_992ae02a-f5f6-46fb-93f3-69f08bfa0b33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_a32f2547-f954-4a52-8abb-29f46e631e30" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_992ae02a-f5f6-46fb-93f3-69f08bfa0b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4abdebab-6279-40ba-bb43-b0d1067be0c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_992ae02a-f5f6-46fb-93f3-69f08bfa0b33" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4abdebab-6279-40ba-bb43-b0d1067be0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_af1ea10a-8fc0-4bb1-98eb-335b7e4374c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_4abdebab-6279-40ba-bb43-b0d1067be0c6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_af1ea10a-8fc0-4bb1-98eb-335b7e4374c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckAgreement2015Member_b6b2e926-fd92-49c9-b36a-6464aa244c11" xlink:href="mrna-20201231.xsd#mrna_MerckAgreement2015Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_af1ea10a-8fc0-4bb1-98eb-335b7e4374c9" xlink:to="loc_mrna_MerckAgreement2015Member_b6b2e926-fd92-49c9-b36a-6464aa244c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_49d04995-ab05-4a3b-96c5-533647044cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_992ae02a-f5f6-46fb-93f3-69f08bfa0b33" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_49d04995-ab05-4a3b-96c5-533647044cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7d87c46f-e29e-408d-9885-dbb66f0ba2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_49d04995-ab05-4a3b-96c5-533647044cea" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7d87c46f-e29e-408d-9885-dbb66f0ba2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_21d4e746-c0fd-4284-9dc6-6053bc9c2cef" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7d87c46f-e29e-408d-9885-dbb66f0ba2d7" xlink:to="loc_mrna_UpfrontPaymentMember_21d4e746-c0fd-4284-9dc6-6053bc9c2cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentResearchAndDevelopmentMember_780591be-35b0-478c-b666-a8b0b6c39fe8" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_7d87c46f-e29e-408d-9885-dbb66f0ba2d7" xlink:to="loc_mrna_UpfrontPaymentResearchAndDevelopmentMember_780591be-35b0-478c-b666-a8b0b6c39fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1bf3cd83-3638-4355-8844-430940014a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_992ae02a-f5f6-46fb-93f3-69f08bfa0b33" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1bf3cd83-3638-4355-8844-430940014a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_97105583-7f9e-4b22-bdcd-9d0926360357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1bf3cd83-3638-4355-8844-430940014a8c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_97105583-7f9e-4b22-bdcd-9d0926360357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_dbc86417-0350-4a7d-9932-4e57f0f033a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_1bf3cd83-3638-4355-8844-430940014a8c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_dbc86417-0350-4a7d-9932-4e57f0f033a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_a08db4b4-2645-48f0-8372-3d58e5146c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_a08db4b4-2645-48f0-8372-3d58e5146c57" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f033979-7322-47cc-ac90-2d518d8f0c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ce356526-a6b6-465f-960d-09146ece063b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f033979-7322-47cc-ac90-2d518d8f0c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckAgreement2015Member_694a6634-1f46-4386-94dd-4f1c5c1dbd4c" xlink:href="mrna-20201231.xsd#mrna_MerckAgreement2015Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f033979-7322-47cc-ac90-2d518d8f0c71" xlink:to="loc_mrna_MerckAgreement2015Member_694a6634-1f46-4386-94dd-4f1c5c1dbd4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_70a34813-71f3-43b8-826e-c9b6186b5dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_70a34813-71f3-43b8-826e-c9b6186b5dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_42760de0-4476-4085-8ab6-92610fa65601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_6824b110-62b8-48b2-9618-390ccf430ccb" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_42760de0-4476-4085-8ab6-92610fa65601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_75bf0fea-6856-4ecc-91ee-8c4241c54133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_42760de0-4476-4085-8ab6-92610fa65601" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_75bf0fea-6856-4ecc-91ee-8c4241c54133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_06cac6ad-9ac3-4272-9c79-3439d7ff685c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ce88b4d6-8d14-4422-a905-f760f684dd60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_06cac6ad-9ac3-4272-9c79-3439d7ff685c" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ce88b4d6-8d14-4422-a905-f760f684dd60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6b446b42-d410-41ac-847f-512db98db9d3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ce88b4d6-8d14-4422-a905-f760f684dd60" xlink:to="loc_srt_ProductOrServiceAxis_6b446b42-d410-41ac-847f-512db98db9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_292e476b-0e30-44c9-b145-a040157c76f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6b446b42-d410-41ac-847f-512db98db9d3" xlink:to="loc_srt_ProductsAndServicesDomain_292e476b-0e30-44c9-b145-a040157c76f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_95c10415-39e0-4c62-8c22-fe33e51b2673" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_292e476b-0e30-44c9-b145-a040157c76f0" xlink:to="loc_mrna_CollaborationArrangementMember_95c10415-39e0-4c62-8c22-fe33e51b2673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_8cdb301a-1da6-4481-8ab8-5ca91a14dff6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ce88b4d6-8d14-4422-a905-f760f684dd60" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_8cdb301a-1da6-4481-8ab8-5ca91a14dff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_86f6db2c-54a9-4cae-ba76-9389a36dd933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_8cdb301a-1da6-4481-8ab8-5ca91a14dff6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_86f6db2c-54a9-4cae-ba76-9389a36dd933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckMay2019AgreementMember_763a981c-63d9-4ff4-8470-047342fac53b" xlink:href="mrna-20201231.xsd#mrna_MerckMay2019AgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_86f6db2c-54a9-4cae-ba76-9389a36dd933" xlink:to="loc_mrna_MerckMay2019AgreementMember_763a981c-63d9-4ff4-8470-047342fac53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MerckAgreement2015Member_66d0f342-8742-4943-a0bf-bad2d2a8640f" xlink:href="mrna-20201231.xsd#mrna_MerckAgreement2015Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_86f6db2c-54a9-4cae-ba76-9389a36dd933" xlink:to="loc_mrna_MerckAgreement2015Member_66d0f342-8742-4943-a0bf-bad2d2a8640f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SeparateAgreementsWithMerckMember_b02c7b07-7d6b-4a10-aa12-29726c96ec27" xlink:href="mrna-20201231.xsd#mrna_SeparateAgreementsWithMerckMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_86f6db2c-54a9-4cae-ba76-9389a36dd933" xlink:to="loc_mrna_SeparateAgreementsWithMerckMember_b02c7b07-7d6b-4a10-aa12-29726c96ec27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f6ceae1f-0964-4fa3-8c61-6cc1cc1e8bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_ce88b4d6-8d14-4422-a905-f760f684dd60" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f6ceae1f-0964-4fa3-8c61-6cc1cc1e8bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8661953c-1dbe-4bbd-abda-248bc46175db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f6ceae1f-0964-4fa3-8c61-6cc1cc1e8bc1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8661953c-1dbe-4bbd-abda-248bc46175db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_cfa04768-3175-4e08-b10b-6494fb98c50e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d75c1e0c-6059-4980-8195-24d0b3b1e9c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_cfa04768-3175-4e08-b10b-6494fb98c50e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d75c1e0c-6059-4980-8195-24d0b3b1e9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_23645aba-fd2c-4701-84bf-628cb7398989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d75c1e0c-6059-4980-8195-24d0b3b1e9c4" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_23645aba-fd2c-4701-84bf-628cb7398989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fc9d8654-bc13-4e94-a016-8ff923877199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_23645aba-fd2c-4701-84bf-628cb7398989" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fc9d8654-bc13-4e94-a016-8ff923877199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_9e184509-6930-4d70-add7-ac7a23328ea7" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_fc9d8654-bc13-4e94-a016-8ff923877199" xlink:to="loc_mrna_PCVSAVAgreementMember_9e184509-6930-4d70-add7-ac7a23328ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8e583666-1c4d-4161-8296-14fc0adb7c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d75c1e0c-6059-4980-8195-24d0b3b1e9c4" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8e583666-1c4d-4161-8296-14fc0adb7c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e525fb14-6e1f-4bf7-8a8e-cca00bc41e53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8e583666-1c4d-4161-8296-14fc0adb7c41" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e525fb14-6e1f-4bf7-8a8e-cca00bc41e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_f8198288-fb5a-4f0b-a711-a9ec322008ca" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e525fb14-6e1f-4bf7-8a8e-cca00bc41e53" xlink:to="loc_mrna_UpfrontPaymentMember_f8198288-fb5a-4f0b-a711-a9ec322008ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_98e129c8-301d-43ef-9ce7-632348846d6c" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e525fb14-6e1f-4bf7-8a8e-cca00bc41e53" xlink:to="loc_mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember_98e129c8-301d-43ef-9ce7-632348846d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalSupplyReimbursementMember_19358b22-2817-4aa7-b8e4-3dc1acf92e98" xlink:href="mrna-20201231.xsd#mrna_ClinicalSupplyReimbursementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_e525fb14-6e1f-4bf7-8a8e-cca00bc41e53" xlink:to="loc_mrna_ClinicalSupplyReimbursementMember_19358b22-2817-4aa7-b8e4-3dc1acf92e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d677d1aa-6a0a-432d-bd73-e2caa4aad6e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d75c1e0c-6059-4980-8195-24d0b3b1e9c4" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d677d1aa-6a0a-432d-bd73-e2caa4aad6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_2772d90a-e7c6-4a6c-b6e9-8a75d49bb14a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_d677d1aa-6a0a-432d-bd73-e2caa4aad6e6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_2772d90a-e7c6-4a6c-b6e9-8a75d49bb14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_39fc3281-fd06-4eff-b849-53130fed640a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_39fc3281-fd06-4eff-b849-53130fed640a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c2088955-c0e2-498f-9f0c-d024213e8110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0d4cd46f-c399-47a8-95b5-f8a08f054b36" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c2088955-c0e2-498f-9f0c-d024213e8110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_bf2a6229-1771-4ace-8964-2ea63d227620" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c2088955-c0e2-498f-9f0c-d024213e8110" xlink:to="loc_mrna_PCVSAVAgreementMember_bf2a6229-1771-4ace-8964-2ea63d227620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_568c88ed-8f7f-4391-b687-f4c67498d2b2" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVPerformanceObligationMember_0376f77a-b7d5-4c9c-9116-56ad32fbd2a1" xlink:href="mrna-20201231.xsd#mrna_PCVPerformanceObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:to="loc_mrna_PCVPerformanceObligationMember_0376f77a-b7d5-4c9c-9116-56ad32fbd2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_KRASPerformanceObligationMember_dc5cbebb-362b-4916-9ff1-2e1def85c8e1" xlink:href="mrna-20201231.xsd#mrna_KRASPerformanceObligationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:to="loc_mrna_KRASPerformanceObligationMember_dc5cbebb-362b-4916-9ff1-2e1def85c8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalSupplyReimbursementMember_1d3dc9b7-d3d7-43a5-9e6a-a72004209b27" xlink:href="mrna-20201231.xsd#mrna_ClinicalSupplyReimbursementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_faa9f277-e99d-40a8-af95-1233499ca21d" xlink:to="loc_mrna_ClinicalSupplyReimbursementMember_1d3dc9b7-d3d7-43a5-9e6a-a72004209b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:href="mrna-20201231.xsd#mrna_PerformanceObligationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationAxis_ec5486f8-6a5f-4440-8c76-184fc8940da8" xlink:to="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVPerformanceObligationMember_8d272ef3-65c2-47d8-a1e2-e7b70c94e647" xlink:href="mrna-20201231.xsd#mrna_PCVPerformanceObligationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:to="loc_mrna_PCVPerformanceObligationMember_8d272ef3-65c2-47d8-a1e2-e7b70c94e647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_KRASPerformanceObligationMember_1c520075-27db-49a0-85b4-f88f94b910a6" xlink:href="mrna-20201231.xsd#mrna_KRASPerformanceObligationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_PerformanceObligationDomain_81b793d9-513a-4808-8c64-bf7233af94fc" xlink:to="loc_mrna_KRASPerformanceObligationMember_1c520075-27db-49a0-85b4-f88f94b910a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8e197653-29fd-4376-addb-20c9d6fea0f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8e197653-29fd-4376-addb-20c9d6fea0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1982b941-024d-4f60-b4ad-514e96313e0a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_7b755d8e-a806-41a0-ac69-5a46772f5e19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_7b755d8e-a806-41a0-ac69-5a46772f5e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_ce3022a2-f8c7-4e62-be56-9a5e4e34813c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_98743fd8-43e4-4a73-9778-ae53e5aa2b33" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_ce3022a2-f8c7-4e62-be56-9a5e4e34813c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVRevenueRecognizedDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_6aece740-42f1-4f71-b099-add02a23567b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3fd98f7-16c1-406a-b33e-38d5ab2e6c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_6aece740-42f1-4f71-b099-add02a23567b" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3fd98f7-16c1-406a-b33e-38d5ab2e6c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_56ccb764-3a6e-4670-bdd3-7c843aa9c555" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3fd98f7-16c1-406a-b33e-38d5ab2e6c6d" xlink:to="loc_srt_ProductOrServiceAxis_56ccb764-3a6e-4670-bdd3-7c843aa9c555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_289ca828-50ff-432f-9bf4-52ba5cced70e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_56ccb764-3a6e-4670-bdd3-7c843aa9c555" xlink:to="loc_srt_ProductsAndServicesDomain_289ca828-50ff-432f-9bf4-52ba5cced70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_9ef7018f-7d59-4959-b2d7-024add3d9a23" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_289ca828-50ff-432f-9bf4-52ba5cced70e" xlink:to="loc_mrna_CollaborationArrangementMember_9ef7018f-7d59-4959-b2d7-024add3d9a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_3da119c4-5448-4c8f-a3e2-be3a5703a44d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3fd98f7-16c1-406a-b33e-38d5ab2e6c6d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_3da119c4-5448-4c8f-a3e2-be3a5703a44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_a58f9bc6-6e3a-4239-a1ec-4adb5d1567ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_3da119c4-5448-4c8f-a3e2-be3a5703a44d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_a58f9bc6-6e3a-4239-a1ec-4adb5d1567ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_f79af18a-0768-401b-8da2-ab0b7f10f483" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_a58f9bc6-6e3a-4239-a1ec-4adb5d1567ea" xlink:to="loc_mrna_PCVSAVAgreementMember_f79af18a-0768-401b-8da2-ab0b7f10f483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f26c2df9-157d-40a1-a594-1758ac0def6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3fd98f7-16c1-406a-b33e-38d5ab2e6c6d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f26c2df9-157d-40a1-a594-1758ac0def6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61538431-a947-4530-a5ae-8982789d9695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_f26c2df9-157d-40a1-a594-1758ac0def6f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61538431-a947-4530-a5ae-8982789d9695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_4ee492db-5a86-4d22-a0ab-178ab767325e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_19d38aaa-a257-4b79-b37a-ca69ada17541" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_4ee492db-5a86-4d22-a0ab-178ab767325e" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_19d38aaa-a257-4b79-b37a-ca69ada17541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98565203-d7b3-49d2-9895-72afbc4eff2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_19d38aaa-a257-4b79-b37a-ca69ada17541" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98565203-d7b3-49d2-9895-72afbc4eff2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7e946df8-d1e9-4f7d-868a-11829602c094" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_98565203-d7b3-49d2-9895-72afbc4eff2a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7e946df8-d1e9-4f7d-868a-11829602c094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PCVSAVAgreementMember_ea747874-b462-4969-918e-07ab2a403ebb" xlink:href="mrna-20201231.xsd#mrna_PCVSAVAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_7e946df8-d1e9-4f7d-868a-11829602c094" xlink:to="loc_mrna_PCVSAVAgreementMember_ea747874-b462-4969-918e-07ab2a403ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d8b5c89a-0d6e-47d0-95bf-ba4171009f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_19d38aaa-a257-4b79-b37a-ca69ada17541" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d8b5c89a-0d6e-47d0-95bf-ba4171009f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_8219f59c-7dc4-4f39-9ca7-f776fd9dbb08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_d8b5c89a-0d6e-47d0-95bf-ba4171009f59" xlink:to="loc_us-gaap_ContractWithCustomerLiability_8219f59c-7dc4-4f39-9ca7-f776fd9dbb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_e0342be5-f48e-4739-8e27-7169633c581c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_e0342be5-f48e-4739-8e27-7169633c581c" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c611250f-a182-40de-979a-f07a515518a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c611250f-a182-40de-979a-f07a515518a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_1326194d-0a0e-445e-a5a3-dec1c95e1d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c611250f-a182-40de-979a-f07a515518a5" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_1326194d-0a0e-445e-a5a3-dec1c95e1d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_b5aaef98-2cd0-419f-804f-f12ff9c129ad" xlink:href="mrna-20201231.xsd#mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_1326194d-0a0e-445e-a5a3-dec1c95e1d74" xlink:to="loc_mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember_b5aaef98-2cd0-419f-804f-f12ff9c129ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8be6922e-778b-48b2-babc-01e7ac6c7c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8be6922e-778b-48b2-babc-01e7ac6c7c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1752581d-1718-4c16-ad27-38a4ae5e2df4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_8be6922e-778b-48b2-babc-01e7ac6c7c58" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1752581d-1718-4c16-ad27-38a4ae5e2df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_7e577199-1d88-42f8-9d81-9905aa146f4a" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1752581d-1718-4c16-ad27-38a4ae5e2df4" xlink:to="loc_mrna_UpfrontPaymentMember_7e577199-1d88-42f8-9d81-9905aa146f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentFundingMember_f0a5345d-33cd-47f9-8391-4f3cac7495ab" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentFundingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1752581d-1718-4c16-ad27-38a4ae5e2df4" xlink:to="loc_mrna_ResearchAndDevelopmentFundingMember_f0a5345d-33cd-47f9-8391-4f3cac7495ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_12de247c-44e2-421e-af3b-025dd865d0b3" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_12de247c-44e2-421e-af3b-025dd865d0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_0cc59668-88f2-40f9-8981-b70539c826c7" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis_12de247c-44e2-421e-af3b-025dd865d0b3" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_0cc59668-88f2-40f9-8981-b70539c826c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DevelopmentMilestonesMember_64778a61-383e-456f-bb47-c529a35c619b" xlink:href="mrna-20201231.xsd#mrna_DevelopmentMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_0cc59668-88f2-40f9-8981-b70539c826c7" xlink:to="loc_mrna_DevelopmentMilestonesMember_64778a61-383e-456f-bb47-c529a35c619b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RegulatoryMilestonesMember_9b304dba-32a9-4c73-af07-68448b95edab" xlink:href="mrna-20201231.xsd#mrna_RegulatoryMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_0cc59668-88f2-40f9-8981-b70539c826c7" xlink:to="loc_mrna_RegulatoryMilestonesMember_9b304dba-32a9-4c73-af07-68448b95edab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RegulatoryMilestonesSubsequentProductsMember_a98dae33-e6de-43d6-84a9-c596b4122602" xlink:href="mrna-20201231.xsd#mrna_RegulatoryMilestonesSubsequentProductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain_0cc59668-88f2-40f9-8981-b70539c826c7" xlink:to="loc_mrna_RegulatoryMilestonesSubsequentProductsMember_a98dae33-e6de-43d6-84a9-c596b4122602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2db92d8a-c028-458c-bb1c-d5235a7c66e6" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_69c6fcaa-856b-4c44-9a37-337edff5714d" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_69c6fcaa-856b-4c44-9a37-337edff5714d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac68e0d3-6699-4cee-979c-a9d9df3ea44e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac68e0d3-6699-4cee-979c-a9d9df3ea44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod_12281c99-9222-4ac6-8273-b62e122668be" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod_12281c99-9222-4ac6-8273-b62e122668be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods_3053541a-0443-4080-ad5f-eb2346643ac1" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods_3053541a-0443-4080-ad5f-eb2346643ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_e1c7edcc-9e07-4cc0-ba86-51877eeaf4ee" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_e1c7edcc-9e07-4cc0-ba86-51877eeaf4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_50b2c7e5-ec1b-4eac-964f-8a799731b11f" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_50b2c7e5-ec1b-4eac-964f-8a799731b11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_f469cfbb-b421-47fd-ad17-4a00dd1ad6ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_f469cfbb-b421-47fd-ad17-4a00dd1ad6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_6c6955d9-3a63-4614-8a8b-e8d740e01d7a" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_6c6955d9-3a63-4614-8a8b-e8d740e01d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_33850dce-b171-42ad-ba62-ddaad7369f5b" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_33850dce-b171-42ad-ba62-ddaad7369f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_58cc3dae-68e0-40ab-9b59-60f6b0d72e69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_58cc3dae-68e0-40ab-9b59-60f6b0d72e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_95a21967-7d18-4440-89e3-6195eeee707d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_95a21967-7d18-4440-89e3-6195eeee707d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_4cec7e56-fce6-4e45-bb70-ea0bed7dabe8" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_4cec7e56-fce6-4e45-bb70-ea0bed7dabe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d168af41-111f-49d4-9c2f-8bb3cebf45d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_d168af41-111f-49d4-9c2f-8bb3cebf45d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a001fc3e-e36c-45d3-a32f-9e037073a37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a001fc3e-e36c-45d3-a32f-9e037073a37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_e85dfd43-86f3-474c-b639-8ee13efde087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_50811bd8-e1b6-4c11-9818-ff78efea82fd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_e85dfd43-86f3-474c-b639-8ee13efde087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_ad32e718-debe-46cc-9ac9-e5a8d702e65b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1a132248-3cb0-4c58-9662-b7d3a693ba91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ad32e718-debe-46cc-9ac9-e5a8d702e65b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1a132248-3cb0-4c58-9662-b7d3a693ba91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0b149664-1e59-450b-b41d-81cec2e68e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1a132248-3cb0-4c58-9662-b7d3a693ba91" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0b149664-1e59-450b-b41d-81cec2e68e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bbe8ec48-b5ee-432b-bca5-4d4ca32bb016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0b149664-1e59-450b-b41d-81cec2e68e8c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bbe8ec48-b5ee-432b-bca5-4d4ca32bb016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexFirstMember_55eff99a-06d5-4e62-8466-1ec531226cfd" xlink:href="mrna-20201231.xsd#mrna_VertexFirstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bbe8ec48-b5ee-432b-bca5-4d4ca32bb016" xlink:to="loc_mrna_VertexFirstMember_55eff99a-06d5-4e62-8466-1ec531226cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_57b522c6-4cfa-477a-9402-939738fbc071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1a132248-3cb0-4c58-9662-b7d3a693ba91" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_57b522c6-4cfa-477a-9402-939738fbc071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_40bc0337-fb87-405e-9720-3b28af7dff1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_57b522c6-4cfa-477a-9402-939738fbc071" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_40bc0337-fb87-405e-9720-3b28af7dff1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_e17f69dd-9e6b-41ac-981a-42348557bc40" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_40bc0337-fb87-405e-9720-3b28af7dff1e" xlink:to="loc_mrna_UpfrontPaymentMember_e17f69dd-9e6b-41ac-981a-42348557bc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentFundingMember_3a251b0d-f4f0-450e-98a2-30f047345b6d" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentFundingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_40bc0337-fb87-405e-9720-3b28af7dff1e" xlink:to="loc_mrna_ResearchAndDevelopmentFundingMember_3a251b0d-f4f0-450e-98a2-30f047345b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e96e7d41-615f-4fe1-9dc1-473a7f97f5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_1a132248-3cb0-4c58-9662-b7d3a693ba91" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e96e7d41-615f-4fe1-9dc1-473a7f97f5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_2839ee29-1d6c-474c-9ef8-00a442d58a51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_e96e7d41-615f-4fe1-9dc1-473a7f97f5cc" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_2839ee29-1d6c-474c-9ef8-00a442d58a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_f805d5e9-10a2-4846-85db-2060df03fc33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_f805d5e9-10a2-4846-85db-2060df03fc33" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f670b1c7-f67c-4f89-b344-f1618bbdce6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_d0c5e9be-6943-4991-8b95-e8b8d33db6ed" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f670b1c7-f67c-4f89-b344-f1618bbdce6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexFirstMember_46d78e19-4303-4c56-ab44-31886e99a1bb" xlink:href="mrna-20201231.xsd#mrna_VertexFirstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f670b1c7-f67c-4f89-b344-f1618bbdce6b" xlink:to="loc_mrna_VertexFirstMember_46d78e19-4303-4c56-ab44-31886e99a1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_e7d66a6c-9b06-4628-b6a2-619ba49f56b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_e7d66a6c-9b06-4628-b6a2-619ba49f56b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2f90f567-f226-4caf-805b-b115c212eb22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_257054ef-a9f9-4e67-8201-4e2d4a875815" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2f90f567-f226-4caf-805b-b115c212eb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_d3fccaa3-8220-4a36-83fc-5b0a36c2a57c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_2f90f567-f226-4caf-805b-b115c212eb22" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_d3fccaa3-8220-4a36-83fc-5b0a36c2a57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXRevenueRecognizedDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_27c2dccd-65c8-4389-9368-1836c371d41c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_17116ed3-ad3c-41d2-bffe-7f9079d3ecec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_27c2dccd-65c8-4389-9368-1836c371d41c" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_17116ed3-ad3c-41d2-bffe-7f9079d3ecec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a9420e3b-31bd-48a8-8829-6a50021a67e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_17116ed3-ad3c-41d2-bffe-7f9079d3ecec" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a9420e3b-31bd-48a8-8829-6a50021a67e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c99c877e-0434-4103-8bde-fcd0104dba45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_a9420e3b-31bd-48a8-8829-6a50021a67e2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c99c877e-0434-4103-8bde-fcd0104dba45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexFirstMember_61be810d-ec46-4b43-92b3-0830e20b7a24" xlink:href="mrna-20201231.xsd#mrna_VertexFirstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c99c877e-0434-4103-8bde-fcd0104dba45" xlink:to="loc_mrna_VertexFirstMember_61be810d-ec46-4b43-92b3-0830e20b7a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreement2019AgreementMember_ca86a67c-805f-46b1-a16e-7dca937b545e" xlink:href="mrna-20201231.xsd#mrna_VertexAgreement2019AgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c99c877e-0434-4103-8bde-fcd0104dba45" xlink:to="loc_mrna_VertexAgreement2019AgreementMember_ca86a67c-805f-46b1-a16e-7dca937b545e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreementsMember_fa48d860-5d5f-4903-bbb1-7ec69bcd25e1" xlink:href="mrna-20201231.xsd#mrna_VertexAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c99c877e-0434-4103-8bde-fcd0104dba45" xlink:to="loc_mrna_VertexAgreementsMember_fa48d860-5d5f-4903-bbb1-7ec69bcd25e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e337b307-3bce-44c5-85fa-f199f6653f22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_17116ed3-ad3c-41d2-bffe-7f9079d3ecec" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e337b307-3bce-44c5-85fa-f199f6653f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b6e6b598-adc3-45da-8300-4678b8dee1e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e337b307-3bce-44c5-85fa-f199f6653f22" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_b6e6b598-adc3-45da-8300-4678b8dee1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_f0806f8d-1bff-42ed-926f-af3bfe1c25c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3cb7f23-6e36-4bf9-a340-0889d99089d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_f0806f8d-1bff-42ed-926f-af3bfe1c25c6" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3cb7f23-6e36-4bf9-a340-0889d99089d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e2d758d0-aebc-482b-8bc1-e32766ac0e1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3cb7f23-6e36-4bf9-a340-0889d99089d8" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e2d758d0-aebc-482b-8bc1-e32766ac0e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e20f5937-5021-43d4-aa67-30df4f64e283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e2d758d0-aebc-482b-8bc1-e32766ac0e1d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e20f5937-5021-43d4-aa67-30df4f64e283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreementsMember_4834147e-0cfe-4291-929a-25489e6a27b7" xlink:href="mrna-20201231.xsd#mrna_VertexAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e20f5937-5021-43d4-aa67-30df4f64e283" xlink:to="loc_mrna_VertexAgreementsMember_4834147e-0cfe-4291-929a-25489e6a27b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_VertexAgreements1Member_62990329-13ef-4013-b8d7-3a6415660b6d" xlink:href="mrna-20201231.xsd#mrna_VertexAgreements1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e20f5937-5021-43d4-aa67-30df4f64e283" xlink:to="loc_mrna_VertexAgreements1Member_62990329-13ef-4013-b8d7-3a6415660b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_260f2c44-d9fd-487d-a1e3-8a4398e3c122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a3cb7f23-6e36-4bf9-a340-0889d99089d8" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_260f2c44-d9fd-487d-a1e3-8a4398e3c122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_ec832fd5-e27f-4c89-a14d-6e20dde2039b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_260f2c44-d9fd-487d-a1e3-8a4398e3c122" xlink:to="loc_us-gaap_ContractWithCustomerLiability_ec832fd5-e27f-4c89-a14d-6e20dde2039b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_2d97facf-e6be-470b-bc5d-9f49ac0a5030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_324e0771-5a20-4ae9-ac25-d0f96daa288e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_2d97facf-e6be-470b-bc5d-9f49ac0a5030" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_324e0771-5a20-4ae9-ac25-d0f96daa288e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e643f169-bbec-4b29-83e0-e716661fa0ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_324e0771-5a20-4ae9-ac25-d0f96daa288e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e643f169-bbec-4b29-83e0-e716661fa0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_858cbefb-e2a8-4655-b0c8-3aa4416db565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e643f169-bbec-4b29-83e0-e716661fa0ca" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_858cbefb-e2a8-4655-b0c8-3aa4416db565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Vertex2020AgreementMember_02500b2d-2ac2-46f8-95e0-52d7f7c3fc46" xlink:href="mrna-20201231.xsd#mrna_Vertex2020AgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_858cbefb-e2a8-4655-b0c8-3aa4416db565" xlink:to="loc_mrna_Vertex2020AgreementMember_02500b2d-2ac2-46f8-95e0-52d7f7c3fc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_f85bab6e-03bf-462e-bb21-02e7c36180d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_324e0771-5a20-4ae9-ac25-d0f96daa288e" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_f85bab6e-03bf-462e-bb21-02e7c36180d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_49469b60-2c9f-4482-95f3-07f2bd71bc0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_f85bab6e-03bf-462e-bb21-02e7c36180d0" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_49469b60-2c9f-4482-95f3-07f2bd71bc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_8ce02b1a-61e9-42c8-8e03-655fe41ce7ee" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_49469b60-2c9f-4482-95f3-07f2bd71bc0a" xlink:to="loc_mrna_UpfrontPaymentMember_8ce02b1a-61e9-42c8-8e03-655fe41ce7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_749a18f8-c083-486f-946b-d17a3f763cec" xlink:href="mrna-20201231.xsd#mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_49469b60-2c9f-4482-95f3-07f2bd71bc0a" xlink:to="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_749a18f8-c083-486f-946b-d17a3f763cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_324e0771-5a20-4ae9-ac25-d0f96daa288e" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_93599db5-eb86-421b-8845-c6c23b0c34bc" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_93599db5-eb86-421b-8845-c6c23b0c34bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1416b8b4-ab72-4359-a557-7457f52bf601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1416b8b4-ab72-4359-a557-7457f52bf601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_bc69f821-0a21-4c18-86a0-84a65c8478f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_bc69f821-0a21-4c18-86a0-84a65c8478f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_008339cc-1684-4dd3-bfa8-aa2619e75963" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod_008339cc-1684-4dd3-bfa8-aa2619e75963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_601cbd9f-5f07-4233-baab-74bb950ce2d8" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod_601cbd9f-5f07-4233-baab-74bb950ce2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_473a49d8-7a9b-4a27-8a17-05b07695e84f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_473a49d8-7a9b-4a27-8a17-05b07695e84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ba7ac0a3-7c7d-4bd7-a02f-84590f3e95ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_690bb228-1bd4-49af-b89b-67efadd18ca4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ba7ac0a3-7c7d-4bd7-a02f-84590f3e95ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_7625ca05-29d2-48e4-87ac-f34c2ed78692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_7625ca05-29d2-48e4-87ac-f34c2ed78692" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdafc82-f9a4-4d69-8f11-41738391fa50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_fa363300-d72a-46e0-a0f1-ab8f3c526a07" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdafc82-f9a4-4d69-8f11-41738391fa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChiesiAgreementMember_23af5b8c-c460-4c6f-98c6-8dc457827482" xlink:href="mrna-20201231.xsd#mrna_ChiesiAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_8cdafc82-f9a4-4d69-8f11-41738391fa50" xlink:to="loc_mrna_ChiesiAgreementMember_23af5b8c-c460-4c6f-98c6-8dc457827482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_80643447-ed80-4d54-99ca-0bf33aec3e68" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_e84afb96-0c96-414b-bb01-db96a118f014" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:to="loc_mrna_UpfrontPaymentMember_e84afb96-0c96-414b-bb01-db96a118f014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_7df209b1-bd01-4f20-b637-ac8203105ad5" xlink:href="mrna-20201231.xsd#mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_d2595849-6f98-48cb-85e8-d24b8a7b2e20" xlink:to="loc_mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember_7df209b1-bd01-4f20-b637-ac8203105ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_cac684bd-3e80-4c5c-a55b-88741a9f229c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_cac684bd-3e80-4c5c-a55b-88741a9f229c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_d4998c1c-c913-4cda-a4ba-423609a9d61b" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_4ffaf04c-e312-4381-846c-8c86a1a81fbf" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod_4ffaf04c-e312-4381-846c-8c86a1a81fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4d79a62b-9dc1-41af-bcd1-f0785be01076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4d79a62b-9dc1-41af-bcd1-f0785be01076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_6dd3d2b5-f19d-4911-b06f-0dc9c18e7792" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected_6dd3d2b5-f19d-4911-b06f-0dc9c18e7792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_d37b7311-35a6-487f-8564-adfca3a3b230" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod_d37b7311-35a6-487f-8564-adfca3a3b230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_94cbf9d1-0fcc-4ee9-97ac-837ab5e1a24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_94cbf9d1-0fcc-4ee9-97ac-837ab5e1a24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e64f9dbf-0558-4938-baaa-ef07c4c53981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e64f9dbf-0558-4938-baaa-ef07c4c53981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ff21c4f6-6747-457c-8136-a467cbef1249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8cbe542b-2b64-4ff3-bbd1-fc2bd977f499" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_ff21c4f6-6747-457c-8136-a467cbef1249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7f30cd51-d5cb-498d-a88c-362d00aa1e27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_79cce3b9-7cc7-468a-8b62-e12eee42fef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7f30cd51-d5cb-498d-a88c-362d00aa1e27" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_79cce3b9-7cc7-468a-8b62-e12eee42fef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ae7cb6f6-0a27-417a-bef6-62f37350133f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_79cce3b9-7cc7-468a-8b62-e12eee42fef9" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ae7cb6f6-0a27-417a-bef6-62f37350133f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f160e34-3a89-4d87-ba41-1581a27580d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_ae7cb6f6-0a27-417a-bef6-62f37350133f" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f160e34-3a89-4d87-ba41-1581a27580d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChiesiAgreementMember_3f389a60-696e-4e5f-bd1a-51db999dab81" xlink:href="mrna-20201231.xsd#mrna_ChiesiAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_3f160e34-3a89-4d87-ba41-1581a27580d1" xlink:to="loc_mrna_ChiesiAgreementMember_3f389a60-696e-4e5f-bd1a-51db999dab81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_580fadce-ea96-4e21-9f2e-1a1737af0b42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_79cce3b9-7cc7-468a-8b62-e12eee42fef9" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_580fadce-ea96-4e21-9f2e-1a1737af0b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_580fadce-ea96-4e21-9f2e-1a1737af0b42" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_UpfrontPaymentMember_25786189-8d4a-4aa4-8a6b-b11f9fc9fd0c" xlink:href="mrna-20201231.xsd#mrna_UpfrontPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:to="loc_mrna_UpfrontPaymentMember_25786189-8d4a-4aa4-8a6b-b11f9fc9fd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentFundingMember_f33a805b-f4c6-4d57-860d-ae161e7b69c2" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentFundingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:to="loc_mrna_ResearchAndDevelopmentFundingMember_f33a805b-f4c6-4d57-860d-ae161e7b69c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChiesiAgreementTransactionPriceMember_130b056c-67ff-4760-8619-75697500a33d" xlink:href="mrna-20201231.xsd#mrna_ChiesiAgreementTransactionPriceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:to="loc_mrna_ChiesiAgreementTransactionPriceMember_130b056c-67ff-4760-8619-75697500a33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RemainingUnsatisfiedPerformanceObligationMember_8c4efbe9-0d5e-437d-a352-5f4a0f8a1d17" xlink:href="mrna-20201231.xsd#mrna_RemainingUnsatisfiedPerformanceObligationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ce80ae3a-2507-4a39-9b25-4b45a6cd2cbe" xlink:to="loc_mrna_RemainingUnsatisfiedPerformanceObligationMember_8c4efbe9-0d5e-437d-a352-5f4a0f8a1d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_70cbaaa8-219e-42be-9007-60869a493972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_79cce3b9-7cc7-468a-8b62-e12eee42fef9" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_70cbaaa8-219e-42be-9007-60869a493972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_50645e4f-7153-4bdc-b92a-4b8a7e527e6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_70cbaaa8-219e-42be-9007-60869a493972" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_50645e4f-7153-4bdc-b92a-4b8a7e527e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8e2cf6c9-b475-48ac-98f3-fff6e4b80c4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_341c0e76-4dc3-4fdd-aa0b-124eafaf1302" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8e2cf6c9-b475-48ac-98f3-fff6e4b80c4d" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_341c0e76-4dc3-4fdd-aa0b-124eafaf1302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ac0ba7c1-12bb-4d22-ae78-1a25e20fece4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_96b549c7-77a3-40f1-bda5-7c6e50cda6d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ac0ba7c1-12bb-4d22-ae78-1a25e20fece4" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_96b549c7-77a3-40f1-bda5-7c6e50cda6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_34ec48e1-5ce0-4ed8-8ffc-2a986b56f253" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ac0ba7c1-12bb-4d22-ae78-1a25e20fece4" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_34ec48e1-5ce0-4ed8-8ffc-2a986b56f253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_dbca0214-f9cd-4730-b041-a554603abdfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ac0ba7c1-12bb-4d22-ae78-1a25e20fece4" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_dbca0214-f9cd-4730-b041-a554603abdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_cf8fb08e-5d61-410f-bd66-325b63494bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ac0ba7c1-12bb-4d22-ae78-1a25e20fece4" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_cf8fb08e-5d61-410f-bd66-325b63494bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_467f6305-882b-4105-9546-db70945d63ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_467f6305-882b-4105-9546-db70945d63ab" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_89c3f65e-97d8-4d16-8a52-fac6dd525b47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_89c3f65e-97d8-4d16-8a52-fac6dd525b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_89c3f65e-97d8-4d16-8a52-fac6dd525b47" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_fe17820d-2fcb-4c42-b75c-aa34db8051fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_fe17820d-2fcb-4c42-b75c-aa34db8051fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_be82f7ba-ef33-4b14-9f85-4c88a99a193a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:to="loc_us-gaap_CertificatesOfDepositMember_be82f7ba-ef33-4b14-9f85-4c88a99a193a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_73138a8c-59e5-4a34-b389-02ca7c1d3e2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_73138a8c-59e5-4a34-b389-02ca7c1d3e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_36a7e0e6-99da-434e-9839-76d316a0fde9" xlink:href="mrna-20201231.xsd#mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4427849d-747a-4d36-8f27-d9639165aa6b" xlink:to="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_36a7e0e6-99da-434e-9839-76d316a0fde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21da6dfb-ffd1-4018-8e8f-382e0ca04d05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21da6dfb-ffd1-4018-8e8f-382e0ca04d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c575f866-6ba8-4322-ba46-71f9f2927d09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21da6dfb-ffd1-4018-8e8f-382e0ca04d05" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c575f866-6ba8-4322-ba46-71f9f2927d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_61e9becd-e2ed-4e5e-a12b-5301959baa11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c575f866-6ba8-4322-ba46-71f9f2927d09" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_61e9becd-e2ed-4e5e-a12b-5301959baa11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e680e86b-7d19-46bc-a7eb-72815a5c5ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c575f866-6ba8-4322-ba46-71f9f2927d09" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e680e86b-7d19-46bc-a7eb-72815a5c5ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0270bc7c-fe8b-4325-b35e-be31d13ff7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0270bc7c-fe8b-4325-b35e-be31d13ff7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b33d1a89-9d9c-4bd9-b30a-57dc2e1be7e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0270bc7c-fe8b-4325-b35e-be31d13ff7c9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b33d1a89-9d9c-4bd9-b30a-57dc2e1be7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_47ae6e05-612f-4c76-a64b-1e19e7f541bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b33d1a89-9d9c-4bd9-b30a-57dc2e1be7e8" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_47ae6e05-612f-4c76-a64b-1e19e7f541bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CurrentMarketableSecuritiesMember_9aef32dc-aece-4cf7-83a4-fc5611a47324" xlink:href="mrna-20201231.xsd#mrna_CurrentMarketableSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b33d1a89-9d9c-4bd9-b30a-57dc2e1be7e8" xlink:to="loc_mrna_CurrentMarketableSecuritiesMember_9aef32dc-aece-4cf7-83a4-fc5611a47324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NoncurrentMarketableSecuritiesMember_56d11299-d898-4a26-a740-a8f950b41e38" xlink:href="mrna-20201231.xsd#mrna_NoncurrentMarketableSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b33d1a89-9d9c-4bd9-b30a-57dc2e1be7e8" xlink:to="loc_mrna_NoncurrentMarketableSecuritiesMember_56d11299-d898-4a26-a740-a8f950b41e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_b25e8149-3ddd-4eea-9003-49a90f5107e4" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e2d20b82-6c56-40b4-9aec-f1e358982c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e2d20b82-6c56-40b4-9aec-f1e358982c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5ed869ab-caa8-4753-9c39-981619365648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5ed869ab-caa8-4753-9c39-981619365648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_219ae3a2-f785-4bf1-b7ec-079eaf7f1a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_219ae3a2-f785-4bf1-b7ec-079eaf7f1a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6bd99594-30ce-45e0-bacb-63b6b67a00a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_200dccfd-e185-48d5-a177-dc87a9b1adaa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6bd99594-30ce-45e0-bacb-63b6b67a00a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9f104431-5410-4302-928d-565e9ca3c5b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_5bab40e9-8cf3-4a00-b52e-a3ce0ff35505" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9f104431-5410-4302-928d-565e9ca3c5b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_5bab40e9-8cf3-4a00-b52e-a3ce0ff35505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_cd8587c5-77e0-426a-8c57-10ba5715111d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_5bab40e9-8cf3-4a00-b52e-a3ce0ff35505" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_cd8587c5-77e0-426a-8c57-10ba5715111d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_3068ccb5-84cb-4379-9495-17c53e285d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_5bab40e9-8cf3-4a00-b52e-a3ce0ff35505" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_3068ccb5-84cb-4379-9495-17c53e285d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_33cda75e-92b0-4493-a1ce-da7b319d33be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_5bab40e9-8cf3-4a00-b52e-a3ce0ff35505" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_33cda75e-92b0-4493-a1ce-da7b319d33be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_6602074e-de0c-4148-8d35-eb2c12da5447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9f104431-5410-4302-928d-565e9ca3c5b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_6602074e-de0c-4148-8d35-eb2c12da5447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_de9a78ca-72ab-4c9a-a7ae-450cfc1092b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_6602074e-de0c-4148-8d35-eb2c12da5447" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_de9a78ca-72ab-4c9a-a7ae-450cfc1092b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_707a722b-dbf7-411f-9724-8d4b971cddf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_6602074e-de0c-4148-8d35-eb2c12da5447" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_707a722b-dbf7-411f-9724-8d4b971cddf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_ea42edaa-6b6d-46f9-8a81-316b24a4d178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_6602074e-de0c-4148-8d35-eb2c12da5447" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_ea42edaa-6b6d-46f9-8a81-316b24a4d178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_a16ecad8-83e6-4133-9050-6be439842c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e5215d98-687b-44ce-882f-16aa3192f90e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_a16ecad8-83e6-4133-9050-6be439842c77" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e5215d98-687b-44ce-882f-16aa3192f90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2a0a1a5e-93c8-401a-8481-53637266497b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e5215d98-687b-44ce-882f-16aa3192f90e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2a0a1a5e-93c8-401a-8481-53637266497b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c783f1b9-b3ef-4b74-9bba-38e4ef6e990c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2a0a1a5e-93c8-401a-8481-53637266497b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c783f1b9-b3ef-4b74-9bba-38e4ef6e990c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_69feaf81-adfe-488b-8f7c-8470c14780c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c783f1b9-b3ef-4b74-9bba-38e4ef6e990c" xlink:to="loc_us-gaap_CertificatesOfDepositMember_69feaf81-adfe-488b-8f7c-8470c14780c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_5280ff5a-53db-482d-a6c9-24f2e38445c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c783f1b9-b3ef-4b74-9bba-38e4ef6e990c" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_5280ff5a-53db-482d-a6c9-24f2e38445c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_8509249e-13af-48c4-9dc1-c6e5d54798b9" xlink:href="mrna-20201231.xsd#mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c783f1b9-b3ef-4b74-9bba-38e4ef6e990c" xlink:to="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_8509249e-13af-48c4-9dc1-c6e5d54798b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e5215d98-687b-44ce-882f-16aa3192f90e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_4f8c36bd-34cf-4af1-aec1-dd6532dcd9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_4f8c36bd-34cf-4af1-aec1-dd6532dcd9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_005bffc8-99b3-4c84-95ae-e7ef649c9122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_005bffc8-99b3-4c84-95ae-e7ef649c9122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_61e40c93-3925-4108-897b-2f0683bab593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_61e40c93-3925-4108-897b-2f0683bab593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_82152cb6-d41e-4298-8f0a-6926343cd87a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_82152cb6-d41e-4298-8f0a-6926343cd87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2250d29f-3777-4ad3-b477-1dcf64b663e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_2250d29f-3777-4ad3-b477-1dcf64b663e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e4b93a62-6997-43e3-845b-b5b27a90d5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e88962f1-3a31-4dfe-ad0a-ce81cf723cb7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_e4b93a62-6997-43e3-845b-b5b27a90d5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e233dfb3-de9a-4285-a7ef-7298c9c66388" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_41081f3a-1adf-43cf-a72b-ab9a776cc9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e233dfb3-de9a-4285-a7ef-7298c9c66388" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_41081f3a-1adf-43cf-a72b-ab9a776cc9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_f7ac4630-e90b-47f0-89c7-76aa8a7ea402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e233dfb3-de9a-4285-a7ef-7298c9c66388" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_f7ac4630-e90b-47f0-89c7-76aa8a7ea402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_77ca479d-f3fb-4984-9da2-bc48e4741a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_77ca479d-f3fb-4984-9da2-bc48e4741a68" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7964a98d-c436-4054-8cd8-8134be366a7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7964a98d-c436-4054-8cd8-8134be366a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_581fcda8-9af8-4026-bd10-65095498c89d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7964a98d-c436-4054-8cd8-8134be366a7c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_581fcda8-9af8-4026-bd10-65095498c89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_89742ad9-eb4d-4692-8e0c-805457a07a8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_581fcda8-9af8-4026-bd10-65095498c89d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_89742ad9-eb4d-4692-8e0c-805457a07a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_3c514eaa-3d04-4652-8b0c-5b43a5e12ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_3c514eaa-3d04-4652-8b0c-5b43a5e12ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_3c514eaa-3d04-4652-8b0c-5b43a5e12ad3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_30a207b7-02de-451e-8f97-49cd196c4bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:to="loc_us-gaap_MoneyMarketFundsMember_30a207b7-02de-451e-8f97-49cd196c4bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_89450c83-0448-4159-aaef-e13382703950" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:to="loc_us-gaap_CertificatesOfDepositMember_89450c83-0448-4159-aaef-e13382703950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_248e5335-1b46-4645-b0c2-7af1affb4ecb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_248e5335-1b46-4645-b0c2-7af1affb4ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_9d9c750b-f685-4437-9aa5-60073e28dde1" xlink:href="mrna-20201231.xsd#mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874a4add-2bba-446c-8424-6bb359cadf11" xlink:to="loc_mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember_9d9c750b-f685-4437-9aa5-60073e28dde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f8d4ecd0-e5b9-4dd3-933c-9ac70407216e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f8d4ecd0-e5b9-4dd3-933c-9ac70407216e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5da4e27b-26b9-4e63-b7b5-90a81a9254e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f8d4ecd0-e5b9-4dd3-933c-9ac70407216e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5da4e27b-26b9-4e63-b7b5-90a81a9254e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fc741424-aa5a-4606-9696-c6f3c2990515" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5da4e27b-26b9-4e63-b7b5-90a81a9254e8" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fc741424-aa5a-4606-9696-c6f3c2990515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1f52cc8a-cb8e-4b6d-ac03-fcaa35760aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5da4e27b-26b9-4e63-b7b5-90a81a9254e8" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1f52cc8a-cb8e-4b6d-ac03-fcaa35760aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ce83f96a-134f-4965-b38e-e520ee07cb58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_50337df6-a4a1-493f-a9ef-48d70eba0bd6" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ce83f96a-134f-4965-b38e-e520ee07cb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a69ab99d-ee95-4c6d-96f0-3ae4d7a7d3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ce83f96a-134f-4965-b38e-e520ee07cb58" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a69ab99d-ee95-4c6d-96f0-3ae4d7a7d3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_dbb1d06d-e119-4467-b3d0-bdfab1c83f8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ce83f96a-134f-4965-b38e-e520ee07cb58" xlink:to="loc_us-gaap_DerivativeAssets_dbb1d06d-e119-4467-b3d0-bdfab1c83f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_39322b30-bb94-4100-93ec-b7d559d88459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ce83f96a-134f-4965-b38e-e520ee07cb58" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_39322b30-bb94-4100-93ec-b7d559d88459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="mrna-20201231.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_eccf54d2-4af9-46e7-a5e1-a5bfca779ee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ccf34fcc-bbfe-4ec8-bfa8-b67cea369414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_eccf54d2-4af9-46e7-a5e1-a5bfca779ee1" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_ccf34fcc-bbfe-4ec8-bfa8-b67cea369414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_944b139c-011f-4f2d-8f1b-8fa8e0e6dc72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5c9b6ea5-d03c-427d-9516-077e291b4253" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_944b139c-011f-4f2d-8f1b-8fa8e0e6dc72" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5c9b6ea5-d03c-427d-9516-077e291b4253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_81f0c677-bf50-42b4-a441-d5717593083b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_81f0c677-bf50-42b4-a441-d5717593083b" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9c9f26a7-8b91-440d-8caa-b855d0c07743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9c9f26a7-8b91-440d-8caa-b855d0c07743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4cc9c1e5-5f22-4c82-88de-6b683f5aeaa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9c9f26a7-8b91-440d-8caa-b855d0c07743" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4cc9c1e5-5f22-4c82-88de-6b683f5aeaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_1a1164c2-1bb5-4c7f-93fd-5d4f6d86e1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4cc9c1e5-5f22-4c82-88de-6b683f5aeaa6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_1a1164c2-1bb5-4c7f-93fd-5d4f6d86e1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_25704cb9-dc86-4d1d-96c4-a6cc5e6d9643" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_25704cb9-dc86-4d1d-96c4-a6cc5e6d9643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_134dbe88-77e4-4873-bb4d-0d9e87f8d77e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_25704cb9-dc86-4d1d-96c4-a6cc5e6d9643" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_134dbe88-77e4-4873-bb4d-0d9e87f8d77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseMember_eb103ad3-58d9-44bb-bf62-e80ea250922f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_134dbe88-77e4-4873-bb4d-0d9e87f8d77e" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseMember_eb103ad3-58d9-44bb-bf62-e80ea250922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ffec2803-a217-48f2-8b13-5e95795d4db1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:to="loc_us-gaap_HedgingDesignationAxis_ffec2803-a217-48f2-8b13-5e95795d4db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_966dbb02-0b3b-4b43-9b2f-cd51346c22da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_ffec2803-a217-48f2-8b13-5e95795d4db1" xlink:to="loc_us-gaap_HedgingDesignationDomain_966dbb02-0b3b-4b43-9b2f-cd51346c22da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_bb0bbb1a-3c3b-4720-8c85-800ab3559f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_966dbb02-0b3b-4b43-9b2f-cd51346c22da" xlink:to="loc_us-gaap_NondesignatedMember_bb0bbb1a-3c3b-4720-8c85-800ab3559f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_8b09807c-a6e7-4812-afc8-319231befdb6" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ae9be3fc-c350-4d33-b0d7-d8d77c9f90b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ae9be3fc-c350-4d33-b0d7-d8d77c9f90b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_3495f292-81ba-4c3a-af19-d512e8f41af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_3495f292-81ba-4c3a-af19-d512e8f41af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_4f8c2f4e-2de9-4506-a9ab-52af166e1c49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_4f8c2f4e-2de9-4506-a9ab-52af166e1c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_b30e0ae7-1b74-486e-8205-4857b07a841b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_b7d07695-64c7-4531-ae25-0983d442e003" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_b30e0ae7-1b74-486e-8205-4857b07a841b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/Inventory" xlink:type="simple" xlink:href="mrna-20201231.xsd#Inventory"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/Inventory" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_af9f4049-a653-4043-b126-9be11ced6249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_87491d97-b740-454c-bc15-f3dae21cc376" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_af9f4049-a653-4043-b126-9be11ced6249" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_87491d97-b740-454c-bc15-f3dae21cc376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/InventoryTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#InventoryTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/InventoryTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_76d22e34-3e73-4bfa-82a5-9151013e39e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e865b6e8-01b3-466a-9ce4-d5526a6dda37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_76d22e34-3e73-4bfa-82a5-9151013e39e8" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e865b6e8-01b3-466a-9ce4-d5526a6dda37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/InventoryDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#InventoryDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_fe55d558-0638-4a6b-9b9e-6e3032f7f42e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4aee0598-5a48-4003-a5ef-724c8635070d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fe55d558-0638-4a6b-9b9e-6e3032f7f42e" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_4aee0598-5a48-4003-a5ef-724c8635070d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ba91a4e3-2c55-4144-8379-f9b3b91cadd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fe55d558-0638-4a6b-9b9e-6e3032f7f42e" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ba91a4e3-2c55-4144-8379-f9b3b91cadd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_eb0621b1-2ec2-4123-ab3b-528f4690a9db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fe55d558-0638-4a6b-9b9e-6e3032f7f42e" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_eb0621b1-2ec2-4123-ab3b-528f4690a9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_12ce67fa-f18b-4569-a436-80366a13e43b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_fe55d558-0638-4a6b-9b9e-6e3032f7f42e" xlink:to="loc_us-gaap_InventoryNet_12ce67fa-f18b-4569-a436-80366a13e43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="mrna-20201231.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2d34ca94-c224-4337-b897-078676667f75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_974131e5-2a55-4db9-a5de-61a6a6ff23f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2d34ca94-c224-4337-b897-078676667f75" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_974131e5-2a55-4db9-a5de-61a6a6ff23f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_54d53ea5-f0c1-4591-ac9f-893e4b18d50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1a4b1fc3-53d7-4e86-8793-dcc1d55c96cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_54d53ea5-f0c1-4591-ac9f-893e4b18d50f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1a4b1fc3-53d7-4e86-8793-dcc1d55c96cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#PropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1b51080e-8035-4575-808c-7826fc351da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_668f9dab-123c-4db0-8052-f93bd82495c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1b51080e-8035-4575-808c-7826fc351da3" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_668f9dab-123c-4db0-8052-f93bd82495c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3c05098-dd1c-462f-8627-e53db1f8dfd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_668f9dab-123c-4db0-8052-f93bd82495c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3c05098-dd1c-462f-8627-e53db1f8dfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a3c05098-dd1c-462f-8627-e53db1f8dfd3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_b98bf5a3-2c77-469d-9cb1-e5982331c3d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_EquipmentMember_b98bf5a3-2c77-469d-9cb1-e5982331c3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3a609a53-59a6-40a6-bdc5-1e07e1656ce2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3a609a53-59a6-40a6-bdc5-1e07e1656ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_a8b9eab9-8f72-4a1a-b04e-4b7235bf6eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentOtherTypesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOtherTypesMember_a8b9eab9-8f72-4a1a-b04e-4b7235bf6eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_56c543d1-f4a2-48ff-a02d-38e513b5728c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_ComputerEquipmentMember_56c543d1-f4a2-48ff-a02d-38e513b5728c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_f8e465c3-2830-4d45-934b-e5f4d2708524" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_f8e465c3-2830-4d45-934b-e5f4d2708524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FinancingRightOfUseAssetMember_e280ced9-ea8b-40b9-b4d3-3c6a10f75dad" xlink:href="mrna-20201231.xsd#mrna_FinancingRightOfUseAssetMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_mrna_FinancingRightOfUseAssetMember_e280ced9-ea8b-40b9-b4d3-3c6a10f75dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_563f49a4-b854-4738-98c2-eeee8cfc0fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_42c480a8-af35-462e-acb1-52317a55576d" xlink:to="loc_us-gaap_ConstructionInProgressMember_563f49a4-b854-4738-98c2-eeee8cfc0fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_668f9dab-123c-4db0-8052-f93bd82495c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_afbce671-fbe4-424e-add4-26f79472e052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_afbce671-fbe4-424e-add4-26f79472e052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5f9d01ea-20d6-4256-9588-dab7215eccfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5f9d01ea-20d6-4256-9588-dab7215eccfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_36a46252-56ea-4131-b639-ec43519da6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_36a46252-56ea-4131-b639-ec43519da6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0fbec848-9c10-408d-b7d3-0987d5796a72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3b6202be-ff5d-4ed5-90dc-6e361911f947" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0fbec848-9c10-408d-b7d3-0987d5796a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponents" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68ef75a5-9fea-4eb7-a3c1-03c7b8a7e973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_dad05e5f-c52c-4e5c-87a4-fad9a212ebbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68ef75a5-9fea-4eb7-a3c1-03c7b8a7e973" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_dad05e5f-c52c-4e5c-87a4-fad9a212ebbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_887813d0-7660-46cc-a2f2-ae2f0824d90a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_27dc38de-43fb-4d60-8348-6564d5d4feb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_887813d0-7660-46cc-a2f2-ae2f0824d90a" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_27dc38de-43fb-4d60-8348-6564d5d4feb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_590db856-bf50-4c4d-80bb-341103ee4e6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_887813d0-7660-46cc-a2f2-ae2f0824d90a" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_590db856-bf50-4c4d-80bb-341103ee4e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_75f4f7f1-db1e-4bed-8397-398a73cd66e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_887813d0-7660-46cc-a2f2-ae2f0824d90a" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_75f4f7f1-db1e-4bed-8397-398a73cd66e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_e5cb554d-b0a1-4aec-8a8e-ae4568805327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_887813d0-7660-46cc-a2f2-ae2f0824d90a" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_e5cb554d-b0a1-4aec-8a8e-ae4568805327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aefddf60-590c-444c-bee7-674b0ce30540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OtherPrepaidExpenseManufacturing_9e7e7cad-31e6-4e52-852e-7ec97b60aa1f" xlink:href="mrna-20201231.xsd#mrna_OtherPrepaidExpenseManufacturing"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aefddf60-590c-444c-bee7-674b0ce30540" xlink:to="loc_mrna_OtherPrepaidExpenseManufacturing_9e7e7cad-31e6-4e52-852e-7ec97b60aa1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_e5595b64-74c4-453c-a542-1bc269501288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aefddf60-590c-444c-bee7-674b0ce30540" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_e5595b64-74c4-453c-a542-1bc269501288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TenantIncentivesReceivablesCurrent_673f6c64-0cfa-4ef8-8afe-fac85584e022" xlink:href="mrna-20201231.xsd#mrna_TenantIncentivesReceivablesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aefddf60-590c-444c-bee7-674b0ce30540" xlink:to="loc_mrna_TenantIncentivesReceivablesCurrent_673f6c64-0cfa-4ef8-8afe-fac85584e022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent_67f40d7d-c6b5-48ba-95ed-31523c11efec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aefddf60-590c-444c-bee7-674b0ce30540" xlink:to="loc_us-gaap_InterestReceivableCurrent_67f40d7d-c6b5-48ba-95ed-31523c11efec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_620934d1-29e0-41e3-a7fa-c7f31d2a2aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aefddf60-590c-444c-bee7-674b0ce30540" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_620934d1-29e0-41e3-a7fa-c7f31d2a2aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62605d8-eabe-4b93-8b19-41c3ee5aac41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedClinicalTrials_bd5b29de-545a-4e54-b2f1-d6c74b6c900c" xlink:href="mrna-20201231.xsd#mrna_AccruedClinicalTrials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62605d8-eabe-4b93-8b19-41c3ee5aac41" xlink:to="loc_mrna_AccruedClinicalTrials_bd5b29de-545a-4e54-b2f1-d6c74b6c900c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f64d403b-6949-4f11-a918-353f54be482e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62605d8-eabe-4b93-8b19-41c3ee5aac41" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f64d403b-6949-4f11-a918-353f54be482e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RawMaterialsAccountsPayable_d4e1931d-6e0b-426a-824a-f3a6aec4b264" xlink:href="mrna-20201231.xsd#mrna_RawMaterialsAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62605d8-eabe-4b93-8b19-41c3ee5aac41" xlink:to="loc_mrna_RawMaterialsAccountsPayable_d4e1931d-6e0b-426a-824a-f3a6aec4b264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedManufacturing_200336f8-21c9-458e-9a1b-d9b46dc0d12b" xlink:href="mrna-20201231.xsd#mrna_AccruedManufacturing"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62605d8-eabe-4b93-8b19-41c3ee5aac41" xlink:to="loc_mrna_AccruedManufacturing_200336f8-21c9-458e-9a1b-d9b46dc0d12b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedDevelopmentOperation_64a6abde-0ee2-4f6a-99f3-bfda7aea06e8" xlink:href="mrna-20201231.xsd#mrna_AccruedDevelopmentOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62605d8-eabe-4b93-8b19-41c3ee5aac41" xlink:to="loc_mrna_AccruedDevelopmentOperation_64a6abde-0ee2-4f6a-99f3-bfda7aea06e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedPropertyAndEquipmentCurrent_c778ed20-3966-47ad-a35d-a2d34240b510" xlink:href="mrna-20201231.xsd#mrna_AccruedPropertyAndEquipmentCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62605d8-eabe-4b93-8b19-41c3ee5aac41" xlink:to="loc_mrna_AccruedPropertyAndEquipmentCurrent_c778ed20-3966-47ad-a35d-a2d34240b510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_Commercial_a0f67993-b633-4712-a7de-249a0f4aaa33" xlink:href="mrna-20201231.xsd#mrna_Commercial"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62605d8-eabe-4b93-8b19-41c3ee5aac41" xlink:to="loc_mrna_Commercial_a0f67993-b633-4712-a7de-249a0f4aaa33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AccruedExternalGoodsAndServicesCurrent_8dc7f7ce-1fd5-4e69-b6dd-5455ce313876" xlink:href="mrna-20201231.xsd#mrna_AccruedExternalGoodsAndServicesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62605d8-eabe-4b93-8b19-41c3ee5aac41" xlink:to="loc_mrna_AccruedExternalGoodsAndServicesCurrent_8dc7f7ce-1fd5-4e69-b6dd-5455ce313876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cbb99a67-94e9-4fc7-b643-68b10c40154e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f62605d8-eabe-4b93-8b19-41c3ee5aac41" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_cbb99a67-94e9-4fc7-b643-68b10c40154e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_524771d8-e86e-440a-b718-04f7c4d58396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_808a9499-335e-4dc5-bc7e-e1b102a5f0c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_524771d8-e86e-440a-b718-04f7c4d58396" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_808a9499-335e-4dc5-bc7e-e1b102a5f0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_267a97dd-c699-4717-af9a-b62c2faf55a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_524771d8-e86e-440a-b718-04f7c4d58396" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_267a97dd-c699-4717-af9a-b62c2faf55a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_8fd3dd4b-6b55-484d-97dc-5fe63a20741c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_524771d8-e86e-440a-b718-04f7c4d58396" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_8fd3dd4b-6b55-484d-97dc-5fe63a20741c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_93c8e048-cfb9-424c-b29a-1995d98fca16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_524771d8-e86e-440a-b718-04f7c4d58396" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_93c8e048-cfb9-424c-b29a-1995d98fca16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#OtherBalanceSheetComponentsDeferredRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54b5043c-5c8d-4e9c-befe-a041d8721af4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityTable_fb95e7fa-9dc3-4a09-8f94-1e209666a56e" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_54b5043c-5c8d-4e9c-befe-a041d8721af4" xlink:to="loc_mrna_ChangeInContractWithCustomerLiabilityTable_fb95e7fa-9dc3-4a09-8f94-1e209666a56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_41ecfe15-a927-454c-9449-2faa70a2da80" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityTable_fb95e7fa-9dc3-4a09-8f94-1e209666a56e" xlink:to="loc_srt_ProductOrServiceAxis_41ecfe15-a927-454c-9449-2faa70a2da80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_66cea332-3bbe-4c84-8d0b-0c0996fdcf55" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_41ecfe15-a927-454c-9449-2faa70a2da80" xlink:to="loc_srt_ProductsAndServicesDomain_66cea332-3bbe-4c84-8d0b-0c0996fdcf55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ProductSalesMember_66b74c27-3ee5-4c2b-b073-dfe75d691988" xlink:href="mrna-20201231.xsd#mrna_ProductSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_66cea332-3bbe-4c84-8d0b-0c0996fdcf55" xlink:to="loc_mrna_ProductSalesMember_66b74c27-3ee5-4c2b-b073-dfe75d691988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_4eccba6b-e21e-4cac-a545-75e60142b01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_66cea332-3bbe-4c84-8d0b-0c0996fdcf55" xlink:to="loc_us-gaap_GrantMember_4eccba6b-e21e-4cac-a545-75e60142b01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CollaborationArrangementMember_85897a8a-c09d-4bce-a122-3457578bb22b" xlink:href="mrna-20201231.xsd#mrna_CollaborationArrangementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_66cea332-3bbe-4c84-8d0b-0c0996fdcf55" xlink:to="loc_mrna_CollaborationArrangementMember_85897a8a-c09d-4bce-a122-3457578bb22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityLineItems_3de3e557-4d33-4d8e-a113-9704ce426520" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityTable_fb95e7fa-9dc3-4a09-8f94-1e209666a56e" xlink:to="loc_mrna_ChangeInContractWithCustomerLiabilityLineItems_3de3e557-4d33-4d8e-a113-9704ce426520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:href="mrna-20201231.xsd#mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityLineItems_3de3e557-4d33-4d8e-a113-9704ce426520" xlink:to="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_12b1c800-1609-43b9-9ca3-27d4764da869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:to="loc_us-gaap_ContractWithCustomerLiability_12b1c800-1609-43b9-9ca3-27d4764da869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_6425b586-4cd6-4629-ad08-d32ff7cca9d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress_6425b586-4cd6-4629-ad08-d32ff7cca9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod_5e4fcdab-e30f-48c2-87f9-1edd84cbeb31" xlink:href="mrna-20201231.xsd#mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:to="loc_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod_5e4fcdab-e30f-48c2-87f9-1edd84cbeb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_caabd233-4091-4964-8f20-a957c4351610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward_e31affea-dc0b-4139-9ae6-808c62f362aa" xlink:to="loc_us-gaap_ContractWithCustomerLiability_caabd233-4091-4964-8f20-a957c4351610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/Leases" xlink:type="simple" xlink:href="mrna-20201231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1dbf5a82-7c3c-4e6e-b91e-1f00d0e8f890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_4d1b8fb9-9994-4ce8-b230-048852985133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1dbf5a82-7c3c-4e6e-b91e-1f00d0e8f890" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_4d1b8fb9-9994-4ce8-b230-048852985133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_3779a7bd-c6b1-41ec-bd12-f0ad1c4f7be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1dbf5a82-7c3c-4e6e-b91e-1f00d0e8f890" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_3779a7bd-c6b1-41ec-bd12-f0ad1c4f7be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8985def6-dd34-41c2-9a25-515cf3d25b74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock_d8c3c15e-f5a7-445f-af91-2f3eea2a5b29" xlink:href="mrna-20201231.xsd#mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8985def6-dd34-41c2-9a25-515cf3d25b74" xlink:to="loc_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock_d8c3c15e-f5a7-445f-af91-2f3eea2a5b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_ba946d9e-9c95-4c20-afd9-660827f7785a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8985def6-dd34-41c2-9a25-515cf3d25b74" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_ba946d9e-9c95-4c20-afd9-660827f7785a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_5d324ecc-bc7b-4b93-a314-1d299d73d7b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8985def6-dd34-41c2-9a25-515cf3d25b74" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_5d324ecc-bc7b-4b93-a314-1d299d73d7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5f604107-e716-4578-9d10-443d9dce8c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8985def6-dd34-41c2-9a25-515cf3d25b74" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_5f604107-e716-4578-9d10-443d9dce8c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_57d4693b-0d9f-420d-9bbe-ffbdb0278e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_57d4693b-0d9f-420d-9bbe-ffbdb0278e28" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_520f9a8d-d680-40ba-937a-f5019e2d8d88" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:to="loc_srt_StatementGeographicalAxis_520f9a8d-d680-40ba-937a-f5019e2d8d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cbb7d63d-f2ad-4452-8c50-c0c47da38bf6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_520f9a8d-d680-40ba-937a-f5019e2d8d88" xlink:to="loc_srt_SegmentGeographicalDomain_cbb7d63d-f2ad-4452-8c50-c0c47da38bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_CambridgeMassachusettsMember_c9590e94-7ade-4b82-983c-8c73c366f4dc" xlink:href="mrna-20201231.xsd#mrna_CambridgeMassachusettsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cbb7d63d-f2ad-4452-8c50-c0c47da38bf6" xlink:to="loc_mrna_CambridgeMassachusettsMember_c9590e94-7ade-4b82-983c-8c73c366f4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NorwoodMassachusettsMember_b0fe5f63-027e-47b9-a203-05afb9c6a632" xlink:href="mrna-20201231.xsd#mrna_NorwoodMassachusettsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_cbb7d63d-f2ad-4452-8c50-c0c47da38bf6" xlink:to="loc_mrna_NorwoodMassachusettsMember_b0fe5f63-027e-47b9-a203-05afb9c6a632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_79be82c0-4498-4ea5-ad2d-f3c24ec738a7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_79be82c0-4498-4ea5-ad2d-f3c24ec738a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_79be82c0-4498-4ea5-ad2d-f3c24ec738a7" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TwoHundredTechnologySquareMember_721adce1-98bb-4c53-8f23-bd90f0c5736d" xlink:href="mrna-20201231.xsd#mrna_TwoHundredTechnologySquareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:to="loc_mrna_TwoHundredTechnologySquareMember_721adce1-98bb-4c53-8f23-bd90f0c5736d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FiveHundredTechnologySquareMember_0a435fee-282a-4754-a571-13033bafbd4f" xlink:href="mrna-20201231.xsd#mrna_FiveHundredTechnologySquareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:to="loc_mrna_FiveHundredTechnologySquareMember_0a435fee-282a-4754-a571-13033bafbd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember_c913bb8b-2db8-42ee-a8a4-58d41bfcd67a" xlink:href="mrna-20201231.xsd#mrna_OfficeLaboratoryAndLightManufacturingSpaceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:to="loc_mrna_OfficeLaboratoryAndLightManufacturingSpaceMember_c913bb8b-2db8-42ee-a8a4-58d41bfcd67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MTCNorthMember_bb030d0b-81a4-48ea-a161-53b0c0c79725" xlink:href="mrna-20201231.xsd#mrna_MTCNorthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:to="loc_mrna_MTCNorthMember_bb030d0b-81a4-48ea-a161-53b0c0c79725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_MTCSouthMember_121ce135-17e5-4fac-82b4-47b3f16e9282" xlink:href="mrna-20201231.xsd#mrna_MTCSouthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_bf76d787-4aca-4e6b-8f04-2fa828c784c1" xlink:to="loc_mrna_MTCSouthMember_121ce135-17e5-4fac-82b4-47b3f16e9282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_d0b0292b-23a7-4df0-990a-ee46135459ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:to="loc_us-gaap_LeaseContractualTermAxis_d0b0292b-23a7-4df0-990a-ee46135459ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_96270f93-4f34-4be5-91ef-126a46e86034" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_d0b0292b-23a7-4df0-990a-ee46135459ee" xlink:to="loc_us-gaap_LeaseContractualTermDomain_96270f93-4f34-4be5-91ef-126a46e86034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EmbeddedLeasesMember_b19c5e50-19d5-47f1-a04b-ff37b68e120b" xlink:href="mrna-20201231.xsd#mrna_EmbeddedLeasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_96270f93-4f34-4be5-91ef-126a46e86034" xlink:to="loc_mrna_EmbeddedLeasesMember_b19c5e50-19d5-47f1-a04b-ff37b68e120b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_fd6b449b-1277-4d2d-8585-002e896edbf6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLeaseNumberOfProperties_4287fc9d-f93c-4313-ad1b-4530ef80cdfe" xlink:href="mrna-20201231.xsd#mrna_OperatingLeaseNumberOfProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_OperatingLeaseNumberOfProperties_4287fc9d-f93c-4313-ad1b-4530ef80cdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_11ae7e8a-12b2-4a16-acdc-3cc4227fb3ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_11ae7e8a-12b2-4a16-acdc-3cc4227fb3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_fcb98f9a-ea9d-46db-b749-30604048766a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_fcb98f9a-ea9d-46db-b749-30604048766a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods_21440d93-e496-42a0-95be-b33e06ccc093" xlink:href="mrna-20201231.xsd#mrna_LesseeOperatingLeaseNumberOfExtensionPeriods"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods_21440d93-e496-42a0-95be-b33e06ccc093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LesseeOperatingLeasePercentageSubleased_b35b2284-6fd8-4469-8aea-1845690e7dbc" xlink:href="mrna-20201231.xsd#mrna_LesseeOperatingLeasePercentageSubleased"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_LesseeOperatingLeasePercentageSubleased_b35b2284-6fd8-4469-8aea-1845690e7dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements_1e097cf4-4602-4455-a249-7d12a516743e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TenantImprovements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_TenantImprovements_1e097cf4-4602-4455-a249-7d12a516743e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AreaOfRealEstatePropertyAdditionalSpace_9c89f378-5c71-463c-bb54-b326312f22f3" xlink:href="mrna-20201231.xsd#mrna_AreaOfRealEstatePropertyAdditionalSpace"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_AreaOfRealEstatePropertyAdditionalSpace_9c89f378-5c71-463c-bb54-b326312f22f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_00b57a5f-3322-4b19-bb27-ff812b3306a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_OperatingLeaseLiability_00b57a5f-3322-4b19-bb27-ff812b3306a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_11efccea-2d31-4cd7-99ea-0c051de531f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_11efccea-2d31-4cd7-99ea-0c051de531f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_472c2c96-c52d-40ed-a4f8-1d65b78dfbd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_472c2c96-c52d-40ed-a4f8-1d65b78dfbd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0c49fd13-4370-4f1b-a11d-60a7c13aded7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0c49fd13-4370-4f1b-a11d-60a7c13aded7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e4508be0-e358-4e82-8dd0-05bc281f7ad7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e4508be0-e358-4e82-8dd0-05bc281f7ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LeasesImputedInterestRate_50a39c42-899b-44ce-9daa-e13c953cc7d2" xlink:href="mrna-20201231.xsd#mrna_LeasesImputedInterestRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_LeasesImputedInterestRate_50a39c42-899b-44ce-9daa-e13c953cc7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LeasesIncrementalBorrowingRate_3abcec5c-1553-4229-9a55-417d3068c91f" xlink:href="mrna-20201231.xsd#mrna_LeasesIncrementalBorrowingRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e3dff99b-59bd-4cba-81ff-8c9722f40297" xlink:to="loc_mrna_LeasesIncrementalBorrowingRate_3abcec5c-1553-4229-9a55-417d3068c91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e4502757-8626-47f2-84fd-c3f195bcabac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e4502757-8626-47f2-84fd-c3f195bcabac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_148ec66d-17ff-4e0a-bb1d-115779e0586a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_148ec66d-17ff-4e0a-bb1d-115779e0586a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseRightOfUseAsset_a6c6b922-1054-4b90-b631-5b0514c0ad03" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_mrna_OperatingAndFinanceLeaseRightOfUseAsset_a6c6b922-1054-4b90-b631-5b0514c0ad03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_687e8e42-fed2-4b29-8d17-2d8e941e3305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_687e8e42-fed2-4b29-8d17-2d8e941e3305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0ff52e82-953a-49cf-9b4c-13e82c0a5d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0ff52e82-953a-49cf-9b4c-13e82c0a5d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseLiabilityCurrent_fadc2ec5-c49f-4de0-9c89-d182b2a662a0" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_mrna_OperatingAndFinanceLeaseLiabilityCurrent_fadc2ec5-c49f-4de0-9c89-d182b2a662a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_134c6f50-77af-4cb6-8b2a-5c875546607a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_134c6f50-77af-4cb6-8b2a-5c875546607a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_feadfd7c-f5eb-4b45-ae5b-763efe9cf8c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_feadfd7c-f5eb-4b45-ae5b-763efe9cf8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent_2b504018-69d0-4585-9e97-f5255702b8b7" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent_2b504018-69d0-4585-9e97-f5255702b8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingAndFinanceLeaseLiability_cd0f8c20-1c13-4322-ba92-9573211cff3f" xlink:href="mrna-20201231.xsd#mrna_OperatingAndFinanceLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_mrna_OperatingAndFinanceLeaseLiability_cd0f8c20-1c13-4322-ba92-9573211cff3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_2e1dd109-a766-41fc-9ec8-91455dbcc58d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_2e1dd109-a766-41fc-9ec8-91455dbcc58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_427a8970-2e93-4336-9e49-1abfd13eb65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_427a8970-2e93-4336-9e49-1abfd13eb65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_4245c025-2650-4c3d-bdbf-31f1c08a20b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6fc559cc-5f2c-48bd-a973-c95d0aaaa81f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_4245c025-2650-4c3d-bdbf-31f1c08a20b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesLeaseCostsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/LeasesLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_9e1f3599-8d05-4c14-a67c-58943a8e7506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_OperatingLeaseCost_9e1f3599-8d05-4c14-a67c-58943a8e7506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_53d9b7cb-26fd-4a3f-bf5b-59d56938d250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_53d9b7cb-26fd-4a3f-bf5b-59d56938d250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_056419ad-a18c-4722-98b6-38012206a733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_056419ad-a18c-4722-98b6-38012206a733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FinanceLeaseCost_e2ebb8c6-5cd3-495e-a54e-cc6b6035018d" xlink:href="mrna-20201231.xsd#mrna_FinanceLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_mrna_FinanceLeaseCost_e2ebb8c6-5cd3-495e-a54e-cc6b6035018d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_2c2334ca-0810-45f6-9f8f-9d9759f04fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_ShortTermLeaseCost_2c2334ca-0810-45f6-9f8f-9d9759f04fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_57abb07a-8f0b-4302-8743-c6bd42ad5ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_VariableLeaseCost_57abb07a-8f0b-4302-8743-c6bd42ad5ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_bc5db15f-7044-424c-b82c-58628d5075da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_OperatingLeasePayments_bc5db15f-7044-424c-b82c-58628d5075da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_d70ed530-ca14-432a-ace2-fbd43ce5d24d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_d70ed530-ca14-432a-ace2-fbd43ce5d24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_0e6c8df7-7dc0-497e-987c-44b28379fa8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_0e6c8df7-7dc0-497e-987c-44b28379fa8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments_b80a0e64-5f81-4526-bc07-d3ea139a0cfd" xlink:href="mrna-20201231.xsd#mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments_b80a0e64-5f81-4526-bc07-d3ea139a0cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4b80b0a5-cad2-49b5-9b27-a3505acaa344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_4b80b0a5-cad2-49b5-9b27-a3505acaa344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ce6df210-a72d-4ac7-bbfe-6594144c7f12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ce6df210-a72d-4ac7-bbfe-6594144c7f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_LesseeFinanceLeaseExpense_46b50757-2e61-4c4e-9dc8-79ac1a5dc615" xlink:href="mrna-20201231.xsd#mrna_LesseeFinanceLeaseExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_mrna_LesseeFinanceLeaseExpense_46b50757-2e61-4c4e-9dc8-79ac1a5dc615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f3a24aa0-b445-4e72-902d-cba87e125422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f3a24aa0-b445-4e72-902d-cba87e125422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_498e35c3-27df-4ca7-b442-26c653536e13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_498e35c3-27df-4ca7-b442-26c653536e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6984fd53-dc93-4ac6-829a-3eb807b5e6b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6984fd53-dc93-4ac6-829a-3eb807b5e6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a152c7a5-8a3d-4fd8-b194-1572b9de7a94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_468c56df-4f01-454e-a1e6-cba421acb7ad" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_a152c7a5-8a3d-4fd8-b194-1572b9de7a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_21ff349f-3ebb-4266-9dcb-601eea99acb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21ff349f-3ebb-4266-9dcb-601eea99acb4" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3f304a19-c928-445f-af49-cb3f06509419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3f304a19-c928-445f-af49-cb3f06509419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a4fd8af6-5035-4f66-b35d-37b911ae69d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a4fd8af6-5035-4f66-b35d-37b911ae69d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c963e13a-124d-433f-8367-af257097f34b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c963e13a-124d-433f-8367-af257097f34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b27077d5-54d8-4e35-a365-d8dd57ed6c31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b27077d5-54d8-4e35-a365-d8dd57ed6c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8d8d03fc-083a-4e93-8597-b0c3fa6d4861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8d8d03fc-083a-4e93-8597-b0c3fa6d4861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_401d9969-bc00-4c85-8977-0ce572ddc10c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_401d9969-bc00-4c85-8977-0ce572ddc10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_73d63106-b862-4cca-bdac-ce9bb3412cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_73d63106-b862-4cca-bdac-ce9bb3412cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7cc6129f-9b24-4b7e-9bd6-4a94fcd8b70b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7cc6129f-9b24-4b7e-9bd6-4a94fcd8b70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_82a75a11-6de8-481b-887d-0c923d7641d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_23406bbb-7dc4-449e-b6df-f9b1116c6895" xlink:to="loc_us-gaap_OperatingLeaseLiability_82a75a11-6de8-481b-887d-0c923d7641d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21ff349f-3ebb-4266-9dcb-601eea99acb4" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7de2d285-75f9-4e04-9dcc-88c6b7b665a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7de2d285-75f9-4e04-9dcc-88c6b7b665a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7dfe5840-a374-4e4c-94f6-31f3cf5444bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7dfe5840-a374-4e4c-94f6-31f3cf5444bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2e0c4035-f7bb-47f5-89ab-c4a65dcc8dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2e0c4035-f7bb-47f5-89ab-c4a65dcc8dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5ff035fc-05cb-4401-bcc9-5731a2434b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5ff035fc-05cb-4401-bcc9-5731a2434b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_412461d2-f27f-430e-aacd-3cd98188edb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_412461d2-f27f-430e-aacd-3cd98188edb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_0f78e88b-479b-41f6-930f-70f4fbc355c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_0f78e88b-479b-41f6-930f-70f4fbc355c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_22f08cb2-85b2-481d-8798-216a6d1ec130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_22f08cb2-85b2-481d-8798-216a6d1ec130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_7107d2d3-8bc5-4ece-9212-d5a058274273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_7107d2d3-8bc5-4ece-9212-d5a058274273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4080cc0d-7e19-47e6-b03d-7ae8168f0174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f027dc8d-7864-475b-9d82-0d1a4c35a73c" xlink:to="loc_us-gaap_FinanceLeaseLiability_4080cc0d-7e19-47e6-b03d-7ae8168f0174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="mrna-20201231.xsd#LeasesMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6d851e4a-358f-49d1-aa32-01a1d0329d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_cf6b1f9b-6b2b-4a31-959d-0c418077453c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6d851e4a-358f-49d1-aa32-01a1d0329d3a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_cf6b1f9b-6b2b-4a31-959d-0c418077453c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesStrategicCollaborationsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_37ba2abb-1c1f-4ae4-8aaa-6abf6884ae0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_563c1040-bf54-4849-b6c3-4ff53d3d61ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_37ba2abb-1c1f-4ae4-8aaa-6abf6884ae0a" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_563c1040-bf54-4849-b6c3-4ff53d3d61ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_47833705-f972-4cd2-9542-d2e58d27d12a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_563c1040-bf54-4849-b6c3-4ff53d3d61ba" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_47833705-f972-4cd2-9542-d2e58d27d12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4540696-d690-4129-8846-a293d68a0cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_47833705-f972-4cd2-9542-d2e58d27d12a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4540696-d690-4129-8846-a293d68a0cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_f3b4034c-35c3-4c01-a594-656ec3cfacf6" xlink:href="mrna-20201231.xsd#mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_c4540696-d690-4129-8846-a293d68a0cab" xlink:to="loc_mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember_f3b4034c-35c3-4c01-a594-656ec3cfacf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_47f6e65d-27f8-4b72-b102-0d25faf57984" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_563c1040-bf54-4849-b6c3-4ff53d3d61ba" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_47f6e65d-27f8-4b72-b102-0d25faf57984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_aa444ef5-0cc3-4332-9507-1c1d4dac77ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_47f6e65d-27f8-4b72-b102-0d25faf57984" xlink:to="loc_us-gaap_ProjectMember_aa444ef5-0cc3-4332-9507-1c1d4dac77ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PersonalizedMRNACancerVaccinesProductsMember_56ef8459-f8f9-455a-98dd-e58c4e5e934c" xlink:href="mrna-20201231.xsd#mrna_PersonalizedMRNACancerVaccinesProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_aa444ef5-0cc3-4332-9507-1c1d4dac77ff" xlink:to="loc_mrna_PersonalizedMRNACancerVaccinesProductsMember_56ef8459-f8f9-455a-98dd-e58c4e5e934c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5e20031b-f6ec-4375-a85d-031faa7f6da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_563c1040-bf54-4849-b6c3-4ff53d3d61ba" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5e20031b-f6ec-4375-a85d-031faa7f6da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_5839bcb3-5cdd-46e3-8236-7769e46ff07e" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_5e20031b-f6ec-4375-a85d-031faa7f6da3" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount_5839bcb3-5cdd-46e3-8236-7769e46ff07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesIndemnificationObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_54fd1a7d-3e2a-47aa-8e74-5120799b0884" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_20dcec50-c61d-46ef-ba5b-55400c311c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_54fd1a7d-3e2a-47aa-8e74-5120799b0884" xlink:to="loc_us-gaap_LossContingenciesTable_20dcec50-c61d-46ef-ba5b-55400c311c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_722f3643-be4d-450a-86a3-1bdc6e3b514e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_20dcec50-c61d-46ef-ba5b-55400c311c91" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_722f3643-be4d-450a-86a3-1bdc6e3b514e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_138e2285-6598-42d9-925c-54838843c0da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_722f3643-be4d-450a-86a3-1bdc6e3b514e" xlink:to="loc_us-gaap_LossContingencyNatureDomain_138e2285-6598-42d9-925c-54838843c0da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndemnificationGuaranteeMember_7d91670f-7eda-45a1-a12d-fdfa2ba5ddb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndemnificationGuaranteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_138e2285-6598-42d9-925c-54838843c0da" xlink:to="loc_us-gaap_IndemnificationGuaranteeMember_7d91670f-7eda-45a1-a12d-fdfa2ba5ddb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a2fa60a9-434d-4e81-9a52-4bb669006c34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_20dcec50-c61d-46ef-ba5b-55400c311c91" xlink:to="loc_us-gaap_LossContingenciesLineItems_a2fa60a9-434d-4e81-9a52-4bb669006c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_1da72f42-48ba-4f87-80c1-d5bfbaf5c154" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2fa60a9-434d-4e81-9a52-4bb669006c34" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_1da72f42-48ba-4f87-80c1-d5bfbaf5c154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_fa0bb83a-ced8-4c25-994e-4c4a13d57ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2fa60a9-434d-4e81-9a52-4bb669006c34" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_fa0bb83a-ced8-4c25-994e-4c4a13d57ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_acdf754b-f9c4-4a7e-820e-bb50e251c95a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2fa60a9-434d-4e81-9a52-4bb669006c34" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_acdf754b-f9c4-4a7e-820e-bb50e251c95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8db0832a-8bdb-442a-a73d-3b1a75d7c0a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_e1edddad-1237-47cf-8106-01490ed55d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8db0832a-8bdb-442a-a73d-3b1a75d7c0a7" xlink:to="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_e1edddad-1237-47cf-8106-01490ed55d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_3daacb10-6f0b-417a-b80c-706074b30ac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_e1edddad-1237-47cf-8106-01490ed55d87" xlink:to="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_3daacb10-6f0b-417a-b80c-706074b30ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_7e12f301-4ae5-478b-9a88-de09bcb61a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis_3daacb10-6f0b-417a-b80c-706074b30ac9" xlink:to="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_7e12f301-4ae5-478b-9a88-de09bcb61a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SupplyAndManufacturingAgreementsMember_27fccf72-fe3c-4891-b8ce-76024bc71a77" xlink:href="mrna-20201231.xsd#mrna_SupplyAndManufacturingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_7e12f301-4ae5-478b-9a88-de09bcb61a4f" xlink:to="loc_mrna_SupplyAndManufacturingAgreementsMember_27fccf72-fe3c-4891-b8ce-76024bc71a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalServicesMember_93b229a5-ca69-4bf9-b300-9a1d9c4678f7" xlink:href="mrna-20201231.xsd#mrna_ClinicalServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_7e12f301-4ae5-478b-9a88-de09bcb61a4f" xlink:to="loc_mrna_ClinicalServicesMember_93b229a5-ca69-4bf9-b300-9a1d9c4678f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ClinicalOperationsAndSupportCommitmentMember_07282ff0-cf50-4a9a-8494-5042b8dbb4a4" xlink:href="mrna-20201231.xsd#mrna_ClinicalOperationsAndSupportCommitmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain_7e12f301-4ae5-478b-9a88-de09bcb61a4f" xlink:to="loc_mrna_ClinicalOperationsAndSupportCommitmentMember_07282ff0-cf50-4a9a-8494-5042b8dbb4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_f67f6a4b-d6b8-4144-8f2f-0f8bb2c6a113" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable_e1edddad-1237-47cf-8106-01490ed55d87" xlink:to="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_f67f6a4b-d6b8-4144-8f2f-0f8bb2c6a113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_a5761ab9-97ea-42f4-97c0-c80bfe4f8717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems_f67f6a4b-d6b8-4144-8f2f-0f8bb2c6a113" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_a5761ab9-97ea-42f4-97c0-c80bfe4f8717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#CommitmentsandContingenciesLicensestoPatentedTechnologyDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d6c5a0d1-6708-4b7f-9624-eb91927b7d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a8e6a201-bf47-4a43-9a2d-2f7c319bb9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d6c5a0d1-6708-4b7f-9624-eb91927b7d00" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a8e6a201-bf47-4a43-9a2d-2f7c319bb9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_037158a2-8341-4875-88cc-197ea28c1512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a8e6a201-bf47-4a43-9a2d-2f7c319bb9cc" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_037158a2-8341-4875-88cc-197ea28c1512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_3285eb66-f037-401e-8a6b-303778e0c341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_037158a2-8341-4875-88cc-197ea28c1512" xlink:to="loc_us-gaap_ProjectMember_3285eb66-f037-401e-8a6b-303778e0c341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_TherapeuticAndProphylacticProductsMember_3f01dd18-bc7d-4021-8b84-7e4f7d035f4c" xlink:href="mrna-20201231.xsd#mrna_TherapeuticAndProphylacticProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_3285eb66-f037-401e-8a6b-303778e0c341" xlink:to="loc_mrna_TherapeuticAndProphylacticProductsMember_3f01dd18-bc7d-4021-8b84-7e4f7d035f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DiagnosticProductsMember_8676dcbd-3315-426f-b596-3b90a4c3b5db" xlink:href="mrna-20201231.xsd#mrna_DiagnosticProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_3285eb66-f037-401e-8a6b-303778e0c341" xlink:to="loc_mrna_DiagnosticProductsMember_8676dcbd-3315-426f-b596-3b90a4c3b5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9acab9f-fff7-4947-ad59-ef3d6fcd33fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a8e6a201-bf47-4a43-9a2d-2f7c319bb9cc" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9acab9f-fff7-4947-ad59-ef3d6fcd33fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb99cac-21e4-4283-99fe-e2e54f308e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c9acab9f-fff7-4947-ad59-ef3d6fcd33fa" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb99cac-21e4-4283-99fe-e2e54f308e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_SublicenseAgreementTermsMember_d289ce90-b298-4b33-b95f-a9ce3cb0299b" xlink:href="mrna-20201231.xsd#mrna_SublicenseAgreementTermsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_bfb99cac-21e4-4283-99fe-e2e54f308e89" xlink:to="loc_mrna_SublicenseAgreementTermsMember_d289ce90-b298-4b33-b95f-a9ce3cb0299b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_a8e6a201-bf47-4a43-9a2d-2f7c319bb9cc" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount_5c059c9f-8a05-4b57-8550-8d89b057b9c5" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount_5c059c9f-8a05-4b57-8550-8d89b057b9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount_f0326f39-f521-48d4-b1d5-e87a9fcc8218" xlink:href="mrna-20201231.xsd#mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:to="loc_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount_f0326f39-f521-48d4-b1d5-e87a9fcc8218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross_d0e98aca-5585-4d49-96b9-baf664072dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross_d0e98aca-5585-4d49-96b9-baf664072dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_22b7b932-2464-4a6f-abec-cb8e5135c78f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_553c1f53-e94c-45b4-8aca-4d67824575e2" xlink:to="loc_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_22b7b932-2464-4a6f-abec-cb8e5135c78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock" xlink:type="simple" xlink:href="mrna-20201231.xsd#RedeemableConvertiblePreferredStockandCommonStock"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_faa14cef-6d7d-4c7d-8dfd-29a6d735b417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b4c2f411-0221-477a-8a39-d3a15a2a0796" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_faa14cef-6d7d-4c7d-8dfd-29a6d735b417" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b4c2f411-0221-477a-8a39-d3a15a2a0796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7ea459af-1701-4f55-9d06-394c13ba304e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_98e9840d-8464-4d5a-8597-4e383ecce789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7ea459af-1701-4f55-9d06-394c13ba304e" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_98e9840d-8464-4d5a-8597-4e383ecce789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e568579a-14f7-4ff2-95ff-b6ad94be9f7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_98e9840d-8464-4d5a-8597-4e383ecce789" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e568579a-14f7-4ff2-95ff-b6ad94be9f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6d216f1a-aec5-4cd8-bf7b-157b231c4a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e568579a-14f7-4ff2-95ff-b6ad94be9f7b" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6d216f1a-aec5-4cd8-bf7b-157b231c4a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_4d063539-d040-414b-b0aa-a09f8fbb7bde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6d216f1a-aec5-4cd8-bf7b-157b231c4a80" xlink:to="loc_us-gaap_IPOMember_4d063539-d040-414b-b0aa-a09f8fbb7bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PublicEquityOfferingMember_6f182c02-9b73-49b7-8dab-1826f880f51b" xlink:href="mrna-20201231.xsd#mrna_PublicEquityOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6d216f1a-aec5-4cd8-bf7b-157b231c4a80" xlink:to="loc_mrna_PublicEquityOfferingMember_6f182c02-9b73-49b7-8dab-1826f880f51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_4054e4a1-9213-4b58-8e37-2bd4e35d2b13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6d216f1a-aec5-4cd8-bf7b-157b231c4a80" xlink:to="loc_us-gaap_OverAllotmentOptionMember_4054e4a1-9213-4b58-8e37-2bd4e35d2b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_717165e6-173c-48fd-a858-c8029a2ae4da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_98e9840d-8464-4d5a-8597-4e383ecce789" xlink:to="loc_us-gaap_StatementClassOfStockAxis_717165e6-173c-48fd-a858-c8029a2ae4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f58a9061-81f2-4735-9ca0-9ace1221ab01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_717165e6-173c-48fd-a858-c8029a2ae4da" xlink:to="loc_us-gaap_ClassOfStockDomain_f58a9061-81f2-4735-9ca0-9ace1221ab01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b552b152-dc2c-46db-ae0a-7bf2070e22de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f58a9061-81f2-4735-9ca0-9ace1221ab01" xlink:to="loc_us-gaap_CommonStockMember_b552b152-dc2c-46db-ae0a-7bf2070e22de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_98e9840d-8464-4d5a-8597-4e383ecce789" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8d0b3be6-8811-41d3-a42a-0f89a8e80f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8d0b3be6-8811-41d3-a42a-0f89a8e80f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_e2ee5b7f-ba6e-4115-b87f-f2503abe1473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_e2ee5b7f-ba6e-4115-b87f-f2503abe1473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1a233eb7-21cc-4db5-b590-c1116eaa28e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1a233eb7-21cc-4db5-b590-c1116eaa28e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_7a7eea3e-b012-4382-a2fa-d688a3951cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_7a7eea3e-b012-4382-a2fa-d688a3951cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f9282064-9268-46a3-b1bd-f1358f2e7999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f9282064-9268-46a3-b1bd-f1358f2e7999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a514768e-b25f-4b8a-abd9-2d4aa4a3619f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_a514768e-b25f-4b8a-abd9-2d4aa4a3619f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_b72a9797-dcf4-48fb-8ba2-d0b5e4836cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_b72a9797-dcf4-48fb-8ba2-d0b5e4836cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_PaymentsOfUnderwritingDiscounts_c59b6f85-235a-4939-bf4c-9fabb38f9ce5" xlink:href="mrna-20201231.xsd#mrna_PaymentsOfUnderwritingDiscounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_mrna_PaymentsOfUnderwritingDiscounts_c59b6f85-235a-4939-bf4c-9fabb38f9ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_359f4cdd-2402-494f-9094-0e8d1b64cb94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_359f4cdd-2402-494f-9094-0e8d1b64cb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_7acbbfa7-c808-4256-a7b1-e8a3638e5d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_7acbbfa7-c808-4256-a7b1-e8a3638e5d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_d139654f-5f08-4dc2-a6fe-41a7a867f457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_d139654f-5f08-4dc2-a6fe-41a7a867f457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_924b4e90-0177-47ef-be8c-34fe99196151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_924b4e90-0177-47ef-be8c-34fe99196151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8d665703-579b-4b92-b5fc-b9016172d9d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_9873f44d-f1e0-4f8f-b752-f64c625e2419" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8d665703-579b-4b92-b5fc-b9016172d9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4f3cd1b-4d17-4c53-b850-d7e244ef19a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_69e58e86-d99b-45f6-9194-6ddc426533fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4f3cd1b-4d17-4c53-b850-d7e244ef19a3" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_69e58e86-d99b-45f6-9194-6ddc426533fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_075fac16-48d6-40a7-8064-9b252fb30e20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_fc7676c6-fee9-42bb-8257-b240cb965d07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_075fac16-48d6-40a7-8064-9b252fb30e20" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_fc7676c6-fee9-42bb-8257-b240cb965d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_a72cf17f-f707-4173-8ee8-b3259f4f7977" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_075fac16-48d6-40a7-8064-9b252fb30e20" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_a72cf17f-f707-4173-8ee8-b3259f4f7977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_bd4a3d45-7a17-4d38-a895-c7b852fbab8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_075fac16-48d6-40a7-8064-9b252fb30e20" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_bd4a3d45-7a17-4d38-a895-c7b852fbab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2ff29d40-1719-48f6-ae1d-5db1c2ef6519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_075fac16-48d6-40a7-8064-9b252fb30e20" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2ff29d40-1719-48f6-ae1d-5db1c2ef6519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_15df5de4-ba44-49ae-880e-2397260e225e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_15df5de4-ba44-49ae-880e-2397260e225e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_16033c05-0d51-4903-be63-4a2b7be2804e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:to="loc_us-gaap_PlanNameAxis_16033c05-0d51-4903-be63-4a2b7be2804e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_46c5d506-186f-4c0a-98da-fc0496bbb658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_16033c05-0d51-4903-be63-4a2b7be2804e" xlink:to="loc_us-gaap_PlanNameDomain_46c5d506-186f-4c0a-98da-fc0496bbb658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StockOptionAndIncentivePlan2018Member_f8cbb66a-1ca0-4f6e-b0c0-8739b2de550d" xlink:href="mrna-20201231.xsd#mrna_StockOptionAndIncentivePlan2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_46c5d506-186f-4c0a-98da-fc0496bbb658" xlink:to="loc_mrna_StockOptionAndIncentivePlan2018Member_f8cbb66a-1ca0-4f6e-b0c0-8739b2de550d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_StockOptionAndGrantPlan2016Member_2cf8dec5-3a03-4e47-97b9-1ff7e66190d9" xlink:href="mrna-20201231.xsd#mrna_StockOptionAndGrantPlan2016Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_46c5d506-186f-4c0a-98da-fc0496bbb658" xlink:to="loc_mrna_StockOptionAndGrantPlan2016Member_2cf8dec5-3a03-4e47-97b9-1ff7e66190d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_EmployeeStockPurchasePlan2018Member_606843fc-950b-4558-bc73-c99797075649" xlink:href="mrna-20201231.xsd#mrna_EmployeeStockPurchasePlan2018Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_46c5d506-186f-4c0a-98da-fc0496bbb658" xlink:to="loc_mrna_EmployeeStockPurchasePlan2018Member_606843fc-950b-4558-bc73-c99797075649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8b5c7841-f066-4cdf-af7c-a62e82398202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:to="loc_us-gaap_AwardTypeAxis_8b5c7841-f066-4cdf-af7c-a62e82398202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8b5c7841-f066-4cdf-af7c-a62e82398202" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ServiceBasedAwardsMember_2ee3fd39-9ddc-4286-919d-41d4ed135169" xlink:href="mrna-20201231.xsd#mrna_ServiceBasedAwardsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:to="loc_mrna_ServiceBasedAwardsMember_2ee3fd39-9ddc-4286-919d-41d4ed135169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_febadd08-3acb-4f26-885b-68a61ea2657f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_febadd08-3acb-4f26-885b-68a61ea2657f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_989d872e-b289-4b11-bfff-3d60ed5bf5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:to="loc_us-gaap_EmployeeStockMember_989d872e-b289-4b11-bfff-3d60ed5bf5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_c7fbe6de-1cdc-4450-a9bf-86ce75310438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c744eab3-8b9b-4738-8879-ade8c8fa292a" xlink:to="loc_us-gaap_PerformanceSharesMember_c7fbe6de-1cdc-4450-a9bf-86ce75310438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_f69520d3-e8ad-4456-a80e-2b6321e2df32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:to="loc_us-gaap_VestingAxis_f69520d3-e8ad-4456-a80e-2b6321e2df32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_da1fa6f0-33ab-4a50-a99d-6455ed5f26b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_f69520d3-e8ad-4456-a80e-2b6321e2df32" xlink:to="loc_us-gaap_VestingDomain_da1fa6f0-33ab-4a50-a99d-6455ed5f26b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_73f9d3bd-270e-4944-a9f5-8ed034115e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_da1fa6f0-33ab-4a50-a99d-6455ed5f26b7" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_73f9d3bd-270e-4944-a9f5-8ed034115e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c1a3d868-4cea-4af1-8ba5-a4af6dab5530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_da1fa6f0-33ab-4a50-a99d-6455ed5f26b7" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c1a3d868-4cea-4af1-8ba5-a4af6dab5530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d6e4ff91-1b3d-408d-a833-4885dc2524dc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e59e62b0-d14e-433f-bd2b-efa423199d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e59e62b0-d14e-433f-bd2b-efa423199d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized_da71e9cb-9611-4f32-9574-2f9a9ee223c8" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized_da71e9cb-9611-4f32-9574-2f9a9ee223c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a1d0b41b-8e05-4c06-a5bd-64c5f75fe471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a1d0b41b-8e05-4c06-a5bd-64c5f75fe471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f92f24d1-b4a6-4132-b0e2-bdcd7fe714d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_f92f24d1-b4a6-4132-b0e2-bdcd7fe714d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments_4e2081f6-617b-4ac0-8c6a-0af2c113c38b" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments_4e2081f6-617b-4ac0-8c6a-0af2c113c38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40cf2122-3ec7-4b4f-b8a1-bb28ad24b553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40cf2122-3ec7-4b4f-b8a1-bb28ad24b553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9026cdba-9e01-45e0-80bb-f13d57ab2eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9026cdba-9e01-45e0-80bb-f13d57ab2eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2b9ef3e6-fd9f-426a-b5ab-16b40f794007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2b9ef3e6-fd9f-426a-b5ab-16b40f794007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_8adb94a1-6d17-4ebf-8903-f15da636bdee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_8adb94a1-6d17-4ebf-8903-f15da636bdee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_8b821511-23c9-439b-898f-c19030559a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_RestrictedStockExpense_8b821511-23c9-439b-898f-c19030559a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod_9895a368-8e17-4a11-9785-9ec9049fd46b" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod_9895a368-8e17-4a11-9785-9ec9049fd46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_c753cc5b-3d43-419c-a1d2-f65beda54583" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods_c753cc5b-3d43-419c-a1d2-f65beda54583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_26ac5a4b-04f4-4011-ad96-ef33f54fea17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_26ac5a4b-04f4-4011-ad96-ef33f54fea17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate_fc581e9e-7b7a-4aab-b686-d9be4f1d9034" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate_fc581e9e-7b7a-4aab-b686-d9be4f1d9034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_75dee7b9-5dc7-41fb-ab5c-80d67e466e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_75dee7b9-5dc7-41fb-ab5c-80d67e466e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_2c207623-8d97-46c6-938e-7a47b3fa58ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_2c207623-8d97-46c6-938e-7a47b3fa58ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_74931f49-e172-400f-a077-cee3fabc1f00" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount_74931f49-e172-400f-a077-cee3fabc1f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0889f4a7-6b35-4f0b-8b55-0e9e7d7c72c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0889f4a7-6b35-4f0b-8b55-0e9e7d7c72c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_9c2da066-cfd7-4321-a841-cbc0d9739b3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_SharePrice_9c2da066-cfd7-4321-a841-cbc0d9739b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f2d2b831-45ed-4c7a-8f9e-cf390931f341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f2d2b831-45ed-4c7a-8f9e-cf390931f341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f96f2f6a-e4f9-4f0b-afc3-34c25fc34e2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f96f2f6a-e4f9-4f0b-afc3-34c25fc34e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3efac41b-0f51-4e2d-8a3c-9a096c8bbb2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3efac41b-0f51-4e2d-8a3c-9a096c8bbb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2a702aef-bb16-428e-b6ee-1f05d09627bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2a702aef-bb16-428e-b6ee-1f05d09627bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_5f383d39-068a-4934-ac05-4389580933d9" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod_5f383d39-068a-4934-ac05-4389580933d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_a9884b8d-f58f-462f-9893-5374fa860111" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0a7ecc82-3662-4f62-ab9f-4273277d5b89" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod_a9884b8d-f58f-462f-9893-5374fa860111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_970738e4-43fe-4f2b-93ba-c8b46378df3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5232f8df-e094-4531-b2be-2f924f5bd441" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_970738e4-43fe-4f2b-93ba-c8b46378df3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5232f8df-e094-4531-b2be-2f924f5bd441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_22f08333-dc15-4ecf-9e35-00226cb547a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5232f8df-e094-4531-b2be-2f924f5bd441" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_22f08333-dc15-4ecf-9e35-00226cb547a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a7574423-e167-42c6-b671-d51e5b2fcf47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5232f8df-e094-4531-b2be-2f924f5bd441" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a7574423-e167-42c6-b671-d51e5b2fcf47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f6c038ec-6c60-4529-9018-c5a2fb5af6c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5232f8df-e094-4531-b2be-2f924f5bd441" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f6c038ec-6c60-4529-9018-c5a2fb5af6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5afc61ef-8af4-41dd-a92b-345f53febefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5232f8df-e094-4531-b2be-2f924f5bd441" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5afc61ef-8af4-41dd-a92b-345f53febefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5572948-0a76-4cc5-bc45-82ee9a7c3ad6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5232f8df-e094-4531-b2be-2f924f5bd441" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f5572948-0a76-4cc5-bc45-82ee9a7c3ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_32a77cea-d04f-4237-9c68-395fad933d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_970738e4-43fe-4f2b-93ba-c8b46378df3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_32a77cea-d04f-4237-9c68-395fad933d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8f4ee97e-4118-4e53-8b36-c6ea8a17a8aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_32a77cea-d04f-4237-9c68-395fad933d4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8f4ee97e-4118-4e53-8b36-c6ea8a17a8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1c8104a3-21ac-4073-8d57-e47439e26054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_32a77cea-d04f-4237-9c68-395fad933d4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1c8104a3-21ac-4073-8d57-e47439e26054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_808a1f95-24ec-44a0-85ae-afc7bc49c479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_32a77cea-d04f-4237-9c68-395fad933d4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_808a1f95-24ec-44a0-85ae-afc7bc49c479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f8398ecd-0d06-41b8-b559-73644f3353f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_32a77cea-d04f-4237-9c68-395fad933d4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f8398ecd-0d06-41b8-b559-73644f3353f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12bf54b1-98e0-4a4b-a372-6d223fe0e9ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_32a77cea-d04f-4237-9c68-395fad933d4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12bf54b1-98e0-4a4b-a372-6d223fe0e9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward_3ade1a1e-3303-48fa-9fb1-85c59db329bb" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_970738e4-43fe-4f2b-93ba-c8b46378df3c" xlink:to="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward_3ade1a1e-3303-48fa-9fb1-85c59db329bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_fd57cc32-ee29-4f71-a014-4e556e5d1d38" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward_3ade1a1e-3303-48fa-9fb1-85c59db329bb" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_fd57cc32-ee29-4f71-a014-4e556e5d1d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ffc5049b-9703-46ee-ba95-dcb84a47eecb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward_3ade1a1e-3303-48fa-9fb1-85c59db329bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ffc5049b-9703-46ee-ba95-dcb84a47eecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue_c5e76f97-1fe7-48eb-ba1f-4d639d767d79" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward_3ade1a1e-3303-48fa-9fb1-85c59db329bb" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue_c5e76f97-1fe7-48eb-ba1f-4d639d767d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_ba5c0667-0714-4656-90c1-0a4bacccc573" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward_3ade1a1e-3303-48fa-9fb1-85c59db329bb" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue_ba5c0667-0714-4656-90c1-0a4bacccc573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_8cf1f8a5-f4ca-4411-b3d1-fb919e6bb1ef" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward_3ade1a1e-3303-48fa-9fb1-85c59db329bb" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_8cf1f8a5-f4ca-4411-b3d1-fb919e6bb1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_430cd334-c28d-4f7b-92bb-b99d40f626ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_970738e4-43fe-4f2b-93ba-c8b46378df3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_430cd334-c28d-4f7b-92bb-b99d40f626ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8e843608-1a8e-431f-aae3-cf55295cf52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_430cd334-c28d-4f7b-92bb-b99d40f626ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_8e843608-1a8e-431f-aae3-cf55295cf52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9c7510cb-fa8c-4fb9-adeb-29a310dc2f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_430cd334-c28d-4f7b-92bb-b99d40f626ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9c7510cb-fa8c-4fb9-adeb-29a310dc2f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_00b112ae-72d8-47a9-9327-b8edef8e995b" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_430cd334-c28d-4f7b-92bb-b99d40f626ce" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue_00b112ae-72d8-47a9-9327-b8edef8e995b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c427d478-ce55-4a72-bc66-bb30ea806dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_430cd334-c28d-4f7b-92bb-b99d40f626ce" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_c427d478-ce55-4a72-bc66-bb30ea806dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_7dbbaa34-5f5d-4ecc-a9a2-1468edbeb6ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_430cd334-c28d-4f7b-92bb-b99d40f626ce" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_7dbbaa34-5f5d-4ecc-a9a2-1468edbeb6ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_06296bff-07fc-4c3b-8a65-6c5de6c6af44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_430cd334-c28d-4f7b-92bb-b99d40f626ce" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_06296bff-07fc-4c3b-8a65-6c5de6c6af44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_08006e9d-20cc-4e05-8042-863b907b7c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_430cd334-c28d-4f7b-92bb-b99d40f626ce" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_08006e9d-20cc-4e05-8042-863b907b7c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_67dc2128-5c08-4d76-9807-ead8bacb0e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_970738e4-43fe-4f2b-93ba-c8b46378df3c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_67dc2128-5c08-4d76-9807-ead8bacb0e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_a495f4a6-5185-49f3-9bc2-262d7c72195a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_67dc2128-5c08-4d76-9807-ead8bacb0e12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_a495f4a6-5185-49f3-9bc2-262d7c72195a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_cff30ea9-3231-424c-bc1e-46df56df67ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_67dc2128-5c08-4d76-9807-ead8bacb0e12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_cff30ea9-3231-424c-bc1e-46df56df67ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue_791ed675-7455-472b-a554-33cc277bee6c" xlink:href="mrna-20201231.xsd#mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_67dc2128-5c08-4d76-9807-ead8bacb0e12" xlink:to="loc_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue_791ed675-7455-472b-a554-33cc277bee6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_0cf12a0a-dd00-41bf-8936-b67b644f3986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_67dc2128-5c08-4d76-9807-ead8bacb0e12" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_0cf12a0a-dd00-41bf-8936-b67b644f3986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_c5fc6353-ef1a-43a2-9930-2bdccda03eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_67dc2128-5c08-4d76-9807-ead8bacb0e12" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_c5fc6353-ef1a-43a2-9930-2bdccda03eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c2e33a6a-3649-4db6-9df0-a7a343b183c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a5152aa8-6db7-4d98-abc4-c8e4d1cd5aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c2e33a6a-3649-4db6-9df0-a7a343b183c3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a5152aa8-6db7-4d98-abc4-c8e4d1cd5aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_de2a340d-5ae1-4dad-80c0-f641b9efe1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a5152aa8-6db7-4d98-abc4-c8e4d1cd5aaa" xlink:to="loc_us-gaap_AwardTypeAxis_de2a340d-5ae1-4dad-80c0-f641b9efe1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e50e4abe-467c-4902-9d22-95cfe6cb60d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_de2a340d-5ae1-4dad-80c0-f641b9efe1a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e50e4abe-467c-4902-9d22-95cfe6cb60d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1211235f-1e1a-4ace-a35b-51d1b3d34f5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e50e4abe-467c-4902-9d22-95cfe6cb60d9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1211235f-1e1a-4ace-a35b-51d1b3d34f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9ebc0ddf-fc5d-40dc-957c-c37c23c28053" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a5152aa8-6db7-4d98-abc4-c8e4d1cd5aaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9ebc0ddf-fc5d-40dc-957c-c37c23c28053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9ebc0ddf-fc5d-40dc-957c-c37c23c28053" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7e45144d-2508-4e8b-af03-17bb33790989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7e45144d-2508-4e8b-af03-17bb33790989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_072cd153-0d04-4826-ae74-8358fa897bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_072cd153-0d04-4826-ae74-8358fa897bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_92933273-3c6e-40eb-89fe-789ed0dd462f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_92933273-3c6e-40eb-89fe-789ed0dd462f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6a82e035-2ecc-4716-80a0-635f27108c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6a82e035-2ecc-4716-80a0-635f27108c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b45e3803-49e7-4d0e-95f0-c351aee455df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c51564bf-ec4a-454d-9591-3a3753cfae4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b45e3803-49e7-4d0e-95f0-c351aee455df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9ebc0ddf-fc5d-40dc-957c-c37c23c28053" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_77f75308-d1a8-4478-ab03-766e40083e5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_77f75308-d1a8-4478-ab03-766e40083e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_80d25fca-c339-475b-8813-abadbe9cd42d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_80d25fca-c339-475b-8813-abadbe9cd42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c0425920-d657-4f42-aac2-356333d4c58d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c0425920-d657-4f42-aac2-356333d4c58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fd6ca1c4-e418-460e-861b-a4d855a2e504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fd6ca1c4-e418-460e-861b-a4d855a2e504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_65050dd3-e395-4301-841c-0093ab815110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_43702df4-f02a-49c0-af90-dc4a600adc2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_65050dd3-e395-4301-841c-0093ab815110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1146752d-5de7-4eb3-9dda-46dc4d038698" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cfba536-bd5f-462d-b334-c33db54d8a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1146752d-5de7-4eb3-9dda-46dc4d038698" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cfba536-bd5f-462d-b334-c33db54d8a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cd530501-1f7d-4932-8216-c5a3cd5efae5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cfba536-bd5f-462d-b334-c33db54d8a97" xlink:to="loc_us-gaap_AwardTypeAxis_cd530501-1f7d-4932-8216-c5a3cd5efae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1443bc29-8adc-47b7-afd8-57148085a3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_cd530501-1f7d-4932-8216-c5a3cd5efae5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1443bc29-8adc-47b7-afd8-57148085a3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e2a67f9d-72f9-4a1e-96bd-15c71c50e49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1443bc29-8adc-47b7-afd8-57148085a3dd" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e2a67f9d-72f9-4a1e-96bd-15c71c50e49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_80d18424-6fba-4839-8323-235d59f341fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1443bc29-8adc-47b7-afd8-57148085a3dd" xlink:to="loc_us-gaap_EmployeeStockMember_80d18424-6fba-4839-8323-235d59f341fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd683b11-3b5e-4afe-a18a-827901d25c43" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cfba536-bd5f-462d-b334-c33db54d8a97" xlink:to="loc_srt_RangeAxis_dd683b11-3b5e-4afe-a18a-827901d25c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b3a1b01a-948d-4ac9-87c9-9193ea0324be" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd683b11-3b5e-4afe-a18a-827901d25c43" xlink:to="loc_srt_RangeMember_b3a1b01a-948d-4ac9-87c9-9193ea0324be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_9d38bac4-a899-49ed-b44d-30f4993afb5d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b3a1b01a-948d-4ac9-87c9-9193ea0324be" xlink:to="loc_srt_WeightedAverageMember_9d38bac4-a899-49ed-b44d-30f4993afb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9cfba536-bd5f-462d-b334-c33db54d8a97" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0e5b733f-68cb-4192-87e9-2f7b6577d59e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0e5b733f-68cb-4192-87e9-2f7b6577d59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ea803ded-e98e-419b-a146-c3f8117c27df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ea803ded-e98e-419b-a146-c3f8117c27df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_751c198f-cc27-4f7c-ae12-9e6c23febedd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_751c198f-cc27-4f7c-ae12-9e6c23febedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_82a56160-2c5c-4653-841a-858aa7adfede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_82a56160-2c5c-4653-841a-858aa7adfede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_4d1a8ae2-efaf-41fc-97b9-617da5a505d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37f26af9-97a3-40cb-aef0-f78ae45744d5" xlink:to="loc_us-gaap_SharePrice_4d1a8ae2-efaf-41fc-97b9-617da5a505d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#StockBasedCompensationStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_620ae4ca-a300-403a-8463-acc5d8af33f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3dd80219-4539-49c7-b76f-02cc660f009f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_620ae4ca-a300-403a-8463-acc5d8af33f1" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3dd80219-4539-49c7-b76f-02cc660f009f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d140218b-7a6f-410d-b075-5fd9071231ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3dd80219-4539-49c7-b76f-02cc660f009f" xlink:to="loc_us-gaap_AwardTypeAxis_d140218b-7a6f-410d-b075-5fd9071231ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c2a4701-5f38-450f-8816-4bd1a15d9dfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d140218b-7a6f-410d-b075-5fd9071231ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c2a4701-5f38-450f-8816-4bd1a15d9dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ee14120e-92af-434e-a122-5fef0479a156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c2a4701-5f38-450f-8816-4bd1a15d9dfa" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ee14120e-92af-434e-a122-5fef0479a156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember_acbbc0f5-5424-4c1b-9e45-f7affde6b944" xlink:href="mrna-20201231.xsd#mrna_RestrictedStockAndRestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c2a4701-5f38-450f-8816-4bd1a15d9dfa" xlink:to="loc_mrna_RestrictedStockAndRestrictedStockUnitsRSUMember_acbbc0f5-5424-4c1b-9e45-f7affde6b944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a2e1c949-2be2-4fc3-9f44-418ee2ebd954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c2a4701-5f38-450f-8816-4bd1a15d9dfa" xlink:to="loc_us-gaap_EmployeeStockMember_a2e1c949-2be2-4fc3-9f44-418ee2ebd954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_08dfae45-47cd-48fe-85a2-9ba0f249e1c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3dd80219-4539-49c7-b76f-02cc660f009f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_08dfae45-47cd-48fe-85a2-9ba0f249e1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_99e59679-3098-46d4-a49b-9bea58d74c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_08dfae45-47cd-48fe-85a2-9ba0f249e1c0" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_99e59679-3098-46d4-a49b-9bea58d74c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a07d90eb-1a0c-4558-90a3-895b893c7023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_99e59679-3098-46d4-a49b-9bea58d74c13" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a07d90eb-1a0c-4558-90a3-895b893c7023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5f92b296-ee87-47af-af23-171f1d26b2ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_99e59679-3098-46d4-a49b-9bea58d74c13" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5f92b296-ee87-47af-af23-171f1d26b2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdc03bac-3a71-49f6-9da0-261d1cd7abf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3dd80219-4539-49c7-b76f-02cc660f009f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdc03bac-3a71-49f6-9da0-261d1cd7abf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4ab3f16a-8f5f-4bf9-ab45-8443e67c1bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdc03bac-3a71-49f6-9da0-261d1cd7abf8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4ab3f16a-8f5f-4bf9-ab45-8443e67c1bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/EmployeeBenefitPlan" xlink:type="simple" xlink:href="mrna-20201231.xsd#EmployeeBenefitPlan"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/EmployeeBenefitPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_77b23d92-fab3-47a9-b095-e9bf4cf294bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b31905c8-4051-43ae-8b7c-62b0e890b61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_77b23d92-fab3-47a9-b095-e9bf4cf294bc" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_b31905c8-4051-43ae-8b7c-62b0e890b61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/EmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#EmployeeBenefitPlanDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/EmployeeBenefitPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_afdb3f60-39a3-457a-b863-f3bde7328d09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_28df7f61-53e3-40a1-a0d2-32d53b60ff09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_afdb3f60-39a3-457a-b863-f3bde7328d09" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_28df7f61-53e3-40a1-a0d2-32d53b60ff09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_f84e2858-ffb4-4dc1-b19d-c52c2db3e8b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_afdb3f60-39a3-457a-b863-f3bde7328d09" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_f84e2858-ffb4-4dc1-b19d-c52c2db3e8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_ac00a5ff-14bd-40ab-acd8-fb37fd98ac5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_afdb3f60-39a3-457a-b863-f3bde7328d09" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_ac00a5ff-14bd-40ab-acd8-fb37fd98ac5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9a84f87b-d62a-498a-80fd-e05738a6a32e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_364f81d0-1c6d-46d3-9e65-5ddfbc374b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9a84f87b-d62a-498a-80fd-e05738a6a32e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_364f81d0-1c6d-46d3-9e65-5ddfbc374b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c26b5881-dd7a-4de6-9fd1-09d7483a86be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_8f5bcba0-dbd4-46dc-906e-0c36c64a2d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c26b5881-dd7a-4de6-9fd1-09d7483a86be" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_8f5bcba0-dbd4-46dc-906e-0c36c64a2d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8c0accba-0bc6-40c4-9cb5-053c7fd0d9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c26b5881-dd7a-4de6-9fd1-09d7483a86be" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_8c0accba-0bc6-40c4-9cb5-053c7fd0d9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3e05b835-c4c9-40c0-be03-55de7a911cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c26b5881-dd7a-4de6-9fd1-09d7483a86be" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3e05b835-c4c9-40c0-be03-55de7a911cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_55495554-903b-4422-abe7-aef86b26c0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c26b5881-dd7a-4de6-9fd1-09d7483a86be" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_55495554-903b-4422-abe7-aef86b26c0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_e606391d-b33d-4eee-b777-03ed9893ab4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c26b5881-dd7a-4de6-9fd1-09d7483a86be" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_e606391d-b33d-4eee-b777-03ed9893ab4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_07fbf118-fd67-4b7f-ab7e-06a0fc35eefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1867cfef-12fa-4390-9624-4cf89cd21bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07fbf118-fd67-4b7f-ab7e-06a0fc35eefc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1867cfef-12fa-4390-9624-4cf89cd21bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e80578ec-76b5-4a2e-a801-4f310b6be23b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07fbf118-fd67-4b7f-ab7e-06a0fc35eefc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e80578ec-76b5-4a2e-a801-4f310b6be23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8e660fcc-cb0e-4699-9438-ea9e811c35f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07fbf118-fd67-4b7f-ab7e-06a0fc35eefc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8e660fcc-cb0e-4699-9438-ea9e811c35f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1ce269bc-39af-4d3d-a857-8fbb42f5a3f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_eadcbc1c-06db-47f0-9ee5-c0b60b5dc472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1ce269bc-39af-4d3d-a857-8fbb42f5a3f3" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_eadcbc1c-06db-47f0-9ee5-c0b60b5dc472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ec026061-6b37-469b-88f9-4a0848aa6002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_eadcbc1c-06db-47f0-9ee5-c0b60b5dc472" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ec026061-6b37-469b-88f9-4a0848aa6002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ae46ce6f-83d2-41e3-81a5-e9db82df5e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_eadcbc1c-06db-47f0-9ee5-c0b60b5dc472" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ae46ce6f-83d2-41e3-81a5-e9db82df5e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c95931e5-5770-4d7e-b2ea-d07e0d032860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_eadcbc1c-06db-47f0-9ee5-c0b60b5dc472" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_c95931e5-5770-4d7e-b2ea-d07e0d032860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e5e1dd34-b649-4f81-9d59-e8e11f3f9003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_eadcbc1c-06db-47f0-9ee5-c0b60b5dc472" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e5e1dd34-b649-4f81-9d59-e8e11f3f9003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_abedead6-5f27-4f41-a8a1-f406211cdcd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1ce269bc-39af-4d3d-a857-8fbb42f5a3f3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_abedead6-5f27-4f41-a8a1-f406211cdcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_29402fbd-26ec-4ec5-a8b0-44046ce60906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_abedead6-5f27-4f41-a8a1-f406211cdcd2" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_29402fbd-26ec-4ec5-a8b0-44046ce60906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6c431b41-a0e4-4db0-93de-abcba081921c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_abedead6-5f27-4f41-a8a1-f406211cdcd2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6c431b41-a0e4-4db0-93de-abcba081921c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_dc13c17f-cd22-4588-a5d5-dc88080b5532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1ce269bc-39af-4d3d-a857-8fbb42f5a3f3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_dc13c17f-cd22-4588-a5d5-dc88080b5532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3957661c-88f6-4e37-b055-278a4b0bf155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_131cf100-7848-4127-8351-1dd4ee9e091e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3957661c-88f6-4e37-b055-278a4b0bf155" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_131cf100-7848-4127-8351-1dd4ee9e091e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b048154e-bbcc-4d83-b58d-d5bdb8e9e2f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3957661c-88f6-4e37-b055-278a4b0bf155" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b048154e-bbcc-4d83-b58d-d5bdb8e9e2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_d5f539ea-9931-4809-a3c0-7b1556627ece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3957661c-88f6-4e37-b055-278a4b0bf155" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_d5f539ea-9931-4809-a3c0-7b1556627ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_45e0a89c-6616-43f8-8ab7-f2d22950c56c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3957661c-88f6-4e37-b055-278a4b0bf155" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_45e0a89c-6616-43f8-8ab7-f2d22950c56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_b350bd2d-1a68-4b66-b19b-4a0362503c54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3957661c-88f6-4e37-b055-278a4b0bf155" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_b350bd2d-1a68-4b66-b19b-4a0362503c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_e7a0602f-afb2-4513-b6e6-89b97c28afb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3957661c-88f6-4e37-b055-278a4b0bf155" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_e7a0602f-afb2-4513-b6e6-89b97c28afb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_aa896e56-82e0-4db8-bd47-04dc144c7ad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3957661c-88f6-4e37-b055-278a4b0bf155" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_aa896e56-82e0-4db8-bd47-04dc144c7ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d75ca21e-6989-4b1f-a3b1-a06f1da83e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3957661c-88f6-4e37-b055-278a4b0bf155" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_d75ca21e-6989-4b1f-a3b1-a06f1da83e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a4c507fe-5c94-47f4-9386-706c719fb5c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3957661c-88f6-4e37-b055-278a4b0bf155" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a4c507fe-5c94-47f4-9386-706c719fb5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_aff94115-ba8e-45f1-92e2-7f6bf4b86e7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aff94115-ba8e-45f1-92e2-7f6bf4b86e7f" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e9e908ae-4734-4750-b461-e754b5800828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e9e908ae-4734-4750-b461-e754b5800828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_854130d0-08b6-4afb-b416-fa49ede9850e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_854130d0-08b6-4afb-b416-fa49ede9850e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts_4a1f2bff-beca-4aff-b819-41f761e7ea41" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts_4a1f2bff-beca-4aff-b819-41f761e7ea41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_6babcb70-387b-4518-b8d6-0b3817fda7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_6babcb70-387b-4518-b8d6-0b3817fda7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_ebbbd8ef-ecd6-4f60-b613-d432a77fe438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_ebbbd8ef-ecd6-4f60-b613-d432a77fe438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_e62c6652-1458-4678-aa1b-e3e30fb55555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_e62c6652-1458-4678-aa1b-e3e30fb55555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsOperatingLeaseLiability_39c27846-69b3-47f9-8d36-48bd227cd74b" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_mrna_DeferredTaxAssetsOperatingLeaseLiability_39c27846-69b3-47f9-8d36-48bd227cd74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsFinancingLeaseLiability_0703b616-bbc1-49c8-a737-8f31fb479c02" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsFinancingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_mrna_DeferredTaxAssetsFinancingLeaseLiability_0703b616-bbc1-49c8-a737-8f31fb479c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts_ed662682-3b9c-40ea-af60-f19ff9d99a0c" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts_ed662682-3b9c-40ea-af60-f19ff9d99a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_508d2b2f-0a22-4a95-b600-6c90f06787ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_508d2b2f-0a22-4a95-b600-6c90f06787ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_5b7a0e8f-7b11-4ba8-b3f4-1e1f64008b43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_5b7a0e8f-7b11-4ba8-b3f4-1e1f64008b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e1782767-8f53-4573-b968-629db2a76d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_e1782767-8f53-4573-b968-629db2a76d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_11d90762-a707-4bd5-b524-54d2d81e9816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f287a525-aefa-43f7-834e-0c6023493b0a" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_11d90762-a707-4bd5-b524-54d2d81e9816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a604dbb5-3b9b-462b-8112-60800effbfb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aff94115-ba8e-45f1-92e2-7f6bf4b86e7f" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a604dbb5-3b9b-462b-8112-60800effbfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset_62b13695-4952-4236-bb48-ddca934c52c5" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a604dbb5-3b9b-462b-8112-60800effbfb4" xlink:to="loc_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset_62b13695-4952-4236-bb48-ddca934c52c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_1e48ab68-3795-4c0f-92f5-0abd6156104f" xlink:href="mrna-20201231.xsd#mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a604dbb5-3b9b-462b-8112-60800effbfb4" xlink:to="loc_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_1e48ab68-3795-4c0f-92f5-0abd6156104f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b1d7f560-3d6d-4740-bb5d-fd8d136baead" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a604dbb5-3b9b-462b-8112-60800effbfb4" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b1d7f560-3d6d-4740-bb5d-fd8d136baead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_97e10f17-a3f7-4b53-a4dc-525dd8be4707" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a604dbb5-3b9b-462b-8112-60800effbfb4" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_97e10f17-a3f7-4b53-a4dc-525dd8be4707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_fb6088dd-2475-428e-9fdb-ff61b453489a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_a604dbb5-3b9b-462b-8112-60800effbfb4" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_fb6088dd-2475-428e-9fdb-ff61b453489a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a405c5ca-954b-470b-beef-ab265aea7ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_aff94115-ba8e-45f1-92e2-7f6bf4b86e7f" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a405c5ca-954b-470b-beef-ab265aea7ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4bba1049-4c8c-42b8-91bd-b2dd7ed3642d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_185da875-fdd1-4964-928e-35ceea5488b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4bba1049-4c8c-42b8-91bd-b2dd7ed3642d" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_185da875-fdd1-4964-928e-35ceea5488b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_a09af1eb-dedc-4594-861e-91c7fa2b0206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4bba1049-4c8c-42b8-91bd-b2dd7ed3642d" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_a09af1eb-dedc-4594-861e-91c7fa2b0206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_c7478415-5703-4675-b1f6-5f19ead6f883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a09af1eb-dedc-4594-861e-91c7fa2b0206" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_c7478415-5703-4675-b1f6-5f19ead6f883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f0afddc5-1c5d-40d7-9f65-b93cd7740197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c7478415-5703-4675-b1f6-5f19ead6f883" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f0afddc5-1c5d-40d7-9f65-b93cd7740197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_26257cd7-8ff0-4a95-84e0-997c4c37d3e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f0afddc5-1c5d-40d7-9f65-b93cd7740197" xlink:to="loc_us-gaap_DomesticCountryMember_26257cd7-8ff0-4a95-84e0-997c4c37d3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_29d7a8c9-5e7f-4b1f-bd58-27df14cb981c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f0afddc5-1c5d-40d7-9f65-b93cd7740197" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_29d7a8c9-5e7f-4b1f-bd58-27df14cb981c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_8c919324-9aaa-434e-88b0-2d6c00412ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a09af1eb-dedc-4594-861e-91c7fa2b0206" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_8c919324-9aaa-434e-88b0-2d6c00412ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_dab7a8d1-1606-44a9-9b61-ea8b4f039909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_8c919324-9aaa-434e-88b0-2d6c00412ef3" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_dab7a8d1-1606-44a9-9b61-ea8b4f039909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_c2daccb8-d8a5-47c2-9b9c-8ce2f3a363b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_dab7a8d1-1606-44a9-9b61-ea8b4f039909" xlink:to="loc_us-gaap_ResearchMember_c2daccb8-d8a5-47c2-9b9c-8ce2f3a363b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_FederalOrphanDrugMember_3610fcf9-450f-419a-acbd-19c6e58dacf7" xlink:href="mrna-20201231.xsd#mrna_FederalOrphanDrugMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_dab7a8d1-1606-44a9-9b61-ea8b4f039909" xlink:to="loc_mrna_FederalOrphanDrugMember_3610fcf9-450f-419a-acbd-19c6e58dacf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentCreditMember_51625e28-5e72-4cb6-9204-ccb5ae33b0bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_dab7a8d1-1606-44a9-9b61-ea8b4f039909" xlink:to="loc_us-gaap_InvestmentCreditMember_51625e28-5e72-4cb6-9204-ccb5ae33b0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a09af1eb-dedc-4594-861e-91c7fa2b0206" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0612bec1-cfca-48f0-88b6-b72982a33634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0612bec1-cfca-48f0-88b6-b72982a33634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_14638329-ca03-4ca3-a228-3b594f48436c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_14638329-ca03-4ca3-a228-3b594f48436c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_07ee6c10-efd8-44e5-936e-a97de7deb886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_us-gaap_OperatingLossCarryforwards_07ee6c10-efd8-44e5-936e-a97de7deb886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLossCarryforwardsSubjectToExpiration_81740551-9a95-4288-98c9-69511153bd40" xlink:href="mrna-20201231.xsd#mrna_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_mrna_OperatingLossCarryforwardsSubjectToExpiration_81740551-9a95-4288-98c9-69511153bd40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_OperatingLossCarryforwardsNotSubjectToExpiration_bd5d8a33-b2d0-4f6a-b33b-edbedff67ca6" xlink:href="mrna-20201231.xsd#mrna_OperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_mrna_OperatingLossCarryforwardsNotSubjectToExpiration_bd5d8a33-b2d0-4f6a-b33b-edbedff67ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_29b7a948-4586-4c77-b101-aed3bfa0d6ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f030098c-15c8-46cd-92fd-5042f33f1d7c" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_29b7a948-4586-4c77-b101-aed3bfa0d6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fef60fb6-62a4-4658-84ab-7c2faf005522" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1f0b1db5-d252-450c-b514-3e623454ce79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fef60fb6-62a4-4658-84ab-7c2faf005522" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1f0b1db5-d252-450c-b514-3e623454ce79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6aa661a5-6f07-45ce-a346-b14f2b6b1c30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1f0b1db5-d252-450c-b514-3e623454ce79" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_6aa661a5-6f07-45ce-a346-b14f2b6b1c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_db161806-0a86-49ca-a7b2-c04f7a8892f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1f0b1db5-d252-450c-b514-3e623454ce79" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_db161806-0a86-49ca-a7b2-c04f7a8892f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_2c447dd7-849b-4403-99d0-ee7e8b4e21a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1f0b1db5-d252-450c-b514-3e623454ce79" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_2c447dd7-849b-4403-99d0-ee7e8b4e21a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d25ba01e-0f84-4870-895d-0ff806619939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_1f0b1db5-d252-450c-b514-3e623454ce79" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d25ba01e-0f84-4870-895d-0ff806619939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShare" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShare"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/NetLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_479cb07e-d905-48e5-867a-3e3f3de29ddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_e24aadb4-e3c1-4330-bc37-198059ee9626" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_479cb07e-d905-48e5-867a-3e3f3de29ddb" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_e24aadb4-e3c1-4330-bc37-198059ee9626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShareTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShareTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/NetLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1bbe1aee-b9a1-4a5e-be27-984bc17c0029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ae5ab3f3-d38f-469f-88c5-4c47cba3db25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1bbe1aee-b9a1-4a5e-be27-984bc17c0029" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ae5ab3f3-d38f-469f-88c5-4c47cba3db25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_40e13ce8-08fc-4259-88dc-fe3901ab27c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1bbe1aee-b9a1-4a5e-be27-984bc17c0029" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_40e13ce8-08fc-4259-88dc-fe3901ab27c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0cc462e6-4e7d-486e-a298-c7366e5dbdb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_fcff9843-9519-40d0-975c-8ff0788dcb25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0cc462e6-4e7d-486e-a298-c7366e5dbdb5" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_fcff9843-9519-40d0-975c-8ff0788dcb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_541fcf98-c0e8-428a-a588-4f65c29e3922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_fcff9843-9519-40d0-975c-8ff0788dcb25" xlink:to="loc_us-gaap_NetIncomeLoss_541fcf98-c0e8-428a-a588-4f65c29e3922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockRedemptionPremium_4dd611db-627a-401b-856c-88939e02c478" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockRedemptionPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_fcff9843-9519-40d0-975c-8ff0788dcb25" xlink:to="loc_us-gaap_PreferredStockRedemptionPremium_4dd611db-627a-401b-856c-88939e02c478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockDividends_05f73c63-8a54-4009-a291-d56cf97441f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemablePreferredStockDividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_fcff9843-9519-40d0-975c-8ff0788dcb25" xlink:to="loc_us-gaap_RedeemablePreferredStockDividends_05f73c63-8a54-4009-a291-d56cf97441f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_03bc4a79-43b2-44a8-a62b-c568304e87d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_fcff9843-9519-40d0-975c-8ff0788dcb25" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_03bc4a79-43b2-44a8-a62b-c568304e87d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_c588d29b-fa0b-4892-b73e-f71cbfccca28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0cc462e6-4e7d-486e-a298-c7366e5dbdb5" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_c588d29b-fa0b-4892-b73e-f71cbfccca28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_86d1e21e-767d-4707-b54d-61248bff60b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_c588d29b-fa0b-4892-b73e-f71cbfccca28" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_86d1e21e-767d-4707-b54d-61248bff60b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_9d1fdc64-4638-43f2-8051-b4b5539622d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0cc462e6-4e7d-486e-a298-c7366e5dbdb5" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_9d1fdc64-4638-43f2-8051-b4b5539622d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_69744bd6-d0b6-402a-aad4-3c6a41c0894f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_25618528-a6df-43f5-b08f-3cafb5f03310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_69744bd6-d0b6-402a-aad4-3c6a41c0894f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_25618528-a6df-43f5-b08f-3cafb5f03310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a33107f4-c191-46fb-892b-a73e8a8089d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_25618528-a6df-43f5-b08f-3cafb5f03310" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a33107f4-c191-46fb-892b-a73e8a8089d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_195eda4b-7170-42a7-838f-e48f907ac31e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a33107f4-c191-46fb-892b-a73e8a8089d4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_195eda4b-7170-42a7-838f-e48f907ac31e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9c5c13a1-325c-4ee5-bbc9-45175552ed1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_195eda4b-7170-42a7-838f-e48f907ac31e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9c5c13a1-325c-4ee5-bbc9-45175552ed1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fd363e64-7414-4f00-be82-67c19263ddc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_195eda4b-7170-42a7-838f-e48f907ac31e" xlink:to="loc_us-gaap_RestrictedStockMember_fd363e64-7414-4f00-be82-67c19263ddc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1487968e-9a5c-4df0-b934-bc212d222373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_195eda4b-7170-42a7-838f-e48f907ac31e" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1487968e-9a5c-4df0-b934-bc212d222373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ca40557-283a-4617-b8a0-e1768c056272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_25618528-a6df-43f5-b08f-3cafb5f03310" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ca40557-283a-4617-b8a0-e1768c056272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e6fe655d-e223-4891-a08a-2d26a79532ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1ca40557-283a-4617-b8a0-e1768c056272" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e6fe655d-e223-4891-a08a-2d26a79532ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/GeographicInformation" xlink:type="simple" xlink:href="mrna-20201231.xsd#GeographicInformation"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/GeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_386a88bb-20ce-4f18-b159-01110e2090e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9fae5061-100f-409a-9ca3-155c2bd2e64c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_386a88bb-20ce-4f18-b159-01110e2090e5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9fae5061-100f-409a-9ca3-155c2bd2e64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/GeographicInformationTables" xlink:type="simple" xlink:href="mrna-20201231.xsd#GeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/GeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_256fb88d-cd38-4856-a453-04dcb23e38a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_9a67cd7b-d6d6-4579-93a5-42eb2322d9a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_256fb88d-cd38-4856-a453-04dcb23e38a3" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_9a67cd7b-d6d6-4579-93a5-42eb2322d9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/GeographicInformationDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#GeographicInformationDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/GeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c7402172-92f6-44bb-a707-c6e8a4797d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_e9e9b4da-0c21-4783-94f7-e731f00cb049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c7402172-92f6-44bb-a707-c6e8a4797d79" xlink:to="loc_us-gaap_NumberOfOperatingSegments_e9e9b4da-0c21-4783-94f7-e731f00cb049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_2d4c8884-4be2-434f-9f3c-f8f7fb1d917a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c7402172-92f6-44bb-a707-c6e8a4797d79" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_2d4c8884-4be2-434f-9f3c-f8f7fb1d917a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_227eb161-62fd-4f9e-85a3-833ef0e637db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2d4c8884-4be2-434f-9f3c-f8f7fb1d917a" xlink:to="loc_srt_StatementGeographicalAxis_227eb161-62fd-4f9e-85a3-833ef0e637db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5358cab4-7514-49f8-87fd-3e5eddcb2944" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_227eb161-62fd-4f9e-85a3-833ef0e637db" xlink:to="loc_srt_SegmentGeographicalDomain_5358cab4-7514-49f8-87fd-3e5eddcb2944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_52e7aa38-1224-47e2-85fd-9a3aa559b3ac" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5358cab4-7514-49f8-87fd-3e5eddcb2944" xlink:to="loc_country_US_52e7aa38-1224-47e2-85fd-9a3aa559b3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_31aee2a0-7923-4cd9-b547-5f21bde80705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5358cab4-7514-49f8-87fd-3e5eddcb2944" xlink:to="loc_us-gaap_NonUsMember_31aee2a0-7923-4cd9-b547-5f21bde80705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5447aeb3-2a4e-4e92-83d6-411459e3d298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_2d4c8884-4be2-434f-9f3c-f8f7fb1d917a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_5447aeb3-2a4e-4e92-83d6-411459e3d298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ca14fdc9-3425-4dbd-816b-5b65adf04b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5447aeb3-2a4e-4e92-83d6-411459e3d298" xlink:to="loc_us-gaap_Revenues_ca14fdc9-3425-4dbd-816b-5b65adf04b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SubsequentEvent" xlink:type="simple" xlink:href="mrna-20201231.xsd#SubsequentEvent"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/SubsequentEvent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_53c6940c-cf96-44bd-aa97-df6c2dab50b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_db255a99-336b-455f-803f-49289cebe813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_53c6940c-cf96-44bd-aa97-df6c2dab50b9" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_db255a99-336b-455f-803f-49289cebe813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.modernatx.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="mrna-20201231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.modernatx.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_3382f3a6-563d-4d64-92ae-dfe8dc167c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_e416af66-75d7-4cee-b1c9-50ea75f0bd14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_3382f3a6-563d-4d64-92ae-dfe8dc167c74" xlink:to="loc_us-gaap_SubsequentEventTable_e416af66-75d7-4cee-b1c9-50ea75f0bd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2c2bc859-66f4-4fff-a2a9-9a572b5c8014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e416af66-75d7-4cee-b1c9-50ea75f0bd14" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2c2bc859-66f4-4fff-a2a9-9a572b5c8014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4e5096c4-fdc1-4066-bb3f-8deb6dacbec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2c2bc859-66f4-4fff-a2a9-9a572b5c8014" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4e5096c4-fdc1-4066-bb3f-8deb6dacbec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_81d56aa6-a288-4535-87a4-38fbb1105b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4e5096c4-fdc1-4066-bb3f-8deb6dacbec1" xlink:to="loc_us-gaap_SubsequentEventMember_81d56aa6-a288-4535-87a4-38fbb1105b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e416af66-75d7-4cee-b1c9-50ea75f0bd14" xlink:to="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NumberOfDosesOfVaccineCandidate_97208bcc-7c5c-4eb0-b780-691679751e79" xlink:href="mrna-20201231.xsd#mrna_NumberOfDosesOfVaccineCandidate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_mrna_NumberOfDosesOfVaccineCandidate_97208bcc-7c5c-4eb0-b780-691679751e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_27d54e8f-3aba-40dd-951c-61c85cee7d33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted_27d54e8f-3aba-40dd-951c-61c85cee7d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_NumberOfVaccineDoses_e8b08e14-9a74-4a0d-9433-0f28c9ff3368" xlink:href="mrna-20201231.xsd#mrna_NumberOfVaccineDoses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_mrna_NumberOfVaccineDoses_e8b08e14-9a74-4a0d-9433-0f28c9ff3368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mrna_AdditionalNumberOfVaccineDoses_2c20dc65-fa28-4345-98b6-7d233320d033" xlink:href="mrna-20201231.xsd#mrna_AdditionalNumberOfVaccineDoses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_mrna_AdditionalNumberOfVaccineDoses_2c20dc65-fa28-4345-98b6-7d233320d033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_3ea3d39a-48cb-4454-8490-2cca99899bf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_79b33358-648f-472c-9961-e55e6e522c4a" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_3ea3d39a-48cb-4454-8490-2cca99899bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>exhibit1027supplycontrac001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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MPD1_Z FL?^ P_P#BJ -NBL3_ (2(_P#0$UC_ ,!A_P#%4?\ "1'_ * FL?\
M@,/_ (J@#;HK$_X2(_\ 0$UC_P !A_\ %4?\)$?^@)K'_@,/_BJ -NBL3_A(
MC_T!-8_\!A_\51_PD1_Z FL?^ P_^*H VZ*Q/^$B/_0$UC_P&'_Q5'_"1'_H
M":Q_X##_ .*H VZ*Q/\ A(C_ - 36/\ P&'_ ,51_P )$?\ H":Q_P" P_\
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MQ/\ A(C_ - 36/\ P&'_ ,51_P )$?\ H":Q_P" P_\ BJ -NBL3_A(C_P!
M36/_  &'_P 51_PD1_Z FL?^ P_^*H VZ*Q/^$B/_0$UC_P&'_Q5'_"1'_H"
M:Q_X##_XJ@#;HK$_X2(_] 36/_ 8?_%4?\)$?^@)K'_@,/\ XJ@#;HK$_P"$
MB/\ T!-8_P# 8?\ Q5'_  D1_P"@)K'_ (##_P"*H VZ*Q/^$B/_ $!-8_\
M 8?_ !5'_"1'_H":Q_X##_XJ@#;HK$_X2(_] 36/_ 8?_%4?\)$?^@)K'_@,
M/_BJ -NBL3_A(C_T!-8_\!A_\51_PD1_Z FL?^ P_P#BJ -NBL3_ (2(_P#0
M$UC_ ,!A_P#%4?\ "1'_ * FL?\ @,/_ (J@#;HK$_X2(_\ 0$UC_P !A_\
M%4?\)$?^@)K'_@,/_BJ -NBL3_A(C_T!-8_\!A_\51_PD1_Z FL?^ P_^*H
MVZ*Q/^$B/_0$UC_P&'_Q5'_"1'_H":Q_X##_ .*H VZ*Q/\ A(C_ - 36/\
MP&'_ ,51_P )$?\ H":Q_P" P_\ BJ -NBL3_A(C_P! 36/_  &'_P 51_PD
M1_Z FL?^ P_^*H VZ*Q/^$B/_0$UC_P&'_Q5'_"1'_H":Q_X##_XJ@#;HK$_
MX2(_] 36/_ 8?_%4?\)$?^@)K'_@,/\ XJ@#;HK$_P"$B/\ T!-8_P# 8?\
MQ5'_  D1_P"@)K'_ (##_P"*H VZ*Q/^$B/_ $!-8_\  8?_ !5'_"1'_H":
MQ_X##_XJ@#;HKG[KQ7%96DUU<:1J\<$*-)(YMAA5 R3][T%2_P#"1G_H":Q_
MX##_ .*H VZ*Q/\ A(C_ - 36/\ P&'_ ,51_P )$?\ H":Q_P" P_\ BJ -
MNBL3_A(C_P! 36/_  &'_P 51_PD1_Z FL?^ P_^*H VZ*Q/^$B/_0$UC_P&
M'_Q5'_"1'_H":Q_X##_XJ@#;HK$_X2(_] 36/_ 8?_%4?\)$?^@)K'_@,/\
MXJ@#;HK$_P"$B/\ T!-8_P# 8?\ Q5'_  D1_P"@)K'_ (##_P"*H VZ*Q/^
M$B/_ $!-8_\  8?_ !5'_"1'_H":Q_X##_XJ@#;HK$_X2(_] 36/_ 8?_%4?
M\)$?^@)K'_@,/_BJ -NBL3_A(C_T!-8_\!A_\51_PD1_Z FL?^ P_P#BJ -N
MBL3_ (2(_P#0$UC_ ,!A_P#%4?\ "1'_ * FL?\ @,/_ (J@#;HK$_X2(_\
M0$UC_P !A_\ %4?\)$?^@)K'_@,/_BJ -NBL3_A(C_T!-8_\!A_\51_PD1_Z
M FL?^ P_^*H VZ*Q/^$B/_0$UC_P&'_Q5'_"1'_H":Q_X##_ .*H VZ*Q/\
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MPD1_Z FL?^ P_P#BJ -NBL3_ (2(_P#0$UC_ ,!A_P#%4?\ "1'_ * FL?\
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M=L @!2<DCMS3-DUA\3Y[_P#L^^:P71HK-)H[=W!D65FV\#T(YZ>] $L?B[4
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M?*#N!XR:?XH^(%WX1\/3ZMJ6@G$-Z+0QQW6=^5#*ZG9RISCL016!\764^*O
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?NCZ4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?X4?VEKG_0OC_P #4_PKG+>\O=(\07UI$\CQ:S-*+,G++;W"/M<>R^7A\?\
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MGDL;^1K1YV\G>&AV\[3D L<<#&X].E '1_VEKG_0OC_P-3_"C^TM<_Z%\?\
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M@NF\EL'T).#D9.* )?[2US_H7Q_X&I_A1_:6N?\ 0OC_ ,#4_P *YO6=-O\
M5?&>L6FFSK;3K86$D=P9F0P'SI]S*J@[B50 @X!P >*H6<DZ^+0OF-:6_P#;
MTZ_:Q*2'Q$,6S+T 8L2"<C*X R10!V?]I:Y_T+X_\#4_PH_M+7/^A?'_ (&I
M_A7*2SW$O@/7]6GD=/$%O<78B8'YX94D801(/[I'E_+T;?SG=RGB2=YI?$\Z
MN-\/AAF8Q/D13@S9P1T8%<9Z_+[4 =9_:6N?]"^/_ U/\*/[2US_ *%\?^!J
M?X5S>L2SZ9IEJ1'!817,]G'=2VL[%A;E\.Q.%V\LJEAT#$YXXZ@Z)I;7.%C
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MI#%:VVXJ&(!8ET ^IX/2@#?_ .$KTO\ NZC_ ."RY_\ C='_  E>E_W=1_\
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M""J<FKZGI^G>']1GNOM U*X@@N(1&H1/.'!C(&?E8C[Q.1GOS0!J?\)7I?\
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M.X50H+-M/8= !R:ZK4;Z/3=.GO)<;8D+8)QN/89]S@?C7'MXHOY?A[JMZMU
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MEOO2+:B)%O)2-57: J]%&!VJC;^'+2T'^C3W43^=-,'67G=*VZ3@C!!;G!!
M[8IG_"2+_P! C6/_  #-'_"2+_T"-8_\ S0 -X5TW[(UHGGQVLEN+:6%9CME
MCRQ(;/<EVRPP3GK4TOAZREN;F93-$+M56YCB?:DP4;1D=OEP,C&0 #TJ'_A)
M%_Z!&L?^ 9H_X21?^@1K'_@&: )I= MI-0NKY9[J*>ZB2&4Q2[<HF[:!Z8WM
MR.>:BD\+:=-)?-)]H,=^5^TQ"9E20*H0 @8XV@#'0CKFD_X21?\ H$:Q_P"
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M_H$:Q_X!FC_A)%_Z!&L?^ 9H VZ*Q/\ A)%_Z!&L?^ 9H_X21?\ H$:Q_P"
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M_P# ,T 7ETNW36I-6!D^U20+;M\WR[%)8#'U9CGWJ[6)_P )(O\ T"-8_P#
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M C6/_ ,T?\)(O_0(UC_P#- &W16)_P )(O\ T"-8_P# ,T?\)(O_ $"-8_\
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M)H(;R)?)4Q7)ADVYR$.U@2,\X/>K<ZZ;<Z3)#))$;!D,;E9=J[>A&X'CTZT
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MP5#G'WGC#8)P!R1T IBVWAZ]NG"26LLDT@E>&.XRLKC'S-&#M8\#DCL/2@#
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M%358;ZRU'P] =8O9!>7QMYV#*NY%MI6Z 8!W1@DCOGMQ6NVCZ.L5O=@>4MO
M(TN$N70^4.0"X8%E[\DBGRPZ-=OI[M+ QMY-]GLGP ^TKE0#R=K$=^"?6@"C
MXH358/#4::3>.-2C>)8I7Q^]8$</VPW0^F>*R4\3S:WK_AF33YWBTRY9Q<1X
MP7D\AI-C=P4PN1W+8[5U=RVGW+I#/<1%XYE*H)MI$@Y48!Z^U5Y=)T:">U=X
MHH)(I99H-LACQ(^3(P (R3N;/U- &1%XAN1XV2VE9O[+O!):V^8F4+/%\Q^8
MC!WCS!P?^60]:S9=;U'2A=6NI74AM;RYE33;T'#1NLK+Y#GU(7*D]>1U SU+
M:5I%QI=I&0KV=FRS0.)VPA3HV[.>.>IIDHT 6C6<\]HT$DGGF.:<-EBV_<-Q
M_O?,,=Z ,K7O$-SIGB"P,;-_9L$R07_[IF&9>%._&%V'RR<GI)[5);:C-J6J
M>(S/-<10Z3*L$4$#!6/[I9#(?4G?@ _+A>G)K2FL]$NX+S29GAE6[9C<6[7!
M+.3UXSD=!P*=>:5I*;[NZ_<$Q"&2?[0T1=!P [!ANZG&<]3ZT <Q#J]W>ZG:
MF!M3N[:70HKQ4B=(W9RQ <C=@$C' S]*L/KEUH7BJX6_NI)]*N%$$&0"4N$B
M63:/4R*7P/5 !UK6>P\.02PS>?#;.MLMO$8[QHL0J>%&UAP#4B6_A]?+C#VC
M;Y(YHT:<-\R8",H)X(V@#'I0!R4.JZR=.MVNKNXDNG\1/:2K P7]W\W[M<X&
M!@8/7CK6KJ,VN6LME<Z9]J=X_/EGTZY=6:>-64; PX#8)93GG@'@Y&I<Z5X=
MMR(;AXX6^TF\ >[9&\TYRX^;.>34RKH=C=)*;N))QE@TMX2Q# 9)W-SD*O7T
M&* .<U'5FOO!?B'7]*U6Z"6UO<36I5L;6$"L 01D%6W?*>Y(/2NPT^W>WM_F
MN9I]Y#@RMDK\HX!],@G\:H7,7AYK2^TV>2R2&[9_M4 F">86X;(!!Y[^M7[E
M[&VM1;7-PD,3IL'F3;21C'#$Y_'.: .<TSQ)<R^*;JWN-[65Y;M/IP\EE_U1
MVNH8C#;@4<8[$^E5]-UF2?PGHOB"\O+LW&I36Y*VY4HAE< 1;20-HSL+?>[Y
MKHY]/TDP6%Q-L$5@0]M*9B!'\NW.<\\''.>#[U!_96@QP+=XA2T$PN5(G(@$
MF[<'"YV9W<YQUYZT 9'AZYO;V:Y\]]0=4U2[@$WFKY:QH[A5(SNZ #..N.?6
ME8ZYJ5M%::7K%RYFNIX9+"]7Y?M$9E4/$V.-ZJ3_ +R_,.0<=#'9>'K$AUN8
MXEDE:Y :];8[EB2^"V"=V3GUJPT.B1Z;:B1[8V<,BR6[RS;@KJ2058GJ.>_J
M* ,KP]->>(M#;59;Z>VN);F941"-D*1RL@0KT)PGS$\Y)P1QB&-]4A\1W7AV
M6[N'2Y(OK:\WC=%;@@/%]0V #_=DSU7G<CTS28]0D>(*D\Y\]XDF8+(?[YC!
MVD]/FQ4OV;3I=2.J!D:Z@C:!I1*<(A()4C.!R >1VH O@8&**C%Q";?[0)H_
M)V[O,W#;CUSTQ2B6-E1@ZE7^Z0>&^GK0 ^BD9E1"[L%51DDG  J![ZTCBBE>
MZ@6.5@L;F0 .3T /<T 6**B^TV_VK[-Y\7V@KO\ *WC?M]<=<4[SHMLC>8F(
M^'.X?+QGGTXYH ?138Y$FC62)U=&&593D$>QJ.*[M[@2&&XBD$3%9-C@[".H
M..AH FHJ%[NVB6)I+B)!,0L19P-Y/0+Z_A3OM$/G^1YT?G8W>7N&['KCK0!)
M6*?^1V3_ +!S?^C!6U6*?^1V3_L'-_Z,% &U1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5BZY_R%?#G_ &$6_P#26>MJL77/^0KX
M<_["+?\ I+/0!M4444 %%%% !1110 4444 %%%% !7G6I2&/QM$ZSPPE-<9F
MDF7<B#^S5&3R.,D#J.2*]%KD[?7;+2/$>JP7K/$M[JJ013$#9YAM8"%8YX)Z
M#MG ZD4 <WI+?8G\.F\ BCAUV_?SV7RXY$:*?$B*?N1EG  Y[<G.3OW^HV%Q
MXVT.[,T9M5LKY#*_"$EX!U/KM;'KM.,UTR:C"QO=ZM$EFVV5Y,!?N!\C!Z88
M=<57@URWO-'L]3L89[J"[4-&L:@, 03\VX@+C!!R>O% '"Z9:W=CJ>FW5Q;R
MP^'%U2\D@BD0J+=65?)=E/W$W"8C( 7>O3C'7Z!=O=ZIKS"&W%LEVBQ3PH0+
MC]S&2Q;)#$$[,C^Y3(?&%G-IMEJ LKY;:]:W%N[(GS^<<(?O<=LYY&1D5;;Q
M!;$7;P6]S<P6CM'--"@*JZ_>49(+8Z' (!R.QP 5/#"HEYXA6-553JC, HP#
MF*+)_,'\0:YTWDVF>%O$\5Y;13:TUU<R?9[E"PO$+'R0@!!=?+V*,'@C'45U
M47B6VGDEBBMKIYH[LV9C"KN+@ L1\WW0",GWJ?5];M-#6T>]\Q8KFX2V615R
MJ.WW=WH/?M0!R\=QY/BKQ)YUY:1Q/+:EXY(2S3 1KN"#=UZCH>:JWEG=Z?!J
MVHZ6CW5I?SW$.H6:')5RS*DZ#U VAAW7!ZKSV<^MVD&OVNBGS&O;B%YU55X5
M%(!)/U/'XU);:M9W>JWNFPR[KJR$;3IC[H<$K]>AH Y-KA8?%_B,R7EK# PM
M/,2:+>TRA3O5.1DXR.AY(K)2)CXCFNKD :7!XB:9Y8D_>12>3&L;,?\ GD26
M5B!UQDXW8[S4=>L=+F:*X9\QQ>?,RC(ABW;=[>@SGU^Z3V-2'5[<:A>V6R8S
MV=NES(%C)W(Y<#;ZG,;<"@#DM=NKE=5@\4V^Q[/3;D6K;)26>!CLFP@7D[BK
M=>1"N.O-RPU2QL?%WB::>XC59/LQCP<F3$?1?[Q^E:D'BBTDCNGN;6]LC;F-
M66YB 9VD)"JH4G+$\8Z\CUJ:\\0V=@^RZ66-DB$\XP#Y$9;:&?!X&<],_=)[
M&@#.\1^;%XD\.W4ZL=)ADF^T'&5BF*@1._H!\XR> 6%8&KW<UY>N8$LTC3Q#
M;?9[A(F*S?N5)=CNPV"=A(Q]VN[U+48-*L7N[C<54A0B#+.Q. H'<DFJ,WB6
MRME4W,5Q"PA6XF5T -O&S;0TG/ R#TS]T^AH XK:+7P=:VKG[/J,>OP37<4B
M_)#(;D2.4''[K!+*<_=ZG.:TM7NE?4/#TB7UD\L>LR/-=)%B(#[+, 3\W. T
M:YW=2/I780ZE!-JUUIJB07%M%%,^5PI60N%P>_,;4:9J4&K67VJV#B,2RPD2
M+M(:.1HVX_WE- ')WUA_;%UI;V-_#'JEK%=36UW$FV-I?,CW97/*-EP1D]R#
MD9JE<W=S/:^'KJZMQIMU_;TCS1W W"(B&=6)P1E<D8;(!W+ZUZ+10!D6FH06
MNAW%[+/%,D+2/)+!'M20Y)^49.>N.IR>YK T(7FB^*I;74!%Y>MP_:\QS&11
M<K@2#E1@,I3:/^F9YKMJ* ..\.6%Q9W\FA36[+8:/.TUI*P^5XY 3$H]=FZ1
M3Z;$/>JWA"Y2.VCCFO+3:-2OV2V\K]Z-UQ*0^=W"[23G X/7U[JB@#SO1;*]
MT:'0K:VC>YT6]>&9<?,;&;;N=3_TS8Y(_NMD=",7-$:.'0/['DPNH)K$K&V(
M^?;]M:4/C^[L(;=TQ7<44 <-H=PL>KZNDEW:K"^MLWV9HMTLN8T"E3NZ;\'.
M/X3S7<T44 %%%% !1110 4444 %%%% !1110 5B>#O\ D2="_P"P?!_Z+%;=
M8G@[_D2="_[!\'_HL4 ;=%%% !1110 4444 %%%% !1110 4444 %%%% &-X
MN_Y$O7?^P=<?^BVKC[H6EQI/C>T:$W%W<7S&SAB7,K2?9H51DQR,./O=%*DY
M&#78>+O^1+UW_L'7'_HMJUT^XOT% '%^'F>PU36H/$TB&^N3"(Y)1\D\(@1=
MB9^]B3S<J.<MG'(JM-#<:3XGEU+1;9I?,:/3I[<<[5,*>1(P]$?*D^CMZ5W]
M% 'GV@K]DT/4=(MG#SW>KW$"M(^TNI.7<L 2"5#8;!^8BMKP3++;:?<Z#=8$
M^D3&W3#%@T& T1#$#.$(0GU0UT]% 'E=MY[RV'DM'<>7XIN9?LL,9$X1IY1Y
MF_)P@5MQ^4!EXSSS:\FZ/PY;2<,/$_VDG;C][]I\_<)O7;_%NZ;?RKTJB@#@
MDC:W\3QPP-#J6GW>H3>;9SQXN+*0JZO(I_BB/(^8=&&">!4JVDUS=>.8].5%
MO]ZFQ?@;)?L:(K*>V&R,_6NXHH X0B.YT_PC!I*&.ZM+B)IDQM>WA$9$RR?W
M<_=P>K$>F:JZ?9WFD6VGI8QO=:-J-U!(Z*=QLIQ*K,P_Z9M@Y'\+>S''HM%
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M !1110 4444 %8NN?\A7PY_V$6_])9ZVJQ=<_P"0KX<_["+?^DL] &U1110
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MR]:_Z&)__ ..C^R]:_Z&)_\ P#CH VZ*Q/[+UK_H8G_\ XZ/[+UK_H8G_P#
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MJH3^ ;- '545B?V7K7_0Q/\ ^ <=']EZU_T,3_\ @''0!MT5B?V7K7_0Q/\
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M_P!_(L<6;!1O9EW*!QW )'L#Z5*9+H7'DGQ8=WF^3N^Q)L\S^YNQMW?[.<T
M=317+))=26]W.GBPLEFQ2YQ9QYB(&2&&,C@@_3FI+I+^Q$#77BEH5N)%BC,E
MG&H+MT7)'!/8&@#I:*YJ9;^W>=9_%1B^SQB24R6<:JBG."21CG!_(TMK'J-Y
M))%#XGD\V, O&]BB.H.<$JP!P<'!Z'!]* .DHK$_LO6O^AB?_P  XZ/[+UK_
M *&)_P#P#CH VZ*Q/[+UK_H8G_\  ..C^R]:_P"AB?\ \ XZ -NBL3^R]:_Z
M&)__  #CH_LO6O\ H8G_ / ..@#;K%US_D*^'/\ L(M_Z2STG]EZU_T,3_\
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MWT9&5A[,*+35WN]8U33EME5K 1X<R<2%U+#C''3WH Y^WO+Z[UWP[J][IMY
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M?"R3+#JK/GR'U.X:WS_<W<X]B^\_C6]2*JH@1%"JHP !@ 4M !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8GBC_D&6O\
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ME@<>2RO.[R1L J'!.T(3G'\?'>NHHH **** "BBB@ HHHH *Q;K_ )';2_\
ML'7G_HRVK:K%NO\ D=M+_P"P=>?^C+:@#:HHHH **** "BBB@ HHHH ****
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M>.>.MHH JQB_\V(R-;^6=QE5020>-H4]^^21S[5:HHH **** "BBB@ HHHH
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MZ*Q/[/U__H/0?^  _P#BZ/[/U_\ Z#T'_@ /_BZ -NBL3^S]?_Z#T'_@ /\
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M7@9<W@WH0S9(VLJ*%(P!\HV]<#0:#48M0\5-%I$UP-0,8MMS(J28@5#N).0
M<YXSCH#0!T,NJ6$%PMOO+S",2".")I"J'@$A0< X.,]<''2JL>L:*MRJPJ6G
MN[<70\FT=FDC./F.U>>HZ^M8/AG0K_PE+=6UP)KR">TM4CNH/F97BA6)E(Z@
M$KN!Z?,<X[UK32M;>ZTN;58[_P"T#0S;W<]J\887#,I(X('8]..* .JN+[1=
M(LX=1F\FV@F9$2;R2.7("Y('RY) YQ[U++>:7INIVUJQBAO=19O*1(_FF*C+
M$X'8<Y-5->LO[<T**SNK&1H[IXQ<09!*(?O9.<<#TS[5SUEH^N)JWAV\U2%K
MBYLY989IXR"!"L4D:.>?O.S;B!TW 'I0!UZOILFLR0J+=M2BB65QM'F*C%@I
MSUP=K#\*;?W^F:;,LUXT<<I1G#^668(N-S$@9"C(R3P,CUKFCIVK0:UIGB&.
MV+S33O'>6RH%D2"0#&YM^UMACBZ#G#8Z\V_$>E7L^IS7=K ;@3Z3<6*H"!MD
M8J5SG^$X.3VP* -2;5M'N=331[AEDN),A$E@8QN0-Q57(V,P R5!SQTXJ'4C
MH.MZ)>6]] MY8Q2&"6(0.S!UQPJJ-VX9&"O/I5*TBN5U+3+&XTF]D@TQ0L-W
M^[\MI/+*&4_/NZ%E V]6/L:FTQ+FP@UAIK.[_P!(U&1X_)"E]C!0''/3@^_M
M0!9@U_2+?2K>X_M!I;9X3*DKJS$1K@%GP,J!D EL8[]ZU+FZBM+9KB4L8U'_
M "S1G8^F%4$D^P%<1-X4U$Z#';0W$ZZB]K<:?O8(5%O)(2C2\8+JNW.WECGU
MR.E2*_TRW='D^U6:(D4$5M;XFC'"[F9I"&P.>%'T- #V\2:4NE0:F+AWM9VV
MQF."1V8\Y&P*6!&#G(XQS1)XCTR+5$TYY9A<NXC ^S2E-Q&0-^W:#CWXKG)?
M#]PWAVVTZ:WOI-0B-PUC?12*CVQ+DQF1E89;!7=P0V#G)//2S6T]QJ]DSKNA
MM8GE+= TS#8,?13)G_>% $UEJUEJ+8M9O,/EK*/E*[D;.UAD<J<'D<5=KD/!
M>BWNCRR^=&R02VT6Z*3!^SR@MNBB.3^Y&<J.@SP3D@=?0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNH[F"!(HUMV*SD(P90Q&W'(!)('-9G_",:I>>$M/\/3S[+C2].B(N'B=U^U
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *Q/%'_(,M?^PE9?\ I3'6W6!XPB,VBPQ"5XB^H6:[XR R_P"D
M1\C.>: -^BL3_A'YO^@_K'_?V/\ ^(H_X1^;_H/ZQ_W]C_\ B* -NL36_P#D
M,^&_^P@__I+/1_PC\W_0?UC_ +^Q_P#Q%87B+3/[/N]%N)]=U<Q)=R,[;E9D
M MIV)4!,YP,=#P30!W%%<A<&SM;>&>7Q)K6R6W-T,,A*PJ 6=ALX W+GZU9N
M+*"TN[*UF\3ZJLU\[);KYL?[PJI8X^3T% '345B?\(_-_P!!_6/^_L?_ ,16
M99"SO[2^N8?$VL".PEDANM[HIB>/E@08^PY]QTH ZZBN-MI+2]MK&:T\0:[.
M;Z#[3;Q(4WM%Q\Y!3Y1R.N.N.M(9[+_0O+\1:[*;R22*%8PI.] 2ZL/+RI&U
ML@XZ&@#LZ*YG3K*'589);/Q)K#B*0Q2*S*C1N.JLK1@@\CJ.A![TVYLTMKP6
M8U[7)KHQ^:886C9@F<;C\F ,\#/7!QG!H ZBBN,$UG))9)!XBUV<WL<DD'E;
M3N"$!\_)P06 (.#GCL:MSVD-MIL=_/XBUJ*&79L#%0Y+X"KM\O.XD@8QG- '
M445R,BV]N)1=:_KUN\?E@I)MRQD)5 N$.XD@C R?6HKJ:SL;>\EN_$.NPFR1
M9;F-MA>.-LX? 0Y7@\C/0^AH [.BN4FMXHO)V^(-<F6>$S1- R2!TRHR,)SR
MZ_G]:H-J-@EC>7KZ]XB6VLQ*9Y#&,)Y1PX_U?4'MWP<9Q0!W5%<M8VL.HW-U
M;0^(=;%Q:E1/#(51DW#*G!CY! ."..#Z&EM;:UO+6ZN8/%.J-#:RR13N9HP(
MV0_,"2G&/Y4 =117'9A\J"7^V?$?EW',#",'S>,\#R\CCH#@FET\V^I22I!K
MWB!1$TB.\BJBJT9PRDF/&0?Y'TH ["BN-:6T6&:;_A(->:&V56N9%V$6^5#8
M?Y.H4@D#. <G J.\N].L+BXBN?$NN*MO%%-+*-K1I'(2$8L(R,$JW/;&3@4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !6)XH_Y!EK_V$K+_ -*8ZVZQ/%'_ "#+7_L)67_I
M3'0!MU5.I6 DN$-[;;[<;IU\U<Q#U;GC\:M5POBA?^)LVM6-O)+%8!8-5A13
MF\A+ [%7'SE,EN.N63G+  '<)(DL:R1NKHPRK*<@CU!KFO&,,EQ_9$$*%Y9+
MB=$4$#)-G< =>*Z2*5)X4EC.4<!E.,<5R?C[4Y]%@T;4H(%F-K?/*Z-G_5BV
MGWGCJ0NXX[XQ0!#=^']2:TB:& --+H3Z8\;.H\J0@;6//*_>SC)X& :35O#>
MI7>FS-;&5;S3EA&F*QCQ(T.&#$YRN]LJW(^4"K\/B>6?4]7TZ-;<W%I-;K;X
MR1+', 0Y^GSYQG[A/L'6'BDWFHV<)B00WD]W;1 $[T>!F!W#T8*Q[8X'.<T
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M0S?VA9[/,)VY^T1XSCM0!O45B[O$_P#SSTC_ +[D_P *-WB?_GGI'_?<G^%
M&U6%X@B2;5/#T4JAXWOI%93T(-K/D4_=XG_YYZ1_WW)_A6/K+>(AJOA\R)I0
M87S[,/)C/V:;KQTQG\<4 7M)\&6&D7&DSQ33/)IMJ]LK.V3+N((9O4CY\?[Y
MJ_%H-JFO-K#I$;K8T<92((%#8W$]V8[5&3V& !DYKM<>(D5&8Z*H<@(3+(-Q
M/0#CFFB[U]IO*#Z&90<;!-)G\L4 #>&B_A/4=":\XO3<[IA%]T3N[M@9[;R!
MSZ4[4](ODO)=9T:2V75FM1;NERK>3,JL67.#E2"S8(SPQR#QAY?Q, 24T< =
M29)/\*BBNM?G)$+Z)(1UV32''Y"@" ^%TNO!MYHNZ2V>_P#,>YED"NYDD8L[
M?*<=2<>@Q6EJ^G7VH16\=OJ$=L$;=*&M_,$I'3C<, 'G'/:H-_B;=MV:/D\X
M\R3_  J$W^N!RAFT$.#@J9WSGTZ4 +)X6CGN&DGNFD6>6VN+I?+ \Z:'!5N/
MN@E$R,?PCIS4VCZ%+HENMA:WH_LV-RT,)B_>1J6+; ^<;03@?+G'&>]0+?ZX
MS[%FT(M_=$[Y_E3HKO7YR1"^B2$=0DTAQ^0H =I7AF'2I[:2.8NME;26MFI7
M BC=E8@\_-]Q!GCA?<FH[7PQ]CT_2(8KS_2M+1DAG,7#*RE2"N?H>O51VXJ9
MG\2J,LNC@$XYDDZ_E4(OM=*NPET(A#M8^>_RGT/'% $$'@BPM8$M+>5ULB+7
MSHF&3(;<@H=W8G:N[CD#MS745SPO]<*%Q-H)52 6\]\#/X4^.Y\03*6B;1)%
M'4K+(0/TH WJ*YTZAK84,9]!P> ?/?G]*#J&M@ F?00#R"9WY_2@#HJ*P4N/
M$,K%8SHKD '"RR'@]#TIRS>(VD:-?[&+K]Y1+)D?48H W**P_-\2#=D:-\O+
M?O)./KQ21W'B&54:,Z*ZN-RE99"&'J..: -VBL7=XF_YYZ1_WW)_A41O-?$
MG,FA^2>DGG2;?3KC% &_16+N\3_\\](_[[D_PI _B8D@)HY(X/[R3C]* -NB
ML7=XG_YYZ1_WW)_A1N\3_P#//2/^^Y/\* -JBL!;O7WB>57T,QH2&<3287'7
M)QQ2M=>($$99M$7S2!'F60;S[<<T ;U%87G>(_-\K_B3>9MW;/-DSCUQCI3]
MWB?_ )YZ1_WW)_A0!M45B[O$_P#SSTC_ +[D_P *-WB?_GGI'_?<G^% &U16
M+N\3_P#//2/^^Y/\*-WB?_GGI'_?<G^% &U16+N\3_\ //2/^^Y/\*-WB?\
MYYZ1_P!]R?X4 ;58MU_R.VE_]@Z\_P#1EM1N\3_\\](_[[D_PJE"=3/C;3_[
M26T'_$NN_+^S,Q_Y:6V<[A]* .GHHHH **** "BBB@ HHHH **** "L71?\
MD,>(_P#L()_Z2P5M5BZ+_P ACQ'_ -A!/_26"@#:HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD62=M0CDE8'(9C;0[B/]G=N ],8[5V%% '*6+V$&M>+&NVMX[8SP-*9<!/\
M4H,MVZ\<UEQ)<Z;X8W01P+-%KT9MI;52L<Z2W";RJDG:"LDBD9(X)KOZBDMX
MII8I)$W-$2R9Z XQG'K@G\S0!C^,HKF;PEJ,=JKLY0;E099H]PW@#OE-PQ7.
M213C6=0U>!X9=-@O]\-JV2MUNM41_+P#EMV0  <G>.^:] HH Y;1)M1\/>&;
M&#5[4"&SL%-Q<^>&VL%^X%ZG'W0<\UG:2]_HWB.ZM;QU1M;MFO(C'-Y@6Z0
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M34O^AIU7_OS:_P#QFMNB@#$_L34O^AIU7_OS:_\ QFC^Q-2_Z&G5?^_-K_\
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M34O^AIU7_OS:_P#QFC^Q-2_Z&G5?^_-K_P#&:VZ* ,3^Q-2_Z&G5?^_-K_\
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MG4O-:>P-M&%1XI/,W+*K#/' ((QZ8Z8)[ $/_"1'_H#:O_X#?_7H_P"$B/\
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MXP 0P&Y1D'N<#BN>EUB\O[/3!']HAM)='NKY@E\RS;XVBQ^\V\_>(YX.XY'
MH VKV^M=0FM9;G0];9[63S8=J,@5\$9(5P#P2.<]34.IMIVL7-G<WWA_6I)K
M*3S;=U1XS&W3(VN.W%/A\6XBW1V$TEI:J@O)C+EH<P++NY'S##J.N<GI3M#U
M.\U#Q1>-,#%;2:79W,,(F+A2[S9/08)"J#C(X'- $3MILD.HPR^'=8EBU'/V
MJ.6-G63*A>A<@?*H'&.@HN'TZZU:TU27P_K1O+162"14=1&K8# *'QS@9X[5
M!8ZS>-K\ZRY>YEOI[2VA^TLL.Q(U8EAM.",<$ D[SV%7M$\53:[J"06^FB.
M6T5Q-))/ADWF9=H4+R0\)'4 @Y]J ,^&STFVDNY+?0_$<+7<IFG,4\Z>8Y&"
MQQ+UP /P%6K>6PM;BUG@T#6T>T@^S0@(^U(_E^7;OP?NKR1G@5++XJGBU"]M
MSIR>7;WJV*2"X),DK1QR+\NS@;7/.3RN,'.1+:>(KR\F^SKI)CNH5B>[A>X4
M&)7D=,J<88 1LW.TXP.N0 "-K^T;4'O_ /A']66[>'R&F6WVL8\YQD-V/3TR
M:RH-*T"WL!8)X:UQK$,6^RR-+)"23N.4:0J<DDX(ZFK<_BN6ZT=KY=-F6PD2
M&6&X2YV%PTJK@\9! (.!D'D9'>*^\;7MK#/(-)C$>^\@AE-R6S-;K(V&7;PK
M+&W.<Y&,=Z +TU[:3W5I</H6M"2TSY&R-D5,C'W0P!XXY%5;R/2+_3;S3I_#
M.J_9+V4S7,<<+1^:YQDL58$YP*V)M9>TTW3))XD:ZOI(X$0/A-[*6Y;' PI/
M3VK%;6;O7=4TZPC62SBD-Y'<^5<%762%U3*L%Y'.1G@Y&0,8H +F#2KNZLKJ
M;0?$!N+)&2VE5Y5:,,,-@B3N ,_2E:/3'@N(7T+Q ZW+(TK.\K.VW[HW&3=@
M>F<5=@N;C5_%>M:?-/-!;Z?' (5A<H6:12QD)'7IM Z?*<@]L32=9UC7QH<$
MS[!/9WLDDD4QA:22">.-'X4\$'..AWGC@9 -N\U"TO[>*"[\/ZK-'%(DJ![;
M)5T8,K9W9R"!S4.KS6&NQ0Q:CH&M2I#*LT85'3#J<JWRN,D'D5G>'?$5\VFV
M4IMI[^^NK&TO;I/M!VHLI8;T!7 ^ZY*Y ^48ZUTN@ZM=:Q#//-91V\*3RP1E
M9_,+M'*\;9&T8&4!')SGMCD S+^YLM3^S?:M"UMFMFWPNB,CHV,9#*X.<$CK
MW-+I]W9Z8\\EMH6M>;<,&FEEB:220@8&69B< =!T':NHHH Y:^N;+4+F&ZGT
M'61<P@K'/%$T<BJ>J[E8':<#CIP*2":PMK6YMX= UI5NB3/)Y;&24XQEI-^X
MG''7@<5U5% ',:3=V>AZ;#IVG:!K,-I",1QF)GVCT!9B<>U&I7EGJT<*7F@Z
MRX@E$T12)HV1P" P96!!PQ[]ZZ>B@#E;.>PL9+B2/0-9DEN5"S2SQ-*[J,X4
MEV)VC)XZ<GU-4)/[!L+>W6;0=:6TCFC6&WD$C0*Y8! (RY7[Q&!C .,8KN:Q
M/%'_ "#+7_L)67_I3'0!E:A'IFJ:G!J5UH.O_;($9(I8FEB**V-P&R08S@9]
M<5#/9:+=:;=Z?<^'M>GMKQ@UP)6E=I,8P"QDW8&!QG%=M10!R6H'3=4@MHKO
MP_K4AM6W03!'66(XQE9 X<'UYY[TX2V0LY[5M$UZ1+A/+E>3S&D9?3>7W <G
M@'N:ZNB@#E;2>QL=%72+;0=;CL4C\I8PCY5,8VAM^X#'O4=L=-L]!_L.W\/Z
MW'IWEF(1*KY"'^$-OW ?0UUU% '*W4]A?:(VC7.@:S)8/'Y31&-OF3T+;]Q_
M.F3G3;K0?[#GT#6Y-.,?E&)E?)3IM+;]Q'XUUM% '*74MA>Z(VC7.@:W)8-'
MY31%'RR8QM+;]Q&/>DF?3KBPMK*7P]K+16I!MV,;>9$0, K)OW XXR#TXKK*
M* .5M+BRLKB6YBT+6VN94$;SRQM))M'10S,2!GG P,\U+87]MIMLUO:Z'K0B
M9WD*R1M)EF)9CEF)Y))_&NEHH XXQ:1]FL[=/#>L0QV18VP@C:(P[NNTJX(]
M/IQTJUI]Y9Z7Y[6NA:R))W#S2R1-(\A P-S,Q)P!@#.!VKIZ* ,7_A(C_P!
M;5__  &_^O44/BN&>6>.+2M69[>01R@6WW6*JV#S_=93^-;]8FA_\A?Q+_V$
MD_\ 22WH 7_A(C_T!M7_ / ;_P"O1_PD1_Z VK_^ W_UZVJ* ,7_ (2(_P#0
M&U?_ ,!O_KT?\)$?^@-J_P#X#?\ UZVJ* ,7_A(C_P! ;5__  &_^O1_PD1_
MZ VK_P#@-_\ 7K:HH Q?^$B/_0&U?_P&_P#KT?\ "1'_ * VK_\ @-_]>MJB
M@#%_X2(_] ;5_P#P&_\ KT?\)$?^@-J__@-_]>MJB@#%_P"$B/\ T!M7_P#
M;_Z]'_"1'_H#:O\ ^ W_ ->MJB@#%_X2(_\ 0&U?_P !O_KT?\)$?^@-J_\
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MMI?_ &#KS_T9;5M5BW7_ ".VE_\ 8.O/_1EM0!M4444 %%%% !1110 4444
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M_P"$HL_^?+6/_!7<?_$4 ;=%8G_"46?_ #Y:Q_X*[C_XBC_A*+/_ )\M8_\
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M^6L?^"NX_P#B* -NBL3_ (2BS_Y\M8_\%=Q_\11_PE%G_P ^6L?^"NX_^(H
MVZ*Q/^$HL_\ GRUC_P %=Q_\11_PE%G_ ,^6L?\ @KN/_B* -NBL3_A*+/\
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M:"0N98IB3/)R\0PA^]VQ^/?-0Q^$M%BAEA2VD$,DJS>7]IEVHRN)!L&["#>
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MU@Z_TYNKX<T6S1)/)V)&D2$O.Y5EC.8]^6PVT]"V:M:CHFGZK(KWD+.RPR0
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MJI GDV-M7:K%-VTL% &XC.!UH R-<UFXL_$,L<LKQ6-I;07"^1( \DCS% K
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M\Q5<L-Q#?,0Q8Y.3DGGDU*WAK2C.TX@D68RO,95GD#;G4*W(;(!"KD=. <9
MH P9O%QUBWTVYT8R+:-?V<<TC$*Q$JI)LVD'C9(F>1R?8UL:1XB_MJ$R6MJ"
M4E6.:,R@209&2)%(!5AQ\O?/!(IQ\*:+]I6=+1HF5HF"Q3/&FZ( 1DHI"D@
M#..@ Z"IK31=,B DM1(2K)F07+L3Y>0JLV[) R1M.1US0!J444U)$E4M&ZN
M2I*G/(."/P(Q0 ZBBFB1#(8PZ^8 &*YY /?'X4 .HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *Q=<_Y"OAS_ +"+?^DL];58NN?\
MA7PY_P!A%O\ TEGH VJ*** "BBB@ HHHH **** "BBB@ K%T7_D,>(_^P@G_
M *2P5M5BZ+_R&/$?_803_P!)8* -JN-NM5FL[SQ+=3SF VUU:6T$A0,$A=8B
M3R< %I) 6/ QD@[<5V51?9XA=&Y"XF*!&8?Q*"2 ?7&3CTR?4T <99:O>7J>
M'+MI%>[?5;JQG*#[\*B?KP/^>4;9P.1T&<50\6)'+XHUZ/[1IT3OH,2#[9'O
MW-YD_ Y!SR.QZCCU]!>"'[0MTX&^-"JLQ^Z#U^G0?E1:W,=Y;1W$))BD&Y&(
MQN4]#]#UH Y*QO\ 6(SHUJ5NXHM2L8#$)T5I+61 #*LC8Y8H>"?XE;U%7M>U
MF6SUFWT\WPT])[=G@G:$2":8,H\O!ZG!^Z"&.>#Q6G:1VD]Y/J<+3R7 !A:-
MY21$1C*A"=JDX&2.O!SCFJ^F^*--U,V/E&:/[?&9;0RQE1,H&3@]CCG!P<9X
MX- '-WGB?5UMKB:&54N(S?I/:M&I-JL0<PR=,_-MCZY#>:",4#Q!JD5Z0=56
M2-+JP788HP&6? <9 SA>6&.?4D5WU!Y'7% 'E6HZSJFI>$]1^T7T5[;W&D7K
M3H(E7[/+&X6/D=V!;@]UR.XK6U3Q!J=T-=@M-06VN;2"Z M$7=*5$9,4J?+P
M#@'=D@[L<&NTTW3H-*L([.VW^3'G;O;)Y))Y^I-6Z . GUVZANY4M-1B93_9
M:K.8XV9EEE=),D#GY>1Z9SWJM=>+]1M]/CC;5;.&9OM\45Q</%&))(;@)&7W
M87:4Y.WGG(%>D$@ DG %9DNFV>ISPZBEQ< M$%5[>X9%DC/S#(!P>N<]>>M
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MYU9L;AV13T/W>G/-+Q9J%Y;S^*9+6]N(UMO#@NH/+E8*DN9_G&#C/R+^7UH
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M;IO+.[*YW<@@#);IUJ6;QW=)I[7<>E1,L5G<W<P>X*D""7RW4#9U/49Q[XH
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M-V[5&!O6(-W4.3QUK/AGUNST.Z2RGU.(P6=_<0I]FP9)Q=.8\@IDE@>G<=*
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M/>;B)W5PRJ/O-'&67 ZL*S-5O=1ETBZM'NM0N;"[L+QK>=+)XV:7"[(B""V
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M)(!W4_A[2;F-4GL8I0&9LOEF)9=IR3R<@ <]@/04^+1-,@F6:&RBC=0H&P8
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MA.15RB@"C::-IMC?7%[:V4,-S<DM-(BX+D\D_B0"?7O2?V+IWGB?[,HE$YN
MX8@B4KL+]>NTE<^G%7Z* ,B/POH<3Q.FEVP:'8(SM^[LSMQ],G'MQTI!X4T
M1RQ_V3:F.5&C="F1L8[BH'89YP.];%% %--*L(],.FK:1?8F0HT!7*LIZ@@]
M<Y.:JW6AQS0I:Q-%'9/)ONXGB\QKC&, L3Q]T D@\<<<&M:B@""\LK;4+<V]
MW DT)96V.,C*D,I^H(!_"J/_  C6B[KT_P!FVX-\"+G"X\T'KGZXY]>]:M%
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M[D<9J+2O"MK8;7G$4LB2++&(E=(XW4,-RJSMAL,03GD<5OT4 9!\+Z&6D/\
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M"]'32X]6N+>'[-9:A?-<VMJ%VB--JKD+_#N*E\=@PZ'- %W^P;O_ *&36/\
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M+]330-3US3A9BULKXV:PS1,S2[91$[;@PV_,3@8/ Z\\ &K_ ,(DW]I#4/\
MA(=9^U"+R=^^'[F<XQY>.OM3_P"S&^V_8_\ A+-3^U&/S?)WV^_9G&[;Y6<9
MXS61J_B_5-/M?&DD<=FSZ$D<EONC;$@:(2$-\W7G&1CZ5=NM9O8_&,MA'#98
M&BM>1S-&3(&$@&TG/*]\#% &A_8-W_T,FL?^0/\ XU5>^\)MJ-HUK=^(-8DB
M8JQ&Z%2"""""(L@@@$$<@BL73?%FO3:'H=_=Q6#2:ZL M(K>-LQ,8GED+;G
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M&GER,<LP(''    '3%;]% &/KWARU\1>'GT6\GN$MWV9DA*J_P I# @[< Y
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MECX>UJ'P)\.K.31[\7.FZV+B\C^SN3#&)F8L>.F&!_\ U5Z]_9.K?]#)=_\
M@-!_\11_9.K?]#)=_P#@-!_\10!YSHGAV]7Q3K6EZ[INL2H^O?VO8W4  MV.
M1M9I,?*5 ^[GV ]?8*Q?[)U;_H9+O_P&@_\ B*/[)U;_ *&2[_\  :#_ .(H
M VJ*Q?[)U;_H9+O_ ,!H/_B*/[)U;_H9+O\ \!H/_B* -JBL7^R=6_Z&2[_\
M!H/_ (BC^R=6_P"ADN__  &@_P#B* -JBL7^R=6_Z&2[_P# :#_XB@Z5JHZ^
M);H?]NT'_P 10!M45B-I>J)C=XFNER<#-O ,G_OBE_LG5O\ H9+O_P !H/\
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M_P"O>#_XB@#;HK$_LK5#T\377_@/!_\ $4G]FZEO*?\ "3W.X=5^SP9'_CE
M&Y16(=+U0.$/B:Z#$$@?9X,G'7^#WI!INI&0QCQ/<EQR5%O!D?ALH W**Q/[
M*U4''_"2W6?^O>#_ .(I3I.JCKXENQ_V[0?_ !% &U16*-*U4]/$MT?^W:#_
M .(I#I6J#KXENO\ P'@_^(H VZ*Q/[*U3&?^$FNO_ >#_P"(I?[)U4]/$MW_
M . T'_Q% &U16&=-U(/L/B>YW 9V_9X,X]?N4[^R=6_Z&2[_ / :#_XB@#:H
MK%_LG5O^ADN__ :#_P"(H_LG5O\ H9+O_P !H/\ XB@#:HK%_LG5O^ADN_\
MP&@_^(H_LG5O^ADN_P#P&@_^(H VJ*Q?[)U;_H9+O_P&@_\ B*/[)U;_ *&2
M[_\  :#_ .(H VJ*Q?[)U;_H9+O_ ,!H/_B*/[)U;_H9+O\ \!H/_B* -JBL
M7^R=6_Z&2[_\!H/_ (BC^R=6_P"ADN__  &@_P#B* -JBL7^R=6_Z&2[_P#
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M3QK,HL-0:4S1O"K/&LA)98V[#D_>#=:VHK1;73H[*SQ"D,0BBR-P10,#C//
MH X7X::!I.H?#;PY+>:?;7!BAD*K+$K+N9SEL$=>,9^M-^%N@:3/X%T74'TZ
MV^UQO<_OA$N]@9)4()QDC!Z'T'I75^&O#_\ PC/AJVT6WNVF2V4K%++&-V"2
M>0" >OM2>&O#Q\,>'(M'M[QIDA+F*66,;AN8L<@$ \L?2@#@?A_964_@#1XY
M?"_VCS;AXVOO+AP@\]\/G=OXX XX(';FK?B _P#"-?$?_A*HL1V:BWLM4"C
M\J8L%E/NKA,GK@FNDTCPA=:+X=CT.SUVX2U3> X@3S0&8LV&['+'G'%7KOPU
M#J']K17LHEM-2MQ;20>6!L4!@,'/7YC^.,8H X[Q&?[6^)/A6XD^>Q@U&>TA
MC;E7=8',CX[X8*H]#&?6O2+JYALK2:ZN'"0PQM)(Y_A4#)/Y"N>D\&P"3P]]
MFNW@CT,EH$*!O,8H4)<GDY!)XQR2:UM9TV35;-+9;HP()4D?"!O,"L&V'/\
M"<8/J,B@#A/">LM:^.YK:YU".X7Q#;_;D19 WV>X08:'CTBV?7RS4>KZ?87'
MQ/UR.?0QJ1DT.%EBCB0L7,DHR"Q&TG ^;/&!S79^(_#@\0'37%X]I-I]VMW%
M+$@+;@",<_PD$@CO1;^'FA\77'B!KTO+/:I:O#Y8"A%8L"#G.<L: //3HUU8
MWOPWL_$MLFIZA'%>)=!D68OB+*J2?O;1CGU&:AUC0KRP^'.J)J=KY-M+KT,N
MG6<S+(UK;M<1 )P2%!^;Y0< '%>DZGX>.I>(M(UC[8T3Z693%$(P5?S%VMN.
M<].F,?C2^*?#P\3Z1_9KWCVL9ECE+QH&;*.'7&>.JCM0!KB&(0^2(T$6-NS:
M-N/3%>*RV=LG[/FM,MM$&%W<$$(,Y%V0/R''TKU:+2]0%Y'<7.L23K$K;(?(
M5$WD8#-CDX!/&<<_2L-OA^C>"+OPLVJ3?9;F5Y6F\I?,&Z3S& [?>]NE %ZQ
MLK0ZY"T?AG^S'BA=TNO+A4DG"E?W;-Q@YP<=!C...*TIH=!NM+T'Q?I MKU+
MQ#8Z_ F^*\DW[AO?[RN_0ANO7TKT5=,OWNH);G5GDBA)8PI"J"0X(&X\D@9S
MCU K,_X1"2;3+#2;_5I;S3K-XI LD*B64Q$% [C@@%0>%!..2><@%;XE:G=Z
M=X9@BLYGMWO[^WLGGC.&BCD?#,#V.,C/;-5/B#I]IX?\"W6K:/;PV-]I2I/:
MS0H%(PPRI(^\K#((/7-=;K.CV6OZ3/IFH1F2VG # '!4@Y# ]B" 0?45G7/A
MJ75+>"SUC4FO;&)T<P^2$-P5(*^:0<,,@'"A02.>.* .1U.VU+2O%5UXKT*V
M8M%9VSZEI<:@?:HF\PLP'_/5< CUP1WJS=S:/K?AOQEJVGI;3V]WIGF+,L8R
MW[ECS[@^O((KM;?3I(-9O-0:YWBYCCC\KR\! F[&#G_:.?PZ5DKX)T^VL=?M
M-/8VD6MEC.JJ"(RR;6*#MGKZ9)^E %GP5#%#X'T)8HT13I\#$*H&28UR?K7*
MZA;?\(!XS_M/3+".6Q\1,MJ\" +Y5[@^60>R/R&]",UTMAX;O;*PT_3_ .W)
MWL[-8D$8@13(D>,*S =#@9QC/XU/XA\/?V^VFDWC6XL+V.]0*@;>Z9P#G^'D
MYQS[T 3Z%H=KH5@88(HA-*[37,L<83S96)+-@=LDX'88%<;XV\/:/;:CX69-
M-M2]UXB5KAVA4M+O29F#'&2,]CZ#TKT89P,]:Q-?\/'7;G2IC>-!_9MVMY&J
MQAM[J&4!L]L,>!^= ',:W9VUIXT\,^%[6W2VT?4)+J]NK:-0L<S1HI"8'&W)
MW%>A[U/XK"^'/$OA6_TJ%+=[W4ETZZBA4*LT3JQRP'4H5!![<]B:Z;6M!M]9
M-G,\DD%[8R^=:W46-\38P>N05()!!ZC\#42Z ;C5[75-4NA=W%F&^RHD7EQ1
M,PPSA<DEB.,D\ G &30!E_$70X_$/AZ'3RWE32W4:PSC[T3D\,#U'.*Q9O$5
MQXF^'7V1B8-4FAG@U)%.&@,"D3_3)VJ/3S0>U=SJFG2:B+4)<^1Y$ZS_ .KW
M;BO0=>E9I\(6$=SKUU:$P7.M(%N),;@OR;25'8D<GU.,YH X71I/M$'PU\.N
M@33+O2C>740&%N72%"JMZC+;B#UP,UT'B<+X=\5^%;S2H4@-_??V?=PQ*%6>
M-D)!8#J4*Y!ZC)'0UJQ>#+:/1=%LA=RBYT556QO44"1 %V8(Y#!EX8=_8X-7
M$T SZQ;:KJ=T+NYM%9;5$B\N*$L,,P7))8CC))P,X R<@'*>#_#VC:A?>,DN
M]+LYA_;DJ O"N57RHC@'&1R2>.YS7,:C-+=?#7Q+I=[(U['HWB".RM;B<[W,
M0GBPI8\D@,5)]*]%L/"EUILFJM;:Y/%_:=TUW,4@3<CLJJ=A8$ 84=0:CO?
MEA-X2_X1RSGEM+5IEGEE_P!9++()!)N9FZDL 23].* ,37+2T7XM:8/[$74
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M5<7&F/;744B 2Q-OVO$_<$<CZ>QKJ%THQZQ;WL4RQPP6S6R6ZQ@*%)4]<_[
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MHH *Q=<_Y"OAS_L(M_Z2SUM5BZY_R%?#G_81;_TEGH VJ*** "BBB@ HHHH
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MXG8_$.*634XI].\0P,+2%90WV=X22@P#QYD9+<]^* .N^Q^)?^@UIG_@L?\
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M,T,%E/I&I0VK17FB7*%  64^8$^ZPXQN4<Y&>U '1_8_$O\ T&M,_P#!8_\
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M_P!H1(ERSK.CEBVP%?E 8%<#H2,#D4 :_P!C\2_]!K3/_!8__P ?H^Q^)?\
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M?\3N[11(#N1%?Y4YY  [=J;';0R_&*_@DC5X3H<4AC;E=[3.I;'3)  SUXH
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M)%XQD-SQT- '6?8_$O\ T&M,_P#!8_\ \?H^Q^)?^@UIG_@L?_X_46BPV/\
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M2JE20#C@@XQD'&0!(O#LVFZQJ&H:/=Q6ZZBPEN;>>$R(90,>8N&4J2 ,CD'
MZ<YJS>#!)H&O60OA]OUQ76]OGAW9W)L 5 PP%7A1DX[Y.:FTCQA;ZAXGU+PY
M=0&SU2R(8(7W+/&55MR-@9QN&1C(R*F76]3F>:.WTB.62.\-L?\ 2L* $W%R
M=G Y Q@G)H IOX/F1]$O+34DM]5TR$6S7(MR4N8,8,;IOZ9 (^;@].M.MO#>
MJV7B/6-9M]6LP^IK"K1R6+,(_*4J,$2C.=QS3=$\5ZAK<1GBT15MTO);.1Q=
M[F1D8J6V[.5W#KUP<XJ@WQ$:WT6]UN\T=H],L;Y[*YDBN [QE9/++["HRN['
M0YQVH N2^!HSX:UO38K]S?:V'^VZA/$'=RR[>%!4  <*.@]ZT;72M9@@L;9]
M7M?L]ML#B&R9'D"C@;C*0 2!GCD9'&:U+R]AL=/GO9VQ!#&TKD#/R@9X]:I^
M'=<M_$GAZRU>V5DCN8]QC;K&W1E/N&!'X4 8,7@%)-)US3[^_$RZG?OJ$<L,
M!B>UF.W:R'<>5*@@\=ZZ;38+ZWTZ.&_O(KNZ1=K3I!Y0?CJ5W'GUP<?2LO3O
M$=QKD4MWHUA'<:>DC1I<37'E^>5)#&,!6RN00"2N2/3FJ.H>,;ZQT&ZUDZ!(
M+2TMC/.)K@(ZD%@R !2"PV\\XYZT .T_PC?:?IVKVT>LJ)M0U)M129+7:87+
MJY7!<[A\N.W6KB>'KBY\26.M:G=6\LUA%+';K;VYBYDP&+$NQ/ X';)Z]K>E
M:E?WLF+O35MHWA66*5)_,5L]5/RC!''Y^U17.O\ _$];1-.MUN[^.$3S[Y/+
MC@0G"[F )W-@X !Z$G% $7B3P]/KTVD/%?1VPTZ^2] : R>8RA@%^\,##&BY
MT;5Y#J<<6J6IMKXG]U<69D\D% A PX!!P3@CJ32VWB7S[G4M.EM1#J]A$)GM
MFERDD9SM='QRIP1]T$$8(Z5DV/Q $UAH&HWNEO;6.N2I!;3),)"DCYV+(N!C
M.",C/OB@#1L?#=WHD5E!H^HI':VME'9B"ZA,H?9G#Y#*0W/T]NF*;> K=_#M
MSIYO#'>3ZC_:GVJ*(*([G>'#*F3\HV@8).1GG)S5RX\27B>+G\/6VF133+9"
M]$KW6Q2A<IC&PG=D?3WIMKXOCNH]7@^PRV^JZ4GF3V-PX4E<$AE9<AE(!P?7
M@@4 7(M,U*XO;2XU6^MI5M&,D<=M;-$&D*E=S%G;C#-@#')SDXJC:>&]4L/$
M>M:O;:K9YU1H2T4EBS"/RTV#!$HSD=:DTCQ#J6KZ1IFJQZ1$+.^6*0!;LM(B
M28Y*[ . <G![&JD_C*\BO_$%O'HOG+H:H]P4NAND5H_,&P%0"=O8D<T /O\
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MW8@9RLHA\LG<[/R-Q[M3?&7BJV\&^'9M6N()+C8P5((SAI#U.#VP Q/L#6W
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MD_0=ZVZ $90ZE6&5(P1ZUR&B:%>67A!/#4=V]I<Z?,H@N?+WAXDE#H<9&<J
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M>:%X2_G;>5&=PQAL-T/*BJ&K>&IK[Q+H^MV5[%9S:>)$=3;[_/C< %"0PP.
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M<+%$T>T*"T4C9=LX(*EN,!N:[#9XH_Y[Z/\ ]^9?_BJ-GBC_ )[Z/_WYE_\
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M7&H:0I!6: REA( ,%BO#A22K 'CI7J6SQ1_SWT?_ +\R_P#Q5&SQ1_SWT?\
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MJ5G=WMY903;[BR95N$VD;"R[EY(P<@YXKDI+F!?C6FZ:,8T!D.6'#>>IV_7
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MQ!! )!^N#6KJBZ/XCM=&TN:=7L[R&XMU+D*TB["@=1[D94_2M[9XH_Y[Z/\
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MM1,ZI'&[R*&V@CYF558GJ"V.U<O!KTMK\+&U$:GK@UQ;F:.WN9);AH=XN&5
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MA5R1D!5VKQ_=SWJCH_AS7-.\*:5HUQ=6=S)I\\16<EUW11ME5Q@\X 7/MG%
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M5I,D7B'4V5DM=4UB>[M%88W1'"A\=MVTD>V#WH\:R1IXL\#AG52=3DP"<?\
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MY##9QQ2G*AXD.!P<_,W>NXMKF2VNK72IH[NXE%KO>],6(F*X4AF[.<YQZ9H
MHVXU^SB\JVT+0X(\YV1:A(H_(6]&-?,WG?V%H?FYSO\ [0DW?G]GK?KS/2M>
MDO\ 4Y=(U+5[W2?%4=X6^S3MMAN(!+D+$"-K*8QC(^?.3F@#K2->,WG'0M#,
MN<[_ .T)-WY_9Z$&O1RF1-"T-9#U9=0D!_/[/4>K>-=)T:2?[293!;3)#<SI
ML*P,VW&X%@Q'S+DJ#C/L<%_XUTG3KGRYS(81=+:27*E"D<K$  C=NQD@$A2
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M5U)!'# X.1BNMM-4CO;VYMX()FCMVV-<_+Y3-W53G)(Z'C@Y'6@"G]I\3_\
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M+LN;)BDC!)$RKQL5.,<$&O)_#?B;6)M*\$W-KK,VI:CJ4X34[-RL@$!W;Y2
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M#9\P &,G:3Z4\^%-$52S6\H &23=2\?^/51CTKPQ+K<VCK'<?;H8%N'C,TX
M1B0"&)P>01P>U "6/@Y=*\=S:[83^5975O*+BR_A%PS1GS5';<$^;W -2OHF
MI'XCQ:^!:?8$TQK(J96\W<9%?=MV8Q\N.M6O^$2T;_GVE_\  J7_ .*H_P"$
M2T;_ )]I?_ J7_XJ@"A=Z-K(^(,?B"UBL)+5--:R\N6Y='+&0/NXC88XQUJM
MXET'7_$'ABZT]8],@FEO(IHT$[^6B)(DARWEY+,RMG@ 9'7G-^+0?#\U]=6B
MVUT);94:0M+.JX8$C#%L-T.<$X[U9'A/12,BWE(_Z^I?_BJ *46@ZEI7BF75
M-)^R"RU%=VHV4LK*!,, 31D*?F(X8$#. >M5="T7Q!HRZ\KV6DW*ZEJ,UXBM
M>R* KA0%;]R?[O/UK1?P[X?BNHK:2*59903&#<S /CD@'=@G'..N.>U3?\(E
MHW_/M+_X%2__ !5 &5>:)X@F\5:#K(&G3&PLYH9P]P\9>24)DJ!&V%!3C/.#
M5NQ\.W<_BT^)-8E@-Q%;FUL[6W)9($)RS%B 6=L 9P  ,<]:M?\ "):-_P ^
MTO\ X%2__%4?\(EHW_/M+_X%2_\ Q5 %7Q7HFI:Q>:!)8BUV:=J27LOGRLA8
M*CKM7"GGY\\XZ5=ATVXEU;5GOK>U>PO(HX@GF%RP 8,&4J!@[O4TS_A$M&_Y
M]I?_  *E_P#BJ/\ A$M&_P"?:7_P*E_^*H J>#_"K^$TU&T6[>XLI)P]FLA)
M:&(( (R3U"D$#VQ2^%M$U+2-1\03WPM?+U*_-W%Y$K.5!1%PP*CGY,\9ZU:_
MX1+1O^?:7_P*E_\ BJ/^$2T;_GVE_P# J7_XJ@#/T/0]2\*0WFGZ9#;7>G27
M$EQ:K+.8F@WG<T9PK94,201SSC'&3?\ "_A__A'[*Z\V83WM]=27MW*JX5I7
M/(4=E   ^E+_ ,(EHW_/M+_X%2__ !5'_"):-_S[2_\ @5+_ /%4 5=$T34K
M#QCXCU6Y%I]EU-K<PB*5F=?+CV'<"@'/7@TNL:+?GQ5IOB+3!!+-;6\MI/;S
MR&,21.5;*L <,&4<$8(/459_X1+1O^?:7_P*E_\ BJ/^$2T;_GVE_P# J7_X
MJ@!]E:ZBVH76IW<5O'.\*P0VZ2EE55+,2S[1R2PX XV]\UR.F> ]8TWPKHJP
MS6,/B/1Y)#!.DCM#-&\A9XI#M!VD'T." 175_P#"):-_S[2_^!4O_P 51_PB
M6C?\^TO_ (%2_P#Q5 $5Q#KD\MRESIVFWEA<0HK6LEPV%?G<,F/#*?E[ \'@
MYK"@\!WFG^%M M+*X@-_HU\;V)'9A"P8ONA#8+!0LA ;!^Z#CM71?\(EHW_/
MM+_X%2__ !5'_"):-_S[2_\ @5+_ /%4 +#;:G?:K;7E_;V]K%:*YCBCF,K/
M(PVY)V@  ;ACG.[MCFI;^&8[Y=1GU_3[&XNKN5ONR-(OE8VHF2H(^4<\=2Q[
MU:_X1+1O^?:7_P "I?\ XJC_ (1+1O\ GVE_\"I?_BJ ,31O#_B.P\%66AW1
MT^>>QNH##*+E\-!%,LB@GR_O!5"],<9JWX@\'#5->TS7+.86M];S0_:@#\MU
M LBOL;U*E05/X=^-#_A$M&_Y]I?_  *E_P#BJ/\ A$M&_P"?:7_P*E_^*H J
M^+-$U'6;G07L1:[-/U*.]E\^5D+*JLNU<*>?F[XZ5TO;FL3_ (1+1O\ GVE_
M\"I?_BJ/^$2T;_GVE_\  J7_ .*H J7^B:E<^/\ 2=;B%K]BL[6:!PTK"0F0
MJ<A=A'&WU[TZ^T"YA\7Q^)=+,3SO:_8[NVF8HLL8;<K*P!PRG/48(..,9JS_
M ,(EHW_/M+_X%2__ !5'_"):-_S[2_\ @5+_ /%4 5[70KFZ\6KXCU01)+;V
MQM;.VB<N(U8Y=V8@98X P!@ =3GBSJVEW&JZM8)/!:RZ3!NEE1Y&WM+C"?+M
MP5 +'D]=I[4G_"):-_S[2_\ @5+_ /%4?\(EHW_/M+_X%2__ !5 &;9^&+S2
M/'LNJZ5#90Z3>6B0WD/FLKM*A)615"$9 )7KS^%&D:1K7AN75+>RM[.]L[N]
MEO8'EN6B:,R'<R, C9 ;."#T/2M+_A$M&_Y]I?\ P*E_^*H_X1+1O^?:7_P*
ME_\ BJ +-A83Z;H@M4:.>YP[LS$HCR.Q9CT) W,?6LWP9HNH^&_ ]AH]T+62
M\LX3&#%*WEOR2#DJ".OH:L_\(EHW_/M+_P"!4O\ \51_PB6C?\^TO_@5+_\
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MKUP00?#FKD'_ &(?_CE<K>1WEOIR>'M&\&74.AW4;QWC22(7C5L A$+D'*Y
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M<H_M^X_Z%W6/^^8?_CE &W16)_;]Q_T+NL?]\P__ !RC^W[C_H7=8_[YA_\
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MRC^W[C_H7=8_[YA_^.4 ;=%8G]OW'_0NZQ_WS#_\<H_M^X_Z%W6/^^8?_CE
M&W16)_;]Q_T+NL?]\P__ !RC^W[C_H7=8_[YA_\ CE &W16)_;]Q_P!"[K'_
M 'S#_P#'*/[?N/\ H7=8_P"^8?\ XY0!MT5B?V_<?]"[K'_?,/\ \<H_M^X_
MZ%W6/^^8?_CE &W16)_;]Q_T+NL?]\P__'*/[?N/^A=UC_OF'_XY0!MT5B?V
M_<?]"[K'_?,/_P <H_M^X_Z%W6/^^8?_ (Y0!MT5B?V_<?\ 0NZQ_P!\P_\
MQRC^W[C_ *%W6/\ OF'_ ..4 ;=%8G]OW'_0NZQ_WS#_ /'*/[?N/^A=UC_O
MF'_XY0!MT5B?V_<?]"[K'_?,/_QRC^W[C_H7=8_[YA_^.4 ;=%8G]OW'_0NZ
MQ_WS#_\ '*/[?N/^A=UC_OF'_P".4 ;=%8G]OW'_ $+NL?\ ?,/_ ,<H_M^X
M_P"A=UC_ +YA_P#CE &W16)_;]Q_T+NL?]\P_P#QRC^W[C_H7=8_[YA_^.4
M;=%8G]OW'_0NZQ_WS#_\<H_M^X_Z%W6/^^8?_CE &W16)_;]Q_T+NL?]\P__
M !RC^W[C_H7=8_[YA_\ CE &W16)_;]Q_P!"[K'_ 'S#_P#'*/[?N/\ H7=8
M_P"^8?\ XY0!MUBZY_R%?#G_ &$6_P#26>D_M^X_Z%W6/^^8?_CE9][JDM[K
MGAV-])O[0"_=O,N!&%/^C3\?*Y.?P[4 =71110 4444 %%%% !1110 4444
M%8NB_P#(8\1_]A!/_26"MJO/M:UG4-$OKZ33Y(%:[\1VEE)YT1<!9((%+#!'
M(H ]!HK*L7OQJ<D,^H6EU$D(9TCA*.C$_*3\Q!! ;TZ>]:C E"%;:Q'!QG%
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M$5CA69@"%4GH6(!H TZ* <C(Z44 %%%% !1110 4444 %%%% !1110 4444
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MRO.2Q&XD]^E>FT4 <-X*AU6RT_3-#U3P^R7&D@Q?VE(8VB90"H>(Y+[F&,C
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M;WEQ!);R-C$@6%$8C!R.5/7%8FNZ3JS77CJ*#2YYTU?34CM98V3:SB%TVG+
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MT6-(YLCRYLKD[!DD!3QSC\:OT44 %%%% !1110 4444 %%%% !1110 4444
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M]D"@#533XI+/[8GBS4&M<9\];B$IC_>V8J"%-/N)4BA\;74DCG"HEY 2Q]
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MOPK 2'G!!QT'??\ B" ?ASXDR/\ F&7'_HLT 6%T&5T#KXBU=E89!$D6"/\
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M10!0N-+6T,(N?%.IPF>00Q"2:%?,<@D*N4Y)P>/:IO\ A'Y_^AAUC_OY%_\
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M5O,ASG+'(Z8Z'K0!LVFEKJ%JES9^*=3N+=\[98IH65L'!P0F.H(J;_A'Y_\
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MY /;G@YH W;72UO8WDM?%.ISHCM&S130L ZG#*<)U!&"*F_X1^?_ *&'6/\
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MK!J6BG45:YA>1H7#HNT@.H8?,?3U]B =#_PC\_\ T,.L?]_(O_C='_"/S_\
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MNU1$CLYG01LJ8VA]BJ7 P.&)!QSFNFK)NO%&@64DL=UK-A"\4@BD5[A04<]
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M&QE@BN[VWMY)V*PI+*J&0CJ%!/)^E6: //[2*_\ [4\$WQTJ^6*WT^>TG!B
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&J7,<?VN:$EUC&%+J2IQGH"1^M8WPG?[5X M=2G;S+^_FFGO9&^\\OF,#GZ
M!0.P KI]$T:VT#28=,LVE-M#G8)&W$ DDC/U)JE%X5M+2]N;G3KJ]L%NI#+<
M06\@$4CGJVU@=I/<KM)^M %(70M/$<'A+2&2RC6REOVD"!MH,NT(@/ &YFSZ
M  #KD8UMXPUV^.B6Z?8H+F?5+K2[TF%F4O"DAWI\PX)0'!^F:ZNZ\-6,]U97
M<+36EY9JR0W$##?L;[RMN!# D G<#SSUYJ/_ (1335;3&B\Z+^S9GN(-K]9'
M#!V;(.XG>V<_WC0!Q]UKFNWNGV$,FH1Q7$'B<:;-+%#@3HK$J2N>.@R ><>E
M:$OB+7;;4_$\TUU9G3O#Y662-+4^9<1_9O-*@[_E.3UP<^@[[+>"],>UF@:6
M[_>:A_:7F";:Z3YSN4@#&?3I5RS\.6-G>:G< S3'4MHN4F8.KA4"#@C^Z /?
MODT 8D7B#5+2]\,/=R07%KKHV.L<>TP2F(RJ4.>4PK YYZ'/:IOAS_R*DG_8
M2O\ _P!*I:T=-\+6&F?8Q%)<RQV*LEE'-)O%LI&"%XR>. 6)(' X)JUHNBVV
M@V+6=H\K1-+)-^]8,0SL6;G'=B3^- '"ZC8ZAHGB;7/%^BQR7#0W:Q:GIZ'/
MVJW$$1W(/^>B98CU!(JS_P )1L\/SZYH=Q#-;W>MVZ!BNY7CE:%#Z$$!C]".
M17:V.FI83WDR3S2-=R^=()""-VU5XP!CA5&/:LZ;P?HTFBW>DQP-;VES<?:B
M('*&.7<'W(?X2&4'T_#B@#GO$'BS6=,B\9&U>U+:1';2VQDA)XD!+ X89]C^
MAJS<ZEXE7Q-J6BIJ-BNW3EOX9_L9)C^=U,>-_(^4'<??CGB]-X#TFXAU..::
M_D.J1QQW;O<DF0)T]@?<?08'%:#^';=]6EU-KFZ^U2V@LV;<N/+!)Z;<9R2<
M^_IQ0!Q4>H:EXBUWP7J5I-;V5[?:#<S-(T)E6,L;<G"[AGD\9/YU<TKQCJ^I
M-:Z/-"JZKYE[%<36JJ58VTBIF-9& ^;>#R3C!&.XZ"#P=I]K#I26D]W;R:7"
MUO:S)("RQ-MRAR"&'RKU&>!S3;_P3H]]965NHN;62QD:6VN;6=HYHW?)<[^I
MW9.[.<]Z ,636?&'VKP_I<[:=8W]^MTD[&$RA&C7*. 'QR""5SP>YZ5U]C#J
M<=S<-?7=O-"RQB%8H2A1@OSDDL<@MR!V''-4E\+6*7FEW2RW0ETWS/))EW%C
M)]\N3DL6[DGZ8K0M[!+?4+R\6>Y=KK9NCDE+1Q[1@;%/"Y[XZF@"W7.W6K75
MWXND\/V4Z6Q@L5O)9FCWEB[E44 ]AM8GZ@ BNBK&U'PS9:CK%OJWFW5M?PQF
M'SK:4H9(B<E&]5SSZ@]"* ."\/\ B"Z\/_#OPS)*)8-.>VF^TWT-L9UMY _R
M;U'(C.7R1Z#D=:Z2VU_4];N=5M-+N[1)=,M+>02A/,CN)98S(#U'[O&,8YY/
M/%:%EX-L--T^ULK&ZOX(;>&2  3;]R.06#;@1U'& ,<XQDTX>#M+AE62Q-Q8
M_P"B)92"VDVB6%!A%;(/(!(####/6@#F-+\37NM^)="U47#V]C<>'9KZ2S\O
M< 1+#N&>Y[ ^G;DU<@\6:H-*\,:](89+/6[F&"2U5.8!-GRRK9Y*G ;/7)(Q
MC%=&?#&F"_TZ\ACDMWT^ VT*P2%$\H[3L8#JN44X]JAL/".F:=]GCA,YM+29
MI[6T=\Q0.<\J,9XW-@$D#/ '% &?K.@65_JNB6=E;1QRZ??+J$TZ+\T:C<<%
MNI:1CSGJ-Q/09-5C1?BEX;<(H=K"^#,!R<&#&:GB\#V45XUS_:FML7G\^2)M
M0D\N1LY^90<$< 8Z8XZ5JW.B6]UKMGJ[RSBYM(WCB"L-H5\;@1CG.U?RXQ0!
MPMSJ.L-XB\7>(((K6X&@ 6]M:W&[.P1"64H0<*S[OO$'A0.E:OB:YAU)/ ^I
M1Q;1<:M;RH6'S*K02MC]:W[SPU87EU>3L9H_MT:Q7D<;X6Y4# #<9Z$C(P2.
M">!4FIZ#:ZJU@97EB%A.MQ;K"0H5U!4'&.<!B,=.: ,-&>?XP7$4_,4&A(8%
M/3YYF\PCZ[$!^@I?AA+++X L/,)*QR3Q1$_\\DF=4_ * !["MZ_T:WO[N*\\
MR:WNXHWA6>!@K^6V-R'(/!(!]01D$59L;*VTVQ@LK.%8;:!!''&O15' % %B
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *Q=<_Y"OAS_L(M_P"DL];58NN?\A7PY_V$6_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MQ=<_Y"OAS_L(M_Z2SUM5BZY_R%?#G_81;_TEGH VJ*** "BBB@ HHHH ****
M "BBB@ KA[Q;2YU'7=/U/1WU+3+K4 MP$MVF\K%K;E6(7)Z\9 R#@]C7<5BZ
M+_R&/$?_ &$$_P#26"@#@$T+6;#0]9MM(34[S0[6]L[G3[.Z+I.R1N'FBC+X
M?;P-N>X.,]3<U&S^U:?+KVB^']:5_MMK<7L-P\L=S=I%N!"H[9!0,I'3<5P,
MX%>FT4 <[X5@L2;_ %&RTN_L1>R*\K7YD669PNW<4<DK@ #MG'3&"><:RM)?
MB'XFN=6TJ_ELI[2UBAD6RG97*B3> 47_ &EY_*O1:* /)[32=9LO ]G9SV-Y
MY$7B*":PMO*,DL%BDZ,OF;<\@!CSST'6KU[I]^VD^.-$N]/NKBZU6>6:PF6!
MFCD#QJL0+@80HR@'<1C (KTJB@#SE8;O3-;UG3-<T6]UFUU2"V$,\,!ECDV1
M!'CD/2/YP6!; ^<G-4]5MM8M?'&K:S;:==7-I;_86DL5MG*7BJ'5O+./F>,L
MK =#]0"/4J* (X)EN($F19%5QD"1"C#ZJ0"/QKD=!M;R6^\9QQ_:;"2\O2]K
M<R6S  ?9XT#KN #893Q[5V5% 'G=IX;\0V'C[1)&U*.>QMM/GC,D>G[%5=\7
M[LG>?F;&<]?E/7-:OC?2;Z>[T#7=/MVNYM&O#-):H1OEB=2C[,\%@#D#O@UU
M]% &5!K U- EE;7J,P.Y[FTD@$7'7]XHR<]AG\JX73M*U*Z\+^%=%EL;JWU?
M2=2BDN9GA8(%C9O,D$I&UPZDC@DG?R.#CT^B@#RG^SKE=$FV:5>+,?%XO0!9
MR!C#]I#>9]W.-F>?PJ[J5G>BQ^)%E_9M[(^H(TEH4MV99MUK'& I Y.X$8[8
MYQ7I-% ' 6MJQ\96EW-IUT84\." R-9N0)-X)3[OWMN>/PK,T&WO]*M?A_=7
M6F:B5L].GL[E$M79X9&6+:&4#('R$;N@XYKU*B@#RS04U&QL/#T,^B:A RW6
MH^9<I:%YK<O,S(H'(4.&Y<@@8QD9R$\.V6HV.G^ 9+C2=07^SS=07">02T99
M"%)'92>-QX]\<UZI10!Y;+I^J"#5KBVT^[,<'BN/49+?R&5KFV58P2@(&_#+
MN '79[BF^+=)N]2'BC4K*PO'MKZULH$@^RN'GF24LS^61N "%1DCL?2O5**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB:E_T-.J?]^;7_XS1_8FI?\ 0TZI_P!^;7_XS6W10!B?V)J7_0TZI_WYM?\
MXS1_8FI?]#3JG_?FU_\ C-;=% &)_8FI?]#3JG_?FU_^,T?V)J7_ $-.J?\
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MZI_WYM?_ (S6W10!B?V)J7_0TZI_WYM?_C-']B:E_P!#3JG_ 'YM?_C-;=%
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MGH VJ*** "BBB@ HHHH **** "BBB@ K%T7_ )#'B/\ [""?^DL%;58NB_\
M(8\1_P#803_TE@H VJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K%US_D*^'/\ L(M_Z2SUM5BZY_R%
M?#G_ &$6_P#26>@#:HHHH **** "BBB@ HHHH **** "L71?^0QXC_[""?\
MI+!6U6+HO_(8\1_]A!/_ $E@H VJ*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+DLA\W(6)RR^4VV3*@9&T\'(X)%8U_J,%SX;@LX/$.CQ7R-"7(N@$<*RED#
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MF0RA$6"1G)C.)!M"[LJ>HQFL>>ZB_P"$2MM-B\5:=)J$7D[[B:Z4>:$=2P+
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M86-E"TMVNX"W+'<V/7=V]* .HUKQ,MEJ&FVEF\<CS:@EI<;HG8*"I8@./E#
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M<9Z8H ZBT\6Z%>Q/+!J"&)+7[89'5D0P]W#, "!WQT[XJ:/Q#I<DD\:W#>;
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MP(KD;A)D[NI^[C;COUJY_P )%HG_ $&=/_\  I/\: -*L77/^0KX<_["+?\
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M8 ) Q(<-@@X.*;JCK_PJ"\?<-O\ 8+\YX_U!I%=?^%.!]PV_V!G.>/\ CWH
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MJED W''[]>>?SJOX> T[XAZK#K\IEURXB L+Q\*L]F#GRT48 96/S#J<@]*
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M $E@H VJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !NCS?%'_/EH_P#X%R__ !N@#:HK%\WQ1_SY:/\ ^!<O_P ;H\WQ1_SY:/\
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MM#S?%'_/EH__ (%R_P#QN@".P\':-8:$^D"V\ZVF1%N#*>;@JH&Y\8!)VC.
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MQ1_SY:/_ .!<O_QN@#:HK%\WQ1_SY:/_ .!<O_QNCS?%'_/EH_\ X%R__&Z
M-JBL7S?%'_/EH_\ X%R__&Z/-\4?\^6C_P#@7+_\;H VJ*Q?-\4?\^6C_P#@
M7+_\;H\WQ1_SY:/_ .!<O_QN@#:HK%\WQ1_SY:/_ .!<O_QNCS?%'_/EH_\
MX%R__&Z -JBL7S?%'_/EH_\ X%R__&Z/-\4?\^6C_P#@7+_\;H VJ*Q?-\4?
M\^6C_P#@7+_\;H\WQ1_SY:/_ .!<O_QN@#:HK%\WQ1_SY:/_ .!<O_QNCS?%
M'_/EH_\ X%R__&Z -JBN9M-4\27=W?VZV&DJUG,L3DW<F&)C5\C]WZ.!^%7/
M-\4?\^6C_P#@7+_\;H VJ*Q?-\4?\^6C_P#@7+_\;H\WQ1_SY:/_ .!<O_QN
M@#:HK%\WQ1_SY:/_ .!<O_QNCS?%'_/EH_\ X%R__&Z -JBL7S?%'_/EH_\
MX%R__&Z/-\4?\^6C_P#@7+_\;H VJ*Q?-\4?\^6C_P#@7+_\;H\WQ1_SY:/_
M .!<O_QN@#:HK%\WQ1_SY:/_ .!<O_QNCS?%'_/EH_\ X%R__&Z -JBL7S?%
M'_/EH_\ X%R__&Z/-\4?\^6C_P#@7+_\;H VJ*Q?-\4?\^6C_P#@7+_\;H\W
MQ1_SY:/_ .!<O_QN@#:HK%\WQ1_SY:/_ .!<O_QNCS?%'_/EH_\ X%R__&Z
M-JBL7S?%'_/EH_\ X%R__&Z/-\4?\^6C_P#@7+_\;H VJQ=<_P"0KX<_["+?
M^DL]'F^*/^?+1_\ P+E_^-UG7KZRVN>'1J%O81P_;WP;>=W;=]FG[%!QU[T
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M6?48W8NT9&UF$17 <C/\1 )SSTJ*X\)3+XB\.36<-F-(TBSFLS!+(VYTD1%
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MCW$G:22>F<8R<=*X;0+YK+6M,TGQ*M_8:ZLS%+LS.]KJORL.&SMSSN"$ K@
M>E>@V%F]G"ZRW<UU)(Y=I9MH//0 *    !P/UR:QX?"BB+2X+O4KJ\MM,D26
MW294W%T4A2S!03C/'3WS0!QCZU>Z1HWB4VUU,MQ/XF&F03RR&06L<GE#*AB0
M NYB!TR175:Q#I>@G203J*23WL4$<D4S.9I#R%EW-\P(!Y.<5-'X*T]M.UFP
MO)9KRVU:Y:ZG23:I20A>4*@$8V*1W!'6I9O##7C::-0U6ZNH].N$N8=RHKO(
MH(4NP'/4] ,T <U;:E>>%-<O9K^XEG\,7M\\!DE=G.GRY 7+$DB)LX]%/H#4
M.IF2&U\&^6]]*)]4DBF2*Y<-,GES':26&1E5/)[5V\.B0"SO[.[<WEO?.[RQ
MS*N,/U7@#CZ\UF-X)M5LM"M+:_N[>+19/,M=NQB3M9!N+*<_*Q% &%XNW6_@
M'6[FU74]/E2XA55ENGWJ?,C!92&. 0V, X/U)J[XF,WA;4O#]_IMU=>5=:G#
MI]S:2SO+'*DN1N 8G:RD Y&,C.<UJ:MX4.MZ7>6%]K%\Z71CW,!&"@1MP"C;
M@9/4D$G\JLGPY#<:I::AJ-Y<WTMF2ULDVQ8XG(P7"JHRV"1DYQDXQ0!M5B>+
MO^14U#_<'_H0K;K$\7?\BIJ'^X/_ $(4 4GNKQ/BE;V?VR8V4FCS3?9CC8KK
M-$H88&<X8]2>M9-]XPADU_51>2WEMH.C2)!/-;1/B29@"Q=U&51 RC [DD\"
MM^72+Y_'EOK:_9_L<6GR694R-YA+R(^[&W&!LQU[UFW?A*[\GQ+86DEO]@U\
ML\C2,0]N[QB.0A<$."%##)'.>U %'4=0CC^)ILKG4KY--?15NECAGEV^9YI7
M<-AS]T?2M#X>:Q>:UI&H3SW1N[2/4)H;&YD $DD"XVEP,8.<CD D $BA?#VJ
MV/C--8L(K&2SBTI--CBFN71\*^X,2(V'MBDT?PWJ^B+KFHV\M@^K:M>)<-"V
M];>)1A2!CYBVW)W8&3C@4 :WB^26#P;K5Q!-)#/!8S3121.5975"0<CW%99F
MN/\ A4QO?M5S]K_L;[3]H\UM_F^3NW9SZ\XZ>U=)J5C'JFE7FGS$B*Z@>!RO
M4*RE3C\ZYNTT7Q /"T/AJ[&G&W6V%E)>QS.7>$+L)$13 <K_ +9 )SSTH SO
M%%UK7AOQ#9ZCI+W5[86]H\FH:>\K2-)$&4%X]Q/SKG..X!%;5A>6NMZXEW97
MTTVGW.G+-'Y5PX0Y<C< #P<#'M]:T6L[P^)H[X+!]D6U:$GS#YFXLK9V[<8^
M7UK)T3P>/#?B'5;_ $V0?8KR,-'8LQ5()=Q+[>#A6R#CL<^M &9X"M[OQ#X&
MT>_O]6U%Y6\\S%;EE:4^8RKD@\ !>@Q2_#VWN]8\*Z7J]WJVHR7#27 G5[EB
MLJB22-1C/&,*<C!^6MCP3H>H>&?!UKI%W]FEN;;S,-%(VQ]SLW4KD?>QT-'@
MK1-0\->$8-*NS;2W$#2LK0R-L;?(SCJH(^]CH>E ')^$M2BU#PG;R:AJVL?V
MG/>2VR3K+.5#>>R1_P"P0 %SGKCUK9*3WGQ2U#39+^_2S32H;E(8KIT59&D=
M2PP?11QT]J=X<T/Q)X>\+#2$@TB:999I4G>YD*J7E:0'9Y7.TMZC..HJR-%U
MNV\<76NP)8SPRZ?%9*LMRZ/E'9MYQ&1SNZ#TH B\.:MJ%MXSU?PKJ-TUZMM!
M'>6=U(H$AB<E2C[0 2K#@XY'6J7BG7ET7Q8@\0R:A:>'YK9%MKVUD=(HKC<V
M[SF0Y&1LVY^7@^^-W0?#DMAK&I:YJ-RESJFH;$8QJ5CAB3[L: \GJ22>I["I
M[VWUAKZ[$<&GWVFSPJ@MKF5D*MSNS\C J01QCMWS0!G/IL\GAT7;Z]=W7D6D
MK136]QM$Q)++(Q3 8XV\#CK4?@.WN;KPUH6M7&IWT\]SIZ-<1S3,Z2.ZJ=V#
M]TC!Z>IJQHGAF;0? C:%;O#)-Y<P4%BL2&1F;:."0J[L#CH*ET+2M6T/P'9Z
M1$;-M2L[-;>)S(WE%E7 8G;G'?&/;- &3+XCU"V^(%F97'_"/WS2:9#Z"ZC^
M;<3_ +1$D>/6/WI_Q$BN]/\ "FNZW:ZI?0W,%INMTAF9$C([[1P2<]_04W6_
M 4%[X/6QT^TL;;6(A%)#>G[T<R,&\PN%W,<CGCG)K3\4Z/JGB/P+>Z0/L<5_
M>0>5(WF-Y2$]2#MR?I@4 8OB^WN]$\ :UJMEJVHK,MBLD>^Y9C'(N3N4DYYW
M8(Z<"M72I;&;5;&*UOM4^T"!KB2.=YC'(@ 4@^9Q]YU(QZ5)XHT/4->\"7>B
M0_98[NZM_(9GD;RT]2"%R>GH*MP1ZX9;));?3H(8N)I8[AI9"H'W5!C4#)"Y
M.>@]<$ '%Z5K9N]3.CZSJE_I'BI;W?Y<\S+!=1"7(6$'Y&4H-O #9[GDUU?C
MOQ#/X8\(7FI6L:/=@I# K_=\QW"*3[#.?PK+UCPOK'B/0+;1]7337>.6-_[1
M25S+'M8'<BE.'(&,[L<D_P"S70^)M MO%'AV\T>Z=XX[A1B1/O1N"&5A[A@#
M0!A^);6^\.^$;O6;+4[R;4M.@-R[7$S-'<!!EU:/.U0P!^Z!CC%9,^NQ7?CK
M3&GO-1ATN^T'[<((99>)#(FTXCY'RL1Z?C6_JFD:]K^@/H>H/900W""&\N[>
M1F>2/^+8A4!2PR.6.W/\5$?AR\M_'EIJ]NEHFFVVEG3EB\QMX&]6! VXP N,
M9H UM "'1H)HKJYN8+A?M$+7))D5'^8*2>3C..>:YOQOXAU'1[JUO+%O] TJ
M2.XU8 9+0R$QX'^Z"SD?[*^M=J%V1[8U4!1A5Z#V%<U!X4M[VPOSKVF:==7]
MY)*9''S@J>$7<R@C"!5X';/>@"'Q\NJ3>'86T"^DM]1:=/L[QO\ *YP2%8="
M&P!SZU5U#Q=)JOPYBU/2',-]J%LXC];=E5C*3[IM<?[P4=ZET?0?$5CX7T32
M[U["XN--FCS,)W >),A?X/O8P/PSWI(O!#V$OB66RG1QJ:R_9+>5BJ6S2J/-
M((!/S. V,=OK0!@W6I7<7@[X>WLNHWX?4;BU6^=)Y"TRR0.[#Y3G[P!XZ=JZ
M":6W;1?$=QINH:G_ *-:LFV:64&.58RX92YW#AESV.![U4D\)ZW_ ,(_X.L(
M_P"SVET&:"64M.X67RHFCPO[LXSNSSTQWK;O[/7=2LM2MWATZW6XLW@C1)W?
M=(PQN=O+!  Z  YR?:@#C?#VMW]W<^#UT?5+K4+B>UCEUV*20S1Q(T0;>Q.?
M+?=]U01GGC K<FU*6P^)>JK-=73:?:Z&E]]G\UB@?S) Q S_ '4''2FVO@_5
M-.L_#MY82V<6M:5:QV-QEV\F\MU4 JQVY!R-RG!P?7-7U\/7\WCB[UF[CLS8
MW6EI8/"LK,_#LQ/W "#O(Z]J (?"4=UXD\,VFNZG?7:7>H)]HC2WN&CCMT;E
M%50<-@8R6!R<]N*T;M]0TOPM!9_:_/U>54LX;AQDO*1CS"/8 N1Z*:I>'='U
M[PQIL>B0?8;[3K;*VEQ-.\<J1YR%=0C!BN<9!&0!P*NW&BW&HZS:MJD5G>:=
M;0-M$G+-,V,OL*[1@ @<Y 8]: (? NLW&L>%X?MY_P")G9.UE?#OYT9VL?\
M@0PW_ JZ6N4T?PU=Z'XRU.]L([*'1-0CC+VT;%629 1O50NT C (SVS[5U=
M!1110 4444 %%%% !1110!B:+_R&_$?_ %_1_P#I-#6S(I>-E61HR1@.N,K[
MC((K&T7_ )#?B/\ Z_H__2:&MERX1BBJSXX#' )^N#0!PNB^*9=)^$*>(]3D
MEO9X89'8L?FF?S&51^)VCVIH\71:'HNJ7.ISW4VO6FGF^EMIHWAC9>PB0\;
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M"1U&#CC&>>E8$7A>[_X2#5M>^S6-K=WE@+,00RL4E;)/F2-L'S<@#Y3P.O/
M!S^E^(M2D\+^!=+COIO[3\1*7GO9&WNB)'YDI7=D!B, <8&<XKJ;Y++1]4TE
M/[9O;>26<J()IY9ENP58;/FW889#?+CISQ61;^!+U/"GANV-U;P:WX?*FUN8
M]TD3X7:RL" =KC@XY'')K3U#1=7UO6=!N[R.RM(]+N3<OY5PTID)C9-H!1<#
MYLYSVZ4 8B:_J/A7QAJ*ZG<23^%Y[U+6.XE<LUA,8HV =CSY;%\ G[I ]:;X
MON[S3? ?BR^M-0O8[FTNOW$HN')C'[O@9/3YF_/Z5U<.BM=+KEMJ]M:RV>I3
M;_*5R^4\I(\-E1@_)GCU]JYJZ\ ZBOPYU7PK:W\=R]U,?)N;MV!2+*[0V%.2
M NWWQGVH W+$Z?-K45O9WVJ>8L+R21SR3E'3[O\ RT/!R005]#ZBL/PA9WVN
M>';^9M<U.&^34+N"&X$Y<1JDK*@V-E6  '4<^M=4/[=FO+=I+73H(DW&1DN7
MD=ACA1F-=H+;23SP.GIA:!H?B;0]%O-/A.E)-<7<]PET9I)!%YKE_P#5[!N(
MS_>&: +W@/Q#=>)/"\=W?HB7T,TEK<^6/E,D;%2P]C@'\:N:Y_R%?#G_ &$6
M_P#26>G^&?#UMX7T&WTJVD>41[FDFD^]+(Q+,Y]R2:9KG_(5\.?]A%O_ $EG
MH VJ*** "BBB@ HHHH **** "BBB@ K%T7_D,>(_^P@G_I+!6U6+HO\ R&/$
M?_803_TE@H VJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)]*[>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=[,7&2'#@ 8(. .@-;&J^++/2M5_LLVFH75Z;8W2PVML7+H&"G!X&>?\G (
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M]ADL?8&N?\5ZVWAS5M*CU6ZOX/#\D+K-?PY)%QN7;YK 952-V,8&3Z"@#?\
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MIND<#&W>> .,#)XXK5_LRZM+ZSGM]5N?LD;,;J&X<.)%V, =Q&00VTX! ]J
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M "%?#G_81;_TEGK:K$US_D+>&_\ L)-_Z2W% &W1110 4444 %%%% !1110
M4444 %>>7MDZ>.EU[K!IVKM'<?[$<UC"F\^P8)GT!)Z"O0ZYG7K3PW8W'VS5
M6N('O95BW133J)9" JC$9QN(  XR<4 2ZE::E=R:C:W.EV.J:5<A1%#--M(^
M4 A@5(VY&<@Y'/%8NE^#M2TA?!L"2P3Q:+Y_VAVE8'$B,H5 0<A=V!DC@"KL
M&G^&9&>"+^U%>*+S/*,UXC; <95203VZ5%:+X/O]'N=6M;R\EL+;=YTZWEUM
M3;][^+MW]* .9T>>7;;W\>GZ??:.-3EO;-(-4P49W8!EA,>=^')V%_O,< '
M&S?>$];N-$\262)9>9J>KQWT!:=L"-3"2&^3@_NCTSUZU9_X1;P-8*FM?96M
MI+DX2?SYTFE9N@ W;V)],9-6%MO"S221&;44FCA,[0R7-VD@C! +["P;&2.<
M?R- &;KWACQ)JUS>LR:?< :A:W=C)-<NIBCC:-FB"A"%.58EQDG(R/274_"&
MKW\'C.S#6:PZXBO!*9&W+((4CVLNWA<IG.3P>E6+8>$;R*WF@N-2>"Y9%AF^
MT7@C<L0%PY..20!SWIEQ+X+M+JZMKB_O(9;3;]I\R\NU6'=]TNQ;"@]B3@T
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ML#JP>38"-P<X^4XP.3DXZ'_A$])]+[_P87'_ ,71_P (GI/I??\ @PN/_BZ
M*GA_3-6M_$VN:KJ$%K#%J"V_EQQ7!D9#&A4@Y0#OU_\ UU3UGPG>ZKKFN_/
MNG:QI*6,DN\^;"R^;R%QA@?,'<=#6O\ \(GI/I??^#"X_P#BZ/\ A$])]+[_
M ,&%Q_\ %T 9EGH.JWM]X=N-72VBDT5'):"4N)Y&C\O(! VK@L<'G.!VS5CQ
M;X?_ .$@^RQ26$=Q#$LC+,MP8+BWE^78\;@<?Q9Y].#TJW_PB>D^E]_X,+C_
M .+H_P"$3TGTOO\ P87'_P 70!AC2=3TK4-/UG6+FVN;;3M!EM;ZY=FW2/\
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MB>D^E]_X,+C_ .+H VZ*Q/\ A$])]+[_ ,&%Q_\ %T?\(GI/I??^#"X_^+H
MVZ*Q/^$3TGTOO_!A<?\ Q='_  B>D^E]_P"#"X_^+H VZ*Q/^$3TGTOO_!A<
M?_%T?\(GI/I??^#"X_\ BZ -NBL0^%-) R1>X_["-Q_\763IL7A#6+^:QL+Z
MZFN84$C1_;[E24SC<N7&Y<_Q#(H [&BN4CT_PQ+?_8DN;PS[VB'^GW.UG499
M V_:6 SE0<C!XX-:!\*:2!DB]Q_V$;C_ .+H VZQ/%W_ "*FH?[@_P#0A5/3
M](\-ZM'-)87-S<QPRM#(\>I7! =<9&=_;(J&VTKPIK#-:PRW-P'0N%:]N=LJ
M X++EL.H..5R.1ZB@#K:*XU5\'2>(#H27]RVJ D&W6_N21A=QYWXZ>]:LOAC
M1H(GEE:[CC12SNVI3@*!R23OX% &[17+V&E>&]3+K:37SLBJY1KVZ1MK9VMA
MG!*G!P>AP?2G1:/X<FU2XTV*>Z>\MXTDFA&HW&45\[2?G[[3Q0 >.--GOM(L
MKJW1I)=,U&WU#RE&2ZQN"X [G86P.Y JY>-J,]V)K2"SU#2)[8!XGEP6))(*
M_*58%3SDCM2?\(GI/I??^#"X_P#BZ1?".CHNU$O%&2<#4+@=>3_'0!R\'@;4
M+#0(+*RCM(_^)]'JOV43,(K:)9%;RD.WG[OH!ECVK/OC)=:UXBEMK32[S2GO
M8S=0OJOV;=)"J ^8AC;G<O4,H8*,@CD]S_PB>D^E]_X,+C_XNJ;_  \\+RWZ
MWTFFL]XN,7#74QD'_ M^: ,Z?0]6U*X\2W\=O!%'K>D0VUO'-*5>-PLN?,&T
MX_UO8G[IJAJWA+Q)J.CS:6XT^:VDT1;*%9;APMM<!65G"A,/NRN&."N#CJ<]
M9_PB>D^E]_X,+C_XNC_A$])]+[_P87'_ ,70!EV_A_5U\1B_E6S$%SH\=A<;
M9F+1.C.<J-OS@[\9)7IT[5FZ+X:\26<GA$7-OIPCT&VEM7V7+$S QJBN/DXS
MMS@_G73?\(GI/I??^#"X_P#BZ/\ A$])]+[_ ,&%Q_\ %T <Y'X.UC_A7=GI
M&^RCU:PNA=0%F,D$C+*7"O\ *#@AB#QQ73:!#J*022ZE8V%C*^ +>S?>HQGD
MOM7).>F.,=3DTS_A$])]+[_P87'_ ,71_P (GI/I??\ @PN/_BZ ,2;PQJT"
M>*M.M/LTMCKSR2I-+(0UL\D8CDW+CYAP&&#[''6KEIX>O+#QAI]Y D+:99Z1
M_9P+2GS2=Z,#MVXQA,=>]7_^$3TGTOO_  87'_Q='_")Z3Z7W_@PN/\ XN@"
MMXI\/7.J7FD:QIDL,>JZ1,TD G)$<J.NV2-B 2,C'(!P0.#5QHM2U>SEM;^U
MBL8)8GCE$<_FNVY2, [0 .<YZ\=!3/\ A$])]+[_ ,&%Q_\ %T?\(GI/I??^
M#"X_^+H PK#PMJLFE^&M*U,6PBT&>.47$4A)N!$C)%A<?*3D%LGL0,YR*Z>$
M]<72+6U,=EYL7B%M5;_2&QY1G:7:#L^]AL>G'6NE_P"$3TGTOO\ P87'_P 7
M1_PB>D^E]_X,+C_XN@#F=2\):[-I'B?3;=;!DU+4EO;>1YV4XS$2K#8<8\L]
M,YR.E:OB/1];U;48Q$MI-ILEC)#);3S,HCG;&),!2),#( .,'FM'_A$])]+[
M_P &%Q_\71_PB>D^E]_X,+C_ .+H YC3?#GBC09=%O[*+3;F>+2(=+O;62Y=
M$_=$E)$?8<_>;(V]^,]:VSI&L1>,;/60;2X3^S6M+G+F,J_F!\HN#D'D8)&.
M.M7/^$3TGTOO_!A<?_%T?\(GI/I??^#"X_\ BZ .:TKPGK=E9>%(94LBVDW]
MQ<W!6=B&602@;?DY/[WOCI5'5],O-+TR>VNAIRWNH^(_MMAONVC /^L'S[/D
M<!#V8'..<UV?_")Z3Z7W_@PN/_BZANO!&@7UNUO>6MQ<0MUCFO9W4_@7Q0!5
M\'23K=:I#=:=#;W<DBW,\\-Z+D3.PV_,0B[2 BC;C&,5(FA7FC^+=1US3$CN
M(-4CC%Y;.^QEDC&U70XP<J<$''0'/:IK7P1H%C;K;VEM<6\*_=CAO9T4?@'Q
M4W_")Z3Z7W_@PN/_ (N@#*;PS?7%UKVM7 MSJNH67V&VA$A\N"( X!?;DDLQ
M8G'' &<9,4WAS6'\-^$M/2*T,^D7%K)<$SL%98DVG8=G)/;(%;7_  B>D^E]
M_P"#"X_^+H_X1/2?2^_\&%Q_\70!S^O^#]5UK4O$,L<MO;)?6EHEK+O+,DUO
M*TJEEV_=+$#@G@&K.J:1XE\3>&9[>_73M/OT>&:UCBD:>(RQ2*X9R5!VDJ!M
M . 2<GH-?_A$])]+[_P87'_Q=5K_ $3P_IEN)KN2]C1G"*!?W+,['HJJ')8G
MT )H R=4T+Q#K?A&]LY-.TBQO9VA"0P3$I\D@=F9]@/.,!<''J<\:'CBREUO
M1+70XUQ/?W<!< Y\N..19)&^@"XSZLH[U7$?A(P7$INK]1;LB3(UW=AXV<X1
M2A;<"3T&,\BJ\;^"I+F14N;_ ,U)$@E)GO!L8XVJQ)^7[PP#Z^] '=45SMUH
M.@6(A-U-=1>=*L,>_4;@;W;HH^?J:@U73?#.AVRW.I7%Y;6Y8+YKW]SL4DX&
MY@^%Y/?% '4T5S5]HOA_3H4FNFU!8W=8U9;VZ?+,0%'RL>I( ]S5&1?"46H3
MV#7&I?:H%#RQ+<7A**>A.#P#@\]* .SHKF[#1/#NJVBW>GW,]U;MD"2'4YV7
M(ZC(DZ^U.BT'0)KVXLXYKI[FW5&FC&HW&4#9VY^?O@_E0!T5%<?>V_A73]17
M3[F?45NWC,JQ+=7;ED'5AM8Y SR>U.-KX3_L1M:6]N9--52[7,6HW#JH'4G:
MYQC!SZ8YH ZZBN,@7P?<2VT2WUW&]UC[.)KZZB\[/39O8;OPS6G=>'=$LK66
MYG-^L42EG87URV .IP')H ET7_D-^(_^OZ/_ -)H:VZXFR@\&W)@EM9+_%^R
MF*;S[Q4G8K\I#D@'( QST%6+BU\+6LT\3SZ@[6_^O\FZNY1#QGYRK$)QSSCC
MF@#KJ*Y*_M/"FFZ=#J%U=W:V<Q41SI?W+HV[&W!5SUR,>N:=8Z?X8U*:>"UN
M;QY[< S0&_N5D0'H2A<,,]N.: .KHKE=+TWPQK27#:=<W<_V:9H)@+^Y!CD7
MJK N"",T+IWAA]:DT=+F\?4(XQ+) M_<DHAZ%B'P,^] '545RFKV'A?0;87&
MI7%[#&<XQ?73D@=3A6)P.YQ@4YM-\,+IL&H"ZNGM;C;Y$D>HW#^;N^Z$ <EB
M?0<T =317.V>@:#J%L+BUDO)(B2N1J%P"&!P007R""""#R"*2;0-"AF$+M?F
M4H9-B7UR[;1WP'/_ ->@#HZ*XBRE\%:@;7[/J-T5NW,=N[WUTBS,/X49F 8\
M'@<\58N[7PM8ZDNG3RZD+QXS*L*7-X[,@X+#:QR 2.?>@#KZ*XJY_P"$/LM.
MDU"ZN[^&UBE\F222ZNU\M^,!@6R,[EQGKD5=OM)\.Z;9)>7;ZC% [*H8W=T3
MEB H(#9!)('(ZD#K0!U%%8@\*:20"!?<^NH7 _\ 9ZIWFD^&K"YM;:ZNKF*>
M[D\N"-M2N-TC8)P!O]C0!T]%<O?Z7X;TQD6[FOD=U9PBWUR[;5QN8A7)"C(R
M3P,CUJW'X8T::))8FO'C=0RLNI3D,#T(._I0!NT5R=Q8>%[6XDAFN+U6B94E
M;[;=%(F;&T.X;:I.1P2.H]145]'X0TW4X=.O+ZZAN9G6-%:_N<;F^ZI;?M4G
ML"030!V-8FN?\A;PW_V$F_\ 26XJ%/#VAO=26H>]\^-0S(=0N =IZ$?/R.V1
MW&*D?P?HTC1L\5VS1MN0M?SDJ<$9'S\'!(_$T ;M%4-/T>STQW:U$^7 #>;<
MR2_EO8X_"K] !1110 4444 %%%% !1110 5Q/Q,\PZ;H'E%1)_;]CM+#(!\S
MC(]*[:L[5]"T[78X(]1A>58)5FB"S/'MD7E6^4CD=CVH 99#44U*8ZG)9LK(
MJVIA0J?XBXY)/9?;@5Y_J7D:'XS?4%$@\(ZA>I'J."!$M\,@/_US+;5<\#>!
MGH17?KX=T]97E_TMI7B,/F/>S,RH2"0I+Y7) Y&#P*;-X9TBX\._V!+:E]+V
M"/[.9GY4'(&<YQ^- '.7[NWQLTB.[/\ HJZ-.]D&Z&X\Q1)C_:\O'X$UU6IP
MVQBEG94^TK:S)&Q/S;" 6 ]LJOY"H;CPSI%WIMM83VS20VI#6[&9_,A(X!63
M=O4XXR#TJ6/1+&.VF@Q<.)D\MWEN9'D*^F]F+ >P- ''_#]=47P%X5D>6Q_L
MQ+9'G#1D.J"-BIR3CA]AZ=JK&SU#4_&?Q!TZP6TS=VMG \ERS8C#0N,[0IW<
M$\9%=;;>$-%M+2WM((;E;6W*F*W-[.8UVG*C87P0"!P1BK=IH6G6.K7>J6\+
MK>7FT7$AF=O,VC"Y!.. 3CCB@#C/&^C1>'_@I=:5$YD%K;VT)E88,A5XUW'\
M /Y5I_%1$'PR\12!1O:TVEL<D!A@?J?SKH]8T6PU_3GT_4X3/:2$%XA(R!L'
M(SM(SR :34]$T_6=)?2]0B>>S<!7C:9QO [$@Y/XF@#DXS(?C5$MUGRET#-D
M&^[N\X>;M_VL;,^V*DU82CXQ^'#9YW-IMT+[;_SQ!7R]W_ R<?C747.AZ?>0
MVT<\+N;4Y@E\UQ+&<8RL@.X9'!YY'6EL]&L;%YY((G\ZX $LSRN\K@= 78EL
M#)P,\9XH \ZLX9_ \,?BFQ2231;QF.LVJ GRCN(%T@]A@.!U'/:NZ\)O'/X/
MTET*O%):1D$<A@5J_8Z9::=8?8K>-OLW/R22-)UZC+$G'M4EE96^G6,%E:1+
M#;0((XHUZ*H& !0!R6I*J?%OPXJ@!1I=X !T W15!IRE/C1JR7"A0ND0FQ7&
M!Y9D)E*_\#QG\*ZJ;0M.N-:@UB6%S?P(8XI1,XVJ<9&T'&#@9XYQ3[_2+'4I
M();F$F: DPS1NT<D>>#AU((![C.#WH Y6<2K\;+0VF=K:(_VW'3:)?W1/OG=
MCVS5OQ5HVI7FL66J>'=3AM=<LH)%6"Y4M#<PNRED?'(^95^8<BN@L-*LM-:9
M[6$B2=@TLKNTDDA P-SL2QP.F3QVIE]HEAJ%W%=SQRBYB0QQS0SO$ZJ2"1E"
M.#@?D* /-?$FM/K7PKUUIM,_LW4[;5+:"]MRV]1.)X#N4CJI!4_YR?2-/BU,
M7EQ)J36CJ%46[0(5P#G<#DD]0O?' JM<>$M$NM);2Y[-GLWE\^1//D!DDR&W
M.P;<QR <DGH/2ME$$:*@+$*,#<Q)_,\F@#"\965_?>%=3MM,CM&N)[=HW6YR
M!)&0=RY'0D$@'L37-Z'>_P!I>/= O1;M;6D_A;SK6!O^6;-)&74>X78*["\T
M#3[Z^:\N$G:5HA$ZK=2K&Z<\,@8*PY/4'K4UYI-E?^09HB&M\^2\4C1/'D8(
M#*00".V<<#TH YSX:F0^&;G.?(_M2]^S>GE>>^,>V<UV%0VMK;V-I%:VL*0P
M1*$CC08"@=A4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 C*KJ58 J1@@C@BN/N#?6OQ0LI+FTMI;>[L)K
M>SGB+"2#:5=PX/!#?+@CIMQWYZZ:))X)(9 3'(I5@"1D$8/(Y%4=.T.PTK:;
M9)BR)Y:O/<23LJ==H9V) X' ]!Z4 >86)G_X53X+9=W]H'6K<DG[WFFX?S<_
M^1,_C7I6FZX=1OYK4Z3J=J(@3YUU $C?!Q\IR<^OTJ2+0-,AOA>1VH$HE:91
MO8HDC AG5,[58Y.2!GD^ISI4 ><0&Y7P3\0S9[A<B]U Q;.N[RQC'O3L!=0^
M&(L?N^1(/EZ>3]EY_#.S\<5VVFZ-8:1]I^Q1.GVJ4SS;I7?>YZM\Q/)]JCL_
M#^EZ>X>VM=A6,PH"[,(XR<E$!)"*<#A<#@>@H YRRL-6\*>)]/M(]5GU/1]5
MGF5XKM4\VVEVO-O5E RI*L""."1ZUG^/==FU3P!KD,>DZK9"-8O,DNH BO$9
MD$F""<_)N_"NSTKP_INC*HLHI1L4HAFN))C&O]U2[':.!P,#@>E7YX(KFWD@
MGC26&52CHXRK*1@@CN,4 <'XDO[G2_B+:W>GVDUU(FB3"2&",N6!FC$>57D@
M$L>.<!L55\(WT'_"RM3ACL]462?3+8R2W5F\;-())V9WR/E!S@=N,#I7>6&C
MV.F.\EK$PD=%C:221I&V+G:NYB3M&3@=.3ZU(FG6D>IS:DD(%W-$D,DN3ED4
ML5&.G!9OSH M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD2.2/)V>9D[E(& <*W3(STH QI?&NHZKX6\-ZI9S&PN;O68=-OH41'"DR%)
M-P/ID'T/-7=0U:_B\=:EIDOB)M/L+?2H[U)'CAPCL[J=Q9>5PH.,@]>:J3^"
M[_2_#'AS2[&(WUQ::Q#J5[,K*@8B0O(0&([M@#T'-6=4\(OXA\:ZG-J>FO\
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MQ^8A5) (7ISBQKWA6>RO_#^J^'+2YFN].N-C12WK,OV5EVR(/,<@<;2,=U%
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M,$T,+O\ O9B1&@&2<=3CT&1D].1ZBH+C5["UU6STN:X5;V\#M!#@DL$&6/L
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M#R/2KU% %2]TVTU'3WL+N,RVSKM=&=OF'H3G)_'K3-1T>PU?3&TW4+?[39L
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
( !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>exhibit1027supplycontrac002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M4%^RQ7$,,4:2L,I#$K$NV"0,LS<9Z >N*T=7\3:+H,L<>J:A%;-)C&\'"@G
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MMXC_ +2CBAS-"?)8J6/R-F-1C[KC!Z_A7'7'A'6E^'5YI,5@KWMWJYOA$LJ
M1Q_:5EPQ) W;1CC(SWKM[>6[EU:-TT22T1D(GN)WBR5&=J ([$\L3D\ 9]:
M-BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3WU'2;^\>^A,$J++;N^-Z,KLH*Y&00<\XQ73I)=_8Y)9H 93DK!&P) [ L2
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M8=&S@C.0>0,<U[7PS?Z=I-[.T*W.J:GJ\.HW*0N D86:-MBEL9"HF,]SZ \
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSR6Y5%G5F782>025(''UQ6UJFJV^DPPO.LCM/,MO#'&N6>1N@&< ="<D@<4
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M,1&KX558DDAA@8^N#Q71PR>=#'*%= ZAMKKAAD=".QH ?1110 4444 %%%%
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MN#CRC,\F =OWL-C'3CK72^*+/5[RSLUTEHCLNT>ZADF:(3P@'*;U!(Y*GIR
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]\0Z5IP!N[Q(D(5F<JQ6,,<*78#" GH6QF@#3HJ.>XAM;>2XN)4BAC4N\CL
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M1--$T(,A:-<;GPH)VC(R>@SS0!KT5AR^*]-CUO3=+1GE?4+=KF*6-&:,QC:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU)+*3SHF8J&5VW###^YC'O6AJEY?6NH:1#;/;B*[N3#+YD3,0!%))E2&&/\
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MFG636H+IT%G&3%^\!WENI"  8/90* /1J*;&&6-5=][  %L8R?7%.H ****
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M1110 4444 %%%% !1110 4444 %%%% !1110 53U+38]4MTAEFFC1)4F'E,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^8%&6*[P5[G##/<U>\/ROX8@GN-0LKW=K^N2S((X2WV=9&"Q^;_<R%7Z%L4
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MZ)IM_IMGXN\));7DMH1-+IES) 5C?SD)>,, %&V0G'0?-QTI-"-W<ZUX/?\
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MB-Q$C$I;'*R')"!,]V^7 ]6Q7*R:%;ZO\3]8;4M+FEL9M+AMXYI('$9<-)O
M;&.C#O6YJT$E_JFFZ-$UY;V\(^U27,<&Y2R8\M-S*4SD[_J@]: +'A77CXF\
M+VNIB,07,BE)X2,^3,I*NI'7A@?PKD_^$_U>T\*S>)+NTLI;.WU%K*:WAWI*
M5$WE;T))#'.#MP/K5WP_;7?AKQQK6G-'?W.EZ@JZ@EV;8E$N#D2H2BA<L K<
M#U[FN8TSPYJ,&C1Z[!IMW+?Z9JUU=-IMU&X6YA>5B#&C\"0*0RL.<\'K0![#
M7-0>*)+KQX-"AMU-D+&:<W)/+RQR1H57MM&\@GU!';G6D>35]$E^Q33V,UQ"
MRQRRP%7A8C )1L'(KB[#P[XAT_XA:7+)J,<]A;:5-$9(]/\ +0+YD6(L[SAC
MC(/7Y3QS0!O0ZMK\/BNTT^^LK-K*]AED1K=F,EMLV_ZPGA@=P&1CGUZUO7LL
MT%E/+!&DDJ(65'<JI('<@''Y5R'V.'6_%NC:_I=IJ-E=0.ZW[W-O+ '@\M@(
MV5P QWE",9Q@G/3/1_VB+RPU$BTO(OL[R08E@(,A ^\@&2RG/!'6@#&3QDT?
MP[T_Q+/;(;F]@@,=LC$*TTI557/.!N89/H#5NVUR]76[W0KB*WEU&*T2\MVC
MS'',C,4P<EBNUEYZ\$$#M7,QZ%?WGP@T"U2TF74=,6SN#:RH4=G@969,-CD@
M,!VSBM15D/C34/%9M+TV-MI4=E%&+9_-F8R&1RL9 8@?(.G)SCI0!>TC6]43
M4=9M->BLXXM/CCG%Y:[A$48,2K!LD,H7)YZ,#QFK]AK<4VC0:K?20V=O=A7@
M65MI"L,H&)/WB.<#IG'.,GBM4\-R7T'BR[T&"[M[;4]'>-X)DDC\^Z(;#!'P
M0=N%)P =PZX-:=[>--HOA"[M;":>V<HYNK>W,TEH# P#*@!Y.[;D@@ G(H W
M]3\006.DQZU%-!<:4I!GEB;=B,D#S%8'!"GDCTSW&#*VK?9O$$.EW(0"\B>2
MTD7^(IC>A]P"&![C/ V\\''!=6GP7\16%W8W<-RS7\,<4Z8:1I9I/+V^N=Z8
M(X)/%;.J6-Q_PD?@.S#%KBS,LT[CLB0>6Q/L6=1^- ';T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUN"9KB&,!"Y+N!\HQSSVY'/O56YUS3;34+*QFNXEN;T,8$WC+*!DM].@^I%
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MDF96(8AS'MQL^4_Q9 Y([58\6^)8?"F@R:I-!)<;& $4?WF'5R/]U ['V4T
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MK,-081Y$B$%2-I+ GGDXX!'>NRLO"]M8G4;A+FXEU'4 %GOIRK2$ 8   "J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(Y13YAX7@<?@*Q-6GG?6O&]SJ.GV5_;:5:V]Q'#+(P*A$>5=IV_*21DGU]:
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MLN]7C=^?E/WAP>.P'/6K.C>(S=VNB:9I-E;6\\^C1:AY3,1%;Q$*J( !D\Y
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M@7$8U344OW&LW=NMNEU# O[E4R5"(Q(ZLQ.3R3V &.BHH YI?#=W+Y=\]_\
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M **** "BBB@ HHHH *R]>O-)M+%!K,2R6DTHBP]N9DW$'&X ' XZGC\ZU**
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MZ$DNGV1O&T+$(N,#R]QP >"..01D ]2NKZVLA";B98_.E6&,$\N['@#U_P
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M=70R'?( TC#:PQ@; #V*M7,S^(5U'X':]8WMW"^IZ;;3:=<8<'S'3*JP]=P
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M%?R=[@3PO(Q;UVL 1Z 8&!Q52UU.X'@+1?&))_M:ZU='FD_B>*2X,1A_W A
M"] 5!Z\T >M8XQ1BN1OU*?%;12LDF)-+N]R&1BN5>'!"YP#R>@J+XAW,EQI@
MT2TU6+3;VYC>X6=Y5CQY>"@!)_BD*#_=#T =G28&<X&1WK'\*:]%XG\+:?K$
M6!]IA!D4?P2#AU_!@1^%<9IWB<+\1K6].JPSZ=KZ/:0VZRJWV=XB3"< Y'F*
M7/U8"@#TO SG SZTM%<UXMT#1]3L+B[UE9Y8X8"(D25E\MN<,@4C,A)4#J>
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MLK0>>'UV"-E103)&4D)3GJ#@<'CBHM"NQ'\4[RQM8Y]+L3IH8Z?<#8)Y=_\
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MY6RT\M<M-+LPSQEE51M.6"X;G Y7W(V_"?\ R)NA_P#8/M__ $6M &Q1110
M5 MI$MZ]V<M,R! 3_"O7 ^IY/KQZ#$]% !1110 4444 %%%% !1110 4444
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MBSTGQ#I&CSJQDU)V19!]V,A25#'U8JP'K@^E3:YK\.BBSA\I[B]OIO(M+9"
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M1<'=M0ACDCK@9-.O?%R13:F+&T%[#I5LES>2++M(5E+A8Q@[FV#=@D#E>>>
M"2\\+!KV[N=-NQ8M>V:V=R!%ORB;@C+R-KJ&8 G(Z<<4FI>%([G1=(TJPG2S
MMM,GMYH@8C)D0D%5^\/3DTLOBA;B^CL]&MTOYFL1?L3+Y:B)CA,':<LV#@<#
M .2.,Q:AXSMK?P3%XHLK62\M94C=4#!" [!?FSTP3R!GI0!IW6FW%UK5A>M=
M1_9[17/V<PD[I&&W?NW<$#<!P?O'VQ1F\-S_ /":IXCM;^. FS^R36YM]PF4
M-N!)W#D$\''0D5T!(4$D@ <DFL3PMXGM/%>G3WEHCQB&YDMV1^&&T_*<?[2E
M6_X%0!EV7@_4['2M4TZ'785BU*YGN)9%L3YB&8DL%)D('7C(/XU<T[1+O0;K
M1M-TFY*Z)9VIAFMI(@2V =K^9UW9QP!C&X\<4S3_ !+J>J:CK%G;:59@Z7<"
MWD:6^90Y*!P1B(\88=:Z&SFEN+*WFG@,$LD:N\).3&Q&2N>^#Q0!0\2Z,WB'
MPY?Z.+D6XO(6A:4Q[RJL,' R.:CU+0O[2M=/WW"I?:?,EQ!<+'P' *G*Y^Z5
M+ C/?K6LDL<A8)(K%3AMIS@^]"RQN<*ZL<!L YX/0T <W)X,MY[6[::X)U*Y
MOH]0-VL>-DT>T1X7)^4!0N,\@GGFM'3-$^PW^HZE+.LVH7Y022B/:BJBX157
M).!DGKR6/L!#J?B!K#Q'HNE)!%*FHS2Q/)YN&A*Q-(/EQSG;CJ*N:YJ9T;0[
M[4Q;/<_9('F,2,%+!5)/)^E &=I'AZ\T;P_>:=;ZG'Y\TT\T=S]F_P!4TKLY
M^7?S@L<<^F<TW5_"<>K>"&\-F=(5,"0K.L1.PI@JRC=D$%01SUJ>\\216FB:
M9?& M<:D\,5M;[\;I)!D MC@ 9)..BG@]*JS>,[:RL]5-[ 8[W39HX)+:-]_
MF/+M\K8Q R&W <@8(/IF@ O/"US<W6FZK'J@AUVQA,!O!;YCN(SC<DD>[D$@
M'AA@\CTJ[=6>KG3+IO[5"7YA*026UI\D9/\ $(V8[F^K8^G.5L-<:XU:\TF[
MME@U"VA2X\N.7>LD3Y 96(7^)6!! QQZTOAS7/\ A(--ENS:M:M'=36S1,X8
M@QR,A.1QR5H LV\>HOH<,<\\4>IFW59)A'N19=O+!<C(SGC-8VC>&]9L)52^
M\0K?6?SF6#["L9F9@02[;B3US^ [<5;?Q19IXSB\-,K"XEM6N%E_@+*1F/\
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M,"Y6!K(3#?\ WR2PYQP...:WEEC?=LD5MIPV#G!]Z3SXL,?-3Y1N;YAP/4T
M8;>';EIM,U!M3$FKV22QFZDMQMF23EE9%(P,A2,'C;WR<P1>#+:TM]-:TN"E
M_8W,MTMU(F[S9)=WF[U!&0VX\ C&%]*Z1YHHXQ(\B*AZ,6 'YU!<S7:7=FD$
M,+P2.PG=Y=K(-I(*C!W$D 8R,#F@#/L- &G:7?V\,X-U?RR7%Q</'D-(_4[<
M]   !GH!R>M58?#%S;^"+7PU%J486&!+9IVMR?,B4 %2N_@L!@G/<XKH?-CW
MA-Z[CD 9Y..M.9@JEF("@9))Z4 8'B?PV_B&RL8X;U+*YLKN.[AN!!O*NGH-
MPX.2#UX)J*7PYJ)\6GQ##JEJDYL!8F)[)F7:'+[N) <Y/Y?G6S>ZK8Z?:Q7-
MS<QI%++'#&VX?.[L%4#UR33=8OWTS1;S4(X5G-M \WEE]FX*"2,X/IZ4 <V?
M"VHZ-I^J7.CZHYUW4KI;B:Y>V5E<C@1[,X1,#&<D@9.2<5TNK6MY>Z9/;6%]
M]AN)%VK<>5YA3U(&1SC\JYQO&EW:>&;3Q'?Z+MTJ>".XDDM;GSI+>-P"&="B
MY !&=I)'/!KJDNK>2&&9)HS%, 8WW##@C(QZYH Y^P\,7JV-SI^L:NFH:=-;
M-;?98[-8%"MP22"23C(_$TZV\)(TUH^JW0OULK-[*W5HMGR. KL_)W.54#(P
M.O'-="TL:N$9U#MT4GDUFRZP+FSU%M'-O=W5G*8622;8GF *2"P!Q@-Z=>*
M*&F^$Q9SZ0US>FZBT:%H;!#'M*@J$W.<G<P0;00!U)QSQ:MM#FM_%E_KAO$8
M7=M%;^1Y)&T1ER#NW<GYSGCTK7:6./.]U7&,Y..M#RQQE1)(J[CA=QQD^@H
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MCR?84 :5%9-UKB66D6VJW$6VS=4>=]W,*MC#'U4$\GL.>U:U !1110 4444
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ME/<>9\AXXWA-P/<#;GM79T4 </=P/H?Q4.NW?RZ7?Z8+,W)^[!,DFX!S_"K
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M38KO/VE+6)9L]=X0;OUS4U[80Z@L<=QEH4<2&+^%RI!7=Z@$ X]JM4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2.0GR+1TB:;'.0N[.<=BWO3/&FVSMO%RZ7<"+1?[+MYB()=L<=V9&&$P< E
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M>10<!@X7#<')Q5F\\5^%M9U^UM9==TXQV%V&CMUG5I+BY&54!0<D*3Z<MC'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-*(S!B
MJEAT)'2G44 -,:,P9D4D=R*;Y$/FF7RH_,."6VC)QTYJ2B@"-H(7D\QHHR^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJJY)[DDDG\* /20<@$=Z6O,_'&LW-K#X@GT_4KD7&F6ML^T3&&.V9F)& /\
M6LXQD,, #KSBI==:]N-<\8QIK&HPPV>CPW=ND%P4$<N)^1CM\@R.A[YH ]'J
MM:7L-\)&MR7C1S'YG\+,#AL>N"",^M8MSJ5ZWPVFU2)B;\Z0;A2HZR^3N&/Q
MJ#2+L:1\,](EM$627^S[=+9">))7150$^[,,GW)H W-/UBPU6>_ALYUEDL;@
MVUP!_!(%#$?^/?F#Z5::XA3S=TJ+Y2[I,L/D'7)].E><:=;W'@[QWISW%NL%
MCKD"V,\GG;_,O(P621N!\SC>/<XK+\0V<0TKXIMY]T'0@H/M<F.;6-NF[!&<
M\>G'3B@#U\'(R.E%>:^+K][.SUB+3-4O/.TW13<A/M;HL#$N5D+Y+2L2N A!
M "\D;L&VNIMKVL:OIEWK,NFR6^G6\UI)#-Y6-ZL7FQD!\, "#D#;[F@#K;;6
M[:YU^]T9$F6ZM(8YI"R84JY8+M/?[AK2KS'5H)+GQ'XGGBU&\ADA\.VTR36\
MAA9G!N"K'&#U&=O3GD&K5E+>Z[XCTRWN=4OXH+SPTEW+';SF(>:70;@5P0>>
MW\LB@#T2BO+O#FH:F\7@#4I]5O9YM4$D%VDDN8Y%$$C [.@8,@.[&3SDFK?A
MV]OM?BTK6?[?6VG-U)%>6GF.Y<Y93#Y9.$9< A@,X7)R"30!Z-34D21G5'5C
M&VUP#G:< X/X$'\:\LT6\U*/3?".J2:QJ$\]WK,]E.LLY:-XMUP "O0D;%(/
M4=,XXKH?A_;Q0'Q$5EF9_P"VKI,27#O\H8=F)YY'/7I0!N7_ (ET[3KBXBF>
M0BU19+N1%RELC9VESVZ$\9P!DX'-.U'Q%8Z;.\,GFRR10?:9A"F_RH<D;V]N
M#@#).#@'!KB9O]$LOBDM[_K&#RC=_%$UJ%CQZ\JR_4$4WPG%/I%]XD76<I*N
MB:<[>9W1+=U?\G#Y^M '=77B"QMI((HS)=2SPFXCCMEWDQ#&9/\ =Y&.YSQF
MD/B&PD6Q-FS7KWT)GMDM\$R1C;E\D@ #<O4CE@.M>??#:UO-.UK3EU,,CMX6
MM?)\SC:J2-O7V(WIGTR*S]"TV^O_  YX3L]-NI-,UT6]]?6=ZPRBVYE&(F4_
M>#"2(X[!<^@(!ZYIVH6VJV,=Y:.7A<L 2"""I*L"#T((((]15JN9\%ZA WA:
MQCEMH].N!+-;-;&7=NFCD99"K'E\LK-GDG.33?%6J2VNL^&],,SV]IJ5X\4\
MR.4/RQ,R1AARI9@!QSP0.M &MI6MVVKSZC#;I,CV%R;682IMR^U6X]L,*T))
M$B4-(ZHI8*"QQR3@#\20/QKS"RECTR7Q':IJ%VC3^)X8(]LA:28M#"?*\PD%
M00""V<@#N>M2YN)]1T(P7MW,_P!C\8P6T>R\=BL?G1?*7R"P!8X)Y&!W H ]
M<K-U[6[;P[HMSJMXDSV]NNYQ"FYL9QTXKB9KV\U:[UV"W\0+I=SI-W&L!>9V
M*0A$8,T>[$JOEN6R3GKP*S?%=ZVN^"_'<UU=3QS:==O:QVZ3,BQQ+LVDH#AM
M^6.2#UXZ"@#UJLVQUVPU'5]1TRUE,EQI_E_:,#Y5+[L 'N?E.?2DU^XU&VT:
M9]*M)+J\)542)D#*"0"PWD*2!D@$\D5QO@FXN$\>^(+4Z%>6$7V6S#>?+$YC
M($F"Q5V)+9)R,\@YQGD ZW5?$=GI&I6&GW$5T]Q?EQ;+#%OWE5W,..F!SS3]
M/\1:=J6HS:=%))%?P())+6XB:*0(>-P# ;ESQD9%8'BG_DHO@3_KO>_^DS5G
M^*Y9)OB=X=;2D\^]TNTO+B\"<[8FCQ&CX_O..![9H ]$HKS/3-3U&;1+#Q/9
M:['<O)ILTDMCO>7[5,(BX 4G$;*ZD$*!UQZ58_M1[?PBOB;3-=GO+I]$EG%J
M\GFK-*$#^9M_@VG((4 <@>E 'HE%>=2O=#2K_5+#Q09;:?199HX8IGE8R*-P
MF5F)V=<$  <CH:98Q7DNM^%[>36=4:+5]%DENU^U,-SH(2K*?X#\YR5P3WH
M[:\UNVL=:TW2I4F,^H>8(65,H-BECD]N!6E7DNGO=:V/ J7FH71E-UJ<#7*R
M8E98Q*@^;KG:H!/7OG/-3V^M:GIICTB\U25]/_M^;3X]0NI2K/&(=ZQM(,'/
MF93=D$[<>M 'J=07EW#86<MU<,5BC&6(4L3[ #DD] !R37GEY%JEH^B6!\2W
M,Z3Z\]LS6\A#)"T$CB)G))<J0,,3GD=Q7?0Q0:7I,<=Q=/)#:Q#?<7<@9B%'
MWG8]^,YH S]'\5Z;K5Q=VL:W-I=VBAYK>]@:&14.</ANJG!YJ2P\3:=J$L*1
MO)&+B%KBV>5=JW$0QET/H,J><'!!QCFN8URU&KZ9XFU2UD0ZE>Z-+:6-NK#S
M?)57.2.H+,_3L-N<'(J$A+W4_AK]C >(6TLS8Y @^RA3GV)=!]2* .DT_P 9
MZ5J.LII:I>6]Q,C26QNK5XEN47J8RP^; P?7'/2K,7B;39KQ(%=_+DN&M8[@
MK^ZDF7.Z,-ZC:P]"5(!)&*SS)8:UXEL=2^U0"#3_ #([0^8,S32#8S#_ &0N
M0/4L3T )XBR@G_X53X3L%##45UN&)E_B65+EFD)^@5R?;- 'JUI?07IF6,D2
M0/Y<L;##(V <$>X((/0@BK-<A'))%\8)X8R1#/H223 =-Z3L$/UPSC\*Z^@
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M*=FMU)E0=%;CYA[&N=\&:UJLVJ:QHVOX74(76]@4?\^\PR%'KL8,A/L*O_\
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MM&"<;@3P.@/(J6'@K4(?#VG>&;J6V?3-.O8YXKE7;S9(HY/,1"FW .<*2&/
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M77TA (((!!Z@T <SX?L7E\6>(=?_ .6%WY%K;'^^D2G<X]B[L!Z[<]"*Z>@
M 8' HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ]L[>(OHTEC=2M>&60REE._[O()!P!P!Z=*?IOA[7(+#P/!<64*MH;;;@QW
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MN*=</&&&5.!G<#V*YR>.O%<M;>$M83X>^']/"PQZKHMW%=+$TN8YC&QRNX=
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MR*[R>85)RR\;5VG'J6/ QSCZ38ZW%\-=-TC3PHU'3)H[6\A,GE,\<;X8*_\
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M **** *U]IUCJD @U"SM[N$.'$<\8=0PZ'![BK/2BB@ HHHH **** "BBB@
MHHHH **** "FB-!(9 BB1@%+8Y('09_$_G3J* &M&CLC.BL4.5)&=IZ9%$D:
M2KMD177(.&&1D'(_6G44 %,2*.-"B(JJ220!@$GDT^B@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *JWNFV>H^3]KMTF\AQ)%N_@<=&'O[U:HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJM;W]O=7-U;Q%S):N(Y0T;* 2H88)&&X(Y&:LT %%%% !1110 4444 %%%%
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M4-G;2W$[E8HD+N0I8A1U.!R:;87UOJ>GVU_:2>9;7,2S1/@C<C#(.#R.#WH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'_$%9'M=
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M_,)Y$A+LP"$A1MSUK2LM4U;7&OKRPOX+:.PU9[22WF0%&BB8+(6.-P<\LI!
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M/=^$]<@\-:Q']MLOM*PZ9JB  JZVX"Q2+V;R@0&'!YZ5O0@#XMWI ZZ%;_\
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M3#*87#!' !*DCN 1Q[U9!R ?6N,\,6[W#^.;>&0PR2ZQ*B2#^ FVA /X$YH
MZ:VUG3;R[^RV]Y%)-AF"@_?"G#%?[P!X.,X/6I(=2L;F^N+&"[AENK<*TT*.
M"T8;.-P'3.#U]*\V@CU6&Z^'WA^?37M=2TV4F:5)4=&MXH6C=EVDD*VY/O <
MD"NFTT ?%37\#KI=E_Z'/0!U,\\5K;RW$\B10Q(7DD<X55 R23V %9UCXFT/
M4[">_L=6L[BT@.V6>.4%$.,X)Z=Q^=+X@TB37-'EL(K^:Q9V5O.B16(VL&QA
M@002!D=QQ7&2VWB34]#NM,D2VN=4T/5[:;="HACU"--DP!'1'((R.F0.QH [
MJ#5]/N+:XN([N+RK8D3ESM\G R=X."O'/...:=::E9WSNEO.&D0!F0@JP4YP
M<'!P<'!Z'!KS7498M6UCQK=7L5WI^F)I=O:7.THTGVD%F7&UBI<!T&,]P#6U
MX1N-4/BN[MO%$2KK\=C&(IH!^XGM@W++Z/O;Y@>GRXXZ@'8WNI6>G*AN[A(M
MY(0'DM@9. .3@<GT%$^IV5M:Q7,MS&(9B!$RG=YA(R N/O$CGC-<R&D?XQLD
MI/E1Z # #TRTY\PC_OF//X5Q_@F2XDUKPA%.6^Q1)JQM,]#MGVK^2$@>U 'J
MC:K8)81WQNXC:R8$<JMD.2< +CJ2> !S4UK=6][;K<6TR2Q-G#H<C@X(^H((
M([$5Y+HDEPWCZPMG+?V>GB/5VA4_=WB%2,?\"><_G78>"FD_MOQC&,_94U@^
M5Z!C#&7 _P"!'/U)H ["J<>J6,NJRZ6ERC7L,0FDA'54)P"?J0:P/B3)<0^
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M!!8L,]<$C I;_0-;F\-^*[2/29FGO]:2[ME\Z'YX@T)+9WX'^K;@X/2O2:*
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MEU6T>SBL-.N()075C)-,BQMMVD_*%#')QG<..N.U$:*[.$4.V S <G'3-.H
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MND".%DCE4<,KA@%(Y^8-WJ+PKX>?P]97]Q<?OM1U"<W-QY;EL' "QJSG+!5
M&6ZG)XS7244 <9X<&J^%OAG"MQI$LE_91N6M//B4L-Y.=^XJ  <\GL:NZK<7
M>MV%WI1\/7$EM>V@"3S/$(OG7D."V]2I/.%/M72/&DJ[9$5UR#AAD<<BG4 <
MCK'AL/96D-A:/+JT%H+.+4FE:(1I@ F0JP+CC=LP03UQG-5YO"$=C9Z%HPLC
MJ/AVTM);>XM3M)>0A=DK D!O^6G3H7! XR.VHH X_16U'PII&D:9<6=U>0RW
M<D"R-.C/:0ESY*ODY<A2H.W. ">@K*MO".H+X;TOPD]N1:6.IK.UWO78]NDI
ME0 9W;C\JD8XPQSTSZ&8T9U=D4NN=K$<C/7%.H \[O/"6HOX?U[PO%;L;;5-
M1:XCNPR[(X)75Y 1G=N'S@  YRO/7%F]\/:G:)XNL=/M?-BU\;[>;>H6"1XA
M$^_)S@;0PP#G)'7KW=% &5I,4NF^1HJ64@L;*SB2*\9UQ(0-NW;G(("@YZ<U
MJT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-<TBU\*WIM0]SI(NK>ZM%E7+QS-G<C$[<@A>"1D9]LZ$G@ZYNO#OB1&(@O\
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MPQ@A5"1Z<#I[5HT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!C_>  !/?&:B\&:-J.AV.IQ7Z6^^YU&XO(_)E+#;*Y8 Y48(SBNFHH \[M_
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MPW+.N(&E14?>"<_*5W#:#GIQB@#MKNX-I8SW BEG,4;.(XEW.^!G '<FO/\
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21110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>exhibit1027supplycontrac003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
MY"2*Q5P#Z;E./:HM(\0PW^AOX@N)E@TV4DVX(_Y9!BJL>Y9^H ]5&,]0"2T\
M'^'+&YAN;;1+&.> !89/)4M$!_=)^[^%2:CX6T+5[V.\U'2[:ZN8L>7+,NYD
MQS\I/3GGBL;3/%)F\6^(X+F[8:;86UK(B2VS1-&TADW#! 8YVICZ\=:WAK^F
M^1+,TSH(IA;LKPNK^80"%"$;B2&!& >M $U]I5CJ=@;&^MUN+4@!HI,LK >O
MK^--TK1M.T2U^RZ79Q6EOG(BB&U ?8=!65JGC32M/T&YU2,S7"V\ZVSQ)"^]
M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD=" ?PH O44BJ$4*,X P,G)_,TM !1110 4444 %%%% !1110 4444 %%%%
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M#MQ=Z6\=Q#*9+Q5EC*QDPNAQ\W(W,.G;\JH0^#Y]*\=1ZKIDH72;@R3W5EP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 445@^*_$+:!8VHMXDFO[^ZCLK.-SA3*YZMCG: "3],
M=Z -ZBL*>'6;-;9UU>&=S-']HCGA5%,>X;S'@@J0,GYBWIUYJIINN3KXD\4P
MZE>1+8:;]G>)F4((T>,LV3WY]: .HHKG-7\1PMH.MMIET8M2L;)[@1S0,KIA
M25;8X!*DJ1GIP:9X=\8Z3JMO:VKZE$VI?8DN)E92@8;1N920%8 ]=N<4 =-1
M639Z_IVKNUMI]Y_I#6XN(]T3+NC;A9%W ;ESW&1^=5? VJW>M^"-(U._D#W5
MS;B25@H4$DGL.E '045R?AS5]0\86$FLVMV++37FD2R1(E=I41BOF2%L\$J<
M*N,#N<\5+GQ!J^CZ_H%OK%U D5TEZ;E(("=YC8>64'S-RK#Y1D_6@#MZ*R$\
M3Z/+8V=Y#>>=#>[OLXBB=WDVYW80 MQ@YXX[U&_B[08XK"0ZE&5U",R6NQ68
MS*!D[0!G/MUSQUH VZ*RH/$FD7.EP:E#>*]K/)Y,3!&W/)DKL"8W;L@\8R,'
MTI+?Q-H]W#<2P7H<6\HAE78P=9"<;-N,[L\;<9H UJ*RH/$NDW-OYT-T7 G-
ML8Q$_FB4 DH8\;@P )QCISTJ]9WD%_:I<VSEXGS@E2IX)!X(!'(- $]%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7,>-O#UWKECI]QIKQKJ6E7L=];+*<)*5SF-CV# D9]<5T]% '#^)[*^\
M5)H$*Z'<0R6NK6UY<?:O*VQ1HV7&0QW9'&%SGVJCKGAK6M3N/&'V6U,1NY+&
M>R>21 DY@VED."2H)7'('6O1J* .&U30]0\1:G>ZFEE+9,VA7&GI%<,H:264
M@@':2-J[>OJW%0C1=6OX_#\Z:9]FN=$T^9-MV4(EF:#RQ'\K'*9Y)Z<+C/..
M_HH \\\.:=K=OXHT_5+O1KR*,:*UK/YD\)V3!U;"HK[54X(4* /4"M_P#IUY
MI7@32=-U&V:WNK: 12QLRM@C/=201^-=)10!Q'A"RU/P9I9\.2Z5<WEG;2R&
MRN[9HR'B9RX5PS JPW$=,'UJYJ%GJEQXR\-ZB=/9H+6&[%P\;IB,R! @Y8$G
MY><#%=710!YMI.E^(-/L]'MI=$G,"7E^]SY,L*S()9F>(A]_RH0WS;3NR!VZ
MM\.:#KEC%X(CNM(FC_LHW2W3>=&P0.C*I^]D@D]N<=:]+HH \MFT_4K'2;5&
MTJX.ICQ)<7]I!'+$7,9:5]P!<*PV-M(+*1NZY RZ2POKK3WDT_1;X:K::NNK
MWEC?-'$;H2(\9$;([*.,X!/5.>N3Z!JNAZ;K<<2:C:)/Y+;XFR5>-NF58$%?
MP-36&FVFF0&&SA$2$Y8Y)9CZLQY)]R: .,NM"34M,CD/AN\TQIKT3E[.X1+R
MW81LHG+*Q!/\.T%OE//H.E\+PZK!X>MHM:<27ZE][A54NN]MI8+P&*[2V.,Y
MK8HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYNGE2W3^[&&/RC@>_'6K=QHEO<:[!K!EG2[@@>WC*L-H1R"W!'/*J?PK3HH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1=1DM@"D*-([OC/9N%'7A\]J;=Z3J&B_$'3=8L4OM0@N[=[/4F.P^6@.Z)^
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M\46=G)?6ES8_8;R&$CS8]K[DD4$C<.2"!ST(!K=DU:Z^PW-Y#I-W(D,19(2
MLLS>BJ3Q_P "Q4MMKFEWFI3Z;;7T,M[;_P"N@5LO'_O#M^-2VNJ6-]<W-M;7
M*2S6S;)T4\QMUPWH<'- %F-B\:L49"P!*MC(]CBG5GWNN:9ITWDW=Y%%)L\Q
ME)^XG3<V/NKP>3@<&I'U;3X]-CU%[V!;.0*T<Y<;'#?=P>^<C&.M %RBJ5EJ
MUAJ,DD=K<H\L6#)$<JZ ]"5." >W'-7: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCM(KN*Z$"Q/&79U\M@O!^X2#UZU8\,:IJ&H7GB*"^EBE-CJ1MX-D>P!/)C<
M\D]7/-,\,OK/VF9=1T%K(R@RSW<EU'(TTG  "H3@ =.>  .<YI/#5CJ%AJ'B
M:>YL7C6\U W5OF1#O7R8TQPQP<H>OJ* (-/O=8A\=?V7/K-KJ-N]F\]Q L:1
MO:.&4(%P<E6RWWLD;>O/.7%XPOV\.Z9XI\\-:76I"UFL2BXCB:8PC!QNWJ=I
M.3@_,,#C&M%I4VL>)M(UZXT9]*N;%)1*9'B9Y=Z[0F8V;*@G=DXY P.3BO<^
M#+;4O$%K.--2PL+:\^WRKN!-U<#[I"J2JKGYB>&8@<8R2 =C-YI@D$!02[3L
M+@E0>V0.U<MX?O\ 4_\ A)M8TZYU>#5;.UABD\U(T62&5BVZ(JG7A01QGG'-
M:":/+I,]YJ=M=:KJ$[(Y2RFO,QDDYPH;A>F >PJA:Z3,_B:7Q/%H[6-P-.>V
M:V>2,/<N65QN*%E&-N <D_.>@'(!0\)^([W7M<NQ-JSPRQ(TAT*YTXV\T*DX
M0EVY8>I QD_A4RQ^*[+Q%H]M=>(X+M;J1WGMX]/6,+$BY8AMQ.-QC7_@5:%M
M9W.KZ[INM7NER:;+902Q[)9(WD<R;<C*$C8-N>3DG' QS=MK*X?Q1?:C<1[8
MD@CM;3)!ROWY&XZ98JN#_P \Z .:L_%5_=ZU)8),XU:'5##/I;1 *EIO($P.
M-V/+PV[."QVXY KO*\_?PG?7%U;7$ULRZU;:LURFKK(H#6YER4/.XCR<1[,8
MR!VYKT"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I-PW%<C(&2*6O-M3U2\
MT+Q%X\UB*XN+AK#2[6:*V<@QYVSD C&0H//!'?.: /2:*X];_4=.\4^';4:A
M)J%EJ]O-YWF*OR.B!Q(I4# .2".G*XQW["@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9FWH[*@W @'"$GOAE]:MZ1JM[XJUC7!!>RV6G:7=FP00*F^:5 #(S%E. "P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "N?\36D>KZ;=>'H0HDU",K<N /W4+?*SG_ &B
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF+5/"FIZ+IT=K8F_B,;2+" !GJQ"XR:U=/L+>P@"PVMM [ >9Y$84,1WX'-
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M!L]P\]'QS&8_O!@>,8KG5UC3++XQZHUWJ%I;C^QK=,S3*@W"60E>3U (X]Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH)
M!). .I- !135D1U#*ZLI&00<BER,9R,4 +12;E_O#\Z6@ HIGFQ[RF]=X&2N
M>0/6G;AG&1F@!:*0D#J0* 0>A!H 6BDR,XR,T,RH 68 $X&3WH 6BD9E12S,
M%4=23BAF"J68@*.22>E "T4A90NXD!<9SGB@$,H*D$'D$=Z %HHR,GGI37=8
MU+.P51U+' % #J*0,&&00>,\&EH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<8PI;&3QGF@#UEKZS6S%XUW +4@,)S(-F#WW=*&U"R2&.9KNW6*12R.9 %8
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MF2*52?-C88^5F!7KUV8ZBLO0]#>TU'P3#JMBS^1;WX/G0EO)B9U,".2."%X
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MOM,TBZDT:]L+&]GM[KQ ES-)=VK#>#"ZN^PJ-B$[ 20 3^9Z?P1"+:]\4PI
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M;J.Z&EQ2L);9T"@ (020 &S_  ]<<]* .AHHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!A($!!(964[=PQD\G'-KPKJ>HZII#RZK;PQ745S+ 7@SY<P1RHD0'D*<=R:
M-NBN8T;Q:-4\6ZKHCV_E+;HLMG*?^7F,,8Y&'^[(I'T(/>HY]9UJ3Q]+X>M9
M;"*!=.6^$LML[MDR%-O$BCMG/Z4 =717-Z%XDN+O7]1\/:K;1V^J62).K0L6
MCN(6X$BYY&",$'.#W-=)0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDPMC;>4A+6CKMD'R(I)&%8;CU'J:N.\T'Q3EU9K&_:Q;14MA,EI(P,GG,^W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ7S7+&Y67&-V\_[/&.F.,5=T?P_9Z)+?2VSW+R7LWGSM-,7W/M"YP>!PHZ4
M<'JNHZIHFK?$#6--GMX_L)M;AXY82_G!;=25SD;1C//)_+G7\4>*=3TA[^XM
M9;=X[1K7;;I&7^61U#^<W&PX;Y0#GN01TVKSP?IM\NM+/)<E-9"K>*)  P5=
MH X^7Y1CC^=07W@/2-0>_:XEOO\ 3UB^TJERR*[QA0CD#C< JCTX'% %6\\3
MW-IXP_LJ]E:P26YB2Q>6#,%XA52RB0?=EW;P%.. .#G-+X_$S1^'!;M&LQUR
MWV-(I95.U^2 1GZ9'U%:TGABRFG+S374L)N(KDV\DNY/-C"A&Y&[C8IQG!(R
M<Y-6M7T:UUJWABN3*K03+<0R1/M:.1>C#MW/!!'/2@#CAXNUG2KS4M&U$V]W
M>P7MI;VUU#%Y:R+<9QE"V-R[&'W@#\M6YM?\0:7(+2_M@3>:A':V$_[OS"C1
ML[;T#[=P,;*#D Y!QP0=F[\(Z3?Z7>V%[%)<"]=9;B=WQ*[KC:P88VE=HQC
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M4GEN,;NN.* -2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4LK[0NYBH).!P*W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ JEJZ2R:->QP0M-,\#HD:D L2"
M!R2!^M7:* .+L='U2'X/#0I+%UU-=(:R\CS$.9/*V<-NVXS[U0O/#.K:E/90
M&TDMHF\-7&ERSF2,^5-((\<!LD#8>1[5Z'10!Q_A2SOS-;RZIX5L],O+6$Q/
M=J\<AE/ /E;>54XR=V.PP>HGO+#4K+QZFNV]K)>V<^G"REBB= \+K(75@'(!
M4[B#@YR!^'4T4 >7V^E7/AK6/!=M);M/.USJ4[PPLO[OS0S[5R0#MW8Z\X.*
MMR^%]5@MTOH+$R3R>)AK$EFLB!DB*[,9)"EL88\]21DUW%SI-E>:A:W\\)>Z
MM,^1)O8>7G@X ..1P?45=H \YUCPOKFJ3>+6AMA ]W-8W-FTDJE)F@"DH<'(
M!*XR0.N:LZYH>IZ[<:EJJ:;-;3-H,^FQ6TDD>^624YY(8J%7 Y)_B/ISWM%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&#M8<C(X//-7:* ,]M#TMGLF^PP@V/\ QZ[5QY/&#MQTXXJ$^&-%:WEMVTV
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M(;3_ (]T>$$1#T7T' XZ&I;WP[HVHS6\UYIEM-);H4B9HQE4/\/^[[=*TZ*
M,VU\/:/9-9-:Z;;0FQ1X[4QQ@>4K8W!?3.!FM*BB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *9)+'" 99$0'@%F I]5+W2['49('O
M;6*X\@EHQ*@8*2,9P>^,C/N: )5N[9VVK<1,?0.#3H9XKF%9H)4EB;[KHP8'
MZ$5P'PUT/2[GPG!<RZ?;-/#J%Z4D\I=P_?2IC..FTD8]*J> =:U#3=!\&6$D
M%J=.U&.6!"I;S49$>0,>V"%(QVXY[4 >G45Q^D>*M4U>?2;RVTTRZ3J(9F<1
M,C6R$91RQ.'!X!  P3WQ6MJVM26NM:7HMJ(Q>:@)9!)*I98TC +' ())+* ,
MCJ3VP0#:HK@Y?'.II$MNFGVK:A#K2Z3<*TK+&2PW+(O!(!4@X.2.>M4-:\7>
M(8M&\16,RV=IJNF36BF>W#-'+!.X4%<D%6^\#UZ<>P!Z/Y\/V@V_FQ^>$W^7
MN&[;G&<=<9XS4E<9J'B4:'XCU(ZC9VC+8Z']N>[A0B610[ Q\]!D$@9/)JP/
M$>IVNJZ+:7L%HRZS$YMVBW+Y,RQ^9L<G.Y2N?F '*].: .KHK@]!\::OJ)\+
MW%Y9V4=IKGFQA868O$ZH[@Y/!!"$8^ASVK=\5>(AX<M[.>4B&UFF\N>\DA:2
M.V&TD,X4@X) 7.0!GF@#?HKBK;6=8O/&NC6XO+$V<^DRW4B0*721A)$-RMNY
M&&^4]LG.<\.TOQ9J5YKEEID\5FDM[93SCR@SK;2QL@*%PVV7&_DJ1@J1WH [
M.BO/?#/BG6#H?A&:_DM[IM:N'BE8(RLGR229'S$=4QC'0^U6IO'%Q::=>7-W
M%'%#:ZQ)ITUVD+R)#&J;A*Z YP3M4\X&[/:@#N.E1P3PW,0E@E26,D@/&P8'
M!P>1[@BJFDW1U/1X;F62UG68,=]LV^*1<D J<G@C!_&O/_!6L:AH^@^&+8V]
MH=,O[ZYLAM+>:C;YW5O[N/D(Q]#GM0!Z?17'1>+;Y?$NFZ;<P6P2^N[FV,<1
M+M!Y:NZ%I 2A+*F2G!7</2IO#?BM]=U6:T:2VBF@63[38.C1W-NP<!<AC\ZD
M$G< !T]: .KJ/[1#]H^S^;'Y^W?Y>X;MN<9QUQDCFL74-8O&UU]$TM;<7D=E
M]L9[@%EP6*HH (ZE6R<\8'!SQS4KZO)\0K2X@L[.UU:;PZS31SN72-_.3()7
ME\'CJ/7V(!Z'17##QK?W7AG3-7M[:UMUN],>\(E)E)E4*?*5%(8CEB7Y  Y'
M-2Q>*]7U+4-%M=.M+*,:IHYU%7N'=O*;]W\I  R/WGJ,^W< [2BN,T[QG<ZG
MI_AAEMHK>YUKS5=WR\<31JQ( R"2Q4X&1QD]JBT[QK?WMA8"6SAAO+ZYN8(C
M$KS)L@)5I-HP2"0, 'HV<\<@'<5'#<0W 8PRQR!&*,48':PZ@X[UR=GXHU:>
MXT[2;K3X[+5KN2X^:528_)AQ^]"Y#?-N3"D@C)R>.6?#B-XM.UR.5(ED77+P
M,(1A,[^P[#VH ZR:^M+>>*">Z@BFF.(HWD"LY]%!Z_A4]>9W$MXFI>/KR\AL
M-033?(N(X)XF S' LJ8.3C!R>G4GIFMNW\2ZP9='M+N'3X[K6B7M#&7811+$
M)'+@XRV2  ".O7CD [&BN$N/'&I6QFLS8VK:A::S;:;<9=EC=)BI21>I&5<<
M$G!'>H[_ ,7^(K"V\3%K32WDT +/*P:0">(QB3:H_A;&1DDC@<<\ '?U";NV
M%R+8W$0G(R(MXW8^G6L7Q=J]SIG@/5M7L 1<0V+S19&=IVY!Q[=?PK.M/#^F
MS?#:*W=%8RV G:Z/^L,Q3=YV_KOW?-NSG- '8T5YIX9\8>)=5TOPW:1VUD]Y
MJ&D2737%T[CYXW1-Q51T8,#QZ]JEL_%NM:UJ7A=$\BP>6\O;6_M]C2#S8$<$
M!LC*Y&0/7'I0!Z%%/#,TBQ2QR&)MD@1@=C8!P?0X(X]ZDKAH/%AM/[57^SK2
M&[?7UTN'RLA99'2,B20X!)"DD^NT#WIFN^-]3T$:W:2VEI/?:?!!=PN-R1S0
MR/LSMR2&5@1C//!R.E '>45SNDZUJ,WBG4M$U*&U5X+:&[A>V+$;)&==K;NI
M!3J,9ST%4]2UC4+/X@Q6[742:5%H\]Y+&8B6.V2,$YW=<=..,GKG@ ZZBN.A
M\77J0>&]2NK:#^SM>DCBC6//F6S2(7BW'.'! P< 8)[U%X_N9GU#POHQ9DL=
M3U(1W>#CS$52WEGV8@ CN 1WH [""[MKG?\ 9[B*78<-Y;AMI]\=*FKA/B$J
MZ'::-K.EQ)!?6^I6]NOE*%\V*1MC1''52#G'8@$=*@U#QMXAM;+Q!J4.F:?)
M9Z%?-#<)YS^9+$J([%.,!@')YX[>Y /0'=8T9W8*BC+,QP /4T1R1S1)+$ZO
M&ZAE=3D,#T(/<5P\>M:K-J_C!F>TNK*QM87@MI(V565HF?!.3UR0>.>.F*M:
M3XCGU%=(TO38;.UN9=&BU&0-&3%$K85$5 1QG=WX"C@YX .PHK@[3QQJ>J2Z
M'!::?:13W\MW;7 GD8B":#(;&!\RY&1ZCCCJ.@\*:U<:YHSW%Y%%%=074]K,
M(22A>*1D)7/.#MSSZT :IO;4'!N8<_\ 705,K!E#*05(R"#P:\SL%\GQSX^>
M'0%U)TEMF50(@-WV93CYB.I]*W-<UN?P78Z3)'9P+H9Q;RA5(>V8K^[ !(&P
MMA><;<CMT .QHKF[W7+^RFTS2Y$A_M6\@EGD:*%Y8XQ'L#84$,W,BCJ.Y]JR
M!XI\5376D:<NC65GJ%_;73E;N5]J/"R '"C.U@X([C/MR =W4<<\,LDL<<L;
MO$P6158$H<9P1V."#^-<W:Z[K&J&2XTRTM);>WU$V,\3,0Y"-MED5B<#:V<*
M020O49P,V;Q7)IDGB29M-MX19:E#!/<6\+2'RVBC8S2!<,VU6 XZ >@H [JB
MN03Q;+<1Z;!:S6=S<7ZW$T5S:QM-%Y43*H;:K9R=Z9&[CYN>,$L/$VJZA<Z?
MH\^G16&KW%O-<7"S@ND<4;A P4$$[RRD D8&<].0#JX9X;F/S()8Y4R5W(P8
M9!P1D=P:DKCOADKIX1D21(T==2O@RQ_=!^TR<#VKL: "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M I'!9&"MM8CAL9Q2T4 8OAWPZGAO1WTVVO9YD,DDJR3!=RL[%FZ  \L3TJA8
M>![?3[?0((]1NV31)'>WW!,ON5E(?Y>>';IBNIHH YG0_!L>@W&RVU;4'TR-
MVDM]-D9#%"22>#MW%1DX4G ^H%7]8T"'5;S3[]9Y;:_T]V>WGC . PVNC \%
M6&,CV!!&*UZ* ."\4: UG:Z4EBMY+<S:]#?75S% 9&!&0SL%4@  * ,= /K6
MS>^#K34=.U6"ZNIS<ZFT;S72!593&08PHP0 I7.#GJ<]:Z2B@#GI?"-K=ZI/
M>WUW<78N=._LZ>*4(%DC))).U0026/3 ]!18>%4LSIYFU"YNVTV)HK%IE3,0
M9=NXX W,%^7)[$\9.:Z&B@#EK'P/;Z?;:!!'J-VR:'([V^X)E]RLA#_+SP[=
M,5MZA82WDD$D-Y);M%N!4*K)*&&"KJ>H[\$?TJ]10!R]IX%T^PETQ[.ZNX!8
M6\MMM0KB:.1P[!OEX^8 _+C'3I4>D^!8=)NM'F76-0F_LF"2VMTD\H PMM^0
MX0$XV+SU..M=910!R47@."VT;3=/MM6OHSIEU]HLIR(V:+AEV8VX8;78<@GW
MXJQ8^$3IHG-IK%\'GOWOI/-$;*S,A5E(VC*G(.,]0,8Z5TM% &;HNBVV@Z0F
MG61*Q*TC@D#[SL78@#@#+' ' '%8]KX'M[6PT>S34KMH]*O&O82P3+.V_(;Y
M>G[Q^F.H]*ZJB@#D;3P#!9SZ<\>L:B8].O);JVB/EX3S ^]"=F2#YC<DY'8C
MK6A9>&(K?4[+4+F\FN[BQ@>"WDE50^Q\9W, -V-H _'.3S6]10!S^L^%EU/6
M+;6+34[S3-1@B-N9[78WF1$Y*,KJP//(..#3D\,10ZY%JL-]<K+'8FR56VL"
MI8,6)(R6W '.?PK>HH XVU^'=K9064-OJVHHEMI[::V/+S+ 3G!RG!![K@U<
MTWP;'IEUI5Q'J=W))INGMI\7F+&08SMY.%'(V+CZ=\FNFHH \WUCPY)H^GZ'
MHT$VM/IUH9I/MEM:Q73!R?E5XMA!'S.0P7C'OFM&#PM>:UI-O]NU2_@NK&Y\
MW3+Y8(X+B)=@4AD4;-IRPVE1QC(KMZ* .8NO!J7#:==#5KY-6L)'=-0^0O)O
M #JR[=A4@*, #&T8K0T#0$T"*]1+VYNC=W<EV[3[.'<Y.-JCC_/%:]% '-R^
M$(ICXAW:C=8UU-EP-J?NQY8C^3Y>/E'?/K4MSX5@N+/1T%W/'>:00;2\4+O'
MR["&&,$,O!&!^%;]% ',W7@RUNHOFO+A;A]1BU*:X4)NEECV[ 01@* BC [#
MKG))>^#(+X>(1)J%T%UV)8K@*$^10FSY/EX^7US7344 5TLX_P"SELI\7$7E
M>4_F*/WBXP<CIR*PT\(K%HW]AQZI>+I&SRA;C;O$73RA)C=LQQ_>Q_%7244
M<3?Z9/'\0=#&G1SVEG::7<6XDBM2T*9:+8A., 84D<C[H^AT?^$+LHQI36UW
M=P3:=<2W F0H6F>7=YI?*D?,6)X QVQ72T4 <M+X&LI[?4HI;RZ+7M^NI+*-
MH>WN%"A6C.WML7@Y[^M.U+P7;ZO9ZA'>WUPUU?QQ0S7**BL(XV+*BC! &XDG
MJ3D^V.GHH R+?05@\2W&N&[FDGGM8[5XRJA-J%F!&!G.7;OWIM_X<M[_ %^V
MU=KB>.2*W>UDB7:4GB=E8JP()ZJ.A'<5LT4 <WIO@ZVT^'3K5KRXN;'2Y3+8
MV\NTB(X*KE@,L%#$+GIWR0"-/6M$L]>LEMKL.ICE6>&6-MLD,JG*NA[$?EV.
M0:T:* ,1O#WVR]L[G5;V6^^Q/YMO$R*B+)C D( ^9@"<=AG(&>:YO1M EU6X
M\6VE^;R#3[[56D:![<H)XO+C'RLPSABK*<=AQC.3W]% '/S>%(9-1U>[BOKJ
M'^U+=8)XD"%!M4H&&5R#M.,9Q[5%!X.ALI-*N+*_N(;S3K(6"S[5;SH!C"NN
M,'! ((QSGUQ72T4 <Y#X-L[:[TB>VNKB,Z8\\B#Y3YSS9\QGXY)))XQR?PJ]
MH.AQZ!:7%O%<S3K/=2W3&4+D-(Q=@, <9)K5HH YRV\*R66LZKJEMK-Y'/J;
MH\Z^7$5!1 B[<IQP!4K^%H+BW6WOKN>^@%O+"T=P$8.TF=\AP!\Q!(XX )
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1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>exhibit1027supplycontrac004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
M=S[5\P2VEQ+^SU8Z<D3&\;Q']G\G'S>9M8;<>N:^C+/7])_M=O#HU&%]6M;=
M9)K?)W!<#D]NX/KR* .'3XE^(=-\=:9HGB7PNNG6FK/Y=G+'<"5P20!NQD'D
M@$#&,YYJ?Q!XZ\9V6LZA%HO@LW^EVC;1>R3^4'*J-Y&>P.X9]JH/XG\)^(_B
M%::O>:S9O'I+-:Z59HX:2>X<A6DVCMD*JCOC=P,5U?Q&N91X5.E6KE;O69X]
M-A([>8<.?PC#G\* -#P=K5YXC\):?K%]:):37D?FB%&+!5).TY/JN#^-;M16
MMM%9VD-K @2&&-8XU'\*@8 _(5+0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 45QB:OJX\6>(="N+^*%H[)+W3)6B&-AR'+^NUP!VX/KS4/A_P 3WWB#P)HM
M]%="/5;VX6"7]T,*ZL?.&T],(CD=^!0!W-%<%?\ BW4$T;Q%KMM*GDZ%>O;M
M:,@_?)%M\PLW4,<L5Q@#Y<@YK9US6;VSU;PRMI)#]CU*\\B97C)<KY,D@(.<
M#[@[?C0!TE%<]XMU6_TB#2I;)X56?5+6UG$D98F.255.TY&#@]<&H]7UZY_X
M2NP\,::4CNKBW>\N+AUW>3 I"_*O0LS' SP,$X/2@#I:*Y276;W1?%NG:%?W
M/VFWU:.7['=;%62.6,;F1P!M(*G(( Y!!!ZU3TGQ/?6.HZ[I'B6X!O[3$]F8
M(@OVFV;Y49%YR^\[2/4@=Z .WHKG1:>*)='M8#JMK!?NI>YNOLP<1GC"(F0#
MU^\2>AXY&,.T\7ZN^C:;:W20#5[S5Y=*%Q$A\MEB9]\RJ3_=C.!G&[VXH [U
MU#HR-G##!P<5@1>!_#$$\L\6AV<<LN3)(D>&?)R<GOS6)?\ CJ70H=>M+F,7
M>H:=<V]O:CA/M)N #%NQP"#N!P.BY YQ6]+:>(8+6*:+4XKBZ\R,SPO;JL13
M<-XCQ\RG;G&YFH <O@[PXNEOI:Z-9K822><]N(P$=^/F(Z$\#KZ59OM TK5-
M.33[^QBNK-""(9AN7CIP>N*Y2X\9WB:+J?B9&3^S-/U$VOV;8/WD*2"*23=U
MW9+,.V% (R<UN:OJM_9>,/#MA"\/V*_:X693&2^4B+##9QC/M^- $K>#?#CZ
M6FEMHUHVGHV];4I^Z#>H7IFI)_"FA7.EQ:7/I=O+818\NV<9C7'3"GCCMZ5F
M7>MZC?:_K>FZ7*D!T>TCE8N@;SIY S*A]$"J,XP3NZC'-32O%T_BV]LK;2I!
M9I)I,>I32%!(5>0E4CYXP"KENYP,$4 ;LWA/0+G2XM,GTJWEL(CF.V=<QKZ8
M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KC/BOG_A6VIX )\RVQG_KXCKL
MZS]9T33]?T]K#4X6GM6(9HQ*Z!B"",[2,X(!_"@#E=6TK4+'6=6\9W5_8:=-
M%I)L;8 /+&GS[_,D. 6.[ "@?GFJ[^(O$%LOC"& 37$^G6$%U9)>)&) 763=
MD)@$?N\@'GM[#MK[2K+4]*FTR^A^T6<R>7)'(Q.Y?KG.??.:YW6/!5F-)U#^
MR+&)[^[@CMI3=W,I\^)6Y5G)8[MI8!R"1D=A0!FW?B#6--.N:I#=3WVCV&DB
MZB,\"INN,/E"0JD@!58@=,D'T&WHPU]=:22[U"UN=)N+0.BF16E\T$?,FV-0
M4*GG.2#CUJEX?\+M;7;326%Q8VSQ-%-:SZK+>K.&XP5<E0!SR.3TX'79T+PI
MHOAO?_95F8-XV_-,\FQ<YVKN)VKGL,"@#DOB3JOF:5KFGW.G:F]K!ITK1O%9
M2/#)*T;89G VA4Z\G[W/&T&NMT/4%E\(6=\L%PJK:!O*EB*2':N/NGGG''J"
M*TKVSM]1L;BRNXQ);7$;12H21N1A@C(YZ&I(8D@ACAB7;'&H55] !@4 <!:^
M)=7.B>$_$'VO[1'K-U##<V?EILC68'&P@;LH<=2<@'/M>\(6\R>+?&+O>W$H
M74(U*.$PW^C0D$X4'(Z<'&.V>:W;+PQI&GS)):VA01R--%%YKF.)VSN9$)VH
M3N;H!U/J:GL=%L--O;R[M8I$GO'$EPS3.^]@  <,2!P ..PH R/'MI>W7@[4
MXK""TF+PL;B*X)7S8@,LH8=&*@@'M6?XUNDO_AC%>)"84G>PE6-NJ!IX3@_3
M.*Z.Z\/:=>7TEW<).[RH(Y8_M4HBD4=FC#;&_$<U-JNCV.MV/V*_B:6WW*^Q
M9&3E2&7[I'0@'\* +U%(JA%"C. ,#)R?S-+0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7->.-9N]
M!T%+ZW$RP"YC6\G@B$CV\!/SR*I!!QQV. 2<'%=+6=JSZG&EJ^FP1SE9Q]HB
M=PFZ+:V<$@\YVD>N.HZT <]%J%S/X?UG5=+\2?VAI_V'S;*X58F:*51(7!PN
M#_RSX(R.:L:;?ZC<_"^WU66_D.H2Z4MV;CRXP1(8M_"[=N,]L51TOP<JZ[KM
M[!8_V/8:I9"VDLU93YDI+;IBJ$JIPP P>>2<=WZ98Z_;>"X/"\VFJ)XK06/V
MX3H8-@78) ,[\[>=NWKQG'- $&L:Q?:=XJ\,6$_B&2ULK^TN'N))%@7<\8C*
MG+)@9WGBJL7CZ;3-'\7:E<3+JNF:.R"ROHPJBZ9E&8R5&TE7*J648YZ<5KZS
MI>I-XVT#5+.P:>STVVN8I,2HK,9 @7:"><;#G..M9$WP^N-<E\6M?B+3K77(
M8HHK6!M^QX^1,^ !NW <#L.M '1'3?$;Z"THUR1=8>$L$$,7V=9"/NA2N[:#
MQDL3WR>E5[;4-2?XGWVE/J$IT^'38KI+?RX\!WD=3\VW=C"CO5W3+OQ$;**T
MO]*C2^10CW:3JUNY'!<#(?GKM*CTSWK,:QUFU^(E]K<6EFXLYM.BM%(G16+(
M[L3@GI\WUXZ4 3^/-1U#2]-TV;3KU[62;4[:UD*QHVY)) K?>4\X/%9NO>(]
M6\+>+//N)9+SPVMO$;W,:;[,R.ZB4;5!*#9\P.2,Y%6/$VGZ_KVC62_V<B7$
M>K07?DB=3Y<,3AL%N,L<$X' SC/%;:VL\_B*]DN+ FQN;&* F1D8$JTA92N3
MQB0#\Z "RN9Y_$]XBW[S6(LK>>&,!"F9&E!(8+DC"+CFJOC+4;_2[32YK"Y$
M/FZK:6\P,88O')*JL,GIP3SU^E5O"'A.X\+:IJL2W1FTJ1(4T]'.6MT5I6,6
M>X!?@^AQVJUXQTZ]U2PT^*QM_.>'4K6Z?YU7"12J[=3U('']* &ZIJMS-XRT
M_P .6D[VPDM);ZXF15+[%9455W @99LDX_A]ZP=/\8W^JWFDZ%YWDWTE_>VM
MY<QHN=EKP64$$ ONC[<9;';'0ZEI-RGBO3_$=G"9GBM9;.XMPRAFC<JZE22!
MD,O()Z,?3!Q+#P7=Z5/I.L*$GU&"]O+J[AC8 .+K)=4)P,J1'C.,A3TS0!I:
M1K=]?Z5XAM7G47^DW4UJ+@Q@[P%#HY48&=K 'MD$XQQ6CX0O[G5/!FB:A>2>
M9=7-C#-*^T#<[("3@<#D]JI:1H5UINE:[-)&'O\ 5KF:Z:)&'R;E"(F3@<*J
MY/KG%0V%AK.F_#;3M(AM6&I0V<5F^R5!LPH5G5LX.!DCWQG% $>A>*;N]\:7
MVF7B*EC=0?:M(<?\M(T8QR9/<D[7'^RXJ6+5[S7O&>JZ/9W3V=EI"1"XEB53
M)--("P4%@0%5<9XR2>HQS2\0>$IK?^PK_P -VTS7^EW2-''->N4$!7;)'\[$
M#*X' Z@5932-3T/Q?J&NZ=9_;+/6(XC>6GFJDT,L:[0RY.U@5X(W#D9!- &]
MIUMJ5M>W:W=\;NU*H;<NBJZGYMP;: #_  X.!^F3I56LY+N8/)<PK IQLBW!
MF7U+$<9]AG&.ISQ9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "LW4M=L=*E6*Z^TEC&TI\FUDFVHO4DHIQ
MU[UI51UA0-%U!L#)MI 3[;30!E)XYT.33FOTDO#:BT:]60V$ZJ\*X)924 /#
M X';GI6]:W,=Y:0W46?+FC61,C!P1D?SK@M-4'X 1$@$CPXV#Z?Z.:IQZKJ?
MAUH6AO+B]C;PM-?BVFP4$L(CV[0 "!AR"._'>@#TZBN1\/'4IM0L-1_M>&?3
M;VRW&$SF8RR<$2I\J[!@D$#Y>1P#4EY?37_CT^'GN)[:V32_MBF!]C2N9"F=
MPYPH XZ?/SGB@#JJ1G5!EV"C(&2<<DX _.O,-.U?7M8D\+6MSJUS;&ZFU"UN
M9+=$4W @W*L@RIP3M[<=P!Q56274[J#3K'4-2NY_L/BW[!'<A]C3PB,LI?;@
M,RDXSCJOK0!ZC!>I/>W5J(9T:V*AG>(JC[AGY&/#8Z''0\59KS;5_$NIZ-+X
MQ9;V62.TN+"*!Y I%JDP4.XXP<;B><]!G-3>(K_5=%U'6;"RU"Z-LWA^?4(I
M'82/;3Q' (9@?E;/0YY4XQ0!Z'17"Z%=ZC#XLTBWGU.YNX=1T-KJ6.;;M65&
MB *X QQ(0?7C//-6O&=_J>GS17%O#=7&FQ6\ANTL)0MS 21MF"G_ %B@!OE]
M^AH Z_>I<IN&\ $KGD#U_0TM>9P7\4?B'Q3K"ZW-# FA6=Q%=2 NB!DG(?R^
MX'#;?7/K4=]?:EY'BS39KJ\CA3PZEY$))\RI(1,"V1G;NV#*@D#MC- 'IZ.L
MB*Z,&5AD,#D$>M+7!:1-<VFN>%M.2]N&L[K1)I)8WDSEU\G:0>HP';I6;8ZY
MKLWA#1=2Q=ZI!MN_MJ6DP2Z(67:DJ#C>% (*]]PZXH ]'OKR'3K">]N-XA@C
M,CE$+G:!DX Y-&GWL.I:;:W]N6,%S"DT988.U@",CZ&L>6[BO_A[)=P7+7,4
M^EM(D[+M,@,6=Q'8GKBN4\.W=WH\GA)'U69K*^\//+-'-M,<)BCA*LH !& [
M \\_6@#TNBO-M'UC5?[7LHAJ4CP7GA^6\%Q>$!9)5:/;/LY\M2')V@].H!%;
M'@[5;N;4[S3=6BO[35(;:)Y+:XD$L3\N#-%(.JL< CC&T<"@#L:S[/6;.^U;
M4-,A,GVFP$9G#1E0-X)7!/7[IY'%<W<WEUK>O^)-*36)-+FTR* VTB8P@9-Y
MF93@.,Y7!./E[$YK UDW::GX^U&RU.YM9K/2[6ZC> *N]UBE9=P(/''3WYH
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MV5Q=-'-.(/OQVT9EDSQP%7DG!!^E6J\GDFO=+\$^.=0LM4O(KN#5;@)(9 Y
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MTK4[;6=)M-3LV9K:ZB6:(LN"589&1VJY7+_#IE'PX\-+N&XZ=#@9Z_(*ZB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *BN;:&\MI+>=-\,BE77) 8'J#[5+10!GQZ)IL6CG2$M
M(UTXH8S;#.S8>JX]/;I21:%ID%S;W,=F@FMX3!"^22D9_@'/W>!Q[#TK1HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4452U35+;2;9)KC>3)*L,4<:[GED8X55'J?R
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MI) (&X9(YP ;-%1W$PM[>28H[B-2VU!DG'85A67C#3[[^P#%#=!=<B:6U9D
M"@(7(?G@X';- '0T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@8P,=L=*0:3IP2W3[!;;;:0RP#RE_=.<Y9>.#R>1ZF@"Y1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1M&NYDC*1R!S'\P5RP&X8SC%:M[XE@L/$^GZ%-97?G:@KM!. GE'8,L,ELY
M[8^E>4V43GPA:W>HRO=>%4UJZ.IVL8 *8N6,<C$#+1JV"R^A!Z#%>B>/+&74
MO"Z:KI)674-+D34K%D.1(4Y*@CJ'0LOOD4 ;DVK^5K2:6MC=2R- TYECV;%
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M^,H]8P\&C:HD NWLWGD$.V.16*G<%D+8W#&0".15#X7,K^$)"K C^TKWH?\
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MVEM)<+</;Q-,GW9&0%E^AZUSGP\FGG\'QM<W$UQ(+R\3S)G+N0MS*HR3R<
M?A63+XAOK7X@6-Y)<@Z!J$DFDQQYX2=.5D/NSB5/HJGO0!WQ12X<J-P! ;'(
M!QD?H/RJM-IMA<7*7,]E;2SIC;*\2LRXZ8)&17'>+YA!X^\*Q23Z@MK<QW@G
MAM))OWFU$*Y2,Y."3SBNA\._9GBNY[,WXA><KY=ZTI967Y20)/F4'&<?CWH
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MZC@=*MT4 5XK"S@BDBAM((XY!AT2, -]0.M20P0VT0B@B2*,=$10H'X"I**
M&"&(0^2(T\H+MV;1MV],8]*9;V=K:*RVUM#"&Y(C0+G\JFHH J6VEZ?93/-:
MV-K!+)]]XH55F^I YIC:-I;,6;3;,D\DF!>?TJ]10!5FTVQN8!!/96\L0 41
MO$K* .@P1T%3PPQ6\*10QI'$@PJ(H 4>@ I]% !1110 4444 <]J/@[3;W7[
M;7[<&SUBWSMN8E&) 1@K(IX88[\$=B*VIK6*[M?(O8H;A&'SH\8*-_P$YJ>B
M@"M#I]E;VAM(+.WBMCG,*1A4.>O &*<+.U%K]E%M"+?IY6P;/RZ5/7"^'HKR
M7P5J=W8M<OJTMW>I'(LJER5N9 H'F94   <CH* .O72]/39ML;8>6<IB%?E/
MMQQ5HHK,K%02IRI(Z=N*\^\+Q^*%TO61<?:@2+G[*(F0?O\ SI=Q7S1D'.-I
M;Y-NWCK4O@N/Q*MUJ1U/[0(3YWW2NTW&_DC>-W^Z1^[QGB@#M7L;22Y%P]K
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MG&%R4QC '[SISUJG9VVJ-\,-1;6OM G@M'EM"T@4HH@&PC;A@1SD/EMV>V*
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M('0$>E-BL[:"!H(;>&.)L[HT0!3GKD"IJ* *UII]E8*RV=I;VP8Y80QA,_7
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MCF@#H***AFNX()[>&655EN'*1*>KD*6('X*30!-1110 4444 %%%% !1110
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M_P!['- 'F^AWEWX;UOQ/X6#6XO)HGU;2H8VRN9-V^, ^D@SCT8U%I&H:;?\
MAN/4_#][+-XGBT>99;>-\R-/LR3<)U+"1< MW8XR*],,49?>8TW_ -[;S0D,
M4;.R1HK.<N54 L?4^M 'F,.HZ7=^%;C5O"=[-/KBZ(ZR06\FY@^ =TR]?.#
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M#$S%FB0L>I*C)H P_!%X][X"T"[GG\V5].@:25FR6;RQDD^N<YKB/!D^G_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5E:AH:7^L6.J+>7-M<V<<L2>4$(99"A8$,I_YYKTQ
MWK5HH **** "LF]T-;_6=/U&:]N,6$IFAMU"!-YC:,DG;N/#GOUK6HH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHKB=7U2\TSXDP"WM]0OT?19G^Q6\@PSB
M:,!L.P0'&1G@\XYS0!VU%9N@ZW:>(M&@U2R\P0R[ALE7:Z,I*LK#L000?I6E
M0 45Y_KMC/I_B;PK9KJNJ.FH7<ZW?^FRJ) (7<  -\H# 8QC@=Z??&\T#QKH
M-M!/JFI))9W[?9S<%C(0\;(#O8+\H=@&8YQW)H [VBN1D\4:;JEEX:O_ "=2
M2._OA' (W$>R8!P4E ;D?*_'(RH]JU=.\1PZK<[+6VF>W\Z: W *%5>,D,&
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MBOS $#@>O% '045RFD>(]/6SD^SQ:@\]QJEQ:I;7$@>1IE+&0*2Q"HNUB.<
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M*P)+R,.F5'7/(JS#X]74KWPZNEZ?/+;:H]P)&8HKQF)2&3!;&0V"3G&!QG-
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M][#SO-*, ,#!R 03GVKT"B@#B-2\):K?6_C2%9+-?[>14A)D;]WB%8LM\O\
MLYX^GO71:A8ZA=^%[BQM;I;+4)+5HHYXR6$4A7 8' /![]:U:* .!A\$ZH]Q
MJ;S/IEK'J&B?V<Z6P=MD@\SYLG&[/F9)//&.>M=;H5K>66AV=K?F W$$*QMY
M!)3Y0!P3R>F>@K1HH X&Q\&ZS::3X;T]IK"1-&U$W(<.ZF2/;(H_A.&_>].@
MV]3GA9_!FLM%?SVUY9V^H?VW_:]BQ+/'GRQ&8Y!@'!7<,C^][<][10!GZ2FJ
MBV+ZQ):FZ<_ZNT#>7&/0%N6/?) ],<<X.E:!K^C:K?6]K>V)T2[O7O0SJWVB
M$R-N>-1]T@MG#$Y&>AKKJ* .%'@B]_L&_P###36SZ+=7C7"REF$T<32^:T>W
M&"=VX!MW1LXXY=JOA'5;^#QG"DEFHUY$2$M(W[H"(1Y;Y?;/'T]Z[BB@#@/%
MFCWZ0:SK4QM5MT\-7-DZ+*Q8-@OD94#'&/\ .*O:)I%WJ*^&M6NQ;*NFV!^S
MI#(S>:\D:KN8E1M 4'@;OO=>.>NEBCGC,<L:2(>JNH(/X4L<<<,8CB140=%4
M8 _"@#S^S\&^(=)T[0YM.N].&JZ6;F-DE+F"XAF<.RD@;E((7! /3WK:O-"U
MFZU+P_JC75F]Y823&X4JRQ[94VX3N=O'7&>>17444 <'+X*U*:&^D^T6L5W_
M &ZNLV1#,R;@JKY<G ."H(R,_>]N9-=\':AKEIK\[M:0ZCJEE'8(HD9HX8T+
M-DMM!8DN?X1T%=Q10!SUOH]^OC=];E^S+;OIJ691)&9PRNSY^Z!CYL?AGVID
MNB:C9>+KK7=+:VE6^M8X+FWN)&3#1EMCJP5L\,05P.QS7244 <5%X,N]-M?"
MEI826\D6BW#W$S3,R&5G216V@ XYD)Z]L>];?BC3=1U724@TRXBBE6XBD=)B
MRI/&K M&Q7) 8<' /IT)K:HH \]F\$:PWA_Q%ID<NF(-4OX[R$('18@!%E2,
M'_GE@8ZYSQTKH[?2+Y/'%QKDGV<6TVG16FQ9&+AD=WS]T#'SXZ]O?%;]% ',
M7VAZK#XS3Q!I,EI(LUF+.ZM[IF0;5<LCHR@\C<P*D8/J*P].\&>(]#T_09].
MO=-;4]-@FM9HY@X@GAD</C(&Y6!4$'%>AT4 <Q<:)J]SKGAW49Y[25M/:=[G
M!9-QD0KA!@\+GN<G%1:?X2D;0/$&DZMY#0ZK=W,_[EBVQ93D=0/F7U]JZRB@
M#C[KPGJ4_@^RLUU-/[>M9HKW[:Z$I)<*<G<.I0C*^H&/2C5=$\2ZWH44-]+I
MBWJWEM<>7"SB%%BD63 8J6)8KCH ./0Y["B@#G=5T*[U+Q3I6H_N!:6MK<P3
M(9&WMYP0?+\N.-GKSGMBJ/A_1?%>DZ8FD7&HZ=)9V4)ALYTC;SI5"E8Q*#\H
MQQG&<X'OGL** .5\->%7T/6;R^BBMK"WNH5$EC9RLT)F!):4*0 A(P, <]Z>
MVA:G8>*-5U;2WM9(]5@B6>*Y=E\J6,%5=<*=P*D J<=.O-=/10!QND>#KC0-
M5T5[)X);/3-)DT_]Z[*\C,R-OP%( RGK_%[<ZO@[1[KP_P"%;+2KQH7FMPRE
MX6)5@6)[@'O6[10!P5IX.UJUTC0M.,U@Z:5JIO%?>ZF2/,A /RG#?O/H-O4Y
MX6Z\&ZQ*NJ7%O>6EO?/K":M8N2SH&6-8]D@P#@J&R1_>]N>\HH SM(35A;-)
MK,EI]I8C]U:;O+0#T+<L3ZX'88XR>=N?"FI2KXFL$FM?L&O2EY)RS"6%6B2)
MU";2&.$X.X<GIQSV=% 'G^N^"=8U%M3@@N-/:VE:U:Q:YWE[98BA,0P,!6*$
M[ASS@@\$7KKPE=WWB2UU>1;*WO+>Y5S?VKNDLL ',+IC# ],EC@8[CGLJ* .
M1\+:%XCT"*#1Y[ZPET6S)6VE1&^TO$/N1N#\HQP-PSD#H,YKKJ** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "N'UJSCU+XEVNF75[>QV=QHT[O!#>21*[+-$ ?E88."
M>F,XYXKN*YV^\,_VAXQM]9N1:S6L5D]I]FFAWD[G5]^3QQLQC'<\T <+I>L7
MB6GA[3]<U81Z=<+?1PWMZ6VW)28+#O8.O)BW$$GYNO)P:N+IWVC5_"FD2^(=
M0U"TN+/4$DN(KJ2+[0J-'L.5;G;N(# Y8#DD&O2+FPL[VV%M=6D$]N,8BEC#
M+QTX(Q0;"S::*8VD!EB 6-S&-R =@<<4 >::UJ=]H]QXT^RW=V8;>?3E=FG=
MVMX'"^:RY)*_*6.1TZ]JG\37^I^'=0UQ_#SRRVHT!KLQAS*L,X?:DBY)QE-Y
MQT/EY]:]%6QM$EEE2U@6288E<1@%Q[GO^-):6%G81&*SM(+>,G)2&,("?H*
M."LWTA/B3X>GT^^6:*XT6Y(=KDR>9\\)#<D_,1G)ZG'M7?VEW;7]K'=6=Q%<
M6\HW)+$X96'J".#4-MI.FV3!K73[2!ANP8H54_-C/0=\#/TJQ!!#:P)!;Q1P
MPH,+'&H55'H .E $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0] U-Y)#8:DLFF7$9D/EK,PW1/MSC<=K)GW% ';45Y7X9U%AI?BC0B\[3O>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA44*HZ # H Q+#Q;HFIV,4]K?12/(O%J&'G!NZ&/J&'0@CBLWXFZ3>ZU\/\
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M2O[Q8V/5,XQ@X!W#M76T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]^\#C4HH(YUD*@P,2CKV(SR.O(]15RBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** *NIW36.DWEXBAF@@>4*>A*J3C]*YV;Q1=Z;X/LM:ODMY9+T1%$BQ$(_,
M3(&'?+D'LOS'LM;7B'_D6=5_Z\YO_0#57P_:P7G@K1H;B)9$-A#PPZ9B R/0
MX)Y% &38>/4G\)'6Y[11Y4L<$RK<1+ER%W$!GR,%CA&PYP.,D4FC>.C?>$;K
M6+FTC$ME'&;A5N(XU9RH+8WL#&!GCS-I/XBNHMM+L;2SBM(;6-8(@@52,_=
M"G)Y)  Y//%,LM'T[3].CL+:TB2UCC2-4(W95  H).2< #KZ4 <_X8\67/B>
M"]@AC@M[NV8_O'&Y<&1@N8MXD'R*.3@$DXR!6MX5U>;7?#EKJ-Q'''-*9 RQ
MYV_*[+QG_=JY8:79:7$8[.W6)2S,3R2=SLYY/.-S,<=LUA_#O_D1K#_?G_\
M1ST =11110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% $5U;1WEI-:S F*:-HW
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,P52S$!0
M,DGM2US?C?3-2U30XDTH6\MS;W4=Q]DN3B.Z5#DQ,??KSQD#- '0)/%(@=)4
M9",A@P(IWF)MW;UV^N>*\ULM0T75],\6J-'DTG6?[-VW^F7$07&U9-L@QPX.
MXC</0>U:VC6UO_PI6SC,,?EMH*,R[1@DP DD?6@#L_-C_P">B?\ ?0I^<C(K
MS;7;*TB\?>"572$NE^P7B^1'''R L6/OD#C)[]ZY^YU^[\.:-\1;BPC?2[F
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M"/:F_$.&-]/T61D!>/7+ H?3,Z T =<\B1(7D=44=68X H=TC0N[!4 R6)P
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M^+?@<@9Y/;%.T#Q1=>(]-O)]-DTZ>XCMP5@8O$T%P=V8IE.64 @?-@9YXXH
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MCXBT_64U&6VFL(Y8H42-2N)-N[.1S]T>E1V_@O3?/U>XU!Y=2N-6B$%T]SM
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MJSLVY7TYRWU)JO'X69;J\U ZC(NJ7%D+(7L4*(ZJ,D.1@AGR>IXXX YKHJ*
M&0HT4$<;R-*RJ%,C  L0.IQQDT^BB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
C "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>exhibit1027supplycontrac005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M=3T?6Y]/U&TB=849$>WDW$$B12,X.U1D$8QQ5[1]7DU#PG9:S/;-')/9)<O
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M;3DM6C5U(9U0+D'.,=^:C\-:7J&D_#BSTBYM?].MK+[.8UD4AF"XR&SC'UH
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M@R!1O(Z$XYH ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.@S@9R?4F@#MZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME)M1RI>*48*L&QD\!N&S^M<@OB;5+3X=>%M:O[F]EM+K9)J][;QAI8D:,D$
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M:,PVD$<V_ (^:0Y Q)G@'G:!P>35G_A+M-6TBOY4NHM-E*A+Z2$K"=QPI/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 A(4$GH.:PM+\666JW]K:);7<#7EHUY;-.BJ)8@R@D ,2#\RG# '!^N
M-N99'@D6*3RY&4A'QG:<<''>N%T+PKK]EKFC:G??V8TUK936MY*DTCR7#,8R
M)22@R24/RG[N>">@ .]KF?%TDOVKPY;)<3PQ76JB&;R)FC+IY$S;=RD'&54]
M>U;FFF_;3H#JB6R7VW]\MLS-&#_LE@#CZUS_ (RECAU'PG)*ZQHNLC+,< ?Z
M-/WH R/&5]XBL-9T^WTK[1]E#*(ODSYDOERX3<9 9<@9*MM&57YQFCQ;J7B6
MV;2A8^?M=;<MNA$8:X+\(2).2W.8SA?]L=_0%974,I#*1D$'((I: //_ !5J
M7B.WT71WMS<)YB0&\=H1"1(98@ 65R4)8[2@# @MDC&:GUF?4D\*:/J5U/>6
M^J?;[.*8!C ,/<HKJT2NR'*DCJW'>NYKD_'\\2Z/8PM*@E;5; JA8;B/M4?0
M4 =9152V.H&]O!=);"T#+]E,3,7*[1NW@C .[.,9XJW0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 -D8I&S!&<@$A5QD^PSQ5#0=9M_$.AVNK6L<L<%RI9%E # 9(Y
M)';UK1KQ_P ,VUS8^&?!&IZ=J%\;JYO5MIK4W#-#) 6?>/*^Z-H!;<!GCDF@
M#V"L_5[J&U@A$UC+>F641QPQ1JYW;2<_,0 , \DU;@N;>Z#FWGCE$;F-S&X;
M:PX*G'0CN*EH YFP\96M]YBV^E:D(X+LV,C^4FV.8$*5.'Z9(&>G/6M30=:@
M\0Z/%J=M%-%%(\B!)@ P*.R'."1U4]ZYWX=D&+Q1W_XJ*]_]"%<QX?$MAH_A
M&_M[R[62XU^YM)8_/;RFB:2Y)4QYVGE0<XSGO0!ZE:W;W,MTC6D\ @E\M6E
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MGT4 5[NPL[]$2\M(+A4;>HFC#A6]1GH:C&D::)(I!I]IOA3RXV\E<HO]T''
M]JN44 9XT+2!'!&-*L0EO)YL*_9TQ&_]Y1C@^XIRZ+I2+ J:99J+=BT($"CR
MV)R2O'!)]*O44 5[:PL[)I6M;2"!I6WR&*,*7;U..IJ.72=.GO5O9;"UDNUQ
MMG>%2XQT^;&>*N44 4[O2=-U"X@N+W3[2YFMSNADFA5VC/JI(R/PJQ<6\-U
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MXVW1,\:1MD@X(&S(&.<]1BMMM?CDU6ZTS3;22]N;0*;DHRI'$6&54L3RQ'.
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M;RS)-)!$\J<J[("R_0]J /*KU+"TT_XI+'(EM?(99H_+E,<@'V6)@W!!P7_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQPZDC!'J* .IHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]20#@=SB@"Y=^*)M*T^/5-5TN2TTUBOF2F4-);AB &E0#@9(SM+8^F2.B!!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.0RKT4\G.!SQZ5S;SMX@^)U[HMYEM,TJQBF^RD_)/-(3\SC^(*HP >,DGKC
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MY/,DFQ=H< ;>-V1@GO0!Z.RJV-R@X.1D=#2U' 8FMXF@(,10%".FW''Z5)0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZTNWNKQ8;EY9#()=LB-(Q9F5E (.YB?:K%AHT-D"TL]Q>SF/RC/=L'<I_=X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLZ(K233E=S*NX%5500#P22>V.8-9U_5_#EKY-Q]GO+V_U&*RTIMFQ3O4?-*
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MJW]G"RM;++&2YW$@!@VWG(ZD5E:QX.O-1\"2LBWJ^("1?QQ?:1A+T-O&!NV
M!N.O"T :7C/7M8\-WFGWUE";VPR[7UHJ R")0,O&>N5SG:<Y [5HKJXOM4TB
M>PU!7TN[M);@E54APOE[2"1D#YSGZ=J9')JMY?:%=76C3P.L4GVM?-B80.R@
M8X?YAD'IGBLK2_!MQH?C1WLG4^&[BWG86A_Y=9Y&CW!/]A@"<#H0>F: +?AK
M5-2\7Z5_;D-X;&QGD?[%"D2L6C5BH>4L#RQ!.%VX!')/-4M5UC7M-U'PO97=
M];VTFHW%Q!=ND2[ $1W5DW9QG X)/!]:D\(6FK>$-'3PY<:5<WMO9NZVE[;/
M%MEB+%E#AF4JPS@\8XX-'B?3=5O]?\*WG]CM>0V,\TUVL4D6U0T3(H D9=Q!
M([=L^U '0:1+-+/>;M4BOX$945D10R/C+*2O!X*'\36K61I D2[NU31&TRU;
M$A+M'F:0C!($;,  %7KU)]N=>@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.!T&YB2 .P'%(- L%\1-KP$W]H- +8OYS;?+#;@NW.,9)/2@#4HHHH ****
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M8=XV$%@-K;R<@D9!SZUGZ!X7U30;_P (Q-:O/#IFG7<-S-&Z;4DE:-@H!()
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M&0,63$BY)&'7G!.0>U '444R'S?(C\_9YVT;]F=N['.,]LT^@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.<8 VDG_ &L=0<:U !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4(5+=P8HWB9N"6^\"K#..0>@Z5JR^$=/GTO5;*66Y9]50I>W19?.E7;MQG&
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MBT_E(KR_,"-O4A>#TR>N!,WBVYM]>6.Z\A=+O-+-_8,(6$K.N"\;?-@D!E(
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M[CP38W5EJMH]Y?"+5+M;NXPR9\Q=N-OR<#]VGY>YH Z6BD4$* 6+$#J>II:
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M%M;/.#^[5&1@@)4@KW&"#UJAXPTS4+_X;:[#%I]P][J=P)8K14W.%\Q,;L9
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M[)$.Y3@X[>XKS2TTB[>SU*"ZM=<L96\0/=VM]"@>2'=#@2E5W;U/*L,8^?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !5%]9TN*]:RDU*S2[5-[0-.H<+ZE<YQ[U>
MKB_^:V?]RY_[<T =7:ZA97UG]KL[NWN+8Y_?0R!TXZ_,#CBH3K>E?8?MW]I6
MAM-^P3"92A;.-N<XSGM7G=I]H\#7%SXDM_,ET"^O[H:M;C+&V<7#JMP@_NX
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M$1*PSV[9'F ,24P0002<>IK6B\0Z5,MR5O%#6NWSD=61TW?=RI /S=N.>V:
M*5QX.TZ\TW4K.YENI3J>!>SLX$DR@8"D@ *H'90._J<[$%K]GL4M4GEPB!%D
M."X Z=L9_"L?4?&6DZ>MINDE=KF\%F%$+@I)C<0PQD87G!ZTO_"1:=9W.L7%
MYKUF;.S\K?'M"FT)7D.V?F+'D# (Z4 167@JQT_1QI%M?:DFGC</(%QU#,68
M9QNP23W[U;O?#5E=ZJFJPRW%CJ"Q^4;BT<*70<A74@JP';(..U2VWB/1KN2\
M2#4K=VLD\RX^? C3GYB3QMX//3@U!/XLT:#3=0OC<LT=A")YT$3>8J$$JVTC
M)!P<'H<'GB@#1MK%+6)U225I).7F=MSL?7GC\,8'I570M!M/#MG):63S-"\K
MS$2ONP[DLQ!QW))JI:Z]!J-]HY@U.&#[5;O*;!X\RRC Y!."H4YYQ@YJ]'KV
MERWJ6:7D9FD9EC'(61E^\J-T8C!R 21@YZ4 /N]+CO-0LKUYIU>S9FC16&S)
M!4DC')P2/;)Q5:^\.VE_KUAK,DMPEY8*Z0&-PJ[7QN##'S X'7TXP:C3Q?X>
MDNH[:/5[5Y9)S;(%?.9>FW/3.>!ZG@5MT 95WX?M;W7K'699;@75BKI %8!5
M#@!QC'.<#KZ<8K5HHH **** "BBB@ HHHH S-?T*T\2://I5^TOV2? E6)MI
M8 @XSU'('2G_ -E*=2MK]KJY>:WA>%<E<%6*EL@#DDHO/M[FJ?BGQ"/#VG6[
MQPB>]O;F.SLX2VT/,YP,GLH ))]!2R1>(;=;=UO+.Y8S1BXC^S&,>66 <H=Y
MP0,GG/2@"S+H6G2ZK-J?D!;R>U-I+*O!>/.0#[CL?>JD7A2RC%E%)<WEQ:6+
MK);6T\N](V7[ISC<V.VYC@X/85<N]>TNPG,-U>1Q,K*KDYVQEONAVZ*3VW$9
MJ2/5[&74KC3H[@->6Z"26$*=RJ>AZ=^<>N* *^F>'[72=2U&_@EN&FU"027'
MF,"&8 *"!CC  '%17?AFVN]?76_M5Y#?);FV5XI  (RP8KC&.2 <GGBI9_$F
MD6UE'>2WJK;R1><)-K$"/^^<#Y4_VC@>]1W?BWP_8W(M[G5[2.8B-MGF G#G
M"'CL30 2^%]-NM,O+"_6:]BNY!),UQ(2Y8 ;2",;<;1C;C!YJ6RT1;4Q^=?W
MUZL1S&MU(&"GL> "Q]VR:A@\7>'[FY@MX-7M9);B1H8@CY#.I(*YZ9X/UP<4
MC^,/#J2^6VL6FX7'V4D/D++Q\I/0=0.>_'6@":Y\/VMUXAL];DEN!=VD;QPA
M6 0*^-PQCG.!^7&*TY%+QLH=D)&-RXR/IG(K/LO$.D:@+LVNH02"SYN#NP(Q
MC(8Y_A(!(/0X-0/XKT*&&YEGU*&!;;;YPFS&R;ONG:P!PW8XY[4 9\/@'2(M
M"30S-?R:2I.;1KDA&!;<0Q&&())."<5NWVF07^DS:8VZ*VFB,#+#A<(1@J..
M...*SY?%^AQV&IWB7R3QZ9'YETL(+LJX)!P.H.#@CC@\\5HZ7J$6JZ9;WT((
M2:,/M8$$9'3D"@ TO3HM)TNVT^W>1H+:-8HO,.2$48 SWP!]:MT44 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 4=1TN/4S;>;-/&+>99
MU6-@ S+TW9!R!UQZ\]A5?6?#UIK=SI]Q<R7$<NGS>?;M"X4J^,9Z<C!(QT.>
M15#QQK6HZ#HD%YIK6PE>\@MV%Q$SKB214SPR\C.:KZQX@U;PM>Z=+JOV.[TF
M\N4M'GMXFADMI'X1F!=@RD\'H1GO0!IW'AFTDU>35;6XNK"^F54GEM7 $X7[
MN]6!5B.@.,XXS4E[X;TS4M*;3[R%YHFD$ID:1O,$@Z2!P<AA@8(/&,#CBI9]
M=TRVOH[.:\1)I)!"NX';YA&0F[&T,1R%SD^E(^OZ9'*\;7/S+O\ NQL0Q3.\
M*0,,1@Y R01CK0 EIHPMBC37][>-'_JFN74^7QC( 4 GW;)_,U0L_"%KI\5Y
M'::CJ4*WD\EQ-LG +2.<LP.W(S[8QVJ&T\5V6M:?HE]9ZG%8I?7"[(9XLO<+
MM)\M02,'D'<,XQBKO_"7^'C<K;C5[5I6N/LH"OG][Q\I/0') ]SQUH 7_A&+
M$:OI^II)<)-I\!M[=5<;%C( *D8YSM')YXK5NH!=6LL!=T$BE2R8W 'KC-4I
MM?TN"^%E+>1K.95@Q@[1(PRJ%L8#$$$*3DY'K65-XOTZZM]?AAU!=/DTPM$]
MY<Q'RXWV*=V#@$ N.,\XXXYH U]$T>VT#1[?2[-I3:VR[(A(VXJO89[_ (TY
MM+C;6DU0S3^<D+0*FX; K$$\8ZDJIS[#M4<^MV&GVT37EXI9H?-+(A.4 &9"
MHR57GJ>!GK4=UXGT.S>))]4M5>:'[1&H<,7CX^90,Y'(QCKGB@!/^$=M!XG/
MB%9;A;YK<6S!7 1HP20I7'/))SU]\4[_ (1^U_X28Z_YMQ]M^S_9?O#9Y6[=
MMVX_O<YZ^]7;&^M=3L8;VRG2>VF4/'+&<A@:L4 %%%% !1110 4444 %%%%
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MB\GC\JZOP\TQ\/6"W%K-:RI B-%-C<"% .<$CMZUIT4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% ')?$2SO-0\/6]O86<UU,+^V
MF*1 <)'*KL>2!T%0>)M.U#QC)INF+836FEQ7D=W>7-R5!<1G<(T4$G).,DX
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M9!F*7&]?K@D?K5JB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M**0LH."P'U- "T4@96Z$'Z&EH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "N"^*6BZ:W@3Q)J;V4$E\;/ G>,,ZA>@4D9 Y/3U-=[63XET-/$OA
MZ\T>6X>WANT\N1XU!;;WQG@4 9=U_97A&R@OK#3;>*\U&2VL42)!&LDC-A"V
M!T&YB3UP*DCU[4_[9U30&M[5]5@LA>6<FYDAG5BR@,.2F'7!Y/!!]JNZMX>A
MUO0H]-O)Y \31RQ7,0"O'+&04=>HR"/IUI@\/2&2^O7U&0:K=6HM5O(XE7R4
M7<5V*<C[S%CG.3[   &S"93!&9U19BHWA#E0V.<$]1FGTR%&C@CC>1I750&D
M8 %B!U...:?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7-2:[J!\>MX=C2U$/]F_;EG96+#]YLV$9_'.?;%=+7%E9E^,)NS:7GV4:'Y'
MV@6TAC\SS]VW?C&<<]: )_"OC)M=O-1TB]MTLM8LI)%\O)9)XU=D$L><$KN4
M@CL1[U'-XNN;:UT=+@V4%UJMY+;)+)N$,6S=UYRS-MP!D9)Z\<TIO#LVN:#'
M?:?YNGZ_I]]=SV%Q/ \9^:=VV.& )C=2,_4'M2PQ17G@_3--\4>'Y98+WSFN
MX1 \OV:3>6&=HR!R0&'L>G- &CK/B#6M#\-:[J5S96AETQ?,BVLVRYC"@D^J
M')(QSC'4YI+?Q3?IXDL-"U"UMDFU*S>YM+F!F9<K@LCH<$<$$$'GVKD;C2]4
MM? 7C/2;0ZKJ&DM"(M'6>"22<ED.] ,;B@. "1CK]:[S1]'TRTC@U@6MP;TV
MJQ&6X\V25$ZE KY91GL ,T 9OA[Q%KNO^%K;7(X-.C\YG46[,X)VR%,!LXR=
MO''4@5H'7[C4?$E[HFD)#NT]$:\NIP66-W&5C5006;').0!D=<\<;X+M;+3O
M!.G'4-&UD:K:S23+$MA<!B_G.R#[NWD$=>!GG'6MC38Y_"?C77YKZUN7T[69
M(KJ"ZMX7F6.0)M>-]H)7H""1@COGB@#<^V>)'NI+5;&Q4QR+_I#.YC>,J3N
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MVW?C;G'/6@#K+1YY+.![F(13M&IDC4Y"L1R >^#4U%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*/NP498_0<?F*2SFNY1/]KM4MRDS)%MEW[XQ]USP-I/ISCUH LT49&,YXHH
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MJGBJVL-$T_5K>"2\M+Z:WCCDB90 LS*JL<G./F'0&MN65(8GEE<)&BEF9C@
M#J30 ^BL?PUXBM?%&AIJ=FCHK/)&T4HVNCHQ4AAV/&?QJAIGB?4=8&IFST:-
MO[/O);.0/>;2[IC.WY.AR,9Q^% '3T5'!*9K>*5D:-G0,4;JN1T/O4E !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?#L6I:;-;JJAH8G$J?:#'V"X(W8X^\.QKT_7=#.M'3<77D"QO$O%'E[M[("
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ME1Z=*]GQQBC H \=U*\M&\%^/1#(BQMK<;QC&T%2+<Y ]#AC[\FKVO3:3?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC$F/[V  ?7 ].8IO"]W?Q:9;:KJB7=KI]Q%<IBUV2R21\H7?<1UY.%&?89R
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M4#I69>^'I;OQ?INO"]5!8PRPK!Y.=XDV[LMNZ_*,<?G6Y(',;"-E5\?*67<
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M(^8CG R<8SC(J&3Q;8V]C<7-W!=6SPW:V0MY(P999F"E40*2&)W#&#CJ>G-
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MEG]MM@UQK:ZL'V-A0)5D\O&>>4 S[]*[89QSUH **** "BBB@ HHHH ****
M.4\=ZU=Z9::386,I@N=7U&*P%P "85;)=AGC=M! ]S[4FMV^BZ!%ISS7U_9.
M]Y"D<J//,9WW@B-\;MV[!'S>M:7B?PY;^)M*2TEFDMYX)DN;6YC +03(<JX!
MX/T[@FL_5- U?7H]*@U&YLHTL;Z"]>6!&)F:)MP 0_<!/^TU $E_XQBM+;5+
MV&RDN;#29/+O94<!E(4,^Q<?-M# GD=P,D5/'XIA;79]->)8XTL!J$-RTOR3
M19P2..,<9],CKFLZ;P?=*GB&QM+V)-,UYWDG5T)D@>1 DI3LVX#(SC:>>>E7
M=7\(VVI2Z(T,IMETQBA51GS;<IM:$_[+83/^[0!!>^-%L[=LV0-[%9I>3VCW
M"HZJV[:BY'S2':WR\#CKR,H/&DESJL5AIVA7MT\EE!? EXXL0R-MR0S#!&#D
M'!XI^I^']93Q.VMZ#J=K;-<P);WD%W;M*CA"Q1UVLI##<PQG!!JQ:Z#=V_BY
MM9>[2:(Z='8E74^8Q1F;>3TY+'C'^% &=;>/?/-I(^C74-I/J3Z8TSRH2DP=
MD'R@G(++C(Z9'6FW/C_[/;W]VVB7?V33]1%A=2>;'E22@#!0?FYD''I^51IX
M+U!=+M[3[;;%H=<.K%MC8(,IE\O&?5L;OTI;OP7?W.BZ]IXO;93JFIK?J_EL
M?* ,9VD9Y_U0YXZGCB@"^OC.&WFUB+5+&:QDTR&*X96D1_,CD+!,$' 8LI&"
M>N.<<U2OOB%%IT&I--IDLK64,<^;6998Y$=MO#\893U7&>01D5)JO@R;6M0U
MR:YO$ABU.QAM5\D'?"\3,ZN">#\SYQQT%,O_  UXEUOPO>:7J^L6#W$R+$DD
M%JR( &#%V!8Y8[0,# &3UH DO_&=S:VWB*/^R'AO]*L/M\<4TRE9HB'P<KG!
M!C;(^G/-=!HEU<WNB65S=HJ3RPH[A6R"2 <]!U]*P]0\*7.IZIK5S-=0QQ:I
MI TTJBDM'_K/GSW_ -8>..@K<T6TNK'1K2TO9HIIX8EC9X4**<# P"2>WK0!
M?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XWXF-+
M%X:MI(;BX@D_M&TCWP3/$Q5YE5AE2#@@D54\7O<>#3I>MZ9>7A@^W0VMY9SW
M#S1RQ2-MRH<DJX)!!7&><YK=\8:#=>(])AL;:XAMREU#<%Y4+?ZMPX& 1U(]
M:BOO#5UKNHV$VM7D+V=C.MS%96\157F7[K.Q)) SD* .>N: (KKQQ:07BI'!
M]HMQ>_89'BD!D1]VTMY?4H&X)SD8)P1S4]IXI.I2W*Z?:)<+!//;OBX >.2/
M<,2+C*!BO!YX(..<56L/#>MZ5J]XEEJ]N-$O+M[QX9+<F>)G;<Z(X; 5FR<D
M$C)QZTD?A"23Q1;:W<-:QW4#S!KBV0I)=1.&"1RCH0H*G/.2HQB@#/T_Q,=5
M\/\ A#4=8TV0S:E=QF![>?:D<C1NP+ $$C&X;2"..:MOX^\L74S:+=+:6FIK
MIMS.TL?R,S(H8*"21F1<X[>O016?@O4K70O#6F/J%K(-$NTG5Q"R^8B(R*I^
M8X8AR2>G'2EN?!=_/I&L6(O;93J&K)J0?RV/EA7C;9C//^J SQU/'% &CJ7B
M]=,U%(+BPE2W:_AL%ED;8TCR;<,BD?.@+J"P/7/!Q63=>)KB?3O&O]JZ69=.
MTHO"T=M<;9'C$*.W/RD$AR<@Y'09ZTNH^"M7O;N]E75;3$VI6^H1--;,\B>4
MR,(BVX?NP4)  'WC]:LW?@^_FM_%EK'J%N(->0XW0G=$[0K$Q)W8(PN0,#KU
MXH T1X@S*-/TNQ:[N8+*.ZEB,VW8CY"+N.<N=K8!P..2,C-&#QY#J,NE)I.F
M7-Y_:=G+=6[%TC \ME5D;)R""V#].,U)!X:U#3M;75K"YMO.FL8K.[AE5MCF
M/.R12.01N8%>X/48S46F>"Y-&U#0Y;.YC:#3+.XMRLBD-,\S*[/D<#YESCG[
MU &YX>UJ+Q#H-KJL,,D*S@YBDQN1E8JP..#@@C-:=8GA/19_#WAV#3)YXYWB
M>1O,C4J"'=GZ'TW8_"MN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y
M/QQK%U8_V+I-C,UO/K%^EHUPOWHH\%G*Y_B(&!Z9SVI=9AT706TLR7M_92RW
MD4<3(T\WVA\Y\M\;MQ8 \M]:T/$_AN'Q+I\,+3O:W5K<)=6EU& 6AF3[K8/!
M'4$=P:I:GH&K:[)HXU&XLHDTZ^BOF>W5B9F0' VG[@.?5J "^\:06=G?ZDMI
M)-I6GW)MKNY1QN1@0'94Q\RJ3@G(/!P#CFQ_PE")J^K:?-;>4;"S6]21I,K/
M$V[YEP.@*D'T)'7-9DG@FX-EKFCQWD7]CZQ<O<2!E/FP^80947L0QS@G&W<>
MM:>K^%H=3UG1]028P&P+)(B#B>$X;RS[;TC/T!'>@"KJ?C6/38[@&R$ES:0)
M/=6HN%$B[AG8@_C< 9QP.1@G-.7QA-<ZW+IMAH=Y=&**VG>3S(XP(IBWS89@
M>-I^4X)Y].6WOA[6H/%%QJ^A:K:V\=_'&EY!=VYE&Y 0LD>&7#;3C!X.!5NP
MT*[LO%6H:L;F.6*ZM(+8(P.\&+>0Q;H<^8<\=J ,W3_'HOETF=]&NK>SU*[D
MLDG>1#MF4R  J#G!\MN>Q_.FM\0"D#71T.\%I%J9TR9_-CW))Y@C!"YY!8CO
MQGOSAEKX+O[;1]#L3>VS'3-4?4"_EL/,#-*VS&>/]:>>?NCCFDD\%Z@^C7=C
M]MM@UQK0U4/L;"@3++Y>,\\KC/OTH OIXTAB&KKJ5E+93Z8\*O&9%?S/.XBP
MP. 23CG@'OCFJEU\08K*&_,VF32O9RVZ%K659(I%F<(K*YQG#'!&,CCMS2ZG
MX*N-5NO$,LE^MO\ VHMJ8'B0E[:6W.Y'YX;YL'''3'>EU#PYXCUOP])8ZKJM
M@UTTT#JUO;,D:B*19,D%B2S%0.H '0=<@$6L>-[RTT3Q0\6E&#4M&MUG\N:5
M65D=6*/E<_W6ROJ,9YS77V4DTUE#)<1B.5ERRJVX#\<"N6U/P=<ZK-XI,EY#
M%'KEA':+M0DPE%<!CS\V?,/''2NGL([F&PACO)(I+A5 =HD*H3[ DG]: +-%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !6)J_BS2M#^TF_>Z2.UC$L\J6DLB1
MJ>F652.W3.:VZY#XH #X8^(R  3:,3[]* -[3M:M-4GEA@6Y22)$D99[:2'*
MMG!&]1G[IZ5HURWBO5I]'T#3I;=O*-U>6EG+<@#,,<CA6;G@<< GH2#5:-KY
M/%FL^'1J-TNGR:6EU%<F3=+9NS.A =L]=NX;LX(/:@#LJ*C@0Q6\<9E:4JH7
MS'QEL#J<<9-24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5=1TVRU:R
M>SU"W2XMG^_%)RK?4=ZM44 59=-LI]-;3I[:.:S9/+:&4;U*^A!J!="TL6%S
M9&SC>WND,<ZOEC*N,88GDC''7BM&B@!D,4<$,<,2!(XU"HJC 4#@ 4^BN/>Y
MO9/BJVD_;[A; Z+]J\A2 !+YVS<#C/3MG% '845Y]X8\2ZC::Q+H/B.=I([N
MXN%TG4&PIF6.1D,3D  2#;D<<@^HIFJ:[?Z/X=TJ]N[C4)-,:]F74[R!0\L4
M0+A#P.$R%W$#.!ZF@#T2BO/]8U.Y@^'7B#6M(\1O>PI";C3[I&1C&%090D##
M?-G[PSSSR*-+UJ_D\:6&D6FKR:KI]SIK37C?(S6<@QM.] ,;LD;3GID4 >@4
M5YGX1UMM6\)Z=-?>*;D:Q<SO$$5HR2PE95!3;TVJ,].,UNV6IW7B7Q?K5A'=
M2VNF:.T<#" [7N)F7<Q+=0JC  &,G.3CB@#KZ*P/[%U5KJ1'UZ\%F)%DCV",
M2!=I!C)V\C.&SUZ#/KB>!CJVL:8NHW6N7DCP:C<PM$XCV21I(Z!2 H.< '(/
M44 =U15;4+V/3=.N+V8$I#&7*KU;'0#U)Z >IKG/!&LZE?1ZII>NF,:SIMTR
MS"/[K1R?/$P]MIV_\ H ZRBN!O8M6L?&/AG1F\1:C)%?6UV]TW[H%GC6,@CY
M.!ECQ7:Z?;SVMC'!<73W4B9!FD #.,G&< #.,= * +-%%% !1110 4444 %%
M<I\2M0O=)\ :KJ6G74EK=VR*\<B8.#O4=""#P36?XLO]=\.ZSIMYI4EQ?V45
MM--J%@V&:2)&B4O'QG>/,+8S@XQ0!W=%<S%J@U35K"]TF^:YLKK39KB&,.!'
M(ZM&%)XR/O$$?F,BN?\ "6OOKK6<#:Y>6_B&V=3JVE7BJA;CYPB$<*#R"AZ8
MSG- 'HU%>3ZKXBU&PD\;,GB6:"ZTN>,:;:N(G\TF)7$>TKN;<S;>#GGK6K-K
M=Y_PF^EVNJ:I-I=M=:$;R:W#JH2X\Q 0"P)X#,,>U 'H=%<)JGB.?3M%T]-*
MU%KV?6M46RLKFX56\E22'?  #!=CD>N1G-=!+H]_#]F>SUB\+I,AG6X97$R9
M^;M\I[_+@<8QS0!MT5P%S%JUGXVT#1&\1:C)#=65S+</^Z!9X_+P1\G ^8\5
MVEI:S0Z:EK<7DMQ*JE3<'"NW/!. !G&.@H MT5XY:^,KZ+X;6>K1^)7N/$DD
MQ2*R?RG^TOYQ41E N0"HZ@C'7-==XPO-5T"]TSQ&MW<?V+ X35;)-I"(PP)0
M<;L*V"P!Y'XT =K16%I;S:KJ]QJT-],=*VB&VA4J8Y6&=TH.,X)^4<X.TGG(
MK=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **9-+';P
MR32N$BC4N[,<!0!DDUR'A#Q#J5]KFKZ7K*"*XQ'J%BA&#]DD&%4C^\C AO<T
M =E17'Z)J-UXMUC7'^US6VF:9>MI\,,#;&ED0#S'=NN,G  ('!SG/$&M:EK&
MB7-AHD>HF>\UK4C%:W4L:EK>W6-6D.  K,,-C(_B!.>E ';T5C-I%[!=64EK
MJUVT*2$W44[!Q,I1AP<94ABIXP..E<;HFN"YM]=35/%%W!<V^KW-E;*CQ[P@
M<)& NWDY/>@#TNBN$\07]U9^.=$T^;7IK"RN;"XDG97C13)'L"D%U./O'BHO
M#%WKOB/PU)J-[JMS"EK)=10301I']NC5AY<Q!4XX!Z8!SGTH ] HKC? 7]IZ
MEX9T/6[S6;NXDN;0/<0RA-C,P^\,*"""/7')KHM;OI+#2I9+<*UTY$-LK=#*
MYVIGVR03[ F@#0HKE?"&JW^O>#GBNI_)UNT,MA=R  [+B/Y=^.G/ROZ<UF^5
MJ?\ PL4Z!_PD&I_9/[&%WNS%O\WSMF<[,=.V* .\HJ&TCEALX(IYO.F2-5DE
M(QO8#EL>YYJ:@ HHHH **** "BBB@ HHHH **** "BBB@ HILDB0Q/+(P2-%
M+,S'  '4FN/\(^(]1OO$&K:9JZ".1UCU'3UQ@_9)!@*1_>5E^;W:@#LJ*X_1
M]1NO%FN:Y_I4UMI>EWAL(XH&V-+*@!D=VZX!8  $#@DY[0:WJ>L:%+9:/%J!
MGO-:U,06ES+&I:V@$:ES@ !F&UL9'.X9SCD [>BL9M(O8+BSDM-6NS&DN;F*
M=@XF0J1UQE2"0?EP.,8KCM&UQ9H_$":KXGNX)K75[BTMU1XPX0, @"E>3DXY
MZ]Z /2J*X3Q%?7=CXT\.Z?-KTUC9W=G<M<NK1HK/&(]K N#C[QXIGA2ZUOQ+
MH<E[>:M<QQ6MQ=007%O&D?V^)67RYCE2.@8?+@'K0!WU%<7\/SJFJ^%]#UR]
MUF[N);BVW7$,@38Y/0C"@@@@=\=:3Q;J<VG^,O"]L=7EL+"^-RMUAU56V1AD
MY8''/IUH [6BN&\-ZK>Z_J?B33;?5Y;K2[8QI::I&J"1)64ET!"[7VG;SCO@
MYJIHNN:K<:1=^%;V]F'BVWF-NTX R4;YENE&,;-G.,?>&T\F@#T2BHK:$V]O
M'$9I)B@P9)2"S>YP /TJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "N7.CZD/B2=>$4!L?[*^P@>:?,W^;OSMVXQVZUU%9MYK=K:Z@FG
M(DMU?M'YHMH%!8)G&YB2%49X&2,\XSB@#'?PJ-9\*W&D:S$L,CW4UQ#+;R[F
MA=I7D1T; (9=P_7M2Z7IWB'1M&TFUWVM]+ LHOM\AC\XLV0R?*><\X.!R1FM
MK3-8L]5-PENS+/;/Y=Q!*NV2)L9 8'U'((X(Z$U-=WGV1K9?LUQ/Y\PBS"FX
M1Y!.Y^>%XQGW% ' W/@2].@^+X-.M;2R;7E5(;)9<10$(5:0D+@,Q.2%&.!S
M7>623P:5"DD*"X2(*R*^1N Q]['3\*MU6AO/-O[FU^S7">0$/G.F(Y-V>$.>
M<8Y],B@#D/#&C^)/#_@RVT5K#39KF%I&65KMC&&:5G5L>7DXW#CVZBK<6A:G
MH/BK4M6TJ.&\L]5$;7=M)+Y3QS(NWS$.""&&,@XY&0>U=;10!5MFO3%)+=)$
MKG[D,;[@OU8@9)^F![]3A^!]&U#0=$GL]12 2M>3W"F&0N"LDC.!R!R,XKIJ
M* ,77-/NM4N+"U\F)]-$PEN]TI5FV@E  !SA]K=1]T5DMX9O-,\>6FLZ+! M
ME+:M;:BDD[!G&X-&RC!R5.[J1P:["B@#F-6T?4;OQWH&KP1P&RT^&YCEW2D.
MQE" %1C'&SN1UKIZ** "BBB@ HHHH **** .;\>Z+?>(_!>HZ/IPA^TW:JBM
M,Y15PP))(!/;TJXUO?R^(["^:VB6"*TFAE_?98,[1$8&.0/+/.1U'%7[^_M-
M+L9KV^G2"VA7<\CG@#_'MCO6>?$<$0MWN;'4+:&YE2&&26#AF=@J@@$E,DC[
MX7\Z ,?3O!DFA^)=1OM+N/+TZZM9?*L\X%O<.REBGHK;0<=B#CK46I>&]2\0
M7F@W&H6%C;:AIMU%<2:C!,6)5.61/E#8?H0V  3UQ7;44 <QX<T;4=.\2>([
MZ\B@6#4KF.>#RY2S*%C5,,,#!^7/!-17NDZP/B'#K]K;6LMI'ICV6U[@HY9I
M%?=C81CY<=>]=910!Q^M^&]3\0:='(WV/3]1L-02^TX(QDC#+R?,.T$[RSYP
M.,@\GKN6<^M7)C%W8V]EM(,K+<>=N]E^4<'U.#[>FI10!S&HZ-J-S\0-&UF*
M. V5E;3P2%I2')DV8(7&,#;Z]ZZ60NL;&- [@<*3C)^M.HH \UM_!WB%OA>?
M!T]KI>^1)(WNGN7=4#R,^Y5\O)89X&1R.M=AJ6E7#^"[G1K5Q<3M8-:)).^-
MQ,>S<QP?J>*V20 22 !U)I(W26-9(V#(P#*P.00>AH S/#-E<Z9X7TO3[Q8U
MN+2TB@?RVW*2B!<@X'''I6K110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!C^(K.\U*QCL;>&*2WGE5;S?*4)ASEE& <[A\O;@GFL75O
M"MS;^)]$UKP_! LMJTD5X)KAE\VW<<J.&R0P##H,BNGU+4[/2+)KN^F$408(
M."Q9B<*J@<LQ/  Y-5(_$%M]OM[*[@N+&XN<_9UN4 $Q R0I!(W8YVD@XSQP
M: ,?3]$U7PSKFK3:9!!>:7JER;UX6F\N6"=@ Y&00RM@'J"#ZU)XA\.ZEK4>
MG:C#+;0:SIEW]JM58DQ8(VM$S8R0PSE@.#CCCGJ6.U2<$X&<#J:@L;K[=807
M1MY[?S4#^3<)MD3/9AS@T 5+6?5[@H;FQALU7EP)_-+GT7Y0 ,]SS[<Y'.^'
M](U_1+368I--T^Y^W:E<7L:F\8*!(V0K?NSR/;-=9>7GV0VX^S7$_G3+%^Y3
M=Y><_,W/"C')]Q5F@#DY]%UB?QKH6KRK:R0V5E+;W+"0JS/)L)*KMZ H>I[U
MTE^DLFGW$<"*\K1LJ*S;021CD\XJQ10!@>"M*O-"\':7I-^(A<V<"PL8G+*V
M.X) /Z4_4M+N-5UVS%U!&^E6R/(,3$.9R,*< = I<=?XNG%;E% '(Z3X=OM#
M\<ZC>6$,"Z'J$$9F0SL9%N$R-X4C&"N ><Y J<:/J/\ PLHZ[Y<'V#^R_L/^
MM/F;O-W[MN,8QQUS73T4 %%%% !1110 4444 %%%% !1110 4444 %%%% &1
MXBL[S4=.6QMHHI(9Y%2[\R4I^XR-ZC .2PRO;@GFL36/"MS!XBT/6?#T$"W%
MG(Z70GN'42V[KAD'#9.0K#H,BNHU'4;/2;"6]OIU@MX@-SM[G   Y))(  Y)
M-43XAAC:V%U8W]JMS(L4+RP\,S' !VDE/^![?3KQ0!DV.B:IX:U_5;G2X(+S
M3-5G^UR0--Y<D$Y #E>"&5L ]00?6I/$7AW4=<M]/OHYK:WUC3;L7=H"2T0X
MVM&[8R0P)R0.., XYZJB@#,M)]8N2GVFQ@LPO,@6X\TL?1?E''N>?;G(Y[0-
M(U[1H-<CETW3[D:AJ5Q>QJ;P@;9,85OW9YXYQFNTHH Y*ZT76;GQCX=U:5+5
MXK"TGBNF$A!9Y0F2B[>@*'J>]=/=B4VDHA17D*$*K-M!/N>U344 <]X'TB]\
M/^#-,TC4!%]ILX1$QA<LK8[@D _I5;Q!I&JWGB[P[JUC!;20:9]H,JRSE&?S
M(]@VX4].O-=510!RFC>'+^'QOJGB:]^S6QN[:.U2UMG+A@I)\R1BJY?L,#@=
MS4B:-J(^)4NO&*#[ VEK8@^:?,W"4ONVXQC!QU[5TKND4;22,%1069F.  .I
M-*"& (.0>0: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KAO#2O:_%+QE%>9$]TMI/:EO^6D"H5.WV5L@^Y]Z[FJMYIMCJ/E_;+2
M&<QDF-G0$H3UVGJ/PH \Q\3M=IXI\;ZKI=S-;Q67AP1RSP-MQ=*7D09]0F,^
M@8>M;>HQ7>DIX8EBUC4I6O\ 5X!<":?<&5H6)4#'"Y0''3)-=A_8^F'3FTXZ
M?:FQ?.ZW,*^6V>3E<8.:)=&TR:*UBETZT>.T8-;JT*D0D="@Q\I^E '#7,FN
M:G>ZE:VU[=+J$6MQI$\$Y$*V>$+*>=N0I?((W;L8]H?$-_J5JGQ$6'5+Q/L.
MFV\]J1+@PL8Y"=OIDJ,U<F^'S7M]=MJ-AX?NS<322#4FM2+I0Q) XXW*, -N
M'0'%=<_A_1Y3<&;2[.5KI EPTD"L9P.@<D?-^- '/:0]U9^/Q8G4+RXM[G1E
MNW2XE+@2B0+N4=%R#R!@<#BNSJE%I&FP7B7D6GVL=RD?DI,L*AU3^Z#C('MT
MJ[0 4444 %%%% !1110 4444 %%%% !1110!POQ0,D.G:#?.&.G66M6UQJ&!
MD+""?F;_ &0Q4FM#QMK%YIECH\VGR6[+>:I:VK^;'YBE)' W+R.1P0:ZAT61
M&1U#(PPRL,@CTK.@\.:+;21/#I5FC0MNBVPKB,^JCHI^F* .+O\ 5+Z]TGQO
M>G4+FSU'1)Y!:)'*55$CA5T+)]UPYW?>!R#@=!4]WJFI:1X@LY[DW!37=.$4
M%L\KE(+X '8!GY0P;KV\L^M=E/HVF7-Z+V?3[:2Y  \UX@6(!RN3WP>1Z5:E
MMX9GB>6)':%_,C++DHV",CT."1^)H X+4)+J;Q!=>%_[:DLVM]*BDM9Y;ETD
MD<F0/+D,-Y4JF0<CVYI+:&_U3QE#87'B&_:$:':W;/9R>2LLOFL"X7' 8*,C
MT-=EJ>@Z1K30MJFF6=Z8&W1&XA638?;(XJ4:7IXU Z@+&V%Z4\LW'E+YA3^[
MNQG'M0!YK87>I16&CZFVL:A+,?$TM@RR3DHT!GE3:R]#P!@GD8XP*;J=SJ<>
MB>+-136M26XTS74CM<3D*B$6^5*]&7YVX.1[9S7H@\.:&(4A&CV BCE\]$%N
MF%DZ[P,<-[]:5_#NB20W$3Z18-'<R"6=&MT(E<?Q,,<GW- '"ZWJVH>%]0\4
MQVU_=S0PZ=:78-Q(93 TDTD<CKGH J[L#@;>!3/$CZAIOAGQ!?V/B=GB>RCG
MMXK>=Y6A8-C>LC,2%8'I_LDCO7H2Z/IBW,ER-/M1/+'Y,DODKN=/[I.,D>W2
MJL'A;P_;:=-I\&B:='93-OEMUMD$;MZLN,&@#B/$RW%K-XTTLZA?3VS>&C?
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MYEU'Y5PWDKF5,8VL<?,,=C5BUM+>QM8[6T@B@MXAM2*) JJ/0 <"@":BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVDW4TJ%27 9XV 8L%WYY(Z,:T-6M]?\ %?A:]4: NE:F(HBHN98V,TD<BR;
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MU/\ >QP/SKA+[P]/JOB'1-:M-"GTC7(;F-[^[5T"/"/]9&Q5CYF[H.,],XH
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M!&Z[L[\$98=,FI7\(W6G>/;'5=)=5TFYN7N-1L^@2?R9$69/3=NPP'4X/K@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSL^U0, 98DX JS110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!2L-*M-,AFBM5E59I&E??,[DLQR3EB2,GTJE:>$M#LM+N],BL0UC>.S
MSV\TCRH[,<DX<G&3SQWYK#T.YUS6=3\2V_\ ;DD7]G7YMK;_ $:)EV^6C_.-
MH)Y;L1TJUX9\8&_T^^36$C@U+3KYK"X2W5F660<JT:\L0P.<<D8/IF@#8L=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ98I'?:P!)VG<HZ>OXU]4T75M:\*:DB>#[/2]2FA2 +'+"SRXD5C\ZX 08.
M3DD]!CGT>B@#A]8T'5-4UKQ)+'9F.'4= %A#))(F/-_>G! )('[P<^QKIM 6
MZCT&QBO;4VUQ' D;Q%PY4@ =5X[=C6E10 4444 %%%% !1110 4444 %%%%
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MY]E\Z#6+N:>WOO,39&LQ!8.I.[*'., Y^7IVUM6\,74WB/3;RQ=?LTMN;#5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQR. 'C=!\PY4$$ C!YQ4GBK2]3U5M&UVPLF-UH]]]HCLW<*\\)7:XY.%<@Y
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MTC(XKK!9VFDZ.]M8V:0V\4;!(+:+ Y]%'J30!@>#-7\0>(-#TC6KR33?LU[
M9)88+9T>,GIAC(P(XP1CO4NOZUJUEXM\/Z38R620:I]H$CSV[NR&./>,8=1S
MTH^'5G=:=X T>POK:6WNK: 12Q2+@JP/Z_450\7Z>U[XS\+7$FE2WUA9&Z:Z
MQ!YBKOC"IP>O/IG&* +>FZ_JU_K'B#00;'^T--2)HKQ8G,+>8I(5TW95ACD!
MNA!]JIZ1XNU/4?"=P94M(O%$-RUB]GY3;$N,_*"N_)0K\^X'[N3VQ1X4T2[T
M_P 9:Q>65A)I?AZ>%!'9OA1)<9^:58P3L&W /3)YQ4D6F.GQ?N-573I5M9=)
M2 W7E?*TXD/Z["!N].,T =?;+.MO&+J2.2<#YWB0HI/LI)('XFI:** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *JWNIV6G^6+NYCB:0D
M1HQ^9\==HZG\*M5PWAIY+GXH^,WO,F>V6TAM@W\$!C+?+[%\D^X]J .RL[ZU
MU"W$]G<13Q$E=\;!AD=1QW'I3;O4+2P:V6ZG6(W,P@A#?QR$$A1[X!_*O-==
MU'4-"\:^,KK1G1$B\/)?S;TWH+E2X4D9')1?T'7%;UWJ7B#2QH$EQJ-M<+J>
MJ10NBVFPQQO$S;0=QS\RGG&>?:@#M:K0ZA:3WUS913JUS;!&FC'5 ^2N?K@_
ME7$W_B;76N;V&R>.*_@UB.RBL'AW[[9MF9L9#'AF?((4!<'H31K7B;6]/7QO
MY5Q;;M'L8;FU)M^ 621F!&[D_*/\* ._HKE-*U35E\9G2K^ZAN8)],6^39#Y
M9B;?L*CDY!R#SSQ75T %%%% !1110 4444 %%%% !1110 4444 -=UC1G=@J
M*,LS'  ]36=%XCT:9HECU.V/G,$A/F "4DX 0]&_#-<S\3IW2PT"UD)&G7FM
M6T%^?X3"23M;_9+!0?R[UI^,]5&D66EYTR&^2XU*VMU5YS%Y4C2#8XPK9PP!
M[4 =-17"WOB75;C2O%.JZ?-'#_8,\D26KH&6?RHU=]YZC=DA<$8P"<]*D;Q3
M>6NN*+IV^P:EI8N]-C"*'\X8WQ9QRWSH5^IZXH [:BN+N]5UZ6_N]#L92VI6
M6GPSM,D<6V6:3>!N5R,1Y3^'GGJ,<QIJ7BC4/%,>DK?6-@1I5O?2A;?S@LAD
M*N@.X9!VD \?UH [BBO.++Q-XA-MI>H7-[;213:])I<L"6VT,GG21AMV201M
M!_GFFZAXF\1V^F>(M22^M<:1K"VR0_9>)8CY/RL=V1_K#R.<^W% 'I-%<#J'
MBK5?#M_X@M[V>&]%K:6MS;N(1&(VFE:(J1NY4%0W)SC.3WIOB#6?%FA:)KMZ
M&C$$%LDUI+=)&90^[#J5C.TKRI![<@@\4 >@45YYX@U?7;+_ (2W37U)2]OH
M1U*VGA@$;0M^]!09)R/W8P3R,FNQ\/I(GA[3Q+,TS?9T.]@ ?NCTH TJ***
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>exhibit1027supplycontrac006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
MGYL'@=LUU L;47AO%MXUN6 5IE7#,!T!(ZCV-6* ,/Q+>ZQ;6T46D:3<WK3,
M5ED@EB1H4[D>8RY8]!U ZGI@X<^E:A?V6AWL.AOILNBWZR0V+SQN\D&PH_*L
M5#8<D9;G;R>:[BB@#SG5_ ]_KL?B#4UVVFI7=Y:W5A',00GV90$W[<XW'?TS
M@,.^17766JZE>1QI)H5U97!P)#/)&T:>N"K$MWQ@<\9V]MBB@#SJY\(Z@_AO
M5?":6[&TOM3:=+S>NQ+=Y1*X(SNW#YU QSE3G&<;^N6-]<>,?#-Y;V4DMK9/
M<-<2JZ ('B*+P6!//H#7344 <?<Z5J6F>(O$&H6%HUVNL6D03:ZKY4\:L@W;
MB/E(*G(SC:>.F:6A^%+KP9?V4]G;O?Q#1HK"=8F56\Z)BRM\Q VMO8>V!ZG'
M>T4 <[X6\.2:)X(MM$GE4S^5)YSIT$DA9FQ[ L<?2N5M-)U6X^%>@VEE LFI
MZ)=0--9LX3S6MI/FCR>!G;N!/'0]\UZ96;J6H:7H,$NI7\BVL3%5EF*'&>B[
ML#W !/L* ./FTW4-4UCQ'=WGAJ[>QU*QLX5@DGB21MCR;QE9/E8!P0<]1U%5
MU\/>);>2QNQ)=:C;:5JJW%M#>.GVF6!H3&^YLX9E+G:6() .3TKN]/UK3=4F
MFAL[M))X,>;"<K)'GIN4X(SVR*OT >=:WX8U34+3Q5J%M9N)]3EL7@LV= [+
M;LI))SM#-@@ GHHSCH-&*TU:Q\2Z[?OI,UU::S;0LD:R1[H)$0H8GRV,$$'(
M)&=WMGM** //H[#6]#\-Z/X970;O5K*VLTCO)H+B!!,P',8$CJ=GKQR,#N:T
M_%EKJVN?#^>VATEUU"X\L_8Q-&3'B16P6+!>@[$\],UTUY>VVGP>?=SI#'N"
M@L>K'@ #N2>@')J6*19HED4,%89 ="I_$'D4 <WKFEW4_B3P]K]O;/-_9_GQ
MS6X*APDR ;ADX)4J,C/0G&>AJV.@WEAX=\4!+5O.U:YN;F&T5ERF] @!.=H)
M*[CSCYJ[&LN\\1:7I][':7-R5E>6.'Y8G95=_N*S $*3QC)'4>HH YR;P]J%
MSX*\+)]F9-2T22TN#;,ZY<Q+L= P)7)4M@YQG&<5H:7I\EMXBU[Q/J"_98KB
M&&*-)6&4AB5B7;!(&69N,] /7%:.K^)M%T&6./5-0BMFDQC>#A03@%B!A03Q
MDX%3:O?:78V:R:M<016[2*J^:>'<D!0!W.<<4 8_P[T^XTSP-I\-U&T4TAEN
M&C88*"61I I'8@, 1ZUU%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.LC.1U)95'R^@Y[YI9],FU3Q*\U]!<16=M $M)(;HQEF8YD)V,#T" 9]&]:
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MD#&PXP!SU)/I63XH@O8_ E]=7&@6&DSR75@!;V\BNSE;J/EG50,<X YQR>^
M ;M_\0]+MM&UN[@AO'NM)A\V6TFMGAD((.UL. =AQUK1O?%^F:=&[77VA3#;
M?:[A1 Q:"')7>PZ@95NF3@$XK \1>%-0\1GQ#>I MK<7>C?V;;0S.N6.YG+.
M5) &2 .3W-1>)-&\3Z];ZE;/I]N;>\T=H((OMFU8+@AP2^!\_!3'8$'IG- '
M1W_C'2=.O9K.0W<MS%;"[:."UDD)B)(W# P1P>1TQZU/)XFTU;2VN(9)+E;F
MV^UQ+;QEV:' ._'8<CKUS@<U@P:1K U^2_EL $;04L<),K?O0S-CG'&& SZY
M[<UG:3H/B;PZ?#][::?!>20:-%I5[:-<B,J8SE9$;!!&2V1UQB@#JY/%NDKI
ML=_#)+=6[VHO,V\3.5@/1R,9 X/'4X. <'#Y=0&I3:4FFW>8+I&NS-%@[H0H
MQC([LZ'Z USNI:)K</B5-731M,UF.[LH[:ZMI9!']G=&=E9&93E,2$$8SP#[
M5T6DV$]E)<SSP1*XBB@ABM@%38BY^4=OG=Q] M '.^%O%S0>#X=5\1:A-,]Q
MJ,MFCBW& 1.T2#]VH S@<GO^5;]OXMTJXANW#7$<EK<1VTD$T#1R>9)CRP%8
M _-N&#[]L&N1L_#&N0>"++2GL!]J@UM;Y@)D*F,77GG!SUQQCU]JOWGAV\O-
M4\3/=Z,MY8:G+:%8FG569(U"L00?E8'YEY'3J* -VZ\8:58_9Q=?:XI+B=[:
M.,VLC,9%4L5P ><#C^]VS2Z?XNTC4]/>[MY9LQW!M7MY(6299O\ GF4(R&[_
M $YZ UQMS8ZKHL_A6&ZDN;[;K\C6D=Q,KSK!]FEPCOG#,/F(R>F!FK6J>#]5
MN)+W6[6VM7OY-6BU!-/N6'ER1I!Y&QF&0&92S9Y ./3- '56_BO2KF!WCDD\
MY+HV;6QC(F$X&[9M]=OS9Z8YSCFL^Y\=V"-IHM+>YN#=W[V$@$)S!(BL75AU
MW?*>!]>E9MYHFN,FEZWIVBZ=9:A8WC3'3(Y5 FC:,QL&D"@;\-D'&!CK5[5]
M/U[4ET'4/L-LMU9:G]J>T%Q]R,Q/'C?C!8%]QX]0,XR0"];Z]IL%YKTTNIW+
M)931I/%/$56W8HN%C&T,V[(/?);CK3KGQCI%E!J,EX]Q;OI\(GN(7@8R+$<X
M<  [EX(R.!@YQ7.:KX3UC4I_$\L,<<$MS?6=]8M)("DC6ZQ_*^,D F,]NX/M
M3O$OAK5/$2ZQJ"61M[JXT1]+@MY)4)+.VYF8@D!1A<<Y^]P.* .IT[Q)IVJ:
MG-I\!G6YCA6<+- \8DC)P'0L!N7(QD5B>+_$AT/7=*@O[V?2]&N8Y ^H11JP
M$^5V([,K!%(+'..2!R #5FTTS4!XXMM4DM"EHND?8V8R*2)/,#] >F!C/K^=
M7]5%^]X8FTN+4M(EMRD\!9-^_/&%?"L".N2.V,\T ,LM0?3=,1]3U$7[3W!2
MSEB12UPK<H $X)V@Y(P.">!TQ-=\6+(-"O-,O9XH/[;^P7T'D_,2$D+1E=I;
M(*KC;USWR*R[3P5K.AZ=9W>CP1>;8ZQ-?VVE23_(EO)&8S"'Y ;!+#J 21SU
MK<U:QUS5AH%Q+I\4<EMJJ7DT,<RMY42QNN-QQN;+9X&.HSQD@&M9^*=,O;&2
MZB:<&.Y-HT#PLLHF'.S81G."#Z8YZ9I(?%FDSVLDRRR"2.Z^Q/;M&1*)_P#G
MGMZDXYSTQSG'-<E>^%=<E.I7D%C;23IKXU6VMKF13'<Q>0(61B,[6QN()! .
M/?%N]T+694TG6;+1K"RO+"_^TMID4J@2QM&T;9D "F3#$CMQC- #]'\6_9KS
MQ//JUS=FRM=3AM81+!AH=\<8"D*.F]\9YZ@Y(YK2\2^(%70O%$&G74UOJFE6
M#7!81CY"4=D(W J0=A_^M6#?>&=?U&P\6'[%!%+J-]:7MK$UP"6\D0DHQ P"
M?*(SGJ?3FIKS0]?OY/&$[Z=#%_;.E1VMO']I#,L@25<-QC'[P$G/;C- '0CQ
M):Z?HUO->-/-*EDEU<>3$9&2,KR[ =LAO<X. <&M:.^@GTY+^W8SV\D0EC:(
M;MZD9! '7(KAI= UFSUBVU"+0K#5H;C3H+.YMKJ9$:WDBW896(8%2'.0.> ?
M:NYM8GL]-AB\F,O%$%\NW4(N0.B@X 'I0!QGACQ#-J.G:=X@O=0O4:]\R$:=
MY *3.6)01\9^55.3G& 2W3-;<OC71(+%KJ:>9%2[6RE0P.7BF8@!7 'R]1R>
M"",$Y%<UI?A;6]/T+PE+]F4W^A32&:U\U=LT<BLK;&Z;@&!&<="/>I-4\*ZI
M<RZAJ4-K_I-_J]C>&W,JCRXK<IU.<;VV-TR.0,]Z .SM=3_M#1VOK.WGW%7\
MN&YB:%RRDC!5@",D?UKCO"7B&X\1Q64D/B"4ZI Z_P!KZ5<0QQM$<$.JKM#J
M V,')R!SDUW-UY[6,_V?Y;@QMY><<-CCVZUQFI>';W7M7T'49]'BT_5["YCF
MN-1BF4AHU'SQJ1\[ANF&4  GZ$ O>$]1U&]U_P 46][?R7$-A?+;VZ-'&NU3
M&C]54$G+'K63XIUG6=(\&>)M3MM7F%S8WBI S10D(F8^,;.?OGD\]*U;/3M3
M\/\ B;7;N"P:_L=5ECN4\F5%>&0($96#D J=H(()[\53\3^'=6U3P#JVFP01
M/J>ISB9D64"./YU(!8XSA4 SCD^U "CQ%-%XTT;2],UI-;M[Q93>1_NG:U15
MRLNZ, *"V%PV<YXJSX:U.^\8PWFK)J$UEIPNI+>SBMTCRZ1MM,CEU;DL#@#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4C/;K5;Q<MPWQ#\$"UEBBFW7V&EC+J/W(SP&7^= '0P^)M*GMKZ:*>5S8?\
M'U"+>3SHN,C,>W?R.1QR.E);^*-)NO#)\107$CZ6(VE\X0/G8.I"XW8X/;M7
M+>%VN+7XI^);/4V2YU*>TM[@75NNR(0 E5C*$DJV23RS9'I4>EZ6=-^(=[X7
MBE']AO"NMI:[?]7(9"IC'_3/>OF8]>.F<@'H%O.EU;QSQK(J.-P$D;(V/=6
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M?:C:ZA<VB2W=KG[/,V=T6>NT]L]_6L9/'FD/,%$5^(_M_P#9SSM;,L<<VX*
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MG%:6D0BMXE"QQKT11T ] /2IZ** "BBB@ HHHH **** "BBB@ HHHH ****
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MG^K*CG.X\ =<\8S5:X\>:191:@UVEW!+I[Q+<0&+>ZB4X1OE)!4GC.>.AP:
M-JPTG3]+\XV-E!;M,VZ5HT :0^K'J3]:0:-IZZN=5%JOV\Q^4;C)W%,YVY_N
MYYQTS6!JGCRVLM&U^Z@L;QKO2(!-);31>665@2C\G[IVGW&#QGBNGM)VN;2*
M9X7A9QDQR8R/R)'ZT 34444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1V\]O?2>6860MM=&V-QAR"N.PJY8Z-J-MXU.IR);FT_LF*RW1MM)D1V8D)C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHK+O_$>BZ5,\.H:K9VLB()'6:95*J<X)ST'!_*@#4HJ
MC8:SIFJR2QV%_;W+Q!3(L4@8H&S@D#IG!_*KU !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV>0OX9S6I#K=YKGBG4](TZ9;6TTH1I<W(0/)),XW;$S\H"C&20>3@8QFN?\
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M_#VC3:I:EM2M[F2=TL_]6T00X7YNF7/7TKL-/6\2QC2_ECEN5R'DC3:K<G!
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MN!M8[CZ8X]ZYWPG9:CX+LYO#\FEW-W817$LEC=6Q0@QNQ?8X9@58%B,]#ZT
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M$4E88RH9SZ L0!^)K@M:\(7]YX&\V WI\01NNH0PF9=JW@;?P"=H&XD=> :
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M8H ZRV26.WC2>;SI0/GD"[=Q]<=JEHHH **** "BBB@ HHHH **** "BBB@
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M7OM0DUCQ%I5_>M>C3KJ-89WC1'*20I)M(0 <%B,XZ4 =-1110 4444 %%%%
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MH:Q#HWCW3)=7FE%EIL-U!.L:1NHD$@:/Y5^[^[X/WL'KWKTNUC>*VC1YI)F
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M42:&=X7V$Y*DHP)7V/%68M TV#5_[4B@:.[^SBU#+,X41 Y"A,[0 2>U:5%
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M=IG?>5 4'!) P !QCI5^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&_RHQA=\C.WXLQ))]R:GHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEU%9(F<KG"A'Z[<GYL8YP"><1W*7!^**2QP7*Q?V+) +G[.YB60RJP&_&W.
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M:7MM<,HRPAE5R![X- '%ZSI%QI/@SPCI,<-Q=2:?>Z<)3;P/)A8F3>YV@X&
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MGJ/8@_C0!+15*WUC3+MBMMJ-I,1P1'.K8_(^Q_*HSK^C D'5K $<'-RG'ZT
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MK&.626.WC6)&EQN*J,#. !T'I0!:HHHH **** "BBB@ HHHH **** "BBB@
MHHHH J:G?QZ7IES?2JS)!&7V(,LY'15'<DX '<FN \(7<NB>.+K2[J2Z9-<@
M&H*UQ!)$!>* )T3>HR"-K#'0#%=WJFEKJBVZ/=7$*P3I/MBVX=E(*AMRG@$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS)M<?4=OI0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"BF\Y;@R*(X;P;/EB 0E3(#R,X( XSTJWX%C@\6Z5=>(=9MXKRXNKV=(H[A
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MQ+XIL_# T\W:,RW=TD!*](E8A3(WHH+("?5A5K7]=M?#VF?;;I7D+2)###$
M7FE<X5%![D_XT 8^G>"_L=G8Z=/?_:--L+LW=O%Y.UR^\NN]]Q#!6;(PJ\@>
M^7:3X2N]&U"5;779QHK7#7*:<85S&[-O*B7KLW$G;CVSC.;TFIZS:BV>YTB
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MI96 C;GYQC^E0Z7XPO-=M&ETS1U\RVFGM[Y+JY\L6\T14% 51MV=V0>.!^%
M'645S'A?Q+J/B/3M,U-M'AM["_B,BR)=F1X_0,OEJ.<'D$_K4VM>(KO3/$>C
MZ/;Z?#<-JGG!)9+DQA#&FXY 1NHZ4 =#17.6?B:YO+W6-*73576=-1)#;FX_
M=3*X)4K)MR,X(Y48/YU7TSQFVJ>"Y-=BT]5O$=H3IS3G>)PVWR2VWAR<#ICD
M=N: .KHJ*W:=[>-KF)(IB,ND;EU4^@8@9_(5+0 4444 %%%% !1110 4444
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M#7/37>H^)? GAS4O)ENM3\.ZI#/J%M&I+S"(LC.@_B)!WC'7D#FO6<@]Q2T
M95GXCTO4O+&G727;N1F.'EHQW+CJF/\ :QZ=>*Y+P#=V_A'1I/#&MS+97EG=
M3>7)<'8MU&\C.KHQX;.[! .01R*]"HH \_\ 'US;W<OA)I3-#$-925_F:-TB
M$<@WG&&09(Y..HSBM.*ZT>VMM:BL+Z:Y62!KB:62=YEC.P(J[V)Y.,A<]CZB
MNKCDCE4M&ZN 2I*G."#@C\#3J . ^'WAZQN_"7A;4+PS7%UI]HHABE<[;:3;
MAODX^8=/FR1VQ5F_EC'QBT@EQA=)N(V/8.TD952?4@$@>U=M31)&96B#J9%
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MM[=W8*"*YDBC7RU5@V-J@!MVW#$\D>E &)J/BC4[FTT.?2KO39K:]U>.U%Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M* "BBB@ HHHH **** "BN&^(.K:G:0A]'GVR:2J:G=Q@X,\:MCRO^!*)3_P
M>M3>,/$DJ:'H0T>YV'7[ZWM(KM "8XI 6+KGC.T''N?:@#LZ*Q)/#=N@MFL[
MB[MY(9HY&;[3(WG*K E9,L=V1GD\U@^"9#XRT>7Q'J<DTGVNYF6U@$S(EO$C
ME% "D?-\I);KD^@ H [FBO.O%EK)HD7A6!]0U*5)-;,<KI-*TDD+B9PC;#N?
M'RCN?E%;5NEE/9ZZ]G_:D2I#Y++<R3I\P3>'02'<OW\9&,X]J .KHKR'PW+J
MUWI_@B72;K5Y;BY@!U>2=YG@,1CY8F3Y0^[&W;R?I6W/H\-O\2-(TA;O4S9/
MI,\DB-J,YWNKQ@,3OSG!/YT >AT57L;06-A!:"6640H$$DKEW8#@%F/)/N>M
M</J?B*\LO'6G:C]J']@R7#Z-)%GI,V")O^_BF+VP?6@#T"BN4\<Z<O\ PCFN
MZLMU>QW%OI<OD"&ZDC6-D1V# *P!.2.3_=%6/"FEQPZ7INHK<WCRSV$?G+-=
M22J[%5;=AF(!Z],=: .CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **B
MNKF&SM)KJX<1P0HTDCGHJ@9)_(5Q/A#6=23Q7JFD:S/ODOHDU6R4G/E1MA7A
M^J$+]=Q- '=T5Q'AZ=O%VN^(KF^DE-GINH-IMK:+(RH#&H+R, 1N8EN,] ..
M^8/$+WFAWFEZ%8ZA=*->U7;YSRL\EO L0+HC,203LX/;<<<XH [ZBL9O#EO'
M<6<UG/<VY@EWN@N'99UVE2'!)W=<Y/.0.:X;0KJS-OXF746UNX>'6KJWB,,E
MT1''N 50ZG:H&>YX% 'J5%>?>)0EMX^\,6MQ=ZA]DELKOSU@GF7S"@CVL1&<
MY&3S[T[PKI>I:EH,MQKT^J!;>XNET]9IY897MBP\MI0"&+ *<;N<'WH [^BN
M%^&UB;KP=X?UJ:\OI;V2US,TMW)(LN[/568C/ .<?SI/&4H@\=>$4DFOEMK@
MW:SQ6KS?O-L0*Y2/DX//2@#NZ*\^\+W!UK7O%>E"\O\ ^R(_)2&&YGD2ZA<J
M=[+N(E1#\NTMW!QQ5719M16UO/A]?3WCZM"QQJ'FONDLV)(N ^<AQ]S&>'QV
MS0!Z7145M;QVMO'!%OV1C:-[EV_%B23]34M !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<Z=!O?\ A/3XC6>#R?[.^PB J=W^LW[MWUXQ
MC\:Z*L>XU]!K3Z/86[7E_%$)IU#A$@5B0N]NQ;!P ">,\#F@"NGAJ*]\-7>B
M:TD-S!<RS._E@C_62-(,9Z%2W!]@:AT[P]JNC:7I-I9:JDK6*R+,US&6^U!C
MD;B#\K=]W/.>.:T=)UZ#4[N\L&B>VU"R*BXMI""5##*L".&4\X/L00",5<NY
M[F%K86UH;@23!)3Y@3RDP<OS][! &!SS0!R%_P"!;B_TWQ0/M%K;WWB%$CF,
M<9,<*JI4$#@NQR23QGCCCGKK6*XM],AA8Q-<1QA,C(4D#&?7%6JK0SW+W]S#
M):&.WC"&*?S ?-)SN&WJN,#KUS0!R_A_PUK_ (?\*PZ';ZCIY,1DVW)MWW#>
M[/D+NQD;N/H*M-X;O-.\2W>MZ)<P(;]$6]M;I6*2L@PLBL.5;'!X(/UYKIZ*
M *MM'=I'(]S-')._14!6-/0#J?J>_H.E9/@_0+GPYI,UC<W$-P7NIK@/&A7_
M %CER,$GH3UKH** ,G5M+GU.\T\,;=K""4RSP2H6,IVD+[8!.[D'D#IBLV?P
MK)#XSL-=TEK2SCBMGMKN!8<?:$8AATP 5(R#@]2*ZBB@#GM2T&[O?&6C:W'<
M0)#IL<\9A926D\T*"<]L;!V.:Z&BB@ HHHH **** "BBB@# \::!/XH\*7NB
MP7$=NUVH4S2*6V@,#T!&>GK5HV-])KMEJ#O;B."VE@D10V6+M&V0>V/+Z>_M
M4VL:Q9Z%ILE_?.5B0A0JKN9V8X55'=B2 !5236KZV2WEN]%GCBGFCB^25':(
MNP4&0 \ $C.TM_6@"E#X,MK'Q-J6M:?,T!U"U>.6 ?<$S%<RKZ$A1GUP#45W
MX9U'6%T>#6+JSF33;J*[^TQ1,LLKQ\C )(3)ZD$Y&1QGCK** .>T'0;O2M>U
M[4)[B"1-4G2<(BD&(J@3&3UX4'/%17F@:F_C>+Q%:W-HJQV#6(@EC8DAI%<M
MD$8Y4#&*Z:B@#E]5\+76OZ:T>HWZ17L-VEW83VT6!:NGW3M8G=SNSGJ&QQ@5
MJ6<6MN8QJ-Q9*$(+&T1@92/]X_*/;GZUJ44 <]?Z!=W?C72M=2X@6&Q@F@,+
M*=SB3;DYZ#&T<8-;\F_RV\K;OQ\N[IGWIU% ' VO@75XO )\(2:K9"U=)(I;
MA+5C(4=RS!06P#\Q /./2NGOM&,GA.;0[%UC5K,V<;RY;8NS8"?4@?G6I--'
M;PR33.L<4:EW=C@*!R23Z40S1W$$<\3;HY%#J<8R",B@"AX?T^;2/#VG:;/(
MDKV=M';^8@(#A%"YP>F<=*TJ** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** ,*Q\/J7OI]6M[&\NKF=I YAR F JI\V>  ![\G'-8-G\/
MYQX-B\/WFI+FQNA=:7=01G?:LK%D&&)W;<E>V5...M;T7B)M0N+R/2+%[V.R
ME,$TWFK&AD'WD0G[S#H>@SQG@XN:+K5GKVG_ &RS+@+(T4L<@VO#(IPR..S
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW,/?YG!'R]6)!]*OW\>HZ-XBT^]-OOGU^Q&GW 5-R0W@7<KD=-I'F;O78*]
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M4"ON$>^!"^.>,MG\<UV'DQ8QY2?]\BE5$4DJJ@GJ0* '4444 %%%% !1110
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M[G )/S?*A)]@:]6TM[&338'TUH&LRN8C!C81GMCCKFK(BC!)"*"1@\4H 4
M  < "@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSM91&ZY7Y>3\PX..G6I[KP=M\=V'B/3Y_(0NQU&V_AG(B=$D _OC?@^H/MR
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M'&3!H7A?6X=&_P"$?U2VTI+2&U>T74;8DS7$90HN4*C8V""3N.2,=\T ;/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5=<L-%-D+^<1?;;I+2#/\4C9P/TJ;4M3L]'T^6_OYUAMHAEG()ZG   Y))(
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MX8>'?^O1?YFJOBZ.67XA^"$AN#!(6OL.%#$?N1V- &];^*+*Z744A@NVO-.
M-S9>5B901D$ G# @'!!(...>*99^+=/O_")\2V\=P]AY;2 !5\QE4X.%SUR#
MQU[8S7-^%3-:?%'Q-97,PU&YDMH)WOU&WRE&56!E' (Y88Y(.32:?IB6'Q3O
MM$AE(TF:V36_L>/E6Y,A0X_V<J'Q_> /&.0#OK>8SV\<K0R0EQGRY<;E]C@D
M9_&I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J'2M
M.:]-ZUA:F[*[3.85WD>F[&<5;KB)XY+OXL3Z;)>WZV7]BI=""*\EC42F9E+8
M5AV &.E '86ME:V,1BM+:&WC)+%(HP@R>IP*CGTK3KF%8;BPM98E)*I)"K*"
M3DX!'<\UQEIXDG\,^*]9T+6;Z2ZL;>Q34K2XE \U8V?RS$Q&-QWXVD\\\DUI
M?\+ TJ-M02X1X9+)(I&_>1NCK(X12'5BH^8@')&.O3F@#>&BZ4+$V(TRS^R,
MVXP>0OED^NW&,U82UMX[46J01+;A=HB" (!Z8Z8KF=9\67MA_9J0Z/.7NM32
MR;<Z8P4W[D.[# @$ \8P<X(Q45UXJL-&G\57\EGJCOIBPO=QF164@H2IB4OM
M QUZ$GL: -U/#.@Q[=FB::NTY&+2,8/KTJQ?Z5IVJ*BZA86MV(SN07$*R;3Z
MC(XK)3Q? +W4K6ZTZ_MI+*S^W!617:>'YAN0*Q.<J1M.#R.*JWGC86]CKA73
M)Q?Z78+?-;R.@W(RL1R"<$;&R.OIF@#IHK6W@MA;0P11P %1$B *!Z8'%,L]
M.L=.C9+&SM[5&.YE@B5 3ZG KG+;6X[G5O#0O[6^@OKNSFFC(E40'"H7WJKG
M)Y4C(.,]CFK$7C.QD_LV=K>X33]3F\BSO#MV2.<[,C.0'P=I(YXSC(H W);&
MSGN8KF:U@DN(?]5*\8+)_ND\C\*;<:9I]U=175Q8VTUQ#_JY9(E9T^A(R*YM
M?'ULSY;2=12W34_[,FG<1[8IBP09 ?)!8@9 /6NNH JRZ983WD=Y-8VTEU']
MR9XE+K]&(R*M444 %%%% !1110 4444 5[RQL]0@\B]M8+F$G/ES1AUS]#35
MTRP2>*=;&V6:)=D<@B4,B^@..!6!XWURZTFSTRSL)!%>ZMJ$5A%.5#>2&R6?
M!X)"@X![D4FL0:?H46GO)K.HVDCW<**\EQ-,)SO!,9!R,N 0, >W&10!TSP0
MR/O>)&;84W,H)VG&1]#@<>U5+?1-)M;H75OIEE#<#.)8X%5AGKR!FLR_\86E
MC#J-T+6YN++3)!'>W$04B$X#-P3EMH8%L#CW(($\?B>UDUVXTHPRHT5D+Y)V
M9/*FB)QN4[L\'KD#&1ZB@#1MM,L+.>6>UL;:":7_ %DD42JS_4@<U%<Z'I-[
M<_:+K2[*>?&/-EMT9L>F2,UC7WCBRL+3S9+6<3I:+>2VK21)+'&V<#!8 N=K
M?*">G;(RG_"<03ZC#9:?I.HWSS6D-\CPK&%,$K;0_P SC&.<@X/L>: .@M].
ML;.V:VMK.W@MW)+111*JMGKD 8YJ*QT32M+=GT_3+.T9A@F"!4)'X"L"V\>V
MUP]JQTK48K:?4'TTW$@CVQSAV0*0')(++C(!'(YZX;<>/[6VAO;A])U+[+8W
MXL+J8+&1$Q* -@/EAF1?N@GVH Z633+":]2]EL;9[N/[D[1*77Z-C(JQ)&DL
M;1R(KHPPRL,@CW%<]'XRLTDU:/4+2YT^33(HYY%GV'?&^X(R[6(Y*D8/.:H7
M7Q'TVRCU'SK.Z:2QBCG=('CEWQNVT,&5\<-P1U&1@$4 ;\/AW0[9T>#1M.B=
M#N1DM44J?48'%7KBV@O('@N8(YX7&&CE0,K#W!XKF+WQJ;6UU\?V1=QWNDV7
MVT03L@\Z(A\,"K' RC9!YXZ5NZ+>3:AHMG=W$+0RRPJ[*Q'4@'/!(P: +5M:
MV]G L%K!%!"G"QQ(%4?0#BI:** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** *]K86=E&\=I:00(Y+.L484,3U) ')IEKI6G6,<L=G86MN
MDIS(L,*H'^H YKC?#=G)JVK^+(;C4]4 M=3,%L4OI1Y*>4C8 W8/+'J#1X<\
M:2V]GJ5CKUPL]_IVJ-IL<XVQ_:OEWHQR0JG8"3T'RG'I0!UUCHFDZ9(9+#3+
M*T=@06@@5"?R%%YH>DZA<K<WNEV5S.HVK+- KL!Z9(SBL2T\>:;>HB1QNMV]
MZU@('= #*J%^'SM(*C@@G.<8ZX5_%-X?$^CZ8FD7"17MK-<2>8R!T*,BX(W8
MXWY.">V,T ;MWI&FWXC%YIUI<B+_ %?G0J^SZ9'%,BT328(YHX=+LHTG 654
MMT D Z!@!R/K7-67B[3[#2;>>&QU:1+S5YK$)(ZR.D_F."#ESA<JV,$@#'2M
M"V\817%G=2'3+Z.[M;Y;"2T*JSB1MI4Y5BNW#J2V< 9H WK6SM;" 06=M#;P
MKTCA0(H_ <5&^F6$E\M\]C;-=J,+.T2F0#V;&:Y;4?'3)H_VJPT^62>/6(M+
MGC=T_=L9$5B#G#9##'UYQ@U9/B+3+'6M=GO4OK62PL8)[HS2;HMA\S;L56(W
M9# X )..M '33V\-U \%Q#'-"XP\<BAE8>A!ZU$VGV3V/V%[.W:SV[?LYB4Q
MX]-N,8K*_P"$HCBU+^SKO3[NVNY+5KJWB8H?/1<;E4AL;UR,@D=1@GFJFC^.
M+76+G2$73;ZVAU>W:>SGF";7VJ&9<!B00#W&#@X)[@&]_9>G_8/L'V"U^Q@8
M^S^2OEX_W<8J:WMH+2!(+:&.&%!A8XU"JH]@.E2T4 %%%% !1110 4444 %%
M%% !1110 4444 %%%% %>ZL;.],9N[6"<Q-OC\V,-L;U&>AIMYIEAJ/E_;K&
MVNO+.Y//B5]I]1D<5@>-M<NM,CTC3K"7R;S5[]+-)]H/DH<EW /!8*,#/&2/
M2C5X=/T/^SF?6-1M))+N*-#)<33K<'<,Q$'<,L <8P?PR* -R^T?3-3,9O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBUM(H)%# C<B!201VR*UZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JG>Z58
MZA)%+<P!IHLB.9&*2(#U =2& /< \U<HH SCH6EG2YM,^Q1?8Y\^=%CB7/4M
MW8GOGKWI9M#TVXBLXIK572R</; L?W3 8!'/4#@'M6A10!YW)X"GN]1O9+W2
MM'DFN9Y)1JL5S+%.H8G:?*5<;E&!G>,XR><UUTOAK2+@WAGLUE:^C6.[+L3Y
MZKT#\\@?U-:U% %"'1=/@OX[Z.V NHX?(64LQ81_W.3TSSCUYJ_110 4444
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M8O%S\AR>5Y/!]3ZU8L+"TTRRCL[&!(+>(82-!@ 59HH **** "BBB@ HHHH
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M6=V[KR@".6&21L(*8((S]* .MHK-MM?TJ\TYM0MK^&6U60Q&13T<'&W'7=G
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M@#C).3^I-9UWH%E>ZY9:Q,9OMEDKI RR$*@? 8;>AS@=?2M2@ HHHH ****
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MW\J=E*R<_.2#EC\QY.<Y-2#P]:YN&>>]D>>'R&>2Y9BJ$\A<GY<]R.3@>@H
MX#POX<O_ !#X:\ 7,BVUO9:7;K.TJRLTLP,>W8!M 53GYN3TQ70WBJGQ?T1$
M4*JZ+=  #@#S(JZ;1])M="TJWTRR$@M;=0D2NY8JHZ#)YQ4,V@64_B&#7',W
MVZ")H8V$A"A&()7;T.2![\4 :,44<$2Q1($C4855' %>5ZYJ1M-=LO'2QW@A
MM[O[+*QB;RCISX3=NZ'Y\2@^C>U>HW=LMY:2VSO(B2J49HW*L ?0CD?452N-
M L;KPXV@S+(U@T'V=DWD$QXQMSUZ<>M %#QM%'_P@WB6=57S'TF=2XZE1&Y
M_P#'C^=6O#449\-Z+,4'FKI\2!L<@%%)'Z#\J?)X?LI?#C:#(UPUBT!MV!F)
M=H\8VE^O3C.<U<L+*+3;""R@+F&!!''O;<0H& ,]^* +-%%% !1110 4444
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M2@ HHHH **** "BBB@ HHHH PO%7B$^']/MC!"L]]?74=E9Q.<*TKG@L>R@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4-K)Q<R-@*,G[N#NW9SC:>M6I;CQ!:?9GD@LKI)9D298-Z- I."1G/F8_P"
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MZ1E#$H,=.%'/^U4V@W^KZA#:W5[;VBVMU:+.C0,VY&(!VD'V/4>AH VZ***
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
(B@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>exhibit1027supplycontrac007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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MS)E5\H<@,O)QZTWQ[]L@\+Z:FIW4-PL&NVT^JM$FQ/LAG8KN7)PH C')/W:
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M5"J.PSN8^['L!CK: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *JZAIUIJME)9W\"SVT@P\3_=8>A'<>U6JYGXA7UYI?@+6-1T^Z>VN[6
MRQ2( <$>Q!!% &PNCV"2VLJV^'M%*0'>W[M3U YZ<#\AZ58:U@:[2[:%#<1H
MT:2X^8*Q!(SZ$JOY"N+\3WNL^%/#2^([75)[V*T$<EW9W21D31$@,5954JPS
MD<D<=*VM1\9:5IL$ES,9FM(#&+FX104M]X4KOYST92< X!!.* +-MX7T2S:
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M$GV@E<,9/,]\X^0 <9SGMB@#0CT;3XM5DU2.U5;Z1=CS@G<R]E/J!Z5>HHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0C((/>JMEIEG
MIUJUK:0B&%F9BB$XRQRQ]B22?J<U;(R"*X/PQ_;&N+XC#^(K^&2SU>XM+9EC
MA8(B!2H(*?-][OR?6@#J+7PYHUGIDVFP:;;)83DF6VV9C?/7*GCFGV&AZ;IC
M*;2V"%1M3<[/L'HNXG:/88KGO"WC.2_T>5-5C4ZM::C-I<L=L,">:/DL@8X
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M 'H<#-<7X?TOQ'H:ZZ(['3Y)-0U.>]A9[M@J*^T , A.1M[?GWKM** /.I/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBH+R]M=/M7NKRXCM[>/&^65@JKDX&2?<@4 3T5B#QAX;+L@U
MS3]R$*P\]<J3T!YXS6W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %,EBCF0+(@=0RL 1W!!!_ @&GT4 <3X>BCG^('CV&5 \;R62LK#@@VPR*J
MWWBW5/\ A&M=\2V<J"/2+Z6'["R#;+'"X5]S?>#GYB"" /ER#SGK+#0++3=6
MO]3MS-]JU H;EGE+!RHVKP>!@<<8J!_">E/=74OE2+'>2K/<VRR$0S2#&&9>
MF>!G'#8YS0!>MH[TWUQ<2W2O9RQQ^1;^3M:(@'<2V?FSD<8&,5=JI#IT,&I7
M5^CS&6Y5%=6E8H F<;5)PO4YQUJW0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^O5C4Z+=V<I(\W[28]L?K@JQW=\8_'%9.OV&H7'CWPM?V]A+-9V/VK[1,K(
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M2SFU.:<Q,AW!O,+9Z[3M!(!4'J376T4 8L_A/1KHZF9K>5_[4C6*\S=2_O5
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MN),H&&&S\WS9'&3FJB>#M#CC@C6VF"07C7T8^US?+.Q)+_>Y)W-[<GUK=HH
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M*_:YOEF8DE_O<DEFZ\<GUK=HH H:?HUCI4]Y-9Q.DE[-Y]P6F=][X W88G'
M XQT%7Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
MV]T'3K^_BOY8G2]B0QK<P2M%)LSG:64C<N><'(K2HH R(_"^CI;ZA UF)EU+
M O#.[2M/@;1N+$G@<#T[5/I^B6.F2>; DK2^6(O-GF>5P@Z*&<D@?S[UH44
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M6KJ=+C,5H1/)E$./D/S?,ORKPV1P*V:* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHJKJ#WD=D[:?%%)<[E"+*Q"X+ $DCG@9/X4 6J*XVT\0
M>([S6M=TR&TTUY=):$'YG'G>9&'P/0X..>]6]%\5)<ZAJMEJMS8VLUOJ;6-J
MGF;#,!'&XP&/S-\_;VH Z>BJL^IV%K=16MQ?6T5Q*0(XI)55W)Z8!.3T-6J
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M^BJMIJ5AJ#SI9WMM<M ^R9895<QMZ-@\'V-6J "BBB@ HHHH **** "BBB@
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MNX+5XD\AS'<*L01_F7&2""=@.XXX]:ZVQAT;PW=7X;58TEOK@W<R7,\8.\@
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M(TG>VCC9U7!90,@'UP2?S-:-0VEO]DM(;<2O*(D"!Y,;B!ZX 'Z5-0 4444
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MKM+&W5N?)@"!AM]-Y)8^N!Z"H/B9I=I8?#[Q!/:P*CW<]M-,H  :031+N^I
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M>6VMP1%YY4L 23C( SUK5H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\_6@#JZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(,:\'UYQZ<URP^(TUOI-QK-_HRPZ7;:B^GW$L-WYCQLLGE[]A1<KNQT.>>E
M'>45R6J>*M7TR\T^"30[;;J-^UG;E[]E;@.0[CRC@$)G )ZBNAT^XO;BV<WM
MFEK<([)L28R(P'1@VT9!'MQ0!<HKCK7QCJ5W8:U>QZ' T6D7<UM,BWQ\R3R@
M"Q0&,#H> 2*=J?CD6>G:'K%O8+-HNJ-$K7DDYC^S>9C:77:>.0,YX/7UH Z^
MBLN74[K_ (2&+3+:SBFA$/G7,YG*F$$X4;=IR6PV.1]TYQQG4H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9)2%G*_P@K@YQCH>]=+XJT/3]*\$>+;R#S);[4["59+B5R\D[>4RHH]N<!5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/D\'RC7;G4;/7+RRBO\ :=0M840I.RJ%W*6!,9*@ E3G@=^: ,S5?'&K:?\
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M78Y8Q$D;<GG!##)X':@#CO#_ (LU?3M(^P+ E^8?$D^APS7,Y5C&N2C$X.[
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MD7EO ZQSMY;I-Y95@2N<CS,$''3K6E_PAH'AK1=$74'\O29K>6*4Q#<_DD%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM6';WC,1''0@[NO-5]94IH?C>_6_O%N=.UM#:R?:Y/W/RV_0%L8^9A@Y'44
M>O45PUG%;:?X\U_33=31Z=)H\-S,);ISM8O*KON9LJ=H&2".@-=;I2VB:/9+
M83>?9B!!!+YIDWIM&T[B3NR,<]Z +E%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSMV:3[Y,2DM]>.:F$,2P^2L:"+&W8%&W'ICTI]>=Z= ;G5OB!!+<WACMY46
M"[D'D@VZN=F&^7YB3Q0!W<.GV5M<27$%G;Q32??D2,*S?4@9-.6RM5N)+A;:
M$32C;)((QN<>A/4BO-]-US4;+P_>^&/$5S(VHC39+G3=0#E#>1"//W@<^:G&
M><G@^]7/$UY+H.I:=>ZE9ZA=^%UL?+E>UD=FM9MV3+(JG<R[<#=SMP?6@#N1
MIE@ H%C; *=RCREX/J./:I!9VJW;78MH1<LNTS!!O(]-W7%>;>()[=/"'AFX
MT[6KN\LY]=A474-U*7E@DF<E"RG<V 0N#S\OK45\^K1:1X_D@FU1-$M[ RZ;
M-<R2K(DZQ,7,;.=Y0$#J<9Z<4 >E_P!GV1N&N#9V_GL06D\I=Q(Z$G&>*5["
MSDF>:2T@:5P SM&"S '(!/?! (KDO#KV%RVAB/\ M@7GV47#2S&Y6-R$56#>
M9\K9WY'7IGM4?@J0^,M+N/$.I232"YNIDM8!*R);Q(Y10 I'S':26Z\]@ *
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MJ#"J%'7 &*@M[&SM)))+:U@A>0Y=HXPI8^Y'6K%% $36UN]PEPT$9G0;5E*
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M?SV(9I/*7<2.A)QGBJ&AZ3#9)'=Q3W;&>WC#I-<R2KD<[@'8X/)SCKQZ5L4
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MI^4KB*+RXXTC&%4 DDGGDD_@*Z*H$O+>2]ELTE4W$,:221CJJL6"D_4HWY4
M8MMH%W!XZO?$#7$!@N;2.U$ 4[E",S!L]#G<>,5T-%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-LTET@:Q>-ODM[LHQ?R\= #Y9(''S'U->B%%*;"HV8QMQQCTH2-(D"1HJ(.
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M:TFM[#Q@4W, (X(6=L !B=B'/ SC&*]F\F(@CRTP>HVCFE\M"""BX)R1CJ:
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MMN\%U=@-&]P<^=AR0!)CRR#UZX[UZSY,7_/-/^^12-!$ZJK1(RJ<@%00#ZT
M>4O8:?/KNH65[?7%[#%X7A?==S,KNP>4"1ER,-M"'IGH>M3:+-8W'B#P#J.H
M/!)<77AYE$\V"TLX-N0,GJX)8XZ]:]1,49))123U)%*(T&W"*-O3CI0 ZBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML+&VM[F\DU"W-U:O;["DL8P2P)8?WEZ^M63XALX--O;_ %!9M/ALFVS_ &H
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MW_V#+?\ ]%K0!T=%%% !1110 4444 %<^GBVVEEUB*.POW?2"!=*$3()7?\
M+\WS?*0>/Y\5T%<!HY']O?$?D<3Q_P#I*E '36GB?3=0\+CQ#8.UU8&$S9B
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M\G]F7AWA W&Z+C!J'P&TD'C/QC8W$BWUREQ!++J:#:)=R?+$5'"E ,<>O.*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2^6L:[H6W#/S.,$%6!!P<C@&I8_%TEYXDT.SLK*26PU/3GOUGW*#MS'C@G@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCE4C.&ZE#U' Q-,UGQ*NA^&?$$NMRW?VS4ELKJS:"-8WC>5H]PVJ&#K@'KC
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MB*\DOI=RR6A&R/[/*%C3GG&XLQ]=QZ8 ]2LK*VTZTCM+.%(+>,82-!A5&<X
M["FW&GVMU=6ES/"KS6CM) YSE&*E21_P%B/QH \KOO,_X5K\0_.W&[.KW>/[
MV[<GDX_X#Y>/PK0CWK#\33J>/-\E=^[IY7V,8Q[9W_CFN\FT/39[XWDMJK3,
MZ2-\S!79/NLRYVLPP,$@D8'H*6]T/3=0N#/=6HDD9 C_ #,!(H.0K@'#@$G
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ME= Q XR0H)Q6=X<U#4?$&G:9X@76!!'+<RK<V3QJ4*[F18AT97!"\Y.3GC!
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M;:.W%HXBCNOMBKY\G$V=V_[W7))^IS7)MX(O+C4+U[G2[5+FXN))5U2UU2>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK;F=E+E!DELX'\1Q6QXML=2U_P"'^HZ?!9;-0O;4P^2TJX1F&#ELX('MS[4
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M@*IYP>2P'!4UT%<Q\/=(O?#_ ('TS2-0@6&ZM49'".&4Y8G((^M=/0 4444
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M;.RDKF(=$X/W>3QTY--3PYHZ?V?MTZ#_ (EP*V>5SY ..%ST' X]AZ"M2B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***JZA]N-DXTYH%NBRA
M6G0NBC<-Q(!!.%R<9'.* +5%<38ZQXIO]?\ $.EQ7.D%M): (392#SO,C#X/
M[[Y>N,\^OM733ZYI=M=BUFO8DE,BQ88\!VY5"W0,<C )R<B@#0HJM%J-G/J%
MS817,;W=LJ--"#\T8?.TD>^#5F@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW0>OX4 7Z*J3:G86]_!8S7D$=W."8H&<!Y .I4=3BK= !1110 4444 %%%%
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M]-L]XMK9!'$KN6*J!@#)YX% %VBBB@ HHHH **** "N T<#^WOB/Q_RWC_\
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M=3]<YH LZ?%']CM9M@\S[.B;L<XP#BKE16MNMI:Q6Z,[)$H52YR<#ID]ZEH
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M?6UNR&^@6 )A"P5FBP<C;G.&+9 /(K2?Q?H":A]@;4X?M6](_+ )PS@E<D#
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M<3-'L!0 [@,'.\<]!WQD9YZ+0[^UUV^D@T7R;-O#T=C"ENR>6L@>5O+7+ X
M=1D@ X/2FZ)I&L:=>^"YY=+F(L]$;3KL"2/,$G[GEOFY7]VW*Y[>M 'H%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!G
M:KH6F:VL(U"U$K0,6BD#,CQD\':ZD,,]\&I[#3K33(/)M(O+0G+$L69CZLQR
M2?<FK5% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !45S;07EK+;7,*302H4DCD4,KJ1@@@]14M% &3IGAK2=
M(D$EE:LK*,)YDSR>6/1=Q.W\,5K444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX5U0:_8-&M[,D<*W2_N8C;R*&<9X9V*]>GRC@YR >JM/"LRPM*@E<$JA8;F
MZX%#SPQ/&DDJ(\APBLP!8^WK7E%_<RS>!?'>MR-MU&UU:<V\W\47V=E$0![
M;<X_VF]35XL=97XAW-^NV6V@2"#/WK=5MA*"I['>Q;([@>@H ],9U0 LP4$@
M#)QR>@I:\ZU29M4\-?#[5+R-3>RW]A*SE>0SQDMCTR:ZOQ3J LM(\E9C#->R
M"UCD4$E-WWG&.ZH&;Z@4 ;'F)Y?F;UV8W;L\8]<TR.ZMY6VQSQ.WHK@FN,^&
MM\HTN^\-R3&:31+@V\;N#F2V;YH6.?\ 9^7_ (!7$10X^%&NK!X=,[)?7I2]
M7RP+;$S_ +T8/F?)U^49^6@#VYF"J68@*!DDG@4V&:*XA2:"1)8G&Y71@RL/
M4$=:S;"2"_\ "EM(+E;^&:R4^>R\3@H/F(/KUQ7%^ M:U&QT;P3ID\-J;'4=
M.*Q,A;S4:.,-EB>"",\ <>IH ])HKB]/\7ZA+KMAI]U:VS->V]S)Y=N2Q@>(
MK^[\S)20D-@XQ@CFK?A'Q2WB0R'S[7='$IN+41M%/:RGK'(C'/'9L '!H Z4
M7$+7#6XFC,ZJ&:,,-P!Z$CKBI*X"_758OBAJ;:%#8&[;1+=F-V6"L1--_=Y)
M/ SGCWJ:P\=7.NV-E_9EH(;V?3_MDB2Q-,$.]HPGRD<;D?YNP X.> #N:*XL
M^+-9NHS;6VD_9M6AL([N>UFC:8"1RX6+*$8YC;YCGJ..N&3>*?$4NI36-OIM
ME:3)H\>I%+MV9HW)8-&P7 ."I&0??VH [>D9E12S$!0,DD\"LG3M=BO/"-KX
M@FC,44MBMZZ#DH"F\CWQ6?9W^KZK9VMQ<65F^E:A8-.^T_-;DJ"B-DD29!/(
M P1[T =)#-%<0I-!(DL3C<KHP96'J".M/KS;P'K6I6.C>"=-GAM6L=1TW;$4
M+>:C1QALL3P01G@#CU-:NE^+=2N];L]-GM[/S;RRGN L18K!)&R QF0$K)]_
M!*]"IXYH [2BN$\/^,]7U)_"T][:64=KKT4FU86<O$ZQF3))X((4C';CFG6W
MC/4[PZ+/;VEJ8M3U">R-N^X2V_EF3YF(SGB,Y&!@L.3W .YJ.:XAM]GG31Q[
MW")O8#<QZ 9ZD^E<G9>*=5U*>PN[#3?M&F7-V\$@$;*\,89E$V\G:PRHRH&1
MNZG%8>LZM<>(]/\ "NM1I:KI\VOV_D(4)E""0J&W9Q\VW)7'&1R<<@'IA.!D
MU!:WUI?(SV=U!<(C;6:&0. ?0X[US/Q-DNHOAWK+VLRQ-Y!5R5))0G! P1@G
M/7GO5:XN]8L?%[:5I=CHWVZ\T\WDUVZO&)#'(J ,!D\*V!R?Z4 =M17$7'C>
MYC\//XHB@@?1HKUK=XL'SO*$WDF4-G&=PSMQT[YJO?\ C37+2RUZ^6RT\P:-
MJ2VLD9=RTT9$1X/16_>]<$<8QWH [^BN9L=:U>3Q%JNB74-C]IALX[RU>(OL
MPY=0CYYX9.HQD'H*W[(W1L;<WPA%WY:^<("2@?'S;<\XSG&: )Z*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#&TSP['IFO:MJZ7EQ++JC1M-'($V*478NW"@
MCCU)K.N? ]M=6&L6;ZE>B/5;Q;R8J(\JZ[,!?EX'[M.N>GO7544 <P_@R,:Y
M<ZC;:OJ%K#>E6OK.%D\JX8 +NY4E"0 #M(SBMC6=,_MC39+%KJ:WCD(\QH@I
M+*#DJ=P(P>A]LU?K%\6:Q<>'_"NHZQ;1QRO90M-Y<F0' &2,CI]: #Q'X;A\
M26-M;3WES;-;7,=U%-;[0ZR(<J1N4@?E5.X\'))KLVJVVKZA927<:1W\=NR!
M;K8, G*DJV.,J0<>G6J.N>,[OPT=&NM1M8I=-O$W7<T ;=:#"_.1SN0%@">"
M.N*WY=1G.NV%K;M;O:7-M+<&0 EL(8P-I!P<^9U]N^: ,Y_!<"ZY=:A9ZG?6
M<%[M-[90%/*G*@*#RI920 #M(R!0O@R*'7+J_M=6U"VM;V7SKO3XV3R9I, %
MN5++G W;2,U5T3Q3J6O:39:U80V,]E<W"1R6ZNWG6R%PI+'D%@#DKA<>IQS7
MN_%^M6^I>*(8+&QGBT"*.9@TK1M.CQF0@'!"D $=P?:@"'1O#LVIR>*K746N
MX=/O=7>4V[P[!/%LC'#$9VL5(/L.,9R=;5/ ]GJDVLN]_>PIJT<2SQ1,@57C
M ".N5SD #C.#Z54C\8W>HZMX?M],AMQ;:UI[WT;W"MNC"A#M(!YSO_3O5_4?
M$DV@:+<WVJPPS2"Y6VLX[1O^/EVVJJC/W6WE@?0+F@"K=> 8;V/65NM9U&1M
M8MH[:[8^4,A,@, $P#AB/3VSS5V[\(6>H:C<7=]<3W"W.G'39H&VA&B)))X&
M0V2>0:EDN/$-K';S26]C<>9/$DT,)=3 C. S!CGS-H)/1.F?:LFZ\0^(K37-
M#TN:TTU)=6$Y'SN?)\M ^#ZGG'% %FV\$0?V+<:3JFJZAJMK+;FU073(#%%Q
MP"BC+<+\S9/ ]\SZ=X5>TBB2]UO4=3,4B,C793(5"&5?E49^8*2QR3M'-;&G
M/>262-J$445UE@ZQ,67AB 03S@@ _C6-JOBR'2_%NDZ))"Q2^RCW'\,4A!,2
MGW?9)^0]: +.H>'8]0\2:7K;WEQ'-IJRK#$@38PD #;LJ2>%'0BL]_ UL]A<
M69U*]V3ZF-49@(\B4.),#Y?N[E''7WK1UN]U>RCGGL8+1K>WMGFD:=FRS#)V
MJ![#DGU%5?"^KZQK5AIFI75K9QV5]9+<CR78O&[!2JG/!&&;GV]Z ))/#,4M
M];7=Y>3W*V5U)>6Z.BEHW8,"H8#<5&XX7Z<D#%8/@CPW-)X5TB/5FND^Q7,E
MREG-$(]L@D<H3QD@;@P]_7&!WM% ',Z;X,BTK4Y9K75M073I+AKK^S-R>2LI
M;<2#MWA=WS;0V,_E2Z)X-AT&X*VVJ7[:8DK2V^FNR&&%F))P=NX@$DA22!UZ
M@8Z6B@#E(_ EM%I-MIB:I?BVM;];Z 'RR499#($^YRNXGKS[U--X,M)7U6-+
MNXBL=7?S+ZT7;LD8@*Y!QE=X #8//;!YKI:* .9O/!5K>#7U:^NHX];@2WG1
M @$:*A0!/EX^4GKFMB?3$N=!ETJ2>79+;-;-*I ?!7;D8& ?PJ]7(VWB/5KJ
M\\46T<-D'T5U2,L'Q,3$).>?EX('>@#1/ALW%WI\VHZE<WR:?+YUNDJ(O[S:
M5#N54;B QQT'.<'BJVC^#8M#N&6UU6__ +-$K30:<Y0PPNQ).#MW$ DD*3@'
MG'2J^C>-1KO@^]U2WMQ;:G81,;NQGSF*15W;3C!VL.0W<'ZBII_$=U_PD-GX
M?BDL8;Z:Q^V&2<-MD^;;LC7()/!).>!C@YX &P>!K:WT[3;)=2O3'I^H-J$1
M(CRTC,[$-\OW<R-TP>>M2:;X,BTG4I9;75M073GG:Y&F%D\E)2=Q(.W>%W?-
MMW8S^55-7\3ZUI>D:5<2:?:1W=[JBZ=)"SLRINE9%<-@$C"@XP,Y[57NO'%[
M9Q>*;:>QMUU'0+47AVN6BN(BA88. 4/RD$'/XT 3Q_#VW@@@LX-8U"'3K:^6
M^MK11$5@<,7VJQ0G;N)X)/6I=0\!6]__ &K'_:U_!::E<QW<MO%Y>%F0I\P)
M4GGRUX)(]JT-.O\ 6;J+3+F5+ P7:+)(B%E=%*9R,GYL$J#]:@TS7KWQ'+>2
MZ0MM%I]K</;+<7"LYN'0X?:H(VJ#D!LG.#QZ@!=^"[#4+C6I+VXN9X]7MHK>
MXB)4!1'NVLI"@A@6)SGKBK>A:%-I"'[5K-_JDH7RTDO"F43T&U1DGC+').!S
M6?<:SXDATFZOGTVQM_LD,\DJ22N^XHS[0A &044-D@?>''6K'AK5=8U>RT[4
M+NVLTL[ZQ6Y!A=MT;,$(0@]>&//^S0!:GT%)_$]MKINYUF@MGMEA 7RRCLK-
MGC.<HO?M5"Q\%65C!;6*W,[Z7:77VJVLGV[8G#%E&[&2JL<@$\$#D@8HU/7=
M2M_&=AH5K':%+RUEN!+*&RGEE01@'G.[KQ3-/\2:CJG]O:?!96R:SI$BQE#*
M6@FW)O3#8!7(X((^4^M &GH>A1Z$+X1W4\XO+N2[?S0ORNYRP&T#CZYI;K1Y
MY=6?4K74[BUE>!(&C"H\3!68@E2,[OG/((_&L33/&%SJO@R+4K>" :Q)-]E-
M@^X;+D-AHF[C&"2<?=&<8KK8?-$*>>4,N/G* A<^V: .>?P5IDGA\Z49+@$W
M9OOM:L!,+G?YGF@XV[MW;&,<8Q5ZVT>87D%U?ZE->O;Y,*M&B(C$%2^%'+8)
M'7&"<#FM:B@#FK;PD]G?:K=VNNZC#+J<HFGVI"=K!0HVYC.. /6F#P%HT6A:
M?I=H;BU.GRF>TNXI/W\<I)+/N(();)R""#GITKJ** ,ZVTVYC(>[U.:ZE0$1
MDHB*I(QNPHY/UX]A6-IO@N72-)DTVQ\2:K#;O)))D+!N!D8LV&\O(Y)^E=51
M0!A+X8AC\4)KT5Y<)-'9?84@ 3RQ%NW?W<YR!SFK-IH=O!H\^EW3M?6T[2F0
M7"K\PD9F8$  8RQK4HH S]$T>VT#1;72K,N;:V3RX]YR0N> 3WJ.^T&SO]2T
MN^DW))ITSS1*@ 5BT;(0W'3#$\8YQ6I10!S]UX0L;J6\5I95LKZX2YN[1=NR
M61=O/3(!V+N /./<Y=J/A6TU"XU"3SYX$U.%8+Z.+&)U4$#DC*G:2I([>X!&
M]10!CZOX>@U:/38_M$MK'I]S'<PK %P60$*#D'Y>>@Q5B32_-URWU-KN;]Q"
M\26^%\OYB"6Z9W?*._3/J:T** ,-_#49\6OXBBO[F&Y>T%H\*!/*= 2P)!7)
M8$G!S[=*SK?P'';:%=:*FNZH+&ZDE>91Y(9O,8LXW>7D [CTYYX-=;10!3@T
MVWL](CTRR'V:WAA$$03GRU P,9ST'K6)9>";6Q3P_''?WC)H<;Q6X;9\ZLFP
M[R%_N^F*Z>B@#C[#X?6]A_9036=2==+BF@ME8QC$4@ *G" G&T<]>.M:VG>'
M(K+5AJL]U+=WPM19B>155FC#;OFV@;FR!S^0&3G:KG/$WBR'PW>Z3#+"TD=Y
M<K%/(.EO&3M#L>P\QHQ^)]* +%YX=\_7FUBVU"YM+F2U%I+Y:HP:,,S C<#A
M@6//3GD&J%UX%L]^FS:1?WFCW&GP?98Y;0JQ>$G)1PZL&YYR1G))K1\1^((_
M#]I;,(3<7EY<):6EN&V^;*W0$_PJ "2<' '?I0T^O6LUIYT-E=0S2A)S '1K
M=2#R 2=XS@9^7&<XH H7O@J.;4;74;#6-1TZ]B@^S2SP,CFXCR6PX=6!;)8A
ML9&XU8/A. :I-?QWUTCRZ>NG;,JP6,$D-D@DMECR2:BT?7K_ ,3V\NHZ0MK%
MI@E>.WDN%9VNMC%2PP1L7<" ?F)QG Z54O/$VM6UUX?M7L+6"XU6YFMI(Y&9
MA"8P[ @C&X$)Z#KGVH WM*T6WTOP]:Z)O>XM;>W6V!FQN:,+M ;  /''2LO1
M?!PT2U^R1ZUJ5Q9PQM'9P3LA%JI&."%RV <#<3@5/>:CJ]AI>KW4R6+FRMS-
M$8RV'8*S,C#.5. O/^U6';^.=30>'OM>F6[_ /"06C369MY3\DHB$@C<$="#
MC<#U[4 :5KX'M+6'085O[QH]%A>& '9\ZNFP[R%S]WN,5%IO@.+3)=)DCUK4
MG;2[:2TM@XBP(FVX4X09QL7GJ<<\<4S^W_$7_"6KX>-OI?GG3C?>;NDV\2!-
MGKU.<_I75V;SR65O)=1+%<-&IEC4Y".1R >^#F@#G++P3;:;;^'XX+Z\==!W
M_95;R\R;D*$.=O/RL1QBN:\/Z?K,=U#<03ZU;7\DWF75M>:? 8EW/ND4S[ S
MJ.<$.2<#CM75CQ9#_P )W_PC30LH:V,D=P?NO,NUGB'N$=&_&H_%FN:QH&EZ
MGJMM:V<EE8VOG8E=@\K#)8#' &,<^YH 73/!D6DZE++:ZMJ"Z:\[7(TPLGDI
M*3N)!V[PN[YMN[&?RJG'\/+>""WLX-8U"+3K6^6^M;11$5@<,6VABA.W<3P2
M>M;NDW&KSONU"&T$$D*2126[-G<>JL#[8P1[UJT 9?B+0XO$FA7.D3W$T$-R
M LCP[=^,YP-P([>E1C0%/B6#7'OKAKB&T:T\O"!&1F#$GY<YRHZ&MBB@#F4\
M%64<=Q9K<S_V5<7?VQ[ A=@DWAR <9"%QN*YZY['%,NO ]M=Z?K=D^HWHCU>
MZ6ZG*B/*, @POR\#$:]<]*ZFB@#$_P"$=']NW>L#4+I;JYLELCM"815+$,OR
M_>R['G(]JU+*![6QM[>2XDN7BC5&FEQOD(&-S8 &3UXJ>B@ HHHH **** "B
MBB@ HHK$\6:^?#7AVYU*.U:[GC7]U;I]Z0@$D#Z*&8^RF@#;HK)O/$FF67A9
M_$<L^=-6V%T)%&2R$9&!ZG( 'J:HMJ'B7^PFU5-/LS,83*FFEF\P<9"F3H6]
MMN,\9[T =)17.KK]SJGB&_TC2$@ TX(+N[G!95D8;A&J C<<<DY&,@<]J/B#
MQ-K7A_P]JFHW&GVIDL9XDC =BEQ&Y1=X/52"S<<_=Z\YH ["BLN*36$OHXKC
M[ \3HQ+1;@Z$8P=I/(['\*X\_$+4K/0KK7;[3K5].L]3?3[@02L)5"R^5YB@
MC#<D?+QQWH ]$HKC]8\0^(-*OM+@:TT_;J6H-9P@NY*+AV5V]250<#UKI-/?
M4'MG&H101W"NR@PL61E_A89Y^H]<T 7**XFT\5ZW=:9X@OTL]/==&O+BV:(R
M.AF$0!+!L$*2#T(/UI=5\;7-IH>A>(K:UB_L._\ )-U+.&#V:28PY X*@D ^
MG7D4 =K162^H7DWB)+&S6W>TCA\R[E;.Z-B?D5<<$L,GV !YW"M:@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N8^(D4US\/M<MK:":XN
M)[1XHHH(FD9F(P  H)KIZAN;JWLXO-NIXH(\XWRN%&?J: .<_=W-[H$4UG</
M ]E+'*LEJ^T;E0;7RN%S@C!K+\.>']5\-^,X]-&Z?P[#97#:?,Q):WWR0Y@8
M]P-N5)[9':NTM=1L;TD6EY;SD=1%*K8_(U9H \JN-,2:]TWQ#X9LM2TCQ'<S
MP&^LQ;21P3(6'F^<"-F "QW Y)Z9)%:=AH<&L>/?&2ZG97QL;L6BQEA-#%.%
MB(<9&%< \$'->A5#<W=M91"6ZN(H(V=4#2N%!9CA1D]R2 !0!POB"Q@'Q#\/
M%M.NVTVTL+F)FMK65HXB?+V+E%XX4\>U0Z_HSZCX<@C\/:?=G^Q-6BU.&&Y1
MXC<N)&DD1?, ./WAP3P3QVKT:B@#(L_$%OJ*QBUM;[S6(W1SVDD/E^NXNH Q
MZ=^V:Q/$:3/\1?!\\=K=206_VSSI8[=V2/?$ NY@,#)XKL'=8T9W8*B@EF8X
M 'J:;;W$-W;17-M-'-!*H>.2-@RNIY!!'!% #I)%BB>1@Q502=JEC^ ')_"O
M.M8\/WWB#P9J6I+=7MM?W$G]HV]NUKAXI8\&%<%=X("(#CN6QUKT>B@#G#J<
MVK^ 9[V6PN[>ZGL7$EH]NXD20H05"8R>3@8'-.\"1RP> ]!MYX9H)X+"&*6*
M:-D9&5 """ >HKH:* "BBB@ HHHH **** "N TH31:QX_FDLKU8[F1'MV-I(
M/. MU0[/E^;Y@1Q7?U5N]2L+ H+R]MK8O]T32JF[Z9/- ' >)O#FH2:#%XB\
M.0NNKKIWV:[M'0I]MA*8*,I&1(O53U[=#6KXET_1M;:+2]?TNZ:**VCFMK^"
M"0M#(2P(5T!*,-JGT.:[&*:*=-\,B2(?XD8$?I3Z /)KRTUR7P=X?M=234[Z
M2#Q#$Z3&"3[0;-)3MDEVC*MMP><'IWKJ/%&A6=CX&\3C2[&>2]U*RE5BHDGF
MGD,95 2<L>N #P/:NQHH XK08]-LH]$E@TW4QJ0MTMF#VLZ*@8*7+%UVC&S/
MX8'6JW@DOX-T^?PWJEK>+]GNIGM+F*VDECN(G<N#N0'##<05.#QQFN^HH Q-
M=EEN?!^JL+6</+:3+'"L9>1LJ0OR@$Y/I[\TWP6DD7@?0H)H989H;""*2.:-
MD9&6-0000#U%;M% '!>)+=)OB7HD]Q9W\EE!87*236]O,RJ[-'M&Z,=P#3_
MFFW6G:[XC%M:W-MX>FFCDLDNXV61I2O[UOG^?:3C&[\.*[JB@#A=,T]8/B]K
M%TEC<QVTUE$RRF"00M<98.P)&W=L"#(ZC\:[JBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@!"< GTKA[O06\8Z=KLMS<7EG#?!K589+
M3:RQ1D[&PZ[N6+.,?WAW%=R2 "2< =35%-:TJ241)J=DTA. JSJ3GZ9H \\D
M&N:[X7\*:[-IEZ=7T*[62]LY(6CDG4*4D:,,!N)&' ^HZ\5WEOK-OJJ+%:07
MC>8,.9;:2 1CODNHY]ASGVR1JT4 <%X$ED\)>'8?#&KVMY'<Z>\D<4T5I))'
M<QERRNC(I&<$94\@CI1XQC>^UWPA+/IMZUO#>2RW A@DD\I#$ZJ6* X))7CW
MKO:AM;NVOH!/:7$4\)9E$D3AERI((R.X((/N* .2NOLD?A[Q)9Z5IVH[9K66
M1B]M,-\KQ[ J!EW-P@SC@9'KQ+X*\/6,7A_P_?W%E.-3M=.B@S=F0M WEJ'"
MJY^3D8. ./:NNHH XQHYO^%QI=?9;K[+_89M_M'D/Y?F>>&V[\8S@9ZUU6HW
M@T_3KB[,,\_DH7$4$9D=R.@50"233X[NVENIK6.XB>X@"F6)7!:,-G;N'49P
M<9ZXJ:@#S/Q!H.J6OA:QURUGN[O5]/NEU)+:.VYDD=OWL8 7?@J[J >@ STK
M?\=/)JOPRU<6=I>237=DRQ0"V?S2S#@%,9!^HKK:* *FF-OTJT;:Z_N5RLB%
M6''0@\BK=%% !1110 4444 %%%% !1110 4444 %%%% !7-7,,^M>*'19;JT
MATZ':C-;?)-))D,077:=J@ $?WVKI:@N[ZTL(Q)>74%O&3@--($!/IDT >61
M>'-1U'P!XF\ +'=*;24C3+J>!TCGBW"5%WD '# H<=L8XKN]-\3K?648?3=0
M@U':!):2VLB['[C>1LVY_BSC%;-O=VUVF^VN(IDQG=&X88_#Z&IJ .$TA)O"
M/BWQ"M];7+:?JURM];7<$#S*KE0KQOM!*D$ @D8(/7/%.^(SSZO\/-2AM-/O
M96ED@$,:6[F20"5&8[ -R@ 'KCH?;/<T4 <S8G2K;6HY-/L-1$T\9CE>2VG5
M$C7+9)=<9SP .3N]N,+P3X=M+^RU!]7TZ[WIK=U=PPW:S)&092T;B-L*>#D'
M!KT.B@#C?&R32:UX2:&UNIEM]5$TS0P/((T\J1=S%0<#+"NQ)P,TM% 'DMII
M-A=:3XP@U?2M:9[S5;J6".*UN094;&QE &TY(_BX]>*[7P_9WLGP]L[+Q7 D
MMRUGY5["L>[(((V[5')VX!QWSBNEHH X[X76T]I\/M,AO+>Y@O0A^T+=1NDF
MX' SNY/RA0/8 =J[&BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "N1^*(!^&'B+(S_H;?TKKJS/$&B6_B/0[K2+N:>*VN5V2F$J&*^F2
M#B@#C_B39VUI\/'URW5+75-+2*>RNHU"NC[E&T$=0V<%>AS5V?Q/XBO!?G1-
M)2XET^:."2W?:/-<HCN-YD79@28&5/*^_&Q)X4M;Q[0ZG>7FHQ6CK)#!<,@C
M#KT8JBJ&([;L@=:AN_!=E<:]/JL5]J-HUV%%Y;VTX6*ZVC +C!.<<94@XH J
M?\)7<'Q<^AS26]A,9L6\-U X-U%L!WQR;@K,&/*]< _6L/3]?UF'P+;ZE>2V
M5^\NM_9V$UN>%-ZT>1\V,C@KZ8'7K783>&+:YNXYKBZNIHHKP7L5NY39'*.A
M4[=P )SC/7VXJD? UA_9;Z:M]J"VIOA?(@=#Y;B7S0JY3[N\YYR>V<<4 8^M
M^+O$&GGQ9+;III@T#RI0LD3EIXVC$A7(8!6P?O<CVJUXJ\6ZCH0O[B!;1H;2
M*"582C222AVP^XJ0(AC[I8')SUQBM*]\%V5^FO)->WNW6U5+H*T8P%78 OR<
M?*,=Z@U'P#8:FVI>=J.I(FI0Q1W21RHJNT8 1_N<, !T^4]P: *HU#6/^$R\
M4Q"[MGM;/3[>2&WD@) +"8]0WJO)QR,#C%)H?BB[U:+0-.M$L[2[N]$34YF\
MDM'&IVJ$1 PXRQ[\!<=\C9?PK;-J=U?K>WT<UU:):3A74K(%#!7.5/S .WMS
MTX%00>"[*TCT@VEY>07.E6WV2"Y0H7:' 'EN"I5A\JGIG(SGK0!B0>-=8O?[
M%@AM[*&ZN=3N=+O!(KLJ20I(=Z8(RIV X/KC(ZUT'A/6+W5[*^74!!]JL;^:
MS=X%*I)L/#!221D$<9-(/"%@CZ6\4US&VG7,EVA5E/FRR!@[OE3DG>_3'7V%
M7-&T.#1/MWD7%Q+]LNGNY/.*G#MC.-JCC@4 :E%%% !1110 4444 %%%% !7
M"_#.=M5TC4]<N@'U6[U"X2<OUC".52+/954#CW)ZFNZK#3PQ;VFIW=_IEY=:
M?)>MYES'!L,<LF,;RKJP#8ZD8SWS0!S>F>*;:"T6WTO3$L9+W79=/5)&#(DJ
M[FE?"X^7Y&(&1DGM5B]\3Z_!'XFL;:"SGU71HH[J(^4_EW,+JQQMWY5QL8=2
M#@>O&F/ ^E#2!8"2Z#K?'45NPX\Y;DL6,@XV@Y)XV[<$C%:NG:1#I\]U<^9)
M/=W94SSR[=SA1A1A0  !G@#N3U- &%>^+S%I<^L6AAN=/2UMV0A2#)-,P"#=
MNP  R$C'1AS5'6O$GBO1-&UZ^FTZU\JSM5N+6XD0*KMG#QLBRL<C@AL@<X[5
MNP^#M%@\+W'AP6Q.FW'F;XRW/S,3P>VW@+Z!1Z54;P-;3:!=Z1>ZQJ]['=1>
M2T]S.K2K'_=4[<#/<XR<#)X& "M>:OXHLM<TC39'T@G4YK@*ZPR?ND2+>N?G
M^8@YSTS@?=SQ2A\8:Y)8:1^ZT_[5/K<VD7+;'"$H9<2(-V1_J^A)Z]:ZBZT"
M*\U/2M0EO+KS]-W^5C8 Y==K%AMYX],5GQ>"+*(6P%_?D6^I/JB9:/F9]V[/
MR=/G;CW^E &%<>+O$EGI6LWLO]ER?V)J2VLX6"0?:4/EG*_.?+(67OOR1VK4
MU'Q'KT]UJT7A[38[M],N$@:&3://8HDC#>9%V?+( #M;D5:N?!%C=V&L6<E]
M?>5JURMU<8:/(<!1\OR<#"+Z]/K2W7@JSN-<EU6/4=2M9+E$2]BMIPD=WM&
M7&W@XXRI4XH P=3\8^(+.+Q)=I'IHM]$NXD:-HG+S1ND;D9#X5@)#\W(..@Z
MUL:9=ZI-\2-?M);R-K&VM+-HX/).5W^=T.[KD<G!R,#C%2W?@BPO+76K>2\O
M5CUB1)+D(T8P555 7Y.!A%'?I6A#H$$'B&76DNKK[1-;QP31[E\N79NVLPQG
M(WMT('/3@4 :U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7!>!].LK^'QC;WEI!/#+XANU=)8PP883@YKO3R",X]ZYJS\'1V":A'
M;:SJL<>H7+W5PJO$"7?&XAA'N7H.A&.U '(^#?$-[8:=)H5OONMFNWFGZ?+)
M^\(MH5WCJR[\?='S#CZ8.W=>*]<T?2X+C7M/6P3[7+#/>I 9XTB S'*R(Y*!
MNARQVD>X-:E[X'T:YT.QTJV6;3H["02V<UG)LE@?G+!CG).3G.<Y.:LQ>'!!
M% (]5U'SH]YDG=T=I]P .\,I4_=7& ,8H PK'5=8O_&^EQ+J5C):RZ$;IE@B
M+1.YDC!96W\CT/.!GKG-5;'Q7K#Z'X>FM[;3(I=2U:YL)5$3JB;7GPZ@-U_=
M9.>I)Z5T%EX,TW3;O3;BQFNK9K"U:T58W7;)&6#X<$?WAGC'ITXJ*W\$6-K:
M:9;)?7YCTZ]DOH<M'DR.7+;ODY'[Q^/?V% %&S\3ZO)IEZ+@Z>+NRU@Z=+.%
M98V3"MO6/<69R' "!CD^O2LNY\3ZUJ6EZ<T,\%K*OB0:;,PMV E17.T[2P*Y
MP,KG/;(KH9? ME)YK+J&H1S/J?\ :BS(\>Z.?9L^7*8VE>,$&D'@/3UM)8$O
MM14OJ(U-)?-4M%.#G*Y4C!.<@@]?I@ S[_Q=/HE[XKDN;6TD_LV*S\EHD*-*
MTQ95#DD\!L?0$]:GU3Q)J^BZI/IMP+.>273)[ZTG2%D7?#C>CKN.00P((([B
MM"X\&:9>2ZPUX]S<1ZM!'!<Q2.-NV,$(5( 8$9)SD\\T\^%8)8Y?M=_>W5P]
MFUDMS*8_,CB;&X+A ,G R2">!0!EZ'XEUFYU;08=16Q-OK&EM>(+>-U:%T$1
M()+$,")/08QCGK79U@VGA2UM+O1[E+R\9M)M6M+=6*8,;!0=V%Y/R+R,=/K6
M]0 4444 %%%% !1110 4444 %%%% !1110 4444 %<-X6F.K?$#Q;=7PW7.G
M3Q6=JC?\L(2F[*^F\DDGO@>E=S6-=>&[6;6CK-K/<6.H-&(I9K<KB9!T#JP*
MG'8XR/7% '-77BNST2]\67$.DB*[LI+6*=O,&RXEEP(FX&>CKN)YP!UK2N-:
MURU\0R:"?L,MU<Z>]W8W'DLJ;T8*T;KO)Q\RD$$=3QQS9/@K2Y[;68KUI[QM
M8V?;))6 9MBA4V[0 NW P0,Y&>:O6&A16=\M]/=W-]>+!]G2>YV;ECSD@;54
M<D DXR<#TH Q-*\7S:AH=CJA$(2.PDN]2C6)MT3I\IC7YOE.]9!SG[AI+/7/
M$]R;>Y_LVW_L^YL6G\XA1]GDVAD!Q(3(I!(R IXSWXW-/\.Z;IK:GY$'RZE.
MT]PK\@EAA@/8G)QZLWK6;I'@FUT:W:V@U359;58VCMH)YPZ6JD8Q'E>P.!NW
M8' [T 84/BOQ2?#&A:Y(FD%-6FL(TA6.0%/.8!\MN/J"...0<XR9+_Q?KVF:
M=XB$BZ=/>Z1>6T2NL3I'+'-Y9'R[R0PWGG)!QTK=_P"$-LO^$?TK11>7HMM+
MEAEMVW)OS$04#'9@@8';G'-,OO!%EJ']K^=?7X&JRPRW 1HQ@Q;=FWY.!\J^
MO2@#,N]?\3P:EK^G))I/FZ?91W\4QMY,%&\S]VR^9US&?GR.OW?24>+-4U6.
MWAT:SC^V2:3!J3"1!(H,N[8G+IQE&R>>HXK7F\+6\^HZC?->W@FU"S6SFP8\
M"-=V,?)P?G;\_I5&7P%8D:6]KJ>J65UIUJ+..ZMIE622 =(WRI5@,>F<\T 9
MLOB7Q5)?W-BMKIUA<PZ+'J+QSJTQCD+.K1DHX##*<,#QGH:=8Z[JNK^*/"LT
M5Q%!9:AHCWTEL8BWS$P$_-N'.'(!QQSP<\;G_")6:W\]Y'=WB/-8#3RH=6 B
M!8@Y922V68Y).<TVU\'V5G)HDD-W>J^CVQM(6#K^\A.SY'^7D?NUZ8/'6@#H
M:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB J*.Y)( H @CT>[2[TN=KZ(BQA:)E%N1YNX*,YW_+]T>O>HX_"UA!XR?Q/
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MX2\/MX6\-6>B_:_M26JE4E\O82"2>1D\\UMT44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5R/Q&TF]U7PW!)80M<7&GWT%^+=/O3"-LL
MH]3C.!W(KKJ* .$\<7MMXJ\&76AZ+*EW?ZF$A2).L(+ L\HZQA0"3NQR,=3B
MJ^BZ)HTGQ"\1"ZM+:=K:.RDADE0'#HCAG&?XAQDCGD9KT.B@#Q^RN(--\#^'
M[AI!%!:>(+AF@:-O+93).5#[5)4!2'4X(R%]<AMQ!HC>!=4N+"XL+JXGUZ"Z
M9;9.8,W*,$Y ;A-YS@<%NU>F:SHC:K-9W$.I7=A=6C,8I;?80=PP0RNK*>/;
M([&K.GZ=]BWR2W4UW<R!1)<3!0S 9P,* H R>@[F@#R[Q)I^F74OQ)E-K;RS
M?8H9+9M@)\WR6^9/]K=MY'.<5ZKI\HGTVUE#[]\2G=G.>*LT4 %%%% !1110
M 4444 %%%% !1110 4444 %>?>!I4\)V6H>'-=D%G+#>S2P7$S;([J&1BX=7
M/!;D@C.1BO0:* /)HIM4;0X;Z\:]NM+3Q/(9S.7DS8JS")L'K&#L8GN!D]*T
MF\,P^)+CQC:6QC&C7\<#6DB &-;L*Q:6/MP?*R1U(/?->CT4 ><7#ZOJ_@#4
M==_LV:'5Y+6.W-O&@$OEQ,/.51ZL?- '<!*QM=A\/ZIX+\4:GH\MY=M<Z>L4
M@EMA%'YBGY $"+F49(XR0  >U>P44 ><ZGHGAZ+QCX4%OI]B+>X-U+/MC7;*
M6B4 OZY('7J1ZUA6UO8OHOAZV>*(Q6_BNY5(RO$=N7GP,=HR"GL017L=% 'C
M.K:;ID.@>.3;VENLMOJD<E@(XQF+Y8"3$!T^8/G;W!]*TM5.GW_B#7=*U^;4
MDEN[B*?3&M( WGQ!$V"&38Q5E=6S\P R3W)KU2B@#QKQ'I^GM:_$:9;6%KI)
MH)+1P@+B00QY:/\ VMX.2O<<]*Z_2%M(_BEKLA@3?=V=G+:RK%D. )0[!@,=
MU!.>XKMJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!&7<I7)&1C(K@O -S!X1\(Q>'M;F2TO=,DECQ)Q]H0R,RO'_?!##IDYR.
MM=]10!XX=!%MIVEW.KVBQMJOBZ34?L\R_-#!*'&UQV! 7<#Q\V#712:=8:=\
M0I+33HDL(AX<DA4VL>"A\T$!0.K 9('7BO0:JZC8Q:IIEU83M(L-S$T3F-RK
M ,,'!'0\T >7^#I]"U/5O#,D]YIJW=AI;6JP;&\RX<A3N(=!@J%8X!)R[<XY
M-:UM;"3P]X:@DAB*1^*;GY"OW86DG//HA!3V((]:])L-!GMGB-]K5[J20$-$
MEPD2A2!@$[$4L0#WX[XS@UM4 <;X#CM[:[\4VEJD<5O'K#M#%& JJAABR5 X
MQN#].,YKLJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "N"T4GPIXX\21ZL?)LM6G2]L[U^(B=@5HV;HK @8!ZCI7>T4 >4ZG+K-];>
M.Y=,FOKVR22T%FJ2O(DD6$:X6+G#$C>.,^@K9BT_3M<\9&33(X9M#NM'>#4%
MB4"*1BZ^4I XWA?,]P,9QD5WM% 'GOANPU5]$N+*6WV7_A^WGTVRF90/-DQ\
MDH_[9B+GU9ZS/#ZZ#JEK;W1;4!J5GILMM?6UQ;+$D0*_.LQ\M=_S@8R2223Z
MUZK10!XY%HNCP_#GP9<BPMTO)+O3!=R[,2'8PW[SU^4%@<]![4FOVEA!8^.+
M*V@ACMUU'3Y;:&% JAL0[V0#H>&R1Z'/>O9** /+=1TG0SXD\70BQLC:MHD,
MB((U\LS?O@6 Z;\%.1SR/6JIO+?;HB^(Y[M-)O?#UO;QSK;B91<<B9&RCE78
M%/3.TCJ*]<HH \F.BZ.-?U"VN+8S6\?A>%%^WJ&D+JTH&_(_U@0I_M $58T(
M0_VSX"O+V#S&D\/M 96A+G[0/((!.#AAA^O3!]Z]1HH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=-O[:],U_IX>*]F966=T0,X/S%LX.<D<X/X]JT4XT]H@XEG,9&Y_E#-CO@'
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M*L]+>QD578LS,T9W#Y>G[OI[^W.YI@U :="-5:V:^P?--J&$><G&T,2>F.M
M%NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCF:-KAWBN$R R.C$@Y!//4'H:T[_ ,=Q6T=Q-:Z?)>1VCQI<QQL?.!958B-
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MFY6 ''^L4@Y.1Z'BNIH 1$6-0J*%4= !@4M%% !1110 4444 %%%% !1110
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M#FMVB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M#G!QUKDM)\,:UHR:NMKK5F#J-_+>ES8,6B+X! _>X.,#!(_#M76T4 <7+X 6
MSTC3HM#U&2TU+3[I[M+V=/-,\D@(E\T<;@X8YQC'&.E:%SH&HW^GQV^IW5AJ
M DW_ &R">T/D29"A0B[B4V[>Y;.3TSQTE% '(Z5X,GT:_P!(N;75 ZV.G'3Y
M5GA+F1-X<%3N^7!&.=W'OS4-GX'O+33]$M3JL#_V9J<NH;OLI'F>893LQOXQ
MYK<\]!Q7:44 <5-X)U K=&+5[</-K0U4(]H6C;Y OE.N_P"8?*&!R.0.*:/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)6:2V+8)&TH!@.-P /'2M_31XG2RCL[^/3S,BA&OHIV._'&_RBG#'TW8SWH
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M4 8_B:"_TS5?#T<>M:CC4M7:&<"7 \MDD<(HQP!A1GKQ78Z=926-L\$EY/=
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MX,&,@$ DY.1W[YH ]5HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ5RB@"I_96G?V>=/^P6OV)A@VWDKY9'IMQBI;6SMK&'R;2WBMXLYV1(%&?7
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
>4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>exhibit1027supplycontrac008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 17-K;WMM);74$<\$J[9(I5#*P]"#P
M:I:9H&D:,6.FZ=;VS,-I:- #CTSUQ[5I44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L/Q/<WEM;Z?\
M8YTA,NH01.60ME2XXZCCU]1QQ6Y5'5-,BU6VCADEEB,<R31R1$;E=3D'D$?F
M*F:;BTC?#3C"K&4]OO.5N;V^TG4_%5_:+:L;9()I1(K?O (LD#!X)YY.?H:T
M]=\0W>EQW,\26YB@ACE6,@N\@8G=G:?W8 Q@D$$_2K4_AFWN$U19+R[QJ4:Q
MS\IP NWY?E]/7-17GA*VO?M@>^O52\A2*=49 'V#"M]W@_3@^E8\M1)V_K?_
M (!Z*KX2<HNITM?3>RBOTE_P-T^QN;Z7QAJUO)<1FU@@MRD7EG(W>9WW=<CD
MXYXZ8HO]1U4>(%TJP2S&^S:X62<,<$.J\@$9'/\ G&#<@TB.WU9]16YN#++"
MD4J$KMDV9VL>,Y^8]"![5G7=K<S>-[>>,W$,2V$D1F2/*[BZD*201T!/X?A5
M-24?G^IA"5*=6^EE'MU4?\RE;^)M5OXM)2WMK2*YO&N(91+N*QR19!QCJN15
MJ37=0:QU6ZMTM6_LHE)HR&_?.J!WVG/RCG R#TJ['X=M89M-DAFGC^P%V105
M(<OG>6R,DG)/&.M+-X>MY9[YTGGABOP!=0QD;9.-I/(RI(X)!'Y\TE&I;5_U
M;_,TE6PCEI&R]/[VW_@.G]7,J_UF36]*UB.Q$*P06(=_/0L7,D6\#@C&%(YY
MY/3CF31M3NE%EIJB'RQHT5RCE3D-PN#SR/RJY<^&+:6ZN9K>ZN;074 @N(X-
MNR10-J\,IP0#C(QQ2KX:ACDM'BO;N-K>U^R$J4S+%Q@-\O;'48-'+.]QNMA?
M9\BV]-G;6_S_ #*NF^(+S5[>QCMUMXKN?3UO7+J60;C@*!D'KGG/&.^>!+S5
MW\4:=;SM#"K:<\TULJEQO#Q@@-D9Z\'''/7-/3PA;00Z>+6_OK>>QA^SQW$;
M)O:+^XV5P1QZ5>?0K<WUI=I/<1R6T30_*P/F(Q!(8D$GE0<@@T*,[:^1,ZN%
M4G[/9I]-M[?I;MY=:F@:\^L3,CO"DT<>9[0QM'- ^1P03\PZ_,!@XJ>ZU&]F
MU&]L-,6#S[2W24^>"0[/NVJ,$8'R<GGJ.*EL]%BM;R*[>XFN+B*W^S))+MW;
M,@G) &3D#D_U.8[[P_%>:HFHPWEW9W/E^3(UNRCS4SD!@0>F3@C!YJK3Y3)S
MPSK-K16TTND_U5M-ORN0C5=0O+N]L[..WCN;*"-I5E!<-(ZEM@((P  /FYZ]
M..:=IXDO=6N-,6PCMXHK^P>Y#3*S&-E9 00",CYO;^E:;:# MZUU:7$]I))"
ML$OE$$.J_=SN!Y&3@^]+%H%K;WMG<6TDL(M+8VL,2;=@0X]03GY1W[4N6?\
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M6_KS_P" =4:^#4M4K>G2\7_\D-N;[5[1HXYS8*93(RLBNY  &U=F0S'ELD<
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M;ERR, "K?+TX'(P>.M7=4TN+58(HY)986AF2>.2(C<KJ<@\@C\Q0HRY6GO\
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ME9V;V\<DT<KKN:/)3/13TSCUQQGZ^M2UR6J:SJNE03L]S;7$MJ(-RQ1'#;F
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M@W:W?_@A.&)IQ4^;^7;TO'\/NV"Y\/6EW:7,$\DSFY9&GEW .^W[HR!@ 8Z
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M%Z^TH/E*AHSG=EN,\#OGWBT6VF^S6L=[H=S%>Z? T1GDEWI]S;^Z^8_>XXP
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MC 4# %/JHQY495ZOM97MV7R227Y!1115&(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 55O#?;HELA ,D^8\V2%&.P
M'4YJU2,P52QS@#/ R:3*B[.]KG/:)JNKZO9Q7?EV:Q--+$Z@-E=A90W7GE1Q
MZ&I_#NOQ:OIEF]Q/:K?SQ>:UO&XW 9ZA2<XJOX-26U\.M'<03PNMQ.Y22)E;
M#2,P(!'/!'2L;1[*>WL_""FQN(Y+>67S_P#1V!CW1N,MQQDE:PC*247W_P"
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MFZ@NJ6,CE;ERX@#<CS5;.TY!Z>IZ=Z4:LG;3<JK@*4')<S]V_:^[5_31??\
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M7SM]W I@ :8&0#RP>A;GC\:XK58[Q=*\5:;/87<]U=RM-;21P,ZRH54*-P&
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MMO-;2!3&44A258CS%).<XP "0,9R!@BJ^J^&KJ?1+*V@DB,MI&RD1ADWYP,
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M>,?$ GD21O)M,,B;<C$G49/-=)5PES*YAB*2I3Y4[Z)_>D_U"BBBJ, HHHH
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MZ+0W)=3$I\KO=KMT:?Z-_>9R>&;5+6"W%Q<[(+LWB?,N?,+%N?EZ98\>]/\
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MSTYJE=:G-'K^D6T#PO:7J2LQ R3M4$$-G&#GTIM07]=R(5,5+2[TN_N7^2_
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MPA&-V".<@]B?SJ;[9;;XT\]-TB&1!N^\HZD>W(_.H!K6F%)G^WVX6!0\A:0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[BU@>X6TO8YYH(^6>,9!P.Y!(;'M6U#-'<0I-#(LD4BAD=3D,#T(-.) !).
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MLKJY_LC5;5YC"KRL[?: 5?*LH);[AY]^V:V/#RZ@EG<+J#>:XG81SF+RGF3
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M98Q/HAMHY&C*KYFXD*3VX/ZUUL,\5S"LT$J2Q.,JZ,&!'L14E'LD^O\ 6O\
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M6\]E-' !)9P&WA/]U#C/U/R]?<^M.MM+AM+J]N8I)1+>,'E)8'Y@H4$#''
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M3"JD1<D@$GDA0!GN<\XK;?1+-KBRG42I)9JR1LDK E6P2&_O9*@\]34 \-V
MM!;@S?+<FZCDW_/'*2264^Y)XZ<D=*.2:>G];"^L8:44I+\%_>_S6GE8R+[Q
M!JEG#JENK0-<6%W;1B5HSB6.9E R >&&XY/3CIS6KI-[>OK6JZ=>2Q3?9A#)
M'(D>SAPW!&3T*_K4L^@6=S:2P2M*WG3)/-)NP\CJ05)..VU>!@<58M],AMM1
MN;]'D,]RJ+)N(P0N=O&.,9/YTU&:E=O^M?\ @$5*V'E2<8QU].ON_P"4OO\
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M'RY(UB,1#@,J[N3\P+$C=DGZ476EZHWA[7=/33Y'EGOWFA(D3$BM*'!&6XP
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M(0A4]6XY/?%/FDH)]=?U)5*A/$2BVE'W>J[QOKMM=Z=NUSI;35K&^N9;:VN
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MBG5!9PBVLH(!%'$(XU41Q_=3 Z#V%3UNCS)))M(****!!1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MYJ]11322V,I3E/63N%%%%,D**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR8:IXYUDW&'73XX$M$/(4.I9G'N3QGT&*O:?<VK>*=5MH;)HKF..$W$N5VR
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M7+0>([^Y.FO%#;[;V[EMFA8-YD(3=R3GT3G@8W#\9X-;U*]EM[BRLA-9/=-
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MXSSC.,]JO3:OIMNY2;4+2-PXC*O,H(8]!R>OM3-5U*+3K*:1KBWBF$;/&LS
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M+1I94^U[7O9FFVS2*"[G&=HX]N*MPWMK<2/'!<PRNGWE20,5^H'2I5)==_\
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M5DVIR7L<MU!YP43P0R[8IMHP-RX]..",CK1RS*]KAFEHKV[==+IZ[.SMVO\
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M5M)-K3R."C4C"I>3NK27WIK]3%C\0WOV'1M4=(6M-2FCB,*J=\0D^X=V><<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%("&4,I!!&01WI: "BBB@ HIK.B8WLJY.!DXR:=0 44A(! ) )X'O0"#G!
M!P<'':@!:*** "BBB@ HHHH **** "BBDR-VW(SC.* %HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBD+ $ D GH,]: %HHHH **** "BBB@ H
MHHH **16#*&4@@\@CO2T %%!.!D]** "BBB@ HHHH **"<=:* "BBB@ HHI
M0P!!!!Y!% "T444 %%(""2 1D=1Z4;ANVY&[&<9YQ0 M%%% !1110 4444 %
M%%% !1110 44FY=Q7(W 9(SVI ZD*0P(;[O/7Z4!8=12$@8R0,G S2T %%%%
M !1110 44W>F\IN7>!G;GG%.H **** "BBD)"C)( Z<T +1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5S/C]$;P9>LR@E6B*DCD?O%''X5TU9FOZ
M3_;FD2Z<;CR$E*EG";C\K!ACGU%143E!I'3@ZD:6)IU).R33?R95N]5O;;6'
MTFPL+9MEG]I1GF*+@-MVX"G'^>E5#XO5[73I(XH89+ZT^T0K<R;%=^/W0;&-
MW/\ +CTTVTF9M9.I?:D$AM/LVSRN.N[=][UJB/"Q_L./1WO$ELUM1;%)8 W
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M0TG3&TS[9F?S?M-R]P?DV[2W4=3QQ5)_#2,NHVR7)6PU"0RW$&S)W-C?M;/
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M%JB_ ISP<FU9)7E;?;2WKUTNOD7]2NY;*T$L4*R'>JL7<(J*3@NQ/8#FL/\
MX2J<V/G1V4<KKJ:Z>V)2H.2H#KD>C#@_F:U]8TLZK;0QI<M;R0SI.CA0PW*<
M@$'J/_K5F_\ "*OME7^TG;S-02_^>)3AUVG'&."5'^>:J?/?W3'#?5>1>UWO
MY[?(4>)98%U"*\M(UN[6YBMDCBE++*TH79\Q (^]SQQ@FHM,65?'FJF>.%':
MQMR3$>'^>3DY[]OPJ>\\+)?-J32WCJUY+%,C1I@PR1@!&&2<]!UJS8Z//;ZQ
M+J=S?F>:6W2!U6$(OREB#U)_B/>IM-R5_P"M_P#@&CJ8:-*7LW9M6Z[^Z]/F
MI;F?,_\ :OCM],N1NLK.R6<0-]V21FQN8=P . >YS5R^2Q\/!]3A@",X2W$$
M?RJ[LX"\=!R>3CI]*FO]%%SJ4&IVMP;6_B0Q>8$WK)&3G8Z\9&>1@@BDOM%.
MJZ=+;:A=,SOM*O"NP1LI#!E!)YR >2>E/EEKIKT(]M2;IWE:-DFM?GY:[]RK
M=^(+BPN+ZTGM(FN8+)KV+9(0DJ+PP)QE2#CUSD=*9!X@OI;F*"2R@C-S8->6
M["8MRNW*N,#'WQTS5F?07NUNI+JZ5[N>T-F)4BVA$;[Q"Y/)/OC@<>I%H+1W
MEC<-=!A:V;6FT1XWJVW)SG@_(/UHM4N4I83EU2O\][=/GW\^AEV'B'53I7A_
M-I;W%SJ<1(<SE0&$1?)&WOCMT]ZMWOB.[T]T%U9PI^]@B9!-N9O,*@NO'W59
ML<XS@]*=9^&9+1-'0:@TBZ66\K="/F4H4P<'^Z>OK^5-O?"SW<M\5U*6..ZN
M(KK9Y:L5="N.3R5^0<=JFU11\_EV_P S1SP4JNMN77^;^;_Y'R_$M'5[N>2X
M;3[);F*VNA;2 R;78\;RN>,+N[GG!Z<9;H=_?7NH:RET(O*MKPPQ["<@"-"!
MT_VB<^IIL?AZ6WU.YGMM4GBM;MQ+<6P13O? !(;JN[ SC\,5<L-*-AJ-_<I<
MLT5Y*)C"5&%?:JDYZ]%''UJTIW39A.6'4)*%M4K;WOI==K[[:>?0Q+BQM+GX
MDJD]K#*ITDN5DC# MYH&<'OCC-11W,^@^+-0TVRCEN;5M-^W16GF?ZN0/M*J
M3]U6ZXZ#M6S/HT[^(?[8AO4CD%M]F$;0[AMW;L_>'.:@F\+07%IJ2S74[WFH
M((Y;HXW*HZ*H P%'IW[YJ'"6Z6MS>.)HM*-25X\J5M=[[]-O)WZ=2E?>)[K^
MR]?^S+;FXT^U69)D<LC!E8\<=1M/L>*LZEK]YI-@T\MK"1#:&X),W^M(SE$X
MSG R3C R/K3G\+M<?VF;G49)/[1M%MI@L2J!@, P]/O'BF7/A66Z%P)-5E_T
MJQ^QS_NEY'S8*_W?O'([_7FBU7^K>8*6"ND[6Z[]HW_&_P#6V\?+NK/+(&CD
M3)5AG(([UYIX?5;JP\+VFGQ&UU($74UT0$$D"L0ZYZR$\#'..O%>DPV\D&GI
M;B??(D83S73J<=<#%8D/A*.'0;'3EO'6?3W#VMVB /&<]QG!!!((Z$4ZD')I
M_P!="<'B:5&$XM[M6W[25WW6JT_ EU+7Y[>>\AL;)[N6S"F2-5<ER1NVJ54@
M'!!Y]?QI+KQ!,+?4I[.U5TTZ+?,LSE&+;/,*# ."%(Y/<XITN@71U1]0M=6E
MM9+A%2[6.)2LNW@, V=K8XSS5#7-!EMK/6[NRO9DCN[1A+:B,2>8XCVJ5/4$
M@ 'KFB3J*["E'"2<8Z7T[[Z73_&UN^MNE^+7YI+N2W^RQY&G)?*WF'G<2-IX
MX^[UJ"+6%OKOPW.^G0E[^W>:.1GRT!,88J/E[@@9]NE$&B/=I9WT-Y);,^GI
M:3(8@25'(QG[I!)J>V\.-:_V+MO2PTN)HDWQ#]X"H7G!&. */WC_ *7= _JL
M;VT=FNO\K7YV_JY5M?$]Y)IYU"XT^&.V,K6Z!)R[M-YWE*,;?NGKGKP>*6[\
M2WUE9WTTFE,1;20A)#OC259&"Y7<N<J3R/UJPOAB,^'IM(FNG97F:9)HUV/&
MYD\P$<GHW2DN/#]W>Z1+9WNKO<2R-&3,854 (P8 *.,DCDT6JV^7EN-2P7/>
MRMS?WOANM?NNGJ0SZ_JD-SJ=J-.M3-90+<@_:6VM&=W'W,[LH>V*?+XE>:$'
M3[-IIA9QW9C*N<[P2J953@G:>3[=>UF;0Y)K[4+HW:AKVU6V9?*X4#=R.>OS
MG]*JKX7GMY+.:QU:6UGAM4M)66%66:-/NY4]&&3S[]*'[3^K"3P;6MD]/YK7
MLKWWZWV_(23Q#J+W;6UMID:R"P6] N9BA7)(*, IP00120:Y>7^KZ%]GCC2S
MO[%[ID9CN'^K[X[!_P :NMH;?VE)>)=G+V0LPKIN. 2=Q.>3DFHK7PX;0Z.T
M=ZX;3;<VP(C'[V,A>#GH?D'(]Z+5/Z]1<^$2T2O;S_E?ZV*OC>*.2PTW>BM_
MQ,[9>1G@N 1]"*Z.0%+=A%&A*KA4)VJ?;H<#\*S]<T=M9M[>%;G[/Y-PEP&$
M>XED.1WZ9J1+*^,_FSZ@L@5&"1K!M4,?XCR2<#/&>]79J3=MS!SA*A"+EJF]
M->MC!L_$UO;Z-HPAMK6Q2\M3) DK[(@PQB(-C )SU/IT-:-IJ&H3>++FRD6)
M;:*SAE"ACN!8N#VY.5Q]*CB\,-%HD.DF\26T2V^SLDUN&##LV,\,/7]*M6FA
M+8ZI'>074@1;2.U:)@&WA,[26ZY^8Y]:B*J:7.BK/"-3Y-W>V[ZW7H[:=?-D
M5S=&Z\76VE'_ %$-HUY(O]]MX1 ?8?,?KCTJCX?6/7KO6+[48DG:&_DM((Y5
M#+$D>!P#T))))^GI6G=6+0^([;5XU++]G:TG4#)"E@RMCV((/^]GM2+HDEGJ
M5S>:9=BW%VV^>"2+S(V?&-X ((8CKS@^E/E;E=]R%5IJERQ=FXK7SOJM._Y6
M6QB^)])M+2RL(TB5HYM9MVV,,A0Q"LHS_"<=.G..E2>(84T"]TC4-,46YFOH
M[2>"+Y8YD?(Y4<;AU!ZUJZIH<FI6UM$;YE>&Y2Z+F/=N=#D#&0 OM^O4U(VB
M_:M1M[W4+EKE[4EH(@@2-&QC?CDEL="3QV%2Z;N[+L:4\7%1ASSO;FNM=;[>
M7^6^YQ-_]CANO$\'V+-S/>1V]G,JA!#*T2[3OXV?-S_^NMOQ%:.FG^%XKXI<
M7*ZC;132$9WG:=WX$C-::>&HG;6%O)5N(-48-+'Y>W:0H48.3V _'FH[CP[=
MW5CIUM-JQ=K&X2>.9H 7<ID#=S@]>>F:GV<DGIO_ )F[QM%R@^;X;7W_ )$M
M/FM5\]>F])#'+"T+HK1L-I4CC%9/AJ^EO+"XAG8O+97<MHSMU<(WRD^^TKGW
MS5F."[@G:ZN[PW"I&56**#:,DCG&22>,?B:CT'3GTZQD\[ N+F>2ZF .0&=L
MX_ 8'X5OJY(\SW(T9)N[NK?C??\ 'Y% ^)IEL9K@V:9AU,6#*)3R#(J;QQ_M
M9Q^M17_BB]LSK#KIT+0Z4Z>:QN#ET90V5&WK@]#Z=34D_A5YOM4::E)';SWJ
MWHC$2DK(&5CR>H)7\,]ZDN_#+7<.M1->[5U7;O(BY0*H7CGT _&LG[6VGZ>?
M_ .V#P*E>5K?]O=X_IS?U8CUW4'O;+7+"V@AE6TM3YYE; +,A8*!@\@8.3ZC
M\(+/7)K?1K2ULK4W-Q;Z=!,R;7.[<ORH"JG!.T\GVZ\XN7/AR66\O;BWU P?
MVA (KM/*#*Y"[0ZY/RG''>HU\+SVTMK/8:O/;316R6LS>4CB9$^Z2IX##)P?
M>AJIS7"$\)[)0;[/KO97OIWO:WE\G+KVHW&JI8VVF1JS6L5TWVB8HRJ[$,I&
MTX88/'ZU-XBO[VR;2UL_*_TF]2&3>2#@@G P.^WFIX-',&MG41<EA]E6U\ME
MR=JDD$MGDY)J35]+_M2.V"W#026UPEQ&X4-\RY&"#[$U=I\K[G/SX=5HM)<M
MM=][=?1]CEQJ4^A:AXHO(+.%[>&[A><>9L.#%'G: #D\D\XK7O-46RUW43_9
MJ236VFBX$L9S)*NYL)C''()[]:+KPNUU;ZQ"U\0-49&D;RN4VJJ\<^BC]:LS
M:+/+JD^H+?&*:6T6V&R+[F&+!AD]<D\>E0HS7]+S_P" =$ZV%G9O>R3^+6RA
M_E+^K$VCZH-5A>>*2VFM^/+FMY-P;U!'52/3_P#54#ZO=S27?]G62W*6EPL$
MBF3:SGY2VW/'RANYYP1QWGTW2(["]O;S,9GO-GF^5'Y:$J#@XR>3DY.>>/2J
MO_"/21:M=75IJ4UO;7C![FV5%(=@ "58\KD  X_2K]^R.9?5O:2:VLK7O;I=
M::]]=/ETCN_$<D5KJ=];6JS6NFRM'/E\.^T N5&,?+GOUP>E17?B6\6;4EL[
M&":.SM([P.\Y7S$8.<8V\'Y..WO5B7PVK'4H8KIH[+4F+W,&S)W$8<HV?EW
M<Y!]L4Z7P]ON-2DCN1&E]:+:[!%Q&JA@".>OSG]*EJI_7S_X!M&6"6ZO]_\
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MJVO?SVNOEM<Z)=VQ=X ;'(!R,TM-12J*K,7( !8]3[\4ZMCSF%%%% !1110
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MT^PU%XIQ$]Z+F^$,8=T0HP4E<'.S]WG@_=S6?=66EM%IDMM'--;3ZP)F:>/
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MM3<B)T5HQ)LX9PN<X/0L*V* "BBB@ HJK+?PI>"R5U>]:%ITAW8)52!GV&6
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M0D2A_-3 P_3Y<DD8]J +-%%% !14#7MLE_'8M*HNI(FF6/N44J"?IEE_.IZ
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MPL&BATS^T'\/LE@]VKF65T9=O+<F7&#ST&<XYJ/2GU2ZA\(W6ER::-2),>H
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M);!C</,<NQ((QSR!CC- &,WQ)>^7PW+:-IEN;R]GM[V&:^'[LQK*,;@OW2R
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MXQN&,\9[+2=#CL-(M[2X^S7,\,80S"V"!L# .W)]/6N?M/AZ+6RT:V-[;/\
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M5BU9RD<NG2!H?EG&Y_W@W)\P'  ^8<\<@'LXN8"C.)HRJ]6#C I[.JH79@$
MR6)X ]:\N/A_Q#8^)[GP[!+IATO67_M260:>WEQLA42)M\WHS"+(R<[WQC%:
M_C5=>MO#F^[N--O+7[5;B5(]-G&Q?-4[VVSDE5QDC'(&.] ';)=VTL:21W$3
MHYPC*X(8^Q[U7U+6+#2=-N=0O+F..WME)E;<./;ZD\ >M>-7$6L*FMS&YA>&
MV\165^\ATB5!M_<DRJ-_"C!R.20I.1G-2:S;ZOJ=GX^>%[>X21+:8E-)E7SP
M(U^:/,AP0/\ >)ZC@T >H?\ "1[?%\ND2I;I:)IZWBW7G=<R;,$8 '3U-;<U
MQ#;Q>;--'''_ 'G8 ?F:\HO+&?4_&$QFN-&EMO[!.PRZ3((L>8QVA&EX?!R#
MGH>G.:JZ"==@_P"$3FU*]L4TXZ']GCEN[!WC@G&S<D@\T8D*C&XXSAACF@#V
M%YXHE#22HBG)!9@ <#)_0$U6CNISJ$ZR?918K"CQ2+-ER26W;EQ@+P,'//->
M.VWA_4Q<^%+74'TYK;[=?+:I=:<["*V99/+#@R9V-\NU"1C*@DXQ6H]K<:+X
ME\2EY-*%I#I=IOBATB1DE$;28C2,3<L/D!&3P5& .H!ZO'<02MMCFC<XSA6!
MI(KF"X1GAFCD12061@0".HXKQEM.UR30M7U6VN=.FU[4+599[.RL2S00(Z9@
M1A)MY!)*X)8[AD\&HKR'4;G3KS7=(U%M0MI7M%U15T62 -"D@)'E[QO(7(8
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M+2ZQ/;RM;OYJ(H+G[0RKAF#%1\W ^<$GBNFL?'&@OIJSWFO:,LHW%A!>HZD
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MJ.-JYSGN >F,UN:C\5=.AN)S87-C<QVUTL#0>80\R94/(C_<&W)X/7:>1D4
M>BT4R&:.XA2:&19(I%#(Z'(8'D$'N*?0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9
MVKZ8^J16\0NF@2*=)V4(&$FQ@RJ<]L@'CTK1K(\1:_!X=TZ.XEB>>:>=+:UM
MT(#33.<*@)X'J3V )H BU_PX-<O-)NUO9+2XTRX^T0R1("22I4J<_P )!(([
M\<UGWO@A+ZSU^VDU*55UN9)IRL:YC*JJ@)^"+USWK2DN]=M3:M-96<T<LR1R
MB"5LP!CC/(^<#/7Y?7%:0O[-KPV8NX#= 9,(D&\#_=ZT <QJ?@-=3DU4MK-Y
M#'J;P331QI&0)8MFU@6!('R+\N<5<DL!X>U#5?$C/?7SW,$$4EM;VXDD(C+!
M2JKR3^\8G],8K9;4[!9EA:^MA*TAB5#*NXN "5 SUP1QUYJK%XCTF;5+[3DO
MX/M%BJM< R ;,Y.#SU &3Z9% &7X>\.QVFBZH(DGT^35III]N?GMPY.T#J%(
MR6V] S-46H>!8-4M]7%U>$7.JVJ6EQ/#"J$QH6(..07.XY8]@  *Z$ZOIJPO
M,VH6@BC8([F9=JL1G!.>#CG%22W]G#:"[ENX([9@")FD 0@]/FZ4 8NJ>%?[
M9CDM[^^,UI*\4K0M",H\>.8VZIG:,]>^,9S5[Q%HR^(O#][I$EP\$5W&8I)$
M4%@IZXSQFBX\1:3;:C8V$E]!]HOE+P*)!\R@?>Z]#P!ZD\5<%_9F\-F+N W0
M&3 )!O _W>M &3/X;9]7M-8@OF@U."V-I)*(@R3Q$[MK+GJ#R"".2>QQ4$7@
MVVMKC19;6ZEC_LN::< J&,\DH82,Y]3O8\8P3Z<5M/J-J9&@ANK9[KYE2$S
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M1[,22A$:.)A@XVJ-S=/F;/0>^9(_"G_$PTJ\N=1EN7T^UEM=LD2 2K)MW;L
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MY,;B ,#. !^E6* /(X-&N_)BU&QUZ\M%N-3-W'=R:0Z@S^2REWC9OEC(RI)
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MG9O8;>^:Z.-2D:H69RH W-U/N: '4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$#))8CG'"DUB>!?'UEIF@^%=+O;G2X[2;3MIF%\IDA>- <2)C"@\@<YR/?
M/6:*\\LOBMIUY?V"+)8"UOHG<.]R8S;,%W()2RX&[IE<X/'/6HM'^*UO?2:'
M)>_V3:6NIB17QJ*M);.JLP\Q2  IVX!SU(]<4 >D4@96+ ,"5." >E<+XH\=
MVEI=:''I&MZ+)'<7XBNBUXORIL9N2,[5RH!/N!WKF[/QO8>&[[Q5=V<ND3VA
MUB.1U%\J.Z-%"K-$H!WX)8DY X/O@ ]?HKSW5_BMI5E+=FQFL[Q+29(GC6?Y
MYP0I9HR 5^4-W/)4CC@E_C[Q[IUAX3G.C:]IYOIY([=)(;E':$.P5I, ]E).
M>QQ0!WV1G&1D4M><:]J7P]TCPS)_I%C,J *9;*>*2Z#$@!]V[<QR1DY.><\9
MJ_=_$C3C/?Q:=>:5(UC"DC"XOT3SG8%O+0C()  RW(R0/4@ [BBN$LOBCHU[
MJ^FQ?;-.ATZ_L3<I<2WBAXI!MS%(G16PV<D\[33)/B?I@@M46^TM;JX@:X.;
MDO'&H("JQ520QSTQQ@]>,@'?45YI!\5Q?RV<5K;Z3!)<6)N6%[JBQ")UD"M&
MQVG!P21ZC!P*4_%>%?-F<:.+:#5!8R[=3#2-&651,B[?F4;LG.. ?3- 'I5%
M>;:G\58K-M=:V&CSQZ4R,O\ Q,QNNHR@<^6 O+#)&.F1C)[6C\4M-M+^^CU"
M?3!;Q6)O8'M+Y96?!P8B, >9T( )Z^V: ._HKS:X^+%K;KJ6/[-N/L]@UY"Z
M7A1)'7K#EESO[C ^;VJ5?B="9[FWDGT2)VTTWMK(-1#KO! ,4G PW(. 3T//
M&: /1*175P2K!@"0<'/(ZBN/\*^-=,NO"FEW&K:]I"WTEI$\H^VH#N* G<#C
M#9SD=JP;7XDZ78::)+*VT:*2?6Y;6:&/4%4<R$&XSM^8,1NR0."#S0!Z?17G
M8^*NG6]EJ!O[C2X[FTOH[7,%X)8G1PA$H( 8JH<YP.JGD=I;SXEP6LNFP13:
M%<R7D\L)D355$<85&9'8X.%; SW&< ,<9 ._HKSFS^+6FO:O#?2Z?;ZFEZUF
MRQW7FPX";_.5E&2A' XSN.#CJ);#XI:=>110236%O?27<MN#+=A8=B+N\[)P
M=I&  0#N..V: /0:*\UNOB)*U_X?B6\T6V\Z]GBO%.HHZE$CDV/N7.U&(4\C
M.<#ZZFF_$C2-1OY$&IZ1%;Q7,MO*);U4D0(6"N >&5\ @@\ CKS@ [:BN/UC
MXBZ%8W4%I:ZOIDLLT;R>:;C?'&%VC!V9.26X'' )[8.6GQ3M9]&M[Q3IMK*U
MK--/'=7Z#9(C!1$ /F)?D@XZ#IDXH ]$I-R[PFX;B,XSSBN$3XFZ;?6UM_9]
MUIBW,NG)?.EW?(BHS#Y8<_W\@@]-N 2.:PY?%MG_ ,)TFK64VC1WD_A\>:EQ
MJ,:HDGF@^6TB;MS#IQ0!ZQ2$A022 !R2:YC2/'_AW4]!L]2DU;3K:2XMUF:V
MDO(]\;$9*G)'(/%<GK'CS2/$WP]UDR7ND>7<Z1.Z0FZ7SHYMAQ&T;8.X'H1U
M(X'0D ]3!! (((/((H1UD0.C!E(R"#D&O/-%^(5DLT.E7=SHR1_V8L]O*-24
MJ2N%,<AQA6Y!P,\9ZXJGIOQ*L(-)\.6NE6VB6RW]J[>2^HK%'9,H!"/A3@'/
M7J2#QWH ]0HKS6#XM6TMC9,T>F)>/J3:?=1-J2A8B 2)5;'S1G ^;C&>],E^
M*XM[*_GD716;3KL0SK'J8)GC.P[X1M^; ?G.!E2/H >FT5Y[K'Q6TJQEO/L$
MUE>K9RI&\:S_ #SY"EC&0"ORANYY((XQDU]3^*\-F^MM;C2)X-+>,@_VF-UU
M&RACY0"\L,XQT!&,GL >E45P=MX[M9/'M[9R:WHHTB*RADB?[8HRS-)NYZ%O
ME7(SP"/6KU]X_P!&75HM,L-6TAY6@:=YYKU1$@! "Y!Y8DGCL 3Z @'6LP52
MS$!0,DD\"D1UD0.C!E89#*<@UY3K'Q!L]<TWP])!=Z9 7U=8KZUGO5^4IYF<
MD#F/<JD-W^7CFMW4O%_AOP?X5GFT2XT:<Q/YGV*"_106=_F*XSW8G& /I0!W
M=%>;7'Q6BL9=7@NDT=YK:Q:^M#;ZHKQW"KP8BVWB7IA0#G/'K5NW^)5L[6D-
MQ<Z)#/?/F$KJ2ND48C#,TIP-K9.T*.I[\9H [ZD#*6*A@2.HSTK@(?BII,D;
M6SW&GIJ0O_L6W[8IA(V[_.#_ ///;[?>^7WK!T_QK8>'KSQ??K<:1+(^J6V(
M8;Q0LJ-'$C2(<<XR6/'!##/&: /7J*X6Y^*&C6=[K44EWI\D5C#!);O#>HQN
M6D+#8.P*E5R<G ;)Q6=XE^(DMGH&M_9;W1!<PVZ/:W$.H)()"V0RA,[MZ]N,
M'(/M0!Z72%E#!2P#'H,\FN:NO'?A[3]&GOKO6]+=X(FD>*UO$D+8&<*,@DGZ
M5R,WBO3#\0M$U6^O]&BC32KLR26]XLA0DQ$1L>,D8./7)P!CD ]4IGFQD*1(
MN&.%YZGT'Y&N!L/B=I.I:E:6=U)IXL;^W=VD:? MR #Y<N\ '<">03R".>#6
M#X7\5Z%I_A+P-:7#Z3.WFE&>6[0/9-LD(?;VX!7)(^\/6@#U^BN#L_B787%M
M?K-=:/#>VU^+2.+^T%*2H2N)0V/N[6)X!QM(ZU!>_%?2H+H_99K*YMX[P6TB
MK.1(RY"M*IQM*@YXSR 3D=* /0Z*\Z3XIVPEU2:=M(2PTZ>:-V34U:6=5C#(
MT2;1OW$[>HQ[X-!^+6EVLUZ+N2TD@AL_M,4MM.2'?=M\G#A?FY!!Z$9SC% '
MHFY=P7<-Q&0,\X_R:6O,;7Q)IA^*L-[>:GH<:MH<B-/;WJ,N[SHSL9CCD8./
M4=A6EJWCRT@\8Z-:6FMZ*VERPSR7+F\7AEV  D9 X8D#N1[4 =Y2,ZH,NP49
M R3CD\"N B^*>F%-*O9;C3EL-1G$(5;Q3/;!L['D3L#@;O[N1UYJUXM\:>'(
M-'B;[5HNJH;NW5H'O8SMS*H$@ SG:<-VZ9S0!VU%<3H/C%-4\;ZSI[:II,EI
M$84LUAN@6DRA8E1_$<GG'3 'O7;4 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVD%A;%#$ZRY=@5'#*0,,6X !.>*K+XD \77.DS+;QV<5A'>)=>=][=(R8.0
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MLC!F89&$;([#&,#' KHO[0LMP7[7;[B <>8,X/3O4HEC:1HUD4NOWE!Y'U%
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M5.13Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1N.0VT_*/E) .>&Z"^M:;#X9>YNK6+289+Z%&DTV22.UE,Q\OS%$@(RF=C<
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MGS(SYO$>-QP <@-\W.1?U'3]36W^(EM-)I[231F7']D28N%-L@4Q-YN%)88
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M*\;!E/S @\CH15Z&-HH4C>9YF48,C@!F]SM 'Y 4 <G=^$=1O+6"W:ZT*-(
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MPN;^*R@T^6 V+B1HY=BA9"9?F99-O]W&6^E>MSW$%K%YMQ-'#'N"[I&"C).
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M1[^]VZI>)>NX,>Z*5"A4I\N,#RTX.>GO0 M[XOTJ'1[AAJ%G<7*0,=K*RH[
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M.>.==IP<HV<?0C*GV8U';^&]/M=0UB]C1Q+JVW[0 V!PFSY?0D=?6@#C]/\
MB<CZC!;WCV3B?39+S;;;OW4JE<1>9DK)D-]Y<<KTYK0\._$/3=4#-=:I8K^Y
MC9H!$\4T$ASN1U8D\<8/&>:LV7@"WLCIY&LZI(;"RDL(=S1C$+A0%X0?=V+@
M]>.21Q6MI_A^*RU9]5FN9;J^:V6U,TBJI,:DGG:!DDGK[< <Y .4U_QQ8ZE'
MKFEV-Y8B*ULLNUS&SB9W5B$4 C;@ ?,<\L..*R;3X@IHG@;3%M+BQ/V+0()B
MDH:1Y950 Q!5(*#C[YR/F'H:[;4/"$-YK%WJ5MJ-Y8RWUN+:\2#84G4 A20R
MG# $C(QQ5 _#FR^R&U35M36%]*729E#1_O85#!,G9P0'/(QGOGN 9UQ\17GU
MK[#I]QI<4+Z:+N.:Y\QMLA;&PA<9_/W]C!I'Q0-Y<>'IKQM/BM-6A;S(T+F2
MVD6,ODL>"I((QC(R.374VOA..TU.+4%U.^>>/3QIXW^604!SN^Y][/X>U06?
M@>SLK?0((]0OFCT/>+8,8_G#(4(?"<_*Q'&* ,33?B7%+K6G6M]/8B*]MYI7
M\@,?LS(R[5,F2LF03G;C!'O4%E\4/MD^B.'L5AU&299X6#B2S5,GYCR">-IX
M&&(K;L/ L.CG2I[?4M2N6T>*6.S@D>( QN!^[)"#CY5YZ^IQ6%X8TW5[>YM9
M+>YUV"Z,BM>P7]A (L%@9!YP0,_\6"&8DXSQF@"2'XI1SW-E<PK$^F3SO',/
M+97@C&X"7>3AONC*A<C=U..<S4/&%MK=YX,U:6YL8[=]2\X0A&\V!##+MW-G
M!R",@ 8..O6NTTWP3;:7>S&#4M0.F22M.-+=U-NCL<G'R[MN23MW8SVJM:?#
M^WLX],MXM9U+[%I=W]ILK<F,B+Y679N*;BN'(&22!WH =K/C_2+)[&WM+VWD
MN+VX$*NX8I$-I9G8<$X"XP",DCIUK O_ (IFRMM4A7[!/?6%U;(K@ND5Q#,P
M&Y1R59<L""3]W/.<5W.N:#;:[!;++)+!/:3K<VUQ"1OBD7.",@@@@D$$8()K
M-O\ P7::E97D-Q>W8GO9X9[BYC"!V,14QJ 5("@J.,>O/)H 9:>,["VTN6?6
M-3L#/%O=OL@?:4!)7AAG.,9]ZX^Y\66^J^(O ^K7-U81Q/-+,T:(WF6X:VDV
MJS9PW49P!R.]>JRP1SVSV\ZB6.1"CAA]X$8.?K7*V'@.&P?2%76M3DM]'E9[
M*&0Q$1J4*;"=F64*Q R<XQS0!BCXI6_]GV.LB6T;3KF[$+VX5A/%$SE%E+9P
M><$K@8!ZG'+O^%GI/>6\MDD4UBU\UM+&8V5TB#E#,)"=IY&=NW.#US70VG@J
MQM(4LDN;AM+BN_MD5@VWRXWW[P <;M@?Y@N>OMQ267@R#3]8GNK75-1CL9[@
MW4FFAU\CSB=Q8?+N +?,5#8)]N* ,G1_B/8:AJ)BN;^RM@K2J]I+&Z3(%;",
M"3AU8#.0,<BG:QX_C@\0:=IVFW6G-!=PS,]Q/O/E,FW' QD'=TSVZBMVV\,0
MQ:E8WUQ>3W<M@)!:M,$W('X(+  D < '\<GFI[[08[[7]/UAKNXCFL(Y8XHT
MV;&$F-V[*D_PCH1TH X[2_BA!J5MI5N\]E;:A="X-Q(RN\40A<ID+D$[S@@9
MX&<].:%[\1Y;ZUT^.#4+2RNHM<6QO<1,Z2(OS"1/F!"$;<CKR1GCGJ[7P)9V
M,5@;74+Q;JPGGFM[EMA8"9BTB,-H#(2<XQD8&#Q5BX\&V4]A%;K=74,Z:@-2
M-W&4\QI\G+$%2O0XQC& /2@#,\7>-M*LO"&I7%O-87\\<!;[/<*3'+Z@C'/T
MJAJGQ$ECUF^L--GTD0P:<MW%-/YAW/N8%"!C^[Z\9[]*[+7=$AU_P_=:-<3S
MQ0747E221%=^T]>6!'Z53D\*Q2ZK=:BVHWGGW-@NGO@1X$8+$$?)][+L?3GI
M0!ST/Q*MM3BM(["XLK:YETQ+YS<AG57?[L0 (YR#EL\8'!SQ1E\36%QXX\.7
M\UQ:VMV=)NEN "9%BD)@(4D8W '=70?\(%;PKI+V&L:E97>FV:V"74)C+RVX
MQA'#(5.,9!QP:U/^$:MQK>FZHEU=*]A;R6\<>Y65U<J6+$@L6)13G/\ .@#D
M],^*$-Y!X6FGDLXQJ@D%X@#9@(C9P0?3*@?C61K?C.T\06WAS4A=626O]NP.
MD)C;SHXUD(#ELXY R5 XSU..>OT[P#;:=)I'EZMJ+Q:1,\EE$QCVQJRLI0_)
MEAAB,GGI@BF1_#RU@@@M(-7U&+3[6^6^M;1?**P.&+;5)0MMR3P2>M &5)\3
MTEO$DL$BGLQ?FUEB,;!Q$KE&F$F=O!&=N.1WS5GQCXS@AMM+&D:S;1-+J=M'
M.6B9SY9<9Z$8''/J,CBM>V\&06>M7-[:ZIJ,-G=3FZGTU77R'E)R6Y7< 3R0
M& )Z\<5I:]H<.O64-O+<3V[P7$5U%-!MW))&VY3\P(/T(- 'F5QXQ70M;\9Z
MIID^FR[!:SLLBN/M&V'YE0#[I//))Y['K6]K'Q,B2:^BT5H)Y;2)'$<D3-]H
M=ANV!@0$XP-QSR>G'.W=^"+6\CUZ.74K\KK<20W.#'E55-@V_)P<=<YHN?!<
M<NKIJ=IK.IV%R\"6]T;9T ND3[N\%2 PR1N7! /% %37?B#8V'A*[U2RFMVO
MHK4SK;3D_>"YVG'?MUK.;XBM#-#:7%UIPN+H231R6\4LJQ1*$PKKE2SEG/((
M&%S[5V.LZ);ZSX>NM$DEE@M;B V[-"1N"$8(!8$=/:J&K^$HM53394U.^L]0
MTT$6]];E!)A@ RL"I5@<#(QV% '/Z=\21J"6%G.;73M2EAEFN3,&DCB".$&T
M @G?D$#(P <\]8-.^*"SG1OM4M@OVN^N;2Y"!_W:Q^9M=23_ !;%X/\ >KH[
MOP=#)<:??6^JZC:ZC9(Z&\C*-).CD,ZN&4J<D C X/3'2L3PUX7DOO#=K'<2
MZAIM[I^KW=W;S>6!( \LN"1(I#!DD].] %*]^(]O+H-Y+,NF7,EMK"6HCD1B
MKQ"5%$H4Y^8;MW7C;5B3XDNNM:NGG:6NF:8ZNSDR&6>(Q%SLXQN!P.>*VV\!
MVCZ3>Z<=3U#RKS4%U"1MT982!U< $ITW(I/T[5H6WAFV@U'6;N6XGN1JZJMS
M!-LV85-F!A0?N\')- '(Q?%)+>0W-ZD4FF_87N6DAC9&AD49$?S$[]PR P"\
MCD<U6'B*&_\ B#X2O+J\T\F2UN@5@1@T3.L>$+$G=Z X'?CFNHTWP-:V6G3:
M9=:GJ.I::T#6T-K=R*5AB8;2H*J&/!P"Q) Z8I=/\%+8WND7,FMZE='28Y(K
M99O*QY;A1M8A 6X4<YS0!U-%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5'//#;0
MO-/*D42#+/(P55'N3TJ2N,^(46J!-$OK$7+VMG?B6\BMK?SGV[&"N$ZMM8@X
M&?7M0!T::]H\D+3)JMBT2N(V<7"%0QZ*3GJ?2ISJ-B'N$-Y;[K9=TZ^:N8AR
M<MS\HX/7TKQV]T_5]5M/';VES=3.+NRF:#["%EF"QPOG9U!"C.W&3CD9-3ZM
M;ZY=7WB6]@AU&]AGT^S"";2BGV@+*^X;" <H&W;>&/Y4 >JC6])-I+=C4[(V
MT+;9)O/78A]"<X!Y%1R^(=&AM;^Y;5+0Q:>#]K*3*WDX[, >#QTZUY)K6DZ[
M>6?C?:VK72WL-M)#YFDE3<X7&  H*E>F,9P.:V=1T+69?$&N1V<]T8[CP\(4
MD73?+25@9<19P #AA[\X[4 =S;:_!J+Z5<66H:>+2ZB>62*60&9AM!&S!Q\O
M.[.:@B\5V.KZ4MYHVJ:<H^V"W+74GRL!*4( !!W,%;9Z\5Q=GIVM3ZGX(F$^
MH1^3:RQO))I17[-^Z5=K97C)!'S8Z9Z'-9_]CZZO@F.Q<ZCY]KK@<P#3"V!]
ML,AD5@,LNWY\CCG&>U 'KD^J:?:W<5K<7UM%<2D".*255=R>@ )R<X-*=3L!
M?"R-[;?:R<"#S5WDXW8VYSTY^E>3WVAZK<ZSK.C:P^M7"WMVES:RV]J?L\X
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MX)X&,5E>-M)UTZ58S+J=Q>+;:G:3ND%BK.JK*I+A5!+;>N .U<UK.B:Q>?\
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M9\TZF6%_-&U>@"DD 8&,'DXKV2T25+6-9IC/(!\TA386_#M0!-1110 4444
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MG9RQ/.[KGFD\7^)-*G\#Z[ CW+,^G7"KNLY@"3&P&24P* .SCD2:))8W#QN
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M/F*<G@ 8XY/6J6D^.[J+PCH%Q>7$5[<76IHEP9=/FRJ-,V65A\I8=L=.@'%
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M]A.A4,SJ48$$G&T8; !R>* .YHJO97L&H6XGMRYC)(^>-D/'LP!JQ0 4444
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MH **** "BBB@ HHHH *S-=T2#Q!IZV5S//%$)HYLPE02R,'7J#QN4'\*TZ*
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MI(/(( /)]:@NO NERKIALI[W3)]-C,,$]E*%?RSC<C%@P8$C)R,YYSFNGHH
MYJ\\$:;=W/G?:;^$O8FPF6*?_7Q$EOG)!);+,=P()R<YJ6T\(6=E=Z;=07E\
M)K"S^Q*QE!\V+((#_+S@@'C'ITXKH** .9A\#Z=;Z=8VL5U>K)87,EU:W09/
M-B=RQ< [<%6W-D$$8/L,2W/@^QNK7R7N;L2-?1ZA+.K)YDLR%2A;Y<8&Q1@
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MS1110 44SS8_.\GS%\W;NV9YQTSCTI] !1110 4444 %%,66-I7B61#(@!9
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M..3SPBW"8!$BJQRO7!!Z$=36;<?%73_MBFSN+*>V6^^RR1%RLGEAMK3!S\F
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MJ%51@ #@"EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLL:NY:8* #QGD]">AKR75?#.I?8O&USI\D#V%WIR1B*#3"%NIPC_ .K0,<$
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M'SB<Y\O:<XZ8.,U873=8N]9O-&U>\OOMB:L;VUV:6S0S#?NCE$RMA0HP""W
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M0R!RPW[20#C;T/H,G3M'U>;3/":3J5,.LW19)M)<F!6,YWL<X*$LOM\PY.*
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MY/<TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6\,T,,L\22S$K$C. SD#)"COP">*\HTW7M(2_P#AS(UU&&M]+ECF;8<J?(C
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M^3L&#$#GCK3E^)L%G+I$^HSVC66HQL7\B-P]H^SS "22) 0"N0%Y .,'@ ]
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MGDD]23R:I6?B+2;^Y2VM;Q9)GSM4*PS@9/45J4 %%%% !1110 4444 %%%%
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M7^U::=,D0%%!B)SN&%SNR<^GM38_!42W-Q=2ZSJ4UQ<Z>-/E=S%\R MAL!
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M)&H@D*^7&5SDJ  06SS]!TJY110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(2!U
M.* %HHZT4 %%%% !112$A022 !R2: %HIL<B2QK)&ZNC@,K*<@@]"#3J "BB
MB@ HJ*>YM[;9Y\\46]MJ^8X7<?09ZFI: "BFM+&CHC.JNY(12<%B!GCUXH26
M.3=Y;J^UMK;3G!]#[T .HHHH **** "BBB@ HHHH ***:)8S*8@ZF0 ,4SR!
MZXH =12,P52S$!1R23TI$D210R.K*1D%3G- #J*** "BBB@ HHHH **3<,XR
M/SI: "BBB@ HHZ4@(/0@T +1110 444QI8TD2-I%#OG8I/+8ZX'>@!]%%% !
M1110 4444 %%(2!U(%+GC- !13(I8YHEEB=9(V&5=#D$>H-/H **1F5%+,0J
MCDDG %-DECB7=(ZH,XRQQS0 ^BDW+_>'YTH.>E !12;@>A%!('4@4 +12%E4
M99@!D#)/KTI: "BBB@ HI&8*I9B H&23VI$=9$5T8,C#*LIR"/44 .HHHH *
M*8LL;NZ*ZLR'#*#DK]?2CS8S,8?,7S0NXIGD#IG'IP: 'T444 %%%% !1110
M 4444 %%%% !13/.B$C1^8F]5#LNX9"G."1Z<'\J07$+>5MFC/FC,>&'SC&>
M/7CF@"2BFO+'&5#NJESM4,<;CZ"G4 %%%% !1110 45$+FW-R;83Q&=5W&(.
M-P'KCKBI: "BBB@ HHILDL<0!D=4!8*"QQDDX ^IH =1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5P'QCGT^/X>7L-Y+;+-*T1@25E#,1-'NV@]<
M \X[5W]8WBGP^OBC0)](ENGMH9RA=XU!;Y6##&>!RH[4 <QJ'Q$M;?7)-)TF
M[\/FW2P^T17,M^%CWAL>60HP#[ ].>V#7'Q9TVYL]/>&\TRUN+O3_M6V[G_=
MB;'^H9P0$/7EORKK'\/R/XA;6C?8N#8FQV"(;=N[=NZYSGWQC\ZS4\#!/#<>
M@'4FETX6(L7BF@5\H,X<>D@!Z\C@<<4 8FI_$]H[[68-,DT"9-/CCEB>;4PO
MVH%6+*F!C?QCT!QR<\+=?%O2IK/S=,N['SA8QW8AN'.9'<$B'*\*PQ@D]"1Q
MUQ9L-&NI/&/B>T@EN[.QFL[2V65[9B)%5'5C'(PQN&0,_,.>E:D_@A(M1M;W
M0]5N]&>*UCLI$MT1TEA3.P$." RY.&Z\T 9,GQ.M+N"X?3+C2Q-;6\4K6]Y>
MHC32.NXQ*V[ *C +'(R<8XS5<>/H7\2^((Y=7T273H+&!K>"2Z4+(S"4LN[)
M!.0 < \;>.YZ";P9LUMM2TS6;[3C/!'!>1Q;'%PJ#"G+@E7 XW#G'YU9D\+(
M-8OM0MKZ:#[;9I:2PA59"$#A6Y&<@.>,^E '-Z3\1='FT_1+"RN]&T^6;2TN
MI%DF40VO"@0@ CYLDC&1@*?I4*?%FUN(M)$+:5'/<W4UI=K-?@+;M&KG<"!S
M&Q48;N".,FNAM/!::<-%EL;^2*]TJS^P).T88308&$D7(S@J""".?KBI%\&V
M\,FE2074B-87DM\6903/-*'#L_3KYC=,8X[#% %+P[\0](U*RN#J>JZ3:W5O
M=26[!+Q=D@4\.FX@[2,?K6=?_%/3H;/4=1M+O3)K73[@PM;FY GN$4@.\?..
M,G P=VWJ,UUNA:&-$_M#%RT_VV\DO&W(%VN^,@8[<#'?W-9LO@JW<:M:QWDJ
M:7JTQGO+/:#EVQOVMU4/CYASU.,9H Y6;Q!H>L^/]0@U'5M#N=$DTF% LTZE
M2&DD+ 9.-_"$^P6NAU?Q[I5I);PZ?K&BM&T<CR3R7:,(]H&U0BMN8MD].FT^
MU;$&@^1XIN-<6Z.9K6.T,'E@*J(S,N#USES_ (4W5?#QU'6[#58M1N+2>UBE
M@(C5&#QR;2PPP.#E%Y% '"GQIH.MZYX#UN2]T^VF9+A[A&N$+6^Z _*QXP-W
M'.*T/ OB3PY86VNQ-K&EVZ-K5V\2FYC4%"PP0,]#6SIG@A-+C\.QQZG/*NAA
MUA\R-?G#)L(; '13Q[\G/2M70=#&AK?J+EI_MEY)>-N0+M=SE@,=O3O[F@#D
M/^%HP#4-5,EQHBZ=IDK!W%_NEN(Q"'!B7&&;<=N.G8$XJ*3XKV\/VIEETNY1
M;![J)EN3$%E7GR6W#+$CHRCDC&!76V_A>!)=?^TS-<P:VVZXA90H \L1D CG
M!51^-8EYX8O-'\%:Q:OK.IZNJ:;-;V5O)$K,@,951\B[I&Z#)_J: ,N+XM6U
MI=V[:L^E"QNK*2YC>RO1+)$Z(',<BG&&89Q@]1CGK5Z'XF6,=]I<=W?:.8=2
MB8AH;P?Z)(%W!)3SP1D;L#D8QS6AI/AB+5-%TI]::2Y$.FFU2WDA,102(%DW
M@\E\#;GC )XYJYI_A06?]F"XU"2\7249+#S8P"F5V!G(^^P7*@\<$YR>: .%
MOOBA?7G@VXU&"\T&RE8;$C%[YDZMY_EDA<#C9\P/XX].@E^).FKJ[:>NKZ,K
M1K"QDDGQ'.&;#[),[05'\)R2?3K6HG@F >")O"[W\[0.S,DX50Z$R>:/8X;V
MZ5+J7A,ZO ]KJ&HO<VDCQ2.DL*[E="#NC88V$XYX/M@\T 1:MXZT6UM$:PUC
M2)YGFCC.^_B58U9@&<_,,A1DX')Z5SA^+-K_ &=YL<NE2SIJZV#!KOR@\191
MYRJ02%PW.>!@\FNU\0Z$->L[:(7<MI+;74=U#+& V'0Y&5/!'M]/2L;_ (0-
M0DZ_VQ=.)=5CU4^9&AQ*FTXX X)49_3% &6GQ4L+>#5([VYTI[RUNHK>V%M>
M Q7 E"[6W'D!2QW'!QM)]JK:+XCT>#XF:W<W>LZ*J2Z;:A9X)U5)6#RYSEC\
MPR!U/&#WQ71:AX%MM3;6FN;Z<-J<T%P'B4*UM+" (V0\]-HSG.:MZ7X;FL=?
MFUJZU:>\NIK2.UD4Q(B$(S,#@#(/SGO_ $P <E<^*=!UKXF-::AK&G/HNGZ>
MLT*27*&&6X=\%CSABJC !Z$DUHZCXF\'>'GGUO3]0TN2[D1+;[/;W4:B5F<!
M6;'3!)RV.F>N!70:MX;CO]7M=9M+N6QU6VC,*W$:AA)$3DQR*>&7//8@]#3=
M2\,)KFD7%CJUY+.TP7$L0$?DLK!E9!S@A@#DYZ>G% '-7?Q/L]/GU.TDO=(N
MYX+!KVUFANPL4^.#$?O%7!Q@<[@>W-1VOQ.CENHX+B\T.$76F-=P2+>;Q%*N
MW]W*..3OR #_  D<]:Z2X\*_;H[Z2^OFFO;JP;3_ +0L07RXFSNVK_>).2>F
M0. !BE@\*+%J&F7;WKO]@L'T]4\L 21MMR3_ +7R+TXZ\4 <7IGQ,G30O#*2
M7^AW-[J,)^T2S7OE^0XA+CS!@X^88/Y 5H7GQ0@L&C>:ZT5E6XMK=XX+U93)
MY@7S)%(/RJA8_? R%)XR*VM/\$#3X_#\:ZM<2KH9;[.)(T^93&8]K8 X"GKU
MSS[4S4? :W\VIE=9O((;^\AOFB5(VV31E,$%E)Q^[7CH/TH IS?$>RFFN7TV
M]T>6&UNUMFCFODCDF7Y=\B$L  NXXSG=M/3BF>&O'5I<ZMX@&J>(-'6VAOS'
M:@7"KF,11D%<MR,ELGUS]*UH_!IMM;N[RSUF]M[.^D$UY8J$*32  %@Q7<FX
M ;MN,^U:.F:"NE:QJM]#>3-'J,PN'MF"[4DV*A8'&>0B\9QUH X*[U/PA>_%
M]+FZO-%GM3H3*999(F3S//&!D\;MN??%5XO%NE^%?&VKV6BZC8W.D2Z3]O@M
M?MT:0QW2OM\M'8[4##DCMC.*[RZ\-2S>+/\ A(8=3>"X%F;(1B%63RR^_//.
M<CK^E5KCP)876G:S#/=W<MYJ\8CN;]V7S=H^ZJ@ *JC^Z!@\YS0!R^K?$^-=
M'\406FJZ3]NT^T66TN4D^2=F5B512?F92O4$@Y'TJUJGQ+ATK3))H]0T6Y:U
ML1<-MNPYN9,G]TJJQ93@ EB",L/>MJ3P,ET=9-[J]Y<'5[!;*Y^2-!\H<!UP
MO! <\=/7-1WG@(WPNQ+KM]_IVF_V==D1Q_O%&_!'R_+C>W Z\=^: +Y\8>%;
MRP_>ZWI)26/+12749ZCH1FO'/"^JZ)+H_@O3[.>RTG5;21;RZU&66.(-"K,'
MBW Y=F! V-CCDU[S;V<MMI,5FMTSR1Q",3R("3@8R0,"N<@\ 6L'A33=$6_N
M%DTN02V-\BJ)H6!)],'()4C&"#R* ,S6_BEIEI-?1:7>Z=<R6:(PC:4G[4Q&
M2B.ORK@8Y.>3C QFEOOB?IYM=3N-.O=+QIT E,5S<@/<OY>\QI@\8! W?-\V
M1CBMBY\(7#ZXVK6>O7EA<7,217RV\<96Y"<*V&!V-@XW#M69XH\(O;:=XDO]
M*OKZ,7^GND^GP1"47$BQ%$*_*6!(VJ<=<?C0 R'XF:?)>S6YU#2%4:5'>QR&
MY&/-8L#">>HV_7D<57@^(NC7][X4N;AM%$EY:R32327:E[&0Q E.1\N2=I.<
M\8Q6M:^%VOXM.U.._N["9])2PN8O) +H!D AQE2"6_/MUJS9>#5L?^$<\O49
MG&A0-!#YD:GS R!/FQCH ,8_'- '-V7Q7B?37U&^ET6&'S'MT@COR\QD\_RU
M;;M_U>WYB>N!D#FFW7Q9AM;+4W1],NGM98!!*+CREN$D8*V$;+!DSR.A'.>U
M=*G@BU/A&Y\.W%Y<2033O<).F$EBD:4RAE([ASD?UI+CP?<ZAH$^FZGX@N[R
M69XBUR\4:E5C<.JJJ@*,D#).2?RP <_<_$V2*YU>UCN?#K26<"74$O\ :&8Y
ME(;]V.,EP4QQ_>!QVJ6[^+&EO; V%YIXN/L,=WY<\A8,[@D0@K]UAMY)Z9'!
MYQTEQX7-QJ>K7QOF634K%+*11$,(J[\%>>O[QNN>WI5 >!7MI=.N=,UZ]T^[
MM;*.PEEBCC87$*?<W*X(W#)PP'<\=J ,67XI+/=-!9OHL(.F)>JUWJ &V0DY
MA;:,;AC& >^?8D/Q'M]0U_PW)%K&E6NG7FG/<W4,MP-T4G[KY&;(P0'8 $=0
M?PZEO"RC5YM0COI TFG#3@CKNP@).[).2V6/)_*H;+P9'8GP\T.I7"OHMJUF
MA")^^A(0;6R#@_NUY&.] ',?$C7O#.IZ7HZ+JNE7136;-F GC?;'Y@WD\],=
M?:NNE\7^&H[5U@US1F94(2-KV-5/' XS@?A4OB;P[_PDEI:V[7LEJ+>ZCNU:
M- S%XVW+UXQGKQ4D6E7XNO/N-8EGVQLL<9A145CCYR!R2!D#G')H X?3/B=H
M\>B:'#;3:-IAN;%IA$TF(('&-L!*X\O.3RWIT-7;#QY;S>.;N"XU_1DTM+""
M1 +E<>8QDW -NP6!5?H,?4ZUOX)^R^';?0DU)I+".S-D\4\"N)$[,1V<=CT]
M0:NV'A6#3-;AU&TO+A$2PBL6MSM99$BW;"21G(WG.#SQ^(!@WGC70[WQU9:>
M^MZ=_9MM9->._P!J39).7"(I.<':-[8]2I["LSPGXD\/:SJ6OZMKVJ:6UP-2
MEM+..ZGCQ%;)@+L#'C=RQ(Z_@*[&^TMX/%UEXA@1I,6KV-TBC)\MF#HX'?:P
M((]')[4T>&&LM:O-3T?4'L6OF#W=NT0DAE<#'F!>"K8X)!P<#(S0!P?C*;P;
M'INF066H:3/#)XAM+AX1/&ZQH64/QGA,#)'3GTJ;Q3K?AK0=3T'6/#>J:9!.
MVHQ6MY!9W"!)[=\ABZ*<?+P0Q'%=KK7A4ZS9V<$FI3H]M>QWWG;%9GDC.5XZ
M!>!P!V^N93X9CNM8M-4U2\GOIK,EK6)PJ10N1@N% Y;'&6)QVQ0!X_J>L^%U
MO?&MLL6GS7&HWL<.GWBR1*D#M N)/,SE%5\DL!C/N:Z/Q7JNA2Z1X*MKO7-*
MU*[M-5LA=3^?&^X*C!W//"D\G-=I#X,M"^OB^F-Y;ZXP>Y@>, *0@0;2.1P!
MZG(SFH+KP9<7FE:18SZ]=2?V7=1W4%P\2&5FC!"AST88/H"?6@"]+XJ\)S6[
M6\FNZ.\+KL9#=QX*],8STK#\'^.M'ETFYMM0UZP$UC>SVB2S72 S1(Q\M\D\
MY0KSW()KI(K&[L[EK^\U&YOO+B*1P)"J@$D9("C);@#DX'/3)J/PMHSZ-I4J
MW&W[7>74U[<[3D"25RQ4'N%&%SWVT <H?BG9+ITUP;O2FEAU<6)C%T/WD)D5
M/.7G@88MW&!UJ#4_BLMH^N/;OHDL&ERQ[1]OR]U&55CY8 Y89(] 1CGMNW7@
M);DWL2ZS=PVEUJ*:D(4CC^2975R0Q!)!*#@],GK4M_X)34+?Q%#)J,H77=GG
MD1KF,*@0;?\ @*CKGF@#"\4>.=(U33?$.EV>I:.\5O8D,;BX4BX=T)V1X/88
M^;GD@8XJK:?$K3=.\-V%C97^G/=6FDV\A660D2R%,>4"OW6^7DGID<'G'47O
M@PW&H:C>6VK3VC:I:BWOXXXD99BJE5<!L[6P<<=1CZU"/ CVL]A<Z7K]_8W5
MO9QV,TJ)$_VF)/N[E9=H89.& []Z ,E?B>MWJ\-I:2:'!$]E!=M)>:B%V;V(
M>([01O4 \<_6K/BSQU9V[:,FC^(-'(GU&.*Y)N%;;'@MGAN%RH!/OCO716OA
MU;3Q)_;"7<C?Z"ECY+#(V(Q8$MU+98Y/_P"NI=?T)==@LU^U2VLMG=I=PRQ!
M20ZY'(8$$$,: /,T\;V?AS5_&.H:?<Z-/;_;[>9H_M85IU,$0?R@,Y.=QSZC
MZXW]0^(FAV'B+5I8CI%P]MI(GAN8;I&EN"&?$&<=B,[03][/>M:]\#I?6GB"
MVDU*8+K;H\["-=R;$5!M_!!G.>]7;GPS)<:U=:J-3EAN9[!;',48&P*Q<.N<
M_-N8]<C'&* *.C^/M#O5D>?Q#HC184Q2)<"-CG.0T;MN4@]C_P#6%*Y^(]E)
M+>-I=[H\T=G<I 8IKY(WN =I=D8L  H;C.=Q4CC@GH])T"+3-2U'4BZ/>:AY
M?GM'%Y:-L!"G;D_-\QR<\\>E4&\'F/7KW4++6+RTM=099+ZRC"%)G "[@Q!9
M"0 #M(S['F@#$U#XHZ?%:ZK?6-YI<UOILQC,#W2B:Z"@%VCYQQDA>#N*GD57
MU#XIQ+<ZLFFSZ))#9V<5W!)-?X-QN#DQ@ ??^4#';(SZ5T<_@R"1]8AAO98=
M/UEB]]:A0=S%0KE&ZKO  ;KZC!YI]QX1CFN]9G2\:)=4L4L7C6(8BC0. 5]\
M2-UXZ<<4 <W%\0X;OQ?;B'6='CTQ])%R(YKD+B5F&59LD!ACIC@$\4W2OB>^
MH:/:ZA--X?MQ="$+$VI*)("S$.TBMC( P0 <GIQVZ:U\)_8]0T^^M]2F2:TT
M\:>1Y:E98U(*E@1D$$<X(S[57C\#I#X6TG1(=4N(SI4\<]M<A%+90G 92,,/
MF/IV/:@#'L?BKIEW$ENU[IL=X^H2V:RO/MB\M%+><03D C "YY8XSWJMJ7Q"
MFW:+&NJ:';/)JCP7)2\617A57*295OD5MJY!Y!('UV9/AY&R321:W?QWO]HG
M4K>Z"Q[H)67:_&W#*PR"#Q]*T;OPHU[::>LVKW9O;.\%Z+S:FYWVLA&W;M V
ML0 !Q@'DYR 4/$GQ"TG2=':]T_5M(NY(G3S81=J6\LL S* <DJ#NQWP:HM\3
MM-&IZY9C4M(;[)%&]C(+@;;HOGY=V< AL XSC(/M7=W%M%=VDMK<()(9HS'(
MK?Q*1@@_A7/6'@?3+!]!D1YGET>)XHY';)FW@9+^OS ,/0T <YJ'C#P_>:GK
M]C<3Z$0=(7%ZEPC&X)\P>6<_W2,A<G[P/>LG2M>T!+KX;3-JNG+);:8\5PYG
M0&+_ $= %8YXYSP>]>@7/AK[1K.I:E]M=7OK%;%D\L$(@+$$>^7;KQTXJ&U\
M(K:R>'&6_D8:% T$(,8_>J4"?-[[0.F.?RH YOQOXET*:^\+W-AJND7%U;ZL
M&!:[0!%,$H)9ADJN=N>/3VHMOBS8QQW%IJ5QID6H17BVPDM[GS;=T9"XE! W
M8 !!'][ R,Y'9Z[HBZTM@XN7M[BPNENX)%4,-X5EPP/4$.W<'WK,U#P/:ZC9
MS^9>W,6IRW:7PU"'"O',B[4*CD;0OR[3G()SDDF@"KX?^(FD:C%=KJ.I:9:R
M6\YCCD^TJBW"8!$BJQW+UP0>A'4U@7OQ:>W@U2\A71);;3;PQ/$NI S7$("'
M?$,8)^8GTXP*]#TG3Y]/M2MWJ,^H73G,EQ,JH3V "J % ]![GO7&Z-H4^L2^
M+K*]:YM].O=69WADM60SQ>7&#L=@/E;:5/!X'&.M $6J_%C3('NVTRZL;H6D
MB)Y)D(>Y!"LQ1_NK@-WZE2.."98OB.EWX@O[*"]\/0V=I,B_:)]1QYJ-'NR@
M P2&(!&<#GD]MF;P<1K]UJ-AK-[807VTWUG"$*3%5"A@2"4)4 $K@G'8\UH:
M?H1T[6M7U)+LN^I-&S1M&-L91 BXP<] ,Y_2@#S?PYXNT>UT:POM1O-'N-8E
MU2YBMI6G >'S)I=\CG.0FP#'J-HXR"-74/BQ;:?!JD(ETJZO+&:W"-'>!8[F
M*5@NY.OS+SN7/&,YK?B\"P)X>M]*:_G+VEZ;^TN@BB2*8R,^?0C+L,8Z$CWI
M^I>"X]5M+\7-\XN[^2W:>YCB PL+!XT53G W#/.2=Q]L &(_Q'DBU6STZ2\\
M-;KF*XD^TQZF6BBV,H0-\HY(;..Y!Z57L/BM'/#H]S=R:-#!=W36ES&E\#+$
MP+CS<$ "/*=^S UVEUH;77B+3]9-V5FLH)8%C$?RMYFW<3SG^!<<^O6LN#P0
ML&EZ98+J4A33]1;4(V,0R[EG;:W^SF1NF#TYXY ,9OBMIKWUN;:ZL);1[XVL
MB&4K(D88KY^X_(5R,[>NT@YSQ6/XD\::9X@L]%O8[_2%MH]>MBD;SKYZ1I.
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MY&]=I],U/38T,<2(SM(54 NV,M[G'%.H **** "BBB@ HHHH **** "BBB@
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MMJ%NZ64IBG?S%VJ0!DYSTR<9]0:+_P 2:1IMA!>W&H6XMYYD@BD612'=F"@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<1\6
MG0?#G4(V<!I);<*H/+8GC)QWX )_"NWHH YG3[G1(M?C^P:O)?3W,1C\D79N
M!&JY8ORQVCM[DK4>J>/-%M=*L[FWU"(?V@&^S2R1OM4 X+LN,X![<9/'')'5
M44 8OA232G\/PIHTKS6499!,ZE3*^<NW(&26))..N:PK^P'C>?6HXKZR^P+
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
6*** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>exhibit1027supplycontrac009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCH0#^% %ZBD50BA1G &!DY/YFEH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JEJ6JVNE) URS;[B8
M001HN6DD()"C\ 3SQ@&KM8/BBWU>XBT_^RXQ+&EV&O(1-Y3O%M885_X?F*DX
MP2 1GF@#1TK5K36;+[59NS1B1XG#J59'1BK*0>A!!%7:X[POIVN>']/FM6TN
MU83:Q-*1'=\1V\CLV\?+SMR!MX)]J[&@ JO?WL6G:?<7L^?*@C:1@HR2 ,X
M[GT%6*Q->L[G4[BPL?LTCZ>9A+=R1S;" O* 8(;[X5B1V7OF@"CX)UW4=5M]
M1L=;2.+6=.NVBN(X_N[&^>)A[;& SWVFM!/%.EO?VMH)9/\ 2Y7AMYO+/ERR
M)DLJMZC:WL<'!-8O_"/WND?$&VU;2;>:6PNK0VVI&:Z+L2&S$Z[V))&6!Z<'
MC)I/">F>(]'L8O#MY:6QL+1G6/4EN,M+$22H$>,A\$ DG'4C- &U#XJTJ>_M
M+1)7S>>8+64QD1SF,9?:W? !.>A R,TQ?%VDFYA@:2=#<0/<6S&!]MQ&@!8Q
MX'S8!!QU(.1D<UB>&=)\1V>@Q>%]2M;:.SM(&M5U&.?<T\6TJFV/&5;!&<GL
M<9SQ'X:T?5M/L8;35-!TFW;3K=HAJ4#*SW("%057:"A(Y8D^V.> #6T_Q[H.
MI75E;V\MSF^A,UH\EK(B3@+N*HQ&&8#J!SVZTS1_&]GJ>CVM]);7,#WEU);6
MT!C.^5E9\ =L[8R3S@8/-<]X1TNZUSPCX":2V-O;Z7'%=M,SJ?-Q"R(J@'/.
M_)R!C&.<YJ?3]#\4:;HFEZ:MI"]O:ZA.URD=WL>>)VD965L94 NN1G)P1TX(
M!T9\:Z(++3[KSIS'?SO;P!;:1B94W!D( X8%&&.IQQFI;7Q7I5WISWJ23*$N
M39M#)"RRB?./+V$9W<@_3GI7):;X7URSL="M9-/A4:?KUQ?/Y,ZD>2YFQC..
M?WHX] >G2G3^&?$"B]OK.VB%Y#XA_M>UAEF 6XB,0B*%AG:Q&[KP./? !UMO
MXHTRZ@D>)I3-'=-9M;F,^:)@-Q3;W.WYL],<YQ5K2-9LM;M9)[*1B(IG@E1T
M*O%(IPR,#T(KE]>TOQ!J]KINJC2[$WMC=F;^RII@R2Q-&493)MQOYR#C P!S
M71Z!;36]@S3Z;::;)-(9#;6V"$X ^9@ &;CDX]!SC) ((/%>E7%_!:1R2DW$
MTT$$OEG9+)%GS$4^HVM[':<9I/#/B-?$EM=SI:3VZP74MN!*A&=CE/IG*GCM
M7+0Z!XFEUO1K^^L[>6>QU.XEFG^U\/"Z2*I1,84 .N1U)&3GK71>$-,U#2(-
M3M+V"-8WU&YN8)4EW>8DLK.,C'RX# ?7- %F^\4Z5IS7!N)9/(M9%BNKA8RT
M<#-@@.PZ<,I/ID9Q3)_%VE0:S)I/^F27D9B#I%:2.%$A(5B0N-N1RW0>M<_/
MX9U=-.\6:''"D]KKDTTT%V9 !!YRA7#J>?E()7;G/ XK4T71KS3?&&I7)MV-
MA+86MK#*9%+,8?,SD9SSO'Y&@"72_$.FKI?V@:C=7BSZA+:P^?%MD:7>P\I5
MVKPN".1P%))XS4&H^+=(N=!U&9=0U"Q6TG6VN)XK1]\,N\#9\R%3S@$C( 8<
MC(-<U<Z9J&GZ78V3V:?VM)XAN-0LXQ=I&^PM)(2K$,N0K;2&&/F/?!J>?3+_
M %+PEK^B6^BS6VJW%S'=3>==Q2"5G<,6+K@# CQMP.-OKF@#J-1\:Z-IESJ%
MO.;MI=/C2:Z$5I(_EQMN._(7E0%))'%;$^H6EOIDFI2SHMG'"9VF[",#<6^F
M.:Y'4=$U6YU'Q=/'8G9JNE16EMF5 ?,590=W/ S*.>>A]L[D5E<KX)6P>RBF
MNET_R#:S,#'(XCV[6(R-I/'T- &/XQ\130>&[FXL9KJPN;6XM#)YD0&Z.294
M/)!!!&[H<C';I6JGC#1S;ZG-++/;C3=OVE9[=XW4-]PA2,D-VP.O%<C<>$-8
MBT/4M-TZ*Z_LZ6:RDL[&\NED:V,<H>4*^XX0A5"KD\YZ"M'4](\1G5/%%]I=
MND<M_;6:6K22H"WE,WF#OM)5R%/.#SQ0!<\3>)-_@[Q/+I=S<6>IZ5:N[AHP
M'B?R]Z\,""",<C/X&GP:C?'X@:;9-=R-9SZ'+<- 0NWS5EA4-G&<X8]\<UAW
M'A?6Y;#QI#'IL40UJS2.V7[7YC!_**'>2/4Y)R?;-;L&EZB/&VEZH]H5M8=(
MDLY29%)61GC;H#R/W9&?<4 ;U]JMM8300/YDES/N,4$2[G<+RQQV R.3@<@=
M2*J0^)]*N;"WN[:=IA<2M!%$J'S&E7.Y-AY##:V<XQ@YJCJ^EW\?C#2_$-C%
M]J2&VFL[FV#A7V.58.FX@9#(,@D<'VK ;PGK>ESVVNZ;#!<7ZZK=7TVGO-L5
MHYU"E5?&-ZA5/IG=^(!U=OXJTN\M(9K:269YI9(4MUC/FF2,D.I4]-I')/'3
MGD99I_B[2-3ELHK2:61[V&6: >4PW")@L@Y'#*Q (-9&J6'B5M3T;Q%:V-K+
M=VHGBGTT7&W]U+L^[(1@N#&I/ !R1VR9+[3]>?7] UM;"WFEMXKJ&XMDN HB
M$IC*D,1\P'EX/&><@=J +K>.-#6RT^Z$MR\>H2216P2UD9G>/=N7 7K\C #J
M>U:4VMV-MH/]M7+R6]D(1.QEB9752,@%,;@><8QG-<7I7AK7;*R\+17%E$7T
MW4[FZG,<ZD>7)YP&,XY_>CCT'7M77^)X=4N/#E[%HK1C4&0>5YA !^8;AD@@
M$KD XX.* ,W6/&]GIFA:U?);W,ESI2 S6K1X92RY0GMM/7(/8]^*W)M02'2I
M=0:&?9'&TAC\L^80.VT]ZX"[\(:W>6?C&&.Q@MEUBRA6WWW9D;S$4@JY(R2<
M\MD_C7?%+F]T=XYX5M[B:%E,>_>$)!'7'- '&?\ "87%Y<^"]35KNWL]3BE>
MXLUAW>8?L^]=N%W-@GC'!KI[3Q1IM]IL%[;--()Y7AC@\HB4R(2'0H>01M;.
M< 8KF-(T'7+9/ Z76GHO]B0O!<F.X5LCR/*##..IYQV'OQ5+_A%=>MXH;^+3
M+6ZN+75[VZ-A<RKMG@N'+<-R%=?EZ\<'F@#OM(UBRURQ^UV,A>,2-$ZLI5HW
M4X964\@@CI54>*=+-_;6HED_TJ9[>";RSY4DJ9W(&Z9&UO8X(!R*GT.VEM]/
M_?:?:6$DCF0VUK@K'GU8 !FXR3COCG&3SWA/3O$>B6\>@7-I:M86LKF+4A/E
MI(BQ91Y>,A^<$YQWYH V5\5:4;BV3S9!%=3FVM[DQGRI902"@;IG*D#L<<$U
M5B\=:'-/%$DEUB2]-AYC6DBHDX;;L9BORDMP ?;U%8%AX2U4>%])\+7<2^3I
ME]%,+]9%Q+#%)YB87[P<X"G(P.3D]*:WAO6CH\MO]@_>MXF&J@><G^I^T"7K
MG[V!C'KWH V3X\L+=O$$E];W=O::-*(Y9OL[MN^16S\H./OC'MSQ5[_A+]-9
MQ&D=ZT[/*L<)M75Y%C"L[J& RH#KSWS@9-<SKGAC7+JP\;V-M:12)K3+):RF
M<#!\J.,JP/3!0G.>XQ[;NN6NM7VJ:8\%HDNG&&5;JW>X$3+(VW86(SN088%1
MUR#@XH OKXFTR:RLKJUDDNEO8#<VZ01EG>( $MCL!N'7') ZG%4+?QM8W^MZ
M38V$4]S;ZC9/>1W21G;M#(H'J/O\YZ<5S6B>'O%/ARW\.7L&GVUW/9Z:=,O+
M/[4%^7<&61'(QG(.1Z$?ANWNBZQ<^)=*U%X8&0Z?<V5V(IMOD>:T; KD?-@(
M1T&3@\9X -6'Q5I4UQ:1++(([UV2TG:,B*=ADD*W3. 2/[P'&:;IGBS2]8U!
M[.R%W(Z22Q.YM)%1'C(#*S%0 W/0\_I7.:?X7U5]!\-Z#?P(BZ'>0S&\20%9
MDASY>P9W!F^7(( 'S<GBMSP?IU]ID&K)?6_DFXU2XNXOG5LI(Y89P>".X_G0
M!?U#Q!8Z;--%)YTLD$(N)T@B,ABC.<,P'KM; ')P< X-4;WQMHEF]LGFW%RU
MU:F[@%K:R3>;$-N67:#G[P.!T'6JQTS5-*\8ZMJMK:B^M-5MH5*"54:&6(,H
MSNQE&#<D9((/!S6=H/A*_P##^J^&(U3S[73-+FM)YPX&9)&C;*J3G:"A_,4
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M33K^PTR]MFED@U-]ELPB.6.UFY'51A6//I6O7&>$](%MK^KR07,<VD6]P_\
M9Z)R(FF"R3 'H0&Z8Z;F%=1ITU[/:;[^S2TG\QQY23>8-H8A3G ZC!QVSB@"
MT2%!)( '))KC_"OBB\U3Q%JNG:C&L0=([_3,#!>S<;03[AER<]-X%;7B2&\N
M]*-E:6[2K<NL5P5D"%821YF"2/F*Y ]SGM6!K?ABZM->T'6= MYYKFSF:.Y6
M>\9@UJZX=1YC'G.T@#C(YH W;_Q3I>FRR+<2R>7#-'!/,L9:.&1\;%9AT)W+
M]-PSC(HNO%.EVETL,LLFTW2V9F6,F-9VQM0MZG('H"<$@UBZ?8>)-'UW5K>V
MLK:XTW4[O[9'=R3[6MF95#JR8._!7*X/L2.QHVG^(]%U74M/2SM9],N]0EO8
MK]I\-$LC;W0QXR6!)P<XY&>F* -FX\5:7:W<,,LDJI-<&TCG$3&)IQG]WN'\
M601Z9!&<\51MOB#X?NI[*..>Y"7D[6T,\EI(D1F#%?++E0 Q*G //YUE:'X>
MU72]2ET^?0]*N;-;Z2Z@U9V4R*C2&3:4*Y,@)(#9 Z'M@YGAW2[KQ#X*L]-^
MS&.WCUN:Y>Z9UQLCO)),*,[MQ(V],8).>U '467C:RG75I;F"XMH;"_%BK/$
M<RN=@  ]2[X ],$XJQ-XST:VT^XO+B6>)+:[6RG5H&+13,5 5L @ [UYZ<CF
ML&31?$UE#KT6GV\++=:PM\CBX"/+"?+WHIQ\C81AN[<8YY%&;PKKO]EZ]:1Z
M; HO=8M;^$)=!OD0P%@20.?W3<]R?3F@#L;?Q;I,\>H.TLT!T]D6X2X@>-UW
M_<(4C)W=!@9)XZTZ+Q1IDC7T;O+#/9/&D\$D1#@R?ZL #[V[.!C//'6N6UOP
MMK6IZEXBNK2-()+C[!/8O,X*M+;.7VN 20"2!FKNM:=XC\2^'6:73K*QOH+B
M"YM[.683)*T;;F61@,;6' QG'4]<  Z/3-<L]6GO+> R)<V3B.Y@E0J\9(W+
MD=P1R",@U6N/%>E6U^UI)))E+J.SDE6,E(YY "B$^IW+[#<,D4GARWN4BGN+
MK1++1Y)=H^SVS*[';GEG50#UX'.,=><#E]>T#Q+J=[=DV<%PL6K6MY9R&ZV*
M((WC8H$QP_RMECR0< \ 4 =1I'B--6US6--6TGB_LZ983(Z$!R45LY[<,,#K
MCFJOB[Q"FGZ)K,=G-<+?VEB\YDMXA)]G^5BA;((Y*],$XR>G-.T33=1T_P 5
M>(;B>"+['J$T5Q%*LN2"(4C*[<>J$Y]"*QM3T+7H-1\6I96<5[::_;?NY#.(
MVMY1#Y15@>JG (([YSZT ;5MXFMK+P[97%\T\\RZ?%=W)AB,C(A7EV [$AO<
MX. <&K9\3Z8=I@DDN8S'%*9($+JJ2G]V3CL>OL.3@5R*^'-<TW4+*\&AZ;JT
M<VF6]E=6T\ZJ;>2+=AE9E.5(<Y &>.]6=8\+:A<7D-SIUJ+#5+>*".WU"QE$
M<10$;XY8B?FC'.!@]>W< MW'C&UNM+\3F<ZAIL&ER/;M>16Y9U C1BX&&&<O
MQD= "<5HWGC#2M-N9+*5KV:ZAM5NG2*TD=C$>-WRK@]#G' _2L#4/#>M2:1X
MYTV&TBD769));27SP,EX8X\,".,%22<^F,U?.E:H?$]QJ/V%O(?0ULA^]3/F
MAF;&,]/FQGUH U+CQ=I$%O!.DLEPDUD=07R(RQ^SC!,A'I\PXZGL#@U$?%ML
M_B6PTJ"WGFBN[!KU;F.,E2NY N._1\D]N/6N7B\-^)5T#2M'DLX9+6'0OL,D
M9N@@2Y"[=[8!WH0.!Z]1W&CI&AZW8:IX:O9;* BUT8Z==(MP,QMNB(8<?-D1
MG@=R.<<T :VD>(-._L.VN4U"[OQ=74T-N9HMLTKAWR@3:N NUAR!@+DT^3QI
MHD-A]LEGE1%NUL9%,#[XIRP4(X ^7DCD\$$8)R*YG3?"^MV%KH%Z+93=Z5J%
M[+):>:O[Z&X=SE6SC>H9>#@<$9[U+J7A34[@:C?0VW^DZCK-E?-;^8H\J* Q
M]3G!<B,GC(Y SQF@#KM)UZRUJ2\BM?/2:SD$<\4\+1.A(#*=K '!!R#1/KMG
M!>O:XFD>.6*&5HXRRQO(0$#8Z9W ^@!&<5GZ-IU[;>+_ !%?SVQCMK[[.8&W
MJ2?+3:V0#QST_I69K7AR_N_$IU338);&_2> +?07 $5Q -N])XR?FP-X7C/W
M>10!%H?B]+*ZUBWUF[NI@FN/90SFW)2)2(Q&K,BA5RS8&?7GUKH)/%>E17_V
M1I)"1=K8M*(R8UN&4,(R?4@CGID@9SQ7*W?AK6IM!U^S2Q_?7VNQZA#F9,>4
MLD+G)SP<1'CW'O@U;0?$VHZ@TTEE!.;?6H+VVD:[V+]G1E.P( 0'&#N8\GL2
M,  "ZOK.KVUG\13%J<ROI<22V3;$S#_HXD('RX(W$]>?>N^LW:2RMW<Y9HU)
M/J<5P^J>'M8NX/'D<=F,ZU"L=F3*N"1 (B6YX&1GZ>_%=M8K(FGVZRQF.18U
M#(2#@@>HXH L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN42#Q,--%RJINF@:$R88E>67(&>^.0>:[R>VGT_PQ- FH74L\%LVV[EVM*2
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M=#@@]30!NW'@SPW=:5;:7-HMFUE;-N@B\L 1GU!'()[^M69?#ND3! UA$%2
M6P1,JIB'2,@8!3D_*>*R9O$VG:9<^)+R274YUTWRFNX3'E(%V9S&O!(Q\Q//
MK6M-KMG;X:;?'%]D:\>8X*1QCJ6(/OQC.<''0T 5-;\-Q7MAJAT^*VAU&^M_
ML[S3(65TZ;&']W!8>V216/H/@F*SO4N9-&T[2MJLCII]Y+*)U92NULJ@"\YQ
M@G('(QS?O/'FDZ:+X7T5Y;RV=I]M:)H=S/#G&]=I/ /!!P1GD"IHO&%E)J%G
M9O9:C UY<-;V\D]N8TD94WY!)Z%<D>N"!R"* +L/AS2+<V)BL8D^P K: 9Q"
M",$+SP"./IQ4-IX1\/6$UO-:Z-9Q26S,T++$,QENN/3Z5?LK^.^DNECCD46T
MQA9F PS  G;@\CG\\CJ#69<^+M,M2TDOG?8H[G[))>A088YMVW:QSG[Q"EL;
M0>": '2^#O#D^DC2I-%LS8B3S5A\L *_]X>A[<=N*FN/#.B75C:64NF6YM[,
MAK9%7;Y)]5(Y'X=:Y^YO;[7/&NIZ$DNHV$5G:V\D-Q;,J[9&:3+MR=RD(H (
M/?('6G>-=4N-,U[PQ&NK26%G>74D-T04 *B)F'+ X.X"@#I]-TC3M'ADATZR
M@M8Y)&E=8D"AF)R2:AO/#^E7]\M]/9K]K"[//C8QR%?[I92"1['BN?N-3LX-
M FU%_$&IW&G3W<4,4\"J7C=9O+*AE7&QF !)]3SR*9<WNH#Q1XMM5U"X6*#2
M()[< K^Y<^=DKQWV+US0!TEYX?TF_M[>WNK"&2&V<20QD86-AT8 =#R>>O-2
MV>CZ=I\\D]K90Q3R *\P7YV Z MU(]LU@Z+XD6'P?H<MT+F]OIM*ANI5B :0
MCRUW.<D#DGIG).< X-74\4Z=J%I;-IKSWC7EJ;J(6J@NL73>=V .3@ \D@\'
M!P 6[OP]I5[?_;IK-?M>T(9XV:-V4=%9E()'L>*T(88K>%888TCC085$& ![
M"N;^'U]<ZIX TB\O+B2>XFA+/,_WF.X\FLKPP-8UR'Q#O\17\,MIJ]S:6S+'
M"RHB$;004^;KSSD^HH ZC_A'-'^QW5F=/A-O=2^=-&PR'DSG><_Q9 .>N0*E
M_L33#I]Q8O9126USGSTE&_S<@#+ELEC@ 9/H/2N2T'XAHVD1KK<$@U./4YM(
ME6SA9TDN(P3\OIN49 ^M;4/C*PEMM1F>TOX'TZUCO+B&:'9(L;AB#M)Z@(V1
MUXH L1^$?#T6C_V2FD6JV)D$ODA.-XQAL]<C YZ\4[_A$_#_ -FNK<:/9B&Z
M=9)T$0 =EQM)]Q@8ILWBBPC$(B2>XEDL_M_E0H"RP<?,02/7 '4\X'!JYI6J
M6NNZ3!J-DTAM;E-\3LA0LIZ$ C- #8]#TN&XGGCL81)<1""4[>'C P$(Z%0"
M0![FFVF@:78PO#;6:1H\?DD;B<1_W 2<A?\ 9&!7F$OBO6K/0]5O;;7I+O5[
M77I+*UTR18F^U1B8($VA0V=N3N![5WZ^,],;5+JQ$-]FSE,5U,;9A%!B/S-S
ML>B[>] %Z'P[I%NUBT-C&AL 5M-I/[@$8(7G@$<?3BK6GZ=9Z5:"UL+>.W@#
M,XCC&!EF+,?Q))K/M?%%A<7UI:.EQ;/>PM/:-<(%6X10"2O)P0"#M;!QVX-8
M&I>)9;SQ)X1;3GO4T^^NIAN"J(KJ,02,"._4*1G (Y&>M '6ZGI-AK-H;34;
M5+FW)#&*3E20<C([X(S3;G1M.O);26YM4EFM"3;RMDO$2,':W49^M9L?C#39
M+.TN@EP(KF_.G*2@RDX<IAN>FY2,C(XJ6?Q3I\%TD12X>%KL6)N4CW1K.> A
MYSUX) P#P2#F@!\'A?1+/5Y]7M-+M(=3FR6N5B&XL>I^I[GJ:Y/2/ $MO<6[
MW>E:1;W44BROJEC<RK+*P;<6\K:JJ6YR-Q ST(XKIO#?B*37WU/=836J6=[)
M:J9"OS;, YP3SG/X8HL]3?5_$NJ644C1VNEB.%RAP9)G3>>?15*_BQST% $@
M\(>'1<>>-&L_-^T&Y#^6,B4YRP]#R?SJS#H&E06%S8QV$/V2Z+-/"R[DD+?>
M)!ZD]_6N%\+:U+J^F""Z\5W*:Q+J%S;PQKY1.(Y'V[DV=-B<]*U-+;4]3\:>
M*]/?7+^&VL'MA;+$(OW?F0AV^\ASSZYH WK3PGH-BY>VTN".0P?9_, )?R_[
MNX\XYIMWX0\/7VF6NG76D6TMG:'-O$R\1?[O<#V%<3J7BS6X?"7C2SFO/+UO
MPX04O((U43(Z[XV*D$ D9!'3CBM+3M8OYO&UOHMKK$FJ:?<::9[F4>67LI01
MM(=% ^;GY6STSTXH ZR7P[I$VW?81!5@%ML3*J8AG$948!3D_*>.:?\ V'IG
MVUKS[(GG-(LK')VLZ@!7*YP6   .,C JIX8UE]7L;I;C;]LL+N6RN2HP&=#P
MP'8,I5L=MV*I:=XSAN$UB:\LY[2"POS9(S!6,K_( H"DDLS/P/0COF@#?O\
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MDRYR@P<Y^5@"1@XX)K/?XC:,FGW.H&VU3[';"7S9Q9/L5HY/+92>S9]>WTH
MZ34=.L]6L9;'4+:.YM9<;XI%R#@Y'Y$ U17PIH"Q7<0T>SV7B+'<J8@1*H&
M&]>@_*J__"8Z:KZHDT-["^G6XNI4DMF#/"=V'0=2/E8=B,<BH8O'&G37$%O'
M9ZD9;JU^U6J_9C_I"?+G9SU&Y<YP.<YQS0!>C\*Z#%H<FBII-K_9LO,EN8P5
M8\<G/4\#GKP/2E;PKH+:&=$;2;5M-)R;<Q@J3G.?K[]:AMO%FG7VF65[9K/.
M;P.8;=5"RG8</D,0!M/!R>I [BJL7CW1KE-.-JMY</J"2M!'%;,6)B.'0^C
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ML)+?FV1HX65V5D5L94,#G!VC(]A7.VNLWEU\3H;,B^M[1]&DG^S7"J%+>;&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP_:K9"K>3(64_,2.2!SS_P#7K,\/Z7XDT.'6UCLM/>6_U.>]A:2[8*BR$8#
M(3D8Z#\^]=I10!P,7@>]TRST.*UDCO+F#6FU;4;B1O+\Z1TD5RJX/]\8'HO6
MI]=\/:U-J_B*73X;26WUG2EM-\LQ1H9$$H^[M.X'S!W&,5V]% 'F-[!J,.M:
M?9V<-C)J=EHBVMZL>I>0^QS@ %HF#+\C$< @GKSSVOA>2-O#-FD&GK91P(8$
MMDE$BJ$)0;7'WA\O![U;OM&TO5'C?4--L[MX_N-<0+(5^F0<5=5510J@*H&
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MK6H[I+<VUUJ,MY!)'(2S"3!PRX&,8(ZG-5M#LY-'\7>)8G7*ZC+'?VQ)QO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-/#]O87D\ A"))&7<YSRPP H_/GH.]R^TR]O=9U&9;8I%<Z3]E1W=>),N<$
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M:&E:AAK2G&7?2Z[R^]:+1:V98\0ZA<V.IZ-%%>_9H+NX:*8[4X 1F!!8'!R
M*;IFJ7-UKNH:8MTMU;0PHZ7D2KE').8V(^4G !X X/-.\065W=:IHL\%FUQ%
M:7#2RX9!P49< ,1DY-16>EW<?BJZUA+/[):M:"$VRLNZ>3=G>P!V@@<#G-#Y
MN?Y_H.*HO#J]K\K[;\VGG>W_  ="OHUWKNI>$+?5H;])+YXV?R985\M\$C;\
MH!&<=<FD'B.?4_\ A&+JRF:"WU21EFCVJQ&U&) )'JN,T[1+76]-\(6^E1:?
MY=\D;)YTLJ>4A))W?*2QQGIBFCP[/IG_  C%I8P//;Z9([32;E7.Y&!(!/\
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MC!JQ15Q@H['/5Q$JJ2DMM/Z_KTL%%%%48!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5S'C35[G18=&N8+LV\4FJ007(V*P>)B=PY!(Z=N:Z
M>N4\=:#=ZU::7)9K<2266H17+Q07'E,Z _-M)(&X=LD=^: -?1?$.F>($N#I
MT[NUM)Y4\4L3Q21-C.&1P&&1TR.:U*\^A\)WMG=ZUKL46JR7-UY$<%D-4,<K
MJG!9Y-Q7/S,0,G 4=S@=-_PCI'W=:U@#L/M.<?B1F@#;J"]NX=/L9[RX)$,$
M;2.0,G &3CWK+_X1UO\ H-ZQ_P"! _\ B:R=7\,7%U>:?:?:=9N+-IM]U-]N
M"A54$J, J3\^TY / - %KP5X@OM9M-0MM8A2WU?3[MX;F%#PJM\\9'L48#/?
M!K07Q-I#:A!9"Z/FW$CPPL8G$<DB9W*KXVDC!XSV/H:Y.Y\&WECX\MK_ $XZ
MM+I]Y;&'4I1J)5PRG]TV2X9L98$=@>,FJWAGPEK=E%%HFH17R06<K^7J4>J'
MRY(\G:5C!W*^#@Y '4Y/0@':Q>)M(GU"WL4NCYUR9!;DQN$F*??".1M;'L>Q
M]#3%\5Z,URD'VEP\D+3PEH) L\:_>:,[</@$'Y<\$'I7%>'/!VMQ:7#H.IQ7
MMNEG&\*ZC'J9,<B8*J8XP<J<$9! '7KFJ_AWP/>6\$$6JZ/+:7.G0.G]HQ:C
MN$WR%<Q*#N3<,9SCC(YSP =K8>.O#NIW=K;6E\[R7<)FMLV\JK.H&XA&*@,P
M'50<CTJ/2/&^FZII$&H.EQ;_ &FYDMH(GMWWR,K. %&.3M0DXSMYSTKA_"GA
M.;7?#'@F9O[2MH;...ZDF:]^4CRBJK$H8E<E@>@P 1WJ:P\'^(=.T[2[;[/J
M+1VNH7'VE8-4"M)$YE*O'E@%^^N>0Q^;\0#NV\8Z$MG8W9O6\F^E:"W/D29:
M1=VY,;<A@588.#D8J6U\4:1>:<;Z&Y?REN#:E'@=91,#CR_+(#[O;'3GI7G>
MG^ ]9M[/1K>6WU!3::W/<2^7J>X+ QEVNN6!W?O%Y^\?FSC/*S^!M=A:[O[.
M*_:XM]=-]#;OJ.TW,#1",X8,=LG+<MCCB@#T2W\3:3=6K7$-PSA+AK1HQ$_F
M"9>2FS&[< ,].G/3FK.EZO8ZS:-<V$QDC21HG!1D9'4X965@"I![$5Y[K7@[
M5[ZRL-4ALKN2>WNS+)I4^IDO)$R%#^\SM$F3GKC'&:W_  ]X/AMK"1VBO]*:
M>4RFU@OVR"0!ERIP7..2,]ADXH V!XKT;[,+G[4XB^V_8"Q@D&V?<$V$;<CY
MB!D\>]5[KQOX?LI[J&>\E5K298+DBUE*PLV"I<A<*IW#YCQSUK@[KP/KBQ7U
MC#::A*O]NI?QS_VF DD/G*YPI;/F  Y) Y&02:EU;P+JUS9>,HX(=2=]0>(V
M0?4 1*!$BDOE^>5/WNV/I0!UOC?Q*FD^&M;-C=RQZE9V;3*\-N91$VTE-_RE
M1DCOVYZ<U?F\2V&F:;'-J$\F4MDGN&CA>3RT(^^^P':.#R?0^AK@=3\&:['%
MXKL[>VU.\BU>!I+24:D%"2&$(8YU9QNY48(W C@XI;GP-J4.KB:72+G5[.^L
MX8I4;4PCVTB@J0Q8_/&01TR1@\&@#O)?&.APZD-/-V[W1$1"16\CC;*<(V54
MC:3QNS@=R,T[7?$D&A7NE6LL%Q*VH7!A4Q0LX7",Y)V@Y/R]!SWZ US.E>"K
MBT\77,KG48;#^S;>WCFAOBHWH7+* &W!,,-HQQS4WB;P?=2W6B76GRZG=_9+
M[S)HVU%@P0Q.FY2QX(+#..<9ZT 2:/XPBM+_ %NVUN_E?R=:-G;R?9B5B1HX
MMBNR+M4%G(!;&2>O%;7]M64&MZNLVK2;;*VBDFM7@PL )?#AMN6+8Q@$_=]Z
MX.]\#:O+HOB2".#4VGN]6CN+93J VR1 PY9LO][]VW7G[OX7KWP3<W&MZ]++
M::G=V-W8V\*1R:C@SE6<NC'?GHXQGC.?Q /0++4;>_:=8?-#P,$D66%HR"0"
M.& SP1R.*IR^*-(AO_L;W1\W[2MH6$3E%F8!EC+@;0Q!'&>X'4USWAWPC?6]
MQ?B\U/6UL-R"QBGU F6-0OS!BC$$9Z9.>.:Y[5/!GB"YNYE^SZA.L&M0W=O*
M-4VH]N"F<*6SY@ /+#C^$]!0!W][XKT;3WF%S=,%AF6WE=(7=4E8 JA901N.
M5X]P.XII\7Z+_:QTL7$QO%DCC:,6LIV&0$IN.W !QU/'O7FUQH,CW>L,FGZY
M?:";_P ^5K/5HBCO%MWLWF.K;@Z'/N@P?7H]/\'SW/B#Q!<22ZO!97]O MM<
MF^.Y\(P;<-V[C<, CUZ4 =7!XGTBXOHK-+HK+/$TT!DB=$F1<;F1R K  @\$
M\'/3FH_^$NT4221M<R(R6QNP'MY%WPCJZ97YP,C[N>H/>O/M'^'E]<Z:--U+
M2GL;NVM9;9=42_\ ,63=&8PT: [ESD$AL<9'.>)-+\$ZA)IDBWN@SV>HV]G)
M +B+4@_VARNW]W@@JK=3NQZ8/4 ';1>.= F>!([J=FN+?[3;@6<Q\]./]7\O
MSD;AE5R1GD<&K=OXFTJ[TVVO[:>2:&Y+"%8X7:1BI(8;,;@000<C@]:XBP\%
M:C#<^$&ECU55L;"2&\9=0'[IRB* F'^[E#T[8_#)3P#K=K;:?>?V=>7C6]W>
MB>P;451GAFEWH\;;MH887<"1GGZT >B#QKX?:*QD2]>07ZR&V$=O(S2%,[U
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M8'!Z$]#7GFJ^!M4N8?&J01:FYU")$L=^H#$Q$00^9E^1G^]V_*K.N^#WEO\
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MVM;B^R\AA;>=[!BO.<+DG&,\9X@U3P9KFI-XEE2RU.,:AI,=O:I-J:LYE'F
MK)\^"/G!QDC&?7% 'HECXFTG4;V>TM[EA-!")V$L+Q@Q'(#J6 #+D'YE)%8D
MGB=KOQSX>L]/NY_L%[;7,LD;VQ1)0H4HZLR@D?,>AQT/<9P=3\!:CJ>I3I')
MJ<$-QH,ED+B:^W;)V.0K .24]0,BETSPUK<VN^&+J\T_4[5;"&:.[:35%D4,
M50 QX<G82IXP#C@B@#T^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "HYIHK:"2>>18XHU+.[G
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M^T,W4D-FEMGS-\8\R,R'A?F_BYYX'<=%X0\6ZKJ7@_3+V[T+4KNYDMP9)X1
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M<702 SF $X3"M@R9V@D#&W)SW !ZO5"\UJPL;I;665WN63S!!!"\T@3.-Q5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+&)#CA2>G0<]>!47_"-Z:-)M]-"2K;V\@DAQ,P:-@<@ALY[GOWHY)]_Q]/\
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M%-C.TCQ0:<)(FFC5'^>.3.0,<?+QD \\UN77A[3KV2YDN8Y)6N8!;R[I6^9
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M?(U5E1[DVNI>1MMHU\P0[$8[5/#,-W\ZJZA=G5-+T*X@U)Y5;540N(PI^\V
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M<+)G6WT]R8P-T81B#Q_%\HY'J>*G35[UHM01KJ-##JHM49DRYCVHVU0 <O\
M,<<8]>E+I?AX26=Y;:A;S0K_ &D]W;.LWSC)^5@RL3G&<Y]:O'PMI1CD01S@
MO<"Z+BX?<)0,!@<\''!/?O4J-1HWJ5<(IM-?<EWOW[:&-_;NK-8IME1)5UH6
M#-+$"QC+#&0IQG!YQ^E0ZO?ZE_8VOVDE\QDLKN"-9D15+QR>62I&,?QD<5T
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M%51@ = *6MDK(\R<E*3:5D%%%%,D**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JAJ]TEI:(SWPLRTT:
M"0Q[\DL/EQ[],]LU?K%\46EU>Z.L%I;M/+]I@DVJRKA4E5B?F([ U,VU%V-L
M-&,JT5)V5UV_73[R6Y\2:1:2SQ3WJJ]NRK,-C'R\]"V!P/?H*M3:G:6\WDR2
M-OR@.U&8*6.%R0,#)]:YK4]+U*Y3Q8L5A(W]H0)';'S(QO(CVG^+CGUQ3[[3
M=0DOEO+""ZM;X"%2V]&AG08R)%R>5^;D<],$UESS[?UJ=RPN&?+[_P"*WM%_
M+5M==O)FL_BG1$F$3:A&&\[R#\K8#^A.,#\:LW6L6%E)LN)]F&5&;8Q5&;H&
M8#"DY'4CJ/6N26SFU;2O$VDQ6S$W.IR*)CMV)]S+'G.1C/3T_"Y)IEW'JNHV
MMQHJZC:7LPFBN&D78F54%9%)S@%<C .:2J3[?UJ7+!X9.SDTUNKK^[M>W=Z>
M1T,^L6%K.(9K@*WF+$3M)57;HI;& 3D<$]QZUG2^([6XLM7*W$M@+)VA-U);
ML0I"J=V",'ENG?&>AJO90:G8ZAJ%C)I@NK:YO#=0W9=/+0-@X=2=V5(XP#GC
MIUJI>Z7J;Z3XJL8[!Y'OI7DMW$B!7W1HH'+#&"ISG'XTY3G;1$TL/AU)*4NV
MMUU:OI]^C.DN=5L[($7$YRL8D?;&S;5_O-M!VC@\GT/I3+C7M,MI4BDNU,CP
M^>BHI<NG'(V@YZCI67%;7]EK6HW+6,MS;W]O%M563,;HI4HV3C!SG(R.M5]'
MT6^TC4-&5H'GBL]+>VDF5UQYA9&  )!Q\I'3TI\\^Q"PV'M>4NE]UKI?Y6>G
MGT.GM;J"^M(KJVE66"50Z.O0@U7&L6!N8X!<#?(YC1BK!'<9RH;&TG@\ YX/
MI5/PK9W-CX9M+2\@:">,,&0LK8^8D<J2.]8UKHFH-H&G:'<6[+)97D<AN]R[
M&1)-X9><Y(XQC@D]J;G*R=B(X>A[2<7/1.RU6VNOGLMM[FBNIW>IZ[?6-I<R
M6OV)XL;K4LLF1N<,2.., 8(]>:=K&HW=KXCTFQBNDAM[Q)C(60$J452,$^N:
METNVNX?$FMW$UJ\<%RT)AD+(0VU-IX!)'/J*@UC3[B\\5:)<"P,]G;+.)G)3
M:I=5"\$Y/(]*E\W+?K?]?\C6/L?;*.G*H>6_)W[\W3N0ZOJ6I6&DI=6^H03>
M9?1P1R"(8,;,J'(SU!W<CBI]2U2_T&[LGNY(KG3[F=;=W$>R2%V^ZW7!7/!X
M!'O3?$VF32:/:VFF6)D$=Y%,8XV10JK(';[Q ]>*-7L+WQ#/8VTEHUI807"7
M,[RNI:0IRJ*%)XSU)(Z<4GS)NV^A=-T91BYVY;ROM>UE;;6_:W7R*-WK>K6\
MOB5X[NW$>DA'C2:'B0&,.5)!'/8$5T=OJ<;Z'#JEPC01O;K/(I!)C!4$@X&>
M*Q].T<R>)=<NM0TI#!<2PO;R3"-\[4"GC)(Y%;FIVSWFDWEK'C?- \:YZ9*D
M"J@I:OU_,RQ,J#<*:2^S=JW6*NM/._HR,ZO8"2-#< &2 W"94X:,8RP./<?G
M4%GXDT>_NH;:VODDEG3S(AM8!QC)P2,$@=1U%8=I;:DUYI$\VF3016NFRVTQ
M>2,E7(CYP&.1\AQW]A5?1+";5_#GA15@D@6S19FG)7IY3* N#DY+ _0<\U/M
M)MV2_K3_ #-'@L/&#E*7XK1^];UV6GF=6FL6#W$<"W WR,RQDJ0KLO4*V,$C
M!X!['TJ"/Q)I$LT<27JLTDQ@7"-CS <;2<8!XXSU[5AV>C:@^BZ+I%Q;-%)I
MMU'(]P&4HRQDD%><Y88&".,G/NS^RM4_LTQ_V=+YG]O"]V^9'_JO.WY^]Z=N
MM/VD^P?5,+=ISZVW7=Z_EI_F=?<7$-I \\\@CC3JQK$T_6VG\0:U#-<8L[2&
M!U$D1C,9;?NSD _PCK4WB:SO+O3K=[&,2S6MW%<^06"^:$;)7)X!],]Q6+?:
M9JNJ7&N316$EL;JWM3!Y[I\SQ.S%6VL<9R!^-.<I*6B_JS,\+1HRI-SDDWIN
MM/>CTWVO^)K:OKB#0M7ETZXV7ME;M*5DB(9?E)!*L!P<=>E3Q:BGV^&.2^^<
M61F>U6+)(ROSY SQG&!ZUD7%E=:AH&K&+P^;*]N+)[<*\L;22,00!N#8V@GN
M>_0=[MM9WH\36%V]G(D$>F-;NY=/E<NAQ@-G^$\CBES2;O\ Y]RW2H1@XW6E
M^L6]EUUZWM;\S4@U:RN;:UN()C)%=-MA94;YS@GT] 3D^E-&M:>;I+?[1B1]
MVS*,%?;][:V,,1Z UG:+H]SI]_=Q28%A#*[V(!Y DPS#';:<@>S&J'A_3KNT
M2TLK[0U,VGY"7QD5E< $!D&<AB..0,<\]J?//30S>'P_OM2NEMJNM[;]M+I:
MW9JKXMT-T#I?!D.,,L3D<MM'./7C\O6M074+7;6H8^<J"0KM/"DD YQCL?R-
M8.C:*\G@A='U2W:W9DD1U+*2,L2&!4D9Y!^HJUX8CNVTI+S4'22\N%4LZ]"J
MC"D>Q&6^KFG&4W:_4FO1P\5-TV_==MT[]FK+R=_D6[K6=/LYFBGN C)LWG:Q
M$>XX7<0,+D^N*9;ZS!<:Y=Z6D<PDMDC9G,;!26W<9QCHO7OGCI7/^)-/U:_;
M5X(M/>2.1(3;/%(B*^T@L'Y!+=0 <C&.E:UC;WD/BK4+J2T<6]Y;P;9-ZX1D
MWY4C.<_,.@Q[TN>3E:VG_#_\ MX>A&BY\UY6[K?W?\Y:>07]_>0>+-)L(I@+
M:[CF>12@)!C"XP??=S5R>:X37+>%)?W#V\LC1[1DLK(!@^GSG]*I:S977]N:
M1JUM UPMIYT<T2$!RL@'S#) ."HXSWJS$+B[U(7C6TEO'# \48E(W.6*DG )
MP!L'7GD\>KUNUY_Y$-0Y(25OA=]M[RMYWV,G0]:N];M(+JWOH6N!*HO;%H@&
M@&[#*.C CU.0<'&*NV.HW.N7M]]EG^S6-G.;8.JAGED7[QYR H)QTR<'D5EW
MFDW&IW6F7Z:5)8:U%+$T]TKH%V C>"5;YP1D 8STZ#-7=)L;OP]?:C"+9[G3
M[NY:ZBDB(+1,_P!Y&4D'&1P1GWJ(N5TGL=5:-!QE*%N;HM--==5H_*^MKZ;,
MU].>Z(N%NIH9BLO[IXAC*;1C(R><[ORK.\3ZVNF:+J+VUQLO+>W,BD1&0(<'
M;NXP,X[TGAC3)[ ZM-/;"W-Y?R7$:?+NV$*!G!('0\5EZCI^JQP>*+&.PDNE
MU-7DMIT=  3$$V-N((QM&.O6G*4N31&5&C1>)]Z2:5NR3U5_+N=%-K%G96R2
M7DQ4B)9)&",P0'^)L [1UY.!P?2I7U2S281&4EBR)E49E#-C:"P& 3D=3W'K
M7-2V%]#JDLDVB-J%I?6\2,@E0&%U7:5<%L%2.<C/?@U)<:1>Q:HEQIL$MK,L
MD".$93;7$2A0Q92<J5&0" #P.O8YY]A?5</I>6ZONK=-.ZMJMO/:[-FWU2U4
M:C-)J2RQ07'EL/+V^2<+\G^T23G_ (%BB3Q%I44=T\MV(Q:C,X=&#1_4$9[B
MN=U"QNDM-;\VRE$EUJ<,UF%EC#.0(P"O.,C8QP<9 [=FW<%UJ&EZ_;KI5]'J
MNHV^0LWE*KA0$ 4AR !D9R<\_DG4DM$OS\S6.#H2M*4M-.L?[M_NN[ONM>IU
M$.N:;.]RB7:9MH_-EW J G/S D %>#R,CBH9O$>G165Y<AY7%I")Y(Q"X?80
M2" 1G!P>>G!]*R]0L]4DU6[NK33@V_2#;Q^>R%&EW$[6&[D<_2J3:3J=U)JQ
M%A<1B]T?[,C7$R$^:/,X(#$#.X=./ITINI/:WX$0PN&?O.6FGVEY7_4Z4:W:
M+80W4QD3S(O-V"%RP4=3M S@9ZXQ3KC5[-;9'CN@WG0F6)HD,OR?W\*#\O(Y
MZ5STEKJ45[97[Z++=0O8I:S6PF020LI)#?>VD'<0>>PJ>UL;[2-<\^'2Q)9W
M%E' (K9E MF1F.W#$?*=_4=QTHYY=OS$\+02NI:[[Q^[RMY[]-S4\-7\VH>%
M]/O[N0--- ))&P ,]^*K:-?7OB"P&J17'V6VE9OLT8C#$H"0&<GUQG Q@=ZE
M\+V4]KX3L+&^@:&:. 121E@?U!-5/#T-_P"']-31I[">XCMF98+F%D*R1DDC
M(+ JPS@]N.M-.7NW[?B34C2O6]G:_-IM;EUO;IV^7S&W5]K,.J:'8R7$,<EZ
MTZSE8@0-BE@5R> ??-3G6;K3/$,&F:HT,D%W%));7,:E#E!EE<9/;G(Q]*CU
M6WU&7Q!H-ZFGO-':&=IS%(@V[TVJ!N8$T3Z3<ZWXAMKZ^@-M9V44J0Q,X,DC
MR+M9CM)  7@<D\]JGWKNU]U]VE_U-5[%QBZG+;EE>UK\UY6MU_E^1-HU[?Z]
MIRZHEP+6"8EK:$1AOD!(!<GJ3C.!C&>O>M6R^UM81_;-@NMN)"@^7=Z@>E8G
MAZ/4-"TR+1[FPFN!:Y2&YA9-LJ9^7(+ J0."#QQP370QF3R0TBCS,9*H<CZ
MFM*=[*^YR8NT:DE"W+?2UMNGGMO?4Q- UIIO#MI=:C-NN)I)$&R/)<J[# 51
MD\+V]*T4U:QDLUNDN%:)G\L8!+%\XV[<9W9[8S7+:7I.JZ?%H5U)929LVNH[
MBW#H6VRMN#KAL'&!D9SR:=)HVJ6D_P#:]K:F60:H]X;'>H)C:+RC@YV[_P"+
MKWQ6<9S45H==7#8:5634TKMVLU;=V7EI9WV5SI$US3I(5E2XW!I6@"*C%_,7
M.Y=F-V0 21BJ\WB2Q1M-\HRSI?R,D;Q1,P&U6)S@=<KC'7KZ&J=V-2E-A/'I
M!CB:X=YXHFC$Z*4P#NS@$GJ5.<=^M9MAI6JVEEHF[3I"]CJ%P\D8F0DI)YN&
M!)Y'SKUYZ\4W.=[)?AZ$PPN'Y>:4N^G,NTOU2\M3H[?4K8/J4LFHK+%!,%92
MFWR#M7Y,_P 1).?^!8ISZ]ID4%U-+<^6MJ 9Q(C*T8/()4C.#VXKG;S1M4G?
M6)8;5E<ZE;WMNKR+B=8UCRO!XR4.,X[4_6])OM5_M>]@LY5>XTO[%% [(&=R
MS')^;  R!R?7VR<\TM%_6H+"X:4ES3WMU6FD?\WKY:]3HK35["_N9+:VN \T
M:AV7:1E3T89'S#CJ,BKU<]';7R>)DOOL$ODKIGDYWI_K-V[;][]>E;EK+)-:
MQ2S0-!(Z!FB8@E"1R"1P<5I"3>YQ8BE"#3@]++JGK\A;B>.UMI;B9ML<2%W/
MH ,FLCPWK%QJMO=1WT(@OK6X:.:$?P@_,A_[Y(Y]C4^KPSWC6MDL$K6TDH:X
MEC=5V*O(')!Y8+T!XS6:-,O-,\817ME;W%Q:7=OY5Z[2J=K*?W;?,P)X+#CM
M4R<E)-;?U_7WFU&G2E1E&37,U=:]NGS5]._*; UBP-W':_:!YLCM&GRG:[+]
MY0V,$C!XSG@^E":Q827D=JMP#+*6$>5(60K]X*V,,1W /8UB^'[?4[.VATB\
MTS(M)'V7Y="C(2<,HSN#D''3U.>Q9H=IJD6E0:+>::(VM(VA%^71E9<%0R '
M=N((SD#OSVI*<G;3\/Z^\N>%HQYK2V_O+5:Z_EIOJ;:ZYIS3"+[2 QC:1"R,
MH=1U*DC# >V:AM?$VCWMQ%;V]\LDLT9DB 5OWB@9.TXP3CL.:Q]"L;J*"U@O
M]"2"XL(3']L,BNK?+MS'@Y&[C.0.,BJN@64VJ>'_  EMMGB2RV7#S,5P0(V4
M!<')W%@?H#GFDJDW;3^M#66#P\5)MO3K=6VDUM>^RTWU.@L/$EC?:?'>?O8D
MDF>&-7B?<Y#,!M&,DX4G Z<YZ5,WB#2EM[>=KQ!'<N8XB0?F89RN,9!&#P?2
MN>L[/6++2["T.F2,L%],9FC>/S"C-(5:,EOE'S*">&P3CUIEGI.J0VFEPOIT
MH-KK$MRY\Y&_=L9<-DMD_?'OUXI*I.RT_#T'/"87FDU+2[M[RV]ZWY+[SIX-
M:T^XLS=Q7&8A)Y1RC!@^<;=I&[=[8S2Q:Q836[31S[E64PE0C;Q(.J[<;MW?
M&.G-<Q)I>L0S7%]!8,SPZR;U(&D0>?$8A&<'. W4C.*MZI;:C=166I0:0-T%
MT99+$R*LDB,A0L2#MWC.<9Z#K3527;\"'A*%U:>C_O+33;_@Z+[CHK*^MM1@
M,UK*)$#%&X(*L#@@@\@CT-0MK%@EPL#7 #-+Y*L5;89/[F_&W=[9S3-&@$-I
M(XTY;#SI#*8<@MD@#+D$C<<=B>U<ZNB:B_AQ_#TMN^Y;SS%O-R[3'YWF[^N=
MV,C&.OMS5.4DE9&-.A0E.2<K)-+=;.]WV=NRW-&;4[O4-?O=+LKF2T>UCB=9
M#:EU=F+[@V1]W"  @C.3@FI-9OKZWU[1K*UN%CCO7E63=&&(V(6!'Y4^QMKN
M+Q;JUU):NMM<0VZ1RED(8IOSP#D?>':H=;MKV3Q%H5W;V,MQ#9O,TS(Z#&Z,
MJ,!F&>34OFY;^?X7_P C:/LO;**M;E>]M^3O_BZ/J.&K7FG>([72M1,,L-\C
MFUN(T*$,@RR.,D=.01CZ5>AUW3KAML,[2'RC,H6-OWB X+)Q\XZ?=SU'K6;-
MIU_JOB&TU*>W%M!IT<GV>*1PSRRN-N6VD@*!TYSS6?I-AJHU72+JYTV6(QV<
MT%P3+'LC<E"-JJV GRD# STSZT<TT[=+_P"0W0P\X*3:4E'6S6_O/\DMNK-N
MP\26-[IMI>_O8Q= F*(Q.7; SP ,GCN,CWK2M;J"]M8KJVE66"5=R.O0BN1T
MVSUBTTO0;272Y=EJCPW!CEC$@( "E6W<(><X(;@<>NSX3L[JP\,VEG>VYAFA
M#(RE@V?F)SD$^M.G.3:37]:&>+PU&$92IRZZ*Z>EY?/HOO(]'U"[\16KZC!<
M?9K)I'2V54#-(JDKO8GU(/ QQWJ"\O\ 6+6\T2VFGB22\NI89]D?&U0[*5R3
M@D =<]:/#UM>^&[(Z.]A-<VT,CFUN(60AD9BP# L"&&<>GO3M;M]2GU+0KJ+
M3Y)Q:W#RS"*1!M4HR@?,PR>1TJ?>Y$W>^E_OU-K4UB)1CR\GO<NW\KY?GM>_
M4U]6FEMM'O+B!]LL,#R*2,C*J3R/3BN>N=9UFV\/Z)JMNHO)+E4>YMA& 74Q
M&1MGH0 <#G-:E]-J%_INHP)I<\0:U=(Q))%NE=@1@8<@ >Y'7VJO86U]!I?A
MN"2PE$EH$6X&^/Y,0,G][GDCIFJE=O2_],SH*G3IWFHMWVNMN5_UIU\RTNJ+
MJ']DW6GW8:SO'(.%!R C-^!RN#^--\2W>IV%A'<Z6J2SB5%^SN.)03R >Q]#
M52/P_/I_BB&ZL6 TR:1YI[?_ )Y3%&7<OLV>1ZXK4U9)Y([406[S%;F-VV,H
MVJ&R3\Q'Z4>\XN^Y#]C&M3<+..^OJ]'Y]/Q13CUI=5L-.O-.G,<<]P(I49!N
M3@[E(/1@1BK\NL6$$WE27 4^8(BVT[ YZ*6QM!Y'!/<5D77AZ>'Q-;:EIS!+
M::8/?VYZ%@I"R+Z-S@^O7M5&71=1DT/5M!>W9OM5V\D-WN79L=]^X\Y#+SQC
ML,>RYIJ^G]?\$U]CA9N-I66G:ZN];]^7\5KH=G6!<:I>7.IZI:6+I'_9L".=
MR[O,E8%@I]%P!G'/S=>.=>&:9[JXA>V>.*+;Y<S,")<CG '(QTYK%GL+RRU;
M6;JUMS<#4H$V88#9*BE/FR?ND%3D9Z'VS<V[*QS8:,%*2G:]E:]K7NOEM?\
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MFUK4UTJ:?[2IDBUH69/E#F+SE3'Y'K4<%CK#ZII-S/IDBO:WL[3;)8Q$$=9
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MU2^D\12II<R"_P!,2"!7DCW;P)!AOFP/OCOC^5=58*Z:?;))&8W6)59"02I
MZ<$BG&4F]=C*O0HTZ::=Y:=5V3>WG=%BBBBM3B"BBB@ HHHH **** "BBB@
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M\]M#IZ***V/-"BBB@ HHHH **** *FH:;9:K L%];I/$KB0*_3<.A_6K0 4
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M-*2Y.2  , G X':K%%%5:QFY.3NV%%%% @HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT %%58M2LI]0GL(KJ*2[MU5YH58%HPV<$CMG!JU0 444C,J*68A5 R23@ 4
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MU@TR0646I&\F_<V^=*N<"1NAYCYVC+$=2%-=55&ZTN*[U"SO9)9@]FS-$BL
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M"3.=V./3'&,4 <LOCO6+>SB&IZ=JD,:74JW%W#I4NY+<#,<C*5*C.?F SC'
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MO6T^>5I9K-ILQR%F+,#D;@I).5! [8HU3P;I>K7EY<S-=1F]M?LES'!.429
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M6,G]AW*['8N"CIM+%,H,-QU/)Q747?A+3M1L;ZWO'N96U#8+J9G D=4Y5<@
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MKIH3/$.0LFW&X=?0\]:CU'P)HNI2W[2BZB2_CC2XB@N&CC;RP C;1QD  >G
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MA73)\)$X0-O9D!$N7)"KGC:,'-=)=^!-'O);QI'O5BN[I+R2".Y98Q,I5MX
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M /F.<9 &<:>C>&-6\+:IJMHVHZPVDW=RUY;W-DD,A#O]]9$,9;.>05&TCTH
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MG-6Y?"6LV-\?['U'6+>\,]HDH80R6MQ"JQAF'R81D (!(W'8.#G@ [BSUFT
MU:YFUFUN+:VNO+.Q HMCM7]V3D[FR<^OS 8HD\6Z!#'>/-JMO#]C&;E)6V/"
M./O*?F'48XYR*\ZU/PWJ<-CXC::YUII)]9@FL47[.&N6 B D *@,RE&.W*Y"
M#IDFHKS1;_4]#\3PH_B7^W-3M<F"[MK>)+H* B@;0P&,C/S \T >H6WB31KR
M6\C@U&W9K-/,N/FP$3GYB3QMX/(XX-5[CQ=HUOIFH7_VEGCL(!<3QK$WF",@
ME6"D9(.#@].#SQ7#ZSX:U^75M1GL)M3N2^@-;Q&YCM]DDNXD0,#'@K@]QCG&
MZJDWA3Q!J%SKK1_V[&M_H @C:Z:V&^4"4>4P PJ_,,!<=3R* /1U\2Z:-*M]
M0GE:))HO.V^6[,J@#<2 ,[1D9;&.GK4E[KNGPV22QWT.9X#- Z*904P#YF%_
M@&1D\#D<UYM<Z!X@AO=,U"5?$UQ93:<MI/!:S6R7$#J21E<!2AR>^1CD]JLV
M7A;6O#VOQM"=8.G7&FQV\8LC;,UJZ,Y\I@R ;</]X<9SGC% ';>#=7N-:\$Z
M3JU^Z?:+FV6:5E&U<GK@=A5/P]K&J>+-,_MJSG@LM/F=Q91O 9'D16*AY#N&
M-Q!(48P,<GMF>#/"VJ0^!M,L=0U35["5+812VH^SD)QC _=L<?4YJAX7T/6_
M#6F+H%W=Z\$M'9+2:Q2W>&:(L2OWD)1L'!#'&>AQ0!K7NM>);;6_#.ER/803
M:FUTER3;M($,2E@4^<<$#OZU:'B6^TCQ;;Z%KPM6BOH))K*]MU:,,8QF1'0L
MV"%YR#@CL*P=;T#7&\4^&;W[7K5REJ;EKB6,6Y-L'CVJ%^0!B>AX/?I2S>#-
M6\2^*;:^U+4-4MM-T^"5+<W#6YGDDE78Y 1-JIMX^;)SV% &_P"'M6U;Q5I*
MZW;3P6-E<,QLX7@,C-&"0'D.X?>QG:N, CDUNZ:]_)I4)U!8HK_81*(P2@?D
M9'.2._TK@O"^C:YX>TF+0;ZZUX-9DQ6TMBEN\$T>3L(+(2AQP0YZCJ175Q:)
MJ/V<//XCU=9,99$%NV/;_4\T 5?"GB1[SP?8:EK$Z?:KB6:,"*,YD99' "(,
MDG:N<#)P":V8]<TR73EOX[R)[9G\M74Y)?.-@'7=GC;C.>,5YAHWA3Q%IUKX
M:O9)]7C6RDO(KJWC$)D@65R5D0;"&!P-W4_-QC!%.G\'>(M./]N6=SJDY&MO
M?-8H8!,8GB,1D *[?-Y+;>F#V;- 'I*>(](DM4N([U71YFMU5%8R&5<[DV ;
MMPP21C(P:IW7C+2+=]'\N9KB/596C@DA1G7Y59F)P.VW&.N?H<<E<Z-K?G:5
M>P1:PEO+>2R7"+'9"ZBW1%1)P@"LS$AB&)"XSU.,K3/"?B.RTWPZSC6E>PU6
MZ,L2/;,R))YP65"1SG>N2Q/WB0.E 'I-GJ]KYNL32ZS:SVUK.$8*H46OR+E&
M;/S')SV^]BGOXFT6*TO+J;4(H8K+'VGS@8VAR,C<K $9'3CGM7G5_P"#_$4[
M>(I;:[U1I!JUK>P1R&!?MJ1+%DYV8# H<9P/E7([T[Q#X0UC5DU_4K6ZUB0W
M&C?88H9TA22YD+,=K ( $&0,G!Y.#CJ >D6&OZ5JEY/:6-]%// H>1%/(4YP
M1ZC((R.XK1KSVQT35+/QS;ZD9M7GM8M'\LEUA&Z0/N\GA1QCOQS_ !5W5C<2
M7=A;W$MM+:R2QJ[02XWQDC.TX)&10!8HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBV9_"EQI_G&%D6*=_*V*3CC[K?3'N*[?4O$FBZ.Y74=3MK4C.?-? !VEL$]
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MJ6VCW^GO>>7YK:@S>=,R @$JS,0 , 'C//8 GHZJRZC907]O82W4*7EP&:&
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MK2.26V@6;!"'"NQ3N#D#)_"@#B4\/W5K-I\RZ=/]FF\5R:FL*P$_9X#$R!F
M'RY;#8ZC=TR#C9>TN-,\3>)A=:=<76GZK:PBT^SPF1?DC*-"V/N<G()POSGG
MK7<44 >:>'=-UCPGJEI#JMG=ZA#+H=M9)/;QF40RQ[]T;>@.\88\?+R:@\-V
M>IZ1!X$NKK1[_%II=Q97$:1;GBD;RBNX9X!V-R>!WQ7?/XET&.Z:U?6]-6X1
M@K0M=('!/0$9SFM2@#RG1K?6]#L/"^I3:)?RPV4E_#=VL<8::/SI=R2JF?F
M P>X#&MRZLYH=7\)W]GH,UM9P7%T9+:"-=T7FHVUG4' W,<GT)YKL/[2LAJ8
MTW[5#]N,1F%OO&_8" 6QZ9(%%QJ-E:7=M:7%U#'<73%8(F<!I" 2=H[X )H
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M(I.)6#N""I!^89&1QVH RK3Q'J-QJTMFMY:3PG0(M1CN(8\JTK,RDKSRAVY
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M7JQ17NB/=SP)$-A?$!)Z_P"V0/2M#PMXGN=5U=M/U"4VNHQ0,]SIL\&QT;<
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MS>B ?\+7\6G_ *<K#^4M:FO:C=V]]8VEG=11><)=ZHGF3LRJ"H1.F/FRS-@
M8Y&<TK>%+7^V[S5XK[4(;R\5$F:*8 ,J9VC&,<9/YTUO!VFM/8W'GWXN;3S0
MLXNF$DBR$%U=NI!('TP,8Q0!@Z?XNU2XT_PCJMY);V]AJ\1BNBL?^JN"A9""
M3PI*L,'/.WGFI_"OB;4M=M[2WGEC348KN9;Y/(V@0H 5(4G(+"2$\_WF]*V(
MO!NC1^&(?#S0R3:="Z.B32%R-CAU&3VR ,#M]:T;;1[&TU>]U2&$+>7JQK._
M]X("%_0_H* +U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9=C@<G 'U)( '<FN:T7Q.U[XA\2PW-U"+#3C;^46B,31[U)8/NYSD#T^E/\
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MG\FVN!(YC\U?E(#IG&Y21AER1R,BN)TG2]2@/P^$VGW .FZ=)!>$J,1.840
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ME[#)=3W*&3]V4A.]Y%W88GYE/''8YXH [JBBB@ HHHH **** "BBB@ HHHH
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MNMH))"HN <#[N,GCBI;?QQX?N?LGE7DA%U/]F1FMI559MQ7RW)7$;Y&-K8-
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M=(Y9!&S)$SD! [ 84G*]2.H]10!-INBV>DSWLUH)0][.;B??*SAI" -V">.
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M/V:661I5,:OLA=PAD.U-Q4$+D^OUZ4_5M:T_0K1+K4K@6\#2+$)"I(#,< '
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M3[;>76T,R(6VHB \;B<G)!  Z<\7=][I%U/<:CJ22Z/';%S+,BI)&X(SN*@
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MC^UI<Q6JVD<BW4F5B7HHY_/UQS4B^%]-2]CO%%P+B.T-DK_:')\HD$@Y/))
M.X\Y[T^^\3:3ILS1W=T4\N1(I9!&S)$[XVJ[@;5)W+U(^\/454LO%^GW5UK<
M<JS6T6DS>5++-$RJ<(C$Y(Q_& !U/4#!% $EOX1TJR72?LT4RG2$9;%6N'(C
M!7:0>?F&..<\5RNB>&-6ADMP]MJVG7:2B6::/63)9LQ?<^R(L20<G"E1UZ]Z
MZY_%6CQ1WSS7$D)L8A/<QRV\B.D9S\^PKN*\'D C@^E4;K69]?TMG\*WY2YA
MGBRTMFQ252 VWY]ORD$'>N<#IDT :^KZ-9:Y;107J2%89DGC:.5HV1U/#!E(
M([_G5"X\&:-=0:K#-%.T>J[?MB_:'_>;5"COQP .,=*O3ZY86UX;6220R+)'
M$^R%W5'D("!F (4G(ZGN/44NK:WIVA00SZE<BWBEF6%'*L1O8X ) ..>YXH
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M"77C>VK0"ZU66ZAW.C;HV50#\I.#\IX-<]KOA_7+BS\=V5MIIF760KVDHGC
M8^1'&5()!!!0GGC'3->BT4 <#KWAO5-=UC5/+MGMH+WP^;!)Y'0A9M[-A@&)
MQR 3CUK3\+VUX]R+O4/"EEH]W' 89)D>.1Y22"0A3D)QG#8.<<<9KJZ* .1U
M+1]0T[QRGBC3+4WT<]F+*]M$D5),*VY)$+$*2,D$$CCI3_%.GZMXH\+7MG;6
MWV&8^7) ERZEI)$D60!MA8!3MQU)Y[8YW=1UBRTJ2SCO)&1KR=;:#$;,&D;H
M"0,#H>N.E)J^LV&@V#7VI3F"V4A6D\MF"DD 9V@XR2!^- '+ZEI&I:UJDVLG
M39K62/1I[)+9Y8R\LDI!QE6*[5V]21DM[4W3-&U:#4_!4DNGR)'I>E2VEVQE
MC.R1EA Z-DC,3<CU'X=1I^N:;JEQ/;6ESNN8 #+!(C1RH#T)1@& /KBM&@#S
M71- UZRM_!MM<:2X&C74_P!H=9XB"K1R('4;LXRZG'7KQTR_Q1HWB/5)]7B3
M2S.GVVSN+*2*Y2.-HXWB9PRY!:3Y6Y;C&,$8P?1ZHV>L65_J%_8V\C-<6#*E
MPC1LNPL,CJ!G(YR,B@#EK"S\0Z3K6KV8T>&\L-3O/ML5XTZ;;=F50RR(?F;:
M5RNT'/'3M1U7POKEVGBNUMK=%-WJ%OJ5G.\JA)C&L/[I@/F&3$1DC'(/->BT
MA(52S$  9)/:@#@]=T/4]=N-4U5--FMYI-!GTR&VDDCWR22G.20Q4*N!R3W/
M''/7Z+%-!H=A#<0M#-';HCQL02I"@$9!([>M7JK&_M%U)-.,Z?;'A,ZPY^8Q
M@A2WTR0* .0UK0=2F\3OJ>D075E>B>W!N$G0VUW -NX31EL[E&\ A<_=P?2Q
M\179-(TETC,KKK=@1&I +'SUX&>.?>NPJGJ.E66K1Q1WT'G+%(LL8+$;74Y5
MN#U!Y![4 <+XC\,ZKJK:]J5MIKB:^%C!%;&2,,RP3>8TC'=MY!P!G/R^_&Y>
M6&I6OCJW\06]G)=VDVG?8IX$=!)"P?>KC<P!!R5.#V'6NJ P,44 >;:;X7UO
MPUJ>DZM!9F_4&]6ZLH945H!<3"4&/>0IV[0IY'J,TV+0->ATFUF.DLUQ:>)I
MM3^S)/'NDA=I?NDL%R!*#@D=*]*W#<%R,D9 I: /-)?#_B4QZE?0:<BW<?B%
M-7M[9[A<7,8B6-H]PX5L;NO&0/K6MK=GK6LZ19W:Z*+>X@U6UO#9":,RND;#
M<2V=F['09Z <\X':T4 8WB2R_M3PW+:3:8;X3&(26J3!&QO4L5<E<,O+ Y'*
MBN'O[/5](M] BOGN[Y$\31FR%RZ-<F'[/)P[ [68'=@DYQC)]/4:Y_Q#=Z!%
M>Z;#K(E:Y,IDLE2*5R9%!Y78#\P&??&>U '+ZOX3U>YO=1\06EA$]S)J5M=I
MIEQ(H\^.*%HF#,,J&;>Q'4#:N?:>]T;5F@T[6]*\-VMC>V>H"Z?3%DC5[A#$
MT3%G7Y-^'.WD@ =><#M=-U:PUBV:XT^ZCN(E<QN4/*..JL#RI'H>:N4 <9KE
MEK.KZ1I[KHPAG75[:\>V26/<D<;JS%VW!2QP>A/89JWIUIJ%MXX\0:C)ITOV
M2ZM[9()!)&=[1"3<,;LC.\8S^E=110!YCHNA>)?#ECX5OH=)-W/86$NG7MB+
MB-7"NR,'1BVT\H,@D<&M?5[#Q!>7-K&-*C^QRV$\;I:SK&89G8%0[<,4V]0N
M06Y((QCM)I5@A>5]VQ%+':I8X'H!R?PJOI>IVFLZ7;:E8R&2UN4$D3E2NY3T
M.#R* .*T#1=<TZ[\(7$^F<66BMIMTHG0F%\PX8\\@^6WW<]1^%:S\-Z[:1:9
MJ"V+?:-.UR\O&LS+'F:"<R#*G=MWA9,X)'0C->DT4 >=:OX8U6[DU?4H+&3S
MM1U33YQ;&2,,D5NR%F8[MNX[6X!/ 7WQ:O="O+O5/%3W6AR7=CJ/V(1QB=$:
M01G#E2'!5ESN7)'*CFN[HH Y[PCI^J:;97=OJ-S<7$0N2;-KME><0[5XD9>&
M.[=@Y)QC/H..BTVZ\0Z'XUT"&S<B]UN:/[463RXP?+RQ&=V5 R  <G'OCU*J
M5AI5EI9N#9P^4;B4S3?.QWN>K')ZGCGVH Q=#L+^R\4>*+R>QD6WO)89+9_,
M0F0)"J$8W9!RIQG'6N=T'PYKNC6WA*]>P=Y=,@N;2\LUEC+;96#"1#NVG!49
M&0<'VKTFB@#SI_"^JPS6UW%8N[3^)O[7FA62,>1%Y9CP<L 6/#$#/)//'/<:
MQ:R7VB7]G%CS)[:2)-QP,LI S^=7:* //]'TG7=,U#0-5DTN1Q!HXTJZM%FC
M,D14JPD4[@I!*D$9SC:?4#H?".BS:)I5REQA9;N^N+UH@<B+S9"P0'V!&<<9
MS6_10!YM::+XEEUO0;V^THK+97MT;F1+I!%Y<B2*C1(#POS+G@,3U!ZU>\,:
M9X@MM @\,:EI<4,=E"]LNJB9&$D>TJK1J#N5R",YQWY/2N[HH X/1],\0W?A
M,>&=4TJ&R:VT][#^T1,LBR#RS&K1J/F7/!.['3'.>*<&GZ@GAB^_M3PK8:==
MV6ESQ-?(\<AF/ED'RMOS*K8R=V.PP>H](J&[M8;ZTEM;E-\$JE)$R1N4]0<=
MC0!P^@:9=:O%X'OWLWM8=)L?,,DC(3(7@$85=I)QR6)..@XZXJZ/I'B73=&\
M.Z;)I#-;V3SQ7?DW,:R,#GRW5\@B,YY (;VQD'T*SM(+"SBM+9/+@A4)&F20
MJCH!GL*FH \VT#P]KMA%X-BN=**?V5<W9N"D\;!5=9%4CYLG)<>^/?BF1Z!X
MCL?*U6UTSS+FSU^\OA9//&IN()]ZY5@Q <!\X)'>O3** .$US3M;O)-(UR+0
M+:>2VFF\_2&E0.T<JJ-V\_(9 5!ZXP2,]SN:4MWI\%G%!X=@LXKJ=WN(K>1%
M%J"I(9L<.S$ ';Z]3C)WZ* "N$M]*O8?&'BF_O/#4E[9ZC]G%N"UNVX1Q[6W
M!G& 3^E=W10!Y[HOAK6=.\)6F@7L$DL%U>O)<K!<#;9VQ8L(58L&8<*IP.C-
MCH,W+K0+[2?'NF:UH]I=75O-;O::F9+O>?+R&C8>8^25;/3L37;44 >:R>"+
MS5M8\3W<UHVGWD]Y#>:3J!:-FBDCB51G:2<$J<J>"#ZU>UR'Q%KFF>&Y)M E
MCOK+5(+N\BCN(2NU VXH2XSDD8!Q[UWE% '(:IH^H^*=>T:6\M#8Z5I5T+[9
M+(K33SJ"$X0E55<DYR2>F!UJ1/#XUT:O/K=G>PM>%K?R%NRH:W *JN(WVG.6
M;GNY'2NKHH XKPII^O+H.C:3K=F\7]G2'?,\J.)XX\B'[K$[N48^\?O3[;2M
M2\,^+M8U"SL)-0TS6&2>1()$66WF5=I.'90RL,'@Y![5V5% ')^)]#U#Q-I5
MM-%'':7VGWT-_8Q3,#EXS]V0KD ,"1QG'!YZ"/Q-INH>,]'30Y=-FL+.XEC>
M]EGDC.(T<.40(S98E0,G  R>O%=A10!Y]JG@UO$7C36I-2TUUT^ZT^&WM[P/
M'OBEC=VWKAMRD%E(..W/%=/X:FULZ8MOK]J$OK<F-KF-U,=R <"10#E<CD@@
M8)K:HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YOQM>:AI>A#5K"YDC2PFCGNXT16\VW##
MS1R#C"Y;(QTKI*CGACN8)()D#Q2*4=&Z,I&"#0!P-EXBU"ZU_5-&&I3DWDT4
MVD3[(^;;)$I7"X.TQN03G(9/6FZ[?WL^F_$NPN+IYK>TTT_9U95'EA[9V89
M&>?7-=O#I&GP36DT5I$DEG ;:W8#_5QG;E1[?(OY56F\-:3.VI-+:LQU- EY
M^^?]\H& #STQQQVXH YRV_Y'KPI_V ;C_P!"MZU?$5Y<C5;"PM+Z6.26&>1K
M:W1?-?;M ?>W"HI;GN25 SR*TH] TV*]M+Q('%Q:0F"!S,YV1G&5Y/(.!U]!
MZ4:CH.EZK=VUW?6BS3VP81.6((#8W*<'YE.!D'(]J ./\.^)M0\0IX<L+J]:
MUFOM$-_+/"JJTT@95PN00,9+$ >G8$&Y;WVJ7FMIX9GUP+=PZ3]H:]MH54SS
M>8T9;:<@!"@R!U+>G%:LO@;PU-IMG8-I48M[)BUL$=U:(GKAP=V#TQG& /2I
MM1\(Z!JJ627>FQ,+)=ML8RT9C7&-H*D';QTZ4 <_+J&O:CJ<V@6FJ6ZWUMI4
M,XND81":5RZF0*4?* H.!C[QZ\8@23Q+JWB*?2#XD^R,NBVUV9+*&-T$[-(K
M%2ZY,9* X//H173ZIX0T#67M'OM,B=K-=D#(6C*+_=RI'R_[/3VK,;PPUQXZ
MN=0FMBFFMID5C%Y-PT9RKNQ!5"/E(<#'MTH Y_P[JFI>(/$/@[4;R[GAEN=%
MN99HHMHC=EDA!(!!X;.?7&,$5TGBV[U*#6/#=II^HR6:7]Z]O.4C1\KY,CY&
MX'!!48[>H/2MF;0-*GN+"=[*+S-/4K:E<J(E./E '&/E7@\<#TK)\5:)=:SJ
MOAZ2*$O;V-Z;B<B8QMM\IT&T@@YRP/4=* .5DUGQ)9M<:4VLRR26?B*UL5O3
M!'NF@F5'VN-N-RA\9&*W;.;4[GQ'?^&I-;NU;3[&*9+ORXA+.\K2?.1MVD(%
M48  ))SFMZ7PSI$]M%;R6I,<5P+I?WSAC,#D2%@<LV>Y)J6]T+3M0NXKNX@;
M[3'&8EFBE>)]AY*ED()7/.#QF@#C/#7BO4O$]QHFGW4IL99M+EO;AX  9G67
MRAMW X7@OQZKVSFCX.OK^QM?!]E'>N8+S4-4BNE*)B78T[@],@[@#QBN\O?#
M.C7XL1-8JIL!BU:!VA:$8QM5D((7  QT.*@_X0WP^-/@L4TY8[>WG-S"(Y'1
MHY#G+!@01G<<C..: .8L?$^HO)::?<W[#[7XAO-/^UE$#)%%YA1!QC<VU5SC
M/7O@T[Q!;ZE!-X=MI]?FG8^(?*WQ(B,(FBD=$<8(9EPO. #D'&>:Z23P7X<E
MTNXTU]*@^R3SFY>,$C]Z3G>"#E3GT(QVJ=_"^BR:9;Z<U@AM;>43Q+N;*R#/
MS[L[BW)R2><G- #/$][)8Z5$8KXVLLMU#"K",.\FYP"B \;V&0">!U. ,UR-
MEXIU070TN[N9(?-\12::MQ($,D40MQ,J9 VEBQV \\'N>:[K4]'T_6;$65_;
M++ KJZKDJ493E2I4@J1Z@UG2^"?#<UI>6LFDP-#>2++.N6^9U  8'.5;@<C!
MH RKG4-1TO5-*T.YUGSO[0U&:,70C59(HEB,B0D]"YX&[&2.V>:2;4-3T_6=
M%\.W&K_:&OKJZWW:1JLBQQIYB1'J-^&7+8&0IX!.:VI_".@W.B)H\VG1O8HX
MD5"S;@X_C#YW;O\ :SGWJ5O#6COIMOI_V)1;VT@EAVNRO')R=X<'<&Y/S9R<
MGUH XF[U_7XI)]-74Y%>S\1VVGB[\F,F:"4(^UAMQN4/C(QGBM6"?4+G6]3\
M.2:U=9TS3XY?M)2,2W#RF3YB-NW"!5&  "2<UT,WAK2+BUAMY+4F.*X%TN)7
M#><#D2%@<LV>Y)-+J'AO2=4OX;Z[M-UU%&8EF21T8H>J,5(W+_LG(]J .'\*
MWU];Z/\ #:SM[QXK6]L72>(*I#;;<LIR1D$'WQ[4:/K6O?8?"FIW.LS7!O\
M59K"X@:*-8W0&?#<*"&'EKR"![5VD'A31;5-.2WLO*7359;0)*X\H,,''/<<
M<TD7A/18;:SMX[1EALYS<VZ>?)B.0YRP^;K\S?\ ?1]30!R\NI>)+VZEAMKB
M[@O$UTVS1PP*T2V6?O[F4KG9ALDYW?+[5J?$KSAX*F:&YF@87-JI:(@%@T\:
MD'CI@_Y'%8\7@>]EO+IKG3+:&[FN))O[4L]4GBY9B0XA4 ;AD<$X..2<UW>I
M:;9ZOI\MA?P+/:R@!XV)&<$$<CD$$ Y'I0!RQOM2U/6O$>E0:I/:2:/! ()
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0:KI5P+BSFSL?:5Z$@@@X(.0>M<GX#5)$\1W=\63Q)-<;=6A/"Q,J;8Q&/\
MGF4P5)R3DY/%8>A3W7A*ZCTBR4^5XCL8;K32%RL5WL19L^V"LI_W6H ]$TKQ
M%IFMW=_;:?.TSV$QM[AA&P59!U4,1@GZ9JQ'JME+K$^DI<*;Z"%)Y(NZHY8
M_P#CI_3U%<9X$2TT.Y\:)N\JSLM1&68YVHMO'DD]^!DFLJ_-]H&KZ1XSO-.D
MM?,N&AU65I%/^CSLJH& .?W9$0_ T >@OXBTV+Q!#H4TS1:A/&TL,<D;*LJK
MUV,1M8CT!S5@:G;G5CIFV7[0(O._U9V;<XSNZ=>,=:YGQ9X<M_$VMV]J\KV]
MU%9236EW']^WF61-KK_4=QD5@V^L:UK4/B33I[9K?Q-8Z*]O(L8.V24[_+DC
M/=6X(]#QVH [9?%&G2QRSVXN;BTA9EDNH+=WB!7@X('S8(()7(&#Z4QO%^E"
M\LK13<R3WMM]JMUCMG?S(N/F&!VW#\ZK?#Z>SE^'>@-:,@A2PB1L?PNJ@.#[
MA@<^]8VIH[?$[PTNES00(-(NO++1%UV;HL  ,O;'>@#M+#4H-229H5F0PR>5
M(LT+1L&VANC <88<]*MUGZ1]HBMWMKZ[BN;Y'=Y7C3:-K.Q3C)Q\N!C)Z5H4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$3',:D*2#C!Y8# YYZ4 7Z*IZ5JEGK6FPZCI\OG6LP)C?:5W $CH0#U!JY0
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M)IK,]HHGDQ$2"#CYO0D<]B: .?\ #>I^(=<@T/7TOK1=.O QNK:24' 8':J
M1@AU;@Y8YP?:K'Q"ADE@\/\ EW4T _MNT4B,(<DOP?F4\C'';U!K7T_PAH.E
MZM+J=EIR0W4K,[%7;:&;[S*A.U2><D 'DU<U/1K'6%MUOHFD%O,L\6V5TVR+
MRK?*1R.U '*SZMJE_)XKBM-2DM)M#5$@!CC/FMY(DWR KR&)Q@8X!Q@](])U
M&35_'/AO4Y8?)DO/#$L[1?W"\ENQ'X9KI[OPUI-[=R74]JQFFB$,Q69T$R#H
ML@4@..3][/!([U-)HFGR:I'J1A87D4#6Z2)*Z[8S@E0 <8R >G8>E 'G_@[5
MKB/1O!NA0S-;)?Q7DLDZ %CY3G"+N! )W9/'1?>K$_B'7K;1M4NI+V1E\/ZR
M(;J588\W5G\C,3\N RK)DE<?=/KQUR>$M$CTZTL([-D@LY#+;;9Y \+'.2C[
MMRYR>A[FKL>DV$6FS:>MNOV68.)48EO,WYW%B>23DY).: .+T_Q%J5UKFJ:*
M=2G,MS<Q2Z5.8XN;4DB0KA<''ER8)SD,GK5?Q!X@UNQL_'C6^INCZ4;=K-C#
M&?+#QJS#[O/+'KS7>1:1I\%S:W$5I&DUK;FV@8#F.([<J/;Y%_*J5UX3T6]&
MI"XM&D&I%3> SR8EVC"Y^;C  '':@# N=4U[2]=\0V$%X=2DCT5=1M$GC1 D
MVZ5=@V@?(=B_>)/O4^@7FL7_ (BMG%[>3:.=,2:4SVZ)_I+'&S.P'I\Q Z$#
MUQ5_7O#$5Y8ZC-80QMJEU9?8M]U-(R/%SE&Y/&"W.#R<\UG^&_"\EAJ4-XNG
MRZ4L88/$-7FNEF!4C;L;Y0 2#GKQC')H /%?_(^>!?\ K\NO_29ZI>*F\GXI
M^$IK%2UZL%V;M8^K6H0$!_;?C;GO76ZEX?TW5KRUN[R*5KBT)-O)'<21F,D8
M)&UAR1Q]*DL-%T_39YI[6V"W$^/-G=B\LF.@9V)8@=@30!RWAK4/$.L)H&N?
MVA9G3;^ O=6[2@_,R;E$0$8(96!!!8\ ]QFL?0=0OM.\%^$C9W)B2YUR2VG3
M8I$D;33$CD9'W1R,5VFF^#] TB_FOM/T];>>8LS%)'VJ6^\47.U"?50*6/PE
MHD5E9V:6CK;V=Q]IMT%Q)^[ER3N'S>I)_$^M &$-6U:V\0ZQX=N-2E:\N'AF
MTJ4QQ@K _#X 7#&,JY.<Y&WUJ.74_$6K3:P^D7]K;-I5^(-ES( A1 C/Y@\L
MGY@6((88X]#GLY-/M)=1@U![=&NX(WBBE(Y57*E@/KM7\O<UFW/A#0;O71K4
MVG(VH?+NE#LH?;]W>H.U\=MP.,"@##T[^W=8\1>(K<>(KBVM]/O1#"D=M"<J
M]NC8)*G.UGR/ISG/"^%M<U+6?L&GW-XZZEIK2IK.$3YG0[5&-O <G>I&/E6N
MA&E1:4NIWVDV@?4+L&5EEN'"S2A<+DG.WH!D#H/:F:#IT]M]LU"^M[>'4=0D
M66X2!MRIM0(J[B 6P%ZXZD]J *'B[1;C5Y-.DTO5!I^MV3O/9.Z;T<;=KHZ]
MU(8#CD=17.1>--0@BNK+4M/BTK75U*SL[V>)O,A*S<+,A/JJD -T.,YZ5WFH
M:/8ZI)!)=Q,TMN289$E>-HR1@D,I!&1Q55_"VBS:;>:?/8K/;WIW7(G=I&E(
MQ@L[$L2,#'/&!C% '*^-;?4+;P]<P7&JK=@ZMI[VOF1*)(4-Q&,/MP&&X,1P
M..,TR[\2ZIH,GB>UFU!KM;.XL4@N+E40PK<,%8L44#"Y)!*GWS74KX/T--*7
M319O]E$RS[3<2%F=2"K,Y;<Q! QDG&!Z5-)X9T>:347FLQ,=2C6.[$LC.LJJ
M, $$D<#IB@#EM2U3Q'X?N%M[S4+9X-3O[6UM)-RO-;>82)"?W:J1\ORY!P3S
MD<5D:M=:CH&H>/[VSU*8W5O:Z?)%-(D;$#]X-I&W!')[9]Z[:'P1X<@T6?2%
MTU6LI]OF))*[L=OW<.S%AM[8/';%/C\&Z"D=\AL6E^WPBWNFGGDE:9 " &9F
M).,GGK0!D:OJ-Z?$7B+2WN&>R30!<I$57Y'9I5."!G&$'4FLO1=2U.ZTW0/#
M^G7*VL@\.6]VLF]59F("#&Y'!"X!(Q_$*ZN'P?H=N\LD=F_FS6WV225[B5G>
M+).TL6)/4\YSCC. *9>>"?#U_::?:W&G[H]/79:,L\BO$N,;0X8-C  QG'%
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M:+4>=YIGQO;8)"-I<)G:&Q_%C/)I9M!TRXOFO);4-*SI(XWL$=T^XS)G:S#
MP2"1@>@H X2+?Y7Q-.IX\WR%#ANGE?8QC'MG?^.:L:C]I/@7P+]LW?:OMVE^
M;NZ[_ESGWS79WN@Z9J-PT]U:B1W18Y/G91*@)(5P#AP"3PP(Y/J:?J6CV.KK
M;K?1-(+>59X@LKIM=3E6^4CD'I0!G^*9I'L8M+@@EN);]_*>.$J&\@<RGYB
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MQHUK>1ALJT,BC.53&5)SSDYZTGB2UN+SXC>'X+:^EL9&TV^_?Q(K.HW0?=W
MKGZ@_P!:Z2S\/Z983Q300/OBW^5YDSR"/=][:&)"Y]L4_4-$L-3N;>YN8G^T
M6P80S13/$Z!L;AN0@X.!D=.!0!PVE^)]<NWT[1+FYC-Z]W?VS7HVP_:!;,%!
M7Y& 8AB3@?P'&*N0ZEXC34-.\-WU_:MJ$D%S,]S;RA#($= BY,1&\*^6 4=
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MRPR?3K0!Z)'(DL:R1NKHX#*RG((/0BG4R%(HX4CA"B)!M4+T '&*?0 4444
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M=CN/F/(N  ,<>7^M9-IX^ANO%;:,+*0'>(0-Z;UDW.')^;;M"JAX);YON\'
M!V5%<:WCZ%?%@T7[%)GS3;XWIO\ ,W@;OO;=FWYL9W]MM&K^/H=*\2C2392.
M4R' =-SEMGE[/FP 2S9WE3\O&>,@'945AR:Q>6_B^TT>:" V]W;3SQRHQW+Y
M9C&"",<^9^E;E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#9L98P'81%"3\W R<\]JN7>FZ@/$C:G)9NEHOA^2T=S(A*RE@V,!LXP#R.]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***IZCIEMJL,<-T&:))!(4#$
M!B < XZCG./:@"Y17G?@K1+*]N_$C2H^^Q\1.MLXD8&-$6)@@Y^[G/'3DUK-
MXX1=.M=9^Q Z'<78M1=";YUS(8UD*;<;"X_O9P0<=0 #KJ*J6D]Y+<WB7-D(
M(8I MO()0_GKM!+8 ^7DD8/IFK= !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !0>G%%% &!X;\/3Z!/K$DE]'<C4K][XA8#'Y;,JJ5SN.1A!6=:^!OL^E
MKH;7RR:%'>"ZBMC#^\4"3S1$7W8*A_\ 9SCCWKL** *EI!>Q7-X]U>+/#)(&
MMXQ"$,*;0"I.?FY!.>.M6Z** "BBB@ HHKG=2\1W=IXJL]!M]-CGENK>2X25
M[G8H5"H8$;#SEAB@#HJ*P-/\3B]U:\T6:R>SUBVB$XMIW&R:,G ='7.5SP>
M0>HJIH?BK4=>\/6NMVNBQ_9;CD1_:R90H8J3MV8)&"<9YH ZJBL&W\0RW'C*
M\\/_ &%5^RVR7+7'G9W*Y8* NWKE3GFG>)?$$GA]=-9;,7(OKZ*R7][LV/(<
M GY3QQSWH W**Y^/Q)-_PFI\.7%@L+-:&[BN//R)5#;2%&T?,"1D9Z'-/N]>
MN;>?6!'I\<D&FVXF:7[1C>VTL4QMX8* ?^!+ZG !NT5SVDZ_J6JZ5IFJ)I$0
MM+](I1MNRTD:2 $$KL . ><'UK/F\;W4+^(6_L3S8="8"Z,=T"[+Y8D+(I4
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MX4[6&T88AN ,YP:6Y\47EAHPUR^T=H=+""64B?=<0QG^-X]N.!R0&) SUZ4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %L_=Y('/?BI=2(\3?$+P[=:=E]/T07%Q=7X&(BSIL6-'Z,>I.. !SS7>T4
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MU*UU"_&J6UI=>39:GM -U%M4Y..&*DE=PX)!]*Z^BB@ HHHH **** "BBB@
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MH++7;46LBP0F%8I81^Z8@NW!4E,\#A:]&HH X?4+ >-YM:CAOK+[ L#:9B2
MRD9 :1U(=<?-M R#S%D5S=Q=:AXL^%=J(U-YK&A7T+7EO&<M<?9Y,$K_ 'MR
MC</4\"O7** ,>R\4Z+J4<9T^_BNI7QB")@95S_>3JN.^[&.]/UO_ $C['IHY
M^USCS!_TR3YWS[' 0_[]:M% ',?$/1;OQ#X UG2[#FZG@_=+G&\JP;;^.W'X
MU+I/B_1]0TZ!H[E$O-@#Z>>+B-\<H8S\P(/'3'?IS7144 <G>@^)?$$]G;75
MGY&G0F*:*>(S!I)5(;@.N-J97//^L8=JXI+.^UWX4Z_X&AN$N-7T=_LT)SC[
M3#'(KQD<]U 3KP1@U[#10!P'BCQ=!>_#R]NM*OVM-:$ ,-H'V7,<W'[LQGYB
M<Y&,<_E576'LH_B3X=2^OVMTBTFX665KHQ,K%HR S9!R<'@GG%>DT4 8OAN>
MP-I/::=>O?0V\S[KEI/,!9V,A7?D[BH8<^X[YQM444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM]6EAB\^9I&5 J$+N8DXY/?O735RG@B:*<^(Y89$DC;6IBKHP((V1]"*ZN@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !36C1F#,BEAT)'(IU% !1110 4T1H'+A%WG^+'-
M.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :D:1YV(J
MYZX&,TZBB@ I" 000"#U!I:* &HB1C"*%'H!BG444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% #3&C.'**6'0D<BG444 %%%% #1&@<N$4,>K <TZBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH :D:1DE$5<]<#&:=110 4A 8$$ @]0:6B@
M!JHJ#"*%'H!BG444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4TMS_IF@R.'BNI2^UE5.J2$]QUX[5Z=/IT4NI0:@A,=U$IC+@??C)!*,.XR
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MQPP(YP>U=%I>@RVMZM]?W-O<W:(R(\%HL"@-C.1EB3P.^/:MDQHS;BBD^I%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M')"Y. 3VS4] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>exhibit1027supplycontrac010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
M=S[5\P2VEQ+^SU8Z<D3&\;Q']G\G'S>9M8;<>N:^C+/7])_M=O#HU&%]6M;=
M9)K?)W!<#D]NX/KR* .'3XE^(=-\=:9HGB7PNNG6FK/Y=G+'<"5P20!NQD'D
M@$#&,YYJ?Q!XZ\9V6LZA%HO@LW^EVC;1>R3^4'*J-Y&>P.X9]JH/XG\)^(_B
M%::O>:S9O'I+-:Z59HX:2>X<A6DVCMD*JCOC=P,5U?Q&N91X5.E6KE;O69X]
M-A([>8<.?PC#G\* -#P=K5YXC\):?K%]:):37D?FB%&+!5).TY/JN#^-;M16
MMM%9VD-K @2&&-8XU'\*@8 _(5+0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 45QB:OJX\6>(="N+^*%H[)+W3)6B&-AR'+^NUP!VX/KS4/A_P 3WWB#P)HM
M]%="/5;VX6"7]T,*ZL?.&T],(CD=^!0!W-%<%?\ BW4$T;Q%KMM*GDZ%>O;M
M:,@_?)%M\PLW4,<L5Q@#Y<@YK9US6;VSU;PRMI)#]CU*\\B97C)<KY,D@(.<
M#[@[?C0!TE%<]XMU6_TB#2I;)X56?5+6UG$D98F.255.TY&#@]<&H]7UZY_X
M2NP\,::4CNKBW>\N+AUW>3 I"_*O0LS' SP,$X/2@#I:*Y276;W1?%NG:%?W
M/VFWU:.7['=;%62.6,;F1P!M(*G(( Y!!!ZU3TGQ/?6.HZ[I'B6X!O[3$]F8
M(@OVFV;Y49%YR^\[2/4@=Z .WHKG1:>*)='M8#JMK!?NI>YNOLP<1GC"(F0#
MU^\2>AXY&,.T\7ZN^C:;:W20#5[S5Y=*%Q$A\MEB9]\RJ3_=C.!G&[VXH [U
MU#HR-G##!P<5@1>!_#$$\L\6AV<<LN3)(D>&?)R<GOS6)?\ CJ70H=>M+F,7
M>H:=<V]O:CA/M)N #%NQP"#N!P.BY YQ6]+:>(8+6*:+4XKBZ\R,SPO;JL13
M<-XCQ\RG;G&YFH <O@[PXNEOI:Z-9K822><]N(P$=^/F(Z$\#KZ59OM TK5-
M.33[^QBNK-""(9AN7CIP>N*Y2X\9WB:+J?B9&3^S-/U$VOV;8/WD*2"*23=U
MW9+,.V% (R<UN:OJM_9>,/#MA"\/V*_:X693&2^4B+##9QC/M^- $K>#?#CZ
M6FEMHUHVGHV];4I^Z#>H7IFI)_"FA7.EQ:7/I=O+818\NV<9C7'3"GCCMZ5F
M7>MZC?:_K>FZ7*D!T>TCE8N@;SIY S*A]$"J,XP3NZC'-32O%T_BV]LK;2I!
M9I)I,>I32%!(5>0E4CYXP"KENYP,$4 ;LWA/0+G2XM,GTJWEL(CF.V=<QKZ8
M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M01PR2HB"4\.Y("@#N<D<4 8_P[T^XTSP-I\-U&T4TAEN&C88*"61I I'8@,
M1ZUU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)+IKZ7':H\WEOB19&<G;DD##8S0!>\(:WJ'B?P%8ZO- EI?W=NS!<'8&R0K
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M"(YC*K)OP64\[H^#Z'I5SPK:^)- \'?V5'HN-1$UP\<D]Q'Y"^9*[J6*L6.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5#]DMOM7VK[/%]HQM\W8-^/3/7%344 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=@6BC^I5'X]U]:Z>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%J_F09N)-B-M*9";MN=K,,X[UH4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !67XD5W\,:I'%%)++):2QI'&A9F8H0  /<UJ44 >?>-?#%]?:?)KWAM
M&CU5[)K6ZMW0K]L@92"K*<?.N<J?;'0UU:AQK%_J$\4OEVT2P0J$+,PQO=E
MZY)1?K'6M10!YSK'AJ^UGP/>WWVK4(=4F?\ M**U\A,Q72X,:_<W_+M1,@]!
MGI7;Z+?3:EH]K=W-I-9W,D:F:WE0JT;X^8<]1GOWJ_10 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5%<W5O96[W%U/%!!&,O)*X55'J2>!4M9?B3_D5M7_Z\IO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%M+M#-@ N!T((_A8$#/0X!J&Y\&Z;>6-[;7,EU*]_)')=7#2 22^604&0,
M@8"@#KZG/0T4 8DWA>SGN]1NI)[HRZC:K:7!#@;HUW8 &.#\S<C^\?:L/_A&
M[NW\;:2;07T6FV.CR62W:21DAB\952#DD;5/.WJ!WYKMZ* .*U/PW+#X@\*1
MZ5:W,5AIQN3+<0R)F,R)@$[R2Q+$D\'KDUL3>$M-FM+:W+3J(+T7^]7^:2X#
M;M['')SVZ=L8 %;M% '.W/@S3;NUU6VEENS%JLZSW0$@&YU"@8...$7IZ?6L
M'4M&U2;Q/?3O:>( LOEI!<Z5J4<<;HJCF1'=<-N+]%(QCOG/H%% %*RMKJ/1
MX+:[NGDNEA5))UQN+8Y/3&?? ^@J'0-"M/#>CPZ58-+]D@R(EE?<5!).,]3R
M3UK3HH P8O".EP2R",3"T>Z^V&RW_N?.W;MX&,CYANVYVYYQFH[SP9IM\FKI
M/+=%=6='NP) -Q0 +CCY<!5''I7144 8LWABPN;Z]N[EYYI+VR%C<!G 5X?F
MXP ,'YFY'K56X\,)+::5I"M,VFV,T=Q(\\ID>4Q\QISV#!2>V% '4XZ2B@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **Q;GQ;H-I,89]2B1Q-Y&"&_UG]P''+<=*OV&I6>J0O-93K,
MB.8V*Y&UAC((/0\B@"W1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 <5X_C2+_A%%10H/B.U; '<[R3^))-:.M:G);>)]&T2U?[*VJF>:6X15
M+?ND7@;@1N.5Y(/"GZC2U;0=/UQK0W\4DAM)UN(-D[Q[)%Z-\I&2,GK3]2T6
MQU9;?[7$Q>VD$L$J2,DD3XQE6!!'!(/J#S0!@:'?:SJPU73I-0$-SI.JK ;L
M6ZM]IAPDFTC@!BK[21C'4#M775EMX=TUK-+7R9!&MRMWE9G#/*&W;F;.6Y Z
MD^E:E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9!&X=/O*03P1[XJ[I6I1ZOIL%_##/%#.H>,3IL8J>AQU&?>@"[1110 4444
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M:P[AU4#<S#ZLV/\ MF*TZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZJ/7FO1.E4YM*TZYO8KV>PM9;N'_ %<[PJSI]&(R*N4 %%%% !1110 4444
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M'Y)A'%OB0^JLQ!QWQ0!V%MJVG7K[+74+6=^FV*96/Z'V/Y4QM<TA&*MJMBK
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M(C+ ,  1@$'Y9#\N>N*=K_CB;3M'TFXM;:!Y]2B$J!)UF"<H3A5(,BX8C<O
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ML:9IB1/?ZC:6BS,%C:>=8PY/0#)Y-1"YTS7H9;>UU&.<(1YGV.ZPR^Q*'(H
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M:KHEEK21I?"9XT='$:SNBEE8.I(4@'#*#SZ5HT %%%% !1110 4444 %%%%
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ML-GO_<B;.[>%[?-\V,[<\XS3+WP=I>H#6%N&N2NK[/MBB7&\( % _NX  XH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/'(XZD97B;79_$'A#Q3;6MA$L=EII^U1WF=XD>#S"@ X#(K*<G/S<<8S0!Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2-HP I"+'@<\C:HZ^]4(? VF1>#)O"_F7!M),XEW_O$PP*$-ZH%0#V05T]%
M')7/@Z]U'PW>Z3JGB*ZO7NHQ";AX$0H@.>%4 ;C@98YZ4_Q<@U331X;DM+V>
MYOXQLNH(&$4#JP(D+]$*GYP,Y.W ZUU5% $5K;165I#:P)LAA18XU]% P!^5
M<_=^%KJ[TW4-*?6';3K]YC-&\"M(J2L2R(^< ?,1DAB.QZ8Z6B@#E9/!?D:W
M+J&DZO=Z9%<Q1PWEM"B,LHC7:A4L"48+\N1V [C-.O/!PNY/$)^WE$UNT2TD
M41 ^4BJR J<]<.W7OBNHHH Y.7P9<)J4&H:;KUUIUS]ECM+LPPHZW*)G:2K@
MA7&3AO?I4=YX$$DVK?8-6N+.WU>U%O>0E%E#D1^6'4MR&VX!ZYQV/-=A10!R
MDG@MA<V\]OK%S$RZ:--G)B1C-&I)4]/E(+'D#H?QIUCX,6Q?P[C4))DT2T>T
MC62)?WJ,JJ=V,= BX_'.:ZFB@#F/#WA&;P\T=O'KE[<:5;$_9+&54Q"#G"EP
M-S@ G )XXZX&-#6-#.K7^DW7VHP_V;<_:44)NWML9,'GIAV_'%:]% '(W/@*
M"YM-2M_[4NXA=7_]HV[QA0UI<9#;E..>1T/8D>]37/A.[O\ 2HK6_P!<GNKE
M;J&Y:Y>!%R8G#HH1< #(YZDY//3'444 <Q>>$#>/XC9M0*C7;9;:8"'_ %2A
M&3*\]<,>O?'TK=M;62UTN&T28&2*(1K*4X.!@$C/]:M44 <C;>!8[30M%L(M
M0D%SHLGF65WY8W#@@JZYPRE6((&.W0\U+?\ @N._LKQ'O2MW?7D%Y<W"Q#YF
MA*&-57/"CRU&,D]><G-=310!'+$9;9XF;ET*D@>HKG6\*37-KIUCJ.JO>6-A
M+%,@> ++(\9RF]P<$ @'A03CD]<]-10!@/X<FM]?O=8TG4!:S7ZQB[BE@\V.
M1D&U7 W*5;;QUP<#BHM6\(IJWA2]T*2_E7[>Q:ZNB@,CDD$D#@#H .. ,>]=
M)10!SEUX4.JWVF7&KZC)=1Z;.MS!;QQ+&AF4$*[=22,G ! ^M+!X8ETO5+V[
MT74?L<5]*9[BTE@$L1E/WG3E2K''/)!/.*Z*B@#G-<\*OK-MIT1U.:)[*]2^
M$IC#L\J9QGL%YZ =A5G^R-1DDEDN=8:4M T4:?9U5$+8R^ <DX&!SQD^M;5%
M ',Z;X3DTO0-'TB#4<Q:7(K1R/ "SA00 W/N>1[?C=U#PSI^H^(=*UV1"FH:
M:7\N5."Z,C*4;U'S9'H1[FMFB@#.UK1X=:M(HI7:.6"=+FWE7DQRH<JWOW!'
M<$BLZ7P?97EEJT=](\MSJCI)/<( A5HP/+V#G:$V@C.><DYS7144 8#>%;6\
M;4I=6<7L^HVHLYFV;%$(W?*HR<<LQ)SU/;  ET_P\+;4H=0N[M[RZM[7[) [
M(%V1Y!8G'5VVKD\#Y1@#G.U10!C:=H4FGZQK&I+>!Y-39'9#%@1LB!%QSR,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#)! 8@?4D#\*T=(U$ZMID%]]CN;19E#K%<A0^T\@D*3CZ9S0!=HHHH ****
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M6W\70W5M:WL.FWSZ==SI#!>*$*-N<(KD;MP4D]2/Z4 =%1110 4444 %%%%
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MJUINRSN-,GF\037*S6_V>*UD\KYG;8P*A%4G 1LYS@9/'-;[V5I);K;O:PM
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M!5\/Z%9>&M!M-'T]7%K:IM3>V6.2223ZDDG\:YR1E_X7=;+N&?\ A')>,_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRM:\%Q[V?;JC+N;&6Q:3\G'>NKH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "JFIZE;:1I\U_>&46\*EY&CB:0JH&2<*"<#Z5;K*\3?\BIK'_7C-_Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%^Y' K:\)Z1?:-::C'??9]USJ5S>)Y$A<!99"X!RHY&<5OT4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%<Y?\ C*RTZ6-)K+42LMY]
MABD6 ;9)LD;5R?53STXK7T[44U**9E@N(&AD,3QW";6!P#^(PPYH N4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% '%_$+ /A/M_Q45I_)ZM^
M(K^:/Q7X;TEI)(;'4&N/.>-S&7D1 4CW#!&<L>",[,=,BMZ\TS3]1,1OK&VN
MC$V^,SPJ^QO49'!I]W86>H6XM[RU@N(00PCEC#*".AP>XH Y#0S/=)J]AJ.J
MW<=II^M+'977VG8\J@(XA9SRXW,4.<D].HKMZJ-I6G/:Q6K6%L;>&021Q&)=
MJ.#D,!C (/.?6K= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX!2.I'09- 'HU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLLA &YBH).!QUK=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPV5I!;1%BQ2",(I)[X'>@"Q1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-;R1V<UH@MXXR_R2.JOYS<;&^;Y0#GH2"#QKW7@W3;VWU>":6Z,>K2+)=@2
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M">HK=H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** .<\6:'?ZVVB_8FME%AJ4-\_G
M.PW!,_*,*>N[K[5)KNCWNI:QH%Y;FW$>FW37$HD<@MF)X\+A3_?SSZ5OT4 <
M W@W7(A+?65W8PZI%K,VI6N\N\3I*NQHI. 1P>HSS79:6FHK:;M5DMVNG;<R
MVP/EQC &U2>3TSD]R>G2KM% '%7O@RZU8>+K>]F@BMM=\LQ/"[,\)2-4!((
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?DZ[X*BWN^S477>YRS8M)^3[UUE !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU+X+J%VD/SDKR,9YSTKM:* .,_X16\/BZ'6H(H;"X%T[74]M.VV\M\,%22+
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 45S=_XRM=.EB6;3=2*37GV&&18TVRS9( 7
M+ XRIY( XK7TW41J,<S?9KBV>&4Q/'<*%8' /8D$88<@T 7:*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
F444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>exhibit1027supplycontrac011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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MC$<B?:I1%(H[-&&V-U/4<YJ;5-'L=:LUM+^%I(%=9 BRLGS*0RGY2.A /X4
M7J*15"J%&< 8Y.3^=+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<3HMQK>L:UXFM3
MKDT*Z=>BWML6\3#!C5_G&W)Y;L1Q7;5Q6B6VM:1K7B:Z;1)Y5U&]$]MB>$#
MC5/F^?(Y7L#Q0!CZEXXUA? 7B.Y+Q6FO:#="VG,2!HI/F7#@-DA65LXSD&NL
MLKA9]4CAM/$YO\1LTT)\ABJ] P*(,'<1UX//I7*:IX(U<^ O$5LJ1WFNZ[="
MYG$3A8HSN7" M@E55<9QDGM78I/>2ZE;R1Z!+;X5EEGFDAR$QG:H5SDE@O7
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MCREDE\^-K<%9%9F!W;]ORG'RY]J 'ZCKDZ?$*+2GU_[%I<VDF\5AY(S()0H
M9U.05)./;K72Z)*T]@TW]HC4(7D8PW 51N0<<[0%/(/('(Q6#>6&I1_$I-;3
M29KFP326LMT<D08R&4/D!G'&!U]:W]'^T>1,)=/%A$)3Y,&Y6;:>2S;20"6+
M< ],4 :-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% $,EI;2SQSR6\3S1_<D9 67Z'
MJ*FHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5P<T:]ISZ1X)T73Y'C=X-5T]2\2LJM_I<?.&9C^9- '<4444 %%%% !1110
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MZ$&N+BT.XT#X;:[;7,B22R6EQ*2-V1F'&&)8Y(QC(P, 845TOA__ )%O2_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HJM?7]GIEH]U?W4-M;I]Z69PBK]2>!5>VU[2+RYCMK;4[
M2:>0%DCCF4LP'4@9YH T:*S9?$&D07#02ZE;)(CB-\R#",>BL>@/(X//-27V
MM:7IDT,-_J%K:R3?ZI)I0A?_ '0>OX4 7J*JV6I6.I([V-Y;W*HVUS#*'VGT
M.#P?:K5 !15+4=7TW2(XY-2O[:S21MB-/*$#-Z GO[466L:9J,KQ6.HVES)&
M,ND,RNRCW .10!=HHHH **K7.H6EG-:PW$ZQR74GE0*W\;[2V!^"D_A5F@ H
MHJO?7UKIEC/?7LRPVT"%Y)&Z*HZF@"Q12 AE!!R#R#2T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI-UY4M\-0<><<F<,'W9[?, <=..E &-J7B;5+/6H1%<130-K4.GM'#'F)(G
M&&<@'S0Q)PI( P"*RY=7UK2]"^(.JPZEYL]A?R"%9X595"P0D  8[''IW.3F
MNIF\":)//-*RW@\V\6_*)=R*JS@@[U . 21SC]*ENO!FCWB:M'(EP(M6_P"/
MN-+APCG:JD@9P"0J@D<\4 53JVHZQK^LZ3IUTMG)IEM ZLT8?S9959AN!_@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHY'MFD(C<QNLD3QLK8!P58 C@@].]1Z9K%EJ_P!K^Q2._P!DN&MI@\;(5D4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS:Y.YEM$C5T\KDREL!%7U+$@#ZU6EG\3Q:6U[]GT][C9O-@H?*^JB7.&(_W
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MC,SL/E(R<@@\>M)\,XI['P';6]Y:W5M/#+<,\4T#HP#3.PP",G((/'K7944
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M@U;QWXP&IV%Z;"[^R"/S%FBAN D6'!Z*X!XP<UWT<<<,211(J1HH5448"@=
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M)"(,L0"?T%<[X%5UT.\=XY$$NJ7TJ>8A4E&N)&4X/.""#^- '34444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(-N"LK%6 /<9!K7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH RO$FBCQ%X>O=(:X-O'>1F*215W,%/7&>]7+:T\O
M38[.X99PL0B<E,!QC'(Y[59HH YJV\+3V&D'1;#5Y8-*P4C3RPTT,9_@20G@
M#. 2I('?I3;WP;!(V@KIUR+"#1&+6L*1!QG84^;)Y&"??/.:Z>B@#G[;PNL>
MOW&O7-_-<:I):_9(I"BJEO'G=A% ZEN26)Z>E;%A!/:Z?;P7-V]W/'&%DN'0
M*9& Y8@<#/M5BB@##\3>'CXCM[*'[8UJ+2\BO%98PQ+QG<H.3TSUIK>&4O-8
MM-3U:\EOI;(E[6$J$AB<C&\*.2V. 6)QV K>HH Y?3/!\NDZG,UKK=XNDR7#
M70TS8FU9&;<</C<$W<[0?T)!>/"*3ZG:WU_=_:9;2.:*&01!)2D@(*N^?F !
MX&!V)R:Z6B@#D[3P6UK8^'K3^UI94T.4/ 7A7+!8S$JG&. K'GKGGVIK^""^
MGW%F=3;$VK#52WDC(D$@DVCG[NY1[X[UUU% ''3^ S-/.RZW=QQ2:HFJI&(H
MSLE!!(R021QP#T]ZEOO Z7EIXBLUU2>.UUQB\T?EJ?+8HB,RGKR$'7@<]>W6
M44 <\WAF6+69M6L=1-K=W5LEO>8A#)+LSL< GY7&2 <D8/(-,L_!]OIFHZ5<
MZ?/Y,.F6+V,$#)N!5BI+,<@DY13^?K7244 9/AO1!X=T*#2UN&N$A+E9&4*2
M&8MSCW)K6HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1WH 6BHXIXIT+0RI(H8J2C @$'!''<&F6][:7;2+;74,S1';((Y Q0^AQT-
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M:_M8[JSN(KBWD&4EB<.K#V(X-34 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0X.*O:I.=9\2PZ597%FS:<GVJZBF^<%F#)&I4'L-['/0[#0!M?VG%+H@U6S
MN(7@%Q%AL;T*[A@_2N>A\=[O#%OXDGT2]329HA.TL;)(T,9_C= <X'4[<D>E
M8GA#4H-&TGQ%X0OKVW$VB&00GS  ;9UWIU/\.XJ?3 J+P_XBTRV^#&G6B3Q7
ME_)I8@CL(&$DTDA3:$V#)ZGGT[T =9?^+%M]7T>PL[(WO]KQ236LT4RA"J*K
M$G/J&&,9S4UAXGAN]9GT2XM)['58H?/2WN"N)H\XWHZD@C/![CTK@[2&/POK
M?PUTS5;VWBN+/3[M)S)*H",8X^,D],Y ]<5MS.GB+XHZ/J>FL)--T2TN?M-\
MO^JD>4!1&K=&*X+'&0._- %@?$:"+1I=:O-)NH-+AO&LY[@.C^4RR>669<YV
M[N,C)YZ5L:OXC?3/$&EZ.E@UQ-J2RM"ZRA0/+4,V[/3@C'6O++&/SO##ZG+.
MVI>'[37;N75-,C((\OSV9)AM&Y@IPY4DAASCBNI\4:KI5[X]\$SQZS!';M%?
M-]HBN$  ,:8^8\<T =7>^)#I6FW=YJ>GS6_DR1QQH'5O.:1@J!6R /F8 YQC
MKTIPUZ:VN9H=4T][1(K5[MKA9!)$40C< < [AG)! ]LUAW=SX9D\.ZK8:A?C
M5]->>,7<KRAPGG.%4%UZ;3@\8VC:?>LO1Y[GPYK5WI,>KGQ%X<73);H>:RRR
MV@7&(VD'#*X)P#S\I[ Y .KL?$ES=G2I6TB5+35.8)UF5]@,;2 R ?=R%[;A
MD]:Z"O+=.@C\,Z[HH\(:V+[1-2NA')HSR>;]G0@EI8C]Y N.5/'..N*]2H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1LA3M )QP"<5R
MMAXQN=1L;V\M_#]Y-%97,MM*L4L;2,T;;6VJ2,C(XYR?2NJ9@JEF(  R2>U>
M<^!/$FC:=HVNR7.IVJXUN^<() SN#*2-JCEL]L#GM0!TI\::/)H6GZK:2/=Q
MZC((;.&)?WDTA)&S!Q@C!SG &#FIF\0M9:G96&KV@LVOF,=K,DOF1O(!GRR<
M JQ ) Q@X.#GBO--+T+4M$3POXDU"UE@M(M8O;NYMF'-I%<J51G'8+P3_=W<
M]#76>-#%XEO/#>EZ5/'<W$6K07\SPN&$$,6278CIGA1ZD\=#0!J6OBNZO=1U
M>RMM#GFDTN589MD\8WL4#C9N(SP1UQ6GH&OV/B/3VN[$R+Y<K0S0S)LDAE7A
MD=>S"N0\,:[I%EXN\;O<ZI9PJ;^)@7G49 @0''//((^M5=#NYM)M?$^OOML3
MKVIA=*BNQY98D"-)"IP0"?F(Z[1F@#M=%\2V&NW^K6=HS>;IES]GF#=SM!W#
MVSN'U4TOB7Q'8^%=';4]0+>2LB)A!D_,<$X]AEC[*:XFZC;P)XQT#4;NYLX[
M"_A&CW&S*G*@M%(VX\G.Y2W^US6[J"IXLUF]LK6>QGL[&!K6>.3+@RRK\W"G
M@JA S_TT8=J .EU#4[/2M+GU*]N$BLX(S+)*>0%'?W_K65)XAOHM*.JR:%<"
MTV>8$$J^>JG^)DZ 8Y.&) [=J\\=KWQ%\(-5\,0RI>ZWH,RVTL4;9:YC@E5E
M('4[D4?5@17I-EXKT34K&*XM+^&<RCY8$8&7=_<*=0P[@].<XH V20JDD@ <
MDGM52SU!+G2(]1E MX7B\[YV^ZF,@D]N,$^E5M?)DTY;!"0]_(+48Z[6R9"/
M<1AR/<5%XMTRXU?P9K&EV1"W%S92PQ#.!N*D >P/2@""T\2W.HZ7_:UAH\\^
MG,ADA/F!9IT[,D9XP>HW,I([59U/Q':Z5X3E\07$<GD);"?RE&78D#:H]R2!
M^-97A'Q-I#^%-.ADNX;:[M;:.WGLY6"S12*H4H4^]G(X&.>,=:?J%R=;\06^
MF64MINT^,7=U!<?-AG!6-2H/8;R1V.SVH WX]3LY=)35%N$%BT N!,3A?+V[
MMQ/ICFLJV\17E]I?]K6>BSS6#)YL0,@6>9,9#+&>.1R S ^PZ5P-E;7-WX'\
M6_#B&[A?5=.5X[-5DQYD#CS$49/;)0^G&:Z&Z\56TGPNN[NROA8:G:Z<P$#,
MJ307"1\1E&[[AC!'/&.M &S>>*VMM4T6PBTYYY-7ADE@(E"A=BJS!L].&&.O
MX5KV%Y<W+SI=6+VKQ$ 9<.K@C.01^(Q[5YUJUW'_ ,)1\._[2U4V]Q]BNGN)
MI)5C<,T,9YR,#)R.E=MX=N;!C>VMCJAU,QR^;).9!)M+YPA8<9 '3L"M &Y1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 48'I110 8S1@>E%% "8'H*7 ]*** # .,CIT
MHQFBB@ P/2C HHH ,#THHHH ,#THHHH ,48'I110 8'I28'I2T4 %%%% !11
M10 4R6*.>%X9HTDBD4JZ.,A@>H(/44^B@#&T/PW:>&XVMM*DEAT]G9ULV.Z.
M(GD^7GE03SC)'H!6L8HVD61HT+KT8J,C\:?10 8HP*** #&*,#THHH ,#THP
M*** #&*,#THHH **** "BBB@ HHHH **** "BBB@ P#VIJ1QQJ51%4$YPHQS
M3J* # ]*3 ]*6B@ P/2BBB@ P/2FR1I*NV1%=>N&&13J* "C%%% "8'I2XQ1
M10 8'I1110 8%)@>@I:* $P/04U(HXU*I&JACD@#&:?10 T1HKLX10[=6 Y-
M.HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *,#THHH
M *:D4<0(C14!.2%&.:=10 8'I1C-%% !C-&*** # I@BC61I BAVZL!R?QI]
M% "$ D$@9'3VI:** &>5'YGF;%\P#&['./K3\444 &!3##$T@D:-"XZ,5&1^
M-/HH ,#THZ444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !117&:)/?2Z9XEU!;F[FO
M(;V]@MURTP4(YV!8BP4D8  XSTS0!V=%>?>$M7\1W<FK"]$P6-)V7$ EVSAA
ME ?,XV]H^1SPYIW@K5O$5]KM]%J2S"W5V,FZ$$1R^7"=F=Y\O@[M@##+-\YQ
M0!W]%><^&=8\37?BU[>_$_D$+]H#6X'E_(Y3*>8?)W8SP7R0 =F<5O\ AYYH
MO%7B*P-S<2VUM]F,*SS-(4W(2V"Q)Y- '3T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !117,:B\UQ\0=+T\W-PEJ=-N;AHXIFC#2)+ %)VD9P';
M@\<T =/17G.IZSXFB\=1VMNL_P!F_>"-1; [HM\ 9]GF#?MW8#Y4@.V%;%'B
M36?$UMXP6WL5G^SC=]G"VP.\;8]Y">8/.VYSDE,$G&_&* /1J*\_\::OXCL=
M?LH=,68VY<>4%A $DOE3'8#O'F\#=L(491?FR:T]2ENK?Q!X3E6ZNE:]N7BN
MHR[*C@6LKX,>2%.Y0>/3K0!UM%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 45@^,EO/^$6O9-/OI;*\C3=#-&1\K9&,@@@CVK!MO$UWJWAZ[LKYG
MT[Q%IL\,5[%"V/O.H\Q/6-U)(],^HS0!WE%9DLDDFNVEG%(XBMH6GFPQYSE(
MU;U!_>'ZH*YR\\37]IX^L$<J/#]R[Z8&Q_R^ !PV?0X:/_>4T =M1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7*>!Y(S#KD8=?,&M7I*YY \T
M]JZNH8[2VBG>>.WA29_O2*@#-]3WH FHHHH *Y70)$E\<>*FC=77_1.5.1_J
MS755#;VEM:!A;6\4(;DB- N?RH FHHHH **** "BBB@ HHHH **** "BBB@
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M;2X&1N"E2I&1D=SCZT 9.DMX@UOPK;ZT-4-K?7EN+J"U6*-H(PPW(C97>W!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN
M+\=:AKN@:!JFM6>HQHD+PK;VYMU889D1BQ/).68\>@H [2BLA);C1A<3:MJ:
MSVK&-8"80KAR2"N%^\22N !GG%(?%&CKI]_>M=,L6GG%VK0N)(3@'YDQNY!!
M''(Z4 ;%%(I#*&'0C(I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFP75O=(&MYXI5.<&-PPXZ]* ):*ACN[:65XX[B)Y$.UE5P2I]".U34 %%%%
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MG1RQS F*1' X)5@: 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZQ9W#WEI$,1J\>"LH4<*QSM)'7ZUT>J>&AJ?B#3M9&I75M<:>DJ0K$L97$@
M;.Y3G[HIUGX9M[34+K5#=7-QJMQ%Y/VV<JSQQ@Y"(H4*JYYP!R>N: .)\6ZZ
M+/Q);^)H[MQ;Z+>"SEMP"5D@?Y;B3IR58I]/)/K78^*-+TZ\T34[^:U@GG73
MY4CDD0-M7:Q^7/3GT]!Z5.OAV'_A%'\/R7$LL$ENUN\SA3(X8$,QXP6.22<=
M3FDMO#WV?PF/#YU&[EB%N;87$FPRA-NWKMP2!WQ0!S&C:-IJ_":ROUL;=;IO
M#@C:18P"ZM"K$$]^5!YI?!EO'-X7\(QOX<4(;2W<WI$>598@RL-IW<D#KZX/
M6NFMO#L=KX13PZEY<&W2T%HLQ">8(PNT=L9QWQ4%AX6DL-+L-,36[]K*S6*-
M8BL0WHF,*S! <$  XQD?6@#H:*** "BBB@ KAKR5M5^,%OI%Z ]A8Z1]NA@8
M95YFEV;R.AV@8&>A8FNYK(U;0(M1O+;4K>9K35+172"Z10WRMU1U/#(2 <<'
MC@@\T <WJ/\ Q)_BOH,-BBI;ZU:W27T*C",8E5DD(Z;N2N>X..PJ7X3PQ)\-
M[!5C109KK("CG_2)!S5GPUIVIIJT]_XE@$NM!3!%=P<V_D9W8C7JF>-V[DD#
M!(P!:M/"C:8EQ;:9J]W9V$\SS?9T2-O*9R681L5)4$DG!SC)QB@"I87T>A?#
M:QGMTC20VL:0*%^4RO@+D#MDY/MDUG?#R[2PO]9\*-=R7:VDOVNSFFSNE@E)
M+9SU*R;P3[BNI;0HA/I1AN)8;?3!B&V4*4/R%!DD$\*2!@]ZBOO#<=[XHT_7
MUO;FWN;*)X D039*CD$J^5)(R 1@C!H XB!KCP-JFH:_ &D\.7>H3)J=LB_\
M>C!RJW" ?PXP' ]CS74^'M*TC4=.^U/:6MRBWUZT+%%=,/</\P[<@#GT^M;%
MAI"65M=V\L[W<5S+)*ZS(N/G)++@ 9'/?-1Z%H%IX<T--(TPO%;1M(T0)W&/
M>[/@9[ M@9["@#D_A;HVFR^!=&O6L;?[5#+<E)A& W,LJ$9ZD;3C'TH^&6CZ
M=>_#[2VNK*";R;F[9%DC# ,9Y%S@]\<9]*Z?PYX=C\,Z!'I%K>7$T41<QR3!
M2Z[F+'H #RQ[4>&_#L?AG0ETFUO+B:)&D9'F"EE+L6/0 'ECVH Y?X:Z)I=Q
MX6CN9+"V,\.I7ICD\I=P_?2KC..FTD8]*K6EG<>$_$=SX.T^)%TW7/,NM/E
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M74EE=72JMR%57CFVC"LRG^(#C((XZYP, &#X4EDLO'_BO08.-,MQ;74$0^[
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MSJ&IW5]#I\RSP1RJ@)D4$*SLJ@L1DD=.>N:WZ "BBB@ HHHH **** "BBB@
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MD)PP4*-N8SC@#UI\?A"QM=(ATVQGN+6%;I;N9@0[W,@<.3(S ELL 3],=.*
M.6\(ZG)IOCJYL;N[:8:_ -04-G$5THQ+$N1R FS'LE:?Q"_XFMD?#\-\]G,\
M+79E3.0R?ZE3@<9D ;Z1D=ZW/$'AN+7Y=,F:\N+2;3KH74,EN$W;@",'<I^4
M@D$=ZMV&EFROKZ[>[FN)+MU8B0*!&%& JX ^7J<'/))[T <-K_C2ZO/@JWB"
MP=K:\N(XH)77@VTC2+%+]"I+8_ UU\OA31I="72!91+;(H"$*-RL.C@]=V><
M]SUJI9^"=/M[;6[.XFGO+#6)I)[BTF"[%=_O%-H!&< ]>O/6K-AH%S9VR6<N
MMWUU9Q@*L<RIO*CHK.%!8?D3W)YH OZO>/8Z5<3Q -.%V0J>C2,=J#\6('XU
ME:_/+X6^'VH3V&7FT[3G:%F&<LB'#'UY&36S=V:7;VQ=F"P3";8.CD @ _0D
M-]5%32Q1SPO#,BR12*5=&&0P/!!'I0!S/AG0-,G\#6$%S;Q78O;2.6ZEE&YK
MAW4%G9NI))Z]N,=*A\60VW]@6GA9[R2"*^B,$LR@EU@10&/'<G8O_ S5[2_"
M\FC6JV%EK-\FF)Q%;,$9HE_N+(5W;1T&<D#H1Q5^UTA;75Y[\74SB2!($@8+
MLB1"2-O&>=QSDG/'H* .'@\97Z_!C4=50[M:TJ"2TG.,XGC^7?@^H(?\:V39
M:+HWPV>:YT_^T+)+'[3=D!6DN/DW/(2Q&YCR<YSZ5HVOA.UMM:UJ_:YFFBU@
M*+JRD5#"<+LR!MSDKP>>>]5QX,">'I_#T.KWBZ1+"UN(6".\43#!1'(SC!P-
MVXCUH YK5F@NO%7P[N(]-DN$DL[LK!-Y9D*^3'MW$G;G'/6NVT&!46[F_LE=
M,DDG(:)=OS!1A6.W@DCT]AVJG=>$(9]1T6]AU&[MGT>%X;58Q&PVNH4[MRG)
MPHK4L-.EM+BXGGU"YO))@J@S! $5<X"A5 ZDDD\_D* +]%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M* "BBB@#,\0:PN@Z-+J#0-/LDBC$:MMR7D5!S]6%4M;\4Q^'[&"6_M76XF(
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M+_D,^+_^PS_[:V] '44444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTFXL(;I;=;B-HI',6\[&4@XY&#SUYJS8VJV.GVUHK%E@B6(,>I"@#/Z58HH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "L?P_HDN@V\MJ+P3VK3S3QJ8MK*9)6D8%L\
MC+D#@5L44 %%%% #7#&-@C!7(.TD9 /TK*T/17TB34II;K[1-J%W]JD81[%4
M^6D> ,GC$8[]ZUZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7,RW-PEK&( I/F.<*#EAU/&:9%XGL_[7@TF]AN=/OKA2UO'=( )L<D(ZEE)
MYQG/M0!M4444 %%4GU$$6+VUO+=P7;8$T)4I&I4L'8DCY3@#C/45=H ***IW
M>H""SO)K>"2]FM1AK>W*F0MM#;1D@9P0>3WH N44@.5!((SV/:EH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ6<K3710A<*KQ+$./+&<Y/).3CH:IWPCL?#/Q,GM;VYM[V*]FDC,=Y(K@>1
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M9W@?6;34+BZFU>6.*_B>4LD@>%G=@F<(493]T# !!K-NO^13UW_L<$_]+(:
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M8R.V8UE9%@,6=N63:0V,Y.: .\OKS[#;K+]FN+C,B1[+=-S#<P7=C/09R3V
M-3B1#*T0=3(H#,N>0#G!Q[X/Y5S/CVYN;/0;:XM+J:WD&I6:$Q-MW*\Z*RGV
M(8URNHWCZ#JGQ!U2VFG$\!M-I:9W$:M&N]@A)!V@LPXXQQQ0!ZE17F7B%K_3
MO#/B/4+#Q,SPMI?VBWB@G>5HG7/[Q9&8D*P(&/8D=ZT&LKB7QU+I+:SJHL[K
M2!=R*MVP(E$FW<I'*<'HN <#B@#O:QT\1VTVIK9P6MY,AG>V:ZBB#1)*@RRL
M0<CN,D8SQG-5/ M]<ZOX T6\OIFEN9[-#+)G!8XP3D=ZXJRNWT+PW?S6LUQ&
MEQXJDL[B=IW;R86NBK-\Q(!QQNZ_-G.: /6**\S\3WFJ:0_B^QL;^\%I!H0U
M"&4S,[VT^9%VAVRV&";L$\8.,9KN-"L&LK'>]]>7;W&V9FN9=^TE0"%_NKQG
M'J30!5E\6Z?%'-.(;R2SBF,#7<4!:/S VTKQSPW!;&T$'GBK,7B"TF\1S:$L
M<_VV&$7#@I\HC)(#;LXY((QUXK@=3AOO"6GW_B3PY>QZAX<DFDEOM&NN=I+D
M2^2_\)W9^0\9S]*W[5@GQDO=X*>?H,#1AN-VV:3=^6Y<_44 ;USX@MK6;4(Y
M+>ZS80"XG*Q@CRSNP1SS]QN!SQ]*JP>,])E@TZXD^TV]MJ106D\\#+'(7&4&
M[HI/;=C-4]582/XMD0@HFEI"Q'9PDS$?7#J?Q%<+JJWMG\)O"&I7=U%=Z;;+
MI\CZ8D7ER7/"!%5\G)!(. !G:>E 'J=WKMK;:B--B2:[O_+\UK>W4%D3. S$
MD*H)!QDC.#C.*HWOC/2]/TR^U"Z2[CAL)5BN@;=MT3-MQQU(^=>5R.>M8O@Y
MC;>/_&MK>G;?S74-S%NZR6WEA4*^H4@@XZ&G?%-[=OAWKWEE#*OV=92.Q\U"
M 3ZX/3W'K0!VJ2EX!+Y4BDC/EMC=].N,_C7.GQWI T&YUMDO!IUK,T,\WD$^
M6RMM;*CG /!.,5T,MQ#!)"DCA7F?9&O=C@G _ $_A7F_AQ4D^'.K(ZJR-K5R
M&##((-WT- '>W>LVMKIL.H#?<6TS1B-[<!]WF$*A'/()8<^]7M^(][!A@9(Q
MDC\J\OOH+GP->6^AJDDWAO4M1MCI[C+&QF^T(QA/_3,X)4]CD>]>I4 9NF:]
MI^KZ7)J5M*PM(WE1WF0Q[3&Q5\AL$8*GK3-.\0V.ISQPQ>;&\T'VF 3)L\Z'
M(&]?;D9!P1D9 R*X-;>YNO@WXL@LPS3O<:H%5>K#SY,@?49%6/$<<VIZOX57
M1CN?^Q[^12AZ(\"*GX%V3'TH [&Q\3:;J%S;Q0N^VZWFUE9<)<;/O;#WQUYQ
MD9(R.:GBUJRGUV?1D:3[;! L\BM$RKL8E002,'D'IGI7G]L#<^'/A9!9@^<D
MT#L!U5([9Q+GTP3@^YQ730_\E:O?^P'!_P"CY: -W4]8L='6U:_G6$75REK#
MG^*1SA5J+7M=L_#FF-J-^)?LJ,JN\:;]I9@J\#GDD#\:Y;Q9I-SXQ;5+&"V2
M6"V@-M;S&;9Y=T=KEQP<[<1 'UWBLCQ-KK^(_@;)?R 1WGF6T-TA'^KG2YC5
MP1_O GZ$4 =[#XBL9-6BTN83VM].C20Q7$13S0OWMK?=8CN <CTJ35=;MM'E
MT^.Y29C?72VL1C3(#MG&X]AP:XS7A>6'Q*\(7&I7,>HI*\\%M!#'Y36[LGS3
M$9.\;>#G 7.>:UO'\9E7PW&)'C+:Y;C>F-P^5^F: .OHKS:'49K*+6=+EU:_
M*0^(8;.TS*7FD5XXI/)\QB"H)+_-G('3/ IMCJ&NW.D:G;VEPES=6>OR0):/
M?,&GA6,.84GQNR"203_=P>* /2F;:I;!.!G &36?H>LVWB#2(M2M%E6"5G4"
M5=K H[(<CZJ:I^$-1CU/P]'/&+U66::.2.].98G61@R,<G.T_*#DY %>?:+%
M?:?X3T#5]/U.]%P^M/;&R\S,,L3W<BNNS&,A=S;NHP><= #UZBO.M&O[[77M
M=4&O):7,&JR07=J9';<HD9/(,6=JG&TAL9XSW-)X>O;[7XM,UC^WTMI_M<D-
MY:>8[ECEE,/E$[49>"& SA<G()- 'HU%>5Z->:E'IGA/5)-8U">>YUN>QF66
M<M&\6ZX !7H2-BX/48QG'%==XPU=M,?0X7G:VL[[45MKFX5MI12CLHW?P[G5
M5SZ$]* -35M;MM'DL$N4F8WUTEK$8TR [=-Q[#@UI5YUXCM/)M])M$UBXNQ_
MPDT&UW;>]L&4GRPQSNQG()R>?:HHM1GLVU?29=6ORD7B"&TM 92\LJO%')Y/
MF,<JI);YLY X&>!0!Z517E*ZKJDFBF(:K<Q20>+$L0T5QYA$+2J-A=AE@-Q'
MS>G-6KJ_U33(?%EE::C<R166HV0C,]P6E$4HB,D:.QSN.Y@HSU; [4 >F45Y
MQJ5]JVB:;XDUI+R[73/.MH[/[0[,88F:-9Y,-E@!N8C/3!XQBF:SJ-]X=T^_
MNX-?2:SNY+-0%D:;["DDH1YA(Y8X*DX!X!&1WH [B'6[:;Q#<Z(J3"ZM[=+A
MBR80H[,HP>_*G\J=J6KPZ:\$1BEN+JX+""WAV[Y-JEFQN(' '<CJ/6N9TFUB
ML_BOJL<4TTBMHMJP\Z9I2O[Z88!8DXXSU[TOB.RBG^)'A0M)<*7AO?\ 5W#I
MT1,8 .!UY]>^: .LT^\34=/@O(XIXEF0.(YXS'(N>S*>0:LUY1]OU33O!>N>
M(AJ^I37-I?W5DHDEW1Q0_:]F_;C!9$!()Z?2MO5);[3/$5S86%]=O87.B3W3
M%IVD:"6,J%=78DC<&(QT^7([T =Y17F.EB^GN?!(DUG5&76=(=KT?:F^<K%$
MP*_W#EC\RX)SR<\UL^$WEU+PW9?;]8NUDL]6N(HY#/A[D1S2HD<A/WQM R.I
MV@T =K1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 55O\ 3+#5;;[/J-E;WD!(/E7$
M2R+D>Q!%6J* *EUI6G7MO';W=A;3P1,&CCEB5E0CH0"."*9_8NE;KMO[,L]U
MXNVY/D+F<8QA^/F&/6KU% %/3-)T[1;3[)I=C;V5ON+>5;QA%R>IP.]*NEZ>
MNHMJ*V-L+YEV-<B)?,*^A;&<>U6Z* *-KHVF6-RUQ:Z?;03,6)>.(*<L<MT]
M3R?6HCX<T,P20'1]/,4DOGNAMDVM)UWD8Y;WZUIT4 49]%TNYNUNI].M9+A5
M"B1X@6P#D#/< \CTJU)!#,\3RQ([0OOC++DHV"N1Z'#$?0FI** (/L5KY,T/
MV:+RIR6E38,2$]2P[YJK'H&C0M;-%I-BC6JE+<K;H#"IZA./E!]!6C10!R&O
M>#8KM;*+3M-T-K&!I'DTZ[M (9'?'[P%1PP^;L<[CWQ6IX:\/0^'[2:.&WM;
M;SW$C6]FA2&,X ^4'OQR>,^E;=% &4_AC0))YIY-#TUY9CF5VM4+2?[QQS^-
M79K"SN+%K&:U@DM&3RV@>,%"OIMZ8]JL44 9<?AK0H=+73(]'L!8*_F"V^SI
MY>[.=VW&,^]6HM,L(+Y[V*RMH[MT"/.L2AV4= 6QD@>E6J* (XK>& RF*)$,
MK[Y-J@;FP!D^IP!^59UKX9T&Q6[6UT;3X5O/^/E8[9%$P]&&.1UX-:M% &+J
M&FZA%8VMAX>;3]/M1F.4- ?W<9&/W2J0 P/KQ6I:6L-C9P6EN@C@@C6.-!T5
M5& /R%344 9MUX?T>]GDGNM+M)II<"1WA4M( ,88]Q@ 8/%+J.@:/J\<$>I:
M79W:6YS"L\"N(S[9''05HT4 4I-(TV6[^UR:?:O<^7Y/G-"I?R_[N[&=OMTJ
MM<>%] NM-BTV?1=/DL86W16[6R>6A]57&!^%:U% &==Z!H]^+47>EV<XM.+<
M20*WE#&,+QP, <#TJ-O#&@O9VUHVC6!MK9_,@B-NFV-O4#'!K5HH S1X>T54
MB0:18[8IC/&/LZ?)(>KCCAO?K2_V!H_]L_VQ_9=G_:>-OVOR%\W&,?>QGIQ]
M*T:* *U[IUEJ4*PW]G;W42L'"3QAP&'0X(ZBF?V3IQO9;PV%K]JEB\F2;REW
MO'_=)QDCVJY10!DV_A?P_::?/86^B:=%9W#;IK=;9 DA_P!I<8/XU8_L32OM
M N/[,L_/$7D"3R%W>7_<SC.WVZ5>HH KV=A9Z?:+:65K!;6R#"PPQA$7Z <5
M!%H>D06EQ:PZ791V]R29XD@4)*3UW#&#GWJ_10!GC0M)%C+8_P!FVAM9O];"
MT*E9.WS CG@ <^E7(8(K:!(8(DBB0;41%"JH] !TJ2B@#,'AS11.)QI5F) _
MF[A"O+YSN/'+9[]:FO\ 2-.U3RC?V4%P8B3&TB E">NT]1^%7:* *:Z1IJ:<
MVGK86PLF!#6_E+Y;9ZY7&#GO4%MX;T*SEAEMM%TZ&2'_ %31VJ*8_P#=(''X
M5IT4 4=0T;3-5>)[^PM[EX23&\L8+)GKM/4?A23Z)I-UIXT^XTRSFL@<BWD@
M5HP<Y^Z1CKS5^B@#,MO#FAV<XGM=&T^"8*4$D5LBL%/49 S@T)X=T2*T>TCT
M?3TMI'\QX5MD",W7<5Q@GWK3HH BDMH)85ADAC>-2K*C*" 5(*D#V(!'IBI"
M RE6 ((P0>]+10!5LM-L=,B>.PLK>UC=B[+!$J!F/4D =:2STRPT]G:SLX+<
MO@,8HPN0,X'';D\>YJW10!4@TRPM;F2YM[."*>3.^1(P&.3D\^YY/J>:5=,L
M%U%M16RMA>LNPW(B7S"OINQG'M5JB@"M::=8V"2)9V=O;K*Q>00QA ['J3CJ
M3ZU2_P"$6\/?9Y;?^PM,\B5_,DB^R1[7?^\1C!/O6M10!1M-$TJPN#<6>F6=
MO.5V&2&!4;;Z9 SBI+S3;'43";VRM[GR7\R+SH@_EM_>7(X/N*M44 9DWAS0
M[B*XBFT>P=+EQ).K6Z$2N.C-QR1ZFC_A'-$"NJZ18J'D65MMNHRZC:K<#J!P
M#VK3HH BM[:"T@6"VA2&)<X1%  R<GCZ\U5M]$TNTNVNK;3K6&X9BQDCB53N
M/4\=SW/>K]% &<F@:/'K#:NFEV:ZDPPUV(%$I&,?>QGIQ21^']&AU675(M*L
MDU"8%9+E8%$C@]<MC)S6E10!FIX=T2.*")-'L%C@D,T*"V0"-SU91CAO<<U:
MOK"TU.SDL[^UANK:08>&9 ZM]0:L44 9J^'M%6SM;,:38_9K1M]O%]G7;$W]
MY1C@^XI)O#>AW$=PDVCV$BW$@EF#6R'S''1FXY(]36G10!E_\(WH6&']C:?A
MI5F(^S)S(!@-TZ@=#6=XA\*PZC8RKIUII<<\\\<MVMS:ADO%3G9(1R><'//3
MH172T4 <MX>\'VFE27$[Z9I5G]HA,,MKI\1$4BD\E\@!CV'RC )ZYK6L_#NB
MZ?ITVGV>DV,%E/GS;>.!523/!W+C!X]:TZ* ,VP\/:-I4PFT_2K*UE$8B$D,
M"JP0$G;D#.,DU/<:5IUU>0WEQ86TUU""(II(E9XP>NUB,C\*MT4 4[;2=-LK
M>:WM=/M8()RS2QQ0JJR$]2P P<]\U';Z'I-K:RVL&FVD<$J!)(UB7:ZCHI&.
M0,GCI6A10!GIH6D1O:O'I5DK6BE+<K;J#"IZA./E'L*2/0-'ACBCBTJRC2&?
M[3&J0* DO/S@ <-R>>O-:-% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MACA*O;$QL=H^;((<*"&&3G/%=E0 4444 %%%% !1110 4444 %%%% !1110
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M"[VBE90'1E'."5!! (Z@X[]C10!RWAS1;I/$NN^)+Z$V\NI>5%#;,06BAB7
M+$$C<Q). 3@8[YJQ=VESJWB=1(+VTM;"'=!/'M EE?(8\Y^ZH ' SO:NAHH
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M"R9(X&035W4!JVH_#F]T'4-$N&UEK![51&JO#++L*K(KYPH)P?FP1Z<5WM%
M'G-]H%Q'J_@=9-$:[L]*LYX[M4C1D1VB15P"1GYE/2NNT)4A:Z@MM'?3;)6#
MHK*J[W;)<A5)P.GIDD_CL44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>exhibit1027supplycontrac012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUL$9'H<$_G7->,/^0CX3_P"PTG_HB>@#J**** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@"G9Z5I^GR2R65C;V[RDM(T484L2223CKDDG\:N444 %-=$EC:-
MU#(P*LI&00>U.HH JV.FV.F1R1V%G!:I(_F.L,80,V ,G'4X &?85:HHH **
M** "BBB@ HHHH **** "BBB@ JG=Z5I]_/#/>6-O/-""(I)8PS)G!.">F<#\
MA5RB@ HHHH *IS:3IUQ?17TUC;R7<1S',\8+H<$9!ZC@G\ZN44 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 45B^+K^ZTGPAJ^IV4BI<V=I+<1[EW*2BEL
M$>AQ6=9:O<K:6FHW.MVTT*6AO+V 0C<L?EDY4@\8;'7J,^E '5T5R>C7FO>(
MO#4.NP745G+=Q^?:6;1!XPAY02-]XDC!)4KC/0XYQW\<7>JZ3X2U/395LX]7
MOOL=U%*@<Q,%DW8/'(:,C/<=J /1**Y32O$-XWC34= N)K>]M[:S2[%Y FTQ
M$L5\J0 D;L#<,8X[5T.G:C::MIT&H6,OG6MP@>*3:1N4]\'!H M45S'CK5M0
MT71[2ZTV=(Y9+ZWMF\R,.I620(3CCD9R.:KZUKNK>%+[3)=0EM[W2+VZ2SED
M6(QRV\C\(YP2K)G@\ C/>@#KZ*S)O$.E07T5G+=;)99OLZ,8V\LRXSY>_&W=
M_LYS2-XATU9&02RNR^8!Y=O(P8QYWA2%PQ&",#)R"* -2BN4L_%EGK6FZ#?P
MW\FG+J%POEPRVY)N 4)\L$CCC!W#CY2,U='C3P\;D0#4D,GVK[&<1N56;@!6
M;&%R2 ,D G@4 ;U%94WB/28+_P"Q27@$WGK;'Y&*+*P!6,N!M#$$8!.>1ZBL
MFY\8V-Q!XB@6[GTPZ7F)[Z6U9EC;8K;P"N#C<.#UQGIS0!U=%9=SKNGZ?"GV
MJZ9F\CSF\N%W;R^[LJ@E5]SQ^517/BO0[22VCDU",O=0FXMUB5I#-&,<IM!W
M=1P.3F@#9HJKIVHV>KZ?!?V$ZSVLZ[HY%S@CIWY'/&#5J@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#"\:6EWJ/@
MK6K"QMGN+J[LI8(HU95RS(0.6( '-1:;X<LI/#*6D^G)9SSZ?]CN0BJ'P5PP
M)7(/.?6NBHH Y#P]_;7AWPK;:)-I,MY>6$(MH)HG00SJO",26RG&-P(R,'&[
MC//R^"KW2="\'Z5#8-JHT_43>W[H8PK%EDW8#L,_-)P/05Z?10!P^E:%>P>/
MY]9L]+.D:5]A,4MJ'C!NY]V0^Q&*C XW$@GITKKM.N9[O3H+BZLWLIY$#/;R
M.K-&?0E>#^%6J* .3^(&GZAJ>B6=OIUC+=RIJ%M<,J.BX2.17;[S =!Q4/B'
M2M2\7W6F6,MA)8:5;7<=Y=27$B%YC&<K&BHS<$XR21TXS7944 >>:5HNH6NI
M3Z5J/AI+V)=2DO;;5'F1H@CRF4,REMPD4L0,+R0.0.:GT[0]4M/$XN+&&\L[
M">>Y>_L[B1)(,D/MFAY)1F8@D#C#-D ]>\HH \VT_1=<C\+>!["71YTGTB^B
M-T/-B.$2*1"XP_()<8'7&>!27>A:U+X?\06R:3.9[KQ#'?0+YD7S0B6%BV=_
M'$;<'GI7I5% 'FNMZ7XAOK^X;^Q)W$&N6E[ 8)HHXI8$>,DD;@6E^4YW\  8
M/K-J>BZU)9^/[*+2I)3JZ%[2198PKEK9(MO+ @AE.<@#'>O1** .+L;+5=(\
M4W&IMIT]U::AIMM"R1LA>WEAW_(06 VMO/()&1SZUGZ#X7U30K[P?$UJ\\.F
M6%Y'<RQNFV-Y6C94&2"0-K#..PKT2B@#F_ EA>Z9X4AL]0M'MKA+BX8QLRM\
MKS.ZG*DCHPKI*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZBB[H=38*03YHY9FR6*OSG'>O5: "BBB@ HHHH **** "BBB@ HHHH ****
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MCC\ZW&SM.T@-C@D9%+10!RFF>$M0TNPO;*WUYHXKRZFNI)8K4"5&E8LVQBQ
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M8H,*^T,I# <9!P1U!P*W** ,G1]"BTNYOKUY6N-0OW5[FX8 ;MHPJJ!]U5'
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M&  JKDX'&>IY)J[10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.[;M8]"2,BKVC:Q#K=B]U!%-$$GEMWCF"[E>-RC#Y21U4]#0!H4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!2U;5+;1=+N-2O-XM;9#)*R(6*J!DG YP!56T\16=Y-9Q
MI#>H+P9@>2V=4;Y2_P!XC ^4$\U3\?\ _).O$O\ V#+C_P!%M5"TL-=D\($I
MJ$4IDT8QVL<4/EE)3'\ISN.3T&>,?C0!K-XKT[R)[F);F>R@9EFNX(&>)"IP
MW(Y8#!R5! P?0T_4/%&F:=_9QDDDE34G"6CV\9E65BI8 %<]0"?2LKX>W%G'
M\,-%<LD4-O8JEQOX$;H,2;L]"&#9S7!:1:W]OX*^',3'R)6UMI+<3(6V1,L[
M)E<@XVD<9'!% 'K.GZ]I^I7UQ8PR2)>VZAY;>:)HY%4]&PP&5..HR*TJ\\L/
MM-K\9+F#4YDO;N[T?,%Q;KY0M85DY1DRW5CG>6[8P*[?2K=;72K:!+V:^5(P
M!<SR!WE']XL  3[T 0:YK]CX>M8KF_\ .$,DJPJT432?.QPHP.>2<5'#XFTR
M75(M,DDFMKV92T,-U \1E Z["P 8CN 216'\3/\ D7+#_L+V/_H]*J_$T"Z7
MPWI]I\VK2:Q;S6JK]]%0DR/[*%SD^] '>T5YYI]_J6N2MJ$>L1V4]EK,EO<0
MM,S#RUE9%A,7W<LNTANN3D>E.@U"^7Q%_9NKF]5;V6[%E?6ETQM[E '81E00
M89$4=AR4)SF@#MI]0CA^RE(IKA;B;R@]NF]4X)W,1T7C&?4BK=>5Z!/<V/@G
MX=/:W]RHN[J".Y0REA(K02,0<Y(&4' P.M%S?:K!INLZH-:OVET_Q+';0QF0
M>68FEA0HR@<C#GZ=1@YR >J56O+V.TM+F<1RW#6Z%VAMUWR-QG 7N3V%<!K6
MLW<>K&YL=2N)$C\16EC(3)Y<<:L8U> 1Y(DX9F+D @MQG;52Z,MA8_$V^L[^
M[ANK=VDA<7#-M(M8G& Q(Z_D.!@4 >HHV^-7VLNX X88(^M.KBK:\N-;\47V
MBW-Y=6L=MI=M/;F"4QO(TF\/+D?>VE5&#D9)R#FL71]4UGQ!/X-%_J5W;_VC
MIMXUTMLPC$IC:,)(,#(W!MW'KQB@#T^BN:\ WMU?^#+.:]N'N)UDGA,LG+.(
MYG123W.%&372T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 5[VQM=2M'M;VWBN+>08>*50RL/0@]:?;6L%G;1V]M$
MD,,8VI&@PJCT ["I:* ,V;P]I%Q/)-+IUN[RL'DR@Q(PZ,PZ,>!R<]*??Z+I
M>JO"^H:?;730G=$9HPVP^HST-7Z* *5GH^F:>9C9Z?:P&?\ UICB53)_O$#G
M\:FLK*UTVRBL[*WCM[:%=L<4:[54>@%3T4 4]1TG3M7B2+4K*"[C1MZI/&'
M;L<'O26>D:;I\SS6=A;02N-K21Q*K,/0D#)%7:* ,S_A'-%.M_VU_95G_:>,
M?:_)7S.F/O8SG'&?2I;?1=-M+DW%O90QREF?<JXPS'+$>A)ZD=>]7J* ,J/P
MSH<,,$46D64<=O*9X42!0(Y#_&H X;WI6\-Z(\,T+:5:-%/,)Y4,0P\G7>P[
MMP.>O%:E% &1/X5\/W4\\]QHMA++.5,KO;JQ<KC:22.<8'Y"I9_#VC7,UU+/
MI=G))=H([AVA4F9!T5N.1P.#Z"M*B@#.N-!TFZ$ GT^W?[.ACBR@RB'JH_V3
M@9'0XJ232-.ENH+I[* W%NACADV#=&IZJI[#V%7:* *UAIUEI=M]FL+6&V@W
M%O+A0*N2<DX'J:LT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCIJ01W2-'(J2/]QN2J\_(I[A<"@#F7N/$EIX&L/% UZ[NB(;6]O+46\.&@V
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSM/7"DG'?%<AX:T5- \77$N@1:C;>&WM&>YLYX95C2XW#;Y*.-V2-V<#'3Z
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MZ&PE1RP!&55Y0V >F<*0#Z]:Y"T\,7ESX<\6> F2[2S+N^EWLT!6-E?#[,@
M?+)GIC(/'2M/5+V^U+X<7NEW6DZA#KOV%H%A2V=U^T!,*R2J"N"V"&R,=\4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2AAFF8AI2/(E)5G &X9&>P)YQ0!VM%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.2*1D9'5"0000>HK"T_4+*WTJ'4XUUDW&GZ6U]*;B2X6.?$1!7$AP_)SD#C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHKA/B/%>:7X6U?6K75;^*Y#P"%8IV1(E+QH0%!P<Y8Y/K[4
M =W16%(T'AC=-+>7MREW+%!;VTLIE8RDGA"Q[CDY.!M)IJ>*H7CU6--/OFO]
M,"F:P1%:9@PRI3#;6!&<<]B#@\4 ;]%(IRH.",CH>U+0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5SGCG0[WQ)X3NM(L&MTFG:,[YW954+(K]@<_=Q^
M-='10!S_ (FT.[UNSTV:VDA@U#3KR.]A#L3&S*""C$#."K,,XR.#CM4":-JL
M%_K.NP+8KK%Y!%!!#)([0(L>XC<P4,<EVS@=A73T4 (,[1NQG'.*6BB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJIJ>J6>CV$
ME]J$WD6L0S)*5)"#U. <#WJI!XET>XNH+9;U(Y[@9@CF5HFE_P!P.!N_#- &
MM165<>(]+M=3.FRSR?;1'YIA2WD=MF<;L*IXSQGIFF3^*=&M;%;V>[,=NTWD
M!VA<8DSC:1C(.>,'K0!L45&9E$'G$/MV[L;&W8_W<9S[8K%/C/P^-)BU4Z@/
M[/FD\J.X\I]C-G& =OKQ]>* -ZBJ=]JMGIMO%/=R/''*ZQH?*8DLQPHP!D$D
M@?7BJA\3:4+ZYL1-,]U;;?/BCMI7:/<,KG"G&0#CUH UZ*QY_%&C6T%G-+=E
M8[Q]EN1"Y\QN?E  ^]P>.O!J>TUW3+ZUN+BTNUG2V8K.L8)>-AR0R8W ^V,T
M :-%9EAXATO4]';5K*Z$]@H8^>B,5(7[V..<8/3T-6K._M[^QCO;5VDMY%WH
M^QAN7L0",D'MZT 6:*P4\9^'GAEG_M%5@BD,<LSQ.D<;@X*LY 52#UR:W(Y$
MFC62-U>-P&5E.0P/0@T .HJO:7UK?Q/+:3I,B2/$S(<X=&*L/J""*R3XST$2
MPQ?;6+SEA"%MY#YNW[VW"_-CVH WJ*Q3XMT0&T'VQF:\W_9U6"1C*4)#@ +D
ME<'([5>L=4M-1:5;:1R\) D1XFC9<C(R& - %RBBB@ HHHH ***JW^I6>F1)
M)=SK&)'"1K@LTC?W549+'KP 30!:HJA9ZS87[3I;S,9;< RP/$R2H#T)C8!L
M'!QQSVI-,UO3]9LY+O3YS<0(S(SK&WWEX(&1R01C [T :%%5;#4+;5+075G(
M9(6) 8HRY(.#U [TZTO[6^MC<VDZSPAW3?'\PW(Q5A^!!'X4 6**HZ;K.GZN
MMP;"Z68V\IAF4 AHW'564\@_456;Q-I*J&-Q)\TK0@"WD+%U^\ -N3C!SZ4
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MWN+7.!=&)Q"W8;9,;&R>!@G)X% &S114-K<Q7ENEQ V^)\[6P1D9QD>WOWH
MFHK'?Q1HR)-*;S-O"2);E8G,"$=<R@;!CH>>*OW&H6EIILFHW$Z1V<<1F>9N
M J 9S^5 %FBD5@RAE(((R".]9#>*-&2.67[63;PDB2Y6%VA3'7,H&P8[\\4
M;%%95UXCTJRN;6VGN&$UVADMT6%W,J@ DKM4YP",^F:M6.IVFH^;]FD9C"P6
M17C9&4D9&0P!Z$4 6Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&/.G9V>63'3<[$L<=N>* /'Y_.N_#NKZ1>B.V\/ZCXGNX+W4%^=[?]_E<J0
MH9@%WDG;GI7;^+5G'CWP,MJT:RB6\"F4%E_X]SUP0>GO70V_A;1;73K[3X[/
M=:7[.]S%+*\BR,_WB=Q/)[XJ-_"&C2-8,T-T7T\,MJ_VV<-""-IP=^>1Q].*
M *.KZ5)K&@:EIFMWT%K/<RQK!<6HVE '3RC@DGB3L3U)]:R-/U35;;7!H'C2
MUMY)Y+&X^RZO:$JEQ"-IE#)U1\!2<<>GOU3^&-)DM[J&:"69+KR_.,]S)(S>
M6VY!N9B0 >0 :=%X=TV*:28Q333/"T!DN+B25EC;JJEV)4' SC&<#T% '$V4
MFM>"[G1='UA8=9\.R7,5KIVHQ_+/;.?EB61>C#'R[A^/7%>EUCV_A?2;62U:
M."4K:$-;Q27,DD<1 P"J,Q4$ X''';%;% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7%?#Q8VTKQ$LH4QG7K\,&Z$>:<Y]J[1@&4@YP
M1C@XK!B\%Z%%!/;K:S_9[B1I9H6O)FCE=CEBR%\-D]<CF@#RKPN9Q=>"HY"Q
M\._V[J/V+=]PJ%;[-^OF;:[SXB"47_@Y[//V\:]"$V_>\HJ_G?\  =F<UU=U
MI.GWFG+I\]I$UHH79$%VA-OW2N/ND8&",8QQ4=KH=A:7@O%CEEN50HDMQ.\S
M(IZA2Y.W.!G'7 S0!SO@S_D:/&__ &%4_P#2>.LKP1>KI-KXTN;:,R:3!J\O
MV").CN0H9(^V#(<#'&2:ZQ?"&C)->2I#<JUX_F7.V]G E;&,L-^#P /IQ5J3
MP_I<EA:V(M1#:VCK)!#;NT*HRG*G"$=#S]: .$T);GPMX\MEN[2YM[?Q#!LN
M))BFU[],N6&UFQO4L,<?=%;/C6Q_X29G\/M9W-S:K;-+.;<H"DK K#G<RYQ\
M[X[%4-=%J^@Z=KJVRZC \HM9A/#MF>/9(.C#:1R.U366E6EA<74]NL@DNG$D
MQ>9WW, %!PQ.. !QV H \RU[7]1U?X#W\TOF1ZG;;;'5%4_.A254FZ>JY/T:
MO37@L)M',#+"=.:#;C(">7CU],56LO#FE:?/?S6UJ0VH,7NP\KNLI(P258D=
M..G3BH['PMI.FA$M8IT@0Y2W:ZE:%,<C;&6*@ ] !@=J +.MW$MOI,WV=MMS
M-M@@;TD<A5/T!.3[ UE>,8[G3?AQK$6CJR36^G2) $^\H5,<>X'2N@FMH9Y(
M))4W- _F1\GAMI7/OPQJ7K0!A^%8K%O!&CQ6JQM9-81!0 "K*4'7^M9_B2&#
M4K>R\/164U[I\L?F74=NZ?ZA1A!EF'WFVGKR$:M&V\)Z-9EQ;6\L,+L6:VCN
M91 23D_NMVS![C&#5^'2[2WU*XU"-)!<W"*DC&5R"JYVC:3@8R>@[GUH \UA
MU76!\&?$&EKYRZ[H<$EC(#CS-B@%7X)Y,1!R">0:ZLZC;Z3\+%U/28K>:TM-
M*$\43#Y)(UCSMX]0,5L6V@:;9ZS>:O! ZWUX%%Q)YSD2!1A<J3MX' XXJJ?!
MVA_9)K-+:6*SFW>9:Q7,J0L&^\/+5@H!R<@#!SS0!R=[+=7/BGX<S6XMX9I;
M*[<(59D0&&,[>N3@<9S7<:6+Q?/747MFO/,)_<# \K)V<$D^O7OFH;OPQI-Y
M=V5U+;RK-8H8[5H;B2+R5( (4(P R !^%6K#2K339)Y+=93).1YDDT[RLV.@
MRY)P,GCIR: +M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.",$)&H1<^@&!4E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-9M=:DO(%CM\)(OFEHY1*$^X(R%(+=%VXZ"K.FQW$7B=+6$Q:GIEQ<WK&.>
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MDA/&0H( /=37K%% ')_#9?*\#VL&QH_*GN4$;*5*+Y\A08/0;2N/;%=9110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7,>)/%=SX<L[^_DT>
M2:QLVC0RB=5,A<J/E7'0%P,^QKIZXCXMRQQ_#;4E>15+O %!."V)HSQZ\#-
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M! !4O@D=2#6K92:3I&M:)97UZ\_A62UN393ZCM$#7!D4A>0%VA-P3/8G&>*
M.^\,ZX?$.BKJ#6WV9C/-"8O,WX,<K1YS@==N?QK7KS?P2WA__A#=)BOFB"Q:
MY<+8J2PQ/Y\QC QWVDGGBO2* "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWBF]O;:;0K>SNWM?MNI"WEDC1&;9Y4KX&Y2!RB]JZ&N8\7?\A/PG_P!AI?\
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MZ?J3Q/>V<-PT1#)YB!MI!!!'X@'\*N44 %%%% !1110 4444 %%%% !1110
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MR[,41L97DGC@8'0=L4MOX1T*UALX8+ 1QV4IFME65P(WP1D<^A(]@<=*VZ*
M,I?#>DK>R7:V8$DLPN)%#L(VE&,2&/.TMP#NQG(![4RX\*Z-=)J*3V9=-28-
M=J9GQ,0 !GYO0 ?0 5L44 -1!'&J+G"C W,2?S/)IU%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>exhibit1027supplycontrac013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"LSIL?!&["D9."1SZF@"AXQLK^^\+:E;:7':/<W%NT3BXR Z$$%<CH2"0">
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M*15"J%&< 8Y.3^=+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY6;'!&&SGI67IEZ-.\->$+C4&N8M&3[9%=21P"003-)F)I%*M@8WC..-X]:
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M')$9[B8S%?)3.%( 4[MQSCD?=/I5;Q?X@N/#6D1W]O9Q71:YBMRDDQCP9'"
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M[G5O[02&[L[18&1F,D-RSLK#& 5*#@\\Y[>] &E1110 4444 %%%% !1110
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M;.,XX]:Y;6-&OO$GA#5-5BO!;SSR?;K5'M6$L+PG]RN2<J<*,C'5V]:])HH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,2%)49;'
M SC-+2$A022 !R2: .7T[QA-JFFW%_::#>R0V\\L$BB2/?NC8JV!NYY!]S5]
MO$ N-5N]-TNU:]GL]HN7\P)'$S#(3<<Y;'. .,C)&:Y'X<V(U#3;F[AU:XV0
MZY>2&WC=#&P\U\9XSR#GKZ5=\%E= USQ7IFIR+!<7.K2ZE \K!1-!(JX*D]=
MI4J<=./6@#4N?&UE;^'=4U86MPSZ2S+?69VB:$J,D=<'@@@@X(/!J8^*X[:[
MTR#4=/N;-=3<1VTS%'C,A7<$)5B0Q ..,<=:\^UV/S='^)_B%7"Z;J-M%!:2
M$X$YBB*LZ^H+' (ZXXJWK$D:ZGX+N;'5SKETMW$@TUWC=41EP\X$8&"@_B;(
M&?6@#U>JVH79L-.N+L1&7R(VD**0"P R<9XS532QI(U+5CI\JO=F=?MRB5FV
MR;%P""<+\NW@8I_B"1(O#FIO(ZH@M9<LQP!\IH PT\=Q+X<M?$-UH^H0:3<1
M),;@>7)Y,; $,ZJQ8#GG ..]=5%+'/"DT+K)%(H9'4Y# \@@^E>:Z=KVFP_!
M33[))H[N^N-&2VAL8&$DLLC1;0H0<]3SZ<YK+2"'24L_"WBW5(+")-"MH[6:
MX V"0;Q+Y;D@"13LP>N ,4 >PU2GU >5?+8QB\O;1,FV60*2Y7<J%CPI/'7U
M!KSO799M/DBN_-CUF"WL;5+JTNCY5]&,G;-$>F]B?F7 R5QGM535(]-M(OBF
MJF&WOA$TT6QO+DP;2,[AC!P7_ F@#UJ-F:)&=-CD LN<[3Z9IU>9R6^FZIXQ
MCM[V?S;>3PRLC1&X8(3O'S8!QTY_#/:LB#5[2_\ "WAV"_NU>\D\./('O)=T
M3-A%^5>KSY& <@@$]<T >NO=V\=Y%:-*HN)49TC[LJX#'Z#<OYTRQGN;B!GN
MK,VL@D=1&9 ^5#$*V1ZC!QVSBO,M$N-.O?$'@74;Z6WEEN?#S)]HE8%I)P8.
M W=P2_N#GWJ'2-1\K2]"CGGWZ(_B"_AOG>3<N-\WD+(2?N%MO7@_+ZT >N45
MY#K8:VTWQ!%%=/'HT6N:>+!DG*JA9XO/1"#]T$MP. =W3%=5X46VLO'/BO3;
M.0"VC%I,L(D+!7=&WMR3R<+F@#M**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHJGJ.FP:I#'#<^88DD$A5'*[\ X!((.,G./:@"Y17G?@O1K6^N_$C2M/O
ML?$3K;L)WS&B+$P0<_=R3Q[FMAO'$:Z?:ZQ]BSHEQ=_95NQ+\ZYD,:R%-N-A
M<8SNS@@XZX .LHJI:7%W-<WD=Q9?9XHI L$OFA_/7:"6P/N\DC!],U;H ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "@@$$$9!HHH :L:)G8BKGK@8ILUO#<*%GBCE4'(#J& /XU)10
MUD1E"LJD#L10L:)G8BKGT&*=10 @15+%5 +'+$#J>G-#*K## $>A%+10 U8T
M3[B*N?08I)(HY=OF1H^T[EW+G!]13Z* (V@B>19&B1G7E6*@D?0TXQHQ)**2
M>#D=:=10 SR8O^>:>GW11Y48*GRTRN=ORCCZ4^B@!HCC 4!%POW1CI]*0PQ&
M-HS&A1N&7:,'ZBGT4 ,$,0C6,1IL7A5VC _"E6-%;<J*">X%.HH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ H/3BBB@# \->'KC0)]8DEOH[D:E?O?86
MQ^6S*J[<[CD80>E9MKX&-OI*Z"]\DFA1W@NHH#"?-"B7S1$7W8*A^^,XX]Z[
M&B@"I:0WL=S>/=7<<T,D@:WC6+88DV@%2<G=SDYXZU;HHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2K%NBCWD,Q"J,#GDD"@#4HK&B\3Z<VJ0:;<&>SO;@$P174+1^;CDA6(VL1Z
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M..'5K?33#.9IXWE1E4%-J%0Q)SQ@NOY\9I+G6+"SU:QTN>X5+R^$AMXSU?8
M6_(&@"]161K7B33O#TEF-3=X(;N98([@KF,2'.%9OX<XZGCWJU>ZE'975G;O
M#,[7<ABB,:@C<%9R"<\?*K'\/6@"[17-?\)OIWVFQM_L>I>;?J[VJFU8&55
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MW%[<6V/M"VR@B'(R S,0-V.=H).,<<BK.F:I;:M:M<6IDV+(\3"2-HV#*2K
MJP!'(H N451TC6+'7+$WFG3K/ )9(MZ_WD8J?U'Y8-5WU^V:_GL;."XOKBV(
M%P+=05B)&0&9B%W8YV@DX(XY% &M16!=^,-+LM#?6)5NA9QS_9Y#Y#!TDWA,
M%#AOO$#I^E7K?6$GODM'L[R"1T9U,T6%(7&1D$C/(X^OI0!HT444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '&7?\ R673
M/^P'<?\ HZ*J:XOOC1<7-@0T-EHIMK^5/N^:TFY(R?[P&3[ UUUUH&CWUX+R
M[TJRGN@NT32P*S@>F2,XJ>+3;&"R-E#96\=J<@P)$JH<]?E Q0!P'PYBOH?A
MOX;O7U6.'3X(C+/$T(&8QO&-V?4@].<8K6T@C_A;?B;_ +!UC_.6MR+PKX>@
M6-8M"TV-8V#(%M4 4@Y!''!!YIT_AG0;J[DN[C1=.EN9/OS26R,[?4D9- '-
M^/+F&XD\*^3('$?B:VC8CH&"OD?AT^N1VIWCH_V!JFC^,T!$=A)]EU':.MI*
M0"3Z['VM^==(?#FAM;6UNVCV!@M6WP1FV3;$V2<J,84Y).1ZU>GMH+FV>WGB
M26!UVM&Z@JP]"* .7O(9%^'NO7EPA2YOK.YNI5;JNZ(A5/NJ!%_X#4/A2.^M
MO"WA>[N-5C%BMC;AH#"%+%HE5!NR<G<0,=\^U=;=6EM?6SVUW!%/!(,/%*@9
M6'H0>#5&#PUH5L\+P:-I\3P$-$R6R QD="N!Q^% 'EVIC4MGCSR&SI+ZLL>J
M)#'FX%L8(Q(T9)(R!U!4\9P<UZ3-H>C:]X,31XPLND36B1P-&V<(%&QE/J,
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M\<GZU:O=)T[4K1;2^L+6YMEQB&:)708Z?*1B@#COBQB[\,VNE6I#:Q=W]O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD<H8JRJ2"1D'H2H./85=HH **** "J,ND6$VIPZC+;A[N$DQ2,Q.PE2I(&<
MX)'3O5ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^U%V7BK/(JRC:%/ 8 $@ $C!('.:VJ* ,E?#6EK>_;!#,+C[*+/?]JESY/\
M=^]^.>OO50>!_#RI:(MBZK:VQM(@+F7'DG_EFWS?.OLV0*Z&B@#$@\):+;?V
M88;1T.F1F*U83R91#C*D[OF'RKPV<8'I2+X0T1=-6P6T<0)<F[C_ '\F^.8D
ML75]VY3DD\'N?4UN44 8\_A?2+FQ-G-;.\37"W3GSY SRJ05=F#;F(VKC)XV
MCT%6;71K&RU.[U&")UN[P()W:9VWA1A>"2!C)Z"K]% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%4]1M[NZACCL[UK,^8#)*B*S;,'(4,",DXY(]: +E%<+X9FU
M[6+G6M^OW!_LS6VLT1H(-LD""-B&Q&#N(9AD$=N*7POXPC5)+/6+RXFN9-8N
MK&&=K<[,K*RQHSJH0,0O XS^(H [FBL>X\3Z7:WD-O-,ZB:Y^R)-Y3>49O\
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MZR^T[9(-KJI!VMAUP0<$>HQV-;MIXHTJZN+NV\]XI+. 7$QN(6B'E'/[Q2P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@NH+G3IY4Q)',X8.C'*A@57KCN*]0HH SM$M6M-,17L+6P9F9S;6H&R/)Z9
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MX&2<XYXT/ ^FWFC^$;/3[^#R;F$R;E#AAS(S#!!]"*Z*B@#B_!]CXCT2PMM
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 450NM<TBQN/L]WJEE;
MS8SY<UPB-CZ$YJ=+ZTDM/M:74#6V,^<L@*8]=W2@"Q169'XCT.9T2+6=.=I&
M"HJW2$L3P .>35B/5-/EO6LH[^U>[3[T"S*9!]5SF@"W156[U*PL&C6\O;:V
M:0[4$TJIN/H,GFDBU73I[U[.&_M9+I.6@292Z_50<B@"W15*76-,AEFBEU&T
MCD@7=,CSJ#&/5AG@?6HX-?T:ZFCAM]7L)99#A$CN49F/L >: -&BLU?$.BO<
M?9UUC3S-NV>6+E-V[TQG.:GN]5T[3Y(X[V_M;9Y>(UFF5"_T!/- %NBJT^HV
M5K/#!<7EO#-,<11R2JK2?[H)Y_"B]U&QTV-9+Z]M[6-C@-/*J GZDT 6:*J6
M>IZ?J.[[%?6USM^]Y$ROCZX-6))8X5#2R*BEE4%C@9)  ^I) 'N: 'T57O+Z
MTT^#S[VZ@MHLA?,FD"+D]LFJ</B30KB98H=:TZ25SA42Z0ECZ  T :E%99\2
MZ"I8-K>FC:2&S=Q\$=<\UIJP90RD%2,@CO0 M%%% !1110 4444 %%%% !15
M%M:TI+W[$VIV:W6[9Y!G7?N]-N<Y]JDFU.PMKN.UGOK:*YD^Y"\JJ[?0$Y-
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^= 'FGS'X)>-BZ*KF]U$LH.0#YQ[]ZZ37W:+QQX">.W:=A#>XC0J"?W*=-Q
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MK$X';->G0>$8;6ZU&>#5-2B;49?.N0DB#>VT+D$)E> !\I'2B\\%Z/=>&?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^8J6B@#.T/1X=!TF/3X)IIHT>23S)BNYB[L[9V@#JQZ"M&BB@ HHHH ****
M"BBB@ HHHH ***1E5U*L RD8((R"* %I"P498@#WKRCP;I^GW>DW-G/X8^T1
MRZS=P_;A'%B%1*^"#NWC& !@<'%;GA-8_%.L>*+_ %>".Z:TU673;:&9 Z0Q
M1JOW5/ +%B2>_'8"@#O**\>UR5HM%^)GATCS-/TNWBN+(/SY'FQ%RB^@5AE1
MV!QTQ5Z^EBT_7?!AM=,DT#S;A$FO65$BN%,9'D'RRP+,<$;\8QP<T >IT54M
M)+Y[B\6[MX8H4E MFCD+&1-HY88&TYR,<]*K^(HHYO#6J1RHKH;67*L,C[IH
M TZ*\PL?#VGR?!FPU&VC2PU.#1DNX[^V CE658@VYF'+ D<@Y!R:T=-\=:AJ
M'AZUEM=/^TZDNE07T\?ER$2/(I(1=BG;G83D\#(Z\X .^I'=8T9W8*JC)9C@
M 5R,_C1EU6UTXV\5E=W-K#<0V^H,8GF+D[HT/3>F.1U)...M9ESX@U(Z5X\F
MU&QL;^RTR21%M7<JKQK!&Y4Y4YR&)/J3V% 'H6<C(HKC[CQ+JL>K_P!D:9I5
MDQ72EOXWEN&1<;MNS 0XZ<?TZ4V7QI<R^'M.U>VL88X;S33? W$W5]JL(% ^
M9F(+'<!@!>AH [*FHZ2+N1E89(RISR#@UQMMXDU34_%7A]+6."/3]0T9[]HI
M&.[):'J0.P? ^I]JCT/Q1%_9NFVUGI=K9WFI:C>01V\;?ND,3R&20D $YV9Z
M#)8=.H .XHKA[SQW=V5MJ$;Z9$^H:=J-O97$0G(5EF9 DB';SD./E.,$'D]]
MK0M<O+_5]8TO4+2""YT]HCN@E,B.DB[EY*@Y&"#Q0!O4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQDGKSDYK1T_1&L?$&J:LUUYC:@L0:+R]H3RP0,'/<$Y_I6Q10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !115/4;\Z?#&Z6=S=R22"-(K<+N)()S\S*
M 3DF@"Y17,6'C2/49KA(=$U4+;7PT^XD80D12DJ.0)"2!O7) /Z5T] !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 444$9&#0!Q7P]8&Z\98(./$
M=QT_ZYQ5S\.H7]WX-L=;BN)E\3+K(@FA\QN6-SL>!DSC8(SG&.  W7FO3;>P
ML[1F:VM((6?[QBC"D_7% L+-;UKQ;2 73#!G$8WD>F[&: *NFQZ>E_J;6=X9
MYWG!NHS<&3R7V* NW)V<8...M:51QP0PO(\<4:/*VZ1E4 N<8R?4X 'X5)0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML]=T._CLYY((U:.4-(BAPKAL!E?..Q%;FBV>MZ1K'B6Z_L<RC4KT7%MFYC4
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MHVD#S7$J9V+A<JJ G)Y)/ P.M !XZ\2W_AZT@GTZ$3?9V6[OQC)6T5E$F/\
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M[9V2=@XQ&RC+!O0@5Q_AWP3=Z=9:NEU/#))?13VZB=#,0IDD*LQW#*L&#,N
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M[@#NXHU[3SI/AGPSIY:)C;ZM81EHHRBG$J\A221^9H [>BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH YL6E];_$*XU$6$LME<:=!;"='CPCK)*S;@6#8PZ]
M:Z2BB@ HHHH YNYM+Z[\>Z7>BPFCLK*UNHGN'>/:S2&(KM 8M_ W4"NDHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC.S$_,!R<*"3Q51?#]QX7U"*PDTC4M:T:?2K>P#64NUE>+>&61-ZC:X<G).
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MT81Y3*"R$[A(I8@8'4#D#FMWQ[87VJ>#KRQTZT>ZNIFBVQJZ+TD5B<L0.@-
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M254:) WW?F!)(#DD]:(-!UQ-"TNW;2)A-!XE?4)%\Z'Y8#/(X;._!X<<=>M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !14%Y#+<6-Q#!.UO-)&R),H!,;$8
M##/<=:XE8-0D^(MUH/\ ;VJ+9IH\=TI$B;A*TKH3G;Z*..E '>T5S]SXEM])
M@N8YUN;UM-A1M0GMXP1%E<[F&02<?,0H) QQR,Z,&K0W5]!;V\-Q+%/:_:H[
MM(\P%20 -_\ >(.0/3F@"_1110 45QE_)>S_ !1M])34KR"QDTB2Z:*)P 9%
ME1 <D$CACQTIMCJFI6?C>\\):E>R7D,UA]OLKLA4E10^QHV*@ D'!!P..N:
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M>VT19'.61ID5@2>N03SUK.\=:GJ]AHWE: JOJ85KK:W.88<,X]RWRI_P/VH
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MHVHZS>:/XF%U)]DAE(2">#>?+$0(*L"F 3]_)..F!J3:T+#XJW%A>ZL8-/\
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MG'>70NKE85$MP,8E;'+<<<]>*N4 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWL5O# TK0PQQM*_F2%% +M@#<?4X &?84);PQSRSI#&LLN/,D50&?'3)[XH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>exhibit1027supplycontrac014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M0!W.2.* ,?X=Z?<:9X&T^&ZC:*:0RW#1L,%!+(T@4CL0& (]:ZBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME(Z$ _A0!>HI%4*H49P!CDY/YTM !1110 4444 %%%% !1110 4444 %%%%
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MX9DA#*RMU!W #CKG%4KC5KX>(_".KSZ;->WS^&YYYK:$*'9B(68 ''.<\>]
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MXN?M36HM#'E?+$08L% VYX))SG-;%% &#;^%;:VN=9N([V]\S5R#<DE."%V
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M16-H^M7&H:KJFG75G%;S:>8@QBG,JOO7<,$JI&/I6S0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 445C?VU<2>+)M$@LXF2"UAN99WG*G$C2* JA#DCRSU(ZT ;-%<K:^.+:
MZ\4/HJV%V'7:F3&=X?<X8LN,! %4A\X.\#J#0?'%L/%(T3[!=^9N\O/EG=OW
MXW;<8\O;\V_..W7B@#JJ*Y74_'%MIGB*/2'L+MW(.[;&2SGY-GEC&'!W-DY&
MW:<]JT7UJXA\5VVC3V<0CNK>:XAG2<L<1M&"&4H,9\P=">E &S1110 4444
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M .7T/_D?/%?TL_\ T6U=163I6AC3-1U"_>]GNKB^\OS6E" #8I P% [&M:@
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M$D#.WF*,<.3(V6[T?\(CHG]J_P!H?8(?-W^;LV#9YN_?YN,?ZS/\77'%;=%
M&)>>$=$O]1-[<6$+R/N\Y2@VSD[,%QCYB/+7![53U'_DIF@?]@R__P#0[:NG
MK).AA_$D.M37L\DD$,L$,)"!$60H6Z#)/[M>I]: -:BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_A 9)_"-IX5O=7:31X$CB=(;<1R3(A!"LY8X!P,[0#[T =5%+>MJ<\;VT2V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^+48M!O-&6U22&P:0)-N/F(Z&-F7>I7!P,[* /2IKRUM@3/<PQ (7.]PN%!
MSSVR1S[T+>6KSK ES"TKIYBQAP6*_P!X#T]Z\^L-&TVU\;:3$^GO]BA\/R0@
MWL>\KB6,HKL1C<$!X/( -97AVQCM-(^'LJV30W<-[(MR_D$2(ABE7#G&0.8Q
MSQ]V@#T;Q)K]OX<TDWLQ0LTD<,2,X7<[NJ#\ 6!/L#2V&I3QQ/\ VQ-I\)>8
MK:RPS86X3 (8!NAY(QD].O-8WQ'C67PS"GDM*_\ :%FP58RYVK<1LQP > H)
M/M5&;R(?%?B.+6K<R:;J%A E@PB+H\05A)$N!][<V=O4Y&,XH [>>\MK7_CX
MN88OEW?O'"\9 SSVR0/Q%9OB77XO#NEI>2(C&6XBMH_,?8@>1@H+M@[5&<DX
M/2N#T70"^O>%[3Q)8QW=POAV2"[-Q#YB^9OB*HY((+!0W7T-=WXF:Q_L@6VI
M:<U]87,BP3PK"TN%.?FVJ"< @'(Z=>U $9U36('O8[G3K7]Q:_:(9HYVV3')
MRIRN5(Q[]13=#U^ZUGP7;:\+.&*6XMOM*6_G%E (R 6V_P!*YGPOI<^GZWJ6
MCZ-J-S>^&'L"8OM+&1;2<M@1QR'DKMR2O.W ]>9?"NJQZ;\.[/1;F&X36+2T
M-HUCY3>8TB@J,#'*G@[ONX.<T :<WBO4H]0\-V2:9:-)K<,D@)NF A*1AR/N
M'=P<9XJ6#QG!#<Z[;:Q MC-HL*7%PR2^;&T3*2K*< Y^4C:1G/3-87B&T2#Q
M1X%@N?M/DV45RMQ+;&1?+_<JJY9.5R1CKS6)=>%K[66\;:5HB7/]DZC9QO'<
M7RN'EO%.=JR2?.Z84#)) )XH [M=:UZ;0&UBWT6 JT!GALGN")V7&5!(4J&(
MQ\O/UI\7B*ZD\<OX>%E"(5L%OOM/G'<59R@79MZY4GK2:-XIM+O2[=)(+F'4
M5C59;!X&65' P5P1C&?XONXYSBL:2^BLOB]<7=RDRVYT.. RI"[IY@F=BFX#
M&<$&@#=\6>(+CPY8V=S!9Q77VB\AM"KS&/:9&"ALA3G!-4[OQE_9/C*VT+5;
M1((+N-3;WR2ED\UBP6-P5&TML;')SBLKQOJ2:OH.GR6MO<M''KEH5)@<,Z)(
MK.^TC(4<\D=O<5JZCIVF^(M<U72K^/SK6ZTV!.AQD/*<JW0,,J?4<&@#9AU"
MYD\0W>G-!$L$%O%.)1(2S;VD7&W&!CRSW[U2\4:QJ^BZ?<7VGZ7;W<%I UQ<
M&:Z,195!)5 %;+8!/.!TZ\XR?!5OKUGK>KV>NYG>TMK:WM[_ /Y^X@TQ5SZ.
M P##U&>]7O%LFD:G:7.@WT]_'</#YL8M%F5B>=I5D&&((SMR>V10!9NO$+#4
M-+TVSMMU]?P/<[)R4$,2A<E\ G.65<>I/I5*'QK%=VNFQVUL/[3OKR6R^S._
M$4D.[SBS <JH0XXYRO3/&9:V6I:5XC\-:WK;%W_L1M/OYAR(Y\QR;F([,5<9
MZ9QZBLG2]"O=-U+1?$EU!)' VL:C=3QLIW0170(C9AU&-J9]-_/0T =SIFOM
MJ5EJ6RV47^G3O;3V_F?*74!@0V/NLK*<X[^U3>&M8/B#PSINL& 0&]MTF\H-
MNV;AG&<#-8GAFUDMY?%.M7"M%#J-\9( ZD$Q)&L8;'7YBI(]1@]ZJ^&=0DT7
MX1:0_DR"]BLHX$A>)LK-@* RXR #R?0 F@#:TGQ7:ZKXGU;1$C9); (R.W2=
M22K,OLKJR'W%3>*_$4?A?P]<ZJ]O)<M$/D@C^](>IQ]%#,?937'ZSIEYX4OO
M#6NQ7!O5LY/L-PD%JWF2VTOWW;!8L58*_3KGUKH9S)X@\1NEK<1I;Z?!@>=;
M%TE>488C) .U %R,_P"L84 =):W,-[:0W5O()()D62-QT92,@_D:Q'\1FW\8
M7.D7:VT%G%8)>"Y>7!):0I@YP!]WU/6LCX<R3:=97WA>Z\UFT>Y>&UG:-E6:
MW)W(5)X.W.T@$XVBJ^MV=K=_$#4VO+19X1X?$:F2'<GF>9(2H)&-V&''7!H
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M$6;:OF8P><G;GC- &K1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4$^5HL?WC'Y;D>I:@#O:*X66V^V?%VYL9;J^%I_8D=P(8[V6-!(9G4L K#G
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M#=>;DQY\A]V_>%QLVYV8.[S/NX[T:CXUT_3=<33)8;II,-O*P.3D!-NQ0N9
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MVH37R^6"NPR'.PYZXQU_2NAHH Y'1/#^NZ'#JR0W.FR&_OY[X&2-\1F0YVD
M_,!CVS746L<D-I#%-,9I415>4C&]@.3CMDU-10 4444 %%%% !1110!Q5UIV
MK^#(-3NO#6GIJMM=W#7;:>TGEO#(WWVC."'!(SLX.<X/.*9;^$-/UGP9JE@M
M](;K5IOM=U=F+9(EQN5ES&>5"E5 0\X'7))K;LO$9O/[5F^PRK::=-+"[H3)
M)(T>,[8U&3GMCGVJ+1O&-AK+WBP0W.;;S&^2%W#(I !R!PY_YYGYN.E $HL-
M9U VL>JRV*P02I,XM5<F9T(9?O?<&X X^;IC-+#H0N-6O[W5H+*[\XHMONBW
M&*)1POS=]Q9LC'WL=A46A^,+'7M0N;.WBG5XG.TF)L% B-ECC]V<N1M;#94\
M4S2_&FGZKK3Z;##=+)\NPO X/1BV]2N8L;<?/C.1C- &?I_A#4M.T'Q!HT-U
M9BSU&2=[1 C 6@E!W+_M*"20..I_"_XL\(P>+=*ACN'%MJ%N=\%S$3F,D89<
M\$HPR"/3Z5>TG6GU#4]1T^>S-O<6/E;\2!U8.I(P<#TK7H Y_P 9Z#<^)O#S
MZ7;3PP&2:*1I)%+8\N17 P/4KCK2>,-!O/$WAB32H9H+:29XG>1P7"[)%?
MQG)7':NAHH Y[QAH-WXG\)76CQ306TMR$#2L"ZIM8-P.,_=QVZUOQ^88U\T*
M),?,%.1GVIU% '.^&]!O-&U+7+FXF@D34[PW86,$&,[57;SUX4<\?2NBHHH
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M=G+E=K8.5--TOQII^K:R^G0PW2R<;"\#@_=);>I7,6,8^?&21C- '1KG:-P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVI'G!U"Y/S\$ #UJ*V\#7EFNG-!K2"6ROKF\&ZTRC^>6+ KO^\N\[6SQZ'-
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M[<A(H<L2%0N3DER<EO3TYO6WA^>'Q/!K4E]&_EZ?]A,*P%=PW!MV=QQR.F*
M-ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9J1GDT/Q9K,-[>(JP3K9A;APL9B0@NHSP3(&]L*/4YA\,W=I>V'AYO[0U?\
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MT8>6.-U#$Y(()X.<$F@#OJ*X+XA6USI'A;4=6M-5U&.X$]JL(2Z<+$AEBC8
M9P<@L<GG+5HZ]X6U&;1-0BT;7=2M[UE5[4O=.P21<Y4DG.UN <].HH ZRBN)
MT;6/^$VM]-%LU[8_8CNU.-9G1XY5RIMV.<D[@6)ZX _O@UVU !1110 4444
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M/'#'=R(JR.[AB,'T4<=/:LRZUK5;)?&GAV[U">>;3=-;4-/O@?+F"%&(#E<
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M]0C;T_X"*9X8O)?&(U+5[JYNDLH[R6UL[:WF>(*D9VEV*$%F8@G!. ,8'4D
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MB@#0HK/T[6K'5)[F"U>7SK;;YT<L$D3)N&5X=0>0*T* "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110!Q_AJU^W:;XIM/,\OS]5O(]^Q7VY &=K
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M9M VL@#+A_E.3SR'X?H?%HUG[6-OG_:O]3'N\S?G&W9MQMXW_P"LSSNKM:*
M.*UCX?IJOB;^U3=A1)\TF88R5*[/+P"A5QE6R7W$9&,8J]J/_)3- _[!E_\
M^AVU=/7/RZ;J%SXWL=4>*".RL[2Y@#"4L\AD:(@[=O 'EGOW% '04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2)/,#8P#G&!C/K0!U5%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.0?EXZ=\U=DU75_$6H7^F6E]'8W<&G6]Q;OYYCVM(I8R[=I\Q0V%()QQZG-
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M^$=M7$T('#;YSE0P/?U%5HM:O]/\.^"/$U]J,QL)K6"/5=S?+F6(;)F],2$
M]OG]J /1J*X6YU'4(]3T32)IGC.JQ75T1+<M"P8%"D(< D%5<\#&=G7J#3D7
M7SJ/AG1KKQ+,6N1?0W,]D$!?RURAR5^^N<$XQD'@&@#T:H[BXAM+:6YN)5B@
MA0R22.<!5 R23Z 5PEY?:EH.OWNBS:A=7)U:V3^R)I6R4F!"2+P!G&Y9?IN[
M"NKUFTL)/#%]9ZI*YL&M'BN9';YO+*D,Q/KC)S0 RU\2:?=W=M:J+J*6Z!:
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MA?F;:>OL/?/H]I:M!>WTQOI[@32*PAD*E8,*!M7 R >O.>M %RBBB@ HHHH
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M+^V2XB5PX1\XW Y!^H/(J*[T'2[Z9)KFS225(C#YA)W-&>J,<Y93Z'(K1HH
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M3R6M[;J<B*5&P1GT(P?H:K>'];U+Q;92:OI\UO::8\KQV>^ R/,J,5,C?,,
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MGG.PGC.*O_V=J&I>-XO$][836UEI=G)#96Q*M/.[XWN0I(48  !.>YQ7:44
M>=ZSX7O]5\#7-T+B_CUAV_M*.VV)^[NU.Y%'R[L @)G=T'I6S/-?^((-&M;B
MQOM/$NVYO&"*?)D3!6/)R/OX;.",)[UU=% '#V&EWVA?$2],<5[>:5K%LC75
MPZKB*Y3Y03M X9, D#JHS2>"X;[P;HR^&;[3KR:.SDD6SN[>/S$N(F<LN<?<
M8;L$-@<=37<T4 56N+B/39+E[4F=8V<6Z'+$C)"YZ9Z#TS3=*LVL-+M[9V#R
MJN97'\<AY=OQ8D_C5RB@#A_#UK>>#=3UJQGL+JYTV^OY+^UNK:/S-IDP6C=1
M\P((X.""#U%:NMM>:I96^G&RNH8;Z?9/(@#&& #)W=1EB-N.<!LGH:Z.B@#A
MIM+U#0_B)8ZK:+?:A:W]LUKJ3E4_=;3F%_E"YP2R]"<&G>%[&[\&OJ>D7=G/
M<:9+>2W5E=6\9EPLAR8W5<L&!SSC!!ZCI7;T4 >2WGAC4U^&?BVR@T>07>JZ
ME--:VZ*N\Q&12F><* H/!(Q7;6,5C!K%O)IOAR2TEE5HYKC[.L*I'][YL?>.
M0 /3)KI** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BHVGA241-*BR-
MT4L 3^%.$B&0QAUW@!BN>0#T./P/Y4 .HIOF)YGE[U\S&[;GG'KB@R(LBH74
M.P)52>3CKB@!U%1K/"TIB65#(.J!AD?A4E !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !14:SPO(T:RHTB]5# D?A3DD23=L=6VDJ<'."
M.U #J*:LB.6".K%#M8 YVG&<'\"/SH$B,[('4NN-R@\C/3- #J*CBGBG!,4J
M2 ==C XJ2@ HHHH **** "BBB@ HHHH **** "BBB@ HH!!Z&D!!Z$&@!:*:
MKH\8D5E9",A@<@CZTZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML/M.G^+1;11B]FU*\B27>8FR0,#S%^91G'(Y':J_A3PWK^GS:HU],766.:)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;7&]9(7EQD1E@<JQ[9 ![&K'B7Q+8^%M.AO=0+"*6XC@&T=-S8+'V498^PH
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M)19U.\2,JJRG&"-S8.<$8H ZFBN7\0>++KP]97E[<:+)):6LD432+.HWM(4
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M$<CCWXK5AOM1-Y##<Z7Y<4N1YT<X<(0,C<, X.,9]: -*BBB@ HHHH ****
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M5YH\>O6QMO$#:A<3QO#';"Y6;T<O@?= "\GZ#KC/3T4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
..444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>exhibit1027supplycontrac015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
MT9X([F%H9061A@@$C/Y5GZ1X;T;0/,&D:;;V0DY=8%V!CZD#@FJ&OMKUQ:/>
M:%JMC:6T5OYZ/+!YPN#@G!.X!4P!R,DY]N<_5_$VJQ_#&W\26T4-K>RV]O-)
M#-&7"^84# <C!&[C.?I0!OKX;T9=3_M(:=;B[\PS>9M_Y:$8+XZ;\<;L9QWI
M)/#6BS:E=:C)IELU[=P?9[B<I\TD>,;2>XP /H!5/Q5XFC\/QV-NC0?;M0F\
MFW\]ML:8&YY'/]U1S@<DX'?-/EU*3_A$+O4M,U2VOY$MY)8[G:'B+*"< (1Q
MD$8SD=R: (K7P!X1L;N&[M?#FFPW$+B2.1(%#(P.00?4&MFXTZSN[RTN[B!9
M)[-F>W=O^6;,NTD>^"1^-<U<^*+NW\'>'+L>6=2UIK2W1BOR+)*H9GQZ !CC
MV J>TU;49M7UO05G1[[3TAN+::1 !-'(#A7 XX9&!(QP0?6@#J**SM"UB#7]
M#L]5M@RQ7,8?8W5#T93[@@@_2M&@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#D/&/ABZUK5M$O;%PC1226M[GC?9RK^\7ZY5<>A.:30_"]UI?C?6KTLHTJ9_
MM5I$/X9Y0!,?;_5@C_KHU=A10!Q/B/P;;^(+R:V@L7M(+V5&U.Z$K*LZ(0=H
MC#89S@+O9>!G!)Q5_P 3V%[=:OX9DLK&2>&QU#SYV1T4(GDR)T9@3RXX':NG
MHH YKQI8WVH66EQV%G)<O#JMI=2!'1=L<<JNQ^9AV!X%0:SH]W;^,M/\66,#
M7!BLWL;RV4CS&A+!U9,G!96'(SR#QSP>LHH X.PE@\>^*M,UZUWQ:=H33H$F
M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 %%%% !1110 4444 %%%% !1110 4444 %<VEW?7/Q!O-/^WRQ65KI]M<+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFK5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !5.32M/FU!=0DL;=[Q%"K<-&"X )(&[K@$
MG\S5RB@ HHHH *III.G1:BVH1V-NMZRE3<",;R#C(W=<' _(5<HH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI%C()#C:2&4X/(.!@YQ5C3?$MEJ>K2Z;'%=0W"0+<J)X2@EB)QN7/49XYP:
M-FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#EO#NB7]CK?B2YOX(/L^IW:W$(63>0!&J888&#\N>,TYM"N]*\
M8WOB#342XBU*"..^MF?8V^/(21">#\I*D''8Y[5T]% ')#P]?7&LZKXANXX?
M[0N+#^S[2V63*Q19+'<^.69CDX'   SUK"G\&:]J/PTT_P '3P:? T,<,4E]
M]H9S'Y9!WQKL&6XXR1UZUZ510!3@:_&HS0R0Q?8$B3R9_-)D=^=P9<8 Z<Y[
MU;<L$8JNY@.!G&:6B@#AO#6D>*=!\)?V1#;Z:MYYT[K<O<LR)YDC.#M"98C=
MTR,XZBJ8\!WGAN+0Y-!@L]4^P6\MM=6^H-Y?V@2.)&D5MK;6W@GH>#CM7HM%
M '$:YX6NM7LK2.;3[9;F&&1H+FQN#!)93L<CRV &4Q@$]]H.TYP+&GZ)KFG^
M(KJ^E:VO%N]+MK>:8R%',T0DR0NTC#&0'.1CGBNOHH X+1/"VLZ:O@M)HK8C
M1;2:"Y*3$[BR*H*?+R/ER<XZTRR\.>);&QL;81V<MNNI7EQ=VINF19HY7=X\
ML$)(4MRN,'WKT"B@#SO2_".O:;IGAI!%I[3Z/J-S,8Q.RH\4HE (.S@CS1\N
M.@ZU)=^#M7N1K$T;6T5RVN0ZO8AI"5?RTC79)@?+G8>F<9'I7H%% '":_P"%
M=2UZ/Q!?"&&"]U#2!I=O TV0HR[%W8#U<8 SPOO@:EKI&HKXUMM6EBA6U32?
ML3XERPDWA^!CE>,9S^%=/10 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[6UGG5)[MF2!#UD*J6('T )JS0 4457O;ZTTVU>ZO;F*VMT&7EE<*JCW)X%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP57VPH'08ITGA?3)[S4;FXC>=M1MUMKI)7RDD:YP-O08W-T]: ,NXU#5]/\
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M-P\B1E?NG83M)'8D$CM3-3\':3JNL+JLHNH;LQB*5K6Z>$3QCD)(%(W#D]:
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M9E4A0OR@\*,#H.] %NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXB"&X573>&1@B_*X./0YKTRUG-S:0SF)XC(@?RW&&7(S@^] $U%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 07L\EM8W$\,#7$L<;
M.D*G!D(&0H]STKFO^$IU<^(IM#70K=KV*R6](%_\I1G9 H/E_>RI]O>NLKB(
M)XF^-=X!(A/]A11]?XQ/(2OU (./>@#L;>?S;:"61#"\J!O+?[RDC./J*FKS
M753:S:MXSLO$"IYTD*-I9D'S-%Y7 @[[Q*&.%YW$>U=QX>6_3PUI:ZJQ;41:
M1"Y)ZF78-V?QS0!I4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRD'/;V(X% '<45Y%?ZS+;3^,K=-<U%-5M[P0Z-;1SO([2&%75!&<A@6)SD'
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M'&R@ X.1N.3SEC2>.K:ZT#PG=75CJVI*S7EJ$+73LT8:9$<!B<D$'H<X.2*
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M@1C;#]QHS_M !'(]7- ';T5P\,4U]\3M:T^6_P!06TAT^WGCBCNY$5'=I Q
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M(';FIJ* "BBB@ HHHH **** .&DMM3^']EJ,FCZ4^L:;/=/=+;1/MFMBYRX
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M1>5C4;3N 8*26QG!' .!O44 <C=>$Y;3QEI>MZ!;:=:1Q0R6]]&,Q^?&Q!4
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MT>"15<+C<5<KM;&X=#WK0H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM745S^AZ;J$'B#6]3OHH(5OO($<<<ID(V(5.3M'K704 %%%% !1110 4444
M%%%% !1110 4444 <=X7M/M^A>)+,R>7Y^K7\>_8K[<R,,[6!4_0@BD\.^!$
MT(W[+= &XBDMT"Q(V(RV4)++G(!Y4?)_LUI>&=,U#29-3ANHH/(N+^XNXI8Y
M221)(6 *E1@X/J:Z"@#C_"W@6/PYJMQ>K<A]P,4:B-.8]J8).W*G<KG:A"<C
MCBHM ^'Z:)XA&I"[#B+/EXAC!?<IWY 0!/F((\O;G'S9KM:.U '+Z%_R/7BS
MZVG_ **-=17/Z%INH6^OZWJ=]%!"+\P>7''*9" B;3D[1704 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %<Q9_\ )4-8_P"P19?^C;FNGKGUTW4(/'-UJT<4$EG=6-O;,3*5
M=&C>5B=NT@C$@[CH: ,JS^'\=IXK;6!=@J'6=?W,>XR%I-P*[-H&UD 9</\
M*<GGD/P_0^+1K/VL;?/^U?ZF/=YF_.-NS;C;QO\ ]9GG=7:T4 <5K'P_35?$
MW]JF["B3YI,PQDJ5V>7@%"KC*MDON(R,8Q5[4?\ DIF@?]@R_P#_ $.VKIZY
M^73=0N?&]CJCQ01V5G:7, 82EGD,C1$';MX \L]^XH Z"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?%7J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFO(D94.ZJ7.U03C)]!3J "BFK(CLZJZLR'# ')4]>?2G4 %%,$L;2M$'4R*
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MI&6 9L=<#O0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $%Y:0W]C
M<6=PNZ"XC:*1?56&"/R-< GAS0W^+=Y8MHVGFT_L"%O(^S)L!,\@)QC&< #-
M>C5B1^'BGC&7Q%]L8R26:V9@\L;1&KEP<YSNRQY_2@#C)+BZ\+^(_&EWH]E:
MRQV.FV4\JS2%-ZQQS$@8!RQ"]3Z5OWWC"Z?[4FC6)NI[6UBN#"T4C&5I%++&
M&4$(< ?,W&2..IJU>^$1>W'B&4W[H-;M%M)E$8/EHJNH*\]<.W7/.*KOX*FB
MU&"_TW7KS3[C[+':W9ACC9;E(^%)5P0K@$C</RH Z%KBXET?[3#%Y-P\(D$<
MX^X2,X;'<=*\_P#!]X+?1/!SO;6DFNZK9,D-VP.1"$$LC.>K'=CCN6ZCFO1'
MML6!M87,>(_+5V^<@8QGD\_C7.0>"(K72="M8;^1;K0SBRN_+&=NW8RNO1@R
M\'&.@QC% &!XKUG^V?"6L6=[:QQ:AI.JV<,@7YE.9H621">1N1NG4<CGJ;-Q
MJMIX9\9>-=7EAS'!IMC*Z1@ R.6G &?4G R:VK[P9#?:3?VCWCK<:A=QW=U<
MK&,N\90J .@4>6@QSP#W.:6]\&6NJ7FM2W\[30ZO:1VD\*KM"K'N*LIZ@Y<G
MOV]* $EU_4[/7H-%NK:U-S?6DL]E)&S!#)'C=$^>>C AAUYX'?.T[QY+=S>%
MQ-!;PQ:RDJ39+;K>>,',9[=5=03CE3QZ;MCX?>+4+2_U"^:_NK.W:WMY&C";
M5;;N8@=7.Q<G@<< 9-9]U\/](NK75(&:95U"^2]+*V#$RL&PA[ MO/\ VT:@
M"*36Y9M7\*_:M+LI3J$UP;>X).^!1"[*R@C@L@&>>-Q'/6JEMXWU:1;2ZGTR
MSCLY-9?290EPS.&\UHPZ_*!C(&<\\]L<]'J6@C4-7T?4%N#"=+D>2.,("KET
M,9!]MK'&.]92^" NGQ6G]I/B/5CJP;RADR>89-O7[NXGWQWH KW_ (UO88[V
MXL[""6.UU>/23!+(R2.S%%\S(!P,N.-IRHSGM5[XA1K+\-_$/G1HQ73IG /(
M5@A((^A[URIM]4DU_4;NWFU.TU1[IVAM[C0UGC.WY$Q<[0 I4 _?&-Q'N>^U
MW23KWAZ\TF6?R%O(&@E>-=Q"L,-MS]>] '$>)=%L=-^& US2XHM-U33K&.Z@
MNK5!&VY5!*MC[RMR"#D'-:DGC34)[29M,TPW-W:6\$LUMY4A,DDD8D,:LH(0
MA6'+=SC QFM"?P>NHZ?::;JNI7%WIUOLS:!%C2;9C;YF!E@" < @'N#1?>$I
M)?$,NKZ;K=YICW4:1WL4"(RSA.%(W [& XW#MB@#(201>//$=W%91EWT&UF>
M";Y-YW3Y#X!YP,'@]*LZ7XFEAL_!FW3[2TTO6;1%7R\@6TIA#I$!TP0"!_NX
M[UJ-X8']L:AJ$=XR&\L4L?+*9"(FXJ0<Y)^=NOM4<O@VTN/!=GX9GN)FALXX
M4AN$^21?**[&!'1OE'(]Z (7\4W'F6=JD4?VB^6>>!UADE46\;*JN50$DMO0
MCH #UXP:+>+O$,C:':)H,%M?ZFER#'=SL@C>(9!X7.QN"#UYQ@=:V->\++JL
MNG75C?SZ5?Z=N6VN+=%8!& #(R,"&4[5X[$"@^&&.IZ-?OJ<\LVF^:2TJ*3.
MTHPY;&,<= H 'TXH HCQ5J%K>:U8:E:6T5[9VL=Q:I$[,+H/E0 2!_RT&SZD
M'O6WJ]G>ZCX9O;**Z6TOKBT>)9XR<12,I 8'K@$_6L6>TM_$?C*RN6TZ^@.B
MO*&N)XC&DQ.W:JY_UB[@'ST!1?6NBU2Q&IZ5=V!FD@%Q$T7FQ'#ID8RN>XH
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MNM 70[K4Y+G3S91VDB30(3A,X=",;'P0,X/W0>O- "?%"-)/A[J1>-9"AA9
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M =/U"9%N;709X9=SC[P$((S]0?RJ_P";%K/Q;M]4T^17L-(TV6&]O%/[HN[
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M6_OS<"#5VM8)"D:@1QW$84_*H!/O[5Z';-%:ZW!YFORWSW,9BBMY#%D$?,6
MC5>PY)ST'KR ;U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5I=.L9Y#)+9
MV\DAZL\2DG\<5,T,30^2T2&+&-A4;<>F*?10!472]/1PRV%JK*<@B%00?RH?
M2]/D=G>QMF9CDLT*DD_E5NB@"LVG6+JBO9V[*@P@,2D*/;CBIV1'0HRJR$8*
MD9!%.HH CF@BN(S'-$DB'JKJ"/R-0QZ;8PR+)%96R.O1EB4$?CBK5% $$-E:
MVSEX+:&)V&"R1A2?RI8[.VBC>..WA2-_OJJ !OJ.]344 106MO:@BW@BA#<D
M1H%S^5)/:6UT%%Q;Q3!>GF(&Q^=344 10V\%LA2"&.)3SB-0H_2B&UM[<N8(
M(HB_+%$"[OKCK4M% $$-E:6^[R;6&/>,-LC R/?%$-E:VX806T,0<8;9&%W?
M7%3T4 4_[)TW_H'VG_?E?\*N    # ':BB@ HHHH **** "BBB@#%\2>%=(\
M5V(M=5MA)L.Z*9#MDB;^\K=0?T]16C9P3P6RPW-S]I91M$AC"LP_VL<$_0 >
MU6:* *MKIMA8N[VEE;6[2??:*)4+?7 YJ6*UMX'=X8(HV<Y<H@!;ZXZU+10!
M4_LO3\,/L-MAOO?N5Y_2K BC$0B$:",# 3;QCTQ3Z* (9[6WN@HN((I@O02(
M&Q^=)+96LT:1RVT,B)PBO&"%^@[5/10!!)9VLT212VT+QI]U&0$+]!VJ5(TC
MC$:(JH!@*HP /I3J* ((+.UMF+6]M#$S<$QQA2?RJ>BB@ HHHH **** "BBB
M@"L=-L6NDNC96YN$^Y*8EWK]#C(IPLK47'V@6T(FSGS/+&[\^M3T4 51IM@-
M^+*V&\8;]TOS<YYXYI#I>GE0IL;;:#D#R5P/TJW10 @      Z 5%/:6UUM^
MT6\4VW[OF(&Q^=344 ($4($"@(!C;CC'I4%K86=CO^R6D%OO.6\F,)N/O@<U
M8HH BGMK>Z4+<012@'($B!L?G23VEM=!1<6\4H7[OF(&Q],U-10!4.EZ>S[S
M8VQ;KDPKG^53RP0SQ>5+$DD?]QU!'Y5)10!!!96MJ2;>VAB)X)CC"Y_*AK*U
M>X$[VT+3 @B0Q@MQTYZU/10!7EL+.>1I)K2"1V&"SQ@D_B138]-L89%DBLK9
M'7D,L2@C\<5:HH K-IUBUTETUE;FX3[DIB7>OT.,BBYTZQO,?:K.WGPVX>;$
MK8/KR.O JS10  8&!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !5633;&60R265L[DY+-$I)_'%6J* $ "@   #@ =JKKI]DEXUXEG;K=-
MUF$2AS_P+&:LT4 5IM/LKB0R36=O(YZL\0)_,BI3!"8/(,2&+&/+*C;CTQ4E
M% $/V2V%M]F^SQ>1_P \M@V]<].G6F1Z=8Q.KQV=NCI]UEB4$?3BK-% $#V=
MK).)WMH6F7&)&0%ACIS3;C3K&[FCFN;*WFEC^X\D2LR_0D<59HH :Z+(C(ZA
MD8896&01Z&G444 5KK3[*^V?;+.WN-AROG1*^T^V1Q3Y+2VE>-Y+>)VC^XS(
M"5^GI4U% $$UG:W$BR36T,CK]UG0$CZ$TEW865^JK>6D%P%Y431A\?3(JQ10
M! ]C:20I"]K T2?<0Q@JOT':DAL+.VD\R"T@B?&-R1A3CZBK%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !17,I<7ES\1+VR-[.EG:Z?;3I FT*SO),
M&)XR>$7OVK!L?$OB.;QP]E+"PM2R1L/LK@"+S)@)/+SN7=M"[R=OR9QAA0!Z
M)17G;>)?$8\="Q$+?9?.,6/LKX\GS0/-V9W?[/F9V?Q8Q1K_ (E\1V?C 6EI
M"QMDWB+_ $5R)1B+<=F=TNS<3E"!\W?:: /1**YJ]N+NT\>Z/;)>SM:WMO=/
M+ VTH"GE;<<9'WCW[UTM !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !17':3?ZE+9^)]0-Y/--:7EU!;0F'S$4)@H B ,Q]@<G-4/"GB+
MQ!?RZHM["R+$DTBDV[2[)0P'EY4@?+_SS/SG/7B@#T"BN!\&>(=?U37+RWU&
M%D@#,S$PL?+D\N$^4"#B/&XMM;+?/C/RFH?#7B7Q'?\ BPVM["RV[[?.!M74
M181ROR9W0[\ _.3TP,$B@#T2BN9\/W%X/%'B'3I[V>Y@M/LQA\[;E=Z$MR .
M]=-0 4444 %%%% !1110 4444 %%%% !112$9!&2/<4 +17 Z=XIU+2/%]UI
M6O3&;2[N[,&FZ@RJI24*I\B3: ,G.5..>1S6W::A=VFD:O=SW,EW+#<RQVZ2
M*BY(;:B#:HZD@<^M '1T5RWBJ^UC2/"R6VCL+K7&BQ"T@SO\M=SL1[A<#_:=
M:VM$U:WUW0[+5;0Y@NX5E7U&1T/N.A^E %^BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#E[/_ )*CK'_8(L__ $;<5TVQ0Y?:-Y !;')
M[?J:KRZ983WJ7LMC;27<8 2=XE+J!DC#8R.I_.K5 #=B[]^T;\8W8YQZ4%%+
MJY4%E! ;'(SUIU% '+ZO_P E$\,_]>E]_P"T:ZBJJ:9I\=^U^EC;+>,"&N!$
MHD(]VQGL/RJU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!R_@K[OB#_L-W7\Q73*BIG:H7)R<#&3ZU7ATRPMKN6[@L;:*YESYDR1*KOG
MDY8#)Z"K5 #514+%5 +'+8'4^I_*@(H=F"@,V,D#DTZB@#E]#_Y'SQ7]+/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!!>726-C<7<JNT<$;2,$7<Q"C)P.YXZ5@GQG -3DTW^R-5-[';"[:$0H6
M$18J&^_SRI&.O'2NEKC(2/\ A=5X,_\ ,O0_^E$E '76\Z75M%<1YV2H'7(P
M<$9%2UY_>7D^I7WC6"XO[FQFTF)&LO)G:,1)Y.\2X! ;+[LYR,+CUK?\/R/?
M1:3J6HW4L6K3:5&T]AYV$!;:S/Y7J&XW=LXH Z&BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1'+J>EO9WNS][;B1'!;'.TAB"#VSCWK2HH Y/X<:/>:#X0BTZ^L/L<\<\[E
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MGF(NT)*CMDLP'12.,\UU=% '*?$'3M1USP1=:?IMD\UW.T)6,R(NW;*CG)+
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M;(Y?<>IPN[O@8&>^*VZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M SA<9('?&1GZT 2T5534["2^:Q2^MFO%&6MQ*ID ]USGN*M4 %%%% !1110
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M::M]$88BAB._84)+'<.0<\=^* .IHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>exhibit1027supplycontrac016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
MGYL'@=LUU L;47AO%MXUN6 5IE7#,!T!(ZCV-6* ,/Q+>ZQ;6T46D:3<WK3,
M5ED@EB1H4[D>8RY8]!U ZGI@X<^E:A?V6AWL.AOILNBWZR0V+SQN\D&PH_*L
M5#8<D9;G;R>:[BB@#SG5_ ]_KL?B#4UVVFI7=Y:W5A',00GV90$W[<XW'?TS
M@,.^17766JZE>1QI)H5U97!P)#/)&T:>N"K$MWQ@<\9V]MBB@#SJY\(Z@_AO
M5?":6[&TOM3:=+S>NQ+=Y1*X(SNW#YU QSE3G&<;^N6-]<>,?#-Y;V4DMK9/
M<-<2JZ ('B*+P6!//H#7344 <?<Z5J6F>(O$&H6%HUVNL6D03:ZKY4\:L@W;
MB/E(*G(SC:>.F:6A^%+KP9?V4]G;O?Q#1HK"=8F56\Z)BRM\Q VMO8>V!ZG'
M>T4 <[X6\.2:)X(MM$GE4S^5)YSIT$DA9FQ[ L<?2N5M-)U6X^%>@VEE LFI
MZ)=0--9LX3S6MI/FCR>!G;N!/'0]\UWFJ:WI^BQPR:C<>0DT@BC8HS!G/11@
M'D]AWI-,U#2M3EN9M.GAEE5@EP$X=6 X#KU!QZC.* ..FTW4-4UCQ'=WGAJ[
M>QU*QLX5@DGB21MCR;QE9/E8!P0<]1U%5U\/>);>2QNQ)=:C;:5JJW%M#>.G
MVF6!H3&^YLX9E+G:6() .3TKTJB@#SK6_#&J:A:>*M0MK-Q/J<MB\%FSH'9;
M=E)).=H9L$ $]%&<=!HQ6FK6/B77;]])FNK36;:%DC62/=!(B%#$^6Q@@@Y!
M(SN]L]I5.ZU6PL;NUM+F[BBN+M]D$3-\TAP3P/H#0!Q4=AK>A^&]'\,KH-WJ
MUE;6:1WDT%Q @F8#F,"1U.SUXY&!W-:?BRUU;7/A_/;0Z2ZZA<>6?L8FC)CQ
M(K8+%@O0=B>>F:Z>\O;;3[?S[N=(8\A06/5CP /4D\ #DU)%(LT2R*'"L,@.
MA4_B#@B@#F]<TNZG\2>'M?M[9YO[/\^.:W!4.$F0#<,G!*E1D9Z$XST-6QT&
M\L/#OB@):MYVK7-S<PVBLN4WH$ )SM!)7<><?-78UEW/B+2[34([*:Y(FDF6
MW&(G9%E8;E1G VJQ!! )!Y'J* .<F\/:A<^"O"R?9F34M$DM+@VS.N7,2['0
M,"5R5+8.<9QG%:&EZ?);>(M>\3Z@OV6*XAABC25AE(8E8EVP2!EF;C/0#UQ6
MCJ_B;1M!DC35-0BMC)C&\'"@G +$#"@GC)P*FU:_TNRM8VU6X@CADE1$$IX=
MR0% '<Y(XH Q_AWI]QIG@;3X;J-HII#+<-&PP4$LC2!2.Q 8 CUKJ*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=%CUZWU>\CU.\MY[&2-'M5,@:9&'#@[8T!7[I!Z@Y]JI>,O^0QX/_P"PT/\
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MG+9 S(.OH?QJ#0=8L=6\]O#5GK%I?V-O#-%<2QJUK+&I0@[@0R,"/NY/!XH
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M"[2 21G<.*W[KQ;H]E9"\FGD^SB%)Y)$A=Q%&_W6<J#M'U[<]*P]5TO7-?\
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MQCM9$B6SDB#@ *Q'[L[STR1CI0!N>#M1N=2\#:+J5]*9KFXL8IIG"\LQ0$G
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M[O+6$R&6S=8Y@T;* 2H88)&&X(Z9K@_^$>UO^PC;_P!FOYW_  DQU/;YT?\
MJ/M/FYSNZ[>,>OYUWEK<7DUW>1W%CY$,3JL$OFAO/4J"6P/NX)(P?3- %NBB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#(
M7PMH*ZBVH+H]D+MG\QI!",E_[Q[;O?K6O110 4444 %%%% !1110!2L]'TW3
M[N[N[.QMX+B\?S+B6.,*TK>K'O\ _7-7:** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K)O?#&A:C?_;KS2;.:Z("M*\0+
M,!T#'^(?6M:B@!%544*JA548  P *6BB@ HHHH **** "BBB@ HHHH ****
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MDT:VDO(YK6#[;');6\DF+D']PI**<#*LQ!]%- ';7=[:V$/G7ES#;Q9V[YI
MBY],FJD7B#19Y5BAUC3Y)&.%1+E"3] #53P[J5IXM\-:3K#P*691+L8?ZF8
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MB@#(U_P_;^)-$?2;ZXN5MY"AD:(JK/M8,,G:<<J#QBM5%*QA2[.0,%FQD^_
MQ3J* ,C1?#UOH=QJ,UO<W,IU"Y-U,)BI'F$ $C"C'"@8]JUZ** "BBB@ HHH
MH **** .=E\'VT]C/ITNHZ@^FW$CO-:,Z%'WL69=VW>%))X##CBK4?AVVB\3
MOKZW%S]J:U%H8\KY8B#%@H&W/!).<YK8HH P;?PK;6USK-Q'>WOF:N0;DDIP
M0NP%?EX^48_^O5;_ (0>P_L;1]+%[?"VTB>.>UPR;@T?W,G9R!D_UKIZ* $
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M46WB#[3=1WD$!MPL;*$>,G)5AMR1G!Z\=L5#!X5@L;VYN-+U"^TZ.ZD,T]O
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.-P'KM&XD^BDUMPS1W$,<T+AXI%#HRG(8$9!% #Z*** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BH
M+UKA+&X>SC22Z6-C"CG"L^/E!/IG%<H-:\2-XNG\/(=*,T6G)?"4PR!26D9-
MF-_'W<Y]^E '945G-K%G9Q6ZZI>6EG<R(I:*295PQXP,GD9XJT;RU%\+$W,/
MVLQ^:(-XWE,XW;>N,\9H GHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *XZ&*?_A;]U=_9+H6K:+%;"X,#B,R+,[%=V,=&!KL:* . N[6Z@U+QI:7
M^GW5W%J\*M9/% TBR+Y/E^42 0A# GYL#YLYZUO>'XGTV'2=*OK6:;4K?2HU
MEU#R<QDKM5D\SU+?-CN!FNAHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** .$U&TAN_B_9VLP<V[Z++,T2R,JLXF10Q /) )&:2SDFTG
MXCW/A=KB>[TF^TPWT45S(TK6[J^QE#,2=A!! )X(XQ6O>^'=0F\:0^(K74;:
M(Q6+V8@EM6?(9U<MN$B\Y4=JDT_PR]IJM]K=Q>B[UFZB$ G>+;'#$#D1H@.0
MN>3EB2>] '&> GM+WP3X=-W::E+>W# &]R^ P9F#%\\CY0/?I6]HD:GXK>*%
M.XI#:V;Q(6)5&<2;RHZ G:,D5/H/A;6M \+6F@V^MVABMT\L3BQ82;2Q)Q^]
MP&P3@X..N#4T?AO5K7Q9JNN6FJV2_P!H10Q&&:R=]@BW;?F$HR3N.>* *?Q
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M 8="!Z\U<\6^'[CQ1X8FT=;V*U:8QEYC 7'R.K\+N'4KZUNH'$:B0J7QR5&
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M1B*"-8T'HH&!_*@#C/"3+XOFUK5M57[1''J,UG:6TAS'#%$0N=O3>3DECST
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>H'6LG4_!%KJ?B&/5WOKQ) &R%E;<I^3;Y;9_=@;3D ?-N.:=J/_ "4S0/\
ML&7_ /Z';4 =/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ INQ-V[:N[UQ3J* &F-"22BDGKQ2-#$VS=&AV'*Y4?*?4
M>E/HH 0@$8(!'H::8HVC,;1J4;JI'!_"GT4 -\M-@38NT=!C@4!%!R% /J!3
MJ* &1Q1Q B.-4W')VC&3ZT[:IS\HY.3QWI:* $**Q!*@D=R*;Y4?_/-?RI]%
M '*CPC<EKFWGU=;C3KB21VCGLT:8!R25$N>G.!E20,#/%=0(T$:QA1L4  >E
M.HH 155?NJ!]!2-%&[*SHK,ARI(R5/M3J* &F-"22BY/4XI=B[=NT;?3'%+1
M0 V2-)4*2(KH>JL,@T%%)!*C(Z<=*=10!DVFD7,>LSZA>ZG)>+EA:0F)46V1
ML9&1RQX R><9]36L0",$9%%% #$ABC=W2)%=^695 +?7UH$48=W$:AG^\0.6
M^OK3Z* &^7'Q\B\>U BC$ID"*)",%L<D>F:=10 P0Q!RXB0.3DL%&2<8S^5'
MDQ!R_EIN)!+;1DD<9I]% #0BC.% SUXZT1QI$@2-%1!T51@"G44 )L4,6VC)
M[XIK0Q.BHT:,JD%5*@@8Z4^B@!I1"<E5)]2*/+CX^1>/:G44 (RJWWE!^HIK
MPQ/LWQHVPY7*@[3[>E/HH 38I;=M&[UQ00#U .*6B@!D4,4";(8TC7.<(H S
M^%)]G@\_S_)C\[&/,VC=CZU)10 TQHQRR*3[BG  # &!110!&((1,9A%&)2,
M%]HW$?6G&.,G)12?I3J* &^6A &Q<#H,4!$!R%4'UQ3J* # SG'/K01D8/2B
MB@!KQI(FQT5E/\+#(I6574JZAE(P01D&EHH 3:NW;M&WIC'%)Y:;=NQ<>F*=
M10 A16 #*"!ZBF20131^7+$DB?W64$?E4E% " !5"J  . !VI/+0Y^1>>O%.
MHH 88HSG,:G(V].WI1Y,1E$IC3S ,!]HR!]:?10 C*KJ5=0RD8((R#2+&BQB
M-44(!@*!QCZ4ZB@!BQ1I%Y2QHL>,; ,#'TH$,:HJ"- B\*H48'TI]% "!%4D
MA0">N!2&.-I%D9%+KG:Q'(^AIU% #?+0Y^1>>O%(8HR23&O(P>.WI3Z* &F-
M"22B\]>*YZZ\-WKZQ<WEMJR)!<[/,M[FS68)M4+^[;(VCC.#N&23W-='10!4
ML]-M;*P@LXXE:*'E=RCKG.>F <DG@#VJP\4<A4O&K%3E2PS@^U/HH 0*%4*
M H& !TIOE1_\\U_*GT4 ,DBCE4+)&CJ#D!E!P:<45B"5!([D4M% #/*CQC8O
MY4X(JEBJ@%CDD#K2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1XD.YQQ_ST##!R/D]ZA\-ZG%J-EH##Q)<S:E<6\<\T&Y&5_D!D# +P.>W?%
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MHL?NRFX%7)_BS\P)(&,<7?$/B-=*\9"RUV_O-*TF>WC%A>186$SY;>)'P0&
MVX#?+C.: .\HJCHZ7,>DVR7EV+N<)\]P  )?1N..1@\<5>H **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHKC+^:_G^*-MI":I=V]C)I$EVT41
M7_6+*B Y*D]&/% '9T5YUJ'C*_\ !FL:SIVK3'4H(-*;5+&=D5)"%;88GV@
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M=3"%IYH"ZNKH %.<#@[G4CGL: .HHHHH **** "BBB@ HHHH **** "BBB@
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M8\*Z+J.DZKXBN+V.W6+4K\W</E2EB%V*N&!48/RYXSUKIZ** "BBB@ HHHH
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M* *R:?9)9&R2SMUM",& 1*$Q_NXQ4-OH>D6DRRVVE6,,J_=>.W12/H0*OT4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5RL.FZ@/BA
M<ZPUDXT]]*CLUF\Q.765W)VYSC##M7544 <3+HVK66J>*EALOMUKKB*\,GFH
MHAD\H1%9 Q!V_*I!4'C(QZ[>A6EYHMKIFA?9C-96>G1QF_,H^:1 %V[.O(!;
M/3M6W10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%4;G6=*LIC#=:G9P2CDI+.JM^1-6!=VS6OVD7$1M\9\T.-F/7/2@":
MBLV/Q#HLLBQQZQI[R.0JJMRA+$] !FK$>I6$MVUI'>VSW*_>A652X^JYS0!:
MHJM=:C963(MW>6]NTAP@EE5"WTR>:2+4K">Z>UAO;:2X3[T*2J77Z@'- %JB
MJ<FK:;#)-')J%HCPC,JM,H*#_:&>/QJ.#7=(NIU@M]5L9I7X6..X1F;Z &@#
M0HJ@NN:0]Q]G75;%IL[?+%PA;/IC.<U+=:E86,B1W=[;6[R?<6654+?0$\T
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MWDVFI6=Q+C.R&=7;'K@&@"[1110 4444 %%%% !1110 4444 %%%% !1110
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MMD"WT2QR.@PP*Y*,/=2<@T[7_#UOXDT1])O;FY6WD*&1HBJL^U@PR=IQRH/
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M08SO[,>E;5<OJ_\ R43PS_UZ7W_M&NHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKQUYIR312NZ1RH[)C<%8$KGIGTH ?1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCJ.-O1K>RL_B1";"&***?0E\QHEPLD@E!&XCJ^"QYYQFN\HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_2]2TJVU1=2BMXWNM3N+N,0RF3Y9'W '*CG_ #Q0 ZWU)K77O$!O;MOL=K'
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M"_?"D+\IX]1S6]K>KW^D?#:ZU:*>.[O[?3_-^T1Q_([[1F0+Z=6QZ4 =/17
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M5A(@/^K=1CY<8PQZ\5CZ5]J\02_#U[O4;M+BYT:[>:XBDVRL2(,_-CC/J.:
M/1]5UJUT>2PCNEE)OKE;6(HF1O;.,GL.#6C7E8N;^?1]$AO[J2[-GXM%I!=2
MXWSQ1LZJS$<$]5)[[:T;2_U+7+FZO(M9BL9]/UE[>6)IF(\I92BQ&+[I+KM(
M;KEN#VH [J_O[;2]/GOKR416T"&21SS@#^?TJ'3M4&H2W4)L[RUEMG"NMQ'M
M#9&058$JP^AXZ'%<]\485E^'>JEFD78J,-CE<_.HYP>1ST-(9'O/&UUX;DNK
MRWM;?3$N+<QW+K)(SR.K/OSN;;A0 21\W(/& #L:*\LT[4-;\0+X.AO=7O;5
MK^"_CN7M&6,S>4=J2CC@D8;TYXKMO$BZE#X?2+2I5DO!)$JK-/Y37 !!9/,
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M;.^L%MRK#]VL@BW*..AWGWH ]0HKS75-9U'PU<^+XXM0N;B*UM+*YC:Y;S#
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M$5R&/R_* V>O.,U?N?'NFVKWV^RU$Q6%XMI=S"$;(6;9ACELE?G7H">^,<T
M;IT?3&O+F\;3[4W-U'Y4\IB4M*F,;6..1CC!J.#0=)MK66UAT^W2"5!'(@08
M9!T4_P"R,G Z#-4=0\6V.FW4\4T%T8K:>"WN+A4'EQ/*5" Y()^^N2H.-P]\
M4)O%1FN/%5I=6-[;VFDQ!7N(&0R8,>\LN&R#A@1QQCG!XH ZBTL[:PM([6S@
MC@MXEVQQ1J%51Z #H*JQ:'I<,SS16$".[.Q(3^)_OGV+9.3U/>L^W\16J6EE
M!:0WU_.U@EWY2[6F$1&%9RS ;B<]\D@^E1?\)SI4@TG['%>7O]JQ22VGV>+.
M[8/F4Y(VL.G.,'KB@#2B\.:+ MHL.E6<:V;%K8+"H$)/4I_=_"HX?"WA^VF2
M:'1;".5)3,CK;J"KG.6!QP>34VAZS;:_I,6HVBRI&[.ACF7:Z.C%65AD\AE(
MZUHT 9?_  C>B?9A;?V39^0)OM C\E=HESG?C^]GG/6KMU9VU]:26EW;Q7%O
M(-KQ2H&5AZ$'K4]% %.VTJPL[>2"WM(4BE&)%VYWC&/FSUXXY[5%I&@:1H,4
ML>D:;:V*2MOD%O$$W'WQ6C10!472[!-2?4ELX1?.@C:X"#>RCHI;KCVJO;^'
M-%M-6GU6WTJSBU"<$2W*0J'?/7)QW[^M:=% ',ZYX2MKCPIJ>E:-9V=K-=V;
MVD;,"JQJP(P, X49SM Q6II&D6VFVT>RT@AN/*6.0Q<C Z*"0#M'.!@#GI6E
M10!GVFA:58%C::?;P;E9?W: 8#'+ >@)Y(%1Q>'-%ACM8XM*LT2T<R6ZK"H$
M+'J5'\)Z]/6M2B@#.M]!TFT#"WT^WC!1H\*@P%8Y90.P) ) Z]Z8?#>BFUMK
M8:7:+#:DFW5(@ODYZ[,?=SWQ6I10!1FT72[F"V@FT^V>*U8/;H8AMB8="H[$
M=B*B;P[HKZVNM-I5F=348%V85\P<8^]C.<<9]*TZ* *NH:=9:K:-::A:0W5L
MQ!:*9 ZG'3(/!J*ZT33+WR/M-C!*8 1$S+R@/4 ]<'N.AJ_10!2?1]-DN;2Y
M>PMC/9KMMI/+&81TPA_A&/2I;RQM=1@$%Y;QSQ!@X61<@,#D$>A!Y![58HH
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MD]G U]$ACCN#&#(JGL&Z@<G\S4T]O#=1".XB25 ROM=<C<K!E/U! (]Q4M%
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MY_UR0PJHD]F '(Y/'O18>&]$TJQGLK#2;*WM;C/G0QPJ%DR,'<,<\<<UJ44
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M(50BD(=S$)G.!R?:N[HH X#5?!FLW]UKMW#-90SSZC::C8$R.PWP*@"RC:,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>exhibit1027supplycontrac017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% '%?$HN-.T QJK/\ V_8[0QP"?-XR<''Y57N]*O\
M1=0U[Q1<:C:V-YJ1M;6)(4:5457"\9 +RMN(7Y< XZC-=9JVAZ?KB6Z:A"\J
MV\RSQ!9G3;(IRK?*1R#TI^J:/8:UIK:?J$!FMF*MMWLK J05(8$,"" <@YH
MXEO$NO0:7XH5?.DFTW48(8VECC,L4$BQ,YP@VLRAW(Z]NO>2\\0:UI,'B/46
MNWGTRWDMH;":>)$7,I17<L%&Y4+=>G4<D5?UWP9;?V9=+I&FPS2WEQ!)>QSW
M<J&=8R#\KY)5_E7YNIQR<\A=#\)QHETEW8S06%U 89=/N=2EO5DR1\QWDA<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !116-XDFEBMK%(I9(O.OX8G,;%259L$9%*3LKFE*G[2:@NILT5R
MOB6[U2PEM(;#S6AS$ 2/O/Y@ 4N6RV[H5(^K"H];U#6(=-TYX_-!D$1G8Q>5
MAS(@ )W':23MVX/!/(QFLW52OIL=5/ RFH-27O'745R6N:AJ\/A6*<&:*9X9
M#<N(/+,>%/.=YV$'IC=G]:=JEQJ/_"'7-_<//;7\&XJ$S%M^? & Q##'0YYZ
M\4.JM=-E<(X&347S+WI<O]>1U=%%%:G"%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5A>*"%@TPL0 -3M\D_P"]6[3)8HYDV2QI(O\ ==014R5U8UH5%3J*;Z#@
M0R@@@@\@BEI$18T"(H50,  8 I:HR"L'QFZKX3U ,P!:/@$]>16]44MO!<;?
M.ACDV_=WJ#CZ9J9+FBT:T*BIU8U'T:?W$M%%%49!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<[XWFFMO"MS<6
M\\T$T;Q;7BD*$9D53T]B:Z*L?Q/I=SK6A3:?;/$CRLAWRDX&UPW0#G[N*BHF
MX-(Z<%*,<33E/9-7]+ZFK\EO"26(1%R6=B< =R365%XBMY)+ O!-%!J'%K.^
M-KG&X C.5) )&?T/%226^I7W[B[6UBM'1EE$,C,S@J1CE1@<Y_"L^U\/W9L]
M)L;Z6&2WTN17CD0G=+L4JF1C"X!R<$YQ2DY7]U&E.G146ZKU_P" _O=[??ZV
MOVVN1W4UKY5I<M;7>[R;E5!0[1G)QRH('!/6HK;Q%'<W,-N+.X26XMGN8%DV
MJ752!@C.5/S#K4&B:1J^E6R::][;M86X*P2*A\XKSM5L\<9'(ZX[57TOP[J=
MIJ&F75Q/9LUK#+#.ZJQ>8ML.\D]6.WG/3WJ.:II_78V=+"ISU5EMJ]=VOT3_
M $Z%KKRZCI&A7M[:W4;7ERGE>3( H8AB-V&R5QG@CMR*OW'B2UMH9KIH96L8
M)_(FN5QM1L[2<9R5!."?KVYK/MO#FHP:/HM@TUJ_]FW*2[@6&]%# =CR=WX8
M[T]O#-P=/U'2!+$=-O;AIMY)\R-7;<Z 8P><X.1C/0XY2=1+^M[&DXX-SWTN
M^_P\W3SML3WOBJ*RDU)3I]Y(NG;6N'79@(PSN&6Y&.W7VK;F5Y[9EAE,;.N%
MD R5SW&>]<]?>'KVZ7Q$B/;JNJ0I%&2S?N\)LR>/?-;K+=IINR#R1=B/"[R2
M@;'? R16D7*[YOZW.6M&BHP=*U]+_='];F+IMK<V'BF:VAOKNYL3:"25;F4R
M&.4MA=I/(R W'L*Z.L72+36K:7;?26!A.6D:%7,DCGN2>/\ ]0 P*VJ=-61&
M+ES5-T]%JNH44459RA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L+
MQ00EMITC<(FHP.[=E ;DGVK=HJ9*ZL:T:GLZBG:]AL<B2QK)&P=&&58'((IU
M%%49!6!XREC7PQ>0%QYLR8C3NYR.@[UOT5,ES1:-:%3V56-2U[._W!1115&0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=BI4[L]L,>F*A7PM]DU74K[2]1GL?[17-Q B*T?FXQYR@CAR,9[' )!KH:*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !111G/2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHS0
M4449YQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM*T2Q_M6-AI6HO?A_LI'F%C(=I&_C_6MS[#\0#L:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBN:\<)JS: DFD6\ETT5S'+<VD4OER7$ /SHK>IXX[@$=Z .EHK
MSW1_%&B1:3K_ (@T9[IULK57NM(N9'CDM6C$C-A&SL+ XX^4E?K71-XGQK"Z
M>+%W:33&U&-ED&6 95*8.,'+#G- '045Q=EX\N+X:&Z:#,$UNV,MF?M"9WA
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M89PP[$=Q5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,XPQ(QD<, <'I69?>%=6O!XO'F66==LTMXFWN/+(B,99AM/'S9P">F/>B_\
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M[5&$\R%"BEPW"D YXSD@<CG,>G^&O$BWWAB34)],9-$62)I(F<M<(T?EAMI
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MWNOBG?FWN(IA'H\*/Y;AMK">7(..A]J .NHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MNJP7MR([>=( [!7)PS;  $&#\V.F,UO4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ5&]\9Z3I^FW]_="[CAT]U2[!MVW1%L8XZD?,.1D<]: )X7UR*",C3[)2]X
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MH]=URS\.:5)J>H>:+2(J)'C0OMR0HX'/4@4 :5%9L&LQ37D5JUK>0O*&*--
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO$]_8P7$D))B>1 63/7:W4?A39]#TFZT[^S[C3;26RSG[.\*M'G.<[2,=>:
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MT/2I9;N633;5I+Q!'<LT2DS*.@<X^8>QH XW0;J74]2L- N+BYMK:+P]:W,
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MLVYP?F/R]00?SQB@">BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHJ&ZN[:QMGN;N>*"!!EY)7"JOU)H FHK.AU[2YY5
MA2\C\Y@66)@5=E R2%(R1CN!BH!XKT V2WHU>T^R-)Y0G,H\LOG&W=TSGC%
M&Q15:]U"TTZ-)+R=(4=PBLYP"Q. /J20!ZYJR#D CH: "BBLR7Q#I$,LT<E_
M"# =LS9RD1]';HI^I% &G169<>(M'M#:B?4;>,W:;[?<_P#KEQG*^O'/%,?Q
M1H4=K+=/JMJL$,@BDD:0!4<XPK'L3D8SZT :U%9T&O:5<S^1#?0O-L,GEJ?F
M*C&2!WQD?G4$'BOP_<K&\.LV+)*_EQMYRA7;.-H/0G/&* -BBJ=]JMCIK1K=
MW*1O+G8G)9@.I '.!D9/;--76M,DTT:C'?V\EDS;5G20,K-NVX!'4[N,#OQ0
M!>HJHNJ6#:>VH"[A^R*"6F+@*N#@Y/8@@@CL>*=:ZA:7D#SV\Z/&A*N<XV$=
M0P/(/L: +-%5K'4+/4[475C=0W-N691+$X925)!P1QP0126.HV6IQR26-W#<
MI%(8G>%PP5QC*Y'<9H M45EP^(]%N=8DTB#5;.34H\[[5)09%QURO48J:+6-
M.FNA;1W<;2EV10#PS+G<JGH2,'('(P<T 7J*KSW]I;75K:SW$<<]TS+!&S?-
M(54L<#O@ FH9=8TZ&Z-M)=QK*'6-@3PKMC:I/0,<C /)R,=: +U%9FK^(M&T
M 0G5]4M+'SL^7]HE";\8SC/7&1^=37>L:=8-&MU>10EUW@.V/EX&X^B\CD\<
MB@"[152^U.RTU4-Y<QP[\[0QY( R3CT Y)Z#O2W.I65I;QSS7,:QRD"(@Y\P
MD9 4#[W )X["@"U15-]5L([&.]:[B-M+M\N16W"0GH%Q]XGL!2G5+ :<-0^U
MP_9#C$V\;22< ?7/&.N>.M %NBJT.HV<]FUY'<Q&W7=OD+8"8X8-GH00<@]*
M=9WMMJ-G'=V<\<]M*-T<L;;E8>H/<4 3T444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@EE\Z0ESO:7=N\S=G.[< 0<\8&.@J>RTNVT];@P!_-N7WS3.Q9Y&P%!)/H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBLKQ%J+Z;HTLD&XW4I$-N%C+GS&X!V@$L%Y8@=E- &C#
M-%<1^9#(DB;BNY&R,@D$?@01^%25Y]X FBT77M8\)H;K[*I&H:<;J-T=HG.)
M%^< G;)DY_VZU-$UG5];L--U^":S&F7+R&>V=2&CB&X)M8=7R!D'CDXQCD Z
MVBN3T/4]<U[3](UJWN+)+#4(7DEA=#N@#+F+8?XF!P&!P#SC'2N=T/7?$,/A
M3PE*M_;3S:O?O!-)<6Y+#<)7W<,,\ITP.N.* /3J*X)?%FKVNA:D]SY$T]CK
M:Z;+=K$51(6:/,S+DXVK)SSCC/3-;/AO5-3U'5=:AN)K>?3[.X6&TN(XB#,"
MBL26#;3M+%3A1R/J* -.ZU_1K&Z-K=ZO86]P!N,4MRB/CUP3FKEM=6][ L]K
M/%/"WW9(G#*?H1Q7(M_R6N/_ +%U_P#TI6L2ZN)?#WQ,\0IHIM(()=!%_<)<
M/LMTNA(55WQ]W*]<<G&: /3J*\QU[Q-K#^'_ !O:Q73Q-IVG0W-O=-;^5*1(
MLFX;3TYC."0",^P-:OB77]8T.PNV@N[:62RTIKQ46 L\CJ6/[Q<X2/:N,Y!)
MSCI@@'<T5G6KW]S=6UYYT*Z?): FW\L^9YI((;?G&W&1C'7G-7+EY([69XEW
M2*C%!ZG'% $4>I6,UX]G%>6[W29W0K("ZXQG(Z]Q^8J)-<TB35FTI-4LFU%1
MEK03J90,9^YG/2O,[&62+X>_#N\A<M>2ZM;,\G\3&4R>=GZAGS76ZSX?L;_5
M=%L[*VCCFL+Y=0FG1?FC4;B06ZEI&.#GJ-Q/2@#J'O+:.ZBM7N(EN)03'$S@
M.X'4@=3BJUSKFD6>HPZ==:I90WT^/*MY)U61\],*3DU@:Y&@^)7A.0(H<PWP
M+8Y(V1]Z/&6@6.L:1<:/#:Q&_P!4D5O-VY>/:5S,3U&Q0,>^U>] '27>I6.G
ME!>7EO;^9G9YL@7=CKC/U'YU'J6M:5HR1OJFI6EDDK;8VN9EC#'T&XC-<M9*
M+WXB>+X;\;X8=.M((E?IY3B4O^;=?H*K^$6M[GX7Z-J&K62WU[/IR6RQRJ&>
M<<[4&?[PP2?Q/ X .WN+ZTM+0W=S=0PVP )FDD"I@]#D\4W4-2L=)M&N]1O;
M>SME(!EN) B@GH,GBN$\2:%_8?P/DTFX=;B6RLHT+GD;@R_=SV'0>U=QJ$5@
M%6]OXXV6V#%6D7<%SP2!ZGIZ\X'6@"1-1LI=/&H1WENUD4\P7"R Q[?7=G&/
M>FC5-/-A)?\ VZV^QQY+S^:NQ<=<MG Q7G-WI$VB:1X>LS%]GMM2\4K<2VH^
M[#&S/(D6!P,%4R!QNSBMK3H8;CXC^*K:XC22QCBL;MED^XLVUQN(Z9VHAY_N
M@]A0!U5EJ^FZC8&_LM0M;FS7.9X9E=!CKE@<<4FG:UI>L0//IFI6E[#&=KR6
M\RR*I]"0>*P=!\/VDE[KVHM:HEAJT\3QVVW"NL:@>85_VVR<=P%SU(I-.T&S
MOO$^LZO';HFGWEI'9%$&U;K86+2$#J,,$![A3V(R ;VFZWI.L^;_ &9J=G>^
M2=LGV:=9-A]#M)Q4L&I6-U<R6]O>6\L\6=\<<@9EP<'('3GBN/U+3_+U?6O$
MFD0I";+1I[.-XE \^8?..G4)L SZLP_AK'$R:7H7PQNK<MN 02% 6+Q-:,\N
M0.3DJ&^H% 'IDEW;Q7,-M)/&D\X8Q1LP#/MY; [XR,U&=2L1?"Q-Y;B[/2 R
M#?TS]WKTYKS"/Q)I=_\ $;PQJ$EQ+]JN%NHVC:WE'DJRH(XQE?4DDCC)/.,5
M#+/<?\*BU/5,G^U?[=:?=_$LRWP11_WR N/3B@#U6;4K&WNX[2:\MX[B3&R)
MY &;)P,#KR0:+C4K&TN(X+F\MX9I?]7')(%9N<< ]>>/K7F=V[3^#/B?=W3$
M7,=[<JCDX9!%#&8<>F."/<YI;.2;4M$^(MQJPQ<_9EC<-P41;-77'I\SLWU)
MH ]+O-2L=/V?;;RWM]^=OG2!-V.N,TZ[O[/3XEEO+J&WC8[5:60*"<9P,^P)
M_"O/?!DUQK&OZB^M9>0>'M.7;)_=E1VE_-AS]!6=\.;R]U#6/#']H.[B'PNT
MD._G+&<(6^NQ8^??WH ]7\^(0>?YJ>3MW^9N&W;C.<],8[TD%U!=0">WFCEA
M/21&!4_C7CN@S:CJ\VA^&XVB&G176I7($ZEHY8X)]D2$ C<JEL[<@?*OIBM;
M4?$.I>*$T;0)((K2:XU>XL=1 9C%(+="Y4'@E'PO'!(RN>IH ])AO[.YMWN(
M+J&2!,[I4<%1CKSTJ/3]7TS5T=]-U&TO4C.':VG60*?0[2<5R\,VH^*=+U[P
MW+)%IE_87"6SSV\/F1/&5612$8]&4X*DGOSS7/:CJFM:9X5U/0S#9VFK#4;7
M3_MUA'Y,<B7!4"7 ^XVTD'K@X([4 >G07MK<RRQP7$4KQ';(J.&*'T..AJ"S
MUK2M0NI;6RU.RN;B'/F10SJ[I@X.0#D<\5SFFW%Y#J%_X+\NWL6ATY9K&[LT
M.U8V+)RK$X=6&>ISUXK-TBZNO!$VHZ=JUM:7:VUBMU;7UC:")YT#;/+D1<_,
M&*\C@@Y[&@#O1=VYO#9B>,W(C$IAW#>$)P&QUQD$9JM8ZYI&IW4]K8:I975Q
M <3103J[1]OF .17GGAW5-+O?B==(+N2XN+_ $=%FD$$L8>3S)"P&0"JA< '
MT Y)S73_ -B6ESXWTV^T^VBMX=(MYH9)(4"AV<*%BXZA0"Q]"5]\ &[)K6E1
M:DNFR:G9)?MC;:M.HE.1D83.>GM1=:UI5C>Q65WJ=E;W4V/*@FG5'?)P,*3D
MY/'%<A'8:IX:\86MQ=O9:K8ZM>.@F-HL=S:2,K,N'&=Z84KSR!CM1J]AJF@>
M)TU^1[+5-.O+Z&&6"6T43VF]EB1HI.20&*Y!]21R: .]HHHH **** "BBD8
MH020,=0>E %!=>T=[O[*NJ637&_R_*$Z[MV<;<9ZYXQ5V66.&)Y976.- 69W
M. H'4D]A7F%E-?>#X=)T/Q'91:AH"W,*Z;K5KC,;;QY7G)V))QO'!S[FNB^(
MKR?V3I%N"?L]UK5E!<^AB,H)!]B0!^- '46U_9WL#3VMU#-$I(9XW# $<G)'
M2F6VJ6%Y!)/;7MM-#']^2.565>,\D'CCGZ5Y7\0;FYMM<\36UJS+:W6FZ=]K
MV] 6NC$Q/UCR#[#VKJKJ))/BLEB8P]I=: XNHL?*P690F1WX=QCT)H Z&R\2
MZ#J5RMM8:WIMU<,"1%!=([$#KP#FKS7=NEW':-/&+F1&D2$L-[*I ) ZX!8<
M^XKEA#IMGXHU'4XK***VT2Q*-]F@&XR.!(X 4<D(L>/^NAKF=,U_3;OXI:3>
M-<R27EUIUS'(/(E C8R0[(ERH^4 -STR2>-V* /3I;VU@N([>6XB2:7_ %<;
M. S_ $'4U!<ZUI5E?16-UJ=E!=S8\J"6=5D?)P,*3DY/'%><^&->U2QT73O%
M-Y!;W*>(-26&Z(W>= KR&.(*>FQ/E&S'<G.2:U]4L-4\/^*8]<D>SU33KZ_A
MAEBEM%6>S\QEBC:.3DD [<@^I([T =E+JFGP70M9;ZW2X)4")I0&R>@QGOV]
M:MUY/K]Q-8ZGKH+/<^%+G4(O[4N(TS+93!8]P7GYH\+'EL93)QG''IVI6LU[
MIEU:V]TUK+-$T:3HN6C)&-P'J* (['6M*U.:6&PU.RNY8O\ 6)!.LC)SCD \
M<T:EK6EZ,L3:GJ5I9+*VV,W,RQASZ#<1FN:\'Q7VBZQ>^'M1@L)'BMXYX+^S
MMA!Y\1++MD0<!E([<$&M7Q=87-YX<U)-/TVUOKV>V: 1SOLW*0> =IYYX!P,
M]Q0!I:AJVFZ1:BZU*_M;.W)"B6XF6-23T&2<59BECGA2:&1)(G4,CH<JP/0@
MCJ*YK29(M2\!Z;>Z1IL4S_V>J6L%^^,*5 V,VT_W0#QSBCX=O"? FF0PVTMK
M]F5[:2"5@S))&[(XR."-RMC':@#J**** "BBB@ HHHH **** "H;F[MK.,27
M5Q% A8*&D<*"3T SWJ:O,[G4M7;Q%XM\0016MPOA\"WMK6XW9V"(2RE".%9]
MWWB#PH'2@#T6:]M;?R?/N8HO/<)$'<+YC'H%SU/M3;S4++3D5[V[@MD8X5II
M @)QGC/MS7(^*KF#4[+P;J4<6!/J]I+&77YE5E8X_6ID9Y_B_<13\Q0:$A@4
M\CYYF\PCZ[$!^@H ZFYOK2SMQ/<W,,,+$ /(X523T )J6&:*XA2:&1)(G4,C
MHP*L#T((ZBO(_ MS<W6K>#[>Y9C:V]GJ36N[H2DXB3\HS@>Q]ZZ_X?22&TU^
M Y^SV^NWD5N.RIOS@>P9FH Z7^U-/^W?8?MUM]K)QY'FKOSC.-N<YQS]*634
MK&&\2SDO+=+I\;86D =LYQ@=><'\C7ENJQZMIGA2+0[JPG_M=_$"/97RLA29
MGN?-$@.[<#Y9<$8X .>*6^FE?X=_$.^F9A>1ZM<LDG\2&)D$./H%0B@#U&YU
M*QLYXX;F\MX99?\ 5I)(%+<XX!Z\D#\:+O4K&P>-;N\M[=I/N"60*6Z=,_4?
MF*\]C9[]/B2^IKB1;=(2K?P1"TW #T&YW/U)J#P;//K+^()=;S)(=!TZ-A)_
M<>V9Y/S=GS]/:@#TJ\U"RTZ-9+V[@MD8X5II @)QGC/MS4>H:QIFDVJW6HZC
M:6=NY 66XF5%8GH 2<&O./A[=WNI:]HK:FS.T?A2!XO,YW%Y2';ZD)'FM7P)
M]C/P^L[[4H%G%LUS;6^]-[&+SV5$4'J2%10!UP!0!V[7UFEC]N:Z@6TV>9YY
MD CV_P![=TQ[TZ2[MXK0W4D\26X7>96<! OKGIBN&N] _L+X)ZQIEQ&FZ+3+
MV7ROO+"761PB^R[MH/M3O$+R&T\"6V2+:?4K;SO1ML3.@/\ P)5/U H [6&^
MM+BT-U#=0R6ZYS*K@J,=<GIQCFBTO[2_B,MG=0W$:G:6B<, <9QQ[$?G7D_B
M>XN$\0^)]/C)&GW&J:,MP!]T>8P63_OI4C!^OO77PLZ?%Z^MD'^C3Z'#+.O8
MR"9U4GWVEA]!0!U=K=VU[$9;6XBGC#%"\3AAN!P1D=P>*FKD?AVBQZ#J"(H5
M5UB_  & !]H>NNH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *HW>EQWFHV5Z\\ZO9LS1HK#8205)((Y."1[9.*O44 9%]X=M+_7K
M#6I);B.\L5=(3&X"[7QN##'S X'7ICC!JKIG@W2](U&2ZLWO%B:5IELS<,;>
M.1L[F6/H"22?09X KH:* .>T;P;I>A79FL7O!"':2&T>X9H(&;.XQIT&<GZ9
M.,9IEOX(TNU@L(()KU8M/NC=6R&;<(W.X8&0?E =ACW^E=)10!Q6O^&)+;3)
MTTR"_NQ>ZDE[>K!=+%.I !WQ$[5SE(^"<8!QS5_PMI^H6DDTL\VL"U= %@U6
M>.:0-G[P*$[1CL6.?08YZ:B@#$N?#-M<^(/[;%Y>0WWV?[*&B=0!%NW;<%2.
MO.>M1OX-T632M2T][>1EU+F[F:5FFE(Z$N3GCL.@["M^B@#FCX&TF3^TOM$E
M]<'4K1;.[,URS>8B[L$_[7S'D=.U-N? >DW9F,T^H,;BR^PW)^UL//C^;&_U
M(WMCZXZ<5T]% &;9:+#8W-O-%<WK""U^RK%)<,R%<@[BIX+\8W>G%:5%% &-
M:^&-.M+F"6-9#%;2R3VUNS9C@D?.YE&.IW-C)(&XXQ5&/P19QWKW/]JZVQDG
M\^2(Z@_ER-D'#*.". ,=,<=*Z>B@#,N]$M[W6K#59)9Q<6(=80K * X ;(QS
MD ?3'&*SK[P9:WVI7%^VK:W!-<8#BVOWB7 Z !>@&3^9/>NDHH Q[SPW87D@
MD!F@<VWV.1H7VF2#^XQY..N",,,G!&35?4?"%EJ$UI(MYJ-DMI#Y$$=C=- B
M+Z +[ #Z 5T%% &)=>%K*\\,MH$\]Y):2<2.\Y:63YMQW.V3UI^L^'8=<AM8
M[F_U"+[,V]6MK@PLS8P"2H&2/ZUL44 8<7A6P32I+":>]NE>99Q-=7+2RI(I
M!1E<\C:5!';KZFFW7A*QN]/N[62XO%:\E6:ZN(YMDLQ4  %@!A0 !@ #CW.=
MZB@#G8_!]JEA>VC:GK$PNT$;R37SNZ*#R$)^[G/..M%IX/M;..=$U369/-@,
M ,U^[F)3C.S/W3P!D<CM7144 <_I'A&ST:XBEBO]5N%B0QQPW5Z\L2#&.$/&
M<<?0FI[#PSIVG3VTD(D9;-72SB=LI;*WW@@Q^'.<#@8'%;-% %&YTFUNM6L=
M2E5C<V2R+"0V !( &R._W151O#&G-=M,5D\IKH7C6V[]T9QC$F,9SD XSC(S
MC/-;-% &->>&-.O;FYEE601W;1M=P*V([@IC:7&,]@#@C( !R!BEO_#.GZC<
M7,LPE5;R-8KR*-L)<HN<!^/<CC!(.#D<5L44 95_X?L[^Y^T%IH)FMS:R/ V
MPR0DYV'CIG.",$9.",FB?P_8R?8FMP]G+8Q&&WDML*8XR "@R"-ORKQC^$$<
MBM6B@#&_X1C38X-.CM8WM6TW/V26%OGC####+9W!N^[.3SU -*_AC36L8+94
M=&@N3=QSJW[U9R26DR>I.YLYX()&,<5L44 8TGANV>TDBBN[ZWFEN!=2W4$V
MR620 #+$#!& !MQC  QQ4DWA[3KG2KC3KB-YHKE@\SNY,CN,8?=U##:N",8V
MC&,"M6B@#(?P[;R17GF75X;J[B6&2\67RY@BY*A64#;@DG@<DG.<U9T_2XM/
M+2>;/<7#J%>XN'W.P&<#L !D\ #J3U-7J* ,Z31K635I]4#2QWDUH+,R(^-J
M!F88]#ECS69I7@RRTFY@FBU+6)E@)*07%^\D62#R5)P3R3SWYZUTE% &1IWA
MZ#3WC=[R^O6A+&$WLYE,6<@X)ZG!(R<G!(S@FBW\/007;SRWE]=*9C/'#<W!
MD2)R<_*#S@=@20.,8Q6O10 4444 %%%% !2$;E(/0\4M% '/P>$+&*ULK)[J
M^GT^R9'@M)Y0Z*R8*$G&]L$ @%B.!QP*MS>'K.YM=0MKI[FXAOIO.=9IF;RF
M&W'E_P!P J&&.AYK5HH R!X;TY[;4(;I&O#J*A+N2<@M*H&T#@   =, 8))Z
MDFIK#1K>PNI;OS)KB[EC2)KB=@S^6N=J\   $D],DG)S6C10!5L=/AL!<>3N
M+7$[SR,YR69OZ   >P%1R:3:RZW;ZNRM]KMX)+=#NXV.5+<?5%J]10!BP>%]
M.MY$$8E^S1W)NXK0L/*CF))+ 8SU);&< G( .*?:^'H+>Z::2\OKM?.,\<5U
M<&1(F))^4'G SP"3CMBM>B@#&F\,V$[WH)F6VOW$EW;*P\N9L $D8R,A0" 0
M#CGJ<R7>A1WCW[F_U&(WB1H?)NF3RMA)!CQ]TG//KCFM6B@#.@T:""VN(_/N
M9)KB/RY;IY?WQ&"!AAC;C)(P  23U)JN?#RYM@NJZJJ0VRVS(+DD2J/XF)!.
M\]W!!]ZV:* ,N;0XF%DMI>7EA%:1^5'#:2!8RF  "I!!P!P>HJ[9V=OI]I':
MVL?EPIG R2<DY))/)))))/)))J>B@ HHHH **** "BBB@ HHHH *Q[SPU87E
MU>3L9H_M\:Q7L<3X6Y4# #<9S@D9!!(X)X&-BB@#+U30;75EL5E>6);&=+B!
M82% =>%/0\#)XZ4^_P!%M[^[BO/,FM[N*-H1/ P5S&V"R'((P2 ?4$9!%:-%
M &2WAS3A;:?#:QM:?V<,6<D! :$;=I R""".H(.>O4 TL?AZSM[2RMK:2YMX
MK2X^T 0S,IE<[BWF'^,,6)(/4UJT4 4%TBV_M-=1F,EQ=1JRPO*01"IZA
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !114,]W;6Q GN(HBW02.%S^= $U%("" 0<@]"*6
M@ HHHH **** "BBB@ HJM/J%E:S1PW%W;PRR\1I)(%9^<< GFI?/A^T"W\U/
M/*;Q'N&[;G&<=<9[T 245&T\*3QP-*BS2!F2,L S 8R0.X&1GZBAYX8Y8XGE
M19)<^6C, 7P,G [X% $E%5EU"R>\:S6\MVNE&6@$@+CO]W.:LT %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ^P7OEM!:GI;$&0NJ^BDON [$FIKS1+N+Q))KNEM!]HGL_LDT<Y*J=K%HW!
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MC8OF^5G9OQSMSSC.<9J6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$!4KTW$9?=US@9QQ6[96WC(:PUU=VN@A9) K2I=3.\4&[.Q%,8&<=23R>3P
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MLK2*?F5>5+#ZXH K:IKMSX,U6"&XN9KZWGTBZNG\YLMY]NJL6'H&#'Y1P,#
M'.4L=7U'3Y?!MQ=W<EP==0QWBN<JLK0^:K(/X0"I7 Z@\Y(S6C+X7N=<U&.[
MU\0 1:;+8+%;N6#&; E?)48X4 #GJ:9I_A>_\_PXNI26[0Z!$RQ-$Q)N)/+\
MM78$#;A<G&3R?0<@%CQ#J<D7BGP]HSS/;V>H_:#)(CE"[HH*1AAR,Y8\$$[,
M>M<S9^*]0N[FW\/+=N\C^()].-ZI&][>*/SCR/X\$(6'/4]>:[&YM=2U'11;
MZCINDSW;.YV2$R0)ACL;#+ECMP<<<Y&1UK*7P-'IVGZ/_9LBO?Z9>M>F6;Y?
MM+R!EFW8!V[@YQ@'&%'04 8]]XKU#3[O4_#L5PYN$UFRL+:Z;YGCAN5#DG/W
MF4"0 G_9SGG)X@\5W_AF\UW2+>9Y9!!:2Z?),?,:(SRF%@2>6"D;QG/4CIBM
M.Y\$S7B:AJ$LL*:Q<ZE;ZE%@DQQM %6.,G&2"JD$X_C.!Q2ZGX)FUXZW>7LD
M4%]?1V\=MY9,BVX@;S$).!G,A)/'3 ]Z ,[Q+XJNO!-YJUK'++=QIHIO[;[0
MY=EF601D$]2I+H<=L'&,UJ&[U#1?%6E:,;V2Y_M33YVWW!W[;F((=_LK!SE1
M@?*, <Y35/!;^)[C5+G63% ]WIG]FQ) YD$0+;V?)"Y.[9@8Z)[\6TT75;C6
MK36K];-KS3[&2WMHDF;9)+)MWNS;<J#L4  '@F@"I9VNK:1XZL[./6K[4[*Z
MLYIKR.\*-Y+*RA'4JHV[BS#;T^4XZ5<T6\O9/'7B:RGO)9K:WCM'@C<*!%O$
MA8# 'H.N3[TS0;7Q9!?A]5@T0),Q:ZN+>XEDE? .U55HU"J#C R<#/4DFK6F
M:1?VGC'7-5F%M]DOX[=(@DK&0>4''S J!SN[$]* .4B\47Y\(VOC0W$NV?51
M&UKN_=BU:X, 4+TW 8?=USQG'%.OO$FHMX>\4>)X;B1#H^H20VUN&Q&T4+*K
MAE[ESOY/(^7&,<Z4?@JY72K?P\SP?V+;ZE]M5]Y\QHQ*9EB*XQPYQG/W1TR>
M%O?!=U-I^N:)#)"-+UB]-U+(7(DB5RIE0+C!R5.#D8WGCY>0"[JM_=IXT\*Q
MV]Y*ME>BY\VWPNU]L6Y2>,\9]<5U-<]JVC7UUXI\/ZA:K:BTTTS>:'E97(=-
M@V@*1QUY(K7U'[=_9UQ_9JP&]*$0_:'*QANQ8@$X_"@#DG\2W\'Q!M$E91H%
M\9-.@;'2[C^8L3_M?O$ ]8_>IO'NH:C9V]J((=:CTX%I+R]T@1--"!C VODE
M>220I/RCUJ#7/ :7GA".STRWL[?6H#%+!=NY^2=&#>87"Y))!SQSDUOO-XE$
MMN$L=*9'@_?L;N0&.7/.T>7\ZXQ_=/\ .@#%UBPU'4O!5I>^%]=O)[J&%)X)
M6F&+]/O;7P  6'< $''05-X8U0>,?L_B*UGNH--6/RX[4RX\R0??,@[;3E0.
M_).1MJ?^P+VSTG2] L/L_P#9,2B.\E:9DE= #E44*0-QZ_,."0,<$5K#P[JF
MA^-+Z]TA+%=!U!%>XM6F9&2X'!D10A49  (SR1F@"#QKXDU#1;RSNK,C^SM-
MECFU?C),,A,8 _W<ES_NKZU+\1=0GT[0;&\M+Z6U)U&UB>2*3 ,3R!7![=#U
M[58B\)PZAINH_P!O:?8SW]\\IE*2%U*GY47<5!&$"KT[9[UBR>%/%-SX$T71
M+N33);[3KJWD:?[3)MDCA<,O_+/.X@ '\_:@"?6];BG\9^$K'3-6<PW,\T=U
M%#.3O186=<_\" YZFNA\4:S)H^G6XM]OVR^NXK&V+#(5Y&QN([[5W-COMQ5/
M7M%U34O$OAK4K9;,0Z9-++,LDS!FWQ%,+A#G&[/..E+XVTV:]T_3;R!&D?2]
M2@OS&@RSHA(< =SL9B!W(Q0!4N]1NKOQS:^$K6ZGAMH-/-_>SJW[V4%]B1AO
MX<G+$CGH!BKVHZ;=V4%]/;ZI=_8UL)=L+REFCE&"KJY^8]#P21Z=34&IZ'=2
M>)K+Q9H,MM+<_9#:3PS.5CN8"V]2'4':P/(.""#CBM&ZAUB_TN]C>&TAEEMW
MBCA\XLI9AC<S[,C'H ?KZ '%B?Q'<> /".IZ1J,KZU=+%)(MQ)F.Z)A>5D8'
M@;MN 1C&:W+/Q%!XFCT"]LY;FV,E\]M>VA<HT3K!*S12#U#(I]P/0T_2- UC
M3O#WA;3W2Q>722@G87#[6587CRO[OD_-G!QTZU)<^#D'CJQ\2V,_D?,QO[<?
M<N#Y3HDF/[Z[R,]P?;D ZJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *JZEJ5GI&GRWU_.L-M$,LYR>IP  .222  .23BK5<+\3O-@M/#VH
MLK-IVGZS;W-]@9"1#(WGV4D$_GVH Z%O$*PBW:ZTS4;:*XE2&.22-2-SL%7<
M%8E.2/O >G7BHE\4PRZSJ&E6^FW\]U8"-IPBQX <$H02XSD*?RYJCXTU>[T^
MUT*73KF,)?:M:VCDHLBF.1OO+GN."#TK&M[*^OOB-XVAL-4DL9C9V*AUC5LD
MI+@G(XQ[>M '2/XOM4N],M%L-0>XU*)Y;>,1JI(3&\'<PVE=PR#2ZCXNM-)T
M:_U2_LKZ""Q8"=6C4LH(&&&&PPY'0GOZ5C>*8I9OB=X-2&Y:W<V^H8=55C]V
M'L015+XA^9;_  K\465SJ'VV[CB\QW*@%4>3* @<#@8_#/>@#K5\26B:I:Z;
M>07-C=78;[,MP@VRE1D@,I*[L<X)!J&Y\76=O%>W"VE]/9V4C17%U!&&1'7[
MPQNW'!X)"D YR>#CE_%27>G>,_!MS>7@U2-[XP167EB-XW9"#<#;]X(,Y!X&
M:K:S:76@6^M^*O"FI12V"S3R:KHUY\T,KHQ64H>L;D@\=#D?2@#N-1\266FW
M,\#I/,UK +FZ\E WV>(YPS<_[+' R<*>*?=^(+.WG@@A66\GG@:Y2*U 8^2,
M9?D@8Y '.3G@'FN/M9Q;ZUX^O+Y&A2XL+:[19>#Y/V=E(_!E<'WJIX"LKO2/
M$%@FJ[HY#X5M%0R<;?+9O,7GNN],_44 =M?^*=*T_P ,CQ"TLDVG-&LJR01E
MRRMT.!TZ]\8[U=U?5+;1-)NM3O/-^S6T;2R&.,N0H&2<#V%>9+#-;_LYSB=6
M4O!+,@88Q&\Y=/\ QUEKN_'/_)/_ !)_V"[G_P!%-0!I3:I;P:.=3??Y'E"4
M +ER",@ #JQR  .I.*S[?Q5:2Z/<:G<66HV,$+K'MO;5HI'9B H53R<E@![F
MHY=-TO6?".G:=JS$03Q0A%6X:%F<*&7:5().1G'M7+W,4EGX+\1Z1JLT^KZ=
M#>1VEG<3R'S,.8P-\@Y/E2/]_K\OJ* .YLM6AO+VXL6BEM[RW1)'@FV[MC[@
MK J2""58=>QJ"V\2Z9=:EJUE',=^E*C7<A&$7<&/![XV'/ITZYQQVF)XDT.Y
MUS23&=8U<0V\D.IJRI++;LS( X<[5=-KD#HQ.3R3FOX?NY;3Q3XMCNO#D\%G
M%IML983-'*0JI*=IPQW%\MZ\YSUH [FR\16M[<6D/DW$!O83/:F90!,@P21@
MD@X93AL'!Z<'#+?Q-;W6NMI<%AJ;[69#>"U86V5SN'F=#@@K]1BN+\(6EWH6
MLZ(MS*M]I=_I[MISM(6;35PLC19/WH\;0'Z_* >,5J6.BIX?\4Z6WAS4)Y-,
MU(3&ZLWN6GC4;"RSQEB2OS[5.#@[Q0!T$/BG3IKJ*-?-$$UR]I#=%1Y4DRYR
M@.<YRK#)&"5(!)HE\4Z=#=2Q-YI@AN4M)KH*/*CF;&$)SG.649 P"P!(->=V
M5O.?A=X1TQ5(U%-;AB=/XDDBN&:4GZ!')]J2\MK@?"OQ3I9!.IR:W+"$_B:6
M2Y5HR/JK(P]N: /1;OQ3IUG<W,<GFF*TDCBNKE5'EV[OC:K'.?XE)P" &!.!
M2ZCXEL=-N+F&19I?L<(N+MH5#"VC.<,_.?X6.!DX!.*\_O(I(/ 7Q'L9U+7D
MNIW(2/'S.9A'Y.!WR&4#Z5>M4?2Y?B&-3;,ALX9MS?QQ_9=F1ZC<CCZT =M>
M^(+2TN([>-)KN=X#=>7; ,1",#?R0,9. !R>P.#5/4/&.G65E!>6]O?:E#-
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MGZM>F;2I+"(M->,ODDLAVJN?WI96)8OZXYQ@ 'J=5KZ[:S@65+2XN29$39
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "JFIP37.E7=O;B,S2Q-&OF,0N2,<D ^OI5NB@#E+3PWJ%O\ #'_A&&>V
M-VNFFP$H=O+.4V;ONY]\8_&JEQX,O-0GM$O)+=;5="FTB?RY&+GS-F77*XXV
M=_7VY[:B@#G?#=GXGM8HH-=O=/FBMH_+C>T1P\^. TF[A3CL,Y)Z\8J#5M#U
MI/%D>OZ%<67F26@L[JWO0^QD5RR.I7G<"S<="#VKJ:* .7&@:I8>)CKEE/;W
M4MS9):WD5PQB#,A)612H;'WF&W'3'/'-+2_!EUHNH>'Y+:6WE@TRVNDE+LR-
M+).ZNS  $ ;E/&>A]N>UHH X.R\&ZO9Z9H")/8_:]*U*XNCDN4=)?-R.@.1Y
MO3OMZC/%V'PUK,6D>*;6&^@M+K5;F6XM;B%F)A+HJC/ P1MZCU]JZ^B@#SN?
MX?ZCJ!U59I]/L8]0T^W@ LT8^3-#(SJPSC<-S DG!.,>]:M_H7B/Q#X0U72]
M9N].BNKJU:WC^QJYC#$??8MSR<<#ISUSQU]% %2,Z@-,!D6V:_V?=5F$6[L,
MXSCWQ^ KEK_P);:CX)N--N++3SK$\#;[T+S]H/)EW[=V=WS=/:NTHH X^Y\-
M:Q<2:)K7VFS7Q%ID30RM\Q@NXV #JW 9<D!@0#@^M;L?]L31N]Q%9PN$(6"*
M=G5F/=G* @>P7\:TZ* //M.\!ZEIOAC0([:ZM(=?T0;(;E2QBGB)^>.08!VL
M/K@@$5U5O::@=?>^N(K589+1(65)F9@P9F[H 1\V/PK7HH YCPUX/A\,:WK%
MQ93$:??")H;3M;,#(7">BDOD#L2:N7^CR:IKMM)?6UG<:7;Q/LBE^9O.;'SE
M2N. "!S_ !&MNB@#D]-\-7>A^,=2U'3(K"'2;^",26BL4(F3($@ 7 R" 1[9
M]JS++PCK]OX&O?##/I86\-P'NB[OL69V8XCVC) <@?,.F?:N_HH R8='-AX3
MCT6S?S#!9"TB>9L;L)M!8@'^5<_8^$]6M1X37S[1/[$TZ2SDD5V)9FC1 Z@K
MCC8#@^N.W/;44 <!I7@_Q!97VE7LMUIGVJTL;BUGF4.SSN^PB9B>K$Q\@],]
M^@U/#7A5]$UJ[U".*UL(;J!5ELK*1FA>;.3*%( 0XXP!]:ZNB@#F[G1]4@\6
MW6M:>UG(MU81VC)<.RF)D=V#C .X?O.GR].O-9%KX,U?PS=6$WAB\LW2.PCL
M;N'4%8+($9F652G1LN_'3!KNZ* .0N-!\267B'^UM'O["5KNVB@OX[Z-PI:,
MMME39T/S$;3QC'-/G\.ZH^OZAJ FMI5N-'33E+N58NK.V]@%P 3)T'I7644
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
)HHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>exhibit1027supplycontrac018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M6X@CADE1$$IX=R0% '<Y(XH Q_AWI]QIG@;3X;J-HII#+<-&PP4$LC2!2.Q
M8 CUKJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]1VJE9:)J4/PD'AZ2V U%=*-CL$B[2_E[ =V?NY.?7VJC=^%=3U.>SAE@-O
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MH5VJCKE3GG[PX]C^(!<MO$B>(K;0+_2KV:WANKQH+J HF]&6*1FC<,I*L&0
MXQ^N:M^,/$$N@:;:+:)&^H:C>16%H),[!)(?O-CG"@$X[XQWJA<^#I(?'MAX
M@TN80VTDK2:E:?PRN(I$251V?YL'U!SVYO>,O#<OB32K9;2=+?4;"[COK*60
M$H)8SP& YVD$@_6@!NH)<Z5%:22^*?+D,\>\7WD(DR[AO484$';G&#^?6L*Y
M\2&U\;:_9:GXI;3].M+2WN+=3]G4_.'+@%D);&T8ZGFKWB&PUGQ/9Z3:MI7V
M.6WU*VNYY))T:(+&X9@I4EF)[94>^*GL-&O1X\\0:A=V0.FZC:V]NC%U.?+#
M[MRYS@[^/UQ0!G:UJ>IZ-XF\,:9>>)&@MKV&[^TW#1P)O,80H<LF%)W<@<>E
M/U_6+RR^'^OZSI/B)[PVRL]M<^7"VUDX9.$VL-P/.,]>>*O:]IVIS>-_#VK6
ME@9[738KI9L2HK,950+M!/.-ISG'6J_B?3M9UWPAK^F6^E);O>Q>5;QM,F6=
MLEW<@X Z<#)X/KP 53XEN(/$'AZSTS7$ULW[E;RUQ$S0Q;"3,&C4;0#@?-D'
M.!S4(\1WNH:WK>BMKDFDZ_#-(NGV4L48BGB _=NI9<ONZG#9![8'-O6- U3Q
M#>>'&%C'IQTN[CN9;QYE:4J@(,2!<Y#=#D@8'0TGBC0;_P 3Z'?:7J.A07%T
M99O[/OQ,@%N"Q\N0GAU*C;D*&SCWX +ESJVI:IXDU[3-/NS:+H]I$P*HK>;/
M(K,-VX'Y0%7@8)W'GI5'1O%MSXOO]*M;.9[".;1EU.X>)59@[ML5!N!& 5<G
MC)POOFW_ &!JFDZGJEW8 7LFJ6$,$DDCA"EQ$K()&S_"P89QD@KT.>(M*\(S
M>%+[2[K38S>I;Z0NF3QA@C,4;>D@R<8R7R.OS#&<4 5;OQ9JEU\(+[Q!:S1V
MNJ6L,RR.L89?,B=D8@'@ E<C.<9KJ?$EU=V?A/4[RRF6&Z@LY)HY&0-AE0L.
M#QVKF[KPA?6OPFO/#5J$N=1N8)0[!@J&65B[')_A!8CUQCBNDURWNM0\):A:
M06[?:KFSDA2)F489D*C)SC&30!2N=8U"W\ 0:G!;W-YJ$EG$P6WA$CEW5<N$
MX!QDMCC.,5BZ=KFI2^ ]4U33-8N==OHB5$<EDD$UNRXWH8@!\X!)P>IQV//0
MVS:KI7A?3(H-+%U=PQ10SP&X5" %PS*W(/3@$C([CI6=>^&[ZZTO7YK;R[74
M-6>)S$'^7:@5=C,!U958$CIN[XR0!WAKQ"FJR7M_;:D;SP_';1NEY.JH5E^8
MR+PJ\!=A.1P21G@@1Z+KFL7_ (I\002H%AALK:>QM'7:5WF;[YZ[FV*2/X>G
M8DQQ^"X;O5=4N!!<:397\,(FM[>8(SSH^[S/D)"\!5X^]SD>K-+\%7FF^+-8
MU&/5=0,5Q8PPV\L]T93Y@\W)<'J%W*5SZF@"+PCXEO=<O+!([J>>6.%QK5M<
M0K&;.<8 4 *"#N# #)RHSUY*>'_$%YJWC*:WO=5O]/D4R/'HMWIZ1"2(9572
M0C<XZ,<'KQTJ32/"MS:ZEH>H"R6TO]/M'M[V9901?93 !(R6&_Y]S $>AR:U
M8;._UO4M)U+5-,33I=->215$ZRLSO&T9 ('W,,3S@DA>.* .?@\7Z@WANQ\7
M-<'[#=:F(#9[%VK;-,858'&[?]U^N.2,=,%UXOU!/#VL^*HYR+/3M2:W2SV+
MLD@CD6.0DXW;C\[ @@#"C'7,T/@V]70K+PLR+_9EIJ8NOM.\?/ LIF2/;UW[
MB%/&, G.>*+GP;>R:)JWAA$7^SM1U$W7VG>/W<+R+)(FWKNR&4=L,"3QB@ O
MO$VIS6'BW6;&X\N#0)FBBMMBE9_*19)=Y()YW%1@C&,U/_PD-_KU_KJZ5=M:
M0Z78PRP_NU;SII8S*-^0?E"[!@8/S-STPR^\*:@++Q1H]DJFT\03&87!8#[.
M9$5)MPZGA=RXSDM@XQFIW\-WND7VMOH\"RQ:M910)ND"_9Y8T,89L]4*[>F3
ME3QS0!!I'BJY\7ZE86MC<26$+Z-'J4SQ*K,))3M5/F!&%VN3QSQ[Y?I=[K?C
M+PG9:E;:R-%?RW69X($DW3H[(V?,! 3*9P.3GJ,<OTWPI/X5U&QNM+A^V11Z
M1'ILL>\(Q:,YCDYXP=SANXR, U5AT37=!\-Z9X?LM+AU.U6-WOY#=B#S9'8L
MR#()V$L<^HP/6@#H_".HWVL>$-+U#4HUBO+BW5Y @P"3T8 ],C!Q[U@>%_%Z
M)&]GK%W=3W$FL75C%<-;G9E976-&=5"AB%X'^(KKM,EOI=.CDU"TBM+DYS;Q
M2^8$&>!NP,\8[#K7#)X;UH:/!;FP_>IXE.J,/.3_ %)G,O7/WL'&/7O0!U7_
M  E>E?V@EIYDF7NVL5E\L^6;@*6,>[UP#[9&,YXJQ:Z]9WETD$ F99'DCCF\
ML^6[1DAP&]B".<9P<9KCKS0?$UYJEO<3V5O,]IKOVN*8W>U3;88*JICY2 PW
M=R1W[7M)\.7]EXKCU*U@ETV"62=M1MUN ]M<DYV2(F24<G!)PO<<]: )_$>N
M7&C>,]!0SW3V5S;79EM((/-:1T$>T@*I8GYCWQW[9K4LO%>E:CIEO?64LDZW
M$C11Q+$PE,BYW(4."I&#G.,56US3K]O%.A:S:6WVF&QCN8IHDD59/WH3!7<0
M#C9SR.O>N<N?!VK6?V;5[2SLK^\&I75[<Z;,X$;I. "JN1C<H5#DC!.Z@#K;
M;Q5I=[917%F\MPTKR1K;I$?-#QG$BE3@J5/!SCJ/49J1^.]!G%G]GFN;A[R&
M26".&TD9G$;!77&W[P)P1U'? K$U'P]JPN-)UFST#2I)(//CN-'WJJ;)=AW*
MY7:9 8P2<<Y(SQDW8-%U&+Q/H6HC2K:WM[6UNTFAM&0+&TK1E5'3=CRSDX')
MH Z;2=5M-;TNWU*PD,EM.NY&*E3P<$$'D$$$$>U4;3Q7I5[?6UK#)(3=-,EM
M*8R$F:(D2!3[8/7&<'&:@\$:9>Z/X6@L+^$17$<T[$!PP(>5W&"/9A^(-<W9
M>'_$TFMZ%J&H6<#3V5U=?:K@7?WDD5E5HUVX50"/EX.>OK0!H>(?%#->^'AI
M5S<K!<:PEK+*D0,,ZC<'7<1G@KU& <'!-'C3Q0UMI+'2;FY2:'4;:UDGBB#1
M[FF17C+$'^%CR.AXSGBLFQ\-^)K70_#NAOI]O(NB:G'+]L^T@+/"F_#!<%@V
M&&0>_3/8N/#/B6'PYJ'AV&Q@N8CJJWUM>&Y"AXS=+.58$9#CYAZ$?D0#L[_Q
M1I>FRE;F218EG2VDN!&3%%*V-JLW;.Y1GH,C)%87CGQ0UIH-VVDW-S'<6UW!
M!)/#"&C5FD0-&S$'^%NHZ' R#Q5>W\/:O9:[J4#Z%I5_8W]V;N._G=2]MOP6
M5D*Y?!!*X([9QVHWOAGQ)'H&N>'[>Q@N8KG4_MUK=FY" HUPLK(X(SN!!&>A
M'Y$ ],HJG:SWTE[=QW5E'#;Q[/(E6;>9<KELK@;<'CWZ\5<H **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY+V2QB:XD*F5L$"4K]TN.C$8&"0<8&*CU'POH6K:E!J.H:5:W-Y  (YI(P6
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW *W!Q"(P9&EXS\H4$MP">.PS37UC3X["&^-TC6\Y40O'E_-)Z!0,EB?0<T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M***RO$6HR:;HTLEON-U*1#;A4+GS&X!VCDA>6('930!HPSPW$7FPRI)'EEW(
MP(R"01GV((_"LX>)_#Y=T&NZ861_+<?:X\JW]T\\'VKD_ ,L6B:_K'A-/M0M
M%(U#3OM4;HYB<XD7YP"=LF3G_;K/TP:Q):?$"WTO2[*^\W5KA/+N+@H6)AC!
M&W80WXL,]..M 'J(((R.117&^ I'O/!'A:;2-2,FG16_EW!NH/WLP52F!\WR
M$./]K@8SWKLJ *LFIV$-ZEG)>6Z73XVPM( YSG''7G!QZX/I4%WK^CV&H0:?
M>:K96]Y/CRK>6=5=\\#"DY.37FE]+*_PY^(5[*S"]35[ED?^)6B9!#CZ!4Q7
M6^*]%MM9\.W&D_9(CJ6KA=S%<M&P"@RD]@@ Q[[1WH ZBXO;6T:%;FYAA:9Q
M'$)'"EV/15SU/L*KZIKFDZ(D3ZKJ=G8K*VV,W,RQACZ#)YKGO&\**?"Y(#,F
MN6H#MRW1N];6M0Z?';SW-S8QW<\T7V9(64,9LY(C /'))SVQR>!P 7I[^TM;
M9;F>YAB@; 61W 5L],'OGM4-SK.EV6F#4KK4;2&Q(!%S),JQG/3#$X.:X:QT
MJ?0O$G@'0)YC+%9:==-NYVO,J(N1GT5W ]C5SPA]E \2S7RH;73]=N_LQD&5
MC#!&;:/7<SCCGD@=: .PBU33YM-&I17UL]B4WBY653'M]=V<8H&J:>UA)?"^
MM_LD>3).90$3'7)Z#'?-><7FD2Z-I^@V_E?9[;5/%:W4MJ!A84;>Z1D=!\R(
M2.F[(K;TV**X^(WBRVGC62R2.QNF1_N";:XW$=,X1#S_ '0>PH ZO3=6T[6+
M3[7IE_;7EODKYMO*KJ".HR#UIUGJ=AJ"NUG>V]P$QN,4@;;GH3CUKS;Q3926
M/A#QSX@T]3;1ZI'"D:QC;NC7"/+@="P=^?[JJ>];FIV\0^)6B6$48-K<Z/=P
M740^Z85:/8#CL"Q _P!X^M '3Z;KVD:R\R:7JEE>M"<2BVG60H??!XJS#>VM
MQ<3V\-S#)-!CSHT<%H\]-P'3.#UKG;72;>Y\=C6K.%(8+*R>Q:2-0HG=G4E>
M.H39CZL1_":C\/QI'\0?%X1%4$61.!C)\MJ -R#7]'N=5ETN#5;*74(L^9:I
M.ID7'7*@YXJ<ZG8"^%B;RW%V?^6'F#?TSTZ].?I7.:CH-E>Z]H5O86\<7]CW
M/VN6=%P4&Q@(\]27+!B/1<GJ,\9+/<?\*AU#4R6_M;^W6FW?Q"<7P11_WR N
M/3B@#UJYN[:S1'N9XX5>18D,C!=SL<*HSU))  J.ZU.PL9(X[N\MX'D^XLL@
M4MR!QGW('XBO,/&WB33;R\M'N9+E&L-:M4AA-I+@!)U\R3.W!)P0N"3MZ?>(
MK5@=-2USXAM=_/#]CMX8PXQB V[/T/0%G<_6@#NKS4['3MGVV\M[??G;YL@7
M..O7TR/SI;S4+/3XUDO+J&W1CM5I7"@G&<#/L"?PKS3X=SW.KWUX^M$R./#N
MFHOF_P 4<B2,YY_O$<_2H?AQ=WM_K/AG^T&=Q%X6+P[^<DSA"WUV+'S[^] '
MJ4]_9VUJMU-=0QV[8VRLX"MGI@]\]O6D;4;%+$7S7D M& (G\P;#DX&&Z<FO
M*/"4]Q+KOA.TE+?8(+G6#:@]#Y<FR/\ [Y5G ]J-,GN'\?6>G,3_ &8GB?47
MC4_=WK;!P/P=Y&^N: /6[>Y@NX%GMIHYH7^Z\;!E/;J*;;7MK>>9]FN(IO+;
M:YC8,%/H2._M7D^JWVH1WGB/1K"5HK;4?$MK9>8&(\L2PH\P!'3.,<=W/<U>
M\1>(M6L=/U+PI#%;VETDUC:6UW9@QQK!<OL!"Y)1EVLO4]B* /2H+VUNI)([
M>XBE:([9!&P;8?0XZ'VI8[NVENYK6.>-[B!5:6)6!9 V=I([9P<?2N*'B:7P
MK<7V@W-A!LL;.&>Q>RA?8T;N8PKH-S#:PR2,Y&3C/%<]H_B.QTO6O'%[I\TU
MW=)I<-V'EMI$,TL<<S,6W*-O)&!Z<#@4 >J_;;4WALQ<1&Y W&$,"X'J1U I
M6N[9+R.T:>-;F5&=(BPW,JX!('4@9'YBO/-#U>]\(66@Q:C'%>6^KVTMU-=6
MZ,9S<+$9F+<GS-P# 8 Q@#&,53T_7M.N_BAHEX\TS7MU8W4<@-K*HC+/#Y<8
MW*/E #?-TR23C=B@#T:#7-)NM3FTRWU.SEOX1F6V2=6D3'7*@Y%-&OZ.VKG2
M%U6R.I 9-H)U\T<9^[G/3FN:UM#I_COPO-+I,7]GJ\MM;7,$OSQS21GATV_<
M(5NA/)!.,59UW0;+4;_2-/L[:-);._CU&695^:(*Q8DMUW2-Q[@L>U &]J.N
MZ1H[Q)J>JV-DTN?+6YN$C+XZXW$9ZC\Z-2UO2=&6-M4U2RL1+D1FZN$BWXZX
MW$9ZC\ZY+Q=8:KI&HS^+(9;34+*%8_M&FW-HI98E^\T4G4,,LV#P?RIWC73=
M6LKB?Q3:36=[;V5MF;2[RU5E>),LY23JKX)[8.!GI0!W*LKJ&4@J1D$'@BEI
MD3B6)) " RA@",$9I] !1110 4444 4+O6]*T^X$%YJ5I;RX#;)9E4@'@$Y/
M )J['(DT22Q.KQNH964Y# ]"#7G^M1:[X;UO6=9TZSAU[1;XJVHZ>"!<0E8U
M0E,\.NP E#SZ=:W_ .T89/ARVHZ$SF(:6TMD2/FXB)3(]>!0!LV^IV%U<R6U
MO>6\L\>=\:2!F7!P<@>AX/O0FIV$E\UDEY;M=+G=") 7& ">.O0@_B*\ZA)M
M-&^%LECS,[1H2.KQO:LTF?7) 8^X!K/L9YQ\+/!]^I8ZC)K<$K-_$TLEPXES
M]0S@^V: /1[GQ9X<L[Q[.Z\0:5!=(VUH9;R-74^A4G(-:5S=VUFB/<SQPJ\B
MQ*9&"AG8X51GJ22 !7-:]I&G37VEZ7#86PDO+S[3.XB&[RXCYCL3U.Y_+4_[
M]<CXX\2:;>7EH]S)<H;#6[1(83:2X 2X7S)<[<$G!"@$G'3[Q% 'J=S=V]G#
MYUU/%!%D#?(X49/09-07VLZ9I=K'=:CJ-I9P2$*DES,L2L2,@ L1S@'BN%N+
MS5=5\;:[?6 M95T*SA-C!=(^UVEC,C, "-K$83<<X (QR:L:G!JOBK1M*\6:
M+-:@_8!,FE7]JLL<N\!RI?JK< !AZ>] '9R:MIT5O!</?6PAN!NAD\T;9!C.
M5/<8YX[59AFBN(4FAD22*10R.C JP/0@CJ*\\UC4=0NY_#>N>%X4?5I-+>;^
MS)QA&M7$;$9R-K!O+ ]3QT!(Z;P/+8S>#M/?3VG: J^?M"[9!)O;S R]B'W#
M X&.* -&77=(@U--,FU6QCU!\;+5[A!*V>F$)R<_2K]<&UAJOAKQ?;7MQ+::
MII^JWS1LSVBI<V;N"4*N/OH -O/(&.U7?B+=7D>B6&GV4AA?5=2@L))0Q4I&
MY);!'(R%*Y_VJ .HMKVUO#)]FN(IO+;:YC8,%/H2._M1->VMM-!#/<PQ2SL5
MA1W :0@9(4'J<#/%8'AW4[A-;U+PU=6MM$=-AADMY+1"D;PN&"C82=I!0C&3
MFJ_C"-/^$B\&R;%W_P!K%=V.<?9IN,T ==1110 445R'Q%NKR/1+#3K*0Q/J
MNI06$DH8J4C<DM@CD9"E<_[5 '3V]]:W?F?9KF*81G:YC<,%/<$COQ2VMY:W
MUO\ :+2YAN(=S+YD3AER#@C(XX((_"N?\/:E/_;&I^&+RTM8_P"SH87@>U0I
M%)!(&"C82=I!1AC)!KC99I[/X%>(7LR8W6XOT!3C:ANY%;'IA2: /3[/4K'4
M=_V*\M[C9C=Y4@;&>G3UP:+;4["\GD@MKRWFFCSO2.0,5P<'('OQ]>*\_P#&
ML]QI&OV+:,"DH\.ZB,1]EC2-HOR;I]3ZT1#[&OPO^Q?>9/).W^*)K4L^?495
M6^H% 'H=U>6UC$);NXB@C)VAI&"@GT&>I]J9_:5C_9XO_MEO]C*AA<>8/+(/
M .[I6#XCMM33Q1X?U:TM)+VSM/M$=S!$RAU,BJ%D 8@'&"#SG#&N$T>XN;O6
M=()C>+1[WQ9>SP(Q&"$A8KT)&#*LC#!QD9H ];34+.2R:]2[@:U4$M,)!L '
M7)Z#&#GTQ1;W]G=V[7%M=0RPH2&='!"D<G)[5Y/K4]POBC6=.0L--E\3Z2)5
M_A^>-&<?0LL>?K[TOCRXN8=?\36MN6%G<VFE_;,=!ON3&V?K'P?84 >K6>HV
M6HQM)97<%PBG#-%(& XSSCVP?I26>IV&H;_L5Y;W&S&[RI V,].GK@_E7EWQ
M,O+RPUC7?[/9D\WPLQG*<8Q<!5;ZA7EQ^-='J<$<7Q#\,V5LG^BW&E7EO<(A
MP#"OE;.GH3@?4T =/IVOZ/J\\\&FZK97DT!Q*EO.KLGU /%6HKVUGN9[:&YA
MDG@V^=$C@M'NSC<.HS@XSZ5SB:/;7?CFSU.R@C@ATNUEM7DB4*)6<KB/CJJ!
M23V!8 <@XCT&-(_B1XNV(JYAL2<#&3MEYH Z0:G8&^-B+RW-V.L'F#?TSTZ]
M.?IS1)J=A#>I927ENET^-L+2 .<YQQUYP<?0^E>4PSW'_"H=-U++'57UU9]W
M\1G:^*L/^^25QZ<5)?2RM\./B!>RLPO4U>Y9'_B5HG00X^@5,4 >JR7MK#=P
MVLES"EQ/GRHF<!WP,G ZG J>N-UI=WCSP5+)&JSL+O><<_ZCI79$X&30!'Y\
M1N#;B5/."!S'N^8*3@''ID&H;_4K#2K;[3J-[;6<&X+YMQ*L:Y/098@9KS.\
MU467BO3/&G^F"WNK@V%UO@D6);.0A8'#$;<;PK]?^6I':NO\7:!JVL&UN=*O
M[6*:S#LMI>6JS03L<?>SRO (##D;CZT :<OB30H(;::;6M.CBNAFW=[I LH_
MV23\WX59DU33XKV&RDOK9+J8;HH&F4/(/55SD_A7,7B:;XM^&4,VI6YT^*:W
M25%C&7M9A]TQXZL&P%QUX'>HOA_J%SJ9OO[>&WQ/8E;6[B90/+CQE"@!(VO]
MXD=3D=%  !V<D\43Q))*B/,VR-6;!=L%L#U. 3] :@O]4T_2T1]0O[6T1VVH
MUQ,L88^@R1DUY]X]FGO9Y]1L$O'NO#KQSV:Q02-'+*"&F5F4%<&/"<G@EJN>
M/M0BU7P1HNHV!66*YU+3YH=QP&#2J1DX..OH: .SN-8TNTG@@N=2LX9KC_4Q
MR3JK2_[H)Y_"KI( ))P!7 >(9-0?Q_X'^VVMK"HN[G:8;AI"3]F?KE%Q6IX\
MNY(K'2+!21'JFK6]E.1WB8EG7Z,$*GV8T =#-J=C;V2WD]Y!%:MC;-)(%4YZ
M8)ZY[>M0KKVD/')(-4L]L2EY"9U&Q1C);G@<CKZURTTC77QKMK2ZYM[/1&N;
M.-ON^:TNQW'^T%P/8$^M=#KEE:FSO[\QJ+H:?-#O[E",X/K@C\,GUH GC\0:
M+,;81:O8.;HXM]MRA\X^B<_-^%6+C4+*TFAAN;RWAEG;;$DDH5I#UPH)Y/':
MO.K;1+;Q#\+O NEW+21QS1P8DB;:\;BUD974]B& /X5:TK7KV77=&\.>(-JZ
M]I]ZS-(!A;R'[-.%G3Z]&'8_6@#T2BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***P_%/B'_A'["V,4(GOKZZCL[.%FVJ\KGC<>R@ DGT%
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M$LP=9#\V>A;8,#' (SSF@#2A\*:?'IDMC+->W2R2K/YUU=/+*CJ04*NQR-I
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MN /7WI+C0?$J:?<1V37NI65G/:75I%?,(;J0(S&2#S!@L ""K'N<9/6O4J*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5C:['J8BFN;34C:0P6SOL2)':1QR
M,E@<  =NN?:MFJ>KI++H]['!"TTKP.B1J0"Q((')('ZT <5::CXBG^&P\2G6
MCYLFB/=LGV>/]W-Y8=2OR].""#GK[5OZ!XJT_4H+>UDNV^W+8I=2F6%HU=,
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MV\32Q!G=LEW;#E0O3OG.>* $E\1W=CKOAZTM=4BU==2D*7-OM0RPKL+&4&,
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M&WN(YIV*%U;AY7<'*DCHPKF;'1?$LFN:!?7VEE9K.ZNA=2+=((PDBNJO$@.
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MG97+?*.5VGCGKUJY0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN?T%M;DU&ROIM4M;C2KRSW>690[/)PP>/$:X7&<C)'3\:-V[#XWZ<MV<6_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9G+N6:,'(!8G)QGKUQQG%:=EIMII[2M;QL))B#)))(TCO@8&68DG Z<U;HH
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M<8).W))ZGGJ35NBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU/5K75+@W(O+5'2"2*X>/8&QN "D#G _*G6'AS2M.:]>&UWR7V/M4L[M,\P
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M?@[Q%!XEUK4KQ(7M[F*SM8+NUD^_;S+)<;D;Z=CW!!HM2\WQ;U9+GE(]&MQ
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MK/ILVFR_9-[_ &#4;3SH;ACC&3GY2!D X.-QH VY-<TF%(7EU2R1)AF)FN$
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M5[2O$%U>:UHV@Z\J1>(=.OF\X 86YC-M.%GC_P!EN_H<CB@#T*BBB@ HHHH
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M86B/<E6*0YSL& .IQDG).!DG%,T[PO8:;/:21O/*MC$T-E'*P*VR-C(3 !Z
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M-%K8VMC&\=M D222/*X4=7=BS'\22?QJQ10!7MK&ULVG:W@2-IY3-*5'WW(
M)/OA1^5<_P""NGB'_L-W7\UKI98EFA>)BX5U*DHY5N?0C!!]Q573-)LM'@EA
MLHW1996FD+RM(S.W5BS$GG'K0!=HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5C:Y_:R1RW-C>PV\$%L[LK0>8TCCD=Q@
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M1 <(64C &=QZ]@"3PMXJN==GTMH;A;L3P2-J4(BV'3Y5Q\A[CYMR[6R3C(.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKEOB5_R33Q'_ ->$O\JH3:QJND:YJ]E<:Q"T":)_:$4MU"JQVL@9E/W!DQ\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:-22H+%\Y!)PW4#@'%:MCI=II\D\L".9IROFRR2,[OM&%!9B3@#M[GU-7**
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MTW3;72-.AL+-'2WA!"*\C.1DD_>8DGD]S5NBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ*YNK>RMWN+J>."!!EI
M)6"JOU)H EHK.CU[1YH)YX]4LFBMP&F<3KB('.-QS\O0]?2I5U73GTXZBE_:
MM8A=WVD3*8\>N[.,4 7**S)/$6APM$LNLZ<C3+OC#72 NOJ.>1[BKEI>6M_
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MX-5TU*QD<(E[;,Y. JRJ2?UKB?AY=+IFJZSX3-Q//';/]NL9;A65Y(93E_O
M$[9-V3_M"L:RBEDLOB#!;^&UU8OJUP A:-028H^.3GCKP,\\<T >LT5R'@FY
MO+KP=X8EL-0M]0LOL^R\N9PXD?:I7Y/<.,'=V![UU] $375NEPEN\\2SN"4C
M+@,P'<#J:;+>6L-Q';RW,,<TO^KC9P&?Z#J:\LO[B67P%X]UB1RNH6^K3M#+
M_%%]G91" >V-H/\ P(^IKHO&/AO3]:T*9/L$+:[J6P6\[+F6&0 8=6ZJJ ;C
MC'?NW(!VSR)& 7=5#$*-QQDGH/K4=S>6MFBO=7,,"LVU3*X4$^@SWKE/'%O'
MYGA61T5Y8]<ME61E&X9#9Y]ZU/$>E:)=6LUWJ^G0W^(?)2*6,2$Y/W8P>C,2
M!QR<#TH V9IX;:%IIY4BB7[SNP51]2:;+=6\-L;F6>*.  -YKN N#WSTKSVP
ML;W2]<\ ^'=0F,PM=/N)I-QW*\R(BKUZ[0[8_ U:\+6EA?V_B&#5889M.TK6
M[I;>.X :*--JN>#QA2[@>@)H [I9X6@$ZRH82NX2!AMQZYZ8I([JWEMOM,<\
M3P8+>:K@K@=3GI7E\NF2Z-HNB:<D;6^FZMXH$@M&&!%;'?(D17L"44E>VXBM
MRPM8;[Q[XKT>YB6;3=EE=M PS&965PV1T(/EH2.Y'- ':6]S;W<(FMIXIHCT
M>)PRG\11!=6]R'-O/%*$8JQC<-M/H<=#7EVN6C>'_"?CG6="465E?"%+9(!L
M48Q'),@'"YW'D==@;N#6[?6L5I\0]&TJU0Q6=[H]S;W$<1VCRXS'Y9XZ$;V
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MDB.)$5P2A]QVKSKQ;<R^%]<LCHJ"/_BGK]2B#C$"(T1Q[$D#_>/K1;C^S/\
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MEOF*@@$@>@++^8H \SL_#U^?"/A_PB]M.LVG:I&]Q,8F$7D12M('#XP=P"
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MAWUIH\?B:RO;V^D6]E'E6MK)=L(W8!CN6+."P!;G'% &EIMBNFZ;;V:,7\I
M&<]7;JS'W)R3[FN?^'Z))X+A5U5E-W=\,,C_ (^9:ZJL[2=$M-$B>*R,ZPN[
M/Y;RLZJ68LV >F2Q- $MGI5A86IMK:UC2$ELJ1NSN8L<YZ_,S'\:6TTNQL8Y
M8[>V1%E>220==S.Q9\Y]68G'3FK=% %2TTRRL9)Y+:W2-YY#+(PY)8A03STX
M5>!QQ6%X*Z>(?^PW=?S6NEEC$T+QEG4.I7<C88?0]C5/2M(M-&@FBM!)B>9I
MY&DD+LSMU))^E %^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "L[6((O[,U"X\M?.^R2)O[[=I./SK1J"]M5O;*:U=W1)D
M*,R$!L'@XR#0!P.GV\3_  &MYVC4RQ^&G5'QR 8.1^.!^5%IXFU+P]'!'?-!
M<V*^&WU...*(H\9A$8*;B3NR'ZX'(Z5UD/AJR@\*'PVDEQ_9_P!G-J,N-XB(
MV[=V/3C/6HU\*:>+JUN)'GF-M9-8*DC*5:!L;E88YSM7GV^M %;1[WQ%/JMN
MUW!&VEW%KO,I\M&CFX("!7;<A&>O(QU.:??ZK?7/B2XT'39H;:>'3Q>>;*F_
M<SNR(N/[H*'=WY&,5+H'A*P\.$"TN+^6-%\N"*ZNFE2W3^[&#T' ]3@8S3M9
M\*6&M:E;:D\UY:7UNAB6XLKAH7:,G)1B.JYY]CTQ0!GP:SJ^HZU+H:S6EI?6
MFG0W-S+&AE1II"PVKG!V H<]SD<C'.1IGB_7-?F\.1VQL[+^T[2\,^^!I#%+
M ZH2OS#*DDX!]N3TKJ9O#%BU];WUJ\]E=06_V42V[C+0YSL;<"" >0>H.<'D
MTD7A73K>\TVYM?.@.FP/!;)&PVJKXW9R#DG:IR>X]S0!R$.O:UK,/@F<WL=O
M+=:A=6]RL47R2-$DZAL$YQ^[SC/4^PK0M-;\27(\0W9O=(CM])NKFW5)H6C5
M]L2LA:3>=@#-R<'(STXK7C\$Z7%I]A9I+>!+"Z>[MY%F*NCONWC<,<'>_P"?
M&.*D_P"$0TQM.UFPF,\UMJ\CRW2/)U9@%)4@#'"K^5 '.2>.+[2SKHN0MPEE
M9VEQ;R2PF'+S.T?S#KL#*#R <9Z\&I_&TWB/3?!_B64ZC;")+'S+:>*/;,K<
MB12.@'W<'.1D^QK6_P"$%T>5[MKMKR]-Y9K9W/VFY9Q*BEB"?<;C@CIU'/-/
MA\%Z:FAWFDW,]_?07<)MY'N[II'$>,!5)Z >WXYH W;=94MT6>42R ?,X7:#
M^&37E_B753;:];^,XQ>>7IEY]D<"WD\IK$_)*^[;M)WG>#GD(M>E1V(BTT62
MW-S]PIY[2;I>>^X]_P#(JJV@6C^&#X?=Y6LC;?93DC<8]NW&<>G&<9_'F@#F
MM:F-Y\6/#5A<$-8)97%[ IY62X!"@^A*J21Z9S777-A:R7D=\\:_:H8GB23O
MM;!9?I\H/X5F2>$--FTG3["1[ICIQ!L[KSB)X,# VN.>G!SG(ZYJ[#I'EHQE
MO[RXG*%!/*R;D!Z[0%"CZXS0!Y#X8$FL:%\.M%N(TL(HF74+>_+;C.T3-F!,
M#Y6(.3D_='&>W9^*]!O=2\5C4]%G$&N:;8QRVI8_),"[[H9!W5@,>QP:V4\#
MZ.GABV\/_P"D&SM'62U;S<2P,K;E*.,$$'//N1TK4@TE8-2^WF[N99C"L#!R
MNTJ"2,@*.<D\T <]X0\16WB;6M0O88W@G2RMH;JVDXDMYEDN-T;>X/Y@@UI>
M*[I181::1,3J$GDR>1&SNL/64X0$_=^7(Z%UK0MM&L+/5[[5+>!8[N^2-;AU
MX\SR]VTD>N&(SZ >E*=+C.M+JAFG,RPF!8RPV!203@8ZD@'.>PH Y;X:WIBT
MR]\-S&4S:'.8(O.1D=[9OFA8A@"/E^7_ (#7%Q+J<WP3U:"+3;:>R-Q>F67S
MB98HQ<.6D6,J 64 D#>.@^E>IGPY:CQ++K\<]S'?2VXMGV.-AC!) *D8)!).
M3S^'%9\/@/3(=&DT?[5J+:9*SM+;&XP)-[%G!90&P23D9QS0!=CN;>]\#K<V
ML[W%O-IV^.63[TBF/(8^Y'6N4\&ZKJEA9^"=/GFMI;#4=##)&L15H6BBB()?
M)W9#'/ Q@5WCZ? =+.G1+Y%MY/D*L0 V)C&%]..*R8?!VFPC25$ERT>E6S6M
MLC.,")E"E6XY^55&>O'K0!B:1XIU>XUFPM)3;78O=,GN@84*Q>=&R +$Y^_&
M1)C<1S@$'M5[PAXEDURXN+>ZN#'>P0QFYT^XMC#-;R$G=QT:,\;2,_4YJ2T\
M Z19_8MD^H/]BMI+2 /=L0L+@#9CT&T8^G.:U;#0K>QOOMK37%S=B 6RS7#
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M%5+"P73TG5;BYF\Z=YR;B4R%2QSM7/11V':K= !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDP7TN$#EI)=P"C<#\@V'/<[AR,<Y?@W5[P^%_"V@V+2QRR:+]K:6(1E^&5
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MV@@8R.<]ZTO^$DU_Q NH_P!@QB"ZLEMRD,OE^6[21)*1+N^8+A]HVXY4GGH
M#O:*X:XUWQ!JLFK'0UC2;3+F.$12-'Y,GR1N_F,?F (<@%<= >>0,_7?$OB*
MR3QC=6]_;)%H30RPQ?9@?-4Q+(48D].2,CGITZ4 >DT5G:]>2V'A^_O+>>U@
MFB@9XY;LD1(V."V.<9].:XNX\::CI"^)!-OF6QCLFM'NXEC;=<.T>7"X^4,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<L>>E:%% !1110 5G:UHUOKEBEO.SQO%,EQ!-'C=%*ARK#/'!['@@D=ZT:*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %4K[6-+TMT34-2L[1I 2@N)UC+ =2
M,D9QD5=K.UB"+^S-0N/+7SOLDB;^^W:3C\Z (5\5>'GBED37=,=(HS+(R7<9
MVH, L<'@<CGW%:D,L<\,<T3AXY%#(PZ$$9!KSW3[>)_@-;SM&IEC\-.J/CD
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M&N5^)?\ R33Q'_UX2?RJL==UG3];U33KFXT^01Z1_:-L\BF&.)@S+M=LG*\
M[N.] '9T5PEMXGUPW6M64$(OY[?2X;VTS 8FD=S(I4*2,KE/ES@GIGH:V?">
MOQZ]#>21WIG$,@0PRVY@GMVV\I*AZ'.<$#!'KC- &Q:ZC97TUS%:74,\EL_E
MSK&X;RVQG:<=#CM5JO,;FYUW3]8\?:GHUQ91_8;B*YDAN("_GA;2)BNX,-G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZEY9N0OW69-V&QZG=SZX]<Y37="BU^WMH9KJX@6WN8KI3!MR7C8,N=RGC(%
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M K':F$ E:/T4OG&/[I(X(J+P':K<>#;RS,DJ1MJ-_%N1R'"_:9!PW4''&>M
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MX4%R"P>1QG[H(VC/'4\Y7&IXZ\+6.HZ?+=VZ.WB&XD1=.NED/F0R9&W81]U
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MK76Q'_:=V]W*RV@+QNRJOR$L0.%'4&I;CQ+<Z9K>EZ=JNGQ1+J;M#!/;7!E
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M&L&Q$3;Y=ELL@F(Z AB> ><<]O2GZAX@@TSPP-:N?+C#1(RI)*$4N^ JESP
M68#)Z=:SV\4WUAX6N=;UG3+:U$;(L207PF1P[*JL7"@*N6Y.#@ F@"9_#-Q=
MZ?%'J6KRWE];W:WEM=M"B>4ZC  1< KC<#W(8\CC#)_"L[V6HBVU9[;4-3G6
M6[O$A!+*JA0BJ3\J[5 ZD]><G-7].U>6ZUB]TNX@C2>UABF,D,A=&63> ,D#
M##8>/0@]^,_3_&,%_J6OPK:R"UTF&.83@Y-PK!R2J^GR<'OUZ8R 7M&TK4=-
M647NM/?Y14A4VT<20@9Z*F,YXZ^G&*@TKP[<Z1H-YIUMJ>V6>::=+D0#,32N
MSL0I)!P6.,^V<U%I/BA]1N-)1[:$1ZK:/=P/!-YFQ5V9#_*/[XY'?BFZ/XGN
M]<UF:.PL+.;1XI7B:^34%9P5R.8@IQEAQENG/M0 ND>&=0L (+[7I=0L/+=#
M:M:QQARW5F8#+'ELY/).3S2V'A)+)],WWC3QZ1$\6G*\?^J#+L!<Y^<A/E!X
MX)SDG-06WC6.>*QU VJKI%]?&QM[GS<N6W,BN5Q@*S*0.<\J<<G!/XUCABO=
M0%JK:18WPL;BY\WYPVY49PN,%5=@#SGACC@9 'Z9X:UFPO%EF\4SW$+3>=-%
M]CB0S'T+@9QP!QV '2DA\,ZW'J,MTWBJ8I/,'FC6RB!9 ?\ 5ACDJN,@8Z9)
MZDFDO?&B6J:O>1V@ETS2)UM[R?S,.&PI<HN.0@<9R1G# =.9=0\5M#=ZM%86
M:W::1;I<7C>;M)W*7"(,'<VP;N2!RHSR2 "-_#.MMJ=S>)XJGC6X<;D2RBRL
M8Z(K')  S^))ZFIM1\)17LVJB.Z:"VUA%34(E3)D 7:2K9^4LF%)P> ,8/-#
M>*1>W\-GHD$=[*]@NH%GE,:B)SB,9P?F;!^@&3VJ%?%&IZIIVGW_ (;T--0M
M;NW$S27%X+?RR3C9]ULL"#GTP.N: +6O>#](UW1+S3GM+>!KF P"X2!2\8Q@
M$$CL ,?2G3^&HTU"*_TN9+"Y6U-FQ6$,C1;MP^7(PRMD@]/F.0<U6T[Q5+-H
M6EZOJ-DEI;WSB-MDWF"(N^V)BV!E7^7G P6'49(Z.6:.%-\LB1KG&78 4 8$
M7A"TL(M'_LJ3[+-I4+00.Z^8'C<#<KC(+9(#9R.1]06Q^#K2VLM/2UF9+RQN
MGO([IU#,\LF[S2X&,A][9 QVQC K>%U;EF47$6Y1N8;QD#U-(;VU#Q(;F$/+
M_JU,@R_T]: ,'_A#;7[+D3M_:']H?VG]KV#/G]/N_P!S9\FW/W>^>:67P=:7
M-CJ"7,SO>WUREY)=HH5DFCV^64'. NQ< Y[YSDUOM=6Z3K \\2S,,B,N Q'T
MJ'49KJ"V5[1;9I/-C5OM$A1=A8!L$ \XS@=SB@#&N?!UIJ4&K_VI*9[G5(XX
MI9HE\ORUCYC$8R<;6);DGD^F 'S^%(-3>XDUN5;Z2>Q;3R5C\L")CE\#)^9B
M 2<_PC '.=N2ZMXFVR7$2-N"X9P#D]!]32RW,$#QI--'&TAVH'< L?09ZT 8
MD/AN436EQ=:DT]U8VLEM9SB$*T>\ &1@<AGPJ]@.O'-6;#1[F.>"ZU6_&H7=
MO&T<4@@$2J&QN;:"?F.!SG'H!DYTFN8$D$;S1K(2 %+ $DYP,>^#^1H2Y@DF
MDACGC>6/[Z*X++]1VH YZS\&P6EM8Z?]I+Z7877VJUMC'\R,"612^>54MD#
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MRDQ7.UV.X'>,X!';BNCHH RM/T=[32+BRN)X[IYWE>21X<!S(23N7/(YQU'
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MB$MM-'-&25WQL&&0<$9'H010!Y]?23P^,&N+!TOK>YU&U-SIMU 4FB;9&!/
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MXIYYVN;A[F628KN9VQG[H  X]* -*BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9&LW6KV
MHDEL(K3[/#;O+(]QN)+#D*H'L#DGVK7JCK1(T._PDDC&W<!(T+LQ*D   $F@
M#E;?Q/XAG\$CQ+]ET[R9-)>_5!ORCA ZHW/((W#(QR!71Z+KEGJUK"J7EK)?
M"".6XMX906B+*#RN25'/>N7T^WND^!JV#6=VMZFAM;&V:W<2^9Y)7;LQD\^U
M9D^E7\UU80Z997-K-)X3N;-9OLSQK'.WE%%9L *<ACST_&@#T6UU33[Z>6"T
MOK:>6( R)%*K,F?4 \5F:MX@DM]?LO#^G1)-J5U$]PQD)"6\*D R-CDY8@ #
M&3W&*P_"*V>H7]G?'0]8LM3L[,VTS7PD1(0<9C3)VR D @C( &<C@&36;.ZT
M?XCV?BI;6XNK"73FTVZ%O&9'@_>>8DFQ<LRDY!P"1P: -M[K7+>ZD@EBLY(O
MLLDR7:*RCS%*X1D).,@DYW'.#P,<\R?'>KQ>!M&\4G38;F.]*M/:6X;S$C(9
MB4)/S$*I."!FNL?54N[*Y>"VNV@6%B7:WD5BW950KN;\!_\ 6Y#PLEQ9>!/!
MEK<V%_'/;2HL\36<NZ+"."6&W@9(YZ<T =1)KOVN/0[K2)[:>RU.;8)2I/R^
M6\FX8(Y^3&#Z^V*E\1Z_#X=TM;J2)IYIIDMK:W0@-/,YPB GID]3V )KEH_#
M.H>'_&^FC2DW^&[J\DNI8!_RXS^3*"5](W+=.@;IUK3^(&B7^JZ9IMWI<8GO
M=(U&'48[<L%\\)D,@)X!(8X]Q0!I22^(K:.WE:*PN=\T:30PJZF)&8!F5B3O
MV@D]%SC/M6>FO:M<>+=9T:(V$46G00SB:5'.Y9-_!^88QLZ^_:L[Q;<R>(;+
M1HM,M=3%S_:=L\R&VFA9(=X\T.2  -O4$X/;-0)H%MK/Q%\3)J.FW9LKBQMH
M(9FAD2-BHD#A7P!QN6@#5N]?UVUU_0='D@L(Y]3BN&D;#,L;0A3QR-P;<,="
M*DU_7M8T#PKK.K2QV,\FGKYD83<%E4 94\Y5LY]>WX9WBVV6X\?^%I9["]N+
M*UAO/M$D-I+(J%UCV9**>I4_E5;Q/#%+\.O$NEZ+I.I%'B80H;24-++(26"J
MR[B!P<].<=J -JY\2W^D:EH=OJ4%M-!J\WV=);8LKQ2%"PRASN7@Y((QZ5 G
MBG4]2_MU]'CL99-)N)+<V$I832%/XL@_*&.=HVG( Y&>,/4-*,VM>%[SPWI^
MH1ZE;W*+=3W-O,D4=J5_>J?- &3P!MYI/%>EVNK"]U6RL-4TSQ=:O+'9W-G;
M2*;@JQ$89@-CHP"YW'@'L* .JOO$-VVL:GIVE00RRZ7:)<W'FY^=GW%(EQT)
M"$ECG&1P>T-MXO&N7>FVFAB+S+S3?[3:2X!(CB)"JI (^8L2.O&T]>E9L5OJ
M.AZ_X@U"YM)KB35K"V=/LL3.#<1QLC1\#Y<Y4@G Y//!JGX:\.7/@K4](N+J
M*:: :"EA.UO$TI2>-R^,*"<-O8 ]/E]Q0!LWGC63_A6T_BNPLHWDAA=WMII2
MH1T)5UR <X92.V<=JW=<U&?2_#M]J5O!'/+;6SSB.20H&VJ6QD ^GI7#7.@Z
MAI_P0U+3)+2>34KN&XE-M#&9'#S2,X3"YY&X ]LBNO\ $A:X\$:JL,,\DDUA
M*D<2PL79F0@#;C.<GTH COO$\.F>"H_$%ZT,.^VCD =]J>8X&U2>PW,.>PYJ
M@OBC4K+P9>^(=272;F.-0\#:7</+$R$@;F<J. 3DX!P :NV.H1Z5X-TE[RRO
MG7R(8)(H[.21XSL .Z,#=@$<\5B+H]WI>A>)I] LGA@OYDEM[/R<%5*JLSK&
MPX)&XA2.2!QSB@#HM)UF:[UBZT^1K>Y2&VAN%N[4$1GS-WR$9/.%#=>0PZ=Z
M>E^+&U/7M;M$M#]CL+6&>"1>7N YER0/0^7\OJ#GH16#I?A2XM&U?2/#EW/8
M:#=0QR1K=6[L()B_[Q$#%6*L@Y&>">#VJ;1M)\3V/C?7KJ:ZM[A#IULD3"P,
M,<SKYVU5.\@;21GKPPZ=P#3T'Q;)J[Z*Z_99X=5MGN +;)-KM"Y5R3\W+;2<
M+AATYX9X?\5W?B76[C^S9]$FT>"1XW\NZ9KM<9 )0+M +#(Y^Z?7BL;PSHT^
MEZWINJ:?#>PRWMNS>(+>6!D1I@A;S%!  ?S#C"\$'(X&:UH;:TU[Q3H_B#3M
M/N[.>V$HO);BT>V:2-D*B)@P!<[]K#&0-AYY&0!8O&SR65MK1AB_L2YU'[!&
MW/F >88EF)Z;3(,;<< @Y[47'C9X;/4=96&(Z-I]_P#8IB<^8V'5'E!Z *S=
M,'(4G(X%<_;^'K[_ (0K3?!AMIQ/;:JIEF,;>7]G2X,PD#XVG*[1C.=QQC@T
MMWX>OSX/U[P>MM.;B^U1V@F$3&,P2S+(9"^-HVJ7!!.<KTY&0#H;_P 8S0QZ
M]?6MO'+I^@R".ZSG?*0JO+LYP-BL.H.XY''6IKKQ3//?:I!H\4$ZZ79QW4YD
M)_?%U9UC3'W257.XYQN7@\US][I%_9:/XWT*&TGFGUNYEELI%C8HPGC5#N8#
M"[&#$Y(XQZU8@TJZ\+ZAXD6.UN;I-0L+<6;0Q,^^6*$PE&(X4\(<G PQYX-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDNE^&8[C3EAB&MZ?A_.5O^6@[ 4 =]=W]G86;7EY=06]J@W--+(%0#UR>*L
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MNTFF7C 01%=C9AR,ECD=,'CO^ !WE%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5[ZU%]8SVK2R1+,
MA1GCQN (P<9!'Z58HH Q(/"]I;^$#X92YNC8_9C:!RR^8(BNW&=N.G&<9J(>
M$+ W5K/-/<SBWL'TX12%"DD+;=P8!1DG:O/'3ZUT%% &!X?\)VWAW:L.H:E=
MQ1+Y=O%>7'F+;I_=3@=L#)R0.,]:L:QX=M-9GM+IY)[:^LV+6UY;,%DCR,,.
M005(ZA@0?2M>B@#)E\/VUY8W-IJDT^I)<0M!(;G:/D;J $50/J!G@<\"JT?A
M.V$06XOKZZDCM'LX)IG7?#&X ;:54?,=J_,<GY1SUSOT4 <Y=^"]/U&#4$O[
MBZN9K^V2UEN&*+($0EEQM4#(9B<D'\N*W(K54LQ;2N]PNW:[3X8R9Z[N,<^F
M,>U3T4 <_IWA2+28/L=CJFI0Z:"=ED)$*1J?X58KYBK[!N.V*?/X5LWU*>_M
M;BZL)KBW6VN!:E0LR+D+D,IP5!(!&#@]>E;M% '.OX,TZ/4+2]T^>ZTR6VM5
MLL6;J%D@7[J,&5NG.",,,]:I#X=Z9%IVDVUK?ZI:3Z4C16UY!.%F\ML91CM*
MLIP.".U=?10!6MK)+33UM())5"J0)6;<^3R6);.6)).3WJI!H4$'AUM%-Q/+
M \3Q-))L,C!LY)^7!)R>2.<\UJ44 <[:>$_[/TS3;"RUW5X(M/4QQ$21L73
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD)"J68@ <
MDGM0 M%,2:.1 Z2(RD9#!@13MRXSN&/7- "T4W>G]Y?SIU !14?GQ"4Q^:GF
M ;BNX9 ]<4_<N<;AGTS0 M%(6"]2!]30&!Z$'Z4 +12;AG&1GTH)"C)( Z<T
M +137=(T+NRJHZEC@"E9U1"[L%4#)). * %HH!! (.0>AI 0P!!!!Z$4 +12
M9!) /(ZTDDB1(7D=40=68X H =12*ZN 58$$9!!SQ2T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*@$9'<\]:U* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:64A8G5W8Y0[L]NA!H ]2HKC]"O5M+Z[T+[).GB".S^U">_=6^V G;O+H6P
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M3!8\AL^^,_C0!LT5YE97,VEZ7X U=9&DO-7FCBU!R>;CSX6D);UVL 5] ,#
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M_>D"@,?SS0!>HHKF/'6M7ND:-:PZ:&^WZE>Q6%NZ@$QE\DN W!(56(SQG&:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK-US6[30---Y=!W
MW2+#%#$,O-(QPJ*.Y)_Q/% &E16+)JFL6RV\ESHT7ES31Q-]GN_,:+>P7<P*
M 8&><$_ES52'Q)J%WXDU?1K72[=I--6%WDEO"@<2ABN,1GGY3G^M '2UFZCI
ML]]J.G3"ZC2VM)3*\#0EC*VTJ/FW#&-Q/0\X/:LFX\4ZA!J^BZ6=&1;O5()I
M0LMUM$1B"EU8A#G[PP1U]J77?%%]X=\-ZGK%]I"$6!!,<5UD2H<<JQ0<@DC!
M Z4 37WAN:?QAI_B&TOH[5[:W>VFB^S[OM$;$'#-N&,$9''4GK5?2O#6K:/<
MZO-:ZO9L=2O&O&$M@QV,55<#$HR,*/UJQ-XEET[6=-T[5K!8/[2=HK:>"?S4
M\P+NV-E5() .#@CCM5=O%MS-;:K>Z;I27EIIL\MO+BZVS,\?#X3:1@'/5@2!
MD#ID U[:QU&">R+ZH98(8&2X1X1NN)3C$F[/RX^;Y1QS[5I5SVH^)_LM]J-K
M9V1O&TRV6YO<2;"BL&*J@P=SE58X.!TYYI6\4QW5W:VFC0I?S7%B-0&Z7RU$
M)P$.<'EB>!CL<D8Y *T7@N&.."Q^U Z1;WYU"*T\KY@^\R!2^>4#L6 QG@#.
M!RDOAWQ&^K7-['XHAB6=L!!IH9HH^R*Q<X]<XY/..@J2_P#&EK;^!?\ A*K.
MUFN[8Q"41!E1ER<$-GH0>#C/2M77]5_L+0+_ %7[-)<K9P/.T2,%)55+'D^P
MH K:IH<VHZ_HVII>)$NF/(XB:$L9"Z%#\VX8X/H>:JZMH6O7NM+?67B""TBC
M3;# ^GB7RR1\S9+C+'IG' X'4YOWNNPV'AP:Q,H56B1UC,@7<[X"IN. ,LP&
M3QS6>WB>[L?#=SK&M:1]@$3HD<0NDEW[V558LO"KN8<]@": )7\.W*ZA;:I;
MZDHU1++['<7$MON6=<[@Q0,,$-DC!QAB,=,49/!U[:Z=I6FZ+K,=E9:>G^KF
MLQ.9I,Y\QCO4$YR<8QDY[#&SI^KO<ZO>:7<VRPW5K%%.3%(9$9)"X')4$',;
M9&.F#WXHV/C"TOM2UZW6"1;?2(HY6N,Y$P8.257T'ED9[]N,$@$]UHE_?^$K
MW1[W55GNKR"6&2[^S!0 X*\1AN, ^O;-0ZCH&J77AZRTJTUB&U\E52>0V?F"
M=5&-NTN, ]QDYZ=,@NTSQ,;ZYTN.6T2--4M6NK5XI_,^50A(?Y1@X=>A(SD9
MZ9;IGB.[U?6)(K/2EDTF.1XCJ(O(S\RY!_=CYOO# ]N: &2^&;W4-'DM-8U@
M7=RL\=Q:W$5JL(MWC(9"%!.?F'//(..*<WAR]!U:]@U1(-8U%(XOM:VV5AC3
M.U40M_M,<ENK>P%16_C."=;.\^S;=*O;UK&WN_,R6D#,H8ICA&92H.2>5X /
M!/XS@A%Y=_9MVDV5Z+&XN_,P5D+*I(3'**S!2<@\-P0.0!;'0/$-E936_P#P
MDL)_<&.W*::JB%B1\Y&\ESUZGJ<G-.TC0=>TU&CE\10SQ+$ZQ(NGA )#_P M
M'.\E^<DC(R3DFFWOC*&T_M2Y6U\W3=*G6"]N1)@HQ"EMJX^8('4MR.^,D5)J
M'BM;6ZU.*TLS=KI5NMQ?,)=I4,"P5!@[FVJ6P2!RO// !'HGA_7M,N8S>>)(
M[RV#,\T:V"Q/,Y&,L^\GK@\#L!P.*9:^"H;>+3[%[D2:3IUVUW:VOE896RQ5
M6;/*J7) P#PN2<<VI?%"7%[%9Z/;K?S/8B_.9?+40L<)@X.68YP, <')'&8[
M7QA;:K+ID6D1I/)J%DU]'Y\OE 1@JI!PK'=EL$8XP<GID AO/A_X?N-5TJ^@
MTK3K86$S2M''91@391E . .A(8=>0*6[\%Q72:G9BZ":5JETMU=VWE99G^7>
M%?/"OL&1@]6P1GBW:^*;>XTO3-4>%HK*^98O,8\Q2,=JAO\ 9+?*&!ZE>QR-
MXD#J<4 <SJ'A!;N76%@O/L]KK2*E_$(\LV%V,4;(VEDPIR#T!IUUX4'VJ\FT
MRZ6Q%]9I9W*B+?\ *@(1DY&U@K,,G(Z<<<]'N'J*0N@95+J"W09ZT <\OA..
MPNK6YT2=+&2"P&G8>+S5,*G*<;A\RG.#G^(Y'3#+?P;;:8FC-I$PMY]*@>VC
MDE3S!+&^-X< KDEE#9!'(]ZZ0NH;:6 8\XSS5>_ENX;=7L[>*>3S$5EEE\L!
M"P#'.#R!D@=Z ,"+P5!:0Z9)9W134+"YFNA<R1[A*\V?.#J".&W=CQA?3D?P
M7$76]2Z":LNHG41=>5\OF%/+*[,_<,?RXSGOG-=.753@L <XY-*SJI 9@"QP
M,GK0!@#P_>VWV^[L-2A@U6_N4GGN'M=\;*BA!'LW @;5'.[.23[4E]X3@U32
MM0MK^X+W5^8WDN8DV;'CP8RBDG 4@$ D\DY/-= 74'!8 ^F:0.I8J&!9>H!Y
M% &$= NWO;C5'U")=6:R^QP7$=MA(5SN)V%CN);!.3T4#U)EAT$W,AGUU[74
M9S ;?:+;9$$)#,-C,V=Q5<Y)^Z, <YV%=')"LK;3@X.<&A71P2K*0/0T <U;
M^!](L?%']N6%E86LJV?V>**.S151]Q/F9&.<';QCCO3=)\/>(+"]$MUXFBN8
M6E,MPBZ<L;S'L"^\X'0=.@P,5TZNKIO5@R^H.16/I6O-J/B'6=+-NB+I_DE)
MDEW^:)%+9Q@8QCWH ;'HVH7$R#5]3AO+:&Y^T0QQVOE-D'*!VW$-M.",!>5&
M?0C:-J%Y-)'JFIPW6GBY%Q% EKY;C:X=$9]Q#!2!T4$X&3U!=9Z\]QXIU71I
M;=(ELH+>9)O-SY@E+C!&!MQL]3UK9R,XR,T +10"#T-<UIOBJ:[\/W.MW&FE
M+2)Y%5+:0S2L$E:-B5VKC[N>">* .EHKEM%\:P:OI-]>K871^Q!FD$*%U<!F
M "$XW-M4,1CC=CK3M \:0:]!?20V5R?LOFMF-"0ZJ[! "<?.RJ#M[9P3F@#I
MZ*Y70?&D?B*ZO;6SL91-#N:,R!E3;A=HD;;\C$L1MP2-I/IG3\/ZS+K4%ZT]
MJEO+:7DEHZI*9%)3'()5>#GTH @N-'U9IM3^SZK;BVOFSY-Q9F7R?W:H0I#C
M(.W."#R:=I?AXZ1:6&F6UWNT>UL?LK6DL09I3P Y?Z!@1C!W5N44 <QIW@];
M-M'BFO/M%GHN[[!$8\,N5**7;)W%4)48 ZYZTV#P7##':6)N@VDV=\;^"U\K
M#*^XNJE\\HKL6 P#PHSQSU-% %!M-\S7X]3DEW"&V:"*+;]TLP+MG/.=J#IQ
M@^M8VO\ @+0M=B&=-T^"X-U%<R3BS1GDVR!V4G )W8(/U/6NHHH Y^3PR8-5
MN[_2KF.R-[:I;7$9@WK\@(1E (VD!B.X( XXY2V\/W^F06NG:5JD=KI$%JEL
ML#6N^5=HQO63< "1C[RL,C-=#10!A'PU':WVF7>ERI:MI]FUC'$\9D0PG8<8
MW @@QKSGUSGLNF:!-HUO8VMA?+%;13S3W47D B<R%G(7G]V [9 &> ![UN44
M 8=KHVH2RVS:UJ<-\+28S0"*U\DEL$ O\S D!CC 49YJ66RUWRIO(UFW$C7?
MFQF6RW*D&,>40'4DYYW9S[5KT4 8B:)>6UO?S65_#%JM],DTMU);;XR5"J%$
M>X';M4#[V>2<TJ:)=(=2O5OHUUB\MU@%TEO\D00-LQ&6.0&=FY;G/IC&U10!
MS.IZ#X@O;^UN;?Q%! +>(*L;Z<) 9,8:3[XY/('' ) ZG.]8PW%O8PQ75T;J
MX5?WDY0)O;N=HX ]JL44 %96OZ)'KEG!&93!<6MQ'=6TP7=Y<J'()'<$9!'<
M$\CK6K10!DZ?HQM-2U#5)9DEO[U8XV=8RJ*D8.Q0N2>K,3SSGMQ5'3?",5MX
M3O/#NH7"WEK=-<%V6+RSB9V=A]X]"YP?85TE% '.0^%%GNH[C6+E=0>&Q>PC
M'E;!Y;X\QF^8Y9@J@D8'!P.:33?"GV2YTA[J]^U1Z/"T-BOE;6 *A-SG)W,$
M&W( '+''/'244 926.K_ -E"UDU>-KHE]]VMJ%;:6)7:N[ (! R<CC)':J<O
MA"Q32--L; FV;3+A;FUE(WD2#.XOR"VX,^[D$[B<YKH:* .8F\%V]U9ZC]IN
M"VH7UW'>M=HFWRY8MOE;5R>%V+QGGYN>:2[\&0:I'JTFIW'FWFHQQ1F:&/8(
M%B.Z/8"6Y#DMR3D^W%=110!SDGA*#49M2GUJ5+N:_LA8/Y<9B5(?F)"@ECDL
MQ).>R^G)!X:NDNX+ZXU))[^SLFM+.4V^%CW8W2,N[YF.Q<X*C@],UT=% ',Z
M'X?UW3+F,WGB..\M@S/+&M@L33.1C+/N)Z\\#L!TXJY8Z'-9^*=4UEKQ'6_B
MAB, A(*"/=@[MQSG><\>E;5% '+1>"XHX[>Q^U Z1;WYU"*T\KY@^\R!2^>4
M#L6 QG@#.!R77@N*Y34;(7072M2NUO+JU\K+,^5+JKYX5R@)&">6P1GCJ:*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_E@QOLR5<]RPR1G/3BJFE>$;O1='ETRQUZXCBDDEE\SR(RZM(Q9L'&.K''%
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M]JMGODL;*VF@B@>65YYV3D=%4!3G@'TQQZUKU0UM@FA7Y(8_Z/( %4L22I
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9(U8_P!M629(S\K2J&'T(X-4?$6G:EIGC&?7O#<0:>RL87NM.C 5;Z)GE#C
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M>4J%WL!RV!P,GG H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD'UK4H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ K/UG28M:T_[)+<7%OB1)4EMWVNCHP92,@@X('!!'M6A10!F:=I#V<HGN]2
MN]1N%4HDMR(UV*<$@"-%'.!R03Q6G110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !16-H?B6PU^[U6VLRWF:;=&VE#<9.T'</]D\@'OM--;Q ;G6;K2M*M1=W
M%F%-U(\GEQ0EAE4+8)+$<X .!C)&10!MT5RFI^,Y-+TZ:ZGT:X#0W\=@\32J
M"6D";74\@H3(.>#QT["[8>)DNO$%UH%Q9RVFJ0VPNUC=@R2Q$[=RLN> W!R
M?K0!O45SOA_Q=::]J&IZ9Y+VNIZ=*4EMI6!W+G =2/O*2",]B.0*TM(U&34[
M:6:2V$ 2>6 #S-V3&[(3T'&5./;TH T***S/$&MV_AS0+S5[I7>*UC+E$&6<
M] H]R2!^- &G15,:I9'1QJWVA!8&#[3YY.%$>W=N^F.:R$\37DVB-K5OH<\M
MAY)FB3S0+B5,9#",\<CD L&QVSQ0!T=%-C<21I(O1@"/QIU !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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<H **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>exhibit1027supplycontrac019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME4'C)+@Y(/"GCG(PH/&M[/%;Z7B(:M)K4ND/,J?)B-3(TH7/7R\<= S=P,4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"M\^L6E_!:,R[C%;H(]I.<!F4R$<X&5R1S@UGP??Z_=:YK A\BZD-G_9\,S
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M&NGHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M,_4=%L=5FM9KI)?-M69H9(IWB9"PVG!0@\CBM #  HHH **** ,^\T2QO[ZU
MO+E)I);602PCSY BN 0&V!MI.&/)'>M"BB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'<,OA7^VI+7").MM)B>(#<0 6 +Y #$C8?GX^[F@#KZ*XW2O':7?@^;7+FS
M-H(EN52>)07(7?MWN-H!8\/M)QP.14_AGQ3=>*-/N1;QP07EL5#N_P T9+$G
M&S<)%^4#[P&<\9% '5T5D>%M7EU_POIVJS1)%)=0B1D0DA3[9K7H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@PQZ=:?7 :;%X0&DZIJ!GN+S1KVZMY)&F@/DF?<JJ8T1%YW!-Q QGJ>&KOZ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC'USP!^\ZY[5K2ZC906J74MY;QV[@%9GE4(V>1@YP: +-%5S?68DBC-W!OF
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M 9)KBWASPAGD"*S=ADU@^'O$-]KN@:%J96P@-\S>?$\C [0'P(O[S9 Z]LT
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MLKWS&:$O&C,8=N3C )VMCZ5S7A^1K+2/"EO-IMY"4EOXQ<BTE=K4&1MJ",#
M+H1AF! "G YKU>B@#RK3+"\A^&'AS5;>PNO[6\/2>:+=X2DKQ@E)HP"!G,;'
M&.,J*U?$$=[HI\/ZE<17C6J7$TNI-91>:\,LJ_*^W:2RJ2R9 ) (KT"B@#"\
M)65E9:*PTZ&[BM)IY)XQ=*59MYR6"$ H"22%P/H,UP%KH,=UH$-C#IK1>(X=
M?>X68VY1X4^ULYD+X^X8LXYP<@#FO7** /,-+ACN=3_LC6[76&U:TUF2]@V0
M$0R RLR3"8+C:$8 @MVVXZ"DT&&&ZNK72];M=7.M:=J4MR!Y!6%LNQ\X2A<%
M"C'*EN>F.E>H44 >06>GQ6^B:5+%ILD5S'XL>4LMHP=8#<2'=]W(38PYZ8-=
M?\0K9+JPT8-:FXV:Q:.P6$R;4$@+DX!P-N<GIBNPHH \FUS2;=X?B2L.E%FE
MMH_L82T)WOY !\OCD[P,[>X%;4$@B\3ZL^N6\T^G:EI=NEHY@9U955Q+#@#A
MB6!V]6S[5W]% 'EGAJ/4_#NIZ)%XG@NIH6T%+6*00M.(IMY+Q-M!PQ3RQGH=
MF*K^'[5HM&^'&^PN8Y;2\F$N^U=6B0Q3 9R.%)9.>AR*];HH \RF@2;1/B5$
M;*5FN9)FMU-LW[W_ $6-%*#'S?.I QW%17$@MM0MX]:@U0Z1J.AV]I&]K:-,
M%<;Q)$ZA&92VY>PSM]N/4J* /-(5_L;7+^SU*PO38W.B06VFEX7N-JHKB2%B
MH/SDE2<]<#DXK6\%M9Q>'/!]M>:=,NIII@2*26S8-!M1!(I8K\F>/3=CO7:T
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5D^)/$>F^%-#GU?593';0X&%&6=CT51W)_SQ6M7
MF_QL\-ZEXC\$1#2X6N9[&[2Z:W09:50K*0!W(W9Q[&@#>N/$VM6GAU];G\-$
MP+"9S;178:X5<9^9"@7..H#$CMGI74NVQ&;!; S@#DUYOXT^(\UEX9L=0\)2
M65_?7$Z1M821M+* RDG,:L&4@@ @CO76VOB:SD\2W7AU_/\ M]G:K<S3&$I"
M5..C$GUZ?7DX- %;PIXQ@\5W.L0P65Q:_P!F71M)!.5W,XZ\ D#!'J:F\5>+
MK'PI:VK7$<MQ=WLPM[.TAQYD\A(  SP!R,D],_2N.^$TJ'7_ !T XS+K4LL?
M/WT+-AAZCWI/BCI%ZOBGPAXIB@EN;#2;O_34B4NT2%E/F!1R0,'./04 =C<:
MWJ^GFS-]H:>7<W$4!>TN_-\DNP7+[D7CGJ,\^G6H%\8I?>*[OP[HUH+VZL8P
M][-)+Y<,)/W4W!6)8^@&!@\YXK$\0^.;Y/%7AK3O#,^G:C::G,5NWC0SM;("
MGSDHX !#-U'\-9/@ZW/@KXF>,H];D6VM]8F6]LKR9ML4J[G9DWGC</,''7@G
MI0!UFG>-TU./6[6WT^0:WHY(N-->0 OQD%'QA@PZ' [9QFD\+^.8/%'@J;Q)
M;VR0I%YF^"2;)0IU#$+P<8/0\$5S7@?3+G4?BSXK\8QQNFDW"+:6LC @7!41
MAG7U7]WP>AW<=ZA\/>&=1T3XHZ_HL$6/#=\8M6)[*VX_NQVY<<C^ZF.] '1:
MYX\NM!OO#=C=:(/M6NR>5&GVOB%\J,.=G^V.1GO^.F?$6H0PZN]SI$:'3[<7
M"-'=[XYQ\^Y0VT$,#&001W%<+\73')XV\ !IC&D-^[3R(V#"A:+YB?X>AY/I
M6\NJ:9:>$]5T"UU(:@;73KF22[\S>/F+; S]&=MQSCN/<4 5T^+$4?@[3O%E
M[HTL6C7DYA,D<XDDA.YERR;1QE3T)/M6EXQ^(MOX*U#35U#3I9--O3S?0OD0
MC(!++CI\PZ'GFO&[*PU"W^&7A+4[I)]5\/6-W)_:>BXP8R9GVR84!CPV<,2,
MD=B<>UWS:!XLOK?3II;>[L[[3)?W6[!*EXR..H88R.X(]J -D:M--JD-M:V\
M$UM-:FYBN1<<, 0 ,!3UW#G/2L'P5\0K?QA?ZCI[Z?+I][9+'(899 WF1N,A
MP0!QT_[Z%<_\/-(UGPAXEU'0-6N#-I-A:M)IMW)QF%W!*D]!M*\CMGT(K*E\
M/Z@_B+P7XA\.2#;J.GKI>I21G[BB+.\XZ, IQG^)%% '9Z#\0E\1>,-5\/V>
MF%381^;]HEGPLJG&TJ IX(8'Z&JV@?$2]\2:1J&H:=X?1A97,EL8'O@LDKHH
M8A!LP>/4CH:Y_P (-;6OQW\7LC1Q6ALX4A;("$(D8(4].,'Z8K"^%;:=807F
MJ:EK!LOL6M7-Q]FDEPLT;0% PCZL<MP1Z$4 >A>)_B5;^$=3TN+4],F&GWZJ
M3>QOD09_OKC^1Z ^F*WKO7;B">Y%M8+=PQ6)O(GBG^:;@X11MQDD=<XYK'NE
MT?QC<#3M1C0Q:CI*NUJ[ 2(&8,/HPX/MBL3X9Z/KWAGQ!JOAW5I6N;*PMT_L
MVY(_UD#.QQG_ &2,8[?3% &LWCN_3QI#X4;0HAJ4MG]K!^W?NPO/RD^7UX/;
M'O75Z??/=:3#>W=N;)VCWRQ2L"8B.H)Z<>M>9W<B?\-*64N]?+&D&$OGY0^7
M^7/KSTKT;Q'ITNK^&-5TR"01S7=G+ CG^%F0J#^M &)H?C*Y\4QSWN@:0)]*
MBD:)+NYN?)-P5ZF--C9';+%:;??$"UL+'2S+I]R-5U6X>VM=-)42%U<H2YSA
M0,#)YZ\9KG_A1K=EH'@FW\.Z[-'I>K:=++'+;7;"-W!D9@R _?!W=5STJ#QU
M97*>/O!WC5;>X;2;5C#=;HB&MU8G$C+U"_-DDCC SB@#L)_&"Z7XET_0];M%
MLYM2!^QSQ3>;%(ZXS&254JW(QQ@Y'.>*S[7XDVG_  G\OA'4[%["ZZ6UPTFZ
M*X. <*<#G!_,8ZXSSOCN >-_''@ZRT*5+N/3KHWM[=P,'C@0,A +CC<=IP.O
M3M6GXB\*:;\0=*UBV@NHDU*TOVDL[N-OFAD")W'.TD8/TSU% '3G7-3.](=&
M2687WV0*MUA<!"YD9MG Q@8P3DUA:/\ $.\UNXUN*T\/[SHUW]EN@+O+$ABI
M9!L^8#:3S@XJU\-;C5Y?"LLGB)/*U1+J2.ZW#&63"[O3D*#D<'.1Q7,_"%U_
MX2KQ^=P'G:N\L6?^6B;Y/F7U'(Y'K0!T5OX\O+SQ1KF@6FAK+=:.BR2DW>T2
MA@" GR=<'OCZUL^$/%=AXT\/0ZQIRRI$[,C1R@!D<=0<<>A_&O(I[#5M7^)7
MQ"C\/ZJ]E?36T7V5TV[;@JBAD#$?494@@UT_@3Q/I6G_  QAMK&TBTG4H'%F
M]G/E<73-MWG=R5).XGG !':@#MM%\6:;KNMZUI5G)NN-)F6&;GALKG(^C!E/
MNM5-1\9)%XI3PQI-D=1U?RO/G0R^5%;1\8,CX)!.1@ $\BO.M1@G^'GQ3T/6
M]D*:?JD L;Y8)&D^[@"9\J/]DDX_A;UK1T]3X.^->N:GK#"+2=<MU:UU&3B$
M,-O[MGZ*>#C)[#UH [F;Q#JEO+<VSZ!(]W"D+1B.X!BF\R39\KD C;U;*C ]
M:Q[?Q_?W?B36M!MO#ZRW^D0K+,JWO$F0" A*<GD=<5UUAJMGJ;2&QF%Q%&!^
M_CYC8G/"MT8C'..F17F?@^1#\>?&D@=?+F@A$3YX<JJ9"GOCVH ]5@D\Z".7
M:5WJ&VGJ,CI6-8^+--U#Q=J?AJ&3-[I\,<LG/!W=0/\ =RF?]X5=UO5H-#T>
MXU"X9<1+\BEL;W_A4?4\5X]XIM+[P1XK\,>,MMO(&;[)J)M'9VN4?<S2E=H]
M6/&1G:/2@#T'6_&\ND>-M+\+QZ6MQ<:E&TD$IN=BC:&)#?*2/NGIFK.A^,[?
M7+_5-)6UDM=;TPXGLKAP,@]&5ESE3D<X[CCD5P_BV^M3\<_!=]]IB^QQ6LID
MGWC8@97VY;H,Y&,^M6?#=C/??&'Q+XU*-;:&MH+2&XF!07!"QAF7/5!L/S=#
MQB@#I/ WQ!MO&DNHVWV"73[RP9/,@E<,2C#(8$=O_K>M1^&_B"/%'B35](LM
M+,?]GJ'\Z:? E5ON$ *< C!YZ UQJ^&[\^+?"FM:$P^R:SI2Z?JKIT15B!+$
MCHVU0!Z%!5OP+-;6_P 8_',IDCBMW6+RG)"HP48.T]"![=* -_0OB3+X@\%Z
MGXDL]#8QV,KQ&V-SF20J%+;<+C^(8'>K>A?$.T\2^$)M<TNUWSV[[+FQFEV/
M$V<8)P?J..>>X(K@OA3<PV'PEUU;N58&_M"5MLAVG!6/!P>><'\C6CXS\(WN
MA^)8O%OA4C['J4B0:O:Q\HZ.P_? #ZY)'0\]"U '8:OXVDTCQIH_AEM,62?5
M$+1S"XPJ;02V1MSV./7VI\?C1[XZW)I6FK>PZ/.]O<(MR%G=T&6V1[<$9X!+
M#.#CWY+QG(@^.O@J0N/+ABE$K9XC+*V-Q[9]ZQ_%6AZ9/<ZIXM\+ZQ/H?BBV
MGF22S5L?;71RORQ]6+[1C&5).",YH ]#\2^,[KP[I6HZLVBF;3[%(F>4W.QI
M"^WA%VG.-PR2131XSOQX?;6I-""VATHZI&RW>[<@4,4/R</M8'T/K63\3I;N
M;X)WHOXUCU*>UM_-A7_GKO0LJCO@Y_*IVFB_X4+CS%S_ ,([Y.,\[_L^-O\
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MU8#C'4@>H% 'K5A<27>GV]S+$L3RQJYC5]P7(SC.!G\JL54TK_D$67_7"/\
M]!%6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***QO%/B!?"^@SZO+:O<PP% Z1L WS,%&,\'EAW
MH V:*;&7:-3(H5R.5!R!^-.H **** "BBB@ HHHH **@O+RWT^RFO+N58K>!
M#))(W15 R34] !161XEUS_A'=&;43:M<JLL4;(KA<;W5 <GT+"M>@ HK-\0:
MM_8/A[4-6^SM<"S@>=HE8*6"C)Y/L*JP^(_-\1V.D&S9?M>GO?+-O&!M9 5Q
MU_Y:#GCI0!N4444 %%%% !1110 450US4_[%T&_U3[.UP+.!YS$K!2P4$GD^
MPJ>QN?MNGVUV$V">)9-N<XW ''ZT 6***:[K&C.[!4499F. !ZF@!U%16MS#
M>6D-U;N'AF19(W'\2D9!_(U+0 44A. 2!GVK TCQ%<ZUI4=[:Z6V?M\EI-$T
MZ@Q*DC1M)G'.-N<#UH Z"BBB@ HHHH **** "BBB@ HHHH **** "BBH+B\M
M[1H%GE5&GD$40/5W()P/P!/X4 3T444 %%%% !14!O+<7RV7FK]I:(RB/OL!
M S],D?Y%3T %%%07-Y;V?D_:)5C,TBQ1@]7<] /U_(T 3T444 %%%(Q(4D#<
M0. .] "T5@:+XBN=<T2QU*UTML3W4D$T;3J# B2.A?./FY0<#^][47WB*Y34
M;RRTK2VU&:Q\G[2@G$3#S,XV[AAB ,G)7@\9/% &_14%E+<3V,$MU;?9;AXP
MTD'F!_+8CE=PX./6IZ "BH#>6ZWR61E7[2\32B/OL! )^F6%-L)KJXLTEO+3
M[).2VZ'S!)M ) ^8<'(P?QH LT444 %%%9'B?7/^$;\/76K&U:Z6W +1JX4D
M$@9R?K0!KT444 %%%% !1110 445D^)];_X1OPW?ZP;5KE;2(RM$KA20.O)H
M UJ*13N4'U&:6@ HHHH **** "BJ\M[!#=16K2+]IF5WCBS\SA<;B/ID?F*H
M>&M<'B+14U$6S6VZ::(Q,X8@QR-&>1Z[<_C0!KT444 %%%% !115%-8T^2WM
MYTNHVBN)C!"P/$C@D87U^ZWX#/2@"]1110 456DFNEU&&%+3?:O&[27'F >6
MP(VKMZG.3SVQ[U9H ***R-#US^V9]6B-JUNVG7IM#N<-OPB/NXZ<../:@#7H
MHJMJ$US;V$TUG:?:[A5S'!Y@CWGTW'@4 6:**K&^B:>YM8&66[MXUD:$-@C=
MNVY/;.TT 6:*@LY9YK*"6YM_LUP\:M)#O#^6Q'*[AP<'C-3T %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7$?%R:.+X:ZIYDB)N: +N.,_OHSQ7;TA4-U /UH \]U>W
MTG5/B3/;WLL<UM)H!D:-ISL/[W@XSCIS^&>U;G@&Z-_\-]"FN)S*S:?&)9&?
MDD+@Y/K72[$_NK^5*  , #'I0!XWX<-E;:;X"U&&X'VR?4Y[:68SEF>(K/\
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M<V[_ -_S-_"\G(ZUIZ/8:;??$;Q$UY(TTUD+*XB$DYS&XC?<VT'&?7MS[UZ
MT:,RLR*67[I(Y'TI=HY( !/<"@"II>JV.MZ;'J&F745U:2Y\N6,Y5L$@_J#7
MF%E/->>&=%NHG"^,8]76.[7.)BWG$3(XZ^7Y9)P> H4CH*]3LK*&PMA! "%W
M,Y)ZLS$DD_B>W'IQ4PC02&0(H<C!;')'UH X/P)I^FW.K:]J ;S[NTUFZCA?
MSV;RT94&,9Q@^_I[5+J$MI/X^U'3_$?DC3GTR-[#[0P6,_,_G%2> XS'R.0
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M]-N=5U[4 WGW=IK-U'$_GLWEHP7C&<8/OZ>U=YY:>9YFQ=^,;L<X],TH4+T
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M[%!] N,>V*["D"A>@ ^E+0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5ROQ%O+ZQ\$7\UAM6
M0[(V<R%"JLZJ<8!YYQVQG/:NJK&\4Z'+XC\/SZ7%=K:F9D)E:'S,!7#=-P_N
M^M &!#>S:%XDN-&TCPQ!]JNK==0F$-]LA^^(SM!7 ..> ,GKZU;F\<)%IBZV
M+(-H9O/LK70F^=1YGE>9LVXV;^/O9QSCM6BNA7(\8)KSWL1 L?L;0+;D9^??
MN#;^.>V*RXO WE:9-H9OE;0I+S[4+8P_O%'FB4Q!]V-F\?W<X)&>] $-_P"/
M+NR@UJZ_L/?;:/>K;73?:P&9"L;;T&WDXD'RDCIU[#8TS7[FZ\1WNBWVGK:3
MPV\=U$R3^:)(G9EY^4;6!0Y'(]":S+[P1<WNF^)+/^U8D&MW2W!;[(3Y.%1<
M??\ FXC'/'4UK0:%/'XOFUZ2]C?S;&.S,"P%<;79]V[<>[GC'I0!3NM6U)OB
M#;Z$L%LVG2:9+<2%I2&8^9&F<;3T!.!GG<>1@5S?@+7[C3?#WA?3Y]/_ -#U
M"6>WBNO/RXD#2N,IC[I"D9W9SV[UU][H,\WBJTUVUODA>&TDM)(G@WAT9U<$
M'<-IR@]<@GH>:R;#P/<66G^';3^U8G&C7;W0;[(1YVX2#;]_Y>)&YYZ"@":W
M\:-=WMA]FTN>?3[RX:W6YB#LT>-P$CKLVA"5Z[N,C(Y.)_$FL:IIVO>'+*PA
MMWBO[J2.8RRE20L,C@#"G RN<^V.^1%H?A74M"N6MH==9]#69IH;(VX$D>YB
MVSS=W*!B>-N<<9QUOZ]H4VK7FD7EM>K:W&FW)G0M#YBN&C:-EQD8.'.#V(Z&
M@#./C1GO(/LFESW5C)?-9--"'9T(<H9"H3;L#*03NSCG%53XYU(Z;K.HKX=S
M9Z2UVD[F]4$M!U &WH1GGMBK>F>%-2TC4[A;37F71)KIKO[";<&2-V;>RK+N
MX0L2<;<\D9[T1^$+A?#?B+2&U.)O[9EN9/-%J1Y/GYW#&_YL9XY% #(_%NJ3
M:M#IL>A1>?=V'VZT+7H"E05#"0["4(WKC:&SGMSB*#X@07-AHLRVT-O/JL,K
MQ1W=SY2>9&P4Q!]I!8DG'3(!/M6A!X:NH=<TW4_[1A9K+3GL?+^S'#[BAWYW
M\<QCCZ\UFP>!9X_#$&@7%]97MDD4L<D=S8DJQ=RRN!YGRLN3WYSVQ0!T>HZS
M!I'AZ?6=15H8;>W,\R#EEP,E1ZGM6>OB2YAUNRTG4-.CM[C4+>26S9;@NKN@
M!:-SM&T@$'(!!&?3FS<>&[2\\'GPU=2336K68M&E9OWC *%W9_O<9^M5K/P[
M=_;M-O=4U"*\N=,@DBMG2W,>6<!6D?YCEL+C P.6]1@ QO UF=85]=U2TA.H
M0:A>K%=1SL7(\Z2,HWRKE%4  '(X!P"*H>*-5U+4M(^(EA=06ZVFFV1$)CE;
M<"8#(&QM&2<COQ@#GK78>&-#F\/Z9+9S7B76^YFN ZPF/!DD:0C&YLX+'%9>
MJ>#+B_D\3"+54A@UZW6*1&MM[1,(_*W [QD;>V.O?'% $FD>(;M]1&BW.EB*
M4::MY;,+@-YJ A"&^7Y&R1T+#GK6;H_C&PM?#_AV"QT^WLEU&S>6TMKBZ\M!
MM( B5RIRYW<#V-;4/AR[B\0P:O\ VA"6ATPV'E_9C@_,&WYW^JCC]:S(O DR
M>%+3P[/?6=Y8PVK6SI<V)8,<_+(!O^5EY[\^U '2:CK$.D:!-J]\CQQP0>;)
M&O+ X^Z/4YXK,O?%%SHT%_<:SI+6]M:VR3I/!,)5D9FV^5R%P^<>WS#FK5YX
M;M;_ ,'MX;N9II+=K06IF+?O#A0 ^?[V0#]:S'\(W^J^'+O2/$>N-?K-"(4D
M@MQ 4P01(1N;<^54YX''3DT /U#Q?<:1=W%GJ&F(MR+"6^MA%<[DG6/'F)N*
MC:PR#T((/7M3=-\77M_J%E9RZ0ENVHZ:U]9,UUN#;=F4?"_+_K%P1NX[ \4Z
M[\*7>J!IM2U*"6^33YK&":.U*JGF@"20KO.6.U>,@#GUJ2R\*W%IJFA7C:C&
MXTK3WL=@MBOFAMF6SO.W_5KQ@]30!BZ1XXU>3PWX:N[C2H;FZUN1HX_*N=BJ
MVQY!G*\#Y".^ ,\GBM#4_&MUHT(EU'1UMPAMDE1[L;F:4J&\H;<2!"PR<CO4
M>G^!KRPL/#MF-9B>+0[DS0YLR"Z;'0*?GZX<\^H' [FM^!KS5KC6FCUI(8-3
M:WDVO:>8\30E2%#;Q\A*YVX'))SR<@&E<^);HRW_ /9>E-J$>GW"6UP$FVR%
MR%9O+4C#;5=2<E>X[4S0=8U34/%'B.RNH;=;73[B.&(QRDM@Q(XR"HSG?SSQ
MC'/6H$\)ZE::[>WFGZZ;>RU)EDO;8VP9C(%"L\3[AL+!1G(;IQ6CIVA2Z=XD
MUC4UO5>WU)XY6MS#AD=8UCSOSR,*.,=>] ',3WFHZ7\1/$DVDZ3_ &C+_9MG
M*\1N1%T:?."0<L<# QCCDCOH?\)_#>Z<EUHUB]ZYL([XPL65MK[MJ#:C?.=C
M#!P.!SS6C<^'KT>(KW5K#48K=KVTCM95DMS(5V%RK(0PP?WAX(/;Z'-'@:XT
MF\LKCPQJ_P#9HALH[&>*>W%PDT:$E&QN7#C<W/?/2@!;?Q-K%]XL6TM=.B6T
M;1TOTAN9&BEW.Q&'&P[6!7&.V2<]@MAX\6]D\-!K&.%-<$J@M<_-!+&#NC(V
M\G(([<@CTSI)X=FA\46^LQ:BQ"V"V4\<L6]Y0K%@P?(VG).>#GMBLR[^'EG<
MV^JQK>3PM>7R7L$B<&T8,'.S_>?S"3_MX[4 6W\6R8MH8[*-KNYCEGA0S.4,
M*,%5RRQDC=N4@;>F>:@B\;/=6=GY&DSQ:A/:M<O9W>^(Q!6V8)",<E@<'&"!
MGC@&SK?A>YNM0T[4M#U)=+OK&)K==UOYT4D+;<HR97H54@@C%07_ (4U-[^P
MU73=?-OJL$+6]Q-/;"6.YC9MY!3<NW#<K@\#CF@"*W\:7]_>V-G9^'IEN;S3
M7OECO9O(,95U1D<%21RW4 ]N,'(W/#VM+XA\-V6KP0&+[5")!$[?=;H5)'H0
M1FJ4?AR[C\26NL'5!+)!826;++!DN7=7+DA@!RH^4# '%6O"VB/X;\-V>D/=
M+=?9E*B41>7N&2>F3Z^M '!76KZEK?AC0-4O[6$W"^)42)8)2=P6XD3;R !@
M*!G)SC)QTKJ(O&I2*_AO[ 0:A::@EAY$<QE21W175@VT'&ULGY<C:>#4$?@:
M[BTVUL$UB+[/::M_:4 :T)('FM+L8[QGER-W' '%+?\ @2:^EU>X&KF"ZO+Z
M&_M9HK?FUEB147@L0X(7D<9R: -K0-<GU=KZ*YTZ:SEM)A'N8,8YE(!#(S*I
M(['C@BN?\/NOBWQ)XEN-443VNFWQT^UM).8TV*"TA7H68MU/0# [YZC1[/4;
M6W8ZKJ*WUV^,O'#Y,:@= J9..^222?H !F?\(U=6'B"]U;1+^*V_M#:UY:W$
M!EC=U&!(N&4JV.#U!QTSS0 2/;^%)5MK;S)YM7O@MI;22G;&WE#< QSM0+&6
MP!QG '(JC?>/&TZRU@S:46O])N((KBV2<;628@1R(Y49!W=" 001[UH:MX9G
MU6.QN&U'9JEC="[M[@1?NU8 J4\O=G85)!&[/.<U2U/P3)J=CJP?4(X[[5)K
M>2>=;<E56!E*(J[\_P )Y)/WC[  %/7?&FJV6C>*U338;;4M(M$N8RUQYB-'
M('VM]T?,-C97ID#YL<UH77B?5[?7(=%@T**YO'L3>96]"I@2*A&2@/\ %GIU
MX]Z;JG@N35IO$33ZDJIK6GQV15+?F+8'PP);GF0\8'0<U;M?#U]'XFM=;NM3
MAFDBL&LI(TM2@?+A]P.\XY4#'/'>@" >,'3Q!8Z9<Z>(!>W4UM%NG'G#8KL'
M:/'",$;!ST(]>)K+Q+=ZE]BN;'23/IEW+)$ERLWS(%W .Z;>$8J>02>1QS@9
MEOX%OX+JPD_MU'2RU.:_CW6>9'$@D#*[;_F8"3 ; P ,@\8N:!X4U#0)3:1:
MV7T..9YK>S^S@21[F+;#+NY0$D@;0>@)QP0"CX>\8W]UHVGO?VMN^H:E?W-M
M:Q13$*1')+NW$K\JJD?7DGC@9J6\\>O90WJ2Z2S7]C?V]E<6Z3C&)BHCD1B!
MN!##@@<@@XZTV#P'-;6EFD.K*+C3M0EO;"4VWW!(SEXY!N^<$2,,@KT'OF;4
M/!,FH17DIU"*._O+ZVO)YOLQ*X@*F-%7>"!\G))/WCTX  .AL[N^?2VN;_3_
M +/=+O)MH91-D G&UL#)( .,#KBN?M/&LD][<64NFQI=Q:;_ &AY4=T'*X.&
MBD^4;'!(]:Z6^M6O=,N;3SWA:>%HO.BX9"P(W+Z$9R*Y*Q\#ZA:3V\SZU;LT
M.DMI>V.PV(5)!5L;S@Y'///;% $NE^.)+R;1VOM+6RM-6T]KV";[2)"NQ4=@
MZ[1@8?(.3G'('2LR_P!3GUGQ#X#U,6*PV=U=RR02&8F0HUM*5W)M &1@]3C&
M*U(/ [I%X=@GU&.6#2+&2Q9/LQ4W"/&J$YW_ "G"CU[U#8>"-3M%T""37HIK
M70IR]J&LL2/'Y;1A';?@D*V,@#ITH Z/6-4FTT6WE6JRB:0J\TLOEQ0*%+;G
M;!P"0 ..I%1^&]=3Q'X>M]6C@,7G;U,>_=AD=D.&XR,J<'CBHM>T.ZU2_P!)
MO+2_2VDT^9I?+E@\V.3<I7E=RX89R#GCG@TOA?0W\,Z'_9TM\+I(YI94D,0C
M(5W9\'DY(+'GCZ"@#GX_B'="TMM1N- >+2GU!M/GN1=*S0N)C$&V;>4W  G(
M(ST/4WSXT9[RW^R:7/=6,M\UDTT(=G0ABAD*[-OEAE()W=.<5B>$=&DUWPR]
MK<W<7]GKK5Q<M L1\Q@MTTB MNQM)"MG'(X]ZW=,\*ZEI&IW"VFO,NB3737?
MV$VX,D;LV]E67=PA8DXVYY(SWH J)XZO/L>JZA+H1CT_39KB">8708AXF ^Z
M%SM.22>P!X-7U\7 VUJX@MIGOKM;:P-M=^9%<93>7W[>  'SP?N]\BG:;X;O
MM,TW5+>'58O/O;Z2]246I C+N&*E=_S#C'4<&LS_ (5W!&\EW:7,5E?#4(]0
M@^SV^V"*14V,/+W<AP6W8(SD>G(!)J'CQ]-LM:,^E%K_ $B6!9[=)QM=)B D
MB.5&1R>"!@@_6M;2-?N+[7=2TB]T];2XLXXIE*3^:)(Y-P4_=&&!0@CD>A-9
MNJ>"9-5L=7$FH11W^JO;F:=;<E$2$@HBKOSU!Y)_B/L!J6>ASVWBN^UM[R.0
M7=K#;F!8"NWRRY!W;CUWGC'I0 EWKTYU>\TO2[*.\N[.W2XG62?R@-Y;8@.U
MLL=C'L!QSS6);^,;G6M9\,#2X(3I>K6EQ</YTA20&,HK*0%(!4N>_)'48YU[
MCP]<1^)IM=TN^CMYKJV6WNHIH#(DFPDHXPRD,-Q'<$'MUJI;^"ETZ;P\^F7W
MD#1X9H")8?,,ZR[2YX(VL63.>1R>* .?\'Z]/HNDV-L^G!M/N]<N[(7'G_.C
MM<2[,)CE?EQG<"/0BM\>-&EO+7[)I4]U8SWK6?G0AV="&9/,*[-OE[E(SNX!
M!QZ00^!KF+2["R_M:(_9-7;5-_V0_.3([[,>9P,N>?IQ5C2O"NI:/J$T=KKQ
M&B/<O=)9&W'F1LS%R@EW?<+$G&W.#C- $WASQ+J&OW$Q.C"VLX9[BV><W08^
M;%)LP%V\@X)SGC'3H:IZAJFHW7BK6M#E@MCIL.DK/D2G>=YD&<;>N4QC/ YR
M<X&OX:T.;0+.[MY;Q+G[1>3W8983'M,KEROWFS@D\U7O?#=Q/XDNM6MM02$7
M6GBREA>WW_=9RK [AC_6'(QS@<B@#"\#>(;F#1_"&D76G[(;[1T>VN1/N9FC
MB0L&3'R@AL@[C[@5IV'C*6[UBWTR;3%@N;FSENHX3<@R1E"HV2KM^1B'4]3W
M].66?@NXM%\,I_:JE=#LWM 5MBK2AD5-V=YVD!0>AYJ#2? ^HZ9<:+,VN0RM
MI5K/:IBQV^:DFP[F^<_/E 6/?)X!YH ?HGCFXU67P^\VC_9;37(W-O)]I#NK
MHA<AEVC@J#@YSQR!5[Q3K&IZ9J7A^VT^&W=+^^,$IEE*' B=P!A3@'9U]L8Y
MR*>F>";C3K?PM#_:L<BZ"7P?LI!G#1LG]_Y>&/KS6OX@T*769-+GM[Q;6XTZ
M\%TC/#YBM\CH5(R.SGG/4#K0!QNDZ[/X:;Q'.NG";3QXC\F>7[1M:(2"% 57
M!W8+#()7@\9[=!J?C1K.:[^QZ7/?Q65PMO<" .923M+%%"$-M#C.6!X/H,P7
M'@>ZN-)UBQ_M>(?VEJ::B7^R$^65:-MN-_/^J7GCJ>*L#PIJ=KKM]=Z;KQM=
M/U&037EH;8,WF;0K-$^[Y"P49R&QU% !\1-;O-#\)/+I\GE7=S<0VD4V,^49
M'"E_J 3CWQ5V7PCIIL5AMQ)!<(487:R-YSE2#\[YRX..0Q.:M^(-"L_$FB7.
MDWX?R)P/F0X9&!!5E/8@@$?2H+*PUQ(4M]0UBWN(TP&EAM#%+(!ZG>0">Y '
M?&WL 9M]XV6TT_4=6BL?/TG3;IK:ZF$V)!L8+(ZIMPP4D_Q G:<=LUM4\=W6
MGMK[1:*)[?1!'+/+]K"[XF3?N0;3E@.QP#ZU-)X(+6VL:8E^JZ/JUPUQ/;M#
MF1"Y!E5'W8"L0>JG&3[8-1\%37T?BB(:G%%'KL*0X%J3Y"K'LX^?YN/IS0 Z
M3Q#JH\:7UA':V\MC;:7'>(/.*NY=G']W&?DQC/ YR<X#=-\8:GJ&B6>K'P_Y
M-K>I!)#(UX"JJZEG:0[?D5<#GG.X=.<6G\,7?]NMJD.IQ(TNFK83(;4L&VEV
M5U^?CESD<Y]158>#;N+PSX?TJ#5HQ+HLD3)*]J6CG$:%0'CWCU!SNX(!H ?I
MWC:/4[6T$%HAOKF]GLDA$^8RT.[>_F;>4PN0=N3N QWJMJ7B77HI="B328K2
M6\U22SGCGG/S!4D8%&"'Y&V9R0#VQSD0_P#"O[R*(36VO>7J,&J3:C:7)M00
MAESYD;KN^=3N(X*]L>^I?^&;^_@TJ236%.HV-Z+PSM;9C8[&C*B/<-HVOQ\Q
MY&3G)H RW\50Z-:>)=0@T+$MIJT5O<JEP,SLZPJ),D8'#H,>W6KK^-C8)XB.
MK::;=]%MTNF6&;S?-B<,5P<+ALHP(Z#U(J&\\#W-W8Z[;?VM$O\ :M_#>EOL
MA/EF/R\+]_G/E+SQU/X,\1:/=:?#XFUH7+3'4;&*T,,%D9&BV[EWXW'<!YK$
MC;T7\P#5LO$5U/XH.AW&G1Q2"S2]\Z.X\Q=C$KC[HYW*1],'Z9FKWDNJ?$W3
M_#$KLNG1Z9)J4\:D@7#>8(U1L=5&2Q'0\9S5;P9]JBU$+;7NG:C9/$$EF@TV
M6W>,*/D&]W8$#.-G;)/'.>BU;P\+_5K'6;2X%KJ=D'C24IO22-OO1NN1D< C
M!!!&?4$ P=1F;PQ\0/#UIIB".RUE+F&>S!VQK)&@=)% X4]0<#D$9!(KFKE[
M^X\'^*?$<MK;C5M.NM1%M>)=N)(@N^/:,(-RJH& >"0#@&O08M DFU^'6]3N
M8[B[MHGBM$CB*1P!\;VP6)+' &<C@8 ZDYG_  A=T?"6NZ$^JQ'^UIKF4S"T
M(\OSV+, N_G&XXY_.@"E96NEZ-XLT1Y-"MX+_4+69C=0W+%(_+09.TJ 692N
M6P#QR3@5LV/BBXODL+X:6PT>^A>=+P2Y,2!=RM(F!M##I@G' -/N/#=Q=:QH
ME_-?0D:;#-$\0MB!-YBA2<[_ )>%'KWJIX?\(WVC6BZ5/K1N]$@5H[:U-OLD
M$9! 223=\ZJ#@8 Z#TH 2T\9W%Y<V8BT6=[:]MGG@G0OA"%W!9<H%3<#P06&
M1CTS=\*>(+WQ+IL&I2Z2+*SN;>.>W<W(D9]P.05 &,<<]P>W2JF@^%]8T:S7
M3Y/$7VK3[:,Q64;VH5T7!51(P;]X%!P,!<X!-:OAG1G\/>&M/T=[E;G['"L*
MRB/R]RJ,#(R>?QH X:SUZ[\+2^,KZ#1VO--M=9:6ZD6X"O%'Y$)8HI!W8Y)&
M5XZ$]NAU'QP+?[7)I^F3:C!9RI%/Y <R-N"L3&H0AL*ZG!9>_IRZ?P=+-_;M
MK_:*C3=;G\ZZB\@^:,HD;JK[L %4'\.1D^V#_A$M0L]=O+K2-<-EIVH,KW5G
M]F#D.%"%HGW#82JJ.0W3- &WK6KPZ+IWVN56<M+'#&@ZN[L%4?F>>#QG@UR>
MO>*]5D\(>*V@TZ2RN].M&:.Y+N(W5HV(>)S&"64CE<#!QSS73>)-"3Q%HLE@
M;F2UE#I-!<Q %H948,C 'K@@<=Q6;=^&M7U7PKJ>E:IKL<US?P&W:>.SV1QH
M002(]_WCDY.[TXXH YO4-.EL-7\,Q6VDV$:ZM/B]@%V_E7!CMY2H9?+QZ,3M
MR2 #G -:UIXBMM%AAT_1M&N)]+M[YK$F)I9)(CO*LP4J045\C[PP!P, "M:]
M\.W=Y?>'[K^T84?27:0C[*2)BT;1_P!_Y1ACZ\U6L_"NI:;K-X]CKK1:/>7+
M7<MD;<&19&.7"2[OE5CDD8)&3@C.: +%OXENKYK>XL-):YTV:\>T\])L.FQF
M4R%,8V;T(SNSC!Q7-OXENKOP9J=_KNDVUW;Q:L;7R8KD@#;<B-3RH^ZP4^_/
M Z5N:/X4O]$OIHK;6S_8CW3W267V<>9&S-O*"7=]S<2<;<\XS5:?P-<RZ#JF
MD)J\:V]YJ)OHR;3+19G$Q4_.-WS#&>..QZT :,GBAK?7=6TRZLTA^Q60O89/
M.)^T1G<#@;>,%<'KU'7-5]2\7W-D+B&'23<WUI:I<7-M'(Y(+ D1H5C.YL*>
MNT<CGDXO:OX:@U?5](U*69HYM/=BP08$R$ [#[;UC;O]W'>JFH^&=2/B5]:T
M76AI[W,*0WD,EL)TE"$[67YAM<!B,\CIQQ0!T-G<B\LH+I8Y(Q-&L@25=KKD
M9PP/0C/(J:F0Q^3!'%O=]BA=SG+-@=2>YI] !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117
M)>.YI;=-$EE4G25U*/\ M+C*B+:P4O\ [ ?83GC@9XH ZP,"NX$8ZYILC,(G
M:)5=P#M4M@$^A/.*\A\2VT*Z+XR>U:/^PY)[%[/RF_=B?<OG&+''3;G;WW=\
MUZII>FZ=I=F8M,MX8+>1S-MA^ZS-R6_&@"KX8US_ (2/PW8:N8!;F[B\SR=^
M[9R1C.!GIZ5=M)KJ0W'VNWC@"3,D6R7?YD?&&/ VD\_+SCUKR3POI-DVD^"Y
MM*C1/$5M=*E^T9_>I  _FI-W"XP &[E<=:6Y2Q;0M4CS$%7QG$R;6P53S8LD
M$=!M#<CL#Z4 >Q@@]"#6$OB"XE\1:KH\%C&\MG91W4+F? F+EP%/R_+S'UYZ
MUY]JC1Z1<^+K;285CTR.^TZ6[M[->!;D+]H*JOJ!AL=LYJ6[ET&XU?QH^F-9
MO9W'AR)U:W \MW'GC((XS]P<=_>@#U6"21K6)[A$BE9 TB*^X*<<@'C(![U(
M6"C)( ]37EVGVFCZAXG\.)?QVL]N_A9A*DV"C$-#@,#P< ,<'^[GM6?I^JVU
MAX2\!7FI7D;6D GBF@N2=C80JI+$$!E   /4,?2@#V*BN2^'5MIUOX11+"^L
MKU&FE:22T<.BEG+"//4[5*KSC@#@5P[75C:Z?'IS%$O+/QD)&A"?-#$UUN#8
M ^52A&#T(H ]DW '!(STH) (!(!/3WKQG4]+T>]L_'<02,ZY%JC/I:HV)DF,
M,)0Q#.02_4CMUX%;%Z89;WQ=9>)_+^VM;1MIS./F9/)'^H[[A*&.%YW$>U '
MIQ8#J0/K02%!)( '))KR#^SH+N_U6+Q%%;SWP\*VK7(FP1]I EW-CIO'R\]1
MD8ZUZ%X98:CX"TC[1BX,VFPB7S/FWL8P&#9ZG.<YH 9/XJB%[X?2SB2ZL]8F
M>)+E9<;=L;N"!CY@=GJ.M=!N!7=D8]:\:T&/2YO#WPXLVC@ %RZWD17;EQ;2
M*P<<9.=JG/7(!ZXJ2.[ATO1Y%#-'X>L_$]RETMM&'6"W*OY9V8(\L2,IZ8'&
M.E 'L(((!!R#W%8<?B"34-4O;'1[-+K["XBN;B6;RHEDP#Y:D*Q9@"">,#(Y
MSQ5?P5:Z7;:7=/HUW<W-A<73SQO*%$>6 +"(!5 3.>@QG=BL/P9/'X5O->T3
M7)4M)9=3FO;:XG;8EU%*0P*L>"PY!'4<4 =EI=_/?+<BYLGM);>8PE6<,&^5
M6W*1U4[N._J >!># C(((/<5Y,=0U*?1[V]GN+J[TB/Q2(Y7=BZ'3EQR/[T8
M<C)YR <D@&M"7PU;^)+WQ78:<T/]B7=I UO)%@PQWPWY>/'' $9;'7//>@#T
MJD#*02""!UYKS>:XU/5O 6H^(H].F@U5K1+;R(D E"1M^_"=\D^:!ZA5-8NM
MQ^&K_P $^*=3T*^GNEN--$<B")(H%E7[GRJB_O>2.YP!GM0![%N'J/2C((!!
M&#T-><:MHGAZ#Q5X12WM;06]Y<7,L^#E9MUN1EO[VXA1SU/KFL*WCT\Z?HUI
M^Y%O;^,+F**,-@1VY,V%'HG*^W(H ]DW+Q\PYX'-!8 @$C)Z#UKQ?5+#2;;P
M_P"-VMX+:.2PU:-]/" #[.2L#$Q#^#+;\[<9P1VK3U&32M2\0ZSI>O7U];:A
M)>1SZ6;:)#)+$%0QFWD*$YW!@0#CDD]30!ZJ6 ."15=+^UEU&:P296NH(TED
MC!Y57+!2?KM;\J\B\2VFFFU^(MRL<+75O=V\MF_!:.3R8LM'Z-O#9(YR"*ZJ
MT?2[+XI:Y>3I C2Z9:W$$PCR65?.\QU('IM!(]AZ4 =Y2.ZQHSNP55&22< "
MH;*\M]1L;>]M)!);W$:RQ. 1N5AD'!YZ&L7Q5<K/%;:#%<PPW.J2>4?,&X"(
M L^5R"0P&S@CE_:@"QX8\2VGBK2#J%FKHJSR0/'(,.C(Q'([$C#8]&%8\OC>
M>+0M0U)M+3-EJHTUXQ<]?WB1[P=OJX.,?C6=I\LGA7XG7%G>W5LUOXA@%POD
MQF)8[F/"D%2S8WKCG/)7%8E[<P'P3XHQ,ASXH5A\PY'VF$Y^F 3] : /7:0,
M&&001[5A^+UAG\*7:27_ -BCD\L"Z"!U0EUP6!X*9QN!XVDUY_+=B*TL+W4+
M/3[4:?XEA:YO[$_Z+(K0X,JD_<'**PS@,.M 'KM8OB+76T.TLKB.V6Y2XO8+
M1OWNW8)9 FX<'.,].*\ZDU&.W@\17-O'(^EIXF@GODBB;FT,,6YMH'*;@"<=
M0#U!J]KQ\/2>'4GT5_\ 0+S7;&9Y$9EB9O-CWF/I@ +DE>,YYR#@ ]0!!Z$&
M@L 0"0">@]:XOP?%9V7C#Q=86"0PVBS6TD<$("HK&$!R%' R1SCO7,>/+ZS-
M[XB5%$-_:26$F^56>5U#HV^'_GG&N2"1G)W9QW /6R0" 2 3T]ZHRZFLBZA#
MIWEW5]9IS 9-@\PKN5&;!VYX[< BN!GO=&O/$.O:7XECF-Y<7,,^E;499)8
MD900,.01(KDX(Y8YXS5/5[?387^*$,EM!'=R6OFP_N@&8&T7E3CO(/Q;WH ]
M5B=C!&\RK&[*-RAL@$]@>]/) ZG%>;VT]B_B"WA\1?9FTB?0H!8/<X\DN,^<
MH)XWD%/? ]C69I=@);WP';>(4$TIL[Y9%N^6>+*^2) >OR8X;OGOF@#UO<H&
M21CUS2UY!IH5_".D16FI:?!/:7M^+:VU)=UK-&)G C8Y^4[&4J1VSP17?Z%-
M!=^ K&2>Q%C;FQ56M96R(D"XQD]1@=?2@#?W G&1Z]: 00"""#TKQKP_IVDF
MS^&[2P6_G7,$L%X6^]*GV=ODD[E=X4;6XSQCM3X7L;#3K.<-##I^F>,90'&
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MW\76&AFU!2\M9KA;CS.5,90%=N.^\<Y[5?L)KN:S62^MH[:X+,#%'+Y@ #$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2+Y_E.WC#;AP,YJR?#5W%KNJW]M?QB'4;.*W>.:$LRO&KJK;MPXP^2,9R.M
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5GSZ7YNKPZE'<R12QPF$JH4JRE
M@QSD>PK0K@/&,-N?B-X0\S3_ +8LL=\)(516\S:B;<AB <9)&>G:DTGN7"<H
M.\3OZ0$$ @@@]"*\IM9DN+;XC6)22ULH[3=!I-U]^#]RVZ15Y"HS8(VDC(SQ
M73Z1J[RZ?I6@V5K!<W T:&YG%PY6,(R[54X!R6(;MP!GG@%D'7@AAD$$>U4)
M]+^TZM:7TES)BU9FCB 7;EE*G)QGH?6N)\"ZTUAX,\'Z5#;J;K48IMAD;"1B
M/+-D@<GD #ZGM75^%==G\1Z-_:$UDEH3-)"(UF,G,;E&.=J_Q*<>V/I2:3W*
MA.4'>/I]YMT5%<PI<6LL+[MCJ0=K%3CZCD5S?PV=I/AMX>=V+,UE&2Q.23BF
M2=316#XUUJ;P[X+U?5[9 \]K;,\0(R W0$^P)S^%9+:1HFF>!FU#5+5KYEL_
M/O+X -</\FYY Y(8$<D8/' % ':45QO_  ECPV,-KI-A->SPZ;%=[)5<,ZL&
M$:_NU?#-L8\XQQUYPDGC+5I;Y[.ST%%F&DIJ86\N3"RAB08W782K J1W'N*
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MKI-(L;VRMF_M#4FU"Z<Y>;RA$H Z!4' 'XDY/7H!H44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR#/56 !STR37644 >97MK/INE^/]':)I+S5YI9K! .;CSX5C 7UVL"&]!R<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7EQYYDF01HTA #&-=JX' R0,$Y[YKIZ* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %8GBOPMIWC'0)M(U-7\ER'2
M1#AXW'1E/KU_,UMT4 <%XE\ ZGXN\.6>AZOKL#06\R2M<0V9667:"!G+E03G
MDXZ]A6[/HNMMKNI7]MXC>*WN+006UH]L'2VE_P">OWAN/7CCKSG KH** .(\
M(>"=;\.7R27_ (OGU2S1'V6ILUA'F,<EV8,2QY;KU+9ZUI^+?!UIXK2QF:=[
M34=.G%Q97D:AC$X(/(/#*<#(]A7244 <7JW@F]\0^(O#VKZMJEN&T25IHX[6
MU*><Q*'DL[8'R#CGJ>:L1^#6TOQ=?^(=#O([:74D"WMK-"7BE8='&&!5N3GJ
M#D\9YKK** .9\,^#X=!U+5-7GN3>ZOJDF^YN2FQ0H^ZB+D[5'N23@9-/B\&Z
M=%X^G\7*/],FM%MBF.,@\O\ 7:%7Z#WKHZ* ..\7^"+CQ1KV@:I%JL5H=%G-
MQ%&UJ9?,8E#ACO7CY!T]:N3^'M7NQJ"W&LVOEW-I);0Q0V)1(C(<O(1YA+L>
M.X_4UTM% 'F9^$$+>!-,\/-K!6]TJ=I[#5(K;9)"6<N<KO.>OJ.@/:NTM=,U
M1-1L[N\U.WN/)M6@D"6AC,C$J2^=Y"_='&#U-;%% '.67@ZRTOQ9J?B'32L%
MQJ, CGC*90R Y\S (Y/<=^O7-5F\"VEXOAB34Y4N;K0&#0RI#L$@";0""QQR
M$;KU7WKK** .-TKP1=:9X^UGQ4-6ADDU.)8VMS:$"/:% (;S.?NC/'Y52\+_
M  _U;PEIM_:6&OV3M=W3W:S3:86,4C+M)4>=CIZ^IZUW]% &+IVC7MC>VDLF
MHQSQ0626K!H"))&&,N7WXY(SC'XU!I/@_3]%\5:MKMB/*;5$07$*CY?,4L2X
M^N[D>HSWKH:* ./F\$SR_$R'QC_:D8,5K]E%I]E/*<\[]_7GT_"NPHHH X]/
M!,Z?$Q_&/]J1DO:_9?LGV4_<XYW[^O'I^%-\1>"+K6_&FC>)(=6AMGTH,(H'
MM#('W==Q$B_I7944 <Q-X3DU6TU2RU^]AO;&]MTMX[:WMC ENJDDE<NQ+$E3
MGML'%1Z%X;UW0M&@T6+7X);&W7RH)GLO](2,=%W;]A(' .WL,@UU=% '&ZWX
M'GU?QOHGB1=62$Z2I6.!K4OYFX$'<V\>OI2VG@BYM?B5?>,1JL3/=V@M#:FT
M.%4;,'=OZ_(.W>NQHH Q(?#ZW&@7>D:R\%_!=/,T@6 Q@B1V?&"S<@MP<]@>
MM<WJ_P ,AJ/PWM?!D&K?9[:W<$7#V_F.5#EE&-RC/."?Y5W]% '&ZUX#&JW.
MB:K#J M->TA0L%['!E'7&"CQELE3D_Q \GGFMZWM=9+&2[U*V+JA$<<%J5CW
M'^)\N2V/0%>IZ\$:E% '$ZK\.;/6?!T^C7C63:A.O[S4Q8@2,^[<7QNSN)Y^
M]CMTJEKOPUO_ !!X'TGPW=^(D)TZ5)!=_826D"*54$>9Z'DYYQ7H=% &)_9>
ML3ZO875YJULUM:,[FWM[)H_,<H4!+&1N &/&*S?'?@N7QK:Z=;KJ26265XEV
M";8REV4$ ??7 YKK:* *=_IMOJVDW&G:C&L\%S$8IE P&!&#CGC\^*Y.+P+J
M5OX-D\)0Z\HTID: 3-:YN%@8G,>[?M)P2-VWIV[UW%% '!>(OAC;ZMH&A:)I
MM\FFV6CSI/$IMS*SLN>IWKUR2?4FNJAT^]CUV6_DO('ADMTA,*VY5@5+'=NW
MG^^>,?C6G10!SVA^$-/\/>(M:U73QY0U;RGF@ PJR)ORP_WM_3U!]:H6/@F>
MS^)5_P",#JD;F\MA;-:_92-JC9@A]_7Y!V[UV%% %;4+"VU33KFPO(A+;7,;
M12H?XE(P17(6_@;4K+P=+X3M=>5=+='A25[7=<1PL3E-V\*3@D!MO /2NXHH
M X#Q'\+[;5_"6C^&]-OETVQTN=+B/-OYS.RAAR=R]2Y)]Z[N*/8I+;#(W+LB
M[0QP!G&3V []JDHH Y3Q'X)CUCQ!IOB.PO3I^MZ=E8K@Q>8DD9SE'3(R/F;H
M01DUL6UEJ$K.=5O+>>-HS&;>"W*1D'J6W,Q8]NH')X/6M.B@#B](\$W_ (9T
M>]T70=9C@TZ=W>W%Q;&22TW]0K!P&&>1D<'KFK.D^"(?#N@:9I&B7*00V=P+
MB1YX3*T[<Y)(9<$YZ\XP!CBNKHH Y[5O!^GZKXHT?Q$1Y6HZ8[8D4?ZV,JPV
M-]"V0>W/K5'QWX)E\:1:9&NII9)87:W8S;&4NRYP/OK@<UU]% &1K&DW.KQ6
M<#7-L+>.99+J&2V,BW 7D+]\;1NP>_0>^>=U'X=1R>-]+\3:->6VDRV*&-X(
MK(%9U.<AL.HZ$C./3T%=S10!Q\G@B2Q\97/B?0+^.SNKV,1WMM/ 989\8PV
MRE6XZY/TY-=)96][$LKWEZMQ,^,!(O+C0#LJY)^N6.?;I5RB@#C_  CX)F\+
MZ_X@U1]4CN_[:N?M,D0MC'Y;98X!WG(^<]NU=A110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7*WBM<_$NSM9)I_LZ:5).(DF=%+B:,!B 0#P2.?6NJKD;VZ
MM[3XI637,\4*R:/+&AD<*&8SQX49ZGVH Q[QO%O_  GB"'[7]EW/MXCS]F\V
M+=CGR_IN_>;=_?%&N-XM_P"$V06?VO[-B3[/M$>?+S!YFWG9_N^9\WW\=J]&
MHH \]\8MXJ'B.T_LK[1Y&_\ T; 3!D\B7=CG&,?\]>-^S'&:U-462W\8^%'6
M:Y1[J29+A#,=K[;=B-R [,@@'@=:ZZN1UZ[MI/'WA2UCN(GN(I[AI(E<%T!M
MGP2.H% '74444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5AZIXE32]>T[1SI
MUW<7&H+*T#0F,+^[ +9+,,<$5N5P7B]D/Q)\%H;\V;>7?GS$*9'R1_WP1S]*
M .BL?$L.HMJEM;V=RNIZ:!YUC-M60EE+)A@2I#8X.<>N*U[>226VBDEA:&1T
M#-$Q!*$CE21P<=.*\G@=H-0^(D,5Z^H1_P!GBX;6%DV2+((VVPEDPOR@9&T+
MC)SG-:NDW*W^M:/IFL-NT^7PY#-:B1R$EE_Y:G.>75=A'< DCJ: .QU/7$TS
M5M(L'MI9#J<[0)*I&V,K&S\\YY"GH*UJ\LTVYO9;3X?-J4[RR_VK<K%-*V7E
MA$5PL3D]R4V'/?(/>H_MEY=^#VU..5T\76^M>2R!R'W&YV^25[Q^20<=,?-[
MT >KU62XN&U&6W:S=;=(U=+DNNUV).5"YR", Y(QS7F>N7*W>K^(=+DUFUAU
M$ZA;&TNFOU@:TBVQ%X\;@XXW_=!#>9UR#C1U ^5XI\56<>KRV2?V':[)Y9FD
M%NQ:9=_)XX"Y((]?>@#O[FY@M(#-<2K'&"%W,>,D@ ?B2!^-5K_4?L4L$20/
M<2RAVV(0"$5<EN<#J57KU85Y;K3^;X=U&UU;3(+*ZL-4TUYVMYB]HRM,@\R/
M.-F5SE3TSGOFO0;)[>ZNKZ^A=#9VT"VENX;*XVAW93Z'*#_MG0!0TSXA:=J$
M&C7$MC?V5KK#^797%PL91W.<(=CL58X.,@9KKJ\Q^'OAJWUSP%X0O+Z]GF@T
M]1<P6J[503 L S$#<2N3CD<]<UG0K)9_#_6-?L[B]EOH+^ZMGF%U([16OVS$
MF!NZB,$ANHZYH ]=<E49E4L0"0H/7VJ&QGFN;&">YM7M)Y$#20.RL8V(Y4E<
M@X]JXT1+'XSFM])F;^R+G16FN4MY3L23>!$ZD'Y692_(QG;GM7-:;JR-I7A*
MRUS4;>VT^\T%72>_W&.2X^7=EMZX<+@@D]SCF@#U^HC<PK=I:F51.Z-(L>>2
MJD GZ LOYUYI'>V%MJECHOB+6WFTJ31<V5_>2"(7$GF,'?<3@N$\LJ>N"2.I
MJY9P:=;_ !+TAI)Y)2^@!8)[Q_WL[+*@4GIEB#GIWZ4 =EJ^MVNCBV2822W-
MW+Y-M;0@&29\9( ) P "220 !R:@B\0QKJ]OI5_:RV-W=*S6WF,K)/MY8*RD
M_,!S@XXY&<''/^+(WLOB#X2URXXTR#[3:S2G[L$DJ (S>@)&W/J1ZTOC&(ZQ
MXJ\)6%@P>YL]1%_<,ASY,"HP.[TW%@H]>?0T ;,_B=4O;A+>QEN;6SN1;7MP
MC >0Q0.6VGJJAER1R,]#@TRP\27NHW%B8- NFL+V))X[P2Q[$B9206!((;[O
MR@'[W7@URFF6&F_V5\1"$CPE[<*?G/"BWB/K_>'Z46ZPV>B?#-K65XA// )%
M29@LF;1R<C.#R%H ]-HKSCPQJ&F:NUI+J&I2P^)[;4IUN+:.;$S'>X\MD/)A
M"%6XX&T'.<U4\+7<&MSZ7=7.O)!K\-Q+'>V,2E;B1OF#QR OG8.H.T!<#&*
M/4J*X;X9V%O)H$6KF>YGO&EN[<R273R#8+E\#!8C/ YQGD\\UW- !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIBRSQAOX5D+A< <#<AP !S70P:98VT*11VL6U(Q$"5!)4   D\G@"HM+TO\
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M2+M>38-S#T)[BIJ* (X;>&W4K!#'$I.2$4*"?PJ2BB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD/B/:S?
M\(TFL6B%[W1+A-1B ZLJ']XOT,9<?E77T$ @@C(/44 >5G2]1L_%=MB"7RO%
MUL1J(/\ RQ='\PACV_<N\0]U6K/Q$O+ W^IV,KHEXF@RRP?:6RI.6QY"<'S<
MKRP/R@+P>WI6 2"1R.E!5202H)'&2* /)]7U(O;6NKQ366L1#2K4W5A*^+@
MEL36S\Y<L2",?,449Z52\1G3S;_$'4?/C%Y9ZA;26T@FP8G$, RO/!R",^Q%
M>QF*,LK&-25^Z2.GTIVT>@H \VUZYM/^$P\4+]L4(WAA9#B?&&WR\CGCC9T]
MJK^&_L-GXB\%M9W"+-J&@2?:2)MQF95@*;LGD@E\>G(' KU':/05'<0"XMI8
M=[Q>8A3S(SAER,9![$4 >2^$I]+UB_\ #2/K.G/>V8G%YB\7S=08_<)3.\G/
MSD. 1TP<FHM(GM--\.Z;!&EO#8Q^(KB'65C4+Y<?G3^4LN.B;O+Z\8QV-=]I
MWA6XMTM8-0U-+VVM#&T*_8TC?*$%"SC.<$ \!<X],BNE**005!#=1CK0!Y!X
ME"6NC^,5M[@1Z(MU8&S\N7;&DQ=?.6,@XQC:2!P"6]ZZ#2[[1_#OC?Q2!=PV
MVG1V%I=R@R[E#DRAWZDY("9/4\5WRHBH$55"CH .!39H1-"\6XIO&"R@9'Y@
MT 1K>6TE@MZEQ&;5XQ*LVX;"A&0V?3%><>!?$VDZ;\(--5[F&YN5MI%6RA82
M32N6;"!!R2<CMW]*]*M[>&UM8K:! D,2"-$'15 P!^52  = * /'O#VCW?@6
M_P#!E[KI\NSCTJ6PN)F.4M)GD\Q=YZ*"/DSTR.M>K6^J65Y.(K2XCN6 W,T+
M!U0>Y' SV'4\^AJV0&!! (/!!I(XXXD"1HJ*.BJ,"@#F?%7BW2-(==)N=:L]
M/O;J,D//*J^3'T+X/4_W1W/L#6)"NF6GBCPCJFFR1_\ "/KIUQI]O-G$:,"A
M3D_WA&P![X]Q7H1 /4"AD5U*LH*GJ".* /.=#UZQ\*Z+J^J:G=06\>KZW=3Z
M>L\HC$J$A5;)Z*0N[/H1UR :U_\ V9=^'M+U#1]0AU&"P\0P:AJ=W!RA9B?,
M;(XPN]3C)VJHSTKT\@'J!1@8QCB@#C]&7[3\1/$.L1NIL$L[:T$P;Y'D7>[X
M/0[0Z@^Y([&E^&,\4W@2U,4J2 7%UG:P./\ 2)#_ "-=>JJBA54!1P !Q2@
M=!B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ JAK6M:?X>TFXU35+E;>S@7+NW/L !U)
M)X %7Z\P^.VCZCJW@*)["&2=;.\2YN(8QDM&%8$X'7!8'Z9/:@#IYO&3VV@M
MKEQX?U6/3Q%YV<1M($QD,R!\@8_$=P.<=)<3I:V\D\F[9&I8[5+$X] .2?8=
M:X3QU\04\/\ @RQU[28K/4[6]E2%8F;AE=2<C&>F,$8[UNW'C70=.U"]TW4-
M3BBO;"V2YNP8V5$1B #G!'5EXR3R* *_A[QW9Z_XAOM";3M1T[4;2(3&&]B"
M%XR0-PP3ZC\_KC2\1^)],\+:>EWJ4C_O9!#!#$F^6>0]$1>Y-<;HEI?V_P 8
M[N]M-375M*U/3!/+,51C!M;$:!U &T\X'?DG)&:H?%F">R\7^"?$<Z,VCZ=>
MXNW RL!9DP[>@XZ^WN* .[7Q'-%+91WVB:A:&\E$4;,8W56()PY1SMX!]NV<
MU%;^,;74=3U&QT>RNM2;3FV7,L!18UD_YYAG8;FXYQP.Y%:IU339I+>%+N"6
M2X^:%8V#E@!G<,9X'KTZ>HKS/X*QMX<T[Q'H.KNMOJ=GJ+SS"5MI:-D4"0$]
M5.TG- '7_P#"P=(E\(W/B.SAN[NVM7*7-O$BB>%@<,K(S#D9' /TS4NF^.=,
MUKPK#X@TJ&XO+>218FACV"6-RP7:P9@ 02._0Y&17G7P_MI8[3QEXBE/DZ3J
MNM1R632?*'07!.\9['>!GVJ37?#&H> _&EMJ/A^/=X<UR^MX;^T'W;:4RKM=
M1V!/3L,D=Q@ [;Q%\1+3PQ8W=]J&C:K]BMIUMVGC6(J[D _*#("0,XSC&0:F
MU+QU#I&EZEJ%_HNJ0PV$4,\F1"2Z2%@"N)"#@J<C((XKF/C^0/AA("0";R'
M]>M:OQ1=#\&]78,N&M(\'/7YDH O1_$72Q+H2WEE?V,6N*IL9YUC,<A8 JI*
M.Q4G<.H'6MW7]=L?#6B7.KZE(8[6W4%R!DG)   ]22!7AZ2R6&I?#J[\5R_:
M?"XLK<V$J (EK=>6F/-(^\ 5&,D<?0Y]*\8Z?_PFGVSP_!'!<V\%L3-NGV>7
M/(I$1X!R5&6P?[RGM0!V,EY;0V+7LD\:VJ1F5IBPVA,9W9],<YKGM-\:IK&G
MOJFFZ)JESI8W>7=*D:^<!U9$+AR.#VR>P->9Z->:IXJ^!NO^$TW-X@T8?8Y(
M5.7=(W! 'KE59/?;[UWOPZ\0:2WPUT=S>6\'V.T2WN$=PIBD0;6# \@Y&??-
M $NI_$6RTO1+C6I='U1]-MXH))+A%BQ^]5"J@&0$D;USQ@9J_:>,K.6T-Y>V
M5WIME]A%^MS=^7Y;1''0H['(R.",\BN?^,K1_P#"G=7*#8C+!L4KMX\Z/ P>
MG':J?BW2;[7O@!!::6K37']FVDHCCY,BH$9@/4X&<=\4 ="WQ LHO#L?B*;3
M-2BT20J1=LB<1L<"0H&WA#D=LX.<8J7Q!X\TWP])HPDMKJ\CUB58K.6T\MD=
MFQMY9QP=PYZ5RFLZUIT_[/:F&5':?2XK**%>7,^U4\L+U+!L\>U<KXDTR\T7
MPS\*=,OY/)O8=1BW[L$Q$LIQS_=R!Z<4 >NZ9XQT_4?$MWX=D@NK+5K:(3-;
MW*K\\9Q\RLC,I'([Y_6J-M\1M*FT+4]5N+2_LDT^Z^RR07,(25W) 3:"<?,6
M&,D>^!S7'>"IFL_C!KEMXM;?XFEB"V%UPD4]KQQ&O8_+D\D\,.QSV?C32_#K
M>%KJQUS,5AJ-RB3W'F8996("2%CTP0HYX  '08H V+367FU5=.N=-NK2=X&G
M5I-C(RJR@@,K'G+CBH?$?BG3?#$-L;TRR7%W*(;6UMTWRW#G^%5X]1R2 ,]:
MX;P7:^)?"7CM/"UUJ_\ ;FBR6+7$$\@S+:J&  8\X!Z 9P<<8P14/Q$CETOX
ML^#?$MZ#_8D&ZVEE/W()&W ,Q_A!W+S_ +- '?Q^(95U"PLKW1[ZSDOG9(G<
MQN@*HSD,R,<'"GZ]L\U5M/&EKJMSJ,6BV%YJ<>GN8IY[?RPAD')1"[#<P]N.
M1S6K/?65TRV<-W$UU-&S0^6=[+\I^?CH.<9Z<X[UYO\ !-D\/^$]7T;5F2SU
M#3;^1[J.9@I5"JXDY_A.#@].* .O_P"$^TB;P;+XHL([F^LH<B:*!%$T9!PP
M*L1R,CC\LT[3/'6F:WX4B\0Z5#<WEN\BQ-#'L$L;E@NU@S  @D=^AR,UYY\-
M[.>T\(>)-:N@;;3]3U59[02_+F/S1\_/0'('_ :?X@\,:AX%\90:IX>CSX>U
MR]@AU"T'W;>0RKMD4=@3^62.XP =KXB^(MGX8L+F_P!0T;5?L5O<"V,Z+$0[
MD9^4&0$@=,XQD&I]4\=0Z+I>I:AJ&BZI##I\<4L@Q"Q=)"5!7$A!P5.1D$>E
M<M^T$0/AD02 3>Q8'K]ZM?XLNA^#VLL&7#6\6#GK^\2@"_'\1-,%QH<=[97]
MBFN*IL)IUC,<A8 A24=BI.Y>H'6MOQ!K^G^&=&FU74Y?+M82H8@9.68*,#ZF
MO$DE>PUKX=W?BR7[3X9%C;MITR (EK=>6F/-(^]@J,9(XY[-GT/QIIA\<QZA
MH5O';W-O;6Y5V:?;Y5TXRC8 .2B\_P#;3VH [:YO;:SL9;VXGCCM8HS*\K-A
M54#).?3%<[8>-5U32GU>RT/5)M* +1W(2,&51U=(R^\KQQQD]@:\RLK_ %3Q
MG\ M7\/P[WU[2-MK/ IR[I&X(P.^54K[E3ZUZ+X$\1:/)\.M&G%[;Q);644$
MR,X!CD10K*1USD=.IX]: ':M\0;32-)NM6FTC4Y-/M8H9);B-8MH\P*0H#."
M2-ZYP.,UIZ+XE76GM@NEW]K'<VBWD$MP(]LB';P-CL0?F7@XZUSGQB,:_"#6
MMH"*8X0JD;<?O4P,=OI71^"R&\"^'RI!']FV_(_ZYK0!H:OJEKHFD7>J7K[+
M:UB:60CK@#.![GH*2/5(+C14U6T#7-O) )XQ'C+J1D8R0.GJ:P/%4*^(KAO#
M:0PW<(A,U_"T^PA6#+&.A_B#-[&,>M<?\)M7GL] UWP7JTJ#4-!>5%RWWH3G
M!![@'/X,M '067Q7T:\\.1^(GT[5;?1FF\E[R2*,K$V<?,JN6 R0,XQ5_P 5
M_$'2_"%I9WE[;7ES978W)<VBHZ*OR_,<L#CYEY /6O(_#=_:1_LUW]@SK+>7
M<\D%O:I\TDDC.N JCDGO^%=W9^%#=>"M"\(ZTZI=3:'<0LK$$QONA*X]2AQ_
MWS0!UGBOQGIGA#P^NLWJSW%LS*%%JH=F#=&&2!CISGN/6J&J_$6PT>ST*ZN=
M,U$IK;(EJ$$1(9\%0WS\=1ZUY5J,>KR?L^ZFVNQ>5<:<$TNW#'EE2Z0,W_CJ
MI_VRSWK6\>RQ_P!@?"L[UQ]KM&SGMMCYH ]"U7XBZ1H?BVR\.ZK;W=I/>JK0
MW,@0P')( +!B0<@CD?IS6VVL,NHWMF-.NF:U@2<N#'MD#%@ OS9S\C=0*YSQ
M3X7TOQM>:QHE\R;_ +#:O%(N"\#[Y]K@?YR"161\-KC7XEU_3/$X'V[28(;0
M7!/^OB'FLCY/7ANOMSSF@#8TOXG:-JWA4^(8K:]BM&N5M(4F5!)-*Q "J Y'
M4]20.IK7G\3?9/M276DW\<UO:M=>6JH_FJ"!A"&P6R<8./U%>/\ P_M-!U7X
M(PZ5X@E,-I>ZL\"SJX4P2D;D;)Z<C'/]ZNN\"P^)O#?C>X\)ZEJHUO2X[#[5
M;WCC,D +A0C'D\X/!)^Z".A% &^/B#"WBA_#8T#5CJJ6WVHPYM_N<?Q>;C//
M3-$GQ$LH];T;2!I.J->:Q:BZMDVQ#Y=I8ALR#:P .1ZUS$#K_P --70W#/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!3CTG38KDW,>GVB7!.3*L*AL_7&:F>TMI'D=[
M>)FD38Y9 2R^A]1[5-10!#;6EM91>5:V\4$><[(D"C/T%2LJNI5U#*1@@C((
MI:* *UII]E8;OL=G;V^\Y;R8E3=]<"BZTZQOF0W=G;W!3[IEB5]OTR.*LT4
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M]UI8E8K]"1Q5JB@"*:V@N(Q'-#'*@.0KJ& _ T[RH_+$>Q=@P N.!CIQ3Z*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBB@ K@?'VIZGH&MZ1K%E<3_ &*UCEGU*U#$K+ 'B1F"],J)2W']VN^K'O\
M3)K[7(998;:33Q9SVLR.YW.)3&3\NW&,1D=>] '+?$G7KV#2[6/1KUX?WUM-
M<3PMSY4DRQJH(Z;LL<CLA]:Z6]\1V^GR7MO!:7=ZVG0K+=>1M8Q*02 =S LV
M 3@9./J,\Q+\/;^#P,N@6E[%<W NX93<W3LN(H9%,2#"GHB*OUR>];!T#5K/
M7]9U'3VLWCUB&/SXYY&'D3(FP,N%.]2N,@[?N]>> "Z_B6QO4AATY+C4&N;,
M7BBT8*1"W"MEF7!;D#G.0>F*P/"/BM+7P)X?-]--=ZC=6;38DF0.X4X+,TC
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MP1S)N"NH8;E*G!&>0>13ZHVZZE'?LDSV\E@MN@23D3-+D[BP^[MQC&.^:O4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9VRRL(]HF*"0J#ABV"P)_A8>E &_!X;N8)K*S2]@70[54<6:VVUVE5BP.X'
M0':0H7C:!TX/1UP?B[Q!J&EZY9ZE;S;=%TJYCAU1?[PF&,G_ *Y[HV_X'[5W
ME %%-&TN.Z6ZCTVS2X3[LJP*''&.#C/2HM=\/Z9XDTY['5+99HF!VL#M=#ZJ
MPY4_2N!B\0WQ\$V?C4W,_GSZJH>#S&\O[,UR8!&$SMX7!SC.X9]:V?$>D7]G
MJ6FZEI^L:BVJ3ZE$@@-PWV=X"V9$,7W0%C#'=C.5SG)H Z'3-#6QT5-'NI([
M^QBC$2+/ N2@Z!\?*Q]]HK7KE=<GN8?'OA6..[G2"?[4)8%?"/MBR"1W(/K5
M#XD".QT=M4;5]3L+E'C6VGMWE\B [AEI50;2O7.\'C@4 =S17#:AJD%UXQU'
M2]4U-["T73(IM/D2Z, D+%_,D# C<5Q'QSCTY-;'@;6+G7? ^CZG?8^U7%NK
M2'&-Q'&['OC/XT =#17">+&BTOQ'H5T=9U*TNKG48T+,\OV0Q<YB91^[!;H"
M?FR0<X%0>.;J\MM7BGU*+6K;PY"BAK_2K[RC&['YFE1?F*#Y>>WS'O0!Z%17
M(>+](4V-YK#ZQK,9@M]MO;65\\",W\(PI^9F8@9/J!VK'\0:C-X/;1AK<]]>
MZ2NGF"6:&Y82BY7&99"&!*D<;B<*3SC.: /1Z*S?#RW:>'=.6_NH[N[^SIYL
M\;;ED;'4'O\ 7OUK2H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<-G;@#MC\<]JZ>B@#E/^$-MKSPY>6FJV&G7.HW:S>=<>7]YG)Y#%=RXS@=<
M#'2M7PS9:EIGAZRL-5N(;FZMHEB,\6<2!1@,0>AQUZ^O>M:B@#CH_!3I90:*
M9HO[%M]1^WHO/F$>891"1TVB0YW9Y  QWJ1]-\8'69[Q+S1!&[;(B\$KR00Y
M'RK\P&3C)..3C/  '6T4 8.JZ/>7OBC0]3A: 0Z<9BZNQ#/YB;>,# QU]_;K
M2ZO8:OJJ7^FEK!=+NX##YA#&9 RX?Y?NMU..1CN#6[10!AZKH4FH:7'H\#QV
MUB(A"TR_-,L>-I5,C"DCC=DD>F>0MQX.\.78L_M.BV4QLHEAMC)$&,2+]T*3
MT K;HH YW4=(U/7$GT_4S8#36N4E5H=_F,B.'5"#P#E1E@>F< =1)J>FZOJW
M]H:;<RV T>[C\K<B/YXC9<.I!.TDY.&XQGH<5O44 9FJ:8VH'3HE9$M;>Z2>
M9#U<("4 ^CA&_P" U5OM&GD\0_VK (+A9+(V4MK<DA=I;=N! /7D$8Y&.1CG
M=HH S/#NCIX?\/V6E1R&1+:/8&Q@=<\#G &< =ABM.BB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM;N41&W))(%8?,I[&@#JZ*YJ_P#&^D:7-J-O.+Z1],5&O&2T=A&C G>2!C&
M22/PSS5S4O$^G:8D[OYLZV]N+JX-NF_R83G#M[':V ,DX.!Q0!LT4R&:.X@C
MFB8-'(H=&'<$9!I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3Z>+";3[>2TW^9Y+("I?.[<1W.><GG/- '(7FI7NI-XU(OY[&YT7 LUC?:$
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MM0\A/M!3&"^.>G'Y<>E:%97AK27T'PW8:6\QF:VB$>[).!V )YP!P,]@*U:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MJ6NE:=8S236EA:V\LGWWAA5&;ZD#FK=% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %<C\1_!0\=>%CIT=P+>[AE6XMI6&
M5$@!&&QS@@D>W!YQBNNHH \V\::9XP\5^&K&QL+.?2=72=&GNTOE2':%(8!D
M;>0200"O:NDFG\56VJZC!9:9I\FEPV0-@SSLLDL_&4?KA>O./3GDXZ6B@#BM
M/\.R:EXJTSQ3>Z(FC:A:P2QSHDJ.9V< #+)PR@;CDX.2.*Z#45NVUC2VALWE
M@BD=II0Z@("C*."<GD]JU:* .$M?A\FD?$__ (2;2V$5E>0R"]M0<*)B.) .
MG.6SZ$GU.*_@WPSJGP\?6-.M+!M2TFYN3=V302HKQD@ QN'9>FU<$9^@Z5Z'
M10!Q/P^\&W/A>'6-1U)XY-7UF[:[N5@.4CR6(12<9QN;GCK[9JI\.O#6L>']
M?\676I6@BAU;4&N[=EE5L*6<X8 \'YAZBO0:* /.]%\.:S8_&#Q%XFGL2-.U
M"U2&$B5"^Y%C'(SP#L./PJ#X?>";W2KO7)-=TZ-3<ZJ=0M)0Z.4^;(&0<@^N
M.Q/->ET4 >>:OX:UBZ^-&B^)X;+=IEE9/;2MYJ!BS"3D+GI\X]^O%-\/>%M6
M\"^*]<N-/LCJ>BZO*+@1PRHDUM)DDC#E593NZYSP.*]%HH YW5O[9O\ 19+;
M^S]INY1%(D4Z[XK<X#DL2!O(W !>!D<G%<GK_@S6;/XA:#XH\.QRW3P*8=0$
M\Z+YD)X"KTR0"W7CA>>*].HH \^^*_AG5_%FBZ59Z1:"22WU".[D,DJH JJP
M(Y/7YA[>]7_B7HNI>*/A]?:/IEJ6O+ORMJR2*H3;(KG<<^BGIFNRHH \TU7P
M-J=W#X.UNRCCCUKP_'%'+:RR +/&  ZAQD \'!Z<\XJWXA\+ZAXW\4Z!<7UF
MVGZ1I$IN72:1&EN)<J54!&8!1MY).3D\=Z] HH YTZ,FM0^(-.UG3#]@OY@5
M#NIWIY4:9X)*D,A(].#UZ4_AWX4NO!NA76D7%R;E%O'>WE)R6A*J%SZ$ 8Q[
M<<5UU% '!#PG?Z#\3KSQ7ID'VRSU2W$-Y:JZI+'(-N'3<0I!V\@D'D]:72/"
M=]+\1=1\;ZK"(7-N+6PL5=6=$ &6<@[=QYP 2!NZUWE% 'FGPS\#WNA6U^NN
MZ?&EPVJ/?VLJNC[ RA<9'(.,Y[8-=IXJM+G4?"6KV%G"9;F[LY;>-=P4;G0J
M"23TYK7HH \4M/AEK^E>'?#6J:/;P6OBS1F,<R-(OEW<3.Q*EA[-CG!P2.PK
MH?%_A[7=?\8^$-:ATC,&EL\EW"\\>?FVY5><-C!ZXKTJB@#!T&/4(+A[0Z6-
M.TBVA5+6,RH[NQ)SD+D*%   SW/I6'X;\!MH/Q U_64F_P");>LEQ;VP/"3L
M&$C8['D@>SD=J[JB@#SWQ9X;UC4_B9X7URSLO,L=*W^>QE16;=_=!/./?%)X
MI\+7/BO1]2L-9\.PWEWYDPTR^CFC4Q*6/EEV)#+C(R &! Z9XKT.B@#RS5O!
M6NG7? $L$9O8?#L82[N&E56E.$&5!.3]T]<5JV7A34/#'Q%U;Q#IUL;W3M9C
M!N;>-U66&8'.X;B%93\W<$$UWU% 'GND^$=13QAXA\::C;@7M[!]ELK".128
MX@JC+MG;N.T'@D#GDT[Q=X!_X3+P58P.AL==L(5:TGW#,<B@94LI^Z2.HZ<'
MMBO0** .2O=-O;A8=.U'1(-5T1K"*.6!F0NDZELE0Q (QCG((P,9YJ/X=>$I
M/"&D7]J=T4%S?R7-O:F3?]FB. J%NYP,G!(YZGJ>QHH Y&\\/2^(VUL:O#>0
M0W$?V6***:,B2 +^.&+,YYQ_#SQ6%X.T3Q5HGPZE\/:IIXGN+>3;:-'<(0T1
M;=AB3P1S^&!7I=% '!>-_ "^)=1TC7[ ?9=8L9XF<Y"^=#N!:-B.X&<?B.AX
MK:YX=UN?XQ:/XIM=.,VG6%D]O(!-&KLS"3E03T^<=<=Z]&HH X?PEX-O+#QC
MKOB[6'A&H:IB..WA8LL$(Q@%B!ECM7.!CCOFH?%'@_4CX_TCQMH:Q3W5I&;>
MZLI'V>?$0PRK'@,-QZX!P.?7OJ* ,VUO=2N9"\NE/:0*A)2:5&E=NP 1BH'7
MDM^'>O.?"7@S7=&\$>+=*O=-4WFIRW$EMMFC8?O(]H!.>,'DUZQ10!YQX8\.
MZYI/PUTGPM=Z>XD$CQWTD,\>!"9&<[23SD$*1CH6]LQ:AX/UK2_BIIWBC0HY
M;J"2$V^J>?.@:1. "O3)  /./N#FO3** .>_LA=8CU_3]8TPFPOY@5#NI$B>
M5&F>"2I#(2/P/7IQMK\)I&^&^K^#[N_+!KYI["Z;YBJA4\O</;!4CZX[5ZG1
M0!YIK^E>+]7^'L&@V]E-9ZY"L,0OX+U4A^0@,X8,'PR@\;>_XU'XJ\'ZW?:[
MX&N+2R%W#H3%KQGG7,N?+SMW'+'Y&ZXZUZ?10!@:%'J$%VUH-*&G:1!%B!&E
M1G=V;)X7(55' &>_M6_110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>exhibit1027supplycontrac020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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MB P!'K74444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!Q7Q*+C3M ,:JS_P!OV.T,< GS>,G!Q^55
M[O2K_1=0U[Q1<:C:V-YJ1M;6)(4:5457"\9 +RMN(7Y< XZC-=9JVAZ?KB6Z
M:A"\JV\RSQ!9G3;(IRK?*1R#TI^J:/8:UIK:?J$!FMF*MMWLK J05(8$,""
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MG7T5_!:7]H50O"YE5'C;<I[$X(Z@@UL7OBG2M.,YN)9/(M95AN;E8R8X';&
M[#I]Y<GH,C.*R==\'RW7B;3]?TJ7[-,9X1J4)X6ZB1PRD_[:$#!],CTJA/X7
MU9=+\5: D*36NMW$TT%X9!B 3 !PZDYRIR5QG/ XH W!XJAD\0ZQI#6]W&FG
MVT4S7*0EL[Q(20 #T"#'')SQQ6/=^)C%IGA*WLKF_NX-690U[Y/[V2+R7?/
MP')5<X&0,].M7+?1-1TSQ-J]Q!;+<6-YIMO CF8!U>$2C!!'.=Z\Y ZUGV/A
M_6;32O ELUCN?1"/M>V5.T#Q?+SSRP/;B@#3T74K;2SK,5_XAO;]]/:-;AKN
MW$?D[A\BJ%0%R05Y&=QQCKBKY\7Z3&M\)Y)8)K)XDFADB(<&4@18'?<3@8[]
M<8KF]8\*ZSJ5UXIDMDC@DNY[*ZL))7!5WM]IPX'(!*_D<^U:6H'Q;J>@O(FF
MV]C=^;#FT6Z#.\:N#)B7&%)'"GJ.N02, $VJ^-[*PT2\OX;>XFEM;R.RF@\L
MAHI79 -WM\ZG(SG(Q5J/6K'_ (2&\634+J)K?3TN)K6>+RXHH]S'S=Q4'/!!
MY(&WUKE)O"6N/I'B:VBL+:,WNHVM_:I]JW;_ "S 64DC@_NFY/<_C5[6_"^I
M^(=6UKSHA:0:CH2V"RK*&V2AW;D=2OS@=.<'ZT =);^)].GNTM3]HBFE@-S
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MF;4;47 >VG<_=DC3)*,3R>!W'/6@#J+[5K:QGAMF$DMU,K/'!"FYV5<;FQV
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MKP7%9Y^WC6TE&W[P@5'\X_[NT@'ZBM>"_%II&I:Z4,C7,I:",'F11B.%5/\
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M/8 ]/HJ*VGCN;6&XA??%*BNCX^\",@U+0 4444 %%%% !1110 4444 %%%%
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MK(CA"A8]&+$8!_2M%O$5M%&?/M[F&<W(M([=U7?+(4#@+@D$;3G.<#!R1@T
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M$L<8); [L3DDGN2222>2364W@[PX]T]RVC6C2O.+ELQY'FC^/'3=[XYK<HH
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ML,9BCD"995/4 GGL/P %:]% &+8^$O#^F17<=CI-K;)=@K.(DV[U/5>.@Y/
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MM)@';][#8QTXZUT7C+2+O6O#K6MAY1N4N;>X197*JWES)(5) .,A2,XK?HH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)"!NAP,#/?%>/VW@'Q%_PB/BK1Y_#\3W6KZBUS:SRW$6R!6((8D,6##'0 T
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MO](ULB%I&B"2VTIVX.5P&7YNF,\'FF?$#1O%'C+P%?::FD"*\GO5:"!KB/\
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M2:KOX0U*;XJ>(=<O] DN](U"R2WB"2PF0.HC^;#.,<H<'KTH W/$C>-+#PE
M-,U"*;7OM,B*6@0)<)F1E&W'#;%4<'&>OM6\+>.F\::7I4UO</8:A'>?9M3L
MPBDJPC=CPP) )3@_4=16V)==NA9W%WH[HRZB7$"3Q,8H!&5!8[@"23G SC..
MU9-]\/A#\4-+\7Z2PA5F==3@4[5DS&X63'<[B 1]#ZY ,SQWKWBCPH-%>/6
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/%>A_9[B<Z@BQ6\*W$K.K+MB;.V3D<H<'YAQQUJU)K6G1) \ETB)/$TT;,"
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MBMK7*J?,D$<H*]>,&1>3QUYXKT&LVVU_2[S4CI\%VKW6QI%3:0'56VL5)&&
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MS&WAR#3XKC:#Y\R>;N'7OO7D\?E7:Z?JECJT4LMA<I/'%*T+LG0.OWA^%7*
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M:Z@)S:RB003/!)@$;74X8<^E6: .+EMKS6?$.D:V=.N;(:?87*7$<B@,[R!
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M<0ZE)<[K4KO9EE WY$F&(P%ZGK@FO1:* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *PO$6KRZ?=:-80N(7U2\^S>>0#Y8$;N< \;CLVC/&3G!QBMVLW6]"T_Q
M%I_V+4H3)$'65&1RCQNOW75E(*L/44 8%SJNKZ9J&EZ)=7\,L^I:C-%'=I&
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M@O+432HA\C$T[,R\?>;;@9R,GI@8KTFRL8=/TZ"PMMZP01B*,%RQ50, 9//
MK)3P;HJ:4=-$$QM_M/VM,W#EXYMQ?S$8G*MN)/![GUH Y?6_%&O:5:^*+.*Y
MC>YTI[22WNY(03)%.P&U@,+N!#<@=,<5W-A:W\%E+%>ZC]JG9W*S) L>Q3T&
MWD''J>O>J5UX3TF]TVZL;J.:6.[D66Y<SN))67&W+ @X&T8 P.*VD78BKDG
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M9=(,LEE)'<-&?]&#J6![#.=N?QQ[UQB>#;^;4-"O5Q:Q-81V.M6[$$RI'AD
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MSEE).,<'CD=:@U3PYKDOAGQOI$.G>8^J74L]I()T"R"14 &"<C&TYSCMC/8
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MT^M8RZ9K-GK/B.X&F&[M];@C=%69!]GE6+RS&^XC*\ Y7/\ %QTRWP_X:O\
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MF)8R$'DR1Y'S<\N#QV!H ]&HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&[N[>PLY;NZE6*"%
M2[NW0 5-7'_$^)I/ 5\5GDBVO#G9CYOWJ#!R#ZYH Z'3=8M-4>ZCM_.66UD$
M<T<T+1LI(!'# 9!!!R*OUR(N[W4/%NH>'EU.YM5L;"&:.953S)GD9P7.5P0N
MP# &,DYSQ7/:9KGB'Q+)X9B;5IM-;4M-O'N/L\,9_>0R(BR)N4XW9)P<C!XQ
MUH ].9@JEF(  R2>U48-8LKG6+K2HI'-Y:QI+,C1LH"N2%()&#G:>F>E<_\
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M&)DV$+NSR0<DYSVK7\,WNOZLN@:X=2M&T^_MRUU 9=VYV3<HB C&TJ0006/
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M*[1]2#Q[\U)H_B?5]3L/#.GRW2_:M0AO#)<%Q"TS02!  0C $@EC@#[OID4
M=YI^E66E"<64'E">4S2X8G>YZL<GJ>Y[U6E\1Z;#J26+2R&5Y_LVY(69%E*[
M@C.!@':<\FD\.+JB:+'#K-W;W=_$SI)/;]& 8XSP!NQC. !G-<#9ZE=^'=$\
M37L5[,[OXC-IYDJH5B\QXD,IPHY ;Z9QQ0!Z;>WD&G6,][<LRP0(9)&5"Y"@
M9)PH)/X"J,/B/3)[G3+>.9S+J=N;FU!B8!XPH8G., @,."<\US&KWNH66K:W
MH<ES)=V,V@S7L;RA=\+@E"N0!D,#D9Z$'MP*=B_EWWPX<*6VZ-<':.IQ!#Q0
M!Z117G-KXDU:7PYX6\2QWC3'5+V&&ZL]J^6$F8KA>,@QG'.>=ISGM4UCQ%KN
MDIK%E_:-U/?Z7?K>82.+,VFE0[<;.P61,@9W >M 'I%_?0Z=:&YG$IC#*F(H
MFD;+,%'"@GJ1]*LUPFOZSJ"^%;W7M-U2189+^V2TVI&5,)FCB;JN<,2Y!STV
MXQ5+Q!J6NQW'CA[;7+FW31K.*[M(TBB(#>4[E6)0Y4E?K[T >D45P&L:UKLL
M^J1VSW,,JZ/%=:8MI!YOF7#;\A^#W"  X&-Q[$CJB-3@\+/FX0ZHMHQ$MQM"
MB;:3\VT ;0WH.@H U:HZMK%EHEJES?R/'$\J0JRQL_SNP50< XR2!D\<UP7_
M  F=W:6=Q#=/?V&HBXLK:X@OT1OL@EE*-.CJ-KH><'D KR,<59\;6M[:^&]1
MAFU;[7&VH:=);1RQCS+<&YB!#$8W LI(X'<9H ]"HKSF^\1ZIX?D\502ZB]T
MEE)8>3/=*BF$7#[')*J!M7EAD''N*FU;5/$'AM)S<ZC;O;WUU:6]JQ<226GF
M2!)')V*"N#E<@\^HXH [*#6+*YUBZTJ.1S>6L:2RH8V4!7)"D$C!SM/3/2K<
MLJPPO*^[:BECM4L<#T Y/X5YEK#WNBZYXYN[34;@W5MX>@N()7",R%3<$#[N
M",C/([_2NCM-5OY/&MG8O=,UK/H1NWA*KCS1(B[@<9Z,>,XH Z+2]3M-9TNV
MU*QD,EI<H)(G*E=RGH<'D5;KRSPCJ=ZWASP;H-K,(/M.C/<;_-$;.R% %5BC
M= Q8C'8<X!![31;76I+'2I-4UB.2ZM3*EV+15,5T<E1DE005P"=N/FSVH WZ
M*** "BBB@ HHHH I7&DV5WJ%K?SP;[JUSY$FX@QYZXP>XX/J*NT44 %%%% !
M1110 4444 %%%% !1110 4BHJ+A%"C). ,=:6B@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M /H:-7_[]VO_ ,9H VJ*Q?[#O_\ H:-7_P"_=K_\9H_L._\ ^AHU?_OW:_\
MQF@#:HK%_L.__P"AHU?_ +]VO_QFC^P[_P#Z&C5_^_=K_P#&: -JBN>CCO\
M3O$>GV[ZS>WD%S%,7CN$A !7;@@I&I[GO70T %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@^7^ ,P!=O15')/T'>MRN*OK'_A-+O68HKVS^PQP/IA62 RGY@&D=2'7&3M
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU10!R'B>/Q(/">L^;=Z48OL,^\);2 D;#G'[SK6E%%XG\E,7FD8VC_EUE_\
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MG/IL[2Q6DLY$CJ8PK;8SGN><=Z .G\KQ1_S^:/\ ^ LO_P <H\KQ1_S^:/\
M^ LO_P <IWAO[.^GS7%JU]Y,US(52]>0NFT^60!)\P!*%L'^]6Q0!B^5XH_Y
M_-'_ / 67_XY1Y7BC_G\T?\ \!9?_CE;5% &+Y7BC_G\T?\ \!9?_CE'E>*/
M^?S1_P#P%E_^.5M44 8OE>*/^?S1_P#P%E_^.4>5XH_Y_-'_ / 67_XY6U10
M!Q?AV#Q#)I4X2YTDH-1O#B2UD/S"ZD)/^L_O#(].*VO*\4?\_FC_ /@++_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N2\5Z+!XAU>VTFY=DCN=+O%\Q>J,);8JP
M]PP!_"NMKE?$D.DR>(M/EUN"TEL;?3;V=S=1JZ)M>WRV"#T&: 'R>%?[7O;J
M\UUX97GTUM-$<&0HC<YD;)YRQV\=MO4]:9;>%))KG2WUB>&Y32[22U@"*1YN
M]0C2/GH2BXVC(^9CGH RRT[P;>2RPGP[IMM-%"MPT=SI\:-Y39P_3IP?<8Y
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M_ */_P")H V<CUHR/6L;_A$/#/\ T+ND?^ 4?_Q-'_"(>&?^A=TC_P  H_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM;6/^A;N?_ J'_XJ@#;HK$_M;6/^A;N?_ J'_P"*H_M;6/\ H6[G_P "H?\
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MP-J@<Y/.0.,H?#-]KUQH@UBV^S1:78S02D2*WGRR1B(E,$_*%WG+8/S#CK0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT]_#]I'"9GU?55B W%SJ,@ 'KG-9/C:UB?PN/"=C*]FMW:O"K11L_E0HF ,
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MRTH'W.F3Q745BW__ "->B_\ 7&Y_DE;5 !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[Z[OO_7?R1F7&IW<-_HX4VYMK^3RV0*2R?NG?(<-@\KCIWK:K"UL :QX< &
M+U\ ?]>\M;M5&]W_ %T,:ZCRP:5KK_VYH*R+34+NYU?5(28%MK*18PNP[VS$
MKY+;L#EO2M>L/1O^0]XB_P"OJ+_T1'1+=?UT%02<*C:V7_MR13T3Q8VK:H;9
MK=$23)B(E4X 12<$$^9R3RO &,TFE>+6U'65LS;QK'+Q&PF4X*AMV&SB3D#&
MWH,YQBNAAL;:WFEFBA59)2&=AW(4*/IP .*(K&UAN9+B.%%ED"AF _N@@?3@
MG\ZE1GI=F\Z^%?-RT]TK:[/O_7;S9ST?BUG\0?8/L\?E>:+<-YRXW[B,[LX/
M ^Y][.>*U+6^NSXANM-N&@>..VCG1XXRI^9W7!RQS]T<\=:NBQM1=FZ$*>>4
M";O8$M_,DUEP_P#(\WG_ &#8/_1DM%I)J[Z@Y4:D9>SA:T?QNC<HHHK4X HH
MHH **** "BBB@ HHHH **** ,6__ .1KT7_KC<_R2MJL6_\ ^1KT7_KC<_R2
MMJ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MACE_\!(O\*VZ* ,3^RM:_P"ACE_\!(O\*/[*UK_H8Y?_  $B_P *VZ* //\
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M^Z.:ZBL6_P#^1KT7_KC<_P DK:H **** "BBB@ HHHH **** "BBB@ HHHH
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MEZ!J'DD:=%:B66:\U&;<6"A52\<'L>?G'Y5I7'B*QMM66P:"8N0P)$+9W H
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M>+T5WZ?U_6@[_A+O#7_0PZ3_ .!L?_Q58=IXN\.S>,+VY76[!8/L440DDG5
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MJKZK8C5-'O=/,GEBZMY(=^,[=RE<X[]:LHNQ%7.<#% #J*** "BBB@ HHHH
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M?O;_ %"L+1P&USQ&#T-U&#_WXCK=K.M=->TU6]NTN 8[MUD>(Q\@A%08;/\
ML@]*<DVT%&<8QFF]UI]Z?Z$6G^&]-TV\:YMH=KY_=C/$8VA2!Z@XR<YY)-)9
M^&M,L;_[9!#AUQY8SQ'P0<'J=VXYR3GBM>BCDCV!XJL[WD]59Z]/Z_7N9"^&
MM,74_MX@_>;O,QGCS-Q._/7/..N,<8J*'_D>;S_L&P?^C):W*SK;39(M8N-2
MFN!))+"D 58]H559F'<Y/S&I<4FK(TC7E*,O:2OI9?>C1HHHK0Y HHHH ***
M* "BBB@ HHHH **** ,6_P#^1KT7_KC<_P DK:K%O_\ D:]&_P"N5S_)*VJ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "L6Z_P"1UTK_ +!]Y_Z,MJVJQ;K_ )'7
M2O\ L'WG_HRVH VJ*** "BBB@ HHHH **** "BBB@ HHHH **1F"J68@ #))
M[4M !1110 4444 %%%% !1110 4444 %%%% !12!@PRI!&<<4M !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8M_P#\C7HO
M_7&Y_DE;58M__P C7HW_ %RN?Y)6U0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[,7RO%'_ #^Z/_X"2_\ QRCRO%'_ #^Z/_X"2_\ QRMJBJ,C%\KQ1_S^Z/\
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M ,!)?_CE9-CX=\2V>MWFK/K-A<W-U#' 1+9L%1$9V4 *P[R-USVK)M8_%O\
MPGKF7[7]EW)N.8\_9O-EV@G'E_4+^\V[><YK<TN,6OQ%UBUB>06_]F6DPC,C
M,H=I;@%@">"0H_(4 :'E>*/^?W1__ 27_P".4>5XH_Y_='_\!)?_ (Y6U10!
MB^5XH_Y_='_\!)?_ (Y1Y7BC_G]T?_P$E_\ CE;5% &+Y7BC_G]T?_P$E_\
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M/L.N=&\37>I6EY)JVFXM)#)'"+-MNXHR9/SYZ,>]:'E>*/\ G]T?_P !)?\
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M7V:LOB[2?[1GLI%\FXV"VA="#\G7<QKJ*Q;_ /Y&O1?^N-S_ "2MJ@ HHHH
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M_P"A=TG_ , H_P#XF@#8R/449'J*Q_\ A$?#/_0NZ3_X!1__ !-'_"(^&?\
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MK2_%VDOI^F6=FSPW <V\"QEA\G7 &:ZB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KBO'?WW_[ FH?^AV]=K7&>-+>[O-3MK*RM6N);G2[Z+ =5V O;_,=Q&?\
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MO&'_ - %:]<QI%QK6FZ+8V#>'IW:VMXX2XNH0&*J!G[WM5S^UM8_Z%NX_P#
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MVL?]"W<?^!4/_P 50!MT5B?VMK'_ $+=Q_X%0_\ Q5']K:Q_T+=Q_P"!4/\
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M_:VL?]"W<?\ @5#_ /%4 ;=%8G]K:Q_T+=Q_X%0__%4?VMK'_0MW'_@5#_\
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M>3:=?&^MF"SVVA:E-&2,@,IMR./J*ZRN+\=_=NO^Q=U3_P!H4 4;OQ1K=O\
M#K0[^)EEO]7M8U%T6C5HKF6,&,)$0 ^6.,9X SS5FY\:7Y\#IKD%I;K'<2&*
M.=;Q&*H<JDH7&&<O@>5GKQFM;P/%')\/O#.]%;;IMLR[AG!\I>1[UO"VMQ"L
M(@B\I2&5-@V@@Y! ^O- '&V/C+4!X(EUNXLK:46CK'+(UZD?F*N%ED(QA&#;
MOW>>V,BH-&\3:S?>"-9N)W5;S3+9P;P&/>\Z(S,&A (3'R]^0<\5W/V:W,+P
M^1%Y3DEDV#:Q)R<CODUE>*(HX_"&O%$52]C.SE1C<?+(R?4\#\J #PCJ-SJ_
M@W1M2O&#7-U9132LJX!9E!/';DUM5S?P]_Y)SX;_ .P;!_Z *Z2@ HHHH **
M** "BBB@#(\5_P#(G:Y_V#Y__1;5J0_ZB/\ W1_*LOQ7_P B=KG_ &#Y_P#T
M6U:D/^HC_P!T?RH ?1110 4444 %%%% !1110 4444 %%%% '%Z%<73:E#81
M74D,#W&J3.$5"69;T@<L#QACTJ6_U_58/$@M8HE-NI91^Z?##=%EB-NX[=Q&
M5^7Y^2,&J_A[_D8[;_>U?_TN%=J8T,BR%%,B@J&QR <9&?P'Y5C9RO9]3T%4
MITE!R@G>+^^[U.2UG7]5L]=^SV\2F&/./W3D/E5)R I+;<Y^3/7!QBI?$>N:
MGI^J006D0:/(;[C?.=DAV$[3N^[NPGS?+C'-=08T9U=D4NF=K$<C/7%#1HY0
MNBL4.Y21G:<8R/S--PEKJ*.*HKEO33LFGYON8=W=WD.I:$RW3B.]F,<T/EJ$
M(\EWXRNX<J.IK>K#US_D,^'/^OY__2>6MRJAN_ZZ&->W)3:5KK_VYA6)8W-W
M<:WK(>ZD\FTE2.*$(NW!A1N?EW'ECWK;K#T;_D/>(O\ K[B_]$1T2W7]= H)
M<E1M;+_VZ)G:!KVJ7^L/!=1*L3')'EN-F(U( ^4%<YW?/@\X&:;H^OZK=Z\+
M>XB4028S^Z<!,!\8!7*[L _/CIQG-=:L:([NJ*K.<L0,%CC'/KQ0(T61I%10
M[8W,!R<=,U*A+3WC:>*HOFM22NDEY/O_ %^IR4>OZJWB<VIB7[/Y@B_U3XV[
MV&_&W=GC;G[G&<UK6D]TGBF[L9+J2:W6TBG175 59GD!P54<84=<UK^6GF^;
ML7S,;=V.<>F?2L6'_D>;S_L&P?\ HR6CE<6KOJ-U*=6,N6"5H_C=:FY1116I
MYX4444 %%%% !1110 4444 %%%% &+?_ /(UZ+_UQN?Y)6U6+?\ _(UZ+_UQ
MN?Y)6U0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !-;5% &+_PCQ_Z#6K_^!(_^)H_X1X_]!K5__ D?_$UM44 8O_"/'_H-:O\
M^!(_^)H_X1X_]!K5_P#P)'_Q-;5% &+_ ,(\?^@UJ_\ X$C_ .)H_P"$>/\
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M (1X_P#0:U?_ ,"1_P#$T?\ "/'_ *#6K_\ @2/_ (FMJB@#F!X&T\%3]LU
MLCO(K-,"59VWN02O&6.:N_\ "/'_ *#6K_\ @2/_ (FMJBBPW)M)-[&+_P (
M\?\ H-:O_P"!(_\ B:/^$>/_ $&M7_\  D?_ !-;5% CG7\'6LEXEV^H:DUR
MGW93,I9>,<';Z$BK'_"/'_H-:O\ ^!(_^)K:HHL-R;W9B_\ ".G_ *#6K_\
M@2/_ (FJZ^#[5+QKM=0U$7+_ 'I1,NX\8Y.WT&*Z*BBP*36S,7_A'C_T&M7_
M / D?_$T?\(\?^@UJ_\ X$C_ .)K:HH$8O\ PCQ_Z#6K_P#@2/\ XFJ\'@ZU
MM9Y)H-0U*.608=TF4%N2>3M]S^==%118:DTFD]S%_P"$>/\ T&M7_P# D?\
MQ-'_  CQ_P"@UJ__ ($C_P")K:HH$8O_  CQ_P"@UJ__ ($C_P")H_X1X_\
M0:U?_P "1_\ $UM44 8O_"/'_H-:O_X$C_XFC_A'C_T&M7_\"1_\36U10!B_
M\(\?^@UJ_P#X$C_XFC_A'C_T&M7_ / D?_$UM44 8O\ PCQ_Z#6K_P#@2/\
MXFC_ (1X_P#0:U?_ ,"1_P#$UM44 8O_  CQ_P"@UJ__ ($C_P")H_X1X_\
M0:U?_P "1_\ $UM44 9-KH$5MJ$5Z]]?7,L2,B"XFW!0V,\8'H*UJ** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;F6/?Y<@8 HR'!W=L'!&: -ZBL[4->TO2W*WMXD.T*7)!*QACA2Y P@)X!;
M-4WUVQL]2UB2[URU^S6,,330%0IM<[_F9\\[L<#'&WWH W:*S+#Q%I&J7DMI
M97\4T\48E9%)^X> PSU&>,CH>*;!XFT6XNH+:/483-<+OMU8E?/7INC)X<>Z
MY'(]: -6BJNGZE9ZM:"ZL+A)X"[)O3IN5BK#\""*X2^\6^(;3_A,;B.?36A\
M/.K)%+;L#.AB60@L'X;G .#SCB@#T6BN)@\2:OJ7BW3=/M9+>UM+[1?[3"SV
MY>2-MR+L)#@?Q^G:JS^--5;PCXLO46S-[H,DL:W$<;-!<[$#<#=D'G!&XX(Z
MT =_17$6OBO4K+Q)HVF:J]E/;ZI8278GAC,1MC&H9MX+,"A!X/'(KJ[+5+/4
M))([:1F>-5=U>-D(5L[3A@.#M.#[4 7**S;OQ!I5C=&VN;Q(Y%9%?()6,N<(
M'8#"[CTR1FHI/%.A1:I_9CZG;B]\U(?)#98.P)53CH3C^7J* ->BLZVU[2[N
M_6RANT:X=#)&I!'FJ#@LA(PX&1DKG%.U#6=/THJMY<"-F1I BJSML7&YL*"0
MHR,GH,B@"_14*W<#V0O(Y!);M'YJR1_.&7&01CKD>E8>D>-='U:QTZY69X?[
M1=DM8Y8V#2$9Z<=<#/MSZ4 =%165=^)-&L)'2\U"&W9)EMV\T[?WC $+D]3@
M@_0@TEAXFT75+*XO+/4H)8+9]DS X\MO0@\@^GKVH UJ*I:?JUCJAG6TG#O;
MOY<T;*4>-L9 96 (R#D9'-17NOZ7ITK1W=XD13;YC$$K%NX7>P&$SVW$9H T
MJ*Y77/$$P\3V?ARSN7M)[BUFG-R+<R;64QJ@P1@@ER2?;&1G-;AO!IVGVQU.
M>,W+*L;&%&_>RXR0B#+'H3@9.![4 7J*S(_$&E2V,%[#>)+#.Q2+R@79V&=R
MA0-Q(P<C&1@YZ5')XHT**RM;R35;5;>ZD\J%V? =QG*^Q&#G/3'- &O17.7O
MC?1;;1_[3AN&NH?M:66(HV)65F"[6&,KC<#S[8ZC-E_%N@QWRV+ZI MVSQ1^
M2<[@TF=@(QP3CO\ CUH VJ*S;+Q!I6HW2VUI>))*\9EC ! D0'!9"1AU!(&5
MR.147_"3Z-O=!>AF6%YP%1CYB+]YH^/W@'^SGK0!KT5F:!K=OXAT*TU6V21(
MKB)9 KJ01D XY'/7J.*Y&7Q5=ZI#K%Y::[!HUMIMW);L]U9ET\M47YSG:=^]
ML@9Z  CO0!Z#16)=^+-"TUGAO=5@6>&%9I5&2P0]&VC) X)^E3W?B+2;&*.6
M>]C\MX#<JR O^Y&,R':#A.1\QXYZT :E%9%YXIT.PF\FYU.W67R/M 13N8QY
M'S #)(Y'2IGU[2TLK>\%VDD%S'YL+1 R&1,9+*%!) !!)QQF@#1HK$;6[*XU
M/2OLNN6@AN89)E@"AS<IM!#JV?E"\G/?-+:>+O#]_<VUO::K;S2W1=80A)#E
M<[@#TS\IXZD#/2@#:HK)G\3:+:S"*XU&&(F4P!W)"&0=4#_=+#^[G/!]*O7M
M];:?;^?=S+%'N5 3R69CA5 ')))  ')H L45D-XHT..S6[DU*"*%KC[+F0E"
M)LXV$'D-D]".*?:^(]'O;.[NX-0A:"T8I<.QV^4< \YQC@@CUSQ0!J45RVC>
M(9]3\<:SIHF#6=K:6\L:&!HG1W:0,&W<]%4]!P:U[_Q!I6ES-%>7B1,BJ\F0
M2(E8[59R!A 2" 6P#@^E &E161=>*="LM1_L^XU.W2\#QH8=V6#2'" XZ9(J
M:/7M+EU%+!+M/M,F_P I2"!)L^\$8C#%>X!..] &C16;JFOZ3HKPIJ5_#;/-
MN,2NW+[5+' ^@-12>*-$B@@G?4(Q!.L;K+@[ LGW"S8PF[/&[&: ->BLV[U_
M2[&Z%O<WB1R%TC)(.U7;[JLV,*3D8!(SD43:_I<%V+66\1)#*(,D'8)#R$+X
MVACD84G/(XH TJ*RY_$6DVT-_+->I&FGL%NRRD>3D9&[C@8(.>F#4&I>,/#V
MD33PWVK6T,L"JTJ%LL@;."0.G0T ;=%9MYK^EV-JES/>)Y#Q><'C!D'E_P!\
M[0<)R/F/'O5?6=?L['3)98KV(3-:M<0L$,JA .)"%_@Z?,2![T ;5%8.@:E>
MZIX#TS5))(Q?7.FQ7#.4ROF-&&)V@CC)Z5G>#O&^GZWHVD176I6[ZU<V*7$L
M"#!8[06VCH2/0<B@#KZ*S(/$.E76F+J,%XLEF\HA6558@N6V;1QUW?+]>.M,
MU_Q#:>';>UENEE;[3=16L8C1F^9W"Y. <8!)]\8')H UJ*XRU\:06?B+7K76
MM1MX;2VFMUM28RA"R1AOFZGJP&3@=.E=%J.NZ9I.?MUVL(4!G8J2(U)P&<@8
M12<C+8'!H T:*S=>UNT\/:!>ZS>$FVM8C*VWJWH![DX ^M9T8\47&B?;?M-C
M!J,D/F1V;0%HD8C(1FW!B>Q88'^SVH Z.BLZZUFST^*,WLOER-$96C52[*HQ
MN8A02%&>3T'K0NNZ8]Y:6B7D;S7D1FM@F6$J#DLI'!'(YSW'K0!HT5GMK6GK
M 9C.Q42M" L;%F=<[E50,L1@YP#T/I5&?QKX:M[:&YEUFU$4\3S1D/G<B\,<
M#G@\'WXH WJ*P7\:>&T=E.L6N5E6%L-D*S8P"1P/O#D\<BI+WQ=H&G2W45WJ
MD$<EIM^T+DDQ!LX+8Z#@\]N^* -JBLRT\0Z1?ZA+86M_#+<QQ^:R*>J9QN!Z
M, >"1G!IB>)]%=Y4_M")#%#]H8R90&+IYBD@!E_VAD4 :U%8UIXKT*_F\JTU
M&*>0V_VI5C#$M%Q\R\?-U&0,D9J3P[K]KXET:'4[-9%AER5$B%3C)P>1W&#0
M!JT5PNM>.M^AW]YH\GE-8:I!9RM<0-AE:6-'(S@#[Y]>F>]= /%N@?8;V].J
M6ZV]BVVY=B1Y9(R,@\\CICKVH VJ*R8O$VC7$3R07Z3!)S;XB5G9I NXJJ@9
M8[3G@'CFGP^(=)N!9&*^B<7KM';D9Q(Z@EE!_O#:V0>1@^E &G16<FO:6]I/
M<K>1^5!/]GE)R"LN0-F.N[+ 8ZDD5@>*O%\=OX5U:[T/4+<W]AM\V.1,M'\P
M!#(<%3SW'X4 =A16?IVN:9JUQ<P6%Y'/+;%1,JYRN<X/N#@X(X.*KZ_K=OI5
MA<_Z4D=VMN\R Q-)L 'WV"]%SW.![T ;%%<WHWB:$^#M%U35K@+<7>GQ74NR
M,L>45G;:H)"@GD]!D5HW6N:?%:12)?1'[1"9H'C4S!DP#YF%Y*#(R>G(YYH
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MG2\"+<2/</YDBI]U2P(( YX&!DD]S0!>TZVO[>WE2_U 7<KR,R2+ (O+4]%
M&<XYY/XUYA#]NF\):%++J,UQ</XK95DN%5@I6YF7.%"YZ#C..PP*];C01QJ@
M+$*,98Y)^I/6L$>"M#"JJP7"HM[]O1%NI0J3;BVY1NP!N9C@<9)XH YX>*=5
MT]=4T^YN1=7$.MP:=!=&-$.R6-'&0,+N&YE!Z9VY![]-H!UM+C4(=7>.2)9%
M:S<LOG&,CD2! %X8'! Y'N*9<>#M#O(-4AN;1IH]4D66[629SO=0 K#GY2 J
MX*XZ"KNCZ+9Z':F"T\]]QR\EQ.\TC]AEW))QV'04 <3JNL^*<^,9[+5;:)=
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MM$A(9P0S,<_.2"<EL]34+>#-%:SEM##<&&6\^W.OVJ3F?<'WYW9^\ <=..E
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M"F3>F,Y4#)/'I7"S:=K4&HZ7JK^&7U"W?3$L+FQ^T1"6W=&)#\ML8'<00&[
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MQY=:-/"L=C+ 6TZ?_GL\3E)Q]02,#T4GO6[K<]_;Z/<OIEJUS?%"L**5&&/
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M[;\2(3NW(<XP#GCD=:KRZ#K;:'?P+I$WG2^)DU%%\V+F 3I)NSOQG:IXZYH
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M-&VU+6VA\4:C<>)%M[?2+RY@C6>VC,6T0H4+E5W':S9XY/3G/ !Z#2$@ DG
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MC6QMT95'EAXRS#( SSZY-6+C5[2V\3302ZC<AX-/,\ED+<E-F\?O0P7+'^'
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M35N8PEAYJI[*VO\ 7],CN_#>DWU]/>W%J3<7%O\ 9I765TWQ\\$*0,_,PSU
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M/8 GM6?X7OKK4?#\-S>R+)<-),K,J[1\LK*,#Z 4^9<W*0J,O9.KTNE]]_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSTK4LKCQ!-"D-[I]I;3C EN([CS(SZE%V@\^C8Q[XY .>\4_VQI5[H8BU^]
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MVBI<7D<4$4"MN\N*,$\GIDLS'C@#'-4]$T#5+7PIK&ES2I9W=W/>203POO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "F[$\P2;5W@;=V.<>F:=10 4444 %%%
M% !1110 4444 -=%D1D=0R,,%6&013NE%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116#XJU>73;;3[6V
M;9=:G?1V44F,^6&R7<#U"*Q'OB@#>HKG-;\3V_AF"YWV-W+;6%JMS<3 \!"Q
M& S'YW^4DC.?Q(HU/56TGQ)HK"1FLM7D:U=6.0DNPO&R^F0C*1WR#V.0#HZ*
M*XSQ\\\=UX72&[N[=;K68K:<6]P\7F1LDA*G:1W4<]>* .SHKAM:NKSPCXHT
M![>]N;C2M6N_L$]I<RF4QR,I*2([98<@@@DC'I6A'X[TR74K*VC5I(;V=K>&
M>.1&_>#.-R@[E4[3AB/3.,B@#J:*\MN+[^TM)\3ZQK<&LI%I=[.H^PWHB80H
MBJ8L*X!')8^_(-=3>^,4L+VYTZ#1]0NYK6P2^.QH\-$2PR&9QR-IX/)]^M '
M4T5R[:]I][K7AN6*"^=]0LYKFS=)-D178K$.N[EL%<9&!D\UDV_BS^U/"FGZ
MEJ^FWL*SZNEO']EG"A6^TF--Q# E00H;CGGC% '?45SFH>,+6QAU*Z6TN+BR
MTN3R[ZXBVD1' 9L G+!0P+8Z=LD$"#4/'$-G=:E;V^DWUX;"TCO9'A,>UX6W
M'<I+C/"'CJ>P[T =517/-XNM)+A8+*"6[D-G%?&-&57,4A(4JI(+8VDG'3CJ
M3BNAH ***X5_$.H6WQ LYII?^*?U%I-,@'9;F/Y@Y_WR)4'KL4]Z .ZHK$O_
M !'%::K+IL-M)<W<-LMU)%&ZAS&S,H*@D;L%#G'3CN0*G\0ZW#X=T6;5+B"6
M:&$J'6+&X!F"YY('4B@#4HKG[[Q=8Z;>ZM;7<,Z?V99I>R2?*5>-BP&WGKE#
MUP/>G3>*8+6V$UW 8?,F2&W)E0I<%EW H^<;0 V2<?=/7C(!O45R]GXYT^\M
MSY<$WVS[=]@6U!5C)+MW95@=I3:"V[/0'OQ5?P9<W-QKOBU+D7*"+445(9YC
M)Y8,$9(4Y.%))( ]>@Z4 =A17*7?B"RTS6_$,[6>HO/ING17,ZB4%)(OWA!C
M4O@'Y6SG!.!UJUI/BR/4]7ATY].N[1[BR^W6[S;-LL>5!QM8D$%UX('6@#H:
M*YW6->N['Q5HFCPV+2PWZS/)*KJ" BC@ D?W@2?;C-<[X2\3OIUA;VM];W\\
M-SK5W8I?22!PK^?((U.YMY&%QG! X'T /1**Y)/$VF:=<>(+B2.\A>WOX+:<
M7,P*&218PA3+%43#J3T[DC-=%87DEY%(TMK);.DA0JY!W8Q\P(."ISQ_3I0!
M;HK!C\41SSVQM]/O)[*XNWLUNXD#*'4L"Q .0FY67=TS[$&L3PUJTMC%K:NE
M[?.WB&:T@7>TA0;5(RS$[4 !Y[?I0!W-%<O!XXLI[6QG%I<8NM2;2V *'RIE
M+#D[N5^4\C/;BI)/&EC"NH>=#+"]E?QZ>PE955I'5&4ALX"X<<G!]J .DHK
MN/%,-HD$=Q;-!>3M*([>>5$RL9 9]Q.-IRN.YW#CKBYX?URV\1Z-!J=HDJ1R
M[@8Y0 R,I*L#@D=0>02#VH TZ*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5Q<_:+-;Y8H@H<0D AB&8#OTSDX. <&LA=?-_P",]$NM.O)[G2[W1KFZ2!"
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MAN=3MH;>[8NKI Y>,X8@,I(!(( (X[T :E%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M45%-<Q0/"DCX:9]D:@$EC@GM[ G\* ):*R=1\3:3I-E]MO+B1+8S?9Q(D$D@
M,F[;CY5/\7'UXI;;Q'I5SJ*:>+AXKR12\<%S"\#R =2H=06QWQG% &K1110
M4444 %%%% !112*RN,JP(R1D'N.#0 M%(&5BP# E3@@'H>O]:6@ HHJGJFIV
MFC:9/J-](T=M NZ1EC9R!G'W5!)Z]A0!<HK+L?$6E:CJ;Z=:77F7*0)<[=C
M&-P"K!B,,.1T/&1FM2@ HHHH **** "BBHY9DA5F<GA2VU5+,0.N .3VZ>M
M$E%4M)U6TUO2;;4[%S):W*>9$Q4J2OK@\BKM !12%E4@%@"QP,GJ:6@ HHHH
M **** "BLFS\1Z??Z@EG;M,S2(\D4ODMY4H1MK;7Q@X/Y]1D5K4 %%%% !11
M10 4444 %%(K*ZAE(8'H0<TM !1110 4444 %%(S*@RS #.,DTM !1110 44
M44 %%%5K^]CTZPFO)4F>.%2S+#$TCD>RJ"2?I0!9HH!R,U6EOHXM0M[)DF,D
MZ.ZLL3% %QG<P&%/S# /7F@"S1110 4444 %%%% !112;E+%=PW  D9Y /\
M^HT +1110 4455FOXH;^&S:.<R31O(K)"S( N,@L!@'YA@'KS0!:HJAH^L6>
MNZ<M_8.[V[221@NA0[D<HW! (Y4]:+O6;.RU6PTV=W%U?EQ !&Q5MBEFRV,#
M@="<T 7Z*H:MK-EHL$,UZ[HDT\=NA6-F^=V"J#@<9)')XJ_0 45#=74%C9S7
M=U*L5O ADDD<X"J!DD_A573M9MM3N+J")+B.:V*^8D\+1G##*D9&"",].F.<
M4 :%%%% !1110 444TNJG!(W8SCOCZ4 .HJO87L>HV$%Y$DR1S('59HVC<#W
M5@"#]:L4 %%%5H;Z.:_N;-4F$ENJ,S-$RHV[.-K$8;ISCIQF@"S116;<Z]IU
MGK-II$\SI?7BLUO'Y+D2!1EL,!MX'7F@#2HK+TWQ#IFKM?)8S2RM8R&*X4V\
MBE' R5PRC)QZ9ZTMKKME>KI[VPN9(K]6:"3[-(JX49RQ(&T$=,XSVH TZ*H:
MEK%GI4ME'=NZM>W"VT&V-F!D.2 2!@=#UQTJ_0 4455LM2L]1-R+2X2;[-.U
MO-M_@D7&5/N,B@"U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %9^J:)8:PUFU["SM9W"W,#+(R%77H<J1D>QX-:%% 'G?CO1+#1/"+K81-$
MMUK=I<RJ9&8;VGCR0"3M''08%3_%$"2S\/PVO.KMK-NUB%^^"&RY_P!T)G/;
M'6NNU71M/UNW2WU&W%Q"CAPC,P&X'(/!Z@]/2DM=#TVRN_M<-HGVK;L^T2$O
M(%_N[VR<>V: .&OO$>K2^$_$'B.UNY([S2M1FBCL\ QE(I OELN,DNO.>H+#
M!QQ6G;:A?:]-KDD>L-I<VE:BL*QE%9$B549MZG&[>"W.>.,=#GHW\/:4]_)>
MFS3SI7627#$)(ZXVLR9VLPP,$@D8'I4<_A;0[K6TUF;3+=]17;^_(Y.W[I(Z
M$CL3DCM0!QNKZ]JUIH?C66+495ETS4HH[5R%S&C)"2O3D9=NO/-3ZS=ZO)K'
MC*"'6[NVBT_3(+NU6)8_D<K,2,E3E24&0>3ZUT]]X1T#4KJYN;W2X9I;I56<
MMG$FW&"1G&0 !GKCCI4[^'-)>2[D-H UY"L%QAV DC ("D ] "1CW/J: .,&
MOZOIMYIE\]]->K?Z!<7\EHZJ$66-8F7R]H! .]A@D]N]6K&?7KBRM=7CUN#[
M%>::[D+*)6>79O62,&,!<88%>1CMD5U47A[2X;BSGCM<2V41AMV,C'RXSC*C
M)Z<#CV'H*K6'@[P]I1NC8:5!;&Z5DE\K*Y5N2!S\H/<# H Y3P_J6L/<^#'N
M=8N;A=<TEY+F-U0*KK%&X=,+D'+-G).<UL?#))/^$&LY9;F>=Y))V)F;<<^<
M_?KSU.:VH/#FDVTE@\-IL;3T,=IB1OW*D8*J,\#  QZ #M5C3=(T_2(Y8]/M
M([=)9#(ZH, L22?IR2<=.30!P%C::U+I/C.;2-5O!J4&L3- K,K"38D9V'*G
M&X?*/3C'2I-;\3W>H^"-:\3Z'J4]O;0V,?V;"H?WN-SD[E/0,J'T*MWKK+W2
MYM/>XO\ P[IVG_VE=S*;AKEVC5UQ@ME0?FP%[<XYZ5G:]X6N+CX<WGAS31 U
MQ/"4+R?NT+LVYW( .,L6. .] &)KFLZ[X0UC4\:C-JEN^BW&H*EQ&O\ H\T3
M*,C8!^[(?[IR?EZUO:5;ZK+JFZXU6&XTB]L=R1+<F21GR,R(X1,*589 X!(Q
MBMJSTBRMD=Q:@231B.7S',IV#/R9;/RC)XZ<GCFH=%\,:)X=\W^R-.AM/-^_
MY8/3K@9Z#D\#B@"]%8VT$RRQQ!66,1)CHB#^%1T Z=.N!Z"N,UB?59_%FO:?
M#K5W:VT&C17D*PK&"DA:4<$J>/D'7GWQQ7=UG2Z%IL][<7DEN3<7,/D32"1@
M7CY^7@].3^9]: .,TG6M76\\(WMQJ,]T-:TJ2XN;8H@0.L4<BE %!!RQ'4YS
M3]#U36M0T[1O$KZQ9PZ?<VKR7B22F12QC+#8NP;"A4Y&X\ YR1FNMA\.:3;R
M:>\5IM;3D,=IB1OW*D8*KSP, #'H .U06?A#P]I]]=7EKI%K%/=!A,P3A@WW
MOEZ#/? Y[T <KH^KZM)J\-JVHW3P77A]KT3RJ@9YE= )E3!V!@^0A]L@&HO#
MVK:SO\%75SK$UR-9TR1[F.94$8=85=6&%!!R3GGG/;BNMMO!GAVS:)K?2H8W
MBB:"-U)W+&W50<YQQ^';%31>&-'A^P^79A18(8[4"1\0J1@A1G@$<8].* ,#
MPAK-_/JW]F:U]MM]52S\V2*0K);W.& ,\+K_  Y(RO&,CCKF5HY&^+W-W<"-
M=%$@BWC8"9L'C'? SWX%=#I^B:=I;*UI;[&2,0H6=GV1CG8NXG:O3@8' ]*6
MZT73KW4(K^XM$>[BC,4<P)#*IY(R/?GV/(H \W\#W%_IVF?#Y4U&=[748)8)
MK5E7RP%B=U*\9SE>N3G)K9\-ZEKNNV^B^($U&VBM;B1A>6SS;@V<@1JFP;71
M@!][G!SFNGM_"^C6JV"P60C73R3:*LCXA)&#M&>,@D?0D4EGX4T'3]8FU>TT
MNWAOYB6>9%QECU8#H">Y R: ,;Q=%)+XL\'(MW<0H][.&6)P <6TISC')XQ^
M)JG'J6J6NMZEX6N=1N'O[BZBFT^Y(4-]D;E\87&4V2#)')*9ZUV&HZ1I^KK
M+^TCN!!()8MX^XV",C\"1[@UGZ98:E-J[ZIK4-BEQ$CV]JMJS/MB9@Q9F8 Y
M;:G'0;>O/ !Q>J7OB$:=XTU"W\1W43Z#=L]K$8HBCJL$<A1_ERP.2!C!YR2:
MT)M5U[7[K6[?3[R#3+O33 8Q--M$8:))2TB;#N4EF7DCA>,'FM/2/"A36M?O
M-5MHGCO[Y;F%5G9E*K&B@2)PI(*%AG/6M;4/"F@ZKJD.IWVEV\][" JS,O.
M<@'^\ >QS0!4\9:Y<:%X0FU& JLVZ&/S<96(22*A?!_NAB>?09JJD^H6GCHZ
M$+VYFL+O3&N@[D&2WD215.&QT8-T.<%3CCBNHNK6WO;66UNH8YK>52DD4BAE
M=3U!!ZBJEIHFGV,<B6\+J9$$;.979]@SA0Y)8 9. #@9.* .>^%T+1_#G1V,
MTLF^#.'(PO)X'%<U=ZGXDA\/ZSKT.O74DVDZU+;Q6C11>7/$)E38^%R20< @
MCMQGFO2M,TNRT:Q2RT^ 06T?W(E8E5]AD\"N=\->%#92:G-JMM$TEQJLU_"J
M3LZ?,VY"R'"[UXYP<8&#Q0!E7^NZC%K5O-::C+/ WB!+"0A52%8R-K0A>2S*
M<DOQSP#QBII-3U2QU_5?#4^H7#WE])'-I,Y"Y2!N) .,$Q;7;G.05S70S>#O
M#MQ<37$ND6SRS3BY<E>LH_CQT!..<=>^:2PL-2N-;;4M8AL4:V$L%DMLS.?+
M=@2S%@,,0B# X'/)SP <EKE]K4<GCHP:[>0KH]I%<VBHL?RMY+/@Y7E25^OO
M4E[K^KZ'J-S<?;9KY9/#<^J?9Y578DT93 3: 0I#D8)/0<YKL9O#FDW#Z@\M
MIN.HH$N\R-^^4# #<],<?0D=*?'H&F1WD-VMMF>& VT;M(S8B.,IR>1P./8>
ME '(7,^OP:1>:M!KL/V.;1Y9X=LJS.9E7>LJ9C "XX*\CD8Q3+&\U8:IIEM/
MK%W/'JGA^6ZD#!%\J5/*PT9"@CB1NN>QZUTUEX+\.:;;WEO9:3!!%>*4G6/(
M#(>J]>%/H,"K</A_2X+FUN([7$MI";>!C(QV1G&4&3TX''L/04 9/PZ1_P#A
M76@L]Q+*\MC"Y:0@E24' XZ?7-<Q#K.LV/A/4?$-SKEQ,T&H3V 258UB1/M@
MB$K83[RKDYZ?[/KZ'IFD:?HUD++3;6.VM@21''P!G_/X5%;^']*M=/N=/CLH
MS9W3.T\+DNLA?[Q(8GKDY]: .1U/4==\.><9]2@-K?W5I!;YE\Z2S$D@220L
M44%2#E<Y ;U'%4?%&K:OHK^+X;/5[K;8:1;WEL7VL8I&>4-R5Y!V#@Y]L5V5
MMX-\.V>CW.D0:1;"PN1B:%@6#@=,DY/';T[8K*T[P;%9^)-5/V"U_L2\TZ&S
M\DN79]K2%MX(Y!$F,Y)XH J^(_$FH:)K^O-;S&6&T\/?;X[=@"JRAW&[@9QA
M1D9[4]O^$ECCN;FQUBREAN].+6<<MR)"T^1B16\M0%(8#&" 2N!VKH++PKH6
MGSB>VTV%9O(^S^8V78QY)VDL3D<]^W'2HK'P9X<TRTNK6RTFWA@NAB9%S\PS
MG'7@9[# H X;5-5EU73([=Y]7L+NWUW3H[BQN67?#NE3&'&1(A(+ Y//T ':
M^,M8N/#?@N^U&V.^:"-%61QNV[F5-Y'?&[<?I5R7PWI%Q9S6MQ9K/%.Z/*9G
M9W9DQM)<DMD8&.>*OO9VTMDUG)!&]JT?E&%E!0IC&W'3&.,4 <5K5_JNC:Y)
M86NI7$MM=:/<W2R.$=[>6';AP2N-K;P,$$9'&*V?!D=])X>LM1OM4N;V6^L[
M>9EE5 L3&,$[=H!P<\Y)J]!X<TJWM9;:.U/ERQ>0VZ5V/E?W Q)(7D_*#CFK
MEE96^G64-G:1^7;PJ$CCR2%4= ,]A0!Y]/JFM6D'C+6#K%U,NA74WV>T,<?E
MNOV9& ?"Y(5GSP0>#G.:FU75==\/:5J&NIJ5M<V#:;YL,33>>WF;E'G*0B_)
MM?)7ITQC-=I:Z+I]G)>206P5KUM]SN8L)6QC+ D@\8'T&*J:7X1\/Z+#<PZ?
MI-M!%<J4F0+D.ISE<'/R\GY>G/2@#!\0:A>^&;&74(==^T6MR+6-%N-I\G?,
MJ23B0 @+M<<;2 0#C'%4_$<_B30O"WBFZ_MA$\JU2YL5CD$TL'4,"S(,JQ''
M&1S@^G56/A#P_ING7.GVNDVR6ETNR:(KN#KS\ISG@9.!T&>*;;^#O#]KHT^D
M0:9$EA/_ *Z$%L2>S'.2/8G% &1K.KWOA_Q?%]HN9IM.U.S>.T@X 6\3D(#C
M/SJ>,D\J?6I)9=4L?&'AW2I-5GEBN-.NC<$HGSRQ^5B3[O7YVXZ=.*Z:73[2
M=;99H%E^RR"6$R98HX! 8$]\$\^]17&D6-UJ,&H30EKN!&CBE$C HK?> P>,
MX&?H/2@#S[0=7ULVG@[4KG6;FY;4KZ>SN872,1L@68@X"@A@8UYS[8Q5S[;X
MEU"Y$=O<WL%XNNO;S>3$K0K9 GD,RE,A0IS][=E?8=7#X6T:"&RABL@D5E*9
MK9!(^(G.<LO/!Y/YGU-<C;> [I[N9KS2]-CNI)Y)CJUG?S1R%F8MO$(4 -ST
MW$?7I0!O^/[V^T[PA/=Z=>/:W*3VZAU56R&F1"""#QACTP?>LVYDU2+Q&OAB
M+5YYG>RDO$N)YUAE9C(5P"L9!"<<8_B&<BNMU/2[+6+,V>H0">W+*QC+$ D'
M(S@\X(!^H%5=8\,Z-K\=NFJV$=U]F.86D)WH>^&!SSWYY[T <C ?$6H>)+/1
M+SQ+)$S:*TUQ+IZ1@-,LP0LA9#C/?\<8J#PGXCU?Q#=Z;H^J7<D4@T^XGEN(
M (VNGCN3"&!QP,+N('4L.W!WI_"SS>-[;4!;Q1Z7;Z6;*,03M$Z'>&& F/EP
M,8S^%;<_A_2IX[-#9I&+(;;5H28FA&,$*R$$ C@@'!H X*VUKQ!J8\/6DNK3
MV[RZK?:;<3PQ1C[0D*3!9!E3ALH.G&<\=JV/#-I<6_Q \113ZG>79M[2Q3=,
MR_/\LF20  .<GC R372OX?TIS8G[&B_8#NM0C%1$2,$@ ]2"1^)]:E&D:>-7
M;5A:1B_:,1&?'S%1G _#)YZ\F@#DO&VK7UJ=7&G:C,L]AH[W:P0JJB%QO*RR
M,?O [" F#T.>H(=J&O7FBZSHVJ7MU*VD:E9M$\"A=L=UL$B$<9^<!U SUQZU
MT6H^&=%U:[:ZO]-@N)V@-NSN/O1G/RGU')(STSQ5@:/IPL;:R^QQ?9K5T>&/
M;PC(<J1[@C.: ..UV[U6QM9+1=7N)-0M]&ENY(H@J^7)VE9SU0$,H3!SSD'J
M+5GK.HW'B3PDKW;>1J.D37%Q %4*9%$)##C/\;<9Q70ZAX<T?5KQ;N_T^&XG
M6(P[W'6,\E3ZC/.#T/-);^&](M9;*2WLEB>RB,-L4=AY2'J!SWP,^N!0!Q'A
MJ[DB\.Z39PWDL;W6KZB#;0*!)<*LTY(#D@(%.&)]L#K@U;2ZU'7X_ DEW?RQ
MWKWNH0O=1!-X"),@(RNW.%'./?%=W_PB&@&W@@.FQF*"9KB(%F.QVSN(.?XL
MG(Z'/-*GA+08K6.WATV*&.*9KB(PDQM'(V<LK*05)R>A'!Q0!PM_=ZE)X;O]
M/U&[>^_LWQ-96T-W(H#2Q^= X#;0 67>5) &<5K/J6NZU<ZO+IVHVUF^E:EY
M)6:;"+$FTL'CV'.]22&W9&1C&.>KG\/Z5<:?'82V:FVCE$RQAF'[P-NWD@Y+
M;OFR><\]:AG\)Z#<ZVFLS:7;OJ*;<3D'<=OW2>S$<8)R1@4 9/Q2C+_#/7L2
MO'MM68["/F&.A]J5[JYN/&G_  C)O[J*&'2_M@E5E$LKM*5SG'1,#C'.X9S7
M1ZEIEGK%A)8W\ GM91B2)B0''H<=1[5!<Z#IUVUL\T#&6V!6&99765 >H#@[
ML'C(S@X% '!66M>(-:'A6VFU:>S>\FO[2ZEMXXQYWDAU65<J<$[<^GMTKJ_%
M>JS^&_":SK<L9%EMK:2\E"Y17D2-I2,8R Q/3&>V*TFT#2VFL)19HKZ>"+38
M2HA!&#M .!D<'U'%6[RSMM0LYK.\@CGMIE*212+N5E/8B@#BO%3:OH>FW<MG
MXBF.^\L1#$T:,\*23+&X9CDLK9)'0C! .*6X?5E\02>%H-7GDE73S>17-Q,L
M4KL\KC^&,AA'A>,#[W.>V]%X-\/P:5_9D6F1I9^8LIC#-\S+@J2<Y.,#&3Q@
M8Z5/K'AC1=?^S_VKI\5TUL287?.Y,]?F!S@]QWH X?7];UNUT+49$UE9]2TS
M1DN)?L2!88Y@7)E8M]X/LP$ QP>F0:U;5+BY^)FHM]ONHP=$MI5564JC,\P.
M 01V!^O7-;]YX2\/ZA*TEUI-M(S6_P!E/RX!BYPN!Q@9./3MBIAX;T=;F&Y2
MPB2>&W^S1R)E66/GY00?<\]>3ZT <7X:\1ZCK,'A#3[V\E1M1TF6]N+A,*\\
MBE $! X^^6.,=!VSF(:YK\L6GVC:I-$\?B:327N%BCS<PA'8,05P&& .,#*G
M(/2NV'A?1EL+.R2R6."R;=:^6[*T!Z?(P.Y>"1P>E22>']*EBLXFM%V6<OG0
M!69=DG.7X/+<GD\\GU- &7X,N[R8Z[97EY+=_P!GZH]M#-,%WF/RXW 8@ '!
M<C..F*Y[Q)K6LV8\?_9M4GC_ +.L+>XL\)'^Y++(6 ^7D':.N3[UWECI5EIL
MMU+:0^6]U)YLYWL=[XQN.3UP /P'I56Y\,Z/>/?O<68D-^BQW>9&Q,J] PSR
M!SQ[GUH R-+N=0M?'T^ESZE/>6TVEI>;9E0>7)YA0[-H&%(QP<].M1?$:%[7
M2++Q);H6N-!NTO"%ZM#]V9?H48G_ (#71Q:+80:DNHI"?M:PBW$ID8GRQSMY
M/3//UYJW<6\5W;2VT\:R0RH8Y$;HRD8(/X4 >5QWMY8>++FXB=Q#XTMMUFRK
M_JI48(C8[?N&60Y[H:Z[5+BXTOQ=X6T^SG>/3Y8[F.2U55VL(X@4YQGCZXKH
MFL+1WM7:WC+6A)MSC_5DJ5X]/E)%1W.E65WJ%K?SP[[JTW>1)O8&/<,-C!QR
M.#ZT >;-?W'B#0_!/B&>]E:2\UN)W@!'EQY\P! ,<%<8SU)SGVU].U+7==9-
M4M=0MK9+?5Y+:Y@EFROE+*T?E&/9PY&T@[LY(['%=!_PA?AS[29_[)@W_:/M
M07G8)?[X7.T'GG Y[U,OA304UYM;72[<:DQRTX7DMC&['3=COC- %C6[^33=
M(GN((_-N<".WB_YZ2L=J+]"Q&?09-<-X?C?PGX^2P>TNK:PUVV!5KAHR7O85
M^=OD9@"Z<G/4J:[Z]TVTU![=[J,NUO)YL1#LNU^F>".>OYGUJ+4M#T[6)+:2
M_MO.>UD\V EV'EOV88(P?>@#B)]3UJV;QGJG]KW<R:#-(UO9[(]D@^RJX5\+
MD@,V1@@\<DU:GO-7T^RN]6D\16D.F3:4\L<CO]I991@K.@"+E<,,J.,E<=>>
MNM=&T^SGO)H+<+)>MNN269O-.,9()(/&!]!BJ%EX*\-:?:7EI:Z-:QV]XA2>
M/;D.IZKST'L,"@#.\,:AJ+>+=:TN[DN#;P6EI/#'<LK2(S^:&R5]=@.,G'Z5
MU]96G^&]&TJ[^UV6GPPW/E"$RC)8H"2 2>O4\]:U: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N9\?3ZO9>$+W4=$NY(+NR47!5$1O-C4@NOS*?X=V,
M=\5TU-DC26-HY%#(P*LI&00>U '"OXEFC^(NA01ZM+-HVKZ>7CA\J/:LI&Z-
MB^W/SJLF!GJM;5EJQM;:ZU&_OIIH+J^,-C 47. =BJFU06W,K,"2?E(Y !-<
MNGPYO[?P,VF07P&JVM^MQIURW/DI%)B%?PCSQZN:Z+Q!X<N)=.T+^Q]GFZ)=
MQ3PPRMA945"C)N[$JQP?6@">Y\:Z/9Z?J%W=M/"=.D6.[A:$F2$MC;D#(VG(
MPP.WWK+NO$DDOB_0C%->6FG.MZMS#=0^0K&)%(?Y@#CYB<YQ^55-?\)ZGJUI
MXEO(+=$O=7CM8(K=Y0 B0L6W.PR,DLW SP!ZG%KQEX6N_%.JZ,P66"WMHIS)
M-'*%DAD<(8V49^;:R D=/K0 SQAXCNK?2M U&QOKG2[>[U6WMYVFBC4F%\[B
M1(IV].O%0>(M3NHO!/B;5='\4SW:VML5BD583Y4J#<VUD0 @AE!ZX(X(J75=
M-\3ZWHWAU;VQMQJ-AJEO>79CG'ENL9.2G?)ST/ ]:VO&6CW&L^#-8TW3X4^U
MW\#1C>P4;B ,L?8 ?E0!:O?$-II[RQ,D]Q+;P"XN%MX]YBC.<,P]]K8 R3@X
M%,C\4:;/>VMK;-+.]W9F]MFB3*31#&2K="?F7CKS69%I>K:9XIU/5K:T2Z@U
M6UA62%I@K031 J,]BA#<D9((Z'-4CX&N['PQX:L=,O534-'94^TD=8W4I-@?
M1BP'JBT =%IWB6PU6STV[M%G>'4"P@.S!^4$DL.JC@]>_'4BH]:U9X-7TG1;
M9MESJ+2,T@&3'#&N78>Y)11_O9[8JEX7\*R>'M2U(!T_LT2L=-A'6!)-KRK]
M#(./0#WI->LW@\;>'-<_Y=HEGLIV[)YH4HQ]MR!?JPH KO>ZG9_$671[K59U
MT[4=.::P^2+]S+&V)%!*98[65ANSWK+\+>(]3UOP"HDU69M<^WFQ:Y$,:MN+
MY#!-FW'E$/@CH#6]XT\+R^)(--:UG^SW5I=J_F@X/DN#',H/J48_B!3;/PFU
MG\0+S6XY%73Y[>-A;#H+E08_, [?N\+^)H G\87^JV'A]H-"Q+K,RL+;S #G
M8I9F( ]%QZ;F7UJ2+49O%/@A-1T*[:TN+VT\VVE"JWER%> 0P(.&X/'8TC:3
M+J7B*YNM1@D2WAB6&R:*Z9#@G,A.P@C<0G'/"#H:I^#-%U'P[/JVG/ JZ.UV
M]QIQ\[<T:ORR$=ANR1R>O- ',2>,[\:!X)ULZK<)%=7"6VK0&&+KGRW=CL^0
M++M!QCAA75ZE<Z@S>([JUU.>&"RM-D**D9"SA#(S#*$GAHQ@DC.ZLL?#Q91X
MMMIY@;+5BYLH_P#GW,BJTC#ZRJK?\!%:]KH^H6O@!]-E(N=5GM)!.^X //("
M6.?3<Q_ 4 9'A'5I->TS07_X2R2YU*:RCN[RT40$$;5#@[$#)AG&.0<CZUT&
MA:M)<ZCJVCW3[[O3)44R8 \V*10\;$#OU4^ZD\9Q1X3TR?2_"NC6-]"B7EC9
M1VK,K!A\JJ#M/H2H/X5CV%OJ*:_XLU_3;6.Y>Y>WM;2.67RUE$*X=MV#@;G<
M=.2GOF@#M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "FNBR(R.H9&&&5AD$>AIU% "
M  # '04M%% !1110 4444 (0&4JP!!&"#WH551%1%"JHP !@ 4M% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ND:QF#PJ1D.Z[,JF#G<>*OZEXETO28I);F9S'%$)IGBB:011G.'8J#@<'\
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M=ISMX!/.<2S\-:]9Z+H\7]FQ&;3?$,U\84N5.^%S/@ACCIYJ\'G@\=J]*HH
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MR/J";+K>N1*, <@\= !^ ]!56#P9X>MM'DTF'3(TL965I(@[?.5^[DYR0,#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1RSQ0F,2
M.%,C!$!ZLWH/P!/T!-25G:KHL&KR6,DLUU"]E<+<1M;S&,DC@JV.JD'!'>@
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M**X)=1\5?VIX;TF]U"TM[F]@O!=O;1"0;HBNUE)X!PW(Q@'/45F6VJ:MK/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"2T0W4(DG^T22PW,D<KR<?,7!!/0#!., #& *;=^'K.;1;W3TC<B['[UVN)
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MO.P;@<X&YN.AW'.<FD?PII$J6ZR02DP7?VY7$[JQG_OL01N/.,'C'&,5M44
M8O\ PBND?:IYQ X6XG%S- )6$4DP((<IG;G(!Z<D G)IMUX0T:]75EN+>9UU
M8*+T?:9 )0!M X;Y>!CC'%;E% %>6QMI]/>QGB$UL\9B>.4[PZD8(.>O'K5+
M3_#NGZ:8VA$[/%";>%YIWD:*(X^52Q) X'N<#)X%:M% &?HVBV.@6"V.G1R1
MVRLS!'F>3!9BQY8D\DD_C6A110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7*
M?$;2[_6_!ESINFV37=Q-+ P0.BC"3([9+$#HIKJZ* .=UO3)8/"FI)X>TFSC
MOYXLK 8HU#MWW?PDXSC.1G&>*R="T.[?Q!XA?4]*N(],U:SMX\W=RDKMM$BN
MCX8X)W]OEQT/:NXJGJFDV&MZ>]AJ5K'<VLA4M%(."001^H% ''>'])U/_A#-
M56X?[?=_9Y=-LG4@&6"(ND9)8@;F)))S@\4_3](U:'4?!,LFF2JFF:7-;79\
MV(^7(R1*!]_GF,\C/:NWAABMX(X(8TCBC4(B(,*JC@ #L*?0!Y9:^'M?TVTT
MB^.@F]:SN]0%QI[3Q!WBN)O,61#NVY7:O!(ZFMM=%O4USPO=VV@1V5K;374U
MQ#;O&!!YD94;OF&YB3D[01SU/4]Q10!YM'H&N1:7:O\ V5*TMMXHEU,P":+<
M\#O*00=^W.)!P2.AKJ/&UC>ZKX&U?3[&U,]Y=VCPQQ*ZCYF&.K$#%=#10!PF
MGZ!J/AO5K/5='TH_9KZ&.'5M.1XT:.15PLR?-M)_A8 \@@]14&E:)J-IJ5QI
ME_X8M[V ZC)>VVJ2R1LBJ\IE^9"=WF*6(&!@D#D#FO0J* /)M0M]9T?PJFB:
MAIC^5!KUO+'J(F0QSI)?+(#MSO#_ #8((QP3GM5W7M"UZ2V\8:=::/)<C5+R
M&[MK@3QJA 6%64Y;<&!C/;&.]>@:EI5EJ]ND%]"98DD655WLN&4Y4\$<@@$>
MXJV!@ >GJ: //[K1]2C\2:PL_A>'6-/UAXYXY998P+=Q$D;)*K'E?D!RH;J>
M#4\V@ZG%XK74-*@NK%FO(A>#S4:SNX J@N8RQ*2 # ( .5&<CD=U10!YS!X<
MOF\/OI.HZ/>$1ZS<7,5U9W:)+&KO*Z31'<""-RJ0>?F/!KK/#,&KVOAR*'5I
M1-?HTH$CA0SKO;RR^WC<5V[L=\]:VJ* /-M$TKQ%'KGAS4;[1)HY+6UNH+S%
MQ%L5V\LCRD5MJI\A P >F[UI='\/ZW:Z5X'@FTJ5)-+O)9+L>=$?+5HY5!X?
MGF1>F>]>D44 >76^B>)+7P[I6@2:+-/)I>LQ7)O$GB\NXA6<R%QEPP;!Y!'7
MOS75_$#3K[6? FK:9IMJUS=W4/E1QAU7DD<DL0,5TU% '$V>B7_AOQ"FHZ+I
M9.FZFBC4M/1XT:WF4869,L%.1\K 'T(SS5/0M$U&RO?[+U'PQ;74<%^]U;ZO
M))&R;#(9 Q4G>)1N(&!C/.:]"HH X?PI9Z[IEK#X>O\ 1U:*RGD,6JF5&1XR
MS$,JYWB3#8.0 .3D]#6\(:+J.GQ:=IFJ>%[83:2-D>K>9&ZRJJE5:,9WJ[#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/ "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>exhibit1027supplycontrac021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT47FN8HG;.YDC)VJ3N;H!U/J:GT[1;#29KN6RBDC>[E,TY:9WWN0 6PQ(!P
M./04 9/CNSOKOP?J<.GP6DK20MY\=P2OFQ ?,H8=&*Y /;-9OC&[2_\ AO8W
MD<)A2XN--E6)NJ!KB$A3],XKI+KP]IU[?27=PEP[RQB.1/M4HBD4=FC#;&ZG
MJ.<U-JFCV.M6:VE_"TD"NL@1963YE(93\I'0@'\* +U%(JA5"C. ,<G)_.EH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@* 3DD]QZ5S:>&];TZ30[V/1++5/+TB'3;RRN944QM'DB1&(((^9@1UQCZ4
M=7+XNT=+&.\AG>ZA>U^VYMXRY$'_ #T([#KQU.#@'!JK'XSLYO$ TZ&"XEM_
M[.6_%U'"SJZ.?E*@#)& >W7 K-&D^(-#\2)J>EZ987=O>6,5K<VD<P@6W>-G
M960E3E/WC C&>,X[5<?2]8@\8_VJ+>&YAETA;25DD"%95=FX4]0=W'/;F@"S
M8^.-%U&T6ZMWNC!(L1A=K611.9"0JQDCYCP<@=.^,&GW'C/1K33[Z\N9IH5L
M)%BNXF@;S(6;&W<H!X.1AON\]:YZV\+:S!X*\)0+$@U/0)H97MVE&R<*C1N
MPX!*L2">_7'6DU_PKJ>JVOB:]@M=EWJR6D,5L\J@HD+;BSD$C)RPP"> /4X
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M(\>XLHV;<B3!VYSCOST.UXITV]U"\\/R6=OYJV6IK=3G>JX01NO&3R<N/R-
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MYBB4'.<$#,HYQV/'2JNL:;<Q^&/#<%M<PV?B733;QVZLP<Y8"*08!Y0KN/\
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MT9<N 4*Y\P9VYR!W[8(!LVGCG0[V:T2&2ZVW=P]K%*]K(D?G*6!0L0 &.QL
M^GN*S?&/BAH-/B_LFYN4D35;:TEFBB#1DF9%DC+$'L2"1C!&,YXJA;^&]:BT
M+2+1K']]:^('U&4"9,>29I'X.>6Q(!CU!J"3PUXE@\.S^'8K&"XBBU=+VWO#
M<A1)%]J$Y##&0XY'I[]B =E?^*=+TUKDW$DGDVCJEU.D9:.W9@" Y'3A@3Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'I+F8(^U&D_T<D[1QR6.?P]*++Q%J8CLK"YOIG6\\2WFG27;8#+%&TNQ 0
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M6N-4M=)L9KJ.+,<CE1(X"(H.-Y&"#S'0!VDOAG19HKR*33XFCO6#7*'.)B,
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M+I\6B6L,J2+-?ED8, ^H3L./4%\$>QH T:*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I" P
M((!!X(-+10 R*)(8EBB0)&HPJJ, #T%"PQI(\BHH>3&]@.6QTS3Z* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "D95< ,H8 @C(SR.E+10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR@$2$XV$=0<]0>F.:E@\2Z-<V%Q>PZC"UO;R^3*^2-CG&%(/.3N7 [Y&,YH
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M4:3::?IZWVMVLUQ<6:W"R*NPW"X&9%09(!R"![XJZNOZ7)IMOJ$5XDUM<C=
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M8$'YNY+O2M<^WP:A907%GK.VT6YA0"2PO  N_(/W"GS888.%&,]O1:* ./\
MB2=OAFU;RC+C5;$^6,9?_2(^.>.:Q?$?AG5-9U'6=:TNV>,M'8B*WE_=F\:"
M8RMD'ID;4&['(],&N[U71['6[>."_B>2*.5)E597CPZD,I^4CH0#^%7@, #G
MCU- '%W.GW6I>(K[7HK.YAB_L1[$12IMDFD9]P&W/\/3)X^<XXYJCHFF:A:W
MO@9Y].N$73=%EM;IBH/E2E80%X//^K?D9[>M>AT4 >8Z5H^L6.E>$96TFY:3
M3=4NY+B!2@=4E$X1N6 (_>)GGC/M74>--/U"\M-*NM/B:X?3M2AO);96 ::-
M=P95S@9&[< >ZUTU% ' :IHU]>_\)EJEM9W &J:2MC;6Y7:\T@20;R#T^^JC
M..A[8KK-*BE;PU:6[K);S"U6)@PPT;!0#^1K3HH X#PS::M)X=LO#VH:"]G?
M:9:/:#4W\MHQ^[*!X6!W$M\I/ [Y/0&*PT;4[O1?!VF7&GRV=UH-Q$]U,<;-
ML43)\C#[WF9' Z G.",'T2B@#S*TT?5(O#^BP-I=R)H/$LE]*NT92$S2L'Z_
MW77@<^W%3-9:Y86FL01:'+/O\0?;!*%B<^0SJWF0ACCS%QQD<'UKT>B@#RM=
M&\06L-]=V^CW;M:^)%U1+>:9&>Z@,*H0IW'+CDX)QD  UM:U;7VIZ;8ZC:>'
MIK9H]9MKV6VQ&MQ(BG#.P#;=V,<$YPOX#NJ* .>\:VMUJ7@/6;.UM9);NZLI
M(HX5QDNRD 9SCJ>N:R#9WA\6SWQTZY^SMX?6U#E!S+O9BF,YS@CV]Z[BB@#!
M\$VMS8>!]$LKR!X+FVLHH98WZJRJ 1Q[BN.TS2-7@\/^#;"?2+I)=*U8R7).
MQ@$"3+O&&.1F1<=^O'%>GT4 >87.CZVL.I7EMIES*T'B4ZDMJ)?*>ZMS"(SL
M8$8;)+ $C[OO79>&;>)(+J\CT>?3#=RB1TNGW3R$ #>^&;!XP!DG Y]!NT4
M>=>+=%_X22QNS/X?O(?$-M)*NE7]KA6X8^4_FAOE7&,A\=\#I5SQ'I.J)?Z#
M>V=R@U.YC_LJ^D4[?,B="S2+_M(RLZ_4CO7<UG0Z%IL&MW&LQVP_M"=0DDQ=
MCP !P"<+P!T SCF@#D_%FBWGVTSZ!#>VFH6^GI#;/$JR6MT SXMYD/ 4?WCC
M <\\8JOK&A:Y>7GC&"VLV$FI06LMM/Y@$3-&@#1DYW#)7'3H<YKT6B@#S+5]
M.NM>\(Z[+;^%-0L]4N=.-F/MDXDED8G(13O;Y <G)QUX'6M[[/<_\+ &I_V?
M<?8_[$^S^9Y?_+3S-^S'7./P[9KKZ* .<\!6=UIO@/1K&^MY(+JVM5BEB?&5
M8<=N#^%<LVB:U/X<U58+&9+J/Q&=5BMI2%^U0K.L@4'. 2!P#CD#.*],HH \
MW\4:+J&MGQ'JEE87*_:] .FPP.H1YY2S-D@G@+D#)]3VZ]_8?+IMOF)HR(E!
MC9<%<#IBK-% '&OX?/B:RUJ75#J%H+_?;M;83_4+E4['.<E^#P7(ZBJ5MIVN
M:Y\+5L-2M9;;Q!8QJT#RX^>>$[HI 03][:N?J:[^B@#@]-\/:Q'XJ6]N% L]
M4CCO=1CWY$5S$?D1?;#1C/?R/>L[4K#7+G4T<Z#<@VOB)+I1;&)(7@&0)/O
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ML:@&-.5(&. P>(CO\Q]*?I^C:GIC0-!I=@WV>,Q6XEU6:3R4.,JN8N!P!ZX
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M:2V_EJBL9B;?S'+9!(!#;1C'0GGH.EG\&Z-<VNI6TL4YAU*99[I1<R#S'7:
M>#Q]U>!CH*;J'@K1M2NKRXFCN4DO;?[-=^3<R1BX3:5&\*0&(!(R>>W2@#4T
M;_D!Z?\ ]>T?_H(J[4-I:Q6-G#:P!A#"@1 SER .!R22?QJ:@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@]1D>W [@'HM%-C?S(T<#&X XIU !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !61XAT8ZQ96_
ME,J7=G<QWELS?=$B'.#[,"RGV8UKU6O;^UT^)9+J81J[B-!@DNQZ*H')/L*
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MN/\ "<GC\L5TU% '-0>!]*MDM$@EO$6UOGU"(>>6Q,^[)YSQ\[#'OZ\U)?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPB%-V=N<GC.#CUQ7FFJ6.H7&A>/X5T[5;A[Z2"6U:6S(:?\ =1+D *.<J>,
MC'.#6UJED;GQ3XHNO[,N9(KC0(X(9/L;GS'S-N0?+R<,F1_A0!V$VH;-:@@%
M_IZP&WDEDA=OWQP5PZ\XV 9R<=QS3K;7M'O+J.UM=5L9[B1#(D45PC,R#JP
M.2/>N,TBWN(]<\'SS6%XJV_A^6"Y=K63Y)"(<(WR]?D?CV]Q6;X>TRYL]*^'
MRG2KN&:TNYVNA]C=3$&BE7+_ "\ EDZ_TH ]'EUK2H+@P3:G9QS [3&\ZAL\
M<8)Z\C\Z;K=X]CI4T\5Y8VDHP$FOCB('(Z\CMG'/6O-+:6S6XBLM1CU.+3['
M7KB_CN6TV5U8^9)PTJ@IMW.26S]W ..379?$:VFO/ FHV]O;37,\GE[(H8C(
MQ(D4\  GH#0!L77B#1;%Y$N]7L+=XF59%EN44H6SM!R>"<''K@U-<ZII]G*D
M5S?6T,CXVI)*JDY.!@$]SP*X'6-/DN=2\?2KI=U)]LT:*&V?[&Y\U_+E!53M
MY.63C_"HKNVU6+[->Z5'?B_^R6D5QI]U9.]O>JN/XBO[J126YSQ@$B@#LH/%
M^@S7.I0_VI:1_P!G2>7<-+,JA3@$\D]!N )]>*N0:[I%U<&WM]5LIIU9U,4=
MPC,"OWA@'.1W]*\\\16%\^D?$73UTN^EFOI5FM3';.ZR@P1(-K 8)W*W Z8Y
MQ6]K<,=AXG\+ZK:Z;<?88S<I-]ELW9D:2-0A9%7<,[<9(XXSB@#J5U73FL?M
MJW]JUINV^>)E*9SC&[.,YX^M4;KQ;H=I-ID;ZE;$:D[);NLJE6VJS%MV<8^7
M'U(%<#IRZMI-IHVIRZ-J,EM9:QJ+W=JEN6E59GD\N54'WP W5<\,<9K:O;?R
MM0\+ZG8:%=V]E'J=Q-+%';DR#S89!YCH.5W.W?ID9QR  =79ZB'DU.2?4-/D
MM[:;:#"_,"A%)$I)(#9R>W!%2KK6E-9S7:ZG9FV@.)9A.NR,^C'.!^->>7VG
M:HW_  DDUII]TR)XAM+\P>0R_:[>-8=X3( ;E"<#KM]Q4OB?3;G56\6ZGI]G
M=M;7GA_[&L1MG5[FYS(5(0@-E591G'\7L< '?V^L:7>2W$5MJ-I-);#,Z1S*
MQB'^T ?E_&I+34;*_P!_V.\@N/+QO\J0/MSTSCIFN O=/1]:?=I-^UA)X6DM
M95M[9T+$L#Y:G;P^W=@>M;?@Y-7AO=1@U":2^M42$6NHW%J;>>4?/F.12!N*
M<?, ,[O4' !T5UJNG6,R0W=_:V\CXVI+*JDY.!@$]SQ6)KWB=;+7;'0;2\L8
M+^\BED$ET=RQ[=H52H93EBXQST!ZUA7MK=Q7'C?3[_3[J[&K)OL9(X&D253
M(Q%N PA5@?O$?>SZFK%O8W]EXJ\'1W4=S</9:1/;75TL+LGFL( ,OC')1C_.
M@#H+WQ#;Z#I^FMK]Q:V]Y=O' 5C?Y#*<;MI;!VCDY/;WJAI_BZ$Z_K6GZK>Z
M=;1VMU#!9L9!&9O,B60#YF^9OFQQ2^.(9W@T.XAMI[A+35[>>98(FD98QN!;
M:H).,CH*Y+Q#IUW=V'Q&:+2;QKB^^S_9/]$<M*5AC'RG'.&4]/3- 'I=WJNG
M:?)''>7]M;O(0$6:54+9.!C)YYXJMXCO+_3O#U]?:9!%/=VT+3)#)G$FT9*\
M="<<5Q>JP+)XDURSUG1-9U#3=8CA:U:T6785$85HI-I'EG<"P+8'S'D5Z)!'
MY=M%&5QM0+MW%L<=,GD_4T <<_C.X6X\(2J;)M.U\!6FPP:.0Q[U &[G<?E]
MCZUT5G>75SK>H0'R39VNQ RJ0YD*[F4\XP%*'ISN]N?./^$'U4^'?$&G",J=
M(F=O#S ?,/G6Y&/QV1_\!(KMK>>]T;P:U[+9RRZI,C7#V\,;2'SY,MLPH)VJ
M2%SV"T %AXLBO?&M_P"'C 4$$ EMYSTN"K%90/\ <8JOUS1>:]?6?CJPT21+
M=;+4+662WG*L6,L>,QD9Q]T[L^Q'O7-^(/#]]H-GH&MZ=/J.IWFDW*G[.MLI
M>:*4XGX1 V2#O^8]1ZUM>.["]U'0+/5=&@:75-,NHKVUB92C28.UT((R 49@
M10!'HWBZ\O\ 0O$5Q<K:)?:/=3VK11!F5F097OD[LC XYXJ:XUO6X?%>FZ#_
M ,2\27=C)=/*8G(1D*@J!N&0=_7VK(M_"5]IGC>S6W'F:7>VD4NIRX^_<V[9
M5_J[.I]PAJUKFFKJ/Q1T=[G3[B>RBTZXC>7R',:R,R%06 QT#=Z .LTN6^EM
MW-]]F+B0B.2V)V2)@8;DD@]1CVKEAXKUGR/%L)@L1J.A'?'$0P6>(Q[U8G/&
MX!A[%3UKKK"Q@TW3[>QM5*P6\8CC4G.% P!7'^(_#]]/XYTR]L8\V>H6YL=5
M/81(PE0GZX>/Z/0!IV?B&YU/0O#U]8M:M)JNQF!1BJJ4+OCYL@J%(Y[X'&:V
M6U73UOQ8&_M1>MG;;F5?,.!G[N<].:Y/P3X?OM&U;5;6YCVZ;87$J:4?6*8K
M*X^BG:H/LPK,T:R$EZFCZWH>KS:C9ZM)>0W6Z46K9E9UF#@[,A7Y4\D\8YH
MZ+PYXNAOVN+35;W3X-174+FT@MUD"-,L4A0%59B23CM73R!S&PB95?'REER
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ME #3 %-N9"2V>F <<FO6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Y@AN;:6"YC
M22"12KHXR".^:EKB/B3/(8/#NFEBMEJ6LP6MY@X#Q'+>6?9BH!]1D=Z .FLM
M6TF4+!:ZK:W#+A0%N5=NN!GG)/:K36D,EY'=.NZ6-2L9)X3/4@>IZ9]*AO-+
MLKU+83P)_HLJ30$  QLIXV^G''T)%<@GC74&\.Z7XH5+=]+O;Q('MA&1)'%)
M+Y:.'W8+ [21CN0.F2 =Y17"7/B_5X-#UJ\VV33:=K::>H\E]KQ,\2Y(W\-^
M]/.<<=*N1:OXBO/%FLZ?;'3OLFF/ VUH7\R9'C+%0V_"MG'S8Q[4 =?17GMI
M\0)7TNZN)7A-]"+>&73I+=H)[:XED$?SAFY3+ @@@'!YYXZ;1+K7Y-1OH-6L
MD2T4(UI<#:K/G.Y60.^,'&#GD'VY -RBN*\3>*M3T6YO'A^R/#:S6J" 1M(S
M)(ZJYD8$",_-\H/7&>0>*NN>*?$-G+XN:T;31#H,,=R@D@=FF4QERAPXP>,;
MOTH [N>>*V@>>>5(HD&YY)&"JH]23TI+>XAN[:*YMI4F@E0/'(C95U(R"".H
M(KD[_7+O69=<TW3F@@6PT^.65IXRY=Y49@O!&%"KR>Y;MCFWX-:1/AGH+0LB
MR#2;<J77< ?*7J 1G\Z .FHKB=(\7:GJ">"I98[0)KMM))<JL; HRQ;QL.[@
M9XP0?K52W^(,L5GJ=Q?^5%>:=92SW.E2PM#-&X8!=K$D/&>1O ]#WP #T&FR
M21PQ-+*ZI&@+,[' 4>I-8.DW?B)]<D@U&RC_ +-:W$D=R B,LN[!3:)'R"#D
M'C&"#GBJ;W.I/\4&L?MD?]GII(F$!B)Y:4J>=W7Y1R0>.,=30!TUK=V]]:QW
M5I/'/;RC='+$P97'J"."*FKR_P  ZOJFG:)X&LI&M'T[4[1X@BQ,)(F2,R!M
M^[!!"D8VC&1R:WM%\1>(-:;1]3M].C?1K\%I<[%:!""48-YA+'H"-HZ\8QR
M:/B#3]%>]M[^_P!4?3+M$,4<\=[Y!9"<E2"<,,C/(K3TF.Q2R!T^<7$3MN:;
MSO-,C=,E\G)X Z\  =!7+_$DX@\,,(S(1XALR$&,MRW SQ61>PZYX3?Q3XKM
MK>TM4OKBT6&PE.\?>6-Y&V'"NV_/&?N\YH ]-HKC-7UCQ%H\3QSW6F/,MK<7
M*&&VD9G*D;%\O>2% )W/G&<#C-/L_$VHZZUM:::+6VO)-&AU-C.A==TN0B
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M(QRKABWIQCBN#\1W6IW?A+XCK>WD<\%M<^3$GE%2@\N%@ =Q&/F/&,YR<]J
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6MSIUL+2.Z@N LDD _Y9N<8(XXX&.V*U=;\1:?H!LEOI@C7MPL$0/<GDDGL
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M]H9MS%L8 9>PY)]*R_$GBM;30C?Z->6<K0WUM;7*N"Q022HA!&1M;#Y&?RH
M73O 6FZ9+I<D%[J1_LL2+:*\X*QH^,IC'*C Z\\8)(XJ6W\$V%K#IT4=Y>[+
M"]DOH<LG^M??NS\O(_>/Q_M>PQK:7KFE:VDKZ7J-K>K"^R0P2A]A]#BL74-9
MU>/QW9Z#:264=O<V,MUYDMN[LI1E7'#J"#NS^% $DW@FPGT_4;%[N]\F_O5O
MIL,F?-#*PQ\O RB<>WN:DNO"%E>-K9EN[S_B<P+;W8#(/D52H"_+QPQ'XU#H
M7BO[6^N0:K]FMWT>Z%O-=1OB&3*A@1G[I^8 KDX/<YK8CUK39K26ZCO86ABD
M\J1@W*2<#81U#<CCKR/6@#C-9T:^_P"$A3$?B);>&TBM[6ZTR: []I8MYBOP
MK9(Y P0.3V'9:-!>0:/!#J$\D]P P:23;O*Y.W=M 4L%P"0,$@TO]M:;]C%V
M+V$P%S&'#9RXSE0.I(P<CKP?2C^V],:P@O4O[=[:XX@E1PPD//"X^\>#P/0^
ME &9%X/M4LK*PFU#4+K3[)HWBM9W1ES&04W,%#M@@'!;' HNO!NG7D6N17$]
MVZZRRM<C>HVLJA5*87C 5?7I1X+URX\0Z)->W,EO(RWMS DENI".D<K(K#D]
M0 >IZUFZAK/B>PUS0=.DFTI6U::9#_HDC>0$C9QSYHWGC!Z4 7KOP3976I0Z
MDFI:K;7JPB">:VN=C72 D@2<<\DX(P1GC'%;5YI=I?://I,T7^A3P-;O&I(_
M=E=I (Z<5F_\)'::/;"+Q)JNF6M\H>1PL@C4QA\*X5F) (*]SR<5>&N:4UZM
MFNH6YN'?RU0./F?;NVC_ &MO..N.: *MKX8LXBC7<T^H-';-:1F[V'9$V-R@
M*JCG"Y)!)P.:KZ'X/M/#Z>7:ZCJ<L4:%+:*YN/,6U4]HP1V' W9(''0FIH=?
ML87U"6\US37MX[M8(]C!?)8JO[ICN.Y\DG''4<4^3Q%I=UI&HW.GZUIZ_959
M7N7D#1P/CY2_(XZ'J,^M %.+P1IL.A6&E)/=[-/F$]G<;U\V!P2<@[<'[Q&"
M""#@U)=>#K&\@=9;F[\Z2\BO9;@,@DDEBV^7GY< +M7   X]SFP_B71[&"-=
M0UJP6<6RSN?,"Y0X&\*22%)(Q]>]7'U;3TM;>Y-Y"8;D P.K;O-!&[Y<?>XY
MX[<T 9FL>$;/5]5M]5%[J%C?Q1>0;BRG\MI8LYV/P01G)Z9&>#6I-IL$NCR:
M8K20P/ 8 T;D.JD8R&/?WK+EUN>_O-+E\/7.FZAITDS1WK1N9&4;00593M7'
M4ANN0!R:M^'KC5[C3"VM16R7:RNN;975'0'Y6 ?YA^/7&>AH I7?@S3M0MM1
MCO9[J>;4(HHIKDLJR 1,6CQM4 $,2<X^N0 *B?P+IL_]J&\NK^[;4[5+6[::
M8?.J;MI^4  _,>G'M533_$EY<Z3J<E[J6FV-Q;ZR]C%-+&1&ZI(HV[2^2S#(
M'/4UMW7BG0+&:6*ZUFQADA=8Y%>=049N@//!^M #!X:@83O<WEW<W,UJ;3[3
M*4WI$>JKM4*,G!)QDX&>@Q%;^$K.UET62.[O,Z-;M;VH+)C85"G=\O)PJC\/
MK4/_  D$UMXRU73[Z:VBTRTTV&]$I4J4W/(K;V)Q@;,YP.M=%#-'<0K-$X>-
MQE6'0B@#G8_!-A%:6ELMY?;+74&U*/+)GSF9F.?EZ9=CCW^E.N?!6F7<.M02
M2W@@U=_-GB67"I)A1O3CAOD7KGI[G.G;ZYI5U.T$&H6TD@0R;1(.4'!8>J@]
MQQ4-KXGT&]NK>UM=8LIY[@,84CG5C(%SG;@\XP?R- $7_",P?VJFI&^O3=)9
MM9;V=#E&(8DY7[VX ^G&,8XJO:>#K*P31!;W-V1HD;)9HSI@AEVD,=O/R\5>
MUSQ#I_A^.T:^E"?:KA+>(>K,<9]@!DD^WO6-9^,8(/$6N6.LZC86]O;7$$5F
MQ/EEQ)$K\Y8Y.6 SP.G3- &'H.CZW'-"RGQ)I]]YWF7$<TUO)9@E]S@$[G9#
MEL8.[D9QU&]X[L;K4(-$CM(KEFAU:"XD>W7+11IG<_((XR.,'/H:WK[6M,TV
M18[V^@MV;;Q(X&-QP,^F3P,]34?B"XU*TT"^NM)CAEOH(6DBBF4LLA49V\$'
M)QB@#/O/!FGWT4AFN;S[9)=179O5=5E$D8PF/EVX R,;<<GN2:A_LP>%8;R3
M3=.U'5WU2[WSPF="%9DP7.\@!3M&>O7@8XK+?QO=@>"[Q); Z=K[+%,QB8.D
MC)N4+\_0M\ISG!QUS74V=W>7.NZA#N@-C:B.-<1D2>:5W,"=V,!2AZ?Q>W(!
MF0>"[$> XO"DC/%:>2(Y?LYP2<[FP6!P"V:NOX<ADUB753>W?VJ6S%DQRF/+
M!)SC;UR2<^_I5&Q\6BZ\=7GA][?RX5M_,M+@])W1MLRC_=)48]0U+JFN:CIO
MC;1]+<6HTW4XY524QL769%W!"=V,$9(X_A(H @/P^TU;?2DM;_4[.?3(/LL%
MU;3A)6A_YYN=N&7@=1GWK3C\,VD.KPZE!<74<T-FUD@#JPV%@Q)W DMN .2>
MOXUC:)XMO+NS\4B_>R%WHES)%BWB;:R!=R,07));D8!'((I]WK7B&U\2>']%
M>335EU&UGEGD^S.PC>((2%'F#(._]* +=KX)TZSMM%@AN;U?['WBV<2@-L<8
M9&('((^AXZUI:SH<&MBR$\\\7V2Y2ZC\DJ/WB?=SD'(YZ5)I4E])#.;Z6TF(
MF*Q2VR%%9 !U!9L$-N'7M6#X>\7Q7,]Y9:Q?V,5\NJ3V5M&I\LRJAPN%+$Y/
M/?D]* +FI^#[+4=;&KI>ZC8W;1"&=K*X\H7" DA7&.<9.",$9ZUE^)O!EL;'
M6[[3'OX;J[T]K=[.UDQ%<L(RD>Y<=1P,@C@<\5T]SK6F6=R+>YOK>*4LJ[7<
M#!;[H/H3V!Z]JKWOB?0M.DN([S5[*![?;YRO,H,>[.-PSQG!_*@#)L_"D%]:
M:7>SS7]E>1Z8EC<1Q.$\Q,#*/D$\-G!4@\]2*0_#[3$@TI;6^U2SGTRW^RPW
M5M<!96AX_=N<$,O [<=L5NVVN:5>ZA)I]KJ-K-=QIYC0QRAF"],X';D?F*=;
M:UIE[>-9VU]!+<*GF>6K@DKG&X>HSQD<9H SKWPE97UO-:27-VME/;+:SVP=
M625 6.264MN.XY8$$^N1FEF\)V<FHW][%=WUM+>^29!!* H>+&QP"#SA0.<@
MCM5S4?$&CZ0Y34=4M+5Q&92LTRJ=@(&[!.<9('U-+_;VDFQM[Y=0MWMKG_42
M(X82\$G;CK@ GCI@^E "Z;H]OIDUY<1O)+<WL@EN)I-NYR%"CA0 ,!1T%95_
MX(TW4$UF-[F]CAU@JUU%'* NX*JDJ"#@D(H/TXQDUL'6-.^QV]VM["\%SCR'
M1]PEXS\N/O< GCL#4<.OZ/<V1O+?4[2>V#!/,BF5QN/(7@GGVZT 4;SPG:WU
M[>W<UY>&:\L/[/E(* &++'@;>#EFY]_I3Y_"ME<:9IEFTURLFELK6=TK*)HB
MJ[1SMP<KP0001U%:EE?6FI6B75E<Q7%N^=LD3!@<'!&1W!XJO'KFE37GV2/4
M+=I_GP@<<[.'QZ[>^.G>@#/N_!^GWFG7%M+-<B>XNH[Q[Q743><A78X.-HP$
M4 8Q@=*R-<\*-9Z9JDNG_P!J7]QJ<MN;S9=*LNQ-H+1YVKNPO0G'.,8^6NAT
M#Q%I_B2SDNM/EWQQS21'/!^5V7..P.TD>U9MKXJBM_$&M6.L7UE;Q6UQ#%:E
MCY9</&K8.2<G+ 9X'2M:5&=52Y%>RO\ BE^HF[&9I_AJYU2POM/O+W7UTB\M
MFAEAU%H/,R2.8]BY48W@Y]1CUKI(/#\$&NQZO]JN7N4M!9X<IM,>=W("CG/.
M:CN/%>D6FJWFGSW*I+9VXN)B>RG=P/4X4G ]J2W\7Z%+IEK>RZE:VZW$ G"2
MS*K*N 3D9[9 ^M5]6K6ORO[N^H<R-/4;"WU73+K3[M-]O=1-#*OJK#!_G5%_
M#6EN^C.;< Z,?]#Q_ /+,>/I@C\0*LIK.FRV,%[%?026T_\ JI(W#!^N<8ZX
MP<^F#3H]5T^66UBCO('>[B,UNJN"94&"67U'(_.LW3FNC"Z&RZ6DVLV^IM<S
MAX(GB2$%?+PQ!)QC.?E'.?YG-63PY;2>*H_$0N;E+Q+;[*41E$;Q[MVUAMR>
M>>O':B?5)UM=3N(@A$4@M[4$</+PO)_ZZ-M_X":E.OZ1'!)))JEILAE%O*YD
M "R_W3Z-R./>J]A4Z*_]?\$+H?-HMC/KUKK4D6;ZV@DMXW]%<J3^/R\?4^M)
MI>B6.C)>K8Q^5]LNI+N8CO(_WC^@J:;5+"W:99KR&-H45Y S@;58X4GZG@>I
MJ$Z_I(@$[:C;+&9OL^6D _>_W#GHWMUI*E-[1871%H7A^W\/I>);7%Q*+NZD
MNY?.*G]XYRQ&%&,GM5NVL?LU]>77VJZE^U,K>5+)NCBVKMP@_A!ZGU-,_MG3
M,W@^WV^;+FY_>#]SQGY_[O'/-8E_XBFN?$$FAZ1>6<-TEHMPCSJ75W9B A (
M(&%)..>1Z<W3P]2;M:UM=>W],&TCHKVU%[936K221K,A0O'C< >#C((_2N=7
MP'IS:)::)<WE_=:3:A EE*Z!&"$%0Q50S $#@G!QS707-];V$"R7D\<6>.3U
M.,G ZGN:P-1\5PV.O:7OO[%=%O+.>X-P3W0QA2'S@@[^F*5+#U*KM%=_P5P;
M2+5UX2L;B^U"Y2>ZMAJ4:Q7T,#J$N !M!.02IV_+E2IQ]!4DOAFR;5XM2@EN
M+6:.S^Q!8'"H8@25!4@_=)./UR*T[2\MK^TCN[.XCGMY1N26)@RL/8BJ(\3:
M$98XAJ]D7ED,2 3J=SCJHYZ]JA4IMM*+T"Z*-EX,L+!="6&ZO-FBJRVBLR'A
MEVD-\O/RG%6O$'ANS\0I:F>:YMKFSE\VVNK239+"V,'!P1@@X(((-%QX@TZX
MT:_NK#6M/C^S@H;F1PT<+XXW<CU'?FHAJMX/&=KI1>![2;37NMRQD-O5T7KD
M\88\8_&M%AYN]U:U]_)7"Z&/X/LFNM/NUO-02ZLUD3SUG^>=9-I<2$CG)5>F
M",#&,"HM-\$:?I7]CBVN[[&D)(EL'D5OE< $'*\\  =.GKDULZ?=27;W<AQY
M*SM%#@<D+A6)_P"!AQ] *NUE*+B[,9FZ)HL&@V3VEM-/)&\\DY,Q!(:1B[=
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD '/WQ@G'&:+34$\-:[I9275M._L&2.RN);%H[J-MI"6TBX^=AP00 1CGJ*
M/2VU*UM+*";4+VT@\Q0=YE"HQQD[23R*EGU"RM0#<7=O#N4N/,D"Y4#)/)Z
M=ZX;3&FL/$=M<:I:W#Z;=:%!;P.;=W$4BDF2)E )4L"IY'.W';%9>BZ%<6-Y
MX%@U.PED-K#?;R\#2"!&(,*.V" 0N  3P10!Z6VIV"6<=XU];"UDQLF,J[&S
MTPV<&ITFBD@6=)4:%EWB16!4KUSGTKRS2[*Y3P[IZ6\]]H]]:ZAJ#VLKV+O"
MJM,Y5)$(X1D88/'3@YXKNM">67P79'4M.2SD^R 2VB(2J #&T*><8_A/(Z4
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M@[  ,;NISGGTJY110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%0S7=M;VYN)[B** =9'<
M*H_$\5(CI)&LD;*Z,,JRG((]10 ZBBD+JIP6 /N: %HIH=2<!@2.V:565AE2
M#]#0 M%("",@@]N*3S$QG>O'O0 ZBF[T !W+@]#FD\V/_GHOYT /HHZC(HH
M**** "BBB@ HHHH **1F"J68@*!DD]J2.1)HDEB=7C<!E93D,#T(- #J***
M"BBB@ HHIGG1>=Y/F)YNW?LW#=MSC./3- #Z*** "BBB@ HIK.J_>8#ZFFM/
M"B,[RHJ(-S,6  'J: )**0$,H92"",@CO2T %%(S*BEF(50,DDX IL<L<J*T
M<B.K<@JP(- #Z*** "BBB@ HHHH **** "BBF12QSQB2*19$;HR'(/XT /HH
MJ'[7;; _VB+87\L-O&-^<;?KGC'K0!-1110 4444 %%,EEC@C:2:1(XUZL[
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MP-& ") N[=GG/RC&/UJ/3M+>3Q5J'B&="C2V\=E;(PP1$A9BQ'8LSGCT4>N
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M(=9FDM503ONCD"R,K$[<;?W9!'7O[5L>&=+C^VZOK\=G/8RZK(KK#<+M= J
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MFN8OO!,-^FNK+J$ZG5YX+AF1%'DO#LV%<CD?NUR#G/-=-#&T4"(\K2LHP9'
M!8^IP /R% $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !44UQ!;*K3S1Q!F"*78+ECT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** ,P:' =>;5I+F\EDP/+MY)R8(6VE2R)T#$$@GW/J
M:TZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH6.@&PTNXTVXFNK&Z\1V\_F3*J1Y(Q(8@%7"=-Q QG/O4.KV5C%H?CFRM;6
M6=MJ]G<1011@I&N+?S&50.!P^<?[7O7L5% '/>)+>WOOA_JT-G;I)#)ITWD1
M)%P?W9V[5QZXQ^%<C+!::;H7AGQEHNGI-)80I;W,4$(5IH9%56 X&65]I_[Z
M'<UZ?65>:*U]K$%Y-J-U]EA"G[ -GDO(K;E<_+NR#@XSCY10!P^M:+I>G:UX
M+@U:*TVRS7C7C. L<DCQ,S[NQ4N3P>,8%9:1-H&GK*?M$7A)?$$SH88A(L-N
M8L(P4JP\H3;B.".C#M7I6HZ'_:&NZ3JGVIHVTUI&2,("'+J4;)^AXQW]:UZ
M/+;*RL;/Q#X1GTJ>[GT:75+V19)U"IYDENQ7RU"J F1)CCJ3C@BK>O.]KXQE
MN;=K34D:]LTN--N$VW,3#9LEMVZE1D,5(QP_(YKOKZQ@U&V\B=3@,KHRG#(Z
MG*L#V((S5A0510S%B!@L>] '$7BPM\3=4ENEW:;'X;5;X%25(,TA ('7Y1)Q
MUKK-*^Q'1[$Z:H6P^SQ_9@JE0(]HVX!Y'&.M.L["&S>>5<O/</OFE;[SD# ^
M@   ']235J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&&UM[9G:"WBB+G+%
M$"[C[XZTLMK;SNCS012,ARC.@)7Z9Z5+10 QXHY<>9&KXZ;AFE9$=2K*K ]0
M1FG44 1?9;?&/(BQ_N"GHB1KM154>BC%.HH B>UMY9DFD@B>5/NNR LOT/:I
M:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC2.-!A408"CT %5!HNE*DZ+IEF$N/]<H@7$G^]QS^- ' ^))K^SL-'U>QO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]%!W$87 Z4 >BT5YPDU[+H[ZQ9^)M\%SH\LGE1S-*SR!-PE7=Q&0>"  .0,
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MHAN9VMT(!$3.Q);&<Y/.&'M7&:UJ>JPZ/XU:+5KQ)++5[:.WD#C,:.L&5''
M^=OSH ]0HK@EM-1N->\5^'[;6;]<V%M<6LTDY+P3/YH)![+E%.WIUP!4%OXF
MO[WP9>>(;2.<76E:7)&]LSL0;Q0?,#+GYMA4<]]Y]* /1*K6%Y]NM?/^S7%O
M\[IY=PFQ_E8KG'H<9'J"*X^&ZN[77?"9L=0N;NTU>VE^U^;*9 0(@ZS+G(0[
MN,#"_...E96C>(+MK'PS9:CJ,_D:AJ.H0373RE7<QR2"*/>,%<X[8/R =\4
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M>WE(A6SPA<'^'(4OD$;MV,=J /1:*11M4#).!C)ZFEH **** "BBB@ HHHH
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MHVEK//.-.M1-<1^5-)Y*[I$QC:QQR,=C4]E96NG6D=I96T5M;1C"10H%51[
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M0:* &HNQ%7).T8R3DFG444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6%XJ\._\)#8
MVHAG%O?6-U'>V<S+N594/ 8=U()!^M;M% '+:QHFH^*8;2QU6&UM=.CGCN+E
M(9VE:<H=RH,HN%W $GKQC SFI['2=2M?&>M:NRVK6M[;V\42B9MX,7F?>&S
M!W]B<8[UT5% ' IX0UM?A[;Z ?[/^UQ7R7)<3OY947/GXSLSG'R]/>KUEHGB
M/2-=U06$VGMI.IW/VMI)6;SK5V4!PJ[=K@[<C)&,\YZ'L** .-L=!\0Z5K>H
M16CZ9+H][=O=B:;=]HMRYW.H7:5;G)!)&,\@XQ5[0M(U729/$4KK9M)?WKW=
MJ!*Q )C10K_*,<IDXSUKI** (+,W1LH#>K$MV8U\X0DE ^/FVD\XSG&:GHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIMJL%_%8S285XXX#"49AD!V5F.1D#@>]:6MV&OZQI%A=MI]O'>VFI07JV*W
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9=SX:T*]U :A
M=:-I\]X,?OY+9&?CI\Q&>*U** "BBB@"I<:98W=Y;WEQ:0RW-MDP2N@+1YZ[
M3VS[5;HHH **** "BBB@ HHHH **** "BBB@ HHHH JV6F6&FF<V-E;VQGD,
MLQAB">8YZLV!R?<TEMIEC9W5Q=6UI##<7)!GE1 &D(X!8]_QJW10 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116'XGUB32K6
MRAMR!=ZC>1V4#$9"%\EGQWVHK-CN0!0!N45PGB&^?3?'GA[3Y-7NK73[JTN6
MF!FQO>/9M.3R#\QZ=:?X3U2^\02>([:'5)+C3K6Y6/3M2*J'+;,NI  #JC<9
M(Y&>O6@#N**Q_"VM_P#"1>'+34C&(Y9 R31@Y"2HQ1P/;<IQ[5B?$#4)],;P
M[+%?SV<5QJT5M<M&V T3(Y(_-1R.: .SHKF+'5M/LH+S45U:[O+-IH[2**3Y
MCY^<;8^ 26+J.>/ESTI]UXUTZPM=6DO+>\@FTJ(3W-LT:F3RR"0Z[6*LIP>0
M>,$'% '2450TK55U:&65+.\MD238OVF+9Y@P"'7GE3GVY!XJE;>*["YMC>;)
MX]/^SRW(O7"^4T<9 8Y#$@\YP0#P?2@#<HKF)/'>E0R7L4\-W%-:61OS&55V
MD@!PS+M8].X.",]*(O'%G(UCOTS5(8;Z>.WMYYH%1'9TWJ<ENA&1GU&/3(!T
M]%<UX@UVSATVZ^T_VG;PV][!;M/:$!B[.A !!^[EE5LXZD>M6=0\566GO<Y@
MNKB*TECBNIK>,.L#/MP",[CPRD[0< C- &Y17.ZEXTTG2YV6X,I@CN4M9KE-
MI2*1B  PW;L9902 0">3P<7+;Q!;WE]]GM[>XDC^TR6IN%"F-94!+*?FW#[I
M&2,9QZB@#6HK UWQ#-I&LZ'I\.GRW/\ :4\D;.C(-H6)WP-S#GY1[8![X%<_
MH'BO^S9-2@U,ZC<Q'7Y;*.Z9=R0[F58U8DC R<< XSSC- '?T5@S^+;"WO\
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M[::*4 ,DB'!!P2#V.02.:Y7Q[XD=/"^JG2FOEDLYXH9+RV*JL<A=,H3G<>&
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MN0%0.5.<D@L,Y SG(R.: .LHK(U7Q%;:3J5CI\EO=S7-\)/(6"/<&*+N())
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M%:WNS^Z<$C<C$ \$9&<&I[:[:YGNHC:W$(MY!&'E4!9?E!W)@G(YQSCD&K-
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M7U*ZBGD@1T1A"H+#<P4'DCC)%&O:W;^'=)?4;J*>2!'1&$*@L-S!0>2.,D4
M,T*/5!!)+JMM8VDSX @LF+JH&>2Y522<],<8[\UK444 %%,DFCC9$=P'D)"+
MGEB!G _ &J&AZW;Z_8/=VT4T:)/+;LLR@,'C<HW0GN#0!I4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<GX\DN8K/1OLU[<VK2ZQ:0.T$A0LCR ,#ZC'K7656O-.LM15
M%O;.WN5C8.@GB5PK#H1D<'WH X&\60:[?>%F\17%@L&G)+93W5U(97+M)ODW
MAUW[2$&&R  /4TG]K27KZ_::AK,HFTS2X);:6&5K7SBT)9KC:",Y?C!R!MQW
M.>ZU#1=*U9H6U'3;.\,#;HC<0+)Y9]5R./PJKKOA^RU>WED:PLI=06!XK>XG
MB!:+<",AL$CKGB@#D] U&YDUKPVMYJ%QY%WX6\^<27#!7D!AR_7AL,WS#GDU
M3T#5+^ZL/AU/)J5U(UW+<1W),Y(F AE(W\_,05'7TKL]+\-VD6A:+9ZK965W
M<Z7!''%*T0?8R*%W(6&5)V@__JJ['H.CQ+;K'I5B@MB6@"VZ#RB>I7C@_2@#
MSI+J^T_PGX@\0?VMJ4D]EJ5W:*)+AI(XH/M00ML[E$!(/4?2I?$1NK#PMXEO
M]/\ %;W$;6"3P16TTC&!@<;UE,C$!A_#G!VDCO7HMMI>GV<,L-K8VT$4Q+2I
M%"JJY/4L .<^]5X?#FAVUA+80:-I\=G*V^2W2V01NWJ5Q@F@#D[C3Y7\<7^D
MG5M6%G-HZWCHM](I$PD9=RL#E.,?*N%X'%9.DZ[>:W:^'M/U+6/L9O= CN4G
M:5XC/.3AR&1U)90%.,_Q$XKT@Z-I9G,YTVS,QB\DR>0NXQ_W<X^[[=*AG\.:
M'=64-E<:-I\MI VZ*![9"D9]54C _"@#B[.WO+[Q/8:7=^(K^\@?0'DDGM9G
MMUG=9D42@*<@D<Y!Y^AP<_09WU74/AWJ.HW<[W$VDW322FX=-[+Y6"<$#)R<
M^O?->EOI.G27(N7T^U:<1^5YIA4ML_NYQG'MTIB:'I,:6J)I=DJ6C[[=1;H!
M"WJG'RGW% '(^%]0OXO$=M9:O]HDEN;6:6TOH;II;6]3<C;BA/[IU!'&,88X
M/058\664-SXZ\&F1YU+SW*GR[B2/@6[GC:PP?<<D<=*ZFSTG3=/<O9:?:VS$
M$9AA5#@G)' ]>:=<:987EQ#<7-E;3SP_ZJ26)6:/_=)&1^% 'G-]J^I7/A3Q
M+K4-Y=0ZUI>IRQ00+*P0!)%$<1CSM8.I'49)?(/3&SH]M<:AX]\0_:-3U(1:
M?<6TD-LMTPC7=!EE*]"I)SCIQ75OI&FR7_V]]/M6O./WYA4OQT^;&>.WI3X-
M.L;:[FNH+.WBN9_]=-'$JO)_O$#)_&@#D_$]O"_Q"\(R32RH-MYDK</&.(P1
MT('KGU'!XKF;7S[&W;4K:^NXI?\ A,Y;<QI.PB:.2Z*.K(/E;(/4@D'H17J=
MU865\T+7=I!<- _F0F6,.8W_ +RY'!]Q5;_A']%\KRO[(L/+\WSMGV9,>9_?
MQC[WOUH XB*^NM:U#4)#XD73+[3M8:(VY+DF)7PB>5O"L)$Q@[2<MQR*W_B'
M<7%IX,N;FUN9K::.:WVR0R%#@S(I&1V()%;;Z+I4FJ)JCZ;9MJ"#:MT8%,JC
MI@/C-37EC9ZC;FWOK6"ZA)!,<\8=<CH<'B@#S/Q))?*?B#<QZOJ43:5##<6:
MQW3JL3^3OZ \@GJIR.>E;>M:A=Z#XHT_43)<SV6K6K6BVWG/Y:7F-T6!G"[P
M&7/8@>IKJ6T+1W^T;]*L6^T@"?-NA\T#INX^;'O5K[);>5%%]GB\N$@Q+L&$
M(Z$#MB@#CT$W_"96WA>\O;PVL6C">.07,B/<3>9MD8N&W$J-IQGC?],9&CZK
MJ]PW@EKR^N&:34;VUD8/M6[BCCG$;NHX.=BG/XUZ'>Z98:D(_MUE;W/E$M'Y
MT2OL)X)&1QQ22:7I\SVSRV-L[6O_ ![LT*DQ=OEX^7\* .,\+Z@FN6FGZK<:
MY<V^J)?S175FLY*LP9U\@Q$X 4!3D#.%R3R357PK?76N)HFM-XD6*[:5TO=/
MR[&1SD-"8R^$*$9!"@@+D\$UW46C:7!J<FIQ:;:1W\HVR72P*)7'H6QDT0:+
MI5MJ4VI0:;9Q7\PQ+<I JR./=@,F@#&\3W2C6-&T\7<Z2W'GN+=)S DJH@RS
MR+\RA=P.!G)(XP,CC_#]]?:V/ \=SK%\RWEE>K=^3=,IE,90*6*G.[!^\,'G
MK7IMYIEAJ+0F^L;:Z,#^9$9XE?RV_O+D<'W%0Q:#HT#Q/#I-A&\6XQLEL@*;
MCEL<<9/7UH \^T77+R6V\)Z5?7]R;>[O=0MY;EIF$DOD2.L,;2 YR0,]<MLQ
MSDYW_A['' OB:&.5Y%CUVX +R%V^['U)Y/X\UT#^'M%EL#8/I%@UF7\PVYMD
M\LO_ 'MN,9]ZL66F6&FJZV-E;6JR'<X@B5-Q]3@<T <"6U!+WQOJ,.HZE-/H
MTSR6-K]H8Q%OL:ML*?Q LV0#T(X[Y@FU*\L]!NO$>C>)5ORVC2RI9 O-O=0&
M$V&=MA7D$  '.,=*]&M].L;2>:>VL[>&:<YFDCB56D/JQ R?QJ*PT32M+DG?
M3],L[1[@[IF@@5#(?5L#GOUH XO5M2ATOP_>ZYH?B"ZNP^F+((6F-PJKO&ZX
M&22K!6/ P#CIQ4.I>?:Z!XEU"P\5-<POHTEQ!#;S2.89$5BLJR-(Q4'@;> =
MI([UW5AHNE:5'-'I^F6=HDYW2K;P+&)#ZL .?QJ.V\.Z)9V4]E;:/I\-I.<S
M01VR*DA_VE P?QH Y+4=1N= OO#NO37%Y/87=I]CN8!,[+YS(&B<+G&YBI3/
MJXJS=QWNF>(?!=F^H7;&>2Y2[7[0[+*WV=VYR>0&Z9Z8'I77BRM1;1VPMH1!
M$5,<00;4*D%<#H,$ CTQ3;C3K&[N(;BYL[>:: DQ221*S1YZ[21D?A0!YCIU
MQ?Q:;H6IG5]1EN&\2S6+"6Z=D> SS)L9<X;@#!()&!@@<5=DDU?5=0N[2'4;
M@7T6OA?,@NRD0LAC<F V,A<J1C=OY]Z[D:!HPB2(:18"..3SD06R85_[P&.&
M]^M<D_P^:[N;D:E:Z!=^?+)(=1:PQ> ,Q(^;. R@X#9XP..U &I\1IKBT\!:
ME<6EW/:SQ",I-#(58?.HZCV)K)U$&P\46_AZ76KJ"UN[6:ZBEN[N3=),7 9%
M=74C:O(7./F/' QW%W86FH6QMKVUANH#@F.>,.IQTR#Q4-_HNE:I:QVNH:;9
MW=O$08XIX%=4(Z8!&!0!P5I:WM]XFTK1KOQ1J%W ^AS/+<6DS6_VATF10XVG
M(.#]X'GUP2##X6U?5-0O- T;6;VY>VEM[XQW2RM&]ZT4X2,EE(/^KRW!YSFN
MJO/"PO?&5KJLUM8RV%O8/9K!(N2"S*VX#;@8"[<>A_"MRXTK3[RVBMKFQMIH
M(2#%')$K*A P-H(XP/2@#S2*ZU:[DT6QN-5OUA'B&\TY9XYRCW-LD<I7<PZD
M%=N[KE<]>:V- L[32?B'XB$U]<E;;3K#$MW>.Q8!9]S/EL-PN>1QR>,FNQ?2
M-,E%L)-.M'%KS;AH%/D_[G'R_A27FCZ?>R2S36%G)<R0-;F6:!7)C/5#GDKS
MRN<&@"+6-0EM_#%_J6FJMU-'9R3VP0[A*P0LN,=03CI7(6EW=++X*O;#4;JZ
M75XREZKSLZR*8#(90"<(58#[H ^;'I7<:;I]OI.FV]A:KM@@0(@P!Q]!P/H.
M*9:Z/IEE))):Z=:0/)D.T4*J6R<G.!W/)H Y?X=6\]SH<.KW>IZC=7#O<P%9
M[EGCVK<.%.T\;@%QGKCCIC&9?6\*>+O'4C2RB3^QH"BFX?!)CN,_+G!''3''
M)&.:] LK"STZ PV-I!:Q$EMD$81<GJ< =:CN-(TV[N&N+G3[2:=HC"TDD*LQ
MC/)0DC.WVZ4 >=:-->Z-)X7-G<W=Q]M\-2RO;2S,\;211PF/:G13\Q'R@9SS
MD\UI>$;B34Y="UF+Q0LZW5JPN;(%W\YRH))!<B)D8'.U0.<>E=E%HVEPRV\L
M6FV<<ELNR!T@4&)?13CY1["DL]%TK3[N>[LM-L[:YN#F::&!4>0]?F(&3^-
M'->+[S_B:BQBOKB.9-,N+DPI<M;QJ 5 E9U^8D'("\CDDXP#6!HLEWXGU/0[
M:[UO4DCN_"\5U.+6[,1:;<@+Y7D'GM_(D'T>ZTK3KZX@N+RPM;B:W),,DT*N
MT>>NTD9'X5SY\&VQ\66]\+#31I4&GM9QVHB V$OOW!=NT#J,>Y^E '):-<:M
MJ[>#;74=8U!1=P:A',\$YB-RD3 1.2.<E>=PYYSFEMI;XP:!;7MW->)9^+Y;
M6VN9VW/+"D<P!9OXB#N7/^S79:OX9.I^)=#O3!9M8:;',A@D&2?,"@;1C V[
M/U[5LOI&F21VT<FG6C):G-NK0*1$?51CY?PH \]O=>O-*/B/S;^X%FGB*UM9
M9WE)^RV\D<)?:?X!EB,CINR.:U=3EMM-B>"W\0WTZWFIVR10+<;]K,,^2)B=
MRJVTL><@'@<@'K!H^F!;I1IUH%N_^/D>0N)O]_CYOQJ(>'M$72QI8T>P_L\-
MN%K]F3RLYSG9C&<^U 'FDMW<:AHJ6MQ?.S6_C&*WC=;@RM$F]2 ';DX)."?Z
M4[Q)'=V&@?$#2OMUW>:9;VD$L#7<S3/#(X)>/>V21@(V">-WO7IAT+2#!/ =
M*LC#<,&FC^SIMD(X!88Y(P.OI3FT?3&L&L&TZT:S8Y:W,*F,GKDKC!H XK6;
MR?5?$>O:._B!=%EM+>&2S<R.A"E=QE #J' ?((;(^4#C)STVNR3KX'U"9;J1
M;A-/DD%Q$#$V\1D[@.J\C.*N76A:1>RVTMWI5E/):X^SM+;HQBQ_=)'R_A5R
MXMX;NW>WN88YH9!M>.10RL/0@\&@#SVQ%UJNO>&[.XU345M[OPV9YTBNWC\Q
MP80&R#D-\QY!!]\$YJ6NIZC#X$\*^*[G4+N5+&0+J0,[;9K<LT9=P#ABAVOD
M^AS7H::)I4<D<B:99*\4?E1LMNH*)_=!QPOMTI\.EZ?;V#6$-C;16; JUND2
MK&0>H*@8YH X^[O;N'4_#=O//=0V>MWD\D[&9U*?NRT,(.<IGC(!&2I'0D5D
MZM?ZK9Z#XIMX]0O/(TW5K6.RNO.;S-DC0EXR^<L%\QAR2><=J]*O+*TU"W-O
M>VT-S"2"8YD#KD<@X/I4,FCZ9+8BQDTZT>T5MP@:!3&#G.=N,9SS0!QTVH)J
MVL>)[*^URXTJYTVXA^R^3.4V0^6CA]F<2;F+@Y!XP*JW5]=:QJ6O0GQ(NCWN
MF7R"%&+DI$%1E/EAU617RPY!.3CL,=U/HFE7-];WT^F6<MW;#$$[P*SQ#_98
MC(_"B?1=*NM2AU*XTVSEOH1B*YD@5I$^C$9% &=XOO$M-)MU:[N+=KB]@@3R
M#M:5F<?N]V1L# $%@<@9QSQ7"R:IJ+:!JL:ZK<136GBF"UB:&[:1DB9X-R;V
MY9?G<?,/;'&*]1O;"SU*U:UO[2"ZMWQNBGC#HV.1D'BJQ\/Z*RNIT?3RKNKN
M#;)AF484GCD@  'M0!Y[J>L7GAZ^\06$>H7?V!=1TV-IY[AI&M(I\"5@[$E1
MQQSA2V1BMW0+>&T^*'B.**:60-IUBV)9VE(^:;@%B3CH?QKJ&T;2V:Y9M-LR
M;I=EP3 O[Y?1^/F'UI+#0])TM]^GZ796C[!'N@@5#M'.,@=,D\4 <Q?VLVH_
M$Q]/;5-2@M!I,=SY-M=-&/,$Y&>/4#!'>LWP_?76N-I^JMXD6VO8M0DBN[#+
ML7^9E,!C+[5P,$,%R N>Y-=__9UC_:']H?8[?[;MV?:/*7S-OINQG'M44>BZ
M5%JCZI'IMFFH2#:]TL"B5AZ%\9- '%^&-3_MC1M)UUM9N1JQ,PN=/$Q*RRX;
M,)B)PNP@$$ '"Y)Y)IGA*YFUI= UD>* SW-NZ7EDK.QFD*98;2Y$3(P/*J/3
MN*[>#1M+M=1FU&WTVTAOIQB6YC@59)/]Y@,FDM]#TFSO+B\MM,LH;JYR)YHX
M%5Y<]=Q R?QH \[M+W48?AWHWB5]0OYCIE_-)>@W#GS[87$B/N&?FV+AAGLF
M.E:OB*>[B\+1:O!>WD+WFK6DB!9W $+SQH%QG@,AR5]6-=G!I>GVUB]E;V-M
M#:.&#P1Q*J,&ZY4#!SWIUWI]E?PK#>6=O<Q*P94FB5U!'0@$=: /-/$DM\G_
M  L&YCU?4HFTJ.&XLUCNG58G\D.> >5)ZJ<CGI6AXAO=2N-6UJRBO)Q.^DQ/
MIBVMSY7E7#&3E^1U(0Y;(VJ1WY[5]#TB4W!DTJQ?[3CS]UNA\W'3=Q\WXUS.
MJ>"GOM:GN'L?#U]9R*B0QZAI^][157&U"."N<MCCECSTP ;TMO/;>$Y(9;F4
MW,=HVZ=9#NWA<DANO6N"L[RXT[PUX0O+K6[P)KB6Z7MS>7+LB-]G9E (8%-S
M8!((R0,]3GT6PTBUL=%ATHQI+;1Q^64= 5(]-IX"]@.PP*<^C:7)IATQ]-LV
MT\C'V4P+Y6.OW,8_2@#S^YAOK6ZT&P'BFZNH;C6YH&DMY64I$UN[B$N68OM(
M&&)R,CN,U7CU+5-(U.30Y-0O)]'_ .$ABLA?33,TJQO!YGE>9][_ %A5=V<\
MXS76ZUX3CO9= ALK2PBT[2[HSM:E-J,/+=-JJ%P/O[OJ/QK=;2M/;3VT]K&V
M-DV=UN8E,9R<G*XQUYH \V\17FJZ?8^,K.VU*]2UL9+&2SN!.QDB:5AYD>\G
M)&,'!)QO],5IW^CV^G?$3PPK7VH2J\-_(7N+Z1B"/*( ^;IR>/3@\ 5V;:+I
M4EB;%],LWM"VXP- I0MZ[<8S[U)-IMC<-;-/96TK6K;K<O$K&$],ID?*?I0!
M+;W5O=QF2VGBFC#%2T;A@&!P1D=P:\V&MR_\)!HMW;:I<26MUKEU:R/-<E1(
MBI+E!#]T(A10&X8XSCYN>^TC1K3189X[2&*(7$[3R+%&(TWD '"C@< ?7J>3
M2#P_HHN&N!I%AYSS"X:3[,FXRC.')QG<,GGKR: .3T+4+^#Q5;6FJ_:)1=FX
M>RO[>Z:2VNDSNVO&3^[=5X&!C@\U8\;W&IVMP+BT6:[L8+.1KNUM+MK>YC4G
MB>/! ? 5AM)^G6NIM=)TVRF,UII]K!*<Y>*%5/)R>0.YY/K1=Z3IU_*LMY86
MMQ(JE \L*L0IZC)'3VH \_99/$&M^(T7Q!JMK9QZ79W=LT5TT7E,ZRG?@?[H
M)'0]\X&*NGZQJGB**+3M7UG^Q[Z30K6ZA=G>)F=P^^4;74$@A<J<@>G)KKXO
M"J2>,-4U>_M;&YMKN""&)'7>T?E[_5<<[NG^R.O;9U#1=*U9H6U'3;.\:!MT
M1N(%D,9]5R.* .(CU ZKJ6JZ1JGB*:TEM=-M9;6[AE-MO#(2]P%S@_.,$'(
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MVYR<BO2*HG1=*;51JK:;9G40NT79@7S0,8QOQGI[U>H **** "BBB@ HHHH
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M9XZUMT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% ".BR(4=0RD8((R"*9#!%;QB.&)(T
M'144 ?D*DHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %9>O6MY>V,4-E'"[K=6\S>;(4&V.5'/0'DA2!6I10!R>O>#AJ/B+3
M->L9OLMY#-$+Q1]VZA5PP5O]I2 5/U'?C0ELM5@T/418^1_:UW)(X>20JJ%O
ME0Y"G[J!!TYVUN44 <1XA\#B70[ >';6UM=6T^>&>UDEE8(A0C<"0"2"N5Z<
MYKM(C(T*&9%20CYE5MP!]C@9_(4^B@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M'\1ZRVD6=LL(5KN^NH[.V#?=#N?O'U"J&8COMQWK8KE?&]G(ZZ'J:@F/2]4B
MN9_:(AHW;Z*'W'V!H O-?00>)[73WU.[:Y6QDE-J8,I,H9 9"P7[P)QM4_Q=
M*S;37+&72]"E37[^1+R_>.&=K7!NF#2 Q/\ ( @X/93A.O6K5WI]Z_Q T_5H
M[8O90:=/;O('7.]WC88!.<8C/YBN>L?#FM0>'?#%G)8$3:?K3WEP!,F!$6F(
M(.>3^]''L?;(!U5EJSQ^*+O0+I]\BVZWMM(0 6B+%64X[JP'/<,O<$G+\=:Q
M=Z-+X?:#4S8V]YJ:6ERY6/ C9'8G+J<'*CGI4L=F]Y\49=20?Z/8:5]C9NQE
MDD#E?J%12?\ ?%'C'2]0U.]\./96AG2PU1+R<[U7"*CJ0,D9/SC\NM %BPU6
MWMH+O4)?$']HZ=OCAB?8C$2Y(*J8U&_)9   3G(J2?QAHUK9:E=7,TT(TP!K
MR-H'\R($9!*@9*D=&&1P>>#5?Q9H-SJ.G6LFE)&MW9ZC#J(A8[5G*'E">Q*Y
MP?4"L3Q'X8U/7(?$M_#9M#<ZCI*:;;VLDB;L@NQ=R&*CEP!@DX!]<4 =GIFK
M6NKQ326HGV12&,F6!X]QP#E=P&Y2",$<&J8\5:2U];VHFD+7+R1V[B)MDSQ@
MEE5L8)&#]<'&<5JVQ<VL7F1M&^P;D)!*G'3CBN1\'6/B+1;*UT"]L+8VE@S+
M'J0G#>=%D[<1XR'P0#GCJ030!LP>+-'N;;3;B*XD,.I3M;VK&!QOD7=E3D?*
M?D;KCI3O^$FT]@[1BYE4)*Z-' S+((SAPIQ@G/'OU&1S7&V7AWQ%;V7A_3CI
ML7EZ3K4ET\YN5Q+$QG(91U'^L&0><]B.1?TOPSJ-KKAN;2&;3+6Y2?\ M"T:
M=9+:21ONR1+DE&).3T&..: -G2/%]GJ>@:7J+13QRZC&'AMA$Q=CM#':,<@
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MHHH **** "BBB@"I_9=C_:G]I_9D^W>7Y7G_ ,6SKMSZ9YQZ\U;HHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(6E,^H,KW&]\@E5"K@=L* .*T:* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ***H:OJL.D6/VB4%V>1(88E/,LCL%11]21SV&3VH
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MEQ?99+6SM[>:*>"7?O\ ,,@(/88\OH/6MA]0LHI)(Y+RW1XEW2*TJ@H/4C/
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MP'J1QGTR!C)R 6*XCXC0_:F\,0^5<2*NMP2S&!7S'&%<%BR<J!D<Y'6NWHH
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M2/!RHE(;@<[-P[&O1M6T*'5[S3;F6YN(FT^X^T1+$5P7VLOS94Y&&8=NM:M
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M+Q)+;EOL]LV\P(^1\O5< ].!U%=9\/8C;Z-J,'DR01IJUX8HWC* 1M,S*5!
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MYQCS_*\P<=>^/UH [.BN4@\8+/XDNM+9[6%[29UGMIB4G\E4+"9,\.I(' '
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M(M_/BD8B8E%?.TCY>'&1N/.:Y]M)TV]^,U\MUI]K.IT*%R)858;C/(">1UP
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M*'UU[O?*]DEFT0CPNU6+!NN<Y8_A^=5O&/B8>&M!N;R VLMY&H9+>:;:64L
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M6D^'_"-Y=0:C'IMO]LBN_(MB\EO([YC=HRI.-N\9 XW^]>O44 8GA.QL]/\
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MQ9V]WJ_A/S[07"IJF93Y)<+&890=W'"[BG7CI6%JEI96VO:WH.KV.I)I=_'
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9** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>exhibit1027supplycontrac022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac022.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M6X@CADE1$$IX=R0% '<Y(XH Q_AWI]QIG@;3X;J-HII#+<-&PP4$LC2!2.Q
M8 CUKJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-%%YKF*)VSN9(R=JD[FZ =3ZFI].T6PTF:[ELHI(WNY3-.6F=][D %L,2 <
M#CT% &3X[L[Z[\'ZG#I\%I*TD+>?'<$KYL0'S*&'1BN0#VS6;XQNTO\ X;V-
MY'"84N+C395B;J@:XA(4_3.*Z2Z\/:=>WTEW<)<.\L8CD3[5*(I%'9HPVQNI
MZCG-3:IH]CK5FMI?PM) KK($65D^92&4_*1T(!_"@"]12*H50HS@#')R?SI:
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!D'PMH+:B^H'1[+[6[[WE\D99O
M[Q]3[]:UZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+6/_  5W'_Q%;=% &)_PE%G_ ,^6L?\ @KN/_B*/^$HL_P#GRUC_ ,%=Q_\
M$5MT4 8G_"46?_/EK'_@KN/_ (BC_A*+/_GRUC_P5W'_ ,16W10!B?\ "46?
M_/EK'_@KN/\ XBC_ (2BS_Y\M8_\%=Q_\16W10!B?\)19_\ /EK'_@KN/_B*
M/^$HL_\ GRUC_P %=Q_\16W10!B?\)19_P#/EK'_ (*[C_XBC_A*+/\ Y\M8
M_P#!7<?_ !%;=% &)_PE%G_SY:Q_X*[C_P"(H_X2BS_Y\M8_\%=Q_P#$5MT4
M 8G_  E%G_SY:Q_X*[C_ .(H_P"$HL_^?+6/_!7<?_$5MT4 8G_"46?_ #Y:
MQ_X*[C_XBC_A*+/_ )\M8_\ !7<?_$5MT4 8G_"46?\ SY:Q_P""NX_^(H_X
M2BS_ .?+6/\ P5W'_P 16W10!B?\)19_\^6L?^"NX_\ B*/^$HL_^?+6/_!7
M<?\ Q%;=% &)_P )19_\^6L?^"NX_P#B*/\ A*+/_GRUC_P5W'_Q%;=% &)_
MPE%G_P ^6L?^"NX_^(H_X2BS_P"?+6/_  5W'_Q%;=% &)_PE%G_ ,^6L?\
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M_P#$4?\ "46?_/EK'_@KN/\ XBMNB@#$_P"$HL_^?+6/_!7<?_$4?\)19_\
M/EK'_@KN/_B*VZ* ,3_A*+/_ )\M8_\ !7<?_$4?\)19_P#/EK'_ (*[C_XB
MMNB@#$_X2BS_ .?+6/\ P5W'_P 11_PE%G_SY:Q_X*[C_P"(K;HH Q/^$HL_
M^?+6/_!7<?\ Q%.C\3V$ES!;M#J$+SN(XVGL)HU+$$@;F4 =#6S6)XB_UFC?
M]A*/_P!!>@#;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCZ7)$'FN)IXS.^S)!5S\PP5)R,'-=;2  $D #/)]Z6@ HHHH **** "BBB@
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M, *AXI' *PCGYI?F'RCU'(R,W;;0S'XGGUJXN!/(;..T@!3!C4,S.?3+$KT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#0KZE_W_MO_CM']LZG_P!"OJ7_ '_MO_CM;5% &+_;.I_]"OJ7_?\ MO\
MX[1_;.I_]"OJ7_?^V_\ CM;5% &+_;.I_P#0KZE_W_MO_CM']LZG_P!"OJ7_
M '_MO_CM;5% &+_;.I_]"OJ7_?\ MO\ X[1_;.I_]"OJ7_?^V_\ CM;5% &+
M_;.I_P#0KZE_W_MO_CM']LZG_P!"OJ7_ '_MO_CM;5% &+_;.I_]"OJ7_?\
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M[6U10!B_VSJ?_0KZE_W_ +;_ ..T?VSJ?_0KZE_W_MO_ ([6U10!B_VSJ?\
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M:F-9(C(?O.H/*L>_.#UQ6W;6XMH1'YDDC9):20Y9B>I/;\!@#H,"@":BBB@
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MK;K$\1?ZS1O^PE'_ .@O0!MT444 %%%% !1110 4444 %%%% !1110 4444
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M3[1XH_Z!FC_^#&7_ .,4?:/%'_0,T?\ \&,O_P 8K;HH Q/M'BC_ *!FC_\
M@QE_^,4?:/%'_0,T?_P8R_\ QBMNB@#$^T>*/^@9H_\ X,9?_C%'VCQ1_P!
MS1__  8R_P#QBMNB@#$^T>*/^@9H_P#X,9?_ (Q1]H\4?] S1_\ P8R__&*V
MZ* ,3[1XH_Z!FC_^#&7_ .,4?:/%'_0,T?\ \&,O_P 8K;HH Q/M'BC_ *!F
MC_\ @QE_^,4?:/%'_0,T?_P8R_\ QBMNB@#C?%D_B,^#M<$VG:4L1T^?>R7\
MC,%\MLD PC)]LBM?[1XH_P"@9H__ (,9?_C%'C'_ )$?7_\ L&W'_HMJL_\
M"0Z*5O&_M6SVV7_'T?.7$'^_S\OXT 5OM'BC_H&:/_X,9?\ XQ1]H\4?] S1
M_P#P8R__ !BKIUK2UT^+4#J%J+*8J([CS1L<L<+ANAR>GK2R:QIL5ZMG)?0+
M<,P01EP#N(R%^I'('4T 4?M'BC_H&:/_ .#&7_XQ1]H\4?\ 0,T?_P &,O\
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M Q/M'BC_ *!FC_\ @QE_^,4?:/%'_0,T?_P8R_\ QBMNB@#$^T>*/^@9H_\
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M (Q1]H\4?] S1_\ P8R__&*VZ* ,3[1XH_Z!FC_^#&7_ .,4?:/%'_0,T?\
M\&,O_P 8K;HH Q/M'BC_ *!FC_\ @QE_^,5FZI+K;WFC"_LM/A@_M"/YH+QY
M&SM;'!B4?K76UB>(O]9HW_82C_\ 07H VZ*** "BBB@ HHHH **** "BBB@
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M10 4444 %8GB+_6:-_V$H_\ T%ZVZQ/$7^LT;_L)1_\ H+T ;=%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<W
MK,=]+XNTE=/NH+>7[#>$O/ 905WV_& Z\].<_A725BW7_(ZZ5_V#[S_T9;4
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MLQWFC-?:C97$/]H1_)#9-$V=K8.XRM_*NMK$\1?ZS1O^PE'_ .@O0!MT444
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M,9+<1EB-]OQ\ZL,?AGBNDKF]<OAIGB*TOFADF2WTJ^E9(\;B%>W)QD@=!ZT
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M\9XI<\;7+^KU.9QMJK]NFY!_8=__ -#3K'_?NU_^,4?V'?\ _0TZQ_W[M?\
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M2 SB0;=FP$ ]\YR1VHYXC>&JK==&_DMRM_8=_P#]#3K'_?NU_P#C%']AW_\
MT-.L?]^[7_XQ6W15&!B?V'?_ /0TZQ_W[M?_ (Q1_8=__P!#3K'_ '[M?_C%
M;=% &)_8=_\ ]#3K'_?NU_\ C%']AW__ $-.L?\ ?NU_^,5MT4 8G]AW_P#T
M-.L?]^[7_P",4?V'?_\ 0TZQ_P!^[7_XQ6W10!B?V'?_ /0TZQ_W[M?_ (Q1
M_8=__P!#3K'_ '[M?_C%;=% &)_8=_\ ]#3K'_?NU_\ C%']AW__ $-.L?\
M?NU_^,5MT4 8G]AW_P#T-.L?]^[7_P",4?V'?_\ 0TZQ_P!^[7_XQ6W10!B?
MV'?_ /0TZQ_W[M?_ (Q1_8=__P!#3K'_ '[M?_C%;=% &)_8=_\ ]#3K'_?N
MU_\ C%']AW__ $-.L?\ ?NU_^,5MT4 8G]AW_P#T-.L?]^[7_P",4?V'?_\
M0TZQ_P!^[7_XQ6W10!B?V'?_ /0TZQ_W[M?_ (Q1_8=__P!#3K'_ '[M?_C%
M;=% &)_8=_\ ]#3K'_?NU_\ C%']AW__ $-.L?\ ?NU_^,5MT4 8G]AW_P#T
M-.L?]^[7_P",4?V'?_\ 0TZQ_P!^[7_XQ6W10!B?V'?_ /0TZQ_W[M?_ (Q1
M_8=__P!#3K'_ '[M?_C%;=% &)_8=_\ ]#3K'_?NU_\ C%']AW__ $-.L?\
M?NU_^,5MT4 8G]AW_P#T-.L?]^[7_P",5FZIIEU:7FC2S:YJ%XG]H1CRIT@"
M_=;GY(U/ZUUM8GB+_6:-_P!A*/\ ]!>@#;HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD?&#*EV[,0 -!U+))
M]X*ZZL.^BCF\9:6DJ*Z'3[S*L,C_ %EM0!P]@D5SIOPM@:YF6*>T\N2.*X9
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MRQQ_R\(?Y UT.BZ7<Z?#(]_??;[^;'G7/E"(,%& %4$[0.3C)Y8GO5^:W@N
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M: )865X8V5"BE00I7:0/3':GT44 %%%% !1110 4444 %%%% !1110 4444
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M444 %%%% !1110 4444 %8GB+_6:-_V$H_\ T%ZVZQ/$7^LT;_L)1_\ H+T
M;=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-KK_ ..4?\(KIO\ SVU7_P &UU_\<K;HH Q/^$5TW_GMJO\ X-KK_P".4?\
M"*Z;_P ]M5_\&UU_\<K;HH Q/^$5TW_GMJO_ (-KK_XY1_PBNF_\]M5_\&UU
M_P#'*VZ* ,3_ (173?\ GMJO_@VNO_CE'_"*Z;_SVU7_ ,&UU_\ '*VZ* ,3
M_A%=-_Y[:K_X-KK_ ..4?\(KIO\ SVU7_P &UU_\<K;HH Q/^$5TW_GMJO\
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M]M5_\&UU_P#'*/\ A%=-_P">VJ_^#:Z_^.5MT4 8G_"*Z;_SVU7_ ,&UU_\
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MT4 8G_"*Z;_SVU7_ ,&UU_\ '*/^$5TW_GMJO_@VNO\ XY6W10!B?\(KIO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^A<TC_P!B_\ B:VJ* ,7_A#_  Q_T+FD?^ ,7_Q-'_"'^&/^A<TC_P  8O\
MXFMJB@#%_P"$/\,?]"YI'_@#%_\ $T?\(?X8_P"A<TC_ , 8O_B:VJ* ,7_A
M#_#'_0N:1_X Q?\ Q-'_  A_AC_H7-(_\ 8O_B:VJ* ,7_A#_#'_ $+FD?\
M@#%_\31_PA_AC_H7-(_\ 8O_ (FMJB@#%_X0_P ,?]"YI'_@#%_\31_PA_AC
M_H7-(_\  &+_ .)K:HH Q?\ A#_#'_0N:1_X Q?_ !-'_"'^&/\ H7-(_P#
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M\I.<9P<>AKK=!U3^V_#^GZI]G>W^V6Z3^2_5-R@X_6@"K_PA_AC_ *%S2/\
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M_H7-(_\  &+_ .)H_P"$/\,?]"YI'_@#%_\ $UM44 8O_"'^&/\ H7-(_P#
M&+_XFC_A#_#'_0N:1_X Q?\ Q-;5% &+_P (?X8_Z%S2/_ &+_XFLW5?#VBZ
M;>:-<6&CZ?:S_P!HQKYD%LB-@JV1D#-=96)XB_UFC?\ 82C_ /07H VZ***
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M6[Y/PV_N^%?_ "7H\GX;?W?"O_DO0!S.J6]Q96%P]U8SA9O&4%S$C1\RQLZ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4C*K?>4'ZBEHH 9Y4?\ SS7\J/*C_P">:_E3Z* &>5'_
M ,\U_*CRH_\ GFOY4^B@!GE1_P#/-?RH\J/_ )YK^5/HH 9Y4?\ SS7\J/*C
M_P">:_E3Z* &>5'_ ,\U_*CRH_\ GFOY4^B@!GE1_P#/-?RH\J/_ )YK^5/H
MH 9Y4?\ SS7\J/*C_P">:_E3Z* &>5'_ ,\U_*CRH_\ GFOY4^B@!GE1_P#/
M-?RH\J/_ )YK^5/HH 9Y4?\ SS7\J/*C_P">:_E3Z* &>5'_ ,\U_*CRH_\
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MZ* &>5'_ ,\U_*CRH_\ GFOY4^B@!GE1_P#/-?RH\J/_ )YK^5/HH 9Y4?\
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MVC&"VPC!7<"O!ST.* ,N/P5+)\-XO#37K0W$D<9GN)5\YMP96(/(SC:%!ST
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MXI:R+&\@MRVDVT>Z2$R98/,3C##E0P)'/WA7<;UR!N&3G SZ4!E894@CU!H
MXF;X>>7$EKIVJFVLO['.DM%+;B5@ISF1&W#:QS\W!S@=,"H=5TJTU.#1_"4L
MMU/J.GM#(]U';/$BPA2K_/@KATW)M#$Y8>AKNPZLH8,"IZ$'BJ]_J-IIFGSW
M]Y.D5M I:1R>!CM]<\8]: ,Z_P!"EO/$VE:O'=QQ+I\4T8@,!;?Y@4$[MPQC
M8.WK6/%X'NHM(L;#^UHC]DU8ZIO^R'YB96DV8\S@9<C/IBNSJGJ5ZUEI=Y=P
MQI.]M$TGEE]N[:,XS@X_*@#!TOPIJ.CZE.MKKSKHDMRUT+ VXWQLS;V59<_<
M+$G&W/)&:K'P/='3FM/[6ARVM#5]_P!D/#>;YNS'F=,C&?2NCT;4QJN@:;J;
MHL'VVVBG\LMG:74-MSQGK6A0!B:7H4NEZ]J]^MZ'M]2E6<V_DX*2"-$)WYY&
M$'&!C)Y-):^'W@\3:OJLMU'+#J4$4+6_DD%!&& ^;=SG><\>E;;,JXW,!G@9
M/6@LJD L 6Z GK0!R.C^#+VPTYM%O->DO=#2%[>WM3;A)%C92H1Y 3O"J<#@
M=!Z5BC2=0T+Q+X)L;_6%U"&TFGCA;[,(F2/[.ZIYAW'<<X7/RY/;)KTFD+*N
M-S 9.!D]30!Q-OX$O;>+3K9=;C^QZ;JC:A;1_8_FPQD)1VW\\RG! ' Y![7=
M)\*:AHVH2I:Z\XT1[EKI+ VXWQLS;R@ES]PL2<;<X.,UU)95(!8 G@9/6AF5
M1\S =^30!R7_  A N-1%_?WD,EV+*:S>XM[;RI)TD &9#N.[:!QQUY]JV_#^
MF7&C:#9Z;<7:W3VL*PK*L/E@JJA1\N3S@<\]<].E6I=0M8=0@L'F474Z.\<6
M>2JXW'Z#(_.K&Y2<;AGZT <:G@>Z2WAB_M:$F+6VUC/V0\LS,WE_ZSIECS1>
M^ Y+T:LYU8PW-WJ$6I6LT5O@VLT:*BG!8AQA.1QG)KLE974,K!E/0@Y%5KW4
MK/3[5;FYG1(FD2)6S]YV8*H'J22!0!@:EX7U/6/#4VFW^MI)=SRQ2/<+:;8U
M$;JX58]_&2O)+$\GV @UGP9>:E=:X]OJ\=M#K5BMK=(;7>P9490R-O&!A^00
M>G!'6NNED2&)Y9#A$4LQ] *YO3/$&LZL--O+;1(/[)OXH[A;E[W#QQN,X9-O
M+8*G ..2,\#(!4_X0R^M[^XN[#68X3>V4=I?)+:;UE**561,.-C $CG</:H8
M? VHZ<FCS:3X@%M?6%@FG32O9B2.YA3[N4WC# Y((;N:[;<N<;ADG&,T;U#A
M-PW$9 SS0!RNO>#I-?L7T^\U".:T>!$S/;;YHI06)FC<, K'<.V!M';BM/Q+
MX?C\1Z#)ICW$EN^Y)(;A!EHI$8,C8/7! X[UKEE!P6 .<=>]!900"P!/0$]:
M .+O/ EQK5SJ$NN:K%<"^TQ-/E6VM3#MVNSK(I+M@@MG'/3\*O2>$FU5XW\0
M7D=^\=C-9(8H#""LH D<_,WS$*!Q@#GCGC=BFNC?W4<UO%':QJAAE$N6D)SN
MW+CY<8&.3G/;%60P)(!!(ZX/2@#D['PCJ*Z!<Z+JWB![^S:S>RAVVPB=8V79
MESN.]@O / ZD@GHFG^$M4M=3L=0N-;@GGM-.?3PJV6Q&5BA#8\PG.4&><'MB
MNM5E;.U@<'!P>AH9E12S$ #J2: .0T[P5<:?;^%H1JD;C0 X4FU(,P:-H^?G
M^7ACZ\U#)X"N3:3&'6_L^HKJTFJVMW';<0NX(9&4L=ZE6(ZCK6[J.N26'B31
MM*%JKQZD9AYWF8,9C0O]W'.?K6P'4L5# L.HSR* .9N?#.I7RZ1)>:TDMS8W
MXOI'^RX60A&0(JA_D7#$]6.>:J3>![B6WU%1JL:S7.L1:O"_V4D12(8\*1O^
M9?W8[CJ:[*D#*6*AAD=1GI0!Q.H>!+Z]?4L:\JI>W=M>YDLP[I)"8R%W;QF,
M^7D* ,$GGJ#=N/"-Q+<>(WCU54BUNW6.1'MMQC<1"+=D,,C:,XP.>^.*ZD,K
M$@,"0<'!Z4M '*VWA&YT_4+#4;'4HDO(-/33K@R6Q:.>-.4;:'!5@<\Y/!(]
M,):^"A87>@RVE\%32C<.RR0;FG>;.]B0PV\DG&#UKJ@RL2 P)'4 ]* RDX!!
M/IF@#'\-:')H%C<VTEVER9KN>ZW+%Y>TRN7(QN.<%C6#IO@>[TN?1YY=?66/
M29;B12UH%:5)0=WF-O.7Y^_QGTSS6I/XBO1XOD\/6VFP22K9"]$TMV44H7*8
MP(R=V1],=ZU["[GGL!/?6PLYM[JT9DW 88@$-@9! !' ZT <+X(T675_!^E1
MWEU']CM-0ENOLXA*R%UG=T#,6Z9(;[HR,=NJ>'M&?Q!8>(K">[B&FSZ[/++$
M(3YDD8D# !MV-K;1SM/&<'N/1)'V1LPVYQQN; )[#-9/AG7?^$@\-VVK2P+:
MF8R Q^9N"[79/O8&?N^E %2#PFID\2)?727-KKK9EA6$H8P8EB(W;CGY5'8<
MU#:^&9+2+2I-6U..[BT2-OLS>1Y9)V% \AW$$A"1P ,G/L.I+*HRS #U)HWK
MOV;ANQG&><4 >>> ]#GU+P3X4>_N8S#IJK/';K 5<3!650Y+?P[CQ@9./3G:
MM_"%Q#X/UC0&U*-O[1:Z/GBV(\L3LQ;Y=_.-YQR.U:.CZY)JFJZW8R6JPMIE
MRL&Y9-_F!HUD#=!CAP,<_6I/$NNP>&O#UYJ]Q$\J6R;A%']Z0]E'^>.M '/:
MAX#O+Z.[B&N+''=Z0-+F!M-Q4 ,-\9+_ "9W?,O.<#D<$6Y?!C75^)[K41)%
M-I/]EWL0@QYR98Y4[OD^\1C#<=\\UTMI=0WUG!=VT@D@GC62-QT96&0?R-2J
MRMG:P.#@X/0T <_X<T+5](CC@U'Q VI6]NGEVR_9A$VWH#(P8[V XSP.I()Q
MB74?#[WOB73]8BO!%]GMY;::%H=XFCD*,0#D;3E!S@\$\=ZVPZM]U@>W!I:
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M$("&$A4L2?7Y%Q^/6M>@#R7PLVDWR:;/=7FJ1^)=-MY4U"WCA5)%8H1*96V
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MG)>22!]+NHM@/F)*/W9;V$BJ">P<UVU% 'GO@G1WM@VC:G:QM!X;DE@AGDC
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MCH=P]:N7#II5MXH@T^-H])M=>MY;B"RC#;+8Q1>:53!!7>"6 !!PW'6O7J*
M/(=4M/#SZ,E[I5Y/=6EWKMA,9'58XE82*)#$%5<?*,L1QGOD&H]>L;&/2_B+
MI]C:P"UB-K<16\,8V(VQ?,95' /')%>Q44 <]KC32> M2;PR )FL939?9UV_
M-M.W8/7T_"N<L+SPMJ.D7^IZ)$T4ZZ.\%SM5HUB &0D@.!YF2?4]>QY]$HH
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M+Z"N_2WACO99\YN)5 ))YVKT 'IDG\ZL4 >9WOV634O%EEXABV/):Q'2_/\
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M5"F1@.6P.!D\X%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%<]XMU6:P@TRRMG,<^J7\5DLB]8U.6=A[[%8
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M&)& 7<1D?>'K6A?^)9H9M1CTW3)=1;3?+^U)$^')8!ML:X.Y@I#8) Y'.<X
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MYY.XUU5% %;3XKR'3X(K^XCN;I$"R31Q^6)#Z[<G&?3-6:** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "N'^+<L4?P[O$DF6,O<6H7+ $XN(R<?0 G\*[BC&: ,:"&UT2"^
MU6XU2>:T,(EDEN)-XC1 Q)!';!S_ /KK5@FCN;>.>%P\4JAT8=&4C(-/(!&"
M,@]J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO[GX::EJERS3S:7<!YY)BI=PL6,G/))S]>^:=I&N12>)/#-S9:DSPWSWRO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]M!I]_J$EL8Q<"RC5S%YGW<@L"?4X!P#D\4 ;E%06=P;NR@N6MYK=I8U<PS
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M&:80QM(8H$+R/@9PJCJ3V%,TW4(=5TRVO[<2+%<1B15D0JP![$'H: +5%%%
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M"P&3S92S22R[=OF2,Q9FQVR2>.PP*=>Z98:D(Q?65M=",ED\^)7VD\$C(XH
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MI1I!('P6)(!V XZ#MBJ>HW\>I>*M?T74=8FTK[-90R63QW)A(5@Q>8<@/A@
M<Y V].3GL8=.L;>ZDNH+*WBN9%"O,D2J[ = 2!DBH[S1],U&X@GOM.M+J:W.
MZ&2>%7:,^JDCC\* .'U6_CL/%>M7TM]/ D7A2.0W2Q R)^\F^<(>-W?'K6-J
MNJ7UG;>++:+4KF'R?#T-Y %U!Y9(Y?WOS;B<AB%4D*<=^>M>IR:5ITMS)<R6
M%J\\L9BDE:%2SI_=)QDCVJLOAO0EB$2Z+IPC$7DA!:ICR\[MF,?=SSCIF@#E
M]3MIM'E\+O!JNI2&^UB/S_.NV<.&@<E<9QMR@.WH#G&*AL+../Q/X_DCGNDD
MC$)5ENI,J3; Y^]Z]/3MBNVDTG3I4MTDT^U=;8@P*T*D1$=UX^7\*0:/I:R7
M$@TVS#W(Q.P@7,H_VCCYOQH \_T366OAX7TO6-2N((+SPY'<I-]I:)KBX(4.
M3(""653G&?XB3G Q'XAU%H=)O8+37[V[N;#P^UPL[7)MUSEPD^4_UCL4  QM
MP.OS<^@7'A_1;JRALKC2+":T@.Z*"2V1DC/JJD8'X5)<Z-I=Y.D]UIMG/-'&
M8DDE@5F5",%02. 1VH XG3_)O_B-97<]S+YD_AV-RR7+J"YE"G !QU/3IGWJ
MAX=UF^NK'P587U[=-;:B;[S[@SL'EDC9O+0N#GIN.,\[ .G%>BC1],#6[#3K
M3=;(8X#Y"YB0C!5>/E!'&!3?[#TG[ +#^R[+[&'WBW^SKY8;.<[<8SGO0!YU
M<7>K+#]B_M.^6"V\5PV-O<+.=\D#;2R,Q^_M+%<G/3!Z&NH\(M-!KGBG2S=7
M,]M97T0M_M,[3.BO!&Y7<Q)(W,<9/&:WY-(TR6WAMY-.M'A@;?%&T"E8V]5&
M, _2I+?3[*TGFGMK.WAFG.99(X@K2'U8@<_C0!QB075WXZ\38U#4F73H[2YM
MK6.Z=8RY20E2H/*L0,KT/Y55\+74^JQZ)K4'BN)YKBT<75FV]Q+*4R=RF0B,
MHX.=JCT[BN]BTZQ@O);R*SMX[J88DG2)0[CW;&351] L(5OYM-M;73]0O(V5
M[V"V02;B.&)Q\V#S@T <5X6DU'5I_#=Y_:%TRQ6<CZJ3>%HYY?EV%5#$$$[F
MX &T@'L!7T35I+K7_#7E:M=2V6JV=XSR379WS@%"CF/.V(Y)"A><<'&,#;T;
MP*EG=6D]UI_A^&6T966YT^Q\J>0KZN3D9[CG.2,UT<?AW0XB#'HVGH0[.-MJ
M@PS##'IU(X)[T >;:7?W=EX!\+:O<ZOJ,CZS/:6M_<37;%8HR6)9><(6.U"P
MP><YSS5B_7^SIOB<;*]N8YH-.@GCD%RQDC802,,,3NQD>O?TKT<:/IBZ:VFC
M3K06# AK40+Y1!]5QC]*AB\.Z)!!)!%HVGQQ2H$DC6V0*ZCH",<CVH XR>.X
MU'Q-):2ZIJ4=NWAR.Y\N"\>/$N]AO!4@@\#H>>^:CLM;N[JP\%3:E>RO;7NC
MM+<I#.8Y7FV18D.""1\S#CHS GU'=C1-)$GF#2[(.8O)W"W3/E_W,X^[[=*Y
M_6_!WVR\M&M+/0YM/@@,*Z??V(>*,ELETQT)P 1CMVYR :/@VTU&S\*6,>KW
M,EQJ#)OFD>;S#D]!NZ<#'3C.<5Q$EYJ!TA@NJWZ.GC$6:R"X;=Y)G5=F3U7'
M8\5Z#H&BP:#IQM8(X(U>0R&.VB\J)"<9")D[1QTSU)/>G_V!HWEE/[(L-AE\
MXK]F3'F?W^GWO?K0!Q)L-3NXO&VB:;JFH+-93PRZ>[WDC.CM DFPN6W%&;(P
M3@;CBEU'Q/=77@/4_%^EM<Q+]DABA0LQ\KYAYTFT\;DW,,D=8CV-=[!I]E:W
M$UQ;V=O#/.<RR1Q*K2?[Q R?QJ5+>". P)#&L1SF-5 7GD\>^30!R($]KXYM
M+"QO+J;2[_2Y99U:Y>3RF1D"2*[$E=P<C@X.,]17.^&->EOK3PA8:UJ5Q';W
M^C23^>URT;7%P&08,@()(4L<9YSGL*]'M=(TRQ@D@M-.M((I!M=(H556'H0!
MR.344WA[1+BPCL)M'T^2RC;>EN]LAC5O4+C - '+!YK;7_!=K#K=Y?02QW<4
MLSRX%R$C^5F X8@]&[]?>L/2[B^BTSPYJAU;49;B3Q%-8N);IV1X#-.NQD)P
M>%7!()&!@XXKTV33-/FF@FEL;9Y;<;87:)2T8]%../PJ :!HRQ1Q+I-@(XY/
M-11;)A7_ +P&.#[]: .%9]5U;4+FTBU*X%[%KY5I(+PI$+($93 ;J%^4C&=_
M/J:Z'XBSSVG@34;BUNI[:>+RRDL,A1A^\4'D>H)K,/P_:ZGN%U*VT"[$TKR'
M4&T__3,,Q/WLX##. PZ8'':NVN[&TU"V-O>VL-S 2"8YXPZG'3@\4 >>Z^MS
M<:YXUC_M74H8[/1X+JW2"[>,1R[9SN&TC^X..A[@\5W6AW,MYX?TVZF;=+-:
MQ2.WJQ0$G\S2MHNE.\SMIEDS3((Y28%)D0=%;CD>QJU!;PVL"06\4<,,8VI'
M&H55'H .!0!Y/=Z%<WM]XF^'T?F0VMQ(VKVTPX5$D!(4'MBY ..X!KK? >IW
M'B/3!X@O8FBF>".TVN,8:,'S2/3,A=?^V8KK!%&)C,(U\TJ$+X^8J,D#/IR?
MSIAM+8VSVQMXC ^[?$4&UMQ);(Z')))^M 'F7B6#5;O37\:65E!))972ZC:2
MBX/F-:1J04"[,8=#(^-W\?X5TGC. >)/ #:CI#B2X@2/5-/D7N\>)%Q]1E?^
M!5TPTZQ6P^P"RMQ9;=GV<1+Y>WTVXQBG6EE:V%LMO9VT-M OW8H8PBC\!Q0!
MY5)JE_%KFF>,K&.81^)XGT^.)ER(F*@VK$>A*NQ/8/6]XZLEL[/P586DIA6'
M7+6*)\!BH$4H!YZUW"VELL4,2V\0C@QY*!!B/ P-H[8''%17FEZ?J#Q/>V-M
M<M$=T9FA5RA]1D<4 ,TRTO+2.=;R^:\=YBZ2,H4A< !<#@8P>E<O)80S?%^0
MM)<JQT0/\ES(N#YQ'0-C'MTSSUKM@ !@<"JCZ5ITEXUX]A:M=,GEM,T*EROH
M6QG'M0!Y?IUY?67@#1-;EU;4I7U"[@M+Z>:Z9EA@-P0S@=$.,+N'.#Z\U=\4
M7&I:5_PF5E97]Z+*#0UOXI/M#E[:XS(-JN3N (0-C/';&:]#BTK3H+!["&PM
M8[-P0UND*B-@>N5 QS3%T72TL7L5TVS%I)R\ @78WU7&#T'Y4 <<FGO-XX33
M'U753:7FBFZF07T@S*LBJ&4@Y3ACPFT' XK9\!7EQJWP]T>XOIY)IYK4"24L
M0[8R,DCG/'7K6R-'TL3+,--LQ*L?E!_(7<$_NYQT]NE36EE:Z?;K;V5M#;0+
M]V*&,(H^@'% 'D>EVT)\#^#8H[B8/)X@ <^>S,OSW XR3MZ'ICG)ZUHOK5UH
MUEJMFVI3I8P>)8[)KJZF>1K>W>*-\&0MN"[VVY+9 ;J*]"_L'1N/^)38<3&<
M?Z,G^M/5^GWO?K3_ .QM+$=S'_9MGY=W_P ?"^0N)O\ ?&/F_&@#*\+6\EJ^
MI1G71JD+3B2)1N;[,"HRF]G8M_>P3P&]"*YB],VF>+?'6IZ>L\M]:Z/;SP1F
M=V5I-MP0"N<,.!A<8';%>@6.GV6F6B6EA:06ELGW8H(PB#Z <4D>FV$5[)>Q
MV5LEW(,/.L2B1OJV,F@#C+2ZN(=7\&W&FW]S=V^JP2?;%EG:59$$.\2@$D*0
MV!\N!\^/3&'8$?\ "#^$_P#L:6_]*IZ],M-(TRP:1K/3[2W:3(<Q0JF[)R<X
M'//-,&@Z,((X!I-@(8Y/-2,6R;4?^\!C@^] ' 7^JZC=>&/%>KQWMU!K.DZE
M+';0I*P50C+Y2&/.U@ZD=0<[^.@Q+X@&K1:SJFBV]Y?QW6N6:7&ELMW(!;SH
M<2JISPH!5\=^1Z5WSZ3ILM\+Z33[5KP8Q.T*F3CI\V,\=JLM#$TR2M&AD0$(
MY7E0<9P>V<#\J . 35IM=\!ZSXB@FO;,KI+1Q(L[J8YHXV:1ASU#_)GK^[//
M-1V\5QJWB;3K*XU34DMI_#2SR)#>/'F3>@WY4@@\]0>>_>N^>QLY+1[22U@>
MVDW;X6C!1LG)RO0Y))/UJ!=$TE)%D72[)76+R0PMT!$?]S./N^W2@#@-+UV]
MNM$\"W&I7TKV]Y82->+'.8Y99 B;7.""0,G..[J?IU_@NTU&T\+6JZM<RW%\
MY9Y'DF\T@%CM&[)&0NT''&<U0UOP>+RYLS96>AR6%O$\8TZ^L0\*EB"73'1N
M .A_#G.QX?T.#0+![:"*VB$LIE:*UB\J%&( PB9.T?*#[DD]Z .5\+ZC'KEE
MIVJSZW<PZLE[-'<V*SG#ON=?(,1. % 4Y SA<D\DUG6>K:G=>$O#OB*&\NCJ
M]QJD<%W;&9BC;I2DD1C)VKL&2#@$;,^N?1(M'TR#4I=2ATZTCOY1MDN4A42N
M/0MC)I8])TV&^>]BT^U2[<EFG6%0[$C!);&<XH \S>:^@L+[4QJVI-/9^*UM
M8E:[<H(6GC0HRYPPVL1SG';%)K ^P1_%"YM;V[M[N ))"T=W(&4_9(WR!N]<
M_0<# XKT@Z!HQB>(Z38&-Y/-9/LR89_[Q&.6]^M/GT72KF6:6XTRREDF01RM
M) K&11T5B1R!Z&@#DKR&*PO]+L!J^I337RSW;13W[HC!8T#,9 =R*N<A%XRQ
M. !D8WAGQ))JD/A6PUK5)5@O-)ED,PN#$UQ<*RC:74@Y"$MC/.<GH*]'FT?3
M+A;99M.M)%M#NMP\"D0GU3(^4_2HIO#NB7%@EA-H^GR6<;^8EN]LAC5NN0N,
M \GGWH XI;2W7QMX0\S5KJ^"Z;>(+R2X9#,4>'!.T@'.3S_$,9SQ5%+N_DT;
M3U_M:_5O^$NFLC(+AMS0B:10A)ZC"CKZ5Z9-IUC</;/-96\C6IS SQ*3$<8R
MN1\O'I5<:!HPC6,:18!%E\Y5^S)@2?W@,?>]^M '!37NHZ;HWB^UM=1N"EAJ
MUO'"US=,THB=8&>-9'.<G>X7)X+#!%=)X8@NGUW6;[[5<OI<C1K90S7+2;?E
M'F'!)P"W3//7L15G7O#$=_I\L6FPZ=;333I-<":T5X[H*<[)0,$@G'.>W<<5
M'X<\*P:->27PL=)LIWC,1CTNV\E&&0<M_>/'' QD]<T <OX^UB:W'B26QU.Y
MCN=-L[=\?:3"ENY9F&U1_K&;C(88P ,G)%7KK4H=7\0>)=-O==FTMK*.![*6
M&Y\K;&4#&4#.'^?<ISD84#N<]C=:)I-]<-<7>F65Q.T1A:26W1V,9ZH21G;[
M=*2?1-)N;BUN)]+LI9K0 6\CP*S0@=-A(^7\* .(AAB3Q7XYF6ZNHY_L=N\9
M%RZMDPR'(7/48XXXYQBHQJ-UI7AWP3XJN;Z]DLQ:00ZFIF=E82Q*%F9<X)$A
M&3CG>?05W\VE:=<7$EQ-86LD\D7DO(\*EFCZ["2,E?;I3TL+..R6SCM($M4P
M%@6,!!@Y&%Z=>: ..U$7VGW?@_?>7D<UYJK_ &J(W#LI#PROY9R>54A0.WRU
MCZ7HUQ=^'?%D6D7]Y!JD6LW3VP6]E&XHP(5ANZ-]TG_:'H*])N=/LKR6&6ZM
M+>>2!MT3RQAC&?521P?I5#4--NHUDF\/KIME?W$RM<SSVI?S5 (.=I4ENF"3
M0!G>%]13Q3'-KL9N4LKB!+>&!Y' ! )D;;G&[<Q0G&?W9YYJIXP;4+*6U;3(
M3<V5M:R_:-.M;IK:8)\H$L1& Q0 C:<?>&*ZG3K&/3=/@LXB66) NYNKGNQ]
MR<D^YI+O2M/U!T>]L+6Y= 55IH5<J#U )'0T -TBYBO=%L+J!Y)(9[>.1'E&
M&964$%O?!YJ[2 !0   !P *6@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N8^($.HMX.OKK2;BXAO
MK-?M,?DRLAD"'<R'!YW*"/J173TA 92" 0>"#WH \[;Q$@^(?AVYM[R[?2-7
ML OEM,QACF<%X6QG[S+'(N/8'J:ZK0W M+[59KF7[/<3R2Q^;,S)'"ORJ5R<
M!2%+_P# _85S2_#00^")]!@OVCN1??:[.Z&=UMLDS$%_W4 'U)KIM8TF>XT6
M#2=/BMQ:9CBFCE<J#;J1N084_>4;>>Q- &%X4UW4Y/%6I:9K)(^VPIJFFJPP
M4@;"-$?]I2%)'JY-+=33:;\2_L=Y?70TS6-.<VZFX<+#/$<R!>?ERA#>VTXJ
M?6O!Y.KZ)JGAVUTVRN["X+RMM\L2PLI5XSL4YSD$$]".AJYXN\++XJL;&)IO
M(EMKN.;>IY*<K*@/^TC,/RH Y7PEJ]WJO@7^S+B]OCJXU#[$T\DS+.0Q\Q9.
MO'[@[L=,J:LW]]#9?$F^LKZ\U;^SH]'BN5BMYKEMLGF2*S?NSG[JCKQ70P>%
M([?QY=>(TEQ'<6D<36XZ><N1YGUV$+],TD&B7\?Q!NM?8VWV2:PCLP@D;S!M
M=GW8VXYW8QGM0!J:4AMM%A*2W-V"ID0S/ND96)95))Y(!"Y)[5SVG_$2POWT
MASIFIVUEJS^5:WD\:",R\X0X8L"=IP<8)Z&NP 5$  "JHX'0 5YIX&TBYUWP
M)X3%Q]F2QL9Q>!XY"SR,C/L7&,+\Q!)R?NXQSP =0_C2PCB@NV@N/[,FN_L:
MWX"^7YF\H"1G<%+C;NQC/L0:I3>*]/T;_A)K][757-A=11W<9<. 61-IC4O@
M+AE)Q@Y).*K6_@B\C\._\(M--;OHJ7HN(YMS>=Y0F$PB*XQG<-N[=T[9I-6\
M':MJ%MXLBCDLE_MJX@EA+2/^[$:QJ=WR]3Y>>/7VH OWWC7[+::_C2+N.]TF
MS^V^1.8U\Z(AL."&.!E&R#R,=,\5N:3J#W>A6U_=QFV9X%DD$A7CC)/!( []
M:P-2\+7^J:KKUP\EM%#JFC#35VNS-&P\SYB-HR/WOKV]^-FQTR=_"Z:5JAA+
MM:_9I?LY.W&W:<$\]/:@"G;^,+.:72O,MKF"UU;BQNI NR4[=R@X.5+*"5R.
M<=CQ63H4MSXD\0:Q+>#4[4Z9J@2W,=RJHJ+%$?*=58AMQ=B>#U'((&)=/\)Z
MC_9_A[3-3FM9+70ITEBGB9M]QY:,D6Y2,)@,"<%LE?>M3PYH]]I5]KDUV;<I
MJ%^UW'Y3L2H*(FTY4?W,Y]Z ':GXGAT^2]2*QO+XV"))="U0,8PW( !(+-CY
ML#/'U&6WWBNVM#J!AL[J[73HUDO# JYB!7=C#$$L%^8@=B.YQ5&;0M?L?%FH
M:GHMW8?9-46+[5'=JY:&1%V!X]O#94#*DCD=:1O#.IV>IZ[)IT]M+;:U&OF_
M:68-!*(_++@!2'!4*<97D=>> "6Y\<6J73V]EIM_J##3TU*-[<1[)8&)PREG
M'H>#@^F:;;^,&OO$>BVEE8RRZ?J6F-J"SY0$+NB R"P( $G/4\C /-5[/PA=
M:5J0:R:W:RBT./281)(P<E"Q#-A2.<_I3-*\):OIDOAJ1+FSWZ9I3:9<'YCD
M'R\.G R?W70XZ]\4 :=CXQL[R^M;:6UNK07=K)=V[W"JH:.,@,6&<J?F!Y'3
MWXI8_%BSK \.DZ@\5U:O=6DVQ0DJJ <$Y^0L""-V,CW&*Y_3_ ^LBZTJ34KC
M3Y#!:7-I>S1[S+="4(#*6(^\=G0\#/!/0:_AK1?$>G:;#I&J7UC+8V</V>"6
MW1O-G0+M4R \+@=<9R0.1W -'PCK,_B#PKIVJW-JUO)=0)*5)4@[E!RN">.>
M^#QTK:KF/#6E:]H6A:'I,DFFR162>1<NN_<T2IA"G^T6 )SQC.,]:Z>@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH 1T61"CJ&5A@@C((ID,$-NFR&)(DSG:BA1G\*DHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBN<\975S;6>EI;7$L!N-4MK>1HCABC/AAGMD4 ='17">--5
MUS1[C3[;3!-)!F'YBN"\OF@*AD+8;>."F >^X5#XFUWQ#:Z-HTL*2!IU@:Z8
M6QMRLAEB 4LSG9N)*;"&.&)R #0!Z#17G_B?7?$%MX%M[Q?-@N9;:8WDBVC0
MFWPA.[)<^65..N_=VZU)K>HZR?AW>ZO<R7&GZI;%RJ1H8@O[P  @LP<8_BS@
M]0!F@#O**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y;QOQ;Z%_P!ANS_]
M#KJ:AN;2VO83#=V\4\1.=DJ!ES]#0!*0& R 1UH(##! (Z\TV**.")(H8TCC
M0;51% "CT '2GT (0&!! (/!!KE_B,0/A]K'/_+$?^A"NIJM=Z=8WYC-Y9V]
MR8R2GG1*^W/ID<=!0!9HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEAU[9J*;1-6M-=>Z;PS:ZS9:A9012Q3RQ*UK)&I4@[LAD((SMR>#P: .KO\
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M:6B@!D420Q+%$@2-1A548 'H*/)C\_SMB^;MV[\<XZX^E/HH **** "BBB@
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M% &G165H6L#5[:Y$BJEW9W#VMRB]!(N.1[,I5A[,*U: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#N5F8C))/TJ--,UJ&RM-,&B7DCV?B=KYY04"/"T[R!E);GY7&>F,'OC/J-%
M'G<>AZL-:F32VO;2RO);S[9:W:AXH&82;;B!^JEF()4$\.V0,58\'V5PSZ7'
MJ?AF[M-1TJ$PM>7%QYD0^7:?(^<DAL _=  &.H%=Y37021LC9PPP=I(/YCD4
M <KX.MI/[7\5:E@BWO=4(A]&$4:1LP^K*P_X#764R**."%(88UCC10JHHP%
MZ "GT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<M\0]
M6OM"\'W&IZ?=FVGAF@7<45@5>5$;.X'LQ-=37+_$'2[_ %OPA/INFVWGW$LT
M#@%U4 )*CG))'930!4U#Q+!H6FZIK::^=7LM.M"TUN/))\UB/+ >-1C.""#G
M[P-37;>([/PG)K1U(2:C#;&Z>R,*"W8A=QB'R[QQD!MW7GVK1\0>'+3Q)X<U
M+3)H_LQU"W\IW &Y2.5)P<'!YZUG7">([SPF^BOIRQZC+;&UDO?.0VXRNTR@
M9WGCD+M'/&<<T 9D_BFXU/6_";V6JRV&EZU83W4@V190HL94;G4X^^0?I6OX
M%UR_UW3+^2^,<RVU_-;6UY&FQ;N)2-LH'3G)&1P<<5D77@H+K/A:R33/M>AZ
M7I]Q93M*R?,)$10=I.3]PY^O%;?A.RUC1(I=$OD:YL+5MMA?&12S0_PI(,YW
M+]W(&" .E %/Q#J=_;>.=%TR/5WLK&]M;F68A(OE:/9C#.IQ]XY_I5/2?$NK
MZCX"\0ZC),HFT^2[2ROXH@%NHXE)24*<C!/!QP<'%6_$?AZ;6_&VCSW&EK=:
M3!:75O<EV3!\T(!A2<\;3GZ\5!!I7B"Q\)ZSX9EMWOXEMI;?3+SSD#/&R$(D
M@8@AESMW=P,]>H!+X=U9]4T_0IAXI$]_=01336>("&R@:085 RXR><]< ]:I
M6FOS2>(/$FGZAXJ:R^Q7D<%HFVW#,'C1APR$L=S8XK5T6'5+/0]"L'T%EN[.
M&""2XEEB*1@(%D9=K%CQG QSQG%,\/Z)=1>(/%%QJ6G;;;4;N.>!G9&RJQJG
M(!)!RN10!3NM7O[3QW:Z+J'B$6=JVCBZDD"PH&G$@0X+H>",G%'B76=1TWP0
MVJZ;KIN,WT,<-UY41WQ/,D9S\NTXRV"!SP>:MW=CJ<?Q*76X]+EN+%=)-EE)
M8@QD,H?(#,.,#\^U5?%.E:OK?A&?3K715A+7T,D5N98^(TE21F8[L9)#8 SV
MH LZ1K>H2>/;[05O1J>G16*W!O B![>8OM\IB@"DE?F P"*S-(\037?]OKJ?
MBQK.6RU2>SMT"VX)1=NSY2F6.3CCK6M8:/J'ASQ)/-I5GYFAZGF:XM%=%:TN
M.,N@)P5?N >",CKBJ>@:?J>EP^(8KWP]-<KJ&J7%Y$JS0X*/MVALOP?E[9Q0
M GB7Q#K?A76=.NY";[2/LKR:I$D:[H%4HIFCP,D MD@YXS^&O<ZXEOJ$NH_V
MBTFCQZ6U\5C5&5E'.X-C)&WGK4T4.H3:[8W%Y8C8-/DBN'5U*"1VC8J 3DCY
M6&<>E8>F> 6TW4-9T\3E_#=]9/#;V^?FM?,)\R-?]GG*^F2/J :'A^36O$'A
MZUUJ;4WLI;Z(7$%K%%&T42,,H&W+N8X(W89>^,5F:AK&JV'B?P[IFI:V+&.[
MTZ62\91"!Y\8C'RLZG )9N/RK1\,KKV@Z)::%>:4UT]C$MO#>P31B*6-1A"P
M9@ZG &0%;VS46J:?JS>.M%U==.:ZM[*RGAG:)XUW/)L(VJS#@;3U]>] &E9Z
MO!9:+<ZI<:M)J=A]HVQ3QPAV W",KB)?FQ(&Y Z'VK?K"CN-5M[&[DM=!52L
MJ^19M<(C2;FS)(6!*K]YCCDG:?7C=H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/0=3CH.: +]%>4V'Q)US3/"OB^Z\16EI+?>'[@6Z2VV5BN'8X4<\\$J3[$<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAD#.['([5=^&WARZL+?2X=;\.W=OJNC1RP)?27FZ$HQ/^K4.<Y&,@J ,9SG
MKT^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*UW49]-CL9(?*VS7D
M4$OF G"NV"0<C!K5K"\40O<6VGHD$DP74()'5(R^$5LL3@=,5I22<TF9U6U!
MM%FY\0Z7;Z7+J(O89;>-O++1.&!?^[QWYI5\0:6VH268O8-\<0E9C( N#G'/
M?@$USFIV5W-#XJ$-I.WG3V\L0$1'F!5CW;?4Y4_E5N[$W]M:I<M:7 @NM*54
M=H^ 5,I(;T.&'!YYK?V,+?UY?YO[C+VL[_UY_P"2-^WU;3KRX-O;7UM-,$$A
MCCE5FVGH< ].1^=.74K%Q(5O("(T,CXD'RJ/XC[>]<GI5F+VV\*3VUK(AL[7
M?-(8B@*M#MV@D?-N8@\9Z9JSHD5W8NT9CNKK2X[(F..YMR)X3Q^Y!('F C/_
M 'R.>12E1BKV?]78XU9.UU_6AT,]Z#':&U=)/M4B['!RI3&XD8_V0<'U(J--
M3A%[+%/<0Q*9!# KL TK@9;&3SU P.X-10N7F^VBTFCAM[0>5"8]K98;F7;Z
M@*@X[Y%5-4TNX;PRGDKOU&U9;R/;_%,#O8#_ 'B6'_ JB,8WLRG*5KHUEU.P
M:*25;ZV,<3[)&$JX1NF"<\'VIIU?35C>0ZA:A$D\IF,RX5_[IYZ^U85AIFH0
MZ[()HS]BO-M]-Z1S+QY?_HLY[[#ZU'JN@W=WJ.I64&8[+48EN&F'_+*=.!CW
M)$1_X"U4J5/FLW_7]7)]I/END='-J=A;.4GO;:)AM!5Y54C=]WJ>^./6E_M&
MQW7"_;+?=;C,P\P9B'^USQ^-8R:;=:SX6N%OX_L^H7L8<K_SQ=0-GY%0WU)J
MA;6.KW&HVU[<6YC758 FH0]H=F"O_?2[U/\ O>U)4H-.[U7]?Y_AW&ZD]++?
M^O\ (ZUIX4MS</*BPA=YD+ *%]<^E1Q7]I/%++%<PO'$2)&#C"<9Y]..>:R]
M>NI9--U"WATR:Y>$1G:\64D!89*\_,5 SCV [US]Q:ZE))K4MO9WDVZ>TND$
MR!#<)'M++V&3M/&.V#13HJ2NW;^E_F$ZKB[)7_I_Y'9Q:A9S12RQ74+QQ?ZQ
M@XPG&>?3CFEMK^SO'D2VNH9GCQO5'!*YZ9';.#7-:F9;ZQ;4;'1[E"+JWFN(
MY(MDURD;9(VGDX&,9ZXXIUCJ _X2/7+X6=V0ME;.(?)Q*^#+T0\Y]CBCV*Y6
MU_6W^8>V?,D_ZW_R.CN;^SL\?:KJ&'(S^\<+QZ\]J+B_L[0 W%U#$"-P+N!Q
MZ_2L/$MMXAU2:[M+B>TOK:(0E(B^-H8-&P .,[L\\<GFL<Z3J5AH]G'$]R-3
MM].6)E\DS07(RW[E\#@CINR.&IQHQ=KOM_7RV8I59+9?U_P3I?$.LII&D7D\
M=Q;+=0P-+'',?O8!P,9!Y(Q]:OQW*"PCN;B1(U\L.[,=JKQZGI7(7Z7Z6_BB
MTN=/N99M0A+VSPQ&16_<A=F1T*L#UQG/'6MR2X>31YK(V5V)/[/W9,1*DE2N
MP8_BXZ>XHE22BDOZT01J-R?]=RX-;THE@-2M,I&)6_?+PAQACSTY'/N*2;48
MI$L9+2_LQ'<2@*SL&\Y><A,'ENGKWXKG[&TDCN?"9:RF7[+8R),3 W[MRB#!
MXX.0U5[>TN5TS28S9W(:'6Y)V7R&^2,O(0W3@89?SJO8P6S_ *U_R_$GVLNJ
M_K3_ #_ Z'3M4FFOM9BNS$L5C,JJZJ1\AC5\G)///Z4Z?5?LNCBXN9K>WNGA
M,JI*< <9P1G/&0":R[>WN'U36X3;S+%>WL0WM&0K1")0_..AV,OU(HN_M-KK
M^L&>SN9X+ZT1+:2*(R %0P,;8^[DMGGCGK2]G%R^2?Y?\'[A\\DOO_7^OF:%
MAX@LVT2QN]0O;2WFFM([B16D"A0P&3@G.,D#\15]]3L8[>.X>\@$,HW1OY@P
MXQG(/<8KC], M=4\.)>6DPDBT5HV0P%F1@8@<@ D=Q^-.L;"[TU+&W.GSI%(
M+MHWAC#O"'D#)$>R KC)/<8R*J5"%]_ZU_R%&M.W]>7^9UD^K:;;('GO[6-6
MC\T%Y5&4_O=>G(Y]Z2XOT.F"ZLI8IO-VK ZG<K,Q"@\=1D\^P-<=I8-K<^$8
M[VSG22'3YXV1H2S*P$0SM )]16OX>TR:U98WA>&V%S<7D497'EAV(C7V^4L2
M.V14SHQ@KW_X.K_R'&K*3M;^M/\ ,MZ]KHTV*%;:XMC<&ZAA>)SEL.Z@X (P
M<'-:;:A9)="V:ZA$Y;:(RXW9QG&/7'.*XN2*^30WTR?3[R2]AU59VD2$LLJ&
MX#[PW3[IQC.1CI4NH)>S7C[=,NT\K6(9RD,/R21@K^]+?Q,0.0#QCD=ZKV$6
MK7[_ *$^VDG>W;]3J_[8TSS_ "/[0M?-W,NSSESE1EAC/8<GTIZZC9O#-*ES
M$Z0+ND*L#M&,\_A7/6]BDB>*/M.GSLL\SL@$15Y$,*J=AQUR&''K[TMA#J3/
M-97#RW=K(\2I=S0&.1HQN9DD&!GH%W8&=_UJ'2A;?:Q:JROL:R:Y8V]LAU&_
ML[>X 3SD>95\MF&0IR?8_D:N3WUI:JK7%S%$&!8%W R!U/T'K7,3"W;Q3XAC
MFLWN#+8P(%2$OG(D^7('&>.N!Q[53\BYT5],A>.YGN$T@6MP8K<W"KR,<*<C
MD-UX('MQ7L(O^O*XO;27]>=CJVU"*6ZLEMK^R*2LP*%@S2@*>$P>H(R>O -*
MVIPQ7TT<\\,,*%(E,C!2TIY*C/7@I^=<_!#$O_"*BRBNY;:R:2-W>!PR 1,G
MSC&0=V./Z4NNQ>7HFER7,)9Y=4@FEC*;CEGR5QWP#M_"E[*/,H]_\W_D'M9<
MK?\ 6R.CM]4L+NU>ZMKVWFMXR0\L<H*KCKD@X%,?5;)XYUAU"T$L:%COD'R<
M=6&<XY%<OJFG%X_$=['!/'!=+;+$BQ[7DE1OO;#@GDJ,=3@X[5/;S1W4NM3-
M#>)?7=GM$,EE)&"J*1\N1\QR_/U'IFCV,;77];?YO[@]M*]G_6_]?,ZFSD:6
MRMY&EBE9XU8R1?<<D=5Z\'M6;JFK2:=K.F0.\"6=SYOG/)P5V(6!SG 'X5/H
M"/%X=TV*5'CDCM8T='4@JP4 @@^XJEJ\+R>)=!E$$DD4+S-(ZQEE3*84DXXY
MK.$5[1I[:_DS23?(FO+\T6[GQ!IEM;VDYO(6BNY!'"ZN"K'N<],#G-2OK6E1
MMM?4K16W^7@S+]_^[UZ\CCWKE8[6[BTZT;[%<X@UZ2X9!"VX1,TF& QDCYA2
M:I97$^G^+U2QN#)=NGD#R3F3$:#CCG# UM["G>U_ZO;\M3+VT[7M_5KG86^H
M6=Y+-%;74,TD)Q*D<@8H?<#I4$.IPK:?:KN>&&*1V\HLVW* G!YZY W?0UCW
M27 \2S36EM.JR::EO'*L+!5<R'';^$-G\#3[\2Z3X@M+E;"XN=.-D;0+;QF0
MPMN!Y7K@@ 9_V1FLU2CLNI?M'N;JZA9N^Q;N!G\OSMHD!.S^]].>O2H9-:TN
M*))9-2M%C=#(C&9<,H_B'/(]ZQ5A?3O$.G7$>F31VIT][9(H(]PB;>C*K8X7
M@=>F>]9NBV,ZKX42ZT^=?LUO.DPD@.(RP &>.,X-4J,+7O\ UK_E^(G5E>UO
MZT_S.M36-,DG2!-0M6E=MJHLRDL<9P!GKCFE75=/8R@7UL?*7?)^]7Y5]3ST
M]ZP8M.EGO/%*Q6[0RW.T6LSQ%1GR @*G'9LU6MHDO-.>1]$U&"_M[&2!C.7(
M&5P43DAP2!C Q@=J/8P[]NW7^K![6?;O_7ZG3Q:OIL[ND-_;2.D8E=4E!*IU
MW'V]ZJQ:[;W^BM?Z?(DA<^7$#_?+;5R.V20?I61IMK-#?^&#]DFC6#3I(ICY
M+ (Q$> W''*M_DU)X8M[D:9I5E<6L\/V(.TOF(5!<$JH'J,,3GV%#I0BK_UU
M_P OQ$JDV[?UT_S_  "XU_5(;C7@D=G)'I"I(58,IE4Q[SSDA2!QT/X5:@\0
MMJES:6NFQJ))K1+R5Y@2(4;[H(!&6//&1P,U3L]*BOO$WB$WUI.UK</ 8_,5
MUCE"Q@'(X#8([U,UG/H_BZ;4X[=Y;"]MTAE\E-S0NGW3M')4@XX!P:IJGM;6
MR_)?\'\B4ZF]]+_J_P#@?F:\3:D+IX9OL[1F/='.B$?-GD%<_3OSSTQ67I&K
M:MK/ARTOH(K1;FYW$[PWEQJ"1ZY8G ]/TY;:Q._C*[U);>=;(62(&>)ES+O)
M.%(R3MQR!5/0KJ[T7P3I\#:=>M=C<C1K;LQC^8G<1W&"/K^9"Y%RZ)7T_)W_
M $*YW?7;7\T6H?$MR-,;[5;1)J(U :<%1B8WD)'S ]=N#G'7@BM*QU1GO[^P
MNS&LUF$D,BC:K1L"0V"3C!# \GIGO6-<6S7NF6,MI87D?]GZA'<LMQ'MDFZ^
M8P'<X<GW(P*D;1[K5-5U2^CF:TCG$$41DAR76/);*'!P2V.>N#V-.4*;3Z?\
M.OT_K02E4377_AG^IHZ-K,NJ:AJ<+P"**V>,19SN963=D^F<]/SK5F9TAD:)
M-\@4E4SC<>PS7.Z#I^J6OB/69[VY\V*4Q;6\@()2$ W#GMR,5TM85E%3]W;3
M\C6DY./O;Z_F8%K>Z\FLVMG?IIICEC>1_LY<LH7 _BXZLH_.K=CJ4]SKFJ6$
ML4:):"(QLK$E@X8\_E3K**235[^\E1E&5MX=PQE%&2P^K,P]]HJKIL<B^*]:
ME:&58I4MQ&[1D*Q4,&P<8XR*M\K3TZ?JB5S)K7K^C)M<U*?3&TYHS"(I[M()
MC(#PI!.0<C'3O3KGQ#I=MIOV_P"V0RVYD$2O&X8%R<8R/K^%9^M.^I+IA2QN
MML.J*9%> _=3<"_&?EY&#WK-O;.[:Q\0".SN&WZI!<QJ(CET4P[BH[_<;IZ5
M<*4&H\W]:DSJ23?+_6AT\NMZ5 K-+J5H@0*6+3*,;ONYY[X/Y5(NJZ>T\L*W
MUL984WR()02B^I'85SUQ#)-JNOS_ &*XV7&F1QQDP'YFQ)E1QU^9?\BHH+:>
M*X\-LEM<Q?9]-FCF9(#F-RL> <C&<JW^32]C"V_]6O\ \ ?M9=OZO;_@FI!X
MDMI[B"-+FU/FW,D> XR(U##/7J6 _ U?BUG2Y[B.WBU&TDFE!,<:3*6< D'
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M_?;?XT?V!I?_ #ZC_OMO\:TJ*/:3[L/9P[&;_8&E_P#/J/\ OMO\:/[ TO\
MY]1_WVW^-:5%'M)]V'LX=C-_L#2_^?4?]]M_C1_8&E_\^H_[[;_&M*BCVD^[
M#V<.QF_V!I?_ #ZC_OMO\:/[ TO_ )]1_P!]M_C6E11[2?=A[.'8S?[ TO\
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M\W$>?X8YB!4MMX8TRW0J8Y)<G.996)%;%%/VU2UKB]E"][&;_8&E_P#/J/\
MOMO\:/[ TO\ Y]1_WVW^-:5%+VD^['[.'8S?[ TO_GU'_?;?XT?V!I?_ #ZC
M_OMO\:TJ*/:3[L/9P[&;_8&E_P#/J/\ OMO\:/[ TO\ Y]1_WVW^-:5%'M)]
MV'LX=C-_L#2_^?4?]]M_C1_8&E_\^H_[[;_&M*BCVD^[#V<.QF_V!I?_ #ZC
M_OMO\:LVFGVMCO\ LT0CWXW<DYQ]?K5FBDYR:LV-0BM4@HHHJ2@HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8D*<Y[D$8QGB@#6HK)TGQ!;:Q?:C:007$<FGS>1.954 /@-@8)SP0<].:UJ
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M"]#TBT5)+C4;6&,HTA0>2(U,I) ) *_+D#@NM4_";S^'_&NL>'+N&&WAO_\
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M CL0?H.GJ&VM;>RMTM[6"*"!.%CB0*J_0#BIJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J
M.H:K!II@66.XE>=BJ);P-(>!DDA0<#W/M5ZDP,@X&1WH Y_3_&FE:HL+VB7[
MQS221))]CD"ETW;ESC@_(P]R,5I:+J]KKVCVVJ66_P"S7*;X_,7:V,XY';I7
M-?"X ^"AD XO[TC_ ,")*YKP9)=Z?IOP_DAO[IHK_P ^WGMF<>45$4CKA<<$
M,@YZ\GM0!ZS574-1M],MA/<L0&D2)%'5W=@JJ/<D@?SXKA_"U_J6NP:%K_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
4B@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>exhibit1027supplycontrac023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac023.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M%9 F"?)A^8X4'...N,=N];MGX8TBPF22VM"@CE::*+S7,43MG<R1D[5)W-T
MZGU-3Z=HMAI,UW+9121O=RF:<M,[[W( +88D X ''H* ,GQW9WUWX/U.'3X+
M25I(6\^.X)7S8@/F4,.C%<@'MFLWQC=I?_#>QO(X3"EQ<:;*L3=4#7$)"GZ9
MQ7277A[3KV^DN[A+AWEC$<B?:I1%(H[-&&V-U/4<YJ;5-'L=:LUM+^%I(%=9
M BRLGS*0RGY2.A /X4 7J*15"J%&< 8Y.3^=+0 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH I:?
MI&G:2)QI]E!:^?(9)?*0+O8\DG'U/YU=HHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BB@D $DX H **Y/PIXKFUS5]7L;N 0-"T=S9?]-K.1?D?ZY5L^F0*O3^-/
M#UM/-#+J2!X)UMYL1N1$[8P&(&%!W#D\<]: -ZBL^'6]/GU&]L(IF:ZLE5[B
M/RGR@;.T].<X.,9S@TD]^+KP_+?Z?-@/;&6"5HSTVY!VG'ZT :-%<[X6\0+J
M.@:$;V8R:G>Z;#=R!(C@[E&6.T;5&<^E6E\4:.UQY NSYAA:>,>2^)8U^\T9
MVXD R/NYZB@#8HK-M]?TR[L["[M[@R6]^P2U=8WQ(<$\<<#"DY/&!FC5/$&E
M:++;Q:C>)!)<%A"K DN54L0 !UP#]>@YH TJ*R;+Q/HVHZ6-2L[Y9K8RF'*H
MV_S <%-F-V[_ &<9J!O&7A]+:*X?4D1)+AK50R,&$R]8RI&Y6XZ$ T ;M%8\
M/BG1[B*"6&Z>2.?R]K+!(0/,.U QV_*2>S8J2?Q'I-M=?9YKL*WG"W+E&\L2
MGHA?&T,<C@G/(]: -2BL&\\:>'K">ZAN=21)+1UCN (W;RBW0L0,*.1R>!D9
M-+?^,M TR>[@N]15);,*UPBQNYB5LX8[0>.#D]!WQF@#=HK-U#7],TN(RW5R
M0BQ><S1QM($C_OMM!VKU^8X'!]#69'K%U+\08M/CNHY-,FT@WB*B@Y?S54,&
M[C!^G- '2T51O]8L=,.+J5E;RVE*I$\A"+C+$*#@#(Y-9E]XX\-Z;)/'=ZI'
M&]N$:90CL8PX)4G .!QR>@XSC(H Z&BLR^\0Z7IUN)[BZ_=>5YY>*-I0L7]\
M[ <+_M'C@^E-OO$FD:=#YUQ>KY0A%PSQHTBI$>CL5!VJ>?F.!P?0T :M%8JZ
MM;-XAN(4U7S1%9),UC% 7*@L<2AE!+9'&T>E<MIGB6\U?3]*UN3Q"VF6UY<K
M"UI+I^X.S381(W(!Y4;2?F&3D;<4 >AT5EW7B'2K*[6VN;KRW:58-QC8HLC8
MVHS@;58Y& 2#R/45A^-_%7]DZ)<MIEYLOH+B")B+<R(I=T!1FQM5MK9P3GD>
MHH ["BJ&MW<=CH=]<RWPL%CA8_:BF\0\??V]\=<5GS>+M$T\+;W>IA[A;5;E
M@L+L[1G^/:H)]\#ISZ4 ;]%5X;VWN;".^MY!-;21":.2,%MZ$9! ')R/2N)G
M\=_;+?PWJEC+):Z?>ZD]M<)/;D%XPDI!!8=28QPN>3B@#OJ*YR]\3:9=>'FO
M[36Q91?:4MS<-;EF202 &,QL,@G[O(XW9K3EUO3X;S[*\S>:)5A.V)V59& *
MJ6 V@D$'!/<>M &A15>\OK:PA$MS)L5F"* "S.QZ*H')/L*I1>(])GLOM<5X
M'C\\VVT(WF>:,YCV8W;A@_+C.!GI0!JT5BOXMT**R6\EU&..!KD6F75E*S$X
MV,I&5.2.H&,U3U#QSH]GX?U+5H7EN5L&\J6%(7#K(0-H92N5!R/F(Q@YH Z:
MBL*Y\8Z#9W2VMS?&*Y*H_DO#('"NVU25VY'/'-6+;Q)I-W?1V<%X'FE,BQ?(
MP64QG#A'(VL5.<@$]#Z4 :M%9*^)=(:\2T6[W32B0Q 1.1-Y?WQ&V,.1SD*2
M>#2>&O$-MXFT=-2M8IHXG9PHEC9"0&(!Y SD#/&<=* ->BLI/$FD2:@EDMX#
M,\KP)\C;&D0$N@?&TL #D YX/H:KVWC+P]=SR0P:G&S1K*SG:P51&</EB, @
MD<9H W:*H6&M6&IW-Q;6TS&XMMOG0R1/&Z!N5)5@#@X.#T.#46I>(M*TAG%]
M=B(1JK2ML9EB5CA2Y (0$YY; X/I0!J45EWWB+2M->1;N[$8B"F9PC,D(;[I
M=@"$!_VB*KZAXOT'3+BYM[O4%6:VC6:9$C=RB'.&PH/'!R>V.<4 ;E%9EQX@
MTRV4,]R64Q+.6BC:0+&V=K$J" #@X)ZX/I4,&K6HUC65DUB-X[**)YK=HP@M
M 0Q+%^^X#/MM]Z -FBN1M?$SW?Q!;3H[EAIPTEKLQRV[1%6\Q5#9< D8)]NO
MI6H?%FAK]H\R^$7V>W^U/YL3IF'IYB[@-R^ZY% &U16+:^+-$O8GEM;TS*K*
MF$A<LS,N\!5VY;Y<GY0> ?0U+%XDTB>PAO(;P2132F&,)&S.T@SN38!NW#:<
MC&1@YZ4 :M%<QX(UJZURPU.>YN!/Y.IW%O$WE>7^[0@*"O4'USS4^G^+]-OS
MJQ;SK>+3;DVTDDT+H&("=,CKN? 7J>#CD4 =!15&PU>QU*6XAM9B9K8@30R1
MM')'D9&58 @$=#C!KF]0\7)H7CB^M-6OUCTQ--BN8T$!9E8R2*Q^4%B,(#GH
M* .RHK,F\0Z7!90W?VKS8)HC/&UO&TQ:, $N @)V\CGIR*NVMY;7MG%>6L\<
MUM*@DCE1LJRD9!!]* )J*R(O$^C33O"+U4=8#<YE1HU:$=9%9@ RCU4D<CUJ
M0>(=-*RDS2H8_+W));R*Q\PD)A2N6R00, ]* -.BLT:[IYM5N!+(5:1HE002
M&1G7.Y0FW<2,'MVJK_PF/A_RK*4:G&5O=_V<*K$R%,[A@#(88(P><\8SQ0!N
M45S5UXXTB&STNZMVGNHM1N_LL3102':PSN##;D$;6^4C.1TZXGBUZQAO-:EN
M-91X+,Q"2!H=OV0E>F<98L><=>0* -ZBN2\4^)_+\%>(-0T2\$=]ID3%A+ 0
MT3A0P#(X!&001D=#70WVHPZ9I$^HW0D,-O"99/+C+M@#)P!R: +E%8ECXHL+
MK1]/OY!-$U[")8[<02-(?E#-A0NY@,CY@,<CUK2L-0M-3L8KVQG2>VE&4D0Y
M!['\001CL10!9HK%7Q;HC6\4XO&\N6[-DA\B3F<''EXV\'/'/<&K<NM:? ;@
M2SE3;R)#(#&WWV *JO'S,01PN3R* +]%8TGBO0X=.N+^:_2*WMI1#.9$96B<
MXPK*1N!.1U'<&L@^*A=^,=(@L+Y9-+GM[WSU,)4B2$Q<Y89Q\YZ<'WH ["BJ
MUEJ%MJ%DEY;.S6[KN5WC9,CKG# ''O6/!XY\-75W:VL.K1-+=2-##\K!6D4D
M%-V,!L@X!.3VS0!T-%9<_B+2K:^CM)KO9++-]G1C&WEF7&0F_&W=_LYS5-?&
MN@2R30V]Z;B:+S=T<,,CG,> XX7J,B@#H**XOPSXBN+[3M-UR_U.3R-1M58:
M=]A;<LQ ?]T57<Z!20>&Z9R.:VI?%N@PV-K>R:E$+>ZE,,+X/S2#.4QC(8$$
M$'!&* -JBN=_X3KPWY1D&H[MMN+DJL$C.(B2-VT+G'!SQQ@YJU:>*=$O[Z&S
MM=0CDFFA,\)"MLE0 $E7QM;&1D DCO0!L45D6GBC1KU]EO>AC]G-TI,;*'B!
MP70D .N2.5SU'J*CT[Q?H.K75M;6.H+-)=1&6#".%E4==K$8)&1D9R/2@#;H
MK+A\1:3<:A#8QW8,\^_R048+-L^_L8C:V.^":+;Q#I5WJ$=C#=9N)8VEA#1L
MJS(.K1L0 X&1]TGJ* -2BBF331V\$DTSA(HU+NS' 4 9)- #Z*Y;P;XFNM>.
MJ6NHVWV2^LKC/DGKY$@WPL??:<'W4UH:%XDM=?FU&.VBN$%E=-;$RPNFXJ!D
M\@=R1CKQGO0!LT5S-OK-S%XXUNQO+J-=-M-/M[I-RA1%N:4.2W<80=:OCQ1H
MVV\+WGDFR19+A)XWB9$;[K;6 )!Q@$ Y/'6@#7HK+C\0Z7+%=2+<E?LLBQ3(
M\3I(CMC8NP@-EMRXXYR,9JCJ/C/3;![% EU*UW>?8P%M9<HX4N=PVYSM&0,9
M/;@$@ Z*BLCQ)X@M_#6ARZI<132(A552.-F)9B N< X&2.3_ #P*P7\91Z;X
MOU6'4[UH]+BT^WNH4-JP>/<T@<D!=^ $!)(P/:@#M:*QIM6M?[>L(4U=$66U
MEG%H(PWGH-N) _8+^NZLJ]^(_AVWTN6]M;F2]V*K*L$$ASN?RQSMP!NX/X>H
MR ==16;:Z]IUYJ$UA#+)]KAB6:2%X)$94;H<,HZX/Y'TJQ;:C:W>FIJ$,N;1
MX_-61E*@IUW<@'&.: +5%<_IE_J.O^'8]3LYHK3[<!+;F6+?Y4)Y5B,C<[+@
MX) &>^/FPHO%FK6/A*XN;N2TO;UM5&F6%S$NV.YW2+&LC*#Q@EL@'G9QUH [
MVBN8M]4OQXCU#PW)=*UU'9QWUI<M&/F5F9"KJ, X9>V.&]1DZGA_68]?T6#4
M(T\MG+)+$3DQR(Q5USWPP(SWH TZ*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *QO$J7EQI7V&T
MM9YA=NL$[PNJF*%CB1LLPYVY QDY(-;-% '#:OX?OM*\5Z#KFB6UY?-%OL[Y
M&N%_X]6&>-[#[KA2 />L[6=!UJ[TKQS!#I,S2:I=Q268\R(>8JQQ*3]_CE&Z
MX[5Z55*_U:QTR6SBO)O*>\F$$ V,=\AY"Y XZ'KZ4 <QXITFYN?$&D7=@X@E
MU!'TV_C8X9K8J9"1CHR;6 /_ $TKJ-1C;^R+J*WA+L8&2.),#)Q@ 9( J.VT
M/3+35[K5H+*)+^[ $TX'S.  ,>W0=.N!6A0!YKX.T'Q#H6G1Z/<V<[6E]IL:
M2W!DC,EC<+$(V0G=EX^,KC.WIT/%_P ':;?1?V9;ZKX6CM;S2HC"=1:9)$?Y
M-F8<$L-PP3D# R.:Z[5M6L=#TV74-1F\FUBQODV,V,\= ":L75M#>VDUK<QB
M2"9&CD0]&4C!'Y&@#D/"VBSV'B'4[;S$?2=.N'.GH.L;3A9'0_[F2%QVD(IW
MC&5H?%7@N18'G(U"?Y(\;C_HTO(R1TZ_A73Z;IEEH]A%8Z=;1VUK$,)&@X'^
M)]Z9>Z18WUY:7MU$SSV3%X'$CKY9(() ! Z$CZ'% ' WWA?6(I;G7K/3O/D?
M7/[0_LLRJC20^1Y#<YVB0Y+]?8\U<N](O+B/1;FR\,M98UN.^N( \7F*BQLI
M>0[\%LD< DX [\5VFF:K9:S:&ZL)O.A$CQ%MI7#(Q5A@@'@@BKE '#:_HNIR
M^(Y-2T:&\M-0$D"^:LB-:WD0(W"5">"H+88 'I@GI6?-X9UB;PIKGA.6TD<W
MFH230:@'79Y4DPEWMSN#KD\8Y(&..1Z310!YSKF@ZQ>0?$"*#2Y7.K011V1\
MR,"4B$(>K<<^N*EO-(U>XG\9NNDSXU/1X;6US)%\\BQRJ5^_QS(O)XZUZ#4%
MY=PV%E/>7+,L$$;22,J%B% R> "3]!0!Y\=)U:PU.&>?PW+JUE>Z7;VDT*3Q
MJ]M+&&!5@S!61@YY!/0\<UM66DWEIXYL+A=.6'3X-$^Q;X&411R>8K!%7.[:
M I X]*ZR.198DD0DJZAAD8X/L:=0!QWC+1[O4;R*XT^+4(-0@MG^RW]E(@PY
M/^JD1CAT;"GD8&#R*R+(WW_"3^*[6?3?MEW/I-C%*L&T1^88Y05^8C"DD\^@
M^F?2"0!DG JC;Z/8VNJ76I0Q,MW=*JS2&5CO"YVC!..,G''&30!P%MX9U3PU
M<V<$FBMX@L)-(MK"7RID1HI(@P.0[*#&P<_3'2K\.GZOX?\ $%T(?#T>HZ7J
M5E;P>5;21K':O&I0QL'(_=$'J >_'-=]5*?5[&VU.STZ:?;=7N\VZ;6._:-S
M<@8& .YH P8+'4(/B!-J3V#&T_L:*V$L10*TJR.Q55+9 PPQD8K MM"UN/X<
M>'M+;29Q?6>HVTTT/FQ?*D=P)&.=^#\H]<UZ510!YY!HNH0ZSJ>G7WAI=2M+
MR_:\MK]YD,4:LP;$B%MV4;I@'.!TZU1U#1O$47ASQ!H"Z-/>27&J_;;:[CEB
M"2QM<++AMS AE (QC' YQ7H-SK>GVMXUH\S/<JH=X8(GE=%/0L$!*@]B<5/8
MZA::G:BYL;B.X@+,HDC;(RI((_ @B@#.\5VUUJ/@S6+.TMGENKJQEABAW*"7
M="H!)..I]:P;/3=4B\30WLFESB!?#RV9;?'_ *X-N*8W>G?I[UW%!('4XH P
M/!%C=Z9X(T73[^W:"[M;2.&6-F5L,J@'E20>GK7):9H>N6^D>$K&;1YE;2=5
M>6X?S8B#'MF =?GR1^\7WZ\<<^F44 >:WV@ZU-X:\36D>DS&>]UZ.\MT\R+Y
MXA)"Q;._ XC;@\]*T+W1M4_X2TZGI,%[92R7L'VM7D1[2\@ 0,[*22DB@%00
M 25'4<CNJ 01D'(H Y?QA9ZHTVBZMI5K]METN\,TEF'"-+&T;QMM+$#< ^1D
MCO5#4+'5KF^T+7X-','V.]EEGTX-&)6CEB,9=B#L,@)S@'H<9S7;T4 >;ZGX
M:U6>XO\ 4K?3Y6-_KEA>"U#H&CB@\L,[9;&YMK' )/W>^<+KOA[6=0C\=+!I
MTF=1%LUGNDC F,:*& ^;@Y7C=BO1Z0D $GH* .5M+;49OB(=7ETN>WM)-(2W
M\R1XSMD$K/M(5B>A'3(SWKGK+2?$4VM>'[N\T:>&2TN[L7313Q+"BR(ZH\2*
MWW?F!)(WDGG->@:7JMEK-E]KL)O.@\QX]VTK\R,588(!X((JY0!Q/@NWUJPT
M[3-#U30EC?25,(U%I(VCD0 JK18.\,PQG(&.>>U:'@*QO]*\*V^FZC9O;36K
MR)EG5A(#(Q#+M)XP1UP>O%=,2 ,DX HH \T.E^(I]7TJZGT28266N33R&*>)
M(#"RRJKH@;G[ZEBPWY)Z]!83P[K5SX&\0:<EG]EOY]4GO;9)I%VR@W F0$JQ
MQN VG/3->AUDR>)=)AA266Y9$>]^P*6A<9GW[ O3^]QGI[T 4/#,+S7$NHS^
M&3HUPT2Q.9I$DEDP<X#(3\@YQGDYZ#OFR6VM:9XKUP+H?]K:;K)BDCD\V,)"
MZQK&R2ASG9\H;*ANIX)KMZ* .!FT;5[7_A,-.-@U[%KFZ6VG5E"!GA6)DD#'
M*A=H(QG@^O%1Q>'=4L;S5(4LYKF$^'+?38;C?&/.EC$H/!;(SO7DX[UVO]K6
M7]M#1_._T\P&Y$6QO]6&"ELXQU8#&<\U)I]_;ZI8Q7MHS/!*,HS(R$C..C $
M=.XH \ZG\.ZT-*TR33[.^L-=M-(MK9)DEC:"=E!#03H6(* \[L='.#GBK'B#
MPUK>JW/C);6U\LW]K9"TE>10DSPLS,AP<@'(7D#J:]&HH \ZU+3-:\4:Q=RG
M1[K3(KSP]/IQDN)(CY4SL",A7)*\'D?E2Q:?J6I:!?BX\'_8=673)K3S6GC<
MRNZXVQ'=PA/)+8[<'J/099D@BDED.%C4NV 20![#GM3+2ZAOK."[MV+0SQK)
M&64J2I&1P<$<'H: .'U/2M8CT;PI>V^DO=R:7&([O3?.1'96B"$JV[:64@$#
M/(SS3)-)U*QU?0]>T_P[Y5O%)=?:M-@DC\Y?."?O3\VQGRGS8;HW4\UZ#10!
MR_@JRO[*'6?M]C):&YU6XN8E=T8M&YR#\K'!KGKWP[KS)K26]@Q>/Q!%K-L3
M*@2[1?*/ECG(;Y&^\ ,A>?3TFB@#F=.TVYN?&UUXBDMI;2%].BLEBE*[Y&#L
MY8A20 -P [_>[8S%=6M_9>/KC5DTR:\M+C2H[53"R<2))(Q5@S# (<<].N<5
MU=% 'E]GX6U?PJ=%8:2VMVJ:<;.Z@MIE1H)/,:0,F]E#)\Y7J#@ UVO]C>9X
M-FT>""#33-:20)%!]RW+J0 ,=<9ZCK6W67!XBTNXU1-.BN2US()#&/+8))L.
MUPKXVL5/! )(H Y#2M-O;G2&BU/P5&E_:6$MN\DEPCK<DIM*0D-E5? R6VXZ
M<]1%%X;U 6=YIUQ!JM[HC-;FU6>X1;VT92Q8I*&R0AV$9)/W@,]^ZU75['1;
M%KW4)_)MT949]K-@L0 , $\DC\ZO4 >9R:/XHM5TK4;BUEUL6%Q<Q- SI%<R
MVTFS9(Q!"&12GJ,@]CFM(:-=IK7A:[M= %E;6]U=7%S#$\?[GS(F4%_F^9BQ
MR=N>O4XR>ZHH \T30M;BL[:7^R)V>W\4S:D81+%N:!S+AA\^,_.,@D'K5G4-
M-\0)>^+[NSTCS&O)+)K<.T3"58PHD*ACC< "5W@#(!KT*B@#R^]\/ZY<:3X[
MMX='NP=7AC^QB:ZC=W/DJA#$N<$$'/./3-=[J5M-J'AB\M8XRD]Q9O$J.1PS
M(0 2,CJ:TZJ1ZG9RR7J"7:;)@MP74HJ?*&^\0 1M(.1D4 <3I.G:WIVH^'-6
METJX,=OH_P#9=U:B2,R0L-C"08;:02A!P<XVG'4#H?"&C3Z-IMZ+A?+DO-0N
M+T0Y!\E9'+!,CC(&,XXR3C/6I;3Q9HU[JR:7!<RF]<!EB:VE3*E2P;)4#:0#
M@]#@@<UMT >>ZUX+U.^OM?MK240Z?=;-2M'5L%-0"[1Q_=RB.?<_6K6HZ+K,
MFEZ!J2VXFU*TU!=1OK1' \S>C*ZJ20"4#X7)&0@KJ[W5K'3KFSM[N;RY;V7R
M;<;&.]\$XR!@< GGTJ2^O[?3;<3W3LL9D2,%49SN9@J\*">I'/:@#S_Q#X;U
M74;3Q7?VNGRM+JQLHX;0O&K$0L"SMEMHR"1C.<*/6K?C?P[JOB/7='DLHY[=
M+>TN=UQN0JDK&%D5T+?.I,9##!&#7?57OKZWTVPGO;N3R[:!#)(^TG:HZG Y
MH K:'>7]]I$$VJ::^GWI4":W:17"MWVE201Z=Z\\T73;CQ!X+ATJ&SD3;X@F
MN#=L5"(D=Z[EASG<0I0#&<GTYKT6'5K&[FMK>*5V>[MC<Q8C<!HOE&=V, _,
M."0>:=I>DV6C6IMK"$Q0EVD*&1F^9B2Q^8GJ23]30!Q.F:+J%KJ=SI>H>&DO
MH3J4E[;:F\R&)4>4R@LA;<)%+$#"\D#D#FM3PY8:C8Z1XC2XTV:.6YU&[N((
M]\9,J2'*D8; /U(KIK._M]069K9V80S/ ^Y&7#J<,.0,C/<<'M4=GJUCJ%W>
MVMK-OGLI!'<)L8;&(W <CG@@\>M '#:-HFMZ3#X+OI-.F<Z9IK:=>VBNA>,L
ML?[Q/FVL-T>#SG!Z4V3PSJL(M[B/3Y)#<>*/[7D@5X\V\6TKSE@"QP&(&>6-
M>D54U+4K31].GU"^E\JUMT+RR;2VU1U. ": .<N]/U ^.=3U!-/EDM)=%2UC
ME5T^>422,5 +9Z..2 *QM/T37+6S\"(-*;SM*L98;KS)(RD<A@"*#ALD%A_#
MGBO18I$FB26,Y1U#*?4&G$@#). * /-M!TS7H=>T74KO0[N,Q:1/:72F>';'
M*6B8"-%?:L?R$+M [9 ZTFC>'M:MM/\  5M-IL\3Z7#-%>NLD9\DM T8(PW/
M)!XS7I5% '!^%['6TT"T\.:EH@MI=.MFM1J?F1NC+L**\6#O#$8)R!CGGM2>
M$--OX%TVWU3PJEO>Z3"8O[0:9)$DPFS,.&W MP3D  9%=[5&^U>QTV2TCNY_
M+:\G%O!\K-OD/1<@<=#U]* )--N;B\TZ"XNK*2RGD7<]O(ZLT9]"5)!_"L[Q
M)!=7]M;Z9%:SR6MW*$O)HG5?*A'+#E@3NP%XSPQ/:MNB@#B+K0]0T?Q_IFLZ
M5;7E[;W%N]IJ9>=3M0$-$PWL"2&W=,\$UH^%+&_TV]U^"[LWCBGU.6[AGWJ5
MD1PN, '((P<Y ]LUTU% 'G_B+P[K&K:SXF-I;&-+S2[:&UGD==CRQ22.5(!W
M '<HSCN:;-;:M>Z'?WUGX-CL-6\A(-EU)#-)*!(K,J'<5*J-Q7?@%L<>OH5%
M 'FR:!?37'B87N@:A+9:DUE)$&O4\_Y-H8AA)\KH1O'./E ![4\Z+XDCM=*>
M9+G5%T_7A<0F5HEN7M?(9 9#D*6#.><Y*@'KQ7HU% '.>.=-O=6\&WMI8P>=
M=L8G2(,!NV2(Y )P,X4XSBL:\T[5[O7/$EZ-(N$CO]#CM8 TD63*/-)4X?C_
M %B\].O/KWE% '":?I6JP:KX-GETR<1Z=I$MM='S(SY<C+$ OWN>8VY&1TJG
M'X>UD_!W^QCIKIJ<4HD^S&2/+[;D2\,&V\KZGK7H]% '%>*=.OKK4=$U+3S]
MBO[HMIUQ&[#?]GD4LW*Y&^/;O'.,Y&>:Z74M-6Z\/7>EV^V%9;5[>/' 0%"H
M_*B+0],@UJXUF.RB74;A DMQCYF4  #VX Z>@K0H Y+PY>S6OP\T1/[*N+V6
M*WBL[JVAV;HV1?+DR'8 @,I!&<^U9$_@>4Z=J<^G6BV;OJMOJMGI^555>'9N
M!P=JERK=#@9&>^/0(X(HI99(T"O*07(XW$#&3[XP,^P]*DH YG3]-GF\9W_B
M6[A:UB^P16,$<I7=M5FD=VP2 ,L .?X3[5%\/;.6V\-2W$JE/[0OKF^C0C!6
M.65F3\U(/XUT\\$5S"T,R!XV^\K=&'H?4>U24 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8
M'B35Y=/N]$L89?(.IWWV9KC /E@1N_&<C<Q0*,@]:WZS]9T33O$&GFQU2V$]
MN6#@;BI5AT96!!4CU!!H P;JXU;3OLMC/KB3SS:BZ((8$^TR0^676,#&P.."
M6( VCL37/_VK>ZQX<\(W6H/ONE\2F!W*J"WER3H"0O&<*,XXS79/X/T1[6SM
MS:R8LY3-#*MS*)5<C!8R!M[$C@Y)R.#38_!F@0V\$$5DT<4%V;V)$N)%"3$D
M[AAO5FXZ#)XYH P[75?$6M.VH:==VL-O:ZM+:W%O/(H3R8Y3&P/R%A(0 P^;
M&2.,5FC7O$,5L^H/K!D2W\2C3#;_ &>,+) TZQ?,<9R V001TYS78#P?H2Z\
M^M+8[;Z1Q)(5E<([CH[1@["P]2,]^M(?!^AM:R6QM93%)=_;F7[5+S/NW;\[
MLYW 'TR* .)\7ZE=^(/ _C*=;UX(-/NWLEMD1"&$93<7)&[+$DC!&!M]\ZGB
M7Q%JFGW5_<6-^9([.^LH##%$ACC61XU=)68;BY$A(V'@;<XSSO7_ ((\/ZE<
M7LUS9R$WP4721W,L:3XZ%T5@K$8ZD9HNO _AZ]DNGN+*1C=&-I@+J4!VCQL?
M ;&\;1\WWN.M %#3Y]:U#QQK=H=9:.QTVXMRD"V\9\Q'BW,A;&<9(Y'/%7=4
MU6X?QCIWAZ"X:T6>TFO))T52S!&10B[@1_&2>.B^]:5CH>GZ=J%W?6L+I<7>
MWSV,SL&VC"_*20,#C@"FZMX?TW6Y;6:]A<SVCE[>>&9X9(R1@X="& (ZC.#0
M!POA>[N[/0[6SBU%A-/KFHI(L42F>YVRRD[,C8O.&). !QD$BI;+Q-K:^&_#
MWB*]OF^Q+>RVFJH(HQE/->))2<<88)NQ@8)(QBNG3P/X?CB@2.SD3R+F2ZB9
M+J5721\[R&#9PV3D9P?2J=YX;-OIY\.:/I-JFBWXE%Y+)<MF$.V6"(0<Y!;&
M" "<XH K7VL:W#I-OJMLMY>6EQ=O*\5FD1N([3!"-&K#Y\_(Q'+8;%;^@WRZ
MOX8M;RVU$W0FB.V[\H*6/(R4P "".1CJ*LW6D6=Y]FWI(AM<^289GB*9&,?*
M1D8['BI+:T@TO3EMK&VQ%$IV1(>2>IY8\DDDY)Y)YH \YT;7_$YTKP;KMUJR
MW<.LRQVMU9_9D15+HQ$BD#=D%>1G!'85+'JOB5O!7B'7VU]O,T\:C'#$+2+;
MF&1@C$XZX0C'0@],C)V_ WA,:-X8T:#4K=QJ%A"4PUPTB(Y!!9!N(&02,@ X
M)'&36Q'X6T>/1[S25MI/L-ZTC7$1N)#O+DE^2V1DDYP><F@#&M=6U#6]>N='
MBOY+%K73+>Y\V.-&:627=\V&4C:NP<#'+&L6Q\1>(O$0\*I%J(TQ]4L[S[28
MK=),20LJATW@\$DG!R,'\:[27PSI4LUM-Y,R3V\'V>.:*YD23RO[A96!8<9Y
M)YYIX\.Z4MYI]TEKY<NG1F*T\N1T6)" "H4$+@@#J.PH Q/B)]JB\%$Q7T\,
MJW=FCR1;09 UQ&C Y!X(8G _ED&"35=5O[OQ/9V>IR6TNAQQI"6BC;SG,7F;
MY 5^Z<A<+MZ'VQU6J:79:UITNGZA#YUM+MWIN*G((8$%2""" 00>U4IO"NCS
MSM,UM()'@%O*4N)%\Z,9PLF&^?J?O9/)]30!#::I/K?@&'509+*XN].%Q^[Q
MNB9H]W&0>GN*XC3(;N:T^&(&HSB>:TD?SW5&:/-H,A>,'V+ ^^:]3\F+R/($
M:B+;LV <;<8QCTK%M/!^AV/]G?9[65/[.W?9/]*E/E;AM(&6Y&WC!R .!Q0!
MS&G>*-7FM--TR6Z$E[<:K>V+7C!(V=8&?;_"5#L%7^''!P!GCK/#@UB.PFAU
MNXMKBZBN'5)(6R3%P4\S"J ^#S@ =#WJO/X)\/7.E2:;-8,]M)<F[(:>0LLQ
M))D5]VY6R2<@CJ:U=.TVTTFR2TLXS'"N3\SEV)/4LS$EC[DDT <A\+7>;1=7
MFNCG4GUBZ^VY^\) ^ #[! N/:M"^U#[/XMT[P]82_8TODN;N>:(*6+IL^5=P
M(!)?<>.WOFM.?PSI<VIR:BL<]O=S ":2UN9(/-QTWA& 8CL3R*DNO#VF7D=H
MLMN0UFYDMY(Y&22-CD,0ZD-SDYYYSSF@#B3XD\0/#;6HOECN(?$ITB6X\A2+
MB+87#$= V, XP,@_2JFIW^KW%G/87&L7+M8^*K.S6X5(T>2)C"X#@+M)!?L
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M#ZU8O/$6NQZ9JCPZB%EM?$T.GQN\"-^Y=H05( &?]8W/!]ZZEO!NAMIJZ?\
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M^?;))'&"A\^')&U0,=#@YJC8>)=:'A3PIXCO-0+6LLXAU4"*-05=F1),[<J
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MQ&B(3*SP&0LVX$[<$*,8Z,<],=+<>$M%NTU-)[61UU3;]L!N9?WVT!1GYN.
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M')'_ #T&"<=#TK+;1)K?X06>F:@18:GIEG')#(65C'<0 ,K+M)R,C'J02.]
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MJUM(GB-+:>UN45);<^0S;&X(?! 93R"&[D9KK/'U]?:7X)O[W3KM[:Z@"%9
MJMG+J"""".03TP: .FHK@+PZTOB;6](3Q%?+ FE1ZA$XCAWQR%I5*@[,;/D!
MQC/OUR_P[KVIZKK&@I<7CB+4?#0OI8U50!-NB&]>,C[YXZ>U '>4FX;@N1N(
MR!WKS.T\2:])X,\/ZO-]LO8);.5]0>P$?VE&W )*(R,.HPV5 [C@]*T-$E:_
M^(R746JW%S;2>'[6X0\!)-\D@R%(R =H/KG\J .TN+Z*VN[6V=93)=,RQE(F
M9054L=S 87@=\9Z5#J6L66DR6:7DCHUY<+;0;8V8-(W0$@8'?KCI61KM_>VG
MC#PM;073I:WDUPEQ %4B0+ [KSC(P0.AKD)-0N?$6@>#?$,UY+NO-=A<VPV^
M7&-S@)C&<KC!.<DYSVP >JT5P5CJ6O:XW]IV>H6MM':ZO+;7$$LOR^2DIC\L
MIY>0Y 5@=W5AV.*S3J^NPVLVHMK=Q)]E\3C3Q"8H@DD#3K'AL+G.&X((Z4 >
MCWEY%96=Q<R[V2",R.L2%WP 3PHY)XZ"J]YK-I8P022^:SS@F*&.)FE?"[CA
M ,\#K^74UP5Q/J%@GQ,O[75;M)[+,D!.Q@A%I'(, J> <C'H?7FK]_%/=^./
M!4S7UPC2V%T[;-N,A(2>JGKGG],4 =M87UOJ5A!?6CE[>=!)&Q4J2IY'!Y'X
MU'J6G6&IVRQZA;Q311N)E\S^!EY# ]B/6N.M]4U6#6-0\+76I3OJ;WD<ME<E
M$!-FWS,0 N,J$D0DCJ5]:O\ Q*$H\"WABN9H&$L +1, 6!F12#QT(/\ D4 ;
MEIJ>G#5)="MLQW%I DAA$)14C8E5VG !'RD<>E:5><:O;7@\;:Y]EU6ZMIK?
MPY!()XUC+LRRW!&<J1C(YP!GV[RVVO:QXADL-.M[I+6ZGT"WU$.LHC+22Y!8
M#8^0I4<<??YSQ0!Z%17/7=SJ<'@"YNI;V'^U(-/=VN;4 H940DLH88P2.A%<
MYIUYK]OJ_A1IM:N+RWUVR?[1$\48^SNL(D62/"\<\$-NZB@#T2BO+=+US7(_
M"7AW5KO6[B>;6[N"QD+11!+?<[Y=<+]XA0O.1E@<=!4WB;7==T7_ (2:PM=1
ME(L[>TO+6Y=$9HQ+*8VB;(PP^4D'KSUH ],HKS'Q!XAU[P9J.LQG49=3MSI/
MVZ%KF) ;:7SEC/W ,IA]V#S\AYZULZA?:OI'B2WTZTU#[5#?Z7<S(]WMQ!-$
M%Q(64#Y&WC(Z# QB@#M:*\R_X3*^LK6XM[IKVQU0365O/;ZALVP"20JTR2JI
M5D;H#@A2.G:KVHZEK_AXFUO-1@:/4-3M+:U<.));2.7(<L2B@Y*$(2#R><XH
M ["UUBRO=5OM-@D<W5B(S<(T;*%WY*X)&#G:>F:OUQGAJW:U^(OBZ-KB6<>1
M8%6E(+*-LO&0.?QI;AM6O?B-=:7%K=U:V4-A;7BQ11Q'YC+(K+DJ3M(3GOZ$
M=" =E17 ^']1U_7[71]>BU*VAM+EW6[MVE#<'("(OE_*Z-@<L<X.<UDZ=J_B
M1-"\-^('UR>[:YU06-S9O#$(Y(GG>/<-J@AQ@'.<8'2@#T73-8LM8%V;*1W^
MR7#6TV^-D*R* 2,, ?XAS5^O-["]DLXO$"Q7K6TEQXI,*B.,/)-E(B8TSP&(
M!^8\ 9/'6BR\4:FL4-A=W3QF?Q'+I?VE]I>.((SJN<8+$@)G'?UYH ](HKB;
MZ_U32;[3]%;5DNFO]0E1)G(B>*,1;TA+A6!?T;&2/<YJI=3^)=/DT*QNM<0R
MSZU):2/;JCL8#"\B!RR#]XN%Y  /!(- 'H-%>6W.JZ]9:#KMZ->NI'T76DMH
M5>.+$T1:$E9<)SQ*P&-O05JW&I:]K%UKATK4+6RDTF^6(+/+A!&JHS>8GEDD
M,"V#N&.,8P<@'>TFX;BN1N R1W_SQ7F.N:OKUK;^,KV'6[A1HM[";6(11;64
MQQ.4?Y<E?G8<8//4\8WM$CF;XF>*6>]N7CC@LML3,"@!64X'' !R>/4YS0!V
M-%<3XSU6^M9=1CT_494FM=(ENQ! B@QN,[99&;(*_*0$ .>>.XSY-1UK4]6N
M($UJYM(CX=@U%5@CBRDS%P<%E/R_*.#D^XH ]%=@B,QSA1DX!)_(=:IZ3JUG
MKFF0ZC82-):S;MC,A0G#%3P0".0>M<?H?B*^\17NAZ?/=O:M/X>AU69X JM+
M))A>,@X53DX'=AVX.A\,@R_#W3%9][ S MC&3YS\T =;1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !5+4M)L=7CA2^A,JPRK-&-[+M=3E6X(Y!Z>E7:S-9
MU[3] BMI-0DD1;B=8(RD+/EVZ#Y0<?U[4 1:OX5T/7KFWN=3TZ*XGMP5CD8D
M,%/5201E?8Y%9/\ PB[7/C?4-1NK8#3I]/ALXA%<,A^1G+!E4CY2' QSTZ5.
M/'V@C3+^^EDNH%L)EANHIK61)86;&W<A&0#D88\>]7(O%-C/M2*"^:X<R;;9
MK5TE94(#/M8#Y>1@]\@#GB@"U-H6F3WEK=26BF6TC:*#!(6-& #*%!Q@@ $8
M[#TJI8^#O#^FSVLUII<,<MJK) V6)16QE1D].!@=!VQ21^+]'F32GAFDDCU2
M0PVLBQ-M,@!)1LCY6&UN#@\$=:BUK7;&.U99;R^LA'J$%J9H(<[I"Z83.TC:
MVX GW(SF@"SI/A/0M#EGETW3(;=I@0^W) !.2%!.%!/4# J*P\%>'-,ANX;'
M2XH([M&CE5&891NJCGY5/<+@5C_$#Q.VG^$]=;2KBZCO;&(;[BWB#K"Y (5B
M0>2",X' ()QD&MW5/$VG:-'/)=M,8K95>ZDBB+K K="^/SXR0.3QS0!+'X<T
MJ&:QECMF62QB,-JPF?\ =(< J.>F /R'H*JS^"_#MUI2:9/IB26B3&X1&=\I
M(2265LY4DDDX/<^M:6H:K9:7I<FHW4P6U0 EU!;.X@+C'7)( ^M9=QXSTBSL
MK^YNVN(!I\R074;0L6B=PI7.W(P0R_-G'/6@"XGAS28WL'CLQ&VGAA:['9?*
MW?>Q@]3W)Z]ZB/A/0VLOL;6"M!]I^UA6D<XFR27!SD$DG/KD^M2Z7X@L=7O;
MRSMQ<1W-GL,L<\#1-M?.U@& R#M//L:35?$-CHZSM<"9Q;0_:+CR8B_DQ<_.
MV.WRMTR>#QP: )]2T?3]8L!97]JDUN&5U3E=K*<J5(P001U%4/\ A#?#_ESH
M-,C59YDGE",R[Y$QM8X/4;0?J,]:;/XRT:WNOL[S2EVL_MT3+$2LT/',9Z.?
MF'RC)Y''--U'QGI>F7C64T=^]XML+HV\-G)(_EDXS@#G'.?3'- %JX\+Z+=F
M_-S8I/\ V@BI="5V82A?NY!/;L>W:G:=X:TC2;QKRSM-ETT2PM,\CR.44D@%
MF))QDUB7/B W_B#P;<Z3J+2:5J;7!=$ VRJ(&92<C<"".F1TY%:EIXMTJ]N[
M>"%YC]I$WV:3RCLG\HXD"D<Y'N!GMF@!^H^%-#U>ZFN;_38IYIX/L\K,3^\C
MYP& .#C)P>H[8J\^EV<FE-IC0#[$T?E&)6(!3&",@YY_6L:P\<Z)J4U@EN]U
MLOY'BMYI+5TC:1-V4W$8#81CCV]>*L0>+-*N+^"TC>4_:)IH()?+.R62+/F(
MI]1M;KP=IQF@"6\\,:+J&B1:->6"3V$.WRHG9CY>W[I5LY!'0$'IQ44_@_P_
M<6%I92:9$8;-S);A696C8]2&!W9/?GGOFL9?&5KJGAN:_N&U'28EU$6JRQP[
MFRL_E@$X8#<5P?3=C.:W-1\3Z;IC7?GM*T=D%-Y+%&76W##(+D>Q!.,X!!.
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MM98UCMS(+=&5R['8O"\ Y//'M727WB.PL7E4^=.T$ N9A;QF0Q1'.&./7:<
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MN[EHY8HIVMHMX@:3[F\ YQT)P#@$$X%:<MQ'""&)+[&<1J,LP&,X'4]1^8H
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M7A+P]=:'J5R8$N++1Y($"Z=-<"989\G<8CD[8\8XR.>PKKZ* "BBB@ HHHH
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MZ,8X5LXKEV)WX/FG#_/C[N,GKNQQ5+4H;S4?B1_9@UC4+6S.DBY\NVE"8<3
M9Z=QU_PJWX9\)0Z+?O?KINEZ;*T1B,.FAMC@D'<Q(&2,<?+QD\G-;YTNP.IC
M4C9P?;PGEBY\L>9L_N[NN/:@#AM$O]1UP6>KKK4=K-#J<D%W:F5FW*)&3R#%
MG:K8VD-C/&3G)JG;:Y=:AX?\)Z\NI7"WFI:O%%=1).P0*6;=#Y><#;M Z9XY
M/)SWT?A[1HM9?6(]*LUU)QAKM85$AXQ][&>G%8>M^"[:>^L;W1M.TVVNDU**
M]NIBOEM*$SD953DDG/- '/7NL7UOX;\02#4KA9K3Q+%;6[&8[EC:2 %.3R-K
MOP<]:F\0ZEJ=O_PL3R=3NX_L.FP7%KM<#R6,<K';QQDJ/?WKM+CPQH-W=7%S
M<Z/8S3W&WSI)(%8R;2"N[(YP57\AZ4^7P]HLS732Z59N;M0EP6A4^<HZ!N/F
M ]#0!R5W+<:9JNB:5+JUU)#K"S3O+=73)F54CVQ(Z8*@Y=MH/4>G%0JNK1:K
MX5TNX\1W%TLTM[#<2V[;/-5$8J">I9?NEAW&>#S7:7V@Z1J6FIIM]IMK<628
MV02Q!D7'3 /3'M2C0])5K-ETVT!LEVVI$*CR!C&$X^7CTH \YAN]3MM)AO?[
M9U"66R\3_P!FH))LJ]O]J\HK(/XSM/4Y(P,8K2MK_4-;NKVZCUN.PN=.UEX)
M(FE<CREDVK&8ONGS%P0W7+<'M78?\(UH9@,']D67DF;[04\A=IESG?C'WL\Y
MZTYO#NBOK*:PVE6;:D@PMV85\P<8^]C/3B@#SRYO-4@TW6=4&M:@TVG^)8[:
M%#+^[,32PJR,H&&&'/!Z=1@YS<^SW2>(?'3:=>-%?F:T2W^T73B,EXT.SJ<;
MB2H('RYXQ7:MX;T-X9H6TBR:*:7SY4,"X>3^^PQRWOUI\_A_1KJ>:>XTJSEF
MGC6*61X%+.BG*@DCD @?D* .3@ODU;P5XLM+RWOK2XABF2YM+V;S3;DP @))
MD[D/W@<]STKH_"E_)?>%=$EO) ;Z?3H)Y5)^8DHN3CKU-/OM MKK2I]+A1+>
MTNR1=E!\\B$ ,,^K ;<GD#IVQ=33;*.^6]2TA6Z6#[.LP0!A%G.P'^[GG% %
MJO'98EE^"_B\LSC9J&H,-CE<GSVZX/(YZ'BO864.I5AE2,$>M9:^&="6PFL%
MT>Q%G.V^6 0+Y<C>K+C!- %K[)&FEM:AYRAC9=QG<R<Y_CSNSSUSQ7E>B6RR
M^&_AC&MU<*\TS,[B8LZDVDN<%L[>G;IVYKUR**.")8HD5(U&%51@ 5FP^&="
MM_(\G1[&/R)&EAV6ZCRW/5EP."?44 <'9Z]?6[6VCW&H2&V;7;RP%S<SLK%4
M4M'&TH^;))X.<G:!GFNV\,07=KIT]M>:HNHO%<R*D@R2B'!6-F/+E0<;NI[\
MYJ:7PSH4UC<64FCV+VMS)YLT1@7;(_\ >(QRWOUJ]965KIUG%9V5M%;6T0VQ
MQ1(%51[ 4 <%H=]J.O+8ZNNMQVDT>HR0WEL96?<-[)Y!B/RJP^4AL9XR<Y-9
MD5UJO]C:??\ ]N:E]H/B5]/),H*F$W+QX*XVD[<8)!Q@8KT2/P[HL6L2:O'I
M5FFI2 A[I85$C9X/S8STXI!X:T,0+ -(LO)6;[0L?D+M$N<[P,?>SSGK0!P&
MLW^IZ7I7C2TMM7OE&G7EF;:627?(BRB(NNYN=N6/TS5O4TU#2]6\2:5_:=Y?
M:=/X>FO&%VX<P399,*0!A6&3MZ94XK?\5^$HM6T'4K33+.PAO-0>(SS2+M\P
M(ZM\Q"DMPN.?6MF+1=.6SFMVT^V$=RH6XCV[ED&,;3D?,!T&>U '&Z#>2ZAJ
M.C>'YY[B"T7PW!=1>1*T32R$A&.Y2#\H"\9Q\_(/%4X-8UB+PMHOBB^O+AXM
M.O9;?40K%4N;82/$)RHXRORN<<$;NV*[V30-(E@M8'TVV,5H"+=1&!Y0(P0O
MH,<8%4]7TJ_O4@TRT-A!HDD1ANXS$WF;.!LCP0H!7*G/3/% '.7>K744VAI-
M=O!;Z[=3R[IKAXPJ[<PQ!@<H2N&P"/F!'3BHC?:CI]]H^@7NMQW45U-=J+GS
MGB)*;#' 95.XL [<@@DH,]P>YU+2=/UBQ:RU*RM[NU8@F*:,.N1T.#WJO<>&
M]$N](CTFXTFRDTZ+'EVS0*8TQTPN,#OT]: (/#J7MIH!BN]175;B!Y%$ZC!<
M!CA2?XF'W2>Y'/.:XZQUK4Y_#/A/Q'!>SRWVH:A#!>VYD)C=9&99$"'A3'@D
M$ 'Y#G.37H]M:V]E:QVUK!'!!$H6.*-0JH!T  X JK!HNEVMXUY!86T=PSLY
MD2, [C]YOJ>YZF@#F?"EE'%XY\92+)<$I=P !YW8<VT9Y!.#[9Z=!3FMXS\8
M6D:6<8T57"^>X7=YQ7[N<8Z<8QGWKI[;2M/LKN>ZM;*WAN+@YFECC"M(?5B.
MOXT7.DZ=>7D=W<V-M-<Q(T<<TD09T5NH!/(!H \R\$/=:?I_P[:*_NC%J$$T
M$]NTF8BJPNZX7H""HYZ\G)K5\+W^H:[#HFO?VW'"\LKI>V9E=_,8Y!A\L\(R
M$9R!G"\YR378P^'=%MQ:"'2K.,69)M@D*CR2>NSCY?PI;?P]HUIJTVJVVE6<
M.H39\RY2%1(^>N6QGGOZT :5%%% !1110 4444 %%%% !1110 4444 %%%%
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MR/WF,\=.G.!@6'@W7SJ.C76J-ITLMK'=07MRDSM+<K* -_*#!XQLSA<\''%
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MIR>)(( BSV=W#/)=BSAAD\L&60Q^8-IW[<;<\YZ@CKQ6A:7GVRQ^TBVGB;+
MPR@!P5)!'7'4<<XKC(/ \L&DW&EO9VEWH\UXLB:9=73N+:(1D$12%25;S,,
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MZB:TGA$$@19)0 LPV@[DP3D<XYQR#7$Z6UY%K^H^$;B[OY)$O%OXKA[F0O\
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MM$=-NU'*LPW9.<84] :U: .,@\*:MIMQJ_V.\M[F+5[>-9Y+HLKQS+$(C(
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MXKT^:W@N+=H)X8Y86&&C=0RD>A!XJ%M,L'1T>QMF23:'4Q*0VT8&>.<#@>E
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M8=0"KD9&<$ ^U3:KX+N=3T[7#]HMXM0UB:W>5L,8XDA*[5'0M]T\\?>/'&*
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M;X\NK;=H<<YX/(Y[=:YVW\$ZO&[2/>Z:IDT9M,>.&W=1DDG?G<<G))/KT]Z
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M4;",GEH,D@8?.23R/?CJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ (R,'I111
M0 4444 %%%% !1110 4444 %%%% !1110 A4'J ?K2T44 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 48&<XYHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M.E%% "$ ]0#]:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[6U?_H6KK_P*A_\ BJVJ* ,7^UM7_P"A:NO_  *A_P#BJ/[6U?\ Z%JZ_P#
MJ'_XJMJB@#%_M;5_^A:NO_ J'_XJC^UM7_Z%JZ_\"H?_ (JMJB@#%_M;5_\
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MHH Q?[6U?_H6KK_P*A_^*H_M;5_^A:NO_ J'_P"*K:HH Q?[6U?_ *%JZ_\
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M?^@EJ_\ X'R?XT ;5%8O_"-P_P#02U?_ ,#Y/\:/^$;A_P"@EJ__ ('R?XT
M;5%8O_"-P_\ 02U?_P #Y/\ &C_A&X?^@EJ__@?)_C0!M45B_P#"-P_]!+5_
M_ ^3_&C_ (1N'_H):O\ ^!\G^- &U16+_P (W#_T$M7_ / ^3_&C_A&X?^@E
MJ_\ X'R?XT ;5%8O_"-P_P#02U?_ ,#Y/\:/^$;A_P"@EJ__ ('R?XT ;5%8
MO_"-P_\ 02U?_P #Y/\ &C_A&X?^@EJ__@?)_C0!M45B_P#"-P_]!+5__ ^3
M_&C_ (1N'_H):O\ ^!\G^- &U16+_P (W#_T$M7_ / ^3_&C_A&X?^@EJ_\
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M&>> 3]!0!TU%8O\ PC</_02U?_P/D_QH_P"$;A_Z"6K_ /@?)_C0!M45B_\
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M_P#P/D_QH_X1N'_H):O_ .!\G^- &U16+_PC</\ T$M7_P# ^3_&C_A&X?\
MH):O_P"!\G^- &U16+_PC</_ $$M7_\  ^3_ !H_X1N'_H):O_X'R?XT ;5%
M8O\ PC</_02U?_P/D_QH_P"$;A_Z"6K_ /@?)_C0!M45B_\ "-P_]!+5_P#P
M/D_QH_X1N'_H):O_ .!\G^- &U16+_PC</\ T$M7_P# ^3_&C_A&X?\ H):O
M_P"!\G^- &U16+_PC</_ $$M7_\  ^3_ !H_X1N'_H):O_X'R?XT ;5%8O\
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M //OJ_\ X)[O_P"-T ;5%8O_  E6G_\ /OJ__@GN_P#XW1_PE6G_ //OJ_\
MX)[O_P"-T ;5%8O_  E6G_\ /OJ__@GN_P#XW1_PE6G_ //OJ_\ X)[O_P"-
MT ;5%8O_  E6G_\ /OJ__@GN_P#XW1_PE6G_ //OJ_\ X)[O_P"-T ;5%8O_
M  E6G_\ /OJ__@GN_P#XW1_PE6G_ //OJ_\ X)[O_P"-T ;5%8O_  E6G_\
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M_P#X)[O_ .-T ;5%8O\ PE6G_P#/OJ__ ()[O_XW1_PE6G_\^^K_ /@GN_\
MXW0!M45B_P#"5:?_ ,^^K_\ @GN__C='_"5:?_S[ZO\ ^">[_P#C= &U16+_
M ,)5I_\ S[ZO_P"">[_^-T?\)5I__/OJ_P#X)[O_ .-T ;5%8O\ PE6G_P#/
MOJ__ ()[O_XW1_PE6G_\^^K_ /@GN_\ XW0!M45B_P#"5:?_ ,^^K_\ @GN_
M_C='_"5:?_S[ZO\ ^">[_P#C= &U16+_ ,)5I_\ S[ZO_P"">[_^-T?\)5I_
M_/OJ_P#X)[O_ .-T ;5%8O\ PE6G_P#/OJ__ ()[O_XW1_PE6G_\^^K_ /@G
MN_\ XW0!M45B_P#"5:?_ ,^^K_\ @GN__C='_"5:?_S[ZO\ ^">[_P#C= &U
M16+_ ,)5I_\ S[ZO_P"">[_^-T?\)5I__/OJ_P#X)[O_ .-T ;5%8O\ PE6G
M_P#/OJ__ ()[O_XW1_PE6G_\^^K_ /@GN_\ XW0!M45B_P#"5:?_ ,^^K_\
M@GN__C='_"5:?_S[ZO\ ^">[_P#C= &U16+_ ,)5I_\ S[ZO_P"">[_^-T?\
M)5I__/OJ_P#X)[O_ .-T ;5%8O\ PE6G_P#/OJ__ ()[O_XW1_PE6G_\^^K_
M /@GN_\ XW0!M45B_P#"5:?_ ,^^K_\ @GN__C='_"5:?_S[ZO\ ^">[_P#C
M= &U16+_ ,)5I_\ S[ZO_P"">[_^-T?\)5I__/OJ_P#X)[O_ .-T ;5%8O\
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M7PC_ ,BCI7_7NM;5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD^9SP*M?8?$7_0<L_P#P7'_X[47@4EOA]X;))).EVQ)/_7):Z"@#$^P^(O\
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M(O\ H.6?_@N/_P =H^P^(O\ H.6?_@N/_P =K;HH Q/L/B+_ *#EG_X+C_\
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MAI& LYN&? +#(_3I0!L?8?$7_0<L_P#P7'_X[1]A\1?]!RS_ /!<?_CM;=%
M&)]A\1?]!RS_ /!<?_CM'V'Q%_T'+/\ \%Q_^.UMT4 8GV'Q%_T'+/\ \%Q_
M^.T?8?$7_0<L_P#P7'_X[6W10!B?8?$7_0<L_P#P7'_X[1]A\1?]!RS_ /!<
M?_CM;=% &)]A\1?]!RS_ /!<?_CM'V'Q%_T'+/\ \%Q_^.UMT4 8GV'Q%_T'
M+/\ \%Q_^.T?8?$7_0<L_P#P7'_X[6W10!B?8?$7_0<L_P#P7'_X[1]A\1?]
M!RS_ /!<?_CM;=% &)]A\1?]!RS_ /!<?_CM'V'Q%_T'+/\ \%Q_^.UMT4 8
MGV'Q%_T'+/\ \%Q_^.T?8?$7_0<L_P#P7'_X[6W10!B?8?$7_0<L_P#P7'_X
M[1]A\1?]!RS_ /!<?_CM;=% &)]A\1?]!RS_ /!<?_CM'V'Q%_T'+/\ \%Q_
M^.UMT4 8GV'Q%_T'+/\ \%Q_^.T?8?$7_0<L_P#P7'_X[6W10!B?8?$7_0<L
M_P#P7'_X[1]A\1?]!RS_ /!<?_CM;=% &)]A\1?]!RS_ /!<?_CM'V'Q%_T'
M+/\ \%Q_^.UMT4 8GV'Q%_T'+/\ \%Q_^.T?8?$7_0<L_P#P7'_X[6W10!B?
M8?$7_0<L_P#P7'_X[1]A\1?]!RS_ /!<?_CM;=% &)]A\1?]!RS_ /!<?_CM
M'V'Q%_T'+/\ \%Q_^.UMT4 8GV'Q%_T'+/\ \%Q_^.T?8?$7_0<L_P#P7'_X
M[6W10!B?8?$7_0<L_P#P7'_X[1]A\1?]!RS_ /!<?_CM;=% &)]A\1?]!RS_
M /!<?_CM'V'Q%_T'+/\ \%Q_^.UMT4 8GV'Q%_T'+/\ \%Q_^.T?8?$7_0<L
M_P#P7'_X[6W10!B?8?$7_0<L_P#P7'_X[1]A\1?]!RS_ /!<?_CM;=% &)]A
M\1?]!RS_ /!<?_CM'V'Q%_T'+/\ \%Q_^.UMT4 8GV'Q%_T'+/\ \%Q_^.T?
M8?$7_0<L_P#P7'_X[6W10!B?8?$7_0<L_P#P7'_X[1]A\1?]!RS_ /!<?_CM
M;=% &)]A\1?]!RS_ /!<?_CM'V'Q%_T'+/\ \%Q_^.UMT4 8GV'Q%_T'+/\
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MN"<'B@!O@K6-,M_ GAZ"?4K.*:/3;='C>=596$:@@@G@BMW^WM'_ .@M8?\
M@2G^-0Z.=,UG1;'5(-/B2&\MX[A%>)=P5U# ''?FKO\ 9MC_ ,^5O_WZ7_"@
M"#^WM'_Z"UA_X$I_C1_;VC_]!:P_\"4_QJ?^S;'_ )\K?_OTO^%']FV/_/E;
M_P#?I?\ "@"#^WM'_P"@M8?^!*?XT?V]H_\ T%K#_P "4_QJ?^S;'_GRM_\
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M^S;'_GRM_P#OTO\ A1_9MC_SY6__ 'Z7_"@"#^WM'_Z"UA_X$I_C1_;VC_\
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M'_Z"UA_X$I_C1_;VC_\ 06L/_ E/\:G_ +-L?^?*W_[]+_A1_9MC_P ^5O\
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MPH @_M[1_P#H+6'_ ($I_C1_;VC_ /06L/\ P)3_ !J?^S;'_GRM_P#OTO\
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MW_[]+_A1_9MC_P ^5O\ ]^E_PH @_M[1_P#H+6'_ ($I_C1_;VC_ /06L/\
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M#63_ .1Z/M7B?_H#Z1_X-9/_ )'H VZ*Q/M7B?\ Z ^D?^#63_Y'H^U>)_\
MH#Z1_P"#63_Y'H VZ*Q/M7B?_H#Z1_X-9/\ Y'H^U>)_^@/I'_@UD_\ D>@#
M;HK$^U>)_P#H#Z1_X-9/_D>C[5XG_P"@/I'_ (-9/_D>@#;HK$^U>)_^@/I'
M_@UD_P#D>C[5XG_Z ^D?^#63_P"1Z -NBL3[5XG_ .@/I'_@UD_^1Z/M7B?_
M * ^D?\ @UD_^1Z -NO/="_Y'NQ_ZXZU_P"E\==/]J\3_P#0'TC_ ,&LG_R/
M7':3IWBN;48=8L+;1D:VGU&W=)[N5@PDN]S8Q&,8,> ><@YP.E '4W7@K2;S
M75U619O-^9G E;+.3&58-G<NWR\ *0,,W')R:EX*TG5=8&HW"S>8<^:%E8%S
MA0N&SE-NW(V$<DYZU8^U>)_^@/I'_@UD_P#D>C[5XG_Z ^D?^#63_P"1Z (M
M:\'Z7KM_!>72R>;&P#X<D.FQUV#GY.7W97!RJ\\"JGB&)8-?\%1)NV)J,BKN
M8L<"TG')/)^IK0^U>)_^@/I'_@UD_P#D>L;4=/\ &&HZ]I5\]GH:6VG3M.D
MO9=[L8GCY?RL8^<G[O:@#M**Q/M7B?\ Z ^D?^#63_Y'H^U>)_\ H#Z1_P"#
M63_Y'H VZ*Q/M7B?_H#Z1_X-9/\ Y'H^U>)_^@/I'_@UD_\ D>@#;HK$^U>)
M_P#H#Z1_X-9/_D>C[5XG_P"@/I'_ (-9/_D>@#;HK$^U>)_^@/I'_@UD_P#D
M>C[5XG_Z ^D?^#63_P"1Z -NBL3[5XG_ .@/I'_@UD_^1Z/M7B?_ * ^D?\
M@UD_^1Z -NBL3[5XG_Z ^D?^#63_ .1Z/M7B?_H#Z1_X-9/_ )'H VZ*Q/M7
MB?\ Z ^D?^#63_Y'H^U>)_\ H#Z1_P"#63_Y'H VZ*Q/M7B?_H#Z1_X-9/\
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M#63_ .1Z/M7B?_H#Z1_X-9/_ )'H VZ*Q/M7B?\ Z ^D?^#63_Y'H^U>)_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?_O_ "?_ !5'_"):)_SZ/_W_ )/_ (JMNB@#$_X1+1/^?1_^_P#)_P#%4?\
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MM$_Y]'_[_P G_P 51_PB6B?\^C_]_P"3_P"*K;HH Q/^$2T3_GT?_O\ R?\
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M (JMNB@#$_X1+1/^?1_^_P#)_P#%4?\ "):)_P ^C_\ ?^3_ .*K;HH Q/\
MA$M$_P"?1_\ O_)_\51_PB6B?\^C_P#?^3_XJMNB@#$_X1+1/^?1_P#O_)_\
M51_PB6B?\^C_ /?^3_XJMNB@#$_X1+1/^?1_^_\ )_\ %4?\(EHG_/H__?\
MD_\ BJVZ* ,3_A$M$_Y]'_[_ ,G_ ,51_P (EHG_ #Z/_P!_Y/\ XJMNB@#$
M_P"$2T3_ )]'_P"_\G_Q5'_"):)_SZ/_ -_Y/_BJVZ* ,3_A$M$_Y]'_ ._\
MG_Q5'_"):)_SZ/\ ]_Y/_BJVZ* ,3_A$M$_Y]'_[_P G_P 51_PB6B?\^C_]
M_P"3_P"*K;HH Q/^$2T3_GT?_O\ R?\ Q5'_  B6B?\ /H__ '_D_P#BJVZ*
M ,3_ (1+1/\ GT?_ +_R?_%4?\(EHG_/H_\ W_D_^*K;HH Q/^$2T3_GT?\
M[_R?_%4?\(EHG_/H_P#W_D_^*K;HH Q/^$2T3_GT?_O_ "?_ !5'_"):)_SZ
M/_W_ )/_ (JMNB@#$_X1+1/^?1_^_P#)_P#%4?\ "):)_P ^C_\ ?^3_ .*K
M;HH Q/\ A$M$_P"?1_\ O_)_\51_PB6B?\^C_P#?^3_XJMNB@#$_X1+1/^?1
M_P#O_)_\51_PB6B?\^C_ /?^3_XJMNB@#$_X1+1/^?1_^_\ )_\ %4?\(EHG
M_/H__?\ D_\ BJVZ* ,3_A$M$_Y]'_[_ ,G_ ,51_P (EHG_ #Z/_P!_Y/\
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M_"):)_SZ/_W_ )/_ (JMNB@#$_X1+1/^?1_^_P#)_P#%4?\ "):)_P ^C_\
M?^3_ .*K;HH Q/!ZA/!^DJHP!;( /PK;K%\(_P#(HZ5_U[K6U0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ% &3P,2']*35RZ=1P=UYK[]#H/[>NO^A;UC\H/_ ([1_;UU_P!"WK'Y0?\
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M"WK'Y0?_ !VC^WKK_H6]8_*#_P".UMT4 8G]O77_ $+>L?E!_P#':/[>NO\
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M ([6W10!B>#R6\'Z22I4FV0X/4<5MUB^$?\ D4=*_P"O=:VJ "BBB@ HHHH
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M$U'_ *&K5O\ OS:?_&:/[$U'_H:M6_[\VG_QF@#;HK$_L34?^AJU;_OS:?\
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MS)!&\\ 812,N63=PV#VS@5E?V)J/_0U:M_WYM/\ XS1_8FH_]#5JW_?FT_\
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M_OS:?_&:/[$U'_H:M6_[\VG_ ,9H VZ*Q/[$U'_H:M6_[\VG_P 9H_L34?\
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MFC^Q-1_Z&K5O^_-I_P#&: -NBL3^Q-1_Z&K5O^_-I_\ &:/[$U'_ *&K5O\
MOS:?_&: %\(_\BCI7_7NM;55-+T^/2M+MK"*221+>,1J\F-S8[G  S] *MT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<5TC-(1U  /-><>%M&U5O%'@JZ6QO+2WT70VM]1,T#QYD*E?+&1\YW#=QD<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH R=.\.:?I>JWVI6RS>?>R&64/*S*&(4,5!Z9VKGZ"M
M:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJCJ-Q
MJ,3P)IUE#<L['S&GG,2QJ!UR%8DDX&,>OI0!>HKDO#WBC6?$%C!?1Z+:1VTE
MQ/;N1?,S(8RZ[B/*'RED ZY ;..U:'A3Q$OB+P]I]_*(8+JZA\XVRR;BHR1]
M2..N* -VBHENK=[E[99XFG09:(."RCU(ZBLS7M?CT4V5ND)N;_4)O(M+96V[
MVQEB3_"J@$DX./0G H V**R%OM7AU"RM[K3[=H;EV5I[><L(B$9AE2HX.W&?
MY<9TH[JWEGD@CGB>:/[\:N"R_4=J ):*A6\MFE6);B$R/NVH'&3@X.!['K52
MSUW3+][U;:\A?[',8)B'&%<!21GVW ?7(H T:*K/J%E'$)7O+=8RQ0,TJ@%A
MU&<]?:I)[JWM4#W$\4*$X#2.%!/IS0!+15!M9T]=:32#=1_;FA,_E;AD("!D
M_4GCUP?2K4=U;S320Q3Q/+']]%<%E^H[4 2T5$EU;RR>7'/$\F"=JN"< X)Q
M]>/K227=M#-'#+<1)+)]Q&<!F^@[T 345%)=6\,J1RSQ)))PBLX!;Z#O1)=6
M\3A))XD8XP&< G)P/S- $M%1+=6[7+6RSQ&=1N:(.-P'J1UH2ZMY+A[=)XFF
MCY>-7!9?J.HH EHJ&&[MKDN(+B*4H<,(W#;3[XZ56&LZ>VM-I"W,9ODB$S1!
MAE5)P,^YP?RH OT5%%=6\\LD44\4DD9PZ(X)0^X[43W,%K$9;B:.&,'&^1@H
M_,T 2T5#+=VT$:22W$4<;D!&=P V>F#WI'O+6-XT>YA5Y1F-6< O]/6@">BJ
M=M/<M=7RW'V58(G40F.0L^W:"?,!'RG.<8SQBIH[NVFA,T5Q$\2YRZN"HQUY
MH FHJ**Y@FD>.*>.1T +*K@E<],CMFJMUK.GV>IVFG3W,:7=V&,4189(7J?I
MT'U- %^BHA=6YN3;">(S@;C%O&X#UQUJOJFK6.BV@NK^X2&)I$B4L0-SL0J@
M>^30!=HKG['Q*+CQ'K&FW(MH+>R6V:&?SL^;YH<CJ  ?EX S6W/=6]ML^T3Q
M1;VVIYCA=Q]!GJ: ):**BANK>YW^1/%+L.U]CAMI]#CH: ):*AAN[:X1W@N(
MI50X9D<,%/OCI31?6AWXNH#Y:"1\2#Y5(R&/H,=Z +%%9^GZYINJ:;#J%K>1
M-;39,;EP P&3_(9^E6/MUIYD4?VJ#?,-T2^8,N/51W_"@"Q144EU;Q31PR3Q
M)+)]Q&<!F^@[U5L]9T_4+Z\LK6YCEGLW$<ZJP.UL X_ $9^M %^BLB]\06D%
MU>:?;RPRZE;6WV@V[2;>.< G!(SM/8\"CPWK::[H.FWSF*.YN[.*Z>W1\E-Z
M@].N.>M &O142W5N]P]ND\33H,M&'!91[CJ*1+NVDG>".XB:9/O1JX++]1VH
M FHJ*&ZM[AY$AGBD:([9%1P2A]#CI23W5O; F>XBB &XF1PN!G&>>V2* )J*
MBFNK>V@\^>>**+C]X[A5YZ<FDEN[:!0TMQ%&I7<"[@#''/TY'YT 345"+NV-
MR;87$1G')BWC=Z].M*EU;RSO!'/$\T?WXU<%E^H[4 2T5"+RV,JQ"XA,CDA4
MWC)(ZX'MWH%W;&Y-L+B+SQR8MXW>O3K0!-143W,$<@C>:-7(R%9@#CUQ^%-%
MY;-&&2XA8,VU3Y@P6],^M $]%8'A?Q'_ &[IOG72P6UT;FX@$"2[LB*5DR,X
M)^[GI6T;JW%R+8SQ"=AN$1<;B/7'6@"6BH3=VRW(MC<1"<C(B+C=CZ=:5;JW
M>Y:V6>(SH-S1!QN ]2.M $M%1RSPP &:5(P<X+L!G R>OL"?PIC7MJK0JUS"
M&G_U0,@S)_N^OX4 3T5 ]Y:QS^0]S"LV-WELX#8]<4HNK=A&5N(CYA(3#CYO
MIZT 345"UY:K(L;7,(=G\L*7&2V,[<>N".*=%<03[_)FCD\MBK[&!VD=CCH:
M )**@CO;2:!YXKJ&2),AY%D!5<=<GM4%YJD$&DW%_ Z7"QH2@C<'>W\*@CN2
M0/QH O45SUOXAN=2U:\T[2[:"8Z>5CO+F60K&LQ&?+0 $L0",],9'4YQ0USQ
M=JNA:'>ZG<:%&4LKM89Q]K.!$P3]\IV'*@OR, C!H ["BLK5=3N;-=/6SMH+
MF:\G6(*TY0 ;2S,"%.0%4GMFKXN[8W)MA<1&<=8MXW#OTZT 345&]Q!'(L<D
MT:NPR%9@"?PIBWEJR!UN82I;8&$@P6]/K0!/140NK=KEK83Q&X4;C$'&X#UQ
MUI$N[:1RB7$3, 6*AP2 #@G\P10!-145O<P7<7F6T\<T><;HW##/ID4CW=M'
M.('N(5F(R(V<!B/7% $U%0B[MF"$7$1$AVH0X^8^@]:QM \1G5)=2AO$M[6:
MUU&2RBC6;=YH15.1D#)^;H!0!OT5#+>6L!(EN88R"%(=P.3T'X]J<EQ#)+)$
MDT;21XWHK E<],CM0!)16+#K\-LFF6^KW%E%J%\[HD=O-O0E0S$@D X 7DXZ
MD"K5AK>FZG]K^QW<4JVDK0S,KC"LH!/X#.,^H- &A14,=W;36_VB*XB>#!/F
M*X*X'7GI6-HGB%M7U[6[ 1P>1I[0B*:&7>)0Z%LGC ],#/UH WZ*@:\M4+AK
MF%2GWP7 V_7TI);I#$WV>6!IFC+Q*TF W'!X[>] %BBLB/7K>.33K"\N+0:K
M>6WG+#%+E"0!DJQYV[F !QSZ5!X4\1#Q!HEM=W"P6]W,\P^SI+N.(Y63(S@D
M?+UQ0!O452U35['1K>.>_N$A26:.!"Q W.[!5 _$_D">U9FG>)/M/B'6=.NA
M;00V+6ZPRB;/G>:I8=0,'CH,_6@#H**BFNK>V,8GGBB,C;4#N%W'T&>IJ1F5
M$+NP55&22< "@!:*BCNK>9Y$BGB=X\;U5P2N>F?2FK>VKJ[+<PLJ*'<B0$*I
MY!/H* )Z*A2ZMY+<7"3Q-">DBN"IYQUZ=:6&X@N YAFCD",58HP.TCJ#CH:
M):*A@NK>Z1GMYXI44X+1N& /IQ34O[.2!YDNX&B3EG60%5^I[4 6**P?$GB%
MM'T!-4LHX+R-KB"(GS<+MDE6/((!SC=TX^M;U !1110 4444 %%%% !1110
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M],C!'K5ZU\.Z*/%'AFP.FO-IRZ5=Q!;^+>2IDC,:R9''R[BJM@@<8!%>HT4
M>9B/4;;Q"T.D217L$]Y>>7#/"4N--G*2#S PX:$G@;AT=0">E1Z9 U]I7@>*
MT@D@UG3;A5U(.A5XHQ&PN/,)[.V,9^\2",]:]0HH \=M+"SMM(L+B&R2*XC\
M7.ZNL.'2 W#G/3(CV-],&M^P^TVOC.%;5X]1L)M2N6>">$I<Z=(1)ND##[T3
M'(&X?QJ 37H*NK$A6!(ZX/2@2(S%0ZEAU /- '*>-;6>WFTCQ%8V;W5YIET$
M:&, O+!+^[=1]"5;_@-9GA+1K[3-4GT.^@4V&F3MJ%O.$"QLTRD[5'HCF?Z?
M)7H%% 'C]E:6\6DZ-=K:A;U?%<LC2^5B186GE^8G&0A5@<],'WJQ<6UY=^$M
M5TB6)U\5KK#36[[#O9C.&CF0_P!P1D GH I4^E>L4Q9HFF>%94,J %D##<H.
M<$CMG!_*@#SY_M5KXT5[)X[^VN-4S/8W,)6>TDV;#/$XZQ[1SGCG .>*I^$4
MMKV?2+75$U9?$FDS2&:-K?8BL<AY#*$ 9'!S]XY)'UKU"FR2)%&TDCJB*"S,
MQP !U)- '%^,[*SO/%GA 7=K'/&MW.)M\>X!#!( &X^Z6*CG@G%8-_:V":SK
MGAW6+?4H;>YD@;2X[&U!22)(T"1QN$/EE'5OXE SGC)->I(ZR(KHP9&&593D
M$>HIU 'G4@NK7QDK6CI?VUQJ:?:;"YB(GMGV!#<12#JFT#.1CJ <\5BV<@AT
MGP]IAM+K[78>*)'GC6U<^4AEG8'(7&"K*1CM7KDTT5O$99Y4BC7&7=@H';J:
M?0!XYJ&F61\,^+7CL4^TCQ$DEL4A^?;YD!+1X&<<2'(XX;WJ]KEI+;ZKXNCT
M"S(233["00VD8 G"2N9E08VLQBP,<YR!7JM% 'F;PZ)JVFZIJNGWNL0-=?9$
MFO7M-@CD253&?***&VG[YP1MX)]-+P[)?Z@RV-_;6NY=1>XFN[-2L%ZL2QE9
M%!Z$R-'D D$QMS7=4R6:* *994C#,$4NP&6)P /<GM0!P?AJ1?!^O>)-/UC=
M!#J&IR:E:7CJ?*E64+E-_0,I7&#@G(QFNP=+;7=+NK:>!VLKE&A82*5\U&&"
M0#R!R1SZ9Z8-7Z9--%;Q&6:5(XQU9V  _$T <3X L]62+R-:C??H@?3+:5O^
M6ZA@?-^A01 'U#^M5=-^U6OC.%+9X]1T^;4;IFAGA*76G2$2;G##[T3'(&X?
MQK@FO0!-$9C")$,H7<4W#<!ZX]*/.B\\0>:GG%2XCW#<5!QG'IDB@#E_&]I+
M%%IOB"SM7N+W2+I9?+B7+R0O^[E0?\!;=]5%9/A?1M0L==NM%O;9?L$%Q_:\
M<BJ/+\R8',2^RR>:P[@!*]!HH \M\,QVE[/IUEK*:H/$&EW4LDL;6^R,$E@\
MAE" -&RG."QSD#TJGI^DI;?#.6]T[2B;^"_D-PL%N/M#VHO3(T:@CD&, A>A
M'8YKUZB@#E/""Z5=7FI:OI3W\JWOE>=-<PF%7=01\J%%Y P"0.>!DD'&/>_:
M;;QH\ED\=];W&J0?:M.N82)8'V(OVB!QU0* 2#D<,,C.*]#IB312/(B2HSQG
M#JK E3UP?2@#R,R"WL(M-:TNC=6OC#[0\:6KMLB:Y9PX(7&"I!&.V?0TNI:)
M;7VG^,+,Z?GQ#/JS2Z:QA(F&1'Y<B-C(0$$E@<#!S7KU% 'E&N:99SR_$GS+
M**6:33X_L[&#)>;R&!*<<MOV].<XK4TVWL;?QQI4D<$4<$_A^1;IQ'A7??$V
M)#T+8\P\\_>KT.B@#R'0+=+;2_A[//8R^5;3W<4P^S,QC+))L5E R,DC&1W%
M/E2XL-+UL06%V/LWB5KJ\CM[4EVM"X(*@J0X'#8&>%->MT4 >5WZVD=C'K6D
M1ZE=Z3<:S;W6JM);LHD15(+K%L4E0PB+$+SM[X-;WA&2WF\;^+;BTAD6WN3:
MR)+Y#(DA$6"02 "<_P"-=M3#-$)U@,J"9E++&6&X@8R0/3D?G0!PWBC0YG\3
MLMM:>;:>([)M-OF" B)DRRRGW$;2@>X05#I%I=W/@S4'UZT'VBRL9=*7S$!\
MT1[E:11Z2$)Q_LBO0J* /,=(CCMM0^'UU<VK^6FA26SR>0S>7,%@PK8'RD;7
MZXQ@^E9NCV<%OHW@ZZ2U$=\FOSF>3RL2+$S7'WCC(4ADZ\<BO8** .2^(< D
MT"SF:W:9+?5+*:7;&7*QK.A<X )P!G/M7(^(;.TOU^(DOV(22/IT LM\!W;Q
M"0!&",[@VT8'(. :];HH \NU2:VFUN^L_$7]I'3M6T^".TDMK3SEE&TAX\A&
M97W'<.G7/4"NE\9VR#X5:U!+&S"/2)?EG(=@5B."3W8$=?6NIEEC@B:6:1(X
MT&6=V "CU)-4M:TN+7M#O-+FGEB@O(6AD>$KNV,,'!((Z'TH X&#2=+EUO2M
M0TBU@2V71ITU9TCPL@94\M)..7W;C@\\'/452TS3$T[P-X+U"#30L<4MK_;.
MR#]Z55& ,@QN(21@Q!Z8ST%>JV=O]DLX;82/((D"!WQN8 8YP /TJ:@#R#Q5
M8Q?8_%.HI&&T:?4-+D@**2K3"9!-)'CU!4$KU(/?-2:]HDJW/B.[\)68_LV2
MPM%N(;)-J7+K,6D5 .&;R<J<==V.N:]&\0:%#XBTS[!/<W$$7G1S%H-NXF-P
MZ_>4C&Y16HH(4 DD@=3WH \ZU2WM=4UO4=0L&G71IM EM[^2SC(9F+#RPHQS
M(J^9QC(R 1R!6?)>WEO!.NIVMMJB17]CLUFT@D6-P"Q#RQH>6C*C(!Q\Z9QB
MO5J89HA.L!E03,I=8RPW%1@$@>G(_.@#R.3>/!GB2V,5V7/B2*9!):M&70SP
MN6"[1V#,<#CJ:]>!#*&4@@C(([TUYHHGC225$:0[4#, 6.,X'KP*?0 4444
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M_D:9]LMK..;5E$EH(%DF,:"(.Y=0 202  #WZ\<O_P"$$#/-)-KE_++-I?\
M9<C,D0!BYP<!!@C<?ZYJS?\ @Z*]T;2;1-2N[:\TG:;._AVB1"%V<@C:05X(
MQ@T :'A_4-1U'37DU/3S9W4<SQ;3D+*JGY9%!Y"L,'!Y'(KF+?QKK+K;74]A
M8I:/K;:1*J2NSY\TQ*ZD@# (&<]<]J['3;%["S$4MW-=SL=TEQ-MW2-ZX4
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MH;/Y$L18-&\JAAC.,G YQT[5J3>"[61M6@CNYX].U>0RWMF "KN0 ^UL94.
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M$FJ>)]-CBN$NX[*.$@!"\DCLBJQQD88X/I@^E=C!IK0ZU=:D;IW^T11Q&(J
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MK(J'@JR!#A1D!7;W]ZU]#T-=$.H%+F2?[==O>/O4#:[8R!CMP.OYT :U%%%
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MPRRG$:22JI<YQP">:YCP;_:D6HZA;WLHU"VC@@%OJC6Q@EE&7_=2*< LG7(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTRQJ^W/3(S4BRQMNVR(=IPV&'!]#0 ^BD#*>C ]^M-\U6W"-D=P,[=WKTS0
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MW&GB]6Y\WK\^S:5Q@?7)K;>2.)-\CJB^K' H =113!(CLZHZLZ?>4'D?7TH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9S(_T5 S?@!WK?KE)K23Q+K>HYDEM[6VA:P"36IQ,) &E8;@,J?E7(_N-ZT
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M3 X7<0" -Q7KWKDI=-$?AS5VATFX6Y'BE)X-EDX?RA<QMO7Y<[=N\Y''7UH
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MMS"\!8?\L V?F )PQ ..,GKFH=(\0_88&TNUT[3[*5]<DTJV2WBV1*$CW[V
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M1T+A!AAM&W;\W/+=..<%M9N?$GB'P-J-G+%#:7]I<W @FA+E6\M 0<, 3AB
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M-RD$!<%@<$'//2@#U"BN.G\3:U<W%S)HVF+=P6E_]DEA*X>15($C!RX"D9)
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MO=Q>;;3Q31AF3?&X8;@<$9'<$$'Z5+7$Z5XAN3X/?6)3I>EV]O<7GVI_(9D
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M.^U>34+>6ULU)E,,@<AL9"\'[QR,#WH O?V=$VCG3)7DEA,'D,S$!F7;MYP
M,X]!6-8^#(+&?1IAJFHROI-N]M;^88B"CA00V$&<!% QCIW).=:?7-)MK:.Y
MGU2RB@ER8Y7G4*V#@X.<'FKK2(D1E9U6-5W%R< #USZ4 <DWP^L1I=E:0:GJ
M4%Q87$MS:WL;H)HFE8LZ_<VE26.00:Z33[!;"R6W\Z:X;DR33L&>5CU+$ #\
M   ,   5$-=T@H7&JV6T.L9/VA<!F^ZO7J>P[U.-1L6>Y1;RW+VH!N%$JYA!
M!(W\_+P#U]* ."U#PBV@OX>M]-N-5N["VUB.=+5E$D=G%MDW8*KNV@L -Q.!
MT[UM7?@*TNFO5_M348K:ZODU V\;1A4G5E;<"4)Y*#@DCD\=,2^)?%(L?#-S
MJFBW-C=O;SPQ2#=YBC?(JD':1@X?-;EEJFGZF9A87UM=>0_ER^1*K^6WHV#P
M?:@#G9? -G+-*PU74TC?45U-8D>/;'.""2,IG!]"2!GC%6+OP59WD/B"*2_O
M@FN@"Z"F/Y0$$>$^3CY0!SFM:ZUS2;&<P7>J65O,-H,<LZJWS'"\$]SP/6GK
MJNG/?_8%O[8WF"?LXE7S..ORYSQ0!1;PW$^MZ;JK7]X9["W>WC7]WM=7V[MW
MR9R=B]".E9UQX!T^XL;NW>^OQ)/J/]IQW"NBR6]QTW1D*!C'&"#P36XVMZ4E
MX+-]3LUNBVP0F=0Y;TQG.?:E76=+:..1=2LS')-Y",)UPTF<; <\MGC'6@#)
MF\'QSQV$CZOJ7V^RN#<K?;HS([%"A!!39@J<8"C'USF%/ =E%80VD6HZBGV?
M4FU*"7>A>*1BY(&5(*GS'Z@GGKP*WIM5TZWO8[.:_MH[J0A4A>50[$] !G)-
M))K&F13O!)J-HDR!BT;3*&&T9/&>PY/H* ,>Y\$:;>#6ENKB[E75GCEE!=08
MGC"A&C(4$$;5/)/(J6?PG!>07XO;Z[GN;VS-B]T1&KK"<Y50%VC.22<>GH,3
M:9XKT75=(BU2#4+=;65BJM)*J\C/7)X) S@\XK6AGAN+>.XAE22&10Z2(P*L
MI&001P1CO0!@'P?;&YM9_P"T;\/;:<^G)AHQ^[?;DG"9W?(IR,=.E7-/T"&R
MU675)+B:ZOI+=+9II5128U)(SM4 G)Z_EBK$.N:3<),\&IV<BPH'E9)U(13T
M8\\#@\^U%IK>DW]T;:SU.SN+@1+,8H9U=O+.,-@'.#D<^XH HW7AB"76+K4[
M6]NK*>\@6"Z\@KB95SM)W*<, 2 1V/TPG_")V4=_HUS;37%LFCPO!:V\6SR]
MC*%(.5)/"CO5;5_%2VGB+0]-L;JQG^VWCVUS'OW2(!&[9&#Q@H <@]:W;O4K
M&P*"\O;>V,F=GG2JF[ R<9/. "?PH K:[HD&O6,5M-//;M#<17,4T!7>DD;!
ME(W @\CH0:S+KP3:7::ZDNHWY76H$@N?FCR%5-@VG9P<$\G-:L>OZ--90WL6
MK6+VDSB.*=;A"CN3@*&S@G/&*/\ A(-%^Q1WO]K6/V27=Y<_VA-C;3AL-G!P
M>OI0!DW7@J"758M2M=7U2QNO(2WN6M9$7[4B_=W@J1N&3\RX(SQ3?'UC+/\
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M26YU6RAC>+SD:2X10T?]X$GE??I2-K^C);07+ZM8K!<*7AE-P@610"25.<$
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MX?M;BWANKFX6>YENF,Y4D/(Q9L;5'&35J;5=.M[R.SGO[:.ZE(5(7E4.Q/0
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MI0' V.21M!QN[YXSBNGHH X?Q'X>N[OQ.\=M 6T[7K$V6INN/W6PY5_J4:1
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7.^./$TG@_P )W>NI8I>K:[-\)F\HD,ZKP=K=VKHJX3XR
M1R7'PMUBU@CDFN)O)6.*-2S.1*A. .3P"?PH C\0_$:[T#PUX>UAM$AG&L/%
M&(A>E?*,B[ASY9R,=>!7<RS20VC2F!I)53/E1')8_P!T$X_,X_"O"_&ND*/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;B!<;0Z-QN&,@CN3ZXK5M_#CV_B6#6/M[R&*Q-D4D3+."X<N6S]XL.PQCC%
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MF6%<L)0X=2"2/^6AP>V!P: &6OBO7KP:M-;Z!;2PZ;<7%LR+>_O)7C4%=N4
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M$H+ 2L=FS82O.#D @\\@3^&/$&K>('DGFTRUMK&.:XMV=;HN_F12E.%V %2
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M+%0>=I'J: /1+[7=,T[3#J-Q>PBUW!%D5P0S$X"@]R3Q5MKRV1HE>XA4S<1
MN!O_ -WU_"O([V)IM \9(;>YGQK5G>*6LW7='FV+NJ[>F%<\<X!SGK5[5#87
M>NZWI>N)JJ6>I"!]-%M9Y$T0C4"-6\LF-ED#'!*XW9XY- 'ITMW;0DB6XBC(
M(!#.!R>GYXXIR3PR2R1)*C21XWHK E<],CM7E6LZ78S3?$;S;&.65],B\@O&
M&9YA X)4XY?=M!(YSBK7V1H]?LCHT:0WMSX8N8_-C7;NN"8RF]O[^=YYYZT
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MEW%CQG.Y21WJ"9;>]US5]'U]=62^EU%;JQ2WMP1,@VF(I,$.W;C!RP P>Q-
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M+:6VN_&T6B6;>5MTZ86]G&!YR*W[\(,;6)0;2,'.0#UH ]1@N8+J,R6\T<R
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M0H4R<%O0$XS^5>>>--$O;:RO?$GAA!.;^R:WU.S3I<QE"JRJ/^>B9_$9%/\
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M0FO2_"MC;:9X9LK.R6Z6TB4B$7>?,";B5R" 1P1@$ @8&!B@#8HHHH ****
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MOM!(*C=G%5M*L&?3/!]M=Z7=L]IKUX9Q/9-\D9-P5)^7&TEX^1\N3[<>O44
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MZQ E=J$%% '+G(!8>G/47_A""[UBXU2WU"]L9[NW%M>+;E-MP@SMW!E.&&2
M1@X-4!\.K!;5;9-4U1(3I2Z3*HDC_>P*&"[ODX(W'E<9[YH CN/$VN7.LO8:
M;%IT2-HZ:E')<J[D$L1M(4C(XZY'7//2GZ9XMO\ Q##8PZ9%:V][/H\6J/\
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MIM5E0(-N%! VJ!R3TH YKPW*VJ_$CQ;-?#?)IKP6MFC\^3$T>]BH[%R<D]\
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MJQ># ^1PP(894$'J#]34EQX2TNX\+2^'W646LI+M('Q(9"_F&3=_>W_-GUH
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M)J,<ERKN<EF&TA2,_=ZY&,YYZ4_2_%=SXC;3;2QCMK>>YT>+4YS.AE5!+PJ
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MO$@D15NU084O\O#8XW)M.* *^H>)];EGU-=!TQ;QM-N4MW@9>9VVH[@/O 3
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M,]P:OVWA6&VU2QU!=1OFGL[%K%-YC(9&*DD_)][*KTP..E %'X9 #X=Z2 ,
M+)@?]M&KK:S/#^AP>'-%@TJVGGG@@W;&G*EN23CY5 ZD]JTZ "BBB@ HHHH
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M!O1_F'? 4<]*Z'2;R#?<^(AX5UV&^@LC#*MR7>:3Y@WE1*SD.,Y.[@=,=3@
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M-?>&KJWNK1-&U2WFFG>7AXBL:N 6W8'W@",9KI5UW2GT^WOTU"V>TN#B&5)
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M5;PSP10*L$"R),%93G+!BP8OR,D].E 'H1UO2Q>_8SJ%L+CYOW9D&?E&6'U
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M'H=GI$$MS;6UH(A&;>4QMB,@@$CJ#CD=\FM6B@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ*>Y@ME#7$T<2DX!D<*
M"?QH EHJJFI6$C;4O;9FP3A95)XY/>IK>X@NX$GMIHYH7&5DC8,K?0CK0!)1
M12$A5+,0 !DD]J %HJO;:A97@)M;NWG .W]U(&YZXX/7@U8H **** "BBB@
MHHHH **** "BHH+JWNO,^SSQ3>4YCD\MPVQA@E3CH>1Q[U+0 455?4K"-;AG
MO;91;?Z\F51Y7^]S\OXU95E=0RD,I&00<@B@!:*** "BBB@ HJ*YNK>S@,]U
M/%!$O625PJC\34M !1110 45%)<P13Q023QI--GRHV<!GP,G:.^!UQ1/=6]L
M8Q//%$97$<8D<+O8] ,]3[4 2T444 %%5FU"R1KA6O+<&V :<&4?N@<X+<_+
MG!Z^E3QR)-$DD;J\;@,K*<A@>A!H =1110 4455.IV @DG-];"&.3RGD\U=J
MOD#:3G .2!CW% %JBBB@ HJ*"ZM[HRBWGBE\IS')Y;AMC  [3CH<$<>XH2ZM
MY+F6WCGB:>( R1*X+(#G!(ZC.#^5 $M%%1SSPVT+33RI%$OWGD8*!]2: )**
MAM[NVNT#VUQ%,AZ-&X8'\JFH **** "BBB@ HHHH **** "BBB@ HHHH **B
MDN8(9H899XTEF)6)&< R$#)"COP">/2I: "BBB@ HHHH **** "BH;FZM[*!
MI[JXB@A7[TDKA5'U)I\,T5Q"DT$J2Q. R.C!E8'H01U% #Z*** "BBB@ HHH
MH ***BDN8(IX8))XTFFSY4;. SX&3M'? YXH EHHHH **** "BJUOJ-E=SS0
M6UY;S30\2QQRJS)_O '(_&K- !1110 4444 %%%1075O=>9]GGBE\IS')Y;A
MMC  E3CH<$<>] $M%0?;;7SIH?M,/FPJ'E3S!NC4YP6'8<'D^E20S17,$<\$
MJ2PR*'21&#*RGD$$=10 ^BBHK>Y@O(%GMIXYX6SMDB<,IP<'!'N"* ):*1F5
M$+NP55&22< "H+2^L]0B:6RNH+F-6*%X9 X##J,CO0!8HHHH **** "BHC<P
M+=+:F>,7#(9%B+C>5! + =< D<^]2T %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !56Z
MTZSOI89+JVBG: DQ^8H8*2,$@'OCC/N:M4CJ61E#%21@,,9'OS0!P'PTTG3[
MCPE!<2V<#30ZC>M'(8QN7]]*O7_=)'TJAX"UG4M,T+P78R1VAT[4HY8%"AO-
MC9$>0,3G!!"D8QQQR:[;P]X<A\-Z0^FVE[=RQ-))*'G,9=&=BS8PH'5B>0:H
M6/@>ST^WT&"+4=09-$D=[;>8CNW*RD/\G(P[#C'6@"OH_B?6=8FTB^MM,$FC
MZ@I=V";7MT(RCEBV'SP" HQGOBJ_C.9[OQGX/T"?_D&W\UQ-=(?NS&&,,B-Z
MKN.2#UVUI:)X+M]!NO\ 1=3U%M/21I(--DD4P0,23\OR[L#)PI8@=<9QC1UW
M0+/7[:&.Y:6*:WE$]M<P-ME@D'1E.".Y&"""#R* #4['3('AUJX@59-+2259
M$4;@GEL&7Z8.<>H%8,7BW48X/#6HW4%J;#7F2)$C#"2V>2,O'N;)#C P2 N#
MSS700:0^,:A?SZ@ I4+,B*O(P20BC)()'/KP!6?IW@ZTT^+3[?[9=SVFFN7L
M8)BI$!VE5YVY;:K,%R3@'N0" ##T_P 9:Y-;Z-?75OIXM+W59=,DCB#[P0\J
M*X).!_JQD8.<YR.E5O\ A)_$&F:)XIU5I;.\>SUG[+%$\3( N8D&"&/&&SCU
MR<\XK?B\"V<.GV%DNI:B8[+4&U&,DQ9,I9F(/[O[N7;C@\]:2\\"6=Y;:O:G
M4M1AM]3NENY8XVCPD@*$E<H3R47.<].,9- $.J:YXATB%ENO[*6407$Z-$DD
MF_81L01A@W0DL_(&!ZTMIXIU#7%A@TF*UBO&TB'4F%R&=<S [(Q@KW5LMVXX
M.>-#4_"D&J:HFH-J%]!+]C:QF$+(!-$QR0V5.#GG*X-9Z> +:W_LR6RUG5+2
M[L+1;'[5$\>^: =$<%"IQV( (H JSZ]J]GXO#:A+#;V5MH#7]S:)&9"C!AO
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M0A57CVD;3MW+G8,\^N,9- '&6.K:AX=7Q)?6D-F;"/Q,(IXW#>8PD\B,[""
MI&X'G.>>G?>U3Q9J&FZS' T5H8'U6"Q\I0SOY<H4"1G4[4.YN$89(&>]69_
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M8AU76/#D'C75=,M;"6QL=9DGNH92PDD000E]A'"D#GG.?;OH2:S!HOBWQ;K
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MMQ<&V\G,FXO]K\C.>F,<_49[X%V_\7:UI=MXM2>"PENM%LX[V%D#JCHZN=K
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M=N-I.=V>QJ.RT[5E6YL+%+NXTRZTZ[5(=0M6CFT^1@,1K*0 Z,W ')^4'.*
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MI?VMQ-$ 9(XIE9E![D \5Y_;V]_KEOJFI7%I?6^NZE:3V>G0R6LL::;"8V*
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MS$Y% 'I=%,A39#&A&-J@8W%L<>IY/UI] !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<]XMUB_T:
MVTR2P%NS7.I6]I()U8_+(X4D$$8/YT =#17G>H^*/$^GVGBIO.TJ23P_MG+_
M &5P+B-HA)LV^9\A'(W9;/' JYXF\7:EHZWES;BT:*V2VD6#8TCNLC8?S&!
MCX/RYZD'KTH [BBN2O?$M]I'B34;#4/L_P!F:Q-WIACB8/*RG:\9);#,"8\
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M!:V9O&B)1YHW=F^8CKRI_P#KBKWBRUFN=<\*R1VLL\=MJ1FF9(BPC7R9%#'
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MHU+N[G"JHY))["@#S/P[I^JV-M\/Y)](O5^P6EQ:7*;!NB=D0*2,\*2IY/\
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MKV"6+69)H)X$MP@4K'(ZN&SG.8\8Z8/KR=/P]XDN[SQ$=,U26:SOQ',S6,\
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MNM*5=*TN>.Z@O)K@2O/(J'&%/S AFR68\[>^> #<TU+N/3;9;^59;P1KYSJ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'(IU% %+2M*LM$T^.PT^$PVL9)2,NS;<G)P6)/6KM%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116
M!XPU35M%T,ZAI%M!=S1RQ(;213NFWR*FU6!&UOF[@T ;]%<ROBA=6\.Z?K&A
MS0F*YN889%N(B6C+R*C*0&&UE)/!]*V)]9TVTNEM;F_MXIV94V/( =S?='L3
MV'?M0!>HJKJ5PMIIES<-=6]KLB8B>X/[N,XX9N1P#CN*H#Q)I-G:0#4-:T\3
MFU6X=A*$#)P/,"DDA22,=>HZT ;-%<UX@\6V>F6>E26]Y:L-4N8X89BX9 C
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M50L%!9B,GG !)H O45F/XBT:..WD?5+14N51X7,HPZO]P@^C=O7M6?9:]/\
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MXYL+R33KH6\VAQVQ?8"(Y%D+%7.>.#^-=7?ZC9:5:_:;^ZAMH-P7?*X4%B<
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M9"2Y!QC#;CE2".>E '+:IXAUFZ@&GM=+;W=AXEM+"::&+Y;B-F1T.">.&&X
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MFE3Z<][<VR@B2+]WYB+&?XCC(;/U&.E=#HNGRZ;HMM8W%Q)=/$FTR2N78C/
M+'EL#C)Y.*S='\%:3HCN+4W;6OS^59S7#200!L[@B'@9R1WP"0,9- &4GB35
MX(_"][/);RVVO%8FC2+_ (]Y)(C(A4YRRC:0<\GJ".E4M%\5>(+B#PO?WL]D
M\&K7DUG-!%;E2I42E7#%C_SR QCH?7FNGT_PGI^FK:1PR7+0V.[[#%*X9;7<
M"OR9&3@$@;BV 2!Q45MX+TZUM-+M8IKORM,N&N;8&0':[;LY..1\[]?[WTP
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/ %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>exhibit1027supplycontrac024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac024.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
M=S[5\P2VEQ+^SU8Z<D3&\;Q']G\G'S>9M8;<>N:^C+/7])_M=O#HU&%]6M;=
M9)K?)W!<#D]NX/KR* .'3XE^(=-\=:9HGB7PNNG6FK/Y=G+'<"5P20!NQD'D
M@$#&,YYJ?Q!XZ\9V6LZA%HO@LW^EVC;1>R3^4'*J-Y&>P.X9]JH/XG\)^(_B
M%::O>:S9O'I+-:Z59HX:2>X<A6DVCMD*JCOC=P,5U?Q&N91X5.E6KE;O69X]
M-A([>8<.?PC#G\* -#P=K5YXC\):?K%]:):37D?FB%&+!5).TY/JN#^-;M16
MMM%9VD-K @2&&-8XU'\*@8 _(5+0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 45QB:OJX\6>(="N+^*%H[)+W3)6B&-AR'+^NUP!VX/KS4/A_P 3WWB#P)HM
M]%="/5;VX6"7]T,*ZL?.&T],(CD=^!0!W-%<%?\ BW4$T;Q%KMM*GDZ%>O;M
M:,@_?)%M\PLW4,<L5Q@#Y<@YK9US6;VSU;PRMI)#]CU*\\B97C)<KY,D@(.<
M#[@[?C0!TE%<]XMU6_TB#2I;)X56?5+6UG$D98F.255.TY&#@]<&H]7UZY_X
M2NP\,::4CNKBW>\N+AUW>3 I"_*O0LS' SP,$X/2@#I:*Y276;W1?%NG:%?W
M/VFWU:.7['=;%62.6,;F1P!M(*G(( Y!!!ZU3TGQ/?6.HZ[I'B6X!O[3$]F8
M(@OVFV;Y49%YR^\[2/4@=Z .WHKG1:>*)='M8#JMK!?NI>YNOLP<1GC"(F0#
MU^\2>AXY&,.T\7ZN^C:;:W20#5[S5Y=*%Q$A\MEB9]\RJ3_=C.!G&[VXH [U
MU#HR-G##!P<5@1>!_#$$\L\6AV<<LN3)(D>&?)R<GOS6)?\ CJ70H=>M+F,7
M>H:=<V]O:CA/M)N #%NQP"#N!P.BY YQ6]+:>(8+6*:+4XKBZ\R,SPO;JL13
M<-XCQ\RG;G&YFH <O@[PXNEOI:Z-9K822><]N(P$=^/F(Z$\#KZ59OM TK5-
M.33[^QBNK-""(9AN7CIP>N*Y2X\9WB:+J?B9&3^S-/U$VOV;8/WD*2"*23=U
MW9+,.V% (R<UN:OJM_9>,/#MA"\/V*_:X693&2^4B+##9QC/M^- $K>#?#CZ
M6FEMHUHVGHV];4I^Z#>H7IFI)_"FA7.EQ:7/I=O+818\NV<9C7'3"GCCMZ5F
M7>MZC?:_K>FZ7*D!T>TCE8N@;SIY S*A]$"J,XP3NZC'-32O%T_BV]LK;2I!
M9I)I,>I32%!(5>0E4CYXP"KENYP,$4 ;LWA/0+G2XM,GTJWEL(CF.V=<QKZ8
M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
MT9X([F%H9061A@@$C/Y5GZ1X;T;0/,&D:;;V0DY=8%V!CZD#@FJ&OMKUQ:/>
M:%JMC:6T5OYZ/+!YPN#@G!.X!4P!R,DY]N<_5_$VJQ_#&W\26T4-K>RV]O-)
M#-&7"^84# <C!&[C.?I0!OKX;T9=3_M(:=;B[\PS>9M_Y:$8+XZ;\<;L9QWI
M)/#6BS:E=:C)IELU[=P?9[B<I\TD>,;2>XP /H!5/Q5XFC\/QV-NC0?;M0F\
MFW\]ML:8&YY'/]U1S@<DX'?-/EU*3_A$+O4M,U2VOY$MY)8[G:'B+*"< (1Q
MD$8SD=R: (K7P!X1L;N&[M?#FFPW$+B2.1(%#(P.00?4&MFXTZSN[RTN[B!9
M)[-F>W=O^6;,NTD>^"1^-<U<^*+NW\'>'+L>6=2UIK2W1BOR+)*H9GQZ !CC
MV J>TU;49M7UO05G1[[3TAN+::1 !-'(#A7 XX9&!(QP0?6@#J**SM"UB#7]
M#L]5M@RQ7,8?8W5#T93[@@@_2M&@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#D/&/ABZUK5M$O;%PC1226M[GC?9RK^\7ZY5<>A.:30_"]UI?C?6KTLHTJ9_
MM5I$/X9Y0!,?;_5@C_KHU=A10!Q/B/P;;^(+R:V@L7M(+V5&U.Z$K*LZ(0=H
MC#89S@+O9>!G!)Q5_P 3V%[=:OX9DLK&2>&QU#SYV1T4(GDR)T9@3RXX':NG
MHH YKQI8WVH66EQV%G)<O#JMI=2!'1=L<<JNQ^9AV!X%0:SH]W;^,M/\66,#
M7!BLWL;RV4CS&A+!U9,G!96'(SR#QSP>LHH X.PE@\>^*M,UZUWQ:=H33H$F
M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% '%?$HN-.T QJK/\ V_8[0QP"?-XR<''Y57N]*O\ 1=0U[Q1<
M:C:V-YJ1M;6)(4:5457"\9 +RMN(7Y< XZC-=9JVAZ?KB6Z:A"\JV\RSQ!9G
M3;(IRK?*1R#TI^J:/8:UIK:?J$!FMF*MMWLK J05(8$,"" <@YH XEO$NO0:
M7XH5?.DFTW48(8VECC,L4$BQ,YP@VLRAW(Z]NO>2\\0:UI,'B/46NWGTRWDM
MH;":>)$7,I17<L%&Y4+=>G4<D5?UWP9;?V9=+I&FPS2WEQ!)>QSW<J&=8R#\
MKY)5_E7YNIQR<\A=#\)QHETEW8S06%U 89=/N=2EO5DR1\QWDA< $?*>=W/0
M4 :.BQZ];ZO>1ZG>6\]C)&CVJF0-,C#AP=L: K]T@]0<^U,\56,6IZ/?:%!%
M&;G5HS'(=N=BD!6E;_=4#'J0H]Q=T/PYI7AR!X=+MVB5\ EYGE; Z#<Y) &3
M@9P,FJFH^"M!U74);^\MKA[F4 .ZWLR9 Z#"N !UXQW- '+?$#4(X]#U72I-
M/U22QM=+D\J2*SDDBED,1VLS@;=J<'G^+GC:,]?X>OUF\'V%XL%PBK:*?+EB
M*.=JX^Z>><<>H(-7Y-,LY=(?2G@4V+P&V:') \LKMVYZ].*L0PQV\$<$2[8X
MU"(OH , 4 >?VOB;5VT+PIXB%WY\>L7<,%S9>6FR-9L@;"!NRAQU)R V?:_X
M%MYDU3Q8\E[<3 :S(A60)@GR8?F.%!SCCKC';O6[9^&-(L)DDMK0H(Y6FBB\
MUS%$[9W,D9.U2=S= .I]34^G:+8:3-=RV44D;W<IFG+3.^]R "V&) . !QZ"
M@#)\=V=]=^#]3AT^"TE:2%O/CN"5\V(#YE##HQ7(![9K-\8W:7_PWL;R.$PI
M<7&FRK$W5 UQ"0I^F<5TEUX>TZ]OI+NX2X=Y8Q'(GVJ412*.S1AMC=3U'.:F
MU31['6K-;2_A:2!760(LK)\RD,I^4CH0#^% %ZBD50JA1G &.3D_G2T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!W!ESGU]>M '1-XFTY;C5H&,XDTJ,2W8,+?*I!((_O9 /3/3UK61M\:OAEW
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M)I.FQW,=A?62PV6GWERLGV>4[@^U\G$6"F 23D'@=P#LKWQ%8:=YB2-/,]O
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M7DL9]+WLT+V,D6<Y!1D(XQ[$4 .L=/L],MA;6%I!:P*<B.&,(H/T%6*\XO\
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M1Y4ERN"759#T;:O'/1<<=I/".IQ:KH(FC>\9DGFCD2]7;-"P<YC;W7(7.3D
M&@#6CO(9KN:VB;?)#CS<#A"1D*3ZX(./0@]QF>O,-,U^\TOX-/KRMMOKBZD>
M>9AGRVDNRC.0?[@/&>/E':K7B?4-6T.]U:SL-1NC;MX?N;^-W82/;S18P0S
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M*$JH\B:/JI9\X?G[RC('%6[&:2#XL:O:1D_9Y]*MKJ0=A*))$!^I4#_OD>E
M'74444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5SOB_1+G7M/MK>&WL+N*.X$LUI?;E290" -Z@E
M""0<@'ICH37152U#4X--^S+('>6ZE\F"),;I'VLV!D@?=5CR1TH PM!\'VEE
M:WL5SIEE;VU[&L<NGPS// 0,\DN!DG/91T'7MOV.F6>G!Q:PA"^-[EBS-C@
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MZ=-H_P"[CN5*98A$?U.,[^..G<'B@#K[GPUHU[ILVGW>G0W%K._F2I,-Y=^
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MY]!U"\:!'LM*FB3R]--P9DAF!;>T>?NH05P/KP*ZRB@#D;W0M3E\1>(;Z.*
MPW^E1V4&9<'>IEY88X'[P>O3I5.'PUKL)\*&(6L4ND:7-9RR&3<!*T:(K*,?
M,H,>3G'!KNJ* . T30M:TS7M/US5H]/A6WTJ6UU"X:\9W9]R.92S(.#L/!("
MCOQBKGA#2HH=:U>\M+M+C25N'&GK'@I&9=KS[2."N_ICH=PKL)8HYX7AFC22
M*12KHZ@JP/!!!ZBDM[>&TMT@MX8X88QM2.-0JJ/0 <"@#"\2:5?7FI:#J-C'
M%*VF7;3R0O)L+JT3QG:<$9&_.#C..M8&I^"]4G\_6+463:N^JIJ(M)R3 R+#
MY'E,V.I0D[L<,?09KO7ECC959@&;.U>[8&3@=ZHZ)K5KK^F_;K195B\V2'$J
M[6#1N4;CZJ: &:%!>16;/>V-G8S2-N^S6C;UC&,<OM7<?? [#MD\KJGA36;W
M2O&]I%';!];E#6I:8X4>4D?S_+Q]S/&>M=]10!Q&N>&+_5=634+:W2QU.(P_
M9]2M[DJRH"#)'*N,2+][ YSG^'K5;4?!^M7*>((K=K%?M&J1:K8R3.S*SHL0
M\N1-O"GRV!()^\.*ZXZW:CQ(NA%9OM;6K78;9\FQ653SZY85I4 <)J'A[7M6
MT:"X6PTK3-2L[V"\@M(9"T<AB)R'D" _,&., XP.3DXT]!TW6(O%NLZQ?VMM
M;P7]O;(D<=P9'1H]^<_*!CY_7M744UVV1L^&.T$X49)^@H Y^\TN_E\>Z=J\
M<41LK>RGMI"9,/ND>-@0N.@\OU[U@V?@W4D\+VGA2Y\EK&SODF2]63YG@2;S
M57;C(?@*>V,G/:NPT36+;7]&MM4LQ(+>X4L@D7:V 2.1VZ5H4 <]X9TJ^TR]
MU^2\CB6._P!1:[A,<FX[3&B888&#\F>_6FWVE:B/'-CK=I';RVZ6$MG,LDI1
MEW21N&7@AON$8R.M='10!PMEH'B33OA]9Z3;-;I?V]T'F1+AE6:$S%V19 N4
M)4XSCU^M9Q\%:]$MW/:PZ;#-%KD6L6D"3MY<@$2QM$QV#;QNPV#D]A7I=% '
MGFI>&/$.JVWC+=:V4#ZY:10P)]J+;&5"IW'9TY[>GXUI3:%JTNNZI?"" 1W6
MB1V$:^=R)5,A)/'W?WG7KQTKL:0G:I/)P,\#- 'E\EKJ6FWOAW3K**R?6-,T
M06]TJZAY#E#M4;2T;!U)B8_=!! Y&>=_1]2NK'2-"L]-T2W@M5G-G- +OS#&
MB\;XV _> =23CH>]:EDVA>--,AU&73(;J)998XQ>VRLR,CLC<'..5-;B(D:*
MB*JHHPJJ, #T% &!XJT6\U-M)O=.:/[9I=ZMTD4K%5F7:R.F<'!*L<''6L+6
M_".IZI:>(KN&.".^U<VB)"\V%CC@8-EF /S'+= >W/6N^HH 1"2BEEVL1R,Y
MP:\[TGPCKVE6OAF;9:/<Z$UQ"84G.+F"7@L"5&UQA2 >.#SS7HM% &%X>T67
M3;K6+^XVK<:I=_:6C1LB-0BHJY[G"Y/N<<XS7.ZSX4UN[LO&EC;1V;1:VRRV
M\KSLI5O*CC(9=IP!L)R">HX]._HH Y2;1]4D\67FJB"$03:.MDJF;YO-#LW/
M'W?FQGVZ50T;PQK&GS>"_.BMBFBZ?+:7168G+,D:@H-O(_=YYQUKNJQ+?Q-:
MWEG?W%K:7TWV&\^Q2Q)#F0OE<D+GE1O!)] : .2U'PGXC&C^)-#LXK*XM=3O
M6O;:YEN"C1EY%=D9=IS@@X(/0_A6U\2R_P#PK#72X57^R'(!R <CO@9_*NNJ
M"\LK34+9K>]M8;F!OO131AU/X'B@#E=6T+6]5U&XU>U:'3M1ATJ:RLBS[_WL
MA5BY('W1L4#@GDD@8P<>?PCKT_\ ;[I8V$']JZ&+#;]L>1EF'FC<[%,MGS 2
MW7CO7H\<:11K'&BHBC"JHP /0"G4 <GJ>B:K<6WA>:VBMC=:5<K)-#),55AY
M+Q'#!3T+@].0*S-3\'ZQJ#^))8C:137=_:WUB96+HS0I&-LJXX#%#TSP?:N_
MK+U77(-+D6#R+B[NFA>X%M:J&D,:%0S $C."RC&<G/ - &!+HNH:KHKP:KX<
MT=8YY$$UA#-G**&RXD"+A]Q4J.V/O<\:_A72[[1]%^QWMU+<E9I#!YTOF/'"
M6^1&<_>('?\ #)QFK^E:DNK67VI+6[MD+LJI=0F)R ?O;3S@]1FKM '"+X0U
M2Y\$:SH\KVUO>7.HRWUL^XR(";CST#\#C( /7OUI;[0]>UKP9K-A-I.D:;>W
MEHUM'';3;E9B,%V?8"!Z* ?<^G=44 >>>*O#'B37[;5K/R[*6VNM/CBM!-<L
MHM90#O\ E"D,6.,/P0/UV8-)UB#Q9J&J^1:-!?Z=!"ZB=MT<L?F?*/E^8'S!
M\W'0\5T-_>?8+)[G[-<7.PJ/*MTWN<D#@>V<GV!JS0!P6B>%M9TU?!:S16Q&
MB6DUO=%)B=Q9%4%/EY'RY.<=:R)M.U+1QHM@(K ZRNIWVH6ZF^\D^4[.2%<H
MPS^^4%2ISVZ9'JE5;_3+#5(1#J%C;7D0.0EQ$LB@^N"#0!B>"V*:;<VK:<ME
M+#<NTNRZ%PLLCG>S;P!EB6.1@8^F*Q=0\':Q=Q^(H(I+2,76IPZK8S-(Q_>H
M(L(Z[>%S$>03U''%=W;V\-K D%O#'#"@PD<:A54>@ Z5)0!SMCI-W<>+?^$B
MOH4M9$T_[%' LF\\OO=B0 ,9"@?CG'2L[Q=X8O-;U W-E"MM?PP*MCJD%P8Y
M8)-S%ED 'SQ_=.WG.6&!G-=#J>MVNDW6G6]PDQ;4+C[-"43*A]I;YCVX4_E6
ME0!PT/AW6]/\0ZDL%CI-[IVHW/VE;NY.)K5F #C9M(<9&5&1UY-6-)TKQ)HF
MKZE9VZ6,VDWM])>I=O,PE@$AW.GE[2&.<X.X#GG.,5V-% 'G6H>%?$,EKK6G
M6L%B\%WK,6IPSR7#*2!)$[(5"'!&P\Y/;BNBT33-1L?$'B._N881%J$T4T 2
M7<?DA6,AL@8R5SWZUM7UY]B@27[-<7&Z1(]D";F&Y@-Q']T9R3V -3B1#(T8
M=2Z@%E!Y .<']#^5 ' Z-X4UJPM?!T4T5J3HTT[W)2<D$.CJ-GR\_?!.<=*S
M]2TV_P!,M8+26.Q&I7?B*;4;%6O#$0OS/PY0@/@[2"K AB/<>AZOJD&B:/=Z
MG=+*UO:Q--((EW-M49.!]*);:PUS3HOM=G#=6TJK((KF)7'(R,@Y&>: ..T[
M4]3TG3=0%KH5L-0^V)/<J=1$HN&ESNVNJ#]YA0 FT  KVKJO$5@=3T.>R%C;
M7R2LBR6URVU'3>-W.#@XR0?4#IUJ]:VEM8VZ6]I;Q6\"?=CA0(J_0#BF7MY]
MC2%OLUQ/YDR18@3<4W'&YO11U)["@#S\^"]<LH;.ZL6BO?[/O97M=.U.<R#[
M+(BJ8C+AOF#*64\X!QDU>U3P[K<LFD:Q:Z=I#WEH9EFTMFQ"T4NS(639]\&-
M3N*\Y(]*[NJUC>?;H&E^S7%OB1X]EPFQCM8KN ]#C(/<$4 <5KW@V^\1-HD=
MW!:VT$#3O<K9S%# 73:GEG:-Q4X))QG'3M5BZTKQ/J>BZ%#J,5D^H6&I07-Q
M+',0LJ1D_,!MX8C'R],YYKMJ* //]2\*:U=Z1XLM(HK7S-6U&.ZMRTY "*(@
M=WR\']T>F>HJAK*3ZCXD\0K9V5C=V<L4%KJ4)U06S,57<0X,;?PN!N4KD<=N
M/3ZH7.B:3>7B7EUI=E/=)C9/+;HSKCIAB,B@#.TS6K^]U6SA&FQ0Z?/IZW&[
MS<R0R9'R,H&,8/!SS@\<'&=KNAZNGBU=;TNPTW4H;BT2TN;6]D\LH49F21&V
M-_?8$8]*ZN:Y2%)R TLD,?F-%'\SD<XP/4X('KBEM9_M-I#<>5+%YJ*_ERKM
M=,C.&'8CN* .)U[PEJ&I30S6T,%KJEO!&MIJEG*86A;)+HZ#[T7HISG)''6G
M7F@>)H)?%!TI[5/[2NH;J"4SLCD!(DDC.%.PE8V <$XW#IU'87-Y]FN+6+[-
M<2_:)#'OB3<L6%+;G/8<8SZD4V]U!+2SGN$AFNS"P5H;5=\F3CC&?0@_2@#@
MY_!>LW%GXHACM].MEU.6TN+=%N&8!HO+W*QV=]A^;GD]*VKO0;_4[_4M7E@B
M@N9=*?3K:W\W/WB69G8# YV@ 9X!/? ZVB@#BK#P[JUO>>$)7BMPND:;):7)
M$Q.79(U!48Y'[O/..M9L7@K5(=/U>&P@BT^/4-*FMIM/2Z+6QNW&!+&,?NU
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M7*,QW; 3V7.T?2N#M-:U2Y\(^'_$T-W<-J=UJ<<%U:F0F-E>8QO%Y?1=@Z$
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M]TTKF2>&19%48V_)M#@! 2..H[N3PCK:Z3;VI_L_S(_$!U5C]H?'EF8R[?\
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M$L5P4F?+[TV H"G/KSB@#=MO%VGW%D=0,<\6F_9I+H7K[3$8T(#?=8D'G."
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MS^;(IPN<'H.,8SSUH [VBN+\7WJ'5X[%;Z>.8:;<W!A%R;>)5!4"4NOS%E/
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M0!!;65I9ES:VL,!D.7\J,+N/J<=:DFABN(6AGB26)AAD=0P/U!I]% " !0
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M'%-X>2_:8;-[MB- BG;T7))[G(R<9S'#KOB"^31+1]4EMY6UR[TJXN(H8_\
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MEXAU*)I6DV?=EF8*&VM@L0.W8@8)!&NEQKEI)9:7J.LI-=27EP$BLPK3S0A
MR*SE552FY2QP,C;W." =S17FMIXEU^;P?H.JRI=WD317']H'3Q']I!5]J2JA
M&' P=P4=2.,<5/!K6K^)FN[+0M7B66VTZVFMKIF$?G-(A82LAC;*D@ KQCGO
MC !Z'17 WWB#5+#5[9M3EFBTZ9[18[_3PLMLCMMWQR@C<H<G"OZ,O3G/?4 %
M%>>WVOZK=:+XPU:UOFM9]"N9HX+?8I1EAC5SO!&3OR><C (Q@@DV;&ZUG6?&
MEU;_ -KW5E:0V5C?"U6*(D%VDWQDE<[2$P>_H1T(!W-4;G6+*TU6QTR:1UNK
M[?Y"^6Q#;%+-\V,# '0FLWQ#>31ZAI-E!>21O<O(3;0*OFSJJ=F;A%4D$GOP
M!UP>)M+S4O$2_#^>YOY(;Z9[Y)+J)$W_ "QNN0"-N2%_NX]J /5J0L 0"1D]
M!ZUYO;ZUXF@LKRV8W&KC2]6EMII+;RTNKBV$2L&5<!696D4,%QG'U!=I]V^L
M^,/"]U;:W>S03:1=/O**A=EEA!W(5P&Y(/';C% 'H]%>;:5J.LR>#_[:O/$\
MZS37,EDB-;1L"?MAC7: H)D*@H/X?F!(XS0/%6J6;ZC8W-Q)$!KUMI\4TVQG
MMXI8D<Y(&TG)(!.<%AG.* /2"P498@#IS2UY[XMM=1M;.VMY->GE1M>L3$J*
MJR11-*@VN<?/\P)&1Z9SBK-YK6H:;XJ2TU&:]BL)KN&&SO8522!\JH,,P W(
M[/NPW3D<@<4 =S5&^UBRTZ\L;2YD=)KZ4PVX$;$,X4M@L!@<*3R>U4/$E[+;
MOI=O!>/#)=7>SR84#2W"A'8HA/"] 2QZ 'N17#&]U+6]-\)F[O'2\3Q'=6OV
M@*A<"-;E >FTMM4<XQGG!Z4 >K45YFOB+6M+U27P[=:A)<K_ &W!81ZF\:"0
M120^=M. %+C 7./X@<9IVNZ_K>D1>*K*&_E;^S?L=Q:73(A<+,^UHF^7#8VG
M!QG#=>,T >E4BL&4,I!!&01WKS[Q1J.H_:/&M@FH3QV]MH"W< CVJT4A$V<-
MC.#Y:]_IBNLT&W<>%K"$W,S,UJF)3MW+E1TP,<=N/SH GN]9L;&^L;.>5A-?
M2M%;@1LRLZJ6(+ 8!PIZGM5^O(-'BNKCPU\.V;4+@SW&HRL9GVLR$P7&2,CD
M]3EL\GOTK8MO$NJV]M'ILM\9I'\13:4MY.5C;RU1I$!8(5W$@)G;SGUYH ]'
MHK%\.1:O;PWEOJ][!=.ERQ@:-MSI$0"JR':H+#)YQR,5Q>NZ]K^E'7].BU"Y
MFU*SN([ZS58XLS617<Z8V]O+E7/7.SGF@#TZBN%U#Q/<?8[74;&^<V.K:I;6
M%K+M4K%&W#R#(ZE@RC=D?=.*S_$VNZYHL7BZQMM1F/V'3(M1L[ID1GB+%U,;
M97##*$C(SR>>E '>76L65GJMCIL\CK=7Q<6Z^6Q#;%+-\V,# '<U>/ S7F?B
MV>^\-ZMX<U"6:[UF9+B\N%CV(K*OV5LJH4#*CEN[8XY.*[K07$VC6UP-4;4U
MG02K=%54.#S\H4# ]!R?4F@"32M8LM:MI;BQD9XXIG@<O&R$.AVL,, >""*O
M5Y)#-J^D:!K&NZ;JDJ_9?$5RIT_RD,5PKW>QE)*[MQW<$$=!QWK?74M?UJ?4
MKK3=0M;3^S=4:W>.>7">5&0&#KY9.67+ [AC(Q[@'9V]]#<W5W;1B426KJDA
M>)E4DJ&&TD8;@CIFK->:ZYKVMVEIXT-OJLJ/IU]:):L8HSL218BRD;>1^\;G
MKTYJ]-J>NZ9J/BZQM[YM0FM-+BOK+[4L:[)&$H*Y4*-N8U//OS0!WE%<?H4^
MKW?B2-Q=Z@^C#3HY7%U;K'FY8D%>4#?=P2!@ _7%&M2:K=>.[+1K76;FQM+G
M3)YW\F.,LKI)$ 5+*<'#GKD8[ \@ ["BO--%\3:YJ']DZ+=W*?:Y7U")[L,(
M3=&VE6,;?D8 D$L0!_!V&14\DGBC^T_#NBW?B(1SW45['=3V4<;;C'@HPW)P
MX#8;C&0< =@#K]5\1:;HQ<7DLF8T$LHBA:0QQD[0[!0<+D'GV/H<:M>9W]U=
M^'O%7B_5DNKF[FL-"MYQ&X3;*1]HP&PH^4$9XQWK7&H:G9Z[X9A34YKRUUJW
ME69F1/W;K%YBRIA>!U&#D<C\0#M:*\JBU/Q(/AE#XF;Q'<M>3&!#&8(?+&;H
M1DXV9Y5N>?IBM&_FUR+5/%6GQ^(KT1V.G17]O)Y4.]782Y7.S!3,8.,9]Z /
M1*BNKF*SM9;F8L(HE+N50L0!UX )/X5P4&N:YXDD_L^QNXK*\&BVMZC>8$)E
ME#9?!C?<BE5&..ISG(Q(NJ:CKD^LZ7<:@MO)IVDP2,UE@I/++&[-(-P.4&T
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M3_:-R#2K^R-MJD.<&78VZ+'_ 'TX/L,57M_#>KP_#?4])NI$N]8NK.2T#A@
MP$9BC))_V0&/NS5VU% ''6>D:O9>)--U(6220KHRV,Z^< T<BL&X[-GD#GZX
MK-T7PSK-C9>!X)[,!M&>7[65E4@!HG0%>>>7!^@->AT4 >>67A'5!X5T_P )
MW42^187\<PU 2#$D,<WFKA?O"0X"GC Y.3TJ/5/#7B%[/Q#IMI8V\L=]J\.H
MPW#7(4%0\+,A7!((\L^V.F3Q7H]% '-Z/IFI6/C#7[R:"+[%J)@E259<E62)
M8RNW'JN<^AI/$_A^[U34M)OM/F6":!Y+>Y<G!:UE7$@&/X@50CT(KI:* .*T
MGPI>:/I&N62[)H2)H-*B4@>5 ^7VY/3YG*_2-:9+H.K-X1\(:>MF#<Z7<6;W
M*^:N L*X;:<\Y[?KBNXHH \^U7PMK5WIWC;3X8+<IJTHN;29IL;F\J)=A&..
M8SS[CWQ+?:/K:^)I-77P_INIP:C:Q13VUS<*&M9$+8(8H0RD-R ,Y'&>_>44
M <5)H6IIKVI7*6<9@ET*+3XO**HIE4R$X7/RK^\ 'T-;OARTNM,\'Z797,!%
MU:6,4#QJP.61 IP<XP2.*V** /.](\+ZQ:6'@>VGM-IT=94O&29>-T+1@KSS
MRP/TI^G^$]5_X1O0O#5["BQZ1?13?;ED&V6*%RR;5^\'/R@@@ ?,03QGT&B@
M#SO4/#&N2^&?%VD16D+MJ5])<6LGG@!@Y4\@CC&TY_#%:/V+Q'I?BS4[W3]/
MMKRQUA87;S[@1M:2H@0[@ =ZD 'Y><@_6NSHH X*?P_J]IXFU1TT72]7L=5>
M.;[1=LJM:R"-8VW*5)=#L# #W'O70>+M-NM4\%:MI=C&KW-U9R6\0)"KEE*@
MGT'-;M% ''#2=4_X2>74?L)\AM#6R \U,^:&9L8STYQGUK2\,:=?Z5X$TS3)
M5CBU"TL4M_F.Y!(J;0>.HR,UOT4 >9VOA/Q#>75K)J%M%!)+HESIMY<_:_,<
M22;/WB@# 7*G"C &>U7-.TCQ*UWX/%[IEM$-$\R*XE6Z!653"8@Z #//7!QZ
M>]>@44 <OH_ANYTSQ3J=P9$.E22F[M(1U2>08E/M]TD?]=6K"M=!\3MKFAZC
M?V5O+<6%]<O<3?:^)(Y$D53&F,*H#+\O!)'/K7HM% 'G=KX:UJ'0M$M'LAYU
MGKTFH3 3)CRFDE<8.>3B0<>Q]LZ7AS3_ !'H<\^C-9VLNF?;9;F'4#/\PBDD
M,A0QXR7RQ&<XYSVP>RHH X+PSX>U72)X]+N]#TJ6VM+AI(=7+*9'CW%E&S;D
M28.W.<=^>AVO%FF7^H-H=QI\,<TFGZFET\;R;-R>7(AP<'D;P?P-='10!Y_-
MX6U?^QO$_AWR4EMM9NIIX;SS!B%9L%PZGYB5.[;@'/&=M=)XGT:;5/!&J:+9
MLOG3V,EO"9#QN*$#)_K6Y10!QD&FZR_B8ZI<::(XVT7[$42=6(EWEL=N,$<^
MOMS6)9>%=>T>U\.7*Z/9:H]II::;>64\RKM*G*R1L01UR".#@BO3J* ,N/28
M[CPV^E7EO;PQ7$#PS06HVQHK@@JO Z XS@9ZX'2L#1K#7=#\*?\ ".W%B=0^
MS0-;6MW!*BK)'@A/,5R"I P#C<.,^U=G10!Y_HOA35_#4GAB\C2.\>PTIM,O
M8(I #@E6#QEL X9,'..#[8JRW@NXD\'ZQ9[UBU*]OYM4@*G(M[@OOBP?8JN3
MWRU=O10!Q6N>'-5GT32)[6&SO-4L+O[;/;3G$5RSJZRJ"0<?ZP[2<XP*CO-%
MU2ZM='EBT.SL9(=7BO9K:VD3Y(U4J<M@!G.>W&.,\9/<T4 <E?Z3J,GB[5M0
MCM-]M<:,ME$PD4$R!Y&Z$\#YQS[&J/A_0=6TW4O#D]Q9?N].T$Z=-ME0DRYB
M/R\\C]V>?<>^.[HH \\TWPUK-KH?A"SELAYNE:D]S<XE4C85E V\\G]Z/R/M
MF7P]X?U;2+G^S;G0M+N+:WNGG@U8LIE:,N7 V%<^8,[=V0.^>,'OJ* /.['P
MUK,&@^&;.2R'G:=K,E[/B9"/+9IB,'/)_>CCV/MG6TBRUW0DUT1:;!=&XU1[
MJWS=;/,21ESGY3M*C<??''6NNHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG$]GK\E[.OG0_)"TDS!L[\'B1>!SUH Z2W\=Z-)!J5S<R36=M8WGV-I;B"1
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M*** "BBB@ HHHH **** "BBB@ HHHH *HZEJ=AI\<:W\@5;@F-$\LN7."2,
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MOTB6(V;^5&=JM#&Y!^7!&7/7G'>G7-IJEWX]\4_V7JYTV=-.LG$@@23<P\_
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MUO)'(LK;=B^6RAB6W+CCG-9/BKQ.3X*U/4=#O9(;JRN4@DS#AD?S$#(RNO\
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MVD1S#W=5*Y8#O@''?%4X_'OAV5('6ZG"7#QQPNUG,%D9U+*%.W!R >GH1UH
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MDLQ R<%1SCWH T+'P?H6G:7<Z;#8[[2YC\J6.XE>;<G.$RY)"C)P!P,U%?\
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M$9;J:X*VL=Q)(ENS$1MD+(X5?ESM;L.A[ T 3W/A_3;N'3XIXI733Y%EMO\
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M8792>"I')^ZP!%>EVLLEQ:I)/;/;R,/FAD96*GTRI(/YU-10!YI_P@^N6MI
M;&YCCN=(U KI!+9"VDC$.&]PDA&/^F*XZUT-]H]S%XK\,365D[Z?IMO<0R.'
M0;0ZHJ#!()^YS^%=510!Y?#X9UZRTS2+H:+#>S6%]?/-IT\L?[Z&XE9PR,25
M#+\O!Q_$*V1HM\-:\,WL&@V]C!;7%S/<P6K1@1>9$4&<$;F).20/Q.,GMZ*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2ABYY4]0Q'TZ8YSS/AJ]U/2M'\/7$%^?LEYKUU92V9B385::X.[=C=N#*.A
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MR/<2/NC!) (9B#R2<GG))[U:LM1M]0,ZP^:&@<)(LL31E20&Z,!G@CD<5;H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCLJ* /.-%\.ZU9Z;X'@GTUUDTFYE>[Q+&0BM'*@(^;GEQT]#71>*-+O[C4]
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MK5CI<USINKV-N$@\R-7MGB5EV,&;!4ANJD\@]0<UT5WX7T*_U W]UI5K+=,
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M,%6"@$'\10!H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,GFRH&SG((V#IQZYZT >D45Y_?\ B+7I+J^ALY5BOX-9CLXK$PAP]LVS,O\
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ME[8MRY3R]OS$AL!@QYYZ=*M> KW6]9T*TUG5-1BF6ZA.+>.V"!&#L-V[.3D
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MV %LC!R,<=ZI2>)[6_GTBUT>YCF;5!)(DZ\B.&/[[8/\6XJF#T)Y'!! (X?
M6@V[0"**Z2&WNOMEO;K>2B*&7GE%#84?,3@<<^E:^KZ-9ZY:QVU\LC1)*DRA
M)&3YT8,IR".A /X4TZU8&]%B)W\]I# &6)BOF!2Q7?C;N !.,]J@T75VO+S4
MM,N=OVW39520J,"1'4,C@=L@D'W5NV* (KGPAI%XNK+/'.ZZN%6]'VAQYH5=
MH'!^7@8XQ6K+913:>UD[2>4T?EDAR&*XQ][KGWK(U+QMX=TF>Y@O=32.6UV^
M>HC=C&&S@G:#@<<GH.,XR*?>^,- T^X6WN=2C$K1+.JHK/F-B &&T'()(_GT
MH NZ3H]IH>DPZ78+)':0)LB1I&<HOH"232Z?I5MIE@UG;&81,SN2\K.VYR68
M[B2>22?QJ%O$>DI>):M=@.\YMU<HWEM+_P \Q)C;NX(VYSD$=:2/Q'I4T&H3
M)<,4TYREW^Y<&)@,D$8R>"#QG@B@#/3P'H,>@0Z&D-R--AF$T</VN3Y7#;@0
M=V<!N<9QFM&X\/Z?<ZM::JZ2K?VL9B2>.5D9D)!*O@X<9&<'/-0PZM:G7-21
M]70QVMK%++:O%L%L#O/F,Y]0.AZ;?>LJW\3M=?$%-/BNF&FG2)+QDEMVB(82
M1@/N< E<,W3C\J .@U#2HM2DMY'N+R%H"2OV:Y>(-GJ&"G##Z].U21:;;0:>
MUC"C10,&SM<[B6)+$MU)))).<DDFJMOXCTFZN9;=+L)+%!]I99D:+,7_ #T&
MX#<G^T,BL:'Q-)>_$*QTVTN6;3YM+FN6C>V:,E@\85PS $@AFZ<4 :R>&M.B
M\-IH$0N(]/1%C14N'5T52" '!W#H.]5M0\%Z5J6I37\\VJ)<3!5<P:G<0J0.
M@VHX ')[=SZUT-% &1<^&=+N50-%(@6V^R'RI60O!_SS8@\C]1D\\G+KGP]9
M7-U!/ONX/)A\A8K:ZDBC*=@54@<>O6M6B@!D44<$*0PQK'%&H5$48"@<  =A
M5&[T2SO=7LM4F$INK(.(&65@%W !OE!P<@#K6C10!DP:/Y/B:ZU<32@3P+$T
M7G,R,1C#;3PI'(XZY)-2W&B65UK$&K2"47D$+P1NLK *CXW# ..=HY]A6C10
M!@VW@[1[.#2H8(YUCTJ1I+-?M#GRV8$'J>>&8<YZU;U;0;#6I+.6[682V<IE
M@E@F>)T)!4X92#@@D$5IT4 <]:>"=$L9K26VAN$:SN);F ?:9"$>3._ )Q@[
MFXZ<GUJ.XTN?0[.6UT#2EO!J-Q+)<FYNSLB:0$M(0V2P)ZJM=+10!3TG3+?1
M='L],M%VV]K"L*#V48S]:HW'A72KJ35GE2<G5HA#>@3N!(@!4 <_+P2.,=:V
MJ* ,*?PAH]TZ-<0RR[;)]/P\[D&!\;D(SSG YZ\#FH$\"Z&FXE;QW>S-B[R7
MLK,T)S\I);W./3/%=)10!B+X4TM)K.51<"2RM6LX&%P_R1-C*]>?NKR>>!26
MOA'2++^R/(CG4:0K)9#SW(C4C:1R?FXXYS6Y10!SVF^"M%TB^ENK&*XAWL[K
M"+F0PQ,V=S1QD[5)R>0.YQC-:6C:/9Z#I<6FZ>CI:Q9\M'D9RN3G&6)/4FK]
M% %.XTJRNM3L]1F@5[NS$BV\AZH' #8^H JE)X5T=_#UQH(M=FFW!D,L,;LF
M[>Q9AD'."2?Y5LT4 9)\.6!U)M0/VC[4UI]C,GGO_JLYQC.,YYSU]ZH3>!-"
MEL-,M%BN81IBE+.:"ZDCEA4C!42!MV" !@FNEHH R(_#.F0:C#?PQS17$-J;
M2-EF; B)!(QG!)(!R><CK5G1](L]!TJ#3-/1TM(!MC1G+E1G.,DDU>HH Q+?
MPII4$2Q-'-/&EJ]G&+B9I/+A?&Y 2<X.U>3SP.:K#P+H0^S?N[O-O;&T!^V2
MY>$_P.=V67T!Z5TE% &%:^$-'LY-+D@BG5],A-O;M]ID)\L[3M;YOG&54X.0
M,"H=/\"Z%I;W'V2"=(9@X%N;F0PQ;P0_EH3M0G)Y [G&*Z.B@#.L=$M+"Z-T
MAFEN/)6 2SR%V$8)(7)]SG/4]R<"HKWPYI][J+Z@PFANI(?L\TD$S1F6/.0K
M8/.,G!ZC)P16M10!E)X=TV+5+348H6BGL[8VL CD942(XR@0';CY5[=A4VL:
M/9Z[IYL;]9'MRZ2%4D9"2K!EY4@\$ _A5^B@#%F\*Z7<2:K)*L[-JL*P7G[]
MQYB %0.OR\$CC'4TV3PY8V\L%]!#<27=E9M:6X\\_P"K.,KAC@YVKR?0<UN4
M4 <AX)\+'2_#6A1ZG#.+_3[<1K'+,)%A<KM9DP2.1D ]@2!@$BM#_A#='^P?
M8?+N/(^V_;]OVE\^?OW[LYS][G'3/:M^B@# F\&:+-KKZP89TN92IG6.XD2*
MX*_=,D8.UR/<593P[8)=I<'SI/+N7NXXY)69(YFW9=0>GWFXZ#)(&:UJ* ,O
M6?#]AKZVJWZS,+6=;B'RYGCVR+]UOE(Y&:+7P]IMKJ7]HB*2:^"&-;BXF>5T
M4]0I8G:#WQC-:E% &)%X4TF&XDD2&0127/VMK;S6\GSLYW[,XSD XZ9YQGFC
M_A%--_M6]U)6O8[N]"+</%>2IO"@A1A6&, G&,=:VZ* *>F:58Z-9BTT^V2W
MAW%RJ\EF/5F)Y8GN3DFLF_\ !&AZC<7TUQ#<9OI(Y9TCNI$1I$V[7VJP 8;%
MY'/%=%10!Q-AX6DN/$WB>34;:YCT[4'@6-?M V3QI"J%6 8GJ#UQD'!]*DC\
M.3W/CG6[NYM[J#3KJRM[:-X;A460)YF]2%;('SK@X!ZX([]E10!EQ^'M.AU>
MWU.&)X[BWMOLD021E1(<@[ @.W&0.W85 /"FDK<SRK#(([BX%U-;B5O)>8$$
M.4SC.0#Z$@$C/-;=% %.;2K*XU:TU26!6O+1)(X93U17QN_/:/U]:R;[P/H>
MHW%]-<0W&;Z2.6=([J1$:1-NUPJL &^5>1SQ7144 9UIH=C9:M=:G LHNKJ.
M.*9FE9@RIG8,$X&,G\S3+WP_8WVI)J3>=#>K$8#/;RM&SQDYV-CJ,\CN.Q%:
ME% &1%X:TN"_L+R"!HI-/@-M;+'(RI'&<97;G!SM7KZ"K&LZ+8>(-+ET[4[<
M3VTF"5W%2"#D$$<@@\@BK]% '/CP;I/]G16,GVR9([A+GS);N1Y6D0@HS.6R
M<$# SCCI3KOP=HM__:GVJWDF_M/8;K=,_P Q0 (R\_*5P,%<=*WJ* .>C\%:
M*&NWN(KB[:\MEM+@W5U)+YL8S@$$XS\QYZCM5F+PUI\44J,;F9I+?[*99IV:
M01?W Q.0/4]3@9)P*V** ,B/PY8P:=IUC;M<PQ:=@6I2=MR *5 ))^8;3C#9
M'Y52N_ N@W<=DOD7%O+9ES#/:W,D,HWG<^74@G<22<GJ:Z2B@#)3PWIL6HV]
M_%'+'<6]J;2(I*P"Q$@D8S@\J#D\Y%5H/!VCVUKIEM%'.(=,G-Q:+]H<^6YS
MDYSS]YN#GJ:WZ* .?L?!FBZ;JLVH6D4\3RR-,81<R>0LC=76+.T,<]<4L7@W
M1X;.SM$CN!#9W9O8%^TO\LQ+$MG.3RS'!XY-;]% &=8:'8Z9?7MW:)(DE[*9
MI@96*%R "P4G"DX&<#G%5KKPMI5W>W=U)%*K7R+'>)'*RI<J!@!U!P>./<<'
M(XK:HH S9-"L9-;M]7*RB\MX6@B*RL%6,D$KM!Q@E1V["G:MHECK<=LEZDA^
MS3K<0M%*T;(X!&0RD'HQ'XUH44 8$_@W1KBUU*VEBG,.I3+/=*+AQO==N#UX
M^ZO QT%)>>"]%OM9_M66*X6Z=%CG,5S)&MRJ_=$JJ0' ]QTX/%=!10 4444
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M$I&5)(C;')..HX/.-6T_MG4/&FD:Q<>'[JRBATRXMIQ)+"=DC/$P VN<K\A
M/Z"NWHH JZ=<W%YIT%Q=63V4\B[GMY'5FC/H2I(/X5:HHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG>V5)&<X P!WIVKC4M+\<MJ:Z/<ZMIE]IRV;I;!&>&17=N5=@-C!\$Y_A&:
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M@(%+9W,,C.>"<]JP]&TW7M'7PWJ$^CW;PV-SJ*75M&5:11/*6CE5<_, .#W
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M2LRG\01]*R[;3-2M?&"76F+>PVTU_*U_972![<*0X^T0N>49CCY0>=YR .:
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MEC=C*YW#@BKFAZGJ_B"PL-<M;^WBM)[F5)K61!A(@SHNUL9\S<%SDXY(QTH
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M,3*K$[CWQMXX'OFH_"_B"ZNT\0SZM=Q^3IVJRV,16,+E%";<XY+$OCCKQ@4
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M)%0\>HW9'-1:7KVH_P#"?7WAJZ>"\@AL4NQ=0QE&B8OM\J09(W$?,,8X[=Z
M.BT_3[?3+)+6V#^6N3NDD:1V)Y)9F)+$^I-4+;PQIMLT)*S3K!$\,"SRF01(
M^-RC/J !SG X&!4L?B+2I=0CL5NP)Y0YBW(RK+L^]L<C:^.^"<5#+XMT."SE
MNY[[RK:*$3M+)$ZJ8R<!E)'S ^HS0!4M/!>D:4]E<VL5[+-IT3Q6BO>.Q1&
M&P;FQMPH !XJCX'\+/I?A?1(]5MYQ?:=$=D$DPD6*0@@LF"1D@D#)X!(&,UN
M:?XIT35+VYL[/48I+BV3S)4(*X3^^,@!E_VAD>]/MO$>DW<X@BNQYC0FX0/&
MR>9&.KH6 WKR.5R.1ZB@#GO"'A:2WTO;K%M<1RQZE<7D=O).KQ[FF=XWPI(R
M PX/ 89QGFMI?"FDI<S2+%((I[D7<EL)#Y+3 @[]G3.0#CH2,XSS26'C'0-4
MN;2WLM22:2[#&#",%DVYW ,1C( )QG..<8JW!KVFW,_E17!SY;RAVC949$(#
M,KD!2 6'(/>@!+/0[*QU#4+V%9/.U!@]SOD+!R%"C@\#Y0!QZ4[1=%LO#^F1
MZ=IZRK;1<(LDS2;1V4%B2 !P!3;+7M-U"]>RM[@FY2(3>5)&T;-&3@.H8#<N
M>,C(K2H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *YGQ?INH73Z)J&GQ&X?3-06YDM0P!EC*
M,C;<D#< ^0"1TKIJI:IJ]AHMI]KU&X%O;A@ID925!)P 2!QDD"@#C=3T#4;N
MS\<WUO92B;6[!;2VM2R!V9870.V6P,E\<G.%_"NSTE94T>S2:%X94A17C<@E
M2  1P2/UJ.UUO3;V\-G#=I]K">9Y#@I)M_O;6 ./?%3V=_;7XG-L[,()F@DW
M(RX=3@CD#/U'% 'GFF:'KEOH/A"PFT>=9-)U4RW#>;$1Y868;Q\_(_>+COUX
M]2ZT#7A#J5W!I3221>(SJ<5J\R)]K@,(B(5@WRMRQ&['05Z910!B>&[<)!<7
M0T3^R&NI [0NRM*Y QND*DC/8#)X ^@Q=.AU73?'/BC4GT2\FM;X6HMWBDA^
M?RXV5N&D!')XS7:TR:9((7FD.$12S$ G 'L* /-;SP?KLD.K>(3;PRZS>ZC;
M7G]G+-A3! -JP^9P-Y4DYZ;L?6F^(XBGAZ+41X<;39;C6-.+02,C3SE9U W$
M,5] N6^N*[RU\0:9>PZ;+;7!DCU-2UHRQ/B0!=Q.<?+P.^*EU/2++6(8H;Z)
MI8XI5F0"1DPZG*M\I'((!% '%ZQI&L3:IK&O:=IA+7"65NMM((S+(L4I>250
MQVAP& 3=W3/IG.O/#^N2:?XFMXM$NV^W:K97EN);F-V9$\@ODE^H\MLY..@&
M17J1(1"3G"CZU4TO5++6M/2^T^;SK9V=5?:5R58JW! /!4C\* ,/4+34$\>Z
M3JT-A+/:#3Y[65D= 869XF!8$C(PC=,\USMCH6M0^&O"UI)I,PGL=<>[N$\R
M+Y(B\Q#9WX/$B\#GK7H=S>6UGY/VF=(O.E6&/><;W/11[G%3T >9ZAH&O-<:
MQ?6VE-*R:]%J,-L\R)]KA%NL+*"&^5OO$;L=!5N_TB\O;"PN;'PP]C(VLVEW
M/"9(O.*1L"SR'?@G P "3@>^!VEIJUC?WM[9VT^^XLG5+A-I&PL,@<CG(YXJ
M[0!YOK7A_6;V#QNL&FR$W]Q:36@,D8\X1+$& ^;@_(<;L=JZKQ-IEUXD\$ZG
MIL0:SNKVT>-%D891B. Q4D>QP3U/6MZB@#CHK'4=8U_P[JUSILU@VE6\_GH[
M(=\DB*GEIM8Y7@MG@<+[XM^!+*^TWPT+34+.2UG6[N9-CLC962>213E21T85
MTU% '$V/A]I_B'XBU'4]#26RNH;5+6:=8I 3&KA\#)(ZCL,XK#A\,:W%X?UZ
M&UT@0RCQ#_:EG:/+&B7,*M&0F58["0IQG&#BO14U:QDUB325GS?10B=XMIXC
M)P&SC'7(Z]JBO]?TS2[R"SO+GRKBX#&&/RV)D"\MMP.<=\=* .2N+74I--:_
MT[PD;*>>\MC<Q.T+7;QH3N=26*;ER N3D#<>#BLY_#^N?\(WKUBFC7/F7.O0
MWT"O<QN7B$D+DEB_4"-LY/7IGK7HVGZE8ZM:BZT^[AN8-Q7?$X8!AU!]"/2K
M5 'GNN:/K,TWCB*VTJ:=-9TY([6198P"XA:,H<L"#DCMC&>>U:6GZ=J*>-M,
MOI-/ECM8]#-I)(SIA)3(C;2 V>BGD#%=A10!R/B>UU:ZUN!+;39+BQDL9XFF
MMY$CD65BNU7<D,(\#)"]2!D'I63X3TG6=/U'P]/>Z/<11V7AL:?,3)$V)@T9
MV\/W"'GIR,X[>B44 >7^'=%\0>'E\*7LVD3W M--FTZ[M(Y8S) S.KB1<MM8
M'8 <'.,5U7@:ROM/T2Y@U"R>TE;4+N94=T;*23.ZGY2>S"MFQU:QU*>\AM)_
M,DLY?)N%VD;'P&QR.>"#QZU=H X;0_#I;Q3XJOM6T%'BO+F.6TDG2*0NJQ*A
M Y)'*G@XK'LO#FM6G@6.V_L>5+FSU]=16T5XLR0BZ\W"8;;G;V)'3%>HT4 >
M8ZQHVO:E;>,3'H=PK:G+926J--%EA&(]P/SX!&T^WH36U>:=J4OBO7;Y--F:
MWNM$CM86WQ_/*&E)7&[(_P!8O)XZUTYU:Q764T@SXOW@:X6+:>8U(!.<8ZL.
M^>:CU+7M-TB:WAO[GR9+AML*E&/F-Z# Y/MUH X"31O$3>'[#26T68H/#0LB
MT,T2.MT$VE9'W9,? ("D@DG(/&-/1=-U:WUS3;RXTBXCBA\.K9.3)$2)@RG9
MPWH.O3WKKK#6M-U.:6&SO899H<>;"&Q)'GIN4\C\15^@#G? UA>:5X%T?3[^
MW:WN[6U2*2-F5L,!CJI(/YUS.I:!>:[-HVJ)H,^E>*89H&GOT>-4" CS0S*W
M[Q2H8!2,\CH,UZ12,0JECT R: //;#1M0MM6O=+U#PT+^"34I+VUU)YD,*H\
MADRZ%MP="2!A><#D=:V_"6FW5M_PD,>H6#PQWFJ37$8D*,)8G"@'Y2?0\&MS
M2]5LM9L%OM/F\ZV9W0/M*Y*,588(!X92/PJY0!R7@_0]0T2VG@OQYL5AOM--
MPV6:VW;U)]"043'_ $R![USFC:1XC\/6'A2_&BS7+Z?:W%E>V"2Q>:HD=6$B
M$MM/* $;NAKU"B@#@=4T_5K;5M)UF'P[]JMA;36]QIMI,B26^]PZNN656/&&
M /4Y&>M0:MX:NC9VYTG2[G2+^WM'^R/ITD9C5F=F\B9&.UU/RDG&,EN1W]%H
MH QM,U6\FU:?2KW3WAEM[>*7[2K*8IBP^;:,[E ;(&X<X..E9EQH]YI7CV7Q
M):6[W5K?6:VMY#&1YD;H<I( 2-PP2"!ST(SS74JD:.S*JJSG+$#!8X[^O I]
M ')PZ3=ZCXW7Q-=6LEO!9636MG;N5,DC.VYW(!PHP H!.>I..*P!H>M_\*@C
MT3^R)_[36=2;?S8N@N1)G=OV_='K7HEK>6UZDCVTZ2K'*\+E#G:ZG#*?<$5/
M0!Q/B#1-2UGQ0[PVTL-M/H%W8&Z+)B*65D*Y ;=P%/(%00V6N:_X0N-%OM"&
ME7RZ7)8F\EDC=6<IM'E%"6V$@$YQT P>H[+4]3L]'TZ>_OYO)M;="\K[2VU?
M7 !-68W66-9$.58!@?4&@#DO"T%U<7<5WJ/A4:5?6\!AEN)9DE+DD96(JQ.P
MD9.<=N#R1+<V>HZ=X_?6H[26]L+O3DM6$)7?!(CLPX8CY6#GD=".>.:ZJJVH
M7]MI=A+>W;LD$0R[*C.0,XZ*"3^ H X*P\,:KI$'@ZW6RDG%A?W-W=>4Z;8%
ME6;"#+#.TR@<9Z&NC\<Z?>:GX8>&PMVN+B.ZMIQ"K*I=8YT=@"Q SA3U(KH\
MC..]% ' W^EZO=ZAXQG729PNIZ-#;6P,D7S2!9@5/S<<R+R>.#S50:3J^G:C
M;7%QX<FU:SO-)MK.>".>-7MI8@P(8,X5D;><D$]/>O2:0D $GH* *$*2:7H$
M4=O8*TEO;JJ6=J0JY"X"(6( '89QQ7&:WX/OKKP.LEK]M;Q!#(NH0QF9=HO
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M8M&P"(K[53Y"%V@=L@=:[70;C23:RZ=I#DPZ8XM'C._]T0H(3+<D!2OJ*U:
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M:V>-+N%-J!/-4$!]WS@\'(5<@<X]'JKJ6I6FD:?<7]]-Y5M;H9)7VEMJCJ<
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MP!-R Y41JPR"Q( QC&"U;5[X0T/4=/GLKRR\^.>9;B1WE?S#*H 5P^=P8
M@\ 8I#X.T,PV4?V64&R=I()1<RB4,PPQ:0-N;(P#N)R /2@#D;#Q#XAU>P\'
MJNJ"UFU.2\M[J1;=&),2R[6 (P#\@/'&>V.*U;&^UG5DU9;?6X[>XT>]2U;S
M8$V2JB1M(\@QD;]SXVD <>];%IX,T&Q:R-K9O%]AEDFM@MQ*!&SYW8&[&#DC
M'3!-.N/"&AW6NG69;(_;6V^8RRNJR[?N[T!"OCMN!H X6_O=3T>;QUK&GWY@
M-EJENYA$2,LP,, 97+ G&#_#@@]STKT#Q+>R:?X?NKF&\BLY5"JD\J%PI9@O
M"@$LQS@#!R2.#4-QX0T2ZAU*&:UE>/4I%ENU^TRCS6  !^]QPH'&.@J]J>D6
M.LZ5)IFH0F>TD"AD+L#\I!!W Y!! .<YR* ."U/Q-KUIH_C#RKN6*?2I;<VS
MW,432*LB(2K!1M/).._/-6-8\4ZKX5O/$RW-W_:*6>EPW]N)(E01N[R1E?E
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MVM+:UMX;B&&V@:WB6.[E&(VQE?O<C@=>G;% $.M>(3I/@&XU^!X[QHK(3QR
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M&@(&692!R2 .M &>GBW2+.*RMIKVXNKJ:Q6ZCV6DC23QX4%PJ+R3N!*@<9/
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MP7K+/=K)]FD$3!9=GWC&Q&UL=>_KR*R?!GB<WWA71)-4N))]3O+=IF,=NQR
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFS.@4$R^6@)5>03Q@9%3S^)-(M[.*[:]62"6$W"/"K2YB !,F$!.T9'S=.:
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MHVX(*NIPRLIP58'J" :KOXATJ.\2U>[59'F^SJQ1O+,O_//?C;O_ -G.<\4
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M<\4 ;=%1V\\5U;17$+AXI4#HP[J1D&I* "BBB@ HHHH **** "BBB@ HHHH
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MO;?4;"VOK23S+:YB6:)\$;D8 @X//((HEO+:&Z@MI9D2>XW>5&3R^T9;'T%
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ME'E0CEAR03NP%X!X8GM6'<Z)J.C_ ! TW6-+M[R^MKJW>TU-GF0[%!#1.-S
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M)MI(KJ6.1(_[A=6#%>.A)JW-X8TF<L'MW$3I'&\"S.L3HGW5* [<#Z<C@Y%
M&#'XAOH/&<>FZI+=6<<UVZVA\E'M;N/8V$$@&Y)01DAB/NG'6M?Q!>W,%]I=
MI;7C0M<O)NA@16GF"IGY-X** 2"Q; Z#.3S:3P]IJ7:W/E2LRW#72H\[LBRM
MG+A2< _,>@[D]:=J>@:=K%S9W-Y"[3V;,T$D<SQ,NX8890@D$ 9!X.* .(TO
MQ'K^K6W@P'45MWU074=VRVZ$L8U?##/ /RY],]B.*FTSQ5JDR:5I%Q>9O+K6
M+VP>^\M QCMS(<[<;0[!5'3').*Z6S\&:%I[6)M;22+[ \DEL%N9<1F3[V!N
MQ@Y(P>*23P5H,M@UFUI((C=F]5A<R^8DY))D5]VY6))Z$=30!F^!HI(=4\7Q
MS7#7#C63F1U +#[/#C(4 =.. *YW7-1U+2O&?C.[TVPCO"FF67FAF)9$S*&<
M(!^\P,G;E<XZUZ#I6@:?HLMW)8QRK)=R"6=I)WD+N%"[CN)YP!SWQ1;Z!IUK
MK5SK$44@OKI%2:0SR$.JYVC:6VX&3CCO0!R=A+%X7\)>$=$T2^^U07T@MXKY
MBHW*8WERN00"Q7 !!P#CJ*DNM0\5Z3IP-XK7RQ7S^:VF^7)=BUV90E"H5F#$
M9"KR,$"ME_ WAV31Y=);3S]ADF\\0B>3;%)DMNC^;]V<DGY,=:L0^%]+M[:V
MAA2XC^SNTB2"ZD\PLPP2S[LOD<?,3T'H* .5M-9U;7=9TRQTOQ(!9WFCRW7V
MM;-"Y=943=AA@'D@@C Y&,X(;X>\6:OK,VBZ/>3BVO)DO?M-W!&H\TV\HB&P
M,"!NSN/'&..M:3>%3'XUT^>VM)H-*M=-EMA)#<E&$CR*_.&W$'#9)SR<^];D
MOAG2);:QA%KY0L"6M7AD:-XB1@X8$'D$YR>>^: .-_X2;Q!)#:6HO4CN(?$C
M:/-/Y"D7$6PN'QT#8P#CC(/TJQ%KGB*&PUB%&N-4ETS6?LSO#'$MS);>4DAV
M+@(S@OTQR >]=5)X8TB6&SB>V?9:7)NX=L\BD3')+L0V68[CRV>II@\*Z2LT
MTR17$<LUT+QY$NY03,$V;OO<?+QCH1VH YNR\4W&L2Z5IVFZE)*UW!=SM<NB
M0S9CE51&59"H90_S#;_#GH:ZKP\=5.AVXUN2UDU%-R3/:G*,0Q /08.,9'8Y
MJG?>"M U&SM[:XLVQ;S/<12QSNDJ2.2782*0V6)YYYJ1O#%FNJ:/=6RM NF+
M(L869_F5U(*LN<-DD,6;)R/?- &+\2/-\GPQY(0R_P#"0VFT.2%S\W7%4=]Y
M#\8K8ZL(H;B[TF6#3FL\LF%8/)YN[!R.,<8_&NQU?0-.UT6PU"*63[-,L\.R
MXDBV2+T;Y&'(R:;;>'-+M;^2_C@D:]>+R3<37$DLBIUVJS,2HSS@8H Y'P_X
MJU35K7PI8W%V8[G5;>ZN)[I(T#'RF "J""H)W G@\+[YJ*3Q-KX@2U%XB7%K
MXE329+@P*1<0L P)'0-A@#C'(.,5U<?@_1(=.L;&&UDCBL)#):,MQ)YD+'.=
MK[MP!R<C.#FI9?"^D3VUM;R6SE+>Y^UQXGD5O.SG>S!LL<D]<T <3JNM>(]-
MTWQ?(FN/(WA^9)(&>VBS.K11R;),+C'S$94*?>M>^U7Q!JVHZ[::#<06UQI<
MD*1K,R['+1I(3("A;:=Q7Y2/NDUN7/A'1;N/5(Y[65TU4@WH-S*/-P H_BXX
M '&.!4=[X*T'4-3BU&XLW:Z2-8F=;B1?-0=%D ;$@_WLT <GXEU6\\0^$_'8
M2\-K#IEM);"&)482_P"CB1V8D$X.\J,8X&>]:-UXBOM'UC9O\ZPM_#4NH_9@
M@!:2,H!\W7D$C\:V]1\&:'JEW>7-S:RB2]A\BZ$-S)$LZ8P-ZJP#$ X!(R*M
M1^'-*BOX;Y;=S<0VILT9YY&'DG!*%2V".!U':@#$2]U:#14UQ_$%D;2?2FG/
MVJ)5CCGV!U=2H!\L#.02QP!SUJC:ZQJ<][KFEWDT\T"Z)'=QM<Q)&^Y_-5B
MH&%.P$!AN'.:V[+P+X<L+.[LX+ FUNHFA>&2>1T6-OO(@9CL!]%QT'H*EM_!
MFAVTKRQV\YE>U^QO(]W,S-%S@$ELDC) /4 X!Q0 G@;_ ))]X;_[!5K_ .BE
MKC?&;WMU--XHL;"[FFT"Y5[.2/;L>*/(N1][/S9=3Q_RR7'6O1K'3+73=*AT
MRT1X[2"(0Q)YK$H@&  Q.[@=.>*CM='LK/2/[*@CD6SV%-AF=FVGJ-Q.[]:
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M:J#C<),A3DG&2>.E<UH%]J>DZ;I5S;W_ /HMSXDNK*6T,2[61[B;YMV-VX$
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M1$A !7!;!& !SGH*@M_!>@VHLUAM)46RG:XME%U+B)SD':-W3#,-O09/')H
MYG7=>UO18;MHM7-[)ITME#+Y=O&J?.R*_G9'#-O) C/RC;G&>=6/4]5UN?6W
ML-4BL&TK4!;"*6-6C:-%1G:3(W?,&;!!&,#WK0O_  5H.IW-[/=6<C/>F,W
M6YE179,;6VJP 8;1\P&>.M.D\&Z%+K(U8V;"[*HKE)G5)=GW?,0-M<CMN!H
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MUQ5N@#  ]** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[!Y4<2/C&3SR>IJ>STN[OO&B^(;RU>T2#3_L<,$CJS%G<.[':2,#:H'.3\W
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *CG@AN86AGB26)QADD4,K#W!J2B@!D44<$2QQ(J(O"JHP!]*?110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDDC6T?<D4GVCRVVXSM.].>@SSB@#T&WU-!-J<ESJ.G&UMI0JF-\& ;1D2DG
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MV]<9XS7'^*_$VL>'K74)8Y+"5K&P%V$6%V:9MS;@RAOW2;5 #$G))],5:O\
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M?EP#\HXP1Z # "S> ].GL]6MGO=1*:I+'-<DS DN@49&5XSL7/TP,#BNIHH
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M#212 NQ(()9W&1C@'H *V+CP=87-JL37-VLGV]-1DG5DWRSJ059LKC VJ,
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MC(=T>?-#A^/DZ;E4X]JZ:B@#GKKP;IMX^MF:6[,>LQ".[B$H"$A F\#'#;5
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M/%"0V[Z+)>_9WBVMYRQ&;R1+NS@G=@[=O0]<BMF?PI!.^E3?VA?+=:=*\JW
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M;<A0!GYCD_3H !5"Y\&P2Z_<ZK;:GJ%D+T(+ZVMW41W.T;03E25.."5() H
MJWWBJ_:U\17VEPVTD&A2-%+%,&WW#)&LD@5@<)PV!D-D@]!52Y\7ZQ=7UW%I
M$%@($T:'5H)+G>697W_*R@C^YZ\9[]*U[CP?:2W6J/#=W-M;ZLH6^MHMNR4[
M=I89&5)7Y20>0.QYI\OA*U?4KR]CN[F$W.GKIWE1B/9'$I8C:"N<C>W4GZ4
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M ZJ2!T!8@9/ SR17)SV%P=$U=DTJ]^TOXKCNHR+&3>T0GC;>/ER5"A^?KZT
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M,5O76FV\?Q!NYTTB3[)_831AX[)BAD,K,R@A<;B&Y'4YH ZN>^;^T].B@O;
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MP),;<>66[YS\N,\5UGQ"MKBZ\%W<=K;RW$JS6\OEPH7<JD\;-A1R3A2<#TH
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M"TUQ-'#$OWGD8*H^I-5AK&F&T6[&HVAMF?RQ-YR["V<;<YQG/&*P_&<-Z)]
MOX();FTL=26:\AA0NQ0HZAPHY;:S!L#)XSVKDO$>CW%U;^*+V#3[J:SU&^TU
MH+=;5V9VB=#-)LQD J,9(&=AZ\9 /3(-3L+FR:]@O;>6T3=NGCE5D&W[V6!Q
MQ@Y]*YB;QS;W'_"/WFESVDNFZC>/;SR2-\T:B.1PW7"_ZO/S=C766\$$$.VW
MA2*-B7VHFSD\DX]:\LTFSNO^$>\!6-SI-^'T[43]K22RD(CQ%,NX_+TW,F&Z
M<\'@X /2X]9TN73UU"/4K-[)SM6X6=3&QSC ;."<\53O_%6B:=;V,\VHVQBO
MIA#;NLJE9#W(.<8&#DUP\ NK)[DG1K[R6\433K.+&5VMXVB($R1[?FR=RYP0
M-V2#4%G:7]OHNG&73=2_T+Q9-<R@VK%_*9YL.%4?,/G4DJ,<^QH ]&UO7=/\
M/Z2^I:A<)';J0JDD?.QX51ZD_P#UZQ_^$O@M_%5Y97U[IT&E1V,%U#=/*%#&
M1W7!8G:?N<8]:=\0+:YO? U]':VTTTVZ"3R8TW.0LJ,V .IP#P*Q=1A-_P"+
M->O#I=X\$WAU((7>RD^9]TQ*#Y>N&7CKSSR#0!V]YJ>GZ?"LU[?6UM$WW7FE
M5 ?H2:M*RNH92&4C((.017E5LMUIXT235]+UJ?3KGP_;V+BTAE9X)TSYB21K
M\P#!@,XZK7HVAV<6GZ'96<%L]K##"J1P22%VC4#A2Q)R0..I^IH T**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *"0!D\"BN(^)-Q+Y'A[3"Q6RU/68+6\
M(.-\1RQC)]&*@'U&1WH ZJWUC2[N0I;:E9S.#@K'.K$'..Q]>*NU2O-)L;Q+
M430)_HDJ30$* 8V7IM]../H37(IXUOV\/:7XG6.W?2KV\2!K<(PECBDE\M'W
M[L%L[25V]R >,D [NBO/;GQ?X@M[;6+\C33:Z5K,=B\0A??-$S0KD'?A6'FY
MS@@^@[NN];URPU/QW=QW=M+'I-I'-;P2P-M $+28R''7G)[\=,8H ] HKCTU
M?Q#%:Z=+>3Z6BW[AE,4,C2(IBW;%CW9D;=W&,*"<>D&A>,+[7K?0[9$MK:_O
M[6XN9I&1F1!#((R%7<#DLP/)X /6@#MZ*X:2^\2?\)5X4M+ZXL[=YX+M[N"!
M&>-GCV $$L#RK\ ]">=U,7QM?MX=TWQ0L=N^DWEXD#6X1A+'$\OE(^_=@MG:
M2NWN1GC) .\J%[RVCNXK22XB6YF5FBA9P'<+C<0.I R,_6N:T#5M?U;7-3CE
M?3DL-.U&2T=5A?S9%$2,I!W8!!?G@Y'ICFSJ.J7-MXXTC3EAMI(+JTNI-Q0^
M:K1^7P&S@ [QGCM0!T5%<EX2\53:_<O!<2PPW<,(-WI[V[PSVTN1P0Q.].N&
M''YX#M8U[67U34M,T"S2:ZL;6.8^8JL)'??M0YD3:/DZ\]?;D ZNBN'UKQ1K
MVCWFDBXM;&"'581#$LGS-:WK;<+(P?#1\D94=0!W&;6HZKXC_P"$KCT#3I=,
M1GTQKO[1/!(<.LBH?E#\@YZ9XSU.,$ ZZBN!TCQOJFN6FFVT%BD6J307,ER%
M42+&T,HA.T,Z9!8YZ\ 8YSD7K#Q!K]_<6>CW%I:Z9K1L'O+E9/WR*1)Y:A0K
M=&.6/S' P.2<@ ["BN&75->3QMI<6HSVUN@T2>YN[6%#(F]9(@VUL@D\\$CC
MG@YS3[#Q3KT\&GZS-IB?V#<V;W=Q(NP-;+Y?F(0?,)DR/E/R@YP>.E '72WU
MI!=06LUU#'<7!(AB=P'DP"3M'4X )X]*;J.GVVJZ=<6%Y&9+:X0QR*&*DJ>O
M(Y'X5P<MYJ&JZ]\/=5NFMEAO9IITACC.Z+?:2,J[RQW<'G@<BMOQC=ZG;:CX
M9BL+R.!+K4Q#,'B+[QY4CC.&'&4Z=^.>,$ U=.\/PV$J2/>ZA>O'_JC>7!D\
MOC&0/7!(R<GD\\FM:N$O?&FH1^'M6\26L=L]AIEY)!);,C>9+'$^R1@^["MG
M<0,'@#/7CI/$NL2Z)X6O]6MK8W,EO 94BP>?<XYP.I]@: ->BN&N?&-_IMUK
MDDS6=]IVF:='>K/;QE?,=]V(RVX@?=![\,/J5U37O%NE:?K5Y+IUM]FM=,>\
M@N)%51YR9)B*+*Q((Y#<8Y!S0!W%%<,?%^IZ5?77]K+:36RZ&^KH+:-D9-A
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M1Q7)-XKU*'Q%I]I*+.2"[U.:Q9(49O+54=D/FYVE_D^9,<;L<8YL>!@!)XH
M&/\ B?7'_H,= '6U5N]3L-/:-;V^MK9I/N":54+?3)YJU7">((M=T3Q-=^(=
M+T^+7+"XMH[:^L P%Q$$W$&+/# AR2AY/&.M '9-J%DDEM&UW 'NF*P*9!F4
M@$D+ZX )X]*LUP>FZ_9E/!4>@10-H^H/-%&)H2)8-D4C;5YPI!4J>#T-5_\
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MY9"RCKOR1VK0\0^*]2T>^N#&+-X(+RT@\E4:1VCE9%9G<'$9R_R@@YVYYSP
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M(6:)% ;(XR01_P#6JE>:3J']B>-?#\^GSSW&J7,LVGS+$6B=9$41Y<#"&,J
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MV/P?I0T*_P!%G66YL;Z62:9)GR=[MO8@@ CYN?8],5:T30+?0X72.ZOKN1@
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MGC9BORL)&4%-JC&,_0=P!MMXE\5W=EX6,CZ?;7&LW$\3YLWPBK%(R, 9.<[
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M*-4'B32;5Y;::"_O;JUD\F,F*,1K(R;9#C<V$PW4 DC@BM*#P'I$$EJ4EO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOE_:)XHO,<1IYCA=S'@*,]2?2N1N/$5Y9ZIXL$.EPRRZ=%:NAMXBTLRN&R6
MY;: 2%'N >:Q]<UE?$&AZ-?VMUI]^%\16:VTL"M&/O+PZDLR-N)!'7&.* /2
MZ*XE?&-_:?VK9W\-M+J%IJ4%A"UNC!)/.1&5BI).0'.1GG;VS3Y/%.M6!:VU
M#3HTFN=0ALM.N"I2.;S%+%F3<S#8%?(S\V!C&> #KH[JWFGE@BGB>:''FQJX
M+)GID=LX/6I:XKPK'<1>/O&(N3 TA^QG=!&4##RVY().#^)JQJWB35_MNJVF
M@V"75QIGEAHG0GSW90^P-N 3Y2,,0W)Z<<@'4+=6[W,ELD\33QJ&>(."R@]"
M1U .#4M< ][/8>-O$VH6NGO+=)H-I,+51EW??.=O'4]N.N.*LV_CE;JRAEL[
MJSOS=WJ6=NT$+(T;[&=Q+&S;@P"-QD9XZ4 =M17$W?B;Q%IFF-?:CIUO!!;Z
MC'!/,R$"2U=E7SE7>2I4MR"3T)I]KXLOKG4M;TL&T^VVEY##:8B?;+&YP7/S
M9.TK*#CIY9H ZZ&ZM[B26.&>*1X6VR*C@E#UP0.A^M2UY?-JVH^&]2\=:I80
MV;6]I?VTD\<JMND4V\(8+@@*>2<G//;O70ZEXFUA[G5(]!TU;Q],G2!X&3F=
MBB.P#[@$PKC&0<D&@#KZ*XT^)M:.O:Y"8+"/3=&,<D[-O,KQ-$9#MP<;AQ[5
M9T;7-=O]0L&FTQ#IE[;&9ID78;9\!E4DL?,!!(R .1TYX .DDN8(IXH))XTF
MFSY4;. SX&3M'? ZXJ6N=U?4I;7QAX?L5M+61+L7.)I%)DB9(\_*>P/ -86G
M^,M<FM]'OKJVT\6E[JTNF21Q;]X*R2HK@DX'^K&1@YSG(Z4 =_44=U;RSRP1
MSQ/-#CS(U<%DSG&1U&<'KZ5SGCN^U&PTBQ?3;F.W>74[2"1FC+91YD4@8(QU
MY]1D<9S7-7E]JNA^(_'&IZ>E@\MGI]I=7'G(P$NR.5F"@'@G!Y)...#0!Z0;
MF 72VIGC%PR&18BXWE00"P'7&2!GWJ6N2FU^?_A*K>*'3;>;S=#FOH6 _?E@
MT?[H-T .X?B!4_A'Q-_PD@N'%U:RB)(Q)"D+PS6\IW;TDC=B1C"X/&>?2@#I
MJ*YF[UO5KN_UFTT*"TDGTKRE:*YR//D=0^T,"-@VD?,0>3TXY@N_$NHSMX@.
ME16I_L0 21SAB9Y/+$C*K C8,$ $AN<\8'(!UM%<,OB_5]6U"*'1H;&."YT2
M/58)+L.S#<?NLJD?S]^<8,6G^(]7UO7_  I/!-!;VFI:-)?26S1EOG!AR-VX
M?WR <<<Y!SP =]17"Z7XG\27WAR36Y(-'CMP\L(5I&3:R7)B+L6.-H0,=O4D
M#!YP'P>-[C9?V\T,3746K0Z;;OY3Q(YE1&#,C'<,!CQGG:,8S0!V]%<-XGU'
MQ18Z8 TEE;DZO9P17,4;'SX9)4!RF_*$$D'DY&<8SD:OC>]U#2_ &L7MG<QQ
M7UO9/()1&<9"\E1G@^F2<>] &_\ :K?[7]D\^+[3L,GD[QOV@@;MO7&2!GWJ
M6O/IH]5'Q$L#:26)U%_#\VZ:6)A'_KXL94-D]A][U/M5JW\8ZCJ'AS1=3@AM
M+8W]E)/)Y@:8B50,(D:D,P.6);G:%YZT =O44US!;>7Y\\<7F.(T\QPN]ST4
M9ZD^E</8>(]6UK7_  A-%-#;6>IZ1)?36QC+?,/)R-VX9XD(''')(.>-SQ5J
M4FG/HFVUM;A+G5(;=O/7)CW9PZ?[0P>: .AJM>:A9:>J->WEO;*YVJ9I50,?
M09//6N)O?&6NVL.N7@MM.^RZ1JD=I(GSEY8V\KH<@*P\W.<$'&,#J6ZI(R_$
M#6CJ;VUQI,&@+--;O;%]T7F2EEY;&3L&3C!P!CC- 'H-%<;#XHU"V'AJ>ZM[
M3[#KFV*-(58-;2-&9(U)R0XP""0%P>:RW\9^)U\'7_B3[+I'D6IGB$69-S/'
M<&,'KC& >.N1[X !Z-17&7.N^)8]?U+1XUTGS8;!=0@F9)"JJ6=3&PW#<<I]
MX%>OW>U1S>,M0E\.Z=JMM#:0+=Z2;_;*&F9I-JMY:HI#;>3E^0.,]: .WJ*W
MN8+N$36T\<T1)4/&X9<@X(R/0@C\*XRQUS5M5\8Z*89X8;*[T$WYMFC+?,SP
M\%@PY&[ ...>#GAFA^+)KG3="M(;2RM;[5;J]C"QQGR8E@DDWMM!!8G"]QRQ
M/;% '=T5P5QXWU6W:6R^QV;:A:ZU;Z;.266.1)MI21>I4E6&02<$=ZW?#FL7
M]]J.MZ;J2VWVG3+E(_-ME94D1XUD4X8D@C=@\]J .@HK@KSQ/?:+XB\87E[<
M1RZ9I-C;31VR1$,=PE. V[ )( )QSQTQ6NNNZC8^)=)TK4TM9$U6&1H9;967
MRI8U#,C9)W J3AACITYH Z%[JWCN8[9YXEGD!*1%P&8#K@=3BI:XGQ6EW_PG
MOA9M.6V%X8;Y5>X!V@;8^H7D_3(^HJ+3O&^HW@BTR:SABUH7ES:3F)&EB'DA
M271<J2")$P"1C)].0#NZ*R= O-5OM(\S5K%;*^61XRHY5P#A7 R2 PP<$Y'2
MN=M/&6HSZ/H5Z\%KNOM8DTV955L!5DE4,OS<']WT.>M '9W%S!:6[W%S-'#!
M&-SR2,%51ZDG@4@N[8W)MA<1&<)YABWC<%_O8ZX]Z\[GU_6+;PMXWU&[-AJ"
M6%]-%';3P,(]B)'P1N.1@]/7)SS6PRE?BK</"D?FMX?4C<, GSVQG% '6V]S
M!=VZ7%M-'-!(-R21L&5AZ@C@U+7"6/BBYB^'FF>(-NGZ?:M:"1H([9GS(Q 2
M*) Z\D\#W(JU'XAU\BRTV>TMH=;ELFO)T2)I8XANVJF-X)/J<X&. <T =@2%
M!)( '))J.WN8+N!9[::.:%L[9(V#*<'!P1[@URUCXBU;5+NTT>2Q@T[5&T[[
M9>Q7(\Y8LN8U0!6&<E6.<\ #@YX3X8AQ\.-+!"*^)A@<J#YK_I0!U]%</;>,
M=1ET?2+UX;7?=:V^F3*%8#:)9(PZ_-P?DS@YZU7D\9:[%#>WKVVG?9+'6UTV
M5%WF21&>- RG. 09 >0<].,9(!W=S=6]G;M/=3Q00IRTDKA5'U)XJ6O,O'>K
M7.N^!?%AM5M5LM/F-HPEC+/(Z%=[ YPN"<#@YV]L\;NI>)M8>YU2/0=-6\?3
M)T@>!DYG8HCL ^X!,*XQD'D&@#L**Y2RUO7M0\6ZGIL,&GQV6G30"1I-YD>.
M2/=QC@,#CVI?$-[JD7C/PS8V=W#%:W37#3(\)8N4CR,D,./FZ>N#SC% '2V]
MU;W:,]M/%,JL49HW# ,.H..X]*([F"6>6".>-YH<>;&K@LF1D;AVR.>:\TT3
M5]0T&&ZEMX;,Z=-XKGLY8R&\S][<; RD$ ;21P0<CTK:N?$MW87WBMH],A=]
M.EM!OMH6>22-P-SN!R^Q23@=EQF@#MJ*Q_#>L+KFF->Q7MG>0-*1%/: A67
M^\I)*L"2"#Z50T_7-7UE8=0TVWM)-.:_DM9(I"5E$2.T;2ALXSN7.S;T/7-
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M9#YT65(5_E[%%^[CISFHH/ ME;:?86\-]>"?3[J6ZM;LE/,C:1F+K]W!5M[
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MQ]4_M4M^ZSYWF>9C[GW=PSC]:M'PJ@U#5+Z+5+Z&?49()79/+_=F+&T+E.A
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MD9CVN K*&&4.&VNP]/;(%27/A2*<Z+(NI7T-QI*LD,\9CW.C*%8,"A4Y '(
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M 9/+^<%/+P^$'\/'&/7DTVT\%6%G#'9I<7#:7%=_;(;!MOEQR;MX .-VT/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KE_'-M<SZ=IDUM;37'V35K2YE2%-S^6D@+$*.3@<X%=110!YAKFGWE
M[%\1"FE7AEU"RACM ;9B96$)4J"!@X8COCOTYJ:^MY5U_4(]6T+6-3TS6+.!
M(C9F0!2J%7BE4,NW).06X^8\BN_M]1LKNZN;:VNH9I[4A9XXW#&(GD!L=#[5
M:H XC1M*>+QGKNZPD@C?3K*&VF:)F17C$FX*[#G:63GOCVK&\/Z3<7FDV.F7
M6A:I9Z]I5I);)?W$TAMXG,1C\R)MQ#;N. .,]L"O2[FY@L[=[BZGC@A09>25
MPJJ/4D\"JUCK6E:HY33]3LKME&XBWG60@>O!/% '$:?IU]J&G^"+3^S[FQOM
M$F0WC21%5C1(6C=5?HX<E<;2>.3TJ[HM]-H-OXMU"XTK4I5;57N8HHK9M\T9
M2)-RAL \ACUZ FNQO;VUTVRFO+V>."VA7?)+(V%4>I-/EBBNH#'*JR1..5/(
M8>_J* *>H2K=>'KF6%'D6:U8HJH2S;EX&WKGGI7G/]EZG%X6T5K&/4K/6;30
M8;<Q-9M+;W1"X:WF3'R\CALCAR<XKU:B@##\0V_V[PG+!>VUTQE6(2I8L3+&
MVY<LA')*'YNG.VN-N;3Q -)22\BN-2CL-=M;I+E+,QW%S H7<S1  EE^[D 9
M"YQ7IU% 'EFJZ;J>IV'C;R]&O<7FH6-S DD0!FC00;\ GDX1N.O;KQ5[7=/-
MU-XIU^WMI+>R?PY):-YL+1-/( [9*, ?E7 R1_%@=*]",T2SI"TB"5U+*A8;
MF QD@>@R/S%4=5T2TUD1K=M<>6BNC1QSNB2JXPRNH(# CUZ=J ."\FXM+S3[
MB]TC5=1TG4-#M;7_ (E[.3#(@<LKJK#Y6$@Y/'RU8AM9O#VN3VUQX:O;O1M1
MTNWM(8;9?M M_+#AH),G[I#_ 'B=O7FO15544*H 4#  ' %+0!Q^FVEU8_$*
M>1M-ECM;C2+6&-X5S#$T;2ED+<8P&7'K4NM07:>/O#]_%:7$MNMI=VSRPIN$
M3N8BI;T'R-S[5U+ND4;22,J(H+,S'  '4DU5L-6T_4VG6QO(9V@8+*J-DH2,
MC([9'(]: //+#1]4N/"7A_P_/9W,.KZ7J<4LURT;>7MCD+-*LF-K;U)X!SE\
M$=:ZCQW:W-SH=H]K;2W#6VI6=R\<*[G*),C,0.IP 3@5T,-W;7$LT4-Q%))
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.YL/G*,0  <8X&:W;#2Y[77M3OVN[EX+L1[;>28ND;*""44\(#QP.N,_0N]
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MM8S=-MBW@AD _N_,??MG'% ',Z=KFMV7@)=3DO(+N5];-N_GP9.QKYHCC#
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MBVLL9C4[<Y.>1_\ 6KIJI:3ID.C:5;:;;O*]O;1K%%YA!*HH  R ,X ^M7:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *IZCJVG:0D3ZC>P6JS2"*,RN%W,>@
M&:N5RWCBTN+RTT=;>TEN?)U:UN)5C3=MC20,S'Z#\: -'_A*]"_LZ/4!J<#6
MDBEQ,N2H4':6.!\J@@@DX J>]U[2M.4-=WT,2%!(6)R%0G =B.%4G^(X'O7)
MZY9W=KXOO+B?1-1U;2=3LHK?%C-M,3H7RDB[U!1A)G)Z'/K4-O97V@ZWJ%I-
MX9DU'2M3L[:*&.W*210&./RVADWD?)W!Y')[T =G?:[IFFL1>7L46U0[D](U
M)P&<CA5)!Y.!P:@OO%.A:;=?9;W5K2&?"'RVD&X!CA>/<US1L-0T_5?%45SI
MTEY;ZQ;QFU-NNY-PA\IH6_N#(R"<+ACSFD\-:%?:1XJTV*ZAEFCM?#L-@]YL
MRC3(^XJ#UZ8.>GXT :'BGQ7_ &;)IL&G7<!FEU6VLYU:,MD.X#*&S@. <XY.
M.U;XUBP-\MD+E?/=S&JX.&<*6*AL8+  DC.1BO-XM/UV#PUIVA3Z)>SWNGZ[
M%<R7"!#'/']I,IE5BPY(/(/(.<UM6NFZE:^+X[K3$O8;6>_E:_L;M \ 4AQ]
MHA?^%F./E!YWG@ 9H [2\OK:PC62YE$8=@B#!+.Q_A4#DG@\#TKG/"WB@ZEI
MVJ7FH74#1P:I-:0O%&5WJN-H"Y)+<GCKFD\40ZC;^)_#NM6UG/>V5F;B.YA@
M ,B>8JA9 I/S8P0<<X8^]<J-,UV!9-471+]X[?Q#<WKV:2B.::"6,IO3:_WE
MSG!(R,T =K>>--%M8=/E2Z$Z7UU]EB,0) <9W!N/E(VG@\YXK0FUW2[:]CM)
MKV-)I)!$H;./,(R$W= Q'(4G)]*XZ[TJ86FC:AIOAZ[MT375O[BV9PUPRF)T
M,CY<C<68<;NF"><@16NEW:ZMJ&DZMX=OKY)]2>]M;L7!^RA6?S%+C>-K(>,!
M3G:,4 =3-XU\,02R12Z[8(\;2*X,P^4H 6&?8'_.*>?&'AX/,G]KVN^&,2.N
M[G:> 0._/'&>:Y8Z7?/X5^(-L--N!<ZC/=M:*8^9A) L:$?\"!ZXQ5ZTM+F/
MQCH5ZUA<+;6^AR6TDGE'Y)"T1"^N<(W3^M &Y<:U:3MHTEGK5G'%>R[HU(#F
M[38QVIR,=CGGICO1'XN\/3745M%K%F\TLQ@15D!W2#C;GIG((]R#BN+TK2=3
M@\/>"+:73;I)M/U1YKI"G^JC*S $^W[Q.F?T-(VDZC_8ES&NEW7FOXL74 OE
M<F 7"OO_ .^0>.O;% '?W&N:9:7B6EQ>Q1S/(L0#=-[#*H6Z!B.@)R>U87C;
MQ7_8FCSOI]W +Z*>")E>,N!O=05)! 5MK;@#V[5BQ:7=+K&J:3JGAZ^U"&ZU
M%KRTNUN#]EVLP<>8-XVLA'3:2=HQ5'4=/UR/PUXAT%]%O+JZFU;[9;W$04QS
MQ-<)(#N+##*!M(/3 [<@ ]"\0:Y:^&]"N]6O=Q@MHRY5%)+'L!CU/Y4L_B#2
M[6!)I[M41HS+RI)"#@L1C(4=V/ K/\<6%WK'@+6;*R@:2[GM&6.'(!+8SMZX
MS^-9EK]OL_&%[J]SI=Y)8:II\$<:B,/) \1?]VR@G 8/G/3.0<4 =>TOGV1E
MM)HCOCW12XWH<C(/!&1]#7+>"_&UCKVCZ3%=ZE:'6[JT6>2V1@"3C)P/8<XZ
M@5?\%Z-<Z#X*TW2KL@W$$)# -D(22=H/<+G;^%<KH7A^^F\/^#-*FT^:TN]#
MN$FNI9$ ";$<%48</O+#[N1C.<' (!W2ZYICZBFGK>Q?:I"PC3IO*_>"GHQ'
M< Y'>I[N_MK$)]HDVER0BA2S-@9.  3P.OI7!>%-+NH3I^DZQX>OGO=*G9DU
M&6X+6I )Q*GS_>93C;MX).>*W?%^FM?S:>T4FI6ES!YKPZA8+O:W;"C:\>#O
M1NXP?NCIUH V(M>TN=ML5[$[?9ENPJY),)Z2 =U]Q6!J7C&&Q\1:*QU&S&@W
M]C<7/G8^\4,>TAL\@^9T S]:R[2WU^TUO3=0U#2))9I]!^Q2BS5=D4P?=AAG
M"C![9'! [5!H.F:GI<7@2ZO=*NU73M+GM+I502/%(PB"DJI)P=C<CIWQ0!U]
MQKUC=6VD75AKEC'!>W*+$Q D%TO.8TY&&SWYQ@Y%7)=<TR"_CLI;V))Y)/*5
M6Z&0C(3=TW8YVYS[5P,VC3Z1IVB+-#Y+7?BP7B6XP?(1VD8+QQG')QP"35C3
M]+NH]4NM'U7P]?7O_$UDOK6^^T$VNQI3*KL-XVNFXC 7D@>N: .U.O:6+Y;(
MWL0N&9D52>&91EE!Z%@.J@Y%0^'O$5EXEL'O+$OY:S218=2I^1V3/([[2?YU
MS7A"'4;.UL] U7P](]SIMQ(Z:E*J- REF(E1L[M[*Q&,9R3GBM3P):WNG:'/
MI]]936\D-]=,&?;MD5YY'4K@G(VLO7'6@"[8>*]+O[G5HEF\M=+E,4\DH*+P
MJLQR>,#=C/MGI5^RU6QU&2:*UN%>6#'FQ$%73/()4X(![''-<!JFA:Y-#XLM
MK6PE,DNK6^IVY+*([I$$!,8.>I,;#D8X&3S70V-E/J'CS_A(4MY[:U72_L;+
M.FQY',F_&T\X4 \]/GXSS0!HW/B.SB\21^'PY%]+:M<*QC)5<,JJ#ZY+$]>W
M;(K*\&>,;?6M(TR/4+^U_MFZ21S!'\N[:S=!S_" <9SCFI;ZWO+?XCV6J+8S
MSV3:7+:M+$ ?+?S4?YAG., ],],5S6BZ1J5KH_@:&33+F.73]0FDNU\O_5*R
M3*"?7)D7IGK[4 =\-<TPZBEA]MB^TR,R(AX#LOWE4]"P[@'(K)\::UJ6B6NE
MR::UJ&N]2@LG^T0M( LC;=PPR\BN?\-:7=0RVFD:QX>OI;O3KQIHM1DN"UJ1
MN8K*HW\.58C;MZDYXS6M\0K&YU*PT>"VLIKOR]7M;B98TSMB1\N3^';J: &V
M7C3[%KVNZ3XAGLH5TQ(91?1YCC=90<*RLS%7R.F3GVK3'B/3M0U'3X].UZQ(
M:YEA>  .]P40DJISP5X8G!X'O67XR\/P_P#"!:Q9:+I2FYOE4F."(!YGW#EB
M>IP.IJSKUM/<^)O"5U;6<SP6UU++.RQX\I6@=!N'^\P% &Q#K^E7%E)>0WL<
MEO'+Y#R*"0LF=NT\=<D#'KQ2C7M+.H+8B]C^T-(857G!D W% W0L!R5SG':L
M"UT&^M/&U\J(/[!NY$U)N>ET!M9,>A(23/\ >7WK!N;+6KC5;&5M!NT-IXC:
MX9+<1I"82L@$H^8%V;<I9FY!)Z=* .]?7=+CODLGO8A</(8E4YP9 ,[ >F['
M.W.<=J;#X@TFXT][^&^BDM4E\EI5R0'SMV_7) ^O%<MX:AU&R_XD&I^'I+B2
MUU&:ZAU&14:!D>5I!*"3N$F'(P!G/?&2)H-&N;?Q]=V<)0Z-<-'J\T>>4N!E
M-N/1F59,_P!Z-O6@#MJY;0?%IU;Q5JVCRVXA2%5GL9/^?B')C=_PD4_@RFM7
MQ#<7=OH\PL(9I+J7$4;0IN,6XX,F/102V.^,=ZY/7/#UYHE]X;U;1OM^H2Z=
M*+9K;;'_ ,>;KM<<*O(PA&3U% '87NN:9ITPBO+V*%LJ&W'A-QPNX]%R>!G&
M3TJ#3O$=CJFLZEI=LSF;3W5)=RD L5#'&1T (Y]ZYF./4;/7M>L+OP[-JMEK
M%REW:SLB-"/W:(4F#$%0IC!'!XZ#/%7+/^T-&\1^+KQM(O+F*=XKJW,&P^<%
M@1"BY8?-N4\4 =C138V+QJY1D+ $JW4>QIU !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!G'0[!M6.IM%(]UE6&^9V16"E0P0G:&
MVDC(&>:T:** "BBB@ HHHH **** "BBB@ HHHH **** "L[1]"T[08)(=.MS
M$LCEW+2-(S'W9B3CT&<"M&B@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHJ.>XAM8&GN)8XHD&6>1@JK]2: )**YWP[
MXBDUO6=?M=]I+;:?<1Q02VYR'5HU<Y.2"03CCTKHJ "BBL/7_$']E7>FZ;:P
M+<:GJ<K1VT3-M4!5W/(QP?E4>G)) [YH W**R$FUNWU&S@N([2YM9BPEN(%:
M,Q$*2!L);()&-V1Z8YJY!JNG7-Q)!;W]K+-&"SQQS*S* <$D \#/% %NBL^#
M7=(N;F&V@U6QEGF#-%$EPC-(%)#%0#DX((..F#7.W'BVXOM7U2QT2^T9'TQX
MUE^VR'$H*AG(96^4*".QY!!QUH [*BLQ-5A@T6TNK_4=.22:%6$ZR!8)'*Y)
M0D\KW'/2L[PSXG34O!UEK>K3V=H9]^YM^R,8=@,%CZ+GK0!TE%49-;TJ&*.6
M74[)(Y8S+&S3J Z 9+ YY&._2J=YXLT.R.F>;J5J4U)RMM(LJE' 4L6W9QMX
MZ^I [T ;5%9EOJ2B;4WNM0TXVMM*%4QR8:$;1D2DG ;.?3C%9OB?Q-_9W@^^
MUK1IK.[:V(&2V],[@I!VGJ,^M '2T5!>3&"RGE$L,11"1).<(IQP6]O6J,6N
M6%MI]M)J6K::DS6JSR.LZK&RX&77<<[,D8/N.: -6BN=\0^++'1[#3YH[NT8
MZC<10V\CR@IM<C,G494#G@^G(SFK-EJ_V:W2/7-1TI+J1SY)@FV+-&3A&"L<
M@GT!(ST)H V:*HSZUI5K<?9[C4[.*?<B>7).JMN;.T8)SDX.!WP:8GB#1I9H
MH8]7L'EF#-$BW*$N%)#$#/.""#Z8/I0!HT51AUK2KFP:_@U*SELU;:UPDZM&
M&SC!8'&<D54U#Q5HFFZ?!?3:C;-;W%REM'(DJL&=G"XSG'&<GT - &S16;:W
MYN=7N8H[VPEM4@C=(XGS,I;=EFYQM(QMX[&IK?5]-NQ*;;4+280KNE\N96V#
MU.#P.#0!<HJC;:WI5[<K;6NIV<]PT8E$44ZLQ0]&P#G'OTJ]0 45435=/DOC
M9)?VK78SF!9E+\=?ESGC(I8=3L+FZ:U@O;:6X0$M$DJLX .#D YX)Q]: +5%
M5;Z_M;"'?=7=O;;LA&GD"J3C/<C-8GAKQ3'J/@ZRUO6+BRLS.9-S>9LC^5V'
M!8^BYZT =+17-Z_XLL]+N-)M(KZR274Y"L<TT@,<<8C=_,(W#(.T*.1RW7M3
M])U>[AM[U_$6I:&C6SJKFTF(6+C_ ):%SP3U [=.>M '0T55M=3L+Z2XCM+Z
MVN'MFV3K%*KF)O1@#P?K26NJZ=?^;]CO[6X\G'F^5,K[,\C.#Q0!;HKF;/Q0
M+_QRVCVEQ97-B-.-UYD#[W#^8%P2#C&#GI6M=WCPZO8VZW=C''(LC2PS-B9P
M!D&,9Z#G.0>* -"BJ$&NZ1=7,5M;ZK92SS*S111W",SA202 #D@$$''H:L7-
M[:66S[5=0P>8VU/-D"[CZ#/4T 3T51@UK2KK3VU"WU*SELE.UKB.=6C!Z8+
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M#W%.H X?3;H:E\28-3M].U"&U?13 9;BQDA"OYP;8=RC! S[>AJWK\$C>/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKE_&M_)#
M'HNF1L5&JZG%:2L#@^5AG<9_V@FWZ,: .F1TD0.C*RGHRG(-"NCE@K*2IPP!
MZ'&<'\"*Y?5_$%_%?W^F:':)+<V%K',4>%G61GW[8QM(V<)]XYZCC@U!JNIW
M%AK/A/4VMWM7U246-Y;,02-\32*#C@E'0C/HS>M '8U%)<00N$DFC1FZ!F )
MJ6N,^)5F5T"WU^"$27>@W4>H* .6C4XE7Z%"Q_ 4 =<ES;R.R)/$SKU57!(I
M@O[-I(XUNX"\I*QJ)!ER!D@#N0.?I7FL&MVNB_$;4-9BB3^R-;LV6.6,?Z^>
MV0,2/JKNH]3'5W4M+ETK6O L-M#:C4/M%VTCL,*97MY6D;CG&XL<=^F1UH ]
M%HKB;+QI>3V5O;SV\(U274[G3B849X\P[RT@7.X@A1\N>_7BDF\4^([:+3([
MC2;:&XN]6;3]TK,BR)L=TE51DJ"%Y!)(.?K0!V]%<3:^,[[R9+2[MX#J:ZP^
ME*T",8V*Q>=OVYS]S^'/7OBDO/%'B'3-%DU&_P!.@@AM=02&XE=& >U9E'GJ
MN[*[=W*DGH3F@#MZ*YK4?$D]AYSJD<D<E]'86>U"2TA'SL<'Y@OS# QDJ1QU
MK+OO%7B/3K4F?2;?<=4MK.&:3=$EQ',RKN"Y8JRDD')(XR,]* .YJ)[F"*:*
M&2:-)9B1&C, SD#)P.^ ":HJ^K1>'Y9+M[)=22.0[H59H01G:<$@GC&1GKGF
MO/;2XU2_3X::C-+;7&I7,<KB:1"H^:T8G=R2>23Q@'VZT >JT5Q-CXTO+BRM
M;>:WA&JRZE<Z>QA1GCS 7W.%SN((4<9[]>*Z#P]?:I?6,S:M8?9+B*X>)2.%
MF0?=D5225!!Z$Y!!H OW%Y:VFW[3<PP[SA?,<+N/H,U,K*PRI!'3@UPOPY*Z
MW8ZIKNH(LNH76H7$+F09,,2.42(9Z* ,X[DDGK6F98?#VIV'AK1HH87OVN+M
M?,0F.!%(9\*",Y9Q@9&,GT (!U%%<$WCC5"MO;)8VGVY-;.CW0=V"9V%UD3@
MG!7!P<XSCGK5;5?%&O/X=U)5EM+:_L-;M].EEAC8I)&[P\J"V5.)0#R>AQC.
M0 >C45R<6M>(;GQ=>Z+##IABL4M)IIG,@+I(7#[0,X;Y,C)('<G.12M?'%U%
MJ5M#J<-L(IK&ZNY1; M]G: KN3S,E)3AL$KC!'O0!W-%<Q:ZIXAO+*WOD@L5
ML[RP:Y5QDFVD*AD5AN_> @G)&WI[UD^%_$NJ7>D>&+"6X@EU/4].-\]Q)$VU
M(U5,Y7=\S%G'0@8SQQ@@'>TUW6-&=V"HHRS,< #U-<&?'&K21V<$-C9B^.M2
M:-=>8[; ZQLXD3'.TJH.#R,X]ZZFZGO[;PM//>0V<M]':,\L:%O)9@I) R,[
M3[T :44L<\*30R+)%(H9'0Y5@>001U%/K@)/&SZ?HV@DI8Z8E_I<<\$L\+"U
M\XJ"( P($?7@GMTZ5TOBO5[C0O">I:O:I%)+9V[3A) 2K[1G'!'YT ;5%<GJ
M?B>_LM8OK.*"VD6'16U*/=N4[@V"I//'&>E4;3QKJ%O)IT^L6]HME?Z-+J:_
M9MQ>(Q+&S@YX((DR,8QC'/6@#NJ*Y-O$>K6.DG7;^TM7TG^S'OG\AB)(6"AA
M'R3OR"?F 7D=.:AG\1>(K2._FDTN&2VBTY[N.?8T2I*HR8FR26!'(8 =.@H
M[*BO/+K6_%4\7ABY:;3;2'5;V%0D4<CMM:!Y"')8?Q+T'7(YX.=&\\6:A8ZY
M;6LL-J8IM46P,2;G=49"5D9P2JDD9\L@'!ZT =='<0322QQ31N\+;9%5@2AP
M#@CL<$'\:DK@+WQ9?:9;^)[FVTS3Q/8:I;VS8)7SA((0&8@9+ 2 ?05O:'K.
MHW7B+6-'U**U$EDD$T<EMNPR2[\*=W<%#SWR.!0!T-%<KJ_B+4=,UZ[L"MHD
M3:9)>64DB-\\D9 =&P>P*GCGYO;E=!\1WGB"PTZYMEMLRV)GND9&7RI<[1'U
M./F60'K]P^M '2P7$-U D]O-'-"XRDD;!E8>H(ZTD-S!<JS031RA&*,8V#88
M=0<=_:O/-+U[4]03P&;(66GVNI1322VL4!V#;$2%&&'R\]/7!]JK:)J]_P"'
MXKZ6WM[,Z;+XKFLY4.X2#S9P@9<<#:2..<\]* /4:*P?&.M7?A[PU/J=G!#/
M+%)$NR5B 0\BIV[_ #5G3Z]KL-])I!ALCJ:V[7>Z&*26/RRY6-2,J03M;)S@
M8& <\ '7T5R \4:I-<6%A)81:9?SZ7)?RK>'>J.A53&"I&>6R3G@8XYXK1>+
M]8N/#NEZD;2SLVO;&2[VR;I6W *4C$8(<Y!)+#( 7WH [BHI[B"UB\VXFCAC
M! WR,%&3TY-<6/%VN:D_AZ+2;/3TDUG2&U!3=.Y$3@1':=HY'[S'Z^QRO&.K
M77B#P5J-W"EH+&VU2&V ="TCF.Y1&=6SA?GR ,'@9SS@ 'IU%<S\0+^_TOP/
MJ=YILZP7,<8Q(R%B 6"G'(P>>#VI3K.J76L:AHVGM9&\TZVBFGDFB8)(\F_8
MBJ&RHPG+9/4<&@#I:BEN8('C26:.-I6VQJ[ %SZ#U-9GAW7!XF\+6>KVT?V=
M[J$L$D&[RW&00<8R P/IGVKSZ*\U35/#O@35+R2VN=0GUDLCE"@&8[C()R>.
M.@QP />@#UFBN)MO&=Z+26WN[> ZDNL-I*M C&-F$?F[]N<_<S\N>HZC.:WO
M#]_JM['=KJUA]G>&<I#*J[5N(\ API)*GD@@D].O- &Q17G5[XX\0VFF:OK'
M]G:<VG:/J+VMU&)',KQ*5!9#C (#9YZ\],<Z;>)]7&NZ[$8-/CTS1622XD9G
M,CPM"9#M XW#CKQ0!V5%<<GBO4H4\.W=U;VIL]>*QQ+'N#6\KQF2-6;)#@@$
M$@#!YP:S-/\ '&O26/A_5[W3]/&EZI>"RD6%W,L3L[(C\\%<@ CKSGV !Z)1
M7':9XIUC5I-+O;+3!-I5^6R=A1K=,$HY<G# X ( !&>^.;'@[6];\0V2:C?0
M:?#9/YT82%G,GF),R9YXVD*??/UP #I$N())Y($FC::( R1JP+(#G&1U&<'\
MJEKS?4+S4-&\7^-M1TJ&R+VVF6EU*+@-AP@G8@!<<D \D\<<&M+Q#XROM+TN
M74K:WM1!'IBZ@D<N9))CR63"G*  #YR",L/2@#MJ0D $D@ =2:X[4O$NMC7;
MW3M-M]/"PZ4FHQR7!<DY9QM(&/[GKQG//2GZ?XIG\1M8VEA%;0RW&D1:E/\
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M1V";<Y#?NV&[..GR^@!W=%<3K_C*^T[2GU*UM[58$TH:@D<N9))C@EDVJ<H
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M7FT_P=+KVIV,EJ\%F;FXM-P9D8+DID<'GC-9^H>(=6T#3KW5M6M;6738-/\
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M;V*QN=:EN#;2P>6)X\J5P67.UBO('IVSSTUKX<M[?5-9OGGFG&K!!<02A?+
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M@M[VVFF0$M''*K,H!P<@'UXJU0!F>']%B\.Z%::1!/-/!:1B*)IMN[:.@.
M?RK(N? MK<0W\ U._CM[R_74&B7R\)*KJ_RY3."R*><^V,UU5% ',WO@FPU*
M76VO+FZE75XX4F0,J^68ON,A R&!.>2>0*T-$T6;28F^U:M>ZI.0%$UV4RJC
MH $4#ZG&3W/ QK44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-D* 94,P<X(&1SWK>DTVV@^)$DRZ2XLAHC1[X[)C'O,I8J"%QN()XZ\UW%%
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M*_>PR_+UYP1G(J#2+6Z2[^'3RZ?>K):Z3+#=.UK(/)<PQJ%<X^4[E;K7I%%
M' >"X-1LM5M;5/M-SHRV#>0U]:-#<V!W)BW9B!Y@(Z<9&SKC&>_HHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>exhibit1027supplycontrac025.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac025.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME0SK&0?E?)*O\J_-U..3GD+H?A.-$NDN[&:"PNH##+I]SJ4MZLF2/F.\D+@
MCY3SNYZ"@#1T6/7K?5[R/4[RWGL9(T>U4R!ID8<.#MC0%?ND'J#GVIGBJQBU
M/1[[0H(HS<ZM&8Y#MSL4@*TK?[J@8]2%'N+NA^'-*\.0/#I=NT2O@$O,\K8'
M0;G)( R<#.!DU4U'P5H.JZA+?WEM</<R@!W6]F3('085P .O&.YH KZ]X:O[
MM;.\T/7)]/O;"!HK=65)() <9$@(R<[5&01CM6EHNKRZEX4L=8GMC%+/9I</
M"O."5W$#^E-D\+Z1+<0S&"93%;K;*D=S*D;1+T1D#!7')^\#6NJA5"J % P
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MS6TOX6D@5UD"+*R?,I#*?E(Z$ _A0!>HI%4*H49P!CDY/YTM !1110 4444
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MK=F$H5T>-Y&QM/7.\8Y'0YH =H^OV'_"/Z5)#?7>IM>1%K=WB'GW"KU8J
M,CD@#D#J1FA<>(_[1UWP=<Z3J$C:7J<MPLD>P 2!87(SD;@0R],CITK&TGPY
MXE\/V/A>]M;&&YN]-LY;"\LFN F]'96#QOR,@H.#U%=!?Z;J]YKOA:_DM8C]
MAGGENA%(-L8DB9%5<X+8W#)P,X)QVH TE\4:6VH6EGYDBF\9TM9FC(CF=<EE
M5NF< D>N#C-;-<%X1\/:KHWV72;W0]*:'3V(BU<,IDEC&=OR;=P?& 23CJ>:
MZCP]J=YJVE_:+^P6RN!*\;1),)5.TXRK@#(_#J#0!R.L^-+B[T*\O+$W>G_8
M=:@LW9XA^\3SHT<'(.,[FX&#C%=3:^*M+NH[]O,GA:P=4N(YX'C=2P!3"D9.
M[(Q@<GCK7*7?AK7?[,U:PCLHI%GU]-2AD6<#='YR2D$'&" A'UQVYJ36?"NK
MZK>>*)((8H3>FQFLFG961Y+=MVV1020I( [\9H Z_3==LM3O+RRB,L=Y9[?/
M@F0HZAAE6]P<'D>AK%CU>\UWQIJFBV=T]G9:1'%]IEB53)--("P4%@0%"CGC
M))ZC'-WPU;W@$MS>Z!8:/*ZJGE6SK(SXSDLRJ!CT'UJ@=&U+0O&>I:YIEJ+Z
MSU:.(7ELLBI+'+&-JNF["D%>""0<C//2@#3$]QH<EY<:KJ1GL#Y*VQ>-?,WL
M2I3" ;B24 P.^/<Q7/C/1[*RU*XNY)X#IH5KN%H&,D8;[K8 .5/]X<<'G@U4
M\2:5J^O:9;3P11075C?07UO:RR?ZSRVR5=AD#<"0,9 (!SSQC^)_"VJ>((?$
M-_#:>3=W^EQZ;;VTDJ9X=G9W()4<L ,$\#WP #HI?&6F1QZKMCNVFTVV^U20
MFW9&DBYPR;@-RDJ1GIQ5:/QYIL>G:9+>0WL=U?VAN8[>*TDD9PJJSA<+\V-P
M]\<]*KZEH>I:EXDU2Z6V\JWO-!.GH\DB_+*6=N0">/G SZ@U!IVCZTFI>#Y[
MG3TB32[&:VN=LZM@LD:@CIGF,D^Q'7D  W!XNTDW:0"2;#W2V7FF%@BSLH81
MD]0V".V,G&<\5)-XITNWO(K>263;)="R681DQ^>>D>[U[>F>,YXKE-5T#Q-?
MZGYTEG;W!MM;BO+>5KO8OV92,*$QPP&=Q/)]^ -'P_I_B/1+RZTDV=K-ICW\
MMW#J!G^98Y)#(R&/&2X+, <XY![8(!=TSQG9WL&HSSP7%K%:7QLD\R([I7!"
M@ #JQ8G '.,9J>X\9:/9V.I75U)/#_9FW[9"T#&2(,,J2H!RI'1AQUYX-<S/
MX4UTQW?DQ6_F6WB'^V;7,^!<J3S&>/E.UF&3W [<U)XC\+:GK=MXFOH;3RKO
M4].BL+>V>5 0%9F+N02O5\#!/"^^  =IIFJP:M%-+;QW")%*8CY\#Q;B #E0
MP&5((P1P:Q]1\1Q7>A7SZ;-<0RFPFNK6Z$0VL$'WE+ @\D<$<@Y]ZZ*%F:!&
M>,QL5&4)!*GTXXKSRU\*ZK:)??8+26QM[S3IX[K3?M*O;M<OC:\(R=@Y<MT'
M3@T ;?AGQ?97NFZ9;7D\ZWSZ7'>/+/"R)* J^8RL0 V"PSCUK1T_Q'I^M2BT
MM)IXIIK07<#-%M+PL<"1=P(ZXX(SR,CFN;CT#7HI?#4EO;1Q3:;HD]D[R.K*
ML[)$$. ?F7,9S[$<=<'A_1->L_$MEJ][IR C2&M+DF\$DC2[U;(XQ@D' !
M].E %71M>UBYT3X?7<VHRO)J4[1WHVIB;]S*V3QD<H.F!7>W^HVVFPI)<N1Y
MDBQ1(JEFD<]%4#J>OX D\ UP^E>&M9L]$\#VDMD/-T:X+W>V52 OE2)E>>>9
M ?P-=!XKTB^U"31[_3@LESI=\+KR';:)D*,CJ#T#;7)!/&1[YH R_%7BH?\
M".SW6EWTUI<V.HVL%W$T8#H'FC5E8,#P5;(*]>QJ?4OB)IEKHNKW=O!>/=Z:
MJF2TFMGAD&_A&*N =A]?Z\50U?PEJ6IC7=3AA2*[O[BPDCM99 #LMI%?YF&0
M&;Y@.2.%YZX/$GA34O$46NZ@D"VUU=:;'8VMM+(N3LD,A+LN0,DX&"<8R>N
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M3Q]H$FG6MZL]P4N;IK-$^RR;UG&<QLNW*OP>#R>V:=:>(=.N]<#_ &^^@/\
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M^9QM;=R<MQQQ6.-7N-(D\0>0YB%YXMALY9P!^Y22* ,W/ /\()Z%@: /3Z0
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M!B?H>,4 >FT5S?@34KG4O!NGW%_<&:Z8RQ&5\!I-DCH"<=\+D_C724 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M &M1110 44A(523G &>!FL-?&7AYHYI?[3C6*&0Q2RNK*D;@X*LQ&%(/4$T
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M#?&)A]WNI_# QBMB\U_5;VR\77MC>_9)-!F>."W,:,DOEQ+(3)D;L,6(^4C
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M01W\+O\ 9YA/"\<KQ/&X! 960@C@D=>]4(_!>@1;/*L60)>&^4)<2@"?GYP
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M/F1E5 R06QD9('8GVK%T?1O$HUWPYJ.HZ7MFLUNHKUQ=)LRX7:T: X5/EX
M/J/XB ;/A3Q%))H"RZM=27-W)J%W;1;8<O((YI /E0=E3KCM[UT]G=PW]G%=
MV[,T,J[D+(5./<$ CZ&N MO"UY+X>AL-1TF\$BZE=W23V=VD<]L9)'=)$8.!
MT?!'Z&NGT Z]9V6EV.JVXN9/(<W5\)$78X8;%*#JQ4\D<94^M &_1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !61)X5T&;47U"32+-KJ1MSR&(9=O5AT)]S6O10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[0 7SF/(&[CM\PK,F\8Z??:1K,MMJ:Z7]AG-M]LNH"45AMR=IQGDD 9R<9H
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M5$3;1)]K7!S&O(P<]^<8/%//C#P\+@6_]KVID^T?9<!LXEX^4GH#R!SWXZT
M;=%9E[XBTC3I)$O+^*'RF596?(2,M]T.W12>P)&<CUJ>]U;3].TQM2O+R&&R
M5 YG=P%VGH<]\T 7**QK?Q9H%U)>QPZM:LUBN^X&_'EK_>YZCW'%%KXLT&^A
MEEM=3@F2(1;MA)/[P90 =26[ <YXZT ;-%9+^)]%CL3>O?QK LWV=V((*2YQ
ML88RK9(X(!Y'K2ZOJ]K:65^C:E%830VIE-Q-&2L .0KD' (R#QGG!% &K166
MVN6%I;P_:KU78PI*TB1MC:W <@ [ Q!QGT([5';ZK;_VGK'F:S:R068C,D(4
M+]C^4D[WSSG&><8Q0!L45F)XBTETNG-]'']D023B8&-HT/1B& .TX.#T.*98
M>)M%U2Z%K8ZE!/,8!<!5/6/CYAZ@9&?3/.* -:BJ-EK%AJ,IBM9_,<1B4#8R
M[D/1AD<J<<$<&JT^J00^(OLTFL6T:QV3SRV3*-X 91YI?/"C.,8YSGM0!KT5
MCV'BK0M4NX+6QU.">:>(S1*A^^@QD@]#C(..O-7[R_MK!$:YEVF1MD:!2S.V
M"<*HR6. 3P.@- %FBL#4/&.D6-C87B3FYAOKI+6%H5+#>6PV<#@K@Y!YR,=:
MR[3QG!:>(]?L]:U&VAM[6XMX[4E"F%DB5OFZ]V R<#ITH [.BL[4==TS221?
M7:0@ ,[,"5C!. 7(&$!.0"V!P:AD\4Z%#J?]FOJEL+WS4A\D-EM[YVKQW./Y
M>HH UZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "N2\<VTA?PYJ R8+#6(99_148-'N/L
M"ZD^@R:ZVJ.K:CINFV+2:K/##:/^[9I_N'/&#GCG.,'K0!QOBEKF'QE)-86%
M_=/+I)M;IK2*.?:K.Q3*-(A4CYR#R#GIQ4>L6T%_\/-"T72HKJ,/>VEI#'<K
MMEC$$H+EAZJL3DD<<<5M+IWA36=7!@F;^T5@&?LUY-!(\2G W;&4NH+8YSC-
M=#!I]I;-&T,"(8T\M,#[JDY('ID]?7 STH LU2U<.=&O5CC>61H'5409+$@@
M 4J:K8OJTFE)<H;Z.(3/".JH3@$_C5R@#@[/2]13X)'17L9UU(:,UG]F(&XR
MF(J!G.,9/7.*KW>AZEJ&I0Q0VLULDOA>?3C.RX6*=S'M!QSQM;D<5Z)5.ZU2
MQLKRSL[FY2.XO'*6\9ZR, 6('X F@#EO"=O/<W-I/J'AF[T_4;*W,,MS=W'F
MKD@ K"=[$J2,YP!P.O9-2N%M?BU82-;S3#^Q)Q^ZCWE?WT?.!S[<>OI7;5SM
M]<^&;+Q$=3O;R.'4;:#R7E>X<)%&Q#;7&=BYP#\W7B@#E]'\-:AI%WX01["3
MRK6ZO[B=4 *VBS[RB=>VX [<]^U/N]#U4Z+XQ\/2V,EP^KW,TUE=#!B*RJ -
MYS\IC([]0HQGI7HRLKJK*0589!]12T <9K7AW41K>DW6G,7$]L=+U.1FPQ@Q
MN$G^\"& ]Y*DU>PNF\<V%W#ISS6<.DW5NQ  3>[1E4_$(1[5U]% 'F*Z'K-O
MX=U_3+*/4+C3)]%D@M+:^53/;SLI40J_5D (Y)(&!@GFM73;74M(\2QZE/87
M,]E=Z1;VI$:AGMY8BQ*%<]&WGD<9'..#7<T4 >;Z%X;U'1+SP7#-:22)I\%]
M]H=,,L!F(9$SWQRO&>GI4-CH%X?#UC;W-MJVFWMO>WT\-[9@%[;?,S)E.0Z.
MK<C!Z<XZCT(ZI8C5UTG[2GV\PFX$'\7E@@%OS8?G5R@#GH+#5M0^'YTZ_:*U
MU:XT]H':(!5CD9"H( X&,@X' [5A66EZCJ2>#8Y]/FL+C0VW7;L!M&V%HMB$
M'Y@Q(/'&!S@X%=]2,RHI9B H&23V% ',>"K:[M(M:6[M)K<SZM<W,7F ?/&[
M95ACU].M<_.IN?$?Q!T]-/ENI;RWMX454!5F:W("LW\(YSD\5WVFZE9ZO81W
MUA.L]M(6"2+G#;6*GK[@BL[18M#FU/5M1TF0RW4DX@OI!-(P\Q%&%PQP,*PZ
M#O0!P.O^'=>_X1_4]!BTN>Y(T6VMK>ZM3&@N9(U(;S6)#$@_=7I\Q]>.LT^W
MO6^(&J:F^FSPPW&F6T43RA<>8C2LR$@G'WUYZ>YQ76T4 >9:%8ZRFN>%[^]T
M2YM%M;2[@O!F)(+9F\L@1HK8$8V-@XR>,YJMX7(M?^$;%_I.M0VFG.ZV$IMT
M:-?.RB;Y%D)8;7V@[5SD$UZI+&DT3Q2HKQNI5E89# ]016/IOA31])D1K."9
M5C_U<4EU+)'%_N(S%5_ "@#E;.PU>S^'FIV\6BF6^;4IIQ;31HQ>-[HOO4,=
MI8(=P!_B49K#\0V=_::-XQN+G3+U+>\NM.FA:YD1FEP\*E3AC@Y!XZ#VZ5[!
M5'5M'L=<L#9:C$\MNS*Y197CR5(8<J0>" ?PH X7Q5H5]K4OB34[&PG!N=!.
MFPQ,FQ[B5F9LX/0+D#)QU..!6U96EW_PG]M??8IX[0:(+8RLH 63S VT]^F?
M;WKK54*H49P!CDY/YTM ')W%M);?%>ROY!_H]WI$EI&W82I*)-OU*EC_ , /
MI7+S:;KT/A>X\/R:)>7-W#K:7B7490QW$1NQ-OW%AAL$@@],>E>GW%M#=1A)
MHPX#!E]58="#V/O4M '):C;R7_Q-T"2)2%TZPNI;@^GFE$13[DHY_P" &GZK
M:W]GX[TW78[>6ZL!8S64R1#<T#,Z.) O4@[-IQR.*Z6*WB@:5XT :5M[MU+'
MW/TX]A4M 'FL_A[4[3PW'''93227'B5=4^S1X)MX/M(D(/.,[1G /4D#-=CX
MJLI]5\&ZS96D9>XNK":*)#\N6:,@#GIR>];-% '"Z9!?GQ;IVHSZ1>06\6@M
M:N9%4E9=Z-MPI/)"G]._%9V@Z/JMI8_#R*?3;A'TLRB\! /DY@DC&>>?F8=,
M\5Z710!PGAK2]2T[Q! UHE[#I,L<S75C? ,MI(2"/(DZE6.3MR0!Z' J;Q=:
MZI=ZM)!;:5--:SZ5-"MQ:^6KF4GB-W8AECQ@X'4]<]*[6B@#S_P[IVHQ:_X8
MN+K2[F&.U\/FRF:0*?+EW18!P3U"-R/;.*IZIH^L/X2\:Z5'I-P\][?RSVK*
M4*S*Y0C'S<=#G.,8KTRB@#A9DU*Q\5ZT9?#T^KZ9K<<+1%?+VQ,L>QHY@Y&%
MXW9P>IX)JMXBT#5]5UKQ EI;F/[5H4-I!/\ =B:9))'*=<@$,!GW->AT4 <I
MX70WE^=3N/#=[I=XMM]GEEOI_-=OF#;$.]LH#DY..HP.M9_B?2]2DUV;4-$2
M]M]2"0QC@26E\@8Y253]TKEOFX.#QGI7=T4 >9:UHVJ7.E^.XH=,N'EU&\AD
MM %'[U5CB4D'/&"C=<?K1XLL-;U-]=AAT.Y97GLI[5[;RT6=$:-F,A+!FD&U
ME"G@ +]:]-HH X6YL=0DUGQE.-.N0E_I4$-MP#YDBI*&48/4&11GIUYXKHO#
MT<UGX/TR&X@DCG@L8HY(B/F#*@!'OR*V** /,]!T;5+.P^'T,VFW$;Z9YPO/
ME'[G="Z#.#SEF'3/K18^'M6E\(:/X8NK2:.^TW4HI7O>/+,<<WF>:K9Y++QC
MKECD8YKTRB@#E_"5I>Z?>^((+NREB2;5)KJ&8E2DB.%QC!SG@YR!7.>+-/UO
M4)]<@BT2X<&[LY[9[4QHEPB-$69R6#.XVLH!X "X]:]+HH \QECDU'4/B+ID
M>FRSW%^(88UV@KO:T0 ,W1=I.<G\,FGZ?;G3_$WB32WLYM1<:+86V40,)"$F
M7:Q/3=ZGCCDUWEEHUCI]_>WUM%(MQ?,KW#M,[!R %!P20,  < =*+?1K&UU>
MZU6&*1;R[5$FD,SD.%SM&TG:,9/0=S0!R.C>']0T;6O!]O+#)/%INBRV=Q<J
M,HLC>3@>N/W;=O2K'AK1KBQ\3:C8[D;1M-G:>Q4'F.2==S)CMLR^/]F8>E=C
M<01W5M+;S+NBE0HZY(RI&",BJVE:38Z)8)8Z=;B&W3HNXL2?4DDDGW)H Q?&
M5G>W']@W-G9RW?V+5HKF6.(KN\O9(I(W$ X+CO7.7.A:M+X<\5^&YK&62;5+
MR:>TNN#%LE(8%FS\IC.<COM&W->E44 <YXQTK4-1\&7-EII$M\GE21K(VT3&
M.17VD_[6TC\:Q=<MM4\4>';JYLO#\NG7RR6TOE7?EI+=F&42&,E2?EX(!8\D
M] .3WM% 'F_BG1M0U]M;U2RT^Z0S>'I=-C@D4))-*[;@,$\!>F3Q\QQFM>TM
M;N/QU9Z@;"X6T30_LS2;.!)YBMLQUS@'VKL:* /,H=)U5?A?I>F-I=T+Z#4H
M9I(,#*HMWYI.<X/R#/!]JGU_0=7U34/&(L;5T:]LK(6DDN%29X6=F0GMG(7G
M'4UZ-10!P>MQ:CXK\&:\(?#4VGW]SI[0 77EB:9QDA 58_*"3@DC);H*M[+V
M?QSI>K-I=W%;)I%Q#)O524=I(V52 3R0AZ9["NQHH \ST#1M4L[#X?0S:9<1
MOICS?;!M'[G=#(@S@\Y9ATS533&6#[%'=Z7K T>QU:>_M9XH(Y(AN>3:QE60
MEH_WC-]P'D<D#)]7K#L?"&B:;*KVEK)&B-N2#[3*T"'.05B+;%P>1A>* *OC
M33]0O+/2[G3HC/)I^I0WDELK --&N0RC.!D;MP![K7,>*- U'55\2:E9Z?<,
MNH06-O%;%0KS&*4N[LI(P IVC.#P?;/IM% $; S6S!&:,NG!Q@KD=<>M>=:=
MH&JS^&/#'A^ZLI8+S1M0AEFN>/+*0DG>C9YWC QU&XY Q7I-% '(6^@7UKXW
MO3&B_P!A7C1ZBXSTNE&PKCT.(Y,_WD]ZR;?2;R/6-2TG4_#MWJ$-QJ3WMI>B
MY_T4(S[QYBEQAD/  4YP,>M>BT4 <-I.GWT/ACQ=!)I\\<]Y>WLUNA49F67.
MPCGOQUQCOBLFZTW6Y-%M--&B7!5O#8M/,@\M)/M 4J8I'+ A!@$!3@DGKTKT
M^B@#S7299;#QGHRWFG70F3PNL3Q! [HPE48(4GKC_'%5='TR7PMKW@NRNK:1
MI([+4W:.%?,, DEB<+@==H8+QG\J]%_L:Q.N#6?*?[>(?L_F><^/+SG;MSMZ
M\]*)]&L;C6+;5I8G-[;(T<,@F<!5;&X;0=ISM'4=A0!PB>'-1L=.T@)82_-X
MF?5'@CP?LL#&3 /.,@,N0,\DXSBF:AH^J2^'O%=O'I=RT]YKT5W;J%&9(E>
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MQ7W?\*ZOMH!;[1:8STS]IBKM*S=<T*P\1:<;#4DDDM6979$E:/)4AER5(/!
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M7 ::^&H%UNI%9;@#;O5@V5.WCCC% '-GQ/KB>%[W57G91I&LO!=AHDWR6BR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(8[76-/G<'!6*Y1B#G&, ^IQ7D_Q2\9P>(/#.CV^E3W4>E7VJK:7\KPR0$J
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M3(?#MO!X67P\ES<_8UMOLBN2OF"+;MQG;CIQG&:V** ./'PWT=?!!\("YO\
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M49--O)S/<VKS@+,YQG)50V#M' ('%=K10!%;6T%E:Q6MK"D,$*!(XT&%10,
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MYT 3T5'#<0W*;X)HY5Z91@P_2I* "BBB@ HJ)+F"29X4FC:5/O(K LOU%2T
M%%%% !1110 456EU&RAD,<MY;QN.JO*H(_#-3+-$\7FK(ACQG>&&,?6@!]%,
MBFBN(4FAD22)QE71@0P]01UILMS!"Z)+-'&TAPBNP!8^WK0!+1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<#\:E!^$>NY
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M_OQJ,EO%)&%6?NPRA.#GH210!D13W%G\<?%MS9VHN;F/04DB@WA/-<;,+N/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO:*Y2;Q)JMO<G39M/MEU3RGN-D+2SQB,-M3)6/.6Y[8&._2KEAXNTV2TT_\
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MDBCD,C_=WLA"E?EW=">=IZ<99\3(U/A6&7R5DEBU*Q:,'&0WVF,<'MD$C\:
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M;0"FY.Y!YZ<<VT\87=U=6TEAI,UU82WS6;O'')NC"NR&8G;LVAE.1G.#GKD
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MBI8;NVN&=8+B*5D.&".&*GT..E '->&[&VO?$&H^*8;.[M1>Q1Q)'=1M$Q(
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M-Q-*'#D\C _>-@#IQZ4ZX\'AKG6?LM^]O9ZT/]-@\L,=Q78SQMD;"R@ Y#=
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M_JD8C_6,2P]5&X]<51\6M92Z;KNGZ7I<]LG]@+':,EK(_P!H13)M2,8*QA2
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M&2$^?!XE>0[HSNC0W,S%CQE5VLISTP17K,,T5Q"DT,B21.,JZ,"&'J".M/H
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MSVT5R8_.7<(W#JI)QN'()'?!Y&>^#U% $U%%% !1110 4444 %%%% !1110
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MZGAN[OK&RALM9:6+]U(S/$Z([@\C!4B,C'7H?8;-KX16TN-#F34)BVC6;V<
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M%  XZ]2>IH T(-/^P6=W=P0646I31#S)HX2%<H"$W#.2 #CK7GUK=ZGJ=O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+*S?_28OL[*)S& 2/F8*<<9&1Q2:Q9F2#XC+]GO+>.Y^SO$\=JW[TB) =HP
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M?J_A"+5[&662UT>Z2:22 R"(F2,Q(S8(W! 1U[&@#U&*6.>%)H9$DB=0R.C
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MU"P>[B>.1XI#^\&' )VR9Y_VZ .UTVVMK>T!MIFG64[VG:3>TIP!N+=^ !Z
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M^F6EZ\+VIC;S7A27RF<-NP&R"P&.G'7F@#O*@%Y;&^:R%Q$;M8Q*8-XWA"2
MVWKC((S[5QFO^,-4L9=?6RCMEFTN2V2"VFC9GNQ+M^9<,.[%1C/*'/M)JOBJ
MYT#6M8^W06L\5AH:7^Z&,I([;W4IDD_+E<CTW=Z .VHKF;J]\3V%M>W/V>RU
M"-;#SH$MD99#..J!2QW+C!!R#D8[\3>%/$">(;>ZGBOK>ZCCD"!4@:&6(X^9
M)48DJP.?3B@#4.K:<K7@-_; V2;[H>:O[A<$Y?GY1A2>?0U%J>FV?B'2E@DE
MD,$ACFBFMI2K!E(='5AZ$ CM7'7=W-IWB#XA7ULD#RV^EVLP2="R/MCG.& (
MR#C'6M.WU_4]4E.G:5]CAO(-*@O6,\;,CR2AMB !AA04.3SU&* -W3M&6PD\
MV6]O+Z<*566[D#%5.,@!0 .@YQGCK6E7&WGB'Q!//>6&E6,#:E8V<,TL?$D;
M32!CY>XNA"_+C=@]>@Q@UKWQ'XF.I:C9V\>G6CVNCQ:ELGB:4H[>8&B)5P#S
M'C<.GH: .[HK@KSQU<PPZ7/-Y&FV^HZ=!<V]U<P.\#3ODF%Y 0(\#;@GKN]L
M&W=>(]?NY]0;0=-CNDT^^%J\+[!YH&TR'>9!L(#''RGI[\ '945E^(+^XT[2
MC<6K6R2>;&A>Y)VJK.%) '+-@G"CDG [UR,GC765TB^FBBM'N+378=,_?0O&
M)(Y#%ABN<HV)??IT[4 >A5'//%;0///*D42#<\DC!54>I)Z5YYJWC'Q)H(U^
MSNTTR>]L(+>\MIHX72.6*60QE64N2&!!YR<^E7Y]9UJ/6-7\/ZRME*DVDRWU
MK-:QLFU0=C1N&8Y(W*0PQGG@4 =:FJ6$ALPE[;L;U2]J!(#YZ@;B4_O#!SQV
MJW7G>AZS-IFD^ +<QV[6ESI):1FC)E3R[96^4YP,]^*W-&U;7=4M-*U=4T]M
M-O[4W#Q99)(-RAHP&R0W7#<#U'I0!U%03WEM:RP13W$44EP_EPJ[@&1L$[5!
MZG )Q[5QFE^*M6OM433I)+,O<:.]\L\,#^7'*K*I"DMB5/G&&& <=>>*F@Z[
MJR^'O 4MY):79U5U6622 ^8N;=WW [B-V5()QR&Z"@#T6BN#G\:WZ^&&\5PQ
MV[Z5'?&![4QMYIA$_DEPV[&[/S8QC''7FH=7\7>(;%?%%S%_9IM]"N8AL:!R
MT\;1QN5SOPK .?FP<XZ"@#T*J=QJVFV@S<ZA:PC<4_>3*OS#J.3UK*\=:Q/H
M'@?5]3M3BYAMSY3?W78A5/X$@_A6#X[LUT[0?"EK;1B3R-=L%16;&\ANYYY)
MZGW- ';V]_9W<+S6UW!-$GWGCD#*OU(/%):ZA9:@KFRO8+@+PQ@D5]I_#-<+
M%-+'\9;9]0M1IDEUIDD-L(G$BWY5@S;F&,%!T!'<\]JO_#!0OA>[P /^)K>]
M/^N[T ;VCZ1:^&["YC2ZE:!YI;J1[EE^5G8NYR  !DD^U:<LL<$9DED6-!C+
M,< =NM<QXU,&I6,7A^5KGR-15_M+VL+R.L"CG[@)&6*+]"U,^'^JR:WX/CMM
M14O?6+-I]\DJ$%G3C)5AGYEVMR/XJ .MHKEO =]-=:+>VD[L[:9J-SIZNQR6
M2-R$R>Y"E1GVJ?Q;K&HZ-#I;:<EJ[W>H0VCBX#8 <XR"#QT]Z .BJO#90V]U
M/<0J4:<AI0#\K,!C=CUP ,]\#/05P&H>,O$>D67B2VNH]-FU'2&M9(YDB=(I
MX9VVC*[R58$-W(X'%;$VL>((=4&B9M)M0:"2[\V"W^18]X5%V/*,G.<G=V''
M.0 =?17$0:]XIN=8TK2I[?3]-N[S2YKF=9$,_DRQR1KQM<!E._.,C&>O&#6T
MKQ?KMS:^&-1NUT\6VJW;6,T$43[U<++^\5RV,9B/R[3P>IH ] K/O6TW3Y?[
M5U"XA@V+Y2S7$@58P2,@9X!) ]S@>@KF;;Q7J;>(]*L)?L;QW\]W PAC=EA,
M09DQ+G:YPN& '!..,<\[KFJZ[KOPNU74M1;3Q:$R0^5!"X??'=[ V2Q&-JGC
M&<\YYP #U."WBMD98DVAF+,<DEB>Y)Y)J6N0_P"$OD/AG4?$T9MY=.3*VL 0
MK+N#!/WK%L*=_P##@$#KSD#*\5ZOXNLO#/B1WBCMH8=.,UM?*BJX?D/'L$K<
MXP0W;/0D4 >B45#:"9;6,7$B22X^9HT**?H"3C\ZFH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *R?$'AZS\26"6MV\\312K/!<6\FR6&1>CHW8\D?C6M4%W>VUC");J=(4+
M! 7.-S'H!ZD^@H Q7\(6LMK8Q2ZAJ,LEI=K>_:))5:2651@%R5Q@#C  %1WG
M@FPOK77+>:\O?+UIU>Z"L@Y"JHV_)Q\JJ/PK2;Q%HJ6L%T^K62P3EEBD:=0'
M*YW 9/48.?3!S3(/%&@7-C%>PZS8/:RS"".47"[6D)QL!S][D<=: *%SX)L;
MG6I-46_U*WFN$1+Q+><)'>!1@&0 =<<97;Q5N'1!IE_J^K63S3WE\BDV\CJL
M99%P@!"Y7CC.33X?%?AZ?3I]1BUO3WLH'\N6=;A2B-Z$YZ_SJ5/$.C2V[SQ:
MG:R1),T!:.4-^\49*<=6 YQZ4 <7X7T;5K22R$,OB6UDB*?:HK]K=[<@??&1
MEVR,[2&/."3UKH=(\$V&AW+/97NHBU#M)!8O/NM[=FSDHN/<X!) SP*U!KVD
M-]CVZG:'[=_QZXF4^?\ [G/S?A4DNL:;")O,O8%,,@AD!<960C(3']X@@@=>
M: ,:V\$V-I9Z1:QWM\8]*N6NK?<R$[VW [ODY'SO^?TI^G>#;#2=1FNK2ZU
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MKG].\!:;IDVEO!>ZDRZ6\AM(WG!6-'',? Y7Z\]LXXK<36=-DOQ8)?6[71W
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MM;FXWQ6P/9!C/3@9)P,@=35J[UM++4=.61HWL=2D\B&9?X9MI90?4,%;![$
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M^DTR"VMVMXK90@B5#MS@;<@_*O?M5:3P[;KXI;Q(EQ=K=_91;-%&4\N2,$L
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M8M3OK%-7GGN46WC;87$<TB JA)/W4SU/0T 4_&GAQY?"6M&S2\O]4U!88RY
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M;JW-L7O+C>\<9_A0@#';D@DX&2<"DO/'^@V=KK<[W0(TABDRC[SMM4X4=^6
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M<67@ZVM;JVEMYHY[C,<J%2 TSLO![;6%=110!Y^MK=MI?Q"B-A=[K^69K53
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M=%A!"S@/)M!8X'4X )H YU+)W^*-Y=R64AMVTB&!+AH24\Q9I'*AL8Z,A_\
MKBL'PII[K%IFFZUX?U,:GH[-F_FG?[-P"IEC;?@EE/W0."QS@"O2JCG@BNK>
M6WGC62&5"CHW1E(P0?PH \L\)211/X76_M=8MX]-1X;-Y-/8(?.PB"2925/!
M R  20>.E.BL]4AT_3M,_L74'FLO$[W<KK%^[,+3RN'5B<,-KCIT[XXSW>F^
M%M.TMH_(>^DCBQY45Q>RS1Q8Z;5=B..WIVK:H \WOX-1ANO%D\6C3W27&JV4
ML>ZW+YC1(5>6-3P[(4) ]0#R.M"YTO5GTOQ4J:7J4AEUBROXC*B[YHT-N6(
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M:#VXZT :B^(=6AU#6=$N9X/[62XA_LXB'"R02_=<KGYMI63=C'"<8S7:*"%
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M>[57 #(H*@#CY>&8<>M$WA.QN('MYKB[DM98XXIK=G!254^[D8R#P,D8SWH
MP+_Q?J0\/:[XBLC#]GT>]E@-FZ?ZZ.%@LA+9R&/S%<<#C(-7K+5->U3QEJ=C
M!>6<-A8FTFVM:L9)(Y%8LA._@\?>Q^'KHR>$=,DN+U_WRV]_*)[NT5_W,\@Q
M\Q&,C.T9 (#8Y!YJY::);6>MWVK1R3&XOE19@S J0@(7 QQ@$_GS0!2U?6)H
M_$NE:#;.(9+Z*>=YRH8JD>T84'C<2XZYP >.:X[Q%K.I:MX&UF"XECBNM,UF
M"QFDCC^6<>?"58 GY<JZY&3R".AKO=5T.TU:>SN96EAN[)R]M<PL \9(PPY!
M!!'!!!!_"JMWX2TV\T:32Y#.L$MP+F9DDP\LH</N9L==P!XP. .@Q0 NO"YT
M_P ):O<VLZ17Z6DDIN4B )=4.&QZX '.>U<=;QZE-KG@<17T8NI-#N3]HDAW
M;01;G[N1D^Y/O[5Z-<6D5W82V=SF6&:-HI-W!92,'ICL>U8UGX0L;&XTZ>&Y
MO3+IUN]M;M)-OVHVW(.1S]Q?^^?KD P=*\8ZEJNFZ!;^6!J&H173RR6Z+_RP
MD$9VJ[ <E@>IP >.XZKP]-JTVCQG7((8=05F600L"K $[6X)P2N"1DX)K*D\
M :.^DV5@LE[%]AF>:TN8;@I/"SDE]KCL23D'/7V%;]C81:=8I:P-(57/SR.7
M=B>2S,<DDGG)H \:O7DNM#\2:%+!%#8ZKXIN;9]3E;<EHQ9"I*@9R2 %.0 2
M,D=_1M3U6_BUF/P]IOFFXCT_[29MJ.Q^;8N0[*",@EN_(Z5:M_!VE0Z;JNG2
M++<6FJRR3W4<[!@SO]YAQQT'3ICC%07?@?3KQ+ O>:FEU8*8X+R*[9)Q&<91
MG'+*<#KD^] &?)XCUF*?3+'5OLND3SZ=-//<9#Q_:$*CRU).,8)8C.<# /!-
M,TGQ'K\\_A!=22W@DUF":2Y@6W9#$5C#J!N8D'GG/Y"FZ_H=V-:L_LUAK36-
MO:>3#/I&H)'*'9LN)1(Z[@=J'=R2<Y[5IP>%C>Z?IYU.\U#[993/+;3_ &@>
M?&K C8[J,-E3@_S.,D YN]U:[UC1M%FO3&TL/BU;4-&NT%8YW13C)YPHS6I>
M>)]3M==M8Q+;S02ZR-/>.&,LD<90D9D./WN1D@9 '! /-:D?@C28K2*UB>[2
M.+4#J2?ORQ$Y8MGYL\9)X[]\TQ_ >CO.\GF7RJ;_ /M%8TNG5$G))9E /&23
MGZG&* .=L?$.J:=)JOG7JW$UWXF&EVYDB^6'*I\V >@4' [G&3R:G\0^+-;T
M&#Q19K);RW6F:?'J%I<R0Y#QL64JZ@@;@R'!'!!Z<<]!/X*T>Y_M 2+<;;ZX
M6Z=1.P$<PVXDC_NME5.?;T)J2[\):??Z?J-I>27,YU&-8KN=G DD1<X7(
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MW5O?W5I;>:T BD=%<Q@GY3M^8C..W7(W(?"ZW>F:3:ZE).MUH[ 6]Y;S&-G
M39NXZ;E.&'KG'8U+8^#['3%0:?=W]L4EFE4B??S*VYQAP01GGD=>>M %RSNY
M;_PK!=PWT$LTMH'%U;KF-F*_>4'MGD UY[ILFI7FG?#*XDO4DO;CS9!-+'G;
MNLY"<@$;CU/49KTS3],M-+TN#3;2(1VL,?EHF<\?7O6/9>"M,T]-)2WFO0ND
MNS6@><N$W*4QSGC:2H']>: ,/3_%VJ7 MM*F"RZB^HWMFT\$:KO2W)^95=@
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MI X!'!7D>U:.C>'[/0WO9+62Y>2]F\^=IYB^Y]H7.#P.%'2@#5HHHH ****
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MD@'']X,I!_ \9P.;T6#4["_O]$O_  _)>(^JRWUKJ#>6T 1Y/,#-D[@Z9(
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MXE2QN;VT\VU@6.WV[F\J/$C#<0,*7(/^X1VH ZGQ+JDVB>&[_4[>W,\MM$9
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M2/?/'XX[UPD7B[5)/"VD>+(Y0]M>WT<,MAY:X6*2;REVG&[S%RI.203D8'&
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MBO&ZE61AD,#U!'<5R<6J:MK4VL2:9?6]H=+U$6ODSH#&Z($:0R'&X$AFVX(
MP,YYK/OO%&J2Z%XGUVQG2,:%=S0K:/&I29(0"^\XW M\V"",?+P><@'=Q1K#
M$L:9VJ,#))./J:;]GA^T_:2@,P78'/)"]2!Z9P,XZX'H*X._U[7KF]\2K9ZA
M':0V&EV]_;*;568%EE8JV3R/D&?TQ5G3];UN36]$CFO8'AUK29;M8A;@"VD0
M1$8.<L,2'()[<8Z4 =K'%'%N\N-4WL6;:,9)ZD^]/KS72/$/B6^M/!MU)JD'
M_$]C>.9/LHQ&PB:0.O.<_(1@\<CCCF>T\3:RHT^&:[261?$DND32>2J^=$%=
M@Q Z-\H'&!UXH ]#J&\NX+"RGO+J01V\$;22.03M4#)/'M7 ZAXGURWTO7)8
M+N'S;'Q!!81M) #F%S "#C'/[UN?_P!=376O:[I]IXW@:^AGN-'M%N[6=[<#
M&Z)W*E0<$ IP>O/.: .[BE2:%)8VW(ZAE/J#R*?7'1:QJFMWUUI5C>I9W5MI
M=O=+(8U;S9I0^,@@_NQL&<<G=U&.<[Q/XGUG2;'4+J"]MI9K"TMIC#:1AX]S
M$[S*S#A6&-@4[L9.* /0'=8XV=SA5!)/H*BLKVWU&Q@O;242V\\8DB< C<I&
M0>:X])-1'Q \3^7J4H2WTRUDAA=%:-2WG]L ]1GKD]R0 *BT'Q/J&N_\(YIS
MW)M[F]T,:I<W,<:[F8E%"J&!4#+$G@]!0!UL6BV,.M3ZO''(+Z>)8I)#,Y#(
MI)4;2=HP2>@[FK]><0^*M?NQH]L)[:"X;6KG2;N06^Y9?*20B103QG8./7/;
MBIHO$FO1:-=-(MQ?G3]9FLKJ:R@0W!MU4D.L9^4L"4! !XR0,T >@T5D>']0
M76/#EO>VVH1W@F5O+NA%M#?,0,IQ@C&"..0:XW2O$VOGPKI&LWVH0S/JTT5G
M'#';*@A=I&!<,3R2HP >,XZ\Y .^U+5+'2+3[5J%REO!O5 []V8X ^I)JP\4
M<I0R1JQ1MR[AG:?4>]>=^*VUI?!>MPZNT;Q)>6;6;DIYIC,\>1($^7(8$ CJ
M/<5<\2^)-4TR[O9K2[26*TO;.'R(HPR(DCQJXF9AD.=Y("'@;21S0!W=%><3
MZW?:'JWC?49+V6X2SGM(8(I0FR,2(F.@!PID)ZC(SDYYJ[JNN^(?#=KJ%S=F
M*6UD\B.Q>Y*>8DLDBQMO$> 8QO5NQZCN#0!UZ:I8R:K)I:7*-?11"9X1]Y4)
MP"?QJW7%:?;W%O\ %J[6>\>ZSH<)5Y$56 \]^/E !YR>G>DU.[NK3XE&5KVY
M^QVVA2W7V9%4J2)5W#IGD =\\<8H [:BN#M_$NJQV'A+6I)TN+?798H9[41@
M"$S(74QL!GY2,'<3D9/%7O'37:MX<2VOIK59M8ABE$04[QAF&<@]"H/\Z .B
ML]4L=0N+N"TN4FEM)!%.J_\ +-B,X/O@BKE>5:CJ&J:)>>/M7T^]2,V-W:RO
M&\(;S\6\.5)[ C/3!SW[5T.HZQKVHZGKEEH)6.ZTMXDC63R_+D9HUD/F9^8*
M0VT;<$8)R>@ .LOKJVLK*:XO)A#;HI,DC-M"+W)/;ZUG:=JOAW4!!8V%[83X
M02PP1NI)4<AU7N/>F^)W,G@;678*"VFSDA6R/]4>A[UP&@B75M;\#6>I)'IZ
MZ;I<=Y8NC%S?9A",H; V;0067DG([#- 'K5%<1)K>OZI-J,VC>6HT[43:M#,
M8Q"\:;?,WD_.&(+$$8'W<@\FJ^J^(]>%QJ\-E((M0M=2@MK2Q,(<7$#^7F3U
M/WY&R" NSGO0!W]4QJEB=7.E"Y0WXA\\P#[PCR!N/XD5Q^I^(-7LH_'"I>*7
MT:PCNK5_*7AC$[D$8Y4E1[X[]Z'O)!X^@O6D@CD'A>24O,=L:GS4.6/9?7VH
M [RBO/(/$&LS3WUB]]*0V@?;X[KR$0K*"06C!&=AXP'7/'O3O#6JWKVOA/0!
M?S*]WHBW\MTRH7PJQ*$7*XZN2203@>^: /0:*\X'BKQ!<0:?:I<6\-T/$$NC
M7,WV?<)55'82*,\'"KD>N>@J[)K6L>'-8N-.UG4?MWVG3Q)ILJ0)$9;A3M>/
M S\Q+1E1TP3UQ0!W5%06<<\5E#'=3>?<*@$DH4*&;') '09J>@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML8Q,.CA3TQUP.,\XSS6M10!SC>!M"*!5BN8]EXU[&8[N53%*V[<4(;Y0=[Y
MP#N-+'X)T2%(TCAN%6*^.H(/M4A"SG)W<M_M-QTY/%=%10!@7'@S1+NWU"">
MWE=-0N%NIB9WW"90 KJ<Y1@%7!7'2F?\(1HS1ZDDHO)CJ<"V]X\MY*S2HH(
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M HHHH **** "L?Q*EY<Z5]AM+6:87;K!.\3JIBA8XD;+,.=N0,9.2#VK8HH
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MP3O49/'6NNHH C@=Y((Y)(C$[*"T;$$H2.02..*DHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXLAA\*:[=Z)?VKZCIMM)*T,B[FC91G#ID%?Q_6MBSUJRN+I=/^TH=0%NL\D
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M#S[.YAN(22OF0N'7(ZC(H GHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2>3"TFQ%;+,=H. *7XB137/@NY@MK:XN)GFMRL<$+2,0LR,>%!Z $_A7544
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M"<QA=H 7:<D8'4DU7;P/87&B3Z9?WVI7YE*$75S<9GC*'*%&  4J><XY[YH
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M2DD!1MX(+'\Z@MO!UC:_V&%NKMDT6%H+5'*$%"H0AOEY^4 4 9^EZ[XGU/\
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M:>)]@R%((C8ACN/3 !ZYK=M?!5A8+I9LKN]M[C3;7['#<(R%V@X_=OE2K $
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M*1B265,>I) )(!Y Z4V'P38P6&G627M]Y6GWK7T.63/FLS,<_)R,R/Q[^PH
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M<K<7,1O+);%XXR@1(EW;0HV\8WM^?TH H6'B>\UZ^M+&P\BUE?28=2F>6,R
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M110 4444 %%%% !1110 4444 %%%% !6)XL\0Q^&/#MSJ3^69$ 6))&P&=B
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MH]C*RH 01[8KC(]#U&Z\'>+K:UL)(M0N-4N;FW69#$9T:0, &..'5=OX\XH
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M2Y(O(C/ E:(C:#Z9.*PK*.XF\4^%[Z73+V*&UTB>&1I;<YCD;RL XS@D(_\
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M9LH)6.W+"/8"3VS^F:PY+JZU;PQ>SQ^"I%U2'2WM7BOH%42' S"G.70D$\$
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M@]ZT: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2!KI+..[T=#!GSLL4:-N>3OV#(Q@.">] '=45S_AW6F\0>7?6LZOIQLX6^X
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M[,P$T;21Q_>WDJ1YF>_(_"M!O$&M65UXGL;B\TYYM/M[>XMKF:,PQKYN\%7
M)) *<8Y.<4 =O4<\T5M!)/,ZQQ1J7=V. J@9)-<=9:SKNHR>)=/M)XH[K3Q"
M]E/>6^S<'C+8D4$8&0>>" >1QRFB>*-1UOP;J6NQR6\4D,#A+62/<898T^<2
M889RP. ,?*0>^  =C;7$-Y:PW-O(LL$R"2.13D,I&01[$5+7"VNO:[?WWANR
M@N;.!=3T1KR1S;%BDBB+D#<!C]X<#M[]*JZ7XJ\03V'AG4KJ>S:+4;]].G@C
MMRIR/-'F!BQP<Q9VXQ@X]Z /1**X&+Q9JQTBQNF>W,C^(FTN7]U@-$+AH\]>
M&PH.>F>U5]4\4^([2P\3W\5Q8[-$U%(EB-LW[Z,I$VTG=\I_>'D9Y].E 'HU
M%<SI>IZHGC2_T349[>XC6RBO87BA,93<[H4/S'(^0$'W-0:MJ.OS>-/[!TR\
MLK6)],:[6:6V,K(XD"]-X!'/MCGK0!UM%<#X>\9:CXB;1]-D6*RO[BVNIKN5
M%W*#!,(2(P?[S9;G. ,=\BB_B'6M5N]"MVNDM9X/$%QIMV8HOW<YCAD97 )R
M 0%.W/7Z"@#TRBN*AU_7]4E^V:5;*]K#J<EI-%+Y:KY,<AC=MV_<'^4L!C&,
M#'>L[_A*?$4<$M_+<6+06WB$:6\"6Q!DB:98MVXN=I&[/?I[X !Z!=W=O86<
MUY=S)#;P(9)9'. B@9)-21R)+&LD;!D<!E8'@@]#7G3:MK5C8_$/45OXIWTV
M61H(YX-R +;1N%P"..2/J<G-6/$WBO5M*TR]O;6:V9K/38;Q;=(R[,Q+%_-Z
M!$P %P02=W7&* .U74K)]2?35NH6O4C$KP!P75"<!B.PS5JN20Y^+9/KH*_^
MCS5V]U6]@\<:=I"2(+2\L;B9LI\RO&T8!!]/WAX([4 =!17GECXKU_4+'PFR
M364<NJW5U;W#-;L0/+$I5E&[_IF.._J*EL?%VI/#:Z9/) VI3ZW<:6+I8MJ;
M(@SF39G[Q5< 9QDYZ<4 =I:ZE97TUS%:74,\EL_ESK&X;RWQG:<=#@]*M5YG
M9ZK=Z%K_ (H1F%S=W>N6EI'($5?OVT9!() W;1CJ 6_*M#4M;\6:58L9H[5"
M=5M;:WEG12\L$KJIW*CX5@21D<$=@: .\JK+J5E!J%O82W4*7EP&:& N-[A1
MDD#K@>M4W35+7PU<BYOXI-02*5A<Q6^Q<\E2$)/(&.YY'X5P.G'4KI/AK*;Y
M&O)["9Q/+%NV[K9"<C(W'KSD4 >F7=_:6 A-W<1PB:98(MYQOD8X51[FK!&0
M1ZUY_#XKUA_#VCW,K6C7#:]_9=TWDG$BK<-'N4;OE)"@]^M7[?Q/<_\ "9#1
M[^4V$K7,BP030?N[N (2K12C@OG!92>!D8XS0!UT4,<$2Q1(J1KT51@"GT44
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'+<EM*MVM;4,X(6-@H(/'/"*,GGCZU:U30K/5[FPN+@S)-8RF6%X92A!92K
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M\MG$Y+6TA9FS'GH,LW'(()!R*UM/TNWTXW#QEY)[F3S9YY""\K8"@G  X
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M/I%D( VGS3+!?7!_Y8O*&$ _%D(/IE?6@"*+P<NJZ1%%K%SJ?GV]R;BQG>Z
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M'%&I9Y'( 4#J2:Y_5?&^D:9I&IWVZ>633HP\ML()%E&[[F5*Y"D_Q8QUYXH
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M:VF)N+?:989(VC= WW258 X.#@]#@U?H **** "BBB@ HHHH **** "BBB@
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MJ0078N+B24R[0 I)9C@C Y'/%/M?".D6=E':P1W*B.43+*;N5I=X! _>%MQ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !6?K&C6NMVL4-R95,,R7$,D3[6CD4Y
M5AVX]""/:M"B@#'?PW:O97L'VF\6>]=7N+R.;RYW*XQ\RXVC  P !C/')K8H
MHH *YSQ#9WS^(/#VHVME)=16,L[3+$Z*P#Q,@(WLH/)]:Z.B@! <@'&/8TM%
M% !7.>*K2^U&72;:TL994AU&VNI9]\81$1\MG+!B<#L#71T4 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M02/&K#Y,%<H,GKSTXY .\HKDH/%>HM%JT$^FVZWVFWL5M*4N?W*QR*C^:68
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MC62-HV#*PR#QZ5YOX-UJYT/X?>"8;/3X;AM5/D,SS>60Y1WW'Y3G.PY/7V-
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M?:E;Q1SM;6[SJC/M5]JEOO 'T]*-'U2/5-,M+C?$)Y;>.:2)'R8]ZAL$=>]
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MOWF.!DGTX R<[5<MK7C.WL]'NK[2_L]\;2^BLYQYN I>1$)& <X+CTY!YXH
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M%*I/V=6D=I V,=LH#D9+#%, N?"_Q,AFN)8I;77;;RKC[-;M&D,T./+=AN;
M924SD#Y1Z5W45Y:SOLAN89&QG:C@G'X5/0!DZ;#K\5],^J7^G3V9!\J.WM'B
M=3GC<QD8'C/85@>$+ZWLK3Q3=3LRQ)K%S.2$)+1D+AE &6!P<8SGM7:T4 <;
MX=\0:7K?B!KM1=MJ,T)CCC>SEC6V@!W8+,H7<3C.#UV@9"YK5MT:^\975TRG
MR=.MUM8B1UDDQ)(?^^1",^[5L)<P23RP)-&TT0!DC5@63/3(ZC.#BI: .'O6
MM]<\3Z+JV@7UX;RWN3#=QYE6(6^#Y@>-L!3E5P< DXZXR+/Q&TF]U/P_:3Z?
M US<:9J%OJ MD^].L;99!ZG!) [D5U]1/<P1SQ0/-&LTH)CC9@&<#K@=3C(S
M]: ,VS\2Z;J21_897GF?&8!&RR1^N]2 4QWW8]!DX%<UX+,?@^WU31=8D%L4
MU":XMIY>$N8I&W*5;H6&2"O48]Q7>44 <9X.T65Y?$VIW]LT<&N7K/';3*5;
MR @0%E/(+#)P><$9YJKX$TW4[6>32M2C?[+X=DDM;&9_^6ZOAD?ZI$0G_ F'
M:N]JO:ZA97K2K:7<%PT1VR"*0.4/H<'@T <A:3Q1_%[5YG<+%_9$$?F-PI99
M)"R[NF0""16=X"UR'1OAS!$]O=S7\<MT5LHK=VE<M/(RC&. 00<G  .2:](H
MH Y?X>:!=>&O VG:9?;1=J'EF53D(SNSE1]-V/PK)\1Z7J5EXW@N])B<P>(+
M?^SK]TX\EDRRS_41^8![A:[;[?9_:&M_M<'GJ-S1>8-P'J1G-6* .1\52V^G
MWWAN'[&RQ+.ZQ7*Q/(EJ1$R@;%ZLP)5<\#KST/&:!?/HNG>%;C4K6\_LBTEU
M"WN"UJY^SS-*?)=D"YQMW*"!@;L<5[#10!YM+/I_AW5O#]S_ &==0^%OLUU%
M$&@DD%O,\BLKNA!90R[PN1P&QQG%2-8Z99>)/ ZV-BUK9PQWB*LRMNCB9#L#
M%N5!/16]<8R,5Z+10!X[IEC96FA^'+B&TCBNX_$\I+K%M=(3--U.,A-K+[88
M>M:.BI;7NIPZ;K(U5=?L-6DNEC2WVH^9&(E$H3F,QM@@MT&W'05Z9)<P0RQ1
M2S1I),2L2,P!<@9(4=S@$\>E2T <?\1(XWTS2':,.\6L64BG;DHHF4LWL N<
MGTK+!N+;QK')9O%J-I<:H3-9SQ%;BSDV%#/&X^]%M'<8P< YXKT2B@#D/')6
MVO/#&HRHWV>TU96GE5"WEHT,JY.!D#<RC\17&7<4%UI.J^99R@-XP@N(Q+;L
MA\LO#N<9'3:&SZ#.<5[%02 ,DX H \OFL[*/4/&5G!,VF6KW.GR02VL *1R#
M9\^S&UE#JN_M@'.*A>XNT31M1U2TME%CXC)GOK&)C#<(ULRB<#DJ"S*IQD;@
M>:]-;4+)2 UY;C(!&95Z'D'K4L-Q#<*6AFCE ."48-C\J /)_M,UM:ZC?+87
MCZ=#XL^U7L0M7!:V,0 ?;C+!7VL0.1MY%:.H7>G6-YI6NV&GW?\ PCLFI2W%
M^X@D(:5XMJ3^61G8&XR!C/..Y])CDCE4M&ZN 2I*G."#@CZ@U#%?V<\CQQ7<
M$CQG#JD@)4YQ@C/'- 'G>IRV6DOH>H65K?VOAHW-T\[QV[2&.27!28QNK%4)
M\T?=&-P(P#4=QIUOI^G:8^@W\EF42\DMH]7MR;:YC=D+QLN%,>XX*8 .,X!!
MQ7IR.DL:O&RNC#*LIR"/:F?:(!="V,T?V@H9!%N&\J#@MCKC) S[T >7W$EY
M&UG?VEJBRO!8+=>'KV(E_EVE3!)U#(6Y!R!M).*TA9P7/BKQW%%;1M+/8PI#
M^['[Q_*D#A3W.2,X]>:]#HH \N\/WT%QK/@-XXKC%MHT]O<2-;.HBD"0 JQ(
MXP5;V%=+\-LCP1:HP*NL]SN5@01F>0C(/J"#]"*ZRHH+F"Y#FWGCE",4<QN&
MVL.H..A]J /(]4M+5M*\50BV7#>*+6:)5CZKFWWNN!T^63)'HU==X8@M;/QY
MXIALX8X+5X[-XTB0+&S!'#E<<$CY0<>V:[.HEN8&N7MEFC,Z*&:(.-R@]"1U
M H XO4+:*7XF786!6:;P^\3'9P[^;D*3W;'..N*YRQ4KX-\*OI]U'I^HVFEO
M$\&H6;?9K@A(A+%)D AB5&&'/##GFO7** .;F6>]^&DJ+I\EK<3:0RBRY9XV
M,/$?J2#QZURN@Z1I\FJ>$;W2;6*)[:PD35Y$CV94P@>7-QR_F8.&Y^4FO3JC
MN+B"TMWGN9HX84&7DD8*JCU)/ H \DT69M,T;PA+<6\@T6UU+4/M:K$2(7:2
M3R'=0,A?FR#C W*?2NL^'_DJ_B806\D,+ZU+-'N@:-65DC^9<@9R0>E=G10!
MY1K5K=I)X_M]/L9C>S7%M.B10,#-;B.'S55L8.X+(, Y)S72:>D5[\08-5T4
MK_9S:48KQXUVH[[U,2D?WU'F9'50<'&179T4 <;JDHM/B-#-JR+_ &/-I30P
M2RKF))_,S(K$\ LFW&>NTBN6L-)^R'P>NOVV=,A?4547D9*0Q.P-NLFX87Y0
M,!NF .HKUNB@#R0:.-,TW297L9!I4?BIY[:+R&;R+1TD5?DP2J%SD#'\2T:C
M=))K$4D-C=6S6WBA))HEM97<K@IYS/@_*PP%5<#'KV];HH \?\06ML]AXZB6
MV4B36+*6!5CY8@0;V3 YY$F2/1O>NL\.P6EG\1/$45C#%#:RV5DR+"@6-W'F
MAB,<$@%,_45VE137,%N8Q//'$9'")O<+N8] ,]3[4 <)XF^RO\4-":ZEFCMX
M=/NEDEADDCV,S1E060@C(!X)YQ4?B2R35/AKKFDZ!'=WOD.)4:0N[2OYPG9%
M9N7('&><Y SD&N_N+B"T@>>YFCAA09:21@JJ/<G@5+0!R]]K5AK]K9VNF3&X
MGDN[:9HU0YB2.9)&,@Q\G"GAL'.!45S"_B;7;^.&XMA:V<#631W%NT@D,@!D
M( =>,;5SSSO%=;10!Q?PVO9ET&30;R1I+K1IGLUE92!/"IQ'(N>HVX'&>15*
M_$*^)/%UKK\!>WOK2(:>6C+"6(1D-''_ +8D).T<G<"*]!HH \MTC0X[CQ3H
M-KXELX;N['AL179GC$@:8/&0&)X+@!NO/!-;OQ6'F^ +NW4.\DL]MM2,$NP$
M\;-@#G@ GCIBNUHH YVZTZRTS0]7N[>XGD2YM3DS7+SYPK ;2Y)YST'?ZUR^
MF:J8_A!I^DV=I<WFKR:2EHMFD+960Q[?WA(PB@GDL1TKTJB@#A;'39['3_#?
MA"*\A%QI]M'/<221&1':,#:F,KGYSO'.0(QD<TSPDTOA[QEKGARYD62"Y<:E
M:R11%(U>3/FQ<DA3N&X+GHQ-=[4*W=LTWDK<1&4$C8'&[CKQ0!QOC&6(^(+6
MVDM)0\NFW21W0@>8'<4!A5!E0YP#N8' !&.3CEM'CTF?4/ W]M6T10^&Y(IA
M>PX!=/(&'WCD [L9XSTYQ7KB7,$DS1)/&TB_>0."1]16=/H,4_B:TUTW5PLU
MM;R6Z0KM\LJY4MGY<YRB]^U 'E]CI%EIU_X0AU:VC73VO=3^S1W:<):G+0J^
M[HN,$!NF14CZ);6ME81/:+_9C^+3/8Q-'Q':%2&('\,1?)_NX8=B*],U#08M
M0UW2]6>ZN(Y=.,ABC3;L?>NUMV5)Z>A%:U 'GPM-.TKQ7K>GZM8Q1:-<Z=#%
MIR"']UY8W^;$@ P'+,#M'+9'7%4+?2]=T'1O"&O-:/=:U!;#3;Z,\NT<N/+W
MG_8D$>3Z%J]0HH \]U^VMM.U#3]*%I+DZ5<QK>"W>7S&8IOC5%!42.1N+$'@
M'CDXI:%,7;X9&19@\.G2QS>9&RE'\A%^;(XRP(&>I'&:]/J+[1!]I-KYT?V@
M)YGE;AOVYQNQUQGC- %31M:L=?L/MNGR.\.]D/F1M&P8'!!5@"/_ *]>7ZC!
M%#X4\4V!M)([EO$22;! R[HC<Q."#CD;06XZ $UZU;6T5I$8X5(!8L2226).
M223R34U 'E.JVTMO>^-X="M#L:#3IE@M(P/.56;SU08PS&,!2.>H!ZUT_A#^
MQ[[4K[6=)DU"4W44:7$EQ!Y"%ESM 78N6 )!(![#-=?4=Q<06D#3W,T<,*<M
M)(P51]2: )**C@GANH$GMY8Y89!N22-@RL/4$=:DH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *XKXCWLT5OH.F+(\5KJVKP6=U(K%28CDE,CINVA?H37:UGZWHECX@TN33]
M1B,D#D,"K%61@<JRL.0P/(- &)XKDTC1[;1$GT<RH=1MX+/[,J*8)BXV8R1A
M<C!QV-5K[QC?)I&NZU8V]O)9:+<R0S0.#YDPBQYI5LX4C+8!!SMZC/&E<^%3
MJ/\ 9Z:EJUY=Q6%U'=Q*RQJSR1G*ERJC.#Z8S39O!EE+)JD:75S%8ZK)YM[9
MKMV2,0 Q!(RN\ !L'GM@\T 5V\53V^OW5I="%;.33?[0T^18VWS '#H06Y89
M3@==XZ8J*]\1ZXLEY86%G!/JEA:Q2SQK$S)+*X8B-3N&P?+]XYZ].*W-3\/6
M&K7FEW5PA$FF3^=!L..=I&T_[.=IQZJ*HZIX1COM>&LVFJZAIEV\0@N#9LFV
MXC!) 8,K#(R<,,$9- %%/$'B*]\3OI5K8V%N([*UO9!=.Y=5D9E>,[>-PV'!
MZ9]<\4K#QGK<T&D7MU:Z>MI>:M+IDD<9<N"))$5P2< 9C&1@YSG(Z5TMKX;@
ML_$$NKPW5R'DM([/R25,:QH6*X^7=G+-R2>M9\7@:UBT^QLEU._,=GJ+:E&Q
M\K)E+LY!^3[N7;CKSUH R+OQGKUO8:OJ"VFG&#2]76QDB+/NE0F)<ANBL/,S
MG!!]!U-N?QC?Z1=ZY:ZI;VLDEE':RVYMMRA_M$C1JC9SR' RPZ@]!TJY/X&M
M;C3=5L'U*_$6IWPOIB/+W+("APOR<+^[7KD\=:DU#P58:K=:K-?7-U,NIVD=
MK-'E555C)9&4A00P9B<YZT 96K^*_$FC:3K-Y+I4$D=G'%);7+HT*2[FVLA3
M<Q#+P<YP0>V*CUWQ-KUC:^++-S90WEAI']I6L\*,P"GS 58$C+ QG#<#G.WC
M%:<O@@7GA^ZTG4=>U6]^T*L9N96C\Q$4@A5PFWD@9)!)]>!BS>^$+34;W4[F
MZO+N3^T=._LV=,H%\KY^1A<ALR,<YQSTH TM,-W_ &%;-+)%-=&!3OVE%)QQ
MGEC]>:XW3/&?B"^M/#%VUKIBQZ[OB" R9AD$;N&)[KA"-N,].>>.VL+!['2H
MK+[9/.T<>P7$H7>>, X "\?2L.R\#VEC::!;1:C?&/1)&DMMWEY<E67#_)R,
M.PXQ0!4L_%6JSZ;+YT5C'=6VK2:=<3\^6%4$ATC+;F8Y50@).3GG%5D\;:D?
M#5IK;P6J6T>IO9:BQC<>7&LQB\U03D#(!(.< GTYT#X#MEF^T1:MJ,5RNI/J
M22KY1*2.A1U *8*E3CD$CUJ"YT>/0-#NM#MK'4M8CU>6Y.UPC1PM+EB)&^4J
MA+'GD_H* .BTV]GOKK4&;R_LD,YA@95(+E0 Y)SSA]R]!]TUSMQXBNK/6/%@
MATJ&6;3K>UD1K>,M+,'W_>QRVT D*/< \UTVD:;%HVCVFG0%FCMHEC#-R7('
M+'U).2?<UFR>%HVU35-1BU.^AN-16 .8S'B+R3E"N5]SG.0<T 8[^.0OA\:Q
M%=6EYIYO1 ][:V\CK;1>7DO+$&W*0_RD9& P)]*MV7B:\N-8T2S$NGW,&IVM
MU.MQ;99?W3*%*G<<A@X)'4$$9JY%X52WN)[RWOYX;VXNENIY8T0+*1&8PK+C
M&W!R>^><U6C\"V5K_9C6%[=V4UA)<.LD(C^<3MND4J5*@$X(P!C'% %'3O&M
MYJ&FZ2HMXUU#4'NQE(FD1$@D*$[-P))^3C<.IYXP>C\/7NI7^D)-JUA]BO0[
MH\8.58 D!UY) 88.#R,XK#_X5Y9QZ386EMJFI6]QI]Q+<6E[&Z>;$9&+.O*X
M93N.0P/UKI=.L1I]FL!N)KE\EI)YR"\C'J3@ ?@  !@  4 <Q8>+;^7Q)IFF
MW4-KMO\ [4&6 ,WV=HCD RY*.2.H&"IK>UC2[&[@ENKFUAFFBMY$C:1 VP$9
M.,],[1^58VF^ ;73)](>+5M2D327E^RQNT>%1QRAPF2/<G/O73W=O]KLYK<2
MO%YJ%-Z8W+GTR"/TH \^\(MIF@_"71_$DEC$;BRTH/O10KOE>5+8Z$@=?8]J
MTK_Q)XCTVSUFYETN&2WL]->]AN6C:%/,3):)E+,3QR&&!U'%;%AX4L+/P>OA
M>5YKO3A;FV_?E=YC(QC*@?GC-4H?!(&AWFE7>O:M>Q7%LUFLD[QEX86&"%(3
M!)&/F8$\=J *7_"1>)X]1T*VFM])"ZP[^4R-(3$H@,@W>IW ].H].M5H_&>O
M1Z>+VYMM.,5KK(TJ[$>_,F9A%YD>3\N-RG!W9YY%=')X8BDN=#N&O[O?H^[R
M?]7B3*&,[_E_ND],52?P-:R:;<V)U._\NXU(:F[#RMPE$@DP/DQMW*..OO0!
MFZSXJO='D\:7%OIUAY^DVUO,DA!#3AE<_.1R<8X'N>:OKXBUFWUK4]-N;2RF
MEBTS^T;189#&#\S+Y;LW'4#YN!STJ74O!%IJ9U[SM1OE&M0QP7(3RQM5 0-F
M4XX)SG/6G:GX*L]7N;R:\OKUOM>FG3954HH\LDG<,+G=DD]<>U &+=>,-5?3
M_$L$,MI]IL-'74;>ZCMW"$D29 5F^89CX<'!ST..;=MJ]U:ZEX4M[^.SN/M6
MGSS->&,B6/8B$@9)QD,,G/..E7%\$6[SWDUWJNH7;WNG?V=<>88U#Q_/@_*@
MP1O;IQZ@GFI[?PC%#=Z-<R:G?3R:5#)#%YGEXD5P%.\!!V51QCIWR: ,N+QG
M>G3- UR2W@.E:Q<QVZQ*")8!*2(F+9PW.T,,#&[J<<UO^$SUQ8Y;R6TT\6EM
MKHTJ5%+F1E:58PZGH""P/(.?;OM6'@NRL(;.S6YN9=-L;C[3:6<FTK$V25&<
M;BJDDJ">..N!B)_ UJ]A<V9U._V7&IC4V8>5D2APX ^3[NY1QU]Z +?CB6Y@
M\":]-:3+#-'83N'*DD8C8\8(P?0]O0UD:5<O!J6F:3:1Z>NK3Z0MS->&U( @
M0JL:;0^6.7/\0 P>.:Z?6=*36]$O-*FGFBBNX6@D>+;OVL,'&01T)[5G2>%8
M3<:9>0WUS%?Z?";>.Y 0M)$<91QMP1E0> ,$?6@#GX?'&LW\^EV5G8V,=[<7
MEYI]SY[N4CF@1CE<<E3M!]><>]:'Q"U?5-"^&&IZA"R1ZE';HK209VQN[*C,
MN><#<2,^E78_!EE#>:7=0W=W')I]Q-<C&P^?+,&$C297DG<>F,=N@K;OK*VU
M*QGLKR%9K:=#'+&XX92,$4 9?_"*Z/+X8&AFUC:S,6S.T%B<?ZS/]_/.[KGF
MLF^\6W_]G^(=3TV"VDM="F>*6&4-ON/+17EVL#A,!B!D-DKVS6II_AN73[1+
M'^VK^>PC4(D,NPL$'1#(%#$8XZY]ZAG\&V<L^J^5=7,%IJW-]:Q[=DIV[6()
M&5+* &P>?8\T 9-YXOUF:[U5-*@T_P BTTJ'4X9+C>2ZN)#M(!&"=G7/&>]7
M8O%EQ_:VB&Z2W@TK5]/:YBE8'<DJHKF-CG&-A9@<?PGZU<G\(VLU]J=TMY=1
M?VA8K8/'&(PD<2[L; 5X/SMUSUIUQX0TZ\\/Z9HUT\TT&G-"T,C$!SY? !P
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ML6W#/M9/FRIXPS=,=:RW\"V+QW.;Z]\^74O[4BGR@:WGP!E,+C;@8(8'()H
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ML0P(8\8&..3UJ_8^(-7GT>Q\1R1V3:/<6+WL\2!A- NS>@4Y(<XR#P.>1Z4
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M_$?B#67TG4;32TDT:]9O-)**T,9SL<-YA+'( *[ >>.G,_AZ[>'QIXFT0?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVJ1Z_?PZSID)MUOPB,T\1_AD4C:3R><=R: ,W6_B%JUAH\-^NC_85;26O_\
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M:RMVB5F0$850$7+'H,G.!TP,T )I'Q#U.76?"MOJEA:);>)+(SV[6[L6AD5
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MW1!QOAB4.T?T8D ^HR.]7G\$VUQXFL=;O+N2XFL)IIK;=&H=?,S\A<<E%W'
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M(U]>7,M[=E#E?-D.2!Z@# SWQFKUMH?E6^I17-S]K-_(SN9HEXW*%VX'50H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFBW^A6MW'IT6DN^J+/OB@G?8#&%##E]VXEE!X[UTECXN&I'PRC:>%A\06;W
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M9ZS,A*RQ(C1NIPRGS%&0>U7K*WL!KD0M="GL9XH'E61E6-).B[#M)S][//3
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MEP%V*'V2$QA4)4\$%@2"/<@':45QVG^-;N?5-)MK_1&M8-8M6GL9H[D2EF5
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M>([OP]X9TT3:1NT:75+BT:\6X&^)GNI%0^7C[F2%SNS[8Z^HT %%<1I,,?\
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M SUZU/J?@<ZK=:Y-/J9C.II;>6T$.U[:2 EHW5BQS\QSC':MC3]<&KW<XT^
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MK0D\-7#:UH^J)JCF>QBFAF,L(8SK*R,V.0$.4&." #C%2^+?$T'A/P]<ZI+
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M+BVBF P)$#@?49K+UG7?[+NK>TBMOM%W<03S11&39YGE!247@Y<[A@>@8]J
M*EWX42]\"R^&IYXF,MJ8'N3!U8_\M-N[[V?FZ]>:IS>$=6^TZ7J5KXA6+6+.
MU-G-<O9[TNHB0?GCW\-D9R&ZD\8-=6DH:W69D= 4W%6'S+QG! [US5OXLO5\
M16.F:IH,UA%J0?[%.9UDW,BERLBC[C;03U(XQF@"R?#<XU_3-6CU-S+:VTEK
M/YL0<SJ[HY(.0$.Y!T!&#@ <5OLRHC.QPJC)/H*P[SQ/!:^+--T!('EEO!(7
ME!PL.U"X!]6('3L,$]1G.U3Q7K>G2R.OA262R%PEO'<->QH9"SA%(3!/+$8]
MN: *ZZ/K4<>MZQIL_P!CU35;V.6-9+<2?N8T5$1P2-NX*6)ZJ&QC(KI=>TQ]
M:T#4-+2=8/MEO);M*8]^U74J2!D<X/K57Q9KS>&O#5[JT=NER]M&9/):7R]P
M'7!P?Y5MT 4=(T]]-T2STZ699S;0)!YBILW!5"YQDXZ>M<OI/@6]TQ_#RMK:
M2P:$TBVT8M-I>-D*8<[SE@#]X8''2M^PUP:M?7$>GP"6TMI3#+=L^U3(/O+&
M,'=M/!/ SP"<'&J77<4#+O SMSS0!REGX+:"QATNXOUGTJ"^-\D(@VR,WFF5
M5=]Q!4.<\*,X ]<]%907D,EV;N\6Y62<O HB">3'@83@_-@@G/O4>FZI'J!N
M8BOE75I+Y-Q"3G8V P(/=2I!!]#V.0+] ',?\(UJ<'BW4->L]6M$:]@B@,,U
MBSA5C+%>1*N3\QS6A;Z?JT7V1I-821UG>6[Q:@+.I!"HH+'RPOR\Y).WGJ:U
M5='7<KJR^H.:575UW(P8>H.: ,_6-/GU*&WC@N8X/*N(YV+Q&3=L8,!]X8R1
MUYJEJ_A2QU;7=)UI\Q7^G2965!_K$.<QMZC/(]"/K6[N7U'YT9'J* .2E\$;
MH-9TZ+4 FD:Q.T]S;&'+JSX\T(^X8#8[J<9./;HK6VNH+ZZ>2[5[-UC%M;+"
M%\C (;YL_-DX/;&*H>)]?;P_X=EU:"W2[6-XU*>;LX9PF0<'."W2G6NN23^+
MM0T-[546UM8;E9A)G>)&=<%<#&-A[GK0 GB#0YM:ETIX[Q+?[!>I> -"7WE5
M8!?O# ^8TM_H;S:Y%K5C<I;7RVS6CM)%YB21E@PR PY5AD'/=AWXUV=$QN8+
MDX&3C)H9U4@,P!/0$]: ,.V\-MIWARWT/3;Y[6VCC*23!,S-DDLP;.%8DDYP
M<$\"K<7AW1HM.M-/_LRT>UM$\N".6(.(Q[;L]<<GO5G4=0M=*L);V]F6&WB&
M6=C^  ]23@ >IK/BUYF\77>AR6Z1QP64=VMQYN=X=V3!7 Q@H>YZT )J^@R:
MEJFBW<-U';II<[3K$8-V\F-H\9W# PY[>E0^)/!FC>)-/U"&?3[%;R\@:'[:
MUJCRQDKM# D9R.,<]JWV=4 +L%!.!DXYIU '/1>%TT^^M+O2I(+4P69LFA-O
MF)DW;LA5*[3NR??)]C45IHM]H7]A:?I%V%T^W:7[9"UN")0V6R&S\F&)PHSG
M/H#7344 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5Q7Q7D1?A]>1E@'>>UVKW
M;%Q&QP/8 GZ"NUI"0H))  ZDT <#X]EC\7Z/!X<T1Q>SWEU"TMQ!\\=K$CAV
M=G' .%P!G)SP*CAT73M?\1^/M'G6/RKQ;93@#AO)(+CW#<Y]:]!21)%#(ZLI
M&05.:=0!PGAY9-5\/3:AKMC'#<6=F^FL)$ &Y,K,Z_[+,H _W/>N43CP/X>E
MAN+"6>WT!8YM+U%?W=U&0-ZQMU24%<=#U&1Q7LU% 'E^KO>S>(]?DT:%K?5K
MCPK&8HAQ()MTAV_[X!7]*LV2Z;>Z]X8O-#6%+464Z:LB@ +#Y8VI,.S"3LW/
MW_>O1Z* /&_"MM86=I\.KN&.**\>>>&XE'$A0Q2X5SUQNV8!XSC%=?\ $"TN
M5NO#FNQ02W%OI&H":ZBB4LPB92I<*.3MR#@<XS7:T4 9EGX@TK4FC73KV&^+
MGD6SA]@]6P?E_'Z=:DT?6M/U_3Q?:9<BXMBS)O"LOS X((8 BK]542UTNU=W
MD6*/<7DEE?&6)Y+$_P">@'% 'F/B*+3XI=2\2>&-4?2/$T4TJ26"G*ZB\;E0
MK0G[Y?'#*._7N'ZR]C?>(=8TKQ9-?64UVMN^G"WA5RZB-<K"^QB'64.>"#R#
M7J:R(R*ZNI5AD,#P12[AZB@#S)Y]+EU[7=&\4P7+W\US#+IORMYLL*I&4$3K
MT(D5RV".6)/&:KZM:Z=#=?$V*:UA6YFM!+#F'E@;4#*G'>0?]]>]>JY&<9&:
M 0>A!H \WLY[,Z]9)KXMVT>?0($LGN<&'S 3YRY/&\@IQU(7V-9>EZ<&N_ =
MMK\:RR>1?JRW8RQAS^Y60'K\N.&[Y[YKUI)8Y!F.16&2/E.:<K*XRK!ATR#F
M@#D?AJ8U\)-;Q$>5!?W<<: \)&)WV >VTC'MBJEWXM\.ZKK]O;37NZ.QNAY,
M*PNQN+C[JD8&-JD\>K<\!03W5(&!Z$4 4;+6M.U'4+^PM;D275@ZI<Q[6!C+
M#(ZCG([C/2O,O&UY:M?:_LC,%]:7NGR%I(V>5U5XCYD9Z1Q@%@<=3NSC//JT
M5K%%<S7 !,TH4,Y.?E&< >@&3^9J:@#S:XF,7C9;BV:TU.WN=3B$MK-'LO+*
M38JB2,]6CVC)! P-W/6MWQK=VEM<:"EY&-DE\=L\P8P0L(GP9%'WLYPH)'S8
M.>.>J>6.,H'=5+G:H)QN/H/6G4 >-::MG/H?A*VN5!:W\274+K+&4*Q9N<*0
M0,+S&-O3E0:CU"PTJV\->+Y+>WMDFLM=C:P*  P#,#$Q?W03OSMQG!]*]IHH
M \JU%M,U'Q#K6E:_=ZA!?RWD<^F&UA4O-$%0QF"0H2"&# X( R2>I-9VOV6F
M_8/B!=+# ;N#48);1P!NC?RX<M'Z'<&R1UP<]*]C\V/SO)\Q?-V[MF><=,X]
M*?0!Y'XFO;*>'Q_::T(VO9;,OI7FKN\V 6X*>2>^)-Y..A.31>S:7=ZA/IOB
M6XO+:TOM-METV2.W#;QLPZQDQL5D#\X&"<KZ"O7*0D#J0* /)]7GM8YO%VG>
M(58S/I48TK[:H9Y8Q =P0]#()=Q;;SG!Z 8ZY%N+KX3>78A_M3Z(4A !#>9Y
M.!QZYKJL@=Q2T >;WM\EGX \$WQC>31(_LK:@L:%@L/D$*S =55RA/TIEP^E
M6U_H=YI\3#PK/J5Q->2.&\CSGB_=OAN!'OSSPH;GWKO[.RM]*@DCA;R[;<T@
MC)&V+)RV/09)..W;C %M65T5T8,K#((.010!Y+>&?3(KN:-6/A$^(H78(I:-
M;8Q R$ ?\L?/QG''#=C4&J?V5/IOQ.%@L#VT]K#) 8D_=R/Y'!0C@DMCIWKV
M*B@#S^5-+G^)/AN5X[21FTF<[RJG+[H/+Y]<!L=^#BN?%REAH]],GF#28?%<
M[WXMHQ)LMRK!7*X(*!]AZ'@>U>O)+'(SJCJQ0[6 .=IQG!]#@BG4 >43G2],
MMM,O;"XN[GPK<:R9]0DEC A&Z([2JA5 B$NPDXV[A]:W_ CV)\0>,!IXC%L^
MH1RQF)<(P-O'EE/0@G/2NX) ZG% (/0YH \B\27UH=:O)8XS;W-IXBL6FWQN
M\Q0-$ID#?P1%20 .#SSSBNF\'Q65MXQ\71+;)%=O?+*G[G:QB:"+G..A8-^(
M-=O38Y8YD#Q.KH<@,IR..#0!YK\2-/\ $;:#XCND339K.2V$463)YT<7RDJH
M QDMDGUX]!6YK_BJWTRV@TC5+^&SU&ZA)GE@5W2%3P2O&=Q_AS]3P,'JVNK=
M4=VGB"QMM=BXPIXX/H>1^=2T 9VA2:?)H5F=*3;IZQ".W&PKA%^48!YQ@<5R
M7A'4['P]+XBT[6+N&QN?[9NKF-+APAEBE;>CIG[P(..,\C%=\2!U- (/0YH
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M@K+@A@000[4 <-9ZO>>&)/%M]:65H]C#KZ"X4N5;$D=NIV #&06W<]:Z*_\
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M &;- $VJT9))8'.0V2?\\TW3_"U_9V#6TWB?4;MT18[::5(PT*A@><*-[':
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M\<HB\S:X( PP!Q@\8YJ5/#%SH7AN^@?6M2U2W@LY(;*VDC5FC!0@#Y%W2''
MSV[4SPWX::^\,>'VU::X+V>G"&*%H3"\+O$(W+9YW@;E!P.IX)YH DTOQA?W
M>K)ITUI:F>73'O@L<IVPR(RJT+.-RL07&67H0>*KZ9XUU2YT/2=4O;"TACU@
M0I9)"\DKAV1W?>H7H%0D8Y/0XZBWIO@9]-N-.G77+N62QL'T^,/%&%,1VX!
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M0L%\Y?/R"^,*PW+U(/(JO&NEZWHM_>QZ;JXU"'1I;.6&[M&C6'(XA"[ )&W
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MM9 6^7KQG/&1GZTV'4K"XAEF@O;:6*+/F.DJLJ8ZY(/%>9V^AM)X0\6R:9I
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M))B-BJ%AL<X7#(.@%8/AF$WUGI=K-:ZO%XHT>"6/]_"4BBE,95I#)M"NKG!
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MVVIQ:7#%>VLOV>T9WM9&F!C9HRA;:4!4$#C/H>0#UF2_LX8U>2[@1'0R*S2
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MG,^_>;:/=O!#9VC.0><YH OT444 %%%% !1110 4444 %%%% !1110 4444
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MS PR,J!R.G/ !VU%87A:_P!7U728-1U..RCCN[>&>!+8ON7<@+!MW'4\8_\
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M$53Z\XZUTU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 44WS$!P77."<9[#K3J "BBB@ HH) !). *0$, 000>010
MM%(K*ZAE8,IY!!R#2T %%%% !1110 4444 %%%% !1110 44BLKC*L&&2,@Y
MY'6EH **165EW*00>X-+0 44BLKC*L",D<'N*6@ HHHH **** "BBB@ HHI
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MI%.&6,AGDP>Q*H5SVW9[5TM8/BG1Y=3MK"YMEWW>FWL5["F<>9MR&3)Z$HS
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M$J36F^.43,69&7=R 6..?SYSJZ!HL'A[0K;2K9F:& $*3QU8L<#L,DX'88%
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M4WF0LC#^+_6M@\8P/Q5/ ;16<<*:S/YD.KOJL,K0H=KL7+*0, Y\QN>.W'J
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M#PQ/%=/JV@MJ6LZ5J<5Z]M/IYE  C#"1)  PYZ'Y1@T <5X8UFY\/VABCT^
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M&*YLIJ$OB#4KRVN+BWU-KMWBL[O0#-]WY$(G&U=I4##;OE#$9ZD@'J2Y*C<
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M1$7 PQQD)\T?7CE?:O4=*UJQUD7?V*1W-I<-;3!XV0JZ]1A@,CGJ.#0!;-S
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MTPX_T<H"DN].B,S#)4=,>]8WP]LK2?X?Z#%)X8$WF2%6OBD.$_>L0^=V_((
M''!QVH ]5WKNQN&?3-.KRW5--L[OXD>)XI-!&IO)H]OLC1(]V\M(,[F(VDX'
MS9XQ[5V_@^PU/3/"&EV6LW'VC48;=4GDW;LGTSWP,#/?% &UD9QGD]J6O+_%
MOB!;+Q-;>(H]046VBW:V<]J'_P!9#)\L\F.^UBGT\IJ[?4-8D36K'1K'RC=W
M<$MSYLH+)'&A4$X!!8DNH R.,G/&" ;-(S*OWF ^IKBI-8\2-XE\+V=S!;6!
MNXKJ2ZMMWF?-'M PP.""&R!Z]>E)\4[>"X\+V@FACD U2S WJ#P9T!'/J#B@
M#M@01D$$>U+7GGCJSM_"YT?7M$@CLKU=2@MI8[90BW44C;6C=1PWJ">1CBM1
M?%FH7=S%-INFO=V7]H/92JL4@=55S&TP?&S 93\O7'.<\4 =?3(Y8Y=WER*^
MQMK;3G!]#[USNGZ]JFKK::AIUC!-I<UY);N"^V5(T9T\[)."-R?< S@@YZBL
M+PY>2Z/IFMFR@MUC;Q)<1.\C!(X$+#+XR-W8!1R210!Z%17!KXYU&72[*:#3
MK9YYM:?2)-\CQKE68!P"N0#MR0>1[T_7?%^M>'=.N+C4+.P$MI;1SR1PRM)]
MI)8APG1D50!\S+@EL=LT =R2 ,DX%,BECGB26*19(W&Y70Y##U!KDXM4UB3Q
MMXBLB;66RL[&WDBMW#+DOYV<GGDE1DXZ <>L'A[Q.=0T_P /:=IEG:65Q>Z5
M_:!C"'R;:(;%"JHQG+. .1@ GT! .VHKA4\=7]Q%IB0:9;B[GU6;2;J.2=@L
M4T:NQ*D+RIV9SUP>E:6CZYK.K:?>K':6(U"QU,V4X,KB)D4J6=>"<[&X![]Z
M .HHHHH R?["C_X2HZ_]JG\XVGV3R<+Y>S=NSTSG/O6M110 4444 %%%% &%
M<^''DUB?4K/6]2L7N @GBA,3H^T8! D1MIQ_=Q^=:]K:Q6=LL$((1<G+')))
MR23W))))]34U% !1110 4444 %%%% !1110 4444 %%%% !1110 5DZIH4>J
MZGI5^]U/$^FS--$D87:S,C(=V03C:QZ8K6HH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *QO$GAV+Q%901&ZGL[FUG6XM;JW(WPR
M $9&00002"#P0:V:* .;G\*2W5MIZW6L7-Q<VEZE\UQ)&F99%&%7:  JX/0
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MOY-19RJDSSN'#%O;#MP,8X]*AF\,ZA8V.HC2-6N(KN^U#[<76./"L0 5.?\
MEG\JY_BZ^M=910 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>exhibit1027supplycontrac026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac026.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
M=S[5\P2VEQ+^SU8Z<D3&\;Q']G\G'S>9M8;<>N:^C+/7])_M=O#HU&%]6M;=
M9)K?)W!<#D]NX/KR* .'3XE^(=-\=:9HGB7PNNG6FK/Y=G+'<"5P20!NQD'D
M@$#&,YYJ?Q!XZ\9V6LZA%HO@LW^EVC;1>R3^4'*J-Y&>P.X9]JH/XG\)^(_B
M%::O>:S9O'I+-:Z59HX:2>X<A6DVCMD*JCOC=P,5U?Q&N91X5.E6KE;O69X]
M-A([>8<.?PC#G\* -#P=K5YXC\):?K%]:):37D?FB%&+!5).TY/JN#^-;M16
MMM%9VD-K @2&&-8XU'\*@8 _(5+0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 45QB:OJX\6>(="N+^*%H[)+W3)6B&-AR'+^NUP!VX/KS4/A_P 3WWB#P)HM
M]%="/5;VX6"7]T,*ZL?.&T],(CD=^!0!W-%<%?\ BW4$T;Q%KMM*GDZ%>O;M
M:,@_?)%M\PLW4,<L5Q@#Y<@YK9US6;VSU;PRMI)#]CU*\\B97C)<KY,D@(.<
M#[@[?C0!TE%<]XMU6_TB#2I;)X56?5+6UG$D98F.255.TY&#@]<&H]7UZY_X
M2NP\,::4CNKBW>\N+AUW>3 I"_*O0LS' SP,$X/2@#I:*Y276;W1?%NG:%?W
M/VFWU:.7['=;%62.6,;F1P!M(*G(( Y!!!ZU3TGQ/?6.HZ[I'B6X!O[3$]F8
M(@OVFV;Y49%YR^\[2/4@=Z .WHKG1:>*)='M8#JMK!?NI>YNOLP<1GC"(F0#
MU^\2>AXY&,.T\7ZN^C:;:W20#5[S5Y=*%Q$A\MEB9]\RJ3_=C.!G&[VXH [U
MU#HR-G##!P<5@1>!_#$$\L\6AV<<LN3)(D>&?)R<GOS6)?\ CJ70H=>M+F,7
M>H:=<V]O:CA/M)N #%NQP"#N!P.BY YQ6]+:>(8+6*:+4XKBZ\R,SPO;JL13
M<-XCQ\RG;G&YFH <O@[PXNEOI:Z-9K822><]N(P$=^/F(Z$\#KZ59OM TK5-
M.33[^QBNK-""(9AN7CIP>N*Y2X\9WB:+J?B9&3^S-/U$VOV;8/WD*2"*23=U
MW9+,.V% (R<UN:OJM_9>,/#MA"\/V*_:X693&2^4B+##9QC/M^- $K>#?#CZ
M6FEMHUHVGHV];4I^Z#>H7IFI)_"FA7.EQ:7/I=O+818\NV<9C7'3"GCCMZ5F
M7>MZC?:_K>FZ7*D!T>TCE8N@;SIY S*A]$"J,XP3NZC'-32O%T_BV]LK;2I!
M9I)I,>I32%!(5>0E4CYXP"KENYP,$4 ;LWA/0+G2XM,GTJWEL(CF.V=<QKZ8
M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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MNQT# E<E2V#G&<9Q6AI>GR6WB+7O$^H+]EBN(88HTE892&)6)=L$@99FXST
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M(HS<ZM&8Y#MSL4@*TK?[J@8]2%'N+NA^'-*\.0/#I=NT2O@$O,\K8'0;G)(
MR<#.!DU4U'P5H.JZA+?WEM</<R@!W6]F3('085P .O&.YH YZ[M;Z^^),5A:
M7<4$6E:,LUEY\1E4RR.R&3&X9(5 N?1CTS71>%]?N-:\&VNLW=J(KAHW,L,6
M2"R,RG;GL2N1[$5=ET#39?LI^SM&UK$8(7AE>-DC( V;E()7@<'N >HJ[;6T
M%G:Q6UM$D4$2A(XT& JC@ "@#@;7Q-J[:%X4\1"[\^/6+N&"YLO+39&LV0-A
M W90XZDY ;/M?\"V\R:IXL>2]N)@-9D0K($P3Y,/S'"@YQQUQCMWK=L_#&D6
M$R26UH4$<K311>:YBB=L[F2,G:I.YN@'4^IJ?3M%L-)FNY;**2-[N4S3EIG?
M>Y !;#$@'  X]!0!D^.[.^N_!^IPZ?!:2M)"WGQW!*^;$!\RAAT8KD ]LUF^
M,;M+_P"&]C>1PF%+BXTV58FZH&N(2%/TSBNDNO#VG7M])=W"7#O+&(Y$^U2B
M*11V:,-L;J>HYS4VJ:/8ZU9K:7\+20*ZR!%E9/F4AE/RD=" ?PH O44BJ%4*
M,X QR<G\Z6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4ENET>99I$&%9Q"=Q [ G-8]WX8N_%UGIS7$1L(X-'N+57+J[/)/$J9&T_<
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MRLIDB620R%60J274E@"#CIZ4 ;(\=:&TWEB2ZVB]^P/*;20)'-D*%9BN%R2
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M%7;K2=8N==UR^;3PJ7VBQV48693^]!E)!R1Q^\'/L?;(!KRZS82:]I*1ZC=
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M:$JT<NU/W,:[02.01G/4G.*YW1_#.MZ;8>",VD+3Z-'+!=1F<  /'M#*0#D
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M:DQ@;RVFED."V1V7'3IE^0<"@#I=/\1V6JV>F7=G'=2V^HEA#((&PNT$Y?\
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MU_:R6MY;Q7%O(,/%,@=6'N#P:X0ZOJOB'4)-*@O%L[G^Q[:\@83F(^9)OW2
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M4%SX-\.7>F6^FW&CVLEG;-N@B9.(CWV^GX5N44 1P00VMO';V\210QJ$2-%
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M=$&>0$YD(&!GUP.!Z"H+KP_I5Y=2W4MHOVB4!998V9'D4# 5BI!9?8\5IT4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXBWLOFH&!QG'')&0:Z+PYKFH7_BC7M&DN5O;*Q6(PZA&B@AW!W1MCY69< \
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 53M]*L
MK74;G4(8 EW<@":7<<R ?=SSVYQZ9XJY10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBB@ HHHH **** "N3^)%C>ZGX*N;#3[26ZNI9K=ECCQT29'8Y) '"FNLHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)FQA "V['#,6.#V.AIPN8?&MC?3:=?"VGT".#>;=CL=9"S*_]TX.<'D].O%
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M.^_.CZWH.KSWUKJ\E[;W8>46K@S-(DV\-L!"M@J>21C'- %ZZ\8:O;^&]>U
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M.3],G&,T^P\(Z;IPMHX#.;6TE::TM7<-';N<\J,9XW-@$D#/ %8-IXA\4/X
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M6[02NN!($B"-CZ$=ZZ>BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC.[YL=,\XSS0!S'B#5+Z[TGXDZ?<RQO;V.FM]G"Q[2H>V=CD]SFK]GJ.H?\
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M(8(W;[SK$3M5CD\@=SBKVJ:'8ZQ+9RW:2&6SE,L#QRM&RL5*GE2"002".AH
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ME+K$&K/ IOH(7@CE[A&()'YJ/U]35.?PMI5S+J\D\,DG]KPB"\5I6VR( 5
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MJZ".] G<"10NT <_+\O'&*)_">EW,_GRBY:3["VG[OM#C]PW5>#UX!SUXZT
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MVX 8.2023P*?XCUC5[GP[XMB;4#$UAJ]O:Q-!&JYA?R,J<Y_YZMS_3BNGC\
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M7:O7. ,# H UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ'@,IMF4#?$2V%?('4@@$XP>E6/P_KL=@T']B7!V^*4U( W,3DP;PQ;+/DD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'>KJ]F;62;R$E\X;6DSC9G^][=:OK>6SWKV:SQFY1!(T0;Y@I) 8CT)!_(T
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MXN8[:,>K.P7/L!G)/M6+;>,K>V\1ZW::QJ-A;V5LUL+.1CY>\2H6Y)8Y[<C
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M>'V$L4$^%:49*R19R>'5B![[3Z5Z//J5E;7]K8S7427=UN\B%F&^3:"QP/8
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MO&0RF_9O.F95VY92S8 & .A..F,$\GX@TW4VM/B)9QZ7>2OJ:(]H\<>Y9?\
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MN9(FF2)FP2BD!F^@W#\ZKQZ_I,MG:WD>H6[VUW/]GMY5?*RR9*[5/<Y4C\*
M.#31+^S?Q#;SVMQ=2-X:MK!+@0,PN)D257 ..<ED_/V-7](MKZQ\1>';V;3K
MPP#P_P#8Y66(DQ2AHV(<=1PK?7'&:[ZB@#S/3+*_T[X8Z/ NA2O=P7B?:(VM
M@TL"^>7,J(?O,,@CKR<X."*IKI^NV8O+V+1]1F6U\2KJ302;?,N8&@"$KSAF
M!.[''*XZ\5ZQ10!P6M6\U]IECJ5AX?N;95UNVOIH1"JSRJI :1D!Z].#SA<U
MU.G:TNH:G?V!L;RUELQ&2;A %E5P<%""<@%6!]Q6I3$ABC>1T15>0Y=@.6/N
M: .!\06NH0:_XJ\K2[RZ35=$C@MI((]R^8@F#*QS\I^=2,]>V3Q2Z/9W4'B?
M1+JZTVZCCM_#?V:1F@+;)=T9V9&><*W3Z=3BNVOM2LM-6%KVZBMQ-*L,7F,!
MO=CA5'J235J@#S#P[INHVMM\.XY]/NXVT];A+L-"W[G=$R+NX[D@5/X4TZ9?
M[.TK6/#VI-J6DSLRWTLS&U.-P\U#OP2RG[NW.6.>.:](HH \OT_2;Z&PGT_[
M+JEWX?ETQT^Q7,12ZL6+(/)BEP"XQNQUQY:\\BNG\'PZM;3:E#?W,U[:(T8L
M[VZM_)N)%VG*R# W;> &P,Y/I74T4 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %87BK5;S1]
M/M[JVMKF:#SPMVUK$)98HMK9=4_BPP7/!X)..*W:IW^G)?\ V=C<3P26\OFQ
MO"P!!VE>0001ACP0?TH Y?3_ !-<WNK>'(K;4;:]L=4M[R1IXHMN3$5V$9^Z
M<-AE/<57T7Q9J.JIHMA++%%=W\VH![A(^B6TI0!5.1N.5/.1PW'IN/X-TIDL
M/*-S;R64LLL<T$Q1V,I)EW$=0Q.3^F,56;X?Z&=-MK.(WL!M;F2ZMKB*Z=9H
M7<DOM;/ .3D=#0!CZJFM-XA\%Q7MQ9#5!<7J--"C-'CR7VMM.#G;@D9QGVKH
M?!VJWFK:/.VH-&]U:WMS9O)&FQ9/*E9 VW)QD <9J;_A%[ 7.ESK)<B332[0
M,92Q+."'9RV2Q()R3ZU9T?1;;1(+B&U:5EGN)+E_,;<?,=MS'IW))Q0!R-QX
MKU>#0=7O!+"TUAKR:>F8N'B:6).1G[V)#R/0<5=F\3W-OXQ_LF^E:P$ERJ6?
MFP9@O(M@)"RCI+NW?*<<   YS5R\\"Z/?27QE>]6*]N$NI8([EEC\Y2IW@#H
M3L7/]#5UO#5G)="666YEB6Y6[6WDDW(LR]&&1D8(SC.,\XS0!B:%KVOZV-&U
M>WME.E7P+7"2>6HB0@["A#%BP. P(YR<8Z5JZSK,T'B+1M"MG$,FHB>1IRH8
MHD2@D*#QN)9>N> >*;I7@O2M&U![JR:\2,R-*EF;ES;Q.V=S)'G )R?IDXQ5
M_5=#M-7DM)IC)%=6<AEMKB%MLD3$8.#R""#@@@@^E '*VOC'4'OAH5QY*:A_
M;#Z:;L)A"@A,X<+G[Y7"XSC<<].*T)=5UBPO]-T6]N;0W6H7L\<-U$O*VZ1F
M0%E/'FD8']WO[5=O?!ND:AI36$Z39-S]L^TI*4F%Q_SU#CD-VXX XQCBF7?@
MO2K[28;&=[QGAG%S'>?:6^TK*!C>),YSCCTQQC % %*35->TW6/#]A?W%E+]
MMO[BWE,*'YHEBDDC8]-KX5=P&1Z5ER>*M>^R@0S6?F#Q*=)+20$YBS@'AA\W
MKZ^U=+<>$=.N;&SMVEO%DM)_M,5TMPWG^9@J6+G).58@YXQQQ@8@7P-I$<7E
MQO>(/[0_M+_CX9CY_9OFS^7?OF@#)U'Q%JN@ZA;V.LWRPHZ1+%J8L\6LTI<[
MDD.3Y1V[0O(&23D]*VO'&J7NB>#-3U.P,(N+:+>OG1EU/(!XR/7_ .M5G4/#
MEGJ<EQ]IEN&@N@@N+;>/+E"GC(QD>^",]ZL:UH]KK^D7&EWID^RW"[9!&VTL
M,YQGM0!R^M:UX@37]=L+&\LX(;'2H[^%GM2[;B905/S8.?+'/H>G>NDT^^GU
M;PK::@K"WGN[))P5&X1LR!N >N,]Z@F\,6<][>WDD]T9[VT6SG;>/FB&[ QC
M@_,W(]:T=.T^'3-+MM.@+M;V\2PQ[SD[%& ">_'% 'F&DR:E>V'PTN9+Y9+V
MY\^3SY8]VTM:N3D C<>IZBMO3_%VJ3Q6FF3 2ZC+J=Y8M/!&J[EMRWS*KMM#
M$!>"2.IQ6W8^"=+TX:4+:2\5=*=VM%:<N(]RE".<\;20!_7FH[CP'H]S826L
MC78+7K:@DZ3E)89V)+.CC!7.3QTYZ4 :/AV;6)=/D77(8H[J.=T5HR/WD>?D
M9@"0K$$9&3S[5A> L#4_&8Z'^WY3CZQ15U&FZ=#I=FMM"\TG.YI9Y#))(QZL
MS'DG^@ ' JA+X:MCJESJ-I=7EA<787[2;9P%F*C )5@0&QQN&#@#F@#GK_5=
M0TC2UFTUK=6N/$0M7\Z,L"LDX0XP1@\^]5=5\4:]I>A^,U:XLY[S1#&\,S6Q
M"NCQJ^TINZC)&<^F1767?AC3[O3K2P/G1P6MPEU'LD.XRJV\,S')8[OF.>IZ
MYJO>^#=,OTUE+B2Z9=8""\ DQO"@* ,#Y> !Q0!B:GK%[I/C;Q!>2W3RV.FZ
M$EZMH$ !YFR >Q/ECFGW7B77M$L;K6KZV6XTB/37N23Y:,)@,JJ;6;*,,]>1
MC.370S>&M/N-6_M*<327#6GV.4-(=DT>6(#J.&^\W;O]*IZ9X&T;2[.>R7[9
M=6<L+6ZV]W=/-'%$W!1 Q^48X]>.M &.R7X^(_A:6]NX[AI=,O&PD04(W[G=
MM]5Z8SD\'DYXO^+=,UF35=-UGP[/:OJ=A'*OV&[.$N8G*;@&_A8%5P>G//%6
MM.\%Z;IUYI]TESJ$TFG1O#:^?=,PCC;;E<=Q\HZY]\X&-&_T:&^OK>^%Q=6]
MW;QO''+!)C"L5+ J05;[HZ@]* //[KQ ^I:!%+IT-QH=^?$=I!J=G(BEDE:2
M/<,]"I&ULC[W/J:U]=\3:KI-Y,T5Q;SQV]_9VS111;ALE,:N96XVOER552<#
M:2,&MR7P?I<^F364GVAC-=)>R7/FD3-.I4J^X="-J@ <   #%5[KP%HUVUX7
M>^5+N:*XEC2[<+YL>W;)C/WOD7)[X]>: ,*77M0T;6/&M]-=FYBLI[2"WA=
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MIN-0"BXO%G*3L%^Z RXV@<\* .3ZFM.]LX[_ $^>RE9Q%/&T3E3AMI&#S]*
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M9WC&PUG4-0O+:UTR2>SN-(E@CGMY(XV\\EOED8L&V8VD 9!).0>, ':K-$\
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M^T\AYS)$XE(4#$)#9"M@$[MN, <]0 +X;\70R>#-%U#6;K-[>6/VJ010LS$
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M=;3)]*N+9?LHN$G>1&5N0&0A2<$;A['G!.*RY;34=,\>W>KI9S7UA?6$5O\
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ML6G@/5KAK:WM=(TY'B$3L\LS/ JX.5 5<<D#.:[#Q%?3V.CR?8U9[V<B"V5
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M7<ZG;_VM;:5/<3QZ;&CYE1B!(QD7:$^7!48);<!G'#5U2]F\6Z9JDMW<;/\
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M&5^8LIX!/53ZC$'A[6[_ %_1HC/<N+BSLI8]4B*)S<@E-O"\8*2' QP4ZYH
M["PO[;5-.MK^SE\VUN8UEBDP1N5AD'!YZ59KRWPIJFI:+I7@E6O6N+&^T5V:
MT\I (S%"CJ48#=DC(.20<\ 5MZ%?>)=6CT;51?VHT[4+0O.C,A*.R;D,(" \
M'((9CP/44 =O17F>D^(?$'_")^']6O-6$\VN206P0PQQ+ S!V+!MIY8*%Y!
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M:O*C:3_7Y'!79Z?P]/0\U'I7BG6/$-IH-I#,MO>7NBKJ$LL9169R57Y0Z,,
MDDC'<<^H!W[".'S)MF&(RY5,LV/IR:R;'Q=H&HR01VNJV[M<,R0Y)7S6'55)
MQN(P>!SQ5G06U)M#M?[8>U?4579<-:L3&7!()&0/3D=CD5YKX6\.WWB?P!H5
MINMK>QM=7FO'G#LTQ\NZE(55V@*2>-VX\=N: ._D\8>'X9;B*;4XHFMG"7!E
M5D$+'H')&%SD=:N:CKFFZ2EN]]<B);EQ'"VUF$CGHH(!R3V'>O+-;O+VUNOB
M''%;Q'3[F\@MKZZ.7:TA>V16E$8'SA0<GYACK@XK?\762:;X;\$6.GS+-';:
MQ8102R'<'"J0K$CKD 'B@#LH]?TV7SPL[[H(_-D5H75@G3=@C)'TJ'3_ !3H
M>JRP166IP2R7"%X%SM,JCJ4SC<![9I@&H WYU,V?,!%L8!@XP=^<\YSM]NGO
M7#>#_#M]X@\(^ KB5K:VLM*"7@9'9II6"D!<;0%7GGDYQB@#U2H+6\MKU9&M
MITE$4K0N4.=KJ<,I]P:JZ[J$FF://<6\?FW1 CMXO[\K':@^FXC/MDUQ/A)6
M\+>.+G0GM[J"QU> 7EJ;DKE[F-0L_P!UCDL-KGWW4 >CT9!S[5Q^EZEJNO))
MJ5KJL=I';:M+:S6DD:E##'(8RI.-PD; 8'.!D#![KX"%RR:_)<W]Q=$:Q=1#
MSMG 5MH/"CL ,=.. * .FCO[:74)[!'8W,"))(I1@ K9V_-C!^Z>AX[U9KB[
MK5]=&O\ BJPL94GDM;&UEL8'")B20R@C<>I.T8W<9Q6AX1UP:S'?AKB],]O,
M%EM;^!8I[8E!\K!0 P/)##((/7B@#;AO[:XOKFRC=C/:A#*I1@!N!*X)&#T/
M0G'>K->=>(_$>MV$7CLVU^$.E6UO-9GR4/EEE8L.1ST'7-;>F7VJ0>.[O1[R
M_-Y;/IT=['NB1/)<R,C*NT9*\ _,21ZT =51110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M56O]/M-4L9K&_MX[BUF7;)%(N5859JM>W]MIT FNI-BE@B@*69V/ 55&22?0
M4 5;'0;+3VC,37<GE_ZL7-W+,$[<!V.#CC/6FR^'--DN;BX5)X)+DYG^S7$D
M(E.,98(P!.,#/7 '-5V\8Z(EO=S2W,T2V<R07(DMI08G?&T,-N1G<O/3D<\U
M;;7M,2[O[5[G9-81I+<JZ,NQ&SM.2,-G:W3/2@"Y:6EM86D5I:01P6\2[8XX
MUPJCT J.STVST^6[DM+=(GNYC/.5_CD("EC^"BJ">*=(=KN,W$D<UH8Q+#+
MZ2#S#B/"D MN/ P#D\=:J:GXSL=/6SQ!=R-<WZV)46L@,;D;CD;<_=Y&!SVX
MR0 7XO#FF0:G?:C%'.EW?*JW$@N9<N%!"\;L# )QC&,U3M_ _A^VTZ'3DLY7
ML(3E+26ZEDA'.>49BI&><$4^VURP2^UR675I&BLC'YT$T'EK:93. 2H+;NO?
MJ *F/BC256]\V>6)[&$3W$<MO(KI$<_/M*Y*\'D ]#0!K@!0   !P *H7&BV
M-SJ]KJLL<AO+562%Q,X"JV-PV@[3G SD=A5;3/%6CZO?)9V=Q(TTEN+J,/!(
MBR1<?,C,H# %@#@G&:M76M6-GJEKIL\KK=W:N\""%V#A!EL,!C(';.: 'R:7
M:37T=[-&99HCF+S'++&<8RJDX!QD9QGD\\U8N($N;>2"3=LD4JVQRIQ]001^
M%9MGXFTJ_LK>[MIY9(;BX:VB/V:0$R*2&&"N1@JV21@8/-<WJVOSQ^&I+_2M
M:FG9-;BMG:2V5"BM<)&\.&4'"AB,]>.M '6:1H]CH6F1:;IT30VD(Q'&9&?:
M/0%B3BJUIX8TBRAU&&&U8Q:D[R7<<LSR+,S##$AB1R !QZ52TK4;V7QYX@TZ
M:Y:2TMK:TE@C**/++^;NY R<[1US5#4O%7]A>/+JVU"[G.F#2H[E8(K8RLCF
M5E9@$4MC"C.>!0!IGP7H;6^GP&&Z\O3FW6@^W3YA.,?*=^>G'TJRWAG3'BNX
MY$NI1=P^1,9;R9V,?/R@EB5')SC&>]*WB32OL-O>0W#7,-S"9X?LT3S,\8QE
M@J@G R.W4@=:NV-_::GI\%_93I/:SH)(Y4/#*>] ":=IUMI.GP6%FC);0((X
MD:1GVJ!@#+$G %-NM+M;R^M+R=93-:,6A*S.JJ2""2H(!X)'(/4US%[XI^T>
M+O"UMIEY,;*_EN!*/LY$<Z+"[!E<KR-P!^4\C'45I:9K]B;:>3^TY[[?J$UO
M&IMBKHZY)A50H)V!6Y([')H O7_A_3=2U6QU.ZAD:\L=WV:19Y$\O=PW"L <
M@8.1S5:S\(:'I^L3:I:V9BN99&E8"9_+\P\%Q'G8&/\ > SR?6IW\1Z8EM#-
MYDS><KND:6\C2%4.')0#< #@'(ZD#J13;/Q/H^H36\5I=^<]S:&]AV1.1)""
M 6!Q@X+*,=>>E $^F:+I^CFY-A"8A<RM-(OF,R[V))(!)"Y))P,#)-53X4TD
MZE>:BJ7<=W>!1<217TZ>8%&%!"N!P"<?6EB\5:1<65M>6]Q)/#<Q/-%Y5O(S
M%$(#-M"[@ 2!R.]2/XBTU'1?-D?<(B3' [!?-.$W$#Y<Y[].IQ0 DGAG1)-!
MET-M-M_[,E!#VX7 8DYSQSNSSNZYYSFJH\%:!_8<NCR6336<S!G\Z>220D?=
M/F,Q8$=L'CM5J?Q+I5M>Q6LUPRM+<?94D\I_*,W_ #S\S&W=VQGKQUXK"\7>
M*?LEO:KI=Y*DPU:VM)72W+QMNE59(RY4J#M)Z'((QUXH V#X1T9M'&EO;S/:
MB59SNN92[R*059GW;F(*KU)Z#T%0W'@CP_=3W$TUE(6N)TN9 +F55\Y,;9
MV%?Y1EA@GO6GJVL6.AV)O=1E:*V#JA=8G?!8X&0H)') STYJ ^(]+%UJ5L9Y
M!-IL0FNU,$@\M""0<[<-D*>F>AH 2/PSI$8U-1:EEU0$7B/*[+*"NSH20/E
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M2[/1=,@TZPC:*T@79%&9&?:OH"Q)Q574?$VDZ27-Y<-&D;(LTHB=DA+8V[V
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MM&"SPRQM&\9897*L <$<@]#6)XV\2II/AO6S97<L>HV=FTRO#;F41-M)3?\
M*5&2._;G@<T =)#9P6UDEG!'Y4")L54)7:/8CG\:JZ-H>G^'[ 6.F0O#;!F<
M1M*\@!8DG&XG&22?QK-M]:MUU6VCNM6>.5=*-U-:M#B,J"F9B^WMG& <<].*
MGN/%VC6=G<7=U//!!;I&\CRVLJX60D(>5Y!*D>W?% $]GX<TNQNM0N8+=_-U
M YN_,F>02\;>58D=..G3BJ?_  A&@?V?9V'V:X%K93+/;1B]G A=?NE?GXQD
MX'04L7C;0)EU$K>2*=.B\ZY5[:566+G]X%*Y9.#\R@BK4OB72XYA#YTKS-9M
M?)&D#DO",99>,$_,O'7GI0 J^'=/6260_:WDEA,!>2]F<A"02%+,=N2!G&,X
M%3Z1I%EH6F0Z=IT316D(VQQF1GVCT!8DX]JS=)\6V6I^']/U0QW$9O81+';B
MW=I#\H8X4#+  CYAQSUK4T[5;+5M+CU*PG$]I(I9'13DX)!&,9R"",8SD8H
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M3H&HV.J7&G7GAK3[VV.HR7EOJTK1MM1Y3+AD/S^8I8@$<=.15 Z#XDMO#?\
MPCPTEKG[+K*7L5ZMQ&$GA^U"<Y!;<' )!&,<=37I],FFCMX))IG5(HU+.['
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MS;7L=Y%I:B>.43*[2R-\^=V[!;!.>?K5J[\*:)?0W<-Q8AX[NX%U.OF.!)*
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M/0"J^G:C::M817UA.L]K,"8Y5Z,,XX_*N6T[6=:U+68-!O)X;&_@TQ;N\DM
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MM'AFALDNDAD1HTC>[D=8$;[RQ L0@/\ LXJ2#PCI-L-+$*7"?V5"T-GBX?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>exhibit1027supplycontrac027.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac027.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M@CADE1$$IX=R0% '<Y(XH Q_AWI]QIG@;3X;J-HII#+<-&PP4$LC2!2.Q 8
MCUKJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !39(TFB
M>*5%>-P596&0P/4$=Q3J* ,ZUT'2K)XGM[&&,P_ZK R(N,?(#PO''&.*T:**
M "BBB@ HHHH **** "BBB@ HHHH *SY-"TR76H]8>SC.I1IY:7/.]4_N@^G)
MX]ZT** ,_4M"TS6)+:34+..X>U?S(&?.8W_O+Z'CK6A110!232-.CU:354LH
M%U"5!&]R$&]E'0$U=HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:%%2-C(9%SN3R\;MPP<C&1@YH U:*RHO$FDSV-M>078FAN6981%&SNY7.X!
M-V1@Y&.,<TZ/Q#I,MC;WD5XDD-S(8H=BEF=QG*A0-VX;6R,9&TYQ@T :=%87
M_"9^'OLRW)U2)8FN!:[F5AB4G&P@C@YX.>G?%07WBG2KGPWJE[:ZT+%;3,4M
MT]NQ:V? .3&P!/!!Z<@T =)16%_PE%FOB9]"9+CSHK1;J28P/LVDD#G&,?*W
M/3/'7(":5KEF- T^ZEU;^T?M.X17$=N0UP023MC49X /0=!F@#>HK%?Q;H,=
MI:W3ZE$L-U,8(6(/,@SE",9##!R#@C%7-*UFPUNVDN-/G\V..5H9 49&1UZJ
MRL 0>1P1WH O45EWGB+2=/F>.ZNQ'Y3JDK[&*1,V-H=P-J$Y'WB.H]16-K.N
M74WBR/PU8W5Q8RO8R7'VI+0RXDWHJ#E2I3YB6/T&X4 =;16%JGB*+0)-'M+Y
M9I[F_E\C?;V[E=P0LS8 ./NG"\GGT!-9&C>,8H;_ %JTUS4$#PZR;.V(A("H
M8XB@8J"%RSD L1D\4 =I167?^(=*TR4QWEUY6UT1W\MBD;-C:'<#:F<C[Q'4
M>M0^*_$,?ACP_/J30F>4,L4$ .#+*[!47/;)/)[#- &U17/7$'B"VTWSQJ]L
M^H8!:%X%6 GNJ<[@?0EC[BKM]XCTG36D%U=A!$JM*X1F2)6^Z78 A ?5B* -
M2BJ":S8/J[Z4LY-ZD(G,7EM_JR<!@<8(SQP>M0R>(]+BLH[MIY##)&TJ;+>1
MF*+U?:%+;1D<XQR/6@#5HK N?&WART,7FZK%^]MUN8_+5GW1$@!AM!R.1_/H
M#2P>,_#US<P6\.I([SSM;(1&^WS02"A;& V0< D9QQF@#>HK G\:^';9YEEU
M)%\BX%M,WEN5BD.,!V PH^8<G YZU9M?$VCWCWJ0WR9LD$EQYBLFQ#G#_,!E
M3@X89!QUH UJ*PYO%^A6UO?3W%]Y"V*J]RLT+QO&K?=.UE#$'!P0,'!H?Q?H
MHAU*2.Y>4Z=#Y\\<<+EMG.&48^=3@_,N1QUH W**YI=4U/6=/T'4]'(AAN)(
MWNK>>V8EHF + ,<;< D@X(8@#O6J-:L&OTLEF8S/*T*XB<H752Q7?C;D 'C/
M8T :%%5;S4;6P:-9W??+G8D<;2.V.20J@G XY]QZUG1ZQ:7>NZ=';:NNVXLG
MN$LQ#S,AV8DW$97 /3ON]J -NBL9/%>B27%M M^N^ZW?9R48+-@X)1L88#U!
M/45';>,_#]W<6T$&I([W,S01$1OM,BD@INQ@-\IP"03CC- &[17+WGB:'3=/
M\3:BE^=0_LT,WV5+<C[.RQ!O+) R03\VX]-WH*J:5J=Y+JFCR77B5O+U&/?'
MITNGA'D<1L7"O@$(.&&1GY<;CF@#LZ*RT\1:3)J$-BMV//F9TARC!)63[ZJ^
M-K$8.0#G@^AIEIXGT>^G6&WO0[/$\\9,;!9(U.&9&(PX!(Y4GJ/6@#7HK"L?
M&7A_4[BU@L]169[I&>#;&^) O+!6Q@L ,[<YQSBI/#GB.V\2V,MW:Q3QI'/)
M#B:%DSL=DS\P']T\=1T.#0!LT5Q.J^([JY\1ZII%E?3Z=_9]I%<>?]@:979F
MDW!P5^X%CX((SDX)Q71Q>(=*F:Q5+M6-_;FYM3L8"6, ,6!QCH0<=>10!IT5
MA6/C+P_J5S:6]IJ*2O=EQ 1&X5V7.Y0Q&-PVDXSG'.,5E^)?%7V:[T:#2[SF
M?5XK.<_9RR.I8AT$A&W<,$'!R,'T- '8T5SO_"2Z98/K-U>ZY&]K:W"1.AAV
MBU8JOR9 RV2=V?\ :Q5VS\2:/?-?""^3_05#W.]2@C4@D/E@,J0"0PX.#S0!
MJT5E6OB/2;S4$L(;H_:Y(A,D+Q.C-&<X8!@,KP>>G%9WB;Q ^GZQHVD1-<0M
MJ,L@DGAMVD:-%C=OE^5E+%@O8X&3CO0!TU%8-KKMMIMO#9ZMJT=Q>1R"WFNE
MMVCB,I^ZK$91&(*\$]2..0*E?Q7H::N=*-^IOA*L+0A&)5V!*@D# R!UZ4 ;
M-%8NK>)+;2=8TO2Y(KAY]19PC1PNZH%0L2< YY &/?/05B^%O&,-Q$;/6-05
MM0?4[JSA(A*JVR5U120-H8JO )R?>@#M**RY?$.E07\5G+=;)99O(1C&WEM+
MC/E[\;=W^SG-7+V^MM/@$UU*(T+!%X+%F)P%4#DD^@YH L45R/AWQ,UY>>)7
MO;O=:6-^D$!: QLH:.,[-N-Q;>Q &,DXK3;Q=H:6\D[WK(D=PMK(&@D#1RMC
M:K*5W*3D8R!G(Q0!MT52FU:RMYIXIIBCP1K+)N1L!6)"\XP22" !R2*YSQ5X
MK$?@_6KW0[T1W^G;1(DL!#QDD<,C@$9!R"1@^] '845FZAK^F:6TBW=P4,48
MEEVQL_E(<X9]H.Q>#R<#@^AJMJ'B_0-+F\J[U*-9#!]I"(K2%H\CY@%!R.>W
M;)Z"@#;HK#/C#0-MHRZE')]L@-Q;")6D,J#&2H4$D\CCK[4EKXR\/WTME';:
MDDAOCMMV$;[6;!.PMC"OP?E)!XZ4 ;M%9<WB+2K>^BLYKO9++-]G1C&WEF7&
M=F_&W=_LYS56+QIX>GN8K>+4D:26Y-HN(WV^<#C86Q@'(( )&>V: -ZBL;1O
M$EKK=_JEI;Q7"-I]R;=VDA=0Q"(Q() '\>,=3C/0BI+[Q)I.FW$D%W>"-XO+
M,I",RQ;SA-[ $)D]-Q% &K16%?>,O#^FSW<%WJ*I+9[3<*(W8Q!LX+8!P..3
MT'?&:3Q'X@M],TF^,-WLO([-KA"D+3!!@[78*" I(/)P.#Z&@#>HK(T#47NO
M"&EZG?2@R2V$,\\F, L8PS' ]R>E58?''AN<VXBU-6%S$98&\I\2@=0AVX9O
M]D?-[4 =#161#XGT:XTV*_BO T$LYMT C?>TH)!39C=N&#D8SP33&\7:#':6
MMT^HQI#=3-!"65@6D7(9",9# J1@XZ4 ;5%8L'BS1+F"":*]RDUU]B7=$ZD3
M_P#/-@1E6]FQ4.L^+++3M!UV_MBUQ/I,3F6$1/E9!'O56XX!&#GI@YS0!T%%
M<EIVOBQC^U:KK,L\5S:BXCMVL&66$(/WK85<^7EEP2O']XYK:NO$&EVEM%<2
M70:*6$W"&%&E)B !+X0$[>1STY% &G17/KXPTV77H-,@$\XFL?MJSPP.\;(2
M NTJI!SDG/08 ZFK4/B71[A-.>*]5DU)6>T8(VV4*I8X.,< $X/I0!K45REY
MXWT"[T>]>R\0):LEL\OVL6[.(0&V%L$88AOX?IV-7[[Q;H>ESRVMYJ %Q! )
MY(UB=V$9_BPH/'!^F* -RBLZ;7=-ABMI#<B07,1F@$*-(TD8 )<!025P1STY
M'J*FTW5+'6+)+W3KE+BV?[LJ=#]* +=%9?\ PD6D_;([7[6 \LS01L481O*,
MY0/C:6X(P#G(([&L)-:O];\4ZGIFGWLUC_9LD &^R+I,"-T@<LHQD$!<,OKR
M* .QHK#N?$<">)U\.HEPMW):-<><('9$^957G&#U/.<#&#UK)\#^,[?6M"T6
M+4+Y7UB]MC*RB(JKD<L%(&W(&,J#D#M0!V5%9:>(=*?48K 77^D3%UAS&P25
MD^\$<C:Q&#D D\'TIVJ:_I6BRV\6HWB027!80JP)+E06(  ZX!^O0<T :5%8
M">-?#DFG0:@NJQ?9IYS;(Q5@?-'5"I&5/L0*E'BW1#9)>+>,T+0F?*02,4C!
M(WNH7*+D'E@.A]#0!M45G76M6$$,)%UN:YC,D'D1M,74 '>%0$E1D<].1ZBL
M'P5XK75?#VD-J5X)-2OHYY4VPE1*L<C E<#' V\=>1ZT =?167%XBTJ?3X;Z
M&Z\R":5H8ML;%W=2P90F-Q(*MD8_A/I6?+XWTD7.CQ6S372ZG++&CPP.P3RU
M8MN 7(8%<%3R.2> : .DHK*\0W\6GZ:LDFIC3=\\2+.8O,R2X&S;_M?=SVSF
MJU[XS\/:=/=P76I(DEH5%P!&[>5NZ%L X'J>@XR1F@#>HH!!&0<@T4 %%%%
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M6Q] DO+>"95"+.'"J6;KMYYY]:UI?".B3IJ226DA74HUCNU^TR@2JHV@8W<
M#CC'%/F\+Z1<7#3RV\CRO9M8,QN).8#U3[WZ]>^: ,SPAKLNJW5];7<M_%>V
MT<7G6%_"B20L=V65D 5T;'!&?NGIG%12:CJNLZCXBM=.U2/3IM)FBBC62)71
M@8UD+R9&=I#%1@C&TG-=%9:19Z?/)/"DC3R(L;RS2O*Y1<[5W,2<#<QQZDGO
M5*^\(Z'J.LKJUS9;KS:$=TE=!*HZ"15(5P/1@: ,"[U[5+^U\6W=A??9'T.1
MHX(#&C++LA64F3(SABQ'RD8 SUJK)K>NZMJ-TMKJDFG0-X?@U2.-8(W>*5R_
MRY93D?*,Y'TQ76W?AG2+V]N+N:V;S;I%CN0DKHMPHZ"100'XXY!XXZ<4^;P[
MID]_<7TD$GVFXMA:RNL\BYB&<+@-@#D]!W- '':1?:AK?B[PU>R:A/";OPR;
MMX8PGEAV> M@%3P<^N>!@CG+='U;7I_!UKK=[XC"R7<JVRQ?8T^]]I*?N\#)
MD91M .5S@D<$UUL7A3186TYHK5T;3H3;VK+<2 I&<?(3N^8?*N V<$ C&*;_
M ,(?H?\ 82:+]D?[!'*)HT^T2;HW#;@RONW*=W/!% '+6_BW5(HKFSNIG25O
M$2:5%/,D>^*-XUD^;;\A;DJ#TR5SGO)XJAUBVM["WGUZ20/K]F(S$D:2"%G7
M"R?+@X8$C@ X&<UT+^"/#LEIJ%K)IP>'4'62Y5Y7;>Z@ ."6RK?*/F&"2,DY
MJ7_A$M%.D#2VM9&MA,L^YKB0R^8I!5_-W;]PP,'/8#I0 _Q'>2Z;X=FFBOTM
MI@8XUN)8]YRSJO"@<N<X QC<1QBN+U'Q-K]KHOBWR[N6*XTN\MEMWN(HFD"2
MK$2K!1M/WS@CGI7>ZEHNGZOI3:9?6_FVAV_('92-I!4A@0000""#GBLV3P1X
M>ECO8WLI&%\8S<DW4N92F-I)W9S\HR>IP,YH YO5O%.K>&+GQ/%/>B^6UM;2
MXMGFB11"\\CQ$':!E 0&YYQD9[U?M+:>V^+:B>^FN\Z"<-*B @^>N?N*!C\*
MWY_"^CW5Q>3W%H9WO;=;6X\V5W62(9PI4G'&3SC/)J/3?">CZ5?17MK%<&YB
M@^SI+-=RRD19SL^=CQG'':@#*U47+?%'08TO[F.!M/NI#"FS82KP^JGJ&(/?
MTQSGFO"U[J>E:+X5FAOV-G?:Q=64MF8DV;6>X8-NQNW!D'?&#T[UZ+?:'I^I
M7]I?74#-<VFX0R)*Z%0V-P.TC(.T<'(X%4XO"&B06ME;1VLJPV-P;JV7[5*?
M+E.<M][G[S=>/F/K0!@Z5JOB+7!9:Q9W=K'9'4)(;FVFD4*(1(T>T )N$HPI
M&6P23Q@C!\0I636?!T5QQI4NKJ+G/W3(%)A#>V_GGN!6];^#]"M=<EUB"Q\N
M\ED,K[97\MI#_'Y>=F[_ &L9K3U#3K/5;&6RO[:.YMI1AXI%R#_GKF@#"\6Z
MM+IEUH,*6MO<)?ZE'; RD@PMAF#C'7&T\<=>M8-]XIU9O"^O^)+2Z,;:3?S0
MK8F-"DD<+A65SC=N89(((QE>.N>L7PQI8GM)I$N;AK-_,MQ<W<LHC;! 8!F(
MS@GDY(S2OX8TA[V>Z-J0UQ(LT\8E<12NN,,T8.TG@<D<X&>@H P+O6]4T[Q+
MJ.F3WDA^WV:3:,&C0;)"WENA^7DJSQMSGY2?0TE[?^(=1U/6=(T6_CBO-+B@
M"/,4 E=TW[Y!Y9^4_=^7;T;VQUMQIMG=WMG>3VZ27%FS-;R'K&64JV/J#BLW
M5?"&A:UJ<6I7UEONXT\OS$E>,NF<['"D!USV;(H P[.YU_5O%^I6"ZXMK;6M
MM8W(2W@CD4F3S-ZAF&2IV=>O3&.0<WP[K^OSQ^"[V]U4W"ZSYT-S!]GC5 5B
M=U=2!N#93!YP0>@KN8M"T^#4[K4HHI$N[J-8IG6=QN5<[1C=@8R<8 QDU4M_
M".B6D6FQ06LJ)IC,]FHN9?W1((./FYX)'.>IH XU-=\2#3+6_P#[:R__  D3
MZ6T36L?EO$;AH@6P VX#!&".G.>M69?$VK:3?:MI,U^;MX]4L[2WNYTCC9%G
M0,0=JA>#D E>K#.:Z@>#]$%HMJ+67R5N_MP7[5+Q/NW;\[LYW<^F:==>$="O
M1J:W5CYZZGM^UB25V$FT84X+?*1@8*X(Q0!S.L7WBS1=/F,VIVV6U2SCMFVI
M))Y,LBHRR (HZEL$ $COD9K-\3:AK":%XTTR;6+B7[ ]H8;@)&DA2;;NC.U0
M"O7MG!P2:[5/!NA)I::=]EE:W69+CYKJ4N9$(*L7+;C@@8R<# J6X\*:+='4
M_M%HTG]IHJ7@:>0B0+PO\7RD=B,&@"\+!&DM99Y)+B6VR8WDV@[B""V% &<$
MCIT)]:Y7P]X@OY_$@TS69;JUO6CF=+>2)#;W*A@5D@E4<@+U4G/S<CC-=A;6
M\=K;I!$&V(,#<Y8GW+$DD^Y.35"R\/:;I\\,T$,F^!62'S9WD$0;&X*&)QG
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJB7(/S<?ZP<^Q]LT$T'6=.O=/NV\.6^L03:3;6-U;331![:2+=\P+95D.\Y
M.>,^U '=RZM8PZ.VK-.&L!#Y_G1J7!CQG< H)(QSQ6?9^+]&OX?-M9IY%)01
M@6LH,NY-XV K\_R@G(R!@YQ3[_3YO^$+NM-MK2$3M8O!';VP"1JQ0J%7. %!
M/MQ7-7^A:PFA^%+J#2H;VZTB$0W6FSR(/-4QA&*L<KN!4$9ZC/2@#?3QMH$@
MM-EY(S7;2I"BVTI<O'G>A4+D.,'Y3S[4VW\<Z!<_9#'=3;;F?[,K-:RJJ3;B
MOER$KB-]PQM;!Z>HK)31;_\ MWPW?0Z#!806]Q<SW,-LT8\KS(M@+8(WL3R2
M!^)QDT'\/:VV@W%L-,D\Y_$HU)5\Z+_4_:1+G.[&=HQCU_.@#L;SQ-I6GW A
MN;AD_?+;M+Y3F-)&QM5G VJ3D=3W'J*PO'/BG^SM!O&TN\FCO;:Y@A>2*W\Q
M%9G0%&8J5!VMZY&1ZC-*WT'4[77-3L[CPUI^I6-[>M>0:C.T9\@.0Q61"-Q*
MMG;MX/'(ZU1O_#_B2/P_X@T"'2_M8N]3-]:WBW$:JR/.LI5PQ#!EP1T(/K0!
MW,?B/2Y)]4A6>02:6 UXK02+Y8(+ \K\V0"?ES5X7EO]@^VM)Y=MY?FEY08]
MJXSE@V"./7I7(Z[I#WOC#39;.:./[= UMJT&<EX(R'!X[@GRS[35M>+]&G\0
M>$-5TFUF6*>ZMVCC=NF[L#['H?8T 9*>)9+KX@Z=96US<+ITVESW+Q36QC4E
M7C".&90>C-W_  K73Q7HSW'DM=F)C;M=(TT3QK)"OWG1F # 9!..Q!Z&N9N-
M,U_Q#K5E<7FD/IL9TB[L+AS<1OY<DOEX90K$E?E..A]0*71=)U3^R?LVI>#M
M*BO+.RD@^T>9&PO"4VX3 W(K\;MV/3!Z@ ZH>(M-\J>2226%8%C9_.@="1(2
M$V@C+%B" !DYXZ\55F\::#;V]S-<7;PBUN$MKA9() T4CXV!AMR =PP3QSUK
MD)/"'B""RF32#<K:6DUI>Z?I^IW"R,)(G+/$) 6(C*[0-Q.#Z#FMC7[77=?\
M,N/["%M<O>6DHM?/C9]L4R.S.^=O1<  GH/7  -)-?L=4U;38;75+VV>=+D)
M;/9-'YQ3"LQ,B94H>@XSNY!%9/@OQS:7VCZ-:ZM?N^K7H<"1[9DCE<,WRAPH
MCW8'W0<^U:VJ6%]<^-O#NH16CM:6D-RL\F]!L,@0*,9R?NG./:L'2O#&J/X?
M\/:'>V1M_P"R=06[ENC(C(XC=F41X);+$@?,%P-WMD ZQO$VE)?P6;7#*]Q,
MUO#(8G$4DJYR@?&TM\K<9Z@CJ#6%XB\4[;W08]*O)@D^L)9S,MN3%*OS!U#E
M<9!7'RGL?0XI>'?#^IZ?.FE7WAS3YHK6Z>:#66:-B4+EE.S&\2@';GH.N>QH
M66@^);70/#NA2Z1YC:+JD4K7BW,8CGA4O\X!.X-AAD$=>YH [CQ)?PZ=I:RS
MZC-IZM<0QB>*'S3DR* I&T@!ONY/3=56_P#&^@Z;/?0W-U,KV!3[4%M96$(8
M9#,0IPN.=W3WIOCG3KW5O#1L]/MC/.UU;2;0ZKA8YDD8Y8CLI_'%86L:#K%X
M/'BPZ<Y_MBRC@LR98QN81,AS\W'+=^PH [34]1ATO2;G4IEDDAMXFE80J79@
M!G@"N/D\83/K'A2[$MS%8:E97$T]H+5F9G5(V7:-F]OOG[O!QFNFNK*XO?"4
M]@$\NXFL6@"N1\K%"O)&1UKF=.TK6EU#P;/<:4\2Z7836]SB>-MK-'&H_BYY
M0].Q'N  ;,_B/3;ZRT6\M=7FMX+Z\6.%DMR?/;+ PMN4[,D'.<$;36C#KMA/
M>):Q/(SO+)"KB%_+9TSO4/C;D;6'7L?0UQ5IX=UN'P[H5H^FOYUGK\E],OG1
M\0F:5P0=W)Q(./8_C?T[0-2M/%R:A96]SI]M-=3OJ%NTZ26TZG=LEC7<621C
ML)P%'WL^X!U=]JMII\L<4[2&61'D6.*)I&*+C<V%!.!N7\Q52]\4:386GVJ>
M>3R1 MR[QP._E1-T=]H.T<'KZ'T-9GC#1)=8GLVAM+T3V\<K07]A<+%-;2';
M@?,P#(V#D'(^4<=ZQ!H?B"RU;[3?:#I_B!=0L;>*[)>.,03HA5^'',;9SP,C
MGB@#K=0\4Z-ID3RW-W^ZCC2:62*-I%BC;[K,5!"@^I[9/052D\76<NI:YIN;
MNV73;9)'NUMG<#>K$L,*00  1GKSC(%9D&F:_H/B+4?L>CVNH:=JD4&-DJPI
M:R1QB,J4/)C(4$;<D<C%23Z/J\6M^*9$LA<0ZII\4<4J2JO[Q(W0J5)R"2P/
MIC/.>" ;5MKUC#I>FEKR>]DN+19XV2W9I9D"KF0HB\9W#L.3CVIK^,="2+3I
M!>F1-1#&T,4,DGF[020-JGYN#\O7/&,US^CZ)K.BZCH6I&PDN%CT.+2[NV26
M/?#)&0P=<L%93\P/.?NGUJ/3O"NIZ7>>&G%MYBV^H7M[=>7(NV 3K)M1<D9P
M7 ./0F@#L])U>RURP%[82L\)=HSOC9&5U)5E96 *D$$8(K*TWQEI]\NK2RK/
M;0Z==FU+S0NN\@(...6+-@*/F/''-)X.TZ]TVVU5+ZV:!KC5+FZC!=6S'(Y9
M?NDX.#R*YV[\+ZZ\&KQP6T8DCU]-9M&:8!+D*8V\L]U/RL,G SMZ]0 =M8:U
M8ZE<W-K;R.+FVV^=!+&T;H&&5.U@#@\X(XX/H:CU3Q!IVC+*UY+(!#%YTQBA
M>3RH^?G?:#M'!Y/H?0UGZ?I=S<>,[CQ'<6TEFK:?'9)!(R%V(=G9FV$C R .
M?[WM65K&CZG!XON[Z+P]::[I^I6\43I-)&C6SIN'.\<HP;G&3P>* -B\\;Z!
M927,<EW*[6T"7,HAM99=L39(D^53E,*26' [U<N?$6F6J[FF>11 MRQAB>0+
M$V=KG:#@'!Q]#Z&N9FT'5$U'Q T6FKY-UH<-A;B!HT0R()00JEOE7]X,9[ U
M1OO#&KS:;IS65E=V.MV>E06\%]!<QA?,7(:*=2V'BR >C?>..>" =?<>+-%M
M+?4IY[ITCTR18[PFWDS$Q 89&W)&&!R,CFDN?%NCVNL-I4D\QO5,0:)+65L>
M82J,2%QM)&-W0=R,UR'B+P]X@N(_&=E::8MRNM+#)!<"=$0%8DC92"=P.4R.
M,8/45T6GZ?J \=ZIJ4]D\5I=:?;0))YB'#HTA88!S_RT&#CL: -*+Q-I4VHV
M]BMPPFNM_P!G9HG"3E/O!'(VM@<\'D<C-6;W5;73Y8XIFD,LB,ZQQ1-(Q5<;
MFPH)P-R_F/6N.\'Z%J>F)I^EZEX:TY6TL;(]8#1L9D4%59%QO5R, YQWY/2M
M3QAHDFL36316E[YT"2M#?V%PL4]M(=N -S ,K '(.1\HX[T ::>)M)DFDB6X
MD,D=HM\R^1)GR6SAQ\O/0\#)XK&UKQ;$7\-QZ=-<_9M:DW"Y@M7=O)\EY 5&
MP_,2J\$9 ).!U%'^R?$EOJT%[/91W]Q<Z FGW,L,J1I'<*S,6(.#M.\XV@].
M@IMCH>LVUCX BDTUB^C+B\"S1G9_HS1<989Y8'CM0!%:ZMJMU=ZQILWB*^@?
M1C%F\72L^<N"[F1"F,[2%&,9QN .<5T]IX@T^WT/39I+^>^-Q9K<1RK;L99X
MPH)E*(ORCD$\#!('7 K-MM-U./6?&%PVGR>5J*Q_93YD?[S;"(R,;N.1W[5D
M:9H_B3P\WAR_M])^VF#18]+O;,7$:/&R8(D5B=K#.01G.,?2@#J$U[3[_5]%
M^QZP_EWMM+/! D.8[I,+\Q<KP5ST!!^;D5,GBK2)+R*U6XD\R>)YK<F!]MPB
M\L8SC#X!!^7.0<C(K(U'1M3OO$7A^=K18X+>SNX;EX'4+"950*%!(+8VGG [
M''84O"6D:II\-C::EX6T^.?2HC$NI1/&S7 "; 8QPR,PQG=CN._ !NZ=XUT'
M5;BSAL[N60WL;2VSFVD5)@HRP5BH!8#DKG/M4WAGQ'!XFL9KJ"">%8[B6';-
M$R9V.R9R1@GY>0.G0\URFA^'=:L;+P%#/I[*VCF47A$L9"[H7C!'S<\L#QVK
MH/!>G:AI&G7EC?6HB"W]S+%*) PE229Y 0!R.& YYSF@#2_M_3_M@M5>9W,K
M0AD@=D,BJ69=P&,@*?Q&.O%0P>*M&NH=,FANV:/4W:.T;R) )&4,2.5^4X1O
MO8Z5@1:!J4/B]-3T^"YT\27KM?IYZ/:W46& D";B5E/R<@#OG-9FEZ!XAM;7
MPO82:2 FC:I++-.;F/;)&RS .@!SC]X,@X/L>M '3+X^\-M<PP"^D!EN3:!V
MMI519@VWRV<KM5L@@ D9HN_'WANQFGCN+Z1/L]P+:X8VTNR!R 1O;;A0=PPQ
M(!]>#7):=IEUXB\+ZUHD=FZQS>(KAFNV=-B(EWO8@9W;OE( QU(YQFI19WFL
MQ?$+1+:R,AO]0, N&=!'$7MH5+,"=WRCYN <T ;[>()--\8Z^FH7DATFRTVV
MNPJP[_*W-*'(V+N(P@/?'-;\6LV,[6 BE=C?QF6WQ"_S( "2>/E&&'WL=16%
MIVD7%CXRU&ZGMS_9DFF6UHD\CH0YC,F[(SG!#CJ/6H? NCS:?]L66X6XL[*6
M2QTQADE;</N(SZAL1GVA6@#LJ*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***YSQ5J\^G7&AV4
M$AA&IZ@MK)< #,:['? SQEBH4?4]\4 =!++'!"\TSK'%&I9W8X"@<DD^E9^F
MZ[8ZK<S6]L9Q)$B2D2P/'N1\[64L!D'!Z>G.*XC7[O47T/XAZ+<7DTMOI^FF
M>WN"%WE9()"8F.,'!7KUPPY[UV^BV[IX<LX3<S.S6RXE;;N7*CI@8X[<4 /O
MM:L=/N;&WN)6$E].;>#;&S!I "=I8# .%/4CH:T*\@TR*YF\&^ 6:_N&FGUD
ML99-KLA,=QDC(Y/4Y;//KTK7A\2:I96LVGRWQG?_ (20Z4EW<%481F+S%RP3
M&2?D!V]QWYH ](HK$\.Q:O;?;K?5KV"ZVS[K?8^Z2.(@85SM7)!S@XZ8S7$:
MIJ7B--(\7ZM;>(9T?0M0?[/ 88C'+&L4;F-_ER0=Q P0<G.3V /4J*\_&HZS
M)KWB6X;5+Q;;2(X+N*P2./Y\PL[1,=N<$^G/O2V^MZI!;>#-56^>]CUMDBN[
M?:NW,D+2AX\#*[2I&,G(Z\\T =AJ6L66DR6:7DCHUY<+;08C9@TC= 2!@=^N
M.E7Z\JEO[GQ%H'@WQ!->R[KS7(7:V7;Y<8W2 (!C.5QC.<DYSVQ>&OZNNCK,
M=2D,L?BP:=N*)\]O]J$>P_+_ '>XP?>@#T>J6H:;8ZQ;_9KZ%;B)'5_++' 8
M8*DX/4'!'X&N8L=0O]>?4[N'6?L#:;J[6S0F-6C\F-@"K \Y<'(.>,C'N_P-
M'-]N\4R2WMS/C698PLK @ 1Q8/3/3CTP!Q0!UZ[1\@/*@<$Y./\ (J*\M(+^
MSEM+J,203*4D0D@,IZ@X[&O.]4U2]T'7_'VL0SW%P]AIMK+#;N08\E9B 1C(
M4'G@COFMP7VH:;XM\/VB7\NH6.K6TQE,H7Y'C57$JE0,!LX(Z<KC'< ZFUM8
M;*UBM;=-D,2A$3).U1T SVJ:N5\1W.HKXN\.:?:ZE-:VU\+E9UC1"3LCW*06
M4X.?P]JYFWU?78=,M;V36[F9K7Q(=)9&CC"SP_:3%E\+G?M(Y! X''7(!ZA1
M7!)J6O:U/J%UIVH6MI_9NJO;R1S2_)Y4; ,KIY9.67Y@=W<8XXHL-2U[72NI
MV>H6UM';ZM+;7,$LOR^4DK1^64\O(D(VL#NZD=CB@#O P)(!!(.#@]#5/5=6
ML]%TVYU"^D9+:VC,LK(C.57UPH)QP?RKF_A]',+76WFO;BX(UF\C'G,#@+*5
M!R #T ]N.,5S>N1S?9OBH7O;F1([/:D;L"H!M0V!QD $G&/7N>: /4D=)X%<
M?,DB@C(Z@BG !0   !P *\ZGUO5?#=YJ ^V2W\,?AM]3C@F10$EC.,+M .T@
MC@DGCK6YH?\ ;3:K;7<NJVUSI5W9[A&9A([R<$2(1&N%*GD<CIC'< ZJBN.U
M.35+OQ__ &/!K-U9V<FD/<;84CW+()57(+*>Q[Y]L5C:'XFUCQ'9Z!8FZ6&[
MO-%%[)*L@B:63<$)7Y&''WB !]X=AB@#TJH;JYBL[26YG+"*)"[E4+$ => "
M3^%<+%J/B*]OXO#DNI6JZG%I0G>YMI?+$LOF/&67,;9"E%R, 9;TQ3;?4]5U
MI]:TB^U-(KC2]+A,DECC;/-(CEI!N'*C: !TR6SGC !W.G7]OJNF6NHVCE[:
MZA2>)B""48 @X/3@BK->56^KZGI/@3PW.OVQ=)30+<S7%@$>6SD,8Q*\9&6C
MP#TZ8;(Z8[/QAK[Z)X+N]9LF5F"Q^7(1E5$CJN_'< -N_"@#HJRK;Q'IMWJ2
M6,$DK22"0Q2>2WER>6VUPKXVD@^_TS6/]HU&R\<0Z)]NN+BQO].EG#N$,EO)
M&R*6!"XPP<<$'!'''%1_"Z%X_ &G.UQ++O$A ?&%_>/TP!^N: .AU?6K'0].
MDO[^5DMXV5'9(V?:6( R%!QR1R>.:T*\AU2.?_A#?'KR7MQ,1K0C43$,!@V^
M#T!X'&,XP*VM4\0ZIX:O/%43ZA)>1VEC:W<#W*H/(:5Y(V^ZH^4;0V"#T- '
MHE%<[HT.LP:U/]LU"WGTZ>W62"(S>9*K@_,P8(HV$%>.<'IP:R=0&M:GXVU;
M1[7Q!<Z?;Q:;!<P^5%$2DC/*O5E.5^0$CKZ$=P#N*H3:Q90:U;:1)(XO;F)Y
M8D\MMK*F-QW8QQN'&<\UP_A/Q+K&N7FGF]NGB6[\.B\>-%4!9A)L\Q>,C(YQ
MR.:HZ?/J'B.Y^']S/J<\%Y=Z/=R374"(),D0$D J5!/^[_C0!Z-J.L66DR64
M=Y(Z->W"VT&(V8-(W0$@8'0]<=*FM[Z*YN[NV191):LJR%XF522H8;6(PW![
M9P>*\V:_U&]TG18M4G^U3V/BU;(76P*9UC9P'('&>QQW!J[J'BC4M+O?$\<E
M\3#;ZK86D,TB)BUCG6+>W  .-[$;L]LYH ]%JA9ZQ97^I7^GV\CFYL"BW"M&
MR[2P)7!(&<@9R,BHM,MKNSU"_BGU4WD+>7)!#(@\R!2"""P^\"RDC(XY'/;@
M==EU"RU/XA:GI^I36<]A;6UR@C1")&2%F ;<#\O&,#'7K0!ZE17"WFIZWKNK
M:MIFDWL5C<V=K!) 6E"_/(I;>RF-MZ9^7&1T/<@BAXB\1:M:VFH7MIJ8EFL1
M9%TM4400ERN\,6YDWALC'08Z'J =U;ZQ976L7FE12.;RSCCDF1HV4!7W;2"1
M@YVGIGI2'6K$:W#I'FL;R:W:Y1?+;:T:E02&QM/+#C.>:X7Q&9%UGQ^\,\L$
ML?AR"19(FPP*BY/![=*6"QGF\4^%K:/4KJ%F\/W!-P@3S -UOP,KM';G!X]^
M: /2:*YSP3JMWJO@?3M0OG,]TT3"1PH!D*LRYP.,G;V]:YNU\2:M-X9\,^)X
M[MY7U*^AAN;+:ICV2N4VKQD,AQSGG:<Y[ 'H]%<;X3;5M1U/5;F\UNZEAL=4
MN;5+8QQ!'0!=NXA0<C/&"/?--U>75;GQO=:5!K5U9VG]C_:E6&./<DGF%<@L
MIXP!US[8H [2DW ,%R,GD"O-X_$>J:GX9TBX749!?3: U]+!;1JK>9M7$S,W
M 0'<-H')/0@<2:1<WNL>,?#%[/?W"/<^&3=2)'M";V> MA2#C)/UX% '>6%]
M%J-K]H@654WNF)8FC;*L5/# '&0<'N*LUYOHWB75+JU\-6%U>R&34]0U"&:\
MVJKE('EVH,#:"0JC('13CGD17VNZ_;2WFFIJ4H-EX@LK-+HQ(3+!/Y;%'^7!
M*A\9&"1C/>@#TVJ&L:Q9:%IS7^H2/';JRJ66-GP6( X4'') STYKC/[8U&QN
M/$&ES:W.QMM3LX;:>2%&G=9EC9HEVA5W'+ $CY<Y/ R,W6-1O[[P#XNM[Z1W
M-CJT=O#YA4NL>Z!PK%>"07//ZGK0!Z-9Z-IMA>W=[:6-O!=7C![B:.,!I3ZL
M>]7JS/$#ZA'H-VVE&/[?M @$CA0S$@8!/ )Z#/&2*XN/Q?.\=O9QRWEM=7.K
MK93P:EMCDL\P%P@<*P8.R?*V#G?QVP >CT5P9U'6]*U#3=%U34X6&H:G)$ES
M$P:2*$0F1(F8H!O+# .,[3Z\U-=7.KZ1J_A^S?6VO%N-7EMY?W2 ^289)$C?
MCEEPOS#&1U% ';56:^B34H[ K+YTD32@B)BFU2 <OC /S#C.:\\GUS7&M95B
MU>9'3Q8NFA_*C)\@E!M/R]LGGKZYK:C.J67C.PT.76[RZMI=(N97>1(@YD66
M,*^50<@.1Z<=* .Q5@PRI!&<9%+7E6BWFJ:3\,/#/B%-4NY+6 QS:E$P1M\#
M'#MG;N^4D/UR0&KO]!N)KZ&YU![AI+:YG+6B'&U81\JD$#D-@N"<\,* -:L.
M_P#%VBZ9+)'=SW">7,L#.MG,Z>8V-J;E0J6.X< ]ZW*XOXE*J>'M/"J!G6;$
MG ZGSUH V1XMT<SV\!EN$EN+H6B)):2QGS2F\*=RC'R\\]>U:5_?1:;9O=3K
M*T:%01#$TC<L%&%4$GD_AUKE_'<)>Y\+")_)D?7(AYJJ"P_<3<\\9],Y'L:Q
M;K6]:L_"'B0IJT[W.E:TEK#<ND9=XF:$[6^7'25AD '@4 >ET5Q&JZY?Z;XL
M\F_:[@TR:[MXK2\M@DD*DA-T,ZXW(68G#=,,O(YS?\;WFH65GI+:=?/://JM
MK;2%45MR/(%(.X'],4 =117 R2:]<:GJ?ANQUIS>6%G'+#=7$B))(\A<B1E6
M(AU7"K@ =#GD@B.>\UR\UK4;(Z]) L>@P7RM9I&5$S&0,4+(24.P'GGW'2@#
MT*BO.-.U_68I?"FHW&H37:ZQI,MS<6AC14#I"DB^7A<@Y)').<_2GV>MZ\NA
MV/BS[?:W%A)ILMS<6OG;C-((C(HB C&T@JP(W'C.<D9H [6YUBRL]6L=,FD=
M;N^W^0OEL5;8NYOFQ@8 Z$YJ_7FRBXO/$'@#4)M3FN'O8+B5R H0,UL6W( .
M ,X YXQG)Y-[0]5U6>[_ .$9O-1F?6+&_=KJXV(#+:#YT? 7: P>-#@9SN]*
M .ROKZ+3[<3S+*R&1(\11-(<LP4<*"<9/)[59KFO'%_>Z;HEO=6-T]O)_:%I
M$VU5.]'G1&4Y![,>F#6;=:Y?V/C!+;4FNX+&YO4BL;NW"26S@J!Y$HQN1R^[
M![G SCB@#MZ*Y?QG>:A:2: MA?R6GVK58[6;:B-N1E<G[P.#E1C]<USL7B/5
M;*ZET:;4)I@WB1=,6]E5/,2)H%FQPH7<22H..A]10!Z2S!5+,0% R2>@I:\K
M\77^J+I/C'1I+ZX>"R6SFM[@$!]DS8:)B!R!M/OAL$GOW^LW)TGPO?W+:B+=
MK>V=A>7";PA"G#,J@;L'L!S0!JT5P>G76N7NLZYHBZA=VSC3+>XM9;A8VDBE
M<RJ6( (P2BG:<XYZ9P)-"\1W.K:''?RWYM&TVPD&I&95*I=+E6W@#/R&-V(&
M.&6@#MV8(C,<X R<#)_*LI/$FG/-I,):>.7559K5)+=T+;4+D-D?*0H/!P:Y
M;1M6U>777L);ZZ,,VA+>)+,D8<R[]ID5<':&SG:>F.@YJIIU_<ZH/A??WLIE
MNKA9999" -S&SD).!Q0!Z2[!$9CG"C)P"3^0ZU3TC5K/7-,AU&PD:2UFW;&9
M"A.UBIX(!'(/6N*TC7M2E\1^'@-1DO++4_M@>8HJ13;/F1HU^\H4?+DGYNO/
M!K&\/2ZOI'A7PSJEGJLSP3ZI]CETYHT,31R7#J2#MW!AG=G=C@\8H ],TW6+
M+5GO5LY'9K*X-M.'C9"L@56(PP&>&'/2K]>9QZQ/H\GB,P.D;7?BJ.T,SMM$
M8>"'G)! SC )!P6%=AX?AUBUN=1M]4O8+B/S%DM563?+%&PY5SM7(W X.,XZ
MGB@#;# L5!&1U'I2UY==:M>^'I/'>IQWL\CPZC;01^=M9(1)' -^,=%WD@=.
M.?6NHM[S4-/\?Q:,UU+>6%UISW0,P4O#(CJIY 'RL''!Z$<<<4 =.\BH#N/.
M"< 9) ]!U-4](U:SUS3(M1T^1I+:4N$9D*$[6*G@@$<J>M<Y?QS/\6=*47MR
MD0TFX?RE8;"1+#V([YY/7@<BN9\+76H:7HOA&XAU&8V][K%S92V91/+*,URV
M<XW;@R YS[8H ]7HK@M(U+7M=2SUFVU"U@MUU*2"ZMY9<KY0D:/R]GEY60?*
M0=W)]B .]H *",@BBB@"GI^E66E1RQV, A261I7 8G<['+-R>I/)/>BRTJRT
MZ>YFM(!')=/YD[!B?,;&-QR>N !GV%7** *U_86FJ6,UC?V\=Q:S+MDBD7*L
M/<5);6T%G;16UK#'#!$H2..-0JJHZ  =!4M% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !53
M4=,L]6M#:WUNLT)8.%;(*L#D,".00>01R*MUSOC#Q!/H=G8P62QMJ.IWL=C:
MF091&?.78#J%4$X[\"@#0?0-,DTZZL)+8O;W>?M :1RTV1@[V)W-P .3T&.E
M7;6VBL[:.W@!6*-0J L6P!T&3S6!?K/I*V;R^*3&[7$8<7QA19UW#>H^48.W
M.,?_ %ZLWOBO2K W#SR2?9[:58;FY6,M% [8P'8=/O+D]!D9Q0 1>$="@6!8
M=/6-;>X-S"$D=0DAS\PP>/O-QT&X^IITOA30[BRO[.?3XYK:_E\ZYCD9F$DG
M'S<GAN!R,'@>E2QZ_8RZM?:8#*+JRA6>560J-C9VD$\$':>GISBJ]UXLTVTL
M3>2+=&)+9;N;9 Q:"$YP[KU'0G'7@\<&@"_I6D6&B60L].ME@@!+;0223ZDG
M))Z<D]JYW1/"I34]=N=5M59+W4?M<*B=F0J$0*'0$*2"F>0>HYXJ]+XUT=-1
M%A&;NXG,<,H%O:22#RY3A'R%Y7C[PX%,M/'.B7LMFD+W6R[N'M8I7M9$C\Y2
MP*%B.&.QL ^E &M;Z18VFHW>H0PE;J[V^?)O8^9MX7()QP.!Z5#8>'=)TR5)
M+.T$7EEC$F]BD6[[VQ2=J9_V0*S9O'FAP"=Y'NQ#;WGV*XF-I($AD^4#>2.!
MEU&??TYJW;>*]*N&U!&>>W>P5'G2X@>-MKYV, 1DAL$#'.1C&: (_P#A"?#G
MV@S?V7'N-P+K9O;8)O[X3.T'GG Y[TZ;P;X>N+F:XETR)Y)IUN7RS;3*""'"
MYP#D#) YQSFH;KQQHUA#J#WK7-L^GB-KB)X&+JKG"-@9RI/&>@/7%1WWCC3K
M33];N$@O'GTFV^TRV[P-&[QD,59=P&5.UN>V#0!>?PIH3ZY_;3:;#_:'RDS#
M(W%?NDKG!([$C(JW:Z/I]C?W=];6J17-VVZ=US\YP!G'0' &<=<#/2EL;\W>
MD0WS02J7B#F,H0W3L#^E4;;Q9I-XFD/!+*R:NC/9MY+8<*I<]N#M!.#0!;DT
M/2Y=3DU&2RB>[EA\B21AG>G/!'0\,PZ="1T--T[0=-TDH;.V*&./RH]TC/Y:
M9!V)N)VKP.!@<#T%9MEXYT2_EL4@>ZV7LSV\,SVLB1F52P*%B,!OD; /I5;0
MM:EAO/%']IWLDT5IJRV]N&4%@&BB*HH4#/S.<=^: .@NM)LKS4+2^GA+7-IN
M\B02,/+W##8 ..1P:I_\(IHOV8VWV,^2;K[9M\Z3_7;MWF?>^]NYSZ\TR+Q9
MIDQGB!F6[@N5M9+1TVRB5AN5<=#E>0<XP#SQ4G_"2V12+9%=/+(LS^0L)\P+
M$^R1BOH&('&2<C&: &R>$M!EUT:V^F0G4?E)FY^8K]TL,X8CL2"1BE7PGH*Z
M\VMKID(U%R&:89&Y@,;BN=I;_:QGWJ[/JEG;:.^K7$PBLHX#</(P/RH%W$D=
M>E9C^,-*AMM2FN/M,']G0+<W,;P,76)@2K@+G(.UOI@YQ0!HV.CZ?IMS=W%G
M:I#+=R&6=ES\[GJ?;/4XZFJUWX7T6_N+V>YL$>2^B$5RVYAYJ 8P<'TX^G'2
MH[#Q7I>HW\EG&\T4JVPNP9X6C5X<X+J6 ! .,GW':L6?Q)+>>-O#$-C-=II]
M]%<R%7A"QW"K&"K@D;N_0D<$''>@#HX] TR.^2]%L3<);_90[R,W[K^X03@C
MZU#HOA70_#KROI.G16K2_>V$G SG R3M&><# JS=:Q:6>K66FS&07-Z', "$
MJVP989[''K6:WC714M+>Y:2X"7%X]B@%LY/GH6#(0!P<JWUQQF@#2ET:PFU,
MZD\+?;#";?S5E=3Y9.2O!Z9Y^O-9UQX(\-W>G65A-I<;6UB2;5=[ PYZA6!R
M![9Q5._\>6-OH,NI6MM=S-%?1V$L#0E'BE9U7Y@>1PZGWR*FFU2*XU35K>VU
M&_AO8M-2;[,\(5(0=^V1=R\L2"#R1\M %O4O"&@:O%9QWNEP2+9#;;;<H8EQ
MC:"I!Q@#CI3KSPIH=]<0W$^G1^;##]G1HV:/]U_SS.TC<G^R<BH_!]W<ZGX%
MT2[NIW>ZN=/ADDFP-Q=D!+=,9R<]*Y[P;XW@DT?2+76+F[>_O)985NY;9EBE
MD$CX3S H3=@=!Z8Z\4 =(OA+0X[>.WCL?+ACMQ:B..5U5HAGY& .&7D\'/4U
MJ3VEO=6<EI/!'+;2(8WB=0592,$$>F*RCXKTH3P*TD@@GN3:171C/DO,"1L#
M>N00#T)& <UR_B/QE=7'ACQ5)IPN]/GTBX$"3F,?-@1D]00,[S[XP>* .RLM
M#T_3U86T+J6C$6]IG=P@Z*&8D@#)P 0!4FEZ39:+8I9:?#Y%LF=L8=F"Y.3C
M)..2:KZ;X@L=4U&[L(//2YM51WCG@:,E&SM==P&5)5AGVI]_K=K87!MBD\]R
M(3.T-O&7=8P<;B/KD =3@X!P: (+GPGH5V;TSZ>C?;G5[G#,HD88P3@_[*_7
M:,]!4YT#2VN[FY>U$DMU +><RNSB6,9PK D@CD_F?4U@:_XLC-MX>;2I)9[3
M6+M8_M%LA),7ENY"GLQV >H&>A%6]4U2;P;X0:[NI;O59(Y BNZ .=[X3?C
MXW $]3CU- &CHGAK1_#D4D6D6*6JR8W88L2!T&22<#)P.@R:R)/#4M[X\O\
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MI^R0I/=-'&6$$;$JK-[$JW3)P">E-NO%NF6FM-I!6\EO5$3,D-I(^%D8JK9
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MI+,3VRJ^^*IS^%]672_%6@)$DUKK=Q--!>&08@$P <.IYRIR5QG/ .VN^HH
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M% '-VNG7P\?WFL26QCLYM,@ME)=2P=))'.0#TQ(!]0:CFTS4M.\<7&NVEO\
M;+6]LH[::%9%5XGC9BC#<0"I#D'G(/.#7444 <##X2U'2]*\)6-O$MP=,U%[
MVZ99 JC>LNY4SC.&EXZ<"M_QII5WK7A.\L;%4:Z9HI(UD;:&*2*^,]L[<5OT
M4 <1=Z-K%UJWB.\:Q51J.CQV<*K.IQ(OFYSTX_>CGV/'3-!/#>MZ;>:;>QZ)
MI^JH^E6]A=VMU,JF&2+=AT8JP*G>P(QGH?:O1J* *MI$]GID47DQ;XHP/+MU
M")D#HH. !Z5PFF^%=;L?#OA-Q!'_ &CH-P[R6WFC;/&ZNC;6Z;@KY&<<@CWK
MT6B@#S_6O"FIZAI_B:Z@MU6]UF>T*6[2*/+CAV<NW3<=K=,_PCUJ;7_"E_XA
MUC7@4-M:ZEHD=A',7!*2J\CY*@_=_> ?@?K7=44 <G;Z3J>J:WX?U+5+5;.7
M2(9A(%D#B:61 AV8_@QN/.#TXK&NO FJI#>FQN84DLM1^VZ$&SMAWL))5<>A
M)=0.P^M>BT4 <KJ^A71N/"L=A"98-+O!-,[. 2ODO'GGJQ+@G\:Q9?#6M/HM
M];"R'FS>(UU-!YRX\D3I)R<_>PI&/4]:]$HH \KF2>:YURZAT?[=H)U3[7*L
M&I1(C20[0Q977((>/) 8 E1V))[3Q9I5WXA\*2VVGR+!>EH;FW,X(7S(Y%D5
M7'H2H!]*N'PWH1U,ZF=&T\WY;<;G[,GF;O7=C.?>M2@#B]8TWQ'XG\.M]HL[
M73+^WGM[JVM_M'FJ\D4@?#N%&%.,# ..I]!6\0>&]3U_^VM16S^SW5UH<FE6
M]O)*I)9R69F() 4';CDG[W KO:* . UGPGJ>N74L9C^S03^'9=,:8R*2DK,I
M&0#RORX/UJ>SL/$EUX@\-ZA?Z5;VXTZUN(+G;=!MS.(P&0 =#L. <>^._<44
M >=VOAC7+;P_H,8M(3=Z;K<U\\33@!XY&G(PP!Y F&1CL?:G:MX2UC4KOQ'/
M"D4,MQ>65[8L\@*.]N$^5\<@$KQ]0?:O0J* .&UGP]J6MS:QJGV,V]S<:%)I
M5O;/*I):0DEF() 4';CDG[W'04/H>K?VE870TZ&5+?0)K!XYI%*O,WED*1GE
M#Y9!/OTKN:* .3\(Z!=:%>WJQ?:;;1GCC^SV%S.)C!("V_8V3B/!7 )Z@\#N
MW3].:T\<^)HY\B+68()X']=D9BD4>XPA_P"!5UU->..0J716*-N7<,X/J/>@
M#@-)L=;A^&FG:/IX7^T=,FCM;N$R>6SQQR?,%?\ A+)AE;T8$$<&K&EV-_X:
MT[Q9<WEE#%#=7#75LD,QE9RT*($Q@$L67'J2?Q/;B.,2F4(HD8!2V.2!T&?Q
M-#QH[(SHK%#N4D9VGID>E '/:!HM_HGP\LM'@DC74K?3A"CORBS;._JH;]*Y
MS3_#WB&/5%U"XTZ(/)HDEC.3>^9(TQ8'=DC&"1P < >G2O1J* //8/"NJO:^
M$;2:#RET[2IK&[E65259XDC!7GD94GMU%-T[0_$R1>#[2ZTZU4:!-LEG6Z&V
M:,0/$KJ,9Z,"0<<_F/1** .5\66;KK?AG6QS#IMZXN/]F.6-H]Y]@Q7/H,GM
M1-IVJV7C#5=4M;*.[AU"Q@MX_P!Z%$<D9D/[P'^$^8.5W'@\5U) 92K $$8(
M/>D1%C1410J* %51@ >@H X*_P##+6GAKPCX3MY#/);7EM)))C'[N [W?V!(
M51[N!6K86;W?Q)U365&+:WT^'3E;L\F]I'Q_N[D'U)'8UU C19&D"*'8 ,P'
M) Z<_B:(XXX8Q'$BHB]%48 H X+QKX?\0Z]_;EE#!!<65WIZQ61>Y\L12C=N
MW+CYB<K@G@8[<YU].T[4U\;W6JW5HL5O/ID%KE)@VV1'D8^AQ^\ SCL>*ZBB
M@#@_"/A[5M&%KI5[HNE&'3V(BU=64R31C.SY-N5?& 23CKC-;6OZ;>WGB/PU
M>6T D@T^ZEEG.\ A6A>,8!ZG+@_05T5% 'G=SX:UJ7P_K-FMD/.N]>34(@9E
MQY0FCDY.>&Q&1CU(YJ=?#VK6GB'5$&B:5J&GZE<_:H[RZ9?,M2RJ&5D*G> 1
ME<$>A(ZCO:* .3L+#6]&U+Q3<V]A;W2WDXO+3-SL\QO)C3RS\IV\H>?<?AU4
M9=HD,BA'(!90<@'N,]Z=10 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3Y-Z(JD@L&).TYP#UK*UOP]J^HOX^BAL& U2PBBLI&D0+*Z1LI'WLKR1U H
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MM7,3Z#K*Z5XPT-M/:X77)9IK6Z$B>7'YT80J^2&&PC/ .1C'/%='K^BW%WX
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MVF99%D\M60G]V=I'S8^\..M &Y9^(Y;[XBC3(+B0V!TEKKR9;9HF#^:JALL
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M59UCF5V +$#. >I% &9%XSAT[Q+XABUF_,=A;"U>W!MF!B61"6+X7(&<9+8
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M:@$L#@8<],'WJE8:=J2>-=,OY-.ECM8M$:TDD:2,[)2\;;<!B3PIY (JQ/\
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M+R-M028SL+GY=V.=N<^U27.O:79W26UQ>1QR/(L0SG:';[JEN@8Y& 3DY&*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7,>/+.ZO_  XEO9VLMQ-]NM9=D8R0J3H['\%4UT]% %2VO9)[
M^[MVLKB&.#9LGDQLFW#)VX.?EZ'('-6ZJ6FJ6-_<W=M:W*2S6;B.X5?^6;$9
M /OBK= !7+^(TOV\0Z28=,EN+/RITEN+4()HV.S:FYB"B, <E3G*KR._444
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M;0_"]X9KS2=\D N'5XH[J;[/YH;YOW6[R\[O]GK6_!J%K<WEU:0S![BT*B=
M#\A9=R_F.: /.M7T;4[G0?'5M%I=P\VHZ@DMJNP?OD"0KD<\<QMUQ^M6?$^B
M:MK&NZX^G6LJ"YT."""60;$>9)GD,9/495@,].3Z5Z+10!YIJEA<:[X3UZ:W
M\*ZC9ZI<Z8]E_IDPDED8\A$.]OD!R<G'7CO5[4M+O[[Q%>O;V,PAG\-/9)(R
M[5\XL2$/IP>O3WKO:* .?T."]F\"6MD\,VGWBV"VX$N-R.(PN[Y2>]<EIEKK
M)MO UE-X?O(9M#G\J\?]WY8"V[Q;U;=\RDD'_P"O7IM% 'G'AK2;R(VFCZMX
M?O'N]-N&DBU.2XW6Q&6VRH-^0Y5L;=O4G/%7/!D6I6>G:7HNJ^'9%NM'#1_V
MC($:(J 5#Q-DL6<$9&!C+9]#W=% 'F5AH-TWAC3[:ZMM6TZ]@OKV>*\LQF2V
M+S.Z$KR'1E?!&#[XZBXFG:_=ZCX4DO[9HKF#3[R&[N+>,!(7D5 AP#P3MR0,
M@'VQ7H-5K;4+6\GNH;>8/):R>5.H!^1]H;'Y,#^- ' Z=HFIW7A_PAHUQ82V
MMYH=Y#)<3$#R]D*LN4;^+S!@8'/S'.,5!_9&IC13&-+N?-/BS^T=NP9\C[3Y
MF_K_ '>W7MBO3JJZAJ-GI-A-?7]PEO:PKNDE<\** ,7QY8W>I>#[J"QMWN+@
M2V\JQ(0&8),CL!D@9PIK+2#4;/Q'XBN;G2KJYM-9M83;JH5BC)&4:%^<+G.0
M?N_,>:[9'62-9$.58 @^H-*[*B,[D*JC))Z 4 8OAG1[C1O!>F:/<RB6YMK)
M('?.1N"XX]AT'L*X6PT[7=+T3PA<RZ%J,RZ59R:??6=O.$F&X1XE3:XW &/&
M,@X.<5Z%!XATFYM;&Z@O8Y(+^4PVSJ"1*XW9 X_V&_*M.@#@8]'D@U_PG-::
M%+9V=O)>2S1\.;?S5PI<Y/S,<DX)QGKWJGKFCZE=6GQ%B@TVX=]4CC2RP@_?
M$0+&<<\88'KCUKTJB@#BIK6[/C,WR6%S]E_L!K;>(_\ EKO#!,=<X_#WK,T'
M2M1M'\ "XTVX3^S-,F@NR4SY,ACC4#WR4;IG]:[_ %#4+32K":^O[A+>UA4O
M)*YX45$FL:?)J4>G)=1M>20&Y2$?>,8(&[V&6'YT <#I-EK-AI^BP/HER8TU
M"_>=XDC\^%9)':/86/RJP?#$'(Z<5'HFCZUI^F>#&ET:ZWZ7?78N(@Z%@LBR
MJK\MRN7'.<]\5ZA10!YSHNE7<-]_8^K>'KRZ>WU.2\M]1:XS:E3*TBR8W_+(
M-Q&T*>?8DUO^,+2YN[KPVUO:RSK;:M'<S%%SY<8CD4L?Q8=.:Z>B@#S'5]'U
M.XT'QS;P:9<M-J.H1RVBA /-4)""0<\<QMUQ^M+XLL=:U-]=A@T.Z97GLI[5
MK81HMPB-&S-(2P9G&UE"G@ #CO7IM5H-0M;F\NK2&8//:%5G0 _(67</S!S0
M!Y[K>DZG>VWQ!6+2KGS-5MH8[0%1^]80[",YP,-Z\=QD5/JMGJB:KXADATB[
MN$U;0HK>!XPH"2H)@5?)!!_>+ZY[5Z)10!PEK9:BFL^"99=-N42QTZ:&Z) (
MA=DB50<$YY0],X[XK,L+'7'UWPY=W&@W4!L]0N_M"0^4EO$LB2!6C4-R#N#%
MB,DD_2O0]/U2QU6.:2PN4N$AF:"1DZ*Z]5_#-6Z .$\&0ZG9V&FZ%JOAY_M6
ME,RC4I1&T++\P$D;9W;V!P1@8R<GL<JTTK6++PGX=BDT>[,VC:R9YXDV,TD9
M,PW(-W(_>*>W?TKU"@G% 'EUYI6L7&D>(8VT2[#WGB&VO8HSL;?"K0%CPW81
MM_3-=1JEO<OX^T"_CM)WM+>SNTFE5.$:3RBHQUR=C5T%A?VNJ6$-]93":VF7
M='( 0&'XU9H \QTC1]3MM$\%02:7<QRV&J33W2[!^Z1EG )P><^8O3/Z56TE
MD@_L^*[TS6%TBPU6>^M)X[=)(_G>0*QE5R6C_>LWW!U') R?5R 1@\BL.P\(
M:+IDJM:6TT<:-N2W-U*T"'.05B+%%P>1@<=J *WC;3]0O=.T^?3HC/)8:E!>
MO;*P!GC1OF49XSSN&>ZBLC4=*O+V[\5:Q;VEPD=]HRV,%N4VR3R@2?,5/3&]
M5!..A[8)[RB@#,\.))%X:TR&:)X9HK6*.2-Q@JRH 1^8K@X=)U:+P[I&G2Z1
M=>98^(OM4A 5E:+[1))O7!Y&UE]^>!P:]$MM4L;R_N[&WN4DN;/9]HC7K'NS
MMS]<&K= 'F6NZ/JEUI'Q @@TVY>34IXFLU"@><!%$A(R>.4;KBM#6M.U*3Q$
M^IZ+'?6UZTML)(I4#VE]$-N2X/\ JW0;N>#\HQGMWM% ''_$DA?#EFQB,N-6
ML3Y:@$O_ *0G SQS6#XK\/WVJMXDU.RTZ=EOK:RM8H/+VO<-',7>0J<8 4A1
MNQG:?;/:31:'XNMY(#+]KBL;P!Q%,Z;)X]KCE2,D$J?2MH#  ]/6@#D]0M[V
MT\=:=KR6T]QISZ?)9RI$F7MW9U</LZD';M.!D8%<[:Z!K.@WVCZNMA/<6J:E
MJ%Q-80E6DMX[D_NR!G!*CJ >-[8S7IU% 'EPTO6$ADO3HEX!#XK.I>2-AD>!
MD*%E ;D@G./RS2S:7XA*ZMJ$&C7'F1>(H=5CM7D0&YA6*-&5?FQN&">>,J,$
MUZA10!PFNV]YJ^B1:A9^'9K61=6L[V2W98UN9EBE0NS -C.U< $YPOT%=E<6
MT6IZ9+:WD!\FYA,<T+X/RL,%3CCOCBK-% ' V.D^(+7P+JD5W9P:AJD%H^GV
MD,^&2YBCW!&8'C+@Y(/7"YK'O=!UW5)?$7V73[Z-M0TFU6"6^>,;Y(I)&:-@
MK87<"!@ #D]*]6HH X'68M5\5>&;^:S\.2:=J82 A;WRUDN&BE63R@RD_)\K
M#+8!+=.M+KZWOB/P3XA:W\,W-E>WMB;=4G2,3SO@@ [2?E7/!8]SP._>U4MM
M4L;N_N[&WN4DN;/9]HC7K'NSMS]<&@#DI[.[D\6ZA?#3[DP2^'TM4<Q]9=[L
M4QUSAA[>]8>GZ9JVCQZ'+>:%J5_:/H5MIUS;VDVR2WFBW9W+O4,C;R,Y/W?>
MO5** .>OK1+#X>WMI':I:)%ILJK;QMN6(>6?E![XZ5SFAV$FIQ^!=0BLIH(]
M(L#)-(T>W(>W""-?[V2=W&1\OJ:ZO4M2T6ZE;0[VZ&Z\)MC&&=0S%=QCWK@!
MBISMR#@UHV%C;Z;806-JK);P((XU9V<JH& ,L23Q0!YTNB:F/@<^BC3)QJ?E
M-']FVC<6,N[KG&,'.<_K6H]IJ%IK?BEIM.N+VTUJ"-[4HH.&$/EM"X/W.1D$
M\?,><UU!U[2U;4E^VQDZ8F^\ R?)&TMSCV!.!5Z&:.X@CFB;='(H=6'<$9!H
M X7P[H-_H_B?1(KF&2>*R\/+827@7*><'0[0>N,*>?ZUK^-K.\NK+2I;.TDN
MFL]5MKJ2*+&\QJWS$9(!QGUK=N-0M;6ZM;:>8)-=NR0(0?G8*6(_($U9H \Y
MN-(U7^R?&>B3Z;-/)K4LL]E-P4_>Q*@5VS\IC*]^H VYZ5O^*=#U"_\ AU>Z
M+8S>;?&S6)&<X\TKC()_V@"/QKIB0JEF(  R2>U5=.U.RU>R6\L+A+BW9F02
M)T)5BK?D01^% '"7UKJWB77OM$6CWVG)<>'[NP:6X"+Y$TC(5!PV2!M/(%6_
M#4,TWV>XO_"]]9:C86K0R7%S/YH)( *P?.Q(8@'H!P*ZJ^U[2],N$@O+M(G=
MD3D$A2YP@8@87<00,XSVJY=7,-G:375PXC@A1I)'(^ZH&2?R% 'G6BZ1J=KI
M?PZAFTZX632V87HVC]S_ *.\?///S,.F?6MNRT"^L_&E^JHO]A7,B:F.>EU@
MHR8]"0LF?[PKH(];TV6]M;-+N,W-W";B"/G+QC&6^G(Z^M7Z /.;'2KN+5;S
M2-4\/7EZC:I)>VM]]HS:A'E,BLR[QM="2,!3G ^M;7A+3I8U\217]@\<=YJL
M\RB9!B:)U4 _C@C!YKK*JZCIUKJVGSV%[&9+:==LBJ[(2/JI!'X&@#EO VEW
MMFUS#>2B:WTIGTW3I-V2T(;<23Z@>7&?>$^M6-0MKZP^(-OK8MYKG39=-:R<
M0KO:"02;PVWJ58<$C."HSQ726=G;Z?9Q6EI$L4$0PB#M_B>^3UJ>@#S8>'M2
MT[P[HEL+*:1QXA_M%X(@&^RP&9WVGG'RAAD#/.<9KK/%XO9/"MV-.L$OKD^6
M5MY$5LC>NXA6X+!<L >X%;M% 'D^J:-K%S8^,HX]'U%_[3-G);&=D9I-H0,#
MAN#\I.. !QQP*ZJ+37O?'6LRW-A*=,O=)@M2\B860AI2ZD=?NR#]:ZZLOQ''
MI4N@W,>ML5TYM@E(=U_C&WE,,/FQTH PO FGW\%M,=2F6<V#/IEG+G)>"-R-
MY]&.%5O>(5V-0VMK!96L5K;1+%!$H5$7H *FH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "L#Q+K,VG3Z/86S".?5+T6HF(!\I0C.Q /!;"8&>,G/.,'?K.UK0[#Q!9
M):ZA$S+'*LT3QN4>*1?NNC*05(]10!P":M=>'-<\6'SQ/<W6LZ?9I<2H $\V
M*)0[!< [5/MD@>M;&H:YKVF:UJNBVP.I3+IR7]FY5$DYD\MXS@!2W=>!SP<U
MKCP5H9AU**:">X&I;#=&>YD<N4 "L"6^5AM!!&",>PJR?#6GO#.LIN999Q&K
MW#3MYN(VW( X.0 >>,<DGJ30!S%OXT>YAM8+.[N)I[S4S9E;B!(;FTQ 9"CJ
MP"[\H<'&,,.N.9KG5_%&DZ:'U"WFN(X[YQ++8)')=+:["4<QXVE@Q ;:#QR!
MZ;5[X-T;4K*YMKV"2=KB9+B2<RE9?-0!4<.N"I4  8QW]3F:'PQ8VUO;QPRW
MJR0.TBW!NG>5V8;279B2_&!ALC@>@P 2:'>C6/#=M=P:BMT)XB5O(4"[NHW!
M2."/0C@C%<1X1US4#HOA#39+^9[C6DN9Y;IU0NHC^8A>,;F9@<D'@-[8]#T_
M3[;2[&*RLXO+@CSM7)/)))))Y))))/J:QXO!.B6]C;6L$,\2VDYGM76X<O;L
M<Y",2<+@D;>A!Y% ">%=7O;^;6=/U K)/I=\;87"KM$R%%=20. V' ..,C/&
M<5G>&N/B7XX'<FP/X>21_0UU-AIUMIL+QVR$>9(99'9BS2.>K,3R3T_  #@"
MJ=YX=LKO5/[31KBUOFC$+SVTQ0R(#D!AT;&3@D9&3B@##U+24URP\5Z<UZ;)
MIM1@$5P #LD$-LR<'K\P48[YQ6++XB\063W^GZWI44?B:'2+N33+^S.Z&\"J
M"0 >5;<$.T_ID9[B3P[ILND/I;Q2&V>197/G.)&<.'#&3.[=N4'.<\4MKH5I
M:Z@+]GGN+M8S%'+<2ES&A()5<\#.!D]3@9)Q0!@^#9X;/X4:7>:>D<Y&G+<.
M'?'FRE=TFYL'DMNR<'FM3PA>KJG@S2KR*U2PBN+5'B@B?>(4*_* 2!T&.U"^
M$M,@BN8+0W-I:W)9IK:WG9(V+?>PO\&>^W%:MA8VVF:?;V-E$(;6WC6**,$D
M*H& .: .'T_Q1J\^B>%+R6X1I=0U:6RN1Y8 = 9\$>A_=+T]ZK-XD\116UUJ
M+ZA T5GXB73FMUM@!+"TR1\G)((#Y&.XYSVZ6/P+H<4L+K'=8@O#>P1_:Y-D
M,IW9V+NPH)=B0.#GTJ1O!FCO:3VK)<F&>]%_(/M+\SA@P;.>/F ..G'2@#CO
M%^J7?B#P/XKN8[HP6]C?&R6W$:D.(Y$#%B1G)))&" !CKS6YJ&LZ_J.H:Y:Z
M#M2XTJ>.)$E\ORI28TD/F9^8*0Y VXQMSST&A?>!-"U"6_::*Y5-0*M=PQ74
MD<<S#'SE5(&[@9/?ZU)>>"M%OM674Y(KE+DQK%,8KJ1!<(OW5E ;$@'^UG/0
MY% &?IU]KVI^,]6LQJ=O#8Z?);.(EM@YD22,LR;L\<X^8>G0=W^(FNSX\\*P
M0W\\,$OVIGB0*59EC&"<@]F(_'UK=L]$LK'5K[4X!*+J^V>>6E8JVT87"DX&
M!QQ1J6AV.JW=E=722>?9.SP/'*T9&X88':1D$=0>* //=+U#5-(CFN[:[C%K
M-XOGLY;8P@[UEN2A.[J",@C&.G.:W)]>UY;WQ;;VJ"[?3IK46T,2*K^6ZJT@
M7<<,^TMMSP2!QVK7_P"$,T?[+]FV7/E?;O[1Q]I?/VC=OWYSG[W..GM4TGA;
M39+C4+@_:5FU"2*6=TN'4EHB#&1@_+C:.G7OF@"+PGK46N:?<W$5[+<B.X,9
M2X@\F: A5S'(N!A@2>W0BJ&EZIJVO1#5+.^MX((M4EMIK29!M\F.1HSSC<)2
M0&'..0,=ZZ*PTRVTW[0T(8RW,GFSRN<M(^T+DGZ*HXXP*S8?!^CV^MS:M#%/
M'--+Y\L*W$@@>7_GH8L["_ YQUYZ\T <U-XOU0^$7\7V\H,$5^T+:>8UPT(N
M/)(SC<)/XNN.V.]0WOB3Q%;VFOZ@-0@\O2=:CM5@%J )8F,(*L<DCB4X(YS[
M<5UR>%-)CN9I4AD$4UR+N2V\UO):8$'?LZ9R ?3(SC/-1S>#='N+34+61+@P
MZA<K=7*_:'&^4;<'.>/N+P,#Y10!S5Y?:K9:QX^O;?4Y"^GV,4MO'+&K1KB%
MW Q@'&<]^_.:NQ7NOJFE"XUN.1]2B,XAMK51.N(U^5-V5*AB2S/C&5&>:V[O
MPGI-[<7\\R3^9J%N+:ZV7#J)4 *\@'&<$C/7!I9O"FE3MIC,MR)--C:*WD2Y
MD1A&0 48@@L#M7@YZ4 <YX>\5ZAXB@\.V<DZV=U?Z7)?3SQ(N2RLB!4# @9+
M%CP>!@=<ASMK7_"9>$[;4-54RM:7;7*VBKY+R1F,9 8$Y(8@^G.,5J-\/_#_
M /9UA910W4"Z>S-:30W<J2P[OO!9 VX*1QC.*T9/#.E23:;-Y,B2:;N%NR3N
MI ;&X,0?G!P"=V<D<]Z ->O.]4\3Z[:Z3XJFANK<3:;JT%M 3!QY3B#(QGK^
M]/)S77^']'_L/3Y+432R*TSRJLDS2^6&/W0S<D=3]2:JW'@W1[J'489DN#'J
M-PES= 7#C?(NW:>#QC8O Q]T4 <]?^*M5\/3>)XKRYAO/L,-G-;2-"(Q&9W:
M,A@#RJE0W7.,C/>K'C&#5+;P9XM2\U"*[LWTF5K<,@696$;!\[0 5^[CN,G/
M:MZ;PKI-U<:A/=0/<-J-NMM=++(S+)&N=HQG QN;D8/-00>"](AT6[TD_;)K
M:[B\F8SWDDCF+! 0,S$JN">!CJ: ,^+5K]/$$VEI<;;9=!CO(_D4LDFYEX..
M1A1P<U5\/>)M1\1/HFGM=?9;B?0HM4N9XHU+.SD*%4,"  0Q/']WIS6_=>$M
M+N[JVN9!<B6"W-KN2Y=?,BZ['P?G&>>?ZU G@?1(8],6WCNK=]-B\BWEANY%
MD$1QF,L&R5X'!Z=L4 <EX5U/4-,\(^"8H9HO+O=3FM;D>5RPS.^0<\<I^M3O
MXD\116M[J+ZA T5EXA73S;K; "6%I8X^3DD$!\C'<<YZ#J;?P7HUK9Z=:PQW
M"PZ=<&ZME-S(=DIW9;D\_>;CI\QXH?P9H\EG<VK)<F&YO!?2K]H?YIPP8-G.
M1RJG XX'% &#KWB37(+K7H+%A%?64MLNGV9B#_;$<+N;U/)<?*1MV9/>NHUR
M[N=-\,W5REW:1744/%Q<J1$'Z9*C)Z] ,\X%<G=^'-3G\0ZE/)8ZLCW,X:*Z
MT[6V@A9 BJID3<"&PHSA&KK[K18-5\._V1J[-=I)"D<[Y*%V7!W KC!W#/'0
MT </K.KWU[X9^(6FW;3/#9:87@>XC1)2LD#D[@N!U7(X!YYK5M_^2BZ!_P!B
M]/\ ^C(*U#X(T5TU%72[?^TK=;:[9[R5C,@!')+=<$C/7'%78O#UA%JEIJ*B
M<W5K;&UB8S,0(R02I&<'E5Y// H H:WJ]VOB*RT.R,L<EQ:37+2Q>7O^1D4!
M?,^7^,D\$\#ZUA:QKWB?P]X>TK6=2DMG:)WAU.TMP"''S8D1L$C;@,XYP W]
MWGJ==\,:9XB^RM?),L]HY>WN+:=X98B1@[74@@$=14D7A_3X&B*1R8BMWMU5
MI68;7.6)!)RQ(Y8Y)[F@#'O=7O[:YT'1H[MKFYU"WFF>\@6)2_EA/N!OEY\P
M'OPI^HRY-2\7B^\/Z3<WUE:7EZ;N.>6. 2_ZM-T;XS@'!7*],^W%;<G@/0I-
M$L=*\JZ2"P??9R)=2":W/3Y),[@,<8SC\A5M/"VEQW.FW"K.)=-WFW8W#DY?
M[Y;)^<MW+9- &/9ZEK>KKJ36>I6T,NE7ZVCI-$!'*J*AE=^K*6#,5P0!@9SS
M4<^O:\MWXM@M4%W)IL]J+:&%%5_+=4:0+N.&?:6VYX) X[5L3>#M'FUV36#%
M.ES-M,Z17$B13E?NF2,':Y'N*DD\+:;)/J$_^DK+J$D4L[I<.I+Q$%",'Y<;
M1TZXYS0!S5IXRDU!K"SL+R>XDO;N>(F2%(;FW$4:LT3(X"B3)SR"-O;O5BWU
MK7H]1TCP_J<L,-]>373-<P[68P1!2ORX*K(P=,\$  X'(QK7W@K1=2LW@NH9
M7D>Y%V;I9F283!0H<.I!!"@#C P.E.N/!VD7%G96[)<B2RE,T%TMS)]H5SPS
M&7.XDC@Y)R/H* ,WX>I+';^(4FE\Z1=<N@TFT+N^[R0.,_2J%_XJU1O#WB/Q
M#93(BZ+>S0BR=%*RI"0'WG&X,WS$$$ ?+P><]=H^@V&A)=+8K,/M4[7$QEG>
M0LYZGYB<56E\*:3+=W<YAD"7CK+=0+*PBG=<89DZ$\#/]['.: .6OM:\47=Q
MXI.G:E;6J:3%%<6\4EH&,@:'S#&Y+<>A(Y^F.9= U#4-:\:2W8O9H8I]!L[N
M.V=59(FE,F1C /! /7)QUQ@5<M?#4UYXL\3SZC;7,>GZCY"(%N $N$2/:RLJ
MMD G/ID<'TK??P]IS:P-56.6*[%N+;=%,R*8P25!4':<;FP2.,T <EX=\6:E
MKEMX6LIK@076J:?->W%S'&N?D*J%0$%027R<@\+[Y$7_  E6OR0VELL]O'<Q
M>(FT>XF,&1,@0NK@9X.-N0.^<8KIXO!NCV]AIMI;Q30C3"392I,WF0Y&" Q.
M2"."#D'\!4LOA72I8;.(Q2JMI=&\C*S,"9SG+L<Y8_,W7/6@#FH_$.OP:?J\
M9$VHR:9K'V666TA07#6YB63<J'Y6<%P, <@'C-=/X8U2+6=!AO8;\7J.\@$W
ME^6V [ *RX&& P",#D&F+X4TV.>>>)KJ*:>[%Z\B7#@^=LV;NN/N\8Z$=JB;
MPK;1WVESVCS0"SGFG<K.X\UI.7W+T8L3G)Z=ASP 'B#69K/6-"TBW?R9-5N)
M$,^T$QK'&SG:#QN. !G(Z\&N/UW6M7E6]T>6^D273M>TZ$74**IGAF>-@&&,
M;AGG& <#C!(/H.JZ-9:S##'>1L6@E6>"2-RCQ2#HRL.0>2/<$@\54N/"NE7>
MFSV4\4KK/.ES++YS"5I5*E7W@Y!&U<8Z  #CB@#BM4GU73=;\>:AIVH+#-I^
MFVMR6D@5S,8XI6VGH #@YP,\\8Q6S<Z]K6L7E]8Z)^YNK6Q@N(_]65:2568!
M]_.SY0/EP>O/2MF7PAI,W]IATN"-3MUMKL&Y?]Y&JE0O7C@D9')R:BO?!&BW
MUS:7,BW<5Q:PBW6:WNY(G>(?\LW96!9?K0!EVFH>)-2\7RZ<=1M+2&"QLKV2
M.*W$H)=G$D88GD'80&^AQZV/&;78U7PK';7\]LD^J^5(L84AAY,K G(/0J..
MGZ8V[;0+"SUB758$=+F6!+=L2'9Y:9VJ$Z #)Q@=Z?JVB6.MQVRWJ2$VTXN(
M7BE:-D< C(92#T9A^- 'G8U#5-%B\4ZK8W<:16_B1%DMVA#><K_9T8%CR.&R
M,=QWK9UCQ)JECJX:"[CF@76;:Q:*&,&*.*38I$C$ ^;EB<*2 -N1S6W+X,T:
M:SOK1X[@P7URMW<*+AQOE!4ALYX^XO P/E%1W'@70KF:XEDBNLSW*7CJEW*B
MB=2") H8 -\HR1S0!S6J^)/$5I!XIO8]0@$>BZA$D<(MAB6-DB8JQ)R/]8>1
MSG\J[;Q%>S:?X?O;JWN;:VFCC^26ZR8U)( ) !)Z\ =3@53N/!NCW-MJ=O+'
M<&+4Y5ENU%PX\QE  [\<*HXQT%:&J:/9ZUI$NEWZ--:RJ XWE6X((.X<@@@'
M/J* .2C\1:]GQ-:VT-Q=S:<UJ]LLJ1I.T<@!< #"E@H8J"!R0"*W?">M1:YI
M]S/%>RW(CN#&4N(/)F@(5<QR+@88$GMT(I$\&:1'+=3+]M\ZZ$/G2F]E+L8F
M#(V2WW@0.?08Z<5J6&F6VG?:&A#&6YD\V>5SEI'VA<D_[JJ...* .0F\2:I!
MK^GJMU'<6MSK,FGR+%&/)1 DA4!B QE!0;L94'<.HK7\8ZEJ6F0:2=-GBA>Y
MU."UD,D6_P"1VP<<C_/I1_P@NA>>)1#<C;>F_1%NY0D<QSN95#87.YL@<')K
M3U;1;/6DMDO!*1;3I<Q>7*R8D4Y5N#SCT/% '+RZAXDDO-0T*RO?/U/3K2.0
M7(ABC6:20N5WHQ.$ 50=O/7D<"FWGBC4K'5K.'5G?3H+C[*(KF&-9K1W;'FQ
M.^"R,<D*3@'@UO:OX1TG6M3@U*Y6YBO8H_*\^UNI(&>/.=C%"-RY[&I9O#&F
MSR2;TE\B5HGDMA(?)8Q[=GR=!C:O3&<#.: .5N?%&KP:!KMVMRIFT_7X[&(F
M)?FA:2%2&&.N)&Y&.U4O$<MQ;W'Q+GM+F2VGBTFVD62/&X$1S'N#UZ>OI@UU
ME[X&T._FO7GBN=M[,EQ-$EU(D9E0J0X4$ -\BY(YXJS)X5TJ:;59)HI9#JL
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MD;[SB+.P,<GG'>@##T7Q)JD_B+1+:>Z2[MM2MKJ1Y(XP(=\;)M,)P'*X<C+
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#/70],36Y-:6RB_M*2,1-<8RVT=![5H444 %%
M%% !1110 4444 %%%% #9(TE0I(BNAZJPR#3J** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4 ;=%8C>,?#:02S-KNGB**3RI&-PN%;&<'GTY^E6[S7-+TYPMYJ%O"2H?YW
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MMJ%JP,4\:N!G.W(!P?<9K!U/Q6(O%'A_3=/N[26*]NI8+A,%GPD3ME6SCAE
M/!QTXH ZNBJ*ZUIC:BNGB^@-VQ8+%O&YBOW@/4CN!R*1=;TM[W[&M_;FX^?$
M?F#)V?>QZ[>^.G>@"_16-INLVQTB*[NM6LKM99I4CN+4823#M\JC+9*A<$@_
MPDTY-6@NM8L([35K!X9[9YQ;##2S+\NV1"&X49/8YR.: ->BJ$6M:9/>?8XK
M^W>X.[;&'&6V\-CUQWQT[U7B\4Z!/=0VT.LV,DT[M'$B3J2[#.0,'D\'\CZ4
M :]%9>OZ]8^'-+:_OY-L6](U ZLS$ #\SUI]SKVDV:(]SJ%O$CH) S2  (>
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MH6T44B>:KM(,%./GS_=Y'S=.10!H45D/J]O'K<D;ZQIZVT5GYTEN6 D3YO\
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M1E8J_1Q)D#"D_>YQ@U633;U=$51I=V)?^$N-^5%LV[R?M._S.G39^/:O4J*
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MEXF#+N4X(R/0U!9:+:6&JW^I0^;]IORIN"TA(8J-JX'08''% '*^'-&N=/\
M&!2[MY95AT&RLQ>-$2CRQ,Y?#$>ZG_ZXK,L=$U2?PAH?ARXM+B+5=-U2*66Z
M,9\O;'*7,RR=#O7(QG=ER".IKTZD)"@DG ')- 'E-[::Q'X6U?0IM&O[B_\
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MKN*S=(T*PT.*5+%)096W.\TSRN>N!N<DX&3@=!D^IH TJ*** "BBB@ HHHH
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M);:9?ZA>P/,9;^02SAVR"P4*"!CCY5 _"DU+0K/5+^PO9S.ES8LYA>&4H<.
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M;ZA_:1_>#/G[]^[..FX XZ4 8>J>*M:2?5(K)H(K^UU."SM["6'>9X7\O,N
M0Q^^[9!  0Y[FNJUZ\N=.\/7-S#/:1W,:#$MSE8@20"<#)[\#N<#O7&OH6L2
MZQJ3FV\06ES<7+R1W%CJD8M".%1F5F+ [57<-AYS@8P*[35-%M]<T-M+U)GD
M20(7>-C&V]2&#*1T(9010!PNO:U>:AX/^(.GW6]DL+,B&26(1R,DD&_YE'?.
M>P.,9&:V8?\ DIVD_P#8O3?^CH:OOX'TF2+58Y)+Y_[5A6&\+W3,9%"[>_0D
M<9';IBK\?A^UCUBVU7S;AKJWM3:(6<8,9()!&.N54YZ\4 4=9UB\7Q!;Z'8+
M(LTMG)=-)&L;, K*H #L!C+<]>WKD8FL>)/$OA_0=)UG5(K1%#-#JEK"02K8
M8+)&V3\H(#,.<+D_PFNDU[POI_B"6TN+A[JWN[0L8+JTG:&5 WWEW#L<#(-2
MIX>L4,8_>M'';O;K'(^]2'Y9CNSN8]V.2><]30!DW>L:E!>:3HJS?:+V[M);
MF6ZMHT&=A0?(KL!@F3/4\+[Y&8^K^,6O=!TF:73K&^OX+OSW\DS!'BV[' #X
MY# E<\'N>E:TO@'2)-)TVP$U_'_9A/V*YCNF6> $8*JXYVD<8.>,>@J\GA>P
MBOM-O$>Y$NG+(L):4MGS,>87)R6+8&230!EZ?JNMZRMQ=6-U9(MCJ;6<T,R%
M5>.-@LK$C)5CRRCH!@'/6JK^(];1/$WEVPNWT[4XH%6S@_>>0T<3NRJ2=[A7
M;'KCIVK87P;I2:[/JL37<3W$@FGMH[EE@FE&,.T8."W ]C@9S4@\+6:37L\=
MQ>1S7EREW(Z2X(E4!01QTVJ!CH0.1UH P;7Q@^H+I=KIUY]M;4);G;/%$J21
MI$%RC)(5 D&\9SZ$XYXFL]=UZ34M,\/ZDL%IJ4ZW,TT\85LPQLH0JN2%=MZD
MCD#!]1C0O? ^CW]H(I/M*7"W37JWL,QCG69A@N&7&,@ 8QC '%/N/!NF3QZ>
M1)>1W5@[/!>)<-Y^6^_N<YW;NX.1P/04 4/ARLJ:/JRSNLDHUN_#NJ[0S>>V
M2!V^E4+WQCJ2^&-3\4VIB-KIU])";)H^9(8Y?+<ENH<X+#MT!!ZUUFBZ#9:!
M!<0V1G*W%Q)<R&:9I"7=BS'D\<FJI\(Z7Y]TP$RVUW<"ZN+,/^YEE!!WE<9Y
M*@D @''(/- ',:IXA\5 >+;BPNM.6/0)!(D4EJQ-Q'Y"2E"=_P IPQ&1U..G
M>UI.H:GJ?CC4I8[TQVYT>TN8;>6(,L9D\W@X(/4 GG)Z<4^P\-3WOB'Q8VIP
MW<.G:E<1%8_,3R[F-840@@$L.58'[N0><UT,GAZR;6GU:-IX;M[86S&*4JK(
MI8KE>A(WMC([_2@#E_#OBV_UVV\,V1DCMKO4M+?4+B>.,84*44*BG(R2^><X
M"^^1"/%^O316%NALX[M=?DT:ZD:!BD@5&82*-W&0%R.><C(KHH/!FEVMEI5O
M:M<P/I09;*=)!YD2D8*Y((92,<,#T'I4S^%-->.Q0><GV.[-ZC*_+SG=EV)'
MS$[F]N?88 .=3Q1KD&E:EY\4EZVFZPUE<SV-MF46_EJ_F+'DY8%U! SQDXKJ
M?#>IIK&A6]]%?0WT<I<K/"A0,H<@94\A@, CL0:KQ^%;.":>:"ZO8IIKW[<S
MI*,^;L\LG!&,%>-I&.!Q4:^%X[:_TN6QN+F".TFGFF"SD+<-+DOO0<,2QSD]
M.PZ8 ':WK,UMKVB:);L(I=3:8F<KNV)$FX[0>-Q)7KD8SP:Y'5_$&LW-O)IK
MW8@NM/\ $=G923PQX%Q$[QNA(/0X8;@.N.P.*[O5M$M-8-K)/YD=Q:2^=;7$
M+;9(GP02#TP02"""".HJK<>$],NM,DLI1-^\NEO'G60K*TZD$2;AW&U1Z
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M&WJ!T)*@G],58N/"&EW8UI;CSY$UE%2[5I."%7:NWN"!_P#7S0!:U;4F\/\
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M)PP5=JXP/E(&.GISFF1^"]-26[F-QJ$DUY:"SN))+IF,D8W=<\9PS#/;/&*
M,*&ZFU+Q/X%O)6"SW.BW4KLB@ ,RVY.!]33M+\6:M=Z7X.NY7@WZM>2VUTHB
MP,*DS KSP?W8]>IKHK?PO8VUUI-Q')<;]*MVMK;+@@1D*"#QSPJC)YX^M4[?
MP'H]M):-&]]LLKIKJUB-TVR%FW9"@?P_.W'X=.* ,./Q1K]OI&L:U=W5B]MI
M]]<6*VZ6Q7>PF6.-RQ?@#/(_4=NET>;7O[8NH=1B!T\Q*]O+)Y:RA\X=2J,0
M5Z$'@\D'/6GP>%-+BTK4M,E22YL]2EDEN8YVW!FD.7(QC&3SQT[8K/D\$00^
M'KK3;/4-4,TRJD=S-J$ADA52" K]548Y Z]"?0 TO%>N_P#"->%M0UCRA*UM
M'E$)P"Q(5<^V2,^U95YK&KZ1XCMM)EN(;E=0L9YH)S!CR9H@I8$ C*$.,<Y&
M.IS727>GVVH:7+IU_&+FWFB,4RR?QJ1@YJA;>&K2V +7%U/*EN;6*:>0,\41
MQE5..^%R3DG R3B@"EX(O=9U?P_9:QJMW;2+?6<,T<,-N4\IBN6RVX[LY'88
MYZUTU4='TJWT/2;;3+0R?9K:,1Q"1MQ51T&>^*O4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %5[N]M[%$>X<KO;8BJI9G;!.%4 DG )X'0$]JL5SOB_3EU.SLHFCU!62Z$B
M7>GMB:T8(X$@'\0YVD8.0_2@#0?7M,2RCNS<[H9 Q38C,S!3ACM W8'?CCO5
M2Z\9^&[.*.6?6K-4EM_M*$2;MT60-XQVY%<@MIXFL+G1]6U/3;K50+>XM+I-
M/<03+F;=',4#J,LH&Y0>"?:M+3]%ELO%OA^6WT1K/3[;3KJ$HF&6W:22-U4G
M/7"MDC(R>N* .@M-8M#<:O-)K5K/;6LJAE50OV7Y!E6;/S$GGMUQ4I\2:0MK
M>7+WBI'98-T)$96@!&074C*C'.2,8KB=5T'6KJ]\27-I92D_VO8ZA;Q.0HNT
M@6+<@)/!RAQG'('UJUKOA^_\0W'B/4;2UE@%WX?;388IP$::8EVR1V R%!/]
MX]AD@'9_VSIPO&M&NXUG6W^U%6X_=?W\GC;SUIUEJEGJ$DD=M*S21JK.K1LA
M"MG:<,!P=IP?:N&%MJ6H:V+V;PW>FS/AR:R>&9HT+R%E/EG#9&[!&?Y#FM?P
M?I^IZ;?7L$EQ>7&D"&+[*^HH!<1-EMT1;JZJ,8)_O$ GK0!JP^)K";Q)?:(#
M(L]E#'+*[(P3Y]YQG&. F<YQSCJ#4]OX@TFZEGCCO8P\$0GD63*8B/23YL93
M@_,./>N3UW0=6OM;\66]M;2+'K&CQ6]O=[E$:2()@5?G<,[UZ \$^E4;O2-1
M\3>'M0,7AJYTO6A8^1YM_<B3S&#JYBC;>V8V*G).!R.O. #H/$_BQ(/">NWF
MBWD7]H:?:&XV31-D#!*MM."0<'#<CZUI6_BK1)8KHG4[<-91++<DM@1J?XLG
MJ,@C(XR,5S>N_P!H^)O!>N^7X7N++4+G3FM0LXC\Z5SG"@JQ^0$GEB.O INK
MZ=J%QK=_<0:;<M#+X:>R0A0,S%B0F,^AZ]/>@#JK'Q/HFI7+6]GJ4$LJP"X*
M@X_=_P!X$]0,C/IWQ46EZU:_V%;7D^KPZ@LTCI'<00D><0S?*B+DD@*1QG.T
MFN>TO3K^WUOPC.^GSI%8Z)+:W+;1^[D(APIYY_U;=,CIZUDZ7INO:)IOAC41
MHUU<'3I[Z.\L8RGFA)Y"R2("VUB!CC/1C[T =Y_PDVC&SM[M+Z.6&X#F+R@7
M9PGW\*H)^7OQQWQ6?J&O3_\ "0^%8]/N8)=,U5YM[*N[S%$#2(5;/3(':LV\
MAU%M0TEH?#;VUE+'<F06@B6>%W*D*[;AL#X9F*'.0!GCG,T#2=7MK+X>17.E
M7,3:4LJ7F=I\K,#1@G!/!8CISCDXH ]$N[VWL81+<RB-2P1>Y9CT4 <DGT'-
M9[^*-#CL1>2:G;QP&?[,6D;:5ESC80>0V3T(R*S_ !78W[ZGX>U:RA>ZCTV\
M:2XMD(W,CQM&74'J5W9QU(SCFN:UGP]J-RVM:C;V$[IJ.K:?/':X ;RX&CWR
M,"< D*>#SA1ZXH ] T_5+'5; 7UC<I-:DL!*O RI(;KZ$&JZ^(]):&:8WJI'
M#&LSO(K(-C$A6&0,@D$ C.>U7+P;].N (/.W1-^Y/&_(/R^V>E>;C2O$&FZ5
M?6VF6EUJ&F"W@,%IJ<4;SVS"52\<;-Q($0%EW$@,%P3S0!V6I>*]/L_#VK:I
M YF.G1N98=C*ZNJ;@K*1E<C'4=#FJFDZW+%:KJ.IZHDUI=0))%"MHRRQN!F3
M 49*#*\XX[DUSK:5JS6'C^,:3?YU6V LS-(CO*QMA'@X8X.X'T 'ITJS?6VJ
M66H:%JHT?4+ZS73?L5S;6DWESP294A@-ZA@<$'GL#0!T3>,=).LV.G0RM.;V
MT:[BFA1G0H"H&" 0<[NW3'/45=M_$&E76FPZC;WBRV<THABF16*NY;: ./[W
M'UXKF;/1KG2_%'AVYM-#:WT^/3[FU:&!U(M3)+&Z[LMZ*V=N>>F>*DT?1KBS
M\;:A9(R'18)!J<* \QW$P963']T$2/CUD% '3ZEK6FZ.(3J-[#;>>^R+S&QO
M;&<#\*J-XLT);"*^.HQ?9)8Q*)@&*JA. S''R+D$9; X/I5#QE9W5Y+X>-M:
M2W MM7BN9M@!V1JK@L<GL6' YK(U>PO;?Q;JAN= O=8TK5H(D3[+<!5C95*-
M'*I=1L(YSSU/% '677B'2;*X\BXO8T<&,,<$JA<X3<P&%W'IDC/:I9=8L(;P
M6CW&)O,6(@(Q4.P!"E@,!B"#@G."#7GGB;1]:N;?6=/M]!EV!;(VALC&L<RQ
ME"V]BP9F7#*JGC 4X[UJ76FZH/%9U'2H;ZTEGO8#>VLX62UNH@J;I>XCD0#&
M0<DH."#F@#J_[>TL7J69O$$SRF%,@A6D'5 V-I<8/RYSP>*K/XP\/)<&!M7M
MO,6X%JP#9VRG&%)Z#[P'/&3CK7'6WA[5Y?!EKX4N;29;ZTU-)?M_'EF-;CSO
M.#9^\5R-O7<?3FDU/1M4GT+QE!%I=PT]_J\5Q:J O[V-?(RP.>,>6_7';UH
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M:QWC@8E>+S-_?/\ $I]Z .RHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!KHLB,C#*L""/:J6CZ
M+IV@V LM,MA! #NQN9B3TR68DG@ <GH *OT4 %%%% !1110 4444 %,CBCA4
MK'&J DL0HQDGJ:?10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!8?,&YBOW@!W([CM0!>HKE?$'BI;'5=%L]/N[.1[K4EL[F)AN8+ABVT@X!!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *Y?Q_;7%YX:2"UMIKB7[=:2;(HRQ"I.CL>/15)KJ** .$O+2Z;Q#
MXSF6RN6BN](@A@80-B5U68%1QR?G7\_8UL^&+B:ST3P_I4VGWJ2_V:@DE,6$
MA:-$4HY)R&))QQS@UT5% !7+^)#=KXBT4Q:;<2V^R=7N[6)7EA8A,(">$5\'
M+?[(Y'6NHHH \L\+:9J%L/ *WFDWD)TVTNXK@R0$^4S!0O3.,X./IZ$9FBT>
M[C^&T\P@>TU/2=0NM3L_/0IC$\D@'/\ "\;%3[-[5Z;6;J6A6&K7EG<WBRNU
MHQ:-%F=48G'WT! ?E0<,#0 F@VTUOI:R7:;+RZ8W%PN<[7?G;GN%&$'LHK%T
MV.:#QYXGNI;2Y6VGMK58I?(8K(8Q)O ..<;A]<\9KK:* /,=%TW4+;1/AU#-
MI]VDFGS,;M3"W[D>1(F6X_O,OYTR^TR]FT7Q%!_9EV[7/B:"[C3[.Q\R$/ 6
M<<=,1O\ E[BO4:* /-/$&GR3OX^,UG>BWO;.U6W:./89I%5AA2W!.XH,=^@S
M6IX9O$N_%EU?7L.I6^I75I' JW&G/;1,D18D@DL"V9">O3IT)KJ]4TJSUJP>
MQOXC) Y5L*[(P92&5@RD$$$ @@YXJ'3=$M=,?S(Y+N>7;M$EW=23LH[@%R<=
M!G'7 STH QM2BN;;XC:9J8LKF:S.F7%LTD*;Q&YDB8;O085OKC YKF?#NE7]
MGIOP]BDTVZBDL)I_M8,##R=T4BY;CNS+_.O4:* /+M'M]5?7O"UU/H5]:BUF
MO([B!(52"U+@XV\Y93U+\Y)X]!U'P_@NK'PNFGWEG/;3VT\ZMYJX#9F=@5YY
M&"#GIS]:ZFB@#RZ6WU6;5M-E.A7T)M/$<L\L4$*B$1LLP$H;.7+[E+-T!)Z=
MTDTR]_L/4%33+OSI/%:7R@6S;FA%PC^9TZ;5/OVKU*B@#SC5;#4#!\1[5=,N
MY#J<&ZS=(LK*3:)$%!]=X(QVZGBI$^VZ7KTDM[H-]J>F:KI-M:A88 YB>/>&
MBD5B-JMYF<GCUKT.B@#A;FRGA\8+.-/:"UC\.26I,<9\J-]ZL(PV,< '\JQ_
M#6GMJV@_#N:QLI8I-+@6>:=X3&H0VY4J&(PV]F4\9X!)KTVYMUNK66W=F5)5
M*,4.#@]<&H-*TRWT;2[;3;3>+:VC$42NQ8J@& ,GDX% 'GGAZVU0Z_X3NYM$
MOK1;>UN[>XA$"QPVC-Y9"(,_<^5OF.=W')Z"KI]GK&E^'/"DLVBZI+'I+3V]
M]:VY*3?/P)(PK N!CMU#G&>:]9HH \YN]%5+>QN-'M=7T&ZS=7%O/'&UR0SE
M"R3Q_-Q(1NQGC9U!XKLM*DNH_#%D^H6JV]VMHGGV]NI81OM&54#/ /'&:U**
M .$^&GAFVT[PCHLMWI(L]8M8W25GAV29)(()Q\P((]>@JAX:TV?%CI&K:!J9
MU32[AW34))G-KG+8F0[\$LK?=QG).0!DUZ510!Y186^K)X?\):1<Z)J']H:1
MJ\;7CB',; "0&59#PP;=G.<\G/O?T?3Y1>C1]9\/ZG<75KJLE[!?><_V1@96
MD67._ 8!B-N,D^Q./2** /-K:QO+;P+XB\O06N;R35+F>.VGMCF2.2XW!PIQ
MN^3# 9Y*@52O]/U2XT_Q^B:;JDIU.QB%K)/$-TS>44QA>ASVP,#KBO5J* ,C
M4[>:_P#!][;6\3&>>PDCCC8;26,9 !SC'/K7(V>E7-X?"EQ;:5+%-HNGRI<+
M<0F'>Q@\L0C<!N!;G(ROR]>17HM% 'ENBV^I+K&DWLVC:E#$N@3V<D?V8)';
MR;HB(D0<A1M8 G)/')J?0=-O+*/X=K)IUU$=.LIH[S_1V_<L80N&P.[#^M>E
MT4 >6^"+;6?#MS:27NGWD]G>-<QLK6[>9I[>>[J1Q_JY%92>IR!V&!.NA7MW
M\-/%EA%ILJ7]U<:A) DD6QI1)(S)C/\ >7;^F:]+HH \VU"2ZO\ 6-5U/^RK
M^WLI/#$D DN8?+PX9V*D$Y!_#],$NT#3?[4/@*]L[.6!=+L&:XE>$QC:\ 01
M@D#=ECNXR/ESGD9[^^LXM1L)[*<N(9XS')L;!*D8(SVXI-/L8=,TZWL;??Y%
MO&L48=MQ"@8 SWP.* /,M'@UK1-&\&W<NB:A+'I"3VE]:QQ@R@N %E1<_, 5
M(R.SG&:WM?TX_P#"'+JVFZ:NFWFESMJ=I;E51B0275@O ,BEP1ZL,\BNXK-O
M]"L-3U"SO;M97DM"3&@F=8R<@Y9 =K8(!&0<$4 +HEG+9Z7&+D#[7,6GN,'/
M[QSN8 ^@SM'L!7FQT[^W?#OB_1;6SE:^NO$$OE3"$[$(D0^89,8&T GKGC '
M(SZU6=I.BVFC"[%H9?\ 2[AKF7S'+9D;[Q&>F?0<4 <I#HUY>7OCZ.*"2VGU
M J+*ZDB*@G[*L6X-CL^[^?>F6-C>:I)X+(T^YL+C1@?MGFQ%!&! 8S&K='#-
MM/RDC"YXXKOZ* /*;:QUG3O#NB,VC:E,-(U2Z:[MH"4DD21I@)(L,"^!(IXZ
MAB/7%Z6TGTJ]T?Q!IGAW41IZWES+=V?,ET6FC51.49B<Y4@C.<-G&217I%%
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MZ1%Y\,WRY"[63D\8(KL?'\4AT?3KE(994L]6L[F811EV6-)5+,% ).!SP.E
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MYQ@'(QCGFN1O+21?&-K;7]JT.I-J)GTS6(C\LL);?);R'J"(PRA3D$ $=#@
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M6O+BX%Q+YBI*05A&T#:F ,+QGG/)-6Z* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HIDDL<(!DD1 Q"@LV,GTIQ9595+ %N ">M "T444 %%(&4N4##< "1GD
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M.K%@K E3A@#T/6EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPO;P6DJ*I2-E*[6<#<^%) SC\<##-/\ !-U9W.A//K\]S%HN];53;HK-&R;
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M(0AC.H&&^[SGO@X]<5)<ZC8V>_[5>6\&Q=[>;*J[5SC)R>!GBO-=5T2QCO\
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M#FJQUG2UB>5M2LQ&DGE,YG7"O_=)SP?;K7/?$BV%UX56,6KW$@OK1E1(C(P
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M]U MRXRD+2 .WT7J>AKS#6999-4D\K3+ZW-MXFMKB6*&SED\U!L4SE\$$%0
M%3& .0>:TM*DA.I:AHFN:/>SZD-:>^M9/L\ACD3?NBE\T#:H1<*03_#C!Z4
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MD=* ._HKBM"O?$EZOBHQ7=A/<V^IO;VB3Q.D:[4BP"0Q.W!/ &<DG/.*[6@
MHHHH **** "BBB@ HHHH RSH4)\3C7OM-Q]H%J;7RLKY>S=NZ;<YR,YS6I11
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/Q>$X(+BX,.J:I'
M:7$KRR60G'E%G)9L$KO4$DG 8#FM]55$"(H55&  , "EHH **** "BBB@ K,
MU_1(/$6CS:9<SSPP3%2[0%0QVL& RP/<#M6G10 B*515+%B!@L<9/OQ2T44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\B6-<B4$8</]YB1NSGCICO@ K:IK^I6_BBVT.PT^VF>YLI;J.::Y**"C(I#
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M1 \3[.O^U\@R>_M0!B^"O$6HZ7X<\%V=]ID(TO4;6*U@NH[@M(LOE;AO3:
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MPNHK>Z$DVUR&569TP"/E#KP>IR.,<U/ADBP^"HH%@D@6.[NPL;Q-'A3<2%<
M@<;2*Y>^M9Y;'XA+H]KNNWO8GC2),/- (X1*J>N0LB\=_>@#U.&ZM[A&>">*
M55.&*.& /H<4L5Q#/GR9HY, $[&!P",CIZBO/-3AM-2UR?4M+2-M+;09X;[$
M>(W;*^2A7'WQ\_'4#CC(K>^'VFV-EX,TB:VLX8+J;3[=;IUCVN[K& 0YZD@E
MASTH Z0W,"W"V[3QB=AN6,N-Q'J!UH-S LHB,T8D)P$+#).,XQ].:\LO+>ZN
M_"^OZ3-$Z^*?[7>:T?:?,<F4&&5#_<5, D<*%(.*W?#FE:9-X^\57,MA;O-%
M>02VTK0CY3]G579"1UW;@2._6@#MY[B&VB,L\L<48ZO(P4#\32M-$H0M*@#_
M '26'S<9X]>.:Y+7)7L_B!I-UJ*YT4V,\*R.,QPW)9""_9<H&4$^X[UR5KHR
MQ7GAJ*]M UE_;U\]I'+'_JK-HY1&I!'"%BN >,%10!ZU%-'/$LL,B21MRKHP
M(/T(K#T+Q$=3NM6M[R."UDLM2:QB43;O- CC?(R!S\_0#M6?\/DC@M==MX4$
M<*:S<F&-5VJ(RP(*C^Z><8XZUR6JZ+9WMKXXM)M/#Z]<:B9-+)B(FR881')&
MV,A0ZG+ X&#F@#U>2Y@AECBEGC220X1&< M]!WK&TSQ$UUKVMZ;=QP6PT^XB
MAB?S<^=YD8<=0,'G&!G\:XG4HX)M<US1/$S:H9+V2"2Q:TMMPN%6- %CD"$H
MRR*Q^\H&[/<FJGBBQ@NH/B/*UL)KP+;_ &-S'N?>L"#,9QU#K@[>X]J /6I+
MJWBF2&2>))9/N(S@,WT'>L:#Q"Y\4ZOI5S#%#;V%K!<K/YA)<2&0'(P,8V>_
M6N"\97<=T_B%;>UGCG673Y@Z022M=*K1L)%;!5$4%AA><@\\X/0>;!)XX\32
MS+_H\FCVH'FQD!B#,2,$=1N7(ZC(H VO#>NWVOQ6VH+:VPTJ[M1/%(DV98V)
M!".N,9*G.0>""/0UN?:8/M/V?SX_/QN\K>-V/7'7%<Y\.HHX?A[H4:QB.1+*
M)9DV[6$@0!@P]?K7'Q6]W=^$+;36C=/%]KK(E9BA#AOM.6FSWC,)//3'R^@H
M [.[\1W4VMWNE:-!:W-S8I#),D\VSS/,+95" <%50GGU ]ZUKG6+*VU.#3&N
M(A?7$;R10L^"57 R?09(%<WH4=J/B9XHD$4:LT-H(WV8W,%DW[3W(R,X]>:-
M<2&W^)?AZ]N+<F$V5U%YPA+@2;H2H) .. QR?0T :WA7Q#_PD&AVU[<)#;74
MS3#[.LN[ 25DR,X)'R]<5L"Y@-R;<3QF<#<8MXW >N.N*\DT:TMK?2/!EVEL
ML=\NO3^=+Y>)%B8W ^8XR%(9.O'(J]X;2VO;ZQL=7_M5?$>FZA+,T0M]BDEF
MS)YH3F-D;H6YX'I0!V?B?Q#<>'SI7DV,=T+^_BL?GN#'Y;29PWW&R!CVJYJ>
MHW5C<Z;##:0S?;+CR&+SE/+^1WR/E.[A".W6L/XA6T\FFZ1>PP2S)IVKVMY.
ML2%F$2L0Q"CDX#9P.P-7)M2M-;U;1TTR9;I;>Y:XGDBY2-?)D0 MT#%G7Y>O
M4XX- %OQ%KT>@65M*R(\MU=1VD(DD\M-[G@LV#@<'L?3O4FG7VHS:C=6=_81
M0"&*.2.:&8R)+N+@CE001M''/WA67KNHZ'J^E2V6HV,M[ISWIL+M7MI,1LJE
MMV,9V@@?..!G.>*Q/"KR>'-2U>WM]5NM4\)VED+B*:7,S6\@+;H4<#,@"C.!
MDC@=^0#T&21(8GDD<(B LS,<  =2:Y_2]>U'7=/&J:9IT'V"7+6QN;AHY)T[
M/@(=H/49))&,@5>U6U'B#PM>VD$IC&H63QQR,I4KYB$ D'D=>E<KH&K1V?P]
MBT;56DTS5M/LA:/ S-&[-&NU6B88WAL @J3UQ0!V%IJ(DT>VO[Y!8M)$KRQS
M.!Y3$<J3TR#Q5IKB!"FZ:,;_ +F6 W?3UKS30VU&QN?"%WXD%TUK)I$D<TM[
MN;R;QBA)DW?=)4,H)Z<CO2+X?O8_ UQ>VUNQGTK5I]2T:%UPPMUD)$0!Y =-
MX ]&7TH ]+-Q HD)FC BYD)8?)]?2A;JW:%)EGB,3_=<.-K?0]ZX'Q ;FSTK
M2M;EM[M+>;4A>:FMO"))8HVB98RR8;=Y?[K(P>5R.F:R]0TS1&LM$FLXKFXL
MKGQ&ERSW<.T,K(PD94VKMC)QG@ G)Z'D ]/-]:+$)6NH!&5#;S(,8/ .?2GR
MW$$ )EFCC 4N=[ ?*.I^G(_.O-M0T+1(?&.MVZZ79I9IX>1$C%N!&) \V0!C
M&[:5Z<X(]:A\/VME=ZYX4DU&VBEQX5\NY:XCR/-!A^5\C[PVOP>>#0!Z>MS
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MZ@T$!E*L 0>"#WKR_P (W,7@[Q%?V-S((='U9KJ_M6/"PRPR,)D'L4"N/H:
M/4-R[MNX;O3/-+7EN@W TOQUXMU[5T82KI-O?2JPRT*?O3Y8]"$55..I!/>N
MD_X2VZL9]#EU6"W2QUB-BCQ$YMG$9D"MG[X*AOF '(Z<T =6\T43(LDB(7;:
M@9@-Q]!ZFGUYMJ&H76N7W@+6W@MH[6\U'S8% /FQHUO*5!;H=RX)  P0!SUK
M9L_%NH:C/87-AIK7.G75R\#;89%:% 6 E+D;&7*C*CD;NIP: .PHKSN3QQXC
M3PS>Z^-*TS[+:SRVQC^TOO+I<>4"/EP5QD\X.16N/$VL0WVOV$^G6DMY86<=
MY;)#<;4D5]X"LS@ $&,Y;I@]!0!LQZ(BZ[)JLM]>3DX,-M+(##;G;M)10 <D
M9Y)/4XQDUI&1%.&=0?0FN>\.^(Y=6UC5]-E\F3["L#I<PJR)*LJL1@-GH5/(
M)!!%8'Q1T33%\(ZCJ'V"W:\GN[,R3M&"Y_?1)C=C.-HQCZ^M 'H*LK_=8'Z&
MEKFK]]-\*2P#3;"&"XU:X6W"P0';N5'<N409)"J>G7@9 Y%:V\5:F\EKI]WI
MPMM1N[Z2VMY)$98I(DC,AF"GY@,#&TG.>^.: .K>:*-D621$:0[4#, 6/7 ]
M33Z\]\0OJLNI>$YKW3K:+4HM;EAB(D^22/R)MKY&2H8 $KR1BIAXVU9;2!3I
MUF]Y_;AT>?$S*F<9#KP3@C&<]/>@#N99HK>)I9I$CC7[SNP 'XFGUY_JGBJ[
M_P"$2\2MJ6DZ?=SZ3=K;30,28)E(C=6P03D"0<'N.M;=YKVIW%YJ]MH=G!<S
M:48UDAF?:9W=0^Q6R F$9?F.<DXP,9H Z6F+-$\KQ+(AD0 N@894'ID=LX/Y
M5R6N>+KW1]097M;<0+>6ML(MV^61)F53+E3B,!G( 8?-M.#R*70(HX_B1XOV
M(J[HK%FVC&3MDY/O0!UID13@NH/H33JX/4].L;SXRZ<+JRMYP=#G8B6)6R1-
M& >1UP3^=5/-F\*?$B]TS1+?S;*ZT634!IJR!(TG1]H*9^6,/T/09YH ]'HK
MSW4/&FI?V3XGCMFLS=Z;I*W\%U&C&-MPDR "?FP8SA@2#GVQ5[4_$FK:+HL4
MSI:.T>F-=F1RS&=U&?+5 =P^7DOR!GI0!O:SH8U:6TGCU"\L+JT9FBFM67(W
M#!!5U96&/4<=L5-:6D6E1M-<WTD\TI5'N;ID5GYPJ_*%4<L<  <GU--.IR2^
M&QJMO"I=[07"12/@<KNP2 ?Y5R$WB75KKPAINM:GHVDS6=])ISPPF1G*&5T!
M8@KC*LRE<']1R >@TP31&8PB1#*%W%-PW >N/2N.UWQI=Z;_ ,)#):6<,HT/
MR \,I(>X\P _*1]T?-@<')!'%9E]<:GIWC_6[VPM+'[8GA^WGG61VV%EDG)
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M^F^:2TBJ3.T@PY; &. ,!< 8].*KZAX*CU"/Q'')J$RIKH19PJ+F,*@0;/\
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M0L66!I%EC$15HA@'#!]QQ_MY]:BL+._L?$'@6'4HYYKFTTF>&[G$3.JRE80
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MB6G9,DQ*JG<.!DO@@9'O5>?Q1J]QK2:=IEA9?O=)&HQR7,S<98#:0%_K[^Q
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M"F61$#,%!9@,DG 'U-<%HWBN\?2?",.F:-I]M'K$<P6)9"D=N41FP %Z<?\
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M% !1110!2U6PDU.P:UBO[NQ=F4B>T91(,$' W C!Q@\5-96<-A9Q6L (CC7
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M=510!QMEX!^QII%N-=OGL]'N?/LH62,E%V,@0L5RP <@=\?@1V5%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11FB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ K,U?5UTQ[&W2(37=_/]GMXBVT%@K.Q)P< *C'H>P[UIUA^)_#SZ_;6;
M6U\]A?V-PMS:72QAPC@%2&4D;E*L01D=: +FDWM[>P3F_P!.:QFAG>+;Y@=9
M%'1U; RI![@'K6A6/#IVKQVML'UH/<BY66ZD^RC;+&!@QHN[]V#QSDGKUS6Q
M0 5D:UJ]QI<END-I'(LH<O///Y,,6T# 9L$Y8G &.Q].=>L+5]!N=0UW3-4M
M=1%LUDDL;1/!YJNLFW++R-KC;PW/!(P<T 95OXYGU"+PXVGZ0)#KEK)/$);D
M((F102K':>.>H'X46_CF:73M'OI=*6*"\OWT^Z8W.1:RJ[1C^#YE++@'CEEZ
M9HT;P/<:0/#:_P!KI,NB0S0H&M<>:K@#L_& !ZY.?H*6H:3;:1X3N?"MY)/?
MW&KR74EK]GM'7$CN9!EAN";7<$,Q' SV- '8:=J$E_-?9@5((+@P12B3=YNT
M#<<8&,-E>IY4UA7_ (T-K8:KJD&GBXTS2KAH+N038D^3'F,B;2&"Y[L,[6]L
M]#I=@NF:9;62.TGDH%:1OO2-_$Q]R<D^YKG9?!):+6["'4!'I.LS-/<VYAW.
MK/@2A'W# ;'=3@DX]@!UUXR:W7Q*T=@DJZ+9QWBD7! N(V1W_N_*<(?7K4)\
M3ZFWBV.W6TB;3AHO]H%%D)E8EAT&WDC! &1G.<]@[5O!4]]=:R;+54L[75]/
M6RN(C:^8R[5=59&W  8?!!!SC@CK4W_")W::C:WUOK'DS1:6=.D86X)8 Y5U
M^;Y2#]<CTZT 9.J>.;V?P!J^O:1%8.(;-989X[LRA7.0RL-@(=.#@]<]JT_$
M7BZ[\.6ES<76EP[+6T^TR,;S:LARV8XB4R[A5R00.H]<BO=_#Z+4(=;-Q=PQ
M7.K6(M)I+2U\I68$GS63<=S9/J.!BC5O!&H:NVI--KR@ZEIGV"X_T,';C?\
M-'E_D!W\KSG Y!YH L:CXNO[?6+S3K#1H[IX-.345>6[\I70EAM^XQ#?(<=1
M]*EM_%*ZVMG;:;8I<2WFF)J$D=Q-Y:QQ2#"*2%;+$[ATQ\I]LHOA2[&J7%^^
MJ1/)-I2::0;7 &TLV_[_ *N>/3'/>JFG^"+S1[G2KO3=9CCN;33H],N#+:%T
MN(H_N':'!5QSSDCGI0!A^$+V"W\+> (;G3%N'N)I5AF:7!MI DK9 Q\V5##K
MWK9@\=WCF":71%CLVUAM(ED^U[G202&,,J[/F7<.<D$9Z&I-.\#W&GZ?X;M1
MJR2?V)</,K-:X\[<KK@X?CB0^O:C_A![C^SA:?VK%D:T=8W_ &0_>\WS=F-_
M3=QGTH =J'CA[6&^N;;3!<6UGJ::9(6GV.9&*+N"[3\H:11USC)QZZ7C-=_@
M37&=0'33IW&#]QA&Q!!]0>AKAW:\E\1:G=6M[#%?F]:2/3KW0Y979HQL1@ZN
MJD$*"KX.T-R>M>B:SITVM>';W3?.2VDO+9X'?9Y@3>I4X&1GK0!Q%_I*6?PI
MAUW2YY;#5;+2DODN(9"/,98@Y$@SAPV""&!ZUJ#QY/+I*7-CI$EY=)I\%[/;
MIY@.9$WB--J-EL#H<=5YY.+,O@ZZO_#]IH&I:NLFEPQ1PRQ6ML87N$0 !68N
MV%.!G: 3ZBGWGA2]C\0-JNA:S_98GAC@N[<VJS)(J9",H)&Q@"1GD8QQQ0!G
MP3"3XCWMY#:ONG\.03&"8&-B3+)PP/W3@ 'Z4_0O%$4.F>$(K;1X[/2]7@"0
MD7!(MG$9=8\;><@'!R,X/MG6'AR>/Q)-J\>H+\^FI8+')"7("LS!RVX;CECG
M@53'@A6\!67AF34'$EBL7V>^BCV/&\; HX&3@\>O<T 3S>*GC%M&+)6N+R68
M6R+([*\49P9"50D Y7  /WAS6>/'&HNND1)X;F2\U&:XM_(N9C#LDB1FR"R9
M9&"Y#8'!Z9XK2UWPL]^-*GTC4#I=]I1(M91")4\ME"M&R$C*D!>X(P#22^&K
MV?4=#OY]7$MQILTDTC/;\3,\90@ , B@-P.>G)/.0"IJ'C2ZTF2(7^D);AKB
MVMW5KL;V:78&:-=OSJC.%)R,X/ISSUEKUYX6/C"^M]&^UZ9:ZT\EVZW 1XT\
MF'<43!WX&202OMGMN:IX&N]0N-5:/6Q%#?7EO>JKVGF/&\)0A=VX93Y.%P,$
MGGJ#/)X,ED36K-M3!TW69_.NHS;_ +WE%1U5PV &"#^'(R?; !GR:G9Z/X]\
M1:O)DVR:':W#;!DO^\FQ@>IP!^579_&UQ8#46O\ 1+B.&TM%NEN(Q*86&[:R
MLS1KM9<AC@'Y<GMBI]1\%Q:IJ6K37-T/LFHZ<FGM!'%M:-4+E65]W7+GMV%/
ML="\0PZ>\5YXG^U7*JJ03?8@B@!E),BAOG)"X)R."<#F@#4T35&U>TDN=ML8
M?,Q#-:W'G1S)M4[@V!W)&/\ 9K/'B2[N9I'TW23>6<-_]AFD68+(I#;7<(1@
MJK<'Y@>"<=,S>'?#<'A^349(3$IOYQ.\5O%Y42,%"G:F3@G&2<\DU1L_"=]I
MNLWTMEKCQ:3>W1NYK'[."XD;!?9+GY58C)&">3@C.: ([OQPMMI=SK:V(DT2
MUNS;37 FQ( LGEM($VX*A\_Q9P"<=JKZMXZO=,?Q"R:&DT&A-&US(;S:7C9
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M>UOP9ID6HPR20W-]+YSVY"@2JS89=_=F*@Y';KW %UK7O^$C\/V4MS8&RO\
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M8SJZZM&&M SJX_@9MWS*!PO P,=0,4 4;'6;?PQ>>-;Z1%$":S A+,52/?#
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MM*[EP0>00>YZT/X8GAUVWUFQU+9?+:?8[EKF'S5N$W;PQ 9=K!BQXXP2,=,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV$;PNDZ,\$\;[=RG!##E%((]*ZBB@#F9-!U2;7="U2XO+>:33TN!-A"@D:4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>exhibit1027supplycontrac028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac028.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!'W%&V$!L<$C(!^E>:^
M&OB%K7B37O$>EI9:9;?V)*T<DTLK[9,,ZYZ<#Y,_C7I=?._@[1+O7O&GQ(MK
M/4+BUD74"^R(J%GQ/(=CDC.#C'!'7G(XH ]<DUKQ0OA;4+Q=&M&UBRE=39K*
MQ295P04;&<E2",CVXK#\*?$Y_%/@J_U>*"VCU6VD\E=.!8EI#_JUSU.\\ XX
MY]#7<+K>GL=1/VF,1:<=MU*6 2-MNX@GU"D$_6O"_$=K>?#SQS:?$6STW9HN
MHW!%Q:;?GB##&X@_=9AN8#L25/7% 'IOC/Q;K/@SP0NO7-G8S7*,BSVR.P52
MQ ^5^^#[<^U5M>\=ZGHGPQM/&'V.TF::*"9[7+*%67;@!NY&[TY]JS/C5?6V
MI_!N:^LYEFMKB2WDBD7HREP0:YSQMIDT/[/-C=-J]_+&;*Q/V:3R_+&?+X&$
M#8';GMWH [/7/'VIZ-\,++QC]BLY6N(X96M=S *LN, -W(SZ?_7=KWCS4]$^
M&-GXP^QVDS3Q0S-:[F4*LH7 #=R,^G-<KXY_Y-ETK_KRL/\ V2G^//\ DVC3
M/^O'3_Y)0!LZC\4=0\/V_AK4-9TFU;3-<C1Q+:SL9+<LJM\RLOS8##H>Q_&_
MXW\>ZCX4\5:!H\%C:W*:S,(4D=F4Q'>JY(&<_?SVKS3QA$WACPO\/_%"W+:I
M<+;P)%INH8DB7,2MNC4 $$$ 9YZKZ5O?%F1IOB)\-9'C,;/>(Q1NJDRP\&@#
MN_$/B/Q#HMEKNH)I]B]AI4(=7DD=7N"(P[;0 0 "<9R>A]*J>%?&'B'Q+X?T
M77ETJQ%C?SF*9$E<R0*'9-W3##*^V,UJ?$K_ ))IXC_Z\)?_ $&LGX)_\DAT
M+_MO_P"CY* .YNII+>V>6*VDN9%&5BC*AF/L6('YFN3^'?CEO'6D:CJ3V(L8
M[:\:W2,R;SM"*<L< 9^8UV5>,? V![OX?>);>)L22ZA.BGT)B0"@#87XMK_9
M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
MY"2*Q5P#Z;E./:HM(\0PW^AOX@N)E@TV4DVX(_Y9!BJL>Y9^H ]5&,]0"2T\
M'^'+&YAN;;1+&.> !89/)4M$!_=)^[^%2:CX6T+5[V.\U'2[:ZN8L>7+,NYD
MQS\I/3GGBL;3/%)F\6^(X+F[8:;86UK(B2VS1-&TADW#! 8YVICZ\=:WAK^F
M^1+,TSH(IA;LKPNK^80"%"$;B2&!& >M $U]I5CJ=@;&^MUN+4@!HI,LK >O
MK^--TK1M.T2U^RZ79Q6EOG(BB&U ?8=!65JGC32M/T&YU2,S7"V\ZVSQ)"^]
M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ3Z8-<SX;\%^+;;Q;X4UG4M,M8A8K=1W2P7*!8PX8+LC4!47##Y5SG!)Y.:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "@\C%%% &?I>AZ9H@G73+..U$\AEE$>0'<]
M6/N?6M"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBN9\?:O?Z#X2N-4TZ5$N(984 DCWJ0\J(
M<CV#9ZT =-17'^(=<U?P>MIJ-[/;WVCO<1P79\GRY8-YVB0$$AE!(R, \]:V
M9?$^CP6U[<2WFR*QF$%RQB?]TY (##&1]Y>>G(H UZ*Q;CQ9H=KJK:9-J""]
M5XXVB",2K2$A,X& "0>>@XSC(JI9>*=)MM.AGO->CN5NKR:""8PF/+!F_=@
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MQ-S(I=8(HVED*]-VQ03CWQBGV&J66IK,UG<++Y,GE2@9!C? .U@>0<$<'UH
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M*%?&02".<9KA='TK6HE\ K<:-<0_V/;O!=DRQ'8?LXC#</R"P[9..N*]$HH
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M(.0: &QLS1(SH48@$J3G:?2G444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R7CFXD63PW8 D07V
MLPQ3^C(JM)M/L61?J,BNMK,UW1UUFQCC#B.XMYX[JVE(R$E0Y4D=P>01Z$T
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M2.*1(HW#@J >=QSDX] .E6?#6O:K<^)M-LKJ\DNK6\T=[PRO"D:/(KQC=$
MP0B0X#\X _'H$\):(@T]1:.5T^!K>U5KB1ECC8!67!;!!  YSP!4=AX+T'3)
M[6>TM)4EM(6@@=KJ5BD;8R@)8_*,# Z+CC% %+X9_P#)/=*^DG_HUZRDUGQ'
M?7%M'!<2Q7AUJ6UNK58$9(K52^) Q7/W50[LX)8CK@#M-)TBRT/3H]/TZ)HK
M6,DHAD9]N3D\L2>I-<+I_@[41.QFL);*_:=YGU"SUF80EF<L66#.._W",'N3
MUH ??^*=6?PQXA\1V=UY;:/?S0K8M&A22.%@K*Y(W;F&2"",97CKF[=ZYJ>G
M>)=0TZXNY"NH623:.KQH-DN[8\9.WDAGC;G/RD^E= _AC2)+VXNFM3ON9%EG
MC65Q'*ZXPS1@[6/ Y(YP,]!5VYTVSN[RSN[BW22XLV9[>0]8RRE3CZ@D4 <E
M>W_B'4-3UC1]&OXXKS3((-DDQ0>;(ZEM\B^6WR'I\NWHWMA-+N?$&K^*=5M6
MUQ;>WLA:2B.W@CD5O,C+,H9ADKGD'KP*W-5\(:'K6IQ:C?61>[C3R_-29XRZ
M9SL?:1O7/9LBK=OH6GVFH7M_!%)'<WJJL[B=\,%&%P-V%P.F ,4 <-X>U_7Y
MX?!E]>ZL;A=9>:"X@^SQH@VQR.K@@;@V4 /."#T%1KKOB,:9!J']M$NOB-M+
M,36L>QXC<&$%L -N P1@CISFNRM_"&B6L.FPP6LJ1Z:[26BBYE_=,002/FYX
M)'.>II/^$/T3[(+7[++Y(N_MP7[5+_K]V_?G=G.[GTS0!S$WB;5M'NM;TV>_
M^UM!J-E:V]U<(B-&MP%SNVJ%XYP2O<9S3];OO%FB:1J,TNIVWRWMF+1L))*(
MY95C=9 $5<9)VD#/7GBNGN/">AWG]IBYLO/&J!1>++*["7:,+P3@$8&",8Q4
M2>"]!CTDZ9]EE:U,J2L'NI6=F0@H2Y;<<$ @$X&* ..\3:AK$6A>/],EU>XE
M^P644]O.$C211(C[D^50-OR=<9P>O>O2;.-X;.*-YY)V"\R2!0Q^NT ?I6=-
MX7T>XDU)YK5I#J<(@O-\TC"5 " ,%L# )Y&#S5^VL8+2P2RA$@A1=@S*S-C_
M 'R=Q/OG- 'G'@?5;@Z/X0\/P3O:)<Z;/=/.BJ6;8X4(NX$?QDGCL/6KNE^*
M]4N]3M/#]W<>5<'4KVS:^2-0TR0(K*5!!4,P<9XQ\C8 [=/'X0T2&QL+.&T>
M*/3V+6C)<2"2$G@A7W;@#GD9P?2EOO".AZCI<6G7-CN@AF,\965UD24DDN)
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M/<RL\A&,;G+;CC XSVJ[;Z)86NK3ZI#'(+R>-(I9&G=MRKG:""Q'&3V[GUH
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M9MH))"@L2<#.!DDX JDO@S04C2-+.14CN_MJ*MS* DV2VY1NX&68X'&2>.:
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MI\5C9(Z6\2A45Y&D( Z#<Q).!@<GH * +=%%% !1110 4444 %%%% !1110
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M>#R.1FM:N \':%J>F)I^EZEX:TY6TL;(]8#1L9D4%59%QO5R, YQWY/2N_H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ***YSQO-J=EX<DU+2KB6.6P=;F:*-5)GA4@R)\P.
M"4W8(YSB@#HZ*XZ]UF2XTJXU6TU=H;2[NK>WL2D2R>8"ZJWEC'WW)902<# ;
M@9-8\/BG5+875C=7,D0;Q)'IB3R[&>"%X4DP2!M+9)4$Y^\.N* /2:K7M]%8
M)$\RRL)9DA7RHF<AF.!G:#@>I/ KE-1O]0T.[L=,FUDS1ZEJPMTG:-1):Q-$
MSB,GHS,R;02,X;UP:9K-QJ^B6EFBZZ]PS:_;0']T@86\CK^Z<X.2 ?O#!((_
M$ [>BO,-<UC7;6'QG>0ZW<J-%O(3:Q"*+:RM'$Y1_ER5^=AQ@\\D\8U+[4=>
MUC4/$-OI.H6UC/I-Q&D?GRX0+Y:2%I$\LEE;<PSD<+Q@@D@'=,P52S$!0,DG
MH*6N1^);2_\ "MM8>.>2%Q "6B;&02 1G'0YI$NKW4?%>J>'EU.ZM5L+&&6*
M90GF2O(7RYRN"%VJ,8QDG.>, '7U5LM0@O[7[1$)4C\QH_WT;1G*L5/# 'J.
M/6LKP9J]WX@\&:;J5\HBNYXCYA08!8$KN /8XW#ZUQ2WFI:MHOA*>ZU6Z,[^
M([BVDD38N]4:Y"Y 7&0(UQQCVH ]4JO>WUOIUL;BZDV1[E0<$EF8A54 <DDD
M #WKCX=;U"U\8Q6.K/=P0W%Y(EG<1!)+6Y0(VV)B!F.0$$\]2IYQP)OB)"\M
MIH.VYFA_XG=FI$>WG,HYY!Y';^M &YI/B.PUFZN+:U6Z$MO_ *T36LD84[BN
MW+  GCH#T(/0UK5PNJZEJMIKWB*RAU2<1VN@)>6Y*1DQR[I06^[SGRQUSWQB
MJNGZSJME?:-+>:V\L&HZ!+>S_:8T\N"2-8CO&T XQ(V02<T >@RR+#$\K[MJ
M L=JEC@>@')_"JVE:I::UI5MJ5A(9+2Y021.5*[E/?!Y%<AX:U?4Y?$\%C<W
M5Q/:W&B+>;KA44R2!PID51RBL&SM/3C@<U>^&AV_#'0&P3BR4X% &]J.L66E
M2V45W(Z->SBV@Q&S!I#D@$@8' /7'2ETS1M-T6&2'3+&WM(Y9#*ZPQA0S'J3
MCJ:\Y>_N?$&B>"?$$][(S7NM12-;C;Y<8/F80#&<KC&<\G.>V-?3M2U[7#%J
MMIJ%K;Q0:M);7-O+-\OE+*T?EE/+R)"-I!W=3Z'% '>U2:ZM-/:SMDC<+=2%
M(O)B+(#@MDE1A1P>3@9KAUUO4C?76FZK<7]E=S07;VLL.QK:[099&B<#*,JX
M^4X/4\G!IFB7FH6&A?#B.+4;AH;]8X[B-PA#K]D9P,[<\%1W^N: /2**\P76
M-=BMFU%];N)/L_BC^S?):*()) UP(L-A<Y ;@@CITZU=U#7M2AUJ"6TU&2>
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M'/? SZX%7** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWB)WFNIF8O&%8'Y$"X)X')8=Z]26W$VN7R!VD@T32Q9([G),LBAW)]PB0_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %5;[4]/TM$?4+ZVM$D;:C7$JQACC.!DC)P*M5&\$3S1S.BM)'G8Q_
MASUQ0!FP>*/#]S(L=OKNF2NVXJL=W&Q.T$MP#V )/I@U>LKZUU*SBO+*XCN+
M:4;HY8VRK#U![UR'PR@BF\&1-)&K-%J5ZZ$C[K>?*,C\"1^-8G@;5-4TS1O!
M%N9K=].U))H#"(2'C*H\@;?GG[A&,=_;) /4JIW^KZ;I00ZCJ%I9B0[4-Q,L
M>X^@W$9KE]"U_P 0:W_8VK06BG2;]2\ZR>6ODHPRA0ARS,#@,".<G&.E)\1R
MRQ^%V1-[CQ#:$+G&3\_&: .ML[ZTU"#S[*Z@N8<D>9#('7([9%6*X!--U70=
M2\1^(VDL;$ZK<6D<=NSLX15(1G(4?-*P8X49R0HR:AN/&&N1:!K$\)@^T:?K
M4%@C7$!!DBD:'!8!L*W[[KCMT!H ]%JO97]IJ,#36=Q'/$LCQEHSD!E8JP^H
M((KCX3X@B^(NGV-[K$,R_P!EW,Q6*U\M#B>(#Y=Q.=I SGM[FH=-\7:E<V&G
M6[QQM?WVI7MMOMHU4!('DY57;&XA1U)[GF@#OJ*X6Z\1>(=(TN";6[.2&%+J
M6.YN[.$3-'"!F*1HU+;0<_-C.,=L@CIK'4&N/"\&H+=6=S(UH)?M"MM@=MN=
MV>=JY_(4 :E07E[:Z=9RW=[<16]M$NZ265@JJ/4DUP/_  G5_I@OI;T)>0P:
M%_:89(C$&E#;65">3&3C!(SCG)J_XF76E\)>(C>7=E<V$NA7#@HA219O+;(4
M<@QX(QDY!]<T =G%*D\*2Q,&C=0RL.A!Y!I]<9X6UJYUC0Y;BQN88H;&W%L+
M>:$F19D3EG&00IX('<8.><#/T7Q;K3)X7O=3FM9;76=.DGEBA@*M$R1"3(;<
M<YY&,#M^(!Z'17"0>*]4&E>&-=D,,EGK=Q#!):JG-N)@?+*MGDJ<!L]<DC&,
M52U#QIJ^E6MXMW- ;K3=6$-VJ6_6Q8!Q,!NXPAR3R,@CTH [Z^U&RTV..2^N
MH;=))%B0R.%W.QP%'J2>U6JX'QA<SWOAF>X>1'M?[:LH[;"X.U;F)6)/?YP^
M/8#UJS=^(/$%]<:H=!M%E.FWHMO*D\L)* $:3<Q<,IPQVX&.!G.> #J]0U*R
MTFR>\U"ZAM;9/O2RN%4>G)JU7F'C75KS7O OC"6">.&UT^X:R$)CW&384WLQ
MSP<D[<>F3G.!J^)?%6IZ?=Z]!:F&"XT^TAGL()8]WV]FW9 &02,@( N""<G.
M0* .ZHKC+S6_$%S>7VEZ9&C:C8V<,S%8D"/-('(5@\F53Y<<$GD\\<ZNMWFH
M1^ [^^1A9:BFG/.=A$@BD$98@'H<'@'\: -0ZE9#4UTW[5#]N:(S"WWC?L!
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M'0@\@UP/BK5KS6=!\<VMK/'!;Z59R6[*T>XS,8-[YYX&& &.X)Y'%=(9)X?
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M'KP.>!C?MKRWNVG6"3>8)#%)P1M8<X_4?G7&ZYXY#>'M8N]%D"3:;?1VKM/
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MH(S)$%"FS&TD[WSSG&><8J0>(]'\F[E>_BB6T027'G9C,:'HQ#8(!P<'H>U
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M:5MJ<%SI*:B"RPM'YA^4D@8YXQD_ES6?I7BS3-6T*UU>.1HX+HXB1D;>Y.2
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M5I/,5D*ALA3A@#S@X]>U5SXJT)+9[B34X(HTG%L_FG8R2G&$*M@@\C@CH<T
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MY F@#+\96\]_X'URTM('FN+JPFAAB4<L[H54<].2.M8$%C>KXG-X^G7/D?\
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MC!)'<QO8LSV]S#=2).C-]X^:&W$MWR3F@#'.M>(-)D\-W&OW%M';W,CV>H"
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M(L[ Q]<4 ;]%5-.TZ#2[4VUNTS(9'DS+*TC99BQY8DXR>E6Z "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXM;F^74)[(,ODR7 'WR,;N>"1G!(Z5LW6@:=>>(+#7)H-U_8QR1P2>@? /Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWIEMX-MEALK?4+N;4;>PA>"U2=5!"LFPEB/O-L)7/'!/&>: .>N+N\U3Q7X
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M "\=,1KUSW]:EN/!Q?7KC5+36K^Q%ZJ"_MX-FRY*KM#?,I*,0 "5(. .AYH
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M++Q%8+:WHD4QRK/!-$VV2"5>5=#V(JE<>&9=1NM,EU34Y+E=-N!=0*D2QEY
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M82:29HF !$Y>2??C!5HRW.>=VWKQ0!Z0VJ6;2M;PWEH]V2RI"9@"749*XZ\
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MTECBN;RWADD.(TDE52_;@$\UY9JVEYT7QPT6DSFYEUB&6U*63[W4"#YDPN2
M5<Y'H:U[R*3[3XVLM3LKBX&JQ*]@RP,XFC\D*(U('RLK@G!QC=N]30!WHOK1
MKI[474!N$&YXA(-ZCU(Z@5%)K&F0P1SRZC:)%+GRY&G4*^.#@YYKB[K2-=TA
M_#6I6RM<:HUBND:E(OS?>0%9CZA) 2?4.:B\6VWV>XN=)M-,NU1O#\MO!<P6
MSS&;J!!G!5.@))&3N&",4 =G+XATN'7HM$>\A6_DA,XB+@$*"H'?J=W [X/I
M2V&H?\2A;S4;O3Q\[AIK>7]S@.0/F;OC /OFN-T;S(_$OAV[N;&]$$OAW[*S
M/:N=LH>,E7X^7@$_-C.*R] @OM.TSP?=36-TFG65]?B[A-NX:$R/)Y,A3&=H
M#$9QP'S0!Z>-1LC;PW O+<PS,%BD$J[9"> %.<$GVIUI>VE_"9K.ZAN8@Q7?
M#('7(ZC([UY=J&C2&22?[!-)IUSXIM[JWA^S,VR(!1-(5QE49@QYP#U[UU7A
M2 VWBGQ<J6LL%M+>PR0YA9$?_1XU8KD 'YE(..XH Z6XU"RM)8XKF\MX9)#B
M-))54OVX!/-8FM^)?LFN6N@V-S8QZC<P2S*UTV44KL"H0"#EBXQ[ \&N?OH)
M4O/&]AJME<7']IQ*U@R0,ZS1^2$$:D @,K@G!Q][=ZFI[&UO;/Q?X4COTGFG
MMM"EM[JY$3,GG$P=7QC)V,>O:@#I+OQ#::-:Z:-<GMK2\O&6(1"7*^81EL$X
MRHYY..WK531_%"W6IZO9ZC+96K6NH"SMAYN#-F*-QC=U;Y^@JOXWCD$WAJZ6
MVGFBM=8CDF\B%I61#%*N=J@G&64=.]<AK5@\^E>.Y5TNZ>[FU.WDM2+-R[JJ
M0<I\N2 4?D>AH ],2[E&JWD4MQ9"UAA1PJN?.0G=N+CH%P!@^S58M;VTO49[
M2ZAN%4X8Q2!P#Z'%<#J-I%<>)_%IEM=06SO-+M(S-:VS[F(:7<4.WYF4,IQR
M>V*V_!KZKYNJ1:FT5V$DC\K4X[<P&[&S^).FY< $C@].QH LKK]QJ?B"^TG2
M(X2-/V"[NY\E%D89$:J,;CCDG( R.O:[8ZA=XOO[7@@LUMI JRB7,<D>U3OR
M0,<EACMCJ>M<OHP?PAXL\11:A!<?8=5NQ?6MY'"TB;F4!XW*@["".,\$'\*M
M>*I[RZ&AZC;V=U)IMGJD<MU&(FWO%L8"3R\;BJNRMC&?ESC !(!U"ZG8/:"[
M6]MFMBVT3"52A.<8W9QG/%5;WQ'H]AI5[J<VHVQM;+=Y[I*K;&'\)P?O=L=<
MFO._$NDRW5OXJO;>RGFL;Z\TYK>);9F+R)(GG2JF,X*X!;'.TU8US399G^(5
MMI^G3A+O1H%MUCMF599%24$)Q@L 4&!STH ] &NZ2;>.=M2LTC=/,#-.@&W(
M7/7^\0/KQ4ZZC8M>FR6\MS=#.8!*N\8Y^[G/<5P\=I9:OX^TJYGTF26T?1)(
MV:YL'";_ #(R VY< X#8!YQ]:R@]Q)K6C3)I6H6OV;Q%<-/;1V4C+&'68>89
M"#NWE@V5.T!@,#&: /33J-B+LVAO;?[2 6,/FKO  R3MSGI5;1=?TSQ!:R7&
MF7<5Q$DCQL48'E6*YX[$J<'N.:X[PDZ/#8Z-K&BWK:[IM[-*TTENXBRS/F<2
MXVL&5SQDDDXQQD:WP]22VT*ZL9[:X@G@U"[+B6%D!#W$CJ5)&&!4@Y&1S0!L
MV'B'2M3OK^SM+V&2:Q?RYU#CY2 ">_0;@">QXJY:7]G?HSV=W!<*AVL89 X!
M]#BO-=7L]3:'QM:6=A=O/+J5O>"-8&"W-LJ0;T5\;6)".NT')P1BNCL(CJ'Q
M#_MNP25+ Z5Y%P[Q-&)9?,#1C# $E5WY]-P% '2W.I6%DQ6[O;:!@N\B655.
MW(&>3TR0,^I%+_:%D+X6/VRW^UD9$'FKYA'7.W.:Y/4=,M;WXJ6CW>F"XMCH
M\T3R26I>+S#+&54L1MSM#=:Q]%@2XOHM(UO3]8;5K'5I+R)A$XMWS*S+,)0-
MNW8V"I;)^[B@#T0:A9&]^Q"[MS=@9\CS!OQ_NYS0NH63WC6:7ENUTHR81*I<
M#_=SGO7!^%6$EM9Z-JNCWAU_3;R:7[1);N(@S,_[\2XVL&5^F223C'&11TZQ
MO[OPMX8TIK6YAU_3-4CDNG>)ALVNQFDWXPRNI;G/S;\>M 'I,FI6$-Q]GEO;
M9)_^>;2J&Z9Z9STIKZMIL<JQ/J%HLC2^2J&903)@'8!G[V"..O->77<NF?;M
M0TS5);F*R3Q#_:)N)=/G<?(02F]4,>W(*[BW"\$4NJZ6IT7QPT&DSF>75H)+
M4QV3EG4"#YH\+D@%7.1Z&@#TPWSQ:I=)/=6"6<,"28\S$J,2VXN#P$P!@_6I
M+?5M-NY#';:A:3.%+%8IE8@>N >E<=<20V7CGQ#J4NF7=Q:'1[8[8;-V^T2+
M)*2BX&&;#)Q[\]#61-9:A>>&]8OOLES/XGU*%9Y8E@=%AMXY$/V1&90.5+#'
M\3%CS0!Z9:7]G?J[6=W!<JC;6,,@<*?0X/!KG=0\6R:7X[L-!NK5/L5]&/+O
M Y&R9M^R-A_M"-\'/7C%,\*G3=0U2[UJQM=5CFG@2&XEOXGA)*D[4V,!DKDY
M8#'.,GM5\4Z,?$=]J^GQ"6*Z-A;R6=SY3!8[B.25U(?&,@E<\]#0!>\5>+7T
M#5-$TVVM5N)]2O$MW9W(6!6R QQU)(.!QG:W/%=!+J%E;W$5M<7EO'<28"1O
M(%9R?0$Y->:ZG#JEY8^%M6U+3KA-4NM:M+JZ@BA>3[+"B. #@' &2QST+M4]
M_:W,FF>.M'O[*YGOM1F>;3G6%F$RM$JPA6Q@%&7G)&W&>G- ';>(=:BT31[J
MY,]JMRD#R0Q7$H02%1G [GMT]:2PUVV?P]IFI:E<VMH;RVBE/F2!%W,H) W'
MWKA[H7VGW?BFQUNVN[N6_P!)BBL[B.V>9)=L!62/*@[3YA9L''WLU7A:2R;2
MUUFQU@Z5>^'[:R'V>SD<Q2KN$D4B!2R[@R\XYV^U 'ILVIZ?;RB*:^MHI"5
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M"R:]-DMW;FZ R8!(-X'KMSGN*YOX:QS6_@FVM;BWN8)H)[A&2XB,;#]\Y'!
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M="O+M+03#Q+%#;M'&RQNJ2.@DY8DJV,C'8_C77>&-6U"_NM;L-3-O)<:9>B
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MHR;&Y12I:15#M&V21G:V0>,X-+JWBN[M_'^C>&[*& PW0E^TW$BEMC+&7"*
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M&.*Z*PLH=-T^VL;9=L%O&L48/]U1@5#'K6ERF\$>H6S_ &+(NMLH/D8Y^?\
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MP-_[LR#/R_>'N1W';O0!?HK+T#Q!8>)--%_ITHDA+NOO\K%02.V<9Y[&M2@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *Y?Q_;7%YX:2"UMIKB7[=:2;(HRQ"I.CL>/
M15)KJ** /+M<M=5CTWQ[I4FDWUW-JP>>PN(82Z2(8%18R?X2I0\'&<\9JQ=V
MUQ'KM]'JOA[5]0TW5[.".,6CMA"J%7AE4. H.<Y/'S'FO2:* /-KO2+A)_&L
M::7/MN="M[.U"1,X=UCF4HK$<X+H,GKU[&K^EV][:>+-&O9=/NS V@+:O((C
M^[E5U8AQU'&?KCC-=U10!Y=::?J$/@'PQ:-IMX+BVUJ.>:(0-NCC6X9RQ&.F
MT@U>\1Z1J>J^(/$RV%O,IO/#\=K!,Z,B/*'E8IN[9#J/Q]C7H=% 'G:6UIKE
MA>7MSX5UVVN6LOLEPT\S^< 74E(<L=VT@L&P!P/4XW?!\6KP?VE#J,\EY;I*
MGV6]GMO(GG78,B1<#)7@;L#-=/10!P/B71KS6(];ET^"9-4LKF"_TV1XF57E
MB0?*">"&^9#]:CFTN_@\6>#[N:TGDE22[N-2FBC9TBDEBP!N Y .$'LHS7H5
M% 'F!T75;CP9>>%9[2Y&J_VJ9HKWRSY;*USYPG\SH"%)XSNR,8Y%0:[9ZNN@
M>.-$DTB^N[O4;I[JSGAA+QS1L$"KNZ*R!,8..@QFO5J* /-KZSF?7M=L=7\.
M:KJ5CK#QSVS02L(L>4B&*;#@)ADSDYZ^U;6AVC6_C3Q1=7%C,L4HM3#,T#$2
M>7%M;:<9.#^)[9KKZ* /+O#VE7]EIGP\B?3+J*73Y)_M:F!AY6Z&1?F..[,O
M/XTN@V^J-KWA2ZGT.^M!;QWD-Q"L"I!:,^W"ISRO!.XYSV/8>H44 <KXYTZ\
MN[;1;VRMWN6TO58;V6&/&]XU#*VT'J0'SCOBK9N3K6K:8UM:W<=O9RM<2RW-
MN\(R8GC" . 2?WF<@8&WKR*WZ* /,O%6CKKD$^H6ND:CI_C"WEDCL;NUA9/,
MVN1&7D'R&-E )#G(&>/7N+/6#+K,VCSVMRES! DIN&CQ#-G&[RSGG!(!R!U[
MUJU&L,23/,J*))  SXY('0?3K^9]: .3UV"X?XD>%[N.TN9+6T@O%GF2%F2,
MR+'L!('?:?IWKG;73+V+0-+C_LN[6:/Q2][(HMFRL)GD82'CIL9??M7J5% '
M Z''=VUU=:%JOAVXNY4U:6]M[YXE:W*/*9%EWD\.H;&WKP,<=.SL;XWOVG-I
M<VWD3M"//0+YFW'SIR<J<\'VJW10!S_C,W0T &UT[[<PNH&=%B\QHT$BDR(G
M\3+C<!Z@=>E<;#I-U++K*7-KKUH9M:CO+34(8P98C]F51)M4'<,JRE=N &P<
M=O4J* ,3PG_:G_"/QC6$C%X)9072+RO-7S&VR%/X6888CL3VZ5P\&G:@GAC1
MM-GTF]\VR\2&>;,!93%]IEDWC&<KM93GWXS@X]3HH \QU/3=7-QXENK/3KN5
M5UJTOT@7=$UU%'%&KB-N/FRI(YZJ/:NL\+0VKO?:G;:/?:>UZR&5K]F\Z9E7
M&2K,Q  P!T)P>, $]%10!P-C'>6NK:UHVI^';C4$O-3-]:71B5[=E.TJ78GY
M3&5 QC.%&,U0O-'U.;PWXM\-SV5Q+>ZC?S365R(R8G61E9',@X4QXP02#\@Q
MGBO3:* /-M6TJ\DD^("BQN9GO=*BM[63[.Q\]Q%(I ./[S+_ )%7+>"]MO%!
MNY-.O'M[CP]#;B182=LB-(65AU!PPXQS7>T4 >;V5I>Z;\/O"$*Z),;BV>WC
MO"MJ&GM=J,#(J$<D,<9P<!R<&J%G9:YI<<&HC1=1FBL/$5W=36I"M++#,)%6
M1!GYRN\'CKDXKU>B@#@]5MI9?[ U2Q\/W%O#'K9NYX(X5$Q#PR(970'@EF&<
MG.,$XYQE:]IE_=:?X\CCTR[D-_>VKVR"!CYJJD*L1QV*-^7N*]1HH \[UVR\
M[5O%TTMG=C3[KP]' 'C0Q^8Z^=E59@ &PZ@9]<=C4OA>Y$WB:VNM2@U.WU Z
M<MA%Y^FO;Q/M)D;YB6!8X) R, '&:[74M-M-7T^:POH1-;3##IDC/.1@CD$$
M @CIBJNG:#::9()$EO;B11A7N[N2<H/]G>QQ]1S0!SVN30V_Q2T"6:"24#2[
MS!CA:4J=\/.%!/J.!WK'TO2=1T,:1"-(N%MIKR_G5[:)7FLDE?=%",\1AE/S
M'L1C(ZUWDVBVD^NV^LN9?MEO$T,9#D*$8@L-O0Y*K^5:- 'E?AG2KZ%? 4-[
MI%W'_9\5W%<^; 2(BR[5)(S@'D?KTYKH;+1S<>)?&&GZAITQT_5!"5DVCRGC
M\A8V /KD'C\:[.J>JZ9;ZQI\EC=&80R%23!,T3\$$892".1ZT <[X&MM2-I)
M/K#K+<6>[3890<^;'"Y4R^S.0,C_ &!4FO0SOXY\+W$=M<206WVKSI4B9ECW
MQA5R0.YKI+6UALK6*VMHQ'#$H5%'8"IJ /,)M%U6X\'ZQX6FM+G^TYM4>:WO
M!&3&RO<"59O,Z J#T)S\N #D5T>@6;IXW\574UE(B7$UL\$\D) D"0A"5)'8
MY'\JZRB@#C_%*WK^(+-(=,N)()+&XB^V6L2M('8IB(L?N(P&2?51R.^+H5EJ
M$2?#D3Z;>Q'3[.2&ZWPG]TWD*@W8SC+ UZ510!R_@6WN+;3-22YMIH&?5KR9
M!+&5+(\S,K#/J"*XU]._MWP]XST2VLI6OKO7I1%,(3M1@T9$ADQ@;<$\G/'
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M@^SD2,9)G9>W0@J<_P"%3^)G?_A)=1^SVFIR1ZAHL=I<M!8FYV M)M^4,"C
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M+8Z'C/(K+M=!UFS\)^(_!T<,LLX@/V'4&5E2Y4H (F8DX*@!.N-NWT->FT4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]NDI,J1MC#9(P3@@D<?6MB+7=*EMH;C^T+9(YHA,GF2A24(SG!-<MJ=Y-?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K*N= MKKQ!::R\TZW-
MHC)&JE=F#G.1C/.?6M6BDTGN73J3IMN#M=-?)[A1113("BBB@ HHHH ****
M"BBB@ HHHH 0C<I!S@C'!JCI.D0:/:"W@DGE X#SOO;'.!GT&3^=7Z*5E>Y:
MG)1<$]&%%%%,@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>exhibit1027supplycontrac029.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac029.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M;9G7+F)=CH&!*Y*EL'.,XSBM#2]/DMO$6O>)]07[+%<0PQ1I*PRD,2L2[8)
MRS-QGH!ZXK1U?Q-HV@R1IJFH16QDQC>#A03@%B!A03QDX%3:M?Z796L;:K<0
M1PR2HB"4\.Y("@#N<D<4 8_P[T^XTSP-I\-U&T4TAEN&C88*"61I I'8@, 1
MZUU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 <5\2BXT[0#&JL_]OV.T,< GS>,G!Q^55[O2K_1
M=0U[Q1<:C:V-YJ1M;6)(4:5457"\9 +RMN(7Y< XZC-=9JVAZ?KB6Z:A"\JV
M\RSQ!9G3;(IRK?*1R#TI^J:/8:UIK:?J$!FMF*MMWLK J05(8$,"" <@YH X
MEO$NO0:7XH5?.DFTW48(8VECC,L4$BQ,YP@VLRAW(Z]NO>2\\0:UI,'B/46N
MWGTRWDMH;":>)$7,I17<L%&Y4+=>G4<D5?UWP9;?V9=+I&FPS2WEQ!)>QSW<
MJ&=8R#\KY)5_E7YNIQR<\A=#\)QHETEW8S06%U 89=/N=2EO5DR1\QWDA< $
M?*>=W/04 :.BQZ];ZO>1ZG>6\]C)&CVJF0-,C#AP=L: K]T@]0<^U,\56,6I
MZ/?:%!%&;G5HS'(=N=BD!6E;_=4#'J0H]Q=T/PYI7AR!X=+MVB5\ EYGE; Z
M#<Y) &3@9P,FJFH^"M!U74);^\MKA[F4 .ZWLR9 Z#"N !UXQW- &5?6]UX9
M\176OK$EUHITF.WE+3!6M_)+L&.[JI#G.,G(Z&K/P_M[O2/AKI*7\+K<16ID
M,/\ $BDEE3'J%(&/:MQ]$T^6*VADM]T%L$$4+.QC7;]WY,X)&!@D'&!6A0!Y
MY:^)M7;0O"GB(7?GQZQ=PP7-EY:;(UFR!L(&[*''4G(#9]K_ (%MYDU3Q8\E
M[<3 :S(A60)@GR8?F.%!SCCKC';O6[9^&-(L)DDMK0H(Y6FBB\US%$[9W,D9
M.U2=S= .I]34^G:+8:3-=RV44D;W<IFG+3.^]R "V&) . !QZ"@#)\=V=]=^
M#]3AT^"TE:2%O/CN"5\V(#YE##HQ7(![9K-\8W:7_P -[&\CA,*7%QILJQ-U
M0-<0D*?IG%=)=>'M.O;Z2[N$N'>6,1R)]JE$4BCLT8;8W4]1SFIM4T>QUJS6
MTOX6D@5UD"+*R?,I#*?E(Z$ _A0!>HI%4*H49P!CDY/YTM !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%<UXX35CH"2:1;RW317,<ES:PR^7)<0 _.BMZGCC
MN 1WH Z6BN!T+4=#UO3=>N='N[N,?95CGTVX=TDLI%$ASL8Y0G(^[QE?7-5?
M!<MG>^&O"AF75VO[F.%WNF:<(75#(2S,=K!MA&.<YH ](HKA_"LG_"7W>N:G
MJ9>6"WU*6QM+7>1'%'%@;BH."[')R<D< 8K83PK;AV,]Y?SQ))(\2-=R_*'"
M<$ALMMV'&>@:@#H**\_^&VEQZEX%T'5;JYO9;N2W;SFDNY&$H)8?,"V/0@]1
MBN?T+6;\> ? ^G1WERMQKMV8KJ\:5FE\M2[. Y.0Q "@]AG'.* /8**X7QBW
M_"'6^F:SI1DB"W\-O=0>8S)<12-M.03]\$@ANO'H36?<:CJ'@[Q3JVK-+-<>
M&#=I;WD+.SFQ)AB83+DGY,N0P'3@B@#TJBL+P^L1O]<DAD,D9O4\L^874*;>
M%OER< 98GCCFL>VW?\+COH?-F\E=&AG$1E;8)&F=2P7.,D #.* .UHJ*:ZM[
M<@3SQ1%N@=PN?SKG_B!X@N/#'@?4M5LPINHU6.$L,A7=U0,?H6S^% '2T5SL
MGA*W;1FM5O+P7[1;3J'VA_-9\?>)SR"?X>F. !65X?G/BWQ!XEFU$N]IIM^=
M.MK3<0B[%!:0@?>9BW!/0#C'.0#MZ*\PN[BX8>.O#,EW=&+3+5+NPN1.XFA$
MD;-MW@Y.UEXR3P<'(%3C6KTZ)JGA?Q#*RZ[80B2*YC8Q_;8<@+,A!R#V8#H?
MK0!Z117GWQ"TN/3]#>_MKF]CN)M1LT+)=R*%0R1QE5 ; !4>G<FD^(&FQZ)X
M/N;BRN;Z(O?6A^6ZE9DS,B,%.XM@J<8'\S0!Z%17!^%[B:]\=:G-H]Q=OX;A
MMOL\R74CG;?*_(19#N7"=> "2.O6H_'NO7NG7<-[8706WT*2.[OX W-PCDJR
M#_=C+/CW4T >@45QWC/6YT7P]INFW)B_MR^2!KJ(_,L&TNQ0]F(& >V<]:U9
M_#-L#;O8S7%G)#(&8QS.1*,$$."?F/.<GG('- &Y17G=QHUO;?$C1M)2>_-F
M^E7$DD;7TQWNKQ@,3NSG!/YUU&K78\)>";V[C\RX_LVR=X_.<LS[%.T,QY/0
M9/6@#<HKD_#^A)J'A:RN]1NKJ;4[VV2::\6=D='=0Q\L@_(HS@ 8''(/-9UQ
M;26WQ*\,64ES/(HTJ<RCS6"2O'Y8#LN<$\GKZT =[14=Q<16EM+<SN(X8D,D
MCMT50,DG\*X7PCKE\/&&H:;JER)/[4@75+)-P/DKPCP?50$/XDT =]17%Z&&
M/Q3\41F69HH;6S>*)I6*(7$FXJI. 3M'2DU:SU.6+Q8NANXU)EB$ ,[*/N L
MJDG"%AD9&.2#0!VM%<#X1U30]9UIH[47VF:C;VKQ7FBWCNK#<R?O-I.&QM(W
MKU#<]JR/!\MI=^$8UOAK,UW-?S6PN4>XPF;ED0^9G;A1COVQ0!ZK17G7B?4Q
MH?BNYNO$UI?2>'KB&-+6_M7?98L,[]X0@H22#O'/0=N.UT)8T\/Z<D-[]NC6
MVC5;K?O\X!1\^[OGKGWH T**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S]6L[ZZ6U;3[Q+66"<2DR
M1&19%VLI0@$==W7/&*T** .6_P"$7N9=6U369IK6/4+RQ%B@BC.Q$!)W-SEV
MR?;  'O2:+X?US1_#NFZ*FJ67DV<<<+3+:L)&C7 ./GPK$9&><9SBNJHH YB
MU\-WVAZOJ%UHEW;+9ZC.;F>SN8V(28@!G1E/&[ )4@\]"*W8X;J.SD5KA);E
M\G>R$(#Z!<Y ]L_C5JB@#G_">@77ACPA9Z)]JAN);2,I'-Y956Y)!*Y/KZUD
M:?X -OX+TG1)]04WFD3BXLKZ*+&R0,2"4).00Q4C/(].W;T4 <[>Z!=ZY<V!
MUF>W-K93K<K;VZ,!-*OW&8D\*"<[1W R3C%7;/2YDN-7-ZUO/;:A-YGE>6>!
MY21E6R2&!"9[=:U:* ,'PIX8@\)V%U8VLTDEM)<M-"LA),2%541Y/4+MP/;
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M:1'86]U%;;;F&X+R1E\^6X<# (ZE:;XNT"Z\2Z NFQ74-LYFAF>1HRXS&ZN
M!D=2N*Z&B@#G&\.75MXH.N:9=PV[740CU&V>(M'<,OW'&"-K@9&><C''%2V7
MAU!I]Y'JL=E?7=U)*\DI@P&#=%())PJX7KT45O44 </;> KG_A#=-T2]U8/>
M:3,DVG:A%#AHF0G9N4L=P .TC(R/?FNELX=9<Q_VC=6@5#EA:1LOF'WW$[1[
M<_7&<Z=% '/76@7<_CBQ\0+=0K#:VDEKY!C)9@[*Q;=GC&T<8K:O;.#4+&XL
MKJ,26]Q&T4J'HRL,$?D:GHH YK1=$US1-.ATF/5+:>QMU$5O/- ?/2,<*K8;
M:Q XW<=!D&F:EX;U.?Q7INMV>H6T?V&UDMECN(&D,@?:2Q(9>?E'ZUU%% '.
M7>C:WJ%I+#=ZE9NLT\9DC2V81F!2"8\%SRQR"WH<8J+7O";7^HZ-J&DR6FGW
M>FW)F\S[/N\Q"I5HS@CA@>OL*ZBB@#G)] O;?Q1-KVEW-NLMU;);W=O<(2C[
M"2CJP.5(W$=""/2I6T34#IUYLU)(M3N[B.=KA83L0H4PH3=DKM3!RW.3TS@;
MU% '-GP]=W?B6RUR_DM/M-A!+%;B"-AO,F 2Y)S@8X7MDG)JGH/AK7O#_AYM
M*M=5T\GS9I5G>S<E3([/]W?@X+<?2NPHH PI--UB*XO?L][:3VMR%"P7D+-Y
M>$"D[@WS XR5P._/-6/#>AP^&O#MEH]O(TD=K'M#L,;B223CL,D\=JU:* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHH!!'!S0 4444 %%("& *D$'H12Y&<9YH ** 0>AS10 444F020#R.M
M "T444 %%&1G&>310 4444 %%% (/0YH **** "BBB@ HHHH ***3<..1R<#
MF@!:*0LJG!8#ZFEH *** 01D'(H **** "BBB@ HHHH **** "BBB@ HHHH
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MI<W<-\QB,7FJQ6(C:?GPK9SP..N>%\"S7J^#/",45HDEF^E1&><S;6B(C3:
MN/FSSW&,5)-X0N(]9FU'3=8>W:[M$M+U)X?.\\("%D!W+M<!CSR#GI5S0] O
M=#T_1=/CU8R6FG6IMY8S;J#<8"A#G.5VX/ SG- &]1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@#MJ*Y_PAK$VK:7=1W3;[O3[V:PGDQCS&C; ?CNR[2?<FN@H **** "BBB@
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M'N3C:AX5O-0U/Q/*TT$=OK&EI8(026C*B0;B,8/^MZ9[>_  ]O&45IIUH;J
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MT*C=O=F/E@_,0HP!P%[YK0TB]M+WQ*NJW;!-1DM19QQ0P3% N[<<NR+G)QU
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M@SC)XZUC0^#M6B\/Z;I_FV1EL]9.I,WF-AE\YY=H^7K\^,^V?:I)+?3?$/Q
MM[S3;]9?L,;PZI'"<HSQN&A1_1E?<P^AH ZG4KR:ST6YO(K=GFCA,@BRN<XS
MC)../KVKB_"6IK&/#-U>IJAO]<L K,]PKP2.L0E:0IN.TGD# ''! XKM]3@F
MNM+NK>#9YLL31KYA(4$C'. ?6N4C\*ZO:Z9X2%M+8M>Z"GDL)&?RYD,/E$Y
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M)"@-NA!DR0"<'*IT_CK \+22Z'XSUOPQ?+%!'J .JV,<,Y8 .=LR*V%(PPW
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M'KCB/P]J&GZQ)%)J.JS6_B.UU>9);:.?;(P$CJL1C/6+RRK<#'&[.<F@#L-
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MN*GHH J?V5IVS9]@M=N=V/)7&?7IUJ0V5HUVMV;:$W*KM68QC>!Z!NN*GHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/''>2PJI$3. 0.6!/#*3@<;OKC$\3^$=>URXUA4FTZ6"Y-N]B]R[[K;RRI9
MH4@!BI.\'/."#@8QK^5[OQ!KS1MX>FMVN(4N[2ZU&2U:22)$^\FQLC=T/&X
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M:XF$-S]EFFCV%8I-N[YANW 8(&<=35K4=5ATZ2UA9))KFZ<QP018W.0I8]2
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MX9!O(.>76H/#TT>KV^FZK;^+#,UQI\BW5G"[[Y'V EF_>'RV1@1D!>NWC@4
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M:JY:.1D.[:2#RI[FMJO(]#5['1_"VH6]W=)+/XBN;61!<-Y31--<Y4QYVGD
MY(SGO6CH=])K=Q:7TOB5;/5+?5)8KFQ&\R.!(R^08S)C;MVD,$XQN]30!Z71
M7)>--5;3[O0H);Q++3[RZ>*XN)-P0'RV*(Q5E(#,/4<@ \$BL2_MKS2O"O\
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MK'UC4%O/!?@W4+ W6\ZI8B'[2<S'+;'#GN2I<$]^30!Z-1110 4444 %%%%
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MXQB5(V\IL[<!B,L=K8 ].2,C.A+K<;>%FURRA:XC-I]JBC)V%QMW '/3W]*
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M3&WM99EB:4QH6"*0"V!T&>* .3U7P?<ZWJE[+=RPQ6MYHQTQQ$Y+HQ8MO&0
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MGK@],UYU#=V\MSK]E8W5J\=QX76:&"TEW@RKYHW9'WY  N6 !Z<<5[ %4*%
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MCABAB$442)&/X%4 ?E0!Y)XU M+?Q<NE7'E:/_8\4S"WE*QQW1D8#9M. 60
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MOF1AP5 (Y;/K7I_D0B<SB)/.(VF3:-V/3-*88FF68Q(95&%<J-P'H#0!Y_\
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MYO03!J-I\-(KNZDD6YL;A9D^TL!+B(?> //.<_D:]:CMH(HVCCAC1&)+*J@
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M2G:V+;NN<$@_C46GSV>J:E8V4NN60U.VURX:YN!J"QRW,.^0"+8&$G4HH4C
M"9&1C/JPMH!@B&,%>A"CCZ5R]GX,N(XEL[_4X+ZR0Y!DL%%R_.?GES@GU(4$
M]<@\T <A-K-C_P )'IMY;7R12#Q++;7'GS W!79*I5L8VQ950J$'C:<YXJ!;
MRST/3M8\@P6\2>)Y%U(I'N,5J6X+J"#LW%,]B">HS7K_ )$6XMY2;BP8G:,D
MCH?K2F*,[\HOS_?X^]VY]: /++F[L=+ALY+36EN_#=YK4?VZ6 @6MNIC;$:L
M"0(S($W#.T9([D5N^"'TU?%OC*'398&A^UV[HL+AE -NF<8[;LCC@=*[46\
MM_LXAC$.-OE[1MQZ8Z4L<4<0(CC5 <<*,=!C^0% 'FGB.9(]6^(2"[D0IX?A
ME4"X8%'"S\KS\O1>![>M6O#RVUEXYT9+6=L7WAYIIP9R_FNKQ;6.2>0&<#V]
MA7H#6\+,2T,9+=25'-"P0JP98HPPZ$*,B@#AO'%Y8'6HK"YF1)VTRYDC%TX$
M!Y495.KS9X&", D\YK%T:6TU[4O!*WMZUTESX<D-RINFVRNOD9W 'DYWY]P<
M]*]5:-'969%9E^Z2,D?2F?9H./W,? P/D' ]* /*=,E>V\!^&_%R2271T:66
M.Z <R%[3S'C;_>9!M8=\*?6O1O#UH]MI8EGC\NYNW:YF0]49SNV?\!!"_A4>
MHZ)/?7D 74/(TM1_I%C' O[\@@C+]0.,$#J.*V: "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!M2U6XG2VBCF(7:C.6+';\H55 X!)X]>-[PKHLOAWPOI^CRW*W+6<(B$JQ[
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M5<R,LC[BK=R%QD]ACM0!U/AG6_\ A(_#MIJWV8VWV@,?*+[]N&*]<#/2M4\
MXYKQG2]3M+7PKX/;5+E8M!=+R*YF:-9(HYS(#%Y@8$ ;?, R.IK4@DTS1M0\
M-6=[>RS^%'@NOL]QJ./*:<NIC#$@#:$\P)GMTSQ0!W?AO7&U_3IKIK7[,T5W
M/:M'YF_F*0H3G ZE<U4A\;:-/]FV7EN/M%\UBFZ8#$J_PMZ,>,+U^8=.<9WP
MQ:U'AR^AM"ODQ:M>JBKT5?/?;^F*ZW[%:?\ /K#_ *WSO]6/]9_>_P![WZT
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M@Y!MT (^I!'U%3>,-,NM!34M<\/Q_:=*U>)H]3M(CD*[#:MRF/J-^.HY[9H
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M:WW$!3*N  ,D E2V,^G-87C?PU=MX/N#I\EUJ,L6H0:EY3OO>1(RFY%]>%)
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MQ8QC'S8W;L=L\4OC73+GQ-\/M5L+%62YN[0F)'^4EL!@I]"<8_&J$WB;39O
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MEN=!=OLR1(RAA.@#;6(' XSUP<57\8P6:?#U+F#3Y+-7U: _9F7YHLW"QLH
MZ;@#E1D<GK0!T\7A2Y1+BTDUNXGTR>21WMY8(V?#L69?,QG&6/;..]=*  H
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M9I'V\!B,=.K+DCK77Z?>27.F)=W,<4).XD1R^8FT$X8-@9! !Z=Z +>U=NW
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M:=QR2>=N?7)KI-9\836-QJ,6G:3/J+Z<46>.)9"[LRARJ;48$A64\D9SCWH
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M9H(UBM"B1[OO,09"6/3'(QSZFME)(Y"P1U8J<, <X/H:'D2( R.J G +''-
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MYFLH[1H5A*X",S;@=Q[N>,>E:ZS1.C.LB%5)!8,,"D,\0#$RH APQ+#@^AH
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MGA,\IC(P23@GFM7Q'K[:&M@8X(IS<WT%JZM+M:-97";P,'.,]./K6V2%!)(
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M]V=B'S4!Z>A'/S*W-=3110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%N01Z$@'49&<9Y]*6N#\%V?]LW-]JVJV5NU]9ZQ>)!<I,QD7:[1[/NKE H
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MV:(#:S(J,"V?F!"# P,9/7MG6'P_LK)- /VN>6;22V97^]<J0,*Y]%*1$?\
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M=I^?@?O6Y]A^/8*RNH92"IY!!X-89\0/=ZW>:5I-K'=36(7[7++,8HXV895
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M  IJ5MK%MJEUK45Q<0Z<UAM6SV(06#!L;R<Y49YYYZ51M_ -[IMCHG]EZ_\
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M5I>'-#DT&UO(9+M;G[1>37>Y8O+VF5RY7[QR 2<5LT4 %%%% !1110 4444
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MX!F;J 5XP,CU:B@#RL:GIDNI+#XI2673-3T2WBL99(796;#B9%P,B1LH>.2
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M/(]JLZI<Z1>^'-5UCPC;7$GF+:_;?LD3*'ACE!=%1AM+^7O!&#Q@'J!7IE%
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MV/PU,:^$C;Q$"."^NXXT'1(_/?8!Z#:1CVQ77T4 >-7D-A;>'?$-EY"07/\
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MBS\)3VMYHET^K&>32;62VCWVX =7" DX(Q@1K^OKP 5;'QP]_I6DNMF(]0U
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M5Y]1BKE-0,$4.0SX^8@8!/T[4Z@ HHHH **** "BBB@ HHHH **** "BBB@
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M*PEKCJ"H 0[DSVY ]J-2TVSC\.^-6@L$%PFM1R66R#Y@O[@YBP,XW"0Y7T-
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MA@1\I91@$]=I'>NE\!6%SI_A?[/<(Z0_:KAK2*0$-';&5C$I!Y'RXX[ @=J
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MK:&NK7^E7;74D3:;<&XC5%!#L49/FSVPS=,4NGZS;R:992WM_IOVF<B$FVN
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MU&TN)T19&BAG5V53T8@'(!R.:=!JFGW5V]K;WUM+<1@EXHY59U ."2 <]>*
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MK9XK1Y4GA,B&,AP"H*JH7!((VC%=SXUM;C4_ &N6UG#)+<7&GRK%$%.YF*'
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MB2YM;R&94GA>1BS@,%P02QR"".?84 :^@7&L76CJVM6<5IJ"NZ,J$,C $[7
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M=FQE4EAP%'.68Y&,YZ 8  ,G2O$NO:J-+U6WTY'T6\+M-G8K0Q8.QPWF$L>
M"NT=>.G+=-\4:[>0:9K3:<AT*[MFN;AOD#6R;-Z$'S"7_ND;1SSQTK2TKP5I
M^C7[S6EWJ M#*TT>GO/FVB=B22J8SU)."2 3D#.*31_!&FZ+,PMKF_>R#.T.
MGS3[K> MG.Q<9QR>"2!GB@#G+B_U#6;_ .'VL7#6RV]]>-.D"1G=$'M964;]
MW/RGG@<],5Z17*6?@#3[$Z:D6H:F;;3+@SV5NTRE(,JR[ =NXKAB,$DCL:ZN
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKJ%L62 7+ 2#(B/1_P#=/KTK!\8V,UU>:=/9W&HV-_!'.8+ZT@,Z(3LS'+&
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M+BV&V)PJDEQR<#@ <G)-9NCQ:G:>+A>:AI4L0N=!M(Y#;)NBAEC:4R1\'MO
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ME8V3Q2M<R,Q[$Q0Y<AP2N0>!P/6NSM+@W=E!<F"6 RQJYBF7#ID9VL.Q'0T
M96O7.LVD%S=6$EE';6UJ\S?:(6D:1P"=HVNNT8'7GK7/_P#"0^)O^$ ?Q/OT
MLHVBOJ*H+9QY<@C$@0YD.X$;AGCD#Z5U/B ._AS4DCCDDD>UD1$C0LS,5(
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MVT$#KM!_E7/>%;#5=$_X1&^O;"\-M;Z,^G7$2PLSVLQ9&W% "2"$VY /0=J
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MHT_2Y8;DFW;]S(8HU /'4E6_R:JZ5!J=A8Z3&VC7@5=6OW>>.VS-;I(\C1E
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M[GC@MXE+22R,%51ZDGI7'RZKXD-U>Z):S1W.J6%HDYN([=$2621I-@9'DRJ
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MUTRQFO;V=(+:%=TDLAPJCU-9_AV;69+6Y36X8TFCN&6%U*YDAX*LP4D*W)!
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M/)RF,8Q@^V:UE\4:RFDZK<M;-<?8];DLYFL+?,B6Z@?.L9)W,"1GKP2<<8H
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M:&Y:1(Q&'R=S#*CCU _EZU+!XET:Y$ACU"':D'VDL^4!A_YZ*3@,G^T,CWH
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MZGX;\(>&IK!H/[<TN00*I;Y'2X?:\6>ZJ65A_P!<Z]!T^RCT[3[>SB)*0QA
MS=6P.I]SU/UJN^A:;)KB:T]L&U!(_*25G8A5YZ+G:#\QYQG!(S6C0!YC!I.K
MQ>'-(TV72+KS;'Q$;J1AL96A^TR2;UP>1M=??)X'%.U/1=;EN/$EW9:?.Y_M
MBUOX(3)Y7VN..*-756!^4Y5L9QR!7IE% '/^&(8V-YJ*:)=:8]V4\S[:^Z>4
MJ",OAFX P!DYX/&,5T%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDG@<UVDV@Z?<:S_:LT3/=?9FM#ND8H8F.2I3.T@D#M6;8>!M$TZ>PEMTO/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M**RBNY+QDADN_L0+0N"L^[:48;<J<^N*N:3KEAK:7!L9)"UM+Y,T<L+Q/&^
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M16T<&Y+F/"D.'V_P@C@'G?TIEAXUT#4[BRAM+R1S>EUMW-O(J2,F=RARH7<
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MK$:5'<I"47Y9#*RD@@9Z*.I]:Z2N7M+'4F\?G5IK!HK1](CMB_FHVV02,Y7
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M@%LAC@?PG&,U5TB?5]-T74C8+<:@8_$=Y]K2%D2YFB&[)3("E@=I(&,@'&*
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M9G5@H RQ;"@ YY([4 =W17F&J>(==M-&\9+%>W%O-I<]L;5I5C>1%D2,LK$
M@CYC[C/7BK&NW>JVO_"::4^L74T<6A"_@E(1'A<B8,JE5'RGRUZY(YY[T >C
M*P90RD$$9!'>@,&&001G'%96@P.OA:PB-S,S-:)B4[=RY4=,#'';C\ZX/PCJ
MM['HO@O2FO[D_P!L+=2S7#%2X\L%MBG'5BV23D_*>?0 ]2JAJ^LV.A:9<:CJ
M$K1VUNNZ5DC9RH^B@FLGPGJ5_<W.NZ=?RFX.F7YMXKDJ 9(RB2*&P -RA\$@
M#.!7$:]'/_PCWQ0:2]N)E2;8L<A4J 8(6XXR,9( SC';/- 'K3*LB%64,C#!
M!&013J\]U7Q!JOAC4O$*M?27\4&B+J,2SQJ!%)O="!L .S !P<G@\UNZ*FMI
MK?FW.IVUSI=S:!XH_.$DGF C+J1&@V%6&1S@XQUH Z6J*:Q92:Y+HRR/]NB@
M%PT9C8#RR=H(8C!Y!'![5S]U>W^L^)-<T2SU1M-FL+2%[9E16W/('/F,&'S*
M"JC QWSU&,V]OC:>-M1OFO[>)H_"JR_;&0F)2)9#OV@Y*YYQGIQ0!Z!17FTN
MN:W:GQ#;_;;M?L_AY-1MY)TC\Q9?WH+8 ( ;8#M.<>W2KZZUJ[:SI4,5\G^E
M^'9KLI,JB/SU\K:Y(&0/G;(SCVH [JBO,_\ A,[ZPTZ^2\:]L]5B:RAFM]0"
M;8!)-Y;SI(JE60[NN" 5Z=JZ[0H=:MM3U&+4[V"XM6$<EK&)-\L0((8,=BY4
MD9'&>HH WJHZCJUII:I]H:1I) QCBBC:21PHRV%4$G _IZBN4N]7U+4IO%XM
M=0>QET3"VR*JD$B$2[W# Y#$E<<<#CGFJBSW.M>+_!&IR3W%J]YI%Q<- @3$
M9*V[%1E2><X.>>.,4 =Y9WUM?V%O?6TH>VN$62)R"NX-TX/(ZC@U#8:Q9:E=
MWUK:R.TUC*(;A6C9-C%0P'(&>"#D<<USOCU)GD\-+%>7%N)-:AC<1$#<"KD9
MR#G!4$=O;I7,:M<ZCI4_C_5[#4IK>6PN[64(J(5F(MX<A\J>"./EQU^F #TX
M7T)U-M/ E\]81,3Y3;-I)'W\;<Y!XSGO5FN-U+4=93Q?K.GV-ZF%T(75I'.%
M$<<Y>102<9Q\JYR3WJQX0UJ34KK4+6Z_M"WOK98O.L+]5W0D[OF5U&'1L'!_
MV3TZ4 :4_A70;G4'OYM)M'NI"#)(8Q^\([L.C'ZYK8Z5QAU#4=;OO$<5KK T
MN;2+N.*-6C5T""-)&>0'DAMSKU& N1SFJ-]K^J7>C>,-5M+]K2?0;B9(+?8I
M1EAC5SO!&3OR><C (Q@Y) /0:3<-P7(R1D"O,=1UK7KB'Q?=PZO=60TW3;>_
MMH%BB/ENT+R%&)3E<K@]_>M.%KN]^(QE&HW4(?P_'.L:;"B,TC X#*?0'UX]
M.* .\HKS;1=1UB7P9H6L7OB.X>YU;[,GD"WCR['<62+ &&8#DL<  GCLZP\4
MZF8[73[RZ>)KCQ#<:8;IPA>.-%=T7(&TN2H3..Y[\T >C%@HR2 ,XYI:\]\1
M6VI03Z!;3:_/.3XA$8:)41EB:)W1'X(9EP,$CD$$C/-=%XNUB?1=)MG@=4>X
MO(+4S2,%$8=P"Q."!Z9((!(X/2@#H*1F"J68@ #))[5Y[KESXHT32[QGUB$'
M^T;(6H7;+(D4LJQNDA*+E<[BI&#U&>*S/%-WJD>A^.M+EU>[FCLH[66&9@BR
M!91\Z$JH!7CTSSC.* /36OH5U)+ B7SWB:8$1-LV@@'+XV@Y(XSFH;[6;'39
MK**YE97O9_L\&V-F#28)VD@8' /7'0U@S7&H1^.[?1_[4N6LYM&GF(*QAA(L
ML:AP0HYPQ]O:N3TGSF\"_#B:>YFN))M3MY"TI!()AER,@#/KSD\]: /6:HZG
MK%EHZ6SWLCHMQ<1VT16-F!D=@J@X!QDGJ<"N1L-3U_7&_M.RO[6WBMM7EMKB
MWFE^7R4E:,QE?+R)" K [NI'8XK&O]1NO$?A71M=EO)5$OB.W7[(H79&BW>Q
M4/&=PV@DYSDGM@4 >H3W$5LJM*^T,P11@DLQZ  <FJ=WKFGV2@S2R',WV=1%
M \I:3:6V@*"3@*<XZ8.:76=$LM>LTM;])&C2594,<K1LK+T(92".I'T)IMAH
M6GZ;?7MW;1.);R7SI=TC,H?!!*@G"YR<XQG- %2T\8Z)?.J6]Q.^Z9K<,;.9
M5\T9RA8I@,,$8ZYI(_&.B36T]S%-=206[.DTB6,[+&R'# D)@8QSZ5D_#E%?
M2-:#J&']O7QP1GD3$@_G69X)AUB73-8^PW-FL!\0W?F1RV[,S)]H^<!M^.5S
MCY: .PN_$VE6.IC3IIIOMAA,XBCM99"8P<%OE4\9(&:5_$VC)H!UW[?&^EA2
MQN8@9% '!)V@D8[^G>N/U^ZU"/XE6UUH,%M=W0\.3R01R.523]]&0 1Z\8[>
MXI-"M-.3X2WDEI<-=+>M+<71EC"$3._[Q"G.W!RNWGIWH ]"MKJ"\M(KNWE6
M2WF021R*>&4C((]L5BCQMX>;0FUM=0+:6K^6;I8)"F=VWJ%Y&[C/3-<CHCS:
M>U_\.&9P\<_^BR9.?[-DRQ.?5<-%GL2E8CJJ?L]7R(H55OY  !@ ?VA0!ZJN
MOZ8=7ATIK@QWTT9EBAEB>,R*.I7< #C/('(J&Q@T+2]=N[:QLX[?4;W-U<-'
M;,/-YY9GQ@\GUZD^M8OC#PY'XEURP@$[VM];V<\]E=Q_>MYEDAVL/4=B.X)J
M#PGX@N=9\326FJ6WV76M.LS!?0@?+NWJ5=#W1AR/R[4 =B^H6D>I1:<TZ"\E
MB:9(<_,R*5#'\"P_.JFI^(=-TB1H[R6562(SOY=O)($C&?F8HI"C@]?2O/?$
MD]VEQ#X\@TV[;^S[L.MPK1E'T[!1P!OW$$%I1\O<>F:[GQ0T,W@G6[B(HZRZ
M9,1(O\2^6Q'/IS^M "Q>+]$FMVN$N)_)6V-WO:TF4-",9=<I\PY'(SUJROB#
M2VT>'5OM06RG"F&1D93+N^Z%4C+$Y& !SVK M44_!RW<J-P\.@!L<@&W&1^@
M_*N:L#(-2^%!N,_8/[,8)G[OVC[,NW/OMW8_&@#T2#6M-OYI;+<XG\HNUO<6
M[QN\?0D(Z@L.W /7%+I&L:9JL$PTVX$BVDA@EC",K1.O\)4@$'\*YGQTLK>*
M/!'V//VX:J3\O7[/Y;>=^&-N?PK+N-+OM&O+WQCH,+S7,=Y<1ZG8I_R^VXD;
MD#_GHG53W&1[4 =]I=Y8WD$KV ;RUF=')A:/,@8AOO 9.003ZBJ?_"5Z2;N[
MM$DNI)[,A;A([*9S$2,C.$/4<CVJ#P5J%MJWAM=1LY/,MKF[NI8GQC*M/(1Q
MVKF]-CU>3QWX[_LJYM8G\VTR)H2Y)^SKT(8 ?B#0!V<FOZ9';V<WVDN+U!);
M)'&SR2K@'*HH+$8()..,\TZVUNPO(;F2"9V-L<3Q>4XEC.,C=&1N&1R..1TK
ME=*5H_C+K:7(VXTFV%@,8 A#-Y@7_@>,_A1.LG_"Z5:USY8T%A>XZ?ZW]UG_
M &OOX]LT ;MCXRT#439_9[_Y;TD6KRPO&LY]$9E 8^P-:M]>V^G6<EW=.4A3
M&XA2QY(   !))) P*\8\,K+?>'OA[INL%+;1?,6ZMKB($M+=QLQ2%R>$!!)&
M,[L8X[^W,BN,.H89!P1GD'(/YT 8!\;:$);F,W%TKVH4W"M8SCR0PR"_R?*"
M.<FKUKKVG7NI7FG6\TCW=EM^T1^0X\O<,KDD8Y'(]:YWP^BR?$KQPCJ&5DL
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MUZ3[+KPLUNH9XU4+=0,N5E0$8R,X9<<'Z\ '::?IUKI5C%9647E6\0VHFXG
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1** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>exhibit1027supplycontrac030.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac030.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=1P>:[T$$9!R#10!QK66HZQK^BZS/ID]DVF6=P)HF="TDDBHOEKAB"HVDY)
M^[[XRM!T'6;*U^'\4^ERHVDQRI>GS(R(BT)0=&Y&2.F:[K5-7L=&M1=7\_DP
MF1(MVUF^9B HX!QDD#\:NT >9Q:%KD?@O3M);1YC<66N1W+$2Q8>);LS%U^;
MIM(X.#GM3]=T'6KW3_'\,&E3,^K-%]B_>1#S-L*(3RW'*GKBO2:* //-=TS6
MGOO%PM='GN$US1TA@D62-1'(L<JE'RV0?G7& 0?4=:A_LG5K'5/,NO#,FK6.
MH:=;V\D2W$8:VDC4JR."VUD8'.03WX.:])HH \[DTC6=)U#Q###H[7=GJVG1
M16S6;HJ6SQPF,QD.P(3N",]3WKI]$M[FS\"V%I>0-!<V^G)#+$S*Q5EC"GE2
M0>1ZUJ6=_;W_ )_V=F;R)F@DW(RX=>H&0,CW'%2SPI<P20R;BDBE6"L5.#[C
MD4 >:^%M,N==\*_#\K9RVT>F1QW4ERY7E?(9 J8))W%@?8 YYP*M>%-(U&PM
MK#3-4\+*USI"E8]3,R.DJJI56B!;<'88!!  R>>QZW19='LWE\/Z6Q0Z9'&'
MM_G/E(V=@!;J/E/0G&*UZ /./[ UD? W_A'AIDO]K?8?LWV;S(_O9Z[MVW'?
MK6U-;:G:>.DUY+">XLKK35M)(D9/,MY$D9P2"P!5@Q'!."!VZ=%?ZE:Z;&CW
M+L#(2J)'&TCN0"Q"JH)/ )X':G:??VNJ:?!?64RS6TZ!XY%! 8'Z\T <'HOA
M?5-'U+PINLGDAM'OYKED=-MM]H;<J#+ G&<':#3-;T'6;S3?B!!!I4KOJS1_
M8OWD8$N(4C)Y;CE3UQQ7I%% '!>(-.UVX\0:EJ&FZ0)?-T VL(NC$8VF\PML
M92W/![C;GOBLRZT/7+E?%;1:-?XU;0H[: W-S$SF8"8%6P^%YD!P/E STZ5Z
M@2 ,DX HH \WUWPSK&M7#0PV<ELDWAJ73_/=TVI.S(P5@&)Q\I!(!'-7KZVU
M[Q7X6O[>70ETC4C:>4'N)(V\R4,&"JR$GRB002<=1Q7=44 <OX8AFN+MM0NO
M"_\ 8]T(!!(\TJ2R/SG:K*Q_=@Y/.,D]*A-GJ6E>-=8U$6$NH6.J6L"KY3)F
M*2(,-A#$?*P;(/0'.<5UP(/0T4 >>Z?X9U318O =F+:2[72/--Y-&Z;8]T+J
M -S D!F X'05O^-]/O=1\/(EA;-<SPWMK<^2K*K.L<R.P!8@9PIZD5T=% 'G
M^HZ3K%W=>-I5TF8#5=(AMK4&6+YY!',"OWN,&1>3QP:KG2=6L-4BGN/#<NKV
M5]IEO:S0K/&KVTL88%6#,%9&#]03T/'-=I#XBTNXU1-.BN2US()#&/+8))L.
M'"OC:Q4\$ Y%:E '.Z]H,^I?#^[T*S$%K/)8_9XDCR(D8+@*/]GC'TK"U>T\
M0>+O"UU&V@+I6I)'$1]HEC8SR1RI)Y:LA/[L[2,MCEAQUKOZ* .&U/2M1UK5
M;G64TVXMF31)[%;>1HQ)-)(00O#$87;U)QEN*32M(U6#5?!<DNFRQQZ=I$MK
M=N7C(CD980!PV3S&W(SVKNJ* /,](T/7+;3/!=I/HTZMH]](;EO-B(V>7*@<
M?/R,NI]>O'3+_%ND^(-3EUVWAT:69&GLYK.2WFBC25$:-GWY8,TGRL!N^4 +
MC'?TFB@#A;2WUS3=<UNSDT'[?9:M=+>0W+2QF.%C&BLDRDYPIC!&T-G^6IHM
MC?V7C/Q+--9.+._E@GAN=Z[3MA1"N,[MV5/;&.]=-10!S$]G?+\2(=46QE>Q
M329+<S*R8\PRHX7!;/13SC%<[H&@ZU96O@..XTJ9&THW'VS]Y$?*W1NJGAN<
MEATS7>:9JUCK$4\MC-YJ03-;R'8R[9%^\N"!TJ2"_M[F\NK2)V,UJ5$P*, "
MPW#!(P>/3- 'G!T'7[:V2_31GN'M=>O+QK!IT5I[>8N R,&P& 8'!([BNX\.
M6JV]A+(ND)I1N9FF:WRI?) !:0J2"YQV)XQS5O5=6L=$L&OM1F\FV5E4OL9L
M$G X )ZD"KM 'F]_H&M3Z)XLBCTR4S76MP7]M&9(P9HT:W)Q\V ?W3<-CM4U
MWIFIKXEU5[KPN=6T_65BD4&XC MG$:QM',"V"OR@Y7=U/!KT*@\#- 'G]YH>
MJF?QJL6ENT>H:5#:V9C:,+(ZQ2(0 6RHRXZXXJ.^\.ZMJ$VF0BPEAC'ARYTZ
M:5GCQ%+(L84'#9/W#R,CI771^)=)E73"MRP_M0E;0-"ZF0A2Q&"/EX4GG'2K
M.G:M8ZL;L64WF_9)S;3_ ",NR0 $KR!GAAR..: .0BL5UKX=^'+:6RO6>%84
ME>SF$4]E+'&R,ZDD<JX*D<\$\&JVNZ=K-U\+SH>I2>=JM]=K;0OM57=3<;E=
MPO 81J7;'H:[33[_ $RZU#48+%P;FVE5;M0C+ARH(SD $E<<CMCVJZ8(FG6=
MD!E52JL>2H/7'IG^@H P?'>GWFJ^!M9TZPMVN+NZM7BBC5E7+$8ZL0!^=85U
M8ZW::UXCE32+B\MM;L(EA:.2,&WD2)D,;AF'!)W KGJ:[^B@#S&VT?6M*?1K
MFX\.3:E;OHEMIUU:1W$8DMY8MW/+A61MY!P>PK6MM&OK+Q2+B+1A#8IH(LT6
MV9/+23S"WEJ"P. #C. /I7<44 >=>'=$UK2Y?!4D^ERG[#I,NGW:B6/,#GR<
M,?FY7]VWW<GIQ45QH6MOX#UG3ETB<WESK3W<47FQ<Q&[$H;._ ^4'C.<UZ51
M0!QFM:-J.J^+6EBMI8;2?0KFQ-T63]U+(R%>-V[@*>0*R;30=4UCPY/IMWX;
M32M5BTZ:S&HR3)(I9X]F82I+!6X)R!@<<GIZ35+3=6L=72X>QF\T6\[6\OR,
MNV1<97D#ID4 <;80:Y=ZWX1N+GP_<V:Z;;SP7;-+"55FC105PY)7*^F<=JVO
M%MC>WMWX<:SLY+A;354N9RK*-D8CD4GYB,\N.!FMC3]6L=5>[2SF\UK.<V\X
MV,NR0 ,1R!GA@<CCFKM 'FMQH6M2:!J]NNDSF:?Q(E_$OF1?-")XW+9W\<(>
M.O2MOXF,1X$N6$9<_:;0A.,G_28N.>*Z^L36#HFJW5OH&IDR2W*FXB@!D4.(
MR#NW+@<':>O7% '-Z[I&L7NI:SKVFZ8OGMI<5C!;7(C)G82EW;!)7Y5.%W=3
M[=<G5/#^O7=EXRC@T6]/]K6EL+;[1=1,[,H(8,2Y /.>#C'3TKU15"J%&< 8
MY.3^=+0!R?B"'5KK6=.,&ERRV+VLR2M#)''-%(VS:K.6!$?!SL))('4<'E+"
MVUC1K;P@D6BW;ZOIVDR6]S##+#(R1GRU&Y6D48+(2"&S\O0\X]#F\1:7;ZE%
M827)%Q)-]G7$;%/-V[@A<#:&V\X)S1J?AS2=7NHKJ]LU>YB78DZ.T<@7.=NY
M2#C/;I0!QNG::Y'@^'3-(U%+;1;V47:79B$L6Z%QEL-ALF4-\N1@^V*9XETK
MQ!J%SJJ)HLTH74K.YM7MYHHXY8HWB+%@6!:7Y6'S\ !<$=_0[6U@LK=+>VB2
M*%/NH@P!ZU!-JUC!JUMI<LVV]N4>2&/8WSJN-QSC'&1W[T >?-;W6JR?$72(
M-.>::_G6!')7RT9[2)<L2<@+G=T^F3Q5FY\.ZM$/&5O#833I>Z)!8V<I>,>=
M(D4J'JV1RZ\G'>NWLM'L=.N[NZM8F2:\<27#&5FWL  "021G  ^@%7J *.C1
MRPZ'813Q-%-';QHZ,02K!0",@D?K5ZBB@ HHHH **** "BBB@ HHHH ****
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M!\N1%C10'16P?F0G!'((SZ5IW_@O0-3N;V>[L6=[W8;@+<2(LC)C:VU6 ##
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MFK# )?M,Y+Y4Y4]U0!1@X8GZ;NI^#]"UBZNKF^LC))=P"WN )Y$66,9P&56
M)&3@D9'8BN<U3PE/-XAFF.CM<VQABAM9[;6)K5XT4'B4*06.YF.[+'!Z9SD
MD\[Q+<^*K31CK;69?1Q>3%;:)RLHE4$#(QC!(_SFETO5?$6N"RUBRN[6.R.H
M20W-M-(H40B1H]H 3<)1A3RV"2>,$8WM*\-6UE/:W]PTT^IPVWV;[0]S(_[L
MG.TY.&QQR1DXR>:+?P?H5KKDNL06/EWDLAE?;*_EM(?X_+SLW?[6,T 8.AZK
MXBUR+2M<M[NU33IYW6ZMI9%VB/<RA4PFX2*P4<M@G/3C&YX@O;F&_P!+M+:]
M:%KEY-T,$:M/,%3^ N"J@$@DM[#.3@NLO!^A:?K,NJVECY5U+(96VROY>\]7
M$>=@8^H&>3ZU:U/0=-UBXM+B]@=Y[-F:"2.9XV3<,,,J1D$ 9!X/<4 <3;^*
M]<D\(:%J]PEW+!)%/_:$NGQ1O/&RL%23RV!!3ABVT9!([<5U4]VUYX#DO;74
M6=Y-.,L=[  I8^7G>H(P,]>G&:6V\'Z)8P00V=O-;1P>:(Q#=2IM$A!<<-T)
M4<=!CC%:L-A:P:<FGQ6\:6:1"%80/E" 8VX],<4 <)X;U.]:'PGX?74+B,7.
MAB^>Y*QESM6)1&N5Q@;R22">!SUKH?!VK7VJ:??1ZB5>YL-0GL3.J[1.(VX?
M X!((SCC(-31^$-$AM+&VBM9(UL"3:NMS()(LC:0)-V[;@ 8SC  QP*U+*QM
MM.M5MK6(1Q EL9)))))))Y)))))Y)- 'E6H+=OX)\5O-J%Q<./$<<2^>%(&V
MZ@ / !Z #&<8'&*VKWQ-JN@W7B2UN+_[6MH^G^1//&B>2+F0QMG:H&U<;AD$
M^N:Z:X\':%<K>K+9N4O9UN9T6XE56D!!# !L Y52<8R5!.<5+-X6T:XEU"2X
ML_.;485@NQ+*[K*BYV@J3CC)P1SS0!#HB:]!JE_%JMU!/9LJ/:#>IF3J'#;4
M4%<XP<9ZYKG]1N_$E[KWBJRT_7?L2:;;6]Q;#[+&_P S)(2K%@?E.T9[^A'.
M>JT3P]IGAZW:#38'C5L;C),\K$#H-SDG R<#.!D^M8</AE[OQGXAO=0M9A87
MT%O#&4N2HD"!PX=589!W#&1TSTSR 9=CXEU_Q7 (--ECT^]_L>UO5!90#+,K
M')#(V8P5 XP>3STQ:@N_$>H>+H],;6HK5%TFUOI1:P)(AD,C*ZJS#)1@IYZ\
M@C%;VJ^#]"UFZM;J\L?W]JGE120RO"PC_N$H1E?]D\5;AT+3K?5_[5A@9+OR
M%MMRRN%$2G(4)G: "3V[T <9:>*M5:[CTR>\S)=>(KG3UNO*0&*&.,N !C&X
M[0,D'J?:B[\6ZKI6H:GHDT_FR)J=E9VU^\:@JER,G<  I9,,!Q@Y7(ZYZD^$
M=$-K/;&T<QSW7VUB9Y"PGSGS%;=E&]U(J2X\,:/=Z7=:=<V8GM[IQ)/YLC,\
MCC&&+D[LC:N#GC QC% &'X=@EM_B3XI2:[DN2;.Q*O(JA@/WW'R@ \Y[58?4
M;_6/%.MZ+:7[Z?\ V;:P/&Z1HQDDE#G<=P.5&T# Q_%STQJZ9X;TS2;Z:]M8
MY_M4T:12S37,LK.JYVY+L<XR>>O-/O?#^FZA?B^FAD6Z$1@,T,[Q,T9.=C%"
M-PSS@].U '!V>I7OB;5OA_J\UQ-:37=M=/)%$$VJP0 E=RDX;WSQC&.M=AXF
MU>73)=&M(9! =3OUM#/@'RQL=^,\;CL"C(/WJMOX=TI[S3[K[,4ETY#':>5*
MZ+$I ! 52%Q@ =.U2ZSHNG:_IS6&IVRW%NS!MI)4JP.0RL""I'J#F@#F[W4]
M6TF^TS1[C5$GDU+5'A2[$2AX(!$T@1AC:9"5V@XQ@YQFLC4_$?B"QN]1TN._
MS)9:OI\,=V\"$RPW+*"C@ #*Y/(P2".AYKL3X5T8Z2FFM:,T$<HG5FF<RB4=
M)/,SOWC^]G...E+-X6TBYMOL\UM(ZFX2Z9C<2;WE7&UV;=N8C:N,GC ]* .$
M\3:AJZ>'/'.F3:O<2_V?Y!AN D:2%)54M&=J@8Z\@ X/6M^X?79?'1T.WU^6
M&V338[O>UM$[L_G%2"=H&"!CI]*VY_"NC7/]J>?:-*-414O \\A$H48'&[C
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M[*19O,DE9EV[B-HV *6&,G)(].0"3Q*+FV\$:J8[Z=;J&PE87*!5?<J$[NF
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MTFYO'M!<M%,MO]J GB>(-"."ZE@ 5'<CID>HKG=5\/ZMJVNZN_V406VKZ$+
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MN,&.49S'("VUXSA21AN] 'J0((!'0TM16HG6TA6Y9&N!&HE9!A2V.2/;-2T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%87B:]DMDTV&&\>"6YO%C\J) TMPNUF*(20%/&
M2QZ 'OB@#=HKS*+7M>FT;2@=3EAG/B673)7"1L7A#R  _+C< HY&,XY!J1?$
MFJ:>UUI,NHRS,WB2+2HKV54\R.)X4E.<*%+<LH./XAUQ0!W5GK%E?:E?Z?;R
M.;FP*"X5HV7:7!*X) SD#J,BGW6E65[>6MY<0"2XM&+02%B#&2,$C!XR.#[<
M5S'A:W:V\>^,(VN)9Q_H95I2"P'EMQD#G'YU0\8:]J5@^LW&G:C(S:<;3]U&
MBB.WW,-RR%N7+JPX'W1CH3D@'H5%<'XCU/7QJ'B&TL'NH[FWLX)-)6VA$BR2
M-NW;^"!E@!AL +R.YJ25=;N/&\>B_P#"07D$"Z3'=.4BA+&43;3SLQ@@<\?3
M% '<45P6A:GKVN6^EZ_#?VT5I)<NEW;22Y!3<RB-5\O*R*=O\7/.>O%73M>U
M^[T'3_%R7ELUDUO+-=V1FW>9\C$1QJ(P5=6&/O'.#G/6@#N+O6+*RU2PTZ>1
MUN;]G6W41L0Q52[?-C X!ZFK]>:PR7%_J_PYU>XU"2X>],TTB87RPSVDC?*
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M!LP,M/@<KT'4?KFLO1/$NKZGIGA6QFO ;K5+6ZFEN&D$+2M$Z@*I", <,6P
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MQD7R?F4E3@_.?4>@'6I]*\0ZQ=>'O"DMU/*\5U=3V]_<0Q_O6$?FA#M4<9*
ML5''L,T =KJNL66C0P2WTCHD\\=NA6-FR[L%4' .,DCDX%7Z\RU+^V'\%6TN
MLSW$LK>(+40>?&D;>0+Q1&2JJ""5 )!YY[=*TK_5M4TGQ'JFBS:A,\FIPI)H
MCLB?NV)"2)POS;"ROSGY2?0T =W13(D,<2(9&D*J 7;&6]SCBGT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5)'41R'/S#!XZGV&3ZFMNB@#$OO!^@:G<W5S>:9%++=A!.Q+#?MQM) .-PP
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M+Y[[A%_=SNZ9Y^O/6H5\*Z*EE96D=EY<5B2UJ8Y75X,C!V.#N4$<$ XK8HH
MR;OPSHU[86]E/8(8+>3S8=K,C1ODG>KJ0P8DDDYR<G/6H1X/T%;.:T73D6">
MX%S*H=QOE!!#$YR2" ?J,UN44 9\>B:?%J4^HI$ZWD\8BEE$SY91G Z]LG'I
MFJ,_@OP[<Z/!I,VF1O96[^9!&7;,3=<JV=R]3T/>MZB@#'N?"NB75K96\E@@
M2Q.ZU,3-&T)/7:RD,,]^>>^:M:7H^GZ+;O!IMK';122-*RIGEF.2>?<U>HH
MPE\&>'4N%G72H/,6Y-VIR<+*<Y8#.!G)R!P>XJ6U\*Z'9:S-J]MIL,5]*Q=Y
M5S@L1@L%S@,1G) R<FMBB@#'T_PKH6EZG-J-CIL,%U,S,[KG&YOO$+G"D]R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU"UTZ.)[N41K+,D"$@G+N<*./4FF6NJ6-[?7EE;7*27-F5%Q&O6,L"0#^ -
M%RBBB@ HHHH **S;[7]+TVYCM[R[6*1W1.5)"LYP@9@,+N((&2,]JT'=8T9W
M8*J@DD]@* '455T[4;/5]/BO["=9[68$QRKG# ''&?<&K5 !14=Q<06EO)<7
M,T<,,:EGDD8*JCU)/051A\0:5//# EZ@EG.(4<%#+QGY-P&[@9R,T :5%%%
M!1110 4444 %%%% !1110 4444 %%%9'_"4Z)]B^V?VC#]G^U?8Q)S@S;MNP
M<<G)Q0!KT444 %%%-D=8HVD=@J*"6)["@!U%5+#4[+5--BU"RN$FM)5+)*O
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MY)- '&6GB35#XET6%KM+JUU"\O+>1HHP( (UD9!&Q <L @#'E22V#Q6%<_\
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M:Y4L>GSG&1T]:DTWQ+J^J^']#E-ZD=W<VMR\R6L2F:5XV"!U5@45.I8DCDJ
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MG*^9*TA4,Q(7<W)QG&3^G2J9\&:,8&A,=QL:^&HG_29/^/@-NWYSZ@''3VH
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M)!(&P\X]./2GX1TG4]/AL+74_"EA%<:5$8UU*-XF-P FP&(?>1F&,[L=QWX
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MQ"W6%DSDA6^\1N]J[#PY;-%;SW$FAVVCO<.&:WBV%S@8W2,GRD]N"< #GG
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M W==I#$?B*P],\/^)]#LM!O(=)2>?2[J_26Q6Z0&:&XE+AT<X&1\O#8)YZ4
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MEZ=J$!@NK:+9(F]6YR>A4D5QWAK3+KQ!X'T.P6S>.&VUA[MKMG3:%BNI'^4
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M:K"D;!5:+GYF<$EBPX!XSP10!V>KZQ9:'8&]U"1X[<.L998V?#,P5<[0<9)
MR>.:=JNJ6FBZ7<:E?.T=K;H9)76-G*J.IPH)KS;Q'J-SXA\$:YJ#WDL2VVLK
M:+:J%V*D=U&F&XSN.-^<\9 Z=;/BK4;G7O#/Q!3[9+;1Z5%+;1V\87Y@( [,
M^02=VXJ/0#(YYH ] BU*WFODM$$ID>W%P&\IMFPG'WL8S[9S3KC4(+:6TC?S
M&-U)Y<1CC9USM+<D#"C /)XKCY;[4/[?FTU-0FCM#X<^THB!08Y=VW<K8ST'
M<GVJAH=YJ-AX>^'"Q:E.T5^(H[B.14(=3:,X&=N>"@[Y]<T >DT5YM)XGU>7
MP6WBVWNI//AU(Q-IVU=AB%SY/E'C<'QALYSN]N*BUS6->M+?QE>PZW<*-%O(
M3;1"*+:RF.)RC_+DK\[#C!YZGC !Z=6'<+H'B359=,N[6*\NM)>*X*7$!Q$S
MAMC*6&#]UNF:YKQ-K^I65UJ-S8:C)(ME?V4!CCC410AWC#QN3R[,),\?=!7D
M'KJZ-_R4SQ5_UYZ?_P"UZ .LJE;:396=_=7UO!LN;L@SR;B3)@8&<GL.!Z#B
MN?NKV_UCQ/K6A6FIOILME90RVSHBL6>3?^\8,/F52JC QU.>HQ5AU/4=;U37
MM/AU4VLFEVEN8)H$7;+))&7\TA@<IG "].#U/( .WI-PW%<C(&2*\Q?QEJ[Z
M+IFMW\=U::9=Z;!-)<V*JXLYF+%GEC(+&)AMP1G ![\U:C;5X]=\<RZ9>RSW
M44]JMO#-(BJ0T4;%5)7"GYF"]LD9!H ]%HKG/"&L+J]K?;I+Y9X+GRY;6_C"
M36IV*=AQPPZL&YR&ZUS=_P")=6E\+^)/$5I>/%<:/?S11V953&R0L 4<8R2X
MR<YR-PQ[@'H]5KJ^ALY;6.42EKF7RH]D3. VTM\Q ^484\G KE-/EU?4_'.L
M6S:S=06=@;.>.V6*+D.CEHV.W../K[U?\3W][8ZQX82UNGCAN]2^SW$052)$
M\F1^I&1R@Z$4 =+2$X!)SQZ#-<3I6N7X\6QZ9K#W=O-/+<&U90CVE[$,E C
M95U4#*G&<$\\8TM3U2>;QMI_AV.X>UAEL9KR22/ :0JR(J*2#C[Q8XYX';-
M&OI.KV>MV/VRPD:2#S'BRT;(=R,5888 C!!%%_K%EIMU8VUU(Z2WTWD6X$;$
M,^TM@D# X!/)'2O.O#6IWEEI>DZ-#<#S+_5M41[AW$;.8YI#M!"D!FSG@?PG
M&*OZ@FJPMX3M]9O+>[NX?$142PG)V>1,4#_*HWA2,X !Z]Z /1**\]37M3/B
M#1WAU&2ZLK[5[FSD<1HL+(J2E50?>RAC +="0>HZ36.JZLNJ7OA:ZU*=]66_
M22&Y*1AFL6^?=@+C@*\1./O$'O0!WE4=5UBRT6WBGOI'CCEF2!66-G^=V"J#
M@'&20,GBN1M]2U_6Y;F^L-0M;9+#5Y+::&:7Y/)CDV%&7RR0S+A@=W5AVXK&
MU?4;GQ%X.CUF6\E0#Q!!"+-0NQ$CO5C56XSN^4.3G.3CIQ0!Z;?WL6G6$]Y.
M)#%"A=Q%&TC8'HJ@D_A4ZD,H89P1GD8KGO'=]>:9X%UF_P!/N6MKNVM7ECE5
M58@@9Z,"*Q=5NM8N/%.I:?!K=S:6T>AQWL8BCB++*7D7@LIX.P9!S[$4 =Y5
M"[UJQLM0L+&>5A/?R-%;@1L59E4L06 P" IZGM57PY>W&M^#-)OKB0I<WMA#
M+))& "'>,$D=AR:\XT6*ZN/#WPW9M0N#/<7DKF9]K,A-O/DC(Y/4Y;/)[]*
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M7!\\!"Z Q6_"Y7'XD'\^:LZ3XFU:]T_PYI\MVK75])?127+.(FE^SR%%&0C
M,P^8X'\)QB@#TBBL?P['JL>D&WUB]@NKV*1T,]N>JYRN[Y0-X4C. !FN$N?%
M.LZ5#Y-UJ5Q+=:-JS#5#Y<8\RP+*5E(V\866,_+C.U_3@ ]3HKB9];OO[2T.
MU%Y*EOKM[.R2[5_=0)&S(B''5\!LG)P2!V(R=3U[7[.'6;"/4I!)IVM6-M#=
MF)"989VB)1QC!*B0C(P2,?B =\NL63:XVC"1_MRV_P!I*&-@/+W;<AL8//'!
MJ]7E.MWUUX6\;IY^H7-R7TCR9=3FC0FU1[DXE=5 !"Y Z8Z$\9KT^"%DLUB-
MU+,VW'GMMW-[\ #/X8H GHKSG1_$6L7.E>!KB;4'>34KR:"\_=H!*HCF89PO
M!!1>F*K1:SKT=M%J$FMW$OE>)SIA@:*()) ;CROFPN=P!X((Z=.M '?ZSJUC
MHNFO>:C))';;EC+HC,06(4?=&1R0,^_6I=-TNRT>S%I80""W#%A&I) ).3C/
M3))/U)KS7Q)J-SXA\$:]J#WDL2VNL+:+:H%VA(KF-,-QG)^]G/&0!QG.S/J6
MOZQ<ZVVE:A:V<FDWXA"7$N$$:JC-YB^620P+8(88XQT.0#O*1G5!R>O0=S]*
MX_1&U;4/%^NI-K=S]DTR_1([811!71[='*L=N<!GR,8/')/9=;CG?XE^&52]
MN8HFM+QFB0KL)4Q=B#U#$9ZXZ8H V(I=%\9:*Q:".^L&E>,I<0D#?&Y4_*P!
M!#*>?:ET2UTBS:\MM+LOLY@E$4Q,+)O;:&&&8?.,-U!(ZUP&B76HZ7IVEWEM
MJ,JPW'B>YLY;38GEM&]Q,"2<;MV0"""!QC'7.P-6\0/%XFBM)7OI[/6$AAA+
M1Q2-!Y44CQQG 7=AGP3S[]Z .^JE-I-E/J<&I2P;KRW5DBEW'**<;@.<8.!G
MUP*SO"6K1ZQHSW"3W<K)<21R)>1".:!@?]6Z@8RH(&>XP<FLCPYJ6H:[I.E>
M(QJ_EQS2R_:;$QJR,,LJQ+T*NI YR<\Y]@#M:*\XM?$NK3>&/#7B>.\>5M2O
MH8;FRVJ8PDLA3:O&0R''.>=IS[0#6->BMGU!];N)/L_B<:;Y!BB"20-.L6&P
MN<@-P01TZ4 >E&*%YUD*H98P0K?Q*#U'T./TI98HYXFBE17C8896&01Z&O+M
M1N]3TRS^).HV>KW<=Q92AH-PC<+_ */$_0J>.2/I[\UT=Z-2L]0L]/\ [?N[
MJ:[$]QY"11+)M"H!AL +&C$GG+'<!S@Y .QZ# I"P! )&3T'K7GGAOQ+J/B)
M/#VGW5\UM->:(;Z6>%55II=RI@9! QDL0!W'8$&:.+4/^$^\-17>M274J:7=
M>>\"JD<KI)""=F#C.2#@]N,4 =]17/\ B*\FBO\ 2;."\DC>YDDS;0*/-G54
M)X9N$5202?H!UP>3TK7=>U6U\%"35I87U&2\ANVCBC)?REDVMRO#?*/;/:@#
MTRJ.GZQ9:I->PVDCL]E/]GG#1LFU]H;'S 9X8'(XYKAM.\3:FRZ7HUQ?2-+<
M:Y>:<U^RJ)#%!YA4<#;O;:JYQZXYK6\$0O;ZUXPB>>2=EU9?WDF-Q'V>' .
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ME %N[\*:'?2WTES8([WZ*ET=[#S5  &<'T 'N ,U+=^'-)OY;*6[LQ-)9 K
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MQ(,LQ_SR?:GQOYD:OM9=PSM88(^M &9H%M-;V#M/IEIILDTAD-M;8(3@#YF
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MS,'6)D!102"0R@J.1G(YJCK3^$;KQ''8ZKI45YJRV_G(&TQIW\H,!D,$/ )
MQGO6]IM]:ZA:>99AUB1C%LDA:(J5."-K $?E0!YM=Z%KMM:7NJW]A%&!X9NK
M2[D:\\V0RX#;NF,':< < >G2MS1M+NM6_P"$1U.>V-K%I-@Q!9U8RO)"J +@
M_=QDDG!SMXZUU6I-:S-#IEY9R7,-\'1AY)>( +DB0] #TYZGBJVB7FDZKID]
MOIT)6SM9GLFA:(QA2G#*%." .E '$>#=+N]=\#^!5>U,-OIICO6F+J?,VHZH
MJ '.26!.<8P1S5X>$M7N? =]I16.VU#^U)-0MM\@9'/VDSHK%<XSP#Z'GFNY
ML;"TTRT2TL;:*VMH^$BB4*J_0#I5B@#SKQAI=W>:;XA\17=JUEY7ANZLE@:1
M79BP+L25)&!M '.3D\#C-S^Q[[67T?4WLC!_9^ES11H9%+323(B\$' 0!2<G
M!.1QQ797EE;:A:26EY!'/;RC:\4B[E8>A'<4ZUC@AMDBM518(QL14^ZH'&!]
M.E '$S^'M6?X8Z)H:V@-_9_85E7S5V_N'C9B#GG(0X^HZ56UW0?$NIWEVS64
M%PL>J6MY9NUUL588VC8ILP0'^5LL>H. < "O1** //=6\)ZW?2^*8X([11?W
M-I?VDLLFY#)"L7[MUQG:6B.3Z$<5T?AJWO );F]T&PT>5U5/*MG61GQG)9E4
M#'H/K6_10!Q>IZ/XBCUSQ+=Z0EL&U/3H8[:>60?NY8Q*,%2#G.\<].N?0Y4W
MAG79CXC=-+CB&K:$MD@>^\V03#S1\[$<_P"L'.>@X]*])HH X/Q#%=I9^$K6
MWM4;6;>7S8X?M2Q2 1PE9"C$,I'S*"".C=CR,YM&U&[L8S9:(B:IIFIM?W%G
M?7,<L=Z9D</\ZC:K8;(!48PO&"*[[4]*TK6$2VU2QM+Q02Z1W$2OC&,D ].H
MY'K5BSLK33[9;:RMH;:!/NQ0H$4?@.* ..OM#U6ZT[2KFVT:PLKFVU:.^>QA
ME51L",ARX4 O\V>G08YQST6EZG?7FJZG9W=@EO':-'Y,T<_F"4,#G/ VL".A
M[$'O6M2  = !0!QEWHFK)JOBL06<<T.N11I#,90%B(A\MO,!YQW^4'/M4NG^
M'[O2?%6FS0PM-I]CH?\ 9PEWJ&9PR$<$]PG7U/IS77T4 >=Z=X9UFV\/>#K*
M2S'G:3J!N+K$JD;-LJ_*<\G]X/R/MDU+PSK5SIOBFWBL@7U+5K>[M\S*!Y:>
M3G//!_='CW'OCT2B@#SKQ1ILROXMO;VTA^QZII]K9VPGG"!Y@SJJD@DKEI5P
M?4<X'-6=+FU2QU:[NK_0Y_[6FT\I#//J$+K(L.6"$HJ[ 6<DL5(R>>PKMKJU
MM[VVDMKN"*XMY!M>*5 ZL/0@\&L;PNGAY[6[.@:=!:11W#VTRI:B$ET."",
MG&>] &EH][-J.CVEY<6WV:::(.\._=L)[ \9'H?2KM%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ&@:3JMU!=7UA#// "(Y'7YE!ZKGN#W!XJG/X,\-W6E6VES:+9M96K;H(O+
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M3C&?KCC/7%-/AC13 \!L(S$]Q]J=,G#39SYAY^]GG/7- &O10!@8HH ****
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M^'X@,Q2[_/D$)B!' PN"3SSG QWH 7PGKTB>'%:_GGO;R34;RWA4E3)((YI
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M1X)A^ZFW"XF>/R\C@;4P6//.2..,T 7]*\;:7J]SIT,$=Y&NI0&>TEF@*)*
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M<;"X7*G<%) X(&,\F@#>C\8:;)!:2[+A1<7[:;M9!F*X!(*-SZJ>1D>]2_\
M"5:?F]0B82VEXEB\14!FF<*553G!R'4YR*Y2/P?KEMI+)%;:?YUMXA.K6\$<
MY5'C+$E,[/E(#<<'IVJT/#&J7 \0+JFEZ;>6NJW\5PUL;AO]6(40@':,,"@(
M/&2/X: .D/B*W$<8^RW7VJ1Y$2T*J)#Y9PYY;;@9'.<'(QU%6=%UFRU_2HM1
ML)"\$A8?,I5E92592#T(((_"N&_X0_Q!8#3+ZV-OJDEC+<Q)8ZG.6/V24H53
MS2I^=3&#D@\$C)QSW>DP3V^GQK<PVT,Q)9HK8?NX\G[H.!G'K@9/.!TH NT4
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !117+^,M7ETPZ+")UMK:^OQ;SSLY0*#&
M[*-PY7<ZJ,CU]Z .HJI%9Z=IK37$-M:VK3,#+(D:H9&/ +$=3]:X+4%U;3HM
M,M1XDGF$GB%(,P.2T<+H6\EG;)?&,@GG!&:S-5\Z32=5T^XOKV:&P\564,#R
M7+[UC9K=BI;.6 +MC.<<>@H ]26\W:E)9_9K@;(EE\\I^Z;)(VAN[#&2/0BJ
MEQK]E;ZKI>GGS'DU,.;>2-<QD*A<Y;Z#CK7'ZY).=5\5Z<+Z[>S3PVD\2>>W
MR/F89# YR0BY.<GO3+...*\^&JQN[#R96.^0N03:9ZDG YZ4 >CUFZIK=KI%
MSIT%RDQ:_N1:PE$R Y!8;CV&%/Y5Q7AW4=0UFUTG7UUI(YC-(EY8>8[^:WS
MP>63A&4@8(&<+DY!)K/BNSK6C> M?GO9I;N\UB-IT\XF-7,<V4"9PNTC:,#/
M'.230!ZA<7D-M)!'(W[R>3RXU'5C@D_D 3^%%K=PWL;R0-N19&CW=B5.#C\0
M1^%0:EHVG:P+8:A:1W'V6=;B#?\ P2+T85R^KQ6?A[6]&TW3XAIUKKNIRR7T
MT+%#)((F8+NS\I=E4<8Z$#K0!MP^)K6YBU-[>TOIGTZ[%I-%'#ERY"'*C/*@
M."3QP#6Q-#%<0/#/&DL4BE71U#*P/4$'J*\HG>XTG0_&\EC?W44L/B&W"RB4
MERK"V4J6/)&&(ZY]ZWM5U*_T[Q8S7HNI-*FOK>&"[LKDXM781CR9H<@%68YW
M\_ZP9Z"@#M[:UM[*W2WM8(H($&%CB0*J_0#@5+7DDT^M)X=U+7+?7M1DOM.U
M^2V@MVE!BF3[2(Q$R8^;(; [CC&*MZYJ]]9Z)X[9-2N8I+#481:,9R&B#1PM
MM!ST)9N.G- 'IPD0RM$'4R*H9ESR <X./?!_(TZO,=3NY-$\0>/]6M9)S=6M
MC:R1 S.RKE)<G83@@ %@,8&#[UH-'J0BO)]*\36SQWM@IM89+AY5\W>H$@D)
M)0,&"X'<@CH: .^KG;CQKI5K]K\Z*_7[)=K:S?Z')\I;.).G^KX/S].*K^$M
M86==1M[Z*\L+V"Z1)K2]N/.$;,B[1'(2=ZMC([Y)X%="UA:OYFZ$-YCB1\DG
M<PQC/KC XZ<4 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "JUYIUEJ"HM[9V]RL;!T$T2N%8=QD<'WJS10  8&!THHHH **** "
MBBB@ HHHH **** "BBB@"E?Z/I>J&,ZAIMG>&/[AN(%DV_3(.*N(BQHJ(H55
M& H& !2T4 %! (((R#U!HHH KV>GV6G1M'96EO;(S%V6",("QZD@#K5BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *HVFB:587+W-GIEE;7$GWY8;=49OJ0,FKU% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6*_=/.#C(]1@U9H **1G5!EV"C(&2<<DX _.J\-ZD]]<VBQ3J]N$+.\15'W
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M#65']B:BV!N-K(">^-IJ_45S;17EM);3IOAD4JZY(W ]1QVH X/3E4_ &)B
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M35+&6ROK>.XMIAB2*09##K_.JG_".Z1YS3"R19&M_LK,I(S#_<X/W>IQZDT
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "FLB.5+*I*G*DCH>F1^9IU% #71)  ZJP!!
M(S@CH:=110 4444 %%%% !1110 4444 %%%% "$!E*L 01@@]ZKV6GV6FQ&*
MQL[>UC9BQ2",("3U. .M6:* "BBB@".>"&Z@>"XBCFA<8>.10RL/0@]:@T_2
MM.TF)HM.L+6SC8Y9+>%8P3ZD*!5NB@ JK/IMC<W<-W/96\MS!_J9I(E9X_\
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MT;*K0C&7W$8XW+QG/--B\1Z9+'+)YLJ)%$DQ,L#IE')"%<CYLD8 &3G QR*
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MO;ISG%3OXBTR2TM98+IY1>P&>W^S1-*[1X!WA0"<#<.HZD#J<4 :]%<AX/\
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MO#[6<,KE/)-SN+ %"<[.1VK+B\-Z[>7NH22Z=);+?^'3I[27-VDC+/E^H4D
M$L,!> /3I7I5% 'GEEIFORZGI%W/H(BCM-#GL)(I[B-MTI\K (4D%3Y9&<]^
M0*I2^#-<&EWMGI:SPV"+;7-IINJ3K,J3Q3"0Q*X+'RB% PQX)XXS7J%% '/>
M&;:7-Q>3^&[70Y951&C1HWEDQGEF3@J,\<YZ]*YW5M%U^%O&UE:Z:U_;Z_;N
M]M<)/&OE2&W$1C<,0<?*"",]><5Z'10!Q&E:9K.B:_)J1TY[N"^TRV@EBBFC
MWV\T(88^9@"K!SR">1T[UM>$=%E\,^#]/TJ0B6:VB.\1GC<26*KG' )P,XX
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M+:##J4EC:SV=WI\LT08!Y%=9(V)VY&W!!(X->@:5IZ0Z&EG)I]K9(ZONM+8
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MD(#C/XG YZ_F:#IEFVK+JA@'VU8#;B7)R(RP8KCIU -6Z .6^(R*/AQXE8*
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MMV$]Q +:1UE==T0SA, X &3T]3ZTR'PUI-N^G/%:LITU#':?OG(A4C! &>F
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M733<%U!:165L[<YQ@?G[<UG7/AG7?[&U33DLHG$NOC489%G'SQ?:5F.0<8(
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M\C4]8G@_3[K2?!VCZ;>QB.YM+2."0!@PW*H4D$=N*VZ "BBB@ HHHH ****
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M+2GQ ]C,Y89GB6:9 '..>$7Z]Z /3:*\KU"]U6'3O%&I+K6H>;I>O116R>8
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MU!H=-U%%@MQ(!&5:W1BK#'(RY('8CZT =K1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*>A!!K2OO'&FVFFZW<QPW<DVDV_VB6W:W>-V0ABK+N RIVMS[&N:O--U+5-
M\2:4NASV^LZ@T5S(\UW#(LO*J,LF H"QX P,^_)K1UWPYJNL:EXF>*V$46IZ
M"MA \DB\2CS3\P!.!^\ S[&@#L+&^6ZTN*]D5H5:/>WF*4V\<YST%4;7Q/IE
MW=VMLCRH]Y$TMH9(F5;E ,DH2.>"#CKCG&.::^FW.K>#)M*O4^Q3W5D]LX1]
M_E[D*YR,9/.:Q++0M5OAX6CU.U6V?0FWRRI(K+.ZQ-$OEXY"G=N.X#& .>H
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M%=>$=-N(6WQ2Q;T;'5220?RKEO"$&K3:CXJ-C>6T5N/$KF6-[<L[J!$7 ?>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH".X^M7** *5UI%A?::-/N[9)[0%3Y4A+#*L&7KZ$ _A5VBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMU&",]:[32M'L-%TF+2["#R[*)=B1,[/@>F6).*RK;P)X<M/LWDV,@^RI)'
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M5XE/50^[=M/'!..!Z"ISX=TT):+%%+!]E5TB,$\D9 <@ODJ1NR0"2<\\]>:
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MA%NS7$SS,8^?DRY)QR>.]5K7PCHMD^GO!;S*VG(R6I-U*WEJP (Y;D8 '.<
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M ,"@#J**C@>22WB>:+RI60%X]P;8<<C(ZX]:DH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ JGJ&E66J" 7L'FB"43198C8XZ,,'J.Q[5<HH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG7$<43LX3!(91CYE.#\PR.#S0!NT5GZ5JT6J:';ZHL4T:2PB4HT3!AE<D $
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;L^?I[4 >GT5SO@&YN;SX?Z!<7C,UQ)81%V;JWRC!/N1@UT5 !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7*[)VT8M%06MY;7ULMS:SQS0,2%D1LJ<$@X/U!HM;VUOD=[6XCF2-S&S1MN
M8=1FBZ!PDKW6VY/15.[U6QL)HH;JY6*2;/EJV<OCKCUI]KJ%G?%Q:W,4QC.'
M5'!*'W'4?C1S*]A^RFH\UG;N6:***9 451U'6-.TA$;4+R*W#YV[VQG'7\/>
MII+ZUBMH[AIT,4F/+93NWYZ;<=<^U+F6UR_93LI<KL]O,L452GU;3[:P%]-=
MQ);,<"0MP3Z#WX/'M3H=4L+C3O[0ANX7L\%O.#C: .O-',NX_95+7Y7:]MNO
M;U+=%0VUW!=JS02!MC;6&""IZX(/(."#SZU-3(::=F%%5[V^MM/MS/=2B-!G
M'<L<$X ZDX!Z>E1/J^GQV;7;W<8@5MC,3T;^Z1US[=:7,D4J4Y)-)ZEVBJL.
MIV-QIPU"&[A>SVEO.#C;@=>?:G07MM<1221RJ5C.)-WRE.,_,#R."#SVHN@=
M.:O=/0L457M;^UO=WV>99-H!('!P>AP>Q['H:+J^MK(+]HE"%\[1R2<<DX'.
M!W/:BZM</9SYN6VI8HJO-?6L$,<KS+LEP(ROS;\C/R@=>.>.U(U_:):I=&X0
MPR8V.ISOST"XZD^@HN@]G/L6:*C@N(KJ%9H)%DC;.&4^G!_7BH9-1LXKD6TE
MPBRDJ-I[%ON@GH">P/7M1="4)-V2U+5%59]1L[680S7"(Y .#V!. 3Z G@9Z
MFENM0M+)@MQ.D9*EL'LHZL?0#/4\470U3F[63U+-%'6BF0%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !61XFM(;_ $5K2X7=#//!&Z^H,J UKU7N[*&^C1)P
MY5'60!)&3YE((/!&<$ U,E>+1K0G[.K&?9I_<<AI]W/>:._AJ[8M>6;/!=D_
MQP( 5;Z."@]\MZ4OAO4)8]"\)Z7%(83>6KNTH ) C4' R",DL.QX!KJVTVT:
M6YE\K;+<HL<TBL59U7..1SW-54\.Z9%8VMG'"Z16C;K<B5]\1Z?*V<XP<8Z5
MC[.2=[_U='HO&T)1<7%J[OTM?E:;^]JR[(QH_$-\+G^RI7'VC^U#9"ZV 93R
M_-W8Z;\87IC)SCM5*XN;W28/&=U;W6ZYMY(W65XU)_U*8R!@=..E=3<:!IUS
M8_9)8"4\WSPXD8.),YWA\YW>^?;I4+>&-+>"]ADBF=+[:+G?<2$R8  R=WH*
M'3F^O]68Z>+PL7?ET=KJRUM*+?7JD]-BE/%*_P 0K0BZE5?[-E;8 N,>9%D<
MCH>_?W%5[37;QA!:2SJ))]6N+(3! -B1[R,#ID[0!G/6M_\ LFT_M&/4-LIN
M8XO)5S,_W,@D8S@\@?E5:3PSI4MC+9O;N8I)S<G,S[EE)SO5LY4Y]*IPG>Z,
MXXG#N,8S6R2V7GY^:?G;4K3SZC:""VFU&.222[=5,48\YX]I95 QMW#C)( Q
MZ5CPZA?ZI'X9EFO)8I)+^XAE$:H-VQ9E!(P1GY?IR?;'1MX=TUXK9#'-NMI#
M)'*+B02;B,$E\[CD<')IJ>&=*CMXH$MW6.&=KB/;,X*.<YP<Y .YN.G)XI.$
MV_\ @^A4,5AHQVUUUY5VDN_FG;R,FX\07MI+JT3R(QCU*WLX'* ")950DGUQ
MN/7VI=5U;4],FUBT2X\TPZ6U_;SR1KN0KD%&  !' (X]>M;3Z!ILB7R26Y=;
MY@UP'D8AB  ".?E(P,8QT%*VAV,EM<P3++*+F+R9G>5B[IS\N[.0.3T]3ZT.
M$^_]:BCB<*K-P[7T7]W_ ">G6_F9NFWVH#Q!!:75T)XKG3OM6/+"^6X900,=
MCN[YZ5'XA,@\5>&#"B/)YMQA7;:#^Y/?!_E6Q%H]E#>PWB))Y\,/D(QE<XCX
M.,$X/0=?2G76DV=[?6MY.DAGM23"RRLNPD8/ .#D<<U7)+EMYF<<315932TY
M6MDM6FNC\U<Y"72+G2]2TY[J2/&H:X;F6.'/EH?+;8N3C/(SG R<57UEIAK>
ML1+D6;:GIHF].<;L_E'FN]N[."]@\FX3<NX,,$@JP.001R"#WJ$:39?8Y[5H
M=\5P2TV]B2['N3USP,'M@8Z"H='HOZT-Z>9*ZG45W:W_ ),G?ULK?=J<3XP:
M9=:U-(<BWDLK,76.F#<D<_\  =P^E3>,9+F+5-5-IN!/A^0R;?:3@_7!?'XU
MV"Z39"&YB>'S5NAMG,K%S(,8P2>V.U.M],M;8RE4+O*H21Y6+LRC.%);/')X
M]SZFAT6[Z[_\$<,QIPY/=OR_CI%:_=^1@W*JGB?PQ';@>4UI<(X'0Q!$QGVS
MMJ:4S0>.;-I[2(PS6LD%M-&YW)C#,'&.A &,=,>]:EOH]E:Y\J-\^5Y"DR,2
MD?\ =4DY4?3T'H*=9Z7;615D,TCHI17GF:5E7N 6)QT'UP/2JY'^-SG>*IVT
MN[1:^]MWWZ7\[HJZIJ$L6KZ7ID,GE->F1FE !(5%R0,\9)(ZYX!K!TN>XLX[
M^);P"677)(V;8#+*-@.$&-N[@9)&  3Q74:CI-IJJPBZ1MT+^9%)&Y1XV]0R
MD$53_P"$6TH+@13AOM'VK>+F0.),8+!MV1D<'U[T2A-RNBJ&(P\*7))._71/
M6[=]7VLK>1S[ZA?ZAI^D-+=S12#6GM9"@0%U1I I88(R-@Z<9_"M$:CJ]_)<
MS:?)&JV=Z8'25E",B$!]QQN#$9((('3BM$>&=*%L;=8)%C^T_:AMG<%9,DY4
M@Y'4\#CDTI\-Z6=4.HB!UG8J7"2LJ2%>A9 =K$>XJ53GW_$TEBL*[VCWM[JZ
MN_?Y>1SFN7MQJ_AC4[H7!CAAU!;=8 JX*I,JY8XSDGG@CMQZ]S6-<>%M)NI+
MII(90MTXDFCCG=$=P0=Q4$#/ YK7V#R]F3C&,Y.?SZUI",DVW_6YS8FM2G",
M*>EFWLNJC]^SU,+P8,>&81_T\7/_ */DH\+<?VU_V%9__9:U-/TVUTNU^S6B
M.D.YF"M(SX+$D\DD\DDT6.F6NF^?]F5U\^4S2;I&?+GJ>2<?A2C!I1\@JXB$
MY56K^\[K[[ZF-KW_ "-WA;_KO<?^B6JIK\@L_'&AW-LN9S!<_:E3J\*ID;O;
M=T]ZZ"^T>SU"[MKJX64S6Q)A9)W382,'[I'4<4^UTNSLYY9X83Y\H >61VD=
M@.@W,2<>W2DZ<FWZI_E_D:4\53A&&[:C*-NCNY=;]+]MU\S MM6U?[#;:RS1
MRV$EF\\T19>NS>HCP,]B"&)XK2TN2_G%C>R7\4MM=6P=XB@&'(##RR.V-W!)
M/ I^G^&]+TR9Y+2W9 V[$;2LT:9Z[4)VKGV%/TSP_IVCNS644B#D*K2NZQ@G
M)" DA1GTHC&:M?\ ,*U?#24N16[>ZMM=]79KNMR>^>&WC>4P++/*OE)'CF4\
MX7Z<G/H,D]*YF#3FTC6?"6F,^^*WM[GD=#*%7^C/CVKH-1T&QU2YCN+H7/F1
MJ44Q74L6 >3PC >GY"G+HMBEG!;)&X2!S)$WFL75CG)WDYR<GJ>0<4Y0;?\
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M\OZE$+8_'/XDU@W3,?!_C*24GSQ?SX/<%=GE_H$Q7576A6\MK;6\ >%8;D7
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MUN;&.WN;E$W0"X(5B=J@$*26&1[=*U=.M7M/BQ?(]W/<!M$@(,Q!*_OI 1D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=EE8QG#_ "L!@#CDX'(YY&;FF:M:ZM%,]MYH\B4PR++$T;*X )!# '^(<]*
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M0!KT5S?_  G&D_:+V#RM1\VQ56NE^PRDQ!@2I;Y>A )_"K]GX@LK_5[_ $N
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M48ZL(LJ?KBO69_#FBW-[)>SZ7:2W4B[7F>(%V'H3U(]JO6MI;6-LEM:6\5O
MG"Q1($5?H!P* .;\57>FS?"_5+B-HVL)]+?R=O1@T>$"^Y)4#WQ7+^$8;[3?
M'^E0:Z66[D\+V\-N9#U="#,@/=LX)[X&:[^+P]H\,Z31Z=;JR/YB )\J/_>5
M>@;W S4^HZ5I^KP+#J%G#<QHP=!*@;8PZ$'L?<4 4_$213Z-JD,:J]X=/G5%
M RVUE(Q^) ^N/:L'2+B)O@E92B12@T!%R#W$&"/KGCZUUMG86FGQ&.T@2)2<
MMM'+'U)ZD_6J<7AG1(;GSXM+MD<2>: J *'SG>%Z!L\YQF@#E?&VA7&L26<5
MF=FJV5A)=V+_ -V>.2$J/QY4^S&L#Q#JJ>+O#FE^)%B>.V%_806\;C!#F>,S
M'\&"I]8V[&O53I]FU^M^;:,W:H46;;\P4]1GTX'%076AZ5?6T=M=:=:S6\;^
M8D3Q JK9SN Z9SSF@#E+N.ZD^-"BTN(X'_X1[EI(C("/M'IN%7M6M5N_#<6F
M:K+#?R?;[>&\^3"ONE4X*]LJR\=@16S/X<T6YO/MD^F6LEUL$?G/&"^S^[NZ
MX]J</#^D+;);KIMJL*2^>L8C  DSG?C^]D=>M '!P-?>%=:TKPC?&:XTZ2]2
M31[ULL1&N2T$A_O(/NGNOTQ6UXS 7Q5X'   _M23@?\ 7"2NOEMH)_+\Z))/
M*<21[AG:PZ$>AY-5[S2-.U"X@N+RR@GFMSNADD0%HSZJ>Q]Q0!@^+-"&L:AI
MK:?JSZ5K]LDTUE.BAE9/D$BNAX93F//X&D\'Z]>7D>IVNNVUI::I8WBVUS);
MO^YN'*(592><E2HVGD<?2M^^TG3]2>*2]LX9Y(=WE2.OS1YQG:W5<X'3TJC?
M^%=)OM(73#96Z6HF$VT1 D/GEP>S\_>Y/- $7CO_ ))[XD_[!ES_ .BVJMX?
M34+?2]#N;O4K<V'V../R1 4)=@@3YMQSW'0=:Z*]LK74;22UO;>.XMY!AXI%
MW*P]".XJE#X;T2VDADATJTC:#F(K$!Y?&/E].#CB@#B_'MG/=:E_;.B6\D]S
MI,6S5%B?;]JMB0S6W'5MN7]N/[PJ?X@:A9ZM\*DO]+EC>TN)[)X'4?*!]HCQ
MQ[=,>V*[2TTC3K&WFM[2R@@AG8M*D:!0['J3CJ3ZU47PGX>33O[/71;%;+?Y
MGV<0*(]W7.W&,^] ',>+8]23Q)X+-[=VDR?VQP(;9HR#Y,G<R-_*K6A?\E3\
M9?\ 7KI__H,M=-=:+IE\]L]W8P3O:G,#2(&,1]5)Z'W%(NA:4MW<7:Z?;BYN
M5VSRA &E'8,>I'UH \;6"_\ ^&>-/N)KRV?2885EN;/RC')/&)<^6)=QVDG'
M1>>G%=VLPNOB]IDWEL@E\.2OY;C!7,T9P1ZUT,'A3P];+"L.B:>BPMNB46ZX
M1O51C@^XJVVCZ<^J+J;64!OU78MR4'F!?[H;KCVH YG4/^2P:&/^H1=_^C(J
M3Q%H-U>^(_[2\,ZPNG^(;6U19(95WP7,+,Y59%ZCY@^&'(YKIY-(TZ74X]2D
MLH&OHUVI<%!O4>@;J![4V\T33+^Y^TW-C#)<[!&)MN) N2=NX<XR3QG% &=X
M,UF77/#JW5Q8K9727$T-Q"C;D$J2,KE3W!8$_C7/>+]+O/%W]J16=H9#9QB&
MPN!*J^5=*RR%QGKAEC7/;:X[UWEM:V]G;1VUK!'#!&NU(XU"JH] !TJ*STVR
MT^!X;.UB@BD9G9(UV@L>2>.Y/4T <HVK6WB_X=:=>S0HR7ES9QW-NXR _P!I
MC61"#Z,&%8A%YX/U"P\*7/FW&CW-_;OH]T<L8@LJLULY_P!D E2>H&.U=W%X
M8T."V:VATFSC@:43F-(@%,@.0^!_%D YZ\5H2VT$Z1K-$DBQNKH&&=K*<@CW
M% '(Z!_R5/QE_P!>^G_^@RU5\& 7'Q \;:A9<Z5-/;1(Z_<DG2,B4K]"0">Y
MKJ)/#.AS74UU+I-G)<3X$TCPJ6D Z!CW_&M&WMX+2!(+:&.&&,82.-0JJ/0
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M<<8/TJI:Z'I5E%<Q6NGVT,=T6:X1(P!*6^\6'<GOGK4MIIMEI]B+*SM8K>U
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M2A-BLJ\HO]U?[HX' P.* -"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MMSM6;]VFXE,_.5P/IGWH [6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P (IX<_Z%_2O_ ./_"@#5\R/^^OYT>9'_?7\ZRO^$4\.?\ 0OZ5_P" <?\
MA1_PBGAS_H7]*_\  ./_  H U?,C_OK^='F1_P!]?SK*_P"$4\.?]"_I7_@'
M'_A1_P (IX<_Z%_2O_ ./_"@#5\R/^^OYT>9'_?7\ZRO^$4\.?\ 0OZ5_P"
M<?\ A1_PBGAS_H7]*_\  ./_  H U?,C_OK^='F1_P!]?SK*_P"$4\.?]"_I
M7_@''_A1_P (IX<_Z%_2O_ ./_"@#5\R/^^OYT>9'_?7\ZRO^$4\.?\ 0OZ5
M_P" <?\ A1_PBGAS_H7]*_\  ./_  H U?,C_OK^='F1_P!]?SK*_P"$4\.?
M]"_I7_@''_A1_P (IX<_Z%_2O_ ./_"@#5\R/^^OYT>9'_?7\ZRO^$4\.?\
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M/^^OYT>9'_?7\ZRO^$4\.?\ 0OZ5_P" <?\ A1_PBGAS_H7]*_\  ./_  H
MU?,C_OK^='F1_P!]?SK*_P"$4\.?]"_I7_@''_A1_P (IX<_Z%_2O_ ./_"@
M#5\R/^^OYT>9'_?7\ZRO^$4\.?\ 0OZ5_P" <?\ A1_PBGAS_H7]*_\  ./_
M  H U?,C_OK^='F1_P!]?SK*_P"$4\.?]"_I7_@''_A1_P (IX<_Z%_2O_ .
M/_"@#5\R/^^OYT>9'_?7\ZRO^$4\.?\ 0OZ5_P" <?\ A1_PBGAS_H7]*_\
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M/^^OYT>9'_?7\ZRO^$4\.?\ 0OZ5_P" <?\ A1_PBGAS_H7]*_\  ./_  H
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ME<C(/T/8]#6A7+Z9:W2_$/6K][29+2YL;6.*9EP&=&E+#UX#KUKJ* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q/%O\ R+=Q_P!=(?\
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M^$O\-_\ 0?TS_P "D_QK:HH Q?\ A+_#?_0?TS_P*3_&C_A+_#?_ $'],_\
M I/\:VJ* ,7_ (2_PW_T'],_\"D_QH_X2_PW_P!!_3/_  *3_&MJB@#%_P"$
MO\-_]!_3/_ I/\:/^$O\-_\ 0?TS_P "D_QK:HH Q?\ A+_#?_0?TS_P*3_&
MC_A+_#?_ $'],_\  I/\:VJ* ,7_ (2_PW_T'],_\"D_QH_X2_PW_P!!_3/_
M  *3_&MJB@#%_P"$O\-_]!_3/_ I/\:/^$O\-_\ 0?TS_P "D_QK:HH Q?\
MA+_#?_0?TS_P*3_&C_A+_#?_ $'],_\  I/\:VJ* ,7_ (2_PW_T'],_\"D_
MQH_X2_PW_P!!_3/_  *3_&MJB@#%_P"$O\-_]!_3/_ I/\:/^$O\-_\ 0?TS
M_P "D_QK:HH Q?\ A+_#?_0?TS_P*3_&C_A+_#?_ $'],_\  I/\:VJ* ,7_
M (2_PW_T'],_\"D_QH_X2_PW_P!!_3/_  *3_&MJB@#%_P"$O\-_]!_3/_ I
M/\:/^$O\-_\ 0?TS_P "D_QK:HH Q?\ A+_#?_0?TS_P*3_&C_A+_#?_ $']
M,_\  I/\:VJ* ,7_ (2_PW_T'],_\"D_QH_X2_PW_P!!_3/_  *3_&MJB@#%
M_P"$O\-_]!_3/_ I/\:/^$O\-_\ 0?TS_P "D_QK:HH Q?\ A+_#?_0?TS_P
M*3_&C_A+_#?_ $'],_\  I/\:VJ* ,7_ (2_PW_T'],_\"D_QH_X2_PW_P!!
M_3/_  *3_&MJB@#%_P"$O\-_]!_3/_ I/\:/^$O\-_\ 0?TS_P "D_QK:HH
MQ?\ A+_#?_0?TS_P*3_&LCQ1XJ\/S^'YXXM<TYW,D1"K<H3Q(I/>NQK$\6_\
MBY/_ -=(?_1J4 +_ ,)?X;_Z#^F?^!2?XT?\)?X;_P"@_IG_ (%)_C6U10!Q
M4C> 9-0FO?[6L8Y9VWS+%JC1QRMZO&KA&)[Y!SWK:7Q;X910JZ[I:J!@ 72
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MDCR_+D^7(V_>]P.#T'4:3#>6VCV4&HW"W%[' B7$RC DD"@,P^IR: +E%%%
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MOAM]3$2KH,#J&1]WVF4QB,.!_"NW<>><MCMD@'84444 %%%% !1110 4444
M%5=2_P"07=_]<7_]!-6JJZE_R"[O_KB__H)H @T#_D6]+_Z](O\ T 5HUG:!
M_P BWI?_ %Z1?^@"M&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K#\7N(O#-Q(P8JDD+$*I8\2IT Y)]A6Y6+XK
M_P"1>F_Z[0?^C4H /^$HL/\ GVU?_P %%U_\;H_X2BP_Y]M7_P#!1=?_ !NM
MJB@#%_X2BP_Y]M7_ /!1=?\ QNC_ (2BP_Y]M7_\%%U_\;K:HH Q?^$HL/\
MGVU?_P %%U_\;H_X2BP_Y]M7_P#!1=?_ !NMJB@#%_X2BP_Y]M7_ /!1=?\
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M_P ^VK_^"BZ_^-UM44 8O_"46'_/MJ__ (*+K_XW1_PE%A_S[:O_ ."BZ_\
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M_P ^VK_^"BZ_^-UM44 8O_"46'_/MJ__ (*+K_XW1_PE%A_S[:O_ ."BZ_\
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M_P"$HL/^?;5__!1=?_&ZVJ* ,7_A*+#_ )]M7_\ !1=?_&Z/^$HL/^?;5_\
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M\)18?\^VK_\ @HNO_C='_"46'_/MJ_\ X*+K_P"-UM44 8O_  E%A_S[:O\
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MEE);&R0ML#' Z9P,5G^']-?Q/I7B72OM-J=.GU^X:9D8F38)0Q4#I\VW[V>
M3P>M=(\,7AG6=?\ $NK7MO%IUXENARK9BV909]<E_P />@#3M-;2^N;&.WC$
ML=U9_:S,DF513C;VYW9./]UO2L/5]0N-2^(MAX52>6"S33WU*[,+E&F&\1I'
MN&"!DDG!YP!TSFQX%T2+2-)FDB:4PW$[M:K,,-%;;V,48!Y"@,2 >1NQ4^M^
M')KO7+'7]+N8[;5;.-H"94+1SPL<F-P"".0"".A[&@"AXKT067A[6KZTO+R&
M*/2+I?(6YDVA]H977GY2-I''7-.T#Q0P^QZ7=Z==12?V2M[#)N60SH@56PH)
M(;++@'KGL>*T=3TO5=8T'4;*YN+6&2[M)+9$B#,B%UVER3@M@'@8'?KU&:_A
M/4GO;.X34(K=K?19=+$D0;>K/LQ*OI@QCCWZT 6;+Q:M]?3:=-ITT5T-/6_$
M"RJ7V,<;&!QLD&1D'CGK5#2O%EM#I7ABTTO1KV2/5+)I;1&G5MBHH.UG=LYP
M1R?U/%&D>$-6TW4[6^DO=.)BTMK!HHK=D#'<&#Y+'DGDG'^-.TGP?J&F#PHI
MNK:1="MI;=L*P,V]0H(_NXV@]^M &_X=UN/Q#HT>H)!);L9)(I(9""8WC=D8
M9'!Y4\UYEJ6HBWOO&EI_:.L+J7VU+?1HX;J? G:!61!SLP6))#<8S7H_A71;
MC0=)EL[B:*5GNY[@-&"!B61I,<^A;'X5CCP,;U_$L>JRQ26^LSI<)Y&5DMG1
M%565C_$-H8'CF@#0;7IM(T[2+/5&MFUJXM=\JO,L49=%7S#N[#<P P#U';)%
M6U\=VM]!IPM[1TN[Z.:2.VNI!$Q,3!612<AF)/ '!'.14-SX;\2R#2-1CUBR
M_MS34>!IGMV\F[B?;N#H#E3E%.0>H]ZL:UX7O-<TQ++4SI^HH\3B431%-DI/
MRR1$9*[1D 9R>/FSG(!)]OM+SQ<UE)8WD-Z^C^<9C.541EP"H4-PP8_>P#QU
MK \*ZG /#/P^COH+NXN;M2(;D3D*D@A=B7&[+Y4-U!'?K6[:>&;ZRUZVU 7J
M7*P:.NFYFSYDC AO,8^Y'(]\Y[53T[P;?V.G^$K0W=L_]@R%G;:P\X&-X^!_
M#PY/?I0!:7QU927]G%#"9[:[N6M8Y895=U<;@"T8Y5"5(#9[C(&:BM/'JW/V
M&5]&NX;2ZU!]-\YY$.R97=!E022"4(R.F1UI^A>'-<T*=K"+5K:304G>:",P
M'[0@9BWE;]VW:">NTG'''458O!FHQZ58V?VNU+6VM-JI?:V&!E:39CMRY&?;
MI0!KCQ.TTR/9Z9<7=B;XV+7$/S%7!*L^W'^K5@5+9XP3C'-16OBW[397\AT]
MX[JROUL'M6E&]G8J%(/]TAPP/ISQ4&D>&M9T74KJ"UU6W_L.>\>\$30'SXR[
M;WC5]VW86).2,X)'N*VEP:9K_CF3Q!I5R\MK# (KC:I$<ERI94/(Y9$:0'_>
M3TH N_$626#X>:Y<P3307$%H\L<L,K(R,!D$%2#6'I8OY/%]A!ILNJR:-+IC
M'4C<R3&-9<#88WD.0YYR%/3GK75^+-'G\0^%M1T>WFCA>]A:$RR D(".3@=:
MO6L-Q!I<4#^4;B.()D$["0,9]<4 <5X/U^XLOAWX;9K::[EFT]IY+B63;&H3
M&=\A!PS%A@'K@\C%:B>.([K^PA8:5=W#:U9O=VV71  H4E6)/!&\9/3TSTJA
MIO@C5=-LO#ULFIVDB:7:26KI+ SHQ;;ME5=PPX (YSPQ]:ET7P=J6E-X7,E[
M:3#1+.:U.V-D\T.$ /4XQY8^N3TH Z+P[K<?B'0X-3BAD@$A=&BD(+(Z.49<
MC@X93S7%G44FU?Q-J6OQS16^B7L)MY(+@AX]L4;"-0,9WLYR.AW 'H,=;X4T
M6X\/Z&-/N)HIF6>:4/&" 1)(TF,'TW8_"L>Y\$S:E:^*;2^NHUAUN99T>$'=
M;NB(J]>&P8U;MZ4 7[CQ9]@OIK'4--EBNQ9/>P)'(KB=$^^H8X =<C(/&#P3
M5OPYKD^OV*7KZ5/96TT,4UO)+(C>:KKN. IR,>^,Y%9USX;U#5)UOM2GM#?0
M6$UG!Y2L$W2[0\ASS_",+VYY.>-CP_I\VD>'=.TV>1))+.VCMS(@(#[%"YP>
MF<=* .:\,SOXOU'7K^_EF-K9ZE+I]I:I*R(BQ8#.0I&YF8GDYP ,8YJIXTT^
M?2=$M5BU/4"L^NVJJPNY ZQ2.B-&6#9(X;J>_KS6U:^'=0T+6M1N]$GMFL]2
MF^TW%G<AALG( 9T=<_>P"5(/(X(H\2>'=2UW2[2V6^MUGBOX;UW>,[/W;!@B
MJ#G!QU)]?7@ R_%<ESX.N]&U;3KV\:UFOXK*\L[BX>9)$D.T,N\DJRG!X(![
MUSFJZC':ZSXVM9-1UA+P3P0:1'!=3X$[VX947G8,OSAN,9[5W5YX;NM<U33[
MK6KN%[73YA<PV5O&0K3#[KNQ)+;<D@ #GKFJ7_"$?;KOQ/\ VJ\,MIKCQ.%B
MRKV[1H$4ACW&T,#Q@CO0!0\4'58O#G@[^T;J:'4Y-3L(+XVL[1ARW$BG80""
M<UZ JA5"C. ,#)S7&:CX8\0ZIHNC6=UJ=C+=Z;?0W9NVB8>?Y1) 9 >">Y!_
M"N@M(=9;4!+?W-I]F2,A8;=&!9R1\S$GH!GC'?/84 &OWLMGI;+;.$O+EA;V
MQ/:1^ V.X498^RFN?\'Z_<+X+O8]2<SZGH)EM;LDY,IB&5?/?>FTY]2:W+[2
M)-1URVGNTM9]-@B<+;R)N/FMCY^>. "!_O'FLVV\)O8>,+[4K/['#I5_:);W
M5BL9&]USB3C@'#%<8Y'>@#G['4[ZPTCP-K<EU--<ZW<Q17RM(2L@GB9QA2<+
ML8+C'09'>M^TEG3XI:E;&YG>W.D6\ZPO(2B.995)5>@R%7IZ4W3_  =);IH=
MG=7236&A.7LU"G?(0I2/?V&Q6(XZG!XZ5H0Z-=)XVN==:6$P36,=F(AG<-CN
MX;/3G>1CVZT <3>:]>_\(9K_ (P%Q,+NQU206\8D(0013",QE<X(90Q/&<MG
ML,>I]:Y"X\%>=:W^DB>,:-?WXOIHRI\P9=7>(=MK.N<]0&(QT(Z^@ HHHH *
M*** "BBB@ HHHH **** "L7Q7_R+EQ_UTA_]&K6U6+XL_P"1<N/^ND/_ *-6
M@#G9?LVE_$S2+>/5-3BFNH9S<+=/,T%XVT%53=^[##EL)C &.]=Y7/IH^I:C
M<:=-KLMBYT^X-S$+2-E#R;612=Q.T .>!G)QS@8/04 %%%% !1110 4444 <
MWK]JU]XATFV6YEM_,@N0TD)VN%S%D ]B1D9'(SD<U1\.Z7<6'B+7["SU"^?1
MEBA6(SW#3-!<$,9 CN2<!3&<$G!;ZU:\31:C/K6F1:5<06UZ]M=".::,NJ?Z
MOG:",GTI^E:;XGL;2:&:_P!'^6%A;)#9RA?-)SOD+2%FYSG!!.222: ,SPR]
MK:>/]:TNTU#4!$EK%)]BOWF<L^Y@\T;2Y)3E%.#@G/MF?XI33VOPYU:ZM;B>
MWN(51HY8)6C93YBCJI!Z$UKV6D7+ZS%K.IM;F]BM6M8UME(159E9SD\G)1<>
MF#US53Q5X?O_ !)$VFF\@CT>XC"7,9C/F[A(K[E;IR%*X/3.><8H DD\0QV.
MH:CI2VDC/I]@E\&,N1)&2XQD\[OW;=?;FL9M3;4O&/A#4K7SECO](NK@6[RD
M*<K"R@CH"-Y&<=ZT-8\-:C=^(+O4;"]MHH[W3?L$Z31,S*%9V5DP0,_O"#GV
M//2H+'PQ>:7/X:NKB]MGBT+39+24B-E,@*H-P&3C C'KG)Z4 7M,\6+JFEV=
MU%8R)/<WKV36KR#?"Z%@^[MP$8X]/K6IJVEKJ]LMK+<W,-ONS*MO*T32#'W=
MZD,!GDX()QUQD'F_"]GI^H^)M3\3:7</+IMTJ>2-I6-IRH$LB@@=56)<^H?W
MK<\16>KW^GK;Z1=VMJ[./->XC=PR=U&UE(SZYSCIZ@ X7[9JFD>'?L$6H7<M
MK?\ B./3K"ZEE+3):LRA\.>3RLJJW7&"#TK<MS.WC#6O"R7ES%9-96]Y$R2L
M7A#.R2(K$Y4-L'0\9)&*M2^&]5U31?LNK7M@+FWN(;BP:QM6CC@:(AERK,2<
MD8(R!C@8ZU))X?U59M7U6TO+6#6M0CB@21HVDCMXDS@ 9!8Y9CGCDCCCD YN
MYN;WP98^-;O3KNZN-,L;2-K1;N=I_*NBK;U5G)8J,Q$@D\DCUK5BEN- \6^&
M-.6YGGBU6SG2Y\Z5GW2Q*CB3D\$Y<''!R/05;M?#>J7>CWNCZ]=:=+IMQ;/
M(K&V>-LO]YV9W<ENISZDDYJQ8>';G^UM.U'5+F*>;3;1K:W\M2 Q?:'E;/0D
M(!M' YY.> #HZ*** "BBB@ HHHH **** "JNI?\ (+N_^N+_ /H)JU574O\
MD%W?_7%__030!!H'_(MZ7_UZ1?\ H K1K.T#_D6]+_Z](O\ T 5HT %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9
M/B6WN+K09X[6!IYM\;K$C*"VV16(!8@9P#U(K6HH Q/[=O\ _H5M8_[^6O\
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M /Z%;6/^_EK_ /'J/[=O_P#H5M8_[^6O_P >K;HH Q/[=O\ _H5M8_[^6O\
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M /Z%;6/^_EK_ /'J/[=O_P#H5M8_[^6O_P >K;HH Q/[=O\ _H5M8_[^6O\
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M6O\ \>H_MV__ .A6UC_OY:__ !ZMNB@#$_MV_P#^A6UC_OY:_P#QZC^W;_\
MZ%;6/^_EK_\ 'JVZ* ,3^W;_ /Z%;6/^_EK_ /'JAO-7U&>RGA3POJ^Z2-E&
M9+7&2,?\]JZ&B@"EH\$MKHEA;S+LEBMHT=<@X8* 1Q5VBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
..HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>exhibit1027supplycontrac031.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit1027supplycontrac031.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'B-K2(>'IM6_LT-N/G*N"1.>V,@_+C.._:O2KB<6UK+.4=UC0N5C7<S8&<
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M4\"B?PGH-SI<6F3Z7;RV$7^KMG7,:XZ84\<?I2>%-=_X2/PO9:LT8A>96$J
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M)6( 5U(RGWAU'0C&<C-Z[\1Z78H7N)Y$"Q">0?9Y"8HSG#. N4'!Y;'0^AH
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M&R5[EU"D,G5 JY^]@DGI@9-SQ)I-Y>^.?"FI0:6UQ;Z?)<&XG#1C8'CVKPS
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M^S#+!<9_B[9'YU+_ ,)$?^@)K'_@,/\ XJ@#;HK$_P"$B/\ T!-8_P# 8?\
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M'\3"*-I'T;5U1068FV' '_ J -RBHK6XCN[2&YB),<R+(A(P<$9%2T %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 95AX,O[6\TV[GUT3S6%A)81@68161MF"1N)S^[&>>>V*D;P6Y\ VGA4:D
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M:G^%']IZ[_T+P_\  U/\* -NBL3^T]=_Z%X?^!J?X4?VGKO_ $+P_P# U/\
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M_:>N_P#0O#_P-3_"J^H:EK9TVZ#: %!A?)^VH<<'VH TM _Y%O2_^O2+_P!
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M#:!8R:Q:ZO*ADU&VMWMH[EL;MC$$]!C/'''<^M9<?@72TTJ[TYY[N2.XO3J
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M^*H]-'_\BT?\51Z:/_Y%H VZ*Q/^*H]-'_\ (M'_ !5'IH__ )%H VZ*Q/\
MBJ/31_\ R+1_Q5'IH_\ Y%H VZQ/%O/ANXYQ^\AY_P"VJ4?\51Z:/_Y%K(\4
M?\)'_P (_/YPTK9YD6=ADS_K%QU]Z -"Q\))IHOQ9:SJ<(OKE[J?!A.9'QN(
M)C..@X%2W'A/3[NSGL[B2>:WELA8B.0JP2/N5)&=QX))SD@>@IW_ !5'IH__
M )%H_P"*H]-'_P#(M %2[\$VEU_9LO\ :>J0WVGQ&&*^AG59GC.,HYVX8<#J
M,Y&<YI;_ ,$Z?>7=G>07FHZ?>6L1@%Q9W&V26,G)60L#N&<G)YR2<U:_XJCT
MT?\ \BT?\51Z:/\ ^1: 'Q>'+2'6K35(I;A9;6T:SCCW IY9(8YR,DDJISG/
M'UK8K$_XJCTT?_R+1_Q5'IH__D6@#;HK$_XJCTT?_P BT?\ %4>FC_\ D6@
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MT?\ %4>FC_\ D6@#;HK$_P"*H]-'_P#(M'_%4>FC_P#D6@#;HK$_XJCTT?\
M\BT?\51Z:/\ ^1: -NBL3_BJ/31__(M'_%4>FC_^1: -NBL3_BJ/31__ "+1
M_P 51Z:/_P"1: -NJNI?\@N[_P"N+_\ H)K._P"*H]-'_P#(M5]0_P"$F_LV
MZW#2-ODOG!DSC!H TM _Y%O2_P#KTB_] %:-9V@?\BYI?_7I%_Z *T: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJO#$2LQ!*A=V >< Y)/.: /0JRK[Q'I>G:BFGW,\BW<D9D2)+>1RRCJ1M4Y
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MZ *T: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'!S@9)Y.*A'A#0A9V]J+']S;W#740,SDI(V=Q!W9YW-D=#DY'-']FZ[_ -#
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M_C1_9NN_]# O_@"G^- &W16)_9NN_P#0P+_X I_C1_9NN_\ 0P+_ . *?XT
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M3VH [R.:*8N(Y%?RVV/M.<-Z'WYKGM6\:Z;HUYY5W;7XM5E6&6_6W)MX78@
M,_U(!(! )P2#6=\.8+>"TUI(Y9#(-8O5*/.SX43-CAB<?7J>^:M>)KO2=3$G
MA^YO[.&#<DE^99E3:@8/LY/WFP,^BDG@E<@&EJ/B>PTVXNHI%GE%E"L]X\2A
MEMHSG#/SGHK' !.!G'3,&M^+[+0U,CVFH7D21"::6RMS*D,9_B8YZ8!.!DX&
M<8KEC(MG/\2I+H\30)<QD_QPM:[5QZ_,C+]16C;W"Z=X&TCPY=7EO:ZK-I<4
M,QGD5?)'EA'=LGDCD =R/0$@ Z*;Q%8JNG_9M][)J$9FM8K?!:2,*&+_ #$
M+AEY)'W@.IJWINI6NKZ=#?6<GF02@E3C!!!P00>A!!!'8@UQMA;6ME\1]$:R
M=6TK_A'I+.R=6W(3'+&2H/<[ #[A3Z5>^&\4B^'+NX8$0W6J7EQ;_P#7)IF*
MD>QZCV- '7T444 %%%% !1110 55U+_D%W?_ %Q?_P!!-6JJZE_R"[O_ *XO
M_P"@F@"#0/\ D6]+_P"O2+_T 5HUG:!_R+>E_P#7I%_Z *T: "BBB@ HHHH
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M^)H_X1UO^@YK'_@0O_Q- &W16)_PCK?]!S6/_ A?_B:/^$=;_H.:Q_X$+_\
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M5H_#NPN;#PC&;J-XI+JYN+L1.,%%DE9U!'8[2#CMF@#JJ*** "BBB@ HHHH
M*JZE_P @N[_ZXO\ ^@FK55=2_P"07=_]<7_]!- $&@?\BWI?_7I%_P"@"M&L
M[0/^1;TO_KTB_P#0!6C0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5B^*_\ D7IO^NT'_HU*VJP_%\:R^&;B-QE'
MDA5AG'!E2@#<HK$_X1+1?^?63_P)E_\ BJ/^$2T7_GUD_P# F7_XJ@#;HK$_
MX1+1?^?63_P)E_\ BJ/^$2T7_GUD_P# F7_XJ@#;HK$_X1+1?^?63_P)E_\
MBJ/^$2T7_GUD_P# F7_XJ@#;HK$_X1+1?^?63_P)E_\ BJ/^$2T7_GUD_P#
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M9?\ XJ@#;HK$_P"$2T7_ )]9/_ F7_XJC_A$M%_Y]9/_  )E_P#BJ -IAE2
M2"1U':HK6UBL[=885P@);DY)))))/<DDD_6LK_A$M%_Y]9/_  )E_P#BJ/\
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M -NBL3_A$M%_Y]9/_ F7_P"*H_X1+1?^?63_ ,"9?_BJ 'Z!H9T0:@#=>?\
M;+R2\;,>W8S]0.3QP,=_K6Q6)_PB6B_\^LG_ ($R_P#Q5'_"):+_ ,^LG_@3
M+_\ %4 ;=96H:-)J.IVT\FI7*640!>Q14\N9@P968D;N"!P" <<\9S#_ ,(E
MHO\ SZR?^!,O_P 51_PB6B_\^LG_ ($R_P#Q5 &W16)_PB6B_P#/K)_X$R__
M !5'_"):+_SZR?\ @3+_ /%4 ;=%8G_"):+_ ,^LG_@3+_\ %4?\(EHO_/K)
M_P"!,O\ \50!MT5B?\(EHO\ SZR?^!,O_P 51_PB6B_\^LG_ ($R_P#Q5 &W
M16)_PB6B_P#/K)_X$R__ !5'_"):+_SZR?\ @3+_ /%4 ;=8GBW_ )%R?_KI
M#_Z-2C_A$M%_Y]9/_ F7_P"*K(\4>%](AT">2.VD#"2(9-Q(>LBCNU '945B
M?\(EHO\ SZR?^!,O_P 51_PB6B_\^LG_ ($R_P#Q5 &W16)_PB6B_P#/K)_X
M$R__ !5'_"):+_SZR?\ @3+_ /%4 ;=%8G_"):+_ ,^LG_@3+_\ %4?\(EHO
M_/K)_P"!,O\ \50!MT5B?\(EHO\ SZR?^!,O_P 51_PB6B_\^LG_ ($R_P#Q
M5 !?_P#(W:+_ -<+K_VG6W7&WWA?2%\4Z1$+:38\-R6'VB3MY>/XO>M?_A$M
M%_Y]9/\ P)E_^*H VZ*Q/^$2T7_GUD_\"9?_ (JC_A$M%_Y]9/\ P)E_^*H
MV\5S5CX3FM+86$VN7EWIB\"VFBBW,N<[6D"[F'OP3W)JU_PB6B_\^LG_ ($R
M_P#Q5'_"):+_ ,^LG_@3+_\ %4 ;=%8G_"):+_SZR?\ @3+_ /%4?\(EHO\
MSZR?^!,O_P 50!MT5B?\(EHO_/K)_P"!,O\ \51_PB6B_P#/K)_X$R__ !5
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M  )/09J];:II]Y%-+:WUM-'#Q*T<JL(^,_-@\<<\]JX'58[Z&\\;L/#]S?\
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M4TJALXSC&<YQS].:\UU*WOXM-\0Z8-)U&6XD\10WR&*U=D>#SH6W*^,'A3D
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M/[ T;_H$V'_@,G^% $W]IV'_ #_6W_?U?\:/[3L/^?ZV_P"_J_XU#_8&C?\
M0)L/_ 9/\*/[ T;_ *!-A_X#)_A0!EW^HV1\6:,PO+<J(+G)\U<#_5^];7]I
MV'_/];?]_5_QK OM$TD>*]'0:79!6@N25%NF#CR\=JV?[ T;_H$V'_@,G^%
M$W]IV'_/];?]_5_QH_M.P_Y_K;_OZO\ C4/]@:-_T";#_P !D_PH_L#1O^@3
M8?\ @,G^% $IU+3R"#>VQ!_Z:K_C6#IVA^'],$<4&J3-:18\JTEU%GACQT 4
MMT'8'(''I6S_ &!HW_0)L/\ P&3_  H_L#1O^@38?^ R?X4 3?VG8?\ /];?
M]_5_QH_M.P_Y_K;_ +^K_C4/]@:-_P! FP_\!D_PH_L#1O\ H$V'_@,G^% $
MW]IV'_/];?\ ?U?\:/[3L/\ G^MO^_J_XU#_ &!HW_0)L/\ P&3_  H_L#1O
M^@38?^ R?X4 3?VG8?\ /];?]_5_QH_M.P_Y_K;_ +^K_C4/]@:-_P! FP_\
M!D_PH_L#1O\ H$V'_@,G^% $W]IV'_/];?\ ?U?\:/[3L/\ G^MO^_J_XU#_
M &!HW_0)L/\ P&3_  H_L#1O^@38?^ R?X4 3?VG8?\ /];?]_5_QH_M.P_Y
M_K;_ +^K_C4/]@:-_P! FP_\!D_PH_L#1O\ H$V'_@,G^% $W]IV'_/];?\
M?U?\:/[3L/\ G^MO^_J_XU#_ &!HW_0)L/\ P&3_  H_L#1O^@38?^ R?X4
M3?VG8?\ /];?]_5_QH_M.P_Y_K;_ +^K_C4/]@:-_P! FP_\!D_PH_L#1O\
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M&^8E6!(VYSQR.HLV.A:G:^+UU"P@NK"VFO)WU"WDG22VG0A]LT:[BR2,=A.
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M@CM5RN;\$Z?>Z7HEQ;W]JUO*U_=3JI=6RDDSNI^4GLP_&NDH **** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH *P_%\B1>&;B61@J))"S$]@)4)-;E8OBO\
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M3=GG.,UV=% &)_PE_A__ *"D'Z_X4?\ "7^'_P#H*0?K_A6W10!B?\)?X?\
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MX?\ ^@I!^O\ A1_PE_A__H*0?K_A6W10!B?\)?X?_P"@I!^O^%'_  E_A_\
MZ"D'Z_X5MT4 8G_"7^'_ /H*0?K_ (4?\)?X?_Z"D'Z_X5MT4 8G_"7^'_\
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M*.3<%.?FW8#':2%(!^A-9'C_ ,1,GA'Q+'I@OS<6%N1)=VCA!;RE0P&[<&R
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M_HU:VJQ?%?\ R+EQ_P!=(?\ T:M %**[O%^)UQ8M>2O9G2$G6!L;4<S,I(P
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M)_A1_P )+#_T#-8_\ )/\*VZ* ,3_A)8?^@9K'_@!)_A1_PDL/\ T#-8_P#
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M)_A1_P )+#_T#-8_\ )/\*VZ* ,3_A)8?^@9K'_@!)_A1_PDL/\ T#-8_P#
M"3_"MNB@#$_X26'_ *!FL?\ @!)_A1_PDL/_ $#-8_\  "3_  K;HH Q/^$E
MA_Z!FL?^ $G^%'_"2P_] S6/_ "3_"MNB@#$_P"$EA_Z!FL?^ $G^%'_  DL
M/_0,UC_P D_PK;HH Q/^$EA_Z!FL?^ $G^%'_"2P_P#0,UC_ , )/\*VZ* ,
M3_A)8?\ H&:Q_P" $G^%'_"2P_\ 0,UC_P  )/\ "MNB@#$_X26'_H&:Q_X
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M:XD4J',K@NH5B.0 /P- '8T5EWVN16E^;"&VN+R\$!N&@M]NY8\X!)9E')!
M&<G!]*YK5_%?]I?\(O\ V1'=W&GZO<N)'@=8G95BD8Q@EE96#(,]/ND9[4 =
MS17*Z_#JNA>!I8](EU#4+JW9269Q)<M#Y@,@4D?,X0L%SSP.IZT_#^OZ9>Q7
M.LZ/K%W?Z?;VK?:-/EE+302 @Y(D.X' 888XXXZF@#MJ*PK?Q797,VD11P71
M_M:S:\M6VK@HJJQ!^;(;#K[<]:SK?X@Z?<PZ;.FFZH+?49'@MYC"N&E7=^[(
M#9!.QL'&WU(YP ==17+?\)WIZ:>UW-9:A$T>HIIDT#1*TD4S%0,[6((^=3E2
M>M1W'CZTM8M4:;1]65]*PU['Y49,417<),A]I7&3@$MP>.* .MHKGM6\8V&D
M)<RR6]W-!:VT=W<30H-L<3DA3\Q&[[K'"Y.!],I>>+H+77)='BTO4[R[BCBF
M86T2E?+D8J&R6' *G/Y]C@ Z*BL&P\66FI:5:7]O:W>+JZ:T6!E02K(K,&W#
M=QC8Q/.<#.*T-3U6WTM(/.#O+<S"""&, M*Y!.!D@= 222  #0!>HKC?$'C,
MP>$O$ESIUO/'JFE0N)8)0FZ!BA9'/S89<8(P3GTZBM&Q1=%TF_UFXEU/RC;^
M?):W=P)O*\M26*<MC<.2-Q' X'- '0T5R'A6*]\1>&;/7-2U"[CO-0B%Q&MM
M,4CMD;E%51\K8!&2X;)SVXK/_M#5-#\96EK<R:AJKIH&^6"W((EE615,@5BJ
M@D9ZD=<#K0!W]%<[_P )E82Z?8WEG;7EVEY9-?QK$B@B)0I))9@ ?F QG/Y4
MP^-;%Y["&SLK^\DU"P-_:B"-?WD?R\99@ ?G'7 ]\X% '2T5S]KXPTZ^L](G
MM([B:354=[: *%?"#+[MQ &TX!YZD8S4=KXWTR\TNWOHXKA1<3/!#%*$1W=,
M[^K;0%*L"21R,=QD Z2BN:L?'&F:G#;&SCGEN9YIH!:Y19%>+_6*26"G&1T8
MYR".,FDO]<;3[W0+\B9++6)4M9()AAHI'0M&V.QRNPC_ &@>W(!TU%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH)( !)R2!UH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>image_01a.jpg
<TEXT>
begin 644 image_01a.jpg
MB5!.1PT*&@H    -24A$4@  !MP   !-" 8    EU< D    "7!(67,  $SE
M  !,Y0%USO"5   "TDE$051XG.W9,0T , S L/(GO7%HCFF2C2!_Y@
M  !K\SH         ?F:X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
M    0&"X 0      0&"X 0      0&"X 0      0&"X 0      0&"X 0
C    0&"X 0      0' !ZR+JF7P5#D4     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>mrna-20201231_g1.jpg
<TEXT>
begin 644 mrna-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[2764&AO=&]S:&]P(#,N,  X0DE-! 0
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M;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L
M BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T
M;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M     $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M
M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="
M0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M     $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M    0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M       *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',
M4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M              !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R
M:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P
M4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +
M8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #P     $  0/
M 0 !.$))300F       .             #^    X0DE-! T       0   !X
M.$))3009       $    'CA"24T#\P      "0           0 X0DE-! H
M      $  #A"24TG$       "@ !          $X0DE- _4      $@ +V9F
M  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8
M      $ -0    $ +0    8       $X0DE- _@      '   /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H     /__________________
M__________\#Z   .$))300(       0     0   D    )      #A"24T$
M'@      !      X0DE-!!H      S4    &              #E   #XP
M       !                          $              ^,   #E
M                  $                         $     $       !N
M=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O
M<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   #E
M %)G:'1L;VYG   #XP    9S;&EC97-6;$QS     4]B:F,    !       %
M<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M       &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R
M871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG    Y0    !29VAT;&]N9P   ^,
M   #=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$58
M5     $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,
M8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T
M   /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU
M;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP
M965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S
M971L;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T
M<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@
M  P    "/_         X0DE-!!$       $! #A"24T$%       !     4X
M0DE-! P     &ND    !    H    "4   '@  !%8   &LT &  !_]C_X@Q8
M24-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "  D
M!@ Q  !A8W-P35-&5     !)14,@<U)'0@               0  ]M8  0
M  #3+4A0("
M             !%C<')T   !4    #-D97-C   !A    &QW='!T   !\
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M0S8Q.38V+3(N,0
M                    6%E:(        /-1  $    !%LQ865H@
M             %A96B        !OH@  ./4   .06%E:(        &*9  "W
MA0  &-I865H@        )*    ^$  "VSV1E<V,         %DE%0R!H='1P
M.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE8RYC
M:
M  !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U
M<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M,BXQ($1E9F%U
M;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M    9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN
M($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6:65W:6YG($-O
M;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M     '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>     5A96B
M     $P)5@!0    5Q_G;65A<P         !
M H\    "<VEG(     !#4E0@8W5R=@        0     !0 *  \ %  9 !X
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M$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( "4
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M:M7+^J7U=RL8X[L&FH$0VRE@KL!_>%C!N_STN*<K,0*'?])1PX,?#'-.?N2
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M3X:@8G6.E9MGIXF91?9^Y78USM/Y#3N7'XN=T/K?4\CJ77\NH8]-AJZ=@6O
M:UC?^U%E7YSKOY?_ %'H^G=ZC5]0<VG;3DXF%D-UHR<<MJ<QX^@_]%LW[?Y:
M7NDZ@QKM(^HI/(Q@1#(,W'0XI8\?'BQF7Z/^LX?TWK;+*ZJW66N#*V N>]Q
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M)')$C#D$(@0UGA]@<&$QXOGX8?/^^OU'J6#TS&=DYMK::FCN=2?W:V_2>_\
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M_1;;)GTY+]FV=GTG?NJRC&)'%?4VMSY1D]NK]&..,W^]'B>:^J5;;:^N5/\
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M &4 ( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\
M= !O ', : !O '  ( !# %, -@    $ .$))300B      %^34T *@    @
M# $   ,    !#Z    $!  ,    ! X8   $"  ,    #    G@$&  ,    !
M  (   $2  ,    !  $   $5  ,    !  ,   $:  4    !    I $;  4
M   !    K $H  ,    !  (   $Q  (    >    M $R  (    4    TH=I
M  0    !    Z    2  "  (  @ +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q.#HP.#HS," P-SHT,#HU,0     $
MD   !P    0P,C(QH $  P    '__P  H ( !     $   /CH , !     $
M  #E          8! P #     0 &   !&@ %     0   6X!&P %     0
M 78!*  #     0 "   " 0 $     0   7X" @ $     0
M2     $   !(     3A"24T#_0      "      !    _^$!@$U- "H    (
M  P!   #     0^@   ! 0 #     0.&   ! @ #     P   )X!!@ #
M 0 "   !$@ #     0     !%0 #     0 #   !&@ %     0   *0!&P %
M     0   *P!*  #     0 "   !,0 "    '@   +0!,@ "    %    -*'
M:0 $     0   .@   $@  @ "  (   #P     $   /      4%D;V)E(%!H
M;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3@Z,#@Z,S @,#<Z-# Z-3$
M!)    <    $,#(R,: !  ,    !__\  * "  0    !   #XZ #  0    !
M    Y0         & 0,  P    $ !@   1H !0    $   %N 1L !0    $
M  %V 2@  P    $  @   @$ !     $   %^ @( !     $
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M5R"-+M9\=/8&ZG0B%;+DQ@Q%0$PLSS&LJ,%TB8"]T46;EY8P3 !ZAZJ^"@%
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M'^LGB)HXQS\^(P/LU0B_XY?$?=O&Y%O#'XV+O[EQ]#;. ]A1>>?+ NT;MMT
M]WF6W))Q\7)]=+;WG\!YM6*W)9+V8V*SR$Q7TSRSG$%KD4'\I()-#=\QL?6Q
M)&/<EEFA2=UI!SP.7$B<AO!V!-\#5@[CN:V,8(7L8F26QY:EGISE'E91ZGV>
M0(H=@/40NO>X'NRL_;&UG>B/W0*7*9.KM?K?C<57HY%EIQ[SQ%9Z]6JTP\L?
M?'AV>S$:4Q;LGOX[RHZH8&;'-7,MB#LO!YXF-IRS*%VE;D)EV_RA$,GWV,KO
M8%%BSMO:P*)U):D6M1T'B75PA&39T_82CH0>3$8QD&TH)I>/3<2_U[/W+)99
M,3D'+RE3['8D)+R]BEFKRLQY>0(K/%(26959'/>$,D(\:'A<Q.SZIZP],J4,
M&T[L]?[Z,%CE1L?AIL@X6GG<0L/X*'"7YI8:\]6+F&E:GKR5.*=DQ4Z'M,76
M;^IY.,#Q-+5B:6-M+VUR[IGE.6:,0R5=X ZJLY4$)Q,AXJDU([01<-;I,M%V
MKV0DD"F=0\8_8-HL0F9 [F'7>[MRR5W?$X^1DE"K[99C+"2/O *UX&7WEE*L
MK2R+ZH&6-")"YCT?\&7A;Q.\*@ZP=3Z<4VTJ4U@[8P61"I0S4M!BMO.YA9@(
MY<'1FCE@KU9"(;UJO8DM@T:XBN\9V:<!]&TU^.R=O1LUG9S5C3),I8BJTDFR
MEV!7HBXZLAVY=%^[/,.P4%5["0(-G$<H8 =V%5Z9TQ:?'AMC&:)+&7DE@\P=
MZ4X>U)D!]?Y(E8/V,WJ6BC7O7D=\PD[D6;=;/N@,F*R%G:W0_%XJ6AC6-)MY
M9:JT]2P8 (^-MX:-Z\*TH>WL@O9#S8[*CF'&I (IYF92G!?X>$E#FB4<*R,0
ML*0)DFXO(^1"S"1P  !<JC^ROV!U>8=0@O'K(F'GU(B41+J2OLK -'V"O.A_
MV1+4_>3]9[W="?RH1]FJN5/&]XD:UT7'WS7N('[S1M[:VV:3#_8RM?%U["I\
MO<LHX^(<'UTHK<EP\-P7# LZ.[O97D2T6K'U1637N<#*%(K9J_6SN$C/&ETC
MXHC"+R#CMR8J:<PX1CH]_! 9O)K,4R1Y[(QB63V]D-LRKE<39DEKPD=[$ 30
M(2O*V40+'8JN0.\JB!>5+QCM\\7&Z9>)#ISXJ\4W1KKGMO%8G<>91H\'DJ9:
M/%Y#*"-Q!-@[%LV+>V]R1@L:4;V;-;($25$G9K*XNQF79=F9'</QC\<9M0A5
M:X&2K[;+,O!*N"._5+UUB.R)R#))V0"^*:H/D7!6;DZ:*J[3LJKMVZQSH)\G
M#VFN;KI6V01FSD)YRJMW*K2Q6'*J> 6 Y(!(!X]2.>--/KALB3IOX*=R[%EO
M)DCMC;^'Q:7TC,0N01;RQC5IVA;GRI9*[Q--$&=8IBZ1R2HJR-:]IW:PTU-!
MQ>>(KD-[D'[1K:O(3!;,]=Q]=RE9*:HZ&TRMDGCHI,,3U)RPZ7397MNFQ;6[
MCU1=NG;TM8*LS*QGF[Q8[OW%/).V%QKN "([DD'=YLTS$**<13W^T$A9@GO2
MR'R/14E634/P:^&O;<.W/U>NK5:D<3!#9R6T\9FUB&*JXS'AWL;OS$5CF*5.
M^*7Z(AL)Y,<,!RI2;S\?)#]1M'X!V-XNL1-LW>3TW;+O)((/G.,Z;-FA*G6N
M^F508J;L<>4TW999 P]+US"R,+$(. 6;-3S#8B<DX^C$[$A\E)<O)(9653['
M7=42(<?B2S*"TC@'WA"8XU;E5:5>'/*ZQ?="MSW,I<Q'1K'T<-@:SO!%NC-T
M1>S.3[&*^UT<99(H8NI(/6"*]6O7'C[)912E9JL6X+;P6>'M9X92+88BF:6Z
M%(4T9ZIY!NI)=N;ER!4I;#,V&(<'*/M<GL4Z3$?>00  #M2[*P,B%4AL0-\1
M)%;G9@>./Q9VFC/P^!C(YY/')TB,/XX?$=BKJV[&\Z>;B#<OC\OMS!-3E'/)
M1CCJ..N1J?AS!;B8#X,#R=(SW.['MS'"6O\ ";G=MV1IJRXN9R[=@M9B-A;R
MD D]=)@WJ.6Z^S.6(L%5GSE28IS**2$6\DNR@LPKTN>",\A&3PF2VM8CR-*R
M\D ?M2TBD/'W'D07(@2K1R<!>1Q#*P"E8I#$IOITLZ\=+O&%MZ]TKZG[9HXO
M=DU.2Q%C#+YE3(O!"_FYG9V1F!NXW+XY>^PU%WDMPU>^2.SDJ:Y 04Q['=W=
M1WIX#KV7:Z@E#SJ:RE<R'4@6%92IW>-;ME9./34/R4<13U!TUEX)Z8.IQ%/V
MQ'';D$'S9NR<%F(LW02TJB.9&\JU".?P4Z@$]I/J8Y%99(F]?=;M8^8C@9==
M>.C>9Z'=0LELW)R-=H,BY/;F8*!%S&!LRRI4LLJ^[';A>&6GD(!Z17*\IC[J
M\D$LBFO2*/P&[>?I7L/U06U%.H7ZQB_ZM:^7/_U<6K?_ '-C]OO4?\T,=_CF
M/6 ]AVU7)G%&=TU7-]LG:YM;VK4ZMXJKD)6UO"GFI=G&-UW<-7SNRNV3&7DR
M VGKW9U&;I\1F[@(-@D5$S!Q#1[ XBSN5XEMSR)C<7"M9/+ 'Q]1#!W=R+*X
M'FV9BKD QIV\&(1V%\0/5K:_A1BSB;#Q&/R75GJWFLIN[)W\G'YRT*4]N6."
M[D5A,,]BG5;S<?@,4L\5=IX<C?L,7$\=VBW!W#0V<;<LEP.7,28N6K]XKD%*
M0<9)/;5:+$BEZX039OI@K.PRLF@A.GC_ !<<609@UZ&4G(H]D>^0R3&H[7P^
M.M17*M>19X4=8R\\LJ@NI0R=LC,!($+H". %=O3G@C-;?GBAZU=2]KY#9^\-
MV+DL#D[]2_:JP8G%8UW]B=IH*9FQM2K(]!;'DV37F,O=/5K2%^8R'7/Z1#\F
MW!OTX*?4*TZCG4/^4\9Z\?R9-_!GU9?[FW_-.W[^8:_Y08G2Q\ J;GN)K4,*
M;(\:R;K&&W' M"@DLMV<>^O'2<B5\[>!,6-!JX:_"!XN^$S&A4CQ2;<RL>[L
MDDJAX9PYAXO03*;BCIX2N_D4*2%YV/=Y0#3/+Y]@#M,LG<W96@YX[D+AE(>2
M.TO41.E?A:S.^NNVZ*L.Z^IO4'<.0?9N*YC2Q4JM!#":>->:.7Z.AC@XGW#G
M?*:7LL18NJLGFQQ7'U8OX+NP?'D WBIK%TCE*7!$A'UHR!:["M(O%NV4JJJ4
M?7)"O0,>F8X&.DDTBR*)%$"G76, J&GM;9."@0++#/;DX]Z6:S.A)X]2$K/
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M>53ZCT9H OQ'Q^(U:G$Q4=!149"0[)O'1$-'LXJ+CVB946K".CVR;1BR;(D
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M2N/9<32^BL7DY.9+5;'>:LD<41J5I8BSB4KI_']\,;0O\DVY'^3F,/\ :O\
MV]WOU/\ [_\ &?\ @.1_XM3_ *5]FL\_\S@ZS?[K^F/]D]U?]D-']\,;0O\
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M/+D)8Y["6-+I#SZF/+YP'2ZS;?1F[WM2J?*6]C[Y('), 6NTC ?$]K13(/\
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M ?X[B9EUU!_*910QA_?$=2#:@XV_COZ6P?Z]N<ZK3XJG9_$/U89CR1NB5/\
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M(J+9HT:H$30;-FZ)")(((D(DDD0J:92E* !-55454151% 554!550. JJ.
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M$B:(?PW8>*S]>L3<[,&TBLIT(-D%N^5,W?Z ,F?B9O!5\Y%7BL33PBO*TJ&
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M?<6'WE'CA]__ !0Y'_YWEKK+A]B'XYFP/_S,?_0M<%MP=41^+MVI_P CF/\
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M?%.LD*M7,=2#+8B0^?(9.^QYTR1>2L9B[IT=<)&W#<5H/=MVIX_B_4),^?\
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9-&C1HT:-&C1HT:-&C1HT:-&C1HT:-&O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>mrna-20201231_g10.jpg
<TEXT>
begin 644 mrna-20201231_g10.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #B @0# 2(  A$! Q$!_\0
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MG[T>Z09^53S7K_A__D Z;_U[1_\ H H T**** "BBB@ HHHH **** "BBB@
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M,;?2X(S)&V-R-A.5.!D'@XK?O-'L-0NH+FZL;:YN+=72&::%7>-7&'"DC(#
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M(I;&"/6O''P_TCX@6-I!J8N(9[&X%W97UC</;W5I,%*^9%(A!4E692.C*Q#
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MS=$65=Q[MD[BQYJ]KWP7\.^(-2O]3<WUEJ]UJ$.JIJ-C=-%/;7,=L+97B8<
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MJT/E7UG;WL7]RXB61?R(K0\LATKQ%I.NH'TW4[/4%Z[K6X24?^.DUHUP.J_
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MN 9UGQ$^"/CC6_BA<^,O!'Q-B\"27FEV^F7MJ?#L.H?:1#),\;L\DBX(\]P
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MU1MBY"@@9)R:Y3XE?%3Q5HNH?$36-)OK6UT3P!%:27&FRV@D;4MT2W%P&D+
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M8%DP#]TD'#=#@UZU6B:>J/+J4JE&7)4BXOLU9A1113,@HHHH **** "BBB@
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MM;V-U/(KZQ<:;Y2+;2YD#0JQE(R/W3X1L\D8%>E^'_\ D Z;_P!>T?\ Z *
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M"ZCQ)],@BKYIQW5_3_(\_P"KX'$?P*W(^TUI\I1O?YQBCV2BO&O^%^:IX/\
MD^(?@36/#<:_>U;31_:6GX_O,\0WH#Z%<UZ)X0^(7AGQ]:?:?#NNV.L1@986
MLZLZ?[R_>4^Q JHU(R=D]3FQ&78K#1]I.%X?S*TH_P#@2NOQ.AHHHK0\T***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#Y6_;F\30Z+_PA, \&>%_%5]"-0UN"?Q2
MTHBM5LHXI91&(_F=RC&38>"MNY(.!CO/V1/$$?B#X5WC):^&[1[77-0MI?\
MA$GDET^603%FECE=B9=Y;?O_ -K&!C%>4_%WXC7MU\?IO!-M\='\/S37<%I;
MZ:_@2#4+33[BXA CMWO'X\R56; /:3:?2OHWX.^ =0^&?@>VT#4M9M-<EMY)
M&2XL='@TJ%49LA%MX?D7!)Y'7.30,^;_ -I#XO?\(/\ M W&DS_%;2?A%;OX
M?L[F.\_X1:/5;K4F,]R&261E)18]JE5Z'S7(Y!KZ@^&>JC7?A[X<U$:^OBD7
M5A#,-;6U%L+[<@/G"(<1[NNWMG%?-W[4WQ@\;_#SXMZ+:PZKKOA[P@UM;F"3
M1- _M%;Z:1IUN/,<(Q5H0+=DB&W?O))P,5]$?!_5/$>M_"OPE?\ B^T^P^*+
MG2[>74K<Q^64N#&"X*?P'/5>QR.U '7T444""BBB@ HHHH \D_:G307^"7B;
M^WM/O=0C%C=&U6RL;FZ,=Q]FEV.X@5BB#G+OA!D9(R*]+\/_ /(!TW_KVC_]
M %<1^T3XBMO#OP6\8O<P7\XNM(O;9!86$]V59K:3#.(D8HG'+MA1QDC(KM_#
M_P#R =-_Z]H__0!0!H4444 %%%% !1110 4444 %%%% !115+6M0FTK2[F[@
MTZZU::%=RV5D8Q-*?[J^8Z)G_>8#WH XGX._>\<_]C1>_P HZ]#KR7X-ZEX@
MM=6\16FK>!=>T*'4M8NM2BO;V6Q>%8W"[5;RKEW#':>BD>]>M4 %%%% !7G?
MB_X ^!?&=U]NNM#CL-6!W)JFDNUG=*W][S(R-Q_WLUZ)14RBI*S1TT,37PLN
M>A-Q?D['C7_" _%/P+SX6\;P>++!/NZ9XPA)FQ[7<0#%O3<N*4?M#3^%#Y?Q
M$\%ZSX.V\-J4*?VAIWU,T()7/H5KV2FD!@01D5G[-KX7^IZ7]H4ZVF+HQEYQ
M]R7X+E?JXMF-X6\;>'_'%B+OP_K5CK%OU+V<ZR;?9@#E3['!K;KS;Q5^SQX%
M\47W]HKI']A:R.4U;096L;E6_O;H\!C_ +P-8G_"'_%KP'SX?\6V/C?3DZ:?
MXIA\JZ"^BW,0^9O=UQ1S3C\2^[^O\P^JX/$?[O6Y7VFK?=)73]7RGLE%>.1_
MM&Q>&G6#XA>$]:\"R9VM>RP_;=/)]!<0@C\U%>F^'/%FB^,+$7NAZM9ZO:'_
M );64ZRJ/8[2<'V-7&<9:)G)B,OQ6%CSU8/E?VEK%^DE=/Y,UJ**\9U30_%9
M^,%CH47Q/\36^EWNE7FJ&&.STD^4\=Q;HD:LUB3LVS,/F);A?FZYL\\]FHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /E3XE?LF_$'Q5XN\5WOA_XD:7H>AZYK]EXC^P7.@_:98KJU6
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M0SQBVDS$WF*V%;(Y7#<<$5V_A_\ Y .F_P#7M'_Z * -"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O/-0_Y."T#_
M +%?4?\ TKL:]#KS6]^!]K?>*!X@;Q;XJBU%8Y88VBU%0L<4CJ[Q*/+X7=&G
M'^R* /2J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP7_T*&@_^"R#_P")H_X5;X+_ .A0T'_P60?_ !- %W_A./#G_0P:7_X&Q_\
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M^)H N_\ "<>'/^A@TO\ \#8__BJ/^$X\.?\ 0P:7_P"!L?\ \55+_A5O@O\
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MT[P'X?AT?3!,8$DEGDFN)#)-/-+(TLLLCG[SO([L3ZMQ@<4 ;E%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
F444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>mrna-20201231_g11.jpg
<TEXT>
begin 644 mrna-20201231_g11.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #B @4# 2(  A$! Q$!_\0
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M.<C#Q.OS $XR,J03A^%O^2W>/_\ L&:1_.\H ]#HHHH **** "BBB@ HHHH
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MQ'_PCGAFRC6UM]2NK]UM]1OO%4GAZ"!5C+2(]Q&=[AP /*'7&[(*BHOV4H_
MDS:A?:-<6%EXONGNGU/1=-\3G6+=2)8XWN(B6)",(K902HPJ(HZ9/4?&[P+X
MK\37$$FG>$_ _P 1=*1O,32/&49C:TD*A2T,GE2HP('1D##+8<@A5L_!/X1O
MX-NKC7=3\)>"/"6LSP&V6S\&:<L2)$65F$MP41I22B\!55<?Q9R 9ZW1110(
MS/$^AQ^*/#6K:--(T,.HVDUH\D>"RK(A0D9[@&N3U+X.Z?K5GHEM>ZA>NFA6
ML,>E-$RHUG<QKM%VO&&EVX7# J%WKM(=P>_HH YGQ9X)C\8VN@QWMW(DFDZG
M;:H)(4 \V2$D@$'HI)[5RMW\#(+KQ5->?V[>)X>N-:A\13Z (HS&]_%L*.)<
M;Q'YD4<I3NZYR 2I]0HH *\\\+?\EN\?_P#8,TC^=Y7H=>>>%O\ DMWC_P#[
M!FD?SO* /0Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBJ&M:YIWAO39=0U:_MM-L81F2YNY5CC7ZLQ H*C%R:C%7;+]0W5U#8V
M\EQ<S1V]O&I9Y96"JBCJ23P!7CTOQWU;QW(]I\+?#$WB)<E#XAU0-::5&>A(
M8C?-@]0@_&G6O[/]QXNN([_XG^)+GQE.K"1-'AS:Z5 >HQ"IS(1_><\]Q6/M
M.;X%?\OZ]#VO[-6'UQ\_9_W=Y_\ @/V?^WG'YDNI?M#VVN7TVE?#G0[OQ_J<
M9V27-H1#IMNW_32Z;Y3ZX3=GUJLOP7\4?$8B;XG^*7N;%N3X8\.L]K8 ?W99
M,^9,/J1STKU_3=+L]%L8;+3[2"QLX5VQ6]M&(XT'HJ@8 JU1[-R^-W_(/[1A
MAM,!3Y/[S]Z?R>T?^W4GYLRO#?A71_!VEQZ;H>F6NDV,?W8+2(1KGU..I]SR
M:U:**UVT1XTYRJ2<YN[?5A1113("BBB@#SSQE_R6+X<_]<M4_P#145>AUYYX
MR_Y+%\.?^N6J?^BHJ]#H **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#QQOC1X(\#?$SQGIWC'QQ9^&]1CDMWM+'7]36T@:T
M-M$1+;K(P5P9?.5BN2&0CCOUOPB\;6_Q"\)R:WI]XVIZ--?7*:=J#*5^TVZR
MLJN,@94$,JM_$JJV3G)X'XJ:?X%\7>)KVP\:ZY\-;TZ=.AM-.\5:9#<7-B&A
MB8J3)<)]XDOPH!#*.<5Z'\*?%MAXP\)B?3)]-NK*RN9M.CN=' %E*(6*!H0"
M0%XQM!(4AE!.,D [&BBB@ HHHH **** "O//"W_);O'_ /V#-(_G>5Z'7GGA
M;_DMWC__ +!FD?SO* /0Z*** "BBB@ HHHH **** "BBB@ HHHH **** "L;
MQ)XS\/\ @V"&;Q!KNFZ%#,Q2*34KR.W5V R0I<C)QV%;-8/CNUAN?!NN>;$D
MNVQN"-Z@X/EMTS0!)X:\:^'O&D4\OA_7M,UV.!@LKZ;>1W C)Y 8HQP3@]:V
MJY'X1VT-O\+_  B8HDBW:/9EMB@9/D)UIWCSXI^%?AG:+/XBUFWL'D_U-KDO
M<3'H D2Y9N>.!BDVHJ[-J-&IB)JG1BY2?1*[.LK#\7>-M!\!Z6VH^(=7M-(L
MUZ274@7<?11U8^R@FO,O^$O^)WQ3^3PMHB_#_09.FM>(XA)?.O\ >BM <*?^
MNAP16WX1_9]\-:!JBZWK#77C+Q-U.L>()/M$B'KB)#\D8!Z;1D>M9<[E\"^\
M];ZC0PNN-J:_R0M*7S?PQ^^376)B?\+8\:_$S]U\.?"YL-*?@>*/%"-! 5_O
M06X_>2<=&.!D<BKNB_LZZ7=ZE#K'CO5+SXA:Y&=R/JP LH#_ -,K5?W:CZ[J
M]<HI^S3UF[_UV)EF<Z:<,%%4H]UK)^L]_5+EB^PR*)((DBC18XT 5448"@=
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MGP6[2-!%;QI&TJE7*A0!N! (..H(%7J* "BBB@ HHHH **** "BBB@ HHHH
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MVK7"R_8;-6#""+:BDKD+EGW.VQ=S':* .\HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>mrna-20201231_g12.jpg
<TEXT>
begin 644 mrna-20201231_g12.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #! 10# 2(  A$! Q$!_\0
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MA1G[5JO/%>A5P.B_\EX\8?\ 8M:)_P"E6JUWU !1110 4444 %%%% !1110
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M^G:;+<2/:V<G@Z.9H(BQ*1F3[0-Y5<#=@9QG KW&B@#P'_A5W[07_1<]$_\
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M!FW1110(X'1?^2\>,/\ L6M$_P#2K5:[ZN!T7_DO'C#_ +%K1/\ TJU6N^H
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M!@0.JDT",S1?^2\>,/\ L6M$_P#2K5:[ZN!T7_DO'C#_ +%K1/\ TJU6N^H
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MSWRBH;.ZBOK2"Y@;?#,BR(V",J1D'!Y'!J:N<[ HHHH **** "BBB@ HHHH
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M2FXIVUCOIKV9!=?%37M-L);J\^&/B>.&",R33+>:2(U51EF!:^5MO!/(!QU
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M1=]H3Y?E1B, X.*]874_B=&<KX-\'*?4>*;H?^XVG_VQ\4O^A0\(?^%5=?\
MRMK:>.<:LYX:/(I*S6C]=UU.>EE:G0I4\;/VDJ;NI:QUZ/1[H[^BN _MCXI?
M]"AX0_\ "JNO_E;1_;'Q2_Z%#PA_X55U_P#*VO+/<._HK@/[8^*7_0H>$/\
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MBD+@G&,F@#Z5HKY=U;]G3QE9?$Y+CPQ?1Z-HEOJ^F7.F7Z39.G:9;Z;/;2V
M0G<0\SJ^W[A#EF.Y<'G]/_9]\?6_PU\)VDVAQIK5CJ5J/%-O;ZT)%\10Q6LU
ML;I?-!C$A\R.8AP"[KEOF1"0#["KGOB!X]T7X8>$-2\4>([E[+1-.C\VZN(X
M'F,:9 W;$!8C)'0&OG#5/V;?%TGB3Q+#;WFI2^'M9T"+3;B2XOX9K^*>.*RB
M66VN2%9MRPN9(IE",T601YI"]/XT^$OC?Q1^QKJO@"YAT^Z\;7^GR6K?9@EM
M;L[7!<.P!*QDI@LJ94,2%^7% SUWP7\4O#7C_5-:TS1KZ274]%:%=0L;BVEM
MYK?SD\R)BDBJ2KKRK#(.#SP:ZRO"_@'\)_$?@'XB?$'6[Z*.P\/Z\NGFUL[J
MX^V:@9X8/+EDEN,LWEDX"1F1PHS@(#M/NE @HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
7 **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>mrna-20201231_g13.jpg
<TEXT>
begin 644 mrna-20201231_g13.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #$ >T# 2(  A$! Q$!_\0
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M4E8XU2""(%B2>P&6))/<DGJ:YCX$2++\&_!KHP=&TR$JRG((VCD4 =Y1110
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MKGPT\(77Q]\.WDWA71)KN;1=4O);B33H6DDG6YT_;*S%<EQN;#'D;CSS7KU
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M\EP\+_\ 8NZO_P"E.FUW5 !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!2U;1=.UZT^RZG86NHVNX/Y-W"LJ;
MAT.U@1FK4<:0QK'&BQQH JJHP% Z #TI]%!7-)KEOH%<G<?"CPC=2!YM LY'
M":A&&922%OI#)> '/_+5R2?J<8S7644$G#M\%/!4FJ?V@V@PM<B8W"@RR>6D
MIB,32)'NV*[1DJS  L#R35O4_A/X3UBU6"YT:)E2WM;6-XY'CDCCMF=K<(ZL
M&0H9)"&4@_,>:ZVB@#B1\%_!2Z.-+3P];162H42.-G0QYN?M648,&5A/^\#
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MNXTA:-G=A%&DGF1I#EOW*K( ZK'M"L P (!KN** .$G^!G@6YM[:&7P]#)'
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MAW\6HZ=<#Y)HCT/=6!Y5AT*G!'>MBNA.^J/E9PE3DX35FMT]T%%%%,@****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YU^.'[.7BWXU:UOU34
M_ FH:-:3-)IEMK/A6:YN+56QE3,MVF[)49  !P,CBO<_".DSZ!X5T?3+HV;7
M%E9PV\ATZV^S6VY$"GRHMS>6G'"9.!@9.*^6_P!K#6M#U#Q_H$MWJ7A[7=(L
M;6[LKG1;_P"(_P#PC7DWF^%M_P"[;<[JAVE6Z"1>G?Z3^%[VTGPV\+-9PP6]
MHVF6QAAM=2.I1(GE+@)='F=0.DI^^.>] '44444 4]7M[VZTV>+3KN.PO67$
M5Q+#YRH<]2FY=WYBN.^ JNOP8\&+(XDD&EP!G"[0QVC)QVKL=6OIM-TV>YM]
M/N=5FC7*V=HT2RRG/13*Z)G_ 'F XKCO@+(TOP8\&.T;0LVEP$QO@LIVC@X)
M&1[$B@#O:*** "J6M:Q:>'M'OM4OY1!8V4#W$\K=$C12S'\@:NUY-\:F/C/6
M?#7PW@)*:U-]NU?:?N:;;LK.I]/-D\N,'W:HG+E5T=V"PZQ->-.3M'=OM%:M
M_<G;S.1TS1[MOA2/%NK1&+7/%OBK0]6N$?[T,+:K9K;0?1(0G'8LU?0]<'\9
M%">#;!54*H\0Z"  , #^UK2N\IQCRJQ&*Q#Q5:59JU^G9=$O)*R7H%%%%4<@
M4444 <+JO_)</"__ &+NK_\ I3IM=U7"ZK_R7#PO_P!B[J__ *4Z;7=4 >6^
M+/ACJ6@Z[<^+_AY+#I^NS'?J&CS';8ZP!_? _P!7-Z2CO][()KH?AY\3M,^(
M5O<PQQ3:7KE@PCU'1;X;+FS?T8?Q*>JN/E8?D.QKA?B)\*[;QI<6VL:?>2>'
MO%U@I%CKEHH,B#KY<J])8B>J-QUQBLG%Q=X_<>S#$T\7%4<8[-:1GU792_FC
M_P"31Z72Y3NJ*\V\#_%2ZEUQ?"/C6SCT#QBJDPB-B;/5$'66U<]?4QGYESWP
M37I-7&2DKHX,1AJF%GR5%YI[IKNGLT%%%%4<H4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 ?+?[5EKXDM?&7A4>'?#]YJNFMF[O;?P[IEA=WLLGVB
M!9&F6X&X1^1YN&3 ,@0.0,5[G\&[C4[KX2^#9M:-D=7DTBU:[.G&,V_FF)=W
ME^7\FW.<;/E].,5\O?M=>"_!T'QBTJ^N;?PIH>KZIH]S=7.N>--7OK.PN! T
M*"WB6WFCS,002<\*,['/3Z:^!M]9:G\&? UYIVA_\(U87&B6<L&CY)^QHT*E
M8LGDA0<9/)QD\T#.XHHHH$4]6UBPT#39]0U2]M]-L(%W375W*L448SC+.Q
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M=--TF'O)>3'9%^1)<^R&IE+E5V;X>C/$U8T8;R=OO.=\"_\ %POBYXD\8/\
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M\T3S\PR_$99B)8;$+5/?H_-/J@HHHK0\T**** "BBB@ HHHH **** "BBB@
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M.RM]1L+A=LUK=1+)%(,YPRL"",@=:X[X"PQV_P &/!D42+%%'I<"HB#"J H
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M96D>[E&=8O):WML*UJM4[M/Y76JZ'-V'PC\:)8V\5W\7-?>1(U5S!96:@D
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MA7E;'Q5:)?JWMYR>7*!^+4?\)Y\2/#/'B#X?Q:Y;K]^^\)Z@LIQ[6\^Q_P
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M63) P7$A[DF>57YK:G5'%8B-"6&C4:IMW<;NS?>VQZI1115'*%%%% &!XO\
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M:]I[:;XO@MM'N]2\1ZC93FXMTAE$MK8VN0QCD8 +)\RA%D;<7=C@ ^QJ***
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4WRUW[]HWXQNQSCTH
MHH %15SM4#)R<#OZT-&K,KE5+KG#$<BBB@##D\#Z+/XVB\6R6>[7HM/;2TN3
M(V!;M*LI39G;G>BG=C/'6MSRUWA]HW@8#8YQZ444 -$,?S_NU^?[_ ^;MSZT
M]5"@ # '3%%% ',>/_AMH/Q.T_3[#Q#!/=V-E?P:DEM%=2PQR30MNC\T(P\Q
M V&V-E<JIQD"NF$:JS,% 9NK8Y.*** &B",($$:A0=P7:, YSG\Z<T:N5+*&
M*G(R.A]:** '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
64444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>mrna-20201231_g14.jpg
<TEXT>
begin 644 mrna-20201231_g14.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $: CT# 2(  A$! Q$!_\0
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MEQ^SKX9FL8K*.[U6VM9;5K'5(XKA?^)Q T\D[I=%D).Z6:=B8RA/GR#.UL4
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MZ38V^FZ=:IY<%K:QB..-?15' _\ KU?H **** "BBB@ HHHH **** "BBB@
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M!PI[9VC/T%9?A?X?^&_!,UW+H.B66DR76T3-:PA"RJ6*KQT4%F(4<#<<#DT
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M4\=WDOB758[CP9X?O;[P[+%?21_VA-#JNJ6\+SA2!=;H[&Q0A]P;SR<9D!H
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MJVDV^M6+VEUYWDN03Y$[POP<C#(0P_ U0\->#M*\(Q21:7%/!$X \N6[FF4
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M;BSF61,^A(/!]CS6I7F_B+X"^&=4U*35]'^U>#_$#<G5/#TOV5W/7]X@'ER
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M5Z-6,<#%PC\3W\EVZ:OKY>K/*>*J9S6^M5K<J[7M*2ZZMZ1Z:[Z]$<A\/_\
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M37^9<6I5[J2>GS-^O,/BA\._"7BCQ1X=NM<M$N+F>Y-M*TEW)'F 6\[A0 X
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MZY+_ "%<DL)AZE=SG!-VZHR=*G*=W%'(_P#"IM+A_P"/+4]=TX=A;:K, /\
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MBF0Z?IUK8&3&_P"S0+'NQTSM SU/YU?HJ>5-IM:BLKW"BBBJ&%%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P '=M_\72_\+V^&O_10_"G_ (.[;_XN@#N:*X;_ (7M\-?^BA^%/_!W;?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M; YP /:NBHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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K 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>mrna-20201231_g15.jpg
<TEXT>
begin 644 mrna-20201231_g15.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #S 54# 2(  A$! Q$!_\0
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M/_CZF^B_UI[?ZY/H?Z4 <(UYX_4 _:O#/4#_ (];H?\ LU*;KQ^ 3]J\,_\
M@+=?_%UV]Y_JT_ZZ)_Z$*DF_U3_[IH X077C\@'[5X9_\!;K_P"+H6\\?MG_
M $KPSUQ_QZW7_P 57=P_ZI/]T4RU^Z__ %T;^9H X?[7X_W$?:O#/_@+=?\
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MK]:?;?\ 'O%_N#^5+#]UO]X_SH A3S?M4O*9VKV/O[TYO-\Z/E._8_XTL?\
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M-GCZ5,LA\Y_W;=!Z>_O39'/VF']VW1O3V]Z $ELK<*,0I]X=O>B:RMUA<B%
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M]UOZ5&L#>=)^^D[>G^%->!OM,0\Z3[K<\>WM7<>B3W'W5_WU_F*6X_X]Y?\
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MQ)_PVEXPU.+2;VZMM-\(V&G2-;PJVR26XED4XR.&$9P?:OHJT.82>GSL>?\
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M+>?ZM/\ KHG_ *$*DF_U3_[IJBB**ZB$:#S%Z"F6]U$8W#.I&]N#Z9-6(?\
M5)_NBF6OW7_ZZ-_,T <=XB^%7@#QC))_;OA#P_JY8#Y[S3896[_Q%<_K7#S?
MLH_"ZVN5DT73M0\*S-N/G>'=9N[#:>.BQRA?TKVM?]<_T']:9)_Q]0_1OZ5C
M*C3D[RBON,)4*4W>4$WZ'S9\3O@%XGL_#UHGACXU^,;+_B:6),>LSQ:@@'VF
M/!#&-9,J<, 7(;;@C!XZR32_CIH,;+:>,/ _BR( \:OH]QI\K#_?@F=<_P#
M*]%\=_VA<V=M;6.DW%_MN[6X:2.6)% 2='8?.X.<*>V.16_#<276G^;+;26D
MC*V892I9>O4J2/R-8JA#F?+=?-_\,<ZP\%-\MUMU?_#'CD/Q.^+NB1HNJ?"2
MQUF-0,S>&O$T,AQ[17"1'_QXTZ/]I_3]*ROB/P#X^\,8)+S77A^2ZA7G_GI;
M&48KV:V_X]XO]P?RI8?NM_O'^=:>SFMI_>E_P#7V51?#4?S2_2QY/HO[57PC
MUB^>-/'VCV4[!5\C5)382 \\%9PAKT72?$VC^(A'-I6JV6J0X/[RRN$F7\U)
MI=4\/Z7XA::#5=-L]2@VJ/+O+=)5[]F!KSS6OV5_A)K-VLTG@'1[*X;)\_2X
MC82 ^H: H<T?OEV?WK_,/]HCV?WK_P"2/4+J9%C +8.]>O\ O"G2747EM^\7
MI7CD_P"S+9:2H;PY\0/'_AH!E"0VWB"2ZA7D#_5W0E&*<WPW^,.AJ6TKXO6F
ML1J/E@\2>&H9,CWDMWB/_CM'M)K>'W-?\ /:U%\5-_)K];'K%Q-(^G%+2YA@
MNM@"231F15/'501G\Q7.^!]5U?4/MTNIWUA)!%>7-LL=M:O&Q*2E0VXR-U Z
M8[]:XB/7OCUH,:FZ\*>"?%D0 _Y!.L7&GRL/]R:)U!_X'5K]FSQIXE\:>'O$
ML_B7P;<>#KB#7KV**">X6;S5\UBQ!']UB5W8VMC*G'2554IJ-FGZ/_AB56C*
MI&-FGKT?_#'JRW47G,?,7H/ZT-<Q--%AQWJ5?]<_^Z/ZTDG^NB_&NH[#CO@R
M0WP[TXCD>==?^E,M%+\&_P#DG>G_ /7:Z_\ 2F6B@#A_VC+C3%FT2VUY&M-+
MN-T=O?VFCB]OGO&91%:VLV[_ $>:3)VL4(8C&Y2.=#QU:WH^&&@Z1)I>M2,8
M(1-)<FYU&:,JF-EPUG,LLCGNZED)!)/0US_[4>AV6L-X?,^F:AJ,L+&67[';
M:7,B6:21M<NPO02"J<@IP#@GM6UX_O+O2?A7X.B\.2ZA"))+:**PM9!#>7D(
MMW;RE>WBD5& 42$HH3$; $ \G0.IUOP<AUNT^'^F6NO23W%[;((%N;J!X9IX
MU "R2))+(X8\YWMN/4\UQVL3>.'\ ZA_:4=NS?VG#YQU#Y&6WWQ[A$(P06#Y
M +?*1T.,5Z3X#U*/6/!>B7L4S7"36D;>9)*\K$[1G<SHC$YSDLJG.<@=*J?$
MS_D2K[_?@_\ 1R4P-]?/\Z3 C[=S3'^T?:HN(\[6QR?:K*?ZZ3\*9)_Q^0_[
MK?\ LM(#YI_:X\20V_Q ^ .C7+[2WCB'4G1(W;<L-K<8 X^8[G' YZ5YY\5O
MVO-#NO\ A9.@>'M"UMM8M[5K::-=($B;0AAF=V#$PHA?.\KSP.]<!^WI)I_P
MS_:2^&&MZ?HSM%I-E+JHM[>Z\E);G[0H1N#E2,-EE&2,#M7IGPO\7>#/">B_
M$'PS:ZE!K/CZ]THRZU<3RJEU+=/;R/<2/))C**[8V@_(  >:6:8B5-8>C0JI
M-)MZ)M-N32M=ZM:[=CZW+<+0PV%>/QM"4E-I0O*T9\KO-M\JM%<MG:2>KMLV
MO:?V9?C%;?%+P#9#^TK?^WK6!%O-&FB,%S984*NY#RR, &5\ $,.XKV&/[1M
M.!%]X]SZFO-;CX6Z%\5/#>C7NLZ3/I&M6=O$+#7-/NECOH/W8P\4\1)QS]UL
MJ>X-9*>)/B+\(?D\1V,GQ%\*QD@:YH\ 35+9<];BU'$P'=XN>"2E<<:U2"3K
MJZ_F2_-=/EIZ&53 X;,)N67S49O7V<G^%.;;4EV4FI]%SO4]<C^T?:)L"//R
MYY/I7F_Q8^ .A?%:_L=7D>X\->,M/4_V;XLT&4V^H6G^R7QB6(]XI R$$\#K
M79>"/'&@?$+3WU;PYJUMJ]@^U?,MWR4;'*NI^9&'=6 (]*WV_P!<GT/]*]&C
M7E3:JT9?-?UJCYNM1J49RI5HN,EHTU9I^:>Q\YQ?'+Q?\$KBVT7XXVEJ-):5
M([3XE:1"RZ5.=P"K?0Y+64AX^8YB))PR]*]<\>3:A?>!K[5M%UA[9H+&:\MI
MM.DB9+C$19/F='4J>#D5T^KV<&H6+VEW!'=6LY$4T$R!TD1CAE93P00<8-?)
M7QV^%_BS]F7X>^(M=^![7M[HMW%)!<_#B2TDOK*,S JUS9E3OM-F6D9,F)@"
M,*<5ZU&-'&U8I6A4;_[=?_R+_P#)?\*.=WBO(T?V8O"TUK^T%\7-=ELKJ?59
MAIL%U>WFH"38TEFD\@V( K!F9<8'R@8&!D'ZEM_M'EM@1XWMW/\ >-?!7[+_
M .TE-X5N?%_B#XG:)XN\(W.H:A;+J-S'X>EN[".6"R@A:*5X86:%L!7P0!MD
M7G@D_8/PZ^.WPY^)T87PIXXT'7YF8G[-9W\;3C)S\T6=ZGZBO)A@\13A.;IO
MEYI:I::2:W6AQX)Q]F[=Y?FSME^T>:_$6>.YIK_:/M,7$>=K8Y/M5A0?.D..
M.*;)_P ?47^ZW]*S/0(IOM&U<B/[R]SZBEN/M'D29$>-I[GTJ6X^ZO\ OK_,
M4MQ_Q[R_[I_E0!##]H\E,"+&T=SZ41_:-IP(OO'N?6IH/]3'_NC^5$/W3_O-
M_,T 5X_M'VF7 CSA<\GWIS?:/-3B+.#W/M3X_P#CZF^B_P!:>W^N3Z'^E %:
MZ\_RUR(\;UZ$_P!X5))]H\M\B+&#W-.O/]6G_71/_0A4DW^J?_=- $,?VCRT
MP(L8'<TRW^T;7P(_OMW/J:LP_P"J3_=%,M?NO_UT;^9H C7[1YK\19P.Y]Z;
M)]H^T19$><-CD^U6%_US_0?UIDG_ !]0_1OZ4 ,D^T;1D1?>'<^M$WVCR7R(
ML;3W/I4TWW1_O+_,43_ZF3_=/\J (+?[1]GCP(\;1W/I2Q?:,-@1?>/<^M2V
MW_'O%_N#^5+#]UO]X_SH KI]H^TR\1YVKGD^].;[1YJ<19Y[FI(_^/J7_=7^
MM.?_ %T?XT 5[C[1Y8R(\;U[G^\*?)]HV-D18QZFGW7^K'^^O_H0J23_ %;?
M0T 4+B^.FZ>;FX:*."- 6<[C@?@*Y3X<:]!?1ZG;6\J-.VI7DX1T=24,[$,,
MJ.#D?G7<0?ZF/_='\J9:,663)S^\;^9J6G=,AQ;DG<8/M'FMQ%G [GWH;S_.
MCR(^_0FIE_US_P"Z/ZTDG^NB_&J+..^#.?\ A7>G9Z^==9Q_U\RT4OP;_P"2
M=Z?_ -=KK_TIEHH POBK%;:/XCT[7K;Q/%X?UMK.73Q')I3:FT\#,KDI"A#@
MJP!W#Y><,#\N///BM#I%C\&_".GZ)<?V]X8MY$L'"RE;K=%&S*R*MM)MD&QM
MV0@5<@ 9Q70?M&QZO-JNA)H%EXOGU(0R_P"D:!JQM;&%2R@?:H4E627)^[L7
M/WAO7/,7Q0O-2E^&?@)(K5M2DNI(OM#0@3O+)]DD!3[/,ERTX8%\@EF4)N+G
M!-'0.IZ?\*9!-\-?#)'EC&GPKMCB\H)A0-NS VD8P1@<@\#I3OB=SX)OP>F^
M'_T<E3_#J">U\!^'X;FTAL)X[&%7M;>'R4B(0?*$V1[<=-NQ<=,"O.M>^*%Q
MXB^']Q*^@WDC3ZC;VNVP"2BU1FC</.2PV@9VMC+ ]5'2F]Q'KZP1F:3Y?2FR
M01_:H1MXVM_2D6Y*S2?N)3TZ ?XTQ[D_:HCY$O"MQ@>WO2&?F#^UWKWQ!UK]
MN;0;2/1-+T]K2RM;30X=1>.XC9'G=EN9@"5YE5SL/144D<D'ZJD_9?\ AIJ/
MP^\:V%YI,7B&ZDL!>2^)+S]YJ-Q=&*1VN?//S!B^3@87MC'%?.7B2ZT36/\
M@I<';4+>.QT<V(=SJ)(7$>1\[-][?/\ =!X_ U]V:EX.@U73;JXT;4[R/[=
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M#/F>'M8NK, ^R+)L_P#':%^#?C/28ROA_P"+_B"-,D>3K]E:ZFAYZ$E$?'_
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MHS\Z_P 0]11<7<!@D FC)VG^(>E27"KM7@??7M[BBX5?L\ORC[I[>U #(;N
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M6O8%5?.?@=!V^M,D4?:H>!T;M]*S^JTOLJWHVOR:.O\ M[,)?Q9J?^.$)_\
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MONC_ 'E_F*)_]3)_NG^5 $=NTGV>+"K]T?Q'T^E+"TFUOE7[Q_B/K]*=;?\
M'O%_N#^5+#]UO]X_SH BC:3[5+\JYVK_ !'W]J<S2>='\J]_XC_A2Q_\?4W^
MZO\ 6G/_ *Z/\: (KEI/+&57[Z_Q'^\/:GR-)Y;?(O3^\?\ "BZ_U8_WU_\
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MM(.,MI]U#=C]'5C^5*WQ:\-V\B_VE#K.BG!R-1TZYC Z?Q!2/UK?M?%T,UT
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MJCY&;H'^4_,:U--\.6=W:P30ZK\0[43"W<))-<!E\Z5D 8,IP4*[G!^XI!;
M-$Z=!2:C/3T'AL7FLJ$)U\*E)I72GL^JU73U?J>JK:Q^=(/F[?QM_C37M8_M
M,0^;&UOXS[>]>4KIA1&DC\0?$9 (I)=K6Q<X2;R2N&A/S$G<%ZE/F''-37EA
MJ=BTQC\4^-G\@76<:5'-N\E03M_<_-OSA,??((6H]G3_ )U]S_R.KZYBU\6%
ME\I0_62/4I[6,*OWOOK_ !MZCWHN+6,02'YONG^-O3ZUYC]E\2FY\B/QAXB'
M^D) 'N/#\)3)A\X-N\L?*!\A;IO^3KQ47VCQ@T,)7Q3JI$ZVV!<>%!\OG[L;
M\$;=FW]YG[F1NQFCV4/^?B_\F_R%]?Q/_0'4^^E_\L/5(;6,PH?F^Z/XV]/K
M1%:QE3][[Q_C;U^M>56NM>-?L:3+K-PR^4)-D_A&=7P9?*Q@2_>R-V.NSYNE
M.F\2>.[.&X8S6]PL*WCLO_"-7FYQ;L%<*%D^8OG,8'^L )7.*7LH])K\?\A_
MVA67Q86HO_ '^4V>H1VL?VB4?-C"_P ;>_O3FM8_.0?-T/\ &WM[U\Q^&=>^
M)5M\1+[S;*\DLEFFCB:ZT^Y^QG:GFHR!1OVE<JI;JWR'YJ]+MO&WQ!NKBW0:
M-IVZ3R K2V5]$J^<A=2Q*' 4+A_[C$ \FMZN$]FTE-/YGF8#B#Z[3E4>%J1L
MVOAOMUTZ/H>GW5K&L:XW??4??/\ >'O3Y;6,1O\ >Z'^-O\ &O*I/'WC^2UA
ME;PQ9N'%O*%\J\5AYDWEJ"##P5/S./X4^8\5+/\ $7QY%:W$C>#(9A%'<.5B
M>YW-Y,@C8*/(Y+$[D'\:_,.*P]@_YE]Z/3_M2GUI5/\ P7/]$>H16L9C3[W0
M?QM_C3+>UC97SN^^P^^?4^]>9S_$WQQ8R/$W@!K@QM,FZWN965O*C$A*GR.0
MP.U3_$P*CD4MC\3_ !G(T<8^'%T?-G2,,;TJJF2,R@L3%PJCY6/\+_*>:?L)
M=U_X%'_,/[6H=85/_!57_P"0/35M8_.<?-T'\;>_O39+6/[1"/FZ-_&?;WKS
M&'XO>+9/+D_X5=K($R6KX\]05\]V1005&"A&9!_RS4AFX--N/C'XDA5;B3X7
M>(BJ1R2;86C=B%E$1 7J6)^8#J4RPXI>PGW7_@4?\Q_VKA_Y*G_@JK_\@>IR
MVL84?>^\/XV]?K1-:QB%S\WW3_&WI]:^>_BI^T5XH\*Q6[6_@[5M)?SIXG%]
M;+.DGD@,2FPDD-G"-T?&%R0:[/2_C-JUQIMHLW@#Q5=23!4-S#;0F)F:'S=P
M(D "8^7)_B^0_-Q6LL'4C!5+JS\T<%+B+!5L54PB4^:"3?[N?7Y7^](]0M[6
M-K>(G=]T?QMZ?6B*UC(;[WWC_&WK]:\YL?C1=2V]MGX=>-8_,6WQOTZ,%?-!
MQNS)QMQ\^?N9&<4D?QP,<+.WP]\=#Y/-V_V-DX,OEXP'^]GYL==OS=*Q]C/^
MFCTO[3PU[7?_ (#+_P"1/14M8_M,H^;&U?XS[^].:UC\Z,?-W_C;_&O.V^-D
M4$MP[^"/&WRI*2JZ$[$^4<'&TG.[/R_WL'%/D^.%BMR$?PEXT0K(\6?^$=N"
MO$>_.0/ND?*#T+?+UH]A4[!_:F#ZU+>MU^AZ!<6L:QC[WWU_C;^\/>GR6L?E
MM][I_?;_ !KSUOCCI$RQ*^@>+(-\D S+X=NP%W_,,_)P%QAO[I(!I@_: \.R
M0JS:5XIAWQ(^)?#EZI&]RF"/+X8?>([+R>*/85?Y6/\ M3 ]:T?O1Z)#:QF%
M#\WW1_&WI]:CM;6-EDSN_P!8P^^?7ZUYK?\ [1WAC3=-GE6R\03R0032B+^P
MKP>9Y;!=H/E?>;[RC^)03TJ'X7_'ZT^(3:H+?P]JUM'92R!W$#3;B$,G&U>C
M $*?XF&T9-4\-64'4<;)&,<ZRZ>)AA(5E*I.]DM=M]5=*WFSU1;6/SF'S=!_
M&WO[TC6L:S18W=_XS_C6-!XR@FOEA&EZPADEA@#OITH0&2$RABV.%4#:S=%?
M"GFB/QA#<?99!IFKH)8[>0+)I\JE?/<H P(X*$9<'[BD%L US'M&9\&1M^'>
MG =!-=?^E,M%'P:_Y)WIW_7:Z_\ 2F6B@#MJ*** "N6^)G_(E7_^_!_Z.2NI
MKQS7_#7B?3_ =VMSJPM-M_;23I)F]-T@:-9,,Y'E>8^7&,[<]* /7T_UTGX?
MRKXN_P""C7CKQCHMY\+]!\.:3'<V-UJDE_=327D$3W)AC8?9HT=@2=CNY;&!
MA,'.17V6L<WFR8F Z?P?_7KYE_:>_8LC_:/^)GA7Q/=^*[S2SHMNL4-K"J[
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M\-8->U.]O;K5K_?<?*BJ(O\ 1XS&T;QQDH2%97?.<G+9SD+@ L?V#XF=0?\
MA*XR.H_XED?_ ,561XJ_X2'P_H\T\GC*S@GD5H[?[5IJB-I=I*AB&R%XR3V
M)-=]%&L,21H-J( JCT K)\3^'?\ A)K.&V>^N+.%)EED2$(5G49_=R!E.4)P
M2.,X&>,@@'*>$3XDU[1X6/C&QDOX$2*]CL].4QQS;06"DL"4R?E;N,&MH>'_
M !.O3Q5'Z_\ (,3_ .*K1\->'/\ A'8;M6OKC4IKJ=IY+B[">82<  E57(
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M\D\9C%U:E1+%G^)2P(!_"L#PU\.=/\+ZP^IV\TTER]LMLVY8U4J @S\J@_\
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M&#[)X%\.W'AG06MKN2.6[GO+N^F\HDHKSW$DQ5<\X4R8SWQGO70T4@"BBB@
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IHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>mrna-20201231_g16.jpg
<TEXT>
begin 644 mrna-20201231_g16.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $_ D,# 2(  A$! Q$!_\0
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M]X76PN%DFU:YU>>^BU)O$$^H2-J(N(D:.)UFS\H5'= @ 3;(X*G>V0#G+?\
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M"?B3PCXK\-:K9/J&E>)[AKO4DFE.YYC'&@D5AC8P\F-@1C#+D5H^%_ACX?\
M"=EK-K9VK31:PR&]%TYE,JI;QVZH<_P"*)%V].IZDT =/#-'=0QS0R++%(H=
M)$.592,@@]QBO,+/7O%L?[11T;4K^S'AF?P_<WEEIUI$=ZM'<VR>;+(W+.1(
MP"J JC^\3FNE\!_#V/X?K]DLM4OKG1H-.L]-LM/O)GE%LEN)%W!F)RS*Z G
M)\I<Y-:TGA73Y?%UOXE9'_M6"QDTY'WG;Y+R)(PV],[HUY]J!'FOQ8^/.I_#
MG7/$-I8^$TURQ\/:%;>(=2NFU,6SBWEFN(RD,?E-OE MF8!F13D@LN!NKGX]
M:_'X@D\)R^#K)/&KZE%8VUBNM,UD\;VCW7G27/V?<FU(G4J(F.[: 2#N'=>*
M/A7X?\83>(Y=2@FD?7])BT2^\N8KNMHWG=57'W3FYEY'/(]*Y?XI?!V37KHZ
MWX=MK5_$,FH6][+)=:E<6+CRK>6!3!<0JYA?;*0<QR*Z%U*_,&4&<+XX^-WB
M/Q%\/+J\TJ"3PEKFFVGB:\O8(YTN=@TQ)K4 .4 (:YDMY!QR(R.1FM_PU^T=
M/XL\.:+=^'="CU>;6M5;1-(:]U#[*+N6&"66ZGG B=K>-1!)M!5G?Y3L4,#6
MA\,_V==.\+^ M6T;799-0O=<M;ZTU%H[J61$ANKJZN)(XY)/WC'_ $HJ96^9
M_+1B >*=\0/@7'=(VH>$[6WBU>34+6_F2YU*XL09(;>2W$T,\*N8)S&ZHS^6
MZR1H493D,H!V'PM\=W7Q"\.75_?:1_8=]::E>:9<68N1<*LEO.\+,L@5<JQ0
MD<#@BNQK@?@C\.;GX7^ UTB]N%N;Z>_O=2N&2>2=5>XN))B@EE^>3:'"^8^"
MY!8@9P.^H$%%%% !1110 4444 %%%% !1110!YYXN_Y+1\//^O/5O_0;>O0Z
M\R^(%]_9OQ<\ W/V>>ZV6>J_N;9-\C9%L.!WZY_"NU\+^)K?Q9I<>HVEO=06
MLJJ\3747EF12 0RCTP: -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *KWVH6NEV<MW>W,-I:Q#=)/.X1$'J6/ %0:Y9W>HZ/>VMA?MI=[-
M"T<-\D2RF!R" X5OE8@\X/!Q7S!^T1\ ?BGXL\ BWM_'5UXW,%RD[:/+8VUE
MO ##<K)C<1G[K''4CD"LJDY05XQN>UE>!P^.K1IXC$1I)NVM_OVY?ODCZET_
M4K35[.*[L+J&]M)!F.>WD$D;CU# X-6:^2?V;_V??BGX2\%7,=QXUNO @N;D
MS+I,=E;WIQM \QB^0A./N@] ,\U]2^'K"]TO1;.TU'4FUB^AC"37\D*Q-.W=
MBB_*N?04J<Y32<HV*S7 8? UY4\/B8U4G;2]_7;E^Z3,WQI\1/#?P[M;.X\1
MZO;Z3%>3?9[<SYS+(%9RJ@ DG:K'Z U1M_C#X(NO"5QXGB\4Z6^@V\WV::^^
MT+LCFR (F[B0EE 3&X[A@<BN/^.F@^(-<\<?"4^';G^SKNWUR[DDU%[$W<5J
MATN\7=(@91ABP0$L.7'4\'DO$_PQO/AOXE\->.-5N;_QB!XG?5_$4UGIQ)BW
M::]E;SQ6D09BD.(P<;W&]GR=O&QX9[!I?Q:\&ZQX:U+Q!;>)-/\ ['TUBM]=
M33");1@ 2LP?!C.&4X8 D,/458\&_$GPS\0OM@\/:S;ZE)9E1<PIE98=P)0M
M&P# , <$C!P<9Q7BWC_6(/B"I\3:!X,U&YT;1=?T>_U'4!IDD5SKD,#2%Q'
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MOZ5TGPO_ .2;^%_^P9;_ /HM: .GHHHH **** "BBB@ HHHH **** "BBB@
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M3V93U5AZC!H XOQ)XXL_A_J_BW4[I&N)BEE#:6<7,EU.RR!(D'<D_D,GM3_
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MWJEO+(WEQK'' /,D=P9)BV(Q@XY')SCI7G?PIU+XE>"/B%>ZOXDTWQ/JNEP
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MX0?^BUH H^,/^0SX-_["[?\ I'=5T]<QXP_Y#/@W_L+M_P"D=U73T <QH?\
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M F>.YKNJ*0PHHHH H:]_R ]1_P"O:3_T$U5\&_\ (GZ%_P!>$'_HM:M:]_R
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MV\<Z)\?+G4O"FGZLGVM( DUE:NR3LL0#\A2"0"03V%,1]@45YC_PL3Q[8_\
M(0^&-PZ#K)INKP3Y^BG::9<?'F#3[>1]2\%^+M,**26GTHM%D#^^C,,>](9U
M/@__ )#GC3_L,+_Z16M<)^TY\4G^'G@;R+">Q?5=1<VQM;G+.8&1P[JH8'@[
M1GIS7!?#GX\>(?B=XAU[1O".BVVEZEJ<_P#:+W]_<^;'90K#! S; H\QLH"!
MTRPR, FO4?\ A5.D^$/!_B6^G:37?$%U83M=ZSJ.))Y3Y;<+GA%'95Z8'7%,
M1SW[+V?%GA^_\;ZH?M.OW\YLS,?NPV\04)%&/X5[GU/)S7N%9_A^".WT.P6*
M-8U\A#M10!G:*T*0SF/AO_R*%M_UWN?_ $HDKIZYCX;_ /(H6W_7>Y_]*)*Z
M>@!LG^K;Z&N"T/PM9^-O@;HVAWZYMK[0K6)FQDH?)0JX]U8!A[BNSU32;/6[
M-[2_MX[JV<@M%(,J<'(_6HM#\/Z;X:LOLFE64-A:[MWDP+M7. ,X^@ _"@#R
M7PYXTFOO"^AVWB"58=;\-ZTMCJK.>\<,I$WNKH V>_-;WP)M)M1T/5/&%[&R
M7WBB]>_"O]Y+8?);I] @R/\ >KP7]L+4)O#OC^--/8VRZQI<9O@AQYQ5Y$5C
M[A"5SZ$BOK#P@T;^$]$:*%+>(V,!2&/[J#RUPH]ATIB,_3?^2D>(?^P9I_\
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MNS*I)P<#)':NG\%>$[3P+X6T[0;&6::TL8_+CDN""Y&2>2 !W]*I_P#-3/\
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M? QOE.-3:_Y=RW5])<NV_P!H^L*Y6>>*U^(LDTTBPPQZ,7>21@JJHFR22>@
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MJPCRSJ-*.^D;VE+5O66L5Y<WDSO--TRST:QALM/M(;&RA79%;VT8CCC7T50
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M9/W1]%%%=I^?A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$"R$#T&14]CI]KIMN(+.VAM(0<B.",(H)Z\"K%%,Y^>3CRMZ!1113("BBB@
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M(^[UYX] HHI17*57K.O)2<4K)+3R5E^ 44451SA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<)X5
M^,_ASQAX@32;#[<CW"W#V-W<VCQ6VH+ X28V\A&'"L1Z;@=R[EYH K^+O^2T
M?#S_ *\]6_\ 0;>O0Z\\\7?\EH^'G_7GJW_H-O7H= !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?//PM\!^*+
M&^^&6@ZEH-UIEKX!MKR"XU>::%H;]C$;> P!79R'1C*V]5VE0#R:^AJ* /++
MKX%W%]K&GZK/\1_&+W]@DL=M-OL!Y:R!0XQ]DP<[%Z^E9/Q#\!^*] T"UNM'
M^(WC*ZNY-7TNT=-EA)BWFOX(;A\"TXVPR2-NZ+MR> :]IK@_'GQ!U;0_$ND^
M&O#6A6_B#7[^SNM2,-[J!LH(K:!HD8F012$NSSQJJ[<'YB6 7D @_P"%4ZM_
MT4[QE_WUI_\ \AUE_P#"I_%W_"39_P"%H>*/[!^QXVYL/M'VG?U_X\\;-GXY
MKN? ?C"S^(/@O0_$VGI)%9:M9Q7L4<P DC#J&V,!T89P?<&MZ@#SS_A5.K?]
M%.\9?]]:?_\ (=9?ASX3^+ET^4:Y\4/%#7OVNZ*&S-AL^S_:)/LP.;/[_D^5
MO[;MV.,5ZO10!Y1XF^$_BYM$N!H/Q0\4+JOR^2;TV'E??&[=BSS]W=CWQ6I_
MPJG5O^BG>,O^^M/_ /D.O0Z* /*+CX3^+O\ A)]/,/Q0\4#019W(NU<V'V@W
M.^#[.4_T/&S9]IW9YR8\=ZU/^%4ZM_T4[QE_WUI__P AUZ'5;4+Z'2]/N;VY
M<1VUO$TTKGHJJ"2?R% 'C_@7P'XKUJ/73JGQ&\96YM=7NK6V^2PCWVZ,!&_-
MISD?Q#@UI>*OA/XN;PSJX\/?%#Q0FOFSF&GM?&P^SBYV'RC)ML\[-^W..<9I
M/@+\;KCXUZ6^HFU\-VMO]F@G-OH_B0:I=6[2KN$5S&((Q"X'!&YN0P[9KUB@
M#SS_ (53JW_13O&7_?6G_P#R'67J'PG\7'7-*-G\4/% TH>;]O$QL/-/RCRO
M+Q9X^]G.>U>KT4 >>?\ "J=6_P"BG>,O^^M/_P#D.LO1_A/XN6^ULZG\4/%#
M69O%.F"W-AO%MY$.1+FS^_YWG].-I3OFO5Z* /,=6^%'B-M)O1IOQ/\ %BZC
MY#_9C<&P\L2[3LW8L\[=V,X[4[3?A1XA&FV@O_B?XN-]Y2>>83I^SS-HW;<V
M><9SBO3** /%O%_@/Q7I.L>#[?3OB-XRGMM1U=K2_?98/Y5N+.YE#9%I\O[V
M*)=QX^;'4BNF_P"%4ZM_T4[QE_WUI_\ \AU@Q_M%0-I?CZ_D\,ZI:1>&I[6V
MM8+T>1<:E)<!!#B-AF$/)(BC?S@[BHZ5UGP_\>:AXEU7Q!H>NZ1;Z+XAT5X#
M<6]E>F\MY(9D+Q2QRM%$Q!VR*0R*0T9ZC!(!SMC\)_%PU[5#=_%#Q0=(*P_8
M5B-AYP;#>;YF;/&,[<8]ZU/^%4ZM_P!%.\9?]]:?_P#(=>AT4 >4>%OA/XN7
MPUI0\0?%#Q0^NBUC%^UB;#R#/M'F&/=9YV[LXSSC%&O_  G\7-'9?V/\4/%"
MR?;(3=?:C88-MN_>A<6?W]N<9XS7J]% 'GG_  JG5O\ HIWC+_OK3_\ Y#K+
MM_A/XN_X2>^,WQ0\4?V!]CMQ:JIL/M N=\WGE_\ 0\;-GV?;CG(?/:O5Z* /
M//\ A5.K?]%.\9?]]:?_ /(=<S\-_ ?BOQ#X0M;_ %GXC>,K749);A7BV6$>
M%2>1$.TVF1E%4^^<UUGQ.^*P^'-[X;M%T+4-7DUC5;/3FN(4*6UFD]S'!YLL
MI&,@R#;&,LQ[!0S#F[CX^&3XT7G@&QA\->98W5O:SMJ7B06M_*TD$<[FWL_(
M<R[8Y%/WUR<CC!- %KQ)\)_%S::@T/XH>*%O_M5L6-X;#9Y'GIYXXL_O>3YF
MWMNVYXK4_P"%4ZM_T4[QE_WUI_\ \AUZ'10!Y0WPG\7?\).I'Q0\4?V!]C(9
M<V'VC[3O&"/]#QLV9]\XK4_X53JW_13O&7_?6G__ "'7H=% 'E'AWX3^+EL9
MQK?Q0\4-=_;+HQ&S-AL^S>>_V<'-G]_R?+W=MV['%'B?X3^+FT&]&@?%#Q0F
ML;/]&:]-AY(;(^]BSSC&>E>KT4 >>?\ "J=6_P"BG>,O^^M/_P#D.N9U;P'X
MKM?B%X=TNW^(WC)](O+&^FNY]E@=DL;6XA7?]DPN1)+P>NWCH:]5\4:O<:#X
M=U+4;33+C6;JU@>6'3[3'FW+@?+&I)P"3@9/ SFO*KCX]ZSI.IZCX<U/PK9)
MXRBN=-MK2QL=8:>RG:]\\Q[[@VZ-&46VG=QY3$*%*[MX% '3?\*IU;_HIWC+
M_OK3_P#Y#K+T7X3^+ENM7_M3XH>*&MS>9T_[,;#<+;RH^),V?W_,\WIQC;[U
MU7PW\<R^.-+U(WNGKI.L:3J$VEZC91W'VB..>/:V8Y-JET9'C<$JIPXR <BN
MMH \M\0?"?Q0V@ZD-&^*'BI=7-M(+)KLV'DB?:?++XL\[=V,XYQFK5K\*=<^
MRP_:/B?XP,^P>9Y;:?MW8YQ_H?3->D44 >4:I\)_%QU;1CI_Q0\4#3A-)_:0
MG-AYAC\I]GE8L\9\S9G/\.:U/^%4ZM_T4[QE_P!]:?\ _(=>AT4 >4:7\)_%
MPU;63J'Q0\4'3C/'_9H@-AY@B\I-_FYL\;O-\S&/X=O>M)_A5JZHQ'Q.\99Q
MQSI__P B5Z+7E_Q*^+6N_#V;4K\>$DN_"VDBV^VZG<:CY$\QE<*5M(1$PF9=
MRY#/'EFVKDT =)\)-0U;5OA3X+OM>\XZ[=:+93ZA]HB\J3[0T"-+N3 VMO+9
M&!@\8%=97C_AKX^'Q9\7-5\'6,/AI8-.OI;*3S_$@759/*C5I)$L! 24#DID
MR#[K-[5[!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7G/Q!\)Z__ ,)EHGC#PO/I(U6SL+K1Y+76
MI)(X)8KB2!U<.BL=Z20+A<8<.PRIP1Z-7P!_P5 _:1U#X:ZI\._"OAN\\C6+
M6_B\3W6T]!"Y%LC8ZJSB0D?],U]:!GVU\-?!<?PY^'WAWPO'<M>C2;&&S-TR
M[3,R* TA';<<G';-=+7.?#GQUI_Q-\!>'_%FE-NT_6+**]B&<E0Z@E#_ +2G
M*GW!KHZ!!1110 4444 %4=;L9-4T74+*&9;::YMY(4FDA698V92 Q1N' )SM
M/!Z&KU% 'EG@#X=^([3QU%XI\3G1+:[L]#70;>VT$/Y4R>:LC3/O5=G**$B
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MP!7C.A?!?Q5I_ARTM)F\.P^)=-U>W\0VM[]LN+B75;I0T=P]Y(\:MEXY-@9
M0F5 7:BI7T#7YN^*/VRO[._X*2V4(OL>#+$?\(9<?/\ N]SN#),>P*W.P%O[
MD7O0,^[OA=X,U#PCI^M7&L3VTVM:YJDVK7JV6XP1.ZI&D<98!F"QQ1KN(&X@
MG"YP.THHH$%%%% !117D7[6'QC7X$_ /Q9XKCE$>IQVQM=-!ZF[E^2(@=]I.
M\CT0T >M0S)<0I+$ZR1. RNARK ]"#W%>.>.OA]X^\2?%2UUN-O#FJ^&-+$,
MFDZ3JEQ<1K!<@9>ZD1(RLDH)Q&6.$ R &)->/_\ !+[XT-\2/@"_AJ_N3/K/
MA*Y-HQD;<[VLA9X&)]OWD?TB%?8U ]CQ^\^%GB?6O%FEIJ-QH*^'-+\1OXCM
M[RS@:*_E8B39 R!0@(,FUIMQ:1%P5!8M7L%%% @HHHH **** "BBB@ HHHH
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M>)H]#M;B[,T]U/8VUY)8S)9W5S ',T,5P5$;NGER9 //ER8SL;%7XF?$S4_
M^O\ A+3K+P]-J%KK&J6]C=:I)*B6]HDKE0 ,[WD)'"A=H&2S#@, >AT444 %
M%%% !1110 445\\W7C/XD76E?$SQ3I7B+3!:^%-4OH;?0;S2P8[F&VC60HTZ
MN'5F!8!\$*<'##B@#Z&KYKBT:/\ X>&SR_85^R_\*P7Y_)&SS/[5)ZXQNQ^-
M=M#^TAI%RHO8=!UB;P[#/9VE_KR+!]FLI[E(7C1E,@E8*+B$.R(RJ7Z_*^V#
M3?VI/#-[8^)]3FT[4;71- ANY;C4=]O*,V\OE/$\4<K2PR,WW$E1"PST((H&
M>RT5Y[\+_C3I/Q0U'5M,MK673M6TR*"XGM);JVN?W,V\1NLEO+(AYBD4KNW*
M5Y&"I/.P>+O&VD?%OP]H6HZKI.J-K$][+>:%IUHW_$ITU$E-O=-.6W%F=8(V
M#J S3-L $9H$>R445C^,-8E\.^$M;U6W1))[&QGNHTDSM9DC9@#@YQD4 ;%-
MDC66-D=5=&&"K#(->&^'_BIXYT2S^'^M>,'\.7_A[Q:UO;%])M)[.;3IIX&E
MB+>9-*LJ$KY9(V$%@<$9 W(_VFO!BZ7+J=W_ &IINEMITNKV-Y>V#QQZE:1E
M TMOW;_61D*P5B'5@"O- '%_LEZ6MIXM^/$CV8A/_"P+TPLT6WY/(@^Z<=.O
M2OHRO.G^.&D0Z;;S2Z/KT.IW5]_9UMHKZ>?M=Q-Y/GDQ\^6R"++&0/L&""P8
M8K:T_P <?\)?X!NM>\)6PU*]\NXCMK&^+6I^UQ,\;039!,965&1N#C!QF@#J
MZ*\P^#WQ*U/QIKGC#1-3NM)U6?P]<06[:GHT$EO#)))&6>(Q222,&C( +ABK
M;AC!# >GT %%%?.MUXB^(>H:7\4O%&F>-/LP\*ZK?0V6AW6FVSV4T5M"DHCD
M<()ANRPWA\C(.#C! /HJOFSXD:/'-^V]\(I?L*O;G0-9,K^4"NXB/&XXQGZU
MUMK^TI:WEHVK0>&=1D\,6DUC::GK EB M)[F."0*(BP>1(Q<P[V XR<!MK8J
M6?[5_A^2/Q?>7FGRVFF>&[>\GNW6]MY+J+[/*(S'-;;Q)"\A.8]PPPY8KP"#
M/<*6O,?A#\>-&^+>J:QI5H+6/5-+AM[F:.QU.WU&$Q3&0(1- S+N#1.&0X(X
M/(92>?\ #OQGU'Q=^T%I^BZ?/:#P-<:/JIMW&TS7MY:7-C&\RGJ(A]HEC4#[
MQC=N5*&@1[=1110 445XY>?$#XBZQXV\>:;X5TOPY>67A>XM[=;;4IIX;B]:
M2SAN2HD4,J<R[02IZ9- 'L=?-FIZ/&W_  4"T>7["IMO^%=7&Y_)&SS/[14\
MG&-V/QKN--_:>\$7_AW2-8::_BM+W2[35[J2.PFFBTN"X7,9NY44I#T;.X\!
M2QPOS5OP?&SPK/KE]IOVF[B2RDN89M2FL9DL1);J6N$^T%?+W1A6SS_ P&2I
MP#.\HKCO!/Q7T#Q]>2VFFF_M[M;9+U(-2T^>S>:V<D)/&LJ*70D8R.1D9 R,
M\#HWQ[N==^,FJ>%8[OP_8Z99ZLVDQ+=M<"[NY$MXY)!&P7R=X=I (RVXK&6Q
M0(]OHHKC/C%XXNOAM\,O$'B6RM8;V[TZW\V*WN&*QNQ95 8CD#GM0!V=9?BB
MVCNO#NI)+$LP^S2$*ZAN=A_6O.!\6-=\">*+;2_B/;:'INFWUA=WUMK>E74I
M@C^RHLDT<Z2H"G[LEPX)!"."!@9TX_V@O!K65U/)/J=K/;FV T^[T>[@O)A<
M.4MS%;O$)) [!E!52 5;.,' !PW[!.G_ &']DOX>"2V^SW)LYO,#1[7_ ./F
M7&>_YU] UYY=?'CPE:V%A<^9JL\MX+ATL+?1KR6\C6W<).\ENL1DC5'(4EE
M)90,Y&7?$GXP:9X)^&=OXOLI['4+34'M(]/N)[H0VDGVET6.5Y<';$%?S&8
MG:IP"<"@#T&BN&^$/CZY^(7AV]OKE])N#;7LEHEWHMT9H)PJH=VU@'B<%BK1
MN,@KGD,#7<T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\*U\*_"N7P?I^J?V7/)%<8U/1;&#3_L\LKL_F0PQKL0*S?*"&X4;BQR3WM%
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M&1U,>Q2N2"3[E10!\VM^R;?1PZ3=_P!N:;JNJVD-Y:^1K=G<W=G!!/,LL:0
MW(E40E< -(P8,PPOR[?1]=^#,.H?"?P_X/L[V&TN?#[Z=<Z=>M9)Y*W%G)')
M&S6Z%5V,T>"BE<*Q"D$ CTNB@#B?AMX%O_"=QXFU36+^VO\ 6_$6H+J%V;&W
M:"VBV6\-NB1JS,QPD"DL3EF)Z# ';444 %%%% !1110 4444 %%%% !1110
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HB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>mrna-20201231_g17.jpg
<TEXT>
begin 644 mrna-20201231_g17.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #9 @<# 2(  A$! Q$!_\0
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MSL^7[O%27WPA\&ZA_8XF\/6?EZ3#';V<4:F.-(4962(HI"NBLJL$<%01D#-
M'-:S^TOX)\/_ !0M? 6HOJUIKMW>Q:?;R2:3<_9);B1 Z(MQL\LDCT/&#GH:
M]5KP#]K#_D,? G_LI.G?^DUW7O\ 0,****!!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M6;XD:Z7P[JIL?M'VT6DI@^QB,S>9L.WR_,^3=G&-_P N<9XS6E10!\::3X'U
M#5M=LGU'X<?&NWU2XG2.3Q)<^.8U>W#, 9#'%>B,*H.2JQ8P,!>U?77A_2Y]
M%T6SL;G4[K69K>,1M?WPC$\V.C/Y:JN[&,D*,^E?%(M+76?VEO%$^HZ-IFL7
M-KXMBBM[S6?B+<:;>VR*L!58].0E)$4DF-2!O! /<U]ST#"BBB@04444 > ?
MM8?\ACX$_P#92=._])KNO?Z\ _:P_P"0Q\"?^RDZ=_Z37=>_T#"BBB@04444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_:@^+GB+P+XT\(:%H_BM_"EGJ5C>W=Q<V/AB77[MGB>!44P1D%(R)7_>8/S
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M6HLO$6AKH?B.2XL6+SIYUS+++;@2 1L_VVY7#;@H,9R=A# $?[6'_(8^!/\
MV4G3O_2:[KW^OD_]IGX2^'=#^,'P@\=6D=\/$&J_$+3;:Y>34)Y+<I]FG^[
MSF-#^Z3E5!Z^IS]84#"BBB@04444 %%%% !1110 4451UBQN=1L6@M=1GTJ8
MD$7-ND;N,'D8D5EY^E!44I-)NQ>HKD/A3<ZGJ?@'0]5U;59M4O-3L;>]=I8H
MHQ&9(E8HHC5?ER3UR?>NOI)W5S2M2=&I*DW>SMI_P;!1113,0HHHH **** "
MBL^WU_2[NZ%M!J-I-<$D"&.=6<XZ\ Y['\JN^8BM@LH/IFD5*,HNTE8?1113
M)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO/&1BO,OVJ/":Z_XT\'W&J?"R;XF^&X[.\@GCL[R.UGM+EY(/**L]Q$K!@)
M5P3D Y'0^U_"^QM--^'N@VMAX9?P=9PVJI%H4GE[K-1T0F-F4GOD,<YZU1@?
M--QI[1_$2\UT_#GXX:=XEO-02_N=-TC7(UT>>==@&76[6!HR$53NQE1@CM7U
M?X?N]0O]%L[C5=/32M1EC#364=P)Q"Q_A\P !B!C) QG.,]:\+_X:$\6:I\5
MM6\.:=IW@FQTG2]:329?[;\3FWU.5<1EI8[81'.X2?(I;YL#IGCZ$H$%%%%
M!1110!X!^UA_R&/@3_V4G3O_ $FNZ]_KP#]K#_D,? G_ +*3IW_I-=U[_0,*
M^&/VS_BGJ?A'XQ6-E:V&D7$5O8PW(:\L$F=RPF0HY/WD&[<%/ 8 ]17W/7SS
MKVAZM\1/VGFU3238M;>!+*.W>&_W>7-<744I8 J#RJ-&?; ]>.7$1<HJ,7JV
M?8<+UZ.$QE3$XB"E"$)-INW9+H]VU'RO<X3XS?M9>(_"OA'PTVD^'-?\,WUQ
M'B2?5+"&*WFQ&N/*)$@<9).!M(!%>\?L[>/K_P")OPAT3Q%J99KV[:X#LVS)
MV3R(/N*J]%'11_6I_BY\)H/BQX?M=.NETF.2$/B:^T]KLPEE )BQ+'M/'4Y[
M<5R'P'BN/A/KNH?"?59(G2W5]5T*[BB,275K(Y:6, LQW1R,W!8DJP/09J8J
MI"K>3O%_F=6)J9;CLGY,)14,1"7-+=MPUO9];73MT2;V1[C11178?"!1110
M5XU^UMJGB+1?@IJE_P"&+C4+34;>:*5[C3699(X0V9&)7D*%ZGIBO9:\E_:<
MGDN/A<= @=DNO$NI6>B1%>O[Z9=__D-7K*K_  Y>A[.2V698=M)KGC>^UKZW
M\K'@O[/_ ,4?&OP]^$NL3>,O!OBSQ#X>\CS+.\P62*V%N-J!7(98=H!\Q05
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MAS\JM7LO[)\-A-JVL:]?:1-!JGB67^U;:232I5C@WO<-LCF,>Q5\GRNC8.[
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M][:_C<\>_;<\-QW>H>$/$1\2>%-/GT!9-033?%TDZQ;8KNSE:Z@$"NWF QK
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MWLHH_O7BY-<M'WFO-:Q6UK.5E\SZ TO3;?1M-M-/M(Q%:VL*00QC^%%4*H_
M 5:HHK8\)MR=WN?(7[=WPE\0>+AI7BG3(X9]/TNV^S30[SYS/)* H1<<]1WK
MZ!^ R+'\%? R)-'<*NC6H\R(Y4_NEZ5>^)@W:)I@(R/[:TS_ -+8:XOX'D^!
M?$WB[X:3'9!I5Q_:FC*W\6GW#%@B^HCEWH3[BN114*SEW/LZF,JX_(H867_+
MB3:\XZ)_-.2^3?8]BHHHKK/BPHHJ*ZN8K.VFN)W$<,2&1W;HJ@9)/X4#5WHC
MQ32?#.D?%+X^>.=1UK3+35]/\/6EGHEFEY"LL8E(:XF8!@0&!=%SUKVNUM8;
M*VBM[>)(+>%!''%&H544#   Z "O*_V9;:6X^&;>(KE#'>>*-2N]=F5NH\Z4
M^6/IY:QUZS6-)>[S=]3VLWJ26)>&O[M*T$NEXI)M>K3?S/'/B3_Q;CXM^%O'
M4?[O2M6V^'-;/\*AVW6L[>FV3*%CT#@5['7D?[6,GE?L\^,VV*Y^SQ !UR 3
M/&,_4=0>Q ->4?L"^-M7\6Z7XOM]4N/M0L39B*1QF0[O/)+,>3]T5G[10K>S
M[ZGK/+IX_)'FG-;V#Y'YJZY?NYK>B78^LZ***ZCXX***Q/%GB^Q\%Z6^HZE'
M>-:1JSR26EI)<>6JC+,P13M  ZFDW;5FE.G.K)0@KM]#S/XRVLWCKXG?#[P3
M:W<EHL$TOB2]FA5&>)+<;8#M8%2#-(.""/EKT3P3X0?P;HJ:6^K76KVT:A(?
MMD<2F-1GC]VBYSGOFO//@W>+X]^)GQ!\<A)1:K/%X>TX7$9CD2.W7=/\I&1F
M:0\'^[7LU8TTI-S[GN9E4GAX4\OZ0BKZ+XG[SUWNN;E^15M=+L[.0R6]I!;R
M$8W1Q*IQZ9 KXQ^(G[.NI_"_XM)\6[S5+>]T!/%*:G>PV\3>;:6\ESO,C?W@
MNX X]<U]L54U32[76M-NM/OH$NK*ZB:">&0961&!#*?8@FG4I*HM>@LISBOE
M=64H.\9KEDNKCU2;V?9G(^,=4\26^M^&X]$U;2H=/UB[-H/M&G/<,F+6>?S
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M;99HU42+^[B1OGA0IMSM.1QGFO<Z*B4%-69Z&#QM7 U%4I_-66J[/R>S./\
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M7TMO\%]<L;5L7FL/;Z3 /[S7$R1D?]\LWY5Z;8646FV-M9VZ[(+>-8HU]%4
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M'M@BN:D_><?Y=/Z_ ^GSJG*.$IXA*RKR<_\ R6-__)G-+R)J***ZSXP****
M"BBB@#R+XL?\4S\6?A?XH'R0S7L_AZ[8?Q+<QYA!]A+$/^^J;\)_-U;XD?&+
M7K<(SOJEOI4/F$A=UK:J,$CG&^4Y^IJ3]J@V]O\ !/7+Z6ZBLKK3W@O[*:4X
MQ<12J\:CW8J5'^]63^R-XFL/%GPZU35K>XC?4-2UN^U*^ME;+V[S3,45O?8J
MGZ$5R?\ +[E^?X6/M(QE+(WB[;?NGZ<ZJ)_I]R['H'@71?$6C7VKMJXTO[/?
M73W@-E+(SJ[!%VD,@&,*>>OM78T45U)65CY&M5=:?.U;T"BBBF8A114-Y=)8
MVD]Q(LC1PQM(RPQ-*Y &2%1068\<  D] *!I-NR/G?Q<I\$ZAIWQ+@&V/1?$
MM]8:N5_BTZYN"CLWKY<GEN!]:[+XE,-4^.'PBTX$20QR:EJ<@'(_=VP1#_WU
M+^E7?"5OI_CCPWXL\.ZAI^J0VVIW5\TBW^EW-JKP32, RM+&HW8;. <CTXKP
M_P#9_P#B3:^(/C3H.B:SJ<,NJ^&_#]UH$4A;B\N$NL!XS_%F"%6)]S7"VHM+
MO;\#]"I4JF(A5K<KYJ$9IZ?9G&7*_P#MV3EKYKL?7]%%%=Q^>!1110 4444
M%%%% !1110 4444 %<OX[\'R^+AX>\JX2W_LS6+;4WWJ3O6+=E!Z$YZUU%%
M'S'\?/V8?"'Q ^*7A'4-1N-<-YK6JRF58]9N4@BDBT^=HWCB#[8R#&O*@$Y;
M^\:X+X7?L'36_B[5&\5:\TNCVK&&#^PK^:UN9\JIWL\;!H\'(V$G. :^FOB!
M_P E"^&'_86N_P#TVW5>*?LRZ;IEG\1;M+*\>XMI--DDLKJ+2$LC.KV^F,YF
MD%Q(TDWE_9)B?+0%[J4YW;D3*5.,Y*36J/7PF:XO!8>MA:$K0JJTE9.ZU[[;
M]"LW[$NEGXO),NN>)O\ A7G]B-$T/_"6WOVC^U/M*X.?,SM\K<,9QGM2>/\
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M_!O]B?21\,=#;Q]KWB6\\6K$_P#:5QI_BZ]^SLXD;!4K(!@+MS@=0:]+UOX
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MOV(=-F\ :G#\/]:\3VWC!C";)[[Q9?&(*)X_.R&D(_U6\#CJ16!\1=#\+/\
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MOA3X0>$/ ^JRZEH>C1Z??2@^9,DTC%\@ DAF()PJC)YP!794 %%%% !1110
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MG_HAZU_"O_(L:/\ ]></_H K(^+'_)+/&7_8&O/_ $0]:_A7_D6-'_Z\X?\
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MA\1[[XS>&?!FM^([NY73M!TOQ)XIB&H++-9:B+$VLFGR[&(5)93'=[<X;:Y
MPW(,^K9M3L[:[2UFNX(KJ2)YTA>10[1H5#N%)R54LN3T&X9ZU#HOB'2O$EN]
MQI.IV>J0(_EM+93I,JM@':2I(!P1Q[UXI\2/@W>ZI\:KSQ3I6EW5PFI>"-8T
M>\NHM1$;FXD:S%M#%YA80Y6.8AEC*!MS,"6YM_LI^!=:^'_A?7=-OM%NM T/
M[=&=&L=4%G_:"0BVA60SM:?NW_?+)M));:!GL "/<*\_\>?\E)^&7_80O?\
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M4W"[E<JJG&[((^@J*** "BBB@ HHHH **** "BBB@#@/B!_R4+X8?]A:[_\
M3;=5W]<!\0/^2A?##_L+7?\ Z;;JN_H **** $(]LBCI2T4 %%%% '*?%C_D
MEGC+_L#7G_HAZU_"O_(L:/\ ]></_H K(^+'_)+/&7_8&O/_ $0]:_A7_D6-
M'_Z\X?\ T 4 :E%%% !28 S@=>M+10 4444 %<!\-?\ D<_BO_V,T/\ Z9M-
MKOZX#X:_\CG\5_\ L9H?_3-IM '?T444 %)@#) P3UI:* "BBB@ KS_QY_R4
MGX9?]A"]_P#2">O0*\_\>?\ )2?AE_V$+W_T@GH ] HHHH *0@'&1G'2EHH
M**** "N.^,W_ "1_QS_V K[_ -)WKL:X[XS?\D?\<_\ 8"OO_2=Z .BT'_D!
MZ=_U[1_^@BK]4-!_Y >G?]>T?_H(J_0 4444 (    ,"EHHH **** //_AG_
M ,CA\5O^QFB_]-&FUZ!7G_PS_P"1P^*W_8S1?^FC3:] H **** $P,DXY]:6
MBB@ HHHH \_\<?\ )4/AM_U\W_\ Z2/7H%>?^./^2H?#;_KYO_\ TD>O0* "
2DP,YQS2T4 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>mrna-20201231_g18.jpg
<TEXT>
begin 644 mrna-20201231_g18.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $= F@# 2(  A$! Q$!_\0
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M./2@#[&HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPGK]B=2D'R:A9M;J;6<'^\8P5;KRIR<YK4_9O^"7B#7A\(_%=EX1T+P78:3
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M@]!5BJVFS?:--M)=K+YD2/M<8894'!'8U9KB9T!1112&%%%%( HHHI@%%%%
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MG_;-4F5=V!'<M>",XD8 DXP<D9K%IS=HN_;3IYFL6H*\D<-I?B32/'7AO1O
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MQ^[MZ\"LKXD>+_%WPO\ &VH>'M0@L4MO$T$=EX6UJUBDO(KF>09*SQ(O[N(
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M3KQ5;PM?6^M6[FY\N8[\E?O;E7 !(/3![^M<3H=JUQ?7.8Y)(HV5 V-W4 Y
MQP2,_D*ZFQTNV9&BU&XEM[D[@MPJ*JG)) QCG((I1JU)RYI%2IPA'E1NZ]:O
M??Z%I\2QP*,.SX&]'3=][G\CQR>]>2S:.&UF:W>WD2QB<Q1_OB//')R W7 [
M<9!Q7J7ARZG2*.RZQ.Y5&D/+@CD'CIZ"L3Q5X>M-*VLV\_OE"N!NED;MM/?
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M$9CM#?, .IP*\!\J?OI)]_P/>7-)>ZVUV_'[CL+/3;BX^/&OZ;_PA=OX8\/
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MF& /QK%M?C!::SXRL/&US<V-_P"&;C36U+2/%LUN(8M+CDPKP-+*=Z,_8*H
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M,DK^;(V9#_K#C@GUJ7=,>C&W!^5B>!G/%3Z#:BZUJT0#B,^8>/0=S]<5$P#
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M/)!7K^5<C>7MQ8WEHWVA[F!I0Z>8H)X!^5=PP 01CGMUKO/B%H=_!J!^QND
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MA3UQGBNN^,6O>!-<\-Z?X&T[6U@\5:G?2Z;9WT<B2W#RH$N9(XWPZ* 2!M8
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M@2*-6<N0JJ ,L223@=2237S)^U0IF^)7AN+SC%OL63Y20VTRY)!Z8R%!'?\
M"OJ&T&+2$#^XO\J\J^//PWB\96^G7[2R1R6?F0X7IM<=>H(P1GKST->3BZ<J
MU-Q6YZ.&FJ=1-['BMAJ&HL98HDCE*HD"%E&$< !PF>0"#GD\$#UQ5N>Z>1HU
M01RQJ4CD383@8QC)Z#IG/I7I-AX7MH=.ALX3$3MV[HB0>?X\9]_>LN2VN;6\
MGMIK6W6(,J>?\V]DQG'L>>G2N"6&E%*[.^->,I:(Y[6M67Q5-;1Q0^2T V;R
MH900,G&,$=/7G%;.DQK:K*MG&@FN5#S2,<'=CHH/'IGZ8K"NXT^T2O%'NCD7
M<%4<+@=SD^@)Z=SZUV'PPM(+JZ<W4R7$\JL258CH.V>G(Q6=.,I5=]32HU&G
MIL9%QIEY:[MY&7"Y,AW GT /]?2M^Q\/VU];BYF!@X$A?=AN.2#CJ.O6LWQ
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M(P%Z\TVKQ:?]/OW]?,5[-6(M4LM5UBZG$6J_8-* BDADL6(NO-5CO5B?E*,
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M1M=NQ)I=EK=H+"2QC3*-"H.&;<XSN)R<\=:Z"'3_ !-=:+XC\/>.96\=:7K
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MN5DRCS(\^A</G=DJ<XYXYJPP*QAMWL,GD5%<6C:?>26[]8R!R.#Z'\:3S-P
MZ^Y[5V&&V@[Y4A#=7ST]ZKGYW#$@,1G'XTBD3;0GS =6I?**K\W)8YSTQ_\
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M<7.J:#<+Y9CFD/F/&0V3&!G&",-CJ*W? _B&PT6WDG:]AE4Y*2;2)OE)!##
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MZ+:B92F,F2XA7UX!+'^5=XU<U;>QK3V%6EIE/K U,/Q7ISZE:P(K+M5V9T<
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M(0K%7,0< MGN!W^AKP..32-'^)45GJ&M7$,SWMJ)[JZGW6MLT3 ,82.C-A0
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MDA4JUPP^7(Z=/PK\Y?VGO#_CG3OB<;C0/MGV!@! UG(0%]<D&OI?X#VFO_\
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M2O*/C8[V^HZ%.O(59EQCCG8,FO5Z\F^.5TUK<:(1'YJGS=R]^J5RXS6C)/\
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M0>4(X'//7CI7!+VL:EELSOC[.5/S1MZQH>JO(9FC\V*-'A1PQ!(ZDLQ'(/\
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MWP9\4O#=Q<^(M+M[^.QD(*,N\%@,\>G7M5SX?_"W0]$M8M.&G)9Z0I*01Q@
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J9P@Q@9]117T]XXTV/1,/&?,.X  C "YZ8HKQ:E-\WO,]6G5C&/NQ/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>mrna-20201231_g19.jpg
<TEXT>
begin 644 mrna-20201231_g19.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #" :8# 2(  A$! Q$!_\0
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M(L[V;2Q>VUQ8S""[L-4LY+2ZMV9%D3?%( P#(ZLIQ@AO4$  ZJBBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEKTZOUTV[;_,8K#YECL10KTZKH0BW[ME)RT?Q=%Y+7>[:>BYO_A<V@P_\?\
M::YI7K]MT:Z4#ZD(1^M36OQJ\"W3!1XHTZ%C_#<R^2?R?%=K4%S8VUXI6XMX
MIU/59$##]:\_GPCWIR7_ &\O_D?U/8]EF$=JL'ZP?YJ?Z%"P\6Z'JG-EK.GW
MG_7O=1O_ "-:F[*Y7#'''/!KF[_X8^$-4_X^O"^CS'^\UC'N_/;FLB3X&^"]
MK?9M)DTYF'#V%Y/;D>X".!^E'+@W]J2_[=3_ /;D'/F,?^7<)?\ ;TE^')+\
MS9\-^,(O$6IZC9Q3:;*]@_E3+9WOG.K;5/*[1@<D?53725\[_#3]F>Z\'^)=
M9O;?QA?6<D+?9H)+"-%=E*H_[P.&4C!7Y<=1G/ KTO\ X1_X@Z;S:>+-,U8=
MH]5TO8?^^X77_P!!KNQN$P<:O+A:Z<;+=273T?YGDY9F.93P_/C\))2N]G"6
MB?\ B3^Y/N=[17!?\)#\0--XO/".G:LHZR:3JNP_]\3(O_H5+_PME+/C5O"W
MB72<?>D;3C<1C_@4!>N'ZC6?P6EZ23?W)W_ ];^U,-'^)S0_Q1E%?>U;\3O*
M*XW3_C%X*U*01Q^)+"";_GE>2?9W_P"^9-IKK+6\M[Z(2VT\=Q$>CQ.&'YBN
M>I0JT?XL''U31V4<7A\3K0J1EZ-/\B:BBBL#J"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\G_ &D)
M)?$/PUU_P3HFH1Q>,]=T^0:7IO\ :0L)KT*R>8B2Y!4%3M8K\P5B1@X->L5P
MGQHT_P"'=_X%NO\ A: T-?"L;J\DVOR1Q0Q2?PLLCD;)/[I4AN>* /$_@EX4
MTGX+^(+K7]?^$.F_!^T:S^RG6Y?&7]I+-(\B;;=8VQDL1D$#)*@8R:^IZ\'^
M!/PG^ US-'XO^&\>D^)YK9O*BU8:O+K#V;8^[&\TLAA;&.%VG!]*]XH ****
M "BF^8N\)N&_&=N><>M,M;J&]A6:WFCGA;($D3!E.#@\CW!'X4 >9:EXXL?
MM]\1K^]\Y?)ECF0I;22(2MC$0I95*@G'<BL/X*_"[0O$G[._A+2/$6CV]V3;
M^>Y9-DL<Q=CYBNN&20<?,I!XKF?VBM6M;7PGX]TN74+:RO-8UK3[&!9YE0NK
MP6R2D GD*CL2>@'6O=?"/D:=X;(#+':V\]T Q.%5%GDP<^F!7/\ '5L];+\_
M^&/JE*6"R:%>DW&4ZE[WM\$79IZ?SOKT/BO]M*'Q7\.X?#6C)XENO$>AR>=-
M;KJ$8>ZM<-& LDJX\T'HK,-W##)KZ=_9CU+3-4^#NA3V2VT=[Y>-2CA*[TN@
M3O$@'(;/9N<8JEIBWNO:7J/C1K-)SK=[:)9I<2&,PV,=R@@ &T_ZPEY#_OCT
MKH/%7PL?5-2_X2?P[>#PGXSV 27=N/,M[P#I%=1\"5?1N'7L>,5Z>)>)P_\
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M"$::Y8A1114EE34-)LM6B\J^L[>\C_N7$2N/R(KE+KX+>"KF4RQ^'[>PF/\
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MQPQ&:8$,JK+*_EC[V/FR!B@"W\+O$7A3XE_M)W?B[X9K%>>&XO#DMAK^O:=
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M"'(K%\"GXO>([+2[/6-=\60&]U/2(=<6WLKVUFM9FDE-X$GF4!8\!580 Q*
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M+73?::Y'^-X?^3G9^&)=5N+[4Q?:C%=0VUP;=$CM1&3\B-N)W'^\171U\@_
M+]LB\\6>)/$EOXB\+W<-DSF\2XT2QGO#;9VILE5 S8('W@!R#QSQ[M9?M&?#
M:\F$+^+;'3YNGE:H'LG!],3*O-13K4YQNF>IFW#N:X'$RI5<.[I+X5=;+^70
M](HK,T?Q1HWB&,/I6K6.IH>C6=RDH_-2:TZWWV/E9PE3?+-6?F%%%%,@****
M "BBF2QI-&\<BAXW!5E89!!ZB@!]%<IX'T6PTZ;69+6TA@D^W2Q;HUP=H"G;
M]/:NKI)W1M6IJG-QB[_A^K"BBBF8A1110 4444 %%%% !1110 4444 %%%%
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M#.7^%OQDU[QXOC+6-1T6UTKP]HBQ)%9QR--J#2FQM[N19,?N_E\\H-I.2N>
M:\PO/VMO&>E2Z5:W?AG1;F\\1:?I6HZ,NDSSW9B6]>X(6= H9RD=N<>7_K&.
M!M )KZ=TWPWIFBQ7J:990:9]L<23-:1K&6<1K&&X'4(B*/0(H[5Y-\/_ -E+
MPGX1AUY-7CMO%2ZO#!;3QW>EVMO$8X9'DC9HX8U5I=\A8R8SD+M"XH Y'3?V
MFO'&H7!GE\):7IVGZ4NDC6;>ZN91>%KS4)K-C H7 "^4)0),,0VP@$$UEZ7^
MUKXW\0V-O<Z?X)M;>'7+JU@T2ZU)IH8$\Z_CM=LS8S(=LHDS$" 59#CAC]$6
M/PR\):78FRL_#>F6MF8K:'R(;5$39;R&2!< =$=F9?0DGK56P^#W@?2]3O=1
ML_"6CVM]>W,=Y<7$-FBO),DOFI(2!]X2?/G^]\W7F@#YJ^*_[57CVQB\3:5H
M=AIED39ZFNE:^L4QA$]C+$DY7S !-DF4?(NV-@ 6?FNED_:.\6:;-XM@LM-T
MBZ?PQ_:FJZJVJZA)$)K6VN3#Y5KA#M8[)""^53,:G.[(]IN/@C\/[S4=3OY_
M!FARWNIK,M[<-8QEYUF0I,&..0ZD[A_%G)R:=>?!7P#J4=@EWX/T6Z6PN&N[
M7S[)'\J5BK,XR.K,B$^I52>0* //OAC\>/$WC+QQIEIJ>BZ7:>'=:N-:MM.D
MM;B0WD1L+D1;IU90O[Q<G"GY2.ISQE>(OB+XFM_V=?C9KL.M36^LZ-J&O6^F
MWZQH7M%AE=8=H(VG8 ,;@<XYS7N5GX-T+3[JVN;72;."XMI;B:&2.$!HWN&W
MSLI[&1N6/<]:YV?X$_#ZZU?4]4E\(:5)?:GYWVV9K<'[3YH(EWCHVX$YR.:
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M?Z-X;TF;0]!AL[9XYC;R31R&2Y9F(,@6"%!L !P[?Q +[/110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
K!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>mrna-20201231_g2.jpg
<TEXT>
begin 644 mrna-20201231_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X2@\17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#$Y.C R.C S(# Y.C0W.C(U   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,W-@  DI(  @    ,W-@  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C Q.3HP,CHP,R P.3HT-#HR,P R,#$Y.C R.C S(# Y.C0T.C(S      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  %I          8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ : $  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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M2?\ /W-^2?\ Q-)#(PNI;=F+[$5PQQGYBPQP/]G]: "R_P!0W_7:7_T-JL4
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MG>.]#7$A)5><+@/@$L6&22N2 .G2D\KQ )D=9F"LR[A($8A0S]<8'3;G'X4
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MP#D!AGF@"&33K.6W:W:VB\ISEE5=H/Y5)]G@W!O)CW @@[1U P#^5  +:!0
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MT]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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M  0VO_QN@#T&BO/O^&>_A9_T33P?_P""&U_^-T?\,]_"S_HFG@__ ,$-K_\
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M33P?_P""&U_^-T >@T5Y]_PSW\+/^B:>#_\ P0VO_P ;H_X9[^%G_1-/!_\
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M*>&I_%-J*]6[(]7I&K\J_P#ALCXP_P#0XO\ ^"^T_P#C5'_#9'QA_P"AQ?\
M\%]I_P#&JX/K]$_4_P#B&&=_S0^]_P"1^J7\)YKX_P#V[/'NM_#7Q=\,=?\
M#]VUG?VPU @_P2*3;91US\RL!R/;.17S:W[9'QA;KXQ?_P %]I_\:KBOB/\
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M::C)I4LT%E=6LKOOL]Y, ?<B[653MVC(PHP: /2J*** "BBB@ HHHH ****
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MM+&W7ZO(Q^\[M_$Q[G^F*Z4#%.HKI22T1\;5JSK3E5J.\GJV^H5Y_P#M"_\
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M6/&'_@)HW_ROH_X5IXB_Z*QXP_\  31O_E?7H%% 'G__  K3Q%_T5CQA_P"
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M% 'G_P#PK3Q%_P!%8\8?^ FC?_*^C_A6GB+_ **QXP_\!-&_^5]>@44 >?\
M_"M/$7_16/&'_@)HW_ROH_X5IXB_Z*QXP_\  31O_E?7H%% 'G__  K3Q%_T
M5CQA_P" FC?_ "OH_P"%:>(O^BL>,/\ P$T;_P"5]>@44 >?_P#"M/$7_16/
M&'_@)HW_ ,KZ/^%:>(O^BL>,/_ 31O\ Y7UZ!10!Y_\ \*T\1?\ 16/&'_@)
MHW_ROH_X5IXB_P"BL>,/_ 31O_E?7H%% 'G_ /PK3Q%_T5CQA_X":-_\KZ/^
M%:>(O^BL>,/_  $T;_Y7UZ!10!Y__P *T\1?]%8\8?\ @)HW_P KZ/\ A6GB
M+_HK'C#_ ,!-&_\ E?7H%% 'G_\ PK3Q%_T5CQA_X":-_P#*^C_A6GB+_HK'
MC#_P$T;_ .5]>@44 >?_ /"M/$7_ $5CQA_X":-_\KZ/^%9^(O\ HK'C#_P$
MT;_Y7UZ!10!P=K\)8KBYBE\1^)-;\9I"XDBM=9:V2W1@<AC#;0PI(0>1Y@;!
M (P0".Z52#DG)IU% !1110 4C#=2T4 -V]*%7%.HH **** "BBB@#D_$GPYL
M-?U :G;7E]X?US8(CJND2+'-(@Z)('5HY5&3@2(VW)QC)SDK\,?$>1GXL^+S
M_P!NFC?_ "OKT*B@#S__ (5IXB_Z*QXP_P# 31O_ )7T?\*T\1?]%8\8?^ F
MC?\ ROKT"B@#S_\ X5IXB_Z*QXP_\!-&_P#E?1_PK3Q%_P!%8\8?^ FC?_*^
MO0** //_ /A6GB+_ **QXP_\!-&_^5]'_"M/$7_16/&'_@)HW_ROKT"B@#S_
M /X5IXB_Z*QXP_\  31O_E?1_P *T\1?]%8\8?\ @)HW_P KZ] HH \__P"%
M:>(O^BL>,/\ P$T;_P"5]'_"M/$7_16/&'_@)HW_ ,KZ] HH \__ .%:>(O^
MBL>,/_ 31O\ Y7T?\*T\1?\ 16/&'_@)HW_ROKT"B@#S_P#X5IXB_P"BL>,/
M_ 31O_E?1_PK3Q%_T5CQA_X":-_\KZ] HH \_P#^%:>(O^BL>,/_  $T;_Y7
MT?\ "M/$7_16/&'_ (":-_\ *^O0** //_\ A6GB+_HK'C#_ ,!-&_\ E?1_
MPK3Q%_T5CQA_X":-_P#*^O0** //_P#A6GB+_HK'C#_P$T;_ .5]'_"M/$7_
M $5CQA_X":-_\KZ] HH \_\ ^%:>(O\ HK'C#_P$T;_Y7T?\*T\1?]%8\8?^
M FC?_*^O0** //\ _A6GB+_HK'C#_P !-&_^5](WPS\1%2/^%L>,/_ 71O\
MY7UZ#10!S?A?P%IWA6:>[1[G4M6N%VW&K:E+YUU*HY"ENBH#R$0*@))"@DYZ
M)5(QWIU% !1110 4444 %%%% !1124 +12;N]&Z@!:*3-% "T44E "T4F:,T
M +12;A1NS0 M%%% !124FX&@!U%(#FC- "T4F:6@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **;N%+N% "T4F<TM !24M(: #-
M&ZFYI-WM0 _=1NIH-*&!Q@T .HHHH **2C<.* %HI-U(&#=* '4444 %%%%
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M:#/)I5WN'^NC'"L<]0RE6Y[-7 \!AW-4(W4K;]SU(9OC51>+G9PO:W5::_\
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M5R< >Y)/YFOJWQ)\*H_A#\._"&LVJK_:6BS*-7FC7_7)<,HE8^H23R]OHH-
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M#_A&]5\.NQ\S1;YUB5NOV>4^;$?H"SK_ , H ]?HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!#T/>OCW]L3QE_:OC+3?#<$F;?28?/G Z>
M?*/E!]P@!_X&:^N=0U"#3=/N;RZD$-M;Q-+-(W1$498GZ#-?FQXI\23>,/$V
MJZY<[A-J-R]P5;^ ,?E7\% 'T% 'HO[,?@K_ (3#XKV4\R;K+1XS?RY'!D!
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MMKJL1TJY(X F3,D!/N1YJ_@*XRSN;72O%VE75^ =(U*.30M35N%^SW "J3Z
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M0!U*<AO5<?W.?0RW$K#UK3^%GEYU@Y8O#-TU[T=4;/[._B0S>%[GPO=29O\
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M/QL^'OQ>^)NLW%D;;3_^$;M[IY+&WM[I8Q(H)$;R[CDN!R>P).!WKZ>/-&*
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M?QR119)WG"C<58?PX/X5O^(?@QXY\1:=]@U+PM8W)C?='=VVIHJJPP!(@89
M]CCKBOK$C-(!CTKT_P"U,4G=2M_P#Q/[!P/+RN+^_ON?*_P:_93U/3O%$&M>
M,5MX[:RD$MOIT<@E,LB\JTC#C /.!U.,XZ5]3[3U[T[;S2UR8K%U\;4=6O*[
M/0P&7X;+*"P^%ARQ0TKD8KROXK?!^?Q+>#Q#X>DAM/$2QB.>&8[8+Z,?=5R
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M$D\#XW1R7<3*<=.#%S7:_#OX4^'OA?ILEIHEJR/-@SW4[>9--CH&; X&3@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEHKD/0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***0T &:*:3BDW!NAH ?FBF[ORI%8=:0$E)FC<.*.],!:*** "BBB@
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M<$IJSDH^3U;M^")PN'KU7[)IJ#DNZT4;WUUU>AX#XH^*VD:;XRO/A]JWQ/\
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MYDCY''SKZB@#H**:&!QC\*=0 4444 %%%% !1110 4444 %%%% !29HKS/\
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M1ICSL+<[B<L\6TPMW^16/WQD ^D-1\2:3H]UI]K?ZG9V-UJ$AALX+F=(WN9
M,E(U8@NV.<#-:.[O7R'\8-4M_B5XZ\=S16VO27OA2SCT[PS<:;X?O]0@&IQR
M1W<KF2"%T4B2*VBY(( ?@@BOI7X;>.+3XE> =!\362^7;ZI:)<>61S&Q'SH?
M=6#*?I0!N:?K%CJT<TEC=P7J0S/;R-;RK($D0[70D'AE/!!Y!ZU:WCT-?/\
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M ][KO@[P[>Z5IWB6^FU'Q3X_U'1DOKZTM'%EMGN9)KE52% TKI$1A]R!BN$
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MRLI((]Q4,EQ]LT5IS%) 9+?>8IEPZ97."/4=,?6OF'X3ZAXK^&OP%^&'B?\
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M\3/%6AWQ@U/55U*S\-^+X_#^JW@MX4:]L[JWC-M/(%7"2)-<P*WE[%(#' '
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M&UO9R74'D%$8 QJ8G^5<#"N..:^J H8G//-.5=IXZ4 "KCMCZ4ZBB@ HHHH
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M_:4\/:_X(\+ZQK":AINJ:[#++;Z7!H][/+*8]AD$*K"6F"B5#O0$$;R.%;:
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M5KF6*-D@!P3F5E& 3T&:[**9)D5T8.K#<K*<@CL1[4 /HHHH **** "BBB@
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M#;LF']G'3K&XBL;2_7_A$Y/"Z>%;W2;JW,LT]NAE*2).'79)F9LDHP/8*>:
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M6,!,-W \$R'RUR'C<!D8="",BJ>K?$KPQH>I^&;"]UJWBN?$KF/2"-S1WC!
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M9H@.21N )'L"ZYI\FN/HXNHVU-+=;MK8??6)F*JY'8%E8#/4J>.#6@>_/Z4
M?-Z>%=<L/#MKK)T?4IHM#^(FI:W/IL5LYN+BS>>Y42Q1'!DP)5E4*"6"G:"Q
M -+XAZ'JOQ$U3QEXGTSP_JR:1<Q^'M-MX[S3I[>YO&@U,332BVD42*B))C<Z
M#(5R 5Y/TEI>H1:MIL%Y"EQ'!,F]5NH)()0#V:.15=3_ +P!JT% SSC/OUH
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MU%%% !2,,C%+10 T+3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$O",%A>VLMC=7_VZ6WEN;C4M3NKRYD,$@EA4SRR-)L1UW! P7);CYFR >/\
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MB,0-ND56;*LR+PI#Y8A9/V:8=5OAX^\0ZF]G<+KGB W5K<Z>K_9)X5M;>/=
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% "4FT\<TZB@!B+M^E/HHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>mrna-20201231_g20.jpg
<TEXT>
begin 644 mrna-20201231_g20.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ) !0 # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** (_.C_OK^='G1_WU_.LNBKY2.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z
M/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\
M?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.
M8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_
MG1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LN
MBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z
M/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\
M?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.
M8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_
MG1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LN
MBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z
M/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\
M?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.
M8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_
MG1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LN
MBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z
M/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\
M?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.
M8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_
MG1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LN
MBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z
M/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\
M?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.
M8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_
MG1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LN
MBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z
M/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\
M?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.
M8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_
MG1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LN
MBCE#F-3SH_[Z_G1YT?\ ?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z
M/^^OYT>='_?7\ZRZ*.4.8U/.C_OK^='G1_WU_.LNBCE#F-3SH_[Z_G1YT?\
M?7\ZRZ*.4.8U/.C_ +Z_G1YT?]]?SK+HHY0YC4\Z/^^OYT>='_?7\ZRZ*.4.
M8U/.C_OK^='G1_WU_.LNA?O"CE#F"BBBJ)"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "A?O"BA?O"@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3R/0"H-<^*5UKUXM[-H6@QW[72WES=BQ\U[N11C]X)&90IZE4"J2<D5]N_\
M"KO!G_0HZ%_X+8?_ (FC_A5W@S_H4="_\%L/_P 351XGR^+O'#/[UY+]%]Q,
MN!<XJ+EEC4_D^[?RU;^]]#X;\8?$K4/&&D:?I+V5EIFEV,DDT-I8B38'?J<R
M.Y ]%4A1V%?7O[-/_)$_#G_;S_Z4RUT__"KO!G_0HZ%_X+8?_B:W=-TNRT6Q
MCL]/LX+"SCSLM[:)8XUR23A5  R23]37BYOG>'Q^$CA:%)PM+FW\G?YZGT_#
MG"V,RC,9X_%UU4<H<FBMUC;RLE&UBU1117QA^F!116'+XZ\-P^)4\.R>(-*C
M\0.H9=):]B%VP(R"(MVXC'/2@#<HHHH **1F"*68A5 R2>@K+TGQ5HFOR(FE
MZQ8:D[VZ7:K:722EH7)"2@*3\C%6 ;H=I]* -6BBB@ HJKJ>J6>BZ?<7^H7<
M%A8VR&6>ZNI%CBB0#)9F8@* .YKFM+^,'@/7/-_L[QMX<U#R=GF?9=6MY-F]
MPB9VN<;G95'J6 ')H Z^BJFG:M8ZPD[V%[;WJP3/;2M;RK((Y4.'C;!X93P5
M/(/6K= !1110!\E_\%+O^2$Z%_V,D'_I+=5^:=?I9_P4N_Y(3H7_ &,D'_I+
M=5\#?!F'PY=_%3PO:^+K3[;X;NKZ.VO8O.>+"2'9OW(0PVE@W!_AK[S*)<N"
MYK;7/A,VCS8SE[V+O@'XHVOASPAK_A'7]%DU[PQJ\L-V\%K>BSN;>YBR$EBE
M,<BCY6965D8$8Z8KNO _[2FA>!;;6M-T_P  O9:%>7]EJ,-II^NS12[[8'"7
M$SHYFC<G<R 1C.<;>WH-Y^S[X2\%^([S0M4T>ROYO"/A]K_Q'J%U<WC(UQ-=
M$0 6\#AI"L/E@*DD(/F;G8XP7_$[X'^ _A???$G7+3PR?$,&C3:-%:>'+VXN
MXDMENXM\KN8Y!*?F!5,R$*20=^!6DJ^&JNSBWS:^3U277T?H1&CB:2NI)<OW
MK1M]/5>IRD'[8RV_BJQUE/![%;;Q;>>*?(;5<EC/!Y1@W>3P%)W;L>VT=:X>
MY^->B^(O!NA:3XJ\'-X@U#P_:W5GI=T-6>V@$<K,Z>?$B;Y#&S$KLECR  V>
M_<K\.O#/A?P1;^(+GX7ZEK>J:QXJGT;_ (1>]OKM+S2XEA1XX$,2HQG8R95I
M(W!4+\A.2>TA^&?AA_ACI>I:[H-[J<ND^ ]0U2'3=6U2[VV]S'J)C52JR+L
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M1"+<)FB=2906(&T,F "<GG$MGZ+D&4Y;BLOEB\<G=3Y59VZ1M^;_ "W/=?\
MAM/P1_T"_$'_ (#P?_'J/^&T_!'_ $"_$'_@/!_\>KYG'P>UF31_[6CNK%].
M.E+JRS^8X!5IO)$/*_ZW?QMZ?[5;=S^S_?:'XLT/1=;US2K2;4+^&RFAB>4S
MP^8 0P1HQY@.=H=-R!N"PZTN9GU4N'>'HNW,[Z]7TWZ=/U/??^&T_!'_ $"_
M$'_@/!_\>H_X;3\$?] OQ!_X#P?_ !ZOG^X^ NH7.O7EIIVK:<;5M3FTS3'N
MY)$>_FCR6C3]WPR\*6?:A;@,:CTO]G[7=4L=+G_M31[2XU*UGO+>RNII4F*0
ML1+N_=E5*X)Y;D=.A%',R?\ 5_AU+F<FOF^S?;R=^UG?8^A/^&T_!'_0+\0?
M^ \'_P >H_X;3\$?] OQ!_X#P?\ QZOGG_A2M]:6&IW+S6NJP)HR:O9W5A=/
M''(C3",85X-SG.1L/E^N[L</QA\,[OP3#.+W6-'GU"UE2&[TRWNB;FV=EW8*
MLJAP.A,9< ]2*.9FM/AK(*LN2+=_\3\ONW2UMKH?47_#:?@C_H%^(/\ P'@_
M^/4?\-I^"/\ H%^(/_ >#_X]7S1#\'=6;P+;^*I]0TRQL;J*::VANI71YQ&V
M&56V>6')SM1G#-@X!I;[X,Z]8:+<7K2V<MY;6T-[<Z3%([7<$$I CD8;=I!W
M+D*Q8;AD"CF8_P#5GA^]N9[V^)[WM^>G:^FY]+?\-I^"/^@7X@_\!X/_ (]1
M_P -I^"/^@7X@_\  >#_ ./5\VW_ ,%]2T_6+31WUO0WUF6^@T^;3ENV\ZUE
MEP%W@H-R@D!C$7"]ZF;X)WRWNH1'Q#H8M=/N5L+J_+W @CNF<JL&3#N9LJ3N
M52@')84<S)_U;X?LG=Z^;^73KT[]#Z,_X;3\$?\ 0+\0?^ \'_QZC_AM/P1_
MT"_$'_@/!_\ 'J\$_P"%!WP\*^9]LC/BHZ^=#&CX;&\+DC?LV[N0^[<$V=R>
M!G1_ O6[N^T^.RU#2]0L;MKE6U.WED^S6[6XS,)2T88;1@Y"D-D;<T<S(CP]
MP[*[YGI?J^FO;UMWL[;'T9_PVGX(_P"@7X@_\!X/_CU>_5^<_P 4/ EAX&7P
MN+"]:_&J:/%J$L^[=&SL[KF/**P3"@@,-PR<^@_1BJ3N?%\397@<OIX>K@4[
M3YKW_NV7ZL****9\*%%%% !1110 4444 %"_>%%"_>% !1110 4444 %%%%
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MQV]HS\@K'PK^T%I>M7&L66C_ !*M-7N(E@FOX+74$GEC4 *C2 ;BH"J "<#
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M7Y7U^J%7$_*_$#_F%_[?_P#; HHHJC\A"BBB@ HHHH **** "A?O"BA?O"@
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M /8EUS^S? =CJD5V7M+_ ,076DZC;"0M&KN%>VE"YPIW?NR1C<)5SG:*^O\
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MQ)H_O;48C< P( ). &..G)]&T'XP>']<UV#10]Q::G.2L,,T1(D(4L0'7<O
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M>&R/:@#Y8\/_ !@^+%G>:#=:KXHL+_3;/QU_PAMY FEQ12:DK.<W#L/]60,
M(@7IDD]^'DUA?#6H_&+5KWX-Z5X\TF+Q5?1S^(;Z2$MI^YL8*>3)+L7(<LN
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M'!!%>*>,/CIXVF^'>JZ;;QP>&/&-O;:'<6VK6\L=]')'?7"Q;VC>%51_E?*
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M:/J.M",,[V^FB(.J*I9G+321H  .[ GH 33$8/\ PH'X8?\ 1./"/_@BM?\
MXW1_PH'X8?\ 1./"/_@BM?\ XW3-/^,FGZ]J&C6>A:+J^NR:AI]MJLK6J01+
M86LY(BDG,TL>"VUSL3>V(V^7IGK--\5:+K4ENFGZO87[W$3SPK;7*2&2-7V,
MZ[2<J&.TD< \=: .,T?X/Z)X/^)VDZ[X8\.:+X?T]-'O[*]_LNSBM6FEDGLG
MAW!%&X 0S\GINX^\:]'HHH **** "H+VU%]9SVYDDB$T;1F2%RCKD8RK#D$=
MB.E3T4 ?)O@/XA>)O&NI^&_ $NKZA'K'@<ZA+XHO5N9$ENOLVZ"T#L#EQ,72
M5MQ^;RSG--\(ZIXL\/\ [.>C^)+N]O+&76UT>"Y\02>)[W5)DMIYD2XN3%<K
MY=JX1\YC+ ;LY^49^H+3PKHMAJ>I:E;:/86^HZD%%]=PVJ++=!1A1*X&7P.!
MN)P*S-!^%_@WPJ+P:+X2T+1Q>1>1<BPTV&#SX_[C[%&Y?8\4K#/GWXH>(SX9
MTOQEX4\/W_C*SU2UN='D$>JZ^9(FBFODBW07:32W40E 8,'(PN"$&3GVOP[J
MT'P]TC3-*UNUU.UOKII'8PSZGK]O#\V,R7\L7R+C!_>[ O..!FGS>%_ASX!L
MQIP\/>']%L[Z1;AK:WTR*.)VB96$KJJ8 C8H=[<*2.1Q792QVFL:?)%(D-]8
MW,91T8"2*5&&"".0P(/T-5RM*[13C))2:T9\P_ GXPZUKGQDGN-7O-7ET+QQ
M'<SZ/:WUG=0VMG]G<^2D#RH(W\VV_>L8F(W+SUKZGK+?POHLD.EQ/I%@T6E,
MKZ?&ULA6S95*J8AC]V0I*@KC .*U*1 445S'Q&\>6WPY\+R:O<6\E[*T\-G:
MV<+*K7%Q-(L<489N%!9AECP!D]J /G[]J"X\0^.O'$.D^%=.U+5)O ]DOB!C
MIS0*D6I,VZU$WFRQDH(XIB5CW-B4?+TK$\:?%V&?QMJWC/0_%W_"-W-]X#L-
M0TN$00S?VC<>;<M'9D2(V2S':8X]LA.=I&UJ]L\9?%_Q%\-_!NJ:YXG\'6]M
M]CGLXD;3]7%S;3K/,L1VN84D#INW%3%@\ ,<G&M!\:O#^JRZ4NE722M=ZN=&
MFAU""ZL[B&<0--L\EX-P?:H($GEJ5.0V< H9Y7^TE\;/$G@31]'73=2;P[K<
MFA7&L-;R1P)%/-&(LP;YHY#(PW-^YC57(Y,J <X?C#X[>)K?4-1E3Q>N@ZG'
MK>DVECX:2UMW%WI\YMC)= R1M(P8RRIYBL$7;MQN(->M^"/VCO"WBGP?'K5]
M.-+N8M);6M1LH5ENQI]N">99$CP"0I*J0&8 E5.#6/XGE^#EOXDUGQ#J\TD=
M]I\NFZCJ*K)?"U,LQ"64TELA\F5R57#%&9=H)Q@4 >/:]^T!XAUF^\<6"ZO#
MJ&DS:#X@==-U"VM&:SGM'VHCVWE$H-I.4GDE,@^8J@(4]3)\4?&EKJFNW,'B
M)H=/T;7O#VFPZ4MC;""2"[CMQ,K'R]XYE9EVLN#QR, >U?\ "\?!G]FR7G]I
MW'[O4#I9L_[-NOMIN@F_RA:^5YS-L^;A#\OS=.:72?CEX)UV&&6QUKSDFBO9
MD/V2=<I:,%N3@H,;"PX/)S\N: /'/#OQ>\7WW[0%YX1O=?\ M-A=W=]:10:5
M';L]@B(QB:2WEA2X@*@*?.<SPR%@%&"#7>_LH7<EU\&=/%SKL^N7T5W=177V
MJ2)I;643OF%MBJ0>C$/EOGZXP!H?\--?#?[.;D:_,ULOV??.NEWACC\^)98
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MU^G%4IYL9]:9-<=3G@<DY_6O'?'OQ=^W1RZ=X9NF$;/Y$^M0IYF'/'DVB_\
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M[VD9PIC.#MR>..<=ZY&'QSJ7BZ[TS31=1RSZC!;VKFXD";9P-BG.W(!RJXX
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M++LSC:0 PP/FKT'P?X7M?!/A/1O#UC)-+9:59Q64$EPP:1DC0(I8@ $X S@
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MLSVL/B*6*IJK1ES19Y[XC^+?_"/>(KO2_P"Q9[I;?:IFCF1<$JK[F5L80AB
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M=VQCO]*[OX8Z;!X@_9A@L_#Q^U7-RK?:XXE%M)))Y^;B(G<,G9NC#$C<H4Y
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MMDUJ:W<-#;C#2/$RD#*-\IW9&.>*XW5M8GU[_A&K>+7(["*\N(X+J($@2HS
M$Y'("GL.:_1SP3HFC>"/"]AHNF2QQV5JF(U+ENI+'D\]2>M>5GF)672Y8*[E
MM]Q[_"F!><P]I5E90M?OOM\U?4T_#NC_ /"/:!IVE_:IKW[';I!]HN"#))M4
M#<Q'<XK1JO\ VC:_\_$9^AS1_:%K_P ]U_7_  K\S;<G=G[I'EBE%;(P_'T.
MA1^%=5O->L8;RPAM9#,KH-S*5P4!Z@MTX/>O,=#_ &2?AW#K\7B&)=0O879;
MFVLY+H_9TZ,I&T!B,\C<QKH/VA)H+[X97MO%=XEDG@184_Y:L9  IXZ#[WU4
M5VWAN"S\.Z#8Z6M_]ICLXA#'))]XHO"@^X7 S[5Z\)U,-@E4I5&G.332OLDO
M\SYNI3HX[,Y4<11C*-.,9*32;4FY:?<OP]#<HJM_:5I_S\)^M']I6AZ7"?K7
MCGTO,NY9KA_C9=+9_"OQ$[' :W$8^K.JC^==A_:%K_SW7]?\*\]^,E];ZII^
M@Z"DR.VJ:K!'(,_=B1M[M^&!7?E\;XNFWLFF_1:O\$>1G$^7+ZZ3U<6EZRT7
MXM'>Z+:-I^C6%JPPT-O'&1[A0/Z5=JO_ &C:_P#/S'_WU2?VE9_\_4/_ 'V*
MX9-R;;ZGJP48145T+-%5_P"T+4]+F'_OL4X7ENW(N(O^^Q2+N35C^,=172/"
M6M7KMM6WLII<_1":U!<0GD31D?[XKSSX[7_F>!3H]M*IO=;NX-.A"L"?F<%C
M]-H(_&NO!TO;8BG3>S:^[K^!YV95_JV"K5ENHNWK;1?-Z&O\']/;2_A?X9@9
M=C?8HY"O^^-__LU=A4-K##9VL-O"56*%!&B@CA0, 5-65>I[:K.K_,V_O9T8
M6A]6P].@OLI+[E8**-I]*-I]*P.H^0-6\=F?X@^)DN)"7_M.>,[C_"CF.,>V
M$5>/J>YKI-#US3I8];EU*+[58QZ1J$;0]@45)<8]2B.0?:O,OVGO ^L_#[XH
M7.OVMK--H>M2>>)HU)5)C]]#CH<\C/7)]#5W38]4T?X3>(O&L]G+ LEG_95L
M95($GG,$DD*GJ%3*AO5SVJ2B+P_KK;(UDEWR!0K-_>8#!/XFOI#X#SP7FDZQ
M-MS>"[$;R$Y_=B-3&H]  3QZY/>OB#PQXBVJ@WDX_O')KZU_97UQKBRU[3.7
MC5XKX2-UW.#&PSZ?N5/_  +Z4P9ZS\1-2FT?X?\ B:_MV9+BUTRYGC9>H98F
M8$?B*^2O!?BZ)[6."/!2- D<?; & /T%?9>KZ9!K6DWNG7*[K:[@>WE7U5U*
MD?D37YT7/A#Q9\,?&TOAS4--O+B992EO-! [K=)GY7CP#NR.<#D=#R"*&)'K
MOB#6X5\)ZY,_[^>];2S;S-T4"1FP/1E,=R2/1L56\/ZT'V_-Q7/?&BSOOA]X
M/\.Z/J$3VFHZY<OK%Y'N!, C"I#"".,@O)(V/XG(Y'7F?#FO%E7;)M;LV,X_
M"D,^Q/@K;BX\.3WREI;N\N)//D)^[Y<CQ(@'955!P.Y)ZDUZ;'$(QZGUKS;]
MG6XBN/AG:*BGS;>>>"61NLK"1F#GW(8$^Y->FU1(5Y1X\^+T^CZI>6NEO:K'
MIS;9WGC,AFD"AFB7##: I&6YY(X.#78?$+Q8WA/0#- 8_M]RXM[7S?N*Y!)=
MAW55#,1WVXXSFOD+Q!JL5NNH"V>2[$SR2%KAL/,S9W,Q'=NOXU\9Q#F\\"HT
M,/*TWJ_)?\$\C'8IT4H0>I]/^-/BHFAVMK%:F&*^EMTN93.ID$"N/E7:&7<Q
M(.!D#"DFF>%?C!;ZIX6UF^OHT%]H\!GN(X.%ECP2'4$D@'!!&3M]3Q7QK-\1
MK[Q)<OJE]MBN+E8PT2.65!'&L2@>^U!D]R2>]36OQ$N]*DEM[: W2:K#_9LP
M#X*QM(DC$ ]<B,J?9C7A?ZRUOKTI7_=:I+Y:/U;_ #./^T)>V;O[I]M>"/B(
MGBJZDLKFVCL[]8_.5(9_.CD0$!B&*J<J2 00.HQD<UV5?(O@#Q'-I_BG3]7B
M?>]D)&:W)_UT;C;(H]P,,/=,=Z^MK>XCN[>*>%Q)%*H=&'0J1D'\J^KR',I9
MCAFZK]^.C_1_UV/3P6(>(I^]NCA_C%\-?^%G>&K>QBEAM[VUNH[J"6<-MRIY
M4E2" ?QZ8QS7S;??LF^.;6 26?\ 9SQ1%XH].BNSA23GSE9E'WB6&"<@ >I
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MGAL=?3[1;*^!-$T,JN,=R%)P>@_$5C>%_'&B>++..]\/ZK9ZH-@F1(9U+#N
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MR'R=/*XQ^\8U:&F6JWQO! HN2,&0=3QC)]\<9ZXXJ+1VW6\GM(PJ_0 4444
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MUL?[>NDNK@_:[M8;,E1,RJ" 2P)  "Y(&<5RFOV_B+P/XXN=<\+VDNM6%_\
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M]F7*J:EJEMI,"2W4@B1Y4A7/5G=@J@?B:FCNH9?N31M]'%>:_$#3[KQ9\0-
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MR>!4,EW!%]^>-?JXKQVZUJ29=MUXI5_]FTM7<_F0O\ZK[K>\XW:_J?TQ&O\
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M2YR%B7NXXRYYR.Y&X]1\/_A?HGPYMI_[.CDN-1NCNO-4O'\VZNFZDNY]^<#
M_&NNK1U(P7+2^;ZO_)$*FYOFJ_=T_P""PHHHKF.D**Q/%OC70_ NEMJ.O:E!
MIMJ. TI^9SZ(HY8^P!->827WCCXW$QZ;]J\ ^"GX:^E4#4[Y/^F:_P#+%3_>
MZ]",C(K:%)R7,]%W_K<QG547RK5]OZV-CQY\9);?6G\)^"+%?$WC%AB2-3_H
MNGCION)!P,?W0<]N,C.A\+OA-'X(DN]:U>\.O>,M2^;4-8F&3V_=1#^",8
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MS;S2;E=QO- L[D#K+9.T#?7 ./\ QVG[.$MF>5[6K'?^ON/8HKB*?_5RH_\
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MM;L='CW7EU'!W"L<L?H!R:J-&AA_WCW[MW?WL.6,/>9>I&8*I). .237-_\
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MUE?^])\V?SXK8CA2)0$0* ,#BGT5NY-[G*HQCL@HHHI%!1110 4444 %%%%
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MHO\ -^;^21?K-U3Q!9Z6PC=FEN&^[;PC=(WX=OQJF5U?6NI_LFT/9?FF8?\
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MEB/6VT\;?P+GFE]:4_X,7+\%][T^ZX>TO\*N:>J>)--T7(N[N..3M$IW.?\
M@(YK+.M:WK65TO3OL,!_Y>]0X/U5!S^?%:FE^&=,T;!M;2-)/^>K?,__ 'T>
M:TZ7LZ]7^)+E7:/^;_1(7+.6[MZ?YG-0^"8KJ19]9O)M8G!R%E.V)3[(.*Z*
M&&.WB6.*-8HU&%1  !] *?16]*A3H_ M7UZOU>[+C&,=D%%5[S4+?3X3+<SQ
M6\0_CE<*/S-<U<?$:RFD,&CVMUKEP.,6L9$:G_:<\ >_-=L*4ZGPHZZ6'JUM
M:<;KOT^;V1UM4M5UNPT.#SK^[BM8^WF-@GZ#J?PKF_L/BW7_ /CZO(/#]L?^
M6-H/-GQZ%SP#[BKVE_#_ $;39A</ VH7G4W5\YF<GUYX!^@K7V=.'QROY+_/
M;\SH]C0I?QJEWVCK^.WW7*)\::CKGR^'-'DN(STOK[,,'U ^\P^E(O@2ZUIA
M)XEU:745Z_8;?,-N/J!RWU.*[*BCV_+_  ER_B_O_P K!]<]GIAXJ'GO+[WM
M\K%>PT^UTNV6WL[>.V@7I'$H4?I5BBBN9MMW9P.3D[MZA115/5-8L=$MC<:A
M>064 _Y:3R!!].>II#C&4VHQ5VRY17 3?%ZVU.5[?POI-]XEN0=OF0QF*W4_
M[4KCC\J9_P (QXS\5\ZYKJ:#9-UL=$&)"/1IFY!^G%3?L>I_9U2GKBI*FO/X
MO_ 5>7WI+S.B\3>/=!\()_Q,]1BBF/W;9/GF<]@$'/X]*YK_ (2#QIXTXT32
MU\,:<W_,0U==UP1ZI".A_P![@UT7AOX=^'_";>;I^G1BZZM=S9DF8GJ=[9(S
M[8%='1J/V^$P_P# I\\N\]OE%:?^!.7H</H_PCTFUO5U'6)KCQ+JPY^U:FV]
M5/\ L1_=4>G7%=P %  &!113.&OBJV*DI5I-VV[+T6R7H(QPM,5CNZTXMSC%
M* !TIG,+117/>)OB!H/A$!=2U"..X;&RUC_>3/GIA%R>?4\4C6E1J5YJG2BY
M-]$KG0UFZ]XETOPO8F[U6^AL;<=&E;!;V4=6/L 37%G7O&OC7Y=%TU?"VFM_
MS$-63=<$>J0]C_O<>]:&A_"C1]+O!J6I-/XBUCJ;W4V\TJ?]A#\J@=NX]:5^
MQZ7U.CA]<74U_EC9OYOX5][:[&6WC3Q/X\_=>$M-.EZ:W!US5DVY'K%%U;V)
MX]<5L>&/A=IF@WW]J7LLVO:ZWWM2U [W!_V%Z(/3'/O79446[DU,PDH.EAH^
MS@][;O\ Q2W?IHO(****H\H**** "BL[7_$6F^%]-DO]5O(K*U3J\AZGT ZD
M^PYKS[[=XH^*WR6 N/"OA9_O7T@VWMVOI&O_ "S4_P![Z=>12N>AA\%.O'VL
MGR4UO)[>BZM^2U^6IK>*/B4ZZHWA_P *VJZYXB/#A3_H]F.A:9QTQ_='/;KC
M-GP5\.T\/WDVLZM='6O$UT/W^H2K@(/^><2_P*/;K^@V_"_A/2O!NEI8:3:)
M:P#EF'+R-_>=NK'ZUL'H>]%NYM6QD*<'A\&K1>[?Q2]>R_NKYMA13(W+=12R
M,57BF>2.IAD .*:CG<.<USWC;QYI7@>UC>\9KB]G.VUT^W7?/<-T 51[]^GX
M\4;;FU&C4Q$U2I1O)]$;NI:E:Z/8S7M]<1VMI"N^2:5@JJ/<UY;<:AK'QND-
MKIGVC1/ ^2)]08;+C40.J1 \JA[L>OYK5O3O >K?$&^AUCQUB.TC;S+3PW$V
M88O1IC_RT?VZ?F17IT<:Q1JB*$11A548  Z "IW/8YZ.6?PVIUN^\8>G\TO/
MX5TON4]%T2Q\.Z7;Z=IMM':6<"[8XHQ@#W]R>Y/)J\0#UHHJCPY2E.3E)W;$
M50O04M%%!(44UI-O'>HF8L<F@";AAZBA5"]*BCSN&*FH BFM8;A2LD:NIZAA
MD&L6\\%:9=-O2(V\F<[H3M(^G8?E6_134G'8B48RW1RT^AZS;Q[([^/48!_R
MPU",2CZ D$_EBL6XLTMWWW6BW-A(.?M&ES$J/?:V<?F*]#I&4,,, 1[UHJC1
ME*BGLSB=-UV]M6']F^((+CG/D:@I@<^VX\'_ +ZKI+7Q]JNGM&-5TF98S_R\
M1@.C>F&'&/Q-27VA6.HY\^VC=C_%CYOSZUF0>#_[/N!)IE_<V+$\JCG:?;'^
M)-.\);HE1J0^%_U\SHJ*9)NSQG'M3QG'/6L3J"BBB@ IC28;&*?2;1UQS0 M
M%%% !1110 UF"]:<#D9I&4-UI1QP* "BN<^).K7>@?#OQ1J=A+Y%]9:7<W$$
MNT-LD2)F5L$$'! X(Q7S)\*?C1J/BS6O"L%Y\>OM&I7TMO\ :/#_ /PARKO<
MD%[;[0$ '=?,&/45+=BE&^I]?45XOJW[5WA+1=0U2WN=*\1>1I6J-I5_?QZ=
MOM;5PP4.\H; 1B2 /O'!^4<9T_&W[2'A?P+XDNM'N;+6M2-@D<FIWVF6!GMM
M-63E#.^1MR#G@'\^*=T+E9ZK17E/C+]I'POX/UN;35L=:\0/:0)=7]QH=B;F
M#3X7 99)WW#:I4[N,\5-XF_:)\+:!<:-;VD.J^))M4LQJ,:Z#8M=&&T)Q]HD
M ((0'.<9(QTHN@Y6>H4'D8KP#X;_ +1'V/X-^%-:\3?VEXF\2:U-=);V.C6"
MRW=T(YW4E8D"J J!<GC\377S?M%^$[?P&OB=DU(AKW^S/['%F?[0%[_S[&'/
M$GMG'O2N@Y6=W/#+8N9HI'=,_-N.?S]OY5->78DTN29."H!(]"".*\I^#/Q6
MU#XF?$CX@VLRWUKHVGQZ?]DTO4[);:XM'DB<S)(N-V=R]R1Z'%>F7EC<+%+%
M"N]9!C/MZ'WH"UB2\TRU\3:%<6=TGF6UTK*P^I/(]Z\_^&.M7.@ZA>^!-8D)
MN]/8/93-_P MK8MD$?3_ .MV->G6-N;6SBB/51SBO/\ XS>'#-I=OXFL+B*Q
MUW1#YUM-*0%E7^*%L]0W.![D=S0-=CT&$;H=V.68M^9)JK<:2ETS9)16.6 '
M?U%8_P .?'VG_$;PS!JMBRJ^?+N;?.6@E'WD/\QZ@BN@O;G[/%Q_K&X4?UID
MB6,D1A\N(%1$=FT]>*R]4\+1W^H?:U:')!+1W,1E3<0HW*-RX)"J#G(.T<9Y
M-NWDATO3YKN[E2V@53))+,P544#JQ/0=ZY_7OC%X*\-V:W%YXETTJPW(EO<+
M,[@]-JH231ZCUZ&U)I=K8VYN[^5KL6R;QY@ 2, <[(P,#\LU5TRW>\O@)E :
M)Q=7(X($Q7]U"/:-#D_[39]:\!\;_M72ZT_]F>$]$>5F=2)KR)I'?:P(VP+\
MW8=:SO"GQ/\ BC::DUQJ,ZFP:&:_FM9XK='*AN<;?GC8LV!OX[8J.9&G*['U
M;-<PVR@S2I$#P"[ ?SJ2OG_6OAOJ.K6/]M^)]:F$]X5^RV,4A;R]W.&)P.!R
M<#M7KW@#SO\ A%[0RLS)\WDF0Y;RL_)G\*JYG;0Z*BBBJ$%%%% !1110 444
M4 %8FCKCQ#KA]6A_] -;=9.CKG4M6D_O2JOY+6]/X)^GZHY*RO4I>K_])9JL
MP523P!R:QO"<9;39;DCYKJ>28Y]SC^E6M>N#;Z3<%?ONOEKCKEN*LV-J+*S@
M@7I&@7]*%[M)^;_+_AP:YL0O[J_/_AF3UBWR_P!JZY;VO6"TQ/+Z%OX1_6M.
M^NEL;629N0HX'J>PJOHUFUK;-)+S<3MYDA]SV_"BG[B<_D@JKVDE2Z;OTZ?>
M_P +E_I7/JI\2:FLAYTRT?Y!VFD'?Z"K&I3R:E,=.M6VC_EXF'\"_P!T>YK3
MAABL;98T CBC7 ] *<?W4;_:?X$R_P!HER_86_F^WHNOW=R7IR:Y^YD?Q-<&
MVA9ETV,_OIEX\T_W5]O>I)I9?$$AAA+1:>#B27H9?]D>U;$<<5G $0+%$@X'
M0 4U^YU^U^7_  12_P!IT^QU\_\ @=^XZ*)(8UCC4(BC"JHP *I:GJT6G[8P
M&FN7^Y!'RQ_P%02ZA<:BS0Z<,(#A[IQ\H_W1W-6=/TF'3]S+F29_OS2<LWXU
M/*HZU-^W^9?/*I[M'1=_\N_Y%.ST>6ZN%O-4(EF7F. ?ZN+_ !/O6S4=Q<16
ML9>618U]6-9K:E=7WRV$&$_Y^)^%_ =30^>KJ]OP0+V>']U:M_-O^ON-&YNX
M;.,R32+$@[L:RFU&^U;Y=/B^SP=[J<=?]U>]*NE6]NWVG4)_M,W9YB J_1>E
M3?VN]QQ96SS_ /31OD3\S5QBE\*OYO;^O7[C*<Y2TF^5=EK)_P"7R^\=I^AP
M6,AG<M<W;?>N)N6_#THNM=MK>3RH]UU/VB@&X_CZ5'_9-Q?<W]TS)_SP@^5/
MH3U-/:\TW14\M6CB/_/.,98_ES^='QRUO)^0*].-HI0CW>_]>K^17:#4]4_U
MTHTZ _\ +.$YD/U;M^%7;'2;32U)AB56_BD;EC]2:J'4=0OO^/.R\E#_ ,MK
MH[?_ !T<TC:']H&_4[V2X4<F,'RXQ^ JI7MRR=EV7]?FR(\M^:$7)]WI_7R1
M+=>([.&3RHBUY/VBMUWG\^E5RNM:IU:/2H#_ '?WDI_H*D76-+TU?)M0LC?\
M\[5-Q/Y<?K2?;=6O?^/>S2T0_P#+2Z;)_P"^1_6FH\JO&-O.7^7_  Y,I\[M
M.=_*/ZO?\42V/ANQL9/.,9N+CJ9[@[W^O/3\*+[Q)86+;&G$LO01P_.WTXJ!
MO#[W2[M2U":Y7O&I\N/\0*%U#1-%79"T*MTVPC>Q]B1G]:+*H[MN;\OZ_0?,
MZ4;14::\]_N7^9%_:&KZEQ:62V41_P"6UX?F_P"^1W^M/7PJMVP?5+R;4&Z^
M63LC'_ 13O[:O+K_ (\M*F8'_EI<$1CZX[TU[/6+E2UUJ,-C%W6V3/\ X\W2
MKO*&S4/S_5_D9VA4^)2J?@OQLOS-1([32K?"B&TA'T1:S9O%U@LACM_-OYO[
MEK&7_7I6/<3>%M-DW7E]_:-QT^>0SL3Z87C\ZLQ>)KJ:,)H_ARZ>/LTX6WC^
MHSU%9\L-W>7X+]?T-^:LURJT5Y>\_P!$OQ+?VO7]1_U%I!IL9_CN6WO]0HZ?
MC3'\*BX4OJ^I7%ZHY9"WE1?]\C_&H#8^*]3_ -=J%GI,9_AM8C*^/0EN,_2A
M?AY87#!]3N;S5W'/^E3G:/HHQQ3]KR_#:/IO][_S%]64_P")>7J]/N6GX#9/
M%7A;PV/*MY[?S>GEV:>8['TRN>?J:C;Q9KNJ<:1X<FC0]+C4W$*CWV=2/H:O
M?VEX9\+J526PLB.JP[=_XA>:K_\ "?0W7&F:7J&IYZ21P%(_^^FZ?E6>LO>M
M?S9TI*"Y4TEV17;PSXDUC_D*>(C9Q'K;Z3'Y?Y2'YJMZ;\-_#^FR^<;%;RYZ
MF>]8S,3Z_-QGZ"HC=>+]2_U5G8:/&>]Q(9I!] O'YU%-X1N[E=VM>)[R1#UC
MMRMM&?8XZBI<FEK))>7_  !V6_+?U_X)T%]K.F:'&!=7EM9*HX2214X]A_A6
M!)\3--G8II=I?ZU(./\ 0[9BH/NQQCZU%::+X/T>3,-G#=3YSN96G8GURV:V
MUU:ZD4+9Z3-L' ,Q$0'X5R/$8=;/F?E_P+CYF^OZF*=2\::OQ:Z58Z+$?^6E
M],97QZA4Z'V-)_P@&H:ISK?B;4+Q3U@L\6T1]B%ZBMSR=;NOO7%M9+_TR0NW
MZ\4G_"-)/_Q^7EU=^JM)M3\A1]9J/^'3MZZ?YO\  7+S;W?J9=CX8\(>%V#1
M6EE',O.^7][)GURV2/PK3_X29)ABRLKJ\]&6/:GYFKMKHMC9X\FTB4C^+;D_
MF>:NUG+ZQ4UE)+\?Q?\ D6HM:+0Q?,UV\^[%:V"?[;&1Q^7%-_X1R:Z_X_M3
MN;@=TC(B3\A6Q-<16Z[I94B7U=@!^M9TWBC3HVVI.9W_ +L*ER?RXK"<*,?X
MT[^K_31?@)J*^)DMGX?TZQP8;.,,/XF&YOS-:%8W]M7MQ_QZZ3.1_>N&$?Z4
MGD:[=_?N;:Q7_IBAD;]>*J-2G%6I0?R5OSLAJ26D4;54;K7=/L<^=>1*1_"&
MRWY#FJ7_  BT5QS>WEU>^JO(53\A5ZUT6PL<&"TA0CHVT%OS/-7S5Y;12]7?
M\%_F.\WT*'_"4&Y_X\-/NKST?;Y:'_@1I,>(+[O:Z:GL/-<?TK=HI>QG+XYO
MY:?\'\0Y6]V8/_")I='.HWMU?^J,^Q/^^16G9:39Z<,6UK%"?[RJ,_GUJ*Z\
M0:=8Y\Z\A4C^$-N/Y#FJ7_"4?:.+#3[J]]'V;$/_  (_X5DGA:,M+<WWO]63
M^[B_,W:*PL^(;WH+334/J3*X_I2?\(J;KG4=2NKWU0-Y<9_X"/\ &M?;3E_#
M@_GI_P '\"N9O9%V^\1:;IN?M%Y$C#JJG<WY#FJ'_"43WG&FZ3=77I)*!$GU
MR>M:-GH=AIV#;6D4;#^(+EOS/-7EI<E>?Q34?17_ !?^06F]W8Y_[#K^H_\
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MB]M=#@/_ "SM4\Z7Z%CP/J*ZWIP.!13]K&/P02]=?^!^ ?684_X--+S?O/\
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MM]UW2RC_ .^F_P *A:ZEA7:&M[)/3.YOR%0-Y4_+_:;[Z_)'5V;U_P"#_P
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MFL/K$.C^Y&N_3]2"U\1>']/)CTNT:=QQML;4EC^.!G\ZL?V[K=YQ9Z$T2_\
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M)3.Q^H/R_I79T461,LQQ-N6F^1=HI1^^VK^;9';V\5I"L4$20Q*,+'&H51]
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MM4>54J3K3<ZC;;W;U845'YC;L8XJ2@S"@G S110!'YWM3E8.*:T7I3D7;]:
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M6M)<U1)"EI$K:A>+96=I9Q';!!"J*HZ<#']*Y^\U$\_,?SK)M]<N-O\ 9VI
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M_CV\,W3_ /7Q,D/\Z/MOBRX_U>FZ=:?]?%PS_P#H(I.M4>G,Q..*:M.HDO\
M$OR3_0Z2.)(5VQHJ+Z*,"G5S!T_Q9=?ZS5K"R_Z]K8R8_P"^S2?\(?J-Q_Q]
M^)M1?U^R[8/Y UE<P]A37QU5\N9_I;\3J*H76OZ98Y^T:C:P8[23*#_.L/\
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M>D _*E\\+TB _ 4UK+T=Q]&I/L\G:1OQYJ[TQ>QAW)/M1_YYX_!:/MC]D;\
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M?Y&@/9X=;U'\H_YM&_-=0V_^MFCC_P!]@*HS>)](@^_JEFI]//7/\ZIQ> M
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MM6_Z[*9?_0B:-0]G@X[U)/TBOS<OT(KSXH>%K7Y6U>&5NRVZM*2?0;0:J_\
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MFY/S=PHHHIF 4444 %%%% !47S\YS4M% %>IH\[1FCRU]*=3 ****0!1110
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MRM1_;4R_?TR['^ZH;^M!7O=O_)BHNH:.N=NGX^EI_P#6H_M;1.]LJGT-J?\
M"K7_  D2+]^QOH_]Z#_Z](?%%BOWS-'_ +T3?X4!RR_DE]__  "LNN:#&>5C
MB/O;$?\ LM.77]!;C?#^,!'_ ++5A?%6E-TNP/JC#^E2_P!O:9*,&\A(_P!I
MO\:!.+ZTY??_ /:E5?$&AH<B:%3[1G_"I8_$FC]5NX5[="#_ "JPNH::WW;F
MU/T=:DQ93'.('/\ P$T&3]GUC+[_ /@%7_A*-*_Y_HOS-*OB;2VSB^A'U;'\
MZN?8;;_GWB_[X%-;3;1\;K6%OK&#_2@B]#L_O7^17_X2+2_^?^W_ ._@I/\
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M_P#D3F_^$^T[M#>D>HMFI/\ A.K9ON:9JDGIMM#\WTYKI:*-1^TP_P#S[?\
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MZY;1OY;S:;=1W"(V =I9"0#@@X]ZT;F\@LK::XN9H[>WA0R232L%1% R6)/
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M>*"5.#M\):J1^!%M@TT?&#0!TL/%7_A(ZM_\C47OJQ69U45\/#6O1:BY_P!
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M>A^G<&1G3CBK;VC;K_-VW^1I:UX+N](F,<-Q;:J\8E,RZ>7=[?RSA_,1E5D
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M^*HW\V5X-/M;7'DVT,7_ %SC"_RJQ113.=R<M6PHHHH$%%%% $>P],5)110
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M7 ( ZK7O@[X3\20O%?Z?.T4GVH2I!J%S )EN&#S+)Y<B[U9@#M;(!' %7?\
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MOV];'H1Q6(JTFO:/FCKN]5U^[?TN2?\ ")Z'_P! ;3__  %C_P */^$3T/\
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ML+.'+R?B^^CM:VWJPK$\7>*H/!^D_;9K:YOG:188;6S4-+,YR=JY('0,220
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M=RQLBAI)@NQ0&QG !Z$XYJ;Q)KFMZYJ4DVOW_P!HNA;I%Y6Q%940;5+%0,G
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ML0K;F!*_*P;D#J.*]+T#X/\ C#5-76WU#3I=(L5;,U\D\,NY<''E#<<DG'+
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M !130^6QBG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*1CM&: %HJ/S3GIQ4E !1110 C+N&*%4+TI:* "BBB@ HHHH **** "BBB@
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M^-'.@]FSC:*[+_A'[#_GA_X^W^-(WAS3FZV^?^!M_C1SH/9LXZBNQ7P[IZC
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MSP_\?;_&C_A'[#_GA_X^W^-+G0O9LXVBNR_X1^P_YX?^/M_C1_PC]A_SP_\
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MR]+?_P ?;_&G?\(_8?\ /#_Q]O\ &CG0>S9QM%=E_P (_8?\\/\ Q]O\:/\
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M?;_&C_A'[#_GA_X^W^-'.@]FSC:5/OK]178_\(_8?\\/_'V_QH'A^P7D0?\
MC[?XT<Z#V;-&BBBL#H"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
6HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>mrna-20201231_g21.jpg
<TEXT>
begin 644 mrna-20201231_g21.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ) !0 # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI#GMUKY!_X>@?"S_H >,/\
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M!\+/^@!XP_\  .U_^2:/^'H'PL_Z 'C#_P  [7_Y)H ^OZ*^0/\ AZ!\+/\
MH >,/_ .U_\ DFC_ (>@?"S_ * 'C#_P#M?_ ))H ^OZ*^0/^'H'PL_Z 'C#
M_P  [7_Y)H_X>@?"S_H >,/_  #M?_DF@#Z_HKY _P"'H'PL_P"@!XP_\ [7
M_P"2:/\ AZ!\+/\ H >,/_ .U_\ DF@#Z_HKY _X>@?"S_H >,/_  #M?_DF
MC_AZ!\+/^@!XP_\  .U_^2: /K^BOF_Q-^WAX"\*_#[P9XQO-'\1R:7XK^V_
M88H+:W,\?V6412>:IG"KEF&W:S9'7'2N0_X>@?"S_H >,/\ P#M?_DF@#Z_H
MKY _X>@?"S_H >,/_ .U_P#DFC_AZ!\+/^@!XP_\ [7_ .2: /K^BOD#_AZ!
M\+/^@!XP_P# .U_^2:/^'H'PL_Z 'C#_ , [7_Y)H ^OZ*^0/^'H'PL_Z 'C
M#_P#M?\ Y)H_X>@?"S_H >,/_ .U_P#DF@#Z_HKY _X>@?"S_H >,/\ P#M?
M_DFC_AZ!\+/^@!XP_P# .U_^2: /K^BOD#_AZ!\+/^@!XP_\ [7_ .2:/^'H
M'PL_Z 'C#_P#M?\ Y)H ^OZ*^0/^'H'PL_Z 'C#_ , [7_Y)H_X>@?"S_H >
M,/\ P#M?_DF@#Z_HKY _X>@?"S_H >,/_ .U_P#DFC_AZ!\+/^@!XP_\ [7_
M .2: /K^BOD#_AZ!\+/^@!XP_P# .U_^2:/^'H'PL_Z 'C#_ , [7_Y)H ^O
MZ*^0/^'H'PL_Z 'C#_P#M?\ Y)H_X>@?"S_H >,/_ .U_P#DF@#Z_HKY _X>
M@?"S_H >,/\ P#M?_DFC_AZ!\+/^@!XP_P# .U_^2: /K^BOD#_AZ!\+/^@!
MXP_\ [7_ .2:/^'H'PL_Z 'C#_P#M?\ Y)H ^OZ*^5_!W_!1CX;^-_%VA^'+
M#1/%45]K%]!I]O)<VELL2R2R+&I<BX)"Y89(!..QH\8_\%&/AOX(\7:YX<O]
M$\52WVCWT^GW$EM:6S1-)%(T;%";@$KE3@D X["@#ZHHKY _X>@?"S_H >,/
M_ .U_P#DFC_AZ!\+/^@!XP_\ [7_ .2: /K^BOD#_AZ!\+/^@!XP_P# .U_^
M2:/^'H'PL_Z 'C#_ , [7_Y)H ^OZ*^0/^'H'PL_Z 'C#_P#M?\ Y)H_X>@?
M"S_H >,/_ .U_P#DF@#Z_HKY _X>@?"S_H >,/\ P#M?_DFC_AZ!\+/^@!XP
M_P# .U_^2: /K^BOD#_AZ!\+/^@!XP_\ [7_ .2:/^'H'PL_Z 'C#_P#M?\
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MZ!\+/^@!XP_\ [7_ .2:/^'H'PL_Z 'C#_P#M?\ Y)H ^OZ*^0/^'H'PL_Z
M'C#_ , [7_Y)H_X>@?"S_H >,/\ P#M?_DF@#Z_HKY _X>@?"S_H >,/_ .U
M_P#DFC_AZ!\+/^@!XP_\ [7_ .2: /K^BOD#_AZ!\+/^@!XP_P# .U_^2:/^
M'H'PL_Z 'C#_ , [7_Y)H ^OZ*^0/^'H'PL_Z 'C#_P#M?\ Y)H_X>@?"S_H
M >,/_ .U_P#DF@#Z_HKY _X>@?"S_H >,/\ P#M?_DFC_AZ!\+/^@!XP_P#
M.U_^2: /K^BOD#_AZ!\+/^@!XP_\ [7_ .2:/^'H'PL_Z 'C#_P#M?\ Y)H
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M4DE9U# $@'##."?K0!@4444 %%%% !1110 4444 ?0'QF_Y-/_9U_P"YC_\
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MTL7Q8^!T7P)M_ UO#\0=(O9(!/JLVE0V,<6K7P7*&X=W9VA1\[4&  <X+<T
M?,%%%% !1110 4444 %%%% 'H'[/?_)??AI_V,VF?^E4='[0G_)??B7_ -C-
MJ?\ Z524?L]_\E]^&G_8S:9_Z51T?M"?\E]^)?\ V,VI_P#I5)0!Y_1110 4
M444 %%%% !1110!]M^#OV-_A[XBT_P !V4]C\3I-5\3:';:D^NZ?:V\VB64T
ML18K+(8PR@,/NYSAE^;G-<'IG[%[^+O GA+4-!\3:39ZOJ6HZEIUQ+KNII;V
MMQ+!/Y4"6B*AD=W"NV/FZ=N_'?%3]I+6?$VA^#M&\*^(/$NB:1I?ABST;4-/
M6]>WM[B>-665Q''(5=&!498 D#D5-HGQVT33?"_P/TR2VU(R>!]<GU34]D:;
M)HWNHY5$/S_,P5&'S!1D]<<T 9/P[_9GUWXA:UJNC-XF\(^&=9T^_;3/[-\0
M:RD%S<7"G:R0Q*'9^>-V,$\ G!Q=\+_LG^*->L=>OM4U_P *^"[+1]5ET2:X
M\3ZJ+2.6\C&7BC8*P8@>N,]LX./4? O[5GPU\-WVO:M<^'O$EKKLWBNXUZVO
M=&-M!+?6[R;TMKN5B75%R<QQDJW<X)RSX?\ [4O@3PSX^\<Z[=:C\1;.RUS6
MY]3CTS3#8265U%(^[9<6TX8*V/E+(Y+#'W<4 >2?#W]F7Q#\0+'5M2.O^%O#
M>AZ??'3?[9U[5T@L[FY'6."5 XD.,$$<$$8)KD?$'PWO/ 7Q*?PAXRF7P]+;
M74<-]=[#<+!$VT^<H3F0;&# #KD=*^FOA+^V]X?\'V/BW2;BPU[P9I&H:Y/K
M&FMX/@L9I;=)<9MW2[1HPHV@Y4=20  !7A'CSXT+XR^.@\=7MK-XFLH;J%Q9
M^(DMF>[MX@J^7,(8HXOF4'@)QGJV,D Z[X^?!;X?>#?AMX<\8>!]7\1/;ZI?
MRV<5KXF@CBDOH47=]LMPJJP@)*@;AD[QTQ@_/U?0_P 9?C?\.-6^&-WX,^&_
MAK6-+L]6UT^(+XZR81':2["HAM4C)"Q\X!." ,<@\?/% !1110 4444 %%%%
M !7T!^R'_P UJ_[)GK7_ +1KY_KZ _9#_P":U?\ 9,]:_P#:- 'S_1110 5W
M/P5^%\_QC^)&D^%H;R/38KDO+<WTB[EMX(T+R28R,D*IP,C)QR.M<-7=?!/X
MHS?!OXDZ5XICLDU.&V\R*YL9&VBX@D1HY$S@XRK'!P>0* .^\=>!?@=J'@/6
M=2^'WC#Q%%X@TFYBA73/$T4)_M97;;NM1"H88Y;Y^V 0N0:=KO[%_CSP_P"&
M+W4I[_P[/J]A8?VG>^%K;4Q)J]K;8R9'@VXP!SPQZ\9/%2^+_B)\$-#\&ZI9
M_#OP;KT_B+4KR&Y34O%30$:4L;;MEMY3%F!R5(?J,$EL 5VOB']J;X:W&K>(
M_B%I/A;Q%#\4]?TE]-N(;JYB.D6[R1")YD(/F,=JC"D 'VZT <Q'^PGX^N=(
MMKVWUKPG//<:=!JT>G?VJ8[K[)+MS,4=%"I'N^=B0.#@L>*JQ_L2^-YO%5UH
ML6M>%Y(X=$3Q#'JZZDQL+BS9]N^.;R\<<DE@HP,Y((SNZI^U%X7O/$6J:A#8
MZPD=U\-!X-0&&(,+S !D.)?]5P>?O?[-3M^U/X4;P&VB?V?K/VL_#K_A$=_D
M1;/M>_=OSYN?*QWQN_V: .>US]A_QYHFF:U>G5_"M^FGZ<=7@AL=6\V74K-4
M5GN+5-F6C7< 6;:">!G(SFZ#^QUXW\0^%;#5(=1\.6VK:E9G4-.\+W6J+'J]
M[;[=P>*#;@@J"PRP.!VKK-*_:B\+V6M:9=RV.LM#:_#3_A#6588B?MFW'F >
M;_JL]_O?[-=]H/[?FGVOPRT73Y[[QIH?B/2=,2Q6TT&'2VT^Z>-=J2/)<P2R
MIN &0JD#L#0!X)HO[,.O:M\);?XB3^(_#&C:)<"X6WM]4OY(;J>6$L#!''Y9
M#RML;:JDYQSBKWC;]C_QMX!\'7NO7]_X?NKC388+C5=!L=2$NI:;'*0$>>(+
M@#)'*LW7/(!(SO%_QIL=>^#/P\\,V\-X-?\ #NIWVH75Q/&@MY#--YB;"K9)
M]054>E=;\9_C)\'_ (FPZ[XJM_!OB ?$?78X!,+Z[4:9I\JA5>:#RV5Y&*KC
M$@VY.<<8(!E^(OV7YH?C!K_@R/Q)X7\(+I<-M(9?$_B1-DC2Q*X2.0V\32L=
MQ/RP@+P"3P66Z_9F?PCX1^,S^*IYHO$O@8:8;9-/G5K2<74N"S;DW,I0JRX*
MD9Y':O2KS]J[X8:W\1/B#X@U#0/$UJ^M+8-IFL:4EM%JEOY$"))#YC.WDH[)
MRT9+$'L<8YWXI?M2>%?'5O\ &9K33]8@N/'-KHJ6D=Q%%MMY+3;YPD82$E3M
M^5@,G/(6@#Y=HHHH *^@/V"O^3L/ W_;]_Z07%?/]?0'[!7_ "=AX&_[?O\
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MM'[SS?\ B(F1?S2_\!.2_P"'4O\ U5'_ ,M[_P"ZJ/\ AU+_ -51_P#+>_\
MNJNM_P"&T_&__0+\/_\ @//_ /'J/^&T_&__ $"_#_\ X#S_ /QZC_5'-.T?
MO#_B(F1?S2_\!.2_X=2_]51_\M[_ .ZJ/^'4O_54?_+>_P#NJNM_X;3\;_\
M0+\/_P#@//\ _'J/^&T_&_\ T"_#_P#X#S__ !ZC_5'-.T?O#_B(F1?S2_\
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M2O\ P72__)%'VSQ)_P!!#2O_  72_P#R15<J_F7X_P"1/M)?R/\ #_,^+?\
MAU+_ -51_P#+>_\ NJC_ (=2_P#54?\ RWO_ +JK[2^V>)/^@AI7_@NE_P#D
MBC[9XD_Z"&E?^"Z7_P"2*.5?S+\?\@]I+^1_A_F?%O\ PZE_ZJC_ .6]_P#=
M5'_#J7_JJ/\ Y;W_ -U5]I?;/$F#_P 3#2LX./\ B72]>W_+Q0UYXDYQJ&E#
MKC.G2GUQ_P O'^[^1]>#E7\R_'_(/:2_D?X?YGQ;_P .I?\ JJ/_ );W_P!U
M4?\ #J7_ *JC_P"6]_\ =5?:37GB3G&H:4.N,Z=*?7'_ "\?[OY'UX&O/$G.
M-0TH=<9TZ4^N/^7C_=_(^O!RK^9?C_D'/+^1_A_F?%O_  ZE_P"JH_\ EO?_
M '51_P .I?\ JJ/_ );W_P!U5]I->>).<:AI0ZXSITI]<?\ +Q_N_D?7@^W>
M(U)/VW2Y!SA/L,B9ZX^;SC_L]NQ]>#E7\R_'_(/:2_D?X?YGQ;_PZE_ZJC_Y
M;W_W51_PZE_ZJC_Y;W_W57W1X?\ $ UC[5!-$EKJ%JRB>W6428##*NIP"5/(
M!*CE&':OF_XB?MD7NE^(;S3_  OI5E/:VLC1?;-0WOYQ4D%E567 ],D^O'2O
M2P.5XK,JCIX>-VM]=$>)FV?8#):,:V,G92=DDFV[;Z>76YY/_P .I?\ JJ/_
M );W_P!U4?\ #J7_ *JC_P"6]_\ =5=;_P -I^-_^@7X?_\  >?_ ./4?\-I
M^-_^@7X?_P# >?\ ^/5[W^J.:=H_>?)_\1$R+^:7_@)R7_#J7_JJ/_EO?_=5
M'_#J7_JJ/_EO?_=5=;_PVGXW_P"@7X?_ / >?_X]1_PVGXW_ .@7X?\ _ >?
M_P"/4?ZHYIVC]X?\1$R+^:7_ ("<E_PZE_ZJC_Y;W_W51_PZE_ZJC_Y;W_W5
M76_\-I^-_P#H%^'_ /P'G_\ CU'_  VGXW_Z!?A__P !Y_\ X]1_JCFG:/WA
M_P 1$R+^:7_@)R7_  ZE_P"JH_\ EO?_ '51_P .I?\ JJ/_ );W_P!U5UO_
M  VGXW_Z!?A__P !Y_\ X]1_PVGXW_Z!?A__ ,!Y_P#X]1_JCFG:/WA_Q$3(
MOYI?^ G)?\.I?^JH_P#EO?\ W51_PZE_ZJC_ .6]_P#=5=;_ ,-I^-_^@7X?
M_P# >?\ ^/4Z/]M3QHLBF32=!9,\JL$RD_CYI_E2_P!4<T_E7WC_ .(B9%_-
M+_P%E#X>_P#!-#_A _'WAKQ-_P +'^W?V+J=MJ/V7^P_+\[R95DV;OM)VYVX
MS@XST->>^/O^"?'Q#^)_COQ'XRTG6_"\6E>(M2N=7M([NZN5F6&XE:5 X%N0
M&"N,@$C.>37V[\%?C!:?&#P[/>):FPU"S<175KNW!21E64]U.#UY&"/<W-!U
MRXT_P7X4M+*W\^]GTR!PTH811HL*Y9F YY*KM'/S9Q@&OEJ^&JX:M*A65I1W
M/O<+CL/C<-#%X>7-"6S[]/ST/SX_X=?_ !3_ .@_X/\ _ RZ_P#D:C_AU_\
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M=*?7'_+Q_N_D?7@Y5_,OQ_R#GE_(_P /\S\[?^'7_P 4_P#H/^#_ /P,NO\
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M/+_P%GB7_#K_ .*?_0?\'_\ @9=?_(U'_#K_ .*?_0?\'_\ @9=?_(U>V_\
M#:?C?_H%^'__  'G_P#CU'_#:?C?_H%^'_\ P'G_ /CU/_5'-.T?O%_Q$3(O
MYI?^ GB7_#K_ .*?_0?\'_\ @9=?_(U'_#K_ .*?_0?\'_\ @9=?_(U>V_\
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M!%>'F&4XO*W%8F-E+9IW1]3D_$.7YZIO!3NX[IIIJ^Q^4W_#!7QV_P"A&_\
M*O8?_'Z/^&"OCM_T(W_E7L/_ (_7Z2_'?X\0?!^WLK:WLEU'6+U2\<4C%8XT
M!QO8CDY/  ]#R,<^#-^VGXVW'&E: !VS;S__ !ZNW!</9ACZ*KTHKE>UW:YY
MN:<8Y1E.(>%Q$WSK=)-V]3Y3_P"&"OCM_P!"-_Y5[#_X_1_PP5\=O^A&_P#*
MO8?_ !^OJS_AM/QO_P! OP__ . \_P#\>H_X;3\;_P#0+\/_ /@//_\ 'J[_
M /5'-.T?O/(_XB)D7\TO_ 3Y3_X8*^.W_0C?^5>P_P#C]'_#!7QV_P"A&_\
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MXB)D7\TO_ 3Y3_X8*^.W_0C?^5>P_P#C]'_#!7QV_P"A&_\ *O8?_'Z^K/\
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M7/AGS+JNO_!/'R[/_:R]EC8\DGL^GEZ?D_(^Z**X;X2?&CPK\:_#QU7PS?\
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M*.E^[6]O*][>04445T'$%?2_[9G_ #)X_P"OS_VA7S17TM^V;_S)_P#V^?\
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M[&2TD6=P<X*H1N/0]!V-=/\ !#4[#2?'B7&I7$=M9_8;Q':298@=UO( H9N
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M/JL=BS31['*QS[6C5PV<HV. 0,$5Y#\7M:L?$7Q,\1:CIKK+93W3&.1!\K@
M L..Y!/XUK@L;6Q%10J4^7W;_EI^+MIT^[#,\KPV#HNI1K<S4W'U7O:_))7U
M?Q6TLG+D*ZKX3_\ )4O!W_89L_\ T>E<K75?"?\ Y*EX._[#-G_Z/2O0Q?\
MN]3_  O\CQ\O_P!\H_XH_FC])J***_F0_N8**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BN&^(?QE\,_"_5M#T[7[F:VFUA+N2V9(]R;;>'S9-QSP<8
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M\_O_ "67_P B'^HG$7_0-_Y/#_Y(^::*^EO^&,O^IP_\IG_VZC_AC+_J</\
MRF?_ &ZC_6C*/^?W_DLO_D0_U$XB_P"@;_R>'_R1\T@%B !DGH*^F/VS$8IX
M0?!V@W8)[9/DX_D?RK;\&_LFZ7X=UVVU#5-:DUF.W<2):K:B%&8'(W_.V1[<
M5Z;\2OAKIGQ.T#^S=19X7C?S;>YBQOB?&,\]0>X[^W!KYC'\18*IF6%KTFY0
MI\UW9_:5MG9Z'W64\&YI2R3'X6O%1J5N3E5T_@ES:M-K79:^I^?]%?2Y_8S&
M3CQA@?\ 8,_^W4G_  QE_P!3A_Y3/_MU?3_ZT91_S^_\EE_\B?"_ZB<1?] W
M_D\/_DCYIHKZ6_X8R_ZG#_RF?_;J/^&,O^IP_P#*9_\ ;J/]:,H_Y_?^2R_^
M1#_43B+_ *!O_)X?_)'S317TM_PQE_U.'_E,_P#MU'_#&7_4X?\ E,_^W4?Z
MT91_S^_\EE_\B'^HG$7_ $#?^3P_^2/FFBOI;_AC+_J</_*9_P#;J/\ AC+_
M *G#_P IG_VZC_6C*/\ G]_Y++_Y$/\ 43B+_H&_\GA_\D?--%?2W_#&7_4X
M?^4S_P"W4?\ #&7_ %.'_E,_^W4?ZT91_P _O_)9?_(A_J)Q%_T#?^3P_P#D
MCYIK[\^$X*V/@($8(\+G(_"SKR?1?V.["UU&&74O$<NH6B'+V\-H("_MNWM@
M?09^E>\Z9;QVOC+28(46*&/2[M$11@*HDM0 /;%?"\49QA,RA2I867-9MMV:
M_.Q^K<!\-YCDM6O7Q\.3F225TWO>^C:_$^#?BTC1_%3QB&4J?[8O#SZ&9R#^
M5<I7V_\ %?\ 98TGXD>(I=;L]5DT*^N,&Y MQ/'*P &X+N4JV!SSSZ9SGB/^
M&&_^IU_\I7_V^OKL'Q1E:P]-5:G+)))JTNB\DT?G>9<"YZ\95E0H\\')M-2B
MKIN^SDG^!\KT5]4?\,-_]3K_ .4K_P"WT?\ ##?_ %.O_E*_^WUV?ZT91_S^
M_P#)9?\ R)YO^HG$7_0-_P"3P_\ DCY7HKZH_P"&&_\ J=?_ "E?_;Z/^&&_
M^IU_\I7_ -OH_P!:,H_Y_?\ DLO_ )$/]1.(O^@;_P GA_\ )'RO17U1_P ,
M-_\ 4Z_^4K_[?1_PPW_U.O\ Y2O_ +?1_K1E'_/[_P EE_\ (A_J)Q%_T#?^
M3P_^2/E>BOJC_AAO_J=?_*5_]OH_X8;_ .IU_P#*5_\ ;Z/]:,H_Y_?^2R_^
M1#_43B+_ *!O_)X?_)'RO7OW[%BG_A:.JG'']C2C/_;>"NJ_X8;_ .IU_P#*
M5_\ ;Z]?^#?P-TGX/VMTUM<R:EJ=V L][*@3Y0<A44$[1GD\G)^@KQ,ZXBR[
M$8"I1H3YI25MFOS2/J.&>#,YP>;4<5BZ7)"#NWS1?39*+9\F_M2(R_'/Q(2I
M 86Q7/<?9HAG\P:\JK[T^,G[.ND_%N^AU,7\FC:O&@B:XCB$J2H,X#)E<D9X
M((XXYXQYG_PPW_U.O_E*_P#M];Y7Q+EM+!4J5:IRRC%)JTGLK=$SESW@C.Z^
M9XBOAJ7/"<I23YHKXFW:S:>E['RO17U1_P ,-_\ 4Z_^4K_[?1_PPW_U.O\
MY2O_ +?7J?ZT91_S^_\ )9?_ ")X/^HG$7_0-_Y/#_Y(^5Z*^J/^&&_^IU_\
MI7_V^C_AAO\ ZG7_ ,I7_P!OH_UHRC_G]_Y++_Y$/]1.(O\ H&_\GA_\D?*]
M%?5'_##?_4Z_^4K_ .WT?\,-_P#4Z_\ E*_^WT?ZT91_S^_\EE_\B'^HG$7_
M $#?^3P_^2/E>BOJC_AAO_J=?_*5_P#;Z/\ AAO_ *G7_P I7_V^C_6C*/\
MG]_Y++_Y$/\ 43B+_H&_\GA_\D?*]>H_LQVZW7QP\.1R)OCQ<[AV_P"/:7^M
M>K_\,-_]3K_Y2O\ [?7I7P;_ &<=)^$NI2ZHVH2:SJS(8DN'A$21(>NU,MR>
MF<]...<^9FG$N6U<%5I4:G-*46DK26ZMU2/=R+@G.Z&9X>OB:/)"$XR;YHOX
M6G:R;>MC:U#1+7^R_B!)#:YN89)# 8D+.K"Q@8;0(Y23N.0!')S_  -]TIH_
MA*"QU*>]E56?S6,$?:-<G!^N/RKH]%MXKO4/%T$T:RPRWZH\;#(939VX(/MB
MJ$.@Z[I$26EH+'4;6(!(I;F8V\@4  *RI$RD]>0%&,#;WK\:24HVZG]*R;A*
M[V9>HJK]C\2?] _2O_!C+_\ (]'V/Q)_T#]*_P#!C+_\CT>S?E]Z#VL>S^Y_
MY%JO*];\'^,M3^*">(+BQT/6-&TU0NC65QJDUO\ 9G(Q)<2(+:0/*>B\@*.G
M)S7I7V/Q)_T#]*_\&,O_ ,CT+9^).,Z?I0Z9QJ,I],_\N_\ O?D/7C>E*5%M
MJSNK;_\ !.7$0AB%%2<E9WT3Z;7NFGW];/H>1^(/@EJOBRUU&TU*]MX+?5_$
MHU74'M)Y%E-G%&%@B1M@^?,<>>@')!) JM:_"'QCH_A'PSH6GZE8_9=)6\A>
M.&]GL?,#N?L\QEBCWEU0G<@*AF)^?O7LJV?B3C.GZ4.F<:C*?3/_ "[_ .]^
M0]>!;/Q)QG3]*'3.-1E/IG_EW_WOR'KQU+&5[*-U9>G:W?M^2.!Y=A')SM+F
M:M?7:Z?;NK_-]S#^&?A27P/\/]!T*XD2:ZL;1([B2-BRO+C,C D D%BQR0#S
M73556S\2<9T_2ATSC493Z9_Y=_\ >_(>O MGXDXSI^E#IG&HRGTS_P N_P#O
M?D/7CAFIU).<FKO7='JTG3HTXTX)V226CZ?(M4556S\2<9T_2ATSC493Z9_Y
M=_\ >_(>O MGXD;&;#2E]2-0E;'3/'D#/\7IT'3/$<C\OO1I[6/9_<_\B7P]
M-N\5ZO%YQ;;96C>3O)"YDN/FV^80,XZB-2=O+O@"/\V'1HW9'4JRG!4]0?2O
MTW\.Z-/ID<\UY,)[ZY8-+Y;/Y: 9VH@8\  XR -W4@$UXCX\_8[TGQ3XBNM4
MTK7)-#6Z<RRVK6@G0.3DE/G7:">W/Y<5]SPSF^%RVI5CB964E'6S?PW[:]3\
MKXXX=Q^=T<//!1YI0<[JZ3M*SZM+2VNI\:T5]4?\,-_]3K_Y2O\ [?1_PPW_
M -3K_P"4K_[?7W_^M&4?\_O_ "67_P B?D/^HG$7_0-_Y/#_ .2/E>BOJC_A
MAO\ ZG7_ ,I7_P!OH_X8;_ZG7_RE?_;Z/]:,H_Y_?^2R_P#D0_U$XB_Z!O\
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MS/Q*\(R^.O!>HZ-!<I:7$_EO%+(I9-\<BR*' ()4E #CL36Y]C\2?] _2O\
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M_P#E*_\ M]'_  PW_P!3K_Y2O_M]'^M&4?\ /[_R67_R(?ZB<1?] W_D\/\
MY(^5Z*^J/^&&_P#J=?\ RE?_ &^C_AAO_J=?_*5_]OH_UHRC_G]_Y++_ .1#
M_43B+_H&_P#)X?\ R1\KUU7PG4M\4_!P S_Q.;,_^1TKW[_AAO\ ZG7_ ,I7
M_P!OKM?A7^RKI/P[\1PZW>ZM)KM[;'=;*;<01QMC&XKN8L1VY&.OI7'C.)\K
M>'J*G4YI--)6E^J2/1RW@7/8XRE*M1Y(J2;;E%V2=]E)O\#W.BBBOP\_J<**
M** "BBB@ HHHH **** "BBB@ HHHH **** /F+]MSQT_A*S\&6UO8:*NH33W
MM]:ZWK=DETEA):VYF58E?Y1+*P55)[CH3C'?_LW^.+7QUH_C2ZM-&T[2UM?%
M-_:/<Z6H$.HLK*1<Y'WG964,V>64GC.!YW\9?C%::A=CP?K^G_#/Q!)<:M=Q
M6^G:YKOR)#"J>7)*?)=89CNE!5BN,84DDUZQ\ =4&H>!S!%IOA32+2RN&M[>
MS\'Z@EY9QIM5N65$"N2S$KCN#GF@#TJBBB@#P70_BAXDO/%VF>!Y]3 UW3O$
M&H'6;UH(QOTF",3PL5V[5\Q;JR0L #_K,$$5SNE?%OQ39^,O"%]!JWB3Q'X8
MUN6[26XU/1;/3].NMME+=(;&/"WJ &(*#-O5ER0[<,??H_ N@Q>+K[Q0NF1?
MV]>V2:=<7A))DMT8LL94G;C+'G&3P#D 8YO1_@'X'T/4M)OK;2KE[G2)!)IC
M76J7=PMA\C)LMUDE98HRKD&- $.U,J=BX .*T_QIXP\._ 74OB7?>(X]?FO/
M#B:O!ID]E$EO8W+QF0".2(*S0 .H*R;WPF=_)%:OCBR\0^#_ (;3-JGB;_A+
M'EUG1_(FU/3+4/$KWMLDBD)&(V&2S(WEADR/F) 8==H7P<\(>'?[16STC=!?
MVS64MK=W,US ELQ):"**5V2&(D\QQA5.%X^4833?@YX3TK2+G38K"YN+:YN+
M:YE:^U*ZNIF>W=7@'G2R-)L1D4J@;:.>/F;(!Y+%XZ\;06LOBB;Q9-/:P>/6
M\.KH8L;9;9[)M1^RC>_E^:9%#@AU=1A%!5CN9E\._$;XF>+[Y_$&DZ)XBNK,
M:U/9IIJ_V.ND&TBNF@<L[S+>"4*C.3T#C'EE>OLK?#'PTVEOIQTW-F^K?VXT
M?GR\WHN!<>;G=G_6@-MSM[8QQ5&?X+^#[CQ%)K+Z9-]IENUU"6U6_N%L9;E<
M8G>T$GD/("JMO:,MN56SD T <'X?\9>+-&^*$%AXSU/6M)%_?W,%G:R:5;3Z
M)>Q%I?LR6UU"/.@GV(C,+E_F)D"IRI7W.N+TOX/^%-&\1+K5K87"W<=Q+=PP
M2:A<R6D$\I8R2Q6K2&&)VWOED0'YWY^8Y[2@ HHHH **** "BBB@ HHHH **
M** "O@36O VE^$_VB/B#X1U/2[.\T^\G7Q+I<=W DBA+C GVA@< 2C;QZ5]]
MU\G_ +:FBGPWXM^&_P 0X1MC@O'T#47'>&X!:(MZ*CJQ^K"O0P%2-/$PYU=/
M1_/^KGEYI"K+"5'0DXSBKIIV=UV:[[?,X_Q-X5T?3],M[;P_\/M$U36+Z3R(
M99M+A-O:\9,LS;>% [=SQ5KQ%\--.^&/P'O=,TPP2:G?:OI$MW?2VXV33?VE
M;8)B4J!&N3B-2 !D9R2:W])U7:!S6WJ<>G>*M$N=)U6!;O3[I=DL18KG!!!!
M4@J00"&!!! (((KZ;%97'GE4BM;66FQ\K@^+L74P4,#.HW"_-)N3;FT]+W>T
M>B5E?5W=K><^(M*U+3;;PO)?6[AH_$6C>9*MNT49/]H6_0$G ]LFO>]:U /N
MYKY/^!=G%KWQ4^(T&M:AJVLVGAO5XO[(M]1U2YGBMR'GVML>0J[+L0@N"05!
M'/->_:EK6X'YJY,OP;MS?UIH3G&91;Y.J7YJYG:]=!MW-+^P_H?]MWGQ#^(L
MJ[AK&IC2[!C_ ,^MJ-NY?9W8Y]TKS7XR>-&\,^!=:OX6/VD0&*WV\DRO\B8'
M?YF!_"OK?X$_#Y?A7\'_  EX6V!)M/L(UN0.AN&^>8_C(SG\:O/*GLX4\/\
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M+F%T4,S.@3Y5&0,D]>U<A5TZ6#JW5.,7;?1&5:OF6'475G-<RNKMZK[SI?\
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M /BZ/^%L>-_^AQ\0?^#2?_XNJ>C^#;W6O#][K$$MNEM:75O:.LC,'+S%@I
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M_P#Q='_"V/&__0X^(/\ P:3_ /Q=<K17=]4P_P#S[C]R/*_M#&?\_I?^!/\
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M8!NW ]NQ:MC]DEO#W_"M]231X-7M]6CUF[3Q"NO2K+??VH&'GF5T 5CC9@J
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MXUVZ^7&,_:STV]<CG[@^N6_O-G7^ULP_Z")_^!2_S(_U0P7_ $+8_P#@I?\
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MZ")_^!2_S#_5#!?]"V/_ (*7_P B4/\ AEWX8_\ 0L_^3]U_\=KN?"?@K0_
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MA[H[=N-UW*>FS&<MS_JUSGKEL_?;)_:V8?\ 01/_ ,"E_F'^K^3_ /0'2_\
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M*6M%=)@7&)+KC'6[E/3'^U_LC]?4YQ/ NFQ2^"_#TA>X#-I]LQ"W$BKGRTZ
M-@#Y1QTZ^IR =115)=)@7&)+KC'6[E/3'^U_LC]?4Y%TF!<8DNN,=;N4],?[
M7^R/U]3D NT52728%QB2ZXQUNY3TQ_M?[(_7U.1=(@7&)+KMUNY3TQ_M>P_7
MU- %VBJ0TF 8_>77_@7+[?[7M_/U- TF 8_>77_@7+[?[7M_/U- %VBJ0TF
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M2_LF#_GI=?\ @7+_ /%4?V3!_P ]+K_P+E_^*H NT52_LF#_ )Z77_@7+_\
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M^PE8?^ED-;U8/C3_ ) ]O_V$K#_TLAH WJ*** "BBB@ HHHH **** "BBB@
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MG)]./4$ "@X<=DSITWB,.[Q6K75?Y_GZGZ-4444'RQ%<_P#'O+_N'^5>!?M
M?\P'_MX_]IU[[<_\>\O^X?Y5XM\;O#UWJVDV%Y:Q-/\ 8V?S$C&2%8+\V/0;
M?UH/:R:<:>/IRD[+7\4T>&T4=.#10?K)<T?5)=#U:TU"!4>:VE65%D!*D@Y&
M<$<5N6?Q$U.S%N!':S>1+,ZF5&;]W*/GA/S?ZL]<=0>]<O1085*-.J[SC?\
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M36HT&[T^T%U?6]W##.;F2-,AQ;L 0TH"J,A\;MRH2R@'A_B+PKXL\=ZYJKV
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M/_XNO":*#[__ %?P79_>>[?\+WT#_GSU+_OU'_\ %T?\+WT#_GSU+_OU'_\
M%UX310'^K^![/[SW;_A>^@?\^>I?]^H__BZ/^%[Z!_SYZE_WZC_^+KPFB@/]
M7\#V?WGNW_"]] _Y\]2_[]1__%T?\+WT#_GSU+_OU'_\77A-% ?ZOX'L_O/=
MO^%[Z!_SYZE_WZC_ /BZ/^%[Z!_SYZE_WZC_ /BZ\)HH#_5_ ]G]Y]%^'_BQ
MH/B*^CM(GGM;B0[8UND"[CZ @D9KLJ^1(Y&AD21#M=2&4CL17UW0?*9UEU+
M2@Z3=I7W\K?YA1110?-A1110 4444 %%%% !1110 53L_P#D>M-_[!MY_P"C
M;6KE4[/_ )'K3?\ L&WG_HVUH TO$7@?0O%C1MJNG1W4B#"R99' ]-RD''MF
ML3_A2?@O_H#?^34W_P 77<44'7#%XFG'EA4DEY-G#_\ "D_!?_0&_P#)J;_X
MNC_A2?@O_H#?^34W_P 77<44%_7\7_S^E_X$_P#,X?\ X4GX+_Z W_DU-_\
M%T?\*3\%_P#0&_\ )J;_ .+KN** ^OXO_G]+_P "?^9P_P#PI/P7_P! ;_R:
MF_\ BZ/^%)^"_P#H#?\ DU-_\77<44!]?Q?_ #^E_P"!/_,X?_A2?@O_ * W
M_DU-_P#%T?\ "D_!?_0&_P#)J;_XNNXHH#Z_B_\ G]+_ ,"?^9P__"D_!?\
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MBBB@ K!\:?\ ('M_^PE8?^ED-;U8/C3_ ) ]O_V$K#_TLAH WJ*** "BBB@
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M10 4444 %8/@'_D1?#G_ &#;;_T4M;U8/@'_ )$7PY_V#;;_ -%+0!O4444
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M_P!OW_0^U OY^/\ B6W0_P"!1>W^W[_H?:@"[15(7\_'_$MNA_P*+V_V_?\
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M/MD6\F;;FPN%SC.6CXSM_P!OMN/_ 'P?;(?4_P"LU;_GVOO9\Q_\(=K_ /T
M]2_\!)/\*/\ A#M?_P"@'J7_ ("2?X5].+>3-MS87"YQG+1\9V_[?;<?^^#[
M9%O)FVYL+A<XSEH^,[?]OMN/_?!]L@?ZS5O^?:^]GS'_ ,(=K_\ T ]2_P#
M23_"C_A#M?\ ^@'J7_@))_A7TXMY,VW-A<+G&<M'QG;_ +?;<?\ O@^V1;R9
MMN;"X7.,Y:/C.W_;[;C_ -\'VR!_K-6_Y]K[V?,?_"':_P#] /4O_ 23_"C_
M (0[7_\ H!ZE_P" DG^%?3BWDS;<V%PN<9RT?&=O^WVW'_O@^V1;R9MN;"X7
M.,Y:/C.W_;[;C_WP?;('^LU;_GVOO9\Q_P#"':__ - /4O\ P$D_PH_X0[7_
M /H!ZE_X"2?X5].+>3-MS87"YQG+1\9V_P"WVW'_ +X/MD6\F;;FPN%SC.6C
MXSM_V^VX_P#?!]L@?ZS5O^?:^]GSMX>^&^N:SJD,$VFW5G;[AYLUQ$T85<\X
MSC)]A7TG55;R9MN;"X7.,Y:/C.W_ &^VX_\ ?!]LBWDS;<V%PN<9RT?&=O\
MM]MQ_P"^#[9#P\PS*IF$HN:24=K>9:HJJMY,VW-A<+G&<M'QG;_M]MQ_[X/M
MD6\F;;FQN%SC.6CXSMZ_/VW'I_<;_9W!Y):HJJEY,VW-A<)G&=S1\9V]</VW
M'I_<;&?EW"7DS;<V%PF<9W-'QG;UP_;<>G]QL9^7< 6J*JI>3-MS87"9QG<T
M?&=O7#]MQZ?W&QGY=PEY,VW-A<)G&=S1\9V]</VW'I_<;&?EW %JBJJ7DS;<
MV%PF<9W-'QG;UP_;<>G]QL9^7<)>3-MS87"9QG<T?&=O7#]MQZ?W&QGY=P!:
MHJJEY,VW-A<)G&=S1\9V]</VW'I_<;&?EW"7DS;<V%PF<9W-'QG;UP_;<>G]
MQL9^7< 6JIV?_(]:;_V#;S_T;:TY+R9MN;"X3.,[FCXSMZX?MN/3^XV,_+NJ
M6-U*WC337-G,C?V?<CRV*;L&6TR>&QA<G/.?E.,\9 .XHJE'?SMLSIMTF[;G
M<T7RYV9SA^VYLX_YYMC.5W$=_.VS.FW2;MN=S1?+G9G.'[;FSC_GFV,Y7< 7
M:*I1W\[;,Z;=)NVYW-%\N=F<X?MN;./^>;8SE=Q'?SMLSIMTF[;G<T7RYV9S
MA^VYLX_YYMC.5W %VBJ4=_.VS.FW2;MN=S1?+G9G.'[;FSC_ )YMC.5W"W\[
M;<Z;=+G&<M%QG;UP_;<?^^&_V<@%VBJ2W\[;<Z;=+G&<M%QG;UP_;<?^^&_V
M<BW\[;<Z;=+G&<M%QG;UP_;<?^^&_P!G(!=HJDM_.VW.FW2YQG+1<9V]</VW
M'_OAO]G(M_.VW.FW2YQG+1<9V]</VW'_ +X;_9R 7:*I+?SMMSIMTN<9RT7&
M=O7#]MQ_[X;_ &<BW\[;<Z;=+G&<M%QG;UP_;<?^^&_V<@%VBJ2W\[;<Z;=+
MG&<M%QG;UP_;<?\ OAO]G(M_.VW.FW2YQG+1<9V]</VW'_OAO]G(!=HJDM_.
MVW.FW2YQG+1<9V]</VW'_OAO]G(M_.VW.FW2YQG+1<9V]</VW'_OAO\ 9R 7
M:*I+?SMMSIMTN<9RT7&=O7#]MQ_[X;_9R+?SMMSIMTN<9RT7&=O7#]MQ_P"^
M&_V<@%VBJ2W\[;<Z;=+G&<M%QG;UP_;<?^^&_P!G(M_.VW.FW2YQG+1<9V]<
M/VW'_OAO]G(!=HJDM_.P7.FW2YQG+1<9V_[?;<?^^#[9%OYVQG3;I<XZM%QT
M_P!OW/\ WR?;(!=HJDM_.V,Z;=+G'5HN.G^W[G_OD^V1;^=L9TVZ7..K1<=/
M]OW/_?)]L@&=X<_Y#'BG_L))_P"D=M6]7+^';R8:MXE/V&X)?4(RPW1Y3_1+
M88/S]><\9Z'V%;:W\[8SIMTN<=6BXZ?[?N?^^3[9 +M%4EOYVQG3;I<XZM%Q
MT_V_<_\ ?)]LBW\[8SIMTN<=6BXZ?[?N?^^3[9 +M%4EOYVQG3;I<XZM%QT_
MV_<_]\GVR+?SMC.FW2YQU:+CI_M^Y_[Y/MD NT526_G;&=-NESCJT7'3_;]S
M_P!\GVR+?SMC.FW2YQU:+CI_M^Y_[Y/MD NT526_G;&=-NESCJT7'3_;]S_W
MR?;(M_.V,Z;=+G'5HN.G^W[G_OD^V0"[15);^=L9TVZ7..K1<=/]OW/_ 'R?
M;(NH3G&=-NATZM%[?[?N?R/MD NT52%_/Q_Q+;H?\"B]O]OW_0^U OY^/^);
M=#_@47M_M^_Z'VH NT52%_/Q_P 2VZ'_  *+V_V_?]#[4"_GX_XEMT/^!1>W
M^W[_ *'VH NT52%_/Q_Q+;H?\"B]O]OW_0^U OY^/^);=#_@47M_M^_Z'VH
MNT52%_/Q_P 2VZ'_  *+V_V_?]#[4"_GX_XEMT/^!1>W^W[_ *'VH NT52%_
M/Q_Q+;H?\"B]O]OW_0^U OY^/^);=#_@47M_M^_Z'VH NT52%_/Q_P 2VZ'_
M  *+V_V_?]#[4"_GX_XEMT/^!1>W^W[_ *'VH NU@^ ?^1%\.?\ 8-MO_12U
MHB_GX_XEMT/^!1>W^W[_ *'VK#\"WDR^"?#RBPN' TZW =6CP?W2<\OG_P#5
M0!U-%4OM\_'_ !+;K_OJ+_XNC[?/_P! VZ_[ZB_^+H NT52^WS_] VZ_[ZB_
M^+H^WS_] VZ_[ZB_^+H NT52^WS_ /0-NO\ OJ+_ .+H^WS_ /0-NO\ OJ+_
M .+H NT52^WS_P#0-NO^^HO_ (NC[?/_ - VZ_[ZB_\ BZ +M%4OM\__ $#;
MK_OJ+_XNC[?/_P! VZ_[ZB_^+H NT52^WS_] VZ_[ZB_^+H^WS_] VZ_[ZB_
M^+H NT52^WS_ /0-NO\ OJ+_ .+H^WS_ /0-NO\ OJ+_ .+H NT52^WS_P#0
M-NO^^HO_ (NC^T)_^@;=?]]1>_\ M^WZB@"[15(W\_/_ !+;H_\  HO?_;]O
MU'O0;^?G_B6W1_X%%[_[?M^H]Z +M%4C?S\_\2VZ/_ HO?\ V_;]1[T&_GY_
MXEMT?^!1>_\ M^WZCWH NT52-_/S_P 2VZ/_  *+W_V_;]1[T&_GY_XEMT?^
M!1>_^W[?J/>@"[6#XT_Y ]O_ -A*P_\ 2R&M$W\_/_$MNC_P*+W_ -OV_4>]
M8?C.^F.D0#^S[@?\3&Q.2T7.+N+C[_? _,>^ #J:*I&_GY_XEMT?^!1>_P#M
M^WZCWH-_/S_Q+;H_\"B]_P#;]OU'O0!=HJD;^?G_ (EMT?\ @47O_M^WZCWH
M-_/S_P 2VZ/_  *+W_V_;]1[T 7:*I&_GY_XEMT?^!1>_P#M^WZCWH-_/S_Q
M+;HXS_%%SU_V_;]1[X +M%4FOYUSC3;IL9Z-%SU_V_8?]]#WP-?SKG&FW38S
MT:+GK_M^P_[Z'O@ NT52:_G7.--NFQGHT7/7_;]A_P!]#WP-?SKG&FW38ST:
M+GK_ +?L/^^A[X +M%4FOYUSC3;IL9Z-%SU_V_8?]]#WP-?SKG&FW38ST:+G
MK_M^P_[Z'O@ NT52:_G7.--NFQGHT7/7_;]A_P!]#WP-?SKG&FW38ST:+GK_
M +?L/^^A[X +M%4FOYUSC3;IL9Z-%SU_V_8?]]#WP-?SKG&FW38ST:+GK_M^
MP_[Z'O@ NT52:_G7.--NFQGHT7/7_;]A_P!]#WP-?SKG&FW38ST:+GK_ +?L
M/^^A[X +M%4FOYUSC3;IL9Z-%SU_V_8?]]#WP?;I]Q']G7./7=%S][_;_P!D
M?]]CWP 7:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBL/QIXWT'X=^';K7?$FJ6^CZ5
M;#,ES<M@9[*HZLQ[* 2>PH W**^;?AQ^W=X#\>>,&T2^MK_PI#=2;=)U'6%$
M<%^.GWND3$] QP1CD$A:^D:;36C$FGL+1112&%%%% $5S_Q[R_[A_E6#6]<_
M\>\O^X?Y5@T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IV?\
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M7SQ]"%%%% !1110 4444 %%%% !1110!@^'/^0QXI_["2?\ I';5O5@^'/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_8#F_P#2BWKBQO\ N\_0[<%_O$/4^[:***^'/N HHHH **** "BBB@ HHHH
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MW3;KPO)<>)_$>K6_AEQ_9%E>3VX@MHO(> Q%8X4\U3&^-TI=QM&'&Y]WJE%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM>W\_4U=HH I#28!C]Y=?^!<OM_M>W\_4T#28!C]Y=?^!<OM_M>W\_4U=HH
MI#28!C]Y=?\ @7+[?[7M_/U- TF 8_>77_@7+[?[7M_/U-7:* ,ZXTF!;>3Y
M[GA3_P O4OI_O>W\_4UA_P!FPC'SW'_@3)[?[7M747/_ ![R_P"X?Y5@T 51
MIL*D'?<<?]/,GM_M>P_7U-"Z;"N,/<<8ZW,AZ8_VO8?KZG-JB@"JNFPKC#W'
M&.MS(>F/]KV'Z^IR+IL*XP]QQCK<R'IC_:]A^OJ<VJ* *JZ;"N,/<<8ZW,AZ
M8_VO8?KZG(NFPKC#W'&.MS(>F/\ :]A^OJ<VJ* *JZ;"N,/<<8ZW,AZ8_P!K
MV'Z^IR+IL*XP]QQCK<R'IC_:]A^OJ<VJ* *JZ;"N,/<<8ZW,AZ8_VO8?KZG(
MNFPKC#W'&.MS(>F/]KV'Z^IS:HH JKIL*XP]QQCK<R'IC_:]A^OJ<BZ;"N,/
M<<8ZW,AZ8_VO8?KZG-JB@"JNFPKC#W'&.MS(>F/]KV'Z^IR+IL*XP]QQCK<R
M'IC_ &O8?KZG-JB@"JNFPKC#W'&.MS(>F/\ :]A^OJ<BZ;"N,/<<8ZW,AZ8_
MVO8?KZG-JB@"JNFPK@A[CC'6XD/3;_M?[(_,_P!XY%TV%=N'N/EQC-S(>FW_
M &N?NC\S_>.;5% %5=-A7;A[CY<8S<R'IM_VN?NC\S_>.1=-A7;A[CY<8S<R
M'IM_VN?NC\S_ 'CFU10!57385VX>X^7&,W,AZ;?]KG[H_,_WCD7385VX>X^7
M&,W,AZ;?]KG[H_,_WCFU10!57385VX>X^7&,W,AZ;?\ :Y^Z/S/]XYJ6.GQ+
MXUTV,-/M_L^Z;)GD)^66TQSNSC@9'0\YSDUJU3L_^1ZTW_L&WG_HVUH Z)=)
M@3;B2Z^7&,W<IZ;>N6Y^X/KEO[S9%TF!-N)+KY<8S=RGIMZY;G[@^N6_O-F[
M10!2728$VXDNOEQC-W*>FWKEN?N#ZY;^\V1=)@3;B2Z^7&,W<IZ;>N6Y^X/K
MEO[S9NT4 4ETF!-N)+KY<8S=RGIMZY;G[@^N6_O-D728$VXDNOEQC-W*>FWK
MEN?N#ZY;^\V;M% %)=)@3;B2Z^7&,W<IZ;>N6Y^X/KEO[S9%TF!-F'NCM*D9
MNY3TVXSEN?N#.>N6S]YLW:* *4>DP1[,/=';MQNNY3TV8SEN?]6N<]<MG[[9
M(])@CV8>Z.W;C==RGILQG+<_ZM<YZY;/WVS=HH I1Z3!'LP]T=NW&Z[E/39C
M.6Y_U:YSURV?OMDCTF"/9A[H[=N-UW*>FS&<MS_JUSGKEL_?;-VB@"E'I,$>
MS#W1V[<;KN4]-F,Y;G_5KG/7+9^^V2/28(]F'NCMVXW7<IZ;,9RW/^K7.>N6
MS]]LW:* *4>DP1[,/=';MQNNY3TV8SEN?]6N<]<MG[[9(])@CV8>Z.W;C==R
MGILQG+<_ZM<YZY;/WVS=HH I1Z3!'LP]T=NW&Z[E/39C.6Y_U:YSURV?OMDC
MTF"/9A[H[=N-UW*>FS&<MS_JUSGKEL_?;-VB@"E'I,$>S#W1V[<;KN4]-F,Y
M;G_5KG/7+9^^V2/28(]F'NCMVXW7<IZ;,9RW/^K7.>N6S]]LW:* *4>DP1[,
M/=';MQNNY3TV8SEN?]6N<]<MG[[9(])@CV8>Z.W;C==RGILQG+<_ZM<YZY;/
MWVS=HH I1Z3!'LP]T=NW&Z[E/39C.6Y_U:YSURV?OMD728$V8>Z^7:!F[E/3
M;C.6Y^X,YZY;/WFS=HH Y?P[IL1U;Q&N^XQ%J$:K_I$F3BTM3\QW?,?E')R<
M9'0G.VNDP)MQ)=?+C&;N4]-O7+<_<'URW]YLYWAS_D,>*?\ L))_Z1VU;U %
M)=)@3;B2Z^7&,W<IZ;>N6Y^X/KEO[S9%TF!-N)+KY<8S=RGIMZY;G[@^N6_O
M-F[10!2728$VXDNOEQC-W*>FWKEN?N#ZY;^\V1=)@3;B2Z^7&,W<IZ;>N6Y^
MX/KEO[S9NT4 4ETF!-N)+KY<8S=RGIMZY;G[@^N6_O-D728$VXDNOEQC-W*>
MFWKEN?N#ZY;^\V;M% %)=)@3;B2Z^7&,W<IZ;>N6Y^X/KEO[S9%TF!-N)+KY
M<8S=RGIMZY;G[@^N6_O-F[10!2728$VXDNOEQC-W*>FWKEN?N#ZY;^\V1=)@
M3;B2Z^7&,W<IZ;>N6Y^X/KEO[S9NT4 4ETF!-N)+KY<8S=RGIMZY;G[@^N6_
MO-D728$VXDNOEQC-W*>FWKEN?N#ZY;^\V;M% %)=)@4*!)=?+C&;N4]-O^US
M]T?F?[QR+I,"XQ)=<8ZW<IZ8_P!K_9'Z^IS=HH I+I,"XQ)=<8ZW<IZ8_P!K
M_9'Z^IR+I,"XQ)=<8ZW<IZ8_VO\ 9'Z^IS=HH I+I,"XQ)=<8ZW<IZ8_VO\
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M?\?<O_Q5']DP?\]+K_P+E_\ BJNT4 4O[)@_YZ77_@7+_P#%4?V3!_STNO\
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MX7^67W+_ #(^OTNS_KYGTA17S?\ \+<\6?\ 06_\EH?_ (BC_A;GBS_H+?\
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MO4Q%"'+9(^>J05K'HGBSP_9:YIUS8:A:0WME.NR6"= R,/0@UYC\-?$GB?\
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MULNJWN]+?U^(^2'+=/I^)R%%%%>><X5Z1\!_^1OO/^O%_P#T9'7F]>D? ?\
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MQ:31-?HT<SF%@,@O@C.XX(SCGUI^L:9K_AU;Z]FU5R_VHZ?.\-Q)OD8(&Y)
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MD_\ [96']CX[_GW^*_S,_J=?^7\4>/T5[!_PS[_U'_\ R3_^V4?\,^_]1_\
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MOX)GOK03:DU]&R6R2?*8PNT@R+@\'UKI_P#AGW_J/_\ DG_]LH_X9]_ZC_\
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M,'15W&^GK;_([<91G647#H>%T5[!_P ,^_\ 4?\ _)/_ .V4?\,^_P#4?_\
M)/\ ^V5\O_8^._Y]_BO\SS/J=?\ E_%'C]%>P?\ #/O_ %'_ /R3_P#ME'_#
M/O\ U'__ "3_ /ME']CX[_GW^*_S#ZG7_E_%'C]%>P?\,^_]1_\ \D__ +91
M_P ,^_\ 4?\ _)/_ .V4?V/CO^??XK_,/J=?^7\4>/T5[!_PS[_U'_\ R3_^
MV4?\,^_]1_\ \D__ +91_8^._P"??XK_ ##ZG7_E_%'C]%>P?\,^_P#4?_\
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MZ-&C##P5.FK)'1"$:<>6.P4445L617/_ ![R_P"X?Y5@UO7/_'O+_N'^58-
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M4[/_ )'K3?\ L&WG_HVUJY5.S_Y'K3?^P;>?^C;6@#KZ*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH P?#G_ "&/%/\
MV$D_]([:MZL'PY_R&/%/_823_P!([:MZ@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "L'P#_R(OAS_ +!MM_Z*6MZL'P#_
M ,B+X<_[!MM_Z*6@#>HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMUA6%X2L<-W+#'N1R65]D:[@?XL\#H #NJ*** "BBB@ HHHH **** "BBB@
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M% !1110 4444 %%%% !1110 4444 %%%% !5.S_Y'K3?^P;>?^C;6KE4[/\
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M_P!%+6]6#X!_Y$7PY_V#;;_T4M &]1110 4444 %%%% !1110 4444 %%%%
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MO_V$K#_TLAK>K!\:?\@>W_["5A_Z60T ;U%%% !1110 4444 %%%% !1110
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M:;Q)XAT_1O$A:34]'L+B".":4PK%Y@<PF93B.,[!($)3#(RLRMZC10!X;9_
M>]UKQQ\0Y=7UG7+#PYK4]G$UE:W4'DZO;1V4,;B7Y&DCRRR(QC:)F!P21MQU
M^I?!BSN-8U"]TGQ%KWA6WU3RO[2T_0YX88+LHH0/EHFDA<QJJ%X'C8A5YRH(
M]#HH \P\:? '2?&<WB(-KVO:38>(K5+;5]/T^>$17A2,QI*S21/(KA-@.QU5
MA&H8,,@WM6^"^E:OK&LWTFIZI%'JTFGSW-G$\/E&:SECDAD!,9<$^4JL-VTK
MG !^:O0:* .'\/\ PIM/#.O7%[8ZYK4>ERS7-RF@+<(EC#-<,6FD78@E8EF=
M@KR,BER552%VL\+_  FA\/Z[8ZM?>)=>\47.G6TEIIW]MRP2?8XWV[]K1Q(\
MC,$0%YFD? ZY9B>[HH **** "BBB@ HHHH **** "O#?VS? \_C+X"ZS=6"Y
MUCP[)'K]BP&2LEN2SX]S$9!]2*]RJ.XMXKNWE@FC66&52CQL,AE(P01Z$4]M
M4--IW1\3>$?%T.OZ'I^IP-^YNX$F49Z;@#CZCI^%=7;ZUP/FKM&_8-^!3L6/
M@49)SQJU\!^0GIO_  P5\"?^A&_\J]__ /'Z^@>;)K6G^/\ P#ZMYZI)<U+7
MU_X!RK:W\OWJS[S6L@_-7=?\,%? G_H1O_*O?_\ Q^C_ (8*^!/_ $(W_E7O
M_P#X_4K-(K_EW^/_  "8YW&/_+K\?^ ?._C^QD^)7B;P9\/(2S?\))JL:784
MX(LX3YL[?@JBOT%BB2")(XT6.- %55&  .  *\L^&_[+7PN^$?B0:_X3\+)I
M>KB)H%N6O;FX*HV-P ED8 G&,@9QD9Y->K5YF*Q#Q53VEK'BX[%O&UO:VLMK
M;A1117&>>17/_'O+_N'^58-;US_Q[R_[A_E6#0 4444 %%%% !1110 4444
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MFF> QP3!]K;2V3E2.F1WK<TOQS;62B[NB]S?WMWYMTL)\M4C4;50Y4[A@L<
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M^F%%%%<QN%>A?%G_ )A7_;7_ -DK@(87N)DBC7<[L%51W)X%>A_%>!VM]-F
MRB-(I/H2%(_]!-?2X"+>5XVR_D_]*/#Q<DL?A;_W_P CSFE52S  9)X%)2JQ
M5@1P1R*^:/<.LOO"MK:1W"3S?95TY(UNIT4RR2S2<A%7<!A1QG(Z'KT"OX#C
MM962[U$Q!KQ+.(Q6^_>64,&Y88 !&1S^-9MSXNO&U2\O;;;!]J97DBD195++
MC!PRD9SDCC(S4[>.=06PMX8FV3I))-+<2!9&D=CPPW+\I XR#FOH/:9:W+FB
M]-M]=6EU72SZ:IW;N>-[/&I*TM_3337H^M^^ZVL76^'-S'I\\[SMYD:32*$@
M+1%8R0<R9PI.#@8/3M5;5?!L6FV5_*+\RSV0A\V/R-J[I/X=V[J/I63_ &]>
MM:I;O(DL<9W(9H4=UR<G#,"P&><9I+K7KZ^BN8YY]ZW,WVB7Y5!9P" <@>YX
MZ5SSK8#EM"D[V[];/7?O;Y=#:-/&<UY5%:_;I=>7:_\ F=IH'A'29H[!-0CV
M&2S$DDN]AF263;%W[ '^M5;CPS8:)#<?;+19IK&Q$DZO(X#SO)A =K#@#TQ7
M,W'B;4KJ-DDN<JQC) 11_JQA.@["IW\9:M+)=22SQSM=%6F$UM$X<J,+P5(X
M'I79]<P'(HJEJNMEVZJ_=1^^7?7F^JXOF;=31]+OOTT\W^!KW/AZR:">9;<6
MY?2%OA&'8B*3>!QDYPP[-GK7&UKW'B2YN;&YA<EI[IU-Q<,V2ZKC8@&/E4>W
MH/2LBO*QE2C4E%T5;OI;K_7Y+1(]##PJ03]H[_U_7Y[A7LWA'_D->&O^P'/_
M .A6E>,U[3X8A>W\0>'8I!M=-%N%93V(>U!KZ_A%/VU5^2_,^;XC?[JFO-G>
MT445^GGP@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% &#X<_Y#'BG_L))_Z1VU;U8/AS_D,>*?\ L))_Z1VU;U !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8/@'_ )$7
MPY_V#;;_ -%+6]6#X!_Y$7PY_P!@VV_]%+0!O4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !6#XT_P"0/;_]A*P_]+(:WJP?
M&G_('M_^PE8?^ED- &]1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\I^'_"ND>,OB9X6T
MW7-/@U;36U7QG))8WB>9!*1J,6!)&?ED /(5@0&"MC*@BE\/])T"'Q'\(;G5
M;33@+/5/$FDZ?<7T:$Q>3>2+9V\;OSE I$:@Y&#MKV*T_::\"WD+SQ:I"]I'
MKDFA37*W,!CMW2*67SY6\S"0E8),,>3C..N.XA^(/A:X\+OXFB\2Z1+X<3);
M6$OXC9KAMIS-NV##<=>O% 'S/;Z1X2\*? /P3<7?ASPW+<>(IT2^U?Q-,;?3
MU=8YY(I+]PI^T1H5"QP2D(6V ,A"D<]X+;18+:?3]:N='G^&EMX[D?4!!8FQ
MT,6\FE));-Y$KNJ6KW#!U)8QL[1NIPRU]<'XA>%E\.P^(#XET<:#-N\K5/M\
M7V63:&+;9=VTX".3@\;6]#5*Y^+O@6SN=-M[CQIX=@N-2CCFL8I-5@5[J.0X
MC>(%\NK'@%<@GI0!X1\3(]#N)OAS';:KX?TWX3_V9=)9S^,=-FU'2'N0T?D"
M02SP@'RA+Y+R,4*[MF=R&L+Q):K:>!K=(->B\1V!\&>+FLKRVL)K.!8#]EV1
MP)+)(QA4<1MO92@7:2N*^G]2^(WA/1]8ATB_\3Z-8ZK/.MK%8W.H0QSR3$(1
M&J%@Q<B2,A0,X=?45+JWCOPUH&MV.C:GXATK3M8O\"TT^[O8HKBXRVT>7&S!
MGR>. >>* /E_XD^)-+\-^$_CUHVJ7T-CJ^M:7;7.F6$S8GOHO[+BB,D*?>D5
M7BD#%00NQBV ,UJ^/=8TO3]4\;V>L:=HMY9:AXHLH3<>*+Q[?1[1UT:%TENP
M 5E3<H"POA7<I\RL%8?2EUXHT:RAU26XU>P@BTH9U!Y;E%6S!0./.)/[OY"&
M^;'!!Z5R-O\ '3PK>>)/$FA6E]!=:CH,]K;W4*7MLI+3NB97?*O"-(JMG!W?
M*H9BH(!\Z^ ='TG7-/D\.2-INI:!_P +(A\NUTRP>RTV6UDTP28AMG=P+>1B
MYP&9) [,,JXK["TS2[/1=/MK#3K2"PL+:,106MK$L<42 8"JJ@!0!V%4;3QA
MH-_XBN] MM;TVYUVS02W.EPW<;74"'&&>('<H^9>2/XAZU%X?\>>&O%MY?6>
MA^(=*UF[L&V7=OI][%/);MDC$BHQ*'*L.<=#Z4 ;M%%% !1110 4444 %%%%
M %#7M%M/$NAZCI%_'YMCJ%M):3Q_WHY%*L/Q!-?"7P?\7:KX(\'R^%[C0=2\
M0:OX8U2ZT.Z73U3*"%_W;$,P^4JP QG.PU]^5\@^/M-_X5S^UM?[1Y>F^.])
M2]C[*;VU^211]8\.?<U\_GE!5L&YVNX:_P"?X'O9+B(X?&1YU>,M+:_+;S,C
MQIKK_$3P^VFZI\,O%8*'S+>\@6!9;:3'$B-YG'N#P1P:R?@S'J/C?X>ZGK#:
M88QX=D2S>&.0Z?;:AI\$4I-O ]LK&(F4K+($W*[*JGY>%].\=>%+WQ]X?&DV
M^M/I-K)N-S''&3]J7:=L;,&#*F[&[;RR@C(SFN+\-_&Z;3O".G>"[I/^$*\8
M:;/'8ZC8Z?IQN'%N%<+<6,&UO/1W6,?*K%0[$C@$^)EE6\;PZ=#[;-L9A)9?
M]6]DN=N\=9>YWU;WEV6EM7KMZ1X2^#4MGH5IXOT368='\57EFL\<<=C;364:
M.%<6S2-$;AX^%!?S@QQN&T84<5JFJ07'QN^$GC+38#82>.-#N8-1MP<[XTMD
MNH2W8LARN[&<$#I721Z'8^'?AG9R>)_%FI^&O#WV&(W^B-<P0VD&8P9+=)#&
M9U3)*A%EX "K@<5R?@.^E^+GQ)C\?1V;Z?X+T.R?3?#$4L)B:Y,@43700@%4
M*JJ+Z@=NE>MB<3&4)2Z6:_#1'P]"C*,E'KH>J:MCYJ\T^$>E#X@?M:WFH,/,
MT[P'H^Q3U"WUWD?^B0P^HKM_$6K0Z?97-W<2"*WMXVED<]%5023^0H_8A\/S
M1_">]\87T1CU/QGJEQK+AQ\R0EBD*?[H5-P]GKP\BHJMC)U^D%^+_P"!<]7-
MJKIX:-+^9_@O^#8^AJ***_03XXBN?^/>7_</\JY+7+BPM]-E;4MAM.C*XSD]
M@!ZUUMS_ ,>\O^X?Y5Y%\6)&$>F1@_*QD8CW&W'\S7E9KBOJ>"J5U&]EL]M6
MEK]YZ&7T/K.*A2O:_;R5S.?4O!:L0-*NV]U9L?\ HRF_VGX+_P"@1>?]]G_X
MY7'45^1?VK/_ )\T_P#P")^C?V?'_GY/_P "9V/]I^"_^@1>?]]G_P".4?VG
MX+_Z!%Y_WV?_ (Y7'44O[5G_ ,^:?_@$1_V?'_GY/_P)G8_VGX+_ .@1>?\
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M10 4444 %8/@'_D1?#G_ &#;;_T4M;U8/@'_ )$7PY_V#;;_ -%+0!O4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6#XT_Y
M ]O_ -A*P_\ 2R&MZL'QI_R![?\ ["5A_P"ED- &]1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'6VD'7'^S_M#]?0X^-_U1H?\_7]R/IO]8ZO_ #[7XGB/_".ZK_T#+S_P'?\
MPH_X1W5?^@9>?^ [_P"%>W+,6QB"ZYQUMI!UQ_L_[0_7T.!9BV,077..MM(.
MN/\ 9_VA^OH<'^J-#_GZ_N0?ZQU?^?:_$\1_X1W5?^@9>?\ @._^%'_".ZK_
M - R\_\  =_\*]N68MC$%USCK;2#KC_9_P!H?KZ' LQ;&(+KG'6VD'7'^S_M
M#]?0X/\ 5&A_S]?W(/\ 6.K_ ,^U^)XC_P ([JO_ $#+S_P'?_"C_A'=5_Z!
MEY_X#O\ X5[<LQ;&(+KG'6VD'7'^S_M#]?0X%F+8Q!=<XZVT@ZX_V?\ :'Z^
MAP?ZHT/^?K^Y!_K'5_Y]K\3Q'_A'=5_Z!EY_X#O_ (4?\([JO_0,O/\ P'?_
M  KVY9BV,077..MM(.N/]G_:'Z^AP+,6QB"ZYQUMI!UQ_L_[0_7T.#_5&A_S
M]?W(/]8ZO_/M?B>/:1X-U/4;Z.*2SFMH=PWR3(4 7OUZFNZ^('AZXURP@DM5
M\R:W9CY?=E.,X]^!73K,6QB"ZYQUMI!UQ_L_[0_7T.!9BV,077..MM(.N/\
M9_VA^OH<>OAN'\-A\-5PS;:J6N_3:WH>;6SBO6KPKV2Y-EZ[GB/_  CNK?\
M0,O/_ =_\*/^$=U7_H&7G_@._P#A7MRS%L8@NN<=;:0=<?[/^T/U]#@68MC$
M%USCK;2#KC_9_P!H?KZ''D?ZHT/^?K^Y'I?ZQU?^?:_$\1_X1W5?^@9>?^ [
M_P"%'_".ZK_T#+S_ ,!W_P *]N68MC$%USCK;2#KC_9_VA^OH<"S%L8@NN<=
M;:0=<?[/^T/U]#@_U1H?\_7]R#_6.K_S[7XGB/\ PCNJ_P#0,O/_  '?_"C_
M (1W5?\ H&7G_@._^%>W+*6V@07/..MM(.NW_9_VQ],-_=; LQ?;B"Z^;&,V
MT@Z[>N5X^^/IAO[K8/\ 5&A_S]?W(/\ 6.K_ ,^U^)XC_P ([JO_ $#+S_P'
M?_"C_A'=5_Z!EY_X#O\ X5[<LQ?;B"Z^;&,VT@Z[>N5X^^/IAO[K8%F+[<07
M7S8QFVD'7;URO'WQ],-_=;!_JC0_Y^O[D'^L=7_GVOQ/$?\ A'=5_P"@9>?^
M [_X4?\ ".ZK_P! R\_\!W_PKVY9B^W$%U\V,9MI!UV]<KQ]\?3#?W6P+,7V
MX@NOFQC-M(.NWKE>/OCZ8;^ZV#_5&A_S]?W(/]8ZO_/M?B>/:1X-U/4;Z.*2
MSFMH=PWR3(4 7OUZFO6;/_D>M-_[!MY_Z-M:L+,7VX@NOFQC-M(.NWKE>/OC
MZ8;^ZV*MJ9!XMT^[-M="W6QN(FD-M(,,\EJ5!^7C(S]-K9QM./H\KRFEE<9*
MFVW+=ORV/%Q^85,PE%S5DMCL:*I+JT#[<)=?-C&;24==O7*\??'TPW]UL"ZM
M ^W"77S8QFTE'7;URO'WQ],-_=;'MGE%VBJ2ZM ^W"77S8QFTE'7;URO'WQ]
M,-_=; NK0/MPEU\V,9M)1UV]<KQ]\?3#?W6P 7:*I+JT#[<)=?-C&;24==O7
M*\??'TPW]UL"ZM ^W"77S8QFTE'7;URO'WQ],-_=; !=HJDNK0/MPEU\V,9M
M)1UV]<KQ]\?3#?W6P+JT#[,)=?,5 S:2CKMQG*\??&<],-G[K8 +M%4H]6@D
MV8CNANVXW6DHZ[,9RO'^L7.>F&S]QL$>K02;,1W0W;<;K24==F,Y7C_6+G/3
M#9^XV "[15*/5H)-F([H;MN-UI*.NS&<KQ_K%SGIAL_<;!'JT$FS$=T-VW&Z
MTE'79C.5X_UBYSTPV?N-@ NT52CU:"39B.Z&[;C=:2CKLQG*\?ZQ<YZ8;/W&
MP1ZM!)LQ'=#=MQNM)1UV8SE>/]8N<],-G[C8 +M%4H]6@DV8CNANVXW6DHZ[
M,9RO'^L7.>F&S]QL$>K02;,1W0W;<;K24==F,Y7C_6+G/3#9^XV "[15*/5H
M)-F([H;MN-UI*.NS&<KQ_K%SGIAL_<;!'JT$FS$=T-VW&ZTE'79C.5X_UBYS
MTPV?N-@ NT52CU:"39B.Z&[;C=:2CKLQG*\?ZQ<YZ8;/W&P1ZM!)LQ'=#=MQ
MNM)1UV8SE>/]8N<],-G[C8 +M%4H]6@DV8CNANVXW6DHZ[,9RO'^L7.>F&S]
MQL$>K02;,1W0W;<;K24==F,Y7C_6+G/3#9^XV "[15*/5H)-F([H;MN-UI*.
MNS&<KQ_K%SGIAL_<; NK0/LPEU\VTC-I*.NW&<KQ]\9STPV?NM@ SO#G_(8\
M4_\ 823_ -([:MZN;T&Z\C4M>ED@ND2[OHY86:UD&Y?LULF?N\?-D<]-K?W3
MC775H'VX2Z^;&,VDHZ[>N5X^^/IAO[K8 +M%4EU:!]N$NOFQC-I*.NWKE>/O
MCZ8;^ZV!=6@?;A+KYL8S:2CKMZY7C[X^F&_NM@ NT5275H'VX2Z^;&,VDHZ[
M>N5X^^/IAO[K8%U:!]N$NOFQC-I*.NWKE>/OCZ8;^ZV "[15)=6@?;A+KYL8
MS:2CKMZY7C[X^F&_NM@75H'VX2Z^;&,VDHZ[>N5X^^/IAO[K8 +M%4EU:!]N
M$NOFQC-I*.NWKE>/OCZ8;^ZV!=6@?;A+KYL8S:2CKMZY7C[X^F&_NM@ NT52
M75H'VX2Z^;&,VDHZ[>N5X^^/IAO[K8%U:!]N$NOFQC-I*.NWKE>/OCZ8;^ZV
M "[15)=6@?;A+KYL8S:2CKMZY7C[X^F&_NM@75H'VX2Z^;&,VDHZ[>N5X^^/
MIAO[K8 +M%4EU:!@I"77S8QFTE'7;_L\?>'Y'^Z<"ZM V,)=<XZVDHZX_P!G
M_:'Z^AP 7:*I+JT#8PEUSCK:2CKC_9_VA^OH<"ZM V,)=<XZVDHZX_V?]H?K
MZ' !=HJDNK0-C"77..MI*.N/]G_:'Z^AP+JT#8PEUSCK:2CKC_9_VA^OH< %
MVBJ2ZM V,)=<XZVDHZX_V?\ :'Z^AP+JT#8PEUSCK:2CKC_9_P!H?KZ' !=H
MJDNK0-C"77..MI*.N/\ 9_VA^OH<"ZM V,)=<XZVDHZX_P!G_:'Z^AP 7:P?
M /\ R(OAS_L&VW_HI:T5U:!L82ZYQUM)1UQ_L_[0_7T.,CP;=#3_  CH5I<0
M745Q#8V\4D;6LN581H"#\O8G]#Z' !TE%4EU:!L82ZYQUM)1UQ_L_P"T/U]#
M@75H&QA+KG'6TE'7'^S_ +0_7T. "[15)=6@;&$NN<=;24=<?[/^T/U]#@75
MX&QB.Z[=;24=<?[/N/U]#0!=HJD-6@./DNO_  $E]O\ 9]_Y^AH&K0''R77_
M ("2^W^S[_S]#0!=HJD-6@./DNO_  $E]O\ 9]_Y^AH&K0''R77_ ("2^W^S
M[_S]#0!=HJD-6@./DNO_  $E]O\ 9]_Y^AH&K0''R77_ ("2^W^S[_S]#0!=
MHJD-6@./DNO_  $E]O\ 9]_Y^AH&K0''R77_ ("2^W^S[_S]#0!=HJD-6@./
MDNO_  $E]O\ 9]_Y^AH&K0''R77_ ("2^W^S[_S]#0!=HJD-6@./DNO_  $E
M]O\ 9]_Y^AH&K0''R77_ ("2^W^S[_S]#0!=HJD-6@./DNO_  $E]O\ 9]_Y
M^AH&K0''R77_ ("2^W^S[_S]#0!=HJE_:T''[NZ]?^/27_XFC^UH/^>=U_X"
M2_\ Q- %VBJ7]K0?\\[K_P !)?\ XFC^UH/^>=U_X"2__$T 7:P?&G_('M_^
MPE8?^ED-:/\ :T'_ #SNO_ 27_XFL?Q5=B^TN".""[D=;ZSE*K:2_=2YB=C]
MWLJD_A0!TM%4O[6@_P">=U_X"2__ !-']K0?\\[K_P !)?\ XF@"[15+^UH/
M^>=U_P" DO\ \31_:T'_ #SNO_ 27_XF@"[15+^UH/\ GG=?^ DO_P 31_:T
M'_/.Z_\  27_ .)H NT52_M:#_GG=?\ @)+_ /$T?VM!_P \[K_P$E_^)H N
MT52_M:#_ )YW7_@)+_\ $T'5H!GY+K_P$E]_]GV_EZB@"[15(ZM ,_)=?^ D
MOO\ [/M_+U%!U: 9^2Z_\!)??_9]OY>HH NT52.K0#/R77_@)+[_ .S[?R]1
M0=6@&?DNO_ 27W_V?;^7J* +M%4CJT S\EU_X"2^_P#L^W\O44'5H!GY+K_P
M$E]_]GV_EZB@"[15(ZM ,_)=?^ DOO\ [/M_+U%!U: 9^2Z_\!)??_9]OY>H
MH NT52.K0#/R77_@)+[_ .S[?R]13EU2%W"A+C)..;:0#OWV^U %NBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
**** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>mrna-20201231_g22.jpg
<TEXT>
begin 644 mrna-20201231_g22.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 89#Z # 2(  A$! Q$!_\0
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MI-K92;XHL/\ WB235N@"O;Z?#;R;UWE_5G+?S-6*KW"W;R#R9(HX\<[E)/\
M.IU!"@,=S=SC% %*\BU":0BWFBAB_O8);^6*LVL,D,.V68SO_>*@?AQ1<W M
MH]QCDDYQMC4L:6WF,Z[C#)%[28!_0T +-,EO$7?.T=< G]!3;:Z6Z0LJ2(,X
M_>*5S4M0RWUO"^R2>-&]&8"@":H9KR"W8++,D;'LS &IE8,H92&4C((Z&H9+
M&WFD\R2"-W_O,H- $RL& (.0>014,]G!=,#+"DA' +#-3=.!5>^M9+J,+'<-
M;GN4'6@":*&.!=L:+&OHHQ3JQ%T"Y,H,FI3,GL2#_.MI%VJ%R3@8R3DTT)BT
M444R2&X-Q\OV<1DY^;S"1^6!4JYP,]:9/<1VL1DE<(@ZDTEM=17D?F1-N3.,
MX(_G2*)"=H)I(WWJ#M9<]F&#3J*9(4C,%ZD#ZTM9O_"/632,[HTK$YR[D_UH
M&:59]UH=K>3&64.S-U&\XJ]'&L4:H@VJHP%]!5:^2\?:+22*/U,@)/X4 B>W
MMX[6%8HEV(O05'>K<M%BU>.-\\M(,_E3;&&[C!^U3K*3T"IC'XU:H IZ=!=P
MJ_VNX6=CT"J!C\:M.PC5F.<*,G R:J+J7F2;$M+DC^\8]H_4BKB_3% ,SO[8
M+2!4L;M@3][RL#]:T5)902"I]#UI))%A0N[*BCJS' %)%,D\8>-U=&Z,IR*
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MEV<DIE>UA:0G)9D!R: )XIDGC62-U=&Y#*<@U'=6-O>[//A27;]W<,XJ8 *
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M59H\XW*>*Y*\>61Z>%GSP?D0:AK5CI7_ !]7,<3==F<M^0YHT[6+?5,^0)L
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ML?>7 7Z5I4 %%84VIZU-=&.VTI8XLX\VYE'YX!_QK;CW^6OF;?,Q\VWIGVH
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M91QE3^% #6NH5.#*@/\ O"I:@AL8(?NQC/J>:FH 8]O%(VYHU9O4C-/"A1@
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M2#4G;)J"&]AGD*1OO/7@'^= $U#,%('//H":** "EI*CN+9;I0K,ZC/\+8H
MDHIL,*V\81,X'J<TZ@ HJOLNC+DR1K'G[H4DXJQ0 8;=U&W'3'/YT5%<W7V8
M*?*DD!_YYKG%21OYD:MM9<C.UA@B@!:**%96) 8$CJ : "EW#.,\TE-6WB$A
MD$:^8?XMO- AU1K:PJ^\1('SG=M&:DIDL;R,NV5HU'4*!S0 ^F3QO*FU)#$>
M[ 9-/HH$,@A,*X:1I3ZOBGT44#&*\C2N&CVH.C;LY_"GU6N-4MK9RCR_/W50
M35B*19HPZYVMR,@@T"&S7$5NH,KJ@/3)ZT^.19%#*<J>AI<#_"DH &57&& 8
M>XH"A1@ */04DL8EC9"67/=3@U4M])M[:3S &=QT9SG% %RJBZ7"LHDS(6SG
MES5NH)OM1?$0A"?WG))_*@">H+I;EMOD/&@[EP2:ECWJ@#D,_<J,"B63R8V<
MJSX[*,D_A0 1JZQJ'8,_=@,432^3&S[6?'\*#)J.WN#< GR9(A_TT &?UJ:@
M"K:WKW,A4VTL*XSND&*M444 1S7,5O\ ZR54_P!XXIT<B3('1@ZGH5.144UA
M;W$F^2)7;IDU-'&L2A44*H[*,"@".6TAG<-)$CL.,L,T^.-(AA$5!_LC%.HH
M &&5(!P?6JL-B\<H=[J:7'\)( _*K59_VJ_DEPEJL<>?O2-S^E &A5'[==2,
M1'8MMS]Z1PM7J"=H)/:@ 7.T$C!QR,YHIL<JS+E<D>X(_G3J &QR+*NY#D?3
M%.HHH **H?V+;FX$SF25@<X=LBK] %2^TN+4"ID:08_NMQ^526=C#8QE(EQG
MDD\DU).LK1D0LJ/V+#(J"RCNT+FYF23/W51<4 2W2SF/$!17SUDSBH[..ZCW
M?:)DDST"KC%6:HC55:[\A8)F.[:7V<#W^E %ZJ%]JQLY/+%M-*W8@<'Z&K]-
MEF2!=TCJB^K'% "0R-)$KLAC8C)5NHI]16]Y#=!O)D63;UV]JE90P((R#P0:
M (8[ZWFDV1SQN_\ =5@:FID5O%!GRXTC_P!U0*>V=IQP>U !16='I]XS[IK]
MB/[L:A:T1P,4 %%1W#RI'F&,2OZ%MHIMJ;@H?M C5L\"//\ 6@":B@D 9/ [
MFJT.J6MQ/Y,4PDDZX4$C\^E %FJPU*W:Z^SJY>7."%4G;]35FC &<#% !113
M+B%;B%HV+!6X.TX- #ZKWMD+Z,(TLD2]_+;&?K3[6UCLX1'$"%SGDY-2T 16
MEJEG"(DW%1SECDU+4/EW'V@MYRB'M&$Y_/-34 1+'(LQ=IB4[1[0 /ZU+52\
MU.*S.&25V_NQH3^O2IK:X^TQ[_+DC'I(N#0!+113?.C#A"Z[ST7(S0 ZD,B!
MMI9=W]W/-+4$.GV\$S2I"JR,<EN] $]51I-F'W?9T+=<L,U8F\PQMY142=BP
MR*H)8WSG,VH$#^[%&!^M &CP!@<"F31F1<"1H_=,9_440Q&%-ID>3_:<Y-/H
M BM[?[."/-DES_ST;-2U6$UVUP5^SHL(/^L:3DCU  JS3$-5BV<JRX..<<^]
M.JK=:E;63!9YEC8C(')-26MY#>(7A?>H.-V"!^M,3%N+J*U7=-(L8[;CC-%O
M=174>^&19%SC*TLUO%<8\V))<=-Z@XIZJ$4*JA0.@% "T44SR4\SS-OSXV[O
M:@0^F[!O+9;.,8R<?E3JANHYY(\02K"W]YDW?UH FJM>QW4BJ+:5(CW9US^5
M/M8YHX\33><_KM"BG7$ZVL#RN"509.T9- R.RAN(8R+B?[0Y.<A N/;BIV.
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M4UR&,EJUN.V]@2?P%6>:@6^MVE\I;B)I.FP.,_E0!/S5>:_MK<D2W$49]&<
MU8YJA+H=A-,)6M4W[MV1QD^X[T 7599%#*0RL,@CH158:39!MPM(=WKY8JWS
M5:^MY[B-5@N3;'/+*@8G\^E %CIP.,5%=1R30LL4OD.>DFW=C\*;9VK6L95[
MB2X8G.Z0C],"G7-P+=/61N$7^\:!-I*[*]C8R6.]YKV6Y)Z^80%'T':KJL&
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M<_\ UJ +S9VG')[9K-L8=5^UE[NXM_(SQ%$I/ZD#^M:E5;R^-JR*+:>X+?\
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M5DU"&238I9F]E-6*&<+]X@?4T %(\J1C+NJ_[QQ3@<]#FJTVGPW$A=PVX^]
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MP89!R/:@@,"",@]13888[>,1Q1K$@Z*B@#\JBOM0MM,MVN+N9((5(!=S@9/
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M# 5AA1[XR>:U.:SI+G4FO-D=E$ML&P99)>2/4 "M'F@#,U&;5EG"V,%L8O\
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M:WYT 2K-&TC(LBLZ]5!&1^%*RAU*G(!&.#@_G65I7A73]'N#/;H_FXV[F<G
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M%_3K0!J5C'Q!-]L$"Z3?$;MID,8"_7.<?K6S52\U>RT\XN+J*%O[K.,_EUH
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M "@ DC292KHKKZ,,BE2-8U"HH1?11@4^LB;P^LU]]J:_OL[MPB6;"#V  Z4
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MH 155>  H]A14"VC+(':>1N<[<X%3T ,:'=)N\QQ_L@\4^HVDE$F%AW+_>+
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M/:14[Z=3:TY7TO154E!.0TKGJ-S$G&1U Z?0"JENNKW4EQ(D,MY#!@2"W52
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MX$@7<1^%9EGX>G@D5YM7O9]ISMW[5/UZT ;5%%86H:QJD=V8;/2'E13CS)'
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M@4!F P">YIMS=16<+2SR+%$O5G.!4M(RAEP0"/0TP*.GZ]8:I*8[6X69U&2
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M4XJ6H)+19KA)3)*"G1%D*K^('7\: )ZIZEI[ZBJ(MY<6BKDG[.P4M^.*N44
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MG2K2J%4 # '  H 9-"EQ&T<BAT;JIHAACMXPD2+&@Z*HQ4-^EW(BBTDCB/\
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M+@N8Y'_N@\T@+G-5TU"UDF\I;F%I>GEB0%ORJQS4,-I!;9\F&.+=UV*!G\J
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M.L8RS!1ZDXJ-[>&:2.5XHY'3E'902OT/:EFMXKC;YL22;3E=Z@X^E2=.!TH
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M$6)_'I^M7H9#+$CE60LH.UNHXZ&B29(4+R.L:#JS' J*/4+69ML=S#(3QA9
M: *^N:W;>'],EO;IL1KPJC[SL>BCW)K@=>GGUR"*]FN8S/*\=O:VUC(2%!D5
MG&\'EB$Y88 "UTFO6\>H>)K>"[7?##9O<6Z<@&3<%9OJJD8_WS6+!IMI:^*[
M<QP(C&VD=6'4L&0$D]SA@/;)]:]C"45R^T>Y\QF6*ES^Q6B-VUM8K&UCMH$$
M<$>=JC)ZG)))ZDGJ34:Z;;I=+<)$J2JK+E5'()!_I^M6JSVL[N28LUX53/W8
MUQ7IG@%\M\O-4-35=0MS;7/[ZU/#PNH8$?B./PJQ(VU0,DX[FLV^N&C0E$\Q
MO[N<5K&"EN83J.&J9E^'_#]CI^J7>GJC7MK:".6![EBYBW9.P@G:2N 0<9 (
M]J;K/CB999VL1!):P\-<3;B)'[A,=ATSSD]*QA]LNKC4(;G$%B\PD,*-\TI*
M*/F(ZKQT[\YS5_P_IBZC<+?2J%L[=MMM%C 9AP7^@Z#Z$^E5&BH*\OD9RQ+J
M248/U?;_ ()TUE=W$EM"TMJMG^[4^5OR4.!\O QQT_"L_7M1DL<:I!((KVV3
M 8#_ %RYSY3C^($\#N">*?<:Q;^=Y(F!DSC;UYK&U"Z%GJEGJ<@\R&QD64QG
MD8R0YQZA2"/<4I4KTW[M]"J>(Y:T5S<NJU/0KGQ9IEFRK+<KYO=$!<J?0XK6
MCD$D:NOW6&1QBHX[>#(ECCCRW(=5'/OFIJ^//TX**K:A8KJ-JT#2RPJQ&6A;
M:WTS5+3O"^GZ7.)X8V,PZ2.Y)_PH TIHS-&4$C1$_P 28R/S!JA8^'[>QNOM
M/F3W%QVDGD+$?2M.HY!*63RV15S\^Y221[<\4 25E7BZS)(1;O9P19X+!F;^
M@K5HH CMUDCA19I!+*!\SJNT$_2H[Z\33[=IY%D95[1H6/Y"K%% %+2]4758
MFD2WN(%4X'GIMW>X]JNT4G7B@!C3QK($:10YZ*6&3^%25E6_A?2[6X$Z6BF4
M'<&=F?GUY)K5H RI/"^ES737$EHLDS')+,Q!_#.*TXXUB1410JJ,!5& *@U"
M.ZFAV6LJ0.W!D9<E1Z@>M/M;<VL"QF62<CJ\IRQH AU.SN+ZW\NWNVLR3\SH
MF6QZ#TJCI7AQ].E$DFIWES@YV-(0A/N*UII/)A>38TFT9VH,L?8>]8/]N:S=
MS!;71S%&#R]TVWCZ?_KI =#^M4(;Z]FN@G]G-##G!EEF4'\%7.:NQLWE*9 J
MOCY@IR >_-94_B[2+>0H]ZA8?W%9A^8!%,#8IDTT=O&TDLBQ1KU9R !^-0V&
MH6^J6_G6TGFQ9QNVD?S%2R01S%3)&KE3E=R@X^E "6]S%>0K+!(LL;=&4Y!I
M\D:3(4D571N"K#(-.I/I0 V*&.! D:+&O]U5 %.K+BT$+<K-)J%_.5.X(\^$
MS]% K5H QI/"=G/,))I+F<YSB2=B*UT18T5%&U5& /05BZY-KJS!=-M[=H<?
MZQV^;/T)']:OZ2M^+4?VBT)G)Z0@@ >^>II ,U:74HXP=.AMY7[^<Y'Y ?XT
MFCG4VA8ZF+<29^40YX'O6@S;5).<#DX&352QU);YF"V]S"%_BGB* _3-,"Y6
M+)XD_P!):"#3;ZX*G!=8=J_F2*VJ* &0NTD:LT;1,1RC$$C\B12LZQC+,%'N
M<4ZJ%]H=CJ4RRW5NLSJ, L3C'TSB@"\K!AD'</457OM/MM2C$=U"LR*=P5AT
M/2IH88[>)8XD6.->%51@"G'\J (+33[:P4K;6\< /7RU S]:L5DP:/=QW:S2
M:M<RJ&R8]JA3[=.E:U &1'HMU]J$TNK7,BYR8U"HOTX%:]8FHZQJ4%YY%IH\
MEPN<><T@53_GWK6MFF>%3/&L4O=4?<!^.!2 IZIJ%Y:.B6FFR7I/5O-5%'XG
M_"K=K)+-;H\\/D2D?-'OW;?Q[TMS=0V<)EGE6&->K.<"J.F^(]/U>X>&UG\V
M1021L8<>N2*8&GTK%7QCI4EXMLER7D9M@*HQ4G..N*V2 P((R*CCM886W1PQ
MHWJJ@&@"6F>3'YGF>6N_^]M&?SI]1SP^?"T99D##&Z-MK#Z&@"2LW5M$36"H
MENKF*-1CRX7"J?<\<U=M[=;6(1JTC =Y'9S^9)-0:K)>PVA;3X8YKC/W96P,
M>OOV[T 1:/H=MHB2+;F0^806,CELX_\ UU;NFG6W<VR(\^/E61B%_$BLO2O[
M>:X#7_V-(.ZQAB_X<XK:I 9.EMK4EQF_2SC@Q]V'<7SVZG%:U5H[^.2Z: ),
M&7^)H7"'Z-C'ZU9I@8&H^,K/3[I[<07,\J':?+CXSZ<UJZ=?'4+83&VFML]%
MG #?7 /\ZM5 M_;22^4MQ$TG]P."?RI 3U535+.2<0)=P--T\M9%+?EFIYH4
MGB>.10\;C:RGH1Z54L]%L-/DWV]I%$_]]5&[\Z8%N6%)HVCD19(V&"K#(/U%
M5(-#TZVD#Q6-NC]F$8R*O5G7^ES7LRNNH7-LB_\ +.$J!^>.?QI :-9FL:;>
MZAL6VU%K&,#Y@D88M^.1BM(4C$A25&YL<#.,TP*6EZ8^G1D/>7%XYZM.^1^
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M6L+6]O'&\K3,HP9'ZM[U(Q*J2!N/8>M9NEWVI74A^V:<MG'C(;S@Q^F *TZ
M,NUN=7FN5\ZRM[:WSSF8L^/; Q6I5"[U[3[&;RI[N*.7NF<D?4#I5^@#.U#Q
M%IVER>7<W:1R=T +$?4 '%6;#4+?5+87%M)YD1) ;:1T^HISV<$C%G@C9CU+
M(":E50H  P!T % #988YTV2(LB]=K#(IP 7  P.PI:8L861GW,2W8L<#Z"F
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M27K^KJ .O;O^9I 7Z;(@D7!R._RDC^5.K/U2]O[8JMEIQO"1DL9511[<G)H
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M ***A5KAIOFCC6+UW$G^5 $U5XY+IY!NACCC[Y?)JQ4=Q=16JAI6V@G X)H
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M2-&1$RJ_8L,B@!884@C$<:A47H!1('*$(0K=BPR*AM8KE&8SS+(.RJN *L4
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MVFF$KV\3R_\ /1D!;\ZL54U"UGNHU6"Z:T(.2RH&R/3FI+6%[>$(\[W#?WY
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M^%=)27S!8Q;LYY!(_+I6G'&D2A4544=%48%0:A:M?6<L"3R6S.,"6/[R\]J
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M9 5.?;FM>LB'7+BXO%A72;M(RV#+( H SR>M:] %._NKNW:,6UBUV&^\PE5
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M "BBBF!3OOM^^,68MMO\;3ELCZ ?XU;3=M&X@MCDJ,"DD<1HS$$A1D[02?P
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M<#')R:;+O\MO+*B3'READ?C5336U%]YOTMXQ_"L!8G\2:O4 (N=HW$%L<D#
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M?Y@UT=G?17RLT6XA3C)4BN'\/XTWXH:[98'E748G ]6^5O\ V9Z[_(Z=_2A
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MY-Y#@30]0,YPRGNIP<'\#@Y%16P\Z.KV-L-CJ6)?+'1]BW''=_:W:2:(V_\
M#&L9#?B<_P!*L\U%<221QYBB\YLXV[@H^N31;R2R1YFB\E\_=W;OUKF/0(-2
MO)K* /!:27CYQL1@,?6J^DZAJ%\Q-UIPLX^?F:7)/_ <5I22)"A=V5$'5F.
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M?]Z1ES^0)JU31,C2&,.ID49*YY ]<4Z@;&R2)"NYV5%]6.*=FBB@1%<65O>
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MWUOJ$/FVTRS1YQN0Y&?2HY])L;J4RS65O+(>KR1*Q/XD59CC2% B*J(.BJ,
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M.!KA9VC#2KT9N<?3TJ?FF C*&4JP#*1@@]#0 %  &!2\T<T ,FC:2%T5S&S
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M%XKA([9?OQ^7EF_'-7* ,#4+'7;J0F&^@MX^RHI&/QP:V;2*2&VBCEE,TBJ
MTA&-Q]:KZAJB:>4#07$[-T6"(M_]:K%K.;B%9##) 3_!* &_0F@ NK@6MN\I
M220*,[8U+,?H*CT^^&H6XF$,T )(VS+M;ZXJU10 4A('4TM0R6L,TB2/$K21
M\HS*"5^E $U5ETZW6[-R(_WY_CW$]L>M6:H7UG>W$JF"_-K%C!5858G\3TH
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MBVZWMH86Z;D0 _G7R9^C$\T,=Q&T<L:RQMU5P"#^!J&UTRTLF)M[:*$GJ40
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MK59^I>(-/TE@EU<*DA&=@!9OR%,1H4$@ FJ.F:U;:ON-L9&51RS1LH_,BKU
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M )P,_6@!(HQ#&J L0HQEF+$_4GK2MG:<<GMGI21ES&ID55?NJG('XX'\J=3
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MUU#?]FN(I]GWO+<'%,"S3//C:0QB13(.J;AG\J?5:'3+2WN&N([:&.=N6D5
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M% S9JKJ$ES#:.UI"L]Q_"C-M'XFHM)COTM\ZA+'),W.V)<!?;/>KK,%4DG
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M0@Z\4Z@!D%O':ILC7:,YZT]LX..O;-1I'*)BS2AD[*%Q^N:DH JK!=&3<]R
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M.A FTFL=;0=%AN%W$?\ ;4+^AKD-6'B_PF"=>\+7EK$O6?R76/\ [[P5/YT
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MBDDD2, NP4$X&3BEHH *CDM8)F#20QNPZ,R@FI*9-$9HRH=H_P#:0@&@!X
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MTZ@"E%HUE#.)D@42@Y#9)Y]:NU6O8+F?:(+D6P[GRPQ/YGC\JFB0QQJK.9&
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MO0!-&ICC52S.0,;FZGWHF:18R8E5W[*S;1^>#20-*T2F9%23NJ-N'YX%2<T
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MJZMI:J!@ ; !_P"0J&^%GQ792#J^F\^A4'_T52]H@Y6;T420QJD:+&B\!5&
M/PIU<Y!\)?BK;J0FL:><\_O)0_\ .,U)_P *N^*__07TS\T_^-4_:(.4W/*W
M&3<[,K\;>!M^A'/ZU%8Z?!IL)BMT*(6W89RW/U)-9'_"KOBO_P!!?3/S3_XU
M1_PJ[XK_ /07TS\T_P#C5'M$'*RUJUUJT,L::?8Q7"-UDDEQCZCC^M:<>[8N
M\ /CG;TS[5A?\*N^*_\ T%],_-/_ (U1_P *N^*__07TS\T_^-4>T0<K-F[N
MX;&!IIY%BB7JS'BH]/U.VU2)I;67SHU.TL 0,_B*QYOA1\4[B-HY=4TJ2-NJ
MN$(/X>51#\)_BG;QB.+4])B0=%0( /P\JCVB#E9T5%8'_"KOBO\ ]!?3/S3_
M .-5F7WP)^(^I3F6YU'3Y7/K,<#Z#9@4>T0<IV59,GANWGNC/-/=3MG(5IR%
M'L ,8JI#\*?BI;PI&FK:8$0!5&5/'_?JG?\ "KOBO_T%],_-/_C5'M$'*S?H
MK _X5=\5_P#H+Z9^:?\ QJC_ (5=\5_^@OIGYI_\:H]H@Y6;]%8'_"KOBO\
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MI]0_;!Y_E".1CW;;\OYU-0 44V29(1F1U0?[1Q3D99%#(P93T(.10 I8 9/
MJ-+F*5BJ2([>BL#3V4,"#R#V-)'&D8PBA!_LC%  Z"12K#*G@BF0VL,!S'&J
MGU YJ2B@ HHHH *9.\D<9,<?FO\ W<XHA:5LF553T"G/YT^@"*V:9U)FC6,Y
MX .:EI#(JN$)^8]*6@"..ZBF<HDBLR]0*DHHH **** %Z\4R.%(<[!C/7DFG
M-G:<8S[U51;WS,O)#L] IS_.@"U3'64R*5=0G<%<D_CFGU%<7/V?:/*DES_S
MS7- $M07%X+=U7RI921G]VN:G5MR@X(R,X/6EH K07,LTF&MGC3^\Q'\JL5
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MP%^S;X,\(Q0SS6']M:@H!-QJ.)%!]5CQM'MD$^]>KQPK&BHBA44;0JC  ]*
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MNH5D5653V=<&@!+BZ2UVEPYW=-B%OY"I5;<H/3//-%,\^+S-GF+O_N[AG\J
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MK!$P/625\ ?@!3 N53U!KY5'V)(&/<S,?T _QJQ;^<(5\\HTO?RP0OX9-24
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M'JFL6VCQ*]RY&XX55&2:-+U6'5[<S0+($SC]XN,_3UJV\:R+M=0P]",TH 4
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M'/SRG ]ACH*VNG%5-2%^RH+$VZMGYVG!.![ =ZFM5G2%1<2)++W9%VC\LFD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-JVHNOIB!?U6(&NOHJ?:2'9',)\.])_Y:/?S'WOI4_'Y&6IU\ Z$OWK)I_\
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M/1=H51_7]:U: ,31M)U2SNFEOM4-TF"!$%P,^M;=4-4U*:P""WLIKV1OX8^
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M#2%%)R,!B>V*_2NOYFOBO\'/%'P(U+PI_;:M9W.N:)9>(["6(E'2*==RC/\
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M>C3/<:1J]G#?V<TD3Q-)#*@=&*. RY5@<$ \T :]%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 <I\5O^2:^)O\ KPF_]!->??!;_DF>C?\
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M&PCW);6[,F]KS"]T6,8_6K=>:?#^ZU1-2U4174VK:?%B/SYI/E,@ZE<GIU_
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M^",DPD_QH/YKWZCW^B/$'C*'2?#]MJ]E"-5M;AT"-#)A2K D-G!XZ#\:V3N
MO_"865CJG]GZC>VMO=G'[H;OER,C+8VC\^]>8?$70&TOQ2]U<F1["^?S%FCY
M(SU'U'IW%+XZ2V\22'7]+$KHRJMW&R\Q,  "?PP/P]ZJQZU?6WAL66I6QO\
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M+!POF02X!(1]J'< 2I4'!&0?3_V:_C[H7[2WP?T/QUH1$:WB>5>V1;+V5V@
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MQS0!S?[$?_!0SPU^ULT_AZ^TW_A%?'UI ;B33#+YEO>1 @-);N0"2,@M&PR
M<@N Q'TQXL^(7A7P']E_X2;Q-H_AW[5N^S_VM?Q6OG;<;MGF,-V-RYQTW#UK
M^>/]BC6M1T#]KCX0W6ELR7,GB:QM'*=?)FE6&8?0Q22 ^Q-?I]_P5:_9<^)_
M[2G_  J[_A7'AG_A(_[%_M3[?_I]K:^3YWV/RO\ 7RINSY4GW<XV\XR,@'U_
M_P -"_"O_HI?@_\ \'UK_P#'*^$_^"SGC*S\0? #X;'1M2M=5T74-?DNDN[&
M=9H93%;R("KJ2K8\QQQ[^]?%O_#KC]IW_HF?_E?TO_Y)KZM_:D_9K\7>&_\
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MFOQZ_P""GW[?VG_%2WO/@_\ #RZ2\\,07*-K>N1-F/4)8FW+!">AB5U5B_\
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M5\0_@_\  'PC\5?$-HMOIFOSF-[ *3/81N@:VDF[#S1OX_AP@/S-M !^F/\
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ML*]5_P""*G_)K/BG_L<[K_TAL: /@#_@J/\ \GV?$W_N&?\ IKM*^O/V+_\
M@F/X#^*GP9TCXB_%>?5?$6N^*8/M\-K%?O#%;0N3Y;%EP[R,N&.3@9 QP2?D
M/_@J/_R?9\3?^X9_Z:[2OVH_9- 7]EGX-@#'_%&:-_Z0PT ?@]^VE^S_ &G[
M,_[1'B7P/IEU/>Z+ (;O3IKK'F^1+&KA7( !*DLFX#G;G S@?NK^Q[XPOO'W
M[+?POUW4YGN-1NM!M5N)Y#EI9$01L['U8IN/UK\C?^"O'_)Y.I?]@:P_] :O
MU4_8#_Y,V^$__8&3_P!#>@#Z KXU_P""DW[+?@WXM?"/Q)\1M<EU1/$'@WP[
M>2Z:MI<*D!*@R#S%*$M\P[$<5]E5XI^VM_R:/\7O^Q9OO_134 ?A_P#L,_ [
MP[^T5^T?H'@;Q4]]'HM];W<LK:?,L4V8X'D7#%6 ^91GBOV%\3?LZ^%?V8?V
M&?C1X/\ !\FH2Z3)X9UV_+:G.LTOF/I[JWS*JC&$7C'K7Y>?\$G_ /D]KPA_
MUY:C_P"DDM?LI^UC_P FL_&3_L3-9_\ 2&:@#^=SX1> =:^+'Q'\/^!M"F\B
M_P#$EY#INYF(C"M(I+2 =43:)".?N9 R!7Z^_!W_ ()&^$/@[\6/ GC>W\:Z
MGKC^'KL7US8W]G&L=S,B,87C*G,>R7RWP=^0N,CK7Y[?\$P[2*]_;F^&,<J[
ME634)!SCYDTZZ9?U45_0)0!^%?\ P5X_Y/)U+_L#6'_H#5^E/[+?_*.+PS_V
M)EU_Z+FK\UO^"O'_ ">3J7_8&L/_ $!J_2G]EO\ Y1Q>&?\ L3+K_P!%S4 ?
MAA\(_ ^I_$_XE^&O!>DW9LKSQ'J$&E";)VHLTBJ6< C*KG<1WVU^I_[1'_!*
MGX2_#G]F'Q?K?AU]:;Q=X;T>?5AJ]U>[_M7D1F617BP$"LJOC: 0<<G!!^ ?
MV _^3R?A/_V&D_\ 0&K]U/VL?^36?C)_V)FL_P#I#-0!_/I^SS\.-8^-7Q:\
M._#G2M4ETM/%%W'97DBN=GV=6$KLZ @2;!&7"GJR+T/-?HU^V5_P3#^%?PC_
M &7]?\6>"1K$'B7PU#'=/=7M]YPOX_,191*I 12%9F!C"\J!@YKY'_X)<?\
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MQ9QND<<;P01^7AN<[H6;CCYOK7X9WEI%J'[34]K,-T,WB]HW4'&5-[@C/T-
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M#TH 7;3(69TRZ;#GI4L;"1%8=",TZ@!N/:H9O/\ ,41*I7N6J=6RS#'2G;:
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M5)EW1NKKZJ<BFA,5F"\D@#WHZ\CD&J]UIMM>.KSPK*RC W5855C4*H"JHP%
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M\RW9G3.-Q1ES^8J=E#=1FEYI@0SV=O=']]!'+V_>(&_G3XX8X$"1QK&G]U0
M*?S51=+MENC<^66F)SN9V;'T!.!2 M\U5?38)+P7+!VD'0;VVC\,XJUS5'4(
M;^1E^QW$,*XY\Q-QS_GVH O<TUMW&W'7G/I45G'/% %N)A/+W=4VC\J6ZNDL
M[=YI,[$&3M&3^5,";FCFLC3?$D>J7!BBM;D=S(R@*![\UK\T@&JP8D<\>H(I
MW-'-'-,!LDBQJ6=@BCJS' %$<BS1JZ,&1AD,IR"/6DFACN(RDJ+(AZJX!%.5
M0JA5 "@8 ':@!DUO%<*%EC250<@.H(I8XDA3;&BHO]U1@4YL[2 <'UQ5>WMY
MXY&:6Z,RXP$V*H'OZ_K0!9YJ&2W,DZ2>;(H48\M2 I]SQ4W-9VHW6HP2J+2Q
M2YC[LTH4_D: -'FJEQ=7$<VR*S>9#_RT$B@?D3FK2Y*@L,-CD9S4=Q<Q6<+3
M3.(XEZL>@H >A8J"X"MCD Y'YT[FJUGJ,&H*6@+LO]YHV4'Z$@9JSS0!$MPC
M7#0C?O49.48#\\8_6I>:.:.: &K&BMD*H/J!3N:QKKPRE]</)-?7A5FR(Q)A
M0/0<=*U;>!+:%(HQA$&T<YI 0ZAI\6IV_DS[O+SDA6(S['VIUE86^G0^5;1+
M%'G.!3KOS_L[_9?+\_'R^;G;^.*J:7'J:,YOY;>1<?*(5.1^)H OR;]C;,;\
M?+NZ9]ZI:;_:19FOC; =%2!6_/)/Z5?YK-OM=AL;E;<PW$TC8XAC+ 9H TN:
MI:AJ7V#:!:W%RS=!!&6Q]3VJ[S3)9DA0O(ZQK_>8X%,!MO*TT*N\30LW.QB"
M1]<5+S4-O=P70)@FCF ZF-PV/RJ;F@ YIDT*7$31R+OC8893W%.50N0H YSP
M*=0!4M-+M+$YM[:.)NA95&?IFK=9MSI4UU>"7^T+B*($'R8L*/S[UI4 5[RT
M-Y&$\^: 9Y,+;2?;.,_E4D,8AC5 68*,9=BQ/U)JIJE]<V:H+:R>\=L_=8*!
M]2:73;B^G#&\M8[7CY0LNX_CQ_6@"]1167?>)-/T^X\B6?,O=$4L1]<4 :E9
M6I^)+#2;@0SR-YN,E54G ]ZT89EGB21=VUAD;E*G\C2M&K,"5!(Z$BD D,RW
M$*2)DHXW#((X^E2444P"BH;>V6WW[&D;>VX^9(S?ED\#Z5-0! MK&MP9OF\P
MC'+L1^6<5/4%O]HW2^?Y>-QV>7G[OOGO4] &;>C5)+C;:M:PV_\ STDW,_Y=
M*T%#!0&.YL<G&,U5U+4HM+@\V59'!. L2%B:--U :E;F46\]N,X"SIM)]\9Z
M4 +J.H+IMOYK12S<X"0H68FJVDZQ+JC/NL)[6-1P\W&3Z8K4JE-K%C;W @DN
MX5FSC87&<^A]* +M5YKZV@;;+/%&WH[@']:G.*SXO#^FPR>8ME#OZ[F7/\Z
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M\,O&&G_M.?"&ZNO">N6UM#XPTB26:;3IE2-!>PDLQ*X  !))K^BZB@ K\_\
M_@JY^QW+\8O </Q-\):<UUXR\-P^7?6UK&6EU#3\DG"CEGB)+#N59QR0HK]
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MX[^R9^SS9?LO_ W0? MM<B_O( UUJ5\N=MQ>28,K*#T0<*O&=J+GG->Q444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJS'B@!]%9(\5:>T@02,<G&[8<5K4 5?[6M#=?9A.IGSMVC)Y]*M4U8T5BRH
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M_P _G6M$7:-3(H5\?,JG(!^M)<7$5K&9)I%C0=68X%-M;N&]B\R"02IG&Y:
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MN))[8VK'I&SAC^E6?Y4 4=+O+N\C9[FR-E_=5I Q/Z<5?JO'?6TTQBCN(GE
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M8X H PFU;6Y;HK#HX2'/WIIE!^O'_P!>MY=VT;@ V.<=*S)/%&E1'!OX6/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% '*?%;_ ))KXF_Z\)O_ $$UY]\%O^29Z-_VV_\ 1TE>
M@_%;_DFOB;_KPF_]!->??!;_ ))GHW_;;_T=)6D-Q,[:BBBMR0HHHI %%%%
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MI++ UL[=8V.2* '74[V\)=(7N&[)'C/ZFFV<T\ZL9K8VQ[*SAB?RJ=F"@DG
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M?@:CT^SFLXR)[R2\<_Q2!0!] !5NLBQU:_NM0,$FDR6]N,YN))1^'&.<GWH
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M4DG  R:?39(UD4JPR#P10!%!<1W4>Z,Y7.*<(U3)50,]<"B.%(%VHH5?:GT
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MZ/CL?8C*G\*^O-)U2WUK2[34+5M]M=1+-&WJK#(_G7@GQ@\!CPWXEUG0B/\
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M0"2?PIFCZY!K2NUNDRJG\4B8!^AK2H HZ7JT6K1M)"DJJIQF1"N?IZU>HHH
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MJ37_  =<N%@UVR80[NBW$8+(?RR?^ BO$?'VE.=-D+HR7%G)\RGJ.<,/\^E
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MMNR%\]@H^@!K0HH 3FJU_P#;/LY^Q"$S>LY(4?D*GC#!1O*LW<J,#\LFG<T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSU&\:YGFN79CG;Y@V_0<<"M.QTVVTR(QVT*Q*>N.I^I[U#J#:GN"V,=M@_\
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MSIV94SCY5+'/T%)87R:C;^=&DB+G \U"I/O@]JM44P"BHKB-IH61)6A8CAU
M)'YBL^P\/QV5Q]H:ZNKF;^]-*<?D,?K0!JU2_LU/M1G:>Y9LY"><P0?\!!Q5
MVJ%__:32*ME]E2/^)YMQ;\ /\: +]4[_ .W_ "?8C;C^\;@,?RQ5B$2+$HE=
M7DQRRKM!_#)J2@".)9!$HE96DQ\Q0$#/L,FG\TS>?,"[&QC.[C'TI_- %>"\
M^T32QB"9 G'F2)A6^GK5CFHY+B*''F2)'GIN8"GJP8 J00>010 O-'-'-'-
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M-G?-:PZ9=W+JVW(0@'Z<'(K<M9'FMT>2(P.PR8R02OMD4Z29(4+R.L:#JS'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MII-I'>&Z$"FX)SYC9)_#/2KG- &:WAS39+IKEK1'F9MQ+$D$^N,X_2M%5"@
M# '  K/U:SO[P(MG>+:+_'\F2?QJQI]O-:VJ1SW!NI%ZR%=I-("6=7DA=8I/
M*D(X?;NQ[XJOI]G-:;_/O)+MFQRX  ^@%6I'\N-FVL^T9VJ,D_2LJ/5-1N)M
MJ:0R19_UDTP3] #0!JNWEQLP4N5&=J]3["LVQU*^N[C:^F-;6_\ SUDE&?\
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M3 %>DUYY\:O^0#8_]?/_ +(U3+9C6Y]74445S&@4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <I\5O^2:^)O^
MO";_ -!->=?!G_DFNC_]MO\ T<]>B_%;_DFOB;_KPF_]!->=?!G_ ))KH_\
MVV_]'/6D-P.UHHHK8@*3-&ZFT +NI*** "BBB@ HHHH *,TFZDH ,T444 %%
M%)0!R18*P!(!/09ZT4%59@Q )'0XZ45)J)L7?OVC=TW8YI:K7UK/<;1#=&W
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M-4\327,D5S*TO$-NK1 /@"-SM4@<L6/W!7TQKGQ6\7?L3_LLFZ^(_B)/'OQ
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ME3VWQR(5/;*UY7_P3=^)_BKXL? W7-7\7ZY=:_J4/B.>TCN;M@76(6UJP08
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MLKFZ9AG,,>5'U-&GWUU>,3-8-:1XX9Y 2?P%7^:SY->TZ*;RFO80^<8W?UH
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M+_@I]\;])N5DO+W1=:C#9,-YIBH"/3,10_K7ZZ_\(SH__0)L?_ 9/\*^5_\
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M?$GX.^";;7;;QA<:3HWCN:^62QU;655$-KY:@1Q3/\L;!PY(RI;<G7;Q]O\
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MW@XX)KU7]AG]G'QO^S5X+US0_%FN:9J=K?7,=Y:V>FM*ZVDFTK+EW5<[@(^
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M/"+)OX]S@4@+-%%,259&=5.2IP>*8#ZH7&O:?:W'D2WD239P4+<@^]7ZB%I
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M444 %%%% !1110 4444 %%%% !11534M4L]&LY+O4+N"PM(QEY[F18T7ZL2
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MQ]<='#?C]VN ^"UB+CQ1X,@(R&N[5F&.V]6(_G76_M22F/X=V:@9$FI1J?\
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MKZ;JC:AG-C=6H'>= H_GG]*O\TP,O2=6GU*1UETZ>S11D/-QGVQ6IS1S1S2
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MP.IQ&SDAMWKO[=*:<KZBT/K*^U"UTJQN+V]N(;.SMXVEFN+APD<:*,LS,>
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M^E8/&4\=256G\UV"BBBN8[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M50H]AB@!U%%0R6\<LT<C!M\>=N&('/MGF@":BBJU]]J%J_V,1&X_A$V=OZ4
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MUVK$"6(@W YQ\RD\!E4]J_1C]H+X!^'_ -I#X;S>%_$*R6;[A<65]$JM-97
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M:Y[999\ ;B3CCIQG!K14!0 !@"JM]!=S-']FNUME!^;,.\M]#GC\J +=%(.
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M((XV=L[5&3@$G\A0!2TEM2:-SJ26R/QM%N6_'.:OU4L=2CU#?Y23*%_BDB9
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MF_\ 037G'P:_Y)MH_P#VV_\ 1SUZ/\5O^2:^)O\ KPF_]!->;_!O_DFVC_\
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M5\][A)9(U?\ U>TE&..O5ACZYK*^!][Y/C#P7+GEKFVC/']XA3_.LY;B.?\
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MK:W\<KNR\22>&]%T/_A*_$H7YM.TN7Y;8]C<3'Y(Q]>>G'-/F3XU20/=_;O
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MH<\O&H)(].>E-TW3VT^)D:ZGNRQSNG;)'L.* +E0PVHADED\R1S(<[7<D+[
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MX#L<'I_A/QEXI -OIU_-&W1F7RHS^+86NLTG]G/7+A?,U._L],BQEL$RNOU
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M=SH2TCL_ZW/M/PW_ ,%"O@]K5K%)?ZGJ6@3,/GAOM/ED*GTS"'!_STJW?_\
M!0#X+V>[RO$%[?;3@?9],N!GW&]5KXVU#]BR[60FQ\4PR)G@7%F4('U#G/:F
MVO[%=ZVW[3XKMXO7RK)GQZ=76O(_L.G?K]Z/HEQ3B+6]W[G_ )GUC_P\>^$G
MVCR]GB#9NV^;]@3;C/WO]9G'X9]J]0^&7[47PS^+EU'9>'_$]N=3DX73[U6M
MIV/HJN!O/^X37P<?V*;?R<#Q=()<?>_L\;<_3S/ZUY-\4O@7XA^$ODW\LT=]
MIK2 )?VFY?+?L'!Y4G'!R1[YJ*F2P4;JZ_$TH\45^=*237HT?M!17R'^PO\
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MT>3P#H\FO?VNT#&YW^84W?NR_P#>QZYYK(\6_"^/Q)JQOX+S[&\H F4Q[@Q
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M+7UEX\^$_@SXH+9KXN\+Z5XC%F7-M_:5JDQAW8W;=PXSM7..NT>E5/%'P1\
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MKZ9_U^?^R-7K->3?M&?\BOIG_7Y_[(U3+8$?1]%%%<Y04444 %%%% !1110
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MQ'Z>E8/7D]:2BO5ITXTE:*/"JUIUI<TV%%%175U#8VLUS<2+#!"C222,<!5
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M:=F?H,9*236P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 5<DU3TWQ%%JDVR&VN0O_/1D&T?4YK6JM)J=G$^Q[N!'_NM(H/\ .J)+-)N
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MFZA?7DI%QIILXL<.TP8GVVXH T97:.-V5#(R@D(#@L?2N8DU_7I)]D6C;!G
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M%,5X!D0$C\:DM[6"SCV00QPI_=C4*/TJ7FL:Z\+V][>-/<7-W,"V?*:7"#V
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M; ]SCK0!;JFK7S79REO':@\?,S.WOT 'ZU<K,U/Q%8:1,L5S,5E8;@JH6X_
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MR-2<T<T -CC6- B*$51@*HP!0REE(!*Y&-PZBHH[1(KB6<%R\F-VYR5X]!G
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M,5M'<7S X)MHMP_,XH W:S[W6[33YUAE=S*PSLCC9SCUX%7E.Y0<8SV/6G4
M,BD6:-77.UAD;E*G\C3Z** "BBB@"#[' ;@3F&/SNGF;!N_.IZS[RUOY[E6@
MOEMH .4$(9C^)/\ 2K_I0!3U*WO+B-%M+P6;9^9C$'R/QJS!&\<**\AF<#!D
M8 %CZX'%4]6U1],B1DL[B\9CC;;INQ]:?IE]+?V_F2VDMF<\)+C)'K[?C0!:
MF=HXRRQM(?[JD9/YD"A&9D4LI0D<J3TI]0FZA6;R3-&)O^>>X;ORH FHHHH
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MO)K=?J?7]%%%?('Z4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@BGU$7$:EFX &32PS+-&'7[K4 -L[S[4T@V%=IZU:6F#BD6XC:4QAOG SB@
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M#G.1ZTD4R3KN1MPIS&@!*KW%TL+QJ03N..*5KJ-;CR<G?3V_6@!#44TA2-F
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M.#]'->(6^CGQQ\1M$T!1OMQ('N,=D'S/_P".C ]S0!]"?!?PR/#7PWTBWDC
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M_P"-7.M4+?0=/M9/,BM(U?J&(SCZ9Z5?H!E"30=/FF\U[.$OG).WK5Y5"J%
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MQ&0+&TOKE6[VL!VC_@0'\S70:=\"?&.KL'N+>*R!_CO+@$_DNX_I5^QA'XY
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M'TW1117YV?M04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOV7?ARP/0>E6P: %:1%8*6 8] 3UI)[:.Z4"0<CH1UJO<6*W,BN7*D#'%6Z
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M )% #;>X2Z@2:/=L<9&Y2I_(TZ2)),;T5]O(W#.*?S45Q:QW2[9-Q7T5RO\
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MFOS-_P"">UY#8_M?^ 9[B010K]ORS=!G3[D#]30VTT@/TD_;#_;#_P"&3_\
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M?+"EAC#;>,_)O_!4#X5^&OAQ\7?#EWX9TBST.#6-*,MS:6$"PPF9)64R!%
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M51T)K]1?A#^S1\/?@3KFNZIX)T4Z-+K$<,5Q#]HDFC41ER-F\L5R7Y&<':O
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M44 %%%% !1110 4444 %>3?M&?\ (KZ9_P!?G_LC5ZS7DW[1G_(KZ9_U^?\
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M0?!<\<4A2^U1_LR%3@K'C+G_ +Y^7_@0KTJ1R>,U\N_M/ZNUWXSL+ -F*TM
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MQ4XD;_?/\(]AS]*]IL[&VTNTCM;.".VMXQA(XU 45Z.%RRKB6JF(TCVZ_P#
M/#Q^>4<&G2PGO2[]%_G^1C>$?!VG^"M+%I9+N=N9KAA\\K>I]!Z#M^9K6D:G
MR-5:1J^TITXTHJ$%9(_-JU:=:;J5'=L8[5@>+/$]MX5TF6]N#N(^6.+.#(_8
M#_/2M'5=3M])L9KNZE$-O$NYW;M_]>OGCQ)KVH_$;Q-#';022M(XAL[.,9;D
MX Q_>/?_ .M7EYECE@Z=H_&]O\SVLGRN68U;STIQW?Z?ULB3P_H6M_%WQM'9
MV_[Z^NWW22$'RX(QU8^BJ,?7@#)-?=7@OP?I_@'PW::+IB;8(%^:0CYI7/WG
M;W)_P[5R_P %?A/;?"SPWY<FV;6[L![VY'(![1K_ +*Y_$Y/H!Z"S<5\E1IM
M7G/XF?HE>K&RITU:*V!FJ-FH9JC9J[4CSVP9JB9J&:HF:M4C"4@9JC9J1FJ)
MWK5(YY2!WVU"S4,_YU$S5M&)S2D#-4+-0SU7DD"*68X4#))/ K>*.64AS-7A
M?QR^,)TY9_#FB3?Z6PV7EU&W,7K&I'\7J>W3KTYWXH?';4=6OIK'PW<26>FV
M[X:]A)$DQ!Z@_P *YZ=S^E:?[(_[.LG[0_Q"G&IR2Q^&=*V7&J3*V))2Q.R%
M3U!<JV6[!6[XKYW,,TA3IR4'HMW_ )'UN49)4Q%:#J*[>R_S.R_8I_90F^+6
MNP>,/$]HR>"]/E#10S+C^TYE/W!GK$I'S'H?NC^+;^GZJ(U"J J@8 '055TG
M2;+0=+M--TZUCLK"TB6&"WA4*D:*,*H'8 "KE?E.*Q,L3/F>W1']!Y?@88"E
MR1U;W?<****XSTPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** .4^*W_)-?$W_7A-_P"@FO,O@[_R3G2/^VW_ *.>O3?BM_R3
M7Q-_UX3?^@FO,?@^?^+<Z1_VV_\ 1SUI#<#LZ3=245L0%%%% !112;J "DW4
ME% !1110 444FZ@!:;NHI* "BBB@#GZ2218E+.ZHHZLQP*6F3V\5U'LFC61,
MYVL,BI-2&'5+2XE$4=PCR'HJFK-,AM8;?(BB2+_=4"GT %%5;[3Q?X#SS1J/
MX8FV@_7BI+.S2QA\N,NPSG+L6/ZT 1:EIJZE&J--+$%.?W;8S]:DL;-+"W$2
M,[J.\C9-4=0U2^MIRD&G-*O:3.0?P'2K>FS7<\;-=P+;G^%5;)_&@1:I@,OG
M$%4\G'#;CNS],?UI]% PJ/[3']H,&3YNW<1@]/KTJ2B@ HHILT*W$31OG:PP
M=I(/YB@!],FB6:)HVSM88.TX/YU6L=(M-/8O!%M=A@L22?UJW0!2M=#L;.42
M0VZJXZ,26Q],FKM4-2LKVZF0V][]FB PRA<G/K5V&-HX41G,C*,%VZM[T 4[
MJWU":8^5=QV\7;$6YOU->:?M!^!9/$/@A-2A9I]2T?=-O"@,\1_U@P/0 -_P
M$^M>E:AK26,GE"":XEQG;&A(_.HK?7+6ZQ;7GE6D\ORK:W$B[Y%/^R>2#SVJ
M7V$?.OPU\;W&DWVE:]:-_I=I("Z9QN(X93[,"?P:N]^-_A6TM]:BUO3D\S0/
M$4/VN$@<*S#]Y&?0Y.<=MV.U>3^)-#'PS^)-]HZG&F71$EN2<[5;E1^!ROY&
MO;OAG/'X_P#!^I> ;QU%XNZ^T:5S]V902T>>P89/XL?2L1'%_LR^.&\#^.+O
MP=?R8T_5'WVCL>%GQ\O_ 'VHQ_O*HKZSD\QL!#@=S7P=XUT.YC'GQ+);:GI\
MA/&5=2IY'J"",_A7UM\$_B9#\3O!-M?NRC4[?%O?1+QME ^\!Z,/F'U([4 >
MB*:E4U6W$*2HRU2QL2HW##4 /A616)=]PJRM0JU+&SEB"N .C9ZT 2/YC2*4
M;:HZU8!J%6I79POR $^] %@&G U$IHE+>4^S[V.* + -1+#+]J\SS<Q_W*JZ
M=-*Q=7RRCH3_ "J^#0!(#39E=XF5'V,?XJK74TR,@A3=GKQFK2MTSUH +=&C
MB57?>W]ZI0U,Y[4D._RQYA!?OMZ4 2CN<Y_I2TVJ[-<?;%P!Y&.: #4+5[OR
MMCA-IR<G]:N4VFR%UC8QC+XX'O0 ^3=L;80'QQGIFJ>G07$+2-,Q.[H,Y_&K
M4+/Y:^9]_'./6GYH =N-030O)/'(LA0+U7L11%YWG2;RIC_@QUJ:@!=U170D
M>!EA.USWJ*]:X6,?9QEL\U87)4$C!QR* ([-9(K=4D.YQU.<U-NI*CB:1B^]
M-@!^4YSD4 +L;SB_F-C&-G;ZT^DS5>9IQ-%Y84Q9^?UH 6ZAED:(Q/MVMEN<
M9%3YI,FF2%_+8H 6QP#0 _=4<>_YM^WK\NWT]Z2%G:%3(-KXY%.S0 NZHV5F
MD5@Q '5<=:8S2BX P/)QR>^:D+4 !:HIPS0N$.&(P#3\TV@"&T62.$"4Y;\\
M"I":":IV\D[3R"0$)VX_E0 _;+]J9B_[O'"U(QI2:J7<DRL@C4D=\<T /NE>
M2$K&<'^=-B#+&H<Y(J1C3&;CUH 1FJNGF!GWG(SQ4@8LN6&T^F<TUC0 UFJ-
MC0SG=C;QCKFF,: &L:\1_:B^)1\)^#?[#L9"-6UH&$!#\T<'1V_X%G:/JWI7
MK^M:Q::#I=WJ-_,MO9VL;32R-T50,FOAS4O$5W\4O'FH>*;]2MNK^7:0MTC0
M?<7\ <GU9B: -GX:>![C5;[2]!M!_IEY* [XR%)Y9C[*H/X+7?\ QL\3V<VK
M6^@Z:VS0?#L)M(CGAW7_ %LA]<D8SWQGO6QX0'_"K?AS>>*Y1Y>NZTK66DJ>
M&CC_ .6DW^!]E[-7@'C"]FN&@TFT#2WEXX!5>203@#\3_(T =M^S]X8;Q;XQ
MO?%=W&3:6)\JU5AP92./^^5.?JP-?1-_J$6FP&6;=MSCY%))KB/A;<Z5X=TJ
MQ\*V^4O+>(M(2/\ 6R=7/UR3P>P%=_6\=$!G:5K/]JL^VUGAC49$DBX!]OK6
MC4*WMNT@C$\9DSC:'&?RJ:F UIHXV"LZJQZ D FG5FOX;TR28RM:*7/)Y./R
MSBM*@ HHJO:VLMNTC2W4EQN/ 8 !?I@4 6*K6=O<PLYGNS<!ONKY84+^566;
M:I."<#.!UK"DUC59IS';:4R*/X[AL#_/XF@#=K/N+C45OE2*SC>VR,R-+@_7
M';]:N6WG&!//"";'S",DK^&:DH *AN[R"QA,MQ((XP<9-34V:&.="DJ+(AZJ
MX!% %'3]>LM4F:*WE+NHW8*D<?B*T*BM[2"U!$,,<(/7RU"_RJ6@ HJG)I,$
MTWFR&5SG(5IFVC\,XJY0!GW>BI>77G275T%X_<QR[4_(?XU>AA2"-8T&U%Z"
MJ>I2:C&T?V&&&4'[QE8C%6;7S_)7[1Y8E[^5G;^M "W'G>2?(\L2]C)G'Z4E
MJLZQ_P"D/&\G_3)2H_4FBZO(;&$RSRK%'TW,<?A5:RURRU";RK>8ROC/RHV!
M]3C H O$[02>@K)7Q TDY2/3;V1,X$GE;0??G%:U-DD2%"\CJBCJS' H <IR
MH.,>U-DD6-=SL$7U8X%)%-'<+OBD61>FY""*CO+&"_C$=Q$LJ Y ;UIHEDL<
MB2KE&5QZJ<U7OM-M]3C5+E"Z+R '9?Y&G6>GVVGJ5MH$A!Z[1R?J>]3G...M
M,16L-+M-+0K:PK$&ZGDD_B>:M51AL[P3!YK\NN<^7'"J@^W.3^M7J!D,]JMP
MRDO(FW_GG(5!^N*EQ2T4 5[V>>WB#06QNGS]T.%_4U+"S/$C.GEN5!9,YVGN
M,TLDB0QL\CJB+R68X JK;ZQ:7<HC@F$K?["DC\\8I 7****8@I JKD@ $]32
MU3U/2X=6M_)G+A>OR.1_]8_C0,N454TS2X=)MO(@WE<Y)=LFI[AI$@=H4$DN
M/E4M@$_6@"2FONV-L 9\< G S]:HZ=)J<DC&]BMXH\<"-B6S_*M"@"E:KJ'G
M;KF2W$?_ #SA1B?^^B?Z5=K%U3Q-'I\K1):7%PZG&50A?SJYI.HR:E;F62TE
MM#G $HZ^X_\ U4AB:KK$>DJF^&:8OG A3=4VGWC7UNLS6\EMD\)* &QZXJS3
M5E1FP'4GT!IB'4U9D=BJNK,.H!Y%*0&!!&14<-I! Q:*&.-CU**!0(EJH-(L
M1-YHLX!)G.[RQG/K]:MU1U:UN[RW5+2Z^R/NRS;<Y'I0-%ZJ]Y;27482.YDM
MO5HP,G\P?TJ2W1XX8TDD\UU #.1C<?7%0ZE>26-OYD5M)=OG CCQGZT 36\)
M@A6,R/*5_CD(+'ZTLC&.-V"-(5&0JXR?89JAI-_>WQD-U8&R0?=+/DGVQBM*
M@#"74M:NIML6F1VT><%[B3/Z"MWT]>]17%W!9J&GFCA4G ,C!1^M2T 4[[6+
M+36"W-RD3$9"DY./7 J>UNH[R%)H6WQ.,JV",_G3;BQMKP@SV\4Q'3S$#8_.
MIE4*H51A1P *!"T5'<0_:(6CWO'N_BC;:WYU%9Z?%8YV&1V/5I9&<G\S0!9K
M..@VS7QNF:9I,[MIF;:#],_ITK1JE=?VD;I1;BU6VXW-(6+^^ ,#]:8%VLN;
M^V)+P^3]DAMAT,FYV;WP,5J53U36+;1XEDN68!N!M4FD!<0,%4,06QR0, GZ
M4[FLO2/$-OK3N+>*<*HR9'3"_3.>M:G- !S1S1S1S3 9)-'#@R2+&&.!N(&3
MZ4_FH9K2"Y9&FACE9.5+H"5^F>E3<T 5KK3;6^DC>X@2=H\[?,&0,]>/PJPJ
MA%"J JC@ #@52U6UO+N%5M+S[&W\3>6&)_7BHM)TRZLMSW6H2WCD8VD */\
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MT989VOU'L:<2%!).!38IHYT#QNLB'HRD$5#J&G6^J6Y@NH_-B)!*[BO(^AH
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MP _$C%:#*&&& (]#0J*@(50H]ABF(6@* 20 ">M%,G@BNHFBE19(VX*L,@T
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M-?3'[&_A^6S^'6H:],<?VYJ$DT*^D4?[I3]25?\ #%?*DLV>0<CJ*]U_9?\
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MBQ\1-#UJX^+'P[@^'>H6]RD=E:P7:W N8BN6<D,V,'B@#V>BBB@#X-_X)O\
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M]ZND^AZ$-,.VNI] T445V'*%%%% !1110 4444 %%%% !1110 4444 %%%%
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MB0?0 4^J-[H=GJ$@>YC:4CH&D; _#.* +JLLBAE(93T(/%,FMXKA0)8DE /
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M.LB[U'4UOO)M=+\V$=9Y)@JG\.3_ )Z5KUE:CXFTW2Y/+N+I1)W1 6(^N.E
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M/.M9!+%G;N (Y_&FW&DV5U<">:UAEE& '= 3QTJRJJBA5 51T &!2&#*KC#
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M@7?2;3=W]O"O\2(C2-^#9 _\=KHK'X(Z/;[3<W-U=$?[0B_5 IKYIJ@M]3]
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5Y-^T9_P BOIG_ %^?^R-7K->3?M&?\BOIG_7Y_P"R-42V&CZ/HHHK
MG*"OQ[\+^'_V@/\ @ES\1O&;^'O 4GQ ^&6K3+(;R&"2:-X(V<PR-)$"UM*J
MNRMYBE22<!OE:OU^NUFDM9EMY%BN&1A'(Z[@K8X)'< ]J_/+]FC_ (*-:MX=
M^)WC?X<_M.7]GX/\26%X$L+S[$;>S7:,/$S '"L-LD<C?*RL?F'R@@&3IO\
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MKM_"GB#PS;R6D]O>Q2$3QB1VCDB*J=^4(!4?-N!XQ@GYK^-GQ^A_:2_X*)?
MGQ;HVGWMIX,CU[1-/T*\O8C$=1BBU0&6Y5#R%,KR(,]HQG!R  ?2/_!;3_D@
M7@7_ +&8?^DL]?9/[,_@G3?AU^S[\._#^DP);VEIH=IGRUQYDKQ*\LA_VG=G
M8^[&OC;_ (+:?\D"\"_]C,/_ $EGKM/V/_\ @H/\,KSX*Z#X<^(GB:U\"^-_
M"]C%I>I6.NEK<S>0@C6:-F&&+JH)3[P;=\N-I(!XY_P4HMT^&7[;7[/?Q"T=
M%M]8NKF"*Y,?R>>MO=Q@!R.NY)VC)Z[0!T J7_@M%_R-/[/7_7[JO_H>G5AW
MGB@_\%&/^"A'@S4/"-I<S_"[X<M#<SZM-$T<<PBF\XL0P!!FE6.-4^\40M@8
M;'8?\%K/".LS>$?A3XWL+62?3_#NHWD%U(J%DA>X%NT3/CHI-L5STRP&<D9
M/TKK\P/V:?\ E,#\9/\ KRU#_P!#M:^C-/\ ^"H?[/EQ\.(/%-UXQ^R7;6XD
ME\/_ &65]0CFQS"$"X)!XWYV'KN YKXZ_P""??BS6/'W_!2SXA>)=>TJ;0]3
MUC3-1OVTRY_UEK'+-;O%$WNL;(#P.G0=* .E_P""E?ARQ\8?M_?L\:#J<*W&
MFZH=+L;J%AD/%+JK(ZGZJQ%?JDJA0 !@#@ 5^8/_  4#_P"4DG[,/_7[HO\
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M@- $FZF?9X_.\W;\_K38E$:XR3SGYCFGT 2;J7AN#R*KR0I,Z,V<J<C!J;-
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MQP X$LSYW>^ >*0(V:R;F^U4W3Q6VG)Y:G FFE !]\#FM.'>(4$I4R[1N*C
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MA5*\UFQT]MMQ=PQ/_=9AN_+K5M6#*"#D'D$54O-&L=0)-S:12L?XF4;OSZT
M3VMU%>0K-"XDB;[K#H:9)I]K-)YCVT+R?WFC!/YU.JK&H50%51@ = *AO+=[
MJW:-)Y+9F_Y:1XW#\Q0!. %  &!395:2-E5S&Q& X )'OS5/3=)_LXLQN[JZ
M9A@FXE+ ?0=!5^@#)TW06L;CSY-0O+N3IB67Y/\ OFM:LV^_M=G(M/L<:=FF
M+L?R &*MV:SK;QBY=))\?,T:[5/T% $W-'-5[Z^CT^'S)%D89P!'&SG\@*=:
MW NH5E"21AOX95*L/J* &7^H0:7:M<7+^7$O5L$_RJEIOB2WU:7;:P7,B?\
M/8QX0?B36MS1S0 <TC,J]2!VY-+S6==>']/OKL7-Q;+--C&7)(Q],X_2@#1Y
MJHVDV;7WVQK:-KGC]XPR>.E6@ H  P!T%5-3ANY[<+97*VLP;.YD#@C!X_E^
M5 %SFCFJ.EVM[;0G[;>_;)3Z1J@7\AS5N9FCB9DC:5@,A%(!/MR<4 5;.UO(
MI6:XOOM"G[L:Q*BC^9_6KO-<]!KFL3W2Q_V&T<9."SS 8'KG%=#S2 .:.:.:
M.:8#))4AC:21UC11DLQP!^-5+37+"^N/)M[J.:7&=J'-6+JS@OHO*N(DFCSG
M:XR,TEK96]DFVW@C@7N(U"_RH 2\L;?4(?*N85FCSNVN,@'UIMCI=IIJD6MO
M'!GJ47!/U-3RJSQLJ-Y;$8#8S@^M)!&\<**\AF<#!D8 %O? XH DYJ"YLQ=[
M0TDJ*.HBD*9_$<_K4_-#9"G !;MDXH 51@ #M3)VD6%S$JO*!\JL=H)]"<&B
M'S?+_?! _HA)'ZTVZNH;&W>:>01Q+U9NU #X2[1J955),?,J-N /L<#^5.J.
MWN8KR%98)%EB895E.0:DH$S/N-:C@OULQ;W,LIP<QQ$J >^X\8K0HHH$-\E/
M,\S8N_INQS^=.JAJ6A6FK3127*R.8Q\JB5E ]\ ]:MV]NEK$(XP0@Z DG^=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4IM:L+>4QRWD*..JEQD5:AF2XC62-@Z,,AE.0:9+(+C5+.UE$4US%%(?X6<
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M]2;'FQZ;#_M?:992/^ [%'KW[5FXTOM2;^8:FA=?M)ZHJ[-/T6QM$'W5D9I
M/RVUA77QV\9W^5AO(K;/:WMD/_H0)KI+7X-O'CS=3ME'?[/888>VYG;W[5K6
M_P *;", 2ZEJ,X[KOCC'X;$!_7O4WH1V0:GEMUXP\9ZMGS=5U0JW55E:-3^
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 <I\5O\ DFOB;_KPF_\
M037EOPA;_BW>D_\ ;;_T<]>I?%;_ ))KXF_Z\)O_ $$UY9\(?^2=Z3_VV_\
M1SUI#<3.QI***V)"BBB@ HHHS0 4FZDS10 4444 %%%)F@!:3=29I* "BBB@
M#$HHJ"\OHK+9YFXLYPJHA8G\JDU)Z@OK^+3XO,EW8[!5))J=6W*#R,\\]:*
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M^HIA$U-EVQ2_]= .%/\ M#Y3[5]$6]S'<Q++$ZR1L,AE.0: +22;L]1SCFI
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M6)_L$9!N+G&%"YZM^N%[X_+ZI\&^$['P7X?MM+L(!#'&,NV06D<]68X&2?\
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M<+ &SGZDU>K,B\3:;/<)!'=!Y7;:JJC')^N,5IT 4[?6+2\NFMXI=\JYR-K
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M0,EF. *HV.NV.I7#0VL_GNO)*HVT?\"QC]:GDNK5EP\D;#KC(-,_M*UC&!(
M/15-.S N451;6+=>['\*Q-4_L74KD378DD=>@:8A1]!NXI\LNP'4U4U#3X=2
MA$4^\QYR51V7/L<'D5E)XJTVUC2))8411A5,RC@?C5#5/'">0!8S6BRD\M-(
M2 /H!UJO9R[ =7#"EO"D4:[40;57VJ2N$TOQPUNK_P!H7]O.W81(<?7..:MM
M\1+$<B13[>6_^%/V4^P'16=K>PSN]Q?"XC/W8UA" ?CDFKU>;W'Q@BCN#'#9
MO,,XW;2N?I5]?B5;LH8A@<9V^7T]NM/V,^P&YJ'B2XM[AH;;2+R[*G!<H40_
M0D5HZ9=7-W;^9=6GV*3.!&9 _'KD5R#_ !,ME7+;E'J4'^--3XG6TF=KLW^Z
M@/\ 6CV,^P'<S31V\9>618D'5G( _.J=OX@TZZG$,5[#)*> H<<_3UKB;[QU
M8:DBI=6LDZJ<@-&O!_[ZI+'QIIEADV]G]G;IN6%=WYYI^QGV"Z/0;JUAO83#
M/$LL3=5<9%06>C6.GMNM[2*)O[RJ,_G7(_\ "R8/23_OV/\ &J-]XV6^NXY%
MO[JUC48,<2  ^_6E[&?8+GI-%<1'\1K555<DXXW-&?\ &BX^)$"PN8?+>7^$
M,C ?B:/8S[!<[>JU]+<0VKM:PBXG_AC9]H/XUR=G\18&A4W3PI+W$2R$?J*G
M/Q$TY5+-/&H'4L&'\Q2]E/L!TFGR7,MJK7<*P3]T1MP'XU:KC8_B=I$D@1;F
M-G/0 -_A5I?'NGMTECQ[DC^E+V4^P&VVL6*7'V<W</GYV^6'!;/ICUJ[7++X
MXTY6)WP@GJ0V#_*G_P#">:=_STC_ ._A_P */9S[ =(RAL9 .#D9I>:Y:?QM
MIES"\4CH4<88+*0<?4#--L/%&D:=;B*V,4<>=V#,2<_4\T>SGV Z2\M4OK9X
M'9T5NIC<JWYBHM-TFVTF-EMD9=QRS,Q8G\361_PG&G_\]8?^_H_PIO\ PG>G
M?\](_P#OO_ZU'LY]@.BF,BQ,8E5Y,?*K-M!/N<'^5<_Y?B:ZFYFL[*,'^!2Y
M_7_ZU-_X3O3O^>D?_??_ -:JM]\2=/LPN%:8M_#%EC_(4O9S[ =7"KQPHLC^
M;(  S[<;CZX[57U/4/[-MQ+Y$]R2VT1VZ;F)^GIQ6!#\0K&:%9"RQY&=CD[A
M]13C\0-/_P">J?\ CW^%/V<^P&MI>K7.H28DTR>TCQ]^8@?IUK3YKD/^%D:7
MNV_:H2W]T;B?RQ2GXB6'&)E_[X?_  I^RGV Z2;5+.WDV2W<$;]-KR*#^6:M
M5Y^GB;08+@S):P>;G=O\ECSZ\U<;XD6J]"&^D;?XT>QGV"YTTVAZ=<3&66RM
MY)&.2S1@D_7UJZJA%"J J@8 '05Y[JGCXW4*K:WCVAS\S+;AB1^)XIMC\0/L
M<;":YN+QB>"T*+C\C3]C/L!Z+S1S7 -\2T_A28_5%']:K?\ "SIC,5%O)Y6/
MODJ#^6/ZT_83["NCTCFJHDO#>E3#"+4#_6>82Q_X#C^M<"WQ(DYQ%(1_O@?T
MJM-\398\ PN#V_>D_P EI_5YA='J/-4=6UJST6-7NY?+#G"@ DMCZ5YQ_P +
M&NIAE$..^9&J*7QS>2]8HF';<2<?K3^KS"YZ1I6O6VL9-NLVW^^\1"G\>E:6
M0O4XKR!O&FH-@!85'H%/^-1_\)3J=P=B%=S=!&F3^%5]6EW"Y["9XUZR*/\
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MA1@# ]J***D04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:\F_:,_Y%?3/^OS_ -D:HEL-'T?1117.4%%%% !1110 4444 %%%% !1110
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M)'T;\S7?Z#\2O"WB>98=,UZQNIV^[")0LC?1&P3^5<1\:/\ @G'XG\+";4?
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MHTK]@HHHKA/7"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCW)/<GN3S53P]<67B7P_9W']G);V^"([=T!" $@;>.G%;<<:0H$151%X"J,
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M@>_[FU13^B]*]<70[0=48_5C3UT>S7I"/Q)/]:/:PZ07W(#QAIO&]UR_B/Q
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M5:32C/R?3[G>+?\ A/6Z***]D_$@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KR;]HS_D5],_Z_/_ &1J]9KR;]HS_D5],_Z_
M/_9&J);#1]'T445SE!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M30!++N91M;::7=[U'NIK/A2?TH EW5&K-\VXY&>,>E0M=+'"TLQ6)%&69S@
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M"X0F-59^P9L#\\&GB@"O>R7$,!:VA6>7/"N^P?7.#3[5Y9+>-IT$<Q'SJIR
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M+:R3R0AKB)89"?N(^\#\<"G331V\32RNL<:C+,QP!6=;>*-+O+E;>&Z$DK'
M54;G\<4 :4TR6\;22NL<:C+,QP *R;?Q=IEU=);PS/)([;5Q&V#^G2M:2-)D
M*2*KH>JL,@TV&VAMQB*%(O9% _E2 EYHYHYJM>6LET@1+F2V'<Q ;C^)!Q3
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M444 %%%% !1110 4444 %%%% 'P;_P $W_\ DMO[4'_8PP?^E.HU]Y5\&_\
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ML-5CXFL9CAP1UVYZC]1W%=9))7 >/OAE9^+)/M]I)_9NLI@K=1\!R.F_'?\
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ML 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 <I\5O^2:^)O\ KPF_]!->5?"/_DGND_\
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M;#X/^.-?8-+I\ENA_P"6E],%Q_P$DM^E:MW^T]J\RBWT'PS;:=!T5K@E\#U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KR;]HS_D5],_Z_/_ &1J]9KR;]HS_D5],_Z_/_9&J);#
M1]'T445SE!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!\&_\ !-__ )+;^U!_V,,'_I3J-?>5?!O_  3?_P"2V_M0?]C#!_Z4ZC7W
ME0-A1110(*\D_:R9U_9O^(!0D'^RW!V^A(S^F:];K \?>%8?'?@CQ!X<N&"0
MZM83V3/C.SS$9=WU&<_A6E.2C.,GT9A7@ZE*<%NTU^!^2O[+!0?$2]W8W?V9
M)LSZ^9%T_#-?5;-7Q3X9U#4/@Q\4F35+9X;K2[J2RO[;O@$HX'KCJ/7 K[(T
MW5+76=/@OK*=+JTG0/'+&<JP-?LF6SC*ERIZG\T9O3G3K<S6C_-%LM3"U-9J
M8S5[*1\\Y#BU,+4QFII:K2,G(5FIK-32U1LU:)&3D/9O2HV:FLU,9JT43%R'
M,U1LU(S5&S5:1DY'R;\&5B_X6YX76\ *_P!H1@B09^?/R_CNQ7Z#LH92",CH
M0:_._P 70S>"/B=>20#9+9WXNX/8;A(GZ$5^@NCZI!K>DV6HVK;[:[A2>)O5
M64,/T-?$45R2E![IGZ=6DJD85%LT95Q\//"MY<?:+CPSH\\^<^;)81,^>N<E
M<ULV=C;:=;K!:6\5K OW8H4"*/H!Q4]%=-DMCFNPIN>M*33&-49MB,:8:4FH
MV-6C-L1FJ)FIS&HF:M4C"3$8UYY\<_%]QX,^&^IWMFYBO9MMK!(#@HSG!8>X
M7<1[@5W[-7RE^U)\1HM<UBW\,V$HDM=/<R73*>&GQ@+_ ,!!/XL1VK.O/V=-
MOJ7AZ;JU4NAYO\-? Z^--5F^TR-'8VH#3%#\S$D[5'IG!Y]J]<N/A/X7FM?)
M73O)..)8Y7WCWR2<_C6?\&]#?2/"QNI5VRWS^: ?^>8&%_/D_0BNZ9Z]_+<!
M1CAHNK!-RU=U]WX'R&<9KB)8V4:-1J,=%9VVWVWU/G'QEX4N_ .NPB*X<H3Y
MUK=)E&!!]NC XZ>QKZU^%?C)_'7@;3]3F(^V8,-SMX_>*<$^V1AO^!5X!\=[
MA/LND1$ R%Y&![@ *#_,?E7IG[,,,D/PYN&<Y674)73Z;(U_F#7BJE'#8Z=&
MG\/_  S/I?;RQF5T\36^*]K]]6OT/7':H&:G.U0,U>S%'S\I#7:H':G2-4#M
M71%''*1YK^T$<_#N;_KYB_F:@_8MX_X3'_MS_P#:]6?CR!)\-[\XSMEA(XZ?
M.!G]?UK+_8SFVZEXJCW8W0V[;<]<&3G'MG]:^:QZMC(^G^9]EE,KY?/_ !?Y
M'T%\0_!MI\0/".H:)=X47"9BEQDQ2#E''T.,^HR.]? T;:EX#\5?.AMM2TVX
M*.C?WE.&4^Q&1]#7Z+LU?+O[67P[\B\M?%]E$!'/MMKX*.C@?NY#]0-I^B^M
M<>(IM)5([H]+#5(R;HSU4CK-#UZV\2:/;:C:-NAF3=CNI[J?<'(_"IY&KYS^
M&WQ$D\%WCP7 :;2YSF1%ZQM_?7^H[_A7LTGQ"\.?8OM7]L6ACV[MHD'F?]\?
M>S^%?8X+,:6(I*4I)26_^?H?F^9917P==QA%RB]FE?Y>INRR  DG '<UY#X]
M^+C+))8:%(/E^62]&#^"?_%?EZUC>/OBI/XB62QTW?:Z<>'<\/,/0^B^W?OZ
M5V7P5^ +^(O)UWQ+"T6E\/;V+95KD8R&;N$].[>PZ^3C,SGB)>PP;]7_ )?Y
M_<>_EN24\+'ZUF"UZ1_S\_+[SS;1? ?B[QX/MECIE[J:,V/M4APC'O\ .Y /
MYUZ5X2_98U>\F27Q#?0Z=; Y:WMF\V9O;/W5^OS?2OIR&&&RMXX((D@AC4*D
M<:A551T  Z"FLU<%/ 0O>;NSV*F9U+<M-**,?POX3TGP7I::?I%HMK;CECU:
M1O[S,>2:TV:AF]:A9J]:,5%61X-2HY.\GJ*S=Z@9J&:H7>NF,3CE(&>H':AV
MJ%GK>,3EE(&>H))*1Y*A=ZWC$Y)2!WJO))1))GO4#O71&)QRF#O4$DE$DGO5
M=Y*W2L<CE<PO%G@W2O%\*)?PGS4&([B,[9$]L]Q['(KR;Q)\%K_38Y)],N!J
M$2\^2R[9<>W9OT^E>W2257DDKSL3E^'Q5W..O=;_ ->IZ^"S;%X&T:4KQ[/5
M?\#Y'._LC_M1:O\  _QC9Z)K%Y--X(O9Q#=VD[<6+,P'GIG[NT\LHX(SQG!K
M]7E82*&4AE(R".AK\2/BUI\=CXPE>-=HN8EF('3)RI/XE<_C7ZX_LXZ]-XF^
M W@+4;AVEN)-'MDED?[SLB!"QYZDJ3^-?BF>8-8:L[;W:?GV9_3W"692QN'Y
M7LTFO+NCTBBBBOES[\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y3XK?\DU\3?]>$W_H)KRGX
M1G_BWND_]M?_ $<]>K?%;_DFOB;_ *\)O_037E'PD_Y)[I7_ &U_]&O6D-Q,
M[#=2445L2%%%% !12;J2@ W4E%%, HHHI %%)NI* %W4E%% !1110!E$9!!&
M12*H48 P/:DD#%"$(5L<$C('X51CTVY%PLDNHS. <[%554^W3I4FI?K*DT6X
MEOC.=2N%C+9\I3@8].O]*U:IWUQ>QR*MK:I,I'+O(%Q^% %VJNH74]K&K6]J
MUTQ.-JN%Q^=2VYF:%3.J++W$9)'ZU(S!5+$X &30!6T^XN;B$M<VWV5\\+O#
M9'X58DD6&-I'8(BC)9N@%5[/4K>_+B!V?;U.Q@/S(JRRA@01D'L: ,^QUZRU
M*X:""4LX&1N4C=]*T*2.-(QA$5!_LC%+0 456OM.CU *)))5"]HY"H/UQ4\,
M*P1+&N[:HP-S$G\S0!7OM-34 HDEF15_AC<J#]:=8Z;!IRE8%90>NYRW\S5B
MB@ K,2/6)+@&2:TBASDB-68D?C6G5:^U!;';F&>9FZ+#&6/^% %FH+R\^R[<
M033ENT*9Q]>U26\QGA5S&\6[^"3&X?D:D9@H))P!U)H$-C<R1JQ1HR>=K8R/
MK@TM,AN8KC/E2I)CKL8'%.DC6:-D<91@5(]0:!#8[F&60HDJ.X&2JL"13Z@M
M=-M;%B8+>.)B,%E4 X],U/0!2CT.PAG,RVL?FYW;CSSZ\U=JG?:=)?2 B]GM
MX\8V0D+^.<9JS;6_V:%8_,DEV_Q2-N8_4T .D0R*0':,_P!Y0,_J#2M&LB%'
M =6&"K#((]ZBO)I+> O%;M<OV16 _4U1T^]U.XN<7%@MM!S\QD!/Y4 4E^'O
MAU9_.&EP[_0EBO\ WSG'Z5<T]KJ*Y:WCTV*SL8R0K*P&?0A0*U*'D6-<NRH,
MXRQQ0 4444 %-,,;/O**7_O8YIU-FB$T31L64,,$JQ4_F* '456L=-M]/#>0
MK MRQ9RQ/YFK- $:6X29I-\A9NS.2H^@Z5)5:3[:;@B,P)!ZL&9C^' JS0 5
MA^(O ^@>+4*ZMI-K>MC'F.F)!]'&&'X&MRJ4&I23W1B%E<(@)!ED4*O\Z /(
M->_9=T>=FFT35;O2Y>H24"9![#HP_,UP-Q\+?B)HK,+6'^UH%/'J1]'P?P!-
M?55<WXS\7IX:TF2:W\JXNPP01,V=N>[ './\:EQ0'RU<>)-6T622/5]#N+5H
MVV.Q1D"GTY']:L6?CS3696\V:U<'AF4Y!^JYKW".\UWQ1"MPMGI>H/MP)+*Y
M,-P@/;.[CZ$4S1? (US49(?$/A:SDLVC.+F:.(3J>,#S(P"W?M^-9\H'#:-\
M9M9L=HL?%UV@'2-KQBO_ 'RQQ^E=C9?M$>-5BVR:I;ZA#_=N+6)@?Q"C-7-2
M_9O\%7V?)M;O3R?^?:Y8X_[[W5SEY^RGI98FQU^^MCV\Z))/Y;?;\J?*P-[_
M (7I<W.1?^$O"]]_M2:=\Q/_ 'UC]*/^%L>'IL_:/ASHC=QY),7\A7'R_LQZ
MU;\6GB_</]N)X^/P<U4?]GGQS'@P^(M/?/7S)I1_[3-+E8'=?\+*\%R\S?#2
MT9^G[K4I(QCZ!.M*/B-X&4@K\,[?<.1NU60C\1LYKSJX^!OQ&M<+'J%C=#UC
MG_\ BD%*OP-^(S 9U'3USZS=/_'*5F!Z'_PM3PS'S#\.-(#]C),SC\BM._X7
M9#:G-AX&\+6Q&,,]CO;'N003S7 K^SWX]9L2^(--1.[)/*3_ .BQ_.H;'X$:
MSJ=Y]ED\8(90"2(4F=1CW.T4^5@>@R?M#^+HXBMF^GZ6N/\ ETLD '_?6:YC
M6/CGXFO0PO/%UQ%GJL-P(?PPF*EM_P!E2!F!OO$]S<CN([8)_-V]ZWM/_9C\
M(6>#.^H7Q[^=.%'_ (XH_G3Y6!Y'JGQ"L[F0R7.H37TW]YMSG\S_ (UFQ>,I
MM2F\G2M)NKZ;LJJ6;_OE0:^CF^%O@3PKIT]TV@6BP0J69Y@TS#Z%R3GTK&A6
M76K4QZ+X>FM],)RLM]?S1Q'/<(' _+-'*!Y3IOP_^)'B;!CTM=(@;_EI=$1$
M?4-EOR%=;I'[+TUY(LOB/Q%).>\5FI/Y._\ \37HO@30DT&^G:76;:::==HL
M;:8LBG@Y&YB2>/U-=Q5** XWPU\'O"/A4H]IH\,MPO/VB[_?/GU&[(!^@%=E
MTX%1+'-]H+F8&''$83'YG-2U8%"^M+^ZF_<7RVL/HL(9C^)-784,<:(SM(RC
M!=L9/OQ1*YCC++&TI'\*D9/YD"EC8N@8J4)_A;&1^1H 2:3R8V?8TFWG:@R3
M]*;;S&:/<8I(?]F3&?T)J2B@ J"XO[:UD2.:>.)W^ZK, 34]&T=<<],T '49
M'(HHHH @OM/M=2A,5W;Q7,?]V5 P_6N7OOA5X?O&W);RVISD^1*<'\&S^E=?
M396=8G*+O< [5)QD]AF@#.T'PW8>&[5H+"'RPQR[,2S.?4DUIUF6,VKR3 W-
MM:Q1=PLAW#]"#6G0!2M_[2:[)F%JEMS\L99G]N3@?I5VLZ^\06EA="VD,C3$
M9VQQENM:*G<H//XT 9NI>(K+2Y/*FD+38SY<:[FJU87RZA;^:D4L2YP!,FT_
M6K&,$G'-% !1221B6-D;(# @X.#^=9]GX=T^QF$T5O\ OAR)'8L?U- &C57^
MR;,W37!M8C.QR9"H)SZU:K-U&UU.XN!]DO([2$#_ )YAV)_&@#2JO<?:V8"W
M,*+W:0%C^0(_G18P3V\.VXNC=29SO*!/PP*==77V6,,(99B3C;$N30!+&K*@
M#MN;NV,9_"F7,QMX7D$;S;?X(QEC]*BMKJ6X;YK26W7'WI2G\@35F@#*L]4O
M[JZ5&TI[> ]99)0"/^ XK5JM>:I::?@7-S'"3T5FY/X58CD6:-71@R, RL.A
M![T 5[C5+.SD$<]U#"Y&0KN :L*P90RG(/((H,:E@Q4$CH<4M %*ZT.POIC+
M/:QRR$8+,.:LV]M%:1"."-8HQT5!@4EU"UQ;R1I*T#,,"1.HJGINC?V=(9#>
MW=RQ'2>7<OUQ0!HU"(7^T&3SWV8P(<+M^O3/ZU*V=I(&3Z5STFI>()KC9#ID
M,*9QNF?=^.015$G14C9[#)]S3(/-\E/.*F7'S^6"%S[9[57U+5K72(1)=2A
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFE1CHO>?D&IYG-XNU35+A8;9299#A4B0N[?S)_"M[2_A%XV\4%9)+&2UC/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-(JJ@PH"CV%+0 U8D4Y"*#Z@4ZJMYI\=\Z&5Y=B_\LU<JI^N.M6@ !@<#L*
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ME_CO.6_[Y-9MO\.?$?B*X,VI7/E-)]XLQEE;\3G]16K53[4E%!H>@'Q=\*/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP&>3X)\.D^^DP?\ Q%.A^$O@>WE62+P9X?BD4Y5TTN $?0[*^9_UDK_S2_\
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M!W52W #'&: ' Y /2FS31VZ%Y76-!U9R *=534=)M-61$NHO-5#E?F(Q^1H
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MRW(X?&<?A1''Y:!=S/\ [3')I9"RQL47<P&0N<9/IF@1':PO!"$DF:X?J9'
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M@R0HP-Q)/XD\FG445^<'[F%%%% @HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ,>U%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M>3?M&?\ (KZ9_P!?G_LC5ZS7DW[1G_(KZ9_U^?\ LC5$MAH^CZ***YR@HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KR#]I;]GK2OV@_ <FFS>5::_9AI=*U)EYAD[HQ')C? #
M#Z-@E17K]%7"<J<E.+LT95:4*\'3J*Z9^(\3>(O@CX]O-/U*SDL=3L93;WMC
M-P'&>GN",%6'!R",@\_1.@>(K/Q-I,.H6,GF02#OPR,.JL.Q%?4G[77[*=G\
M?/#_ /:NCI!9>-]/CQ;7#?*MY&,GR)#]3\K'[IXZ$U^:.@Z]KGPE\57=A?6D
MUK-!*8+_ $VY!1@RG!!!Z,.Q_I7ZCD6=12Y9[=5V?=>1^!<5<,34N>G\71_S
M+L_-?UY?3#/[U&SUE:#XEL?$^FI>V$PEB;AE/#(W]UAV-7F:OTZ$HSBI1=TS
M\0J1G3DX35FC.UCQ7I.@S11:AJ$-K++RJ2-R1Z^P]SQ5]9ED175@RL,AE.01
MZU\Q?$'5SK7C'5+C=OC$QBC/;:GRC'UQG\:]3^#/B8ZIH+Z;,^9[$X3/4Q'I
M^1R/IBO#PN:+$8J5!JRUMYV/IL=D;PF"ABHMMZ<R[7_RV/1V:F,WO3&>HV8U
M[Y\J.:2HV>FL]1L] '+^++@ZQK&G>'4)\N?_ $F\VG_EBI^Z?]YN*Z7(50J@
M!1P .PKB/!=Q_;?B;Q#K.=T?F+:0-VV+UQ]?E/XUV+25PX5^UYJW=Z>BT7^?
MS/2QT?8N&&_E2O\ XGJ_NT7R'L^*C9Z8SU$SUW'G6'R3"-68D #DD]J\&LK=
MO&WCR"! 6&HWZH/9&?'Z+_*NX^(OC6&TL9M,LY1)=S I*R'(C7N,^IZ8^M:G
M[,?@F74/$,WB2>/%I8*T4#,.'F88./\ =4G_ +Z%?'9I66*KPPT'>V_]>1^A
MY%AI8'#5,955G)67]>;_ "/ITX50H  '  X%0NU.=J@=J[HH\^4B-ID:1D#
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MYHNHQ""^ME)P&9,D,N<?,C,N2 3GBO:: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** .4^*W_)-?$W_7A-_P"@FO)/A/\ \D_TK_MK_P"C
M7KUOXK?\DU\3?]>$W_H)KR3X3_\ )/\ 2O\ MK_Z->M(;B9UU%%%;$A1110
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M (UJT 8.F^#[:QNOM,LLEU*.09#P#Z^];U9FHS:LMRJ6-M;F+O+,Y_D*TQG
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M1U#25U"16>YN8U QY<,NQ3]<5>J*YFDACS' T[]E4@?F2: '00I;0I$F=BC
MW,2?S-$N\QMY9428^4L,C/O3;:2:2(-/$L+Y^ZK[N/K@5+30KF98)J_G;KR6
MT$>?N1(Q/YD\?K6G67+KR+>BVBM+NX/0R1Q?*/Q.*U*!,R;SQ+:6=TUMLGFF
M!P4BB)Y_K6I&V]%;!7(SAN"/K233);QF25UC1>K.< ?C4%KJEG?2&.WNHIG
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M2Z!D4X8(I;'X@8K7!# $<@U$MM"LF]8D#YSN"C-2TP(HK6&!W>*%(W<Y9E4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-JVFPO\ &J2)#87AL9F=4\F0KB4#8/W8?J>]?,?_  4@_P"3P/V=?^ORU_\
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M^RX6<EC));.+_-'UWHNHG4M$T^\/WKBWCE/_  )0?ZU.S5B^#(VM?!N@PO\
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M%S<+$Q&0O)./7 YH&BW39YTMXR[Y"C^ZI8_D*99WD-_;K/ _F1-T;!'\ZEH
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M9+EK=2[2+P<1MM'_  +&/UJQ10 $!A@C(H50HPH 'M15&^T:VU*:.2?S"4&
MJR,H_2@"]2,HD5E895A@BHK.SAL8?+@38F<D9)R?7)IUQYWDOY&SS<?+YF=O
MXXH CL].M=/S]F@CAW=2JX)^IJQ7-?V9XCGN-TNI0PI_TR&1^6!G\:Z*&-HX
M41Y#*RJ 78<L?6@"C-:ZE)J >.^2*TX_=>4"WYG_ #[5K2?=]:A=MB,P4M@9
MVKU-2!C)$&*LA/\ "V,C\J12V*>HWC6-JTJV\MRP( CA7+&F:7?37\+236<E
MF<X"R'D^_M5RJD.L6-Q="WCNHI)N<(K9/'6F26ZKG4K1;@6YN8?/)QY>\;L^
MF*L4GEJ&W!1N]<<T +49MH3+YIBC,G]_:-WYU)5>_MI;JW,<5R]JV>9$ )QZ
M<T 6*9/#Y\13>\>?XHS@_G5;2]-.FQLK7=Q=LYR6G?=CZ>E7* &0Q>3$J!F?
M:,;G.2?J:?\ K5&0:FS?NVM(E_VE9R/U%7OKUH PL^(9KK(6SMH >C$L<?U_
M2MU<[1N(+8YP.*S]4\06.CLJ7,N)&&1&JDG'K5BQOH]0MQ-$LBH>GF(5/ZT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KY[_;T^"I^./[,WBG2[:#S]:TI/[:TQ5&6,\
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M#1_%?@;XB>#M*O\ XAZ3J+SQQZHK+<26NU4:-5R,F*1'W#MYBU]:?%K]FO\
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MAAG;(NUA]14M% !14=U;K=6[PLSJKC!,;%3^8JMINCVNE*1 AWGK(YW,?QH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?.OQ<_8[L_BO\ M,>!/C!+XHGTVY\*Q6L2:2EFLB7'D7$LX)D+
M@KDS$?=.-N:^BJ*0PHHHIB"BLV7Q-H\&L1Z3)JUC'JL@REBUR@G88)X3.X\
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M6&"-R\X(Z@TVS\"ZQ>(&-N+=3WG;:?RZ_I7KTDE5I).M?-?V/04F^9V/L_\
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M?IFK#*&X8 CW% &7:^(K6^G6.VCN)PQQYBQ'8/<DUJ5#)?6\<FQ[B)'Z;6<
MU-0 V6:.",O(ZQH.K,<"FPW,-R"898Y0.NQ@<?E4;:;:R3&9X$>0_P 3#/\
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M7IF@9JU2O-'M=08F<2O_ +(G=5_(-BKM9^KKJ<D:KIKV\3'[TDQ.1]  1^=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5KC4[.UN([>
M>[@AGEP(XI)%5GR<# )R>:Q=:^)/A'PWJL>F:OXIT72M2DP4L[W4889FSTPC
M,"<_2OS,_P""J6H:WI/[5WPGOO#6[_A([73K6;3-BAF^U+?2&' /!.\+P>*]
MU\-_\$I?ASJ'@M_^$[U?7O$7C[4$,^H>(H]092MRW+&)6!#*#WD#%N3QG B[
MO9#/N!6# $'(/((J#^T+47@M#<PB[(W"#S!OQUSMSFOSV_8'\?>+?@G^T-XS
M_9G\9ZO)K%GI223:%<3LQ,>Q4D"1AB2L<D#B4)G"E3C[Q->5?MI:-XC\5_\
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M^R.ASDN[Z@?H_J&H6NDV<MW?7,-G:1#,D]Q((T0>I8G K$\-_$KPCXRNFMM
M\5:)KERHW-#INHPW#J/4A&)Q7YI_M,:M8_M _P#!0J/X6_%'Q3<^%OAMHRQQ
M6EJ+@6\4TK6JS!B[?(KRN^T.1]T*HY.:]-^/O_!+KPE;^ 6UOX(1:GI'CS3W
MBN;"-=6)CN_G&<22N/+< [E<,!E<8YR#F?0#] J*\[_9[B\>6WP;\+VWQ,CC
M3QO;6WD:B\<ZS"5D8JDA=>"S($9L?Q%J]$J@"BBBF(**** /A#]N+01IWQ8L
M]01?DU'38W9O5T9D/_CH2O<_AWXV_P"$L^#?AJ2^L[BTO+;3XS87T*-.9I8E
M\LAE5?EW[3P>"&/((KC_ -OG0?M'AOPKJX!7R+F:S9@/^>B!AD_]LFQ]34G[
M-/CIM:^')CN+&:!;"Y:W\RWB:2$#:K#D E?O'[WYFN; 4Z:QM2,I6;V/TCBG
M$8K%\&Y?6IT^:%-N,GO;>*7EI9_<>T6TPN;.UN ,+/"DH'ID9Q3ZQH]>M(3%
M %FACE=O*>2"18V;J0K$8[_K5QKKWK[6,>9:.Y_-]27([-6+FX>M16<RZ#J=
MOJ-N3'#-<)!?1 _(XD(5),?WE?;D_P!TFJC754YKI]6AGTZPAFO+N1XXSY43
M-'"=P;+O]U<8!P3FLZ]->S?,:X2M+VT>35GK5%%%?+GZ&%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 $X!-5ZL5 RE32 2CZ44JKN.!0!.IRH-% X&**8!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %>3?M&?\BOIG_7Y_P"R-7K-
M>3?M&?\ (KZ9_P!?G_LC5$MAH^CZ***YR@HHHH **** "BBB@ HHHH ****
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M/\+=13J "D9E12S$*HZDG I:S]2T&SU9@URCN1T_>, /PSB@"]',DPRCJ_\
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MVG R>V3BL2WC\027:M/+9P6^>5C4L2/QK;H P\^(IIAQ801?\"8__7K;7.T
MG)QR0,52OM7BL9!'Y-Q/)_=AA9OUZ?K5N*0R1JY1H]PSM;&1[&F RZN?LL/F
M>5)-SC;$NYORI+6Z:Z4DV\L '3S0 3^1-3$A023@=S59=4LI)1$MW TI. @E
M4L?PS0(M52N-9L+60I+>01N.JM(,C\*L75LEW"8I-VQNNURI_,$5F1^$-(AD
M#K9*2/[SLP_(F@2-:.1945T8.C#(93D'WK/'AW3A?&\^RJ;@MOW%B?F]<9Q^
ME:*J%4*H  & !6?JUG?W@C%E?"SQG=^[#;O3Z4P1HU%=1R30,D,WD2'I)M#8
M_ TVQAEM[6..:<W,JCYI2 -Q^@J>@"GI]C)9J_FWDUVS'.9<8'T %6SQ[U6,
MUW]JV+;1^1WE:;!_[YV_UJU2!F7)<:M)-B&S@BB_O3R_,?P4&M-<[1NQNQSB
ML^[\1:;8R-'->1I(O!7J1]<5;M;J*^MTF@<21-]UA3&5K[7+#39!'<W*12$9
MVG)/Z5<AF2XC62-@Z,,AAT-#1(SARBEAT8CD4^@04@8-G!SC@U3U/3VU*'RQ
M=SVH[^00,_4XS^M8^F^!;33[Q+EIYIY(VW+D@#/J<=:06.D8;E(R1GN*P[?P
MW-;Z@+D:M>.@8,8G;(;V/M^%;M8NJMKLEQY=@EK%#VE=B6_+''Y&@$;59^J+
MJ;[%T]K:-?XWFW$_@ *GT^*YAM56[F6XG_B=5VCZ8J6>9;>%Y6#%4&2%4L?R
M%,!MJLZVZ"Y9'GQ\S1@A3] :E8[5)/2L>S\46U[,46"YC5?^6DD>%^G7/Z57
MU7QE9Z?E2ZA_[IY;\A51BY; .M?%@O+Y8(]/NC$6V^<4P /[Q]!6E=:Q;6JE
MF<''4YX'XUYQJWQ"EF8K%MC!Z-,PS^"]*N:'\._%OCIDFCM)1;-R+F[/EQ8]
M1GJ/]T&NA4.57F["N:&L?$BUM05CD#'ML.!_WT?Z5S?]N:SXCN1;V,<LLDGW
M8[5"[M^(R?RKT=?@WX*\$[;OQGK<=S<X!^RQDJ#_ ,!&78>XQ3+[X\:5X;M6
ML?!OA^"TB''GW"! <=]BG)^I;\*TCR_\NHW\^@O4R=#_ &>=;UY1<:W)#I-L
M/F8SGS)<=S@' _$CZ5N1Q_"OX8*51?\ A)-23J% F ;](Q^I&*\WUKQ1XI\>
MR9OKRXN8<Y$>?+A'_ 1A?ZU6L/!HM70ZA?&1Y3B.&-<%SZ* -S'V JW&3_B2
M^2#T.T\1?M":_JJ_9M'MX=%MONJ(5\R7'IDC _!?QKB6TO6?$5T;F_GFEE?K
M-=R%W/YY-=YH/@#4+A5-KIZ:; P_X^+X$.1[1CYC]&*5VFG?#72X &U!I-6D
MQREQ@0_]^A\I'^]N/O4\\*>D58-SR31?"$=\X6SMY]9E!P3 H\I3W!?(0$>A
M;/M7H.D_"^[D1/M]W'I\/_/O8 ,_T\QA@?0)]&[UZ+'&L,:QQJ$11A548 'H
M!3JPE6E(9DZ/X5TK06,EE9I'.1AKAR7E8>A=B6(]LUK445BVWJP"BBBD 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% 'YE?\%#]6LM!_;N^ &IZDRIIUDVF7-RS $")-49G)SQC:#UK]-:_+3_@I
M]X+'Q(_;#^#7A)KLV"Z_:66E&Z";S#Y^H21;]N1G&_.,C.*]+L;']N_X?Z&/
M >EV7A7Q/8V\?V6T\;7%Q"US'&!A&/FS*68#'+P.<]2W6L[V;*.9TC;XR_X+
M*WEYI'^D6VAVDGVZ6/D KI/V=LG_ &99D0Y[C%'Q0_Y3!> _^O.'_P!(KBOH
MK]BW]CO_ (9ML=;\0^)=67Q+\2/$C&35=47+)&I<N8HV8;FW.=SN<;B%X&WG
MD?''[+OCK7O^"A7A;XOVEO8GP9I]O''/*UT!."MM+&<1XR?F=:+.PCZ>^+FC
MW7B#X4^--+L5+WM]HE[;0*.ID>!U4?F17Q=_P1OUNRN/@3XTTB-U.HVOB1KN
M9!C<(I;6!8R?8M!+^1K[]KX!\??L7_%GX#_&C5?B;^S;JMAY&L.\FH>$M1=8
MXB6;<R+O(C>/<69<LC1YPI(IO>X'UC^T]KECX;_9R^)M_J+JEJGAR_0[OXV>
M!T1/JS,JCW85\W_\$AM*N=/_ &6]4N)U(BOO$]W<0$YY06]M$3_WU&_Y5PWC
MCX)_M<?MBK:>&OBE_P (]\+? Z3I->6NE2I,;G:00=D<\QD(/(5Y$7(!Z@5]
MV?"WX9Z%\'?A]H?@WPW;FVT;2+<00JYR[G)9Y'/=W8LS'U8\"C=W ^ _^"/O
M_(S?'K_K\TS_ -#OZ\R^,'PE7XB_\%1?$?A'6/%&H^#1KPCDLM6TQ]LC'^SX
MW1 Q(X;RV3_>&!GBNW\%?LR_M1_LI_&;Q9<_"C2],\0>$=>OE>::2[M0LENL
MKO%O2:1'215D=?ER/F;D\&OI/]M3]BG_ (:/;2/%OA/6%\+_ !+T%56QU)G=
M(YXU8ND;N@+1LCDLDB@E<L,'(*S;2PSS[_AUO_U7/QW_ -_O_LZ=\!?V,_AO
M\)/VH--UJ#XUS>*_B'H:S>;X=U&[MVO762T>/+IO,N%CF##C' K+M?$O[?\
MINDCPZ?"'A+495'E#Q5+/:><?^FFW[2JGIW@[\BO0_V,/V*-2^!WB+6OB-\1
M-=3Q5\3]<5UGN8Y&DBM4D8-)AV +R.0-S8  &U>,EG97T0'B7Q0_Y3!> _\
MKSA_](KBE_X*H?\ )=/V??\ K\E_]*K6O6_''[+OCK7O^"A7A;XOVEO8GP9I
M]O''/*UT!."MM+&<1XR?F=:/VY_V7/'7Q\^*'PFUSPG;V,UAX;N'DOVNKH0L
MH,\#C:"/FXC;]*+:,#[*K\V?V._^4H7Q]_Z\]7_].5I7Z35\:_L\?LN>.OAO
M^V]\5OB?K5O8IX5\16^H1V$D-T'F8S7EO,FY,97Y(GS[XIO="-K]H3]G_P"
M?[8'Q!F\.7WB2VA^)^DVKK*^@7T9O888W4%)XR&4A6D'# ,-Q (YKYO\2?L-
M?M _LJZ/J7B/X/\ Q<N-3TC2X9+V72M[VKLB NV+9S)!,0 ?O$$\X'.*]?\
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MS]S**JZ9J5OK&FVE_:2":UNH4GAD7HR,H93^((JU7XN?T]>^J"BBB@84444
M%%%% !1110 5Y%^UW_R:_P#%+_L7;S_T4U>NUY%^UW_R:_\ %+_L7;S_ -%-
M0-;G#_\ !.'_ ),Q^'G_ '$?_3C=5]*U\U?\$X?^3,?AY_W$?_3C=5]*T""O
MB/Q%\)/V5?\ @HSXF\3W&DS37?C#0Q%!J>M:+'/IUVN[>B;UFC"3X\HC>4;
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M_$FW\4>,[?4/[1\3ZWX@DGWW962$Q0VZ@.%CC2-U&XC[W9<*H!Z%_P %DO\
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MF+"VW\\5J4UY$B W,J \#<<4 .I&95&6(4>YI:K76FVM\R-<6\<S+POF+G%
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MYF_&5A_Z"JD>M=?H_AO3-!#?8;..&1QAYCEI7_WG;+-^)-:5%<[FY#"BBBH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% ",VU<U"6+=34L@^6H:0!4D<AS@U'2K]X4 3T444P"BBB@
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MBJ,"@!D]K#=*%FB28 Y D4-@^O-.CC2%0L:*B_W5&!3JK3:>LUVD[37"[?\
MEFDK*A^H'6@"S52TL9;::21[V>XW?P2;=H^F *MU0U;^TMB#3A;[N=QG)X],
M8H OU3U&:^C"BRMXYF/5I)-H7\,<T[31>+;#[<T+3_\ 3$'&/Q[U-<7,5I"9
M9G6-!U9J &V7VG[./M8B$W<0YV_K4U9=GXBM[^Y\F*&ZSG&]H2%^N>WXUJ4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "FM&&YZ&G44 ,$0[G-/HHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O&OB)\+-4
MEURYU/2(OMT%V_F20!PLD;GJ1N(!4_7(STKV6BMJ-:5&7- Y<3A:>+A[.IL>
M">$_A)JNO76[5(9-+T]#AQ(,2R^JJ.P_VC^&:^;?VM-)32_CCK7E((XKB&VE
M15Z#]RBG]5-?H;7P_P#MQZ<8?BAI-V!A+C247//++++G]"M>=F]:>(I<T^C/
MU+PKHTLOSETJ?VX23\[-/]#[*\(ZE_;'A/1;_.[[5903Y]=T:M_6M:N!^ >H
M?VG\&/!TV<[=.B@ZY_U8\O\ ]EKOJWIOF@F?#9A1^KXNM1_EE)?<V@HHHK0X
M HHHH **** "BBB@ HHHH **** "BBB@ HH) ZG%(&!X!!H 6BBB@ HHHH *
M*** "HVB]*DHI 0^6WM4B1[?<TZB@ HHHI@%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7DW[1G_ "*^F?\ 7Y_[(U>LUY-^T9_R*^F?]?G_ +(U1+8:/H^BL;Q1XPT?
MP9I_VS6+Z.RA)PF[)9SZ*HY8_2O-_P#AJ3PA]I\K[-JNS./.^SIM^OW\_I6*
MBWLB[-GL-%8GA7QGHWC6Q-WHU_'>1+PZKE7C/HRGD?B*VZD045PWC3XS>%_
MUPUK>WK7%\OWK2S3S'7_ 'N0%/L2#6#H_P"TMX-U:Z6"5[[3-QP)+R !/Q*,
MV/J:KEEO8?*SU>BHK>XBO((YX)4FAD4,DD;!E8'H01U%)=W<%A:RW%S-';V\
M2EWEE8*JJ.I)/05(B:BO)]8_:8\':5=-!$;[4PIP9;.!=GYNRY_"NA\%_&/P
MOXZF6VL+TP7S=+.[7RY&^G)#?0$U7+)*]A\K.WHHK"\6>-M%\$6(NM9OX[1&
MXC3EI)#Z*HY/\AGFI$;M%>/)^U'X0:Y\HV^JHF<><T";,>O#[OTKTKPUXLTG
MQAIXO=(OH[VWZ$H<,A]&4\J?8BJ<6MT.S1KT45P'C#XX>%/!=U):75Y)>7L?
M#VUBGF,A]"<A0?8G-))O8-SOZ*\LT+]I+P=K5TL$LMWI18X5[Z(*GXLK,!]3
MBO4(I4GC22-UDC<!E=3D,#T(/I0TUN#36X^BJ]_?6VEV<MU=SQVMM"NZ2:9@
MJJ/4DUY9JG[3G@W3[HPPC4-14<>;:VZA/_'V4_I347+8+-['K=%<9X+^+GAG
MQY)Y&FWVR]QG['<KY<I'L.C?@379TFFMP"BN>\7>/=#\"VJSZS?I:^9_JX@"
MTDG^ZHY/UZ5P$/[4GA"2X$;6VJQ)G'G/;IM'OPY/Z4U%O5(+-GL%%9?AWQ-I
M?BS3DO\ 2;V*]M6XW1GE3Z,#RI]B,UJ5(@HKSSQ=\=O"7@^[DM)KN2_NXR5D
MAL$$A0^A8D+GVSFJ7A_]HSP;KUTMN\]SI3N=JMJ$01"?]Y68#ZDBJY9;V*Y6
M>H44U'61596#*PR&4Y!'K5?4M3M-'L9KR^N8[2TA&Z2:9@JJ/<FI)+5%>1ZC
M^T]X.L;EHHDU*_4''G6]NH0_3>ZG]*ZWP7\5?#?CUC%I=_\ Z6!N-I.ICE ]
M0#][_@)-4XR6MAV9U]%%<WXQ^(6@^ [=9-8OU@DD&8[=07ED^BCG'N>*6^B$
M=)17C]O^U%X/GN1$\&J6Z9QYTENA0>_RN6_2O3]"\0:=XFTZ._TN\BOK23I)
M$<_@1U!]CS3<6MQM-;FC117G'BKX_>$/"MU):O=S:E<QMMDCT^,2;3Z%B0OY
M'BDDWL%KGH]%>9^&OVAO!WB2[2V-S/I<SG"?VA&$4GTW*64?B17I8(;!!R.U
M#36X6:W/FS_@H/9RW7[-&KRQKN2VOK.60^BF4)G\W4?C7YL_#F15FOX_XF5&
M'T&?\17[ _&[PUI7C+X3^*-#UJ\AT^QO[)X?M5P<)%(1F-_<APIP.3BOQDLY
MKGPCX@D2XC*RV\C0SQ_0X(_3/X5]GP]B(TI+FZ/\&K'Y;QE@IUHWBOB5OFG>
MQZC14-G>0WUND\$@DB89#"IJ_5TU)71^ N+B[/<****HD**** "BBB@ HHHH
M 1E6165QN5A@@]"*X/QQ9W%N+7<?,ME++'(3EAG'RGUQC@UWM8/C:T-UH,K
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M:4FLBQ?[#K%S99Q'*//B'IG[P_.M,FL*<^>.N^S.FI25.5EL]5Z,5FIM%(2
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MN)IPQR/.8,1]#B@"Q534-)MM4\O[2K.(SD*'('X@&K=0W?VGRO\ 11$9<_\
M+8D#'X4 211)#&L<:A$4855X %0:A]L\G%D(/-SUN"0H'X#FI;?SO)7SS&9>
M_E@A?UJ2@"O9?:_+_P!+,/F?], <?K4TTJPQM(YPBC).,U0M]:2ZO/(2UNQU
M!E>$J@^I-:- &+_PDZS3^7;V%Y<#./,6+"_KC]:VJ"0HR3@4*P89!R/:@ )
M&3P*9#<17&[RI4D"G!V,#BEFA2>-HY$62-A@JPR#3;>UAM(_+@B2%/[J* *
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M$?OGD !']* -FLNZOM46Y9+?2UDA4X$LEPJ[O?'.*U*KW^H0:;;-/<,5C''
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M,****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH IMK6GQL5
M:_ME93@JTR@@_G2?VYIO_00M?^_R_P"->(^ _AWI7C[Q1XP_M-KA?LEY^[\B
M0+]YY<YR#_=%=O\ \,[^%O\ GIJ'_?\ 7_XFLN9E<IV_]N:;_P!!"U_[_+_C
M1_;FF_\ 00M?^_R_XUQ'_#._A;_GIJ'_ '_7_P")H_X9W\+?\]-0_P"_Z_\
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M !H_MS3?^@A:_P#?Y?\ &N(_X9W\+?\ /34/^_Z__$T?\,[^%O\ GIJ'_?\
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M .)HYGV#E.W_ +<TW_H(6O\ W^7_ !H_MS3?^@A:_P#?Y?\ &N(_X9W\+?\
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M?IZJTL:GB69E#9/J%! 'H=U>*UZI^T5X>FT_QTVL*A-CJT231OV#JH1USZC
M/_ J\KIPMRJPX[$UG>3Z?=17-M*\%Q"P>.6-BK*P.00>QK[1\ _$!=>^&$/B
M2^_UEO;2/=[0!\T0.X^V0N[\:^*.O:OKGX=^%WTKX4V_AB^'D76JVDYFW=8C
M,&"@CUP1D>M9U4K(F9\N^*_%%]XRUZZU7493)<3MD+D[8U[(OH!615K5--N=
M'U&YL;R)H+JWD:*6-NJL#@U5K=&AV_PA\=77@;QG93)*PL+J5(+N$GY60G&[
M'JN<C\NYKZ&_:&\<7/@_P6D%A*T%]J4GD+*IPR1@9=@>QZ#_ (%FOF?X<^&+
MCQ?XSTO3H$9E:97F8=$B4@NQ/;C]2!7O7[1VE2^*?!L6I6B%SI-RS2HO/[EQ
M@O\ @0OX9-832YT9RMS(^8.M%%%=!H?2O[+WCFYU*TOO#=Y*TWV.,7%JS')6
M/.UD^@)7'^\?:N(_:0\<7.N^,I-$CD9=.TO"^6#P\Q4%F/TSM'T/K6W^S+HL
MVFMK'B:6,B#RQ8P;N/,8LK/CZ;5_.N0^/_AV?1_B!=7Y4M9:H%NK>7'!^4!E
M^H8'CT(KG27M#-6YCS6K&GW]SI=[!>6DSV]S PDCEC.&5AT(JO2JI9@ ,D\
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MXKV<%NELE=[W_42]\801Y6VC:9O[S?*O^-8DE]J7B"X2W19)WD.$MX%)R?0
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MO9_".+P=<#RK^[T^4ON/^KFDW.JGZ$@?A7R5>6<^GWDUK<Q-!<PN8Y(W&"K
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 4=>_P"0'J/_ %[2?^@FO-_V
M??\ D1)/^OR3_P!!2O2->_Y >H_]>TG_ *":\W_9]_Y$23_K\D_]!2B/Q$R/
M2Z***V,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH+!>II-P/>@!:**
M* "BBB@ HHHH **3</44M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7S]^VU:_:/A)8R9P8=7A?IG.8I5Q[=1^5?0->+?M?6_G?!'47
MSCRKJW?Z_O O_LWZ5S8E7HS]#ZGA>I[/.\)+^_%?>[''_L+W6[P;XEM^,QZ@
MDG7GYHP.G_ :^F:^4OV$)RUMXUAQPCV;Y^HF'_LM?5M9X-WH1_KJ=_&T/9\0
M8I><7]\8L****[3X<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(Z9;S><86FDSG,SEN?IWK8H R6\*Z6]T;A[;?(3N.]V8$^X)K650JA5 50,
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M>?9;"VN+IFZQVJ':/=CV'NQQ7H&C_ -=/M?M_B[6+?2;1>6BCD7=]"[?*#]
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y9\#?\
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M'3D5-10!7\ML]*ECCV\GK3Z*0!1113 **** "BBB@ HHHH **** "BHFFP<
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MTCL?R_K5?X6S/I?QH\:Z1/E3=_:MH(QN99=ZGZ%2Q_&J:U8^K/4*YKXL*_\
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MJWAW1?"FOIS)INM !>[(R%F7Z$+C\:X?]O&\&C_L[>(A$X":E?V=JONOF"?
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MCIMKY+7,UUSG=,<GZ#VJY10!R6H74^DWF(;9YV1LC!P,5T>EW%Q=6:2W-O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!Y9\#?^1H\>?\ 7XG_ *'/7KU>0_ W_D:/
M'G_7XG_H<]>O5@C5;!1113&%%%% !1110 4444 %%%% !1110 4444 %%%%
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MB@ HHHH **** "@T44 52,<&BK+*&ZBA8U7H*0 O"@>U+113 **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!7DW[1G_(KZ9_U^?\
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M ZEF(]]H./2A7T$X\RL^I^8/QZ^ _B/]GCQP^GWOF3Z<S^9INL1H1'<Q]O\
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M .N#6]7)^"S_ *1<C/!4?SKK*C!2<J$;EYC%0Q,[!1117<><%4=<;;I-T?\
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MX;<'TF R?P7)'TKB_A;_ ,B)IG_;7_T:]2MS.1U5%)NI*T,Q=U)110 4444
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M/<M<.O+328!/^%9^M^)X-'M6E6,W)!QM5@H_,_TKA-4\=W5[D0*8P>C2<M^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>]>EZ'K$'B'1-/U6U#BVOK>.YB$@PVQU#+D=C@BO@G_@LQ_R0KP1_P!C(/\
MTEFKKM6_X*8?!CX)^'_#?AJZN-8\3ZM9:7:0WB>';6*:.VD$*91I))8U+ \$
M*6P>#@@@%P/M6BO)/@!^U5\-_P!I?3KF?P1KGVF]M%#W>E7D9@O+=2<!FC/5
M<X&Y2RY.,YXKO_&_CK0/AMX7OO$?BC5[70]#L4WW%[>2!$0= /4L3@!1DDD
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MKS?]GW_D1)/^OR3_ -!2B/Q$R/2Z***V,PHHHH **** "BBB@ HHHH ****
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M!79JL,>K)9B)?L:J+,0]5\O&W;]*1N</\*8$MOA/X;$9!\W[1*[+W8S,/T
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MV2.&_P!3N;&6,&SN$>S>(# \LJ5QCZ5Q_P -T>'X:Z-;R,'>TFNK;</X@LS
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M%<]\+_\ D1=,_P"VO_HUZ] ^(%S]H\'^*MZAEFL9CM(S@J-RG\,5Y_\ "_\
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M<H=RS7I#A#ZJ@ 13[@ ^]=)6<JS86.*TWX;IM#:I>O.#UMK/,,7XL#O;_OH
M_P!VNMT_3;32K9;>RMH;2!>1' @1?K@58HKG<G+<84445(!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=PRN<$UTWQ"_:S\!R?M*1?L^^.O!RR6NI+&$U+7E@DTVZ:2'S(E$;@[@S$Q
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M7:D99BW0':.K"O-O@%X!O_A__P $IO%<&IP/:WNJ>$-?U9H9!@K'-;SM"?\
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M^%@ZXV!N&ED ]_\ 6Q_X"OLNOC_]B6%/^$O\1RX^=;%%'T,@)_D*^P*Y<#_
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M#O+7QAINEZKIH*6FHIN$9Y,3 X=3]"#7SU\9OB<WC+5#I6GMY>@6,A6)5/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*ZDDD$JR1G.>\?K7U%^SS^S'X"_9D\,S:/X*TUXI+HJU]J=X_FW=XR@A3(^
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M!A1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%]Z?3=U %1E*]1@UY7^T"?\ BF]._P"OO_V1J]>Z]:\H_:( 'AC3<#'^F?\
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ME.([B,<A&/8C)P??\L5+WN8SOK<^6J*Z[4?A+XRTNY,$OAO4)'SC=;0&9/\
MOI,C]:[#P/\ L^ZK?745YXG4Z/I:L&:%F'VB<?W0H/RYZ9//M6W,MR[H]"\(
MV-XW[.IM1G[5+I5\T28^8QL[$#WRN<?6OE^OMB.]%O<0-;Q+#! JQ0PJ,*D8
M& OTQ7BWQ%^ 5S<7TVI^$(UN[28EY--WA98">2%S@,OISD=.:RA*S=^I,7;<
M\0KW[X7_ /(BZ9_VU_\ 1KUY%=?#OQ18V]Q/<^']2MH+=#)+--:NB*H&2=Q&
M*];^%_\ R(NF?]M?_1KT2=Y$5#J&4-VH"@4M%(P"BBB@ HI,TFZ@!=U)244
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M'#90#C[1.@7/OL'4^['/J*\SCT'4M8G>YOIG#O\ ,\MPQ>0^I.>?S-=%X?\
M!_V[!TVPDU-O^?EL+ /?S#\I_P" ;B/2NYPCO4?-^1\MZ&'J>I^(_'5QY^HW
M<]V,Y5IFVQK_ +JC@?@*M:?X3@2X6&4R7MX1D6L"%F^NU><>YP*]3TOX9EL/
MJMZS#O:V),:_0R??/U79]*['3=)L]'M_(L;6&TASDK"@4$^I]3[FIE625HA8
M\ZT;X<ZE<(OG"+1;;^X LL_Y#Y%/XO\ 2NTT?P;I6BRK/%;^?=C_ )>KEC)*
M/7:3]T>RX'M6W17+*<F,****@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS0MNQZ\4@%MQ\Q/M5BFH@C7 IU, HHHH **** "BBB@ HHHH **** "BBB@
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MHUK;R:.8HKGKSX?^.M%;9=>&_$5B1QMFL)X^V<<J.U0)X7\8W#+&FD:Y(S'
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MHH 6IOMEQMV_:),>F\XJ"LSQ4VJ+X8UAM#5'UL6<QL5EQL-QL/E@YXQNQUH
MU.O)ZTE?%/\ :?[;/_0(\-?]]VG_ ,<H_M/]MG_H$>&O^^[3_P".4K@?;,<C
MQME&9#ZJ<&O+_P!JRZFF_9O^)(DED?\ XD-W]YB?^69KYV_M/]MG_H$>&O\
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MQ"[B!D*._M61:76M7-U^]L[>SMP>=\F]R/;!K7J&ZNX[.,/('()P!&C.2?H
M:!$U4-6UVST54-T[*7SM55))QUJW;W"W$8=5=!Z2(5/Y&I* *.E:Q'K$;20P
MS)&.CRIM!^G/-7J*9<0K<0O$Q9588)1BI_,4 /I)$$L;(20&!&5.#^!K-T_P
MWI^FW'GPP?ONSNQ8CZ9K3H QM.\):?IMU]IC5WE!RID;.WZ?_7K9JAJ5MJ$\
MB&SO([9 /F5HMQ//7.:O1JRQJ';>X !;&,GUQ0!D:EI>IZA<,(]3^R6O98H_
MG_/-:-C;-9VL<+S27#*,&20Y9N>]3_K5&WO[F:Z\MM/F@BYS+(Z8_($T 7JA
MAN'F<@VTL2CHS[<'\B3^8J:HIKN"V*B::.(MP [@9^F: ):*** "HIK2"Y(,
MT,<I'3>@./SJ6B@!%18U"JH51T X%$BEHV56V,1@, #CWYJE9Z2MG</-]JNI
MV;JLLQ*C/^STJ]0!5L;.>V:0S7DEWN/'F*HV_D!5JJ5[=7T+[;:Q6X']YI@H
M_E5N'?Y:^:%$F/F"GC/M0!!?M>+&OV..&1\_,)F*C'X"IX]_EKY@428&X*<C
M/?%+(XCC9VSM49. 2?R%5['4$U"-F2.:, X_?1E,_3- %FBBB@ HHJ*YM8;R
M/RYXQ(F0=K=,B@"6F2PI-M#KN"G(!I]% !4=UYS6[BW9%FQ\ID!*CZ@4VUAF
MBW^=<>>6.1\@4*/3BIJ *&EV^HPN[7UY'<*1\J1Q;<?C5^LU]8D75%LUL+IX
M^AN A" _4]16E0!1U349=/$?E64UX7./W./E^M6[>222%6DC\ER.4W X_$4V
MYNX;./?/,D*?WI& %4[/Q%I^HW7V>VN/.EQG"HV,?7&* +\TT=O&7E=8T'5G
M( 'XU%:7]M?AC;3QSA3AC&P.*?<6L-Y&$GACF0'(610PSZ\TZ.-(5"(BHHZ*
MHP* &75I#>Q&*>)9HR<[7&145OI5E:L&AM((F[,D:@_GBK7Z5AMX<N9IP\NL
MWQ3.2D;"/^7^% &Y5'5M-EU)(UCO9K-5.6\DX+=._;_Z]7478JJ"2 ,98Y/Y
MU7U&XFM;8O!$DLF<8DDV >^: );> 6L*QJTCA?XI'+,?J33+R:>&'=;P+<29
M^ZT@08]<X-8K>)FT^$O?R6RL?NB/<!^O)_ 5R^K?$&2;<ELI8?WGX7\N_P"-
M;1HRGLA7.AU+5=969O+>RM80!U8R,/7)QBLN\\??9;<1"?[9.!S)$H0'\?\
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MVZ'F>7O!U.:&L);/]/ZZ$]%%%:GB!1110 4444 %%%% !1110 4444 %%%%
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M8QG?;^'+##=]MQ/V_P"_>W\JUO%VJ1V8O+ICB"SA8_\  44D_P!:!'4?L_\
MB2]\4?"?1+O47,M[$)+625CDOY<C(&)[G"C)[G->AUYG^S9IDFF?!?PZ)L^;
M<++<MGTDE=E/_?)%>F5:*"BBBF,**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "OA__@D[_P D9\7_ /8?/_I-%7W!7P__ ,$G?^2,^+_^P^?_ $FBJ>H'
MW!1115 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% %'7O^0'J/_7M)_Z":\W_ &??^1$D
M_P"OR3_T%*](U[_D!ZC_ ->TG_H)KS?]GW_D1)/^OR3_ -!2B/Q$R/2Z***V
M,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDM;L%8_C@T 6JCN8Y)(76*3R9"/EDV[L>^*BT^P338/*22:49SNFD+G]:LT
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MK8V]BI6W@C@4]1&H7/Y5-55K.5KX3?;)5B&,0*%V_B<9_6@">:-I(71)#$[
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?^@FO-_V??\ D1)/^OR3_P!!2B/Q$R/2Z***V,PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBFR/Y:DT *S!>IQ3?.3^]59F+')I*0%Q6#=#FEJD#CD<59AD,
MBX/44 24444P"BBB@ HHHH ***JWVJ6>EQ^9>74-JG9II N?IF@8ZXD);:.E
M15A2>//#_G%1JMN>^<G'YXK6L[^VU&'S;6XBN8LXWQ.&'Z4@L3@D'(X-6XVW
MJ#WJI5F%=L8S]:!$E%%%, HHHH **** "BBB@ HHHH KSR;FVCH*BI6^\:2D
M 5\-_M"W9U3XQZ_LR^QXH$4#NL2*1^>?SK[DKX2F_P"*L^.C#[R7WB# S_<-
MQCT[+_*O,QVL8Q[L_5/#]*GBL3BGM"'YM/\ ]M/N_2;-=.TNSM%.5@A2(?\
M 5 _I5NF0_ZM:?7IGY;*3DW)[L**ANKRWL83+<SQV\0ZO*X4#\37+:A\5O#N
MGEE6Z>[<?PV\9;]3@?K3%9LZ^BO,KGXX6JY^S:3/-_UTE"?R!JA)\<+QO]5H
M\:C_ &I6/]!3Y65RL]<HKR'_ (77J7_0)@_[[:G)\;+Y<[]'C;TVR,/Z&GRL
M?(SURO,_%?Q=^RW4EEHD*W$B$JUS)RF1UVCO]>GUJI=?&I+NQN('TF6W>2-D
M5TG#;21@'[HKS2SNDA4JRGDYW"A1[E1CW.@NO%WB74&+2ZQ/%GM"WE_^@XIU
MIXS\2Z4PDCU6:X5>J7!\P$?\"S_.L8ZA".['\*T-%\/:MXKD$=A:L("<-<2<
M1CURW]!DU16G4]N\&^)!XJT&&^V"*4DI*B] PZX]NA_&MNLKPOX?B\,Z+;Z?
M$WF>6,O)C&]CR36K69@PHHHH$%%%%  > 35(G/)J[63JVI6>APF:]N8[:'LT
MC8S[ =S]*3&BS0#M.1UKSO5?C)8PLT>G6<MZW_/1SY:_AU)_(5SEU\4/$=XW
M[@6]DO;9'D_^/9_E1RLOE9[HIW*#17S_ ">*O$]Q@MJ\X_ZYG;_("H_^$D\2
M(0?[9N\C^](V*OE#D/5_%_Q(T_PK(;8*U[?XSY$9P%STW'M].M<!>?%;Q)>,
M3 MO9)V"QAC_ ./9_E7*JLLMS-<7+^=<2-N:1CDDGJ:?),D7WV"U5D7RI'16
M_P 3_%-FP:2:&\4=5DA49_[YP:]3\&^+(?&&D_:HXS#-&VR6(G.UNO![@UX/
M"\^H3K;6,$ES.YPJHI)_*O:_ASX2D\*:*RW)!O+A_,E Y"\8"Y[X_K4NPI)6
M.KHHHJ3$**** "BBB@ HHHH **** "BBBD 4444 %%%% !112;J %S3<T44
M%%%% !124FZ@!<TF:2B@ HHHH ***;NH 7-)FDHH **** "O*OVA_P#D6=-_
MZ_/_ &1J]5KRK]H?_D6=-_Z_/_9&J9;#1ZA1110;A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S_ ,0/^1'U
MW_KSD_\ 0:XSX8_\B/IO_;7_ -&O79_$#_D1]=_Z\Y/_ $&N,^&/_(CZ;_VU
M_P#1KTNI$CJ***3=5F0N:;FBB@ HHHI@%%%%( HHI,T +2;J3-)0 4444 %%
M%% $M%%9FK>';;6I$>X>;"C 1'POY5)9IT54TW2;728?+MH]@/4DDD_G5N@
MH;.T[<9QQFL^Q@U,3E[NZA,>3B*&/\OF/^%:% %*)=1:8&5K:.+/*QJS,?Q.
M,?E5VLZZUR.UOA:_9KF:7&?W41(_.M&@#/U#6H[&0Q_9[JXDZ[8(6;]>GZU8
ML;LWULLI@EMR?^6<R[6'X58J"'4+:XE,45S#+*!DHC@D#Z4 3U0AU[3[BZ^S
M17223YQM7)J_56TTNSL)'>WMHX7;JR* : +7!&#R*K6NF6EDQ:WM886/5HT
M-6:S;K3;VXNBZZI)!#VBCB7C\3F@#2JI>6=Q>91;Q[:+OY*@/_WT<_H*MJ,*
M 3GW-#9"D@9/I0!#9V@LX]@EEFYSNF<L:FJK9->LTANT@C7^!8F+'\20*M4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQV>9GF7^]XB4UV;T^Y:?@%%%%;GAA1110 4444 %%%% !1110 4444 %%%%
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M_L/G_P!)HJ^X*^'_ /@D[_R1GQ?_ -A\_P#I-%4]0/N"BBBJ **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** *.O?\ (#U'_KVD_P#037F_[/O_ "(DG_7Y)_Z"E>D:]_R
M]1_Z]I/_ $$UYO\ L^_\B))_U^2?^@I1'XB9'I=%%%;&84444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !4%S_  U/4<T>]>.HH K4444@"I+?_6?A4=/CD$>3C+4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHG@O2-!D6:"V$UV/^7JX/F2^^"?NCV7 ]JW***YVV]QA1112 **** "BBB@
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MR[HYH7#HX]01P:FK[9--71\RTUHPHHHIB"BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%% !1112 **,TW- %6\\+Z;J%\UW<0>;,V,[G..!@<9]JTT18T5%4*BC 4#
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ML?%7C/X8W0MA/?:65/\ QZ72$QGUPCC'XC\Z]'\-_M1.BK'K^DA_6XL&P?\
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M\/BXK62_1-?J?EO DJF&Q&,RZ;NH/3U3<7]]E]QZQ1117PI^O!1110 4444
M%%%4=4U[3-#C\S4M1M-/CQG==3K$/S8BEL7"$JCY8J[+U%>::Y^TA\.=!W";
MQ/;74@Z+8H]QGZ% 5_,UY_KG[;7A6SWKI>BZGJ3KT:;9!&WT.6/_ ([7/+$4
M8;R1]%A>&LXQG\'"SMYJR^^5D?1=%?&&N_MO>)[P.NDZ'INFJW1IR]PZ_0Y4
M9_"N U+]H#XG^,KC[/%X@U#>WW8-)C$+8]O*4,?SKEEF%)?#=GUN&\.LWJKF
MKRA37F[O\$U^)^@U]J5II=NT][=0VD"]9+B0(H_$FN!\0?M$?#OPWN%SXHL[
MF0=([#=<DGTS&"!^)%?&=E\$_BCXZF6>30-6N';_ );ZL_DG'KF9@<5WN@?L
M1^++XHVK:SIFE1MU6+?<2+^&%7_QZH^M8BI_#I_?_2/0_P!5.'\!_P C+,DW
MU4+7_P#;W^!Z'XA_;@\-6>Y=&T+4=4<=&N72V0_0C>?S KS'Q%^VKXTU+>FE
MV6FZ-$?NLL9GE'XL=I_[YKU;P]^Q'X2T_:^K:MJ>K2#JL92WC/X %O\ QZO3
M/#OP%^'_ (7VFR\*Z>TB\B2[C-RX/J#(6P?I2]GC*GQ2Y1_VEP7EO^[X:5>7
M>6W_ ),U_P"DGQ#/X_\ BC\4)GABU/7]9W'#6^G+((_Q2(!?TK:\/_LI?$GQ
M&ZO+I46E1R'/G:E<JGXE5W/_ ..U]_P6\5K"D4,:Q1(,*D:A5 ] !3Z:R^,M
M:DFS*IXB5Z,?9Y9A(48_?^7*OP9\F^'?V%?NOKWBG_>@TVW_ )2.?_9*]2\-
M_LH?#CP[M9](DU>9>DNI7#2?FB[4/_?->P45UPPM&&T?U/D<9Q=GF.NJF)DE
MVC[O_I-OQ,[1O#FD^'(/)TG3+/3(>GEV<"1+^2@5HT45U)6T1\E.<JDG*;NW
MW"BBBF0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI_A^PCLM+L;?3[./[L%M&(T'O@#K5RBBN$]<****8#9IDMX7EE<1QQJ69F.
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH HZ]_R ]1_Z]I/_ $$UYO\
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MSO\ 4$]/PQ6_16%V<W,V%%%)NI$BTFZDHH **** "BBDW4 %)NI** "BBB@
MHHI-U "TFZDI* "BBB@ HHHH ***3=0 M)NI** "BBB@ HHINZ@!:3=244 %
M%%% !7EG[0G_ "+.G?\ 7Y_[(U>IUY7^T&?^*:TW_K[_ /9&J9;#1ZI1110;
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M10=%WM%(?P(Q_P"/5R%U\)_B%X4F,L6BZE%(I_UNG-YI^N8B31]8K0^.F/\
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M &-I$/AZ(G_5V5]=[?P4R[1^ _*O5_U@P\X\F(CS'D1\),_C4]K@W[+UDO\
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ML]C:KK6J:FZ]5AV6\;?488_DU?1E%;QP5"/V;GSV)XWSW$Z>WY5_=27XVO\
MB>;:%^SC\.?#^#!X7M+EQR6OBUSG\)"1^E=_IVDV.CP>386=O90_\\[>)8U_
M("K5%=480A\*L?)8G'XO&.^)JRG_ (FW^84445H< 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'EGP-_P"1H\>?]?B?
M^ASUZ]7D/P-_Y&CQY_U^)_Z'/7KU8(U6P4444QA1110 4444 %%%% !1110
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M>'.3YR8!)]V&UO\ @5=W7R#^Q)XR,.L:IX?F?Y+R 7$0)_Y:1G# >Y5L_P#
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M3S;ZX9S_ '2<X^G85;M[.&V^X@!]3R:GYHYIC#FJK*5;!JUS28W#GF@95QG
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% '/_$#_ )$?7?\ KSD_]!KB/AG_ ,B3IO\ VT_]
M&O7;_$#_ )$?7?\ KSD_]!KA_AJ?^*)TW_MI_P"C7I=2)'44FZDI*LR%I***
M8!1112 ***,T %)NI,T4 %%%%, HHHI %%%% %JF?9XA*THB02-U?:,G\:?5
M34K6ZNHU6VO/L;?Q,(PY(].>E266ZJ:E9W-Y&BV]XUF0<EE0-GVYJQ#&8H41
MI&E91@NV,GW.*?0!%:PR06Z)+.UPXZR, "?P J6LU;K56O/+.GPK;Y_UOVGM
MZXVY_2M*@"E:3:A+.?/MH;>#_9E+N?3L!5VLS4O$FGZ7<""XF(F(SY:(6/Z"
MM*.02QJZYVL 1N!!Y]0>E $4UY%;L%=B6/\ "BEF_(#-3*VY01G!&>1@T44
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \!\)Z3'XCNOB'H\LPMQ>W"K',V=J2+-(R%L?PY&
M#['-<,GPY\1/=)#_ &7,JM>G3A,PQ%YP<H5W=.&!&>G%>B?#5E7QAXL+\H+]
M2WT\R6O2[>X"K TDBL/[42T<=/WZZEN<?^.NWT/O54ZCA'0MQ329R/B#P''J
M_@"R\+Z?-YU[I:B2UDZ+<RY=I4&>@8R';G^Z!WKR/0?AMK>M7VEQ/:26-I?J
MTL=Y<(1'Y2J&9_<!2"/7( KZ!T_>U^HM_EE;<(N,D,0=OZXJ:WO(;BUTJ6$C
MR+N(SVZ^D*V$@(_ R0@CU'M5QJ.*:14H*YP_Q<\,)XB\-VUSIQVMH,)C6&0_
M-):JJJ".VY=N2.X8^E<+X-^&&IS^*X(=:M)M+M;5%O;CSU*NT0? 5!W+$%1Z
M<GM7LGVB*TL;Z>;_ %,4(DDX!S&KJT@_% _YUIZFXANY[69Q)<K;33,?57N8
MPA^F8YOSH51Q7*@E%<QYA\9/"%WXFO+?Q!IT37%Q*T=I<VL8RXD+;8F4=PV0
MOL0/6L[X4^ [_2_$LFK:M ]BNDOA;>5<223LF4&.P 8,3]!WKU?3YEA^SD\;
MKV*(-Z,Z2QQ_^17B_*BZD#)<Q_Q0_9HI!_TT\MG/X[)(1_P&CVCY>0.5<QY+
M\4O .HZEXL&IZ3!)J*ZP[R>3"-TD<RKND4CTZL#Z'':M?X+>%[GPO/-XBOD\
MJX#-:VUHW#[ED D9QV *E0/4GTY]$M9!MMH%.)9X[N.,>K@0/C_OB.:FWUQ%
M<+(T;!P+NX3>.A*N$8_BZN?QHYVX\H**YCPWQ9\*]5T_Q%/;Z19S:G8R1&[M
MW@0L1#NQAO1E/RD>V>]>A?"OPN/#OA*[_M&0AO$5N%DCCY,-JT;JK?[S"3<!
MV 7U-=WILV;ZWBC;RI!;6TY8] J7%P';/L7C)^H]*RO.6XL--E0%8Y;.*2-3
MCY8V7=&OX(5'X4.I*2Y6$8JYX+K?PYUW1KS5(Q92WEMIY4RW=NA:+8PW(^?0
MJ0?49YQ7KND> 5TWX?7?A*\G2._OBTT\V<I!<90HA(Z@>6 Q_P!IL9P*Z?4K
MR%-,UZ24@6]I#(UPO9D>PB"#\<%/J#ZU)JF%URX\WYMLV)/<@_-^N:)5)2M<
M(Q5SYT'PY\1_:A#_ &5.,WO]G>:5_=^?NV[=W3&0>>E>Q:]X&&K?#VS\)6%R
M)KK3<36LG1;F;,C2(,] QD.W/]U<XR:Z];H, X<<ZI]CP#P+@:F6;/Y,_N..
M]5=-W/JD8@.V5F(B/HQ!V_KBB524OD*,59GSYH/PWUS6[[2XFLY+*UU -)'>
M7"$1>6HW,^>X"\^_&*]/^*WA5?$'AFVFTS(;08-BQ2<&2U1%7=_O*$W$>A/I
MSV]I>VTUGHDL>/LUW'YEM&3R(UT^4$?\!+QK]?I5/[5%9V.H3SC,,=NSR#U0
M$%Q^*!A3=1MI]@459GC7@[X7ZK<^*+>+6+2?2K2W1;V=IT*L8@^ %!ZLS#:/
M3D]JZSXT>%[SQ5=6_B&Q4W%RYCL[BU4?/N9R(V7U!W!3Z$#UX]-U)_*O+BVD
M<23"WGF+ ]5>YA"'WR8YC^)]:J6,XM_)9CA&O((R<XY<.D9_"5HS^%+VC;Y@
MY5RL\F^%O@#4-/\ $SZIJ]O)8II+J1!,N'DG9-T:@=@ 0Q/I@=ZSOC%\)[W7
M/%D.N:%'-)=ZH[,AM1F6*8)ND1A_$I&YA[$CMS[7=3*PNH"?WMNMI'(.X<I*
M_P#Z+>$?A1:R+BU@!Q-.EW'&.Y<+"^!_P".;\Z/:/FYA2IQE#E>Q\S>'?V<]
M<UBQDO-1UF/24%P\"P?92TS%#AR5R H!RO7.0>.*LZM^SU<:#KY@T^VN?$D;
MP_:H+C9N;R]VT[D'1@W!'/J.#7T?J%PEQYS(P<"\G3<#G)3:CG\9%D/XU;TV
M5GO+:VC;RY?LUO.K>BI<SB0^V#)#_D5O5Q=>M_%FY>3;?YG!ALLP6#][#48P
M;ZJ*7Y'S?XX\+MX9^!MU=W.!=ZM<6LL<2\^5;@L5)]W)!QV 'K7;V?\ QYP?
M]<U_E2?M!(FJ?"'[3 K"%8K:XC7H1&T@V#IV1U_*HM$N1>:+87 Z2V\<@_%0
M:_ .-[_VJI/K!?FS]@X;M]1LOYG^2+E%%%?GY]4%%%% #7C#_6JDT-7:21 P
MK.45)%QERF)-#6?/!UKH)H:SYH/:O)K43TJ=0P)H?:J$T/M6_-!UJA-#UXKS
MVK':G<P)H:H30UO30^HJC-#2 P9H>M49H?:MZ:'VJA-#UI@84T%4)H>O%;TT
M/6J$T-;PF<\HF%-#[51FAK>FAJA-#7H4ZAR2@8Z1[9@:^N_B%X3N_$V@Z)K]
MBC7%REK;VEU;J"7)8@1NOKDN$(]=OKQ\H-"2X"C+,<  =:^_-#\O2;"UB8JB
M1SVD.[L,N$0_02&,_A7[/X?-\^(FO[O_ +<?G7%:7)27K^AY9\+? .HZ9XL.
MIZK!)IZZ.Z2^3*N'DF9=T:@>G1B?08ZFG_%;P)?ZIXDBU;2H9+\:LVUK>(9D
MCG5,L,=P0I8'V([5ZQ<L?+N86/[R".SC<<<.1</^>R2+\AZ4EK,%6VAS\T_V
MF-/^NGE!Q_XXDP_X%7[)[1\W,?GG*N4\X^#?A&[\-WUQX@U",V\\+26=O:R#
M#^8"%D9AV"C*^Y/M7,^-/A?JL/BF9-&LYM3L[M7O+?[.A9ECWX*L.Q4L%/KD
M'O7ME]-'+]IV$,8[V6)B/[R1PH__ )$60_C5K36\Z[@M86"736\,J<\A5N)%
M<_3,D/\ WS1[1I\PN5<J.!^$/AL>&_#MQ=Z@S;]<A$9AC^]':D,"Q_VFW9 [
M #UKS'7OAMK>BW^IQ1VDE_:V"K+)>6Z$Q^4REE<^F5!)!Z8->]/<Q7EG97$/
M$$T32Q#TB:1VC'X(4'X5=DO(8K?5'EP+>SB6>Y!Z&%K% !^)CF&/4^]-5'&3
M?<'%61QFC_#G[/\ #BZ\+74R0ZQ?R+=M(?N03#;Y<3'Z;@Q[%^^WGR:S^'/B
M*\N+2(:9-$ES<FT2>48B\P%@P+=.-CY_W37T8GRZU:^8=S!H1(>N6 7<?SS1
M8W@:PTN1SS+/;VO?F>.9_/[=Q#<?]]4E4E&_F$HK0X_QIX)BUGP)::-ITH:X
MT2/S+=Y/E%R N9A[$D;ESZ8[UY9X=^&>LZQJNG6]U;2Z99WD1N1=W"$+Y("E
MG7^]PRX ZEAZU[H@9H+P(=LC6EP$;T8POM/YXK5NKR">:!XG4Q7D<UW;#_IW
M,*8'YR0?]\41J2BK(<HJYY]\9O#3>*-+@U;3E;S=)C\A[8\LUMO^1AZE2Q!'
M?<#V-<CX ^&>I)XO1];LYM.M=+,=W<),N&?YCY:*.^XHPSV"L>U>PVEU%90W
M%Q/_ *B)K>20GH(UNH2^?;:&JS>EH9+FTE.;F"W0S\$_>FE\L?7Y)3_P*A5'
M&/*#BN8\M^,'@R\U[5;77M-C:ZFO6ALI[6,9<3!-J$#NK*@^A!SVJ+X1^";[
M1=>N=;U.)[)]-9[:*WE!61[AH_3^ZJR!O?*]<UZC:3"-;1=VUY+T1*<?Q/;7
M*I_X\0/^!#TI;J9)(;I 0S17*1.1_P ]%MH2WY*T:_\  :/:/EY Y5S'D'Q(
M^'.I7?C!KS1K634(-9>6ZCCA&6BD!#2QD=L%@0>X8=\UT?P5\,R^%;>77]0C
M99[Q3;0VC95O*60>8S>F6CVCZ,?2N_M6:3[+;1_ZZ>"Z6'_>62V9Q]2N#_P
MU#>W"7<:3QD&*2>Z:-AW7[5*-WXL&;\:'4;CR@HKF/"?$WPNU?2=<O+73K6;
M5;..'[9'<6Z%O]')8!F Z'*,"/53C->E?#OPC%H?@F\L=2E*R^((E:?ROF-O
M$8V$1]V_>%R/3 ]:[G3[I8]17,@18+>UNGXZ0*]P&)YY 99#_P #%9*,&T_2
M^,'^S[7</?R$HE4<E9A&*N>"ZI\-_$&EW>HQ'3I;F*QF6&6X@7='EMI0@^C!
MT(]F%>Q6_@%+?X=R>#);F-+Z5C</<9_=I=Y7"Y'50$"$^I)KI=2N =+UUMV#
M MQ#(.0=\D$0@/XB2$ _[/M4UTT8\43,1^Z^V,3]-]$JDI6",4?.%I\.O$-U
M<VL7]F31)<79LDN)1MB\P,RD;NF 5;/^Z:]>\8>!XM:\"6>@Z;*9;O1DWVKL
M,"Y.TF8#/0L?F7Z8[UUUC<J++3GED#K)=P6OI^^2Z8R]^XBG/_ O>J5N)6%P
M(3B<V\PC.,X?RVV_KBG*HY._848JS/"?#WPSUK6M4TZ"XM9=.M+R,W O)T(0
M0J 6<>O#+@=RPKTCXQ^&O^$FT6WU+3AM;1X_(^S,?F:VW (5]64DY'<'/:O0
M)[R&Z:UE@($5XDMW;C_IV^S#CZ9E@_[Y]JSX;J&QM[BXN"!!"T$LI.,>6MS"
MTG7_ & U#J-M,%%69XCX?^%^I3:K>1ZU;2Z7;V%O]JN%G4J[@[@BJ.Y9E(SV
M 8]J]9_9]_Y$23_K\D_]!2MCQ$Q@LM5LYVW7<-BS2>HW3.$_] E/_ O>L?\
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M_6]+!-WI5PBCJZH2OYC(K-6\0GG*_A5\R+NB>BFK*C]&!IU4,**** "BBB@
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M_P#CII#X=\*M]V_U"/V95/\ ):TC8VY_Y8I^ K'\77%MH/AN_OA&H>.(B/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%JE[?7-RZO=8#QPL5C"#A4"Y^Z!P!0J;<FNP.2LCZ9VF/7+99AAU>(2@C'S
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MPW0P:I#]LG<_>,6_$<6?8J2?4XKA_AKXQOM+\86B32R7EMJ$D=I=1R$N70L
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M_P"S9K(N]3U74LBZU">5?[K2';^72FVNGZIJ./LNGSRJ?XEC8C\^E:]O\/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?^?A0/*'OYK?*?\ @&X^U>H:?\/=+M622\$FK3KR&O2&13ZK& $'UQGWKI@
M  !@"NN59L+'":;\-Y9,-J5[Y2][?3\K^!E8;C]5"&NKTG0-.T&-DL+.*VW\
MNZC+R'U9CRQ]R36A17.Y-@%%%%2 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4Y=2BO9M'NKA]]Q&EN)HG8_>91N4J2<DCD9/;I74T4<SO>^H<BM8K>%=%L/
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M\'Z<)YAYL\F5A@4X+GO] .YK>KQ[XS6T\?B"PNY%9K(PB-6QP&#,2/KR#_\
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MN8M-NG']X0MC\\5H0_#WQ!/C%@R#_II(B_S-+YA\SHGTG2T_UWB2S]/D._\
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MD8'Z9J"36];NO]7;PVJ^K<G^?]*I19)U>ZHIKB*W7=+*D:^KL!7(M:ZE=?\
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MI/@700T.F_:1CS7$!@AB!'!8!GF?:2%8A<D$4V-EO]NK_E(1^SC_ -?FD?\
MIV-?H_7YP?MU?\I"/V<?^OS2/_3L:_1^A=0044450PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G_
M (@?\B/KO_7G)_Z#7"?#;_D2]._[:?\ HQJ[OX@?\B/KO_7G)_Z#7!_#<_\
M%%Z=_P!M/_1C4NI$CIJ3=2459D%%%% !367N*=10!%2A2:DHH 0<<4M%% !1
M12;J %INZDHH ****8'I%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKY+XG\U$])\$_ "ST^X34?$UP-;U'KY)R8$/OGE_QP/:O6U58U"J JJ,  8
M%>'_  K^)%QX;U"T\+:_<O/I\Y$.DZI.Q9U?HMM,QZG^XY^]]T_-@M[C7V\<
MAI</-X2G34;=>_G?K^AU87/X\24(XZ%3F3Z=GVMT"BBBM#K"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"KJG
M_(,N_P#KB_\ Z":C_9]_Y$23_K\D_P#04J35/^09=_\ 7%__ $$U'^S[_P B
M))_U^2?^@I42^)&$STNBBBF8A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8'C+QA:^$--\Z7][<R
M9$$ ."Y]3Z =S0/<L^)/%%AX6LS<7LN"?N0KR\A] /ZUXMXJ\<ZEXQ8Q/BTT
MX-E;=.<^A8]S^0K)U'4+OQ!?R7VH2F69^@/11V '8>U,_E6\8=6=$8);E?[&
MO9B#1Y$HZ3MCZFK%%:<J-+%?[/(WWIF-)]EC7EF)^IJ6:985R>3V%;.A>#YM
M6A%_J4WV#3!R';AG_P!T'^?\Z6B#0PH%>XF6&S@::5CA512S'Z"NDM?A[>-&
M)M8O(=,AZ[6(9S] #C]<^U:\>M0Z>AM/#]DMLA&&N&7,C^Y)_K^E5AIDMU(9
M;R=I7/7G)_,TM6+4([;POI/$5I-JLP_Y:7#;4_+C^574\3:CL\O3[*"PB["&
M(#_ZWZ4D-G#;_<C4'UZFI^:.5!;N4I)M9O"?.OI%!Z@.1^@JO_8K2-NEN&8_
M3/\ 6M7FCFF.QFKH<7=W/TQ_A3AHUOU^8_4UH<T<T 4?['MO1O\ OJE_LBU_
MN'_OHU=YHYH I?V/;?W2/^!&D_L>V_VOSJ]S1S0!1_L>V_VOSIO]BP?[?YUH
M<T<T 9_]BP?[?YTG]BV_K(/Q'^%:/-'- &=_8</]^3\Q_A2_V+;\<O\ G_\
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M_J-G9+W#RDG\NGZU*GA+P[:8^U:S-=-W6VCV_KS2]T-#E+J]N+PYNKZ6X/\
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MG?\ ;3_T8U)?$1(Z6BBBK,@HHHH **** "BBDS0 M)NI,TE "TE%%, HHHH
M**** /2**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBC..M
M!13?,%*K!NE "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 >%>#_^2@>-?^OV3_T;)7<5P_@__DH'C7_K]D_]&R5W%*&QU0V"BBBK
M+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %75/^09=_P#7%_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\4M1]#\Q?V\OV$8_V5QI7B3PSJ=YK'@K4Y_L?_$PVFYL[G:SA'9%575E5BK
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M!-1_L^_\B))_U^2?^@I42^)&$STNBBBF8A1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(O#\6IW/AVQN_MFC>+--0OY #903E1^[D P#N 5N<9&0/W/HH<;@?A=\1O\
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M_P"C9*[BN'\'_P#)0/&O_7[)_P"C9*[BE#8ZH;!1115EA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !6;XB\-Z;XKTF;3=5M4N[23!*,2"K#D,K#!5@>0R
MD$'D&M*BFFXNZ)E%27+)71Y!J UGX9976'GUWPRO$>M)'NN;5>PND4?,H_Y[
M*/\ > ^\>BM+N"_MHKBVFCN+>50\<T3!D=3T((X(KO:\]UCX4_8;F;4/!]VF
M@7DK&2:P="^GW+'J6B!'EL?[\9'J0U?4X/-]H8C[_P#,_.,VX54VZV!T?\O^
M3_0M5SMYX(M/[0EU/2;BY\.ZO(0TE[I;B/S2/^>L9!CE_P"!J3Z$5&WC0Z'<
M+9^*K&3PU=%@BW$[;[&=CP/+N,!>>ROL;_9KIE8,H(.0>017TB=.M#2S3^9^
M=RCB<!5L[PFODS*M_&OC#P]A=4TBV\3VJ_\ +UH[BVN<>\$K;&/NL@SV7M6S
M8_&/PG<R)!=ZE_8=VQV_9M:B>R?=Z*90%?\ X"2/>F*VTYP#]:\-^-OBJTU3
MQ -#N89#96BJ7\ENLC#.2#P< @<].:\_^Q*&*G:%X^G^1]!'C+%X"G>O::VU
MT?WK_(^IX9H[B)98I%EC895T(((]013J^(_#VEZKH+->>!M?N+-U.][6TDV9
M/JT#9C?ZE:]2\$?M13V,ZZ?X[L!;;3L.K6,3;5/_ $VAY9/=E+#V45X^+R'$
MX=.5+WTNVZ^1]=EG&>7XYQIU[TI/:_POTDM/OL?15%5]/U"UU:Q@O+&YAO+2
M= \5Q X>.13T*L."*L5\T??)WU04444AA1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 5=4_Y!EW_ -<7_P#034?[/O\ R(DG_7Y)_P"@I4FJ?\@R
M[_ZXO_Z":C_9]_Y$23_K\D_]!2HE\2,)GI=%%%,Q"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "O _B)<O>>/-1W](=L: ]@%']23^->^5
MXC\6M)?3/%HOMO[B]0,&[;E 5A^BG\:N&YI3W.5HHZT5U'4%%%% !1110 H8
MKWQ39/WG7K2T4@(O+/UICV8DZ_*?6K%%%D(J_OK?MO6GI=HWWOE/O4],:))/
MO+2LUL Y6#="#]*O>%]<'AO6&:9?,L;A?*G7&?E/?\/Y9K*:S7JK%:9);RL,
M;MP]Z3\P.[O]-ET207=HWVK39OF213D8[ ^A]Z?;ZC!<=&VM_=;@UR>A>)M4
M\-Y2+$UJQ^>WE&Y#Z_0_2M^/7/#.M<S)-HUP>NT;XL_@/Z"INUN+5&K3N:J0
MZ"DV/[/UVSG'9?.VG\@34Z^%M;8926.1?[RR9%',@YD2<TG3K4;>&-57B:]M
MX/7?-C'Z56ET?3H.;WQ%: CJL3>8?T/]*?,@NB:2_MX?O2KGT7FJC:QYC!+>
M%I'/3C^@J.36/"FG?<%WJC]N-B?K@_H:K3?$2[56CTG3[?3HSQN5-[_F1C]*
M5WV#4UX] U2]C,MVZ:?:@99YV" ?A_C5.XUCPWH.1$KZW=#_ (#$#_7\C7+7
MMS?:M()+Z[EG;MO8G'T'0?A5=O*MNV6_6G9]0MW-Z_\ '6MZDOEP.NG6^,".
MV79Q_O=?RKFKC<TC/)+YLC'+$DDGZFM[1_">J>(5$RJ+2RZFXF.U<>W<_P J
MW8+'P[X=^Y&=;O!_'*,1 ^PZ']?K2T6P:(Y;1O#FJ:WC[%:,T>>9F&U!_P "
M/]*Z*'P7I.DD/K&I&XF'6VL^>?0L?_K5=NM4U?6%VM)]FM^@CC^1<>GJ:CM]
M'@BY?,K>_3\J-0U);?78+#,>B:3#:]O.9=\GY_XDU'<?VIJG-W=MM/5=W'Y#
MBKJJ$7"@*/0"G<T[(+&?'HL"_?+2'ZX%6H[2&+[L2CWQS4W-'-,H;3N:.:.:
M #FL'Q=KPT/3&\MO]*FRL0[CU;\/\*V;BXCM8))I6"1QC<S'L*\IU.\N?%6M
MC8I+2-LAC_NK_GDUR8BKR1LMV?09-@%BZWM*O\.&K_R_S\B?P3X?.L:G]HG7
M=:VYW-N_C;L/ZG_Z]>J<U1T;2HM&T^*UBYVC+-_>;N:O<U="E[*%NISYKCWC
M\0YKX5HO3_@AS1S1S3:Z#QQW--J":^A@^_(,_P!T<FJ?]JR7$GEVMNTKGIP2
M?R% &G4,UW#!]^10?3J::OA_5+B,RWDT>GV_=IG"C_/UJE-=>&-'_P!;=S:K
M,.J6ZX3\_P# U/,A7'R:TF0(HVD/OQ4\%CK>I?ZJU:)?5AM_G_2L>;XD-;Y7
M2=,MK%>GF,-[_GQ^N:S6O_$GBEBJR7EVIZK$"$_$+@"C4-3J+C1;6S.=5URV
M@8=8U;S&_+K^E4I-<\*Z?Q''>:FXZ$_(G]#^E4+;X9ZJR![N2VT^/N9Y1G_Q
MW/ZFKD?@_P /V7_'YK,ERW]VUCP/S^:I^8OF0R?$5+?/]GZ)9VY[-+F1OS&*
MIW'Q&U^X^[=+ O\ =BB4?J036TA\,6./(T>2[8?Q7,I&?P!Q^E6H_$30_P#'
MAHEG;CU6#)_,8H^0:=C\_)?!?QO_ &;OB[XA\2_#[0M4\=>#M=EDFDTVP>5W
MCWN9-GEQY961B0&56!4\\G N>-M4_:0_:>T*X\&Z1\']6\$:=J&(KZ_\0O+!
M^[!!(#S)%A3T.U6)&0*^^9=>\077_+;RE_V0H_\ KU6DCU2X_P!=?R$>GF,1
M^51[-]'H3ROH>8_!/]F'4?@_\--'\+Q36[FSC+7%RT@'G3.Q9VXSQN) ]  *
M[K_A6-__ !:EIRGNIG;(_P#':O\ ]BESE[@L?I_]>E&A1]Y&_2M4FM"]2A_P
MK64\+K6G,W8>:W^%)_PK&_Q\NHZ<Y_NK.V3_ ..UH_V'#_??]*0Z%'VE;\A3
MU[AJ9C_"_6@N4%O,.Q28<_GBJ<WP_P!?M^NGLP_V)$;^1K=_L0KREP5/^[_]
M>I5M=0A_U5_(OTD84:AJ<=/X;U6UYFTR[0?WO);'YXJBR"-MKHZ-Z'K7HJ:A
MKUO]R\9_J0W\Q4K>)]8VA;BWBNE])(MP_2EJ&IYKLA;JS#\*E@\RU;?;7)5O
M0'&:[J75=*N?EOO#UL">K0CRC^@'\ZSKS1= O\?8Y)].<_\ /8[U_+_[*B_D
M%Q/"]W_:UQ]DGU=],N6.$WEMCGTSG@_6MK4+6^TYV@M]<FNIP<>7"T@ /H3G
M^6:Y>[^'^I+'YMG-#J,0[POS^1_H36OX2\;-I4QT_6U:,CY4N'3#I_LOW(]#
MV^G16U,Y7Z&A:Z;XOF'&K36:'G_CZDS^52-X=\3LQ+:V\I]7NI,_RKL(Y4FC
M62-U=&&0RG(/TI]7RHQYV<<NA>)U&%U@@>UW+_A4BZ'XFYW:W(OTNI3_ $KK
M:*=D',SC_P#A&=>:3<VL-[MYTA-(W@_4YMWF:LQSURS'/UYKL:3=2T#F9QZ_
M#W<V9M09SWQ'C^9-7;?P#IL7,C33^S/@?H!72450<TNY1L]#L+'!@M(T8=&V
MY;\SS5ZBBD2%%%)GG%(0M%%%, HHII:@!U%-6G4@()+<,<J<&H_LK^U7EA>3
MHIJ5;-OXF ^E+0"E'"(^>II_7I5Y;6->H+'WJ10%Z #Z4N8"E';R-_#CZU(M
MF?XFQ]*G:9$^\P%0M?(/NY:E=@/6VC7KS]33P%7[H JFU\QZ #]:A:X=NK&B
MS T6D"_>;%0O=HO0Y^E4"WO3=U/E N->>@_6HVNG/?'TJONJ&:]@@SYDR(?0
ML,T[ 6VD+=6)_&F;ZS#KELS[(O,N'_NQ(2:F']J3+NCTN2)/[]RPB'_CV*-$
M!<W4FZLR1IH\_:=6L+8=U@S,P_  C]:K--IS9#W6I:@?^F2")#^9/\J7,@->
M2ZBA^_(B?[S 54DUNTC.!+O;T0$U26XMX^;?180?[UU*TA_+('Z5,NJ:DO$4
MT-DO]VUA5/UQG]:+LKE9;CN+VZYMM+NI5_O,NU?SILBWR_ZZ:PL?::<,WY*3
M_*LZ:.6[YN;JXN#_ --)"12+9PQ](Q^/-*X^5EF2:U'^NUJ69O[EI;G^9Q41
MDT[.5L+V]/\ >NI]@_(#^M*JA>  ![4O-(KE%6\>/_4:;86X'0LAD8?BQ-/;
M4M3E7:VH21K_ '8%$8_\=Q4?- Z4:#Y40O:B9LS223'UD<FGI:PKTC7\1FI*
M*!V0 !>@Q]****0Q<TE%% !1110 HZTZF]#1N'K0(=2;J;10,**** ' T%J;
M10 [FFT44 .%&:;10 ^BD'>C- A:2D)H':@+#J**0F@+"T"DI:!#J3=244 %
M+NI** "E6DHH =2;J2B@ IU-I<]* %HIM"]:0#J**0FE< _BI:;DTZF 44#I
M13 ***.:3 **3=2T@"BC(HH .].--HZT@"BBB@!:2BAF"]2!]:!!149N(U_C
M%"SJW"AF/^R*8$E% 6=ONVLS?\ -.^RWAY^R.!_M'%(5T-HIWV6[_P">*CZR
M*/ZT?9KC^+R5/H95_P : N-HI?LUQZP?]_5_QI?L\_K!_P!_E_QH"Z&T4[[-
M=?\ /*,_]M5_QH^RW?\ S[$_[K T!=#:*<T-RO6UE_!2:B:1E^]%(OU6@+CZ
M6HEN$/?'X4X3(?XA3&2YIN:;N4]"/SI:0!1110 4444#"BBB@ HHHH ?29I,
MT4$CJ3-)NI* L+FBDHH&*32K3:5:!#J*3=0.10(6D90W!&:,TFZ@!-VU-DH\
MR+MZK]*9;JUG=JH;=#*/E;L?_KTYG51\QQ5/5))HM'D\H,)I)%$ QR,\;O8<
MC\LT":-VB@$,,@Y%%22%%%%( HHI-U "TW=110 4444P"BBBD 444F: %I,T
MF:2@ HHHI@%%%%( HHHH **** "BBDS0 M)NI,TE "TE%%, HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ](HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ***;)G;Q0 K,%&34;2'MQ47._';%.I#';CZT
MY9?6HZ*!%BBF1-QBGTP"H&8L:GJ \4@$I0=IR*2CJ<4 6 =P!HH7@ 44P"BB
MB@ HHHH **** "BBB@ HHHH **** /"O!_\ R4#QK_U^R?\ HV2NXKA_!_\
MR4#QK_U^R?\ HV2NXI0V.J&P4445984444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5_%L_P!?PKOYD?'W!]8,L@CMH6E<]..OX"K*Z#JEW'YMW*FGVPZO.P0#\/\
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M10,****!A1110*X4444 *6I*** "E_AI**0"\4M-HIB%W4E%% !3J;2]<4F
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MM7TI/+7THL%V7/(N>T!/T8&D\FX'6VD_*JGEKZ4H0>I'XT6"Y9V38YMY1_P
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M')^1(I5NKR#[PW#_ &AG]:NT4 01ZP/XX\>ZFK,>H02=) #_ +7%1R1))]Y
M?PJO)IL3?=)0_F*5AFCG=WI:R/L<\.3&_P"1Q3A?7,/^L7</]H46$:M%48]5
MC;[ZE#^8JU'-'+]QPQ^M("2BBBD 4E&ZFT +NI***8!1112 **** "BBB@ H
MHHH **3=3: %W4E%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#TBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*KM:K,?WLDDO^^Y-/E8<S+;:??K_ *Q;6W'K-<(/ZTUK5U_UFIZ?'_NNSG]
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M&IS(B>6I57:,=$8@$C\R:2D6M0I5ZTE% QU)FDHH <.E+30:-U "YH%-I10
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M*#0 M%)NH#4#';J4&FT4 /HI%I:!!1110!%):Q2=4 /J.*KOIW='Q_O5=HH
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M0L>I\EFAY]_W=?'-?6O[,ZE/@OHFX8W7%\X^AO9R#^1%>OQ5!?5Z<NO-^G_
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M7I@>P[5=AMX[==L:A14E)NIHH6F[J2BF 4444 %,EF2&,N[;5%)/.EO&7<X
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!XU^U=^S?;?M2?"^+P;=:[+X>BCU&+4/MD-L)R2BNNW:67K
MYG7/:N(_8[_8ALOV1=2\3W=IXMN/$QUR&WB99K%;?R?*9SD8=LY\SVZ5].44
MK*]QGA'[7G[*MK^UEX)T;P[=^(IO#::;J']H"XAM!<&0^4\>W!=<??SG/:LS
M]CO]CNS_ &1=-\46EIXHG\3#7);>5FFLUM_)\I9!@ .V<^9[=*^BJ*+*]P/G
M7]L3]CNS_:ZTWPO:7?BB?PR-#EN)5:&S6X\[S5C&""ZXQY?OUK3_ &0_V5;7
M]DWP3K/AVT\13>)$U+4/[0-Q-:"W,9\I(]N [9^YG.>]>[T465[@?'W[5W_!
M.W3OVI/BA%XRNO&]UX>ECT^+3_L<.G+.I",[;MQD7KYG3':O>/V<O@O#^SS\
M&?#WP_M]5DUN'1_M&V^EA$+2^;<2SG*!FQ@R[>O;->DT465[@(RA@01D'@@U
M\ ?$K_@D'X0\9^.]:UW1/&MUX6TW4+AKF/1X=,2:.U+<LB-YB_)NR0,?*"!V
MK] **&D]P/%M+_9XOH_V7[SX.ZQXRN-;$VDS:-'K\MD$F2W92L8:/>0QC4A1
M\PR%&><D^*_LS_\ !-/3?V;_ (O:7X\MO'MUKLMC%/$+&73%A5_-B:/.\2MC
M&[/3M7VG12L@"OCC]J+_ ()K>%_VD/B8_C6#Q+<>$-2NK=(K^.VL5N$NI$&U
M9CEUVML"J<<'8#UR3]CT4VK[@> _LH_LHI^RG\/?$/AG2_%,FM3:K>-?1WUQ
M8K']GD,*QC]V'.X H&ZC/2OFNQ_X(ZZ$WB6WU36/B;J.LQ_:UN;R"32E1KL;
MPTBE_.)!?D;L'&<U^B5%+E0#8XUAC5$5411M55&  .@ IU%%4(^/OVJ_^"<>
M@?M.?$U/&O\ PE=QX5OY+**TNX;>P2X6X:,L%E)+J0VPJG?A%KV7]EWX"S_L
MV?"J#P,WB>;Q396EU-/9W$]J+=H(Y"&,04.V1O,C9S_&>*]<HJ;*]QA1115"
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!'7
M>N*KLI7J*LT4@*P1FZ"IHX]@]Z?10 4444P"BBB@ HHHH \*\'_\E \:_P#7
M[)_Z-DKN*X?P?_R4#QK_ -?LG_HV2NXI0V.J&P4445984444 %%%% !1110
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M% Q]+FF4Z@0X4M,IU(!P-+3: : '44F>M - Q:<#3<T4 .W4M,IVZ@0M%(U
M- Q:,TFZEH 7/-.IE/H$%%%)0 M%)FEH&%%%% @I" >",BEHH K26,<G(&P^
MW2H/)N+7E"2OM_A6A10!4CU(=)%P?45;219%RK!A4<D"3?>7)]>]5FLGC.Z)
MOZ&D!?HJBMY)$P65<_H:M1W"3?=;GT/6D!)1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!Z11110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 >%>#_P#DH'C7_K]D_P#1LE=Q
M7#^#_P#DH'C7_K]D_P#1LE=Q2AL=4-@HHHJRPHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *>K4RB@!Y3TII&.M"L5I^0U $=%/,?I3.E !1110 4444 5=4_Y!EW
M_P!<7_\ 034?[/O_ "(DG_7Y)_Z"E2:I_P @R[_ZXO\ ^@FH_P!GW_D1)/\
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M_P!^D_PJ3[)IJX_T]F_W831]GTS_ )^)V^D=&@R/^VKOM+_XZO\ A0-9O/\
MGNP^F!4GD:;_ '[K_O@4X1Z6.UX?P6C3L! =6O&_Y>)/^^JC.H7+=;B4_P#
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M: %HHHH$%%%% !1110 4444 -95<889%5I+$=8S@^AJW10!16XFMSAQN'O\
MXU:ANHYN <-Z&GD!A@C(JO+8JW*':?3M2 MT5GK+-:\,,K[U:ANTFXSM;T-(
M":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ](HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO?\ ")Z-_P! NU_[]"C_ (1/1O\ H%VO_?H4>]W#G/(?^%O:'_<N_P#OT/\
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MT"[7_OT*/^$3T;_H%VO_ 'Z%'O=PYSR'_A;VA_W+O_OT/_BJ/^%O:'_<N_\
MOT/_ (JO7O\ A$]&_P"@7:_]^A1_PB>C?] NU_[]"CWNX<YY#_PM[0_[EW_W
MZ'_Q5'_"WM#_ +EW_P!^A_\ %5Z]_P (GHW_ $"[7_OT*/\ A$]&_P"@7:_]
M^A1[W<.<\A_X6]H?]R[_ ._0_P#BJ/\ A;VA_P!R[_[]#_XJO5-0\":+J$'E
MFS2V;M);C8P_H?Q!K@=<^#6L0L9=&UU)=O*PWT" _P#?07!_[YH]X.<R?^%O
M:'_<N_\ OT/_ (JC_A;VA_W+O_OT/_BJ3^V=?\'KCQ%X*M;ZV3[UW;0@<>I9
M05_# KH]!\?_  ^UK:CV]OILS?P7L 0?]]#*_F14\S[ASLYW_A;VA_W+O_OT
M/_BJ/^%O:'_<N_\ OT/_ (JO6K?PYH-U"LL%A931-RKQHK _0BI/^$3T;_H%
MVO\ WZ%5[W<.<\C7XP:'W2[_ ._0_P#BJD7XM:%(.%NC_P!LQ_\ %5ZQ_P (
MGHW_ $"[7_OT*/\ A%-&'33+7_OT*/>#G/)V^*FB]0ET?^V8_P#BJA/Q<T->
M"EX#_P!<A_\ %5[!_P (OH__ $#+7_OT*#X5T9NNF6I_[9"CWA\YX_\ \+>T
M/^Y=_P#?H?\ Q5'_  M[0_[EW_WZ'_Q5>O\ _"):-_T"[7_OT*3_ (1/1O\
MH%VO_?H4:]Q<[/&[[XL:)<65Q$J76Z2-D&8QC)&/[U==^S[_ ,B))_U^2?\
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M7;5 4_[/A(P4_4U')I$#?PL/^!FM#;1MH S#H-N>AD'T:C^Q$7[LTP_X%_\
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MM_#.DPMN73[?>/XF0,WYGFM&.WBA4*D:JHZ #BEIK-MI:@#+SP*?DTE(W(H
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M?NW#*?1UI@24JTBQRG[K1R_[K4?.GWXF'X9% A]%,$R'OCZT_.>G- !1110
MH-.IE.6@8M%%% @HHHH **** "BBB@ HHHH **** "BBB@!&4,,$9%5I+3;\
MT9P?2K5% %2.\:,[90?KWJVDBR+E3FF21K(,,,U6:WD@;=&21^M("]15:&]#
M<2?*?7M5GK2 **** "BBB@ HHHH **** /2**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)UOPGH_B-"NI:;;W9/&]T
M^<?1AR/P-:U%(9Y7J7P%LX9OM.@:M>:/=#E?F+*/8$$,/S-5/M7Q/\%_ZZ&'
MQ+9KU,8WOC\ 'S]0:]?HI<JZ!<\PTCX]:1--]GUFRNM%N0<-O4R(OUP P_[Y
MKO\ 1_$.F:_%YFG7]O>+C)\F0,1]1U'XT:QX>TS7X_+U&PM[Q<8'G1AB/H>H
M_"N U?X"Z1--]HT:]NM%N5.5V,9$7Z9(8?\ ?5+5 >H49->/_9?B?X+_ -3-
M#XELUZ"0[WQ^)#Y^A-6]-^/5G#-]FU_2;S1[H<-\I91[D$!A^1HNNHSU6BLC
M1/%FC^(D#:;J5O=D\[$?#CZJ>1^(K7I^@]!****=PY>P4454U#5K/28?-O+F
M.W3L9&P3]!W_  IDV+=%</??$Z*:1H='L9M0D_YZ,"B#W]?SQ61</X@U[/V_
M4/L<#?\ +O:\?@2/ZDUHJ<F([C5O%FE:+D75Y&L@_P"62?,_Y#I^-<Q<?$2_
MU+*Z-IC;#TN+K@?ET_6L^R\.V%C@K )'_OR_,?\ #]*TZV5-+<#(N-/U36CG
M5M4DD0]8(3M3_#]*M6>C6=A@PVZAA_&W+?F?Z5>HK5)( HHHI@%%%% !1110
M 4444 %%%% !139)$A4N[*B#JS' %8LOBNUDN/LUA%-JET>D5HA?]?\ #- &
MY4%U>06<?F7$R0I_>D8 5AZA-J<2YU74;+PS%_SQ)\^ZQV^1<X_';6/]NTF.
M3S++2KC7+G_G\UF0B/ZB)3R/JQ^E1S+H,WX_$W]I3&#1["ZU>8=?(C(0?5L<
M?E534)KJ'<-9UVST7UL[$?:;GZ':<*?^!"LR\U#5]4A\F[U!H;0#BSL5$,('
MIM4 '\15&WLH+?\ U<:@_P![J?SJ7)E^S?4O+?:;"Y?3M#DU"<_\ONN2;\^_
MEC"_F32WMYJNL1B*_P!2E-N.EK; 10CVVJ /TJ!6*FK%(T4$06]C;VN/*B52
M._4_G5FFBG4S78****0PHHZ4UG"]31ZC47)V2'4,P7DG%5Y+H1KDD*/4T65G
M>ZU,4L;2:[8=653M7ZGM6$JJZ';'".W-5?*A9+O'"#/N:IS7 W?O'Y/0'_"M
MEM M+!A_;&L1QOG_ (]+ >=(?;(.T'\:V]+T6X;']C^&TMQ_S^ZRVYC[[,<'
M_@)J.64]9O0IXRCAU:A&[[LY?3-'O]6;_0M/FNA_ST*[8Q]2?ZXK0ET>&R4'
M5==M;/M]GLQYTGT.. ?^!5UMUX;651_PDGB1I0H'^C1R+!$/;'^&*DM=8\(>
M'3FS6$2CC?'$SN?^!D?UK2-HJT4>55Q%2L[S9S^GZ/!,P;2_#5WJ+=1=:M)Y
M:?7;D9'XFNCM_#6OSQ^7/JL&DVY_Y=]*A"?^/8'Z@U'<?%+3TR(;6XE/^T%4
M?S-9TWQ6D_Y9:<J^[RY_I3]Y]#G-^T^'VC6[^9-#)J$N<F2\D+Y^HX7]*W[>
MUALXA'!%'#&.B1J%'Y"O,9OBCJ;_ '([6+Z*2?U-9\WQ$UB7_E^$8]$B7_"G
M[.;$>QT5X=-XSU.7[VHW7_ '*_RJC-KUQ-_K)YI/]^0G^M"HR ][DN(H?]9*
MB?[S 54EU[38<[]0M5]C,N?YUX(VH^B?K3&U!QT5:KV#"Y[G)XPT>/KJ$7_
M<M_(55D\?:(G2[9_]V)_ZBO$FU"7L0/PJ-K^;^_^@J_8!<]ID^)&DKT%P_\
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M1),AE#=N1FH6TVUDX:VA<>\8/]*EW$FEH I-H6G,V?L4(/3Y4"_RJ)_#.F2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUH/_ &)I<MW&OWKN;]U GN6/'YD5DZA<6>XKJ^NR:E+_ - _0U_=_1I3P1]
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M!3BER* $P3UHVYZTC,<<4D;=: %6,+WI&<*<=:6D90U #L@T'VIN=HI ^>U
M N>].S2;J8V=W'- #RH-!.T4"@X[T (K;J=3!A>@Q2-(5XH 5E+'/6G=*3=G
MI2'H: ';AZT@P.E,53FG4@!F-%%(>!3 4\TU5(I%?<:>: $+8I:8WS4JG H
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M!IFEZ;HP'27RO/F_[[?/Z8JO>1W.K/OU+4+J_;KB60[1]!VK-U)="U!LK_\
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M:;MIJ9W<CBGT (S;:4<TUE#4OW10 O."*8H(-"R;NV*7- #J;PW6F,"S4Y>
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MT;T;[T>T^J&F(FHJ->?N2@^S\4I9T^^A'N.10(?135D5NAIU, HHHH ****
M&20K*.>OK5<&2U;U7]*MTA 88(R*0!%,LRY'7N*?5.2W,;;HSQ^HJ6&Z#<-P
MU(#T^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3RU/50?PI0H7H,444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1169K7B33?#\>Z]NDB;&1&#EV^BCF@#3JGJ6L66CP>=>W
M,=M'VWGD_0=3^%<)>>/=7UXF/1;3[%;'C[7<@%OJ!T_G6=#X:CDG-SJ,\FHW
M3<EIF)7\N_\ GBMHTF]P-B^^)-SJ3-#H-@TO8W5P,*/H/\3^%8[Z%<ZM,)];
MOY+Y^HB4X1?I_P#6 K855C4*JA5' 51@"ES71&"B(9;6T-G'Y<$21)Z*,?\
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MKEL[&5%#' NV-%1?]D8J6BBNXZ HHHH&%%%% !1110 444F: %IO'>C=24[
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MUQJFM7\/E3ZI)!;_ //M9*(8\>F% S^(J.G<U!HJ:*<.EVL/(B#M_>?YC5L
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M3\U'P*1FVT .DR32@X&*:#N&:6@!=U' Z4Q5*M3LXH &8TJGY>:3K10 NZD
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MK<FBP7%HH;?%]^-E]\9%-5U;H<TACJ*** "BBB@ HHHH &&>HH4M']UBM%%
M#C)N_P!9&K^XX-*I3^&1HSZ,,BF4?7F@5B;]XHSM#KZH<TBRJ>^#[U$ORME2
M5/M3O.;HZK(/<<TQ6)J*A!C[%HC^8I^),9&V0>JF@!]%,$J]#\I]#3Z8@J&6
MW#\CAJFHH ]*HHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HJ-I?3F@3'N*0$E% (89%
M%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;(^Q<]Z=3)E++Q0!%YK
M>M21R;N#UJ&I(5.[/:D!-1113 **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *"0.3P**AN6/ [4A@UR/X1FA;D=QBH
M**5QET$-R.114%NQR5_&IZ8@HHHIB"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME(R[N] #PU(S<''6F\*M(L@;B@!JN=U245')G(QTH >5#4O"BD7.T9ZTI]Z
M&K)NXQBG4Q5"FE:3:?6@!)%9CGJ*<N0HS2!MPR*4MZ4 +FDP%J-<AJ=0 -)M
M[4Y6##--*AJ/NK2 =N_.HU4YYI%DR<4^F 4<'WIL@/;FE7(7FD [=M7@4U9#
MNI=P/>C:!0 [=2,-W2FLVVC=Q0 \?*,4W=GO1VIJKSGM0 ZD9BO2E+ =31PW
MO0 JME<F@FDI@<YH >HP:5G I*:PS]: '=:*1>E&X9Q0 @:I-U-I&H 5OFI5
M^6FJU+0 ;\T4T+@]:<S;: !B:56]:13NHH ?3:;S2T .+8HSFFD9HI /IO-
M:G47 7<:2FMFA<XYI 2"DW4E% "YI**,YI@.6BD4TG2D ^BF[J6@!:**3- "
M@TZFTH-(!:4-3,TJ^E #J :2B@!VZDI** "BBBF 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 '7-9\_A_3[ABYM5BD/62$F-OS7!K0HHN!EKI=Y:_P#'IJDRCM'<J)5'
M\C^M(UQJ4)_TG3H+U?[]M(%<_@V/YFM6BG<9C_VSIZMMG>?3GZ8ND*K^!/!_
M U>C1I5#0R1W"GIL;FK+*&4@@$'J".M9TOAVPD8ND'V:0_QV[&(_CMQG\:-
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MW\S]#_B-\4M"^&/PXU'QKJLYDT:SMUG5K?#-/O($:IS@ERR@<XYSTKY<T/\
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M?F   'I4FZF?+G..:223:O I +(F]1CK1&NU<'UIL<A<'(I^[TH -PZ9YI.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!LDFP>M)')OXQ@
MTK*'&#0D83I0 ZBBB@ HHHH **** "BBB@ HHHH @F^_^%,JQ)'O'O4!1EZB
MD E2V_\ %4:QLW05/&FQ?>@!U%%%, HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:_ KPGX9U_6[JUU?3X)$N(8]/GD"DS2,,,JD'AATKU'_ (>$?!+_ *&.\_\
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MW2-GEF57_P" L0?PKQK]C?X_:;^S_'KGPC^*+MX5O].OY);6ZO%80_-C?&S
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M;V,9" ^A/I[UIP76H6J[;&RT_P .1?WFQ/<?I_4BK4-NXA$1<11#I%"H1!^
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M(H3-("3<:AF5V;U%$DVTX S3E;<H- #ER%&>M!]^E,?+*0.M1Q*RGG@4P)0
MO08ICR[3C&:?2,@;DC- "@Y -(XRIQQ2.^U21S3(Y?,;D4 $*E6)/%2,P7J<
M4F:AE1F;(YI 3$*W.,TC-M4FD4;5 H#!NA!I@-23<V,4^D4!<X%123,K8% #
MWC+-D4]1M4"FJ^Y0:&^8$4@%5@W0YI< =JACC*-DGBGLX[G%,!)I"N,<4X-N
M4'I2<-[T,3C-( 89&*:L>TYZTV.0LW/2G[J %9@O4XHX^M,D7S,<XIRX50*
M%YJ*-V+<]*?Y@;@&BD [<*:Z"3O@U'(Q7'84]"2H)H <,1KCTI@DW'%.-,6,
M!LYH ?3)"W&*5I K<T;L]*8 I.T9I>M--,7.[O0 ]8PIS3F<+UI,FFLN[O2
M>&##-(S>E)]U?:FK("V,8H 1,AJDW4E,DSQZ4 /8!NM'W:1,XYI: &B7<V,4
MZFB, YI'DVT .?)Q3DX7FFJVY<TM "[J H7H*C4$-3Z0"22;<8ZT*VX4%0U
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !15#6-
M<L=!M3<7UPL"=@>68^@'4FO.M5\;:OXJW0Z8K:7IQX,[?ZUQ[>GX?G51BY;
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M@+TJ-5.X<4HDRV,4ZD XL!2,JOUJ.0'BECR%YH ?PHP.!3%EW-@BG4@0 YH
M6D?+4.VT4*VY?2@ 7Y13MV:3=4>#F@"3;WI';;BC=ZT<-[T *IW"ES24P2<T
M@%VG=3LXHS2,NZ@!<Y^E%-7Y?K2AJ8"*YW5+3*1FVKQ2 <Z[L8H7Y:16+#FB
M@!VX49%,VTI.* !F/:G*<BF\&EH =3=GO3=QS4E !29I&YI!Q0 ^D#'=BDW4
MZ@!VZFM\U(U"T *.*7>,XI* O-(!](U(S;:%;-(!5I:*;SFF N*=NXI*3K2
M<#2TVC- !SFG4T4XT %*M)10 ^BBBD 4JTE% #Z*04M, '6G4VG4@"BBB@ H
MHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !3)H8[B,QRHLB-P5< @_A3Z* /2**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@!KC*\4RI::4'TI ,HI_E^]+M'I0!'4B@A:-H':EH *
M***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)M'H*6B@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH "=HS42S@L!C&:E(W BHEMP&!R30!+1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%8GB3Q?IWA>'=
M=R[IF&4MX^7;\.P]S19O8#:9EC4LQ"JHR6)P /6N#\0_$U%E:RT*+[?==#/C
M]TGN/7^7UKF=4U;5_&C9NW.GZ;G*VL1Y8?[7K^/Y5/:VL-C$(X(Q&OMU/U]:
MZ(T^X%1=)EOKHWNK7#7]VW]\_(OL!Z?I[5I\#I]*9NHW5N _=2;O>F9I-U,!
M^ZC=49:C=0(?NHW5'NJU:Z?+=<@;$_O-_2CU&0;N:O6NE238:3]VOZFM&UL(
MK7E1N?\ O-UIUS>Q6J_.W/\ ='6L^;L L-O';+A%QZGN:ANM2BM\@G>_]U:R
M[K5I)\JG[M/;K^=9%]JMOIZYF?#'HB\L?PIJ/<#5NM0EN<@G:G]T5DWFKP6<
M@BRTUPQPL,0W.3V&*;/9WC6ZW.KW2^'-.==R*XW74P_V(^HSZG ]S4%OK!LT
M:+P[9?V1$PVMJ-QA[R4'J0W1,^BX^M',N@)-DU[8RP1K+XAO?[$@8;ET^W&^
M\E'N/X,^K8^E01ZQ<1PO;:):+X?LG&UIE.^[F7_:D/(^@Q^-5;>QCAD,IW2S
ML<M-(=S$^N:M5&^YO&GW*MK80VF2BY<]9&Y8_C5JBBF;;!1112&%%%5)[^*&
M18ANEG8X6*,;F)],4Q7MN6ZJW6H06G#O\_9%Y8_A5N;1KBWA6;7;U/#]NPRM
MOCS+N0>R#E1[MBEM=4^P\>'M-731_P!!*^Q+=M[C^%,^P_&A:[&,JG83^Q=0
M:W6YU&:'PY8-RLMYDS2#_8B'S']/K3+>^L+%MVBZ6;VX[ZIK #?BD7W1[$[J
MB^P))<-<W4DE]=.<M-<,78G\:L,];*G_ #&#DV0WD-QJUP+C5KV;49NWF-A%
M]E7H!]./:I5"QJ%10BCH ,4QI*8SULDHZ(D>TE,9ZC9ZC:2F!(SU&SU&STQG
MH >STQFIC/5>:Y6'&3ECT4<DT 3L]2:7IM[XAN)(;!5$<0W3W<S;88%_O,QX
M'_UN]7%\.QZ?"EWXDF>P@<;H=-AYNKCTR/X%]V_ 4^]OKG6K>.U,*Z7HT1S%
MIMN3C_><]6;W/Z5SRJ7TB7&+D2)J$&EPRV'AQV9Y!LN]<D7;))ZI$/X5_4^U
M5[6UCLX@D0X[GN?<U*B+&H50%4< #C%.K,Z8Q40HHHIF@5\X?\%"/^36_$?_
M %]67_I0E?1]?.'_  4(_P"36_$?_7U9?^E"5G4^%DRV(?V._ACX.US]FOP/
M?:EX3T/4+V:VF,MS=:;#+(Y%Q* 69E)/  Y]*]8U;X"_#;7+"6RO? 7AR6WD
M&&"Z9"C#W5E4,I]P0:^'O@-KO[55K\(_#L/@'P[IMYX16*3^SYYY+(.Z^:^X
MD23*WW]W4#I65XL_::_:0M?&$'@/Q'JFF_#[5KX^6MU?6D5M%M;@,)R'4*2"
M-ZG /<&L5.*BKHCF5MCHOV7M/7X/?MU^+O ?ARXDN/#<RW5N\98N(UC431[C
MW:-LQY/]YO6OO7QEXVT+X>^';K7?$>J6^CZ3:C,MU<MA1GHH'5F/90"2> *\
M+_91_9'3X"W&I>)->U=?$7C758S'/>1[C%"C,'=49OF=G8 L[ $X' YSX3^V
MAXVT7QI^U)X-\!^,-8;1_ &BQQW6J,=^UI'5I&SL!;+((XU.,KO8\9-"O3CJ
M->ZCU6Z_X*7?"2WU(VJ6GB6Y@W8^VQ6$0B^N&E#X_P" ]Z^A?AM\5/"WQ=\.
MIK?A/5X=6L"=CF/*O$^,[)$8!D;V(]QQ7D&G_M0_LXZ5X;7P_:>(M#M]#$?E
M?V:FF2^05QC!3RL'@=QS7SA\$_'7A'X?_MP+I_PSU9+OX?\ BR/R9+6W618H
M96C9U55<#&V9/E./E20@'K3YVFKNX7L<_P#M-?M">$/%_P"U1\.O$^G37C:7
MX4O+6/4FDMRKJ8+XR2;%S\WRCCUK[;_X7?\ #SXE? G6_&MU!-J?@:-)([V&
M\L\F148!@8C]X9(KYG_:^T^UA_;5^!T:6T*12W6F^8BQ@!\ZD<Y'>OI#]K.U
MAL_V9?B#%;PQP1_V:Q"1J%'WE["E&Z<F"ZG1? 3Q%X)\4?#/3]1^'NGII?A>
M269;>VCMA;A6$C!SL'3+ GWKD/C%^V5\,_@KJTND:OJ5SJ>M0C,VFZ/")Y8<
MC(#L65%;_9+9Z''(KR[]F'QK)\.?V [OQ+!M^U:9;:I<6^X9'G"63R\^V\KF
MJ7_!.KX1Z3<> [SXE:Q:1ZKXHU;49A!J%X!+)#&C89E+9P[2>86;J>!]:YFT
MD@N]+'J'PE_;@^%_Q>UZWT6QO;[0]6N6V6UKK<"PF=LX"JZ.Z;CQA2P)S@ G
MBNY^-'Q[\*? 72].O_%<UW#;ZA,T$!M;<RDLJ[CD#H,5YS^U9^RGI/QVCTC4
M;"_M/"WB:RN-SZJMMODFAVGY&"E2S!@A4D\?-ZUX]_P4HT_5[/X/_#;^TQ-=
M,EVT+ZE+#Y(NY5MU#R*F3@,<G ) SC-$I2C%MB<K:'W)%?P2V<5UO"PRHKJ6
MXX(R*\YT[]H+PSKWQLD^%.FO,WBR.,RN;B/R[95$ G),A..$(/UXKNO#=WHN
MGZ)IC6=G)XBOA;1YN=0!2V0[1]V,'+?\"/X5\0Q33:O_ ,%3-7DORDDKVR;O
M+4(H TB(*  !@  #\*N3:M;J9NHWL3?\%$(+:S^,'P75-2CUF9;J0S+"A6%?
M](M\*K'&[//(%?67QN^/VF_![P?:ZKXMNI=)\/W%XMC'9:+;97S&1W 8#DC$
M;<DGM7R+_P %!D2/XL_!=44*HN9. /\ IXMZ[+_@IPV?@+H/_8RV_P#Z2W51
M\+F^QGN?5GAG4K'6]!T[5M.4BSU"VCNH6=<,8W4,N??!%<3JG[0GA'1_C!8?
M#.YFNQXHO45X8UMR82"C.,OT'"FM;X/-CX1^"/\ L!V/_I.E?(GQ _Y29^$#
M_P!.T7_I+-6TI-)-"/J7XJ?M">$?@WKOA[2/$<UW%>:ZY2S%O;F120R*=Q'3
MEUKS?X@?\%!/A1X!\23Z*9M5\03V\ABGN-%MHY8(V!P1O>1 V/5-PKQ#_@IA
MI\NL>./A;80/Y<UTMS!&Y_A9I8%!_,U]@>'?@?X$\,^!4\(6OAG37T3[/]GF
MAFMD9K@8P7D;&6<]2Q.<U-YRDXKH!B?\-8?#%?A;'X_;Q+$F@R2FV561OM/V
M@ $P>3C=Y@!!QC&#NSMYK@O!7_!0[X3^,O$D.CO)J^@-/((HKW6+6..V9B<#
M+I(Y0'CEP ,\D5\U_L)_!GP_XJ^-'C+^V[2/6-.\*NPLK*\'F1><\K(LK(?E
M8A8CU[D'J 1ZY_P4F\ ^'X_@_I/B&WTJTM-8M=6BMDNK>%4=H7CEW1L0.5RJ
MD9Z$<=3F.>;CSC/M,-2;JX3X&ZE/JOP5\ 7MU(9;FY\/Z?-+(W5G:VC+'\23
M7;[JZ5KJ(DW4;JCW4;J8B7=1NJM)=)"N7<*/<U>TO1-7UY/,L;%EML9-Y='R
MX0/7)ZCZ4FTMP(]_'I44=P;JX$%I#)>SMTBMT+G]*TFL?#NEMB_U";Q'>#_E
MTT[Y( ?>3N/<5+)XHU1K<VVG16_AVR/'E6*_O3_O2=<^XQ6?,^B*46PD\+W%
MG&)M>U*U\/PGD0Y\VX8>RBF0:II&F'.B:*U[<?\ 00U@[N?4(./QK,CLHED,
MC RS,<F20[F)]<FK"U.^YK&GW)-2O=1UYLZIJ$UTG40*=D0_X".*BAA2%=J(
MJ#_9%/I*$:\J0M%%%,H**** "G4VG+TH$PHJ%KI/,$:!II2<".(;B3Z5JQ^%
M]3DA$]\\&AVG_/2\8!S]%]?:E<GF2,]Y%C4LS!1ZDXHLX[K5I/+T^SFO&[E%
MPH^I[5>AF\/V<O\ H-I<^);M?^6T_P D /T_H:T'DU[6(Q'-=+IUIVM=/7RU
M ]-WI[4C)U'T*4WA^'30&U[68;$_\^=I^\F/L<=#4UK?6UG_ ,@/041NU]JI
MRY]PO8_A5JS\+VEG\RH!)W;JQ_X$>:TX8$MUPB@>_>EZF=VS(N-/U#6VW:I?
MSWBYSY6?*B'_  %>?UJ>RTN.T^1$5$)Y2-0H^IQUK2\P%MN>:6E<0B1I']U0
MOX42)YF,TV9BJ\41,60$T@'*H5<"D\Q=VW/-+D5&(@&SS0!+G\34,Q;'&<>U
M.=Q&N32QMYGW>: $CSM^;K2U(L)[\4D<.V3)R?K2N!&(06R!DU)Y97&>*GX%
M-8;NM #$5<9ZT_\ 2D "C I/,^;&* #YMU.HIDF2O%(!Y^;@]* ,=*9'E5YI
M=U #?.PV,4[--VC=FB1MHH 23YAQ0@PN#2*VX4M  &'K1@9SCFH_+._/;-24
MP$D;:/>D1MRTO!^E-W!?84@'U$5.[-1M>!6QCBG&4]ABF!-N &3Q3#(I[C%5
MYE,BXW8[TR)2@.><T6 L^8%Z"H&O&WX &,XH+#=C/-)@>E,"1F/<FHY%,BX'
M'>DD8JN138I"P.>U #HUV#'>E\P!L9YI-U1&'<Q.<"@":FR,=I(I2P5<G@4B
MR"3I0 R%BV<]/>GT?H*@DD99..?2@"5HPS;LTYB%Y/ HW4R1=RXS0 JR!NE&
MZF1Q[.^:&E5.#UH 25WW#''TJ0,<#/6DZ^]#9VG'7%  PW#FD6,)TID.[<<Y
MQ[U)F@!DDPC;&,TX-D TQHP_)ZTOW5]A0 K9VG'6HX=RGD8%*DH8XQBG4 +^
M-(R!NM0R!F88&14BYP,]<4 .)"KGL*8DVXXQBG'G@TT*%Z4 /W9J*52S<<T2
M2[3@#-.#94&@!5^Z,FBD8Y!'2HXU*MGM0!)M"\@4V23;C'6E9O?%(<-UYH <
MLFY0:&^Z1W-,/RK3(Y"S8(H =&I#9-2,P7J:;4<BEB,4 2'YO0BAOE4FFK\J
M@=:<&#=#F@"*.0LV#TJ6DX'05'(Q7&* '2(7P0:<HV*!FFJ25!/6AOF!]: %
M60,<4O ]JC2/#9S^5.R!UH 220C@<4J$[031FE[=,T@$/--6/:V<TR-V9^34
MM  SA>M*&W<]:BD7>P.<4Y<@4 .)[U'&S;OYTY9 QQWI<_A0 N:8PW?6F2L>
M,=*='G:,T /&%'M35E#'TI::L85LT 29J*1B2/2E9]M*K!AF@ 7(%/S3:B7<
M&[T 2^6%.:223;VI<TC*&ZT@!6W#.*6@#:/:F"09Z4P$VG=4NZF;O2AB=O%(
M!QH QTIJ>]+FF @?+8IU-XW9Q0[;<4@!E+8Q3H_E7!IJMN&:=0 NX=,\TW'.
M<<TSRSNS[T\GUH &;:*56)6CK10 4FVF[CNQ3Z #=ZF@-^5(R[J15VT 29IG
MF'=BC</6G<>G-(!:1OFI&8[:16)H <HVT;AG%)2;?FSF@"2FN3BE)Q0&!H 1
M<D4M%,).Z@!^WFG;@*;0>: %#9IU, Q2[Z #FG44UNG%2 [K0.*9'WI], +T
MY:9MI=V* %:A>]-#9IRT@'44WG-.H *<#3:5:8"T4F>:6D Y:6FTHZ4 +111
M0 X4M-!XIU !2KTI*5:0"T444 %%%%, HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /2**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HIKDXXIN32 DHHHI@%%%% !1110 44UFV
MTW<:0$E%-5MW%.I@%%%% !1110 4444 %%%% !112,=HS0 M%0F1CWIR2'.#
M2 DHHHI@%%%% !1110!$93VZ5(C;ES33$.QQ3E4*,"D M%%%, HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BHWF5>.I]J;]I'=32&344BL
M&&0<TM,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM LET*!AAKV4^9>2#_?_ (<^BX^M5K?3X;>1I3NEG8Y::4[F)]<U.SULJ?\
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M%[-8:K))(XA1'OU5PGR*N65!E,_,>K'BCE:<EW(<DFSQ?]GWPZ_C;_@GO?\
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MG@\4[..M Z4UOF&* ' AJ6FH-HQ2[AZT -W'=BGT4UC@4 .;YJ%XIJ$]Z=0
MI8#BEIFVG;L4@!NG%(K'O1NW44 .HVU&<[JDH &;'6@&@C- 7% "CK2<[J3=
M3QTH 6BD:A:0!C%&ZEI-M,!]#4?PT T@!:<O6DHH =BBBB@!1UIU,I_>@ HH
MHH 5:=35IU !2K24+UI .HHHH ****8!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >D4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !.*3=2D9I-M
M "T44UG]* '45'N/K1N/K2 DHI@<]Z?UH ****8!1110 4444 %)M'I2T4 %
M%%% !112;A0 M%%% #77-,J6BD R-3U/%/HHI@%%%% !1110 4444 %%%% !
M2,-RD4M% $!4CC%.C0YR:EHI %%%%, HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "F3,5C)'6GTV1=ZD4@*E%!!4X(P
M:*DH?"Q60>AXJU56%"S@CH*M52$PHHHIB"BBB@ HHHH **** "BBB@ HHHH
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MQ[5, %  &!6+;EN;QI]R&\6ZUFX%SJUW)?S#[JN<(@]%4< ?2I50(H50%4=
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M7-J+S4)(= T[&?M%\=K,/]E.I/Y9JU;ZAH6B-_Q(],;6KP?\Q+5!B('U2/\
MQY&*CF734=F4-'\+ZOKT/VBWMQ:V(&6OKUO*A ]<GJ/I5Z.'PSHK8S-XLU!>
MR?NK1#]>K?R-0:E<W_B";S=7OI;P@Y6'.V)/HHXIJ1K$H5%"J.@ Q4:O<U5-
M]2WJ&O:OK$(MYKA=/L ,"QT]?*C ]#CDU3@M8;5<1(%_G^=.S2]:#912%!S2
MTG-'-!0'-'-'-'- Q:*3/(I:!!14<UQ';KF1POH.Y_"KVGZ#JNKQ&:*!;&S
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MX' %38I@)NVCK2*X;H<TDB[EQFFQQE,Y- $G\JB>9O,P*<955MI/-+QUQS2
M*&4,,&FR,=IQ3(68YSTH DCCV9YS2-,JM@TO(J-H0S9)- $N[BFMG!^E(6"C
MGI2)*K].OO0 R)F9N>E2T5#.SY&W[OM0 ^1 W?FG#"K["FKG:,]:4C((/TH
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M+TIJMFG4 %*.M)2KUI .HHHI@*O6EIM.H 6A>M%"]: '4444@"BBBF 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'I%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 444C&@!:*;1DT@'4444P"BBB@ HHHH
M **** "BBB@ HHIK-CI0 ZBHJ*0#W;M3*9N(;GI3Z "BBB@ I5;;244 .\SV
MIX8-TJ*E7@C% $E%%%, HHHH **** "BBB@ ;D&H]I]*DHI "\ 4444P"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+R,$05FY=$.PEK9Q6<>R)<>I[GZU2U#7(K3*1_O9?T'UK)U+7I+HE(<Q1?\
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M)+W0-(<F..3Q/?C_ );7.8K1#[)]Y_QP/:L75-6O=<N//U*\EO)1T\QOE7V
MZ >PJOD#@# JN7N8.3EN:6K>(-1UY52]NB;9/]7:0@1PQ_1!Q_6J"[5& ,"F
M;O>CS*K1;$DF11D5%N%)N%,";=1NJ'<*-PH EWT;ZBW"C<* )=]&^HMPHW4
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M8"=6##--:95[YJHORYRQ)IIF ;'>F ][B5I,*-HS3F8MU)-,S3)BVSY?TIV
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M HQ3MP''>DIK*=U("0=:&.!3?K3N&H 16S3J, =*8S$&@ *'-/[44C#<,4
M.:DJ)5VT_=0 C,0U+FDH- !UXI57%(IYI] "9I:;MIU !2JV33:?2 *7%-[T
MZ@!: :04H&* %I3UINZI* $HH/2D6D ]5Q2T44 %*O6DI5.: '4444  I]-6
MG4@"E6DI5H 6BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!Z11110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%%( HHHH **** "BBBF 4444 %%%% !3:
M=2%:0"4448- "K2T44P"BBB@ HHHH **** "BBB@ J*I:B?Y>M( HIGF>U.!
MS0 C+GFE7[HI:?L&* &44[R_>E\OWH 914@4+2T 14Y5[FGX'I10 4444P"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** &O($Z]:1) _'>FRQECD41QE6R>*0$M%%%, HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "H9+C'"\^]/F;;&?RJK2 >9G_
M +U*MPR]>14=% %Q7#KD4M586VR#T/%6J "BBBF 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<OF9R.13]U,C01]*CDN-C$ 9I ))"S,2#4^X =:;G--D7<I ZTP'Y5QP012
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M%>N>%I+NZOEN'T749K,S!4@VAS&R[@,G&>F32;LKC/T!HHHIB"BBB@ HHHH
M**** "BBB@ HHHH **** "F2KNQ3Z* *_E^].CC/-2[!2T@$50M+113 ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%;..:BY(ZHYU+KQ^5+))L XI(V#KG'UI )$I5<&G[NV:/J:K>7(TG R<]13
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MW"D](Y1B-_[K*N2-K5^GF:<7= >*?LW_ +6WA#]J+_A(O^$5T[6]/_L/[/\
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MUS7+?3=:TWQ%X1%P1Y=YJEHA@P3@%C&[, 3WVD>I%'-%:#/HCXR_%C2/@?\
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M1TH 4<4NZA:-M "T^F=Z?0 4444 *M.I%I: "G4BTM( HHHH ****8!1110
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M@ HHH/2@!-U :DHI .HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
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M'AC7[@R>-O#<:PW#2GY[RU&%CGYY+#A']]K'[^*^F?#DG_%/:7DY/V2+_P!
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX^%GP9\1>'O[<C-GJFLZJ&5([=QB2(.R+'&&4X+,V2I("Y((^HOV>_V3]/\
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MH **** "BBB@ HHHH 1ONFH*L4QHPW(X-("*BG^4?:G+'MZ\T .0844M%%,
MHHHH **** "BBB@ HJ)W.<#@4W<1WQ2 GHIL;;EIU, HHHH #T.*JU:J*2')
MR/RI 144NUO0_E3EA+=>!0 RI8&/([4GD'UJ1$""@!U%%%, HHHH **** "B
MBB@ HHHH **** "HV@'8XJ2B@!B1A>>II]%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 444UI%3J: '45&MPA;'3ZU)2 ****
M8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM.I"H8Y-*3B@ ;)I(U*Y)H5LTM "[J-H/)II!S3Z  G:*5&W4+AO<4JJ%Z4
M+3&4YI6;!IP.10 #@4<4'FA5.: '**:S'-.W"EH ***13S0 JKCFG4M(1F@
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M(F!UIL"&,'/>EBF\X'C&.U/YH 3<,XSS2$#=G'/KBH'MW:0GL3UJPS!>IQ3
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M^E/:0)U- $<TA1@!P*DC;<H/3-+D$>HII;B@!Q_2HDA"-G.:;&[L_/3O4W-
M \@C&32+()%R*;(GF+CI1&GEK@4@'\U77S/-P<^_I4BS+NQ3]U,!>:CD4.,&
MF3%MHQ^E+'NV\T .50JX%,68%L5)S4:Q*K9 YH ES44VYE '3O2R2"-<TJ.)
M%R* $C!5,&G9-)405O,SC'- $GEC=GO2N^P9ZT4?>7U!I "L&&110JA1@5$;
MCYL8XZ9H /+8R\],U-TYINZF3 LHQS0 ]L,,8S0.,4R)2J\TZ@!OG?-@#CI4
ME1^6-V<<TK/M7)H ),LN!38E*J<]Z=&^\=.?2EH =NIFT;LXYJ-HV,F>V:EH
M 1VVJ321L7SFG=<YH V]!B@!<G%1,C>9^/6CSCYF.V<5)0 $@=>*0$,/6DD7
M<N!UZTV)2N<T 2 8Z5&92K>U2;ATSS1M&<XY^E !377>N*61MJY%-CD+9R*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"WYGFM:BH<F]V 4444@"BBB@ HHHH ****0!1110 4444 %%)NI* %W4E%%
M'FGQDT=Y8;/4D4LD>89?8$Y4_GG\Q7C4L9B<J?PKZIO+.'4+66VN(Q+#*I5T
M;N#7A_CCX>W/A^5YHU:YTTG*3 9,?LWI]>AKIIRZ,#@Z*EDM7CS_ !#U%15T
M %%%% !12$TV@5QQ-)244 %%%% PHHHH **** "CFDW4E KADT444""BBB@
MHHHH **** "BBB@=@HHHH&%%%% !132:2@5Q2:2BB@#T;P_);^+/"=AI,=[;
MV.L:9/));QW3;8[A'Y(W?W@?\^EUO!OBJ-BK:"[_ .U'<1E3[CFO+ Q'0XJ=
M+^XC4*LSJHZ ,0*SY7T+4G'8],_X0SQ/MWS:?;Z?'_STN[N,#]#FJ\FBV%GD
MZKXOL8L=8=+C:X8^V[M7GL:W-\V[+.>[M_C6SI'AF?4)MD43W4@Y./NK[D]
M/K2Y7U8<TF=$NL>%+%LV&C7>MSC_ )>-6GVH#_N+P1[&K8\7^(-6C^S6;II]
MJ.D&GQB"-?Q'/Z_A3M-\)01L%G=;J4?\LXR1&OU/4_AC\:ZBUTZ*W5<JI*C
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ML>2.M-EFV8&,FG\=ZB>-7;)S^= $BG<H/K0X)0@<&FEQ&N3P!3$N-[8QCTH
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M+5MONFJ5(!ZS,N/2K$<@D7(JI4UM]YJ )Z***8!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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G %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>mrna-20201231_g23.jpg
<TEXT>
begin 644 mrna-20201231_g23.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ) !0 # 2(  A$! Q$!_\0
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MHP# X[<&K2L& (.0>XH::=F)--70M%%%(84444 %%%% !1110 4444 %%%%
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MKG4O3\(23_%I_(\:\$_L[> ?@GX-NO'%M\2/$PO#H$TEQJUUK3W<95H\O<K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP.]4IOVN+:^^"OA_Q+I.B27/C/Q',^FZ3X9W[GEO48I(-P_Y9(027Z8%/_:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ#7I- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]$O3;;U8)6V.>_9N_P"2"^ _^P1!_P"@UZ37FW[-W_)!? ?_ &"(/_0:])I
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M'1E"1<A=Q4G..*^E@ H ' %5=5U2#1=-N;^Z,@MK>,R2&*-I&V@9.%4%F/L
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR><X]J] T'23H6CVFGF^O-2-N@3[7?R"2>7_ &G8 9/X"LXZ0:>_,W]ZBO\
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M5G._96_&_P#P_KY'B_B[Q!/\??AWXO\ !VEZ)XD\,7^H:9+##>ZUIQMH=S#
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MDF*&=UC_ "7 _"K6E_"W0?V=/"_B[Q;:S:WXJ\27-I^_U+5)S>7USL7$4*X
MPN2, #WK;_9I^']Y\-_@[HFFZHFS6;GS-1U!3U6XG<RNI_W2VW\*5.T4X]E^
M+E*2^Y-KY^8YZV?=_@HJ+^]V_I'J-%%%( HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8RRRR-T!/1!_M,0!76UR?Q0^)FA_"/P7J'B;Q!<BWL;1>$'WYI#PD:#NS'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]U71+._NS>2(9IX]S8&,"O9O^%->!_\ H5]-_P"_(JM!'#?L@_\ )'8,'/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTP7)!F$18[R.!G)-=%114%!1110 4444 %%%% !1110 4444 %%%% !1110
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MHQG;=?U?S,>7EE*/9A1114%!1110 5R_Q2_Y)CXO_P"P/>?^B7KJ*Y?XI?\
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M-14W'8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$O3;;=V"TT1SW[-W_)!? ?\ V"(/_0:])KS;]F[_ )(+X#_[!$'_ *#7I-(
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /-/C5X7U_Q-<>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5\2?&;Q)\6_$?[36L>#+'XMVOPET6.PANM%6:TA==27&)2'D4
MC<K9R,CC'%?;=?F/^TE)\(M/_;)\5'XM:!K_ (PT>ZL+<026(N%_LR94&441
MNN]&!!SG@YXK-_Q(I^?Y&L?@FUY?FC[%_9K\+^./#LFMGQA\7K;XHB7R_LZV
M\,,?V3'7/E@9S[U[G7RI^Q%-\#)IO%/_  IOP[K6A./*_M$ZL+@>9_<V^;(_
MZ8KZKKHGT]#GCN_4****S+"BBB@ KE_BE_R3'Q?_ -@>\_\ 1+UU%<O\4O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** .;\9Q>%Y9- _X29;)G75(6TO[9C(ON?*,?
M^W]['XUTE<+\4OAO)\1)O!SQWJV?]@^(+76F#)N\T0[OW8]"=W7VKNJ "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KD?BG\1(/A;X-N?$-S937\4$D<9@A8*QWL%SD\
M=ZZUF"*2Q"CU)KQ#]K[4HH?@]-;8+->74*QLN,#:P8Y_ 4P-GXJ?&BY\$_"/
M3?&FFZ;%<O?&W9;6[D("K*A;DKW%>>_M>:P^J?"[PE(\:HUY<QW3;3PI\DG
M]OF_2O,_B=\<M(\:_!G0_!MG97D-Y9K;":XF"B/]U'M.W!).35#XC?$KQ#\5
MO"6@Z9_PB\UM:Z<J^7<P!Y/.P@3/W?:J2)'_ !9^*7B+XP:1HMG-X5GL8;!S
M(DL$4K^9E0O=>F.:]9T3]C+PYJ&BV-U+K&I0S7%O'(Z!4&UF4$C&/4U[[X)5
MX_!^BI(K*ZV<0*L.1\HXK;I7[#(+"T73[&WM58LL,:QAFZD  9_2IZ**D844
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/_1+TVV]6"TV.>_9N_Y(+X#_ .P1!_Z#7I->;?LW?\D%\!_]@B#_ -!KTFD
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'FOQIU3Q)IEQX
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MIX3TG1WF%P]C;) 95& VT8SBMJI*"BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%T?Q19ZK>^9,8_\ 1X]^_']X_,/E[UZ30 4444 %%%% !1110 4444 %%%%
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M:RWE_HND67E6<UQ*-B $EB)"Q#GYN0AXK]1J >X4444""BBB@ HHHH ****
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M-M'MWXZ9^F370444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5#*';>WNH0U]DT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCNNO+\^PE6IO9]+_ ".ZHKQ[PY\:=4UK]G^^\?2Z?9QZE;PSRK:(S^23&Y4
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MYOF\K/3II\PGC>7VEFO=2MYGT!XJ^)'AOP3H]EJFMZFMC87KJEO,T;L'9EW
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MRY<9;+')^4=,5\Y?#KXO>(_A[XI\5:U%X/O+Q]>N//>)K>91%\[M@';S]_\
M2D^%/Q<\2?"NY\130>$+R^.LW?VIQ);S+Y9RQP,+S][]**V5MJK[.*U4>75;
MZ<P4\=9PYI/K?3[CZ/\ AG\6-7\9?%?QUX9O;>SCL-#EV6TD",)&&\K\Y+$'
M@=@*3X,?%C6/B'XM\<:9J5O9PV^B7GV>V:V1@S+OD7+Y8Y.$'3'>OG+P/\7?
M$?@KQ]XJ\41^$+RYEUZ3>]NUO,!%\Y; .WGK1\-?B]XC^''B#Q1JL/@^\O'U
MVY^T/&]O,HB.YVP/EY^_^E%7*VU4Y(*]HVU6^G-^HX8[6'-)[N^G3H?0OP1^
M,&J?$BS\:2ZU#9VL6C7;01M:HPS& ^2V6.3\O:O&OV=_BKX6\#_#_P 6:;K>
MK+8WM[=3/!$T3MO4Q!0<JI Y&.:Y3X<_%#Q)\.=/\56UOX2N[PZ[,TS-);S
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M&U\=WEO)X=U5M)G:6_GQ)((HY-RX/3$@'/H:+ ?:5%?+/_#-_P 4O^BAS?\
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MJ** "N*^*7PUC^)MCX?MI+U[$:3K=IK(9$#>88&)"'/0'/6NUKY?\06_B/\
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M%% !7SQ^T(OC+5OB)X FT'X>ZSK]AX;U8:G<7MK=6<:2H89$V1B296+ L.H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BDKX"^'_B;X_?'SXQ?%K2/#GQ;C\+:;X6UF2TMK6;2()PR;V"KNVYP
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+Y@U")7S]KN+O;N8D<X4\DU^K]%2[M13>U_S37W;>:\]2XRY6VEO;\%9_?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
+!1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>mrna-20201231_g24.jpg
<TEXT>
begin 644 mrna-20201231_g24.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $: IP# 2(  A$! Q$!_\0
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M2CYL8Z>M%,9MJ@LPX;&YABN@L7=M4G##GTR:=SSZ8Z4@X9NG/OR:.3@\CVH
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M2;CNC)+*&&"I7G/N>U,RJ72L!&AE7N,2-CM] *:FY84PC J^-D4F[\R>WM3
M=&8H8W6!8U"-\RKA0#WSBI/,+2;51MA7(EX*_3K3#RTRDDJ5R Z?(/\ 'Z4U
M?);[/-B,G&U'^[U[ >] #5E!C@E9L8;:7EBPYY[#MFN2DD^R7%W"4"OYC,R
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MF6[194\[G)89+GH.O %2^;H/2PS1_P!IC1M>TSX83:)H=[JD_CNQN]46QM9
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M'S8&>,YJZ=*=5M05[&%;$4L.E*K*UW9>N_Y(]0$(JO=O!9PO/=30VT"=99I
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ML&F0,/\ GI>R8CX/7R][>U9WQ:_9KAU'3&\7^+-3O_B#K-LH;4[2]1(;-[4
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M*F"'3&_>>G487I^-+M/V@D!R"GWMPV#\/6F3,5$4FY8\-M8R(2Q!XP,=,FH
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M6M[0S:?9RW"JW1F53M'TW8KYT^&OB#QA=>'X?%EYJUQ<W5Q?R6UM>2S.5,B
M$P3)G88Y,L%P 5*^I%>P?M'7@LO@GXCP<&988![[YD&/RS5+X!^$K77?V>--
MTV\!6'41<3,R\,K&9BCKZ%2JL#Z@5@4>G^$_$%MXLT.SU2V!C2=?FB8_-$X)
M#QM[JP(/TKYB_9WT>W^('Q&^)-QJ"^;#=12HS]U\VY9@P/8CRU(/8@5U^@>,
M+_X2ZOK5AJ\,CQ^6TEQ' A8B0*0EU$HY:.0 !L<J0,]&JE^Q+HTZ^'?$VLRQ
MD"\NH[=&/\7EJ2^/^!28_ U[M*FZ&$KS_F44GZN__MI\GB*RQ>882DMX.;DN
MUH\OX\VGD;/@'Q#<_#WQM>:1K+B.&YF6WNY.B+/@"&Y'HDJX4GL=OH:Y'7E_
MM[]M;3H4^=;'R<XZ#R[9G/ZN*]R^(WPRM_'5ND\$T=KJL4;1+-(F^*:,\F*4
M=USTQRI)(ZD'DOA7\ 9O!/C;4/%>L:FNHZG<0F&*)7>00[MH8F1\,QVJJC@8
M&>M8JM0G&=2?Q.-K>>FOZO\ X)TRP^+ISI4:7\.,T[WVC9WBUOO9+R]#:^+W
MP^D\3V*:A86XN=3MHVBDM^!]LMSRT>>S@_,A]<CC=6%\-?BI%JDMMX:U8W,F
ML)F**X\EB954=)QC,4@ P2P ;&0<G%>R2(>N.> 3_GM565!ENS-U8=3[^]>0
M?1F1<1C!#*"",%6&01Z?2OEVVM/^%;_%!; 92TMKK^SAD];&ZS):D_[DH*5]
M4W&.AKYS_:1TLPZS:7\0VR7FE7,61U,MLZW$1^H^<5K3>MB9=SO"ICADP95Y
M)S]YCSV%.5#YI?"A6 XV_-^)J*QNH]0L[:]7&;J%)@?4,H/]:G;/'WNO:M;
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M9A65K6VA0JC DD(,@Y[>U:;+NF9'RZ,N=I3Y1]3W/M71)DVL2K&#()-[$8P
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M[2"K!=I!''?-9_B#X+W]]IWBV72]971M7U35;'6-%O&M-YTRXMK:&",LH(#
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MB3>.])#.D4TEQ(#@+:H9&;Z 4\ZMK5PWFVGAZ]%L5X>\06Z9]=[D<>U5R2[
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MN;8&'IO@G1-)8-!81F3_ )Z2#>Q]\FMQ5"* H"CT Q114/WMP"BBBD 4444
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M^E+(?E=0!G;GY@=OXFH_+1H9HE5,*V=D;;??DCH:E\QO,51&S*1DN"-H]NM
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MU_-O\*ZO)HR:SYF:<IRG_"?^&_\ H-6OYM_A1_PG_AO_ *#5K^;?X5U:[F8
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M"CW)K"A\076IK+%HEHM\L1/F7CXAM81G^)V.*TBK[&9O37$<,;R2,(D3J\G
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M=3YX)EV1J.V$7 'N:R<2+,)7WROCALDD?G5VSTZ6_D?RY%AACQYDD@R%ST
MY9CZ"MB/PW;[1G[7(>[%TC_3!_G3LD6DC/TJW75VF-R6EAAVKY;,06=B0H)Z
M@<$G'IBMX:';J@'V2SX'> G]=V:@MM&6QD:2#[4K.NQU9HY$<=<%2HS_ #K(
M\6^)H_#-IP('OW_U-JUJS%^V?]80!^'-1*:BN:6QT8>A4Q-14J4;R9!XRUK2
MO!]AYYM+2XOW^6VMH]Y+MTR5W$8'T]JS/ ?@&[LYYO$.NVJR:S>?,%N(5 MU
M/8!R &(]N!QZU!HO@C4=4U :[KM[&-1?#1V_DNH@';A5P#Z =/K70WFCV&FV
M[76HWLGECJRPA=WL"Y))^@KF2]H_:5-$ME^K/>K588.D\!@O>G/2<EK?^Y'R
M[OKZ&^MPD;!IGC9U&%::YBPOL &P/P%<9XL^(,\EP-(\.F.^U&7Y6FA;='#Z
MY<C!/TX'Z5GM#/XP+0:7:)I&E9Q)J%RV^5QZ G _!1]37;>&_#>G>&[39I]M
M),W_ "TNF7+/[ESP![=*IRE5TAHN_P#D1"A0RW]YB[3J=(=%_C?_ +;OW,'P
MC\-;71I#?WF-5UB7YI+RZ7,:'N(T/7_>;KZ5VC@V\))N)$ X 7 &?0*!C\,5
M"MXT^X0LLA7J+?\ >[?JW"+^+5'"LKN7$C;^@:%@6'TD(PO_  !<^];0A&$;
M11X^*Q57&575K.[?]62Z+R':/HOAV36GN=5U2WTTV[QL;./";Y0H+<C[HSV'
M?->MV.L6FK9DLKN&Z7//DN&Q^5>/1^'[2,?\>5M_VT,DA_$EA_*GKIL.GR"Z
MBACMI8^1-9,T,B_0Y(/T(P:'%G Z;>I[9163X6U*XU/2%DNB&N(Y'@>15VAR
MIQNQVR.H]<UK5!@%%&ZF,U1S=A"-(=P '%!:FEJ:32 <6II--+4W)IVT <S4
MQFI.?2FDT@%W4W=36;UIK-0 XM3"U)S36;\*0"DTUFV\DX%-9NXJN',RL#Q[
MU25P+&[//:F%J8/E4#TI":0"23;6 Q2[JCD&74]J-U/E RV)C\M1YA&<?+S_
M -]'TJ+"N;B+".?O[3&0HXSR>_3-,;#K<1 1N58$1QRE6YY^8]LUYG\0;=_&
M7QB\+>"=2OKZR\.76B7VJ-:Z?>R6CZE=130QB%I8F60I&DC2%%89)!.0M06>
MH(?,:&4!9-RX\Q7^7\!WS3HR5BD.V;"L>6&XGGM[5\^WOQ*O? %QIO@7P;JU
MWXZNHGU2:34]0L9M6ELA;21+]A/E.C2%&G53,S$JH .YJPM'^(6O>+?BUHMQ
M))?:1%J>IZ/)+H\=]N$/F:#>RR0@@[2ID56ST)53UHN!]/;0+AUS& R9*!<,
M3TR3Z=JCC9ECA"P[L-M80R#:GU)ZT^%I5A@9TDC.,-#D.0?5C[>M-DSY,Z)Y
M1(.0K@JH[\GOZTQ#F9_WX5G4XRKR)E%X[8Y-212*T<;[L[@,,1MS^':D55=D
MD)!;;@%6.,'VK%U'Q%!8^5:QR7$]^SX2WC02S2<],#IFJBF]B35\R01S;HL%
M6X6.0,S#UYQCZ5F7GB1&U#^S].@FU>_=>+2V3<%]2S= /KQ6;=V]Q>7!BU:1
M[:24Y_L32,/=/_UVD'RQ_CD^PKJ='\#75U9BWN5CT+26Y.F:>3NE_P"NTOWG
M/U./:ME34=9?U_F!S#6<FJ7 @U.5M9O%.!H^COMMXS_TVG'\ES]:Z^P\"W&H
M6T<6KR16]@ARFCZ>/*MU_P!['+GW))KJM,TFST>V6WLK=+>)?X4'\ZMU3GV
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MUT2UPGEP@%AE4&[GL.I]A2>HUN:'_"?7O_0L7HZ?\O$?_/3;Z_W/WGTXI/\
MA8%Y_P!"S>D_]=X_^>FWU_N?O/IQ7.?\)!)M_P"0-J'_ '[C_P">FSU]/G_W
M?>C_ (2"7!/]C:A_W[C_ .>FSU]/G_W?>CE\C0Z1O']Z,X\,7IZX_?Q\XDVC
MOW3Y_IQ7F?BK5/'UKKVJ7_A714@FU'=']INI$=[= R@%1G&6"AAP<#'>NH/B
M"49/]C:@<9/$<?:39Z]Q\_\ N^](_B"1"2-&U!MN[_EG'SB0)Z]P=X_V1ZUM
M2G[*5^5/UU1R8G#+%0Y')Q\UH^V_HVORU/-_#ND&WT.,7$SWEW=$W-S=2G+2
MRO\ ,S$_4_I6)XA\.;E8A<UJWVG:O_:FHV=K?RZ1"LSM;P7%LC/Y)8[60]US
MD#TXKF-6\.Z]'-YA\0WMP5_Y9SQQM$?^ @"OY(SNC-8NJL5_$YG=VZW_ "?0
M_H+*90CAZ<</\%E97Z6\S@?$7AL_-\GZ5O\ [,NJ7G@OXJ3M:VDM\MWI\T;V
M<3!3*5VNO)X&"#1J5Q?Q@I/8VLO^W"6C)_ Y_G74?!'2;RTUR]\1RZ-<RV:V
MKPVIMU5O,?<H?!..W ['YO2NWA&G7K9M1A2U2=WY);_Y&?$#I0P%6531M67J
M]O\ ,^D)OB!>IYOE^&+V7;YFS$\8W[2 F.?XP21Z;:63X@7B^9L\,7LFWS-N
M+B/Y]K )CG^($D>FTUS<OB"6+S/^)-J$FSS,;8X_GV$ 8Y_BSD>P-+-X@DC$
MA&BZ@^SS" L<?S;6 &.?XLY'LIK^I.7R/PPZ.;Q_>IYWE^&;R7;YFS$\8W[2
MNS'/\8)(]-M$WQ O(_-\OPS>2[?,V8N(QYFW&S'/\>3CTVFN;D\020^81HNH
M2>7YA^2./Y]A &.?XLY'T-$WB"2'S,:+J$GE^9@I''\^S&,<_P 6>/\ =.:.
M5=@-[PWK$FM>-->FDL9;$1VUM$@E=6,BAI<.,= <]/:NLKAO MXUWXJU_=;3
M6WEP6\8\X*-^&D^9<=C_ $KN:$0]PHI>O2J;:Q8+=?9FOK5;CIY1F4-],9IB
M+4DBQPN9&58E!+%S\H'<FO+?%&K>#]0+?\2:XD=NE[9JL!^HR1N'U&#5_P")
MGCH6<4FBZ?)')<3(5N91AA$A&-H[;B/R%><Z3HXO_P![.\SP!O+2-7PTK #/
M/90,9/O@5274UC%VN7O#]];+:K"LBB2*21O+F98V<$C#C/!.!@C/&/>M;^TH
MNF/_ !]/\:H7-Q8Z+&1MMX7 XBMX59OQ9LG\S65-;ZEX@C)GF.F:8W7?@,X_
M(?X4I5%'1:L]:A@YU%SS?+'N_P!%N_D)KWCU;>8V.F+%/?,=N]I4,<?OG.#_
M "JOX?T>RTNZ?4]2U*QOM58[C-)<;A'], \^_P"57;.XM-'5K718IKJ5OO%%
M#9]R=N?Y"DFTV_U)E_MB^\B('Y;<S)&?R'/Z&N?64N9^\_P1[4FJ%)TH/V4'
MNWK.7RZ+RV[AJ'CAY)?LVCQ'5;HC_EWAD=5_,#/\JS8?"^H:C=&\U^'SY?X(
M;JZ6"-?^ K\Q^@Q6KHNK:!=75WIVC:C;ZC>6O_'S:Z:YN98NW[P;ACG^]6C-
M,+)3)) EFF0#)>WD5N,DX'"Y/)('7O6JIN>M1W\NAYOUY8=.&#7+?>3^)_/I
MZ+[QMK;3QJH2:&TC48"V%GT'IYDO3\!4C6MM+(#.1<R?WKR9KEOP7A1^1I9&
M,,4DT\EM!#&"SR+ 7"*.I,DS  #UQ5F.*9T'[VX9<9&;G8I'TB5?YUN>/K)W
M)/+\Q5W1W-PJ_='DML'T4  ?E3FN?+ZQ.H_VRJ?S(J!M-63[Z0GW96D/YNQI
M\>EQJWR!0?\ 9AC'_LM5J&I)#+)=MM@\J1O[L;&9OR0'^=0SWEII]]Y=]<M#
M*AY C$DB'VC7(#>[MQZ58@:?2[@SVS>7,BEO,B0(X/96VX#!CQ@COQ4R_"F<
MS2%=06*!FW!98]T@SSR0<$U#N3*5MSKO"/C'0M0,6E:<9X940E(KB,JSXY8Y
M[GJ37337$</^LD2/_>.*XS0/ EAH4_VCS)KB\VE1*QVA0>H '2NACMHHCE8U
M!]<9/YU'*<S\BRVIP<A"TW_7-"?UZ5#)>S28$=NP'J[!?\:=2[3Z4<J$,\^Z
M;'$*?FW^%,_TAC\UQC_<C _GFIMIXIC2*H)9@OUIV0##"6QF>8_\" _D*/LL
M9ZM(W^](W^-,:[C[.#_N\_RJ*2^5?[WXC'\Z8$WV6W_N9^K$_P!:1K>WQ_JE
M/UJJ;X=L'_@0_IFF_:R<]OP/^%(99,%OC_4Q_E33!;_\\E_*JQN&/?\ )?\
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M&PTE4,4* DGYQGGDG..O<D<5Z[16U.M.FFH.U_Z^7R.6MA:.(E&56-^7;?\
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M5;?J>9'"1CCY8Y2^*"BU;=IW3;\EH2T5']A\1?\ 0OG_ ,#HJ/L/B+_H7_\
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M^-)#JKMG-K/_ -\__7HLQW1K;CV:,_5F_P *8RO)C+Q8[ -BJ(U3UMIQ_P
M)IRZK&"-T<R_6-_\*6H:%Y89/0-]&!_K2^7)_<;\JI?VQ:?Q2A?]X8_G4@U.
MT;D3Q?\ ?8I:B-_2?!6GZ7<-=RB34=08Y>\O&\QR?QK?HHJVV]R0HHHI %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!YE\1OVEOAM\)?$3Z%XK\
M2#2M4CMH;V6'['<2K#;RR&-)I'CC94CW@@LQ !(SU%<)\3/VR/#^A^ 8=?\
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MEW4@)]W2G!\=_P!:K^92AJ0%CS">_'UI,(>J*3[@5&&IP:@9Z11110(****
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M1?\ V,:[L_LS^V/-AV^=YG[OS/L_F^7OX_UFWFDW89[DK+(BNC*Z, RLI!#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3/44[;3?X:=#_']:0$@_.GJOK2+4JT@&PVXC);.2:LJM-6IEI/8!56G444)
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>mrna-20201231_g25.jpg
<TEXT>
begin 644 mrna-20201231_g25.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &  J # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_(U?55% 'RK_P /1OV8O^BF?^4#5/\ Y&H_X>C?LQ?]%,_\H&J?_(U?55%
M'RK_ ,/1OV8O^BF?^4#5/_D:C_AZ-^S%_P!%,_\ *!JG_P C5]544 ?*O_#T
M;]F+_HIG_E U3_Y&H_X>C?LQ?]%,_P#*!JG_ ,C5]544 ?*O_#T;]F+_ **9
M_P"4#5/_ )&H_P"'HW[,7_13/_*!JG_R-7U510!\J_\ #T;]F+_HIG_E U3_
M .1J/^'HW[,7_13/_*!JG_R-7U510!\J_P##T;]F+_HIG_E U3_Y&H_X>C?L
MQ?\ 13/_ "@:I_\ (U?55% 'RK_P]&_9B_Z*9_Y0-4_^1J/^'HW[,7_13/\
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M;]F+_HIG_E U3_Y&KZJHH ^5?^'HW[,7_13/_*!JG_R-1_P]&_9B_P"BF?\
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ME>)K*6&SMFVD1L2DOFD*8F$C!\D ^4[?_A1/_#S_ .%W_"I_^1S_ +:\6_\
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M_P#VWKZJKY5_8%_YN-_[+-XC_P#;>OJJ@ HHHH **** "BBB@ HHHH ****
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MVEE>^KO^7SV&HX^./J3JSO3UTOWMRV5ERV5[N[O^6Q1117M'T(4444 %%%%
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MMNJ84445]6?-!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]5M?$[3I ;5Y!-'-$\*EMZ2@G!&"*]>^#_P6T[X;_ WP;\.M46U\26^@V-I
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\J_L"_P#-QO\
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MX[F5#)+# DDJ;8%61VGC(*G& #LOVUO^%$_\*KTK_AH/_D3/[:B^R?\ '_\
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MG8LW(QQDU\-B*3J8V&)]G+W5V71Z6U];GYOBJ+K9C3Q?LYVBNRZ/2VO76_\
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MQBVVM=[:[NR=OA^S9G;4445^N'Y>%%%% !1110 4444 %%%% !1110 4444
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MR\/^+?L/_"5_:_["U2"]^S[]+39YGE.VW=L?&<9VMCH:^U: .(^,7_(E1_\
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M*O[ O_-QO_99O$?_ +;U]55\J_L"_P#-QO\ V6;Q'_[;U]54 %%%% !1110
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M.HZEIT4C%U5?,DC#AC&&8;MH)QP,G&:]5HH _.K_ (+5^$]#_P"%!>%O$_\
M8VG_ /"2?\)-:Z;_ &Q]E3[9]E^RWTGV?SL;_*W_ #[,[=W.,U[7_P $N/\
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MQO\ O57_ !/\PHHHKN.,**** "BBB@ HHHH **** "BBB@#Y5_8%_P";C?\
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MPT'_ ,B9_;47V3_C_P#^/_R)]G_'E^\_U7G]?E]>=M<K_P $N/\ DQ/X9?\
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MBMKHR1&(BYC!Q,%#;E#?=8 BOFSP7X:CT]FUE;[4)Y=2L;.-K2XNF>V@$49
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MIMWI=E=:?JBR)?VDUNCQ7:R)LD$J$8<,ORD,#D<'BM*B@#\2_P!E/2;'0?\
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M\$UG9'0[[5;6RNI[FX7<T5K>6I6606TH#ER,(!MXW+^HE?.'BO\ Y.F\8_\
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M>#O^Q,\0_P#I=HE 'T?7RK^WU_S;E_V6;PY_[<5]55\J_M]?\VY?]EF\.?\
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M1ZU%--%X*\8P>&+P0""<,SW4T<BO%N:,&(#)8HV<(<\K_P $N/\ DQ/X9?\
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MC+,?WG  !)/8"O%]A6_D?W,]CVU+^9?>?9M%>5?\-8_!#_HLGP__ /"HL?\
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M_P#A+V/_ ,:KU6B@#RK_ (9.^"'_ $1OX?\ _A+V/_QJC_AD[X(?]$;^'_\
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MQ_\ C5'_  R=\$/^B-_#_P#\)>Q_^-5ZK10!Y5_PR=\$/^B-_#__ ,)>Q_\
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MI Y4X^W:Y3X>_#?3/AKI.I:=ID]W/!?ZE=:I*UU(I<2SR%W"E57"@GCN!W-
M'RI\)O'U[J?CKX'(_C77=0\1:K<:L?%FDW&I3/%'=);R$12VY8I!L8';$ HP
M P7O7VM7F?AKX#Z?H/B?2-;OO$OB3Q1/HOVDZ5#K]Y'<K9&?B0K((UED.TE
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M >@45Y__ ,,__#C_ *$O1_\ P&6C_AG_ .''_0EZ/_X#+0!Z!17G_P#PS_\
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M=F=)\0W6H6^O2VR2N(([:58C=6[;N(LL9#N#?*,9!YH ]S_X0SQW_P!%&_\
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M0\/Z-J!TJRU#3-.FLGNKB+_CY)1[B8>6C$("#\Q#'H!D V_^$,\=_P#11O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD6,%E86L-E9VZ".&WMXQ''&HX"JH& !Z"K-%% !1110 4444 %%%% !1110
64444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>mrna-20201231_g26.jpg
<TEXT>
begin 644 mrna-20201231_g26.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^%0@FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI
M2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN
M<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0($-O<F4@-2XV+6,Q-#,@-SDN
M,38Q,S4V+" R,#$W+S Y+S W+3 Q.C$Q.C(R(" @(" @(" B/@H@(" \<F1F
M.E)$1B!X;6QN<SIR9&8](FAT=' Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M
M<F1F+7-Y;G1A>"UN<R,B/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G
M+V1C+V5L96UE;G1S+S$N,2\B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z
M>&UP1TEM9STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(*
M(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @
M(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(@H@(" @(" @(" @("!X;6QN<SII
M;&QU<W1R871O<CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]I;&QU<W1R871O<B\Q
M+C O(@H@(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC
M;VTO<&1F+S$N,R\B/@H@(" @(" @(" \9&,Z9F]R;6%T/FEM86=E+VIP96<\
M+V1C.F9O<FUA=#X*(" @(" @(" @/&1C.G1I=&QE/@H@(" @(" @(" @(" \
M<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB>"UD
M969A=6QT(CY%;GIY;6%T:6-297-T;W)A=&EO;E]-3T%?9FEG=7)E<U]F;W)7
M;W)D7S(P,3@P-S,P/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*
M(" @(" @(" @/"]D8SIT:71L93X*(" @(" @(" @/'AM<#I-971A9&%T841A
M=&4^,C Q."TP-RTS,50Q,SHS,SHS-2TP-SHP,#PO>&UP.DUE=&%D871A1&%T
M93X*(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P,3@M,#<M,S%4,C Z,S8Z
M-#5:/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&5$871E
M/C(P,3@M,#<M,S%4,3,Z,S,Z,S(M,#<Z,# \+WAM<#I#<F5A=&5$871E/@H@
M(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E($EL;'5S=')A=&]R($-#
M(#(R+C$@*%=I;F1O=W,I/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(" @(#QX
M;7 Z5&AU;6)N86EL<SX*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" \>&UP1TEM9SIW:61T:#XR-38\+WAM<$=);6<Z=VED
M=&@^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.FAE:6=H=#XQ-3(\+WAM
M<$=);6<Z:&5I9VAT/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIF;W)M
M870^2E!%1SPO>&UP1TEM9SIF;W)M870^"B @(" @(" @(" @(" @(" @(#QX
M;7!'26UG.FEM86=E/B\Y:B\T04%14VM:2E)G04)!9T5"3$%%<T%!1"\W44%S
M54=H=F1'.7IA1SEW241-=4U!0311:VQ.02LP04%!04%!0D%"3$%!04%!14$F
M(WA!.T%117-!04%!05%!0B\K-$%$:T9K8C)*;$%'5$%!04%!068O8D%)44%"
M9U%%0D%514)G549"9VM'0E%92D-W9T="9V=,1$%O2T-W;TLF(WA!.T1"04U$
M07=-1$%W441!-%!%03A/1$)-5$9"451%>'=B1WAS8TAX.&9(>#AF2'@X9DAW
M14A"=V-.1$$P645"05E':%521E)O9DAX.&8F(WA!.TAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X
M9B\X04%%46=!;4%%04%W15(F(WA!.T%!25)!44U2068O14%A24%!04%(05%%
M0D%114%!04%!04%!04%!449!=TE'05%!2$-!:TM#=T5!06=)1$%114)!445!
M04%!04%!04$F(WA!.T%104-!=U%&0F=C24-1;TQ%04%#05%-1$%G44-"9V-$
M0D%)1T%N34)!9TU20D%!1DE227A15D5'13)%:6-9155-<$=H0GA7>%%I4$(F
M(WA!.U5T2&A->%II.$-2>6=V16Q1>E)4:W%+>5DS4$-.55%N:S9/>DYH9%5:
M2%1$,'5)24IO34I#:&=::$I21E)Q4S!6=$Y62T)R>30O4$4F(WA!.S%/5#!:
M6%=&;&%7,7AD6&PY5UHR:'!A;71S8E<U=EDS4C%D;F0T95AP-V9(,2MF,T]%
M:%EA2&E);4MI-'E.:F\K0VLU4U9L<&59;5HF(WA!.W%B;DHR96XU2VIP2U=M
M<#9I<'%Q=7-R839V;U)!04E#05%)1$)1545"45E%0T%-1&)114%!:$5$0D-%
M4TU514954DYH26=:>&=:17DF(WA!.V]B2'=&34A2-%-.0T962FEC=D5Z2D12
M1&=H85-5>5=I63=,0T(S4%-.94I%9WAD56MW9TI#:&=:2FI:1D=I9&MD1E4S
M.'%/>G=Y9W F(WA!.S K4'IH2E-K=$U453504FQD65=6<&)81C%E6#%2;%IM
M9&]A5W!R8D<Q=6(R4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\F
M(WA!.RM$;$I75VPU:5IM<'5C;EHV9FMQ3VMP86%N<4MM<7$V>71R<2MV+V%!
M07=$05%!0T5135)!1#A!.54T<3=&6%EQ-T9867$Q>E1L>#4F(WA!.T1L+TQ8
M9D97.%9D:7)434)U9&@T-'%G3&I83D]H2E9P-&<V;6I+6%AA;C T84MP3F9E
M9$Q72G5-5$=4>$U10D$O=T)K4T%F;W<X2S(F(WA!.VQ5=FYP:VPU4G)+>$)Q
M1EEG2V9N4FHK<DAH4F),9$,Q=3,Q93 Y94Y41S9M:VM:3F%%*RM!:6MG<&IG
M5C)+=7A6,DMU2D$V-'$W1E8F(WA!.T\T=4ER94IP<%<T>')4:V%%.5118D-P
M-S1G2VA"<G5L;B]D>"]W0T%K+S5P=SA*5G8Y3C9:+W8W+VA8+T%+63A*5E5'
M<39996PS1"\F(WA!.T%-:D4O<FIW;%9W,4A4>C!U;U0O04TY1B]R:G=L5CAD
M,V%Y349J;6ID:C!65T)0:C)/3D966$%R<U9D:7)I44]P<#@X5E%T>'%D:$(F
M(WA!.U535$M'2#=.9#A.2V=8.#%A57!P5U$O2D1J4W!R0E!$4$5K<U1"-#-&
M5EE91E%'=#-6,6)24E-1349$4'=F644W9VMD9FQK9W%44V4F(WA!.UHW>3)$
M3DQ.1GA!-4U:1C)51'964VQ".#A.0E501#4O4V--8F%A,G5E1D]2:5!+;%)5
M5C1U975.0E5.<4AN+U5%:60W93-3<6IA2F8F(WA!.S-J3CAI>&E'4$-%5W@V
M1#@P<G$X=6I94R]U<&QC>4Y'5V<Y4FQ59DA'06MK<$%(=4LT949&-S!U5#AX
M3$]B55=T3&5#6DY19SE887,F(WA!.S%%.5)U54Q.>%%*4E559V-Z.&500V],
M,&E$5S=D3DAT3#(V9C0U-&MF:74U6FEO2F]"-R]!15I#=#)42$Y2+TUU1S)V
M4F),<# S<$<F(WA!.VQ,=#-I5TU62&8T;5EE2%1$4W!.4#4V+U1%3$Y:6$U5
M;'15;WAT;D5G<C-6;E4O,'=G2VQ.;F5(56UA4%0S5S5+3S!,:45H*TUK6F\F
M(WA!.S9.>')1<65O4%1#:%!N.'%X4E=:=4PK*U<S-&ES<E!14G)8>%EK1$1S
M<4)I,$-'5T4S14=P5W,Q<W)C1VUI9C%">7!8:CA.4E=H-E8F(WA!.WA!5VUE
M95=D3'1B0S%:279I:W)6-50Q8FQ4*VU1:U9#;G$O;3(R<T5M359V2F1V0U-'
M:E%Q<$I5,%E,>4DV2'AX-%5P2S,U:6IH13 F(WA!.S!35T5K>D9)<F$V64-1
M<T1106-8;S%E;W T-#!&5WDK9611<6%#140R5G8K87-.0D-$;3@W-FE246-!
M9D@T<69D>7@T471O2G9.97 F(WA!.VM52E)Z+TU63F9W65DP1G1K;FLW>E!0
M95-M=W5L6&Q1;48Q<4\Q94Y#5#191$91538X>7I,1G!B5B]B9$9R.&TU9CA!
M1W5-57-+=60F(WA!.V%T66MD,FQ616I&6&1I1E913W139'-+;U5A<DA/2&%'
M4DI!:D9'2W-';WDY46%6,T=&0U<S,G915VAI3C%-;'5*:7=5>4]Q0W%I=E4F
M(WA!.S1A64=2,C)3,C(X-%%86E-/,5=D-5="1$-J2W%Y059-6DIO,6%!.49O
M85I82V9#440Y4D8P>$=12%EC,EAE5$QI+VLX>%),34@K<DHF(WA!.WDY3U)M
M2E9I63)(,%5Y,E$R6E)*=GEE:VMG06LW061C<&)%1E!Q='1'4&<K32M)-F9F
M:'!5;G8O041-,&%V4GA'<3 U3E$X5G(T=68F(WA!.VA(>4]'9W%26&9N1T$R
M:D)Y6FM:>4AK5#1J5V=O=W%/9TDS2S=52C9D8VY'0DI95'E#23-32%504&1W
M>G)A>E-W4G-Z06DR<7)3<T<F(WA!.V]09U5C1TA4;V]0>7=W:%IP:&UY8T5B
M+T%!4$Y413DW9DLP<U)L;&AD85)E;'-!<DAM3C1W=DQB=60O;S)W8VU1,T%)
M2W!P:%=4>DHF(WA!.T)!3C=O>7 V,&)C4DMQ4%1M>%AT4E=R:F%99W954$U#
M8W1(=6U(5TI05D(W:C O:4Y0;T)Y=5!.;3AZ6G!B,'-&:#E91F5,1FM$2T8F
M(WA!.THW<W<K164Y8VY255)S*V$S>34U0U-Z<S55,'570DE*<&YM;%53;6%K
M:C!Q3U$U04%!0VDQ;T)S3G-.251/8GEH8W@R8SAZ,T-03D@F(WA!.T=Z>'AB
M<6I-<3%!85-J1E%4,5!!,#A-9&Q95#5F.'0R4FTQ1U)283)'<5=C.%-80WAV
M1$E&:65(,4AJ1$)1.70V:5-G:#)5=G151' F(WA!.VMG44%X;&IK5#!&2#,O
M,F9J;VTS;%!Z2&-Y95EB:3 P;WAI0UI)=SAL=WDS4DLR;S1S43!(;VQE6% T
M5V9L>7!7;U!W-&LS149L2T(F(WA!.VI-:2MG-FIR-5!24$Y52F)2;TQL0E9G
M9U5G9%1Y05EF:78T-5=%<U)T+TQ&,W%N1U,U:3113'5#+U4Y1'-P-B]4:'!A
M1F]R>79P=FLF(WA!.V5#4S8P=E-)23-A>EEM-41.5U@Q4V9I1%)(-'A4<%5Q
M0C)W,G1B,&QK1FI(4"M9,74X<W1V1BMJ>$TQ;EI00TDU>#8T1%-H2%)9*V8F
M(WA!.S)%62]A1S%A;EDU1T)S>7-C<2](.6A9>C))04DS=CA!02]A2&56=% X
M=39:-7 Q>3$P>7IE>6MK:G0P=$A7,6MJ4EE9*UEE1TIN=#$F(WA!.VDT>'5P
M64MS:DQU0CA/5T5G9V0V36-41V-I9#1M<2](3FQ3,W,Q<7E);'-42$UX-49!
M4C9D1D-R>4%8979(8S1+8D1U;G9L,E8U27 F(WA!.VDU0EE-2S V9#ES<FMH
M:&UV4EAK=7-854U%5'E6:V,O0T-2=35/4W!735-A4#5C,7A,:E9N;FEU8FIY
M,TE:5$)P-WA'57I2>#AK:2LF(WA!.T8T;VU-9RMY2&%H3D0W-"LY4D=T;W%/
M<S8W63)V;#5.8S!Y,G5T5U%80G1R;7I1=W=Z44AG>FAP03=K04YW;TXY>5)H
M:4])06=88E@F(WA!.TQ*1TXR95A.6&AE83DQ;E1B0S!U8G933'E4.2]E-F$T
M<W V<$=/4FI78FEX-6)62VYB8S$R=U1X4TU226-R5$A.15IF1&Q9:U%N82\F
M(WA!.U9D678W;E1R5S-H<S<R,U=5=$DP=G%%1THP54-70U P=T]D5RMW,4)4
M=C!Z26QI<4EK9DIX<V5Q17-P>#%Y-'0W-VI82W5R25!,9&HF(WA!.TQP>6]T
M>4QD-VQP06969U9W3T\Q0CA:63EA*T=9-4QL;S<X=TQY2S(P:4UY>4-*4%4U
M=$EX-'%&5E-$53=5*S%K67!E8UAM;7)Q=6PF(WA!.WET0U$T6F1R:595;71K
M4C%O<$%92&)F8C1G4&)'=7!,14-T,5A4.4)/:6%,2DIC6'1V8U5:<$-,3TML
M9'%C84Q295AW9F0W0W5%,$<F(WA!.UEG4TQ(2DTY3G-T179D3U15<GEC<&)F
M831/<4(P*S$Y=6I38T-/0DIR,#<P>&A)4T9J:W!G46$V;S=Y<F]V;$U33F4V
M96E4065Q27 F(WA!.W!'1716;%I194IQ4E0Y=U!E=%)K:51)9VYO2UAW;U%&
M4D<U3FXS+VHW;5A7<WE'.&EJ0G%X4%0U0W5!.&U+639H8G108CA51E="1$(F
M(WA!.V9(<V5V<V-G17909&9V=%=G-&=33$96;5(K235-1U$P<'EB8G@O6GE3
M<V5N53,Q;$Y:5%)#-5-53C9J<VY/54M24G%354QQ2V5",G@F(WA!.UAH<RMA
M5S)':V%4-69T24QA,&AD24QY44UI4D9:041)94ML;6525E5.5'5E,51K6GIJ
M1#9J5SEF1FQ(2$M1<T,W*S50<B]Y=C5+1C4F(WA!.T5T.4UL>G)6>D1-3$I5
M84Y(6DDV;WI29VUR8T,K-4(R<4LU8D5K1WAZ665(1V4P=#1N;70X+U)A4DPU
M8F)Y.7!C9'17.&I$:E0S;FHF(WA!.W0R:U)367EQ971&3W-J9D=1239G=#!&
M8TA/471H34524$0P1WEN*U=-=#=.-F0Q95=L43!53G):-FA*2D0V=D-%8UA4
M,#!#<V%U>D0F(WA!.VU61F5.92M1;G!Z:GE%,E-#0G0S9#0X,D=L,4)Y-&=3
M3R]F=DA1=EEB<$$Y=DEH1E%63E%E-#A-06(R32MN8S-,,VQH8U=3=S9954TF
M(WA!.U5C>5,O1DER<4]615962V9A27)Y<EA*;U-:9DIO,&5Y=B\X041B;3)V
M3'5":U-A9#-M5DI10TEN.4II1DE1;71+:79I2S1+4T13;G F(WA!.V-E;U<Q
M:#9E<C-R,SDR>%!+4F=Q9TQ86D%Q8E4R<G95*RM0:"MB335024M9=DI)<CAI
M0WII5S-D4C9L,7HO945I=$8T1D159C=,=FLF(WA!.W%P:5I%=%@K:F%8<4UK
M9'A,8FE+-&IL17EZ=V9U<$,V<49"6C!O5RM&45!O>$Q&-D9B:75K>&8X648O
M-&=-<C9P4U@Q.5(O4TAO+U8F(WA!.U4K<&-A+U<O5BM+=%!S*VQX.&8X<BMM
M5%%T=#E*,#9Y;75R=7IT230W<3903S1D049A5FA5:FMF;51I<DAT6F@X>E-A
M>$).1F9F53DF(WA!.U!52TQI,D5556YQ.%=*4'AK;&QR5VY42E5L6&PQ4&=X
M-&)%.69F-DUA46<T-W)72'9684M21G-U3DI%6E=-:$\O4G59541P*WEC0E8F
M(WA!.VUF;'%.;71(;$Q%3C9L3V=P44%F,7E%:W%M<E)8-DI.3EHR-'5P9TMX
M=VPO5$1(*UAL4G%F9&A"5D%A6G!+,F1U.&M7;E(R53EY,W(F(WA!.UA58T%Q
M1$DS56QW<6-V;E1$845V:3AR95A.3TYZ3VQI:4YE6$)U<FET5S5416QQ,$IO
M3C)*<#!W>$YC:T572TM3,V5J*UAL,49R:4PF(WA!.U,W05)Y<SAL>5AT*U5Z
M>5-/6DAB;4=!*TIY5TY63S50:6-.2E<V:G R:6%K.#=81G)Y839#:6-P2DEN
M3&DS26))=T9A.3A*2G%M26DF(WA!.T%B05)N;')2=% P<&]R5%0T>D9(3$UJ
M=GID;DI9.%9Q4WA*-D1)36U596$W0DQQ,59M="]R:G=P23!D;7I"16Q99U56
M;4E.2S!P-&4F(WA!.T]#2U5(.51E-C!A4WIM:49K,7A#.%1X=TU'169-1F9G
M8FEO<4LQ*WIH46@Y2#AV>&%:<$ES4%=K=D=6;6LY861I1UIJ<TML96=!;TXF
M(WA!.W-1;&HR<C9*<6M-.$5/;EA+5T9K:DTQ>$5S4U1"=S=!;C O541C0TMT
M,C8T449"<FMI8FTX=FMT:D1P=D-&=U)X-6]X44-U+W=O>4@F(WA!.W P,W=O
M=$]F3%@Q<64W:5,T8F153$U62&-#;%%'-54S3U)K;&PV<5%!2S%P,U!82S%3
M3%4O3%9L8U1E<$MJ>FAN6GI(56A1>D=V-TXF(WA!.T0Y-7E9:W%L9&%'2CE.
M=4Q#1TYR4T\T4FM,=TM%6F59<'E886QC2DM%0D@U4#E$4EET359:3#1)1U8U
M8C92-5=937I31W!03%E-,48F(WA!.U=L1EA98D%$145"4TQ&2&MX*WHX=2M:
M2713=5HY5W55=DEH3$PY4VAI9U)04U)N64E055E'46Q9-D%M=GAB-UI)2G1.
M0EIE6FUU;W@F(WA!.V)70TYB;%)Z;F0Q-4%I=$%&6E=(+T1$05-&=$=A5#56
M=G)#,W1B4T=%4E=T=7=+2GI6:6\U8VHX4DI9.69(0DMF16),1$A!46E):FLF
M(WA!.T=:6E=Z569Q9'0O2BM*+W)H<W$W-FQB9GEF:68V-#)656TP:E1'*S%B
M;V-E27%T1VEA54]L<V<K+T=Y<EDP:E1!82]6,"MN9D<Q4F$F(WA!.WAO<UEJ
M55511&E&2%%!8E5W2VAV,&1"-'0Y-"]P:W5*5R\P9D(T=#DT+W!G-&Q5<&1%
M<TI2*SA6;3DK4D@V<U!%5E=F-&0P871F<7<F(WA!.W(W<W@O:F<T:7%O3D4P
M<V1,9&9V62]X>'155$)B45<V8TE50TI7=$(T-$96359D:7)42W)#:D%%94)X
M5E)A=W-M3E=G4G9M;U V.$XF(WA!.W%S3VPV868K4%=,-6A&0BLX1$<Q8513
M9$]34EI%9T-U:$1+45-+16(K3TYQ:3A#=$=/33E60BM9>%998F5!.5DQ*S19
M8E92:S!U=VLF(WA!.RLS0T0Y2D@V:FI:5E%F>2]P:F1%6F9K>"]J6$AI2W%L
M:G!&<EIZ3DQ#6#5-=D5H:4-+16<K2'1I4W%.=TLW1EA9<3=&6%5'2W5X5C(F
M(WA!.TMO9E5,;')A>6QM44%U;RM$;'5/4DY"5VQ.<6Y#07%22'I(<4$K,$EF
M*T%B+VUV2E5&5TXU<G5L-G!%9F]B+VUR1V=R43@V<V=O.7,F(WA!.W)N>%9Y
M;C1%4"MV2&A#2$AZ,T%.,G1Q95 W=VXO:E1(:%<P4EIE8W)3-G4T<EI9<4Y-
M=U94>4HS4'I59G)W8TLR>4A)<%-F5G18=3<F(WA!.U<X14U):DME;7)-6%9I
M86MS2V)-=FAK9T912CAZ6'$O8450,$LS+TY71V=Q=RMB-3%0>%)X;C)!27(K
M2G@T47$Q=E!K869A<WE/9T8F(WA!.TA*-FUG-DIJ=V]T63,U:#)I;&M.="LK
M0V,Q:CE1-RLQ949/=5!#=' U;U=U,G5S5WIY=VQ1.%1C2EEG=UEQ4T$R+U1X
M.$UI4E-56F8F(WA!.U1T8C)C.'DP-7AO>DE'-D9G4&A(8G%C47%12'I(<4%(
M>$-(+T%)0G8K83AL459A,VUU-EAQ<U(K4W0O>E9J459B+VI9>&<K<&)Q.5 F
M(WA!.S)G-5%$-W<R4$-%5W O.$%+>$Q%27IT0T9283AM.5$P,D945#1..79$
M0E$W,71F8B]M1'!K;'I&2$EQ=W=3;$97-&54:79*>E-N>$LF(WA!.V\R1R]8
M16=$<71S<7E+6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&57,X=S-*
M=')%4RMG8FM"<2]6;$94259"64PP8BM8=T\F(WA!.TE69SEJ6F59.5@O96%2
M<6QH8E-/5FYM9W5B94LT8TIZ9%=4,'A)4V=Q2U8T<G5+9DI+96QP9DIE4V-Y
M2V9$5V=R:S!+1%-33S%E:D,F(WA!.V]5:7 R3T9&=%=/:&$Y9#,Y=U=A4C=9
M:4XW9$-&:E96*TE.=E)3,TIV9CA!:FI465%/145E8DID03AQ6$9L<61V8WE3
M4FM)>6YG=%0F(WA!.U-N:'--5T9S*WET5T9E8C<O:F8O04M05TU14U1.-F=V
M-4954FM*1GE:1$MX:D,X479,-U@Y<#9+1'934C,Y;C5M<U=3-C%(54Q/*W,F
M(WA!.W(P0G)'2WIT;&=-64MQ5'EK4FU%=&$W2$5&4T5#,3%+>3=M:'E31D8W
M5R]U<%4K<E!*>55.4TY6-4MX23(U56]A1')T:'!7+TQ(;#,F(WA!.U<Y5W-,
M5R\Q2S)&;F521U9F,VET1E@T:6A):4Q33W1A9G0O<7!I1V,T.$IO1S-P6&Q0
M4VAP,FYY4D5)6DAL3'4V0VY),$$S,GE-;4$F(WA!.U)7=E1E:G!K:W9P1V-O
M>457-$97:TED5'=!04YA,#953U)3.'(Q3%8O369Q>#,K;$=/-'1,;31J5V%W
M9VET-7)L2754<$M21$ES;G F(WA!.T)76&IY3S%C9'=61S1V;VE:-WE5,T5I
M0V=24V%':#A4=#1:2S!+3%-S>F139F(O87E316UJ,"]Z1DYQ:U=M=W<S35-H
M;S=N.4M-4&<F(WA!.VY14TEK:THU>&U.9&YP<V$K1D]U46Q%,W,R>'@R3"](
M2S)5*U1V245L:#E4839K:G5),6LU;4YY.'%K8WEY53E8;61H,#-W46IT=G4F
M(WA!.U=%;VM(8S)8<4]+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+
M<$XU;79*<E=',6$S:CE7-$5W9$ET.7=&25!4=S5$2E)&<3@F(WA!.S@P-WE.
M6FYZ<V1F9E=*-V9843=83#)A>G=V2E(Q;V5A1DMH4&E/=S)O861-94%.+S5M
M6$1W-V-+3W8X07DU<G%A;&5.86DS6%1J8F@F(WA!.V)2>7)34VED:6]:;5$Q
M2#AZ5C-(=&MT,FM%9%50638V;FPW4TI:.69)9W9%:V5-5'9';W%Z8G@X5FEJ
M1D8T0W4K+UA)63533696<U<F(WA!.V,T4G99,D5:<$=V,T,R:6%R<75O,C91
M5"]$1DE5.4)':C--9%)),S)J56UT96XS-5EI4D951U)73W!,4&1X0D=$5EE-
M04)7;T%R=%$F(WA!.VY!5T1*635/63-"53EW8W)6-3$U=W,U9DU&:'%':GIU
M.71P4#%K>3-&,FMO:%%H2$)O-TU'0E55*R]F=&MZ0S)E4$E91WAZ53E".&\F
M(WA!.U%A9C55*W!A6'%*,5-/3F)I5%1J3S1K9U-A46LP4F\V55%-2U4V9%13
M=&%O:E-C=55Z3FYM;#,V3S@P,EHP*U,Y:'1Z1D9+<3,X5G0F(WA!.T=#1U)M
M,EEY>7$R,U1L>&]E=$UJ27I"1F-U<5EI0D(V1D=8,VTU;3%7,3!F4F)M0T\V
M:$M.<4YS.$UJ9G5I<#5H2%AG<V)62SA73E$F(WA!.V5L3G=C<V%W0C%45S Q
M-DM-=%DO5TEP8GE)1C5)95,K<4%X0G%Y.&=F,BMT2UDP<VI:=&LR:#-B>5=R
M3W=Q<&-M;T(R;T(X>&M*25<F(WA!.V5:<G%30WET<%E%.5=8-GA',&-7.5=O
M0V5N6$=)=%AN;'0U2'1*4%!#*UE:.5AN<SED95$S271&=4EM:TE+8TMC0W1F
M5'!88G!4-&4F(WA!.VU004<X86U81'<W8TM*,6Y3.6)I,6U/,3!U=U Q3UI/
M5GAQ8G-K<5(W12]$0WEC=5IC1'5243%W-S-S5V=/,'95-4Y$,'4W=4YE0U(F
M(WA!.U0R-W50<DQ)<6EJ1E)&4EDT>%)F8S<U2$A+4DAQ,DQ:3T5B.4IS2S)N
M83%C6$9S;7$V:F9W<EE%:W=41E1#<E%T.6IK2$EO5#$U9#DF(WA!.W%E3U1Q
M,F9'26EH>EI(66%N1E!004E856]X57@X4E5%9&1Q131L;UI.1DQZ,DE+=%-T
M1&QA<6U+=7A6,DMU>%8R2W5X5C)+=7A6,DLF(WA!.W5X5C)+=7A6474W9#5G
M;U5G538Q=V=Q9U1P5$Q+6FA':&U+:%1)2V-I;S-P5VQA6DQI5G,R5C!0,DLO
M26I',$I8<4=J=DY2:&)-2$(F(WA!.S5654AC.61W3W5%4U9+2CE'=7%"6&EK
M0TQS<2MM855(:'1H-&Q41'DS6F5N<6E-5F%Q2W@K3#55+VIK6D976#5"2UA8
M3VU.3W-Q4V@F(WA!.TI)<%%W94YH5E=6=7%K155)3U,T;%=,<#!Y2T521D-R
M<T979T%(>7<R<6Y067I-=$AG.5%D84=J0V]W.%-%:&TP0V%/4FYG=&Y1=#$F
M(WA!.TE2;4Y+055R=68R4F@T;%%2,&U22$QU:FAJ=51X2VLY=#AB5FUE9U%I
M3%-O44)1;FM4.4Q(2WIZ4VEB=4(U:U96249$53%X0E9!;E,F(WA!.T-*>D])
M-'I/5D-'54%C*TE*25AK4E=G3$AB2F-3=&UY=5(K>%@V4FIX25-Z561(96-F
M-WI(:T1Y<4%D>E5'<' Q,T%W:5-P4F-A3&0F(WA!.VM"6&EC4FEL1CE-.&9H
M-E4R<'1H-&Q2;FPR=T5E<5$Q52]#1U!X0VY25%1"27%Z2VU6<&1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U8F(WA!.V1I<G-69&ER<U97=$EQ.61H:7%$=718
M=&)D955J<6](9&E!4'AX5DDW;GIV67%3<7DP<#-%8FMF4G-C;'=L8E5,1'HU
M8F974D9/:W(F(WA!.WAY1V=E:3=(-E=',E!#:3)9239U:75H-4MW0E5J=41U
M36EL=D9867$W1EA9<3=&6%EQ-T9867$T<V\V:T0U-'%G-719,#9(-U5W4&DF
M(WA!.T9Q>$@S66%+<&)C96)B6D%21D5Z3C)*;T(K=78T63!Q5#-F;E<W5#1U
M555#;EEC-D@X5'AW.$M,8C S.'<W5E))="]Y:TDS:F5'3G0F(WA!.R]%8C!(
M=C%W.$,R>E)71$M'1S195D(V.69L:T5T4$Q'9TID9V](5W!P:7%(9E9,2E R
M*U$X5D)99F5-3DMH6DYF=# V4G-4,C-7;C F(WA!.S<T,'%%;#@P1F9S=W%F
M;7@O<&AP54I.-7-U:B]!2&%+;G98;"M&0FI3;TM8>G!D=W-"3$Y#<#8X5S1O
M4U!P<FIW<7E04B]-96QA;$@F(WA!.T5S5C%#8G1X.%9U2D9,,4$S;T%A:V)6
M=T=*0W!P9U8R2W5X5C)+<TMN,4LW:G$X.7I+2D)8;4$W2TMJ<CA)24$S-UI9
M5E-N52]W03 F(WA!.V)B4TE9>F4V:$1%<S=#3T5Z8U=9<V$P03E-,7)T*S%G
M<$%)4$I#,RMS,U8P>$TX<&M09W@R2'E8;TU+<4YH<#DQ<44T4S-1069T>3 F
M(WA!.V]O2'I'1E985TY!=C=%25E9<$PP4T5J.3!%2$=L4'1'4C!!<B]$1F%2
M3VTK5DPK5F\S=D(Y6&E)1%!'4T=K1F0K4'=K<EAS9#A553DF(WA!.TET66]O
M<F5.26AX:D$K145K,$(S-FUP>7-S:TYR3W!T<'1I,3!T=3DP5DE!:6IP53$Y
M>F=69RMP9FUL-6IT8C)30TAY<W,X5E-)6E0F(WA!.W%6=D<S,F=&339L0TEQ
M<E9Q0FU)-V=6=SA*5FQE:RM:235R6#%.56MS8DME=%!49W95=55P,E!Q1DE/
M,RM4:E)634ET5S R-%!',78F(WA!.TQE6GEA0E9L4G5V*W%4:E)62C=J>FQB
M2C5L,#=1-%!1;6QV;W!*,E!Q='I%86@K3%)Q:V)P2E9O;D(O94QX<&M42VI8
M5G5J9TIH>&HF(WA!.S9E.4XY3W5B*V8Q=G)T=6QS,&-N1TI9-41,>FHT9V@R
M-4I'5E!,:TMB-T-T9#9!=%)68G$K=#=99G9'*TDW:$)U8TY)4V4W.'=V46DF
M(WA!.T]K63AE<F8P1T=L62]Q6&U!3$).8U131F])451,25-#;T,Y5%-V8G5A
M54=.<7AE5'IT8C-29&)+5T=74E9,:$1-:%DX4E5G2VAB<C F(WA!.W%4.#A%
M-T$R,TQ%,S!9,5HO;5!P5V]I-U-6-W5&-UIG03-&16EC;6Q05#1-,&I$-U$S
M4%@V2S0K9E9$15)X1%ES2C5/1W)4931N<V(F(WA!.TXP858Q:%=6,&A795-I
M<5I*0C!,:S=F1E5686U:26Q+>EDR6FA--TA46DPV4DDW864S:TQR>DA#94M4
M-$LP-55J6FI4,WE1<$Y04S4F(WA!.WID5W5M5VE-=U5P1T5L-$=O2E924VI%
M02]S;DEP67ID*UIT3VAB-'!G>CEA<E=2=G T.&E-3D950U!-3C5E<WE73FY,
M3S8W=%=I:6XF(WA!.VIS5U T67%L1G@U9S%6*UA"631Z,E%H;DYF;E90,5I+
M249I*U1#6DEI835Q5W%E84Y-9W1R1UA5:DQ:5S!D179P65I+>5-U>6=!<4\F
M(WA!.T]X0D).1B]T=VM2<S<K-6=*5'%.:F9R-4I46C,X96]J,6MC,T9S441&
M27I-+U5K8F-Y861.>&U43$1#34%43#%%6"MZ.&5B:#0Y5FPF(WA!.VYL;$51
M.4530G9T.&90.$%54C-O>4]';3!A57)V4E(O5$U7:3=";&YK:$Y55%4W94]3
M3U9B14TX=W)'95!Q1TUX9SAQ8F)(>'!G23(F(WA!.U-(;W56<&1I<G-69&ER
M>GIZ9$A,1'%R>'AQ6$5H3$M!2VLX<4UF>%DU36)Q;$XW87=W4DID*V%P4F)7
M2W9&2&)V359A<E--1E)+<V8F(WA!.VAB;3)W-FYT53113C)59T]'=V9F*T]Q
M8F%Z<'%7*VY,8V%067)D4W!X6FA):GEL,%E6*T9F56AQ,U0R*U=*4&-X23)T
M56=T.5HQ1'DF(WA!.VQF5W0O85)X6$XK:SA%1G%K85%H27!636%E<5!7=55R
M43AM;S-48FI88DIB03<W:&A2;$4Q-EI5969F.$Q8841P6#9,.'9796TS17,F
M(WA!.TM345)M2C0W3E-S0TM34G=J4E%G04-.>'%6.3996C%F<#5,:$UX04-6
M1UA63DI,,DYI5U9J,&]!86HS-DA)<VU3,G!R8E%K+WE,*W(F(WA!.TMI;$HO
M3TYJ3F4V3SA.=7%.8V=H-V8Q1E9L1'(W3T-V46MB-#<P94AM;4I&-SAM1RM6
M=%EA>FAK,'953&TT=G169W0T-7(K,2MR=U(F(WA!.U$R-W-&5U-*6EDT-V5&
M=FE*<'9U06%E1U=$;%I54DI.0D-295IO9%IL439"<#A525%R.5E&-5DK='E$
M<V\K1C=A62MN4W)G;&Q0,E0F(WA!.S$R<DEG:')X>FI/4$9%,DQP3F)73%,Y
M5W-N*W51=U=D.4%X37DR-T975E%X0U-/:VE2<W909U-!>6UN66YR9UHP5T)N
M4TY0="].56XF(WA!.W$V>&18>C9:8DY%-5<Q3"ML1$UJ37-3=&%#<4M6;&5I
M.&9I<69L9S113C-+37!$1G8O169X=#A(<#,U9&%%,FU15&QR=5,V6C%18S4F
M(WA!.TMG<TMS=TQ+931"0VIW1S)#6F-9:V1!>4Q73E!L=31A=VM#5D990W9E
M;W%0>$=20E$X=3%J,2]R8E)Y5%!*1E)3<3$T<5%W<CEK57(F(WA!.W8T,7EA
M<4DP=6953DYK<U1A2DI:4VAO-4I':E)E2W-.>#9X04MI:"]M=V-057!J1RM8
M3FEL;C5B:3 W5S=Q,C!Y>G59;55W>'@S:4HF(WA!.U!C,E)%;G=U>$994DIW
M3#!01GE"=3%25$EZ;%A)5V]&<SDX<%=M:C-L;398=6Y.8C,Y:DUQ5')01U92
M;FI)6C5)0E9G.%(V<3-V5$4F(WA!.U,T=5DU36A%>% T-VLS.#!E;S)I;$Y.
M:D59:FM35C5%2$%P1V@U1C T+UI0449T=4LQ3E)42W1423A"26%S9TE#5V%)
M.#9A:$\Y:E F(WA!.U!F85%%4THW;31C=39Y>'%$1D=O8FIX*T-2>5%"-$AU
M0S)0<$IY36IU5$9R>&MK*U0P<U)W6$9U<5-+<VE51E995F]A92]1-S5M='HF
M(WA!.WEV53E/=C=M-T)G9V5B-$5$37%K9TAP=6-N4W%Q84)Q9'!A6$9X9'A7
M-'0T:TUJ<F-%35!H0C-&1'AR+T%+>'!J4S!$>EDR,S5E*U(F(WA!.UIT275F
M3DM82FYJ:VME5V570U5W<C8V4V5K-FE4:U98:$EV1#=/,4MD<V%#>#-:0C5B
M:3AT6&5N:5<V=%-:26U:2318;65D=UEY238F(WA!.VQM4T0T:E4K3S)2>%I"
M3TYJ;"MR,W-P44U44C5Q+VQY3WDQ3U=7.'1*5$9P8W)).6]H<W=K<%)A.&\U
M1G5%9#!O,5%A9TY8=W!43#4F(WA!.U-I44M&2'(U=$UC95--:GA3=4HU0W$T
M9DQZ-D<R6&E32T=/:U5F0TUE0SA61E0X<5I7>E)U:5-E<DI-,SAO569F6"MM
M46ML3G-I<G,F(WA!.U9D:7)S5E-R6#=2-6]H.5AL*W$S3$1I=#!I23=Q07=.
M4&I$03EX=C0U2TMP3'$O;'I4.5HP=4Q4.5<U6%-2;$A-;&946G!%1D]F=V,F
M(WA!.V%6<65M4U%J5F=M4TEX4D]K4TQX5T5+;C)%1S%+5G P=W%X1TA1-WEX
M,6UF54QJ57)Q-%IM67!B=$\W=W)Z2DY&46AD9T=O2S%P:%8F(WA!.U5U<$QU
M5F]20DY*07-22EI9=V@U9SEM-4MX2#!5>$MO=4XU;5%,2CEK9$%C0W,X=&\R
M:FA61V%T04%+.5%+1&)+:V]06#E)=#E8,'DF(WA!.U14-VE0,6)E96=L4V]&
M5C8P,W=H5TUA4BM8=&AO0FMB43=-5S!K>4Q(3DM8-7554W9%5F1T=7174%4W
M5D]W>5%)5G4T.',K84I,;U0F(WA!.U(S.#AC44-G,C1-4E$P2DI.4V5F>%9O
M9"LR,DAI0T5.3C5%=F)J54EB*S5J.5<T9U(T-#5/459G<V=)64=J-S=-859R
M4W!P,4](:40F(WA!.T]->4=X-45V449#*W9(>&U397-%-6A,36TS1U%O-#E2
M4TYI<EI%:TQ/6FQZ6E9O3FQD,G%Z+U=%-$9Y=DAC1W1+,39%-45L:6UU0E4F
M(WA!.VAN.'1A9$AC0U9B9C%N2S U3T]D2TAP5#=0-%I-4U9"=C5B;G5T3W5T
M4#%75U158F4V2D)6,%-,:6QA<6\Y24IU=$LX=DA',$M6=#4F(WA!.U)J,#=3
M64Y*,&E!5V5N5W%"26)207E,44=P<7EN=SES1WI+37%9-UIE5F(R>#%*-S%B
M<3EM5F=W5WEK;F531E-10GDK23AM4%@W4E F(WA!.S199T%-<DM,<SE).'EE
M;599>3-B13$Y5U%225%+055P1T5&4&]Y5FA#67<K6'1B27),1%@R3' O>E9G
M<TU76G)%:71Y555*1D]P<%0F(WA!.S5D36=Q1#%'>G5P;&MA,EI&;4M%4FU1
M17%(;V5*64Q1:U8V-S5)1E5!;6M8.#)N=&)A;7-.=SAQ=DAC<D5#<U1O,5)4
M:359,$MM:#,F(WA!.W<X4W%F*T<W2DY/1VTO54EJ<#8P<&%C1F%06G59*TAC
M9F$S*V5.:%=(-B\U2'5M:FAG<W!:9$MT-#5$2WIA979O:5-Q1E-J<'A+.&4F
M(WA!.U)",DYD:'8Q<DMW5D=Y3%%85G9!:TU33T9J54MR>6-M2G!S0WA053=D
M8TLR=C!Y-#%M3T@O5$HP33%A,6=$2710:WI0*W9!:&QF;&\F(WA!.TTQ=E!-
M,4]4>55.04(Y;%(R2'IY16MP>&M69&ER<U9D:7%L8U%#6E%P3DM'=&-)2W%!
M,#%/-VXW<U!%<EHP>45I:&1V;V]0-%DX4W$F(WA!.U1A2&%..7!P1#E)+W!G
M-&Q79C1D,#)T4TA0<U<O<&IX2W5844Y+2%=)=#@R8BM">'-Q;4]"6%EQ-T98
M67$W1EA9<3=&6%EQ-T9867$F(WA!.S=&5W5+,7)15CAC5F)X5C)+=7A6,DMU
M>%8R2W5X5C)+<6)7,7,O,F]K8C5Q1&EQ-DM'2TIE35-,1W1A.%9!07(Y1TMR
M<U9D:7)S5F0F(WA!.VER<U9D:7%N8U1E;$57-G0P564K3$M%8DM73S=U875X
M62LK4F-K04)%5VQY-G5%8VQK8EE%-VM(=&A$6$]',6\O0S!/>%9)4$YM;2LF
M(WA!.UIR*T]'4%)B-6).06MW=4MS55IM64M):4=61V(T9FER4FPO;W%N5FUL
M,&QP06PS27,Q,'-A:31L:E5O:GE"4GI:54IB:4,R-$945$8F(WA!.U981EA9
M<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9
M<3=&6%EQ-T953F0V;%I7:$%U2D]"659!;WHF(WA!.V)F-T5(0T%Q2$AM1%-4
M,&QB+VM63"]Z5&@T4W%Y-3%3=VY25FIK2F)L5F%O-$(R4#=204=226)-6F]Q
M95)C:%%U=%)S-T1H3&138T4F(WA!.S5$;T-384=U=T=%0S)->E%29&@U;C!3
M+W5%=')A-#54=EAJ1U5D4V5)2D\U541O4$A*531Q85E&44=U:VI3-6E$5&10
M>&M81$AM<D8F(WA!.W9R:GA!:$IP14AC4G5Y:B]!255J2G%O>6$S9$I5+U=*
M46]&9513=BM.5&EQ2&9Z4F52:&HY86(T1'AF-#-)53 U9D9V.$\R*RM.26$F
M(WA!.U1Z;'%O5#DQ8S%1359*2W$R-FYI4E9G5#%'3WE,6$PU,S%K<U%S;V-Q
M44-!<61D:G8X4&AJ45<S;T9P23!L<$1)*S=V1W)-9F-G134F(WA!.T$X,E-R
M9U8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMS
M5#@U3S949D$S0C)H05(V,#,U3E=M4T$R5C4F(WA!.S5,8V5A64Y45V%F5694
M,'%)2S!O36M!4G%U47ET>G1Z26\T:V(K<C=944-Q2S%(>D%Y.&],93972UE1
M:3=%<GAY>E$K9UA-6FM":#(F(WA!.T\V14=H<4\K>'<P;UEX<59P-3)V3F9T
M3')5-&]R>E),3TUZ2S=)5FEJ5C!M:#E25751.&E334$Q2TM+:6TK*U$T9E8U
M3UA!+W5U6'$F(WA!.TIO9EHK=%9G.&]A,V5E6$Y+=4PW5DDO<61U>3-%:EAT
M>3=!2E-K4$(Q36%C83=!5C0O-C(Q8GE91S9&3DTW<F1N+S5F5S!B-C4V=VLF
M(WA!.U-33DE:5VEK4G<V<WAC2U-R2U-$4W)$<FQC:',P=E--<E-G3F4O-#55
M+SA!<U X06EA-%DX,65:6%8U3C9S6$=3:6QW2$).0G=P=6$F(WA!.S!/1E=.
M*U4U4$\Y,V8V<VUR471C5U131#9G07$X;&HT9T5"56I7<6UV5FU**RMI>4%+
M1FPW8BMD3$,U=5HY4G1B4DY.;&QD15HS93,F(WA!.S5P239Q;V8Q5TMC,6A4
M8S%P,5!48DIW1FYD:%!96"MM=G945U119DY6<#5D=715;70T-4QQ3V-Z>3)-
M4W$X66A59TXV<E-38VE2-F(F(WA!.V8S9%!98E9)>'A%<$%(<6U-94584&)Q
M5UIA5$(U5W8W3T5):4YQ2FEG=6)P23!N:$-2,TUF<5)"9S!K<6AU1DMG4TA)
M>4)J26<Y1TTF(WA!.TUS6D=H>C(K,6Y-0TMK16%+2TMQ<4%004%:5U<Q9FER
M<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-64W(F
M(WA!.WI$8U=T<F$O5TQQ<&=46C9),&@S24$K0D%Z2&,K1U-I5F5F*V%5:#%A
M4S$P5T]W=F]R3R]:2E8Q1S!I5E%62T4X6D%W,E%C+VE$.%,F(WA!.TMD1&AK
M3#),4&I)1WE195,U3&EY=# P,C0P=C9Z6D=/-F=&.6-7-U%Y2F(Y6'0Q:EE"
M;6ID:'DY+T$W6DU'=V)/.2]0>B]T,V%V1&DF(WA!.TM&1&@O1WE0,4LW<UDO
M2WI*.5)U<C)Z:B]U8DM%4WAY,35-=VIF,7EK:GA)>CAF<S=Q855094(T:G4S
M5D--44DS-F9X*TXP;W-V3U4F(WA!.U=T84<K:V9O:694:$-G:&E%<5)80TMS
M6$9H5TYQ5C1L3G=6<'0Q=T%B3'A86DQ/9GEV=%E,4T)#3&(P-35O>7-K9V=J
M:%HV4#A$;%DF(WA!.VEW<'AB>'=N:S%V43AG<4,Q<4XU9$UN4D)Y66AA1%EF
M=$$Y.$UE87-&,&Y23$,U1GEQ4W,Y,V)/66TY4T-A3TI85FEP<'I%9G%J-&4F
M(WA!.W%M;F9C15I0,TM%0VYK+WI8839F3&)1-GA/+W)';U5435!3;V%G22]W
M34%4,7 K3U)L9$=U8DEC3C<X:TAR3W!7,79O3G1(<D=L4S8F(WA!.VIE2WI)
M<&I2<C!)2TE88FY)-W5!-5A9-S=:3TE)<G8O045O;TAN>2]1=&=T6C=+,&HP
M>31V2FPP+U574"MG96EX84U%:'EP94AK9R\F(WA!.V5Y17,P9TYF2'%C;$5M
M2G9Q>'IX:FM"1E5#;2MM-F)95U8K8FEY4U):1VII="]I:S5R-E5+.$DQ<%%.
M<V]!1E1T5#4T2D5K,E=N2' F(WA!.S112DUE-$0U4%-O>E9A8U-V2&%H.79$
M2U<Y9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I
M<G-685I%8C<F(WA!.U-G,#961F-683E+3"M29G5'2W%C.6YB>DIW9$)3=&1G
M34E+<&)Q2&QQ>G5B2V%#34)*2D)14T5!,$926'!4<4YS94EQ:44X=F%*2&$F
M(WA!.W1A>#)54U%U07)H1C1K9V1+<U!I4#,T3%9'4E<Y=D914E)*1T%+1&EO
M1D(T8EEQ<5EQ=&MJ5U)#:F1$,7!I<4A/;E$Y;5EF9"]42F,F(WA!.U-R5'!Q
M.7!$.3)017%8,VYL;4]:9SAB4G!)4#(O5$%0,V<T4DY#06LX;EA41W9R23-Z
M3$0K0G<X83!U=&9,5C=$4$53<6-!>6QY1W(F(WA!.W-$=C%W1U-7535"6%EQ
M-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6"\O
M6CPO>&UP1TEM9SII;6%G93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]X;7 Z5&AU;6)N86EL
M<SX*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#IB,3@X8S0P
M-BUC960W+3EA-#(M8C%E82UC8V1C,C R-&(Y,C \+WAM<$U-.DEN<W1A;F-E
M240^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z8C$X.&,T
M,#8M8V5D-RTY830R+6(Q96$M8V-D8S(P,C1B.3(P/"]X;7!-33I$;V-U;65N
M=$E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z
M-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\+WAM<$U-.D]R:6=I
M;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.E)E;F1I=&EO;D-L87-S
M/G!R;V]F.G!D9CPO>&UP34TZ4F5N9&ET:6]N0VQA<W,^"B @(" @(" @(#QX
M;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z83 X9CEC-S$M
M9C!F."TP,C1A+3@U.68M9F%D-F4U-3(R-S1F/"]S=%)E9CII;G-T86YC94E$
M/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.F$P.&8Y
M8S<Q+68P9C@M,#(T82TX-3EF+69A9#9E-34R,C<T9CPO<W12968Z9&]C=6UE
M;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YU
M=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X/"]S=%)E9CIO
M<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR96YD:71I
M;VY#;&%S<SYP<F]O9CIP9&8\+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@(" @
M(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP34TZ2&ES
M=&]R>3X*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z.&1C,CDU
M-3DM8S8R.2TS9#0X+3@S.60M-&5D-F(V,#0Y,C)C/"]S=$5V=#II;G-T86YC
M94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#$V+3$P+3$Q
M5#$P.C4T.C,Y+3 W.C P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#0R R
M,#$U("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @
M(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z8C$X.&,T,#8M8V5D
M-RTY830R+6(Q96$M8V-D8S(P,C1B.3(P/"]S=$5V=#II;G-T86YC94E$/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#$X+3 W+3,Q5#$S.C,S
M.C,U+3 W.C P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#0R R,BXQ("A7
M:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @
M(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @
M(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \:6QL=7-T<F%T;W(Z4W1A
M<G1U<%!R;V9I;&4^4')I;G0\+VEL;'5S=')A=&]R.E-T87)T=7!0<F]F:6QE
M/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/D%D;V)E(%!$1B!L:6)R87)Y(#$U
M+C P/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@
M(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"CP_>'!A8VME="!E;F0](G<B/S[_[@ .061O8F4 9,     !_]L A  !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @("
M @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1" ,B
M!Y\# 1$  A$! Q$!_\0!)0   0,% 0$!              0%!@(#!P@) 0H+
M 0$!  (" P$!             0(#! 4&!P@)"A   00! P(#!0,%!PH,"0(W
M 0(#! 4& !$'(1(Q$PA!42(4"6$R%7&!(Q8*D:&QP4)2,_#1<B25MM87=QAB
M0S24-56U=C<X6#GA\8*2LE/3M"75-E:&MWAC<W4F&3JB@Y.S1%1D92=7EXBX
M61K"TG1%A:5&9M<HF-CB\I9'9WFCQ-3%Y<:'2"E)*DH1  (! @0#! 4)!00(
M P,"%P ! A$#(3$$!4$2!E%A$P=Q@9$B,O"AL<'10E(4"&)R(S,5X8*2-/&B
MLL)#)!8)TE-S8X.3HT14)347XK/3=+0F&.-DE%4V-SC41=56)__:  P# 0 "
M$0,1 #\ ^K+7:FPL,QF&%+4T@A;I!<6I;CBUD>&ZW%+4?W= >2A*+6T-3"7B
M1\3X64!.QW(".I7OMMOTT!1#;EM-D3)*9+I42%):2T$IV&R $[=VQ]NP/70'
MLR2J*SYJ(S\I16E"6HZ"M>ZMSW*VW[4#;J= 4PY$F0A2I$)<,@CL2MUMPK!!
MW.R-BC8^PC0"I2TH25K4E"$C=2E$)2D#Q)42 !H#T$* 4D@@@$$'<$'J"".A
M!&@$C==!:<\YN)'2[W=WF^4@N!6^Y4%D%042?'??0"S0""-$D,ONO/6#\E*^
MX(94AMMIL$@CH@?$I(&P/0>/30"MY;C;2UM-*?<2DE#*5(07%>Q/>XI*$_:2
M?#0"2"]8/!Q4Z$W" (\I"929"U#<[]_EH"  -NN_7W#0"U2TH25K4E"$C=2E
M$)2D#Q)42 !H"Q$E-3&0^R'0THD(4ZTMHN)&Q#B$N!*BVL'H=NN@%!2DD**4
ME0\%$ D?D/B/'0%#;S+W<&G6G2@]J_+<0OL/N5VD]I_+H!,N RY)3*<7(6M!
M2IMM4AX1VUI\%I82M+95^4'0"W0"7^W3(!WBHB#?=.SKLAP[="%=S33.Q]FS
MGAX]>C$8BK0#8W9AV7\JB!9[ J"I3D0L1$]N^Y\R0MI2P2.G:E6^@')2@D%2
MB$I2"I2E$ ) &Y))Z  : 0L6E;)>\B/.BO/'NV;;>;6I79U5V@$]VP&_3?IU
MT!5.K85DVEN:PE]""5(!4X@I)&Q*5-K0H$@>_0%V)#C064QXC*&&4DD(0/$G
M;=2E$E2UG;J223H"Q80WYC:&V9\B  HEQ49+?F.)Z;)#BTE3>WO3K-+ C+L*
M&(3/E"1,E'?<NS9+DEXG^R7T2/L  U0)Y4BT1);:B5K3[![2Y*?FH80G?[R0
MTEIYX[>_;\WMT YZ :IMS$@/(CO(EK<<"2!'AR'T@*) W6VVI).X\ 2?LTK0
M-T'4'< ^_KU!!_.#L1H"DK0%=G>GO/@CN'<?;T3OOX#0-T$\J,F6PY'6X\VA
MP;*4PZIESM]J0XGX@%#H?>-4UEF!7QZYGR(WF]A/<2\\Z^HJV"=]W5*[1L!T
M3L/LT2H"J<F:N*ZFN6PU+4 &G)(4IIO<CN64I2HJ4E._:""-_'IH!)41[>.R
MX+>P:GO+6"V6H[;"6D ;%/<VVUYG<>O5(VT5>)1U6KL0I?:I7:E2NU [EJ[0
M3VI'3=1VZ#WZI"Q%?7):#JXLB(22 U*\@.]O3992P^^E(5OX$A7O T!:EV==
M *1-G18JE#=*'WVVUJ&^VZ4*4%J&_M VT H9>8E,I>8=;?8=22AUI:7&UIZI
M/:M)(/4$'W'0#="H:>N>,F' 99?(4/-'>M:0K[P07%+\ON!V/;MN.F@'"2V\
M['>;CO\ RKZVU):D>4E[R5D;!SRED)<[?<3MJ C]916$.5\S/R&PL^WN*8Y[
MHT;N4-MW&DOO!83OT2"E._LU$GQ8H2194E"RA(6L)44(*NP+4 2E)400D*/3
M?8[:R T5KM\Z^\;2+7Q(O:?(1'?=?DE94G;S%D)9+81ON0 2=NFVHJ\1B.DA
M]N,RX^[WEMI)4H--./.;#^8TRA;JS]@!.J"Q G-V,?YAIF4R@K4CLF1G8KNZ
M=MR&W0"I'7HH;C<$>PZ@%*V6G%(6MIM:V]^Q:T)4I&_CV*()3O\ 9J@N: B\
MS$Z^PL38SI-E*5W!2(BY?9#:"0 $--LMMNH1TW([^I\=2@H2< ) 2D;!(  '
M@ !L /R#5 SEB\-B7180$UG<DB+\BXJ06QMWI\_YE(#BMNBNH&_W>FVH!YU0
M,<>X?DSU0T4MLTRA:TKGR668T79'<.]L./AYU"U)V3VI).^^P'74J4>5K0TA
M;CBT-MMI*UN+4$(0A(W4I:E$)2E(&Y)Z#5(,T+)*.QE_(PK%B3*(60VV'2%!
ML=RRAPMAI8 &_11W&I5%'&9!A6#269T5B6RAQ+J6I#2'4!Q(4E*PE8([@E9'
MY"=""AMMMI"6FD(:;0D)0VVE*$(2.@2E"0$I2![!J@9K6LL+%QH1[R75Q4HV
M>8A,1_.>7NKXQ+=2MQKX3ML!MTWU .[#7D,M,^8Z[Y:$H\U]9=><V&W>ZX=N
MY:O$GIJ@03Y5DPME$"J^?"R/-=7.CPV64E6QW[TO/N*2.NR6]MO;OJ <SJD;
MX$:7EE&BV32B4MVP4^F,6F8\AU"'U'M+:W4-EM);/WSOLCKW$;'955H8DCU2
M'B4I2 E("4CP"0 !OUZ =/'0'N@$L2(F(EQ(?E/EQQ3A5+DN2%)[OY#?>2&V
MT^P #0%FS%J8BQ3& F<5)"%6/GF,E!/Z16T<%PN ?='AOXZCKPS**XX?##(D
MJ:7)#38D+90I#*G@@>:II"U+6ALKW[022![=4A9G340&"^MF9( 4E(:@Q)$U
M]2E'8;-1VUJ"1[5*V2/:= *&U^8VVYV+;\Q"5^6X.UQ'<D*['$@D)6G?8C<[
M'0#?9W553H2Y9SX\,.=WEI=7^D<[?O%ME/<ZX$^WM2=MQ[] >19=5D->MR.M
MJPKI/F1W.YMP-.A/PNMJ0\A"B-^AZ;: HK\?I*EPNUU9#B/*24EYIE/G=I\4
M!Y7<XE"MNH!V.E .Q!((!*200%  D$CH0"""1H"/55 [ E.3I=W<6TEQ*T=L
MN3V0FDK4DGR8# 1'0KX?;N![ -2A1_=+B6G%,MI=>2VLM-+<\I#C@22AM3H0
MX6TK5L"KM5L.NQ\-4@VUB[IP/*MX]=&W*?EVH$F1*6!\7?Y[CT>.C?PV[0?M
M]VA19-F1J^*_-F.%J+&;+K[H;<=\MM/WEE#*''%!/MV!V&A"W6V,.VA,V$!U
M3\20%%EU3+['F!"U-J4&Y#;3H3WH.Q*0".HZ:RBN(*EP:[SS.<APOF4[*,Q<
M=CST]@ "C(4CS!V@#8[] -940%C:DN +0I*T'P4DA23[.A&X/74;(V,,W%:F
MRFIGS_GI3J%I<;;79ST16E(.Z/*BLR&F4)2?8!L?;ON=8F-21Z$(XU!R,VBI
M,F^C?AB75*;K8U0TVM;6ZNQMZ8_(?=2I*=NXI'Q'?;MT*2/0@TP;";+ERV7Z
M:97QXY[6)<I^$M,PA7:2TS&D/N(20-P5="-O ]-"CMH098V1T4R<:R):PI4X
M>9O&CO)?6/*W\W<M=R 6]NH)W&E46C%=A5UMJTAFR@Q9S33@=;;E,H>0AP)4
MCO2%@@*[5$?D.A!6TTTPTVPPTVRRTA+;3+2$MM--H 2A#;: $(0E(V    T!
M<T : 8[>3?,JCM4E7#FETGSY4Z?\I'B@%( +3;+\A]2P2?A&PV_-H!Z1W]B/
M,[?,[4]_9OV=^P[NSN^+M[O#?KMH"-N9?0MWJ<;,MU=NI:$&,U$ENI;4XV'D
MAQY#*F4#RE!1/=VI!ZD== 1?DUF+-B45;.:CS(<NV<<DUSZ&74OIA5LV6S)>
M9=2I3D2++;;"P!L7'6PK<'8^5]'687=V]]-I6V^ZM4L>VN.#/7GF9J[^EZ>2
ML7.1W+RBTLW'ED\.-*I5IZ.)K]/JX JW;>/\,FSFV<QM"0AMM,(//18WDCL#
MKD2P"/G2K<I6MX*3\.VO=6WJ+U4VDDXTQ6;PQ3[EAAVH\2V>Q?T^PZ>WJ'-W
M7"K4G\*;]U)<$HT27MQ,(X/01\AY"I<>NXLB7#F6[#]BQ6.2VU.L)<<DN'OB
M^1(CUX?:0'U)4-F5*[E;DD])UC>N:3:;\XRC&Y<C1<,&TFE7-\OTG4:'9Y:C
MK;1WM5%W;4YN3Y8-1CX:]SF=6W1J+E)T[L*)=):?'Z:@:=9IX#,%#ZDJ>+9<
M6X\I'<$%UYY;CSG9WG;=1VW.WB=>A3Z'+5^WD3L5#>.2*N+*4L^;(LT/NI0W
ML.WR&V4+27"?$K!  \#OT.O I[C\:]BP2C(;*-9SU/*7YL2*F*RTT4("6$A*
M4%TA:5*[RE)^+;;IH@/2U=B%K[5K[$*5V('<M?:">U"=QNM6VP'OT("5=R4J
M[5)[DA7:H *3N-^U0!("A[>N@$-A;5=2AIRSL(<!#[GE,JER&F ZYX]C?F*3
MWJ \=O :%'#0@@B557 <>=@5L"$[()4^Y$AQXSCZE*[U*>6RVA3A4OJ2HG<]
M=6*X@7+"E(4$J[%%*@E>P5V*(("NT]%=IZ['QUF!OK84R&VL3;>9;.K(/?)C
MUL9#6V^Z6&Z^%%(0=_\ 3%.*Z>.@'+0#!#<R9RUE"=%IHU*CS4Q%1Y4N39OD
M+V9==2J.Q%90ML;J3\123L"?'3&O<#W(<DJ,7@BPN)!894ZEEE#:%.OOO*"E
M!MEI'51"4DDG9( ZD:C:68+])=PK^ S95XE",^A"T&5"E0U'O2%$(^8:0A]*
M"=BMI3C9(.RCJIUQ0'?0%M#S3I4&W6W"@@+"%I64D[[!023VD['Q]V@$5K4U
MUW"<K[2*B9#=4A3C"U.)2I3:@M"NYI:%@I4-QL1HU7,',OU;\Q97 R*X]-W'
MJ*W$\;F81Y.1V:(:W;2>]E0=?%=5/B2W'JX'R""W+<6V^[)3,<2/**$K7]$^
M3_E;M'4NV_\ 4V\7+C5O4N-NU"BC6VDW*XY1?,G*6$53X<6ZT7K?J[KK7].[
MG;T>W6K3NQC&Y*5Q.2Q;I%132IABW6M<$J5>K/#OI8IN3<($J_LKKCS,JFTO
M%WLKY0V+D:DKXTF7'@,TDE]%8Y&DP6FI#4EC=;J]P'%))2GV[K]4M!9C)66M
M3&D''"$HMS223<9+EQ3]U.+S3.ZN^:G4-WJ6_N>T:A/:I0I:M7(*5N-ODBW[
MD91?.I1>+E7%K)I& JGCJ@O,2H\BB6<2#.;J4L6J6\?=M)]M)DO*G*1\K229
M4R38L)<\L-=CZBE W4@!9/5Z75Z;IU:K7^'8N6+R?B*]&3=%*<TW1NONR][F
MBVXQ3K!*5?I[6=':7JSI7;-^U&LCH]?;TD9WY6(J47=E",[JK&3E6V^:,:R;
M2JY<3JYQCQ7RW046+MU-=D..HK*;&*6DI\I?JWZJ;71X2&[2[RZKASI\['+-
M24M*AQ8<B,Y&6TOYIMQ3WDM>D=U\RH:?<;=G:H>+M<+?+/F7+SRRK!)M1BN"
MC@UW'%UOF5I]#J-/I-GC*_L]FPK<O$JIS:5%)5;Y<D\L:NIO'A6+LX9B]3C;
M,MZQ7 :?=G6<A ;?MKBQER+2\N'F4K<0P[;W$U^2IM!*&R[VI^$#7J;7:N[K
M]9<UM_\ FW9N3];/4FX:V[N.MNZZ_P#S;LW)^OAZLB4ZX;? XAYK !H"AQ/>
MA: M;96A20ML@+1W CO05!0"T[[C<$;Z L0XB(4=$9#TI\([CYLR4],D+*E%
M1*WWUK<5U/0;[ =  - 7GO.\ISY?R_/\M?D^=W>5YO:>PN=GQEL*VWVZ[: H
MC"2&&OG%,*D]OZ8QDN(8[R2=F@ZM;G:D=-R=SMOL-]@!?T : LO2(\8)5(?9
M82M8;0IYU#06XK[J$E:DA2U;= .IT!? W.J&Z%W5,"R^EY3#R8[B&I"FG$L.
MNMEUMMXH(:<<:"VRXA"]B4A220-MQXZ B^.T^45SK[M_EGX^E[JB,FEA5K49
M?0;M.QUJ=6G8>!V'V;[DQ5XC ?K67*@U\J7"KWK64PUWLU\=UIEV4ON2/+0Z
M\0VC8'<D[G8'8$[ @):&=;6->B5<TOX!,6XH?AYL&;)260$EMU<B.TRVE3A)
M^#;=.W7J=@ KLK6MIXQF6L^)710I*#(FR&H[7>K[J MU20I:MN@&Y.F0*X%A
M!M(K4ZNEL38;VY:DQG$NLN=JBE7:M!(.RAH"R[35#\U-D]55KUBE*$IGNP8K
MDU*6_P"C2F4MHOA*/8.[II0#EJD()8X(Q;7#UM.R/+"AQ;9:J8=V]7U3"$-M
MH+;3,-#4A/F*1W*4EU*B2=8\M77$I-R%(;(; 6I*-FPXXL!2DIV2''2EU8!(
MZJV4?;L=9$&& O+'7T*LF,>@Q=]ULPI-C9R"-SLA+[T:J:2HIVW5Y:@#[#J8
ME)">G7W>X;_O#J=4A$ZG+H]S;2*N+2Y*TW&0XI5O/IGZ^H<4VI*?):?F+9DJ
M>7W;I261N!OJ)U+0ENJ0U.]7F%6N2\?UMOC.,3<BR/'[UE9_!8$FPOD4$^!8
MQ)\>)#@(<L+&,Y9+AN.QVT.[>4'>W]%W)\Z\O-XL;1U%"YK;[LZ&<)*3;I!O
ME?+S\*)Y-Y.A[ \M]YT^S]1QGKK[LZ"Y;E&572#E3W>?A1/)O)TQH:>\-9+/
MXWQB]I^;5_J+4,VC3^ X_E5;:4F7RQ>NV-MD$B-2+BL6EM2KL7PXRM+#KL=Y
M,P.J2RV@(^CM-N.V[VHW]KO6[R4^24HR5*JG*G6E)4RX25*5=3TWYX:OIG2=
M:ZG<=LOO\GJ(PN7;DY1\)WI82\&6;AA&M6Z7'-1]SE23<]3Z_':R78,P9,CY
MYZ,QV5D9R4MYQ;?ELON)9[NV.RPC=;@!(0GH%'M2?:_3BC:TLIT=6U6B;?8?
M/._WY683O1A.ZX1;4(<O-+NCS.*;?"LDN\P3Z=N;T\796SCZ9#U#!Y-OZ2+E
MN;0;F+:1:R&R_/CXW)B53U'#0*J ;Q:I;PFI7V.+>W<2AIE'HKSCZ2ZHZCO7
M-WE?TTMOT-N3L6;<9>(X/E=QSF\)3I%-)>[1423JY=)Y9>?_ $A#=;/3LMOU
M^EU&KU/@W;VHE"*A<3<+:=I5<%S/EFF^:#>+E2B[UQFEQXT=AV0[+<98::<E
M/AM+TE;;:4+?>#*&F0Z\H=R@A*4[GH .FOE4^Q6S'<[,\G&1/45-Q]:V$9A:
M6W+NQF&DJU'?=QZ/(=KIC4F*A.Q"D++BCN WOMNJ\J&.>+9D@;[#< '8;@'<
M ^T [#<?F&J8D7FYGCE?=1L=?GE=U)=CM)KXD29-=9,KM\E<M42.\U#;4E:5
M;NJ1L@]Q^'KJ561:/,?IL*)8Q7X,^.S+AR4>7(C/H#C+S9()0XA0*5)W'@=4
M"6JI*>C96Q35<"K9<4%NH@1&8H=6-PE;ODH275I!V!5N0.F@"XK56\!Z BSM
M*@O%&\ZG?9C3VTH4%%++[\>4EH.;;*(3W;>!&@*ZJM;J8+,%N58S0T.LJUGR
M;*<\H[;K>DR5K62=O!/:@>P#0#CH0- ,]W=1Z**B7(B6LQ+DAN,AFHJYMK)+
MCO=VE3$)IU3;?P[=RMD[D)!*B 11V0H+0E8"@%I2H!:5(6 H @*0H!2%#?J"
M 0= >+<;;[ XXA!<4$("U)3WK5X(1W$=RC[ .NA"O0%IJ.PP7BPPRR9#RI#Y
M:;0V7WU)0A3[Q0D>8\I#:05*W40D#?IH"[H T!%,LR.=CL-AZMQJWR:7(<6A
M$2K:64M(;2%*=ER4M/B.@E0"1V*4L[[#8$@5"?#;[);Z/,D9#BCF+)0XU^'M
MOST2WY;3@<+OFL?+QWHRHW:@;K2/,*^B1VG<&/MU>T^.PC8W=A&K88<2T'I*
M^T./*2M:664)"G'WE(;4H(0E2B$D[; Z9#,OUEG N8$:TJY+<R!,;+D:2V%!
M#J I2"0%I0M)2M!!! ((V.@$*,7QMN:_9)H:?\1DO*D/SE5T1<QUY1W4XJ2M
MI3W<3U\?'2B ^*!4E20I2"I) 6GM*D$C8*2%I6@J2>HW!'O!T!CJ)QXIJV;N
M9^:9M:267TO-QW;E$.O^%7?Y2X5?%BM%E1W"D)[6U))!3MJ4%3(VJ0;XZ[4S
M9J)4:O;KD^5^'/QYLEZ:]\(\X38CE>PQ&V7OV]CSNX\=M"E5E90:>!*L[*0B
M) A,J?E2%A:DM-)\5=K:5N+))V"4@J43L 3H"!8ERGC^:6TBII8-\HQF77UV
M,F PU6]C:T(3N\B8Z^TI_OW;#C:"=COL>FHG4K5#)*DI6.U:4K3ND[* 4-TJ
M"DG8[C=*@"/<1JF(GC3H4PO)AS(LM4=00^F-(9?+"U E*'@TM1;4H#<!6Q.A
M2.Y-@^-Y@N"O(8+LX5RG3&;$Z=&:'G>7Y@<;BR&4N=WE)ZGX@!MOL3J-)YA-
MHE#+3;#33#*$M,LMH::;0-D-MMI"&T)'L2A( 'V:I")6M1E]A:AR#ES5#2MA
MHHB0**%+LWU=A#XDSK9<V*A)<)*"B./AV!&X*E1I]N!<"7-I*&T(4XMU2$)2
MIUP-AQPI !<6&D-M!:R-SVI2G<] !TU08^=S._=O%4]7@%_)CMR5QW;FS=9I
MJSL:64KE,.NMR52(Q"24; +6-MD]=8U=:4+1=ID361B8_3R?ACN1,XM&M%S;
M=Z4(01!ARI<9$D@E3:YC+2H^S6WZ125%+>Q[B.U6V/,JTXEHZ5,@:R(6VF6F
M0H,M-M!:UNK#:$H"W'#W+<4$@!2UGJ2>I.JE4##D5%,OF8\:/D5UC[*%K5*5
M1KB,2Y:%)2$($R1%D/1?*()!;VW[NN^PVR:J$.M9 15P(T!$F?,3&;[!*LYC
MUA/?)4I:G),R0I3KSA4H^/1(V  2 !<@6[47"HA%&NM;G^:ULNU:E/Q SW;O
M;M0WH[RG2CHGXP 3N=]MC'7@!:P'TLM"2MIV0$)#SC#2V&5N;?$IIEQZ0MM!
M/@"M9'O.J#6[F>SP*NMJ6+83;1G(,AO\>KY,.!,LH]=/C0Y*7E(MFTO-53Z?
ME5>4XWLMZ4A;;!0M182,[4OXL8-M1<E55HGZ?ECD>IO-;:]H6QW=\N6HO?(P
M5NS.DI22K5T2P]V/,U-JD'C5$/RJFCBFEU(=DF*XVZTP77B^]"0I"?*$9]X+
M>WB. +94M2UMJ V.R4@=R[:Y7;QY:>S_ $<#Y.CJ9K4K4TCXB:;PHI=M4L,5
M@TJ)KTLEF 7_ !1QS@U%EF1V-'27MN9U//N[);$F^M[2+/F-6$2"F,R[8_(.
MO5:GFH;#?8RPA'<"I)6>EGSRN-3;E<JUVY/@N"PR/L/I&[TIL'2&DWJ,;&BT
MUVS#GN3Y>9R><93HG)\R=%W9&PK$BMR6D:E0)IE5-Y6H>B3Z^0XR7X%A'"VI
M,24R6WF5.,.A25I*5I)W&Q&L<T>P[-ZUJ+4;]B2G9G%2C)8IIJJ:?%-8C)CF
M XGB;[LNCJ&XTU]M33\]Y^5-FNH<6EQQ)DS'WW$)=<0%*"2D*(&XU%%+(VMM
MDGF"6J+(3 <CM35-*$9V6TX_&;>(^!;[++T=UUM)ZE*5H)]XU2#+CD/)83,I
M.2W4*Z?<?\R*[#K!6)CLE/Q,*;2\]YH"ONJ)[MO$GQU%7B,. XV\N?!KY$FL
MJ7KN<V$_+UK,N'!5(4I:4GNESW68[+:$DJ422K8=$D]-5@28]/O+& 9%_0)Q
MN;YSB$UR;:-<J\E(3V/KE1&6F$EPD[('<0!U/7;45>('Q2DH2I:U!*4@J4I1
M"4I2D;E2B=@  .IU068LJ--CM2X<AB7%D(#C$F*\W(CO-J\'&GFE+;<0?802
M- 7>Q'>'.Q/F!)0%]H[P@D** K;N[2H [>&XT!5H" RN/XLS*H^4NY#E7?%>
M:DLU"+ET5"'FE)(0F.4%Q$-TIW<82L(620?A)2<>7&N):X4)]K(ACFL3RM(M
M65W+F$5U*U)47V:QNXG64F,DA0;0[*6Q&0IP#M\S9)3N26SL!K%<U<:4+@3"
M\NZ['*F;=6SRF*^ VER0ZAIU]8#CJ&6TI:90MQ2G'G4I'38$[D@;D5NBJR$3
MPSDBJSI^6W35.0M18:5%RTL(42/6K="D)3&:?:L)#JY*TK[^SL!"!NK;IO%)
M2R*U0G[CC;+:W77$---I*EN.*2AM"1XJ6M1"4I'O.LB%MB5&E)[HTAB0G9*N
MYAUMU/:L$H5NVI0V6!T/MT!"LAXXQK*[>/;Y FQLOE6D-1JQVP?;J6>T]RG$
M1(Y:4''E;%P]^R]@% @;:Q<4W5EJT32)$BP(S$*%'9B1(K2&8\:.VEIAEI [
M4-M-H 2A"1[ -9$(S*B9L_=-+C6]# QYI]I:XZ:J5,MI+"-BZPY(>F-Q6B^=
MT]Z$;H&QV4>AF->XN'K)=JD-!/6!EF32&Z#%V\"M&:*-?.3G,XDK>%3YS,!U
MB/!;4B.8@78IEN%*5.E[]"2E.R5 ^P_+FVGN-^\KL878VE%0;59IR3>#QI'E
M57')M5JL'Z1\\+\ULFDTKL3N:>>H<Y7$I4M.,'&*JFH\T^=T4L&HRI1^\L,<
M462VW@R[VH*'-@$K*P4]-CN4H/M]VOH;0.5[0SM32YEV.OU(^,-UC'3;K:U%
MMMQEVJGULW>HLZ@MS(D5J8E-BV^V9-?'5+8BRTNCNE(5&!%0)KK;A6E20VHO
M =RMN[7J#J/IG2:E758C%:R6,9/.J?&5*M-88\U/4?2?1/7FX[?+3RU,YRVR
M+I.$<N5IXJ#?*FF^;W5&K6.;,[%$"YKV_.88GU\]AB0&9<=#S#[+@;D,*<CO
MH4D['M4 H;@@>T:]+SA*W-VYJDXMI^E9GU-9NPOVHW[3K;G%23[4U5/V"B/&
MCQ&6XT1AF+'93V,QX[2&66D;D]K;3:4MH3N?  #6)L&R]J7[F$(3%S:T>[[;
MCLNF<C,S7&4I6E49+\F-*#"'%*"BI "P4C8[$@@AV;1Y;;;?>MSRT)1YCA[G
M%]J0GO<4  I:MMR=AN= #A="=V4(6ON0.UQQ32>PK2'%=Z6GCW);)*1V[*4
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MG;IW*6O<G=1Z  7Y[TJ/#D/082K*6VWW,04R&8IDN;@!OYB00RR-CN5*\ /
MGIH"Q2R;>7"#UU4QZ66IQ03!CV@MBED!/8MZ2B%#:2\I6^Z$>8D#;XR20,/2
M8/,KMKNHHHIFW-E"K(N_:'ILAMA*U^/EMA:@IUPC^2D%7V: 6QI#$R/'EQG$
MO1I3+4B.ZG?M=8?;2ZTXG< ]JVU C?WZ 3MU=8U-<L6JZ"W8/#M>GMQ(Z)KJ
M=DIV<E);#ZQVH ZJ/0#0"_0A"WL/<DY*SD,C*<H6U&=2]&HFK!J+2-J0GM"'
M8L6,R9+7CN'%*4K?92E#H5,2U)F?L\?9OT_?V.VA",UD_*7X]J_:X_7P'F4$
MT\&/>?.NSEI:=442Y/X?'CPDNN!"4J <VW42-D@J%P'S7#.X$++$Y,EQU^:E
MR.2L-141FT!()W05.DJ<4I(Z>.QT NT E#T@R2U\FI,<)W^;+S.RE; ]J64J
M4[XG;<[>&@%6@#0 0"-B-P?$'J- &@#0!H T : 8XU_&ES1"8CS5$E8+ZF"A
ME/8DJW5W*#B$G;;<I'4Z >U)2H%*@%)/0I4 01[B#T.@#=((3ND$CX4[@$@>
MX>X: 1SH#-@R&'U/);[NY2675-=_3;M<[?OI]NQZ;Z I@UD&N21#CI:*@ M>
MZEN+ Z_$XLJ5MOUV\/LT%*#+8L90_+4F%*B1H?=^C4G;O"=O%[O9<<*_'HGX
M=3$CJ2"(U(9CH;E23+?&_>^6FV0HGV!ML!(2D=/>=4HEF39D=]EF-5OS4N;%
M;Z'F&6F^NQ!+BB>Y(Z]0D'V$Z <@20"04D@$I)!()'4$@D$C0".38U\,A,J;
M%CK.VR'7VT+(/@0@J[R/S: 4K0U)9*%I0\P\WLI) 4AQM:? CP4E23H!!&K*
MJK*WH\>/%*AVJ=)Z['KVAQU1*4G;P! T&"'%:>]"DA:D=Z2D+01W)[@0%H)"
MD]R=]QN"-] )XD7Y1"D?,2I/<KN*Y;Q>6#X;))"0E/V ;:R2X@O/E]+2C&;9
M<>Z=B'W5L-'J-RIQMF0L;#KL$G<].GCK(A3&,DM RT,-O;G=,9QQUH)_D[+=
M:962?;\(T!:GSFJZ.J2\A]Q"5)2$1V5/.J4K?8!*>@'3Q) ^W1X!NA37SA8,
M?,"),B)[RA+<YE+#J@ #WI0''#Y9WV!.V^VBQ"=1:2$@E1"0/$D@ ?E)Z#0'
MH((!!!!&X(Z@@^T'W: C[&,TT>:J>F*79*E^8%R779(0YW=WF(#ZU[. ^"CN
M1MTVT21@W4?%=W:KMV"MCVE0)2%;=.X @D;^/4:R(,,"#>MSW)5A;M/QE)4$
MP8\9+;0)Z(V4ON<0EOQZ**E'Q.WC,2C^>@)VW^P;;G[!N0.NJ0;H<JPD/+3(
MJEP6$I)0Z],BO.K5N-D^3%4^A(VWZES0"N1(8B,KD27FV&&QNXZZL(0D;[#=
M2B!N2=@/$GH-0":OM:^U0XY7R424-+\MQ2 M/:LCN (6E!ZCP/@=$T\@6Y=+
M53GQ)F0(TE\)2@./-]Y*4[]J5)/PJ W/B#J@<6VVVD(;:0AMM"0E#;:0A"$@
M;!*$) 2E('@!H"Q\LOYHR?FY784A/RF['RH^';N ^7\_N)Z_TGC]G34 JU01
MR<_DZIGDUD&L;ACM_MV?(=<[QT[]HT93;J"-]@"5 [=2-]A,1B2!'?V(\PI+
MG:GS"@%*"O8=Q0E2E*2DJ\ 22![=4#._>,-3C7-0K.9(3V^88L-2H[7>D*3Y
MDEY3+"1VJ'7N('AOOTU!4>]4%A4F,A8:7(80XH@);4ZVE:B>@ 05!1))T!Z^
MPS*9<COH#C+R"AQ"MP%)5XC<$$?E!!&@+$"OAUC C060PR%%?;WN.J*E;;J4
MX\MQU9Z>TGIH!ILV<HD2NRLF54"!VIV?<:>E3RLI'>2RXW\J$A7W1OOMU)Z[
M"8E'.NBS(C!;G63MF^I967W(\>,$@@? VU'0D)1N-^I4>OCMTT(-MQ<V,!]B
M/7T$RV4\4A;R'1&BLE:NU(4^6G^H\5$A*4CV^(!LH_ME9;074I0X4)+B$++B
M$+('>E#A0V7$I5T"BE)(Z[#PU2"&RMJZH90_8RFXK3C@9;4L+45N$%00A#:5
MN*.R3X#IJ 6/,,R6G&)#3;[+J2AQIU"7&W$GQ2M"@4J'Y=4""#25-:ZX] KH
ML5UP=JW&6DI7V_S4J\4()\0-@?;J4*+9+2WX[[+3[D5QUI;:)#007&%*20EU
M <2I!4@G<;C5((JFO?KHZF9%G-M%J<*_/FELK0#_ *6CL0E01[?B*COX;#IJ
M <'O-#3I8#:GPVOR4O*4AHN]I\L.J0E:TME>W<0"0/ '5 UU8O\ ](J[<I^O
M1IJK9F_#U^\Y(EO_ !?#T[0T.O7?V:@"WO:ZD;;<GN.I\XJ2TAF._(6LI *A
M^A;6E&P/\H@:!N@I@3V+*,B7'3(2TY]T28S\5P] =PW(;;4I!!Z*&Z3["=9&
M LT(&@&]RJ@NV+%JMI:IT9M;++OS$D(0VM*T+'RR7A&45)</4H)^WH-2F-2C
MAJD&1N#=?BSLMZ[WJ_\ 2*IFOBH_D=OZ>8XEV0H!77X2G<^T#H9C7N*/>J0-
M 6WGF8[3C\AUMAEI)6Z\\M+33:!XK<<64H0D>TD[: L0I\*Q9^9@269<?O4@
M/,+#C96G;N2%IZ$IWZZ LSJ>JLUM.6-=#FK8!#2I4=I\H2HA12/,2K=)*>H/
M30"YMMMI"6VD(:;0 E#;:4H0A(\$I0D!*0/<- ('ZWYB<Q-5/LFQ'"=H3$KR
M8+I2HJ[GV6VPMXDGJ%*((&VVV^A1RT(4*+G>@)2@H/=YBE.*2M&P^#L0&U!S
MN5T.ZD[#KU\- 5Z B"LRA.7/X) KK:SD(=+,J1$B)$.(I*BAPNOR78Z>QI8V
M4H?#[ 2=AJ5*3#6252"=J3$6ZN*S(C+>CI'F1VG6E.L)W[4][*%%3:=QL-P-
M9@;KR@K<BB(@V;;KC"'D/H#3[K!#B I()+:@%CM61LH$==QUV.HP+:NIKZ6&
MW K(K<6*V2H-H[B5K4 %.NN+*G'75!(W4HDD >[6)@>6<>SDL-MU=@U6N^<@
MO2'(29RBP >]#+:WFFD.J.VRE!8 ]GMT X(24H0E2U.*2E*5.*"0I9  *U!"
M4("E'J=@![AH0;+2PE00P(E3-MG7W"CLB+BM(92GM*G'WI;[#;8(5\/CN1[/
M'0HZZ$+*9#"GW(R7FU2&D-NNLA8+C;;I4&UK0#ND+*#MOX[:%+VA!-'A0XBG
M518D:,IY7>\J.PTRIU?\YTMH27%?:=SH44Z$+331;+I+SKOF.J< =+9#05ML
MTUV-HV:3MTW[C]NA2[H0- 6GWA'8>?4AUQ+#3CQ;8:6^^X&T%90RRV%./.J"
M=DI2"5'H.N@$]?.38Q&Y:8TV('>[:/817(4M':HI_21W0%HWVW&_B.N@%:UH
M;25N+2A VW4M02D;D ;J40!N3MH# $^P;EVN1.O1WC*%I8QXEB_WNB15P7TU
M_P K&<!7'B,0Y\5U)83V%71Y0*G2H^W>D=-&UHK<N51G.-6Z9XNC;SR:PKAP
M/FOS&U\]1NU^#FYVK<W%5>$:12:2K1*J>*56\V:\V\6'C;BEQHZ9<5+_ 'A,
MQR?-G0VEA#2T0)+\UQM##"=UMM*:41U0E24=H1[)M:6W8C^8CA7-?2_2>*;%
MYAZE:BUM&Z14].FUXS;YXJM8\RHU)++@Z4>+6.PGIZAXZ]C-CD%8B5^.6%@N
M!D!FK9=5$>@[OQ(</R&F4I@F).0]XJ6I;A"EDH 3Z/ZZU^X:K=ORVJHM-:3=
MI)4]V7WGBZR=*/AA@EQ^C^BM5MNX;5^?V]R<I3<9N6=8\$J*B::DN...1EZC
MAY0Q)EO7]S G,N) BPX%=\JW'5W EPON+6^L=HV"5%7COOKPD\Q'&XM/P>"Y
M-^0L[,H4A"8=1#7.FNJ6=AVLH(V0GQ4HD #[=AH!'CUU,NX[TB50V=$$.)2R
MW:);;?D(*22X& KSFNSH"%I'4]">NQ.H'B5*BP8[LJ;(8B164A3TB2ZAAAI)
M(2"XZXI*$ J4 -SU)VT FK+:MN8ZI55-CSXZ'EQUO1G XVEYM*%+;*AT[@EQ
M)_(0? Z 7*;;64E:$+*%!2"I*5%"AX*22#VJ&WB-"%>JL00F9ACLZW_%)&59
M2EH/EY%9$LS A-M]=HS8AMLN(:[?A*@?,4GQ5N=]94+4F^J0@4R?R'^/(8@4
M=$* 24-KF2I[CDI<;O(7( ;>84PXIOJ&_(=[3T[E>.I[U>X$]U0)?FT_."%Y
M$HJ^7^8,CY=SY,#O\L-&40&C()Z]@)4$]3MTT H6A#B2AQ"5H.VZ5I"DG8@C
M=*@0=B-] -TNYIZ]U$>=:UD%]?8&V)<Z+&=7YA*6PAIYU"U=Y&R=AU/AI5("
MF;"CV,21!EH6Y&E-J9?;0\]'4MI7WT>;'<:>2E8Z'90W&X/0G0#11XICV-AS
M\%JHT%;J0AQY/F/25M@A7EKE27'I"F^Y(/;W;;C?;?422R#;8S<E7Z<4PC(L
MH?OH^-5^.UDVZMKA^"+%<>KKHKTF4B'%+K8>GO\ 8$,IV6IQ9"$I*U)(WZ?3
M7]9?AI=,G*_<FHQ7:VZ(XFOU^DVO0WMRUTE#1V+<KDY/)1BFV_8L%Q>!P$S/
MEBCR3D!WEU]&9"5?(CC,(=W+I[%$&150*^LJG\;;BOLS'(B:2M4Y.9(=6AQ!
M6R"CNU]R>5>U;]TOLCV+=_RUS16Y.5J5KF\2LY.4U<B\)4;]UPJTE1IJC7QG
MKO-_I/KSJ56-IL;A;W*Y!\W/!3M<L$HQDIVVW;35*NXE'F:55)T?17"\HQG
MZZ+8W5W38\<CMXL2/)NKB%3QYMR]7QX4:(P_,=92Y)>AUR0EM.ZE=IUS>JM/
MSZF:A%R<I)M9XT2R]2/8VTWX6K,7<DHK)5=,ZNGTFI^*0;WDWFV52W>*-_)Y
MGR3&K+6OQ=F<U02L*HK.OQ:_EU=Y7A?S$%>'T;IDSF7&CYRU@&.LI0WZSZUW
MS2;?L6KT]G4VX[E;M**CS*5RLZ.CB\4W&335/<3IBU5_;GEKJ]HV#R;NW]MU
MB_J>KG=NRC)1C*%YN-APA#FE6'+97+.OOIN=(\W(NXC[\6LA+>=*FHD)@%10
MV](4AEI(2.UMI+K[I"1X *4=?*C?%GK3-UXE4*8Q/BL38WG&/(0'&2_&DPW5
M()/:I4>6TQ(;"@-QW(&XV(Z$'2N%0*=8 -0'@&Q4=R>X[]22!\(3LD'[H^'P
M]^@+;Y>2P\J,AMV0EIPL-NK+33CP02TAQQ*'%-MK7L"H)40.NQT!#,27GSLB
MP<S%FEC1E!(@1ZPK6ZA8<4%E2_,>26"V!MW**]SU ZC15XE)QH03,/NNN2$.
M0Y,5+#OEM.OJB*;F([0KSXXC2I#J6MSML\EI>X^[MUT!>==;9;6\\XAIII"G
M''75I;;;0@%2EK6LA*$) W))V T VU=Y37:7UT]I!LTQEI;?5!DM24M+6"4!
M9:4H#O"3VGP.QVT**I-? FN1W9D*)+=B.%V(Y)C,ON175 !3D=;J%J9<4$C<
MIV)VT(. &PU3!NI&)U->S+Z#8-9._ IH7E+71Q*^/W3G4J*G?G+!YQU:F7AL
MDH2V-D_=*5?%IQ!*-4@Q2[&Y:M8L*'CSDNN=\LR[IRS@18\4*4?,#</N>GR7
M&T#?;RT)4H@=VVY$*/NJ0- -EE34]PEI%O55UHE@K4PFP@QIH94L +4R)+3G
ME*6$C<IV)V&I1/,HXH0EM*4(2E"$)"$(0 E*$I "4I2  E*0-@!T U2"&TKF
M[:"_7O2)L5J0E*5O5TMZ#+2E*TKV;DL*2ZV%]NRMC\220>A.IF4*RMBU,-N%
M$,@LM[GNES)4Z0M2NJENR9CS[[BB?>K8#H !L-$J AU\_P EN6!C8W7XM%KP
M>EE;39LIUQ._B8L9AA4=>WBG9X>Y7NCYN )M!3-1#C)L78[\]+*!+=B,N1XS
MC^WZ13#+KS[B&^[PW42?'IX#(@VW]M-IXC4B!16%^^[(0Q\I7KC-N-)6E:B^
M\N2ZVE+*2C;< ]5#?8==1E'EI2UMMK<;+2U(0I;2E)4II:D@J;*D%2%%!.VX
M)!VZ:I"YH T : T3YRM8?ZUYO8V-BP^G%(U;607G5(DLT;%A0U\^?1Q(KJPQ
M%N+:3.;<?6@>?*:DQ6E=R6VDI^F/);;M/_2+FO=I+4ROR7.UC**4:)-_=3KE
MA6M3X8_4MK]UW#K'3=.Z*]<NP_+VN2S!M\MV<I5;C''G:Y95I51IP-0LUP*-
MQ]B;34)OYO('* 3[H[1H*+.]M8K%N_"=6VQWB%2S75P:\NEQ<:$ A14=SKZ$
MZ:A;G;NZN$(PG*<U2.',E-J,I5Q<FHU3;PYFLCSK4Z:>@TMG;_%NW_"MP7/=
MDY3D^5<SE+O;QHO0ED:7\688SR9RIB_'ENZY71LBRA-9:*#L6(I3$H/6LZOK
MGU/2XT258,;Q8JU%T(?>0HH7L4'Q'S'W35[#L.NW*U&$]4K:HL6H\[4*OT)\
MS[>-*GH7;^CY=1^;^@VW?G8TT-PN*].%B3;C"U&5(N<HPK<N>#1R4<Y-I'TZ
MI*RE)6$I7VI[TH45H2O;X@E90V5I!\"4I)'L'AKX2/TE;KZ".7^88SBX0;ZX
MB5ZW4E33"RX]+<0-QWMPXR'I:V]QMW!!&_3??4;2)1L>8$Z-9PXUA#4XN++:
M2_'6['D17%M+&Z%JCRVF)#?<.H"D))'75 KT(&@&YJM2U92+,S+)UR0RE@1'
M9SRJV.A);/='KTE,9MY1;&[A27.I'=L2"*7ISLMF'(=@143IB&E*C1') B-O
MN_R6UR5-NAE)/BKM5L/8= ,>-NY@^F8[E<:A@A:V_P .AT[LR2^RV OSOQ"5
M(4&'7">WL\I &V^_7IJ*O$8<!WM;%JHKI=D\Q,DM0V5/+CP(SDR8Z 0.R/&:
M'>XLD_8 .I( )% W8UD*<FKC9-U%W3-%]3+3%]#:@RWTH0VKYEIAN3))C**^
MU*E%/<4G8;;$DZ@D"E)0E2E*"4I!4I2B E*0-RI1.P  '4Z$+$67%G,(DPI,
M>9&<+B42(KS<AA:FG%LNA#K2EMJ+;K:DJV/122#U&A1NLL>H[F3 F6M7#L)%
M8M;D!R6T'OEEN%M2EMH7NV5%323U!V*01UT \Z$&=^!9NVT6:U>28U:PT4/T
MK<*N6S-=(=V=>G/QW9S025I^%I:!\'VG0H\:$,<QKOD.7E*X1Q"!78NQ*<9=
MM9UJRY+DQVUE*941F(ZLA3Z %(;4T0-]E+2=3$N%.\R*2 "20  223L !U))
M/0 #5(1VAR['<G<GMT-DBR_#'$-2W&6)28Z5N!10&I3K#<>4%!!ZM*6/;X$;
MJU+2@^28L68T6)D9B4PH@J9DLMOM*(\"6W4J02-_=H"MIEJ.TVPPTVRRRA+3
M3+2$MM--H 2AMMM 2A"$)&P   &A"YH T!'K@98J5"30.8\S"[D_B+MPS929
M01W_ !B%'A/Q&2H-]07'0"KIL!UU,2DAU2##*OT1[5JH9J[FP?6A#C\F%!!K
MH27#L@2["2]&BI=*?B\M"EN!&Q*0"-Q1^T((FIM:)!KV9<(2T!:S!:?8$A*=
M^YQ9C)7YH'<K<GM\3UT**U)2M*D+2%(6DI4DC<*2H;*21[00="#12X[1XZPY
M&HZJ%5LO+#CR8C*6U/+3N$J><ZN.E 40GN)[0=AMI2A1U>0IQIUM#SD=;C:T
M(?9#2G6%+24I>:#[3[!<;)[DA:%HW'5)'30"2MAO0(J(S]E/MG$*4?G+(0!*
M6%'<(7^'0:^,4H]A\L*V\2= (<BGW5=6K?Q^B.0V:G$M-0?Q"'6MH"TK)DOR
M9KC:/)9*0"A&[BBH ;#=0CKP"[RY0O7LBM:=R*% K[-2EER+72W9K#;?3R^Y
MYQEK9[Q[@DK2/8H[]"K3',"RRLH51!DV5B^(T*(WYLAXH==[$=P2-FV4./.*
M4I0 2E)42=@-7(">HMZ_(*]%A7&0]!?+C:%RZ^= +R4_"I2(]E&BO.,*WZ+"
M2A74 ]#J)U&0G;AXSCZU2&HM%2.2AY:GVV*^M7(""5]BG4I94\$%9.VYVW^W
M3!#%CPZA$EAQOS%I1(96CS8[JFG AU!3YC#[2DK;6 K=*TD$'8@ZH,:8QQ54
MXQ>G(6[W)[6< ^E M;-+[)$AI3*U24LQV%3' VL[%PE(.RNWN (L8*/:')LR
MCK,@: - 6([KCR5J<BOQ2EUQL(D*C*4XA"MDOH,61)0&G1U2%%*P/O)!Z: P
MO:3&9.6YHW,0VOY!JEKVWUE+L1NG=JV+%V&XZM2VF)2[-UUR0Q\"@R(SBTE+
MB%'G:*,7S-K&OS4_TGRQYUZ_5?\ 4=O2>(O C8ARQC.K56Y2YH_=E)\OIC"+
MKP6.LE<9=BE<=;3C)"@VME2%M$)V3LA2"4$)*=NGAMKLN.&1Z3SE4TTR[ J;
M*LLJXRH,!-M>W%53-3IBW&XZ'K*9$K67I:4K#:VFRIOO^%2E)0  2 -:+O):
MC*]RISIZWPS[#O-DTVMWS<-)T]&_*&GO:A**E)NW"4L')0K3FIV4<L%4ZQ8M
M42*#&L?HI<QNQDTU+653\]J(B"U,<KX3,14EN$AQU$5#Q:[@V%$)WV!UTJ5%
M0^[M'9GIM):T]V7/<MVXQ<J*/,XI)OE6"K2M%ED+D0Y"9JI2K6>XP0H"N6W5
MB$@J\%)6W6HL"4>S=\CW[ZIR1?H!$\_-1,ALL04O0W4OF9-5+0R890E)92B,
M6UN2B^HD="D(VZ[[] %N@,<2N4\4:M$4U<NRR*>7Q'=;QVN>M&HSA5V_II2"
MB*4I/WNQ:^W8[[;:QYEDBT9D<C?H>H/0@^W61!-'E0Y/F(B28S_RZO*=3'>:
M=\E0W ;<#2E>6H=IZ'8]- 1#+<&CY@Y%5,R'**R/%3LF#26,6!$=<*BHOR$J
M@/OO/%)"1NYVI2/A )43'&O:5.A)::IBT59$J8:Y3D:&VI#;DV4],E.=[BWE
MK>DOJ4XXI3CA/L2D=$@)  J5%0F8DO!DRVD-8X:2.XO^EFW!FOACQZ,U\1MH
M/J/392I" G^:K4=> PXCI!;EM0XK<^0W+FML-(E2F6/E6I$A* '7FXWFO>0A
MQ>Y">]6P]NJ#'MIR9'A7J\?@8KF%Y,:=#+SM?3*:B(7W!*NQ^>[$"VD'Q=(2
MP1LH+*3OK%RQI1EIA4R9K(A3WH"PV5H#A25!ON'>4@[%03OW%()\= ,>18S2
M97 35W\-4Z F0W*$=,N;#!?:0XAM2UP9,5UQ*0Z?A4HHWV.VX!$:3P83ID4X
M]BN/8I%5"Q^JC5K#BN]WRO,=??4"HI,B7(6]+D%'<0GO6KM!V&PT22R#;>8X
M6;-C(AN,U4]BMF+*0F9(@&R2TC^66XWS<-!>V^ZI2E(2?%"ATU7W JK8\R+"
M88GV"[26V%^=/7&CQ%2%*<6M)^6BI2PT&T*"  /!.Y).YT K=+@;<+*$./!"
MRTAUQ3+:W DE"''4-/J:0I6P*@A92.O:?#0%N,J4ME"IC,=B01^D:C27);*3
M_H)#L2$MP?E;3H")Y?FF(XJPB-E%@VPFS9>;1"^6DS'9<<CRGPIB*R\4LE*R
MDJ7VI/4 D]-%)P:DG22>!)0C<BX22<&J-/)IYHQ!F7&O'L?C]W*<1I*W'?P2
MM1?-6"8RZDNU$-/S%DNX7.2S)=":M+K@=D'O"D))5V[@^P.D.M-RV_?K5S<M
M3<N;=>ER75.3<8J=%SI/"/(Z.J7PIQ69Z:\R/*S8]YZ0OV-@T-FUO>FAXEAV
MK:5R<K=7X3:]Z?B1YHI2;]]QDZN)#N(\NP',<C&,UM[C,^\C-?B=A6Q9]3+M
M)=9'8@2Q*$2.^_*>K)#D]EM;RT>2H%:-]RG?R#K/JK:M1IKMK9[WB7Y3Y*Q4
MHT6;DFTJI_"FLZO@CP[RR\N.I-%KK&JZFT<K&BMV_$I/DES2Q482C5TDOC::
MJDE6C>&X!0/++2-VT]G8GR]DEL=O:/+Z;)*!X=-AKT_GB\SZ6225%D1'%\(J
ML4>FRXDRZL9UBE"9LZZM'["1(\M:EI4L$-L!84L_$$ ]=M]1*ADW4F.J0:*A
MN^0V\;Z5427E.;QTU%?-A-LM#N^%Y<RRGJDN*Z=4I: V/0[] ] Z.*4AMQ:6
MUO*0A2DLMEL..J2DD-MEYQIH+61L.Y24[GJ0.N@$T"2_+BMOR:^55O+W[X4U
MR"[(9()'QN5LR?$4%;;CM=)V/4 ]- *EK0VA3CBDH;0E2UK6H)0A"05*4I2B
M E*0-R3T T!:BRHLUAN5"DL2XSH):D17FY##H2I2%%MYI2VUA*TD'8G8@C0"
M2PIJBU7$<LZNOL'(+OGPG)L1B2N(]ND^9'6\VM3*B4 GMVWV'N&@'+0#9'KW
MV+"3.7;V<EF0CL162!6_A\4]Z5)<C>17,30M*1V_&^L$$D@JV( <] 1.CO+^
MSL[&)98E*H8,+N$>QEV<&49[A<2&TL1H8< 0IDE:E^8H((">I)[0)>D>W6+,
M6RK4,1!(JJN7(9F2JV!)EQQLQ*D0X[TA@;D[,ON-J=;&Y_DD:%%^A".Y%C<;
M)6(\:78W4*.PZIUQJGLG:T3.Y/;Y4QQ@!YUE/B$A21N=_=IF5.@\PXC,&+'A
MQ_,\B*RVPUYS[TEWRVTA*?,D27'7WE[#JI:E*)\3H!#:M7KWRR:6;601YA,U
MZP@2;%9:!04MQ&6)]>A#BQW;J6I0'39/M #OH0:9-NW&LX=5\C;/NS&U.B7&
MK)3U9&0DK']N68;$..XHH.R"LK\#ML02**&T%#:$*6IU24@%Q>W>L@=5*[0E
M.Y/N &N&=P6'79:7VVV8B'&5 %R0N2&O+Z]0EH-.K<(3U]@)]N@%6@$K\V+&
M<;:>=[772 VVE#CJSN=@2AI"U)22/$[#0"K0!H T!X$A.^V_4E1ZD]3X^).V
M@+$KYKR5?)".9&X[?FBX&0-_B*O*25D@> &V_OT 1A+#?]N+CK=)W_M9IQMM
M(]WZ5YU2S]OP_DT!;E3!&*$B-,DK7U"8L=3@ \/C=44,(W/L*@?S: 5@[@$@
MI) )2=MQO[#VDC<?82- 6WGV(Z>]]YIA'AWO.(;3[_O+*1X: ]:>9D-AUAUM
MYI6_:XTM+C:NTE*MEH*DG90V/VZ 3(KH3<A4L1T&4HD^>X5NNIW&Q"%NJ66Q
MMTV3L-NFE!1"AY#CC3B&7?(=4@I0]V!SRU$=%]BB$J(]QZ: CT*@F1YB)<B\
MF2^Q7>6BE;:'#L1VK!D/)*-CX #4H2@_RG7&([SS3"Y+C:"M##9 6Z1X(22#
MU/Y#JE&^IFV,U#KDZN_#DI4$LH6XI3KGB5%2%(04)3TV)\= +)DZ)7LE^:^W
M':!V"EDDJ5L3VH0D*6XO8>"03H"S7VT"T#BH+RGTM$!:_EY+2 5;[)"WF6TJ
M5L.H!)'MT%:BLQXY=\\L,E_I^F+2"[TV _2=O?T ]^@+V@&B51UTZ2)4UMR6
MM.WEMO/.&.T!MT1'0I#6QVZ[@[^W?5)0=P      -@!T  \ ![ -$JE&YE5L
MJ:Z'VH#=>DJ#*FW'W);GB$*4"A#2-QU4.NW@"?'6>/J)C7N%[BPTVMQ044MH
M4M00A2UD(25$)0@*6M1 Z  DGPT!'6,A<E2TQHM);K;)V5*?C_*L('M45/E(
M[1[B0H^P'4K7($EU06VWF7N[RG6G>P@+\MQ*^TG?8*[2>TG8^.@+<J)&FLF/
M+9;D,J*5%MQ/<DE)W2=O>#H"XVVVRVAEE"6VFD)0VVA(2A"$CM2A*1L E('A
MJHC? C=Q6WTZ6TNON4UL1M "FT,E;BG"25N+/0.=-@$D@#;[3JF!(6&UM,M-
MN/+D.(;2E;ZTH2MU20 IQ26TI0DJ/78#;0"5R3,3*2RW7..1RI 7,,F,A"4J
M[2M89*R^KR]STV!)'3IUT OT QKR.E1._#?G?,F^8&O(8CRI)#A.Q05QV'6T
MJ2?O;GX?;MJ55:<0.[S#$EM3,AEI]I6W<T\VAUM6QW'<A84D['[- 4L1H\5O
MRHL=F,T#N&V&D,M@^&_8VE*=]AH"MQ'F-K;[UM]Z2GO;5VN)W]J%;'M4-4 T
MV&6T-)4XL(&P4ZXMYQ7M)6XXI2U$GWG][0%$D22PX(A83)V'E*DI<6P%;C<N
M):6AQ0[=^@(ZZ \BIDH8;3+>:?D 'S'6651VE$J)':TIU]20E) ^\=]M^GAH
M!LM+M%8XRPFNM;!]X!26Z^$X^E*2I22IQ]10PDCM.X[BH#8D $'4J4>$**T(
M64J05)2HH7L%H*@#VK"2I/<G?8[$C?5(>%UI+B&E.-I=<"BVV5I#C@0-UE""
M>Y00#UV'30%2T!Q"D*[NU:5(5VJ4A6R@0>U:"E:%;'H001[- 1^+B>/0WT26
M*QH/MK\Q#KKLB2I+G=WAP?,O.CS$J&X5X@^&I1%']P+4VXEI8;<4A0;<4CS
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M4[G0%NJMZZ[BF;5R4RXH=6SYR4.MI+C825I >;;4KM[AU V^W04H.6A T :
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M W&_B-*I 4U]E7VT1N?63(T^&\5AJ5$=0^RLMK4VX$N-DI)0XD@CV$: 7:I
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MS(>,>.^^&7I!89=>#$=*5R'RVA2PRPA2D)6\YV]J05 %1'4:%( WG%S+EB)
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M$2)'@L)CQD%ME&Y2DN..$=QW.ZW5K6>OO.@$MFBU<:;15/1([A7NZ[)0MPA
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M(Y?;C!6YZE3S@*4I2/L).H0]AKF.1T*G,,QI!W[FF'U2$)&_P_I%-,_%MX@
M@>\Z>D%UUYIA/>ZL(05)1W'?;N6>U(Z ^).@+NJ"RTPPP"&66F0HDD--H;!)
M.Y)[ -R3J O:H$+==&;EKF_IW)*^[93TF0ZAI*O%MAA;A881_8I!ZZ@%VJ!%
M%9F-+=5*FB4%J):;3%;CH93OT2"E;BU[#VJ.H!;J@3L/^>%GR7V>QQ2-GV_+
M*^W;XT#N5NV?8>F@*WGV([9=D/-,-)V[G'G$--C?PW6LI2-_RZ IC2HTQH/Q
M)#$IE1*0]&>;?:)2=E .-*4@E)\>O34!?U0&@&MZ)8NSFGV[9<:"V$]T!F%$
M4I]23NKS9<A+[@0OPV0E! \#OUU,2CIJD&5J9<N6CD9=,ABJ1WA-FNQ84X\0
MG="FH32%N *7T(6I) .^_3M, ]:H+"GPF0W'\M\J<;6YYJ65F.@(*1VN/[>6
MAQ?=\*=]R = 5N,LO=OFM-N]BNY'F(2OM5MMW)[@>U6Q\1H"TU,ANNKCLRHS
MK[2=W&&GVENMI!"=UM)45H2"0.H]N@&:[QMB]6W\W8VS,="0DPH<IJ/$=.Y)
M6\CY=;CBR#MU7L .@'7>4#51PJZF#3QOE8#1;;*N]96XX\ZXL@ K<==4M:CL
M/#?8>P#0#7<LY6_(:322JB%$&WFNRDOORUGH5=K7RZXX0.HVWW/CW#?8!B25
M.X "B"H =Q [03MU(&YV!/LW.J"(7F36%9+$*OQBXN5A*"N0RR^Q!!6D*"42
MQ%DH<4E)^+H D]-]]]L6Z9($L96IQIIQ;:FE.-H6II?WVE*2%%M6W3N03L?M
M&L@6DRXKCZXK<F.N2VGO=CH>;4^VG=([EM)47$)W4!N1[=$1O@>2HL>;'=BR
MV6Y$=]/8ZRZD*0M.X.Q!]Q (/B"-QJYF!9@UE?6-J:KX46$A9!6F,PVSYA2"
M$J<*$A3B@#T*B3J))9%%3J"ZTXT''&BXVM =:(2ZV5I*?,;4I*DAQ&^X)!&X
M\-4@G@Q#"CA@RYDW92E>?.=2](/<=^TN);;!2GV=.F@$EU(MXL+S*2N:LYOG
M(28[TEN*D,D+*W0MQ2$+4D@#M[D^.^_38@7ZQ=B[#:<M6(T::KN+C$5U3S30
M[CV)\U0'>OM^]MT!Z GQT!9N;JOH82I]F\IF.%I:!0VXZM;JPHH;0AM*CW*"
M#U.P&W4C1NA3RDN8U]!381&9;+"W%MH$Q@QW%]G;NXA/<M*VB3L% D$@CQ!T
M6(';0@: 3LQ66''W6_-[Y*PMWS)$AY/<-P/+;==6VRG8^" D?9H#V3\S\N]\
MGY'S78?(^9+@CAS^27O*!<*!XD#J?#<>.@&ZF:O&F%_CLROER%*W;_#XKL=M
MI/7=*G'7E%[?IM\"-MO;H!PER4PXK\I;3[R6&E.EJ*RN1(<"1OV,LM@K<<5[
M /X- ,M!D*K\27$TUM6,,*"$/6;#4?SU;J"DMMAY;O<C;XNA2#TWW&HG4H^2
M),:(T7I4AB,RD@*=D.MLM)*CL 7'%)0"3X==4AZS(8D(\R.\R^C^>RXAU'_7
M(4H>S0"&91U%C)9F3ZZ)-DQT!MAR4RA_RDA9<'EH="FTGO5ON!OOM[AK)+B!
MTUD"'2L=R&99N3/URFQ(/F]S%="K8K09;!!2TN0XZ\)!Z=5+;._N Z:Q=2-T
M)MJ&!'8$[(GK69'L*)F'5(+B8-@S91Y*W?+40A;\?=MU")*.H 3NVKH=P>X"
MX$BT(-\*VK+)<AJOL(<Y<524R4Q)+4CR5+[NT.%I:@DDH(_*"/$:%%+\6-)[
M?F8[$CL)*//9;=["=MRGS$J[2=AX: K;4RH=K*FREOX>ULI(1M_)V3T3M[M"
M%$B,U*0EMX.%*76GD^6\\PH.,K#C9[V'&UD)6D'8G8^T'0%_0$:NTY<J1%&.
MKQYN* #,5;BP7)*_,\&$1!Y1;\OQ[B%%7M ZZ%)+H0C<S(7(EU$IT4%]+1)+
M0<M8L$+JHOFG;N?EK=0D)9'5SV@> 4>FA22:$&U5S3H=4PNVK4OHW[V53HJ7
M4;>/<V70M.V_M&A2_,A0[*.J+.C,3(KA0I;$AM+S#G8H.([VU@H6 I(.Q!&A
M#R%75]8T6*V##KV%++BF845B(TIP@ K+;"&T%9  WVWZ: QG:3(F36;[JV#.
MH:YKY.&U,1W5T^Q3(DILIR82U%J?%:2VRW'>=1VDAQ36[:TK7Y_TWM/AV'J=
M3!>)-IQKFH]O=7VT/3/7'4:U&L6AT-QO3VDU.C:C*=:-8/WE%*F.%6\UG#<I
MG.+9#:E)#3""AAEM"&6&4;#X6F6DH;0-DCP'L^S7LW9M-;MRK!4;S>;?I;Q/
M174FMNW84N2]V-:)))*O8E1*OSFI>?2YH0[\@TS(D]P"&GW5,MJ&^Q)6$J((
M'7;IOKN=SE+E484KWGC&Q0@YRN7*T[AQX,M\JILZI'V(CL^38R&H%W6TZ)<J
M.*.4\U'?DO(""4-5+CR9!>4$H#B "L(5MKUYU9I-)=VJ=W5SC'4QQ@VZ8K[D
M5^TJ][>.5$O<WEYN.X:7J*U:VZU<GHY^[=C%5]UNGB2?#D;3622PS;;Z6Z].
MGTX&@ G;J>@'4D^S0!H",4>*0:&5+FLS;B?*F)[77K6R>G%*2L.$-I4$(!4I
M(W405=-M]M*"A(9/S)8>^3+ E>6KR#)#BHX=V^#S@TI+A;W\>T@ZR2J"U %@
M(R/Q14-4SN5WF A]N-V]Q[.Q,A;CO=V^.Y\=9 6: - )I4R)!9,B=*C0XZ2
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MC)M^ZL7*K34GSMJJ35>6CJG0P+R4N.^U8%Z&R(TGYA+D&+%*HJ67^]*HK41
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M:K+,ZD8DQD,3'*>)E3T*3?1($6+8S($B1)8G2([#;3DTN28T1T/2EH*UI[2
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M(,=\15,HE%ET1ER&UNQT2"A7DJ?:;<9<<92YL5)2M*BG< @]="&+L=H>5$9
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M]RYB0H+?PB-'8<4_(WW)4IYU+SC!2!L!V@$G?P]I5XD'M2@D%2B E(*E$^
M&Y)^P#5 EAS69R%.L!_RTK* MZ._'#FPZJ:#[;:G&_\ 1 =I]AU *]4!H!HM
M*.ON"P9Z'G4QR2EI,F0TRO<@_I&FG$H6=QX_>^W;4 [    >   _(.@U0>Z
M- ,RK21^*(KFJF>XQT\ZR4E+4-O=LK^!3A!?V.R3V^T]-]M0#SJ@86\FH7I[
M=8Q9,OS75J0VU'2\^DJ0DJ4"^RVN.GM2D[[J'AJ511TEP84]M+4Z+'EM(6EU
M+<EEMY"7$[@+"7$J3OL2/R';0A?;;;90EIIM#3:!VH;;2E"$#W)0D!*1^35
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MTD?#T\->GZ(^F!?/:EOPI3,"6F!-=8<;BS5QDS$Q'E)(1(,5;C2)'E$[A*E
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MDP_4-S<*YYT.M-RZ;BF5+04M[% ?:XXBVOD*63L R$[;;]Q 4>1^:N?B?L/
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M+C,9Z/'L+NS7(6EQ^5>6LFTDK4@$ I+I2RP#W'<-H0%'QWV&T2H&ZCQ/^?\
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M2A!=4-_%6YT ND,_,-I1YSS':_%>[V%)2M7RTEJ1Y*BM#@+,CRO+<&VY;4H
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MZVRTG[SCJTMMI_LEK(2- >,2&)*/,C/LR&]^WO8<0ZCNV!V[FU*3OLH'\AT
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M<6E(405%3;+8 /\ *6"?8#L=0A7C]Z]>QU2E4MK4L]"RJS;CLJD ^UME#ZY
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M)89D-A06&WVD/("T[@*"7$J2% $['QZZH+J4I2D)2 E*0$I2D )2D#8  =
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MZ-(C>=&0G<!*HC2^]E*=MMBD ;:89 IMZ>#>0U0+%,E<5:TK4B+/GUSBBD*
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M%#=).RDJ!'L.^@(ABO'>+8=+F3Z2)(;FST+:D294Z5+<+"W4/ED!YU3?;YJ
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M%@@C?H1MH"B9"A6#"HT^)%G1E%*E1YD=J2PI23NDJ:>0MLE)\.G34 I
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M8EM24I!W <5XZUXU[CV9[M.-2=+6EM"W%=W:A*EJ[4+<5VI!4>U#:5+6K8=
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M]?Y:DI"1U\  -"EVP-@(;YJD0W+#M'RR;!U]F'WE:0HOKC-/OA*4$D!*=U$
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M2>ONT!?T W2:[YN7&D+F36VHI2M,-AX,1G74J4H.2/+0'WMMQ\)7V?#X=3N
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MCQU2%F)7P8"5I@PXT1+BNY:8S#;(6KWJ#:4[[;]/</#4 LU0&@&:Z7>(CH_
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M\  =QJ4 [:H([&_6A5U(5+_"$4*2\F.ADR#8K'^D.+*DEGNW3\0W  5TWVU
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M("4@)2D )2    -@ !T  T FFPVI\5Z&\N0VT^D)6J+(>B/A(4E6R)$=;;R
MKMV.Q'<DD'H2- 4U\"/61&H47SO(9"@CSY$B4[\2BM14])<==5NI1.V^P\
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MMU/0#J2?9JD&2LR3'[J1)BU%U66<B& J4U FL2ELI*B@*7Y*U@)[QMOX;]-
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M(3T!/4[>P>/YOMU01Z'9W<NR+*Z!<&J2%@SIDZ,)*U!*B@MPHY?.RU[#JL;
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M>D1EJ'O0M2?MU0,=_F&,XLJ,B_N(M8N9W&,A[S5..I0I*5K"&6W5AM*E@%1
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MU)/V: MWDC)6OEF\>KJR6ISS/F)%G-=CM1NWM\L!EAI;KP7N=R%#;;PZ[AZ
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M#N_8HJ0KH=MP"&8+.-XM2XG#=@4<546._(5*>"WWI"W'E-MM=Q<?6XL -M)
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M(EQ8\I#:PXA,EEM]*' " XA+J5!*P"1N.O70%]*4I2$I 2E("4I2 $I2!L
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MMX;>&I^8O+[S'AP[!\_S'?6-_P H;$?]=9'_ (+ZOYF_^)CPK?8'^8[ZQO\
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M$>KBW8^5L/4!BC\?N[BT+'*V4+.Q'Z01\<:\Q(!\%;C3\S?_ !,>'#L+53Z
MO5C11U1:CGC"H+#CA=<0S(R3=QP@)[W%KQA3BR$@ ;D[#H-/S-_\3'AP? =?
M\QWUC?\ *&Q'_761_P""^GYF_P#B8\*WV!_F.^L;_E#8C_KK(_\ !?3\S?\
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M'IXZ M3,8QVRG(LK"BJ9T]"$(3+F5\62^E#9);'F/-+.[9/PGQ3[-*5(W0D
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ML<AFNR)4-AJ-20I"I)+CK044!"5!:T[\'<;T+>FE;='.:HEGGA7U5K]9[/\
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M_18Y#%AD-U4T,!3R(XG7-C#JX9D.)6IM@29SS#)><2VHI3W=Q"3L.AT!%?\
M&SQ7_P"W+X__ /ORQS_Q2T!.(DN+/BQIT&3'FP9L=F7#F1'FY,67%DMI>CR8
MTAE2V7X[[*PM"T$I4D@@D'0"C0!H T : - &@#0!H T : - &@#0!H T : -
M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
MT : - &@#0!H T : - &@#0!H T : - <-/4#QM6<K?4!RW$;?YCY)[#L?GK
M$:QEU;A5!PRE<2DRX/\ ;2$*[MB$[$^\:[?8];/0:]:BW3F49+%)Y]SP,+D5
M*-'D9EJO1;Q+![?.H8LDIV)_%+7*<D03T))9O+MYC92DC<!(3]FW37EESJ7<
M)Y3IZ(PC_LQ-/A0[#(E7Z9>(*HH5%PK$H[B4A/G0L1QR+(4 DH)7(-<^^XM2
M#LI2E*4KKN3OKAW-\W*YA*[<:[YR:]E3)1BLDC(;'&F)QXCL%J"4Q7FW&ULI
M\EMDAU ;65,-,-QU]R!L0I"DD="".FN&];J)2YF_>1<# ]?45M4E::^*B.'.
MWS% K6M?;OVA3CJUN*">X[#?8;ZZDY178HL7(Q16.QF)2EI'FRD+<0AOKWE*
M$[]SGNWZ: K@M3&8R&YTM$V2"2M]$=,9)!.X2&TJ4GX/#?IN/9H!#.MUPY;,
M1NJM9I=["J1%B]\1I*UE'Z20I24!2-MR/8.N@'G0""=:5U:&S/F,1?-)#8=5
MLI?;]XI2-U$#?J=MAOH!<"% *!W! (/O!&X/[F@$T:!"AJ<5%B1XZW3NZXRR
MVVXZ22HEUQ*0MQ14=]U$G?0'LQE]^,\S&E&$^XGM;E):0\ID]PW4EMPA"B4[
M@;^&^^@$%/5R*QIY$FUG6KCRPLKF+W2UMW;AA!*U-A95U'<1T&P'M!"V:[,:
MCJ7!BHF2-P$LN2!&1L=]UJ=*'.B?<!N?L\= >PUS'&$JG1V(SY\6H\E<E &P
MVW<7'C[*W\0 H#WG0"K0!H"E:T-(*W%I;0D;J6M00A(\-RI1  W.@+3[*9;"
MF_.>;0ZD;.Q7E,N@'J%-O-GN&X]HT E@5K=>'.R58RBYMN9]A)FE('L;#[BD
MH_,-] .)WV.VV^QVW\-_9O\ 9K)+B"*L0LN>EAV=<U\2(AP*$:K@AU4AL$'L
M<=L$.+8[AN"4E1]VWLRQ)B225(^5CNR"S(D>4@K\F*T7I#NW@AIH$%:SOX;C
M0$?@7MK82TM#&;"'$[MG)E@\S%*$]>J8W:MQU6W@$DC?Q('70$D<<;9;6ZZX
MAIIM)4XXXI*&T)'4J6M1"4I \2= (8%O66BGT5TZ/,,;L\[Y=P.);\SN\O=:
M=TGN[#ML3X'0%R76U\]3*YT&+,5&*RP93#3X:+G9WE =2H)*O+3^X- *4I2A
M*4(2E"$ )0A"0E*4@;!*4@   >S5,&ZC/.J')TII\W%O%8; WA0I#,5APC;<
MK<;8$I05[07/R;:$'D#8 =>@VZDD]/>3N2=4"1<B2F6B.B ^MA20I<[SHB6$
M$]VZ/*+_ ,VI2=AO^C[>OCX[ :2>J!_C'CF?&S.TG\=XU=7JUNW-ED4NPN,Q
MF_*,Q8T!.&X9^'Y)$=FN(;*%2TURTLK\LJ6R?TR>)?C"+Y_=3>;>?J7]@-7:
MOU5\EQZA6'<$\=P<;@V%@[*_77D&+8SLJN;*P[&I4Z/B;%G/<DVTAQI!:?E.
MEIUOM3\LWL -"U#A'EMKULHIO?31S;GK<7(O5!RA)QRHG$38T7F3*UX35.!+
MH67\?X:QIB1E;P2I04E3%065)[-U!.QUIE<G/XFV"IJH]'/$C"B[9YKR*MA)
M*E4,''>%,+E. CM;<N[]K*\LGL;#=:EUT!T[CJ#OK #3"]5&!JE.T_#7IXX\
MN)[: ?*BX/F?.V3+*BH(=><RV;=XLHK\KX0S6L-E04>W8[ #+51R!]1K*$]F
M#<3<P8HQ(W:2U%HL$]/;00KR$E!9C1\1^7:W4D_$$CX.X]4$I 5RN(?J;9*V
M7KAB[8=DKAE;&3^HJ3>O]Y:"=Y"ZVTL(ZC#" @J\S9/3L*P-] .1]*GU"MM_
MUJP4]/ <PY_N?LZT(&^@&YG@7ZD]#YTBL<1(<\QGM3C_ #W;U$A\-N'9P+L'
MH*=F^[N3WE"D]=@2=M $S(_J<XHTMG)<!YCR&#%6K=LYGAW-3#R%&4KS&Z^R
MGWJY0<2C[JFNX H2H#]&"!B>]]4DVD?$7GSTW8E72) ;;D.<@<$7G#]U)!"D
M;HN.,Q@X1)7W='E=X^$!)V &@+L;(?1URK%6P_49MQ_)=24^;C=YC?,F),E0
M':_*QC(6L4R>&V%*[5H_%9:P.H!)[= )ZKTFS&K%61^EWF&GMKUP_H(/&N76
MG'W(+S86AOR)?&>9II';MM3A"5QZS\2;<!'4@@ZRC*476+:8'3_.6]4/&'XE
MA'+F/2<R8$9V!86$*O/&',%(R^EQIV8U"DPOP21,CLJ_0=D9F0MQ/<'4KV4.
M1'53I2>*[<F"8\3Y3@?-^34M;7<S6M?F=3,9L:Z+FV/QH/*+9KGVUOU*["1/
M@V;DE41WM ;F7D%:.]82PL>0+!1N25)^]WY_+V@Z<S3.$5XUJ(KDWM'RZ)KK
MS,4J*DA1><89?>"4H)("4GN( W&^X[ @STB,K#CZLA?HE-';Y=FH:G=R3OU*
MWI:T;) Z=O8HGQ[AX&#$6W-Q%HX?SLMJ6\V74LI;A179;RG%I6M([&QLA.S9
M^)12G?8;[D;@*X,M,Z(Q+2Q)C)D-AP,3&%1I38)([7F%[J;7T\/=J@O.O,QT
M%Q]UIEL$ N.N);0">@!4LA().@*T+0XA+C:TN(6 I"T*"D*2? I4DD*!^S0$
M*>X]QB5.5838TN?)6YYI,RRGOI"@>X)V4_NIL*ZA))3[-MNFI1%)OJD(C^"Y
M*Y:-37\N4F$TZ5_A<*EBQFEM%8465OORIKBPI [2H@J'BDI.IB4D\EXQV'7P
MR_)+2"L,1DI6^[M_(:0M;:5+/L!4-4@TU%I867F.2:*941PG=E<]^-\R\>X
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ME1767'&3OU03VJV&XT IB1(T&,Q#AL-QHL9M+3##20AMIM V2E*1_P!,GJ=
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M2CLM"'$E#B$.(5MNA:0M)V((W2H$'8C?0AZE*4I"4@)2D!*4I "4I V  '0
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M.SHA"4I!).VY.JE0"7)).0Q:Q;N,5L.TM?.:0B-.E"*PEE15YKQ65M^8I&P
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M&VK??K[-2B>+*I-8(E[333#3;##;;+++:&F66D);:::;2$-MMMH 0VVV@
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MDD%82%$=.[;P[NT#P)'Y- >HB^4D)<=*RI9"5.%*22H[A V4 3[M 7?ECO\
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M,8QC+GP@5I67JZ4N')^'?X0^@%:4*WZ@>.@%3#089:92MUP--I;"WW5O/+"
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M6MYXI *PQ&90[(>[ 1OVH.VXW\1J-I9@4U-O7WD)NPK'G'X;I(;=<BRXA7L
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M!W;;]-P:Z\">DL8\QD$:M;:R6? LK0.+*Y-;$7"C^4>WRV_+<<65N).^ZP$
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M453H"7' IQUU:0=PDO/K<=[=^NV^V^@H+Y3*Y$=YAN0]$6Z@H3)C^7YS1/\
M*;\U#B K;W@_9UZZ 1U=:[7(=0]:6%F7%!07/<:66@.[=+7EM-D!15UW)\!M
MMMH$*Y:Y;<=:H4=J3)Z!MIZ08S1W/4K>#+ZDA(Z[!)W\.GCK-*GI![#,Q49H
MST1VY922\B*XX['2>Y7:&W'4-K5\&V^X'7?;<==4@AM[VJHFD/6DM$9+O>&4
M=JW'7BV$E8:::2M:NWO&YV[1N-R-] VEF5U%LQ=1/G8S$QEA2RALS(YCJ>2
M#YK*2I7>RK?HKP)!]V@3KB*VX4-EU3[42,T^O[[S;#2'5[[[]SB4!:M]_:=
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M:0D.2'B 77E@;J4>JCU.J0A.33^1D6;$+$:&A=@*9;<>N[V>X8Z75K6E<?\
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MYU#26DJ+-LJBLL)<(*3#D384:4]&"U)6KR%OMK+9[D @CJ#X>)U:"K'4
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MS+,[OD>K3B&Q728;CMQD]NBOC87RTU(G*K:2'.F)AL.R&TK=*.Q*G$@D%0W
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@.0&3_\
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M+&DX]QW1(CS)P;.09;:J:GYAETU!6X9F0W:FFGI:BZM:T,-AJ(R5*\II&Y!
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M.I>67Z<5QF]R1<*18-T=9+M'(44H$A]J&TIYU+9<(0"&TDDGP .N9*7+%R?
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MT0(D*-N!_-;3O[=4P;J1Z_O[JMG0X%/B=CD"Y31><EMRXE=6Q$ASL['YDGO
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M!LRGF@LIWZ[;[:52+1O(5PYL.QC-3:^7%GPWP5,2X;[4J,\E*E(4II]A:VG
ME:2"03L01H!EJ,1QRCERK&LJF&;*:IQ4NR>4_-LGR\L..I<L)SLF84.+ )3W
M]I('3H-2B#;8]RT2G(SZ(3[,66MI:8\B1&5,89=(V0X[%1)AK?0@]>T.HW]X
MU00W&:+,X%C)G9-FHOX[C"F8U7&HX%7$86IQ+@?4ZR%R'5MI!2D;@['XE*Z
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M!(6(@2ZI[N</<D)*"HEH ;=4HV^\=OSZ =6&PI(4 0#X!25)(_*E02H'[-M
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M.QVWV.W0[=-]CJF!&:.EN*V7+E6F33;P24=K<9Z)&AQHRN_O+C3;)7LK8=H
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M7+Z/;D<ZK3ZX7I[L%K'$'I_]7_.5?YFS&4X3PRBMPV2P!W!]%QEN1T5BWYZ
MHM)<@H*RD@]IVW\XT'E5U;KX*=NTE%KLG+YXP<?]8[>QTWNE]<T(8>AOZ$U\
MYF3TX?5G]-OJ Y+I^%+O&^7O3UR_DA<:Q3"N?L+9PU.:S&>\N0L/R"!;W=):
M2W C:.T^[$>F+(1'0ZL@'J=_Z#ZBZ<MN]K[3\)8MI232[7&48NG>JI<6<;6[
M-K] N:_!J/H:]=&EAWJJ.H.O##J@T : - &@#0!H T : - &@#0!H T : -
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M<0D *W W W(%%E=5%,(QM;*%7"8^(T3YR2U'^8?(W\ID.*27% =3MX#QT Y
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M/1F[[7>VO52LW(M03IZ.[ZT^*Q[3)OJD^I7Z1O2#E-?@/+7($Z5R/80VK/\
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MOF/-RV7U7%,U)K)*)@,%MC9>M-+Q;6$X]G%!/@\CJ9]-/Z@6"?4#]'F%^H^
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M:,VA0^$-H0 .@Z=-*<2E5Z[>,U[B\>AU\VR[@&V;*4[%C!':HJ7W,M.*=6%
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M=17D42^FUCD?'+>-262W$=MA)KT68:9 5Y@:C..ML^<H[;*6%I !^$[@@Z\
M48U67-36)BWN0.Y+/\YQU5B[ B5W:VL([8S<>("/*:4DD*6I:R5'J$A*4D!-
ME.2/XW$8?C8[?9&_)>++<6BA&4IH@ ^;,<WVC,'?8*V5U]FVY!N@'2DGR[.L
MC3IU5*I),A*E+K9KC#LF.D+4EOS51UK;"G&P%=N_<G?90!!&@"VO*:B9;D75
MI JV7G RRN?*9C!YT]?*9#JTEYS;J4I!('7PTR Y(6EQ"'$$*0M*5H4/!25
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M\0.F@,QQF_F6UHD,%"0X4]BC]Y*=BE0*2#^X= /C7P.--!IPA25'O2G]&V$
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MMK#"WFU.LH>*3Y:G6D.,K<;2O8J2%I)'0$>.@&NFBW$9E[\:M6;22Z\5H,:
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MTHV6OYB^7 ZB^E/_ (MG!W^3/$_]RH^NE.:; : - &@.#GHI^H'ZBN<_K/\
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MAL$%1&O$3JVFLTSCI^U'?\Q1ZYO_ '6;_P![#]/NA#I]]/7_ (@GH=_\L_\
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M\Y^G?,9,I>>W^<5&;9MGN0UN-M38,*J=4](:IU"S,YEMF55IE- ?=KH T :
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M>X[LK81V)&P(P!W>CM+\T+[_ -'V!(:[1MW;@]_=OW;]O3;0#LSVR$.(CO\
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MP/S\2+,:+,R,Q*9*DK\F2RV^T5(4%(7Y;J5)[D*&X.VX.H^PQ;%  2 E( 2
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M ?3$]9Q\9AR).093.BU'*J8]MG.:WDJUS3/+J.W)6VW,N+"=):95Y2%I;"4
M#[(UH0XA3;B4K0M*D+0M(4A:% I4E25 A25 [$'H1H#C9]4E/UI&:.HQ+Z2-
M#Z2J;&D\:VS659-R^N3%Y6ILN;E.P\;I^$*ZSFKX@BI@TD8*4<FK'8"7W64I
M6&T.I2!JC^S&9IZ?V/0_R1Z>N/</Y;XW]2?I]]0&;UWKLP;GB?7VO*B_4SEB
MFTY/F]K9U4*LB3,?O?U5745GF18TYA..NQY27WF3.F :O?M$GHF]*?HV^AYZ
MOH7IIX0PGBN3R)S-P?F/(614\.389IG>27OJ%Q6[L++,,XOI5ME^0I39V3ZX
ML:5-<B5Z'"U$:89 ; '6OU-?5R]'/TX,9].^$^IFZS^KO>2.',?RG&&\.P6=
MEL9VIJ:^KJ9BYDB)*CIB/B8H!*""5)ZZ&<82ED?,AR%];[T9\F_4/YM]4,EW
MD#&.-I'#6"\(<<,?J/+FY%FL6@NI627&:9!!BR_)QXHLG5Q8D9;CSSD(M+66
MEAQI/T-Y<>872?273T=NW"]?EJY7)7)*-IN,7*BY4ZXT44VZ?$W3#%]7K-OU
M5^[SP4>6E,R>ROK;>AR^EQ:VNON252K&7'AQP[QY8-(+\IY+#(6LRSVI+C@W
M/LU[;VSSR\OU>A:=S5<TI**_@O-NBXG GL^MHW2-/29_]1'(-9@."Y3D]K(6
MTQ!KGVXZ&B?F9=E,!B5L**$_&9$J<^VA)'W 2HD)22/J?4[GI.G.GM3O&M;C
M:M6G2F<IR]V$8]\I-)=F;HDV=3H=)=W#7V])9592DO0DL6WW)?89+]-_IJQA
MCTS<&XOR?A;$?-,6QIZTBV;(F8WG&&6.46]KE$B-5Y-328&38]8QW+LIE(8D
MM=SZ5>8G<;#Y[VO:K2VK3V=7;I?A"M<8SBY-RPDJ2B\<://,^J])HX+1VX7H
M_P 2*KV-5;>#6*SQ-D\,5D=+,O,/R*ZD90FDCU%G1Y1.C1XUM.H[I=K%8KL@
M,&-#K9M[43*)\.2H[3*9$9Y@K;2]YBW.YTL;L9RL79.?*DU)YM.JHZ8-IIXI
M*J:PK6O,M\Z;MR?-2E'QHZY]ZIGV4)1+E  ]?ZOMUW-FR<N$*X$1GS.BNOO]
MO]74Z[K3V#F6X$&LK ?$.[]_^MKN(04$<V$>5=YH7ZJ/1]P=ZK9^)V?+D'(Y
MDK"8MQ"HC19#(I$-L7CL!^>)*&6G?F%*<K&NTG;M /OUX+UGY;],]>7=/>Z@
MC>E/31FH<EQPPFXN5:)U^%'4;KL.W[S*$M:IMVTTJ2IG2OT&E<_Z3?HWC]WE
MTV?#8$]<ZG'^&+]FO"O_ ,GCRW_\K5__ !Y?8=3_ -#[#^&[_C9!['Z77I&C
M=WE4^<C;WYM-/7_6WL&G_P"3QY;_ /E:O_X\OL'_ $/L/X;O^-D#LOIM^E:+
MW>559F-M]N[,9BO_ -'T_P#R>/+?_P K5_\ QY?8/^A]A_#=_P ;,.Y_Z!?3
M[58U>3,?A9/&LX,!^;%<E9-)DLDPQ\RZRMM3*4DR&&EMI).R5*!]FNJWS]/W
M0>GVC4:C;X:F.KMVG.+E>DU[GO-4I]Y)I=C=3B:_HG9[>CN7-.KBO1@Y*LFU
MABUZTFCZD/35^SD_2?Y]]/7"7-AP'FZH>Y5XMP?/)E2CFJ[<;JK')<=@6EG6
M,O*K$*?8@6$AUEMP@>8A 5L-]M?$^XZ3\CK[VCK56KLHU[4FTGZT>G+[G9O2
MM5KRR:]AT<]&/T.O0=Z#.;H/J"]/N/\ )M=R+78YD&+1I.4\CV.35(J<FCM1
MK1"ZN3#9:6^MIE/8ONW0=<*AHE<E)4>1A3]IVI;2^^AGZZX-1#<G2V*O@&Z=
M9:4VE2*O&_53P9D5W,)=6A/EU]+5R)"P#W%#1"05; TP.B'TT\AI\K^G3Z"\
MBH)S-C46_HU],LN%+84%)4A7#&%H<:=3OW,2HKR%-/-+V<9>0I"P%I( '!/Z
MZ,IC*?K/_LWF!4#C=EEV.>I#F//KNC8=9$VOQ![+?33/;O'VW'$=L-</CFZ6
MD^*_P]T("E#;0"CUM?\ HVE]&S_RS_U(?^4D]:F@/J^T : ^8'Z6_P#Z,$?M
M!/\ [IC_ .4RGZ [0>OWZA/IE^FOP';^H'U.9DJBHFWG:?"L-I&$6W(7*V:K
MAORJW!..\;\YA=O?6(9^-UUR/75[.\B;)C1D+=2!Q+]$GHJ]6WU./5OQW]6K
MZJ^'6'#^&\.3%77T[?I_2W);:.((+\]%S2<S\U5TUJ-(5R>XXS"F(:DQXEI)
MLH45^6Q B5U?6 ")_5?I<M^IQ]7?TX_19R_D:\XI]'%9Z:)/K-]14/$6J2#G
MG.ES79G?T&,X#19':P;631U="BCC+\Z(&EN,V-L7F7C&A.- :>?4T^F%P9^S
M^8#QW]6?Z85GDG%'(O W)&%81R?Q!R-EDWDW >=N+N4+J-C&18N7LU%ODV.9
M!+4ZVAV372D*;KER7F$,2&6W= ?;707$?(:*EOXC,J-%O*FNN(T><VAF:Q'L
MX;,UEF8TTZ^VU*:;?"7$I6M*5@@*(ZZ =M &@#0!H T : - &@#0!H T : -
M &@#0!H T : - &@#0'(#)_^<PRC_)]7_P!Y%'KE:/\ G>IF,LC=[7;& : -
M :KH;;;W#;:&P>I"$I3O^7M WUQ#DE2@% I.^R@0>U12=B-NBDD*2?M!!&@&
M*HQZ)3.R'V)5G*=D@!Q5A/>E[)![@$I5LC<'^405;=-]B=")4'69\Y\L[^'_
M "WSFP\CYPNB-W=R>[S?)!=V[-]MO;MH4KC?,>0U\WY)D]B?/,8+#'F?RO*#
MI+@1OX;]= (+6V14M-N*@VL]3I4$,U5?(GN_  5%?E)\ID?%T[U)[NNV^QV
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MC9'FU,R04^:ZZI4!TE6IY,A#89[F2VM2Y'F)3V+!2&VPUL5+[P22=P!M[=]
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M9"E'8*.Q^W0$4RG Z/,78R[MRV<9C-EH0HMM-B0'DE:E*4_$8<2TMU044E8
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M5]6G,5);0IPI;O>7'7"$)*B&VF[)3CBR!T2D%1/0#?6O\OJ/_,?SGMGQ]/\
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M:Y#D5$<)4KHGX_B]F^HFGD5IHE;C;;J2AUM#J#L2AQ*5I.QW&Z5 @['5(5
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M=RUJ87>;PI<OQ<KIZ:'S+>@6JXXK?1[PE<<>4535#)<&J9V7V,&)%;L,ASJ
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MN-1A%-MMT22S;?!+BQD:?S^=[W*7K)WBOC+(>1,?J'7&;#)VK")CU4^XSO\
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M-J5VI!/:DGP!T!54755?0Q/II\:QAEQ;7GQ7 X@.M[=[2_!2'$A0)20#L0?
MC0%_\.KS,_$3 AFP[ W\]\JQ\YV =H1\SV>?V!/3;NVVT(+- 8_K\)LF;==K
M;9OE-LD/K?8K43%5-8CN42E#\6N6TF0AM.P"1V(.VY2=]M9*/%EJ36Q7.;@R
MUUC$>38)8<,-B4\J/&=D=I\M+SR&W5(;*O'8=?#<>(R?<0CF+JSIP.NY@C&(
MZ5('R\6B19*?;7OU^:?F2G6".WV-@_V7LU%S<:%=.!+E$)!4H[!())]P W)_
M,-4A#,=S>'D]C-A5U/D#<6$WW&YGUOR%8^OO"0S',EY$Q3JTJ[D@L@]H)4$]
M.Z*57@5JA*I/R3*%3)GRK2(J"ZN5)\I"(Z&_C+BGW=@TA!Z[D@#QU2%F#;5=
MGWFMLJ^P#>WF?(S(\OR]_#O\AQSLWW]NE01S)<!QK+GV)%]'FS/ETA#3";6R
MCQ  22H16)3;"'%[[*6E*5J&VYZ#:.*>94VB05%/64,!FLIX3,"!'[O*CLA7
M:"M14M:UK4IQUQ:CNI2B5'VG522R)F,]E#S&1<1W*VZIZ^B0652([E0],LGN
MT[OM^>N:W'2EWP2H)24 [[*(ZS'U# E>J!GC6SDFSE5WX/<,,Q4%7XM)9B,U
MDA84$^3%49IG/+.Y(4& WL/O>&X#QH",N9EC#=VUCAN8KEV\YY*:Z/YLI]#H
M'<6W_EFW6XJTIZD.*1L.IZ:560IQ'N9 @V#7DSX42<R#W!J9'9DM!6Q&_EO(
M6G?8^[0%46'$@,(BP8L:%&;*BB/$8:CL(*U%:RAIE*&TE:U$G8=2=]8M\ ,&
M2X_-OVH[43)KS'4LJ4ITTJXC*Y7<4=OFO.QG9"?+"3VA"TI/<>X*V&V+*2",
MR8\:/'4^])4PPTRJ3(4E4B06FTH+[ZD)0A3SI3W*(2 5$[ :$&3(7LJ;1$3B
MT*DDNN.+$QZ[FS(S,9L>7Y:FF845]R25[KW^)'9VC8*WZ,>!1^:\WRF_.\OS
MO+1YOE=WE>;VCS/+[_B\ONWVWZ[:$/AZ_:/_ $O^IGF'ZF7IJSSB#TY\\<LX
M53^G'A^BM,MXRXAS_.\:@7M7S_SA<V-%,OL8Q^SJ8MS"J;>))=BN/)>:CRF7
M%)"'4*/ U4)RNIQ3:HN'>S;!I+$^WRNF+L(,::N#-K526PX8-BAAN='!) 1)
M;CR)3+;A2-^T+40#L=CN!SS4*G6FWVW&7FT/,O(6TZTZA+C;K;B2A;;B%@I6
MA:200000= ?!93\+_4!_9Z_7%S%R+P;Z8\M]4OH\Y8195D%6,5F47559\=&[
MD7V%5&2Y7B-!DL_C7D_ #(5!7)LZQV#8MJE.1V7FWD+8ZY1N::XW%5@S=A-8
MYFW'I2]0OUF_J,^N;$>0N)L Y'^GCZ+:>7B2>3J^XQ6NN<<M,9Q>WEW>00Z_
M(>7>-8$CDKE'-FYZZM#];5M0ZN.J.Y(:;;:6I_9"=^[<JDXVS%J*7:SW]J;]
M,'J6]0F?>C6;P%Z>.<N<(>+XAS1%R:5P_P 2Y]R7&QV3:77'+M9'O7\+Q^Z:
MJ'[)J"^IA$@MJ>2RLH!"%;-7"<G'E3>>2$&E6I]&WK"Q#+LF^F3ZI,!QW&,@
MR+/,@]"7-V(46&T-'9VF57N76WI_R:FK,8IL:@L2KFQR"SN9"(L>"RTY)>DK
M2TA*ED \J:;LM+/E?T&F/Q+TG#S]F1X3]0OIB].'JLC\W>G;F_C"_O>8,(GX
MYC')7&>8<;W>0US6'NPY5G40<VIJ658UD*2KL>>CMO);7\)Z^&C21E"#YDTZ
MFRXTVJ,XJ>GS)?7!]'?ZH/J>Y07Z"^8N=K'D^!S1QUB=)6T6<U5+E&.<A\IX
MKR3B^=8EEF*X+R! R%E/ZHP0]!8;6Z!(>C.N1I32@CCQ=RQ>E+E;K7Z3-\LX
MI5,]_5'X-]9/IA^K/A'U1Z;TO9/ZB>*<UG\,\M5%))PC*LFIZ"YH>*L/PB^X
MJY&A0J6RM^-\JH9M6X[1/SX?:RX(KK2)$B)+C-97HW(7_&2JL'_82+3ARUQ(
M+]4R\^J]]7_C+CGGIKZ<_*_$G _"^2R,<X_XNH<:S_DGF7,;WE"L;DY'GR*=
MK \<RS)<&HF<"AQ381\?KZZ(Y8MH2[,6MY<:7G>OI2Y&HKVB/)!TKB=>OJ5<
M3\V^H+]GZ]-6'X-Z;N<;;G"IQ/THT&1<-QN&<_E<R8Q:\=T+.*YS%FX C&E9
MQ#JJRYJ'UHD.PFFGX2V9/1MY!.^[&4M,DD^;#"F)A%I7'5X&_'T7N*^3^+/H
MR\&\7<G<<9[QSR;48AZEXUKQUGF'Y#B&=UDF^YVYMMZ./88CD%=7Y!"?N:FV
MBRHB'(Z52(\EIQL*0XA1V6(M6$FFGC]+,9M.;:R.0W[+%Z8/4KZ>L^]94SGW
MT\\Y<'P\HQ#A>-C,KF#B7/N-(V12:JZY&=LX]$_FF/TK5N_6M3F%/HCEQ3*7
MD%8 6G?1HX3BY<R:RS1G=:=*$0YO]*_J>MOVH6E]0%5Z<>>;/@=KE_T^6;O-
ME?Q!R%,XC;K:7TM<:X]<6#G)$;'G,-1!J;^ _!DNF:&V)C+C*REQ"DA*$_SG
M-1\M5C3#(J:\*E<3)WUROIW>L+$?6KQ;]5WT*8/9<FYEA,CCNSS_  ?%*>;E
M^95^8\5)9C8YF0P>O::M<QPJ_P 4KHE+:P*XOS6&XGF$%F2XN+=1:FKBO6\7
M]A(2CR\DC!O+GU?_ *S/KTC<<<#>C?T,\Q^EKE:ORVML.0.2*6)DEW%G.PXT
MZ"FKMIW)?&&+89Q9@[E@ZY(FHN9=BMY<5ID2 $N(>QE?OW*1MQ<7\O850A'&
M3JCJ1]7/@KU89']%*3Z>\B1R;ZPO58F)P3)SS(^+^+9606>9Y-6\HXY<Y4]3
M8OQOBD!QZIQR.AQAAY%8U*=KHB)<P>>M]P[K\9O3\KK*>' P@USUR1L'^S\<
M5\G\+_2\X8P#F+CC/.)\\JLOYDE6F$\EXAD."9=6QK/E+*+&MD3\;RBNJKF&
MQ85\AM]A;C*4O,K2M!*2"<M-%QLI233Q)<:<G0X9?6.X+YMY/^N?Z/\ E#C7
MAWE/D/C3&G?2+'R/D3!N/LMRW!L??QOG>^L\B9N\MH*BPH*IVAK7D2)J7Y#9
MBL+2XZ$I(.N/?C)ZB+2;6'TFR'\MKB;X_M''TL^;/6)0\2>J7TMT-AFO,W!%
M19XKE7'=*ZRWE>6<>.VIR>DN,$2M<==CD^#9"].=-:VM4JQCV*C$!D1T,2MF
MJLRG2</B1C;DE@\CF?S1]7[ZMGJO].$#T1\7?3XYSX>]1%Y'QO&,\YCXPH>7
ML=RKR<=M:J=;2<3PQK <;<X7=N)%>AJUG2KZ9&A0I$A*?E@M+K.J5^_.'AQB
MU+MQ^2,E""?,W@?4_P#2Z]/OJ8]._HPP+ O5[S/R#S!ZBKV3?9GR'D6=<C7/
M*ESAMAD[C1K< J<SR6SR)RRAX7418[;A;?D5ZK-4I<8N1UH4OF68SA;2FVY>
MTU2:<JK(Z T]8NIA)B.6EI<+"U+5-MWV9$Q95M\)5'CQ64MIVZ!*!]N^MA!U
MU2'AT(W0C%WEU%CTVKKK23(:F7+WDU[+%?832\H*2A14N'&?0VE*W$@]Q!Z[
M[; D*I&*39)=4A0E#3:E%*&T*=5NHI2E*G%@$[J( *U!(/O.PT CM(DB?73(
M<6PD54B2PMIJQB(97)B*5T\UE,AMQHK Z=1N-]P0=B!2$XGQO68M-7;.6M[?
M73J%H<L;FR>?V2YN%AJ,E26ME ^+GFK!)V4-]M1*GI*Y5]!,[@6YK)@H37BX
M+6T!5J9 KTO%21WR?E4KD%"$;D!(ZJ 'AOJ^@BI7'(Y%^MWB_+\7G5?,&99K
M29*G-9E)Q@<<-6_!D4QKJ?,<M@JQN>98BR(&U?->D1EQ69'F*+XD+*$LCW[Y
M&]1*QN,^EY::$EJ>:X[J^)<D:I2K@XKA2C3?$^B?(;J6%G<;G2GY6,HZE2N.
MZG[RY(Y2K@XKA2C39HSPGR[QMQCR[8W7)]4B32Y/CT+&(>1FG;O1B<UFY7,\
MR;##4B>S372924R)$5MQ3+D5DNH+)4ZS]4W+=VY:=NQ/ENRE'"K2E3F23>2:
M<L.:BQEBG12\<_5WT#U'O=O0=:[78>JV?;-)?CJ8QQG8@Y1N>/R-UE;I%JZX
M)R@HQE*+AS2M]CLC<<?ADNK*RAH-(W\$MH&R$) V"4I'LUUFUQC;OT@J5=7Z
M7FSX!U<G*&..'S&@?)%'$J&;AN$GRV)UC/M#&1\$:/(L"'IORS0)#29DTN27
M0.BY+[J_%9U[SZ4MPM::48?#)N5.";SIZ75OO;?$]=;RW*:;S6'L^5/0D<^,
M>Q_A;DWE)VDY7Y;''G'55$=G9-?8]09!F-Q8/B9'C,XG4.8S47D/'[6=&6^\
MJ;-2L16V1V1WE. M^,^:O5G4G3VPNUT?MES==YU#E;:BG*WIX\N-R[&.+K6D
M(5BI/F;E2+4NLVW>>@=KW6W#KO>]'M&G:YX1NW%"Y>Y6JJVGC1?>G1I8*E75
M?1CPIZF_3;ZJ+J_K>.[@9+?8#)%E\EDV.7-#;)KI,EJ.UDV.P<FAP[!RC>FQ
M6VUJ0VVN.[Y0?::4ZSYGYB]1]&=2=**R]_TL].K\:PYJ/+.+I6DEQ3])]7]#
M^:?0OF-+50Z-W"UK):2:5Q14HNCRG%22<H/)22SP=&T;8:\9/8! X&*Y$QDL
MRYL,YMI]4X^MZ#C[<2)#B1TK4>V-)=2'C)891L$]B65J(W4HG?>4=:U,JJE*
M8DUE/.1X[KS45^:XVGN1$BJBHD/G<? TJ;)B10H_Z-Q"?MU2$=I;7)K"0L6N
M)C'X:?,[79-] GS'-CLUVQ*QF3''?_*[I [?9W:F(=.!*=4@P4V44.0NRFJ6
MP19?)*[9#T9F2J(E7<4]K<TLIAOJ[@>C;BCTU$T\BM-9C]L"02!N-]CMU&_C
ML?9OJD/= <V?7OZ9N#;;ACF7EN?A]75Y5'QQ^ZR*VKWOP^)>F.J%%F9->8U\
M6/YIFV.T+;K].N9%?F.S6&&4J4.U&N/>MV_#ES54'3FI]-,FTLJK.AZN\Q.E
M=CELVX=4:;;=#>ZKLZ*[X-VY"/-S.+2][BWPK5MT1[<89AUQ48TXS%\YNBIV
MHN*WT"PGPKN#428<-KRZ_(JZ3%MT0[*+%8,A >\J5Y:"ZE?:G;V-X%F<(T6$
M5[K3::7<UCCA7''B?AY_4=PT]^^I2H[MQN["48RA*:;?O6Y)PK%N7*Z5C5\K
M53$V8@I:=25*64M[%:NT*60D@J4$)0@*5XG8 >X#6\ZQXNN1&OIQ<>X5CO-/
M*%??.6%SG&&XVU,XA78FF<H\;XER^\=_&J?&X#52S:PLAQW(*F/"F2W93Z5U
M#]<TR&O[80KP7<;%W3:Q6+DG*S&+=I84C&3QCEG%I*N/N\OH/U&_1MJ^D]\V
M[<MZL:=V^ME*W#5S<N974HI*]!.KBYNLKC359SE18MRZW2\IMF<D8H8N&7\N
M*I^.W*R!1AQZ=F.\EM;DIEY3SBI*8P60MLAMS=) !.V_#JZTH?<=%2M2:ZIB
M6EOL-NLL./-(>D>9Y#*W$)=?\I/>[Y+:B%N>6CJKM!V'4Z%+4V##L8RX<^,U
M+BNE!<COH#C+GEK2X@+0KX5@+2#L>G30&L_K5YL8].'I1YVYQF\32N<:7C3C
M^TR/)^*HDBOBG+,,97'C9JQ*<M*RXK5557B4F;.F-O17FWHD5QLIV5K"Y+D@
MY4K19%BN:261\)'IUX9_9\_6URCR'FV5<F<\?3]KZ:SK\B;X6Y,Y2XT9XRRJ
M);RK5^=6\;9G,Q.TOZZKIW(C+<JLE6/SZ6I;8@NE"5F/UL8Z6Y)MMQ[GD<IN
M[%<&*O1WB?!_-7[1CQ>/0Q#38>F3C'*L8M<3N*FAL85+#P/@GTYTF+9#D+Z9
MD>-8)K,AS?''(T:SG_VQ9R[..^\X[(E%3EMJ,M6O#^!?4B2;5KWLSZ@OJD_1
M>XP^IAS)QQR?F^8\JXM98+QN./V3A=[@U30JKT91>Y$T[,8R/$,HN)%FJ1>.
MA2F>UE+24#M[B3KEWM.KTDW7!&F%SD5#06O_ &2/T?*C(-KZC?4HQ,W/F(KY
M_%\J-MXI*'9/&,-TGV'='LW]NPU_D8=K,O'EV(Z'^A?Z/OT[OIH<@*Y'X_GY
MIR-S<8C]+5YWRS>5F:91B3=G&-?<0L/Q[!,1QRFQQVX:>6RM]R"_9?+N+8$G
MRG'4KVV[%FRZK&1C*<YJCR.V;\=B4R[&E,M28[Z%-/,/MH>9>;6-EMNM.)4A
MQ"AT(((.N0:Q'"@5%.VF+70JZJ:=5\$:%&C06W%)  [66$-)6I*=AT'0:8("
MR0R)##T=2W6TOM.,J<CNN,/MAU"D%;+[2DNLNI"MTK20I)V(.^@&"@Q.IQQR
M6]7JLG'IO8)#MC;V=HM8;*B@)^?E/I005$DI 4=^IVU8QIB&VQQNA=&KEC'C
M6IN2A @JM_F?PY*RZV'52?DTJD$)8[RD)'5>V_3?63K3#,GI**-J[:KFDY#+
MKYEIW+4\[5Q7XD-*2?@;;1(??=<*!XK/9W?S1MN2KQS'H,->I_\ X#,X_P#)
M:_OOQ_7'UG^7EZOI1LL_S%\N!T\]*?\ Q;.#O\F>)_[E1]=(<TV T : - &@
M#0!H T : - &@#0!H!--FPZZ))GV$N- @PV7),N;-?:BQ(L=I)6Z_)DOK0RP
MRT@$J4I02D#<G648RG)0@FY-X)8M@QS YNX7M6YCM7R[QA9-5[/S,]V!GV*3
M&X,?M6KSYBX]LXF,SVM*/<LI3LD]>AUS)[9N4&E/3WTV\*VY*OHPQ,>>#R:]
MI\GOI4_4_%LU]:W%_$E[6Y1P+QUZK^0XO#5Y1NQYN.,8WD/R]Y-Q;'+B X[5
MVU+BUB^6F'V'' ZEWS>[L=; _0#R\NZ_6]/:.]N<)0USL0YU)-2YN55;3Q3E
M\33Q3=#Q75J,;LE#X:NADW.9_:A[XNNRMOX!^3J=?073^GJXG576:#\MNQ+.
M#9U\YM$B'-8?C2&5_=6TZA2%#_0J .X(Z@C<==>?ZW;])N6@N[9K8*YH[UMP
MG%\8R5'Z'V/-/%8FO2ZJ_HM5;UFEDX:BU-2BUP:=5_:N*P,R^@?U#+EQ7O3C
MFUB7L@Q&(](XUMI2CYF1X9%[W5TCBUDI7:8NP/T:$GXH"2$I[8REJ^4I;9J^
ME-[N=);DW)07/I;K_P"-8;=.[GA\,DLFG3"*;^__ "FZYTW5>SV[4VHZR$:.
M-<4XKWH>KXH/-P:XQ9M;R)Z=.">1[%^YS+B_%+:YE**Y=PB$JKMIJ]TD.3K*
MG=KYLYT!  4\M:NWX=]B1KDW^G]GU\_%UFGMSNO-THWZ7&C?K9[6N[!M&OF[
MNKT]N=QYNE&_2XT;]9I'RKZ1<KPA=C8^EK);["Z3)W*YC/\ CFJRPT4FU@PI
M2'#(PS,+J%?/8Q<N,*=;\UWO\H.$H46]XR_']RZ9W7;[5V71]^6G5Z-)VN9T
M;64H2;K%KC[T72J4DL#POJ3H"=ZW*YTY/P+DU24:]F3C)X^E.2[I+(@O''H?
MQAV]R#-.6\>0RBV9^4IL 3F=]E4JM82RTQ^+Y7G"Y$"7>90^&U*<^33%KTNK
M4XTTVDMLL=?T_P!!W%%ZGJ>?YC523]VKHJ\7).M5E%*3HL7*3RU=*>6]C;[4
MKV^?QM1-8QYG[92BUBLHI-I9MR>3Y:^E;M0,:;Y>SUWBM4IF1+X_L%QYSST=
MAU#R*B-E/G,V$*DW208Z65;C8]W>._7D$NE[\K7]/_/ZI[(VF[$FG5)UY5<^
M)0_92IQSQ.X?E_H?S"E&_=_)5J[;2;?<IU32_NM]]<3-(AUM%6Q*:GA1JVKK
M(S4.! AM)9C18S"0AIEII  2E*1[MR>IZ]=>56;-K3VHV+$5"S!))+!)+@CS
MJS9M:>U&Q8BH68JB2P22X(U;P+T[^HSFSGKF'%?2QQ1%Y-?B5F)Y7FT1_.,/
MP>MQ25<M/LMV#TC*[6K;F/WKS;BU,1BX^5'S"GRT]/4N_=?[=Y<;]J_'BI6-
M7X<N6LE2XHUDTHPG\2=76F+3KP/GKS'WC1]-;Y<E&*:O<K:JU23BG)T2>>;R
MQ=3 ?(LS+^,<UR#B[FO#KCB#E#%Y)C7F'9<XPTM(5W&/84]PVK\)R"FG(25Q
MID1QR/);^-I2VRE9]@]+>8_3G4^CCJ+=ZW8NO[LYI)_NS?*GWQ:C-/./$Z/:
M^H]NW.TIJ<;<^R35/4W2OHP:["(8'QUFGJAY-PWT^\/Q5Y'FW)=W"I_,K$&P
MA8UCYDM+R'++]Z,HM0Z''ZI+DB4XM:=F4G;=12#TOF9UQLVT=-W[-N_;N7[L
M:/DDI4C6K3:JN:=.2,<WS5I1,X74V]Z/2[=.W;N1E<FJ>ZTZ+CBN+R2SQJ?H
MQ8/B57@&%8A@E&DHI,*Q?'\2IT*"4J15XW4Q*>O2I* $)*8D- ('0>S7YY7K
MLK]Z=^?QSDY/TMU9Z&E)SDYO-NOM)1K48AH T : - &@#0!H T : - &@#0!
MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - <@,G_ .<PRC_)
M]7_WD4>N5H_YWJ9C+(W>UVQ@&@#0&K"U%"%J2A3BDI4H-H* MP@$A""XMML*
M6>@[E)3OXD#7$.26HSCSK*7'XZHKBM]V%N-.K1[@I;*EM$_D)'VZ 9[W)Z7&
MVVUVLP,K>W+$=M"WI#P20%*0TV"0A._52NU._3??IJBJ0X5=DQ;06;",B0AA
M_N+:93#D9XA"U([BTX H)44[I/@1U&H"^W'B1?-<:9CQO,4IQYQMMIGO4HE2
MENJ2E/<I2CN2?$Z OJ!*2 HI)! 4GM[DDC8*'<%)W'V@C0$2BX541[1%R^_:
M65BTX767[&P=?\E9\/+;0&6^U/L204CV#H-J2A+M0HF9;F)D25OR6'8R_*^4
M8;B+9=CA(7YOG2%2GA*+A(VV0T$[>!WUFE0'LR6U!BORWDO+;805J1&8>E/J
MZ@!+;#"''7%$GV#IXG8;G5(,M%DB+Y3WDT][ 9:2%"5:P6H;#Y*@ B/_ &RX
MZZHI/=]P  =2#L" _O/-1VEOONML,M)*W7GEI;:;0GJ5K<64H0D#Q).V@+42
M;#GLB3!EQIL=2E)2_$?:DLJ4@[*2'65K05)/0C?IH!!8T%-;O,2+.MC3W8P[
M6#*1YJ6TE7<0&E$M$*5X[@[^W04'<)2A(2D!*4@)2E( 2E(&P2D#H !X: C%
MC37$VTCS&,GF5U>R6RNLBPH9\TI'Q[RW0M1#I W"T+ '0 ;[ZM#6ZMDFU0-;
M4FU78OL.5;+%8TG]%8*L4K?DK(!V;KVXJNQ /0E;R3[DG4Q]0'35!RC]<TI,
MWG7B"(AZ.ZW5X!FDX)04..-/S+>N@/=RDDJ0HICI !VVV4/:=<#5OWH^@H]<
MEQVYWU!>$Z-9=#=5ROQA&2EIML-)5@'&U+#8;91\0;AMKJTI: 2"ECV(( '#
M!WJA--Q_,6@+_2*\U8&ZR3T.R4@$GK[- 2)A [TN;KW[>WM[E!&VV^Y1OV]V
MY\=M] +&TLVD=UDA]#:7>PJ(\M14WL=T[]R5)W]X_-OH"1QP&_+;&_1*0GQ/
M1OM2=U>&_P 0\>I_=T KC-(A,H;3YRT^<2.BWG-WG=R3V@J[$J5U/L'4Z <F
MF&D.N20DAYQ"&W%!2R%(:W*!V=Q1NDK.Q WZZ 4*CLS1%<7YR0RZU+:&[C"P
MM(W2EUL]JOY7Q)4 ?8= *VWFI#DN*"X%L);0\4^8UM\PV5I\IY/:>\(Z[I.Z
M3[CH!6E0;<99[75]R5[.=JEI2&DCJ\Z?!2]^F_51WT!"[CC[CZ5/EY/>X5CM
M_;N.17%65GC=3<VC?RZDMQ41I$J$[*0W&4K=("O@\1X: FQA,.36+!?F%Z(R
M\TT$K5V=KVW>2V/OJV3T_P"EL!Y$E1;F(74-R$LET)*7D.QG.]E2' 1VJ2HH
M[@.H)!Z@^T: :K_'<2RMUBKRC&J/)4PVS81F;^C@7$6*75*CJ=C_ (C&DM,O
MK""#V[**1[M *:VOIL3K*RDJ*YFNJV71#@P:R S'AQ3)==?41'A,LQHS2GW%
M*40E([E$^\Z 7?+,0WY]HI3ZUNLH4ZC=3B6VHK1^&.RD;]R]B2.I*O#QT CF
M5]/EE2B/:U[5A4S0EQZMLXS;T66V.Y/D3X+X=CRHR]]RVL*0KH=CTT S8[C6
M&TR;VJQC$J?%F7RVQ9BDHJZA:L>YI]IITFNCQQ)+*5N!"E E(5N.BM 3)IM+
M3;;2>[M;0AM/<HJ5VH2$CN4=RI6PZD^.@&UT,U,63(6N9(09"GU]Q<E/!4A:
M&PVR@#N#2"0 D= -] 1NOX\P.HO/UEJ<,Q:JR IF)5<UM!50+)S\04%S5NS8
ML1J2XY*4#WJ*B5[G??<Z ^4GZSO[0[D7I:Y[A>D;TA(IZW/,"R>K8]0W,/(&
M"SLFI\.$IJ/)&'X3A<V32.9/8P:Z>U8SK!3@BJ2&XL0N+<>>8ANMVN9<TLC+
M.(_M47TXJ?$L<I\MD^JC-<IKJ6NAY'EYX/P#&QDEVS$;;M+IF@JN5'(-%'GS
M0MQJ(VXZ(S:DMEUU22XJCP9]P[1?VJGZ7\.,U%9H?50IMGO[5.\5X@MP]ZU.
M$J5_C1&Y[E'4J3P9]Q0K]JJ^F'YKCHH/5-W+0E!WXLQ+LV05%)#9Y3[ K=1Z
M@;G5J/!GW"5W]JC^F*ZZT\:#U2][*7 C;BW$TH_2#M45(3REV+Z>&X.WLTJ/
M!GW":1^U/?3(?;6TK'_5"I#B2A8_Q68DG<'H1NGE$*'3W:E1X,^X1N?M3/TS
ME#9-#ZG]MB!_[2S$O;X?_A/TJ/!GW#6/VHOZ:*$>6BC]3Y'<I6[G%^)K5\2M
M]MSR<3L-6H\&?<-KW[4!]-5QWSDT/J;\P-EL*/&&* =FY/4#DW;?<Z5'@S[C
MF!ZG/KB^C'E+U+TW,."4O-36/P^+\>QN<W=X92P;)_**/,[ZY2XB(QF\YE->
M:>;'0'$N)5YB5?!ONI2H\&?<)K;ZW7HQ>]9['/5? YR&!C/.9<DDL/83CS=Z
M[6\B5EY^&LJKD9H8RW&+6<R5H,C9M"-]UD#6RS-6[BE++^P.Q-K@;I__  1Y
M]/K_ &E]1/\ [CC%_P#Z8FN=^;M=_L,/R]SN+#_[1G]/&4CRI6.^H*2WW!7E
MO\98H\CN&X"NQSD)2>X GK]NGYNSW^P?E[G<7D_M'?T^$I"4T?J'2E("4I3Q
MOBX2E(&P  Y$V  T_-VN_P!@_+W.XTH^GIZC^/O5O]>+U">H3BMC(H^!\@>G
M?_P$SEE;%J,@1^JF%>G_  BT^?KH5C;1H_=<XU(+7;(<[V"A1[2HI&NS-7-5
M*<<G'[#.Y%PL*+SK]I]9>N<<48KH9*L--8^:6/W=7YEL9LA;0W([&($5#*'5
M$;'O7(2!X=A\=1UX%'AA+Z6&4R7&WI*6FTR'66E,-.OA #KC3*G7U,MK<W*4
ME:RD';N/CJD&.TR)-9-CP4TV0V;LA"7/.JZEZ3"8"EE"1(GN*8AMKW224]Y4
ME/4@ C>-T*2'5(1R7F&*0'5,3,DHV'T+\M<==I#^80O<CM6P'B\D@C;JGQU*
MHH^.LQYT9;+R$OQI+7:MM6_8ZTX.J5#H2A:3U'M&LTN)!!5X_1TO>:BHK:U3
MB>UQ<*&Q'=<3OW=KCK:$N.)"AN 20-6B60+UK'LY<)UBHL6*F:YL$3WZ_P#$
MPPD@]RFXJI<1M3WAVE94@>U*M'EAF1NA53P[&#!1'M;==W,2M:ESW(42O*TJ
M/P($6$E+*$MCIOU)]IUBN\Q$&3SLB@UWF8Q2,WEDMT-I8D3H\%EALI43(<,A
MU@2 E0 \M*T$[[[]-B=:89@OXY)OI=3&>R2MC55N>X28D24F4P.T[)<2M"WD
MM^8.O8''>W^>?85:8Y@+S)J'&F!)O+6)7-J!+:'EE4A_8@$1HC0<E22">H;0
MHC1M(#RVXEUM#J.[L<0EQ/<A;:NU:0I/<AQ*5H5L>H4 1[1H0I##"752 RT'
MU@)6\&T!U:4C9*5. =Z@D> )Z: NZ B=7B+%;;R;IV[R2VER/,[&K6V+L"(E
MW<*1$KXK,.&A"4G9(4A?:.HV/74IQ+4>+RCI<FIK7',DIZO(<>OJZ947E#>5
M\2VIKFIL8[D2PJ[6KGLR(-C73HKJFGF'D+:=;44J202-7,'*^A^B=]-&/FUC
MGF0>C'@&=;NVPM*VNKZ#(HV'1E*6\MV._P =R<CD<?.P5%2.R(*L1D;$=A24
MA.E6+5:N*J7F9TUD+HN.L6KX-'C2H=#10X5+18SAU&TU$K8$2.(]?6UE36LQ
MX-75PHS"6VTI2TPRA*4) ^%)W8)=Q#S$\EM,C1,>GXI:XTPR6A$5:J0AZ:%^
M9WD15-LR&"T$I)[DE)[NA.QT3J"8$[=3T ZDGV:$$D.?!L6E/5\V).90X65N
MPY+,II#J4I6II3C"UI2XE*TDI)W (]^@&J;BF/65K'N["JCS;.(&DQ9,HNOB
M/Y"RZT66''%1FU(</<"$ ]W7QTHBD@T(0Y5#DCUXJQ?S.6W5(D)=CT4"HK8K
M264*2I,:5.D"=)E!SMV<4 V5 GM[.FTH4F.J0L%<CYD-AALQ?*[E2"^0Z'NX
M@-)C!DA2>T E16/';;0%_0!H"Q(BQIC?E2XS$IH*"PW(9;?;[P" KL<2I/<
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M "RMC2X<&/&G6+]O+:2H/V,AB'%=DK4M2^XQX#$:*TE 4$)"4;]J1W%2MU$
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M@7/#61@1==IDYR5%:UBS?ZN!ON>R5^\AMJ*RT%^7&J&6I$Q92[\'QEL*\=P
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M#B&UH#J0/O#O""H'M*VTK0H@[>\;Z 4I4D+"2I(4K<)!(!41U(2/$D ;_DT
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M$K0AY"74J"'4H<4D*&Q[5$>!.@+U?6P*F&S K(<:!"CI[68L1E##+8\20A
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MK==<A:TEN/-*<VHQBEQ;>",]/I[^KO1TVFA*YJ)ND8Q3;;[$D9Z^G[PE.O\
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MCR'PM])<;CH4ZYN\M*5.]A._:GQ('@- >+BQTR%S0T/FEM!A3H*BI3*5=X;
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M<.QGK:IK[-R&5&*9\1F6EA2O%;2)"'&TK^W;<:4";60ZI2E"4H0D)2D!*4I
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M!=9W)W.HK>HG"ZY-M)J3:C&N*A1UCQ=:R]YMD^NON+_(K^+7//"#7#,_N/\
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M][8[[:J:>033R'>77P)_E?/08<WR%%;'S<9F1Y*U#8K:\Y"_+41T)&QVT J
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M;;BZ<>]<%@;(I)X'1[TI_P#%LX._R9XG_N5'UXN;38#0!H T : - &@#0!H
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MJM\:'T1K>H;.U78;;L5JW.$6E+!OF>5(M-5D^,L:OMH0&4H)6L)4%I2I24K
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M;/.+:*:)V.\(9-RYB$7%4)$GSD5[B*C :V>BN4E;R5&L%;+)6%)D)(5W\?\
M*6^+DUV&7.^X[2<F^B;@?D7T>Y+Z&:RDG\4\!9#Q\.,XU-Q4[54EKB^,"4Q,
MVQR7?T^3UR+)R4R779,V)-<D/.N.O>8ZM2SO=N+AX>4:&-<:\27^E7TR<<^C
M_@CCGT^<7/7]CB7&N.QL:J[W,)%-/S&ZAQ'Y+[,G)+.AH\<JYLU*I:QNQ"C-
M >" 2HFP@H145D@W5U-@);<EV.ZW$D)B2%I[6Y*V!)#)/BL,J<:2M0'AN>W?
MQ!'361"B#'=B1(\9^9(L'F6PEV;*3'3(DKZE3KJ8K,>.DDGH$(2 .F@%>@#0
M$;RC+J+#H"+&^E+C,//",P&H[\AU^04+<#3:&4* /EH)W44IV'CK/!(9CU F
ML64&)81?-^6FQF93!>9=CNEE]M+C96P^A#K:BA0Z* .J"@U=:9@L37038)':
MF<8D<S$C;MV$HM^>!V]/O>&@%V@$35?#9F2)[; $R4E"'Y"EN+6I" D);3YB
MU!IL! ^% 2"0"1OH!;H T!;>=2RTZ\M+BDLMK=4EEIQ]U26TE92TPRE;SSA
M^%"$E2CT )T QT&0"_1)=12Y!4-QG$M)-_5KJERB>XE<9A]PR5MI &ZE(2/B
M &YW )U#5"0: - ,UACU';2HLRTJH5E(A?ZC7.81+1&5W%?F,,OA;+3O=U[P
MD*W Z_"-E$\P/.@&-^MMGK=B<WD4N+6,I3WTD>OJE-2EI\3(G2HDF<$+/B&E
M-';P(/74HZYX ?-4#.Q.LW;>7"=I'8U6Q'0Y&NESH3B)LA2D!<9NO9<7,9#:
M23WN!(.W0==8-U8'?4!C^MY.Q*WR->+0)4UZU;<?9(_"YZ(_FQ@HOI+RV$^6
MEOL/QK"6R=ME'<;JE)\M"'$*;<2E;:TJ0M"TA2%H4"E25)4"E25).Q!Z$:$+
M;)CI268_DA#'Z,M,]@2SM_I90CHWM[MAH!GR3'8645CE18O3VH;SB''TU\QV
M$X^E 5LP\XUU<CJ*MU(/0E()\-"ES'L?K,7J8M+4,K9@Q YY:7'%/.J4ZXIU
MQQUU?Q+6I:S]@&P&P &@*[QBZDU[C-!80ZNQ6M'9-FP56#338.[G9&3(CI+J
MAL 5%21U^$]-A#C9]=ST29!ZT/ITY[C^)4-CG7.'"<NLYIXOK\:HY$S(<INL
M58E0<QQ>BH:U%A;64_*<$M;)$*LB!YZ9:M0D(2XL(2=&HMNY::7Q+$SBZ/N.
M)W[.+]/[U*<:<W\V>LGU0<"\RXEFN&8=CO#7#^.\U8;DW'.46DC*(L6/E6;U
MK7(593VKL##\+QF#1,26FWV76;B2UN#'44Z-+:DI.<TT\E4RFU2B.PW[13Q#
MRUS?]-/),&X:XNY#Y;SJ3R[Q-:-87Q?AF2<@Y4Y7U]G.=LIS-!BE9:V[T&O0
ML%YY+/EM@@J(!UOU,92LTBFW5&N#7/CD:L^F;BSE##?V:'(/3CEW&O(.,>H6
MP].WJ^QZ#P/D&%9+4<RR[[+N:>;K3%*9CC"?61\V<M,FK;B)(KV!!\V8Q*9<
M9"TNH*L()K2<K3YJ/#CFP\;E>%4/G[+WP-SEZ?\ TC^H'&^>.&.5^$\BNO4:
M[>4]!RYQUE_&]U;4IXSP2 +BMJLRIZ:=.JS.AO,_,--K:\UI:.[N2H"Z2,HP
M:DFG7B+K3EAV'.#]H.]%/J=P#UZ<'^O_ (6X(F<]</8Q6<3S++%Z;#+7/*'&
M,SXAS.?D\C%N2<+Q^-(GHXVSB.IAQR9LB+(=DS8SJF7/),C5J;<U=5V*K'#Y
MC*W)./*WB8I^HSS=]5'ZS?IABG"OIL<C\)>G;T^9#C')DS'6:W.<\Y+Y:Y%E
M..<74C7%M.YQWA>19;5XQ0\@V4R5#IZ*5&@06I+\R?W,L,JQNRO7X80:BO\
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MD] &=^N[Z%?J2Y]PC,_IP9QZA<GY%KJ;#*R?04V:PU/O8A:73M3D7$7*>/\
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M%I[B MMHD>S7;V.GKDL;M$N]_4OK8J8AMN;<GL>V/6Q(T!L=K;"5ERQD-@?
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M5XYQIB-QE6:9 BMQS&Z^?;W-[;O'LB08;+TV2Z\M""I0:8;5VI2DJ5L$I!)
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M%DJ"RRAQ]Q89;4H J" GNV'=OL-E$BDILDV*X$E%0[$8LE-]L1Z>RZ_$:=)
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MCH:,8C%SV1Q@G),NK\@C5J,AM:7&;',V8%;F=UC33\A>-V&3UD0LMIR%ZJ:
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M8I1S)^&?@U1'JQ-FV#<)#K$>38R'ID[Y-+RS"8E3I+CTN>]#B%#)D/K<??\
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MGHBL+4DDE,BAQ#\=R:$5E':"N>VD G<CQ'"_J_4FXX;?IO#@\FU7_6GRQ?\
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MA*6 $!IPK0OSTJ1NZ%-CJA*#\/7[W70"%Y;J7&D-MH^7*5AQ7=VJ:"0/*"$
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MLT [: ^:_A)*4?M*GJ]"4I2#Z><<40D!(*E\.^F%:U;#;XEK423[2=]<./\
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MAHQ,;B.0[:#56K-I%CDV<6?5]TZ+-<;2I"<K=[GEX<U2XB.-%59'>_7(, T
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M'4T4$]OQ=JQW>W?4H6M$39MMMEMMEEM#3++:&FFFTA#;;;:0A#:$) 2E"$@
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M?11KY5/T0#0#1=6XIHJ))K;>T+CR&4QJ6 N?*'<E2BZMM*FTMLH">JE* W(
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MEN5UK[T-ZRNZB54R%):+,H]\77S7;5V,+CYHR,<)*JS1L)]9GUW>M[TO>O\
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M*T[$.O)^8=!'\I*WRX4'^QVUP97KD\VZ%'OPZ#H!X#6L!H T : - &@#0!H
MT : - &@-6_6E_Q:.2O_ "3O[_\ %=<?5?R)>KZ46.9N+Z4_^+9P=_DSQ/\
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MT[(95&=6M"(X5\7EH[$$^(V)!CBFZLI-4I2A*4(2$I2 E*4@)2E*1L$I V
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M3ZJ]O,AL<YC1+;,[*&AF57UL^H=@-JIZ/';7>04)5,<F268[R2UY/EN ;/\
MH[]-M9Z5^&:CCQ,R';Y792GLGSZ^AI6F-;Y7/CQ6):*U3[,>4NDI8D9B%#+C
M;:W&6 \MMMUUQ( VAAF7V/?.K84OYEU3'E @)C;@LA?<!^D2-]R/9MUWT!RT
MYO\ 1URQ!OK.7Z?K*;209CEO=8=<4%W4T^2<975Q$L*^UHX<6[?@5MAA\R#;
MRV(R&GD.PX,E45MMOY>/(U[.V_K7:M9TPNF.K+-^]9L2C*Q<M<KDN5^["2E.
M&"BW"L95Y)<J2:4CV/H.L-LU?3:Z<ZHM7[MJS*+LW+?*Y+E>$9*4X8*-85C*
MO(Z))I2*OIX^@W(?3&YE/(O(KM _R5?,#&,>KZY\64/%L);F,2;#SI3+:6/Q
M_))4)DN)8<?9C1HS2$NE3KZ$Z?,/KR/6%^QI=OM2T^QZ6%+=MT3<FDG*2BW%
M<J2A"*;I%-U7,TM77O6ZZLO6--H;4M/LNFA2W;=*N323DU&L51)1@DW15=?>
M:75AQQ78YY027@A1;2L[(*]E>7WE.Z@@J'4@>&O6YZ]-$?4[Z8;ODN1^O.&Q
M:N;D]K5,8[GV(R)@JH&65;??%A7%98O=K,3):BO>5'<#ZFD3H8:07VE1& Y[
M Z'ZUCTR[^W[G:EJ-@U46KEM4YDVN5RBFTGS1]V46X\RY7S+EQ\ZZ-ZPCTZ[
MV@W&W*_L>IBU<MJE4VN5RBFTGS1]V46XUP?,N7'23@[Z;_+EMZGF^<_4SD0R
MFDH;:#ES2<AM*ZXR[-<GI0Q&P^+?BED3ZC\$QB+5PUR%K>;^:,5F.(Q86[V=
MSN_7VU6>C(]&=*6;]G2SG+QKEWEC.<7/FI[DYU<\%.3:7+'D4>5TCV^Z]<[9
M:Z1CTCTS9OVM/.4O%N7.52E%SYJ>[*=7+!3DVERQY5'E=%V_6J3\RUL6?E/*
M<\WN*B_YO<CRNS^3Y?;W;Z]3'JXP+ZA^%6.:<0CQ:^1$JLWQB2[;87=S Z(C
M4MYI+-E16ZXS;LG]7\CB(#,GL0Z6'D,2DM.NQFT$#!?IDQ#U%<5W;F&Y7B54
MYQA9RK6R5,<RNFDOX/<26YMA8+Q=,%<FPO:'++SL=<AR8\!<:3)?E^9\:HN@
M-X0M83^D*"YNK<H!"=NX]O11)W[=M_MT W%R5\VX%!GY+R4E"P5><7^X]Z5#
MP[>W^+[= )9#KQ+)C>2I!= =*RH_H=CWELH.Q<[@/'IH!)(=5V.!HH+P0KL"
MCT\PI5V%>WQ!!4- -B7'O);^8[ ]V_I.PGM[NNY'MW_C\- -BW7=W?,"  L^
M5V$DEO8;=P._Q [[^S0#5(=\>O38_E\>G]7OT!RL^I=SB[2815>G?$YY9S#F
M5IW]:7XKH$K&^+(,A(OY;R #V*RMULUC*5[(?9^:3N%!)T!I#RA80?3OZ;Z3
MCZ*PIO,.1X^.<C9A7,!Q+L+&(T5^)PSQ^IE"E.KD6JK)V\F-]J5)1(@$@EH[
M ;M>DCC.)Q5P[4T#\Z%89G:S).5<COQ9,:2\WF=^EI^=7S#'6L-NTT5IF%L=
M@KY8K ^+7;V;?AVU'CQ-;=6;%V-156[;;-M65]HTTLN--6,*--;;<([2MM$E
MMU*%E/3<#?;6T@K888C,MQXS+4=AE(0TPPVAIEI">B4-MMA*$) \  !H!BOZ
MFXM?DTU>2RL>;9<4J9\I @RWIC9*.U"7IB'/E2@)5L4I4"5=0=MM 2%([4I3
MN5; #N5MW*V&VZM@!N?;T&@/F=XL%V?VDSU<)H55;<Q7 &*AUVW;EO1FHG^)
MGTQ^<MMB&ZPZ]("NWM27$)/7=0UPXU_.2IV?4CDO_+KT_:?3'KF'&/=9I4!9
M?CQY39:DL,R&B02V^TAYLD>!*'$J3N-_=J@^.?TBK]?GUV[CG_F^L^HAG/H7
M]/''?+=IQEA?IZ].\:919]!HTUE7D%;)S&9BV7X#<-HM*JV;;7;6<BT%G9QK
M&/'C1(L9+*>O@[NHK+FY8)Y(LFHX4J<_O57Z1^#/2']8;Z7O#N%>J+F7U2\R
MS/4]Z=;GU"9/RQGM;EMSB4JU]0O'47"L9C2Z=M-OBMR["CV4^3!FS9,YIF7$
MD!2$/ME6J<(POPBFW*JK[2IMQ;X'9+ZF=;#J?KJ?1@@P&W&HS9R=2$.R),I8
M*\DM%+)?EO/OK*E'?JHZWW?\Q P7PLZ>_6X1<*^EIZS/PQV U&3Q!9*MQ+;>
M6^[!%K4?HX"FSY;<A3NVY6".W?;8ZVZC^3+T$CF?.GZ[.-LNSO\ 9<_0I?XW
M&E3*_B/)^'>2<V^5;6OY?$94/F'C-$F0AM:3\K&RCDBK[U%*PGHH@ %2>-<3
M>DBUPI]9FG[[/KUXH]37$G+/IMPCU.X'>TUGQ%E& 5V>?C5=>8['JL5HQ3BP
MO(^06-M94E92O84MEZ):LR%L/5\B,ZV\TVIM:4<V,U**FLJ&NF-#YO\ ]FZY
M%Q;E_P!7/UN.6L&2$X3RCZCN..1<.2EDQDIQ;-N3?6%DN/I3'+4<L 5-FSLC
MRT=OAVC;8<72M2G<DLF_M,YY(^K*TR.@I'8[%O<5M:_+_P!3,S);+#KP[@CN
M;;<6%J1WG;?;;?IKF52,*-GRY_1(RJAX!^I1]8#TD<JVD'$N9,Z]1C_+''-!
M;2$P'.0,+;RGE2_>GXLB<(SMD^G%<[IK9##84^[73%OI06X[ZD<33OENS@_B
MK4SEC%/@83_:B.:.(F;'T2>FK')F+2.5H7.0YARVDI4POQK$,9=C5V.4KV0-
MQ%(57'.IUN\]'0Z@NR45*G#VH2@N8ZN4?=BLZU$.TV/_ &L[_FY^%_\ R]?C
MG_RA?J/UEK/Y2_>^IBWGZCZ-^'ZQZNXWPDOV]I;NRL/Q5XN62XI# _ H.S,1
MF%$AL,,)W\ DD^TG7*CDC ^3'ZBE;Q?A/U^_IICT35N+U_J,L<MHF/4[CG%A
M@U463ASN7)7>#/8>,,B'"RB?P\K*'+ER4V9GX,S">DI+*&%'AW:+4P\/XN-/
MEV&:Q@ZY'U[XZO+'&Y#F4LT,9:E(,./2.3WRVCX^\2Y$P-H6X/A \M&WB=_9
MKFX\3 ,ER:+C,1J2_!M[-Z2Z68D"EKG[&;(=2@K(2AH!MI('BI:DCW;GIH"[
MCMU(OJ_YZ316^/J+RFVX=TTRQ,<;2E"@_P"0T\ZXTVI2BD!P(7ND]-MB0')Z
M+7AX3WXT,2&@.V:\RQYS0&Z4[2%I[T =VPZCQT K!! ((((!!!W!!Z@@CH01
MH0Q^GC#$EW2[^?%F7-D7U2&EW-C+L6(SA<+J0Q&?=+'E-J.R$*2I* !L!MI0
MI.9?S?RS_P B8XF>4L13+#AC!\I/EJ?2R4NJ:2KJH)()'0$>.A#$=/BG*@R*
M/:7V=PW*MN6F1(JJV,[Y$AE)_P!1(9<CQ4,,J1\/>5+6/$]QZF493,FJ0B]#
M?V5Q-MH\O&;6EC5\EQB)/L%,I:M$(><;0]&9W3(2EQM 7OVJ1LH#N)T*2&3*
MC0H[LJ9(8B16$][TF2\VQ'90" 5NO.J0VVD$^)(&A!MI\AHL@0^NDMZ^U1%6
MA$A4"4U)#"G HMAWRE*[/,"#V[^.QV\#H!!>X7BV328TN^IHUG(B-^5'<D*?
M_1M]REE'8VZAM:"M9)"@0?;X#62BGF*DCCQV(K#,6*RU'C1FFX\>.PA+3+##
M*$MM,LM("4-M--I"4I   &PUD"&9!B-I?VL:4<SR&GJ6$H"Z:C=36&0I!"E*
M<LXZDS-GCN%#^;L$]IW)C57G@6N!-T(#:$-I*BE"4H25K6ZLA("05N.*6XXH
M@=5*)43U)WU2&/LCF\FBX;B8I38P:GL:+EO>RY3I*U=OFI^2A2(LEKR23ML'
M0L#?<$[:CYJX4H7#B3Y@/)99$E;3D@--A]QAI;#+CP0 ZMEEQZ0MEI2]RE*G
M%E(Z%1\32$*B<B8[8Y <;K?Q.QGI==:>>BUDHU[!8*@^X[.=0TQY#13MYB2I
M"CL$E1(!G,JT+1TJ3.1&C2VE,2X[$IA?WV9#3;S2]O#N;<2I"MOM&J0HC?)M
M)$2'\LVB,GL$6-Y2$L)2=NP,M;!I(/LV&@(_DV%X[F'R:<@B/SFH*W'&(Z;"
MPB1BMP)"E/,0Y3#;RAVC92@5 ;@'8D&-)YA-K(>JNIK:2"S6U,*/7P8X5Y,:
M,V&VDE:BM:MAU4MQ:B5*)*E$[DDZJ260S*Y[4]Y@(KID>"_YB"I^3"7/3Y(W
M[T-LIF0@EU1VV65* &_PG?< *6DN):;2ZX'74H2EQT(\L.+  4L-A2@CN/7;
M<[: N: - ,%[E&/XTF(J]M8M;\^ZMF&F0I7F2'&TI4YY33:5N*0V%I"E;=J2
MM()!4D'&3X >B&Y#)2I(6R\V0I#B" MMQ.Q2MM8! 4E6Q!'Y=8@;*B@I,?:=
M8I*J!5-/N!U]N#&:CI=<2D(2MSRTI[RE(V&_AH!WT QT=(JE;E-JN;RY^:DJ
MD^9>36YKD;N&WR\53<>.&HR?8D@G[= /F@#0%*U!"%+4%%*$J40A"W%D)!)"
M6VTJ<6K8= D$D] -] )X4M$Z*Q+;9E,(D(\Q#4V*_"E(220 _$DH;D1UD#?M
M6E*@#U /30"E2DH2I2E!*4@J4I1 2E(&Y4HG8  #J= 5-E*PE:5!2% *2I)!
M2H$;I4DC<$$==4C9$XN"8]$R%S*$MV#URMQ]T2)5Q:2FFE2 M*TLQGI:XZ&T
MMK*$([>U"#LD#8:4QJ8U)CJD(FBMRM61NSG\EC)QM*4F-21::,B2M?:042[*
M0N2Z4!6Q*FP@KWV 1MN9C7N*262]\O'?D!EZ06&77O(C(#DA_P I"E^2PV5(
M"WG.WM2"1NH@;C5 R4%O:W"'WK#&Y^/,I4/E$V4J [+E()4"M<6$](^4[0!T
M6KN)/3IU,0'>=/@UD9R9938E?#:[?-ESI+,2,WW$)3YC[ZVVD=RCL-R-SJ@:
M*3+,;R1R4S17$*U<A!LRA#<+H:#I6ELE82$*"RV=B"0=M2J8H++BBI\@C-PK
MNMB6D1J2W+;CS&4O-(DM)6AMX(5T[@AU2?M2H@[@D:9@<VVVVFT--(0TTTA+
M;;;:0AMMM "4(0A("4(0D; #H!JD(?D&*3<@7+0O+\CJJ^4PRS^'TQJ(B6O*
M6TXIQN<[5R+)#CCC>Y*74G8]OW-TF4J6I=Q7"J/#VGTU8FOR979\Y864UZ=.
ME>7N4>8XX0TVD=WW6T-I)ZD$]=$DA6HZWL:ZEUKK%!9QJBR6MORY\J +)MIL
M+!="8JGF4*<6GH"HJ ]WM#T 454>PB5\:/:6*;:P:0H2;%,)JO3*65K4%B$R
MXZW'"4$)V"CX;[[G0%NYLS3U[T\5MI;%E30^1IHR)E@[YKB6]V8ZWF$K2WW=
MROB&R03H!=%?,F.Q(+#\8O-(=^7E)0B0SWI"O+?0VMU"'4[_ ! *.QZ:H*W'
M6F0%/.MM)*@D*<6E *B"0D%1 *B >GV:$+F@#0!H"VVE3:.U3KCRNY9[W T%
M[+6I:4;,MM([6DJ"4]-^T#<D[D@W0]U3 -"":9+8@QW94E2TLL@%9;9>D.=2
M$@(8CMNONJ)/@E).A1'47,2[CN2H;5BTRAY3(-E4V50X[VI2KS66;2+$>=84
M%=%A.VX(\01I6H:H.+B6B MU+9#1\Q*G DALI!/F!2ON%(]O3;0%:5)6E*T*
M"DJ 4E22%)4E0W"DD;@@@]#H0A,? ZMG(W<G=LLCF6#DEV2TS*O)GX?%+A5V
ML1X4<QV_E&4+[$-.=Z @;$'4IC4RKA0F^J8D4QYK-O/DOY5+QOR%I(B5U%$L
M"6%=Z2EQVRGR4J>V;!"DB..Y2NX*2!VF*O$KIP)0ZXEEIQU?>4-(6XL-MN/.
M=J$E2NQII*W75[#HE*2I1Z $ZH&.BR!-^B0ZS47M='96$-/W5:JK^<WW/?%C
M27!/+7;L>Y;3:2#TW.X$3J&J&I/-/#-#QABV8\P\7/9'B]ACLJ7R!EF&5MK8
MVV!Y74(GHML_;3A%FNRK\;M)U09LYJ1CZ*MY=L$OR!)2Y(9D>U.A?,'?=MW+
M2;5JK_B;/*Y&VXSI[D9.B<99JCIFVJ88'SGYO>2O2.\[#N74FUZ1V.IK=J=_
MFM-TNR@N:2G;QBW))_ HR<J-UQ38;2?%F0&9L*5'F0ID9J5$EQ7FY$65%D-)
M>CR8S[*EM/L/M+"T+22E:2""0=?8VVQ4Y)K%,_,W>IN%MQ>#536?.I6R7NO\
M[V[:]M]/6<8GSSUCJ:1D:FIXFR;U$YY"X5Q.QCTD_*ZC()]QDTIZ4VC$L3J6
MXD6XR2/'@J;FV-C%GW,*/$CH<8#DJ4WYCS386L<+SL\Q-+Y<=$2U%RW.[K=;
MS:>S&,W;:E*$F[G,L5R8/#&M,3L/TO>2VX^>'FM#;M/?M:?;-M4=9J9W+:NQ
M=N%V*5KPW[LG=;Y?>PI6J[.ON/\ H&](.-/3),3@_%;=^:3Y[N>NV_*?ELK(
M^8CP6^4+/,6*IB4T"VX(J6"6U* (W.OS*W;S"ZXWSE_JNZ:V]R4I6Y)99/W:
M5>%:NK;Q>)^\/3ODCY1]*.Y_0.GMKL>+7F_@QG7FJFEXG/RJC:I&B2P2I@/O
M$OIA]-?IWR[*<WXMQ.)B-_ED 55GY.0Y%<1(=7\ZW8OUM'3V=M9Q*"OE3V&G
M5L1&FF]V6TI2E#:4#B[QU1U1U+I+&BWG4WM3IM-7P^>F%4D_>HF\$EBW@=QT
MIY9=#=#[EJ]VZ4VZSH=;KDE>=OF2DHMR247)QBJMND4E4S/:<B8[5H*WY"6T
M[$AV4]'@,';V^9*<0H#_ *G72VMNU%UT2Q[JM_,>=T,67/J&QR'W(BR67EC?
MX(3$B>OH.G;(6(L)6_\ 9'7:6=@OSQDFEWT7S8L52,*W?JA6_,_#:]#ZY3BB
MA*)$E;02L_R'HM6R6D@>WO>&VNTL[!9A\;5>Y5^=_83F7 BB,BY+Y'D&GHZ:
M??ON+0X:C&\;?NI"EE1\I08:C6<[N[M^T@[[ZYST>W:2//?<5'MG))?4A63R
M,S8QZ+_4OG1:=FXNYCT,[!N9F]VQ6^5_H35I<GWK*4C_ -A /8-<&[U%LFC7
M+;FI/LMQK\^$?G,U9N2X>TS@GZ?&$XS!:F<[<\4.,0?@>?@5$B'1H?2GN!0S
M?Y)-B+?2M0(2@5Y[E =">FNKEU7J-2^3;-+.;[75^V,5_O&?@)8SE0\_%/IN
M<&L$Q:^SY1LHA[529@G6L9QU(V'S"[E[%<+F(4=BI;;3VP\/:DV-GK'<GRKE
ML0?!43^;FG[6A6Q'O8@LOJ/MU,)=/P3P13T=<D;177H?EUKJ0.U#C<&GCXK0
M,J;2>@%BZ/S=#OM]%3NR\3=-5*4^../M?-+_ %47QGE"-$82N/43ZS.6RMJ)
MDUECU<^2D1\0B.POEDJ.RVGY&-QJR0E/L)=MG1[-_?VMO8^F]NQN1C.:_$ZU
M_P 3?^PC'FNRX^PB59Z8>2,MEJF99>V4F7+4'91FVSB93RCM\:?P!,BU<61M
MNE^:?<=O#7)GO>WZ:/+IX1Y5EAA_K8>R(5IO%FPN&>BVGKE(?E,/><H .OM1
MHE*7=QU3+>>%A<RO=W%:5'V[>&NIU/4]V?NPIR^M^S**]AFK:1LACGIWPJB\
MM8KJU+B-CYB8IL)05[5-S[54EYLD_P U &NDO[SJKV<I4]-%[%0R44C+D+#\
M?A!/;!3(4D !4M1?&R? >4=H^WY$:Z^6HNRXT]!D21MIME ;:;0T@>"&T)0@
M?D2D #6EMO%Y@KU &@#0!H T : - &@#0!H T : - &@#0&K?K2_XM')7_DG
M?W_XKKCZK^1+U?2BQS-Q?2G_ ,6S@[_)GB?^Y4?73FPV T : - &@#0!H T
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M,=E*G'%J)\ .GB=AN=<2/^<E^[]2.0_\NO3]I])-;._$H;4SY*? \WNVC63
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M2E'HD+*B 3ML#J<RX%HQ^6TTX4%QMM9;4%ME:$J*%C8A2"H$I4"/$==8$*]
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MHZ"OQZ&8=>)2DK<+SS\Z=+L)<AY0 4Z]*F//.J) \ 0D>P#2E 7K?\9^1<_
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M >;70._ZF6DT^M5F_;N.%+\7:3:SI.7N94:K)-U6%<#X_P#.#]-WG1T;MO\
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MHSW7)/%@T : - &@#0!H T : - &@#0!H T : - &@-6_6E_Q:.2O_)._O\
M\5UQ]5_(EZOI18YFXOI3_P"+9P=_DSQ/_<J/KIS8; : - &@#0!H T : - &
M@#0%*E)0E2UJ2A"$E2UJ(2E*4C=2E*.P2E(&Y)\- ?'7]2'ZD//GU2N?)OTF
MOI-37+;%[9R;3^I[U/4\V3%Q)S$HLENNR^KJ\OKFW_P?AJG\_P"7N+B/WR<K
MDK15U:'HKP%M,S?&*@N>9]!GTW/IN<"_3/X%@<0<00$W.5W*8%KR[R[:P(\?
M+^5<OCQUMFRLBVN0:G&JDR'6J:F:=<C5D9Q7Q/2GI<N335*3FZLZ%:&(: -
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M.O&F"?K21TTUZZ/*0T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
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M&X=J^&DQW;*B8BL.7<Y3TB%87]^9K%O/R&5)C2!*:F2[E@/( =4&FT(:!+:
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M)75;"M(H6'4LS8[;Z6W0E20ZT5I*F70A9'<DA6Q(WV)T:3S![44U50PD5U-
MC5T)M;CB8\5L-H\QU7<XXKQ4M:CXE1)V '@!HDED,Q1/B&=#D1!*EPOF&RW\
MU =2Q,9!()5'>6VZ&G"!MW=I(WZ;'8Z N1F$Q8[,="WW$,MI;2Y)?>E2%A(V
M[GI$A;CSSBO:I2B3H!FR%[)VH[(Q>#33)3CBDO.74Z5$C1F^T=BPU$B2'9/<
MH]0%-E('3??I'7@%3B/4;YCY=CYLLF5Y+7S)C!8CF1V)\XL!TEP,^9OV]Q*N
MW;?KJ@8K?*:NG>3$<$ZQL%E&U72P)5M8(0OJ'7X\)MTQ&.WKWO%M) .Q.HVD
M*#W%?,J.S(,>1%+R OY>4A+<AH'P2\VA;@;61U[=]QOL=CN-4%N;8U]:VEZQ
MG0X#*UAM#LV2S%;4X02&TK?6VE2R!X [Z 5@@@$$$$ @@[@@]001T((UBWP!
M91'9;>>D(; >D!I+SG7N6ED*#0.Y( 0%G;;WG6($-VU;/5-@U128T.X<BNIK
MI4QLNQ6)13^B6\@-O;H!\?@7MX]JO @1W"Z3+:B/).695^L<J2M+B&FX,:+&
M@G8!Q++R&6I#X60-@0VA/L1N2=$4<LHR)6-P$3&Z._R!YU[R6H./UKMC("NQ
M2_-D>7\,>.GMV*SN=R  = 7<<M["ZKQ-L:"PQUU;A#<*Q=BN2%L[)*7E(CN+
M6P2K<%#J4+&V^VQT(.DV?"K8SDRQF18$1H;NR9C[4:.V.IW6\\M#:?#VG0%4
M*9%L8D:?!?;DPYC+<B-(:/<V\PZD+;<0>FZ5I.XT PM87BC5L[?)H:Y5P\^J
M2NQ>8$B3\PM?>7VUOESR70KP4CM*1T&PZ:%)/H0I2RDNAXESN#9;[?-=\HI*
M@HDL=_D%P%/WRGN Z;[$C5(W04:I@6TEPK<"T(2@%/E*2XI2U@I!47$%I :*
M5[@ *7N.O3PT!<T UU]Q"M'9K,3YSOKW_EY)DUEG :+NZP1&?GPXS,Y +9W4
MPIQ W&Y^(;PHZ:I"E*DK 4A25)/@I)"@=CL=B-P=B- 0G)..\6RZUK[>_AO3
MWJV.8[$=4IYJ$MLO%\%]AI2"Z0XH_P H)4.B@1L-1I/,M:$S889C,LQH[3;$
M>.TVPPPRA+;3++2 VTTTV@!#;;:$@)    V&J"(7%)F,VV:EU6;HI*IOR_,J
M$XQ76*G^W;S/,L9<GSD^81_(2GM!_/J8C F2=]AW$%6P[BD%()VZD)*E%()]
MFYV]^J0B:+W(7KY5<SATU-,T^67<AEVE;&;4$[A;T6L"WITAGN'PDA'<.O3I
MO"DL4H)!4HA*4@J4I1 "0!N22>@ &J0@,SE3CV"XEEW*JUYU:U-I;K_F+5:E
MI4E!0$U;$PE2E*^'^=[-]CJ51:,GK:TNMH<1W=KB$K3WH6VOM6D*'<VXE#C:
MMCU2H!0/0C?5 E9K:Z-*D38\"$Q-E_ZJELQ6&I4GJ#_;$A#:77NH!^(GPT I
M=;\UIUKO<;\UM;?F-*['6^])3WM+&Y0XG?=)]AT(-5/21J5DM,2K>:I7WY%Q
M<VEQ(43MOVKL94A+ /:-TM!"3MX:A1?-5-3$D*KFXKTX-+^4;FO.QXBW]OT8
MD/L1Y3S;7=]XI;4=O :H&3&V,L9CNJRRPI)DIQ2"RU20)<5B, %>8%2)<MU<
MKO)&WZ)KMV/WM^D5>(PX"V\METM>Y/156URM"T(3 I8S<N<X7#MW(:<>CI\M
M'BH]W0>PZI!-CMV_?053'Z*ZH%I>4S\I>1V(TE82$GSFVV9#Y+*N[8%0020>
MFVQ)8F#5!PGVE;5MMNV=C!KFG74L-.SY<>&VZ^OHAEM<AQM*W5GP2"2=4"AV
M3'CC=^0RR/'=UU#8V_*M2=9*,I?"FP,KUWCK+XE+DQ%RDLJCID,M%^1Y"EI<
M4PE]EM:@TMQ 5V]P25 'V:VQTU^647Z\/I%&,=CR+CE:DF1(#0V[@N4]%A-%
M/\[OD/H5MOT^[KD6]NU%SX5[*OZ$*&/)W/6+0$K2FRAOK[W"E25.V2B%+4I*
M!^&1&6>QI)[4DJW('51.Y/.M[%J9YJ7S+Z6,#']IZE&-EB!'L7E;$@-1H<-I
M1'@E+K[TF0G<^)[1KL+?3K^^X^UOZ*(E48F>]1.;6SKZ#CS=9' 5Y;ME<OV:
MU*W  3%BIA-(^$D[[E(/OUS[6QZ>'Q/V)+[1S=AY77?,>;K4SB]3DMT=P/E\
M2QF99.)43VI2E5; F3-RH; =VY/37(EI]LTJK?<(_OR2^EI!<SR,HTOI(]4F
M=?I96&7<*,HI*Y&97D*H["1N@&OM+ 6IV _D1B$[;';H-<.YO^Q:7"%R+E^Q
M%OYTJ?.9JU=? S34_3:RSR$V'(O)>"8I#83WJD0H<W(#%[MB4N/6IQ6(RLA/
M4I=4GIT)UUMWK'3-\NDL7;D^^D?HYG\QFM._O-(?1P#Z&^.PAW/N>G\OELI_
M3P:"Y@RH:U)2.Y#E;A=9?7,=1/@DRTD#W^.M?]6ZGUF&DTJMQ[9)I^V;BOF'
M)9C\4JEI?/OH0XW0M&#\'/YC+CDJ9GWU/%G0EJ1M^G_$,VM+JVBJ.W<"(0[?
M8$^&JMJZIUK_ .9U2MQ?"+:?L@DG[1SV(_#&OR[R'WGU/<A+?X7QAQQAF/Q&
MNYM$5I-MF4F,.GQM1<;9H8T583L2%QW$@>\==<NST+!_Q-;=NSEVND$_7+FK
M[1^8EE%&';/U/^LWE$K;J;',H,-XJ#1H(<#$(;"'#L0)^.Q%Y&TE/L6]NI(\
M%;Z[.'3_ $YH<;OA.2_$W-^R3Y?88\]Z1H=Z8>(.4>0>4/5Q5WM\Q"SVI]0,
MN?F2KN5*MLB-;DV)X].P^6[92W9$M^)*KHS_ ,NIR&ON#:MB0.T=?M6X;9H;
MFKARN4OS4G&F"Y'&/+APX_>,IVY2Y:O@=%\=]#CTP-NY!=Y!;*.P4@!V#'<&
MW7=0=J:UY._\Z(1T]^N7>ZIA#"Q;A'YW];_U@K,5F;#XGZ/,"Q]*?+I8#>^W
M<I]Y2G%'VJ=CU3-;!?)]O=W?NZZC4=2:R]G-_+O=69J$5D9XH^(,2HTI$2''
MC[#8BN@PJQ"QT![_ "&E/**MNI+FY]IUU-W<=1=^-M^EMF5$3B+C5%#V+-9&
M*AL0M])DK!'M"I!=*3^3;7%E>NRSDRCVE*4@)2D)2!L$I   ]P Z :U ]T :
M - &@#0!H T : - ?(-]8UK..6?5URQ=8YCUO=8/Z:N,^+<5S3)(<=3E!C R
M>9%N8;<ZP)3$%A.R+DUJ*&$*7)4I"R4=D=U3?HGK[\QKM]OW+,92TVCLVXSD
MOACS--5>57*XE3//@G3^@3_MXSZ9Z"\@=AVW>-7I]-U-UGO6Y:K1Z><J7]3^
M6A*S-PA\7APL;=.XYM*VDXI2YKMM3Q+]*NJ]2E;SA:<K^G*HK\U5QO&HH_*W
M%R\GK,<NN0.,LMFS&+B-2)O7H%)-DTS],W):4[+9<8L?DRE#R%.HUP>BH;O#
M<9:[:8JYX*7B6^91<[<FZTYJ)TI55:I+EP>)Y[^N?7>36L\L['0GG!J+NVK>
M)WI;7N2TUS46=#N.EA!VI7O 4[T(WHWI6YJ-J<9Z?\PG*W)0D?:7$DIF1(LM
M#4AA,J.S)2S+8<BRV4OMI=#4J*\E+T:0V%;+;6 I"@01N-?0<7S14L55<<&?
MSAZBR]/?GIY2A*4)N-824HOE;58R55*+I523HU1K 4:IJ#0!H T : - &@#0
M!H T : - &@#0!H#5OUI?\6CDK_R3O[_ /%=<?5?R)>KZ46.9N+Z4_\ BV<'
M?Y,\3_W*CZZ<V&P&@#0!H T : ^9G]K YZYS].GTOL?Y ]/G,_+'!.>/>JCB
M?'GLVX:Y%S#C#+G:"QP[E2584;N283<4=RY3SY-='<>C%XLNK8;4I)*$D ?3
M-H#YF?5_SUSGC/[3Q])[@+&^9^6,?X)Y&]*_/V0\A<*TG(N857$N=W]-Q?ZN
MK"GO,RXX@7$?#LHN*J?C5<_&DSH;[S#U?&6A25,-%(!Z>^>N<[K]JB]=/IYN
M>9^6+;@'$?ITXCF^*<'6?(N83^'\8S23;>CIN3E^/<9RKAW"Z7*)#>3V25V$
M:$U+6FQD@N$/N]X'TS: Y&?4\^K#BGH =P+ACCSA;E3U4^MOG^GMY'IP]-'%
MF)W]F]E;M=+162<GS7*H-=*@XS@]'.=[IJV!+L"A!(8;CAV6P!H5^S->I3U>
M^IOBSZA>4>MC/\JS#FO%?J \CX7=XS=91.O\5XEF5&&X8+WB[B^L<O+ZCQ'C
MW%LD7+9@U]4^J"D N)6ZMQ;S@$Y]?>!?5>]>'KY3Z+/3URWS!].[T%<8</UG
M('*?K'XYQN6UGO//(]\[7.-<:\29_ M:.SH_U=A6[+"TP;"L5&?BVDF8J<$5
ML/0&K'$V0^O/Z/GU2_1%Z)N8O71R9]1;TH_43A\L46+JY]5,R#U$<%\@\84]
M9;/9$K++*[R;(+C#YLBZKFN^18IKW83MDI$!B16HD2@,S?4AYX]:GK6^IM@?
MT<O0GZB[[T?XYA/ KGJ9];/J:P>K1-Y,HL3L[BJJL-XWX^G"=365!;2E7-3(
M<>K["#,D_CC2R\(E?,C3 -;;+_T(-]![UE>B\<S_ % .9/7]].KUJ<V4GI?S
MN3ZGYUCD?*? _,&=I>&"9-"SK(KS++I=&%1WYZC'G,07JR%91I%:'VJ^=H#[
M M &@.#WU[KV<CA#TU84E#R*;+/4UCUA=R0R5176\5Q/*)4*HD2=E!I=C)L?
M,;1MW.&,3W)"%;^U_)S2VM3UA:\5JBY,/3<@W]%/6>SO*;2V]3U9:\2E$X?_
M &R+?T4]9\_%Q+^]U]^OO(^X#$]U,^_U]_Y?W/;H# EA<WG%EO+Y1XQRRUXX
MS&M0J6[9T<I4>#=>6OS!77E2H+K;=B<\0DMO-.-NK4.]*_#6B=_4:*RUI5&[
M9E--Z>:YK=V4G2D5G;NS;I&Y:Y9.;7-S+ ^3/U">1GEUNO3NY>8/-'9NH])I
MYWI:FU2-N_**;4+UKX9RNR:@I)*3G).7/@CZ:>&,HR7-^(^-,QS*K;I<KRC!
ML8O\@JV678S,.VM:>)-FM-19#CLB(V7GBI++BE.- ]BB5))UU^Y6+.EW"_IM
M.^:Q;NRC%UK5)M+%43]/',_-O27+E[2V[MU4N2@FUWM=G#T<#($O[A_)_7UH
ML_$;+F1\R>,8[ZU_IL<I<_P?2;Z=Z+UQ>C7F[E;)N5\0J<#Y+HL;R_A[D3(D
M1F,EQ&>^U"R.0NLK6ZYF-Y2:V4RN-$BK,J+*<DLN>HMJM]:>7>Y:V/2NW0WO
MI/6:F=Z$;5Z,+EB[*BG!NDWRJB5.22I&+YHR<D_--9+8NI=)8_J^IEH-XL6H
MPDYP<HW(+X9+&.+JW\2=6\&J,UJX!;]4^1?6EQO//5;CN+8;R3FOI0RC-XW%
M^(747(8W#W':KR]PW$\,O;:%(FQ)60*?J392UM2'DN+MT+_0E1CL[^AUU9J/
M/O3[AU;;M6=RO[-<NJQ;DIK36>:=JW;G)-ISK'GDTW5W$_=KRQT[^]GM>7=S
M3;-*=S2V]=&#N23CXLZ*<II.C4<>552^'CFV_*CZO?3']0_UB\V\?>B[/.?L
M(YD:PRFH;6KRV%A=<F-1XWC*I%E&FNX[E2[%!FQ78Y;++':ILGN/AKS"Q=\Q
MNA?-WJ'JG9.F-7O.V[E&S"$H7HV(I0MVZR4G;N\WO)QIRQI3-G278=,=0]%[
M9M&OW:SH=5I7.4E*#N.LI2P:YX4P:=:LD3_U!/48WFV'XQRIZ!,UXKI\JNH<
M"7?R^6X.03:FM>DML3+>/CK''-7)MDPDN;AL/L)<5\/F))WU[*VOS>\P[NZ:
M72]0=%:K;-HO:B%NYJ;FNC*-F,Y4<^3\K!S:S4%).62Q/#]QZ0Z4TFWW]9I.
MH+%^_9LRFK:L.'-RJM'-WFH+MDU19LR[F-GG7)\&514F!76+4ULD,3,BS)35
M4]&KUN)4ZIFD0MR9(<?8W2 E2D]=CT/</<>JW'6ZVQ/3[3IM1XER+BKUVW*S
M:A54YVKO)=G2M8JW;:DTES1B^=?,'4OGKY6=)69W;VZZ7<-PM_#IM%-:F=R2
MRAXMKGT]I55)RN74XJK4)R2@^A.+?5+^I3Q;A='Q]C7-O&#F.8MC5)B6-?.\
M*XD)F.TF.U;%-51X"F(Z6)JXT"*VGNF)D%2FQOXJW^3-Q_2SLD]2]1/4J4YS
M<I_S%5R=7ASR[>#1T>W?K\ZRN6':6C4%2D%2S+E25$D_#CE@O>4LJFK'J"]9
MOK7]3M6_C'/OJ<S3*<)E;HF\?8?64/%^&6L?N!^2R&IP2#3(RF$".X(L?F"E
M>Q2H%(.NXV#R$Z1Z=U$=1)*[=BZY.O\ CG.Y)5X\G(^\\7ZN_5AYC]:Z.6BE
M<E9TLU1KFCRM4XV[5NU"5'EXOBKM79N[])[ZGV2^CG.\=]/7/.53[STG9S:Q
MJ;%<CR"8].F>GS)K!;<6O4BQEO%3'%5B\4HG1E'R:PGYQD-]LI$OU'YT^3\+
M,9=0;##WL6XK.7'DEVSI7PYYR^"57RL^A_TR?J/N>+#H_JZ[_P JZ*,I/"VW
M1*Y"K]VU6GBV_AMM^+"D>>)]L:5)6E*T*2M"TA25)(4E25#=*DJ&X*2#T.OD
M0_1[/%9%6@#0!H T : - &@#0!H T : - &@*''&V6UNNK0TTTA3CCCBDH;;
M;0DJ6M:U$)0A"0223L!H1M)5>0W4UY2Y'7,7&/7%7?5,KS/E;2FL(EI72?*<
M4T[Y$V"\_&>\MU!2KM4=E @]1H86KMJ]!7+,HSMO)Q::?K6 Z:&P- &@#0!H
M T : - &@#0!H T : - <>\M_P"<MRC_ "?UW]Y%'KDZ3^=ZF8RR-TM=GF8%
M!7[OW=9*/:"C<[[^W2JR!KEK2EQ.20>!DN03<E74N8?/@5#8D=]U-?2A)\E!
M+;C;33+L=T/N]J$H2\5;*[B?A*=*NN6!*DXU0(8EI73W)+,*;&EN0W/*E(CN
MH=+#@*DEMSL) 6E22"/81UT L4E*TJ0M*5H4"%)4 I*@?$*2=P0= >-MMLH2
MTTVAIM [4-MI2A"$CP2E"0$I ]PT!&LIQM>316(@N[6G::=+CXJWDLF6@]NS
M<@D=RDH[=TC?M"CN0=AL:J1JJ'"DIV:.O:KF),Z6AK=1D6,MV9)<6H *)<=)
M"$?#T0@)0GV#J=5*A@,V5HS1UN*UB#M1&*BX9LFR+BGF]BCR4QV_(?8*% J[
MRI)5T&VW71UX#$>J5FVCUL9J[FL6%FD*,J5%CB,PM2EJ4E+;0 &S:"$]W:GN
MVWV&^V@&V]RN#02(<1^%<3Y,[<M,U-8_/4E(5V=SA;[4#=6X"05+Z>&VC= 2
M1M?F-H<[5H[T)7V.)*'$]R0KM6@]4K3OL1[#J@02;BHA/IBS+6MB25I2I,:3
M.C,/J2H]J5)9==2X4J5T!VZG4J@."DA:5(/< I)22E2D* 4-CVK04K0K8]""
M"/9J@:*;'ZG'VY#55&7'3*>,B07)<R8X\\=]W%O3I$EXDE1/WMMR3J)4 KLF
M)TF#)8K9Z:R<ZWVQYZXB)Z8J^Y)+GRCKC3;Y[ 0 I0 )W.^VQ ;L?JK2J8=1
M:Y#-R&0ZI!\Z5%A0VF @*!3'8B-!Q/F=WQ=[CGW1MV]=R5,RER\L+>OBI<IJ
M!W()2E$?+(L8%8VVD;?&[)G.#8'?H$(6>G7;1UX 75S\R3!C/V$'\-FNM]TB
M )34WY5S<CR_FF4H:>V !W2 .NA!/<W=7CT!RSN):84%I3:%OJ;>>V6ZH(;2
MEJ.VZ\M2E'P2DZ-I9E%-?/BV<./80EN.1938=86XQ(C+6V20%%B4TS(;"MMQ
MW)&XZ^!&F9!2EMM"EK0VA*W""XI*4I4LC?8K4 "HC?VZH*] ::^J;TOIY=BI
MS_!'VZGF;&HB&Z.9,DNIJ<EJ(_FK>PZY:6OY9F+-+JU,/[)+,D[J4E"E*3Q[
M]E7%5?&@:J<;\BXGRYB3O!G.R7<.S##W'\?P_+,@8<<L>-+)3JFI/'G(4=QO
MYRPXKL9*UKCR0AQ=.XM3C25QUO,IZUIIT>91]XAYEY3] F:V/&?(M/=V7"KM
MDB;:8\PXU:V_&7XH4R_ULP22V])AY'@]PA_YEV.PXIE:%?,QU]Y=\^ [L83G
MF)\AXW59;@^2563XY>0D3:JYIY;4R)(9<W3O\![V9##J2V\RXE#S#R5-N)2M
M*D@"<QWRA#:7'0I?1/>KM25KV)Z#PW(!.WNT XH?[.]Q;A" G?M( 2V$A14K
M<#O^(>.^XZ=- *VWBZ676WCY6RE% "2ET+2.TJW'<GM\>F@.97U!4>I[ENE_
MQ%\+<,Y)<89.G5%AF.=,9!A<.%DB8ORUC78Q71[')8,R#7PK@-O3GI:(ZE/1
M&T(!8*UN ;'>B7TUM^F'AZ/C5J[#FY]E4\Y1G]A#5YT1-L[':BPJ&MDJ0EUZ
MJQVN:0RE1V0]*7(D)2@/]B0-P$.!ILHDOAT.+4G=\-@+#A/:SL E*^G0#;KH
M#D]S%Z?N>.+KF79>GB'<R#7_ (M-XQR*A=Q^3*Q)BXK9U?88-E=5?6=<J91Q
M8TQ;=?*9;D):9;B.NI,R&ER1WT=QTVJV]:/7<RN0:Y9)5JEP?9AA7'@\6CY7
MU?E%UCT/YL7?,'RN6EGM&Z6KL=9I+L_#5N=RDG=M1]V-R*NJ-^-MS@U)7+2E
M"%Q2@V_3=]%&7\/VE]S3S! :JLXF0I.-X70+F0;BPHJR1)0J_P BM)3+DZ(U
M;W[<9N/'"'#(9A+?\TA4E3;>K=MQMZM0T^F36EMK"O%TI[$L%ZSN?(7R<W?H
M"YN75?6=VWJ.N-UO3=R4)<ZA;E<\22<J1K<O7?XERB<4HVTG52.OIDH=+S"'
MPEY"-EA':7&BXGX%]O4 ]=QOKICZ/.??JG]/][<W3N=<?U4C()>50V*W/<7K
M)\*JR&=85\!FNJ,ZQB5/FUL,746NB,1);1DLN*;BQ7HOZ=EQN3W.U[E;TT)Z
M75)RTEQ.O:FU1^WC[4?./G?Y-[IUIN&W]==#7K6E\P-JN6W;<VXPOPMW/$A&
M4DGRSM3<I0;3C.,I6YNG*XZ*\0>B?U"\N^J97,OJJKWD8K1VM7E%I9W[E"S,
MSN3C+$.%B>.IQNHL)[%;7MM5<9RS0I/R:V6W&&RXI\J1MN[AIK&W?D-%S.4F
M^:35*I_6U1=RKB\SH]F\HNLNJ?../FEYE+3V]%HK5EZ/2V[BN<EVW'W8U55X
M=BZ[EZ,^93N77";A!<UM=XG?,>?C/MREMM-]Q6RVG=$@+ V*E=P&P]G0_9MK
MH3ZJ->/4=P^_ROC<"PQHP6>0<-<F2L9=G/&/#M85BW&%[B-G-0Q)7!@7J849
MU#R6U*CS8<9U04TEUIP#"/I?N>;<*MT\4YCQ'E=9@3[EQ:T>2VD_$4G!Y+IG
M6=E1RD5N1V2[K';2W6I4%<8NOPY$E3>RX7EJB ;ON2O(;*I+R.JU *V[$@*4
M>Q/BHJ('B= )7'%!TN%T^7Y7;Y6P[0KN*O,[O$$CIMH! Y(#B4J;<';N%=R=
MB%)!ZI'NWVV]^@&>QG,L194AZ6S"8C,NO2);RVFV(C+""Z\\^XZI+3;3+:2I
M140$I!)(T!Q3]4?K4R7FFSD<%^F&RMCCTBP&/9GRSCS,E5IELMY8A.X9Q6B,
MRN7(^;D.>2[9,#N?)"8I+2DN20,:+EX3Z'\+4S >J7>>S7.194V&Y'LJ[@>'
M,0ME^JK'6E/M6W-%GYBFY+Z2Y^#%:FT$RBM: )/Z4/35:6MO5\_\QU[B+)2$
MV/%^!6B"XO%F9);D,9ED+3H'?E\Y*0Y&:6%& E86K^V V(_/T]BG\2>?!?68
M-\$=(WTNK8>1'=2P^MIQ++ZF@\EEU2"&W5,E2 ZEM9!*>X=VVVXUS3$;Z:%8
MP(GDVET_>RU.*<5,?AP( 2DA(2RS&KV&6TM([=_C+BR2=U;; 1=Y1UU2!H")
M95G&.88W%7?3%L+FE[Y1AF.])??#'E^<H):04H0CS4C=92"3TWZZC:691VH+
MROR6IAW=6MQR!.#Q84ZTIEP^1(=BNA;:_B24O,*'V[;CIHG550%D2N@02\J%
M!APU2%EV0J+&9CE]PDDN/%E""ZLD^*MSK**69#YD.=LMJ_1-]?S%N<N4Y0Q?
MB3U<\1T^&C/YG8S14EL,3QSC9!L;*>%U\)NFRKCVC79.E334"OM&I3^S7?W\
M.;5K6<\L(R6?S?4<F*Y['*LTSZ3L9P]K&GYSR+W);E4\-=XOK03FXY;6XM2H
MS+4>*RVITN#N/:2 D $#<'FI<IQ6R6OE]+#QC):7(#3ACH>6IME;X0?*2ZXA
M#BT-*<V"B$J('4 ZAB0S'/\ &&[8/O95^JL6L#*D1X=*FQ?F*?*D%+CDF4XE
MI#:4[@[!14?Y*?$E7B5TX$NFRDPHDB6IF5)3':4Z6(4=R5+="1OV1XS0+CSJ
MO8D=3H0B&*YJYE,J4RC%,HIHL="U)L+N"U!C/$.!*&6TKD%Y;ZT*[B$)6E(!
M[B.F\3J&J$YU2!H!KFTE/9R84RQJX$Z57*4N!(F1&)#L-Q:FUER,IY"RTYWL
MI4%)V(*01UTH4=-"$>DU%J_?1+1O(YL6JCL!#N/L1()CRWP727GYCK3DH)6'
M$@I3V_<&RAUTXE'Q]WR67GO+==\IIQWRF$>8\[Y:"ORV4;CO=7MLD;C<G0AC
MFJS;)K>\:KVN.KNNJ2O^V+F\EM5BH[&Y!<3!^6D)DN>YMM\D^\#KJ5*9+U2#
M- R&FM)T^NKK!F9,JG7&+%E@.+^3?:<++C#[H1Y*'DN CL[N[<'IT.PHY28L
M::P[%F1V)<5]/8]&DLMOL/(W!['674K;<3N/ @C0AY$B1($9J'!BQX41A/8Q
M%B,-QHS*-RKL:892AIM.Y)V  W.@%&@#0$=LSEALX"*=..HIB$&SD6:[)RS2
MKS%=Z($2*VU$4 R$[*<?'Q$_#L/B%)%H0BESDTFKL&*Z)BV37CKR6W%2:R)#
M37,I6LI*7;"PG0HZ7D@;]N^P'B1H4E8_)M]A]GV=-QH03O2XL=;+<B3'8<DK
M\N.V\\VTN0YNE/ELI6I*G5]RP-D[G<CWZ 4: 1Q:^#!7*<AQ&([DZ0N5,<:;
M2A<F0LDJ>>6!W.+._M\/9H!NR*ONK.M5$H;U&.37'4%5F:MJV<1' 7YC3$=^
M3&9;==44_I%=_:D'9/<0I-HWD"QB]1=T\)UB]R>1E$MQ\N(EOUT.M2PUVA(9
M:8BEQ1&XW)6XO<^ 3[<DFLW4,HRJXOJ>"T]C^,O9/-=>\I45NPBUS<9ORUJ^
M8>=D=ZW$]X "4)._M4GIN;:R50N\N8Q89'95_P SDE#&Q^6I7Z*$S:)LW2T0
M3WR"W&:9CJ\-DAQPGKOVGIHJM8ATX%_(<EI,5@HLKZ<F!#<DM0VG2Q*DJ=E/
M(<<;8;8AL2'W%J0RH[!)Z).JVEF*5'*#-CV4.//B%TQI327F%/QI,-U3:ONJ
M7&F,L2621UV6A)VZ[: MQJNLA//2(== B2)*UN2'XT2.P\^MQ7>XMYUIM"W5
MK5U)422>IT J?;4ZR\TAYV,MUIQM$A@-%YA2T%*7F0^T^P76B>Y/>A:-QU21
MTT!#Z;"D5%L;ES)\ON91:<9+5S<H?@^6Z .T0(L.'$2$*'<G9(V5U\=1*CKB
M6I-=4A!\4@9ZQ+LY.97E1-8><4*RLI8@1'BM*<[^]V4_#C3%J;3\"4$N=-RI
M:B>D7-Q*Z<"1W5S#H:]ZRG)EK89+:/+@PY,^4XXZL-M-M1HK;KJE+6H#?8)'
MM('75;IB0M4-TB_KT6+==;UB%N+0F-=0%UTTI2$D/".XI9+#@5\*M]E:)U [
MN.-LMN//.(:::0IQUUQ24-MMH25+<<6HA*$(2"220 !H!+ L:^UC)F5<^'90
MUJ6E$N!*8F1EJ;44N)2_'6XTI2%#8@'H=,\@-UOC&/W[\.3=5$*T=KRLP_GF
MA(;9+A0IS9EPEE066T[]R3OL-25.)4V/@         &P '0  =  -8$([D^-
MHRB FM>N+RIC><EU\T<MB"_+0D$"/(?<B27?EB3N4H*.X^).A2[CF/M8W7BM
MCV-O9,)<4XVY<S?GY+04 "RV^6FUA@;;A!W"23MMOH!K@6N9R+QV+-Q*#7T2
M''T(MCD;,F2ZV@N>0^BO8@%7<^$IW;4M'9W??.VQ F6A!O;M*]VQ?J&Y;2K*
M-';E/PP3YK<=TI2AU0V[>TE0\#N-QOXC0%BTH*2[7$7<5-?:*@K<<A_/Q&98
MCK=\OS%-)?0M*2ORD[].O:/=H!V2E*$I2E(2E("4I2 $I2!L$I V   Z#0$4
MRC$8^5B&W,N,AKXL53BG(=+9"NCSROL[?GRB.M]X,]GP!*T =Q/4[$"DA@08
M]=#BU\0.)C0V&X[ >?>DNAMI(2GS'Y"W7WE[#JI2BH^TZ$":;5*H::QJO6VJ
M2CY]R=(DM+9A@@N&&S'BO"1)6-PD+<:2D]23X:IAF..J0QS:Y],@9(G'8>$9
M=;A*HZ7K6)7AJL ?2E7F,2Y*FXSK+05VJ6IQM(6E2=^F^I7&A:&1M4A;#K2G
M%-)<;+J "ML+27$!0!!4@'N2"#TWT TWV/U635ZJNY8>DP''$N.1V9UA #I0
M%)2AYRNE1'7F?C)+:E%!(!(W (E*ER+E+1U&.P&ZRD@,5T%M2EICQTD)+B]N
M]QQ:U*<==7L-U*)4=AUZ:9 OV+5@_%6W638U?*40!*DP56*&T$$*[(Z9D$%W
MJ"E2E*2-NJ5: NPF7X\5AF5,<L)#: EZ8ZTPPN0O<E3A9BMM,-CKL E/0#KN
M=R:!JR"SN:V.RNDQN3DDEQPI7'9LJNK;CM@ EUY^RD-=W=OLE+:%DD'?;IO
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MN"#;C?TW1[64PCM:G9#5XQ7224HV2&[:4<RN$MK('<H@*)ZE)(U?Z#U!JO\
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M!3MVIRC<NQYXMVHS491E1K1KTT?5<])GJ,,"DD98>(.0)8#?ZF\H/1*6/+E
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MC?%0NRGH)+T5UD)267N)OX3['=>_#^>(- &@#0!H T : - &@#0!H T : -
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M"B-ZG*#2U)R9-2J@3D1KH?XZFB7,18KI4V_D_B J5V#:7S&\SR2\D+[>X Z
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MW $[@?3[H T!RL^L=P#D7.GHLR2SPF NSSO@C*J'GO&:^.A:I=DU@\6VB95
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MZ JT!X=4Q;X'FJ8C1=W#5' <G.Q+&<$'M3&JX,B?)<60>T=C*%):2=OON%*
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M.")(DMH\Q.Q[2H+'@0#H M+NGI&FW[FUKJIEU?EM.V,V/"0XOINAM4AQL+4
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M_P F>)_[E1]=.;#8#0!H T : - <^OJD>@C%?J7^A_FKTAY)?)PZPSZMJ+?
ML[,!-F<'Y)PRZ@Y/A>0/024.RJE=I6B#:--+;D/U$R4TTXVXM+B0.&'#/J3_
M &FST9\:8OZ;.1_IA\0^N>;QM2PL"P'U,8#ZFL#PEC-L=QR*BHH+?/*J^O6;
MFQMFXB8Z')LVLQ>1,99+DAI<DORE ;!?34^G'Z[LU^H#GOU??JOO\7XIZD+'
MBM/"?IZ],_$5E'R7$O3_ ,?24*9M7[')6++)(+F0*BRK%EEF!=7#+J[^TDO2
M@7V(L4#5/U->G;ZR7IL^NSZH?J.^A?T#8?ZK>->9/3!Q[Z?*B;FWJ'X-XNJE
M,L4_!=QDUK'J<FY;Q7-6+"GR7B/Y%"9,%IAYMYQQ"EI\M1 V\XL]:O[2'?\
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M/O[]#6Z:R'4&KVY-O2RM753AE:G\TH8?OR[3[;=?%Y^G8: - &@#0!H T :
M^3WFJNN_JL>OWU!<;<I9=D51Z4/1UF%KQ7BO%]182Z:'E_)V.3Y5#F627OR,
MB+)L)(MZB:EMX+:>9KUQD1EM@RR_V>U:"WK'<U&I3EIK;2Y4Z5D^UK&B2X4=
M6L<SX/\ //K_ 'G>.LUT7M6JCI.3QN64H*XH1T[C;N25MN,9W;EV5(.7-&%J
M$WRMYQU'HEYN]*N3W-=Z,_6?S)Z?\?DROQ)S I6^><?2W9:&5(FQL=MK6+6Q
MY(0DA3TN-92B04>=V'7>/I?3ZF"O:*[*TGG%KG2?8G5/VU/GNW^H3KWROW:]
MT]K6]1&W1QNV9NPKD9+FC.5F4;UKG^[+E44FG2JQ9AOI&R&WY6JN>_51SQGG
MJIY=QU#0P^RS<.0,5PE2'#*;5CV+JL[:,PY FK6[&#2XT-IY1?3$3("'$=CM
MO36GT5Y:F_-WK\<8X4BGVTJZM<&WWTK0]9^8_G_U;Y@V9Z.ZYV-+<BXS<KCN
MW)0XP4N6$;=N7WH0ACBG)Q;3W#E^'[O_ &.O)3T.<V^:/\>/JXON2O3?P-C.
M)-\?TJCAO*'*.:IL93#V2J9AV4[&,(KH 2@V>+E^.J7+D[LLR2$]S)2VI_QK
M<[VIW#Q=#IE;CHX^[<N3K\6?+!+-QPKW]G'W;T'L6W[#=T&_Z^.LU74M_P#C
M:71Z;E35I-Q5[47)M1A;N8J-7%..?-5J,CXI^FIR5QG.H>1^9>2+_G;)N,,5
MA8QQE&N[V?)IN+\+HH#K$*EQ:GM[VY+<6HC+<3#BQUM1(@42S'\W9P<'9]KT
M&BU"O7KCNZA.D?=:C'AVNK[&Z)=G$]E>9VZ^:'5.PO31TRL;-9L4N0>IC>O.
MU;7,K<?A4+<4OY=NKD\$VFXO(-O_ "_[(_QZ\S/D@Q1=>"OR'^!6@-::?D?F
M;TQ>KOBCU6<*\?5/(=IB&*9CBF0XU;7T.@K+R%D-+>TT6-;R'9<.8&83UZ)K
M2V"HE^$VA9"" KP[J/:=;K-5;U&BM\](<LL8KBVLVNUGU+^G7S?V;RQ=Z]O%
M]0E"]*=N$H791G&Y:\.:K:A-JC494HJM)JOO4W]K?V@;U=X1;,9!S/Z1>+9G
M&C$ILW\;C[,[>#F535.R4-NS&)EA=975V$B!'65%!B,,O+3LIZ.@E:?&]1L^
MZZ2R]1?M4M1SI*+:7>DV?873OZP>G-\WJWM5M6+DKLJ1BHW[4I=T9W8\CE3*
M,E%R>"HV=^X7U&O0R]A& 9]:>J?@[%JCDG&ZG*<:K\KY+PZDR05UM%3(2U;8
M[(N3:5$VM>[XLUM]M/RDQI;#A#B2-=;SQI6I]5QZSZ6>ELZNYK]+;MWX*45.
MY",J-<8UJFLI5R::>)N+3W%1D-15W]!:5UY17E=!N*6ZIYT:SJ+BHLXS4VMM
M*NRA.OP["NL(;Z'6'VEK:=:6E25%)!UD>1V[EN];C>LRC*U**<9)IIIJJ::P
M::Q36#0XZ&8: - &@#0!H T : - <><P_P"<KRG_ "?UO]Y-%KDZ7^=ZF261
MN9KLS6!('CH"V5]?LW_/H#6:JM8US$$V(W,;84M2$_.PI4!U?:$DK0S+:9<4
MT>[8* [200#T.L#D"YUUIAM;S[K;++:2IQUU:6VVTCQ4M:R$I2/>3H!)!M:R
MT#JJRQ@6*6%AM]4&9'EAE9!(0Z8[C@;60#T.QT%:D<GX#BMK9*M;.O=L9BMM
MC-L;*0PV 2>QN,Y+4PAG=1V;"?+'L2-2B)1,ES++,9EJ/':;888;;989:0EM
MIEEI(0VTVVD!*&VT)   V &J4CC]?E#UPF2G(8L.E;<;4*R/3M.R7VDE)6V_
M82GW2A3FQ!4VV-@>@W&^E'7N(W0DNLC C]=;V$^QF17,?L:^#%+B&[.<[#;1
M+<0M*0(\1MYR26G4DJ2L@#8==B=M2H)!J@;(ES4SYDZOA6$67-K%)1/CQWDN
MN1%K4X@-O]A(0X%M*2I._<E0((!U*HHYZI T!"\GQ2?DCK:4Y5=4M>E"4NP:
MGR8Q?4%++BW)8'S"O,2H#M)+8VW[=]8M5XE)+60$5<"+7HDS9:(K?EIDV,E<
MR:]U*N^1)<^)Q>ZOL &P   &JL 0FRN.1UV#D6EQ"K9@H<[&[.WNH[B'T;_T
MQB07A)8&W\G99_@U&Y<$#(#'G^0S\SY7S/E-_,>1W^1Y_8/-\GS/TGE>9OV]
MW7;QUD0NZ \("@4J 4E0(((!!!&Q!!Z$$: 3-OPFW?D6GHJ'T)*_DVW&DNI0
M?B*_ETD+2D]V^^VW74!9LZR);PW($X2%17M@ZB--FP%N)Z@H4_ D17RTH'92
M.[M4/$'0"2DQRGQQEV/3Q#$:?6E;H5*F2UN+0"$E3LV1(=Z!1]NB260%-O'L
M9=;+CU-BFIL7$)$6P5$:G)C+#B%%1BOD-.A:$E/7?M[M]CMMH!/1P;>!#+-U
M>*OY9<*_G55L2KV00 &A&ADM=J2"=R2KKXZ+O GR*WM:AF,NIQR9D3S[JD.,
MQ942(F,A*0H./.R5$_&3LD)21T.Y'3<RE^AL;2RAF1;43^/R X4IB/S8<Y2V
M]@4NAV&LA(.^Q2L)4"/#;KH@:1>L*BXYSJ="Q3(\?M*G,ZS'TWN)<KTQC-VV
M-/.3WX[<-$1+K-EDE"7$+,^*WYY9:<4ZVR7$]Z>+J'&3Y&O>I6ORS[P:;<=<
MW\D<#QI%%R#5U&8<3Y19KI[5-K'>M.*,QFQ4(_06J6'4/8+GD6.0Y'FQW(TA
M 'FL.KC;%S@N+2KP!E>TX(POE^9"SSTPY+>T7(53Y=G!P!=\FEYBQF6A >6_
MQQE,,PH?)=&P2ORVFBS<(9^]$427CB#,?$WU#>4N+I POU.XI89=4U[ZZZ1R
MAB-3^'9A2AH^0LYQ@(:93(DQ%@E^1!\A32$=6'G220.L7%G-/%O,=$U?\7YY
M09M5A" \Y4SDN3H*RE)2U<53Z8]K3S%(4%%J6PP[L=^W;0&4D2 P'77'5E!/
M>>\E0;'0;("1OV_DWT O2]W%"@M0 W.R5;)4" /C'B=O9H"OYA,EI09?4GXN
MTN,D=R2D@D ^S<?PZ 5"6CO\KO\ C[._M]O9W=O=U Z;Z ]0^EE+:"M:]U=@
M6O=Q94KN4.Y2? ;=-SL- 5!?:ZX\77#W)2GL)5Y: GQ*4^PGVZ \+Z7@TXE:
MB@$.)*2I*5@I( 6"02GXM]O>!H"VN2EP/-)<4E82$J*04J1YB3VJ0K8@D?9O
MMH"V92&RTRI:E**=DJ6%*4KL2.Y2E[!(4?'KMOH!.I]#"'%*<44]RG%*<45=
MN_L3TZ('L '30%M<C[?ZC_5[M 1#*<TQ;$:.9D>6Y+2XMCU>.Z=>7UK"IJN(
M$*/1^PL'X\9ON*-@"O=7@- <L.:?J;P):IN,^F#&CG%B"]%D<HY;%G4_'E2X
M-VE/4U>\F+>9;*CN[].R+'!"5I,ALG0&J,3@K*<FGQ><O5_R5=P#8QA+I+#+
M8QL,YR& %..HJ^(>+?.BM4E)(<Z-V,A,&H:4YYJ77"5-J :,LYUO<V3)X$]+
MW'DZMH7_ "G+S'J)]^WN;Q$9Y26\DYMSV-%9<F,1G5E;=8TEBOCN*#;,?S2A
MQ6482FZ150/'"/%>.<<9S!S;DFW:L;JC>G,7^?R[5J-5X[;?*K3'Q+CRDA,3
MFY,R)(6D3'V7I,GY=:B^B&M2F5<FTHVY5EDLWW]B^7L,7B=9J^?#M8$*TKI#
M<NOLHD:?!E-$EJ3#F,HD1I#9(!+;S+B5#<#H==@FFJK)F(PW[69O/,-XU*QZ
M%%+?]MR;://ES Z5*Z1H\=;,;RTHV.ZU$DD] !U.O $F;"TMH#JTN.!"0XM*
M/+2M82 M:6RI90E2NH'<=O#<ZI".-Y=2OWCF/1ES95BPLMROEJRQ>AQ%A)44
MRK!$8PF=MMB2O8*^$GNZ:E56A23:I T!;>91(:<8<\SRW4*0ORG76'.U0V/8
M\PMMYM6WM2H$>_0"*KIZNE97'JH$6 TXX774QFDMEYU7WG7U@>8^ZKVJ62H^
M_6<4D@(,GB9)-K0QBUK#IK)4ALKFS8:9R4Q0V[YB&65I6T'U.E!"EH6D)!&V
MY!!UX <*2-9Q*R''N;%%M9M-J3+L6XC4)$ISS%J2X(K/Z)G9LA)"=@2-]AOJ
M=QBWP$>3S+&'6.&NQI65*?*H\FK^<@0VUQ'6G$O%XV&[3[2Q\!;"5%05X;;Z
MC(C0K.OI>>@KGA#UURMZ-N*J&_G2%NSCA3DS K*4X2EQ4RPN>)+#"7)DN0\I
M7>M:W'%@ J42=AJ=BU+XHJOR[#8KMR.4G3Y=HP>G?Z:'H:]#7+(YGX>I[K \
MQGXA:8/Y%[R-?9#62J>ZL:Z=/>16Y%,L9?S2I%3'3YJ' TVA'W05*)D+%JU+
MFC@Q*[<N1Y99'3;6XU")FMKH\E^;'@0F)DKK)ELQ6&I,CKO^G?0VEUWK_.)T
M*+="")J TU.E6"7IJGI;;+:V7;":[!:2RGM28M>X^J%%<7_+4VVE2SXD]="G
MM@N:U!F.5S#4FP1&?5!CON>2P]+#:C';>=\6V5N[!2AU"=]M 1;$CGSIEOYF
M,=C-J)3#@4S4M;[9[DGS'ICTQUGRNW<! 0I1)![T[=I*O$.G =<DRBDQ. +*
M]EF)&4ZEAKL8D277GE E+3;,9IUPD[>) 2/:1H"C&<EBY5 5908-M#A^:IIA
MRUA?(F8E(ZR(C:G%K<C$] LA.Y!'L.A![DS(D- <F2H\5LGM"Y+[3""K^:%.
MJ2DG[- 7&G6GVT/,.MO-.)"FW6EI<;6D^"D+02E23[P= 1*;@&'6-S^L$^AA
MR[?S&GC+D*D.A3C"4H94N,IXQ'"VE V[D$=![M"DQT(8SJZGE Y*N;=Y52)Q
MH/.N(IZFM;+SC(V^78,B9 $E@*/](KSW5; A.Q4"AB4R9H0- (Y]A!JXC\^R
MEQX,*,CO?E2G4,,-)W"05N.%*05*( 'B20!U.@(C1<E83DMF*>CNTS[$H=<#
M"(%HT%(9!+JTOR(+,=2$@>(7L?9XZ53*2N=5UEHEM%G70+%#2BII$Z''EI:4
MH *4VF0VX$*4!L2-M]""U"$-H2VVE*&T)2A"$)"4(0D!*4I2D!*4I2-@!T T
M!$\EQ-61O0WTY-E="8>P+6/6ZJYB4@N!:Q+:#+@>64CM"B?A'L\05"DNT(1N
M5^M[ERVB#^KL7'VTM%Z1,393K:2L@EU#,5AROB0TH/0*4Z]OX]O789)//@"2
MZR!CF'RCB]EDAQ>K_%+2>A\QWGX-:\[ C.H<+;WS$E1;+;4<I45N=OE[).RB
M=@9S)NB+1TJ3^1&C2VRS+CL2F20HM2&FWFRI/W5%#B5)W'L.VJ0I;5$CE$-D
MQF2E/Z.*V6FRE.Q7\#">W9.VYZ#0#=?T%;DU8_3VR'W($E39?:CRY,-3@;4%
MA"W(SC2UM$CJDDI/M&C551C(LX]CM'B%6FJI8X@UZ'7)!0[)??*GW0GS75/2
MG75[K"!T!"1MT TC&F"&+$&3V<W\-6SC=U0P;5;K:?F;,KELL1]SYRT1XI6I
M4G;;L"P4>.^MG@WI+W8OV!4XEJMR6-#K83%M:IMK1F.A$V;#KW8C4I](V4ZB
M.H!MOO\ ;VD))W("1\(V1TM]YKZ!@0O+>98&.JC-P*.3=+?*_-4JUIZF/&[3
ML X[*DN.!:ME>* GX3\6M\=NU,OA3?H3?U$JN(E'.V+IBLNR7JV)(6TE;\7\
M8CV"H[G;W.,^96M2&7R@G8*0HA7LURH;+JY9QDO53Z63GB1VQ]2F%UX3YUM7
MM%:NQ 7$M3W$#<J2I;+#:TIW&^Q.V^M\=@U#S32],?M)SQX#6[ZE*50"F?F'
M$+ 4E4:LW3V[ I*3(FCN"QU!ZZWQZ>N\:?XOL1/$B1F)S]C]2EU-)0/5B9"_
M,D(@T=#7(<7U_2.?+2%^:X23U5K;'IQK-P]K^Q!W5WB*X]14^="?AP';FL=>
M2E*9[,>D,ED=X+@:0['>;"EH!2%;]R=]QL0#K/\ Z=C3.*?]XGB(CV.\TR:
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M^/N0H7SW'>=87FL<H2[YN,9+47C2$K/Q%[\*ES%,K!W"DK"5)4"#L01H"?\
MS&P)';W;';<[;^T D=0-_LT 1Y+Y;'GA"7-SN$$D;;]/$'K^<Z#,$RI'G.!:
M4!CM!;4G[Q/M"AU\/R#04H5JDJ!0$)!25;+)/;VIV)W [#W'?0%*Y*NU?805
M;*[0HGM*MCVA77?;?QT!';_,,=Q.M-KEF0T6,US8_36-];P*>N;4E'<X#-L7
MXL<!(!/57@-] ::9_P#4:]*^#/2H$7/U\D7;*U^31\3U4S-WY:$IWWCW4,1\
M1<4I?PC>R&Y/NW( TNSCZC7/N?R44O"?%5/QU&GD18MYG;KF8YE)=>6GR7*?
M$J3R:R#.WV0&9:IZ5;D[;]NP&'KWTY\EYG-B9WZPN6I%-V(^=KV.7K!YR]+:
MT*<4G!^!,>2;&&R\MY/]/"@P-W>XOIZD )K/G[B#A25$H^"L,DW><.^3"J<T
MS:FK\OY!E3"2&7, XR@MS\6PUQY0_M=Z2+.:D >7(:7N"2;P68'7%?3'S[ZA
M;B1FO.V2WW'=%<O"5.A2+%5UR[D[:DA.UM9S528N*1W&M@E"@]);"2TMA*>U
M6N7;TLI8W,%\YBY=AT7XIXCP3A?$XV'8#3,U=6RXX_)DK;CKM;:4XXM1FW5B
MTPP]:3$-J#27'=U):0E .R1KGPA&"Y8K QK4TGY0XIJ\.SVAJJ[#\WRO%JV@
M=MFFE2YDJ'.EJG2G'*B7=%MJ!C6-UH1\Q+=0A3VSJBM20X'FN!=M*$TDI.-/
MEZ$9)X&>^$N4,[R.BR[(<FJ:)G$<>>@QJAVC8<KX4>%"$C\=16*4J5^(0J*
MAI2?NI5VE*7#[-]F[.47*27(OD_81I&RUI:Q*AA$B6F8XEQY##;<"NGV<A;K
MF_:E,:NC2G]NG512$CW[D:Y+="#EJD*''&VD*<=6AMM/52W%)0A.Y '<I1"1
MN3H"O0!H!--:EO0Y+4&4B#,<9<1&F.1A,1&>4DA#ZHJG64O^6>O:5 'VZJ0(
M]C-%>5 E+O,MG9._)*>WSJ^#6Q(_:3N8\:*EQQ"E#8']*4=.B0>NLDFLV!_L
M)+L*#*EL0I-B]'96ZW!B>5\S*6D?"RR7G&F@M9]ZA^?PT;HB$8QB\R^ZD.NV
M^(M8S5H"DL_.7 E6KZQT2I,-B$EMMK<?%YBT$;@I[AUUBFV8N@_7N14F,PC8
MWMC'K8G>&DN/%:E.NE*E!IAAI#C\AWL23VH2I6P)VV!TK09B'&,RQW,69;^/
M3U3FX3B&I15$FQ"TMWS"UTEQV.\.(;*AV[[#QV/31-/(-4%K^-8[)LA<R:.I
MD6P\KML7Z^*],26  RM+[C2G$N-)2 E0(4 -@=M*(5'O0A ;3"I]I=&R5F^6
MPX"G6W335LYN!& ;[#Y"'HS3;R6'%(^+?N602.[KOJ-%J3[5(1QE.7?C0+[N
M.#'0EW=#,>S5=.**%AD!U<E,%E*7"DJ/8YND$  GN#'U%P) ZXAEIQYPD-M(
M6XLI2M:@A"2I12AM*EK.PZ  D^P: C-!EL+(GI+,2MR&'\LI8\^VHK&MBR E
M0'='DR64LJ*@0H(44N=IW*1I44)3H01-65<_+?@,SX3T^*$&5":E,.2XP<3W
M(+\9#A>9"T]1W)&XT!"LGXOQ#+YYL[N)-?FEEM@.MVD]I"&V@ D-1P^8S.X'
M7L0 H[D[J).C52DNIZ6KQ^O8JJ:$Q @1ALU'83L-S]]QQ:BIQYYP]5+65+4>
MI)T QY33Y5;JA-X_E:,8BH\S\14W3Q[&;)!4@MAA^2\$1PE((Z)!W.^Y'PZ8
M@?ZF Y60(\-VPG6CK2 '9]BXAR5(<('<M9;;:;2"?!*4@ :$(KDN3Y)56<.M
MH\'L,C3*2T5V(L8];6QEN+<2I#TA4>:M'DH;[E%2$CJ -R=M"DY05E""XE*'
M"E)<2A9<0E9 [DH<4AI2TA70$I22.NP\-"#997=74.0&;"4&'K.4F' 9#3[[
MLJ2LI2&VVH[3J^A6-U$!*=^I&@%4Z!!LXSD*RA1+"&]V^;$G1F9<9WL4%H\Q
MA]#C2^Q:01N#L1OH"Q6TU/3MJ:J*JMJFEG=;=;!BP6UGQW4B,TTE1W]^@+5]
M4)OJB;4+G6-:F:VA!FU,DP[!CL=;>W8D!*^P++?:L;$*;4I)Z'0#-AN'LX?!
M>B-V]U<N/N!QR3<3G9/8E'<&FHL<J\B*VE*NO:.Y:NI) 2$BBS*G,J;J5'#X
M]5(N%/M( N'7FHK4906'GT!G;SI#:NWM2I24[$GXB A0%6+L9.Q5(3ELVMG7
M"GG'%KJH[D>(RPI* W'!<[52'$*2HESL;![@GM^'N54JD&O)\ZAXO-AUSE%E
M-U+FL>>TWCU,NQ2$>8MKM6\M^,R7>Y'5"5*6D$$@!2=\FZ88E2J2E-C&$5B3
M*5^'E]AIXQYZV69+!=;2LL/H2ZX@/M$]J@E2AW [$^.LXQE+X4V0CUIG&*TK
M2I$^UB1FBKXWG5MQVE+[0!O(DJ884KL1_/)V&MT=+>?"GI!![CF3#$Q)#2;>
M#Y<AAYKSF+ACYE"'$J;+C*:Y4I]#J=SVJ200H;@[C7.M;1JKN*4J=R?TNABY
M11@6!R)QKB4URSH:Z3.MCYI1:N1Y<^:%.@I6I#UY*:;96M*B%.-M)64J()(.
MVN?9Z<N9RHGWO[*D=U%JR]1=N_W)AP).QW^.18^0#N/ QX4= VW]GF;;:["W
MT_:C\<EZE7YV_J,'=[""2N7\WLI*1&,-I;@#33$:$Y+><=4OHH&4[*<<=4-D
M@  ;>S?KKFQVG26U67,UZ4E\R1/$DR01,7]2F5-!VFPGE2W0X0E#M/B=M#BJ
M4HK0-Y[$"%7L)[DJ'<MU"04GKTUKG=V/3?S)V$UP<DW[&VRI7)=I.J+T>^K'
M+6DOVF!6%0T\O;NR7,\>2M*5>7\3\15R]8(/:\5$!E71*AOW?#KC2ZAV*Q\-
MR/,N$82?S\M/G+X-QF4*GZ</-\T(<L\@X[ID$ K:<M[R=+02A*MO+A8ZN(KM
M)*3^G\1TW&QUQ;G6.V1PA"])^B*7SRK\QDM//C0FB?IT1:O8YASYB] 4[%UI
M./MKZ;E?8'[3*J?R^Z,.[N+9V/\ )(&YXW_5\KG^7TER?][[(OCWE_+]LCT^
MCGTM5?:,F]3M-*?:!'EP+K!8C[;KJN]IQ,9<V\D-->0-CT^(['N V3I_7]]N
M8V=!)+OC-_/2)?!@LY%__$5Z!:LE,SFW+;%3OPI*;J%+0VIGHX4FEP()0EPK
M&WF%0('PGHK5_J/5MSX=+;7J:_VK@\*RN+^7J*?U1^G#">3*.19C<? ID1-^
M2666^X]QD*0FCJ0XL;=HW6O;?[OM$Y^M)_<MQ_\ A_\ B9>2P*1_Z#?A ,_J
MME%QO^D^:,ODMHIW)3Y)2,AJQ\';OOY9^]]X^ >'UI+'GMQ[OX7_ (6.6QV?
M2!G_ $X6P7$\?90XI'QI;$[DA16I/Q! 2]F@:5W$;;*(2?;TU? ZS>'BV_9;
M_P# .6QV?25F_P#IU66PE<99+ #75!"LSB>85]"":?-%E?;VC[_0;]/;I^5Z
MRA\-^V_\#^F I8[!(Q:?3>?6M'^+O,&@C?\ 2/RN3FT+V.WP;YF5'?Q\!TT\
M'K3_ ,VW[+7_ (!2QV/YRIV@^FK(=^8<@Y '">Y(4GDEQ3()W2VAQPO.;-[[
M#=:CT\3XZE.M/_9O_P"$.6QW_.6S@?TYG%*4,^S)H*)4&Q'SWM;"CN$)*\*6
MHA'AU4H_:?'67C]9K#P;3]=O_P 8\.SVLM.\3_3UM A</EO-ZI+14A:6G+>.
M7BKM(4M-YQ[)<(0/ M]J>IWW/A5K.L+>$M-:E[/]VXB>'9[7\O44(X3] *5
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MZ>V<H?PN5RCALFAK\G897)156C,R';5;LZ*TXR[,IW[&N:9G,(6A;T)QU"5
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MLF6'0^TS-CMR6D.@%(6&W4J03VDCJ""#H!<TTVRVAEEM#332$MMM-(2VVVA
M"4H0A "4(2!L !L!J@A.18I<WEK$FP\TNJ& RREI^LK$(1YZDN*67D2?-2E#
MBTJV/F-/#8#;8=-8M-\2DTCLEAAIDO/2"TVELOR%)6^[V@#S'5)0A*G%;;D@
M ;^S61"$RK;/OQXPX6)5QHDOI0+:9>L(4\SO\4@1V$O2F#MX(+*ST\>O3'WJ
MY8%)YK(A"7.0,?;R!S&P+5ZP96EIQ46GL9<9+Q.RV_,BL/.?H21WK[/*3O\
M>Z';'F5:%)MK(A@*EMXW'N;\EP;FMR1QK)\@K<HH)=1C.09"S9-V%+"@S(8<
MHJRP;ARX5E7.)*'U-=R%H4-P2=:$_#G)-/%U6#?T =V\%I\KMDY$<+1@[BO/
M6[;M,5=7FMP9#3S+B'W*I,EVKAOMODN*7(^=>'Z-QMM'<%9**<N?E2^D&2Z'
M'JK&H1@5##C#"W5/NEZ3)EO//J2E"G7'I3KKA44H V!"0!T UM XR3-'D?)M
MQ5[OH$DR7G6O+C=?,6PEIA[SG]]@E*BVGKN5=-B!#L_XQX^Y3IET'(6(TF65
MBDN);;M8:'),)3H2''JNQ;\JRJ)2@D#SHKS+H'@K6,HQFJ2544YH\H>C'(L1
MND1N +[+YL980XK$\\K'KS$8WF]RD1JO-F3'LJYEA.R?)<0^$DDK?)Z#B3TB
MSMOVDJ()W,7JPX9J$XYS-QU?9)@<,)0&LKH:KG3C6%%00$.1+-QJVL\*;6H;
MH1$=A/I.QW"@-<65FY#XDZ%$,#EGTE<I-%NVP&TPB=)2CSY'$N9-W=6XXH'S
M5.\<\FJG6;;2U_$EM%XP@;=H  UK VR_3'Z<,GEHF81S9A=18)*I,5G.\4SO
MB>WCJ[=T]EKA\7,,8^=;4K;N7/:2L_%X;[ 3>EX+]5=$67.+/47E5Y$9V:BQ
M<,]3N$9C7M*6A&T=.*6F5O633JP&P4*B)))0@CN*!H#(<:!]4FE2SY>5\PV,
M!#T9;+B^#\4S1#Y:;'8!9UV.3)+[+B$D+<0\$E7WCW['0J'"PS3ZHZ)+$5I7
M( ,EAY26_P#-8W?<\HI#BF&Q2E3@;2X.\@CLW'OTK4,:Q)^JS<>;$1><P0(W
MD-#R(OIFQ^D[$M%L;LV5IB:YI=61N0E_N.YZ=NXT(1.WX?\ 7#>JD+S_ )ZY
M&QF*^MUZ;^-\\<>\0UJDE,D+3(@(R:A==B%)4 VVV6]DCX>U [0,:.>E;A^'
M,7:\H>H#CFSL]DA1A3^1.:\BDA!2HH2Y#J1B)^\2GS+1I*B""0.W<!X<O_1W
MQ3'[6:7-^0761LC]9[C&^&<1D+&V\@8WC"LMRB:TLHV0A%O#<*"=]E;; >4W
MJCYBRR,_3>F7BU>,5#Z7Z^19\.X:O$8)0I1:\C(>:\M>EY.WV@%'>]<!I1W.
MWAMG&W.?PIL51*L0]%O,/(KYON8^2HF'U]DXJ7+IN/Y)R+++/SR5/+LLYM Y
M#AS%+))<BMS$N;]2#UURH:-O&;P[C%R[#<;B'TJ</\)V:;O"ZFP5>!J0TJZN
M9S=C;/?-MK;DJ?GB+'D.AY+JMVU*+0)W" 0DCE0LPMXQ6)BVV;'ZVD&B"N_7
M*E?B<6GCP4J4(1@SYLR4XCN(2J4F170&65%/4I07 "=MSMN9CQ*86YZQG,,D
MA8VFGAV%_B$*=)?SG#J2T;I;K(X($9<-N/-=0KYF-&4TZ78J%(<>[P$;K[%M
M:;\9R2IC#BLJE1%+#DZ@M\!RCCRAPG*L5NYU!,Q+%\2L,8LZ]]Y=U$=JD+3\
MO#=@06*Y4L.R%NO!*4GN*B3K%W(NV[<4U*E$J"F-3:=YYF,TM^0ZTPPTDK=>
M><0TTVD>*EN+*4(2/>3MKDF)8A6$"R:4_738D]A+A:4]"DLRFDNI2E2FU.,+
M<0'$I6"1ON 1[],P*B H;* (W!V(!&Z2%)/7VI4 1[CH#W0#%9U=G/D,KBY'
M8T\=LH+D:OB5#AD=J@H^9(L:^>ZCNVV^#M&WOTI5@?M; 8Y<N^1I=RQ%@85"
MJZ4/;/VE[=P'WW& 1NIN%33);C#Q3OVI)=23XE.L:RKE@#)0&PT9@W4]U"":
M7"ASVO(G1(TQDDDLRV&I#6Y24D^6\A:-RE1'AX'0HGC/5+#IK8;M<R\V5$P(
MSD9MU!V[UDQ6B%)/;U/P^&F +5U31+Z Y6SES$17E)+H@S94!UQ*=_T:WXCK
M3I95O\2=^U7MT!73U%?0UT>KK&5L0HH6&FW'Y$E8[UJ<65ORG7GW"I:R?B4=
MO ;  : +=JV>@/-4DR' L5]@:E3X;DZ.TGN'F$QFI,0K<[-^TE?:#X@CIH"_
M7M3&(<=FPF-V$UMOMD3&HH@MR'-S^D3$#T@, C8=O>KP\= 8KR[E^OQO(!BM
M?0V^0WP4PA<2(CR$>9)9;D,LLK4V^_)=4PX%'L:* #][?<"-XT*EQ,L1'7GX
ML9Z3&5#D/1V77XBG&WE17G&TK=C*>:):=4PLE)4GX5;;CIJD$KES3LS$5[UK
M6M3W5I0W!<G143'%K.R$(C*=#RUK/@ G<Z$%,N)'G1G8DI!<CO)"74!QQHJ2
M%!6WF,K;<3U2/ C?0#34XKCE$\[)J*6N@RG@M+TQF,@S7DK4%K0[-6%RG$*6
M =BLC<:%'Y0)! 44D@@*3MNDD?>'<%)W'V@C0@QT]/,K');DO(KB\^96"TBS
M35(;AH25'M836UL#=2N[915N-@-@GKN*.<YR6U#E.0([4N:VPZN+%>D?*M2)
M"4$M,N2?*>\A#B]@5=BMA[-"#!C<C,)*9#F4UM)6#X1$8JYTF<^2"KS%25NL
MML(1V[=O8I1/7?;VBES),PQK$667\BMH]:F0I28Z%H?D2'^SM[U-1(C4B4XA
MON'<H(*4[C<C<:5H!RI[B!?5[%I6./NP9(*H[S\*= 4\@'HZABPCQ9!97XI7
MV=JQU!(T(+W76F6U.O.-M-('<MQU:6VT)]ZEK(2D?E.@+:'F9L<N192'&G4K
M2W)BN-/ 'J@K:< =94MM7O"AN.H]F@,=P^*,8C9"WE$E^\M[AB0F5'D6]N_*
M##Z%=S2D!"65*0T?NH65( Z;;:413)FA#%T3_&"U?&;DN38M4T"'ENMTE2PJ
M9,D,=/)C/S+")'>;7V]7'&N[<@A*4@@IRC;N3?NIM%'2^Y%QZ@@RI[ZY#[49
MI;I#+6RG2A._E,H=*'''5GH $G[=AUUR[>AOW'1+'VOV(C:69A]SU+8X_&6_
M&CS8BPHI$61 <=FD ;]R3YJ(8'7^4O7;:?8=1-5DFEWX?-BS!SBC'-SZBK.5
MWHKH,H@_=<F2TQ4;>P+A5Z %#_T]KMK/3]J.-QKU*OSO[#%W.P@\?.>3\RF*
M@8Y#GSYKA'_@_%Z.19SE=ZBE(2AIFQG[J4=@002=<[\CM^FCSWFE'ME*B^I&
M/-.61D>L](GJ8Y+^7D67']VB,E96W(SJQ@TORJE[;J_"[Z<S:H&P'1$4[;>&
MN)<WS8=)A&Y!R7X(\WSI4^<R5NZ^#,^4/TWLR9CIEY[R;A&(5[:0IU=7'GWG
MD)\?+=<LCBL)E?;N"0ZM(/AW#767>L=,WRZ2Q=N3[Z1^CF?S&:T\OO-#TKTU
M^B?"U-.9QS]:Y+(C$B1!QV[K'83JT;*6E^%B-+?WC2AX=J9B?$C8GPU_U7JC
M5X:72>''ME%I^V;BOF,E:M+-U'%'(GH(P79.,\-V>9R6P@HD6U6];P7W&NO=
M(_7G('UMAU1W4E$,H/AV@;#5_I_5FJ_GZF-J/<Z/_4C]9?X*R51*/7NSCTIZ
MOXV]/>(8E4MH=:9L7+B%'\]!2'&__ >.X_5!EOYC[R#*.X&^X.VJND;EY\VM
MU=RX_0_IE)_0/$I\*21#[GUX<]7"U(JSB6/=Y4&DTV.JF/)'P]O6]FW27%I"
M3N>P DGIML!S;72.T6E6YXD_WI4_V5$>))D*F\X>JS*^XG+.0RES<%RCK3C[
M0W"QT=H:VK:9/4[;%/4=.H&W*CM73VG_ .'9_O/F_P!ILG--]I&)>.\_Y3W&
MZLLQLT.'N<5D&8O/]RNXN!2V[&X<>62XG??M/Q;'[=;XW]FL?RXVH_NP^R)*
M2>8F@^GK.Y "$_@<0)'1M4N2OMZC9(3!KY0!5U(]G0ZLMZT<?QOU+ZVAR,?E
M>DS*K@-B99NH;1O\%="N5-**B.Q3I0(7?]WIN=D]=<>6_P"FCE%^MI?:/#9+
MX/I$MVV6V3<S^Q"$H0@4?EE':.H4[+N7%N#W*5L3K1+J.WP@O\7]A>0D+'I$
M>/5V=<K3MMLE=-'5W;CK^E>=/;MOTV_/K4^H^R,?]9EY!T:](,(#9Z9?K45=
M%-V=&TD)Z>*55SZB0=^H/YM:WU)<X*'LE]HY$*1Z0*H$$SKU0!!*3;U&QV]A
M[:0'8_80=3_J2[V0]DO_ !#D1<<](=0O;MD7+.V^_EW%:>[?;Q\ZI=\/LVU%
MU'=7"#]3^T<B+"O2#6)VVF9"O?\ FV](-OR]],CQU?\ J2[V0]DO_$.1#>OT
MA(3]V;=K!W^[,H^GNW*VD;_FUFNI)?AA[)#D0A7Z0Y*!N;&VVWV 2*AP^WQ"
M)1/L\=MM9_\ 4:_#'Y_L'()G/2-8$CR;6S0G;J'(5>Z2=_$%-@R -O9L=5=1
MQXQC[7]@Y"RKTCVB1N;>Q/7;X:J(L_N(M%';67_4</P1]K^P<A1_FE6?^V]I
M_<9C_P 4M/\ J*'X8_XO[!R!_FE6?^V]I_<9C_Q2T_ZBA^&/^+^P<A<_S1;7
M_;B?_<R$/WC:ZG_4</P+VO[!R"AOTCS D!VRMEKZ[J;BUS:3UZ;(5+=(V'^B
MU'U&N$8T]+^P<@J;](4CN27)]NI'B4I72-+.XZ;*7(<[=CX[I.L7U)V1C7^\
M3D%K7I"9)!=FWG;N>Y G4:%D>S98C/)'7[#K!]22X*'LE]I>1#BUZ0JE)"ER
M;Q>X(\MVWJ@ ?>2Q4(.__5;:P?4=W@H>Q_:.1#FSZ1L?3\*U25[G?O>N7!V]
M/N[1Z]'3<>X]=8/J*_PI_A_M'(AX8])^(((+L*,[L-NU=S>E*NGWE%I4=05O
M[NFM3ZAU3R;_ ,,?[2\J'F/Z7<%9V_\ !E=\)W3YCMQ+W)/@KYFQ5W#[#N-:
MY;]K']Z7S+Z$.6(^QO3E@3&Q_"Z5>Q[MET3+_P 73H3)E/\ >CIX$;:TRWK6
M/[T_\7V#E0_Q>#\(B[%JKK&2G<I,6CJ(W:I0(61VQ5;=P/[FM,MTU4LY2?ID
MW]9:(D<7C3&(>WD-2&]AV@-F(R.S<$H_M>(R0@D;[>_6F6MORS:^?[10=&\(
MQU'WH;KO3;])+DCV[[_HG6^H_<UK>IO=OS(HN;Q?'V_NU<8]2?T@6[XC;_35
MKZ:Q=^Z_O,"YNHJF=O*K*]LCVHAQTGPVZJ#>Y.VL7<F\Y/V@7(;;;':VA#:?
M<A*4CH-AT2 .@UA5O,%6@#0!H T : - &@#0!H T : - &@#0!H T : - &@
M#0!H T : - &@#0!H T!Q1^L5Z'1SGQDKU"<<TQ?Y:XDIWE9'!KV N9G'&D,
MO39\?RD#S)5UAQ<=FQ-MW'8BI+ 2XX8Z4^O.O>G/ZEH_ZII(UUUB/O)9SMK%
MKO<,UVJJQ=#])/\ MY_J9?ECUJO*7J_4<O06_P"H2T\[DJ0T6XSI"W*KPC9U
M=(V;M?=C=5FXW"*O.7/_ .BUZVU<;YT?2KR/<.)P7DFR,GBV=/D@Q,5Y#DE1
MD8X@O$?+56>] TE*NQ%NVV$-]TUYP>,>7O47Y34_T75R_P"6O/\ AMY1N?A]
M$^'[5,/>;/JW_N/_ *:EUATQ_P#7TZ/T\?\ J?9K/+N<(1][5:"-.74.GQ7=
M#]YM5EI)2<I\NFMP?U7:]U'X7!H T : - &@#0!H T : X8_7HPK\6]-G%6=
M,LEV3AO,#-0^L);_ +6J,QQ._,I]2U$+"#:XW :[4[[J<!(V3N/7'F7I^?:+
M&I6=N_3U3C*OSQ1^G/\ VM.I/R'G)OO3%R7+9W'IYW8K'WKNDU5CEBEE7PM1
M?E5THHM9NC\^@OFIMO3=RK@SS_FOX;R^[;QVSV=T6JS'%*$1F0$[*\I5ICDY
MP%0W*G%#<@ )GEIJ.?:;^F;QMWZ^J<5]<67_ +I?3:T'G'L74]N/+:W'I]6I
M/'WKNDU5_F?I5K468T7"*PJZON?KV0?F*&@#0!H T : - &@#0!H T : - &
M@#0&K?K2_P"+1R5_Y)W]_P#BNN/JOY$O5]*+',W%]*?_ !;.#O\ )GB?^Y4?
M73FPV T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - : ?52XZJ^
M3_IU^L+'K9EAYBGX-S/D6+Y^X#-IQ- /)]4\TL,O*2^BPQ%L(V [B>TJ2E14
M/).C]5/2=3Z&[#.6HC#U7'X;^:1X)YG;?:W+R_W;3W4G&&BN757\5A>-'UUM
MHXL<29-,S'AGB;+K!2ES\JXRP/(YREDJ4J9>8M56<E2B5+)47I1).Y)]YU^D
MNT3=_16;TOBG:A)^EQ3/Q2W^$=/K[^GC\,+TXKT1DTA;:+^]^3^'?7EVDCD>
MO=QG2IIK,4FV]<W"L%!*G,6XCY.R5Y+0/<VS=N,X\RN25#M^76ZTH([?B\P=
M>FVM>Y/^-=HE[NFMIO&J\2\VL<L? >%>'&F'UK^E+2RCLNYZU\W)=U\8+*C=
MFQ5]]5^8C7ABJ<3I[S+*$G$,%;!W\B&L?_,^N3_%KP+H:SX6];A+\4U_MS/L
MGJ"?/H=,NR/^[$TFR-/1P ;^.O?>UO%'KO5K,P!DZ=PY[QN1KR(Z8T\Y&X]P
MK(I3\^YQJIFSU@)<GJC!F<ZE" EL.RXQ9D.AM" E/<H]H&PZ:TW]-I]3'DU-
MN%R"X2BI+V-,SA=N6G6W*47W-KZ#7JRQK&<8;E2:RG@5Z8S+SKC[,=!?#32%
M*6/F'.Y[;L2>G=MK*U9LV(>'8A&%M<(I)>Q8$G.=R7-<;E+M;JS'.#M/*J9%
MK(':_?V4VX4C_M;<AP(8;'C\/EM!0^Q6O5:O?G-=J]Q7PW]1+E_<MJ-F+_O*
MWSK]_P!1\;^?.]6]SZW6W676UMNEMZ=O@[C<[]WUPG>=I]]NO>Y2K);+!;C#
MN1J9CYJVXSSK#N1*Z.3L'I6'7\&Z;03VK 3_ &J224J  /0Z\/\ ,/:Y;OTG
MJM+%-^[5_NT<9/U1DWZCQ[RDWV/3W7FAW"32I<25<N9-3@O[TX1CZ6?I/\2<
MJ8/SCQE@W+W&MTQD."\B8W693C5JPI&[]=9L)=#$II"W/E+.O>[X\N.H^9&E
M-.-+ 6A0'Y?:W1ZC;]7<T6JCRZBU-QDN]=G:GFGQ5&?O!M6YZ+>MML;MMTU<
MT6HMJ<)+BFLGV-926:DFGBC(FN*=@&@#0!H T : - &@/E_]57H&];7I+Y?]
M1WJM])KN)^H#B#E[DN_YNY)X&GUUC'Y:@6N46TV[RLX:NMA.#((U?,MI;L8Q
MI7S;<<-(_#9JVUK<Y^W;KJ]JE)V%&5F3K*+6?H>:?S=S/B_SQ_36NMM7J.H]
M-.Y._P URY'PV_&MNY+GFO#:<+T%-MT3C<Y?=CCB-WI[]4?&?J9Q^998383H
ME_CQ8C9C@V01E5^4X?8/K?:^6LH:MVI$=QZ(XEN2PMQE904J*'4K:1[$VW<]
M)N5ISTSI-4YHO./I[5V-8>O _,KK3HWJ+H[7+1[Y&MF3DK5V.,)I4K3)QDL.
M:$DI+O5&]AM=D>&#3+\/W?\ L= 0^P^Z?S_PG0&/;;V_G_BT!C&W_E_V1_CT
M!BBZ\%?D/\"M 8%S*\BTR5N2XMJ['0V'GY,"JG6+49HN*1WNB$R^\KM()4$(
M66T#N4$IZZTW;T;.,E+EXM1;I[*_V9LY^BVZ]KWR6)V5=;HHSN0@Y.E:+G:7
M<JM5>"J\#63+>6\(:3Y-);-9E:OI6(E+AJV\BL7E@]0\FN6\Q7H1XJ7)6TE(
M!\3TUP;N\:&"I9EX]YY0M^_)^S!>F31Y-H?+_J742=S<;+VW;X_'?UE=/;BN
MYW$I7&^"MQDVZ>DPQAG'_J3]1W.W%_ _&\.JILZY8MI$''<<^9CR&J>K@Q)-
MG<9)EUT84SR*RCI(,J9),9#BQ'B.]K*G A"_%=XW7>]/<AS2C8YZM0C24DEQ
MG)IJO<NQU2X_0OE'Y6]"=;:R6S;1:N[KJXW(VY:F[SV;3FTY25JW&2DH0A'G
MG*:<J-<KE5I=_>%?V<?.7^1,<N_5-ZD\<RGCK&+N+<.X7Q9C5E7V^8(@/-.L
M5MCD]LU3G&8LW8IE+CQITCR2I##C+BTOM=%J]PW#7QC;UESGMQ=4J16.5<$C
M[.Z&_2QTUTANSW&V[=N,L)*U*].4XJ2ER<UV;5N+:5>6+=%2J>*^K?7%/K -
M &@#0!H T : - &@..V:';ZE.4D_^0!6_P!Y-'KDZ3^=ZF261N&5D^'3^'7:
MI)9FLHT<NP'FL08$U@<@- 02)(Y#>R64B1 Q^%BK4E:&'7'7Y%G)B-K*6WF?
MEY'EHD24[**74)2V#M\1'Q3WJ]Q2=G61BW083D$+\6_!DQ[5R6.WS'44]F8#
M7<GO!<L3%$()[2/B"RG<@;[]-*XT,1Y<;;=3V.MH<1N#VN)2M.X\#VJ!&XU2
M'B%-G=#:D'RMD*0@I/E[#H@I3]S8>S0%S0!H!@R"#?3X[#-#>M4#P?"I,M=6
MQ:NK8"3^B9:E.HCH45[;E25';PVVZQUX >8Z'6H[#3[YDOMLM(>DJ;0TJ0ZA
M"4N/EIH!MLNK!5VI 2-]ATT V6,VXC/,HKJ5-DRK;SWEV<>"61W 'RVG&G5/
M$)Z]2@;]-_;IB!X'Y-OL/L^SIN-4#4N]I46C=(NT@)MW4]Z*TR6OG5)\I3^_
MR_=Y@W925C<#=/7PU*K+B472HD:=&>AS8[,J+(;4T_'D-I=9=;5XH<;6"E23
M]NA!)5TU12,KCU%;!K67%=[C<*,S'#J^NRW?*0DN* .P*MR!T\-*)9%&S)Z2
MUO8:(E9DD[&SW*+[\!AEQ]]![.U >4MJ1&["D]6EH)WZDCIHU4"#$,.7BR'R
M_D-[?29("5KLYSZXK24G?^UH*GG6FG%;#N6HK7L-@0"025 /MS(NH\=DT5=#
ML93DA#;J)T]5>PQ'*5E<@N(C2G'"A02.U*=]B3UVV)UX =6_,+;9="$NE"?-
M2VI2VTN=H[PVM24*4@*WV)2"1[!JD&NWO*VB9:?LG7VVWW/):^7@3[!Q;FV_
M:&:Z+*>WV_T.VID!?%DM3([,ID/!I]M+C8D1I,-\)4-QYL66TQ)85M_)6A*A
M[M 7''6F4%QYQMIM/WEN+2A"?RJ40D:H/5)#K:D]R@EQ!3WMK*5 +3MW(6D[
MI5L=P1X: @N/<;8IC<]RVAQ)$NU6MQ?XC:2W9TI"G22XIM3A#:7%=QW<[?,(
M/574ZB5 3W5 : :KNR=J*R3/9K9]N\PE/E5U:R7I<EQ:TH2E"?!*$E6ZU'?M
M2"=CX& 8L0OLCOF)<B^Q5W&$(<0(2)$X29$E![P[YL<Q8ST?R2D;*4!YG=T
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M !("4@) \   !^0#H-8@]T : - &@#0!H T : - &@#0!H T : - &@#0!H
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MGEJ.B^D>JU''2;IJ](Y4?_SNQ;O*+>7_ ,RDTFF\Z4]ZOU :]QGXFAH T :
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M9\5TN%L_,2'+%#)#C/9LA*6]QO\ ? W28DUFPC(E[86-; 5)JJ5^^F^8VVW
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MF_)0]-FS)<>.WV=G9'A2'W(C*!N2$A':E2BI(!.^E%6I:\"6@         ;
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
MT : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0&FOK]X/PSGK
MTH<OXQF+1;.,XE><BXO<L05V-ACN58136-S76==%:*7WUR8[+\)]ILA;\26\
MVG92P1U>[]/KJ?1_T=<JU-V<5:D\%&XW2#;X*KI)_A;/>7Z<_.7>?(GS9VSK
MO:_$N:*-Q6-;IX-+\SHKTHJ]9]YJ/,J1NV>9J,;]JU)NB9R-]$O"F.^FSBVQ
ML6)/XAREEKC0S:Y<K[6J>HG833ABXS70+ZOJKF%&JV)REH=?C,NRE2520 TN
M.EO[%\H/*?;>ANG;>S6FKVKNS5S5W'%Q=VZLH<LDG&U;7PQ>:]YU<G7WYYY^
M<F_>?G7ESJK=XO3[3:CX.CTE6XZ?3Q=5%NBYKMR3=R_<HN>;452U"W&++S!:
M0WE3I"K.^COO%Q2UQ,EO6&AW!"7 U#38_(,]Z&]MTM I[BI)2L]VOHR&@M1M
M\L7<B_V9R7S)T^;#A1XGK:.G@HT3DGW2:^NAL=])3$)[6;<PY[%P>9"PVPQR
MIQBCS?M^5KYEY6Y#/D935>8]_;63V<U?RCLB8I3JHKD-0<67)1U\G_J"U^T3
MUFBVC;KMO\UI7=\:VHM2C*:MN,I3:]]R5>,G6KDZL]2>8FHT<K]C1Z:4?%M<
MW/%)U3DHM-RIBVN]OBSN1KYR/6H: - &@#0!H T!@OU08E^OGIMY]PQ+9<>R
M;AKDJGB) <*DV$W#[AJN=0EH*6M;$XMK2D!7<4[$$'8];O-C\SM&JT_&>GN)
M>EP=/G/9_DGO_P#TMYQ]*]1M\MO1=1;=>GE3DAJ[3N)UP2<.9-U5$ZU69\J/
MT5\L.->NG&Z8/*:&?\=\BXD4)4I(DB'4LYV&5A+B M*3A7F;*"QW-@[;@*3Z
M5\O;_A=20M_^;:N1]BY_]P_='_N0;"MY_3#K-QY5+^E;OM^JK^'GNO156#I_
MG.7"F$FJT;3^R+7OP_G?#0!H T : - &@#0!H T : - &@#0!H#5OUI?\6CD
MK_R3O[_\5UQ]5_(EZOI18YFXOI3_ .+9P=_DSQ/_ '*CZZ<V&P&@#0!H T :
M - &@#0!H T : - &@#0!H T : - &@#0''GU>?5EQKB[-[_ -.WI-P&1ZH?
M4[3J?@9%7ULA<'A_AV>E7RZGN6,Z0['C&97R=PY507DNJ>9<BORX4GL0KV9T
M=Y9;SU1*&HNJ5G;I4:=/?G'MBGA&+X3G@\'&,CT1YE^>_3?0BN:#1..KWV%8
MN-?X5J2X3DL9S7&W;Q5&ISMLY=<?</9LYR)E'J.]26<IYB]3>>,(B6^7?+F-
MC&!8\VDB-@?&-.MIANDQN A:FRZAEAR0G<E""X^7?LCHWI#;>EM%'3:.$5-+
M-<*YNKQ<GQD\7DJ)4/S8\Q?,'?.NMTN;CNMV<^9Y/#!?"E%81C'[L%@G5MN3
M;,N62_O?D_Z.O9>ECD>EM?/,TW]66$9/GO$UE$PIIJ7EV-7F.9QCM8\4AFWL
M<3MX]K^%**E('F38S3B6AW)"G^Q*E)22H=S.W<\.%ZU%SE:N*3BJ5E'&,U&N
M'-X<I<E:)RY4VDVUW/E9U9MW2/7NFW'=I*WMMR%RS<N.K5KQ%[ER26/)&XH>
M)2K5OF:3:2<^XW]<'"/*5O1X1.GW?'?*5RAB,KCS/,?N:*P;NUH ?J8=M)@I
MHYKQE;HC),AM^5NGL:[R4)\6M[>[<YK37;5Z-M<S49)7(Q_%.S*EZ"[>:%$\
MV?I1HM[V[==-#5:.Y"Y8N?#.#4[<GV1NP<K<NZDJOL,Z7>ZDJW)/0CJ=]A_T
MM=[H*)JAKU5<:F$\B3T</Y?W->>[8\CQW5K,P!DPW"S[@?W->5'1O,UORM/1
MW\_@/SC]_0AK7DB?C=^TD?D&@-LOI8^F"F]6_KLX^QG,<,J\YXBX?H<FY*Y=
MJ\@K?Q/&9D=RJ>IL+QVU8>_M&6_9Y?.A2/E'NX2(D9\E"T-N@?,?ZI^L+73_
M $'#:=-=Y-YUVHAX?*Z2C"W5SGABN$4^VM'5'L[RLZ9L]0[Y-[A9C>VFU;;N
M1FJPDVURQ:>#Q2;7%+%4/O(QW&\=P^DK<9Q*@I<7QNFC)AT^/X[5P:2DJHB5
M*6F+6U-8Q&@08R5K)"&FTI!).W77YF7;MV_<=V]*4[LG5RDVVWWMXL^M=/I]
M/I+,=-I80M:>"I&,(J,8KL44DDNY(>M:S<&@#0!H T : - &@#0'RS>K*E3A
M'UNLKEWC465_CD])&+9%ATB4WYDFM=HY\;%ID6K=(6(_S#7'=FX\D=JE)7OW
M $I7W_2\XQW9QDE65IT]*:>'J3/SB_6YMVIC&.KA*?@NYIKDDG[KAR7;./HN
M137>\LFMCM>QC\Y"Q)DQX<=Z7,D,Q8L9I;TB3)=;8CL,MI*G'7GG5);::;2"
M5*40 /'4;257@D90A.Y-6[:<IMT22JV^Q)9L@E-GN#9DY,9Q#-,3RIZOV^?:
MQO(J>\=@]VZ$_.-UDR4N-W+! [PG<C;6NW?L7FU9G";6=&G3V',UFU[GM\8R
MU^GOV(S^%W+<X*7HYDJ^HMV'W3^?^$ZVG!,>VWM_/_%H#!N=2<F@1E6&.U]?
M>?*)><E8^^ZJNL;1('<$5-PX\JNBSD("O+9DL!F0X4H7(C)W=&F\[T5SVDI4
M^[DWZ'DGW-4?:LSGZ"WM]ZYX&ON3L\S25U+FC#OG!+F<>V4)<T55J%QTB\60
M,GI\RH(.24,A<BMLFG5-%YER-*COQWGHDZ!/B/)0_"L:V:PXQ(8< <9?;4A0
M!2=6Q?MZBTKUIUA+U/L::X-/!K@\";EMNKVG77-OUL5'46VJT::::4HRC)82
MA.+4H26$HM-8,Q_>^"_R_P 9UM.":[YOE.-8\E9O;^GJ"4*6ENPL8L5YQ._3
MRF'G4O/$^P)22=<>_J]+IE747(0_>DE\SQ.VVS8=[WF7+M.DU.IQI6W;G-)]
M[2:7K:-P?HS>GK*?5!ZX<6]1T>DLF. O2XS>V+663X<B)69=R?=4LNHH<>HW
M7T-+DRZTV*+:2$!7RK$!D2/+5-CH7ZYWW<X;GK(^!7\M:32?:WF_1@J<<.\_
M1_\ 23Y2;IT_?EOF[PY;O/XERE'&,HPE&S94E52G#GG=FXMQC51KBG+[7]=0
M?H&&@#0!H T : - &@#0!H#CGFYV^I/E)_\ H K/[R:/7)TBK>7H9)9&WI43
M^3W:[:B1K*=1OL!YK$&!93_RL:1)\F1)^79<>^7BM^;)?\M!7Y4=KN3YCSFV
MR4[C<G6!R!'46#UI :FOUD^H6Z5[0K)+")B$)60A;K;#[Z6_,2-^U1"A[1[R
M![:6]92Q53;:?%KXJ5!'G2GD,H4L@E+;?<07'5!)V2D%1V\-7+%F,GP+L&=#
MLHC$^!):EPY*/,8D,+"VG4;E)*5#W*!!'B""#UT,1L>Q>@DW+>02*N-(N&4M
M(9FO^8\MD,[^2IEIQ:F&G&B=TJ2D*!Z@[Z45:\0/VJ".0::SC75A;2\CGS8T
MO=$:F+$9FM@M!0+00GM=>6^VD;%P*07"25 ] )3&H)'J@- )Y4J-"CO2YC[4
M6+';4Z_(?<2TRTVD;J6XXLA*4C[= 1_&\QQ_+?G_ ,"F+F?AJV42BJ-)CA/S
M'G>0I"I#38=2Y\NO;MW(VZ[;C>)IY%)1JD*4K2L=R%)6DD@*20H;I)2H;@D;
MA0(/VZ AF28!CV63HLZ[3/DJAM!IB,W828\1 [U+4L,LJ04.N$CN6DI4H)2"
M>@UBTGF4ED.(Q BQX45"D1HK+;#"%.NO*0TTD(0DNOK<><*4C;=2B3[3K(A!
M[")R9(O"8%MBU=COG)"1\I-EVWRP4.Y3C;S*8JY"AX=KJ$#[=MSC[U>X&0=9
M - &@$XE13(,026#*2CS%1@\V9"6^GQEGN\P(^(==MNNH"\I*5)*5 *2H%*D
MJ *5)(V((/0@C5!;8CQXK89C,,QV@20TPTAEL%1W40AM*4@D^/30%J=$$Z(]
M$,F7$#R4I,B"^8TML!:5GR7T@J:4H)V)'78G;;QT!;K*]NKAMPFI$^4ELK/G
MV<^593'"M142Y*F.O/* )V W[4CH !J CF26^70)D*-CN)M7D9]"?F;!^YBU
M[,1U;BT>4N.M+DI:$-I"U.)21L=@"=1UX E44RC'9,Y,=$LH!?1%6X['0X=]
MTLN/-M.N(2.G<I"2?'8>&J"+7N>XOCD]FJL[!8M) :4S71(4Z?+<#RBAK9N'
M'>"5.*'PI)"E>P'1M($N;6EUM#B0L)<0E:0XVXTX$K2% +:=2AUI8!ZI4 I)
MZ$ ZH*&8[$<%+#+3"5**E)9;0V%*))*B$!(*B223J O:H&BLHZVG<F.P&Y"%
MSW$.RE/S[";YCC??VJ2)TJ2&?Z0[]G:%'QWV&I2@-=L4E5?'47,N,<F<QNO9
MQ^?9Y'@LK+ULL44_#[Z:[8!*''DJ,B326;KK4EM':I2UH[1MUUQX<MNMN=*+
M%5[&#('&2,CL//OK(5L+'W&'6<7KZRC-"F;&F.QY$J\?@/$RX\>48C8AI>['
ME-%;CB1WH VVZOWLH\/M,&93G2Q ARIBH\N4(S#CWRT&.N5,?\M)4&8L=OXW
MGW"-DI&VY/B-;2#=C%Z]?1C-=HKJA"9)9;C7D9J',>0 DA\1D/.N-H)5M\83
MN0=MQUUBW6+X&</C2[R3RU -A2B$I2222=@!VDDDGH  -80S.3?BE!/O&>#8
MU]FTM^MGP[!EMU<=QZ#*8EM(?;"5.,K<86XA+J L$I)W (]^MIPQ([C]"_/3
M:OTE2]:(4A:+)ZNANST+;Z-J1,6RJ0E38Z)(5\(\-*+/B4PQZ@./[?,Z.CLZ
M2!%OYF(6,BV7B=@7_D<BB/Q?(D,!,=^,M=C%2@+CI*TA>ZT]2H)5HOVW-)K&
MCR[2IF-L+O8-#1&XQK+*@V<I[\$J^,JC'J_&YSF7RE.1(-7D%2RPFP:1 DJ4
MY*=+15Y+;CGG*2"58QG",:PIS=F6/>#;.EKOP:DJ:D.+E&IJH%<'E$>9(^1B
M-1O,45J [WO*W.Y\3XZY$5RQ2[$0QZ+KE6UMDL5^)U&-5++X#\W(IR+)^0TD
MGN#+-/, 2M21T [T;[?I-M2LNP&5M9$&2OO8]E86%?'A6R!7'L=GRZR5"KGG
MPLMN1X<B6AE4MQHC=2D)+>W4*((U*XT*+)M356?9^)5M?8>7_1_.PXTOL\?N
M>>VYV^)\-6B>8*X3%?$9^4K68<:.PM:3&A-L,LLN*4I3@\E@)0VM2R2>@).^
M^A"&97QQ29E-9EW4Z\6W'0VVU7QK$,5J0A16I8C".HAYXGXUA7>0 -P -L7&
MN92;PXK,&)%A1DJ3'AQV(L=*W''EI9CMI9:2MYY;CSJ@A W4M2E*/4DG61#%
MV6U?*]GD+*,9OJFCQL(9(>\MMZ:%A"/F%2F9$&0IYTN%7E(;6EHH [R%;G6+
MYJX9%,J,-N-,M-NO+DN-MH0Y(<2TAQ]:4@*=6AE#3*%.*&Y"4I2-^@ UDE4A
M"FL\COY <?CXSF3RDROE'+;\!6S2LD+\M;[LN5(8=3%0H??\HA0ZI[AMK.O"
MC!.]4#3 R*@L;"945]Q73;. DKFP8TMEZ1'2A:6W"MM"B=F77$H7MOV+4$JV
M)VUC6IBZ^HOV])4W\,U]S C64,N)=^7E-AQL.H"DH<2.A2X@+.Q&Q&^H0N5=
M36TD)FMJ84>O@L=_E18S8;:07%EQQ6PZJ6M:B5$[DD]= *93+DB.\PU*?A..
MMJ0B7%$94B.I0V#K*9D>7%+B/9YC:T^\'0'L=I3##+*GWI*FFT-F1(+9?>*0
M!YCQ9:9:+BMMR4H2"?9H!DO[*]KD1!18TYD3TAU2'M[:OJ(T%M);'FR7I9<D
M.=X62E+++I^ [[?#W /Z"HH25I"%E*2M*5=Z4J('<E*RE!6 >@.PW]PT(1[(
MLKH\6:C.7,IUDS5K;ALQX<R=(DK;\OS$M,0F'W/@\U.Y("=U ;[G0M*CO FM
M6,./.9;DM-26PZVW,BR(4E*22!YT64VU(94=M]E)!VZZ 4H;;;[@VVAL+45J
M"$I1W+5MW+5V@;J.W4^.A!!;UC5S7R*U^1.BLR4A+CU;,>@2TI"@HI;E1U)=
M0E>VR@#LI)(/0Z A..\4XAC%NF]KF;%RS0EQ+<B;9RI/:7D%IQ91W(0ZI3:B
M/T@6!ON #L=*(I-+INX=JYC=!(@Q;=3:1"?LF77X3:_,05E]IE27%;L]P21N
M$J()"@""!9H(]Y&K6F\BL8=G:=RU/2(,(P8R4JV[&6VE.N*7Y?7XSVE6_P!T
M:$$N39/%Q>&W,DUMY:%UPMMQJ*IDV<@J';N7%-A$6,/B&WFNM]Y^[OL=A1?6
MVBI\!$^56V%&E?Q?+7/R#,I#>P*7'40YTYID*!^ZM:5C^4D:J3>"S!&<AY(Q
M#&6?-M+F#'!W"%/RF(K2R" >UZ2XVEP#?J4=^PUR;6COW6DE2OM]F9&TLS#F
M1>HFCCH4FI?$XJ22V:I"9+:@H;H5^(R/+B+;6D[A;*5]#N-=YING[TZ2N*B[
M\/F6/M,'<BLC7:TY)M;FX7*I:*LA7-@^ B8Q7-6V12GW$I:2A$I<=3CCBT@
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MZOI18YFXOI3_ .+9P=_DSQ/_ '*CZZ<V&P&@#0!H T : - &@#0!H T : -
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MXS@I)J2<9)JJE"2=)P:QC.+<9*C3:)!*O*+(8JYM!<U-Y#V3M+J+&'9QOTB
MXV?/A//-?&V01UZCJ->8[=&<&E--/O5#J]2U+X6FC#&3)Z.'VC<_E'_0UY6L
MD='+XF:G\J9)5X?1V&07"I"8$(LI<^58,A]2Y+[<=A"$ I3NIYT#=2DI&_4C
M6O47[.EL3U6HDH:>W!RE)Y*,4W)ON239;=N=VY&U;5;DFDEVMNB7M(OQ[Z=/
M5'ZELGK<-X-]/'+%K87;[+"\MRW"[O#>.\6C/^6IRWR;,+Z)%IX46)%=\X->
M8I^0D=K"'G"AM?J7J;SU\M.F=NN:ZYN5C4WXI\MFR^>Y.7!))46.;>"SQ/,=
MI\O^JMVU4=/;TMRW!O&<URQBNUOZEF?:3].WT(81Z"."8O'E/*9R7DG+'XF4
M\S\BEL^?F6;JB>6ZS <=8CRH^(8YYSL>HC+2E2&EN/N)^8DR%*_,CS'Z_P!W
M\Q^IKW4&ZND&W&S;7PVK2?NQ2J\:8R?%XML^L>ENFM%TMM,-MTBK/.<^,Y\6
M^[L7!&^^O CR0- &@#0!H T : - &@#0''KZI?H#Y3]2L_B+U(>EZ_IJ#U2>
MG@VS&-U62OHAXWR9A-T2Y:X/9V+NS-;.279*8:W5LQ'F["4P^ZQYC4J-LLWK
MVEOPU6G=+T'5?0T^YK!]QZ:\Y?*O3>9NQ2T;49:E6W!Q;Y>>#:DDI8\MRW-*
M=N3]WFJI8.JY'O\ -7K_ *4O89D'TP/4>_R@VXFL8EXU1Y%><42K-Q8CHGNY
M]5XO9X[!J4O=RU=MA)92VD;R@E?F)\KCUA+PJ2T[\>G"7NU[<JKT8^D_.S4_
MI!ZRM[LM-;>K_(\^+_*SE)*N2N0D[,OW^:,>/+A1Z@2.*?4?RKZU6O3K]0'Y
MF*S5\4IY=<X0XWSBL8PG&OQ"PJDTE-G*L.L9QLI+4:4I2]K*3.0MZ.I$KY=Q
M25<+;[]_?]R\#<W)Z=0<E"+Y8X-4K3%K'MK6F-#F>9/1;\ANG5_1;-BQU'<G
M:C.]<Y;]]1N1N/W98VX3]U-Q4?#Y:OE<N5F[N9^E?#,9<Q;./3MA^!\6\H\?
MS4R:=^HJ6\9HLWHGV1%O\$Y =H(:I%G4Y# Z(G/L39==,;:DM!12M"_++NU6
M;3A?VZ%NUJK;PHN527&,Z+%-<6FTZ-'S?H>N-QUD;^V=6ZC5:[9-7&DU*7B3
MLS6-N_84W2,K<LX1E"-R#E"354U,8O)TA;336;8#FO'DTE#4ARUAU^0XZV^I
MUME3J<JPRPR&JB5:EN=R)-B:_9H;O(94%(',AJGE?MSMOO2<?\46U3O=.^AT
M&HV2";EMFKTVLMYI1<K=QK%T\*]&W)RPQC;\3'X7)4;<[;V_G_BURSHC&-O_
M "_[(_QZ T*C7*>.?4+EO',HB/CW+D#_ !EX=N0F.QE\9A4#.:AG?XB_;-UR
M;12?N)<+A&ZG=AT=FZM'O%S12PLZA>)#]]837KIS>WM/96X:)]0^7^FZAL^]
MK]IN?E-1VNQ)\VFN/N@YNS7-KE6424\3<)<G^O3U6)]*'$G(5?QGC6+X5+Y#
MYFY)CM*M+>FQV)<5%*_3X_&B2(WG9 Y,R&"VU'^:AK47G'%N):CK2YTG46\Z
MB&H_(:*?+%1K.47C5_=365%2M*/'V^^OTU^1FCZ]O+=-[MIKWIPC=@W;C9@X
MQ=SPW1793G+E@I>XDG+'A]$W!_T+/IY<01XLO).,+;GG,$*;?G9AS7DUID:I
MTK9M<@JQ&J=HL%5%=D(*DID5LE]*#V*><&Y5X>X)OFE64GFWB?I3LOE+T3LM
MB%J.E\>4$DG<=8JG!6X\MM+L7(^RK.LN)8?B6 X[5XA@N+8[A>)T<80Z7&,2
MI*S',=IXB25)BU=+3Q8=;7QDJ42$--(2"?#661[%T^FT^DLQT^EMPM:>*I&,
M(J,4NQ1227J1(M#<&@#0!H T : - &@#0!H#CCG/_.3Y3_O!K/[R:/7)TF%[
MU,QED;>'^M^^=M=F8!H"@KZ]/?U/V:H,'ZUG($$:TK)K\B-"L8,N3#(3+CQ9
M<>0_%*B4@26FG%N,$E) [@.HT6)&RU9T]5=,)C6U=#LHZ' ZAJ9';D(0Z 4A
MQ <2KL7VJ(W&QV)'AJF L888BLM1HS+4:.PVEIEAAM#+++2!VH;::;"4-MH2
M-@   -4#5=U,FW9:C,W5G2LA97(74F,S,D =OEMIEOL2%1FTD$J[$A2N@[@-
MP8\0.$&((,1B()$N7Y".SYF<^9,M[J5%;[Z@"XLD^.PZ=- ,=L_ERK"/&HH5
M*W  ;<FVEQ(DN*4DJ(<C0J^#Y;OG)0-_,<<2C<^!VZG7@4D^J0@<WD?&(=R*
M!#TZ?:E_Y=46MK9DOL=[_+4DN(:#:_+7T64%0200=B#K'F5:<2DY6A#B2AQ"
M7$*VW0M(6D[$$;I4"#L1OK(@E?L*Z&H,R9T**OM!2T_)885VGHDA#BTGM.VP
MZ;:@/+*NA6\&36V+/S$*8WY4ACS'6O,;W"NWS&5MNIZI'W5 Z9@MU5164<)N
MNJ(3$"&T2I+$=':DK5MW..*)*W75[#=:BI1VZG1*F11-D#5^]7+;QJ570K-3
MC?;(LV'I$=#.Y\WM0R=P\>G:5)4G;?IX$'7AF0]H(EU"KTM7]NW=6*G%N.2V
M8+->RA"DH"([3#/12&RDGO5\2BH] -@"KQ BR7(I- U',3';W(7I)6$M4\5+
MR& WV[JEO*6D,!??\.R5$['PVT;H!]@OO28<61)B.0'WV&G7H3RVG'8KCB I
M;#CC*EM+6TH[$I)!(T WV^1T- EM5S;0*TO?T+<J0A#SVQ"266-R\Z$D]2E)
M ]NE: =&'VI+#4AE16R^VAUI10M!4VXD*0KL<2E:>Y)WZ@'5 FCU=9$E29T6
MN@1ILT[S)D>''9E2SN#O)D-MI>?.X!^(GPU 5645Z; F0X\Q^O?DQGF&IT8)
M,B(XX@H3(9"OA\QHG<?:-'D")8OA]C125R[/,<BR1TMJ;:8GR5MP&N\]73$#
MKQ=>"1LDJ64C<GMWV(BBUFVP3":Y*:B27(,=N7,;8<7%BNO_ "S<A]*"6F5R
M/+=\E+B]@5=JMO=J@8L>E99)^8.2U516(&WRJ:ZQ?FO*.Y[@^A<9MI*0GP4'
M"2?Y(\=%7B!QO+J'C]9)MIXDJBQ0DN)B1G9;ZBM:6TA#+*5'JI0W)V2D=20.
MNC= -V+95"RZ"NQKH5M%B)6E#3MG"$1,L%/<7(9#KJ9#*? J!V[NGOT3J"1E
MILK2Z6T%U(*4N%"2M*3ON$KV[@#N=4%S0%E^/'DH\J2PS(;"VW V^TAU'F,K
M2ZTYV.)4GO:<0%)/BE0!'70%[0&.I&+YQ)MOG_\ &.[#@^<LHJZ_&*UM#<92
M^X,)?FRK ..I1L/,=;<._4 >&L:/M!+K*JJ)R8\BVJX5JY5]TF([,K8]A)C/
M(2E:WH2#'<<;DK+23^A2%*4  / :O*GBU4Q;X$8QW+[;(+!UA6%9!2US7F;V
M=XE%<5;=WE!$!Y*93JG=A]SN2G?XB.FY-MY$)K)DQX;#LJ6^S&C,(+CTB0XA
MEEIM/52W'7"E"$CWD[:R(,U3EF-74OY2HO:NRE(;,A4>',9?>#+:T)6[V(43
MV)4XD$_;K&J:HC.&$T^]$IE(0\PXVZA#C:P4.-K2%H6A8*%H6E0*5(4E6Q!Z
M$:U0:YJ<3L-3%>"VN#0WQXT>(RB/%89C,-C9MB.TAEEL;[[(;;2E"1N?8-;S
MK"-Y'C+V1*BH.29!2PV-R]%HI3%>J8ON"TJ>F",Y,2!V@=J5A)&_3<[ZC52D
MF9:#++3*5.+2TVAH+><6\\L-I" IUYPJ<=<4!NI2B2H]3UU2#))H*\VL>]A5
M5 U>)6AF3=2:AAZU56J04R(L>P:,>8VMU(2D%3BFP!U0KH-3EC7FHN8H_P"J
M0BZ<RH7K1JFA27K.>X5!:*R))G1XP02E2ID]EI4"(D%)'Z1Q/4;>T;RJK0I*
M-4@: ;K.I@7+"8MDRJ3&"PX6/F)++3B@"D!]MAYI,A WW"7.Y(5L=MP#HU4H
MWXWBM%B4%5=0P4PX[CJGWB7'7WGW5#;O>??6XZOM2-DC?9(\ .NHDED"WDS.
M62(K3>)S::!)*E_,2+>/)D[)^#RDQDL[MH5OW%16A8Z  =20=> ':K9GQZZ&
MS:346%BVPA,R:W'1%;D2/%Q;<=OX&F]SL![AUZZJ[P>SIKD-+):KY]BMYT-^
M7!3%[F@?%UY<R5#90TGV_&3[@>NA!>/#PV^P^S[.FXUFE0$<O<OQG&5,(O;J
M#6NR2 RR^Z5/K224^;\NTEQY+ 4-BX4A /B=&TLP2"*^S+89E1G4/QY#3;[#
MS9"FW6G4A;;B%#H4J0H$'1LQ;X"&MH*.G6^[4TU76.R25278$"+$=D%2RX?.
M<8:;6Z M1("B0/9K&A*CA(:6\PZTW(>B..(4A$J.F.I]A1&P=:3+8E1BM'B.
M]M:?>#H"/4F-+II4B6[D>3W;DE"D%N[L6)$5GN<2X5QX<2%!BLKW1L"$=$D@
M; G0$GT(1^D>RAY<M60P:2"UW#Y%NJL9M@]VA2@KYM<FO@M]4[%)0/R@:8E$
MF69KCV%1&)E_+7'1+<6S%:9CO27Y#C:4J<#:&D*"0VE0)*BE/4#?<@:-I9A*
MHY8_?5V35,2[JENK@S0X62^RY'>!9><8<"V70%)(<;.Q\%#8@D$'09#JZZTP
MVMY]UMEEI)6XZZM+;;:$C=2UK60E"4CQ).PT GAV$"Q;+U?.ASV0>TNPY+,I
ML*]Q<86M(/Y] 1^\PG'LDLJ^TN8LB:_6>68;)L)[4)MQIU;S;RH+$AN,X^'%
M]5E)*@ %;I &E 2S0A#8]=FYOER9F1U'ZO)>4XU70Z-3<UQKN_11G9<B;)#>
MR=N]Q.Y7L>U*-QVBDQ4>U*E;%6P)[1V@JV&^P*BE()^T@: QK4\AO2W[!-OC
M4^@CQ!_:SLJ; E/RU!1"D+BQ5J$0H1LHE2U(]@4=M;[>GO7,E1=Y"#9/SWC]
M3YC,62T^^G<!J $64C<; A3@4BO84">J5K)'NZ:[G2[%J+N,TU'OP7VOV&+G
M%&MF0^H2VNIRZVL=CQ9)4I*4ON*LIX4!_I;78F&PK8]4>6L@]-_?Y!I]DTUE
M5N/F?=@OM^=&MW&\B;8KZ2?4!SA)8M)6$S(<-00EO(^1%.8[!;84>]LQ8DQE
M=W+A*[BH&)#=9\?:1OAJ-ZV3;5R*<7/\-M*3];6'ME4*W<GC3VFS:_2+Z;^#
MHD>R]2?/%:Q(2VVM&*U$N/CR71M\,=B U^+YC>1RA/PJB,1%;E(V\ KJ8[_O
M.Z2=O9-))Q_$TY?/A"/K;-GA6X?S) OUF<,<7,N5?I?]/+;SWE_+C-,KBIPR
M&\A6Y#CTB8U:9_D,50 V+OE;@[[^'=LCTON>N?B;YK*+\$7SOV*EN/JJ9>)&
M/\N/R^DP+DG/WJMYI?D0I.?W5+62=T.8QQ#5KQ:"PTZ5!;$S)4F=E#\9QL]J
MBN9'24C8C;N[NXL;-T]M:4U:C.XOO7GS/U1PC_JLQ;N2S?LP&C#/2SE%A8KG
M2V8-7)DN+<E2E(DY+E,DN[J4Y-LW),EU_O))47)6X).^_7?9J=_L0AR0;E!9
M+X8KT+"GJB%;-K<4]*-%#\E^X;<G.CXE*M9)4V%?SFZVO\ME2=OY#SJ_M]FW
M0:CJ"_.JM^ZNY?6_J1FH(V(HN+\6HF$1XT-L-(V/R\5EFOA]P\%"/#2VK?W]
MRU;ZZ:[KK]U\TFZ]^+]K,J$[BP(4%/9#BQXR=MCY+2&RK^S4D!2S]I).N+*4
MI?$VRBK6(#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &
M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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MP4]"=]A$V\T";3I\.LB/S["2S#A14>9(DOK#;32-PG=2C[U$ #Q)( ZG5RS
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MXJ2U!L5@M^/;Y?Q>\:I"["^>^7;-@8OS2D(4ZB$E[Y=I92"MIMU]7F2$-KW
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MC?W>'[FI1 ]0TE'7J3[S_$-$J N:H#0!H T : - &@-6_6E_Q:.2O_)._O\
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
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MZOI18YFXOI3_ .+9P=_DSQ/_ '*CZZ<V&P&@#0!H T : - &@#0!H T : -
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
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MQYKY K&4O6%)C2766(U+1EY)A+R+(IDIJ-$2Z2A'<](6AUN(XRYX-U)N]_\
M,/;M+)PA%+GDG1MM5Y:]E&J]KPX8_9WZ8O(_2];7X;]O5M3L2YI1YXJ4;=J$
MN7Q%&2:E=N33C;YE2,4[B4L*?:'Z,/IM>E'T'QK63P;A<]W-L@KD5&1<I9S:
M)R?D2YJ4/LRU5)MDPZZKHZF3,C-/R(E5"KXTMYAEQ]#BV62CQ%14<5F?I]TS
MT3T_TE!_TFT_S$H\LKDWS7''\-:)1C@FXPC%-I-IT5-\]9'E@: - &@#0!H
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M=["$XKPMS3ZDK2+*IL=N+NMBO*0+::M5-A$!;;@\SOE/EBKD2HQ([FV@_+4
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M_BNN/JOY$O5]*+',W%]*?_%LX._R9XG_ +E1]=.;#8#0!H T : - &@#0!H
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MY\3P,QWUK : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M: - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0
M!H T : - &@#0!H T : - &@#0'R!?M<C^8QN,/IW2..TJ5R!']5UB_@J41X
MDM:LQ:QZI<QA*8L]MZ#)4;M+&S;R%M+/18*21KA:VM(TSYC*)EW(_P!E;]*_
M('!EW,Y'YIYRROU[99$DYKDWK"MN0+JV<F\VSX_XC(M',(DIC5L[ &<HZH:<
M"+]4)(VLFWNU2<GHX..+?B=O>.;V&*?0/ZS^9?55^SX?5"X\]2%[8Y1SOZ0O
M3SZV_3SEF4W<S\2R/*,<I?3=EEGA]KD]H4I7:7]9\U.HWI;GF2)K=,W*D.O2
M7WG%8V[DIZ::E\44U\P:Q-:OHI?1 ],_U"O0'Q#ZK_7):<J\M97DK]I@W!U5
M$Y$GXWBW$W"/!>>WG']5A>/XY4=U:ZQ?99C%V_9"8TM#XF*>0TW+>D39.-C3
MPN6U.Y5OAW)!NCP,DY'Q+E?U_?J[^LC@+F_E+/L5^GK]-;(8'&QX5XWOGL=:
MSSE.-D%[B#DC(I#<.17.R[O*N/<F<=L%MF=7U4"-!@>2MV3,%:>IO2C)OPH<
M!DN\C/U0_I6X_P#1/XZH/JB?2ISWDOA&_P"#,UP&IYGXJO\ -K_.N.\^X_S3
M)X6&QA;QKU<VUM84S*\A@0;"ML9;\)V--^8B&'-BM+=EZRK"\6S54S"=<&8C
M_:@N&> ><?0WZ./JTXO2Y/6\Q^HR;Z9,%B_-Y$_(QZ%PQR'P)S;SI5U!Q_Y=
MJ+^/Q;?Y4+G A:FT*1V@*Z35QC*W&\OB=/91L1SH=)/J:S,#_9\/I(7O$_H&
MEY3@62>H/GU&"81EV593)RC(./+[D?%)5ER#R'76DJ(B0S(JL)XS5#KEMI\R
MNLY[$Q 6IKL.V[336>6W@VPL7B<CL$],O[*](XQ5!]0_U!N0><O4+E%<]/Y'
M]1$F\]0U)D=EGENE<F^R7'*)SC.TQ]#/XF^M<5-['O9"TA)ENR5E:E:%#24]
MZ3<NW$OO'4C]FZ];EGEG)7J[^G7_ )Q<OU;<.^F/\)S+TC<^6L"\@W^0\%3;
ME=#-QNW1D<2->-1,7DVU,F%%E%:J]Q^7$CK5 8AH:W:6Y5RM5YHK)]Q)+B0O
M]E__ .(Q]2O_ ,NOYC_\H_BNII/Y<_WG] EF<Z_V>;Z0W%OU'?1UD?('K,S?
ME/,_3[QOSWG.,<*>FS&,\L,'P&)F\G#,&G\B<O9*K%UQ;RSR.W:MZZJ@$2XK
MT=FJ?#OG1WF4)U::RKL*SKRIX+ZRMT>!N1Z$>!5_2<_:)YGH(]/6?9O8>E'U
M,^G"YY47QOF.0OW;>.643%<DR*LENK$6'#LLAQ_(.,IL.#8ED3/P*S^7D//N
M(4XO9;CX.J\./P-$>,:FLGU1LR]-.??7>Y*XO^M-F?-V$^A_!>(,-D^D^DP\
MYTCC29.N\<P:3,R:Y:P.MMLJ>K+[(Y.4Q[*TIXOSJ+2O8A2)"(D,)&%YP>H:
MOU\.F!5EAF=%?IK_ $Z.$N)?J 8EZKOHZ>NOBC*_0G=X,_5>IOTT.\S7G)F5
M6%I*AY+5US+>.1*Y^=2LTLY^JMJM_*)+-W!G(EM)<77S#'5MM6HQN<]B2\.F
M*J1O#',^L_7,,0T : - 8?\ 4%E=C@_!_*V65/SC=E28)D<N'.@N>0]2O&N>
M93DCT@,R5QH&,!TV,IU#3SC4:*XM#;B@$*\BZ1VZSN_5.W;7J90C8U&MLPES
M_"U*<4XM55>;X4JQJVJR2Q75;YJ[FAV;5:RTI.Y;L3DN7.JB\<GEGD\%D\CA
M_E?)-/1Q4&3WY!8P8LF-!L<OMKK-#2M3(IB6?ZM1<QM+^/CJ[AI2A,=C@/RB
M=W'%*W4?TLV#RZV^U>_-6K-K2VY4<E9MPL.?+3E\25J,)34:+EBWRK\)\F[G
MU1J96_"N7)WI*M/$E*YRUSY5-R4:\6E5]IJ7A46UY)Y>XWXZQFDR=$7DSE;%
M#8)K:FRJ84G$XL^HQ;*9\4LP8Z58Q185C[_FRHQ[4(A+<;=2X@*3V'6>_=/]
M+]&[[K]'KK,=TT]B[)\EZ*NPU2MJ-B#49<T9.<;2Y)+WDWS1E&33XFP[;N>\
M;]M^FO:>;T=V[!>];?)*SS5N2Q5&E%S?,LN#329TWSWZ,?&V56D.52<[\HT5
M4K)1,MZ6VKL;R1+F(*?2XYC=%:-,4%G672&.YIJVG.6P2GM4Y%=6%*7\G:+]
M6W6UK2RL:[0;=>O_ )?EA<CXEN2NTHKLX\\X35?>=N$;2;JE**P7NK4>273\
M[RN:;4ZJW;\6LHODDN2M>2+I&473!3DY]Z;Q-J/59Z9\";] _,G!/&>(5N.8
MYC?&=MD&(X]3QSW*O<&=;SV KYAU3DR==WUS1 29<AUR1+>D+6^XM3BU'Y(\
MP-=NO6&CW#<-[OW-5NM^#N2G-UE*4*2BEP27*HQC%*,8TC%**H?;?Z2.I-'Y
M6>?72&YZ%0TVU6]UM:6XEA"-C75T=Z4NU1AJ)7)-U;<>;&5&<(_HB\D_JCZL
MKO 93ZDPN5^-+^LB10KM2]DF(R(F75\A0V(7\MCU?;I Z']+OOT(/I?RYU?Y
M??):63]V_9DE^]&DE[(J7M/UY_[EW1O]?\AM-U58BGJ=AWFQ<E+LT^JC/2W(
M]W-J+FD=?V:4Q37;'D;E+E&3RUR/A2.4[7$6L,NJZ/!I\,K\,<8C5%WCU;>X
MU<S';S'+J]D6*X]@M,AF2^(+LJ.YVQ5L>65_>?E[T)TIU!TVMRU5J[>U_-.$
MU*Y*"BT\.11I@U2C=<:]C/R:\NN@NDNH>FH[GJ[-V]N#E.$U*Y*$4TW3D4*8
M-4HW7&JX4-MN#,ZR7-<=R"-F#=6K),&RI>$VMI4*+47()$/&L9O?QU56I.]%
M(G(R$!R&''D-J1W(64+2$^HNJ]EL;#O,]!I;DKFGY(3BY*C4;D>9)XNM$TF^
M+X'I[J[8]/T]O4]OTMR5S3\D)Q<E1J-Q<RB\77E32<E2KK@C-6O&SQD- &@#
M0'!CZ\DJ9 XG]/\ 95JV6K*KY.N[6M=D,-2F&K*KHHUA =>C2&WH\AMJ7&0H
MH<0MM8&RDJ22D^!];:N6@N[=K8YV]7S<."55C58KM/MC]*'EC8\YO+CS<\KK
M[M1>]=#7-/;E<5QPMWN><]/<?@SA<_A7X6[BY9/&*K"Y&MN3OC6:V^0\;X_D
M=Y7UM;-N**EM&S32G9-381K6BK;5JPKDR$(E0HSAG*1\NZ7%,+;4D.O("7E^
M^=+=G>L1N7$DW%/#)U2=5V9Y<.UYG\A&\Z/3Z#<KVDTTYSMV[DX^^DI1<9RB
MXRI@WA7F5*II\L76*YX^HC+KAANT<K,EDU17$?80P*C%+2('2ESLD.HOJ"UD
M*<"E#=*'4(V2-@#NHV]9G<KR7)0=,*4I7MQ3?SFS;-UL[?2-W2:;40YJR\13
M<G'"L4U-1CAD^6J;K5X)=W_II<7<;X%Z5\&R_CMC.$'FRLH^4<K?Y"DP9%\]
MD\[&Z:BG",FJJ**J1CZ32=]>N/%0W)C.)D J2ZG;P*5V]?D[VH;E>>;PX8?=
M25,.&>9^XODQTCTETAT%H['1EF_8VC60CJJ793E-SNPC5OGI))T3BFEAP61O
M_J'M8- !Z]#X'0")456Y[%)[?8%;[C[.@.^L>4%]EKR@>NZCXG\G@!JI4!>U
M0&@#0!H T : - :M^M+_ (M')7_DG?W_ .*ZX^J_D2]7THL<S<7TI_\ %LX.
M_P F>)_[E1]=.;#8#0!H T : - &@#0!H T : - &@#0!H T : X;?4J]8O,
MTWF3&_0;Z3<N7QWR#;8DCD3U"<X08[4RSX@XUGNJATN/8DE3J#&Y#RY:TNH=
M!;D0XKT=QA2/.<DQ/<?E;T!:ZDO/<]RCS:"$FHQ>4G&G-*2XQ3]U1RE*M<(N
MOS+Y_>;^KZ+M1Z=Z?N>'NUR"E=N1^*W&5>2$']V<DG.4Z5A#EY?>FG'2_A[T
M.<'8/8'((^&M9WG<E\3+OE3EB2[GV;6ULH(\^W=ML@$Q$*R>[!N8#,;IOO\
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MJCYK['*&OI_6[$.9M)1<XIJ,N:,?=4[<G%2Y5&,HSA*,55I=T=>ICZ*#0!H
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M/M2H @CJ" 1U&F8$E-04F/1U1:2KA5;#B@MU$-A#)>6-P%O+2/,>6D'8%1)
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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MQ>IM&X>$6^/23#J*^P0ZBLC?BM;:P;>=(KVW$"47W'&YH2XE*8WF(6U]3?\
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ME=CBIVY2Y+4KL:IQN693Y9-)J<')UJVD_M7UUI]X!H T : - &@#0!H T :
MXR\C_P#./Y7_ +PJK^\JCURM'_.]3,99&T.NT;[# \) \=3%@ME?7W#^'5H#
M&VL#8)HJI:VMYK$>._WN#RXLIR8UY860TOSG8<%?>MO8J3V;)/0%7B8"U8SV
MZR&]-=8G24,@'R*Z#*LICJE$)2AF)#:>?<)4?';M2.JB "= 1W',P3DDB0PC
M&LMID,,^>F7D%-^&Q)(+B6PW%=,EXNNGN[NWM'P@G1.H)6^^Q%9<D27FH[#2
M2MUY]Q#3+:1XJ<<<*4(2/>2!J@1P[BIL5%%?:5TY0"B4PYL:2H!.W<2&'5G9
M/<-_=OJ5!&K?C[&+ZY:O+>-,FRV"RIIEVSL!!;7'" RMN$B0EAKM* 2E 2A:
MB2H*).\<4W5BA-M9 QT_09],R)R<O-VJO'T2"J-4U5/"<DJB@[):?E6+,E/G
MN( *UE+B0HGM2D;;8T=<\ 9%UD"*FXR,W8KV\0D"G#O8N_?NZAMLMC[SS5:R
M[)G+2?Y(4$*/M"=3&O<"5:H(Y4Y=C=[/F5E/;Q;&; 07);47S'$M(#H9*O/\
ML1U[.G;X5G4JF!RL:>HN$--VU776C;#A=818P8TU#+I':7&DR6G4MN%/3<;'
M;0"N/'CQ&41XK#,9AL=K;$=I#++:?<AMM*4('Y!J@CV4XRG*8;$%VYNZB,V_
MYT@4DQ,)V:WV*2(TATLNDL=Q[NT#8D?DVC50*,=QNOQB$J#7.6#K;COG..6-
MA*L'EN=J4%05)<6EH$)'PMI0G?KMOHE0#M+^;^7<^1,82O@\HRPZ8X^-/>7
MR0X=F]]@"-U;=0- *!OL-R"=AN0-@3[2 22!O]IU0>Z - &@&RXJ8MY72*N:
MJ4F+*2E+WR<R3 ?4A*TK*!(B.LO!MSM[5IWV6DD$$'4 W8SB5!B$1Z%00?DV
M9#WS$E2GY$EZ0]V]H<=>DNNN*(3T ! 'L&B260'6S%BJ#(34JBHL%H[([DQ3
M@CM*40"ZH-LOJ6IM))2GMV4H 'IOJANA8IH4V!7L1K&UD7,U(4J1/DM1&%NN
MN$K6EMF''C,MQT*)#:=BI*=@5';51@,^5Y)-QV,PY7XS=9-+DEU+4:I9"FF2
MUY9[ITG9PQ4.>9\!#;A44GITWU&Z \Q*RRJTAO2,IQ^+CSQ<3\I&9LA.?<9/
M<2J2VAKRXRDCMV_2*4K<[I1MU*O$#=<\GX%03%P+3)(C4QI9;>8CLS;%3#B3
MLII\UT66EAU!&Q2LI4#XC1R2S!+ZRR@W$"+9UKXE09C?G1I 0ZVEUHJ*0M*'
MD-N!)*3MN!N.OAJYD/(U561)#\R+7PX\N4I2Y4MJ,RB5)4LA2E2)(0'GB2!]
MY1\![AI1%%^A"(U>+S8-HJUG9;DERYLXE$&7(AQJE'F(4@J-=70XC+BT!7P]
MVX!Z[=P!U*%'ZV=LF*V8]3Q&)]FVPI4*))D?*,/O].U#DCL7Y8VW/L!(V)3O
MW"NM,,P0O#)O)DZ1(=S:IQVEA(04QHU>IZ18O/%0[5+=:M[&$W'2C??^6I6W
M0#KK%<W$$\ER40XS\IQ$AUN.VIU3<2+(FR5A(W[6(D1IZ3(</L2A*B=9$,-Y
M'/1/D,63<*S@-S& /(MH#];,\Q@]BBJ-(2EP(+91L3[=QXC70[E&E]3X2C]'
MR1[Q\M[RU.RST[^*S>:_NR2DO];F,IX]*$REKG]]S\LEE1]O?')CK)^TJ:WU
MVVDGXFFA+]FGLP^H]7=4Z/\ (=0ZO3TI'QG)>B?OKV*5!YUR#Q\BLK"<9G7C
M61S:Y<NWCK;<CR)-A9O,1UM(2ALL5[DU5<SVA(.R6@"K=7WB2915J4E6J0A]
MI19+.N&9T'-)=16-%DFGCTU5(2YV !\+G2T.O*^8(]J2$;_"-^NI1]I22S9\
M2O94]*>2VD)44IW!<=*1OVM-_><6?<-;;=N5QTBJD;H:RW'J+DP;"1 >Q%^F
M99)!D3;2._:+24]S?DU3$1QA#BQ[5R"U[.[?7<:/9]1J76GN=N2]O'U&N5Q(
MPU<<FYMG-DU48W#L?FK)T1H<*J:DVE_8.KW[&(_R[2Y'F* W2W';"AX;D:\H
ML;7H]'#Q+[BU'%MT45[?K-#G*3HC9GC+T$YU>QOUKYEOX/%V*--&PL43I423
MDQB#](X[,4^\*>@0ML[J=E/./,G[\??<:ZO6]5:6T_R^VP=^_DJ)J->[C+T)
M)/@S9&Q)XSP1DN=ZB_2OZ9HS]1P!A4?D'-V6G(3V:3%+5$\SL4V\Z_E<UE=C
M/:<4O=4>K98@O@;!U [3KA1V??=ZDKF[7':TU:\BS_PK!>F3<EV,R\2U;PMJ
MLC27.><>?_4Y;NTSTVWR.(S(3YF*8JTFGPJD5W)<;-PZN0U6-NL ][:K*4_-
M*=_*[_NZ\GTFT[5LMM7:1MMKXYXSE^ZJ5?\ =2CVT-+E<NNG^@R]QKZ*9]P&
M+#D.S7+94I*S18_)EU=&$[]6YU^IJ+?W*3M_ZR(@('5*O,'77"UG4ENS6&BC
M[WXI).7JCC&/][F[J&R-E?>-_P##>)\-PFMC5=13UT6%%2/(@08+%?6,J/5:
MTPHR4H==<5N5K=*U+/4]=SKQ/4Z_4ZJ;N792<WQ;J_:S<DE@LC):4I0D)0E*
M4I "4I 2E('0  ;  #7"SS*>Z - &@#0!H T : - &@#0!H T : - &@#0!H
M T : - &@#0!H T : - &@#0!H T : TH]>&5Y1A_$..6>)9)?XO8O\ )%1!
M?L,=N+&DFO0G<8S"0Y#=EUDB,^Y%<?C-K4V5%!6VDD;I!'%UDI1M)Q;3YN'H
M98YD2@^DCU#SH4.:/5UGK8F18\H-FRSA10)#*'0@J&:@**0O;?8;ZX7\;\<O
M:_M.1X2^2%7^9]ZB/^5[GG]T<X_PVT_C?CE[6/"7R0?YGWJ(_P"5[GG]T<X_
MPVT_C?CE[6/"7R0?YGWJ(_Y7N>?W1SC_  VT_C?CE[6/"7R0?YGWJ(_Y7N>?
MW1SC_#;3^-^.7M8\)?)!_F?>HC_E>YY_='./\-M/XWXY>UCPE\D'^9]ZB/\
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M#H!X#7$*&@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
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M2_9Y<9*T_P XZF('[5!%*N]O+&T?C2,1L:FJ:#@;MK"PJ^]]Q!(2E%;%D29
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M+#(FVN, T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
MT : - &@#0!H T : - &@#0&A7U$O^!3%_\ *E2?WIYMKAZW^4OWOJ9E',Z!
MT'^P5+_YR:[_ +S9UQED<P=M4!H T : - &@#0!H T : - &@#0!H T : -
M&@#0!H T : - &@#0!H T : - &@#0!H T : - &@.:?H7_V>]1?^_\ A_\
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M"?TDEUML*/1)4MQE*&QOXJ)  \>FO8"A/L9^=/@W?PLG5;R7QW<#>KSO$)Y
M[E-QLCJ''D)W(W<8$OSF@2/Y21OK)QDLTS%V[BSB_8/K&1X]**A&O::04 %8
M8M(+Q2#OL5!M]7:#MTWU*,QY9+@QYU"!H#Y._K6Y1#O/5Q25T::R^WBO#>(T
MKZ&'ENMLS9.1YI?O=Z>K29*H]RR%E&^Z4I!/<D@>D/,6;N;["*^YIXKVRG+Z
MT?O!_P!M;;/Z?Y :K6S5):[J35W4\*N,-/H["6&-%*U.BE2C<FE1IOJ_Z=_5
M-CW&/I9X"PG&<8FW-]3\18,W9/V/92T\2WF8]"L+)"6FE2Y]@MBPEN)<)3&#
MJP5A6QU[=Z<TCM[#HXRP_P"6MOVQ3?TGY)_J+U3WOS]ZRW'GK:?4FX0BZ\U8
M6M3<LP:?X7&"<5PC1<""YYR[R?RJHM9'<KCTQ6E:**M0NLHD=J@M!5#0XM^P
M6VL;H7)6^M!\%#7DMK3/-*G>SU':T\8?"L>UD"8JHK0!6GSE^U2_N_F0.FWY
M=]<R-B$<\6<E02)[B]] H&YB'JM$A4DM=CS8:2MM* H%K9:".Q14#T(ZCKOT
MVL[7-3E=$B2@WE@/$C-V)&Z37.)0>G].A?0=1\):2/W]8JRUQ)X=.)')]Y4.
M(4N5$2A)! \QIAW?_0@'XE=/<-5P[:&7*\N)&(M3,RZ=^&XCC<NTFJ 5Y=?"
M?<<;05=OG/)C@,QF$D]7'%! ]I&M<U:BJSHE["N,(JLZ)&2X?IHY'4VU)LK+
M%,7<.RVVKO(%(?2L%)2$JIX=HT'/$C973M/@=<=W;/W$WZOM-3O65\*;]7VF
M5JAKU2X*TV[0YE$SBMBGL,-J]:R!ORD'XF6?UFBQI0"1\(2T2I.VR1X:X\IZ
M>3I*+B_13Z#1):6XZ2CROT4^@SIQMZHH]M8#&^2*A6)WC2VX[\E<>3#8CR%;
M)2+6OF%4FO;<41L^E2V=U;J#203K&=C#GM.L3CW='2//9=8]GV&/?5WRY<QI
M\+B[&9CL-B97QY^2RXCI;?G-V/F(A4J7D*!1"7&'G/@='@XA._:%I5+,$_>9
M-+:37B2]1@6'B>)X'5U\^Y#5_D5A%9FL,=J'8L9+K:'4".TON9"6RH ON!2E
M*&[:1L1K/FE-T6$4;Y3E)T6"&2PRZUFK5V*;B,^"6FD!9"!X)+CH4>@]J0G\
MFLXQ42)#*J2\^.YUU:R?'N4=OW/#;6Q&:H12^F0G&/(24/20I)0I!"O(V4._
M=8Z?$D;=N_VGP&C,XU-O,ZI+2@] %W#MXRXDN0BALT1G4%#[<.SY3H9L!3R2
MD*"WH;R' #U2A8!VVV'4Z]IVYT[OI1UMYJ5]M9?V'3OTK+0WZ:N#UN+2V@<:
M8B"I:@E(*JN,E(*E$#=2B />3KHS$V"T!2M:&P%.+2A)4A 4M02"MU:6VT J
M(!4XXL)2/$J( ZG0%6@*5K0WVE:TH"E)0DK4$]RUG9"$[D;J4>@'B3H"K0%*
MEH04)6M*5.J*&TJ4$EQ80MPH0"05J#;:E;#KVI)\ = 5: I4M"5(0I:4K<)#
M:5* 4LI25*"$D[J*4@D[> T!5H"DK0E:6RM(6L**$%0"UA&W>4I)W4$=PWV\
M-] 5: I*T!:6RM(<6E:T-E0"U(;*$N+2C?N4E"G4@D= 5#?Q&@*M 4]Z.\M]
MZ?,"0LM]P[P@DI"RC?N"2I)&_AN- ?-3ZH+"3RC]6WE!60N+?K_2]Z>.,\2X
M]JW'"Y"@6O+S4[,,GRN*P1V1;F97S%5CKJ?C=B(0E1(0D)^KO(W;K%K8Y:Y)
M>-<N3;?'!\B5>Y1=/WGVGY[?JHWC5:GK..UR;_*Z>Q;C%5P]Z/BR=.UN:3?%
M0CV(RAKWP?*X: \/@=%F8R^$99BNBOM_Z>N?81U6JE[I#;%?17OZ_P!7[VN\
MTT<4>+:Z6! +1?WOR'^O_%KR/21/"]QGF8VMW.BNO[_[W[VO*M%'(\ W*>#,
M67+OW^OOV/\ 5^37E^AAD>NMUN8,Q)=N_?\ S_U>'V?O:\A2HJ'A$W6;?>8;
MOG>B_P _[VM5]TMLY&DCS73"M^[]_7B6OGF>P]IMY&(K9SJK\_\ 7\->)ZJ7
M ]A:"&"(WK@'=!H#?7T0_3$]4?KZQ^=R5@5UA/$'!\.[GX] Y'SMBTM[;,[*
MJ<5&MG,'Q2K8(LZVIF#R7I,N3"CEX*;;=<=:?::^:?,#S\T_3FX2VS:H>)>C
MQ23;[)-R?+%2SBN6<FJ2?+5(^U/*#])>Y==;1#?=ZNJQHYNGO.25?O1C&*YK
MCB\)R<[<%*L8\[BV=6<$_9M8YG1Y/-OK1RN_QY*RJSQWB[BVDX^G.Q$*7YJ&
M<RO<HS)MH/L;=Q74+#?Q#XQL1Z;W;]1756OLRLZ:'AU5*N:2]:MPMR:_OXGT
MKT_^BWH?:]3#4:_4N\HNM(VG7!\)7KMZ*>5'X6'?F?1%Z>_3_P 2^F'B7$^&
M.$L7BXIQ]BD5Q-=#9><FS+&9-<5*LKZZM9"G)=S=W,MQ3TB2ZHE1(2@):2VA
M/H?<]RUN[ZV>OU\W/4S>+R22R26226"2^D^N-AV':^FMKM;-L]I6M#:6"S;;
MQE*3>,I2>+;]"HDDLT+6AI"W'%I;;;2I;CBU!"$(0"I:UK40E*4I&Y)Z :X!
MW!5H"E:T-(4XXM+:$C=2UJ"$)'O4I1  T!5H"E:T-@*<6E"2I" I:@D%;JTM
MMH!40"IQQ82D>)40!U.@*M 4..MM!)=<0V%K0TDN+2@*<<4$-MI*B-UN+("1
MXDG8: KT!QR^J%]/'.O4;;X)ZHO2_E$/#/5]PK2OT&-1KF7'BXORU@XDVEJY
MQO=/3@J!7V@DVT\ULA_LA.JFO,3%--K:F0=EF]?TM^.ITTN6]'+ZT^YGIGSA
M\IMO\S-FG:N0C/6JUR<LGRJY!-RBE+[ER$FY6YX*K:G[KK'F7Z9?5$US8_E_
M'F>8K-XJ]07%=A*HN4N*KI+T>=66-;+563[*H;F!,IZJ19-EIYI?<]!>4EMQ
M2T.,/O\ L?9]YM;K;<6N350^*/UQ[5\ZR?!O\>_,SRQW?RZW1Z?4J<]ME<E"
M,Y1I*$XYVKJRC<7!KW9I.4:4E&.VVNZ/6(: :9?A^[_V.@(?8?=/Y_X3H#'M
MM[?S_P 6@,8V_P#+_LC_ !Z Q1=>"OR'^!6@,/WO@O\ +_&= 85O_!?Y%?PZ
M P?D'BK\A_@.@,&9E2HO(ACAU46:PXB763VE*0_ GL$KCR6G&REQ!2L;'M(.
MWAL=B.NW3;K6YZ26GGA/.+_#+@_1P?<>6]$]7:WHS?K6\:3FE93Y;L$Z>);;
M7,NZ2IS0?"23RJG]L7T6_7'?>LKTMO5')DQ4SG+T_6T#C7DF>^X7)F55RH+C
MN$9[-^]M89#70),2:HK*I%E5RI "$/(0GU6X7+<Y6;JI=A)IKO6!^W7E)UO:
MZXZ3M:[Q/$U%N$$Y_P#F0G%2M77V.4:J5<>>,GA6AV 2ZVM3B$.(6ME24NH2
MM*E-*4A+B4N)!)0I3:@H [;@@Z'M$KT!2E:%E:4+2I32@AQ*5!1;64(<"%@$
ME"BVXE6QZ]J@? C0%6@*4+0YW%"TK"5*0HH4%=JT'9:%;$[*2>A'B#H"K0%*
M%H<!4VM*TA2T%2%!0"VEJ;<02DD!3;B"E0\0H$'J- 5: XO<CNM._4:REUIQ
M#K:L$JNUQM25H5MA=(D[*02#LH;?EUR=(OXU.YDED;-E9]G3^'7:I=IK*-5N
M@#6-6#&599U]S!8LJN6S.@2@LQY3"NYIT-N+9<[3L#NAUM22/$$$:PS-@CL<
M<H;>9"GVE1 L)E>%"&_+CMOJ8"U!1[0X%(.RTA2=P>U74;'2B ] ;=!T Z #
MV:H(=>87'O[2-92K[*8K<9#:$U57=.5M6X4+*BXZW%:;E%YS?92@\D[ ;;:E
M 3+5!#6$\@KM@9+^&L48D!2FV(MW+MEQ YN6P\Y,A0VY#C/3O\M24*Z]BAT,
MQ[J#$F6J"+0,LB65Y*HX]7D"5PP\'K*332HE05L+\M;;<V2&BXM2]P@A':O8
ME)(ZZE<: E.J T CL*^%:PWZ^QBLS(4E(0_&?3WM.I2M+B0I/^A6@$'Q! .I
MF"S64]32L?+5%; K(Y(4IF!$8B(6H#8+<2PA <<V\5*W4??H"/Y7!S:?\HUB
M5[54+8\SYZ3,KOQ"62>WROE4.I=B!"1ON%(W)VZ[=-1\W #KCM98U-:B+;7D
MG(; N+>D64EAB)WJ7V@-,18X\N/';"?A3NH[DDGKTJ32QQ!1D%O8U+$959CU
MAD,B3(2QY$)^%&;CI.Q+TI^8\V&F]O A*AN.I3XZ,$@U0-<V[J*Z975\ZQB1
M9ULZIBMB.NI3(F.)&Z@RU]]03N 5;=O<0-]R 8!Q<;;>;<9>;0ZTZA3;K3B4
MK;<;6DI6VXA0*5H6DD$$;$:H$E?5UM2Q\M55T&LC=Q7\O7Q(\-CO( *O*C-M
MM]Q \=M]0"[5 T,TT9FXEW8?L7)<N.W%++UC,=KH[#89^&)6J>^1CK<6P%*6
ME'>5%77XE P"Z8Y*:C/.0HR)DI*=V8SD@1$/+W [5R"T]Y2=COOV*\/#5!<:
M4XIEI3S:6GE-H4ZTASS4-NE(*VTN]C?FI0K<!7:GN WV'AH&Z(C>393#Q>.V
M_)@7=FX^5!F)1U4FRDN=FW>HJ0$160CN'](Z@G?IOHW0P%U!;N7E7'LG*FTI
M52._^T+EAN+/;"%%'>XPAUTMH<(W3W=JBGJ4C<:JQ!=<CTM8Z_:.L5=>\[O\
MS8N-Q(CKI/4^?+4EM2]^W^4H^&F&8+J7:^Y@._+2VIL&8T_',BOFGM6A86P\
M&)T%Y+C3J#N.]M:5H4-P01IF0A]/Q?@E#9-6]90-M6+"EK9DOSK.>6W%^+R$
M6$V4TE\==EA/<"=P=]112Q*3>4))C/B$MAN667!%7*;<>C(?[3Y2GVFG6'7&
M0O;N"5I41X$:I""8[1\@1K==ADN9Q+*O*'$II:^DB18Q*TK\H_-J;$ML1U+W
M&Q4I>P"E$#;42?%E)\\YY33KO8X[Y3:W/+93WNN=B2KL:1N.]Q>VR1OU.J0C
M&,7M[=_..6V*2\98:=*(2IUA%DR9K>_WUQ&$)7$4!X@E2=_NJ5XZB;91_L+&
MOJ8CL^SFQ:^$P 794Q]N.PWW*"4!3KJDH[EK(2D;[J40!N3JY$&^CR6AR5J0
M]16D6S:BN):D+C*40TXM'>A*NY*3\2>H]G3[-1-/(HHL*.EMG8[]I3U=D]#)
M,1ZPKXDQV*5*0LF.Y(9<6P2MM)/:1U /LU:)@= -N@Z = ![-"&-<FPV#8W"
M;RUS#*H$-(9 I(-RN!6J#*$I6AEJ*VF4/F2GN=*%>8HD[* V[2MRN.D:LRC-
MPDIQ=))U3[S5BWSR/AF2K,=Q0756;@0E 2[*<C(=4CX6E'RVO.C'H7#M\6O&
MK&DGIMP2G\,+E'V4KCWY=A]AW+4.KNB6X*MS6:&J[KCA5=WNW%\Q&K3D3D/D
M*]128W FK%D1'@P*3YZUR:SDJ/1D(C1"_P!I1OLACJ .NX\/<MC;='HK?BWW
M%I8U=%%?5ZV?&,I2;Y<:FVW&7H*MW:PYOS]ED'C+$HK0GSZXSX"+U,7<*6NW
MN)ZE46-I6E0/<LRW0=TK;;5KJ=;U3;4_RVU6W>OO!.CY?4E[TOF78V9QL/.;
MHB56GK$]/? U?.Q'TN<=QL@M$MJBS<\M(<R'22WVB/C?M+!366Y>E$A!(;28
ML%._<PZ4;#7'L[!NN[36HWJ[*%O-05*^I+W8^G%]J*[L+:I;6)HYD_(G.WJ=
MOU_.3;W.5192DIB1EMU6"8PZ=P4.+3\OC];):95LI(\ZR>;&_:Z=>6Z?0[7L
MEFJ4+*:S>-R7H^\U[(KM1I;N77V_0;*<7>B(2#&M>3++\75\#HHH!EUN-,D=
M>U[K'O<D[% ;%Y4*(Z@[+C*UU&MZF4*V]#'E_:='+U?=CZN:2X2-L;*6,L6;
M^XS@>,8G"B0:>JAQH\%I+,-EF+'C1(;:#NEN#!C-M0X;:23VAM (W\=>*7]7
M?U$G.Y)N3SJZM^EO%FVE,B8ZXQ0T : - &@#0!H T : - ? 7^UL>I'U$<+^
MM'TW4/#O/?-'$]':^E]BWM*;C3E+.<$J;*V/*_(D,V<^NQ:]JH<RQ,.*TUY[
MB%.>6VE/=VI '7:R4HW%RMK SCD9(_\ @=#ZYG_OV\?_ %R7J_\ _$35_*ZC
M\?SLG,NPZ_?1M^EG]1'T(<Y\H<B^L7UM#U.X-F'$[F%8QB7^-?G'/OP#*U9A
MC-XG(_PWE&OAU$/MJ*F3&\^.HR?T_;MV*7K=8LW;<FYRJJ=Y&T\CN35>HST]
MWO(<[B*CYWX:N>6*N3;PK/C"JY0PBQY#KIF/LOR+Z).PJ)>/9)$DTD>*ZY+;
M<C)5&0VI3@2$DCD<\:\M54AB#"_J&>@[D?E <*X!ZRO3'FG+#E@:>+@&,<W<
M=7>365TEUMARDIZZOR&0Y=7;$ASRG8<3SI33J5H6A*D+"8KMMOE4ES>D49N)
MK,&CN7?4T^G7@.>2.,<U]<GI1Q?/H4T5EGC%USSQK!L::T+KC/X7?![(TL4%
MHAQO94::MA] 4@J2 M!5K=VTG1RC7TBC-TJBWJ;^KKKRALZZ[I;>%&LJFXJ)
ML:RJ[2NF-(D0Y]=80W7HDV%*8<2MMUI:D.(4"DD'?6S/(&&.=/5)Z:_3%4U]
MYZC.?>'N#*NW5(12R>5N1L3P0WSL0-F4Q01\CM:^5>R8Z74E;41#SB0H$@#6
M,IQAC)I 3\$^JWTQ^J"NL+7TX^H+AKG.%4*2BZ5Q5R1B6<2*)Q92$-7T''K6
M?.HW70M*D(EMLJ6A:5 %*DDHSA/X6F#.-I:5E'66-W=V,"GIJ>!,M+>WM)D>
MOK*NLKX[DN?8V,^6XS%@P(,5E;KSSJTMM-I*E$ $ZR!I!7_4"]$W.#')/&G!
M/K!].O)O*=9A.;28V&\<\TX)D68O+J*"VD3)V/U=)?R+*Y:J/E%./R("7VXH
M"5+4@*03K\2W*JC)-^D49\L?[(5Z@>>N;.1O7+%YFYNY=Y<C8]A/!,B@C\G<
MDYGGK%&_8WO)[=@]3LY5=6S=8].;B-)>4R$%T-("B0D;<312E)RYFWD92/L'
MYY]67I@]+=?6V?J/]0G#7!D6Z44T8Y3Y&Q3"9=\I+J6G4T%=?6D*QO%1U*W=
M$1I[RD)4M?:A*E#FRG"'Q-(QH/O"GJ+X!]2>-/YCZ>^;.*>;\7B/1XUA>\49
M_BV?5U5-E,?,LUUQ(QBTLTT]H602J+*\F0@I(4@%) 1E&2K%IH$]S7.,*XVQ
M6ZSKD7,,7P'"<;B?/Y%F.:Y!4XKBM!!\UMCYVZR&]EP*FJB>>\A'F/O-H[U@
M;[D:K:2J\$#C]Z[/7[Z9.<?IO?4&LO2!ZO>)>1.1N.O2QR]D:7N#.9L>L^0,
M,=@XM*^1RF*UB5]^M%)&8G/-ICV;26V?F/A;=\Q) TW+D)6I<DDVD\F5+'$Y
MZ?LD_,?+O-'HO]25]S%RIR/RQ>57J?>J*NYY+SC)\[M:VJ'%/'DP5D"QRFTM
M9D.O$R4Z[Y+:TM^8XI7;W*).K1RE*VW)MNI99GU::YAB&@#0!H T : - &@#
M0!H#0KZB7_ IB_\ E2I/[T\VUP];_*7[WU,RCF= Z#_8*E_\Y-=_WFSKC+(Y
M@[:H#0!H T : - &@#0'QU_M)-YS3D7KW^CQZ;>,O45S=Z?<<]3G*$[A[-KK
MAOD/*\+F(A\@\S\$X$,A>K\?NZB!>6N.0,HD.PTR^]"5DIW"5JWU7*\R2XFN
M>:1G]?[-IR@4J"/K3_4I2LI(0I?)>0K2E6Q[2I SMLK2#X@*22/:-7PWVLO(
M^UFOGH7YR]>GTQ/K+8;]);U=^JC-O6MP;ZF>+YF?\$\H\F3;N\S[%EMU7(EM
MC=J]8Y-?9;E53"FV?%=YCMA3.VMC!;<3#FQ51F@\VY$W&7*W5$3<9<KQ1W&]
M0/IZH<S^I?Z1>=Y?K_MN';OC;![FIK_0U'SB'55?J,:E(Y'"LJF8:[R/22[]
MRL_'%D.HQ^T"?P1/Z1/EGRLVO>3KZC-K&M3F#RUS%RG5_M5'IMXD:Y3S^NX<
MG^B/(<DNN,F\XR*)QG-N(^%^H"5^/VF%IM&\6DV3#E7'<^:=C*=2J.VKN!;2
M1BW_ !*<*&/W_4?0/QGZOO29S3EUCQ_PYZH?3MRSGE.J4BWPGC/FOC7/,NJU
M00Z9J;'&\6R:UN8*H8CN%T.LI+?8KNVV.V=4\C.J-B=4&JUEZZO1'3<@KXEM
M_6-Z5JKE1NS52KXSLO4+Q)!Y!1<IE.0E5*\,E9<UD:;-,QI3)8,;S0ZDI[>X
M$:E5E5"J-J=4&L_)WK2]'/">71^/^9O5EZ9^(\\EJCHBX3R=SOQ;@67253!&
M,1,?&\JRJJN7E2A,9+82R>_S4;;]R=Y5+-BJ-@Z.]I,GIZS(<;N*K(:"ZA1[
M*FO*.PB6U/;5TMM+T6?66<!Z1"GPI+2@IMUI:VUI(()&J#&/,7J*]/OIWJH%
M[Z@.=>'.#*2T><CUESS%R=A/&558OM+8;=8@6.:W=)$EO-KE-)4EM:E N)!'
MQ#>-I9BJ68^\7\P<2<WXLQG'"W*7'7+V%27C'C9AQ?FV,Y_BTA]+33ZF&,@Q
M2SMJEUY+$AM92EXJ"%I.VQ&]33R%4\BJRY>XGIN1Z#AVWY/X\JN7<KJ7K_%N
M+++-<:@\CY+11FKI^1=4&#RK-K)KFI88QJQ6N3'BN,I17R25 ,.]JJRX@QY@
MOJ[])_*'(=GQ%QIZG_3QR)RQ2N3FKCC#!>:N-LMY#J7:MMYVS;L\*H,EL,D@
M.5S49Q3X=C(+*6U%>P2=I59<15%GDGUA^D?AK-X'&?+_ *I?3GQ3R/:LQ9%7
MQ_R3S=QG@V;V3$[;Y)^!BF49/5WTQF9W#RE-QU)<W^$G2J6;%4;$M.M/M-OL
M.-O,O-H=9>:6EQIUIQ(6VXVX@E#C;B""""00=QJ@UQY8]9?I X%R2-AW.?JL
M]-O"^736V'8>*\L<Y\8<=9)+:E(:<C.QJ/,,HI[-]N0A]"D*2T0L+21ON-1M
M+-BJ1GC',DQW,**KRC$;^ERG&KR(W84N18Y:P;NBMX#V_DS:NVK'Y4"PB.['
MM<:<6A7L.J!ZT : - &@#0!H T : - <T_0O_L]ZB_\ ?_#_ ._,KUNT7W_2
MOK.)/,Z$:YQ@&@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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MXTS;E:G&78DG\;M,<CU-9.JC(9:LC6?++72RH3DI;;,P1H["XRFBI*TM,-!
M6"0E.4;<L<$R79PM2I+!2Q]?$@\K"^6X+R8\OCS+T/.J\MGS,2O-WU@I!#"F
MXH;?.ZP/@[AN1K6[BKFC7S6G]Y>U"V-QGS/8 EK!,DAH]KEC3N4S:>H3\3MR
MF(V@$GH21O[-8NZNU$\2TN*^7H)W0^FGD*]*#?9-AF,QE*_3(LLK@SY*4;@$
MLQ*1R?%<<^Q3S8('WO#>J[ADWZ@[\8K!2?J-O>,?2CQUB3L6[N)BL]M6%H?B
MO2VVF*!AYL]R'6*EA^4B4M"O_7AY]'0$(21OK5.])X+!'%N:FY+W5[J^<5>M
M+_BT<E?^2=_?_BNN#JOY$O5]*./',XJ9?RAG.=5>+T61Y!.EX_A=#58[C./H
M?>:I:F!4P68+;L>N#AC_ (A,#/F2)"@777%'J$!"$]CH;5NWIXRBES2BFWQQ
M.]TT(QM)I8M8G2/Z9/-^>?XQIO#=M<3[O"+#&;.XJH5E*?E_JM9U#D,I-0Z^
MMPPJNP8D+;=BIV:+Y;<0$J\SS.)NFGM^%X\4E<3Q[Z]IIUMN/)XB^*OM-#>?
MN;,ZYPY"O\DS&SLC&1:V#-!C4AYY%=BM4W)=;B54*N*_(C/QV$A,AP)\U]X*
M6X2HZ[#3V+=BVHP2K3%]IRK5N-J"C'_2=$OIG\^9W)M\SXFR&?:9-BE%@UAF
MV-MRWW9TR@?I[*GK7Z2M>?*W6ZRW1<)+<?N\IF0T/*0DO.$];NFGMI1O124W
M*C[\\?F.)K+4:*:PDW0YG\N\Q9YS;F-EF6=W<RRERY+ZZZM5(=-1CU>M>\>H
MHX!5\O @QF@E/P)"WE@N.E;JEK5VEFS;L04+:HOI])S(6XVX\L5@=0OIY^HS
M/#AO,>*Y1+L\OJ.-,&EY]BKEE)D2YD(5T>9\UBR;&0XZ\J%/+#2X;/\ I'8]
MV?"0E/5;CIK?/"<*1<I4?V_:<+5V8\T9+!R=']IRKY&Y1SOE?*IN8YWD=C>W
M4R2](:7(DO&)5-NN^:B!20BX6*FNC$ -,LA*$A(\3N3VUJU;LPY+:2C\LSFP
MA&$>6*HCK%Z(_5!R$G@3U )R9Z=F<C@_#U9=A\^W>D3I2V9%+D<AC&[2:MP2
MGJN#,QX.M*4M;S<9QY(/ELM(3U&NTMO\Q;Y/=5R5'3TK'YS@ZFS#Q84PYG1_
M:<C\QY!S;/\ )I68YCD]Q?Y+*D_-JM9TQU<B.X'?.:1 2A2&JV-%7MY+,=+;
M3*0 A*0 -=Q"W"W'D@DHG/C&,5RQ5$=>_2[ZJ^3$^DCG+(+Z5)RO)>&(4=O$
M;RV+EC/E,WT5YNN:N'GU*>MF\9FM*?<<<47%1"E"CL@'73:O26OSEN,<(SS7
MH^BOTG O6(>/%+",L_EWG'G(<SRW+,CDY=DN1W-UD\N5\X]>V%A)?LOF ZIY
MM3,E3G?&0PM7Z)#?8AH;! 2 !KNHPA"/)%)0[#L%&,5RQ5(G8_ASU:<H_P"8
MQRKGUE*?O,\XNLH>'4&4V*$SI4R/>2<8KJZVM52$.)L[3&AD16XX\'/F$MLE
M_O4MQ2^EOZ.U^?A;6%N:JUZ*_30Z^Y8A^9C%81EC3Y=IQLL<ORNWR)W+[/);
MV?E3TP6#F22K:<]>*G!7>F6+1;YFI?0K[J@L%/LVUW2A",>1)<G9P.P48I<J
M2Y3LICOJTY4_]!_Y!R.]*E/\C464#BV#F,MI+TI]AYRC4C+G_,+B9EE#J[E4
M02%CX[!I+K@6KN"^EEH[7]15K_A-<U/;A\WL.O=B'YI0^XU6GU'&L9?E@R(9
M>,GR#];!,%A^LYN;$Y!\^%=_SIN3)-B97=U\PN=^_MUW7)#EY*+D[*8>P[#E
MC3EHN7L,E>I*!S)24_%'U,<$J$<@7^55\7TX^ICC)L?AUQR1$P^1?S,'Y;QN
M8AI<3]:*^AIA62VRC9UR,VEAM7G/!OV/Y:=;:?IO57-EUKY=&VYPDW@N:G-!
M]F/O1>6,E*F#/D3]0ODMN/6.I74?3-MW=PA:2NV8_')1PC<@F_?:B^24%[SC
M&#@I--#!Q]]07TRYQ81<>M\ML>*LQD>4AW$N7*.?A$^'(</8(\BVG(<Q9+I=
M^!*?G^Y9\!KZ3T6_[5KH*=B[&DLL53_$JQ^<^"=UZ6W[9K\M-N&FNV[\,XRC
M*,EZ822FO7$W5:=:?:;?8<;>9>;0ZR\TM+C3K3B0MMQMQ!*%MK00002"#N-=
MQGBLCQ_+!Y@X=DG64<S7<> P3%=#[NO_ $-=E86)TVKEP(78KV!_J^W7?:6)
MXGKIYF/K1S[_ .Y^Y_T->2:2.1X3N4\&8SMW/O?G/_0&O*]%$\ W.>9BNY=^
M]]N^O,-##(]<;K<P9B*[=^_U]_\ 5X_U=-=R>)FH_+O)D_";G%ZF+AUKDWZU
M2GJ^*[626VWA9A;*(E7%BJCNF;8S_._0M%;2G".U'>K<#UIYA=>V^AXZ>[K-
M+<N[?>4^:ZIJ*MN-'1IIIMIN6+@J)M-T=/=OD[Y2ZGS4O:G1[5K;=K>[,K:M
M:=VY3G>\1M)QI)-+F2A[L;C<I132<H\V-966W]U+;JZSB?F*5>R'6V&J%OCZ
MW5:*??6&F6_(0%C=Q\E ZD]P/3W^L-9YX="W-,]3&].CX-VEP_%XO+[&_0>_
M-N_2CYQ6M=^0GMTW<6;5K4OBU\'Y?GX<8I<*YTR3>>D'U>0;MJES_CVJX+>?
M@Q;5$'D2P$_)W*R:7$QI:*2@,TP7G%-+!CSOEG$E!WVZ=WIC?OU%:&<FMEM1
MG'*JK/']Y^'%>I3])]6= _H5ZIW*S'4]0WEIK?\ [22MMKC2W!7KC?[\K->S
M*L7O/2OZCZ%Z"G'8&/\ +RY\R+ 9H,1;FP,O?ES'D1HS%753&PS:.OR'4H;9
M96])=60E+?7?7!V3]04+E_DW>U&-GM:Y:+NG%M+M]Z%/VD=[UK^AC?-LT#U?
M3>H6JN16,82;EZ7;N1@Y+A_#NN7_ +-FO69V=KBLVYPC)\3S;#>1XZ%UBL"R
MO$KZ@R^+;S&RS$AR:6?!:F1Y"G7$D(6D+4/ $D#7MJ]YC=-:W9+VKT5_^)*S
M+D5*JKBTGSQYK=$\6^?!+U'RM8\G>MMNZGT^U[CHY*FHASK%2HI*L?"FHWG*
M5.6,?#JY.G>?27]*W/>0_3O9^GGBR'-LTT.3NXKB.;X0N2Z[4"VS26RW9V8@
M]RXT>TH;VV5(^::2EU:&5H4HMN+2?@'JJY9W/7ZK6JC3G)QEVQCA'U.*6!^X
M/0_3\NG^A-MV?40\/5V-'!W%QC=DO$NQ_P#B2DGVO$V+^H/S?G.:<X9;QR];
M6-?@>"2H-168RQ(>CU]A,371)LR_M([:PU8RY<J6KY9;@*6H@;" %*<4OI]N
ML6X6%=HG<EQ^KY<3R_26XQM*?WGQ+/T_>;\\PKG##^/(MQ/GX)G<Z33VV,2Y
M3[];"D+@RY46^JH[BU,UD^))CI+[C:4A^-WI<!(;4W=QT]NY8E<HE<CC7ZAJ
MK<96G)_$N)&O7/S;G/)'.>>8I:V5G#P[ <FLL5Q[%0^ZS5MFBD*KI-X]#04,
MS)UU*CKDH?<2I:6'$-I(0D:RT%BW:T\9I+GDJM^GAZC+36XPM*2^)JM3)_TX
M.;\YQ[FBBXC7:6%G@6;QL@2Y22Y+LB'C]G44%ED#-Y5-.J4F IQ-26)26RAM
MUIWO6%*:;VU;G8MRL.]2ER-/75TI\YKU=J,K;N??1@?U@\UYYROS1GD#([:>
MC',.R_(<8Q?%4R'6ZBGA4%K,J42?P])2PNXGB,7)4A:5/*6KL[@TAM">1HK%
MNS8BXI<THIM]M?J-NGMQMVURYM8LVC^F;S;G47E%7#EA:VEU@M[CUO/@5TQY
MZ9'Q2TI&43&IM>X^XO\ "ZR;&2Y'>9;V:<D.LJV"@2KB;I8MNUXR25Q/VU-.
MLMQ</$7Q)^TTO]2'-N=\U<FY3;Y9:V9K(606L3',6>DO"JQBKARWX<*#%KMT
M16IR(K:1)?#:79#W<M9Z[#G::Q;L6DH)5IB^TY%JW&W!*.=,^TWW^F5SKG+V
M4Y7Q)?V5QDF(0\*GYA11Y3[ME*QR726%3 >KZDR5EQBLMV;4 1PL,HE-H+:4
MJ>=*NOW33V^17HI*?-1]]?LH<766H\JFJ*5:'-_F+F?.^<,RM<QS>YFS7)DV
M2]54RI;SE/C5<ZZI46GI(2B&(L2&QVH[@D./*!<=4MQ2E'LK-BW8@H6UZ^+[
MV<RW;C;CRQ1TY^G5ZBL]=H^5\*RF;:9C1\?X),S[&$SY3\VTA&K/D2<7AS9!
M??7#LPMLQ6"2F.MM?EC99 ZO<M-;YH3A2,I2H_M^TX6KLQK&4<&W1_:<L>3.
M4\YY=RRQS/.[^==6\Z2\^RAZ0Z8-1'=<[VZVEA%:F*RMBI"4MM-!(V3NKN42
MH]M:M6[,%"VJ+Z?2<V$(VX\L%1'*O,ZAJ/ZWLDRS(^:Y_!.9W^'8]E7$G+-T
M\B3B\G,**NH<7?QS,Y$QM4<X[<T]5,8D_,NI;24MAT.MO)CO=0K-NUN[EXOY
M:XX*5N?W>9434N%&JUKZZUH_SZ_5+MNNT._7[T-K_J6SZU6I7K$5[\K7A>'*
MY8Y<?%MW;<9459^]S+EJIQZUX7S?ZC:NNC0.5/3+>Y59)BLJBYSP-F/'6281
MES:VT*:N(%?FF:8==4$.:%!:&WU/GL(4#L=AYE9UVXQBHZK32G*GQ6I0<9=Z
M4I1:3[ZGYW[CTWTC?O.[LF\VK%GF=;.MM:BW>M=L)2LV;L)M9-KEQP,R8]S"
MN79U=)G7&W(/$MI=O,P:9>:-X?:4%M:NM=Z:J)E?'F7YOCT.PD+2I$6/8R($
MF:L=K#2UGMUS;>LK)0OV[EJ4L%S<K3?9S0E))]B;3?!'C^KZ?5NS/4[9K-)K
M[-M.4_!\6,XQ3^)VK]JS<<5G*5N,XP6,I)8F4)?A^[_V.N8>/$/L/NG\_P#"
M= 8]MO;^?^+0&,;?^7_9'^/0&*+KP5^0_P "M 8?O?!?Y?XSH#"M_P""_P B
MOX= 8/R#Q5^0_P !T!B>S4$K*E$)2D%2E*( 2!N223T  T;257D6,93DH03<
MVZ)+%MO))=IT,^F3F'+?&7&OJDY,P9VUQG"^:<VP#BN)F=>X_%>FR^.ZC)\C
MRJNJ9K*FEP9HAYI5*+Z"'1'ENH002LCUO'P-?N^HU4:.SS>[V.F%?1A7UH_9
M7](?3.Y;+T:UN<6G"S9@T_\ S*W+LH>FU&Y&+X5>&!N!A_(&:X#DT7,<.R>Y
MQ_)8DI,Q-M G/-R)#OG!]QNP!4INSBRE@^>Q(2ZR^DE+B5))![6=N%R/)-)Q
M/L&48R7+))HZY^M3U/\ (9]._I^7CSTS$9_..)_K-F-G2O/PG&V8=)CK\O'J
MR6E9E1X5G+R/SG.U:7?EFVD%2D.K!Z?0Z6W^9N<V*MNBKZ7C\QP=/8AXLZXJ
M+HCDMQ]R5F_%N50,SP;(;&BOH$EN1\Q%DO)9GH2X''85M&"PU9UTL;I>9>"D
M.))W&_77;W+5N[!PN).+^6!SIPC./+)51U?^H%ZD,_''7"=#BTNPPR!RQ@T7
M.\M-9*>BV3J)L&GD1L6^?:+4J/"B.3G#+0E252 6TK^#N2OJ=NTMOQ+DITDX
M2HOGQ.#I;,.>3EBXNB^TY8\5\N9YPUEU=F6"7TVJL(<J.],B(D/BKOHC3R7'
MZJ]@H<2S8UTQ(*5H6.Y._>@H<"5#M;UFW?@X7%5?1Z#FSA&Y'EDL#IU]2CU
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M*!(3N0#UU&TLP.3;C;K:'6EH<:<0EQMQM06VXVL!2%H6DE*D*2=P1T(U05Z
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M'_R[!_\ \I!QKK+0_P M_O?4)9GU^:YIB&@#0!H T : - &@#0!H#0KZB7_
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M;DU&$(IRE*4G2,8Q56Y2;226+;HB'\+^E;G?USV5!D?'^'.XKP%BV<XQ8O\
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MPFG/ELUR1AL!3BT1\BNF0HI3U/:W(2E2NT;;G5>EHJ^[\O45V8\4AZP2J9Y
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M/=N -M2BSX@>=4A"*7"&JJT<N9F1Y1?SUEPH%M;+,"/YG<D^160FXD%(2A9
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M@+F7X-A/(52FAS[#L6SBC1+9L$4V7X_4Y+4HGQT/-1YJ:ZZB38:9;#<AQ*'
MCO2E:@" 3N ^NU\!^ Y5/PHCU8]$77O5SL9ER [ <9,9R$Y#6@QUQ%QR6RV4
ME!0>TC;IH!EQ/"\.P*G1CV"XGC.%T#<A^4W1XG15>.4[<J4H*DR45E/%APDR
M)"D@K6$=RR.I.@,?<D>G#T\<R6<&[Y>X&X8Y4N:QD1ZVWY(XNP?.+.O82KO#
M$&?D]':2HC(7U"6UI3OUVU*)YBB,J4U+38Y4UU#CU364-'41&:^IIJ:!%JZF
ML@1D!N/"KJZ"TQ#A1([:0E#;:$H0D;  :H'/0!H T : - &@#0!H T!S3]"_
M^SWJ+_W_ ,/_ +\RO6[1??\ 2OK.)/,Z$:YQ@&@#0!H T : - &@#0!H (!&
MQ&X/B#U&@*0A">J4I!^P : JT : H6TVOJM"5$>TCK^[XZ43!4$A(V2  /
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MW&H3,U+'9RQ@%2X\7750ZV\:D6%>P5J6BK2B2]^EF$GZ^\INK'U!M:L:E_\
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MZ9?2G6^MVV$>717)^-9X+PKM9)1[H2YK7I@S+6NP/7P: - &@#0!H T : -
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MUDIP>30JF7]9%*5*"?'Q]VHVEF"R93"3LXXVV?\ 1N(3_"1J*286)29T,?\
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MU=V=R:]=B&F?KRPJ]][#GWF&S26X<^OQ^,K8!BGIZZ.AI(ZA+3MDBPG-#?\
MFN ^S?;?7LF.BM?>JWWO_0?GVM/96=6_20.QR7D&[*OQC-,@EH7ONP]=V;D<
M!7WDIBA]$5"5>T)2 =;HZ>U'*,5ZC-0M1^&*]A%W*EH*4[)F[K42I;C@2%*4
M>I45N.**B3[?$ZV\B1G7L0B<:K6^@D/O*]S:4 ?]<I('[F^I1%K(>Z#!\KR]
MSLQ;&KJT;"_+7)8CJ<ALK)  D6*VF($;Q_TQ:0-:YW+</B:1)7(0^-I&::_T
MY)JFVIO)F:TV*L%*7#50'A;W;@VW4T CLC(6D_RF/FT_9K0]0Y868N7?DOE[
M#2]2WA:BW]!,J^RXJPE26L!P09!;H^%O(LO'XE)+@^X[%A=G8VKXB.YAJ&O;
MQWU/"O7/YLJ+L7R^TP:O7/YDJ1[%\OM*[.9GF:'?(+9Z- 44E,!/Z",E .Z4
MIKHQ0A9;'@7B5CWG6V%JW;^%8F<+48Y(55V-5=?VK#/S+X_TZ3LX0?>AO;RT
M=? [=WVZV&Q)$@U#(- >>'4Z 8)^35,'N27_ )EX=/*B[.]?<IS<-)V/C\6X
M]VJ8U0CKJ_,\Y[OPF'^&TR>[YFSD.&+ :;2?TBGK!U*2Z&Q]Y#*20#\0VZZU
MSNPM_$\>SB:YW8QP>?8([GD# ^(HLB%ATF+FW(#S+C#F1(2V_0X^IP=BQ#(6
MXQ+E(!Z):4XDG?S'-MV3IY;FH^/W;79Q9C&U<O8S]VWV<6:5YO.E6M7>VEH_
M*GV<Y]B3)FRGBX\X\[81E.O/*4DJ6I9.WB /W!K1N4(QT$U')<O^TBZJ*CIV
MEDJ?2CJOP-"F,Y#Z,;2.\\*S(^ >1<2R>)WJ^4>J<5CXIE%8Y):5VM=IR/)H
MP"QNKN0!T UTD'_RDE]Y.#7KJG\R.%'^0UQ7*UZ\/H1D3@)FZ/%QN,C?7(R#
M,.3N8<MO2XHJ6S;N9Y98K-CD*4HM);7B(*4;[)20!TUR)\OBM1^%1BEZ*5^L
MV3IST6227S5^LD=-'F->JG%ID1QYR%>^G>TAW%8\ZXFK?G8CRS D8Y.D$I=$
M=PR\H$<+ ^$+6 /TBPK5=_R\EQ5SUXQQ^@PG_)?:I_2L2+>G%FR9X#XS=NY,
MJ9>W4?+\IO94TI,IZXR3/LHGS/F E2BB0D=@=2K9P/=_<E"MT)W7*>-/E^%-
M)>A11LG3Q)4RP7S(>H#605OJ&SN;4//KB9!Z6Z/(F(Z"E?E9UB.=W>,8GY47
ML=2Z^8;,E3*EE/<7'$A*ME%.F=/!2?"ZUZG%-F$J>&EV3^9JK$W L(UW!'#<
M53[\IUW X=U)E2777WY$S++2VS"8XZ\\2XZKYJ_6-R3X;;G;?6Z>-V;_ &OH
MHOJ,IXW)/O\ HP^H:)OZTT?(?JTLZ.1(<-KZ=\0SVE0TMPFNY J.-LVP_'EP
MD^8V&)\YK#G'=VQNOR6]U H UK?*X6XOA<:?[KDF_I)@XP3_ !M>JJ?UDWXP
MJ10\4<34H<+Q@<7X&MUTE:O,E6F-U]W-4E3GQEH3+-P(WVV0 -AX:R;YISEV
MSE]-/J#=92?[3^FAB;(59/CL7U^.4LF9\L,1P;-,:V<<+E9:Y;PW=KY!EPE'
MM6Q(C54)MX+1_1MLLJ"MT](N5NPG^)I^A37+\Y51NTGVM/U2P,^4%2,>Q;"\
M:0L.MXQ@N$8TTZ#W!U%#BE15!T*_E!WY7NW^W2+YJR[9-^UMF-:U?:V_:S6/
M.AD55Q3Z]X5)*FN=_(1M*4//K;1":Y/B8#;\AQ(LEY*Q'B)IKYSSD$H:0THJ
M44!2EZL.5W;%<N6C_N\RC\Z,HT<[5>SZ*T-OGXJ**<U61UJ>:QU,&FCNN[A;
M[>/QX]8RZ[NI9[WD0@I74]3K"'O6ZOBJ^W$PCC&O;]9IOEE/D3? ?JEP]BPG
M(A/>J:[QFIL&G1\U#PG.L^XNGW5>UV(6$0F9N2J1(6DE+CLJ0A20"M.MD)1\
M>U*G_"3?I2E3Z/H-D6O%A+]A/UI,W8>DIC90J4P@I;BW@=8;)6M26XLT%E*E
M.E2UJ"&P"5'<GQUJ2K9Y7^'ZC52L*=QI(G&\G' [/%KDV5^'H]:C7#WXBVZ]
MWJX[3S(Y%/>^'!(37IS4 )':!W;)[? ZV\T?'\7_ -CS?WN7[#;S+Q/$_P#9
MU]=/L-V&G6YF2)=D(4IF;<GYAM!6A9:F3"EY*"WLM*^QT]O;U!\-:FJ6J+A'
MZC6U2%.XTKQ"GR=[@7TJ8A*FR7(+'J=IL;NYY<_MB=AN YYRC845>\K9*Q >
MF8N4,*4E(#D6.D; )!VS<?'NR_\ 9-KTN,:_3\[-DFO$G+]AOUM+[3<),!O)
M'Y=-+4M#.3Q[.AE.-$I6TUD<.35/NME.Q2MI$XJ21X$:US]V%5]W'V8FMX1K
MV?4<9O5YP+REZ@O2;Z&,CXG3"_SBN-9^4Y-QK=W;[<5V<K%<:O[>%Q[(E2T-
MLJKL]PS!FHC3+K[+4IZ+%0X2TI:D>;=%=3/I?J">JE)K1RE%2IC1U5)TX\KD
M^9?AE+B>IO.GRYM>8G2U_1V8I[OIN:=CAS<R2N6J\/$23B\$KD8-M),P9PGS
MYCG.N*S+"'#G8QFV+S7,>Y*XXOV78&58!ET);L:RIKBME(9F-L"9&>$=Y3:0
MZEM25!#S;S3?W=T_NNDWG21U6DDFFE5)ITJJIX9Q><9+!KOJE^/'5FQ[AT[K
MKFW[A"<+D92C[R<76+HTT\8RB\)1>,7W4;AG-WJ"X[X:=IZW)Y%Q:9-D:);M
M!A>(T\K)<NMHL%MQV=.CT\'93,"(TRXI3[ZVFR&UA)44* [G<NH]GZ<L*_NM
MU035:85IVNK22[Y-+@L3QK:.D.H>L-4]'L-B5VY6G&G,\5%))RE)_ABI.F+2
M1K1B?KF].O(<L5L?+I.)V<AQ+4:'G%:YCZ)"EJ*4E%KYDNA:[E$ )=EMK5W#
M9)Z[<_IWS$Z0WAJ.FU<(MNBYFE%O]].4%Z'),Z7K'RC\P>G%)Z_;[KI'F:@I
M.:6=?#DHW6N]0:[S,=G*:D,ID1W6WV'VD.LO,N)<:>:=2%MNM.()0XVXA6Z5
M D$'<:]R[>HSC&46G%JJ:R:X4/G'=W*W*4)IJ<6TT\&FL&GV-<3$.3SXT"),
MG37VXT.%'?ERI+R@AF/%C-J>??=6>B6VFD%2C[ ->0W+MK3:>5^_)0LVX.4I
M/!*,55M]R2JSPB%B_K=9'2Z6$KFINW(PA%*KE*348Q2XMMI)=IT@^C3CN8L<
M)<+7%X9,3#E<0\_\@8#4O)\M47]>O4=887/2I!45OID5M<U+\YSXU-/,$;H4
MA6OQJ\RM5IM7U;K+FF5%*]"N-:4ASI>I-1]*=<3^GG]/&@UFW>4>VZ?6OFO.
M4W6E*Q4I*M.R4HRDNZ6&%#IWZDFK \#\@SZ61,AY#C;N$9;C4R 5_-,7]#R#
MBZH"FDM_$MPB6OR_:E[L4-]MCX/;IXT.;X75/T.+/=]O^9%/)U3]C)G=0I:O
M5;G5@MU2*FB]/M+2X] 0^#%4G+>6;.QNK)$=096)"+'$UQUJ;#J.U+86L$-H
M&FTZZ>*?Q.Y5^J.'TFN/\F/;S8^I?VD8Y[9N?\6D:VQV0ZQ?XERKPWE=*&5]
MCLFT;SF#BL.(C;=:_-<RW<I2E?<E)!21OK;'E\2DOA<9)^ROU&<:<^.3BU\U
M?J'N+"DO>I#GJS>>D&NQ[CWA+$\9C%;WRC51DZLHRBR<BMA7D%"<BQV2._;?
MO<6 =R=]<7_!MK[SE-OU47T,Q7\N"XMR;]6'T,;^78MPN+PW;X^ZXW<XWZD^
M(7H[;:BE,Z!DLFXQ.YK) 3V=T6?"M0A[N6A'RY=!4 3ODJ5DI9.U+YJ-%5*R
M3R<'\V(HQ2'8?XY?4U<SGWEQQ:<)XECL9:E_+P\;JN.9-^RN(CO<:\JQE7_G
MDI4=GE/'H5J&HFO#MKC2;?IYJ?4/NP7'WGZZEGDF%-&5>FR_K7I#,NL]0$'&
M):6%NI#^.9UA.3?K2AY (:<932XHX%@A1"%GIL2#:X7$^-NOK35/G864U^Q7
MUIX?25<<QK9>7^I.]N'5E^QYNB8O!C*62F+CV!X#1*QCR&R=FX[]+E[2D=O1
M6Q/CUTPI;2X6Z^MR=?G0=*02_#\[>/T'N7QY'^./TP6<5^2T$9%S+C%S'9[E
M1Y^.WO&K5Q.3,1LI):@.8P'@?Y*NU?WD)(/^7<[:1:]*E3ZQ]R?H7MK_ &EG
MB:/9)?YYM+EUURTN_4YRLV6UO!YJ%3XPB@Q_'(4=12AY3#-6T TI:&BJ,&2E
M 3L5,/<IDK4?:ZMAT]U++D7SU'&SB3T>H;T[6D9]8J;C%N=L.RV*5A+2J2IH
MZ'+:QYQ "R\T<EFQ@KN "'&V^I*@#C)TM7%]Y.#7IJT_F(_Y<^VL6OH^@9."
MXUBWA.4V=T])?O,IYPYIR2Z,M3RG6;%O*6L07#[75*2RB*QB#:4M(V2V.@ U
MLE3G2C\*A!+V5^LRE3FHLE%+Z_K)- A3V_5+QA9-NK739%P=E>.Y+#*NZ*(F
M&<DU=U2SGF%+:92XFYS9J.EW=:TI=6  %$G5<:5B:7Q*::]<6G\R,)?RI+CS
M5]J_L(CZ<HUPSP;@\[(GY$C),GL,^S#)')*W%O?CEUR#DL:<APNJ4L.I%6CS
M!N1YI5U.^YW7.7QI<OPJB7H45]ILG3Q'3)47S(?JF/=UWJ6OY]'Y[S.0>EF)
M<FO6'78CV>8?RD[28:YY3G<PMUV')>;:0$GJM_\ G*WTW*>!1YJZ_8XU?R]!
MA*GA4?"?S-8C?Z?X3]=P%PY&E3'K"3+P][))4R0Z7WY$S-<EO\SEK>>42MUT
M/7Q2HJW5W).^YW)W3:=Z;7XJ>Q)?493QN2??]"2$S:[VEY9]2MC0/RUOV/IR
MPS,JR/W.!B+G>/8QFV)8R[&6EB0J/+>8QQ2DE"%*7U/:OL2!JE1VX)_^:T_W
M6TW])BZ.$4_QM>IM-D@X>K4T_#'#5:AQ3WE<5X/8+=4M+G<]D='%RF0E*T$H
M6AI^[4A)!(*4@[G6R3K<F_VW\SI]1E)UG)_M/YL/J-"_7+Z5I?J>P#UDXBC)
MK''9N%KX']3G%=M'2J0W1\IXEQ/FD.RCNQV%(>7&O,=KYC3[C2@_$;^5?"'2
MVEMWCWK?BV[,(/EN*<DG_>5'\_TGA?7O2%CK?IS^B7)1A=<W*#DJQYES1I-9
MN,HSE%TQ7-6CI1Z/>DSG7DG-Y_(W"//V/1\:Y_X,F4]=F0AAM%=EE->1%3,?
MS"N99 CM)M8 ;><\G^UG6Y+$AD-H?#+7FFP[M<W"W.SJ4EJ[5$VLI+&C[GAC
MPXK.B_%3SK\J[WECU$])!26BN7)Q4&^9VIPHW!2^_"49*=J3Q<<'5KFEMW+\
M/W?^QUWYZ6(?8?=/Y_X3H#'MM[?S_P 6@,8V_P#+_LC_ !Z Q1=>"OR'^!6@
M,/WO@O\ +_&= :AY5R4FXRR!QAQ716_*O+&163=!CV%8? E7,N3>2GO(CPWC
M ;=+KJ'C^D99[W4]I"_*&ZQX_N74.DT7-:L_Q=6J^ZLD_P!I]W%*KX.F9[BZ
M \ENK.M]78?@7;&VW6FGRMW;D<_X5KXG58J<TH)>\G)*C^F#Z4WH7N/2GQ-?
M,\JO1I'-7J"NF[/E1RN<B2DX[ EPI]/18=&LHRW8]BY0M7LV2\\VHL"9.=;:
M*FVT.+\*C&XHSOWG743;E)]^9^R/E/Y?VO+WI>.WN,8:R48<T8T:MPMQY;=K
MF7Q<JJY2XRE+-8O/^#PLJM.(_0C4W$AX&/RZB9D#J77PU,8XJF\E7/'D1^0%
MJ>>C/TF,]S#3B0@AAL[([ $\FXXJ[?:RY,/[W*I?.SVM*GB7:?A^FE3:.ZJF
MLBH,KQ^2HI9R;$,QQV0XDK2I#60XS;4[KJ2ULM"FT3BH$;;;;ZQD^5*2X-/V
M-,PK2C[&G[&:\8DK)\AI?0 ;&7*,%%+FN99*\ZLE^=:8'Q+'=X_^9*]S)=?J
M7Y&REDJ4TMU>^^XU9<L97TNU)?WI>]\YDZ)W5WI+UO$S%R56M7/%O*]0\M;2
M+'B[D%I+K9/<T_&Q2UL(BR!]]H3(;?F)W'<WN-QOOJITG&2X3C]*(G247^TO
MI( R]?W.8^BFPNI<]19X+S3-KM#BG$&USN7PWA%!/>M$^6@JF16<G\X[J*@7
M5@@!:N[%**C>BO\ S$EZ.=OZ@J)7$OQI>KF?V$FYNKU6O!W,\%$A<5Q/&V0W
M+4AIT,N-O8D(V9,=CI*2A;CV/)0.T]Q*MD]=M9Q=+L'^VOGP^LL<)Q?[7TX?
M6(I*+Z\YWXBGWSDI"J+TNY1FDN*5/)CKSS*+_$\/RY:T)#:%RQ$O(ZG>Y [>
MQ&X&P UPHK4DN-U+U)-KZ#%45MI<9I>I8H2>HN%.G<!<I*JY4F%;TM7C^64T
MR&M;<J-:XKF>-V\5R.II"W?F"AA:6NWKYI2=QMN-MNGC0K\+;3]#31E"BN1K
ME6GM3));0[F1ZI+FQLBIFOQWTW0V*VO0K:$W>YERO*1E$UA#3C\9;J'L?<BK
M/?OV-L="$I(TVVO 2XNY\RAA]-?:81:\)+BY_0L",^H6/8GB2?<TK\F-?X;G
MO$F74#T1;R'_ ,88Y%H<9AH;+2D!2B<I4H)4=BI(VZC6V%/%2E\+C)/T<K?U
M&<*<Z3R::^:OU&NN?-1F/J%Y,U""4QD81 \H-[!.QQ2I43T  *E$D^'77!TU
M7J/>SI]1U\Z\<S9O79MT-1X3MXZQJV"@KZ]/#?QU>4$%LK6LIXZ95K/BU\=;
MS<9MV6\AE+LA[?RF&N\@NO.=I(2G=1 )VV!UK;2S-@N2H+2E:3NE20I)ZC<*
M&X.QV(W!U0)UP83CZ)3D.*N4V=VY*X[2GT$ )!0\I!<20 !T/AJ40%6J!I?I
M8<FVAW+RYQE065LQFD6,YJ GS._N><KFGT0GY':ZI/>M"CL1_-3M*8U [:H(
MO7*S15B_^+M8NU4]Y^6%<_;2+'R]CL'U28\6-WD[=4C;[-8KFKC2@)1K($#C
MY?=2[MRL9P3)$P&)3L9VYEKK8,<I:<+?S4=F3+0J5%<V[DE"N]22#V[]-8U=
M:4P!.EK0VA3CBDH;0E2UK6H)0A"05*4I2B E*0-R3T UD!@KLLQBXF+KZK(*
M>QFMH6XJ+"L(LE[L;(#BTH9<65H05#<IW WZZE4 O,4QS)3'5?5$.T5$#@C*
ME(4I3(=[2X&RE22D.% W'MV'N&C2>8'*MJZZGAM5]5!BU\)G?RXT1E##*2H[
MK5V-@ K6KJI1W4H]22= 0[*L>S2\G1_P7-$XQ5-)3YC,2I1+G2'?%;CLIV2W
M\(\$H3VI W*NX[;1IOB">,H6VTTVXZIY:&T(6\L)2MU:4A*G5)0$H2IPC<@
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M]WN>LK*#55C4.3)<4MZ3(C+==475KVWP=8U9N@VXXFS.LC(- &@#0!H T :
M- <FOKGR9,3Z4'K*=BR'XSJL%Q*,IR.ZXRXJ--Y3P.',CJ6VI*BQ+B/K:=1]
MUQM:DJ!22-87/@9E',DWT7(D:%]+3T5,Q&&H[2^(&):VV4!"%29^17\Z:^4I
M !=E3)+CJSXJ6LD]3JP^!"69T_UD8AH T : - &@#0!H T : - &@#0!H T
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M'$A7E28KP2ZP^C?925#<'5 CL[ZDI VJXN*RJ#Q"6C8SXL+S"3V_H_F'6^\
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MSD&;F.0$I7)HL?E29SZWDG=;$^ZFN&6H>PA0B*'B%'<:R4[LU2S'EAVO[/\
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M33ZVD+)2EPI0HDME0V[ANG?VZE4\@1VXXNP2^LGKBWHA-L9"DK>D+LKAL.%
M 3W,,6#4?M  &W9MMTVVU.5,41,*ZLKZB&S7U<*- A1P0S&BM(9:1N=U*[4
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M!H T : - <E/KK_\TYZR/]YF$_\ E7./=87/@9E',FGT9O\ FN/11_D8K/\
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MAR-)CNH.RFY$5]*'6G$GQ!V(]VN9#4U^+VHY<;E?09@X"IZ^TS"[S6W0'ZG
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M$&>U*9@/OJ[FX+[';'*BE#_EA*$[K6KNVX\DUS4R=:/U_;\QLA?G%<LE7O\
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MW"%*RI,?S"HP-D7Z:1Q\-#L$OS4)*CW_ "X'Z/7,_/7*4Y%S>G#Z*^KYS?\
MF94^'WO3@;P/<4\</\4C@U=)*;XT32-TK45J6S^/L2&[!5RG*FK1R*XQ^M)O
M7%S%.ECR%*6IGR_(/EZXE;G/XU?XU:UX=E*=E,/G-%9<WB5]^OR7H-(8OTY*
M)%^'9W,<I[$DR Z8L+"RQE;\0.!1A%R1>.TD.2IHE'S05(2E0[_ER/@UROSU
MSEHH+G].'T5^69O_ #,J81][TX&[N3<4<<Y;Q>CABPHWH''L&NKH./1JZ0%6
M^,RZ?YM=9D%=.E)6F1>)D6$ER2MY)1,^;?2X '3MQ(NY"?C1?\6M6^#KFGW=
MG91&A.<9>(G[_P!/<:2TOTYZ&-D3;^0\NR+3$F)*750*;$7*S);.(E05\FN1
M-N)M52NN@]JGDF<$[$AL[C;EO6W'&D8)3[W5?15_,;WJ94PC[WIP-U>0N)>/
MN2^.&N*+FI<I<1JF*E&'FA4#/PJ30PG:ZIF5:IJUIL/[1?<9F-R5$S4NJ6M:
M7NUU/%@YVY^+!UN8UKQKG7ZNPT1<H2YT_>X]YIAB_P!.O&H.0(EYERK*O\8B
MO!T5&.8P[275RTE9*8TNQL;.PAT*' !YBV4SU[$I3L=ECE2UMUQI""4NUNJ7
MV_,;WJ)-4C&C])N1R_Q#A'->#,X#D4=W'H%*N*_@]GCT=EQ_!WH%:S3Q(L&O
MD.L,6-"NIC,QY$);K7FH8;4EQMQM*QQ;4IV9<]O&7&OWN/MKQ-$)2MRYHXOC
M7B:@X3]//%*;(XMIG?)#N7X] E(D)QFAQR31/WK;2^]N);7$VTD&HB/% #Z8
MK4EU;:BEMUM6SB>3/6W91I"*C+M;K3T+CZZ&Z6HDU2*H^TVSYQX8P[G_ !>)
MCN4NR<>GT<N1-P_)**%%?<QI4N-&B2ZM=0^Y';L,;E,0H_?%0_&<0N,VI#@V
M4E?'M2G8ES6\<*-/CZ^TU0E*TZQQ[5V_VFKG&OH!P_%LFAY#R#G/Z^UU3,1+
MAXC4X](IJ^Y<CK2[&&16LZR>D-5_F)'GQ(S"U/I^'YA ))WW-9=G'EA'EKQK
M7V+ZW[#;+43DJ15._P"PV3Y]X+Q+U$T\./DT^5CN5TCTU[',SKH+=@Y#8L7/
MF)M);5"Y4!%G1OROTS82\T_$=[E-**5N-KTV9RT[K;HXO->CC7M^DU6YRM/W
M<5V&OO$/H3Q' ,JK\PSK,&^0G**6S84F+P**34T+]C&4'H4S(IDV<Y,G18<@
M)<,%IE#;ZT!+CJFBIM>Z[JKEV/)&/*GFZU?J^TV3ORDN6*I7C]AF_P!07IYQ
M+U$PJV5=V\S%LYHF9,6HS&) 1;LRZR3*?L%T>0U*IE>N5";L)3KL=]AY#T93
M[GP/)4$#39N3T[_AI.#S67K3,+<Y6G[N,7P^PT"XCXOD<.^JA_ I-W$R)ZKQ
M:7)5:P8DF%&?%G30K!*$1Y9+Z"RF1V$GQ(W'36B5SQ=:YTI[OU'#U4N>XY4I
MD=%]<@XI05^[K_!K)1[04;G??VZR!'SOL=B =CL2-P#["0""1O\ :-:C88N&
M!Y2Y;(L9?)N1N1DR"\JOB1(<!E394"8_Z-;D<-[#;JR2!X=>NL.5US8,HG\F
M_P!@]OV==AK,$ @V_(4N];8DXA656/%U7F395ZQ*L$QT@[+#$'SF_F'3MLC8
MH3X%S^5K&LJY8#$R!K($8@Y?1V=S)HJ]V7+FPBZF6ZS6V!KXSK)(<9<LU1DP
M?,!&P <()Z D[C6/,FZ =IU14VGEFSJZZQ+/<&3.A1I?E=^W?Y?S#3G9W]HW
MVVWVU:)@N137,)1"A&$RAH%#<2*6&TMA._<E##.P0$[=0 -M, 13(N/Z'*K.
M-97:[64B-'3'35HM)4>I6 MQ9=<B,*;47G/,[5D+2%I !!VT:3%"60*^#5Q6
MH-;#C0(;">UF+$9;CL-CQ/:VTE*05'J3XD]3UT!$,HA<A39L9&*W&/TU:A"3
M(>FPWYUBZ\5*\P);6RN(EA*.WM *5D[[JVV .O 8DSB(D-Q8S<Q]$J6W'91*
MDML_+-R)"6TI??;C^8[Y"'705!'<KM!VW.V^@(E=979UULU4UN&Y%>%:6U.V
M$5$2)5MAW8]B9TU]IE;C8/Q@E 'AN>NRH)KJ@C:<QQ-=@JI3DM$;-+Z8OR/X
MI"$E4I2PV(J&B\%.2?,/;Y:=UA73;?4J@.5M45E[!>K;>#'L(+_;YD:2@+;*
MD'N0M/@I#B%#=*DD*2? Z9@;\?Q+',5;?:Q^HBU@E*2J0MD.+>>* 0A+DA];
MKZVV]SVI*NU))( ).Y)+(%[(:ZQM:QZ#57<C'Y3JD_\ A*-&8EO-M#?S&T-R
M-DH+@/WTE*T^((U:5(WP*Z*K=IJN-7OVEC<O,!9=LK5X/39"W'%.**UI2D!M
M!7VH3U[4 #<[;FHQ&[+KNTH*@S::@FY)8+DLQF*Z'W CS.]2Y$AQ#;JVHS2&
MR"H)/QJ2.@.XC=,@/%5(FRZV!*L8/X;/D1&'IE?YR9/R<AQM*G8Q?0E*'2TL
MD;@;=-5$(/F/*N&82M,:VLTJL%M><W!BLR)3H:[U-^:\J*R^EAKO0H;J_E)(
MVWUR+.ENWI)13Q[L?4B.21KMF_/S%I'>@TT9-E'D-J0L3(S\6L*%@@H>A24-
M39WN4EP-H]HW&O)]%L-*3OX=V;^Q?.S3*[P1'^+O3WR_S]8(E8UCR(]*AQ3;
MV5VS":+$Z])<*7FXCS$7^W76UGXV8+,AY).ZT@'NUS]5N&U;+#EDTKGX8XS?
MI[/3)I=AA&$[GH-U!QKZ2_2,PQ-Y8N4<M\I,M)DLXNS$CV#4601YC7E8J9*J
MVO9&X[7[F0HN]OF,H2?@'0?G-^W]N.AC^7T/XJTK_>S?H@NYOB;>6U:^+&1K
M/S%ZY>8N7K!6'8.B;A5)9)7'@8C@XDS\OMX83Y:OQ*YALMV/RW:2'1&1"AH:
M5VO=X'>>\VWI?0:&'YC44N7(YSG103[D\*]E>:5<NPPE>G/"."[B+<9^D;-\
MQ?:FYQ)=QVM4I*U8]1OL2KUY"OB[;G(MWJJE"A]YJ()+RAU1(;4-M<K6;[I-
M*N73+Q+GXI54?[L<Y>F5%VQ8C9;QD='..N#,(X[KD0*BF@0FMT./L0FUCYM]
M*0GYFTL'E+L[J9L.KLAQ2E#H=QKQ#6;IJM9/FNR;?"O!=B645W)&]1451&9V
MVVV4):9;0TT@=J&VT)0A"1X)2A("4C[!KK6VW5YE*] &@#0!H T : - &@#0
M!H!--A1+*'+KI\=J7!GQ9$*;%?2%LR8DII;$B.\@]%M/,N%*A[0=8RC&<7"2
MK%JC7:F;]-J=1HM3;UFDG*WJK4XSA*+HXSBU*,D^#32:?:C@QR;CF2>FKFU3
M-0^\R]CMK$R;#K-Y)*+"D>>4] +P)VDMA*'(4M/1+BVG4[=IZ^J];8O;+N=+
M;=824H/MCP^Q^AGZM]$;SLOG5Y8JYN$(RMZS3STVLM)XV[R25RGX75QO6GG&
M,K;KS([;<:9_2\H8/CV<4*P85Y!0^[&*PMZML&B6+*KDD ?VQ73FUM*.VR^T
M*3NE22?9FBU=O7:6&JM?#)9=CXI^AX'YC];=);ET-U1K.E]U7_,Z6ZXJ5**Y
M;?O6[L?V;D'&26:KRNDDTIUKE'BH: - &@#0!H T : - &@#0!H T!$\QP+!
M>1*QBDY PO$\ZIHL]JTC5&8XY3Y/61[-B/*B,V+$"[ASHK,]F+.>:2\E <2V
M\M(.RU QI/,"N#B.*5F,IPNMQC'J_#D5K],C$X-+6Q,913RFW6952FA8C-U:
M:V2R^M#C :\I:5J!203I14IP TX7QGQOQNU8,<=\?81@3-LY'=M6<+Q2AQ9J
MS=B)>1$<L&Z.!!1,<BHD.!LN!10%J VW.Y)+)4 DC<1\4P\R5R-$XQX]B\A+
M?E2EYW&PO&V,R5*G0GJV;)5D[5:F[4_,KI#D=U9?[G&5J0HE*B"Y56M%4%&6
M</<29[<1,ASKBWCG-+^OB1X$"\RS",9R.XA08DJ3.BPHEG<5DR;&B1ILQYYM
MM"TH0ZZM8 4I1)QB\6E4&1=4&,,MX2X8SZV-_G?$7&&:WIC,PC=9;@.*9';&
M'&*S'B&QN*F9,^68+JNQOO[4]QV W.HXQ>+2J!7E7$/$V=V-=;YQQ?QWF5M4
M1FH53:95A6-9#8UD-A]<IF)73;>LF2849F2XIQ+;:DH2M14!N2='&+S2!D35
M!C:-PSP_#RY7($3BGC6+GBY\JU7FT;!<78RY5G.0\W-L59(U5IN53YC<AQ+K
MQ>\QQ*U!1()WG+&M:*H"JX9X?H<K<SNCXIXUILX>EV4][,JK!<7KLK=G729*
M+B:YD4.K9MUR[9$QX27"\5OAU865=RMW+%.J2J#).J#&U[PSP_E&2-9EDW%/
M&N19>PY =8RN]P7%[?)&7:LMFL<:O+"KD6C;E<6D^00Z"SVCLVV&HXQ;JTJ@
M=.0.->.>6,<D8=RG@&%<EXC+>;D2L5Y Q6BS+')+[2'6FGY%'D4"RK'GFVWU
MI2I31(2M0!V)T:35&JH&(>)O1GZ/^!+M>2\%^E+TV<+9&XVMIR_XFX,XOXYN
MUM.H\MUM=KA^+4TY3;C8[5 N;$=#TUBK<(XQBD_0*LV3UF T : T[]1G$TA,
MA_E["JM^9;,,1VN1L>K(ZGY>4T$".EB+DM?!9!<G9?BD1I*.UL&18U2#&V>>
MC5[:.'JK'.O$A\:^=%3X&,N&>4(7%ZQ,DV+,GAG+Y;%C/L6Y#+M=QWD=ZZTX
MSES<CO\ ):X\S5R0'+!Y"_(KK)7SA2&9<M]O1I;_ "/PY_"\NXR:KZ3E!RK$
M1EWKNR"L@I<DHN_4M0X^/**4K6LYQ2T,PH</<AM+;[3FSBOA2E/<>F^M<US:
MJG[8X'TX:[<P#0&-<GX:XFS6V-[EW'&%Y);N-L-2+"YQVLGR)S,9*41F+)<B
M.L6;$=M(2VB0'4(3\( !(UG&[<A"5N$I*$LTFTGZ5D_682MVYR4Y1BY+)M)M
M>A\#(<6)%@QH\*#&CPX<5EN/%B166X\:,PTD(:8CL,I0TRRT@ )2D!*0-@-8
M&9?T : T*^HE_P "F+_Y4J3^]/-M</6_RE^]]3,HYG0.@_V"I?\ SDUW_>;.
MN,LCF#MJ@- &@#0!H#FMZF[I5]ZAZ>C+I7!XTXH8G-LCHU^-\JY-/1,4M(/Z
M25!I^,8O:I0_1M3U!!_2.C7L_P K^E]/ONZSW'74EI=%R-0>4[DN;EK^S#EY
MFN+<4ZQYD_GO]077NMZ5V*SL>U-PU^YQN1E=3QMV8<BGR]D[G.HJ2QC%3:I+
MDDIUZ,\>38V_,/*4@%?SE]5<6XVM024)H<"A*LKR3&(W*%S<XRJPB2-^JOPI
MK?HA.W \S=S>X]5WK476SI8QLQ]*7-/U\\I1?[J[#NO(+8%LOEYI]5.--5K[
MD]1*N?*WR6O4[<(R2R]YOB;T2I4:%&D39LAB)#B,.RI<N4ZW'C18T=M3K\B0
M^ZI#3+#+2"I:U$)2D$D[:]?GNHY(^IKZH.-8LJPPSTYL5N<Y&@.Q9G)-DVZ_
M@-*Z2II9QR,T[&D9O8,=I*7DK9JD**%AV6 MG7N[RU\BNK/,'DW"ZGM_34J/
M\Q=BV[B__1[=8NY^^W&WG24FN4^4?/3]7'EYY.>+LNDDMYZYC6/Y.Q-*-B7_
M .EWTI1L_P#I1C.]E6W&,E,XQ9/EG)G.&<Q+#*+?,>5^1+V0]%IH?DS<ANGG
M'=Y#M7B>,U4=3%3!'85F)6Q6(S8!44  G7V/HNF_*/R*VJ.YZKP;&JY6EJ+_
M /%U=Z26*M))RQPYH6(0@L')+,_,G=>M_P!1OZM.HI;'H?S6LT/.I/1Z6NGV
M[30D_=E?;DH46/+<U5VY=>,8-OW3<?B?TC\B8#S!Q97<W8WC\*ISC&.2<BL<
M*-XJRR2IH,3IJMEJWO7J3>JI)/XYDL14$QK!Z4U*BJ6"TIH'7H7K+SHTGFO=
M73&W;9R;%:D[KN7W&5V;H[,/X<:QMIRO+*Y.7%.+1]<>6WZ7]S_3SI_^O-\W
MQ7.K-1;6GC8TL90L6U6.IN-WIN-R\XQT\J5M6H4JI1DI'9STF9WD^3XSF^)9
M;;2\DG\7YDQBU9DUDZ9%U=XW8XGC>54JL@EJV787M4B\<@O2U N3&XS;[RER
M''E'YHZNV:SL'4&HVS3-O3P<7&N:C.*DHM\>6M*\4JO$^\/+/JC5]8=&:3?-
M?&,==-3A<Y<(RE;G*#DEPYN7FIP;:6"1M?KQL\\#0!H#5KE+UJ>F+A^5(J\Q
MY;QU=_%+C;V-8O\ .9G?LR6E%"H4VNQ:-;+J9?<-NR88^W0D@$'7J/K#SW\I
MNAKDM-U!O6D6OA5.S9<M1>4E]V4+"N.W+NN<G?@>PNG?*KK_ *HA&_M6V7_R
MDJ-7;M+-MI_>C*ZX<Z[X<QPK^L1]2?A7E_Z>_J:XBPO#^5?Q++\;QB!#R&^Q
M^CIL?9,+D7"[?SC_ .?+,N%MNM5ZT;*B-J"RGIL3MX!TK^JCR_ZXZOT?1G3V
MDW:6JUMR4(WKMFU;LKEMRN5_GRN--0:_EIUIZO*]_P#(CJSI?IW4]2;OJ=O5
MC30C*5NW<N3N/FG&%/Y2@FG)/XWA4/I?_5=X&X7]"7I8XFS+#>37+#"N,H-)
M:W%)!Q>9 =D-V-D\'XC,_)ZI]<;].-RKL6 "0D^!X?5/ZL>B.C>K-9TCNVW;
MO._H;[M3NV8:><&TDZQC+46Y../%)]SR.3L7D'U+U'T_INH-!K=OC;U5I3C"
MY*]&256J2<;,XUPX57>CL=QA]27T=\IO1H5;RU7XK:R2D)K<^ARL42VI8W"'
MKV8AS$TK[MT]HL">[H/$;^6]-?J8\F^IKD--#=HZ'6SRMZVW/2Y]MVXO KPP
MNO'TJO0;UY)^8^RPE>>@>KTT<YZ6<;__ ,G!^-_\G]9O#"FP[*)'GUTN+/@S
M&42(DV%(:E1)3#J0IM^/)86XR^RXD[I4E121X'7O6Q?LZFS'4::<;EB:3C*+
M4HR3R::JFGP:=#U9=M7;%R5F_&4+T71QDFFFLTT\4^YBK6TUAH T : - &@#
M0!H T : - &@#0!H T : YI^A?\ V>]1?^_^'_WYE>MVB^_Z5]9Q)YG0C7.,
M T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@&.^R?',6B?/9
M)>U-%$Z]K]M818*'"-O@:^8=;+SA) "4;J).P&JDWDBQC*3I%-LPQ8>J7@^O
M>+!S%4U:5*2M5?1WTIE!3MMM)%:F.\E>_0MJ6.G7;IOGX5SL-RTUY\/H-?><
M^2/3MRIB-Q)C6:AG55!#V.3TX_;PK&8\AQ/;5OS'(#<>3 <!(*)#@#/>5MCN
M"M]EN-V#R]TWV;=^W)5^!YXF"/3I.ARU9[@$F2S"E9O2Q4U$E]?:VY:4AL%,
MPQUW4M]NS4YV@$J2R0.NP/*O5BX7E\,7CZSGWZTC=62>/K)-$F2,7<?Q_(8$
MF"]&?6LDM_I&RKVJ3X/,+V)0X@J"@>FXZZY::DN:+JC9&2:JL42R-=4[J$AF
MQC;;= ZZ&5GV_<>\M>_YM#.J%PF1" 1*C$'J"'VB"#X$'NT%44JGP4??FQ$=
M"?BDLIZ#Q/58Z#050TR[BG02O\1BJ/M#;GG;[;>'DA>YT%4<V/J*9A!?PCCW
M&8SJW#8978WJAY2D)(H:A=>#NX$KW'ZR>P;;'K[->L_,R_RZ#3:7C.]*?^"-
M/]\_0C_M[[.[W6G4/426&EVNSIJX_P#SJ_XM.S'\F_9AQ)=]/R17XSPQ<394
M>8J3D6=6TY#K3+/:J#!K*>K8;!7)05^7,B2#OVCJO;V;ZYOESIW:V*=YYW-1
M)^I1C%?.F>(_KTWU;CYR:7:X2K;V_9+$&JUI<NW;]Z3RP;MSM88X).N-%O,K
M-Z[?X8LTCWJ2PD_N!]7\.O8%#XDYBPK.8P^Y ?4=_P"4\VGI^9*^NE!S WE\
MV4=H5&\^25)'EN.ODD)[MNUJ*.H3U(W/34P69'.AR'^HKR=:Y%F6*\:JBKA,
M8=7KO+>+Y;[;AN<C:85 ;E-/I"DKATC"'FB  43SX]#KTOYE[FKVML[9:=86
M8\\OWIY)^B*K_>/UM_[?'0/]+Z-W3S&UD*:K==2M-IVU_P#-M*WXDXOLNZB<
MH27;ID;V>B'@+E#$>!L9D0:0P7<^4<\ER7G*QE;D6]CQ4T)[GG%3_)./1HSH
M0$ (6ZO8;DE7F?1&EM;9T_:=S"_?;NRP_%3E7^!1?<VSXU_63YCV^N_/+<;.
MFN.6U;+&.W6L<.;3N3U+IE7\U.]#FQ<H0@V\$EMA+XYL815^N/(^)8\A/?WL
M3LA29"5(/Z1 AR'("%.#^:A2B3L-M>7?F4_@C)^H^5?&YOAC)D;?>X%H/]D\
M\NLHD-@E47&ZEUAM92/#SYC'R:PL[[=DL;>T[>+GU,OABHKO?R^@R2ORRBEZ
M1ED\X\9TI[,2XJ:GN)_HY^66 E*"@?A6JN"+-/<=M_@DH[3X>_3PKTOCG3T%
M6GNR^.7L(Q:>I+E"S0(M2[4XU&40AN-C]-';/:=@E#;UE^)RFU%6W5I:%$_9
MTU5I;2QE5OO9FM-:CC*K??\ )&CO*WKEX#Q')7L1YI]6O$6,Y9'=")>+\@<U
M8E5W5:KO6E/S]'>9$S)J6@XRH NM-([DD#J-M8ROZ.PZ.4(OU5^TOB::UQBG
M\NPV?X7QOCSG?&?UWX[]0G V:X8AY$>5?\>\H8MR1"BR5M>;\F_,PVRLZ9F<
MEL'N8<F-N@@@IZ':+66KG\FL_08_FX/X$VS.T;CC@C&]C;Y+DN<3&OO1Z>*W
M45SA]H5W][I"B/%N=T&_B=7FU,_A48KOQ^7L,7=U$LDHKOQ^7L)/7YKC5$H-
M\=\64-=(:Z-65A'>O+5(\ I,IWOL&2/ME+23U.G@3G_-FWZ,$8.W.?\ ,DV(
M\ARW/I]?8V^598WCM#7PI=C:S)=C&HJJOJX;#LF=+L7V%,-,P(D9M;CKDIP(
M0VDJ4H ;ZV1M6;:JDL.+,XVH1Q21COBO(^'^8\9:SKBOE+!^8\/D39E>UEO&
MF98[F>)R+* M*+""B_Q6SMZ]V;"<6$O-ID>8V3\0!.LH7(7(\UMJ4>U.J^8S
MCRR58M-=QF>+ APD]L2,RP/ EM"0I7]DO[Z_SDZR,Z(5Z%,9XSS1P[FN<9AQ
MCAO+'&F6\D\>>7^O_'N,YWBU]G&#^<XEEK]<,3JK65?8SYKJPE/SL=CN40!U
M.L%<MRDX1DG-9JJJO2C%2BWRIJJ,ED@ DD #J23L!^4G69D)G)L-K?S9<9O;
MQ\Q]I&W3?KW+'LT)5"%V_IF=^^QC';_M2R_^YY(<WT%489YPR2LF\9Y+"BK>
M==>-.$K\E2&AY>053I*BZ4+ *4';X3UUP-T_R,_[O^TCCZIKP)>KZ4=#/3[_
M ,!_%/\ O%QW_<]G736OY4?0<6'P+T&8=;#(- &@#0!H T : - &@#0!H T
M: - &@#0!H T : LR)#$2._+E.ML1HK+LB0^ZH(:9890IQUUQ9Z);;;222?
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M3Y]J.X2/TBHGS$7S]D[[#S$C?J=_ T#+C]1?5WG.7N5R\C>=3VI0JJJ:F#'
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MLM,*F[FN40- &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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MI14.X['%_J"NHL> [5Y>Y#CL-1(T6YNS#CL1H[:8[,=#5W:1FVF668R4I3L
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M6'TG2CT^_P# ?Q3_ +Q<=_W/9UU]K^5'T&J'P+T&8=;#(- &@#0!H T : -
M&@#0!H T : - &@#0!H T : Q[RY'ERN*.3HM>EQ<^3Q[FD>$EI8;=5+>QNR
M;C);<*D!MPO*2 K<;'KN-27POT$>1\T_[/%(A)Y%]341Q*?Q%["N.Y$51:[E
MB%%O<E;GI2_VGRTJ?EQMT;CO(!V/9TX>DSEZ#18S9]36N:<@- &@#0!H T :
M - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!
MH T : - &@#0!H#G):_\>N^_WF1/[U:G7&@Z:Q^CZCAW_B-MB=<VK9QR@K]W
M[NJH]H*-]9 QYC==ET)V<O)LBA7C3P:^2:AT[56(:DJ=+NZD.NK?0M*D@=Q)
M';XG<ZT*O$V"K)L@..5WSK=->7SZW TQ7T5;)L)+BR-RITLMJ;C,( W*UD>Y
M(4>FJW1 2XAD%KD=>[.M<8L<66E_RV(EFX%2)#00DE\LJ9C2(X"R4[.-IWVW
M!/LB;>:H"03[&OJXZIEG.AUT1!2E<J?)8B1TJ4=DI4_(6VTDJ/@">NK6F8+%
M9=4]TAUVGMJRV:86&WG*R?%GH96H=R4.KBNNI;6I/4 [$C1-/(#=$P_%H-F]
M<Q*"J9M7WG9#E@F&T90?>)+SK;JDJ4RMTJ/<4=N^YW\3J<JK6F())K($7AU6
M3)MU3K'*T2*U*G2U20*&% CE*P4M)E394BUL'BR#ONVXSW* \$[I,Q!)7%*0
MVXM+:WE(0I266RV''5)22&VR\XTT%K(V'<I*=SU('75!"L?R'*KBQ?9L<'>Q
MZI:"^RQL+R&]+?4G=*&T5<2,[LI2AU)>[ GJ%*Z Q-]@)596=?3PG[&TF1X$
M&.D*>E2G4LLM]R@A *UD K6M02E(W*E$  DZ 2T5_4Y+7HM*649D!QUUEN08
MTN,EQ;*NQSRT3&([BT!70*"2D^PG1.H%,^JJ[5+2+.M@62&'/-81/AQYB67=
MMO,:3(;<#;FW3<;'0"U"$-H2VVE*&T)2A"$)"4(0D!*4I2D )2D#8 = -4$/
MG8B_/R*/?*RS*XK$5V*\U0P+)J)2N*C%DJ:E1FXQ7+C2BT2ZEQ14>\@*"=AJ
M4QJ"9:H(E>MYJ]8P48[*QR#4I1W6,BT8L)MBMTND%N+$CJBQO)2R >Y3X4I1
MVV &Y8\,C%NHXV=]6U2%F2^DN(25%EM22M(2-R7"2$,I ZDJ(Z>_6^W8N77[
MJP,6TC6#//45$A3!3TT299.NI5_;-=VFG84._P"";;)7YCBAV_=:1V*W *M]
M>1:+89RI.][L>_/U+AZ_8:97.PQSB6%\S>H:Z-9BE+8W3#;J1*<82:[%:4'M
M4%V5E(4B PXE![DI=<<DN#<-I6>FNZNW=LV:USWI1C*G'&<O0L_8DNTUI3N.
MB-UJKTR^GOTW5D?+/4SF];E.0EE,JNP2K5)^3D/)5LE$.G86U?Y.A+X"2\^B
M)7IWV?1V_%KQZ>\[MO$W8V:U*%JM'-Y^M_#'T*LNPVJW;MJMQU?88<Y?^H%E
M=M%8PKA*C:XIQ,(-;4,U$&+(S.Q9W(;BT]?4QW(=#NE71BO;>D-J^),@ [#L
MMNZ2LQD]1N,G?OYNKI!=\F\_3)I=QC*^W[L,$81P;TW<K<I62KG-)%IC$:R>
M5*F&:ZFZSZV+WQ+DR52')D&D6ZK[SDQ<A\;_ !-(5KM]3NVWZ"'AV.6[.."I
M[MM=W!R]$:+O9C&U*6,CHEQ7Z;,%XUBJ%;5-1I<E+?XA,4\Y/O+,M[]IMK^4
MIV;( [CLTVI#2-_@V'37B6OWK5:U^_*L%DLHKT16'KS[3?&,8Y&Q$:)&A-)8
MB,-1V4^#;2 A._M)V'Q*/M)W)UT\I2DZR=69"C4 : - &@#0!H T : - &@#
M0!H T : - &@.%OKE]/[G%6;GD#&HBF\#SN>_(4B.A09QW*W?,EV%6>W=+,.
MSV7*A[=H3^E:2D)925>K^I]J>@U7YNPJ:6ZZX?=GFUZ'FO6N!^I7Z7/-FWU[
MTQ_TCO=SFZJVJU&-9/'4:54A;N]LIV\+5[-O^'<;<KDJ;Z^BOU*,<T87^J62
M3@ODG"84=FR4\LE_)*%ORXL+)$*6HK?F(5VLS_'9\H=.P?2E/E?3>\K<M-X%
MY_\ .6EC^U')2]/"7?CQ/E']2_DO/RUZE_K^RVJ=&;G=D[:BO=TU]UE/3NF$
M8-5G8R]Q2@JNTV]K>0,]Q?C##<@SW,[)NIQK&J]RPLI:QWN*2DI:CPX; (<F
M6-C*<0Q&81NX_(<0VD%2@->1RDH1<I9(^8S@]AN/\@_47]1\[),G58TG&6-J
M95:_+.%<?$<,1*=<J<,I'BGY9>69.M"R])*3L0_**5(88C*ZZ*GJKO,\+:^C
ML]+,_A7>= ^3:#&L&SS]6<*IZ_'J2GB\"KAP:R,W$:@6E%DN3,PS'[$APF'5
M-5JDN$J47$DE14#MG<MUU48VUE&OJ56_F1P-?N.EVS3QU&LERVYW[-E=KG?N
MPLVUZYW(U[%5\#H=KL#F&C'JU];>*^G#R<6I*^+F?)LR.S-71.3OE:C&:Q\%
M;5AD\J.'9+<F4V.^-!0$.O-?I%K9;4VISE:;27-4WRM1MQSD\E]K]G>\J^E_
M-SSKZ?\ *G3VM->M3U_5&J5=/H[;I*2KRJ=R5)>';<JQBU"<[DDXP@^6;C+_
M $Z^I:TY=K,6_7+#48?<Y5$O?PY,:3-*/Q?%[*TK;RCMJ>VAQ+.ALT_@TB3%
M1YDUMZ(RI;CC#G:RK5.RXV_&BU*RY.*:XM5X=CHZ?5@=KT=YGZ?J3J"YT=NN
MBO[;U=9V^UJYV)M32MW8VVX\Z46KMKQ;:N0<53F7+*7++EVXUJ/:8: - &@#
M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@,:<D\S\2<
M.UPM>5>2L(X]A.-K=CKR[):FC>G);[NY%9#G2F9EH^2@@-QVW7%$;!).N'J]
MPT.@ASZV];M1_:DE7T)NK]1YGT=Y==?>86K_ "/0VS;GNVI32DM+I[MY0KQN
M3A%PMK'&5R48I8MHYG\L?6K]'^!&5"P=6=\QVC(<0RYBN.N8_CAE-E25-2;O
M-'**>(_>G8/Q*^:VKHI'<D]VO$-;YA;%IJQTWBZB:_#'EC7O<^5^M19]G=!_
M]MW]075*MZGJ9;7T[HI4;6JU"OZCE?&-G1J_#FHZ\EV_9DLI<KP.;?)OUX>=
MKSYB-Q9Q-QUQY$<4I+4W))ESR!>,M#[BV'FU8C2MOJ(W/FP9" #L!O\ %KQ/
M6>96Y7:K16+5J/;)N;_W5_JL^QNB_P#M<^5^V<E[KG?MWW>^EC#3PLZ&RWQ4
MDUJKSCV<MZ#XUX&C]_Z^?J"<\6;E/7<R\MV<Z:0AN@XD@*Q606W#Y:([,/C*
MIJ+%]M?W?C4XIS?XBHD[^.7>INJ-SGX<=1?<G]VTN7_[6DSZ8VK]*WZ3_*W1
M+<-9T[L%G36\7?W6Y^:C58N3GN-V[;BUG@HJ/!)4$\#T+?4-YOEMVMEPES5?
M3GE.K18<J3%XO,*GUH4\XJ7RI<T3Z?/6$J*E* 7MON=M]2/3?5.XOGGI]1*7
M;<?*_;<<3;JOU/?I(\L[#T.CZEZ;TNEBDG;VR"U,/=3HN7;+-^+Y55))8985
M'GD3Z6OJXXLQ>!E?(&.X;C=;873%"PT[F]3:S$V$B#86#*'&L?\ Q9D-.1JQ
MX]P<(!2 =MQKF/H/J*,>:Y"U!/MFG_LU/6NY?]R#],N@DUI=5O&N2:QL:"Y&
MM>/_ #,].\.-57'!/&FS5?\ 08]8=E7P+!/(?IPC)G0HLQ,:3F/)7S$=,EA#
MP8D?+<128WGM!?:ORW'$=P/:I0V)W+R\WIJKN:6K_:G_ /<SQF?_ '0/T_6[
MDH0VGJ^<4VE):3;Z22>:YMTC*CS58ITS2>!JSZF_IE^H+TEX$OD;EO).&H]"
M9C5=7QJ?/W'[Z]LGGV6DUV/45M1TUC=S&V'52741D.>1%:<==[$I)UU.Z]+;
MCL^G_,ZR5CPZT5)XM]B32;?'#))MGO#R;_61Y5^>G4ZZ2Z%T?4,]T\-W)RNZ
M%*S9MJ+;N7[UJ]=MV8-I6XNXX\]R4(0YI2.>U9;V5)8P;BEL)U1;U<R/85EK
M62WX%C6SX;R9$2= FQ'&I,29%?0E;;K:TK0M((((WUXU&<X24X-QFG5-.C36
M33X,^K=9H-'N6DN[?N-JU?T%ZW*W<M7(QG;N0FG&4)PDG&4)1;4HR333::H?
M5=]-'ZNM=RVK'^!/5#;PJ;E-PQJC".4918@4O)$A94W$I,G2VRQ H,U<V2B/
M(W1$MG%!O9F64)E^W.E^LHZSEV_=I*.KRC<R4^Z7!2['E+N>?XA_K#_0=J^@
MUJO-#R7L7-1T2N:[K-NCS3O;?%8RO:>KE._I%BYPQNZ5+FK<L<TK'?G7L0_+
M@- :O\_^G;_&I(BYMAUZG$^4Z.G%-7SYZ7IF*932QY4NQBXKFE8T%2!7-3Y\
MAR+/A=DZN>DN+2'VE.Q7O(NFNI]TZ6UWYS;9+EE17+<L87(K)26::J^62HXU
M?!M/P?KSR_V#S"VI;=O4)*];J[-Z&%RS*257%Y.,J+GA).,DEE)1DN%,+Z:_
MJUG9)(IH?%]/B](93Z8V17^>X(G'66DN!*5^5BMSD.3N13N2TO\ "&WG&DA2
MV65GRD_6^R_J<Z+Z<Z5TNU[5L^L6XV-/"$K:6GLV'<C!1E+Q(3G-\S57)V.9
MUQQ/SAZF_0;YJ=:^8&OW[J#J/;?Z+J]9=N1O2EJ]3JXVIW)3A!V;ENW;7)&7
M*HK5.*I@Z9=+_3W]+SBWCF1"R;F.Q8YCRJ.IB3'HI%;\AQO4R4!"]CC\AZ7(
MRUUIW<>99+^4=2 ?D6UC?7H'S \Z>MO,+FTNNO+2[&__ )K8K&VUP\63;G>>
M55-^'55C;BS[%\G/TL^5GDWR;CMFFEN/5<?_ )_JU&=V+:Q\""2M:=9T<(^*
MXMQG=FCJ&TTU'::88:;989;0TRRTA+;333:0AMIIM 2AMMM"0$I   &PUZD/
MI$Q9SER(KBCB7.\]891)LZ.D<;QV$YV^799=<R(]#AU4ON4D!%KE5G#C'KN
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M@GS75>/9OV-]-@2"H_*'5O6FNZDU,K=INSM2?NVUG)<)7&LV\^7X8\*NLG]
M=/=,Z79+,9SI<W!KWI\%W0[%W_$^-%@M:K>G/Q_#[_9KPI-Q=5F>32BI*C-
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MET)NT=3MW//IC6-NQ)XNW)8RL7'^*%:Q;^.%'5R4Z= ]?0!ZD#0!H T : -
M&@#0!H T : - &@#0'-/T+_[/>HO_?\ P_\ OS*];M%]_P!*^LXD\SH1KG&
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MS\W]7I=1H-7=T.KBX:JS<E"<7G&<&XRB^]--,==<LXX: - &@#0!H T : -
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MYZ /%&4D@$I-&4D@$I)R.G!(/L)!VUP-T_R,_P"[_M(X^J_D2]7THWN]/O\
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M>6BAG&37I^2*I"7T1U/.7%'*HP.\S!64<,6JY^.8VM,VXD8U96,+'KC)V+S
M(&3UM5>5]77MTCD62_&9:J)CDKN95,[6Y#6.FG*-WP^;FA\P:PJ=?]=@8AH
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MZF91S.@=!_L%2_\ G)KO^\V=<99',';5 : - &@#0!H T : - <V/5@MS_.
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MIOC6=<FCI/KZ7/28: - &@#0!H T : - &@#0!H T!S3]"_^SWJ+_P!_\/\
M[\RO6[1??]*^LXD\SH1KG& : - &@#0!H T : - &@$DJ-YZ04G9:-^W?P(/
MBD^[4:J!K^3D]W;Y?Y^Y/;^7??6-&"GS'8ZEMH7V]JB#V[;$CI[1N1T]NF*
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M.3S5 3+60&&#<3)ME)A+QZX@1(Z%ENVG&L1$E+2X$)1'99L7Y^SB25)*VD;
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ME:L2G*=N,$FYM3A!R@JXM+"C=&DVN/IM?:U,FHJ22IB\G4Z6:]3G/#0!H T
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M^#1@#]F#_P"9UX _W]<]_P#E9<RUCIOY2]?TDM? ?0-K>;0T : - &@#0!H
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M3TS<5ZR#,NM2&FGV'$.LO-H=9=;4%-N-.)"VW$*&X4A:""".A!U^-9^AQ<T
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M^:&S;=U9MM_3*[*$-=8YIM<D%#Q(J;Q?-3E;K[JPXGV)H/\ M]>=?3G2VO\
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MPY!0]&4Y8MVO(E8RE)':W$BS<(I:*>TVUW=CL]T[(26PI:4,.5NM'GV4@_\
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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M"1#C)\T)"3)= <?(VVV2H@!I) ^Z@)'V:\;N7KESXG@;![UJ : - &@#0!H
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MX?L_,3^-W!^OOK6_\B'$O[G8M_XE:?E=P_9^8?QNX/U]]:W_ )$.)?W.Q?\
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MZ-3C=33)3\I&2IY*0GYI[M<?VVVV0KM"64[=-D!(UXU<O7+GQ/#L-@^ZU -
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M7#61QPH)"95ME]#/4">B_EG,0L8(2D=5;RNX>P*UTE[RZWB'\F[IYKO<HO\
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M^*[-L)SK3#+8!<=4M]Q+3+3+2$[*>?=4$I !/NZD:[EJ*6.1ZRKA5_";/8I
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M*GA4D#<D#\I_KZ4%,:%/FM^UQ _*M/\ 7U74A27V1_IK?YEI/\!THRYE/S3
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M&6ZXT@6$)^"\LMA)+B&GTI*V5!8[5IW23N-]P=<%.JJ;BY97U95I5\S(27$
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
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MN.](@3$I+L=YYEQM:[!J>K4H9-_5B/NGT':[0P#0!H T : - &@#0!H T :
M- &@#0!H#F?B=?)N?4JW77*6P\QSKR#:7<1U;@D.QJ*!F.28$I86M3B7$0J^
M@G-)Z)5&0@@=A UUT8\VL=>#;^PR^Z=,-=B8AH T : T*^HE_P "F+_Y4J3^
M]/-M</6_RE^]]3,HYDPJO]BZW_XPA_\ >[>NSC\*]!WRR%^J4- &@#0!H T
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M\/ :F2H90BDJ+)$^T-@: A]YD[49*H=:KYF<O]'WM#S$,*/3X=@H//[^"1N
M?'W&F+9&[F74<?T+=G,=D3<_M>\U-.Y%0[#KF%K[7;6P>,@/?HD%7\C]([^C
M2=@XH:'.<Y\D*<G%U.-[U^7*JJTLWV^@9L/Q3"[YU_(L\Y*FT]Y,=\Y+$[$;
MB<U(2 "V[)FT\EU42.E>P;CLQE)2V!N1MV'8XWH)*W;YH_O)?,_M.'J=6H_P
M;/NI85^S[3=?!\JSNJAAC'[;%.7J*"PD)K\>MD,9-716D@(4FLEPX=RIK8$!
M"HL@DC9*@ =<*["RW_$4K4WVK#VY?.=?5O',:,GS:[Y7EJHJQJ?C6*0?*%ZF
M1VMV4V;MNY D-MK*>QAU"DI:W*04^8YNKL;')TND47S.CEV\$C%NI(*RLKZ6
M(W"KF$1V&^NR>KCJ]@%.O.'XG75[=2?R#8 #78))8(QQS%#_ )$AI;$AEE]A
MU)0XR^A+K3B3XI<;6%(4D^X@Z&56L48FR#ACC:_#BW<?9JY#F_\ ;-&M584E
M6Y41$9[JU2BH[[J84=_SZU2LVY8T2?R[#?#57X92,+6/ 618?.:R'C'*IB9\
M3O[8TSR&)JFU>+:92/+@36W0 %LO-(;7[=_NZQE83C3-'.M[A"XO#U,53M7V
M?8)IG(F213Y?(O&-+;2VPAM5DCYK'I:T)("%+=E5TUMSKMT:*&E=  -:?!N1
M^&6'><B,;;7\&XTNS/[!(UR-3EP-8YQ+7/2@4EIVRNW+9*5GO.Q@M53SJR"-
MTD.@C;H.F^GAWGG)>I%<9_?N8>SZQX55\O<C!,6Y6C&\>6$I<K(L9VCK?*V'
MZ-R,MQZ\LD*2!LVZKR"?';V9QL).KQEW_8<>5_2V?A]Z?M_L1FK#<&I<+8WA
MI^;LW&@U)M'T)2ZM&Z268S*2I$2,5)'P)))V'<I6PVWJ-#K[U^=YXX1[";*?
M'7J-#30LJD>P'5(-$O.(N+2$K3)4Y8.A+35=%0),N3YI'8U\L#T#BMNTJ*=S
MX'?6NY&,XTED*T+.0S\JL&69>?Y%#XSI'FO.8I6T*L,UL65 %M3%%&*9$+SS
M\*79*HH:)ZE2=<*-V";CI8N<NWA_B^PRQXX(B</(H]4H_P"+O$V:1TJ_\>F9
M>3?9:\>[<284=YHU-,ZM)\6&%J]SNCM2GCJ).2_#'"/VOV^HWV]/<GBE1=K&
M:=4NW$I5ED%G89!:K.ZYMK)=DGJ2>Q#3CBPED$]$;E*? ;#654ERVTHQ[CFP
MTEN.,O>EW_8*F(2&@D;I[$;!*$)[4[#PZ#H /<-2G%YG(4:8#EW?U>S4Q;)0
M.[J-,6Q0JUF0-1M(%)4!_5_#K'%E2$3UM7QE=KDMHK'BVT2\Y^0H9"U#?[1K
M/E;-,KUJ/Q20XUT3([_;]7\7NK1M7A*$5;$$>XKEJ2IE _LBG6$I6K?QR2?S
MFMZN"^"+?S"N5CTVO2IS*<QPO$&FQN^RJR1<VC(]H,2J%F"L>Y79]F^L5=4O
MY4)R]5%\]#1/579=D4-L1W )RRBK_P 8_*4ELD*3C50[ H5JW&Z'IK35S\NC
M?H2OY?KMU!.VJ_'C\?AVUWNK]F'UG'<Y2S;8HEY&_C<G\/9XMQ_%)1;8>81>
MJCY9;EM[N#3RE+LK"OBN.$;A"F4.CH>U/3="TKN/B2ECP]U?0F8UIP*)F4YG
M9M^3.RZU8BD &!4+:IXB4@?T98K4Q8ZT#W%O;?V:Y<-#86+2K[?G=259&_P^
MO\Q3KK;DIY1[ENRGG75K5[2K=02LG;Q(UR5:@LD!<VIAD?H6FF0/^UMI1^^E
M(/76:265"%U4K[?X/^AJ@M*D!22#U!\1O_6ZZ,(3^8M _0NA _FK0'$^[V%M
M>Y_LM8THP6US)J!_1,/CIU0ZIE9Z>QMQ+B>O]GJ 3+ND-_ZI8E1@/%3C16T/
M_3L=3J-*]H[B\S:1I 'DR&G#[DN J_ZPGN'[FL70"@R>GC^?^KIH4#)^W0%L
MR?MT'HR+2IB$CXEI'Y^OYAXZQ;BL\ *(2;"T<\FJK;&T>WV[(,21)4/#[P:0
MM0Z>\:TRO6H*LG1%0_KP[)@C>T:J<?:4$DJR"ZKJY8[NH/RKDD3=P.H'E;GV
M;^&M#UD'\%7Z$V*,0C',?8/;9\A5W>%?&S0TUI;G;;IV27VJR,23T.RSMX]=
M:W?O2^"#IWM+[1ZQP::P=E*0U79ID2D  )E/P:."L^T[L-VDA(4?#XP0#X'6
M#EJ'G*$?:W]1FH2>2;%S5L]%'_@;$\6HPGJB7.:<OK%H]/C1(M'9C"%_D:3[
MN@Z:QY4_CE*7HP7S&Q6+C[$);"PGV^PO<DEV"!MM$^:2Q"1L1L&X3*@P@#H/
M@2GIM[AK*-N$/@C3Z38K"^\ZEAF3614%#);;'M\MM9*O=W+"25'\IU:-LY$%
M&"P1ZNXC)0KM2\M0!V[6]_S[%0T\.3Q0KQ&Q-T0XGM:>5W* (6>W<$]>FRO'
M6*ACF2K> Y&S>(!3&2/[)T'^ )UGR+M*65V,T;;(83N?'99]G]F1UT4(]XQ!
M$N<M(/FMI]G1 /Y^HTI%<" IR4H;&2L?V( _?&VF'84I27NO?)?.^W^F*VZ>
MX$G4]2,7B'PD[%;BC[RKVZC;)B5I0V!T'YST_K:M:YAE&R0H[)!W^T_P[D:.
MJR(7AL/Y(/Y1OK&K+4LJ>03L$C;PWVZ?EVU:C 5)*>T>'3[/X-8BG$K"PKH/
M9[-4%05MOMU.WLUCF1IYGB5E1]NX]FI2A'WE?<0>O[FKAZR\,"H*W/71]H*N
M\CIOX^S4)4J[^H]FIB3 K[C[^GOWU"YKO*DK ^\H)&WB2 /9[^FF?I(WAB)7
MY4,CRW"E_<[!*!YBMSX!)3X*_.-*/,U.4:4EB+I"7X^/K:LPILKE,.T4:5_J
MYEK=?SC@20'6H3C?:-C\)6 0/:<%1W*Q]?R[32Z<,B-)<]GM_>UN:' O!8.V
MH*=A?"_?X[Z@+P7[]3E[!@5@CIJ8H4+R5#;KIF"X#JU[2'H)'AJX,M2ZD[C?
M6+P!>"_#]\Z4PJ"YW'QW_/IPH# F9>H.(SYT2D)G.C=']IK+4))\#YE@4^=)
MV]S*0A0Z=VN\T>P3E2=_W5WY^SAZS7*]P1BC'Z+F7GFU<J,/H;G($AQ"9,6H
M9,.AK@ZH>6;:RD.LUT5))W"IC^YZ]ONUW,WMFT6_$ORC%]LL9/T+/V(U>_<=
M$;G8]Z,N*>(*N+F7JEY-IX; :^8:PVGGOPV)CC6RG8?SK:$Y)D;B4+ <8K(K
M*T+ZAU:.IZ&]U%KMPF]/LEF3?XVJT[Z?#'TR;]"-JM1@JW&1G/\ U^XS@5&O
M"O33@%-@=&AQ;#&26M7#1+DR%#L$JIQ>+YS4FS?* I+\]R8\^#LY'"];]'TI
M?UEW\QN]V5Z[^%-T7ID\EW1HEP9'?27+;5$:FQ<(]0/J&NT9'E<^\CQY1 3D
M^>.3)5F[%6KS SCN-*4'(L50)\I)2PRVKIY.VO(W>VC9[7A6U%R7W+=$J_M3
M[>VE7WFM0G-UD;N<4>CW#\1=8M[**[;W24CNN\E0U.L@2!WB!6]H@U+3BAOV
M!([%#<)UXYK^HM1J$[5JD+/X8X+UO.1NC;C'TFX55CU53)'RD9)> V,E[9R0
M>FQV60 V#[D!(^S7CMR].Y\3P-@]ZU - &@#0!H T : - &@#0!H T : - &
M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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MQ4H3BZQE%XIIHD&M!R0T : - &@#0!H T : - &@#0!H T!A_P! G^K.>_\
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M .3L]VN6NN>L+%-K@U/2:>:_GO-7KL6OY*P=N+7\5^^_X:2NW_3IZ5X&</\
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M-&KG"*7K_L'.^UGGS>,'<F5D\@]?A*JZ*GPV W\R8-O;OM]FWMUC2[^S\_\
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M)"_?W.J&X!]R=D_9KQ^=V=SXG@9CMK6 T : - &@#0!H T : - &@#0!H T
M: - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0
M!H T : - &@#0!H#&G,6+6V9\:9;CE"W&>NYM>U(IXTV3\G"EV=7.B6\"%,D
M^3(\F)-E04M.GM^XL]4_>&N[%SMN*S:"S*.+N+:+C&C1$A-LSLAGLQEY/D[C
M"43[R>TWL0%*+CD.GB.+6(<)*RU'0HGXG5NNN+5J-J-(Y\0W4R=K8 T : -
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MJCPJJQ;R;,UZZ \M#0!H T : - &@#0!H T : - &@,/^@3_ %9SW_ORJ/\
MU;D^NKTGQ7/WOM.BN_&_2SH',EN-.>6WLG8 J40#OO[.NX  UR92:=$:Q5$?
M,AKO('<%%"MO D '<=3MT5K*+JL0*=4!H T : - &@#0!H T : - &@#0!H
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M)$8Z:IB>CQT*LRK4,PUE$&G7/'J*A4+<W$,-LF19J2Y&MLA8?!%;U*'H-44
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M"5%!5VJZ>!V(.N0I5&/J*C(\.G[IT!85(/O_ '- 6C(Z'<^W?8?U]3$%LO\
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MIE)ZD)<D_AM<TVD'H5'I]GLUR8_FTL;:?H:^UD]WM&7Y.@G."/CV<X;D4E1
M17P+AMJV63]T*KY267$%6^PW5MON/$'6Z,KT564)Q7:\B8<&ACLVK2J2HRZ2
MW:2G<E]48_*;#8=)2"ZRK8^XZWPN-_>B_I(R,JM[!S?Y>*T /^VN%1_.D!LZ
MY"E;?Q-@0+LK7<AQ]MC?V-L[G]UQ)(_=UO4;;58JH'C%J>;E-HN)(M'85=#C
M2+&WL72LLUU7$V,F6II!)=7NI+;:!U<=6E.XWW'&U-]6HTC'WWAZ6%V<#(7X
M@AV(Y4XG&>QK&%'RW9 <WR'(0@]IDVE@@)6E#VQ/DM[,H"BG98UP:.O-=?-<
M^9>A'(M6'-5>$/G8CBU,"&08T9IL[;*<*4J>5L/^VJ^/8^[PUDY-YLY<+<88
M)#GW!'B=M_8/LU@W7(S]!6E06#L?#;Q&_P##IEGB5%1 "5;$[]=&ZO CKP*&
MR2#OOT]IWZZ-]I4N)=)!! &W3Q\?L_/XZB)Q*$#L.YZ_8.@TI0,"^$G;QVZG
MV;?U#3 F!:780V_Z22P@^XNH*O>?A![OWM'&7 P<X+-H1.W,0D(86Z^H[_"P
MRZM1(&^PW2D'I[M]10:SR,'?MKC4>(L3(IJ4_)XQ>/@^#CD)Z.R2 #_3+06@
M=B/;OJ.5M9RC[3!ZA<$Q0Y2Y$@$3CCM(G8J_\+9!6H6.@(V98EN/]Y&^P[-S
M[O#>>);?P\S]"9@[\^"2&=]^@@+#%MR1CD1Y:^Q,>MC3+!Q:U*Z);4Y&AH4L
M@=!WC?KMOMK)*Y)5A;D_30P=Z?:@,S#4*['K;+[,[>,6-7U;"CL1N//E3W$[
MD?S#T/OUC_%?"*]K^PQ<Y/-LM+O,19W^6Q23.4/Y=KD4SXNJOO-UT2)L>O\
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
M&@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M : - &@#0!H#1[Z@7_ 3#_W_ &/_ .YM_KB:W^3_ 'D91S%V+?\ C8QS_P X
M-1_N?'UV,/@7H1WL?A7H'W61D&@#0!H T : - &@#0!H T : - &@#0!H T
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
M- &@#0!H T : - &@#0!H T : - &@#0!H T : T>^H%_P !,/\ W_8__N;?
MZXFM_D_WD91S%V+?^-C'/_.#4?[GQ]=C#X%Z$=['X5Z!]UD9!H T : - &@#
M0!H T : - &@#0!H T : - &@#0!H T : USS[TL\2YS>3<S@P+CC3D:>L.S
M>2.)[=S!LKM7TI*&W<I3!:>QS/TLI/P-9%7VS"-@0V" 1Y;L77'4O3J5O0:B
M4M(O^%<]^W3L2>,%^XXGKSK#RKZ%ZYA+^O:"U+52_P"-!*W=3?'G2]Y]\U(T
MW]1OHZ]4'(6%1L3QSEGC'DBNJLBCY+ '(&+67'&9NJ@UMM7(@6&580<BP^U>
MD,VJRE;6-4[8=2 HA!)3[RZ,_4)I]FUGYC>-OFW*WR2=F::QE%MJ,TFJ<N7-
M+ ^//-+]#.GZLVW\ITKO+TSC>5R$=1;YDG&,XJ+E%UE7G>-(XI=YR]%_S'Z;
M<E'&W,_'MC50;=$AM6#9TS%N<,S&NCJ!F2<&RJ"Y8T%FIEI8=4F(^9$?N0J7
M%0H!(^D]FZAZ(\T-/^<Z?U7@[U!54HODOP=/O1P<X^G%I/E:56? 76OEGYN_
MIXU3TG5^ACKNC;DN5MIW=+<C7"DJ-V9XJE/<4W%/FE1&U'"G,LKTS1D<E\.2
M,AS;TK39J_\ &KP,^\;+*.$YDUXOR\MXTC.NNK;KV7%K?DU;;B85@R5K1VR^
MY[7ISS'\L(]17)V+MJUINM81YK=V"Y;.NA%9-))1NTPHEG1)+",_JS]/_P"I
M2?25JS#5ZJ_KO+*[-6[D;TG/5[3<DZ+GDVW<TK;JKDFW%-NY*4:SL]T,5RC'
MLXQNBS#$;B!D.,9/4P;R@O*Q],BOM:FRCMRH,V*\G[[4AAU)&X"AOL0""!\;
M:G37]%J)Z350E;U-N;C*+5'&2=&FNYGZG:36:77Z6WK=%.-W27H*<)Q=8RC)
M533[&A_UI.2>: - &@#0!H T : - 8?] G^K.>_]^51_ZMR?75Z3XKG[WVG1
M7?C?I9T6US#6&@#0!H T : - &@#0!H T!&<DS/%,0C_ #.2W];4(*2M#<J0
MGYM](\?E8+7F391'N;;6=;(6KEQT@FR-I9FOUQZEF[!UV#QMB%KD\E*BU^*6
M+:Z^I96=_+>4TCOD+85TZ/KAGK[/;SK6W3E_,=.Y8OY>TQ<^PQY8N<NYOW'+
M,S./UKP(70XN#&3Y2AVKC/O1W&RZVL?]M?EC[/9KLK.AM6\5%5[7B_E[#&K>
M>1[3<=8E2E+C58B=)3_ZU6I$]TGV*#3B4PVU@]0I#25 ^W7,4%Q%$3<  !(
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M1VT[^W<#]U*=A^]JN<C8ERY4%'DE#GP!*$]-@A.R2/;OML-M:VV\S(5!*.X
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MCHV6J% &PV/74,"GRFM]RVC?W]H!W\?';5JQ1=AOKK2:0T : - &@#0!H T
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MMMB#N-OS@'1U(75.=J=R=@!U/MU53CF"UW(=3W;A2?>=^G[O4'3,"&<2&1V
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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MR3:2W[!YSW)4J0M[=*=]@/!(\-AKEV]+<BJ02C'V?08UJ4EYII"0E(  &R0
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MDWQMQC\*2%@@!Q06\IY]?CWON*4?X=_W=7Q&E142[C)NN9>^3 V[.U 'B$)
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MU>W0'JUD@]O0[';\OLUE1("=I3H*@HG;_1'?K_H?'6(+OF=#NK8?;MJM8@L
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
M&@#0!H T!XI02"5'8#Q.@+(DM$[;D?:1L/Z^I5 OZH#0!H T : - &@#0!H
MT : - &@*' I2%!![5$$ [[;'\HZC0%$=#B&]G%=RNXD==]ATZ;_ )=15IB#
M23Z@7_ 3#_W_ &/_ .YM_KBZW^3_ 'D91S%V+?\ C8QS_P X-1_N?'UV,/@7
MH1WL?A7H'W61D&@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M : - <P/JS2K:+Z<<+,9"QCKO.V"ISB;Y:C&K*)FAS2912IS_>AJ)'D<C1J*
M*EQS=)>DMHV[EI(]X?IY_IZ\R]//7SC#EL77;JTJW/=HL>/+S>I-\#Y1_6FM
M\G^G[=;6Q6;EZ].[9C=C!.35AR?BRHL:)4[>SB<I?29B,[D'U7<#8U6(=<-%
MF;/)V0NL)#@J,9XZBRL@;L9X 4MB'8Y5'K:MM>VRI$Y \.XCZP_4#ONEVGRY
MU>EN2C^:U?+:A&N+YGBTNY5?J?8?FK^A?HS<NHO/#1[Y:M3_ *7M=JY>N7:/
MDC/EI"#>595:IPJJTJF?4SK\WS]V T : J"E)\"1_!^YX:E$Q5H4)E.I]N_Y
M_P#IC][6+A%F2FT*D3_YP_>_C'];6MVNPVQO)"@28[GB!O\ F)_?V.L'"2-J
MG"7I*BB.OV@?8?\ [8:PYIQ9MC&W+"195":4/A*?S=/X#MIX\XYY%>EMRQ1B
MGT7TR,>E\SJ"NX6&4U;WWE+"2AS(3MU;;*=_-_T6N!IK_+*=>W[3I[NV2E)\
MKX]OVF]'SK7M('Y]O^R US%J(<3CRVK4+X<?5]E2M,MA7@O^ _\ 8DZS5^V^
M)IEM^JC]WZOIH7 ^T?\ 3$C\I[?X=M9*Y!\4:7I=0LX2]6/T%86@^"TG\B@?
MX#K)2B\FC4[=R/Q1:]1C;.>7L!X]0M.0WC/XBE!4W25P$^Y=.W<E)ALJ[8@<
M'W5R5LM'^=OKD6M->O? O=[7@OEZ#!M(UVMN9.5<^[F<'IFL&H'20F^M^U^U
MD,*V <C)=:6TT'$[[>2R[VJVV>3MOKL[.W06-SWG[$8.3>1%87&U2F4JYRVQ
MG9?=.J2M^=>2'GF5.#8C^UW775R #N-GENI(_DC791M0MJF"1*&18_RK;2&H
MJ66F&DA#;+*4--M)'@A#2 E+:1[  !K<J4PR!>[D^_5!3Y@^W^K]W051X%E1
MV2DD^X;D_N#KIZ250I0PZKJLAL>[H5?N> _=U@YK@6I?#;3>Y^\1U*E'<#[=
MONC;6/,WZ"5[3'=]REC-0^*Z&Z_D-PM1;9J:!K\0?6Z!OY:G&=V4J2/O)25.
M#8_#K7.Y"U'GN-1@N+=%[6;+5J[?FK=B,IW'PBFW[$1BYM;UR,J;GF=X[Q12
MJW*<>HGVLPY*G-@@AH5M2ZO\'4[U2'I3M>4*\4J 5KJ+V_:&+<;4X2EV\R27
MUOU)GD6CZ,ZKU[3TNWZR47DW:G&+_O22C\YB=?)N-8TZM7%^ ,MV1.YY#Y1,
M/,,L6X3W_.5]"M"\5I92%=$J\F8OMZ%PD[ZZN_O^W9ZB].XOP6HN*]<I<K?M
M1YKMODKUWKVG<L6-+!_>O78OYK7B->AJICG(<LM<HL3<9C:7>:VVQ[).063R
MHL<$[^5$KFE+:C, _P"E(6EKW)&NNN=76[,?#T&G48]K=/:DL?:>R-I_3O%.
M-S>MQ4GQC:MNGJE.2^>#] R2<JN/*#$-4>M83T0S C-LH2#[$[]ZD_FVUTFI
MZEW;4.BFK:?X5];J_G/;&R^3O0>UI2O:>>JE'C>FVO\ #!0A[8L8E5>0WB@M
M+%A-[O\ 3'O-+0^WS72&P.OOUU\=%N^Y.O+=N5XNM/:\#RZ[U'T!T=;=EW]!
MI.7_ (=ODY_1R03E7TH>8?&%I(*53Y,:&C^4E)+[P_($?HC_ -?KN-+T=K+B
MKJIP@NQ8OYL/G/!-X_4/T]HT[>RZ>_JKG"4EX<'_ (O?7^!DWK.-\=A;+D-N
MSW1MNIY9;1O[PEHI<VW]A6H:\ATO2^V:6DI)W)][HO8L?G9Z>Z@\\NMMXK;T
MT[>DL/A!<TJ=[G6->]0B^-2<1(42$V&845B*WT^".TAH*(Z J"$CN5]IW)UW
MUJS:L1Y+,8QCV))'J;7[EN.Z7OS&Y7[M^_\ BN3E-^A<S=%W+ =*2DM,PLYU
M1438%3#IH:[+*\FLWDL5>+U315YLJ?(4%(CN**2EM)"EN+W2A)(4I&R=R-F*
ME--R;I%+-ON.CU.LY?X5GX^+[/[16UR/0XDU(J.%ZY]IQ7FQ[;EF^82C);E:
MSVR#CT5[SW*. \4G8@B6L$=[B%)Z[K.WW]6U/5-*'"*R7I[7\QU+FVZYR?$Q
MT]-6\Z](DNKERWW%O29<E:Y$B0\X2IQYUQY3BE.+4222=R3U).NZAI+%M))5
MIV_9D:ZB%R82.I/3H-S[/S^ UO22P60&QQY!/=L-S^^1[3]N^HTJUIB!M?L6
MD=%.)W]P/<K\X3N1K"5RW#XFJ@F&-<<\CYFU\SCN'W$BN[>\W4YI-11-M^!<
M7=VKD*J2D>)W>WUP+^Z::T^5R7-V<?8JLR46R1GCG#:/KGG+F/M24J&^/\>0
MY.=V[A!1YD9=E'778W"DA1(.\QT CP4=P.*]?JKO\BU*G;+W5]<OF+RJN+Q[
MAXAS< JNS]3.()>024 %&0\MW3TAE1/9NO\ 5.A73UI;W!("WI70@'?8E7'D
MM1/^?>Y5V07^\ZOZ#?#2WI_#!T[7@/DK*^3+:)^'OYC^K%*H;#'>/J^%B%2A
MM0(4SM2QZ]<EH]QW#X=)\"=@ -:LZ:+YN7FEVR?,_GK\QRHZ&7_$EZE]O]A&
MHV,4L=:GE1/G)"U*<<D3UJENNN*)4IQ8=):+BE$DGM!)ZZR=R62P1S(:33PQ
MY:OOQ_L'Y"4MI"$)2A"1LE*$A*4CW!(  &L:LY*22HLBK62R!=!Z#\@UC3$Q
M;X(-"%B1*C1&R[*?9CMC^6\XEM)/N!61NK[!U.JDW@C&4XP59M)=XBK?QK,G
MU5N$8W<91+;4/,?AQELUD/?IYD^Q?"(T-D;_ 'GE-H_T6EQ6[<*WY**^?U+B
M<.YK;=.6VG)^Q#DG&\7IY"&^0,N=RBX5N&^.>*NVT=4Z-S\M=93LNKCA#C92
M\U',QY*>J2#K3%WKF&GARQ_%/#V1S]M#A7-1<N83?N]B,@(KLHR*M_ 17P.,
M./W%)6YAN+J4NSN0 4I7E-\X5SK5Y3:@%%U920D#R4* 5K?:T:C+Q;K<[W:^
M'H62-#;I18(F5=10*B(U K8S42(R-D--)V&Y^\M:E$K<=6>JE*)4H^)UR\3&
MHO$;I_5_7TP+Z"VM@(!4LA*1[2=A^^-'RI5X"AXAIIPGRUI61X@>(_,=CMK%
M23R&/$N_+'W?U?NZ50HRDQC[OW-_ZVE2T#Y7^KIIB2HS6UY0T2=[:TA0E; A
MEQP+DJ!&^Z(C7F27!M_-0=1T BK9F4Y5TP?!;R\CG?MM[!#=#1D;$^8U/L2V
MU("0-RG="]O9U&N/<U-BU\<DG[7[$$F\AOM(,.L*AR!RY14SJ#LO&.-HCM_=
M*6KPC/6@'96RTI_GDH^WJ-:/S5ZY_(MNG;+!?VF5.UXD95E_'F/K4YB?&2+:
M:=BC)>6;/\3?>*>J'E8Y'6F(5=Q[@IH@GIN/=BK.JN_S;C2[(*G^L;H:>Y+X
M8T](SW?+.>7[)C2LJLX]>V@MMU&),-XU5ML[?T'F1&VI3S!W/PNI7T_<&VWH
M+-M\S2YNUXLY,=(_OR?J,>Q_,6XI3,.)&6KN<5(>!G2BI2MU+4Y)\U(6HGJ4
MA)UR>6$5C5F^-BU#**KWXB\PW'R%2GY$DCP#CB@@?V*>[X1^0ZG.E\-$;?25
M-5Z&EA20V@;[[@;K/^A[C\1U.9ME6(X=C2=MSX]1W'^+PUC5@K*$'XMAUVZC
MH#[O#H=2K%:(22[.)#3^FDL-JWV[5N)+GM\&P2X?S#65&UAF:I3MQQDTB]5N
M6MZ0B@Q^\O%DE/= K9*F!L=NYQY2$AM /B2-AK&3A!?Q)*/I9HEJK2^&LB8J
MX[SA+0>O'L5P:*M/F![)+V-YY:W\6V8RUJ\P[;!*D@[]-:/S%FM(<TY=R-,M
M5-Y)+TXC F/Q;!>,6TY)R',K(?TM+Q[1NKD!1Z(:0YY;WS"%$'J$#?P\1K.N
MJ:K&W&*[9,TRO3EG)^K DU:U&*P<1X%D/+Z%-SR3<HC(7OL$F312WT2TJV!)
M"(ZMO;MT!URYO^+?]4%]?]IKSX>TFL>!S%,;\ES*L/P* H KK<(QL3%#IL$M
M6$[\*<84GN/7RW!]A\1K?Y58\LIOMDZ?,JCWO0()/%<">\AS*LISC,G"$K6B
MXR*3%C%75/:RU2)K'D-=!LE3J_<=QTU/S#C_ "XPBNY?;44[275/'N#492NL
MQ2BCOI\)BZ^/*L#MU'?8RT/SE@'J.YP[$_;K"6HO3^*3IV5P]A:(E+R0X  >
MJ2=C[.NVX_>UKHWF#P;(3U/1(\3[O'5P0+:'VW-P#U'B#^Y]O33,'JE>Q.VW
MLV_KZB2 C;=>6X0M/3KOTV"?^F1IB@7RL#IO^8:8L"5;:5K[B3]H]X'AU]FI
M1 '7PVG=7LV 2/:?=_T]7T I0\EQ/=X=2-O^ET]NIBP4N**D*">BMCM[M]NG
M7I[=540$[/F)[O,W&X&R=]R?'?IN=/0"[WCW'5Q G2VA"NY/=O[-R.GO\ /9
MI3M!;=D)94$GV]2=P-AX#\NC:!474#;8[^W<:E&P));I4D=@4=E==MNOV[$C
MP.GI -N$(3W=2!\1)'3J=M_'V:N0*%/H<!"2A0^P[[?N'?5HFL04(46P=CN3
MXDZC28+"):EN=O7V['[!N>HZ;;Z4]@+Q4H^))_/I@@(UH=4Z2G;MW&RB1\.W
MV;[^.HWB!0IQ"/O* W]^E6"E0;= *ME#Q!W(\?R$:F.8*'7?+02D;[;#[ /#
M?[=M*,%#+ZE@D@';;PZ>._[^I](+I62"/#<$?:-QJX4[P)FVU(45$CPV&V_[
M_314!<+Z0>PK (\?'^'PU,P>;(W[]AOOX_;_ %]6CR!0ZX4!)'@3U.V^WN'Y
M]0%2' H ^&_[F@!P=XVW&^X/4_F^T^!U$RGK:>Q/CO[>AZ#\FJ#P.H6HI!W/
MV^!U*H%6Z1T&P_>TKA@"QYBO, ]G<!M]GO\ W-*T](%&_P"[J5P!0L G<G;\
MGB=3%L'A<2E/MZ= /;]G\&CKD !2ZD^(Z_D(/V:@/4H#8)2>I&VYV_K#;0 @
MJ)WW/M\=_'?2G %T*(._\.@*1[_ZNFL: K4Z$[>\^SW:F-2E:5=PWT=0>*)&
MQ!_-[_S>W5K7,'J5;C?P_/J/L!5W;CMW!_AT5.(/0K;?;VZ.G %:5> /COMJ
M KT!Z3N=_P G]7[NHE0%?>-OMU.7'N!023XZJ5 >:H-R- &@#0!H T : - &
M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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M&9D>+Q#R3)BHLKRNJN/*5T IN>2+F'B;!2K<I+4"P6BZE%8'PAF*\5'8 $D
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ME0%??VC=/Y/WM'C@ 2KN\?'VZE: K!V!'O&CH_2 2=COJ4[2EP+2?;_5_!J
MJ!Z[C8[: K[ST_?U* K2K<:F7H!5I7$!HY=@/-8@W)UL : - &@#0!H T :
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M9QKLY*_"*?NL[RO/,QF79$AUIB.PTX\^^\XEIEEEI)6ZZZZLI0VTVA)*E$@
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MY9$%#KR&4]RSL-]O GJ=S[/R:5;R!2'&W4A0 6/9N 1^^-P=2C[0>*=*$J(
M.R20D>W8=  .O765, (H\AY:EAP[I \>T @]/AZ ;]/?K%4K@!7W)]^KZ ($
MQPEWS H]H)*4^W<^&Y]PTH"MZ4ADA*U'<C?H-R!OMN?;IAPS!4'$JV4/ C<'
M;V'W>WKI[P+$E;G8/*[M^[KV_>V^S;KMOJ--E/&%O=GZ3H0=DD_>(Z=3^?\
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M-5!6%CV]/W]2CX N!1V '[O[^B7%@\U:]H#4Y@;H:R : - &@#0!H T : -
M&@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@*
M5I[TJ2>FXVWT TEOREN)W)W65;[;>(&W3<]-AK72@*2H#Q_<T YQ25,H)]ZM
MOR=QUFL@42F"ZD%/WD[[#P[@=MQN? ]-&J@1(BNJ4 I)0GVJ.WA]GCN=8I,#
MN!L !X ;#\VLP&@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M : - &@#0!H T : - &@#0 0""" 00001N"#T((/0@C0&O7(?I9X1Y*^8D7&
M&Q*BWD;J5?8J4X_:>8=@I]Y,1O\ #)[Q2G;NE1GSMX:T3T]JYFJ/NP*FT:SN
M>EGG[A]Q<WT^\R2Y=6VZMY&'Y*XF(SV*4HEM,64BTQ6RE+Z;NN1X!^([$$#?
M1^7O6L;,L.Q_*GT%JGF5P_6'RMQ?)CU/J)X9MZQ!5Y/ZSXXPJ,S)4A0"C&CS
M'Y%!;.]BMUF-9-("AT0 KH6JN6W2_!^E?*GSCE3R-K./?4;PUR<&&<8S>K%H
M\$;4-RLT5X'5C<L,P+,1S8.-[?$8BI#8_G:Y,+]JY\+Q(TT9NUM(&@#0!H T
M : - &@#0$?R7*L=P^K=N<FMX=/7,]"_+<[5.N;$AB*PD*D2Y"@.C;25K/L&
ML[=N=V7+;3<B-I9FGV4>H#-L_=?J>)ZQS'J/O4Q(S2X;0F8ZE*NUPU[)2^Q$
M[@?Y*9$G905^A(.W<:?;8Q]Z_P"]+L67K[?H])@Y-Y$)HL!J:R6NXMY$C)LA
M?<^8D7%NM4E:I)()>::><?V="@"''%..@C<*'AKM%%)<L51&-&3TO#\_]7OV
MU:,47$H+W]7]6^E!@4%\^_\ J_-JT'J'")73)G:H)+3)Z^<X.T$>]M/13GYN
MGVZUSN0AAFRXDEC5D2+LHCSG1_ICH!V(_F(ZI1U_*1[]<>5V<\%@BEJWNZNC
MANS[>?%KH;0[EORGD-(^Q([CNM:CT"0"2>@&I&+;P)D8I&<Y?G+4T\8T+;5'
M *DVW(^7NMT.&4[:3VN/.6%@N/'4MON!["5/>YE>I<NV-.TKCK<>45BWZEC]
M057ED8U?N, JIQDAN;ZA^0&20NUO!+JN(Z"1W;]L&H4(=ADK;2P0I+WRD-Y.
MRD(/MUO\U>^)^!8[%C-^O*/JJS;;M3NNEM.3^9#7D$W+<]>C2.0,A>M8T$)%
M7C%:E-3B=*TA/8TQ6TT%$:&TEIK9 4EM#BDC9:E^.K;A:L)JQ&C>;>,GZ6SL
M[6WQ7O7WS/L67]OS%QAAB,TAF.RVPR@;(:90EMM(_P!"A "1K)MO%YG81C&*
MY8I)%[4*&@$LF;#AI[Y<J/%3MN%2'FV@?R=ZD[G\FJDWD8RG""K-I+O9\+'T
MG.?/J-<0UOJAK_1'Z8.+>?<5N>:W9^;7&?9M0XM+H;]EBP8KJZO8M^5./G)<
M:57$NJ6AF0D*Z%:3\.O&=N>O2N?E+<9QYL:M*C];1U$-5X%4J8OO.P,/UF_7
M_GO)CQOIQ>FI3RR A#O-&!1N]1Z!*%2?4TRE:R?  DG78N>])5=B%/WE_P"(
MW0UT[DN6"CS>SZ6;'_6]E9%.^CEZAIN7UD:ERR9CWIRE9130GVY,.IR*1Z@>
M%'KNLB2694YF1&@62W6FUH?>2M* 0M8/<<MSJ]NFY82I&O\ BB<O4U_+NN>'
MTHTP]&7T3/3YZG?1]P!S%ZQ<JY=Y9Y7Y'X!XN?Q&TC<AS,?I^(>*/U*JV^(L
M'X^HJME50Q&QK 55Y?\ Q!J<A^R4^\MH*<<"N/IMLLW]/"YJ'*5R4%3')4P2
M]"-5O30G;4KE7)I>I<!U^@]G>8<,*^IAZ4L_SJUS#C'T)\TO5&'VMF^]*=K*
M:-><VXYE[=2Q)5_X,I)?^)YJQ:@M*1':E3)"TH2IU95=KG*WXUB;K"U+#_6K
M]%2Z5N//!OW8O[?L->_0%Z(\<^LQ+Y@^H#Z^,BS_ #BJR/E'*<"X4X=J<OL<
M;Q/",(H6H4Q,:+(IE1[)BJJ'KE%?#C0WH7FR8$J;.,Q^65C3I-,MQYM7JVVG
M)J*K@E\OM=:F%JVM16[=J\<$88R[T=VWH=^M)]//A7'^0\TSGT^R,F1F_ M3
MG-HJ[M.,ZZ^DWT#->/8MJN/'#U9!R"D1/CMLI;80U8I46_FG)3S^N6G>EW*S
M:3;LUK&O#M1B[?AZB$4VX<.XW9]=*>3/J4?5,@?3 A\F95QGZ8^$.*Z[EKU%
M0\'G*K[[.9%E58U>HBS'S&DP9D9$?D+'(,&-.;>A0W94F:IM]X1VD\G5<^MU
MWY'F<;$8UE3C\JKZ39=YKU_P:T@E5C3ZX?HN<.>DC@/+O5UZ \KY5X&YZ],F
M-3^56K")R!>WT#+,9PQI%YF35HFV%A+BSF,=KY,E#;*DU4P-+C2XJV'BMJ:K
M;;>GM/4:1RA=@JYYI9_-ZA=TT;<?$M54HXD9^I;ZEK#U@?0 XE]15W%C0\CY
M"R[BQ&6LPF?EX"\TP_-,IP/-)5=%W5\I6SLJQ>8_'9[E>2PXE'<KM[CAK+SU
M&U1O/-M5]*='\Z,+T^?3*?%F5/3W]"CA#U(>G##N7_6GFO+O(_J9YKXTPW*9
MV9P\U?I(_$-?:XS D8?@V&8RS!5CZH>$X^]%A/,3X\V('F'$Q4,,=B=9V=LM
MWK2N:ER=Z26-<NQ+T&4--&<5*Y5S:]AE#Z(?+O,.'9GZQ_IS\Y9O/Y(N?1;R
M%'J^,,WMUO.6=MQG8VM_2)KC\R_+FL4E<Y3P;"M9D2)3T1B[5##@8B1VT[=L
MN7(RN:.Z^9VG@^[Y9>FALTTI)RLRQ<7\QB;]FL3EJOIJ>HA. JH49VKU.<MI
MPI65+G-XPG+3P'P2,<5D;E9'EV2*$7'D_.&.TZ^(_?Y:%+V!U[-S?DI\E.?G
M=*Y5Y8TJ8Z.O@NF?,_H1AS$OID>A7"6<XSKZSGK,XRY,]7N7Y1=6.3,S/51^
MK$&AI%SDC'FL>HY+F#\@VLN9$D"8MIR U @1)#,:-!8:C*=>PCHM+&L]RN1E
MJ&\?>I]C^61K\*VJN_).Y7M,6_2 S#B[A/ZO7,?IH]&7.63\M>B[.>-+^]IF
M+N?8R:LY51T6)7K]E&3+IL?BV5KBUU^)5$:T9AMB95N@+<D%*7CJT$K=K7RL
M::3EIG'Y\'\V*]!C8:C?<+;K;H1;UKY1Z;<]^L)SGA7U=<LY<Q7T\X5B./0_
M3%14"LU;XW:KK*KQJ2S=2OU(K[3)$P\D6N>[+G5S76V2Y'ER&VH:&48ZEV9:
M^4=>Y*RDN7.G#L^527'!WVK]>59'1KZ;/H#QO!_6%9^HWZ9?J[XHE>@*XPQ%
M3SCQKF',BLHE5V664+(6:E#%6RQ+=B/4EA%JYU6]:E_($A5E!(##P\SDV+5G
M3:I7-)<Y[$EC"-92K]"IAC)IYG&=_P .3=BJCW_+V&I7U"^"+CU%?7RX5X+X
MLYIRZH8S[TMP:K.N4</:_4_)8N%QX',MKR!383(M@^_6*R#'8*ZAJ6M@J1\\
MXZ6%-@H.%ZW>U&[0MR3M.4.#JU&DJX]KR[C3*Y*<7.;YI&)_JS_3CXZ^DG@G
MIP]:WHUR;+N.N1J/G:CX[MZZ5E5UE5?=R+7$<QSBOM)RKQQUV7%D(P"5!MJ\
ME%=/BS0VJ/VA94W'16]MC;U>D;C<4Z9UK@W7'T8\'7(QBW*L99&]_J<^@+Z;
M:[T7\W\O9[G7+O(7K/QCAS.^9<DY\R3/[.0C)^4L4PNRR^=62L7*)M'%P2PN
M:U41M"&7K*+"4DHE+6@ \O4;/9_*SNW'*6J47)R;S:5<NSYS%3:E3[I8P3F_
M/^>?V8CD3+^3KVRRG,:CA+DW )N3W$URPMKRKP+EF?C.+2+*4\D29,Z%BL"%
M#=>>6\_)7&+[KBG'5;2%V=[892FZSY&J^AT7S"B5RB(=R7ZR.2/1_P#L[OHX
MD\*W%ACW,7.6/X3P;@^2TKI8O\53D;F;W^1Y%0R4K;<@W**#&GH$.6TI+\*9
M8LR&BEQI*TXSU5S3;+:\)TN32BNU5KC\WSEY:W'7(V!P?]F@]%\KA3\'YIRK
ME_.O4;D]&JPS+G-G/)K$B!R#:Q?F+2PQ[%W4R**QIHERZI2$VZ+&9+0"IV2%
M+W1MAL>E\*EUR=]K&5>/<OMJ'.5<*4.EGTM>!_6)Z7_32WPEZQ.4\+YAR##L
MKLX_%N78QD.69+;1>*WH<!5/C.86F78Y0S7[2BM$2Q%[')S<>O>9BI>+<9&N
M=H+.IL6/"U4E*2>#3>78ZKY(PDXMU1TB5*"!NM20/>2!_#KFY8U,<"/2LQIV
M'T0F'W+2R<5Y;-73M*L9[SO_ &I#,;N"7=A]U2DDZCDHJK:H*$J&(<C2(:+;
M(5X]Q!C;AW%OGL]EFX?2.WN3 H-S(,P%8_0OH03OT._CP9[A:;Y+*=RY^RJ_
M/E])ERO-X(B,G(.%,<=#T>!DW-U\T=T6V42'L8PMEQ/PJ<@4R>Z=):W'Q,/I
M6A7L.L>37W_B<;4.Q>]+UO)>HV0M2G\"<N_@,=YS)R3DD7\)A63&(XZA*D,X
M[@<)&+U#+2@D*:^8C[6#S2TIV6VMTH/78 $[[;>@TUM\]SWI]LO>?V?,<RWH
MI/\ F.B[%]IC.-5NI>[EGJM2E++6ZEJ[R2HK?<[G5%1/7?Q.N36*^%'+A8MV
M_ACC[62!F VUMLA"#_.5\2_S$[D?O:C<GFS;D+!&8[@H@J5[2K[O3WCPUK=0
M7W'$-H)W2  =^NR0D DDGP  UC0#?'M6I;Z(=6Q+N9SRBAF#3QW9[[K@.Q0C
MR@6RK[.[?[-9.+2K)T7:\#CSU-B'&K[L?[">M<<9VY#_ !#(W\>XUIUI*A/R
MVS91/<1TW^7KD$NB2G?^B<0"3TWUH_,6:\MOFN3_ &5A[3B3UDW\"45WB6L@
M<6-OJ8JH><<[7+*^U2:R,_28>S(2=@)$SX$02%_REN);4!OX;:/\TU6;A9AW
MXR]AQ)7)3^)N7T&5Z^%RO-9,.I:P;ARG>2$O1,9K6;G)7&DG^CF2DEF$W)\
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M6:0$LB<^EI:F@A)2.@ WZ;CW[^ U:)$$+$M]]*B\H]%=-N[M(]VWAN-5)/%
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M1TZG?P]_YSJ5KF#U 4$_%X^[W:,%06%;I"@?>-54X@J':G[@VW\?$_N;[Z)
MI2Z>[M(W!.WMWU'3@!1J H(5ON/;T_)H"\E02-B>O_0UB\,4"X#N/'<:E?:4
M]U:X$*@L^WKJ)%+V_L]FL51X@!T_-J@NE0'_ $-1 NH(Z_F/]7[NL6Z@K!WW
MV]FC5 !('3VZ4!NEK,!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M5H/4;>'Y0H'?]PZM%3 %'P-(V2-DH"B$C<GINH^.YW.I1@31YGG*4DH[=AW
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M;W>TG2CK0%PNI'0_U?ET=?4"X.AW'CJ \*R#N?9MM]NHZ\ 7TG=()\=NHTJ
MW"O#V>W\NXTSS!=1[?S?QZQ:H4J"P3MU_J_/J JT!ZE2B?;X[ >PZ8(%_0'O
M38>_VZF->X%U/W1J5I4%8)&^WMU5B U0;KZ - &@#0!H T : - &@#0!H T
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MF.]!)\@VK5:V_II**3GSOWY422HL,,6\W3O56:YQ7,DO8C6^?D^37]0YC%/
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M]J^?>IZ65A';O\)"0M/O.N<E;MQY(427!*B.;;TEJWC3FEVO'^P51*Y*07'
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M5^%XKEN3Y!88E)C53M>RF#CC;/EEE(:.BRKEZW*3DUS/#N]'T%=$S6/]D?\
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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M^]YLTMMYGBI#;2$M-)0TTA(2AMM*4-H2/!*4I 2E(]P\-=A3@LB#:],\>O\
M5^35 U/2_'KJ$&*=;L1=@XLEQ?1MEL=[SA)V 0@=3N3MUV'VZPG<A;59O$$\
M;XTL84"/?<K9 QQ-CDM'GP*V;%>L>0LB8'4?@N(L*:FL,.G9!DS%1&&U+225
MIUTM[=979.UHHN<EFTZ17IE]2JS-1XRP'V%F"J9MR!POBHXYKG6EL2.0,B\B
MYY2MV7$E#KC%@I(BXRB0@C=JN0R 1W!\G7!=EW'S:R7B2_"L(+U?>]?L.;9T
M=Z[BER0[7GZE_H](PU])$@//35*?GVDI:W9EK8/+EV$IYTE3SKDATJ7W.J)*
MB.JOY1)ZZVN3:HL(K@LCM;.FM6,8JL^UYCSK$Y!\,_TB_55ZSO3W5^J:F],'
MH;N_5A0Y#S<Y9Y1D-5F*\9;Q*WBQ[&+#IG6$TEK\TN;#)?"^Y':!ML?'7C&W
MW]395Q6+3N)RQQI0ZRQ.Y#FY(\RJ;=\E_5*^I/ZQ\RR[Z=/'WI-X\])?/').
M+W>-Y1+YGY.72Y3581?5"V;F=@]?F%?ACUE:3<>DO.L/U$+(IQKR[,A1?T!E
M,\B>NUFHD]'"VK=V2H^9XT[JT^:O:C9*_>N/P5%1D^T[*>FO@S%_I$?3:RNO
MF6#6?6/"?'/)_.7)%K#0JJC9QGT>AFY-:5U.'FE/1JYS\+B4M<Z\@/+C1V7'
M4I6I:1V-FU';]&T\7%.3[WG_ &(Y$(K3V>VB;9\U?IPM_I>>K.JM?4_]6GUE
M9!R!ZE.3;J_EKXG$OEW'<1X:Q:+?6L6@Q:F_4O')I$=^(VF;'C0[%NNA1)#3
M'D*D(?>=Z:R]#J%X^ON-WI/+%)+LP.'#P;BY[\JS?#' V$]%/J-].OHT^I)P
M]P%Z$_5#>\[^B7U8RI&/91Q?DK63R'^&>6IZ9</%Y]!-R/&\>+HM;I4)D26&
M4NR:YYUFP,AZ'$E:VZ:]9TVLC:TLW/37,TZX/AP^7'(SMSA;O*%J5;<N'8R
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MW_9V/2TC<=,2]+?3\E9K5K?_ *@6O1 L?YC/I*X'LH\3@;A-4A]#8_Q1\<;
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M?NVZ^ 'Y_'3#@"L+2#[SX>WQ_<U&J@N#M3UV&Y'L\=C_ !:F.2R*>A2N[;J
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M: - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0
M!H T : - &@#0!H T : - &@#0!H T : - 6GY#$5AZ3*>:C1H[:WGY#[B&6
M&&6TE;CKSKA2VVVV@$J4H@ #<Z)5P68-$^5/41<9C*F89Q$\[$K4*5'NLZ'F
M,+6V24.,TB]@Y&96 0'P//=VW:"$CS%=QI-OQ4[ZQ[/M^PUN7!&)*"@K<>84
MF,E3\M[K+L'P%29*R>Y6ZMSY37=X('Y25*W)[J,>4PPXC^7C_5_4-4>Z4%U7
MO_J_/OJ50KV(?*.@LK][MBI\N.A0#\QS<,,^TI&W5UW8]$)Z]1OL.NM=R]"T
ML<^PJYF9LI<>KJ%KMC(\R0I.STUT)+[I\2E)\&FNG1">GOW/7767;TKC][+L
MX&?<1+.>3:'"FT,/*79WDHI;KJ*!^FG2GW%!ME"D("BTE;A Z@J).P!)&K:L
MRN>\\(=H;2R,-Y0A,9Z-;<\R)TNU>2S+QO@'%Y2XMDXAU(>B2LZLF2ZO&HKC
M9&[.R[-P*W2ED ZL;DKB<-#16^-QY?W5]Y_ZI%%MI8N3R2)OQOSKFN+S[:1=
M4.+S,2LL:EXM7\61H:8.$TM3/E,/RVUUK"76;25+9:4T^Y*^8<>0ZL+<(5VC
MBZK;K%^VH5ES\U7-XR>%./#N6!VEG0RIS771]BX#_P#XT.)/^2AZ>?\ W'^,
M_P#B%K@_T.U_YDO8C?\ DH?B8?XT.)/^2AZ>?_<?XS_XA:?T.U_YDO8A^2A^
M)C/-YIX>CRF*R'Z2. [>[F.(8@4E5QQCTVQER'3LRRW'CX^XYWNJ(  !6K^2
ME6JMAM4YG<:@LVZ4.-?MZ>QA*3<^Q9_V"3FC(JS*[VAR'FV)&QZQJ<9K<>I.
M >,[ 2KB3&@3K.?"5EUNVVY PZ&&K!+7RB$NRPPD%MMI0.N;H+,[4'8T%91<
MF_$DL,DJ17WLL\C@RNRY>1MJ&=%]9B.YOLERVN9HIC<#!N/XK@=K^-\.2J!5
MDCM[)-],"US;VS<"0IQ^4Z\XI>ZD^43VZ[_2[7"W+QKS<[[XO%_8EW(T.3>&
M2$+(B0&$QH3#49A'W6V4A"=^FZE'[RUJ]JCN2?$Z[91452."((WIGV_U?DUD
M!K>E^/74] &B3/0TE2W%I0A(W*E$  >'4G1M159/ 9C[B^$Y+FT*5>M/P,0P
M2O<\NVY!REQ<"BCJ!/=$K04*DW5JOM*6XT5MUY2R H(W"M=3J]TMVGX5I.5Y
MY)8OV<%WLJBWCP)C5Y+08DM4?A.E<EVZ2IJ7S5G4!EVZ<<"5,O/81CC_ ,S"
MQEI14ORGE^?.*%=KBVU ;=5.W=U#YM=+W7_PXO#^]+.7S(Y=C37+V-M4C^)_
M4,C-,E=A(N[B;-R'()CJI$V\NI#LZ=(D+^\Z7)"W5!9]BB5+VZ=VVMO-2/)!
M*,%P6".VLZ2U9][XKG:_J[!ZUB<H- &@/F/_ &:7_P 8'K@_\N/A?[BV>NEV
M7X+O[YPM'E+TFY7UIO01:^JK@F#S=PHQ857JS]+Q<Y!XFOL8=DP,KR*EI9+=
M[>X- G5J38NW3:H7XGCP;W>:NHZ665-)FR%GD;EI'?M>);_S$,53/T?6N_TF
MW46N>/-'^9'(1^DGU+0?J_\ TNN6L-?M*FMYWON'L[X'Y;K^\P(E-R==879U
M>,9P(L<./Q\7R]QV/;-]C:F6W4RX:?,^57NT]Y;AH91_XKBXOTTP?H>?S$MS
M_,6&OO4H_2<@OIK\]?3+X7XCLO2A]1[TO>GKCGU5\#9/EF.7N2<W^G#CW(;'
M/JR7D-G>U[ESG<G"KUPWN-1[1-<CYQ[RYU6S"D0GI:7'2UP=#/0PA^7UL(0O
MP;JY16/KIG]5*'$A>M6[?+."E<3[%CZS;KTY>I[T%\\_4)X[XE](_H ]/F4\
M.X-!_73D_P!3W&?!O'7%N1<96=>S92ZBQP&SF\7-63TY%O'A0XC[JZYV9.>=
M,8"/'5*5R[5[37=4K.W6;<FE5S<:*+[<J^C)MY88G#NW9356E!=B2K[<R)^K
M[U%<:>FO]H']/_->16B_3;QBQZ2I>/1<N?MKZQ<;3=UG-^-)L+6_B1W)K4VY
MM9/R;SC;3+$<J0-D-CN.K41A8WB#U\E*#MU;:P^]14[$_P"TU*KA2.#J7/73
M=T>2_5R^DGEF.6S%]2916S\DJK^-*,V/>5EU92[*OMX\O<B1'L8<E#R'!]]*
MPKVZY6M<7NND<*<K6'H)'"#&+U/9X/IO?6+3ZV>4:*^<]-?JRX=@<3Y?R%0U
M<V_9PG)*6JP.I>CV$"(T],3(@_XJJ2>IAA)D2ZV3)7#1)?C/QQCJ9_T[=OSM
MU/\ +78<K:QH\/\ PI^BM*T*ES0Y>*,_^L7ZWG!^(<>5%!Z(,LQOU(^IC/LA
MQ2IX]PNNQ3-K_&X[4Z\AJM'<J8B)Q69(D3ZQEZ!&K8DYFS$R4TZI"6FUD\C5
M[S8A;4=$U<U,FJ*C:SXY>BE:D4']Y41JO]3S-L_X*]5/TF/65ZA\;C0:?#8D
M*GYXEX!76]AC&%YX\Y0VV:5E0'I-M,>B1(]W8/U##DEV59,5+X05*0K;B[E.
MY8U.EU>H6"^*F2>%?I=.V@@JIQ1D[ZH/U2O2WS!Z,>8^&/33FSW//(G)N!)>
MF1<)QK)W:?C[CV%;5-GE^;Y_;VU54P\=B5]1&7%:C.*,[\2EQFUL)2LJ&W<M
MSTM[1SLZ9\]R4>">"XMX8?36@A%IU:H,N:OH'[-K!:4H!2_3U@24@D;JVYCQ
MQ1"1XG;;6,__ -WO_=K_ &D/^+ZQZ]5_ISYGS_\ 9KN&.0:'$'SBN <0>F?.
MYZY*_+N+S'*]ZEJ[:RQRF2%S[&%1P[G\2EO^6EANLB2)'>4M*UQ-5?MW-HMZ
M>V^:ZH1;25:)+&O85)^(V\C>7T_?7=^FEQ+Z1N&+;C^189OZCX/%/'N+6^ Y
M/B>1Y7R6CER)B=352\ XUPB!4"ILW)&2(5#K+E<AB&[W-^8\H**1E#76[]A/
M476HI)*W!/F;6%&^_P!GH+R/FI%8]K-(OV=JXN,EQGURY#G-(ZC-+GU-*O,@
MHG%!NNJ<FMJZUF7[#L9L^3YD6S=<:VV[>U 'L&MVP1;A=K[JY\>WT'8::Q;G
M65Q5E'MR]@_?LSZ''/0ARLWWN*9/JYST_+)4H-J<'#G FZU)21W$C8?9MK9T
M])1T4\J^*\?[L3=I,;;7#F^I#AQ7''_P2/S\TI(: ](M,KM1MT_\];A+\O4[
MZPC+_P"GLY?^R^J(6&K?[OV"K]H+;0@?3L" -_\ .[I]_?\ _(#Q/CJ;S*O@
M_P#J?8-57W?WCZ)I-A#KA_;3Z0XL;M1F^YV2[[/T;#84ZO<[#?;8>TC7=Q3>
M61LN7X6OC=/I]A.Z;C?,[J(FZOGZWC#$".]=_ESC3%A(:(*@FMIW%)<>D+;'
M<A*OA=3]U>^N/<U5F+\.W6Y=[(Y>MG NZZY)4MKECVO/Y>TE^*0L5AO!7$.
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M4G(LZF0[+.ID=]FN93'H<1J6$5N(XQ"2 &X-33QNV(TVVA*4J.RE.=H\Q;I
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MH59,LOQ3#N0<>L<1S[%<8SC%+=M+-MC&7T59DN/6C2%I<0U8TMU%FULUM+B
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MB1ON-_9OX;^S1*@&6,)29'>X#M\06HGHKH=MNO7XMM2@'%3B00E2T@G[J2H
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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MG,6=F5:M'KQ3Q<_&LK!*]E;Q,GR\J>Q^G4VZD)?9;5.?"#NA*5=!KC=O7?\
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M ,/T^DW6[4IRY;:YI?,O21C-\QR',IC,_DO(W;U^.4FJQ.M3\EC%*E*"TRU
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
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M2^J/8E\N[LM+HW<I<NJEO@NWO?=]/HS4)2E"4I2D)2D!*4I "4I V"4@;
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M_P"K]S3 I3Y_^B_?TJ,0+Y]A_?TJ,3SSU>_]_4]0JRIMQQU:6VTJ<6M02E"
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MPV"_+>;8:![>YQ6W<H^"$)ZJ<6KV)2"H^P:*+;P,93A"//-I1[R5XU@&:YI
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
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M:_J[!*(TB:[\Q-=5(<]G=T8:W\4MHV"=A[@-M9\R2Y8*B.2.(CA&Q [B/;[
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M"I2CX>TJ.WN&K2F9!.U+:DJ6A.Y(3N0L)V*=]CT!/3<^WWZE:Y9%+NZ4#9(
M^P  ?O:M.T@V-N2_F%!T*\HE7B!VI'4I[2!U/@/X=%7@!65^X?NZO+V@0/Q$
MON^8IQ0&P!2 / ?Z+?I^YHZ(%<F4B,V%K[E#N"0D'<[D$]=_#H-,> *&9(D(
M#B-P"2-B!N"/$>W4= >2%N>2YY?W^T]OL._O'V@'IH@(H2W]G//\SQ3V=^Y/
M\KNZJZ[>&ICQ*+BI)!&^_L(]O7^#0")N,RTLK;20=MANHJ[0?';?KUT!8=L&
MFG?**5GM.RU#;9.XWZ ]5;: 5>9N 4^! (/O!U<%Z2#78(D.!M+()3NKO"3L
M=^G;OU'3QU&ZYE%#/>VPA+RMW$I(4=]]NIVW)\=D[:QQ;PR!0KRWT'<I<0?$
M@A0W'V@]"-9UJ0I2&VD]K:0!OOL/>?$[G<D]-*=H$;4TNO+:*>W;N[3OL3VG
M8@CV'VZ@%O>=OM]^L>4HU/QGG)0=20$[H(43]WM W 'B>HW_ #ZN" L=>;:3
MW*4 -]MSX;GP'VZ8@L+;9D=JUI2O;JE0/L\=MTD=P^PZN0+<E\L-%:$A1&PV
M]B=^FYV]@/LU:/,A:B2EOMJ4XD!25=H*=P%= ? [[;;ZQ]!2ZYW.(6D'M[DJ
M2"/82" ?S:4 AB15L*6M:@21V@))(VW!).X'7ITT; H5(92KL+B>[?;;?P/N
MW\-]8YO$%/:CO+B4 +5XJV^(_G]GAK*G:!+,D.M=@;5V@I.YV!W(VZ#<'V:C
MJ"^VOO;0LC;N2"1^7\NK4%B0CSD=H/:0=P3U'NZC\FE&P4--^2WLI6^VZE*/
M0#IU\2=@ -,@5-R6GU%"5 @>((V!&_7[WWAJ427>"\"E [4)"1[@ D?N#;4]
M(&UUR5YX [NWN 2 /@(\=SXCP\=*]@%^H!,^RAT@E2@I/3I[O'V^!U4J@%NA
ME'<=PA  V3U.P( '7;5=%Z0>LR&WPH)WW3MW)4/8?X1K%X9@NDA*2!L-AT'\
M'3W:QJWD4;HRI'F**^\)V._?OL5=P\-^G[FK3M(+N\]![3[2>OV[>[0%DM-^
M8' 5=P(/B-B1[=MB?W]4%N1(\DI';W%74]=N@Z>/7KH"^VX%I"QU[ATW]GO'
MYCJ- MO^8M&S:ME;@^/;N/<#[-3N0/&/,"-G"?'H"=R!^_[=%\X+I6%@IW21
MML4C8C\XZZ8(%M#2$$E(V)Z>)/3QVZZC=2GAD;*"-M@#V[[]2?#^'4JJT!=U
MDWV LN-.+5NGJD >W;8]=SK"6.0%7<$@=R@=@.Y1Z#H.IW^TZN0/"IIP==E
M'?;[1K'%^@!W; D !* 5=HZ> )VUD"VR\MQ120-MB=Q[/L/7KH!3J5[ 6$,*
M\SNW 2%=V^YW(WWV_+K%J@%*G4I('Y_ ^'V:4IF"M7;T) )]G0$_FT2J"TMQ
M0&XZ==A_5[=,$"ZTI12"?$[_ /3VU&JE*^TKW&_Y_P"#4>"!4V@H!WV)/N^S
M6*=/2"H*!.W_ $M%BP5]-]]AOK,'I*@?:![!_'^<ZUMNH+P^WQT!6$$@'?\
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M_P KP_Z>J"C]W0C]93JF MJO^+ORW_3?\)^(?[%_[*_T4[_Q]_\ T(?[7_\
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M(R#0'AU"/(H_J_Z?V:Q69%F=#^"_^*YRY][^G7_P:_\ "3_0*_\ '5_]"O\
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MKQ^]_P!5_5XZR8'/6(+9^^/Z/V>/W_S:/,%1^\/'^+P/[^KP!='W/;XGP_\
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LOI\?9X>/B=&!7K!9@K1X_F_K:RED"\GQ'\>I]T%_468#68#0!H T : __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>mrna-20201231_g27.jpg
<TEXT>
begin 644 mrna-20201231_g27.jpg
M_]C_X2!+17AI9@  34T *@    @ " $2  ,    !  $   $:  4    !
M;@$;  4    !    =@$H  ,    !  (   $Q  (    >    ?@$R  (    4
M    G $[  (    0    L(=I  0    !    P    .P /.'P   G$  \X?
M "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,#HP,CHQ-R P
M.#HT-CHR,0!$;V-U;65N="!#96YT97(   .@ 0 #     ?__  "@ @ $
M 0  !8:@ P $     0  !!0         !@$#  ,    !  8   $:  4    !
M   !.@$;  4    !   !0@$H  ,    !  (   (!  0    !   !2@("  0
M   !   >^0        !(     0   $@    !_]C_X@Q824-#7U!23T9)3$4
M 0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&
M5     !)14,@<U)'0@                  ]M8  0    #3+4A0("
M                                                         !%C
M<')T   !4    #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!
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M0B!)14,V,3DV-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M
M    6%E:(        /-1  $    !%LQ865H@                     %A9
M6B        !OH@  ./4   .06%E:(        &*9  "WA0  &-I865H@
M    )*    ^$  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC
M:               %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                              !D97-C
M "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-2
M1T(              "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U
M<B!S<&%C92 M('-21T(                             9&5S8P
M   L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N
M,0              +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)
M14,V,3DV-BTR+C$                                  '9I97<
M !.D_@ 47RX $,\4  /MS  $$PL  UR>     5A96B       $P)5@!0
M5Q_G;65A<P         !                         H\    "<VEG(
M  !#4E0@8W5R=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L
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M.VL[JCOH/"<\93RD/.,](CUA/:$]X#X@/F ^H#[@/R$_83^B/^) (T!D0*9
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M"KHJJKJ=M:;O2$-=8&M8^SAN[=L4+,'.=<Y[>H7,K)>6UAM) WM:QC?YC?\
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MW_H]]?T++%CYF#UD?7"C.Q<?;T]S:V9-K+7#?M;D>Z^C[137MI]1NS]5R?\
MTATJ2G%O_P#%C@_^FW,_\_\ 3EM+%O\ _%EA?^FW+_\ /_3EM)*4DDDDI222
M22E))))*4DDDDI22222E))))*4DDDDI22I'J#W,K]*L&RZVRJL.=#8J-FZUS
MPUWTFT^QK&O0Z.K/N=412WTK'MJ+@^7;RSUCZ;-FVVEK/\+O_F_TNQ)3_]3H
M_KM;TG(S<3'S'M8,4.=?:_'RKFUBT"QFV[!-=./;MQ7/?:^VK)HI_346UU^K
MZW9+B>HX+^I?7>BVW"?9C5[:7VWXKW5[*VY#K:MSJ7XV17DONK]',?D5?9/1
M].JO]8L]?9Z_UG/Z?U+IF-C-K]+,L#;?4:YSGS?AXIHQRRRO9<W&S,K.^A=^
MBP;/T?I^K96E(^J4Y5WUMP&8N1]EL'3\LFS8VR1ZW3_9ML]JI?7+ZM?6SK&=
M3=T3K3NFX[*2RRAK[*YLW;O5W8_T][#L]_\ ->E[/YYZG=E_6-W7J.I-^K^0
M:J,7(QBW[1B23;9C75O;^L_1VXGN_KJ[^W/K#_\ .WD_^Q.'_P"]22GE*_J)
M_C&;<QY^M+PUKVDGU;W:!Y<3Z3_T=GZ/W>D_]'9_1_YKWKM<GI_5[,3-J9U
MNLO;&,[8*O2,D_SM'Z1WM]JJ_MSZP_\ SMY/_L3A_P#O4E^W/K#_ /.WD_\
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M?3W?.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      ! !CP    $  0&/     0 !.$))300F       .
M             #^    X0DE- _(       H  /_______P  .$))300-
M   $    >#A"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #00    8             !!0   6&    !@!G #
M- !G #  .     $                          0             %A@
M!!0                      0                         0     0
M     &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M!!0     4F=H=&QO;F<   6&    !G-L:6-E<U9L3',    !3V)J8P    $
M      5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L
M;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O
M1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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MU@ !     -,M2% @(
M                    $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0
M  'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)8
M65H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,
MAG9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P
M    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0
M    0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY
M  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0              $G-2
M1T(@245#-C$Y-C8M,BXQ
M                          !865H@        \U$  0    $6S%A96B
M                    6%E:(        &^B   X]0   Y!865H@
M8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6245#
M(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N
M:65C+F-H
M         &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@
M1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M          !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M            =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !
M6%E:(       3 E6 %    !7'^=M96%S          $
M       "CP    )S:6<@     $-25"!C=7)V        !      %  H #P 4
M !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($
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M# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
M$0@ =@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,
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M%2GHV=9Z58X-KRJK'&W[.&L<'$VB9JAL^[VN1L/.PLZMUN'?7D5L<6.=6X.
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MDDDI22222E))))*4DDDDI22222E))))*?__3VNK54YWUP_9?462S(VM=3O\
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MZ/\ -_VDLC$ZE930RC/-%E;8NL])CO4,-]VQWMJX=]!9_P"W/K#_ /.WD_\
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M^54DE/\ _]D .$))300A      !5     0$    / $$ 9 !O &( 90 @ %
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M P,# P,# P/_P  1" 04!88# 1$  A$! Q$!_]T ! "Q_\0!H@    8" P$
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MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5!\GOYY?\
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MB&H64,6]5R??NO='"_Z"#OY,=K_\."=)?\D[UO\ [;^$^_=>Z]_T$'?R8_\
MO8)TE_R3O7_ZT^_=>ZDT?_"@+^3;D:NEH*'Y^=+U5;75,%'1TL$6]I)ZFJJ9
M1#3P0QC$W9G<A5 ^I('OW7NKB/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5+_/,_[= _S$_P#Q
M5OLK_P!U@]^Z]U\6'W[KW7U,/^$:7_;I7>?_ (N7W#_[[K9/OW7NMLCW[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2 [6ZPV/W;UCV#T[V9@J?<_7?:6
MS-R]?[WV]5/-%#F=J[MP\V"SF/-13LDL324\\BI-$ZR1M9XV5U5A[KW7QWOY
MQ7\F;Y$?RH.]LYA-Q8#/;T^-&ZL]72=&]_T6-EJ-M[FP4YDK<=MG=E;1IX<9
MN6BIT:/(8RH\9=HI*FD\U&T4[^Z]U3/[]U[I4;*V1O+LC=> V)U[M3<6^-Z[
MJRM%@]L[2VEALAN'<FX,SDJE:/'XK#87%1RU%343RND<4,,;,S$  D^_=>Z^
MJC_PFH_DFY[^6+TKNKO3Y$XRB@^8'R(PN+Q^=P$4E'6MTKU535,>:HNL_P")
MT9=)LGD*V.GR.XFCFD@66FH::*S4DTM1[KW6S_[]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^8'_ ,*_/C9O[H'^:'L#YBX*DKH=I_(O
MKCKW/8+=JT=0]!CNWNAZ>FV3F-OM/*K0&:GQ5%MK(HFH%UJ&]'[;,WNO=;_O
M\M/^8;TA_,N^*W7GR)Z>W-A*W+Y' 82D[<V!254:[AZF[...4[GV7N/#/--4
M4R1U:5#8VHE9DK*01U$,DB,2/=>Z4_\ ,!^>/1'\NGXR]A_)'O;=>'PU#MC
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M_P"8!LSJ;K?=/^4U4&NIVQFM\[0K)_(DLTP^]PR'14D-:1IHU]U[HYW\N_\
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M_DE?%Y/%XI=<+R1O[KW0-?!_^6W\+/Y<&W-^;2^&'3'^AK;W9N;Q.X][X_\
MTB]K]A_QO,X*@DQF*K/N^UL[G9Z;Q02R)XZ26)&O=U9@"/=>Z/)[]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z_];?X]^Z]U[W[KW1
M.^R_Y=_\O_NC>V<[+[B^#/P[[9['W-+33[D[ [+^,O2N^][;@FHJ*/&T<V<W
M5NG"55?5M%3PQ01-/.Y6-$1;*J@>Z]UI-?#7_A(A\Q.G/G3TSWE\A-R_ #M3
MXS[-[E3>78?3W\8[1WS_ 'JZ]%;43-M7_1]O?K2EV_77CDB3[&NJTIO3;791
M[]U[K<J_X:=_E9?]ZT_@!_Z1O\=?_L<]^Z]U[_AIW^5E_P!ZT_@!_P"D;_'7
M_P"QSW[KW1D.GOC+\;OCQ#5TW0'Q\Z0Z-I\A3PTE?!T]U1L/K.&MI*?0(*6K
MBV5042R1IXTT(X(&E; 6'OW7NAO]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW54O\\W_ += _P Q
M/_Q5OLK^G_.L']??NO=?%A]^Z]U]3#_A&F;_ ,I7>?\ A\RNXA_[#K9)]^Z]
MUMD>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO_7W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW54W\\S_MT#_,3_\ %6NR_P#W5^_=
M>Z^+![]U[KZF'_"-/_MTKO/_ ,7*[B_K_P ^ZV3[]U[K;(]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=?__0W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW54O\\S_MT#_,3_\ %6^R_P#W5^_=>Z^+#[]U[KZF'_"-
M/_MTKO/_ !^97<7_ +[K9(]^Z]UMD>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_]'?
MX]^Z]TE-][ZV=UALK=O8_8>Y</LW8>P]N9G=^\MV;@K8<;@]M[9V]CY,KF\W
MEJ^<A(J>FIXI)I78\*I]^Z]U\X;^:9_PKW^3'9>_=U]7?RUI,;T1TGAJW*X.
ME[USNU<1N;N/LVF4/CVS^!Q>\::JQNV,=.I:6BC_ (?+E%_:G-71RZJ:/W7N
MMZS^5G\C*[Y:?RY_A?\ (7,Y2JS>Z.Q_CUUS5[ZS%=*L]7D^Q\#@X]J=DUU1
M,@4,TN>H,BY;2";\@&X]^Z]U\I#OW^<7_-7V[WMW5M_!_P P[Y?8O"X+MKL?
M#8?&4?>_8$5)CL7B]XUE#CZ"EB%;98X8D2-%_"@#W[KW02_\/2?S;/\ O8Y\
MQ_\ T?78'^]_>^_=>ZW,O^$I_P#.^[H^4.]=]? 7YF]J[@[7[._@N<[2^/7:
MO8.:JLYOK=./Q<QK^P^K<]G*Q'J,C-0P2-F\1/55#2QT<-=3:O!34L<?NO=;
MQ_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>ZJE_GF?\ ;H'^8G_XJWV5_P"ZP>_=>Z^+#[]U[KZF
M'_"-/_MTKO+_ ,7*[B_]]WLKW[KW6V1[]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJU/DY_.+_EA_#K<%5M#Y#?-
M'IG9>\L?63X[+[+PV5RG96]-OY"F($]!N;:'5E)F\EC)EN"8LA2PM8W M[]U
M[I._'7^=M_*D^5FYJ;9G2/SAZ8SN[:^JHZ#%;:W=5[AZCSF=R.0F^WH<7MS&
M=P4&!FR57,_ICI:!)96/T0^_=>ZM-]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW20WYV%L'JS:^3WQV=OC9_7.RL+&DN9WAOS<N%VAM?$Q2.(X
MY,GN#<$]/24ZLQ"@RS*"3;Z^_=>Z)C0_S6OY8V2S1V_1?S"?A?/D]8BC0?);
MJ!*.JE9@BPT.4ERZTM0[$@*D$SL3< $@^_=>Z/9A\QB-PXK'9W 93'9S"9>C
MI\CB<QAZZFR>*RF/JXA/25^.R%$SPSPRH0\<L3LK*002#[]U[IQ]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__2
MW^/?NO=:>'_"S#Y>;KZ5^"'3'QBV=EVPL_R][3S*;YDIZEH:[+=6=(4>.W-G
M=NQ+&5<0U.=RVV9:IP;&*%J=U9*AA[]U[K1W_D_?RE^Y_P";I\EY.F>O<Q!U
M_P!:;$Q=#N[O;N7(XR3+X[KK9]97&AQU-C<0LM.,CG<M,DT&'QAJ81+XJBHE
MECIJ6HD3W7NOKH_ 7X4]<?R\/BCU;\0^I-U=@[RZ^ZH@W$F"S?9N5Q&8W5/-
MNW=-;O7/^:IP5#CJ9(&R61K)J:GBI@(4<1!F"@^_=>Z^+'V[C:/,_,7L_#Y*
M'[C'Y7Y+;UQM?3^2:$3T==VC4TM5#Y8&61=2,RZD8,+W!!Y]^Z]U])O^8#_P
ME)_EJ[K^(?=M+\'_ (Y5O3GRIP^SZ_=/36Y*;NWOS>M)G=V;9B.8INOLQ@NT
M=TYO&&EW D3XK[H4BS4TLT50DH6)XY/=>Z^;S\*?D;NGX7_,7X[?);!&HQ^<
MZ([EV;O3)4,\5=&U;A<+G(X=Z;8R=+2O#4&'(8MJ[&UD"2([1321W4GW[KW7
MW0<?D,?E\?0Y;$UU'D\7DZ.FR&-R6/J8:W'Y#'UL*U-'74-93,T<L,L;+)%+
M&Q5E(9200??NO=3/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=52_SS>?Y0/\ ,3_\5;[*_P!XQ@/OW7NO
MBP^_=>Z^IA_PC2_[=*[S_P#%R^X?_?=;)]^Z]UMD>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZT!/^%0/\_\ [/V1V5NO
M^6W\)=_9#80VC3QXSY3=T;.R;T>[:[<60I5J9ND]D;@QS^3'4E#!)&NYJRFE
M6JGJFDQ1-/3TM;'D/=>ZT!YIIJB5YZB66>:5M4DTTCRRR,?[3R.22?\ $GW[
MKW7!':-E=&9'1@Z.A*LC*;JRL.00>01[]U[K=S_X3)_S_P#M/K_N+K3^77\Q
MM_9??O3'9^1QFP/COV/O"OJ,ON3J+?M?(M!L[KO(YZL9ZFHVUEYC%BJ"*H:0
M8VI>E$304'G\?NO=?2#]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5P_S4_YD
M757\K/X@;V^3O9-&=RYJ&II]F]1];4U8M!D.S>U<Y23U&W=KQUS*XI:..*FJ
M<AE:THQ@HJ>=HDFJ3!3S>Z]U\A+YX_S)/E]_,?[8R?:_RC[8SF['>NKYMI=?
M8^KK,5U;UIBJQU$>W^O]CQRM24-/'$D44DY$E75%!-6U%34O),_NO=$2]^Z]
MU<)_*J_G5?,'^5=VCA,KUSO+,[_Z!K\W#/VA\;=WYVOJNO=WXBJE5,S6;=AJ
M?.-OY[Q*KTF;QT0D$L<25<=91^:DF]U[KZ^7Q4^3?4WS+^._4WR=Z/S;9[K'
MN+:5'NK;E3.L,>1Q\C2OC\YMK.T]-)+'#DL1D(*K%Y*".618ZJGE19'4!V]U
M[HP7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z__]/?X]^Z]U\[[_A<2FX!VU_+Q>I.5_NJW77R(3#"9ZHX/^\";EVF=S''
M1N?"*O[9L3]XT8UF/[42$J([>Z]T;W_A$)3[:7XQ?.:KI5I1O&;OCK2GSKI&
M16-MJEZ^J)-IK/-I&J(54V:,*ZCI8R&PU7;W7NMX3W[KW6BKN7_A%;_>+NS/
M]PG^96:3^.]I97LO^[O^R<?<&E_B>[9-T?P7^+_Z5$UZ-?@^Y^U6]M?B'Z/?
MNO=;U7OW7NOAD?S"X=CT_P _/G'3]9/!)UM!\P?DO#U[)3)/'32;'B[HS:;3
M>G2J2.54- *<H)$5@+:E!N/?NO=?:T^)*Y)/BI\94S/W?\77X^=,+E?OWDDK
MOXDO7&-%=][)*2[2^75Y"QN6N3S[]U[HP?OW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJI?YYG_;H'^8G_
M .*M]E_^ZOCW[KW7Q8??NO=?4P_X1I_]NE=Y_P#BY7<7Y^G_ !CK9/OW7NML
MCW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW09=T]Q];_'GJ3L?O3N'<?\ =#JOJ39N?[ ["W3_
M  C/9_\ N_M':^.?*YW+_P $VO2UN1J_!3QO)]O0T<TSVTQQNQ /NO=$A^$G
M\W_^77_,9WSN_K;X:_(;_3'O78>TTWQNO"_Z)>\NO?X5M>3,08%,I_$>U-LX
M.DGO5U,$7@IIY)O5J\>A68>Z]U97[]U[KWOW7NJU/FW_ #?_ .77_+FWSM#K
M;YE?(;_0YO7?FTWWQM3"_P"B7O+L+^*[7CS$^!?*?Q'JO;.<I(+5=-/%X*F>
M.;TZO'H*L?=>Z.]TOW'UO\ANI.N.].GMQ_WOZK[;V;@.P.O=T_PC.X#^\&T=
MT8Y,K@LM_!-T4M%D:3ST\B2?;UU'#,E],D:,"![KW0F^_=>ZKEZ]_FU?R^>U
MOF5N3^7[UY\@%W1\N-GYO?.W-S=54/5G=4=/A\UUKCI\GOBAJ^Q:S;<6U;X^
M.FG25USA1IE^WC9ZAEB/NO=6->_=>Z][]U[KWOW7NO>_=>ZK4^;?\W_^77_+
MFWSM#K;YE?(?_0YO7?FTWWQM3"_Z)>\NPOXKM:/,3X%LI_$>J]LYRD@M5TT\
M7AJ9XYO3J\>@JQ]U[HZG1?>'5WR5Z?Z[[[Z4W/\ WTZF[8VOCMY[ W7_  7<
M.W/X_MK+(9,?DOX%NVDH,E2^103X:VCAE7^T@]^Z]T*_OW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J'D
M:V+&8^NR4ZRO!CZ.IK9D@3R3O%20M/(L,=QJ<A2%6XN>/?NO=?!<[E["W9VU
MV[VCVEOS*SYW>_8_86\M\;NS52_DJ<MN7=6X:C-YO(SR&Y9YJF>21F)))-R2
M??NO=!M[]U[KWOW7NG'$96NP>6QF;QE1/1Y+#Y"BRF/JZ::6FJ*:MH*E:JEJ
M(*B J\;HZ*RNC!@0"""/?NO=?=Q^+?9N5[K^,OQT[ESL,5/F^V^B>HNS<S3P
M1K%!!E=^]?X_=60AAB2P5%FJW55 L +#W[KW0[>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KYN_P#PMN[IW=D_EO\ #[X[RU138FR?CGE>Z*"B0L@GW;VEV9E]CY>I
MJ@I D\5'LZA6#6#X]<N@CR/J]U[K2/\ ?NO=>]^Z]U[W[KW7TF?^$3G?&Y]Y
M?$?Y=_'W+SRU6 Z0[JV+OC:LM1///)14_=NU:^DRN'I?*Q6*FBJ-IFJ2&,!1
M+4SR6U2,3[KW6Z_[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO_U-_CW[KW6H;_ ,+'?ASN'O?^7YUE\EMG8VJR^9^'/9]=
ME]UTE+ LSTG47<-%2;6WCG!I;R$468QVV))@B,%IS/,Y5(2WOW7NM.[_ (3Y
M?SAH_P"4M\K,YD>S*7,YOXL=_P")Q&T>]\7@H*G)9S;%3MV:IJ]A]I;;PL<L
M:5=7AYZNKIJJF-WEQ]96"%6J4IU/NO=?6"^.7RL^-OR\V%2=F_&3N[KCN[9%
M5!23R9GK_<^.S<F):N,JTU%N7$Q,*W$U9:"=6HLG305"-'(KQ*R,![KW0]5-
M3345-45E9404E'202U-555,L<%-34T$9EGJ*B>4A41%!9W8@  DFWOW7NM7G
M^=I_PI!^+?PCZ9W[U#\4>V]F][?-#>.WLIMS::=99?$[ZV1T76Y.G-$^^^QM
MUX>H?'+D:!'DFQF!@GGJFJTA:NIH:,EY/=>Z^<'_ "X/B5OC^8%\\OCK\:\'
M3UN=J^U^U</5=A9>K%3D3BNN<16_WJ[8WCFJASJ<4N%ILA4GRRJ9Y_'"'$DR
MW]U[K[@L,,5/%%!!%'!!!&D,,,*+'%#%&H2.**-  JJ  J@6 X'OW7NLGOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NJI?YYO_ &Z!_F)_^*M]E?\ NL'OW7NOBP^_=>Z^IA_PC3_[=*[S
M_P#%RNXK<?\ ?NMD^_=>ZVR/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=%+^:'RC7X@]-?Z7&V,W80_O9@MKG;Z[E&U"/XU#4R_?_Q4T&2_S7V]O%]O
MZM7ZUMS[KW53 _GV0GZ?%:7\_P#-;D_K;_GD;>_=>Z]_P_9#:_\ LJTEK?7_
M $WH?]AQM$^_=>Z]_P /V0?]XK2?BW_&;EYO_P"2C[]U[H<?C9_.$C^0_=_7
M_32?'E]I?WYRL^-.XV[8&=&+6'&SU_G&(&VJ/SDF'1H^ZCMJU:C;2?=>ZNJ]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U63_.B_[=*?S'?_%-^_?_ 'WE=[]U[K2*_P"$2?\ V7)\N_\
MQ5"D_P#?OX+W[KW7TJ_?NO=>]^Z]U\U3_A;9_P!ER?$3_P 50J__ '[^=]^Z
M]UNZ_P EW_MTI_+B_P#%-^@__?>4/OW7NCH?(SNS;'QLZ![J^0>\VIAM;I/J
MS?G:6<AJ\E!AXJZAV/MFIW%)BTR50DBQ2U9IQ2P-XG)DD0+&[$(?=>ZT6?\
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MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5Z?S5_^R!N_/\
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M/]+.QB?]A19(^_=>ZU)[\#G@?4E?]B/I_O?OW7NO6X)X')_IR0.!>_\ K_\
M$>_=>ZY6^G))'UL3;_$&_%_I]??NO='F_EI\_-_H%N!_OZ*_BWT)VY6FPO\
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M_>;;?_/08/\ \^U!_P!?/?NO=>_O-ML_3<&#_I_Q=J#_ *^>_=>Z[_O-MO\
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MO=;K/OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KY1?\
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MXZ\ZB[4J'VSE/[Q?(SXN5O\ %(Y%>C[%APF5P&%P5:/&KI/69K%0XN/]I?\
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MO2V^=D92K>GBJ,!O:#O3;FV,?6XR>I!5)ZRDRE=AV &N2&MEA0AY%8>Z]UK
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MTQL;/Y:2FVIB<ANS=F<DGDW!N_(/7FFQ5(6\E/2S5,E/2TM*:ZH?W7NK_?\
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MI@=R;;SD4]'7453"S15%+50O%(A*NI4D>_=>Z!'I'X8?#SXSYS+[G^.'Q/\
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M4'-.!#Y%4A7,(T$Z>2+D$VO[]U[KE;ZV)N2/]J/'^%O]87_I[]U[KAQ<_P"
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ML'8V_8,IB<'M:ARN*BBIM[8^O2G>*:60ZZ<(6#$/J 73[KW6FE_T%<_SN?\
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MXZ__ &JO?NO=>_Z J?Y67_/_ #Y__P#HT_CK_P#:J]^Z]U[_ * J?Y67_/\
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M/&_:O151Z%G'9&TZ"9J?;R2SS0Q(F=HI*O"R23%EB%4)]!>%??NO=?,KP?\
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M:?HNH::4T^<IXX#)(8$EI9))4B+'Q+)(A568+8,P0 GD ?3W[KW6/_037?\
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MZ]U5+_/,_P"W0/\ ,3_\5;[*_P#=8+>_=>Z^+#[]U[KZF'_"-/\ [=*[R_\
M%RNXO_?=;)]^Z]UMD>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NBJ=L;LER&Y8:#'U+)3[<EM')$VDG*JP>HF##Z&(JL8N."K$?J]^Z]
MT8;:.X(MSX"@RT942RQ^*MB6W[-=#Z*F/3S8$^M0>=)4_GW[KW2E]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T7/Y8?+#H?X2=
M#[[^2/R1WU0=?]5]?8\565RE4K5.2RV2J6\&&VMM;#0_OY'+9&<K3T%#3J7D
M<W.F-9)$]U[K0Q^4/_"VOORMWKD*3X7_ !%Z=VOUY05II\9GODW7;W["WANC
M'PSU7^Y:KVOU;FMK4>#EJ(VH[4"Y;*B Q3$U4_G04WNO=&%_EX?\+.SOSL_;
MG6W\QOHSKKJ_:N[,I18A>_N@/[Z4NT]A3UE7/%%D=\]8[RK]P9*3%@/1K55V
M-S4DU,(YIA15"R+'![KW5GGP?_X4Q8KYK?S4)OY;.!^(F.VU@W[#^16RL-\B
M\1\EZ;?N)S^)Z(P&XMP8[=V+V)1;'H(9:?<$.!1H4BW&Z0)5"19ZI8P)?=>Z
MOJ^>7'P;^9I_I\4/D3_[Z#,>_=>Z^:I_PCT_[? 0?^*O]V_^YV"^OOW7NOJM
M>_=>Z8=U9W;>UML;CW-O+*8G";0V[@<QG=U9K/U%-1X+$;;Q&/DR&<RF:JZP
MB&*DIZ6.66IDE(18U9F.D'W[KW7R7O\ A/3L')=K_P#"@+I#.=%TDD6P-A]F
M_(3MBHR5'#6Q4&W^EZ'9VXL322U?BBUPP5J93&X2$2QHIGK8(I- <V]U[KZW
M_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KXLO\\_M'=7;G\WK^87N3
M=]=+7Y' ?*#L[J['22_J@VKTWG7ZIV=0K_M,&+P])$G^"CW[KW54/OW7NO>_
M=>Z][]U[K[*__"=_M#=7;_\ )>^!&\-Y5TN2S='U;N3KV.JG_P X<!T_VIG^
MH]H4_  TP8C!T," "P5 ![]U[JZ'W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_]/?
MX]^Z]UK!_P#"F_\ FD_+G^5WT]\5]Z_$K<FT-N9SM;LKL#:^\9-W[(PV]J:J
MQ6 VO19;&)1T^8!$$B32R%GC(U V(-A;W7NBY?\ "8W^<I\X?YHO:_RNVE\M
MMU[$W'ANI>O>MMQ[,BV?UW@MDS4N3W-N3)8S*O6U&' :H1HJ:((DG"D$CZGW
M[KW6L_O/_A6;_.2P.\-UX.A[0Z8-%A=RYW$T9GZ&V1),:7'926CI_,ZJ S:$
M&H@"Y_'OW7NDW_T%Q_SG/^?G])?^B$V5_P 4]^Z]U[_H+C_G.?\ /S^DO_1"
M;*_XI[]U[I2[,_X5F_SDL_O':>#KNS^F!0YK<N"Q-9]OT-LE)_M,CE(J.H\+
MLK!7T.=)L;'\'W[KW7U:/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5<?\T[^
M9)T[_*V^)&]ODIVE/397/J'VKTUUHM4:?+]K]KY.BFGV[M.A* M%2QK%+7Y>
MMMIIJ&">0!YO##+[KW7RH/B/\;OEO_/T_F7UV,W)N?*[@[![JW;E.U_D9W)4
M8XSX3JSK2EKH8]P[B3&QE8*6CH89*/!;9P\;1P^:2@H(O%#ZX_=>Z8_YXO07
M5_Q9_FD?*/X[=+;>CVOU=T_+TWLC9N&5EEGBQ>)^/NTT>NR=4JI]Q75DQEK<
MA5LH:HJ999G]<A]^Z]U]&+_A*-_VY&^,W_A[_(K_ -_WN'W[KW6QK[]U[KY5
M/RZ_X4T?SGNJOEA\GNK]C_*S"8G977'R'[JV%L_$R?'OXXY&3%[6VAV3D]O;
M?QSY')[4FJ9S!24\,1FJ)GE?3JD=W)8^Z]T7G_H*E_GC_P#>7F!_])N^,?\
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MNT<[!V5T92PYK:^Z>S<IG<!EH:7(;IAGC6II)XIE2:))%#6=%8$#W7NBX?\
M0-?_ #N_^\"]Z_\ HT>@/_LL]^Z]U[_H&P_G=_\ >!>]?_1H= __ &6>_=>Z
M#/N;^0E_-P^/?56_N[NX_AKNK9'5G5^V<GO'?F[JWL7I3(4FWMMX>'SY')ST
M.$W+55<RQKSXZ:GDD;Z*C'CW[KW507OW7NOJ8?\ "-.W_#2N\_\ Q<KN*_\
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M0J](YVYO_N/8&.PSK35:U$T33]6[,VUD=-0BF";37@B-F,1CETR+[KW6P_\
M$[X3_%'X,=>2=6?$KHK8?1VRZNHIZW,4FT<?/)FMT9&DA-/293>F\,U+59G.
M5<43&**KR]?4S)'^VKA/3[]U[HTGOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[K_]??X]^Z]T4KY8_.WXC?!C"[/W'\M>]-H=&X/?\ E,GA-G9+=Z9IJ;/9
M7#4D==DZ&C;#TE40\,,L<C"0+<'B]C;W7NDS\3OYD'P>^=&8WCM_XD_([8G>
M69Z_QF*S.\L?L]<Z)]OXS-U4M%BJRM_C%'2KHGE@E1-!8W4W ]^Z]UK>=3Q?
M\(]OC=\@-K_(;K#L;I?8_?/6&_)MZ[<W7/WI\TLW/M_?-)62O/D)ML;HSM;B
MIF29Y=5-54$D-^/'8 #W7NKC?^@@W^3'_P![!.DO^2=Z_P"M_P ZGW[KW77_
M $$'?R8O^]@?2?\ R1O;_P"M/OW7NI-'_P * OY-N1K*3'T/S\Z7JZVNJ8*.
MCI8(=[R3U-552B"GIX8UQ%RSNP50/J2/?NO=7$^_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JJ7^
M>9_VZ!_F)_\ BK?9?_NK]^Z]U\6'W[KW7U,/^$:7_;I7>?\ XN5W#_[[K9/O
MW7NMLCW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]UKN_\*!_Y'-)_-VZBV/NOJS=6$Z^^6?0M+GH>L\QND5,>R.P]H[@>*LS7
M6.]Z['QS5-#_ )5!%6X;+1P5"TLQJ89:9HJYYZ;W7NM-3K?:?_"L7^5)2#HC
MI38/SBH]AX%LCB=N;7ZXZCP/S>Z>PE!7/2[AJ'V%'!A=_P"#PM-4/,E2JT"T
MA6HEK8W2.K;(Q>_=>ZC;_P#C'_PJ;_G%U-!UY\C=B?+:NV%)F:3(U^%^0.U,
M%\.^E,97[?B@I*7<V6ZXKL=L_'5LU*M0KTTM'@JNKD8U$E,DLBU)'NO=;P/\
MC+^2?U]_)_Z2W-2Y3<6'[3^3W<1Q%3W/VMC,=-2X2DQ^$$DF$ZWZY7)QI618
M.BEFFJ)JB=(I\C4L*BHAB2&DIJ7W7NKU??NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__0W^/?NO=:?'_"O?XC?*'Y
M;]$_#/;_ ,8/C_VWW[F]H=M=G9C=.,ZGV+G][U>W<5D-G8^BH:_,Q8*"8T\<
M\RM'"TMM;*P6^DV]U[HJO_"0;X-?,?XC=U?-3,_*#XR=V]!8G>G5W4V,VED>
MV.N]R;)H]QY'$[LRU5DZ+#U&<@A6>6"*6*25(R2JNI(L??NO=:CO8/\ )H_F
MPY#?N]Z^@_EU?,.KH:[=^Y:RBJH.ANP'@J:2IS,\U/412+16*NC!E(^H/OW7
MNDC_ ,,N?S:S_P!TX_F/S_WX3L$?[W1>_=>Z]_PRW_-L_P"]<?S'_P#1"]@_
M_47OW7NE=U__ ":/YL.-W[LG(5W\NKYA4M%0;NVW6UE5/T/V D--2TN:AFJ*
MB9_LN%1%+,?Z"_OW7NOM)^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JJ;^>9_VZ!_F)_P#BK79?
M_NK]^Z]U\6#W[KW7U,/^$:7_ &Z5WG_C\R^X?_?=;)'OW7NMLCW[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U_]'?X]^Z]U[W[KW7O?NO=46?S<OY_7P]_E++1[#WC29O
MO+Y,9["19_;_ ,?^O<GC,=68K$5,JKC\WVGO.N6HAVW15:>1J(?95M;4:0\5
M"U.34)[KW1X/Y8GS.E_F%?!'X\?,6IVOB=E5_=6V]Q9/*[2P>7GSV*V[FMJ[
M\RVP<WB*3+5,<4DPAJ\5,C-)&C!@RLH((]^Z]U6S_P * /YS?9G\G;:'Q5W9
MUGU3UWV[4=W]A;]PVZ]N;]K=U8F==I;#P6.KZV3:^<V[((J.L>HRE-&9ZVGJ
MD"GTTTGJ9/=>Z&3^4?\ SW/B+_-NPV4P'7L67Z=^1.T\5_&=Y_'O?V2QU=G5
MPZS^"7<O7VYJ)8(-Q8J)FC2IGBI::JIG=?NJ*&.2&2;W7NKM??NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U5+_/,_P"W0/\ ,3_\5;[*_P#=8/?NO=?%A]^Z]U]3#_A&G_VZ5WG_
M (?,KN+_ -]ULD^_=>ZVR/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_]+?X]^Z]U[W
M[KW27WON_#=?;+W?OW<<KP;>V1M?/[OSLT9@$D.&VUBI<SE)8S5211:E@A<C
MR2HM_P!3*+D>Z]U\3&'&_)?^<+_,9K:7!J-W?(SYH=WYK(TBY6J:#$X;^,23
MY:3[ZJIHG^UPFV<%2L7,4)6FQU#9(RL87W[KW7UH?Y-'\NS>'\KCX.;0^)F]
MNX\5W9F,%O'>6]CN/!;1K=G83!?WZJH<QD=H8FFR.0KYZVGI*_[R:/)2K2M.
M)KM1P%2&]U[HH?\ /H_D=9C^<CM7IFJVU\C/]#&^?CIB.T#UUMW/[+CW)UYN
MO.=FS8&7*MN[*XR>#*T"F/;])3I54T5:( S2)1R,727W7NOF"==;L^1_\IK^
M8-A,_64U5L3Y#?#7OF3';LP=%DH:NCK:W9N;;#[TVE+DL>Y@K\/GL<:N@EDA
MD,-70U19&*2*WOW7NOMS[,W;A-_;/VGOK;53]YMS>NVL%NW 5G[?^583<>+B
MS&*J?VF=?7!-&WI=ASP2.??NO=*7W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW54O\\S_MT#_,3_\ %6^R
M_P#W5^_=>Z^+#[]U[KZF'_"-+_MTKO/_ ,7*[AO_ .BZV3]/?NO=;9'OW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[K__3W^/?NO=>]^Z]T$??^QLGVAT/W9UIA)(H<SV)
MU'V1L;$33Z?!%D]V[-K<!023:WC70LM0A:[J+?5A]??NO=?':_DF?+O9?\N;
M^:K\<N^N]\?4XKK_ &-NK??6_:\TU+6OD]C8KL+9.6ZMRVZ&HZ**>=FP-5D$
MKZVFBIY))J>">"-1+(CI[KW7V2>N.S>N>XMEX+L;J;?FS^S-@;GI%K]N[UV'
MN/$;LVMFZ1C;SXS.X.:>FF4&ZMHD.E@5:Q!'OW7NDGWO\A^C/C!UUG.VOD-V
MSL/ISKG;U'65F2W7O_<>.V]CV^RI'K7H,6E:ZS5]=*D;"EQU#'-55$FF*GAE
ME94/NO=?%K_F4?)'&_/7^8M\GOD5UI@\J,%WUW=D:KK;"5-)XL]D-OEZ?:.Q
MDJJ!22E;6TE+222P7)660I<D>_=>Z^TY\?\ 8N3ZOZ'Z3ZTS<D4V9Z[ZCZWV
M+EYH"IAER>TMFT6 KY(2C.NEI:=RMG86^C'Z^_=>Z%SW[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW54O\
M/,_[= _S$_\ Q5OLK_W6#W[KW7Q8??NO=?4O_P"$:7_;I7>G_BY?</\ L/\
MC'.R?K[]U[K;)]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]3?X]^Z]U[W[KW7O?NO
M=?.I_P"%&W_"<'NV#NWL_P"?'P'ZYR':/7?:.0K=_P#>70VQ:"?*=B;'[$RD
M\^0WOOO86TJ&,SY;"Y><C(U=!CQ-64E9-5/' :$H*;W7NM*;$;T[?Z>R>8P6
M!W9V3U;F:>JFH\_A\1G=S[(R<%;"52HI<QCZ.6EE653&@=)D##2 1P/?NO=-
M^2S_ &7VWN+'4^8S6^NS=VY*HBQ^)@R61S^]-Q5]5.J4T-%CHJIZFIED<1QQ
MK'$"2%50. ![KW6[3_PG)_X3@]W3]W=8?/CY\=<U_5_775]?1=@=&]#;ZH)\
M7V)OGL3%SPY#9&^]^[2KHQ-B,+B)@<E24&0$-95UD-*TE.*$.*GW7NOHK>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[JJ7^>;_VZ!_F)_P#BK?97_NL'OW7NOBP^_=>Z^IA_PC3'
M_8I7>?\ C\RNXC_[#K9(]^Z]UMD>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_5W^/?
MNO=>]^Z]U[W[KW1'OG9_,:^'_P#+>ZP@[4^6O;F*Z_QF6FJJ'9VU*2GJ-P]B
M=A9:DI6JIL7LC9.)$E;6% %6>K9(Z.F:2+[NI@$J%O=>ZTKOE[_PKE^$_:^>
MS"[4_E$["^14<4HI-O[_ /EGD.JTRCT5#5A:*IK]D4NU-V/9H%_;ITW(GA9@
M=;A"K^Z]U>W_ "]/YAOQGD_D^=D?S>8O@MT#\<:SK/ =Y9#)];_'W:>Q-K5F
M;3KO.RX'&8#&[SAP^,>)\[5+2P2F2%U1I+B.<JL;>Z]U8C_+/_G!?"K^:MLO
M)9OXU;XKJ+L#:N,H\GV'T7V%2T6W>V]C4E7*M(,G68.FJ*JGR&,^X=:<9;$U
M=32K(\4<TD,TJ1'W7NK1O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5+_/,_P"W0/\ ,3_\5;[*
M_P!YQ@'OW7NOBP^_=>Z^IA_PC3_[=*[R_P#%RNXO_?=[*]^Z]UMD>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO_UM_CW[KW7O?NO=0\AD,?B,?79;+5U'C,7C*.IR&2
MR60J8:+'X_'T4+5-975U94LL<4,4:M)++(P55!9B "??NO=?%R^>?RG^1G\Z
MS^93N+=^U<-N7?.Y^Y>R8>JOB_U%25"3OM?KH9J3&]:;'Q:3)2T\+_;N*[+U
MLD<*25<M763^,,VGW7NCN?S+/^$XG>7\K7X,;9^77?OR#ZXW)O7<';'7_5U1
MTKUMM;/9?&82?>NU\WN.MKZWM/-U6/$LV.;$+2M34V DBG:5W2K5(E\_NO=;
M(_\ *4^*/;'SB_X2B=A?%/H[.[1VWVEW'NSN+!;5RN_*[+8O:>O%?(.BW1E\
M=E\CA*2NJ8%KJ"@JJ&*5*215EF0R 1AR/=>ZTG>BNS?E!_)D_F0[>W-F\5E^
MO^\_B?W$NWNUMAQ9.*HH]T;<H<@E)O[8-?68BI%+DL/N'#O+'!405)AFAG@K
M*:4$0S+[KW7VO-L;EP>\]M;>WAMC(1Y;;>Z\'B=R[>RL,<\4.3P>=H(\IB<A
M%%4JDBK-3RQR*LB*P!LR@W'OW7NGSW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW54O\\W_ += _P Q/_Q5
MOLK_ -U@]^Z]U\6'W[KW7U,/^$:7_;I7>?\ XN5W#?\ ]%ULGW[KW6V1[]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z__U]_CW[KW7O?NO= U\C-G;A[$^/?>_7^T8HI]
MU[ZZ:[0V=MB">KCH(9MP[GV1783"Q35TQ"0JU3/$&E<@(/42 /?NO=?'R_D2
M_*/JCX-?S9?BUW?\BXHMO];[6W1OG8F]<_F\>VOK2H[&Z^S'6-+O3(T]1&TM
M-%AZ[)Q39.14$L-(M25!==!]U[K>5_X6$[AP&[?Y._76Z-J9S#[FVUG_ );]
M)9?!;AV]DZ+-8+-XJNZXWG/0Y/$Y?&O)3U-/,C*\4T,C(ZD%20;^_=>Z&'_A
M*CNS:NQ/Y&_7&\M[[EV_LW:&V>S?D3F-R;JW5F<=M[;>W\10]AU4];E<WG,O
M+#2TE-"@+RSSRHB#EF Y]^Z]UH!_SS_EQUU\_OYK7R<[ZZ%CFS_6^Y]R;(Z[
MZWR]!1UKU78./ZSV)B>KZ7=^/H9H8JEH\W4XV2KQL,E.LPI9:>-T$H8>_=>Z
M^PO\>-D9CK/H#HWK?<(B7/\ 7W3W6>R,XL$D4L(S&U-E46!R0AEA9T9?-3OI
M9'92.0Q'/OW7NAA]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5+_/,_[= _S$_P#Q5OLO_P!U?OW7NOBP
M^_=>Z^IA_P (TQ_V*5WE_C\RNXC_ .P[V4.??NO=;9'OW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[K__0W^/?NO=>]^Z]U[W[KW7S;_\ A1?_ ,)Q^[MA=W=D?.?X']99
MKM?I+M?-9OL'N+I?KO"'([VZ5WMD2^8W=N+:^SL0AGR6ULE.9\AX\;!)+C)9
M)HG@6@6&6/W7NM,BOW9V!2;?DZTRFY=XTNUL3EZBHEV!7YG-0;?QF>IYI(ZJ
M>3:M1(*:&L21I5D8P"0,7!()/OW7NL_]_NR<KM/%=7?WUWQDMC4F2>IPG77]
MX\]6;3ILOD*LSO48K:/F:C2IGGD+EX:<.\C$W+'W[KW6X=_PG0_X3H]Y=M]Y
M=:?.'YP=:9[J/X]]1Y[;?8_5/5/9&VVQV\/D#O#'%,_L[)9'9V?0346SZ*84
MN2GJ,E2C^+6BI:6*6DEJ:F'W7NOI9>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JJ7^>9_VZ!_F)
M_P#BK?97U_[5@]^Z]U\6'W[KW7U,/^$:?_;I7>?_ (N5W%_[[K9/U]^Z]UMD
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO_T=_CW[KW7O?NO=>]^Z]U6%_,I_F]?"C^
M59LG';B^3F_:Z;?&Z*"HR'7W1W7M'1;F[AW]2TU0:.;(XG;M54TE-18Y)0\;
M9;,5M'1EXY(8YI*A?"?=>ZT;?EE_PJG^/'R"WA6YF/\ DG_"SLV&>6F:JW1\
MLL3L?NO>&?:"'Q_=5L:[1I!2LH2GCB1LA6:5AOY/6J0^Z]UR^)?_  J;^,'0
MF\*#-Y'^2-\+NL325,E51;Q^)>!Z]Z?WAM^ID3QM74%)/M&?[B5HRT;:,K2$
M@WUV!5O=>ZWI/Y<G\V?X4_S2]CY7=GQ8[%J:K<FUXH9]]].[]HJ+:O<>PH*J
M40TE=N+:$%761R4,SD1Q93%UE70M)>$5/F5HU]U[JRGW[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=52_SS/^W0/\Q/\ \5;[+_\ =7[]U[KXL/OW7NOJ8?\ "-/_ +=*[S_\7*[B
MO_C_ ,8ZV3[]U[K;(]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]+?X]^Z]U[W[KW2
M3W[O3"=;[&WIV)N:2HBVWL+:>X]Z;@EI81454>$VMAYLYEI*: LH>0002%$+
M"YL+B]_?NO=?$9^2'>/R6_FK?.C=G9M?C-S]H][_ ":[3@PO7O7^%%3EJVC@
MS.3&'ZYZMV?12,1#0XNC--CZ5-2HB1M-,]VEE/NO=;77QP_X1']U;HVI09[Y
M3_-79'4.YJ_&XZL?K[J/JS(=ORXBJKJ3[BLQF<WOGLWMJE6IH7*P3+CZ"LIY
M7UF&K,:H\ONO=9/D9_PB.[DVOM#)Y_XM_-C9G;F[,?C:ZLI^N^VNIZ[J/^-U
M-%2FHI\;A]]X+/;CIA4UC@P0)7XZEIXW*&:K2-GDB]U[K5;^,G>WR<_E%_/O
M:O9"X3<G6G>/QF[1GVYVGUEG#-0OF\1CLE_"NR.K-W4U)*L=5CLO0B>F,D4S
M1L'AK:28.E/4+[KW7VT=D;PP?86R]H[^VQ4/5[:WQM? ;PV]5R)XI*K![EQ4
M6:Q-0\=SI+T\\;%;FU[7/OW7NE/[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JJ7^>9_VZ!_F)W_[Q;[+_
M /=7Q[]U[KXL/OW7NOJ8?\(TO^W2N\__ !<KN'_WW6R?I[]U[K;(]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=?_T]_CW[KW7O?NO=(KLG8N)[0ZZW]UIGWJ(\%V)LK=
M.Q<U)2.8ZJ/$[MP<^ R3TT@MID$-0Y1K\&Q]^Z]U\E_^6)C,?_)N_G_]4;&^
M=6.I-FX_HSM/LCJK=.\MQ40H=OX6#L7KC,;(ZU[NQ\N34A<%6C+8O,P9'4/'
MC:DU(;5&5/NO=?7)Q^0Q^7Q]#EL374>3Q>3HZ;(8W)8^IAK<?D,?6PK4T==0
MUE,S1RPRQLLD4L;%64AE)!!]^Z]UAS.9P^W,/E=P[ARN-P. P.-KLSG,YF:Z
MEQ>'PV'Q=*]=D\KE<G7.D-/34\*/-//,ZI&BL[L%!/OW7NOD/_S.:ZA_G/?S
MX^UL+\$\*-[4'?79O6W5.P]S8JC<8K=--UUU]A^N=V=RY"3QPF+!HF)K,NU=
M/;_<;"D[D,VD>Z]U];CJ_8>.ZLZTZ[ZQP]345F)ZXV+M+8>+JZH 555CMH8"
MGV_15-2 6 D>*G5GY/)/)]^Z]TNO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=52_SS?\ MT#_ #$__%6^
MRO\ W6#W[KW7Q8??NO=?4P_X1I_]NE=Y_P#BY7<5_P#T76R??NO=;9'OW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[K__4W^/?NO=>]^Z]U[W[KW7P[?G=\X/E)\T>U,CD
M_E!VK4]OYG8.>W1MO:6XMP;4V)0[IQ6VX<Y.*;;K;IV]BZ/(U%!"=4D%%554
ML,4CR21HLDDC-[KW4KH3^:'_ #%?B_M6DV)T%\U/DAUCL/'(T>+V)M_M3=+;
M(PZN%#_P7:&1J)\=1E@JAC2TT9-A<^_=>Z9/D)_,@^?/ROPDFU_D;\P_D3V_
MM"6:&HEV1O+M7=M=L26IIT6.&JEV/%4QXEI5"@K*:,N"6:^IF)]U[I ?&7YB
M?)OX:;GSV]?BWW)NWI'>.Y\/'M[-[JV.^/H-Q5F!CJA7-A5S4\$M1%2R3+'+
M/!!(B3/'$TJN88BGNO='5_X?A_G$?][#ODG_ .AE'_\ 4_OW7NMW/_A(I\X?
MEQ\UMC?.C*?*[Y =C]\9#K_=G0-!LJI["S1R[[:H]PX?=M1G(,2H1%B%4])3
M-/87;Q)<V4>_=>ZW&O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW54O\\S_MT#_,3_\ %6^R_P#W5^_=>Z^+#[]U
M[KZF'_"-/_MTKO/_ ,7*[B_]]ULGW[KW6V1[]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ__5W^/?NO=>]^Z]U[W[KW5(F1_X3A?R4LMD*[*9'X([*JLADJRJKZZI?LOO
M@/45E;,U153NJ;J"@N[,QL +G@#W[KW43_H&S_DC?]X%;'_]&9WU_P#97[]U
M[H*]^_R)O^$[/5F2QV%[/^-GQTZXR^6IOO<3BM^?(WLW9^3R=%YS2?=X^AW!
MO>GEGB\JM'Y(U9=8*WN"/?NO=";2_P#";S^1[6TU/64?P2V#5T=7!%4TM53=
MI=[U%-4TU1&)8*BGGBW85='4AD=20000;>_=>ZS_ /0-G_)&_P"\"MC_ %O_
M ,S,[Z_^ROW[KW1[_AI_+H^%W\OF@W_B_AUT7A>DJ#M*LV[7[]IL-N7?>XDW
M%6;3AK*?;T\[;WRN3:$TR9"L513&,-Y#K#:4T^Z]T=?W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5+_/-_[= _
MS$__ !5OLK_W6#W[KW7Q8??NO=?4P_X1I?\ ;I7>?_BY?</_ +[K9/OW7NML
MCW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__];?X]^Z]U[W[KW7O?NO=?+3_GS_ /"B
MSY2?)KY(]J_'3XB]Q;MZ1^(W5&Z\SU[19/J[,Y;9V\.^,GMFN;$[CWCN_=6/
M:GR(P=95Q3QXO!Q214\M$(Y:Z*::9HX?=>ZW&?YDW\X*?XJ?R0^O_GKL7(XB
M;NGY0=,](XSH9V@Q]3CJ7MOO?KJ+=M7GIL89?&W]W,='FLO]IHE0U-%%2SQ^
M)Y"ONO=?)=WWO[M+O?L//;\[&W7O7MCM'?>8K<QN#=&Y\KE]W[QW/FLC.];6
M5=;7USSU51*[L[GDVYL ![]U[K8'_P"$^O\ .U[Q_EW_ "=ZRZ)[,WSN'=?P
MI[<WOB-B;^ZZW-E*VNQW465W97PX'']K=?I5B9\6^,J6@ES./IE6"NHEF1XA
M5+35$/NO=?6N]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW54O\\S_MT#_,3_ /%6^R__ '5^_=>Z
M^+#[]U[KZF'_  C2_P"W2N\__%R^X?\ WW6R??NO=;9'OW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[K__U]_CW[KW7O?NO= G\EMV9C8/QQ[_ -];=J&I-P;+Z3[5W9@Z
MI&='ILQMS8E?F,94(\?J!2>%&!7D6X]^Z]U\FS_A-/\ $3IOYJ?S7>K=A?(/
M:6*['ZVV-L;L?N?,[$W-$]?M[>>9V700T^V<=N6@>Z5M''DZ^EKZFBJ;P52P
M&"I26"22*3W7NKD/^%J/>.!H>U_@[\*-B4^WMO[4Z=ZGW?W%D]H[6I*7&8S#
MR]B9R+8>QL4V'Q@2EHTH*';&0>CI8H8RD5:6MXY(O?NO=9/^$3?Q=QV[._OE
MS\NL_AL56GIS8.S.G^O\AD*1JC(8[=';-?6YO=F4P$S I!+3XG!Q4-3*+2&'
M(F-#XY)@?=>ZJQ_X59]/];]0?SC.WTZUPF VY2]D]:]4=J[NPNVZ"CQE!3[^
MW/A):'<V1J*&A/C6LRCT,>7K9#&CS3U4D\@9Y6ED]U[KZI'QBW3F=\_&SX];
MUW'5/7;AWAT=U-NG/5LDD\KUF9W!L+'Y;*53RU+R2,9)YG<M)(S&]V8FY/NO
M=#C[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[JJ7^>;_VZ!_F)_P#BK?97_NL'OW7NOBP^_=>Z^IA_PC3_
M .W2N\__ !<KN+_8_P#&.MD^_=>ZVR/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__0
MW^/?NO=>]^Z]TE][[0PW8.R]W["W'$\^WM[[7S^T,]!'X#)-AMRXF7#92*,5
M*2QZF@F<#R1NM_U*PN#[KW7QB?C?WY\COY$_\SG-[K79."S7</Q=WQV=U%OK
M8&\Q54VWMY86NHZO9^:A^^PLSR105U++#E<3D*2>6/\ X#3K]Q 2DONO=%\_
MF&_.GM?^9!\MNT_ESW'0X;![J['J,)24&TMMM5MMO96T]JX*GVUM;:N$:N9I
M7CIZ2F1YYY"&J*EYZAE5IBH]U[KZ W\O*NWU_(6_X335OS!_T')V1W'O"KQ7
MR7WUUON3+5FPI\>W?V]<%U+U?4YNJ@Q]=724^(P,NVLKD<8T5/)9JZ(3TC7F
M'NO=:+V2W1\J?YXO\SG;U5NYFW/WQ\NNV]J[9DI=LT-1#MSK_9E+%!BG3!XV
MHDJ&H\!M+;E'+5RO+)(RT])-4U$DT[RR2>Z]U]J+;>W<-M#;N VGMRB7&[>V
MOA<5MW!8Y)JBH3'X;"T,>-Q=$L]6\DKB*")(P\LC.;79B22?=>Z>O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=52_SS/^W0/\Q/\ \5;[*_\ =8/?NO=?%A]^Z]U]3#_A&E_VZ5WG_P"+
ME]P_['_C'6R??NO=;9'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__1W^/?NO=>]^Z]
MU[W[KW5(G\T_^05\&?YK>4H.Q.V,?NWJ?O\ Q&'IL#1=Z]0U>(QFYLUA: _[
MC,+V!@\U2U>.SM-2J3'32SPQUL,=H8:V.!1%[]U[K7"[ _DX?R)?Y#?:_0?;
MG\R+O#Y ?(NO[%R^\LWT?L#+]8)6]35V1ZC_ (+-N.K["VEU_35=5D_M*C<&
M&J*6DKLI%05'[D5515L(D3W[KW5X^XOFC\*/^%&_PZ^;/P8^&/;N=IMX97J[
M:@SFY.R.JMY;<P>U'R6]8,OM7,M39!('K0E;ASKBIY-:V5CP??NO="[_ "@O
MY!?Q,_E(4V4WMM/*9;O/Y,;FPL^W-R?(/>V'IL%5T.W*J:.HK-L]<;(I*FMI
MMOT%3)#%)5M]Y5UM05"35KP*D*>Z]U>I[]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJI?YYG_;H'
M^8G_ .*M]E_^ZOW[KW7Q8??NO=?4P_X1I_\ ;I7>?_BY7<7_ +[K9/U]^Z]U
MMD>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO__2W^/?NO=>]^Z]U[W[KW7O?NO=: ?_
M  N<_P"Z7?\ Y>S_ /,C]^Z]T$'_  A]_P"9^?/K_P 1!TM_[V>:]^Z]U]%O
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U5+_/-_[= _S$_P#Q5OLK_P!U@]^Z]U\6'W[K
MW7U,/^$:?_;I7>?_ (N5W%_[[K9/OW7NMLCW[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU__3W^/?NO=>]^Z]U[W[KW7O?NO=:@7_  JU_E<?.S^91_LAG^R5=&?Z:/\
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MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5+_/-_P"W0/\
M,3_\5;[*_P#=8/?NO=?%A]^Z]U]3#_A&G_VZ5WE_XN5W%;_T7>ROK[]U[K;(
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=?_UM_CW[KW7O?NO=1JVBH\E1U>.R-)35^/
MKZ:>BKJ&M@BJJ.MHZJ(P55)5TLX9)(I$9DDC=2K*2""#[]U[KY4&?Z^R'_"<
M3^>-UA\A::GQ/;OP^I^Q]^5O7V[-AYG![S3,="=H83);)W5LZHFQ52BTF\=H
MT&6<_P /JY:8U-11T]0 ^/JP7]U[KZ-G2?\ -1_EO_(;9^#WMU1\WOC)G<;G
MJ$U\.(R?<FQ=I[UQ:(_CFI=S; W96T6;Q51&2-=/D:"%]+)(%,<D;M[KW0U?
M[.7\0/\ O*SXV_\ H\^L/_KI[]U[KDOS(^(3NL:?*KXW/([*J(O>76+.[,=*
MJJC*7))X 'OW7NC(>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JJ7^>;_P!N@?YB?_BK?97_ +K!
M?W[KW7Q8??NO=?4P_P"$:?\ VZ5WG_C\RNXK?X_\8ZV2/?NO=;9'OW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[K__U]_CW[KW7O?NO=>]^Z]U\'7LOK3L:3L;?\D>P-[2
M1R;UW4\<B;5SKHZ-G9RKJZT]B".01Q[]U[I$_P"C'LGZ?Z/=\7_\-//?_4_O
MW7NNO]&79/\ S[[>_P#Z">>_^I_?NO=+?K3K7L:+L;8$LFP-[1QQ[UVI)([[
M5SBHD:YV!F=F:"P  N2>/?NO=?>*]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW54O\\W_MT#_,3^
MO_9+?97T_P"U8/?NO=?%A]^Z]U]3#_A&G_VZ5WGS?_G,KN+_ &'_ !CK9/'O
MW7NMLCW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]#?X]^Z]U[W[KW7O?NO= SWY\B>
MB_BUUKF.X?D7VQL7IGK+ LL60WCO_<%#M_$FME@DJ:7$8XU;"2MKZA(932X^
MCCEJ9RC+#$["WOW7NM:+O'_A8Y_*GZRR69PG6>V_DW\AJS'U,U+CL_L7K;;N
MT=B9<T]9X'JDRW:6<PN8B@>,-+ _]WW9O0K)'J+)[KW5K?Q:_G!?'SY)?RU=
MY_S0Z_:'8757177V([:SNZMN[@I<3N'?5/CNHJV>ARRXZAVW424]3/720!*&
M+SH"\B"5XEU.ONO=&W^'OSE^*?SXZOB[?^)G<^U>W]FH]+39D8:2KQ^Y=H9.
ML@-1#A=[[-S<5-E</6,JN4AR%)$9 C/$9(QK]^Z]T;'W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=52_SS?^W0/\Q/\ \5;[*_\ =8/?NO=?%A]^Z]U]3#_A&G_VZ5WG]?\ LLKN
M+Z_^(ZV3]/?NO=;9'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_T=_CW[KW7O?NO=>]
M^Z]U\;W^=!_,N[F_F\?/+<LVT:O=VY>E=N[[K.K/B+TU@8LA7I4;?_C']W\)
MN6CVEBY:I*G<N[)1'6U<D'EE/F@H8G:"FA4>Z]TG?F/_ "(?G_\  7XB[>^8
MORLVUUOUAL[<N_\ 9?7-!UK)OQ=Q]OT^:WSM_*;DQM3E<)M>DK,/204\&)F2
MNCGSJU44LD48IG(F\/NO=;7G\M;H?O+Y.?\ "1#N/H;XV[.3L'NCLK/=Q839
MVS3F,#@),_'#\BL?E-S4=+E=S5%+0QU P]/D)*9)ZB/R2JD2-K=??NO=:@G\
MMGYL?(+^3M_,)VKV%D:+>G7\^P^P/]%/RNZ7SU+D<%D-P]=TVY$Q?9W7^[MM
MUD3219+'&&2KQS2TS24F1IH)51M+1O[KW7VE\?D,?E\?0Y;$UU'D\7DZ.FR&
M-R6/J8:W'Y#'UL*U-'74-93,T<L,L;+)%+&Q5E(9200??NO=3/?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=53?SS/^W0/\Q/_ ,5:[+_]U?OW7NOBP>_=>Z^IA_PC3_[=*[S_ /%RNXO_
M 'W6R??NO=;9'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_TM_CW[KW7O?NO= =\G<3
MN7/?&OY"X/9E'D,CO#,]'=LXG:F/Q"/+E:_<N1V%D*/!4>,CC]35$M4\20JO
M)<J!S[]U[KY$G_"=WLSHOJ/^<5\+]Y_(:HP>-V)%O+=F Q.X-S20Q;?VQV5N
M[KG+[6ZKSV4FJG2"%8MP5F/CBJYSXZ69XZMBG@$B>Z]UO#_\+*O^W2>T?_%Q
M^G/_ 'W^]/?NO=#1_P ))_\ MRWT[_CV_P!__P#OQZD>_=>ZT#_^%#_=O2GR
M#_G!_,;L;H"KP68Z^.Z-F;.DW3MEL;+@-Y;RZ\ZVP^Q>P-T8FLQ#/35<%1FL
M?6K%D(9'6M5!6!V\]_?NO=?7<^,6V\[LWXU_'K:&Z*2?'[FVIT=U-MO<5!5+
M*E319W!["Q^+R])4I.%<21U$4B.' 8$&X!]^Z]T./OW7NO>_=>Z][]U[KWOW
M7NO>_=>Z #Y-_*?X]?#3J'<'?/R>[6VOTYU/MF6EI<ENS=$M8ZSY*O+#'X/
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M-O9O*XH+5U-)M[>F)>?&SUM,I2>2GIZTSQH4D**K*Q]U[KZ3G_"4O^9?V/\
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MM3:F*PN$^^&3WAGVSG965QJ9_<N0DG84&--?]Q6U4IEFDBITJJJ'W7NOJE_
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MU[KWOW7NJI?YYO\ VZ!_F)_^*M]E?^ZP>_=>Z^+#[]U[KZF'_"-/_MTKO/\
M\7*[B_/_ '[K9/T]^Z]UMD>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO__1W^/?NO=:
M^G_"@#^<5VQ_)\ZP^.N_NJNH^O.VZON??N]=GYC']@Y+<F,I\/3[9V]29JDK
M,;+MR:)F>1IW219018 BQ!O[KW0&_P#"?[^?'W1_.%['^1^RNU.C>K^HJ/I/
M9.P]TXBLZ_S.Z\I4YJIW=G:_$U5-DDW'+(J1Q+1J\9B )+&_%O?NO=4%[I_X
M6M_+W;NY]Q[?C^&OQNJH\%GLOATJ7W3V=$]0F,R$E$L[QK5D*7":BH)M>US[
M]U[IA_Z#=/E__P!X7?&S_P!"WL__ .JO?NO==_\ 0;I\O_\ O"WXV_\ H6]G
M_P#U3[]U[I^VM_PM;^7FXMS[<V_)\-?C?2QYW/8C#/4INKLZ5Z9,GD(Z)IUC
M:K4,4#E@I(O:UQ[]U[KZ.'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJE_GF_\ ;H'^8G_XJWV5
M_P"ZP>_=>Z^+#[]U[KZF'_"-/_MTKO/_ ,7*[BO_ .BZV3[]U[K;(]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=?_]+?X]^Z]U2=_.G_ )-&!_G']?=&;!S_ '_E^@Z?
MI3>.[-X09+#]<T78<VXIMT82FPOV4M/6YG#K2K M.9-8:4N6 LFF[>Z]T$'\
ME?\ D';8_DW[[[VWQM_Y-9[OR3N_:6SMJU.-S/5F/Z\3;B;0S-9EXZV&JHL[
MES4F<UAC9&CCT:;AFO8>Z]U3+N3_ (1%]<[BW#G]P2?S$=[4LF=S.4S+TR?&
MS!2I329.NDK7@60[T!8(7T@V%[>_=>Z9?^@'+K;_ +V,[X_])HP/_P!FOOW7
MNNO^@'+K;\?S&=[_ .'_ #C/@?\ [-O?NO=)RJ_X1O\ QJZ?W=M6OWK_ #6J
M?:F3H\QM_-8O#[PZ;V#MBJRS)G8Z?'0TL66W[%(ZU56HI(FC1M4IT*&?T^_=
M>ZWZ/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U5+_/,_P"W0/\ ,3^O_9+?97T_[5@]^Z]U\6'W
M[KW7U,/^$:?_ &Z5WE_XN5W%_L?^,=;)]^Z]UMD>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO_3W^/?NO=%;^9'S Z@^"?0FZ?DMWTN]H>I=CUN#IMXYK8VR\UOROVU
M2[@R:87'YO*X7 ))4I0"LFIZ:>J"%(GFC,FE"S+[KW5(W_06Q_);_P"?Q=O_
M /H@.Q__ *F]^Z]U\XW^7%\E.J/C?_-)^./RD[3S&0Q?3W6OR.'9&Z<SC,)D
M\UDZ?:L>1JZK[FCP5"C54TK+*FF%4U7/-K&WNO=?1R_Z"V/Y+?\ S^+M_P#]
M$!V/_P#4WOW7NN+_ /"MK^2XB.R]O]PR,JLPC3H'L0/(54D(ADIU6Y^@U,!?
MZD#GW[KW7S-OGOWUUQWO\]?E+\E/CWBL]LCKGM/Y%]B]N]:T>4IJ3"[CQ5)N
M;>,^YZ+*5-!BI98:&IEJ)&K1303.*=G$:R-HU'W7NOMC_'C>^8[,Z Z-[(W"
M8CG^P>GNL][YPP1Q10G,;KV519[)F&*!415\U0^E415 X"@<>_=>Z&'W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW54O\ /,_[= _S$_\ Q5OLO_W5^_=>Z^+#[]U[KZE__"-+_MTKO3_Q
M<ON'_P!]SLGZ^_=>ZVR??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__U-_CW[KW2([*
MZWV-W%U[O;JCL[;.-WEUWV/M;.;*WOM3,)(^-W#M?<F.DQ.:Q-7X&215F@E=
M/)%(DB$AXW5U5A[KW7RN/E'_ ,)0?YLVP?D)VWM/XT?'9.]>@,5O3+CJ'M,]
MY?&[9M;NG8-5/][MQ\UMK?V[\1DZ7(TM/(E'DEEH(XVJ8I7IS)3M%(WNO=:]
MW37QX[A^07>FS/C5U#M#^]W=?8.\AU]M#9?]X-KX'^+[N,TE.,3_ 'CW-6T6
M)I_7%(/N*JOC@XOY+$$^Z]U<K_T"X_SU_P#O!G_V9GX>?_;!]^Z]U[_H%Q_G
MK_\ >#/_ +,S\//_ +8/OW7NK"O@!_PD(^?F_P#O/KW+_.K"[%^/?Q\P&X,-
MG^R<'1]F[,[#[0WG@,?4Q5U=LC:-)UO/FL32SUX#44^1K\DL=*C23Q0UC)'!
M+[KW7TYZ*BH\;1TF.QU)2T&/H*6"BH*"B@BI:.BHZ6(04M)24L 5(XHT54CC
M10JJ   ![]U[J3[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[JJ7^>9_P!N@?YB?_BK?97_ +K![]U[KXL/
MOW7NOJ8?\(TS?^4KO/\ P^97<0_]AULD^_=>ZVR/?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7__U=_CW[KW7O?NO=>]^Z]UJG_(/XP_\)AOY,/>777R*[8VEMGI3Y-[
M;W%)VOUCB,+W3\NNW.SSGXJIY(-S+U'C=TYRGCI)YYI4IZC.XR+&RLLJ*Y\,
M@3W7NE)-_P *_?Y.L<TL2;@^1U0D<CHE1#T;4K#.J,566)9\DD@5@+J'16L?
M4H-P/=>ZQ_\ 08!_)WM_Q>_DE_K?Z#I+_P#NU]^Z]TX8G_A7;_*#S>5QF&Q^
M7^2$M?E\A18RAB?I(Q+)65]2M+31O+)E0J@NR@L387N??NO=;0'OW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>ZJE_GF_]N@?YB?\ XJWV5_[K![]U[KXL/OW7NOJ8?\(T_P#MTKO/
MZ_\ 997<7_ONMD_3W[KW6V1[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__6W^/?NO=>
M]^Z]TBNR=\XGK#KK?W9>?2HEP77FRMT[YS4=(GDJI,3M+!SY_(I31B^J0PT[
MA!^38>_=>Z^&MWAV_P!^?/GY5;X[:W9%NKM?OSY(=G35]/@L#CJS<6X<WN+=
M.36@VQL?:& PT)DDCIHS2XK$8ZBI@$ACA@AB5551[KW5M>Q?^$NW\[C?>WJ'
M<L7P_@VI1Y.GAJJ&@WUW;T/M?<+T\Z:U:NVU6;D-?0R#]+TV1IX)U/ZHAP??
MNO=+'_H%%_G<_P#>,^Q__2BNA?Z?^'![]U[I4;(_X2L_SK<)O3:&:R'QKV3%
M08C<^ RE=(GR&Z(EDCI*#+15=2Z1Q[@)8A$8A5Y/T'OW7NOK->_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[JJ7^>;_VZ!_F)_P#BK?97_NL'OW7NOBP^_=>Z^IA_PC2_[=*[S_\
M%RNX?]A_QCK9/OW7NMLCW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__U]_CW[KW7O?N
MO=)/?NR\)V1L;>G7>YHZB7;>_=I[CV7N"*EF%/5283=.'FP>6CIIRK!)#!/(
M$<J;&QL;6]^Z]U\GC^6;L/"_R?\ _A0[U#U;\X\92;9PG3W;?8O6IWONJDIJ
M/;=&O8O7V9V;TKW=25&=6&G&%K)\GB<DF4+H*2FG>K!$M*8C[KW7UKX9HJB*
M*>"6.>">-)H9H762*:*10\<L4B$AE8$%6!L1R/?NO=9/?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=53?SS/^W0/\Q/\ \5:[+_\ =7[]U[KXL'OW7NOJ8?\ "-.W
M_#2N\O\ Q<KN*_\ K_Z.MD^_=>ZVR/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_]#?
MX]^Z]U[W[KW7O?NO=?#U^>7SJ^5WS5[.JJCY2]NY#N3(]:Y[=NV=D9O<FVMD
M4FX\#MO^\%0Z;=AW)@<925\N/1]4T=%45,D*2O)*B+))(S>Z]T\=,_S8?YE_
MQZVIB-A]-_.KY/['V+MZDDH-N[)H>WMWY#:&W*"23S-0[=VQFZFIH:"'66D$
M5)!&@=G8 -(Y;W7NAE_X?A_G$?\ >P[Y)_\ H91_]>/?NO=*S87\]+^;YE=\
M[,Q>0_F#_)"JH,ENS;F/K:9]Z!4J*2LR\--4P.R0A@'1F4D$'G@@^_=>Z^S#
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NJI?YYO_;H'^8G?_O%OLK_W6"WOW7NOBP^_=>Z^IA_P
MC3_[=*[R_P#%RNXO_?=[*]^Z]UMD>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_T=_C
MW[KW7O?NO=>]^Z]U2)D?^$X7\E++5]=E,A\$=E55?DJRIKZZI?LOOA7J*RLG
M:HJ9V$>Z@H+NS,=( YX%O?NO=1!_PFT_DC#_ +D*V/\ ['LOOD_[WNOW[KW7
MC_PFT_DC'_N0K8_^P[+[Z'^];K]^Z]TDM[?R$OY!71& D[2[(^)_2_56UMJ5
ME!7S;XWSW?V_M7;^(KTJE;&&;,;@WA#3"5YPBP1,Y:1[(JLQ /NO=7Y^_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[JJ7^>9_VZ!_F)_^*M]E?FW_ "[![]U[KXL/OW7NOJ8?\(T_
M^W2N\_\ Q<KN+_WW6R??NO=;9'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_]+?X]^Z
M]U[W[KW7O?NO=?+3_G*_\*9_FQWO\I.QNN/A/WGNSXW_ !=ZGW7N#8VRLGU+
MD&V_OCMZ3;]?+AZWL[=.^$BCRD5/D9(Y)L3BJ*6F@IZ1H3.D]6'G]^Z]U1H_
M\V7^:=([R-_,K^?H9V9V"?,7Y#Q("QU$)''N(*H_HJ@ ?0"WOW7NN/\ P[%_
M--_[V6?/_P#]+(^17_V1^_=>Z#G;/9'RI^7'>G6E!O/?WR!^3>^:GL'!9*BH
M]T;I[&[HW7-5UVYH9\ID:6GRL^2K&DFEE9ZB5 6=W)<DM<^Z]U]S_P!^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW54O\\W_MT#_,3_\ %6^RO_=8+>_=>Z^+#[]U[KZF'_"-+_MT
MKO/_ ,7*[A_]]ULGZ>_=>ZVR/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_T]_CW[KW
M7O?NO= +\J<_E-J?&#Y'[HP=3)19K;?0O<&?Q%9$\L4M)E,/U[D<CCZF*2%D
M=6CEC1U9'5@1<$'GW[KW7R /Y#GPYZD^>'\TWXR?'3O>BES/46;K=^[SWSM>
M&MKL:V\L7UEUOENP*;9\V0QDL%3#39&KQU/3U[TTT<WVK3B*2.0JZ^Z]U>-_
MPK<_E;?&3X2P_#'NGXD]-;1Z2V+O:G[%Z?["VML?%28_"5.Y=L+0;LV-N.LG
MEDEDJ,C6T=7F::IFG<R/'10$LY#$>Z]U?=_*+_E=_P HS^8G_*E^)W=/8?P8
M^/E?OG>753[-[1W+L_'Y7:.ZJGLCK;(U_56\-P5F<VE6T==29#(56-DS#HLJ
M@/41S1KH\+>_=>ZU.>YH-[?\)E_YZTT/1&\=P[BZ4P5=L[<LF#SE4LU=V'\6
M^V1'6;CZXWH*2,155?B_'6TM%D13*WWU!2Y)(8V/A'NO=?5VP6<Q.Y\'AMR8
M"O@RN"W#BL=G,+DZ5BU+D<3EJ1*_&U],S $QS0R)(A('!'OW7NG7W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW54O\\S_MT#_,3_\ %6^RO_=8+^_=>Z^+#[]U[KZF'_"-/_MTKO/_ ,7*
M[B_]]ULGW[KW6V1[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[I,;WW31;&V7N[>V20R8[9VU\_NG(1B6. O1;>Q4N6JD$\OI2\<+#6W ^
MIX]^Z]UK!?RR>Y?DEWO\T-IT.\N].ZMR[-PV,WQO[=&U<GVAOJOVO4T=/B):
M#%4M3A*FO:F-+%E*_'E8'B,?I5--C[]U[K:D]^Z]U[W[KW7O?NO=$(^;OSZZ
MU^'.W4H:B*/>?;N?Q\M3M'KZDJT@6*(OX8\_N^M34]%CE8/XPJ--5.ABA55$
ML\/NO=:_%-V5_,A_F+[JKZ?9V7WSD=NTM=%'78K960GZVZ?VIJ(K(*;+5ZU$
M%--+$H,T*Y"KJZ]E!\)<V4^Z]T(;_P EKYFXS&TVZ,=N;IN3<-.N.RE/A<;O
MK=5-NFDR331SA(\A4X.#'K54CL7DE3)Z+QL899#HU>Z]TB=B?+_YW?R_.PJ?
M8';8WAEL+1O#+D>K.V:V7<.+R&'5VI_N]A[U\E6]/"#Y1!48>NEH6F!,T%04
MT#W7NMH+X[_('K[Y-=68'MCK>MEGPV6,E%DL96*D>7VSN&CC1LKMO-TZ$A*F
MG,B-=24DC>.:-FBE1C[KW0W^_=>ZT\NV_D?\N>\OF#V1LCH3N;O" ;K[9W9M
MWK38VV.X]S[2PS8W%9*>AQ,-#!_%J3&42/2TOW,EY(XENS%O[1]U[H9?]E?_
M )UOT_O-\B+7//\ LWN!O;_T-??NO=(O=51_-_\ C!2U>[MW[A^1E+B,4M'E
MLIG,IO"#O#:N*IH?,8ZC+S/5[CQM/3J0XJ5J=$?,0G'JAO[KW5G?\OK^:?'\
MA-Q8WI;O;'X7;':F366/9^Z\,KX_;.^JBFIS.^&K,=4/(*#+-&C20^.7[>J;
M5%%'3R^&&?W7NKH??NO=>]^Z]U__U-_CW[KW7O?NO=)_=NU\+O?:NYME[CI1
M7[>W?M_,[7SU"6*"LPN?QTF*RE*77D>2"61+CZ7]^Z]U\47L';?RP_DM?S'\
MUC]OY#*=:_(?XE]KY:?8FZZ[#+/0;EV\Z5&/P6ZJ7'YF!8<C@=T[?JR6#1>.
MIHZN2,Z26"^Z]UO??S4L;WE_-N_X3!=??*K?&T=M4/>>V\'L/YKY/9W7.#ST
MNWY<3LS(9O:6Z:W;U#7U.2K:5(=DYG(YRH:2HF""*9"T<+%X_=>ZU-_Y1'_"
MBKY/_P I3J/??06U.K>N>]NG]T[KK>P=N;;WUD<UMO+;!WQE<;!BL[787<6W
MP[SX[(1TE')58RJA8+-#Y:6:F:>J\_NO=5K_ ##^6GR3_FM_-/,]W]F45#N+
MNKO?=FTMB;*V)L;$RT>%P]//4P;2ZXZSV5BM4U0\,'D@I('J)9JJIF=YZB66
MHFD=O=>Z^UOT3L"OZHZ0Z;ZMRM=1Y/*=:]5=>; R62QXG6@R%?LW:-'MVLKJ
M%:E5D$,LE,TD0D4-I(U &X]^Z]T*OOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJI?YYO_ &Z!_F)_^*M]
ME?\ NL'OW7NOBP^_=>Z^IA_PC3_[=*[SX_[G*[B_V/\ QCK9//OW7NMLCW[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1 OYG_ &".O/A'
MW5415/@R6[L9B.OL9&"RFK;>.<I\5F:8,O\ U:CD)"#PP0K^??NO=5C_ ,B+
MKXRYOO\ [5J P^QQ>T>OL7)XHRD_\6JZC<>>03MZU,7V6-.@<,)+MRJ^_=>Z
MV-??NO=>]^Z]T%O=O;&WNC.I>P.W-T@R8786V<AGIJ1)##-E:R&/PXC!TT^B
M0)-7UCP44+LA57E5GLH)'NO=:D?QTZD[+_F6_+;,Y?L+.5LE#7U;[Z[:W1$P
MC;#[1HZB+&X_;6W4E#1QR2+X,7BX &$$*M-H=*=P?=>ZV^^ONO-D]5;0PNPN
MN]M8S:6T-O4JT>(P>)A,5-31#EY)))"TLTTC7>>HGD>65R7D=W8L?=>Z6?OW
M7NB:_.SXP8#Y2_'[=VTYL5#4;]VWB\INGJS+I3H^3QV\L=0M44N*IZC]0ILM
MXUQ];'RI5TFT--!"5]U[JBK^2?W/DMI?(?<?34]3-+MOMG:>0KZ6A\MX*;=^
MQZ=LQ29%8V! ,F-_B$,N@@N1"6N(U ]U[K9,[QW^O573/:W91GAIY-B]>;OW
M32R3H)8CD,+@9Z[&PF%N',E0D4:Q_P!HL%_/OW7NM7S^31L*7>GS'7>%4D<T
M/6O7V\=W25%3%)(3ELYXME4J0R+Z1,Z92IE4O_9C>WJL1[KW6VM[]U[K'+%%
M/%)!/''-#-&\4T,J+)%+%(NB2.2-[AE8$@@BQ'!]^Z]UIZ?S,>D*3XK_ "]7
M+=6Q-M+!;LH\#V_L>+#A*6':>?.8F@R-)AEB 6%:;*4#UM-"BA(8Y8HT&E !
M[KW6UWT9V(G;G3'579X\ DW]U]M+==7%3(T<%-D<U@X:W*4<:.6($%2\L-M3
M6T_J;ZGW7NA4]^Z]U__5W^/?NO=>]^Z]U[W[KW5<_P#,#_E2?!S^9OM;&8+Y
M8]/4FZ-Q;:H*C&[([5VSD*G:/;&Q:2JK%KZBDV]O+&>MZ1Y5+MC<E#541=WD
M^V\C:_?NO=&QZ2Z%Z\Z%^/?5'QDV=05&3ZKZ>Z@V3TAMS'[L^PS=;EMC;%V?
M3;'QT.ZW6GAIJVHJJ*F7^(O]JB3R/(QC4.5]^Z]UJ7?,;_A&'\1^[NSL[V#\
M6ODCO7XB87<U9/E<AU=6]94/>6P,%E*RNDJJR'8<51N':^1QN.*.BP8ZIR%:
M(&!\4BP>.GB]U[HZ_P#*E_X3!_#S^6IVIB?D/NS?NY?E=\@]IR3R]>;NWMM7
M%[(V'UO6STWVK;DVGUK15F5OFD5IEI\ED<M5_;!Q)20T]3&M1[]U[K9A]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW54O\\W_MT#_,3_ /%6^RO_ '6#W[KW7Q8??NO=?4P_X1I_
M]NE=Y?\ BY7<7X_[]WLKW[KW6V1[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[JAS^>MV(^.ZRZ1ZKIZHJV[-Y[@WMD:5  STNR\.F(H#-
M+]0C2YF5E3Z,T>H\Q@^_=>Z,O_)XZ\?9/POV]G*BF2"K[.WKO#?+-<-424<5
M7'LS'&9K<*T6($T2 D:9-7!=A[]U[JTSW[KW7O?NO=4Y_P [3?4VW?BMMG9U
M)/-%-V'VK@:+(1(X2*IP.VL36[CJ8YU#7?37Q8R15*E;KJ)#*M_=>Z8OY('7
M%!@/CIO[LEH4_C/8/9-3BON?''K.W=DXF"#&0"07;BMK<DQ!('*V'Y/NO=74
M^_=>Z][]U[KA++%!%)--)'###&\LLLKK'%%%&NN2221[!54 DDFP'OW7NM-W
M^6**BN_F&=/5&$=(H6S/:%89 MH1B#UIGVJ$\>A@HD@8QIZ>&9;%3ZA[KW5^
M/\W3?S;(^$N^L; XBK.QMR[,V!22^1495J<P-TY.-%8'7Y:'$U<#*/HKLW]G
MW[KW10/Y$O7WVFQ>^.U)Z0WS^ZML[#QE8^FRQ[6Q4N?S,,!!N1(V7HC*2+$Q
MH ;AA[]U[J_/W[KW7O?NO=:P'\]/)4TG?G3N(31]Y0]/R9.<7!D^WR>\\C34
M>I;?351SZ;GDWM:QO[KW5X'P!H*G&_"_XWT]6ACEDZOP->JD,+T^5#Y2C>S@
M'U0S(WT_/%QS[]U[HW_OW7NO_];?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=52_SS/^W0/\Q/_P 5;[+_ /=7[]U[KXL/
MOW7NOJ8?\(TO^W2N\_\ Q<ON&_\ Z+K9/OW7NMLCW[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6IK_.EW^^ZOEU2;/@933]:=:[4P$L"2
M-(?XON*2HWE4S.EK([TV0H4"\W"*U^>/=>ZV9/CKU]'U3T+TYURM(**?9W6V
MSL)D8!&\+'-4N"A_CU1+%*2RR35IGFE!^CLWT^GOW7NAF]^Z]U[W[KW5'W\]
M#;^3K.ANH-RTT'DQF![4J<;DI18FFFW!M6J?'NZ@Z@C&BE0M:P8HIY90?=>Z
M%O\ DQ;AQF7^&T&)HYJ1J[:_9>]<;E:>$@544V0--GJ66MCOJ)DBJE$;VL57
M2"2C6]U[JV;W[KW7O?NO=$H_F$=\8[X__%3M#<;UT--N;=>#KNO=C4S./N:K
M<V[Z*3%K54D1(U''TK5.2>_&F"QOJ"GW7NJ3/Y(O3-=N7O7>W=-923K@.L-G
MS[?QE9^VD4N\=[LM,D"&56:00XN"O,PB(*-- 68!PK^Z]T-O\]WL&'Q_'_JJ
MGF)GU;R["S-.=6A(@M+MO;4P -F+$Y8'4OITBQ]36]U[JPS^5;U^FP?A%U*7
MB\60WL=Q=@91O')%YI-Q9V=,3+IEL3_N,@H%# :6M=;J03[KW5B/OW7NH]96
M4F/I*JOKZJFH:"AIIZRMK:R>*FI*.DIHC-4U554S%4CCC16=W=@JJ"20![]U
M[K3'^2^]\S\]OG36P=>K+D:'>F\<)UCUJ?"Z1KM'#RC$TV?DCG:\<,JBJS51
MY"OC21RRII('NO=;CVS]L8W9.TMK[,PRE,1M+;N$VQBD8(K+C<#C(L50JRQ@
M*"(HE!  ']/?NO=*+W[KW7__U]_CW[KW7O?NO=>]^Z]U[W[KW27WKO;9W6VT
MMP[][!W3M_9.R=I8JKSFZ-V[JRU#@MN[?P]#&9:S)Y?+Y)XX*>&-1=I)' _'
MU(]^Z]UJP?*?_A8=_+)Z/SV1VGTGM?NWY7YC&9)Z*?<FP\#A]B]6S14Z$54^
M/W?O^JI\G5'RE4@:FV_)3RJ))%J0@B,WNO=$(D_X7%]7"HD6+^77OYZ03NL4
M\GR0V[%4/3B2T<LE*NSG57*\F,3, >-9'J]^Z]T=KXU_\+)?Y:G;>=QVV>\>
MO>_?B_5Y+(Q4:[KW%@,)V9UMCZ>>7Q0U>7S>P:J3-PVN#+HVW)'&"292 3[]
MU[K:DZK[6ZU[RZ[VCVWT[OK:_9?66_</#GMG;YV9F*+/;:W%B9W:(5>-RE S
MQOHD22&:.X>*5'BE5)$=%]U[H0/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW54O\\W_ += _P Q/_Q5OLK_ !_Y
M=@]^Z]U\6'W[KW7U,/\ A&D/^Q2N\_\ 'YE=PG_V'6R1[]U[K;(]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UI7;RW5M/O7^8WE=S;KW
M)A\!UYN?Y+P_Q+<VX,AC<+B*+KO ;O3'P5V1R67DCI8 <11H"TLF@,;>KZ'W
M7NMLG_9O/B;_ -Y0?'?_ -'7UK_]<_?NO=>_V;WXFGZ?*#X[_P#HZ^M?_KG[
M]U[I:[&[SZ2[/RE3@^M.XNK.P\U18]\M68C8W8.TMVY2DQ451%229.IQ^ JZ
MB6.G66:&)IF0('D12;LH/NO=!Y\OOC_1_)SX]]A]12R4]+E\UC$R.T<E4AO%
MB]Y8.89/;M5(ZD,D4D\8IJEEN?!+* #>Q]U[K6*^#ORTW?\ R_.[=X[%[6VW
MG(=DYK)Q[<[5V>8K;AVKG\#/)3T6Z,/13NB2S4_DD2>)7"U5,X979HX#[]U[
MK:PZH[YZ:[RQ%/F^I>RMI;ZHZBE:L-/A<M ^9H8(WCCE_C&W:GQY"A=#+$'B
MK:6)U\B:E&M;^Z]TA.]_E]\>/CAA\CDNT.R]O4&5H 4BV1B,A1YOL#)U;0">
M&CH-H4,C58+AHP:BH2*FCUHT\\2.&]^Z]UJZ_(#O3O7^9]\B=N;1V'M?(KAX
M*FIQ7677L%0\E%MK#SS*<KO/>.00&&.>2-8YLG6E1%#$D<$>O0K2^Z]UM%?$
MCXV[<^*?1^UNI,#-'D*ZD\V;WEN!$>([FWKE8HQF\R(I#=(@(H:6E0BZT\,*
MOJ<,S>Z]UK,?S=-^MV!\V]TX""N6HHNN]N[*Z]H&EGAIZ*GG?&C=&5C\\I5$
M$=;EJB.>20BS(UVT*MO=>ZV0NN/D;\1>O>O=A[ H_E%\='I-C[,VOL^E:/NK
MK<(]/MK!P86!D5LD" 5@! (^GOW7NFW>_P#,-^%FP8YWS'R)Z\RKP4L56(=D
M9&H[$DG6:4PQ0T[;$BR*-*6'KCU@QJ0\NB/U^_=>ZHT^>7\UG)?(/ Y'I?X_
M8G<.T^N,Z/X?NG<^7CAI=X[\I9#XI=O4.+H))Q08R=K>4>=JBK0K'(E/$9H9
M?=>Z/1_*E_E_Y+I+'K\B.Y,3-CNU=R8NIQ^R-H9"G$=7U_M;)($K,IEHY1JB
MR^2CO%X;!J6D9HW)EJ9XH/=>ZNP]^Z]U[W[KW7__T-_CW[KW7O?NO=>]^Z]U
M[W[KW6BG_P +8OEAO_9W6/Q!^'FTLSE<-LON')]C]O=N4]+X*:EW53]<3X?!
M]:X">LB8U$M-#69++U]91NJ0--%CYOW9(5\'NO=%U_E6_P#"1#I+Y._%+H?Y
M3_+KY,=LT1^0'6NU>WMM]8= 0;$VY_=K9V_,%!N/9M/G=_[SH=RK65LU%405
M%=!!B*;[=I&I=1EB:4^Z]U;C_P! :O\ *3_YZ[YC_P"M_IBZ^_\ L+]^Z]U7
M!_,(_P"$;WQYZO\ CUW#W7\//D_W-CMT=2]:;Q[+/7WR%38F],!O&/96*JMS
M9; T.]MBXG;,V%,U# 8J*:JQ^043HHG=8IFFI_=>Z#O_ (1+_*;LB;L#Y<?#
M#*Y>LRO5<.P,-\B]GXFMGJ9Z?9V[J#=5#U]O'^!H\_C@CS4&3QDE9&M.VN2@
MBD#QL9!-[KW7T*/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW54O\\S_ += _P Q/_Q5OLK^G_.L']??NO=?%A]^
MZ]U]3#_A&G_VZ5WE_P"+E=Q?^^ZV3]??NO=;9'OW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[H,NX.Z.I/C[U]GNU^\>R=E=3=;;8@6?.[VW_N/%[7V[C_*WCI:
M9\EEI(D>HJ)+0TM+$6FGE98H8WD95/NO=:WW;G_"OO\ E =9;IJMM[:R?R0[
MSHJ4JO\ >_J/IW&P[6J'O9Q2OVUG=J9!PIN"W\/TGZH6!!/NO=&]^%O_  HW
M_E1?.#<F(V%L?ONIZB[-W!5BAP/7?R*P'^BS+9JKDD6"EH\7NAZBNVQ/55,K
MI!24$>>-742,L<,$C$#W[KW1F?G7_.)_EW_RY9'POR@^0^W,!V*^/_B5#T[L
M^DR._P#MFL@DITJZ,U6T-K1U#XI*J)_)1U.=EH:>H ;PS.1;W[KW5.V!_P"%
MDW\I/,[AI<)7;5^8>UZ"IJXZ9]UY[I[K^3;U'')((S6U46WMYY#)>)0=;>/'
M.]OHA/'OW7NK[OC5_,7^#OR^ZDW%WG\>ODYU1OSK'9>-FS&_\_+N*+:-3UMB
MZ=)I9LCV9M[>RXW);=IPE/42+/F:2FC>.-Y(W:-2WOW7NJ@_D=_PJ^_D_?'W
M=-7M'$=D=J_(S)8VKK,?EJ[X[];0[BVY05U#.:>>"'=/863VSC\@A(U15>)J
M:JFD7F.9A[]U[I[^,'_"J/\ E ?)?<]'LZL[;W[\<<]E:ZEQN&_V9;8D.R=O
MY*LK)/'&LV]]H9#<&"QL2\M)59G)T<"#]4H) /NO=6H?+;^95\&/@UU_M_LK
MY._)/KCKK;N\L93YG8=+%DYMW;I[!Q%;$LM'F-B[,V7'D,KE<?)KB!R=)2/1
MQ^2,S5$:R*Q]U[JAVO\ ^%E?\I6CSDN(@V=\R,G01U+P+N>@Z>Z[3!S1I)H%
M9%!D=ZT^2\3#U*&QZO;ZH#Q[]U[J[3X.?S7?@+_,7HJD?%'Y#[3WUNO&47W^
M<ZQR\>0V7VIA*:..-ZRJGV'NR*DKJJEIFECCJ,EC$JJ%)'5/N2S*#[KW15?F
MS_PH@_E6?!+<F:V!V1W\W9O:FW:EJ//=7?'_  ;]I;DPE9#4O1UN.S6<I9J7
M;E%6TLT;Q5>-K,[%60L")*=;'W[KW1(^J_\ A8)_*"[&W32;=W)4_)KI.@JG
M*/O'M3IO$5.UJ.WT>K'4^X-TY,*?P4QK?XV]^Z]UL?=(=\]+_)3KG!]N] ]H
M;([?ZTW&C'$;SV#N#'[BPLT\2*U7C:F>@=C35M,75*R@JECJ:>2\<\4<@*CW
M7NA:]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T0;Y4?S%^COB%O_"]<
M=F;<[0S.=SVSZ'>U'4;(P>U\GC(\3D,U7X*&&IGS>:QTHG$V.G9D6%E"%"'+
M$JONO=%F_P"'P_B5]?[B_(*WY/\ ='KVP_U_]_5[]U[KW_#X?Q*M?^XOR"OS
MQ_='KV_ O_SU7OW7NL7_  ^/\3;V_P!'WR'^O_/)];?UM_SUOOW7NLB_SQ/B
M8?U;"^0D?]-6TNNC?^MO'NMO?NO==-_/%^):@%=A?(22Y(.C:77?!_H=>ZQ_
MO'OW7NL9_GD?$T?7KWY$?^@GUM];7MQNWW[KW6;_ (?#^)7_ #POR"_Q_P!^
MCU]Q_KD;JM[]U[K$?YX_Q-'_ #3[Y$$:B 1M+K<!K?0C5NP?7\?GW[KW7:?S
MQ?B:Q(;K_P"0\=OR^T>N2"?Z#Q[L8_[Q[]U[KFW\\3XEJ"1L3Y!L1]%&T>O
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M_E']H_S+/BSUQV3\<</'NCY&?$_*[SW!M_K^,TU-E>T^M=]4-"N_MH;=J9M
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M"C=I;S)6.9XU9C08T:M*_P!KZ?[ >_=>ZM"_B.0Y'WU9:X_Y29C8"XL+L?\
M#Z?\4]^Z]UX9#( DBOK?\66JF_ O] WOW7NKX?Y+GR4[0KNUMP_'O<FX,UNK
M8%;L?+;KV[2Y>MJ<FVS,Q@,A20RKB9ZMG>GH*R&ID6:F5O&)Q$Z!6>7R>Z]U
MLJ>_=>Z][]U[J@C_ (4X]P[MZ>_DS?*FHV74Y#'Y;L8; ZFK<MC:F6EJ<?MC
M>V]Z*'>,;R16O#7XJ"LQ-1&QL\56ZF]['W7NOC_>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KZ?
M7\OKY2=O=4_\)G_@QNO:V>S%#O?>.6["Z8I-["I8Y? ;3Q'=G8$%#4X6N1V>
MGE@QF"@P]+*=,D*WDAT,D4@]U[JM.NS^=R594Y#)YS+Y&OJY7GK*ZNR-95UE
M3/*2TLD]342%W=CR68EC];\GW[KW43^(Y"__  .K.";#[F<"YX(L2;^_=>Z]
M_$<@;?Y;6 GZJ*F8\\V)Y_V'OW7NA%ZN[H[1Z9W?B=\]:[VW!M7<.'JX*B.>
M@R54M+6)$X:2@S% [F&LI)1=)Z:H1XY%NK*;^_=>ZWL>I]Y3]C=6]:]A55"N
M+JM][ V;O*IQB%RF.GW1MVFS<U"ID)8B%IS&-1OQSS[]U[I?^_=>ZU5_YX['
M_9LNO5/*CX[;4903;U-V5NT-:W];#W[KW5,P_)N0";@\6X%[G3[]U[KUO\#<
M7(/T+?V>>/\ 8\^_=>Z]<7_V/IM_2UK?[X<W]^Z]UV1S?TD']/'%OS_CS_K^
M_=>ZZYY(M;D6!_J..3^?]]]??NO==WM?ZC5^/Q<FQ'Y_PX]^Z]UQ%K?@<_@V
M_%[F]_\ >^/?NO==CZ&QL0?P2+FU[7_V_P#OOK[KW7@+>HCFQL.?H3>_^O\
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M(AO[]U[K<94:;79R0%!)9W<\?5F8WO\ DEB;_7W[KW507\[CXY]P=[_!K?\
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M. /^9/5%N/H=(W-_Q/OW7NNO^&%LJ/\ N:&@X(M;IZI' _\ )F/OW7NLT/\
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MG(;(CW?B\-45<C3U$&W\C!E<9+#2*Y_9I9XIC&ITB;2J@>Z]T#Y_D+92X/\
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MNO=8/^'8OY67_>RSX ?^ED?'7_[(_?NO=>_X=B_E9?\ >RSX ?\ I9'QU_\
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MT-ONO[2Z-Z8[.RL$--E.QNJ.NM]Y*FIUT4]/7[OVA1[@K(($N;(DE0RJ+FP
M]^Z]T*_OW7NO>_=>Z][]U[KWOW7NO>_=>Z0?:':/772G7N[^V.W-Z[;ZYZUV
M#A*S<>\][[ORM)A-N;<PE"NJHK\GDJUEC1;E41;EI)&6.-6D=5/NO=:<'RA_
MX6M_$[K;>N0VQ\6?B=VC\F]O8FM:@G["WMV'C/COMO.^&>JCGRFS<;)@=W9>
MHHG1*-Z9\OCL94/Y9A)2P^",U/NO=*7XC?\ "T+X;=P[VQ.S?E/\<^Q_B519
MRMCQ]-V%B-[T??O7V$EJ*R*GIZO>%1C,'MO-4E*$=Y)YZ+!UIBTBZ%"9$]U[
MK<=VYN/;V\-O8+=NTL[AMT[4W3AL7N/;.YMN92AS>WMQ[>S="F3PN=P6:QCR
MTU915E-+%44M53RO%+$ZR1LRL"?=>Z>??NO=>]^Z]U[W[KW7O?NO=52_SS?^
MW0/\Q/\ \5;[*_\ =8/?NO=?%A]^Z]U]3#_A&E_VZ5WG_P"+E]PV_P#1=;)]
M^Z]UMD>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO__4W^/?NO=>]^Z]TFMY[2PF_MG[
MLV+N6F-9MS>NVL[M+/T@T7JL)N/%RX?*TP\JNOK@FD7U*1SR"./?NO=?$AW)
MBN_?Y2G\QC(4$$8P?>_PE^1B5>&ER] TF+SM3L'<BY+;F8EHJA4^XPVX\7]O
M60L HJ*"L1T($BGW[KW7TJOAY_PJO_E1?(SKO"Y;N3MJK^)';'V<:[JZR[9V
MWN[)8JDR4:-]W/M?LC:6-K<17T#,I-,]5+1U;*RB2CC;CW[KW7OF'_PJO_E1
M_'/KO,Y;IOMJK^6_;!HY%VKUEU-MS=V.Q57D9(U^TGW3V1NW&T>(H*!68&I>
MEEK*Q0K".CD;CW[KW7S6]I8?OO\ FW_S'L7CJQ/XYWE\V?D9)79^;#TD=/CL
M&^^=POE]TY>EI;%:?$[=Q(JJM@0WAHJ,DZM!O[KW7VV]H;5P>Q-I;7V1MBB7
M&[:V;MW";5V]CD-TH,'M[&Q8C$T2$_414\,: _X>_=>Z47OW7NO>_=>Z][]U
M[KWOW7NO>_=>Z^?-_P +1?G_ +JCW9T9_+@V+GY:#:+;2QWR&[YIL97R+_>/
M*9+/UF$ZHV9GH80H\.-&,K,Z]+*S+))4X^H**U/"Y]U[JGS_ (3X_P @_$_S
M>Z[N#M/N_LC??5/QHZ9S&$V345?6M'AXM^=D=C9K''.5FV]L;DW50Y+%8Z'#
M8]J.KRD\^.JY;UU#''3Z99)HO=>Z"7^?Q_),;^3WW/UHO7>_=T=I?&_OG&[G
MK>LMS;WH\3#OC;.>V=64\>Y-@[SK=OPTM!7U,%+7XZLI\G2T%$E2LTBBCA-.
MVKW7NMF?_A&%\_-U=E]3=]?R_>Q-P9+./T-!C>Y.B?XC.]8^'ZQW9FFPG8FS
MJ:>>4M%0XW/5&.KZ*!(BH?*U?J55C3W[KW6\?[]U[KWOW7NO>_=>Z][]U[JJ
M7^>9_P!N@?YB?_BK?97_ +K![]U[KXL/OW7NOJ8?\(TO^W2N\_\ Q<KN'_WW
M6R?I[]U[K;(]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_5W^/?NO=>]^Z]U[W[KW6N
M=_/(_P"$]_3O\V?%X_MSKW<&$Z)^9>T<1#A,5VA68JHJ]F=I;9H@3C=F]P8_
M$J:IC1W*8O/T<<M721,T$L%=3+3P4_NO=?/S^0'_  G._G&_'K<U1M_*_"[L
M/M7'AG;&[P^/[X_N?;.9I5J6I4K*=-FRS9.C#E"P@RV-I*@(5=H55@3[KW4;
MH[_A.I_.4[XSL6&PGP@[,Z\I-!FKMR=XU&WNE\%C*99OMS/*.P*RBKJEM=@*
M?'453.5/D$1B#.ONO=;_ %_(J_X3R]:?RFH\IW;VINW =X_,;=VWJC;-9O7"
MXRIAZ^ZFVU75 DRNW.ITSD,5?+/D%CB3)9ZLIZ:HFA!I8::EIWJ5JO=>ZV3/
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7QW_ /A2SV;5]H_SK?FU7S.WV6SM
MS==]98FG+3%*2DZ]ZAP&VZU(A-R!-7PUE40H"ZI6*W!N?=>ZW@/^$>6WJ'"_
MR?XLE21)'4;N^47=NX<FZ6U3UU-C\#M2.66RCU"FQE.G)/"CFW ]U[H _P#A
M:SL6@RW\N+XX]AF&%LSLKYE[9V[3U#H/-%@]\],[RJ<Q%#+>]GJL-C"R >K0
M&)&@ ^Z]UK"_\)(][Y#:G\Z'J3 T==44E-V;TWW]LC+00L%CR>/H.OINR(Z&
MJ!_5&M5MZFJ0!_;B0_CW[KW7UEO?NO=?.[^2W_"QSYK=)?(WO_IG _%CXMY;
M!]1]V=J]8X;*Y>7MG^*Y/%;!WU7[4QV0R?V>=CA^XFBI$EF\4:IK+:546 ]U
M[H$_^@VOYU_]XD?$O_J=W#_]D/OW7NO?]!M?SKM_V21\2[_\MNX;?[;^\/OW
M7NBX_+W_ (5K?,/YB_&+O'XM[V^,_P :MK;3[VZZS_7&X-Q;6E[1_O%AL;N"
MG^WJ,AAQELW44WGC'*">%TO]0??NO=:HOOW7NMB3^5C_ ,*.?DO_ "H_C5E/
MC)U#T/T7V1M;+=I[I[7J-P]D2[^7/IF=U83$X&KQT(VQE**G%-%%B('CU1%]
M3R7<C2%]U[JR3_H-K^=?_>)'Q+_ZG=P__9![]U[KO_H-K^=7_>(_Q,_ZG=P_
M_9![]U[KK_H-K^=?_>)'Q+_ZF]Q?_9#[]U[KW_0;7\Z_^\2/B7]/^.O</U_]
M"'W[KW7?_0;7\ZO^\1_B9_U.[A_^R#W[KW77_0;7\Z_^\2/B7;_EMW#_ +W_
M '@]^Z]U[_H-K^=?_>)'Q+^I_P!V]P_3\?\ ,0^_=>Z]_P!!M?SK_'Q(^)=O
M^6W<)_\ EA]^Z]U[_H-K^=?_ 'B1\2_K_P =>X?I_P"A#[]U[KW_ $&U_.O_
M +Q(^)?_ %-[A^O_ *$/OW7NO?\ 0;7\Z_\ O$CXE_\ 4WN'_P"R'W[KW7O^
M@VOYUVY^)'Q+O_RV[A _VW]X??NO=>_Z#:_G7_WB1\2_^IO</U_]"'W[KW7O
M^@VOYU_]XD?$O_J;W#_]D/OW7NO?]!M?SK_[Q(^)?_4[N'_[(??NO=>_Z#:_
MG7_WB1\2_P##][N'_P"R'W[KW7O^@VOYU\_\XD?$O_#][N'^GY_W\/OW7NO?
M]!M?SK_[Q(^)?_4[N'_[(??NO==_]!M?SJ_[Q'^)G_4[N'_[(/?NO==?]!M?
MSK_[Q(^)?^/[O<7U_P#0A]^Z]UW_ -!M?SJ_[Q'^)G_4[N'_ .R#W[KW77_0
M;7\Z_P#O$CXE_P#4WN'_ .R'W[KW7O\ H-K^=?\ WB1\2_S_ +N[A_V'_,0^
M_=>Z]_T&U_.O_O$CXE_]3NX?]A_S$/OW7NO?]!M?SK_[Q(^)?U_X[=P_2W_A
MP^_=>Z[_ .@VOYU?]XC_ !,_ZG=P_P#V0>_=>ZZ_Z#:_G7_WB1\2_P#J;W#_
M /9#[]U[KW_0;7\Z_P#O$CXE_P#4[N'_ &/_ #$/OW7NO?\ 0;7\Z_\ O$CX
ME_\ 4[N'Z_\ H0>_=>Z]_P!!M?SK_P"\2/B7_A^]W#_]D/OW7NO?]!M?SK_[
MQ(^)?_4WN+_[(??NO=>_Z#:_G7_WB1\2_P#J=W#_ /9#[]U[KW_0;7\Z_P#O
M$CXE_P#4[N'_ .R#W[KW7O\ H-K^=?/_ #B1\2_\/W>X?]Y_W\/OW7NO?]!M
M?SK_ .\2/B7^/]V]P_['_F(??NO=>_Z#:_G7_P!XD?$O\?[M[A_V/_,0^_=>
MZ]_T&U_.O_O$CXE_]3NX?_LA]^Z]U[_H-K^=?/\ SB1\2_\ #][N'C_7_P!_
M![]U[KW_ $&U_.OG_G$CXE_X?O=P_P"\_P"_A]^Z]U[_ *#:_G7_ -XD?$O_
M !_=[A_^R'W[KW7O^@VOYU_]XD?$OZ_\=NX?I_Z$/OW7NO?]!M?SK_[Q(^)?
MT_X[=P_7_P!"'W[KW7O^@VOYU_CXD?$O_J;W"?\ Y8??NO=>'_"VOYU_GXD?
M$O\ V$O<(_\ EA]^Z]U[_H-K^=?_ 'B1\2_^IW</]/\ PX??NO=>_P"@VOYU
M_P#>)'Q+_P"IO</]/_#A]^Z]UW_T&U_.K_O$?XF?]3NX?_L@]^Z]UU_T&U_.
MO_O$CXE_]3NX?]C_ ,Q#[]U[KW_0;7\Z_P#O$CXE_P#4[N'_ .R#W[KW7O\
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MB7?_ );=PC_Y8??NO=>_Z#:_G7_WB1\2_P#J=W#_ /9#[]U[KW_0;7\Z^?\
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M]U[_ *#:_G7_ -XD?$O_ *G=P_\ V0^_=>Z]_P!!M?SKY_YQ(^)?^'[O</\
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M.[A_^R'W[KW7O^@VOYU_]XD?$O\ ZG=P_P#V0>_=>Z]_T&U_.O\ [Q(^)?\
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M=O\ C_QEG8G_ -;O?NO=>_Z#?OCCQ_S@AW;?\_\ &6=B?[P?X=[]U[IWV_\
M\+9OCQN+/X3;]-\%>Z(*C.Y?&X>GGG[9V/X89LG6)112S>/&EM*LX+:03;Z
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M\9OD%_Z)GL;_ .MOOW7NO?[*7\JO^\9OD%_Z)GL;_P"MOOW7NO?[*7\JN/\
MG&;Y!<_3_C#/8W/^M_N-]^Z]U[_92OE5_P!XS?(+_P!$SV/_ /6WW[KW7O\
M92OE5]?]EF^05OZ_Z&>Q_P#ZV^_=>Z]_LI?RJ^G^RS?(*_U_YDSV-_\ 6WW[
MKW7O]E+^57_>,WR"_P#1,]C?C_R&^_=>Z[_V4KY5_P#>,OR#_I_S)CL?_P"M
MOOW7NNO]E+^50^OQF^00_P#*,]C?_6WW[KW7O]E+^57_ 'C-\@O_ $3/8W_U
MM]^Z]U[_ &4OY5'Z?&;Y!?\ HF>QO];_ )UOOW7NO?[*5\JK7_V6;Y!6_K_H
M9['M_P"ZWW[KW7O]E*^57'_.,WR"Y^G_ !AGL?G_ %O]QOOW7NO?[*7\JO\
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MSV-_];??NO=>_P!E*^57T_V6;Y!7^O\ S)GL?Z?2_P#Q;??NO=>_V4OY5?\
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M]E*^57'_ #C-\@N?I_QAGL?G_6_W&^_=>Z]_LI7RJ(N/C-\@B/Z_Z&>Q[?\
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MOOW7NO?[*7\JO^\9OD%_Z)GL;_ZV^_=>Z]_LI?RJ_P"\9OD%Q]?^,,]C<?\
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ME?\ LG+O_P#\0GVK_P"\+7^_=>Z^#G[]U[KZ&/\ PAQ_YEU_,;_\/7XR<?\
MD"WO[]U[K?']^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__T=_CW[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U0#_P *CO\ MQ1\YO\ RV;_ .##Z^]^Z]U\@7W[KW7U^O\
MA+C_ -N*/@S_ .7,_P#P8?8/OW7NK_O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= G\E>/CEW^?^_)]J_P#O
M"U_OW7NO@Y^_=>Z^AC_PAQ_YEU_,;_\ #U^,G_NCWQ^/?NO=;X_OW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z__2W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW56?\ZGX:
M=M?S!/Y9GR5^(?1=;LS']J=M_P"AO^ZU9V#F,C@-H0_W"[_VKV=F_P"+Y?$T
M61J(M6.PM8M/XZ.35,8T;0K%U]U[K0<_Z TOYM/_ #VGPT_]'#V-_P#83[]U
M[K?C_DK?#3MK^7W_ "S/C5\0^]*W9F0[4ZD_TR?WIK.OLQD<_M";^_O?^ZNS
ML)_",OEJ+'5$NG'9JC2H\E''IF$B+K55=O=>ZM,]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T'/<6U,GOSJ/
MM/8V%>ECS.\^N=[[4Q,E=+)!0QY/<6V:K$4#UD\22,D0EF0R.L;$+<A2>#[K
MW7S%O^@-+^;3_P ]I\-/_1P]C?\ V$^_=>ZVNO\ A-?_ "?OE7_*4VE\N,'\
MH<ST]EZSO'<?365V:W4F[MQ;K@@IM@XS<E'G!G'W!A<.8&9LM2_;B)9=0$FH
MII ;W7NMG7W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__3W^/?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__4W^/?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7__5W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7__6W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__7
MW^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__0W^/?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%-[<^>W
MP7^/^]*KKCOGYH_$WI+L.AH:#)UNPNW/D9T_UMO2CQN5@^YQ>0JMK[RS%%71
MP5,?[E/*\ 61?4A(Y]^Z]T('1_R>^-7R;QN>S'QM^0W1OR#Q&U:ZDQFY\KT?
MVUL'MC&[<R60@:JH,?GJ[860KXJ.>>)'DABJ&1G52R@@$^_=>Z'+W[KW0/\
M=?R%Z"^->U<?OKY%]X=/] [)RVX*7:>+WCW7V7LOJO:N2W578ZKS%#MK'[AW
MU6T%)-D)J2@KJJ*BCF,SPT\\JH4AD9?=>Z#GIKYS?";Y&[MFV!\>OF'\6>]]
M]TV&K-QU&RNFOD'U+VANV#;V.J(*/(9Z;;>R,O75BT4$U3313530B)'EC5F#
M.H/NO=&F]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T0JN_FJ?RO\96UF-R7\R#X%
M8_(X^JJ*&OH*[Y@?'JDK:&MI)33U5'64M1N)9(I8I%9)(W4,K @@$>_=>Z.Y
MMS<>WMX;>P6[=I9W#;IVING#8O<>V=S;<RE#F]O;CV]FZ%,GA<[@LUC'EIJR
MBK*:6*HI:JGE>*6)UDC9E8$^Z]T\^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z+G\O
M/DCLWX??%_OKY/[^DB_NMT;U=N[L.MI))6@;-5N"Q4DV"VQ2RHKD5&5R!I<;
M2^DWFG0>_=>Z^-KO#^<+_-1WANW=.[9?YBWSAP,NZ=QYO<<F"VK\K^^=N;8P
MLF;R<N3?$[<V]A\_#24%!3&7PT=%2PQPP1*D42*BJH]U[K=X_P"$AG\T[M_Y
M2[?^2?Q"^4G=O9'=?;NPJK&]Y]6;U[AWWN;L;?68ZXS30;1W]MF7=N\JVLKY
M:;"9-<14TE.\C!!DY]%DCTCW7NMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]UK9?S>_^%+/Q(_EF9G=O0^P<54_)7Y@X")*/*=7X*JJL%L'J_)9/"KE,/4]
MJ=@R4\D32A9Z>9\'A5J:PK>*JDQI>.4^Z]T<S^1/\T^[OY@_\M[JGY7?(6KV
MS4]G]D[[[P3)T^S-OQ[9VKAL3MGM_,[9VW@,#B1)43+345!24]/'+655152!
M==1432LTA]U[JDK_ (6*_*/Y-?&/J/X-9+XV?(KO7X]9'=O8_==#NO(='=N=
M@=35NYJ+%;9V_48NCW#5;"R&/DK8J9YIGIXZEG6-G<H 6:_NO=$*_P"$@WS3
M^8_R7^<GR3VE\COEG\F?D!M7!?%&OW%A-L]V]\=I=J[>PVX$[>VOC$SN*PN^
M\K7TU/6BFJ*BG%5#&L@BEDCU:78'W7NOH5^_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z_]'?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U\G+_ (5Q_P#;YSL__P 0ET)_[Q0]^Z]T
M5#^0A_-2S'\K+YP[7WKN;*9%OC5W(^+ZR^2.WJ>]13P;3KLB/X)V52T)#%J[
M:U7(<@IB'EEHVKJ1#>J]^Z]U]BK#9G#[CP^)W#M[+8W/8#/8VAS.#SF&KJ7*
M8?,X?*4J5V,RV)R="\D-135$,B303PNR2(RNC%2#[]U[K44_X6K?]NLN@_\
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M:,4;2M'$ID9(T4M<A5%@/=>ZW.?E?\U/F+L7^33B?Y@GQLV1TMNKY$8WXO\
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M?&[L0UM29\G78/:>/BJ.H]R3%T5WCJ=LRT&/>HD>1YJN@K'>0OJM[KW0N?\
M"DO_ +<C?/7_ ,,?K3Z_^)ZVI?W[KW7R'.E\%V3N_M78NP.GY\K%V5VEGZ7J
M':5/A:RHH,AF,CV\K=9R;96II?7XLM#E9<94QBXDAGDC8%6(/NO=?3W^+G_"
M0O\ E;]9]&T.TODMMG?GR2[RR^UJ6GW=VPW:?8_7&)VWNZ>BG7)5_5.SNO\
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M3R1EH=N=I[BV=MG:U080=:B6IV=F%#,+-XR%)*M;W7N@[_X1#_\ 957S>_\
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M^%CWSG'>'SAZZ^&NT<Q'6;%^(.S#D=XQT571U%+5]W]N4=)GLY3SM1%]9Q.
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MW\9_O3_?[;G_  )^]M]M_#OV]%_*^KT^Z]U8G_),_E%_\,Z_'SM3HG_9@O\
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MK+?_ '=2[+W=V2,?OO<$>3JM@8ZO,<!R^0R%+!62*D-0\,C0,R >_=>Z4?\
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M'R4R>X\A%\5/AQT;LG:4-9 F*KOD'G=_=H[CR./B$JU-5D,7UQD]GTU%-.3
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MU[W[KW6A'_PN3_X]7^6I_P"'!\L^?_(=US[]U[JN#_A%3_V]-[\_\4 [3_\
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M58/+X[*8@U)"R5,-/!5R11-4Z![KW6WE_(5_F^Y_K[^0/\O=^=G9"JW;O/\
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M7=+N6F1Q!*^'Q^*R5711M&6091I"?5%I]U[HB_\ PEN_DU=(_P R#M'N7O\
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MBX_MSJ?I<>_=>ZT8?Y9N PVZOYD'\OS:^X]/]WMR?-WXI8#/:GAB7^#9CO?
MX[*:I*E6C4>"1[M(I4?5@1<>_=>Z^XY[]U[K72_G@_S^?^&:-_=!;'_V4[_9
MC_\ 3CL_>NZ_XI_IW_T0?W7_ +GYJBQ'V'V/]S=T_>_<?>>3R^:G\>C3H?5J
M7W7NJ,/^@YS_ ,%=_P#L[/\ ^B/W[KW1F_A;_P +$/\ 9OOEM\<?BU_PW9_H
M\_V8'N38/4O]^O\ 9N/[V_W2_OQN&# C/_W8_P!&.,^_^U\WE^U_B%-Y+:?-
M'?4/=>ZW8??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__4
MW^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=:3?_"U#Y>;GZU^,7QC^(&T,]+C*?Y([YWGV!VC
M2X^I:*KR&QNEHL2NW-OY5$()H<AF\W%7!2+/-BE_"$'W7NM?'_A*9_+HZ8^=
MOSPWOO3Y$;/QG8_5'Q5ZYQ_9,?7.XL?%E-G;R[,W)N./!=?T>^,75!H:_%T<
M<.4R;XR=6AJZBFIXJF.:C^YIYO=>Z^G!\@/B#\;/E!T1E?C5W9T]L7>73.0V
MT-K8_9M3MS$04.SZ"GQ)PN'J]@>&$?P.LQD&E<75XT0R4NA/"5"@>_=>ZT%]
MB?\ "*7YFT.]J+-97YK_ !\ZZQN)["CK<#G-E8GM'?N\,#M''YV.IPNZ8%KL
M;M.&3/T].OW'\/CJ(*?[F-43((C^6/W7NM@+_A2S\S>T/@;_ ">J'KBC[,EW
M#\A_DB=D_%S*]J8?"R[,R6;HYME3Y3O?LK%8.AJZI,/_ !>BQM30+2QU\[T9
MRZ"&61H?.ONO=?/L_DA?R\<+_,X_F(=1_&K>];E\;U-3T&X^T>YZS 3-2YI^
MM=@TJ5>0PV-KU5OM9<O7SX["BL U4XJS,@+HJGW7NOL)=9?%OXW]-=.T_P ?
M.KNB^JME=(PX^FQLW5V%V/M^+9N6AIL?38L5&X\-+ \>4JI8*.E6JKLD)ZBH
M,2//+(XU>_=>Z^9?_P *H_Y2_4/\O'Y(=3]V_&?:M'L+H7Y5T.\Y9.ML,D4.
MV>MNU=AST$NY\9M*@5KT6'RE)E:.NH<>B^*FE2LBI_'3+!!%[KW5Q7_"*_YR
M[RWAM#Y)?R_][9?)YK!]4X[&=^](+65$53#M;;.X]P_W:[7VI2^8B:&C.7K,
M/E:."(-$M169&1O&\H\ONO=:?O\ .D_[>V?S'/\ Q<?OO_WX-;[]U[K>;_X2
M4_RN_CSLSX.[,_F!]A=:;2WY\AN_-X;TR'7V\-W8G'[BJ^J.O.LM_P!5L7!4
MNQ:;*12)B<G5YC"5^5J<K2::J2)Z.(2HD.EO=>ZD?\+&OASTCNGX$8+YATW7
MVW\1W[U5W9U_MZL[+P6!QM#N7=>P=^4$VTJ_:^^\W1P"HR-)33P8F;&-6RN:
M-X3%3-&E5.DONO=:B'_"9'<];MW^=G\-**"."JQN])>[MB[DQE6OEHLK@-Q?
M'O=4=51UM.?3*BRQP5 CD!1FC4,"/?NO=6??\+$OB_\ &CXQ]V_"3%?&SX[]
M%_'O%[KZL[<R&Z<9T?U)L'J>@W)7XW=N(IL;79^BV%CZ".LFIXY9(X):A79%
M9E4@,0?=>Z4?_".3XL?&'Y/;_P#GM1?)3XX]#?(:CV=L_P"/55M&E[RZ@Z^[
M9IMK5.:S6[XLS4;<@W[CL@E"]6M-3+5/3!#*(H@Y81K;W7NMW'^8KU9UCTI_
M)Y_F'=8=-=<[#ZDZUVM_+\^:T.V.O.LMH;?V'L;;D63Z(W5F\E%@=I;5IZ2@
MHUJ*VIJ:N=:>G0232R2M=W9C[KW7Q1H89:B6*""*2>>>1(8884:26:61@D<4
M4: EF8D!5 N3P/?NO=?48^'W_"1K^6MM[XF;&V[\L=@]B]F?)W=FQ-OY;LKL
MJC[:WSLJ?KK?67QZ9'.[;ZYVOL[(18%Z3%32MCXI\WC\F]1X34'Q^7PQ^Z]U
M#_GE;UVU_)(_D*[!^$_Q:W)N7&5_8<N/^*&Q]UY.KB&^?[I;F@RW87>^_JS(
MX.&BIHJ[+0K7T51)311>*;,AZ>-?&&C]U[K1<_DA?R\<+_,X_F(=1_&K>];F
M,;U-3T&X^T>YZS;\II<TW6NP:5*K(8;'5X5OM9,O7SX["BL +4_W9F0%T53[
MKW7V$NL_BW\;^FNG:?X^=7=%]5;*Z1AQ]-C9NKL+L?;\6S,M!38^FQ?W&X\-
M+ \64JI8*.E6JKLD)ZBH,2//+(XU>_=>Z^9A_P *I/Y2_4/\O+Y(=3]V_&?:
ME'L+H7Y5T.\Y9.ML,D4&V>MNU=AS4$NY\7M+'J;T6'RE'E*.NH:!%\5-,E9%
M3^.F6""+W7NKB/\ A%?\Y=Y;PVA\D?Y?^]\QE,W@^J<=C._ND$K*F*I@VMMG
M<>X?[M=K[4I/,PFAHSEZS#Y6DIX@T2U%9D9&\;RCR^Z]UH+]W_\ ,Z>W_P#Q
M*&__ /WK*OW[KW7VX?Y=?_;OOX*_^*<?&+\W_P":)X3\^_=>Z./[]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[JK+^;7_*@Z,_FX?'"FZ0[7S63Z^WCL[.MN[I[N3;V*I<WGNM=T
M3P+191GP=9-31Y/%Y*F5:?*8MZJ#S!(98YX*BGAF3W7NOG#_ "\_X2S?S<?B
MY7Y2LVETQBOE;U_25,R4>]/C?GZ?=&7J*;[5:RE:KZKSPQVZEG=?)%(E#BJR
M%)HVC%0XDIGG]U[JB+?'6G>'QUWM!B>R=@=K=%=C[>R<LM-C=\;5W?UCO;!Y
MG!UGBFD@H\]!0U]-54=0NEBJJ\4@L=+#W[KW6R]_)5_X4L?,;XJ=W]2=%_+7
MMC='R-^(>\MU8+8N=G[3RE1NKLOI>CW'64NWZ+?&S^R,IYLS4XW"@0RU.WLC
M4U-*:))XZ".CJ7$I]U[K9G_X6>_]NH.L/\/F_P!1V_\ 1/\ 80]^Z]UJB?\
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MFU(JY*S>>],S5X^.22DQ^'Q<=5D*VKT_M11,PNVD'W7NOHU?\+/?^W4'5_\
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MT<<T+I+&CK[KW6H1\H_^$67PL[/W3N#<_P 7_DCV[\6Z3-SM646P]P[8QOR
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E7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>mrna-20201231_g28.jpg
<TEXT>
begin 644 mrna-20201231_g28.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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ML@+$>U3%8_$QXVK4"."\RRS6[^1MOML"6D5!N?EWV(*O$8$I3&5]Z\<@V/\
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M4]0D<<A)^ ]= )Y#'8IK=/*V<-'DLE6EB@HV!3AM6J1FD4--!+.0M)(P.YY
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MB"23VQN=SVC0%@M3S8.2SF,+)'++6L"Y@X6AS$DD;&2+Z0>VBU[;682.Y?\
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MM?$,?0?9A7'>[%8NTTPL>+QU9HS3LQ2TA%?:1>Z:2*G5W>NL;="9.UF/H-M
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M?4QUJ]FQW( NX12QVWVZEPQ*5DEJWN/O-DL?D\52:F99\<S/7R5>O$.Y8>W
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M])<3]6C#)Q4J&4IY*KQ,Y;-76^E?*T:>*CM4ZJ*D;R7LK=FJS)76)]E16=W
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M[  -OT :RU:L=N&\F+CGNR,*[7HH*0M5X74*\DMB>2&<UU6-0RQEW/392!T
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M(T WP5[,VWO1Y'C0X[2J2)#C._*4;L]V$=P,S5,<DE:A"JA>U3,[$DCM  )
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M*DT62BMS9<PT9(!2BQ+Q4HX9[\DG>E@6I(_K7L>TA58D<*1N=B?1Q*2>J0-
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M"!&4@DNVX"@1D4G(FS4\<U3$0\?CA4U[*7+<^6LSLHW#U34@JU8D?<'^9(2
M-OXCVL:]11=$>K>2"EB:T=*RLUB]?CE@K%;/I&OTL<+2VYICU9V*!1UW)Z:
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M6R?:JU:>,E"UV^5I)[EQ))HQN2=B1$I!Z D$ZH+IQ:BM1V%EN6('=8?H*\5
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M5*[@ -,?'93ZNG)!DXX5>0+D;]^M8L6W;9/=JQUYK'TU?L7=0RPD'_M8))T
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MB<8XX)\;PRDF=S%6Q'A>*Y&: 87C(62K$:]B+&/:EN14DMQ&>1YP4CBKB4E
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MVEE%J2*NK#T599-B.AZG0#3,T,78BBR-_ 5\[;Q7=/CXOH:%V_%,6B8C&R9
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M>[5]P&]:"EBLD*6,XVU:+(B:]>RV.J8FICUL;R$_7E;5>_8N3N.A2"7<N"S
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M%3TV(TQ ZR+Y1*ZG$P4+%LRQ*RY&W8I5T@)_G2J]:E?EDE4#Y4[5!)ZN-NM
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MIFN/0U\-D<UBZ3PI7JWHXK%;+1P57$7R'DE"S:/N+$5]V2-G=3W*VY#:WYK
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M1.>Y@8)2^VVZZV I:_-/J:(H_0"I[LAR;VOJ&L^R%7VHZ,</;$99')[GD?9
M!LK;] &V9_-8:<UCC]+&6LP3"D:Y.>6G7:'W4]WW+%>M8F;LCW*KL!O\>FQ
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M4@H4QP?15.;<MI99F!/=(D]8DCI$=P!KVNSYO2F]6W?7;E/W2@O\7H,M_O\
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ML892=B V@&ER.?.8BN<#R!\>EGZ>6/+TZ]/(234Q_I%KFVDM99+"^DI1^WU
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MOC5@N_4>N@$\?F<7GZUI\+DX;:1-)5:Y2*3I7L]GHK.CP/-"2"5(8 ]&'PT
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M7$&4=Z!Q%WJ9.SO["R^X4!"E^P;'M[CMOMMOJD+5$PEE+R1-"1'[,:PNDL;
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M#$E7V6_F6^TR A%Z!MB?AH45LQ6VNTYER@ITHR5DI)6KF2_.X?MCDMV#*RQ
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MLVKFAD+).N0QR2X;)U)ED 2#(I[>3KN(9?:G*F"Q#%-*#&ZDA]ED'4'8KIV
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M @ 'OWV WZ:$(>"6_#D_RZM@H*N#@K]_YG];6A#SL PKTL56AED959MG>5H
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M]KS6Q:=NC2EW'.+H]+BX2URA&5'*,=4=*=(GK0YAY9V+_7\AW5^-[5&4K?\
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ME7@IFH]2J"RA)G>Y:>W(Q([I-HU)'1!OMH4LJ?G!N7C>&-3'AE7&I4-J2XR
MMWRWI9A% K.-MHXT(7K\[: =(]HV9TD@A2JL<!K3I8>2>:1O>^I2:L:T:5UA
M[4[&$LGN=YW"=OS -*3+'9NU(<//CZ\4GO?6]F-BI9">P!)-) E6Y)<:4$_S
M'FAC[F]"Q!T G5CI5<G=@J8J6O-;5+U[))42.K:E8F-$DME@]BPH!/: W8#N
M=N[J QKRX&GR2W3A-TYW)UX[=ON3-VZOT\*E8M[,JSXC'A0-EC5XB=QLIW&\
MPKU@=15X:V;FGESMV:S?K[5L)9MTEJ5X8?:]V:A1BKP67/='N\CO*1W$;@$
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MV<[GV%J.C+$@]-X8E_#?KL XJU4HED$]B;ZB1Y&DNWI[,IF(7:.".8M'%%V
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M^QD<5!)<Q5BG T23-BKT->2Q L/S1135:$]VN[JJ B-&D^ V[N@@&]FU3R>
ML7;$^3PE%JT]B>U-]5@LC1K56=Y;$@G6*U1 CA+GO52(SN0- (8NQC<OQY#@
M<Y=-%HFAKYN.?ZRZ/:;>6<6L[7OI8?<$%I4D4=0-MAL!;2R$&7PUB/B_(J.1
MLU2:'YQ+[.9CCNQK&TCVXJ-BA%/.8Y VR/&F[ @=O0D1NA(LF6AQ/MPST[V:
MCJ!%LVXY*5&Q=" &>:"M]3+! S[M[:%CM\O=_:U3 MQ4>77&1)GI,=<RG9)]
M4<97FK49-V;LCBCMSV)#_+V#,Q 8[GM Z:=H%HA/;H;93'UTFD23ZC'QSID(
M" [>W&)IZ]2.8R1JI/<BJK';<@=Q BUA_/\ !VJG(,'8QE:RLL$^*:ZD\\E)
M.TA7EPEAU'O!2IBBD?N7Y3N&(T YPB5!B:]6ACKF%I55-2K2L0?230P5F[$*
M1^Y*RQ2JNZDGO(.YV.B [K7H,A];%7^MB:I8EI2R3T+M(>\@V9Z<EZK%%=A4
MGY98O<B8CH3J@;86[B[=9X<7E8\NE"5J=FRMU,A*ME-GDBL649@TZ]_S#^SZ
M;#;;4 YI30.UJO'DUR,]:=A94RTGGIM*2T=66.G% (A&HV02+[A ZECUT!9C
M(<K# XR]ZI?LO,[J]+'R8ZO#"VW9 L,M[(22&/K\YDW;\!J@NH'*%+!RB4%?
MZF7Z5,?)8D7Z/I['OO9CA)M$;]W: GX:@&^)M9:U]6V2PT6'B64"B@R<5^U8
MC)D,DMN&M66K3??M(5)['<2=R-AW &*R+WGN0_DV4Q4-&85X)<A%1@@O@&13
M+0BK7;-@5T" [RQP[AQV@_-V@-,2*&/O7,-C,-D:D*NUZUD&K/'C9[=A8N\1
MV[4_OW+#H!N8U=%[=BP(VT ^BL4H\K:J(]YKUB**W,D@RLU&..)$@3V)9@^*
MI,R[%HXF1I&W=E+;G0""Y3"-GFQRY>"3-K2V;$)D2[Q5U?WFL28U)3''*W<O
M\UT[PFP! )W EU)5V$DJDR,3#'LJ%45$#*O4M(0V[$_#?;;5 SA3+#(6GL6<
M<V+***56&C93(1R;)WR6K[Y&2O*A(;9$K(1N/FZ$$!^.[=NX* &^0ABQ9>U2
M2P*J$;O)&P+= #OUV $9722M?EK5L16JXYX38DR$,M>%IKK.JF+Z*&'O<^WU
M,KLO4;;'UU (5L=C:6:N6:>!2"YD8$GR&<AKT8ULNKLD=6Q-[ZWYI]D[MA&T
M8&Q+ D#0#(5,9BL_]37QV:LY/-AULWEERE^A4A#(Y$LEVX^/QL/=&O;%"JGI
M\J;: L>G@J?*HKTV2OG.9*HT%3&R97(35%K1 >[+#B5E:K#%NNY=D[ ^Y&S$
MZ<03_P!+.<A]8<A:^G%8UUQBI4%+W&D5VMN_TQNO9V4*O\X1JN_R;DG5!R%]
MQ'!^ X"U!Y!R]+D.5NY3\OXW1XIBK*X_"7[56LYJ)>M5ZS6Z5%:U5=X:[+)*
MZ#L[27=>6_""[[3;RIP!BGVYY3*\<YU_=^QQFQAI.=UY\E?J24Y*J8BA@:%^
M?%)5QLF3?(4L?,;847KL<C6G=43=B\K8V'IEI::;^H'7//>>X/Q]0J9?D?(N
M&\9Q#3NMW(<OY$F!7V8Q'W)BHGKS?FMX^YL(0R,25 W+=.QM059-) Y.Y3]_
M'B"E8DB\=<<YEY6R()A%_C^"DPW'U95ZQV.0\B2A*J"390T=>:,[$@D $ZI;
MJVLJL&A\U]VGGSE^3K6.+>+/%O#;X#5L=<S\F2Y_RVDDK/\ R\99Q46)HK*X
M8AE]MT/<>AWW'/+=S?PI+V@F/[A?J#>2(8\C>SGE:AB%*6*US#^.,3XVPE83
MQ25UDJ\GR6.H+(.UV/N/:8H6!W7Y=M;OW99L$+>^V'S?;]P\]\_VL<LPE[H>
M;_=SP6.7VV(GG2/"XSFUB[&("ZAJZU@R]R@1_A@[EQYR?K!CUG[1,)9<2YCS
M_P"*OJNT(IM><.4YF9H4ZJQLXBCEZ\:=[-LC2*X()[0""<:MYL%*OV@X""4S
MXGS]XG^MCC8 U_-W+,//[+LBRJES*X_$UR">TE!+W,!N%(!V5:!/4?M>\S4^
MS^X7W M=>)?Y5?A/W<\'2TT+R"RP&&RO-*=V19K"=I@-<O+(>D;;@ZR5R:R;
M]8)Z;QS^H'P2&/+4L[Y8RN-IB0C)Y?Q]@O*V)$6\8;?DM'&Y1:T$SQKO+%97
MN!4@G<=V2OW5Q)1#7'?>!]S7#[34>9\$\=\W%-PEFI1ESG .3D@!FCLG)?FF
M)K2NI!7:LNWQ!&VMJW4U\23)I-DQ_?!X/Y)%33S%X^YSPBSC7DL0',X9^2\6
M:RZHAC@R> GECNR,1V_ZS3CB4$$L QUM6YMR^*J8HUD=;8;G/B_RIPN+-\<Y
M?1O<<IQ5LC9/&.1I#;QD<$1[*&4AX[?DLTV$;]K5'V<-VCM#JNV]2C)5BZHF
M-3&?-/+,R/'E>?@,U22SD)2]C'91I,3EK_&:L%A,F<?BLO\ E^3NH6]L2!%]
MQH6)7N!ZX7924>Y1OH"SQ.7O%G'<[SK,T7XCQBAQ_B;6UJ<]QMGD&*Y'Q](I
M(0PN)PKDJ7<Q1R4RQ-[$S>^C. (VC19">:VI3EW52/%5P]3Q,GAF=X\<X+@>
M#X>_C.$8ZC@Y+K26C+)'8N12Y$P+#':MQFU%++&O8/Y4<D2*-P@7?79&$8*D
M50Q[3)JZ9"&BJ6)Z]_(I"^\RPOCJUB?9BF\2R7WK1%M@=C(0.O4ZR(463(18
MXS3UH;.2CK/(U2C+V0SV51F6O7GN>R%61@%#R=HZ[G8: 8VX8<CA5?D&%BL%
M8DN6<*%3,+]1$#(E=%,,<-Z5'V[=T"=_7T ;0HG2E3D>'F6]ALOAJM@R5OH<
M@\="^]:,(/< Q-^>6K%(P*JON)(57JO:PW >/CJ\^(3&59;N-J&I7K5WI2S4
MKM6M&D8BCAEE4V*T@B0(20)%&_HW4"#NG%%7JP5X99YHZT8K++9L3V[#_3_R
M6-BU9>6Q8F[D/<[LS,VY).@+:UZG?CF;'W:=OV9'KR25IHK<<%E55C%,()?E
MD0.I9"RML1Z;Z I2:58A6MW:]V_ H:V]>$50/>:1H3]']1:DKH4&R]SL6[2=
MSUT E0;+?2R/E8\>+ON3-'!CI;#UUA_[1$UBU%%))+M_$_MHNYZ*- &-DR=B
ML[9BC2HV&ED5*U._+DHOIME$;33S4,?_ #G/=W(J,H&VS'KL \->!H6K&"$U
MW1XGKF-#"\<@(DC:(KV,CAB""-COUT! <:EQOT]NIB>.VN.4:=IXXX9L/#A:
MUMF&[VZ52+L<PN1U9XXV)^&H45PMG%1RW<-C(<@GY7)_K,MJIEO9EGG9VD]O
M*Y&,IDI@P^=EED(W&Y_"D##+C:MC)X^KF;.5NPV%L9"&YE6R5G'M97NAKF(N
M10B9!W)'VKT._4;:%'U57KO8KS91[]N9IKD,%D487K5F?LCBABIUJ\K4X6V7
MW)/<<L3NYZ "#?&U<Y%:M3Y7+4[E>94%6A2Q1HQTM@O?W69KUVQ<=B/XC[8Z
M]%'0"I=('\(O?57#8:I]%_JXH+"LPM#:,_5-<=W,3=TI'MA%&RCJ23TS =T\
MMBQ7FII]#[$?;8>9)/J9).\30&I[9[8HTVW9F^8L1V[#<@1.,KT\5>FP^(XN
MN)QJQ"U)D:5;$T,5-9D[0((J]6=+DUGMW[W,"HO;MW$D: 7K5<;3S-XU<6\-
M[)5XKN0RJU6]FU[4C5Z]::^Q_F3Q LRPC<(FYV'<-P(G\_XUCN328,Y6]8Y#
MDO9F?&*^;RL52-E7VBT$"6L9A(2A#$M[&ZL&8D$'4JJTXC@,II,)@.2-9S/,
M,K/E,IWOC,#:R;"G6K22&%4I8'&0P)94,W8LMA)GW0D-W!FTXC,R+)U_];Q]
MZ;D%O$U*LR(]*-\7!2R5B>5$@AMS7*4UIO<;Y%CAEB+%NG75 \M)>-BI-!>K
M5:,'OOD89J9GEM)VH8?9N?601T4A[7+DQ2]^XV*=I[@$,C^=NU'\FDQ*0M/O
MD)<C';G85-E(^ABJRP+).VYZO(J@;>N@'\YL*JFK#!-(98ED$\[UE6 O_-D5
MXZUHO+&A)1"%#GH67??0A&9O)9'&PP/C<#>ST\\ZPF&G9QU1*ZG;>>U-?M5^
MR(#?JBR'<=0!UT!'Y/#89<A5Y+;Q^4OY6JT,=.*O:RUU*\C@1AH<6EPXFN5!
M)>8QH!U+-N>H#GDL^*H4HLOEVR8@Q-J"U$N,FS'N26#*D4*2T<1*C9*(NPWB
MF22+;<L-M] -^1R8V7"Q7LMF\AQ?'HU:W-9BOKA;(# ,M*U,RM+&9"W:T:%9
M"W0'?0#L319/$T[>)S$]"B&CF_,#"DLL]&OWQR(SYF&4JL_9O[[JS,H[@2&[
MM /#;.1H&Q@;^,G9W"PW#_QE0_ES*M@$4[=<RNJ!@ )5V?;?XC0%^1.46A,<
M1'0FR8$8KID9;%:@S&6,3--)6AMV$"PEBH56W8 $@$L *6)+T6/,T=."_DX8
M%=*D<XJP2W/;[72*U.DA@B+,P#LI8)\">F@$;,7U6/K6<AA:]Z_46OD8L:&I
MW#6RL<1V^AMWUJ0">N\C*DY]H]I)Z;[: 9YI,;=P$[\CQ<LU%85LW,6(9<E*
M3&P98?I\<)VN-W;?*@=3\=QOH!E)>H<@XS8NY"'D/&L8JO+-]2]OCV5BK5=G
M,O\ J%D7J]=P-NW=6=1L5V(W =T[E#DV#+8++Y&K48?2Q92K$T5U! $[S$^>
MH6?<+)\IE:-R=R0W>-P XK,EO#>U@,Y!:=(S6AS$DD>< G0K[LECVK,*6+ !
M.Z]ZA6(Z=H[= )8ZQ.^+GJ5<[CN09NBDL-BZ_P!-%$+KM(T*WJ>+9OI5C&R]
M@V9E3UWW.@):@+ZTX!E)*<M\(?J9*$,U>FSEF($$-B>S,J*FP^9R203TWV #
MA.]D_FHBN>X,J.94VW(7YFCB)[EV)':-CTZ^I 0K&26!ELTTJCOFA6O[D<ZM
M65VCB9NQ1&HFB )0;A0=MSH!&E)]74='QUO%Q*9*J5K#5893 BB-98/RZY9$
M$+J=D^9)%V_A7IH"*XJV&_+I(,%4R-2A7N6$ R-/,57GF9A)-8@?-(MJU!*[
MG:0%E+ C?IH!?#9C"7VN8W#9'\P;#N*UUUL6\@:\[-*/9ER5IIQ8LHT;=RF5
MW38!@!MH"F#BKUFOU4Y';Y#<AG4WC>MXR>U0=PXC@>MBZE&"DK!#LIB4GM/K
ML= /<95R56.<9/*#*32V9)8G2C!0AJP, (ZL,,3S2.L>Q)>21W8GU Z: JKY
M."M>FG2O?G0V)J-.A&:KR1I&6KTWGNVV@DM3.NWNGV8@6&X !) QGC>1YKE;
M-X<HXKC>/8OVW2M#^<09:_.[,@"S+462DU9HBX8ED;NV 0@DB*O$8DSBXS5L
M6<?4XY'A<5"&:&S"^,@BMSLZAC!1QTDCQHR[MWR>V_0#MZ]*!OBJV+Q-ZWA,
M/QZ?%Q&$7;&4K8^M7QUJ>791W7"YFO9#YB6+HY':>X^F\Z@.,/0Q>-M9"M2.
M0ENM]-/D;-^?*WGG9UE^GVO7VE@?M7N_E0N%B! [5!&J!M2FQ%7/WZ/]XI[V
M:M*;+X:SE$G./JG^<@KXN$1I3A"..UW3W&7;=FWW,!D#VZL<\=62S72U,I:&
ML\T:SRJ.XEHX2PD=0$/4 ^A_#5 QA@S"Y2U/9R-)\0R(M+'PXYXK<4G9&'DM
M9&2_,ECND[NU4@BV!'4['<"@_/3F&W&)7 +7'80;DF8EMD#?N!$=*"NIW]#(
MS;?#?H!:\N3ARM>K3P],XB:*2Q?RK9%:TT-D]X6&'&1T9FN22=J%G:6)0I]2
M1L0+(Z\%/-2-3XZD;9* SY+D->/$P+)-#ND%:X183+W)RHW#>T\:J1\^^X $
M8U?BL7+UE-3W.66:)E2T:>1MFM12,UR5N&*;'8D31Q%-N^%ICN/F+=2I7K(R
MRVV%PO(!D;=_.2Y+,11TZV/B;.92C%$AA0FOB<?#9IU SQAGF=!L>YNX MI@
MG4Q)')W,;1R6(DR&<;'RV)9JF/Q;6Z\$.5LS*J$?3&/ZFY+ )%[0K=B,P)&Y
M&J!_<81RTG?)"C&+'8T+?2*N0>1&6*KWV4>16[_F B*NVVV^VA!M8ASCY>E+
M6NX^OA(8I#>JO2FL9"].ZRJBQVOJH8:<$)*-N(Y&8@@[ ]&)22=K F@6.*%Z
M[>[]3*]AXYHME!A]B!:TJ6/<?<-W21=@ZCN] (,,G8R-;Z=L9B4R=B:40RM)
M>@Q\-2#^)IIYWCL6'0'T2**1B?@/70HQSDU#&24LQ)QZUF<F;%?&5I<3B8<A
ME*RV3,.\V9#"U/'0][F21I$C0.=^K;$P69R+CT%[$93+UIY[T%CZ;$M!5RN1
M>.Q-\Q9:6-BLKNO;O[KQ[1@;]PU'3B"1S.;Q7'Z?U^8N1TJGO15UE=99"\\Q
M(BACBA26:61]CLJJ3L"?0:K:68&^4L5D@IY6SGGPF*K%;5II'HTJUR.01M!%
M>L9&LUBK$&_LQO!(Q/:QV^73KX ,A%D,M5IRX+/U\=6G5+)O5J-;*O<K2HLD
M#4IYIVI)#*C=W?[4W>""I'Q=@)"T,A'3*T/IK%X+&B/D)'@@8[JLDTWTD$C%
M@N[=BJH9NFZ@[@05F:TD4?L1P6)N^%91+-)4C]LNHGE0K!<;O1-V5"-F(V+C
MUT E?0-6>44$R4];>S4JO].K/:B5O9]J6SM%!+NQ <D=N_KH#%.76<%%A\?>
MY5A;E]J]JO<J8JC4MY>=<M'&S11QK258)7C)8*TQ2$GX[[:CI3$H_M8K'\QQ
MV-L92GFJ$886TQTURUB+B]Q';%DH<9='<&"!O:=R5W^8!@0%*@E,N].MC9I[
MN2?$4*B"6U;2Q'4$=>,;%'LR(S0HQ(&Z%)"=@&Z[&L#>6S^>X>&[@<VE*O:"
MV(LM%5@MJU12W>84N@0*'*_QNK *#L.H(9Y <5[L>1QK3X3)8_(N%>"&^LL5
MVFUJ'^7(9S0EC1F20'O1&0@].FG8![*;2U7,*UY;HA/MI+))!5>QV?*'D2.Q
M+%"9/4A78#X$Z$+X#,88C96);!C3WU@9WA$O:/<$3R)&[1AM]B5!V]1H!"_3
MI7J[17Z-?(0(?>%:S6AMH9(PQ1DAF5T,HW(4[;]= ,8HDS&(GIY/#V,;5MP6
M*,V+L35O=-%T:#L9L1<L0Q)/ =NR.4E0=M,T4MP;XV#$1QX['6,/C**RPP5+
M-"7'-'!!NQE2I,JSK$^Y8%E#,=R1OHL@6XK+X[/T[ Q%G(K%#W5?K)L=DJ;K
M(59?<JS9NBD=YXBNY<"9 VW=OOL2=<@*8B""O1GKX_+3Y1XY[*/=OWFR\D=T
M;*\4Y2:,(('VW@0Q!?0!2=] .Z$=J&K[%O()D+L?<)K0K15AWO\ /&&JPR$1
MJJ,-AW;D==^NA!MAX<Y7J2C.WZ&2NM8EDB?'4)<;7BKL%]JM[<UV\\C1L#\Y
M8$@@$$@L6/$HOC),K+!))EZE.E.;$OLUZ5R6\J51VB$SV):M/>PY#%@J=J@@
M GJ="#X(BH(U15C"]HC"@(%VV[0H';V[?#0#7'XW'8FJE+%T:F/IQDE*U*O%
M6A5FZN_MQ*JEW/5F/5CU))TR!&8=\6CY/'8JE=I)7N66M328^]3K3WIW)LRU
M+-V%$O'W/62(O'TZ';;1%(GC$_&JEN]B</F,CFKQE>;(6+60RN=6*:(LC12Y
M"4SXZE)&25,2M&=QL5)&HJ9 FXK%*ME[%*;/"?(Y!4MUL+:MXY9JM6%&1VQ]
M*&&O<:LQ!9WD]T]P_B &VLE[3!NO82ONQ"40&2,3-&TJP]Z^ZT2,J-((]^\Q
MJ[@$[; D#XZIB1-*/D'YGD9<A9Q)PY[$Q-2G5M"^H&Q>>_<FLF%G8[CVXX0N
MVQ[MP>Z8UZBD@DELVYHWK0I22*(P6A:9YYIF+^]&]3Z94ACB &S^ZQ8G^$;;
MD!3OD]\Q^RPB$2N+!=.UI&=E,*QAC+W(J]Q8@+\P ).^U(1L7TU+)O3IX66(
MY'W,E>R=2I4@HO9(]HM>G$L4]B_*L*C<)(W;V[D#TG$H_:W"MJ.D?>,\L3SK
MVUK+PB.-@K&2TD3586+'Y5=U9O@#MJ@B;%S#4L[4BM9<Q9;*0&O1Q,F1E[)X
MXBTKS08H2^S[@]L@S%-]AV]WPU,*]8%+($>:Q\\O()*B2UYJT. 9L8E?)S;E
MVL+[]=LE+/ K+TBE50%&XV+!G$$WJD+-W[]NU?;[=^[O/?W[]5]OL[>WMZ[]
MV^_3;XZ JD4:L[)&B-(0TC*JJTA'H7( +']^HPW03*1UY^^&EW2795%NQ E6
M,CVH"L<]QGEAEF54C6->T2.-P-@H)&)@1TN'P@S5?-RXN"7-/&:4&3^C>Q8K
MQ+%,Y46!'(M&-HRR]Y*=W=V;GNV,HJUXE%\D]&J]/(7?K2]65XJJTURMDM+;
MC]M@^.Q@E^K/MJ=C)$XC&Y!7<DYI4Q9!'(5JT=VIE;N9N4:]7LACIG(14<5/
M8F=DC>TO;%);GD,@14>5H]P-D[MR;U@<W!)%8K7I,JM#'5%F^LK21U%@MM,H
MB@,]RPIDKI!(W<HC*%WV!)'RF@OMI>G6JV-NU*RBQ%+8>Q2>^MJEVL7@KF*_
M2%>24E2)3[H !^0[[@!U-[XC_P!7$32]\729G6/V_=3WCNBNW>(>XJ-MBVP.
MPW.A"'SLF4JU_JL#A:>7RY[8$%NY%CXXH/F9FDMM#-,R*QZ1JOS$GJ/74=>&
M93#_ "?PC'>0?'?(N.Y_$+<O9?B^5P\4N,K4KF3Q%W-4/HYKF!GR4E-$FJ6&
M652TD0D$(#[CY==FPWM[EN_L<RVV&YV]Z%V'5*W)3C[4CS><\JVO/>3[OD>^
MJ]CO=M=L7$LW;O0E;FO[LF<=X_FO,3P>IR_DF)I4+G'4M8ZWF</D90S9O"9&
MSQO)UZ]4B<P5<AF:MFE(_8RK%+'85B!VQ_M7E6VY=S*5FSMY2U[RW";LSBFH
MJY!7/BP4G!-3CBJN+@UC67\J?,&\YUR-;G<[R%MV^6WKMJ.YMR<7.5FY*SA;
M>IP5V2E:G5/2IQNIT5(OZ^06[Q[QSE\5[DBXK*\>XO?AGC"2UH;MG$59+C[A
MF5Y5@KF/8E7AM;[]0==\[#L[[?[7<T3N6[MZ+3JFXJ;T^BLJ\5*%*9GCVMVM
MSRKE',-E5QL7K&VFI*CBIRM1<^-&]-MQX.%VM<4S7_EOA?/L]S@R^/\ C/\
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M5=Z>)?&-_AG#N-^,,":V6Y+F\A=ITU/NPT)\YGK%S)W[,I[)IH\1BH&FLV9
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M:?($R%OD=])LG']'CL!:R-.'%M)#"KS''4!!#9M6^R,R.6DE9=R1VKL X@D
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M;;0)'6CKSA&#;@L)B.T]SCIN!J3*^;_%'#,A<QN<\@T+5Y2#+%!E<;R/)+*
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M:6&Y7FDR%:O1*-7-26%%ELW9G7V&6Y)8 ':B$+$L>[$DDGH  Z4SF64/'$L
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M,1WM^&Q.P+?T#0%6K]?3T_P_$: 9>PEB-'['4=_>H<&-@R$[$C=21O\ MZZ
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MMH!/*Y'"T,KB%R&1M07[3O6QN/@L9$QVI)F1#)/0H]T4ZH3L'G4QQ[D[@C<
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M*YN7IY>UOXI&D/<?0+Z: DXQ* WNM&Q]R0J8T9 (BY]I6#22%I%38,W0,>H
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M_2,%0D!>O00LDQV;DSL-]>1/#A8HRK8"'%4=K,AB[?<LY2?W[FRRGN"Q"+H
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M>,F3$Y>ID[=>&2D,E(U:Y%^9Q0* ^0AQC5(?<$CJ\L4?L]&V4("-G8#X7?\
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MUV,059;2D"26Q7Q_^C[0=_;0K^&X]=7W@>5AD$I)]6U.?(B)C)],L]2E)/\
M,41!*]V>&+T!8]Y]3V_V= +]GO0JEF*(ET0S0[^_"'&S,JM)''[J(XZ,44G;
M?8>FA".M8^CG,9+CLKB_]1G_ ),N/M^P5>*"8&$[4[$T0B8Q*R@."%V# '<:
M9YE&E2ECQA9:=?'6.-8Y/?C^GJ^QB9HX(3LUB!\7.SU4F2/<.K)-V]?E.IP
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M,OVYA,(S9N7*YMEPIW"1S(NT?<1MW;@2MM,C-)0;'7*=>LMA9;_OTY+DMJH
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MC]<J+,N0JU:%EY:K(LBE9<@DL%>/L^8N%WV/J/B[ /A'<..J)C,G7EE5*O\
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MA# RQ_>AY!D=/[2QR^#OMW6-B/P=H7 _[$ZU[+\I_P 7U(MWXO0>7U=XY/\
M:SR8[ M*OG"Q$TH:%]I8?M.DAFA)@5(P]:9&B8;=RLA#?,#K3_\ 6^GZC+_D
M_3I,\_5"_3F_4L^V[]2?E?ZE?V1<7ROEY,SGQY-P>1X'Q["<_P"<^/\ .W>%
MCA?+N,9GQ'FX\WF>4XF_C3<2I9QE#(+%2MHO=6M11MK*]:O1O>-;Q^G0(RBX
MZ9'*7(/UL,)Y@\C^/..?K$_IK>+_ #1D/&:7\7C^1XW <V\3>5N'87DDU&3-
MW;OCSF68NX'FCV9\1&\=&:;!U$D5FA:)FD]S6]PI-*_!.GH+HHNXSZ=/OK_5
M+N?9)]F_VX?<5]OOV\8SS7XZ\PY;AO'/&G'L7RO*8>G4\69CQED.8\0Y+"N#
MXAR";'P_E.,JUEHRQ P"3M=PR=I[+E[P[:G%53R[#6H:I4KB<M_IM?KS^8_O
MJ^[;@GVW<P^R_P#Y',#R_"\XRMGGW]]N4YK\KDXEQ#+\EK5OR_*>/./TY?S.
MQC5K[M:0I[FX#$!3KM[F5R>AQH)PTQK4\J?]G,_^+/\ WQ_^:5^YC_X*SP?K
M1MOSY=C]Z,KOY:]'N$8(1!_M:(C5Y9 /-LC]T\KS2;R_:4\I!DD9G[%+[*-]
ME4 #H!I_]9Z?J)_R/ITFLO\ :B<[E_'GZH/V\<UPUV2[F^,?:QXCYEAVS"0V
MJM;)8/[@_N R>.JFM7CIJ^,AM4$WCW[F!;=R3OIN^[=3XZ5[V96<8-=9I/\
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M#(\-J...1X;(A^6&P$E5F0A2 P.P!&@&6+ANUXK$5_++E[GO-*2*U:C'5CD
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MMN<W.C4:47UF+-_8>2G)0-6A?M7DH23XV6[9EDLVFM53[<YDLV4(LS1R'8L
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MV8K[98L.WKZC0$GO':2S7:.=(AWUG8B6M[@:,=YK2*T<W:H?82)M\P^4]-]
M,\-A\9@:0QN)K-5J12N_8\MJP[2R]LDDCV;LLUBPS]PW8NW4;;]-@!&<<N8;
MOR&(QV?LY^YC[4C92:W>;(SU;,K=IK2SQQI4JF-HR!7C"!"K?*#W:B _QUBK
M%9LXMN0?F^2C9[,M6S-B!D*==VC[4-3&5*+)6B]U0K21L_S#=R2-4"]"OE8I
MKTF1R5:[%-,&H05L::"T:Z]^T4DCWKTER9P1W2$QJ2/E10=M 68[\[,U]LL,
M4E<S@8N/'&W),M8&3=K\]D1H\[J4V6.-54@]6W&P$J0""" 00001N"#T((/0
M@C0$+CE%6Y;Q]7CWY3CH KQ7HORJ&G?E<(6%>I2L/;3L[B&::*(DKTW!!T!+
M>Y_,="CJ$5&]U@HC<OW[JA[BQ:/L^;< ?,-B>NP$5%#1Q]J]<%J_++>=7E2S
MDK]JK#[:]JI2I6+$E.@GJ2(8T+$_-OL-I5$J83_>SB^+Y3;IS<LLW,WDD_E<
M>LY*&6#'Q1PBQVU<;5@B%4F&(OWS%I64_P 6QUCJ52CRWY#P]69*SVJR6)5=
MX8'FC6:54&[M'$S!W5 .I (&FL&-)Y(L?F%EI;N).-Z+4J5Z=CZ]2!LSV+SW
MC7?N;T1:R]HZ=Q]=36R%*W/<]9RLBFOB(\&J[0RQVKL^5F?LZ-)":=>I642'
MT$DVZC??<[!J=3&AD]//SM/V0TXT@E1I99T*(QF[U"JT2Q]TA=6)[RW3;;;K
MJU8'3<GO)F*6)AP&9NQV45[&7ABK1XFBC%O]/8LV87DD4+N4B1VV( W/35U,
M$D:N,HYJ/)KC+DV6S792EO016[45>O5B!!L.\C5,96V4?PA#*_P9M]9(@[EJ
M5:^7BR<MO*FQ:C3'04EN9*7%JP[Y3-^5P,U&.8JI[IY$^4#^(==[UE&F4EHX
MS(5<KEN2SXZJ[1T*F,GMT:F-L79BVVP-9+MRU* .U#,RJ%)"CKH!S=@R8R$%
MW\\@Q^%J1^Y:H_E\'NV67W.]K.5M6)$@J[%?ECAC<=I_F'<=KW LO1Y^S?Q<
MF*R&+JX9&2?)&6K+=O7X^X.*]-UGAK58I8AM[I]QOGW ^79F/H!=EYN1QSXY
M,'1Q-JO)/MDY\E?M57K5PT?6I!7I618E="Y'<Z!2H&Q!)4Z\ 2HK5EL/;6O
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M)]U*A[!9&GEK5FB]',_E=2"7OO018ZM:L7TW&T*VK;21U(]AU*PL_7^(:Z#
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M[OF?E<--RU'XMSLXR<Y6XKC=LN4YVXKO7%*=M:I.VC <IQ2_G<?AK=#C SN
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M%%DZ;$CJ-1X@4RD&4GC@&,R=;%]DZR6Y;&._,&EJJ"7A@WNU(ZLC_P#DQEE
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M*]"*,UZ8?Z4CW9"-R&53N2"' =15IZV:ELV^26IHKJO'CL!+'B*]6$*L;RM
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MJ)9@DLA%+"*MV',4L3C*K?49%[%6"5;,&Z=J?76+44%*$@G=NQF/<-B-NMH
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M6*XM9N0D/Q[A\,T;<X\R\RB@$0_O)RFP#,%/M[.U>E$08H@VH'NEX5\/\/\
M!?CGCGC3A-3Z7 \=K&,3SB(7LI?L2&;(9C*SQH@LY/)VG,DKD>K!$"HJJH&Y
M8*^TA?O<]P"^V2.Q=OBHVW#'XG?0$M BL-U(9=R-P01NI*D=.GRD$;?CH"3B
MB_P_#]I_;H!['&$5 [[G<*&<J"['T[NU54L=O0 : >1Q,&9BVZGM[1V@%2-^
MX@^I[M_Z- .H@CJKHRLC %60A@X_$,-P1H"]XS/%-'7L"&0;Q^[&$E:&396V
M9"=NX*PZ'8['X=#H!:%1"L%>:PLEAD(5I#''+8:-09'2(;$[#J=@=AZZ HJ?
M1_53V[H:NT@D3W0D25E(5/;]SN^=6?;;?;J?B3H!VL;M(LB2*8#'TC" ][-L
M5D$Q8[KV_ #8[Z 4]LN%,;A0'!)7M8,%/S)Z, #ML2.HT %H_<$)DB]TK[@A
M[U]PIOMWB,D,4[AMOMMOH"R.%HHPLLC3,#UE=8D9BS=!M$D:#;?8;#_'H!%H
M9OJ?<]Y5JB J8"@W]_W WO&4_,%$8V[?3<[Z 1E1K,:M4M1J!*A:6-8["NB-
M_,B_BV!<=-P=UT!62(LK!&V8J0K$!NUB-@VQV!V/7X: 910R10(EB<3R+\K3
M%!#WDMLOR!F ;J!Z]3^_0#8PRK+-(\H: JGMQ]@5H2H/N%I-]W5O7KZ: :6(
M)':(QRB-%;ND7VU<3)MT4,2#&?VC0#2>$LK!3VL00K;;]K;="0=@2I_KT!&R
MH%*HSJ9&!V!V5G*@=S*F^^X)Z[: BI86'>78$$[KLO;VKL/E)[B&Z]=^GX:
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M.3GX=R=:UJ*KC=X%OQ=LSK*WM:KF[4K;234F9JU272A?_9I?U(?$_&\/PO\
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M8 >F@+>,TL51QGM8?"28&JUFPYIS5%ISR2E^U[4R!Y))#.%!5G8N4 !VV !
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MW&?#<,D,O">&5Y-S+!D/)62KID[BEU,F/CH*X[9I-^$'HK]@'VW6_#WCFSY
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MI!60B5=O[)T!9=.2_P!6&.6C\UF,7'NO./;I]3*U:*!#[UDG8*&>-1ZDGTT
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MW X%_3"^V#Q/]S'Z]'GWB/EOAG'^=^//&OE3[M?*,O!>4TUR/&<[?XOY.RF
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MM+2Z6O<=ER48TU*I[E8O_9H/O_\ N)\@<;Y!]_?W_P"'Y_Q_#V?;L9;%\_\
M-/W!^0#@'..:YB^-Y?S1@>'TN.6<M!4]KWV^MAK&*&1J]D+[(Z?T=V;K=E5>
ME^\U^-!+N(^Q'Q1X=X9X(\0^/?"'B'$8_B_ /&7%L#PGBV(M5YLI'7X[@ZL-
M+MN.+=*QD<MD(HVELVYI&DL6Y7GE]QW;N[HQ48J,<D<[=75GQ/\ ^RPV,OQK
M[TOO5X-QR(R\?3Q")?I+MNW#5:YQ/R]BL+@)+EN&&S&9ZV)S^0*EH7D?=@A0
M%R?/V55<DEE3ZSIO_"F?<[EJ\,0&6@X_%F\O45(Z0C3&17U5I".V*_D9*ZUH
M8_=9VVDWVW[59CL?1?3Q.8ORD%2SCEFR>&BRQI^W?CQWTM7(RI=A0]AI+:$<
M36HB[*C[H>IV(WT[0,N37<'0Q*Y#D4\].C6GKS]D=F[%++:;N2"HT&+G]S)%
MWD/\C^;&S*&*GL# VDJL##*'&<EP$.2L93D.!P\9:[8:%[?';5BK'W*8[ON5
MX\DE.9>H"&,R*002"-,&J\ 2F(M8S+8<QX2U>2DD#4:]TQ7H[*;0A%GK6,Q7
M:2W)$&!65A*K..I8[C18K #C&PI%CY*=/*V,C+6>S5;(7IDOV$N*276RT8@C
MD>L[@-&.S;;M.QWT M19U@:I+DH,ED:J[6I@D$3B24R/"9JE=_\ 5U*C91T+
M!?4G<ZH+<2F92H!G;.,LWB[,6Q-*U2J1QD#MC"7+^0FE<$$E^Y =]NP;;DJ\
M0.EEF2.Q+;C@A6)YVC,5DRJ]6/<QS3//!42O*Z#=TW9$_P ]AUU*T566,93D
MH03<VZ)+%MO))&J/&'D+B_W!>.,9SC"0?4<)Y7 +.'E3*R+;N00320VH,E#C
MVKS8NY1O5W@GK-([++&RMT )Y-CO=MS+:0WFUEJV]Q53]Z:X-/!K@SY?Y_\
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M@!CEQM+(7\;C<+8HB9Y,E?OPX[Z+'6;TYB5_]:;V6NW)(R#W1K(JJFQ8$!=
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MZG6<)N$U)< \3U9XYEYL_3BSU:UBKW&LW1QF7XO=Q_U8GM8G(TH[D%FW[_\
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MJ\2L04J04ZAH8^$,AWDF(;8'Y]M],F!5\85Y-!?L<LRH]U)#1XP;6.KX^0)
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M+^6D<A]/G]= 62KDX,A0AQM+%QX=Q8DRD\DTL-M'"JM=*52"L897D;^-Y)%
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MKS/1KQS63\Z1%EA661F4,SOT /:2=SZ[: <QQ%@DLD:1SF)5?;9V3?9FC$@
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M2TL5WR7H_P 5>.1!ZD>IT!=D<E0Q%22]DK4-.I%VAYYF[5#,>U54#=G=CZ*
M2?PT TO_ %$OY=D*^;CQ>,K-]7D%DJU9(\A4=8VBC>U;*FA&.I+*.XAO4;:
MOGELY*I6L8#*XU(Y)HY#<:J<Q6L58Y")HJS5<E1C21RI7W.Z0)U^4GT <WSD
M17/Y7'2DMEXP/KYIXJZ1EOYLA^G@FDE=5_A3Y 3ZL- )9>SDZM":;$8V/+9
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MZ%H#8!C=8K#)*AW&X!8$'3L(4JV1:HQMC<A3RDD3PUIKONPRQ2R0R1)>:3Z
M"%+7M]S=BA5$A V5?04>6WM1U;#T88;-Q(9&JU[$[5H)IPA,44MA(;#0QN^P
M+!'V'78Z$&V+;+&C&V:CH)D2&::+%23RU%Z_(D4UQ()9&V]2RH-_A\=.T#<(
MV4Q,R9["5^R=9??P\SULNDT,;EH8YU>%*DLT@0'L'>BML.\[;Z<,2C7'O7S&
M"D@LX#)X+'F!Z2XJ['5J6A2BB6-17@P=^XU:((.R-%9)1V]% [26: CC&Q^;
MP$E3$#-X6CV/2KSM3NX?)1*-F,]/\VK?4?-W':5D;=M^O<-PS0+.+-A_HKM#
M#97+Y/Z.U+!<R&5M93(VOK>WV7[+V722*;VA"/EAWA4C?M^8]Q D,1;I206,
M;3Y##G<AC2\=VQ-9QUN]!/.\TD0R5;%)1A@*G=501P[HFPZ@G1 =8NMDJM=T
MRN33*VGF:7WXJ,>.@BC9$5:]>LDMEUB1E+ R2RR$L=VVV +K ^0RF,&6-%EV
M;>..5I4W!/:%E>*$G<;;[J-C^/KH0C<5)E[-:9LY0Q]&9IY%AK4;\V30U.U0
MAL334* $[GNW559>W;KON [2E,79N3-;AL823#5:LHAH&2S0F^LA!D4S)!CY
MITJ1;*I56;N(;J 01H!IB+=.>SEJ='!Y'%117+,EF[-BAB:F2OSR,+=NJ7]F
MS=EED'<UCV^V3HP=MP= 1G&K>!I6[W&\+%G9WIV+4^1O7X,W:J_7=Z1S1OFL
ML&CL3MVCM6-V0JI(^.HJ9($A@[6*2SD<16Y(^<RE.9ILA#;R-2W?I&1NWVG@
MJQP)5BC8=O8(U"GH>IU5T 7Q[?1W[5._R1<ED+KFW5QLWY94DITU[P$I4ZT4
M=V6$ ?-)*\I)7H1U&@%,=5SL=[(6,IEJ=NE*Y&-H4\6:?T<(D8JUFW+<MRW+
M#1=H) B0'N(7J K$%:_]X6RMLVQAH<&BA:*5S>L96=NT=TMN605:=10^^T:)
M-N/[>F('<+6Q<LQ&E6AH*J20VTM%K%FQ)LT_N4EJ(D**2?G,S,Y_LCUT(4A]
MN*Y/7AQLD"2(+<U](ZD=6Q8D;L,;%)Q;EM]H[BQB[.T=7WV&@(M!C\3EV@I8
M;(/;SDGU60R5:J\E1"GNA'OY"S,D:",E@D*%F4-T0!NKB4MDMX3$9Q8)+&0?
M,9\Q^W7!S63C$4&\:.M:);5##TXSOW2=L$9.Y=B=SJ8)]8$+LF-H\DQ]C)<J
MLUK-Y?I,1QN2_4JT+,K*(7E2DD,=O(6&DEZ&21T1B.U00-.()!JN57-)<ESZ
M1XDI[4.#3'5(_>F,++WS9&:2:U,XD)<+$(A\H!W ;NO$"IBS;9CW?JZ$>#2L
MBK46K+)D9K?<YDDEM/*L,-<*0%549MUW+==@Q] )1O<[H^P(4+'W2S,&5.Q^
MTQ@*P9C)V@@D#MW/KTT(1TLEF')P1U\0):]J-FO986*D(@,0*PQ/"2;EIV Z
M;+VJ/C\- ,[&.Q-;,09./C<-K+7W]N?,UJ&-^JK)! D*R7+]B6"RL0@4(H0N
MQ V"Z<:\2F+Y_#</Q7(JW+KG&<UE^1S.GL6L7C\_F_8-6"*K'*]:NTV)HF*+
MM["RHQ;=UW8,VI15KQ(9)FI\1$</9RMO(TF>_!#CX:MW,5#9O60&BK6ZN)F0
M7$_E]4G5X1L=QL3K+ PQ/G^N_HW>0<?^LA_\-#O^=?'5#QX.?IRP^-[>(S5;
ME'LMX8_Y+UH?GD\JX/ZE[P-K?;8P_*/FZZYO ?C^-54K]1GK[FCB?0A>6S+]
M)-5RD-"I'*)KCFM#8:W7*CLBBL32B&JKL=R_9(2-@-O7728"UL7W^G^@FI1+
M[RM9:W7FM=U?U9*ZPVJ@69_@S,RKZ]I]- -LO-FH88?R.AC[]B294E&1R4V.
M@KPGUG[H,?D))R#T[ %/QW^&CKP!=D3+7A-^KB%RF3A18H(8I*<$_;*ZK(JW
M;C0K% @)9]CN0.BD[#0$5GJV,GQU3)YWC0SEG'B*:'&UJ,6<L5[EGVHY12CG
M2*.4Q/M_-(395[OET?6$79/\MLXZIFLY#F,9%CS%>-07LC#/7E,L0CCO4N.9
M">ODG$G:/;/U"=2-NK:<*L=2'&2LT),;7R]O+V\)BZYAO3S3.,,)(7[5B@R/
MYC6BN54=Y #'_)D+D*>O33A7@"2>>"W0^IKWQ#6GK"Q%D:[5F5(&02K9C>S%
M/5*>WUW=67;KH!FU[\XQ<\_&,MB9Y7)AK9%2N7Q\4R2()O<2E<@]Z2.,G91*
MNS[;]-P6>0[12XF>CQ<:8R7%V,R!61[.2CM5\>?F06['TM1YIR>SN,<7N@;[
M R ;G6+;X&+:KU#NTUN&D9H:L63R,$2M%"KK1CGL%1'(8Y)VL_2(P9CU9R%Z
M;M\1B6&:<XM9[^-[[/TL<UG%U)(\AM8[5=ZM>:=*45DI)T5V6,$C?IHJL#8S
MQ9'"339;!6HJ\M><V<'?JT\E9DKH7[89:6/FR5:P]B-01$K.?F"D;[C6?#$!
M5M4[&",TE*]@\>M.:(U)XWQ5NE2AC>+^6E&;WJ/9 F\7M,LB#;M[6 V< 68F
MS1RN%'Y+:RE>JR35JUZS6OQY!'&X-J,\EIRS7) [=PEFCF21@=^[KHLL >4'
MZL?Z6[_J)>//#5K@7DJKXD^XK[>^=5.6^+O+N7Q<V3:*A9DH2<APF5&'^CMQ
M-/D</CLI4GA1OI[^.55C6.>5AIOV?%2HZ363,X3T-]#/5#@LN?\ [J<?I\QS
M. SO.<?A,15YQ>XRK0823EBX^N<Z^*I2LUNCBY,E[K58I_YZU^P/NVYUN5:8
MYF#]AD-&._$DPR%NM<D:S*\+U:4E&.*JQ'L5WCDNWFEEB /=)WJ')Z*OIJ@=
M.S*CLJ-(RJS+&I4-(P!(12[(@9CT&Y _$Z$(*F+6=QEJOR7C]:C%9:2N^+L7
M:V72Q5V79[!AA6LI=O1 7VV!W!U,\RB''HZ:5+>-H\:L\:QE662O!$\-''QW
M"YD%BS3AQUN6>-"0#[L@B=RVX]-]%V8 =8&'&5:L]'%4[E.M2N6:[+<KY")I
MYXW[);$4^1'OWX&9=DF#.CJH[25[=%3@!/$7\0;60P]#(V,A=HS/-D/J+%VZ
MU>6=R#";4X>M%[;+VB"-@(]OX!UTJL@/Z31>_?1<J^0D6QWRUWDH,<;W]P2J
MJ4Z\$L<0"$+[Q>0]IW8G<ZH/.3]3+[0/.WWM?:?SO[8O&/FSB?CJQY2Y3Q63
MF&>Y-QV_+#5\:<?R;<@O<9PM3CTZY*Q>S/(<=C%L3V9_:>E'/"5'O=--ZW*Y
M!P3I7W&<)*,JT.F?M)^VWBWVA_;_ .,OMPX"E%>">)^+TN-8&Q%3>ME\Y:#S
M7^0\NY(ZSFF_(>8<BNVLG=$$21+:M2=GR=H&=N"MQ4%DC&3U.KS.@:\F4EN7
M4N4Z4&-79*,B7);%VU\))+58U(J]6)O["K+*Q'5NT]!F0=UJE6E$M>G6KU(%
MZK#6AC@B7?;?MCB5$'I^&A"&HR5JF5OXZI@K]6-S^86\R8:L>,MV["H619WN
M?6V;(78':$H@7M[AMMJ<2C1,[B*6=FP:-FK&1M;WIG>IF;F-K+)&[(HORQ28
MRA"5C[5C1U7OZ$=Q.E4G0M&164Y_QC!Y:3&VLC9EREE()/RRI3RN9F@3M[(W
M^EQ=.Z](3@@_-VA]MQ\3K%R2P"C4MS'):E"[C;%WD/Y7#+.*5;&O+C8*^5O6
M.Y(8BUBL]^:=>_=8X9D4D L"!J.1:$7E\]96>I;_ #U,9C:C%[\+P56%T$A8
MXY+MIF%2'N]>Q0[;[!AJ.766@A+R@/[<D5B(PLO>Q ]SW49=XVBE64(J[D'?
M9@P]-O76+D6AP=^H;SVW!]NV4X]3EBVYGR/C^!M#W)!9:M4M-R5EKQQQ/W*\
MF 59"60=K=O7OVU\0\[[CP^12M+.[<A'U/5_P_2I^UOZ!/+\>:_U#;3F]V-;
M/)^6[O=5?PQE."V<6^#?_=-Q6:IJ7PU7S8\APN5@RLF-L4WHY*&^V/EJ7 :-
MFK=CL&L\%KZLP"G+#84JXE[/;(/=ML=?1-VU<5QVI1TW-5*/!IUI1UI3'IR/
M]#/)^<<JO\KCS3;7H[CED]NKL;EO^;"=J4-:G#P]7B1E!IQ<-6M-::U1])'V
MN>9O)&0\>X[AWGGQ]RN#R]XRDJ8;ZW(XFK8FY3AG1JV,Y?B,]<L18J_/''5%
M7)SU[<G^L(DSM_K"J/O_ ,L[[F-W9+9\XM7+?,;"2;DL)QR4U+*3PI)IO''[
MQ_F^_JQ\B?+'DOGE^>ODGS7EO,_EAY@E._:M[6XG/E^Z?>O[.]MWIO;:#<O&
MVL;MNU_*E*S&+_3RD^Q,AR6BT=>Q=%J9*=J&U"E:*_:D6RI*1.:F.6:2P(F?
M?YD=%([NFP(^2ZC\I:2N5R<%UJ$UG,Y7'0U+<;"'&Y!Z$=^::2*.""XT"_53
MQ^YL%C1T#=Q[@1MLKTBA/W\RKTI7ERTV'@A GGR$,U. PPPGW)#)/>@L5XH"
MH^=B!LOQ'75J0>KG3EZ%2]ALY6KTI'2T^0AB@NI8HQ]QF2O-+)]-!W]O65ED
M"@'Y=^HM>(H9#+EKT]$38)L;;L2&/V'N6IDHF)I )9?=IPVGE*Q[E5  9M@6
M4==6O02AD3V[0KRM3B@GM!&,$-JQ)4KR2[?*DUF*M=D@0GU98I"/\TZRJ3+,
M<F-+=>O/?QU.U=JI]3% /:MB"Y[1#+2M6X*Y5B2460K$2#N0HW RJ*$?GDHV
ML +6=XW-F%@%:XV AJ5\U:-HLL:Q15^X5;4D)F/<>[VPH)WV&^CRQ,1(K5Y-
MQK?+8W-<?I.ADGQ\MJ3%9"&M4)/;*V%NF6.O)&G6/O!*]"HZ:9K$<22LT8+^
M#6E5R&2Q%1ZM80WJ4OTN1K581%(H6;(P6)(6>&/L=I$]P*3U5OF#- 3F!S6$
M5>/\@$"SH(ZV<HFGER5@<PS-')-[]6>4O&RLY[BK@_$:9K!@=TJUJMBXZJY1
M\A=BKR1+E<A##,TUKYP)[->C]!%)''*=C&C1DJO;W!MVU065JN0AQX6]8J9K
M*0B2:*:2LN+JO9 +0(J1C(R4H0^P[Q[TBCK\QZ: (YLS#B7GMTZEO,QP32?E
M^,L-'5FG7N,-6"YD%A(#[ &214&Y)[0.FIC3K!9CK&1NXDS9S"Q8^W+%.)\/
M#>BS ]K9E$+V/IZE::2=/5 "@WV[CUTQIB!Q7CCN8XUK&,DQ]>:!ZKXV=J@>
M.L\9A:)ORVS9JQJR$@".5MEVZ@]!068M*,-(TL?3EQ]+'/)CX8'JST(U2N I
M:JLJ1-)5._R2K\K[$J3ZZ($+QN;#Y# V8^+YF_:KF6] F8M37<E9CORK[CV8
MI\TLHN+!),K+T> D;=>HU%2F >>([X\*T52U0K\B?D.0I6'BR=RU<@N6(+[(
M"89ZU1HH:*H -H$6,  _VNXZ(,4QGN59KF/M<D_.LJRFXM2TN)K34:S;(@2G
MC:U:R*9D<?/*9&Z@=WXD!3"1\BCBG/(K>'LSO-O67#T;E.&"$+L4D>Y>N/.[
M-UW 3MZ^NXV*O$8#JH<G))>7)U\=%7]]DH+4LV+<DM3YA[E[ZBG42*>4;$QH
M)%3J.]O75[0%.I6K1ST*V,@Q]"/98DKQUH*\_O*6G:*O5(]I03L2P5F;?IML
M2!#<>6I5?(8?%\6L\?Q-*9_:M?3T:%/(V'(6::I7KV#=8$*#[LD:=P V/0:B
MZ$@78/'X3#7LAC,1B+E-V6&W>R,M:Z\%^5NX(IRUUY),C9B5SO\ ._8#MN#T
MT22R QPMWCM'.Y/"5,QE\MG9Y/?R0MS9?*PU#%&TJPM8$+83#JJ3':)#"6)"
M[$A0"I6G$8T,J22"*[) ]X/:LQ_4Q499H!)'7A"0R25JZJDY@]QAWL>_YVVW
M'0:H&-=,C7R=E\CFZ4U2Z2F)Q4>/2C+ (P'?NM27K4V1G$:[L56)1N3V@;;0
M#FJ,L;=YKK8Y:'?&N-BJK9:V(U!]V6]8F=(2\IV[8XX@$ ZN^_2X@;BSG'R_
MTXQ52+"QHQDR<N2+7)Y#&2B5<;#4=559=@S2S(>WT4ZF->H"1>_6S"UZ/'ZG
MY=;!GR&:%ZO5<3CNW5J,=62S<F;?Y6+*.IW(^(#J..M5RDHKX@QS9&);%_+U
MZ]***9ZP]FO%>L"6.Y8L+&=HQV2!4^(&J!O)F\;6S,>%/YC)D;B+.5BQV6M4
MH(O;<))-=2M)C:,;^SML9$W<]1N=].- 1,V0PN!Y L>6Y?8.0SI6+&8/)7*$
M=:!))NV(4:=2E5D4/*GMI+.TCN05#EM]3!/%@GYXY4R%:W)EY*U,)]*N+]N@
ME>[<F,G9)+9G@DNM*%V]N.&2,;J2W<#L %6BR)R,<RW*JXM:S))0-"1KDELN
M2+ R/URQQP+'L/:^G))W/?U %()VAF#>H_1/C$Q@]PY(VHK4MYMNWV4HB*:&
MNG?U#-)W=O0A6]-3&O44K:L9*.[CX*F.ALTIVF_,;TM\56H(B=T1AJBM8>])
M,_R]O=$%]2VJ0:VZ=:M?ARM/C]6[E;4D%&SDHH\=6NP4"0));%V?V[4U:!%Z
M1(79CL  .HG64;Y+%8-,K0S]G"G(9A)(<=3NQ5'NV**3&7^:-R8Z5:(.Y>79
M>WN(WW;8J*M>($^0Y? 8*;&Y'-7KU6023UZ$-1\W82U).B)*LN'Q/O19%D##
MM,T$GM$[J5)WT;2Q8*\CR.&QU:E?S?(_[N4(K*2=TV0K8F*_(5[DJ6)+4:VF
M7M!)CB>-CU[MP.F2C*3I%-OJ(-K?.>&UXT>7EF%B&\<NT.1I3RM'\K]CPJ9Y
M$253L?E5MCT(/4=,-EO)_#:G_=:]X-?\F\S\5@A@CP/*\7%9%A3;DMX3+Y%5
MJ@;E:T2RXJ)YV8CUE("AAT;;75#DO,IY6Z=K7U,8&+\A^Y+ UZW;QK&V;MXR
M*I?+@5*20[,7D7Z&6[//("  A]H'<GNZ 'LAY<WLOBE!>M_4A5&(9G[G)$,4
M^(X)5N7D7VTGNY1$]M2-V/N?11S11%_[*ER==</++_YEWU+]K)5&+Y7[E^9R
M0))%A\3 X*%8J5*:[,DQ4[%7N3RQ$QL3LY6,?CMOMKKAY<V<?CE.7I^Q(5,*
MSOF?G>8KQ/DLQ8BA@FAM1P4ZT=>2&=2?:!&(BC>9HVD(ZF0?M.P.NN'(^6P_
MY=>UM^]L5,6R?.N69JNLN1Y3R(0JRV6$N4OP'LC[V]N:.67N2NP8]T9 !!((
MVZ:[(;'9V_@MP7H1*LQVU<M7X#)^:WJR2;RO8AD2.1EZLS.UF&3M!]2=@?CO
MKH5N"P20J-4:2[5B3'WA-+*(XH+3(+KRN&$9(C1XA+-(P(Z=.X^A]-98)560
M-C8'Q3Y1Y"D(P/CSGO(>]4 L8OA^=O1OOV?S7EHXUZ\<9]P$MN$4'<G;7-<W
MVRL_FWK4>V<5[V51D\DS;>(^SO[F,]&'QWBC+U^\;JV?R6!XVB;^W\\\>:RE
M.XJ+[H+!(GDV#;*2I \^[YAY-:^*_%OJ4I?X4T9JU<? V-5_3O\ N0N8>>[;
MJ>/:64J4I[M?$7.4SRS6[\%?W*]&G/2PUZA':L2/[2/-/#"K ]TBILQXI>;>
M4*2BO%:;S4<%UNK3IV)OH3,O N=1O^E%?B6?Z^Y!<9[,KUS7I-22"JQ_DUV5
M[=QII8U_BD[E[SU"KZ:^!GHA1.1,<IR2TDE-B7V$HR3RQK4W @]V2Q'"SV"
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MK$@B6=E/;W!4^8 1?9A<7R-%BQ%^7,YN.6:7*QT+UV"&&'96CGRLWN5L?#T
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M&24#OGD2/N8N44*"=OZ20.I.@$!66I)=N-8LR)-VRO'*WN15UA1MQ7C1-U#
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M2*[$'=B#L '5B*_)/6:M<KUZL;AK4+TGL6+"@@^W%9^LBCK*R[@DQ2-^!'Q
M;7FSHN4$QL&);'M(3E+%ZU<2Y'$"-DH4Z]-X)Y&']J2>,#_-.@'$RR16H)*N
M/@F:PWMW;AECKR001@%23[4DUHD]%3H!MU(T!'Y>W^6S4[5;C]W,Y"TXQRS8
M^&B):E9V$\C7+MRQ5^GH!H^X@,W<X'R[[: ;9X8:E8HYC(T,CD+:RI0H14JF
M4R@664R2*WY?5$M*%AL2;$J+V[ %QLHT MR'D6 XO%!DL]D?H(Y9/HJR_P"N
MV&L2RE7]N+'4DGDLR@1_Q")F0;]0"=V0*YF>E]#2REO/38'&5;%;(V)_?KX^
M*Y7",\=*]+>@,T->=F4NB&*5MNW<;D: D(\C1MX^/)U<A5;'S1QV(\@DL357
MKEP2ZS,PB['4$=V^P)T!;>?(3TXY,%-C#-,\+)9O">S3^E8]TDL:4Y8GL.R?
MP 2(IWW+=-B CF9<]#2B.!J8R_D&L0)*N3N6,=32N0QL3JU>K?F9P5 5-N@;
MN[CV]K -\])+36KDJ'&O[Q9:*<5:BQ28ZK8IPVE<6;'U]]T-:MV)VN(^YG+*
M.W;<@P(<CQ6"R5*O>S^!_.6Q9^JJTUHMD[4=B7VPT4%>(,LK.ZJ&[OY6PW8A
M02(Z<0.LG#2R>%,F4I9-:JP1WYL=7:ZN0_D)[XJO7P=AYK<JD;&!&E5V &S=
M-4%EN:C?P+7+-K)8/&K!]9/.[VL#=JU:O<\GU)F6&Y10)'NP/8_;\1OH!&2U
M'GN._4<?S[XVO)&0F;-83S0UZKE;,@7+*BB1EB(]V56 ![]CT.IF@2=!A-B*
M_P!!EH\FWTGLP9B0U[J6IXD,/U<XH-4K6"9T)D6(Q D$ K\*!=5OQ4>TR5[N
M12 @2.KT*MBP >TLL8NO6B9MM]O<('XZ 4#65K*SQ126Q&I>**1EA:;8=RI+
M(G<(PWQ*[[?#?IH!/(5*EZG/6O4(,G6= TE"Q!6L163"RS11F&V169_=C4KW
MD*' .XVW "6*FFFJ*9L3-A1&QBAH3R8^21($51$VV,LVZ<0(.W8LC=NWX;:
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M56G$"M)'@OWXI\]+D9IR+$.,F7%1?EE4,0!!'3J07I(W,JAI)WEWV7;MZ]U
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M%?'=C.6-AQ'ML!W[A1H"1NUJ_P!=C[\]O)(]9I8JU*I9N+4L2V%[&DMT:?\
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ML 1J@<8F"Q6JF"WEYLU:BFD$]R>&A7D5V[9!7]C'5ZT,2Q1N-@P:38[LQWT
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MIIZL$M:G$&=2S2LFR]?X02 +\Q<PF.L8NWE\@:4QL/5QL;7[L$=JS83M:/\
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M-7 5<>F1Y5D)IE!C=NR7A_&\) 1VR]2LR_';YE.VU?\ G&Z5;>WC:CTTBO\
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MY4Y/OM6;+!2T"XI:)$446[ R-8!) V0@[C:0>ABDXA2K((Y%>9[*?3K )>X
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MA"SHQ8;#KMKCN<RY?9_-OVHOKG&OJK4R4)O),W#Q_P"R3[E,LJQ5_&MO%5D
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MM.+P6&QO9MV?08NC3[=@@';]/!'V["-?3_-'X:YIWKUS\R<I=K;]X)G6HH:
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M/4IW;Y>)8X;]R6C5",X$LDD\-6[*/;CW(58R6/3IJ LS$UVK1FM8S%+F<E
M:=%K5>C[DDC"-][MD,E=%C8EB Q(&P!)T!Q;]]&2R$GVU?E68I5J.1YCS;@/
M'[-""<WX8I'Y'!F?9CM"I\Y]K#;L>U1ONH+= VG</^5VL'.GF*X>.?:)XWJ0
M?RWSF;\[<ZL[$EIIH\?PSAF'=E[W'9!)QRT =E'SM\HZL_G@]N?M:XV.)?;C
MX+XVJ)7MX[Q)P);<78$"Y2SQG'6\I(8O;A?9\I9E8]RAR3\Q+;D@=)4UD$:"
M4JTG:.\K_"6V).PV'3K^&@)BNLHD8L4,7:O8 &[PP #;G?M().@)5/<<1&M)
M$1[J>XS;NK1+O[@0H?\ 2?A\- 3$7PVV)V)VW_> 3Z[ D: =5U<QPBS[1FW#
M-V ^W[@)(,8DW;H!T/KH!:K]=]5<-CV!3WB%/LW]W;L_F^X=]MN[0'BC^K)]
MV.3PJ4/M;\=9R3'W<[B(,_YERF+G]J]5XSDN[^[_  2*Y#O+1GY,D;7,@$:.
M;\N6!-S%;<$1NAY'_;WGO+'%^73\D\88W)YGCWBOCEOR'Y1P\#"7 X[Q7A[M
M:#DM^UBIV^AL7JL=]YZ21I]3[D4KQ@HLRM:D53U;Y3!+X[Y#QC[D?!F/I4>6
MXRC%R:"CAA%4H^1.,*JMRWQCGWK(L.5QV:HJXQLTRNV.N/6L0]I0AJVC(]L_
M'/-\7Y(X7QSR%@+=:]Q3FN#Q/*N+7H>^.2?C^=Q\&2Q[7H7+?374K6%$T9.\
M<@9" 5.L09BXO_4U37%7Z,]YMM*9?J-NT^VL"J/;ZL=R3^&@'-GZGV)/H_8^
MIV'M?4^Y['=N-_<]K^9MV[^GQT!HS[F//. ^VKPES;R]R&%;[\=QR5\!@EF$
M,O)N7Y:5,;QCCU=SO(B9',6(Q/(BNU>HLL_:PB(UV\NY?O.;<PL<KY?!W-_N
M;T+5N"SE.<E&,5VMI'F<ZYQRWR]R?=<^YQ=C8Y3LMO<OWKDLH6K4'.<G_#&+
M>&+R6)\;O.?)'._(G-N1>5>=\AR>>\A<HNM?RF9JO8AMB:21?H<+QZ"HPEQV
M*QQ]NOCZ=?98D1%4=W4_TQ\O_+?R'\JOEW??/[&WOJUM'<WNXG!.=R2C5QMR
MHIQ2EW=O&#4E+2T_%;D_X<^;_G7\V?G]\Y=I'RCNMWM'?YA&QRO9V[DHVK,'
M+3&=Z%7;G*4*SW<[D90<-<6O BH+UC\?<7D\B>,\WXW\_P#C7#X;S5X7LXK
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M!*C/?G^J-ZA%16.W+'2"71;DLTT"^W:L*E>*.I+*V_\ *5Y>U0"6W.P ?
M       ;  =  !T  T!"XR2A#>RN,H8FS0%>=;MNU^5R4<=D+F1!FFEJVVCC
MCR-@;#WG3N"G92VXV HXJY"A+?O8RO+8>Y3*37$DBO-%$;(5XU2U/&:I[E.X
MCC<]HW^4;'0@E1>C'D,E4CS#7L@'BM6\?-?KSSXV*92T"I2B"24ZTB-NO<OS
MC8[GUT*65*UB#*VY+7()[OU*/)2PKQ8NO!1J]\8,D0@JID;3*Z]IDEE=1W$
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MS_*"6)))&Y.^N6>YW-SX[DWVR?VEHC)  H"J     !L !T  '0 #6@I70!H
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MG[3)V['^$/V[[[=OJ?3??0&-V1!6A*.3[3-V[2=TG<9"/E.X8D'?0'S;?9[
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MOB^7I+(9K%CAV,P7"DS(>0Q-5XU;5E['^7FE:<+$9KXXNOK^B,JU9]<7VO\
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M)X,;:>O!%;;ON59I*#,9-4HLSVFLQQ2UYXYZZVX7BD66JT<<JV$*GNA,4O\
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M9.?<GWLA<L79MV5%)]RS)*^Y6-1Z^BC\!KT(6[=M4MQC%=22]QCF-TJV9/\
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M+K0QP)T]/DB55Z:YI2E)UDVWUE'&H T : - &@#0!H T : - &@#0!H T :
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M>)Y#4B#'YI;RJOS-L?FO->5__P &<KYU!8>)?LS?_P!Y.=M?_,/K+D'/E_\
MG,Y]Y9NRQ\':[FVO_N;=J\__ ))[9!ANJ,R>X4[BH.Q(&P9E4GN[ Q_QZ^%'
MV:8]RKD^(X/Q7E'-.2W%I\>XC@<WRG.72@VHX/ 8ZSELE89>[Y_IJ-21SU&^
MWPT!\/O/N?YORMSSG'E/DI9<YY&Y7G.9Y&%I'D6@,W=DLT<1 TC.RT\'B_8I
M0*2>R&NJ_#7]5_DCY3CY-^6O+]E>CHWVXM_JK]<'XE]*5)=#MV_#MO\ @/X
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M2>5S<RM2C6J?@3XJJT;^ESX;'EO[M..9W)519XSX3Q-CR;DO<5'KR<E$APO
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MR?KF_JO,VY_0B^YY4[-BIX9]R/<6[@0W>?MW V Z;;?'UT-?AP_$AE/^N/\
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MVN[K,#Y&OU\?O \ _?%^EM;S_P!H/D+_ )0.(>"?O/\ %G&?,3X_B?,N+8W
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M^5Y!=K2>WVFY@.+U*T+#O':F8_A)(*VM0?1BRI82:&:$F)NZ)UE"E)D9%+$
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M\W'C;QYF?,/D?@/B7 ,T.5\D<MPG#X+4<:R?EE/*VE3-9IXV9.^# X)+-V0
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M;@EO5[%%>[ZB.L:ERL([$I "R%G11O\ *3MM>P#R>6P8!)0CK6I&*%1/:>M
MT9([W$\-6Z20O51V;,>FX]="##,F>&".W2PD><R,$JK4@>>G4:#W67WIQ<N
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M-7_9K?TG.%\SQG)^08;S!F,99R<?T'CGD?F#(_W4R4PD@*XU!@,3A^>6ZW<
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MY158CLV1]P"VP8@5GIU;526A8KQ2TIH&K2U713 ]=D]MH6CV[?:*=.WTVZ:
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M;8'9=R (,_K,NV8^C3#(N(2,-+F9LG"CR2&(N(Z>,AAL32A92J,TSU]OF(#
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
M&@#0!H#BK$QUJ9M8U<S8RUZLT=B]]==KV<A7%T.U8SP5XX$IP3+"WM*(HT8*
MVP.QUR'24Q2O7EN5+/(),U;]XSF&PN)AFQ\#A>R!8,;4J2"$=P(:;O<[CYM
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M*ED)V.VXT!P_]X/VX<@\N5L3Y2\7TZL'F7QI6OXS&XW(VXZ&-\I\$N-'?RW
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MLV$_YER3?51?4_>-1BV9\Z\YRUF*%\HM1@\-R"M4K1QQQ253*(YEE2'W5/\
M,.X:3M8@="0-NZWR'ET,XN3ZV_MI["5,,R'.N9Y&W)+DN89RS':4118^?(-]
M(C(I=_IX>C%V523U.PW^&NZWL-G:^"W!/L1*LQLV,E)8E>:Z9*S*OMP[2"02
M;[R/)*92K@GT 4:ZE"*R2 XQV'Y%F\C'5PN-LY4%?GJX['WLAD7D99"HCCJ+
M)VK\N_56)"G]XD[ENTM5R48QZVE[PDWD;JX_]LOG_D@0XKQ'S9(Y=VCERN&F
MX]7D!'N>XEC/_E<#(X.X8-LQ]"3KSKO.N4V?CW%JO4]7^&IFK=QY)FZL'^GQ
M]QV7:$7L=P[BZOUE;D'*X9O8 7NV(XO3Y,9)"?E 7Y>[U8#KKS;OFWE%OX'<
MN?PQI_B<3-6+CZ$;9J_IP5L*%R'D/S?Q+C 90LK5<+&PFB52YC7*YS.8+L5&
M#$$PN-EWV&YVX'YO=UZ=GM;DWV_5&,O>9?IZ?%)(DE^W?[&.&@R<L\ZY/E$\
M0/NQ87/8S(46!16';6X?Q_+Y RH0=^VT>I[2NXZO]4\U;G#;[107[T6GZYR2
M]A?#LK-U'8Y?^GOPKN_(_%N;YI.G<%GL4,OE8)W"!E>2+F_)*<4,3, I[*VX
MZGL._5^B\W[K\V_"TNU+_!%^\5L+)5':_>YXZXGNGC+[=^,8 J'^GN*^"P'M
M,W:VYQ_'^-[L&D +!;2;]HZ_$7_Q/>7\=]O)RZN]+VRE]1?%BOABC"L[^H!Y
MIR7>F(QG">.Q$O[<E7$W\A=4, %]R;*9:U3D:,C<$5T'7J#KKM>3N5PQN2NS
M?6TE[$G[2.]-Y4-.YS[JON"Y!W?6>3L[55NX!,'%C..]BL0>U7P-''3?*% #
M%BW[>IW]*UY>Y-9^&Q!_Q5E_B;,'<F^)I_-\PY=R5F;D?*>1Y]G)9VS>;R>5
M9V+B4LQO6IRQ,@[MS_:Z^NO3M;;;6/R+<(?PQ2]R,6V\R!2">7_1PRR?]A&[
M_M_L@_#6URBLVB49D&,X;RO-$#$\>R^1).P%*C8LDG?;;MA1V)WZ;;>NM-S=
M;>U^9.,>UT*HR9LC%?;MY=RW;[7$+M56V.^2>#%E01ON5R4M,C8?#U^&V^N*
MYSKEUO.XGV8^ZIDK<CC;S'X7Y'A.19^AEA4J6ZE^RL\:S"8K)O[A*/7$T3]P
M8'<-KZ!\S[JS<YIN+EM.DKLFN&;J?U(^1G,D_)'*(.6I1V5J./[L5&F/12GH
MZ#U4P?V;8R>O7MY+FTTT=B*.=(J6(*=T4J)(C"Q/>C92RMZ&'<?C\-?<,_-$
MY*MFU@UQ?U4^L_E]=VTK%V5F[^9"3B^U.C]IL[%_:;XKH%6M+G<JP_B2Y?KI
M">OP6I2@F V_&0G]OX<=SS#S"?PZ(]B^UF.B)L;%^$?%6'"BGPK$OV[=;PLY
M3N(Z[LN2L6D()^&VW[-M<-SFG,+GQ79>BB]U#+2D9]C\#@L0%&)PN)Q@0;*,
M?CJ=(* I4!16AB ':2.GP.N2=V[<_,E*7:V_>4EM:P&@#0!H T : - &@#0!
MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
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M6+'R\>Y)#AH>\6+$\>+J9D9&I(B-$E>2>=(:X926$@$@.XZ;>H"V8_O&337
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M**99.A0MW@@].AVRB!X,CCS?.*%VJ<D*QN-0$\9N)5#QQ_4/7#&5(2\B@,0
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M_@_[@+F.JUYI0G?BY^-3\8QT[=H#W./$*L?ME->=<[\7>?&=%V49FN@^K?\
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MWD5^&VPLC$L=S^T;?Y.&YYGMK\JTWVM+W5,O"7$V5B_L]\?U=CE,SR#)./\
MVG:E0B8]/XXY:^0;;U]&4_MUPW/,F\E^7&$5Z7]AEX<39.+^W;Q%BMF3BD=R
M0;;27KV0FWV._6%+,55O3U,9.W[SOPW.<\QN9W*+J2^RI=,4;$QW!^&8CM.,
MXIQVDR'<2U\/CTGW#=P+3B#WF(;T)8D;#\-<4]UN;GQW)OTLM$90 % 50
M  -@ .@  Z  :T%*Z \HON7PIFYURV5HR#)D&DZC^RU>%E/[F4@C7U]SJW7>
M7&_Q'] ?DGS%6_*7+H)X*S3U2DGZF>I."D27"8>6)NZ.3%8^2-AN R/4A9&
M(!&ZGXZ^>VFG:BUEI7N/P;S6$[?,]S"XJ3C?N)KH:FZDIK8< : - &@#0!H
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MH48%?@01H"R2H&HO1BL6ZX-4U4M1V&EO0K[7M+,EJV+,DEI!U]R3O8MU.YT
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M?F>X_P [O9OJ6J7ODO<7Q8+X8HQG.?J#^7K_ 'QX3CW!\#"2"DAHY7*WTV#
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
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M9DDQU=*BTWJU54?ZNS?4SM>>/?=I-D]?X1H"^H<D9;AO+12#W]L>*CSR2FL
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M9@LT'C,FU9(K]*'>R&1EF[G7LWV4[@AV >W#<DIS'%R4_K&3:K)<666FLG<
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M D"D%BR*?38 #KT T Z6%+5JKD8[<QC6L5C@1_\ 5IEF'>LS+_;/:W3^@_O
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M?U+[2,K^2/MLA4Q<8^U_RGS=.T"')<I\QVJTLC*$$AFQG"O'E.%B8XF<=EE
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
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MN.Q=0NQ([TB[E4^?NMC<V[U+&WTGFWK$[+QQCT_3(ZQUPFD- &@#0!H T :
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M4@#0"SXN)\K%EFMY,20U6K)23)6X\4>]F+6)<;'*M6Q:[6[0\BMV@ J PWT
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MW7M[D#.""S,3OH"8AAL1SVI9;CSQ3&+Z>J88(XJ:QH5<1NB">9IV/<QD=@"
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M,$=BQFK.$KU)1--/#8HU8I4'_:;4UVO.JP'X]I1OVZ$+\E6R-Q*ZXW+#%J)
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M56=<95M/')*%W=HM_>@C1F_A4SL=CZGJ==UKD_,;N5MI==%[,_88ZHFOLO\
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M8O[.>=V>QLGF^/XV,[=Z"Q;LV5_'M2"E+7;8?^51_O<-SS+M8_EPG)^BGO\
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MK:Z.A&]O!'V^83QACHLKE(H\GRZY&DER].@<5F/S^S6212T,:.=P/XF(#/\
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
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M")*CS*LQ!_@A8'>5#OVMVG;\=] 72RR>W)[>WN=C>WWG9._M/9W;?V>[;?\
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MR; [ CUT!?\ \9Q4#_WAOY-(SM_WHQ-">7NZ _\ I:L5(^W_ -''<?MZ $D
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M%_8M.K^U);QU:R)8(RZ_Z,NK$*0&WZZ%'-1<C%CXEO25+F32 ^])6AEH4Y[
M#%>R.2:_+7C;H"2TA'4@?V="#3!RY^:I(_(JF,I739D$,&*MV+L(IA(_:,T]
MBM58V3)W[A5[>T*?4D J\2BT7O9"G;BRN-2O#.)Z[4WL1W&L4Y(_;86!$@A1
MIE9@8U>0=NWS;G8"#+!/CCAQ'2P]CCV-K_401T;=),.8H8]S)/'6C<-7AD9F
M(9NQB=V^()+(I;A+V$R&)D7 VY#C:ZRUDN1BTJ(2ID>6M;OQE;/MF3N]P&1
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
MT : - &@#0!H#C,+E/S%G:>A^4?3=J5Q4L?F/U?<N\C7#=^F^F";CL$'=N0>
M_IL>0Z1R#8]]@5A%7VE[&#N9S/W-WAD[!&L03;8AB22>@VZ@7)%%&TCI'&CS
M,&E=$56E95"*TC  NRHH )WV VT!$V7BJ9:K+#@+%NUD8Q4LYFG#BE%2K7<R
M1QY&S9NU;S5D>9F1(TFZD[+N="-T(N]-@,=R2I:EK9*?D&2J"C U2KFLA#'0
M6<%FE6!9L5CH1-U>1Q&S?$D#5XF [L4ZU;-P96QE<T9;"+3JXA+5E\2K!&1I
M_P MJ0[.^TA+RS%U0D'==EV FY[->LJO9GAKH\L4*//*D2O-,XCAB5I&4-++
M(P55'5F.PZZH&=^MD;$E+Z+)C'00V!+=1:4-J>["I4BM'-8<Q5(WV(=A$[D$
M=I3;K .YQ9)A^F:!1[Z&P9TD<FN ?<6$1O'VSL=MF8E1\0=4%++6EB)IQ5YI
M^Y $LSR5X@A=1(YDBKVG+)&257MV<@ LN_< %QOL-]M]AOMZ;_';?KMOH""S
M+U*+T\L^%N9B_6D>I2_+J<5N]6%Q"+#HTTL$=:!TBVD<NH]!OUVU &9EQE:&
MEE,I!D&^BLPO7AIP9._-':LE8E+X_#BR;;1;^I254ZE3UZ@(<ECQR0U;^7Y%
M<P&.H3%YC!E8L/5NR2=@BAN6NU+3@%"$CBEC[RQW#'MV ?9.&Q=J0O2S<V&B
M5TM3WJD&.L/+36-G:-7R=6[4AC<$,9#&Q"CIMOOH"VZUW*8^*3CN8H53/(CK
MDS57,UVJKW^X*T<5RM"\KN H<NRJ-_E)T[ .+ RD=2O'2:G9N#VH[%B\TM>(
MJL3"6RL-6&7W)7F5?Y0,:[,3WC8 @*69+\-%WJUX+^02)>RNT[8^M8G^4,#.
M8[KUHB23_#*0.G4ZH+HXC8@JOD*M46D6.9XD?ZR&K;,?;)]-9FKUWD$9=E63
MVXV9?[*[[: B^35L38P]DYK%SYJC7,=EL;6HV,G/:EB<"&.+'UE>2TQ=A\I!
M0#JVR@D0"%W%U>582G#8&<PU29(+)I5K,V%R"1>T0M*ZE*0R1H$8=\(;H0 =
MB-M,P+W:$=G I3HY6_@:L=6M[>0JLD=VK1K+&Q'NY6"R8BU>/M=Y5+@;DG?0
M%^+FHWL*J83-&_ L$M*#,Q7(<M,;$2F%K+6I?J(+=F.7YCW!D+=-NWIH!WC0
M%H1Q)E'S$D(DB?(3M3>6>=68O[XQ\-6JK(QV*HB;  ;;]=4"CM?@HNP2#(9"
M.%BL<?=CJ]J< E4!EDO-5C<[ DM(5]>OIJ MIRY$X^.7(U*T61]J1YJ="VUJ
MN) 7,<,-NS7HF0L@4%FC10Q/P&Y LHO:OXY3E\9'0GLI,EG&/9AR*)$S/&(Y
MIHXTKS>]#L64!E'=V[G0%,:T5C'K&F,L8FJJO6@I3Q5ZCK5CWBC>*"G/**L,
MD?5%/MR*/55/30"E%*D$34*<4T,-'MKA)(;<: %0X]BQ911:4!NKQNX#="=^
MF@(["Y#$W(;N,Q&3L7),2[5+5B:6W<L0696F/S7<@LJVI8W5NG<ZH !L%V&L
MHH"F#K)C8IL9+GK>=R$3BU;ER5BG)?B6T/Y0:O3@K)5JM[1]I?; ]=B>NLD!
M]C8+]>J(\E?3)6O<E=K,=-*,?8[EHXHZR2S]J0H0H)=F.VY).A HKE ;1R4M
M"16LN:4=&O8B,%,=(DM36+4PM66 W9DCA4;[!3MW$"S'RY.=;/YK0ITA[[I5
MCK7Y,@9JO: )+7N4*202NV_\M3*H7;YM] 6T'F6:U37#G&4*95*4WNT1%<[B
M[2/7J4Y96KP ]1[G8[%NJ#0#+#/063)8W'X2[BJU.RXEL28_\MJ9"U,SBQ8I
MR=R6+KL8]VL=NS[@AVTZBD?@\AA*N5O\7Q:9V6Q3,ER[9O\ Y]D*B32&(-%^
M=9B6R)9I.\%421E/:VW4-J*E: DL90I8K*Y"/\ZRM_(Y,?7FADLK-=2C4$TP
M3Z"B2(:%/W'9%;MW?L[>YNWI.)@W7L+*SFEG9J^1Y<EJSDA++BN-2KA*;05X
M^Z1WJ11P#,WC#'$V[M*R!0Q*]-Q 9-JD$1]3]0^X@%3V4["#(;!L=[^YW@@1
M+"(^WMV)8DG?8 ;@,*UK+2Y*Y!/BH:N*@0"KD&R22V[TQ*;]N-AJLE>L!W?.
M]@2$@?R^I*@6QJE7+215< \27HFM7<Y77$PUI+*'MCAM*+B9:Q99 ?G]AD V
M'=Z["D)#'B,-R22''\<R\V3S2?49//Q4YIZ<4?NL8XKF9R-E!VABS+7@:3VU
M4?(NZ @<Y_=!]OW'?+XPV1P=_P#NIYGQD4B</Y-!C,C:J9*G$YEFX[S%L;2M
M*W'+#LW;+-UIR,73N5I8I--ZTKBZ)A.G8<E>-O,,-"#(?;C]RW%,M3Q^$NV+
M$5! C<R\896^-I.9>-,A8=:O(.(9<D6+>*,II7AVRH\4W;/)YTHN+TRS,QP<
M%YE^S;FF/\J^&,YB>4\ YE.;:K0GL3^*/+^.@ZSPRQ I/PSR'C8F*30RK!?H
MV 5D5Z[N;$!Z^_;9]WOBW[E<;:K<?FL\9YYAX$/*O&G)W@J<HP[L.V:Q3C5E
M7/X/W.B7JP[0KQ^\D$CB, =9QVU5XX_FW<-VD*2H[1N>YNH4D?CT.@':31UQ
M+*J.2Y]QUC#.SMMMNJ[D G]FP_'0$@DB.T<I!#JI"[EE(#]I96&_:3\H]1N#
MH!S%;63O"]P[':-MPR;LO1BI.P8=?4: 4^O06$JD/W21F0,!L@4;@[MOZ]-
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MWQT @TZ0K'&"0O2./^)_13L"VQ"_*OJ= ,0(X7FD0MW3MWOW,2-^OH#Z#J=
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M[$L\P15V&[,22-^F^P$%!&TD;I:2&0,[_P L*6C]L.3$'$F_>X4 D[ =WH-
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M[!F )W(T FV.K/D(LFS6_JH:SU8U&0OK2$4CEW+8Q;(QLDY;_MK1&78 =VP
M "<]$/D*F1>_?B6JDD*48[*PXZ>2QO$);4"H'LS#O"QAG**VQ"]W70#3/XR;
M+58*T.=R7'RMN*1K6*DJ16;"]LD8J=]NO94+*S@_*O<64>OIH!]:@O/!#%1N
MQUI$DB]Z>S4^M:6! 1(BJMBHL<\IV_F'N Z_(=P0 GD6RCU <&V-^J>2/MER
M/U$E18-R9'"5&22:38;*.]!UW)Z;%V#L)$;[#N(+;#N(!4$[=2%)8@$_#<Z
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MM%$.W]FN*=VY<QN2E)];;]Y23U@ T : - &@#0!H T : - &@#0!H T : -
M&@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H#R
MK\_Y*Q]PWW#<:\,T,L,=PKC#S9?FV;$O;1PF#Q-.;+\FY!<E8-65<)QJ*:6%
MGV#3V1"WS;#7M;>FRV4MRU6[+"*Z6\$O2_=4]#:Q\.V[S59O!?3K9I3BC#[F
M?N RGD%L>V.\7>/XZ/&/&_'2ACJ8'B'&D^EXCA:T W2&2I1VN60#O]?;]SYE
M)&L[O_XOV2LUKN)XR?3)YOZNQ'L*'@6E97QO&3]_V=AZ!?+$B1QJJ(BJD:*
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MH\7=1UVU?6:P?TZF>I6O&. - &@#0!H T : - &@#0!H T : - &@#0!H T
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M:-BPFQ7MA,G>PV3NW&X# W*E_#RWK7UV+HM7GFL-<-K"W*M:N7,LTSK)7MT
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M&#'#'21W%M'8F9\FV2:.;N(($8K)L/B2-R(.Y!>^JIF U13'U!OB99FM,/:
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MY7R:;EG(XH\I_=B_DAEO.OD!)$B:L<B,DUF/QAQ*>,*JV<BJSFO&!6IV.U&
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MS$49.Y6*+$8FS0F"]=P;J#?;;?J1Y%_SCRRWA9C=N/L27K;K[#-69\:&Q/\
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MF^MNB25*O]OZ3^1NPNV/+>XWMRXY2W&Y^'A!0A'#**JW)UHJ8+%Y+/F8DZ^
MM\$?=F6"-*^<^(1\QX+DZ\4*RY''H;V/8#=Q8A'<BH1Z&0_(3UV1V_'7;R^\
M[&X3?PO!F-=+4^'U$!B>77N:_;KX6\Q5)&EYO]OG+(O"O*IF)-B[Q>))>8>)
MKUH)(ZI1IT!DL*79-Y%K1HW0+W^M""M;V[M7^5>CXD>WX9_5(Y+UM*[.V_@F
MJ^G)_:>X_C[D];F/"^.<DJ2^_#E<53M++N"9!)"C+*VQ(#3QD/\ ^-:\&[!V
M[DH/-,\%IQ;B\T9EK6 T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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M7RE;SMR)%L7['B6S>P/.H*U9OK(X.?\ A;)%;N8H+*CM)]+%E<;(R$M8;TU
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M: - &@#0!H T : - &@#0'"'W^<M?#>*:?'X92DG)<Q5J2JK;.(82]XOL#_
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MHU!R7QI9X9G^-P4KV0&-S.5-M([-R+(4(LB]K#I)=Q5BK% ZM8K1JL@9%/\
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M^.F:!?QVUB\E@%CXUFI<E6@CGH09BQ8GRL_U4:=9YK%UBUV2*24,=SV'^$;
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M*Y41AHXQ\H[=VU97JOC'ZQPP,&R7BGQ7S#F%B?'X['6YER%60XWQ[DK?Y?\
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MC*]<Y0T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M: - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0
M!H T : - &@/,7[SH#S7S9X+\;[-)'F^18G$V(%W+2?GV<P6-K!55)"6(R$P
MW[6)WV Z;'V-@_"VMZ_T1;]2;.[9]V,Y]"^UFE.&Y(<_^]'[@>;.18K5>9<M
MH8Z4^V_;C:V>MXW!%'A+P#LQG'H%'8S#MW 8C<Z78^#RJS:XN"KZJOVL]I1T
M;>U;717V?:SM)W^)]=>.\<%D,L%F:'\J<YR5>2YQ'B^1;%Y.MAXLYR;/U10L
MY'CF!L3V(8&Q&/O1V8+N;O)1LNG=#-'7A@+.A>6N'^T_EQY*L<^W'^I\V@Y<
MIA<\.$.]&-Z]1/1*<::81U1U---N44G12:_-7]07SAW?D38?^.>6+L8>:+UC
MQKEWN3EM-KJ<?%C;FI*=V;A-6TXRC%0G)K4[:EXO^4L3RS ^6L3XVAY'5O\
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M5'U*:ZS$- &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H U&T
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M:VMV&M6@3?=^Z&5FVV';ON '4GO^Y"(A#[7<WU!D9_<"!#V"%54JS&3;?N(
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MMR1Z_CK@N7KUW\V4I=K;]Y28UK*&@#0!H T : - &@#0!H T : - &@#0!H
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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M!36+;!34!87_  _KUDH](+-SOOOUU<,@<>7/K+M%6PF2I5I9&B=+TU/\UKM
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ML=QWZ*-OF ;2_75\K F/PE!Z5M6DRN7>\E*>)U+!$2I%0L2Y&9O7YY(E /\
M%OTT(,I*U#'9Z*:AQ 2WLIN<CR.C2PM801DD,<C=EL5LE9=B@/8B2DC;0#E>
M+8!<ZW)ORZ-\Z8VB7(S369Y8HVB]ADKI--)#54P[J?;5?E)'Q.X#]L;&V4CR
MIM9'W(J9II26_93%D-*TC69,<DBU9KGS=HD=6*J !MZZ A<]=QF%OX_-9GE3
MX:C#%/6CQ4UFC7Q^2L2@CW94DKM?M3P*X*I'( I .WKN*2%AYTN5LHV;JU<$
ME3:6E+6@1;,\Q8PVFRDTZM#&$9>V-4&Y&Y8[[ 0OR"9J>7''#W,76J^\)<E)
M<IV+TT]4&)D@H""[3BB>=>\&5RX0$$*= /+4EZ-JHI5:]E9+4:7#8N/4-:F0
MQELP*E.W]5.A "Q$Q!M^KKMH!#(B2%1>I8J')9&,"&(-+7JS+#(W\T+<F1RB
M#U*C^+0#3*M%56GEGX[-FLG6;V*R8Z#&SY&F+2;636MY.SCDAK[)M(1(A8;?
M*?30"N7M8S&QPY+)BP4@E2* 05LAD']^8]L?M8['PVI)I^GRL(F9!OL0-] 1
MG+,1C<E5K6<OE<UC:&-E,TT>)R5S'1VS.\,,:7?R\"Y.BOL$5&78N3^! $Q;
MD22A'93)2XJLGL6I;CI!&XJIM(T4WYK!*E=9EV61G02*I.Q5MF "TC3VXZ4^
M-NU4KO-7LRS&#ZY+N.9&<QTY8K4$<+V.Y"L_\Y0F^R$L&4"F3&3-&P,.U%,F
M4 J-DTL245?O7N-B.K)%8=!'OL%926VZ@: 2MMF(L632BQUW-+! JK8EL8[&
M2VB8TGF9HX\E:KUDW9U0"5R $[MSW: @LOR"# 8-;/)#B[>2A6"6;'TK-&K'
M+:]Y7A^C_/;U50M=@K"1W5CV=RJ#LNMENS>NX6H2D^I-AM+,P/DGE;Q:^,@_
MO!=-TQ"&Y)AZ45W(NEDQ=K5Y?R__ (OR!A:4J1[DD1([AN!OKT+7)N8W<5;:
M76TOV^PQUQ,)Y%]QG$;5*:K5PF=O0RJC.#D)\#.1&R2@+/B9;%Q0638HKCW%
M^5ALQ&O1M>6-U+\V<8KJJ_L,?$Z$:_N_<SR2_7>/#XFGBH2K0QR6:]UK\850
MJN#><*Q'J&:'KKTK7EC:QQNSG)^I>ZOM)KD^@U]D?-'D#/1.4Y7:ABE[E67$
M/7IA?[.R-2CCB;LV]&#;_'?KKT;7)>6VLK:;Z\??4QK)\3!;.<R>38SVLI:N
MN=U::2RTK$CHP9PQW._J->A"Q9MJD(Q2ZD2@WJU;N0GBK58+%^Y,>V."K!-8
MGF?\(H8Q+*Q_8-SK8W&"K)I17H*;GXS]M?GSE_M'">)N9O'/O[-K*8F;CV/E
MVZ=R9+D/Y71,>XV[N_MW!&^X.O-O<YY5M_S=Q;JN">I^J-69*$GDC??&/TZ?
M/_(:\?\ >=>"<0BE4_54\KR&7-SHA8@1K'@<5DJ5B7MV)4S(GX,=NODWO-_*
MK>%M7+CZHT7^\T_89*U)YFTE_3_\3\2K^UY9^X?!8>(0A9\3CTP?%Y(^WJ\%
M:[FL[;GL=R@A56DC$].T^AXO_*=_N<.7[.<ET]Z7LC%4_O%\.*^)CNGP/]./
MQM!]*^1Y'Y$L0*&$ N<IMEWW),OU6 J<3P5B60C9@TK#H-P!IXGG'=_#"%B#
MZHK_ !.<O82MF/62L7W1_;/P,=OB_P"V[&R6('[J^2S&-XQA;YD'42G)I6Y7
MEG57)*AI0=CO\I)V?^.\[W7^>WK2?!.4EZJP1/%@OA1CV>_4'\K70T/'.,<*
MXY6](6DJY/,WH8UZ1QK--D*>/(5>AWJ=>FVWQZ;/DWE\,;]R[.7:HKW-^TCO
MRX4-&\@^ZK[@>2=XN^3<[2C8.JQ\?2AQGVT?^RDV IXZR2H_A9G9Q_G;Z]6S
MY>Y-8^&Q!O\ >K+_ !-HP=R;XFD\OR#/\AG^ISV<S&<L_"QE\E=R<_Q_[;=F
MGD^)^/QUZMNS9LK39A&$>I)>XP;;S&<-"[894@J6)6<A4"Q.>YB=@JG;8L2>
M@]3K)SA'-HM&;!PWASR9GNTX[AN<>-SLMB:A8KU">G3ZN6-:P(WZ@MTUQW>9
M["U\=V->W'U9E4),VQAOM(\GY'L;(G#8-6V+"]D8YW5=MR=L6N1/=^ ('7UV
MZ[>==\Q[&'P:I]B^VADK;XFV,+]F%).Q\_S&60_]LK8S';+O_P "[8LQG;]\
M&O.N^9YO"S;7:W]5/K,O#1MG"_:UXFQ/:;&.R>;==B3D\BR L/P&,BQS!=_@
M6/3U)UY]WGW,;F4HQ74OMJ9J$4;6Q/C?@6#[#B^(<?K21C9)SC*UBTHZ=!;M
M1S6NI'^?U.O/N;W=W?S+DVNUT]2P+1&:*JHJHBJB(H5$4!555&RJJC8*J@;
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M/XU16!W!VVT[ +.N>J8,+"]#,9^*N@]RS[F(H7+/>ONNP@CR#U8PA)50'W(
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M^59O;54[E 3=5[F^LOF]&U>Y?L[]MJ4+6XN03JLYQ3DJ5;I6VFGT/'$_1_\
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M8"#-8AFY#3,O;L#O8='!^8ANX;@!3%S4LEQTP<:Y$UM(H):%?D#64SLR6HD
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M<$="- ,LI+DX:4KXBI4NY &,05[UR2A5;ND59'ELQ5+LB".,E@!&Q8C;ION
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
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M\-NK>Q%6A25Y*M6L+$-M;5(J4+3UHZZ5JT<JG;V@TG3??;X@6XB&O26QC:.
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MQ_>!X/X&%7Q%]NN'Q\\1_P!7RF0K<<XY?1E)9)[$F(Q^=OW)5( ^:X& _M]
M-/\ QCFFZ_\ RCO9-="U27M<4O5Z!XT5\*,$Y+]_7FW,>['@ZW$>)0L2(9<?
MAY,G?C4G<>Y/G;>1HRN!TW%5!^S7;8\G\JMXW7<N/KE1?[J3]I@[TWE1'/\
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MVW_#7%*<INLVV^O$HZUB T : - &@#0!H T : - &@#0!H T : - &@#0!H
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MZ _Z$7VO_P#-C_Y>GD+_ ,2S3PX= T1Z _Z$7VO_ /-C_P"7IY"_\2S3PX=
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M.?H^LYKF#H>B^N\P#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M0"FL04+ ?M.JDV!,L3^[\-98(%NHY= *:Q!:6 ].NJD!,DGUUE@@4U&P4UB
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M^F)Y[\TK<9\T6(_'_P!RS2>,/.^!KU\5Q+[@&IL:/(8:0:MB<1YEKTT5LSC
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MMU>92_4 : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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MC\-=RC%9(E#/^$^'_)',;$L?"^!\ZY-]28[#W*F$S=[&1+*"8B<M)7_*JL;
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M*YMIZK%ZC4=SM;E78W$.'?AA.*<O#NQN6FW*VS?.O3/JT- &@#0!H T : -
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M@XYR+)Y:E6>OC(I^'<9%JU(JB>@["=,7&:Q3Q(U-8U.R/"_ZX\_FK]$#S/\
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M7?VH>&N,<&^VG[?^.7..T%S.'\-^.ZN9GDK1)9?,R\6Q=O.-(T#$#W<O/,Q
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M9'@!<_#I_EU:)9D+-]-70"FL<P4+ ?[VJDV!,L3^P:RHD"W4<N@%-8@- 4+
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M<91DFI1DG1IIXIIX-/%/!BNJ8!H T : - &@#0!H T : - &@#0!H T : -
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M2)D=>TA^\%-=VTHK5$TW]O&$=<,CN77.<8: - &@#0!H T : - &@#0!H T
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M4D^G3U #:S[\=*.P]"/)Y*O%&R05_8B#6F")(:TUZ5%KPA_F)+%Q&.@9ME,
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MCYN^8/E_IG':\NYE<CM]3;D]I<I>VDI-YN>VN6I-\6WBS?\ KU#ZH#0!H T
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MY:DFI1G:N1O6+LY6KMJ<K4U&Y&;MR>F<9=X@OLG_ %1O-7VCV,;Q/*O/Y/\
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M:3;U[)H'>-BI]1ON#ZZTM-.CP9RN+BZ233..?OT^XG"_;W]M_E7,FXZ\RRO
M.38KAM6LR^]5S>;HR<>PV;N$LI@H8_-92!AZ//(OMI_:=/'Y_NGL>1[K>)T<
M+,DG^]+NQ_WFC[M_IN\COYB_/7RKY3G#Q-GN.=;>=^/XMMMY?J=TO3M[-W'%
M+-IH^1?["/%UWRI]R_$J4#1)4XKC<WS7)33([I!7Q%1:-&;9$?YTSN6ID;[
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M:AO^Z(;Z\N[S?F%[XKC2ZL/:L?:9**61M2CC<=BX?I\9CZ6.K]#[%&K!4AW
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MSG'L_CJF6PV7QTZ6:.2QMZ%+%2W5F0E7BFA<$?$>A .XUM-Q,Z - &@#0!H
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M>TO\VU.5"J;%N=FED( 7O<[ #IKBDW)U>9Y<I.<G)YLR'4(&@#0!H T : -
M&@#0!H T : - &@#0!H"A(4$GT )/[AU.@(Q[4I;=3VCX  '^O<'<ZN",J(=
MUYC*"&V[E_#T(/QV_9K6ZD:H.-0@: L+_AK)1Z06$D^NK5(%-8MM@H3MZZ@$
MI-G4H1NI_K_>/PUDD!C])U_TK;?AMU_KWV_Q:NI&51TJA5"CT V'^'XG6+;9
MB!('KHE4%A<GTZ?Y=5+I!9HWT -1NH*:@ D#UT F7/PZ?Y=4%FH"F@*%@/\
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M#0!H T : 8Y+)X[#4+>5R]^GB\90A>S>R.0LPTZ5.O&-WFLVK#QP01*/5F8
M:QG.%N#N7&HP2Q;=$NUG5LMCO.9;NWL.76KE_?79*,+=N+G.<GE&,8IRDWT)
M-GF[YS_4&PN ^KP/AJA!R#(HSP3<PS4,T>"KL.Y&.'Q9:O<RKJQW6:8PP KN
M$G1M]?#>:>;;=JMKER4Y_C?PKL6;[71=3/V9\KOZ1N9<V\/FOS'NRVFS:4EM
M++B[\N*\:[WH6ETP@ISHZ.5J2H>8TX\Z?<US)TJ1<L\F\HEV628DR4,/6F<E
M5DF<U<!QC%&4$@$UJP;T&YZ_"FN9\[W&"N7[_L5?5&*]2/VY;E\KODCY;3OR
MV').2+)97+TDN"6J_N;M,W_,N4S=$=^>&OTQ\7&*V;\[\C?*SD)+_<CB%J:I
MC8]]F,.9Y*4BR%PLK=KQTDJ]C#=;$@U\LY=Y+@J7.:3U/\$'1>F6;[%3M9^3
M/F-_6UOIN?+/E7LUM[6*_6[N,9W'UV=M5VX8XQE>=W4GWK,&>G'!O'' O&>)
M7!< XC@.)8L=IDK83'5Z;6I%&PGOV43ZK(VB/66=Y)#\6U\TVNSVNRM^%M+<
M+<.I4KVO-OK9^)?-'G'S5YUY@^:>;.8;OF&^X2O7)3TK\,(MZ;<?W81C%<$9
MKKI/C0: X>_4"_\ %$T__"^X_P#^ W/ZY-[^3_:1E',[9X'_ ."-PS_PD^._
M^ >GKE61V&6:H#0!H#A'[H/OX\4_;V,AQ?#-%Y)\L0]T X5A+\<>/X]9*DK+
MSGD$<=JO@5B'7Z.-)\E)NO\ (2-C,F$IJ.'$QE-1[3Y_O-OW >4ON Y G)O*
MO*&RBU9P^"XQCDFQW#>,-(&B2+CG'?J+06[()2AMSO:R,X8(TS+VH-$I2D\3
M2Y.69V-]MWZ;7E'RW'0Y5Y6L9'Q!P&P([$&-EIQGR;R&I(BNCU<1D89:7#:L
MJOTFR44US=2#156676<8-YY&2MMYY'4O&?"GBGP]YN\QQ^+<'+B<)P+QWQ/Q
M?;N6\EE,SD\WS/D=>7E_);^1RF6O79;D\F%Y7BHRL(AK5VJO%'&G9VK)TBZ(
MDDDZ([5^RZ.5/!Z-VE,?-Y.\UR89/X85Q@\N<SB5JL?01TYKL4TD7: CHX=-
MT=2=L/A-L/A.K]9F0: - &@#0!H T : - ?'I]N7_P >*??Q_P"JF<._^![^
MRW6I?FOL-:_,9]A>MIL#0!H T : - &@#0!H T : - &@#0!H T : - >:GV
M7_\ BU/NT_\ -@8S_P R/R;K;LLY^CZSEN?%Z6>@^N\UAH T : - &@#0!H
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M3\3H"6"6XLJ\UC+PBC8B2#'X@58()/J45I+,TER266>[(RKNB1K$L:@]P?U
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MR[W-N87OBN-+JP]JQ]IDHI9&U*=&CCH5K8^G5HUU_A@IUX:T*[#8=L4"(@V
M_#7!*<IO5-MRZ\3(=:Q : - &@#0!H T : - &@#0!H T : - &@#0!H T :
M - &@#0!H T : - &@#0!H T!YA_?-]\;^(FM^'O#]VO-Y9M587Y)R;VJ]ZA
MXSQMV(2P 5["35,AS3(UG#UJTJO#4A9;$ZL&BBEY-QN/#[D/C]W[2I<3PGJ0
M9WD/(J\%"//<NYQR[-11UU26WF^6\LY+D9OY;-9FDEOY+*6IV[FDD<]HW9F5
M%)'FTE*7%R9<3U1\+>.+&7\-U>36:]SQ=]QGCGFG+>"9SR!Q2Q4K<IKY7C')
ML]@:M3DM_'2SXWGE+'6./I7MQ9$6JF0'N=P;N$AR3E;E@Z33,N!ZM_;SY-N^
M7O#W#><9BM4H\CMU\EA>74*);Z2GS+B69R/%.60U(Y&:6"DV?PMAZZ.6=:[I
MNS?Q'U[4_$MJ?%FMX,W1K8 T : - &@#0!H T : - &@#0!H T : - &@#0!
MH T : - &@#0!H T : - &@#0'-'FO[H_'WAZ*SC??7E/,T1ECXSBK,>U*;9
MNTY[(JLT&)0,!W1;26MB"(NT]P\7F7/-IRY.%?$W/X4\OXGP[,^H^[/EG\BO
M-_S%G#>Z'L/+;:KN;L7WUA7P+>$KKIE*L;54T[FI:3R#\K>;O*WGW/U<;?FO
MY-;-PQ\?X/QFI:>A%.^XCCI8FK[]O*7^T'::8SS[$@,J?*/KW?\ ,]_S6ZH3
M;E5]V$4Z>A+%OK=6?T-\A_++R%\I>4SWNTC:L2A;KN-[N9Q4W%9N=V6F%J'[
MD-$,FTY8OIWPE^GKE<TU/DGG&]+AL>QBLP\%PEI#F+2'YQ%G\S%[D&*C?H'@
MJ&6P48CWH)%VU[G+/*-RXU>YF],/P1>+_B?#L57UIGT=\S?ZO-ARQ7.3?*^U
M'<[Q5B]]>B_!B\JV++I*ZUG&=W3;37Y=V+J>IG#N#\0\?82MQSA/'<3QG"U0
M/;HXFI'6220(J-9MR@&Q>NRA1[D\[R32GJ[,>NOG.WVVWVEI6=M",+:X)4]?
M2^MXL_"GF+S/YA\W<SGSGS-O-QO>9W,YW9N32K73%?#""KW804816$8I8&5:
MWGA!H T : X>_4"_\433_P#"^X__ . W/ZY-[^3_ &D91S.V>!_^"-PS_P )
M/CO_ (!Z>N59'899J@X2^Y#[[N+_ &Q\Y'#.;>)_)^6@R>!K9;BG*\!7XZ.,
M\BNLTHR6)COYS-X?VI\-M']3[(MSQ^ZI:%49&?"4]+Q3,934<ZGDWY]_4D\Y
M>8JU[CO#4B\,<)N1O6LU>,92?(<XRM9]U>._S<U<;+B8)U )BQ=:I,F[(UJ9
M"0=4KC>"P1K<V\LCE[P?]O7EK[@LP<-XIXE-E*D%L09KEV1>3&<)X]+*3)++
MG>1O#.LEOJ7:K52WD)-^X0L-SJ*+ED8QBWD>_GVO_8#XK^WXX[EG(!#Y,\L5
MNRS'R_,T$BQ/&+?:P9.#<?EDM0X=X@W;]?,\^1?J5EBC<PKNC!1ZV;HP2QXG
M9O-^7X?Q_P -Y5SGD,Q@P?$./9?DF5D4=TGT.&H3W["01@%IK,L<!2*-06DD
M8*H)(&LWAB9-TQ/(67.\BXIXIRF>R5(7?(O+\EF.=9G$P'W7R7DSR'EYY\-Q
M.H^P]V$<DS\6,I+L%6$Q*   !-OM;^[\25J/=M6W.;X1BJ+%]<G&$>F4DN)Y
M.\W^UV4[4+\J7=Q>C:MQ6,ISE5T2XZ81E.7X81E+@>L'B7@5?Q=XRX'X]KS+
M;/$.+8;"6\@ >[*Y2I3B7,9F7N5"UC,Y4S6I257>29CL/31*BH>LE14-AZH#
M0!H T : - &@#0!H#X]/MR_^/%/OX_\ 53.'?_ ]_9;K4OS7V&M?F,^PO6TV
M!H T : - &@#0!H T : - &@#0!H T : - &@/-3[+__ !:GW:?^; QG_F1^
M3=;=EG/T?6<MSXO2ST'UWFL- &@#0!H T : - &@#0!H T UO7Z.,K2W<E=J
M8^G".Z:W>L0U*T2_YTL\[QQ1C]I(TSR"3>"S-&\B^YOPQQPR1/RZ',V4W_U?
MCM2UF ^QV/MWX(AB3_38&^MBM3? W1V]Z7"G::NO?>WX[B9UQ_&.97 H(1[$
M.&HI(X9AT[<M<D6)E ()4-UV*C6?@2Z4;5L[G%H90??!PI@WU/#>4PD;=GL3
MXFP&'7N[C):J]FW3;;NW_9IX$NE#]'/I1J'G7W,>2/)V6DX_XOAO\5PI#?SZ
MS11<BL5QL'MY'*QO)%A84)&RUI%=6/:9I-P-9QM0@JSQ9NAM[=M5N8OV&@LY
MPS()*]G/\B?(9:4=TS223W9V;K_%:MS"Q,-_B5&MJ=<E@;E)9)8&'W\-6HP&
M5KC=WHD9B4M*_P""[."H_$]=M9F:=2%]O^09G[NYY0D>YZ-L"TK'<;ML2!_3
MK+3W-3Z<#*F%3(L946"%96'\Z50Q)]51NJJ/PW&Q/[?W:Z[-M1CJ?Q,VQ5%7
MB91#G,Q71(HLE;6*-0D<33-)&B+L%1(Y"Z*@ Z #;;6QP@\6E4NE= Z'(\BW
M2PT=E?0ET6-]OV-$$4'IZD'4\./ FE5JB,AQM[R!EH<-Q?$RY++2DD")55XX
MT(]R:6PS)!#2C!^:65E0;_ D;Z+NB,>_DN(DHQC6Y@C85#P92Q.0OUO)/-\3
MQ^*E'6%6'!R#/WKLDT0EF!K1A+5".FQ]LF2 F60'LW0!VYX7+E/Y46X]>!IC
M=E_RTVNO GQX\^WR(%9>4^0[;$DAZD>,K(J] %9+/'I'+$[G<';;X:SU;KHA
M]/29^)N."C]/2)GQCX(F^6+R#RVFP8'OMX?ZE&3J.T+7P\3!]]CN2!L/3KT:
M]TONQ?I_:/%O_A7K&[^#_'ECYL9YGIQ';81Y+CCUP2&W8_4-F:Y ["-A[9W(
M]?P>->6=M^ACQ[G&'M_8)G[?'DV.+\N<#LKNPWDR<]9AOM[0*UVO$/(#U!ZK
M^W5_4R6<)C]0N,)#NCX2K\32[R'G/*N)9VK2A!Q^%PV;REB;*7WW6*&P9,54
MF$2=#LO</5GV52K8ROSN=VW&2?2T'?<^[;3773]I6+A/&?(V,MQ5)N*^/>18
MZ:)ZWN9.VF.R-"0]LBR,V.JI)-%UW[4[PP4[E68*U7;3J]4H/J#N2MO&LHC=
M/!'$JA[^1>9," A/N5\)1.8F) (*B09))(F5@?6%CTVV&^KX]V7PVWZ<!X\G
M\,'Z25J\>\ <:(=:'*N>VT^96R5DXS%&1?1A#53$VUC)&_9(LX.YWW'33_NI
MYN,5ZW]9'+<2Z(KZ=IDZ>0>3SU&Q?!N.8CA>'<*O9A,?7KLR[$=TUYX88)9>
MT_Z18EEW)/=N=%MX5U7&Y2ZR*RFZS;E+K,;BX9+;LM>SV2L9"U*W?,&EFE:1
MNG^FMRM[\O\ 1V[?CKH325$L#>E14,UJ5*]*%8*T20Q+Z(BA1O\ $]!U)_$]
M=&ZF0YU 1.6OU,?")K<Z1*.[92=Y']/X(UW=^H^ Z?'62*FD8=3BY)Y!N_DW
M&Z,JU"RK:M2;I#%$Q_CO6%#I#&0"1$G=))L0 WIJ7+D+<=4V83N1BJRR,%^X
M7S!Q#PKXIY;QCC5V/)_E>)MY;GW(8)$"Y"?'Q--%QG'3JY1I;=U$@95<H@?V
M=W>28CQ]]O([/9WN;;K"Q8MRDETT6"[6Z)=+:ZCY7\N?)/-/F/Y[Y3Y-Y8FM
M]S3?V=O!T;4%<FE.[)*KT6H:KLW3"$&^!\UGV[^*>0?<_P#<;P_@SSQ2V^;\
MJO<@Y;E;BS)3K8:E]9RCEV2O2P1O].LM"K.J$[*UB6- =V&OS5R7:W/,'F"U
M:W%9N]?<[CZ55SN=E55+K:/]''SH\Y<J^0'R YGSKDZCM[/)N3PV?+X)KNWG
M"&SV,(IXR5N<K<I)5?AVYR>";7U+TN)^#_'JI&]6SY/SU=55I)W^AXQ#*@V[
M:]6!WAEB V #F\A_%3T'ZB4+UQ<+</;]/4?YEIW-Q?DYR=&W5O-NO%M\?497
M#Y*YR8/I>)\?PO%<<!M!!B,-5JQ*O7M.]H+1<IW="L2C]FLEM+6<ZR?6S%6(
MO&56^L2_O?YA[_=_/).[?N[?;PG9O^'M&K[.W[-MM9?IK&6E&7@0_"76?(^8
ML1+CO)/$\/RS$N>QS>QU9+,>_P#:J6HDDI)*G\0[$1]QT=?76#VD%C:;C+J,
M'84<8-Q9I/RSX\X[Q-./\VX=)-9X;RE[ KT;Q,L^'OUMC8QDLI9VFA<!Q&6+
M2(8G5F;M5WEN3E6U=_,7'IZS.W.4ZV[GQHUC<R&):,Q5,?%*[#99# L(!(V!
M!0+,[?L^7]^H84?$]%?L]\;<GXAA.2<FY'4LXI.5C$)B<5;1X+;4\;]?(<E:
MJN \"VFO!8 X5RBLVW:Z$\EZ2DTEP.#=7(S:C'&AV;K0<@: - &@#0!H T :
M - &@(JT6]YM]]AMV_NV^'].H9K(>U2QA'=OZD+O_F_]?2M#%YCC6+;9"FH
MT!:7 ].O^3620$R2?75P0*:Q;8*:@+"_X?UZR4>D"9._KJU2 :Q;;!0G;UU
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ME&/H\G3D.WN&,GX2*5'_ (]U0?UZV*];?&ADI18CE;)BKJD;=;!*]P/_ &L
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MXE[DGR>Y=<P@GS/>I-YO78V=N5,*I?J;LH2J^]8G1=UOVMQO'\;C K1PB:P
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ME'L/0%*T4:G;7FSNW+KK<E*3ZVW[S(DM8 - &@#0!H T : - &@#0!H T :
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MM]G&Y#1<CXJD[.VFZSG"::U79X..5%P/J.\8?KGX>6W6H^9?#DN/KNR"SG>
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MVC^,95E\3_;S3S&7ICVZV?SF+P]&[V+_  FMR7,_WKY5[9WW(=8R3ZCXZO\
MH//][CS#=Z8/A%M_[JT1]K)XL%\*,0Y5]_GF/,!X.-8[BG#*W7V9:F.DS63C
M'HJO8S,MC&.$4#;:DO7?X; =NW\G\LM8WY7+LNMZ5ZHX_P"\8N]-Y8'-/*O-
M7EKFWNKR?R'RO*5YBQDH'+VJ>+/>-FVQ-!ZN,4$=.D0Z=->YM^5\NVO^7LVX
MOIHF_6ZOVFMSD\VS6L4$\QVBBDD_[!&;^L@$#7<Y)9LQHV;#X_XA\C\F[&Q'
M$LQ-#)V]EJ2I+!3/<-QO<F5*J[C_ #G&N*]S+8V/S+D:]%<?5F9*$F;PX_\
M9_SW(".3.Y+#X&([>["U@WKJ ^O8E%+-.3;X[SK_ $Z\J]YDVD,+,93?J7MH
M_89JUTF[^/\ V?<&H=CYW-9C-RKVEDKI7QE9SON5>-_S&5D^'RNA_P FO*O>
M9-W/"U&,5ZW]1DK<4;NP7ASQEQP)^6<-P_>FQ$U^%LM*' _TBODWM^TY/7Y
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MXB7MKQL8H@S>1>O.]*KPBLD;$J&ZOL?^T*Y]QO*H^:<VQ\\'@_B.20Y S+-
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MS+)R'F.6\JY:$#>M5RE[+TYI8V))@?AE7$8?V _41V+LBL/\X;ZP_4>;M_\
MDVHV+;XM*+_WVY>J(_E1S=207[Q?#7CR-J_A3P!B,5*@:.++Y&MA./VFV':)
MK:X:IELED68=/YEY7[=MV^&LEY7YCNWJYGNW)="U2]6II+T1)XT5\*-2<L^^
M/SUR0RQX[+X3AU60,GL<:PE<S>V?3>]G6S5V.;8=7A>([^@4=->GM_*G*+&,
MXSNR_>E]4=*]=3!WIOJ.:^3<\YMS.7WN6\NY)R1PW<@S>9R&2CB(]!!#:L20
MP*/@$50/AKW+&SVNU5-M;A!?NQ2]QK;;S9 5<;D+TD<5.E9L22L%C2*%W,C'
MT5-A\S'\!K=*Y""K)I(4;-M<?^W_ ,K\B[&K<3R%.%MC[V55,4G8=OYB'(O5
M$R;'?Y"Q/PWUYU[G/+[.=Q-]6/NJ9*W(WCQ_[,\[/V2<EY3C<<AV8Q8VO8R<
MX&W5)%E_+X48GINDL@'KU]->3>\S6EA8MR?;A]ON,U:Z3>''_M2\78CL?(Q9
M7D$PV+"]<^FK%AL24CH)7LH"?QG;7E7O,&_N80<8+J7VX>PR4(HW7A.!\+XV
M$_).+X3'2)MVV(<?7:Y\NW;W794DMOVD;C=SL>NO+N[O<W_S;DI+HKAZLC*B
M,MUSE#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!
MH T : - &@#0!H T : - &@#0!H T : - &@#0!H#"/)6-YSF.!<KQ?C/D>/
MXCS^]AK=?B?)<KCX,KC\+F74"K>M8^S4OU[,41WZ/!.@)!,;@=IQDI.+4720
M/GF^Y+P%]_>8SM7-^;,#S7S:V,!K87->.TI\QXY3,O;#/)AN"<-P^$R&#ELH
MJ>]8; UWE7;OD;M.WF7K6YDZW*R[/L7V&::X&4_;/^G=Y2\L9FAG_,6%SGBG
MQA5FBL7<7F(I,1Y$Y@JL&.)HX:4"_P 1QTO:5LW+RPW A[:\)+&>*V=I*3K<
MPA[6'+UGT#\4XKQS@W&\)Q#B.'I8#C/',=6Q6%P^.B]JI0H5$$<,,8)9W8[=
MSR.S22N2[LSL6/II**TQP2,#(-4!H#Q^X_$<=S'SKB75U?'_ '">7K!5RC2!
M>2\HGYI$S,A["LD')4:,  K$55OG#$_>?R?Y9;M<MWG-,'>O;GP^R-N*DO6[
MCKU)>C\8_P!3'.[U_P Q;#D&*VNVVCO=4IWIN+?7IC:BDWDW)+KZR^QR5#XU
M\BTU)#8_SWY7CD@[65:[9#+5<\H0$"/:S%EUL,4W!>9B?G[M?5/FB'A^9N8P
M:I_WEU_WI:J^FM?2?I;Y:75>^7W)IIN27+K,:_PP4:8]%*+LPP-O?<-YZX?]
MN?C/+^0^6.;,L7_%W&..02K'DN6\HM0RMBL!CR4D,7U#Q%[$Y1DJU4DF8$)L
M?-Y?R_?<VW]GE?++4[_,=Q<C;MVXXRE.3HDNA<6W112<FTDV?(N?<]Y1Y8Y-
MNO,//]Q;VO)MG9E=O79ND80@JMOBWPC%)RE)J,4Y-)_+5Y!\B<K\I\UY-Y+Y
M_D5O\JY3<-[)31]T>/QM2!/:QV$Q,4LCFGA,'158*Z%B>U2[EI'=C_3#Y6?+
MOEGRN\K.S?G;?-KL?%WNX;48N48MZ5*5--FQ%M1JTOCN-)SD?P8_J ^=//OG
M]\P%O-O;OKD%B;V_+-G%.4XPG)+4X1KJW.ZDHRGI3?Y=F+E&W%OUI_3<^TAB
M,9]S'DO$NDMB!I?#7'<E %-;'VHC&_DF[4F7O6[E8'9,.' ]NFQMJ"9X'3\6
M_.GYJ7?F+SW]+RV4H^4ME-JQ'+QIXJ6YFL^\JQM1>,;>-(RG-+^IG]*G]/&W
M^2WE3_5N?6X3^8G-+<7N982_36G24-G;EBNZZ2ORCA<O8)SA:MR?L[KZ6/UB
M>1/";@F/F)A()A>^Y?S_ &DLA_<%JO5\J<OHU'6;<^]##5C2*,@E5C157HH
M_1/RRLT\MV;U*5E?]-;TE7K^&E>JG _"/SYW2?GS>;;56GZ?"N5-O!TZOCK3
MKKQ.K/L?!_Y,>>OL>U_/'EXHW]EPG(_9<J?1@DL;*=O1E(]0=?2/F9U\R\PI
M_P#IEW_&S]<_+=->0>3U_P#\=8]L$=E:\0^:AH#RI^^K[ZI_&=C(^%?"N1C_
M .4OVXH^:<TCBAM5?'=6U#'83%8I+$<U2]S6_4F5B65X<;"X9@T[*L?'N-SH
M_EP^/B^C]IDE7$\/<10Y#RCE%#$X&IG>6\]YEFNRC7@GLY3E/*.0W9&FFM3W
M[,SV[5R21FFLV[$H6) TLLBHK,/.I*4L,9-F6/$]4/$W#KV1\+\#\G<8]WQ'
MY]PT_-N$Y_E'$[*4Y,ARG@/),M@:G]_L75)P7.(KJ50N12_!/[Z[M&T;%'6Q
ME<MRK%TDF'0]=?"'D?\ Y7?$O /(\E),9=Y3QVG<S.*C8O%B>15^_'\EQ,+M
M)*TD&+S].S71BQ9DC!/4D:]FW/7!3Z4:W@S:>LP&@#0!H T : - &@#0!H!.
M::&O$\]B6*"&->Z2::1(HHU_SGD<JB+U]2=1M159.B,[=JY>N*U9C*=V3HDD
MVV^I+%FE>6^>.'<=26'&/)R2^H(5*#"+'JXWZ2Y*161E_;"DP._PUY6YYQM;
M%8V_YD^K+U_94^T?+ORD\R\YE&[ODMCLV\7<5;C75:3K7JFX''W/_-O-N8^[
M1>\V,Q<[&-</AO<KQV%<]JQ6IE9KE_O&P*.WMD]0@.OC>[YKN]SW6]-M_=C]
M?%^[J/T=Y0^5WE?RUIWD;2O[Z"KXUZDG%KC"--%NG2EJ2P<F4X5]M_/N;M%=
MS"_W.P<G:_U&4@=\M8B/QJ8;NBF3<>C6&@&QW7O'33:\CWFZ:E=_E6>EYOLC
M]M#'S1\Z_*7EA2VW+7_J7-5AIM22LQ?[]ZC3[+:GT/2=L^._"_ O&D228+%"
MSF3'V6.190K<S$Y8;2>U,46*A$^^QCKI$K#;N[CU/RK9\LVFQ5;4:W/Q/%_L
M]%#\O><OF9YL\[S<.:[APY;6L=O:K"S'HJJMW&OQ7')I_#18&U]>@?  T :
M- &@#0!H T : - &@.'OU O_ !1-/_PON/\ _@-S^N3>_D_VD91S.V>!_P#@
MC<,_\)/CO_@'IZY5D=AEFJ T : - &@-;^4?$W!O,/'/[M<XQ)NP5[*Y'"Y6
ME8EQW(>+YJ*-XZN>XSFZI2]A\M561@)(V[)8V:*9)(7DC??MMSN-GN(;K:3G
M:W-MUC*+:E%]*:Q^U8/ X^8<OV/-=E<Y=S*S;O[&['3.W.*E&2Z&G@^E=#2:
MQ/+-/TA,+<Y9<RN?\]YFSQFW>FLG#X+QWB\'R$P22]P67DEWD^?POULB[F:2
M'"00-*Q,4$*=L2_>MC^I'YE;3D-CD.QEL+$=O9C:C?C8K>TPBHQKKN3L5226
M%E+#(_(^Z_H;^1_,?-VZ\V\V7-]U+>;JY?N;6>Z4=MKN3<YI.U:M[K2Y-OO;
MF3QSH>C/A+[9/"GV]X\U?&7"J&,R=BNM?*<MR);,<SS2 JSKDN2W_=R)JO*.
M\5(6AI1,3[4*#IKZ7YQSOG'F'?2YGSS=7]WOYYW+LY3E3A%.3>F*^[&-(Q6"
M21^H_+'E+RQY*Y3#D7E+8;7EW*+>*M;>W&W&KI64E%+5.5.].59R>,I-XF^]
M>6?(3GS[I.=Y#@'A#F=_ VC3Y7R*&AP+AMA"/>J<HYYD*W%L9E85(82?W=_,
MWR<@(V]FDY/0'7;RW87>:<QL<NL?FW[L8+JU-*O8EB^I'C^8.<6/+_(]WSO<
M_D;7;W+K73HBVHKKDTHKK:/-YN&P\CB\=^"N/+-1I\XR6'\>K'4D=)L3X^Q.
M.FR7-[$,P^:M)6X#A+L->4D;7IX!OW.H/Z6\_;ZSY;\GRV>S[D[L8[>VEPCI
MI+KPM1:3X-Q/P?\ )[D^Y\\_,NWS#F7\VU8N3WM]M82FIZH]7>OSC)KBE(]G
MJ]>O4KP5*D$-6K5ABKUJU>)(:]>O"BQPP00QJL<4,4:A550%50 !MK\N']"#
ME;[L_/N2\,</P^!X'5@S7FGREDI.*>+L',BSPU[WMJV6YCEZYW[L#Q&I,LTH
M[7]ZQ)!$5[9'9?HKY^_-Z'RG\H*_RV*O><>8S=C86:*3=UT3NRB\X6M4<,I7
M)6X/NRE*/VI\IOE[+S]YA<-ZW:\M[./B[NYBJ056K:EPE<H\?NPC.2Q23X4Q
MG L1X%X1>O9:[/R?GG)[EC,\OY/D9!-G.9<NR3/;OSVKC*\QJQSR,06W$<8_
MSB%/\L_,.\_\(Y9N/,7F:\]YYLW]QSNSE*L[U^=9.$9--^'!MN4GFZSHG*,#
M]S\GV\O-6_L\GY);6W\O[2"C;C%4C;M1[JDXK#7)))1X*D:TBY'%O-9<GR/(
MV,GE93-/(2$0;B"M$&)2O6BW(BACWZ#U))+$DDG\F\XYSO\ GN^ES#F,W.]+
M)?=C&N$8KA%>MYMMMM_H/EO+=IRG:QVFSCIMK-\9/C*3XM_L5$DC2>7PW\?R
M?C\/\/\ >UY9WFKLOA_X_D_<=OW_ .&VN[;;J5N23.+<;=23:-79?#_Q?+UZ
M_#7RO9;[+$^/[K:9X&L,MB/XMEZ]?A_AN#KY9LM[EB?'MUMNDUGE<3_%LNQ&
M_P -?*]GO<L3X]N-MPH81)'/1G2:%GBDB<.DB$AHW4[@@_OU[\96]Q;<)I.+
M5&ND\F49V)J<6TT\&?3U^D7]]%GR7AH/MK\G93W^6\;QC/XTR]MP9\O@,75,
MMKB4\A'N36\)1KO8HLQ9FI1RQ$@5H_<_?/\ 2K\Y-QS!1^57FF\[F^L6G+EU
MZ;[UVQ;59[63^]<L16JVW5RLIIT\-5_*OSW^7-G;)^?>16U#;7+B6]MQRA=F
MZ1OQ7"%V3TS6%+C35=;I[I:_;Y^80T : - &@#0!H T : - &@#0!H T!YJ?
M9?\ ^+4^[3_S8&,_\R/R;K;LLY^CZSEN?%Z6>@^N\UAH T : - &@#0!H#"_
M(?"<=Y$X;G.'Y-V@KYBJ$BMQHLDE&[7ECM4+L:,5[S6N0HS+NON("FX#$ZRC
M+3)21G;F[<U-<#R*YUXM\A>)KTU7D6&FDQ0E9:N<I)+;P-U.[M22"^D8^EED
M_P#),XBF'Q3;8GT;.XIA'+H/6M7XS7=?H,'CS-=O](DD9^/0.O\ 6-F_Q:ZU
MN(/.J-ZFA]'<JR_P3QDGT#-V-_XZ_:=;%<@\FC)23'/KK,H: - 5T 37?IXF
MDF<E%'H3NS$^BJ3U))UBTEB*5,DX'XIS/DN6QF;,U?C/#Z#L,ER2ZJK OM=K
M2P4E=H1D+BJ1W$LD46X[F4E5;DO7(0=$JW'DE]9C<N0MX)5N/@;HQ^1\;<!=
M:?CSA\'),U%M'_>ODT+Y"Q/,H.\]"D44UP3Z&!:IV&Q#?Q'4K%VYC=DTNA?3
M[31INW,;CHNA?3[22M<O\M9LEYLS-CHG)*10?2T.P'?H#7C:[_X^Q.ML=O9C
M]U&:L07 C_\ \(KLS/S;+*2=_P"7G\V!N?7908U4?L VUEX=K\,?4C/PH]"*
M%?(>W3F^9)^ /(,X!_6)&V_JU?#M?ACZD/"CT+U"J7O)];;VN77I>U=AWY6W
M/_7]7$=WZ>IZ_MU/"M/[J]1':AT(D8^;^8*8*_FOUD1W#1RU\+,K A002T$<
MY5ATV!V]>FL'M[+X>\Q=B'00UKE&4LOWY[QSQ#+DL#+-+QIDGD(Z O/2G6-C
MZ#=E;^$?AI^GBOAE)>D>&U\+DADN9\7N##F/#&#3O/<TE"]<Q[@[KW=D<<4,
MBC8>BRJ!_3J.S=7PW'Z12\LIL;OB?MXO;]_$N88)F _])F6-N)" I.SY/(W9
M2=U(&ZGU^'39IW2RE%^C]@U;A<4QJ_CO[?[)W@Y;SS&]Q([;E:G=6,L?E<?2
MX)&,4>_4;ESMZZ:MTONQ?T[2^)N%FHOZ=HC_ ,E7A#_G1S__ (;-S_W7#3Q-
MS^!>M?:/%O?A7K+AXN\&1$M+Y(Y/;7;81UL#+6D#$@AR]C%21E  01Z[D::]
MS^!+T_M'BW_PKUCN+BGV\8SJ4\@\B8;_ "SVJ->%SNH _P!6KX:9(SV$_P 1
M8!SZD#9_W3_ OIZ2:]P_PKZ>DF*O)?&^';LXEX?PCSJ=X+6>>7/3JVP ?V+Z
M9&57_:LXV/IJ>#=E\=Q^C QT79?'-^C F;'/O*65A6K3^GX]14=J5L;2KXV&
M%-R0L7U)GMPJI/I&1K*.VLK%JKZRJQ"M6FWUF-R\:RV5F%GD&=M7IOBTD]B[
M+L>I"V+;[H/W*1K<E&*I%41M4$LJ(F*G&</3V(JBPXV_F6C[YZ?'L($(/[E&
MJ941.JJJ J@*H&P50  /P '0#4,@9E12SLJJ.I9B%4#\23L!H#%\]S;BW&<9
MDLQFLS3IXW$4;62R5PN9(*=&C ]FW9GEB#I''7@B9F)(V UKO7;>WM2OWI*-
MF$7*3>2256WU)'=ROEG,.=\SV_)N469[CFN[OPLV;4%6=R[=DH6X17&4I244
MNEGR^^>?)W*?NE\\Y+/8K'Y#(3\FS-'B?COC,$;S7(<,MK\OXUB8*R-+M?R$
ML_U%A5)4W+,I792 /R_SWF6Y\S\]G?MJ3=R:A:AQ4:T@NUMU?[S? _T<_)CY
M?>7?Z<?DM8Y-S&]9LVN7[2YO>9[IM*$K^CQ=U><J*MNU&/A6FUJ\"U;3K*K?
MT6_;C]MO//%GB;BGCK"8[\LK8FD]O/9FVJ8G\TY!D6-S-9682ALL89+,A2$E
M#[56*.,G9!K]"\AY?M?+_*;/+;;4IPC6;7WIO&3]>"KE%)<#^!7SS^;6_P#G
M+\S^:>?M_JA8W5[1MK+=? VEKN;>UAW=2MI2N.-%.]*Y.E9LV??Q?BGB1:;F
M_D>+.9%1N^$X?ME;32CJ89;Z&S#&Q'J)FJG]HUZ_BWI_EPHNE_3[3ZD3O7/@
MC1=+(C&>2L[G+#XOP9XM2E(I]I^0WJXS&4A#C^.?(6S^78@.O4B6>5?P.L90
M2QW$_1E[.)D[48JNXGZ!:[XR'U'YMYQ\CS7<@Q$IXQA;3Y'($[,T<4L@7V*B
ME>GRQ(@]!+Z'2,Y-4V\*+I85["FWA1=+)K&\PH8)&Q_BKA-# _*(FS-FNF2S
MDJCHDL]F8/%$W[)GG7UV/762V[EC>DY=62,?#E-UNR<NK@,[>+Y3R.03\ES]
MJ<[]PAEGDM"/XE8X0\=.N-__ "6"-_AK?&,(8121MC;4<DD+1</PT"]TPLV=
MAN?<F* _N$ A(!_?K(R423KX3"A=TQM8[';^;'[QW'7_ +:9-_70NE(>C&XX
M  4*0 ] *L  _<!'J"B+6Q>-<=KX^DP_ U8/PVW'R;@['UT%$1%SB>(M*WM1
M-3E(Z25V/:#\-X7+1E?QV"D_CJU)I1*\#=\K<R?B+E#?F?'\]2N5ZT<F\K8V
MU%4;(06Z#R=QK%(HC*J^B3JK#8EN[DW4%&/CQPG$YKT='\V.$D;1^S?)9.'"
M<KXG?E,L.$NPS5UW[E@G:YE,;=5"23[4JXV$J!\H()]6.N;=4[L^DY=_%5C-
M9M':#2QH=FD13^#,JG_&1KCJWD<%"X$'J#N#\1K$@: H6 _?^&JE4"98G]@U
ME1(%NHY= *:Q!:6 _;_A^.JDP)EB?7^K66"!34;!36(+2X^'7_)K)+I F23Z
MG5P0*:Q;8*:@#0%I<#TZ_P"35 F23ZZ@+= 0MQ2L[D^C=I!_$=H'^(C6:>%#
M-9#70H_I ]LC? E0/W@'?_+I6AC(?:Q;;,2A('KJ9@A;:%96;;Y7Z@_M^(_K
MUL3HJ&2Q&NIF9$E40K&6/3O.X'[!TW_IUBV8/,=:A )V]= )E_P_KU< 6>NI
M4%- !('KI2H$RY/IT_RZS2!9HVD UBVV"TL!_O:)-@3+$_L&LDJ MT;0#6+;
M8*:@+)-RC!6[6(Z']O\ 1U&JD4;PF14(<]>X[=>X[?O_ &G5= ^H4U*D*:@*
M$@=/CJT!X:XCBW+^59F*IQJCF<Y+\FV&P.#LYB_88DCYA5AMV>UVZ (@/[=]
M?:ER[:L1UW9QA#I;27K9IHWD=.<3^R3[F.92U9H.%0\5Q4G:9K7-;=?#6!NV
M^WY<;4F;@V7U+4FVZ_'IKQMQYDY1M\/%URZ()R]OP^TR5N3.E,?^GG@^+5H<
MIYG\Z<9XM3"DV*F+BJU(I-MBWTO(N47L:NZ[$ ?ESEB1Z;;'R9>:[VXEX?+=
MK.Y+KJ_]V*?^(R\-+XF3L>(_3T\5,/Y6=\M9:H-NZ1\IGU=DW.Y4'BO";AE(
MV]'4?\$'K%'S?O\ \&WMOLC_ .U-"MJ/6Q6S]]/'>)5IL9X:\'\6XG3VVAL6
MUI8^O(!OV_4<?XO1QJ @@$[7VW)^'J<X>4;M]J?,MU.Y+H57_O2;_P )B[U/
MA1HCE?WB^?\ E?N1GFAXY4<D_2<4Q]3#=FY/^CR*QSYM0HZ#_6C_ %]=>QM_
M+/)]OCX6N73-N7LPC[#!W9OB<[9C/9[D=PW^09K+YZ^^_=<S&1N92XW<=SO8
MNS3S-W']O77M6K-FQ'19C&$.B*27J1@VWF*8OC>?S4ZUL3A\CD)WV[8:E2:>
M5M_3MCC1G;?;X ZER_9M+5<E%+K846S=''_ME\L9WL>3!C#0-MO-F)XJ3)OU
MV>I(XO@[?A$0/CUUYE[GO+[6"EJ?5C[<O:9JV^)O+C_V8J/;DY1RY"1M[M3#
M4Y)5;TW$=ZVU-D_>8&UY-[S.\K%OTR?U*OO,E;7$WCQ_[:O$V [';!V,S/&0
M5L9B]+*VX_SH:(H59%_8\;#7E7N=\QO8:U%="7VU9FH11N3$\?P.!C,.$PN*
MQ$9':R8S'U:(<;@_S/IHHS(21N2VY)ZGKKS+EZ[==;LI2?6V_>9$OK6 T :
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MT4/I#S+\PO-?FJMOF>YE'8O_ )-K^7:['%.LZ<'<E-K@S8^NX^%!H T : -
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M*:\+59EIE'<1D;Y\FY>WS+*&]- :U2"+V*-'W/=6O&2&E=G[(P\T\@W9NT=
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MCS-5N#7>EC-YDECL72Q<0BJ1!20!),VS32D?&238$]?@-E'P&MQO2H2.A0T
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MV.P]-RXAC<HJ@[DD; =3TUIN[O;6%6[.,5UM&2C)F\./?:EY2S'MOD*N.X_
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
M- &@#0!H#G'[C_!UWS%@>.Y#BF4QO'O)?C_+3YKA&;R\-B?#3QY*J*'(^*<B
M2FKW?[N<HQZH)G@5IJ]FM7L(KM"$;TN3\VW?(^9VN:[%K]1:>3^&46J2A+JD
MO2G22Q2/C?FWRORWSER#<>7N:I_IK\524?BMSBZPN1_>C))TRDJQ?=;1XV?=
M?]OWFO(G"9SDWA'DL'(^+Q7Z,?(^ 16O*G#\YAK*I8*5[/&<8W,,+<K9"/\
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M,#QW T*^+PV&Q=>.I0QU"I&(J]6K7B 1(T0?O8[DDDDZ_*B2BJ+!(_HP36J
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M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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M_BT!JW+X?^(=G^+^K75M]Q*U+'(YK]A355F:OR^'_C^7\?A_AUU\HV6]RQ/
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M"!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
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M,!Y1\[8B63<?SG_Y:N>9-)O;_BA#PY)-E))*[-OLPUZ>U_(2[?>82S.O]=!
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
M- &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
M T : - &@#0!H T : - &@#0'D=S_#2<&^XOS5Q66-(:7+KV \Q\9]0;./Y;
MB*_'^3JAZ*[T^;<3N32@;E%OQ;_QKKR-U#3>?0\3..1O_P"Q_-Q56\Z^.IG
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M9Q>/51^U57I&YC6$*.G<?N6!SA]FCM+Y9^[B1SW/)Y$Q[NVP&[/R7R<S'8
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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MZ2O[JP""-0W%_9SY>K-E4OT5,'5-9MO)YNKJ]572M6+5G=+<5HTZXO@6^(.
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M-CY\Y_<:XU:UR3C9Y+^828_%W\_FY9+PIRW$D9$N1N$ENF*:3O[)\QC>4?\
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MTGB[EY:8G*GW+?=GXV\*8>[PWQ'XWXO!Y)R5"2&OF,G'#R.UPNO;@*0YF?\
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MCFGJ48VV Z#W!N2/AUUCXMW[MM^EI?:6BZ1L9^+]1)R+G>4.Q&^/Q=/'POT
M._OY6PZJ=]_X&_Q[ZRU7WP@NUM_4%&N2;] !^+ _)QOF&4!/_P U>05J9.Y
M.XK8ANWHH/J?7KZ ZQ?C/.44^I5^LR5N?X6.4L8I!O6\?8U"?1LAG<O<V!;<
M[I'=JIZ#I\H/[]]M8N,ZXW'Z$D9JS<_#[1\F3N; P\7X+5&VWS8B2V?4[G_7
MI[P)VZ?@!Z;'6.CIE-^G[#)6)]0N,WR=.D%K"4%ZGMH<=PT>WP':YQ_N*5'0
M$$';3PK;SU/M;^T>!)9M ^?Y@P"'E>0C4$'MJI'450.FRK7**H/KT&Q/4Z>%
M9_"C)6'FW[!M]9GI=C8Y/R*<;MN&RMK8=WKVAI&"?T=--,%@HQ]1? C7%L#3
M,H4RW\E/L#M[MR1NA]?PV!U:TR2]0\""Z1-</07_ +6[?OEDZ_OV8:.4F56K
M:S0XCQ>/ _[SKOO\7E)_QN>FE67PH<$4&.IIT^FB_I!(/]9(TJRZ(="'4-&H
M.OTL&VW3>)#_ %;J>FL&V9:84R0[^EK#TK0?^P8__0=959-,>A"R00=NPAB
MZ]!&@Z']PUC)NHTQZ$5%>)?X40?^,+O_ %]-2OK,L. Z2.,*-D7_ ,='K\?A
MJ5;)1%X51U"J#^( &@H+IZ']^H447UU&R/(4&L62(H%4[DJ#Z>H!_P NLF)4
M+@B?YB_^.C_>U"+,4$<>W^C3?KU[%_WM8U>0<5JR,GUU'$&@#0!H T : - &
M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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MD!4C2:VQ)W[=X*L2MN?^RUCJ*VHJK:1)/Q3DF0KG)\RRU3BV#B(:27(SPUP
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M=1PAH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
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M!H T : - &@#0!H T!0,I) ()'J-^HT!70!H T : X>_4"_\433_ /"^X_\
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M].']0')/GSY-CS2SHL>9]LE#=[=/&,Z+^9%85A)]'PU5::HG8^OK _10: -
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MVQQU,M2>U^4O-)(%6&*5<A,H9B$$I3O^7=ETW^\HW;>+B_9Q%Y.45<ABXO\
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@/@8_VT/\
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M0#>>&K+_ *=(F/XML'V_8PV<#^G6,H1E\2J1I/,C)L)5F!:*1XVV/:=Q(@_
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M:;GXO83 J,KQWK_ZC7P/_P V;WX;_P#DO33<_%[$,#/M=! T : - &@#0!H
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MF(V9202NX.L]Q+4[,NF:?N,KKU.W+IDOJ/I=UWG6&@#0!H T : - &@#0!H
MT : 3FAALPRU[$45BO8BDAG@FC26&:&5#'+%+%(&22*1&(92""#L=5-Q=5@T
M8RC&<7":3@U1IXIIYIH\WN2\9RWV@V[+I5R&=^U2Y<L7:66KK9R.7^VQK<K2
M28',T((Y[60\&132#\OOP*7XI#O!;7\MC2U6_2'R]^8UGF%NWR3GDU'F"I&%
MQO"[T)MY3_Q/+%T7\]OGU_3]NN0[B]YP\F67<Y!-N=ZQ!=[;-NLI1BL[/%-+
M^6L)8)2<YRGQYC.;Y# >4O'G+['!O)6-Q(BXCY8X8U#)#)<=O,M]./<GQ[M)
M@_(OCS(S%9SCKA>-'/U%*:K:[;*_9W.^0\K\Q;)[/F=N-RT\4_O1?"499I]G
M"JR;/SAY.\[^9?(/-X\W\N[B=C<QPE'.$XUQA<@\)1=,FL&DU244UE^ ^[*_
MP,U\']T'$QX]=&CK1^9^*17\]X*S;$B-+F8R?9/R#Q#8G/S2P\BB7$UV81Q9
M>VW77YT\R_*KG7*92W'*J[O8+&B_-BNN/WNV.+?W3]_?+K^IWR?YIA;V'FAK
ME7.W1.4G_P!M.73&YB[=<72YW8K.ZV=CX7-X7DF*H9WCN7Q>?P>4KI;QF9PM
M^IE,5D:DF_MV:&1HRST[E=]NCQNRGX'7U==M7+-QVKT90NQ=&I)II]#3Q1^E
M=ON=OO+$=SM+D+NVFJQG"2E&2Z8RBVFNM,D]8&\- &@#0!H T : - &@#0!H
M T!IK[$__!Z^YS_PK..?^!CR/KR]M^;=_B^MGAWOS'VL]&]=AJ#0!H T : -
M 81SKQSP[R1BQBN78:#)11EFJ6@6KY''RN-C+0OPE+-<D@%E#&.38!U8#;64
M92BZQ,X7)VW6+.+.6_9%;266SP+F4+1$EH<;RB"2&:(=2%_.<5#,LS$; ?ZG
M'M\3K?'<4S6/4=<-Y^-8]1HW,_;CYVX\9#_=>;,5HPQ%C"Y#&Y99 IZB.I]0
MN4)(V(!@!._3KN!T1W?[WK.B.ZMO[WK-993!<[X_W?G_ !#D&*" EFR>!RN.
M 4#<MWV:\:=FW7?TVZ^FMT=TW^%FZ-Y/)ID$N;7^W7(_:L@/^(JO^76U;E<4
M9^)U"CYFH(V;>2-MMAWIOL2=M_D+^FLU?MO.J,E.(T2Y!+_#/&2?@6"L?Z&V
M;6U3MRR:,TXO(=)*Z'=6/P)'J#^\?'6=#*B)A3W*K?B ?ZQOK$P*Z - 168D
M*50JDCW9%1MO\T L1_25&L9/ RCF=6YF)^$\"X+X\P8%2SR+#T.0\FL1DQV,
MA?S"Q[5YI%VD->.8-#U'S10(-@.X'AM+Q+LKLN#HCEC_ #+DIO@Z(4Q&"IXF
M,>VHEM%?YMIU'N$D?,L?K[4?[!U/Q)UTG2E0F]0H: 1FL5ZZ]]B>&!?\Z:1(
MQ_6Y T)4QZWRW$5MQ'*]N0?V:Z$KO^V63LCV_P"Q+:M":D(4).;<K<1\:P5G
MV6)7ZM8MX5/4;/D+8AH1GIZ'YNG36$[ENW\;2,)7(QS=!WD>'\8XN?J_*?D&
MA0LJ.\X+%3/E<ZX*AU0Q+'//6[]NT'Z<P[D?S -:/U$IX6(N77P-2N3G^5%O
MKX&+#S5AJ%R+"^&?&[7,S89H*>9S<$V7S=F0J0STL33>>=&(!8?ZQV;?Q1
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M! WVUK<<<&@*=@(_#T_:-8TH0IV'\=0&Y=; &@#0!H T : - &@#0!H T :
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M*MF:F#DKR\NS&6DQRUH,_:#+ 460N"P)5=MENU"U71Q(VV=\:V - &@#0!H
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M8JVN.^$)Z\\9(!*2PR!AT]#KIN_#M_XH_4;IY6NU?4?5WKT3L#0!H T : -
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
M- &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
M T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &
M@#0!H T : - &@#0!H T : - !WV.WKMT_?\- <'??W-._A&M'*"%3G?'B-U
M"[L<;GB?0#< $:Y=[3P?[2^LS26:)[BW_@L<<_\ 3#B/_ ?7UZ$/@78CW(_"
MNP>Y?$8GD&)RF!SV+QV;P>;QUW$9K"Y>E6R6)R^)R5:6GD<7E,=<BFIW\=?I
MS/%/!*CQRQNRLI4D:K2:H\BYX,P/Q3X5\-^!^-V.&>#O$OC/PUP^YE[7(+?%
M/%/ ^+>.^-VL]=JT:-S-V,%Q#%8?%SY>W2QE:&6RT1FDBKQ(S%8U D81@J02
M2ZL"*,8JD4DAUS+Q'XH\BY[@O*?(/C'Q[SKD_B_-OR7QGR/F7"^-\GSWCOD<
MC4WDS_!<OF\;>R'$<W(^.KEK6/DKSDP1DM\B['&,FG))M9=0<4\6E5!_R1^*
M/^4W_EJ_Y,?'O_+)_=?^Y'_*U_<OC?\ RF_W+^K_ ##^Z']_/RW^]/\ =?Z_
M^?\ E_U?TGO?/[?=UTTQU:Z+5T\1IC751:NDO\G>*?&'FKAV3\>>8/'G"O*/
M!,S[1RG#_('&,-R[C=Z2NWN59Y\-G:=Z@UJG+\\,O9[L,@#HRL =)1C-:9)-
M=96E)4DJHU)X]^RS[0?$_#>8^/?&_P!K_@/AG!_(N-L87R'Q7!>)N#T\)S_#
M6TDCL8?G%%<(8>78F2&9HS6R(LPB,]@4+TUC&U:BG&,4D\\#%6X)425&9K9^
MW/[>[N)\68&YX(\-6\'X+RV(SWA+"V?&'")\3X=SG'Y*TN!S/BS'2X-Z?CW+
M826G"U.QB$J35FB0QLI5=KHA1*BHLL,NSH+ICA@L,NHW+K,R#0!H T : - &
M@#0!H T : - &@(O-YS"\9PV5Y%R3+XOC_'\%CKF7S>=S>0J8K#8;$XZO);R
M&4RN3ORUZ6.QU&K$TLT\SI'%&I9F !.HVDJO(C:6+R/E'^\']9S[A_O>\LW_
M +$OT6.*YOFW*,E]1C/(?W7UZ<N/P_%\$)A1S69X%E<I##CN%\7H/)[+\QR@
M62>5_;PM=[,E"[+Y]W=3NR\':XOB_I[_ %')._*X_#L9]/T]YWQ^FI^A;]O/
MV68RYY(\XQ83[I_NMYM5R4_//*'D'$+R7C&!M\F29^3XGQ[@N51WY&_,S<FA
MOY_)))FLNDDQ/T=>U+1'3L[,MG<CN+<FMU%U4DVG%],6L4^O,QGL-M?L3V^\
MA"]9N1<91G%2C)/-.,DTT^*:Q.Z/(OZ=OV]<XPK8/ 'R!XEQZV4OT\3XRYOD
M\?P['9&&&Q7JW<9XTY(O)_&6*E@AMR1[U,/79HG*$]NP'VCY=^;7GGRS>5[8
M;QSHJ4NQ4ZJJ;3;[SK19MY'T7YY_I@^37G_;RL<VY6K#E+5JVTY6:22:3C%-
MPBTI-=V,<'0\HO.GVC^?_L^LOY+PF<F\@>-<+*UF3R3P_'6,1ROA-/=F:?R'
MP^&?(1/@(XMDLY2A)/1[ SW*M. [Z_4?D3Y^<@\YI>7?.MBU8W5VD5)XV9OA
MGC"5<FJ-.E,JG\Z/G/\ T6>=?E1K\[_*O=W]_P JVU9RA'#<V8\7155R"7Q5
MU)Q3UT346YX=Y"RO,L]0\U>&[F'X%]UG#\;))<@B5X^$>?.(1K':R/&N3XZM
M($MKD(X0[JA$T$X6U6='19*WN^>OE_LMUR]\KYE6_P"7;E/T]_.[LKCKI3G1
MN5AM]=*X)NL;OP+Y/?.OG/).?Q\R>7VMIYTL5_6;.CCM^:653Q&K;:4-U%1Q
M55J:56DHSL>Z/V\>=N+_ '&>+<)Y+XS6MXB2S+:PW*>*Y-XWS/"N98=D@Y#Q
M/,>VJ*UO%V7!CE"HEJK)#80".9-?A+S'Y?YAY7YQ>Y+S*--S9E2O"4?NRCG5
M270VNMG]H_('GGDGS&\J;7S;R">K8[F%7%_%;FOCMSR:E!X.J3I1M*M#=^O#
M/F8: - &@#0!H T : - ::^Q/_P>ON<_\*SCG_@8\CZ\O;?FW?XOK9X=[\Q]
MK/0+(R,9!%N0BJ&V^!8[]3^.P]-=J)!*E>(S@E:*174GU 8?YR[]0?Z-#)JJ
MH9+J&D- 6LRHI9B%4=23\-!F,&R40.P1V'X]!O\ N&^AGH8[BGBF *,-_BAV
M#C]Z[_\ 4T,6FLQ;0@: - &@#0"+UX9#W/&I/X]03^\@C?0J;60HB)&.U%51
M^"@#^O\ $Z$JWF-,E#[^/NP_3PVC)5G"5YXHYH9I/;8QQR12@QR*T@'1NF@6
M9X/8V"*S+:%I"\@()5^Y6[BS^X3L5(8-MOKV;$82JI8GO02>8C)AH99&8).K
M=Q_@<_+U/0%PVVWPUN>WM=:])MT1):/CRNB$R2H2HW[RA.^WK\J:UNS;X-F/
MAHJ>+P'JUF0?]BBC_*=O\6HH4R9DDUQ*+QU()%EKY&6&1=^UU4B1=U*GM>*6
M)EW!(/X@ZRT)YF6'$:W:< [/K<W).RENQ)E:5D[NWN[?>LR%-]AOTZ[:E+<<
MZ(FI+*@A7KX1]^ZY8[AMN$A$8Z[C<-[4@'74UVD1W-)-5ZV%W 0^\?@)K+@G
M_P!=CVU/]1UDIP>31/%;R9,Q^U"-H8(HA^"*%W_>5 WUD1MO,E>"<8B\@\_H
MX>ZS)A\?'/?RO8_81CZ(5K"!_P#M;6[3QP%]_D#]W7;8XW&XPJLV6Y/PK6I?
M$\OI[2*\J_<)PW"Y"QC<6S9>/&,:F.P>+E005(8%,,/UU[VVJ5)'$>Q15EEA
M'RE.A)^+\S\R<MY8G:C+QMU^&.2?[TLEUI5?4?>ORU_IX\[^>/#W^ZM_Z;R&
M=)/<7XO7.+_Z-G"<ZK%2EHMR6*N/(XDYQY/YSY,L18J5Y8\;/91*'%,##8%6
M:<NOT_NP1F:YF+W<!VO,TC*V_MA!\NOK?F7.N9\YN^#<;\)ONVX)TKPPSD^V
MO50_H#\OOE1\O_E5L9;[8VX+?0MMWM]N91\11IWGKEIA8MTK504$U\;DU4WC
MXJ^T#+9IJ^;\FRSX+%'MECXU4=1G+J;=RC(V>V2'$0MT[HU$EDCN4^RP!U[O
M*/)=[<N-_FS=NSGH7QO^)Y175C+-=UGT[\S_ .K3E7)E<Y-\N(0WW,\8O=W$
M_P!-;=:/PH82OR6-)/3:3TR7C1JCO[$XCB? L!'C,)B*."PE!28:5&!$5Y7V
M!=B29;5RP0.Z21FD<]68]3K[,VVSV^RLK;[6$;=F.27OZV^+>+XGX+\P>8^>
M>:N:7.=>8]U>WG-+OQ7+DM3HLHQ6481^["*C"*PBDC%9%3/&QGLVPQG&L8&D
MGL2&2.O'&I ^GB9?]-9F;925!8L0JCN[5UG*;C@OB/CMVZHM1BJW'DB-R?DG
M-<R@3B?"(I>#\+KCVIWPI]G)9)&?MDMW[S-]15@L*N_LHS2S#N]QI!T&F%AZ
MM=SO3Z\D<TY6K'\R^]5Q_3!?6=&^)/MT\$W:B7);C<]R\<<<MRMD9[>.CIN0
M-]\(DL%B2-9-U,DC2POTVUSW[^XBZ-:5].)RSW]Z?P=U>TV5SC#>%^#5X*%7
MQ9P#+\BMQHF,PT?#\%/,P?N2&U?E&/DL>P778#<S3GHNP[G77:A>ONKE)0XN
MON.:6XO<9RKVLT[3\+<7RLMO*<GP6+KV,@9)$P^ A&#QV-]S<H(HL.U6)'A!
MV5$^0;?.9"3MZD-M"B4EA[?28K<WHY2?O,%Y']KV&M=\O&^07*$A[F%3,11Y
M"N2=]HX[-<5+," [=66=OWZDMJEC;DTSHM[^:^->K T=F?!OE#BTZW,?0?(&
MJXE@O\<O&Q+'(NY5Z\'^JY9)!\"L/0_'6.F]'":U1ZCNM[ZS/";PZ_I0R["^
M5DM1IQ'S1C+\,T*]E'DS4)JN:QQ.X!R58PK-8C^78RI&SL1_,20[N-;@XXPR
MZ#/PVOYNV:<>CAZ#/:/#,G906.#\MQ'(,=+O)&:6102J"0?]8J*;$,<B^C;D
M."""H]-91NQ6#P9FMS&.%Q.+%+'"N:B+W,]F\;@J07>6;(92.I$$_MAC"JPN
M5W&_<X7KZZKO+@Z]AE^JM91K)]2,=_O#XZX>_=BI&\A<CCW,4L(]CC5"<=4F
MFMD213]K#<"$V6;;I[9ZZQ[\\E2/682=Z[@^Y#V_3U&1\6X-G^=9M>8^06F-
M78"GCI4>L)8%;W(J=2D6)QV'5B6;<^[.>K%N[OUOMVU$X[^YA9AX5CXNGZ9O
MW'2RR*@54"JJ *JJ JJH&P55  4 #H/AK:>45,_3U_R:Q8,EXSEJ=.6U':D6
M$V!$8Y7.R?R_<[D9ST3?O!W.P.W[M<VYMSDDXY(R76-^3^4N/X _1UIQE<K(
M1'%2H VI?=?81Q^W$>KN?0%E!WZ'?IK1#;MXW.[$-KTFO\Q8YE>CCR',\WCO
M%^$L(9J\>6+WN5W(6W0-CN+U ;\;'< F2.OV[[F0CKK-7K2[FVBYSZLO3)X>
MJI*/C@C#X<QQNA*9>(\/FY'D3Z\P\E2B\K/ML9Z/&H'_ "Z,!QW1-.UQUZ;@
M$'>.%V?YT]*_##ZWG[C=;L7)XQ6'2Q'*RY[DSQS<NY%DLV(NTP8\2_1XBIVC
M94J8VJ(:E947H/:2(;=-M90A;MJEJ*77Q]9UPVBSFZ^Q"U>I6J)V5H(H%^(C
M0*6_:S =S']I).E:YG7&$8*D4DAXFL'@R_>+]3,R%=#65U054['0"O=J/!%I
M09RY.A =GM1%AZI&3-(.OQCA#O\ XM72VC5*[;CG)5'V.BS><;; <:SF8&^Q
MFK49OIDZ]O\ ,F5)/:&_J6  UKDX0^.21H>ZC7NILG).)\EK],WE>(<1&^YB
MRV;K6LB%!/<4HXY[UHLI'HT(Z[;[:P\:V_@4I=BP]M#5+<W&\$D0EJ/@]>3V
MKO,^5\EE'22MQ7!IC8.[8'L-W+30,4!^(J-Z>FMD?U$O@A%=KK[%]IIE=F\Y
M/W!'D.-5V[L/XVBLR+L5N\QS^0R#/_PI,=CVPU8$_$$2>GJ/36Q;;<R^.;2Z
MDE[ZLUMKTDI%RWE\([<;;P'%H2"#%QGCV+I. 1VG_6_I1>[B"=S[Q)WW.^L_
MT$'^8W+M;?[!5\"&O/DLKN<UR'/9C<DLM[)V9H3N=]A%(\G8H^ ! &MT-K9A
M\*2]"1*L0BQ^,BV[*<+;#UE[IO3]DK.N_P#1K:K<%P Z>S6@1E4P5R1MMLD(
M/[!OVAAT^&^JDED/<(16>]E[&!Z^H((_?N!^&LF4D/J>GK_BUB0O%D$#K\-8
M@I]3^T_X?TZ#W%38_:?Z]0%PL?*-OVZG:4M-C]O^7_J:>X@K]0>AW_;K$%#;
M11\TBK_V3 ?[NHVEF4;MD8!_VS<_@H)_Q[;:Q\2/3[P3M#%<BR@7\MX]F;BG
M8>ZE&PL )].ZP8_90';XL-:)[FU'-KUBC)5N+9*M\V;S/'..@ ,\-O*0W<@J
M^ORX_%_7SL^WP*K^!V/36A[RN%N+?H^MEH"1\.K-O&F>YK94] R' 8/N.W\1
M#V,DX4_M@W'[^F$IWY_$U!>M_891BY?"FQ[8N97*P)0L?28?"J_>N PD(J4G
M8$.'MNA:6Y+NH):1Y#N-P0=8*,8/4JN?2\S?&PW\>70A=$2-%C10B( JJHV
M Z  :9G4DDJ+(<[]-_V;Z@*%@/4@?T[:IC5L!*@&W>O3]H)]?PU&L2I858H)
MXMANX]/P)_R Z).O47 2:PA8_,3^&P/I\/PTI04'$=A2HZ,3U_#X>F_7?6+0
MRP%Q/L/X3_3T_P!S0C%/>) V7^L_]32A4Q3W7V![0-_Z?]W6-$C',N$C$=0
M?V?]<ZR(+*[=OJ.GX^FL6L2BBEF'1A_B_P![1TR8% S_ !;^KI_D UBZ< *H
MQVVW/KJ4)U"@)]-SID,A5>X;_,>O^'XZ5KF,6**6Z]2?Z3HR9#A21ZD_X?MU
M*"C+P?V_ ZA,3,==!Q!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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MW_YK_9A^ESAN2_\ MZV8\LUL/>_^=Y\Q<K6]6_\ ;;AO';$?_LWDJG^M^?\
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M28NK\KJ$9<MI)PNNU+C[T)8JI^A%KTC - &@#0!H T : - &@#0!H T : -
M&@#0!H T : - &@#0!H T : - &@#0!H T : - </?J!?^*)I_\ A?<?_P#
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M .W*!1M\BK L?3KVE%4(4.W5=NTCH1MJ_P#;=1,3*==1 T : - &@#0!H T
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M\(^TS49-TXLTUG>;^'*+2?WDYQY \S9",!AC\-&O!.%F0GN>*3WX\EG&7N
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M,1K<KL68D@MCWP6A=9E]>Z%UF3;]C1%EV_IUDG'I12GO[;AB0?PV._\ CT[
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M?N7ZN,DSV>M7LO>K8XW3#6$TKF&LD<2GM10,HQ4(J,<D#=.L@&@#0!H T :
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M=[ZV<NUM6[L[BN13H_M/0[ZZPGJ5?_LE_P#0>W6Y7[B7!G6^6;6>6J/8_MJ
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M&"C+AN&T9!L]/C=<U[;KOT%K)*)+L\@'J388'\-6/EV^W6Y*#?6V_92AL_\
MSC<GMKN6MS)]D$O7K;]@PA\>5"YGM77M3NW>\LT9GE=SU+,\LI4MO\>W?75'
MR]7X[N'0H_77ZCDN?-7PFUM-BJ],[E?]U07O)^+A>'38R&U.-A\KRJB;?#80
MQQL!M^W6Z'E_8Q^/7)];I[DO>>7N/FMYHNK3MUMK"X.,&W_ORDO82];CV$K,
M#%C*A(Z!I8_J&'[0U@RL#^WUUZ%KENPM+N6H572JOUNI\:WOG/S5OZK<[_<:
M7FH2\-/T6]*IU4H2=BY0QR(+$]>JI&T49949]O[,,*_/(1^"@G77&-%2*P1\
M8O7ZR=V_.LWFY.K?KQ9)8'#\QYB[)P[AV:S4:,4DR$E=Z.*KD#<FQ=G0QU^U
M3O\ S?:&WQ'J,;ERS:_-DEU<3AGOX+"VG+V(G[?"<7A%$GD;RSQGCC$['C_#
M5_O3G3*"0:4TM*7\MJ66] WUZ]3_  D[*=2OSG^1:E+KEW5[<7ZCEN;V_/[R
MBNK[3,>.<7PTSI/P#P;R?ETS=K0<L\LY&3#8S9@Q$XQ2RXEK]-MP?Y=B[O\
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MJI'%&B *   !L-:\6ZO%@NE8E"$/S?T[[?';]NH!*)I.S9M_4[;_ ,6W^]H
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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MZL<B^L*2>]8'[X(!),-_VJ!JMT& \Q=/F/)0K<5X+G\C X!3)9*-,)B64_\
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M7^D^NL7B$B]8D#=W4[?#]OX]-3%"E&*EPA&PZG\.G3]^IB7#/@*B5>WN8A%
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M<;=P(W!V'3J-826)A)48[/0=/PU"#:*25I"'!VV._3H/PU&Z9 <]P'3?2KX
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M &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M5)WV';-%9R+8NI9KDG<'O8,.A._I'#<M?S+D(+JQ]U32Y:L75OK,FH<I\IN
M.-\+\7>.H4*^U;,3YS.1;CH94@IO2FDCV]?JAN?C\=:O VS_ #9W+G5DO?\
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M\?W?'\-&D"V29E VZ[_']W[M3"H!6[E#>F_^_MJ8I@4))4J?B.A/^[J M3=
M1^)W_P"MJJG$!W]=M]]QM\?\NC:!$&$I($*[%F"AMOE()VWV]/Z-9J6!L35#
MM[7.8!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
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M/9M^WKZZE4!RSJOJ1_7M_CU5B!%PLFW</3T(.QV_#?J-NNC2](*M((TW'15
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
M- &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
M T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &
M@#0!H T : - &@#0!H T : U'Y8\'^.O,V*_+^:81);D,3QXSD-#VZ?(<07(
M8FCD?:D+0EANT$RRUW/5HR0"-=RU"ZJ37IXA-HX::E]Q?V:3&7'M-Y>\'02=
M\M9A.L^ IEF=_P"6IOW.)NK.298Q9QCD]SJLC@#CI?VN7>L^[[/<982[3MGQ
M!Y\\<>:\;]3Q'+B/+P0K+E.+93VZG(,9_"'>2G[CI<IJ[ ?45FE@W8 LK[J.
MNU>A=7=>/1Q(TT;HUM(&@#0&GN?><>!< :2E;R!S.?4^VG'L%[=V^LY/:L5V
M17%7''N(W65Q-L=UC;TUT6=K>O8Q5(]+R]'28N21SIF^9>8?)P>.6T/&?%IN
M@Q]!YCG[D#$=+=H&O=.Z[JRDTXV!ZQ..NO8V_+[5O&2U3Z7EZ%_M[3!R;+>.
M\'XUQCLEI4UGOJ>YLK?VM7S(?5XY&41U223_ *)4)!ZDZ]%0BC'$R\RKZ[_X
M?T;ZR+1EAF'P_P /\FA*(L,Q^ _P_JTQ'=%XH;4_5$(7XNWRIM^\[]W]&^L7
M)1S9:]")**C&FS2L96'P'RI_4#W-_ATUJ=VN6!0NY&CBJLEN]:JT*<"EI;%F
M6.O!&NW]IY"B@GX?$ZUU;'::WBY]E^6SVZ/B[B][EST@YR'(;17#\-Q"1KWR
M39'/9&2I2B1$!.SR1%UZH6]-:[MZU95;TDF\EFWV)8L8OX36>>S7#H;/M<UY
M9D_,W((W[AP7QK/8P7CVC*O_ &K,<T:NMS+1J7&TF-@ '8=['X:=6ZN_EQ5J
MW^*>,O1')?VO490MN;TQ3E+H1Q9^H)]WGE?[7_LU\V><>+8/B^&PWC+#8/*T
M?$W%39XO@L\V5Y=QWB[Q\HS^,,V=RLZ5<R97DGGM"66,'9=SKGW'A;2S+=4=
MV_%9S=>/!9+T)';^BN1MNY==$N"^M_[3Q4\-?J0_JY^5?'7$_*GA_P#2TX#R
MC@'.<3'FN+\KJ>6*%=<WBI9984MQIF.64LK%&\L+CLEBC((_A VUQQYAS*]!
M7(V4X/+']IT6==N-;-I4?'CZ\S>O$?O;_6IRG*^,8SD_Z6?$L!QK(\APM#D.
M=C\N8*S)A<';R5:OELLE=.9RO.^.H223! K%BFP!WVUE'<\R<DI6$HUZ?VG0
MKNYKC!4[3WOUZIU!H T : \N_M<^_OE_G[[\/O/^T7,< XWQ_CGVO_EOY#R_
M&Y/*6<WRCZ[(U:3?F]&THH4_;2<L/9)W(UQ6-W*[NKFW:24./2:(77.[*VUA
M$]15^/[M=C-S(/DE*?(8')5*P+3R11/&B_Q2&">*PT:CXM(L14#XDZV0:4TW
MD:-U"5S;RA'XJ>YU,RY+@F\LY>KSOQOG>+Y#)9#CO&L3G/'N>Y!C.,<EXUD,
M!@\=A;%/$1\@M8VEEL&XQRRQ302LP+E70.-VQVNZ?+D[5^,M-7223::;;QI5
MIXXIH^/-:GAF8\WASR\GSY'C_'N/UOF[[V?YWPK&U8U ZN?J.01S2HK%0QC5
M^TL-]MQKL_UK;/"%7+JC)_430^)PI^I%YGL?8W]F'F3[E<1S/QKY'Y[XY/CP
M8/QGA+F>RF(S7]\?*G". 9,Y;F&*IU\?BQB,7RF>Y'[,UGWY8$C'1RR\.\YQ
MNK=B5ZW:DH1IC+NYM++&7'J,HQ3=*G1/VK^8L%Y6^W#[??,^+\#X=.6^6O"/
MB;R?G+OD'D.1Y/@<9FN?\"P/*\O0P?'H8\%3M8C'Y#+R1TY;2VI)($C:1=RP
M.JW*]NK4;MZZXJ<4],%3-5^)U?N.BWM;UQ]R.'2SH+(\C\D<DJ+C\YSF]CL,
MBF-.-<-KU>*8"*'M"B'Z+#5Z%6Q$%&VTL+-M\=90M;>VZP@G/IEWG[3LCR__
M *LGV+#V_L,?H\9P>/[37Q\+2+Z2V ;,N_\ G!IBXC;_ +$+K9*<Y9LZ8;:Q
M;^&*KUX^\GUZ=!T&VVPZ#8?#;6#.F.8HGQT19%^J8E=^FH5.B+P=P-8FMMU.
M$?O9^XG[D/!#>%4^W#[?Z_G^3FODBMQSRC#^86JLOCKA$@IF?EWMTIXFD,?O
M2[+)NI]OTUIO2W$-/@0UU>/4NDY[NYC9HJIL[ZH<:Y_FJ/YK#@:O#^.,VW][
M/(=^#B^'["I*R0+?>&S>#$;+],EG=NFWKK.=ZS"6FKE<Z(JK]GUT.:YOI/\
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M-*OKQ'R4@Q[IFEF8  &5V[0!Z!1ON%'X>FJYI+NT1N:62'7M")NU0J@;;A5
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M3$%5/8-E "_A_P!7U)U0-H[4KR=I4 $GT!!4#?UW)&I3I [[SMZ=?Q_ZFI1
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
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M'0GM/[=NO^/666(&SK%W=SL-_4@L-C_0>NF#X 0L7X85[B6<GHH /4_'J=@
M-*4 FF0$D89%(!^#'T(]1L/74HO2!">S+)$ZHP5B-AL-OB-^IW]1JZ5GQ Q@
MEDB#B=^T,1V!I !T![B!OL-]QK)(9Y"XL1N2JLI8>HW!_P"N-'[""*111LS*
M &;]N^P_ ;G<#14H!&6U[4HC]LMOMU!ZG?\ S1MUVTKT MN2LM>0KN"0!O\
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M_P!VL76E# JLA<;G_>T3HNL%^^I5@[>UJ*&@#0!H T : - &@#0!H T : -
M&@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H!.;^ _L(/]
M&@&!;\/Z]2IDH]);H9$FFY1>[U[1O_5\?VZIK9=H T : - &@#0!H T : -
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M8E3?8@CN4]-];I>8;LO^6DOXOV$5I(ESY<^T0_\ TQU#_P ,[E'_ +KM:_\
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MY#:F?Z4&>?(7+D]B1WDD=I&9CU[;8V=K=E<M5[R2IP5.CB;;=F%N3E'B:O\
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MV^VYW(/S?Y-3)5!(: :SP)*0Q8JP&W3KN-]^H_ITI4%QE6&/<_PHH Z]3L
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M';IM_3I2H.Z=:2AH T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
M- &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
M T : - &@#0!H T!3N!Z @G\-QH"N@#0!H T : - &@$?8CWWV/[MSMH6K*B
M&,'?M_K)(_JT%6*Z$#0!H T : - &@#0!H T!'M/)W;]VP!]/@!^W\=0SHA^
MI[E5OQ /]8WU3 KH T : - &@#0!H T : - 49E4;LP4?BQ ']9T!70!H T
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MI)42"/?Y4)94_L@#IKKA:MVHZ;:48]6!CGBS(A955"KLJJ JJJ]JJH&P  V
M  UE1C O%KIZG^O3$H/,)%[6V(/X^O[P1ML=,NT5H(>VF_\ I&VW_P"#O_7M
M_N::BZF.UDC1>P %3ZCUW_:=_74)QQ(V]R#$8D;6K,4,C;=M>/\ FVI"W\(6
M"(/,>XG8';MZ^NIUU)@9=BN&^2N1T6R\>(H<!XL@5YN8>1KB<?I1P-N?>@HV
M-KDO<BEHW[&B;INPWWUQ7=_8MRT1;G<Z(JK,M+?81MFUX3XQ)[MNUR3SWR2N
MVWS-)Q+QU2LKT(#$FY;['/R]HDKV%7^SOUU-[_<?ALV_[TOL7L:,X6W-T@G)
M^P@\WYG\@9JI^1XFW1X-QD,WM<:\>4(^.4(XV'9M8R,0&1GD>-0)!WB*0]>T
M>FLX;&S;>NYW[G3)U?JR.ZWL9/&XZ+H7VFOZ^)2-F9MEDD)+F/NDF=FW+%YY
M"\A[B=R-R#KJJEED=ENQ:M_!%5Z>))K0[-NQ!&/B?XG/^Z/ZQK"4]61M9+Q0
M(JKO\S #<GKUV_#TUA45=>H59XD!>1T2-1NSLP55'XEB0 -]*5P(VECP+L4,
MAR"U^7\5PN6Y+=.Q]K%4Y9X4!W DFM!?92 ;=7'<JCJ>G74FX6HUN-1CUG+/
M=VHX1[TNK[3/9O&L^!@.0\L\^XSXTH!%E;$U;,.:Y,R%>\(T$#L%60=H$B%>
MSNZCX:Y?U7B/3M+<KDNFE$<ES=W9<5&/M)C!6N*5'5_%/A_*<QN;CMYUY4F:
MEB"0$VFAHSB/Z^N)3W(]>*:0;=>N^TFKK_S-U07X89^O[6<KDVZXM]+,KN\9
M\C\P*KS[R+>CQ1 ']UN"PIQW"QPKO_JEFV4:WD84'176*M( /7UUJC.Q:=;-
MM:^F6+_9[28O-F18'A?$.)?S,'@L?1LD=CY)HS:RTX*]I%C+7&L9.P"-^CRL
M.I_$ZD[MRY\<G3HR7JR%$LC)F"2[,P#_ ('_ *WPUA@BB<LAC0LO;L-A^/J=
MM]AI4%D-@R D@=#MTW&_]>B=07,>[?;H2/7UVZ>NJ!K%$T3,3\Q(V&V^VWKU
MZ>O33M8*FPJMVLP#?@0>F_[0-M*H 0I;O[0&_$?]?;?0$?=LM"P!<1H5W[B>
MW<[G?9B1Z#\- "Y"(QHWS.Q7^R-AO^.[;=#_ $ZNB;?0@,K5J6=>V/:/KN"W
MS]=OP^4:RTM+$@Q1Y8XV]^8MONS[;A  /@H ] /PU4J8H"<=N&9BB]VX!/S+
ML"-]NG4_CJU;=$!3=5W"*%_< /\ $-3! BDL6'L]I#@=VS*1\JIU_>/3X_'5
MKB"1+ :M6\@,9X!.X;O*C;8@#?<#\#TVU*)O%X@4>58$[F8]J@ ==R?@!U/4
MZKHD"Q+"RKWIN1Z'?H01\#Z_CHL>P%))'",47=^T]O[_ -QTT@:UC/LWO%MM
MQVA_7?XGKUVU$Z <=P_$?UC3$#-8(HY#(@._7;<]%WW![1Z]0?COJ\,0)SWQ
M"X3V^[T+'?;8'\/7<[:E*]@'/N=P!WV! (!Z=#^S5[ -K2RLJ^T6Z$D@-VGX
M;'U'IK%@OC9A&HE.[[==O7]F_P -P/715X@JY1U*D!@?4'X?U=01I[@(;)"C
M%5V507/J2=AN?4GX#5JED#&CE9Y9NWO:-"Q"A6(_';<#;??569M44D3E.R9D
M8.?G3;<^G<IWV)^&XVTEF825,BV6)VE[UD&QV_BW';M_F[?A_1J:>)B.FE51
MN>G[ST_KUB_8!-O;F [P& ]"I/\ 5T/IJ@)91'&6 V"@ #_$!^S4IT@0KV#+
MW]-BI'4>A#;[=#O^&G:!QW[[@-U/^'34HJ 9PPR)*S,X[>HV&_S ^A/]/7X]
M=2J6119YHXR%=P">NVQ/]>P.VH"NT98.0.X= VW7_#KJT: VL6C&55-NXCN.
MX^&^PV'[=M,5B!Q'(3&K. &(W*C_ !=#Z;C2C8$YA[J]N_;U!W'7TW_=TZZM
M$LP70*(U*]W=U)W(VWZ >FY] /QU'T@!8C9NQ6W;K\"!T]=CMUUCBP7*VV_0
M;'KT '75 V:6<3  ?R]U]%W':=MR6VW!&IP Y[^OIT_QZ)4 E*BR,&W/0;=/
MWD_']^I1O,%)9A!"SG^&-1L/Q(Z*#Z;[G54?658NA"^_[Y+L23OU[OA^&P]
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ME= &@*%@O\1 _>0/\N@*[[]1U&@#0!H T : - &@#0")@B9NXKOUWVW/;O\
MNT+5BVA T : - &@#0!H T : - &@$)X!.H'=VE3N#MOZ^O3<:%BZ"RJ$55'
MHJA1OZ[ ;?[FA,\2N@#0!H T WM2F*(LO\1(4'\"=^O] &JBK$A_>E#=WN/O
MZ[]Q/^(]-M4R)N"0RQ(Y]2"#M^()!_KVUBS!X"N@#0!H T : - &@#0!H T
M: - &@#0%C21J=F=%/X,R@_U$Z"C+] &@#0!H T : - &@#0!H" R<+)-[VW
MR2@=?P=0%(/X;@;_ +=4V0>%",T,S(L= 8H2SKVO(>[J/F" #M!_#XG^G4-4
MG5]1(:&(: QKE?,.-\(Q$V;Y1EJN)Q\6ZJ\[$S69@I<5J5:,/8N6G4$B.-6;
M8$[; D9V[<[LM%M-R(W3,XDYAYEY[Y8-C&<.6SP?@LA:&?+RDIGLS#NR2HLD
M#_R()!T:*NX7H5DG8-V:]K;<OA;I*YWI^Q?;],#6Y5RR(+C_ !G#<:@,>.K@
MV)%VL7Y^V6[8)V)#S;#LC) /8@5-QOMOUUZ:21"?9U;HP##\" 1_4=99 ;2)
M&Z[ !#\& ']1_$:5838G7Q]FU,L,"M-(WHD2LS;?$GILJCXDG8:DIJ*K+!%J
MV;$Q/$HX$23(OWL-C]-&Q[ ?7^;*NQD/[%V'[2-<D]PWA#UBGK,K:2"K#ZQ5
MX(EV_L111J/_ !U5'77/BWTR+D1D_,<#R'P;]UV*Q%U+MC#^)+[WFAW:*,V:
M><1(Q(-T,@:!NY=^Y=NHZC?Q>?0E"W:<LVY?4;+?$:^"/$*^6OLE\!P-A[_)
MCQW*>1LG%Q:MR&MQ?'9RQ-Y%YE##%G,S+'8LUL9 5+,*T3V&8CM*C<Z\SEV\
M>TG+O**DJ5IJ:[%T]N!E..I".<^U[[D>84H\)E(>(<2X-4E9\?XZX/F(,/QQ
M!WJRSY/V4$V8O,4!>>TT\S-NP=-R->U;YGRVU+7'7*\\YR57Z.A=2H;+5JT\
M;[:CT+ZW].TU1][7C_*>,?M*\/<-S%6G3O8WRME97KT)ULUE2[B>4VXBLR@"
M1WCF!8GKW$[]=>#S#<0W.ZE>A5Q:6?4C.Z[;G_*5(&U_N]=$\R7>YE7? 8+;
M<@?]HEU\@Y/_ ))?Q,]+:?DKM9RED,OCL5#[UZW% I!**6[I9=OA%$G=))_0
M-A\=>LHN61MN7K=E5N-(D<;QOF?),4O(2,5XXX.YV7G7/[(Q5.Z".Y4P&.,<
M^0SEB1 >P58+*$C8LAZZUSO6K<O#5;E[\,<7Z7DO2T>;=YA.6%E:8]+^I?[1
M*IDO'F!L>YPCBMWR[R.(]K\^\GP24>%UYD+ SX'@T<P>[ "P*C)3S,C+UK['
M;6ZWM-]NEWWX5KHCGZ9_^RO2>;*XY2U2;E+I8WY!:Y/S::"UY"Y5D>2?2[?1
M86)QC.-8M54HD6.PU!:M&JL:[ &*.'=0 P.O4VW+=MMEW4J\>OM>;]9@VWF-
MX_I:40@J00UH5](H(TB3]Y" ;L?B3U.N])15(JB(,IKG[=4$'>RL-6)IIY0B
M+_2S'X*B^K,?P&L92C!:I.B!FF%XOBL'B\;Y(\NUK"XBRRV?'WB]&]O/>1;4
M;LL%[*1COFP_$%G51+/)'W68R4@#=RF3X_N][<W5Q[;:9+XI<(_;+JX<>)G&
M/%XMY+I*6+F=Y1R#(<VYA/%8Y#E52.*K GM8[ 8R)0E/"XBMW.E2G3@ C55)
M[0/5F9W?3&$+5M6;7P+UM]+ZSV]IM?"7B7/S7[%T?;]*N"_X:R4>D[CQ-_4Q
M_4S\]?9S]P?VY_;WX%\"<1\X<Q^X7$6C@,9R#D>0X_D9^3-R:'CN)P>.DBFJ
MXP+D)9Q_,L2QJK'JP'77G;W?7=M>A9LP4I3ZZ8UH<UZ]*W)0BJMFG9/OL_7"
MBCDE;])[B96-&D81^7<)-(512Q$<47-'EE<@=%52S'H 3K5^KYI_^CKU_M,?
M$W/_ $_:="_I]_JS5_NV\Q>0/M9\Y^".2_:Q]TWCNE:RMOQKR?*6,G5Y'B\?
M]))E'Q<V3P7&LMCLUCJF1KVS1FK3)9QLJW*UF>$2>UNV?,/U%R6WNP=N_'@^
M/N_V8F=J_P"))PDM,T>Q>O2-X: YX^Z_[F?'_P!G?V^^1_N0\HU.19#A'C2E
MA;.6QW$J%3)<BR-KDG*,'PW X[%5+]_%T6GO\AY%4A+SV8884=I'<*IUIW%^
M&VM2O7*Z8]&>+H8SFK<'.62,33[@N=\Y^R/"_='X;\63<I\A\\^W#C'G#QWX
M<L9)KEC*<@YGP#&<UP7 Y\O4AQYMS>_E4IM8CCA]QE+A4WV&OQI3VOCVXUFX
M*2CVJM":F[>N*Q<:T)[[:/+WD[R/X+\:\P\Z>,)O%'F_E-'(-ROPYC6LY6_Q
MK*Q<ARV-QN-3O>:P\M_%5*UD*[=Q^HV /0:MCQ;EE7+T=$J8UR1S3W=NW'^9
M^9T+%G4=[AV6Q5:+(^6.2T_$^(GB2>OQJ!5S?D[+PN.Y(ZW&ZTJ2X<3@=OO7
MWIK$Q&ZL.FLE>C)Z=K%W9].4%Z>/8JG!>WMZ>"[D.K/U_P"P1QW-$P2O!X<X
MC%P*.12DWD#EC0<C\DY%'7LE>G/- ,=QI+$;;.E*&,ML&$V^MOZ2=W'>2U_N
MK""]&;]/J.*O1G[2#AQ=9[LV8RUJYR#.69#-:S&<LS9"[/.0-Y6>R\OSC;HQ
M[G _M:ZXPC!:8)**X(GO)X6O^%_5K('F!]K?Z@?,//WWX?>=]HN8X#QKC_&_
MM?\ RW\@YAC<GE+.;Y3]=D:M)_S>C:44*?MI8+#V2=R->;M][*]O+NU<4HV^
M/29.-(I])ZC?4_OUZ%&8X%PL]/\ ?.VHQZR[ZH!2Q8!5!))/10.I).^P &H,
M!I2R5O-WUP_%L3E>5YA]MJ&!J37B@+!?<L3Q(\4$"D_,Y)5/[6PUA.Y"U'5<
M:C'K&+R,]N^/3QU%L^9?(F'\>1,BRKPKB[Q\EY];C< K#(M(S5L4TW< DY,D
M6X/< !OKA>]G>PV=MS_>>$?;G[#+3^)D6GE+C7#-X_$/CK'<>MC<)SWR"(^2
M\YF?8]MVECG]ZA@[1]=D[Z\AV)74_27K^.ZN.2_#'"/I>;]YTV]K=GC&.F/2
M_L-:9S+\HYG>7)<KS>5Y%;4DQV,[:>:" -MW+C\2A%&A"VW6-5,9/7UUTPM6
M;"TVTDNKZWF=]O96HXW*REUY>K_:$./B 0OO,5 5>[98T _LK&/D51OZ>@UD
MY]&".M))42HB4CJQG8MV]-M@H&WK^.L*\0QUTB'R*!UVZ]3U_K.L7CGF*J@T
MGRE.NPCEE[[)V[:L"O8LMN0%(@A#R!6)VW("_MT2?H-5R_:MK^8TGT<?4;!P
M_B_R+G:1REFC0X%QS8-)R#F]N+%JL1W/=%1<^^2\8+1ML\;_ -6N>>ZL0>F+
M<[G1'$XKF]D_RU1=+^P?8['^(,3<:OC*O+/N"Y558K)!BXY,3PRC;4*>VU>)
MBKU&1FW5GD6&8 ? C6+>[FN]IL6GTXR.&=R4W6;<G[#9B_\ *SR"NN,ESF"\
M1\:8DIQKQO2A7+=C  BQFY(EK4[; ?/[:VXY"?P.PTJ&T@]34KMWIF\/5_L,
M>\^I#W!>,.%\>G&1@Q*Y/,]QD;.YZ63-98RN2SRQ6;YE2BSD]162%#_F]3JR
MW$Y]VM(]"P0HC-)IY48!1ON-_P"'<;[D;>GPVUI:KV%%MR?7^G]^I6C WGC,
MG;UVVW_IW]?VZN#[06J B $]%!)/]9.LDTE0%J21RA@I# =""/\ <(Z@Z,%>
MBC95_H V'^(:QJ!FDTIL.#N4!8=OP '\)WV]3J@5DL1I_&ZI^S?=OZA\VBBW
MU@B)IXC(60,P)WV([1O^P[D[']PUEHQQ8J-;64DC7=F[>[<*D8V)VVW^8[D
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M.>Y1_3_CVUEE@#O#6@H: - &@#0!H T : - &@#0!H T : - &@#0!H T :
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MF,+G.*\9"'Q;QE^:<E5F][RYY0QZ2TZ\ZL0MGA_"K+V\?3]EU5XI[PNVD/\
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M5Q6A/B<Y_IP2D?K2_JU-_G?W?]?_ $_X[7/L/_RMN?1[RR^!'1GZ9'WB>?\
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M5Q?K?2=\?I!_>GRS[\?M Q/EOG^-Q%/R7Q#G'(_%/D._AJQI8G/\BX[CN/\
M(*O(*.-+2#%OEN,<MQ[VH(F]A;OO&(1Q,D4?7L-[/>;93N?&G1TRPIC[3KL7
M'=MZGFL#U82)5V)^8_M]/ZOPUUFT6<J$+.ZQH@)9FV554=2220% 'Q.E*F+E
MISR+\/%E>2VQC>(8/)\GN[J&&,KR/3A#$@2V+Y4P1P;@[N.Y1\=M2<K=I:KL
ME%=?V'+<WMJ.$>]+JR]?^TV)8\<8;C$:6O,OD?&<6+]JIPOB<@RO*)Y7([*E
MB6 RK3L2[@(P+QN3MMOKE_57+CIM+;E^]+!?M.&YNKL\&],>A9^LS?CMW*TT
M$?ASQ1C>"5"-QSSR1&;?)I@?6S0PTL<]VK.XV/8\<=>3U[_CK3."DZ[NZYO\
M,<O2_HSFJ^"'D7C5>07ER?DCD>=\B9%3WB++SR4^/U6'K'4X_4F, K,?6&Q)
M93]FJK^A:;$5;CU9^L4KGB;3JTZ>.JQ4Z%2M2J5T$<%2G!%6K0QCH$B@A1(H
MT'P  &M,I.3JW612WVU]SW!OZ]VQ._7U]?7UUCIZ04FL)&1W[]?0*-_3X^HU
M51 O5U90P/1AN/\ K:N;H!O.\G8?:!WW&Y'\6WQV_;J..(+(GD9/YHV(.P)&
MQ(Z>HZ:BP!>P#J5WZ$;'8]=C_7I4#/NAJ]Q:5>X].W<%MOPV W]=5*OPH$1-
MR!%F,,<+'YNPR,0 #OMOV DD;_M!UEH5<14MDM3R;[N5'X+\H_Q=3K8E%<"$
M)=$[R+[?>4"C?M.P[^YMR>H).VVJZ@?(^R+W_P 04=_IMW;#NZ[^F^I1@1F$
M<Z;-L5/52IZC]JL/^MJJ@+ T<,9V!"QJ3^W8 D]=^I.L@(075L%PJE>W8]3O
MN#OUZ ;;;:Q[0+%M_4C^O55. (J.*;ZIG/RHCLQ;?964[[ ?CN/ZM3+(#Z2>
M./;N=5W].Y@N_P"[<C2G%@2=8V8.ZHS="&V!)_#T'4:M$!*S9]F/O&S,6"CN
MW Z[GKZ? :8K) (+ FB#D '<@A>H&Q_;^S2K8+;"M-$\:MV%@-CU^!!V)'78
M[;:4]8&M.O) '[V4]Q&RKN0-M^NYVZG?2M,P+&Q#[GM>X._J.WKZC?<;[;;]
M-8U8+%2*-BT<:H3T)^.WX =0!J :6+<L,L:(O<&'7<$]Q)V 4_B/]W0#XN2.
MO3]W^_H!C:B>94]LJ2I;<$[>NVWP_9J]H+XS[$ #MW%%)8C?8?'8?L U<?0"
MR.PECN"[]-NY6'38_B.H(.VBH"_HHV   ] -@!\=@/34:Z 1U>U++/VD#L^8
ML-MNT#TZ^O\ %L.NHJ@?EQ\.NJ!DU<//[S2';N5NT#XKML V_0=/PU**H%9[
M*PJ&??8G8!?7_*/35=.T DJRHLBGY3U!/["1Z?#8C6/ %+,DOLN8M^_8;=HW
M;^(=VWQWVWU%0HWJ&4JYE]SU':)-]]QOW;=W7;TU6Z$%W+=1OMN" 1_AZZJ:
MIU@;PQ"$D@[L1MN1ML-]^@_HT:J"Q[:1R=I[B1T+#T&_P/4:@'!._4ZN0&5O
MWMT]LMV@;GM.QW_;L0=MM2H',3'L7N/SA1W>GKMU].GKHP4=5G3;NZ=V^Z['
MJ 1\=_QT=*8@%"1J$7?8>I/KO^)]-3-8 2BM+(Q7M*D;[==P0/ZNNHJU*.=]
M,0,VCE^H#_V.X'NW] .O:!OOJ8@<^XH/4[;] 3L!_EU<4"R2.-SW-Z_L/4C3
M%@MDF]M=P!L-@ 3_ %:-)+K!=#,)5WVV(.W[#^T:G"H+V8$%0?4$;CX;]-]_
MV:@$8D>,MWL-CT 'J=O1OV#3(!(E=G ?8.?P)&^_3KMTW/\ 7IJ?H+5K OCK
MPQ$M'&%8^K=23^/J3IJJ&VQ.:9D8*H'IN21Z]?0?T:5(.58]H/IN 2/Z-]OZ
M-2J!;,#(BA?@>H^!Z;;_ +]2G$%R'VTV)WV'J?0?$_T:40+A+&X(![CMU&Q'
M]/7X;Z4KD"Y2J[] /V#5: G'-(9"OHN_H0/3KU]-_AK"G24<@['?UTIP DR%
MG[BW3\/Z-NFE$!<,J*68[#?4>8+^Y2O=Z@#?]HVZG^G2H.\-:2AH T : - &
M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M: - &@#0!H T : - &@*%0?70%A38$[[Z L7U'[QH!?0!H T : M[5_#2B!=
MH T : - &@+7.RL1Z['0#'0"<@)7I\#O_A_7H59B@]!^X:$+2WX:A4NDLT,Q
MU6)W<?#H?Z?^KHC&0[U3$- &@#0#61I1+LN^W3M '0^F^_3\=0R5*#K5,0(!
M]0#^_KH T : - &@#0!H"(G+>Z_=OT8[;_YN_P NW[-M9+(R61)P]WM)W[]W
M;UW]?V;_ +=M8F(IH T UM+*P7V^XCKW!3UW^!/[-"JG$7B#"- _\0'7KO\
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M%)Z11HD._41J=>QMMAM]M'3"*^K[7VLUMMXL5DMJJA5V55 557HH4    >@
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
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M".-%'P50 !N>I_$]==>")WA0RK^/^']&^A:,L,P_P_ZXT)1&>\>X9;R 2WE
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MV>:2/L] #KOVW+K>UNSO0;BIJE,_VGHV]G!4\3O->HY(^ZK]&?PE]S/G2_\
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M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
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M4P46Q&TAB&_<"1N0.TD>NQW_ &:C?0!(TX-R=F&YW/S;#K_1IJ9GJ8RDA G
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MH T : - &@#0!H T!:'0L5#J6'JH()']&@ZR[0!H T : - &@#0!H T : -
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M5Z$\E[%PL+$*I.H4@, 2#S;FY.W%.&;94JGOWKI(&@#0!H T : - &@#0!H
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M,:((]NT1@^I]7.WXDC?^OTUKE-M])42T0C0[(-C\3ZDCU]=8R[RH4LMWZ=%
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MEBG%XLVD"D2 #^%%  &W\*C]FP]!K11E$TG23?M&^W0@^O\ NC8Z9 H[; [
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M+67N_?\  ZC506>V?Q'^']&II H  -AK(%= &@#0!H T : - &@#0!H T :
M#TZGT&@$1/&S=H)Z^A(V!_W="T8MH0- &@#0!H!I9WW3\-C_ %_];49E$:Z&
M1(Q;^VF_KM_B^'^+5-;S%- &@#0!H T : - &@#0!H T : - &@#0!H T :
M- &@#0#>Q86!1T[F;?M7?;T^)_ :J52I5&'U\V^Y5-OPV(_Q[GKJT+1$E#*L
MR!U_<1\5/Q&L3%J@KH T : - &@#0!H T : - -+R,U9^T$E2'V'Q ]?Z@=]
M%F91=&8T23ZZVI4-ID>/1DK)W @L68 ^O:3T_K'76N69JEF/=0Q#0!H T :
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M4+&H5511LJ(%V 50!L!\-<[KGQ*$??V_/OO^WUVV&V_[=9*M,0!*N&3<>A#
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MT[_7OV&_IZ[^F^WQT SO6G@1?;_B=B._8$+ML?B""6W_ *M6G206KS^["DC
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M@#H-3%FQ1'M>TKJ%E8!]]@3T##X'TV!U3&4:99#W0Q#0!H T : - &@#0!H
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M;?M!&CR C7K)6#=I9BY!8MM_9WV   V WUC7H W&1B:?V0K=6[ W3JWIU7X
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M\?Q_K_'6+PQ>8*LG<0?B!MUUCPP!>HV&V_0>I.JNE@55E<$#T'P]-0%X VV
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M4RIT(WZ"P3M\@&_KW?X^@WTJ9*45VDG7@6NG8#N2=V;\3^[X :ABW5B^A T
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M2"G&LBGU EDA('P!Z:ZI<SLQ7=4G[#'0S8\/V54A&HL>0[3S?VS#QJ*./?\
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MKNP/7K_%MZ!OQ&IF!.W9^E17[._N;MZG8#IOUZ'??5S 5[2V(O<52IW*L#U
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MR]N^Y0IOOT]!TUCBP/&DV]2%'[2!_C.LJ(#.>JD[!RS*VVVXV((ZD>O[]*I
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MH T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
M&@#0!H T : - &@#0!H T A/*8E!4 DG;KOL/C\-M5%2J70R&2,,1L=R#MZ=
M/B-0C%= &@#0!H!*9#)&RCU]1^\==OZ= LR'(()!!!'J#T(_?J&PNCC:9@BC
MI_:;X ?C_AZZM"ONJK)L   #T  '[ATT-0: - &@$GFBC(5W"D_#K_CV!VT%
M!4$$ @@@]00=P1^((]= 6]Z;]O<O=_F]PW_JWWT!=H T : - &@#0!H T :
M- &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H
M T : :WZ%+*4K6.R-6O>H7J\M6Y3M1)/6LUIT,<T$\,@9)(Y$8@@C8C53<6I
M1PD@<@\B^S3B-JU+:X?RO/</$S%C1>,9VA"220E=9+>.O^V.G26Q,?VZ].'-
M;R5+D5+KR?V>PPT+@8F/LQSAE9'\LE:P&Z2KQ64SL=AT>'^\B*HW)_[:WH.G
MX;?]6P^#_>_830^DG<?]EV'5A^>>1>2Y)-E#K0HU,7W?Y_:;=G-*@;?H-CM^
MW6N7-;C^&"7:V_L+HZ6;%POVG^&\3V-9Q&5S\B;;29K-7.K #YGAQ)Q-:0MZ
MD,A7]FM$^8[J634>Q?;4NB)N; <#X5Q8)_=SBG'\,Z  3X_$TJ]MM@0&EN)#
M]7,^QV[G=FV^.N6=Z[<^.3?:RT2R,LUK*&@#4;0#6+=04U &@+"_X?UZR4>D
M"9._KJU2!YM_=IXTOX_E$W-Z\$DN Y0E2&_/$NZ8W-U:T=41S #^6EZ"JDL;
M'HTHD'38;^WRW<*5OP7\<?:C7-8UX'"UNI8JL1(I[-_EE4$HP^'7^R?V'KKU
MU1]IBDAGK(H: IOJ5)4L+?C_ %:F+)BRPM_1JT*D4U2AH"FHW0!OK&K8P1;O
MJ&+935(&@#0!H T!:6_#5H9)=)CV4S:U7-6HHLWB-NWUB@_;*00.X?YNX_;M
M\=]NUJ6J6$ W0VYXK\F\3Q'%>1>//*F RO)N)\BRV/Y MS 7XL?R'CV?QT)J
MQY#%M9"TK2R4]HC%*R(H'3H2-<^ZV]V=R-[:M1N15*/)I\&2+IGD;#JY?[6^
MX+2H?<9R^8  8O/YSAN/QQ0*P7W;6&D:U#'W$=>@'^(\^CF:^)[>*Z4I-^TV
M.[*2I*4VNMF?<:\FX3$7JM/Q+X0X9QK+/,B4,A?BN\_Y7"X8*MBIE\LL1IRO
MONZ^V\:@[=Q WUSW+$YQ;W-Z<H]"[L?4LS%.GPI'0M#QUSKG4L.5\Q<LRN3C
M#+/#Q>"]V4XW(#?ZS'1]G&4GW.S)4CW( _FC;;7'XUFPM.UBD^GC]K])E1OX
MC<F-Q='"1QT</CJN-I1]JI7IUT@A("JID<(J^Y*RJ.YV)=MNI.N24Y2>J;;9
M28?U&HI%&TD:OU+%?AN-O3K^.F8+#((D  ) Z GUZ[]=1=8&TGLVT9)$$@!'
M0_ G?8@J01_1K--\, FUBA$BO2B;;LA4]?4DLVW0'?N=R/PZZR599!MO,@&R
M]EI)%A1HXU!42R;%W;?UC3JJKM\>NLXV_P 1C48N[.2[L68^K,22?WD]=;4J
M8(# U:_N^\%/<&[MMSV=V^X;M]?7^C5I3,A2S9]A S MNW: #M\-^I^'0:CE
M3(I='*LD:R#<!@=@?7H2#_C&BQ WN>Y) Z1#=CMTWV+ $$C<[ ;[:N'I(-Z4
M,D,;^[\I9]PNX(4  =2"1N=0HN9XBS1!T9P#W)N"0/0[CUU:=)!LD,,!9HU"
MLWKU)V'KVC<GM&^KV9 C[&0>.8QJJ]BD!B=^X[[$[$$;>NIQ _U,P1]ZM)/V
M%9% 7<%6W ZD;L-@22/PU4T@. XBB4%ND: ,['X*O5C_ %:@&WNU[2,-Q*H(
MW!##8^H_B"D#52!4GL0B-0H53VJHVZ[;[=/Q.LJ($93MRS2NDG50I;?M"]A!
M VZ#T._QZZ5IF"0+CX=?\FIB\P19IL;!F]WH9/<Z ]PZ[]HZ[;#T_=I2@',U
MB*N 9&V[CL  23MZG8? :K8+6,<H5NQ'&P*,RJVV_4%=P=M3M UN2O%"60[,
M65>[H>T'?KUW'7;;^G4;]0"G++)$6D]>X@-MMW* #N0-@=CJ)E%Y$$D;QDD!
MU*DCU&XVT TK54JEV]PR,W3T[0 #OMMW'<[_ !TIT@3ER,<<_LD,/0,XV(4L
M 1O\>F_7\-""WR@DJH[CON0 -R3N23ZGKJTZ01EZ6RDZ+$7"]H*A!N&;<[[[
M;[_#H=. )#O8J-]@=AW;?CMUV_9OI@NT#>>!)U <D=IW!!]/QWWW!&H\04C6
M.O'V(20-V+,?CMU)]/@-51HNH"4%V.=F4 AE&XW]"-P"?V;$ZF918L3JU(1<
M9N?5DD.(^\]Q8GV^SX=OP) _#4S _:15]2.IVW)V&Y_?ZG5IT@:RUX9G$CKN
MPV'J0"!Z;@>NF' %MBP*ZABI8L=@-]OVDD[';;4*7PRB:,2*" =QL?Q'0_O&
M^K4A64,8W"?QE2%_?M^.L:HHSIK+$KB7<;D=JEM]MM^X]"0-SJ8L"_NJS%.]
M2P]5!&_3UZ?LU51=H$HX(HF+HNS'?KN3L#ZA1Z#_ "Z40&]BVT,JQA000"S'
M??9CL=MOV:9Y >ZF6>8&-V!INQD(W4$=I.W0]=Q^WIJIM@OCWBA57;^!3W-O
M^TGU_!1TTIQ8*))%.K 'N'HP((.Q_?MZ_CI5 O15C7MC4*N^^PWW)_:222>F
ML</2!I7MN\Q0HO:0Q'KW*!Z;]=B-_P!GKIGGD!Z6)TKT 92U3)+[@?8';<;=
M1L /E._[-0"\DR0@%R=SZ =6.W]0U:\05VCE"N55QZJ2/]_4!29S%&SJ-R-M
MOP&YVW_<- )UGDD0M)U^;93L!T'KZ?MT X8=RE3\01^[<;=/W: 0B@]MBW?O
MTVVVV]=OVG\-1*@+C8C1^PD]WQ('1=_Q/P.CIQ KL-^[8=Q]3L-_Z_74KT%&
M]EI%5>P-U/7M&Y_8/Q&^GO O%W%%[^C;#N_9_5\=4@2J)$*#Y>H._KZ'\.GP
MTIQX@NAC$:[? ;DL?4_B=1Y4*"V$<D '?X;_ !_WM1*H+MR>@Z?NU:)$$![P
MF_M=O=^WL[=]M_PWV_IUC6I1YOMZZ 0D@$C!NXJ=MCL-]Q_7T.V@+W81)OMN
M%  ']0 T!?'(KCNZEO\ -/J#^W\=8YX+("Q[NT[;=VQV^'7;\=3 "4/N_-[F
M^W38$[G?X_B=M'3@!R-O[1 'P&_4_N'KJ M"(IW4; '?\>O[!K+3ZP5>5E<#
M8;>NQ]2-8.O HY[]P".@(!'P.W^YI3U@MD!90!MZ_P (_P /74I4"T2$+L=O
MQ/X#5P6(%>Y"O:/F'Q'^^=8XL%47M^&V_P /]_?KHZ< '>>[;8;;[?[FH!PJ
M[=3Z_AJ@HRDGI_UM0"NWQ^'^[^&I4'?VL"AH T : - &@#0!H T : - &@#0
M!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : -
M &@#0"<I(0D$CJ.HT WC)#KMOU(!_:#Z[Z >: - &@#0!H T : - &@#0!H
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M-OQV'H!TU&N]7@!P %^9MAJML%Q"N 2 ?P.H 8D#H/V?NT!?">[??U'Q_?\
M[NHZE%SU':/CTZ?M_P NI@L@5CB*G=MM]N@&L0*%@#MUT LJ =2!O\.GIJ-T
M!5RW3;T_W?VZ)U!>H)V_=_@=,$@*]G0#?T^.IUE.^M8@- &@#0!H T : - &
M@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T
M: - &@#0!H T : #Z'_=]/Z= (Q_Q'_1>I_A_B_H_P"#H!;0!H T : - &@#
M0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T : - &@#0!H T :
M- &@+'_L_P"D_B_L?^M?\'0%^@#0!H T : - &@#0!H T : - &@(VY_I$_[
MV^@_[S_P>OP_\J:R7H,EEP)$>@]?0>OKZ?']NL3$KH T : - &@#0!H T :
M- &@#0!H T : - &@#0!H T : - &@#0!H T :CR!36 #0!H!-_7X_[GP]-9
MQ!9H\@4U@ T DWK\?Z?]S]FLUD"W20*:P : Y,\U?Z3(_P#B@O\ MG_@W?\
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M --ZK_'^W\?VZR1!SK$H: B,E_H5]?\ 2CU]?X']= 6XW_0R?^CF]?7^!/\
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M/[?_  ?\W]N^L(%)#5 DWK\?Z?\ <_9K-9$(;(?Z6+^/^'^SZ_Q?V/\ A_\
M4U'F"6^ ]?Z?74>8(S)_Z%?X/X_C_'_XS^S\?Z-0HZA_[SP_P_Z-?]'_  ?#
M_'_NZRB0KI(%#Z'_ '/7^C6)2$I_]ZA_'_;_ ,A_C_P]=8R!,/Z#_ :1 S?_
M $\7^A]&_B_TOH?X/V:R XT B?7X_P!/KK8B#6__ -Y&]?['I_#_ !CU_;K%
M@;XW_12_]DOIZ^C?Q?LUKXE)#60&T/\ &_\ WG_]<_Q^O]O_  ]=8@5?U3_2
M?Q#^#T_\;_X'XZ1S!?I($-DO]+'Z?Z,_]GZMZ?LT60'E?_01?]@O^3X_M_'6
M0%3Z']WQ]/Z= 6I_ O\ #Z?V/X/Z-8L",/\ %)_WH]?^W?P_'_1_LU&!QJ A
M)O\ O:?3_2Q_N_L^NLUD"9;T^/\ 1_N_LUBLP)KZC_=UD\@4G_T3?Z3_ ,8_
MB_B_R?[FL&!.'^!?])ZG_2_T>G_!T XD_@/[C^[T/\7_  ?QT PH_P 4GI_"
MO[_4_P"+0$CK!YE+?[7]!]?Z/X?VZJR(,KWI'_%ZM_V/P_QZB*.$_L^OH/XO
M7T^/[?\ =UEP()V?X#Z>H_C_ '_V=%D!6#_0I_#Z'^'^'U/^/\?VZC*+:Q :
MKS!'I_WH_M_Q'_LO_&OV?CHP2B_P?'U_L^NHP,9/]*G^A]1_'Z_#^/\ 9^&@
M)+0!H!.7_1M_1_Y$-1Y MJ^LG[AZ>OQ]-8 >Z M'J?X?Z/7U^.BS*7ZR9"Y/
MXO\ #_%K$%LWJOK_ $_P_P!/[="BB?P+_N^OK\=19 53U_P_Q:/("H^/IZ_#
M_=_;J/(!'_%_:_\ &OW'TUB!QH!(_P ?](_W- /-:RE=9K(A</X3Z_T>OI\?
0V:CS!</X#Z_'_ :/TE/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>mrna-20201231_g29.jpg
<TEXT>
begin 644 mrna-20201231_g29.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" *3 IP# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCX@T2;4HM0>)(UMY)1#>6Q_=[&;:2R%F#%<HI$GPY^ :^ OB!XI\2-J=E/\
MVT)E?[#IGV2[N!),90U]<"5C=219:.)]L?EQLRX.<CURB@#Y@7]D#Q-#8W-E
M:_$U-/M)M)TGPZRZ;H\UG(^FV OU1'E@O4<SLE\N9%*IN@!\HJVQ:^G?LIWV
MI:EXHLKQTAL;?1=-TG2;W5HWDBN+Z-+3[5J216MW'-$3_9^FB/\ ?12));R,
M."&;ZGHH P? ?AV\\)>#='T;4-7GUZ^LK=89M2N-^^X8=6.]W?Z;W=L ;F8Y
M)WJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MAU70-8TZ3PYXB7PTNE3B(W=[<-;6]R&C5'8!!%<>8<G*I$[,!@@ 'O-%>?\
MBG]H3X6>!]>NM$\2?$OP?X?UJUV^?IVJ:]:VUQ#N4.N^-Y RY5E89'(8'H:]
M H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXO\ ?6TU9E_\> K[EM+I+RUAN(SF.9%D4^Q&121\_EM_K&)YOYOT)J***9]
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MEE_Z;K:O-HRC>,5TM_Z2>3AY1;C%/56_](/1****](]8**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ^5?^<IO_ '1G_P!SE?55?*O_
M #E-_P"Z,_\ N<KZJH **** "BBO)_ =O?+\>OB0L^NZM>V-O:Z>UMIMU=%[
M:W,PE9S&F..8UQZ D5TTJ/M85)7MRJ_KJE^HF[6/GGX\:I%J'[;_ (5!TW59
MH8O#=SITB1:=-(\C26^IJ#&@7,B_/]Y<C"O_ '3CZS^$^I?VQ\+/!M_G=]JT
M:SGSG.=T"-_6OFOQQXRTR[_;M\!W47VTP6MDMC*S:?<*1,8M60  QY(RZ_,,
MKC<<X5B/H'X#?N_@_P"%K;_GSM/L/T\EFBQ_XY7*CY_+W_M%9IWO*7_MIWU%
M%%,^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR74OVIOAUI>@:MK3
M:GJ%SIVE:I)H]W)9:/>7#)/':+>2-LCB+&);=A(90-F.C$D ^M5X1XZ_9EN_
M%6E^,-.L?&!TVQ\5>*$\1:K9SZ=Y\-W"ME;6OV"4"5&:%C:H[@,-XRC H6#
M'$_\%0)DN/V#?B3+$P>.1=+96'0@ZG:$&OJVOBC_ (*A?#'2D_9)^)/BQKW7
MVU<+I8,"^(M1&FD_;K2+C3_M'V4?+S_JOO?/]_YJ^UZ "BBB@ HHHH ****
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MV21(8VDD94C4%F9C@ #J2: '45R'A?XO>"O&VJ-IF@^*-,U;4%4N;:UN%=P
M 2<?0@_C77U,9*2O%W)C*,U>+N%%%%44%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%?-_C#]J[6?#/C/XE:$W@::
MW_X1N+1(]*DOKN-#JDVHZB]A',0A;RX!*%/S?.5#-M&5%:DW[7OA/X>?#"X\
M6?%BZA\%):>);SPI,]M%<7T,UW!),%:,11LX62. R#<HVYVDD@$@'(_\Y3?^
MZ,_^YROJJOA7X*_'KP)^T1_P4DNO$GP]UW_A(-%M?A,^GS7/V.>VVSKK$<C)
MMFC1CA98SD#'S=<@X^ZJ "BBB@ KY]^ O_)R/[1G_84T?_TW+7T%7S[\!?\
MDY']HS_L*:/_ .FY:]O ?[KC/\"_].TS.7Q1]?T9UOA?_DY3Q_\ ]B_HW_HV
M^JOXA:TL?VIO!LLL\4=S?^&-3MHXV8!G,<]K( !_NF0_\!;TJ3PBQ;]ICXC
MG.-"T4#_ +[O:^9?VA_ ?Q5@_:I\.>-;:\TJ#_2$CT-&NG\N*WCG@A"3$("H
MEDNU# 9_UK#.!7AGAXBLZ.'4U!R]_IT7.]?T/O.BO*/VCO!N@>)?AK?7NLZ#
MIFJ7MF(Q;3WEI'.\&^:,.(V9<J#C!QC..:]&T#PYI/A32XM,T32[/1]-B+&.
MST^W2"%"Q)8A$  R22>.IIGLQG)U'"VB2=[][]+>7<T:***#<**** "BBB@
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MK-J.F:3-I\JV6GO.LLMXED8!$5_U@.Q@=N<$8ZU]GU^??PW_ &&/#OP[\7?
M>:QNY+;QQ!HNH:Q<ZG-_I4$M_']D>,-$WR^5&T\BC9L<C!W!@&'V[X+\:?\
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M=0ZG /\ @.8YS^$)_#C-K3?CAX&U*\2R?Q#;Z5J,G"Z?K:/IMTWL(;A8W/\
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MC;&,PW,L.XL97W;A&#C QGK7H5,]2G/VD%-*UPHHHH- HHHH **** "BBB@
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MG^5FR<>9B:6M":U3<K]+-);/KH_+\F_-Q#E+%4H6TU?7L?8=%%%;GJ!1110
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MZCIL4Y2":1L#S#PR[\#<$!P,T >]4444 ?*O_.4W_NC/_N<KZJKY5_YRF_\
M=&?_ '.5]54 %%%% '-_$;Q]IGPM\#ZSXLUI+I])TF W-S]BMVGE$8(!8(O)
M SD^@!)X%?FQ^S'\8O#WC+QQ\7I]*-Y(^J?$O1_$]G));,J"REUV*$EVZ*^V
M[!VGDX;&<5^G?B&WLKK0-3@U*U^W:=);2I<VOD-/YT10AT\M06?*Y&T DYP
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M:O(0VAW$D]KRY/RO(S,3ZY/7-=E0!\J_\%1_^3$_B;_W#/\ TZ6E?55?*O\
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MBO0J\Z_:$^#^D_'CX/\ B/P5K5]/I=I?Q)(FHVI_>V<T3K+%,O(SL>-3C(R
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M.%2+371Z,Y'Q?\)?!WCRZCO-<\/65YJ40Q#J:)Y-[#_USN8RLL?_  %A7/\
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M231;-+)QN!&\>4%!8'!Y!Y5<YP*S/V(?A_I/P[_97^'%KI,6S^T]'MM:NY"
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MVOV?^MF+GP[6R2K/F4YJ6L;O2S=Y<W=1M[KV>NJMT=%%%>B?GX4444 %%%%
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MBB@ KR;XM?LQ^"_C5XMT7Q'XE6_FU'1X3#9+'< P1$L6\P1.K)YF3CS,;@.
M:]9HH R?"_A]?"^BP::E_?:DD.<7&HS>;,03G!; X'0<< "M:BB@#Y5_X*C_
M /)B?Q-_[AG_ *=+2OJJOE7_ (*C_P#)B?Q-_P"X9_Z=+2OJJ@#\G]1L8(OV
M\Y+$W]LXD\>>9]H42&,,UWYOEGY<[@3Y9XV[P?FV_-7ZP5^;/PL\6>%O%'[=
MQCT\VVN2-?7%M%%JL'E3/<Q.\LT[(-,7$T8!?YMA#!1]H89%?I-7'A\JJ95.
MI"HFN9MJZ:TNUU2ZIGVW$W$&(SR6&C7GS>RIQ2]U1M>*?23OT[!11178?$A1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %>+?MBW'PWL_P!GGQ1=?%C2+K7_  5!]G>XTNQDE2XNYO/C%O%&8G1MQE,8
M'S =V.T&O::X7XW?!_1/CU\,-;\#^()+FWT_4T0BZL9/+N+::.198IHV[,DB
M*WH<8.02* /B/QA^S3^S%\&;'X6>)?$W[/\ XAT*P\2S6Z7M^=9U"5/#5W)Y
M7DI>C[5P#(Y7< 0#&<C) K]%J^4)OV1_BC\0+K1M*^+'QSD\<>!-,O8+Y]#L
M_#5MITNIR0R+)"+F=68E R#*J!N]00"/J^@ HKR3]J[1?$/B'X"^)+#PQ'+/
MJ<DEDTD,,,DSRVBWD#W<8CC(>3=;+.NQ"&;.U2"17G?P]L?BYI?[.FEVGPI\
M,^"_"FO0Z]>A+'Q?8ZII^G2::9[AA/!9;WN+,R.T3I;.=L:%E  V@ %3_G*;
M_P!T9_\ <Y7U57PK\%?^%I_\/)+K_A;O_"'_ /"2?\*F?[/_ ,(5]J^Q_9?[
M8CV[_M/S^;O\W./EV[.^:^ZJ "BBB@#@?CE\6(O@I\-M2\6S::^K+9M$@M(Y
M1$7+NJ?>(.,9ST/2OA3]G/XR7&M76LZ1;Z$J*NJZ?XAN+UKW_CW@BU='D4)Y
M?SDB[V=1@ M[5]X?&KX4VGQI^'M_X3O;Z;3;>[>)S<VZAG78X;H>.<8_&OD'
MX"_LZV?A[X$>._B!9ZK=7&JWF@ZQIT=FR!8T,$Y*.&'S;BUJGTW'VKQ*_P!<
M^NT_9_P[:[?/S['Z/A(\.2X.QWUU/ZXI>Y\6_(^3;W?^?F_S^R>O?L<WT'_"
M2?%G2UE4W&FZM:VKQ#JJQ6X@4_3,+#_@->4>+?VI?A;\,?V\-5N]:\4-I^F6
MV@3V%^&TN\9HM6,UO&R;5A)<-#:P8=05.W[W3,'[&_P?\<Z+\>O$VOW'B*UO
M;73+I[77%:ZG+Z@\T32)*/EQ)\SJV9/4GK@UL?M'_ 3PM<?MX?!'QM?VJM;:
MPT_]JP@85[BT$264K?WMTMQ;1D'@A%'<U][P8L&W4HXWFM*G4MRM7;2<FM4]
MTG;SL?&<15YXC,:M51MK&U^SC'7\?P/MU6#J&&<$9Y!!_(TZO+OVEGU"V^#^
MKWFEZSJ.A7UK);R1W6F3"*3F9$*DX/RD.>/4"O2;"U-C8VUL9YKDPQK'YUPP
M:23  W,0!ECC)..IKQI4>6A&M?=M6]+/]3R;ZV+%%%%<Q04444 <]X^\+MXQ
M\(ZCI<4PM;R1!+9W1&?L]S&PD@EQWV2*C8[XK@?V<_&$/C2U\<7X06UZWB B
M\L6.7M9Q9VHDB;W5U=<^JFO3?$K:JOAW4SH26\FM"VD^Q+>,5A,^T^7O(!(7
M=C.!TKXM_8[\!_$'X4_'CQ-8>(+VRNK/5OM*ZB_VEG,]W"(I3(A*_,X^U+P2
M,K(YYVTCQ\55E2Q5&T6U+1OMV_-GW)1113/8"BBB@ HHHH **** "O-_CW\5
M-4^#?@&?Q/IWAN+Q)%:,SW<4VI+9".(1LPV'9(TLLCA(8XD0EY)4!*C+#TBN
M.^)7PE\-?%RQTNU\2P:A+'I=ZNHV;Z=JUWITL-PJLJR+);2QOD!VQSQF@#Y8
M_P""G_Q=\$S?LC_$CP8WB[08O&KKI;'PR^J0?VDN;ZTFP;;?YF1'\_W?N_-T
MYK[8KXH_X*A?"/P-%^R5\2O&:^#M!/C)1I:CQ&VFPMJ7%]:0\W)7S3^Z_=Y+
M?=XZ<5]KT ?EO^S'\0A>_M@0:PFB:3;WGB"]EBDDA>YQ"6C(D>,M,2S2% S>
M87&2<!>,?;?CCXA>(M&TCQ1-JNOZ=X9CT5A''<::@DEN;A[<211;9HY 5)<9
MP WRDY !-?'/PY\.CP'^TMXWUZ\\46&FKH<S,)D\,3;)'N(G=5AC:+9;LI55
M#'9N!.TD$YUO!_P[E\<:'XC\2ZUXEMM*TV 2,+B]N%\R^O C2+$%9@2Q&>3S
MSP#S4\.8>K4H3J8N=TI66E_^!^9/C#Q?A<7F>%H9%1:E[%7M-I?#=-WM))76
MONIVT=V[?6'A_P"(%WJ&L^&;+3_B-INJVNM02W$;7]E#]I!7RP(L(T7+,9 /
MD!^0CG!KVVOB71OV7[74/%WA7^P?&EKJ&E7D3W$U]9L#+#)#Y9D5-I9=V9%Q
MD\<YSCGZM_LSQGIO_'MK>FZO&/\ EGJ5DT,A^LL3;1_WZKUL73I)Q]G/\+=?
M0^&X>QN/J0JO&4&K-6:GSKX4W:\F[:WTOO;H=;17)?\ "5^(-/\ ^0GX0N7
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M^('CCQ?X!6=]*M]3NXM92UO+S5=;N%4V6#NGB)AEWSA=A,/[M"7(\P;<MO\
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MDP1M*_EQM(VU02<*H+,<#H 2>PKPC]C_ ,0B\_9CT^[TFUFU.XM9M3:*UV&
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MO-/G66,LIPRY!Z@]J^YQ]&I++L-B7%VES:VTT48K7S4;_>?'Q:YVCCOV;_\
MDE,'_87UC_TZ75>G5YC^S?\ \DI@_P"POK'_ *=+JO3J\K,?]]K?XI?FRX?"
M@HHHKSRRO?V,.IV-Q9W*>9;W$;12)N*[E88(R.1P>U<QX6^$OA/P5JDNHZ+I
M"V-Y+DO*L\K;L@ DAF(/"CMVKKZ*")4X2:E)7:.!^)__ !3=UHGC:/Y4T64P
M:B?73IRJS,?:-EAG)_NPN!UKOJKW]C;ZI8W%E=PK<6MQ&T,T,@RKHP(92/0@
MD5R'PGOKB/0;GP[J$S3ZIX;N#IDTLAR\T2J&MYB>Y>%HR3_?WCM09?!5MTE^
M:_S7Y,[>BBB@Z HHHH **** "BBN$^+/QDT'X-Z78WVN1:A<K>23*D.F6IN)
M1'#!)<3RE1SLCBA=CC). JAF95(!XA_P5'_Y,3^)O_<,_P#3I:5]4LH92",@
M\$&OE/\ X*A3)<?L'_$F6-@\;KI;*RG((.IVA!%>Z?&_Q?J7@+X4>)-?T=(7
MU.RMMUNMP"4+%U7U'/S<<]<4GIJ5&//)132OW:2^;=DEYO1=3Y ^%>E1^*OV
MHI3=:9=0!=:NKTVT.T?9'25Y L@*D;58!2/E]B#7WQ7Q'^Q;J&I:A\6M7=KZ
M0I-I\MU>+(Q8W#F5/F.>K;G)W=>3ZU]N5[&9R_?*FOLI(_.>!Z+_ +.GBFG>
MK.4M;:J]NGFGVUOT"BBBO(/T0**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H:WHMIXBTV6PODD
MDM9<;TCF>(G!SC<A!Q[9JIX5\':3X)TT:?HUL]I9C&V%IY)57 QA=[' ]A6U
M15<TK<M]#%T:3J*LX+G6E[:V[7W"BBBI-@HHHH **** "BBB@ HHHH ****
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MKL\I\ML,IC'/'.1GV[]I3Q1X?\+_  EU1O$XT]])OF2QDBU."6:%]Y/!$0+
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MF85J5>+C+F;L^S=U]ZU.*G)2@F@HHHKQC0**** "N!\3?\4C\1M#\0K\EAK
M70M2/99"S/92G_MHTD/N;E.PKOJQO&7AF#QEX7U/1;B1H$O(3&L\?WX9.J2K
M_M(P5A[J*#*K%RC[NZU7]?@;-%<U\._$T_BOPG9WE[&L&JQ%[348$Z17<3&.
M91_L[U8J>ZE3WKI#G!QP:"XR4XJ2V8M%>7^$M6\?WOQ#UC1M4USPW<:=I"VT
MLWV/0;B":X699#M5FO7"%2@Y*MG/05ZA013J>T5[6"BBB@U"O.?C1\$].^-6
ME:?9WFL:GH4MF]P%N]*,(E>&XMI;:XA/FQN KQS-RH#!E0@C'/HU% 'Y^?\
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M*WJO-'YE3]V*B=/1117S9L%%%% !1110!P,'_%'_ !8F@^YIGBR+SX_[JZC
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M+4/AEIGA+4/"MEX+TZSM[&*\N8YU:Q#SVUMR)'=25LRX$IW&-XV)R6"@#O\
MA<GB[_HA/Q _\#O#W_RUH_X7)XN_Z(3\0/\ P.\/?_+6O5:* /*O^%R>+O\
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M?^$B\3>!_D\16;>(](7IK>CVY-Q&OK<6BY)]WAW9.3Y: 5WU%!4J:OS1T?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E7_ )RF_P#=&?\
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M*GT8'@J>0>"*"XU%)\NS[/\ K\C1HHHH-0HHHH **** "BBB@ HHHH ****
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M^W@]VL^F03R7$DEF(,(C/ 53]Z6*L'8+E5;Z,H **** "BBB@ HHHH ****
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MHK$ HHHH **** "N2U_X<V.IZD^L:9<3^'?$+ !M4TW:K38Z+/&04G7MAP2
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M5M_B5ON:NOF^4\R<9TY.%2-FOZV/3J*\Q_X7!JOAWY?&?@'7M%1?O:CHL?\
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MUGX7_94L="O?%>A>(M3LM7DEBBN=#M89HX9$"G9(9)H]I8,2N,YV-Z5T_P
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MM/X:_!7PG\(VNE\+VEU86\Y;;:27\\UO;JSERD,3N5B7<3\J@ # &  !W5%
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M )-^-N[C.: .*_:(\>:E\._A;J&JZ1+#!J+21V\4LI7*;FY*J?O, #@<^N,
MUXG^R+J>K>.?!?BGP+?./^$7AL7MXY(T E@-P7!56SR#F1N0>>^.*K_M[?%K
M3K?X,V]]X<\=0V<.G^*/[)U6[T;4E_T:X2"7?:SM&XV.K%-T;$$$KD=*Y7]@
MWQ_8-XH\7>$]3\6B&;4XH5TG1;N_$,SLB3-.;2,ON8A?G<QCY< GU%4\PC!2
MPW(K\RL[J^S>V^EOQ\F98SA&KBJE'.UBI<BI5.:GRRY7:I"FDY)<JY^=O7_G
MVEO*)W/P9_9QUCP+\1-5UV#4K/4I_#=XUI#:%6C^U^9:HY)?_EF?+N%QPPW
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ML<Q?ML>-F\'_  GM84U0Z8VJ:BEI)@,/.B\N1F3<!A02%)R1D COBN4_8/\
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M?V#XOCX3Q;:./6?2 S?^.RJ,?A1_8?C+_H:M._\ !*?_ (_76T4>TEY?<O\
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ML#A\;AW6>+QE2OSS<USMOE<M[7;U=E=Z7LM- HHHK ]0**** "BBB@ HHHH
M**** "BBB@ HHHH **** /E7_G*;_P!T9_\ <Y7U57RK_P Y3?\ NC/_ +G*
M^JJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^5?\ G*;_ -T9_P#<
MY7U57Q5\:O&6N?!?]OJU^(7_  K'X@>._#=Q\,TT'S_!6@2:CY=TVJR3[7;*
MH,)'DC=N&].,'-=7_P -]?\ 5N7[0'_A#?\ V^@#ZJHKY5_X;Z_ZMR_: _\
M"&_^WT?\-]?]6Y?M ?\ A#?_ &^@#ZJHKY*U;_@HA8Z#I5YJ>I_L_?'C3M-L
MH7N;J\N_!:Q0P1(I9Y'=K@!55026)P "31I/_!1"QU[2K/4],_9^^/&HZ;>P
MI<VMY:>"UEAGB=0R2(ZW!#*RD$,#@@@B@#ZUHKY5_P"&^O\ JW+]H#_PAO\
M[?1_PWU_U;E^T!_X0W_V^@#ZJHKY5_X;Z_ZMR_: _P#"&_\ M]'_  WU_P!6
MY?M ?^$-_P#;Z /JJBOE7_AOK_JW+]H#_P (;_[?1_PWU_U;E^T!_P"$-_\
M;Z /JJBOE7_AOK_JW+]H#_PAO_M]'_#?7_5N7[0'_A#?_;Z /JJBOE7_ (;Z
M_P"K<OV@/_"&_P#M]9/A_P#X*3:'XL_M+^Q/@7\<-9_LV]DTV^_L_P ()/\
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M?Y6_Y-^-N[C.: /L"BOE7_AOK_JW+]H#_P (;_[?1_PWU_U;E^T!_P"$-_\
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M_P"K<OV@/_"&_P#M] 'U517RK_PWU_U;E^T!_P"$-_\ ;Z/^&^O^K<OV@/\
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M+6V%E-)'?6\5\AMK<M+%;7O[V%0Y>-@ %>2.20<N: />**** "BBB@ HHHH
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M$%G;75N\JJV;73G/GWBIO&\Q_=PW7 R ?9-%>,_M;?%K5OA%\!=;UWPN\/\
MPD][):Z3HLLVUHDN[N9((I3D$$)YADP00=F",&O&?&5Q\<_B)^U%XF^'7@KX
MVGP%IGAWPQINH,\OA6PU(WMQ*9$=VWJICR4#<$@9X44 ?9E%?(/PX_:N^)5Q
M\!O$FIW7@:P\>^/_  ;XMO\ P?K?V/6K70].D>U8;KLS73812CH-J@Y;/"*<
M+M?#']N2#XC:'\)-:D\'_P!DZ3XXUR^\-7=TVKQSIIFHPQNT,:,D>VY29HG5
M7#)T! ;- 'U)17Q]XM_X*##P]\$])^(EGX#CU"U\1>*KOP_X=6Y\0P6-G>6\
M+R*M[/>3QK';"00RE4;</E'SX)(Z'QU^T-XUT;P+\'?B)=:0OA+3M2\46VC>
M)?#IU"RU.%[6[WP1SQWD&X,(Y3%("C(6!8,.U 'U!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>mrna-20201231_g3.jpg
<TEXT>
begin 644 mrna-20201231_g3.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __
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M#GK22D:'GKK^S]U2<$ZLN5A06@J1P.FBOVZ"G QJI;0WT$DG4GV<M-=:WL]
M+JB$A.I U)/$Z>S]U'J:54 K@>2A^C7Q]XIP]1O$(82@@ZDZ<1X<:P-U+JEI
M3^(@<O?X^'.@X$@I*DZI.OT]AXUO UV(^4V2"1XZD Z#]%9P-,@N(0.)\= /
MLHUI4Q:$&GD+/2"=>>A'^L5O$UNK+JFFU$**03[>/'CX^!K0=:[BVOYVW24I
M3J9$-?0/_.B&H/M<?#K(2GW"O=LYT=.Q_::G1G66QU[$#,4P5+TCWV#(B#4Z
M)^9CCYV,LZZ?>Z6'&Q];FE>C?PYL/,KQ?\#-U'FQ5[#<ROB%8^-*%UM*@A2T
M!9Y)*@#]7#7QI1W.A<Z$K!2M(4DZ<"-1_KJ6Z6)9C.0&%)T0/+5S"@5*^!"E
M$:52G)7"DRRW;?O#S'-4^Q(()^K4\JMR[#>>I]8    :    > ' "N9I<3R%
M2[D.Y6MC<PD*IE1L2',>^L-=BY4D%15*PXDJ%DT\OC6,EW)45S"0JF5&Q(<Q
M[ZPUV+E205%4K#B2H67$\A4NY+N5K8W,)"J94;$T\Q6.QKL3J2"0YU85RM86
M7!R'NJ27<K51,)T+5B:?&L9DB58KDDA5LV)(<Q[ZPIV+E205JU8$JPLN)Y"I
M=R7<K6QN83'*J*5B2>?PJ6'8G6$DA5LV-RM847:D@K51L"5"R:>7QK&2[DJ1
MN82%4RHV)IY_"I8=B=822%6S8W*UA11]LN(T3S!U ]OAI6)T9D71F.RPX% J
M'2$J!YCPT/#0FJN;*2X&?6G,4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 6WGVHS+TE_
MS/(C,NR'_);+KWDL-J==\II/WG7>A!Z4CBH\*QNB-/,%GO<W'&6O7.1:K$_B
M,B;U*Q7R"Q(3 2 RQ_Z$24.W%=T:CI'\9Q+K/7KHP$:-CT_I(*.C?/V_P[/I
M4]?Z>/+_ )NT] [WEJ[=9T7E.0[;P&WXQ5'3<L@ES+8\Z$(<0[ O4%B/)O;;
MJ.HAEBW(7TZ$+5QKR)R;I1^S7V</:>5*KI1GR(F6N73 9]\:SZQ.SHEW:0]?
M,,PB\WEB'YRF41L=9P^?/N]_NTB65ZI?2&''"K5*4H0JCJI4=?0VEZZT2%*2
MI1T[W]YSG![K>9MC(F9%NB)ZURA'9:VOA8PET)4A*%ICWS&KRQ;I*UN:@39S
M22G0E"0E9KRYOCJU'VU^QKZD<<J7-:-/2>0VZF+[F)W6O4')K/F4K+KW?9+U
MJ1=H[<[(+RRM\BUKB.6(/6NX.-Q V@"VE45HHZ&@E* D?,89XO!3@X\B6O8O
M;]Y[(2AX>E.5(]V,*8OL7#<2C90Z7\FCXS86,B>4XEY3U]:M41N[NEY)4ETN
M7!+AZ@2%:ZU]?GRN;</@JZ>C@?&RIS/EM4Y-4F"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * T'KY<]8H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4!PHIEMS76I#J&(4)"$I<7^)WJ/\)Y*BKH#ZP >H]10?P@*.HYO1FZ'SY4Z
M:_\ P;="F(C E2EIB/+6_P >*G"6U!+:SSZOO*_M'B134PQ7+G?$IZ5S&XZ$
MCI"%2+7$*$C4)2AKJ:=^[IIP3J!]5/>!R&Q7"6%L1[E)2XN<V^[$2Z6TNI3'
M+*0D$:%[STN%?B0![]-3[0<NJP* 4 H!6.QI:5^(>[]]8K&JY87R_36(*S,8
M\S[ZTI6+*_Q'Z> H:8ZOMJG8UV+*^0^GLJ3%9F,00*VZ[RT6U^'Q^RD32W6N
MQAB*1Q.G+7[:RRJ;72A$\#[@/V5I2L8Y(ZCQ',T9I;=2-2=>8_<*Q6,5BR
M/J%::6U+21P(\:#@6E)2KB>>G.@1;  &@K78LM%Q(U3KQX\N0/LK*.YD;$"
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M4FI_$=DUR(% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M/43T18B3H7&%Z:%7 R2.H]+( //1*A.B/B)SV-!#K[,!R5,='2IZ2\F-'CL
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0&@]?+GK% * 4 H!0"@% * H2 "20
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MMQZ2($B%+G,Z]#A;=#VH2CI/5>\VO@TR1;<6^-ZFY\7)[R;:?:;JUX3SB@%
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MJ5<E7*@@).I Y\S]5:[FNY87S^K3]]$46/*3J#J>!UT^OAS]M*&4H@L@<3P
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ME3Q8\L.''7TG3.\KISJD3>*O >84 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M 'D5I>4/^>ZFP:WD1OAKBRJ<ADHX/0 3_N5N-?J4AS6CQCPUVF#+N<Z>DM!
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M[$ZD@J*O@%<E6%EQ/(5+N2[E:V-S"0JF5&Q-/,5CL:[$ZD@D.=6%<K6%EP
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M8YG_ /*W\Q_E&/\ \P?R_P#S!\I\]\A!^;\GS?EV>KRT@=_T H!0"@% * 4
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M<IR6Y=MA7*?=KA"@)?@7JY/1[C<X+4R'$9E-R: _3I0"@% * 4 H!0"@% *
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M@2K"RXGD*EW)=RM;&YA,<JHI6))Y_"I8=B=822%6S8W*UA1=J2"M5&P%48*
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M&N$D3)\>!#8FRQKI*ELQVVY,D=02='WDJ5Q /&OX6=&VU8_U-=]+&?6&"@%
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M(X?=MD4ZX[XQXTBVOW%.[6:7S'KMNK<H.0HLD!B9;K1D-FM'RT%AIB(PA&A
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M'%^9IX=6FFGU_IX4!DT H"*T]0TY>-8:G0HA'1KQUUH&ZDZTP4 H!0"@% *
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M=KNL2FE+XHO52BZ:5C).+:T=*K0[UKXP^;% * 4 H!0"@% * 4 H!0"@% *
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MDD*MFQN5K"B[4D%:M6 K3!0"@% * 4 H!0"@% * IH-==!K[=./Z: K0"@%
M* 4!;;2I.O4==?KU^-8:Z<"Y6F"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@/DW^Q6?*;%>L9R&WQ[M8,CM-QL5\M4M)7$N=GN\-ZWW.WRD
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MQ.L))"K9L;E:PHNU)!6K5@*TP4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MZTMO+CME20=%%"2>0T _8%0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@-!Z^7/6* 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M"A0"@% * _GK=GGI:[&>IGZU/KKV_=S<WN+V>OVR_<I<+G@>?=M&Y=NVSS>
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M71OW:\SBGZ]MT7/NX9);>*E+%'F<5\7(JN4HK\R@E6=*N,:R:Y8RE'._,O\
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MBBVD@H.AUY_LK'<%@MH)U(^'A1Z6!;)T&IJC>!:+B5< >/U_&G V)%24JTU
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M"N(;!KS2E*3K)U9R;;N>@_:?Z+O>]W3?EM]=P/\ R/VWG>4__/F\K-PQAV9
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MPCK6VV;7&9F*85Y<B3((*C[(880MJSM&$8^D]*JZE"@% * 4 H!0"@% * 4
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% :#U\N>L4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MMN2?(<CH0X%I3U%8U2?E<NUP+"TDDTGKQ];/9/#CY&DJ45SVRKX(^.% * 4
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MQC<H,MZ(-4,+;;6XA<Y,<)OWEJ9+'"=.9:G!.RCT3>P3L.W#@;O[.;?Y5?\
M=ZRQKK$QW<K<[,[AE>08S%OUMN=DO2,>M\)BQ8E;)%SL=V?@NRD6WYPQ'%M!
MT)=>#B.&$'57&/%"/O*YZT+Y?3ZJZ\#NK&,XH@</8?V4,-:NZ+;N-N+M7,9>
MLU]O[^.W:Q9 NS8RX\W?;[88EY@?SACT),4"=,7=\6,L-1V%)==EML%&JTI!
M_4OD_P":I^5?.F#///BV^SW$9X9Y,E.3&Y1?A9&WI'DR\C<VO=CS/2Z_GG]S
M_P NH?,;Y3[S9XMIN-[U799,6YPX<%?%RQQY(_J,$8Q][)XVV>6*Q1:>3(L:
MU:2?CCN#N#N?F=N3A%UP?*<#P2S*7&LFW&#6J=B=D@VT(;5!BWZ!<\%NTR\S
M8K@\Q2GEMQ5N*ZT16E_>/]_]*V/EG8[E=5V/F'HF;<SC7Q<_+GESZUG%K=8X
MI<%[KE_FX'^+W7^H^>^J[)^7^K^2_->VV6/(X^!M5DVD5C27+CFGT_-.4N,G
MSQ@ZJF/\SZF3&^4F6NVG$;ZNXW8KA6^!??S5V3=9:.E2S ;M=IQAY^0AM0*T
MMI*4@ZD 5]OQ]0WV_P >6>+S9L?=:;>WP;9J"UT?/ES/775M.JT/SG/TCI/1
ML^#'N?EWU;^HI1BMYO-]&662HVX^%M]JJQ32:BFJ.LE8VC3M!!VCM,7.MP'X
MN/9_>+;+M6U.U=LNGYG=I^8W-,>UVC))SL@/O,O8W)GIE(B-OO)\Y"%*?#Q1
M%'T3==;ZUYE6Y\M8M\]_T.4:YL^7#CV\5ABG*<6X+6,Z<O-RIM:*#UE+]7V'
MEGROY&GL?/67I*Z-YLQS2VNTP;G/O9O<SE&.+(EE=(RQUYN13E&,O>>5/EA'
MVHQV_0<JQZPY/:_._+,CLMKOUN^80EN1\A>(+%PB>>VA;J&WOEY">H!2@%:@
M$\Z_S(ZAL-QTOJ&?IF[26ZVV:>*=+<^.3A*E4M*I\%Z#_H&Z'UG9>8NB;+S!
MTUM].WVTP[C$W1-X\^..2#:3:3<9*M&U7BSZYUY#Q!_37BD?**Q@*2X3P!UU
MUU^OCJ=:<:AE\_AX\_\ 56FK@6C6(V1BNLJ.I&A!.OL/$UJN&$#I2E)^G,_J
MK#1_>]_VU1788KK2EJU!'+30Z_N/MHT&JDFV_+&FNI)U/L^%%>AC*$CJTU&O
M#AKQ_13@7$M.M)=&AU!!.A'U\_A0.Y:;9#94>KJ.FG+3AJ#RU-4C4N));B$\
M%* .GB??4NYO:4T"@0=""/@0:,R);#3;>I .IU&I/+4'@/"BN42+B6T@J.FI
M('C[?"CN"V%)6.I)U!^GPJN!KN4#38/5T)U]NGV<J%*Q]JQR$L7! 4>#[;C0
M'M(3YP]W^%42.6551SI+H6- ""./'V5".4'P+J0.!T&OMT&O/VT97$FZOH;*
MM->GP^GOHKDR^(L-2-5)!3H%<.'MUJK.@3X&4/L-;^4MDT\OLJ48[F():_%*
M=/'34'3WZZ<J&IU,])UZ2.1T/PYT-X$@=/V?IJG8*YBKD+0XI(  &G,:]7U^
MZI;#T9FH5UI2K30D Z>_E^D4!=2>!]X^VE:%):GQ[RI;T=^.D'I>C/-I(\5K
M0I/Z4ZC2NN-4:EWH<IJKG;2U)MDM25:J$B.HGGH@MN-Z_P"^\Q6GNKYS;NZ-
MQZ51O7@%Q_-L)Q6>2%+>L=N0\0=09$>.B-)TUXC^.RKAQTKX+<1Y,\X_YF?&
MY5RY)+O.9CD/=7G.+N5K8W,/*WO0]8KM![!.XW:WMN[D3N3C-VW4VVO>Z<'<
MNV8[CEUVNQC'+(K,6EP\FE',8F>.Y%=9N%O1;? M%@NKTV9+B,-!3KQ2B9Y8
MPERR'/&-$S6':+^HI[*LVWUB;&[S[>=R79E+R2S7/(]OL\[N=N+7M-@>96.U
MQ9TPSU71[*;G+QMBZ1+:\N!(G,-P)*V_(,E$I;,=V/&BW1U7I)\6+T=5Z3BZ
M_P"I<[%;;NIA&+9;MEW7[?;'[FW5%FV\[N,_V8<Q'8/,%.2&&DY-9IUZOL7,
MI6!!M\*<N2+2I^."%OQ&F.IY,^-&O&G:3XD:\:''_P"J@=:?])'*GV'&WF7M
M[]DG67FEI<:=:<N]Q6VXVX@E"VUH((()!!U%5G_M>P9/A.D]\>[?T:)?HU8K
M@6]NZG:'NIG#78W@6,V[;/!<GVQS_?&W[QL;,XU;;-#M5HPR7=LSPC-[1G[<
M8O39(A?ES\=QR4XAME[IERQ>%1T;H4Y0Y-:6-I/Z83$=V,1])/:=.Y[-VAVS
M)-Q=U,NVCMUX#S4B'M/?+\TY:WHL20$O1;3?<M9O5TA\ B1&G(DM]33R%*8:
M^'J9CKRZGYPNZ+T_\T]1/U[O52VQVFSN;M[OIM%M!9NXS86],7'\G@3=U]NV
M^TNS66Q7F\-)$ZQQKO:<RG-Q+C&=8<MMV^4EK4MEAUEWDX.>625TJ_8<W'FF
MZ7/TJ>B+ZM-V[T,5RCM1[KHSFWGJ$=LWS>*[MXAD,6%CUSW.@8M-7C]QW!M%
MB08X8R2TW&.F/E,",RF-$G.M2HX1%F(9C>C%DYO=E\:.V.=5ROXD:'^L_P#^
MUX_0U_\ 1ZQ7_P!7A9JYYO[L?IQ(R?W(GZH-[]X<([?-G=T-\]RKDFTX%M'@
M>4;AY9.ZF0\BR8I9Y=YFL06Y#K#<JZ36XGD1& H+D2G&VD:J6 >S:2J['1NB
MJS^<&YV8]S/=/V/]T?\ 4$.7"_V3N3@]Y%K[C-J+?:)+K[-HV8VLRB[,Y[DF
M/-'R.J%M_FTVV_E[[VCL"T;>RPELB4E5>3DE*#S?FK7Z?3@>>C:Y^-3^A#V,
M]U>)=[G:3L-W1X:N$B!NY@%IOMYM<%TO,XSFT0.6;<##U*4Z^YYN(YO;9]N4
M5*4I7RW5J0H$^R$N>*DN)ZHOFBF;9IY"CN8[E:V-S"8Y512L23S^%2P[$ZPD
MD*MFQN5K"B[4D%:J-@2H6K$T^-8S&2K%<DD*MFQ)#F/?6%.Q<J2"HJ^ 5R58
M67$\A4NY+N5JHF$QRK2E8DGG\*EAV)UBN22%6S8W)#F/?6%.Q<J2"RXP'7&E
ME:DELZ@#D>(/PY5<72)J=-#)K"BXGD*EW)=RM;&YA,<JHI6))Y_"I8=C\%?I
M9^H'V>=A/J[>O1>>[G>VR[,6W<?O W6@83)O&/YI?_Y@F8OW-]Q,N^QXK.&8
MUDDAIRWQ[S%4?.0WU^< CJ(('DQRC')+F=-?O//&2C*5>TY_VY[G;=>J-_4Y
M;:=Y_8#AF01.V_MVV<N<3N$W]_D:]879-T\F5MSNUA<3(YL*]0+/=$WG.&,^
ML.-0HEW9AWA^UX^_.^5+40BJ363/S0^%(V/O9*JR/>SUW^\3MP[(.TS:S>+N
M<[/L,[U,,G]SN!8=C6VF;)Q+Y#%L[<P#=7-[)N-!<S'#<WMR+C9X6#2X 2W%
M;=<9N;B"YY)=:=ZYI1C&LE74ZY&HQJU4\C/ZH[=2W;%=Z7H';W7C'LHRZT;.
M=T.Z&ZETQ3"+>Q=LTR>W;>[K]DF6SL>Q"U2I=OC7+*+U&M"HUOCN/L-O2W6T
M*<0"5#EF=)1??^!RR.CBS9:^_P!2'N1L#F>W5P[]_2<[KNR_MIW3O4"QXOW#
M95?7\P5;9-U:$J&<TV].U^'''9<6VI>FS+4U>9U_1"BOKC6^6MI357X[C3GB
MU'M'B-75$>W'>7ZA/:UV*=LKW=COGN#&1M7.BVC^0E8>&,HOF[5YR:UO7G$L
M<VSA0Y*(F1W')[8PJ3'?,AFWLPD+ER9+$1IU]':4XPCS.Q;DDJL\#)G]3-OW
MBV/0=]MR?11[TL([+KBJ!=8W<H_=KS)4,'NSD<VK,Y.*7+96P87%MUUBOAR*
MXYF*;?**V@S,6'4*KCX[NX/E[2/$=Z.A[T6+U&>T_*NQ:\>HMBNX2LC[8K%M
MCD^Z%QR&VVYU.1,0L/;FLW_$7<:GN0I<;/H=^M[EI%L>6TI=S*6TK*%H</;G
MCR<_Y2^94YN!XD;>_P!1[OAE6/XEOWDGHX]W>/\ 8]F]\C0K#W18WE<3-WT8
MW*O?Y"C,[WMZG;C';+9<?1,0X%2W,I5;U*0$M2G2M.O%9W=Q?)VD>([TT/8W
MU(O4X[8_2[V7A;N=Q-XO$NY99<9F/[5[5X7"8NVXNZF308[$J=;L:MTJ5!M\
M*U62/*9=N=TG2(T""AYELN+E28<63UGDCC567*2C<\49/]2_O/M(YC6?]Y/H
MU=Y?:WVP9-=[=;V>X&ZS<BR-BTQ+Q+CQ[5<+[BV2;)[8VJW.3&9:'FXGY\N7
M)0%B(B2I(2KEX[7Q1:C].XCQ&KIT/:[NA]1K:;8CTZLO]2+;:$SW![06;;G"
MMSL1AXOD"<9_GG',WR?&,<M_R]VN5GN;U@FPU9*%RHTN#\U%?C.1GVFGTK2C
MK+(HP\1:HMRI'FX'C-DG]2/N%>=B,=[J-@/2E[I-[^W&U81:LKWXWK&1NX1M
M]M?<D08\S<"QX5=I.U^0RMW;9M6\X]"O=[1'L=I8G0I(\T1FOF3S\=\O,HMQ
MXF^*^6JBZ';][_J&X&[&WMKS7TT_3_[J/4/D0<)L>:[O-XG;)NVF)[)3+Q;U
MW%S:S*<RC8?NBK)=Z[/%3YDJPV"WW-A3*T+C39&JDH>-5>XG(F62OPIL]*?2
M\]339/U4.W)>_FT%FR+";CCF53< W/VPS!<)[)-O\XMT"WW5RWKG6]7R=]L-
MTM=T8E6ZY-(9$EI:D.,QY+,B,STQY%DC5&QDI*J/+3>'^HUFWC>_<[9GTXO3
MJ[CO4LB[(WEW']U]TMI)UZQW;6U7:,[-BR&<6O.-;5[O2LFBKG6]]B'(DL6M
MF[*C/.V\RHR42'>;SZM0BY4)>36D54]+?3$]5/8[U/MOL_N^ XQFNT6\.RF3
M,X5OUV^;H168.X6UN2R%7%B+\XAD-?F%AN-PLEQB1Y+C$*6F7;9+$F)&>:*#
MTQY%D6FC1L9*7I/3ZNA0H!0"@% * 4 H!0"@% * 4 H!0"@% * Z&[A^YO8S
MM4P&7N3OSN)8L!QI@/-P$7!\OWW))[*$+_)\2QR(E^]Y-=U!Q)+$-AU339+K
MO0TE;B9E*,%63T,;2U9^-CU!/75WR[G#>=MNWD7W8#8^4F3;YDR)/;8W:SZW
M/)=9=3D=_M3[C6(V>;'6$N6NU/K6H%:'YLEI?E)\63<2EI'2)QED;T5CR,[>
M^VC?+NISZ)MIL-MW?=P,I?"'IJ;:TW'LV/V]2B@WC*LBG.1K'C-G0I)2)$V0
MRVXYHTWUNK0A7&,93=(K4A)O1'[ >Q3T!=B-C&K+N!W3O6KN"W592B8C#EL/
M'97%9G'I:%EG,QYFXLIE)(4]=VV[<KJX6_K;0\?9CV\8ZRU?U':.-+5W/T%0
MX<2WQ(L"!%CP8,&.Q#A0H;#4:)#B1FDLQHL6,RE#,>/'90E"$(2$H2   !7H
M.AD5H% * 4 H!0"@% * 4 H!0"@% * X_E6+V;-L;O.)Y PN19K["5#G(:>$
M=YM*'6Y4>7'?4E:&9,"9';?;4I*D!QL=25)U!RKC[R=&M34W%\RNC2?9'9[M
M_@[@R!;=U8>YN2VAUY5EQ]5M?L$6,^WU%4J,^9DB/F,J$UQ0J&]Y"2%.%M6@
M*.V7+FE"DX\L'Q^EO6>C)DRN.L>6/T]AN3><4P2Z C*K'C-^5$#NCF8QH&1O
MV]"4Z.H9D9-^8/VQA"4\4(4VA.FNG"O/%J/PMKT.GV'!.2^%M>C^!\J3+V@M
MMAQ:=-F;61<:M[]PMF&7*9*PP6>!(0M2KK$QVXON&)#=2]#TDB.XDAQ "_O
M"M2K)I<W,[_%7UCWVW3FYN-_K.X;9G6VB+2+W;KYC3]L;A'YV^V0QKE9V4MM
MH7(8EWRTMR;:VX.@J+:W@M005=)"21X)X\G.XT=[/\&>5QG6C3J>?U@W_P"V
M#']XS>[%L\+9'>N;C#>XB)KZ6X;LEU4=V]0<'>2JWVF"0XI9=CEJ6E@G^"%$
MMU\A+;;N6#EE.NGP_=7Z(]3Q9GCHY>K^)ZE@@@$$$$:@CB"#R(/B#7Q)XBM
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MVX2),E2$I1U]"4I'MC&,52*HCNDDJ([IJ@* 4 H!0"@% * 4 H!0"@% * 4
MH!0'&,VL<S)\+R_&[?*1"N&08Q?K+!E.K<:99EW.URH<=4AQH%QN,IUX)=4D
M$ALJ.AY%6C3O1I^QE1=))\$SRVVO[<-W)&XEG3=<-<L=OQJ^0;G<[EET%XXQ
M*;M4MJ:8;2V'6QDC%P4QY/1"=6E86>IQM.JT^O)GQ\C47637"_\ #UGKGFAR
M:.K:X7_@>FU[Q)Z\0H\9N'MW$<C)T;7>=O6LQC-J*5<8,%^^8\S;$)T2DHUD
M=:==%(.FG@2E7CZG3[F>1.CX^VAG+M&5N8U;K.UE-BM5SCOMMS;C:,#:%M=M
M$52_E(%JQZ[Y/=[=:9 0$=;KGSC*="&V&^"@Y-=5[OI^])5^KTF:5K33T_P.
MS+1BU_=QUJV3L^ODMB3;_EU3&[-B,&YH9=C!@--*BV%-I;0VG732&#]8&@KQ
M3E&.1TBJI]_XGGDUS-T5^\\ZG^RFQVW<^!C=QW@PUC'YLUJ1$L,VYQXFY-QM
MZG XBVQK&HM1I$A]L%KYQM?3K_%$?_J0^1_7R>)R4)<W;^7V_=]9Z?U#<*J+
MK]1ZM-MH9;;::0EMII"6VT)&B4(0D)0A(' )2D: 5\0>(G0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@-!Z^7/6* 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4!0\OI[:QV-5RTY_P!+^^L5@KF*O\)^'[10LLT=
MC2P>9]YHK QJ&&.Y]O[ZPM7]185^$_3Q%4N!IC+Y?']];Q!%P:@#W_94K1 P
MRG4?&M2HPEH:_P"X/:GVN;KJ=5NGVV[![E*>*O.5N!L]MYF)=ZEH<5YIR+';
MB5]3C25'77520>8%8XQ=TBN6+6J1HMG_ *&_I0;D!8OW99ME:RO0]> W3.]K
M2A01&0E2$[:9;B;0T$1!TZ2DJ*R02XYU\_!QNZ.?@XW=&C>X/]+9Z9>6)D*Q
M>9W%;6O.)<,88=NE:KO$CNZ$M!QG<7"\XDR(Z5:=2?/0XI.H#B2>H9^FQM<4
M2]MC=JHUZ/\ 3)9CMB52.U?U1>Y/8_Y(KD6J%^1W1:FWD&8\RT;OMSNKM;\B
MIQ];&LAN&X6RAQ8:65I2B/T[7PR:,_3M?#)HWP].CL1]3+M:W[N-][HO4*N7
M=9V^IVXR6S6?$,EO>X%[RY6?3;UB@Q^]SAF[=X6U @8];;@7'?SR2XF2\$!A
M8=<D(Z0ADC+WI5C0K'#)&7O2K&AS;N O&ZVP^Y&;WS#-K[78HV39%?,@N&\+
MF-2,@F7B'>UR),6# RJ5'NE@PYNVID(0]"E0W2_)CK=#9;7UK_T#^4.Y\I^<
M?)6PZ5O.NX<76=KACB6SS3Y.3D=*\KG!Y%+\LL<M(N*;4O=7^-/[F^D_,?Y9
M_-CK/F/I_E'=9_*O4=W/<RZGML?B^(LJYN5Y(XLL<$H5:G'-!.4XSE%2@^>6
MCN1YSD.X,UF\9EFN59--;D-R[?\ ,)CW"UV::T$+;D6^0UDMMC6HI=0%==NL
M[*DJ/!LD=1_H79>7]]TG:O;[;HW2-WMFFI2AFE&>2/HS8<BJUHXO,UWT>G\4
M]2\X=(\Q;^.]WWF;S'TW?1<90CDVL)X\,UQ4]KN<+HFJJ<=LI+^5M5?8^,;[
M;Y89I*QC>J^W(1.A3MNN63W2_,$**4MVVVX]NW;HCU[E2#HA,:QQ9;ZE*_A_
M>XU]#ZW\OOE-UA_I_,WE7-TS)D?*LV+!RQ3?YI9MA/)""5^;.HQHO>TT/V7R
MI\Z_W'^5XO?>0_F)MNO8,$>>6VW&[<YN*U<(;;K&+#DRN25/#VGB3JWR>\ZG
ML_V\9]F^XFWYN&Y-DAV'-+/=56:\PH;,B$70[9K+D-MFS+1*<??LD^7:+_'4
M]%4ZX4*^]HUU^0U_ WS9\H=%\E^;\G2_+N?+N.AY,2RX9Y$N;E<YP<>94YXQ
MGCDHSI%M73:YG_LI^VSYG^:?FO\ ++#YA\[;3;[+S9@W,MMN<>%OD<XX\.:,
M^1N3Q2GBS8W/'S22E5II24(]Z$   #0<:_-&?O\ $Q5NC730\#S'U:T3-?:%
MCK3J--"/'WT)5S!<C=7(I3K[!\?J]E*&V9\F7!=)*4K;X'4]74.?LT!]M9WE
M5U/C/V&8\DJ0Y'/$#0K<!\/^Q$<!]= D<?F8M>%E7ELM.<?[+[8UT_WY1SK:
M"C.$W7&,B:&HM3ZR=?\ !6R_H!QY,NN$G3PJ&F2TSKNY6:^M]9>LUT0$C\1@
M2@@ZG3@KRND\2.1K&M#))T.L+H%MJ<0M*D+3S2M*DJ3U 'BE0!&HTK&8^\XP
M_E&16D%=LOUY@*024_)7.;& /WAKHR^@$$+/O!/MK*M,RK7$1=_-TK.OI;R=
MR:T D%JZ0H$_7H'#J?>C&7QY'1P$Z\?"BG)/0U9)]NAR2+WCY?;2E-ZQ;'[N
MVDCJ,%^?9I#B .(4ZZY=F XH_P!H-!(_NUKROBBO'EQ2.<VGO@VV>!:R*Q91
MCSQ2?XS#,*]0$'3^T\Q(B3]=3PZ8IX#P/"BRQIJ;'/%7J=LXMW$[,9<XTS9]
MR<<1*=*>B%>IJL>FN+4="RU$OZ+:])=!_LMA9(&HU'&K4XNE&7')!V:.]6'F
M9##;S#K;S+J4K:>:6EQIQ"M%)6VX@J0M"@>!!T-=.)V5P?'W?93B'JSY:F7?
M-TZ2=2=%>'$\R?#XUB54:K'TDZ@)U.J@!J1PU(TU(^-88=H,.^=&9=_ZXVVY
M_P ^@*\.',U/$X,MK943U)/45$\.1'Q)T-.)GI,M(*4 $ZGE^WA\*R-S423S
M^%6RGH4=074=(.A!"AKRX:CCI]1J3*MHI'9\O4DZJ41KIR&GZSSH%8S"?'ZO
MLK+2H'<LJ0'?NDZ<=0>?$ _IX55-:%%6F THJZBHZ:<M-/UFL,2H7E+2G\2@
M/>:&EPD* /!0(]X/#3X@U=#79%M$9H**OO'B" 3P^KP!J&@TJ(R%N);3U+.@
MUT]I)]U;&XX'2FXL=$AF]H1Q#D1$M*=./4RVA[EXDNL'XU\KLY:19B=,B9R+
MMEN'5"RNUJ.GDRK9<&D\=5?,M2H[YU_".GY1OV'C^B.IQ]Z$^YKZ>TX[Q:QD
M;4CD/=7Q!X'<K6Q,/*ON#],C_/?U,^T+U%_\[?Y5_P"2I@UYPO\ R=_RV_//
MY\_-T;DH_,O\P?Y^L_\ *_R_^86OD_D=QZ_D_P 8\W^',L=<BG6PY*R4NPKZ
MGWID?^S(CVK_ /Q[?\F?^3/OE!WG_P#!M_F)_.OR7Y9_Z#?_ '?8+_+?F_EW
M_#/]OZ>O_ .G',D.>FM*,3CS4[CMGU/.Q;_V8]V=Y_VG?YI?Y-?SS?<"O7\_
M?R1_F'^5_P D9E9LM^6_E7^;\&^=_,_RGY?K_,F?)\SS.ESIZ#DX\\>6Q,H\
MRH=&][?I6_\ +']-K;'T]?\ /?\ RY_RXL6PUE_S=_RP_F_\Y_R2QV!8/F?Y
M!_S#Q?\ +OYF^2\WH_.G_DNKIZG].HU+'SX^2O88X\RY3TAV'VQ_R3V.V:V9
M_._YF_RCVIV[VQ_F3\M_)OY@_D+$+/BOYW^3_F%V_*?S;\I\_P"6^:D^1YG1
MYKG3UFDJ)+L.RT5#RIP;T>G=B_5$R[U%^V/N-_R8Q'>6)(1W%=K3NT2LKP[=
M>Y7UYV=FEZ@9A'W1Q56&W*_9$U&OT=S\EN3D"_"6\%.PYKL!/+PZ9.>+HNPY
M.%)\R.>;!>E9_D?ZK?=/ZG7^>_\ ,_\ RF-J9&V/^2/^6'Y+_)7GS-CI?YW_
M )E?YAW;^9.C_)GI^6_((&OYEKYO^SZ/[#'3(YUNC%&DG(]=Q79G6-C\].ZO
M]/7LGD_J=[3>I)L[NPYLA+Q'=?$-Z=S=D8>V;.58SN5N#C>1-WR[WVPY&WGF
M+*VX?S1+*57%*;9=V57!3DQ"$J=<;5YY85S\ZTU.<L:YN=&S>+>E%KZLN8>J
M?N[OTG=>[M;>O;>;#[*G:EG&;9L5"58H&+,W&#G+VX.3/93,389-_P#,TM%K
M\R;D<I\%"4H9K>3W^=L<OO<S/8(5WX%JYY"]W'I3#N#]03M ]1;:G?C_ )/^
M\?;-Y5BS2&C:U&X,'?#;MF[2G583=9;>X.!N8HY,Q?)\CLLBX^5=7W(5W:Z4
M-F"T%\I8^::FG1HQPK)26C1[ )Y"J=S7<K6QN83'*J*5B2>?PJ6'8G6$DA5L
MV-RM847:D@K51L"5"U8FGE\:QDNY*BN82%4S8DAS'OK"G8N5)!45? *Y*L++
MB>0J7<EW*U43"8Y5I2L23S^%2P[$ZQ7))"K9L;DAS'OK"G8L&;'"^GK//3J
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M#+RX=KBB\N=1CDBI2\7%2:E%*27,:AYU+V/W0E2D9+T9WD"W_+N%IVYVOPS
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M=9HW=5W_ $J>V_;WZZ7;IN'\A9M\,:R#8W(WU-L.7E D9MM\\ZOI;0XJZVB
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M?;76A25#Z,9[SFTK(T.O2K3EJ-.(^HZU+5#78RZ@@K5JP%:8* ^07W>OJZU
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M.LJ@.?>$R6T($1_0QHZG66YJO7CP*.LM9'2,*7N?H&KT%B@% * 4 H!0"@%
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@-!Z^7/6* 4 H!0"@% *
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M6*EY(6EB(S'TZ27-5 ')55'JD^VFO=HM/:)*E-']1]K;;+;O<4R8\W.,HNL
M=+T:?8.WO.\59EK2VVVZZ+Q?X666F8VHIZ5)::8*E));^[SX9XU:=%7OFG]2
MHSCE2K95_P!2_@>?W>/><YE[C"VWRYY5-Q"+$CNXC^?6)_'(KZ78[*KD^S#^
M1MD:=+:EJ+3DCR$.%*4I*4I U]^QCC6*L4N?C1U/1MU'DJJ<W$]".T2X9?<]
MCL;E9BY.??\ FKFW8I5R6XY.E8TW(";8\\X__'<:#GFH84LGJC(;*24%-?&[
MQ06X:A;CZ3RYU%9'RFS5>4XB@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@-!Z^7/6* 4 H!0"@% * 4 H!0"@% * 4!X >K]CSC6[.UF2J:*6;YMO.
MQU,C[^CB\=R2Y3W6@.OH!83E:%< %?Q.)/#3[!Y3R+'Y@@G^?%.*]2YOL16/
M3,N],Z;]+7<QG$.Y"TV:XRTQH.YV(W;$5!]U+,<7]@Q<@M/65:),IV39'8;
MU!4Y+Z1J5 5Z_.NV\'JF+=I>YFQ<K_U0?X-+U&YE3*I<&OL/TQU]4(% * 4
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MRXCSW&.L*<3&;_)=YL]WTS/^EW\>7)PE^62[8OZ-<:/0\CK%\L]']3/4@$*
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M1)PS=CK7MYLZA5MM&,Q+3:T0_+BJM\1M^2F8%(ZY<M]]1E3)<AI)29#CBW=
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M\<I?]%-_<>R3Y8N78CV>[(,7<Q/M5V?@/M%N1<K%,RATG3J=;RR]W3(X+AT
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MS!C2T/A*>IV48"E*2VRJNV"?++D?PO[3U;++R9/#E\,OM_C8_82 $CI2  /
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MUQQ3JW8ZP55J<>#KH5UAQP*Y]06H*U]NNNM=*(Z41RRTS')3*TNGJ<9*05Z
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M<0S?L]"K;)QB2^D]!5"%E=;!Z7X+P2>O^A_+/R>Z'TOEW'4E^JW2XY$N1/\
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M1.;)',TXV7'M]5/XF9LD<CTLN)W\;-E1O;-V&?W)$,K8_,,?3C>)FU3HS?\
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MU]-YGR9*0E%QBM=>)6?)*5(M-(W9KPGG% * 4 H!0"@% * 4 H!0"@% * 4
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MQN_'RX/"P3QPWNPP2\-SDLW.I9X:3PXZQ;HWJESO<#:6=<;A<,IP*[Q,?O\
M=$M&_P!IND1R=BN4N,-)CQYEQC1W&IMKO#$=(0)L574XA"4O-NA*>G_&6<N6
M-:5H?ZT8VI>Y*W T/W1PS.[:F0K), N;#:/,Z[OC+J<HLJDMDA4E:HC;%V@1
MU#C_ +1%00/;7##U+9QR*+R*.3LE[OVZ/U-G;)T[/.#<%S1[C2F==+QB]U9R
M'$[M*M\^$\)$69;Y,B))8=03TK;=86S)CNCV@I-?;\6#9=4QK'G2YU:2TDO0
MSZYEGO.G3;@GR.Z>L7].XW:V<]0FX_[-8]SK*+RJ.A+3MWLX9AW]2$?BDO0'
M7&;5>%=/,M&$I(&JDJ/$_&[_ *1N.G1\2;Y]O_/_ .]_*_J?:>_9[W;;_P!W
M&^3<*\']SXKZUQ1OI8MSL!W*B*DX?D<&YNI;\V1;%ER%>8:2$DF7:)J(\]IM
M*E@!SRRRL\4K4.)^B=<V[<7.GNOB?:>F3<)*,KG%,@8_'P]OT^G.ORK=PY,[
M1]]V\N;$CI2_,?CX>W]?[=:\QW.E[ZSQ7P]O[JU.CJ9)531TU?6.+G#GK]#7
MV;I^2Q\!O(7.FKXSP7P]M?>.GSL?5MY'5G4%[9_%P]ONK[ML)V/JV[A=&Q'8
M*S*=[PM@&XCP8=1NMM\ZM9*@%18^;8^_-8U2E1UE0FG&Q_O^8YU^J_+&&7)\
MU/*JPRY9_P#F'9.O^59*S7_%%./K/HWG&6.'D?KKR*L?]GW2];QM1?JDT_4?
MN1?<B-@EV*ASVGGR^I6O[:_VDJN*/\WSY2LCL$0_Q8RHY'-8B-*'#0<VBI9Y
M^RBE'L%2TYN'AS.OG7E#1 !(<AW!.GU:_*=)(^HFMYX]HJC#5NIMZ@=3F56U
MH<=0[\PTH:'3BAQA*A^BG/'M,JCXDO??:2"HIDYK;D$#4EN-<WT_\_'@NHU^
MK76GB0[1S(X)>N[G8BRA?7EDNX.(*@IJW8YD"U:I*1HEV5;8D985J2"EPC1)
MX\M9>6"XF<T3I3)?48V:LB74V[&=PKV^@*\M2;;8[=!<4/,2E*I$J_JF-]2D
MI.ORRM$JUY@IJ7GA95#FD:MYMZL-\B^>WAVS5JC=&H9F9+EDNY!S[OXW;;:[
M1:?*T6?PB4O4#F->$/</@C.?N-'-S?4_[N,B;D,V7*,9V_CNAQ"FL-Q*V^;Y
M:AITHG96<IN,=:1R<9=;6#R(KF\\VZ61#G(\W=U]]-[-T!);W#W9W%S.*\>M
M5NR#+[[<;.@#DF/9GYJK5$;!X]+3*$]1)TU))YRE)_$VR6V[G0=BVPW%W)N"
M[5MW@699Y<PM"#;\-QB]Y--"G" V%QK+!FNHZB1IJ *E1<G[I.K>B-RMN/1[
M[Z-SE17Y.VUGVSM4O3INVZ&56RQAD'IU,K'[*<DS&+T)5Q"[8DGCH">%=? R
M2X4*6.3/0+;3^GCM3AC2][>XN?)2HCY['=K,1CP"@?=*OE<RRV7<@Z5ZD#KL
M*.G37CKH.D=M3XF6L7:ST9VL]'+T_MKBQ)5LNG<F[,A _-MU\@N^8A[I2 ?/
MQQ3\#"G"M0ZB?RL'4Z#1/"NJPXUPJ7R1/0W"=M]N]M+8+)MQ@6%[?V8::6C"
M<6L>*6P=/+2!8H,"*-/#[E=4DM%H51*QS%:ND?6>7VUJU-2J6?-5]7NTK:&T
M,A)Z@#[:PPK0P4 H!0%MIEIA)0RTVRA3CSRD-(2VDNR'5R)#I2@ %Q]]U2UJ
MYJ6HDZDDU@+E:!0"@/J6EOJDE9'!I!(/@%*T2/TI)_17+*Z1IVDRL?E![17X
M/<)O'W7][N4=&2Y9NEO_ )_BNVN17%!ER+!LOB#D.TX?9\>??*OD(7Y3Y4%P
M-)2IQFW-=2E:J _N3R1T?#T?R]MMI&"CDABBI?ZFD\C],IN39_DA\UO,NX\R
M^<M]U#)DE/#EW$Y1U_[-2<<4?1#%&"1Z%5]P/S0I0QZ:G6^<X^UE,5%JN,V0
MG'G?.%[L\9*6AD3!#:6K5<IG%]-A='F?-Q6@A4Y/2TZY\L9#$CY#;X?$I&7P
M\5V]S[NWM]%4_B-WN'AK**7B<'V=Z7;V/A=:T:X1>W&V6_*:2AIII ;;;;2$
M(;;;2$H0A"0$H0E(  ' #E7W;IN*R2/S#K6?24G<Z)R:3IYG'P/VU^B=)Q5H
M?C/F#/12U-;\LE<'>/\ >^VOO>*/+C2[C\BW4_$SREWFEF\><Q,2MWG*9>N5
MXN<E%LQW'X*%OW2_WF4XAF+ @16DN/O*6\ZCK*$J(!  4M2$*^C>=O,>R\N]
M.GO-W)<U&H1K1RDOLBKRE:*[Z)_J_P K/)/5/.G6<73.G0ER53R3Y6UCBW?2
M\I/W80O.6FBJU^GKT@?3JG=GVW%VWVWQ@1Y/=7OG:X;^11GVFG7=J<*=4U/M
MFV5O?U<+-Q4I#$B^J:4&C*88BI+B(:7W_P#*SYH>?MSYXZW-8YN73<>1M/AD
ME;GI_+%>[B7"-7>32_Z"OV__ ";V/RN\L8O%Q*'6LV%)K1O#C^+PV^.2<O?S
MM:.=(JJ@F_8%2E+4I:R5*42I1/B3SK\V2HJ*Q_0I&M H!0"@% :6]Z]_R^RX
M=A\6PRY]OL%YO%XC9-+M[SL<O2(T2W/6&V2WV2AP19:5S7?*ZBAY4<%0U;37
M7;J,LCYKI:??]QZ-NHN3K=6.']G.49W<XF16V[WO-W,0M08-FDQ[)&R&VQ+J
M^5&9;_GKA8\@N#20SY;B8<1'0%.*=7T!1*VZC"+3BES.]-/O7M-SJ*::2YF;
M47!R]?S% <<?WUN5H_,(JT"U0MH[1C2CYK:%)N3,*)CFY"+1H4J<0MI*^DJX
M\"$^;5Q_+_UJ_?&IP5*?EKZZ_@?8G6R_O[B!=KMVZLNWJ#:[@Y9=PL<LF'/D
M1%+4U9;7<+LO($*(!#ORX@,AT'103]XQ*BQ.M%Z4V_7I3[29->'K3V.IP'NG
MV_SK+]LVF,'QC/RY;[M'N-^MEQSF5>G;C9F8LQ2H[&/-Y5D4>\/Q[@IAX:$/
M(+7\-+FI*<VF3'#+7(XVTTIKZ:*A.&48S]YKV?P.D^QC;_<.U[@WO*)MIO5@
MQ1G'9=JGKNL&5 8O-QD2X;L*%%9EH9,EV"6%O+=0E08 Z"4^< ?1U#)B>-03
M3G6NG Z;F<'%15'*IZJ5\0>(4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4!H/7RYZQ0"@% * 4 H!0"@% * 4 H!0"@% * P;G<H%FMMPO%UEL6^UV
MF#+N5RGREAJ-"@06')4R7(<5P;8C1VE+6H\ E)-8W15=@?EQ[@M[;QO7G><;
M]7,R(]L^:7@NSMID%0_)[(PJ4&K@AL@!N8W%6_+6L=21<9#@! ;1IX%')NMQ
M'%C5<DY*,5WMT2]K/.VYRT.H]B\23=[[(R.8WUP["4"(%@E+MW>!4VL>"ODF
M05GQ"UMD<J^4ZYDQX\\>F;9UVNU7)7^;)_VD_2Y:?Z8JFAN5I/DC\,?MXFT6
M39#!Q6R3KW<#JS#;U0RE02[*DK(1'BLZ@_Q'W2!KH0E.JCP!KX0YG4>#VJ;-
MN#V:9(3(R&Z@+CMN ^79K>O7R845M6ODJ+2M%?VD@]/,K*OU[REY>CT_ NH;
MJ/\ X[(M$_R1?#_4U\7%+W>VOR&WP\BYY?&_J-B+1_9_WP^RONAZ3M*SG\'U
M'3Z?IH#M*SG\'NT_0?\ 10':=H/X3_O30'** NL/O1GFY$=UQA]E8<:>:6I#
MC:T\0I"TD*210'?=@EVG=2UG';V6HF5PV'7;9<$I0W\V4)!4XVE(2"HZ R&!
MP4D=: .G^'$Y\BYG8QMKT'A?WO[)W/9K<>%N9CL55G3=+V6KVQ'2$Q[7F,=)
MG-360D(2J%D\-M;_ $Z%*W&W5*/2ZE(J,E)<T;,VYW[M?DT3+\9LF1P]$M7*
M&AUQH*ZOEI;:E,38I/B8TMI:-?'IU\:T&_FU6XL=R,C%,X";C893:(S,Z4"Z
M] ZM$-MR7"?,7$;YH<'\5@Z$$I "3JEI<.VA][</;^3ALQJ1'4N7C]P/5;I^
MJ5]"BGS/DY*VP$>:$?>0H )=1Q'$* Y8\L<FB^)&1E7TGYVX6.1,?WDW VZR
M5D_+3Y^2XVDOCH4MQJZ"=:9S*UI'2N2Q%0['5H.I3B"!Q%?EOGW;3AU'%NZ?
MT\F+E_XHMU^J2/#NHM34N#1V3A,@H=N.UV9LQ[G*LR [:')\9#\>\V <(SB4
M2 XA;L-!"=.)2G[HU+:C7T0\IVAC6)V['I*Y&*7;)<*G*"NB7BM_G6MS0E2N
MG4..$-H6LD(04@ G32KC.2T1494.\[9FF[4:,AD[U[A26EJ;:/S5V?ER5(24
MJ;4)K[ZY#:]?QK!U7R/"NBR3[70Z^)+M,VXR[O<X*9]^RG)\KG)D)\MO(KS,
MGQF"XE:NMEAQU!;(4DI "P@:$ :"MYV^(<I-:ZG)+';TRK5%N+3ROF6T2FI"
MT)'6ST2'="F.T$M2X;C13YT90T6@ZHT5]U2ZKQ,NJG&LVLLG(T,S8[!=G6F(
MJ/,@H(D29EF<4'(\NT/]9^?@,J<<4RA>KC*UE.I2AM"8?:8VW<Y/M%&:R#&9
MF.GR5W#%Y8>AH=D/1DNP9RG7H-PM,Y#:Y-IFQGFUI"FD*86R&NM'4XI9Z**F
MM+HJ$>9.GQ([=VEVE?G9@<POKL>Z9!;$.P8V1_ED*V706]UA<0'(7+/)=M=Z
MO B$LL+;T 9U4KB4H8Z8<5'S.YVPXJ/F=S=A$9F,RVRRCI;:0$I&I)\22H_V
ME$\2?;7JX'K25"7 )X?56\1Q,=3B>7U\_#D:Q7-T9 @'@:HTLJ2$G@-.'[ZQ
M L+=Z3H!K[>.GV?76@AU=7WN6O\ JH@05X>[[36\"U8QW'>@@ :DC7ZJDTB%
M]?$C32M6AO"@K##'?6I*!T^)T)]G/]M:C;&(RM1<T))'UG73D*<"EJB]6LTM
MK40E13Q(TT^) _56*]2:W,)"UE8!).NO4#\3KIR&E::90\?A6E+M(KY'CIKJ
M-1]8-$.)\M#;R5'0*!U_$-=/?KRTHZV5S7<S_#X4>M#> %8KF*Q\U^.XMPJ&
MA"M#J3IT\!P/U#ZJU(IHRFF_+0$]15S/NU\!]6M"D5U^\1[OV"DK(TLOLETI
M(4 0--#KIS)\->/&ET8U4S+:/EI40]6NDEHJ/+@5I"@.(X=-;3W6;3W7Z#LW
M6N1YZZ$5I"]$GAQU!^L?Z*<#0VT&TGCJ21QY<./ "MM8Q*A,*2DC50&NNFI
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M*J^J*3]ARY,HO1U)2K^T'"/J.I.GL*%DG7V$U2U-[CG&)3OEVY+ 4 E,DN)
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MJ 4TO6,K0AD'_'+SOY=QPQ_[OTJN3IT]=-7#C27>NVTHTDN)_K'Y:ZMDY_\
M;^H+DWD=.Z7"L>Y^U.L7K2NRF561J1(^?8)AW-I :;G-(!6XRE2EB)-1JD38
M2E*.K:CJDJ*FU(7]X?FF+<2A!X9KFP.\7P?;%_EEWJ]FFM#[K/$I2YXZ9%Q^
MY]J[O91ZG4EW:>4UU/LI9?(4'&T.>:@*22DEMP)05M*TU22E*NDC5(.H'&:B
MI-0=8<'2GM7;VZM=C:U.D7)KWE21T]?6."^'+7Z"O;L9TG0\>[C55[CIN^L\
M5\.>M?=^GY+'U7>0N=.7MGBYPK[OL)V/JV\@?H/]$G8V1C^,[D;]7:$IAW(5
MLX#B3SK(0MV!%?C7G+I32G$^8Y$?FM6R,E2"$^="?0>I22$?Z-_LH\FY8X>K
M?,?=PI'.X[':MJ^/&UDW,DW>,LGA136E<<TZM:?R!^Y3S'#FV'D[;RK+'7=9
MTG:<TX88OLDH>))IZTG%Z)Z^^;$AM])*2.I/XDZ\4_7[CX&O[Y3J?RF7ZT"@
M% * 4 H!0"@% * 4 H#'=/$<1H!RUY'W5C+B74:](UY_IX>%"7?0G6F"@% *
M 4 H!0"@% * SK:I*9;?5_:ZD@^Q2DD#]/+XUSR*L#)6/S(X9N%C'97ZFG>U
MB?<^AO#;EW+[C#=+9?=S+4(BX]F.WUYD2W;/BENR:8EFWMIPXSQ:T,%8)?9>
M8U\QMI#_ /4/E.>W\P>1MKM.F9(QW.WC",X5I6<$TXR[')_U(UT?-ZU_GE\Q
M\.]\H?-;J'4.NX9Y-CO)Y)X\O*Y4QY9*490T]Z,4O!R**<H\M-55/TRN&+8-
MDR$WK'+JRB//;1,:=M4B-.MCS<A(>2^PVE1Z$.I<"@$+2@#DD"OMVRZWUS81
M6VWV/G4=$YIJ7=[UI>FC;O5GYMU3RMY6ZO.6^Z7F\*4W5K&XRA5ZOW'K%_Y4
MTE911P&Y8<N&%&/<X\GIUX.-+C*5H.0T7(3K[R!7V;:]<CGTR8I0]#4ONB?1
M]_Y5EM4W@W$,E.V+@_ME]IP28%-!:%CI4DE*@=.!' \0=#I7V'!2;4HV9]-W
M2ECK"6DE<U'WA[HM@-HW)47<'=G#K#<XI4)-A1<OSK)6"GJU\S&+ W=,A0-4
MD F-H5#0<:^8Q;_8;/7<Y81:X5J_8JOZCZYFZ1U;J>FQP9)I\:4C_P!*5(_6
M:K6_NLO>]+KT;MF[9NYCN%)6M+=[P?:V^(PT)"U-!Z=DKK$A5JCE\!!<DQ6D
M!7 GJT2>6[^:OE+R^O\ Q6:*R+A.<,=?0I2YWZH,]/3?V^_,7SA*O3]M-XG=
MX\>7-3AJX0\-+O>1*NAVSC'8EZKW<#(0R]M1M/VD8M.6E3F2;H9Y;<]RYB 5
M#S';5CN$C($BXA!(3'ND&$%*3Q6VDA9^B=;_ '6=.V6&6+H44\W!PA*<D_\
M5E6/'Z6H3[D?KOE7_P!/KK75=S#/YLG*.VK5QR9(8H27&N/;RS9J]B>3%WM(
M]?>R;TG>WKLUOB=ULDNUV[B>Y=]'7*WFW%B,==@DN-K9?3MSB9DW2#@[#C*_
M+#RI,^YMM%33<I$=:F*_E#SI\R_,WGG<3GO\LX;3(ZN/,Y2GV>)-T<DN$4HP
M6E(Z)G^B'RL^0WD?Y6;/%CZ1@QY-]BC2.1XXPAC[7AQ*J@Y?FG*4\LFW7)23
M1Z<R)#DE?6X?J2D?A0/8D?36OH48J*HC]N2H6*H"@% * 4 H!0'3N^>#X-G.
M 3H^?7A&,VNROM7B+E)6VE=CFI"H:5>4YPGLSTR?)5%'WWU*1Y>CB4$;&4H3
M3AK*U.WZ=ITQRE&7NZLZK[:MM=E[9$NEWP#,3N/D:0(UPR!$>[8Q<K/$6K5+
M-OL#BXMXL[$IUO4R5K<+JFP$.) 4D[FG.3IF7+'L_C9E99Y'I-478=\7S"]L
MI;0O>38]AD@L/I<.39!&M3L],AC[Z5.Y7<R;DIQI2PK[\HD*(//0US32]V+?
MH3?V?P.:E):1;]'\#ZJQM6YFD.;DAVU<RJ7 A+$B]+Q)S(7K&6WODWF%35*N
M9M;S07T+1_"<2GF0.$2KX34.:G=6E?L)?/R-1KR^L^QF=V[>+=A=\=R5W;=S
M%I5O5\_$@&PNNW-KH6]'9MT>UK3-E7!:CU1OE_XR7-%H*2.H>6"W+FN3FYZ]
MYQBLKDJ5YC6OM9S;MK5G=SLFWF(7[%<LO#4U%GN&53$W-^Y6MA/SLBU6V1^8
M31;74-1B\IG12W6V]5/.%(2/5N\>Z\-2RR3@KT.N:.;EK-IQ[CT-KXT\HH!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#0>OESUB@% * 4 H!0"@% *
M 4 H!0"@% * 4!^?[O S#_,CO/R..IX.6#93$[;C,)07K%%XDQOS6[/+3^%$
MAJ=?I#"U'CK 3_=!'Q^XES9*<$<,CK*G8>>L&RW3-=P+%D%QBK%GR_(;I+@+
M>(_VJU8VXVJ2UT\5!AF,TF,%$ *6DI'$5QUI7@<S;G([RSCUBNM[?Z2BW0GI
M"4*.@=>">F,QKJ-#(D*2@<N*JP&L^%L/"*9\Q9=N%XDO72<\O\;CTM1<!5[#
MTG4CP437[;Y3Z=_M_1X.2IGS?U)?\2]U>J--.UL^3V\.3&NUZG==H_ZG]/;7
MV4[':%H/X/=I^C_50':5H_LC_<C[/WT!VE:#^'V:I- =IV?^Q]1^S6@.6T H
M!0%E]AN2P]&>!4U(:<8=2"4DMNH+:P%#0@E*CQ'&@/'#LT<6G*,O:"M&UV>W
M.+3H.*VIKJ4*UTU^ZEY7Z: ]4,?/^'KX#4_3X4!V3'??C+0]'>=8=2DA+K+B
MVG$A22E0"T%*@%))!X\0:-)JC54#K#>/$D9UM;GF*EH//77&KD("%#4?FT)D
MW"S+(\?*NT1E?M^[0'D5V\70KAY)8W%:H8D1+FP@\=?FVUQ9?P3\JS_SU?A/
MF7:K9];W&**I!SYEZ)I2^IMKU'Q>:/+E:[_M.=;7[3YSD6[EYVRV^S&S8U/N
MEJFY;AMDRQJ4K&LC$4A^[6-F5#9G2;9<HD5#SC9;8/FL15%:V]$E7PT(/(^5
M/4F$.=T5SNB[[7=TF'2%1,BV!OUZ4APH;NN!7&%D<"6G35+C<2 [/FQFE:?]
M7*%CQ2#SIX<L78WPLB=BMEA;YW I3"[<MX6U%?E#\[Q:XX^A2PD+7UKN4-L)
M:"%?=6?NJ5]T<16*&1VBZA1R<(L[[P_83N;OZR9>-8MMM#>6%*D9#?HUYN"6
M@2=6(MB_,T%WB1TOMM:G^Z.-=XX9\;'6.&5-=&;9X!VR8UB\IB\YE=IFX60L
M]*VW+HPB-88;@(7_ +)9$N2$.="O^ON.(.G4&T&N\,,8ZO4[K$HWU9LJ4A*$
MI2 E*=$I2  E*0-  !P  '"NAV5B)XT!BO@G30:\#5(U%A .I/$</T\:TLBK
ME\?WU*N2BRXDJ20.? U11C)2H*U(TTU_=4I&LF>!%6@BPH:ZCV@C](K$'<QO
M**2"2.'&G U+B2)K [D%\3[1I^^MX%&&ID=05U:#4G33D#X<Z+L-H3.@!'@!
MI\!6\"N!9ZDE7 @\1R-.!G LK:2HDG4'3PT_<:=X:15 2@$#D.)/[2:Q7"+!
M?;4OIU(X@ GD3I6\2JZ4*J0E8T4-1]/$<10%L(2C4)&G$>T^!\3J?&M=JE(@
M7VTE223J--= 2![Z-JHXE3HI.O!0(]X(K$'P"4I3^%*1KPX #]@H:K&&](\M
M10$ZG0$DG0#V>^M;X%.Y=:<#B.H#3P(]AT]OC2N@5F/[1]W[J,<"W(=+2$E.
MFI5X\M-#K[**Q1!A\NGI4 %)/,<B"?VBM5F$SL^(OKA15:ZDL,D^_P L!7ZZ
MY\6>?\S])=6M24]21J0-/=KKQ/NUIP-+;+[BE *T((/'0 C0'CPT\:SC0(RP
M>.M;8G\Q(D]*NGGTG3WZ</UUCU9:/GMN/)< U65$Z%)U/Z0>7.MT>G$S4^EK
MJ#5%-U1='(:>RH9G&I\U:)?F$'K)5XI4>GP]A  JF^PVSJ[&L_>M8G+YVP;F
M-H252K+"L63-+3YA\L8SDMFO4U?2V4]6MMAOIXZA/5U<P"/DNA]1_P!GZWLN
MKUI^DWF#/773PLL<G#7\O#7LU/J?GWH?_FCR/UCRW1/]?TS<[:CI1^/AGBUY
MO=UYOS:=NAX(SFW5P9"F%E$A#1?BK1H5(D,:/QG$GEU)>;21]=?ZG_,7HZ\R
M^0.K=)PI3GN.GY7CIJGDC!Y,37;_ %(Q::]*/^=3Y,>99>1OF]Y>\P[AO%CV
M?6-NLU:Q<<4LBQ;A.NJIBGD33]#/TR8+DC>?X+A6<PBVJ/EN*6#(D)0= U^;
MVN-/6R05**%LK?*%))ZD*20>(-?Y-1=8IKB?]*\)<\%)<4F?-W'VDP[=6Q1[
M7ED%T3K8\J9CN2VI\V[*<3N9Z?+N>-WME/S5NDH*$]:05,OA(2ZA:/NUVQ9,
MN#/#/@G*&X@ZQE%M2BU9IK5,\O4.G;'JNTGL.HXH9MGEBXRA-*49)W33JFC4
MU>1Y/M)D;&";OR6)UMFRF(&'[NQ8R(%DR%UY#?RMES.&A:V,3R]P.)\M?5^7
MW$D^2IMT*9'[YY.^8ZWOA]-\QN,-W+W89K0R.W+/A#(^#^"?#E=$_P"&OFU\
M@=UY=>7K_DV,\_15663!K+)A5VX7>3&N*=9P6M9QYG'GEXP1V]WBV9=AM_D8
M%NSCK1;QC-;<E"OF8OF>>YC&30'5HAY'B\]T?Q84K5LD]3:FG='!]D\X^5.G
M^8=OXF=.&[@J0S159PXTDOSXZWB]5JXM._YU\L_F%UOR3ON38S\38Y)5R;><
MJ8\ME6+U\/+1)1FE25$IJ22ILMLWW)LY5>&=K]V;3'VVWICLK#=D>D+5B^X#
M,5*0_?MMKS*2U^91W1_%=M;Q%S@!12M#J$>>K^;>K]&ZAT/=?I.H12;UA.+K
MCR1_FA+CWITE&TDF?WKY3\X]$\X=/_6])R/Q(T63%-<N7%)JO+DAP[I*L))5
MA*2U/*#U(,71C_=$N\LH(:S[;/%+_(<T 2JZV*?>L3E(&G$E%JMD DG^\ .5
M?U7^TGJDH=3ZUT23]S)@P9XKL>.4\<WZUDQU_P!*IQ/\[O\ U(O+T)]+\L>:
MH12R8MQNMK.7%K+#%EQI_P"GP,K5/YW6NE.5^EY=G8_<-GMC25^3=MF9-V>
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MR<W*WV0Y5V)(WK1<%,,M1XD>/$CL-H9899;"6V66DA#333:>EIMMM"0$I"0
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M-:#3J5IKIR &I\:UZDO1EUIU+B>H C334>S4?LXUE-:%(O#G17-5RP\Z6AP
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MT\N:EM/3PH>S/R^$^;U'N?7P!\:* 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MTJKZFJYDGD?A]E9Q"*^'PK>!G$^<J*LKX*3TZ\"===#[1IIK6*Q1GG@$CV)
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M^W?&9)B/]P^P]PA-JZ2AG>/;QX-@D$KAR6\A<;4DCCT$Z:_W3K7W[_>>C_\
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M!XU@+T78?>K)5I18MI-Q[FEWIT?C87D!AI"PX6U.SEV],-A#GE*Z5+<2%$$
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MJ^1RSWLL#YXI1IKVT]%?;]QZIRSO'JE3CVGIS7Q1XQ0"@% * 4 H!0"@% *
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M1Y5TPOER)]Y>)TR)]Y[V+\/C]E?)+B?(&(HG7_FJW@:KD%?C^(^RA3L6G/\
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M+C:DK0HA22" :O.JS@G9O\"LBJTC]:AVFVL4K;A9VVP(*V=<<=VD*<1L"?\
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MI/-"78JW5 G3^\ : Y/!W&[@\?2&X.>Y<IM  3Y^0+N24)1ITA NC\A24CD
M - -.5 ?1F]P7<E+;\J1N!D320E:=8HL]N7HXD))\Z!$C.]0'X3U:I/$:&@.
MH\ER#.LJ<#^6Y)D.1.H45MJOMZN%V+2M"/X(F2)"60$J( 3H . X4!PPH<02
M'$])U^Z1KQ'Q\10'9F/YEN38&VE6:Z3WXO0DML.I9NS/ED I2VQ+;D.L@:\D
M!/&@.UK;W)[M6H!!Q^PRU#314VPWI*]4Z@G2)=H:-5$\>'NTH#E#/='W#24]
M-HQZWQU.*4II=NPZZRUH20H:-B9*GMJ0DD'504=4C4Z:@@8EQN7=?NT%0KYD
M-]@VJ0>AZ.[,@XE:BTL$!J5;;(W#E3F E7);#VNFJB5<: X'NGLG'VNPNRW6
M;>E77(;O>_DW6HS7D6R-";@27W$QPX%29+H?2WJZHMCI( ;'$GXWK23Z/NZ_
M_@V7_P!B1&3^W+_2_L-B>UBSNYKW(]L5D=0XN-BF-+S2:L!($86NPS9MM4M!
M T2Y.M$%&H&I#J3]=?@F%5R(^-PJN1&=*LB<-W=W\P1M"FHV/[JW^?;65Z=3
M-FR*2]/L[>@T'2+>V@Z@ *)) &NE3D5)M=Y,U2;7><.W4E/VK'(.214]4K%,
MGQS(XNA"2F1!N33;)2LI7T$KD@:]*M->1J4Z.I*='4_17'E,S8T>7'5YC$EE
MJ0PYTK1YC+Z$N-+Z'$I6GJ0H'0@$>(KY9(^3)*Y?&L*C<Q%JT5]9(^RJ2-X%
ME2B20?;K^VL"[""N1^GC2Q2N8[AT22/ 5KN'<Q4K43H>.M$S4ZE5<JQ&(MD\
M.%.!5>)\U165Z<=?#3Z>VMX:@OGPUYZ5B+5C'7S'U?Z*WB28;@6#J.K0\01K
M]?L]E:;P)G7AKST3K[^D5A1%?+Z>PUJ^XU&&\A2NGIXZ:\-0/CQK7P9@;2I*
M2%? :Z^'Z*GB:KE#S_15*XXEAY'7IH="!P/OUK%8MEEIM2"22-".0U]O/D*T
MQ%Q7C[Q^RM=BT6E("TJ2?:"#[.?[ZEW,OH6 P$J"NK7IUTX:<2/>:I&4UH7B
MH)'42 -1J3P&AI0I%D*2H?=(4.7 Z_II(TM".V%=7$\=="1I^C0<JVZ =6E&
MI4=!J!XGB?J'&L5BN!5*TK *2"--/]?C6KB%8M.-MJ4DJ2">(U_U::TN:3^Z
MVGP2E(^ %#2RB4VM80 H=1.A.FAT^)YU@KP.16,CYQ22 0MA8T/$:A3:N7MT
M31V(FJHYB-$].G #V</$U*L<BR924D)TU2=1U:_K ^-9<TRTG4#W"LH;0EK^
MK]U+!F$J6M#Q2$IT22..NI^OPTJG8PS4+\Q(7IIU#E[".!_6*E7+5BX.=6K,
M,U[W9V78RN[ISG"+H,#W5@QT,,93'BB3:\H@, !O',^LR5--Y%8UI2$MNDIG
M0% +C.IZ2A?#)ACE5;2/+N=M#-K:?;^)UIB&\-QQK((N([C6O_+;<!_6/'@W
M%\2L-SE"26W'L+R)Q+,"^QGTD*,)WR;E'#G2MK4%9\&2$X.DD?#Y,4\4J37X
M'QMXNVG"]UK;E%PP#.I6Q6399';.;VDEY[;+.S"D,W%F7?K<R4-6VXL2H:%B
M>A =;!5JEX5-6E1/1DJ<DG%/W7<TSVA[9L@S;<RR&VW2TY-MWA686ZX99N!C
MXF/87=W,:N";BG'<1NETBVR5E4F=/@MM2)$6,J#&865*?+I2T>N'%*<N;\J/
M3M=O+)-2I_33/;6*MU2%=940-.@G74\]>)Y@5\BM4ZGSR/EY.GKLDE7_ %M;
M"^9\7D-_'_$KT;9_UD3,UL#_ .7;A66=KT"/?<?FA7W4]/D28:RKJ5]W\31.
MIX5\Y3FV\H]L6@]<#7<STT'*OK)\.K$D\_A4L.P<<0RA3CB@A"!JI1Y ?M))
MY>TUB3;HKDWT,076WE/7\RC37IT(6%:_[PI"].//32NW)+L+4)UL9S;C;R X
MTM+B%<E)((/Z/$5%*7-:I<OCD/=4$.Y6MB83'*J*5B2>?PJ6'8G6$DASJPKE
M:PLN#D/=4DNY*JB82H6K$T^-8S)$JQ7))"K9L;E:PHNU)!6JC8$J%DT\OC6,
MEW)45S"0JF5&Q)/,5CL:[%RI(*BKX&JY*L*+@Y#W5)+N5JHF$Z%JQ-/C6,R1
M*L5R20JV;$D.8]]84[%RI(*BKX!7)5A9<'(>ZI)=R55$PE0M6)I\:QF2)5BN
M22%6S8DAS'OK"G8N5)!6K5@*TP4 H#K;=[=7$]E-NLGW+S64N/8\9@&08\=/
MFW&\7*0XB+9\?L\8?>EWF_71YJ)%;&@4\ZGJ*4!2A,I*,>9V#:2JSR,Q)_+;
M]DN4;V;EAM6[&XZ6TNPDO?-0]ML*CK=<QS;;'W2 AN/98[Q7,=;2GYNXN//+
M+A4%5\=.3G)N1Y)/F=2_BF .]SNZ?^5:!(5M'@$RTWW?6\1U.-LW^2'$W"P;
M/0IB%(*WKZIE,J^%I07&MR4LE:') %7AQ.<M?A1>.#F];(]KXS,>/'88BLM1
MXK#+3,9AAM#+###2$H999:;"4----I"4I  2!H!7R!Z2]0PX9E3A:<AJ'#K0
M\->.GW%-G3X==<L@9'%7_,>F))U/EM*^K@I8.OU_>IC8K4T1]0S;N0O$[/N[
M9XW4[C:V[!EA:02LV6XR +-<72-$ANW79Y4=1XJ/SJ/[*.$9XZ<R(FN)H%VB
M]P[&U.]MD5>IJ6,2S53>(Y(MUSICPDW"2W^47ITDA#:;7=0V77%?@BNO:<ZX
MXI\L];,F+H^X_0V\E2T$)YZ@Z:Z:@'E7M.Z='J?+GV6WWJWR[5>83$ZWS6_*
M?B2!UH6.86DI(6TZVK12%I*5H4 I)! -*55'8R5&:%;Q;!7S$D2\@Q5,B^XT
M@+>D1DI4[=[,T-5.+?;;2#-@-#CYR!U-IU+B0E)</GGC<=8V.<HTU1K3BVYF
M4;=WE%ZQBXKBO:I3+AN=3MNN4="M?EKA$ZDH?:.IT4.EQO75"DJXUSC)Q=5<
MA-IU5CTAV?[AL*W7::MRW&+!F24?Q\=G/H)F%"=5OV.4XEM-R9(!46@!(: /
M4@H 6KTPR*6G$ZQE7TFP==#10"@% * 4 H!0"@% * 4 H#Q=[1O2AR#MD]4G
MO=]1.=O59LOLW=SC]PLENVLB81-L]SP=4W)L'R 2)N5O9+<(M]2VC$%-=+<"
M*27PK7[I"N,<?+D<ZW)4:2<NTY!V>^EY?NUSU'^_?OPG[Q6C,;3WG?E/Y9MM
M$PV99KC@/Y;=(EQ5\]DSV17&-D'G)B] \N%$T)UX\JV./EFYUN%&DF^T=RGI
M>7[?SU6NROU(HF\5HQJR=INW]]PFX;3R<-F7.Z9L[>&]T4)N$/+6LBA1+&VQ
M_F(@EM<"25?*J^\/,'2ECKD62M@XUDI=AK_ZF'HQ[J]S_=IMAZ@W9%W<7/LW
M[Q=N\*1MQ<\C>Q9.5XAFV*M"]0XLF:RU(0];;U&L>2S($I$J'>+?<X3<1HQX
MRXY?=G)B<I<\'21DHMOF3HSJON%]$;N][M_3;NW9SW/^HU+WMWRR;NRL_<Q/
MWXS':F8[8L5L%JVW9P2/LSAN%6_.+>S$QF#<42+LS(CFVQ_FKC)_V!"EJ<7D
ML4I0Y92JZU#@W&C>M3]&V)61>-8KC..+D)EKQ_'[-9%RT-EE$I=JMT: J0EH
MK<+27BQU!)4HI!TU/.NZT19X$)](?NYV ]0KN;[R^PCO)VQV<Q#O5>C77?K;
M_>O8BX;S2\<RL3W[K,RK;]<#.\+1=Y+5[N=PG0(LV7 BQ3<78[PELI9+7'PI
M1FY0=$R.5J54[EWTM/2([L_3D[H.Y;<6X=Y.V^[^QO<MN9<MV-RK'.V'D67>
M#/LI7&W"=LBI.1V_-8F&;=MPLCW$<N5Q5;;9<6[DN VPPS;F7W ACQ2A)NNC
M$8N+OH=';[_T^^\^W?='N;W<^DUWZ9;V'9?O?<Y-ZW;VDDXPK*MI[]?+C<I-
MVN$^T1HLY$&)9$W2=)FQK-=;+>V8,R:_\C(A1E(BMX\+4N;&Z5,<'6L70]+?
M3S[&^ZK8##=_87?MWN9!W^9)W!IQV'=+/EF)2K#MSM]C=NLN36;),-Q/&9F2
MW>P/6/,V\E5\^(EILC+Z([:7(ZS]X7"$HI\[K4J*:^)U/(J%_3Z=[_9YN#N'
M*])?U1\J[6MB=R<BEY3)V%W$PY[/K'B5TF);:<%JGW%_)++?W(\2+'B1[A(L
MT6\"!':9DS):F_-7S\&<7_3E1$\C3]UZ'IYV5>F%O7V[;6]V\;N*[\-X.\S?
M[N]V]M.WV3[D;G07X6%[<V3%<=W0LV)6G;?!I&1Y%.LUNC2MU[A(N2&[FS%G
MN-,K9B0W/.4]TCC:3YFVV4HM5JZMG5G:WZ-F2]NWH][Z>EU-WZL>57[>'']]
M+)&WBBX!/M5HL2MX87RD:0_ACN53YD]-B/WEI3<6OF.0**R.)QQ/'6X4:1Y3
MN#:WTD,%A^C_ &CTE]],\D;@XFC;>^8/?-R\1LPQ2=^;O;HW3=C$,QQ^R76=
MD;,*YX7E;ENEL,R793#[]O'F)+:RBM6)>%X;'+[O*SS>VQ]"OU)8.R<[LKW>
M]97/KQV+X]AEQP+"]K]KMF<:P7<7),/_ "R;;K%@>8;IS)=YS['MLHC*F(D[
M'X]ZO,.;8P[:V51&%(6CFL.2G(Y>X3R2I1O0W![6_1LR7MV]'O?3TNIN_5CR
MJ_;PX_OI9(V\47 )]JM%B5O#"^4C2'\,=RJ?,GIL1^\M*;BU\QR!15QQ..)X
MZW*4:1Y3J#>+T!!N]Z0_;+Z<DWN(39-W.TK+'=Q]K-^[7ADMK&IN:#(]P[I\
MGD.!.Y'(F)Q^XV7<!V*IQJ>J7#FQF);?FMI=A2)>&N)0KJC'"L>7BCK7O$]&
M?U.N]]SM)W.WQ]0[M[NV]7:)N9:MP]OL?Q_M6N.*;4*O%NN>,7B7E617&#N!
M-RW*LJOESPFVKE1VX]HLS;*7&8L6,5K><R6+).C<E5=QCC)TJ]4;E]YOI2[Q
M=Z.\OI+;Z;B]R^&(S[TZ=Z/\YMS9EIV;GV2S[Y761N/L%GTRVXC86MPKD=LH
M24;+N0V!)EWQ:4S6W%J6II?F7+&Y.+;UBRG%NC? ]P*[%"@.)9[DKV'81EF5
MQH7YC)Q['[I=HT,I6IIZ3$BN.1_F0TI#HA-O!*WRE25!E*B"#QHE5J-JM(J*
MYI*/:SS<VT[K=VG,\M<7)K_:+Y9LDNL.TRHN0LP;)9K)^92H\1JYQKE:[>AZ
MRQ;9U!;GW76"R%E;:EZ.)],]OCC!N":DE7MK^)ZIX(*-8IIHW_RG.?R2*B1#
MS7:SS%N!"F+O(N:"WYGX"VFQ7>]SKBAK174L1XR%=(U*.K1/C7,^#]7\4CS1
MC72C,>YYV6<&QG)HNX.V27KG-=C&\LX[DE[QK(Y*DRDBT6&U6?,Y&11Y=O4W
MH^L.2U];9*V602W1<W,U27HT37IJJ?9Z6%'WFFG]/4=F_P [WQ>-S+E'S.P2
M;\W;Y+T*SQML<R5)=6U'<<0H8B[D(S&?J\WTAUORFB.'1U<:\7)'GHXOEK_,
MOMI0\O*JTHZ>E?;8\?K9O/O.K<B%D[659-.R]Z_,(3:W9DWY6;+=EH8&/KL8
M<;AH@ON*^7^42TE" =$A) (^;>#!X7)1*%+_ 'U/>\>/DY:+EH>^M?73XP4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!H/7RYZQ0"@% * 4 H!0"@
M% * 4 H!0"@% * \I/50VD>O>WV'[V6:"J3<=L[FY9<I2R#UR<'RM;<1:Y!
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MFY+$G(,NR"2>M<J\WV>5.N$J4EI'0TWTM-H2GY*$5"/*K'KC[JHCN( ) 2.
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MH?9K0* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M[*E2'E!#,>/';4Z^\ZL\$MM-(*E'D * \V;UE3F<[CY3N-)2H6RQAV[04.I
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M,MI"6VF64!MIIM(X)0VA( '@!7Q-]3Q%V@% * 4 H!0"@% * 4 H!0"@% *
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MKP _=10"@% * 4 H!0"@% * 4 H!0"@% :#U\N>L4 H!0"@% * 4 H!0"@%
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M$?NMLC3G6&^M2EEIM;Y".K[W3IU '45\+DBH9)06J3:/#)<LG'L9RNH)% *
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ME/Y1D";#&L+61VMEF/;XEM$EC$&_-+,1IEE#B(4W(+A86U*2UKY9A+92=.E
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M].^C6J1_0E]/7<O,]XNQWM5W,W#7*D9MEVQ^ W')+E."Q,OMR;LD:$[DTHK
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MZW7)WI=0TXIM]MLD='7KL)Y,.6&XPNF;'-2CV53JJ]QC3T:NG4UM[%>PJ_;
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M=NF-AZ)/M\IB;"E-$D!V/*C+<8?;)!'4E1'"K-,RM H!0"@% * 4 H!0"@%
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M1=S-_;/!MN-04E,>VV^'CZXUN2$I+KD*VPT.N.%A*B!^QZ@% * 4 H!0"@%
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M/5CW,WHXU]!W&ONI[K<*Z8>:[4E#K>B75Y-MYF./7%:E>8&^H-R[;$05*0>
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M_=5M(J2 6E7X5!7MT(/[*RIA%;#;A"E:@Z 'I(&H^O4&M5BZ51DH0E"0E(T
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M7$_6S7L.PH"*DI5^( Z>VAI%2 I/2-!IRX<* HVWT:ZG4G]E#"[0"@% * 4
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MJ=.'#3Q]]:KT*2(+(U'$?I]U2:KEM0"@0>1]GZ:&F,6@%:DDZ'4>'L/'G6\
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M8]=WOXW?EP9-_OFV]F1;$H$"%B^'W2V6^.M(5YLD0Y>3W%MR7(4K53SG4Z
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MY,_ZGZ=%<G]D]L0[K-B1.XF=(8Z'!Y<6XO;'QX;OF% 97YSMK?'2E14GHU4
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MH#?7*7%G[EO6UB6\MOJ4IAAD#4A(2D]- =[X_P"EGZ<^,N)<MW9AV]R5(?\
MF0,@VZLF6-ESH#?2IK*F+RTMCI'^$06NKCTZG6@-A<6[8.VG!O(&$]O&QF'B
M,(R8W\K;2X#C_P NF&T68B6/RG'XGE"*RHH;"=.A)T3H* [MCQX\..Q$B,,Q
M8L5EJ/&C1VD,1X\=A"6F6&&6DI;999;2$I2D!*4@ #2@+U * 4 H!0"@% *
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MU[\DCS'W2]<[M5Q$28FVV,;D;N7!'5\M,CVJ/@^+R.G@GKN63N#)6.LZ:?\
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M>*U3]&]>DZ"@++R%+2 GF#KIKIKP/PHC4480I 5U<-2.&NNFGNX<:,,OT,%
M8ZGM#HD @>)\?;I0%U"NM.O+P/OH"JDA0T/T-#2SY*O C]?[C64*YBV4J!TT
M.M8;5&2@$) //]YUK2'<G6F"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MGH5(*5:+"@/#O,L,N;FA\*5*]IY\\XSR5C:ALU7E.(H!0"@% * 4 H!0"@%
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M43N%[+MH^X%:[_+C2,&W):0#!W&Q%#4*\J=;2$L_GT5!9BY&PA*0C5XHE);
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ME,JZB4Z:'CSY?50%YM/0G3QYGW_ZJ G0"@% * 4 H!0"@% * 4 H!0"@% *
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MAIIKP^/"L-;J7ZTD4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M=45+T2%!"?/NLSS9>9JE-*?B<\LWDG5JE#OZO.<A0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H#0>OESUB@% * 4!Y9>HO/OWYEMQ:U1@G&?D+Q.8F?+
M-E3M\,EAB;&^<*"ZV(\%,=7EI4E*O-U4%$)Z?NGE&&&N6;?];14KP]'M/7CJ
MMM+EXR2?<KKVOCW4XGF;7W@Y"@% >K_IT1;,C&=RYD:X//7V3><=CW6VJ9"&
M85MB0[JY9I;3P4HNKN$B9-0L$#I^73[:^@>;997NL49*F-1='VZJOLT]ITS4
M6'&HZQ]YM_YM*KU)+VGI!7U(\HH!0"@% * 4 H!0"@% * 4 H!0"@% 15R^-
M8RHW+"N1^GC3@%\1CN?A^/V&L*=C&/X3\/VU*N9$Q5\U>[[*I:E<3'/.M9KN
M8B^?T^JMXF\2POE\?WTXFF.OFGW_ +J=H=BT[R^GUT0C9F*KF/I[*,U6997R
M^/V&L+,33[Q]YJJ:&61;7P'Q_?4E*Y85R/T\:U#B8ZT@DD^RMXAW+=:48ZEI
M/ 'VUB6AB+:P"!J/&I12I74Q] -0.7#[*IW-7 LJ6GB/J^'C6H.]2TH \P#[
MQ1W#(* '( >X >VM1O'U&,MX)5H!K[>.GV&L8=T4)ZN/MT/ZJ<#2']H>[]].
M!O Q7W.@:#F0>?@*VIK+33A7J2.((Y>/TTH:7*.QIB/+4@'I.FJN)_3[?;0&
M.AU2EE)XZ<=?9P'.G$U%P_;3B';UEMXD-J*>8'VC4_"B#X& VIPJ&A4>/'B=
M-/'7PTH$9M'9%%#R/NJG8*Y\E2'2H@A75KP/'V\P? 5G$S7F/HCD->)T&OO\
M:TZ<*ED\S[S^VAIU'O=NEC6QNV6;[MYF\6\<PJRO7:4VTMM,F?)ZFHEJLT+S
M2$&X7JZR&(D<'[I>>3J0-2/=TKIFYZSU'#TW:*N?-/E78E=R?=%)R?<CX+S-
MYAZ?Y3Z!NO,75'39;7$YNEY.T81_S3FXPCWR5=#7_P!/CM]OUXEY!WI=R$9F
M9O;O%&;GVFU34J-OVMVS"42,=PBSQ9.IM[3-O;9>F@Z.+= 0]JZA]Q_^JH[/
M%Y9Z3BZ!T9-9G%<TE\;YN]?GF]6^":C&BI3_ ##WG6MW\P_,VY\[>:9*6!9&
M\<&_Z<5"R2?_ &6)+EBG\4E*<ZMMO>//LQ1E<V*B-'#,&U_,MQ75Z^?)^84S
MYCKB>3;9$=/0CF 22=3H/MWESHDNCX)RRRYMQFY7)<(TK1+M?O.K]EJO\R\Z
M>:8>9-WCC@AR[/;\Z@W\4^;EK)K@O=7*KK6MZ+@%?9#Z64) !)Y#B:7T,;IJ
M=8Y;=0 XD*X $#X5]LZ-LZM-GT#S-U%14DGHC6Z\90_9[G&ND9?\:#)1(2"K
M0+"%??:4=#HEULE)X'@37ZELNDX]]M)[3*OZ>2#7HK9^IZKT'X+U3S#FZ7U#
M'U#;O^KAR*2[Z77HDM'W,XAW!.8GF>-V7<2/+CIOUD;7;H9ZPF9(@W5Q*9EL
M="'4.:1I"/-4VH+:4IL+*2I#2T^3RAMM[T;K4^C[G$WB]^2EJN1\JJT^,,B4
M:IZ<T8/XHGJ^8V_Z9YG\LP\R;'<)9GX<)8W1O)'G;C%Q>L<F&4LC4EJH3RQK
MRS=?*7/\6M[^20\[QFYWC =R+*^)=DW!PJX2;#DUOEMMK;;<7-@.QU3$=*NA
M06?,+6J$K2DFM\]^3/+?FK#DAU'!#QYQHYJ*J^SGB_=FK?$JJGNR17RD^9_G
MCY>;O#GZ%O,T=OBGS1QN<DH/B\4TU/$VJ_ ^5U?/"5CVB]-WO/R;N#M67;.[
MR/0I&]NU4*%.DW^&S'@Q]RL'FNIA0LQ;MD=#+4.ZP)BVH]T0RVF,'9#"T!)=
M4TW_ )K?-?Y>S\B]8Y=NF^FY9M1NU%W23=6XR6L:MM4E%UY:O_>W]M'SSA\X
M?*].HM+S#ML:<W[J>2%>5R<8T2G"=(Y.5*+YL<XI<_*O3]MAM"NH E0Y%1UT
M]W(5^4H_II%Y3J6Q]Y0&OMXGPY <332YK52274. %"@=%#JYZCGS! /A4\:"
MI(,M!77T#JU)UX\^>NG+76M1MM>));B6T]2U!(Y:G]G"M?<-64:DMNC1"CJ-
M>!&A(UYCZJRFNHI=,Q+NTV[;9Q6D$B%((.G'5+2U#4^(U%=,.F6/^I#\K-7K
M_P#\:R__ '!_\#,U]DQ_"A'X#U*L;I?L]I>4 %/6R ZH)UT!<BLK(&I)T!-?
M5,JI-KO9\+-4;7>?6KF<R0JV;&Y6L*+@Y#W5)+N5JHF$Z%JQ\+^7HRIIE%UT
M)+OGED!.G7U=9 7S""KPTUT\:ZO-+EY>)3FU&AR*N!R)"K9L;E:PHNU)!6JC
M8$J%JQ-/C6,R1\2_.S&F63&4XA!6KSEM%06."?+'4G[R4GCK]>E=,*BW[US8
M4KJ9-D7*7""I?F%?F*\M3NOF*:T3TE15]X_>UT)YBMR4YM#72NA]@<Q[ZYF.
MQ<(!X$:CV&I(*U:L"5867$\A4NY+N5K8W,)"J94;$D\Q6.QKL7*D@D.=6%<K
M6%EP<A[JDEW)54;&'RKO)<89;;;)27BK50.A"$!.H!'(J*A\*Z02;JSK!5.-
M-K6VM*T**5 @A23H1\:[))IIV.C1SJ*ZIZ.RZK3J6@%6G+7D2/9J17EI25#S
MR5'0R16LV)-/,5CL:[$ZD@J*O@:KDJPHN#D/=4DNY*JB82H6K%MJ.A#SCP*N
MIP:$$CI'$$Z#3VBDFZ4,DS)K%<DD*IFQ)IYBL=BG8G4D%:M6 K3"#BTMH4M7
MX4\].?$@ #ZR30TM,R4/ZA(4"GB0H#EKIJ"":4#5#(H8* 4 H!0"@% * @XX
MVTVMUU:&FFD*<<<<4E#;;:$E2UK6HA*$(2"22= * _G$^J3W:J[R.\O<_<JU
M7'Y_;O&I9VTVE+3[KT-S;[#9DV-!O4(.Z%MG,;O(F7KIZ4E'YB$$:HUKXS+/
MGFWP/--\TJ\#].O]/'VO2=HNU#)-^,EMAA95W(Y*Q<;(7T)$EO:W!A/L^*N%
MM;8D1#>LAG7F:/O=$F$N&Z 1TD^K;0Y8<SNSKC5%7M/T"5Z3H0<6&T]1&O@!
M[36&I5(M.AS7AH1IXZ\_KT% U0NUIA0D)!)Y#B:&D$.I<.@U'OT^PF@:H7*&
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@/*#
MO*C94G=YY^\)FKQV19K,G#%J#BK<(3=MAIO$>$>+29*<A,E3Z-?,U6E1 2IN
MO7MG'D?\U77[OJ/;M^7DTO74W1V"@9NSM/8F<WM.X;]W0Q*^2^:R2RVN2Q9E
M*7^3MPXSN5V&Y@-P^@(:NC:RD@=.C)2FO'FY7D;A\/<G?CP?U'FR\OB/EI3T
M?P^P[%Q&-?6\HFN7>V[HLMNPY/R4S)LWPN?BR6]&PMH6;$+Y"5$NSOF%#*GH
MLD(T*TOMJ'6.<EIK1^A.OM:^]>@F5*:4]2=?K,O;ZSY#\Y.<FX[O7^1*E!$%
MB\;LX_<'&@=%(>=;M^7B\M,H#8)0]=);HZPDH4.KIY9VE36'-_I?X4^I'+*U
MIK&OH_A]QISWJXEG[N067(4V+-4;?Q+0W$C_ )O?%Y/&ME\5(DKN3[@CW6^?
MDZ9T81TI+SQ\XM'I5P\M'KV$\:BXUCXE>RFGU5.VWE"C55S^PV=['+!F5BVG
MN'\SQKA MMRR21/Q:WW)IUB0W;7(41$J:PR_HZQ N$U*E-)*4A:DK=2"EP*5
MY=_*$LWN4;IJ<=RXN?NWIJ;GUX3SB@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MTY:?;K6TJ8^P@>=4[F.Y;*DJ' @Z?Z:(U&.MI*E:ZD$GP(^T&LXAW10@)X>
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MIX;S!'!D2A\+5?0<\^-8Y>[9FTE>0XB@% * 4 H!0"@% * 4 H!0"@% * 4
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MV/H'G'<3ZOY8R8^G=6FVY8W%_IYR=Y1Y$Y86[RY8SA)VQQ;<G\!6=>I0MO\
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M'*C=4<W>IDBD2B+BRVVM8&I2-0/U<?J%::G0P&93ZW4)*NI*E %(2G0#7B>
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MNFDB%,6\@I5RX*&GA6RA">DTFC)8L<EJCFV)[E2;E.3C^1,L0KT4+7#E1B3
MO#;04IU4?K!+$EM">I39\.(]E>#/MO#7/'6'V'@RX/#UC\)S^X6R)>8+CS[C
M#;\=:4-K!Z):2K3130T_B-:G[R2=.!/ Z&O*I.+HCE"<H.JMV&RFPN\<Z9-;
MV[S:8J1=4H(QN]R%E2[FTA*UFW37W#U.2TMHU8<5]YT)+:CY@3U^'=;9)>-B
M^'BNP[-*4>>%N)MU7@.8H!0"@% * 4 H!0"@% * 4!0D#F0/>=* K0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!IIW.;;[-WR\6/(
MLYW'3MKD4N&W 2XW9Y62F^VR"^M+3[UDM@3<(KL<NJ83-4L,%*0@I46SITQ3
MRQJL<>9>RGK^X[X9Y$FH*J]AWYM;MS@V+87:X. R+K<;!.CHGHOMMRB_I_/7
MW4EMR[+=L=S@PT/K4DIZ&FVPR4=!2%)-<9RYY5R-<WH6G=J<YSE*59W.56G
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M$\&FTAG77@X3U5\G6&*/+!4C]IDLU%RX]%]9W+!MT:($$I2XZE("?N@--Z<
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M1N[VE8+N<<2W%VJES;E>L>V^P2^N8_!A9+AJ'2[;L0OUFO<EOY/J+,6XJ=5
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MMY*ODY;'Z!-0I.H((/B""/U5Z5<]:N8J8[97K][0^&HT]NFNFNE*<3:U,DD
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MXB@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0&@]?+GK% * 4 H!0"@%
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M%M@W"[.A8=N<V)#9CR[@X'%NN!R:^VIP]2E'57$GG7H.A]>M H!0"@% * 4
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M\A#KL>$FXWF7"AJEOMQW%(;"^M24*(! .G=M*YU326IUF.Z;MCU_]>-V'_\
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MH<N3B/FKL^"-%^=<9'F2NA9XE"5);!/!('"O!DS9,K]]U79P(<I2N<XKF2*
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M)3JG0\JQI*-9)J/H:,<9)5::B?6PK,MDI+<^RQ[YMQ\VJ8ZPO'DKL,:Z.2$
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MLR(^U)BR8[J0MI^/(94MIYEU!!2I)*5 Z@U]0:<6XR34D>5IIT>C,BL,% *
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M?^VAWI3_ /PQ=V?_ *E["_\ UDU9^GAWD^%'O*C^D-]*;_X8N[3_ -2]A?\
MZR:J_38Z<0L4:\2O_MH9Z4W_ ,,7=I_ZE["__634_3X^\KP8=YIYDW],'Z;-
MGSG+<=C7WN:-NLL\Q82GMS\4,DI".!><_P LVTN??\0E((Y5\C#IFVEAC-\W
M,UV_P,R8HQBFJZG2:OZ<GT\';]DT:->NXP6NTW,6N#YFY.+&2MZ+';,];ZT[
M=]"A\PYHD #0#Q\/D,?0MG+&I2<^9KM7X'?'M82@I2K4V0[3?28[7.Q'>-W>
MS9*?NQ<,@DXA?,%GQ\SRRSWZ S9[[/L]PDS&85NQ2RON2$/V1I/!P]*"HA*O
M#W[/I6VV>3QL+ESTIJ]-:=R/1CV\,4N:%:T/2^XK3<T,>6L+0E?F)?;<&C 6
MVMMJ6VL'I"V75I(5R )X'72ODJT])VL?(1<U/MK0\IM4B.X[$EAI74R)#"BV
MX6S_ &F7>"VSXMJ!\:SO5C5J8#3[$=:4D+5&\Q'6QUGH#((ZV6]>KH;('!(U
M \   */5=X9Q23<#:G"'.M=K4H^2X-7'+<%$D,OZ#5R,/["P/N?A(TTI==YE
MEW%PW!#C86VZEQI?WD%"^I!UX!22D]!]FM*%4XLXS>XS"0;A\T(,EN.9"ID9
MY"U>5H0&Y2$+T6LZ ="M%DD#QTHGH2Z+7B<JMV'YS*M\/S+9:G'IC34SYY^[
M+B*C(>90M$:7!3!6ZA;8=_B!M*CU)("APU\\MSA3:J].[^)YWN8JJ^X[/Q'!
M&,>D?FUSDMW6^EI;+3Z&BS!MC+G^*U;6%J6L..C@M]9+JDC3[H*@?'FW#R>Z
MM(?6_3^!Y<N:631:1.>/17GI"VV5(=Z5%*EH5U,Z@Z=0< T*3IP\37&-78B$
M)3=$;';5=MV5YJF/=+BDX_CSO0[^:3V%?,S6>!'Y1;5%#KR5)/W7W2VR0=4E
M9'37'+N<6'1>]D^I'=1QX^^9Z"X1M=AVWT)4;';8A$QYDLR[S,Z95XF!0 5Y
MTPH3Y32BD'RF4M,ZC7HUU-?&9<^3*ZS>G9P)<Y2>IS./$6TYUK4DZ Z!.IUU
M&G'4#3A7-LQL^A6$B@% * 4 H!0"@% :"=N7J-[ ]T?=5W<]GFW-GW3@[I=F
M5VL-EW4N>786S9,(O$F_/W&&VY@]]9O5QG7!B'-MCC9-QAVM4Q'\>"F7%"GT
M\XSC*3BJU1BDFZ*Z/)ONL]9GO,R/OBW/[#/25[(K%W?;E=N,"+)[B-P=R,VM
M^%;>XW>I*(YEXA9)=VRW;FQ0YEFD21"<F7*^M/S;HQ,C1+>ZW#5*>YRRRY^3
M&JM7,>23?+%'IYV->I?M-WN;F]S&P>.87N?A&]W9G>L/P;N&M.98G'M.'L;@
MWQ&1VZ^V[;O(H=^O;N066PY7AEU@ID3F;:[-;81*B-R8CB9!Z0R*;<>*N:I)
MZ<4>D==#2T]KT</:-?=Q^V@,9.O4G3GJ* SJ 4 H!0"@% * 4 H#06X^H[L%
M;/4.L/IFR+/NFKN"R+9F1OA!OK6%LJVH;QB.+L\JV2<L5>D79N]+AV5]Q+J;
M6NT>8!%,X33\M7/Q(\_AZ\U#.9<W+Q-^JZ&B@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% :1]R/;=>=PLKB9UC-^QRVNW");;->(63W%VTM*EPD_*Q9UNF
M_+R8[R3;TH2['(0ZDL];8=+A2CKBSK$N22;5U3Z?6>C%F4%RR3]1WWM#M1/V
MEPJ+B:<NN%PE)DOW&=_VOM:+3$N<Q+?S0L[+MN:NY926TIZY<AWS.CJ#+/44
M#CDD\LN=45?L^SV'.<_$ES4T.PK;;<BAW<RY^>Y!D5E6'/-QZ]6C#6D!Q2 &
MG8UVQO&\;GM*CJ2 D/?,A38"5:G[]1R4^%)2[=?L;9#I31)/U_B?=Q/&<Q,R
MXW9S<RZR5K>0&K4[BF&LV-MH(66HS@CVA&3R&&21T]5UZ]-?O:G4>?/RQHG%
M>FKK^'U'+*XZ*GV_3ZCH'NB[:\SW6-GRFS9;;YEWLD1RWOV>\L0K%:4PGGR^
MI^U3F&'I##B7E?>:FO/A0.J74$=*^FTW4,-82B^5\5J_IZ"L.:,/=:T9V'VJ
M[&W79;$;PG(;A"F9!E<Z'<)C%K>5)MUOA08SC=OBMRE-M_-RB93JW7$CRSU)
M2C4)ZU\]WN%GFN5>ZD1GR+)+2R-I:\AQ% * 4 H!0"@% * 4 H!0"@% * 4
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MRYN3(J284W6DE1G9'J@^KYN;VO;_ &U'87V*]MZN[_OZWEQ]68VW;^7=%VG
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MBIQ<5 3HVKB4I 3QX423T5S+:<#Y3\FW.HDSH-RC0%OCRWY(,<APMK0_Q9>
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M<3$\RV?L^[O>CV^9DY,W"D7"+!QF1M[C;6P$O);[?KH])0RTFS-.2W&EE22
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!H/7RYZQ0"@% * 4 H!0"@% *
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M]54R2C"E*2KJ).BR 3ST]_CQJ> ,CQ_13B5Q,-]*UI'03J#Q .FH^WC5%$&
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M:].*[=7I3L='W]KYOI>/Q'+F:Q=G'VEQO(.^'-&Q<+9;+E982]'&HAM>'XP
M#U=*D-Y/\O=W$*2KAU+6D@ _74O%Y=V_N3DI2[:RE_[.AG)TO&Z2:<O2W]FA
M%6]_<KL],A+W;QDWNQ/N(CK?EQ+0P3P2KRH>1XN'+4F?Y:20F0EY2P%:C4%0
MK_;^D[^+_0SY<GI?UQEK3T4'Z79;E/\ 3RI/U_8]3>K#<SL6X&-6[*\<DF1;
M+FR5)2XD-R8DALEN3!FLA2_)EQ'DE"TZE)TZDE2"E1^M[C;Y-ME>'*J37U]Z
M[F?%9,4\.1XY_$C+O-_L./,)EW^]VBQQ%$I3*O%RAVR.I0TU2'IKS#9(U'#7
MQKECQ9,L^7%&4I=R;^P*$YND$V^Y5+5HOMCR&)\_8+S:KY!\Q;/SMGN,2YQ/
M-0 5M?,PGGV?,0%#5/5J-:W)BR8GRY8RC+L::?UFSC*#Y9II]^AGGF??7,E6
M,!6O4?;6A6+:N7Q_?6JY2N6G/W?90WL,-Q)XD<:T,ZKS?=O$\#FQ+-/%VO60
MSF_/C8YC-O-VO)C<='W(X>898;5TGI"W$J6 2D$ D>W;=/S[J#R1Y8XE^:3H
MCOCV^3-%R5%!<7HBYA&[6%;@K?A62>_%O,3J,O'[S&5;;U'"-0M1B.*6B0EH
M\%EE;@;.G5IJ-9W/3]SM/>RI/&[23K'V_B;EV^7"DY+W>U:HY^ZDJ'#3[I/Z
M#I7BXT.+/E76X1[':;M>9BNF):[=,N<I0X=,:WQ793ZM>/)MH^%=<>-Y)QQ1
M^*327KT-C%RDHJ[=#6#M>M$B3:,MW N8Z[IF.023YI3P6Q%==DR7FB>(3)ND
M]Y*AJ>+(]E?.=;R1CDQ[2']O'!?7;V)+VGR&^DE*.&/PQ7T^H[VSO"+)N!C\
MO'KXSJR\ [$F-I09=MFH20S-AK6E70\WJ01R6@J0K5*B*^(VVZR[/.LV)ZJZ
MX-=C^G>>7%EEBESQ_P 346)CW<5M,9F.XLRG)\>6I[\IEH:C7%B('%%0?BQ)
M4EN7:G_O=2V7 N+YI44]>I6?L$LO1>H-9]Q_3S<5JJ^EI4?IO3L/>Y[/<4G/
MW9\>'^)SG:#9*Z6B[N[@;D/)G97(=<E08+\A$Y<"6^KJ=N=PDH6XS(N>A(:2
MA2VV0>K4KZ?+\G4NJ8\F+]'LE3;K1NU5V)=G;Q?HORW&YC*/A8=,?TT]!L^H
M I(/$$5\">$XWD.)X[E,),'(K3#N\5)4IMN8TE:F5J 2IR,\GID17"!IU-K2
MK3AK7;#GS;:7/ADXR[OO[?6=(3GC=8-IG4:^V_:@/F0;3<4M=6ORGYU<?E^1
M 1U%XR]->/\ BZ_77R*ZWU"E.:->WE5?P^H[_K=Q:J]B/K9-B6W;>'S=MH\K
M',5_/8W_ &KB+E0XLQZX,NH=A3PS)?1/N;C<N.CK42MQ:$E/57/!N=X]PM\U
M/)R/5T;5.*T5%HS(9,OB>-K*E_IP-=-J-QI.T]WN&W>X,9Z#;VY[ACS%(6X+
M1,=.BW%!()DV:X:)<0ZV%!)/6 4K44_-=1V,>HXX[[9M.=-5VK[I*U'Z.![,
M^%9XK-BUE3V_Q-V(\V)+BL38LEB5#DMH=CRHSB'V'VG!U(<9=:*T.(4GB""0
M:^K2C*,G&2:DKIGQK33H[EP.H6 $J!/LX@^/@=**YJN6'6T*5J4ZG3GQ^P\:
M)&T0  &@X 5KL:8OS"%:#10U(XD#[":FE#5<R%@%)U /O]]:[HPL<N X5+!B
M+E$+/2D=(.G'74Z?LH[FUUJ7@0H!0Y$ CW$:U196@,%]]25E*#H4Z G0'B1K
MPUX::&MX&-M:&2A:EM)4H$*TXZ^.A''W&I5Z%K5(^U:O^KGZV^/N"OWT=B)6
M1FRG5M] 1J-==5:>(Y#C]5%J2KB(MQ:%]?$?V21H3P.OLU X4>CT-6MS)4>'
MQHF$6'BZ4?PR==1J!P)3QU ^-*=A1C1R\'"@A7EZJU"@= >.FFO(DUGVB-:]
MQ]2M5@6U J:<2G@2D@?$&M?:70P68[W6TK3H"5:E6H\#R !UU(K%=DT=3ZAH
M:[%1R^GMHS58^:J&X5'1:2DJUU.O5XZZC3B?C6#C4^F@=*4I']E(3^BK12N5
MD'_9GS_V!W_S6JJC_=7I1CT-85MI#[KPUZG">H>&NIXCQK[(B6M*GJ3MX","
MPD$$$8AC0((T((LT,$$'D17U;<_WY_ZY?:?#9_[LO]3^TYC7!7.)(5;-C<K6
M%%VI(/D,V2"Q)$I =ZDJ*T-J6"TVKP*0$!?W?#51KMXLY1HRWDDURGVJYA6)
MI\:QF2)5BN22%6S8W*UA1=J2"M5&P)4+)IY?&L9+N2HKF$A5,V)(<Q[ZPIV+
ME205%4K#B2H67$\A4NY+N5K8W,)CE5%*Q)//X5+#L3K"20JV;&Y6L*+M205J
MHV!*A9-/+XUC)=R5%<PIYK25>6IQL+/)!6D+.O+1).O&JH[\"HIT+R>8K'8U
MV)U)!(<ZL*Y6L+)J0A8Z5I2M//120H?H((J4VK$'"\YV^QK<&S&SW^&"&^I<
M"?&"&KA:WU#0O0GRA82%:#K;4%-. #J2=!IWPYIXI<T7_$U2<75'GMN%L!G.
M"O.SXD0Y#8V%^<W=K9&5(\IM"@H&Z6O^+(B=('WU:.L:<UG72OE,>XPYM*\L
M^S\&7+'#)JM)&O,E,L+6XXA2RI2EJ6@=8))U)(2/NZD^P5VY&CC+%.-EH?-<
M==(".A9T*E:!O[_WNE)U5T]93HD: G0>',U-'4CE?81;ASI'X6%H3_><'EI_
M2O0D>X&J4&7'%DD]$_6=[;;=O.;YT]'DIMR[?:%E*UWJ\-/1+;Y9XE4)I:!*
MNRB >GRD^5U#1:D\ZY9<^'"M76?8CMX4(:S=9=G ]'-M-GL3VRB@VQDW"^.M
M!J9D$UM'SCJ3IU,0VDE3=NA%0_PVR5* 'F+64@CXK-N,F=^]I'L,E-R]!VQ7
M-6(%:8* 4 H!0"@% * 4!J3A_8MVKX%W?[J=^N)[6_E7=AO9@=NVQW.W6_G?
M<6=_,V#VJ#MQ;H%D_D:Y9=,VVLWR\+:3'D?,V^SQ)B_R_53I4_)+T*$5+G7Q
M,RBK7B;;59HH!0"@% * 4 H!0"@% :D]FG8MVK^GWMA?=FNT3:W_ "DVVR;/
M+IN=>\;_ )WW%SWYW.+SCV+XK<KW^<;FY=FE^C?,V'"[8Q\LS*;AH^6ZT-)<
M<=6N(PC!4CHC$E'1&VU6:* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@- .Y'MMW'SS<61FV"6]C(8E]@V9BY0E76UVR39IEIML2RA
M13=I<%E^WR8L!IT+:6M:75.!2  E2NV+/#%'DR::NG?74].+-"$>66ALCLIM
M?D&U>W\;%7KUC#EQD.RYMV<8Q:;,:4_.0LK@RYS>369=^CQ"0VE;C+'\/J2-
M4A.O#*_%GSTT[W_!T.62:G/FHZ>G^!R_$\0FXSD4VX^1MLS;[C'=^9D8CML,
M)R1,GK0IEIRYL9->F[G )0"L/I#HZ4Z*)3J9DFU35OO=5]BH2W5<:][JOL/J
M8)MM>8MSFY2[:]D&[@]+=U-HVF>M=YZE>4LN+S Y7)FO/+;7U.J7!5YC@^[T
M G3SYYI4@W.E/YM/93[SEEDOA]ZE.W[J&M/==VW;C9A>;;G&'67&[ST6]NUW
M2QXK:D6.ZMJ;?DR&KE),NX.MY$H^?Y*G4>0\A"6P&5)"EI]&SW6+'%XYMK6[
MU_P+P9H17+*OK.]^T+:++-I\!NS69(1!N^37I-V%C0^U)7:8K,-J(P)CT=QV
M-\_+Z"M:&U*#;80%*Z^I"//O<T,V1<GPI4KVG//DCDE[MD;95XS@* 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MW LZC4$$$Z@CB"#R(/LKXVS/-9F,I1UTYCA^O2BN$]3Y=ZNL.QVBZ7JX.>5
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MC7;HV#Q=ZIOX,:<G]B^MU]1NRQ\^=2=HJOX'/\"QDX?AF,XV$Z.VJU1VI90
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MXIXLM)OF;UKVG/+"4)TDZ]YWS7G.0H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M\(6E+B%(4>"AH=/#EQ^!K%<MHQ$PT).JU]0!X )T!TY:\36W,353*ZTI!*B
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M91X:CV<>5 6_(5[4_K_=0&0E(2-!_K/MH"5 * 4 H!0"@% * 4 H!0"@% *
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M].=:;VHM*().A!X>WZJ*Y7Y3X5[NELL-OEWB\3X]NMD%HO2YDI?0TRCJ"1Q
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M3-6&J2I7O.&XE&63W>PVNKQG 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M(1ZEN^7EYEZ:*IWYC>)XSAEJ9LF*6.V6"U,'5$.V16HS:U](2I]]2$^9*DN
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M6%EVI(*U4; L2HR9*4@GI6@DH5IKIJ-""-1P.E4G0Z)T+42 &5AU:^M2=>D
M: $C34DGB=#62G71&2? ^G4JY!(53*C8FGF*QV-=B=205KH8* 4 H!0"@*$@
M DD >T\A[Z ^8SYA?'WM2%:J/5J"/[7'DH$>RM=BG2A]2L)% * 4 H!0"@%
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M*4@](\6[Q1PYN6'PM5]!Y\T%"=(V-CZ\QR% * 4 H!0"@% * 4 H!0"@% *
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MBN$#_>J2/"O#N,?++G5G]IY,T*/F7$[(KSG 4 H!0"@% * 4 H!0"@% * 4
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M%)')FG$-M,A2@"6D:#QXI!\.0J:Z,YV9=60I/@0?B"-**QJ;J40RVD]24\?
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M!+P2[\I'C1VFDJ4E*G.@K*4E72/)N,WCY7.E%P..6?B3YN!W17 YB@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0&@]?+GK% 8DZ!$N45V'-92_'=&BT*
MU&A'%*T*!"D+2>(4""#6QDXNL;FIN+JKG3-SL=WQ%YQ^*%W"S.$DJT)+*? 2
M4I!\AQ(X>8!T*X:Z'[H]^+,IZ/21Z\>52TXF%^<1I:=&"E#ZN3<E1:&O#\*T
M(<2OCR&H)KM4[)GQI#3T&1'N.H?>9E-R'-4Z-]33B%M)"=2?+!1T\:R2JFNT
MF2JC8&S7J%?(:)<-P'@ ^PHCSHSA!U;=2.(X@Z'DH<17QDX2@Z,\,HN+HSZU
M22* 4 H!0'AIZR/JPY/V)1-J^W3MDP%O>;OI[FWV[9L[M^8,N\1,6M5SNB\9
MMV;WBP0%LS,AG7C)0Y!L=M#C+$N5%E/2'0S#6Q(XY<CA2,=9LB<N717//_%/
M1/\ 5I[EK9"W-[V_6-WSVRW)O<5,Y_:;8J3E$C#L*>F]$E4'S<0W'VHV]C76
M*A98F-6:PJB%UL!J=)90A:H6+)+6<G7N,Y)/5LV?[3.Q'UE^S3NBV<:OOJ)S
M.]CLLN%^O5OWFLF[K,A&Z]GLKN*Y O'[O;'-QYVXM^3#M^4B"EP6G,$R"D@&
M$ZQU^7489827O5@:E-.]4<>VRWUWNG_U-?<1L).WCW4F[&63L\LF3V;9>7N%
METG:>T9([B6QDEW(;9MT]=UX? OCLB[RW%2VH:)"ERG5%>KBRK$W^H<:NE F
M_$IPH?I-KT%B@% * 4 H!0"@% * 4!!?A\?LK&5$L+Y?']] KF*]R/T]E9Q*
MXF(>1]Q_90&,O\)^'[10%E7(_P"]^RAK,,\_TUKL4C'<YGX?LIP$C'/,UC-5
MC'<_M>[[*=@,0_B'N_?6LU6+*^7T^JG$KB6#X^X_L-;P)7Q&$\"=-/K^RB*X
MLL])'$_HK5<I7+3GT_53M#XF,X.I&GU_8:+L-5C%7HTA3CBTH0VE2EK40E*4
MI&JE*4K0)2D<231)U2XCBC7K=+N&P["+?+AV.X0\ERE;;C,6#;GT2X,!\I4D
M2+M-84J.A$=?$L(47UJ 20@$K3\QL>D;C<S4LJ<,'%O1OT+[['MP;/)E:<DX
MX^_[C2O"+9>+G+O6>W1UZ1>)+5TD6I^1]YZ7>)C3_F7)04GI4A#CI2WPT*B=
M-.D5]ESY,>.,=KCHL:HGW)<#W;C)"-,$?AJJ^CL.[;3E<2]6^/<(CH6E]"2X
MWU KCO:#S8[R1Q0ZTHZ$'WC@17AR0ECDX2N>')!XY.,C+7==-25_6=3P ^NH
M(.MLDW6MMI2XQ;E)NMQ&J0&E_P"Q,*Y:OR$G1PI/]AO4\-"4FO7AVF3)K/W8
M?6>K%M9Y-9^['ZSY^&;3Y_O'-9OV0R7[/C95U-W"6RI/GL%0ZF,?MI* M"@D
M OJZ6N&I4XM)29W?4MKTZ+Q8DI9^Q</]3^Z_H/1//@VJ\/&JS^EV;TXCA&-8
M%:DVG&[>B(P.E4F2X0[/GO  &1/EE(6^Z=3H."$ Z(2E.@KZGN=UFW<_$SNK
M^I>A?3O/C,F6>67--G)BM)5H#K]T^WZ_;7!6.99<0E7,<=.?'7PH]=34JD$@
M : : >%:;$QO-05E(/CP/@23RIP-J5("D\0#[Q3C0VFM"SH 2 -!J>5##&,E
M(64])*0="K7C\!I0THM05RX@\0? CC1::EJQ$\@/9K]E&#%>>Z"$@:JX$Z\M
M/J]M94TDEP.)"APXD$>P\/TBM5C44H]428TAQ2 GIX=1.ITUY:<./#CK65UJ
M:6F'5N=04-=/[0&GP/A5%F36=P+#RBE*E)Y\-#STUTU/P%4_A*X&.PZM:RA1
MU^[J">>NH'QYUD75&)ZG,AH.'@ -/@-*ED,@Z3T*"?Q=)Z=/;H=/CK1:,),^
M6WYP/4@+ZCXZ'0\>.NO T54]3=::7/J'F?C5&E0>?U_OK&:KGSG&'2[JGCJK
MJZ]=-!Q/MU&E+H(^F/\ # )U( !/M/#4_&J6ACU(D\=?J^SC6J] 8DAAQQQ)
M1H00$G4Z=//C[CK426M2FC(906FP@G4ZE1]_L'U4-2H7QR'T\:JY:L6)#'GE
M!ZNE2=-.&H(.G,:CV5E [$F&/()/7U%6@X#0:#7WZGC6(Q'$\\<";5&05 =<
M]!T.@U"8\C737V$BOD.FK^LW_E?VHF3JCY^TS(?W(PY!05]-Y9>Z1U:@QD.2
M O[I!T;+74?#0<>%?([MTVT_])RW&F&7H/2\K2VAQQ9T0VA2U'GHE *E'3QT
M KZNU5T/AGKH?,A7EB9(^7#;C:E!1;*BDA?2"H@@?A5T@GQ'#G5RQN*J5+&X
MJI]H5C(C<K6%%VI(*U4; E0M6)I\:QF2.-7:U3)4L/,A*T+0A/WEI3Y72-#J
M%$:I)X\->)Y5VQSC&-'<Z0G&,:.YR.,VIEAEI:NM3;3:%+X_>*4@$\>/A42=
M74YIU;9?J32[4D%:J-@2H68TV8F#&6^I)60H)0@'3J6KD"=#H-!J3[!6QCSR
MH*5=#Y,&_*??0U(:0A+B@A"VRK[JU'1(4%$Z@D\^&E='BIJF5+&DJJYR85S9
M$;&')ML28L+>;/6!IUH44*('(*TX*T_36J<HK0OF<5H94:,S$;#3" A&I4>)
M*E*/-2E'4D\/T5$I.3JSFY.3JS)%5P,5R5867$\A4NY+N5K8W,)CE5%*Q)//
MX5+#L3K"20JV;&Y6L*+M205JHV!*A9-/+XUC)=R5%<PD*IE1L33S^%2P[$ZP
MDD*MFQN5K"B[4D%:J-@2H633R^-8R7<E17,)"J94;$T\Q6.QKL3J2"M=#!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * BI/4DI]OT'ZZ L!E6O$C3X
MZ_LK#4Z&36F"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M \A-_MM]S)&].7N.8WD5]_F?(YD_&)EOMD^Y1Y]EF/ZV6##D1HZVU+M-O4U$
M<:!U94R4D: $^O#DQK$DVDTM?3Q]MSW8IP6-:I46IZ,8%CF0V+;G'+%DEKS.
M7DD&Q1XEQ^0W/N*V#+1'4V$_F/\ -]K^2#(0E :C1GX[ Z4H4\ 55X9^]-RB
ME2NFGW4^G<>233FVJ4KV?P/JXC:[W&BY4+Q9-R&9$BVOM,?F&[S.1HNC2PL?
M)8LMO*\?1C-Z44)4F4Y&MZFRK03 D$')<+>J-/;HZKV^@R36E*>RGMTU^FA]
M_;JSY-&CK7>\>WI=C*+_ ,C'NVZF)7IIEOSW- J39LJM<U3R>(_BOS!IS<)X
MUY\SCS43A7_2_O7X''*US:./L?X'G/WA1,Y8W/<=R2/F3&-NPV!APRJ;;;@T
MB*&6_P R:@2+))F6M&EP"R4*=7,\KRU/$ZIKY+9/'X7N\O/QI_'_  /3M^7D
MTIS<:'I%VH,9;&V,PYK,4S&YJ4W VMJXAQ,]K'C.?-F1)2\ \E/RW%@*Y12T
M!H- /B]XX/<2Y+??Q/)GY?$?+8V-KS'(4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MWRZI"EI/!0;0KE\'O.M[G<>YA_IXN[XGZ^'J]K/'EWN3+6,/=C]9L< $D)2
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M6H$K]IZ3RU''P]]:[&Q)'E6!V/GR^O5.@/2--"->?'76M1JL7&O,Z?O:]/\
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MU!S% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M>D%Z?N/!OORKT_<;A)\:^&9\=(E6*Y)(5;-C<K6%%VI(*U4; E0M6) @!1)
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M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0%L. GEXZ4-:H7*&"@% *
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M!0"@% * 4 H!0"@% 0" -.?"AI.A@H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M=EVU.:;9;=6-UJ]1]SK5%R/<+;'-;0,M0JU-8S)-FMV&2(3TJ++UF.EI\1V
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M  X  #ZN%"R:>7QK&2[DJ1N82%4RHV)IY_"I8=BR_*:8.BM5*/'I3S ]I)(
MK5%RM8Q)LDQ):?U"=0H<TJ&A]XT)!%6U0--&16$B@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MC]Z?=][/3C;79' MK&$KL-N,N]J:Z)6277RY5W>ZDE+J([@0AFW1E@D%MA*
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
MT'KY<]8H!0"@% * 4 H!0'#L[_[FY?\ P3\;/_"OQ?C_ />3_P Z_P"[_N>J
MNN#^XKG7%\:-7KI_B(_#^$_A_'_S7V5\B>S@<9D\Z(WB?&?\?LY<SRH:7<?_
M ..X/XN;WX>?_!WN?^Y]OU:T,=C>;#?^YFT_B_P'/Q<_^$/?]#[/JKXW-_<9
MX<GQLY-7,YB@% * 4 H!0"@% * 4 H""_#X_96,J)CJY?&I05S#<Y*]_VUI1
MCGD?<?V4!J]W;_\ @1R7_N<_X5;?^Z'_ !?^$'_N=_\ MC_ZS_V'S:^5Z+_^
M<(?'Q^'_ .Z_R]O?0^0Z?_S,;VX??W'A+N)_Q"?^X/\ QA_X1/\ B'\"^?\
MV;_I=:^[YO@_)_Q6/G\OP_E_XK&LMC_XR3_Z['_],\O\9O\ X)_YU?W/JUKP
MP^+_ + \<?B_[(W!LG_%D7_BK\!_XD_XLYG_ (+_ +C[:^1A\/#U6/?'X>'J
ML;D]I?\ W:__ (-O\1'_ '7?]U7_ %/_ +C/_.W^]_N>JOA^M_\ +_\ :_\
M#\/_ !=QX.H?VOS^JW_$>JB^7T^JOI+XGP*L8ROLHC58L+Y#Z>RJ,5F8M84[
M%@\S[S0*Q@*YGWFJ=@0/+Z>VLXE<465<OTT9K,-WF/P_\U[_ !^JC#!Y#EX\
MN7A6+B%8QCS/O-4K&EI?C\/LJN!7Y2POG]/::@U?>6E<T_&@=BQ_:^'[ZW@.
M):7R/O/[16]AJN6/;[JUV*XL@KD:E7,5RR*W\HC<L+_M?B\?P_BY^'UT+*)_
M /Q<O[?XOC6H(LGG0.Y97^#QY'\/XOA4E=I@(_Q/[7+X>/XOISJN B9%8[(T
MM._A5S_">7N/ZZ*Q2L?*5R\>8Y<^8Y?717),_P#LCW_OK>)?$C6FGRG?\9?/
M\1Y\_P#5[/JIP)_,9:/P(Y_A\?>:&K[R?C1%\2[(_&>7]GER_".7U5BN<G<R
M8W^&>?XSSY_A31<2E8R#\?A5,U&',_ZG_P W^U%2[<3&6H?X7/>GW\E4XEQ/
MI(Y?3ZZUW-5V6Y'^"O\ #R/XN7+]OL^NL1O!^@P(/^(K\/X/'\7,?A^KVUO
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@ H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>mrna-20201231_g30.jpg
<TEXT>
begin 644 mrna-20201231_g30.jpg
M_]C_X  02D9)1@ ! 0$#O@.^  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #B ET# 2(  A$! Q$!_\0
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MBBS\*K=N3)<WTSS22MU8 E5/XA=WU8T =]H^CVVFV4-M;0I!!"H1(XQA54=
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M52?YU:616Y!R* LUN/HIJL",BEH$+1110 4444 %%%% !1110 4444 %%%%
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M*VG9+IV[M(X_UA)Y._(/I6U_PL+Q]X9@Q';:=XOA0<+,_P!ANF^K -&Q_P"
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M^#O%D?B2U9)4%OJ-OA;BW)^Z>S+ZJ>QKHQ6IXLHN+Y9"T444$A1110 4444
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MWCOEL(YE%VT;2A.^T$ D?0LOYUFR:Q9KJD>GO<Q_VA+"UPEN6_>-&K*K.!Z
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M:*))$'8.[!@WX*M<KPDUL[GI4\[H23YTU^)\.:@P;)# X]*QV7;GBOJKQ?\
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M"[>&K[2/#FDZ9>KKU@@N+.RBBD"F8 C<J@X(X->LG%<+\5V_T'PYC_H8-/\
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M'@9P !H>*/V=? E\X;2M%C\,:C;P"WM]0T"1["9 %PNYH60N!QPV>E>F^%%
MTV'_ *XH/TJ.Z;=<2'_:-=AYR;]JS@M!\!SIJ%K<ZH+6&"PVBTLK$DQY48#L
M2 >.-J#A<9RQQC?G;?<2-_M8_*M@YK#'S;CZD_SK-1459':JDJDKR85R?Q,\
M+S^,O#$NG6S6!8RQRM%JEMY]O*J,&*,,AEZ<.I#*0".F#U#-GIQ7#?&!I)/"
MEM8!S';ZGJECI]TP[P2W")*GT=24_P"!TT54MRNYY9K'P4UB;P9'=#5O[72
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MMC2'Q"UM$ /W-M9PA00,?QJQYZGGKTP.*]<\#^*F\:>#;/4I7A>[C=X+@09
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M"O1QT%:QC8\'%8CVCY(["T4451YP4444 %%%% !1110 4444 %%%% !1110
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A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>mrna-20201231_g31.jpg
<TEXT>
begin 644 mrna-20201231_g31.jpg
M_]C_X  02D9)1@ ! 0$#O@.^  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #S 2H# 2(  A$! Q$!_\0
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MN#XZ_P#1O</_ (7%G_\ &J]\HH \#_X7!\=?^C>X?_"XL_\ XU1_PN#XZ_\
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M?]BSIG_I+'0!]?3W,-JJF:5(@S;5+L%R3V&>]2 A@"#D&OGS]J31]/USQ+X
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M?$?_ *7/7N] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5#>0+=6D\+EE61&0E&*L 1C@CD'W%4;SQ+INGZU9Z3/<^7J%XI:"'8
MQW@9SR!@=.YK2?[K?2@#C_A3,5^&NCW-S<R2L]N9I9[F4N>22268]/Y5AZ%X
M,T[XB>()/&FJVGF0LZIIMNXPK0ID++(O<L<D ]@M9'A69_%'@KPMX1M798IK
M-;C594./+M@QQ'GLTA&/]T-7L4,*6\*11(L<:*%5%& H'  %,!L-K#;P^3%#
M''%C'EHH"_E2PP1VT2Q0QK%&O"HB@ ?0"I**0&'XL\*VWBK2W@?$%XF'M;Q5
M'F6\BG*LIZ\$#COS5'PWXJNM5\/WWGP1IX@TT-#=V;-M7SE7*D''W'&"#CH?
M:NJK@OB+;/X;D/BZR'S6\7V?48,@?:+8G /^^A.1ZC(H Z+P7KT_B?POIVJW
M%NEI+=Q^;Y,;EPJDG;S@=L'\:P=6L+:3XQ:!<M"AN%TRZQ(1R,,@'Z.__?1K
M!^'GCXS>!]$TW0=,N-;U&"U2*8@&&W@8#D22L,9]ER35RU^&>N7WCBR\3ZOK
M=N9XBI:ULX6"H%! C1RV=IS\V1SZ4P.P\<?\B5X@_P"P?<?^BVKY7_9Z_P"2
M _#3_L6=,_\ 26.OJCQQ_P B5X@_[!]Q_P"BVKY7_9Z_Y(#\-/\ L6=,_P#2
M6.D!]#?%*7P+8R:/JOCG2;&>VTII+ZUUG4;%9H=+D78#(92I\@G<,-P/D/(P
M*Z;PG+H<WAO3SX;FLI]"$0%G)ILBR6YC'38RD@CZ5\W_ +51;4_B%X3EOOAA
MX3^).BZ/%=-$NN^+(-.$%XYMVQ)!,AC<A " =_#Y^3 W>U?"#1XAX?3Q)):V
MUCJVO6UM-?6>F:@;NP@>.(1JEN1A H Y* !CD\]: /)OBG^T!XL^'/Q&^+MF
MBV.H:5X6^'J^*=-LUM65S<F2X7$S[R77]P"=NW@GC(S2?"[]H[Q-)H?CL:KX
M;UKQW>^&]6LK*%?#]I#]KN([FP@N2S(6CC_=M(X)&/E*<$Y)]LN?A;X6O/%.
MJ^(KG2([K5]5TX:1?33R22)<68+'R&C9BA3+OQM_B/J:N^#_  +H7@'3YK+0
M-.CT^">7SYMK,[RR;%0,[L2S$(B*,DX5% X % 'BW[$NK2:]X!\=:E+I]WI,
MEYX\U^X:POU5;BV+7;,8Y I(#KG! )&0>37T/7A'[(O_ "+_ ,2_^RB^(_\
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M$KP?*\,;R"*\P[("1A$(Y]LG\S0!>^(VKR:/X/U!K:9X=0N$^S6?E#,C3O\
M*BK[Y_+!/:LGX.^ [SP#X8FM-1>"2]GN&F=H><+M50I8@9Q@G\:?HO\ Q7'B
MV36V^?1M)=[;3E_AFF^[+/[@<HI_WC7<T %%%% !1110 4444 %%%% !1110
M!B>./^1*\0?]@^X_]%M7RO\ L]?\D!^&G_8LZ9_Z2QU]4>./^1*\0?\ 8/N/
M_1;5\K_L]?\ ) ?AI_V+.F?^DL= '1_MO:EI^A6/A#67\0_V#KFF7+W&E%]%
M35_.G,L"*D-N9HV:X+,B(5)^5Y=P"Y8>U_!6P32OA-X3L8[^^U,6NG10-=:G
M$(KEW1=K>8@R$(8$;02!C ) S7F/[6FF^-KY?![^#KA+*6"YN)&NET?3K^9)
MA&&18S>R(L;.BS*I0$L[(&*+EJ](^!-OJ=I\&_!D.M6\MIJR:5;BY@FMX+=T
MDV#(,<'[M/\ =3@=* .E\6:S/X=\+:QJMKI]QJUU96<MQ#86B%YKET0LL2*.
M2S$ #W->"?!W]J*YU#X8ZWXF^(3(-0TW5AIESI/AWPSJ:7E@YC5A'<6K^9+N
M.=VY1LP1SG./H+7M(37]%O\ 3)+F[LDO('@-Q83M!<1!@1NCD4Y1AG(8<@U1
M\*^#[/PHET\4MQ?7]X8VO-1O&5KBY9(UC0N551D(JC@#N>I)(!XM^Q+K=MXF
M\ ^.M7LUG6TO_'NOW4*W,#P2A'O&9=\;@,C8(RK $'@BOH:O"/V1?^1?^)?_
M &47Q'_Z7/7N] !1110 4444 %%%% !1110 4444 %%%% !1110 5'/+Y$,D
MFQI-BEMD8RS8'0#N:DJAKNK1Z#HM_J4L;RQVD#SM'&,LP52<#\J (/#'B2V\
M6:/%J5I%/%;RE@HN(]C'!P3C/3(KROXM>+!<?$+P]X?TZ=H+Y@]M-=(-WDBX
M*H=N.=P4$^V0:=\*[[7/''@VUL+";^PM(M&>"XO8SNN9F+%BL7&$&&&6Y.>E
M>G:+X-T7P_'"MEIT"21$L)W0/*6/WF+GYB3W.:8&AI>F6VBZ;;6%G$(;6WC6
M*-!V4#%6J**0!1110 4444 %%%% !17(:M\0&TOXD:'X1_L>YG.JVDUVNH)(
M@BB6+APRD[B<M&.!_P M!Z''0:\URNAZ@UE.MM>"WD,,TD?F+&^T[6*Y&X X
M.,C/K4*:=[=#IEAZD.3GT4U=>EVKZ7ZI^9?HKBO@OXBU3Q=\+/#>MZU<0W.I
M:C:+=2O!#Y2#>2RJ%R>BD#.><9XSBFZIX\U'3_BUH?A"/2(9K#4=/GOGU(W9
M5XO*(5E$6P[N7BYW#[S?W>9]K'EC-[.WXFTL#55>IAU9RI\U]=/=O>U[7V]7
MV-SQQ_R)7B#_ +!]Q_Z+:OE?]GK_ )(#\-/^Q9TS_P!)8Z^J/''_ ")7B#_L
M'W'_ *+:OE?]GK_D@/PT_P"Q9TS_ -)8ZU. Z+]M[5M)T&U\':E)K>H:+XJM
M[B0Z"VFZ-9ZI<7%P9;=1%!#<,I\]F,>UD/"^9O\ E->U?!'3[;2?A'X2L;.;
M4+BWM=.A@$NJ,C7+%5VL9#&2A.0?N$I_=)7!KYK_ &DOB!>6/Q$NM$TW7?B[
MJ;6%U]LO7\!^%+34;71Q);PA(7EDB)&%5I<#<^)SDXP*^GOA+!:V_P ,_#"V
M6LR^(;)M/AD@U6XB6*2[C90RR,BA0I((.  !Z#I0!UM%%% 'A'[(O_(O_$O_
M +*+XC_]+GKW>O"/V1?^1?\ B7_V47Q'_P"ESU[O0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %<3XRE?Q5K%OX1MF802*+G594.-EN#Q%GLTA&/]T-
M5SQM\1--\"K E['<RW%TK?9HX8682N.B;N@))'YU-X&\/SZ+ILMSJ)636M1D
M^U7T@Y&\CA!_LHN%'T]Z -ZUM(+&W2"VAC@A086.-0JCZ 5-110 4444 %%>
M;^+]:UVQ^-'@/2[/6&MM%U*VOI+NP%O$PE:!4*G>5W+GS>Q'W1ZFN_U*SAU+
M3;JTN%9H+B)XI%5BI*L"" 001P>H.:SC/F<DEM_E?]3LJX=T8TIRDFIJ^E]%
MS..M[:WB_+S+-%>7_LR1[?@3X0D+R2RSVGGR232-(S.SL6)+$GK^%>H44Y>T
M@I]T&,P_U7$U,/>_))J^U[.P455U2:Y@TR[DLHXI;Q(7:&.9RD;.%.T,0"0"
M<9(!^E>=:#\;+1/A+HGC+Q-%%IT^JQA[;3;!FN)9W<GRXHEP&>1AC@# )/.!
MFE*I&#M)VZCHX.OB(<]*-]5&RWNTVM-^C'^)O^3@O W_ &!=5_\ 0[2N[\07
MD%CHM[)<3QP1^2_SRN%'W3W->/GX4^)_BQXDT[Q9XNU:\\*0V\<L-IX?T:=H
MIX[>3:2)KE&#;V*H65?E&T#U-=-'^S?\.=K_ &GPU'J<C@AIM3N)KN0YZG=*
M[$'W'3M7-!U7S.,=&^KMT72S/;Q$<#!4(5JS<H1LU"*DK\TG;F<HI[[JZ[-C
MOV<;R"Y^!_@I(9XY7CTN!75'!*D*.#CH:AU[_DXSPC_V+VI?^CK:GC]FOX:1
MVZ10>$[2TV A9;226"7KG_6(X8]?6HO#OP)M_"GQ&L?$^G^(=7EM;6SELUTO
M4KJ2\55D(+;))'+(,K'P/[OO2Y*RA"#BM+;/M\D:2Q&7RQ&(Q4*DDYJI92BM
MY)V5U*7?LD=MXX_Y$KQ!_P!@^X_]%M7RO^SU_P D!^&G_8LZ9_Z2QU]4>./^
M1*\0?]@^X_\ 1;5\K_L]?\D!^&G_ &+.F?\ I+'7>?)GH_C']FGQ3XD\9:YK
M>E_&OQAX1M-2N!<#2-'6V%O"1&B'&^-F).S))/4UZW\/O"LW@GP7I&A7.J3Z
MW<6, BDU*Z $MRV23(^.-S9R<<9)KH:* "BBB@#PC]D7_D7_ (E_]E%\1_\
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M$ZA:>'_$=SK+)K#S>$]5CF60RZ8LDUS;B[6X(%PIDF,3JQ4E8XW!RH!^RZ*
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M&;#P?HL&E:8LZ6<)8H+BYDN'^9BQR\C,QY)ZGBHA*H_CBE\[_H=.)IX.FO\
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%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>mrna-20201231_g32.jpg
<TEXT>
begin 644 mrna-20201231_g32.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "M AP# 2(  A$! Q$!_\0
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MCED1H+Z#)MKZ!]D\#?[+?^RGY6_BK&7Q-JG@W]SXG1;C3E^[KMN,1#_KNO\
MRR_W_N?[M=ZI!'K3)(PZ_,-RU/+]J)K&K[O+4]Z(RWN(KB%9(G65&7<&7^*I
MFPW;-<%-X1O/"LC77A6188?O2:+/G[++_P!<F_Y8-_N_)_L?Q5K>'?&5GK<K
MVDPET[5XDWSZ==_+*B]-P_A=?]I?EHYOYA2IZ<U/6)U=+115&84444 %%%%
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M:GW>*TC+F,91E&5I$E%%%,04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 ?#G[47QP\#K\9/\ A!/BAK/A4> K"6 W6CW$&HKK&^6#
M>M[%<0?*JJ[JNW^[O_V:^GO@3?\ @;5/A7X?N?AM'#%X)\N2/3$M8WBCVI*Z
M-A7^;[Z/]ZN[6VB5F81Q[I/F=MOWJ;;VL5JN(HE5=S-M5?XF;+4 7**** .>
M^(7_ "(/B7_L&77_ **:HOAI_P DY\*?]@JU_P#125+\0O\ D0?$O_8,NO\
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M *2EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4:\CZ*N_S_M#6]NOW/D^=MB_>_VZ]8?]JCX?1_>US3Q_W&+#_P"2*[CP_P"
M]'\,ZGJU_96ZI/J%W]KD9D4^6WDQ1;4X^5=L73_::NIJC(\97]K+X:"3RI/$
MVGQ/C?M^WVK?+_P&6IF_:R^%4:X?QEIZ'_?W_P#H->@P^%[$>,'\2X<:@UDN
MG_>^7RMYD_\ 0FK?H ^:M?\ VL NL7 \,1Z;K.B?+Y%]^]_>_+\W_CVZNML_
MVLOABEG!_:'B_3[6]\M?/M_G_=R8^9?NUTOB;X*^%?%VN+JNI6<CW3-NN&29
ME6?Y FUN>G"_=V_=KMK"QBTRS@M(%\NW@C6*--WW57B@#RIOVMOA+'%N;QOI
MJ)_>>7;_ .A4O_#5WPPQ\OBK3V_[>HE_]GKT+Q=X7LO&^@W.D:@)/LD[Q.WE
M-M?Y'61?_'D%;] 'SKX__:@TB\T>%?!6M6=SJOGJTFR>"X_=;'_A1V_BV57^
M'O[3UO;V]ZOC;5;&&9F7[*'GM;3*_P 7^ME7=7O&OZ#9:_IDMO?6-M?I]Z-;
MJ)94#;>&PU<Y\'?"+^"_AOX8L;W3X;'6H]*LXM3>+:6DNDA1'WNO^L;=N^:@
M#F_^&I? '_0:T_\ \'%A_P#)%(G[4WP^F1VCUW39-K;/EUO3?O?^!5>Q5@>%
M_"MAX2MKZ"R\P)=W]Q?R>:V[][/*97_\>:@#S_\ X:C\!]]:TW_@6MZ</_;B
MHO\ AJ3P$TKQ+K^B;T^9D_MVP_\ CM>R5S]KX8L;3Q=J/B*+>+^_L[6PG.[Y
M?+@>X>+];J3_ ,=H X#_ (:;\$]M>T(?[VOV7_QVO&/&'QW\1WGB6_ET/Q&W
M]E-+^X^R2Q2Q;?\ 8=?O5]C5S.I>"-+U;Q)IFN3P;[VQBGBBX7:WF[-^_P#O
M?ZI: //K3]IKP<MK )]?\/\ F[5W?\3^U^]_WW3YOVH? D/S2>(="3^'_D/V
M'_QVO8?NUB>*/#-IXLL(+.]\SR8+RUOU\IMO[V"X2=/_ !^): ///^&H? O?
M7-)/^[KMA_\ )%$G[4GP^AC9Y-=TM$3[S?VUIWR_^3%>PUR?Q,TB[\1?#GQ7
MI5B@FOK[2KJU@7=MW2O$RK_X]0!QB_M2> 73=_;NF[?^PUIW_P D4?\ #4O@
M+_H-:?\ ^#G3?_DJO3-!@DM-%T^"0;98K:-&7_:"\UIT >.+^U5\/)DW)K^G
MNG]]-8L/_DBG?\-6?#S_ *#EC_X-;#_Y(KT/PEX8L_!^C+INGB3[.L\]Q^];
M<VZ65Y7_ /'I&K>H \83]K'X;NSI_P )!I^Y/O+_ &I8?+_Y,5-_PU=\./\
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M;^T#XD\2?M.:MX%U../PYH"+<?V1:ZEX=NH+C5UB5=\MK>M-Y$J9^?B+[O\
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MV%^\U?3U><^!?@IX2^&FL76J:#ISVMY-!]A3<[.L%K]HEG\B+^XGFW$K_P#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
*4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>74
<FILENAME>mrna-20201231_g33.jpg
<TEXT>
begin 644 mrna-20201231_g33.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ) !0 # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'@C7G\-S#1+'P:;*6^,(\J&X\O'ED]F[5X9XT\&Z]\/_ -AN[L/$&BS:9?\
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MG^%1D_C7YJ?#W1[[6]>L[K5O&>@^&/B##XKD:0W-G<RZW*PE.(25.# R=.,
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M9W?V<D^3,.J-D=:H>,_BYX.^'NJ:;IOB+7[72]0U(XM+64L9)N<<* 3C/>O
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M][TS0!]<:OH>F^(+46VJ6%KJ-N&#"*ZA65<CH<,#S4<7AO288[N./2[...[
M%PBVZ 3 # #C'S<<<U\U>,OVDM3\ _M!>&=(NKB^U7PO>^%!J'V"PL?-NKJX
M)X95'(.!DC.!7K>E_M&>!-5^%4_Q"75OL_AVW+).T\96:*4'!A*==^<#:/6@
M#T'2])L=#LTM-.L[>PM$^[!;1K&B_10,55_X131?L=S:?V18_9;E_-G@^S)L
ME?KN9<8)]S7!?#+]HSPK\4-:N=%M(]2T76H8!=C3];M#;32P'_EJ@).Y:\2^
M/'[:%HWA<K\.[G4(KR/7(-/&L36!-C<@2!9DCD/!('L* /K!M!TXW<5V+&W6
M\AB,$5PL2B2.,_PJV,@>PKYYU;]CV[\2:S.FM^/;[5/#<^I)J,UA+90BYEV-
MN2)KD#>4!QQZ5Z9I/QY\,WVI^,=+GDN;._\ ","W&J"ZB"#RRFX2(<_,I Z\
M5TOPY\>:?\3O!>F>)])BNH=-U*/S;<7D?ER%,D!BN3@'&10!JQZ#IL-X;M+"
MW%V81;FX\I?,,8Z(6QDK[4R/PWI,.E2:9'I=FFFR9WV:P((FSR<IC!S]*\,\
M-_M&:'X7\)_$CQ/KOB+4M=TKP[K36<ZG3DB>TY $2 -^\4$_>.#75?#W]ISP
M?\2/&B>%]/35++4Y[/[?:#4K-H$NX,9+Q$GY@/H* /3=/T/3=)T_[!8Z?:V=
MCR/LT$*I'SU^4#'-0Z+X7T;PWYO]DZ38Z9YO^L^QVZ1;\>NT#->%_MO?%'Q9
M\*?A;I^I>#;Y+#5[G4X;42/$L@*MGC!KQWXX?M;>,],^ 7P^U;PO?1V?BF_B
MDFU:1H5?RU@/ER':>@9P: /MK3_#VEZ1=7-S8Z;:65Q='=/+;P*C2GU8@<_C
M1J/A[2]8N+:XO]-M+V>V.Z"6X@5VB/JI(R/PKYH\;?&KX@^(KKX=_#WP)/8V
MOC#Q!HL>KZCK=]'NCM(=H)94'!8G-=O\&/\ A=FAZAXET;Q__97B"VM8/.TG
M7;;$!NI"/]4Z#H >^/SH ]=/AG1VUD:N=*LCJH&T7WV=/. QC&_&>GO3-4\)
M:'K=Y#>:CH]A?7<./+GN;9)'3!R,,1D5\S>"_BA\3O#W[0?AGP;XHU_2?$=Y
MKEO<W>K:'ID("Z$B\Q,LF<L".N[FN'^('[3'Q$T?XB>*?L^NV.FWVC^(K?2=
M.\"RVJM-JEM(1^^WYW9(.<CB@#[7U?P_I?B!(DU/3K744A;?&MU"L@1O4;@<
M'WJ.Y\+Z->:I#J5QI-C/J,( BNY+=&E0#H Q&15IK[[/I9O+F-H?+A\V2/J5
MPN2/?%> 6O[=GPRN(;"Z?^V[?3;NX>T&HRZ<WV=+A21Y18$_.<# &?O"@#WG
M5?#^EZ\8#J6FVFH&!M\7VJ!9/+;U7<#@_2I=-TFQT:W,%A9V]C"6+F.WB6-2
MQZG '6O.OAW^T7X0^(Z^(Q;O>:/<>'AOU&VUFW-M)!'@L)""3\I SFLCP5^U
MEX%\<>)M/T:V_M2P_M1F72K_ %&R:&UU(J<$02'[Q[C.,T >K:GX;TG6KBWG
MU#3+.^FMR3#)<P+(T>>NTD<?A2Q>'],@TMM,CTZUCTU@5:S6%1$0>HV8Q^E>
M?G]HKPFMQ\0(3]NW^!UW:K^X'3;N_=\_-P/:L_7/VI/!NA^&?"6KB+5-1F\5
M1>=I6EV-IYMY.@&6/EY[#KS0!ZGI6B:=H5B+/3;"VL+0$D06L*QISU^4#%5]
M)\)Z)H%S-<:9H]CIUQ-Q++:VR1L_.>2H&>:X7_AHSP:GPO/CNXGO;/21+]F^
MS75F\=W]HS@0"(C)<G@ <<]:T/A=\:] ^+$FI6VG17^F:MIK*+S2=6MC;W4(
M891BA)^4CH0: .L_X1?1QK']K_V59?VKC'V[[.GG8QC[^,_K6A-#'<0O%*BR
MQ."K(XR&!Z@BO.?BO\?O#'P;U70M-UU-0EO-:9X[**PMC.TCJ,[< YR>U<$O
M[='PW_L_[6T>NQQP77V/40VFL#ICEMH^T'.$!/H2: />(M"TV'2O[,CT^U33
M=I3[&L*B':>HV8QC\*CL?#>DZ;I;Z9::99VNG/D-:0P*D39ZY4#!S7#?$G]H
M+PK\,YM(M;G[=K.JZM&9[/3-%MC<W,L0&3)M!&%QW)J.+]I#P'-\*;GXAC5M
MOAZV)CFW1D3QS X,)CZB3/&/6@#TBQL;;3;6*UM+>.UMHAMCAA0(B#T ' J!
MM#TY[Z:]:PMFO)H_)EN#"OF/'_=9L9(]C7S5X-_:6U#XA_M/:-X?TXWVE^%I
MM!EO;C3=6LOL\ZRCE'.?X2.>#7?>'_VK_ OB3Q;:Z);-J4<%]=/8V.M3V;)I
M]Y.IP8XICU.0>PH ]07PKHJ6]G;KI%BL%F_F6T8MTVPM_>08^4^XIVJ>&=(U
MRXM[C4=*LK^>W.Z&6YMTD:,YSE21QSZ5XY\%?B9XB\7?';XO>'=4O%GTG0+J
MVCT^$1A3$KH2P)')Y]:[;XK?&WP[\(!I,6KK>WNI:M,8;#3--@,]S<,!EMJ9
M' 'O0!VFJZ/8:[9FUU*RM]0M6()ANHED0D=#A@14>G^'=*TEIFLM-M+1IE"R
MF"!4W@# #8'(QZU\_P#QF_:TA\/?L_7_ (X\):9?R:A]H^P)#J5B\1LI]P#&
M=#C  Z8R"<#-=OX<_:(T+4-0\ :+?6FJ6.N>+;*2YM(+JU\LKY0&\R#/RY/(
MZY% 'HFC^%-$\/333:7I%CILLW$LEI;)$S\YY*@9IW_",:/_ &P=7_LJR_M7
M&/MWV=/.QC'W\9Z>]<%IO[1_@J_T'QOK,EY-8:;X/O)+'4Y[J+:!(G4( 3NS
MT'KFO'X_VJKWQE\?? 6E^'X]4T[PW?:9=WE]INI:?Y-Q.$4M&Z9Z@@<8/- '
MU;-"EQ$\4J+)&X*LC#(8'J"/2LF?P;H%UIT&GS:)ITMC;G=#:O:H8XSZJI&!
M^%><_P##4G@AOA;IOCU9+Y])U"^738+98!]J-R7*>68\\$$'/->N0R>=$C[6
M7<H;:PP1GL: ,O2/"&A>'[AY]+T;3].F==K26EJD3$>A*@<5930]-CN;NX2P
MM5N+Q=MQ*L*AIAC&'./F&/6KU% '-P_#;PE;SQS1>&-'CFC(9)%L8@RD="#M
MX-;>H:;::O9R6E]:PWEK(,/!<1AT;G/*G@\U9HH HC0M-6]AO!I]J+N&/R8I
M_)7>D?\ <#8R%]NE5_\ A$]$.G'3SH]A]A,GG&U^S)Y9DSG=MQC.><UK44 4
M=4T/3M:CA34+"VODA<21K<PK($8=&&1P?<4Z#1["UO;B\ALK>*[N !-.D2AY
M0.FY@,G\:N44 8W_  AN@"U-L-$TX6QF^T&'[*FSS?[^,8W>_6KVI:38ZQ9M
M:7]G;WMJQ!,%Q$LB''3Y2,<5;HH 8L,<<(B5%6(+M" < =,8]*S/^$1T,:>E
M@-&L!8I)YRVWV9/+$F<[@N,9SWK6HH IS:/87%]!?2V5O)>6X*PW#1*9(P>H
M5L9 ^E5)?".ASW5Y<R:-827%XGEW,K6R%IU_NN<?,..AK7HH S_^$>TOSK*7
M^S;3S;)=MJ_D+F =,(<?*/I6A110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 <!X@^!OA/Q)\1]-\=75I-'XDL8Q"EU;SM&)(P2
M0DBCAUY/!K"TG]E7X;:)XT3Q-:Z%MO(KEKV&U:9FM(;ANLJ0D[5?WKURB@#R
M/QI^RS\/_'GB&]UC4[&\6XU @WT-K?2Q07>/^>L8.&K5\<?L^^"?B!I_ARSU
M'2VMXO#K*VEM82M ]K@ 84KT& !BO1Z* /(?$'[*?PV\4>*CKVH:&TEU*\<E
MU L[K;W;IC8TT8.UR,#DUN_$CX$>#OBI/I5QK>G.+S2\BTN[*9K>:)",% RX
M.T^E>@T4 </\*_@SX5^#&GZC9>%;)[&VU"Y-W/&\I?,A&"1FK-Q\*?#MU\3+
M7Q]);2'Q);6;6$=QYAVB%NHV]*Z^B@#Q_6?V3OAIKWBJ;7;K0V\VXN!=W%E'
M<.EI<3 Y$DD(.UFS77P_"7PW!\21XZCM&3Q"MB-.$RN0@@'10G2NQHH P_&_
M@S2_B%X4U+PYK4+3Z7J,1AN(T8J64]@1TKF;?X#^$+77O!FL1V4HOO"-H]CI
M+^<<11,H5@1_%P.]>A44 >3W'[,/@&Z\(^)?#4FG3G2?$.H?VGJ$?VALO/N#
M;@>PR!Q5/XE?LE_#KXLZKI^H^(=/NY;NQM$LH)+>\>(B)>@^7K7LE% 'GWP?
M^!?A3X&Z?J%EX4M[JW@OI1-,+JZ><E@,#!8\5!I?[/W@[1?"_BSP_96EQ!IO
MBBXENM35;AMTCR??PW\(/M7I%% 'BW@/]D?P%\-=2TV[\/\ ]L62Z?+YT-J-
M3D,&[OF/H<^]>@?$KX:Z%\6O"<_ASQ';O=:5-(DCQQR%"61MR\CW%=310!PW
M_"F/"_\ PG5KXO\ LDG]N6VEG1XYO-.T6Q&-NWU]ZP/^&8? /_"M/^$#_LZ?
M_A'/M_\ :7D?:&W>?OW[MW7&>U>L44 <'\1O@GX4^*=MH<>O64DDNBW"W.GW
M5O*8YH'48!5QSV''M5K1_A+X;T/Q]KGC*VM9/[=UJUCL[V:20LLD<8PHV]*[
M*B@#QRW_ &2_AO9^$_$_AJUTJ:UT;Q'=+=ZA;0W#*)&!R /1<]J[#Q5\(/"?
MC+P%<>#M3TB&30IK9;5H8U",$7&W# 9!&T<UV=% &=X=T&V\+Z#8:19&0VEC
M"L$/G.7?8HP,D]>*\TD_99^'TWA>\\/MILYTR[U<:Y+']H;)N@<[L^F>U>N4
M4 <:OPF\.+\3(_'HM9/^$D2Q_LY;CS#M\GTV^OO3_&7PK\/>//$'AG6M8MI)
M[_P[=&\T]UD*B.0C&2.]=?10!Y#/^RG\.;C0_$VDG2)$L_$>H+JFHJDY!DG5
MBP(/89)./>MCXG?L^^!?B_I-A8>)]%2]%@H2UN4<QSP@ #"R#D=*]&HH \X^
M&_[//@'X4:%J.D^'O#\$%MJ2%+YYR99+I2,;9&;DC':L[P'^R[\._AOXEAUS
M1='=+VV#+9K<7#RQ608_,(48X3/M7K%% 'D'B#]E#X:^)O%TWB&^T-C=7$ZW
M5U;1W#I;74RG(>6(':S9[UZQ)9PR636FP+;M'Y6Q> %QC _"IZ* /)H_V7?
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M9D.5)QU'M7844 <!+\#?"4WB3Q9KS6<IU'Q19BPU.3SCB2$+MP!V..]5+O\
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M1V>GVT=M$H'\*J /Y5K444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'DG[4WPLU'XP?!K5M!T=D_M99(KRUCE;"2R1.'"-[-@C
M\17C.D^#?B7XM^+%[XMU;P$V@6E[X0GT(1-=Q22QSJIVDE3C:QX'MUK[!HH
M^9_V7_V4_"_A+X:^%;WQ;X!TJ#QW9AGN+F>)99EDWL5)8$@G&*Y_XAZ/\5_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%>/ZU\?XX?C1X>\!Z7I-Q=Q7=Q-!?ZK+&R00.D
M32"-"?OOP,XX J/Q9\5?&%]XUU_0? NB:?J*^'+>.;49]1F9/-D=2RP1!1][
M:#R>.E 'LE%>'-\>]7\;KX1L/ >DVLNKZ[IKZM*VJR,L-G"C;&#;>68O\HQ]
M:[CX1?$6;XB^'[N6_L5TS6M,O)=.U&T1]Z)-&<$JW=2,$>QH [FBBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ..XBF9Q'(KE#M8*P.T^A]
M#0!)156SU.SU!I5M;N"Y:%MLBPR*Y0^AP>#]:6+4[.>\EM(KN"2ZB&9(%D4N
M@]USD4 6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'Y[>5=T<D>HQ%6'J#NYK;\0?#_PQXLNHKK6_#VF:O<Q+MCEOK2.9E&<X!8'
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M@W_H:=(_\#(_\:/^%J^#?^AITC_P,C_QK,_X4-\/?^A0TO\ [\T?\*'^'O\
MT*&E_P#?@46ROO4^Z/\ F%\\_EI??/\ R.JT3Q-I/B6*232=2M=2CC.UVM95
MD"GT.#Q6G7AO[/>EV>B^.OB=8V%M':6<&HQ)%!$,*@VMP!7N5<V/P\,+B'2I
MMM635]]4G^IVY3C*F/PD:]6*4KR3MM[LG'2_H%%%%>>>N%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2\3ZS<7VC7]]9B;R8\JJ2F%NH8*3@^M?0,D:R+M=0Z^C#(I1QP.!0!\-^/\
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M<VHV,4[HN<X!=20,UX-_P3]LK?3?ACXZM+2".UM(/'6LQQ00J%2-1(F%4#@
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M_P#"<^'/^@]IO_@4G^-*/''AUB -=TTD_P#3TG^->5_\,7_"/_H5Q_X$R_\
MQ5>:?M)?LN_#?P)\$?%6NZ+H'V/5+.V62"<7$AV-O49P3Z$U$IU8Q<FEIY_\
M ]'!Y?D>,Q%/#4\154IR45>G&UV[?\_#ZY5@ZAE(92,@CD&EKE_A>S/\-_##
M,2S'3H,D]?N"NHKI3NKGR-:G[&K*G>]FU]P4444S$**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\+ZK:*P1IK:1 Q[94UX!XJOI;[]D\^<%W0ND V]PLN!7T9JG_(-N_P#KB_\
MZ":^;/$/_)J=W_U]?^UJ,M5L_P (UU_^2B?+<0_[CB'_ -.I_D.U[X4_%"S^
M*@\>^ ;S0D34-#M;"2/5MY(V@$X 'KCO5#Q-\2_CE\+=>\(-XLD\+76DZSK$
M&F.FGQ2>8-YY.21C@&OIGPW_ ,B[I?\ UZQ?^@"O!OVPOO?"K_L;[3^M<^)I
M^S<Y1;W_ %/V3A_,WF57#8+%T*<X\G+=Q]ZT8.VOE8^BJ***Z#X0**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'/C)HGQ@O
MM>ANO GBK0-!T**V_P!(CU:U,C>8#DMNZ!<5['7FO[1WA/5_''P6\4:)H38U
M.[MML4?F^7YO()CW=MP!'XT >/\ AO5OC$OB32O[3^+_ ,/KS3S=(+BUM@GF
MS)GE$^;[Q[5]55^>MK^S/>^"_C-X<70/A?<"";4K#5K75II_,M]-A$8^TVTH
MSRP;.#7Z%4 %%%% !1110 5\S_L%?\D]^(/_ &/NM?\ HQ*^DKJ\@L83+<SQ
MV\6<;Y7"KD^YKYK_ &!Y%E^'/C]T971O'FLE64Y!'F)R#0!]-4444 %<5\1)
M%BOO#;NP1%OE)9C@"NUJCJVAV.N1)%?VR7*(VY5?L: /@WQI(DOP8_:6=&5T
M;Q'"0RG(/SI7TA\%=6L8/$.H/)>0(DVG60C9I  _[L=.>:\4T'1[*;X8_M/6
M4ELDEK#?RM'$PR%*Q%E(^A /X5V'A7POI<?[-/PYUM;-%U5[2R5KH9W$<=:\
MC/\ VM++J6-I)-T*CDT]+IP:TM?4^PRKV=;"O"U&U[27+==WRO\ ]M/5_C1(
ML>O^ &9@JC5N23@?=KU2O)_V@+>*3P9H\S(&EBU*VV/W7+#./K7JZ_='THPU
M_KE==^5_A;]#X2GI7J+T_P OT%HHHKUSK/"OA5K6GZ3\6OBE]NOK>SW:@I7S
MY53/';)KVVRO[;4K<3VEQ%=0G@20N'7\Q7#>)O@5X(\3:E>:KJ&AQ3WUQEY9
M=S LV.IP>M<Q^RK"MMX#U2"/(BAU:X1%SG:H(P*^DQD</C:,L92D^:/(FFE;
M:VCOY=CXO+98O+<3#+J\8N$W4E&2;O\ %S:II?S=V>T4445\V?:!1110 5XW
M^V#_ ,FW^-_^O1?_ $8M>R5B^,O".E^/?#-_H&M6_P!JTR^C\N>+)&X9!Z_4
M"HJ1<H.*ZGI99B88/'4,34^&$XR=M[)IF!\,?$6E0_#GPRCZI9(ZZ= "K7"
MCY![UTW_  DVC_\ 06L?_ E/\:\47]AWX4*H TJ^  P -0E_QI?^&'OA1_T"
M[_\ \&$O^-8IUDK<J^__ (![U:ED-:K*I]9JJ[;_ (4>O_<0]J_X2;1_^@M8
M_P#@2G^-'_"3:/\ ]!:Q_P# E/\ &O%?^&'OA1_T"[__ ,&$O^-'_##WPH_Z
M!=__ .#"7_&GS5OY5]__  #+ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>U?\)-H_\ T%K'_P "
M4_QH_P"$FT?_ *"UC_X$I_C7BO\ PP]\*/\ H%W_ /X,)?\ &C_AA[X4?] N
M_P#_  82_P"-'-6_E7W_ / #ZMD'_035_P#!4?\ Y8>Y6>K66HLRVEY;W+*,
ML(95<CZX-6Z\Y^%OP!\'?!V^OKOPS:7%M/>1K',9KEY05!R,!CQ7HU;1YK>\
MM3P,7'#0JN.$FY0[R7*_/1-_F%%%%4<84444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 C'"DXS7R1\;VO/&U[X7U[6_@'KWC.]MQ<1+8?; (;4+)A6DCSABX
MY&>U?7%?-/[7&NZ=X2O=$UF/XI:GX#\21PNEEIMC ;I-0&[D-;@?-SQGM0!V
M7[/WCS7_ !,M_INI_"B]^&EA8Q(;87 01S9."JA1VKV2O ?V4_BA\3_B/IFH
MMX_\,+I=I %^P:MY)MWOAGDF(GY>*]^H ***\U\;?&R#POXBN=#TOP]JOBG4
MK*W6[OX]+C!%I$V=NXGJQ )"CDXH ]*HKRS6/V@-)AT_PV^A:5J7B74_$%NU
MY9:9:1;)O)7[[R!ON 'CGOQ76?#OX@:;\2O#::OIJ30!97M[BUNDV36\R':\
M;KV((H \3_:?_P"2Z?LW?]C3<_\ I%+7TG7S9^T__P ET_9N_P"QIN?_ $BE
MKZ3H **** "O&/VL/!FK^,/A4[:+Y!O-)NH]4*W#85EARQ'UXKV>N9^)W_).
M?%'_ &#+C_T6U &;\$O'%S\2/A5X;\27D$=M=:A:B22*$DH""1QGZ5W%>1_L
MF_\ )N_@G_KR_P#9VKUR@"&\A-Q:31 X,B,H/U&*^9/B-X'\<>&?A+?Z///I
MDFBI*'^0'S3F3(Y^M?4->=_'S_DF.I?[\?\ Z$*\_%2EA6LPI.U2DFX]M+.S
M7572T/*S/"4\7AJE.I>SBUIIHUJ<EI<_QLCTNS6"S\.F%84";I#G;M&,_A7$
M?&+X<_&WXE6GAYOLGA\7.BZG'J< 6; :1 < Y[<U]-Z+_P @:P_Z]X__ $$5
M=KZ"KCEBJ+A*C!<W5)I_+4TRC"U<GQ=+&T,14E*&RDTXO2UFK*ZLSYD^W?M2
M_P#0.\)?]_1_C5[X#_&;X@Z_\7O$?@3Q[::7%>Z99QW(?3LX!8],]^*^C:^6
M_AM_R?%\1O\ L%P?TKRW'E5[]4?H.%Q=+,*>(I3PU.-J<I)QBTTTXVZ^9]24
M445H?'A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO4_#FIOK6@Z??R($DN8$E95Z D9KG?C-_P DN\1_]>I_]"%:W@/_ )$O0_\
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M  9+_P"5GH?_  DVC_\ 06L?_ E/\:/^$FT?_H+6/_@2G^->>?\ #,/P\_Z
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M;2Z[:JS_ #,\9@X9AA7AZK:4K:K1Z--6^:/CGPSX?_: ^''C3QCJND>#-%U
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M[)Z-;I/OV.S_ +;T[_G_ +7_ +_+_C1_;>G?\_\ :_\ ?Y?\:\P_X9:\ ?\
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M'_9\C^(W@C1/"U@GB2X:VN-*U<WCR2?8Y?E92HP,=Z^Y:^;/VG_^2Z?LW?\
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M*/\ AE7X?_\ /IJ'_@PE_P :/^&5?A__ ,^FH?\ @PE_QJ?8Y;_S^G_X O\
MY,OZQG7_ $#4_P#P:_\ Y6>K_P!H6O\ S\P_]_!_C1_:%K_S\P_]_!_C7E'_
M  RK\/\ _GTU#_P82_XT?\,J_#__ )]-0_\ !A+_ (T>QRW_ )_3_P# %_\
M)A]8SK_H&I_^#7_\K/5_[0M?^?F'_OX/\:/[0M?^?F'_ +^#_&O*/^&5?A__
M ,^FH?\ @PE_QH_X95^'_P#SZ:A_X,)?\:/8Y;_S^G_X O\ Y,/K&=?] U/_
M ,&O_P"5GJ_]H6O_ #\P_P#?P?XT?VA:_P#/S#_W\'^->4?\,J_#_P#Y]-0_
M\&$O^-'_  RK\/\ _GTU#_P82_XT>QRW_G]/_P  7_R8?6,Z_P"@:G_X-?\
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M_P"!47^%?0]%'LY_SO\ #_(/[4R[_H7P_P# ZO\ \F?/'_#2?Q"_Z(-XG_\
M J+_  H_X:3^(7_1!O$__@5%_A7T/11[.?\ ._P_R#^U,N_Z%\/_  .K_P#)
MGSQ_PTG\0O\ H@WB?_P*B_PH_P"&D_B%_P!$&\3_ /@5%_A7T/11[.?\[_#_
M "#^U,N_Z%\/_ ZO_P F?/'_  TG\0O^B#>)_P#P*B_PH_X:3^(7_1!O$_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX5\'/B1K.EZIX>^'VO>%YM&N5T]C%<23!O,$:\G Z9^M>ZUXUXD_Y.B\(?\
M8(NOY&O9:];-?9RG3K0CR^TCS-*^[;[W['@9#[6G2K8:I-S5*?(FTD^51BUL
MDNH4445XA],%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7GO[0&J
M^(]$^#_B>]\*+*VN0VI: P)ND09&YD'=@N2/I7H5?+?[1'Q,^(U[\;-$^&?P
M_P!9LO#4TFCW&M7&H74 E,GE](P#T!H \0^#/Q@OI]5TOPSX4\4^)/$.N?\
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M?Y"K%>XG=7.\****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@#YZ^%N8?VNOBW&RD&33]/=?0@ C^M?0M?/OP\_Y/ ^)O_8(L:^@J "BBB@
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M;Q+_ -$_U3_OXM'_  M;Q+_T3_5/^_BUZA11]5Q/_00_NC_D'LJG_/Q_<O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUC\A7J-(WW3]*OZKBO\ H(?_ (#'_(KV57_GY^".;^'_ (VA\?:#_:<-M):
M2O"T4N,AE.#72UYC^S[_ ,B7=_\ 82N?_0Z].K; 59U\+3J5'=M*Y6'FZE*,
MI;M!1117>= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\S_L%?\ )/?B
M#_V/NM?^C$KZ5DE2%=TCJB],L<"OFG]@DAOAY\0"""/^$]UK!!R/]8E 'TS1
M110 4444 %%%% 'S%^W1_P B3I__ %\Q?^C!7F?QJ9?^%4Z3\PROC33'//1>
M.?I7MG[;&C6EY\#=6O98]US:M&8FSC;\U<[KGPO\/W?P]\$--;RO_;2VT-X#
M,?F5HUR1Z'W%>#F5:I@*^'S.$5*-%OF5[.TERZ:/57/I\AJ4U5E1J-IRM:RO
M\.O='TQ:7MO>)FWGBG"\$QN&Q^53U\G_ +*OA&P^'GQ]^+GAC1WNET>Q^RB"
M&YN&F*Y7)Y8U]85]/B*2HU.6+NK)_>KGAXJ@L/4Y(NZLGVW5PHHHKF.0****
M "BBB@ KRGX&S1Q-XQ#NJ'^VIOO$#O7JU><ZA\ _">I:A<WDD5['-<2&63R;
MMT4L3DG KR\72KRJTJU!)\M]&[;KT9RUHS<XS@KVOY;GH'VN#_GM'_WT*/M<
M'_/:/_OH5YO_ ,,[^$/[NI?^!\G^-'_#._A#^[J7_@?)_C2]KC_^?,?_  -_
M_(BY\1_(OO\ ^ >D?:X/^>T?_?0H^UP?\]H_^^A7F_\ PSOX0_NZE_X'R?XT
M?\,[^$/[NI?^!\G^-'M<?_SYC_X&_P#Y$.?$?R+[_P#@'I'VN#_GM'_WT*/M
M<'_/:/\ [Z%>;_\ #._A#^[J7_@?)_C1_P ,[^$/[NI?^!\G^-'M<?\ \^8_
M^!O_ .1#GQ'\B^__ (!Z1]K@_P">T?\ WT*/M<'_ #VC_P"^A7F__#._A#^[
MJ7_@?)_C1_PSOX0_NZE_X'R?XT>UQ_\ SYC_ .!O_P"1#GQ'\B^__@'I'VN#
M_GM'_P!]"C[7!_SVC_[Z%>;_ /#._A#^[J7_ ('R?XT?\,[^$/[NI?\ @?)_
MC1[7'_\ /F/_ (&__D0Y\1_(OO\ ^ >D?:X/^>T?_?0H^UP?\]H_^^A7F_\
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M_A#^[J7_ ('R?XT?\,[^$/[NI?\ @?)_C1[7'_\ /F/_ (&__D0Y\1_(OO\
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M[\3?]^!1_P -'W7_ $3OQ-_WX%>U44?6L%_T#?\ D\@_L_,_^@Y_^"X'BO\
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M]F?]F[P9\7+GQJWB"*^E?2[]+:W:"\>,["I.&(//3O7N'_#!?PK_ .?;5O\
MP9R_XU[\:V&QM.%=R:YHQTM?HO,[L0L-4J?O9N,HVBTE=>[IO==NQ[__ &Q8
M?\_UM_W]7_&C^V+#_G]M_P#OZO\ C7@'_#!?PK_Y]M6_\&<O^->7?M-?LF>
MOA;\$_$GB;04U2#5K"-'@DDU"1PK;P.A/O6M.AAJDU"-1W>GP_\ !,Z6&P=:
MI&G&K*[=OA77_MX^VP0P!'(I:P/A^[2> _#;NQ=VTRV)9CDD^4O)K?KSI+E;
M1Y,ERR:"BBBD2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'C.K"!OVMM"%UM+#PI.;/S.GF?:/GV
M_P"ULZ^U<W\(O%R> _"/Q9UV+2[[6-'T_P 27DMII^BP>=/,,KO6%,@$[RW
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M?_1(?BE_X3Z__':/^&W+/_HD/Q2_\)]?_CM?2E% 'S7_ ,-N6?\ T2'XI?\
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MMI]F][<^7;F6!FD*?O/XB,FO;/\ A@WX%?\ 0A0?^!UU_P#':DD]Q_MK3_\
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M^7_&C^VM/_Y_K;_O\O\ C7AW_#!OP*_Z$*#_ ,#KK_X[1_PP;\"O^A"@_P#
MZZ_^.T >X_VUI_\ S_6W_?Y?\:/[:T__ )_K;_O\O^-?$>G_ +(_PHF_;&UG
MPD_A(-X;A\&V^HQZ?]MN?*6X:Z=&D'[S[Q4 =>U>U_\ #!OP*_Z$*#_P.NO_
M ([0![C_ &UI_P#S_6W_ '^7_&C^VM/_ .?ZV_[_ "_XUX=_PP;\"O\ H0H/
M_ ZZ_P#CM'_#!OP*_P"A"@_\#KK_ ..T >X_VUI__/\ 6W_?Y?\ &C^VM/\
M^?ZV_P"_R_XUX=_PP;\"O^A"@_\  ZZ_^.UX=+^R3\*D_;2B\(#PD/\ A%V\
M$C43I_VVY\K[4;R1/-_UGWMH Z]J /N+^VM/_P"?ZV_[_+_C1_;6G_\ /];?
M]_E_QKP[_A@WX%?]"%!_X'77_P =H_X8-^!7_0A0?^!UU_\ ': /<?[:T_\
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M.![ $US_ ,4FO?!?Q"\ ^.FTR\U'1K"SN--U!;&$RRVXE5"LFP<D;D ..F:
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M1M3T_1O#6G7/VJ?4K=K<FYF4((5!^\5&23TH ^@J*** .$^-GQ$G^%OP[O\
M7K2"VN;Y)(;>VAO)"D3222*B[V'('S9/TKEO#_Q7\2Z;X5\1>)_%LOA6[T;2
MK-I\^&;J6:3S%&2C;^!Z5N_'BWMI_!,;WW@YO&^FP7D,UUIL9RZQJV3*J?QE
M>NWO7AMWX%;XI:WX^O/ GAVY\/>'+[PLVFLMQ;?9([^_\P.A6/\ V5&TMCO0
M!Z=X6^,7C"V\2>$[3QKH&FZ9IOBM&_LZ73YW>2WE"[UBG#<9*GJO&:]KKYIM
M=<OOC5XP^%UK;^'M6TIO"\_]H:S+J%L88[>5(MBQ*3]\EL].PS7TM0 5ROQ.
M\>V_PS\$ZCX@N(&NOLP5(K=" 9978)&F3TRS 9[5U5>3?M1^ ;[XD?!O5M*T
MVW>]O(YK>\6TC;:UP(I5=HP?5E# >^* */@GXQ>);C5[V'Q)INC3:7!I\E]+
MJ/AZ[,Z6;(,F"<-T<CH1P:R]!^/7BTCPGK^O^'=.L?!?BBZ2VLI;>=VO+;S<
MF!Y@?EPX_N],UQNC^'K7XB?$*WN/ WA>\\+:7#X=O-/U>2YLOL<<TLB;882O
M\;*W.[L.]0V=QJOQ"\(?#7X:_P#".:MI^LZ#?V;ZS-<VQ2WMH[48+K)G#!R!
MMQZT ?6=%%% &=X@;5$T6\;1$M9-5$9^S+>EA"7[;RO./I7BNB_%;XG)\7K#
MP;K&D>%Y[=+1M0U:ZTN:X+6,'1<[N-S'H/3FO>6;:I;T&:\6_9\\/WVI:#XR
M\3:Q;36FM>)]4NG9;E-KQVZ$QP)S_"%''UH QD_:)\4?V3;^-9/#VGK\.9]2
M^PK,)G_M!8O-,0N"OW=I8?=ZX(KZ#5@P!!R#R*^/6BUJ^^$-K\&/^$<U1/%$
M>I+;R3M;D6@MEN#)]I\WIM*8]\FOK^WA%O!'$O*QJ%&?88H DJ*ZG%K;2S%6
M81H7*J,DX&<"I:S_ !#%?3Z#J,>ER+%J36\BVTC_ '5D*G:3^.* /!_"?[2'
MB/6+OPIJ=]HVD)X;\3:H=,M;:UNF?4K9B2%>9#\N!CY@/N]ZN:]\>O%@_P"$
MJU[0?#NG7O@SPS>M9WDEQ.ZWESY9'G/"!\N%S_%UP:\?\)^$8H6\#V^A>$M:
MTWXMV6K1RZSJEU PB"EC]JDDD)VNCCH .XKJM4O-7\%^%?B/\.&\.:K>ZWKN
MHW,FCS6UL7MKF*Y((<R#A=F6W9]* /J;1]4@US2;+4;5M]M=PI/$WJK*&'Z&
MKE8?@?07\+>#-"T>1M\EA90VSL#D%D0*?U%;E #9)!#&SMPJ@L?H*^?(?VB/
M%3>'9/'DGAO3X_AVM\;7=]H;^T/)\WROM&W[FW=SMZXKZ#==R,"-P(Q@]Z^)
M?$W@2\\2:=JO@'2;'Q=I<]YJ_F+X;F56TRU7S]YN!<8R8B/F"9ZG&* /;_%'
MQE\7W7B#Q7!X+T'3-2TKPK&K:A/J%PZ/<R%/,:.#;QD)W;C)KU+P3XLM/'7A
M'2/$%B&6TU&V2X17^\NX<J?<'(_"O +[5KWX.Z]\3-%N/#^K:F/$>VXT2?3[
M4S)<.UN(?*9A]U@P&<]CFO8_@CX1N_ ?PG\+Z#? +>V5DJSJIR%D.689]BQ'
MX4 <M\0OV@8_"GQ'\->#],TF?4[F_P!1BM+^]=&6WLE<$@;^C2'LH_&K/C;X
MF^*)/B%+X-\#Z5IM_J5EIXU&_N=6E=(8U8XCB79R7;KZ 5%\>-+NK[4_ARUG
M9RW A\36\TYA3.Q K9=O0>]8/BG6KCX1_';6/$^HZ1J6H:#KVDPV\5SIML9S
M%<0D_NW4<C<.0>E $T7[0FJ^*-%\'VOAG0[<^+?$$US!)::C*PM[$VQVW!=E
MY8!N!CK7:?"7XC7_ (V37=-US3X=,\2:#>&ROK>UD+PME0R21D\[6![\C!KP
MKPMX=UWX4KX"\<ZOH5\]H;S5[C5+*TB,MQ8K?2>9&S(.2%Z-CIFO4/@'IE[J
M7B+Q[XVN=/NM+M/$6H1M8V]XGES-!%&$$C)_#N.<#TH ]EHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KE['Q]X;D\<W/@VRO(6UZ"U_M"
MXM(%_P!7&6"[G(X#$D<'FNG8;E(Z5\_^$_ ^C>!?VI);;1K06YNO#$UQ<2LQ
M>2>0W2?.['DG^5 '<S_M">"[?Q<?#[W\_GK="P>]%LYLTN3TA:;&T/GC&:](
MKXP6XBC_ &._$%E+- -=_MV:%HR1YGVPW8VC'7?TK[&TY9%T^U$O^M$2A_\
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MX\^+]Q:R1R:3)XB46[0_ZLN+>,2X(X/S=<=Z /:Z*** "BBB@ HHHH ****
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MM8AU37-!M[^_B54\YF==Z@Y"N%(#@'LV179T4 ,BC2&-(XT6.- %5%& H'0
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MQS0!\/>-])TKQO\ $;]F;Q!XGN9O-US2HVO[R2[:-698E93G.%8MUQUS7W_
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MG6)N<A\=J\<^.7P+^)7BWQOJUC8V8\1^!KG0H].TFQDU@V=OIUPJ[3--$/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\-:3I>JWVIV>FVMKJ-^5-U=0PJLL^!@;V RV/>M.BB@ HHHH **** "BBB@
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M=VZ4 =C17.^!_'FD_$'27O\ 29)!Y,K6]Q:W,9BN+:5>L<L9Y1AP<'L1714
M%%9^O>(--\+:1<ZKJ][#IVG6R[YKJX<+'&O3))Z5>1Q(BLIRK#(/J* '45!?
M7D>GV<]U,2(8(VE<@9.U1D\?05E^"_&&F^/O"^G>(-(>273;^/S8'EC*,5R1
MRIY'(- &W1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[<>)-!UG3O#FHZ=X9O/B!_:=EIKVCQ-9VWV4H\[Q$?N5>0$[2!US@9K[!HH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#P:XUO]HX7$PA\-^ V@$C",O?7&XID[2??&*9_
M;G[27_0L^ ?_  .N:]\HH \(L]:_:,:\MQ<^&_ BVQE03-'?7!81[AN(]\9Q
M7N]%% 'E_P"TEX1F\6?"75WLESJVD[-7L&!(99K=A*-I]2%*_C7D?@'QA?\
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M%% !1110 4444 %%%% !1110 4444 %%%% !117-ZSX?UN_U"2>R\12:?;L
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MGC<, C/&1@\5Y!)\7/B9H5GXCU*\\3V5_;>%?%4.AO;C3(XSJD,DT:EI"/\
M5, Y V<' S72:GTY/XTT"U%V9M;T^(6DZVMQON4'DS-C;&_/RL<C"GDYK9KX
MG\>(K6OQ<.T?-\0-);I_TSAK[$\3:(WB30;S3%O[O2S<IL-W8R>7/&,C)1OX
M3C(SVS0!)'X@TN6UOKI-1M7MK%G2[F692D#(,N'.<*0""<]*J>%_&_A[QO;3
M7'A[7-/UR"%@DDFGW23JA(R 2I.#BO#OV:?"OAZQ^&/Q!T748(YO#MMXIO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV]]?PQ7<J-+*Y4L=X;< 2B\ @<5;\$?"O2/ %W)/IM[K4^Z$6XAU'5[B[B1
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M"PB@<KZ%D4''M6M8:79:4DJ65I!9I+(TTBV\2H'D8Y9S@<L3R3U- %JBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **\CF\/_&=II#%XK\-+$6)0-8/D
M+G@'\*9_PCWQJ_Z&SPS_ ."]_P#"O7^H0_Z"(??+_P"1/G_[6J?] E7[H_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(+.XUM]5DDW2!SL=O]7$@10J?[1KZ*HH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /%KC]LSX-6MQ+!+XXM4EB=HW4VT_# X(_U?J*C_P"&
MTO@M_P!#U:?^ T__ ,;KUEO"NBLQ)T>P))R2;9.?TI/^$4T3_H#Z?_X"I_A6
M%JW=?<_\SZ55LBZT*O\ X,A_\J/++3]LCX.7UW!;0>-[62>>18HT%M/\S,0
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M\Y978L2,YR.2<YH YWXD_'#7?"?CO4/#6A^&+;6)+'0FUZ>YNM0-NHB5]K(
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M'BN?P_#''L>"*U242-G.[+=..*ZVBL:M*-:').]O)M?BFF1**FK/_+\CS/\
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MG,2N'5UERR@X)#9';( S7N6G_#^PTOPBVFV=AI]IJ#Z;]B>ZM[=8]S&/:22
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MVKM)TIM;CO?"'B>UN-"6.;5H7MX<V5O(,I,Y$N"I'.%);VKBOBA\6O$^F_\
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MTGBN:T?X4^- WB_Q#J.HZ!%XQUF.V@@2&WDN+"**!0%5A( QWG))Q\N>,XH
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M"1')(V @;!!QDC.#2_#'5?$FM6$]SKVL>&M74[1&WAQ) D;8RRLS2OD\]L4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNJIG? 4]P.F1Z5[?5/1]'LO#^EVNFZ;:Q65A:QB*"WA7:D: 8  JY0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &)XV\)VGCSPCK'AW
M4))X;+5+62TFDMF"R*CJ5)4D$ X/<&K^GZ7%IND6VG1M(\$$"VZL[?.550HR
M1CG [8JY10!YEH?P'T_2?$^EZQ>>)?$7B!-(DFETO3]6N898+)I>I0K$LCX'
MRKYCO@?G7IM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
# ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>75
<FILENAME>mrna-20201231_g34.jpg
<TEXT>
begin 644 mrna-20201231_g34.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X8#/:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](EA-4"!#;W)E(#4N,2XR(CX*(#QR9&8Z4D1&('AM
M;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN
M=&%X+6YS(R(^"B @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @
M('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(*
M(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*
M(" @('AM;&YS.GAM<$=);6<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]G+VEM9R\B"B @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+VUM+R(*(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @>&UL;G,Z
M<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C945V96YT(R(*(" @('AM;&YS.FEL;'5S=')A=&]R/2)H='1P.B\O;G,N
M861O8F4N8V]M+VEL;'5S=')A=&]R+S$N,"\B"B @("!X;6QN<SIX;7!44&<]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @('AM;&YS
M.G-T1&EM/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM
M96YS:6]N<R,B"B @("!X;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @>&UL;G,Z>&UP1STB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(@H@(" @>&UL;G,Z<&1F/2)H='1P
M.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @>&UL;G,Z17AT96YS:7-&
M;VYT4V5N<V4](FAT=' Z+R]W=W<N97AT96YS:7,N8V]M+VUE=&$O1F]N=%-E
M;G-E+R(*(" @9&,Z9F]R;6%T/2)A<'!L:6-A=&EO;B]P;W-T<V-R:7!T(@H@
M("!X;7 Z365T861A=&%$871E/2(R,#$X+3$Q+3$U5#$P.C$T.C4U+3 W.C P
M(@H@("!X;7 Z36]D:69Y1&%T93TB,C Q."TQ,2TQ-50Q,#HQ-#HU-2TP-SHP
M,"(*(" @>&UP.D-R96%T941A=&4](C(P,3@M,3$M,354,3 Z,30Z-30M,#<Z
M,# B"B @('AM<#I#<F5A=&]R5&]O;#TB061O8F4@26QL=7-T<F%T;W(@0U,V
M("A7:6YD;W=S*2(*(" @>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#HU.$$Y
M0S0W-48U13A%.#$Q0C W0T4S144W-30W1C%#-"(*(" @>&UP34TZ1&]C=6UE
M;G1)1#TB>&UP+F1I9#HU.$$Y0S0W-48U13A%.#$Q0C W0T4S144W-30W1C%#
M-"(*(" @>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)U=6ED.C5$,C X.3(T
M.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X(@H@("!X;7!-33I296YD:71I;VY#
M;&%S<STB9&5F875L="(*(" @:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4]
M(E!R:6YT(@H@("!X;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#TB5')U92(*
M(" @>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD](D9A;'-E(@H@("!X
M;7!44&<Z3E!A9V5S/2(Q(@H@("!P9&8Z4')O9'5C97(](D%D;V)E(%!$1B!L
M:6)R87)Y(#$P+C Q(CX*(" @/&1C.G1I=&QE/@H@(" @/')D9CI!;'0^"B @
M(" @/')D9CIL:2!X;6PZ;&%N9STB>"UD969A=6QT(CYG,#)S,3,\+W)D9CIL
M:3X*(" @(#PO<F1F.D%L=#X*(" @/"]D8SIT:71L93X*(" @/&1C.F1E<V-R
M:7!T:6]N/@H@(" @/')D9CI!;'0^"B @(" @/')D9CIL:2!X;6PZ;&%N9STB
M>"UR97!A:7(B/E1H=2!.;W8@,34@,C Q." Q,#HQ-#HQ.2!'350M,#<P,"8C
M>$$[4V-R:7!T('8R+C,L($EL;'5S=')A=&]R('8Q-BXP+C,F(WA!.T=R87!H
M:6,@='EP93H@3&EN92!#:&%R="8C>$$[)B-X03LJ*BI4:&4@9&]C=6UE;G0@
M:&%S('!A<W-E9"!P<F5F;&EG:'0N*BHJ)B-X03LF(WA!.U1H92!F;VQL;W=I
M;F<@9F]N=',@87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B!;5&5X=$9O
M;G0@07)I86Q-5%TL+%M497AT1F]N="!!<FEA;"U";VQD351=)B-X03LF(WA!
M.RTM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM)B-X03L\+W)D9CIL:3X*(" @(#PO<F1F
M.D%L=#X*(" @/"]D8SID97-C<FEP=&EO;CX*(" @/'AM<#I4:'5M8FYA:6QS
M/@H@(" @/')D9CI!;'0^"B @(" @/')D9CIL:0H@(" @("!X;7!'26UG.G=I
M9'1H/2(R-38B"B @(" @('AM<$=);6<Z:&5I9VAT/2(R,#@B"B @(" @('AM
M<$=);6<Z9F]R;6%T/2)*4$5'(@H@(" @("!X;7!'26UG.FEM86=E/2(O.6HO
M-$%!45-K6DI29T%"06=%05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-
M04$T46ML3D$K,$%!04%!04)!05-!04%!045!)B-X03M!44))04%!04%104(O
M*S1!1&M&:V(R2FQ!1U1!04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)1
M64I#=V='0F=G3$1!;TM#=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"
M351&0E%417AW8D=X<V-(>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA5
M4D92;V9(>#AF)B-X03M(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X
M9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&8O.$%!15%G03!!14%!=T52
M)B-X03M!04E205%-4D%F+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&
M07=)1T%104A#06M+0W=%04%G241!445"05%%04%!04%!04%!)B-X03M!44%#
M07=11D)G8TE#46],14%!0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)
M4DEX459%1T4R16EC645537!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG
M=D5L47I25&MQ2WE9,U!#3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*
M4D92<5,P5G1.5DM"<GDT+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP
M86UT<V)7-799,U(Q9&YD-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K
M-5-6;'!E66U:)B-X03MQ8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)
M0T%1241"455%0E%914-!341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y
M)B-X03MO8DAW1DU(4C133D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!3
M3F5*16=X9%5K=V=*0VAG6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z
M:$I3:W1-5%4U4%)L9%E75G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U
M8VY:-F9K<4]K<&%A;G%+;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X03E5
M-'$W1EAI,G)86&XR-#%857!.)B-X03MA<W1E<V1-:VU2,&@P.7!N0U5T8GA9
M16=/;%-Z5$90545,4TAA<C U9TQ16594;GE82C5V5%AP6'5O=%)N,4%7,3@R
M;U$S>EAK96YT)B-X03M)2DQB-FET=3AQ=F)+>%0Q2VU&5#,U-S!X5FTO;&I8
M8C-6;SE11C=:3%E85VXS8E=C:U-49E=&67)&2$QY1#A)=CDK,'!4=&=63V-6
M)B-X03MD:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-6
M9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U99)B-X03LU-5$O
M,W4X>B]W1&)89CA!-FA,8D974C1Q-T9867$W1EA9<3=&6%EQ-T9867$W1EA9
M<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W)B-X03M&6%EQ-T9867$W1EA9
M<3=&6%EQ=TA74'I),7943"]53E!B45!7=6)/4T0P;FEE*VMI93-M5UIJ32]P
M5T5S=T5F;W%R;4M+4TU--%@Q)B-X03M+:'%+;WI1+WI$1B]Q8GA89'1B5V5K
M=$AD>5=M<4QD;5)81FA*1DA/>G$P35-X;U105D<U;6]'+TA&55(U179R2RMM
M.'DS1FQC4C-6)B-X03MU,G-0>&UH9%I%4"MI5S-2;$I'2W-Q>%8R2W5X5C)+
M<%A996%.1#%$5W12,%,P=41*<65K*VXK:TE05&Q54BMS3U5F>'-O4G51,RM&
M)B-X03MJ:7%A67%G3DLO5'1B<CE,1S%P-C<O569Q9VLO,VXO63E8,5 Y,F50
M2&)&569I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I)B-X03MR<U9D
M:7)S5F1I<G-69&ER<U9E6&5:<FIY;RMV>%)7,3=Q3C4U:75.5&=S,T-85B]$
M.59J;&U#4T=*66I(8FA9;%!D4T0K,5A#<C%")B-X03M&2V]Q;&DU04%,=%-P
M<#-.04(Y=W=+>'E4.'4O2U1M42]66FMA4U0Q5F5/-W4T,FE0>#%70FML57=2
M=#9R.&\T=4M.53%'2V]N5&9*)B-X03MN;'949%)L,4-Y=%=J;FUJ:VE:1VUM
M9495;4M.2W-51'4P35AQ1TI#+T)">6]+-'%H9DIK8V-D,S5M4TY1:416,V]Q
M9T%$+U),8G--)B-X03M66DQI<G-69&ER<U9154XU95!Q8S%O.$5A=WA):V=M
M17)->$5J3W$O05EW068S92]X6EE9:FAU,DE*=6MB;&)*2SE(<W)/,W4Y5"MR
M)B-X03MW4G<O-E%Q+W4P5F1V<3A2<'-"=%9I8W1Y4TI!<SE0,&QR:$5!;6LP
M>7!S9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER)B-X03MS5F1I
M<55A3$Q),3EQ4%!7-'144U-8;F$R:V%W<6)734-H:DIJ2EHY>EAK,E-L0U$U
M:&E*03AI;2M26D]X5C)+=DIT5752<5 U=WA#)B-X03LQ:U<V:7,O<6MB<4EP
M3'(P<$EP2E!71EDW<4%7-4<S3&Y%-#9.-UE697,T1E-78GIT-4UG:75*<'1F
M,#9+2S!M1G1D4U!D=TMS534U)B-X03M%4E-%=E)84$)V:$\K>'A61C)M=C9&
M93,X*VY797!7='IQ1G%!,7I:=WI2>5122V%536MA<U=51V\V:D95<CAO9C<S
M95HO.$%T<G8O)B-X03M!3E%L=&ER23A69&ER<U9D:7%":"]W0T\S9"\X=S%T
M+WEC;GEW+U%0968P35(Y4B](96IS<EI)2%0O.$%E=E4O*UEL9BMO84A,2CAH
M)B-X03LW=C!L:DAM9G@P4C)6<VY9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ9V10+T%.-CE4+S5I5B\V:&]C<VYY2'4O)B-X03M35TUE
M6B](4DA:5WED:7)S5F5-9FUG=7184&YI3T14-4QJ,31J66958FE.651A,FQZ
M2SAG5#$R;70U94UK>FA6:31V,7!Y;T1H5C=()B-X03MB:6-7.%%U0W)4:$8Y
M57 Y:W94-'5.93%C0W9/3E@X:F5C<G983&Y826\Y3VMV;7)!235,>3=%53!0
M,64V=#!K*T]'-"MR1TU89&92)B-X03MJ1$EX-4AK0WAW<6EV2S-K4'I*<%8K
M<7I8345&<F%7.2]&85@Y=DDP;'I*2F9Y5SAG85-'5T%22TEV<35P.&(X='5M
M2W!R-4%T<FTR)B-X03MF>DI$8S-C;#E-=7-38W)M5EDP6G$R;'0K>D5S840W
M<T-S<WA6,DMU>%8R2W-D+WA4-5EG,2LK:FTQ97EJ:VIG:6IK4G)I24UR>%!/
M)B-X03M:1DE,5D1**S!/,EI0-69)64-O;FXS935X+WI'35-)-&\O365A0790
M4$5U<3(X.70U5# V-3%75C!D1C%"4CE7=$599VIK2C5E4$EQ)B-X03MD-DE$
M.#AS:G!E06<U0TDK6$TO2G)L<65)5FI";#4X:#@O,5=X9GE0;R\U>E=&-653
M,S5I6EIK0G!Q9'=::UIX4598-G4X:$1C5D%Q)B-X03M2,'I,,5=44WE!-&9S
M2#8S13!C3E9%;FHK,"]Q6F@K:R]W07A91%-B47)'.$AC,C$X,&8S0V%(34QW
M.$(U4VM09D@Y4F,S:GI$;D=*)B-X03LO=T$W.6IJ-7(X>7=(+U102U8V1C=T
M8E0R='AT6'-"26AX+TPT>GEY1#1G:%1N;4]C2F9!>"]7,R]J*S)J1F)R4F1:
M=%9(,FUE>&MD)B-X03M2,C-A27E$<FHK54HU4V=F.#5F>E%(3TUH+VUN.49U
M2#5M95-G4#,R;TYB2'5,:4,T:' O>4UJ55DO:V-V45@W:48O3UEU<'(S9VHW
M)B-X03LP9&)E9'9*.7HO8S8S67-F-69R16%T+W=*64A+-6%82T]C6F9*;DA5
M-'!C<%(K86%7.3=:,TER8E1X>D1R*S=D6"]55&Q2:5)Z1&-*)B-X03M!.&QB
M27!D:7)S5F1I<G-69&ER<U9D:7)S5F1I<4(P+R]E=E4O=T1M2E@O<4=H>7EF
M264W.4I9>#5N.&1%9&QB2C)+=7A6-78U<3AM)B-X03LS3W K66UL=31T1&UK
M=5-Q,G0Q9%-88U8P<V%S5$5N,65+4E5M35I99T5/;&9B0W(P5T-,,&])-'$Q
M.4Y1=&5L84-N=F=69FER<U99)B-X03LU-5$O,W4X>B]W1&)89CA!-FA,8D97
M4C1Q-T9867$W1EAI+VPO=T%O,D8S-310;5-E,W5.47-.43%A+T9R1W1Q<S%T
M=U5S4%=U2D=9)B-X03M"13E2:G<K13%+*T]B:E5A>55-67A$63A),S=V=TA4
M-F91>&QL3U4X=4DP4'@U.&YS-G%Q<4950E9554%'=T%'860S1&5+=7A6,DMU
M)B-X03MX5C)+;T<T,$A1-VXO96I4<E=B+T%)>5%X="MS2$Q";&U/4E!Z64A(
M13AW17)U4'DV.&I4='EF4DQ21#1X4FE';F)B,"M&371'<WI$)B-X03LK271*
M,&5(*V)(-4M*+TQF>7EH0G-Z95=,1&\Q=&4S4V(Y<4%Y34)4-5I,.#=K-C!F
M94%G-D](5&E(=6Q,.6)J-4AU67A7,3AY-GA#)B-X03MW*WE(=45N6#923$<U
M3S-V:BMA2%=%4&Q8,T94<&HP;DEF8CDT3&@U93@V>&EK4&UX;D$V9E=,0S-K
M+T=-=VY(>'-2-7<K56HK,69#)B-X03MY:FQ0-6=F;W!O5R\U;7=I:3-M:UA9
M.%I98FE&=6XK43=J.$UB=TAP369%2T)N2%=**T)(-E,W.4HO;4Y!4TIT17-,
M=T1V8EAR>&4K)B-X03LS<E$O4FIW641Y;$EE*U V:79(;4A/350O;F8X9&-F
M3EAM94AE-SAP,V=8=3%T8U=T>'-006,P4%1(.'9J4$Q)4&E#1D]E635W4'=-
M)B-X03MF,71N>CEB>&ET,6]M<S)Y:C=44%I/-FHU=$-:4FHK54HU4V=F:BMT
M5'%G3V-:1"]!1&(K-C-$.'I02EE(-S8O83)09&)I,W5)84AW)B-X03M*94Y2
M:BM2>3E"9G5)6#@U:C9M=F5#4'92='0U,SAN6$ER1')D:7@O;$YX1W)F.$%!
M<U%C<FQP8V\U>%!Y6G@Q5TM82U5F;6UT=F97)B-X03M6>B]V3F-25#DO,V)Q
M+U0U1355645C=S-#45!*2F1!.'IE6#E1,5A5<E=Y,4-#-'5';3E266\S1$U5
M5T-&1V%G-T)H5$PX,D-C66=K)B-X03M%0W8P;'!X6C13:U%#0U=16FI.-W-6
M9&ER>7IZ3"MJ;V9Z671,:&Q%<VA/;GA81'E7=&Q-65AK;&M7,SE*-6Y&>4]B
M5C5.0W!#8DAX)B-X03MO5F5P-$9E339L-2LQ4U-F558P<GIP6GE7,$8R:U4P
M:S!L;EIT1S9I-$UK341','8O4VIQ<U-),3!J1U)G=U)T,7%65&YY:C4Q,64X
M)B-X03LX>#--570W4'%$0S-V-7)J>3EX<S%U3$U7,'1U=')527-,:#4P;&,P
M:V5J2#=.04U66D0K6#DU3F50-6MU2F)/87AD.5AF.$$P834Y)B-X03M,,4%0
M<6QT5&PV5'ER=CA!-C-Z=TMY>D9867$W1E5G.#EA=%!P,VQU-"MQ8C9J96QB
M3%0Q1F%M-'54-F%5<"],570Y1UI';'AI57AF)B-X03LP:F,K-$]0<6-H:D$Q
M.5(R2'9,1"]W07903FUN3')I*UA93&$T:'1965)B,DA*-40X54%9>79,15-6
M4G!$=G-0:#9:9V9M=D5Y:VYQ)B-X03LT5VHQ3650=W=#04YH.$\Y-F9L-W15
M0G!8-F1R9&9P63)T4%AF-FHY545N*S@O-TAQ*W O=7IX-#=9<6HX5F1I<G-6
M9&ER<U9D:7)S)B-X03M69&ER<U9D:7)S5F1I<G-69&EQ0W5.0S!3-2\S;S K
M,FTO-'E1>'0K<TA,0FQM3U),030T;FU!;%9X*UAF:V$T3E@P4S!5*TU566DO
M)B-X03LU3CAC=$=S>D0K271*,&5(*V)(-5!0=$8X<"\X<2\X04Y387I,23 K
M:VMM>G9P>498-G5,:V=X4VUJ3E9/44%A=E1-,E=S3W%I8V16)B-X03M)8FIZ
M9&9I,&\P*U1J+V@U2'ET-T=$6&-D33%,=5A9<3=&6&HK<S(X,$@U=#)2=G1A
M="]75V5&.4]T+U1U-7 P9VYM4$M*;5-.;V\K)B-X03M:9F=+>4%!54I&3G-+
M=EE-0W5X5C)+<V,X;V8W,V5:+RLR=2\O54IB67%Y4$9867$W1EAN,VTW5U,S
M;3)&63 K<V9O1TI7=#=95B]E)B-X03LV<&9!<&)2:V8U15A*+V)-;54O0W=%
M+WA43D0S1#ER<CE2:R]E9"]"+W5J>2MY,%1P=FM(5"M-<TXO3#8R<%-H6G)I
M*VII;&EU1G5E)B-X03M4=C8P9'=722LP>$$R;V%$3E9#15-412]6-VHY-V1(
M<RMO,TMR4%AR9GHX,&9"<G5O-DI-=6XK6E=$,C!H-%=E=4MV1THV.45U1C92
M)B-X03MV-R]:3U=I6FIT3#5R2$Q,1V%N.$IF<C=I<6549%@P,BLK=DQA,TUC
M.&MC>FAL:FI%9$5$<T5/=T9A:C=S>#E&;'AK>45F9GER8F\U)B-X03LX>DM1
M<WDT<4IJ>G5I3VI*8WHR<#)+=7A6,DMU2D%"2DY!3GE4:7%J.61S+SDO>"\X
M1W8Y8TA%16-1578P>'!(+TQD8B]W1$DQ4#8T)B-X03M/3U!E:FIJ,W%2.'AE
M6'=A2%4W445F.$%&.&8O04169SA34&5'4&EW-W@X,4IV3FYL6E-68E=B145D
M46)M14@O04EL:C1S93A-5'%-)B-X03MF.#90>D-K+VYB>6EJ1E1R1F]34#5:
M:UEF94-29SAA2&5J.#%I+VY2*V%K+VXO>5EH;V18='EF.&QI=RLX03102&@S
M;R].-'8U=U<O)B-X03LX<D(X;D@W3W!)+VE54U)X.39Q8TAJ=S<Q+TXT*SDS
M+T%#<T1Y;BMZ94\O*W!B,TPP*V9'330K4$1V6#@S:C<O04Q$*W!O*V9F3' R
M)B-X03MI839M8G5S9&YD16=E3SA9>#AE4#1#4'IC4% O045S=C%/+WAZ<&)%
M0TMZ,4=6>C!23$LT2B]&4FHT=S=J.&PO3E(W<&8V52]Q44=T)B-X03LV.4)Q
M9&US07,O34YO56M365!9,C P17)E;6$X0S5&3TQF=$1V:C0S;$PU3"M:2#@R
M6"ML2U4K55!/<UAM<E=.5S!F571006=V56)J)B-X03M&,4%I46-'4U=T1'DS
M-FIV:TY0<51X,DYI-'5M,69J4VQ#434O9#5P=C58=F)V4V)Q-#AO-FA.5V4P
M:F%B4G(R87!%,6XP54YU=DHT)B-X03M0<W-+:F)F,WIB86E);4)L2$DO54\T
M+W1C:D))=TIX>39C:C-J.6Y64#E$,4(W-C-L95,T9VYD2EI)+SE(2$5"56M:
M1DI"950W45=U)B-X03M9:WI'+U,U1T]6:$UC:7IE5#8W9%1Z+VUT0D90;V9R
M5S94,E!O6%9X0S!B2S!B=E=A2U9*55-61C5C:'I"24DV5D%'1D0Q:D%L:&PO
M)B-X03LK849L6C-C;&LK:6%O.39+=$)B0T\R4U-A04Q/>&Y14S-%9D)!3%-4
M85AG-3)O<')I<4\P1'HU<&UU86]B1S%T8G%/3C!M:W1,-EE1)B-X03MI0S1&
M<S!A5$-,:DLX=%5A9%%E84Q8=%=M2W)V2T@K.3-M9B]!3&$W+W=$54IB67%Y
M4$9867%L*W!A-W R;D-1,V)324EO;FYC:4M2)B-X03ML16-9<3=C=W9#:3%&
M9#ES<VAI;$QK=VYK165B>C<X=DQD<F\S;FY05W8S8TIM;6YT=W<R.5=5.%AC
M1'(K-U%,0V<K954V,U51-&I))B-X03MN.3-J1D0Y2BM*8TQS,T),3E!I<F-N
M8CAE43(K860V4F]'=3-/<C-';S-%.7A:5S$S>F1#<G%*=4Q.5D992&QX;U!B
M3V,P;6AZ>GI()B-X03M*27EH1U8Y9"]+*S4V-U5A=D1(1TE215I3:CAV3D]R
M=GEH<&0S8E-W,W,Q,6-P2VI)5VQU2D1116112VAD=FQM,DA:*T\W:UI3.3AI
M)B-X03LV<DYQ6EI)1T9215IB8D%-3CAO+VQF<%@K;7DS1V]3>F-:,VAH1G)*
M-E@W=4YI;UHK3E-3,5!L;&5,5%DX;#-5<4QQ9$YO2C1,4$9+)B-X03M01C-%
M>#5D.4UM6#AV3DE',S$S56%$;U!R:W5X.%)1-6MJ4G=(2W<U0GA8.55P>3DX
M<&9R5U,O;'AP36]O,2]Q4DA7:'4S22]'=5%L)B-X03MO-R]J;5!L*W!L2$1J
M2$].+W=#9% O:6M'+S5786-4.$XO8W-"*WI+-WE,.4DU3&Q"-U!Y9$UH*U5F
M,DYW>#9B<FDO,F,O.$%I:3!F)B-X03MY>71L2'=T8GIJ*U=A3V%N,#!M;V9U
M>5 U3$U/531N,W@O5DIL-$]J4%!'9CE.*W1S9FPY07!R*VED2FMP-UA#9GAK
M=RM"<4(P>&XO)B-X03M!17<O5VHX;F]F-7-H+W!4*W!5+W=N87 Y=GER<'-V
M=DA)1C9E>G@T9C,T-31O2#-3+U=%+VM.1V52<C-W+V%R9F]F5%4O=E!*;'14
M)B-X03MP5TY,3B\Q.%1H.%A)3V5(-4=*5"]*,FQ02U50.4MF,4MO5%%&040K
M5C-J03A,2T9H+W=H8D@X,TAR:6U0.#!(-VEY+VLR2%-74#A!)B-X03M(=D-Q
M=#DU56I(1U149G%W1S-&-T9X5#(R:D](."]H2$U3:C<T4R]5>2]K>5A49U!U
M359A4%<O2C9G27-L=D5/>71(-F98,EI2:V@R)B-X03ML<'8U=T@R2B]K,TU0
M-%!U4G1V<D=G8V5-1C=A9TAF:7-K63EU;&-U:G)C0C54:CAW,6Y36E(O0DPU
M1D=2,TYT3'1(2VIK.4],02]Q)B-X03MY*T]337520F%P46M/659-;7AD:7)S
M5F1I<D9,;GDS<#)Q,S)O1T]%-F1Q14UK8S!';U)"0DQ(3U5"-69#9FDU0VY)
M2'(X.'A10DUN)B-X03MB:$DY>E1L,'-4=4-,-6=H269.97$S2C!M56%Q0EDK
M8DY!1%@K;5AA1#DQ8W)%4&IA26YQ<VEB4U(U<T]Z.'@X5'<U9GAB2'HX,T-Z
M)B-X03LU1'=N:3)Y43-(;E@T,T-99FQ8-3!B>DQ9,S9T84,Q83%N36A):S5H
M:F1Y4U0P<'A7;D=T3SEC=#%7;#A+=#=U+W-.3FY:*W$X84HR)B-X03MQ:CDK
M-T]C>$A0958K6G Y071V>F-S9EAK-6%H4$A:;F<Y:&$S05%R8T-+25)Z>7-*
M-#)D<"M236$P049E;W=Q.55W2W=I6#AR64I:)B-X03M,:5IV34]Q+U=,:60W
M:C9W9G%$4V]:66YG9$$W5VI&:SE+56]O9FQX04A(:FEQ3C!R.'5.1# K-FMK
M.6$T=3=.;V)I,VDP>34Y0G)A)B-X03M*3'1O,W5/2$=*2D-:1V=8-V)T5&9J
M4W5+<F9Y+W="33 S5$<X>#)7;3)S5FQA4C9U+W R.75I>'AR5S!T<3!644)I
M<DQ-5F1I<GDS)B-X03LX>79.3FAE871$-6%I;4U!6GAA-FYD;6AJ:FEM:VAK
M8FE19'E05&\Q9F-:6%!60T%-461Z,3=U9C)U<C%M94UP1$5$>C)0,DUR,'5W
M)B-X03MT<#=E0S5N4F)8461/5"]C9&%Y9D-P5D)T8U1C<41P=4LO4$YD9WA(
M5454:TMX>"MM4&8O045J*V@V3UA$<&]E2$0V=C1J,V8P4BML)B-X03MJ,FMF
M;DQP9#DU<6)45V4P6%)*2G)Q,G,Y65<V9TM34S)I<3<Q55-%<6A$:FDU1D=0
M>E=U,6-"-DUR4GE2:&Q)94YX5E='-$E08V5))B-X03M/2W!:;T]J6$=M9EA0
M5W59-VM813=344-/,VET=E-H4#)):C91+V5C86XT,C-/05)!-4E%44]38315
M=7A6,DMU>%8R2W5X5C)+=7A6)B-X03LR2W1-<7-/3$%-<#9G-VI!441Z4T13
M2&LP>E1:4#=Y,&AF.$$Q;S%06#5J2W!A8D=E8UEN-$)S1V9)3U5J.#!.2C5A
M.'9Y9F$P*T%F)B-X03LV<4)F*TDP>6E86C)N4#A!0D@U3G-D9&U(.&-V;7 O
M-%4P26999V%).6I(3$ML4"M"661-:"]*941O2SEX:U P<R\U47ID5&9W2#9M
M)B-X03MV.$YW3"]D6'0W15!"8FQY4'5B;&HO2C!2>6YK2"MC5B]/:S@T=U K
M84AF;T\Y5"LU,6DW6"]J2C95;E0U<&HK4VU0<'EZ*U!#9C!,)B-X03LK86=E
M94](,FHY3&8V3CAW3#EN5T%F.$%J2F)2;B]I2E1(.'9Q3VU8-7=(-DM8>#A0
M*W O-TDO=%DS-69S9&0P<E9,-CAK9U<O5FE5)B-X03MN.4(P.5%K;%@U<413
M=3,W3E(K1V%R4E(Q3TA*2U5V,V<V,&0K*W=0,$]D<5DV86-9:4E'3UAF=R]9
M4VEF3CAM:RM99DQ6.4)%66AQ)B-X03M.=$<P,$56,F9Q.&M4;TMS8755-"]#
M1'54>"]M,GIB4C%E4$U+:6%M3V@R:TA3-B]S+THT6C)V=5!4-6AJ;C5"-FID
M86IO,2]D26M0)B-X03LV34TS<'A4<5E7;&560V593%%S.59&87)Y.&9H,GI)
M=WEY165O,DA8841(:V=#2B]T97%:93="-6PU;6EU2B]Z5# O,$9K;F%(-FLP
M)B-X03ML>D9B6$UJ,E-#4U%T1TI),4U!4S95:U-&,DA%8C<P1D-R,#-!<G-6
M9&ER2%!+2"LY,VUF+W1R=B]W0E%L=&ER23A69&ER=VIZ-5DV)B-X03MY+S5Y
M5W-6;W-,0S9M,#DW93-A2TYO2DEQ.&)X<FU1>D(P94Y656]"2#A64G-C>&-M
M;&I):VLX-BMZ<#AE<D1W8V9'2CA)-&@Q*S0K)B-X03LX9$AO,7 K6%%U>D)C
M96)D56XX>%AS0FM+23%B5WE!;%5+549N0S-P<T%T4BLX-4=H3E-C>6UA8D1Y
M3C5+2')5.'8V85!R0V5L8U5T)B-X03M)0C9K9CAJ+T%!9D5V<V-64VEF.'5)
M-T9:-79+5W%86&PK-VMI4TM'1DA.>%E*-EA(:E-Y;4Q23#A-9D$X2V)%.3DX
M5EEB*UAS9C4Q)B-X03MP2G%(,7)K,#5J:#5T-6=,*VE,;FTO<G)::3%D<7<X
M94A%=4LO:FA6;D9X3BMB02MT9E9R5%%8<$]"6D=3-79%-5<O>#%-;T5$.%I0
M)B-X03LW=EIA:C=7+U-O5F).4#A!;3!%=51$639#-W)-=C%25W5R>&552'@X
M:DHO;S4T>699;T)59F$S,D965C@R;R]M64AL14]I85EY0S0T)B-X03M1;'(K
M549R8F8Y-'<K<FUJ.5!G-F4K2W5/<69M56IG;E%D3VMJ*W-&1T-A9S9T.5=Q
M04I">70V8RMP2V9J:7)55W4O;4TP.$MY954W)B-X03M625AN2U1Y1%91>%-#
M<3!L0R]6:'EA:&(T2VIP,3-X5C%R-6<O34IV<3,Q=GEL1$=:6FI(8V5J<6MC
M;VAH2$-K=GA1>&,V.&XK169Y)B-X03LK*WEQ-D1Z1C4W9%E$3#52.4EY4T]K
M=R]33G4S<&]O57$K>2]&>4Q-2T1P5#-X5EEV;69Z>49G.5AY6DYZ:TPK<4ET
M47-M5TE+0GA,)B-X03M&,VI*-2\U24Y-5F)I.# K9$@K<C@O2F0Q2#9Q>4=A
M=#E92#!M5W9"5W!+95A/9W!X<E-U*TMT2C5Y.'DO=59L.&TV:VIV0DQ,2T9L
M)B-X03MS;E=/4TPQ3TU*650O13!N<&II4CA0>$-P1SE&6$PU,3$X:4EV-4XQ
M5D9E0U=E5#0W3FI',&9Q8UE30E!U.&YP:FI48C1H56IE:7)5)B-X03MF;BLY
M9%%4-5$Q.4MW=DY2;TQ7;TM&:#92<&-N-#(T,5AT=4XX5EAJ>C=C:&54*U9D
M9%)F43EC;C9V07A"-6-F4S1P3S='5'910VQ/)B-X03LK2W1T-2]O:VIF-&,Q
M=SA)56YO3$QD=6)+=G!R.&4X:3@V<W9G1#19<7-M+TU70T%U2F9,,G9!2D1(
M3T-M;E-Y:'950V9!=G!C+VI4)B-X03LQ9FE8,F)W3TMT=BM9,6MN<F8W9SEE
M4&]W4EA"<'!6,&51;#E/:4HX4'A33#9V>&].,6\Q9G-N1E='-D(K8F9M9E9D
M9'9.3C!R>3EB)B-X03LS<W)#-&%Y='A-;'!/:5=S-C(W=F9Q>E-T8F9%,W=O
M5DQ-4$-L0T)!1&M%;5)03D]F32]K1'I.-74P>E5,6'I0<D5&;' P=DE1,C)L
M)B-X03LR-FE15R]&=U5M=6)G5$]E6$IE6'!Q=E$K3U9:<TU*8GE!<V1E-7-X
M6EIX,D)/+U1V5F9Y:3AT6$]K5VUQ6$XU9G1Q5B]F>E(K=&-')B-X03M,,&9G
M=# Y0T5C1E-.4#=T1BMY4&YL96QN>#-);2]D-4QK3F5M:4MV;3E!>DMA;FQV
M;79Y-4Y0*V)';#9Q:W-C8GA'>45:*W1W4DQW)B-X03M75U%Y2F-7>B]V-5AD
M5E Q8W!S0T0O;%9+=E5S0W9-9DXS:U,K=G Y6#0V9F,S,7!D-FAB,VM34GDR
M33=->3)J>&MT1'%G;F=E2DI8)B-X03MP-F)C94EO52MY0FA6=GEL-50X>39F
M-6IU8G<V6$)P,2LQ=F9I-3%N:D$Y=F1Y6$5T=3EM9VIH;49W631&:61A3T4T
M:EI4=FER269Y)B-X03LO:C%+3B]-:39L4$1C,V<Q950Q2G)A1G)E32\V2F)5
M<$<X='=W+S1--$9:6FER<U95<$Q71U-:2FTU8S K>E(S02\T14=M5GEX06M%
M)B-X03LX>#5L;4UH07)P-V=Q-5EW9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&EQ6&%F-64P;E0W-C5V)B-X03LW4TIK
M=3=Z939L85=6*UHR;U=$<W=Q3TE!,C)X5DUC5F1I<G-696$V:G%V:W)5+WI$
M=#=7,&958C-64F-X4EAT=&%$:%EE=G W;5)8)B-X03MU2&Q#0FYT:CA81TIQ
M*TE/1EAP5T)867$W1E=/9550.3=V32\O8EAF+W%%='-66DAI<G-69&ER<U9D
M:7)"=DU0-7=E53E/,'53-C V)B-X03LU:#%7-E)L0S)A4T=.;41-051Y2U Y
M:V(Y33)'2',W2DM64TA#3SDQ*V9T2$A#2DU32DAU=&(U8R]/3'ER<5=M0S8Q
M3S1I,&TV3'-P)B-X03MS,VM-<$-J;S-)26Y8-5DU=7IC:UI616-1-S%W9'!9
M-7AU4D54,U<W5U!0*V]7,F]T65=+5SEX2F9.63-':'EL6D]%=&I/:GE85'92
M)B-X03MV:65.3%=6:%1I0GE3;SAC1U531%(U:'IO>4)&:FML;6ME9&9Z0VXP
M;E1B:E5R93%S6CEB:V=J<TQI97I#=TE*3%=A-F1G;'9Q5C=,)B-X03M/4TEG
M:V%(,%=*4#!#3$IB;W8U9RMC=%@Q.6)',&IG;G-,0T-'6%=B<4A4<F=/<DYD
M6&-,9W=8;#-:6%5$1T\P1D530V-H>69T041K)B-X03MQ;5,O;6=S,VYU>3!A
M,W1*=C!*4$=S3GAF5#)D,T$X5B]-<E-1=W4P<4ES6#=T0CA%9T1S6D5+-U9X
M5G)5=GI.,5=Z,6TT<S$P4TM7)B-X03MY=#5P;W9R6G9#<VI*8E!B<$\O<&5G
M=W%0<FEC1C4O1E$Q2S=%;6Q9>&%F;78K67)H0S)L5W-S:SA6=%!A45!$.58Y
M6F)I-U-!3&)Y)B-X03M,93-F<3AK3"]%-E(X1S1C;&\R>7%0;B]!1'-*97=M
M<S=B-GA94S-S<#%'5F)E9&IA-F)'-E$K<$U53$Q"27)Y17,P;$9P1S8O87!I
M)B-X03MQ969M0C4S,79Y>F-F5W).3&$K,#)+1V8V-6)L04IO6C%T<%IR9FY+
M3&IK0DTX86=,.5AP>#5(;41X1$)5='1V>D$X,FTX:70W:&)A)B-X03M.-TM7
M,&DQ;3-L<S)I;EHW,U5&<S%32#!R-C=I47AO-&5V<5-"<3 K2'-Q;75V9FUC
M;6LS;6\R;C9013!L:F1T6G%06$-C>4Q#,W9&)B-X03MD<6]E0VQR<C!Z,7!X
M-68U3TMR:BM91CDK:$9U-4Q#2T,O.$$P;DYP:VQU:WAU67$R87E3>FQ*06M*
M4$M/,V-*5E)1,'%0,F-+;U!4)B-X03LO=T%X9&%J.&Q8=70V;%ER3G%T<SER
M=S Q62]Q;TLS<&E%2412>F%K6DYP<6IG4%5B;TEU4D-K2VMG+T]J5B\P:$Y,
M2%E7.35P<6A9)B-X03M923=C,UIK835L*V]Q<7-"8E-4;%5K=DA5,&A$;B]F
M9DE52E90+TQN-6TS*W0V,4IP4#9'1VXS2WAO630W,E<U:&ME6&A(3$Y(43)F
M)B-X03M&3T5C:%E,27EY1550<'%R0G-#<&Y,-3%V279/<UAL.#9A:'-:8FAB
M36%I3&HY-$HS<UIB-$0V=C963TAP,C=+5SE4<E1B=U9A<U!Z)B-X03M!1C=Q
M1W-74CAV87I9:E-)<#5F<C$Y8696-T\U*W)T>'!B>F-N-3@O=$PX3S8W-'%L
M=FQ0>C5R9#E,<$U7<U%2=WIA;$\Q=3A+=T-&)B-X03MO,FMS;78W8W%Y6%8V
M:F\P545T5TI6=G,Q5D]H5EHY:7)S5F1I<D$P='9**W8K9DQA.'-98F1D5#!O
M,V8Q-E%1=D1D3SEV37-#:UA#)B-X03MC3U-,26IH;%EK340P<&A6;FU"6&XR
M=2MD9DYT=G%T.7!D;6UN,G,P3C!Y5S@X>5184V96,'-*8GER<7-L<6958WAG
M8DY23B]T,')H)B-X03M6,VQJ.'=D678W-%0V;$A#=6Q81G9F>G=7,7!B6$5L
M,T8K:G!,94YU9D(U:DXV;C%I;U9)9U)S4&ER9U9.9GDO,4-$54@X>5A50U1*
M)B-X03M&2G$X;D9B;4-A,FLR=$QB<D9/:V-I+U-U2W-S>%8R2W5X5C)+=7A6
M0S9L839:8S)B>&%N1$)06F).26QY<5!&.$IQ0W=C1F1J:C1V)B-X03MH*W$K
M1W5T,&<T=D4Y3F-6.4]B5VQ7=6M7,6UQ851$8G<R5$5S:3)Q;VM22C9K0T]I
M-"M.-&YQ-'5,>G4P*T0T9G!R:#AQ<$E.83AY)B-X03ME5TQ856)I5R]W0D]A
M8E5T3&QT-TM*+U%I:VU:3E0T:7-$1G$K:V%.-FQ3=CDR,GAO2W%S4CAU95DO
M>7(Q2%-P,3!B>6)B3DAQ3'=7)B-X03LO=T-J3%-,4EIN=3-D2DIK4U-/,G5:
M56HY3DEN8R]74V=(>G)I<6(V9#4U.' V6')T:#5E<W9,<W5K-FQE,CA#:3!+
M-F)94$A&.5IU)B-X03M);S1V5&MU65AM5T]33U8V5S9Y3%)U4S$U-W%P-6,V
M=C545'I42#56;',T,G9R,$161U!O>&U%,T5B8V]M:U!8-G=F<3=3265.85)K
M)B-X03LQ1D)I<4)V=DYV-6%W-G1.<#DR:UIV,&UE2V-N5#4S6#%*1VA%=%IH
M0S!:*TEW*W$S2V<K07-2.$]+<V1T+WID+TQ36DDU2#!D:V@P)B-X03MT54YU
M-G@V9F-F5F\R=5EO=5A#,6YN:W1U16A2>7)Q:E57;U5L1%)64'!V3E!K0S!U
M:$0K:C1G,G8S:VUL,TUK8T5"4V8T=FEL=4=")B-X03LK3T)P8G-,>4YF:6PV
M9D54:7%T-6@Q3%%T3CAW5V]U=DMC.3ED3F)Y=S)E<#(Y=EI4=#9+471*3$1'
M=G)F5RM02#13;VDT:W-",WA6)B-X03MB;S!8:T-A,7-,;RM88F)3<#E0=EAS
M3$,R;7,W8C%B5S<U,4MX3F)E=$=N2G9I-5)V4W95,7A63&)6+WEW,6988CA7
M8W=L,3=Z44$V)B-X03LV9V)&6EI%4CE/:DAO>%181G1*0V].<D%*1VAL-69A
M3E9O=T=+;V93-S-Y4'!",&)Y9EIF5T=M3V]36$9N8VU3=W1M.5=#-6%/4U)9
M)B-X03LR93)6;S)D6DEH2&)W:SA!94M!54]&57HQ6'I"*U<K:#)'<391=6M,
M3%I14VAD5C K,# P=&%T3$UO8W$U.4YB95=1<59*4E=:+V)!)B-X03MQ1E1Z
M0BM553)N;S%X<&1U<V8Q94]T<S)K>79T8TQB>&96-'=,8VE2=T1!:GA*5FA2
M47EI9WA633<V>"],5W@P<695-VY2;V)+,'1%)B-X03MT8F536F1.;&=M16).
M1DIB>%)H255M9%)).%DT24-&87%M:%9G1E5A+VU4.'8Q<W)4>D9D,VQH6E%8
M8W!K=$PK+W=$5'1(865.2&=.)B-X03M0<DEI:U=627DX6D(K24Q59$LT<74Q
M4'HS;VQJ<FUL-DM$.5IV3E=14S)X:FUT55@P,DY&8V5V3D,P=DQE9VA$=#=9
M<3$U9C!B>7)C)B-X03LR*VUA>&\Y;$A9,GEE=&-W5W-%56-#0V4T55)Y4U-X
M>&HK*U5":TIR,V)R=&ER23A69&ER<U9E1D,Q9&9Z5U-71S!T67(T-GI*-C)M
M)B-X03M,2&-#-F$S859'5SA,,4U::DMC-7DQ44]20S!W;V4V-$5P9'%8;'9Y
M-W%S8VM7<#966C,P8W)R3$ML>D)&37)Y4G%54C)$<3%75E11)B-X03M%.4)I
M<39Z.'8V1%I8."MO,F5M,G1T<49Y;U,U=DE9230U<$9&2TLX:7%'641I3W!X
M5DLO2T@K.3-M9B]!3&$W+W=$54IB67%Y4$98)B-X03M9<3=&6%EQ-T95:79F
M2C)N,TYR2D(V.7EP8V)-,#!K9T)"<4MQ>D5(3E9M-TIX>FE9,TQF*VM4.6AD
M:&DW4VY'44Y2*U%#>E1V2F5N)B-X03LR;'%)5&-81'-#4WI*2SA12E X06MO
M,4U';C=(>#0T,6-J.%-0<T1,3C)N3V-R<5!Y0F$Q1'E.;S$Y<DYJ<3!Z>D,T
M<TE$8DEG6E-K)B-X03MG-%-2>'9,>59M6C1L;FLT2&PQ66LQ,GIA46IW9T%D
M2%A3;'A%:SE51$@K6%-J5$QB5#5T9C%/-&IS4%0O4FMS:3)!93(Y3TIO4&<Y
M)B-X03M/,%):03A5:%(Q;59W4C)Y4T9F>7 K6%!L,WEY=#)T:7)Y<&9W4C(Q
M,T9+<T-X3W-C='A,55%W>%%X3'IA.&--<7%%<%-I:F5Q<6I$)B-X03LK5F9K
M-C)V5G8W4WI3,'8T<G5+-W1,<4-+0T]3,U-%2W8Q5T%R2%-/,V1664]G1R].
M:EAK831Q<C-N-69A3F0S33%X2DYC:#4S=4AC)B-X03M+,%E!3C Y=3<P<6@V
M1WI4:CAZ,3)O,G%M;C5B84%H,#1P2F-+9$]J9V@R85 O4T5T6FQN:"MS1&@X
M6$)L64-L3FU99#A64S9,.&Q0)B-X03M)-E)854QX4WI2>7!*2%EE<UDU1S X
M>5-.2GIS6$MC;VY8:V]6<6UG4D(R3E974V%J-6%I=EIP8FXV.617.35*679P
M>5AC1%)R2D5K)B-X03MR0FYL:4IJ64Q+>%9D-E4R1S(R2W!09"M1-V]E6$Y/
M,%-X,64U6#9L97A823%">&%P8V]I17,S1#!R6EE797!R5C1J>7%E4D]+<%IO
M)B-X03MV-6$S,FHK83E-;7-R:&PX=6%7;VM73V$U.5=78357>$9G<VI10S)I
M16)E;#EP:$]W4$A:1DI/2W!L6B]L,6)"-$AU8G%64'%K-VQ9)B-X03LW8W@X
M3&DR5SE..6)2,TAQ4G4T.4M2=CDQ<W9+;35O94E65S9N*U9F;#=54$U&,W)T
M>&,S4S-.,D8Y5D9-055C0DAT>F%)>D9F,TLP)B-X03M6<$-Q-SA1=DDT<6QY
M+VML-5)K:FYC6$TP<EAK8U%K=5=G,#)34FI(-EHU;5)R471)2E!32$M.>3!2
M+VMX5FM.;C5,9V<P46%(3&94)B-X03MZ-F)"3EIY,D--27A*0VQK65I&:DQH
M9FI$>E%&,DI(-U)684%#:7%T+V=J>7A,<&-7;6%J<#EV<71P0DY.8U%P<45-
M5GIX:VYK959Y)B-X03MO9$]),VM)1D(P>%9:<79K=E1,*R]T3'A:2F)8-F]K
M35IT25!35T-A2S%M1GA"1DE':FM:56IL545E;59063%',DMO>GEZ<$UU:S9(
M)B-X03MB5TUZ<DIC2GIK=4A3=D5Z5%-.3$QX<4%E4$YZ5&)P:7%A67$W1EA9
M<3A/;#!J5G)8.'<P9S%/.%A43%,T,6XV>%E#-6IM<&1+9%$K)B-X03MT<6M-
M<UIK9S5T.6=+-TLQ4#)C2TAU3T)+6#8Q<G5N84YB>%0S>&TT>GE#1T=/,W0U
M-W%6-4-R4'A31S-35U)V:%)M3D8R07A61#9:)B-X03LU=3!(53E6;C!Q>FUL
M83ET,61P16MT-VE*1#9427-G4U-73DDS36)32TA#<U-P3D141E5*-5$O,W4X
M>B]!4&)89B]Q171S5EI(:7)S)B-X03M69&ER<U9D:7)#+TUV+TMZ4#!,9&96
M9G%(<6-$6#9P-C,Q:FHK,3984#1E5E!P.$XX>'-N:3$P8TA0-"]!94AH=GEU
M,5!Y<"]Y<W8Y)B-X03M"5S,Q:C9L6&HK-RMU*W0Y631F<RMP=S)R5'@S.&0X
M8V9I8U!4-&\P,VHX075V:F1O5'I"-5,X>#-U=7%K8TM0<&5Q+U9,-U<U26Y#
M)B-X03MO=#=P<4U9=W%S>75W;6M7,T$R3D9J4$QT;5-/5S=N0S8S-7-9,$0X
M=DPK=S!#,71Z-5AU6E1#.71*<D=N6&-79WA2,V]I='!O=4-F)B-X03M52&@K
M<TQ(4$MS;D<W8V-Q9F%R6$9+3CAQ9FQF<6,K=7!Q,G0R1G)P=C90=$Q:3DAT
M,'1B3V5&2D5V3#)F:5EP,S%'83,Y35-X3GAT)B-X03MR;$8S-'$S=VII<6UV
M*T<O>D1B>GAB96%B<6$S;E=W95!3+W%515!O9E=,1V)E-'553#-5;VE54U-"
M>D<S2C(Y155)<GA+<6YQ,VQ8)B-X03MZ>$YR;#-F,C$Q<4E2<#=I5T-*3E)D
M24]-8VQO8E%#2#%L44M6*W-C;#0P8F\Y9FAW<7AI,"]*9E=R8U=916)X;3EI
M=&9R<S%T.5)T)B-X03M:8D]A2SEI;FQ:;G0P:&$U64MO94HS36I,>%E64%!D
M5DA39510>E5V2D5U<'AB,CDU;V0S3G$Y=E%Q-F%L94=12W%X;%I5*W)H-%E3
M)B-X03M+>4M10D]246M65E90+TYU:2M93#-Z9&)8*VHK6'I(9E<X4$\R.'=4
M5%<O1EIJ1DEI=U-6;&5A1T)054Q30TM&+U5F:E550DI#;V94)B-X03MR9GI4
M-5<X:V%887HR57 Q0U!8-7E,2S%V1FUK=4E,;2MU2FQ"=4IF<7E0>E=3=C=Z
M:E553&-72E93<55E5DQV>E!B969.0S!F5V(R)B-X03LV;#%:23!K,4,R1W!*
M8U)X,C9A4T9:3&DP4U8R16XQ=VPO5F1+3GE7:DYS1E923G8U83$K*S$O4SE8
M4S-.,4Y:,W,V6%)D3$M33S-U)B-X03M"<51T8U-Y:39(<F]'=&5):&$R*U!:
M4#)-5EAE8F9+6&YV5F9-97-20S-U3&I2<G0T;71:1&5&630Q5DEL<$-N,7!&
M:DYF54Q%5WEU)B-X03MP-E-0>3)64W102VXU<W!A,T558F%J0D5)3&%+,W1L
M=5%3255.=E=-4VI662]W0C='<V)H=4-28W=7+V8W:D9786UX.'@V:#51;G-0
M)B-X03MQ.3EP,G1M9E19-SDP=DIG0W%M,6$U87IU2&YK9%571&MR.%=(2U%0
M.7!J>5E+,F9,4&XK9GEP66%F<#-M5UA13E1T6C4O6'4U-$ET)B-X03M6;&UT
M+U9K14-U,#=N9C K0C5C:3-J=FEQ1CAZ*U9V349Z-7(P1%5U2#93:G-)8F5.
M-V@T<D5W4GER3T=U<FE63&='5U Q26$X1&%N)B-X03MK1T%"*TA&5U(K4798
M+W=J<'9Q,30X1RMR8W5V,6(Q1RMR5B\U-&--5E0O1EA9<3=&57)T4$LS;"LP
M,4]F5EEB1U X05-D=WAA4RMK)B-X03MR3$XX4DI+<DI)5UI%*TDP5E-&2%E9
M<6UM2W!"-7HX<D1Z2' P3FU46C!I;#E8:'%&;$AF=TXX1$HO9',P5$LV.#9Q
M-D]#1#1I;WA6)B-X03M+9$8O3&U7=W9M3GIQ:C-/;DI$95$R:TUA>E<Q,G Q
M0U-'4UHU3'E/9FUZ5F<K16]Q159/-4Y-5E)0-68V9D)P-RM:3%="-6YI:C%E
M)B-X03M4:3%Z4$YC>6(R;'0Q;&YE4U)V<&)&5U=9<3=&6%EQ-T9867$X+S$O
M.#1,5%1.0F)613!$5G=X:TU+3&9753EJ0VIC;S$U,TTX<499)B-X03M)=C-W
M+V5-3WI5<5)I<7(U8B].83,Q87=T2G!.1C%!>EA&,TY9=$QP.79,9C)194-2
M67I-;#-%9U)O1S565U%G1%IV-51I<4$Q;CAX)B-X03M03D5E<GE*<$YO6'1O
M-')/9C9H4'!D.39W:G5K.5-6-3=X6D9T-U9O17%X:FQ4:V%C97!W<6]W9FY*
M95-A;EDV4DAP9'1D,W5O,C90)B-X03M:>E)83GA(05HO56AI;&IN9#=1<$9X
M96,O=T(R.'A&2TY1<TMH5D]F.#0Y6G5'5DY-,$9A3F-79'-,:6536G)9>3-%
M,79(2D5B<4]!)B-X03LR;E,U4$-33V%3=DAL=W!11E9.=DQN-6]Z-GIR1G!:
M3G!59'9B6$9Z2G!R,T,S66QK5SEH<S)V6$-W*VMV2T0P,4E76&M#5%0T0418
M)B-X03M&5E!69E X07)L=EHR;7(R;W1*9%!A-V5/.'-42%<T4S!.,#%P0D]:
M1&-O>65O-CER9'AY3D1X04Q95F1P+S5I-C%(-4MV9&(Q2WA7)B-X03MB5F):
M-UAH<'%X+U915G9414E11VIM,4EY8E162$%E;S-14F-I1DE623=N.#9D5VDQ
M9%!2<TQE.# V4D=32TLS3C):1$]W,'A50DET)B-X03MN;DE36%5856=7-&-J
M.6IK=$=66D)O;C5M,RMQ-C5&<$@V2%=W=4I9561%=G!B<4=2<&EV<5-28U1:
M;%5+>$)N06QD2D=&1#9953AG)B-X03MQ;6-V;E<X:3@V>&58>G!Q1WAL=49S
M>'%)=5 S9VYE>&QV9U!Q+W!5-&5N8G-P8C%/=$YV0E95,&9Z=RMR87IQ96MX
M-D)Q,FYY86-S)B-X03MP5%5.5'1F<3%H3UEN.4UE:D]':S5"+W1!.&9S-S1Q
M:T,K85!0,#EL1$QB6&5K=3EX<4-71FA+=&IC=D1E.#0Q:VME16TX:DMX=T):
M)B-X03MQ>2]&-FEP>592,U9:;#5E,5<T,4<R=79R2TML>EHS9'AA4RMM0T5B
M,%I#16-!;&E/569%:U8R3S)+<'!I<G-69&ER<U9D:7)S5F1I)B-X03MR<U9D
M:7)S5F1I<G-6634U42\S=3AZ+SET9"\K;U,R>%9K94MU>%8R2W5X5C)+<EI9
M;S59,FEL4EI),T)6,%E!<5%E;TE06$9847=W)B-X03MW>$Q&0VEX>$E/2U)O
M07%Q0C!!03)'2W%F,4]Z-51T-D5F2S5!5S5B9W1:04)X069B-&="='9I<59T
M-4HX;4XV+TQ19$]B-C!V0S5R)B-X03MA44@Q1DA(-%@K1#1H*S=862M!.$U6
M8G502EAK,C1D-4QJ461/;6MK:E-'4C5,4T)I,&-64%12:55.5E1I3TDW57A6
M15<S;'9Y-V$S)B-X03MS9"]B85A:=U@P34ET;V)Q2T-*2E5G6%E22S9Q1T-$
M*U5';4MQ3G0U4SAV=U-X5$Y:43-%.71C5#-6:DYC4GAY4U=Z,TQM4U513U8U
M)B-X03M29W5X3W@Y=6Q":7%R1C59.'1W-F)0<&M7:S)C96TS5$TQ,5EP8GA,
M0DMZ,#5'4TE,=UEM;3E2:7%L2C5/.&]3=W)"3&]E;G9#<6Q&)B-X03MI83%H
M2VA3:7A&47!7;$1(1VEF-G%G9$)I<6Y*-4@X;79W4#9%<UDS:6I30TM32S-J
M:61);VY%:5)+-D)75D9D465)3DU65$IT33 Q)B-X03MR:UA45VM*=6QK17EZ
M;4Y424I"1S!)8TY3=DE23WE6+VQ*2%$T<7)Y>%)3>%!&2VEY4E-+5FMJ64)L
M6E=&0T-$<U%2:7%7-EHU5CAS)B-X03MA549';#906E=!4U%Z24Q7,FEH<$M5
M35IK2$)6*TQG>%=V5VAP:7%),')3-V)43%IO24-Z*W!.3F-3>7E53'9,4$DP
M<G-X54M0=%!T)B-X03MT<TM$=&EQ37A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5C4Q;VHK6E4X-F%M,$UD+U!.>#%->E)A9SDW1G!H<&-7+S9/5T-2,&QT
M)B-X03LQ<D8V;%1!:DAR>49A67$S-5=V=GI!1C4U:3E(4F1*9&IQ:FU94'%T
M>6=6+W%T=CA+:V%C+TIE3D1Y3E!L=%5Q<"\X05@O>DHO=T-R)B-X03M&;S,O
M04A'3'(O=D=9<3<V+W=$;50O,5ET1R\W:D8Q+S-J359133-M9CAW271B=$Y(
M8E%.2DXQ95<Q>F523TY8=694161P2D)(24=0)B-X03LV3G)Y2G4P-#=D:C R
M<7%J=G(O-6LO.$%6:3!B+W5-6%@O94UX5D)7+VU8.'=*.5=V3DQ444Y*1GA9
M>'=3>7-D6'5E0E<T.51H>% V)B-X03M.<E5E:V$Q1TMO,S8O=T1M5"\Q671'
M+S=J1C$O,VI-5E%7;2M:9GI!,4-7*VEH,$135F)4-VLR:WAF5C=K075),&QQ
M=$Y.4'<X6E(Q)B-X03MP:7%.*W8X035K+SE73%)V*S1X9&8Y-'I&6&98+W=!
M>68K<D9O,R]C675V*SA::7)V<B\U:R\X059I,&(O=4U86"]E37A6,S$O=T1-
M)B-X03MN+W%X84XO,T=,<B]!3'AM2W4K=B]M5"]!3E=,4G8X075-6%@O94UX
M5C,Q+SAY9BMR1F\S+V-9=78K.%II<G9R+W=#6E O5FDP8B]U)B-X03M-6%@O
M04AJ359D.68O36XO04MS5VIF.$%C675V*SA::7)V<B]!3UI0+U9I,&(O=4U8
M6"]E37A6,S$O.$%-;B]Q>&%.+S-'3'(O=D=9)B-X03MQ-S8O*UI0+T%&671'
M+S=J1C$O,VI-5F0Y9CA!>DHO-G-7:F8Y>&DV+W=#.%II<G9R+S5K+W=$5FDP
M8B]!3&I&,2\S:DU69#EF+TUN)B-X03LO<7AA3B\S1TQR+W9'67$W-B\X06U4
M+S%9=$<O-VI&,2]W0C1Z1EAF6"]Z2B]W0W)&;S,O04A'3'(O=D=9<6=T3CAY
M+VU"<45T.49$)B-X03MO1VMQ,FXS2G1*:2MR,TE"8U)P3%9A86%F:#1Y:G)4
M1E5B.68O36XO04MS5VIF.$%C675V*SA::7%",&)Z4#A!;4)Q,7!*9%<R9V%3
M)B-X03MK8V1Z9#)B0U16-VM.-FQL8WE7<VA&3DYB-%,X3$9F86QA9$U64C,Q
M+W=$36XO<7AA3B\S1TQR+T%,>&U+<VQX5C)+=7A6,DMS03AH)B-X03LK6CE3
M,5!Z3G%6;F,V=#EF.4IB;')R5#97-"]2.&M6.4Q"1$132D5L2$]&468S>DU4
M4V\R3TMS+WA6>')1,$Y$,DHS1F-696584&UJ)B-X03M7;W9).38Y>G)6<&$V
M-FUO6&1V1F93.&)325%7=7!F5C-C07A8=VE226E&.5-33C%1:T9Y975+<'9$
M<G)(.'9%,5<X,4M7>&1O04@Q)B-X03M6;6=C<35K.4Y::DMT<5E04UIQ3C9P
M=&=O43AY;TA25FEL+S4S,6PO23)J6$MA+V)7;7!I6C$Q2S=-.79#8FA):$UK
M9F]3=EI8;'0O)B-X03MP2E):25=-2V5Q;RM$:GEO1E=39FU(<FUQ5TAL,U0W
M<7DQ0U!26DHU,#EE83AK:G1M-$=#4B]2.6%7,78T23578TQ4;DA2=G-G,4EX
M)B-X03M63'19.#,S=C9D.'5,6C9Q<U9T8TQ%=#5P4'$R-EAS.#!K<4DV8TAT
M2C!K845%*W1(1DY%>6ER8D-M1EAO;4)867$W1EA9<3=&6%EQ)B-X03LW1EA9
M<3=&6%EQ-T9867$W1EA9<3=&56\X,V%L1'!N;'4O=G!T4UA2-&])*U0V:S!A
M>2MI0W=(2E5B-%=B96DQ0D9A8DAP:7)!4$Q0)B-X03LU:&$U938W-6$P.3=P
M-WI4-W0W<%IT46IT:%!(9&-K;6MG53-D<D=B25!B<$=I>F5K=R]E8VA12W9X
M1E=99FU(<FM':2M85W9:=%E/)B-X03MI3#9Y4FDV4F)D<%A:<3A966ID5F=2
M;DDK,TE#<6EP3D]O0W-9+TPW>F@U:3%,>DTQ:G$K;S(Y-E1B2U5H<TIR9#1Q
M2D1#,S%O=W)B)B-X03MI65)4=$EX:FPK<T9'-D)":%8V8F=6,DMU>%8R2W5X
M5C)+=7A6,DMV3V)R.'ID63 O5CE:=$QJ5&)E-&<P-C5L9C%&=51%>3)52S)Y
M)B-X03MK<6I23C9K>&4U<G<U061U6#)A;%AO,D)8;E!L3#AZ=%DQ0S9S8E!6
M3DYT-#)U3&\R3GIC=UA827!C=D9,8WA#3T(T;S)E3#!9=T,O)B-X03M)2&Q5
M8U-!5W=Q>E!Z4G%&-7!V;')69%%S;%(W=7IT2C4T1FQ*0T8T;S)C8VE!>'!T
M-%E&63<U32]-0SDQ,U5O<D,X,#9+,3EA,W5P)B-X03MR931I=6986FTP*S1J
M=$QO4U)E;$59=C-S;%DY>GE88SA4=&ER3F-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U91)B-X03M7=5AD>EHV3'%&-6%O:VPQ8E<P,#!#
M4T5Q:E-*1U=53U%'255K8FM$1E=+955V>D(Q1%9B-GAS8C=4-&]29%)Y4FDV
M:75F56,S5G)$)B-X03M&2D]$05EO=4UF-S<T2$1%;G5Q,4=&53DX-C9R<65K
M*U=B,B\P=4]+5R]H15EH4V1M4U T-592:5=66D-+2WA)*T4W-$912&Q4>G9.
M)B-X03MR=6]Y,FLQ9VQO:E%'-W-P175"37IW:653,U!R2G=J350X-'$X45=&
M3SE14FER2W-69&ER<U9D:7)S5F1I<G-686M9<D=Z2W!D;$)))B-X03M28599
M:G-/4D%Q9F,T<7=#6'I&*U@Q>&]&.35W=G1"9T1A9&9#3S5.>$AP>E1I.5)O
M-V181GE*;G1U4S@P6#%06"M%0VA)-&M"5FMD)B-X03LU-7@P,GHX;R]W0TM,
M:4XQ<V924V8P;&QT6%EI5F=Q05-R36)9,4Q$-'97-"]W0U9I<DA,<GI"*U@R
M9V%B<$AM;4Q1<E='-3%6,F=S)B-X03M:3&8Y17A4:C%H2DTO=T1P6G5)-V)I
M-4)*-'IN:WI$<51I<DIF3F5U>#92;S!T-5!P5GAQ;&QW8C8S1&)M,"M'3&HX
M6$YB;6%"6$1F)B-X03M:-'%72C95>%9*;#%4>5@U83AW-EAP;&QO54=N-G)R
M,$U9+S!D3E!T2%-+4&I':V-V3V%&-5!41W=315-%0E1167%Z5$9867$W1EA9
M)B-X03MQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&54IQ.3)L<'!T>$\Y
M<$QF2W%53FYB>&E75UAL.%!"54I#;71F,FE!3S5!>%9H2&Q8)B-X03MZ5BM8
M,&YM4T14=$<P3TQ49&%L:&5#96ME;E<P,$M7<G9%8F1G<W=L;%9'='HO8TQ)
M9T9..%9:6C5O=4Q73%-*575T2FPQ=4,T26AK)B-X03LP,D=+2V(Q03-8;4HR
M:FA#04-R1U)G=C P>%9J=FMR>F(U1S%$6&)M=SAV-E=T:F589'1&<4YZ3VM.
M=$$P<7E2>'E)6FMJ9C9W1'AU)B-X03M&-'1,1T9B9FEZ67%Z:D9867$W1EA9
M<3=&6%EQ-T96;'A#<SA%:TQ--DQ+:DE8:EEO-$1#;%9:8494-$59<7@R,SAK
M1S-T<FA).60Q)B-X03M-6&0Q24IR;E5!,7-T>$I,1TEK:61U34%J4'!X=T)/
M4$1I=THY44]D.%92>2M7-%EV3#8V3F)8;#%A:&%/="]#-DIC:5@Q9E=-;&5(
M)B-X03MP171*=7EL3T)"2VQE2G!I<4%F>4]H,#!7165T86I$1UAL:VUK:F$R
M57ET8W,W,U)K6#!$13-R=DMZ3CA(=VXK-S19<6TQ+V]6:F57)B-X03M.<EEV
M>FIT3%-A,VUJ:6I);V9Q:VEY4DDS24Y6955A,2M72V]0569+;S%#.6AN=615
M=E1"2$ES:VQG1V<K<E-I2U544DDV1TES0D<V)B-X03MI:DEY<U)S>DU.<U94
M>D9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1E5&<F5M3G%M
M;%A/;FDX=4Q$-GEN03-D;7EP)B-X03M/9THS36)/<VEG:V)6-#1Q:T=L+VQZ
M<#)N,U9L3W5O6&,T<R]42F=D8D]/2U9R8T]T=7IR0F)W.%1%:W!64DAX0D9/
M45DW-'%M,VUJ)B-X03MY-FYM2%-7,'E3*W5B0T=2,6%74S Y2&LV<C%I8U1X
M>GAT1S,W4VQD*V@R<FEQ1#!F>51A85IQ839H.69U-W521F9H1E Y6%=.6EIL
M)B-X03M26G!G24E95'IL.4E61F5!+UI68U9:1FER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<44Q5%=.2C!M,$XU<70W8C9F6G%1<EA.,4MK)B-X03M-65IT
M9T,X:%9A;D96;6LV.6]E<U)'8E-.4G1D4FE5071*8512>G%!4WEG:WAS=S-+
M35!O3TMO-T954'%'<&%D<'1N2F9A:F11,E9L)B-X03M#05IR<31K5TM*05-&
M2$HS2W%+:V=B;D96;6PV='!U<3)Z6%=N6$,S3G-S<W-";%-P6#%)2D=I:T%0
M9FDV159',DMO=D963#8U8697)B-X03LO<5AR>"]81$@V=W1U4RMR-E%B:GHT
M5C5C95<Q96QC5F1*9#)S9'A&8E-426QX3T=-14Q-03=I3VAC;W!.5S0Q1F%D
M359A1C5A3F1V)B-X03M:0V5-,VMC87I35W=D9E972C):56-P6&M&6FM903!O
M4T0T67%S<V13<V(W-G@Y56U%,S%76C=A-$LQ;W,P9$]A8CDQ<G941E9'9E@Y
M)B-X03M&9S%-85A097A286=Y4GER8G5W5FES,&I24E5R=%8S4FQ59%11,'A6
M2#1Q:$QR5TY)<S=M1S%U-S8S=#=Q-$E&=D),2VE34T9M0TM%)B-X03M6:4,Q
M5UE+2V0Y<U9294MU>%93:G4W5U,T;'1O-6ME-&=#;65&5T)D0DI5;UA51W$X
M<4=L975+<75+=7A6,DMU>%8R2W5X5C)+=7A6)B-X03LR2W5X5C)+=7A6,DMU
M>%8R2W5X5DPO34]N>F%L;T=P-F1!>7).95=K.79%>FMH43!S8DEP66=%,'%D
M.7-695@K6E!Y63%N5UHT=E9E)B-X03MW;'1O-TI,8WA43DEF,S!7;%A.;D<T
M2'!%9D1C5%)U1#%!1F5O07=Q9TQ,.&DO3E9R-6US.5%H,4LQ=#E/=&11:79)
M;TE74$M#3D)B)B-X03MT3C9193-9.#=H-%I&9FA);7AQ>&5R2FEQ=C5V+TIN
M>E(U9S@R-FAQ<GEA66)'-VUI4$-6;EHU3&1,:7IL-%-Q8F1Z5E5T2D9!.59K
M)B-X03LK3#164W(X9W%8>69K1#5M5%5O;G-B<E0W1WEG;75M:%=!.$-)-6)M
M86109TYQ>%9P67!K=#5"2$MT15%B=4M+<%9K2&Y(.&\Y63%$)B-X03MY1F]8
M;&I11C V>F)48F-R3UA,4F]T,39)55A%4D5-=TQM6&M78V](*TQK<DLR0E5L
M=5!Y23$K.#%P3&DX5%-:8E9:6C-U<&UE6C5R)B-X03MZ,5IP-55K=45A1&IZ
M451O;3=T<W98;T%68W8U1&595G-)8DU4865)9E1S+W)566MM0W9.2$):2F1Y
M8E)D6EI,4U)Q.5=Q0V1Y84YQ)B-X03MP878K469M835G=6)A,FXP.4Q4:WDR
M3G8V<VE#2T583W!3>$MV2S)N4E!35%5)<41G9#%017%1:V=#;S!F:V1R2UA/
M<#-!5%-P6DIB)B-X03MF56AP-WEE<U Y3'8S=&ES,&=%9DI$=VEL:EIG-TY1
M:G)59T961%$O>4TX,#)/;W@S5#-';G=K8T%T>$%Z0V$S5DY1;'4K15%J=')D
M)B-X03M#3T5W2'=I359284M"5&EQ;TXK44AM1V4S:U-C-EA&># V83%T<F%+
M4V1O:&9M,E-+4%535$-P13!S<6,U3FE6-'%15T\K2W-J.#$O)B-X03ML+W%M
M=BME3%9,=4=/-3!X8E136'5(=49D<F0P<TQU6C=U0W9";$QY<DUH0W14:TLQ
M,D=+<$(O>6]B>E9*64=X;79R3&TQ;6):3E,Y)B-X03M3-&4T:&I';GE747-K
M0E)E5G,X:G)->$QD9C)#9#A68U!Y33@P,VLR<EAE<6Y3>F,S:T8P=&UK8W,X
M<7A45$I9>$ME8C(V8V555G!-)B-X03MJ3G=/>B]:645R:7)+9GEZ.&]A-35E
M,30R,39G.4=Y,&E+,6MU67<S;WE34U@Q,6-2>%)U>5%I5#9V1DE!4VMA<4]6
M07%J-%%&96PT)B-X03MQ-T9867$W1EA9<3=&6"\O,E$]/2(O/@H@(" @/"]R
M9&8Z06QT/@H@(" \+WAM<#I4:'5M8FYA:6QS/@H@(" \>&UP34TZ1&5R:79E
M9$9R;VT*(" @('-T4F5F.FEN<W1A;F-E240](GAM<"YI:60Z-3=!.4,T-S5&
M-44X13@Q,4(P-T-%,T5%-S4T-T8Q0S0B"B @("!S=%)E9CID;V-U;65N=$E$
M/2)X;7 N9&ED.C4W03E#-#<U1C5%.$4X,3%",#=#13-%13<U-#=&,4,T(@H@
M(" @<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/2)U=6ED.C5$,C X.3(T.3-"
M1D1",3$Y,31!.#4Y,$0S,34P.$,X(@H@(" @<W12968Z<F5N9&ET:6]N0VQA
M<W,](F1E9F%U;'0B+SX*(" @/'AM<$U-.DAI<W1O<GD^"B @(" \<F1F.E-E
M<3X*(" @(" \<F1F.FQI"B @(" @('-T179T.F%C=&EO;CTB<V%V960B"B @
M(" @('-T179T.FEN<W1A;F-E240](GAM<"YI:60Z.# U0D8P1C(S-$$Y13@Q
M,4$W-S1",#8Y-30S1C<S040B"B @(" @('-T179T.G=H96X](C(P,3@M,#@M
M,C94,#@Z-3@Z,#,M,#<Z,# B"B @(" @('-T179T.G-O9G1W87)E06=E;G0]
M(D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RDB"B @(" @('-T179T
M.F-H86YG960](B\B+SX*(" @(" \<F1F.FQI"B @(" @('-T179T.F%C=&EO
M;CTB<V%V960B"B @(" @('-T179T.FEN<W1A;F-E240](GAM<"YI:60Z-3A!
M.4,T-S5&-44X13@Q,4(P-T-%,T5%-S4T-T8Q0S0B"B @(" @('-T179T.G=H
M96X](C(P,3@M,3$M,354,3 Z,30Z-34M,#<Z,# B"B @(" @('-T179T.G-O
M9G1W87)E06=E;G0](D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RDB
M"B @(" @('-T179T.F-H86YG960](B\B+SX*(" @(#PO<F1F.E-E<3X*(" @
M/"]X;7!-33I(:7-T;W)Y/@H@(" \>&UP5%!G.DUA>%!A9V53:7IE"B @("!S
M=$1I;3IW/2(V,3(N,# P,# P(@H@(" @<W1$:6TZ:#TB-SDR+C P,# P,"(*
M(" @('-T1&EM.G5N:70](E!O:6YT<R(O/@H@(" \>&UP5%!G.D9O;G1S/@H@
M(" @/')D9CI"86<^"B @(" @/')D9CIL:0H@(" @("!S=$9N=#IF;VYT3F%M
M93TB07)I86Q-5"(*(" @(" @<W1&;G0Z9F]N=$9A;6EL>3TB07)I86PB"B @
M(" @('-T1FYT.F9O;G1&86-E/2)296=U;&%R(@H@(" @("!S=$9N=#IF;VYT
M5'EP93TB3W!E;B!4>7!E(@H@(" @("!S=$9N=#IV97)S:6]N4W1R:6YG/2)6
M97)S:6]N(#4N,C B"B @(" @('-T1FYT.F-O;7!O<VET93TB1F%L<V4B"B @
M(" @('-T1FYT.F9O;G1&:6QE3F%M93TB87)I86PN='1F(B\^"B @(" @/')D
M9CIL:0H@(" @("!S=$9N=#IF;VYT3F%M93TB07)I86PM0F]L9$U4(@H@(" @
M("!S=$9N=#IF;VYT1F%M:6QY/2)!<FEA;"(*(" @(" @<W1&;G0Z9F]N=$9A
M8V4](D)O;&0B"B @(" @('-T1FYT.F9O;G14>7!E/2)/<&5N(%1Y<&4B"B @
M(" @('-T1FYT.G9E<G-I;VY3=')I;F<](E9E<G-I;VX@-2XR,"(*(" @(" @
M<W1&;G0Z8V]M<&]S:71E/2)&86QS92(*(" @(" @<W1&;G0Z9F]N=$9I;&5.
M86UE/2)A<FEA;&)D+G1T9B(O/@H@(" @/"]R9&8Z0F%G/@H@(" \+WAM<%10
M9SI&;VYT<SX*(" @/'AM<%109SI0;&%T94YA;65S/@H@(" @/')D9CI397$^
M"B @(" @/')D9CIL:3Y#>6%N/"]R9&8Z;&D^"B @(" @/')D9CIL:3Y-86=E
M;G1A/"]R9&8Z;&D^"B @(" @/')D9CIL:3Y996QL;W<\+W)D9CIL:3X*(" @
M(" \<F1F.FQI/D)L86-K/"]R9&8Z;&D^"B @(" \+W)D9CI397$^"B @(#PO
M>&UP5%!G.E!L871E3F%M97,^"B @(#QX;7!44&<Z4W=A=&-H1W)O=7!S/@H@
M(" @/')D9CI397$^"B @(" @/')D9CIL:0H@(" @("!X;7!'.F=R;W5P3F%M
M93TB1&5F875L="!3=V%T8V@@1W)O=7 B"B @(" @('AM<$<Z9W)O=7!4>7!E
M/2(P(B\^"B @(" \+W)D9CI397$^"B @(#PO>&UP5%!G.E-W871C:$=R;W5P
M<SX*(" @/$5X=&5N<VES1F]N=%-E;G-E.G-L=6<^"B @(" \<F1F.D)A9SX*
M(" @(" \<F1F.FQI"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9O;G1+:6YD
M/2)/<&5N5'EP92 M(%14(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I&86UI
M;'D](D%R:6%L(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I/=71L:6YE1FEL
M95-I>F4](C B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9O=6YD<GD](DUO
M;F]T>7!E(%1Y<&]G<F%P:'DB"B @(" @($5X=&5N<VES1F]N=%-E;G-E.E9E
M<G-I;VX](C4N,C B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.DME<FYI;F=#
M:&5C:W-U;3TB,"(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z1F]N=%-E;G-E
M7S$N,E]#:&5C:W-U;3TB,C,U-C,T,S0Y-B(*(" @(" @17AT96YS:7-&;VYT
M4V5N<V4Z0VAE8VMS=6T](C(S-38S-#,T.38B"B @(" @($5X=&5N<VES1F]N
M=%-E;G-E.E!O<W138W)I<'1.86UE/2)!<FEA;$U4(B\^"B @(" @/')D9CIL
M:0H@(" @("!%>'1E;G-I<T9O;G1396YS93I&;VYT2VEN9#TB3W!E;E1Y<&4@
M+2!45"(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z1F%M:6QY/2)!<FEA;"(*
M(" @(" @17AT96YS:7-&;VYT4V5N<V4Z3W5T;&EN949I;&53:7IE/2(P(@H@
M(" @("!%>'1E;G-I<T9O;G1396YS93I&;W5N9')Y/2)-;VYO='EP92!4>7!O
M9W)A<&AY(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I697)S:6]N/2(U+C(P
M(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I+97)N:6YG0VAE8VMS=6T](C B
M"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9O;G1396YS95\Q+C)?0VAE8VMS
M=6T](C,V,S8Q-SDW-S0B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D-H96-K
M<W5M/2(S-C,V,3<Y-S<T(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I0;W-T
M4V-R:7!T3F%M93TB07)I86PM0F]L9$U4(B\^"B @(" \+W)D9CI"86<^"B @
M(#PO17AT96YS:7-&;VYT4V5N<V4Z<VQU9SX*(" \+W)D9CI$97-C<FEP=&EO
M;CX*(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K
M970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!_\  $0@!'0%? P$1  (1 0,1 ?_$ !X  0 " P #
M 0$            '" 4&"0$$"@,"_\0 2A   00" @ #!0(*!@@%! , !0,$
M!@<! @ ("1$2$Q05(3$6&1<B,D%15F&8MM@8(S,Y=H$D-#4V.$)R=S=2<8*X
M)29BD52AL?_$ !T! 0 " @,! 0             ! @4& P0'" G_Q !-$0 !
M P," P0&! L&!0,$ P !  (#! 41!B$2,4$'$U%A%#)Q@9'1%2*AL0@6%S,U
M4G)UP>'P(S9"8H*R)#2TMO$8M<(E5**S0W.2_]H # ,!  (1 Q$ /P#[^.$3
MA%&=RV@)I6JY]:YP1(Y ,@49)R):/Q$0Y.R<^JR1SEF# BVFNV[DH7?;-AS3
M9?9NP;*N=79-XQ&H.GB!%Q?H'M!<W80V'J*1WV;9DIYWKL6'3:65B!6AR\3@
M(SIR\O:+TI61J;0M!X@*'SH&4:)RIT&TF\DB<)//R:89>6*;MBMC&^.0R>HR
M'<._M6&A_:/LA,ZZFUKE+CE+*0=:(EU<3CD;$C86PCG8%U->PMDUM*IK/Q"<
M7V^+ZWQ&88,C<;:Q1>/"(H>V*F8&U'%7"&6I3@<6,<\^XXVQOTY\SL=\GGT2
M['^(YUWZJR4]&[<"]A6R<89 R,BF44ZP7[-JM"LI!JTR/<$;9C%?D:V:IZ[O
MVK=_E248R,>*X9$<-G>NR."@-)Y8][@#\,Y^Q7SX54X1.$3A$X1.$3A$X1.$
M3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A$X11!+J I*>A)!'9C5L)D(:53%O8A]F0 LE,$I\U%L ;::J+
MZIZ.DI4@%%L Z1]NNB4T%MM!^'7NF=T=B+&O.LO7A^9KF0NJ3K#<Q40J.@JR
M>:0P$CF#A(<ZT?PT-'44&23=@*A9)/0I#!R:/N<2+:X*QU$:1_TGA%4/QB/[
MM+ME_@0)_'L1X5F>L/?]Q72WA53A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$
MX1.$7-+QB/[M+ME_@0)_'L1X5F>L/?\ <5TMX54X1.$3A$X1.$3A$X1.$3A$
MX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$
M3A$X1.$3A%K4S*R %$)2;B<55G,I$1TT3C<*0,C(\M+CS :Y="(RD?-;IAP>
MYT@DW%ZF"F^H\9EU[Z\\VZ"F,D7+ [XE$P!1:0M$Z[JJ3V. [3C>L.SV$6'9
M\VJ)Z;4H8M?LF(MS,-HN26BY?PH6"+0DP'"U4=0<RI,=[ NWV?$QD=*<#QZ9
MQU S@''G[?Y[BOX@4GW'[3&-P>IY]5]=0CKQ-;UGL+ML^1'),^P<O+1Y'%+:
M.ZQ8;3A"N8^,TG$FWF.:^>%6I!M%QK!H=0(;M2GA\=LYQG'3QWVSTYKSXQYP
M(U\.'M8+<F!;<FY@P/1L.7(-$GSC?>=Q+?75!HHMJX5VVTQG;75-/.<ZXSMC
M&<8\^$9ZP]_W%=0N%5.$3A$X1.$3A%CR984%;)O#),>)9K/Q0I)T3>MF#94H
M>*,P8,:FNZ422W?F31$>'%,]=LN")1\S'LTUG;I!'<BR'")PBKL!F?8IWV5G
M4*/T]%AG6D= X^1@5R-9XD[EAV?Z*I;RH 7@ON.J[$8LW-,T ;K55))HI$#[
MMT1*YD@P: *=L9R<YY8VQXYS_!6)X4)PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G"*AMN5%WOL*8R$O#.YL$ZV5L,<JZ
MP^+5]ULCEJS(D*;HZ[[%+"G%MR=^(7>O5M5=M0,,@,;1%-<)M]I&<<9V?:E.
MWADXZG S\O>MMZ-6%:%M]?X3:D]M.!75&++C<9GM2V?$*JD-)')/7\K"-2XM
M>P*S-3"=L04K1PYUPX<1X^V%$4E-=\1J.K([MEB$8)&",;8+@[<<]QL?Y*S,
M[BVTYA4MAFDDE,-4E<;-1Y.70<K@%,XLJ8'.&"4BBAG9N\3&2(*HOJ1#/%F;
MUN@0;-]W+-VWU5;JE"J&-Z@3P4;D]FL>T5B-;VE\BA1.0V"SB$$8Q(]&*_AD
MLA,;K^0U2R&H #4<10FQ^7.'RY).4[3[(DJRD#",@A4.;%.>GAX]">?]=/;N
MM%%^&W!HZQ8QJ-VQ8@Z"R$;6;2]8P[8PPBO>1*KK1D]PM)"9,XCS12'%9S,9
ME(F=F)PYF.$FX@[:1R-#(;L-9$DB<1]^20=SC(W&^?=GV;JM?C0=1NKDBZ?]
MH^R9_K[4)N_Q4&B6XNY2T!CA"R!NX>61(0*4'RYVP5-,E!XO.1[3=L[2W0:9
MR@GG5/;.,E9A.0,G&^V3CD>B[;<*B<(G")PB<(G"*I'<RI>L-V54TA/:_41F
MNFLF8S%@L6?;B=1LEB[$DHP--3"26RXU42W?/'"ZNBS=J\8[.A)K1_'B)@20
M[UOMEPNLI@MU)-6S#A_LH6A[SQN#68;S=Q.(:T-#B20,971K[K;[1$*BXU<-
M'"2[^UG=P1X8TO>7/Y-:U@+G%Q #03G964B9N-2&/C2</=L'D;V2V:"U1:6$
M1^J Y7<?ELT1PDCJBBT4;;M=$M$M$T\)>A/7&N-?+@JJ6HHIWTU5$^&>/A+X
MGXXF\;0]N<$C!:X.&#R(]BYJ6JIZV!E32RMG@DXN[E9DM=P.+'8R =GM<T[<
MPMCYP+L*LP2'):=BYDGF564L.$P.O9NP N;.GKF-H'Y7+[=9&MLQY>0J!U!:
MS2.!F[4$JSW"CDV6F![!MZU<[[7/7%VEZ$BCM399KC<K?)4LM-N95.IJ.BLL
MD ]);3"<3-?4SN?4!XGE,A[V1Y QJ=/1 :IKV^F75T4-MMEPCIWW:XOI6U-9
M77N.H/HSJDP&)S*6!K*<QFGB$8$4;,G-F>:HML3A$X1.$3A$X1.$3A$X1.$3
MA$X1.$3A$X1.$3A$X1.$3A$X1.$5>NR]H6M4E?#I13U+DKVDZTUBHDE"Q)10
M4_:0UT^V<3*3-U=1Q#1RN#CS-^NT8;90</GJC5J);GSJ@N)R I !.YQ_7V*P
M".RNR26RZ>J2VR>FRR6BF5M$U=M<943T5SHEE773?SUU4RDGG?7&-O1IYYUP
M4+]>$3A$X1.$7S[>(K$+1BG8R.@JLNKQ,99++TC,WL=.M:>[?]3NMU'5_%J]
M6@<2+CHH1[ 5QMDD3>$)>)(+Q06</EVR+Q^<=J-AZJ.FD8/B?L^2L "#G'0=
M23G/0'R\%ULZ5UR/J#J/UNJP5'I%$AM?4S7\18QB73&'6%)P#4%'&(]$2?G-
M>MVD%EI9CHAA!\?B39"/E'&F[L6BFT52UQ*@[D^T],=3TZ*SO"A.$3A%S2\8
MC^[2[9?X$"?Q[$>%9GK#W_<5TMX54X1.$3A$X1.$4*]D_P#AWOC_ +-V;_!9
MKF>TK_>?3O[\M/\ U\"P.JO[L:B_<=V_Z"=35S K/)PBA4/_ ,1=B?\ 96FO
MXYO?F>G_ +L6S]_7S_V_3RP$']Z;I^X+#_[CJ-35S K/IPB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G")PB<(G")PB<(G"*"[V*V''00 W Y8'CV5IU6<0)-2
M\2UDNCM"P[0A4$5?(*_' V[-80QD+UZ@EY.$W;K1OJME-+3?&^P:>@ME345,
M%QHYZGAMUUK8GPUGHI8ZV6BON(C</1Y@]L\E+'&X_5+&%Q;DD8U[44]SI::F
MJ+=604W%<;30RLGHO2@]MTN]!;C(T^D0&-T$=5)(UN'![PT.P <S$';DV@MB
MV,DDC!5!LFF_*(#]12+YSKCR4<ICM'+S5GJIGYX0U=+XT^F%-N82=T3Y9'01
M.@A<XF.)TG?.C:>33*61\9'ZW W/@LW V9D,;)Y6SS-:!),V,0MD?U<(@^3N
MP?U>-V/$K)<XES)PB<(G"+YQ_%-!QNV^QU9R685Q30H)2L-M"N7S[Q!NFO9*
M[.KQ_6<'J^D#.>P6Q*C6S5,-+CDH<L/^-366QDVY$%B;!Z(71;-U!9782 [&
M<G')P:=L^1)Y\AC[UVYZJ(@&W6NC6T5?4D2CK6L(@U#ONMC;W*@7#%L';(([
MT\RV+'MF=?8PGZ(RS4-$U&HS5!!5ZNHGMODJGF>?/KS]_FI:F<PC5>Q"53V9
MED ,0A,<-2V4FW6CA5N'CL=&N2YDFNDT1<.U4F(YFY<[I-6Z[E75+*:"*JNV
MB>Q0JU)]WJ&W KE,JV<D?0L =5VM7.J4MII<[N<EX*O:(L*PJ1U#D9X^T=UH
MS(3WXLV"*!6D:$'7A DT6 &VX\IX3Y>W(Q\<XSY9SY+SOWFZT[.X$@RFQDNP
ML&/UG*&,B#5[89.*Q8'<TF>0JJ7EG2-I%U!55J3J9C2<5$,+"<QTBW-BBK0R
MT&8&OE&Y,'^B/#/COMX94%^,1_=I=LO\"!/X]B/"EGK#W_<5TMX54X1.$3A$
MX1.$4*]D_P#AWOC_ +-V;_!9KF>TK_>?3O[\M/\ U\"P.JO[L:B_<=V_Z"=3
M5S K/)PBA4/_ ,1=B?\ 96FOXYO?F>G_ +L6S]_7S_V_3RP$']Z;I^X+#_[C
MJ-35S K/IPB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"*%;
M]_W&!?\ >KK9_P#(NK.9[3GZ0J/W#JK_ +8O"P&I?T=3?O\ TI_W39U-7,"L
M^G")PB<(G"+@?XR7V@B\]H2PI(7O%"DU(!;E>*AZ []Q+HY*E;ODI: O:Y,R
M-W8]LU9$)S'1X49*VK3<<X/&8V2(;O#( N$70:8*[.1Y9VYMXAUST)'PW\E9
M?PF::[8TE34QC':*32R1X=/ZL)0-S,[Q(=@G[EZO1-:_AB/1J>&C,DD#2N9#
M<^9JZA$7-GWC@6U0?$1Z#,&:%:;E#B"<CKTP!C<XY<R1C/FNEL[VF^D)EV]9
MI1=>Q=(V:W@J$W4*HPUQ+M!SC:/-Y4X!ZJ&FL><%<-43#H2BX(M6&[APS:NG
M":;=4JKDW%^KG8J*7(X[/ *O&#MF]_M[6WZ\'KP7G,P.K2+KC.Z.LN::6_)V
M1)BR,OBARNMH= WIM>* J\KHDD)=Q4K+L1,.5LC&/+&<>>?GG',GKS.HQKHE
MV,AD(EM3)"X$>%]E8[0V]KS5I-W+1M2LIB%T3JR[=8 A3^-H%YU'<1J:IB*@
M=CTA#M]*A;C>7#(>&>I$T29'CRSCGN.0'/;XXQU)V/I>-/15KFNIO9VVF?;F
MZXW7(R$1%17K<$C%%YJXO[C*HFQ>)EI"5J<G;:J)AWGXN\T9V(QV1>8U18;M
M&&,M,E+#N!@==]\\CYX^Q=R^%1.$3A$X1.$3A%"O9/\ X=[X_P"S=F_P6:YG
MM*_WGT[^_+3_ -? L#JK^[&HOW'=O^@G4OO7S(6S=$23QJ/'LD%73U\^<)-&
M;-LAIE19RZ<N-TT&Z"2>NVZJJN^B:>F,[;9UUQG/,)'')+(R**-\LLC@R..-
MCGO>]Q :QC&ASG.)(  !)/(+-R21Q,?+*]D4<;"^261S61L8T$N<][B&M:T
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M/Y6KAV"57T4\_GA3137?&?GC;&?+F=I=7:KHL>AZFO\ 3 <A!>+A&W'@6LJ
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MKEZ#6VKM'T=;)I>\FUMFX)JN/T:.H;4F!KA#N]S3&6"209'$"';MV!7GVO\
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MU-5Q:\9S[R)V?X3U4?"E47NN0<M$+)*+),UU7"3=5XU&.=/6>SS6\%GKX+M
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M?SQGSQGR6QCSQ\LY^N.FW\)G20<&5UVH+)(><=YT_K6F+3D ASV662(8ZDR
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M.>ZWA]&'>>M^=9RZV[L:U7Q*K[1=];9!6%D73':^E,D@$.=2%J=$'I0)&*N
M(8ZA&3K4LR$G3'N )<JW<I_#52:+O.CK9/#-QYK56RY43&RUMOKJ2-SN!KZF
MDG@8YY:7!C7S1L:7%K7.#0<D-)Y KTVEN=MK9#%27"BJY&,XWLI:N"HD;&"U
MI>YD4CW!H+FC+AC+FC.2%0_L!XB,H'5NM9W7)C"B4.%=5ZM[$RB2SZ)S"7[
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M.6&2&)Y'ZS&GDHG1Z"T8PJ>]Z?!.9S' '8*S7%K2HP*D#!62QJ08D$?DH03
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M5#=V&YQ[/M)'\$ SCS./N^:TT9W*LPM=U>1QM6M?I4O8O;:X>H@\\ZL RC;
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MKGT2B%Z]HW5G7>5Z\];>QMH#/#LZ:&#32[*@=R";J25Y*^XFDR?T"-9OXX/
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M^R78Z5]A(JSF].!7*% V8ZB6UUQ(!,() S<<>V:B,8CT)!+Q-9M+47KXE_\
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1^^$3A$X1.$3A$X1.$3A%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>76
<FILENAME>mrna-20201231_g35.jpg
<TEXT>
begin 644 mrna-20201231_g35.jpg
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M$0'_Q  >  $  @(# 0$!            !P@&"00%"@$# O_$ $X0  $$ @(
M! ,""@8(! (+  4" P0& 0< " D1$A,4%2$6%QDB,4%769:8U=88(S(Y=K<D
M)3,T0E%A@0HF-W$I>#9#25)36&-UEZ&X_\0 ' $!  (# 0$!
M  $"!08' P0(_\0 3!$  0,# @,$!0@(! 0$!P$  0 " P0%$08A$C%!!Q-1
M810R4G&1%2)"@9*AL=$(%A<C,X+!\"1B<N$T-39#1%:5\1@E)U-CA-23_]H
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M5AL>\<E8L-I"5.)B"V5GBX"LLSCL61)^)G,>F*U(RWEQ[#;+FP:5TY5ZMO\
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MI.$3A$X1.$3A$X1.$3A%Q?CH7QORWXR+\Q^%^.^ ^(:^-^"]WX?XSX7U^_\
M"^__ %/Q'M^U[O\ 5^OU_B\(N5PB<(G"+RO^)UVCJ)#MV1JVVZ?T*VGIC7-/
M)U/78+LOW[V)K>B/[B#DQTVUS=I]:A-$L5%MYZH2RT,5( 6FHVJ.^"CCB _8
MX.<5>K XO1C<C8NSUX6@D>&'%P()WY?7E;_>GVG-<Z=TC7DZWKNN:S&V@@=N
M6X0].MSH6GYVPK]5ZY)MIW58.8O#==H1V;"04KXB%&@L?"R<DI,;)8B2DR2H
M>9Y_7S^M6BSG"<9SG.,8QC.<YSGRQC&/KG.<Y_)C&/RY_)C_ *8X4*/6]MZL
M>J5:OK6QJ2Y1[F:K=;J%N19PRJW:;!<K#$J51"UTUB9\O,D[/9YT(!7X0Z1)
MD&"TR-!'HD2'FT*(OYK&WM576V6NB4_9%&M-UHKJF+G4Z_:0I>Q5=YN8^->;
M.B($U^<,7')QI(R5B6PWF*3BR1TCVIK#K""*B_9/^\J\,?\ P9WR_P N]/<*
MP]5W\OXK9;PJIPB<(G")PB<(G")PB<(G")PB<(NL,&0]?%S39\L-!AAK"Y1$
MN8G11@R!&;_VDB;/FNL18K#?Y5O/NMMI_P")7EGGK!!/52QT]-#+43RN#(H8
M(WRRRO/)L<<8<][CT:T$GP*\IYX*6&2HJ9HJ>")I?+-/(R&*-@YNDDD<UC&C
MJYS@!U*U_6SQ)M.S#LZC=;JGL+M[L6*KV'@^C0+Q2EB9"_/##MHVI/;CTP0(
M=RG*<F!\L]'95E.'$8]6/+I%%V67ME/'<-4UEMT5;'@.$^H*AL-?,UN.)M):
M(R:Z>=N<]Q*RF<X9P>BYG6]JUC?4OMVE:*Z:WNC#P.@T]3.FH(7'=KZN\2!M
M!# >7?Q/J6@XR!G)QS[N_$8[%_UFS=ITOI?KR9]7*'HU#.Q-TR(+G]N :VP8
M2BNULDWZO-DS0XC_ /L\)7&\EKSSZOE/LQTQM:;17:[N3.5QU 76NQ,D'*2G
MLT&:FKB=]*"XO;SR'C&%\WR7VHZH&;M>*#05L>=[;IX-NE^=$><51>IP*6EE
M:<<$]MC=L,.:<G,T::Z!]8=+&?M@.H:]@[,=>3,G[:W$3E;/V.0))\L9*_/;
M-\5&$$583C"Y-;'!,KQE6%ISZU^K WSM&U9?8/0I;B+;:FM,<=FLD3+3:XXC
MG]SZ/2<#IXAG9E5+48VWV"SUB[-M(V&;TZ*V_*=V<X/DO5]E?=[K+*,8F](K
M.-M/+M@OI8H"1Y$YN?S1EOBX!)LD["D-B)<."24E.(LLB/?*0F5^M/J4_ CD
MA#TI.6\+3A#1*(I*U)7E:L)RVOYJQE6^FF903TU-6.:!!/64DM=31NXAETM)
M#66^6=O#Q -9608<0XN+6ECO>E=2LGC=60SSTP)[Z&EJ8Z2=XX3@1U$M+6QQ
M$.+27.I)@6@M#02'-K'L+?%FTOUYON][;5R>UWZK#DO"=?:@J$QBVV BFQO5
M<:&%#B5KL$DU.,E7QC;444P\72EU]D0$L1-R$-?US1];?;E:_E"^5=IJ'U$U
M3'3QVJTU=L; VDK:NDD[YU7>KP:DS=S'(PL]&$/SVD3<37,SFIZ2T4-Q]"M%
M-<8&110/F?<;C35[I34TE-4L[L4UJM@@$7>O8[B[_O!PN!CX2UT^T"XP=B4:
MG7X8/*BAEVK *UC1IQJ$P9A#[ -CE83!1D=/*0&IR(LMG$EJ(1FL-N^I+<EU
M./7G;%KBR[A$X1.$4<WC3^I=FM*8V1J_7E_96CVU-W2EUNT)RCR].$XP;&SL
MX\L>6$^GRRGRQE.<9QCF3M][O5I<'VN[W.VN!SF@KZJD.??3RQY^L;]5BKC8
M[+=FEMUM%LN32,$5]!2U@Q_^Q%(-NGATPJ@67PN.D1V>HT'T_G7%C3ZLQK!J
MBY7;74Z"I7U]42'6K!#!MYPK&%)PL0XE.4X]*<8\\9W6E[6]?4\?<37OY4I?
MITMXH:"YQR<O7DJJ9]0=L@XG&<G.5I%7V0=GU1)Z1#8ODJJ;ZE59JZX6N2/E
MZC*2ICIP-AS@.,9&%CN.AFVZ7^/I#Q >U5,RC/G$';2(5;?]=@X3]$,10]S%
M#7$PT)QC"8SI!W.,>K'NYQGZ?5^T2S5VU_[-]'UV?7EM$57IRJD\7/GH9I07
MGJ\1#D-MM_F_9S>J#?3_ &EZRH"/4BN\M'J6EC\&L@N$,9$8Z,=*[WI]FO%6
MU_\ 01LOJ3V$&L?[55]I=WU';IR$YQY?!YH\LM58TESR\U8EMYC(\\^G./3C
M&7I79!<OX]JUGIJ5W(6ZOM]YHHS_ )_E".*L>P?Y"'%1Z)VQVW^!=M%:FB;Z
MWRC07"R5LC1G^&;>^:CC>=O7:6^8P%\_I;=RJ-GT[>\/"_3X+'EAVP:$VK1-
ML_&X3G/K>A4]?R&PQ_/_ .KC2W\NN>6/)?GYX2_4W0UP_P"2]IENCD=RIM16
M>XV;NR>39*W_ !%,_P WQMX1OM@)^NNN[=M>^S"YR1MYU6F[S;;UWF^YCH3Z
M-5,P.39#EW0\\?M'\4_J^(?:A[<';PZ[DGEX9P/WCHZ_U=U#^<^E++TL*+LH
MMC/G]/<?GML8_.]CSQYP[LAU;,TR666P:FB +N]L%_MM6"T?2#)YJ25W^EL9
M?_E4M[8M(0N;'>XM0Z7F<0T1:AT]<Z-P<1R+X(:N%N-\N=(&['=6:H/;?J]M
M'V$4#L%J"S2Y'I]H5!O]:0=\U_V<. )A".;8RKS\DI>@-JSG"DXQG.,XQJER
MT7JVT<1N6F[W2,;SFDMU4:?;GBI9&ZG=CKPR''5;=;=:Z0N_"+;J:QU;WXX8
M8[E2"HR>0-,^5M0TGH'1@JPJ%I<0E:%84A:<*0M&<*2I*L8RE258RI*L9QG&
M<9QG.,X^N.:R002",$;$'F#U!'1;,"" 0001D$<B/$>2_OA2G")PBKAGJUJ_
M/9Y/;;*K/C::-=9UGB'@\O[%9#9E9?\ G&:M\-\/FV_#Y^4XL?O_ !^ O^J<
M*^"SEK)3G;'GE6/X4)PB<(M!7B_[4[ Z\V)K6NTCLSKWKQJ6]:VL$DW,+=F>
MN76^]RK!K\O.OQ<?3)^ZIPL^4MFSY +66H:A9*^]-IM%'VO8DW8S0\>4%D.%
M9HSXDCP!Z^[.,<^N5NGTG+LI#3.HY]TL=>N-QFZQH4NV6ZHR84RJ6FRR:J)>
M/6.L3!J&QTJO'"BY1,+)@-MPGQLJ,[%0EA3:<%59I8ZX N  U5+6%%V2L607
M/!V&O'($<H%.!2D9R$3$%ALQMZ&0&D8;ST2=!ELNQI<9UUA]IQIQ:,D6GJW=
M#>RI?4'5&MU*]ZDKG]'BZZ,L,'4]HUB6N <!8J;VSI.SK%L^O6JO;EUV(9)
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M-U#V>:VM>/XE116^"_6^+',R5EOGR&GH1 0<>Y:R;)XL/6Z9VN$E!'5B093
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M4R\M[8=VBQ'BST%:5O.BQ@=#A!AK.!T]S+K2^=&9V9LL[&5&O-2VG2C"T/\
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M'PJ+;'<XG1D^K+D,+<.):,X@]BNJ:S)TW=='ZO;N6C3NI[=/*1_FAKGT#VO
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MQS[P!9V&^5JD&OO2&&C4LY$@QQ3C[+<UQA3J,9#54?TK'J5G^JT/_I*4_:9
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MFI*FVU/(7E"<X(L++=:NN9\4,!'= Z4- PLHG.#ABVJZ*2%"9IK$%)F6,'3
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M6XUTK&$MS'<L1'";\$B^U 1*>QEF,J4MI+[N,MM96O'EPBRB8>!CDE5D#(F
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M3DYVWV(ZG?'EU!WWQC?858*9V,T5JLLSHZ5K[:9436M@%TU\UKBNT>UWC89
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MBD0F\XVQ_HH_+LI_"&V7,I*,;X^I0#7^^V@[*"IUI'M;29K-P<"YS82&H[]
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MS5L*[HW14\#[)1ZO1CU)HLC>V-9W^4$W)H;8S]_*ZRNFX;'0M<FXU:TP7IX
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MG\5DL_I!K5-F>O5:MVT %Y%T$W1-;V.;=BULF:I0=IX>D3350*65V=;7)"Q
M(=)4#.6PK4\'<D;-' 1K(7*%Y9,]-OZ[9_/\%+NU>O.M=RN61V\0BDI=JTQL
M30IC, M)'8<UWM&2 EVV&SAC_8$I#U:%YAE$9^(A);>2U]'E\*%F-OU-JS8,
MZ"3ONM-?W<D+9^&&$;?3:Y99PZ/[V9'L0)9D;-D1&?B,Y?\ :CN-H][.7?3Z
M\^KA%&NY.KVL=Y&&3-R7:HCDJI3M=7&#6;'*!#-E:Q)EHAPCK?8$-EMW!JJ3
M"412U)BK&FX\(G8PT,U&"6NSCBY,XZ^?PZ_5E99JC5Z]>S=MV B29+6?<>W#
MFT+-+B,.18#>&ZW4M9T<7$BNN.K0L#J?6^O@):3Z\(+GQI<XTQ#;)HA1B*7N
M$3A$X1.$3A$X1.$3A%Y(^XQCN]8>R78 1-$>+])I*]A=AT5>)UCK>Q FG6A]
M5U;41?38KK<]16 Y%L?%V-)N]DVDF"94)N,ML'+ML*R-C!\2(7HW  ]3/^;?
MJ>?/ICE^*]1.C)MT)Z2TZ2V0R0C;$(:LU]-OL<K#^6E&+I+J0A^TLDQ^&F,0
M"#1QR<B9#PPQ\+)2XQAIO"/1@O-2GPBUN]WJ7;=BVVET()UJMVP*5=JD3KVX
MMWTAC4Y*ZUG7N+77B[VGZ%$V'LFBRZZ6V"0%M%;#L>"W/=I0D# D5H82N\P"
M<HA2-OG9W'(?.SC'E]W]YZ;J_I3:--WM6"=GUH1J$'6E1[MUZ[;$ESJ>Z-W0
M?["=JM>;>UI8@'R&P%+&62W5*I;;'8W+@( RJD;N2:^/3/DS3ZHA#RYYY?AO
M_0;>&_15P(].>NW5KQ.?#U*:-HA"HD+W2.[S5KF$M@[+O3Y5L-0=7R!B?7L*
MX6OX+$9TL07_ *N^#R]\1A+^74,L);*V26NSY= .9WY;+>5PJ)PB<(G")PB<
M(G"+5^[XD5R;?[!L8\.+Q$7$Z(:==%/-Z3KBF=ZY:VA7];8;T>K-^3FV..0S
MKNR&TS\!?5KL&;-^>),1$!XK</+YS=_,[>_;\UKOUKXL/8X_9]([:*&]3VL3
MOCM?>NM!;PRZCKB<UW=T!7:R:V"$:O=P**V9-+3+Q1HU(@7;<]?/:S 4833K
M"XH"?CO-B)Y,K%@!(\&AP=G .<';;KN!Y^ML#C9*(\0ZWEK-NNNK\/7O\*9T
M]/8@CK&4TW7H]?V^E_;=9U9F;J.:F\N.V.$S!L;VT7G9C I2=8UVPGL(S*A-
MCGRKPC;YS=_?M[]OJZ_#=1KN:V]P+;VFWSK[01K=;;E# ]>Y%"D IO6"#U[J
M)>W,'R5H?W; V4Q*W=80A:*+PLC%U6(+E_E3;D2OD*\=>CDXA0,=?/\ #;[_
M /=8=5_$8V!5Y&O:\;#A=F(E[<J^N;_/8:L$*XP)&YNT>S]/4.+'>C5@-KN/
M-KU>  RH:LBR]NM]V&0C;Q@91XD"+9SY -N?0D?5T_'?RZDG'<3?$BVPU7],
MN#=>Z5L%IWWK^M;EK RK;+.6#&OZ#8=>6O8+8#8\%5?#O_:!YNLO#05H&3XX
MH\+$[-MR*U"CZN>!VTIX1G'AD9'+.0-OCX<O#.V%#_$NVC3!>V-K6FI4BXZ\
MFWPS#I>NX.QA+VQ]<X&^'94.X^!]A-58"7J$G740B*LE?,W"+)L#T/%O@7B"
M2*UIN!7LDX=P/C]HC\E;TOVQV"#T1W9M98'K^9L?J=7;'(AF*07*G]96DJK1
M==W%6WI2R#$(J&^39M4*#<0RY9!UD)%AVF.189L; D448Y>?YD?T7\U3LIM(
M/OT5H\S7JU8=>"NP43J0C89"QD/O2L=S%]%8/<-_9AT)"K,"GQAY%J"6I<X(
M-DM/.$YD:QQ7H$*.L$^3&V?+/WX4EQ=Y[?>[*+U*[JQMO6J24R)C8/V5[ (<
MS&8JSYEF1]H7]*LZ;S[I5M W+B=IJAKPOX:/*>.*:#N%"A8K=;U<NV]AUCKW
ML[:G0H%ZU-[O&#1>GA%-TI7B6GO<H-"U])L%-L-GM/86-<)8'<9DF3(6BJ5G
M7L@_!V!6Q,>QZJ$/E;IRWYCGOOCX=-M\\NJQ?0VQ]V!]?=6-N6[;]ZV?7^T&
M_2#=?KM_$:XAG!'7S:>L+A8-+Q5_=]K_ %^P[=1T6BTG9]JDS1JWP:+GM"H9
M^-&BP$X<0C<C88'Q(YX.>O1;3N%5.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$3A%K2[)_WE7AC_P"#.^7^7>GN%8>J[^7\5LMX54X1
M.$3A$X1.$3A$X11]!U+JH9?BFUANL]?#]HG(#8HULF#3*Y$OQ@6TAEMH:4N,
M<:W8B$!IN-'0W#ED7HZ$,,I2WA+3>$D4@\(N"R-'1ILXE&@08Y$FF*@E/9BL
M-32"8*'&H*9TIMM+\M,-MUUN*E]Q>(Z''$,X0E:L9(L->U/JR2<&VA_6FOW[
M*&91'$6%ZFUQTX+8:._:EE@<66-5/@LMV;_S&VW%D-(0=_UNE."'^D<(NODZ
M1TQ-#EJ[-U%K"77S]DS<CH*50:I(#&K?E>',VLL,=$KA$K)ES"5Y.3&'B?KP
ME7Q7GC&>$7?,ZYU['LT^Z1Z)3&+B4%K!D[8S5PC5F(A',1\.!YYY$%)28+7B
M)%PL?(E.1%8C1\*9S[+?I(N'&U7K.#1"VKAM IPC7!T6<"F**%KHD+5" FS,
M2HMA@2 0J+#'*CFF)LMLFG$?'QF)+V7\K6XI62+FUVAUJM# (Z,/:)20'RV0
MQ8#;48G9IQH95&:.BU%SCT?$TA;)=49^1$+"ZO!*8+=>'NO? NJCX(LQX11T
MSJ#4L:VR+_'U=KJ/>Y:YKLJZLTFM-6V2X2ANCB+DBR(&),/+GCWWX,U3DQ2I
M4-YV*_E;#BT9(N22UM42IS7)R4,2E>IWBTVA"HN4Q 5?*E:S,I7SF(*C(:CH
M(C*:7L=6#+3Z8XX+:;!%:C9S,:<C$SS^_P#'\EGG")PB<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G")PBARD[_U)L2[6/7E/MF2MLJZK&F?"
M< V86/)8IEF^Q5W=J-B,!H%;OL>BW/+=/O<FC%K%&I5K>C5RTNB3,J/"=(M/
MO8CO]T2(>(7X>=K']TNI\^K4*J=U(=XLT'L1J.97J;+M%%U7!K42TFXUO=&
M)5AFC",,)'*RHCQ25 F,0D/NQGD(+T#'\+OFN^C]$^/N6P/\)QX;?ZP/I/\
MO3Z._GGA5X'^R[[)_)?,^)SX;>,9SGQ NE'EC\OEVFT?G/\ VQB\YSG_ +8S
MPG _V7?9/Y+[^$X\-O\ 6!])_P!Z?1W\\\)P/]EWV3^2?A./#;_6!])_WI]'
M?SSPG _V7?9/Y)^$X\-O]8'TG_>GT=_//"<#_9=]D_DGX3CPV_U@?2?]Z?1W
M\\\)P/\ 9=]D_DGX3CPV_P!8'TG_ 'I]'?SSPG _V7?9/Y)^$X\-O]8'TG_>
MGT=_//"<#_9=]D_DGX3CPV_U@?2?]Z?1W\\\)P/]EWV3^2?A./#;_6!])_WI
M]'?SSPG _P!EWV3^2?A./#;_ %@?2?\ >GT=_//"<#_9=]D_DGX3CPV_U@?2
M?]Z?1W\\\)P/]EWV3^2?A./#;_6!])_WI]'?SSPG _V7?9/Y)^$X\-O]8'TG
M_>GT=_//"<#_ &7?9/Y)^$X\-O\ 6!])_P!Z?1W\\\)P/]EWV3^2?A./#;_6
M!])_WI]'?SSPG _V7?9/Y)^$X\-O]8'TG_>GT=_//"<#_9=]D_DGX3CPV_U@
M?2?]Z?1W\\\)P/\ 9=]D_DOF/$Y\-O/G_P#$"Z4?3/E]>TVC\>><?^]XQYX_
MZX\\9^O"<#_9=]D_DOOX3CPV_P!8'TG_ 'I]'?SSPG _V7?9/Y)^$X\-O]8'
MTG_>GT=_//"<#_9=]D_DGX3CPV_U@?2?]Z?1W\\\)P/]EWV3^2?A./#;_6!]
M)_WI]'?SSPG _P!EWV3^2?A./#;_ %@?2?\ >GT=_//"<#_9=]D_DGX3CPV_
MU@?2?]Z?1W\\\)P/]EWV3^2?A./#;_6!])_WI]'?SSPG _V7?9/Y)^$X\-O]
M8'TG_>GT=_//"<#_ &7?9/Y)^$X\-O\ 6!])_P!Z?1W\\\)P/]EWV3^2?A./
M#;_6!])_WI]'?SSPG _V7?9/Y)^$X\-O]8'TG_>GT=_//"<#_9=]D_DGX3CP
MV_U@?2?]Z?1W\\\)P/\ 9=]D_DGX3CPV_P!8'TG_ 'I]'?SSPG _V7?9/Y)^
M$X\-O]8'TG_>GT=_//"<#_9=]D_DGX3CPV_U@?2?]Z?1W\\\)P/]EWV3^2^9
M\3GPV\?_ &@72C\N,?3M-H_/US],?DO.?I_SS_9Q^7.<?EX3@?[+OLG\E]_"
M<>&W^L#Z3_O3Z._GGA.!_LN^R?R3\)QX;?ZP/I/^]/H[^>>$X'^R[[)_)/PG
M'AM_K ^D_P"]/H[^>>$X'^R[[)_)7BX54X1.$3A%070/67:&M]M54_;YM#51
M=/U7M73=<3ZV>L)6W7D;V<WYKW<B2-Z!$Z@!$TLC0Q.MA-:D-!K3?6;P7+D;
M*MZI-PHH644YV(\2#\,_FN;L#H]0+=VGZS[Z%5;5H:I:.H78VI66BIU^%PJX
M$=U)U"FO%F\Q8+8Q'V35KDOEWX^,^\OY\GX)QCTRO=*0[ (ZG&#X8SG'F<_B
M>BM#]RVG/T3:S_8.K?PKA1D^)^)59.YW2.A=F.JF^M TRL:OUY:MM:WL%) W
MAV@AEMU<D882U'+K0*A1"2DQ58]6<0I++^?^!Q.>%(<00<DX(.,\\=-U9O[E
MM.?HFUG^P=6_A7"C)\3\2GW+:<_1-K/]@ZM_"N$R?$_$I]RVG/T3:S_8.K?P
MKA,GQ/Q*?<MIS]$VL_V#JW\*X3)\3\2GW+:<_1-K/]@ZM_"N$R?$_$I]RVG/
MT3:S_8.K?PKA,GQ/Q*?<MIS]$VL_V#JW\*X3)\3\2GW+:<_1-K/]@ZM_"N$R
M?$_$I]RVG/T3:S_8.K?PKA,GQ/Q*?<MIS]$VL_V#JW\*X3)\3\2GW+:<_1-K
M/]@ZM_"N$R?$_$I]RVG/T3:S_8.K?PKA,GQ/Q*?<MIS]$VL_V#JW\*X3)\3\
M2GW+:<_1-K/]@ZM_"N$R?$_$I]RVG/T3:S_8.K?PKA,GQ/Q*?<MIS]$VL_V#
MJW\*X3)\3\2JR=9NDE#T<UOMNSUC5]RSMKLUM[>0#+=!#)^R]8V+,%20]-7\
MPA2,J< H'O-J5"]@<K+_ /HL=K&%>HF3XGXE6;^Y;3GZ)M9_L'5OX5PF3XGX
ME/N6TY^B;6?[!U;^%<)D^)^)3[EM.?HFUG^P=6_A7"9/B?B4^Y;3GZ)M9_L'
M5OX5PF3XGXE/N6TY^B;6?[!U;^%<)D^)^)3[EM.?HFUG^P=6_A7"9/B?B4^Y
M;3GZ)M9_L'5OX5PF3XGXE/N6TY^B;6?[!U;^%<)D^)^)3[EM.?HFUG^P=6_A
M7"9/B?B4^Y;3GZ)M9_L'5OX5PF3XGXE/N6TY^B;6?[!U;^%<)D^)^)3[EM.?
MHFUG^P=6_A7"9/B?B4^Y;3GZ)M9_L'5OX5PF3XGXE/N6TY^B;6?[!U;^%<)D
M^)^)3[EM.?HFUG^P=6_A7"9/B?B567M3TDH6_:9K>LU6L:OI$VE=CNN&Z21%
MR@AEX,5O2NY*ALJR5%.!T*,[ARWAJY,KR%/K<@)5/PJ>P_%PZRHI#B,\SD$<
M^61CBW\,JS7W+:<_1-K/]@ZM_"N%&3XGXE/N6TY^B;6?[!U;^%<)D^)^)3[E
MM.?HFUG^P=6_A7"9/B?B5)G"A.$3A$X1.$3A%YVM8B[/K35VE+=U^Z]]@Z7V
M1UK2>P1[M*8B]:MM4*5?P+>D]S1JO7Y;FQ:35:?V*V)/[#3M'VBD0*ZO81Y0
MZN662/=2()$(%@*YZ@D8)#1N,@9V.V,;9'U_"6*_V'[Y#@4B.3=N4R7L+L=8
MNJ&J"=SUU%A%X"]IZ,T9L#7/93$FR=;NL,B]T72%S%]C!A^-&TK71AZ!\,/G
MQ;4W3%6PF3#?=MD^&Q(QS.,[=2>HV("VU7LSO\:88C:QUKJ"YU[Y;'7(+W_>
M-RUN<P6R])1*BHK]<Z[[1'/0&XZ(;S)+[117I#\B5'4'B-1&9$PJ[=2?AG^H
M4.:,H%FIW9KMJ9*O[#)@[S%TC8@YFY%3QJO_ #-R%L?Y[6=?2R,>(#'UNH,.
MA!2 %9APFH2%12I]B39CI8R6*%<;A$X1.$3A$X1.$3A$X1.$3A$X1.$5'O$$
M!,6#159ADZ-:-CU6-V*ZP%K_ %"I:ZMNV2137(??5!)7SXO7E&K]ILMH Q:Q
M&)2[".@U\JA89F:N7%7$0]Y%(STYX/,@=/$_^_@M>%JMO875 ':+/4F@=AM8
MZ;NNS+<=T8"CZ8N05T%BJ:$UY&+!Q^N+WUG[!W;5%*ONWY%CETBB&=(Z\#6B
MQUB\GX]YH(*Q@I%_*V 1N1G&YSN.?F,G'4$]!C*N=UOW#V9O>_9>K-F-R1@*
MCZRKF\K61DU =7Y945OFI5"/JC6<N%)'LS@A.B[%JW:2#9H'M0K9!#4+43]D
MGSEW PB24$#F/=UZ=?#PY>/DLPZ_Z JH7M+V9WK#U='ULJ(2':9H*8==?K,>
M[@Y8*H[5VEMV1ZF(F+1-O&R[/FD,EY&",*! T\A^N28+UIMR"103L!GS_H!_
M?BKY<*$X1.$3A$X1.$3A$X1.$3A$X1.$56>\P>TV'I/W# 48583MV.=6>P0>
MG!*E!)%+48M)/4MNA5\561@9I\P1L) L_$B!H(IAXE,(O1H\%IR4XTC)2W'$
M,\LC/NSNM;=@)GM;6JUVSH]IS>NG=1F*7K"EWJ,)ZZ;/U (^]$EM#$J+<:OJ
M79O7Z\'!J*_KJ-9PNTMIU#K/L:%)BV[7T&?'+2*J\5H)3X<6_/J/ 8R<CKR&
M0.?CM(VA-[=TS]VZW:QV8U8A\W=(JR7D\9LFOAE;M-%I'67:&PJYMO-C$%=>
MZZ>\]UC;#U.!UXC*UY49+K.Q]D76GA:E&@UX0&(0,;=,>><^\GEO_N59;<U-
MVF)[847;NL1=RO9>)U-[5@0U2.V@Z'TE&V!&/]=RNLZ^8>A0I%:J1J^%(MA:
M?M)2$2M,H*)+)%+>$5^0.9*JZ#P]J[O"JB>RHO>M7O >QSNQDJRQ;%=SS!UR
M[N']/:@<LQZL+B>H7"IJKA&/) BJV\]5*TVM^E <LLU1^,R4NZ8P=O=U/O6P
MWA0G")PB<(G")PB<(G"+6[V5_O$_#)__ &WNW_E#2>%/0^\?@Y;(N%"<(G")
MPB<(G")PB<(G")PB<(G")PB<(G")PBUO=&/_ %V\2_\ ^<V+_P#Y]TMPI/)O
MN_J5LAX4)PB<(G")PB<(G")PB<(G")PB<(G")PB<(M;U(_O8>P7_ ,CW7;_.
2'>7"GH/>?P:MD/"A.$3A%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>77
<FILENAME>mrna-20201231_g36.jpg
<TEXT>
begin 644 mrna-20201231_g36.jpg
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M=WB7MK?8"EF5EM<:(2,Q-CE7=K6XU2(D)4%6<9FQUC?_Q  > 0$!  $$ P$
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MRW!F V;&XC.8\INX9JJ-4CT=&JOF&[4HRT7&OF3M<0YA@# & , 8 P!@# &
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M#$8 P"&/D6^@AVZ_5_LW]UR&"PZKI7>3.P08 P!@# & 0QZ!?1J8_IL[9_\
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MP08 P!@# & 0QZ!?1J8_IL[9_P#=G=V"O7JA[D3.P08 P!@# & , 8 P!@#
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MV?5W(BTZXN]EM&8E& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MNL;S1C]L^KN1%IUQ=[+:,Q*, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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ME(O*V6)2)W@+1;[JO_DLLUVVF8O&*N=9+/?-ZRI+JDH+;/JG5.':WY3KOO\
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MW%L&#$8 P"&/D6^@AVZ_5_LW]UR&"PZKI7>3.P0Q9S\RF/LLA]T6P#Y]X/\
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M-/@)LM_VH?@PK3_AY!O[I /_ !^/KM>ONG>'Z[:?^H/L+\COY)^33X";+?\
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M7XD?"-XW,#^/H3]NWY"OZ]2YC7,X#@1(]:.<OZY(>X7KI8*N:@&Y/XKPT,R
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MW#8*Y9O [=9@T50$NQVFR0]T-1W2V38.6*>VR;-=KJDJVTVVT1V3UYYXP0X
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M4W] 58_NJ.SGJX?M+=?O&S?Y4)^;[U1?W>>5_P#.'M5_J]I)@YY8X8& , 8
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ML$)5L5AOT_,6::8[."ZP"PXFT63XL:8J;CY\,B\(1.&"' .,Z:#)M88DFLU
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M#II+HC$8\N.,LIB?2COX2W3Q<,'"QA=@HX6$IQR]MNX:>=Y/ASEK>"# & ,
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MQ<HLDHZ4$=-VCKV-K?T$H<$& , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M @)Q'K=)0J9?.2J7CNSN8(1W$RRT\JFO,FGN>3>=>;/*M; N@+JS%J,(,[.
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M6'68UB/V?2<\Y]A<T7)(J%WR^FGKU]]TM>-1#FN , 8 P!@# & , 8 P!@#
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M3D(*>UW'9^&=H;R:/QTPP*"=S!&/$T%6KAJ_X%-3S55EP74!B!B2FP!@# &
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3R? & , 8 P!@# & , 8 P#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>78
<FILENAME>mrna-20201231_g37.jpg
<TEXT>
begin 644 mrna-20201231_g37.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $P 9X# 1$  A$! Q$!_\0
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MU'N?D_\ *2P6/%=:[2;6"# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & 0E\D7L(
M]J/<_)_Y26"QXKK7:3:P08 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P"$ODB]A'
MM1[GY/\ RDL%CQ76NTFU@@P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@$)?)%["
M/:CW/R?^4E@L>*ZUVDVL$& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M?8(, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & 5R7OY**_J>PI'459=?.VW;FSX8X;L9W'^KU'E9G':^)/&+8FT%3
M6SI21A58BC"S!XW=;@V$M+GVB:J?KPIMMMKK@J5^5)<[?[E=_@=^@?(W7MS6
M" J">T-VQZHVQ+N2*<*A_:&BSD$'3YR&$/SQEG!K'CKR9U7("(X,+(%%0OSU
M9R!5@S=.FX=5-JZY0!JRO=-<Z?#K3LUY4BPS!!@# (2^2+V$>U'N?D_\I+!8
M\5UKM)M8(, 8 P!@# (2=@/:XZ!_\7]BO\@)+@$V\ 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , @C:W;VW:6L*2
MAI9T3[-SFIF+EMI&+JZ^<UK=C<VT4',W3QR;J,3-@EVQ]9B]5>#_ %43 I?P
M\Y9IN6CA35UPDB+96XK_ );/IZ+?CRKIMF?KWVEIOM )D9.IBLM5<PPBR#S.
M-3VL;,J.:1(N_;*.VPT]#K4B4.D;1=1)!?G1=,<LQ6Y05]7=K:Z_&Y!IKCVI
M]A![NWVM[!5( [!5;Q!580G*JVEO- =H::*KV^[J\B2C2K45*;^HH/%2MRP
M7'I+R[67LRNJ^O6""!:#>1R9$)LU<A5 5M'QL]4]+V>J3X<.>VO+RG)XE&=Y
M/ZCGD^LR[F%QUM/Y&!)TLFEVH1[HD8VQ'A-F4T<O;[3JFHMGC:2&^6;H? 5
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MY 27 )MX P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M61:O6K=LFV><&]V&Q+AVV31230<<.?3(Z))ZI[ZZZ:\<!'BNM=I8?@@P!@#
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M@P!@# & , A)V ]KCH'_ ,7]BO\ ("2X!-O & , 8 P!@# & , 8 P!@# &
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M!@# & , 8 P!@# & , 8 P!@%"GEE#1BFQ#J;NNQOE,5L"]+ >RB T?TR[#
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M3EPINLNLINHIOMOMSSSPOB^M]I3/60# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# *N/*9T\FG=*LJWK2$TGUGM(D-FCTZK+^R
MLON:*C*>U3$\HH2^":T,3C=AF)BX<;:-F;)E,(FPTU0U5(%DT_B<<#*,MV[N
MUIR6L^N^EO(S)'CMZBW;TYIXO7UZ=O+'[>R0O(=3@V0V F=X;5^)]00:)P2'
MN9=-+"F3V-C]TN=FKJ2RT@]5XXTVU09<<[(X$FF[J*CU<O[O,D1(\W%3EI[3
MM8R\' NRQ!U7A*SFYNW>JY>J7EA5/ K(KM] +!9&JIMDY'!5NP:Q8N7>@SH
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MM9&_*48 P#$LU_O,I?\ WI./P40P5<)=7[T9:P08 P!@&\'T^]D_K3[B*H_
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M5B>^8K^"(+FEO?)?/+)O%G#^M<V/2_O+?HWVD\=\9ZAV?+:LUY-P1@# & ,
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M=FZ,,33H8S$UJ4*\*.(KTHU8Q52-.M5@I*-22=_&:B'H:, 8 P!@# & , 8
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MOD/F/E7C7@?5&>FW7>7_ $HY]X@YI_F+98V1,TH/388 P!@# & , 8 P!@#
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MZ-N%IE7=2R T1(UVUBKHK*W-;0UE,B:CN6!0K<(:';;B.UW;A_72^UDNL$&
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MRWI!E7M8^"?NI?9OMYZ(Y_\ P\_.>QG7SCCGGF\Z?XXX_P#/GFRH;QQQ\/\
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MUM&2O>Q-W2NZ[@?U+I,K\*-Z?&3OB&4N;4+0ZL@ ".52'K$%!UFY6;CSS=M
M]SQ':RYX70/L3CX*1 @VG_=C;735K56?%M\.D\H>Z#Q>33EX2-WA>I*F25Z@
M^RQ'K.^,05]53NXH[*Q-@B26QY[ G%P(PAK98(19FM8-K,1A&LT8IJIBDXTH
MO&50OIP5[6OK>U[\]NCAPT?!6GALDEO\/QTD]OA_\_C::[?#_P#S\/'/P_\
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M=VW;CKR<G-=GJ*B\8?62J*'N[JTJ+.SGK9=%Y&;S2I62/D!40K!\4E\9L!G
M:SV@K2)%P-<QN:Q,1(8Y'EB3U1BYU=MEGKM@\<-=P<FVI/BDE?BW96N[WUMH
M9IL#J1!;$[9=>^WY:12UE/.N4)MR"Q*.#E@^L1-#;C'BAQ]W(D'(AR95?#$A
M"&X?888&MTU%%N7S=[KSIKH(G:+BN#M^%[=I\KN-TNK3N?#H4%F,CL"M9S4L
M\&6C2]TU&>;1>T:GL 2@NT1.Q<L]'&!KAF08N5QD@CYL22"FQZFNKAIH]:#7
M[$$VN'*K-<CZR-,$\1O7UK7G:B(W[.;>[9S#NB&C,?OZV;OD0A6:%X_!$>=:
M[!PQ&' 8P @0N D.$9#&4P8GATWD;9D1=NW:(T0R'B[[NFK)1X)<.GEN[\'=
M\ECBI/Q21&N+:C5TVUVC[3=KYM5]:32I*'<7_+XB69TO$K #:QR6DH\UBL+B
M_!V>GXYHF ,S:4;E'I08FFF\:J.&[1RV!RNK;L5?C9/7SMV70C L!\$=6Q>N
MZHHF8=RNZ=J]9*?ED9F$>ZU2N85.-JDN^B,G5F087*$HE4(&5EH^G)5=RKD8
ME)F6ZSKXJFCM%1)'=(5S;;=HIN]VD[ZIK2[:7'D1>K@P(J=3.I,%Z?QBV8K
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M3 & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8!Y6<;3;6'R7FMD8JO/\
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M;R-)?LJ:>.ZHC !Y75?<K##3A3<9MJSX/>23T=^*=VVK7O'6W&]V7MX,!@#
/& , 8 P!@# & , 8!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>79
<FILENAME>mrna-20201231_g38.jpg
<TEXT>
begin 644 mrna-20201231_g38.jpg
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M4F-KTM+N]85))[E=%6/,_ J93K)SVM<FI8RC7"AA>76FII$MR@1[G%< D:J
MHY(=-5)C2:L&K)<C7QP5QO<"(%E+&,LHAI;904W.^^_7OOUWW]=]_P#W]Z[N
MC<*X]S6N6&H47G56K=9ML0- LX2 -;W /#Z]SZL\I!P"C,C;_P",@BN;TVKT
MN##>VJ-'KX2% ;:TTA6ED7YY/Q+G_$V+1!YV-D!0]G(U.;L'^)V\* Q:1RV@
M<?K02O,*;T[##CJ=S>NM(9E/SI:YVYSZYNV'8T6(0]>_]==_JLS#4RK5TY<+
M*#!#QAZ_E!ANYE8C/VYED+!J\*J8N>4=^>_OR(-;!!PT=?RU]$$?&:^6_H^>
MR+$QO$N3!Y0F<,H-<A2P1WJUF$2(\+Z'!Y_N-B*6SKI6-OZ]_1,Z!9#18S9'
M/U_C9T^2[\D?7\M$5'KA\,GEMP[#2[L_-J OFE#.\8L-9YV(Y+6A=PKV^!UP
M$!YM40/6Q)(=/9H@QZN0"+R3U4LG36HDT]2@?5 ?-R3%,'E23MM\=_,G?X^?
MY=!TWZJY!GSCPJP"'@)GEM0("'J#4^7?@'AJ=,M4&A&-V*D5F+M"T+A0ZC8/
MI.5MV&MB8%+M1R0^3'F1F'FR;GU/??Y^OQ58>5> *SSSTV]Z4*6FNV T+F]D
M(4Z($Y+5>?V!F;VX]&,6F=?;179RAMPG0(L=T4.DUNG\[V?<FR[7TQ'0;\MN
MV-$WZ;;]MM^OH-AT\NG[#8=%L*PHF$3")A$PB81,(F$3")A$PBJ/X[_JKV[_
M &N/4_\ SFM.$5N,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$4;=8[!S+A=(*=(Z[= E"I(=
M<=F>?.OK9CZDRW-,Q(42.PV_.)D9CO[$0:-BS)\G:5_8CN:;7M.WM6ZU*%UB
MU,R"%FP<^0[ $]F@#<N<?)K07'R!79M(:,U3K[/5-,Z.P=_4&=NB1U;'T(Q)
M(8H6<\UB:21S(*M:%O6:U:EAKQ M\25O,W?C<>[7RGO])A]&XW> ?0*7-E28
M#1L&Z[M,<C"^WN6-(PI;,4D))QD/1W7AI2%#G-L28LA4?3$EAQS&I<JWH18J
M3LGA<2T/82=G#;=K@0'-<-P2UX#@""1L0M76FAM7<.\[/IG6V!OZ=SE>**P^
MC?8P&2M/S"&U5GA?-5N5971RL9:J3SUW212Q"3Q(I&ME+-TNJ*E75O4G2*IW
M:S\,Y7Y\<ZZ2HW$:'W*X&I/6:IS:-"!="N/6J>%#"F+,+E1215$CC]@F27YQ
M4**8:FCD2)T=O<B0R5VZ;[@==NN_N_?]M^RC6H?$!)]R 0+5Y5\ZW7MX&%Q_
MDO8[PX5N-3Y@3 Q>T<^'=4I?+ZV.-[,(M_9%T N$L9,!(FUBBCXUEJ[3G25/
MF%(AD(V[GU_+]-^F_P"*S$S[&NQP_<PG!_,M_P"P*Y+5Z38NPQB]EKW*;+63
ME]HXSI@CD%:JMK:DD++VV%0CU<L!VH'G:-6 _P"E59$R[WHQ.GPA1-N@._?L
M.OXGIT'<>N_DN^Z'[7I'.^Q^<^1DZ=<_K[R-&E#MCGPVP3'$&KK+AUKCT/J@
M4IMHP*+=>Z5*>Y?5A;+*Y3%O'$H9)+#<-Q6R ;@^H\O7;OL?<.OPZ^85F>B]
M%J/**>5OEZ)J#U<*X,:(D$09Q%;*S!> "'I3"&QY<U[[Q,G"85MF.YII+NWW
M?H8;<<044;^FNY+\[<>(]1B4Z3T$@W=>/\_!U&&;A5Q9FQ=G[#0^,UM#IZ?%
MFPQ<&(>OPX@2ENQ)'VQ\25]ME;NT:PFV_P!?PZ_HJP3?B SJI9;=R/HOGVU@
M?1@DEPT71>1UB]T>ZC^FR?0TKK,6A*#= 1*!B:ZV'C\+ZQ8^B(MXP+,J]+I\
MFR"H=I1/%0IQ9<OGOTZ[_+RZ[;]Q\]EFIGV#=J& G#^I>:;U6NPS^E43E'+^
M?5RT5^UU'M5LZ.+,G0;O/.L$&*D%V'JX2KW YU)RT!*X<H06H%R?Y <C3ZFJ
MS%-O?TVW['UV_'Y[;^:Q6_>VNH\M% A=^\KF:YTZR]KIO&ZX'F]5KD?DMH_3
M:@7_ *! M]7[9-KT*#-&!XG.3H&T!"]0 64%8'!J'QC@4R!-%B;#U_K?;8_+
MKTW\O?M._G_TR%[5SKH%Z.5UWFSW)KO=*#T6+.LE?MM:'%:*.&FC9>M7RL29
M *V55H26B..F(J(4D:5C&ZX;&##P I!8*;;>6V_7\?-8X#]^^,;*2#AP7H[F
M10C8#-8!AH\4TI7YC)N\R ,I,^.ZJ.EC=:NA<H-!T^WJ=35+0>G10((T0,/(
MA**\KO0_@H)#_$../1:O>+#Y^D!^+W#T]*\L!;N.Z[3S5SW<E^C#/E\,=?Y2
M^,"F) "=T<4B828!&CAX)3I$BT.B)D$24_#$V_(!WX@'Y=#Y_#SV78\[^);S
M#HU O5L'4FV";+SCUKS;RM:>?FI$&&:3OK/JH+Y<HW7@TO:51C?-CI@H3/PB
M,1O7W9]-O%'^XFQ5@E]HKRG?;SVW_P#Z\VW_ &MO\WOY]NJF6H^QZ):_474/
M,OY(6#R>= 2,^!T<E*'M4RZV"F!^:6'KM3!.[<2\@CRH+VSD,D_*?5N+*E6D
MV.C?1*I%C2P4VZ;_  _/?]E+?(_0G%>\M&W>0=&KE\U76@LHPV%D/?B(@RS,
M39-6/:BS&(LF36;7&&DI%4M$1I^O6=@:1> DR#<"6IDHL+]"^FZ[YZ(\=#EJ
M7?[>2[+USG'*ADFK5HC)J]0UT#HM,YPFUWVZ.1=5JLC8!:\A6Q@6605:+?.D
M+BUL/,'C+,9KA4#??W G\%G/7>^\;X+"!D.O]! 41FSS9PRLM%W9"R%D)#!K
MYD@-KPJ#'EE#9"$(BRRLF"+ARI30V',GK:U%B276BBC8/[?\CV$#;K2!]!\R
M-5VCCZD6L!D986)H](R_&'ZW1IX63'2XBU1;A:(TFI5EZJ[-(.6^._4QNY-B
M9<&)*['T_KW^GS\NJBWM7Q#.+\WXI-[?SI^)W>NBFNV.EXE&.Q8SX='!.*]
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MDK)L?0]M_EZ_!3'S7JG->RU.'>^2WVH])ID^5/@Q;12; +LH1R>*E.02H[9
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MH#5(--/S(9 C$"Q")R7"BR2DD>)*3F8++JY+D0=-D);VS%?6@BRVJ6NL7NM
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M9:U[WN!<=;_0^$]_O'N_K%SY[U.R\,H9GQOYWH4FZCN9TF^1+98@W8_614R
M%2[W!*"!IVGA[<"+/M?EA-A;-L%.DX$J-IJ.YI+<^0^)_11)R_G@_P"'Y:^Y
M<V9X!W3MW*;GRGSM2^!$Z-09G891^E<2X&!X<CS[T$F-C:@TJ8R<K1F^(/\
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MU]^W7W]>G<K/?35?AV:+P-N\AO8CD;SQT\A%*=$\[ #+QU-WG^;"]:BWZ.%
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M "6X01,61$BR#J$H<G#H4QQ"/G]"'),9I]:4?5O>_I2I>])^>][^6M?/>_\
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M_9UO,V=S[VD?CT_50D#N5LHZ9U^J6TG7J.*'WA@[7.U\9_.-F>>W4"(A_7T
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M&0E4JG&+\-%06OVW-I34C3LF;-D;UIR:3)2W)! H0?\ G(($),F6^I3SR][
MDN!/?<([L?@?HIA^\>CTN$]6!H@P>0%%['#3QN97!$IW;$5+B)IL?7[5,@-I
M8VZXAQBODE./(;84TVAU4AG%589P>M7>D\KIM(O@^J0C%*KP&IQWZA9B]G&E
MX $&-'-EWWS-.IDH9,FR6)6UB$0B;,5A$=S1B4X^XS&I.Y)'FH!L %B7:ZF
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MU:#X;56N=6\IU772*X?K70;#;.B6JXLVL/,"6<L6.7,N^R=.QR,:+/D3"0I
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MF= \EP8[NQV^SAU"CT+_ &_=*_<_Q#^-/0><Q:_R1P?_ 'CU3_Y9HY=;H_\
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M73^L=(5,UB=1T<7>=2%/56'C9%=;9AC:Z.:M,^&+(8]IYHVT[S>5SBYZNA7
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M]X7BO_JQPFP]1^?[+#Q7L3IIJYV^@C_"/J)RRT4=5"MCBN7+QNQ&C0[H@VL
MN,0=]5HA3UR$U\GN0U#>><A;::U+2UN0Q]9-AZC\_P!E_.A^Q.F\MH%YZ;<?
M"/J*%4>=4^S7NTS(=S\;E9D2N5$+-/FY,06.]5R2!&2P,'R76($&._,F.I3'
MC,NON(0HFP]1^?[+,?\ ")[A_F$>F?\ >%XK_P"K'";#U'Y_LL.;]B=-<O\
M*YDCPAZB_2V%3Q][?A[N7C?4--<)FB=?B24E-^J_R]<E9,3-:7 1(W-::0B0
MXREEYM:BO+TWYAWV_P []EEZ_1G;T)4M7@GTSI*$J4K?\H/BO?R2G6][W\M>
ML/GO_%_BU^O?^3"FP]1^?[*=N0=+"=HY-R[L5:AE1U<ZQSND]+KX\ZU#8-P
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MK$JT5L+8)5+LD>Y5"27'19\BL6R$.)AXMC OR&ENBC3(@X:%)(PELRMC"Y.
MIS<2=*9=(LFPB81,(F$6,5"F5+G]?AU2CUL+4JU!DE)D0%7AT44+8F'"L\^:
MF(APVVF=2S!PF1,E)6T[?(%)\V?+<>E2GW5D63X1,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
$F$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>80
<FILENAME>mrna-20201231_g39.jpg
<TEXT>
begin 644 mrna-20201231_g39.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #I =,# 2(  A$! Q$!_\0
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M"M/\)^%K)M/T*P,AM[=I6D*;Y&D;YF))RSL>O>NIHHH **** "BBB@ HHHH
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M:RAUE^A (!P0<<T ?5U%?)?_  \$;_HW?XX_^$C_ /;:/^'@C?\ 1N_QQ_\
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MS5\6_"7P[@N-(^*<'A&WU8K>_P!FPZ5'J" ,HVOND(VL1C(4=ADFO5O^%/\
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MGQ:^(7Q T'6]*^('AK2-+\.ZJ=5TBRN?#LMQ*KFWD@*S2"Y4.,2R'A5YQZ4
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M6&0P.017RE^Q#_R43]IS_LI-[_Z+CKZK@@CM88X88UBAC4(D<:A550,  #H
M*^5/V(?^2B?M.?\ 92;W_P!%QT ?5]>"^!?^3Q/B?_V ],_D:]ZKP7P+_P G
MB?$__L!Z9_(UP8KXZ/\ B_\ ;9'UF1_[OF/_ %X_]RTCWJBBBN\^3"BBB@#P
M3]J7_D/?!7_L>[#_ -!DKWNO!/VI?^0]\%?^Q[L/_09*][K@H_[Q6^7Y'UF9
M_P#(HR[TJ?\ I;"BBBN\^3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3P!^5 'G7_#7WP,_Z+%X%_\ "BM/_CE'_#7WP,_Z+%X%_P#"BM/_ (Y7>_\
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MWXG^$-'U>STH1W-C?:W;0SPMO<[71G!4\C@BO</^&OO@9_T6+P+_ .%%:?\
MQRI_&WB[X+?#?5[?3/%=]X-\.ZC<1B:*WU,6T#M&6*A\,!\N01GIP:T9KKX4
MVZZP9!X30:.\$>HYCM_]$:8*81)Q\N\,NW/7(Q4@9'_#7GP-.<?&'P*<=?\
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M)^S^%V77CMTDK%;D7_[LR?N>/WGR M\N>!F@#G?^&OO@9_T6+P+_ .%%:?\
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MOP;XROK2&PO-<TR&_EMK=BT<3.H)52>2!ZFN[H **** "BBB@ HHHH ****
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MMY;XW$9VFN7U3]J/X?Z*J?;[W4K63RY)IX)-(NA+:1QM"K23IY>Z)<W,!!8
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MP !A15+7?@AH>K^,[[Q4[WMQ?W+6TTNFRW16PN)K9'6W:1 I/RF0GK@D D'
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&1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>81
<FILENAME>mrna-20201231_g4.jpg
<TEXT>
begin 644 mrna-20201231_g4.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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MM3GAHT14Q$7_V@ , P$  A$#$0 _ ._P
M
M
M
M
M
M
M
M
M
M
M
M
M
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M)JR-=8W=5.0TTQ)KAVU'8P[:LEH(^AJC3X#TB*^DC^JE9D Y8
M
M
M
M
M
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M3T(P&:@
M
M
M
M    "C_G!YD.52LQ>XJ\)B++=N6+\RES#8]5ZM)@80_%=<CVE-C4B8@ZIR[@
M(:<]?MGE>I5*2[6S7*[EQ")F(ZRUIQ?X$8WK%]&QMGRSV/MVSD+N+'*+PWK)
MBNM9;JI<J31(M2=EO6#DAPU.6TONFOK(UMI8):DG5HXYF9_!.6;/KZ])QH+:
M'5IZD?8?[DE1>CX[GI-U?ZO0S_7,%+&'Y3TA1J<7U+ZB$_%07]9)>CZ_I$H?
M.       #YIL*'8Q),"PB1I\&8RY'EPIK#4J)*CNI-#K$F,^A;+[+B#,E)4D
MTF7H,@$ ]L\!<0MKAC86@[^=HO9M1*19TTK&9,RLQM%FQU4S(B-5*V+3$Y9*
MZ$E^M6332>I^K+,^HC17%YCQ;-T/YH&XN/&35FF>?^+V+E<OLAX_O.DK"E27
MHC#B&"G9!$J&?4<QK&FG$&[.K6T6C!)(I,22^XI::7)$Q/@OMQ7+,8SK':C+
ML,OZC*<7OX;=A2Y!0SXUI46D-PU)3(A3HCCL=]!+0I*NBNJ5I-*NBB,B)9
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MC25T_P"G8XC_ ,W7(W_N1UG_ $O"%1^G8XC_ ,W7(W_N1UG_ $O 'Z=CB/\
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MD%'L3K2D/H:.0EHV4NK2@U$I1$8=AL
M
M
M
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M[<LMM*L,<R.O2ZZJLO*Q3J2<;-2D.(4AYE;C#C3JX5-R
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MFD:"Z0S7,Q9N93Y-JWGUE8(8;;D73F6Q)\>XA2I4E!O''C.M06U*-"&$M?$
M1-\RJ"S5\J/*7K(QK./7<@2@QS=42G#9B;&XWQVC<424DI?AMEU,B+J?U &.
M;^Q&'R_\U7%>.NU'I<W2NC]6)SQ>"IG3(5=EES/JZZUDOOKANLO$[-FY%7L2
M5)4E2H%8MI!H-U:C#"_-RX]:*U/K_CUD>KM0ZZUS>2-XT>.3+'!L1I<5?L*9
M=);3U1+/V'#@MVA^N5[3A.R$NO$:?0LB4KJ'8*
M
M
M
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MILEI*C(J>472557M;"MJV270RZ/P9[,B*\711_LD'\("N;=OE+\--PHES*S
MWM/Y)()Q3=UJ>4C'8"'5?&:2YALAF?A:(K:^O5$:#%<4DS23B>B32%<69<-O
M,,X9I>MM+9@WR>U+5DEQ>(O0IDK*(5>R1]S36$S9\NZ8;9;(DMHQZTE+<49K
M7%))&13JIFL2YW1G.766U;!&'9?'?U-LMN4JM?Q;*W_ A3+1I?@NPJNYE,04
M%/\ 62-LH<MJ+*-W]S0ET_2)U<<UF/P3;$J0!\=A7P+:!-J[2%%L:VQBOP;"
MOG,-2H<V'*:4Q)B2XSZ5LR(\AE9I6A1&E23,C+H K%G,[3\L_;)[UT1&G9)Q
MZRF3 A;1UE+L)#\&(RN4IMJ/)=4V\[ )A<D_8MP:7G84APXTGQ&GC;E4S#EK
M;7I/B[(FD=U:^Y!ZSQG:^L[E%QBV30TO-DKL;L:BQ:)*+*@O(:7'#K[NGE=6
M9#)J4GN(EMJ6TM#BH5MK@            -([]Y$ZCXSX)+V%M_*XF.T[?BL5
M=>DTRLARBT0WXC=)B]*EQ$JXM'2,NI([6F$&;K[C3*5N)#KR[$VYR=\T2]<@
MQ?:&C.(U=:?$K6GG5S<R3 D_$=M'F_5??2[\=HE$R7;25+B"_P!GE,DM^8A3
M:T1^*QO0O&O"M38I#QO"Z)&/T"?#?F2W.U[(<GFDGHJTN+%;:7IDEXE'T6HD
MM-(,FV&T-$E*9\''UM.LI+7>20,.HTU-$VP4USN:)2")33"U)_NAY2B/K(>;
M+HGJ9G\8R,^OI(/%,SY8Z(Z7\>9?Q)49=K/@NSC;1)L(3OA6!1?%0<IB)*_9
MP'9,8E-)>:[78Y+[VC0XE"TRH:HRC*=+\<<2=N+Q_&->T!K<-#<6&TS8WL_H
M3CR8T*"RY;9%<2%*[WE]KSZU*-QU7[)8CP3UF5:MXC:OF&6MEC7&KBKC:L7C
M2T5UAN?,:.GK+.K09H[E.Y@M<2IHGD,+2XNNBO6M@IM!*;0?7M$3+EK71(7%
M?*0YT:8H6;W4O(C!(V4,^'+FX-7W.60L9FO&VLY#+;EQ0/X_=2$K)*6_7ZZ,
MVOJ9FMLR+NA,Q$^+)?Q7O-\V"2<6NKK6NKZJ6DHUAED;(,3C2CCK-*77F9>)
M1<ER*%(2E!K2J$S%<ZJZ=Z2^"=91Y:K,N$'E\:\X=Q+7)GKF1L?=.61%1LKV
M3:Q3C&S$DR43YE)C,%V1-?KJV5.;0Y*?=>=E3W6D+<4A*4,MPJ6#@
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M,
M
M
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MJW\A6]?(*=+UE&O&W'9,!A;RG4>^]HB6L[2:DB7')PX;)I0E]R32YEN
M    "#/+;R^M <NJ^7.RNC3B6S2B$Q4[6Q6,Q&R1E;#7APV,AC=6H67U+/:E
M)L3/W=MHC1'D1S4:@%*3V8\C/+PSFKU'RHBS,ZTW;O*BX!MZH3,MF6J]E9$?
MJD]YHI\U%:RX1S*>9UL82.BHRGHW@$],2HM37K'BLHHKVFR>FK,AQZSAW-'<
MPV+"KM*]]$F'.AR4$XS(CO-F:5H6D_ZY'U(R(R,A4XG+ ./MJFLOJRPI;JOA
MVM1:PY%?95MA';E0IT*4VIF3%E1GDK:>8>:6:5)41D9& K5UKG^7^5CR$1+[
MKO(N(.Y;9MB]KTI78/8M8))1M38:.XS:RK&(RU&C]A[;J4*;42WXZ5QJ9AS5
MMK^+L[X[D-'EM#2Y1C-K"O,=R*K@W='<UKZ)-?:5-G&;F0)\.0V9H>C2HKR5
MH47PI,0J<P          *N.9WF@:NXWOR];ZRCQ=S[^??54QL-I'GYM!BEN\
MI4:,WF-C5>(])M$33)/L2"L[%Q2>QY43O;<4%9>"<6-S<G]A,;TYK9!:99D$
MM1.XWJAM[P*VFKC=]8B5EC$A+1 QVBB*7W>RX?13JC)R8^IQ3[;DZ>]QS?V5
M6^8S@F/X=5Q')S5;"B5<9B/ K8C#46GJ8\9LFXL2)#8;;:5X#2"2VVA!(1TZ
M(2?0C$HT]LN-N\W?L9"8U?WQ*]*_CN]>V3*)/I+N,O\ 865*+]B1]3+X3]/:
M1$S[F&6<I4J07575#2";1^IU_9+/^N:CZ?Z E2@9R'YGT>M+9O6.JJA>UMV6
MTMJGK,7I&95M!J;B8XF/$AVC=1WSK2X<?61(JXA^LK5\5Q;/5/=$RJK69_!L
M+C;Y5V<;;R")O3S ,ALLDO)?@S*33$*U\*)60S6<AJ%F$VH4U$JXB5J[BIJ=
M;;:>I'(D&M3T<J7+$1'@O9QK&<<PVBJ\7Q*BJ,8QNDBHA4]#0UT2IIZR(@U*
M3'@UT%IB)%9[UFHR0@B-1F9^DS,$N<
M
M
M
M
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MID*9&=2XTZVI3;C:B4DS(R,!]H
M
M
M
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MT*[%U57(;?.!:VJ5]4G%C.NODI*B[.J5$02*
M
M
M
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M664(::::0EMMIMM)(0VVA!$E"$)(B(B(B(B >8
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M%IENE]0Y5=O^M763:OP#(+>3T,O6+2YQ2IL9[_12EJ+QI<E:O29GZ?A,!M
M
M
M
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M5>PHEO"@Q;2TLEPB<@8W%3XG?,D*6Z1D3BS,@$U\<P+)J[BS0ZOE0V6\R@Z
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MV93<:WHL6JJNR8;DQUN1Y"&9D5:2<0I2%D75)F1D8#9@
M
M
M
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MGT1#9GLG/5,9'E;4E"?C2*4G([--BJS4:B[JR+%>4VKL<<<(A"I.(
M                    %;>\.,6U,\\P7B_R,Q^)2N:TU3A]K2Y=*E7+,:X9
MG2TYZ3*8-2ILW9S9GD,;JI*BZ=5?ZT!9(
M
M
M
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MH0#GP
M
M
M
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M;:WC6MZ6B]+1[ZVK,Q,?&)>7Y]OGVN:VWW5+X]Q2=+5M$UM6?=-9B)B?QAR
MYW"
M
M
M
M
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M-M$S.*=I%K3GPZ_+EKO;Q%IB?";8HVTUG]GDK%XM#>;TC]*O27D^"P]R4O\
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M'=Q;7+M=S[/-&M;Q'MI>LS2]?C2TQ[)ZMN#*F/@
M
M
M
M
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M
M
M
M
M
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M:VB8M$Z3$^,2\Q*
M
M
M
M
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M[Z28LN'+ZA=KTUG]?>8JQXQ[=S2/9,?\=6(\-<O28R3/8V'T#:=
M
M
M
M
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M/V1_HUQ<[W?UC^O=W6+99]N.OC3#'NBL=;^^^NLS%:RRWNGNC^N]_&UVD_\
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MX^FG;>^FU\&FNF*T=<F"9_N)F+8]?'',1K,TM*RD;%/%0
M
M
M
M
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M$=AP@
M
M
M
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M/MMDMTZ+;QM6U]
M
M
M
M
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MEO\ 4G^\CW.X:/J\^?(
M
M
M
M
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MB8]TQTF'O%:D
M
M
M
M
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M.CY;=][+^KN]N7V,1I7%R>YK'][&:_E]L^-=)\=8]O5OH9NQ0
M
M
M
M
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M?RS,RF./6GG(
M
M
M
M
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M,M>DZ_J6\D_EUKUCV3T]B6X]3>?@
M
M
M
M
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MFGR]-'R'YSD9Y?F]YRUM?-NMUES3KX_M,EK]=?[YG0O2U@
M
M
M                                     *)/,F\VRZT7G<_BGQ"H\?S[
MDG&@Q).Q,WRA#LO6>@ZZU80_#]ML1'6W,DSV1!?1(8KB5ZO%2XVM],E7B1!,
M1J*1JG1O)+F1<65YO7D]NC;=C"4R_:N7VP;O#-<5,N63BV8F+8#AR8]52J-;
M2E^'#:99^*2E)1U(E5>6!RCGD_ZY?6MZ368Q+DO+4[(E2,RV@Y(DON&:W9#[
MGM$N]YYPS4H^A=5&9AI X>S\GO$9)Q*3$L;P2;EMZ\J#0L6F8[914L/);4])
MM+A<.>N4BHJ8J%//^'T6YVI:09+<28B8B$)CX!Y%7&'&<=B5^9TB=DY#V(<L
MLBM,RV)CK;DM2>LAJJI\4NZB-!JDNF9,-/KF24-D1.2'5=5J?*IUEF_Z$SAO
M_-)3?A-W=_+43\IK)^A,X;_S24WX3=W?RU#Y363]"9PW_FDIOPF[N_EJ'RFL
MGZ$SAO\ S24WX3=W?RU#Y363]"9PW_FDIOPF[N_EJ'RFLGZ$SAO_ #24WX3=
MW?RU#Y363]"9PW_FDIOPF[N_EJ'RFLGZ$SAO_-)3?A-W=_+4/E-9/T)G#?\
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MKRUOR<8WX9>0O]*(:Q[@_05>6M^3C&_#+R%_I1#6/<'Z"KRUOR<8WX9>0O\
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M$DO3\T\;\(&U?Y8@/#]&AQ'_ )IX_P"$#:O\L@'B?EI<1B/I\T['X0-J?RR
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MJ]VZ-N)B9-EC,Y_JB'D^,3C2V638!D7;XD.<T2O"4HFG3,E,/2 L.
M
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MFQ1:QY ZWR*_EN^#!QU^Z+'LCL7>XT>'68_D[-+<V:^I? PPYZ#(_@,C 2J
M     $1N>/)B+P_XB[UY#+3'>ML!PJ4>'0I:4NQ[+8.12HN+8! DL&XVM^ _
MF%U"]:2CJM,0G5$1]H#I;:GQFPQ[&WKC+;*7>[)SVRFYYL_*+9XY-UD.<Y0^
MY;7DNSF.)2[(<8F2UMD9D74TJ69$M:S.N-(@30T=O=&I%7,*;4G=4]TN/)6B
M-);BS8<V*VXVEUI3C:VI#,AI9)6A1I-)I)23_9)5.L(2(_'3Q7_M.N__ &QK
M_P"U#6!NCC%R:QK8.2[+REK%+:*SA<ZJUS!D29T!QM=A*I*G-LC.*:$F9=8M
M]4MK/T?'9-/I,CZ1IJBR8_S]4G^\TW_;<7[ >52?/U2?[S3?]MQ?L!Y0^?JD
M_P!YIO\ MN+]@/*'S]4G^\TW_;<7[ >4/GZI/]YIO^VXOV \H?/U2?[S3?\
M;<7[ >4/GZI/]YIO^VXOV \H]3W(#'X[+LA^IEM,L-.//.*EQNUMII!K<6KX
MO[%"$F9AY1''])YQ*_G,QS_VS5_N(-(]Z=);!V7S<U7J?7ZMF97%MO=/NJ"9
ME5?@3Y,LKQUENN5$B$;3CZ74O$X?3TI;(U&70C#31$=6S6-_4C[++Q4=DV3S
M3;I-OOQVGFR<02R0\TM)+:=3UZ*2?I2?H,/*,1R3EYJ_$+O$\<R:4W37F=3I
M%;B-;,G-)DWT^*Y :D18)(:6E3K3EG'(^XTEU=2&@S/Y^J3_ 'FF_P"VXOV
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MC[ E&L'O$Q\@O[XC[ &L'O$Q\@O[XC[ &L'O$Q\@O[XC[ &L'O$Q\@O[XC[
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MLU+;0Z/9%%6NO+G8A;SWK>/#@6Z7&6T-OR'Z&8E)(4LNL=?I^#J&SP
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M*;B-@2>D!Q!H<;,U=_:IH(L^6K_CN>;9_ASP#^^'?8"Z4
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M-/P/?17RQ_7^T!I^![Z*^6/Z_P!H#3\#WT5\L?U_M :?@>^BOEC^O]H#3\'
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M^O\ : T_ ]]%?+']?[0&GX'OHKY8_K_: T_ ]]%?+']?[0&GX'OHKY8_K_:
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M+;*UI?6.&9OCMDE*9M=>4<A<&2HU)4IJ5&E&SXC4AI2V'T*)QI2FU)4=<3K
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M]IS"+KZA&^_._8#6375X_.K-_@$7[\[]@/,GJ?.K-_@$7[\[]@/,=3YU9O\
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MYPY/R#/WU?\ ; =#YPY/R#/WU?\ ; =#YPY/R#/WU?\ ; =#YPY/R#/WU?\
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MD)-1*)2"_P!20"0@
M               .'R''Z/+:"\Q7)JJ#>XWDU/9X_D%':1VY=9<T=S"?KK:J
ML8CQ*:E0;&!)<9>;41I6VLR/T& XW"<'P_6V+5&$8!C5-A^(4#+T>DQO'X#%
M93U;$B7(G/M08,9"&([;LR4XZHDD75:U'\)@,J   !2IYHGDY:_YY2$;?UKD
M%9ISE#452*U.9R*YV1B&SZV!&;8IZ':,2N;78I>K68Z(T2[BM29L2)T9<CS&
MF8K4<.I)N+RR?,6T1;S*G,N)>U\PB1%/&UE>E:*9N+%["&P2E':HD8(BYG5$
M);:#7VV+,.0VG_9&T'Z!5YA'K\77E1^2KR<_ 5LS^3PGS0/=#T%RVJK*ONJK
MBYR:CVE5(]8B.+T3LQ3+B5I-J3#E(+'R4N'-CJ4VX1&1D1DI)DI*3*-1).)C
MG(9Z+'<G<2>6,26ILCD1FM"[#E-,N_ M#4CV*R;S?4OBJ-"#,OA21^@3K"'O
M]U]^?DI<M?S?MA_Q4&L'4]U]^?DI<M?S?MA_Q4&L'4]U]^?DI<M?S?MA_P 5
M!K!U/=??GY*7+7\W[8?\5!K!U/=??GY*7+7\W[8?\5!K!U/=??GY*7+7\W[8
M?\5!K!U/=??GY*7+7\W[8?\ %0:P=3W7WY^2ERU_-^V'_%0:P=7BK%-^&?7\
M5+EK^;[L/^*@U@?GNGOS\E/EK^;[L/\ BH-82>Z>_/R4^6OYONP_XJ#6 ]T]
M^?DI\M?S?=A_Q4&L![I[\_)3Y:_F^[#_ (J#6 ]T]^?DI\M?S?=A_P 5!K >
MZ>_/R4^6OYONP_XJ#6 ]T]^?DI\M?S?=A_Q4&L![I[\_)3Y:_F^[#_BH-8'B
M>([[,^OXJ?+7\WW87\4AK!J_/=#?7Y*?+7\WW87\4AK"=3W0WU^2GRU_-]V%
M_%(:PC4]T-]?DI\MOS?MA?Q2&L![H;Z_)3Y;?F_;"_BD-8#W0WU^2GRV_-^V
M%_%(:P'NAOK\E/EM^;]L+^*0U@/=#?7Y*?+;\W[87\4AK >Z&^OR4^6WYOVP
MOXI#6!E^K[;E;I;9=+L[ ^*/*N=-9C^P,NQ:ST3L>!4YMADB4F5)J)$YJ@F*
MJ[:LE%ZU6S29=*._WH6A;3SJ3:Q$ZD]5NC',I2V(ZY/$+GM&D.,,N/QBXQ97
M(]6>6VE3L<WVI'A/&RLS3W)^*KIU+T"KSU^*G2SV_CD-?DD<]_S7,N_W0)\]
M?B:6?A\QF5?#Q)Y[^C__ !<R[_= >>OQ-+/'\<5G\DGGQ^:[EW[^'GK\32Q^
M.*S^23SX_-=R[]_#SU^)I8_'$9_))Y\?FN9=^_B//7XFEGY^.&Q^21SW_-<R
M[]_#S5^)\WO/QPV/R2.>_P":YEW[^'FK\3YO>?CAL?DD<]_S7,N_?P\U?B?-
M[WB?,)@SZ_BD\^"_[US+OW\/-7XFEC\<%C\DKGS^:YEW[^'GA&EO@?C@L?DE
M<^?S7,N_?P\\&EO@_#Y@,&73\4KGS^:YEW[^'GJ:6^#Q_&^C_DE<^?S7,N_W
M0'GK\4_-\#\;Z/\ DE<^?S7,N_W0'GK\3YO@?C?1_P DKGS^:YEW^Z \]?B?
M-\'Y^-]'_)*Y\_FN9=_N@/-7XGS? _&]C_DE\^?S7,M_?P\U32Q^-['_ "2^
M?/YKF6_OX>:II8_&]C_DE\^?S7,M_?P\U32SQ/EW&,^OXI?/K\US+?W\//7X
MFEGY^-U&_)+Y]?FN9;^_B?/7XFEC\;J-^27SZ_-<RW]_#SU^)I8_&ZC?DE\^
MOS7,M_?P\]?B:6>)\N(IGU_%+Y]?FN99^_"/-7XGS? _&WB_DE\^OS7,L_?@
M\U?BGYO@?C;Q?R2^?7YKF6?OP>:OQ/F^!^-O%_)+Y]?FN99^_!YJ_$^;X/S\
M;>+^27S[_-<RS]^#S51\Q^-O%_),Y]_FNY9^_!YJFEC\;>+^29S[_-=RS]^#
MS5-+'XV\7\DSGW^:[EG[\'FJ:6>)\M8A_P#Q)G/O\US+/WX/-5&EGY^-G$_)
M,Y^?FNY9^_!YX-+? _&SB?DF<_/S7<L_?@\\&EO@?C9Q/R3.?GYKN6?OP>>#
M2WP?A\LHA_\ Q)O/S\US+/WX/-7XICS1[GC^-C$_)-Y^?FN99^_!YJ_%.MO@
M?C8Q/R3>?GYKF6?OP>:OQ-;? _&QB?DF\_/S7,L_?@\U?B:V^!^-C$_)-Y^?
MFN99^_!YJ_$UM\'Y^-A$_)-Y^?FN99^_!YZ_%'S2?C81/R3>?GYKF6?OPGSU
M^)I8_&PB?DF\_/S7,L_?@\]?B:6/QL(GY)O/S\US+/WX//7XFEF*9=O77V?U
MR:C.>#_-?,*QM:G68.3<0;J[C1WUH-LY$5NQ3(*+*)!]"=;[7$_4,A'FJ:6<
M1A6UM3:X5)7@/ _F;ASTU'A39..\/+BJES&N]+A,RID1MJ5)82X@C2A:U)29
M$9$0>:II9G_XUL+\D[G[^:YE?[Z)\]?B:6/QK87Y)W/W\US*_P!]#SU^)I8_
M&MA?DG<_?S7,K_?0\]?B:6/QK87Y)W/W\US*_P!]#SU^)I9JS+\[T?G]B=QF
MGE^\P<FN%DA+EO<<-+.9;/(:;2TTV_9.LG-?::;224)6XI*2+T$0B;5GWD>:
M&<T/(G$L6JXU'C'#+G-CE+")28=10\2KZHJXB5&:E)C5]>F/$8)2CZF24%U,
M/-7XIUM\',?C50?R3N?WYKN5_OH>:OQ-;? _&J@_DG<_OS7<K_?0\U?B:V^!
M^-5!_).Y_?FNY7^^AYJ_$UM\'Y^-3!_).Y_?FNY7^^AYZ_%'S2?C4P?R3N?W
MYKN5_OHGSU^)I8_&I@_DG<_OS7<K_?0\]?B:6:A5YEG'9!/J7KWE E,60B)*
M4K4\=)1I3OC>'&?,[\B9D.>K.=J%=%'X:NA?%/IB5O4'L*EII?F^)BT3I,3O
M-O$Q,>,3^T9''9W>%HBU>+Y&:S&L3^[9NL?[AE*>>>JUH2XC1O,A;:TI6A:=
M#SE(6A1$:5I45F:5)41]2,O09#CGU&]/H\>=X>/_ ,;MOYQ/^A?>4^'%<E_1
M<_\ -OP^>NJB^'1W,@OZ^AYI?V;043ZE>G4>//\ #?TW;?SJJ.R.])\.)Y/^
MBY_YMZE<]]2_ZK27,4OZ^BI9?V;043ZG>F\>/<'"1_\ CMK_ #JN.QN]Y\.'
MY2?_ ,)N/YMP%AYC_'VI=\"UUMRGK'_D;#434-WT?#^YR;UM?^D.3'ZD>GN6
M-<7/<-:/AO=M/\&53;LGO2DZ7XCDXGX[7/'_ +-Q_P"DUXT_]I')C\%T+^4(
MY/\ 6'V#_GSB/Z9MOYQ3_H9WC_FKDOZ-G_X!^DUXT_\ :1R8_!="_E"'^L/L
M'_/G$?TS;?SA_H9WC_FKDOZ-G_X!^DUXT_\ :1R8_!="_E"'^L/L'_/G$?TS
M;?SA_H9WC_FKDOZ-G_X!^DUXT_\ :1R8_!="_E"'^L/L'_/G$?TS;?SA_H9W
MC_FKDOZ-G_X#\/S-.-)__41R8+_X5L+^4(?ZPNP?\^<1_3-O_.'^AO>,?_\
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M_":]9E+^*VAEIE"*-=?%.K#/FXWI^2QRZ_-]V!_$XG6$ZGS<;T_)8Y=?F^[
M_B<-8-3YN-Z?DL<NOS?=@?Q.&L&I\W&]/R6.77YONP/XG#6#4^;C>GY+'+K\
MWW8'\3AK!J?-QO3\ECEU^;[L#^)PU@U/FXWI^2QR[_-]V!_% :PC4^;C>GY+
M'+O\W[8'\4!K ?-QO3\ECEW^;]L#^* U@/FXWI^2QR[_ #?M@?Q0&L!\W&]/
MR6.7?YOVP/XH#6 ^;C>GY+'+O\W[8'\4!K ?-QO3\ECEW^;]L#^* U@/FXWI
M^2QR[_-^V!_% :P'S<;T_)8Y=_F_; _B@-8#YN-Z?DL<N_S?M@?Q0&L!\W&]
M/R6.7?YOVP/XH#6 ^;C>GY+'+O\ -^V!_% :P'S<;T_)8Y=_F_; _B@-8#YN
M-Z?DL<N_S?M@?Q0&L!\W&]/R6.7?YOVP/XH#6 ^;?>9__$K\N_S?=@?Q.&L#
M\^;?>?Y*_+K\WW/_ .)PU@ZGS;[S_)7Y=?F^Y_\ Q.&L'4^;?>?Y*_+K\WW/
M_P")PU@ZGS;[S_)7Y=?F^Y__ !.&L'4^;?>?Y*_+K\WW/_XG#6#J?-OO/\E?
MEU^;[G_\3AK!U/FWWG^2ORZ_-]S_ /B<-8.I\V^\_P E?EU^;[G_ /$X:P=3
MYM]Y_DK\NOS?<_\ XG#6#JUM*TMR4N;E=Q:<5>5;#<-#\.BKV=#;#?*'%>4D
MY,Z2\J@0E=E8>&DE$@NQEI)(2I1FM2J9G5.KZ_F2Y"_DL\L?P!;"_B,0:GS)
M<A?R6>6/X MA?Q&!J?,ER%_)9Y8_@"V%_$8&I\R7(7\EGEC^ +87\1@:GS)<
MA?R6>6/X MA?Q&!J?,ER%_)9Y8_@"V%_$8&I\R7(7\EGEC^ +87\1@:GS)<A
M?R6>6/X MA?Q&!J?,ER%_)9Y8_@"V%_$8&I\R7(7\EGEC^ +87\1@:GS)<A?
MR6>6/X MA?Q&!J?,ER%_)9Y8_@"V%_$8&I\R7(7\EGEC^ +87\1@:O8SHOD=
M*>9BP^*'+F;+DO-1XL2+Q^V&])E2'EI:9CQV4T?<Z^\XHDI27I4HR(O2!JF-
MH#RAO,0Y)6U8RC3%OQOP.7(91<;$Y!=F+6]7"6EMV0JLU:HO?Z?;)C*/P$.P
MF8:WNC3LB/\ &6D:NXMP)X Z8\OS4[^O=8^T,CRG)Y,2ZVEM/(T-%E6QLFCQ
MU,HF2VVENLTU!6^.ZFMJV5N-0FW5FMQ^2[(DO$)S@        -<TFH=7XYL#
M*-K46!8O5;+S:''K\MSN'41&LJR*OB(@MQ8-M=$V<Z7#C-U<9*&E+-"4QVR(
MB)"2(-C
M
M       ^5<MM)]J#):B^'H?Q2/\ 4Z_5,!YM]Z_C'U+ZI'^L?Z@#W@
M
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MN_L3^,7PI/H2B_T/JD ]P
M
M
M                             #CYUI"KD]9+R4K41FAE/13SG_D4=>I%
M^N?1/ZX#'D64ZX<-N.V;;)&75*>O0B^H;SOH^L70OUC,!D46"EDB-P_$<^KZ
M.B"/X?07U?ZY_P"D ^\
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MTZ3:/CX5U]DVUCKHG!D>$X[=5[L1JN@5LE*?[DFP8;$=R.XG]AW)82T3S!_
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MJN^'XI_5^I_7^R.K,3'278B8GP8_)K_A]'ZOU/U>OV2$#@)-?\/H_J]/3_Q
M' 2:_P"'T$?^A^I_XQ . DU_P_%_J+_SH#%;2@@SD&W.@QIC9=?B28[3Z2_K
M$ZE1$?Q1S8=QN-O;S;>]Z6]]9F/X''DQ8LL>7+6MH^,1/\+6EIJ[%Y1J4B"Y
M!6?PKA/NM%_Y5EPWHZ?@/X$$+WM^Z.8P1I.2,E?[NL3^F-)_2MV7A>/R]8I-
M9_N9F/T=8_0PR1JE$<U' O)T4NI]"<:0X?U/A-EV)U,BZ_4(7&.[[Y(TW>UQ
M9/RZ?PQ9TYX"M?\ $9KT_)K_  35QKNOK-!=#R62O_R41P_U/JJL%']41_I/
ML-=?ZOQQ^%HC^#&G^I=S[=U?_<S_ ,-\*\&=+_9[>8]Z/226_"(^GZRGGB_4
M".Z<4?XK:8:S\>O_ -&%$\'?_C,][1\.G]F7S'B4%CTFEY\R^J^X?I_T&R;(
M_P#1(5_Z2[[+'EK-,=?[FO\ 'JH_JC;TZSYK3\9_BT>AVK;;(TMM);+]1"22
M1]/U2(BZGZ!QQOLN6?-EM-K?&=46VM:1I6(B/@XNKQJ\S#)J;"\/IY^1Y1D-
MG$IZ>FJ8SDNPLK2<\EB+7PX[1&IU]UY9$?U$_5,B(^F<=K\)R7-[W!M-CAR9
M]_N,E:8<5(FU\E[3I72(]\^'Y_#JQSFN2V7%[3+N][EIBV>&DWR9+3I6E:QK
M,S/PCQ_-XNY=P#X=U/#[3$?'IOJ5CM',U0L@VAD$4D.-.6[<=2(&,5DKL2Z]
MC^*-2'6F%*_V>0[(D$ELG_#1]FO0WTFVOI/VA789O)D[EW?ER[S+7K$WB/EP
MTGQG%@B9K69_6M;)DTKY_+'S(]6?47<>HG<D[S%YJ<'MM<>UQSXQ37YLMH\(
MR99B)M_:UBE-9\GFF<X]I>6@                  _%))1&2B(R/X2,!PDV
MO>+]UB*,U)^,2.O19'Z?2VKT=?ZWP@.-CY)ZNX;%DA2>T^TWB09+1^L\R1$K
MT?5,BZ_K& RIEYJ0VEUAQ#K2RZI6VHE)/_1+ZI?5+Z@#V
M
M
M                                                 ]$F5&AL.29;
M[,:.RDUNOON)::;27PJ6M9DE) -36^S$27C@8RTN0M:O"*>MI2C6LSZ$4**:
M36LU'\"EEZ?J)^ P'*4F*6$M13[]YU*G#[SCJ<-<ISKT,O'=ZJ)I/[4C-73_
M %I@-CL,,QFTLL-I:;3\"4%T+^N?U5*/ZIGZ3 >T
M
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M)NN^]S;A>$M?%VEBO[=:WW-HGIDR1XQCB>N/'/PO>//Y:X[6ALZ\%
M               !Q=E40[1LT2$&EPBZ(?;Z)=0?U/3TZ+27ZBNI?U@&K;*/
MDF&NKG0EG(@=>KBT(4['4GT>B9&ZF;)^CIWET_4)?4^@#)\<V'2W:VX<EQ%9
M9K,D)CON%X,E?H+^Y9!]J%*49^AM71?7T%W?" S\
M
M
M                                        !I[/=TXIA:GJYEY%YD*.
MJ#JH+R#;B.=.I>TYA=[<3H1_[&1+>^#JDB/N :CJ&-B;AE(L9[AU] ETU-.K
M;6Q4QR(SZIKX??XMB^DCZ>(9J])&E3B?00"2.,X938LRDH31OS#1VO6,GM7)
M<Z_LB1T(D1VS_P!:@BZE\)F?I 98
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M!E0
M
M                                                          ,*
MSG8F&ZWJ%7697L.FB&:D1FG5FY.L'TI-7JU; :)<N=(,OA)M)DDOC*-*2,R"
M"F0<B=C;JN%8AJ:DM*NKD=Z#.&:/>";%5\4Y%G9(<*'00C+T*)#J23UZ*?41
M]I!OK5_&VMQY$>USI]F_N>B72J6C6JEA.F9*Z/J7VNVSZ3+XW>26>IF78OH2
MC"4B$(:0AII"&VVT)0VVA)(0A"")*$(0DB2E"4ET(B]!$ \@
M
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M.K5'DN3Y'F-[?D>5SY=QOLLZVR9+3:TS\9G7I'A$>$1TB(AE N3H@
M                     #A+_'*3**]RKOJZ/90G/3X;Z3);2_@)V,^@TOQG
MR+X%MJ2KIZ.O0S 0EV!HC/M?SE9CJ6SL[!$,UOE"B.=N10FR4E:FFV6TDS?1
M%=O1;1([UET2;3A=3 ??K+F/32)#6.;793CUFA?JI9,PPZFJ=?2HFO#N(*4*
M?IY'?Z%N))4<CZFHF4D F]$EQ+"+'G0)4>;"ELMR(LR(\W)BR8[J26T_'D,J
M6T\RX@R-*DF:3(^I& ^@
M
M
M          >B5*C08S\R;)8APXK+DB3*E/-QXT9AI)K=>??=4AIEEM!&:E*,
MB(BZF8"M;>GF(XCC[\G$](M1LYR$U*B.Y<XEQS%*]]?5HO8[39HD9/+0OKVK
M3X<+KVJ2N0DS0 P35O&+<N]+9O8V^KV[HZ^>3<AN/9]IY;9Q%]'&H\&J<24/
M$JPB6?8AQI*D? B-VJ)9!9YA6!8EKRG;HL/I(E- 3VJ=\$E.2IKR4]OK-A->
M4Y+G2#(^G>ZM1I+T%T3T(!EX
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MWW+;C-N=Y;QOEO:]I_PK3,Z>Z/"/8RH7-T
M         1[W)QNP'<$:1*E,'CN6&WTCY34,MID..)(_#3<0NK<>X8+T$9K-
M#Y)(DH=27H 5MVEOR7X07'B.->\6M9,X^A**398/9DXZLR2AXB*7B%Y)2HS[
M?W$W7"Z])*$>D+ M"<N]3;[0S5U-DG&LZ\)2Y6#7TAIJS<-M*E/.44PTLQ<B
MBH2A2C-CI(0V7<ZRT73J$I@
M
M
M          0\Y,\X=&<7XCL'*[U.1Y^XP3M;K7&'XLS)7#>;4N+)NC4[ZMC-
M4Z9$?CRS2XM'53#3YI-("H]C.N8WF1Y$_74$!6(ZBB6!-R8L21-J-<TK9+)3
M?O#<K0<_.;YA"$*-EMM]3;A^(U&C-J,R"VSCGPIU9H!B%;*:]^=A-)0MW,[R
M(VA,!_M22_=FE-V3%HVR41FEWN>F=%&1O]A]A!,<
M
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MFY%EM,R&R41J01&74-A@
M
M
M   K&\S3/N8^%X)@E9Q3I9,YG/<@DX9EUSB5-/NMET<^RCI5CR<?\(GH5'3V
M33<M$JT-HGX+S;!H>8[^\PBEQ-\HN6J7'VAS$O9.2Y+92#N']8P+N18)5.D&
MI]Y_86:QY;DJ\L7'W#4]&KWO!-:2-<R0E:VB"\^AH*/%J:NQW&J>LH*&GBMP
MJJFIH,:MJZZ(UU\.-"@Q&VHT=E/4S[4)(NIF?PF Y<
M
M
M                :.WKQRU!R.QA6+[6Q*)=MM(=]D7D?I RC'7W4J+UFAOF
M$^N0C)9DM3*C<BOJ2GQFG$D1 .OIM_A1S+X Y?+W/Q3RS)\[PF.I+D][%X'K
MV2QJM#CRDUNPM=(:FP,MI8S+IF<R.Q(::/N?4U"-*% .QII^QV1;ZMP&UV_4
MTE!LZSQ:HGYO1XXJ2JGI[^9%1(F5D7UM^6\ER";A-O))YYM+Z5DVXX@DK4&R
M
M
M
M
M
M
M
M      !Q]M;55!56=[>V=?2TE+7S;:YN;:;&KJJIJJZ,Y,L+.SL)CC,2!7P(
MC*W7GG5H;:;0:E&22,P'&XIE^)YW1P\HP?*,=S+&K!4E$#(<4NZW(:.<N%*>
MA3$P[:HDS($E42;'<9=)#BC;=0I"NBDF1!D0#"\6V1KO.;#(JG"<]PO,;3#Y
MC==EM;BV4T>06&+6#ST^,U!R*'4SI<BDF.R*J4VEJ2EI:EQG4D75M9$&:
M  ,/PG8> ;*JI%[KG.,/S^DB6#M3*N<)R:ERJJC6K$:),?K)%A139\1FP9B3
MV'5LJ63B6WFU&7:M)F&8              ##\DV'@&&VN,467YQA^*W>;6!U
M.&4V29-2T=KEUJ4FOAG68Q7V<V++O[ I=M%:-F(AUSQ)+2>G<X@C#,
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M'DK6]?-2U;1YJQK6T6CI,2YX5K:
M
M        ( >;%_FLO,L_R .9'_1UV, _G^>0=YE'(GR@:30F4<H:Z^MO*FYZ
M9-F=7C^>1G+>[I= ;DP;-+3!,ERJ,RS DE52G"HBDY%0L)-RUHW8UI#6]*KI
M,)T/Z=U'>4N34M/DF-W%7D..Y#5U]Y07]'81+:EO*6VB,SZJXI[6 ](@V579
M09#;T>0RXMIYI:5H4:3(S#IK?1;/\?KZ1+_E?Z\_YY^=H#MZZ\W)J';OO'\T
M^U=;[/\ <ZX7CV7?-YG.,9K[K7[?B>)1Y'[MVEE[#N&_!7W1I7A/%VGU3Z#
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MN(V].:XK8;?NG!N(M;>[>ODMFP_3M7Z62MO-?I;RVB?JVKTF*TI[9-C89XT
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MO,Q6)V^"E9GS0["XSQ\P@
M
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MN(S4V&,YOCE/E%'+2:>YRNNH+,^.A]"%*\&6PA[PWFC/N:>2I"B)23(!F(
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MM6T>R8ES0K=
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MWWT?L\];4S8\=OVT5IN+6C77+DS1TTA9F,B:D@
M
M                                                     .N#R6X%
M<L=@?26_+V\P+$=4^U^(NCN(&:ZMVEMKWYUM ]U\[M\4YPUM?1>X=GF,+9MW
MZQ-W!CB/6JZEEPT>T>JG23'E&R'8^                             <=
M)LF(LAJ,XI)..D@TD9^D^]Q3:>A?KJ2 Y$
M
M
M
M
M                                                         $4-
MP;"+&]NX/CAO$W[5BXTYV&OIW>O9/90/@^KU\#H E>
M
M
M
M
M
M    /!;K;:FD+<0A3RS:92M:4J><)MQXVVB,R-Q9,LK7T+J?:DS^ C 4Q<X]
MB+QKF]QYQLGS;*VI]3N&V1]"5Z]MS+(!]2^#T^!T_P! !<\:T$M+9K23BDK6
ME!J+O4ALT)6M*>O<:4*<21G\!&HOU2 >0
M
M
M
M
M                                                     "/G*?3\
MO>NAMB:ZIK&72Y;/I_:^ W]?.=J[&AV#C<AJ_P ,M(5K'>CR:Q3=_7L-NO-.
M-K*.XX1*+J8#I=9]RNW]FNR->9]LO(7,@V/IF'CN-TUI?UK;5FHL%RZVR>L8
MRMEE,15O91+BS>:D.O$F0^A!$\I3A*6H.RSY3U+M38.O<TY;;YRN]S;8N[+9
M='BUA?.-^'3:TPR;+BIC8[61VXM?C57>9@N<MR%#CL17$08[Y),UF8"V\
M
M
M
M
M
M                   =1GS&^&U]!\P"GQ#7]:;5=RKR"FR3%'$M=\*#D^47
M":O/TR#2;9)9K+\WK>3^Q0Q#G(^-T29D':SUU@F/ZNP+#=<8I%3#QO!L9I<6
MIF$H0A10*2 Q 8=?-M*4N2Y*6/$></XSKRU+49J49@,S
M
M
M
M
M
M      &"Y#K;"LJS'7^?7U%$L,MU=)R25@UR\GK*H7<NI%X]D/JI_ 2;.J43
M;A?M$G]0!G0
M
M
M
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MF-@Z(P(\BLZB5C=V]ED=3V\6I/JS4B HDURT>)U>)386S@
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M849SBL7L;R"!(>K<BQR1-]4KU2UT]Q$>90^<>/ZRRE#R6TH<20#>@
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M'X3&KYL\OQFYX7E=UPV]\O[YM-QDPY/+.M?/BO-+>6>FL>:LZ3I&L.<%:W@
M
M                                                 KJ\V'G#5^79
MP Y'<J7I,%&6X7A,BCU+73VTR6KO<N:N(Q;6->N IMT[&#%RFS8G3VB2?2LA
MR7%&E"%*(.A7D/E);EXG>2OQ/\YS"%W!<\=8\D,?YX9_D-BJ=/R#YB=GWN()
MUXFZ:?;5-R=S'[:BQW+)[<M!DQ"RJ_\ 6%J90HU!_19X?\FL"YF<7]%<I=9N
M]V&[QUOCF>5\-;I/2:&?91";R/$[%U*$(7<8;DL>94S>TNSUN&YVF:>AF'7E
MP3Z2%N??FT>8'&[BQY6.W.0')3C9NO*M5XWB>#[BAR->7F(XAE&:XE;;<VUL
M^_U5BF-Z9AO6>,1TU5";ES,NGY+S#<I@HQR' ]VC/I-1[,@;,T%D_EV\D:_S
M0==9\6N(' 3"'7\JLLUL6HUS+M\P7M:;B-+5:\U]AL:E\;(;"WKE)KF)\-Z&
M=I&=<D,A(/R^?//SOD+S>OO+@YR\)<RX%<NG<1L\\UEB]QGD;9.+;,HJ>JE9
M'9UU?=1L9QLH]LUBM=.LH<J&=I46,6JGEZU&D,-QGPVUG'/?4.,^?-IS@,_P
MPUO;;MV'Q4MLVA<XG;G&&-IXO@T6OVAEKNHXM6O4TO+9>)RK' 5K4VC,(T/Q
MYQO'#-39DZ$7MQ_2(\NP#S$>4/ENZK\N/<7);=>E8M#'U2UIW9L>QE[;O;C'
ML%R>?)SNML-7Q:C0^N<9K,P65AD<JVO6F'66$G&Z235'#/\ @SYZ6Q-L<VX'
MES>8-P=S;R_>5N;8K,S32];=9S'V/@FV*B!67-U)AU>21<;H(D.<]5XU:'!E
M17[2KGR:J7".3'L&VXCP;Z\TOSMM,^6[E^M>/V*ZDV)R^YK;J;B/ZJXHZ94X
MG*K*#9RYE=26N6746DRJ;CE?D5K7OQ:YF%47-I,<9<6B%ZNVX\D*Y*#Z2EO'
MCMLW7F)^;3Y66]. NK-JW#-#BG(5%];[$P*LMY"4GZGDM?)U_C#:H];'0Y+L
M/9EG86\2(1.>RG$$:S#M>5EG6W=;7W--80;>GMX,2SJ;:LEQY];9UL^.W+@V
M%?.B..Q9L&;%=0XTZVM3;C:B4DS(R,!"WS#.;N/>7YQIO>0-QJW9&\+OWHP_
M7>NM.:FJG;?/-F;*V!;MT>(8E3,,QIKD?UZ8M2WGD1Y3R&6E$Q'DOFTPX%'^
M.?2'N2>C]_Z UGYHGE8;*X&:IY3Y,QB^I=TJV] VO7T5Q92J^)6U>?4<# \=
M5$5#>O816QG)A6U:RM3ZJEQ!+2T%OOF@>:+QS\J7CZUO/?:KS(;+)KSW0U5J
M?"R@/YYM#,3B+FN5U,S8RHL2NHZ:(DG[6UD*]7@,K;227I4B)%D!3]I[S[O,
M7N<]TW8<A?(GY,Z0XW[MV%@N"P-Q,9?E>0SM9Q,_R6MQFHS#8N/6^C\4]EXR
MU(M&G79%FN@:\%1*:6ZI;:' F[RJY[ZATUYT?E_\,+[ACK?96X]_ZGS6YP/F
M-;W.,0MF:&H)4;:[>0X?B,&;J;(<IDT^3L:^<;FHAY33,OHL5$ZRX39DZ'%^
M9KYXF(<'=YX!PMX]<<MD<Z>>6SJ>+D%!QWU5.54Q<6H+!N=(@6N?Y7$H,OFU
M4V365LBS171JN0XW4QU3)SU=#>BR7PZSWF-<ON;_ "?\T_Z/G1<W/+NRC@;E
M&L^?>%3</EV&U:C;.)[@KL[Y'</TVONU<T..5=966FOSPZ(FSB%-GO=MQ%<6
M4=*T)6']#P!3YYNGFVX_Y76,\?Z*AT5F')[DGRSV1(U9QQT)A]VWBTC-\D@3
M,5J[-V;DJJ+*9,1N/<YY20(L2)63IEA86C#*$-MF[(9# > GFA<QM]<E)7%#
MG%Y7VWN#>?3=:Y%LW!MC/9U VKI?.H.,V>/Q+;&8N9UN,T5+"RZ)%R1E[U*'
M87#W8TXI]$4NTC#1/.+S]KC4O+7)>!/E\<(]J>8YRGUQ5E9[IK]>WC^,ZYT^
M9IK77*N[R:MQ+-W[:XJ2LX\>V-QNJJZR?,8A*GNV!28,<-O>6+YVE=S>WEL;
MAAR5XP;&X(\ZM68ZC+K?0>SK-V[A9IB328?KN18%D<[&L-L);T6/81ISM>_7
M)[JV6W)A2[&.U*?8##>:/GJS-7\KKO@-Y?O#?9GF-\O\*ISMMM8U@&40L!U=
MI9#APFTP\XV-,H<FC'<5:[.*5BTMF!60GIC$-RR3/4]%8#0G%[SS^<68>:'Q
MJ\L_FEY:M/Q S3D3@^?[(KK=[D%7[(N:_",2UMNK,*>_B5.-XJNEF1[_ ";2
ML^J-MVRCOL$E;QH,B;)P+"--^:W\[?G)<L?*3^87W?\ Q7^/^.;T_& ^='VK
M[\>\%%QINO=;YJ?FZK?=GU3\8CPO7O>2P\3V/W>KI];[8P?G._S6_P 2;G#Y
M=/#/YA?G,_'\V!.P7YR/G1]S/FF]2RW!<6]J>Y_S=97[]^+[Z^/X'M2F[?5N
MSQ#\3O0&%^:CYU6O?+FSC4W''7.B-D<S.;>^(9V^KN+>H7GHM\_CGK<^!'R7
M*[B!CV96]17VTNGL$5[,&EM),KV9+6XB/'95( 16XI?2 -E6G+/57"WS,_+[
MVEY<VU.0CQ5W'K,<JRI[,M9;-R9^4W!A8BNUFX=B'LBVL;23&KHKL.1<MJLY
ML:/*3"-]E3@93S4^D!.\/_,AG^714\&=N<CLUGZDQ[.-;S](9DK(-@[%SS*Z
MIVTI\ AZF/7*H]+1P8T61*MLB?R-;-95Q)$HXCIMDRL,4T#Y^6[:?FOJ'A+Y
MF_ESYYY>^7\G+1BBXV9U*VG6;@P?-<LM+.'346$6ES3XEC]4=A97=E#K$S:R
M7/4S:64-F9"A-/ID$$U?-D\Y?2'E74FM,:M=?9MR*Y-[WG.UFBN,>K'6T9EF
MKZ)L:I9L[JP;KK^;C..V%[,:K83L>KM;&RL5FS"@R? E*CA$KAYYSG/K:/)O
M2FA.9?DU;_X@89R%M+.IP3>DK*;_ "O"L6MXN*7>65M!L=NTU5BD+'K2WC4J
MX[34FQAV)R5$E->KM<-L,T\Q'SW&>+_**%P'X9<1=H>85S<+'X>3YMJW65J_
M08QJ6EM8$.TKW\ZR6NQ;-K%-HBHM8-C)C^H1:^'7SXRY-E'<>0V8>WRZO/-F
M\H.4MIP&YI</ME>7QS73BLG-L$UEL.[>R7&=NXO7P95K8RL)R*=BV&3BMF:F
MNFS6HR8DV#*A5LQ;-@X[&=80&YN,/FK[-Y!>:ER[\NN]X5;0UC@?&K%Y][1<
ME+NPM'J'-'JNXQ.JA+LZ.5AM734E/LB-DSUAC#T:[L'YL"M6ZI@R=>]1"Y\
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MAAV6#9G'.)DN-6^+93=XA<5MFPMJ.ZA2+2A>4T;C3+JF%(-;;:S4A(;E
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MS7R8HMY\N.F*/J3:6,E:=@
M
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MZ'L-*FWWD.M+)1.+Z]QAV$$I))$E)$E*2)*4I(B))$70B(B]!$1 /T
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MBBZI9;?F274]&TG^S<))?"0"[3N+J2>I=QD:B3U+J9)-)*,B^$R2:BZ_J=2
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M:1?+3#D^G:M+1:;;C#6=;6IIV$QGCYB
M
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M2PU;28A<UK<%$;'&\78IJ;('LGH\HM+2KA1,1B,D:)+$I:.\UO*6HE)"8
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M:OF[(VL=8,UKLW&NY:_W,B-))"*&P/*9TEE^7YOD^,[8Y":KKMGVUK;['PW
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M60
M
M                  !7QL7RT>.NS_,5T+YGN23MD-\D>.FI[C36OX%9DU5%
MUF]B-Y5[GJ9KN0XN[C<FVL;@HN]KLT/-6<="5HC&;9DTLG0L'
M                                   $;=]<6-9\C,@U!DFP)&4,V&DL
MP+-\-3CUK#K8SMR4VCGDFZ;E5=BN="\?'V/B-J95VFLN[TD9!)(
M                                   !6UN7RH.&^Z,LLLWL<0R+!\AO
M)KUE?/ZYR(Z"ON+&2MUV5.?HY\&ZI(<F6\[WO*AQXWBN%WJZK4M2PWOQJX4\
M=^)S5D[I_"U0<@NHC<"[S*_LI>0999P6G4O%!.RFJ\"L@./MH<<C0&8D=YQM
M"W$*4A!D$K@
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MR99RS2U-=_GTK&*LZ1C^;Y9\TK!<WC(
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MC 9Q3WE+D,1Z?07%7>08]I>4;\VGL(EE$9NL9NK#&\DIWI,)YYENTQ[(JF5
MG1S,G8DV,ZPZE#K:TD'*      #BZ^\I;>3=0ZFXJ[.7CEHFCR&+7V$2;)H;
MI=55WJ*>Z8C/.NU=HNDNX4PH[Y-NG%F,.]OANMJ4'*
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MN+_(\@U/B5M=W=K.?4M^996MG+=??=69K<=<4HSZF E$
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M)"7ICJR+JM74.T,
M
M                                                         /Y]
MGG@\7.>?E&^:#<>>-P=KWLMU%L>57V>XXS=-99-0X!=SL?H<4S_"MU4$.0U8
M/:=VRY3,V,6Z9D1TUMP^;!.P)4>J?E!V+?*.^D%<-O-6A4^O:R6YHCEFFG<F
MWW'7.K-B0]?.UT-^;<V.G,S)BOK]F4<&'%=D.LDQ!NXD=IQV1 1';*0L-<_2
M.>=7/#AOPVS*5PFTEEWA6&*E,W'S&;ML-AXYQQPJ\OH^&L,8=46&1L99;[:R
M&ULF6H\UBM=C4,:0B4VIR6MM<,.N7Y1G-_Z2CK[R]]"XKP>\O;CYR*XQ0YFY
M+#7>Z-G-W5GGF=6&1;ZVCD>QIV1V'XWVM%39E=M*VNX*'54D-:V8J#4;ZNLE
MX+I/,A\UWSA;7G;N/R]O*(X.5.S;OCW!UN6WN0.=UJ+K&F;W9^L,)VS15%3=
MY/ENMM/Z\5#H,U88-&06=C,LW&GUQX[#3/B.!H;@!Y^/F):U\Q#7_EC^<]QN
MP_5&T-RS*.@U?L'!ZR#1V,7*\QF3H&"%D*:#.,TUMGV!YS=U[M- M\:?:]4M
M$DVZF41OKBA=-YZ_F%[H\L/@)D'*C0F,:OR[853M#6N$QZ?;U+E=_AJZK,;&
M;#LY#U?AF:X!=JL&&HZ386FQ2VE1GWMK+T$%-3?G#^=EY@/%_4NQO*;X;ZVS
M&;B>LL*NN5^^,E9H,>UW>;[L</J,GS?17&# ]M[8J;K):W7KMFJ'<6#LFZ>.
MS2J RXTMEJ18!(#<'FE><?1>2RKE*YY><K7_ #(ML5W5=9[;L+AX[@W&K3VG
MX5@]DW(?8&IMPW%=G=/FTJNJ+&30X7_[HFC;AHLILA;+C=/(#KW^2USM^D5X
M_P 5\^LN"?#34',G6&><D-H;"SW>6])%[D6Q;_=>456&2,\CV]T[RIU)(L.V
M.S E&Z[5N.*=EN&<AS]BV']&;2=ULC)-,ZCR+<F.5N'[?OM8X%=;5Q&F2I-/
MBVR+3%:F=G..525V^0K36TF3ORHS!'/G&332>LA[_9%!LX
M                                         '1P^EW\:,TTUFG"7S@M
M Q55&S^/>RL1USGV0P8+SY0IF.Y*YM'CUF-TB$Y'\.MHLPK;FHF2'E=91VU;
M$\1!):0H.R!L+S2]08UY2%KYJU.J&Y@TKC)#W-BN-S)OB^-LC)*N-2XOJ.PF
MM--?]>"W!9,8O+<2@DM2TN*Z=J>H#JX_1IO*[@\RN"OF/<H^5"IEWDWF51]G
M\?J+.+>,B=?LXPFSGY!L7;54\\A+<NTN.0$R/*0:UJ)-MA+:S21>E0; ^B%<
ME,UTQGW-[R@]\N^QMC:)V)EFSL'H)TAPG(-OC&1QM4<@L2K3GL1)"H=7DE;1
MV<..A/<Z4VQD^&@B<48:=\Z&QF^<=](*X>>51B4V=9Z.XR3H:MZKJ9CK<)J;
M;U];MSD79>T&3;AQIU1J/'*G&X#CIK7$R)Q^.D_%?-DPO,\VKS]M4>6EGN%<
M+N-NC+CE=S>RROQFJP_C]K]J57XQKMC)8\2'KNIR9K%ZBYO[+),BC28[M+B5
M' .9+K^Q;TBN:D07)05;Y[YZ'TC3B;CB]_<RO)UUC%XRUJO:F33-?56S,>R?
M$\:6XEPIF9Y9"W#O-C F8[#[33D^ZQ>%$3(/M4EM2B;2': \M[S(>./FA\<:
MKD;QRM;1%:BT?Q7/\ RIB+!SO5V=P8L6;.Q++8,*5.@K<7!G,2X4V(^_#G0W
MT.-K)9.M-!USJGZ2ER=HO-'YY<$LCXXZUW!#T_9[?U?PMU?I'%L^J=\[]W_C
MNY,"P?7&%YGFN2[-R;7U+BJ,"M,AR'*;=%'6LUU;2/3&^A,^J2 D7P=YD_2/
MF?,'USQ]\P+@SIZOX_;FJ<MS*RV1KCP$8II#%\;KW)#Q1]J:_P XVQC4NZC6
M\R'7-8[D*$VUS(D-+C2V(OB2R#5'.+Z0)R\VISAR/RU/)'XX8KR1W?K^5DE#
MMS=&?19=AA&+9!B=BFHS5O&HKN38/B=)C.O+CLKIN59):'53KAXH4.&]UB2)
MP4(_2%,O\_@^&^K,(\U/6?&I''V3R5P[*<.VQI:3C"LBC;F@ZLW)6T6OK6+0
MYXX\BIL<)N,@G..*QU32GZ]HDV*#(V'P[=.\O,DH/*K\BGBMRILL)>V/D[7%
MWB3KG5^#^NJJZO(-DYCI7&UT:<DMFFWI%;C-17U$VPFJ90J0^S#..T:''D.(
M"H37'F#?2P[C1F"<\ZSAUQ6W?QZV1AM+MRFTEA%&P>P96I<IJ(V0T.0XIB-)
MMYW:\UZ\QZ8S*K(K,C(+CMD-K>KG4DML@[D&A=BVNX-&:8VU>XK(P6[VCJ?7
M6Q;G"9;TF3*PZUS;#Z?);#%9,B9 JI;\C'I=FN(M;L6,XI3)FIIM1F@@VP
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MBZM+1MTO#=@2'TFR02?^A4_YK+?G^7_M/_HZ\50';]
M
M
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MKL8!2!]#;_S2&2_Y8&Y/[Q]/@.U\
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MLS>K;BM>-<6=$<Z.Q)C+K+A$M"B(-P
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MX7T*G_-9;\_R_P#:?_1UXJ@.WZ
M
M
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M89NK7,\DLZ2HIRQ>NJZ'U7'\1F5T#K&:4DUQC,WI"^Z0Z$N@
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MF,+8&%7EM>3MB<B]*;#Q5N;B%1=3,GI$SL6PRP?6J7%92PMI+;AI<6A)AVL
M'3QY/^1YYA?#+G!M/S$/(OW1K_%+7>4B^MMT<3MK/0Z[$[NVR>T<R'(HF*NW
MD27@UYB]MD[J[*' LGJ*7C4EQU%=8'%=*,P$"/,EX;?2F_-0T;BG'SDUQ;XD
MP,#P[;%%N2I>U?LG6&*WZLNQ[$,ZPF W,L+?>>3QGJ<Z;8<\W&4QT+4\32B<
M(D*2L.QMRSXF>8_:>53Q U#P2VO1Z#YN\8\7XQV\B1:Y4Q#Q^^F:HTM+P+8&
ML)-FQ2Y=AF30[JQLS2W&MXLC'IZHJ/'<;0:'T!0+R[PWZ5'YHV@U>7ER#X-<
M:--:^S+(,-/;W(*+EN"5=?;U^ 9719516\Z=7[VV>W#AKR6EA3IS>*4$FPF&
MT;<>/'B^LL&';]\O/B)5\"^%/'+B)59&YF"-(:[AXU:Y6N.Y#;R3*;"?89+F
M=Y"@O/2'JZKL\NO)KT.,MQQ4:*MMHUJ-!J,)F
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M(>OL%LFCCK=2^A+*5J22'$&H.Q,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                    J!\^KE'O
M;A=Y3W*SDOQHSGYM=VZU^8SW*S7W9P[,?8OOCR2T[@&1_P#N<S_'LJQ*Q]HX
MEE4^)_=<!_P?'\5KL>0VX@.CEQ?\U/Z6ES3P&WVEQ7V!M#=^O:#,+# +C*\)
MXK\*I557YE5TN/Y%88](<F:/ANE81*3*JZ2M))-/ARVSZ]3,B"1_XR_TVG_M
M<Y ?FF\(/Z&@'?)X'7'(G(.&'&"[Y<,VC')VUTG@$[?+-W1XYC5NUM*101',
MP198_B%?58O33$VYN>)'@1F(K2OBMH2DB(!+,      =<'Z4!SUY8^7;P%U%
MNOAUM;YG]FY1R_P'5M[DON-K;8'KV"7>E]_Y99T7L;:6'9MC\;UG(,)JY'K3
M,1N8CU7L0ZEMQU#@3C\MCE_G6PO*#X_\VN3^36FP,U<XR7V[=PY-1XKC57=9
M(6(1,GO+V33XAA]9B^,-VC]11&B/$AQH;+CI)21)-1J 1<\E7S[M>><ADW(3
M"Z+COF&@<FT:W09#":M\X@;&ILQP'*+.UJ:FXD7$#%,0]ULL9F5?]U4ZF9K"
M&W4JCSY1(>\,+_@ !2C](0Y<<A>#WE<;JY&<7-@_-AN7$LPTS58]F/NIA&:^
MSX&5[4Q;&[]CW>V'C66XK+]?I;)YGN?@N+:[^]LT.$E1 ^CW\N.0O.'RN-*\
MC.4>P?G/W+EN8;FJLAS'W4PC"O:$#%-J93C= Q[O:\QK$L5B>H4M:RSW,06U
MN]G>X:W#4HPNN
M
M
M
M
M                !0#]*._S%'.;_O9O^F'Q] 0 ^A4_YK+?G^7_ +3_ .CK
MQ5 =OT!'/EKREU/PIX[;-Y1;REWD#5.I*NJM\QEXW2O9%=LP[C(Z;%82J^FC
MN,O3G%6U]')24J+M;-2O@2 J2L?I,7E+5/%^!RJL]TY5#Q;(,VRO7^%:U=P*
MR5N[.<APNMI;2^>Q_73,IU^)C,=J_CLE=VDFNIO6U>KJE)>-*%!AG"'Z45Y6
M?.+;V/:,H;_<7'W8V;74'&M?5_);#,1PVESS)+-26:O'J/+L#V)LS%*ZZMIB
MTQ84>WFUCD^:XW&C$\^ZTVL.Q8 H\Y9_2,/*0X<YY>:KV+R;CYMLO%["34Y3
MA^D\0RC:[F-6L&44*QJ+S*,;KG,!@7E5+2XU,KU6_K\-YEQMYEMQ)(,(B?\
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MKU?X/O*Y/KXT>I<\=Y#"/9DQN?(?E?'<+KWLM>@!NT
M              !AF?;#PG5V-3<PV!DM9BN-P#2A^SLW5(2M]Q*U,PX<9E#L
MRQL)!-J\./';=?<[3[4'T,!7]9>:=HQJ;*:HL&VWDM5 5_=M[ H**-")DB-:
MI+#,W(V99,DTE2B]91%5U2?4B+XP"3^B^6FD^0SKU=K_ "*2C)8L-RQF8CD-
M>Y49%'@M.,LNRT-=\FNL&&G)""6J))D$V:B[^WJ74)*@
M-);WY ZZX[8DUENPILPD3I9U]'14T9J=D&0V"6_%<BU4)Z1$8,H[/QG7GGF6
M&B-)*62EMI4'YH/>%5O[#9^8U.)9CAC-=D4O''ZG-:Z-6V;LB-5T]NF?$:C2
MY:7JR1$NVB0X9H4;B'"[>B24H/EWUR&POCM2XQ>YK691:1,KR>-B=<WBT*IF
MR6;&5$E3&WIJ+:[I&FX1-1%$:D+<<[C+H@RZF0;X
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MD>[E6;[Y>W&NI/0V$_%7T,^B>X-\
M
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M-J'B;3^.FXB3ZF;KKK<OV<EI$DE)<2W-=D)Z=I-*7\0!8\
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M&1XJB\P.&M>.Y; 15Y'428,W!ZR7#M("'Y!1GVY4)?:1J[C;-)J))F:2"WD
M
M
M   !0#]*._S%'.;_ +V;_IA\?0%6'T-_=^EM:^6/O2BV-M[5^ 7<OG?LZVBT
MV;9_BF*VLFJ?X_<8(;%G'K[VV@2WJ]Z7 ?:0\E!MJ<9<21]R%$0=LW\;+BQ^
M4OQ__#+KK^48"J3Z0_D^-9EY%_.?)L0R&CRO&[;7F O5>08W;0+VDLFF=\:S
MBNNU]M5R)4"8VU)86VI3;BB2XA23])&0"#GT-O\ S2&2_P"6!N3^\?3X#0'T
MVC_$%XH_Y7\?_F8VB NN\K[5NKMW>1APQU#NW'Z?*M0[(X$:TP[9%!?OKAU-
MCAUYK2)!O6Y=BS(AR:GPH#JW&YK#[$B$ZA+[+K3K:'$AT+O+TPGS"\OY@<KN
M/GT</EGO!/%#&+AK+;;)MZ66 :XQ6#67,]W'*?([##\D?SRNN;2T*F.- OJ_
M'ZW(K2LA-KFUU?X11T!VDO*7^CE;3XY\NE^8]YEG):'RQYA,2+6YQ6NJ;#+,
MOQ3&,QMZI5$6?Y'L'/X=+D6<Y)1X[(<@TT$J>NK*'HAV.;ZV(:H@8A]-6_S6
M6@_\O_5G_1UY5 +/O)@_S#/$+_) N_\ YUF #K!?0=/^53S$O\'_ !Q_OCV^
M [EVT"\N/S/*O>G";:LG3/(V;JK*I>.[BT5?6!1=DZRRJG3ZM&RB!6)D4VPL
M-E-LVAIK<HIEQT.(D.-QIJNYY #^?3YL_ K-OHT/-+C)RGX"\FLD+'-K6F:V
M^&8)E]FT>=X_"U[8X=*S#6VRV:5516[8TOF$7*(L=+KL2*Z:4+CR4')9CSY
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MU1:U]]4U=Y4R43*JYKH5K63&NOARJ^QC-3(<EON(C['XSR5%U+KT,!R(
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MUD1&XKJ&,Z%_SCW*_P#XE5/_ )C7@"S\
M
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MBUT.);2YN')QJ44J+,*4J>_)1E-\F6MY*21V$VUTZ=>I_  FB
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ML>JZR!2UM=3U<9N%65,&)65T-GN\*) @1VXL2,UW&I7AL1VDH3U,SZ$ ^X
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M1J7UFV>M?[KF^TYGMV5 \7U:&]X$3U>(:F^U?=U()6
M
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M^O-1U-[8LHC6.01\"Q:LQM60V,9MY]F+87[U>J8^TVM333KZDH^(1$ WX
M                      C5K3CE"UQN_;^Z6<KE6TG;7J_K&/NU+41BD]7D
M-OEX-BB?(<G=QM]/C,M=.H"2H
M                                        (YX3QTI<*W[LW?L7([2;
M;[,J(M1.H)$2(W6UC<4J(DO1)+9G*>6KV$CJ2_1^Z'^H0"1@
M
M
M
M
M
M                   -.;UW?BG'S )&QLSK\ALZ2-:5M2Y%QB)6S;4Y-JXM
MJ.M#%K;4L0V$*0?>9ODHB^ C ;/H[:-?TM1>PT/MQ+JKK[:*W)2VB2W&L8C4
MQA$A#3CS2'T-/$2R2M:25UZ&9>D!ANVMG4.FM=Y-LS)XEO/H<4BQ9=C$H8\*
M5;O-S+*%5M)A,6$^KAN+3(G(-1+D-D2",R,SZ$8<IKS.*G9>#8GL"BCV,2FS
M&AKLAK(ULU&8LV(5G'1)8:GLPY<^*U*0VLB6EMYU!'\"C^$!F0
M
M
M
M
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MX>C]V9=B^!870X_F>P:7&$)Q"LL:F!'9LT1+9Q]R#)1#,E$HY+T+XR?]:9+
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M$HCZ&9>D!E0
M
M
M
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M"N&[/LHN18U0ZGI(#5L[U]C7NRZ2!E"#L8B)1N]Z[7)JNA<2E752^]I)F9F
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MP&RP
M
M
M
M                                           0*S3AIG4O-<URO5'*
M/9>IH&P[BSOLHQ>- ]O5!VERX;ME)I$1L@QE%.\ZH_B/>&[*;+T>*9$0#=FE
M.,VO-+:EL=1PV7LKILF7:R<XF9&VT^[ETR]@LUEJJ?%07@,07:Z.B.W'1U)#
M2.JE+=4XXL(JQ_+TRK"YUK&TERMVIJ;"K6:]-<Q"''GV:(ZY!(2X4>QK<QQ=
MGQT-I\-N0N*N23:4$MQQ234H.?VKHFLT/PSY"TT;+LMSNZR:EF9)E.5YG8>T
M+:WNEIIZXWDJ,E.L1D1(+:4H<=?<+H?<XKZ@:,T#Q*VGLKC]KQUCEALC%]<9
MEBZ7[77$"I7*9CP)KTMF=2U=XK*(IPJB4GN)4<X;C*DK4E2%$HR 3UJN*NIZ
M/05SQVJ($^%AE_6RHUO9%):5DEC<2EL2#RB=8%'0Q*NFIT-AU'5DHZ$L-LI:
M)A"6B"/%AP6S[(-,GHS)^4.26F#5+<)O#JR)K7&*V/5HK9Z)=;&R1\[6;?95
M7UJ"4EAA%A7DA9-JZFAI#9!LC+.)=YG_ !R@Z!S;<<^\=K;'''J_,6L&HZDX
M%-BT"%755!$Q^NL&4+CH:AFXJ1)F292W7EF:S03;: EQCE.G'L?HJ!#ZI2*.
MFJZ=,E39-*D)K(3$)+ZFB6X3:GB9[C22CZ=>G4P$1KSB;D<'>.3[OT]NRUU1
M9Y[!9B9W1JPFCSB!<.-%#)4NM5>V#$:H?<7"0]U<C2U(?4X:#2TXIDP]&C>(
MV2:,VEG6>5&]<@OZ'8]RB^S'&KK"\;<NLDLV'+Z5'D7.8$\X:5)LLDER'#KZ
M^N-U:R)1]J>AACVT.#TS(]JWVW=0;SS;162YDV2<U;QR')LHMVX?@>.]'5#R
M3&9,$Y;D9#SJ'%RFO6"\1"4'Z &QLPXAX5LC1N-Z:V/DN59C88MZU,JMG64M
M#V<M7DV7,F2K1<V<5@4AF6<PV7H[QNI=80@C5XB&W4!H6'P'V?*BLXWEO-+<
M]]KY*/59&)P$6E._*J^I]*UZTFYO?PWHR6S[20[!=:21%T;(DD1!)S;/%G6.
MW];XEKF^1<5R-?0JV+@65T\UMC*\7<JH$*N8>B6#L=YI]$N/7,%*:6V:'C:0
MLNQUMIQL(N9?Y?FP<\HSQ;,.8.ULHQDGXSZ*7)*MR[C&N"9^HNR/7,M44F5'
M(_\ 95))1JZG\)@+',<ITX]C]%0(?5*11TU73IDJ;)I4A-9"8A)?4T2W";4\
M3/<:24?3KTZF PS<6L*C<^M,LUC>V%C556608\.38U)QO:$0XEA#LX[K!3&)
M,91>M04$M*D?&;-1$:3,E$$((/ S:,?'FM>O\Q]FGJE$1NI/"Z['45LKV"AM
MME5(S>GELQ#-<ME)M^#ZFJ.;1]BFE)ZDH)H8%@&M^.>KO=_&8S>.X3AM597E
MO82W/'EOIAQ%SKO(KR:EM*YM@\Q&4XZLDI2E"$MMH0TA#:0@7P9HI^ZMN;JY
MDY77FTK*KV7A^MV)3"4.0:*"Q"B29#1=RFU/0:&%7UA2&^O>XB8GN]*R 6G@
M-4;JU-5[LU[:Z_MKN^QMF?*J;*)>XU)9BW-5:45E&MZN9%>?9?07@SHB#41$
MA9IZDE:%=%D$0JO@?D-WD^'V>\>2.>[LQ7 [1FXQS#+BI74Q538SB%QU75F_
MDV0/VR32RA#R_"9?=02D^(E*U$ TSS&Q"TSSG)QPQ.DS"[P"VM\"FHK\PQQ:
MT7-%)B3<XGMRH?AR8:UDX<7PG$>*@G&G%),^A@-\XWP4>M,ZQ[/.0F\,RY!3
M,/?3*QBAO:IN@Q:%)0ZR^E<RG.ZR%$QHWXZ''6FUQFY*FT$^3K:3;4&Q]S\6
MYVPMLX7O37FT+#4NT,0JW*%5RWC$#,ZFWHUE9(*'+H;&SJHR7_"N)+2G%+=2
MIIQ/[F2VT.)#!ZCAOG%)O4M]0^2.1R,JM:F/39BY::[PZ;*NX"/4$28%.ZAR
M-28S7.1JJ.TRA-9*>82@S\9:E&8#)N0O##$-WY57;+H<OR74VVJJ.S%C9YB"
MU$_)9BLNL0W+*&Q,JI;LZ$PX;34F/,BO^!^Y+4M"6R;#Z=&\8\^UCG*\\V%R
M0V'NB>W16%%7U61-38%# ;L9$%]V:U73<GR5*9R$PB22VU-=26KKU 8;MO@M
M69?LF?M_46U\OT'L&\-Q>1V6(L.RJVYD2'6W9TUR!!NL:FL2[5:.Z812U1I+
MI$ZMGQ#<4X&7:2XFV>M<Y:V9L+>>R=UYM!J["GIY.4RY$:BJ(5LEI-CZE33;
M7(I+3[Y,))/9,0TDNO5M2NBDAIB1Y?F9Q::PU_B_+3:E-IRS0N%*UY85B+IP
MJ5[JA^FCW;>15,.) D,?N;C3=<EAU)J[VE$I1&$\M8:XQG4> XQKC#V'X^.X
MI7^H0"E.D_+D+=D/S9\^:\2&T.3;.QE/2'C0A"/%=5VI2GHD@SP
M
M
M
M
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M5I]NKZ$CT?N9?JF D8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M!DO*D1'BDM)6PEQQ 6@@
M
M
M
M
M                             #^3)J#B%IOGE]*1Y'<4>0,+(+'46U>?
M_F9>]L/%KY_&;Y[W&<Y0;(H?4;N,T\]"\/)L/A*=[4GXC*5MGT)9F [%'F%?
M0\^&T7CEM+8G"#-]U8!O'7N$Y%F6*X5GV8U&?:WV&]C-2]<OX?/*;C=;E6/W
M61,UZHT&Q;M5Q(LI\E/Q76O2V&*_0TO,3V]N#%-]\!=O9;<9O1Z(P_&-J\?)
M]VY(L;3$, FW[V*Y[KURZD...NXO3WMO22J*(X9J@IESF6U>K(CLQP[;OF%?
MX@G.+_(_Y+_\R^:@/XQW"?D5RCX3;?QWFUQC<R"GM="Y9BL+)LE9K;.PP&1&
MSHKKU76NT407(T>3B>T*O%[.(Y$>?8<D)C.+BNLRF&7FP_L->5WYE6C?--XK
M8KR0TV_['MDN(QC;VK;"8U*R34>SH4./(N<3MG$-L%8U<AJ0B946:&T-65:^
MTX:&7RD1HX6+@/Y@?)?_ ,,DQS__ * <3?[Q]- /Z?@"F+S]^>Q^7IY8V_-K
M8[=II]O['K6]"Z)6U.1!M&ME;1B3ZQ61T[IDMSVEKS"XUODC)$A1*>J$-J[2
M7W$'\NKA%L3D7Y5O(/@#YDDW#,@J=7YWEF79)A%BEM347;VJ<,RV;J#D/B-8
M3[D1AZ8Y26<R$VIPU,L29<221F:2[0_M#8%G.*;/P;"]E8'=0\DP?8>)XYG.
M&9%7+-ROO\4RVGAW^.W4%PR(W(=K46#+[2NA=4.$8#+
M
M
M
M
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M1%DXY$ML>R"M4M;U+E&-6T=Z!90G#-R+,CN-F9D1*,/YP?)?_P ,DQS_ /Z
M<3?[Q]- /Z?@#^;?]*%W_G?F-^;#QG\JK0$QRX:U!D&(ZW?B1UO.TLOD7R$D
MXU*OK2V5!0MN73ZTP!VF:D2%FLZET[E!^%T?[@["'GE^3Y@NQO)#I>/^@<92
M]EWET:YQ[8VAT-1>Z^R'']38@NKVS0.K9*3.L+K8F MV-JN.WXKUKDT.%W=R
MU=Q!IGZ(+Y@J.2/!/(.'N;7'K.T^%MQ'J\<1,E,*FWN@L^F6EM@TF,A1MRY/
MN-D;%I2/DE"VX5>BJ2;G5]*$AVY@        %;OF.[0V7K/%M3*UGF=MA=AD
MF;3J>PFU3C:%28ZJYDV&Y'B-.]S3+[G?T+H8#@_Q7^=GY9?_ /+;'_<P"7&2
MW?(#',TTEC&)X=CV:8-81O4=QYS9611+6F=A18;)V-7%7:P%]\I9//E_<L[Q
MU?N1DP?1Q02&   !QMQ<56/U5C>7EC"J*:HA2+&TM+&0U$@U\&(TIZ3+ER7E
M(:8CL-(-2E*,B(B ?9'D,RX[$J.LG8\EEJ0PX1&1.,O(2XTLB41*(EH41^DB
M,![@$1.5FS,CQFOQC",$FV$3,,JG'-4Y3K<19L4\ U(0TPMKHZTJSGF1$I)_
M['&=2?H4-7?N5]0N>[>V/'=G]EYL^/NKDLWU)G!,QFK@Q](BLUZQ.7)I&L3^
MKBR5GI+WOT.[-XCF=WO>Y>Y\>*_;^QQ>33+$3CG+?QFT3TF,=/9,?K9*3'6&
MV=#["^<O6>/WTAXGKB*T=+D/I(W/;-8EMI]]TB]"56,=34KH7H(GR+Z@]-]%
M^^O]8/I[L>;SW\W*XZ_0W7O^OAB(M:?=.6LTS:>R,FGL8)ZG]I_Z'=Y;KB\5
M?+Q][?6P>[Z.29FM8_R=O-B^,TU:QW%FN5T.\=*8[3WDZOI,AG16[JMCK04:
MQ0N[9CJ3(2I"E*)3*C3Z#+T#SOU5[N[EX7UC[0X'BMYFP</OLU(W&*LQY,L3
MN*UF+=)G]7ITF.C-/3[MS@^4]->X^7Y#;8\O);3%:<.2T3YL<QAFWR]??U2P
M&S+PM$_>N:Y7C>V=#4E'>3JRIR7*(4.]@QEH2Q9Q7,EQR(MF22D*-2%1I3B#
MZ&7H68UF]9N[NY> ]3>RN(X;>9MOQG(<ECQ[G'28\N:D[O:TFM]8G6)I>U>F
MG2TO=/3+MS@^8[%[HY+D]MCS;[9[*]\%[1.N.T;?<6B:]?'S5K/MZQ#8F[MR
MU^H:",\B(5QE-XZN'C5"E2O[JD([$N3)9-'ZP4"*IU!&39>(ZXM+:>WN-:,[
M]7_5C8^EW"8\U,7[WW)O+33:;:-?GM&FM[Z?-].DVK$Q7YKVM6E=-9O7$O3?
MT]W??W*7QVR?N_";:L7W&>?Y-9UTI77Y?/;2=)M\M:Q:\ZZ16VDZ[7?*//XS
M=]D^U?F\.<@I,7'*:,\T_7LN?&:CS6*Y< F'"0LS-#DF2\GT$X9+(R3Y%L.Q
M/N-[VP5YKN+N7^HIS1YZ;7!2T6Q5GK%<E<4X_+.DSTOERWCI%YBT3%?1]WW;
MZ*=K9IXOA>#_ *VC'/EMN,UHFN28\;4G)%]8UCQKCQTGK-(\NDSFN&TG)3"<
MEI8&19%0['P>=-;BVD]Q!,WU'&4VYUFI-UJODOEXW81D;D[XO^I07519?VGQ
M'W =H]P[39<[O]ES_9^;-%,V28\NYV])B?VD:QBM;YO+KK;<=/Y->MF.=P\E
MZ/=Q\-N-UQ.TW7#]RXL<VQTB?-@S6UCY.DY*QTUTTKAZ^VW2$HQL8\4
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M<F6EQ)>]GLO$RA2GU=4(+T%\ #:(
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M3(R/H,^B8F-8ZQ+Y=9<67!EMAS5M3-2TUM6T3%JVB=)B8GK$Q/28GK$O<)4
M
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MT5B=M6)M,5G2)M$:Z:S$=4KQLP\,
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M \[6=[BTCY:YK6TW>./"-8S?M=(C2M,^.(\)6/#(&JH
M
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MI6D>>M//>]KQ$5I%OQ60#?IJ"
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M?YT_6O\ @6G_ / V? +/P
M    4<;2@;<X!\O-D<D\:UM<;.X^;O)^?GGN^P;T_&+.SF-6]P[+?BMO'3S8
M&1>-*B/S&D5\V+.5&-U,@C=:PS<UW7!<KDY''CG)L,W6VGC$SUG\-)ZQ,])B
M=-=>KZ&]G;GLC[EO1#BO2CEN6P<1ZG=O:4V?UITIN,>.LXL45BTQ]6E\'EQY
M*8K3FQ9,498I.*?)?8]]YQFEYU,435>KMNYKL.T86S08M84=+6Q%VBF34RQ8
M2Z?(<AL7D(7Z31"BR5N)09=4=24.?)W;LYIIML>6^XGPK,1'7XZ3,_FB6+<;
M]BG?VWWWU^\N8X/C^U\-HG-N*9LM[1CUZS2N7#AI$S'MRY,<1,QTMUAQ/%O%
M<YXG:8Y1<U>1]<BHV5M$Y6;^Z,YE<&;#=?G6UE35$^&E:GJ2PSC-LI:CG!<,
MW(#+4<G/#7XJ$4\9BS<7L]SS'(1IN,OS>6>GMF8B?=-K6TT]G3XNYZP\SV[Z
MT]^]G^@/I5EG/VGP_EVG[S28O6T13'3+EI;PRTVFTV]K_5K\N:]LLU\U?):W
MN\O;B'@FP=.6N]N16!8SLK/=Z9=<YU&DYI21;9^OH'ILI$:4TU.96F-)R:T<
MF6*UM&2'HK\7T$:!/ \5@S[2=[R%*Y,^>\V^:-=(_+[YUG\)A1]SOK?W'VQW
MWA].?2WDMWQ/;?;FQQ;.U=KEMCB^:*5FU9FDQYJX,<8L$1;K7)3-_;)-;U\O
M[CSG>H=@8MK_ $[KK"\ZLL=F*P[)*+':RFL*_)H'98TB#L8[33D>!/L(C<:7
MZ>BHKSA'\(N.]X+89]IDQ8,..F>:_+,1$3$QUCK[IGI/P>1^G7W,>I_;G?'&
M<QW-SO*[_MW%NJ_O6#-GR9:7V]]:9?DM,Q-Z4M-\?3IDK659Q\WK9/EO'J=4
MJ:G?B;T^,RJ@T22R(L;)GH=P<(V_6B=+"_\ K!U[_6/:?[ITZ_%&._US;_1[
M]UUG]^\WT=/;I[_]S\OOU;:Q]O>RG[K/]-(ICGTUG;_U]]76OT/KZ_XKSZ^7
M3]Z_Y9X>3Z'R:^U9;H7R_N/F"Z=U[C&P]/:ZS7/*_'8CN99)>XW6V]A.R6Q-
MRSN62L)3"GI$"MG3%Q8AGTZ16&RZ%\ R+8\%L,&TQX]QAQWSQ7YIF(F9F>L]
M?=$](^#4WU(^YCU.[C[ZY/F.U^=Y7C^V\NZM&UP8<^3%2F"FF/%/DK,16^2E
M8R9/_27MUE&[S!>(.!X!IJNWIQUP#&M;[ T5E=/GKLK"J6)4OSJ&+,C%-E/M
M0VFT27L9GM1;)"W.I,QH\GH7QS%NY[BL&#:1O>/QUQY\%HM\L::Q[?#W3I/X
M1+U;[9/7#N/N7OS+Z=>J7)[OE>V>X]EEV<5W>6V2*9K5MY*Q-YF:QGI.3!,5
M_6R7Q:_JI45/-2FM\-X[9M78H_9T>[*V$_<6,:<N/&Q6W3,BTF04D9"X<@K2
MPH+]4AMUM3C/<W'+M4?B$I.1[+=4WNTQ[JGA>L3^$^V/R3K#4OU'[*WWIWWS
MRG9?(:SFX_=WQUM/3ZF*?FP9=(\(RX;4R1'L\VDZ3&B<8[3"5*7(O%=R<.^8
MMOS,UGKRRVAJK9./LT>U:2C8<>L* G6*1BW2XF$Q,F5C$N9B\*SCV3C#D7UH
MW8KRFB<;->'<ABW?$\M/+[?'.3:Y*Z7B/&/#7P\/")B=--=8EO\ >EO,]B>N
MGH5@]!N[>4Q</WEQ.ZG-QV7+,13-I.6<>GGFM<DUKN,N"^"+UR?3BF;'%YK>
M*YE8^<IH%^E0>':VW#DF:36_!J\3D4^.5S+UHM*B9BRK:#DEV\F.X\1$2XT2
M6\9*(_"Z]2+FMW=L9I^QQY;9I\*Z1'7\8F?T1/X+%M?L0]2\?(3'.\MP6TX#
M'.N3<URY[S&./&U<=\&*/-$==,F3'7I/S^$SQ7#[#=@ZL1R8\P+E)3KPK(,Z
MH+FXAXE(BO5MO5XC$?1D$Z.[52S>L*L[675UM?50Y/\ =QIADIY*C>;4JGB<
M.?;?O/.\E'DR7K,^7PF*^,]/&-=(B(GKTZ^+N>N?/=L]XSVE]LWH]GCD.,X[
M<XL5MS6T9,63<VCZ-+1DKI3)].N3/FW&7'^QURS%)B*7B.$\OKC7BV_\:V?R
MFY'X+C6P,@WEG]Q;8S!RJH9MH-12UME8MSYU2Q/;4F*S/NY#T)I"2-+4.L9)
M!DE1I%'!<=BWV/)R?(4KDR9[S,1:-=(B9ZQK[YZ?A$._]S?JQS'IIRW$>CGI
M5R.[XSC.W>,Q8]Q?;Y9Q7RY<E*32F2:3\TTQ5KEM,];9=QDFT3,:IL;(X#<8
M,SP#,<5H-,ZVPZ^OL=M:ZBRNEQ:N@6>.W4B(XFIN(LJ(PF0DX%AX;BTI/HXV
ME2#(R49"\;C@^-S8+XJ8<=+VK,1:*Q$Q/LG\DO .U/N3]7N![EV',\ESW+;_
M (W;;K'?-M\NXR7QY\5;1]3%:MK37YZ>:L3/ZLS%HZQ"OOC7AB^87#'9/#/9
M$PL?V]QRRY=-0R[-+C[^/2ZV5<MXA)G)2E2G85=+;ML?DDPE:F:U*#27>M'6
MQ<=A_K;B,G$;B?+NMO?2-?9IKY?S?-6?@V:]6.>KZ&>O7$^O/:E/WGL?NK8Q
MES5QZ1&>N2N*=S6GNM>L[;>XYO,1;/-HGY:VT^_5//#:?#JGJ-&<T=-Y\AO#
M(\;',3V?B\6-:-7N/UZ/4ZHGW;.=6TN2LP8K)(380IYOK902'HQR4.*<G:\W
MN>)I&RYC#D^3I6]>NL1X>,Q$_C$Z^^-76[S^W'L[UUWV?U$] ^>XR;;^UL^Y
MX_<6MCG#FO/FR:1CIDRX)O:9F<.7#%(O,VQY?I6I%=?\P.?&"\O]0W.@=":L
MW+EN4Y/;8Q*3*/%8;B&2I[R!<):B5./6V1W,]Z5ZFIKHIEA*5?&(UD.#EN<P
M\MM)V.QQ9KY+3'\GW3$^$3,SX?!DWH;]MG<7H=WQM_4OU)YG@=EP^SP[BOE_
M>+1,_5PWQ:VR9L>#%2*^:+=+7F8Z3%96;U>?7_&SA_H27<X386618_K33V%7
M^.R)*JQR@M(F!5\:U*YD(B6!Q"@3:M<51=AEZRXA/7TC+^/I?%L,&/)$QDKA
MI$Q[IBL1,-"/53DMCS'J?W)R_%Y:9^,W7/<AFPY*SK7)BR[O-?'>L^VMZ6BT
M3[I2SQ:_C97C&.93":=9AY+0U%_$9?Z>,U&N:^/8L-/=OQ?%;:DD2NGHZD.X
MP)6!YANCMOGL#2_+K0>/.YEGFDG6XE_B,:&JRGVN-0K.1=5ST*JC+:L[>,T_
M8SXLV-$-<Q3$Y+C"4^$XLL8Y[9;OZ^'E=C7SY\/C7QF8UUC2/&?&8F(ZZ3T\
M&Y_VP>H?8_\ HSS_ *(^I.ZC8=M]PQ-L.YM;R4QY[XZXKQ?):)QXK3%,.3%D
MR:8HOBFN29\]:SP-=YRF@6*59YCK;<.-YI";\&TQ./3XY8LLVB$I)Z+%MIV2
M4CRH[;QF1KDQ(CQ$DS\+KT(^.O=VQBG[;'EKFCQKI$]?QF8_3$?@N6Z^Q#U+
MR<A$<%RW!;O@,DZX]S;+GI,XY\+6QTP98\TQUTQY,E>L?/XS&(<<\6W)S$YA
M4_,W9NOK'6.JM:T,FBU3C]ZS)8L+[MC7<>I6TF7'A2;)B'-R>99R+)MIN,<M
M#,5DW4MN&CBX_%N^6Y:.7W..<>UQUTI$^,^.GX^,S,^&ND1KI*]^J?,=B>A?
MH9G]!NT>3Q<OWGRVYKFY'-AFLTP_-BMDB?+:]<<VKM\6"F";6R?3G)FOY)O3
MS;@YV\7]JW.?:^Y<<9TH=W;J=J.Q9XTDDD[F6/5SLU^/ZDR;L9JRL6(EE+A3
M(2EI<LZV1X+:_$9::=[?-\;NKY\?*\=_[YB\8_MHC^&>LQ,>V)T]FDX-]N7J
M_P!F[#MKD_1+U:F8]/N:F9QY^NFUSWBD3YYTM-*3;'CRXLL1-<&>GU+5\M[W
MIA&,^<!K"IAE2[UU%MK6FQ:QE+-_0P:*#8P"L&C4S(]5;OK?&[^O\5ULU%'E
M1.K'7PS><-/>K@Q]U[:D>3>XLN/<1XQ$1,:_EF)C\)C\LLAY?[&^[][G_?\
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MGMMUNQ&8OG^
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M$ \;+",+N;)%S<8AB]K;M^!X=K94%3.LF_53[HW9.E1'92?5U%U1T5\0_@Z
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MXVEYMJ6TVM2XSKC*B6E*R29I,C+T#E<;Z@
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ME*$(224(21)2E*2Z)2E)="2E)%T(B^ !Y
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M1D1]2 ?4
M
M                             J+\]V=.KO*DY7R*^9*@ON1=-P7'X<AZ
M*\N#:<A=35EG#6XPM"U1;&MENQWVS/L>8=6VLC2HR,,1^C]V$Z?Y6VBDSIDF
M6FOR3<5?!*2\X]ZI!9VQESK,-CQ%*-J,TX^LTH+XJ>X^A$ NB          '
M3G\@&]N[#S-_,$3/N;6:FZH-E7-P4NPER2MKB+O^K;C6MD3SRRG64=%M*2V^
M[WNH*2Z1*+Q%]0[C
M
M                        .G;]&PR7(9W*_GC G7=K-AW%37Y+:QYD^3*;
ML<A;V3D+*;N:3[CAR;4VK20E3Z^KJB>5W&?4!W$@
M                 !T[>,V29"W])MWA%1=VI1[NYW1CUNR<Z2INQHJG42;&
MJIYB5.*)^MK9U%"=895U;:5%:-)%V)Z!W$@
M
M                                                       %0/GU
M?YI[E9_\(S_I):= 8?\ 1\/\UQI;_CAN;_G3RD!=<          .FE]'V_SG
M'/+_ (G;2_Z0.-@.Y:
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M>,VD2[H;-#SE;;0%F["GLLR'HJY$-_H29$93S"NQU'5MU/12#4DR,PYP
M          5Y^99L/.=:Z*Q.]U_EE]AUS+VU15,FSQZRDU<U^L?P_/)CT!V1
M%6VXN*[*@,N*09]#6TD_A(@%A@
M                 .FE]&F_QN^;_P#Q.A?\YMD [EH
M                     Z:7&G_PG3;G_''?'_,M: .Y:
M
M
M      KL\V#CWM+E3P!WYH72U)#R+9F=_-9[M4T^YJL>B3/=?=.N<RN?%N+N
M7!JXGJ]!CLIU/BNI\12"0GJM22,.LIISR_\ Z1!Q]P*KU=I?)+;7>OZ639S*
MK%<>WGIMFJ@R;FPD6MH\PV_=2'"7-L)3CJ^JCZK68#:/XM/TG3^=S,?P\:6_
MC0 _%I^DZ?SN9C^'C2W\: 'XM/TG3^=S,?P\:6_C0 _%I^DZ?SN9C^'C2W\:
M 'XM/TG3^=S,?P\:6_C0 _%I^DZ?SN9C^'C2W\: 'XM/TG3^=S,?P\:6_C0
M_%I^DZ?SN9C^'C2W\: )9>2%Y;O-7A_R>WEM_E-AE31U^R-4V=*S>P\^PO+9
MUQF5KL+&,HFJEQ,9N+"2P<IB!)>6ZM"&N_XO7J9$ [/8
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MH ?BT_2=/YW,Q_#QI;^- #\6GZ3I_.YF/X>-+?QH ?BT_2=/YW,Q_#QI;^-
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M^NL=K9,FMQVZDSI+LF=)8;4IMCM0GXRNA$9@.W"
M
M
M
M  "!NV.>N%:+VSE>M=GZ_P ]@UU7[%?Q?,J&!$LJO)H=EC5/<37"8LY5$;1U
MMI/>A&J*Y-0:V3[S;42DD$?M N9)RHYF)Y60<-NL-U3@.+S<>Q2PO(R6).53
M'Z6YQMIOO;4N)+EDWD4V3(.,X^S#2RRPIQ2U$I06Y@*P.8_^-YP8_P".LO\
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MCY<KV6JO9IEV'=+7.8=5(;C^LGZX< G/&-?:TLPN.
M
M
M
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MZJ,SZJ/]4P'U /GDQ(LUE4>9&CRXZS2:F)++;[*C29*2:FG4K09I474O1Z#
M%PXCKL9YR+'<>A]_JCJV&ENQ?$2E#GJSBDFMCQ$I(C[3+J1$1@/H
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MFV([2&66R,S49(:;2E""-1F?H+X3 >X
M      'K>>9C,NR)#K3$=AIQY]]YQ+3+++236ZZZZLTH;:;0DS4HS(B(NI@(
MEUG/O@]=9F6O*GEYQNL<T7-*K8Q^'N;7[\R7:FMMKV3!6W?*C3[8GG";.*RM
MR03J5(-'>A9)"7               PJSV3KJES&BUW<Y]A53L#*8CT_&<%L\
MIHX&8Y%!CHFN2)E%C$J<U=V\1A%=(-;D=AQ"28<,S+L5T#-0
M
M
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MABTBMLNRJN7,I9<QJ':1FI+:W(SIH>0AQ!J21*29ALP
M
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ME)I3-LY=DJAU^+U&=TOM>]E)-9*9QB-*D1CRI9);-7_6TY7Q"[OV/I 2_
M
M
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M.%<@L6Q7&,'KB<1CU/DM/E&Z*:Y3C4-QA#=77PE4BV288[&$151&F_$:8:-
M=C8
M
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M/R"ANC?EM)DNK6V^VTF>0=FX
M
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M?LVNLKFMCR8%IC,RV\*051[5KY92(LDVS;1908J75-L*=<0&GM3\SO-?S5W
M]6Y;Y9!X%GR+G&*+:N\,EW)B)ZAIZ=JPA1<TSO'<4@NL3LA?57E(?A5-??3>
MCQH[7Y#9&2@U+R$T!R\X;^95F7F'\5="GRJUKR%UM7Z]WCI^@RJMQ3.L9N*V
M'AE=&R#'_:B)!2V)DC!JV8AZ/&L#)3EBQ(9BH<CRTAE_#'B5RCWGSER+S.N=
MF#56H,II,,D:VXO\>8M_#RFVU?ATR/<0'+G)[JM>=A%8^QLEM4DRHT/R9]Y.
MD.Q:]+<:. U78\<>=/EK<T.1W(SA]HRGY;<8N6N2%GVS=,UF95.#;(P'-#LK
MZ_DR\><N$N,.PXU[EEHJ"FNB6"'X$LH<B,PN+&EF&1<%M9<J=S>:MOSGIR$X
MOYIQMP:VXZ56J-:8QG-_2W5G$O8\G5[$_P .36/P)4U+\?'K:03BJ]J*E$_P
MR4IYHU&&IM0:S\P'RF]N<I\$T'P\D<Q..^_]AVFU-+WN(Y_3XI/U]DML3\=B
M@SZ#8,SYQ0JZO=APY;G@1&)"8"'V)9>*ZS'"27"3@;R2T/IGF_R5W6S4YIY@
M7,#&=D9'(Q3&+>D34XG9/4&2V&#:MI<@L+N)BK$NQRVS:3(>]I-T\-EF%'3*
M\&&J4Z$G/)ZXP;(XB<"=4Z?W)BY89MAB]V3DN>8TF\Q_)$U=A?;!R)VC05UB
MMO>X_--_#8]8ZKU:4ZEM;AH5T6E9 -2^31Q2WWQNU[RBRCDS@*M<[8W[RBS/
M9IT+F48=EK[N&SZBEFTMA)LL$RO+\?8??R*YN4'']9]8;)LE+[DK;,!<J
M
M
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MIS_:]ZW"R1N'0PY%!7T4^WI^_)DPTOR(3<-NJ1+_ +J<=>:A(#LH
M
M
M
M
M                                                          "G
MW@GQ)WOJ_GIYE')_=>-5M%1[[SG$ZO1\V)DE)>S;W7F,V>8Q%6-A#J[.REX_
MXU'7X\MN/+\%XS6M)M->$:""X(
M
M
M
M
M
M
1                  !__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>82
<FILENAME>mrna-20201231_g40.jpg
<TEXT>
begin 644 mrna-20201231_g40.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %% D\# 2(  A$! Q$!_\0
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MX6^-O@S\ /#GA3X@^(3XD\2V?FM+<_:'N!"C2%D@$K_,X12 ">!T' %>TT4
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M]X8N)9+._@V*1*$E&^)LEE*DG[N0<&@#T&BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^6OV^O@!\-OCAX'T&;X
MB_$.'X<1:'<2SV&I7<]LMN\CJ@99(YL>;]U<*K \GKFOJ6O&/VDOV3O!/[5%
MGX?MO&<NK0KH<\EQ9OI-V+=P[A0225;^X,8QB@#\Q?!7@GPR/%UMHGA3X%^&
M_P!IKP^?W3>)/"^FZOH31NK8?SI9F:U.<\&,[<JV2.*_9G3T$>GVR"'[,%B4
M>3G/E\#Y<]\=*_,_XAWG[,7PS\)ZG?6O[1'Q+UZZTL+&-!T;QW,;J3#JC)$C
M!5RH)."0/EZBOTPT_8+&V$3O)%Y:[7DSN88&"<\Y^M %BBLOQ+XHT;P7HEUK
M/B#5['0M'M0&GU#4KE+>WA!(4%Y'(5<D@<GJ169XX^*7@SX8PVDWC'Q=H7A.
M&[9DMI-<U*&R69E +!#*R[B 1G'3(H Z>BN/U'XR> -'T31M9O\ QQX;LM'U
MI@FEZA<:O;QV]^QZ""0OME)_V2:O>+/B-X3\!OIR>)O%&C>'6U*7R+)=6U"&
MU-U)Q\D7F,-[<CA<GD4 =%1110 4444 %%>-^'_VK/!>O:=I&JFVU[3/#^K7
M@T^SUW4-*ECL'G:4PHC2C(C#2#8K/M4L5&<LH/LE !1110 45Q\WQ;\*1_%.
MU^'(U:&;QC/ITNK'3(?G>&V1D0O)C[FXR+M!Y;#$=#784 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !117+?%/X@V7PG^&_B;QG
MJ5O<7>GZ#I\VHSP6H4RR)$A=E3<0-Q XR0* .IHKRWP_\<VNO%6@:!XD\&ZW
MX.G\0HYT>[U"2UGM;R5(VE: /;S2%)?*1Y KA0RHVTDJ0/3H[B*:21$D1WC.
M'56!*G&<'TH DHJ&.\MYK<SQSQO ,YD5P5&.O/M39[V.&PDNU#7$2Q&4"W4R
M,Z@9^4#[Q/8#K0!8HKS3P3\;/^$H\<)X2U?P?KW@W6KG2WUJQAUC[,XNK1)8
MXI2#!-($=&FA#1OM/[U<;L-M]+H **** "BBB@ HHHH **** "BBB@ HHHH
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MTY QO;A<#)Y]*\]^'_Q:\4>-O$6I:?<> )-*L]+U!M-OKUM7@F\F40QRY"
ML,2H./4^E=U'!5L12G6A;ECO>44_N;3?R6KTW)<DG9GJ=%%%<)1Q6O?%30;*
MQOX[+6K#^U(4<117!;9Y@SA6QCN,=:\V\)_M!ZQJNOVEMJBZ/I^G,V9[@QR
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M'.%)P3@$X!Y_X+_ /Q5\'8_(B\<Z?K,=Y>&^UF^N] ;^T=6F/WI)KDW3?.0
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M%P"!QZ9K4H **** "BL_7_$&F^%=%O=8UF_M]+TJRB:>YO+N41Q0QJ,EF8\
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M\)*!I7Q7^'WCW:!C_A*?#,NFE^._V.0XY]!_A0!]15Y5\*_^2O?&G_L,Z?\
M^FFTKYD_:;^,7[4/@GX"^-WU_P"'/AVSMDT]Q+XM\'^)S&VGKE?WRP3H)'ZD
M;00>?;G\[?V7?VA/B+-^TQ\-$E\?>(9XO$'BS28M1BEN25NT:YA@9906Y!C&
MSZ8KMH8.MB*<ZM-QM!7=Y).UTMGOJTO4TBZ27OMI^2O^-T?T!5YG\&_^0]\4
M_P#L;9/_ $@LJ],KS/X-_P#(>^*?_8VR?^D%E71A?]VQ/^&/_I<3"7Q(],HH
MHKRBPHKPW7/VM=$T&ZU"";P/X]F^QO(CRPZ QB;82"RN6 *G&0>F*\.^$O\
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M^(/B1KL=Y9S7>A6^@P0:EK\NK7<RI,TK2R,RB.%1\BK'%P?WCM\SFOH:BB@
MHHHH *P_'6I2Z/X)\0W\.H0Z3-:Z=<3IJ%S&9(K9EB9A*Z@$LJD;B .0*W*\
MD_:,^-W@OX/^$Q:>,M3U72(?$,-S8VUUI&FSWDT;>7AG BC?:5#@@L,9'>@#
M\^?A[\3M5\6>"=%UC6_B#^U.^KWUK'/=2Z!H@DTZ61E!9[5A%S Q)*=#M(R!
MTK]6--.[3[4[I6S$OS3C$AX'+>_K7Y:^&?%GP@\&^'[#0]%_:<^/FG:181+;
MVMG#IEUY<$:\*B@V7"@< =   .!7ZE::ROI]JR2/,AB4B23[S# Y/N: +-%%
M% !1110!SOC_ %;0=#\)WM[XEM&OM%B*>?"FFRZ@3EU"_N(D=FPQ!X4XZ\ 9
MKY%_8-\7>!+CQ%\4+"WTR3^W+SXD^(+G2YQX>N5$%JS!D0S^1LMR$##RG9&7
M.TJ"0#]N5\P_L*?\>OQ\_P"RO>)?_1L57[:K32A&32?2_D=%*,90J-]%^J.E
M^/\ &?AEXZ\'_%VV4K::?(-#\1;3@'39W 61O412E6]]U:_B7P/I6NKXJ^'&
MLQ++X2\;6%QY&W!"/(A69$/8\B1<="!CFO3/%GABP\:>&=4T'5(1/I^I6TEK
M.A_NLI!(]",Y![$ UX3\(GU3Q3\+]1\$:C<#_A//AW?"Q6;&#((AFTF'^S)$
M ,GJ5)->/.+HU_=^UJO5;KYK7U39]MAJD,QRM*J]:/N2_P"O<G>G/_N'4;BW
M_+.,4+^POXZU36O@_/X'\3R[_&OPYU"7PGJV[.Z46YQ;SC/)62'RR&YW$,<U
M]%U\=7?B.'X6_M=>"OB';+]D\*?%ZR7POKB<A+?7+8$V3O\ [3H'@7Z9[U]B
MUZD9*231\+4ISHSE3FK-.S"O,_V9?^3=OAI_V+MA_P"B$KTRO,_V9?\ DW;X
M:?\ 8NV'_HA*]:G_ ,B^K_CI_P#I-0YW\:]'^A3_ &EO@'X1_:"^&UWH_BRT
MF=;)7O+.\M)!'<6LJH?F1B",$<%6!!XXR 1S7[%OP%\(_!/X+Z%<^'+24:AX
MCTZSU/4[ZZ</-/(\(<+D  (A=@J@< G.223[5XH_Y%K5O^O2;_T US/P*_Y(
MC\/?^Q=T[_TFCKTX9IC5D<\ JTO8^TB^6^FTGMZI.VU]=R.2/M%.VMCN:***
M^7-SPO\ ;2\2:9IO[-OQ)TZZO(X;ZZ\/W7D0MG=)\A''XU[#H7B73/$UO)-I
M=['>Q1ML=HB<!L9Q7YD_\%;/C]XR\)_$S0?AUI26A\-:EX=6[NV:TWS!IKBX
MB<"3/RJ5A3C'49K,_8M_X*'2V7AOQ!8?%+QYH?A"YAN(Y=-MKO0Y]MRC*1(Q
M>%#R"$'///H*]>OA\7#+*59TG[/GGK9]532UVWO]QZ-*."JQY.=QJ66_P[RO
MLF]K6\VS]7*\4^*'[)/@CXB:]_PE&G?;O GCI"6C\4^%9OL=V6/7S0ORS X&
M=X)(&,BO.]/_ &_OA]-D_P#"P_A]J"J W[O5GLB0?^NZCGV[5U>G_MM_#FY#
M&3Q!X<FV %_[+\3Z?>E<],[91[_E7#@LUQ&75/;86<H2VTOJNSZ-/JG=,<LK
MJ5%:+A+TG'\FT_P,0?$;XX?L^OY7Q \._P#"W?!T?_,U^$+81:I @_BN;#.'
M[DM$< #)R:]F^%/QP\#?&S1VU'P7XCL];BC_ -=!&Q2XMSZ2PL Z'_> SVK%
MTW]ICX?ZENSK'V;:0&\U-VTG.,[-V.E<-\1O@W\&_C!K2>)+/6D\&^.(SN@\
M4^';T:;J ;_;/ ESP#O4G' (KWEF.3YIIC8*A4?VZ:7*_P#%2NK>M-Q2_D;.
M:66X^BKJE)Q]'^?]>I]&5X;^TY_R'/@=_P!E$LO_ $AOJXNT^)'QK^!?'BK2
MX?C?X)C_ .9E\(Q)'K%O&/XI[(';+QWB/N3VKRC]H;]OSX.>(M:^%9TC6=0U
M$Z#XNMM9U-4TN>(VT"6UQ&P(D5=SAIU^5<_=;N #Z^6\,YC4Q*E@H?6(-2M*
MG[R^"6^G-!^4U%^1Y\JL8Z5/=:Z/0^_:^6/VB?VPYO#_ (EG^&?PEMK7Q3\3
M&PEY=3$MIOAY2<>9=,OWI>NV!<L2.>RMXE\=/VX/&G[1.H/\._V9M%US4X)T
M"ZIXNM+1X)HT8?ZNW,H46^?NF>7;C)V D!JZ'X%?\$^?%.EZ!%9^+_%7_"&Z
M-(?-N-!\&R$7EVY^\UWJ+C>[MR'"#!!P"  *\C_5_$X=*>936&C_ '[\[]*:
M]_T<E&+_ )CJHU*%[SO)+HNOSV2\]7Y,Q/![>!?@3K.H2^+?$>K>.OBQX@/_
M !,[;2(/[0\2ZN_!\@I'E;* 8&(-R\  YVJ1[/I.@_'KXMV,5G:Q:=^SWX'(
MPMO:A-1U^9/4M_JH"P[\R*3SFO;_ (6_!'P+\%=*_L_P5X9L-!B90LLT$>Z>
M?'>29LO(?]YC7<41QV79;_R+:'//_GY52D_^W:>M./I+VC71HTQ&(K8E*G+W
M8+:,=%\WNWYO4\@^%/[*?P[^$NHMK-CI4NO>*Y&WS^*/$4YO]3F?^_YTGW"?
M]@**]?HKSCXI_'30OAE-;Z4L4_B'Q=?#&G^&]+'F7=PQZ%@/]6G4EVXP"1G&
M*\',,RKXJ;Q..JN3[R=_1+]$O1(O X"OC:JP^$I\TGT7XM]$ENV]$M6SRS4I
MY8_V[M'T\^)8(]2D^']XJ!HH]_.H6[B()GDE4=_7"$]*^F5R% )R?6ORFM_^
M"?>H^)OVB--T#Q!IF@Z%;:SIMSXBNHK2&&?[+$MRB-%@1JC2@RH,J-GS$CH1
M7W/_ ,,[^++7R%L/C5XNMHH0 L<D=M(HQT  0#'MBN;$8BM*G0:HOX.Z_FEW
M9]EC\FRZA45.68T[^49-;+K"#5NEM;6OU/<Z*\/?X)_$Z.X62U^.NL1JO\,^
MAV<O/Y $>V*/^%3?&>.Z\R/X\[X>T,_@ZR;MW*NO?Z5Q?6*O_/F7WQ_^2/+_
M +)P+VS*E\XU_P!*+/<*@O;&VU*V>WN[>*Z@?AHID#J?J#7BT?P]^.EO<,1\
M7-'NXN0HG\+QKGWPLG!_&DA\+_M V\CD^.?!UTN,*LVC2J/K\KC^M+ZQ+9TI
M?^2__)#63T$[PS"C=?\ 7U?G21T?BWX$Z7KF@:KI.G7EQI5AJ<$EM=Z?N,MI
M/&ZE65HR>,@D94C&>*_*[QI^RW%\+?\ A=GB#1'O$UGX6WFF:C8QR3 KCS+6
M=SD $C8TA5O[H&<DYK]*UL?VD+6"8KJOPVO)2OR+-:WRX/L58?J#7QA\(=-\
M>>,_'WQW\$>+&(\3^)8GTK5EU,?>\^R9 %*\ C$1C*_+@+@A:^@RG/,9E^&Q
MF&PLZE.%2"YDG:+_ 'E./?>TFM-TVCUYY1/%8:=6IB*-:4'I9WG\$VW=Q3:]
MW=WM+EL?IE8W=AXL\/V]TB1WNEZE:K(JRJ&26&1 <$'((*MTZ<UXI^S=\'_!
M/@/QC\4M1\/>%],TB^7Q')9)<6MNJO';_9+23R4/\";W9MJX&2/08F_87\:G
MQ]^R+\*]5=S)-'HL6G2LWWC):DVS9]\PG-=5\&_^0]\4_P#L;9/_ $@LJZ\#
MB*U/!8NG";491C=)NS]];KJ?G4DG*+:/3****\(U"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R_%,
MD\/AG5Y+74;?1[E+.9HM1NU#0VKA#ME<$@%5.&.2!@&M2N<^(>I6NF^"==:Y
ML8-7W:?<;=)G90+_ !&W[C#<'?\ =Q@_>H ^)=-_X*$>-/"7BFV\-W&E^%/C
M_/)(%:Y^#\MY/=0QX/[R6!H9(>6 &%G'7(Z$#ZW^"/QRT3X[:#JM_I6G:QH=
M[I&H/I>J:-X@L_LM[8W2HCF.1,LI^61&#*Q!!Z]:^7O@QKW[1?BCX9>']=\*
M:Y\"?!^AZK:)>6^A6FG7:?85<9$#JC@"1 =KKCAE8=J^WK&W\FW5F2$3R -,
M\*X5WP,M[_C0!9HHKXY_;C_;+\0_LY^._!7ACPUJO@?0WU:PNK^^O_'%KJ,\
M"*LD4<"1BQ#2!F)FR2A&$ZK@Y /L:BOC;X@_M3?%Z*X\/>&_AYI7@'Q9XIL_
M R^._$FH_:KEM*NK?)18--*L&+RE79&E.W:5W=<UG^-/VV/B-XIL].O/A%X1
M\/7<%AX$MOB!XB3Q-<S;UMI59A8VPAQF?;&Y#O\ (>.!T(!]E:YKEIX<TN;4
M+XS+:PXWF"WDG?D@#"1JS'DCH*^5OV$_&&E_;/C/IH>X-WJ7Q3\0WULHLYBG
ME.\;KO?9MC; .4<JPXR 2*]JL?VCOA_#\._!/B[Q-XKT/P39^+M*@U73H?$6
MJP6;R))#'*57S&7>4$R!MO3</45XQ_P3OU:QU[2OV@=3TR\M]1TV]^,'B"YM
M;RTE66&>)UMF21'4D,K*00P."""*RE&;DFGHO+_@G?1K4*=*<)P;E)634DDM
MFM.5WU7=:=MSZUKP7XJ9^$?QR\*?$2/='H7B#9X9\0;1\B,Q)L[AOH^4+'HI
M [U[U7+_ !.\!6/Q0^'^N^%M0&+;4[9H0_>.3K'(/=7"L/\ =K+$4W4I^Y\2
MU7JO\]GY,[LEQE/!XM?6/X4TX3_P2T;]8Z2C_>BCPG]J7X.2^.O!GBKP=I[&
MUNM=3^VO#MTAVM9ZY;$2Q;&_@\PJ%S_MD"O4/V:?C%%\>O@?X3\:J@@O=0M
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M9;1[=1117C&(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7S5^WCX7\,ZI\(6UKQ!\)[[XKSZ0MP]C:
M6"M(;"1H6/VB2-98V:(&- VW<P&,#J1]*UG>))]2M?#NJ3:-;Q7>KQVLKV=O
M,VU)9PA,:L>P+8!/O0!^5.F_#_P;XH^#>DS>'OV*?$5UX_U#2+:2#4+NRF31
M);MXT+2Y^VJZP$EF7)! *Y[U^K^GPFWT^VB,:PE(E4QH<A< # /<"ORUTO\
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MJ(Z,Q::T8X##!<'GI7V9\)?%7Q5\6^+/$=OKVH>#O[(\/ZT^DW*:=I5W'<7
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M..(EA,2[4JZY)/HKM.,O^W)J,GY)KJ>!?M11Q?LY_M+_  S^.\$B6F@ZI/\
M\(AXL8D*HM;@@PSM_LQRJKGJ>/>O9/V.M8L+[]F7X6VMM?6UQ<P^&;#S88I5
M9X_W"#Y@#D<^M? ?_!6KX@VGQ5^ ?P-\5V("Q:A<7K2QK_RQF$40DB/NKJP_
MX#7@7_!+WQ7\0O"/QR\1ZA\._ T'Q#U5?#DL=SI5QK$>F;;<W5L6=)9%*[MR
MH-I'1B>U;TW&45.#T>OWGEXNG5HUI8?$1M4@^5^L;K\-OD?N-XX_Y$KQ!_V#
M[C_T6U?(7COXO:[HO[,?P0^%'P\E#?%+XA>&M-T_3G4_\@RS%G%]IOY,<JL:
M;L'KG)&2A%?/?[>?[>'Q\\$V?A/2[;P7JOP2FOTU"*_COS8:M#JB 0J!#,8F
M \L,^[;C_6KUXJ'_ ((_^.-:^*'QN\;:OXINQK.IZ3X3L-'T^ZFB56M+.)UC
M2"(* %7:BYP,L1N))))O<YHR]GH]T?I3\$?@_H7P&^%^@^!_#L973]+@"-.X
M DN9C\TL\GJ[N68_7 X %=S17G'Q@^-6G_"RWLK&"TE\0>+]5;RM(\/69S/=
MO_>/]R,?Q.>  >N*FI4A2BYS=DC;!X/$9A7CA\-'FG+I^;;V22U;>B6K=CP;
M_@I5\;I_AW\#=9\*6>FR2W/BC3+JW>^D7]S%"%Q(JGO(01QV!SZ5T?PN_:J\
M>_$SP78:EHWP<U/6KMD\N:[34(;*QEE7(8Q/-R5R/?!)&3CGC_CY\![F7]FW
MXM^.OB9-!XC\?7'AJ\DB503::,BQLZ0VJGH5(&7ZDY]6+?8>EZ7::+IUM86%
MM%9V-M&L4-O @1(T48"J!T %>9"GBJU1U'-PB^FE_+=-=^^Y]SB<9D678*&#
MIX6.(K1?O5'*:@WKS6Y91DXV<8K6*?+S):GC!\5?M :UG[%X$\'^&\]/[9UJ
M6[V]>OD(,]NG_P"I?^$1^/VM?\?OQ \)^&]W7^QM#>ZV_3SW&?QKW"BNKZK?
MXZDG\[?^DV/!_M[V?^[X2C#_ +<Y_P#TZYGA_P#PH'QMJW_(?^-_BRYS][^Q
MK>VTW\MB-BA?V0_!]]C^WM<\8>*^F[^V?$5R^[IUV,GI_GBO<**/J5!_%&_J
MV_S;#_6;-H_PJWL_\$8T_P#TB,3R71?V3_A#H.W[-X!TF7;C'VU&NO3KYI;/
M0=??U->$?M0?LE?#B\\;?#&\BT.#3QKOBZWTFZ@L$%O%]G-E=.558\ <P)].
M?6OM&O _CG\"_#'BSQEX)U74;GQ.;JZ\21$I:^+M6MH(6%E<@/!#%<K' V%^
M]$JGEN?F;/51E]0O/"MTV]+Q]UV?32VAG2S3,\?72KXB4WJ_?DY;)OK?70]@
M\$^$+#P#X5T_P_I:&/3[%#'"A_A7<3CZ#-;E9?AGP[:^$]#M=)LI;Z>UM@0D
MFIZA<7]P<L6.^>X=Y7Y)^\QP, < "M2M92E-N4G=OJSYR3<FVPHHHJ1!1110
M 4444 %%%% !1110 4444 ?$O[<7@,:QK?B_353Y/&W@#4((4Q_K-0TX_:XC
M_O;!M^AKL/\ @G/XQ?X@_!O7O$<LGFW.HZQ;SW#9S^^.CZ:)?_'PU7_V_O$'
M_"M?@_IOQ,2S:\D\'ZO!<RQQXW-!<9M749XY::,\\'&"#7P5_P $P_VO(_!/
MC#0/A"+34FL=?U^>6&2-HBBB2%4C5]WS<>4N<'H.*X*494ZE16T;NOFM?QN?
M79A6HXW!X67M$IQIN,D[[PD^79=8<J7IK8_9"BBBN\^1"BBB@ HHHH ****
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MP(ZU-X._:TT7X;W"V5I^S_\ 'Z[U(P>7))#X6NI(+@(1NDBBFN!M3<1C]VI
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MG[,/PLU75[^ZU35+SPW8SW-[>S---/(T*EG=V)9F)Y))R: /6J*** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
:%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>83
<FILENAME>mrna-20201231_g41.jpg
<TEXT>
begin 644 mrna-20201231_g41.jpg
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M 0$! 0$! 0$! 0$!_\  $0@!%@(7 P$1  (1 0,1 ?_$ !X  0 " @,! 0$
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MI=#SBAW7RR 1Y;_]>WP4S(--XU9$28YQ#UJEPC<B2;6M2M:T/+ L,)"<:F,
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M?K>8J_,C;[8EMPA+)E#P*E):X 5M!A[$% >S'&/  KM[)*>7;)(&Y&^>HQY
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MBQ7FNI_4I"^Y9)):FA[17C!9<NG]-1)4_P!9W!:$A?$,RKWDE1=9K<3%:X)
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M^1Q-(C>')V?(53MP6VCCC3'VTQW>GN6?A'!)P=$6!N;2#UBE^DQ32SA*(/\
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M8^T6XE !.,N)JR"%<1)+ 61$U1!*F.EMAY18PD6VX- X56449X+7<48(3#6
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M[Q6^ES.^K\Y$PB81,(F$3")A%$;M+>M5?7'UUKSUQP_X\[\>?'7])BWXW_\
M@&A"WO7[ A%O?TT+(R!U(';Y]A\_^O19L8^1Q:QCGD,>XAK2XAK6DN<0 ?9:
M 2XG8 9.RESDK!,(F$3")A$PB81,(F$3"* _J!UG&I14K;,5RV=-<C8[-Y_B
M[<XPVT[/K[V,4XZ,JF,RE"K20.7QM"YZ=V!W<FHU2Y)5BM,D6G@1'IMB]VBD
M=?D[\BIEP:$1ZN(JU0R*ENQ+ RZ6:0%ODFDLP= Z7N"MS4:5R.8.[[(W'8EB
MY0(G;BZJ]I2-E(DNR429,G**%EN$3")A$PB81,(F$3")A$PB81,(F$3")A%$
M>&?OX=(_U2>)_P#&+OW"GL/B?R:I<84)A$PB8117[I_<C[&_JK]"?X22["EO
M4?$?FI,-/_=39_T]%_[8K"A=AA%$?IK_ (E\,_UN%O\ E+ZKPBEQA$PB81,(
MF$3")A$PB81,(F$3")A$PB81>3_U".[/4(YDZPLB,1?L^E9-5CE)DPJ[YZYH
MB%(WGV5 F$Y*@ -IEU#S:/QE^>%^U)IRQ(J*L 8E",PKZ"$+8""Y&AI VP=R
M2X\K>O8CI^'5>CSE"5S&=\W4O,K!/L13-9+ F1XDA]M56W4A98W1:3LX_P"^
MM2-+D\-E?OX=""!='$#HO3(AAUHI4:$6A86!V)Z?(Y'R/?XJ0F%"81,(F$4=
M>3OW?J^_HY+_ 'QD.$50G9E45M1?J$U7UQ'8-&6MNKI'7-C7R$MH2&-SHT6=
M9TBIU_M-<A,+-(+EL,6/D9E!+RA*2*1*D"M\7'F.!6EP.JWBWT='54=\CIHF
MRP5T)KGAN0^GJ":=\[H\\GBPR21S"4-#\M<YSCA;E\#^)FO-?:1UKZ.USU5=
M:NUZBX>7NGX>4+IVLGH]1::;%J6AT]!7L8VN-HOMMM5QL<ELGJ9J,0S0T=-3
M,BD=$_T":WK>M;UO6];UYUO7[-Z_^^O_ ,9VI::+^X1,(F$3")A$PB\QWKYU
M!?,XLSEYTB2U0_5Y,7!JIF%P-(^)D:C=^2B0NZAM4%M*Q8C).4RYF,9F=$^>
M1)6DR/&IG)8V!<46U_GNM+?<JVJMWJH?-$\/ACIXWAKA5-$L[Y.5SFC#H&?W
MG1@B(<1S-#OT[] GB9PKT-H_B@-734EAO=NJ:._W74U;03S02:0J'6BPT-N]
M<IJ>HD::745:[]WX;)6R7J"2GBJ135!IK6?3SNQ8OJJ+<SW4ZR-DZQH^+)F&
MS8-8^BDTQ=6I J4)&2:QUQ"O<45APY4U:;D94U8G-U*4GE .=AIU"],8K[%8
M:PFECMU8Z1ETHH@RI@J,"9[6DADT;N9S:B%S>4>,Q[@3N\M+AG5GTC]#0P:N
MNW%+0U);:_A#KR[2W#2U_P!,ETMEI*NHBCFK['<J8T]+/IN]0UAJ9GV*X4M(
M^*-SHZ-LL=/*V&QC.P+6I5TS>IUJGMJL(V3=?1;;%)W2W1MNOT1:;LFK?&=2
MR 6GRVTQ<AM:2%H2&N.H&RSY@A''$?PFI4F7IP*$YGR"39199V/3J.P\C[E8
MMA8IA$PB81,(F$3"*)';_P"[^;_ZU\J?YJ:7PI'7Y._(J6^%"81,(F$3")A$
MPBPZ?5W7]JQ9P@UH06&V1"G<:(UUA\^C#),(LYF-JY.YMQCA'Y"A<6E:- XI
M$K@B$I2&"2KDR=41LL\DLP)%"WTWZ7IVM.=HY)*XJ>M*_D,O6S9++'Z$P2+Q
M1ZDZ6/VC/4C"FD3HQ-2!<]$,B4PQ,T$N1ZDMM3F#)1A)+$(.RR<22<DG<]22
MK \+%,(F$3")A$PB811'AG[^'2/]4GB?_&+OW"GL/B?R:I<84)A$PB8117[I
M_<C[&_JK]"?X22["EO4?$?FI,-/_ '4V?]/1?^V*PH78811'Z:_XE\,_UN%O
M^4OJO"*7&$3")A$PB81,(F$3")A$PB81,(F$3")A%YC?58Y$Y$K*YR;C0/OI
M[4C9M\%2J96>\=F=.=CU+(;/?V/[$0(G.#LU'7W!&A0VMJ4W:-]+)CZH:=4J
M; H$NAGG%GER,<XC&"0,8PUKL=>Y!/PZ?3:T+TE>D*?Z'XCH\^L9/5RQ\A5=
MQ-GLBOZQGCQ/$E52-<E5J2(NYJY=-K L!$(TA.>J;2K DJV6'HM:&[!2+"U"
M!(6+QASL@C?.2,9]_0#\.G16886*81,(F$4=>3OW?J^_HY+_ 'QD.$6B[:K-
M@N?IJUZEE -"8+&X5/AKF9HO1AB4B06?*6[2],$6]:TL;C5!:]$9H01DK$Q!
MQ8P&%A'KYJRF964M12R?<J(9(7'N!(TMYA_Q-SS-/9P!7:-&:IN&B-5Z:UA:
MG<MPTS?;;>Z5O,6MEDMU5%4FGE<.L%2R-U/.P@A\,LC' M<0<UX)LU^LGF6#
MI9N/>K0J=2^43;28TP1JM-8M.N9T(>SEQ@O&Q*WU*V-TH$+6@Z$4^E#T &A:
M!KXK)4/J+=")C_6:8OHJH9.1/2/,+R<]WAK9?@\+T+T@]+V_3/%*_36$#^BF
MKXJ#7^CI6M#(9=-:UI8[[0,@:.D5!+55-J R</H'MYG8YC,G+9>*IA$PB81,
M(F$5)7J6*5$PZ[]/R%(CAZ)J>W:FO61)PBW[!@D?6O-5+18PW7TUKVFRF5:+
MT+R(S?OV#6M$F;RCJB9;]:H6YQ2TMPK)-MOM&Q4D6_GF27X_(K8C1L<=E]'#
MC-?)V-+]8:OX;Z MLA'M--LFNVN;LUA&YRVTV@NQ@-& [/B-"LBZ*Y>K_HML
M9%+NI>(39T&5#=JKNB#*M,]D5H^[#OPK8WDL/N6,ZW_L7Z*NFE3"_(Q#*5I0
M*@)%R3Z[A;8*]K"]SX:F E]+5PGDJ*>3_$QP^\P[!\3@6/;L1D@CHO#;BMJ+
MAK55\5%%17W2U^B;2:MT/?XC6Z8U1;P?[FX43CB&M@_O+?=J3PKA;IPV2&4Q
M&6";1-8]13^IINQ<\]MIF>,SI\5::*FZ%8TNVNF>@A \A2(1&&;^6K6VSR0Z
MVYP!V/*;G->$XV(+#TBUI0'?%3W*>EG907@-CG>0REKV-Y:.N.-AY4U5V= \
M@..\+B'-![_JGA3IW5]AK^)' F2MNE@H(?7-8\.*^;US6_#D$_;3\K0)M4:.
M8\GU34='&^HI:<L9>H8YX*R=FT9;^_CS]_5'[!_QDX;R^6N?8_$?DY2XPH3"
M)A$PB81,(F$42.W_ -W\W_UKY4_S4TOA2.OR=^14M\*$PB81,(F$3")A$PBB
M/PK^Z[7?_5+-_P 69UA2[J?B?S4N,*$PB81,(F$3")A%Y1.3/4IZAL?U0U+3
M)86T!07$],E#3&NTT=,3/$#@M32"V7J+CTXA%MQ+>J[<[!G;O,'!S"<4\)5+
MJE4I$!*)ATR>;VW5%VJK\RCEC9ZO+420.I1$ ^G:TN!?XF!(71!N9><EI ?A
MC-N7]7.+'H?\$]'^CG<-;66YUHU)9-,6[4%-K"6\S34&IZJJ92/CI1;'O-LC
MH[TZI%/9V4$4%5%)/0NDJZUK9A4^KO/2%^4:81,(F$41N^G5K:.(.O#G9R;V
MLE;S3>3.C-<%B=$6K>'JLI.ULS4F,4FE!/<G9R5I6YL0E;&J<%R@A(E*-/.+
M*%QRRQ0L,DTL<4;<<[Y7MC8 =AESR&C)V&3OTZJSL]FN]_N%/:K#:KE>KG4$
MBFMMIH:JY5]1R-+W^!1T<4U1+R,:Y[N2-Q:T%QV!*DK#WMED<5C[['7=L?F1
MS:$"IM>&5>E=&IQ3"3EZ H0N"$T](K(%L.PA-3G&%BWK>M"WO6]9DQ[)&-?&
M]LC'C+7L<'-<#T+7-)!![$%?/7T%=:JRHMUSHJNW7"CE=!5T-?334=92SL^_
M#44M0R.>"5O\4<K&O;W"R3,E\BB/TU_Q+X9_K<+?\I?5>$4N,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3"*O'K_I%NKBTJQIN.<5V%V7:TS@<ZLE$QPY%3"!%#
MH!"G^&1I]=G&477+X>T!4*Y#-8XC(9&)0X+AA'M8X%)"=(MJRD=_:Y?Q_D#]
M5+&D"4JJNXY)QTH"@)!+&I$[R:L52:$@?HNZ" ,.V>1+Z^6NL5=') '>P;5M
M+NZ(O:9O2=6,.Q:PAZG?/OWW_'=1L[>7VRP'\RR."6RZ0*( ZOYPBT^B,=9D
MI;K93?-[H@\:&Q/4R4+35;5"2FE:\[>XVQM*1PE2P]L3N<D*C*5[C,E*% ^X
MK8O6DK9N7H5:ZF6A'Y1;]ZU5S^S5MUW94C9X)-J[Y9EJV+0V:\G-L;05"Z%
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M1,(J^^-/$QNSOVY1?7[Q],):<;A>?(1LO.M=QB$^X@6M[U\O]Z7.6AWK6_\
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M_P!&](W::@>[.PY;O-;BW8ES@&-]IP4_"BBB"BR22P$DDE@))**!H!9118=
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M\()$I)2=*EN:T$Z9.2 )9)!!'*5ZEDDE%@UH)99100@+ '6@A"'0=:UK0<O
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M$3"*-O8=8"N;ECH"LB"-J7*5U3,TK"5K6Q"U*$3.I=8H:$.M>[8D\D0-1X=
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M]*8WMZ%&X.A:7YTS'3-CGLE/4"IFCDEJ9(W%D1<8HVQAP;ASVL<Y[N<\YY0
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M/(^Y3HR5"81,(J^>J/YONJ.#KM#O1#<OL>?<SRLTO7M&K17G"SW&%$*AZ_\
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M!0B!:W[?E_O*HE8/:'?C:L*LW?D1V][HK/B6KOE7_P!I<O56XZ<E!!' ,?\
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M39&^<-.YU7+VZ?8-!^(VQS)Z.W[KJ^+.MG#PW:*X+ZZJK?4G80WS4E/2Z+M
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M_*:$U$=>MM7107&Z6ULT3)G5SJF.,SM>Z5]3!'-.(V<K>3DEY^:+F>X.YW9
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M"W(U,OMFRHRJDC'#Y&&2UTPK=/S^X)FR)HFDXP93<$_9';8VW< =ACM[\?\
M7J-NF8T5.K5KJJHI#9!RG?@W=F \:5B;W?G)2CW\_('9S(T2<9T G,'K29:3
MH?N)![3/>#7NT'0MECD^1^GZK.M=-/NY6.$:YAZ'W*"H\5*AM7Q^>_<%@/<C
MF@IPVKW?_P CO0G%.<F^7TJVKUL&S1)]$["9LF3Y'Z?JLA_'">?PH]$?VAS?
M_J&PF3Y'Z?JGXX3S^%'HC^T.;_\ 4-A,GR/T_5/QPGG\*/1']H<W_P"H;"9/
MD?I^J?CA//X4>B/[0YO_ -0V$R?(_3]5Q%M^3-N1JW!9RKT02C0I3UBL_:[G
M(>B4R4H9YYNP%]"#-'\,H Q^TL QB\;T$.Q;UK9,GR/T_5<./]'2:4L+))V'
MESH=P8I&T-K\S+PJN=T^EK2[HB7!N5A3J^@2%1.E*-02=HE202H+T/V'%%F!
M$#1,GR/T_5=O^.$\_A1Z(_M#F_\ U#83)\C]/U6/27II]AZ%$Y2/F'H9M1.$
MAB\51GB4<]*='O\ ,Y$V1.--^BT=_J30"<Y \MK>%08 "1*)3I2N4)D91Z@H
MF3Y'Z?JLA_'">?PH]$?VAS?_ *AL)D^1^GZI^.$\_A1Z(_M#F_\ U#83)\C]
M/U6/*.FGQ)*VB$*.8>ARY2_1Z1RII:OF.>Q"5L$2<HLT2%PTK!?XD!.FYQFL
M83"3J%1*Q3MT":C3J"4BXQ*3)\C]/U60_CA//X4>B/[0YO\ ]0V$R?(_3]5\
MCKJFJDDU.HY,Z$/3GEF$GD'+.;323B30[ :4<4/H40#"S "$ PL81!&'8@B#
MO6]ZPF3Y'Z?JM=1&XF8Y^E1,,XQMY)(:_?RHE)CFIFYE:5K*^.,1C,S+;0KP
MWFC^9TIB<TCCB,]M4*D6RG3Y(T_2U,N2)B9/D?I^JV5^.$\_A1Z(_M#F_P#U
M#83)\C]/U3\<)Y_"CT1_:'-_^H;"9/D?I^JQZ(]-/L[BD9F\4YAZ'=HO,8^S
M2J-NH3^>T87)@D+<F=F=?I(X7^E7I=+&]6G4:3K4J961HS1:E.2<$9829/D?
MI^JR'\<)Y_"CT1_:'-_^H;"9/D?I^JQZ4=-/L+:-OTFYAZ';&G3FP,VU8E'/
M:K6G*3OS9&&)-\%#?ZE1Y7OCPW(=&_"^"GVITH5FD)"CCRB9/D?I^JR'\<)Y
M_"CT1_:'-_\ J&PF3Y'Z?JGXX3S^%'HC^T.;_P#4-A,GR/T_58\NZ:?6V2,$
M16\P=#D2&4(']S8F[X_/9@EZ&,;:=/AX5)5_C1I_D-OC5[BU:@@U1\WKY0!_
MP5'PB9/D?I^JR'\<)Y_"CT1_:'-_^H;"9/D?I^J?CA//X4>B/[0YO_U#83)\
MC]/U6.MW3;X[2"21=NYAZ&4/L1^Q_O$@T?SV7MN^WT1C@T>5)U_EI%/SB,HP
M[7R9ZGX.@^Q1\$S80;)D^1^GZK(OQPGG\*/1']H<W_ZAL)D^1^GZI^.$\_A1
MZ(_M#F__ %#83)\C]/U6/17II]FS$CDL8YAZ&=&1P,7%HUP3^>TFCAMK@J:U
MH?EU]_I50-D+T2I/O9A -&;*^(5L90RS!$R?(_3]5D/XX3S^%'HC^T.;_P#4
M-A,GR/T_50R[:A51=+5B6=TQQ_TN7&ZQVY2IOF+"_P! MTBB1!R<@M]&@4-=
M^.)ZM YIDB0+DUFM;F0K&B0*0I/G4")0167.ST5XCCBK(WN\)Q=$^-Y9(PN&
M'<KAD8< .8.!:<-.,M!'K?"/C?Q!X(7:XW?0=QIZ4W>EBI+O;[C1Q5]KN45,
M^22C=4TSWQO$]%)-,ZEJ*>:">(3U$0D,-1/%)O2C]H.=*RC-0U)Q?T)&8/%2
M%!;<@^V>>%RL]2N5'+W)S<W%;T6<L<7-S7*#U:Q4H-%O8S DD (2$ITY/TT5
M%36^FCI*6,1PQ \K>8N)+G%SG.<22YSG$DDGW#   ZGKO7FJ.)6J;IK+6-Q?
M=;]=Y8W5-1X<-/#'%3PLIZ6DI:: 1P4U+2T\4<,,,3  UI?(9)GRRR;9_'">
M?PH]$?VAS?\ ZAL^I=0R?(_3]5CSMTT^L3O%6%UYAZ'2.TU=%[-&$FU'/1VW
M1R:V%UDZY,$Y-?YJ=)LAB8W1?LU<:E(,TEVG*,,5&D$&DR?(_3]5D/XX3S^%
M'HC^T.;_ /4-A,GR/T_5/QPGG\*/1']H<W_ZAL)D^1^GZK'4W3;XKE;U"$W,
M/0YDHCL>C$J>6KX_/81(F"8N,M:8VX"5CO\ "@/TYN$%E:8*=,K/5I=M(C5J
M=,2L;S%9,GR/T_59%^.$\_A1Z(_M#F__ %#83)\C]/U4?>J^N;.J#G6WK(9^
M3[?VY16&KUB4Z<'4TNAJ(:DPAO&YRI'![KD4J51]J*6#<G9.SM1IYR%*< Y6
MU)-J'5'6WBKDH+965<40FD@A+FQN!<TY(:7/ W<Q@<7R $$M:1D;D>K<#=%6
M[B+Q;T)HN[W::Q6Z^WR."JN5/)#%51MIZ>>N93T,LPDBBN%PDI66ZWR213-C
MKJJ!YIY^7PGT)^D/+DUQTITOQ?8G.4JO:GI8<PS^3'0,^*(WY.H5&1QB+C[\
M\3Z>0MO1H#4D*:#X<KC3JAET>5MCTXLQQ2H"5W8>EZ"K)'-K:$Q-\-A;5-G
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MDBRG")A$PB81:Y8[AJ232A="(W:5<R&:-AS@G<H@QS>,NTH;U#0:-.ZD+F!
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MA[>[$9())_L-NEK2D9E$B?X../LI2,;9P=R1\QWW[G'EWRL#MFX>GFR+OJV
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MKK8FOB8J#:)%#&Z$7:5QON^(_6RNS!.09<ZR"I7@U@M4HNHB+M4156"/E%)
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M&NECLMK=?)TD3@9:!(6F2QF-0U]:(@PQY,H&\1F*06,/L[&YR>R!/KH4DC
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MYKZAJBF9<WE0"$S:22&E9 [!8G\+U7\Q<H0_,R*4*6$TA6R.#DTJ':)RP,>
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M9,()DLJC%=VS4[$[&/DF;!(*_O-O8&NU(\%(S/3<@/!*T$88DYCBJ2GN[3I
M$QA7M9IZHP\@)'0]P?F.A^65IUX].WC9_CBR).]+HUD>7U+0%&*V[<TL<D)U
M5\N3$B?T/$]J4\P*6 *@,N3$/!#L6H"_/XP?)RIT?6\0D@BGG=Y]R[YD8)^8
MZKO[+X6Y4M^9V3/[!J9*\2RXHE7,)M-Q0RR>1I//6"HYRUV+6FI.T1:4LK*Z
M/4,E;(VJ&25*&X4I3,Y XH)Y,B:E4R'%&3C&=M]OB,'\1LNHL'T]N.+3GMG6
M;.J09'J:W2*I!VT[%R&;,Z>Q=T5(FN5U6&7,C%)FQ@>RXN^LC*J$4M:S2WXA
MG:FV2@>&MN1HB2GF=@#)P,X]V<Y_')6Z@<_T^3=R+HY+"42&Z$%8KJ;*FK<X
M/3::HK1PDR69'15S8T#DGC3RE)DZ,IX;ECNS+71H4F+--2Y$2X+RE)1DXQG;
M.<>_IE8$V<9<TL\_16BVUDG33MNO>;],HW_4GFIAA-X6/6)%-S2=:0'20QJ,
M.>ZV3$1D;":A'%T)8/M-L9$3R(;B(F3TSVQ\LYQ^.ZAU&O2:IE!=5CN\D30]
M\Y9?^8W+F&"<Q$QN6Z^P(Y-;F#T/94GE5HOMC2"22*2.UQ'.4CB*QB11%1"2
M%:$MI5!7L:!QW!&?P(_''Z*>8X]^<Y^6.F/);R7^F=QFYUJW58X5G*%C*TV4
MX7"W2Q1>-^FW,DLUV8ONLZS(KH$5G[O33LYQ;VQEQ\V)M*MCI93$H3#:R24H
M)4<Q]W3&,#&/AC&W;;;LOB^>F!PN_MS,S*Z)2H6-DYX6\HI6&-SZTX@PK*!7
MK7=T.K]_9HI.&5ME!);N_OSTCD$D3.LL0OCTZ/B-^(=UART13S.\^X/09R,8
M(/;IVZK)W/T\N.GF[V_HEPII(?:3=)8G-@J]3&PR(6XSZ M!#!![%D%3IY<5
M5$FL>'M"1*CC5@R&%.<R9])$9Z)[*4HDAQ!1S'[H.P'T.=@>H&VXZ%9G#N,^
M:8 YU.\Q&LD[.Y4A.+LL>K%(9/-5FXI-.BSI*IN9[*+<9(K)=1S4Z72(9R%]
M+=&QEVX[U&T3,%,CTG)D[[]0 ?>!C ^7*/P24\9\TS6R7>WI/6*=TL5\L*BK
M4=9(*3S5*8KGW-)3\52,@VVH9(F9RAP8N4/H26XAN*:7WY\6Y.@>]ITFR"9.
M,=M]NWM=?Q681KFZCXC#+=KMDKQHU!KZF%J3VWXL[*7:1,T\E%VGJU-J+'E)
M(G!U %#,C%RP#BQ(OE& A.I-2-[6C2B^#A,G(.=QC'NQT_!1(;O2*]/YI:EK
M6AI61%&K$%:-I$D-OKHM7/&)-3$F4RZI!1"Q5=LGSN$K*V>51FH6Y1&1,CBP
M,X$T:;U1,<2)6HDIYW>?GV'?KV[]_/NM=6OZ3=33=7S-7D*W#X#S!1O4?_SE
M3*LW./3NS+)LN\D1[RO2"3VS/;5=@Q>%29X?53O9+&=$)$LEAY(B"'-I+=',
M9I X@D]R.7/3 Z>78=/)2M=N#N6'N\T_1;I7#DKLU/.F:T@:%95JEUR;:D>C
MP(FP6FKI,J;ETNNLQECP -K9/UD /EB, "U!+N%844H 6/,<<O;[O;ICFQ\/
K=]%+[")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>84
<FILENAME>mrna-20201231_g42.gif
<TEXT>
begin 644 mrna-20201231_g42.gif
M1TE&.#EAEP1] 7   "'Y! $  /\ +     "7!'T!A_____\  -;6UH2$A/?W
M]P   -[>WN;FYGM[>^_O[\7%Q>\  )R<G(R,C)2,C*6EI:VEK<7.S@@  &MC
M8[V]M;6UM2$A&5IC8VMS<]Z4E$I22DI*2EI24O_W]T(Z.N\( -X  #HQ.O<
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MP(WJ0?B>/!-84 "1&MHW)U1C+A?!HVM&-,,U")0P@3X-:(@ !R6LF:>2'$S
M #X#D#K!E#IR,,![[C&03P@E;"!G<P-XP $" T*0#ZE8M@D1! ,,<,V=S#;K
MK%/\6%"J>"M&4*4'%S#0X@Q=0,#"!L^128&@$V25)P#7L$!D F,VY& " UA@
M@7D$C=/E!MH"P.( +%RPJSPL%""G 3K*8U ""(Q0  4 O M!"?0,<,] ZC#@
M* (52H0 !A2(E\>S((<L\DWJ % R )!@X.MR+.:W@06M<O!<-19?0/% $'B
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M4P#7 L$-P.HJ?MW]P>R-TX'\#*ECP*_4HESP!DC  JZH( ;8P @8Q/\??DW
M (%B 0/G-P($3,QL I%'E1K'E<BM"R*=*@'#$ <W=GF-&SB" #L49H$+=&P@
M7V, )$Q&(X2!K7D:>)]S"**V&NK+:^X 5D*R9T#=  B"N*L1>+I6H_7\AST1
MN 9[#'"->U2QBN<AXE*J@T0M,F<]Z8NB =!AMJZ!T8F3.F(4HVA%-!J+/P 2
MH_J\R!PXSJB(U_F3[#C  GH!X'4#$,\$2+"."ET.=0>!@*"TX16@?? A?$0
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M)Q#7,(@+!2^/8E6-YH#X<" &8%<-<!YYT$H[E8!,1B.L4 +_'D =ZW,NYC5
M #(U1R==Z+!(#&-+*U(RN8@BMO@4^\,A0-,C"@,C(H1TNI@Q[Z( ^O R>TD"
MR>-O+)('?(,F+)!G%<8?[1,CV1-S_@-Q)66-)? D7D0M!E !VN!5*_D;:MA8
MV$0VSR%X%*  G.5X5+=F*]@5Z26#[*59E;4/ZG!S_.$^56-0[S,#K$99I0)@
MY7 0T_>1VB"*;L9#2Q>/_]&<=U0[4@)'=C14^01N"#< $;",838 "C!I'@@
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M@X"%*(DC%8$ NBA"O_N5T(0G1&$*9_(XD77$8+?S%MEZY;\9C&,U W (!$N
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M40ZS (! !/$Q*)'895<.00<#.*"ECC!,+H;#F;CHYZ 3\]C+7_8(G^C#0(S
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M#;$M)++MR0&.8/#X"H88@ O@&1D"(&1!!PA@('XXW>M07I*5 !.VVK.   @
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M?[F':N@OS?\W?1)/,<>]EZZ0WW6JYY-Q''M/ 4$H@]JW_=O'?6$H ]W'@B?
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M>PNNN-$]Y^XW$:1?S4 )08>FN6"*:=Q YE[CM?$;B<_]_JD5J2%)#+ G=!@
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MH23K\MKPTG@K)/%:RS)GEQQ1^**\0FH!6* !8E7DQP4(,L!&2*6RK /(+,!
M5P>&@<"*58O1K3&6[]4D?.P-N*6C""L@L ^>@01["9AJ 1"04</,D@$10!H+
M\'%  ^R#!1N S50_HY%Y4%DDA0PDFA;:)G0!NM#HND:\"OK8N<S8P:S1UEMX
MR(!RL+?'I/'8KF:C:=GP0]/\(&2#*[J:EJZG#9@<+6E-NP"10JK5'G3<"_]6
MB\K"C"[+MB[SY/8ZO5K';"+F'  $6)'CBZP&1]=0@ *B(Z-[)F <%$BV ;G6
M/8/P(]D&L'#O"C#7F'I36K?^=K5(8E?8;/=@K.#'.==2C6%WA'8;.+*:BQ2!
MI>'C308XQRW=H2$&;.";Z*@&,3?@DGP"8)\Q24YP FHN@,9K?00]*,3+!$@
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MJ.P_DINJ<]6[GQD>\<//%00^QE8<M0H5X23$-R-@],HSO0L1X XB-3JC!N
M.+KQ]C17I#4;V)9>Z9V,0%,!=!77A4!64<0(1895K5&[)=1S&)9A14>"28="
M -1 ,)QP2$?%F8LP.: 7^7$( E 5#UW;@SR8 #$'.AA0TJ@-)*1@ 75!R)%0
M[DA$ P%*!!%.BI44JKG:I9 #" A#' 1=*HF?$5H$)/"#/-Q-.;@&5KU=<9U#
M?JG?I[!# <*6E<W@$8H?]GF916Q='/V&F!G7VT$A.E5 <F%%-8P1 T! $DU
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M;(YSK1V."!'KZB@.\:ZVR-!*^-3;?TL!6)5@I0] ?;A":+O+FCAPK(D]MM6
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M@($!"A7444$I@*2A$O&LU%(QJYK!@ $XT& "! 8(-51]YI%0M) 20G"".R-
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M]W+_6&-91_ZE Y^%]R;$G@I&"1>P8#=R9(,< BG@ 05BP 0*! 2!(& @&EC
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M!?YC21X')!1N RS@&MJ$ [2!NAZ"4I3'5F*G_,#/(9K" +"+,"K&F[YO#0&
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M!:1T^S!T117" -R!&PI  V82/!D.(C@FB*!HZW0K%N]2 9V(+^7T*#2/82
M'VAHFRC M<KB*V.,TZ## +BG&DQK')0&2!?B$[]$K<!R,[%&G^YJ+NZB[ZIM
MCKZ&_HXG0#I,(92$SI;DW-@Q-4VNI=Z1?] QE.BQ#$P@'V=C-VO#5?M%!%1C
M'Q7-'^^.:0)RX"H-<TI(M*KDT@ZR'5W"Q%A@!%K+1,N3+LDS0^]A%P'+,F9%
M1B__H  &8T'LTXLF@ P;0%(8H#RQ]=1^"DT\8 *@+QUXAA5<-$-]SP(XX!YV
M@EW_! $V(%<LA@.@ZP(&0TZ0(CME1?M& %3>,ZP2 !(&P *X04'6;D6P=4WJ
M,U9NQC*";P/\ 6=*32D2 DVP]??N)&W8Q&($$U1"@/W \<,4 AW6R"1VD0%H
M[EA*H@&TX0(&4"/L$T,1DRSRH3R?!BD\@ /PH3LH8!?S(0(TTD4Y8!TD<A>7
M4B("T#)=J!7=]&D14"_G=&I/I2'H*P+&3C1"HU9NQQPG98R>D03QA+PZPLRJ
MQE>*Q6NN+7Y ,T-^963%I& .2M[DS<.8HKXNPFL=A\_8_ZUQ1.GS?  $"&@Y
M4ZI*%L!>^-%618J#./4TA,&SL/!R>C5+_B5@8#-KH49_RI--T"$ QP\ (*%'
M:8("8!0 [F$ > ( ^.%$R:@+NI6,(( $., ZY %")Z I]F%BV60#Z,%4&$!-
MM((! *LI.M<#+F!FT&2+6F4#[@1IF^(:RE/J$H /V^0E$: E7%0#@C<A6T)3
M3O2GLO5Z(4 [$Z(:,* G9N!$-Z!C/:  R$\#+"!79J !D)%A-J <^ $ 7#0\
ML^]'FPYNQ1#BT*$"0H5I#: !2)0CJL$"2H!0]2<!3O0<&((5[K,L*X \344D
M3A115;<<+( !C _KHO&%@LH H?\V%L.N/Q25:LO.#5^N;.AP &9% R&B8CZE
MAA&$C(2U4LYHJS0"+3:D:\IL:^ZI&O#B+N#J\+;FC? (>>A683#W(5;+CT M
M'LW-2QBB\Q+B\U35< E7]C*''% /.$&Q2820T58@TG3UB\&8<SPG_U88(V9@
M^\S0]S0@'Q "'2P@!,X"+'08 D84 !3@ MB/(A6B EY%0MPA!#R@ D3B9WW)
M &82.'R/!2* 8,MCV"Z@!&[7Q#1 >=.!>1/  M;WS8AM*Q) F"*@0[O7'31@
M PP '1J 7;4# K1A X"CE]:7'R0T,F>F$$76=%^R8TFY*@Q  UA@M0"+33C
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MG4L@L$N 'JHA <@Z0P^$'0#B0@( !*L92&"  B2"%#@@B)!@ XMJ,P 8X%
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MM322S4!I>X$@4L BZYS +A.PP#HR<Y2%@$L#&M$*IA37DAE$8![ER!]!#(
M$G C3@H # #"<155*8X"I+F(!;CA@4[Q! *-- D$!J"/EAA@ E%AP$_<DH<(
M\!*6W[,50S[EHR(E10&\1 D$R@$K\\Q  1)1G <34($+6( %&XCFKC[C$@QT
M99F?(L$$* ":=QG0 $J*"F#X_Y$ ^D3,1;[I CJ$DYQ[H$^?Q1D.^^22  8
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M;M!R<: ";; %I[H%L("JJ*JJJ,H,J;JJKZJJL@JKI_JJ6Z "@F!7D\JIG)H
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M%$A8@"!P@@<-<0=P&$ 7W3D.%^@FH*NN[HP()! 88)R@"X("$  D2."N  (
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MDUA.8CA&0:HE(!G*,5(0IW=\8R"9>HM!WE' _2W'4R78S&HX=SL(>& "BV'
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M"L!/_=1/"C"?";+_K13A%?3@R9M)Q!E1(=4;H=2++Y8YKQ<A209Q'J(KESS
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MF+D1HT40"-"&=0 L!+G0 CH!Q<W0)PT EET EGW<>8U<QZ5<R+U<>GW<; @
M$1"!;# !%UB!$T#<'O72S>M!)7B!%D#7RKW<QXU<UXW=>HW=UV79SW4!%%#'
M8>55B_F0$T !%6@!UV5=VI5=R"7>UH7=X071ETV!38'4+NQ7J>VE$D$'5K$D
M9:J6>(2TVC)#W)H/\&Q:\0T0\YQ>\YVM1^L0JKS(XPP@_*  S%,'.3P0WP4
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M_V%5YMPFIMP>9N575E?0%5TKIM1Q>C125@)A, '6964?)N%5#F8>'N97-M=
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M#0YJ]?603:F80NV0!$  ;6B H%T->6 '7HD PF@/TRT0*LO-$N"&;W&.!-B
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M7;[W%CF@BJ\<QSWZN4MO>>[^G-.QU0!P63B$$Q6!4GF /E.B0#E2.X]S7*
M&Z# A2*  !:08!WAP'4)5*\F=N3:OKOV.J_U>C[3)( ",,##A, &(, ^)<K+
M7,"G:8"HG17!V9>BU,W9Q$87)$ ^3"#?G P$:E,'",Y-6 DP!=9"G4!)](J$
M65M.]$^]]94 @11(;51^"!#_*'7-OR7(?R0$#AH$!R:&P?%?G>05;2"93C"7
M2#P<[/U+4"51-J3("MP9S94$RM$0R!G3>UDA["P BM2>F8T$O?C$>KT -(D<
MYRQ.-CR)S/D0S4G?&B:,3"2 @/"# GB1 7P#1GG-:KW4QLE=1H!'"?@#"W@
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MY024SS'JX8M]6\,51Y",1,:<($H48^1!4F5H#4CAH#1>36W5X=6\(+_AEH)
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M:9LXB\[.?Q_WCW.)'HY#.0 61\P+!%Q . "'B"5;L'GU)"J&(+' =8A$8;/
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M7@A#E.RZV(,_]3OK  [*WU>'TRUSFRY*MN+E-RD*WI1WFK"F'<'&!;@#6T6
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M4[SW"/FJ \37S<B7'#9RBNAX ^OLCY,H#1V"*JZOC,DCJ/9B'51SK_9T-5!
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M!\<$*+0[Y/\W#]P@!31Z!31:"91 H]_@W,]=HU' W:/A#EX!!=[ W='=WI5
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M]2CDC>444$%MDGETSS@=,<G21E!>QV0$&U$GW4<AW8/2=$DAIT!.ZX7)GIA
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M)BW*GAE$/C1ML, UJYQ/.L8&&\;$X!,6#9Q=67<A+RV!O#D#WSH#/<V;0IT
M__-AI2:#H G$$,C9RRTAB]Z!4:"Z@@7FCAE:8+FX>;;&S#^APY0A(Z/'5(><
MHQU4L;/)A-CDC#P%C8UZ>H9&J+=G;0O7:!Q+/*@54!+R?UH\("0<SWQMCHA3
M OZ0< -0 .5 8@MJ),D11EF2H33S/[^5>1OU;P)4#0/)9XBI$UJ-V2&*S1"I
M5.<[-CY6R1#BMJ0=/HS<L'\"!Y%L*.&S-U*3OZ2,=D][%9H2"#4$I#^:!RA
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M[+%'&/MLM,E>FVX61K@[;[SW)KL O^F6&^^\!\?[[1_O'D'MM==^F^VY1Y!
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MM8L(LIN:: 2 ,\J_E0@Z#<1&#70*R72:<T3+EKNR;M R[)L!&.F&SVL(@DB
M4@JEV2REVK1-VYQ-=A*(+MA-V%PD2$@ #O '15JDWM1-WN1-W1P(3B*(VW3.
MVC2 V^1-=#" V(2$+JC-A #.";@,V[2'YP1/V=3.VS0 =& %YTP!2$@!>[BE
M=$J!B6J+$WC/7+J.%= $#T@!.("#;N+/6X*$_<3._/S.4K*' 0TF=I*CZ*S-
M 84$>]!/]7Q/7W(H^8Q0"DT!D\S/_<S/#=5/#@VF+G #.*A-;&!0 W@'5D!1
M5D"'!O]=3P85T2[8SQCET&[2S_T\R0RET?[D3X>Z)3=P ^<LS_,$S^H<"%PL
MS2-%4JD!D2ZXAU-KJ8<SD7#AEBF54@NDB"E=(YVA3)6;KBG-#*@PTL9H.RQ%
M#"\] 2_E%JGPTADXTZ13.18<-'@KO 1HM4$#S)R1TB>KRPY$-6ZY.L5@&+!#
MT\+K3!711O!Z,M'*C(?PTC=-4BK[GRPKRX:8  _ @$F5" &LMNN[/A+QD3!=
ML[D4U9N9C'( AYU;S -\C$ZE"MVZ+AR;LUAE"0O8 .:ZKMTBKE:UF>7R1E5M
MLUN=M$*#K1+H!NRBKKG*5.QZU5>%4U>]+92XU=-R5E=U@YK_>2Q!8ZZLDZMI
MY=49\%;"$BT0 =5')==R-:XU8@C#=,81^9\(@ !WD(=WC5=WJ(#JM+H$*(V[
M# <(" =\@  *J+HW+39WA0 &J ":T\L3&5@*X%<(,)=;[%."A8!XW5?)#(<*
MB("1R->&A=>"I0!5)%5OC  *B-=Q, E%-8EQ8%@(X <Z75<5\;H(<(=]H(!8
M4Q"38 6&W==X90!\P-04>3)&_08.:C2^S(QWH  &D(>?-=?$6BP?T8<M0SH-
M*(&OL1E0TRZSPQ:;F8 1 -G$2H<"8%K&@-;^LYE.=59DA2T\6Y 32 8/$%9K
M@ZVI:(FZ;:K78E5??2NY%=8.F).X_P4KDB@)Y5HN$FQ6EI".NKVNIDFTW>HM
MZ)+5OI6/94U; PQ9OFS:S-5<%!DA4B--R9 _S!N8<5",/(B >>  !'" 9RN.
MKYD(5H" C2@.MX2 KSV1>XC="6BVV?59 D* MNP(?? \AGB1U.V(XG '<X%2
M%AP' $. ?$@'MS39:\S,< @PC(" RN+ :XD !(C>XDB'"H CH'LR=+ Y#I!=
M^IN:","  :C9/64('3/?<IC=XN"'S?6N!6& #6 !?7C- ?"'$D#8/04\E2-&
M;7','+3=QC!<QPA7LI6(OAO;4+.LDWK5;S6YP?7&M2VT!&"!#9!<R858B?A6
MK!O5;$6MM?\=S:?@M&> 6\F56^82+,WZ+%Q%+K/+C-X*817N@&1@@1WN6U3C
MM.&ZVY0@3/Q%XB1NC"-6"5G;4A'Q%FT07LED@,NS''VPUP0X+V[@ "IF@'$I
M  N( &"$ !(H ':HXB].$PZH .I D7<8@!*@!PL8 ,E$  \82P08S 2H5 UP
M2R]F@ %PV-R" ':P@"Z6!R_.LA+H1HHH7_FS@ E@@ G(L@8@8:?AXS4.!QCQ
MFFKDWK!AY '@@ +P@#&.B@XXHSKQX@&8!P7(EJ9)@"ZKVJW)RY8"(&]!7P3X
M03U6XI"2-4@8KPUP2P3@ $:.TI!MX%V-BE'>LLQH8#U39@1V+L+_:HGS4D7#
M3%7+50O:.JF%8V%&JV"GFP$ E#-U, P8AK,,3CL]L[8F'F+/? A699/ 5;_A
M.JX^&V(/N62V56=A'>)X$T;DB"M5/;!TQF<B]LM>5NB%'B-O68>#>+QU@,<)
M@ C[\X !B,V!2"D+0( #4@P&J!/\4XCN90$,^ :7)>BEDXXC5HSN=9(&H(##
M8U@T<8#\0X<)$&: +0@3': 9H( ['H"=?I%#KEE8Q;$KFQ.'Y;7]G0 (0(>3
M!2\*V( 2D(>(^NDYD<?M/5?Y8%1*UH;:+0T$X)'[W4L ( X.P  BC4Y[O9;Q
M3:D1 ))P>.K%6 DL*X%RJ%D#."]A]HPG_Z)>AO8?_P-IO[& "W!-$\E+$TS6
M&=DNQ5"IK>%%#<8^K5VY<25 ! +&*UW5R794EF"X0LMG=X.W47TW;T4U"]"
M=XMGA]@TQ]1&>@/MM?,Z?Z:WB) .AONLKYN!.KFZQU0OJ^NS<X8S8W1 N748
M/X.WWZL(KH:WZ_,S((KGWSMN)VNW6@;LZ\;N,:H,_4D)O .2_RGD#3CLALB:
M#< 'DPB;";!="-B "<"1N8N*$Z!.ME;5\0J!1B;AT,T_ QB2!EA@DX  #-
M:H.(:G"2S@!7B#" >6 !#L@, \@''K&6.!6O]B:L"!AEF'),$FEMTK" $6"A
MAH@ 'SGO-P69#O\(AUL)\<\ED0X8!WDH9K_9  AP4@6! "!1Q02H@#;Q##?.
M;C!*@.;]5P6P[.E0;*<AP93[%P,X(#4KW91>QI-"$0,#->9*Z#BS+"<#$1T[
M[I;*6P-<"0H86W;.[7P6+!V[;;:#.E8]05)5@ /J<L<$&?5CN*@[KL%:;L%M
MYTXMX$0MX"<BX=]F..H8&4Z#[Q]']$3'E@V@!]>5"$B Q1* -PC(!_->#.+8
M@)P#@+!!@"]M"%; A^'=<))8:>G 7<D4\V+C;V5,Z<SL6;+F8PXXAVH(-9\6
MZQ*'6$C@D7/XVJ;YZ6[XLAODW\^31G<](%X$@%47C4YK\36B ,OQ#,7_;(@N
MZW2MII$0P(#QQMP5@7#+R0@;P8> ];V*>(=DU(:)Z!86*&I%CYI_,>TP2Q$+
M9(7D+ @'Q%=\K<[8Y!81DXY;Q'=\_;L3>;.(X)8B/=NC7NN=%HCQ+4^%MT9#
M/\"'NVV!F"[/+%NURVA(X%2U"]=WVW"PN[%O%5?PNG?"5-=QYY84?8?R3%/>
M8^TSKTSB;L &!,8OE?E13P Y2E0W5FS.9/>?!WH3X5^\3(P;#X&<@8!TF/$\
M;P@8<6^)D&7Z8Y@SC4[1^J$3&''C10 A88!KZ%,(*.;#KODT!8";[N(<OU,
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M1,^1!PMK."=R0X$!&,,&KV[]>G6C,SH<!)Y'M$R/'5@-*#$!P8#T Q!,V("
MPO;$#!ZC5S_!@X8&P!U"F,!AP@ -#-#>!#X%9Y0!:FW 3C[H<>!>9J-%H(]Y
MZJ6''@+))6"8>Q8.<,$&&E00$G<%$;31"7GDP8\V[B'0HCOH@/51!X(!8 !<
M%R"03WO2V?:=6!D]%!I"!/_19:1&!QG@CC:NI?/@4NIT5Y!7D+!W03GIZ3,
M!"GD%!%5U($U U40J2A02%)6E<X%J'VTV&@%E58. OILP($\7JF8QV =8?<G
MH($*.BBAA1I:J$?03<  !!"$DQ8"%K P@0)3)5#!!!:4TZ@[# QH'CH"><0*
M!1JPP((_%H0 X&\(E3E2I/FT^A,^)%Q  0#57  @1GT:$$%:C#8JU8WM<<!E
MHXXVVE!BF%HP0:./>CI!"=P@ %R-!X4$5U_;*18!= P 5^9!VX44@:0<5 /2
M=1$XP $&BG$T0 $:P(<F2 9 9\$&Z:6#E3NP80<>! 5X (%MVB94V ;N4)F8
M!@7_($"LJ(=:?/%+^XVD,4SE"F3 !+,)RVDYIQ:H&+T-6P1!!0.$<-P]7B70
M0003<.,! A4TJH\%W$Q L4RV=2$/!RR0,,"C$!1M 0(&]$E!R!M0P&FR#%!@
M0 <&7&!!"0/H3#(+!6C3D)I@=1#21OSD8PYR2M?KCCK;G3U9 H[QZPX$"'!C
MP0!=3,7=W#,B>=)J9W,74JF/N7-.9QQ$H*9!'7RI[[,C0T#!S.IH/AEXKPX4
MIN%2&FY0 B!CY9;H(B7P3LTB,V!:PYK/#5Y!GF-\.^ZYZ[X[[S8]U#@"P7L:
MO :.>Z6.LQKLHYYA+!SL]U0#48# 6B58_UA?"819,4(&_W0FG0'AU[U!"=="
MTN1%W4,PSX5/#9 0!O@!Z"$#"AA) 0;\GF,A]:[AZE"V8N.>_XG*>P781Q=(
M9)(((*  &X! J&X2'X]$@ $:F,!^&.! "$#/-@9 0 DTL(ZM**T$#^28:B!B
M'.1(QG8 F%XW4(>0SKP'7[V[(>[FYJ?@#&D&K.@, ]"AN30UI@0L^-^&)':/
MP9 ) .AB@3XP\C$"820P9W,; @X4J1#D*2$$44 (-(61&? C9/E TQ#/YA60
ME> "&-G<5"C -?VX*DW:FL ($+"NK*V#:PDK2 ?"431QA>0=I3%'!0!WMK*M
M9$@@ 9P3)^ /.D9R ^F86?0"=_\C%H2 .+*3DNQ&Y\*(5 R4J8L< ,91- <Z
M[)&*[(X&S-.0TM$K':PX'&5RB<-=\K*7OOSE3;0%G0OL@P&>,F8%#/"0D%SJ
M H\QIC$'Q V#N8E[>8!$!/ !EQ$4H  %Z@#'P$E&Z)0CF@Q8WH,X8 !TQ"4Y
M&3$ 1:)Y@=DDY#Y\@>8YYL&H"'0'*1;@ #09T !\4$!@W+,A "R3#P+.( 'C
M")?&9C1%$G3-.M0!P#7@DH_ Q"EE%2#(C$I7 7$A) 'TTH9!K7.\JAP'@B7)
M&U0."IT:N@J8-KTI23J CI")2Z*)^5X5Z74MD6Q- Q2+@/48H$!F.F8 *#1(
M0T>3@ C_1.!JMO$*4ED@'9',H $EH(>;JA&R]YE$:W?R2E@@,0&*2G%[4/T&
M="A0+IT:D0)442  D#*!" GD!.PX(+ET^9(9*<T"U:S*!BQ 0$ *) (.-(K9
M:'37%#*&<9+BFEO"HK"/68 $$(#<-4@@H@!&#Z>F/2UJ4\N[B$5EG>'K"D20
MUR-TE(X5V%0:"RX@+]'\Q #5@!I6MOJ1^#RD;B];E(>"=PY()" ?VB@'L083
ME->F#'X:6*@!6/%:\3$1?_TJW6MI2SM2-J!?]_)*-3J#,(^LM"#3XQ?"N'?1
MFMSC0^S8SSEF@[GHT05.""E8"2H@LX0$4T[T*($[6 %5\1"$_SEN(;!."A#%
MVJFVPKS,FC8*0%*1E$-B4OF@Q/Z8@ FLZJ@20,Y^U/$-WZ!P/U1UQSH&$!7_
M&L !+-B  3:2!^K4[#2)B< \R5H2[YE'B@!,S#DD-1U135 ==KM'23DP@HN4
M")!5I4"HOD0OI_Y)'8:Y )1SXCU_+#8LC?%F0^'(O5'&) $4*($#.1""!RHG
M(12XL125U*(!2,;"?OXSH /=$J^8!@+S]=,)\,>!"JBN8.JL2YP0 F2L&+EB
M'DD0G <PM:^QC +C:&@)^=IH<&Q (&KE #XJ+9)$ET,#AUW)0<ZA@7(L5B'0
M871)IAJI[]:4S2QYU35>=X&4)M2;4/\^: +RH#'C'.RI,IDL2TL0WYIR9WHE
M. =U$K 3=PI6T-X6%,@*< Y,<B\=^DT,O<JQGQEXP+!&&8P!NEF@(X<DJL[N
M*[B(XB"<&9D?Y=!4I E<NE8Y\7N,S24Z+N !-S:9,1"PP B,?-%W[$,#.(8(
M"/?!+!L&Y@3@R4<!''!+[*AC+5LM$P8\,ZZ/A8,$&*2 .\)A9-!U^R6-04\"
M9.T!&=JN,1+0 .<2T(#_V 9RWSXZTI,.3/62NR0S@$#\4+,?"CCP<5FCP'[C
M1)!Q])$%;R2)FSU #UP/UU4&_$QJM'[G4@, '>4XUK%+4H%T;.#!+ND 3-_W
M[JG&%9!E"HG_][A635_7!!(5,(L4(2O4GXCG)[_-NIP,EG7"S\0X(0A'J,23
M&AR-0!O44<>M]W-HI9,>)NK0FH;12J7.-  V.!+;5JA:50>8YZK>,QD#*L 5
MU>>Z(#C"RN4J< X/2%N*\SF,J%#XM) U+0+?B, X(G - ]V( QZ80*CP"C)5
M*?AO-C0 !C: 0>X9YF>@&<E@.%. :5\G 27PK*IYVE:$^)O4PYL .QC0?<H/
M-@+\P(ACU!UCZ="-T L'B,5XO(X'"%'-E9X#/B $9H=.G,:Z 8!TB0I,X1IP
MR,-L&(4Z4$ Y',SY0<+K7-Q!+1.X%( \B,0[5 /U#4!NL=]_A<P!_S+&!&A#
M ZQ+KN6- (Y&GS3@W!C /IB#-J1& CC !GB ,B'4<F3*!2B Z#$335R40DC*
MNG@%*S20W95)W8#(&(U&.!0 PUT':;'4"3%A080A!]C;5+$%]44@',+$3DG
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MR)+2@B[R2X@& 2>HQ0@R781%#_>Q-?+63J6>B8"=4$E1GPPD=-2N 30 /4R
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MT)K>W'A.R#;<LSWR,P:U6P5U)TMW<.@M@QEN3ID+H=QSK!X:?9<Y3DV0-0]
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M^"VY^)OTOXOG2[-?@%%.6>5CZ0/+J9>M*J[1>(55US";'=UIJ';3O(O0H?(
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M*B446VRCZ_212(>RMU@ LF:B A@MH09*'Q=J'X34PY#)E<Z4&\C493H  C1
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M>_*AB@S@ D+@]BRF+#0O.W)+@_$!OJD(+#XXX6+3J&Q8/RG(+N8!2Y,#4PN
M&R8:2-L[!/9+Z2X- :97\^BAO:TWY@+3WS1/)1[4?)W/91)  7I3PN'<6_(#
M$3W Y02K)+?36Q$ I*I!'B(* 514M;MQ-AYNDBL'+:XLL%0TZR[ H )2>EJW
MI$FENW>4=G^44R\ I#I[@4O RGT-O8&W0)5*?2WC>H<.T2;$5#J5 WKNG">
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M ]#!((,2_@P G1%W  <.&_9J>)E@@ 46ZS(RA#2@1(FD !(7*+'7KP5_&QI
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M C<0=.%0!!R  P%#FG$@IYP((# !!-FI X$'!:0$EV<,J=,!AI]!,!2"\5E
M E>NP<84!YPB<,X "&Q0  L<*&H04Q,0MQ $$K P@#H5E.#!/!JB2NA11_GS
M&((J(0 9_Z0&5=#-" I(R< 7ZA5IW&OPR9>?0P8PP(T'!57 @C\6I#I =F\R
M-$ !%QB;9KKJKLMNN^Z^"V];DG[&%HID1156042.:Q9>885F:5CX2LIO>%ZA
M4\$$$R2%;ZLE!5SE4->H*%I<#4M9D@'S;,! P/%^#'+(["ZD3@+M%1 HE@;=
M0U $B?F3E .J"6LB!K VYAX#Z&RX(3K:=6"RHX$R%->*#+V3P)"7#F9:<.NP
M0$)HKO7&D)^0C=.% 1$@\-\ /G?) :Q+&:!-J@9 H ''#'7!  D2]'4;7]^B
MK-&XQ'*@*00D@(/@M2Q8X.D&(<366 &$MWHM;X*.D.K?>#_G4/^Y"XM,>>66
M7XYYYA2^R1W&D#LL)(WSQAACP1I1.FF&_VH451X$$[V=I);N5)/JHGMU,69D
M490  AYL93OL<'DU@P(6C$#BF%R)Z*\!"*R:G<>:3T]]]76C$[;.'>PKI6L%
M)"6/=6TZW+OA!>WS&@0JTY?Q</M$.>XWY82K$J,EC- W>H WQ)P'A$= IW+4
MAP+'FYQY7C4 KE2C!,09@+2JM@$+<$ >"J  2B@@#U0-@$_U\PYX)N4:?Q@K
M ?BP #?6$RU0 4 ^"-"( 9Y6 H9 X#_K@  "#1"7<4D.7=;KH0]_",0@KNMB
MW!,>T7(''*^,*T68N9BD1E>_[7AE7B7_&9/!'%:IT[W)BEV1!P98I9*B=:4@
M>;!:E!XF%G0HC$1";*,;X34#KG$@)?[B2@<HP,")1< Z"B"0G^C6F!)LH )5
MC%1#N#:!9>FN(6<C 3MJU[W2,)(!_Y&:!SS@G*!PH 3IL H9)\ -<X2C2&\Q
M  =&P"2E)$8QBF& #+.50$@D#20)T$<!\+:OT'1@ &EC3 +LQ[=)I@>%[1F<
M7%P".N=!!B_RX< ]\M  RKB2B@9"@+#>B,UL:G.;UO/7\%9"I*6@#G0_(Y#I
M'L:O'MGQFZ SFH@\XR_/\(M(7"3GYS!V3M 0CR<;TD[JA+<0US5$/"BYF+[8
MZ<EV)B "ON2F_T,?FB!*^:L"HD* &!UV GG<+RD)" $+\,$GBLR  AR@!R%Q
MMH&A>:4@)/7?05L5 7;<4I^19$'?UI$>KE1  _Z+BW!"\,@M*N!56MG)/5YU
MCB!531\L*,!C7 D !]P205(;@040,*89)*P$.0'A!OQ1'M'@PSJ760H%>!J;
M&<AG R1ASU[V$9>6<  F?]P?Z QD&8CJ=:]\[:N"MNB0MXRS(6^:ESS1V*^Z
M>7->2SFG\!PKEIIX;'E?J6>'I#0FV14VG$ QDD.8J)2"O8EW]/*K:4_;O3S1
M[TT&:,"W2@"36BK&6"?@  G*D1T/GA2?_X2$/* FCX*@;AP7& $'=I8+4-*,
M8&(,0<U_/.4!/#B@:AKH!E97$JO);* @)Q#.S1P"@;FI[8^Q <I+^4&;#4AQ
M4@ LP&X3@"EP*#(X^@N<_^ B'Q9<=RD#"!-'FYD="K" *,E+P'!4BMH$*WC!
M;F1>2>89%NX-EIU9#*-70'O.)[Y)E\*CHD;&!-C2PL4J$P8=:+L2EY<.[[!
MN^+P  ;.T!+6FTK_8["-'SK/&4R@+PA@0 7X 0$&($ #(8!-=A2   M< !\6
M'$ (-  \ .Q#,4/SL LG0 +8H*0"-J3RU^H&7Q)\;Y(C8$'29+B!^P9GD]I(
MVK@,, !_^(,!ES' J]Q!'7HFV5NN7 <)B**2&4"" 66.@& 7"30#'2X!MRK
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,*9 #29 %F8P! 0 [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>85
<FILENAME>mrna-20201231_g43.gif
<TEXT>
begin 644 mrna-20201231_g43.gif
M1TE&.#EA- '] '   "'Y! $  /\ +      T ?T A_____\  (2$A-;6U@
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MLHCU)@ Y<!\;(, &$!! -<$:6)S03PQ@2*UJ6:9:@VW(D9G5"& 6T"$.S&P
M"Y", ,*GQ=+JCR:*,5AK@99:X2X*MK&M2.<2\  =+;$U&ZA;1P2[DN?VS@8"
MO5]RVWI)>.*PJ:2C+NM"_PA9A"!@9FLD+U>W*U$ED8@@"4 F1)0W0@"6E"57
M=8C,Y-K7O+(W(>IJP)DN=Z8SE4*Z#JFB3B$K6?P2-%[L,: V_TL1P0SX8&$(
M@P X\+J'A!!?DMSH2\J(OLK:$+MW3)EGRDMAAO1. \?U[QH)(B $X.%CEA5O
M2=(2U8,@X R3+6>+(6)']23@#(S-RT1J18 :P<,&!/.5CDV2'R52"L4)4V$0
M^3MD\!E$ )[][&<?@-F$".A5/"+,E#]20.1.Z;7]VR"7NTP:!"% 3U3EX(Y:
MU;*FK1DD%%2MH%4;!GT<>-"(!H.0Z>Q=!S%WQN#),P" LP]<E@=KWWU)H@4M
M 'N#]0,,G]XTHX&INU)DM[T$G). Y($'&XAUK0-2L$KP%AF#">#3G=:'K2-3
MZW[<6@"ZCLRH)\+<8TZFP"Q[JYL+TC(LF;*F>N1Q;U4R).'N^MJ\WG6VA=O?
M81]D-)_34@.TM($F; "CDIX3 ?BDHABW:KT?*6ZVYXWM>B/_V-N-OJ).5;=N
M=VT@J"X];$K61.^"VUO;02HSG3]$*0UT>@,-&/>X%X"K=JKK-@,!38=-15^4
MU$[>!S?XO/'M8?50Y@$9#E88+O>82*<7H*LY,@$(IF;MGH3@!P\YMM-*<NSI
M$%@S^Q"_ *#A[AKD00H0  0><.D> =8EVQ:YSN_=8JRJ%SP+L"%>$'8BUCS:
M(W_^",ZE3G9N!\F[=$P7>.!]]*N3\S%KU;I6KE40NF\5H!"X7G0;AV"VB_@E
M'R^[X.N8Z@J=<-JR'5SO+"LDOP>E-YZ-?)@UJAC(6DX X[X/70Z3P,CR?. $
MF;KHJ>Z0_#Z8BRG"%XPZDX#T6-;H_TVIX#P,3>X-=,UO-^1[&![0 +3]L[YD
MK0G(!6]OPNO9^.%*]T+20EL.(,#Y&KB6\QFC 8%;9;G?WO?1=1='W_JNN@,A
M/MD1W$:U*!;X&)F0 CB+@*&3@?T/6)3CA])#,D!<XK:ONZG%_%GT.&<M1295
M^$,0PS=Z._=YVC,0&X M:;& '*%%"0 !80*![?< KW975<%;]C$P&89R[$8O
M2Y(7"R""UZ$SZ&,18><1:V* 9"<1#1 &"[@!8K(!83 /I2"#&0$89T P85 ?
M'$ P0S<GRE<4TX8O>9=B"5&"_,%B D@3!2A^NX9\A@50&Y : O USH< _7!J
M7,0W+(!9\_\7%'&A 5PGA+\2@:D$,0_0<A_18. 7?BQH;^2W? )Q!A!0='5X
MAZ1G$>S#-XB7@:3Q -($6UK4%]#R=7@($BG8$8$7AP4GA:I#!@(@3:7@7/RB
M.1WF3<&S?0S7;8\T$ LP>?TW9MLS)(_V=0D0!F&8$(L(00/AB,7W$&WT0 KW
M$%\H,7BE?5+Q*$GF-7+S<V1 6VI8AV$PA!#1BB#QA(X(B05QBPGS*E^U5T@8
M2.13BT?16\)C6(0! 6= =PE@#S$V73$Q)% H<G.8$,&S09"UB@B!.Q3$CC\Q
M/,5V)KMW)E=H) EP.4L'92.!C'!$@.48B].H%J63.Q-BC G!0F3_D&AA,&B(
M@3?EQQ3UXCG'M&$"%EJ2\1U-Q0%:DC,A\6XLL8(!^8@Y^'08P6NJU2R#)A_#
M@Y"V@S1D@!_;,0_RT0#O92.'T70DX8\>H8SE:'Q"-D!?I2Y+1$302#/.R&4/
MT 20AD2P-Q10LES8TA?>R!J]\X,26!_*1U.\ 3K/!UA3%9($"(OSMH=EU$.W
M.!H *%,R=33.2#]?&$8,%XT%$7]4]85)V6-^8U56!%QKDE'LP24/P"<-4#?;
MM !A8 /L)HM(URPCJ!M_MW:S!I!D&84+AAS$\R@+T%H-.6B%MI;@84)91#\\
MQCM5)D!J0@:\1SQ'<SMJ$I<(:$8':7IE_\06X1$7SG=,][&&I"(?ZI5;NAF.
M@0$ &Y &UJ),ZF:&;P@ E3ER"P$E8:0FFUEK!F,@G:9:"G!8-I248L0[1(F7
MX,D"\0>>3R=&N?.4,0*/)S$ '+D!F?,=#Q)?"-"#7!@12L,;?/$PIO)Z+.&3
M+$B'K_(JS@@E"L Q! &=:?6%UH=5K/F%:5$*\<!P:SE 0_1MQ"%4R[82G8,O
M"L!82;87@))TMZ$/'#:0\,0JC#496@D8#^62%T&.S6EV+$*>>/F:22D08F"@
MEE6:3Z464>ES =J# 2I Y/D^$4E#N5@37*(,UQ**_.=94VDD[*ETH441H.%/
MC-5O:S(K+M&((_]IF77T(>'YFJ7X'\J@ 4]#/KE'IFSZ?60 #V) !J9@"G):
MIW1*!4T@IW'Z%GS*IQ3B05[49K*)GCIA0EL%G.TG$0P%F0(A*SJB+ONIGD06
M>E_JG.?)FF?71A]BH-2B.\^%/7#* $K  *1*JJ,ZJE00"Z4J!J4JJJ0:IS23
M,(':./*%FZIX$],#8_(1.VYI'@MH&0*031,!)1HW)/:D1PJD:94*I@3%/@%*
M/!J0 Q1*>$."I*WA/*]0!55P TQP U70K=RZK=ZZK4R@K>5:KE7P"B8YA?,@
MB+PG)@( @S<H7S'19AR02EYW9VLE1LQU>S*6D [B'2RJ*U$"$R+9G)__=J!&
M0EB\$9X2>@HVBIHMB80/8@JO@ 8>@ H9J[$&X $=BPH<F[%H8 "H,+(>@ 95
M( :7%9MUM'Z5$:P , !-$"SW"%S4LAE?5Y@A(21]<2@9-T_WU1)>VIQ2:*9K
MBI=B1#_[T"E%J7W56J-B<+(9X #YX  .,+494+4.8 (!D+49,+56ZP#O8  W
M8 K$LZ;M,Q"YR2=Q<0;MMX<S07=V]W4I\Y<604Q]$3-%QI,9 :/+FEII2R&W
M&)?=^28Y>B1#:A#YTYUX*08C&[946[5:&P!4:[7Y(+E4FP$=*P8\R[*^T@^.
MT5R008F9^!*I8E%B\G6<Y7.=F&49JCUK(2 0_]!JG+$^01L3_BE^">FP;^HJ
M0QJMO)&X"HN:-OJ%#. !65NYDGNY^1  E'NYD:N\F_M4/00U0)431]D>8("8
M+LL>@#$MYOFOV7<D":"R+G>[*Q%',<IK/ </T'A"O@.=;V&<KO*F4(2@T*F@
M#8N7\& *R!NYS=N\#N"\ ^R\SIL/7GNU)N !*KNFWR-"#_.',N$PJHD>E1&.
MM3*(_)E@<L6P+N6$?VLPPRN@'Z*GK"H&*)S"K'H(IL  *>S")XS" )B7%G.\
M5]N\!IS#.CS 7ONU9&N^)NHK5488UG@21 E0G*$ (SBHYB$9/5A]A$J06!4C
MD&JPE/FWR >7'Z(&./_P 1^  QT0QAWP 6/\ 3= QF@\QAT QAT0 73ZFMGH
MNZ9P R:0 91+P#J,QP;,O :PP)S[?;/:>29HF_!U3 V 9RVR)KEU8!P@!LJG
MC@1I.#%!:^N[F$GBH R@ R-K B0+LJA@ "0;RJCP#AP[LB6+"BGK(,YX-U 2
MM:APN7E<P'E,P%?[P^[;-R94O<F:GNH2E44L=@7!GL?4#X$9([6S#RN72HA!
M1ZL(DLL) "$,N-]VBV+P :A@M5_[M0B<S2: S=L,MJ#,P&QTGE%K ';<M;-\
MS@8\P)>KN1[  +C3H&F9RZ')IM,65]WIHLKE/T"B 0HUE<K# 0(0,V%P!F<\
MZFLXY'D@O+X)%Z8LX+C=G+7,*]&P'  3W<Y5:P*IC%)#0@;EG+6SK,/J3,L:
M+0:#FSVYG)3T?"\ Y$'4_]L2YJD="G & O  =^BOM4,J=VC0>,&V$EP1?/NB
ME,K0"'&+9( &UXS#%AW Z-S4L%RUX<P $?2I ,  :'"U(AW2SGO.4"W.\0.>
M'B1&]RIY-F;!,>!9=:$81.025 E:9'-T@!%]JK/6"MVE5TRT:45":<$ 'V
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MWG_5M+&/SG_>YJ2*0$9@="L6R(BGK/99Z %A\%#0L). ,.AI 0O_&,[+B+<
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M&GQ.F% MS1R=3E30.^(L*?&^."K%?)J^#\.\,*DT)$P5SDL3OBPS>.Q0B=(
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M.';/S\KZRA8\^CETN5]+.Z4)KZ &!!#D:4<P3Z$ "*6X(^ @4YD" 0A*/4A
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MW*+>W*)[,"!286*!U5C@J,A.> R(M%@>XD4V)M>JE56KK9I)* 6_^(3F9!0
MA ',F14U-IA>0%9*Y(SQV5E:A)'&F)AF\=M-T-R, 8H ?%Q*7$4ZZI6K, M&
M680_ON-PH8;L.:1CV-73,1E3I%9GU!A%' =!^$6?I=4#R%X!!F1S'$XP$AM#
MTA='30B3M89M[<V-89?%')6RX-9OA 5849=@_!ISE!@":5F3G210!J50,0XE
M41:E41XE4B:E4BXE4S:E4SXE5$:E5$XE55:E55XE5F:E5FXE5W:E5WXE6&YE
$0   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>86
<FILENAME>mrna-20201231_g44.gif
<TEXT>
begin 644 mrna-20201231_g44.gif
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M < !QR<[0G%(SC)&@M51!U@M\78 0"003^E+M;%ZUJ5@:W("V'.9/%$DY!D
M)G"+$10V'?5G@94<HQ9O)I [ZQD ]B<0KS2A&3@HO8:;96$!&L  \4,B"C
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MWLS]-G7W^L2GR#BJ!T"']*UM!(Q(ZV8UFPWT"H$>VX!( + XA=Q-(5_@@&0
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MV<R&*I^"BF%TJ0;&KC3 '<LICD-))SUWGOB!\70=4AX CT@^X+;C]-9B&G
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M[K _&$3 OA/2(2I.[@Q"9&X F2P#P'G.#["-!'AC'#EWY -RGG/;*(S4)E%
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M3,)#45E,YI$ZPWB0_NN2P\A&A) [)N1*@F"QD^$]!+(VN&A%&THCQP28;="
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M:>%!!<"@:D2F 4ZD;0 O[0, &P*P&:F5P, J'7BR87 P!,_(DB=3SKJW;H
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M^A&9?SB"#\^EJR]]81>PXB,0EJ2E+E:R %HP\#P"' $R3HM9 AKP!7*TBG(
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M;_PA '_XLY.-YHI-66\ ,AN0C,%W'+1^5I1\K]1>^XH%)H$I$KM+Z=_@X/I
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M$RX-3M")LTT> I'+EB!'9HR#AB %GHG&03C%@?2&1WW5DW605I6 UO#*W#3
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M92DN &BRMG*J*!<U;]1PH@R [)P&8HRQ!\6>*FT.CBUD)GVH8=*NUN0&?22
M6;CB/=V33VQ QR:#,E<?W,V$2;ZSM5W>Y^U7MP6W2QR 2V #/D@TB@^$>J%0
M.D"*(_+$$(##@+V$UIX0"!P8>RDGHL2L&F^21*?+3LQ&:UK FFBD'_[9B+27
M9D'*BP!M%="9*S+'1+0(UG"6X CS_V] [>OBQ$RJRZ4]$S[$D@C_84KUH!RO
MC7^U"@+)PRZ5E0[+1/YQ,X$\E VG1IXQ907[A8_#A%TW+ AXX7=N"(CA)G!J
MCC?P8HU?AU6]BS,E@R;_4Q%:A#MA[D7]'J*Y^C]-0^%&1(K%M]6>KJW'-TJ3
MQM=DU3UH2 *HK$(BQW .@$T/9 P/Q7 V.S)!QLT>U7%2.*40RA0UN[$$:P0H
M,$25F:*  %0D>S%E]W,,@,&:6P(8)'<A)E3T,<XI0 /P&+[DWH/"K<GI.$:V
MAXZ_QCU2QE7O$XRS"_V6]E?M%P(]YU6EN/<@A(%<<%K?AA]YQ'5V[J/0C>7X
MN 4W0!6,P/] T!=5$0"2> =-M>[E>D0"<(/9SD2*^EH#H#%CRZG_8/:#T:\Q
M-Q:YY6QT,06>9?8 F!&:"D855$&><>:!(L?7X JK%O% 4?AYT+E@#L413/+>
MI@6J^BJ8I,?P+H UM8W(90C"CPJ8-(%452S.JI5%$*B9RQDHV\0 >$,ZQ -L
M'P"U;7">CPC*)L XF/)&ZLD0)<#_WE("&&K65;1/AT0SD4@1FH6&K%@FT-.
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M( 4K8# 1R" "$6 8PT-P@ -Z!=V(,,BP[%&@1P*PGY;<@S#OJBYXTC8AG@5
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M#63AX Y.!71@"*;!AO[&E2!"'N0A:)2 &#S '(E!#5( X0C0X]01%-: &/[
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M$D#HKDSZTLEEWHK5/@D^V(=DV. !O&$[ L F>N9WD((\Q @#"J-"'M,C<N(
M9&PBS#-3'A#K'()52R A$B U>_#& K0H=I#_K-P(\B9$ [CADX(5S0XT0+(N
M/&^4Y<ASUQA"[](C11( 2PH  KS!&Y0@M)2 &RIT)51O6C:4W2)%6!"B,XKQ
M,P9@O1SB.&SB$DCE-!93*8+'^J:']0#3<+QB*>=N6AD3'_8AD<X!&["B+73N
M.E#K7?VJND"46O9&#_M+2=4)*HHE%9'R+L>" + A35^)9R9/BR"6$_?N ;[
M!!C@'C"@'[!""2YA#,: !7@ %J2!!:2! >,&,0CV*/=*>J+P,YXB(TK@'H:@
M)I1@!SQL_E3 $Y" #A9@&D0'NJ[#^)HC&3T'-D/($U3@45< !78 %$P)):Z2
M.2/R.[)N;F(0K++N_P"&@E,MY %R8B!;#&.W#.>J /4<(A9$%B)JD$GY\WPR
MA#SS%N?8((T.MS_+J%:A<VU514[G*I\L)!8^47)_%@*K-2D:ZV U9!M>+AGX
MHC98H'1--QD@X>&RRA>M)Q>UB$W]Y@W#+P(.X C$PB(H$T?@LB\:X-KF2O5
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M\&JK;R1=(\B(]J%>3+HE;+%>%H8'I)M36/]2*2!E/S7SNM9# 1J@GX^<F33
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MPBH!<)HENY%A3HQ52DA4B#!$PE<MHP*0!U7! O^H-:&B3#@W96*(>E5*19B
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MJ0+I_WWG* K(R;YF1;_C8!, ]P 334OX*2E>C%E-&, XOC< Y5:65NX(0$\
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M$-92)?83U<0Q884O!3IAK3H"LJ6<.*<4;Z0>5C$8:J1-9$JO,:L2\K 0ZQ
MU8&AKIH6&Y$.+,<&T ( *^H0/-L0_];"'148  ;2+P6 L$?+<9HG<2:9B4B!
MH]"D=3@6EYMQAI5X>BS  G1 !V( MEX[KM7V? MA,O0@.Z @"/E)#*_P!S\A
M3^8(*U1;58* !.81+^LG(TZ71!JD!+%3.YD "I!@0XSJ?W,Q,BNT35>)=<>I
M MU:%LYH4YGV%&_3*'RZA,S3% OW"2BP!CK0<,!H ;D$"CN !*&02\Z)8GJ2
ML@X'NR,E)IL:$P56!Q' MGE732GUI62X93(+O&_!-P;"*"?2/</+?'S29R.*
M%#&Q*I 1%\Z+62B1 !\VDOHF$B#''@Y =SIJ?4R4 NX&;+I#G4KAL0 @!GK'
M*;-;*.RU4/\0<I7'D \XI!0.0 Q4 (XP,A7L(P9\M9\MBQ]- 1^^E!0.)[IK
M22$PNX=/UD:Q1P)J<%['*3W5M(J$IQ++!Z<@@Q@$*QJPYQ$) )R8AQ0Z@ 1G
MI@0\P!H^@13VFYR_P*]H)\)*V;&GYR)B.B?C%2*IEIBS.@(.@ PH0 R>047S
M J&DU!PB&[Q)C)H(P0 !D(":F3)LH;07 0\!T %!9!S@9QP18!QS4;TR"@#7
M^R#O-Q+6D _20,-7B0(KH&[&>54J0 5DH&.G9)@7@B&[YW G,%)8DGO_<2>%
MB<=*< RWRREGE F@BT9*\(MS9Z4H(,>GTG_H&'/@46H)K)B$ 2+_]HH6X.$)
M5BN#1=F@')6I%T*Y/"4P]F%+$ ("ZI /ZP44\OD+RB"ZF:-,^%%5R:F[.8<4
MR <A]."U8_#+7DL/3S-X?C=A5%3$I&2[#I"<7#41 (<5K?4I2DS-7W&0U4%7
M,;H!$*D3K@H:">(4X) @BY<.CX)AI_4ZT"H&P\ #,%1R=( "OHI>M+4"*/ +
M1;DI_8(2(N6@-P)"/+"66XLC!=0I@GR[^,%)^)FL]2"7LN$B]QL]:VFI^8P?
ML*<$8S!-$CI)+!42Z+ 1$*"4)  *JT=FLA!-P2I$]UHWUG,3U+7/VM4<,GF(
M7,'!>/.@%'4G-@0)L" (PR [KU"44( "_X%:"I_P;LB'.?&$!/,D MHW+Q;
M*!#@#=Z@!*\ U-X0#Q! J1YWS%/44MJ7%1K  76@:U2@#>^Q4")<S6LM&CG1
MF)021, G7EFDD,Q+F77VQ7?=$'F-%^=\$6D1N',H!F+[MG_P+BE@":HG"Y:P
M!D2A!J"0G$BP/M-D?ESJGHCZ$[NTU<SGQSFL&08=(W2W W20K"P0+P[]T&*
M JYG'TZWI7Z4-B(P!KM[R2%S<H0Q,NA (6?TN%J7!IZ0 CCW2%$4@E!C 0GP
M->+0  =P7 WP *R2$.D9>+;'8PX'.](Z#&(00]?ZK=B7K)G *2,81=J2 DA@
MWDW]VO/R-*WH(O_0^GJ8(]#'_!F/DW85T@#J8 TIL .>\(MUHD9L#>"A,3*4
MQHM]ID@7D:J3."#',LYM@1?DI).UBEFA@A:\/-CF\4!7Z8V60!0)5I_*0(YY
M2SK"!Q\4E9?^,B?UH'<V>"ABR!#*,,C+5 "''+ZO8GGUPDSE#;K[N2<Z?(9
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M -_IPHI3#S%S>9JA#-\Y'D\Z0:-(?L(V>6.@=\7-AT&WRUZ%Y,I5 +5C"43
M1&JP!H0 "O>Y YF 9B.%PV(E&T#"]>=N>'PHP$77G]P@OU4F H<,"FH>E\GJ
M#6"=L>LU!$B M^$[$NW%'E=1 #;D&=N7A+A>6#.U%792Y^P1 1Z0#\/0B5Z7
ML4'FMQBO^F6(%X$8  1P@,B=D4<KW6V:H9.>$.&U6:2W$6YA)6?ZQ0+F%G)]
M6CT^V"S0XWY:Z,KP"F$P+[Z$%&=$!^9-VNHB?#<B*W.R2R0H\"WG%X0!'M90
M!U6F#*J]/@" 5.O-[/^/\QW*L%<[$+ZZ+(!V AZ70 (D!)5*M15)H0"+"Q
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MC@M(AW6F+["B/"DBJB[YZ'Z^9-X5KK=9BT#FU'P>8=.>L#-ACZ+Y%1M1\16
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MZ=:2YA#CN/(WDCH?T0@-D&N8B-7216_B=#%B( 90\ 2V30%B@ 6K6?.W(;4
MHVTP;N<; ZN$I6V!.._,Z*F""(],H(+3BM)K] 1/V/1PNX^QA0G90FCW,.)O
M1M"Y98WO\I%U20L,;\HA;4J3Z18+=(XAV+R^TX:9;@]].EW9GM/U?&0=1@$)
M%&4U\#A)(XI. ]VSA8F=X*%R&0+J4#"#:A6\ZHC%R2(W&KNR(P(UH""4#.2:
MT-@1AC?_H0^!H9P&40(BC \DD%MM4BT-1\EV"NB,D*":(^DIB1$24 9L"IP<
M_RH7^QZ!D2Z7VA6,RAR !&AV8\9PAB5\1=GPPB>=$'#AULA'TD%A#'?V$ #\
M=+*XN1/VM4P QK=V:\_' @> #7#AR[>C!$!,>$B F<+1$Q^B0E-Q5>U+3\@B
M^^"(%V\>WA)R?QP:&WD;!Q $;2!JB#!E<=Z42);+JGWW6*?Y(%OE+R.#[=/K
M@GTC2*>(U>N+@I9+-Z9N)[&0_HW7SE4!O' (!7:]OGC6641I [(8=W*1C)!)
M5HQ]O[G/ =U7/<4[["$8K<EB$>#X)T@#@"!"Q!,9'0X<D"A0 ( \"PL61%@0
M8@& BA8O7E0 ((3%"  B1A!S\.%#C"9/HDRIDJ/'A_\+%<",X"#%"B)/;CY1
M@4()"0 *0G#\J%*E1I\P85:,$,$#I(4+6TX$X+0 "26@/(G9(0:4084*.U+4
MJ)%BT@7*Z@WQ.'0MV[7RI$90XHE*)IX5T7U<T"# B(H+*VILN;&M2@L5#0,H
MP<9BE0 7#2,&$/GP9,F'+5^V7#DS9LZ= 8QH4#%! -&5-P,8$"!!10:.,2*>
MC#IVY1 !.E@\G?MB@"J9#1-8C1DUX>+&4QH.VM'S\>;' [QF^] !*!5I;A)1
MH2*% [4<-7!#6?3B7\ :RTN5JE",,A(1"G0? @L)"B@Z1 Q9\--O1?WIG8X5
M6T5OC5=>! J4I%1"5?V" A7_#PI"Q0J>K. @%3N\$L$00!6EGW_H\1<B !1)
M!%$$)*BQ0DXWR9(&$2L8,^%]7TD%U#33D%6<82#))%-W,C'GG)#DC8C90M,,
M,4P=R*  2D\DG3>1 G^)Y=-?0$D4D50PA3!$122(0(5-+#XAT HK(*%&"B2P
MV9)20A$VC@+RM$32 B?\N,!L0Q;W5T0Y(CB$$D@0T2).*A#A9 $1 ?5?<V(A
M]9.)D$"2GT4E_>650FRF0(<8#T)!C @)%2!/IC[5:%$!"SC PH]\PJJJ"*!0
M@80./7WUEP8!Q *8JF&1&&MG5?A6$1N.;28@9+L5%IENS/Z&4@#P5#0 &QIP
M)&"T_P"0QAH QYXD&W/.2G;@7P&PH=MF$7!TVV,5[>4MN\+2RY9'"<#3 #P/
M0(#1>/7&"IUT$0VAC">('KH",@<MI)\&_:"*T4M66E1E1CZ]I=XG::5W8@3$
MH"#&+P8-L6%1$Q.I5%I**06BB%&Q+!,H2-2:@A(.**.$#L,,HX02[?5T8+;]
M(1BQKRM-$X)"@ZZ :-,JR**3,30+ @5/"54$%)8NJ_27!9>4P (+GUS"PAC2
M*/$OP,5UF*.?2O"\P@Y*O+=JHZIF;=[)&T657M$>R11*33AA]X0E*U#QB2"_
MA*($?NZ]1QBD%X7@4 3U &GTVH0U7-*4,J4HD"S99:<"%?\.4/FAYFN]5/1$
M(2"H(:40031B6$[YY168.B 3(1)(I"""IEQWY  /#FQN7,8R.TA,R^FEMU>O
MR_DD$;V3)4!L AHU)ED" YR60#H8?6]! AL<EH#ZR@W@K?@>+6N!^=H^,(!%
M X!O?@ 'L&:^_1:M#UH#^$( -,":[K5O Y%I'[?^-QIOD6]\JNI-:A*0G(NT
MCS4<60BZ+O, ],$C .D@3O*N!X!=02>%O?G?FTHX)(&U14,TR0[AY'8K&ADP
M)9/C3X$JEB.I\$ 9'BD*RY20B1TTR0'YH<@0464!20T!!#[3 15UH(3P&.8\
M%;O(CY3QBT_101L*D<D0=%",.OS_2"E/Q-N(BG82LI1G/!LL@ =X\" J>&('
M%;J0&'0P'R3LP&KX 5QZ?MB6A7A#!")0 @NLJ 1O!,F%*K'3W@0UC*;5)7(/
MV>!XF*@?C;RE846ZU'\BH PDU*10.,F.&I20@DL@X5-XM ]"O *GH2!F40!8
M(@#$(+R%*$>20QE+1#8%BE36!%&(0L$.0.$18/KM4>>9V!@IY255%> H5/K2
M5[HC@E?$$@5("(5!WD,[VY7D(Y<CE3!-4AD-Z2 3@G FKLRS$ UP8'KH\<^4
MUJ9"UAR+--!)%V2" YU80#  !#A! ')@OARH4 /P"H %(!J $[P%,L>"3A40
M0QH"(&8O_^U3(;=*(X\%/,"B"M7,1#GZK=6DD WH \!>'@ =B:(0.E^PS !B
MD<(2K/$V>X'. 2AS@!0BU"(4M,  +%J%X'AK(21LYW$,>@("Z*L$*5PC59L#
MPZ$\9 @.$ ,*2)>3%]$%>1;)(1M1%2F,U,YO'EK $!:%IR%.Q$0%@P(@Z:"$
ME4$O:P^) #?*1@<Z?((.+)#&&+1$I*RQ;":*0P(HNJ.IN!0C'[KT'$.@5[1@
M2>PD')'3IDAP$)WYU6<'.2T= -G,F]63>&]$"ER4XH!/\.0]:AG27_QSG(F!
MUD]EK,D**MM;++$12J@Z56!KYY17/"B5VD&<)SZAQ(.D  H[N.5C)EYQLYC5
M3HN!E0SN]/21*K!SB\T=C&_;6I1_A25$%C//I=)"'?H@8PUJ2-$.UK &4!!#
M!\_42#"-(Q;<Y8Z.Y'BF9SG"$>NQ<5$.4 (Q: ;&FW6'=NGT2*MVJUZ3@#9B
M:K/(@YEK2'4J@0HHH(-[.O*3#;JCH?X2,< ,LU$VV*\Q#=VH1%^*+H92M"(Q
M;8 %H',"-@#9,"%L3!7X<='#^#0';(#H"493&LM -1V-R0%N2$,M@1X9.J+)
MC088^E0?2_FF%;$J&Q0 B8%N%&( ,/)&QYQ"8D'G?S>VZ/^62N<40G!U_UUM
MCFJ$@Y&CED"V@T[)5R,YV$$]: <'4X%6J""2\K 5)1YFW2A#\J-@1L0]H-@!
MS720EE))Q2%8<LFBE"$&D"S ELQ-2EQ>@<1,ULTO$1#!,>J0EU'62XNK4A C
M#\(RJLA$"9?8+@I:&0'$#'$AH>PGJ@!U*:5\0H@,'K%*,D9M: \M1![Z2#_5
MLDGK96HZ9)BN@!G<67$7F"V9$I3.K&(?F_DL9B5S@ =@F15)TU*))>JL4SR\
MJ =+10P)(1!2RO.4<T/8P_$]6EZ4D\W!;-HC]B4#"NISM10H"4P.&.PVVRJD
M3!6 4IN^R \-6?"T>*"U6?&$S33T.B9JR+J[O?_X1OSSS(''&W<_O]O$'*(G
MBBQ*"71 02:G BF-B(-7@/$3*<<3/^3L9EF,64QK]F=EWZBF!!9)A]?G'&0
M/* #$%R'</929:FP_0$GO/)$Y4YV:DW46W0GNVB.U>/$%-4B;R&[MUQ#@&I1
MD*8!6(=21]"$PXR@RA^U2 FV(61#[T4TJCE!47;%]0 P  !'[7&15T,1EBQZ
M2$>5>VA]&LG4GZ31[RHDP1P  64H8QB!5(98E<+$$Z8C*MP6D: S,I&0*&3B
MN#NMA9WWG[R2I#^[9L&?#+E;!5A."9,%Q:@BAQ$E6*,.?^H:#[<T<:3/^"*
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M(5J$31W>7MS#13"4D"W&E/G*7HS/5,$>6X +2L1+O#5C[%$44PU!$XP#! P
M.HS# '2C!4# B9" 6%''*W"' XA =T" !2C0 R0 .H"/-@[ -<YC$UQC-W9C
M/'HC!&R /38!_FR  CD ).!'0&X ^#2!!9  .H@5[A$#*+P"/8@ .J #.Z;#
M/$( .D# .H))+]C>$/"C08(D/((C!$31*SRDSYC6.C(5. X !'R3-( D_@P!
M3?HC0N*C/U[C3LHC/MKD.#1!1=HC0]X>)!P$2V;D./^ ).XMTD.^PBMX@$FN
MHS9N)$E" #9N(TUNY$$.@4)"@C)H(TABHP78(T+69$N"#_Z XUIFY$9N)$B"
MY#IN0$V.0UTFI#W*HT%J)3A2)$@N!2BH 2B PCF:Y#^2Y39NP%;JX3=BXUUZ
M(_YDHUHV04:"I 6<E@<<I>U)Y3K:WFJ=EA)X@& ^942F8SC^HT&.@T&F0T""
M) F\PE&"CT:2)5EF(SQF)3HD9%Z&I1XFYD'F(4!F93WN9%JR8TF&YBM845PZ
M #<\I4Q,I06,)#\"Y%6>I4X2ISZFIC]V8T4. 3H<!#=$Y4A")C_*XS[V)E=F
M)#C:5\[DC X V%-Z0&F:E@/_] (Q8*94!F18AB4V!J0>8J1_1J9+_B<]IN9!
MSF-BPB0W0*3/A",ZQ,-ARB8V/L !' !)!B0XW ,]/, #:,"&NJ-:@NAUYB%:
M!@D#%,M+\89O#)4*08=&J&(( !ET0)0%A5!X*)4X^!AT.!D%35[>"1G>W=V<
M%8MR7)UJ2!"X9$SBS2( D!V+0H?<V50*Y0#KJ:)J4$N\E,>Q& ;H 0"Q"$4(
M=$M23*-S=$_>#(8LFAX&3B-TY.%% J=_;F,\:*1;TH,'Q"<$L(D(3";^), 1
M&.AC-H&!!BJ<$NJ?#D 3A,-!'@$W* '^A$,XP*EM@J7/V"D]>(,#Q,, ; !0
MNF5-_\)D+Y# /Z[FHVY .DSFG!Z!!X" JBJ#"$" 9BZFI@Z -] #))BD?_XC
M;Q+JK@XJKFKJINHJ_AP!"&#J2PZ GZ;#17:G(E7%JMHI-RC#2]8DG![D9.ZI
MIDKG1MZG-MKFKGKK2Y9G^W #") K/9 K"-0/_EQDK](D0!HJ_K@E!(!F"M"K
M?;KJ1G9C66[E0;ZK?_;K5G9C>1[!(CD./WIJ8DXK12ZDJQ[$(GD#:'I +Y"K
M-WA#7D(J;U[LJX* JUI Q;IEO@8E_C2!/]JF@4JG'IYLK.9EOZKK$1P!O]GI
MS_ K2'(#I:!C8N)/ILIJH!KLM_HKG.8JO+HE-W"# ^QJ/__6Y&3RJT$>@:>>
MK%2BXR*M:B^H:CHN4L02ZU;ZJ9^Z)4 .ZJVZJZR*K3QFY)OV)[P*BA1"*]CB
M)E"^I.UM0#]H "2X:5KJH2V>K<]^ZTEP#]<!@&O (@#L [JP0>%60>$:HT4D
MP_[4C^*Q1G",D%*)AFMT@.$6[N&1QDZ]10AI$-V%XIR%'F6<1)AVJ2&BBT9
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M#, !5 %K ,0!-@  1 # A@"  @#&$>C 1@-!@E7@2020H 2# P\LL&D  %\
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MEW2E- QE[ '>N,>$2K.Z'^W+2@,(1SI^Y\3"*<X!(N@%",( @0A0\C?4:92
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M2$O6@8!KJ3. !9%,--RX1[U(\[[7Z<2I&"+EZ+@1084B:D&D^D!\ .4W1^I
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M=X *D& -S(H$&NB!."[DE* 5_[($"P,:[>(66W,DZ4(!%" $ID$)+@$*_Z
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M_V'V+@"(&:N3!Q!4(9@1+AU !XXU$C.!&'P5+L%Q',#0 R- !RXA-'5,T^B
M,RV5@ KW#4?5"Z'1 H@U9^I0&^_0,@O  M("@03(4-/UQ%Z7!4B@8.,1 "!
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MSN$5)D :DL$$^KBFLUC&:G(<- "B#\!#W;=,KR563]OP4 #MX4PDOW9^Z+L
M!H !*O3!!Z"]#WH)!5V#()B0B4(J#AF1U]>3*1J&-14 2  4,-L,RU9R/2$S
M7]?@XJSKZ("4_;,SD: 1J> 3*!<*2!T*/,$3Z&!5!Q8R\2?7ZR)+!R 'E<&
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MAM(#F!+ 33I91N2;;[N>92]:!8CP2:Q7T:M=8BHB#%,Z#,PD4 C>"(=-E=L
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MG&_6 ;",U!PK,=U'A(B#]$O;AG!'^,)HY0<VFBQ@&G<_\VOTU,<>G@RG!4B
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M$F8!  Z45H5A%F!4,Q#]4'(-X ZGUP#$,I$S&)0[)BVLDD,'02HA02N*@6E
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MRG,2-6B5(!$+/HJA_WJ!:3#R *59316"#4;!%P\4HEA1 )BC4=345-66 .E
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M&D$U)#=6.HD!4*H[V6$9U59M6C;=,TS8N,RE#9#-;<0AN=A,B6(0B7;,^O
MD/8 '9W6$,&]':-A: $AE-HXP)%MX9T5&K ./:;6])8AW7BT"1#AC7$5US(J
M8#L1.(11XEE!::P<5Z%3[S&^!KQA5XBNU'2JM Q4^GW+F"+)H^V:@5G>,U1P
MR\O"8'L9ZGW9/G9-F8(A4TH _^GGSQM1;_$EJJ5Z %0CTMS0&6O+%;LUW<M+
M'*?XG@^  >1@X4[C-%"5*?(+Y0.[#U_ & , X,IA 5-%2ONP#3Y1$.$\VPCU
MOVX>YUUC&_;CNP-A/R@5*PI@/YIKP;]]B++B&S1.;\1Q;5)8ICT]&G&1.R2V
M34!%3;S)F\(C'-V+N-AF=P6Y&=#3W,?:?#1[$,&\IM4T $T  5VMW^X@#E(<
M'%I&'"X>;3H9.MNXFTYVN<0!'!IY; K+=P   2# #?0 "88:0J<(YU$JN4 Q
MAA90-:F.#^X Y@U@Z1GQONZ0M)A;50M96 ASLR+JX?)BM:PNW#S\XEJ6TOT"
M">+PWF$;D"VDN*89(UU@=H,#$$*< ].4^2_"?)N*!K;N=#UFSD19888-$HJQ
MC&] &1E888AA5G)9I9,&JT*M3,L 2S5-E7WHG<ST<,)Q](P!#0!XN.PEP*P#
M@ X>XMIRWBQ,>?(J__\L:'$\HP$J9P< QY/R0:D7RO5%83( ;$##-YCB _ %
M'=.LL=UR%L'<Z;A!(/;A&N#9C;5Y;H0.>TDS2^0IW#,99:'=]SC>,JPQOG'
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MZ@!M;56.RU9@B,P$M:I?Z%)$+&%NB&&8G@>XJ<XGBLV>J8&BA"P+&XM=G12
M! P_H"JCH$X.9MX \ 82D7C32/!1OQ[ @@>"LZ")<<91&^%_$0QZ;NB$NF<H
M"1_N5W#G1!.G!+&GAY=5JZFU/GWUUV??.8Q"TF"?Q815#)_Y%8/'(T#;)R^
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M %E$K?L8 %]QF_74IR/;#*/&";^SYW^:KI=C@!EG@[8)8@!O)Y; 81"^/P)
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M" #R   @$" !P80* 5@@"*+!!H5L @Q("._@0@ 1,B:T,* !PH0- C1(6"7
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M!:S7$0 CB9-; *-U9P%ATY&C(% 9P6099MI%6-$#^WQ!(D?_:55> I&Q45L
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M@/Y-ABPL;$"$AE(FK30G(2>T6OWL-#SU6& DT:H42PJPEASXIF_T*E%R5C;
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M74=*QY1CU=DE>08??A^CQX;,+&S/H<>BVE<@.M9'8GCI_VT#K'E2 AAIGFQ
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MQR++NMNU>M2KMQ5&6K>;5^%U00-@W<8;5+M.?_\^]/$B+)MU "8CX4;T3=H
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M8IZ'LH':7FT#LAP O9)->57!K'#KQ3Z'09##4^P<O1;>'JFLG,985GS76CS
MF'((R XMT1;M8?DKANF)G+Y27S04JAW%3#"5:LS)4Z%+.HS@1A@$[7G-\#$5
MD25&A/Q0O7(=\G"LT9XMVJ9M77C/6+8,Y_"%9YA+5R M=,IA=W($33"'\BW$
MH&4$68#:A.A(4/ #?,@F::DMXB:NXCJ)UB9$UBS;EZQK,/&G)^W)Z&G>_!7
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@-$_WM$__-% 'M5 /-5$7M5$?-5(GM5(O-5/[<T   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>87
<FILENAME>mrna-20201231_g45.jpg
<TEXT>
begin 644 mrna-20201231_g45.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $8 NT# 2(  A$! Q$!_\0
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M*_X5=HH I?V+I_\ SX6O_?E?\*/[%T__ )\+7_ORO^%7:* *7]BZ?_SX6O\
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M8NG_ //A:_\ ?E?\*NT4 4O[%T__ )\+7_ORO^%']BZ?_P ^%K_WY7_"KM%
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M_P ^%K_WY7_"C^Q=/_Y\+7_ORO\ A5VB@"E_8NG_ //A:_\ ?E?\*/[%T_\
MY\+7_ORO^%7:* *7]BZ?_P ^%K_WY7_"C^Q=/_Y\+7_ORO\ A5VB@"E_8NG_
M //A:_\ ?E?\*/[%T_\ Y\+7_ORO^%7:* *7]BZ?_P ^%K_WY7_"C^Q=/_Y\
M+7_ORO\ A5VB@"E_8NG_ //A:_\ ?E?\*/[%T_\ Y\+7_ORO^%7:* *7]BZ?
M_P ^%K_WY7_"C^Q=/_Y\+7_ORO\ A5VB@"E_8NG_ //A:_\ ?E?\*/[%T_\
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M;1?^0-8?]>\?_H(J)?$VCMKS:&-5L3K:Q?:#IHN4^TB/.-YCSNV^^,5+HO\
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M;_#9^JV.VHJ&X6X8+Y$L<9[^9&7S^3"H/*U'_GZM?_ 9O_CE247:*I>5J/\
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MEY6H_P#/U:_^ S?_ !RCRM1_Y^K7_P !F_\ CE %VBJ7E:C_ ,_5K_X#-_\
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MH\K4?^?JU_\  9O_ (Y0!=HJEY6H_P#/U:_^ S?_ !RCRM1_Y^K7_P !F_\
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M-_\ '*/*U'_GZM?_  &;_P".4 7:*I>5J/\ S]6O_@,W_P <H\K4?^?JU_\
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M?]>\?_H(J[0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0!=HJE_9,'_/2Z_\"Y?_ (JC^R8/^>EU_P"!<O\ \50!=HJE_9,'_/2Z_P#
MN7_XJC^R8/\ GI=?^!<O_P 50!=HJE_9,'_/2Z_\"Y?_ (JC^R8/^>EU_P"!
M<O\ \50!=HJE_9,'_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 50!=HJE_9,'_/
M2Z_\"Y?_ (JC^R8/^>EU_P"!<O\ \50!=HJE_9,'_/2Z_P# N7_XJC^R8/\
MGI=?^!<O_P 50!=HJE_9,'_/2Z_\"Y?_ (JC^R8/^>EU_P"!<O\ \50!=HJE
M_9,'_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 50!=HJE_9,'_/2Z_\"Y?_ (JC
M^R8/^>EU_P"!<O\ \50!=HJE_9,'_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 5
M0!=HJE_9,'_/2Z_\"Y?_ (JC^R8/^>EU_P"!<O\ \50!=HJE_9,'_/2Z_P#
MN7_XJC^R8/\ GI=?^!<O_P 50!=HJE_9,'_/2Z_\"Y?_ (JC^R8/^>EU_P"!
M<O\ \50!=HJE_9,'_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 50!=HJE_9,'_/
M2Z_\"Y?_ (JC^R8/^>EU_P"!<O\ \50!=HJE_9,'_/2Z_P# N7_XJC^R8/\
MGI=?^!<O_P 50!=HJE_9,'_/2Z_\"Y?_ (JC^R8/^>EU_P"!<O\ \50!=HJE
M_9,'_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 50!=HJE_9,'_/2Z_\"Y?_ (JC
M^R8/^>EU_P"!<O\ \50!=HJE_9,'_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 5
M0!=HJE_9,'_/2Z_\"Y?_ (JC^R8/^>EU_P"!<O\ \50!=HJE_9,'_/2Z_P#
MN7_XJC^R8/\ GI=?^!<O_P 50!=HJE_9,'_/2Z_\"Y?_ (JC^R8/^>EU_P"!
M<O\ \50!=HJE_9,'_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 50!=HJE_9,'_/
M2Z_\"Y?_ (JC^R8/^>EU_P"!<O\ \50!=HJE_9,'_/2Z_P# N7_XJC^R8/\
MGI=?^!<O_P 50!=HJE_9,'_/2Z_\"Y?_ (JC^R8/^>EU_P"!<O\ \50!=HJE
M_9,'_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 50!=HJE_9,'_/2Z_\"Y?_ (JC
M^R8/^>EU_P"!<O\ \50!=HJE_9,'_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 5
M0!=HJE_9,'_/2Z_\"Y?_ (JC^R8/^>EU_P"!<O\ \50!=HJE_9,'_/2Z_P#
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M %VBJ7]DP?\ /2Z_\"Y?_BJ/[)@_YZ77_@7+_P#%4 ?/?[>?_)(='_[#L/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD.C_ /8=A_\ 2>XKX-K]:X;_ -P7JSXC-O\ >7Z(*_5+X-_\DA\#?]@*Q_\
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M[7_O\O\ C1_;6G_\_P#:_P#?Y?\ &KM% %+^VM/_ .?^U_[_ "_XT?VUI_\
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M^-']M:?_ ,_]K_W^7_&KM% %+^VM/_Y_[7_O\O\ C1_;6G_\_P#:_P#?Y?\
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M@@_9TX/-?EQ7ZI?!O_DD/@;_ + 5C_Z3I7G<5_P:7J_R.K)?XD_0Z3^VM/\
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MF%0?;Y_^@;=?]]1?_%U=HI 4OM\__0-NO^^HO_BZ/M\__0-NO^^HO_BZNT4
M4OM\_P#T#;K_ +ZB_P#BZ/M\_P#T#;K_ +ZB_P#BZNT4 4OM\_\ T#;K_OJ+
M_P"+H^WS_P#0-NO^^HO_ (NKM% %+[?/_P! VZ_[ZB_^+H^WS_\ 0-NO^^HO
M_BZNT4 4OM\__0-NO^^HO_BZ/M\__0-NO^^HO_BZNT4 4OM\_P#T#;K_ +ZB
M_P#BZ/M\_P#T#;K_ +ZB_P#BZNT4 4OM\_\ T#;K_OJ+_P"+H^WS_P#0-NO^
M^HO_ (NKM% %+[?/_P! VZ_[ZB_^+H^WS_\ 0-NO^^HO_BZNT4 4OM\__0-N
MO^^HO_BZ/M\__0-NO^^HO_BZNT4 4OM\_P#T#;K_ +ZB_P#BZ/M\_P#T#;K_
M +ZB_P#BZNT4 4OM\_\ T#;K_OJ+_P"+H^WS_P#0-NO^^HO_ (NKM% %+[?/
M_P! VZ_[ZB_^+H^WS_\ 0-NO^^HO_BZNT4 4OM\__0-NO^^HO_BZ/M\__0-N
MO^^HO_BZNT4 4OM\_P#T#;K_ +ZB_P#BZ/M\_P#T#;K_ +ZB_P#BZNT4 4OM
M\_\ T#;K_OJ+_P"+H^WS_P#0-NO^^HO_ (NKM% %+[?/_P! VZ_[ZB_^+H^W
MS_\ 0-NO^^HO_BZNT4 4OM\__0-NO^^HO_BZ/M\__0-NO^^HO_BZNT4 4OM\
M_P#T#;K_ +ZB_P#BZ/M\_P#T#;K_ +ZB_P#BZNT4 4OM\_\ T#;K_OJ+_P"+
MH^WS_P#0-NO^^HO_ (NKM% %+[?/_P! VZ_[ZB_^+H^WS_\ 0-NO^^HO_BZN
MT4 4OM\__0-NO^^HO_BZ/M\__0-NO^^HO_BZNT4 4OM\_P#T#;K_ +ZB_P#B
MZ/M\_P#T#;K_ +ZB_P#BZNT4 4OM\_\ T#;K_OJ+_P"+H^WS_P#0-NO^^HO_
M (NKM% %+[?/_P! VZ_[ZB_^+H^WS_\ 0-NO^^HO_BZNT4 4OM\__0-NO^^H
MO_BZ/M\__0-NO^^HO_BZNT4 4OM\_P#T#;K_ +ZB_P#BZ/M\_P#T#;K_ +ZB
M_P#BZNT4 4OM\_\ T#;K_OJ+_P"+H^WS_P#0-NO^^HO_ (NKM% %+[?/_P!
MVZ_[ZB_^+H^WS_\ 0-NO^^HO_BZNT4 4OM\__0-NO^^HO_BZ/M\__0-NO^^H
MO_BZNT4 4OM\_P#T#;K_ +ZB_P#BZ/M\_P#T#;K_ +ZB_P#BZNT4 4OM\_\
MT#;K_OJ+_P"+H^WS_P#0-NO^^HO_ (NKM% %+[?/_P! VZ_[ZB_^+H^WS_\
M0-NO^^HO_BZNT4 4OM\__0-NO^^HO_BZX[2?B]!X@TO5[S2?#'B'49--U*32
MGLUMHH9Y)D"EMHEE0*F&!W2%0<>XSWU>-^';CQCX0TSXB75KX%U.[U&]\02W
M>FVYNK'%Q%)'&@EYN0 JF(L58JQ#*!U.U=7?:WXWC^C?Y]!]%;O^%G^MC:M_
MCQH]QH/AW51HVN)%KFIC2(86M$WV]UYK1-'.0Y6/:Z,I);!(^7=Q7>_;Y_\
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M"%%A<.!H=B RM'@_Z.G(R]?EQ7ZI?!O_ ))#X&_[ 5C_ .DZ5YW%?\&EZO\
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MUG3_ !!I\5_I=];:E839\NZLYEEB?!*G#*2#@@CCN#7Y$5^D7[(O_)O/A/\
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M-_\ '*/*U'_GZM?_  &;_P".5=HH I>5J/\ S]6O_@,W_P <H\K4?^?JU_\
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MF_\ CE7:* *7E:C_ ,_5K_X#-_\ '*/*U'_GZM?_  &;_P".5=HH I>5J/\
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MEY6H_P#/U:_^ S?_ !RCRM1_Y^K7_P !F_\ CE7:* *7E:C_ ,_5K_X#-_\
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MROFSLV?P[]_RUVM'2_\ 7]?H'6Q2_LF#_GI=?^!<O_Q5']DP?\]+K_P+E_\
MBJNT4 4O[)@_YZ77_@7+_P#%4?V3!_STNO\ P+E_^*J[10!2_LF#_GI=?^!<
MO_Q5']DP?\]+K_P+E_\ BJNT4 4O[)@_YZ77_@7+_P#%4?V3!_STNO\ P+E_
M^*KEY/BQI4?C9?#C6E_@W0T_^UO+3[']M,/GBUW;]_F>5\V=FS^'?O\ EKM:
M.E_Z_K] ZV*7]DP?\]+K_P "Y?\ XJC^R8/^>EU_X%R__%5=HH I?V3!_P ]
M+K_P+E_^*H_LF#_GI=?^!<O_ ,55VB@"E_9,'_/2Z_\  N7_ .*H_LF#_GI=
M?^!<O_Q57:* *7]DP?\ /2Z_\"Y?_BJ/[)@_YZ77_@7+_P#%5R_A[XL:5XD\
M52:)!:7]N6^T"RO[B-%MM0-O(([@0D.6_=NP4[U7=R4WJ"1VM'1,.MBE_9,'
M_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 55VB@"E_9,'_/2Z_\"Y?_ (JC^R8/
M^>EU_P"!<O\ \55VB@"E_9,'_/2Z_P# N7_XJC^R8/\ GI=?^!<O_P 55VJF
MKZBFCZ3>W\BLZ6L#SLJ]2%4L0/RJ9244Y/9#BG)I(;_9,'_/2Z_\"Y?_ (JC
M^R8/^>EU_P"!<O\ \57C?P#\3:]JGB"\_P"$NCN3KVLZ5;Z[;S1:L]Q8_99&
M*B&*V"JD!CPHR [.&RTC'('N-:.+CO\ UK;^O,E24MOZZ_UY%+^R8/\ GI=?
M^!<O_P 51_9,'_/2Z_\  N7_ .*J[14C*7]DP?\ /2Z_\"Y?_BJ/[)@_YZ77
M_@7+_P#%5=HH I?V3!_STNO_  +E_P#BJX3XO>(/"'@?P^)O$.H6%I<7PDL;
M%=8U(P1R/(NUE+NWRQXP7//RCH3@'TBBIE'F7*]BHOE=SYMO/^$<L],^&.A>
M$O$&B>);BSGTQ9M+>>1M0U"UC98X[N'9,&2.(&2<,49"J\,%SN^A?[)@_P">
MEU_X%R__ !57:*T<F[WZMO[[?Y&:5K>22_K[RE_9,'_/2Z_\"Y?_ (JC^R8/
M^>EU_P"!<O\ \55VBI**7]DP?\]+K_P+E_\ BJ/[)@_YZ77_ (%R_P#Q57:*
M .:\974'A'P?KFN^7=7?]F6,][]G^W2IYGEQL^W=DXSMQG!QGI7RM_PWA!_T
M(MU_X4<O_P :KZ=^,G_)(?'/_8"OO_2=Z_*VOM^'\MPN.I5)8B%VGW:_)H^=
MS3%UL/.*I2M=>1]:_P##>$'_ $(MU_X4<O\ \:KWGX"_$R#XW>#[S7?[+NM%
M^SW[V7V?^U)9]VV.-]V["X_UF,8[=>:_-&OO+]@S_DD.L?\ 8=F_])[>NW.\
MIP>#P;JT(6E==6_S9AEV-Q%>NH5)75NR/H3^R8/^>EU_X%R__%4?V3!_STNO
M_ N7_P"*J[17YV?4E+^R8/\ GI=?^!<O_P 51_9,'_/2Z_\  N7_ .*J[10!
MXK^UII\4'[/OBIU><L/LOW[B1A_Q]P]BQ%?G-7Z1?M=?\F\^+/\ MT_]*X:_
M-VOU+A;_ '*?^)_E$^-SG_>(^GZL*_1G]DO3XI_V??"KL\X8_:ON7$BC_C[F
M[!@*_.:OTB_9%_Y-Y\)_]O?_ *5S4<4_[E#_ !+\I!DW^\2]/U1ZI_9,'_/2
MZ_\  N7_ .*H_LF#_GI=?^!<O_Q57:*_+3[(I?V3!_STNO\ P+E_^*H_LF#_
M )Z77_@7+_\ %5=HH \5_:TT^*#]GWQ4ZO.6'V7[]Q(P_P"/N'L6(K\YJ_2+
M]KK_ )-Y\6?]NG_I7#7YNU^I<+?[E/\ Q/\ *)\;G/\ O$?3]6%?HS^R7I\4
M_P"S[X5=GG#'[5]RXD4?\?<W8,!7YS5^D7[(O_)O/A/_ +>__2N:CBG_ '*'
M^)?E(,F_WB7I^J/5/[)@_P">EU_X%R__ !5']DP?\]+K_P "Y?\ XJKM%?EI
M]D4O[)@_YZ77_@7+_P#%4?V3!_STNO\ P+E_^*J[10!\S?MUV,=K\(](9&F)
M.N0C]Y.[C_CWN.S$U\*U]Y?MY_\ )(='_P"P[#_Z3W%?!M?K7#?^X+U9\1FW
M^\OT05^H_P '=+AD^$?@AB]P"VAV).VYD _X]TZ -Q7Y<5^J7P;_ .20^!O^
MP%8_^DZ5YW%?\&EZO\CJR7^)/T.D_LF#_GI=?^!<O_Q5']DP?\]+K_P+E_\
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M_P :%[L5%;+_ "2_))?('K)R_K=O\VR[15+^VM/_ .?^U_[_ "_XT?VUI_\
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M=^3_ ,CU6BJ7]M:?_P _]K_W^7_&C^VM/_Y_[7_O\O\ C7F'67:*I?VUI_\
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M8P4M+62ONNQYV7U,3+$Q51RMKO?LSZVHJE_;6G_\_P#:_P#?Y?\ &C^VM/\
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MOTA_:B8>(/@5XFL-+/\ :5_-]E\NUL_WLKXNHF.%7). ">.P-? 7_"M?%_\
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MU*-)0DGJ]GY'5D\)1J3YE;0[>BJ7]M:?_P _]K_W^7_&C^VM/_Y_[7_O\O\
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M "BBO*_%WAG3(O'5OK>@+#9^*+%)IM0O$&9+B.6!XX;65\_-NE,+)&QP/*X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M([:VA01Q0PH$2-0,!54<  <8%344AA7&?$7_ )A__;3_ -EKLZXSXB_\P_\
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HVUI__/\ VO\ W^7_ !KD_'EY;WGV'[//'/M\S=Y;AL9VXSBBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>88
<FILENAME>mrna-20201231_g46.jpg
<TEXT>
begin 644 mrna-20201231_g46.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M )2F?M=_]O'_ *?)Z_?ZOP!_X--O^4IG[7?_ &\?^GR>OW^H **** "BBB@
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MGO$7[/?QPN_@WXIU46&A_&"P\$VHT6X8O(JR&.:]CODC8Q2;6:U&_;\H)(!
M/O6BO)/$_P"VO\"](_8_E_;J\(:G?>,?AQ%X6;Q)_:WA*T%S*^E)$99;E8G9
M'(CC5F>/'F+L8%-RE:^4X/\ @YS_ ."45S^R_P"(/VKX/B1XE_L/0M?BT2#1
M9/#ACU75[^2$SB&SMW<"0+&-S2.R1IE0S@LH(!]C_M+?M5?LZ?L<_#-_C'^U
M!\8-%\$^&DO8K-=5URY\M);B3<4AC4 M)(0KML0$[49L84D=3X \?^"/BKX(
MTGXE?#7Q9I^N^']=T^*^T;6=*NEGMKVVD4-'+'(I(=64@@BOR>_X*V_MI?\
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M^$7Q?^ OQW^$MA8^&OB=K UEM:U+P\%M;VZ@M'L7L[N5HMK"6.6298YC\QY
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MH_\ I"**/^#WG_DUGX'_ /90-1_](110!Y__ ,&FW_*4S]KO_MX_]/D]?O\
M5^ /_!IM_P I3/VN_P#MX_\ 3Y/7[_4 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?RM?\'9GPC\>_ S_ (+-
M2?M :QI4LNC^./#VAZUX>N'4B&5K&"*RGMPW3>KVJNRCD+<(?XA7]1?PX\?^
M%OBO\/-!^*7@;4TO=$\2Z-:ZKH]Y&P*SVMQ$LL4@(R"&1U/XUXQ_P4<_X)G?
MLL?\%1O@9_PHW]I[PO<RQV=PUUX=\1:1,L&I:'=%=IFMI65E&Y<!HW5HW &Y
M254K\T?L<?\ !-[_ (+ ?\$Y?A]#^SO^S;_P4$^%?Q!^&VELZ^%M/^,GPTU%
M[[0X&8L+>*6PU&,R1J3PKN5 X18UP% /T3N+ZQM)H+>[O(HI+J4Q6R22!3,X
M1G*J#]X[$=L#G"L>@-?SN_L/^(_&GQ*_X/-_'VO_ !1NG?4-'\4^,;/2EO"=
MR65MI=Q9V:Q@]!]D$9'JI)[U^SWP*_8I^)-E\8M._:>_;*_:+F^*'Q T2VN(
M/"5II>AC1?#?A1;B,QW#6&G+-,[7$D;/$UW<S32F-BB&)6=6\8_:O_X(RW/B
M[_@HWX3_ ."L_P"QE\5])\"_&#08VM_$>F>)="DO]$\50-9O9'SUAEBEMYOL
MTAB,J%P1'$=@9"S 'YD_M:^+_%7@;_@]-\*:G\,);B+4+[Q1X5T_6!;AOWMK
M<Z!:V]T& ZK]D=L]AMSVJC_P7^T^PU;_ (.A/V<=*U6RAN;6YNOAY%<VUQ$'
MCEC;Q%,&1E/#*02"#P0:_43]D'_@B\OP^_X**>,_^"LO[87Q4TOQW\9O%'[O
M1+/P[H;V&B^%H/L<=B!;K-++-/,+2)8!,[+\KR?(6;</-/V\_P#@WL^*W[;W
M_!2WPW_P4BD_;PT7PSJ?@K4=&G\)>%E^#TMY!!%IEW]KMX[B8ZS&T[-*6WNJ
MQ @X"KB@#X&_X.[].T_4?^"MW[.UEJ%C#/#<^"=+AN8IH@RRQG7KH%&!X92"
M1@\<GUK>_P"#XO3+.T\9_LUW5M"$+:/XIAVH %5$DTHJ !TQO-?;O_!6#_@W
MN^*7_!4W]K'PC^U-KG[=NC^"9O!&@V6G:#HUA\()+U=T%R]TTTLKZPF\M-(V
M%"J%0*OS$,[7/^"R7_! 7XK?\%C?&'@#Q+\1/VYM$\&6_@+0I[2UL-'^$<UR
M+FZN3"UU<%I-9&Q&:"/9'@E%&&>0_-0!XI_P>(:A<:M_P1P^$>JW9!EN?C-H
M$LI&?O-X>UHGK[FI?C%X1\*:E_P9E6&FZAI-JEO#\%-$OX46-4"W:ZI:SK(,
M#[YF^8GJQ8YSN-4?^#OGPMXO\$?\$8OA%X-\>^*=/UO6-*^-6B6E_J^E:.^G
MV]V\>@ZXGF);//.T(( ^4ROSGGL*7[.7_!+K]OW]O_\ X(@?!G]EKPK^W[X?
MT+X->-O!^CZEKVG:[\/FN]=TZ&.5;G[!;W<-S%'<6@G1)$22-)4"+&9G0;:
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M?A4^FRG;+YT<L-RNJS")E?.0T3AE8CY3AA^F% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X@_\ ![S_ ,FL
M_ __ +*!J/\ Z0BBC_@]Y_Y-9^!__90-1_\ 2$44 >?_ /!IM_RE,_:[_P"W
MC_T^3U^_U?@#_P &FW_*4S]KO_MX_P#3Y/7[_4 %%%% !1110 4444 %%%%
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M"D'[/_B[]GK7?%2[_"WB7Q-?66I^&=4 95(35+.5EB*LR!_-CC6/>ID9 P)
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M?\$_?$O[%?QN7XI?\)?:>&H= @@T%TGO[IXUMU6<:IY>R3SHF#E@ K@MMP<
M'Z8T5F>#M:UOQ%X:M=9\1>#KS0+V=6,^D7]S!--;D,0 SV\DD9R &^5CPPSS
MD#3H ***\^_:E^/,O[,7P'\2_'Q_A;KWB^R\*:3<ZIK&D^&I[-+M;*WA>:>9
M!=SPQOL2,G8'WMP%!/% 'H-%?)?_  2@_P""P_[/?_!7SP=XQ\:_L_\ P[\9
M^'K;P5J=K8ZE%XQM;2)YGGC>13%]FN)@5 C.=Q4Y(P#7UI0 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!^(/_  >\_P#)K/P/_P"R@:C_ .D(HH_X/>?^36?@?_V4#4?_ $A%
M% 'G_P#P:;?\I3/VN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[>/\ T^3U^_U
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MA]K6M>=J]OX?S&?!6L3$@[ OW+&Y+,%'W$=V@("/$I /WX_X)E?\HW/V?/\
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MGL/$UYX=TN-GN=6L;9)TFABC7F5T$PG$8RS?9\*&8JI_%'XN^%?BO_P;B_\
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M,UO:N.N-C<?,37P%_P $'2!_P=#:OD]?&'Q!_P#16HU]T_\ !Y[^TYX1TO\
M9(^'7[$WA[4$OO&_C?Q[;ZV=$M/WMPFFVD-Q"K&-<L#+<W$2QY'SF&4+DJ<
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M[FZ^$L!F@T/QM:7>L7%I(62WCT_PO;QWI=A]W,L<D1!_CD"=3B@#](_VK_\
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M_P!(111_P>\_\FL_ _\ [*!J/_I"** //_\ @TV_Y2F?M=_]O'_I\GK]_J_
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MLPM^T'^S=X"\=FWCV0'QEX/LM4\M?[J_:8GP.3P/6K7P?_9P_9X_9YL)M*^
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M$L[.\\<:ZC<3^7'(TDC-&I",TCL5)8D_*7_$+S_P1;/QF/QD/[+$Q)O?M?\
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M[_:8^&ECXL\(ZVJ?;])OF=/F1@R21R1,LD,BL 5DC967L>37?T4 ?.?[*_\
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M;\1>&?!OQ$M&MO&/A_3/BMXF6#4(V4(_742T3/&!&[QE&>/,;$H2IV?V)/\
M@DW^P3_P3EUW6O$/[&/P9U'P5-XB@BBURWB\>:Y?6MZ(B_E-);7E[-"SIYDF
MU]FY1(P! 8Y^C*I>(_#?AWQCH%YX4\7:#9:KI>HVSV^H:;J5JD]O=0N-KQR1
MN"KHP)!4@@@\T ?S+_\ !N_^SC\#?VN/^"Q?[1/@#XMVMQ<VR>'/$6J>'-6T
M+7[C3=2TV\3Q%9*E[87MI)'/!*(Y77?&XW)(Z-N1V4_O)^PK_P $F_V(_P#@
MG9KGB+QO^SG\-KP>+?%KN?$WC?Q/K=QJFL:B'D\UT>YN&8JK28=@@4.RJS[F
M ([7P9^P!^P?\.?$UGXU^'O[$_PCT'6=/F6:PU;1OAOI=K<VTBG(>.6*!71@
M0""""*]<H \'_:O_ .";7[)_[9'C[PM\9/BKX,U#3_'_ ((DW>$/B)X0URXT
MC7-*&6/EI=6SJSQY=_W4H=!YCX4;VR[]DW_@F]^R=^QEXT\4?%GX1^"+Z\\=
M^-YC)XQ^(?BS6KC5M<U<E@Q66[N79ECRJ'RH]D>40[<J,>[44 ?+OCS_ ()!
M_LB>,?B7XU^,WA_4/B+X+\6_$>Z>7QWKW@#XG:MI$FN1L@C\BXB@G$+(J#"G
MRPZ;F*L"S$]/!_P3'_8CL?V-X_V -%^#<ND_"58&AN/"F@>*-3TW[:CEC*+F
MYM+F.XN1(68R"61A(<;]V!CWNB@#P/\ 8C_X)B?L3_\ !.6VUC3_ -C3X5:E
MX.LM?<2:MIG_  G.M:C9SR@*!-]GOKR:))=JJOFJH?:-N['%</\ "_\ X(:_
M\$N_@S^T[=?M=?#3]EZSTKQA=:E_:.R#6K[^S(KSS1,)X]/,WV5&655D0"/;
M$ZJ\:HRJ1]:44 ?+G_!03_@C7_P3Z_X*;ZCIGB?]JSX+F_\ $6CVOV73O%6B
M:G-I^HI;;F86[RPL!-$&9F595<(78KMW-GM?V&?^"=7[(7_!.3X<77PR_9*^
M$T/AZUU*:.;6=1N+R6[O]3D1=J-<7,[-(X0$A$R(TW-L5=QS[=10!5UO2+37
M](N=$OYKJ.&ZA:*5[*^EMIE4C!*2PLLD;>C(P8=B*^-_$G_!O9_P23\7_&F3
M]H[Q-^SAX@O?'TNN1ZRWC&;XP^+#J0U"-UDCNEN/[4WK(CJI5@05VKMQ@5]I
M44 >"?M7?\$R_P!C3]N/X6Z'\%OVK?A]X@\9^&/#M\;W3-*U#XCZ]&IN2'43
M3/#?(]U(JR2*CS,Y1795*@D5Q_B7_@B;_P $V/&'[+.@_L3>)O@=KMY\*_#.
ML2ZIH?@N7XI^)?LMK<R%B6!&H[V0,\C+&S%$:21E56=B?JNB@#R/]F;]A3]E
MG]D#X"3?LN? 7X:S:?\ #V=+J-_".L^(]0UFR6*Y+M<0HFHW$_EQ2M+(SQ+A
M&:1R5)8D_-_@;_@V^_X)._#CQ%XGUCPC\$-:M].\56\Z7?A63QGJ$NCV\LD<
MD8N(K-Y3&9HA*[0M('\AB&C",JD?=E% 'S=^Q!_P20_X)_\ _!.>_N];_9"^
M!'_"+ZEJ-JMOJFIOXCU&]FO47)'F?:;B13@LQ&  NXX S7EW[5__  ;I_P#!
M*']L?XY7?[1?Q4^ -Y8>*M5O?M>O7GA7Q'=:9'JT^<M-/%"X3S6.2TD81W8E
MF8L<U]Q44 >2Z?\ L-?LP^'_ -F6T_8Z\$?#^\\+?#JQLVM;?0/!?BC4M$?R
MF#B16NK"XAN9/,\QS(6E)E9BSEF.:\T^(O\ P1>_X)Q_%O\ 9H\*_L=?$GX)
MZYK'PS\$WWVOPOX1O/BAXC-O83"-HT(8:@)'"(\BHKLRQB1P@7>V?J6B@#R;
M]CO]A[]FG]@?X8O\&/V4_!>J>&_"INFN(="O/&&JZK;VLC,S.8%U"YG^SAF9
MF98MBLS%F!/->LT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% 'X@_\'O/_ ":S\#_^R@:C_P"D(HH_X/>?
M^36?@?\ ]E U'_TA%% 'G_\ P:;?\I3/VN_^WC_T^3U^_P!7X _\&FW_ "E,
M_:[_ .WC_P!/D]?O]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\4_AQH6IV7BCQ9\.WM;"[U-(M/>[MKE-\$JVHN%5H9?)5'!BD:)H=ZA?C_\
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M:^L=#\-6FL:7>QP)>EA'8VR^3.3:0*&)8.8_(AWP_6/_  2Q^%%[_P % _\
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MR/V+HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
M$'_@]Y_Y-9^!_P#V4#4?_2$44?\ ![S_ ,FL_ __ +*!J/\ Z0BB@#S_ /X-
M-O\ E*9^UW_V\?\ I\GK]_J_ '_@TV_Y2F?M=_\ ;Q_Z?)Z_?Z@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH _$'_@]Y_P"36?@?_P!E U'_ -(111_P>\_\FL_
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M/*83>V-U Q698IAY4L;+')&Q4[61TD;V^@ HKY(U#_@KA\/)/A]XJ_:6\%?
M[Q9XB^!G@?7;G2_$_P 7-*FM6M\6LWD7NH6=F9/M%]I]K('66XC4$B&9HHYE
M3<?7OVD?VU?@/^S%^S_9_M'>,?$$NKZ)K=QI]GX/L_#")>7?BB^U!E6PL]/0
M,%N);@NNSY@FW+LRHK, #UFBO!_AA^W#;:O^T+8?LG_'_P"$.J?#/Q_K_AV;
M7O!^F:KJUI?6OB&R@8+=):W5LY5KJVW(9K=@&5)%D0RIN=?>* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
M MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\
M"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH
MQ_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0
M?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!
M](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F
M]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?
MF]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK
M8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"V
MH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,
M?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2
M/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](
M_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_
M\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_
M ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV
M** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
M MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\
M"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH
MQ_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0
M?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!
M](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F
M]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?
MF]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK
M8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"V
MH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,
M?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2
M/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](
M_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_
M\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,?_A!](_Y^;W_
M ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV
M** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJV** ,?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** *.E:!9:/(\EK+.Q=<'S9BP_6K
MU%% 'X@_\'O/_)K/P/\ ^R@:C_Z0BBC_ (/>?^36?@?_ -E U'_TA%% 'G__
M  :;?\I3/VN_^WC_ -/D]?O]7X _\&FW_*4S]KO_ +>/_3Y/7[_4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'A?[6'_);/@?\ ]CW+_P"DS5[I7A?[
M6'_);/@?_P!CW+_Z3-7NE !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117\^'_!0C_@HU\:O
MVQOC#K,D'CK4K#P):W\D'AKPU8W;PVWV5&(CGF12!+,X&\L^=I8JN% %?7<(
M<(8SB[%SI4IJ$().4FKVO>R2TNW9]4K)ZGQ_&/&."X/P<*M6#G.HVHQ3M>UK
MMO6R5UT;NUH?T'T5_/U_P3D_X*-?&K]D7XU:%87WCK4M1\!:CJ4-KXC\.7]V
M\UO';R.%:X@5B1%*@.\%,;]NUL@\?T"TN+N$<9PEC(4JLU.$TW&25KVW36MF
MKKJU9K4?!W&."XPP4ZM*#A.#2E%N]K[-/2Z=GT3NGH%%%%?)'UX4444 %%%%
M 'X@_P#![S_R:S\#_P#LH&H_^D(HH_X/>?\ DUGX'_\ 90-1_P#2$44 >?\
M_!IM_P I3/VN_P#MX_\ 3Y/7[_5^ /\ P:;?\I3/VN_^WC_T^3U^_P!0 444
M4 %%%% !1110 4444 %%%% !1110 4444 >%_M8?\EL^!_\ V/<O_I,U>Z5X
M7^UA_P EL^!__8]R_P#I,U>Z4 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4/%7BGP[X'\,ZA
MXR\7ZS;Z=I6E6<EWJ-_=R!(K>"-2SR,3T 4$GZ5_,-\2AX)?XC^(/^%8-=2>
M'/[:NSX?:\BV3&Q\US"9%!.UO+VY&>#FOT5_X+M_\%&O^$UUVX_8G^#6OYTC
M2KE3X^U"UDXO+M&!6P!'5(F :3UD 7CRSGW+_@B#_P $Y3^S_P##Y/VI?C!H
M/E^-/%5B/["L;J/Y]&TQP""0?N3S##-W6/:O!:1:_<>$Y1\/N&:F<8Z[GB.5
M0I7LVE=IO1VO=N]M(VW;L?A/%T9>(G%%/)L!94\/S.=6UTF[)I:J]FDK7UE?
M9*Y^>/\ P3D_X)[_ !A_;&^-6A3Q^#+^U\":?J4-UXE\2W5LT=K]FC<,\$4C
M "69P-@5,E=VYL*":_H/HHK\\XOXOQ?%V,A5JP4(0348IWM?=MV5V[+HE9+0
M_1N#N#L'P?@ITJ4W4G-IRDU:]MDE=V2N^K=V]0HHHKY$^P"BBB@ HHHH _$'
M_@]Y_P"36?@?_P!E U'_ -(111_P>\_\FL_ _P#[*!J/_I"** //_P#@TV_Y
M2F?M=_\ ;Q_Z?)Z_?ZOP!_X--O\ E*9^UW_V\?\ I\GK]_J "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#PO]K#_ )+9\#_^Q[E_])FKW2O"_P!K#_DM
MGP/_ .Q[E_\ 29J]TH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ,&FW_*4S]KO_MX_]/D]?O\ 4 %%?-?_  4V_;DUG]B7X??#NW\&6.C'Q/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!(111_P>\_\FL_ _\ [*!J/_I"** //_\ @TV_Y2F?M=_]O'_I\GK]_J_
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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M '_@TV_Y2F?M=_\ ;Q_Z?)Z_?Z@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH \+_ &L/^2V? _\ ['N7_P!)FKW2O"_VL/\ DMGP/_['N7_TF:O=* "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9Q@LARRICL4[0@OFWT2\V]%][T/DO_@N)_P48;XZ>/9/V2?@YK9D\(^&;_\
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MSJ3<I.[>K;ZL_;H0A3@H05DM$ELD:5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\
M?524:5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )CX8_Z#4'_?5'
M_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\ ?5 &E16;_P )
MCX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\
M?5 &E16;_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%5=/UO2=5=H].OXYF0
M98(>@JU0!^(/_![S_P FL_ __LH&H_\ I"**/^#WG_DUGX'_ /90-1_](110
M!Y__ ,&FW_*4S]KO_MX_]/D]?O\ 5^ /_!IM_P I3/VN_P#MX_\ 3Y/7[_4
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MFHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\
M^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]
M"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_
M /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FH
MH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?
M&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C
M^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\
MGQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH
MA_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'
M_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^S
MM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQ
MA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_
ML[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_O
MT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/
M_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_
M[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[
M3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*
MFHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\
M^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]
M"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_
M /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FH
MH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?
M&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C
M^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\
MGQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH
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M:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;/@?_P!CW+_Z3-7NE>%_M8?\EL^!_P#V/<O_ *3-7NE !1110 4444 %%%%
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M _\ [*!J/_I"**/^#WG_ )-9^!__ &4#4?\ TA%% 'G_ /P:;?\ *4S]KO\
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M?X.TWXA_#?Q=INOZ#K-FEWI&M:-?1W-K>P.,I+%+&2LB$<A@2#7@7[;VL?\
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M7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\
MT*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%
M[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]
M"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H
M7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\
MT*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%
M[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]
M"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H
M7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\
MT*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%
M[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]
M"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H
M7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\
MT*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%
M[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]
M"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H
M7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\
MT*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%
M[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]
M"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H
M7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\
MT*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%
M[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]
M"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H
M7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\
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MB\S4M1>,++J5ZX'G7,GNQ' R=JJJCA17I=8__"2ZO_T*%[_WTM'_  DNK_\
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M1AO;BKU 'X@_\'O/_)K/P/\ ^R@:C_Z0BBC_ (/>?^36?@?_ -E U'_TA%%
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M2G)_1ZJ>A>'/#WA>Q_LOPSH5GIUL9&D-O86J0Q[V.6;:@ R3R3WJY0 4444
M>%_M8?\ );/@?_V/<O\ Z3-7NE>%_M8?\EL^!_\ V/<O_I,U>Z4 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW"N3QPE/6;UG+^:77Y+9+MYMA1117S1].%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!^(/_  >\_P#)K/P/_P"R@:C_ .D(HH_X/>?^36?@?_V4#4?_ $A%% 'G
M_P#P:;?\I3/VN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[>/\ T^3U^_U !111
M0 4444 %%%% !1110 4444 %%%% !1110!X7^UA_R6SX'_\ 8]R_^DS5[I7A
M?[6'_);/@?\ ]CW+_P"DS5[I0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML/\ DMGP/_['N7_TF:O=*\+_ &L/^2V? _\ ['N7_P!)FKW2@ HHHH ****
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M 'X@_P#![S_R:S\#_P#LH&H_^D(HH_X/>?\ DUGX'_\ 90-1_P#2$44 >?\
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M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
M0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[
M+_P&/^- &Q16/]B\;_\ 0;LO_ 8_XT?8O&__ $&[+_P&/^- &Q16/]B\;_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9\#_ /L>Y?\ TF:O=*\+_:P_Y+9\#_\ L>Y?_29J]TH **** "BBB@ HHHH
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MU/X?>*KSP=K=S;27EA(([K[)-YB(^ 2F[ R1G!QT(([5O? +P!X1^*'Q,LO
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M0!Q_AO\ 9^^"?A+:VA?"_1HW3[LTUDLT@^CR;F_6NNAABMXEA@B5$485$7
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M/<O_ *3-7NE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M444 %%%% !1110 4444 >%_M8?\ );/@?_V/<O\ Z3-7NE>%_M8?\EL^!_\
MV/<O_I,U>Z4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC_D'^M?$O_074_\  F>/_P###GP%_P"@=J?_ (,F_P */^&'/@+_ - [4_\
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M****]$Y0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /Q!_X/>?\
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MAH/AGPM/KOB&_*\06MO;M/,^.^$1CCOTKXL_X.CO^4%'QS_[EG_U)])KM_\
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M%WBC5(;'3-*LI;S4;VX;;';P1(7DD8]E55))]!7YL_\ !7"VU3Q!_P %OO\
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M>7('YEC7LG@S_@AYX# 2?XU?M<_%7Q;*/OV]IK(TZT?US$!*P'TD%>L^!_\
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MND7./^>^G8S_ -\,M?6LO@'0KA/+GDNG7^Z]RQ%9UW\$?AIJ'_'_ .&H)_\
MKM$K?S%>Y_Q";Q%PG^Z\3UGY34_UJR_(\_\ USX7K?QLH@O\/+_\@CYSL?\
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M&"N X'WD//1ERI]B:JT5_/?_ !''Q1_Z&'_E*A_\K/TS_B'W"'_0-_Y/4_\
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M5>6EUK4[F]WGW6:1D_ *!7V^7\#_ $:N&[?5,D5:2VE.'-^,Y)_@?/XG.?I
M9Y_O&:1H1>ZB[?\ I,7_ .E'Y;>(/^"VO[;%V"GP]B\"^" 3\@\*^";8%?8&
MZ\X_CUIDG_!4J2*1HI?@.5920RMXFP01V/\ HM?M3X(_94_9\^&80?#GX4:'
MH'E_<.BZ7#:D>^8T%?,W[:G_  0[^ 7[5OC>Y^*O@WQYJ/@7Q-J+[]7N;>P6
M^M+Z3O,\#/&1*>,LL@#=2I8ECMG60^ W'M;#X7B#(HPHT%/V<H3J4[.?+S<T
M</*FY)\D;-N?+;1*\F98-^-'"6'K8C)LY=6M5<>>,XPE=1YK<LJRFDUS.Z2A
M=;MV2/@#P;_P4CUCQUXOTKP1X=_9_>?4-8U*"QL8(_$N6DFED6-% ^S<DLP%
M?I?^S!_P1M_8C_9I-OK4G@#_ (337X,-_;7C+9=!''.8[?:((\'D'8SC^_WK
ME/V)_P#@B)\ OV2_&<'Q3\5^.-1\<>*+$DZ5>W-DME:V#D8\V.!7D)EP2 S2
M,%SE0& :OK[_ (0?2/\ GYO?_ MJ\6GD/AYP#5KX;@##RPM&NH^V:JUY>U<.
M;D7[VI.24%.>W+S<SYD[1/>P%7C3BFE3Q7&]2&(K4G+V*=.DO9*7+SN].$8N
M4G&/\W*HJS5V7+KP[X?OHE@O="LYHU4*J2VJ, !T !'2L:_^#7PBU3)O_A?X
M?E8]7;1X=WY[<U=_X0?2/^?F]_\  MJ/^$'TC_GYO?\ P+:O!Q.69;C/]XHP
MG_BBG^:/KZ6+Q5#^%4E'T;7Y',7_ .RS^S_J6?M'PRL5R/\ EWDEB_\ 0'%8
ME_\ L2_L_P!YG[/X>O;7/_/OJDIQ_P!]EJ]"_P"$'TC_ )^;W_P+:C_A!](_
MY^;W_P "VKP,3P'P1B_XN64&^_LH)_>HW/1I<1\04/@Q=1?]ORM]USR*_P#^
M"?\ \(I\M8>)?$%N>P-S"Z_D8@?UK%O_ /@G=H<F?[+^*-W#Z?:-+63^4BU[
MO_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M7@XGP>\-<5\>707^&4X_\ I,D>
ME2XXXKH_#BI?-1?YIGS;?_\ !/'Q5'G^R_B3I\WI]HL9(_Y,U8E_^P+\9[7)
MM-8T"Y'81WDJG_QZ(#]:^K?^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VKP,3X
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M"VK]%ROAGAS)$OJ&#I4O.$(Q?WI7?S9\OB\VS3'_ .\UYS]9-K[F[&Q16/\
M\(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M7N'GFQ16/_P (/I'_ #\WO_@6U'_"
M#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\
M"#Z1_P _-[_X%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\
M_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?
M\_-[_P"!;4?\(/I'_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO
M_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _
M-[_X%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;
M4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!
M;4?\(/I'_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q1
M6/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_
MP@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__
M  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'
M_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q15'2M LM'
MD>2UEG8NN#YLQ8?K5Z@#\0?^#WG_ )-9^!__ &4#4?\ TA%%'_![S_R:S\#_
M /LH&H_^D(HH \__ .#3;_E*9^UW_P!O'_I\GK]_J_ '_@TV_P"4IG[7?_;Q
M_P"GR>OW^H \:_:X_9X^,OQGU'P#X^_9_P#CM9^!?%?P\\42:O9R:QX9.K:=
MJ\,MG/:3V%W EQ;OY3I.2'CD5T=$89*BOGCX/?\ !-S]H3XQ>(?">L_MT>,_
M#MOX:^&_QX\1?$?PUX!\(Z4P&KZY+J]_<:?J5W>27,I^SQ)=M-#:(B.&D3SW
M8H8Q]V44 ?-7_!5[]@OQM_P4O_8X\1_L::%\=-,\ Z1XMDL3KFKW7@R36+G;
M:7]O>QK"%OK58R9+9 Q8/E2< 'FO:O#_ ,/M2U3X0#X7?&^]T3Q2;S1GTS7V
MLM">RLM1@>,Q2)]FEN+AD1T)4J97SD\UU=% 'PY#_P $D_B4_P"R='_P30U'
M]I6TE_9WBOA$+0>'YAXJE\/K>?:D\/M?_:O)$0($!NQ!YIMAY017/GU[)^U[
M^P-X*_:.\*?#FX^'NMP>!O&7P8\26FN?";Q'::4+B#1YH$$36<MLKQF:QG@'
MD2P+)&2NTJZLBFO?Z* /G7X4_L2^)[S]KP_MX?M2^.-%\2>/]-\(-X7\%:9X
M:T>6STGPSILDIFN7B$\TLD]W</@/<,4"Q*L2Q@!WDZ+X _ []IWP-\<?C!XS
M^/?[4*>/O!'C76+2;X=>"9?#$-JOA*S2*19[8RJ2;H2;XQEA_P L=W61@/:*
M* /B'3/^"3OQ-\"?LR^*O^"=?P?_ &D-/T#]GWQ9>ZDBZ<WAJ6;Q'H.B:C,\
MU_H=C>&Y$'DR--<+'<2P/)#%.R%96"R+ZO\ M._\$W_@S\>OV9O!/[//@:8^
M!)OA+JNC:Q\'/$&DV@G?PIJ6DA182K$[ 3Q*B^5)$S#S(W8;E;:Z_0]% 'S9
MX3_8B\>_$+]K7PG^VE^V)\0/#OB3Q-\-] O]+^&?A_PCH,]CI>AR7P1+_4F-
MQ<3RSW<T<:1#E(X8@5"R,?-KZ3HHH **** /"_VL/^2V? __ +'N7_TF:O=*
M\+_:P_Y+9\#_ /L>Y?\ TF:O=* "BBB@ HHHH **** "BBB@ J#4=,TW6+1K
M#5M/@NH'^_#<1*Z-]0P(-3T4TVG=":35F>9^,/V+OV0O'^YO&7[+_@#4)'^]
M<3^$K3S?PD$88?@:\J\8?\$9O^";WC+=)<?LY6^GS-TFT?7+ZUV_1$G$?YK7
MU#17J8?/<[PG\#$U(^DY+\F>5B<AR/&?Q\+3GZPB_P T?!7C#_@W=_8DUW=-
MX8\:>/\ 0Y#]Q(-8MIXA]5EMRQ_[[%>5>,/^#:;2I-TW@#]K6XAQ]RWUCPBL
MF?K)'<KC_O@U^I5%>[A_$'C'"_#BY/\ Q*,O_2DSP,3X=\%XKX\'%?X7*/\
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M \=^+/\ P3\_8I^.!EF^)/[,_A.\N)\^=?VFF+973Y]9[;RY3_WU7S'\6?\
M@W=_9 \7^;=_"WQWXN\'W#Y\N#[5'J%HGI\DRB4_]_J^_J*]_+^*>(LKLL-B
MIQ2Z<S<?_ 7=?@?/YAPIPWFMWBL)"3?7E2E_X$K/\3\9?BS_ ,&Z'[4_A;S+
MOX2_%;PEXMMTSLAN_.TRZD],(PDB'XRC\:\4N?V8O^"L/[$]P][X>\#_ !0\
M+P0.7FNO!U]/<V?UD:Q>2+:?]O@]Z_H%HK[+"^+&?QA[/&TJ=>/7FC9O[O=_
M\E/BL7X1\/RJ>UP-6I0GTY972^_WO_)C\*/A?_P73_X*&_"FX72_%OBK1O%L
M=L^R2T\5^'T650."IDMC#(6]W+'/7/2O,?VS?^"DO[2_[:OBMM2\;^+)]&T"
M.-$L?"&A7DL5A#@#+LN[,TA.3ODR1G"[5 %?OI\4/V>?@/\ &RW-O\7O@UX8
M\2@KM#ZWH<%RZ#_9=U+*?<$$5^"O_!0;_@GM\8?V+/C!K-E=>#=0N? ]Q?R3
M>&/$]O;O):R6K,3'%+( 1',@(1D?!)4LN5(8_=\$Y[P=GN:.5/!0P^)2T^&S
MOORZ17,O2]F[:7/@>.,@XTR'*E&ICIXC#-Z_%>-MN;63Y7_BM=*^MB]_P3[_
M ."E7QH_8N^*NESZAXPU?6/ -Q=+%XD\+3W33Q_9V.'FMDD;$4Z#Y@5*ARH5
MC@\?HIJ?_!Q;^Q#9Y6P^'?Q,O&YVF/1+%%/XM>@C\J_-[]@/_@G+\9_VW_B=
MI^G6?AW4])\$13B3Q#XPEM"D$, .6C@=QMEG;[JJN[:6#, H)K]&-,_X-R/V
M,K?#:K\5_B9<L,9$>J:?&I]<C[$3^M1QM'PX6;)YE?VUM53_  Y[:<WKK:U]
M+%\#R\2WE#66)>QOHZGX\E]>7T5KWMK<R-3_ .#D7]FN+=_8WP!\<W')V_:I
M;.'//?;*^.*Y[4_^#E?P!%G^QOV3M8G_ +OVKQ9%#GG_ &;=\<?Y[UZQI?\
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M6>WV#RRS9^NT?2OTZHK[K%>)_&.)TC74%_=C'\VF_P 3R\)X6<%X765!S?\
M>G+\DTOP/B[P'_P00_X)Z>$-AU_PMXG\4% ,G7?$TL>X^I%F(*]I\!_\$ZOV
M%OAML;PI^REX(62(?N[C4-#CO95]Q)<B1@??.:]HHKYK%<2\0XW^/BZDEVYY
M6^Z]OP/IL)PQPY@?X&$IQ??DC?[[7_$IZ%X<\/>%[!=+\,Z%9:=:K]VVL;5(
M8Q]%0 5<HHKQ7)R=V]3W(QC%62L@HHHI#"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH _$'_ (/>?^36?@?_ -E U'_TA%%'_![S_P F
ML_ __LH&H_\ I"** //_ /@TV_Y2F?M=_P#;Q_Z?)Z_?ZOP!_P"#3;_E*9^U
MW_V\?^GR>OW^H **** "BBB@ HHHH **** "BBB@ HHHH **** /"_VL/^2V
M? __ +'N7_TF:O=*\+_:P_Y+9\#_ /L>Y?\ TF:O=* "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH _$'_@]Y_Y-9^!__90-1_\ 2$44?\'O
M/_)K/P/_ .R@:C_Z0BB@#S__ (--O^4IG[7?_;Q_Z?)Z_?ZOP!_X--O^4IG[
M7?\ V\?^GR>OW^H **** "BBB@ HHHH **** "BBB@ HHHH **** /"_VL/^
M2V? _P#['N7_ -)FKW2O"_VL/^2V? __ +'N7_TF:O=* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _$'_ (/>?^36?@?_ -E U'_TA%%'
M_![S_P FL_ __LH&H_\ I"** //_ /@TV_Y2F?M=_P#;Q_Z?)Z_?ZOP!_P"#
M3;_E*9^UW_V\?^GR>OW^H **** "BBB@ HJLFL:1+J\OA^+5+9K^"VCN)K)9
MU,T<+LZI(R9W!6:.0!B,$HP'W35F@ HHHH **** "BBB@ HHHH \+_:P_P"2
MV? __L>Y?_29J]TKPO\ :P_Y+9\#_P#L>Y?_ $F:O=* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH _$'_@]Y_Y-9^!_P#V4#4?_2$44?\
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M&\>!?_"2L_\ XU0!Y9_P]N_X)T?]'2:+_P" %Y_\9H_X>W?\$Z/^CI-%_P#
M"\_^,UZG_P ,O_LT_P#1O'@7_P )*S_^-4?\,O\ [-/_ $;QX%_\)*S_ /C5
M 'EG_#V[_@G1_P!'2:+_ . %Y_\ &:/^'MW_  3H_P"CI-%_\ +S_P",UZG_
M ,,O_LT_]&\>!?\ PDK/_P"-4?\ #+_[-/\ T;QX%_\ "2L__C5 'EG_  ]N
M_P""='_1TFB_^ %Y_P#&:;'_ ,%<O^"<TJ[E_:CT<<X^;3KT?S@KU7_AE_\
M9I_Z-X\"_P#A)6?_ ,:KQ7]A']G_ . WB/X/:I?>(?@EX1OYT\:ZO$DU[X;M
M976-;@A4!:,D*!P!T% &O_P]N_X)T?\ 1TFB_P#@!>?_ !FC_A[=_P $Z/\
MHZ31?_ "\_\ C->I_P##+_[-/_1O'@7_ ,)*S_\ C5'_  R_^S3_ -&\>!?_
M  DK/_XU0!Y9_P /;O\ @G1_T=)HO_@!>?\ QFC_ (>W?\$Z/^CI-%_\ +S_
M .,UZG_PR_\ LT_]&\>!?_"2L_\ XU1_PR_^S3_T;QX%_P#"2L__ (U0!Y9_
MP]N_X)T?]'2:+_X 7G_QFC_A[=_P3H_Z.DT7_P  +S_XS7J?_#+_ .S3_P!&
M\>!?_"2L_P#XU1_PR_\ LT_]&\>!?_"2L_\ XU0!Y9_P]N_X)T?]'2:+_P"
M%Y_\9H_X>W?\$Z/^CI-%_P# "\_^,UZG_P ,O_LT_P#1O'@7_P )*S_^-4?\
M,O\ [-/_ $;QX%_\)*S_ /C5 'EG_#V[_@G1_P!'2:+_ . %Y_\ &:/^'MW_
M  3H_P"CI-%_\ +S_P",UZG_ ,,O_LT_]&\>!?\ PDK/_P"-4?\ #+_[-/\
MT;QX%_\ "2L__C5 'EG_  ]N_P""='_1TFB_^ %Y_P#&:/\ A[=_P3H_Z.DT
M7_P O/\ XS7J?_#+_P"S3_T;QX%_\)*S_P#C5'_#+_[-/_1O'@7_ ,)*S_\
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M\/;O^"='_1TFB_\ @!>?_&:/^'MW_!.C_HZ31?\ P O/_C->I_\ #+_[-/\
MT;QX%_\ "2L__C5'_#+_ .S3_P!&\>!?_"2L_P#XU0!Y9_P]N_X)T?\ 1TFB
M_P#@!>?_ !FC_A[=_P $Z/\ HZ31?_ "\_\ C->I_P##+_[-/_1O'@7_ ,)*
MS_\ C5'_  R_^S3_ -&\>!?_  DK/_XU0!Y9_P /;O\ @G1_T=)HO_@!>?\
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M_P#XU0!Y9_P]N_X)T?\ 1TFB_P#@!>?_ !FC_A[=_P $Z/\ HZ31?_ "\_\
MC->I_P##+_[-/_1O'@7_ ,)*S_\ C5'_  R_^S3_ -&\>!?_  DK/_XU0!Y9
M_P /;O\ @G1_T=)HO_@!>?\ QFC_ (>W?\$Z/^CI-%_\ +S_ .,UZG_PR_\
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M=_P3H_Z.DT7_ , +S_XS7J?_  R_^S3_ -&\>!?_  DK/_XU1_PR_P#LT_\
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MK?\ \$YR 1^U'HW/K87G_P 9I?\ A[=_P3H_Z.DT7_P O/\ XS7<?#;]F?\
M9PN_AWH%U=?L_>")99=%M7DDD\*6;,[&%2228\DD]ZV_^&7_ -FG_HWCP+_X
M25G_ /&J /+/^'MW_!.C_HZ31?\ P O/_C-'_#V[_@G1_P!'2:+_ . %Y_\
M&:]3_P"&7_V:?^C>/ O_ (25G_\ &J/^&7_V:?\ HWCP+_X25G_\:H \L_X>
MW?\ !.C_ *.DT7_P O/_ (S1_P /;O\ @G1_T=)HO_@!>?\ QFO4_P#AE_\
M9I_Z-X\"_P#A)6?_ ,:H_P"&7_V:?^C>/ O_ (25G_\ &J /+/\ A[=_P3H_
MZ.DT7_P O/\ XS1_P]N_X)T?]'2:+_X 7G_QFO4_^&7_ -FG_HWCP+_X25G_
M /&J/^&7_P!FG_HWCP+_ .$E9_\ QJ@#RS_A[=_P3H_Z.DT7_P  +S_XS1_P
M]N_X)T?]'2:+_P" %Y_\9KU/_AE_]FG_ *-X\"_^$E9__&J/^&7_ -FG_HWC
MP+_X25G_ /&J /+/^'MW_!.C_HZ31?\ P O/_C-'_#V[_@G1_P!'2:+_ . %
MY_\ &:]3_P"&7_V:?^C>/ O_ (25G_\ &J/^&7_V:?\ HWCP+_X25G_\:H \
MJ?\ X*X?\$YHT+M^U'H^!_=T^])_(04H_P""M_\ P3G(!'[4>C<^MA>?_&:D
M_;0_9W_9_P! _98\;ZSH7P,\'65Y;Z([V]U:>&+2.2)MR\JRQ@J?<5VOPV_9
MG_9PN_AWH%U=?L_>")99=%M7DDD\*6;,[&%2228\DD]Z .'_ .'MW_!.C_HZ
M31?_   O/_C-'_#V[_@G1_T=)HO_ ( 7G_QFO4_^&7_V:?\ HWCP+_X25G_\
M:H_X9?\ V:?^C>/ O_A)6?\ \:H \L_X>W?\$Z/^CI-%_P# "\_^,T?\/;O^
M"='_ $=)HO\ X 7G_P 9KU/_ (9?_9I_Z-X\"_\ A)6?_P :H_X9?_9I_P"C
M>/ O_A)6?_QJ@#RS_A[=_P $Z/\ HZ31?_ "\_\ C-'_  ]N_P""='_1TFB_
M^ %Y_P#&:]3_ .&7_P!FG_HWCP+_ .$E9_\ QJC_ (9?_9I_Z-X\"_\ A)6?
M_P :H \L_P"'MW_!.C_HZ31?_ "\_P#C-'_#V[_@G1_T=)HO_@!>?_&:]3_X
M9?\ V:?^C>/ O_A)6?\ \:H_X9?_ &:?^C>/ O\ X25G_P#&J /+/^'MW_!.
MC_HZ31?_   O/_C-'_#V[_@G1_T=)HO_ ( 7G_QFO4_^&7_V:?\ HWCP+_X2
M5G_\:H_X9?\ V:?^C>/ O_A)6?\ \:H \L_X>W?\$Z/^CI-%_P# "\_^,TU_
M^"N'_!.:-"[?M1Z/@?W=/O2?R$%>J_\ #+_[-/\ T;QX%_\ "2L__C5>7_MH
M?L[_ +/^@?LL>-]9T+X&>#K*\M]$=[>ZM/#%I')$VY>598P5/N* (Q_P5O\
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M_1TFB_\ @!>?_&:/^'MW_!.C_HZ31?\ P O/_C->I_\ #+_[-/\ T;QX%_\
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MWASXJ^!=3^'?BZ*5]-U:V,%XL$I1RA(/##H>*TM&TJTT'1[30]/5A!96T<$
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M;D:]U;2/A_IUOX2ENG"RZCJ&E26]U%O=CCS;F2U*.['[UPS,>IH \@_X*A_
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M6'[2%Y;WUM>J/M*>%H81:Z+$H/+6RQPS[,?*?,+?\M,EG[8GAWP[_P %)O\
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MJE[;VDO]JZSX<BUURDVG^'Y[R:>Q$I?&Q6MV6< X"I,HXQ@>2_M;_P#!=/\
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MI=]JN@Z/I\VB:K=:?%)<Z>YU>P+&"5E+1;@H5MI&Y<@\5F_M!?#OX!_MX_\
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M]UL$C(YP3ZTFIZ9INM6$VE:QI\%W:W"%)[:YB62.13U5E8$$>QJ>B@"EX?\
M#7ASPGIJZ-X5\/V6F6:,2EII]HD,2D]2%0 #\JNT44 0ZAIVGZO9OIVJV$-U
M;R@"2"XB#HX!SRI!!Y -3444 %9^K>%/"VO:E8ZQKGAK3[V[TQV?3;J[LTDD
MM&;&YHF8$QD[5R5QG:/2M"B@ HHHH " 1@BJ6A>'/#WA:Q.F>&=!LM.MC*TA
MM["U2%"['+-M0 9)Y)ZFKM% %#Q#X6\,>+K%=,\6>'+#5+9)5E6WU&S2= XZ
M,%<$ CL>HJQ<Z9IMX]O)=Z?!*UG+YMHTD2L8)-K)O3(^5MK,N1SAB.A-3T4
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M)PJ@ 9))X'4U5M? W@FR\1R^,+/P?I4.KSC$^J1:?&MS(,8PTH7<>/4UJT4
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MRQ2K_=96!##V(J6SL[33[2*PL+6.""&,)##"@5(U P%4#@ #@ 5)10 4444
M?B#_ ,'O/_)K/P/_ .R@:C_Z0BBC_@]Y_P"36?@?_P!E U'_ -(110!Y_P#\
M&FW_ "E,_:[_ .WC_P!/D]?O]7X _P#!IM_RE,_:[_[>/_3Y/7[_ % !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!^(/_![S_P FL_ __LH&H_\ I"**/^#WG_DU
MGX'_ /90-1_](110!Y__ ,&FW_*4S]KO_MX_]/D]?O\ 5^ /_!IM_P I3/VN
M_P#MX_\ 3Y/7[_4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+_X*%?\ 0N^%/_"GC_\ B:/^'!?_  4*_P"A=\*?^%/'_P#$U\K_ *D<%_\
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MG"7$<BJ3RR;6Z,*Y_P#;"95_;-_9*#, 3\4/$0 )ZG_A"]=K\X_!?B_XT_\
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M([MK3PY"=!OCJ.K7*F0&WM=.$'VRXFQ#*PBCA9RD;.%*C=4?[-W[9?[-/[7
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M*[<(UIX>OM3NYY+69!M2>*[DF-S%,HR!(L@8 LH.UB#5_8I_X)-_L0_\$_\
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M;Y?B;X@G?5+QRQ:Y/G7S^5-\[#S(MC < @ "O2/A/\;_ (+_ ![\,_\ ":?
MOXO>%_&FC%]@U;PGK]MJ-MNQG;YMN[IGVS744 ?+,7_!%S_@G#;_ +)VM_L0
M0_ B^?X9Z]K U:Z\.WWCK6KW[/J D\P7=M-=7DDMK*7RS-$R;]S!@P9@2'_@
MC!_P3M'C7P#\2M4^"M]JGB/X<FX_L3Q#K7C'5+R^O!.BQNFH7$URTFHQ[$55
MBN6DC5,QJHC8H?HOP7\2/ /Q&;5U\!^+]/U<Z!K<^CZV+"Y67[%?PA3+;2X^
MY*@=-RGD;A6W0!\C?LU_\$Y_AY\$_P#@I9\3OVY/A=\/]8\)Q>-]#O+#Q9_:
M7B.2Z'BW5;B]M;@W\=J99$M(+<6LB1$['D:_N?W:1QPM)]/?$7X?>'/BGX.O
MO ?BV75%T[4H&AN_[&UZ\TRX*,I5@MQ9RQ31Y!/*N#7DGB[_ (*=?\$_O NM
M:GH?B;]K+P=$VB71MM>O(-2\^STJ<'#17=U$&@M77^)974K_ !8KVCPSXG\-
M>-?#UEXN\&^(;'5])U*V2YT[5-,NTN+>ZA<922.1"5=&!!#*2"#Q0!X3\"O^
M"6O[%'[,_P  ]<_9>^!7P^\2^'? /B*&YBU3PW:?%#Q$\.VX $_DM)?L]L9
M/F,+(3ELGYCF.W_X)4_L-VG['[?L#V_PRU]/A&ZE&\&CXE^(/*\HS&<P^=]O
M\\0F0EC%YGEDG[M?1%>3_$_]NC]D7X.>/G^%'C[X]:#!XJAMUN+OPQ83/?:E
M:PL,K+-:VJR2P1L.CR*JGL30!R7Q[_X)8?L.?M-_LN:)^QW\:_@_-KW@CPND
M \+1:CXDU"?4-&:&,1Q-;W\L[72%4 3F0AE&U@R\5N?L:_\ !/K]E?\ 8+\%
MZGX+_9R\ 7%B==E23Q!K6L:Q<ZEJ>J%%*QB>[N7>5DC5F"1@A$WL54%V)Z[X
M5?M0?LY_'._32O@Q\</"WBJY>PDO6M_#^MPW;Q0)*(7:18V)B*RGRRKX8,&7
M&58#NZ /)_V,/V)_V=_V /@C#^SQ^R_X0N=$\+0:I=:BEG=ZM<7LGGW$F^1C
M).[/CH ,X 4=\D^L444 %%%% !1110 445PO[2O[2OP0_8_^".N_M&_M'^/(
M?#/@OPU' ^MZW/:3W"VPFGCMXOW<"/(Y:6:- %4G+CB@#NJ*J:!KVC^*="LO
M$_AZ_CN[#4;2.ZL;J(_+-#(H=''L5((^M6Z "BBN4^,'QS^#7[/OA*3Q]\<_
MBCH7A#0X3^^UCQ%J<=I:Q?[TLA"J/<D4 =717%?!']I#X _M+>''\8?L]?&7
MPUXVTB,@/JGA;6(;ZVR6=<"6)F4_-&XX/5".U=K0 445Y;X#_;8_94^*7[1F
MO?LE_#;XWZ-KWQ"\+:.=4\1^'=)=[AM-MA-'"3-,BF%)!)*BF(OY@SG;@$@
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M_!-S]M/X[1_M+?&KX(W<?C9X4@U77O"_B>^T>75H44(J77V.6/S3L CW\2%
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MJ.?A7X@BN;>!?&&@7<GVF%'5"%&IQ&?]]%_K'WEL.8Y)&_3>@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X@_\'O/_)K/P/\
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MU_17R!_P_P"/^"-O_20GX?\ _@7-_P#&Z/\ A_Q_P1M_Z2$_#_\ \"YO_C=
M'U_17R!_P_X_X(V_])"?A_\ ^!<W_P ;H_X?\?\ !&W_ *2$_#__ ,"YO_C=
M 'U_17R!_P /^/\ @C;_ -)"?A__ .!<W_QNC_A_Q_P1M_Z2$_#_ /\  N;_
M .-T ?7]%?('_#_C_@C;_P!)"?A__P"!<W_QNC_A_P ?\$;?^DA/P_\ _ N;
M_P"-T ?7]%?('_#_ (_X(V_])"?A_P#^!<W_ ,;H_P"'_'_!&W_I(3\/_P#P
M+F_^-T ?7]%?('_#_C_@C;_TD)^'_P#X%S?_ !NC_A_Q_P $;?\ I(3\/_\
MP+F_^-T ?7]%?('_  _X_P""-O\ TD)^'_\ X%S?_&Z/^'_'_!&W_I(3\/\
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MP1M_Z2$_#_\ \"YO_C= 'U_17R!_P_X_X(V_])"?A_\ ^!<W_P ;H_X?\?\
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MU_17R!_P_P"/^"-O_20GX?\ _@7-_P#&Z/\ A_Q_P1M_Z2$_#_\ \"YO_C=
M'U_17R!_P_X_X(V_])"?A_\ ^!<W_P ;H_X?\?\ !&W_ *2$_#__ ,"YO_C=
M 'U_17R!_P /^/\ @C;_ -)"?A__ .!<W_QNC_A_Q_P1M_Z2$_#_ /\  N;_
M .-T ?7]%?('_#_C_@C;_P!)"?A__P"!<W_QNC_A_P ?\$;?^DA/P_\ _ N;
M_P"-T ?7]%?('_#_ (_X(V_])"?A_P#^!<W_ ,;H_P"'_'_!&W_I(3\/_P#P
M+F_^-T ?7]%?('_#_C_@C;_TD)^'_P#X%S?_ !NC_A_Q_P $;?\ I(3\/_\
MP+F_^-T ?7]%?('_  _X_P""-O\ TD)^'_\ X%S?_&Z/^'_'_!&W_I(3\/\
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MP1M_Z2$_#_\ \"YO_C= 'U_17R!_P_X_X(V_])"?A_\ ^!<W_P ;H_X?\?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
5HHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>89
<FILENAME>mrna-20201231_g5.jpg
<TEXT>
begin 644 mrna-20201231_g5.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !Y!;D# 2(  A$! Q$!_\0
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M:+XDO++0OA=_PD.DQE/(U+^WH+;SLHI;]VRDKABR\]=N>]8__"U/C!_T1/\
M\N>U_P#B:]K[45DX-_:?X?Y'K4\;0A!1>%@VNK=2[^Z:7W(\4_X6K\8/^B)_
M^7/:_P#Q-'_"U?C!_P!$3_\ +GM?_B:]MHI<DOYW^'^1I]?P_P#T"0^^I_\
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M<DOYW^'^0?7\/_T"0^^I_P#+#Q+_ (6K\8/^B)_^7/:__$T?\+5^,'_1$_\
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MU/\ Y8>)_P#"U?C!_P!$3_\ +GM?_B:/^%J_&#_HB?\ Y<]K_P#$U[3Y\?\
MST7\Q3E=6Z,#]#1R2_G?X?Y#^O8?_H#A]]3_ .6'BG_"U?C!_P!$3_\ +GM?
M_B:/^%J_&#_HB?\ Y<]K_P#$U[7YB[L;AGTS075>K ?C1R2_F?X?Y!]?P_\
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ME_._P_R#Z_A_^@2'WU/_ )8>)?\ "U?C!_T1/_RY[7_XFC_A:OQ@_P"B)_\
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M=3_^0/*O^%A_$O\ Z)9_Y78/\*/^%A_$O_HEG_E=@_PKU7FCFCZS2_Y\1_\
M)O\ Y(/[-Q/_ $&5/NI__('E7_"P_B7_ -$L_P#*[!_A1_PL/XE_]$L_\KL'
M^%>J\T<T?6:7_/B/_DW_ ,D']FXG_H,J?=3_ /D#RK_A8?Q+_P"B6?\ E=@_
MPH_X6'\2_P#HEG_E=@_PKU7FCFCZS2_Y\1_\F_\ D@_LW$_]!E3[J?\ \@>5
M?\+#^)?_ $2S_P KL'^%'_"P_B7_ -$L_P#*[!_A7JO-'-'UFE_SXC_Y-_\
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M^3?_ "0?V;B?^@RI]U/_ .0/*O\ A8?Q+_Z)9_Y78/\ "C_A8?Q+_P"B6?\
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MCZM5_P"?TO\ R7_Y$/9R_G?X?Y'!_P#"8>-O^A!_\J\/^%'_  F'C;_H0?\
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MKU/^?TO_ "7_ .1#V<OYW^'^1P?_  F'C;_H0?\ RKP_X4?\)AXV_P"A!_\
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MCZM5_P"?TO\ R7_Y$/9R_G?X?Y'!_P#"8>-O^A!_\J\/^%'_  F'C;_H0?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
MQFVJ3Z"OEYOVU9Y-:UW1[+P#?:IJEA</%!!8W)E\Y$9P\C8BR@&U>@;[W48Y
M^H),[&^E?(/[(D:M\7OBBS(K.L[ $CD9GESS^ _(5R5I34X1@[7/L,CPN#J8
M7%XG%T^?V:BTKM;NW0Z*P_;<M-:\/B32O!NIZGXC#-YFCVS-((XU )E,JH3M
MYQ]W.0<X'-=/X?\ CCI_QO\ @KXTO;2RDTV[L["XBN;-W$FW,+%2K #((SU
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MFN*T_P +Z7H_PG^(5_H_B^+Q+#>0Q?:(X[$VYC<.2&(+'&=QXP.GMQZ=^RI
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MT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%)2T %%%% !1110 4444
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MK?\ @OM?_C5>/T4?6*W\[#_5W)_^@2G_ . 1_P CV#_AKCXM?]#:W_@OM?\
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MO_ .W_\ C=>:44?V5@/^?$?_  %!_K'G/_074_\  W_F>E_\-(?$;_H9&_\
M .W_ /C='_#2'Q&_Z&1O_ .W_P#C=>:44?V5@/\ GQ'_ ,!0?ZQYS_T%U/\
MP-_YGI?_  TA\1O^AD;_ , [?_XW1_PTA\1O^AD;_P  [?\ ^-UYI11_96 _
MY\1_\!0?ZQYS_P!!=3_P-_YGI?\ PTA\1O\ H9&_\ [?_P"-T?\ #2'Q&_Z&
M1O\ P#M__C=>:44?V5@/^?$?_ 4'^L><_P#074_\#?\ F>E_\-(?$;_H9&_\
M [?_ .-T?\-(?$;_ *&1O_ .W_\ C=>:44?V5@/^?$?_  %!_K'G/_074_\
M W_F>E_\-(?$;_H9&_\  .W_ /C='_#2'Q&_Z&1O_ .W_P#C=>:44?V5@/\
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M\-(?$;_H9&_\ [?_ .-UYI11_96 _P"?$?\ P%!_K'G/_074_P# W_F>F?\
M#2/Q'_Z&5O\ P$M__C=)_P -(?$;_H96_P# .W_^-UYI11_96 _Y\1_\!0?Z
MQYS_ -!=3_P-_P"9Z7_PTA\1O^AE;_P#M_\ XW2_\-(?$?\ Z&5O_ .W_P#C
M=>9T4?V5@/\ GQ'_ ,!0?ZQYS_T%U/\ P-_YGI?_  TA\1O^AE;_ , [?_XW
M1_PTA\1O^AE;_P  [?\ ^-UYI11_96 _Y\1_\!0?ZQYS_P!!=3_P-_YGI?\
MPTA\1O\ H9&_\ [?_P"-T?\ #2'Q&_Z&1O\ P#M__C=>:44?V5@/^?$?_ 4'
M^L><_P#074_\#?\ F>PZ#^U/XYTNZ1KZZM]7A!^:.XA6,D>Q0#!]\'Z5]<^!
MO%UKX[\*Z?KMFK)!=H6V/U1@2K*?7# CC@XXK\YN..U?<W[,I_XLOH'INN/_
M $HDKX7BG+<+AJ$*U"'+*]M-%LS]A\.<^S''XVIA,75<XJ/,KZNZ:6_S/4'8
M*I8] ,U\C^/OVKM>O-8N(?# AL-.C<K%<21[Y90/XL'A0>N,9]?2OK>;_4O_
M +IK\R:\_A; 8?&5*LZ\>;EM:^VM_P#(]SQ'SG'971P]+!U'#GYKM;Z6Z_,]
M+_X:0^(W_0R-_P" =O\ _&Z/^&D/B-_T,C?^ =O_ /&Z\THK]*_LK ?\^(_^
M H_ O]8\Y_Z"ZG_@;_S/2_\ AI#XC?\ 0R-_X!V__P ;H_X:0^(W_0R-_P"
M=O\ _&Z\THH_LK ?\^(_^ H/]8\Y_P"@NI_X&_\ ,]+_ .&D/B-_T,C?^ =O
M_P#&Z/\ AI#XC?\ 0R-_X!V__P ;KS2BC^RL!_SXC_X"A_ZQ9T]L74_\"E_F
M>E_\-(?$;_H9&_\  .W_ /C='_#2'Q&_Z&1O_ .W_P#C=>:44?V5@/\ GQ'_
M ,!0O]8\Y_Z"ZG_@;_S/2_\ AI#XC?\ 0R-_X!V__P ;H_X:0^(W_0R-_P"
M=O\ _&Z\THH_LK ?\^(_^ H/]8LY_P"@NI_X%+_,]+_X:0^(W_0R-_X!V_\
M\;H_X:0^(W_0R-_X!V__ ,;KS2BC^RL!_P ^(_\ @*#_ %CSG_H+J?\ @;_S
M/2_^&D/B-_T,C?\ @';_ /QNC_AI#XC?]#(W_@';_P#QNO-**/[*P'_/B/\
MX"@_UCSG_H+J?^!O_,]+_P"&D/B-_P!#(W_@';__ !NC_AI#XC?]#(W_ (!V
M_P#\;KS2BC^RL!_SXC_X"@_UCSG_ *"ZG_@;_P STS_AI#XC?]#(W_@';_\
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MXWXC_$6V^'NFP2R0M=75PS+! &VYQ@DDX. ,CH#U'OCLZ\)_:<_UGASZ7/\
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M'Q/I>GM?WGAS5K2P10[74]C*D0!. 2Q4 #)'7Z5E_P!F7G]F_P!H_9)_[/\
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M) 'J3CK75]9HJS<UKYH\]8+$MM*G+3?1F-DCBCWK6F\)Z[;WUO9RZ-J$5Y<
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M87$=K(T>!D$[@",<'GV-9_6J-VG))::MZ.^UC7ZAB+)Q@VW?2SNK=S)]J,<
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M35)^]:^VC;MIW]>VIX-X;T3_ (236[73OM]CI?V@D?:]2F\FWCPI/SO@XSC
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M5^4?Q>_Y*QXU_P"PW>_^CWKMS+^''U/@O#+_ '^O_A_5')4445\^?T<%%%%
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M2+:__O6__I1'7\]Y;_OU'_''\S^WL]_Y$N*_Z]R_])9\+T445_0Q_#H4444
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M]!'P_P#^!,__ ,9K[]HH^HT.P?Z_Y[_S\7_@*/@+_A@_XA?]!'P__P"!,_\
M\9H_X8/^(7_01\/_ /@3/_\ &:^_:*/J-#L'^O\ GO\ S\7_ ("CX"_X8/\
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M%1'!4(ZV,:W'>>UH.#JI7[)7*VF:;;:3I]M8V<*V]K;1K%%%&,*BJ   .P
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M !$#/?\ GXO_  %'P%_PP?\ $+_H(^'_ /P)G_\ C-'_  P?\0O^@CX?_P#
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MJ-#L?8_Z_P">_P#/Q?\ @*/@+_A@_P"(7_01\/\ _@3/_P#&:/\ A@_XA?\
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M!_Q#G(?Y)?\ @3/C/_AD/QK_ ,_>C_\ @1+_ /&J/^&0_&O_ #]Z/_X$2_\
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M_F7W(/\ B'.0_P DO_ F?&?_  R'XU_Y^]'_ / B7_XU1_PR'XU_Y^]'_P#
MB7_XU7V911_K1F7\R^Y!_P 0YR'^27_@3/C/_AD/QK_S]Z/_ .!$O_QJC_AD
M/QK_ ,_>C_\ @1+_ /&J^S**/]:,R_F7W(/^(<Y#_)+_ ,"9\9_\,A^-?^?O
M1_\ P(E_^-4?\,A^-?\ G[T?_P ")?\ XU7V911_K1F7\R^Y!_Q#G(?Y)?\
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M^_LG_P ;H_X9S\3_ //WI?\ W]D_^-U]*T4?ZNX'L_O#^SZ'8^:O^&<_$_\
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MH_U=P/9_>']GT.Q\U?\ #.?B?_G[TO\ [^R?_&Z/^&<_$_\ S]Z7_P!_9/\
MXW7TK11_J[@>S^\/[/H=CYJ_X9S\3_\ /WI?_?V3_P"-T?\ #.?B?_G[TO\
M[^R?_&Z^E:*/]7<#V?WA_9]#L?-7_#.?B?\ Y^]+_P"_LG_QNC_AG/Q/_P _
M>E_]_9/_ (W7TK11_J[@>S^\/[/H=CYJ_P"&<_$__/WI?_?V3_XW1_PSGXG_
M .?O2_\ O[)_\;KZ5HH_U=P/9_>']GT.Q\U?\,Y^)_\ G[TO_O[)_P#&Z/\
MAG/Q/_S]Z7_W]D_^-U]*T4?ZNX'L_O#^SZ'8^:O^&<_$_P#S]Z7_ -_9/_C=
M'_#.?B?_ )^]+_[^R?\ QNOI6BC_ %=P/9_>']GT.Q\U?\,Y^)_^?O2_^_LG
M_P ;H_X9S\3_ //WI?\ W]D_^(KZ5HH_U=P/9_>']GT.Q\U?\,Y>)_\ GZTO
M_O[)_P#$5=L?V;=6D=?MFJV<"]_)5I#^H6OH=>E(W6G'AW 1=^5OY@LOH=CC
M_ ?PUTSP#%*;3?/=S "2XF(W$#L . /Y\9S@5V&*.XIU>_1I4Z$/9TE9([H0
(C3CRQ6A__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>90
<FILENAME>mrna-20201231_g6.jpg
<TEXT>
begin 644 mrna-20201231_g6.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ,B!Y\# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?.?[3/QNO]
M-NXOA[X,=Y/$^H +<W%NV&M8V&0H/\+L.2W\*\]2" "K\</VD+Z76&\#?#?_
M $_7Y"T5UJ46"ML0<,B$\;ASESPOU^[C?"_X!V?A>0:OK4G]L:_*WFO=3Y<(
MY.24W<YS_&>3[5T7P@^#]A\--"#R[)]2F&^YNF7!8]<#/(4=A^-=5J&I&X8I
M%\L?KW-!(LUQ%;Y2(!C[=*I22M(<D_A4=5-6UFPT&S>[U&\AL;9>LL[A1].>
M_M0(MT5Y'J_[26A177V71-/OM?N2<)Y*&-'^F06_\=IT/CGXKZQ\^F_#&\BB
M/*FZ@F&1]6"9H&>M45Y/)XO^+^F_/>?#&ZG3KMM8)6;_ ,=W?RJFG[1R:3<I
M;^)?"NJ:',>S+D_7:X0X_.@+'LE%<IX;^*OA7Q8RI8:Q ;AN!;SDQ2$^@#8S
M^&:ZN@0V:&.XA>*6-98G&UD< JP]"#UKROQ9\ M/O+Q=6\+74GAC6H6\R)K5
MBD6X="-O*'W7\J]6HH&<'X#_ &H/$/P[U.'P[\5;*0Q'Y8==@CR2!QEPO$@Z
M?,OS#N"37U'I6K66N:=;W^G74-]97"[XKBW<.CKZ@CK7@_B#P[IWBG3)-/U2
MTCN[63JCCD'U!Z@^XKR;2]0\6?LMZTU]I3RZ]X%N)0;JQD/^JR<9_P!AL8 <
M<-P&'2@9]NT5SO@/QYHWQ(\-6VN:'<BXM)AAE/$D3CK&X[,/\",@@UT5 PHH
MHH **** "BBB@ HHHH **** "BBHKFYAL[>6XN)4@@B4O)+(P544#)))X  H
M EKR;XR?M&^&_A'&]FS?VOXB9<Q:7;-RI/0RMSL'MRQSP,<UYA\4/VF]6\::
MK+X2^%43W$I^2XUW;A47H3%GA1_TT/\ P$=#2?"'X!V.@WPU/4G.LZX6\V:^
MGRRHYY.S/.<Y^8\GGITH$<];^"OB#^T5?1ZKX[U&;0_#8??!H]N"A([80]#_
M +;Y;VQ7L'A_P?H7@>Q6RT/3H+2-1AG49=O=F/+'ZFNDU.^AL8O)0X &/EZG
MV'M7GOB3XC:#HDQBU/6;*QD'_+!YAO\ Q4<_I0(Z*XN@21G>?TKPMOVK- ;_
M )@^I?E'_P#%5Z#8_$_PEJ4GEP>(M.+G@*\ZH3]-V,U)'\/_  C-&KQ^&]%=
M&&0RV,)!_';0!YO_ ,-4>'_^@1J7Y1__ !5<$OQ@T?P_\6M&\:^&+2]T_;)G
M5+1T15F0G$@7#$$LI/7'S 'K7T/_ ,*[\*?]"QH__@!%_P#$UX]X_P#"6A^*
MOBIX7\%^&-)LX+R6Y#7\EG"JA%)!(;:.BH'8CW% SV?_ (;L\!?] CQ'_P"
MUO\ _'Z/^&[/ 7_0(\1_^ UO_P#'Z]2_X41\._\ H2]%_P# -/\ "C_A1'P[
M_P"A+T7_ , T_P *!GEO_#=G@+_H$>(__ :W_P#C]2V_[<OP_FW;[#7X,=/,
MM8CGZ;937IO_  HCX=_]"7HO_@&G^%07'[/OPXN=I?P;I(V]/+@"?^@XH \_
M_P"&WOAW_P \-:_\!$_^.4?\-O?#O_GAK7_@(G_QRN[_ .&<_AK_ -"=IO\
MWRW^-'_#.?PU_P"A.TW_ +Y;_&@#A/\ AM[X=_\ /#6O_ 1/_CE/B_;;^'4D
M@5DUB('^)K1<#\G)KN/^&<_AK_T)VF_]\M_C3)OV;_AG-&R-X/L #_<WJ?S#
M9H O_"_XT>&OB]_:?_".RW,G]G^5Y_VB QX\S?MQGK]QJ[NN5\#_  O\+_#?
M[;_PC>D1Z5]MV?:/+D=O,V;MN=S'IO;IZUU5 $5U<Q6=O+<3R+#!$ADDD<X5
M5 R23V %? 6M:QXF\1^(=8^.M@K+8:7KL$%O$V03 !M /^SM\I&QU,K>AKZ.
M_:\\?3>%_ALNA:=O?6/$DOV&&*(%I#%QYNT#J3E4Q_TTKRKP[X^\3:%\)%\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-P*/C=\&]:\4>(M'\;>"]0CTWQEHZ^6GG'$=S%DG83S@_,XY&"&(..M>S44
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=XFE\ ^.?$7PQU20@-*UYISN?OD*-P'^]&%?C^ZU T?6%%%% PHHHH ****
M"BBB@ HHHH **** "O,/C)\ /#OQCL]]VIT[6XDVV^JVZ@NOHKC^-?8G([$5
MZ?10!\3ZA>?$OX R"U\5:6_B3PY&=L>K6Q+[5[9DQQ_NR 'C@XKJ_#GQN\'^
M)(TV:M'83MU@U#]RP]MQ^4_@37U6RB12K ,I&"".#7F7B[]FOX=>,I'FN_#D
M%I=.<FXTXFV;/<D(0I/U!H%8Y>VNH;R(2V\T<\9Z/&P8?F*DKF[W]A7POYS2
M:9XCUJPW=G,<F!Z9"KQ57_AB,OA9OB%JLD7\2?9\9'XR'^5 6.HNKZVL(_,N
MKB*W3^]*X4?F:Y36/C!X.T,-]HU^UE=>-EJQG.?3Y,_K6CI_["WA!)/,U'7=
M;OW[['BC!^OR,?UKN_#_ .RU\,_#K*\?AJ*^E'_+34)7N,_\!8[?TH"QX!+^
MT#=>)+PV'@GPKJ&O7AX#-$2%]#L3)Q]2M;.G? 'XK_%8J_C#6HO"ND/RUA;D
M-(5]-B''_?;DC/2OK/3-)L=%LTM=/L[>PM4^[#:Q+&@^BJ *MT#/,_AG^SOX
M*^%WE7&G::+W54'_ "$K_$LP/JO&U/\ @(!]S7IE%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!X[XX^&.N:]^T%X*\7VD<)T;
M2K5XKEFE <,?-QA>_P!]:]BHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M02#*2Q.&5AZ@C@U^/ZZI<P]2)!_M"NF\'_%G7?!-T)M&U>^T:3.6%O*?+?\
MWDZ-]"#7T>%XSKQTQ5%-=X_Y/_-'BXCAFE+_ '>HT^TO\T?K#17QS\-?VX[J
M/R;;QCIR7\!^4ZEIH"R#W:(G:WOM*^P-?4W@WQYH'Q TL:AX?U2#4K;^+RSA
MXSZ.APRGV(%??9?G&"S-?[//WNST?W?Y'R6,RW%8%_OHZ=UJOO\ \SH****]
MH\L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[KMZK\O0^%S_ "Q0_P!MH+1_$NS[_/\ ,]DHHHK])/B0HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW3^UD_N'\Z/[63^X?SH \+_X85^#G_0H+_X-+W_X]1_PPK\'/^A07_P:7O\
M\>KW3^UD_N'\Z/[63^X?SH \+_X85^#G_0H+_P"#2]_^/4?\,*_!S_H4%_\
M!I>__'J]T_M9/[A_.C^UD_N'\Z /"_\ AA7X.?\ 0H+_ .#2]_\ CU'_  PK
M\'/^A07_ ,&E[_\ 'J]T_M9/[A_.C^UD_N'\Z /"_P#AA7X.?]"@O_@TO?\
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M^UD_N'\Z/[63^X?SH \+_P"&%?@Y_P!"@O\ X-+W_P"/4?\ #"OP<_Z%!?\
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MJ/\ AA;X.?\ 0GK_ .#2]_\ CU>Y2:Q%&A=QL51DLS  4[^U$_N'\Z /"_\
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MVKZ"_P"&&/@Y_P!">O\ X-+W_P"/5U/P(^&\'PI\(^3<(LFM7I$U[,I! /\
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M!Y+,;+4(;25E('[FY=82#[>8T+?\ I@>&_\ #''PY_Z%Z/\ \#[O_P".4?\
M#''PY_Z%Z/\ \#[O_P".5ZY_PE4'_/)OS%'_  E4'_/)OS%,1Y'_ ,,<?#G_
M *%Z/_P/N_\ XY2?\,<_#G_H7H__  /N_P#XY7KO_"50?\\F_,4G_"40_P#/
M)O\ OH4@/(_^&.?AQ_T+T?\ X'W?_P <H_X8Y^''_0O1_P#@?=__ !RO6_\
MA*(?^>3?]]"C_A*(?^>3?]]"F!Y'_P ,=_#C_H7H_P#P/N__ (Y1_P ,=_#C
M_H7H_P#P/N__ (Y7K?\ PDT/_/-OS%'_  DT/_/-OS% 'DG_  QW\./^A>C_
M / ^[_\ CE)_PQ[\./\ H78__ ^Z_P#CE>N?\)-#_P \V_,4W_A)8?\ GFW_
M 'T*0'DO_#'OPX_Z%V/_ ,#[O_XY1_PQ[\./^A=C_P# ^[_^.5Z#XD^*OA_P
MA#%+K%Y%8+,2(Q(V6?&,X4 DXR,\=Q3O#OQ0T'Q9;O/I%Y%?HA ?RG^9,],J
M>1^(I@>=_P##'_PX_P"A=C_\#[K_ ..4?\,?_#C_ *%V/_P/NO\ XY7H%O\
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M@"/_  -N/_CE)_PSCX _Z  _\#;C_P".5Z/]L3_)I#=H?_UT ><']G/P /\
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MX2#_ &J\\_MH_P!ZC^VC_>H ]#_X2#_:H_X2#_:KSS^VC_>H_MH_WJ /0_\
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MRU^TMK,D7F8YV!W.,^F3_*LWXR-?+\?/!#PW]MI4+6;I9W5Y!YT*7.Z3/RY
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MU^M']N?[7ZUPG]L'^\:/[8/]XT =W_;G^U^M']N?[7ZUPG]L'^\:/[8/]XT
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MOM2BU&TEM;NUAN;:92DD,HW*ZGJ"#U%>4ZE^SWX'U"Z::.SN[$,<F&UNCL_
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M_GFOYT?\)+)_SS7\Z\;/Q\T'OX;\8_\ @H/^-5+C]I#PG:-MGT?Q5"W]V33
MI_5J/K5#^=?>@]A5_D?W,]O_ .$ED_YYK^='_"2R?\\U_.O"_P#AIKP;_P!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y
M[7O&ECHI:%6%S=CCRD/"_P"\>W\Z -Z25(8R\C*B+R68X K"O/$PD?RK)2Y/
M'F$?R%8%G'J_C"432GRK7/!(P@^@[G_.:[#3-%M]+0"-=TF.9&ZG_"@"I8Z3
M+,?-NF()YVYY/UK8CC6-0JC:/:G44 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %5[VSM]2LY[2[A2XM9T:*6&10RNI&"I'<$&K%%)I/1CO;5'P?\
M4OAOK'[-OCA=8T=9KKPI>2?NGR<)R3Y+GG#+_"W<#_>%>O\ @7XA:?XVTN*X
MMIU:0\,IX8'N".Q__6.*^@=<T'3_ !-I5SIFJV<5_87"[);>9<JP_P <\@]0
M1FOC+XH?L_\ B;X(:G-XC\&RSZGX>'SRQXW2VZ@_=E4??0?WQTYSCJ?R?-LE
MK974EB\"N:D]X]O^!^770_0\NS2EF$%A\6[5%L^__!_,]HU"TAU"$QRKGT;N
M/I7)ZAI,MB22/,B[./Z^E<W\/?CAIOBJ..TO7^Q:CC'ER-PY_P!D_P 7\_8]
M:](\Y94RI#*>XY!KY:I[#'1YEI+^MSW8>UPCY7L<4T(:J\EO74W>DPS9:/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M**AN[R#3[6:ZNIH[:VA1I)9IG"I&@&2S$\  9))H FHJGI.L6&O6,=[IM[;Z
MC9R9"7%K*LL;8.#AE)!P01^%7* "BLW2_$FD:Y<7<&FZI9:A/9MLN8[6X25H
M&)( <*25.5;@_P!T^E:5 !1110 445G:)XBTKQ+:M=:1J=GJMLCF-IK&X29
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MZR@?BI- &A115.^UBPTR:UAO+VWM);I_*MXYY51I7X^5 3\QY' ]: +E%%%
M!1110 455T_5++58VDLKN"\C4[6:WE5P#Z$@]:M4 %%5;'5++5%D-G=P78C.
MUS!(K[3Z'!X-668*I). .230 M%8<?CKPW-=?98_$.E/<YV^2M[$7SZ8W9K<
MH **1F"J23@#DDU5TS5K'6K476G7MO?VQ)436LJR(2.HW*2* +=%%% !1110
M 453NM8L+&\M;2YO;>WN[HD002RJKS8Z[%)RV,]JN4 %%%8D_C?P[:WGV2;7
M]+ANL[?(DO(U?/IM+9H VZ*:K"10RD,I&00>#3J "BL:_P#&7A_2[S[+>Z[I
MMG<YQY-Q=QH^?3:3FM:&:.XB66)UEC895T(((]0: 'T444 %%%% !1110 44
M44 %%%% !1110 4453T_6+#5FN%LKVWO&MY#%,+>57,3CJK8/!]C0!<HJ*XN
MH;.!YKB5((4&6DD8*JCU)/2DM;N"^MTGMIH[B!^5DB8,K?0C@T 345'<7$5K
M"\T\B0Q1C<\DC!54=R2>@IEI>6^H6Z7%K/'<P-G;+"X=3@X."..HH GHJ"\O
MK;3;=I[NXBM8%^]+,X11]2:HZ3XKT37I#'IFL:?J,B\E+2Z24C\%)H U:***
M "BBB@ HJIJ6K6.CVQN-0O+>QMQP9;F58T_-CBJ^D^)M'UXL-,U6QU$K][[)
M<)+CZ[2: -.BBJ>J:Q8:';"XU&]M["WW!/.NI5C3<>@RQ S0!<HHJK+JEE#?
M1V<EW!'>2#<ENTBB1ASR%SDC@_D: +5%%59M4LK:\BM9KN"*ZEYC@>50[_12
M<F@"U1110 4455&J61OS8B[@-Z!N-OYJ^9C&<[<YQ0!:HHJJ=4LA?BQ-W +T
MC<+?S5\S&,YVYSB@"U115/3]8L-6:X6RO;>\:WD,4PMY5<Q..JM@\'V- %RB
MBH+R\M]/MWGNIX[:!.6EF<(J_4G@4 3T5D:7XOT+6YO)T[6M.OY?^>=K=QR-
M^2DUKT %%%% !156\U2RT^2&.ZNX+:28[8EFE5#(>.%!/)Y'3U%6J "BJMYJ
MEGIK1"[NX+4RMMC$TJIO/H,GD\C\ZM4 %%9VK>(M)T$(=3U2STX/]TW=PD6?
MIN(J;3=6L=9MQ/I][;WT!_Y:VTJR+^:DB@"W115'5=<TW085FU/4+73HF.!)
M=S+$I_%B/44 7J*S]*U[3-=C,FFZC::A&.K6LZR@?BI-:% !1110 453.L6*
MZB-/-[;B_(W"U\U?-(QG.W.<8]JN4%.+CN@HJE)K%A'J4>GO>VZW\@W):M*H
ME88)R%SDC /;L:NT XN-KK<**H:?KFFZM/=P6.H6M[-9R>5<QV\RR- _/RN
M?E;@\'TJ_0$HRB[25F%%13SQ6L$DTTBPPQJ7>21@JJH&223T '>H-,U2RUJQ
MBO=.O+>_LY<^7<6LJR1O@D'#*2#R"./2D'++EYK:%RBBBF2%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MUWU]/O#\Q7,?MT_$0:_XY\,_#VWM;O5-/T^2/5-8M=.!>9\\+& .A$98\_\
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ML4DBP2V5I&DZE&9<K)&Q&3U3D8K[SHH _-OX3:E^UO\ L8:"?AG'\*+?XO\
MA+39)%T/6M/O1$RPLY8*2"6"@ECL=0R[B Q4+7T'X+;X_?%#X(?%MOBIX8T?
MPYJ6M:+<6?ASPQI$ZRS1;K:93YTF]E+NSQ ?/@;3E4YS]0T4 ?"WP*_8XUSQ
M=_P3E;X+>/[&3PIXBN)+N:+SBDK6DXNVFMY#L8@KD+D Y*LPXS7)?#7XF?ME
M?L\^$K#X<ZE\$K3XCC1X5L-*\0V>I*L;P(-L7F,#\P"@ %Q&V -W.37Z+44
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MU'O5% 'Y[?L__!GXH_$[]N"'X]^(_A=;_!+0;'3);2?25O$FN-8N'CDC+R[
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M9H+>X\(6]S<C@31M\A]SAR/U%2_#WP?XH;Q]>^+/$<%K9RW4'E&WA?)SA ,
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M5\//$-K\5O!WQ#\'Z8^HWUI)]FU.VA=4:6#U^8@'*-(N?]STKWFB@#P?XR?
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MUO@[\%_%3?$&?XC_ !&NXI?$;(T=I80,&2U4J5Y*_*,*64*I(^8DDDU[_10
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M'^TF??BL?Q?X/^,O[05]H\>N>&],\+:1I]S]HC>:;#9XSD!G8G'3Y0*^MZ*
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M< 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %<)XP\0_V;XNTRSW8\U8CCZR,/Z5W+,%*
M@D L<#/?O_2OG;XY>(CIOQO\)6>[ FBM#CZW,@_I0!]%T4W<-P&>>N*=0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!R?Q4\'R>.O >KZ1;S/;7\D
M7FV=Q&Y1HKA"'B8,.1\RCD=B:_.C7_BOXJUKQ)I.JZS=F[UC15C@BEN$P_[J
M5G42#C<0S$$GDXYK]0Z^!_VCO@W=0?M 6^GZ5#MA\53)/;''RK*[;9L_1LN?
M0,* /??V3[+7/$'A[4?'OBB^GU+5];D\FWDN#Q';1DC"*,! S[_E  ^53WKW
MNLWP[H-IX7T'3M'L4\NSL;=+>)<?PJH )]SCGWK2H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BOE'P;_P4&\*^,OVQ-9^!,.D^2MF9K6U\1F^#)=W
MT*!I;80^7\N,3*&\PY:+&WYA7U=0 4444 %%%>=S?'_P);_&NW^$LFN*OCVX
ML#J4>E^1*080"?\ 6;=F[:K-MW9P,XZ4 >B4444 %%%% !1110 4444 %%%>
M=^(?V@/ GA7XQ>'/A;J>N+;>./$%H][I^FF"5O-B7S.3(%V+GR9<!F&?+(],
M@'HE%%>#_M#?M56OP ^)WP=\'3^'9M:E^(VL'2(KN.[$(L2)[6+>RE&WC_2@
M< C[AYYX />**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BN4^(WCN/X>Z)!J,EFUZLMPMOY:R;,95FSG!_N_
MK6GX5\3V7C#0[?4[!]T,HPR'[T;#JK>X_P #WKACCL/+$RP:G^\2O;K;N=;P
MM:-!8EQ]QNU_,V*R]1\-Z=JNL:5JMU:I+?Z6TC6DQZQ&1-CX^J_RJCXX\:V/
M@70WU"\S(V=D-NI :5_0>WJ>PI? WBQ/&WANWU9+9K19F=?*9]Y&UB.N!Z4?
M7L.\5]24_P!Y;FMY;7[?J+ZK6]A]:Y?<O:_F=#1117<<H4444 %%%% !1110
M 44R21(8WDD=4C0%F9C@*!U)/I7DGP8_:,TOXR>)-?TBUL#I\FG_ +VU9Y_,
M-W!O*F3;M&S'R97)^^.: /7J*** "BBB@ HHHH **** "BBB@ HIDDB0QO)(
MZI&@+,S' 4#J2?2O)/@Q^T9I?QD\2:_I%K8'3Y-/_>VK//YANX-Y4R;=HV8^
M3*Y/WQS0!Z]14-Y<?9+2><KN$2,^W/7 SBN(^"_Q6B^,?A!]>ATU]+1;I[;R
M))1(?E"G.0!_>].U '>T444 %%%% !1110 445R/Q/\ B?HOPF\+R:UK<C^7
MO$4-O" 99Y""0B@G'0$DG@ 4 ==17S8O[85]8)#J&M_#'7M*\/2D%-4RS*RG
MHP#1(I_!Z^C[>9;FWCF3E)%#KGT(R* )**** "BBB@ HHHH **** "BBN%^,
MOQ6L_@[X)FUZYMOM\OFI!;V8E$1FD8]-V#C"AFZ'[M '=45S'PU\>6?Q,\$:
M5XCLD\F.]BW/!OWF&0$J\9.!G# C.!D8..:Z>@ HHHH **** "BBB@ HHHH
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M)7/J^BJNF:A%JVFVE]!N\BYB2:/<,':P!&1]#5JMCY^2<6T]T%%%% @HHHH
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MAMJOQ?\ '&FQ^9JL>GS&&UT_[ORLX1]S#< WW54L%W%LJ.0_9C_:#^+OPO\
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M:P)"(P&E;)VA,87[N,_PUZ_7 _ UU/PMT;# [3.&YZ?OG//X8KOJ^AR"-?\
MLZC4KU74<HQ>J6EXK31*_J[OS/&S=TOKM6%*FH*,I+2^MF]==O1604445]$>
M,%%%% 'B_P"U?X_D\&_"VXT^R9O[7U]_[.MDCR7V-_K2!_N_+]7%>.>)/AY)
M^R_J'PR\9VJL8H5%AK_E\AWDW,Y]_E:11_UR3O5SQOHNK_M*?M!:E9:%J_\
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MX2""/3..<9KO: "BBB@ HHHH *^9OVRO^0O\,?\ L*O_ .A0U],U\S?ME?\
M(7^&/_85?_T*&@#U+XW_ !:N?@WX=LM;706UNPDN1;W+)=>2UON&5;&QMP."
M.2.=H[\:OCGXH:5X+^&MSXS)6^L%MDGMD1]OVDR8\I0<'&XL.<' R<<5K>./
M"=GXZ\(ZMH%\H-M?V[0EB,[&/*N/=6 8>X%?$?A*S\3_ !$USPS\%=8C,=AX
M=U.>:_D#G+0(>F?09D53_P!-5]* /HKQ/^T==>$_AAX4\7:AX4\I]>N%B%@V
MH8\B-@S)(7\KG*J&Q@<-UJ*__:,UA/$5A_9WP[UG4_"=[<I:P:TF4,Y9MJR(
MA7&PDC:69=P(.17/_MLVD/\ P@_A*V$:K;_VS''Y:\ +Y3C QT&*^D(84MXD
MBB18XD4*J(,!0.  .PH ?1110 4444 %<-\;O&4_P_\ A3XDUVU.V[MK;9 ^
M,[9)'6-&_!G!_"NYKC?C%X*D^(GPR\0^'X2OVF\MOW&XX!E1A)&">P+*O- '
MGW[*/POT_P ,?#VP\33Q+=>(M<C-W/?2_/(L;DE45CR 1ACW))ST&/<Z^>OV
M6OC!IUUX3M? ^NSKI/BC16:R^R7A\MID5B%"Y_B7[I7K\N<>GOM]J%KI=J]S
M>7,-I;1C+S3N$11ZDG@4 >;_ !>^(R? 7PM::KI_A:*_TJ6\\NZ2TF%MY#/E
MO,VB,AMQ#9Z?,1SS6]XY^*&E>"_AK<^,R5OK!;9)[9$?;]I,F/*4'!QN+#G!
MP,G'%)J/_"._&SP#K.G6=[#J>DWJR6374/S()%QAE/1MK;6!'&1UKXZ\)6?B
M?XB:YX9^"NL1F.P\.ZG/-?R!SEH$/3/H,R*I_P"FJ^E 'T?KW[1C^&_AGX9\
M1WOA>8:UXC<)I^A0W.]G!/RL9-@P"I0X"D_.H]2-+X?_ !<\3ZYXJAT#Q7X!
MO?"\]Q"\UO>>>)[>3:,E2P4 -CMDGV%:'QB^%N@_%+0;'0+R]72-3B8S:5<0
ML!+$Z 9*)D;E (R!['(P#7GWPR^(GC;P#\3[+X9_$">'66OH&ETO68FR\BJ&
M($G0D'8PRPW!AR6!S0!]$4444 %%%% 'SM^VU\+=>^)'PSL+GP[ U_?:'>?;
M7T]%W-/'L(8JO\3+P=O<;@,G -_X&_M6>$OC1:PZ'J0CT/Q2Z>3/H]X,1W#8
MPPA)X8'GY#\W48(&:]7\4?$#0/!>H:/::YJ,.F-JTK06DMP=L;2* =A8\*2#
MQG@XQUP#\Z?MQ?"GP>WP]N_':?9]&\5VDT)M[NW81O?LSJ-A ^^P4E@W4;.N
M,UQ5$Z<I58/U1^BY/4H9IA\/DN8TY14I/V-2/1R=FFMI1YEJUJC7_;"^.6N?
M!WP;;Z1X5TFZLGO%6U_MP0%+:S4JVV*)L8,I5&QC[H&>O3NO@_\ &'Q?\1-<
MOK+Q'\,=2\#6MO;>='>WUPTBRON4>6 84P<$GJ>E?/O[4WB#4_%O[&?PUUC6
M-S:G>7UE-/(PP9";2Y_>'_>&&]/FXKZU^)<-YJOPQ\4PZ,_F:C=:/=)9-$V2
MTK0/Y94_4C%*$I2J2:>B2T-L;AL)A<IPV'G0C[6=2K!U+RNG&4%S:-)KR::2
MU6K;?BNM?M>7VO>)M0TCX7^ K_X@1Z<VR[U.&4Q6P;)&$(5MP.#AB1G!P".:
MZGX+_M-:?\4/$-YX5UC0[WP;XSM%+R:/J!)+J "2C%5)(!SM*@XY&1DCFOV"
M]6T2Z^ ]K8:<\*ZM9W<YU2)2!)YC2,8W8=<&,( ?]@CM7,_&>[L]=_;0^%=G
MX>=)?$&G@MJLEN03'!EGV.1T/E^:<'M(/45*G4Y8U7*][:>O8ZJV6Y;4QN+R
M>&%<'1C-JKS2YKP5^::?N\L[:62M=69UOC;]J3Q#H?QAU[X?^&OAI<>+[[28
M8KAY;;5!"S1O%$Y;886P 9E7[Q]:VOAQ^U#9>*?&4/@[Q5X9U3P%XLN%WVUC
MJ@W17 P3B.3:N3\K8RH!Q@$GBN'^'O\ RD(^)O\ V+T/_HO3ZJ?MD75MJ7Q/
M^#ND:4R2>+5UE)HQ%S+#$9(L,V.BEER,C^!CV-+VE2*<^;9VM\[%1RO+*]?#
MY8L-RRJ4(S=12E=2=/G;:;<>6ZU5EOHSZRHHHKT3\H"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML6P2X79N#9!.=QY=O7%4=!_9[\+:'\,=1\";KZ_T2^E:>1KN5#,KG;AE944
MJ44CCMSD<5Z;10!XAJ'[*NDZUX2@\/:IXM\3ZC8VNW[''->(4M@HP J;,' R
M/FS@' Q7JWA'PV?"FAP::VIW^KF+K=:C('E;VR   .P K9HH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_,
M_P#:V_:*^-7QT_:CN?V>/@/J<GAO^S(A_:NL6UQ]FE:38KRNUP 7ABC#HG[O
MYV?(^;*BOTPK\H_VX/A;\4?V1_VH+C]I?X:1-?Z!J3+)JBB)I8[5RB1S172
MY\B7:&#@C:QQE2$) *VJ_LC_ +;O[/\ ;-XM\*?%:Y\;7%JOFSZ19ZW=7CRX
MY/\ HUVGES<=N7.<!>:_4OP7J5YK'@W0;_48_*U"ZL+>>YCV%-LK1JSC:>G)
M/':OG;]D?_@H)\//VJH;?289#X7\>>5OF\.WT@)E(!+-;2X F4 $XP' !)7
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K.L-6TOQ)#?16EU:ZC';SR6-W'&ZR".5>'BD'9@",J>Q
M!Z$5HU^;7Q^_94_:@^&?Q\\7_%+X ^*UO;3Q/=?;+O1(;B&!U?:!B2"Y/D3
M '#YW<D!1W //_\ @IM^QOX=^ MEI?QP^%DG_"%7D&JPQ7FFZ<YACCG;<T5S
M:X/[I@R8*+\O(("X.[Z#_:(^)=Y\8O\ @E+J?C/4D5-3UCPWI]Q>;5"JT_VF
M!964#@*75B!V! KYMUG]E?\ ;*_;3UW2-,^,^HKX6\(:?<"4M=/:)&AQAGCM
MK4YEEVDA6DP!N8!ADBOT5^)'[..B^,/V8=3^#&ER'2](;0DT;3YI/G,!B11
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MI10P74=P# UK:QJVZ-B =T3C&<\>]?7% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB@\S<D8"J=V>% % '>4444 %%%% !117Q_\ \%0/CUX[_9V^ 6@>)/A]KO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/#-K=:SX4U>^E6"RC\36L4$=U(W"HDD4LB!B> '*Y) &20*^;/\ @DE^R?\
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MNKK49+71=/C^T7LR?;)1O$8("+D$;G*J2" 21BO:?^"L'_)DOB__ *_=._\
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MPAF7:F,@#KSD^@[;6/C3H>B^']'U.6VU"675U+6FGQ0!KE\<'*[L#G'?OWH
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M+]I#3FC%\_AK78]!9]@U7[,#%UQGKCK[Y]J]@H **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK6UBLK:&W@01PPH(T1>BJ!@#\J )J*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^;] \$:+XZ^
M/7C>TURR^W6\(:5$\UX\-N09RC ]":^D*XGPW\,XO#OQ USQ0M^\\FJ(5-L8
M@!'EE/#9Y^[Z=Z +_A?X:>&/!<QFT;1[>SG(V^=\TDF#U =B2!^->)?!6W\3
M76L>+VTJ_P!)M-6^W-]M74+9Y)C\S<@AA\N[=QZ_A7TI7F'C+X&V^O>(V\0:
M)K5WX7UF3_73V8RLGN0&4Y.!GG!QTH BT7X9^(H?BA:>+M6U73'D$#6T\-C
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MA_PA_C#Q#KO]L7%]_:SE_L\BX$>6+<G)W$= <# XKNJ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRP7@$@=3ZT ;%%9WAW7(/$VAV&JVJ21V]Y"L\:S !PK#(! )&?QK1H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]<H__1J5UGAK_D7=*_Z](O\ T 5R?QX_Y))XB_ZY1_\ HU* . \%_':W\/\
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M#UP0..XR*\ETCQ9XH^#^I:7X>\90PZKX<FD2WL]6C',6"-F[_=XX(R,9!.*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY8\DEB?4DDGZUJT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB-VCD90K@,R_=)R#D<9- 'ME%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1O&WP3\7VGQ)\%FXMY]!N8DN+E8V:V(EW8@GQU241N,$C.TX((!']$W[0O\
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M%9^OS/;Z%J4L;%)$MI&5E.""%)!%<)^SWKFH>(?AS#>:G>37UT;F53-<.6;
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M93D$'H0:FG452]NAW9EE%?*XTI5O^7BOZ/K%^:37WCZ***U/#"BBB@ HHHH
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M?_@K%"DG[$_BMG16:.^TYD+#)4_:HQD>AP2/Q-?+'_!#G_D:OBW_ ->6F_\
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MQ>"^U/QE>>(+66T\M+*XB*K&Q*D,"9&Y !'3^*N/^+VGZ]KWP TN:^MI'U6
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!0<?(#G/>4TW_A=\X_9O_L(NX\4^=_8'DX/F^7C[V.O^K_=^N[FO9/ 7[/\
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M;AR'R>,;LCC![5Z)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQH_X5I^VC_T'[S_P<6G^- 'Z'T5^>'_"M/VT?^@_>?\ @XM/\:/^%:?MH_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%<WXQ^)'A3X=V\4WB?Q'I>@1S'$7]HW:0F3UVAB"WX5/
MX3\=>'/'E@U[X;UW3M>M%(5YM.NDG5">S;2<'V/- &[1110 4444 %%%% !1
M110 4444 %%%9NM>)-(\-10RZOJMEI4<\@BB>]N$A$CGD*I8C)X/ H TJ***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH \N\6?'K3? OBR^T;6M*OXH8MAM[R
MW0.DRM&K$X)7H25XST[5RG@!KSXJ?&8>.8M.FT[0K"W:"VDG7!G8HR#V)^=B
M<9 P!FO>)H8[A=LL:R+G.UP"*>%"X &!0 M>*?&3_DKWPR_Z^S_Z,CKVNB@#
MP7XN:/+X+^)=GXXET9==T&:$6^H0M$)?*(&W=@C X"D'IE2"1FGK\7/A[JDD
M-KH?@TZOJ4Q 2UCTN(8SUW'!X'L#7N]10V\4&[RHDCW==B@9H \4^.DLOAGQ
M]X+\5S6LT^D6#LEQ)"N3'\P//U!./7!%;.J>.++XR?#_ ,7V/ANWO)Y8+0 &
M:+8)6;<0B<Y)^3V^\*]591(I5@&4C!!'!I(XTA0(BJB#HJC % 'AOPB^-6B6
M'A_PYX5GMK\:TLB6#0K!D*Q?;N))&%&<GN,'BN;L)-.^"/C#6M.\6>'EU#0;
M^X,]AJ1M4F*@D_+ENO&,@'(*YP<YKZ56&-96D$:B1A@L ,G\:62-)D*.JNAZ
MJPR#0!Y3X$^('A3Q5XLMK;PQX58! [2ZLM@D*0?(< ,!G+=.<=>]9WP)_P"2
MB_%?_L*C_P!'7->SQQI"@1%5$'15& *?0!@>-_%!\'>'I]5_L^?4XX60206P
MR^PL S >P.>?3J*^==:UCPYKOCKP[J/PTMKRU\0RW(:Y@AA,<(3(W%UZ#WV_
M+C.:^J:CC@CB9V2-49SEBJ@%C[T 25XI\>-7FA\4^%]-U:YN;#P9=,3?SVY9
M1(P)PCLO.W&./<GMQ[73)(4F0I(BR(?X6&10!\SV>N>$?#OQXT6\TDPZ?X>C
MT]HTFC@=4D<K(,KD9?)(&[G)&,FNQ_YNG_[A7_LM>S-"C,C%%+)]TD#*_3TJ
M2@#Q3]H;_D8OAU_V%?\ V>*I/B98ZAX'^)^E>/K73Y]3TO[/]DU"*V7=)&,$
M;P/3!7VRN"1NKV>B@#Y=^//QB\._$+P?9Z=I+W+745\EPRS0E %$<BGG/7+"
MOJ*BB@#R;]IS_DE<_P#U]P_S-=9J7_)*+O\ [ C_ /H@UUM% 'SYX+\&S^._
MV9UTNT(^V^;+-;AC@,Z3$[?Q&1^(-:'AG]HK3/#>A6^E>*=/U'3M;T^);>6%
M8,^9M& PR1@G'0\>AKW.HW@CD=7>-6=?NLR@D?2@#QOX0Z5JWBKQ_K?Q!U6P
MDTRWO(1;6-M*"&,?RC=CKC"#GH2QQ7M%%% 'AGQ(\?\ @;6[K5-!\:Z/>V5W
M8R2);72P$NZ@_*\3CD9X."-IXY-4? _]L?\ #-OB4:H)A;BWN!8?: =_V?RQ
MC_@.=V/\,5[[)!'-M\R-9-IR-R@XKF/BLC2?#7Q,JJ68V$P"J,D_*: /)?AE
M\>O#/A#X;:;IEW]L?4[2-U%M' 3YI+L1M;I@Y')J?P7I/BG1?!?CSQJ+)[77
MM:)N+6TV$R1(&9BVT]3AR0",_(/6N^^!MJ%^%?APRP@3)%( 77YE_>O^5>@4
M ?(VMS^$+OX-RW4$KZIXRN?*>]NKE9)IXV\P;LN1A%[ Y&<CKFO1?&&C'XH?
M _17\.2_;KW2!;OY<0.6=(0KQC(Y8;@?JN.M>WK;Q*KJ(D"OG> HPV>N?6GH
MBQJ%50JC@*HP!0!XQIO[4.@+IJKJ]AJ-GK$8VS6<< .9.X4EAQGLV#47QLT.
M^UJT\*^-],TLZB=/"S7.FS1[RT+[7PR\].0>#][/:O:C;Q-,)3&AE P'VC</
MQJ2@#P*+XU?#.XM(S#X3,]_)\JV,>EPER_IGH>?3GVKJO%WQ$T7P[HNB6/B?
MPQ-;Z)JEBCR1BWWQ6DA /DNN!@KGMR".E>G+;Q1RM(L2+(W5PH!/XT]T612K
M*&4\%6&0: /GSX&F#_A:&M_\(@+S_A"6@W2?:@WEB;Y=H7/.>N,\XSGM7T+3
M(XTA0(BJB#HJC %/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BFNZQHSNP55&2S'  ]:X.U^/WPTO=:_L
MFW\?^&YM1+^6+=-4A+,_]T?-@M[#F@#OJ*** "BBB@ HHHH **** "BBB@ H
MHK-NO$FD66L6ND7&JV4&JW2E[>QDN$6>91G)2,G<P^4]!V- &E1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M @[>N#G&*^6_V79K#0OB!^TUXTLK6WL=-TN\EM[-+:)8XTB@-RS84+@#"1'
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^;<H# _=W<LQ-8GPSU73O!'Q]_:=\>:5IEG9VGA/2OLEO9VL"Q1!T0_(%0#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH*^@?V<_ E[\,_@?X-\-:E;BTU*QL%%W '5_+F<EY%W*2#AG89!(].*]'HH
M^3OCYX1\?^&OVIO!WQ6\/>#I_'>C:;I#Z<;&RN$BF@D83J3\P)Y$^=P!S@@X
MXKZ/^'^K:]KW@_3=0\3:,GA[7+A&DN-+2<3BVRQVH7'#';MR1WSP*Z*B@#P[
M]KKX#W_QV^&]O:Z%<QVGBC1[Q-1TR25MBNZ@AHRW\.0<@_WE7.!DUSWA/XS_
M !UUIM+T2_\ @O\ V7JHEBAU'7+G5(OL4:;@)9DC'+G&2$5SSCDU])44 ?)_
MQ"^'_C_X-_M*:C\6O WA;_A.=&\0V"V6KZ/;W"PW$+J(P'3=U!,2-D!NK@@9
M#5H?!GX2^-O'7QRN_C3\3],B\/WT%J;#P_X=683/90D,-\C#C.UY..I,KDA<
M 5]044 ?(=Q\./B=^S7\:/%_B[X?^&8?'G@OQ;/]LO\ 18KI;>ZM9MSN2F[L
M&DDQM#9#;2!M#5;^!?AGQQXS_:K\4_%+Q9X*O?!VF3:&FG6%K?3)(ZR P \@
M@GA)#]W'SXZBOK&B@#XQ\'^&?BM^R;XN\<:7X6^'S?$'PEX@OFU'2I[.]6%K
M25L@),#DX VJ> #L!!Y('8?!'X#>,? ?@SXE>,O$BPZC\5O&%O<SM:6LJ;(&
M*.8K=7+! 2[#)W;0 @SA<GZ>HH \5_8]^%^L?"+X"Z%X?\0V7]G:ZLUS/>6W
MG)+L9YW*?,C,I_=A#P>]87[&?PI\4_#?P]XVO?&>E?V1KNO^(9K_ .SFXBF)
MA*J58M$[J#N:7C.>/I7T/10 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>91
<FILENAME>mrna-20201231_g7.jpg
<TEXT>
begin 644 mrna-20201231_g7.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #0 6 # 2(  A$! Q$!_\0
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M:\$^/O\ R7?]GG_L/ZA_Z;9Z][H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH \$^/O_)=_P!GG_L/ZA_Z;9Z][KP3X^_\EW_9Y_[#
M^H?^FV>O>Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKSKX@?'OPE
M\,]<CTG7)[J.\>!;@+#;F1=C%@.1[J:YG_AK[X=?\_=__P" ;4 >@^(M-\;W
M6I%]!\0^']-T_: (-1T&>\EW=SYB7D0P?39QZFLO^QOBA_T.'A'_ ,)2Z_\
MEE7)?\-??#K_ )^[_P#\ VH_X:^^'7_/W?\ _@&U,"]X5U#XH^)KGQ!%_P )
M/X1M_P"RM3?3MW_"+W3>;MCC??\ \A$8_P!9C'/3KS6__8WQ0_Z'#PC_ .$I
M=?\ RRKQ_P"'?[5?@'3;_P :--=7P%UKTMQ'BT8Y0P0+SZ<J:[/_ (:^^'7_
M #]W_P#X!M0!Z]HL.HP:7;QZM=6M[J*C]]<65LUM"YR>5C:20J,8ZNW]*NUX
MI_PU]\.O^?N__P# -J/^&OOAU_S]W_\ X!M0![7163X5\367C'P_8ZUIK.UC
M>)YD32+M8KDCD=NE:U( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^
M6?"]]\?I/'?Q57PC%X3N_#\?BN5+8^-+O4$G1?LEJ=L CC9?(YR,'[YDXKZ'
M\"R>)I/"MBWC!-(C\2?.+M="DE>S!#L%\MI0'/R;<Y'WL]J .#^-WCCQGX L
M[[6M(ET./3+6WA6RTZ\MY;B\UR_=W LHMDB"(L!&JMMD):0D@+&=V=9?%SQ+
M-XDL]2D72_\ A$+SQ7<^%$L5MI!>QM$TT/VDS^9M;,\##R_+&$8'=D$'>\9?
M!F[\5?$2T\86WC35M&O;.S^QVEO#:V=Q#:@DF22(3POLD<$*SCDJH7IQ4UK\
M$K*V\6Q:I_;6H2:3#JTNO0Z"RQ?9DOY$97EW!/,*DR22;"V [ENP  /'OB?\
M7?!7C[]I+X%Z/X<\4:7K>J:9X@U(7MG97*R26^-/N$.]0>/F!'/>OJFOG;XX
M:'INF?'_ /9^GL]/M;2>;7]1\R2"%49_^);.>2!SSZU]$T %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'P_^VE_R5JT_[!,/_HR6O!*][_;2_P"2M6G_
M &"8?_1DM>"51+,Z^\2:1I=P8+S5;*TGP#Y<]PB-@]#@FJW_  FWA[_H/:9_
MX&1__%5M44P..\/^,-!AFU@OK>G('OF9=UW&-PV)R.>1P:U_^$V\/?\ 0>TS
M_P #(_\ XJMJB@"&UO(+ZW2>VFCN('&5EB<,K?0C@U-110(_1?\ 9[_Y(OX3
M_P"O/_V9J]$KSO\ 9[_Y(OX3_P"O/_V9J]$J"PHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH _.SXS7GB:U^,WBK4;>/XI:7XCD\6?8O[;\.Z7>W5K'X:.
MGJCI;H 83)YQ9E8#*MAP<BOM'X V&@Z9\(_#]MX9T_6M,T9$F,5OXCBECU L
M9I#(\ZR_/O>0N_/7>"  0*^3O'VJ>-O#/[0VK>*5\*?%;5]3L?&%O]GET6SG
MGTB7P\MM&DL"1[A&SM(96^[U .X'-?:O@7Q9_P )QX5L=<_L?5M ^U!S_9VN
MVOV:\AVNR?O(\G;G;N'/((/>@9O4444"/!/C[_R7?]GG_L/ZA_Z;9Z][KP3X
M^_\ )=_V>?\ L/ZA_P"FV>O>Z "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#X?\ VTO^2M6G_8)A_P#1DM>"5[W^VE_R5JT_[!,/_HR6O!*HEA1113$%
M%%% !1110!^B_P"SW_R1?PG_ ->?_LS5Z)7G?[/?_)%_"?\ UY_^S-7HE06%
M%%% !1110 4444 %%%% !1110 4444 %%%% 'P5^TMHW@^Z^,^GRP^$OBM>2
MC72WB:XT>#56LY[3[+(!]G,;[/\ 6^1_J\=&]Z^N?@9#HEO\*]"C\.6&N:7H
MJK-]GM/$BSK?Q_OGW>:)R9.6W$;C]TKCC%4O$'B7XG^']:O'M?!6C^*]!,A-
ML=-UG[+J"IZ-%/&(F/N)E^@KLO"FO3^)=!MM1N=&U#P_/+N#Z;J@C%Q"58KA
MO+=T.<9!5B""#0,YWQ]\4X? OB#POI!T?4-1FUS4(;(W,,16VM%D) >24C;G
M(P(URQZX R:Y[0OCPGB3XOZKX)L;;1"NFW;6DKS:_&FH2;($D>2.R\LNR*S[
M-VX<JQ[5U_Q \&S>,5\.B&XCM_[+UJUU1_,!.]8BQ*#'<YKD-0^%?B+6O%VG
M-?WNBCP[IWB$^(H)K6S,5^[['"P-MPG!<AILEG0;2N26H$<]\??^2[_L\_\
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M_P"C):\$JB6%%%%,04444 %%%% 'Z+_L]_\ )%_"?_7G_P"S-7HE>=_L]_\
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M^"])\/\ _"BM-OOL$/E?:/\ A.+>/?R3G;]G..OJ:Z'_ (6U\?/^C?\ 3?\
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M ?8-</<?&GPC;^'7UTZA<RZ6$MG2:#3;J4S&XG>WA2)5C+2R-*A7RT!894D
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MG[,=S)X.\#Z.NOPPW/A?PO'HD5R+0LDEU%<Z=<Q3E-XS'YFGC<F<L)"-PZT
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5[0<9VY..F36]0 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>92
<FILENAME>mrna-20201231_g8.jpg
<TEXT>
begin 644 mrna-20201231_g8.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #  7X# 2(  A$! Q$!_\0
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MY&9<*' +<;/AV^_9U\)6L5OHMY\/=+@BO4U)$M)[2,+<H"L<HP?O*&8*>P)
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MBJ[L8O 7A^]L+=O*,BV,*N7'WL?(01GC\*]=^)'BD>#_  C?7X8+-M\N(DX
M=N ?PY/X5\#Z9X@\;^+6N_$FAS:;+HLD[)9:9J,;(UU"O'GB=<E2[;B 5(V[
M3WIH1]R>&_!O@+Q1HUMJ5GX3T,PS+G:VFPY4]U/R]0:T_P#A5O@S_H4="_\
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M_3A<5[#7CW[)W_)%K+_L*:I_Z<+B@#V&OG7]N3X<WOQ8^%OA[PO8VUQ</?\
MB6SB>2W1F-NK)*OG,5^ZJEE)8\#O7L'C[XI>$_A=9VMUXKUVTT2&Z=HX/M+'
M=*57<VU0"2%49)Q@#DXK-_X7M\/6\56?AM?&&DR:U>)$]O:QW*MYGF)YD0##
MY=SI\RKG+*00"#0!\+>!Y/BW#XA\4?%)M"U[1?$OBO1+1]2GBTQYKK3[6/4H
M;28PPLA#3+;6[S*FTG#[L'BO5_#OB#XO>+O%NAZ5IOB'Q6/!YOM;>PUJ\TN*
MUN]3MH+>SDM%N3);@1JUPUQ&'*(TB!O]ZO=(OVL?@_-&LB?$+12C+'(&\\@%
M)"55P<?<W J6Z*>&(/%6]4_:<^%>BZE?:?>^.-*M[ZQDG@N+=I"726%]DT>
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M5K0_W=<T\_\ M2@#W&O'9?\ D[J#_L2W_P#2U:SV^.GQ'7K\"?$&/;6-//\
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MACS?@SXT3UVR:>_\KFH_V0IVNO@7I<S0R6S2:AJ;F&7&^,F_G.UL$C(Z'!H
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MV^^U0PAMUYJ4_G3RLS%BSM@#J3@ !0,     &76LX))EF>&-IE!59&0%@#U
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M<])_PTWIO_0B^/O_  FYZ %_X9#^$W_0JG_P8W7_ ,=H_P"&0_A-_P!"J?\
MP8W7_P =I/\ AIO3?^A%\??^$W/1_P --Z;_ -"+X^_\)N>@!?\ AD/X3?\
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MX3?]"J?_  8W7_QVD_X:;TW_ *$7Q]_X3<]+_P --:9_T(WC_P#\)N>F(/\
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MS%Y9;B=PTTTCGJ3M &/[S=L"N,E_Y.Z@_P"Q+?\ ]+5H ]BHHHI#/'OVFO\
MD7O!/_8Y:/\ ^E(KV&O'?VFO^1=\%?\ 8Y:/_P"E KV*@#S+X[>)+G1= LK>
MSN9+:XNILEX7*MM4<\CW(KA?@_X^NM/\4"SU*\FGMK_$>Z>0MLD_A/)[YQ^(
MK*_:@\?Z5X=\06O]KZA#865M&L(DE)P99,MCCV _*O-]#\2Z7XAA^U:/JEKJ
M,2$?O;.=9 I[9*G@U1)]R45S?P]\1'Q1X1T^^=MT^SRYO^NB\'\^OXUTE24%
M%%% !1110!3U:>[M=-N9;"V6\O50F&W>3RU=NP+8.![X-<79?$RZ_P"$)US6
M;JQMYKG3+E[-/L4[-;W<@*J"CLH.W>^PG!P5;KBNO\1:)%XDT.^TJ>>XMH+R
M)H7EM9/+E56&#M;L<5@V7PUL+7PV=!EO]0O-+\IH/(FE10$(4 #8B[=NW*XQ
M@DT <CJWQAUO2+@V5SI%K!<64\T6IWH%Q/9P*B02*VZ.,E0R3@Y< #8W/&:Z
M7QM\1SX9NA;6EFE_-]E6X.Z78NZ29(8%R >&=R2>P0]>*9-\'=&N+,P27NK.
M9FD-Y-]M8/?+(%#I,1PP*HB\ $!< @$YO:_\/[37M5$\C>7:2V!L+B%"58JK
MK)"Z,/NLC X_WO:F(?X=\67^IZ)JTMSI@?5M+N9+2:SL90RS2*JLOEL^WAE=
M3\V,9([5PEU\?+F&TT&1='B6:[T^/4KU)))62WC:4Q[0Z1E1@JQ+OM48'/.1
MZ1X;\(VWA>,):W5Y-N:22=KF7>UQ*Y!,DAQRWR@#& !QCIC$NO@_H%U:6%MF
M]A@M;?[&Z0W)47-ONW^5-C[R[L^AY(S@D$ WO#/B+^WO[3BDB6&ZT^\>TF16
MW#@*Z,#_ +4;HWMDCM7G'[)W_)%;+_L*:I_Z7W%>C>&?#IT'^U)I)5FNM1O9
M+N9U7 Y"HB@?[,:(ON03WKSG]D[_ )(K9?\ 84U3_P!+[BD,]AHHK.USQ%I?
MAFWMY]6U"WTV"XN8K2*2YD"*\TC!(XP3U9F( '<F@#1HHHH **** /C_ /;&
MU[Q!9_$;2M,T[Q=IOAVWN='>X@:6X2*>&6%;N1C(QA?;"[K:N68A2EG.N"6K
MZ^CW>6NXAFP,LO /O7QS^UXFB6_QIT ^(]/>ZT[4=)CM88K'Q=::+->R![J-
MX)DGG3S8C%=2("JJ1Y\J[SOPOV,JA%"J J@8 '04#%7I^-+7.7GC[0M.\3V_
MAZXO"FJ3[=L?DN4!?<45I -JLP1MJD@G:<53U7XL^%M$UB\TR]U%H+FT21I6
M:WD\H%(O.=!)MVEQ'\^P'=CG% CKF^Z?I7C_ .R/_P F_P#AG_>N_P#TJFKT
MGPUXGLO%VD_VA8+=);EB@^V6DML^1WV2*K8YZXQ7FW[(_P#R;_X9_P!Z[_\
M2J:@#V&BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQV7_D[J#_L2W_\
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MU9\(1P/B!H@'_7?_ .M6%X@^.GP%\4<ZCXPT"67_ )[+.4D_[Z S3 H_"_\
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M.Z%XVT*RTO3X5AAB6?G ZLQQRQ.22>2233 ]SHKRC_AJWX0_]%!T7_O_ /\
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MW=Z$#^7$@2-,(JC &3G&26)[T ;W]BZ?_P ^%K_WY7_"C^Q=/_Y\+7_ORO\
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M&X%U=WMTJ(TCB-(U^5%55 2-1P.V:Z2@#+OK'3-/LI[J338I$AC:1DAM1([
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9HHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>93
<FILENAME>mrna-20201231_g9.jpg
<TEXT>
begin 644 mrna-20201231_g9.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #S ,4# 2(  A$! Q$!_\0
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MJ$QU-8C/J:BOA[P;^U]XY\&^+M;T[Q]9R:A,ES;Z3IM@\]A:1F;[#'>3337
MPJG8XP!\O[Q%QD,:]X^$_P"THGQD\8/I6@^$M3BTNWT^SU"]U6^FBA^R_:86
MDBB,).]GW(Z';D#&<X(H ]IHHHH YOXC1QS>"=628XC,0W<X_B%?+SQW$>H"
M:QN&NB$9%:1PNP+P!AADYZY'?ZU],?%>,3?#O7$8D9@X()!SN&.GO7SEI$(M
M7 *(]Q"@.UHEQ$6!!.1CN V!S732^%L:':!;S0[Y(KCR$*AUF=54#@ALYQ_O
M >QJCYC0WMUYB7$9524>X43)-M.4D4KU8G^$G. *W[B&35]/FL)+V.:98G:2
M<J-@Z,HQCMD=>Q/%84.H&9I$BF\BTCF<"1&P9&XX!( QEC^E;+J!<,R27EV\
M<,Z+&%B\U 0D98$L=IX '?OTJ>WCFNK>(W$#RW<(*AE=0S9X5QQCIGJ?YTV;
M5Y1HL=C.A>[GF,?VNTC90">03ST Z_0U774)I+<>5<37<QG7<1'G*J0K?*<8
M&>>*6HRQ''<6\+"UC6!/+5]R,,>9SRK <G@=1BJ@ACOHYHIXI([NY^8BZ=B_
ME;\X!4<8SQ5VZU(7VBB>.-(+?)5HVC =]N<+G( Y]\<TEO,=3DA-Q<BQ59E4
MW3,1YX'#  YP"5(].]--[V#0:DTDRK&;IXS#,1%(I")* #\I&3N'8^XJ?2])
MEN->AU(2-;3O@/; [AO(ZY'&,>U27FEPZC<P7%G/,/)5F$:X/G 9^7YNQ]??
MK4.G3+_PE%K($:(R2 *B* /N\LW))P?EZ=^G>I5]; [6.UN)I9H7A6%)IF<J
MAD&Z-L $D[>G^(%$D]U;VR37[1)"44O&BMD/N'([XQVQ4$D/V/3YY;>9DM&<
M/''"I5EP<L6SS@GVI(XVO+V'5XKR46+VI9[54)!]"">01S]:#,G?4HUO-X"M
M&FV)Y"NQAGD?>QW&,#UJ.RA\S)4R136W[Q>,L%/)CW<Y&1V]!4UOJ$-Y;V[0
M@36C#"^:"1E3G)XXQCO3Y"/(CMHE:%'#$S6[8$8'.23US_6C;0"46RNP,WEL
MDC!S"1NP1]TCT_QJ+32S2),IFM_,F9C;S_,6X _!>]06MC++,+[Y3?1A@ZEL
M_*02JYZ#/'ZU9U#RIK<$L]O=1H&9K<[G7+#(Z$X)&#CWJ?(/,BM[>)6GS%;O
M%/NCVQ'@(N>,=SR>@J4W$+6X9HO*AX"-)A6&>"?4>G(J":.97BD!2*]4;O*6
M,NN"P#%3ZXSGZT^3['=37*7:132K;Y9MIR\>2<!>3P13 [?P1O6&Y$K9DP@)
M52!_%CC)HJEX!-JRW1@W"/9$JQR9!0 -C@\@T5A):E%.3]E;X93^)KG79M!N
MI[VZU0ZU/!+K%\]G)>EQ)YS6IF\DMN /W,<#CBL3Q'^SK\%_#(#:UI<EM#KD
M]SHT$-QJUZ8=^HO^^MX(Q+MA$KY.$"@$DC%>/^*/@S\6;[Q7XEDT_3-8C\03
MZIK5R_BLZ\GV&_TF:UG2ST^.W,V4=7>W W1JL9B+ASG-5KS]FWQI9:EX<A?3
M[Y_#07PIJ&N/?:XLJK=VSW']I3$R3$AEC:/+)PW&W..,AGTGK7[.7@#7IKRX
MGTBXM[ZZOH]1>_L=3NK6Y2X2V6U#QRQRJ\>8%$95" PZ@DYKH?!OPO\ #'P^
MO+Z[T#3/L%Q?6]I:W#^?+)OCMHS' ,.QP54D9'+9RQ)YKP7]B>'7O$</B#Q'
MK>M-KNGZ.%\&:%J$5R98+^SLI9-U\I!VN9BZ*7Y)\CK7U)0(**** .4^*D<\
MGP]UQ;:7R9S!\DFW=@[AV[U\UVKW5Q(EX/LT=O(0R[9"K' 89?CGDJ,5],?$
MR86_@36)#T6')X)_B'I7S): 326\):*\C>4!S<@A\-AD"9'(SBNFG\+*1;OH
MM0_L&TF\U@LLQWQL#OP V.#C@'L>H JL9Y-JK)*LT6P+(NP83 ^92. HV\^Q
MSBM._OI;.\BMI'2:9(\,JYW1JJC 8YQNSG)[UGQSR7?F/);).\@!2-9!LV@C
MDC//WN^.E:W>UA]+DOV=_M&8[2VFB6(%'W'YF*G'T'7D]<U/IZS6,,D8OY%(
MA")&C!CD@X'MS[]JC:.TME_TW<ZE.4X!;)X7'H,[?QI]F4>22W$DD<JX)C$V
M715/RC\1C/UI/5 9L,GEZ>;>ZE$GE[F)5\/D<E2N#@\'GV]:O.MU&8[>!O/L
M"NYEVKD\C.&)]\GCGGN:B6]&R QM<2R"/$A@4X.&Y!R><]/7FK(TZ.WAA"-Y
M<AC:%3&00.21R>_7MZU>Q.Y%YK_)9I--#I^SRUN%0!Q)_=4G].,8IMOMB\1V
M20PSI:PW",TI&6;"'))W?,, #H3Q2:I]JM6A%M+))!(<R322!1 #@C '';&<
M5)H4R7VH6ES:RV9$<N7;RS@/SO.3VQ_*E>RN%NAV#7#WFHVUW(,0EQ%'Y#@'
M:RDY8'&?7';&:T(+F%)FLF:21X'$3.P.\\#!X[>]6UO],OEDM7RTQ^1U;L6'
M;G'2J&I+]EU))F(E7)#21OA@JC 7;CYL9_6HOS:6L06=-F6Y6215DR-P"R$!
M>#@YQQUJ-[F>W5XQ$2L:!F>,ARY;JH!Z8X.:?%((QLD3"LW,F>&R.,<<_P#U
MJFNKA6,L$,8$H1=Y9=JA2>N1UJ>HRG)<2QZ;=1P_N&B(6.>;[K,3UQZ9.*33
MEDD+RR3X> A);@QK&7P.0?49YR/6I,I+<1IY8DB=RH96 0;,_>&>><_GTI+F
MSM_M$\_D/<GR1 85Z=>1M/\ GBJTV$))#;W4WFI$ZHA=S([D*' QT/;OQ4,;
MR>9&UQ,MT?(Q&RQ ><>I56_#IQVJ2_ACL4DNE@DNVAD4B%R<1J1M.T#KQVJS
M9W'ER+:%UDF4%PJJ 5CS@9[9R ,4^EQ'2^!;CS/MHE2.WF"QDQJ<D*=VW/OU
MHIW@6427&IA1&RH8UWJV6)^;(;TQ17-+<H])I&4,"",@\$&EHK,8R&&.WB6*
M*-8HU&%1   /0 4^BB@ HHHH Y3XI[O^%>ZYL^]]G.,/L[C^+M]:^?/#J&RN
MK29E6X18I)Y)V?('?(R<#'\C7T-\38UF\!ZRK\H8>1Z_,.*^:ET^+3]%BNQ!
M)<7MPC;'D4?.&&TJZ@@*H&T=NW>NFCKH/H,DFEO)[VTRK/,^78MN&X!-I'S9
M(QS^(YJ9F2:S67*^7NECY8B-N/O-Z\BI,2_:H8'MV:W1U6*12H*.%(;(/.!Z
MU!J'A^77='DLX]0DCM8=A22('+,K'DMW!XK26BN6M["-Y5O#,;JU\^\WJ8!Y
MJJ#G&,-@<9Y"GGBG::JZ3"+R=H[B[G,<8:-L[B3C._'/_P!85T*^%;N216E6
MWA1UV,REF8[<A<MCCCOUS65_PCM]H\-Q+,Z64;OY2(LWF,[,ORG!/'0G'YU2
M::L0,C6:/4)(0OEPPE5)6)B0S=3DX##IR.E,DTX6]MY".BI"3L9&4+/(R\MQ
M]T@^X[U2F?R8V@$7G[RDDOFD@-(=JE2,[23Z \$].*;?RB":"?++:OA/)@MR
M=[$[@Z@G@#)SQ5:] T'6S7$LD_VA;:-69 L0D$B%2!P,?B.>*LV-Q MYHMQ-
M;_9)27:0HC!%3!R25)7/3!-5MUO:W$D,$ZQR95S"T?E[=IP2=IY4^]7].NK*
M^U?2(5AFAD!:,*L;I&5(Y!_/\Q4/7H5TW.TN,_89X+=X'6W6/;-<2%G7N7.1
MUQC%6EMHKB_69KZ20JJD08&T\$;B,9P:CN-/BVA)))"D2DE?,PPQSN!SG(R!
MSV;THA8-IOF0S&9YU!59&42#=R #GH!4]-#(L1W*PPW*6T*^1;J5 *;58^BD
M>@XZ=:AN+ZWOK>***\$3S_QQCS%&TY89Z=N_K3[6!/LMO$()4@A!S))(00P.
M,'N14\6ARVL<;1W$9MDW%H([<;74Y[ =:- (GCBEU9&E:-DCC9K;;UY4YX[_
M %]ZK76+V&&,!WWDB.1$)&X#B3CIC/>KMY8R1W%M.C-#NCQ'$R9 4$%O<,1Q
MU_.HM46Y^SC[*C2EV1<&3:L>.I..M"Z"(K6_CFL7W-<%;4!'N AW2,!SM'\0
M]Z?9QQ^:L<LRI.KB55B)0,2,G)/4=3BG-Y&GE$\QG:X=5CC+<94<XP..F3VJ
M2YFC^=EGC6X&6P< -@<@GL.:/09TW@-C!'>MNWF9EE+1 %>=W0CZ44GPY41K
MJ1!W1LT90* $7Y2"$QVS16$OB&CTNBBBLAA1110 4444 <K\4HEF^'^M(S^6
M##][GCYAZ5\Q_P#"2F32W-Y-,]JD_D[;:R8R2$LH&WOC/?IP:^E?B]-#;_#7
MQ!+<3BU@2V+/,S[ B@C))[ 5^;WC7]H"7Q!K"V?AF[E6R"M"]_;L\EP<*2RH
MK#CY<X; K.IB(T(W>YV8>@ZST/3_ (@?%"YTWQ)9Z/H>S4-?<Y>28)Y=G#N
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M6N8U1@Q"M'NW'*#G.[#$#FO*O&&@V_AWQ,UOX*O]$\*6^Q5DTD??C$C)EL.
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-W;H6]6]Z***S8S__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>mrna-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mrna="http://www.modernatx.com/20201231"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mrna-20201231.xsd" xlink:type="simple"/>
    <context id="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie96a43c24f044f688f10c58ea55f7047_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i71c171ceb13145969aa0a46d90bf882a_I20210216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2021-02-16</instant>
        </period>
    </context>
    <context id="id8cfdc6a9eda493abd00093bbea4c21e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1191369058cf41a6aec423e2a8b9ee92_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia16dd0e2f0d2488eba0c73974791c3a4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i998364a642404015895ef6268a8bef44_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i234df8a6bf184a26bc8d6f61ec880f13_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3af31ae8238a40b6a097aa5017de8edd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i67dc425fe1144699ae5760509f7e5da9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id76485547ab74bf79a9764e33c357192_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia1bf0bccbb5d48e2b6b391bd4c6436d8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice56444d59b64b31a0940bfed6f9c48d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia5db3bb48bb6499b83759eafea2dc91f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iae26ac15cf594fc4a4c729775db551d1_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ia0f05a78cb4a45e0aae694728346c943_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i67150ae834864a00a45a3aafe2462423_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6d4e1054ad904b07b079bfcd6a3b0dfa_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i938ca78cd25647ac9350433b1e94b211_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i857b3ef318484e959ca8a3dddeb3a486_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i859a2b8a071243a4aab797a9e567cab2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia68cd3c2e44d470a8bb0dd6b86dfbcd9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i812ca2c8b582418791dd8a37f6934064_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i67ede5f832064fd28db4be814bebe8c9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i77c6c82735e645deaa5e5478b0a99aa6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia2745e2110e849418080ca092c31fe61_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i014f1da45cd24ebfaccc119edf9098d7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie937c553bd26477b9acb13ff0d7ed4e0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib152449eaa214910b3c1ff9d8ebc950d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic468680da3a242bd8e509f8061d39e47_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5e0a831810a84041aaa0ec3f4250a1ee_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2737f3bfa09d4954bbdecc2432f59275_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5f1c28d9133c4d19994650191f44a618_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i06ac627610d04fb3ad68a60243ee4351_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3ad70ea4023a49e5923d1a79f4faf6fd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i413042b2017f4a90a355a0f54413c75f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ifbb1a345880141898c0782b97ae50bdd_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2425e3671ff2477f85a228531640c4e2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i14c57127d88a41c5af194b5765483daa_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iec0aa65fa9384232bb27dc252483b1ee_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i20204b229a394d9ba8b28882826012db_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i46a4ad30d8e44c75931d48376d7dd5a7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id01664a6e7894e8083439b3589eb02b8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ife96d591748e4db1a06679e64f49ac18_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6f826ec40d9a42d49d1f345df0664683_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201409Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id2f2085b1dd5438ca46922e561f57fef_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0ea8b1dba03d4c238442398f1dbc7fab_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibfbf4e4b10ca4b88bc9d9e4de34dfec6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6276f01255674c1bb430a10fe7a5d756_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5dd938ce77414d15a896664fd61440db_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i52c971ec763a42d9b277341a14ec9c55_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i93472a617e4d4f6f9147a6e05189a34e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i81f30efddbba4bc19c03af8bc5c7eaf6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id4c8e11b66a049928373daa1783da6a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i87efeddd90154654bf0692ac7c3a035e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icd928a22fd08462eafd4359a764e5cdf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9e68e85a40d74b498b0bb46dec072277_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic97698562fbd485a80018d02cce80260_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id068aa2a6fcb49d59dfae933d3a4da27_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie66e5cf3847f4ccbb705424a971759bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i29f3ebca75ec4b5b92053285ea842b9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ee6a6d175624d8c9cfc907e7bb82743_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i55d13e25166e42e0b68e9e232828cab2_D20200214-20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <startDate>2020-02-14</startDate>
            <endDate>2020-02-14</endDate>
        </period>
    </context>
    <context id="i6566041abeee45e59cb8ea4c0287e489_D20200521-20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="id2137fd0894d40d79052cb2714afe3e4_I20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="i7205067242fc4eb0a524f10be89aa910_I20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2020-05-21</instant>
        </period>
    </context>
    <context id="ie1dc78c134c44ed99d6c12dca67dd5b3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie35d35ef9a724996964e8f367d178412_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib024df048b7a4866887eea7ae4717c0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6112e1e86f8340e6bab6155f0e0c14fe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:MerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i662ae8da17484626ac7417cac28e5c33_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:MerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5ed2d47d1bf04e3aa23981e0213f4b17_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:MerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i99de0fc656f94330bd58911cad710714_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i01b7a2e27528463b8cd957d79fab92e6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i28e4b001726a427395f0430b3d5fa7c3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3739e5568de9403ab6f1602f4947f2cf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i58174bed8d7245f089be80163f527519_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:VertexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib97f41aa68a0406294fb319c1cc8c64f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:VertexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7f19d573adc242b8b4b58f70beb853bb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:AstraZenecaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i16562820b2134dc09272d9b7168eea9e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:USGovermentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i603a16907cb440afbec844ba69c28bce_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:EuropeanCommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1d64ff60176946838aa93ccb8d36219f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:UnitedKingdomGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icc33946b21844fddad6112c90f37042e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:SouthKoreaGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d723b3d7ee4498a8404a7814a0df9d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec2caba51ae04f34a09ef377a92c70a0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i30999b30a90f434baeec1c4aabafdfc4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6025964d375a48f6b8048f71aa7069de_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5ab4195256a147e9aca2014d6016eea5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic83f219ce3544b4fad28aa2afd18bf74_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i89a7968116c24dfeb8928db01baf0eb1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:EquipmentAndLeasedFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0be93c00c40a4fb988eceb1c1a2692d9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:EquipmentAndLeasedFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6805eb08d3d64693bd8d92b3308b8e5a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:EquipmentAndLeasedFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib0ea47aa0744431696869108e3c2ba80_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i84920da0b3254bb3a9cda664635471b7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i388d1c703c504e9b9dab1f15168e6519_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9725be67d18a4c3bb82d57ad987d47ea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibc74a29947d5452483558254ae2b1c81_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75fc0823bd854f9eba408cdefffe8ccf_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:DefenseAdvancedResearchProjectsAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie1df42e92dce49dfb7a34fa78d50f687_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:DefenseAdvancedResearchProjectsAgencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:ContractOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i013d6d10db654139a2efe361d808fc22_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i131a90691cbf4509abc1ae852ebc77cc_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="ieb1114d7eef04248a3529921433f9c96_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie91dd2c660e24460ab55f89af07de6dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic1cec659c0ff4e069c4d60941677a150_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f900a7ac5af4c7da858cc85cc212124_D20160901-20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-09-01</startDate>
            <endDate>2016-09-30</endDate>
        </period>
    </context>
    <context id="idba3a03acc0e45d5b9787c6de18eadbf_I20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2016-09-30</instant>
        </period>
    </context>
    <context id="ie67f5391576f40369296654a31490551_I20160930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-09-30</instant>
        </period>
    </context>
    <context id="i09c0c94594384d508f37a19a6c34c6a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:ContractOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1388a9527fb94a0a94fd4c620dc0bf17_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:TheBillAndMelindaGatesFoundationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:InitialProjectMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5d3ffcdb438747aa92be0aff3569a9ea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4f1e8cedd3d64700b24c4e5f95a07fb2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2aac197e32f541178c0c0244356b6ee8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i79e42df5da2b4678bbeea6e37c176ab0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:OtherGrantRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5b76250e8e294bbdafee9c7d09ab09aa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:OtherGrantRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iddc387885a1442e094e4ff923606bbf5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mrna:OtherGrantRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic5e6e85bd35c473b8a7fdfa429ebf3f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61596579e2804716ad9472fa52f24629_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieaf02eddcdce45c9a3a94c51aaddfac8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iacb86376d0f446bb9527bead47b3f38f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idfe5c56714774f52b2aa95484fa4c6cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CustomerDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i020daf53fdb84218b934041c4093d253_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:MerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie25766984ddb4900bc05c8dc1bcfe74d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:MerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i57e78373a7b8469dbf68fb0f27cf0e87_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:MerckMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="idd3c14a44a694301afc3fd745de06dfb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:AstraZenecaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib00cb507390f4481b30f9a19ccb9a5ac_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:AstraZenecaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i16f428a3385e4f1ab1b775e48d93928f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:AstraZenecaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id39e130ad4a04ca288880a568ba61402_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:VertexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e9ebd18dd5147d1b84a636c49ed2357_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:VertexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1ed1066cb22949e185aa0a6400e44041_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:VertexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if4c1f58ac26245b49538b03723bb287b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4e4582eea62043cc8c8a909446feda2a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iab0e4014c3ae497f8257beaa2afdf2a3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mrna:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibc83b7e084b64944bd3c55a3664b6afa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1e257e74e0c3417fa2d62c019e175efd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InitialApplicationPeriodCumulativeEffectTransitionAxis">us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i25d6ceefa0dd4987937b280087546df3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0ca78eb83d214ed796eefd75b65d5178_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementIncludingArrangementsWithAffiliateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2866ce13b20c40499ee0ef2d3eb66afa_I20140331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-03-31</instant>
        </period>
    </context>
    <context id="iae12a04f8a584ee1b88fb30da6f6e7c9_D20130301-20130331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-03-01</startDate>
            <endDate>2013-03-31</endDate>
        </period>
    </context>
    <context id="i3264926a036f49368bfd0a6e9404c012_I20140331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:DevelopmentMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-03-31</instant>
        </period>
    </context>
    <context id="ic0b34986f0674c9ea594d332b1f04fb7_I20140331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:RegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-03-31</instant>
        </period>
    </context>
    <context id="id123e88b9869491798632873fce6c3a9_I20140331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:CommercialMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-03-31</instant>
        </period>
    </context>
    <context id="i4fae7e79285f4982b083cb9c1f4fbd5b_D20130301-20130331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2013-03-01</startDate>
            <endDate>2013-03-31</endDate>
        </period>
    </context>
    <context id="i82bedeff4e8442618c0111343837f65b_D20160101-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="id653faf9397c4b2abf5814a5f812a2dc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:VEGFAProductAZD8601Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2013OptionAgreementAndServicesAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0ce35496660e4fd3bb2b5b20d645ce3b_D20160101-20160131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2016StrategicAllianceWithAstraZenecaIL12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-01-31</endDate>
        </period>
    </context>
    <context id="i2cbf12bb2be14e679beb021ee4ab6155_D20160101-20160131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2016StrategicAllianceWithAstraZenecaIL12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-01-31</endDate>
        </period>
    </context>
    <context id="i9d91300ccece4f0cb4993ca5f2e28e76_D20160101-20160131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:A2016StrategicAllianceWithAstraZenecaIL12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-01-31</endDate>
        </period>
    </context>
    <context id="i68a34211294a4d41b7ae0a74e31673b3_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i458bfc4f6b6645b1ba08bf68c4e3c5f6_D20180601-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i839376eae85647209c7ffae9f8bb94d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie2c30c2931b74241a4573d9b7e0a96f5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9fce5c39376648a1885a52fda585e94e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:SublicenseReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i508d8e428eb4465394a0583607ec486d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:SublicenseReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2a4f3ca9cebf43ce90d2496d447b9d8e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:ToxicityMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9b49c52ea5674daf9ac712e3b8b21e47_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:ToxicityMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4df3ae247d504d6a89d97300985f10bc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:CompetitionMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic84bc8dd652f4aee96a5499bdf3e2474_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:CompetitionMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i54988c4872c9499ca5902c5f6d9c7c25_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:EstimatedReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b5ed97867924e718b4bd2e71e3b5a48_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:EstimatedReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i978a4c28e8214a16a5f021fa271e26f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac8e23e6e0694998b8904230abbb17b4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2c28ae9af89f4befac5f089672e301ff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i018ccef08c534dd986a7e677e9da45b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:Combined2018AZAgreementPerformanceObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10f35a20934941e3b6fbe7ba24038ed1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:IL12PerformanceObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b8c03d227d64183b38b465e3aef9678_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:OncologyDevelopmentTargetPerformanceObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i46fb7b59b5374455b1a475b17975fd25_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6304d23321e4e298da2bcf056211316_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9441d23013f14c83988a31bdbb559231_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d71f32e33e84216807274b731bdc696_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2028-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7507c06b17446d99769c50840782858_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3aebca79df0b494194b5d4203b40878c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i52cf8a74cf0b4054bf102b486d8851d3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Combined2018AZAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i96c0d1d3251a406d91ab4e10d74e2798_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:OptionExerciseFeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id2b94ca2170140ac9a033fe7b05c864e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:OptionExerciseFeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifb5a3ddf94f642219ac0a81b3fe95f50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i15c7086629714161b7f3158a965fcc28_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib86c1e0cb5a249f09dfbce827ef9dbc4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:SublicenseReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b95e1b3c41e4258bc74f50fafe6fb06_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:SublicenseReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iadda166c80e447af92ff77e10772827a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd9e8d4a63f54baaba0b4b5ed1d455ff_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id54b6e3f162949438276b86a988013e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic177577240b14353b1e60187c3076a64_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic3d6d1acafe2472e83a08aef3a25628d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:VariableConsiderationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0f6399c8db0840dc9f38f108c60c920b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if79cc9521a4944dca9685e052deaf802_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i356a33ce286d48cca156527df59d429c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i563f38b3693b4356b6ea8f9fe73e7167_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VEGFExercise2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="ibdc3067fe5e145fe9f1452bcdebc7ceb_D20150101-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="i6f08b25f930848c1a69931c8014c2742_D20150101-20150131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-01-31</endDate>
        </period>
    </context>
    <context id="ic7359b975668474bab9835c2035fd8dd_D20160101-20160131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-01-31</endDate>
        </period>
    </context>
    <context id="i3e4bfb91e3734bcbac49d735fb9839a4_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="iae641b44702e44228c65d680d89234fb_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i4a11405a9cb548088dc27731169c33c3_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:MilestonePaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i56cc782d9cf240ab9de511487fe001b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaedcaef95a2f47b299253a6c24982262_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0212b2f2863143b0a038e34ad03323de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife317ed77f384b109eae0a11e402500a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8b94988b255b492ab10c9199f363efe2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i018b2aab0ed44437b6b42610898fd072_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7bfd65e4ca8b47f6a09d780605125913_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7561834c28344ed5a15e15ffa2d94708_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i316e60df5f6843bf9f30bdcae4453017_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia449e79cf2a44014b2511df73272f527_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckMay2019AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i392a2394213c44f893b9b592d6e59b88_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckMay2019AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i51ff27e4a88e4237b3e19f6822bca430_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckMay2019AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i46a1cdfdf44f41ceb9bb274d0f145355_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0395a7348b444ec48cc30fa685878865_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i88da5e4006934b50a0e65f87903ba7d4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:MerckAgreement2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id1acf7d5970e4063b3ec0293575fe05c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:SeparateAgreementsWithMerckMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i624e4ab60a804616a11ab12b4aaca0b7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:SeparateAgreementsWithMerckMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8350b0070d0a4021b617d51d1237f6e8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:SeparateAgreementsWithMerckMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i16fd06682d81475283857811586f4079_D20160601-20160630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-06-01</startDate>
            <endDate>2016-06-30</endDate>
        </period>
    </context>
    <context id="ie3347a1fc6b94f67a83914d66ec9adbf_I20170630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-30</instant>
        </period>
    </context>
    <context id="ia0cd83a6a1924769a19a58e5f11bd212_I20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:PersonalizedMRNACancerVaccinesProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="ic50bf5d952c24703b46068d51770fec8_D20180401-20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="i0d5048c0c1ab41668db8aa8a13a9f01d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia61f19b469e44cc391bbf2ed9db3b35b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4ad30b16714046c3b761def5ad1ec930_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd817774a25a4b54a5e146a36338e853_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i791028eb61c741c0b0bcc8de949523e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ClinicalSupplyReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib1c48a89440e425d8cdcde9fe46e6f1d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ClinicalSupplyReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie979852e105e4bda87e75d94f1fc565c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie517b85a81b14dd1be0f4552d417c47e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id3a8ffa0085e4794913a1deaa0b73f5d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ClinicalSupplyReimbursementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf670da31cdc46a09101eb0c8678cac6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:PCVPerformanceObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6260d9dece294c47adb143dbae8f22ba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:PerformanceObligationAxis">mrna:KRASPerformanceObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idfe0cd89ae6041918c135184fa183ddb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i340827b3da36421394e5bd54e37ccfea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf3efea2a5d54653be9c2285642a667c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i950a1adc46aa45c28b3349f86c2a031e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i981f59fd40474c90ad61c969280172a6_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PCVSAVAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5499e80adfa6472b9e1528ab0f94b167_D20160701-20160731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-31</endDate>
        </period>
    </context>
    <context id="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="i3f8781fcff4e440a97e13c637f9373b3_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:DevelopmentMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="i42f4b3b0fa0d4f57b37d2a96d63f003c_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:RegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="i7f178b19838f48b4914e2694d3057ea7_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis">mrna:RegulatoryMilestonesSubsequentProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="ic6a88a9c14d2404d970ffdfe239ee718_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if8af61d149a74aa9bdde3e7ad4d3907f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb6bc087a0004b3e8507b5cc459cb4d5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ResearchAndDevelopmentFundingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id85fae767ef44643861725eb10c2ee6c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9cfd6d8a963b437fba39ba94ab400b91_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i15c73ffb7e51425da60d278c68eae95f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ResearchAndDevelopmentFundingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia11a3663e67e45c08dd00fe0f20b964b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd261966c1e44f1db6dc2b1efb265428_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ResearchAndDevelopmentFundingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie02f591019054030b611751b6c248c94_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifea86eb2da07419ea798ae719f81a8f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib894739b97434938997c5f99e78f77bd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1d7dca1d4c4c4b9686df22df24888acf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5feaa13311494f2aad81d49c0f29adec_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexFirstMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i8e076d5d4a504530950dfa10765531a3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreement2019AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0acd16de5695440eb15012080a75bb86_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreement2019AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i381c45f95fdc4c6cab91ea05c8184f74_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreement2019AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie3f73020d7f8417cace85905171f5d06_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic0d1ada6b97646e1811da4767837e43f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if6a738901f794f2c95c70ed3d3ed65fc_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0798e7f1beab411290adc80b49b4a243_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e5b4776d84349f68d1f905844a0195b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:VertexAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie80373ee84ee409397695d20d023b830_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Vertex2020AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1d3d81698c934b4a954d49e51245e401_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Vertex2020AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icdbe7e517bf742fb984721f52fab2d8d_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Vertex2020AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib95741ea249d4f97a45a3892a2351840_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:Vertex2020AgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ab2427a6c084cf9af1c48d8c688b9d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifed27586ee884f47a07d016946f33a60_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8c83ee462da4e3dba463ddbc3ee245b_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i71d5a04ae7ee4c9facb541e95a628feb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:UpfrontPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8775b14ae8d42ba85896b375b513e87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ResearchAndDevelopmentFundingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6671830e11c43fa9c3834eab410c9a4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7916b94daf6644a1ac5fd27053af9d56_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:ChiesiAgreementTransactionPriceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i927d619ab07840569348f4a56e6f7fd9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">mrna:RemainingUnsatisfiedPerformanceObligationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i485a222ab1ab4c8aac1f1cbc39e1b10a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:ChiesiAgreementMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3f291fa3ef94d0986838b93d6b8a9b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idaa6defda34a4c4d932f1760b89de1bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99a06be594a943e1a989839f0ffb78dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie0f3f6d0fe374c3bb4e9274841921099_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0721e19a82dc4039bc8fd234b6cb6467_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f82068d4e014cd3b0ee0ee048db1dfc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id80775b1abbd4c83a0c7b6a0f1187d02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6823e77a4aea4168b1bc6bd432b8c5f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i39aad2a193424f66b1a29c5062031f07_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i996f146052f5425ab4c0c71f5c174fa6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icef0d3913fd548d9aae035caa234d06f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i964440db25964be9b19c02aff5c46eef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2120d892fa64041a731353e8cb520f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7947068ef4b140cb8095b9ed2268d8ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f339cc94e424df7982cd710e1c8fbcf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie57495990d1840ab8a3259591e49318c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i571622ed8ff84fac92fa646c065d9071_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2dee05d95adb41a4a76b2b9fe164e598_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76e8315a6df54be8bfc95f09f6f3034a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4fcf3aa943004b48b99acf53c21041eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide75e7fae914434e8be15fac3dd2dfa1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie142da5d5a7142dfae28d3de3b0a7398_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if6a6eab513bd479c8ee7b20cf6c72b5c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i85f6292c70ae4905b5aa94e6b6388d63_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5deec5b143314f2491823db42ac2c318_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idf5b8160d74845bcbadcdc11cae28b39_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8d8c21441bd4fc3927d70eb5b4e9cb0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3e09bdef5a344ade862de02fe62cbd4f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5711c49fcbec48988da71f366d87842a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i595f9f5c7de04040938f423373395fd2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib098be9e25b24dd6963f1bce92ec3842_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8337e774481849ea898503604f8098ed_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8c6c58de542642c998e43061db878c5d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i56140fc5415b465091fac71874a1d04c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3679a9fffc96449eb191d1d92e564cb9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8f97faca187a40e7932e5f1ed655d0e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i33126ccd28674b319b0f542852efad14_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id9134c7c3c5e41aaad7c846573608b98_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib0cecee608c2404fb5cd0656311e9766_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia40c55509686422ea2a7aeb0800b0708_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i94845de97f3740f29eb21f83595555aa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mrna:NoncurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i82ef8a8f960d4586b4b70315e91428ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i537052846af24b89bb148e79200f55b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9ab59ae2ae3446928c5af56bfa301632_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib1643b608a454ba48f175331a4403c94_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8b335d06520e4536aa8cb118383a9e23_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6ca9dac78c340bba06590609c9470cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f78c3ac89654cd9b1f1e7b8bc2a2df3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b7c40b209f7432bad8109c7ff3676d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8568db59e98348d5b7ca8485856bbd75_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d25a112fd9d498c8f8fea65aa96a2b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2cf18fd57bb2482194f59b63056872c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c2ec2379a2440c98b39d472944fc58a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idd8faf6c9e064166a193a079404e5f6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i415a12cbcecd4182b9b75a85618710ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f50ef9dcfe04ebd9ffd657cbf135f93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iddd4aa81b7a24685aff1379ef5b70952_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d497d05b06c42e4ac9fccf950c4da8f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice8d50a6d09a405c9102e4f3dd28be53_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i435ec70bb8f44c8f98a7c85f98319563_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac8874c6a20b43398d1ddc844bbce921_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3ff0406894b54724bcaadabdc19dd9da_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id2404bad267f4f3e822b71ad8835e7ce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4a45bbb5f0fd487aa6bea47688234221_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i93edb11d678e409e93fec11af2f7d699_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic32def168edf4442a4f6912414e3f4bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icac57ca879c546568a22b09873f17e85_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iee48996722c54941b70a1cc762872f9f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i48df454a47ab493e9a020ee1d9e830c1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">mrna:USGovernmentAgenciesAndCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7803fa02ca4547a9871f8bdeb3407587_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if68a771f3e9646a3af1d44b31f4770c5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id4bbb095206742338a02ee9ddcc36c12_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i04c7af5cb0944a609bc48c18ac1199c8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79bfa2998ec14f64b6ac249d9dba29fc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17d27b5a687e47f0b3b24ad613e488ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia68a26c9b80a46b89ff40f182120a6bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib5b8e9cfd6ca448aa701acdac947ae5c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee04f0bed89c49668441e99337b4c6e9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i40944c7d8d6941028b74d51f0012965a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7f1f6b5edb444fd9d4b39047aec17fe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i029097fb98da493492487f2642eaca98_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9baf6f70a62949e58d3e834369eaf15d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentOtherTypesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7599583c04c4bb2b5065bb8e0fcccac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibfa4e9080e444a89ba97d4bb414498ec_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7293e7dd6fe468bbf9ea8382a321117_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a3475829320460094cd0d1af2b0eb08_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i931a0fc9cb324f33bb8472be6674ba39_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:FinancingRightOfUseAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f4deb71bcf6418281042297367c1bea_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">mrna:FinancingRightOfUseAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9127d9980c58485bb596c9f9c0fe40f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ec608e56a914901a6ad79ac5be09f26_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icc80cc31c16d4bb5b781ff93fa778e3d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6a5ca8f57aed41fd9ba65d7a8eb8066c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:ProductSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82530c9d21864e758383518f41158ccf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iee1f1d3a45314f5a8987999269779a3f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mrna:CollaborationArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibbcec80ae49c4b8286395ec88c10e2bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:CambridgeMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i620a2c29a9454e86abf8ee51f8558fe7_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:TwoHundredTechnologySquareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:CambridgeMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i9c54db761b0740ec8aba56ebf889d996_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:FiveHundredTechnologySquareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:CambridgeMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="idf6426583a4543de9fc96eca2bc03260_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i7b968f2e54364ba8ad58961ced8da02e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e728091fd7b4fddbe99aa3980407db5_I20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCNorthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-01</instant>
        </period>
    </context>
    <context id="i028772f3641244bba3f25ec35843b217_I20160831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:OfficeLaboratoryAndLightManufacturingSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-08-31</instant>
        </period>
    </context>
    <context id="i266a5c7f3c4d4becbe194489fb7a115a_I20160831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-08-31</instant>
        </period>
    </context>
    <context id="ib99c6b4909974f38905c833f846083b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">mrna:EmbeddedLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i313b37fa8a694900aaf4a540ec5403b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:OfficeLaboratoryAndLightManufacturingSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6f36d10d97c04db1b365a25391679774_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCSouthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3832eb52624b426797a221627ead873a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">mrna:MTCNorthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mrna:NorwoodMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1441021944924f86873ecc11207adf0d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:PersonalizedMRNACancerVaccinesProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2ffbac081c347a18476291631b1325f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:PersonalizedMRNACancerVaccinesProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i62af6315d0994091a5ee85593def32e7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia470ee9b9d754ceeb6681190f52793c3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3ea7b5505cee487fbf7be94bf6d55f95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i794421bf0a8e43a3a51997f49bc8dcb8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:IndemnificationGuaranteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4c7e100fa92b440a8d435619ce329b08_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">mrna:SupplyAndManufacturingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1170ecd035af4400a71afda6f522a17b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">mrna:ClinicalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b6cf5372b6e431587c7ba23a440fa6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PurchaseCommitmentExcludingLongtermCommitmentAxis">mrna:ClinicalOperationsAndSupportCommitmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61eb580f6c4e4674bede2f83be700c34_I20170626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:TherapeuticAndProphylacticProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-26</instant>
        </period>
    </context>
    <context id="i0c3c86543acc46e2b8b0c2c0de911ca5_I20170626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">mrna:DiagnosticProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-06-26</instant>
        </period>
    </context>
    <context id="i7e99c6608c7941008ec26bef45112da4_I20170626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2017-06-26</instant>
        </period>
    </context>
    <context id="ia945c15292e84282b614fb94308ea684_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">mrna:SublicenseAgreementTermsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ica4a9c0275b4439ab3a5bc61a47582f7_I20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2018-02-28</instant>
        </period>
    </context>
    <context id="ic8e4c8c0f7b04ed7b492b9f6c973bbd6_I20180507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2018-05-07</instant>
        </period>
    </context>
    <context id="if52ab1a643294862862c0ab9475e5fb5_I20181211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
        </entity>
        <period>
            <instant>2018-12-11</instant>
        </period>
    </context>
    <context id="ied8820941801441bbf695baf84bd4408_D20181211-20181211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-11</startDate>
            <endDate>2018-12-11</endDate>
        </period>
    </context>
    <context id="ib0015b9f558545eb8bbce9a072884272_I20181211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-11</instant>
        </period>
    </context>
    <context id="i817a91b1df304d8db9ad7e21b92c6d5e_I20181211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-11</instant>
        </period>
    </context>
    <context id="i11303c4705d14f9e9722ef0609332f64_D20200214-20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mrna:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-14</startDate>
            <endDate>2020-02-14</endDate>
        </period>
    </context>
    <context id="i8d8ab51d966d48869f4a4a2010e84ff8_I20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mrna:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="if4562f74238f400d8605ac78ea70d681_D20200214-20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-14</startDate>
            <endDate>2020-02-14</endDate>
        </period>
    </context>
    <context id="iafc11244cc12496099eda35772ccd636_D20200521-20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mrna:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-21</startDate>
            <endDate>2020-05-21</endDate>
        </period>
    </context>
    <context id="i55700871828341ecbb850efa2faf67d5_I20200521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">mrna:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-21</instant>
        </period>
    </context>
    <context id="i6c6d0348fa0f471c99e4a3d4fb593b39_I20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:StockOptionAndIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="i262a8b76871743d192c168dbbc78eca7_D20181130-20181130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:StockOptionAndIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-30</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="icac42209a69c4d4faecce8d9ec2c954c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:ServiceBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i94e125ac24d548f7bcacf7258fb26f5e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:ServiceBasedAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i456564aebcd9408998fe415ad2b5746b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:ServiceBasedAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i94765e821a9d4db08f74e0976fc741a0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:StockOptionAndGrantPlan2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifce35912e3be4df98cae3575af43d851_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28ea496c05f042ce8f74e96e04f6dc1c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:StockOptionAndIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a2b16bb22614c61b08450535a865c3a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4807ee8256114040874d647a3a407087_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf4921fe189a4bb3adbffaca20a7ba53_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4793fdc04065442a8c634bb5b8ed5276_I20181205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:EmployeeStockPurchasePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-05</instant>
        </period>
    </context>
    <context id="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:EmployeeStockPurchasePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-05</startDate>
            <endDate>2018-12-05</endDate>
        </period>
    </context>
    <context id="ieceb0f5d61c741e2ae79714848077fc6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:EmployeeStockPurchasePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic81d102f7ca14bd6bb17285971aa99df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:EmployeeStockPurchasePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f14ad75477c466dafbb2d98521f49c5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mrna:EmployeeStockPurchasePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iab7b67e811134bd584fb576d6e749803_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic8ea87e5e7834335be8ba996294292fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bc50b13e4114cdeb9dfbcfc004a74de_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iade5b4d11372466e90c1c179f3b5ac9f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i38f16929f2a54250afa6263ffee43aa1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7cadb2afe3df43fe8cacb9af45694889_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifa289361628e459292558aa0cf78cd6b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:RestrictedStockAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id16aba6da7f64bd394030c96c373b2de_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:RestrictedStockAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iea322dace75d448fad9eea135238af31_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">mrna:RestrictedStockAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i1d492fe3077f4edc95bfea38191dbe14_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9b7796d6fc41467489873be3464c5281_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8b394cfd73114e379da638593c59398d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i205ef00a043d47539d12683bf81d27bf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i3d40e479571a447ab799a9e823712900_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8f343e6d4c4743d787e7ead6fa87139f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id1a3afd2d01d4284ab41f3b52d9d7bc3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie37236e25e6d4e2c8a87336c27d49324_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i249101ed25324c3c8d67aab92ad128da_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8bb1304918df480cb950ea6c29a15615_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic351569ed65f40cab21d97c586306914_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85f3c831978247f8b69404de24b90b66_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c241daa0d5241ee9eed136d8c0fd4be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifdad93679ee44415aefdf2bf5e771d19_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icee62dcd4e004b8681b4d520ee487a52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">mrna:FederalOrphanDrugMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f5c4be154334b0e874859f16c0dfa3c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:InvestmentCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51dd4a3f885044ac854c50b598512881_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i824d33d947634253bc2e12c49e671633_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3e245ef509484130ac56ee0f5b6a622b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i240d1607bdb54d38918d10a2e1bc9173_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i707c59ec394d4425b93e15c1605fa977_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i224ecb912e2c48888f26b7e1cc4953dd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic87bc10f44de4145997be66dfd27f93c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie596a0c92b8647369ac2d14e1396ef36_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9f5a8fda25cd4c74af63d87a7168e3ab_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i69d8b71e26964171af7d0c08826cb641_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i27c2ab469153406c91a205c6ac53f02f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i14039f4ce16942f3a4976f3e56714742_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7733c373247646ffbbaca5983877f101_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id776b0bb1d8b431e96ac4e765df020ad_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibba4dc7e26f542198f1a60b6226271d0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9ccdf2dca2df4aa3a9aece1c6399177d_D20210101-20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-02-26</endDate>
        </period>
    </context>
    <context id="ia03ce25e1fdb4153b6baf85bdb6588ef_I20210226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-26</instant>
        </period>
    </context>
    <context id="i9483d986200a4cdfb7e88b336fd9711b_D20210218-20210218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001682852</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-18</startDate>
            <endDate>2021-02-18</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="program">
        <measure>mrna:program</measure>
    </unit>
    <unit id="segment">
        <measure>mrna:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="contract_option">
        <measure>mrna:contract_option</measure>
    </unit>
    <unit id="option">
        <measure>mrna:option</measure>
    </unit>
    <unit id="milestone">
        <measure>mrna:milestone</measure>
    </unit>
    <unit id="extension_period">
        <measure>mrna:extension_period</measure>
    </unit>
    <unit id="security">
        <measure>mrna:security</measure>
    </unit>
    <unit id="campus">
        <measure>mrna:campus</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="claim">
        <measure>mrna:claim</measure>
    </unit>
    <unit id="installment">
        <measure>mrna:installment</measure>
    </unit>
    <unit id="offering">
        <measure>mrna:offering</measure>
    </unit>
    <unit id="purchase_period">
        <measure>mrna:purchase_period</measure>
    </unit>
    <unit id="dose">
        <measure>mrna:dose</measure>
    </unit>
    <unit id="numberofdose">
        <measure>mrna:numberOfDose</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF80L2ZyYWc6NWFkYzEwNjVhNDQ5NDM5ODg3NzUzNDliYjc5Nzc4ZWEvdGFibGU6YWUxZTE0YTQ5YTljNGM2ODg5YzNkY2IyMGViZTZkZGEvdGFibGVyYW5nZTphZTFlMTRhNDlhOWM0YzY4ODljM2RjYjIwZWJlNmRkYV8xLTEtMS0xLTA_ace71dc9-0dd3-4092-ab0c-d6c8549bee39">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF80L2ZyYWc6NWFkYzEwNjVhNDQ5NDM5ODg3NzUzNDliYjc5Nzc4ZWEvdGFibGU6YWUxZTE0YTQ5YTljNGM2ODg5YzNkY2IyMGViZTZkZGEvdGFibGVyYW5nZTphZTFlMTRhNDlhOWM0YzY4ODljM2RjYjIwZWJlNmRkYV8zLTEtMS0xLTA_8586cc0c-5a7e-4eab-a2b7-d2dd9ee2a223">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF80L2ZyYWc6NWFkYzEwNjVhNDQ5NDM5ODg3NzUzNDliYjc5Nzc4ZWEvdGFibGU6YWUxZTE0YTQ5YTljNGM2ODg5YzNkY2IyMGViZTZkZGEvdGFibGVyYW5nZTphZTFlMTRhNDlhOWM0YzY4ODljM2RjYjIwZWJlNmRkYV80LTEtMS0xLTA_96daa0f9-6f9d-4234-8661-bd5c6df459cc">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF80L2ZyYWc6NWFkYzEwNjVhNDQ5NDM5ODg3NzUzNDliYjc5Nzc4ZWEvdGFibGU6YWUxZTE0YTQ5YTljNGM2ODg5YzNkY2IyMGViZTZkZGEvdGFibGVyYW5nZTphZTFlMTRhNDlhOWM0YzY4ODljM2RjYjIwZWJlNmRkYV82LTEtMS0xLTA_08a47628-5a5c-42eb-91ca-4b8598056a71">0001682852</dei:EntityCentralIndexKey>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod
      contextRef="i9d91300ccece4f0cb4993ca5f2e28e76_D20160101-20160131"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEzNTY2_b4c654c8-2a80-49cb-b78b-a61c53047d69">P12M</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected
      contextRef="ifed27586ee884f47a07d016946f33a60_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzkz_2d953b6a-57dd-4928-80b3-3c00ab223378">P1Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected
      contextRef="ifed27586ee884f47a07d016946f33a60_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzQ1_9c8cdcb6-3511-498b-8168-a066bbb63f69">P1Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i9441d23013f14c83988a31bdbb559231_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNjA2L2ZyYWc6ZDlmMGU4YWE5NDhhNGQyYjhmNWViNGJjMGNkNWFmY2MvdGV4dHJlZ2lvbjpkOWYwZThhYTk0OGE0ZDJiOGY1ZWI0YmMwY2Q1YWZjY18xNTM5MzE2Mjc4ODkyOA_c5480414-ae84-4b35-a1ad-290fa518761a">P8Y3M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i4d71f32e33e84216807274b731bdc696_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNjA2L2ZyYWc6ZDlmMGU4YWE5NDhhNGQyYjhmNWViNGJjMGNkNWFmY2MvdGFibGU6Y2U0MTRlY2FhNjczNDM3YzlmZTY5ZTIxYmJiNjU2OTkvdGFibGVyYW5nZTpjZTQxNGVjYWE2NzM0MzdjOWZlNjllMjFiYmI2NTY5OV8wLTAtMS0xLTIxMDY4_c09b0f81-4818-449e-aad2-d3b142cfbbce"
      xsi:nil="true"/>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i0f6399c8db0840dc9f38f108c60c920b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNjA2L2ZyYWc6ZDlmMGU4YWE5NDhhNGQyYjhmNWViNGJjMGNkNWFmY2MvdGV4dHJlZ2lvbjpkOWYwZThhYTk0OGE0ZDJiOGY1ZWI0YmMwY2Q1YWZjY180OTQ3ODAyMzI1MTE4_08185581-ec1d-4614-94e5-758d7da14354">P4Y3M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="idfe0cd89ae6041918c135184fa183ddb_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNjA2L2ZyYWc6ZDlmMGU4YWE5NDhhNGQyYjhmNWViNGJjMGNkNWFmY2MvdGV4dHJlZ2lvbjpkOWYwZThhYTk0OGE0ZDJiOGY1ZWI0YmMwY2Q1YWZjY180OTQ3ODAyMzI1MTM0_9924a8f3-a56e-4fe8-bb00-77610482ef39">P3Y3M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ib3f291fa3ef94d0986838b93d6b8a9b8_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNjA2L2ZyYWc6ZDlmMGU4YWE5NDhhNGQyYjhmNWViNGJjMGNkNWFmY2MvdGV4dHJlZ2lvbjpkOWYwZThhYTk0OGE0ZDJiOGY1ZWI0YmMwY2Q1YWZjY180OTQ3ODAyMzI1MTQ2_b29e0f18-3ee4-44f5-a8d9-21239ec0e022">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_509b73a1-344b-43fb-b968-8722c1c25a5e">us-gaap:OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_72c4555a-bb44-4abb-b6c7-1be6c51005ca">us-gaap:OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_2a800648-bfb3-4584-a0d1-7572b92f5809">us-gaap:OtherLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_5ef609f9-9865-4708-ad5f-c12a24e8246f">us-gaap:OtherLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNTk1L2ZyYWc6ZDFkZjA2M2EyNjEzNDMwMmFlMmJjODZjNTJhMjcyNWEvdGV4dHJlZ2lvbjpkMWRmMDYzYTI2MTM0MzAyYWUyYmM4NmM1MmEyNzI1YV80OTQ3ODAyMzI1MjE2_65276b38-96b3-4bdd-8d63-f5d1cd367a08">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNTk1L2ZyYWc6ZDFkZjA2M2EyNjEzNDMwMmFlMmJjODZjNTJhMjcyNWEvdGV4dHJlZ2lvbjpkMWRmMDYzYTI2MTM0MzAyYWUyYmM4NmM1MmEyNzI1YV80OTQ3ODAyMzI1MjE3_4f9b66d1-f583-457d-a7c6-b077d39e7b38">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i456564aebcd9408998fe415ad2b5746b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODEvZnJhZzphMTBiMDMwMTBkNDU0MDMxOTljNTVmMTZhYjBiM2Y5Yi90YWJsZTo5NmJiMDA4YTgwN2Y0YTZlOGQyNjVjMmM2N2MxZmIzNS90YWJsZXJhbmdlOjk2YmIwMDhhODA3ZjRhNmU4ZDI2NWMyYzY3YzFmYjM1XzItMS0xLTEtMA_c7576c9a-071d-41ce-bed3-173795a6d55d">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6NmU5ZjIyMTAyNWQ0NDZkNmI2N2E4NmFkZjUyMWIyOTAvdGFibGVyYW5nZTo2ZTlmMjIxMDI1ZDQ0NmQ2YjY3YTg2YWRmNTIxYjI5MF8wLTEtMS0xLTE5NDgx_abfc3a0c-be4d-47d9-b948-39ddeb58b13e">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTQy_575a7296-dd66-4aaa-862a-965cdf28de8c">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTcz_6ae5696f-f10f-4e19-a286-d9cc7cb67e53">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTcz_a4936430-f0f6-471d-8773-850109d5a98f">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTQ0_be20ff9c-f8c0-49da-904d-7224a75f47f9">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTg1_f38e1578-c01a-4372-a112-280eeab45fec">001-38753</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTg3_68a6a506-d024-43c6-9cc1-31b78b587f5c">Moderna, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8wLTAtMS0xLTEwMQ_1ceb0587-c528-4f4e-bd82-61a9bd8cc851">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8wLTItMS0xLTEwNA_281b9fca-48cf-4e72-a395-8e00f3a59a9f">81-3467528</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8zLTAtMS0xLTMxOTUvdGV4dHJlZ2lvbjo0NzMyODRlMWJlZmY0NDAyODgwMzFjYzg5OTZlMTczNl80OTQ3ODAyMzI1MDYz_5ed87354-6278-4c42-93ce-11a5220e694b">200 Technology Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8zLTAtMS0xLTMxOTUvdGV4dHJlZ2lvbjo0NzMyODRlMWJlZmY0NDAyODgwMzFjYzg5OTZlMTczNl80OTQ3ODAyMzI1MDc2_c47226cc-de56-48e8-af44-7569a45a8816">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8zLTAtMS0xLTMxOTUvdGV4dHJlZ2lvbjo0NzMyODRlMWJlZmY0NDAyODgwMzFjYzg5OTZlMTczNl80OTQ3ODAyMzI1MDky_f1f932c5-1076-4047-b5f5-20c4f35b248e">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MDIwNjk0NmI5Y2ZmNDUyMjg0YmMxOTdlNzk1ZjU4YmEvdGFibGVyYW5nZTowMjA2OTQ2YjljZmY0NTIyODRiYzE5N2U3OTVmNThiYV8zLTItMS0xLTEwNg_74f8f363-916c-4aab-a76d-93cbed4d43de">02139</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTg5_05a54e83-ba63-4f25-a785-9d3815c122f9">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTkz_0223c42b-3a87-430b-9942-cea3d6c0fae3">714-6500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6ODBhMzNhZjMwNWYzNGUzNGJlNzY3MmZmYmU3MjEzMDgvdGFibGVyYW5nZTo4MGEzM2FmMzA1ZjM0ZTM0YmU3NjcyZmZiZTcyMTMwOF8xLTAtMS0xLTExOA_201a9630-0227-42e5-a484-c0581db96ddf">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6ODBhMzNhZjMwNWYzNGUzNGJlNzY3MmZmYmU3MjEzMDgvdGFibGVyYW5nZTo4MGEzM2FmMzA1ZjM0ZTM0YmU3NjcyZmZiZTcyMTMwOF8xLTEtMS0xLTExOA_bc60701c-f6e6-492d-a818-8d55421f031b">MRNA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6ODBhMzNhZjMwNWYzNGUzNGJlNzY3MmZmYmU3MjEzMDgvdGFibGVyYW5nZTo4MGEzM2FmMzA1ZjM0ZTM0YmU3NjcyZmZiZTcyMTMwOF8xLTItMS0xLTExOA_b6b34bc3-ddfb-4e27-b970-fda3ff372564">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTk0_b69daacc-3c68-40d5-b279-bdb315e249ed">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTk1_6abae281-6f19-4031-85ef-a8eff95a4017">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTk2_6f84752b-8ec3-4344-919a-3b0dbb94fde7">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTk3_63d985cb-3763-48e2-9433-b32a058a94b1">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MTk3ZWY0OTBhZTE5NDY4ODk1ODJkMTBkMGVmOGI0YmMvdGFibGVyYW5nZToxOTdlZjQ5MGFlMTk0Njg4OTU4MmQxMGQwZWY4YjRiY18wLTAtMS0xLTUyMzkvdGV4dHJlZ2lvbjo5NjNmYmFlNDQ1MDk0MjY1YTU3NWJhNzZiY2FjYzBmYV80OTQ3ODAyMzI1MDQ5_96309af7-5c90-41b9-abfb-fea15d6dccea">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MTk3ZWY0OTBhZTE5NDY4ODk1ODJkMTBkMGVmOGI0YmMvdGFibGVyYW5nZToxOTdlZjQ5MGFlMTk0Njg4OTU4MmQxMGQwZWY4YjRiY18wLTYtMS0xLTUyMjgvdGV4dHJlZ2lvbjoxN2MzNGZmMzVhYWY0Nzk0OGE0ZTZiNWU2OWNiNmU3N180OTQ3ODAyMzI1MDI5_59c8514e-db07-464c-a9dd-3171567c851f">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGFibGU6MTk3ZWY0OTBhZTE5NDY4ODk1ODJkMTBkMGVmOGI0YmMvdGFibGVyYW5nZToxOTdlZjQ5MGFlMTk0Njg4OTU4MmQxMGQwZWY4YjRiY18xLTYtMS0xLTUyMzMvdGV4dHJlZ2lvbjpkMGM0YzA0YzEwZTk0ZDQ0YjMwNDQwZGYyMzg3Yjg0Ml80OTQ3ODAyMzI1MDI3_350a38a9-2384-4423-ab26-22dab21c86d8">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN182MDQ3MzEzOTU2MDkx_47c7f1ca-8fe8-4294-9618-ad8bb0164f50">false</dei:EntityShellCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN180OTQ3ODAyMzI5NjUx_1f17d0f6-5558-4f9e-bc3a-befce24d86d8">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityPublicFloat
      contextRef="ie96a43c24f044f688f10c58ea55f7047_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN18yNDk2_b087c29c-65d1-4415-9d44-df47aef9a28d"
      unitRef="usd">25250000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i71c171ceb13145969aa0a46d90bf882a_I20210216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN18yOTAy_43eb47fd-4cf9-4e72-a215-cd1fbbfef78f"
      unitRef="shares">399769582</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xL2ZyYWc6YTIzNjA5OTliMDg1NDFkYWE1OTMxM2RlNjNhYmFlYzcvdGV4dHJlZ2lvbjphMjM2MDk5OWIwODU0MWRhYTU5MzEzZGU2M2FiYWVjN181NDk3NTU4MTQyMTk5_fa108de6-9fce-4776-a13b-7783e846cf5f">&lt;div style="margin-top:1.5pt;padding-left:9pt;padding-right:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1.5pt;padding-left:9pt;padding-right:27pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Portions of the registrant&#x2019;s Definitive Proxy Statement relating to its 2021 Annual Meeting of Stockholders to be filed hereafter are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzQtMS0xLTEtMA_53fe8601-3784-4f7b-92e3-06475ea2c6cb"
      unitRef="usd">2623850000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzQtMy0xLTEtMA_063b9451-2c38-4671-8ffb-45de71b248b2"
      unitRef="usd">235876000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzUtMS0xLTEtMA_ca2b882a-94a3-49c5-ac59-3b34cb7021f1"
      unitRef="usd">1983758000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzUtMy0xLTEtMA_ad66ec20-db1f-421e-8d5e-25fbae6adcb8"
      unitRef="usd">867124000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzYtMS0xLTEtMA_fb5d37d0-f4fd-4770-ba26-a6e11c2ed401"
      unitRef="usd">1390560000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzYtMy0xLTEtMA_1881cfa5-4251-4922-b22a-652e65ed578d"
      unitRef="usd">5369000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzctMS0xLTEtMjkzOQ_c51a0e31-cb21-4236-849a-768f746aa0bc"
      unitRef="usd">46527000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzctMy0xLTEtMjkzOQ_b63894d9-f51e-4ae3-a5ac-5a3254228895"
      unitRef="usd">0</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzgtMS0xLTEtMA_feeb65e3-26cf-4654-8665-193bdfe7f9fc"
      unitRef="usd">252152000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzgtMy0xLTEtMA_48fdd5f2-148f-4ac2-b4e4-5a1b24d33442"
      unitRef="usd">19403000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzktMS0xLTEtMA_c1ce5813-c2c0-4955-b754-382de263dbce"
      unitRef="usd">1032000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzktMy0xLTEtMA_90770317-e633-4130-8040-dd6b0e6c9a43"
      unitRef="usd">1032000</us-gaap:RestrictedCashCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEwLTEtMS0xLTA_ea1390e6-0501-496a-baef-1a9fe5e930c7"
      unitRef="usd">6297879000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEwLTMtMS0xLTA_98661ed8-10f7-44ee-87fe-708df0f84d8e"
      unitRef="usd">1128804000</us-gaap:AssetsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzExLTEtMS0xLTA_f364144b-5db2-4b53-b6fe-80442b75695b"
      unitRef="usd">638848000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzExLTMtMS0xLTA_b1cb1da6-6f1f-45bd-8fb9-a86fe9f02e3f"
      unitRef="usd">159987000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEyLTEtMS0xLTA_18a044a3-67a5-4827-a60e-85f76db06d15"
      unitRef="usd">296889000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEyLTMtMS0xLTA_8a82e4fa-5a0c-4dc3-a10a-12ddc2305f6f"
      unitRef="usd">201495000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEzLTEtMS0xLTA_8746cbc5-8be6-432f-aef6-d7e5760e162c"
      unitRef="usd">90201000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzEzLTMtMS0xLTIyNzk_06e7f7ef-f6d1-460b-83ce-5253480b0773"
      unitRef="usd">86414000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE0LTEtMS0xLTA_ef80a292-5626-4e66-bb98-4e8cb447d7d3"
      unitRef="usd">11053000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE0LTMtMS0xLTA_ce771501-f638-454f-a372-38dbecd3373b"
      unitRef="usd">10791000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE1LTEtMS0xLTA_6b91a7ff-bb45-4865-8a33-3c9df03c4552"
      unitRef="usd">1880000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE1LTMtMS0xLTA_37ff6295-9ea9-41b6-9332-c432b04a6e56"
      unitRef="usd">1931000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE2LTEtMS0xLTA_1749810a-3b33-496b-bbe2-c33c0f78ec1c"
      unitRef="usd">7336750000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE2LTMtMS0xLTA_0c211d79-d418-4875-98e9-bbd68102dec3"
      unitRef="usd">1589422000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE5LTEtMS0xLTA_8ad75991-910c-4ff7-a7fb-140d2739d986"
      unitRef="usd">18359000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzE5LTMtMS0xLTA_a57c99b2-0784-4f90-b018-44b8079cfef8"
      unitRef="usd">7090000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIwLTEtMS0xLTA_8f3c0f8d-e992-4945-a477-cc5af8d3bcbe"
      unitRef="usd">469591000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIwLTMtMS0xLTA_68ec129b-0491-44be-bab8-9af6066db0f9"
      unitRef="usd">67652000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIxLTEtMS0xLTA_6268c799-d962-4166-8e2f-dc2eb70f69e3"
      unitRef="usd">3867193000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIxLTMtMS0xLTA_e4e2fbbe-4aac-4ddc-899e-0f0a6301a002"
      unitRef="usd">63310000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIyLTEtMS0xLTA_c242bd2a-4e72-4d4f-8ede-9466bdcdda3a"
      unitRef="usd">33665000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIyLTMtMS0xLTA_6b8a7e00-3d9a-46d9-891a-000db21e8141"
      unitRef="usd">5063000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIzLTEtMS0xLTA_f89d5e73-945d-41be-b562-1827805c6629"
      unitRef="usd">4388808000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzIzLTMtMS0xLTA_8ca39616-2546-4ec3-a151-e4538e80e379"
      unitRef="usd">143115000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI0LTEtMS0xLTA_bf59ae66-04e0-415f-a865-077921f62b63"
      unitRef="usd">177419000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI0LTMtMS0xLTA_d4ac7c7b-cd83-40e3-b9dd-7f7a274836c4"
      unitRef="usd">138995000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI1LTEtMS0xLTA_4f9c1bf0-6218-4c0e-907d-993b08615c3f"
      unitRef="usd">97421000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI1LTMtMS0xLTIyODQ_7a55b6f3-5b25-440d-952f-a00414b97fb3"
      unitRef="usd">93675000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI2LTEtMS0xLTA_9913bc6c-bc2c-48af-b10b-eeaa51445d2c"
      unitRef="usd">109874000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI2LTMtMS0xLTIyODQ_7fa60bf5-e3b9-4003-bad2-fae41cf9b780"
      unitRef="usd">38689000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI5LTEtMS0xLTA_188de67f-7e9a-408d-a683-08f239a56b8b"
      unitRef="usd">1853000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzI5LTMtMS0xLTA_13c0e4ae-3af6-4acd-801c-62c533006d96"
      unitRef="usd">138000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMwLTEtMS0xLTA_cf683f7b-726c-4a1a-a722-edfcda557518"
      unitRef="usd">4775375000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMwLTMtMS0xLTA_d1f71252-1912-4968-a04a-f892c44e0971"
      unitRef="usd">414612000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMxLTEtMS0xLTA_93ee2cc2-9621-44ce-b3b5-cb1e8a85bfef"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMxLTMtMS0xLTA_b05c09a0-e3b1-4a28-afe8-cf98b0593454"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTYz_838a585f-8699-4e90-8733-76c9ec31bb91"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTYz_9ef8bbe7-0412-4ab2-aac1-fc1204cd8dc8"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTc3_1abf0b0f-7cc2-439d-a466-63cf394f63ae"
      unitRef="shares">162000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTc3_f5c6995c-a452-48f9-9dad-14d0a323a020"
      unitRef="shares">162000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTgx_0847ff0a-4c31-4109-9d55-58ed9fdca1a1"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTgx_35f33b83-2a81-4c90-bf57-bdfa8efc43da"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTgx_69643a54-6487-4a0f-b4dd-cd00f22f715e"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTAtMS0xLTAvdGV4dHJlZ2lvbjowZDUxODUxZjI4ZWY0NGYyYjRmODgxMWU4ZWMwMjYzYV80OTQ3ODAyMzI1MTgx_dbe057fc-2da7-47b1-8d40-f8c6197b7456"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTEtMS0xLTA_1407e577-f19f-4fe4-b115-697118ec4a91"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzMzLTMtMS0xLTA_16f592a2-31c8-41d4-93ff-7c837eb735b4"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1MjI4_626ffb61-8e4e-42ca-8ccf-1dc82383ef6d"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1MjI4_ff1dad1c-6809-451e-a925-657b721fce64"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1MjY2_9efe9bf1-2a5f-49d5-8e65-98abcfd9b78b"
      unitRef="shares">1600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1MjY2_c38eca7d-d4d5-486c-803a-e1bca42d2bb9"
      unitRef="shares">1600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1Mjgw_27e55e28-8577-4975-b73a-f3c908197057"
      unitRef="shares">398787678</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1Mjgw_f4a2c7b0-d166-4398-8756-d4de1114f53e"
      unitRef="shares">398787678</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1Mjk0_08465d40-4224-44c4-940f-7114bdec0a36"
      unitRef="shares">336536985</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTAtMS0xLTAvdGV4dHJlZ2lvbjo3ZGRhNjBhYTA4NTA0MTc4ODU0NjM4OTczN2ZiMDUxZF80OTQ3ODAyMzI1Mjk0_4cbcb8ea-b4de-4f86-9c6e-82069ec9eca1"
      unitRef="shares">336536985</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTEtMS0xLTA_6de41199-345d-448a-81e0-914a5e68aaa5"
      unitRef="usd">40000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM0LTMtMS0xLTA_296d3000-7d30-4c15-b19a-3d996f3bce35"
      unitRef="usd">34000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM1LTEtMS0xLTA_cfe60448-d14a-43c2-a408-0462a0b607d6"
      unitRef="usd">4801849000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM1LTMtMS0xLTA_405db83d-8575-484c-9bf7-d1fba1cdf2a0"
      unitRef="usd">2669426000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM2LTEtMS0xLTA_e08ac13b-542c-4585-9841-c1cad889ac66"
      unitRef="usd">3004000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM2LTMtMS0xLTA_7a69eb89-c492-40f4-b3e3-0cace673749b"
      unitRef="usd">1804000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM3LTEtMS0xLTA_2e3d06e7-6a12-49d6-b5cd-94ee0572bd8c"
      unitRef="usd">-2243518000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM3LTMtMS0xLTA_948003eb-241a-4d66-89e5-08c69aa82b06"
      unitRef="usd">-1496454000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM4LTEtMS0xLTA_c76b3fd8-925e-4c21-a5ce-19764ab30387"
      unitRef="usd">2561375000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM4LTMtMS0xLTA_eb871c5c-8344-4413-bcbb-12283b67cd69"
      unitRef="usd">1174810000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM5LTEtMS0xLTA_1a1a049b-fb00-40b1-8847-980708888d38"
      unitRef="usd">7336750000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMDkvZnJhZzo4ZGM2YjVjY2FkNzQ0OTZkYTQyZTMwNDc5MTkxNDU4ZC90YWJsZTo5NGE2YTBhYzlkYjI0NzAyYWE3MDNkZWUxYjFiYWMwNC90YWJsZXJhbmdlOjk0YTZhMGFjOWRiMjQ3MDJhYTcwM2RlZTFiMWJhYzA0XzM5LTMtMS0xLTA_c084cc0c-68c5-474e-813f-1c44266d4142"
      unitRef="usd">1589422000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="ia16dd0e2f0d2488eba0c73974791c3a4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtMS0xLTEtMTE5NQ_8c4387bd-becf-4ae5-883c-2ba062170562"
      unitRef="usd">528905000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i998364a642404015895ef6268a8bef44_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtMy0xLTEtMTE5NQ_de5d6b86-d695-431c-9407-2761e0b021cd"
      unitRef="usd">12173000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i234df8a6bf184a26bc8d6f61ec880f13_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtNS0xLTEtMTE5NQ_4fccc242-4444-44d7-a8fc-18cc940ae3cf"
      unitRef="usd">12556000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3af31ae8238a40b6a097aa5017de8edd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzUtMS0xLTEtNjI4Mw_16e2c989-94ed-41b7-93b4-05ee55eb4606"
      unitRef="usd">199872000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i67dc425fe1144699ae5760509f7e5da9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzUtMy0xLTEtNjI4Mw_886f1d77-5e6e-4149-ad71-356ef2fa37b8"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id76485547ab74bf79a9764e33c357192_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzUtNS0xLTEtNjI4Mw_fdd5a645-0cd7-4b16-b540-d4bc8f495596"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1bf0bccbb5d48e2b6b391bd4c6436d8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtMS0xLTEtMA_2307ea56-85b9-469f-9c2b-e868b3fa4128"
      unitRef="usd">74618000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ice56444d59b64b31a0940bfed6f9c48d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtMy0xLTEtMA_c421250a-c4e6-45f7-a6df-91e2ac81e028"
      unitRef="usd">48036000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia5db3bb48bb6499b83759eafea2dc91f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzMtNS0xLTEtMA_5250b731-93f0-4827-9d27-28719995da3b"
      unitRef="usd">122512000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzYtMS0xLTEtMA_ab4c452a-48b7-4591-958a-5d14a8d61ccf"
      unitRef="usd">803395000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzYtMy0xLTEtMA_8606dcbe-4bc3-4ea5-aa01-53496005670b"
      unitRef="usd">60209000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzYtNS0xLTEtMA_4081b8f3-3021-4944-ba4a-278a6785876a"
      unitRef="usd">135068000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtMS0xLTEtNjI3Mg_67f0cfbc-39b4-4cdf-9cfb-121ad1676293"
      unitRef="usd">7933000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtMy0xLTEtNjgxNA_9da2dd30-c6c0-427c-89a6-ac20569a6e8d"
      unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtNS0xLTEtNjgxNg_80a92df2-1e2d-4220-b1db-7689b6fd1611"
      unitRef="usd">0</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtMS0xLTEtMA_6cea3d74-3ae9-402a-ba28-cf462510bdab"
      unitRef="usd">1370339000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtMy0xLTEtMA_4d99a28e-e952-442f-b8ec-b245a0c2260b"
      unitRef="usd">496309000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzgtNS0xLTEtMA_80b88320-eaea-45c5-aeca-ada6d62c4c3e"
      unitRef="usd">454082000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzktMS0xLTEtMA_5474b33c-0887-4f43-b825-7eb4e6952ec0"
      unitRef="usd">188267000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzktMy0xLTEtMA_654f7ed3-6b99-4385-a388-b75b96f01b6a"
      unitRef="usd">109620000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzktNS0xLTEtMA_a4553b74-6e87-4ee1-bc9b-a2d3f59d393c"
      unitRef="usd">94252000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEwLTEtMS0xLTA_a88bafd6-8736-48db-8362-a7eaa73d966b"
      unitRef="usd">1566539000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEwLTMtMS0xLTA_1eee4039-75d9-44e9-a565-c28269c7ced7"
      unitRef="usd">605929000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEwLTUtMS0xLTA_1465efe8-a894-40b4-928a-50ca04f1a935"
      unitRef="usd">548334000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzExLTEtMS0xLTA_a63c1bcd-7df9-4b86-9eed-fa51a791c4f8"
      unitRef="usd">-763144000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzExLTMtMS0xLTA_0c6c0336-6122-4e74-bc08-418dad3f9854"
      unitRef="usd">-545720000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzExLTUtMS0xLTA_ba67afcd-aee0-4ff6-8950-b3d16e1c0cbb"
      unitRef="usd">-413266000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEyLTEtMS0xLTA_3e21b4f6-0b46-4ffc-8394-77437e2ab039"
      unitRef="usd">24715000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEyLTMtMS0xLTA_e1a8e8c3-e7a2-40e8-8141-d8fa40526e4b"
      unitRef="usd">38530000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEyLTUtMS0xLTA_9cc52e5c-c6c4-4509-9a55-6a3e9617d54a"
      unitRef="usd">27023000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEzLTEtMS0xLTA_b90d047a-9b71-4425-8dab-30637f72a090"
      unitRef="usd">-6084000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEzLTMtMS0xLTA_ad29cfda-f527-49fb-89b5-9456db53f920"
      unitRef="usd">-7526000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzEzLTUtMS0xLTA_68c50dce-166b-47b3-9179-4bc95f8ac793"
      unitRef="usd">1835000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE0LTEtMS0xLTA_c7f69baf-3767-458a-a032-c06584cb30dc"
      unitRef="usd">-744513000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE0LTMtMS0xLTA_9bef7aa2-0d71-4f7a-9441-653fbfed513c"
      unitRef="usd">-514716000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE0LTUtMS0xLTA_64b97b7c-b588-46c5-b484-329999568942"
      unitRef="usd">-384408000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE1LTEtMS0xLTA_ea62a1fd-c988-4b89-839d-d3d1013ae27e"
      unitRef="usd">2551000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE1LTMtMS0xLTA_de6c7a88-12be-4e96-b4a3-8a85299ce769"
      unitRef="usd">-695000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE1LTUtMS0xLTA_9fea19a5-3632-4266-bb68-cb7203017445"
      unitRef="usd">326000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE2LTEtMS0xLTA_77bdcb84-af4f-4c74-9842-959de5cd21d1"
      unitRef="usd">-747064000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE2LTMtMS0xLTA_60309c7d-2658-4fd8-8b87-7f6c4cfaa2ca"
      unitRef="usd">-514021000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE2LTUtMS0xLTA_a76b68d2-acde-4e46-83d4-0913fbd9117e"
      unitRef="usd">-384734000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockRedemptionPremium
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE4LTEtMS0xLTA_c69084bf-80c1-41af-a8e0-82c60ca184a1"
      unitRef="usd">0</us-gaap:PreferredStockRedemptionPremium>
    <us-gaap:PreferredStockRedemptionPremium
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE4LTMtMS0xLTA_c1b08d25-1f53-47d1-ba0f-dd5e47632672"
      unitRef="usd">0</us-gaap:PreferredStockRedemptionPremium>
    <us-gaap:PreferredStockRedemptionPremium
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE4LTUtMS0xLTA_3b06624c-3486-4ad5-bf10-ad821be5d5f8"
      unitRef="usd">4127000</us-gaap:PreferredStockRedemptionPremium>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE5LTEtMS0xLTA_e50d0619-c769-4e26-895f-72c93adbeac4"
      unitRef="usd">0</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE5LTMtMS0xLTA_d74a12cd-8a84-4040-ad9b-0ce80c22a277"
      unitRef="usd">0</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzE5LTUtMS0xLTA_ed97c3a1-729c-4bfc-96d8-83758cf69509"
      unitRef="usd">12996000</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIwLTEtMS0xLTA_59ce2ec2-4487-448f-9d13-97dd0fa7f88d"
      unitRef="usd">-747064000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIwLTMtMS0xLTA_aa672010-e20e-451f-a68a-f890d0838705"
      unitRef="usd">-514021000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIwLTUtMS0xLTA_12e640ec-2cb1-43b9-ad5d-58c7daf45da8"
      unitRef="usd">-401857000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIxLTEtMS0xLTA_91fc91f5-2b96-4514-ba14-98e4faeb2127"
      unitRef="usdPerShare">-1.96</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIxLTMtMS0xLTA_ffd161f8-b675-4007-8134-9d7d544c3a41"
      unitRef="usdPerShare">-1.55</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIxLTUtMS0xLTA_21f1004a-8602-40b2-b36a-6eaedd834562"
      unitRef="usdPerShare">-4.95</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIyLTEtMS0xLTA_e51a3f45-d537-47a9-aa9f-1a9def243fb5"
      unitRef="shares">381333059</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIyLTMtMS0xLTA_8bc3d790-b796-4df9-a0bd-afb05b3feaf9"
      unitRef="shares">330802136</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTUvZnJhZzo5Mzk1MGY5OWNhNmE0ZjEwOWY1OWUyZWU1N2RjOWZmYi90YWJsZTplMGRmNmRjMTA4ZjE0ZmFmYmRjZTVlOTI2NjJiNGVjMC90YWJsZXJhbmdlOmUwZGY2ZGMxMDhmMTRmYWZiZGNlNWU5MjY2MmI0ZWMwXzIyLTUtMS0xLTA_bc40bf9a-bb18-4d30-b3e8-88bb39ac46de"
      unitRef="shares">81114183</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzItMS0xLTEtMA_400b6572-ec01-40b4-9aa3-80cff372893e"
      unitRef="usd">-747064000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzItMy0xLTEtMA_9cc86b8e-e907-40ec-a305-c1becc7bb2f2"
      unitRef="usd">-514021000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzItNS0xLTEtMA_23a62cd2-857c-4cd8-b41c-a5e5ca0dfcb3"
      unitRef="usd">-384734000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtMC0xLTEtMC90ZXh0cmVnaW9uOjBlNzVlMDNmNjIyNjRiZjNiMGJjZjkxZGI0YzVmNWNmXzQ5NDc4MDIzMjUyMDU_8ff094b8-8351-4bef-a041-64c1a162a60d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtMC0xLTEtMC90ZXh0cmVnaW9uOjBlNzVlMDNmNjIyNjRiZjNiMGJjZjkxZGI0YzVmNWNmXzQ5NDc4MDIzMjUyNTk_e9a9ae18-477d-4ad2-b678-6f3c212e89e1"
      unitRef="usd">1148000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtMC0xLTEtMC90ZXh0cmVnaW9uOjBlNzVlMDNmNjIyNjRiZjNiMGJjZjkxZGI0YzVmNWNmXzQ5NDc4MDIzMjUyNjQ_4fef82b4-cf82-4127-8a6e-7832884878a2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtMS0xLTEtMA_89b62ee7-1bab-4ac3-8932-d9f86f537f3e"
      unitRef="usd">2501000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtMy0xLTEtMA_fe3ac4c2-3c12-40c5-84f3-8edf4814d65d"
      unitRef="usd">3447000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzQtNS0xLTEtMA_22bb50c9-a290-419d-a7ac-7f40ff4a0f9f"
      unitRef="usd">-132000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzUtMS0xLTEtMA_c24fac26-5ca0-4b96-b4ce-a75b49424ca8"
      unitRef="usd">1301000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzUtMy0xLTEtMA_fa9843bb-c592-4b0a-a7fc-8e97924ce0d5"
      unitRef="usd">323000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzUtNS0xLTEtMA_67b084fc-f08a-4089-b511-cf3c520698c2"
      unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzYtMS0xLTEtMA_3c37a758-1fcd-4d60-986d-42ad67741e73"
      unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzYtMy0xLTEtMA_402836e4-ce5a-4587-ae9e-6e89f3f01b22"
      unitRef="usd">3124000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzYtNS0xLTEtMA_36eac1ad-149a-45ce-a0c3-ee5ced8abdd7"
      unitRef="usd">-163000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzctMS0xLTEtMA_c16cb75d-d6c0-419b-ac5c-81f077a8c4d4"
      unitRef="usd">-745864000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzctMy0xLTEtMA_cae33287-5962-4564-84fc-dab60ec89889"
      unitRef="usd">-510897000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMTgvZnJhZzozZTgyYWM0NjFmODg0MjA0YTNmMmY3ODZmYmEwNWFkMy90YWJsZTo4YTk1NjZmZjBhNzE0ZjI4YTBiMDlkZGZmNmEwMjI1Ny90YWJsZXJhbmdlOjhhOTU2NmZmMGE3MTRmMjhhMGIwOWRkZmY2YTAyMjU3XzctNS0xLTEtMA_775a253a-25c8-4b3d-8a61-fbc4f0ae76a4"
      unitRef="usd">-384897000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iae26ac15cf594fc4a4c729775db551d1_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItMi0xLTEtMA_99b00008-da7d-43e0-b283-8d92e0764c4a"
      unitRef="shares">448686791</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iae26ac15cf594fc4a4c729775db551d1_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItNC0xLTEtMA_827cb49c-6835-47a8-9e1b-dec1ab2eaee8"
      unitRef="usd">1176661000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ia0f05a78cb4a45e0aae694728346c943_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItNy0xLTEtMA_90bdefc5-b150-45df-90c6-43b5239ba425"
      unitRef="shares">65206999</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia0f05a78cb4a45e0aae694728346c943_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItOS0xLTEtMA_e8ccc0de-cfd2-4790-9496-578ce8a1e1e3"
      unitRef="usd">6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67150ae834864a00a45a3aafe2462423_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItMTEtMS0xLTA_4f488f45-63f6-469f-aa8b-cfe17b71dcc6"
      unitRef="usd">71679000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6d4e1054ad904b07b079bfcd6a3b0dfa_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItMTMtMS0xLTA_6f8773bb-3fa5-4ed6-b43e-0692c5f31502"
      unitRef="usd">-1157000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i938ca78cd25647ac9350433b1e94b211_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItMTUtMS0xLTA_56ebd553-6170-4c26-a852-41027119e427"
      unitRef="usd">-621893000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i857b3ef318484e959ca8a3dddeb3a486_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzItMTctMS0xLTA_70ac5e3d-53ca-4657-a6b2-25255844675b"
      unitRef="usd">-551365000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzMtNy0xLTEtMA_e294b4b5-2f1d-4502-a736-f0ce726c85c8"
      unitRef="shares">856135</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i859a2b8a071243a4aab797a9e567cab2_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzQtMC0xLTEtMC90ZXh0cmVnaW9uOjAwODgxYzM3YmNiMDQ5ZTdiYmIwN2MzNTM4OGRlN2VhXzQ5NDc4MDIzMjUwOTc_c3239ac1-3b55-48b6-89d8-7cd609daddcf"
      unitRef="usd">10517000</us-gaap:PaymentsOfStockIssuanceCosts>
    <mrna:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="ia68cd3c2e44d470a8bb0dd6b86dfbcd9_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzQtMi0xLTEtMA_c895931a-805f-41f3-bd68-ae6970eaa0c1"
      unitRef="shares">55666004</mrna:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="ia68cd3c2e44d470a8bb0dd6b86dfbcd9_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzQtNC0xLTEtMA_81eb14f7-ddcb-446e-bb25-da5b67453a11"
      unitRef="usd">549413000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i812ca2c8b582418791dd8a37f6934064_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzQtMTEtMS0xLTA_ee53e5cf-5ebb-4477-ad2c-fab411ca49dd"
      unitRef="usd">51000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i859a2b8a071243a4aab797a9e567cab2_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzQtMTctMS0xLTA_3084838f-b338-45e2-9f33-21a1951c6bed"
      unitRef="usd">51000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i67ede5f832064fd28db4be814bebe8c9_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzUtMC0xLTEtMC90ZXh0cmVnaW9uOjA5NWE5MjkwODcxZDQzOTFhOTkxYjI4Mjk3NTlhMDg1XzQ5NDc4MDIzMjUwOTE_8f9eeb39-7920-4345-a712-fb9f6eef8c79"
      unitRef="usd">474000</us-gaap:PaymentsOfStockIssuanceCosts>
    <mrna:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i77c6c82735e645deaa5e5478b0a99aa6_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzUtMi0xLTEtMA_b9570912-5470-44e1-82fc-e6b98638d7ce"
      unitRef="shares">5000000</mrna:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i77c6c82735e645deaa5e5478b0a99aa6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzUtNC0xLTEtMA_459e12cf-8576-4d8a-9e0a-c80c64873e23"
      unitRef="usd">111546000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <mrna:TemporaryEquityStockRepurchasedDuringPeriodShares
      contextRef="ia2745e2110e849418080ca092c31fe61_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzYtMi0xLTEtMA_4fee3e70-1bff-48ce-bfc5-febbb90039aa"
      unitRef="shares">269180</mrna:TemporaryEquityStockRepurchasedDuringPeriodShares>
    <mrna:TemporaryEquityStockRepurchasedDuringPeriodValue
      contextRef="ia2745e2110e849418080ca092c31fe61_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzYtNC0xLTEtMA_435069c8-053c-466a-a4f5-29d39d64eeca"
      unitRef="usd">704000</mrna:TemporaryEquityStockRepurchasedDuringPeriodValue>
    <mrna:TemporaryEquityStockRepurchasedDuringPeriodValue
      contextRef="i014f1da45cd24ebfaccc119edf9098d7_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzYtMTEtMS0xLTA_6586cdc4-0995-411d-86c1-76804121ab38"
      unitRef="usd">2009000</mrna:TemporaryEquityStockRepurchasedDuringPeriodValue>
    <mrna:TemporaryEquityStockRepurchasedDuringPeriodValue
      contextRef="ie937c553bd26477b9acb13ff0d7ed4e0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzYtMTctMS0xLTA_40a0d418-f650-4241-95c0-bfe97cbf2b09"
      unitRef="usd">2009000</mrna:TemporaryEquityStockRepurchasedDuringPeriodValue>
    <mrna:TemporaryEquityStockRepurchasedDuringPeriodShares
      contextRef="ib152449eaa214910b3c1ff9d8ebc950d_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzctMi0xLTEtMA_75c849c5-ac7e-4a7c-a44e-b74e927034bf"
      unitRef="shares">544100</mrna:TemporaryEquityStockRepurchasedDuringPeriodShares>
    <mrna:TemporaryEquityStockRepurchasedDuringPeriodValue
      contextRef="ib152449eaa214910b3c1ff9d8ebc950d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzctNC0xLTEtMA_2fad5843-b047-459f-b6af-8af8e8dbec92"
      unitRef="usd">3355000</mrna:TemporaryEquityStockRepurchasedDuringPeriodValue>
    <mrna:TemporaryEquityStockRepurchasedDuringPeriodValue
      contextRef="ic468680da3a242bd8e509f8061d39e47_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzctMTEtMS0xLTA_ffcd2058-9bad-4a76-b14c-2b25556d11f9"
      unitRef="usd">2118000</mrna:TemporaryEquityStockRepurchasedDuringPeriodValue>
    <mrna:TemporaryEquityStockRepurchasedDuringPeriodValue
      contextRef="i5e0a831810a84041aaa0ec3f4250a1ee_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzctMTctMS0xLTA_df5404a7-893f-4d23-9135-3122987d76e5"
      unitRef="usd">2118000</mrna:TemporaryEquityStockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzgtNy0xLTEtMA_707d4e0b-1a13-4792-a559-30ebdc395204"
      unitRef="shares">446864</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2737f3bfa09d4954bbdecc2432f59275_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzgtMTEtMS0xLTA_4dd4d400-d727-466c-ac62-2737d63714b4"
      unitRef="usd">1427000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzgtMTctMS0xLTA_ce73f758-c4da-415d-9933-19237e0354ab"
      unitRef="usd">1427000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <mrna:ReclassificationsOfTemporaryToPermanentEquityShares
      contextRef="i5f1c28d9133c4d19994650191f44a618_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktMi0xLTEtMA_3a188602-3e12-4ac4-b7b4-fb20054464cb"
      unitRef="shares">508539515</mrna:ReclassificationsOfTemporaryToPermanentEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="i5f1c28d9133c4d19994650191f44a618_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktNC0xLTEtMA_11e62259-cfbf-45d8-8622-1705afc95dd9"
      unitRef="usd">-1833561000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <mrna:ReclassificationsOfTemporaryToPermanentEquityShares
      contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktNy0xLTEtMA_4a54884f-5def-4be6-88d5-4f397a71add9"
      unitRef="shares">236012913</mrna:ReclassificationsOfTemporaryToPermanentEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktOS0xLTEtMA_ebcbefb1-c50f-4bec-91a6-37cf523aa948"
      unitRef="usd">24000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="i2737f3bfa09d4954bbdecc2432f59275_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktMTEtMS0xLTA_d8b15a12-861a-4f22-9e10-7c887d4c4bd1"
      unitRef="usd">1833537000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzktMTctMS0xLTA_b3cc1235-ccbd-4246-8d23-af1250c0c285"
      unitRef="usd">1833561000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEwLTAtMS0xLTAvdGV4dHJlZ2lvbjozN2Q4M2Y3MWNjMWQ0MTYwYjNkOGYwNWQ1Y2M3ZTIzNl80OTQ3ODAyMzI1MDcy_b819c120-0996-4cd4-9e98-ab373bc1d92d"
      unitRef="usd">41322000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEwLTctMS0xLTA_ebe9e6c4-1a72-42ac-bb7c-ea1d97131a54"
      unitRef="shares">26275993</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ibfe5ed14b56f48f3a39263f013b60058_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEwLTktMS0xLTA_438feae4-9f06-4987-afd5-6cd853275daa"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2737f3bfa09d4954bbdecc2432f59275_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEwLTExLTEtMS0w_85a1a29c-40f0-438f-a3b3-18a815a5ff2c"
      unitRef="usd">563023000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEwLTE3LTEtMS0w_4dc402c0-65a3-40f1-833f-a3446d060679"
      unitRef="usd">563026000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2737f3bfa09d4954bbdecc2432f59275_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzExLTExLTEtMS0w_1d0447a6-9c06-4cf0-8ed4-914da0246099"
      unitRef="usd">72565000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzExLTE3LTEtMS0w_4f052400-314a-4a71-88c3-148229e26663"
      unitRef="usd">72565000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i06ac627610d04fb3ad68a60243ee4351_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEyLTEzLTEtMS0w_bc8d5db1-17d7-4d2d-9e79-985d4f0a5015"
      unitRef="usd">-163000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEyLTE3LTEtMS0w_cd615ada-bc58-420a-b287-c7b44df062b1"
      unitRef="usd">-163000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i3ad70ea4023a49e5923d1a79f4faf6fd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEzLTE1LTEtMS0w_358077ed-8953-4138-b93a-66eba8daa3c6"
      unitRef="usd">-384734000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzEzLTE3LTEtMS0w_8e0efcaf-6119-4aa3-9d05-7fd37a1748dd"
      unitRef="usd">-384734000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i413042b2017f4a90a355a0f54413c75f_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTItMS0xLTA_1b723fd2-e5e3-4ab9-9c0c-8492463cb65f"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i413042b2017f4a90a355a0f54413c75f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTQtMS0xLTA_2924d50b-6f39-4780-8632-c05529784554"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ifbb1a345880141898c0782b97ae50bdd_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTctMS0xLTA_4c42829f-4812-475a-8d33-9f61adaabb19"
      unitRef="shares">328798904</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifbb1a345880141898c0782b97ae50bdd_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTktMS0xLTA_e7731dce-ba07-4642-8d87-38a739837fbd"
      unitRef="usd">33000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2425e3671ff2477f85a228531640c4e2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTExLTEtMS0w_18049926-b7ee-491a-8ca2-48bf917e883c"
      unitRef="usd">2538155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i14c57127d88a41c5af194b5765483daa_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTEzLTEtMS0w_0e2ace5e-27dd-4709-a544-0276f41f4493"
      unitRef="usd">-1320000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec0aa65fa9384232bb27dc252483b1ee_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTE1LTEtMS0w_8f0a6c32-be12-450a-b80f-b052e3e249a6"
      unitRef="usd">-1006627000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20204b229a394d9ba8b28882826012db_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZToxNjc5MTE3NGQ5MmE0ZTdjYmJjYzkwZjY2Nzc1MzNlYS90YWJsZXJhbmdlOjE2NzkxMTc0ZDkyYTRlN2NiYmNjOTBmNjY3NzUzM2VhXzE0LTE3LTEtMS0w_f3d28014-5fcf-4546-b183-643e78353b29"
      unitRef="usd">1530241000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i413042b2017f4a90a355a0f54413c75f_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItMi0xLTEtMA_387d3f15-493d-4a29-964d-6739e48b45cf"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i413042b2017f4a90a355a0f54413c75f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItNC0xLTEtMA_4898e1f6-f80d-4e4d-bba8-f06487f470b8"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ifbb1a345880141898c0782b97ae50bdd_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItNy0xLTEtMA_1369e879-8f4c-4807-93dd-7d8fcd5351da"
      unitRef="shares">328798904</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifbb1a345880141898c0782b97ae50bdd_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItOS0xLTEtMA_384991d2-5823-47b8-a0d5-ba08b55d97db"
      unitRef="usd">33000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2425e3671ff2477f85a228531640c4e2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItMTEtMS0xLTA_d757253a-9cd5-4c60-9f8e-6829be70a224"
      unitRef="usd">2538155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i14c57127d88a41c5af194b5765483daa_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItMTMtMS0xLTA_2456a841-7711-47ab-9b75-4b9456a5eaba"
      unitRef="usd">-1320000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec0aa65fa9384232bb27dc252483b1ee_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItMTUtMS0xLTA_4cb8eb4e-3abf-4733-907a-bf536992551e"
      unitRef="usd">-1006627000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i20204b229a394d9ba8b28882826012db_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzItMTctMS0xLTA_b0e0e75c-91a4-4480-a66f-4de54b41d9a5"
      unitRef="usd">1530241000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i46a4ad30d8e44c75931d48376d7dd5a7_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzMtNy0xLTEtMA_7e949928-4aff-4746-a94a-5ab05adc3144"
      unitRef="shares">621432</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i46a4ad30d8e44c75931d48376d7dd5a7_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzQtNy0xLTEtMA_fc7ff13c-0e03-4096-b5f3-9d3b4b6ef7cd"
      unitRef="shares">6945306</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i46a4ad30d8e44c75931d48376d7dd5a7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzQtOS0xLTEtMA_fe2b7a21-5226-4314-bc4a-ae1de02d545b"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id01664a6e7894e8083439b3589eb02b8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzQtMTEtMS0xLTA_5123b824-1970-471e-9999-f289aa5316fe"
      unitRef="usd">47258000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzQtMTctMS0xLTA_215f5649-1e66-4218-bedb-52a9bc464dd4"
      unitRef="usd">47259000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i46a4ad30d8e44c75931d48376d7dd5a7_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzUtNy0xLTEtMA_f8a5a052-7cc7-4dc2-86e6-4c777b633886"
      unitRef="shares">171343</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="id01664a6e7894e8083439b3589eb02b8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzUtMTEtMS0xLTA_e06f7c39-74a4-4c41-abae-ee360f096899"
      unitRef="usd">2891000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzUtMTctMS0xLTA_04398cbf-42fe-48b3-a91c-fbec0e116dda"
      unitRef="usd">2891000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockholdersEquity
      contextRef="ife96d591748e4db1a06679e64f49ac18_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzYtMTUtMS0xLTA_2b024963-2e4f-452d-bdd1-5fff586bfe0a"
      unitRef="usd">27984000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6f826ec40d9a42d49d1f345df0664683_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzYtMTctMS0xLTA_83ed27d0-ee4c-4762-9d09-4afa9392a07e"
      unitRef="usd">27984000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id2f2085b1dd5438ca46922e561f57fef_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzctMTUtMS0xLTA_02e17c65-908a-4f66-a33e-a42f959fbc5d"
      unitRef="usd">-3790000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ea8b1dba03d4c238442398f1dbc7fab_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzctMTctMS0xLTA_b88d4c12-6390-4d22-81e6-047066a07784"
      unitRef="usd">-3790000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id01664a6e7894e8083439b3589eb02b8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzgtMTEtMS0xLTA_63c377eb-a9b5-4606-a90d-2c2200ac0ddd"
      unitRef="usd">81122000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzgtMTctMS0xLTA_70bd6cb9-ae22-4c88-9fef-a796e930fef8"
      unitRef="usd">81122000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ibfbf4e4b10ca4b88bc9d9e4de34dfec6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzktMTMtMS0xLTA_e82bb47c-3967-4b66-8cf7-4a56452b6aad"
      unitRef="usd">3124000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzktMTctMS0xLTA_f459e26f-e612-48a6-a177-022878f4d695"
      unitRef="usd">3124000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i6276f01255674c1bb430a10fe7a5d756_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzEwLTE1LTEtMS0w_084f9af9-af46-44a4-b408-7d124fffef72"
      unitRef="usd">-514021000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzEwLTE3LTEtMS0w_8eda2ae7-9bd0-4e8a-9d36-229a04caf771"
      unitRef="usd">-514021000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i5dd938ce77414d15a896664fd61440db_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTItMS0xLTA_14c679f7-b51e-43d5-8244-aaaf91cb7228"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i5dd938ce77414d15a896664fd61440db_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTQtMS0xLTA_66890c10-7ea3-4439-aff3-7b081e3f0f15"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i52c971ec763a42d9b277341a14ec9c55_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTctMS0xLTA_74fb4dfe-bb67-494a-ac44-c9ed916cfe81"
      unitRef="shares">336536985</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i52c971ec763a42d9b277341a14ec9c55_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTktMS0xLTA_4c42f7f0-7e12-4781-9a95-c4f670e6dbb6"
      unitRef="usd">34000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i93472a617e4d4f6f9147a6e05189a34e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTExLTEtMS0w_cd3bec95-046c-4956-bba1-9268e934516d"
      unitRef="usd">2669426000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i81f30efddbba4bc19c03af8bc5c7eaf6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTEzLTEtMS0w_55112b75-2dde-478a-98f4-10dc5be49611"
      unitRef="usd">1804000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id4c8e11b66a049928373daa1783da6a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTE1LTEtMS0w_f37e650a-9baa-4948-94d1-5a401dcbf91c"
      unitRef="usd">-1496454000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTo5MDY1NzYzZDczMmY0YTQ0OTM1YWMzZGY2MTM4MzQwZC90YWJsZXJhbmdlOjkwNjU3NjNkNzMyZjRhNDQ5MzVhYzNkZjYxMzgzNDBkXzExLTE3LTEtMS0w_e8048ad2-ba3e-4023-a032-6193637b8b7e"
      unitRef="usd">1174810000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i5dd938ce77414d15a896664fd61440db_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItMi0xLTEtMTI1OA_eda446bd-b108-4fed-aa4e-9586051f20a7"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i5dd938ce77414d15a896664fd61440db_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItNC0xLTEtMTI1OA_a81c82a5-3c5f-4d05-a665-88542c7af731"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i52c971ec763a42d9b277341a14ec9c55_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItNy0xLTEtMTI2Mg_7da3b3f5-51be-49cb-8687-ab7e8e824de6"
      unitRef="shares">336536985</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i52c971ec763a42d9b277341a14ec9c55_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItOS0xLTEtMTI2Mg_51869c19-c64a-4d07-9409-c96a5c40d074"
      unitRef="usd">34000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i93472a617e4d4f6f9147a6e05189a34e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItMTEtMS0xLTEyNjI_e887cfc1-e1a3-44a2-8301-59ce3d98e20b"
      unitRef="usd">2669426000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i81f30efddbba4bc19c03af8bc5c7eaf6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItMTMtMS0xLTEyNjY_6fb0fae1-2103-4ff9-af00-b42d41c22464"
      unitRef="usd">1804000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id4c8e11b66a049928373daa1783da6a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItMTUtMS0xLTEyNjY_a3f7cf8f-db14-4eef-97d7-0a7cdb68c9e5"
      unitRef="usd">-1496454000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzItMTctMS0xLTEyNjY_bc303d00-de0c-44f3-ace6-fb84fed40cf3"
      unitRef="usd">1174810000</us-gaap:StockholdersEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzMtMC0xLTEtNTE4MC90ZXh0cmVnaW9uOmQ2ZTA3NTM0ZDFmNDRhNmZhYzBlYjg2YTZhOWYwNWJiXzQ5NDc4MDIzMjUwNjg_0e26ec4f-c63f-4891-ae32-0bcfcd65cbd5"
      unitRef="usd">2120000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzMtNy0xLTEtMTI2Mg_f9e0c345-6a58-4fa1-8001-37f6a55840ba"
      unitRef="shares">47863158</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzMtOS0xLTEtMTI2Mg_0a1c49d2-4684-44bc-8c78-5907f00ba1e1"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i87efeddd90154654bf0692ac7c3a035e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzMtMTEtMS0xLTEyNjI_02f2c914-c5f5-445a-851b-8d5ad3b86eab"
      unitRef="usd">1852720000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzMtMTctMS0xLTEyNjY_7c5ff33b-17d9-4243-b110-aec767c28423"
      unitRef="usd">1852725000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzQtNy0xLTEtMTI2Mg_69069c3d-c695-426e-9f91-ff73f88c8dd2"
      unitRef="shares">247349</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzUtNy0xLTEtMTI2Mg_2228bded-135e-420f-b010-ca0f08de6ac9"
      unitRef="shares">13888434</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzUtOS0xLTEtMTI2Mg_eca6cef7-5128-41a8-a100-ba227e832a32"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i87efeddd90154654bf0692ac7c3a035e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzUtMTEtMS0xLTEyNjI_c4d4bc0b-d984-455f-bfb7-428648bdfa94"
      unitRef="usd">179642000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzUtMTctMS0xLTEyNjY_4b79d72c-635c-41ff-ad70-abf917c76661"
      unitRef="usd">179643000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i0bfad56383b4441cb5cae8eab85b564c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzYtNy0xLTEtMTI2Mg_35297af5-beab-4c68-bf54-207a3d3c8cc5"
      unitRef="shares">251752</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i87efeddd90154654bf0692ac7c3a035e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzYtMTEtMS0xLTEyNjI_cf1c1839-26da-4098-b537-68cf9217a77d"
      unitRef="usd">7040000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzYtMTctMS0xLTEyNjY_a56079f9-7150-4345-8b99-0c35897c761a"
      unitRef="usd">7040000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i87efeddd90154654bf0692ac7c3a035e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzctMTEtMS0xLTEyNjI_359d3e4c-0964-4755-9fef-2236670ac857"
      unitRef="usd">93021000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzctMTctMS0xLTEyNjY_550d761c-d51b-4b50-8094-09b1287d0bff"
      unitRef="usd">93021000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="icd928a22fd08462eafd4359a764e5cdf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzgtMTMtMS0xLTEyNjY_ad8b1333-89b6-4fe4-b319-e1b304445b35"
      unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzgtMTctMS0xLTEyNjY_e9dd75c9-58e3-4197-abf7-ec7c90569222"
      unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i9e68e85a40d74b498b0bb46dec072277_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzktMTUtMS0xLTEyNjY_deddb0b6-0bbb-4962-8f6c-d290d318adf6"
      unitRef="usd">-747064000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzktMTctMS0xLTEyNjY_676fb7c6-8306-4ae6-a90b-0823244842c0"
      unitRef="usd">-747064000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ic97698562fbd485a80018d02cce80260_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTItMS0xLTMyMjc_23714fab-e7c4-42e6-872e-12ab5bca16de"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ic97698562fbd485a80018d02cce80260_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTQtMS0xLTMyMjU_58404688-847c-4cae-9c34-1d6cfa52e9b5"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="id068aa2a6fcb49d59dfae933d3a4da27_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTctMS0xLTMyMjI_6d6f3a2a-a138-4b15-8dce-560830138cb5"
      unitRef="shares">398787678</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id068aa2a6fcb49d59dfae933d3a4da27_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTktMS0xLTMyMjA_1066181c-56e7-424a-95c5-bbee7401c1c7"
      unitRef="usd">40000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie66e5cf3847f4ccbb705424a971759bc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTExLTEtMS0zMjE3_776555d0-d814-480a-ac84-16dbf3b91e94"
      unitRef="usd">4801849000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i29f3ebca75ec4b5b92053285ea842b9c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTEzLTEtMS0zMjE2_32ace6d3-8f0f-4ad7-baca-bba5c5f0c175"
      unitRef="usd">3004000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ee6a6d175624d8c9cfc907e7bb82743_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTE1LTEtMS0zMjE0_fd6779cd-348f-4639-9784-f8e30a67990a"
      unitRef="usd">-2243518000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMjQvZnJhZzpkZDQwYjhkNmRiYjQ0MTMwYTQyMzRjOGEyMGI1MWJmOS90YWJsZTpiNTgyNGMxMWIyOTg0YmY0OTYzMDJjNDQwMjhlZmExMS90YWJsZXJhbmdlOmI1ODI0YzExYjI5ODRiZjQ5NjMwMmM0NDAyOGVmYTExXzEwLTE3LTEtMS0zMjEy_923b83df-bf7d-47d1-bfd5-2db466ef5d98"
      unitRef="usd">2561375000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMtMS0xLTEtMA_9fced919-e253-41a1-95f7-d0d9e6183028"
      unitRef="usd">-747064000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMtMy0xLTEtMA_4199136e-81bc-4dd5-947e-f52ee3736366"
      unitRef="usd">-514021000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMtNS0xLTEtMA_d40a47c9-00c4-440c-8f1f-1646ab339498"
      unitRef="usd">-384734000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzUtMS0xLTEtMA_7bae01a2-a4d9-4587-ba68-f653a0e9d2d4"
      unitRef="usd">93021000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzUtMy0xLTEtMA_c10a0b7f-ec0e-4ed5-beda-dd014352edc9"
      unitRef="usd">81122000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzUtNS0xLTEtMA_663c9404-dbe5-42ac-a313-17ad825cd158"
      unitRef="usd">72565000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzYtMS0xLTEtMA_d14b29bc-833a-423d-8232-02f0cafd5b8c"
      unitRef="usd">31251000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzYtMy0xLTEtMA_eb275401-c1aa-4657-ac0b-feab2d0e7ab1"
      unitRef="usd">31021000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzYtNS0xLTEtMA_34228047-6853-4903-ba29-8f0b1d1001ed"
      unitRef="usd">24862000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctMS0xLTEtNzA4Ng_bcba2e81-2b45-4157-b3de-fa99aea49057"
      unitRef="usd">-62286000</us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases>
    <us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctMy0xLTEtMTA2NjU_b3830b9c-4f6b-45df-8158-93dcf22e2317"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases>
    <us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctNS0xLTEtMTA2Njc_837e09f8-752c-4cdb-a6a3-6c3e666ecbee"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfLeasedAssetsNetOperatingLeases>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctMS0xLTEtMA_2491f657-7cc8-4e98-bd30-4b1154b54ff7"
      unitRef="usd">-10185000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctMy0xLTEtMA_ba97a090-4301-4b52-abd2-5b242cd39cbb"
      unitRef="usd">3742000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzctNS0xLTEtMA_db9283fa-e5cd-4bdf-9111-233b6371348c"
      unitRef="usd">1866000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzgtMS0xLTEtMA_19d4a9af-d237-4cdb-aaf6-3d42d4aab1d1"
      unitRef="usd">-238000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzgtMy0xLTEtMA_c86c7499-0f95-4b92-8112-1b27c6d60a68"
      unitRef="usd">-316000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzgtNS0xLTEtMA_363b100a-e6ee-4928-a760-e73fdf045adb"
      unitRef="usd">-891000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEwLTEtMS0xLTA_8520f3a5-f875-4368-a3d0-4041c4e25a63"
      unitRef="usd">1385191000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEwLTMtMS0xLTA_429979aa-e769-4060-802b-d68e84a9e598"
      unitRef="usd">-7216000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEwLTUtMS0xLTA_cda17040-ab18-4631-aab0-6afc0ae891da"
      unitRef="usd">-832000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEzLTEtMS0xLTcwOTQ_b980c570-20df-4b4f-919b-5690e48962cf"
      unitRef="usd">46527000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEyLTMtMS0xLTEwNjY5_ca1d1ed3-88d4-42c8-bdf8-83a5dfa3e04c"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEyLTUtMS0xLTEwNjcx_1591f89d-3ca6-45bf-b6d0-640eb3720f86"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEyLTEtMS0xLTA_4fe68e69-4724-447e-b2a5-6b2adbabf1ce"
      unitRef="usd">241041000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEyLTMtMS0xLTA_bb25e827-d521-41a2-abd8-1432b6e4efa8"
      unitRef="usd">-9751000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEyLTUtMS0xLTA_d6adb1d2-3887-4091-9fc5-1240e6063a5b"
      unitRef="usd">5289000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <mrna:RightOfUseAssetOperatingLeases
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEzLTEtMS0xLTA_36b5d21c-b211-412f-a0c9-2bee5801b3ae"
      unitRef="usd">10542000</mrna:RightOfUseAssetOperatingLeases>
    <mrna:RightOfUseAssetOperatingLeases
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEzLTMtMS0xLTA_ee5189c2-d545-4f29-ae5c-69ade4d516a4"
      unitRef="usd">5664000</mrna:RightOfUseAssetOperatingLeases>
    <mrna:RightOfUseAssetOperatingLeases
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzEzLTUtMS0xLTA_8aef66b6-8629-487c-b8aa-8c4ec8872ad1"
      unitRef="usd">0</mrna:RightOfUseAssetOperatingLeases>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE0LTEtMS0xLTA_22670753-617e-46dd-8b10-b57d0bb1cf20"
      unitRef="usd">11875000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE0LTMtMS0xLTA_9f267732-71b5-45af-ad0c-87d71c6aa37c"
      unitRef="usd">-23964000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE0LTUtMS0xLTA_94f8c805-d2f0-4266-bb35-778f2041f31e"
      unitRef="usd">15017000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE1LTEtMS0xLTA_c8d9c65b-ae6d-4150-8594-ed06eff3430b"
      unitRef="usd">388392000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE1LTMtMS0xLTA_f66a0e50-3547-4c80-b345-f752cebc3ff8"
      unitRef="usd">-3362000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE1LTUtMS0xLTA_e27b4ffe-e97a-4422-9aad-e498eacdda1d"
      unitRef="usd">8787000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE2LTEtMS0xLTA_efd035a9-24a4-4e80-b8c3-240c91d39b94"
      unitRef="usd">3842307000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE2LTMtMS0xLTA_fe6acf14-f2a7-4133-8852-ae13624042e7"
      unitRef="usd">-44119000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE2LTUtMS0xLTA_5949a673-04c5-4c7c-b77c-e437029f178f"
      unitRef="usd">-65260000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <mrna:IncreaseDecreaseInDeferredRentCredit
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE3LTEtMS0xLTA_b05f6ec1-2932-4db2-88bf-b08bb1178eef"
      unitRef="usd">0</mrna:IncreaseDecreaseInDeferredRentCredit>
    <mrna:IncreaseDecreaseInDeferredRentCredit
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE3LTMtMS0xLTA_d7e22cc9-81a8-4d4e-a5ec-d50084e25e63"
      unitRef="usd">0</mrna:IncreaseDecreaseInDeferredRentCredit>
    <mrna:IncreaseDecreaseInDeferredRentCredit
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE3LTUtMS0xLTA_ba30bedf-62f3-4332-bc67-0c8b962bde04"
      unitRef="usd">2420000</mrna:IncreaseDecreaseInDeferredRentCredit>
    <mrna:OperatingLeaseLiabilities
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE4LTEtMS0xLTA_813d383c-bb54-4732-ac36-c33b1ea9638c"
      unitRef="usd">11792000</mrna:OperatingLeaseLiabilities>
    <mrna:OperatingLeaseLiabilities
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE4LTMtMS0xLTA_776a6f19-d399-4ede-b095-8c39fe74c879"
      unitRef="usd">12647000</mrna:OperatingLeaseLiabilities>
    <mrna:OperatingLeaseLiabilities
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE4LTUtMS0xLTA_3bc0f3ad-184f-48f4-817c-b21325f60410"
      unitRef="usd">0</mrna:OperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE5LTEtMS0xLTA_5c358080-181b-4956-a8c6-21177aa8bdd9"
      unitRef="usd">5989000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE5LTMtMS0xLTA_2eb5c217-f939-4bad-9940-a63233d07037"
      unitRef="usd">-6169000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzE5LTUtMS0xLTA_5c07416e-54ac-4f39-b71e-6cf7b36c057d"
      unitRef="usd">910000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIwLTEtMS0xLTA_fe22d444-9b9c-4e91-a859-49a33e6b67b7"
      unitRef="usd">2026971000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIwLTMtMS0xLTA_16886916-be3b-4f9d-8894-776589798cdb"
      unitRef="usd">-458968000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIwLTUtMS0xLTA_c8b253c9-dade-4817-8c68-f03f496cd1c0"
      unitRef="usd">-330865000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIyLTEtMS0xLTA_10135f5d-a4f1-4da8-be37-aba8f23a1197"
      unitRef="usd">2956295000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIyLTMtMS0xLTA_eb1ea61c-c4d0-412c-b4f2-eeb96e6345f3"
      unitRef="usd">1145226000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIyLTUtMS0xLTA_559e0845-c139-4b8e-b9cc-34f7f1c2ff48"
      unitRef="usd">1227709000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIzLTEtMS0xLTA_d16124fc-190e-4f0f-a8c8-cb0d8e236444"
      unitRef="usd">1137129000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIzLTMtMS0xLTA_c228622d-de6c-4e05-b520-43ac77b93cb3"
      unitRef="usd">993181000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzIzLTUtMS0xLTA_12ddf956-1b1b-4e7c-86be-54be365d368c"
      unitRef="usd">783373000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI0LTEtMS0xLTA_367fe69f-4fd4-47a2-84be-94d5956acae0"
      unitRef="usd">214686000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI0LTMtMS0xLTA_68a61d06-94d7-4b7a-a0e4-79a845cb8d23"
      unitRef="usd">168654000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI0LTUtMS0xLTA_48daff39-d2f3-4118-994a-fdacf26edc8a"
      unitRef="usd">177008000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI1LTEtMS0xLTA_f4db957f-bb4e-4dd5-8703-495add146252"
      unitRef="usd">67448000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI1LTMtMS0xLTA_b82cb143-984a-4597-a40d-d888ba0c0bc6"
      unitRef="usd">31554000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI1LTUtMS0xLTA_2e431783-1220-4e3f-8207-664568a8df62"
      unitRef="usd">105766000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI2LTEtMS0xLTA_abbccc1e-65fd-4c63-baf1-237f6495cde5"
      unitRef="usd">-1671928000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI2LTMtMS0xLTA_9c7f854c-ded8-44bb-bd57-63a8f45a5e94"
      unitRef="usd">-14945000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI2LTUtMS0xLTA_a1888073-401b-41ce-bb96-c7202fbbad4c"
      unitRef="usd">-373094000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI4LTEtMS0xLTA_82f27c2e-fd77-442f-b2c1-caf4cff9f30e"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI4LTMtMS0xLTA_ccce2062-3637-4fbb-8d0f-3b19adae833f"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI4LTUtMS0xLTA_a0e3e864-640c-43a8-8d5f-ba27f0d7cc19"
      unitRef="usd">661111000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI5LTEtMS0xLTA_08d13a07-b6e5-46a3-9a43-eae366071692"
      unitRef="usd">1852725000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI5LTMtMS0xLTA_8e6b4259-774f-435b-9291-2ca63580aec3"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzI5LTUtMS0xLTA_fc66f5c3-46ec-4686-83ab-03a4a9305a83"
      unitRef="usd">563026000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMwLTEtMS0xLTA_69e0d3f0-0160-4de0-9769-722d3540a13b"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock>
    <us-gaap:PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMwLTMtMS0xLTA_c8da560b-6d85-4ec0-9394-7ced8d3d84c0"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock>
    <us-gaap:PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMwLTUtMS0xLTA_93b7484f-7757-449f-b629-df4a315a4d64"
      unitRef="usd">8182000</us-gaap:PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMyLTEtMS0xLTA_3185d22a-ad53-48ec-beed-4e3d278dd1ed"
      unitRef="usd">179643000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMyLTMtMS0xLTA_9fa0aee8-8211-489f-8533-266efbf59cf7"
      unitRef="usd">47259000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMyLTUtMS0xLTA_a8c0e64e-80a9-4274-b106-e63ec4770d60"
      unitRef="usd">1427000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMzLTEtMS0xLTA_4de82dee-fe88-4ffb-84ea-173079632735"
      unitRef="usd">7040000</us-gaap:ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans>
    <us-gaap:ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMzLTMtMS0xLTA_e6a83d74-b258-4239-ad27-286db9a4f688"
      unitRef="usd">2891000</us-gaap:ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans>
    <us-gaap:ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzMzLTUtMS0xLTA_579da897-bec3-4465-a4c2-c8cd8999d9f5"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans>
    <mrna:ChargesToFinancingLeaseLiabilities
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM0LTEtMS0xLTA_1da23b5c-b479-48a6-ae25-7615e11e54a1"
      unitRef="usd">-6215000</mrna:ChargesToFinancingLeaseLiabilities>
    <mrna:ChargesToFinancingLeaseLiabilities
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM0LTMtMS0xLTA_a5d0a8ad-0e16-4d0f-8991-4a489d9e98f8"
      unitRef="usd">971000</mrna:ChargesToFinancingLeaseLiabilities>
    <mrna:ChargesToFinancingLeaseLiabilities
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM0LTUtMS0xLTA_03c07454-0cc6-4b97-981f-8a4e94a5f609"
      unitRef="usd">0</mrna:ChargesToFinancingLeaseLiabilities>
    <mrna:ReimbursementOfAssetsFromLeaseFinancingObligation
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM1LTEtMS0xLTA_9fbbac99-b0cd-4683-9141-75bef6f294e5"
      unitRef="usd">0</mrna:ReimbursementOfAssetsFromLeaseFinancingObligation>
    <mrna:ReimbursementOfAssetsFromLeaseFinancingObligation
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM1LTMtMS0xLTA_378924db-9fa4-484c-ad13-fdd9932852d9"
      unitRef="usd">0</mrna:ReimbursementOfAssetsFromLeaseFinancingObligation>
    <mrna:ReimbursementOfAssetsFromLeaseFinancingObligation
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM1LTUtMS0xLTA_0cd7760d-bd5e-4de4-8343-c995e34d384c"
      unitRef="usd">11635000</mrna:ReimbursementOfAssetsFromLeaseFinancingObligation>
    <mrna:PaymentsForLeaseFinancingObligation
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM2LTEtMS0xLTA_cb1cbec2-8d3d-4cd1-b304-dbe378995d9f"
      unitRef="usd">0</mrna:PaymentsForLeaseFinancingObligation>
    <mrna:PaymentsForLeaseFinancingObligation
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM2LTMtMS0xLTA_440bac19-945e-4c65-ae98-5523a9670029"
      unitRef="usd">0</mrna:PaymentsForLeaseFinancingObligation>
    <mrna:PaymentsForLeaseFinancingObligation
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM2LTUtMS0xLTA_05abe876-92fe-464d-9309-40407d616bea"
      unitRef="usd">2175000</mrna:PaymentsForLeaseFinancingObligation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM3LTEtMS0xLTA_8f4a66cb-67dc-41b2-afc4-4d8df58d53f8"
      unitRef="usd">2033193000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM3LTMtMS0xLTA_ea7e0dfd-a9fa-4853-b9b1-f09d7bed3934"
      unitRef="usd">51121000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM3LTUtMS0xLTA_8c3d6063-0331-42ba-a11a-e84026be8b86"
      unitRef="usd">1226842000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM4LTEtMS0xLTA_e92a6175-2d4a-4cf4-aa26-d2a424608834"
      unitRef="usd">2388236000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM4LTMtMS0xLTA_8c55016d-b4ea-49e8-8740-98088077dfc3"
      unitRef="usd">-422792000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM4LTUtMS0xLTA_4c8e0f47-0567-412d-8337-2664d1b58c8b"
      unitRef="usd">522883000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM5LTEtMS0xLTA_4f12d6d8-fc17-457b-bff9-d10aee8ae198"
      unitRef="usd">247699000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i20204b229a394d9ba8b28882826012db_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM5LTMtMS0xLTA_2fb949aa-b129-41e6-a04d-ae839fa8c863"
      unitRef="usd">670491000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i857b3ef318484e959ca8a3dddeb3a486_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzM5LTUtMS0xLTA_9ddaf37a-418e-4b13-9f77-e95d8ce4c3f5"
      unitRef="usd">147608000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQwLTEtMS0xLTA_5f1b0795-fa17-4052-b5e7-5c601d51a740"
      unitRef="usd">2635935000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQwLTMtMS0xLTA_c41640ad-acac-4379-9def-8718b7c41d6e"
      unitRef="usd">247699000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i20204b229a394d9ba8b28882826012db_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQwLTUtMS0xLTA_29204ecc-6d64-4eaa-8070-645c9beb2ef7"
      unitRef="usd">670491000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQyLTEtMS0xLTA_0a63be42-164b-45fb-a88a-c694c256d280"
      unitRef="usd">572000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQyLTMtMS0xLTA_37f81e3c-3ba9-49e3-b4a3-fbc3ac6cc415"
      unitRef="usd">416000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQyLTUtMS0xLTA_4d546c98-ae5a-4af4-b329-f26f4ebd1f7e"
      unitRef="usd">294000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQzLTEtMS0xLTA_2454e999-743a-43f9-ad20-4e94b6e9cbf8"
      unitRef="usd">8528000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQzLTMtMS0xLTA_3605ccdc-c80c-4f28-ac9c-b7e0ccef8501"
      unitRef="usd">5585000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQzLTUtMS0xLTA_2522514a-7cda-4e28-b5c6-74119b80964e"
      unitRef="usd">2998000</us-gaap:InterestPaidNet>
    <mrna:StockIssuanceCostsIncurredButNotYetPaid
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ1LTEtMS0xLTA_0adcbcc5-bf83-4acc-a47f-0c3e2a45484e"
      unitRef="usd">0</mrna:StockIssuanceCostsIncurredButNotYetPaid>
    <mrna:StockIssuanceCostsIncurredButNotYetPaid
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ1LTMtMS0xLTA_8c363df8-4564-4a81-becf-4c881b61bd43"
      unitRef="usd">0</mrna:StockIssuanceCostsIncurredButNotYetPaid>
    <mrna:StockIssuanceCostsIncurredButNotYetPaid
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ1LTUtMS0xLTA_246830ba-5f4d-48f3-9d75-8b4639e2dd0f"
      unitRef="usd">2638000</mrna:StockIssuanceCostsIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ2LTEtMS0xLTA_b5f304ba-7bb6-4f5f-8927-9cc02e72eae7"
      unitRef="usd">17617000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ2LTMtMS0xLTA_dbad3c3b-970c-4e18-b2ae-5d0f360f50f9"
      unitRef="usd">4676000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ2LTUtMS0xLTA_11f17ab1-d088-4a9f-9048-80046b6fa06f"
      unitRef="usd">12892000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <mrna:LeaseholdImprovementsIncurredButNotYetReimbursed
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ3LTEtMS0xLTA_4ce6e6f5-0a09-4a2b-99ea-6ca6fbfa324a"
      unitRef="usd">0</mrna:LeaseholdImprovementsIncurredButNotYetReimbursed>
    <mrna:LeaseholdImprovementsIncurredButNotYetReimbursed
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ3LTMtMS0xLTA_bae3f196-9a59-4ca7-9450-58f4c84473dd"
      unitRef="usd">0</mrna:LeaseholdImprovementsIncurredButNotYetReimbursed>
    <mrna:LeaseholdImprovementsIncurredButNotYetReimbursed
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ3LTUtMS0xLTA_93a2cde4-de93-43bc-8046-3cd6352c920c"
      unitRef="usd">10089000</mrna:LeaseholdImprovementsIncurredButNotYetReimbursed>
    <mrna:LeaseFinancingObligationsIncurred
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ4LTEtMS0xLTA_2c27417b-62f7-4aea-ba4b-07a988615508"
      unitRef="usd">0</mrna:LeaseFinancingObligationsIncurred>
    <mrna:LeaseFinancingObligationsIncurred
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ4LTMtMS0xLTA_2e18212c-2cdc-42fd-afa7-c78c3e64df44"
      unitRef="usd">0</mrna:LeaseFinancingObligationsIncurred>
    <mrna:LeaseFinancingObligationsIncurred
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzAvZnJhZzpkYjcyM2YxMjAyYTI0ZjczOWUzZDM1ZmRjMDljMWNiMC90YWJsZTozN2ZlMzg5NTA3ZmE0N2YxODAyM2MwZGJkNDg4YmU2MC90YWJsZXJhbmdlOjM3ZmUzODk1MDdmYTQ3ZjE4MDIzYzBkYmQ0ODhiZTYwXzQ4LTUtMS0xLTA_2518ef19-2a6a-40d8-a9d7-ce9b1a23e4e7"
      unitRef="usd">10089000</mrna:LeaseFinancingObligationsIncurred>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzM3NTY_33735080-3de5-4fe0-a2f1-3b7aac2b189c">Organization and Description of Business&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Moderna, Inc. (collectively, with its consolidated subsidiaries, any of Moderna, we, us, or the Company) was incorporated in Delaware on July&#160;22, 2016. We are the successor in interest to Moderna LLC, a limited liability company formed under the laws of the State of Delaware in 2013. Our principal executive office is located at 200 Technology Square, Cambridge,&#160;MA. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a biotechnology company creating a new generation of transformative medicines based on messenger RNA (mRNA), to improve the lives of patients. mRNA medicines are designed to direct the body&#x2019;s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Our platform builds on continuous advances in basic and applied mRNA science, delivery technology, and manufacturing, providing us the capability to pursue in parallel a robust pipeline of new development candidates.&#160;We are developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with our strategic collaborators.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, we received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and an Interim Order from Health Canada authorizing the Moderna COVID-19 vaccine (also referred to as mRNA-1273) in the U.S. and Canada.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since inception, we have incurred significant net losses, which were $747.1 million, $514.0 million, and $384.7 million for the years ended December 31, 2020, 2019 and 2018, respectively. On February 14, 2020 and May 21, 2020, we sold 30,263,158 and 17,600,000 shares of common stock at a price of $19.00 and $76.00 per share through public equity offerings, with aggregate net proceeds from the offering of $549.5&#160;million and $1.30&#160;billion, respectively, net of underwriting discounts, commissions and offering expenses. As of December 31, 2020, we had an accumulated deficit of $2.24 billion. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, we had 21 mRNA development programs in our portfolio with 13 having entered the clinic. We expect to continue to incur significant expenses for the foreseeable future. If we seek to obtain regulatory approval for any of our investigational medicines, we expect to incur significant commercialization expenses. In addition, we anticipate that our expenses will increase significantly in connection with our development and commercializing our mRNA-1273 vaccine and ongoing activities to support our platform research, drug discovery and clinical development, including development of any new generations of vaccines against variants of SARS-CoV-2, infrastructure and Research Engine and Early Development Engine (which includes our Moderna Technology Center), digital infrastructure, creation of a portfolio of intellectual property, and administrative support. We may finance our future cash needs that exceed our operating costs through a combination of public or private equity offerings, structured financings and debt financings, government funding arrangements, strategic alliances and marketing, manufacturing, distribution and licensing arrangements. We may be unable to raise additional funds or enter into such other agreements on favorable terms, or at all.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe that our cash, cash equivalents, and investments as of&#160;December 31, 2020&#160;will be sufficient to enable us to fund our projected operations through at least the next 12&#160;months from the issuance of our financial statements. We are subject to numerous risks and uncertainties associated with pharmaceutical development and commercialization, and we are unable to predict the timing or amount of expenses or when or if we will be able to achieve or maintain profitability. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce our operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzEwODI_2fedcd5d-6da1-4e6d-b38d-da4403002c5d"
      unitRef="usd">-747100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzEwODY_5898d99f-04de-4037-ba32-128126f6a2c1"
      unitRef="usd">-514000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzEwOTQ_6ab79c2e-fa94-43ce-86fd-7766c2254e9f"
      unitRef="usd">-384700000</us-gaap:NetIncomeLoss>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i55d13e25166e42e0b68e9e232828cab2_D20200214-20200214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAxNTU_94041882-64d8-46a5-987a-bf36825be273"
      unitRef="shares">30263158</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i6566041abeee45e59cb8ea4c0287e489_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAxNjc_4a88818c-373d-4372-9397-624128fa5055"
      unitRef="shares">17600000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="id2137fd0894d40d79052cb2714afe3e4_I20200214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAxNzk_bf03e4e1-1f77-43ba-b14c-102eaae83fa0"
      unitRef="usdPerShare">19.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i7205067242fc4eb0a524f10be89aa910_I20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAxODc_5167ded2-5554-4122-b48c-7a84acc50d89"
      unitRef="usdPerShare">76.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i55d13e25166e42e0b68e9e232828cab2_D20200214-20200214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAxOTU_31932363-f7e8-4630-9199-bc76f08312d9"
      unitRef="usd">549500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i6566041abeee45e59cb8ea4c0287e489_D20200521-20200521"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzk4OTU2MDQ2NjAyMTE_60cd7e8d-803e-47a2-9bf6-e79d0c31c621"
      unitRef="usd">1300000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzEzOTM_aafac71e-142a-41fe-9f4d-caad676848af"
      unitRef="usd">-2240000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <mrna:NumberOfDevelopmentProgram
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzYvZnJhZzo4YWU3YTA0YTJjOGI0N2FhOGZkYTllNDdmMjE3ODhmZi90ZXh0cmVnaW9uOjhhZTdhMDRhMmM4YjQ3YWE4ZmRhOWU0N2YyMTc4OGZmXzQ5NDc4MDIzNTY1ODc_2daf2603-50c4-442a-af1f-c6cf075f4d40"
      unitRef="program">21</mrna:NumberOfDevelopmentProgram>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzIz_7e7b2a19-6420-4ddb-9845-c8298663d3a8">Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP). Any reference in these notes to applicable guidance is meant to refer to the authoritative accounting principles generally accepted in the United States as found in the Accounting Standard Codification (ASC) and Accounting Standards Updates (ASU) of the&#160;Financial Accounting Standards Board (FASB).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have made estimates and judgments affecting the amounts reported in our consolidated financial statements and the accompanying notes. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, research and development expenses, income tax provisions, stock-based compensation, leases, derivative financial instruments, inventory, and useful lives of long-lived assets. We base our estimates on historical experience and various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The actual results that we experience may differ materially from our estimates. Significant estimates relied upon in preparing these financial statements include, among others, those related to fair value of equity awards, revenue recognition, research and development expenses, leases, fair value of financial instruments, useful lives of property and equipment, income taxes, and our valuation allowance on our deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have determined that our chief executive officer is the chief operating decision maker (CODM). The CODM reviews financial information presented on a consolidated basis. Resource allocation decisions are made by the CODM based on consolidated results. There are no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels or components below the consolidated unit level. As such, we have concluded that we operate as one segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2019, we adopted ASC 606&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) using the modified retrospective transition method applied to those contracts which were not completed as of January 1, 2019. We recognized the cumulative effect of the adoption as an adjustment to the opening balance of accumulated deficit in the current period consolidated balance sheet. Results for reporting periods beginning after January 1, 2019 are presented under ASC 606, while prior period amounts have not been adjusted and continue to be reported in accordance with our historic accounting (ASC 605). ASC 606 applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the appropriate amount of revenue to be recognized for arrangements that we determine are within the scope of ASC 606, we perform the following five steps (the five-step model): (i) identify the contract(s) with our customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when or as each performance obligation is satisfied. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is primarily generated through grants from government-sponsored and private organizations, product sales and collaboration arrangements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Grant Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have contracts with Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS); the U.S. government&#x2019;s Defense Advanced Research Projects Agency (DARPA); the Bill &amp;amp; Melinda Gates Foundation (Gates Foundation) and other government-sponsored and private organizations for research and development related activities that provide for payments for reimbursed costs, which may include overhead and general and administrative costs as well as a related profit margin. We recognize revenue from these contracts as we perform services under these arrangements when the funding is committed. Associated expenses are recognized when incurred as research and development expense. Revenues and related expenses are presented gross in the consolidated statements of operations as we have determined we are the primary obligor under the arrangements relative to the research and development services we perform as lead technical expert.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Collaboration Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for a contract with a customer that is within the scope of ASC 606 using the five-step model. We account for a contract with a customer that is within the scope of ASC 606 when all of the following criteria are met: (i) the arrangement has been approved by the parties and the parties are committed to perform their respective obligations; (ii) each party&#x2019;s rights regarding the &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;goods and/or services to be transferred can be identified; (iii) the payment terms for the goods and/or services to be transferred can be identified; (iv) the arrangement has commercial substance; and (v) collection of substantially all of the consideration to which we will be entitled in exchange for the goods and/or services that will be transferred to the customer is probable. We also determine the term of the contract based on the period in which we and our customer have present and enforceable rights and obligations for purposes of identifying the performance obligations and determining the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate contracts that contain multiple promises to determine which promises are distinct. Promises are considered to be distinct and therefore, accounted for as separate performance obligations, provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer and (ii) the promise to transfer the good or service to the customer is separately identifiable from other promises in the contract.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Individual goods or services (or bundles of goods and/or services) that meet both criteria for being distinct are accounted for as separate performance obligations. Promises that are not distinct at contract inception are combined and accounted for as a single performance obligation. Options to acquire additional goods and/or services are evaluated to determine if such option provides a material right to the customer that it would not have received without entering into the contract. If so, the option is accounted for as a separate performance obligation. If not, the option is considered a marketing offer which would be accounted for as a separate contract upon the customer&#x2019;s election.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price is generally comprised of an upfront payment due at contract inception and variable consideration in the form of payments for our services and materials and milestone payments due upon the achievement of specified events. Other payments the Company could be entitled to include tiered royalties earned when customers recognize net sales of licensed products.&#160;We measure the transaction price based on the amount of consideration to which we expect to be entitled in exchange for transferring the promised goods and/or services to the customer. We utilize either the expected value method or the most likely amount method to estimate the amount of variable consideration, depending on which method is expected to better predict the amount of consideration to which we will be entitled. Amounts of variable consideration are included in the transaction price to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to arrangements that include payments for a development or regulatory milestone payment, we evaluate whether the associated event is considered probable of achievement and estimate the amount to be included in the transaction price using the most likely amount method. Milestone payments that are not within our control or the licensee, such as those dependent upon receipt of regulatory approval, are not considered to be probable of achievement until the triggering event occurs. At the end of each reporting period, we re-evaluate the probability of achievement of each milestone and any related constraint, and if necessary, adjust our estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment. For arrangements that include sales-based royalties, including milestone payments based upon the achievement of a certain level of product sales, wherein the license is deemed to be the sole or predominant item to which the payments relate, we recognize revenue upon the later of: (i) when the related sales occur or (ii) when the performance obligation to which some or all of the payment has been allocated has been satisfied (or partially satisfied). Consideration that would be received for optional goods and/or services is excluded from the transaction price at contract inception. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally allocate the transaction price to each performance obligation based on a relative standalone selling price basis. We develop assumptions that require judgment to determine the standalone selling price for each performance obligation in consideration of applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated research and development costs. However, in certain instances, we allocate variable consideration entirely to one or more performance obligation if the terms of the variable consideration relate to the satisfaction of the respective performance obligation and the amount allocated is consistent with the amount we would expect to receive for the satisfaction of the respective performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue based on the amount of the transaction price that is allocated to each respective performance obligation when or as the performance obligation is satisfied by transferring a promised good or service to the customer. For performance obligations that are satisfied at a point in time, we recognize revenue when control of the goods and/or services is transferred to the customer. For performance obligations that are satisfied over time, we recognize revenue by measuring the progress toward complete satisfaction of the performance obligation using a single method of measuring progress which depicts the performance in transferring control of the associated goods and/or services to the customer. We generally use input methods to measure the progress toward the complete satisfaction of performance obligations satisfied over time. With respect to arrangements containing a license to our intellectual property that is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from amounts allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, we utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. Significant management judgment is required in &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;determining the level of effort required under an arrangement and the period over which we are expected to complete our performance obligations under an arrangement. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Product Sales &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product sales are associated with our COVID-19 vaccine supply agreements with the U.S. Government and international government agencies. These agreements generally do not provide provisions for various forms of variable consideration, such as discounts, rebates or returns. We recognize revenue from product sales, using the five-step model under ASC 606, based on the fixed price per dose according to the contracts when control of the product transfers to the customer and customer acceptance has occurred, unless such acceptance provisions are deemed perfunctory. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all highly liquid investments with an original maturity of 90&#160;days or less from the date of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash is composed of amounts held on deposit related to our lease arrangements. The funds are maintained in money market accounts and are recorded at fair value. We classify our restricted cash as either current or non-current based on the terms of the underlying lease arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash shown in the Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, non-current &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash shown in the consolidated&lt;br/&gt;    statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,635,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We invest our excess cash balances in marketable debt securities. We classify our investments in marketable debt securities as available-for-sale. We report available-for-sale investments at fair value at each balance sheet date, and include any unrealized holding gains and losses (the adjustment to fair value) in accumulated other comprehensive gain (loss), a component of stockholders&#x2019; equity. Realized gains and losses are determined using the specific-identification method, and are included in other (expense) income, net in our consolidated statements of operations. We classify our available-for-sale marketable securities as current or non-current based on each instrument&#x2019;s underlying effective maturity date and for which we have the intent and ability to hold the investment for a period of greater than 12 months. Marketable securities with maturities of less than 12&#160;months are classified as current and are included in investments in the consolidated balance sheets. Marketable securities with maturities greater than 12&#160;months for which we have the intent and ability to hold the investment for greater than 12 months are classified as non-current and are included in investments, non-current in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate securities for impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and our intent and ability to hold the investment to allow for an anticipated recovery in fair value. A credit-related impairment is recognized as an allowance on the balance sheet with a corresponding adjustment to earnings. Any impairment that is not credit- related is recognized in other comprehensive (loss) income, net of applicable taxes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have accounts receivable amounts due from our product sales and related vaccine supply agreements and our grant agreements. We also have accounts receivable amounts due from strategic collaborators as a result of manufacturing and research and development services provided under collaboration arrangements, or milestones achieved, but not yet paid. Amounts payable to us are recorded as accounts receivable when our right to consideration is unconditional. To estimate the allowance for doubtful accounts, we make judgments about the creditworthiness of our customers based on ongoing credit evaluation and historical experience. There was no allowance for doubtful accounts at December 31, 2020, and 2019. There was no bad debt expense for the years ended December 31, 2020, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that subject us to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, marketable securities, and accounts receivable. Our investment portfolio comprises money market funds, marketable debt securities, including U.S. Treasury securities, debt securities of U.S. government agencies and corporate entities and commercial paper. Our cash management and investment policy limits investment instruments to investment-grade securities with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations. Bank accounts in the United States are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. Our primary operating accounts significantly exceed the FDIC limits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Customers&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accounts receivable are generally unsecured and are from customers in different countries. We generated revenue from grants made by government-sponsored and private organizations, product sales to the U.S. Government and international government agencies, and to a lesser extent, strategic alliances in 2020. Historically, we generated revenue primarily from strategic alliances. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A significant portion of our revenue to date has been generated from the following entities that accounted for more than 10% of total revenue and accounts receivable for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.933%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Percentage&#160;of&#160;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years&#160;Ended&#160;December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Percentage&#160;of&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accounts&#160;Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merck&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BARDA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vertex&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AstraZeneca&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government (excluding BARDA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;European Commission&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United Kingdom Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;South Korea Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;* - Represents an amount of less than 10%&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We record all derivatives on our consolidated balance sheets at fair value. The accounting for changes in the fair value of a derivative depends on whether the derivative has been designated and qualifies for hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. We may enter into derivative contracts that are intended to economically hedge certain risk, even though hedge accounting does not apply or we elect not to apply hedge accounting. Foreign currency gains or losses associated with derivatives that are not designated as hedging instruments for accounting purposes are recorded within other (expense) income, net, in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as risks inherent in valuation techniques, transfer restrictions and credit risk. FASB ASC Topic&#160;820,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC&#160;820), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and our assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from our independent sources. Unobservable inputs are inputs that reflect our assumptions about the inputs that market participants would use in pricing the asset or liability, and are developed based on the best information available in the circumstances. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used to value the assets and liabilities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level&#160;2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e.,&#160;supported by little or no market activity).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cash equivalents and marketable securities are reported at fair value determined using Level&#160;1 and Level&#160;2 inputs (Note&#160;6). The fair value of our foreign currency forward contracts is calculated using Level 2 inputs, which include currency spot rates, forward rates, interest rate curve and credit or non-performance risk (Note 7). We do not have any non-financial assets or liabilities that should be recognized or disclosed at fair value on a recurring basis at December 31, 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020 and 2019, we maintain letters of credit of $12.1 million and $11.8 million, respectively, related to our lease arrangements, which are secured by money market accounts in accordance with certain of our lease agreements. The amounts are recorded at fair value using Level 1 inputs and included as restricted cash in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is recorded at the lower of cost or net realizable value, with cost determined on a first-in, first-out (FIFO) basis. We periodically review the composition of inventory in order to identify excess, obsolete, slow-moving or otherwise unsaleable items. If unsaleable items are observed and there are no alternate uses for the inventory, we will record a write-down to net realizable value in the period that the decline in value is first recognized through a charge to cost of sales. The determination of whether inventory costs will be realizable requires estimates by management. If actual market conditions are less favorable than projected by management, additional write-downs of inventory may be required.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to an initial regulatory approval for our investigational medicines, we expense costs relating to raw materials and production of inventory as research and development expense in our consolidated statements of operations, in the period incurred. When we believe regulatory approval and subsequent commercialization of our investigational medicines is probable, and we also expect future &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;economic benefit from the sales of the investigational medicines to be realized, we will then capitalize the costs of production as inventory. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the authorization of distribution and use of our COVID-19 vaccine under an EUA in December 2020, we began to capitalize inventory costs associated with our COVID-19 vaccine, as it was determined that inventory costs incurred subsequent to the EUA had a probable future economic benefit. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Construction in Progress&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction in progress includes direct costs related to the construction of various property and equipment, including leasehold improvements, and is stated at original cost. Construction in progress includes costs incurred under construction contracts including project management services, engineering services, design services and development, construction services and other construction-related fees and services. Such costs are not depreciated until the asset is completed and placed into service. Once the asset is placed into service, these capitalized costs will be allocated to certain property and equipment categories and will be depreciated over the estimated useful life of the underlying assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of property and equipment are described below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.552%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&#160;Useful&#160;Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lesser&#160;of&#160;estimated&#160;useful&#160;life&#160;of&#160;improvement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or&#160;remaining life of related lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset, financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for maintenance and repairs are charged to expense as incurred. Upon retirement or sale, the cost of the assets disposed of, and the related accumulated depreciation, are removed from the accounts, and any resulting gain or loss is recorded to other (expense) income, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate our long-lived assets, which consist of property and equipment, to determine if facts and circumstances indicate that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess the recoverability of the long-lived assets by comparing the projected future undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. If such review indicates that such cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair values based on the expected discounted future cash flows attributable to the assets or based on appraisals. For the year ended December 31, 2020, we incurred $1.6&#160;million of impairment expenses. We did not record any impairment expenses for the years ended December 31,2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted ASC 842 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) on January 1, 2019 on a modified retrospective basis under which we recognized and measured leases existing at, or entered into after, the beginning of the period of adoption. We elected the optional transition approach of not adjusting our comparative period financial statements for the impacts of adoption. Therefore, we recognized the effects of applying ASC 842 as a cumulative-effect adjustment to accumulated deficit as of January 1, 2019, the effective date of this standard. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases are classified at their commencement date, which is defined as the date on which the lessor makes the underlying asset available for use by the lessee, as either operating or finance leases based on the economic substance of the agreement. We recognize lease right-of-use assets and related liabilities in our consolidated balance sheets for both operating and finance leases. Lease liabilities are measured at the lease commencement date as the present value of the future lease payments using the interest rate implicit in the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lease. If the rate implicit is not readily determinable, we will utilize our incremental borrowing rate as of the lease commencement date. Lease right-of-use assets are measured as the lease liability plus initial direct costs and prepaid lease payments less lease incentives. The lease term is the non-cancelable period of the lease and includes options to extend or terminate the lease when it is reasonably certain that an option will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize operating lease cost in operating expense in our consolidated statements of operations, inclusive of rent escalation provisions and rent holidays, on a straight-line basis over the respective lease term. For our finance leases, we recognize depreciation expense associated with the leased asset acquired and recognize interest expense related to the portion of the financing in our consolidated statements of operations. Additionally, we recognize tenant improvement allowances as a reduction to rent expense on a straight-line basis over the respective lease term. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of sales includes cost of raw materials, production, transportation, freight and indirect overhead costs associated with our product revenue during the period and third-party royalties on net sales of our product. Cost of sales also includes adjustments for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred in performing research and development activities, including salaries and benefits, facilities costs, overhead costs, prelaunch inventory costs, contract services, and other outside costs. The value of goods and services received from contract research organizations and contract manufacturing organizations in the reporting period are estimated based on the level of services performed, and progress in the period in cases when we have not received an invoice from the supplier. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment or facilities that are acquired or constructed for research and development activities and that have alternative future uses, in research and development projects or otherwise, should be capitalized and depreciated as tangible assets. However, the costs of equipment or facilities that are acquired or constructed and intangibles that are purchased from others for a particular research and development project and that have no alternative future uses and therefore no separate economic values are considered research and development costs and are expensed when incurred. Certain equipment and leased facilities purchased for our COVID-19 vaccine program prior to the EUA from the FDA were deemed to have no alternative use. The related acquisition costs of such equipment and lease facilities of $109.6&#160;million were charged to research and development expense for the year ended December 31, 2020. We did not recognize such expense for the years ended December 31, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Patent Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs to secure, defend and maintain patents are expensed as incurred, and are classified as selling, general and administrative expenses due to the uncertainty of future benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We issue stock-based awards to employees and non-employees, generally in the form of stock options and restricted stock units (RSUs). We account for our stock-based compensation awards in accordance with ASC 718,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Most of our stock-based awards have been made to employees. We measure compensation cost for equity awards at their grant-date fair value and recognize compensation expense over the requisite service period, which is generally the vesting period, on a straight-line basis. The grant date fair value of stock options is estimated using the Black-Scholes option pricing model, which requires management to make assumptions with respect to the fair value of our common stock on the grant date, including the expected term of the award, the expected volatility of our stock, calculated based on a period of time generally commensurate with the expected term of the award, risk-free interest rates and expected dividend yields of our stock. Historically, for periods prior to our IPO, the fair value of the shares of common stock and common units underlying our stock-based awards were determined on each grant date by our board of directors based on valuation estimates from management considering our most recently available independent third-party valuation of our common stock. Our board of directors also assessed and considered, with input from management, additional objective and subjective factors that we believed were relevant and which may have changed from the date of the most recent valuation through the grant date. The grant date fair value of RSUs is estimated based on the fair value of our underlying common stock. For performance-based stock awards, we recognize stock-based compensation expense over the requisite service period using the accelerated attribution method when achievement is probable. We classify stock-based compensation expense in our consolidated statement of operations in the same manner in which the award recipient&#x2019;s salary and related costs are classified or in which the award recipient&#x2019;s service payments are classified.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use an asset and liability approach to account for income taxes. We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. These differences are measured using the enacted statutory tax rates that are expected to be in effect for the years in which differences are expected to reverse. Valuation allowances are provided when the expected realization of deferred tax assets does not meet a &#x201c;more likely than not&#x201d; criterion. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss. We recognize tax benefits from uncertain tax positions if we believe the position is more likely than not to be sustained on examination by the taxing authorities based on the technical merits of the position. We make adjustments to these reserves when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. The provision for income taxes includes the effects of any reserves for tax positions that are not more likely than not to be sustained, as well as the related net interest and penalties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period, without consideration for common stock equivalents. Upon the closing of our IPO, all outstanding shares of our redeemable convertible preferred stock were converted into common stock. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate diluted net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding after giving consideration to the dilutive effect of restricted common stock and stock options that are outstanding during the period. We have generated a net loss in all periods presented, therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss includes net loss and other comprehensive income (loss) for the period. Other comprehensive income (loss) mainly consists of unrealized gains and losses on our investments. Total comprehensive income (loss) for all periods presented have been disclosed in the consolidated statements of comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive gain (loss) for the years ended December 31, 2020 and 2019 are as follows (in thousands):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&#160;Gain on Available-for-Sale Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss, balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive gain, balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive gain, balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard changes how companies account for credit losses for most financial assets and certain other instruments. For trade receivables, loans and held-to-maturity debt securities, companies will be required to recognize an allowance for credit losses rather than reducing the carrying value of the asset. The amendments in this standard should be applied on a modified retrospective basis to all periods presented. We adopted this standard in the first quarter of 2020. Based on the composition of our investment portfolio and investment policy, the adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Topic 350): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard requires capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). We adopted this standard in the first quarter of 2020 using the prospective method. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard removes certain exceptions for investments, intra-period allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. We early adopted this standard in the second quarter of 2020. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjcz_be356195-438b-4a30-be33-02b05bc3ac13">Our consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP). Any reference in these notes to applicable guidance is meant to refer to the authoritative accounting principles generally accepted in the United States as found in the Accounting Standard Codification (ASC) and Accounting Standards Updates (ASU) of the&#160;Financial Accounting Standards Board (FASB).The consolidated financial statements include the Company and its subsidiaries.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjYx_7760fdde-01d4-4deb-9ec6-9bd4b07b4dae">All intercompany transactions and balances have been eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjY0_295303f8-060a-44bc-b352-9920b8b377e9">We have made estimates and judgments affecting the amounts reported in our consolidated financial statements and the accompanying notes. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, research and development expenses, income tax provisions, stock-based compensation, leases, derivative financial instruments, inventory, and useful lives of long-lived assets. We base our estimates on historical experience and various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The actual results that we experience may differ materially from our estimates. Significant estimates relied upon in preparing these financial statements include, among others, those related to fair value of equity awards, revenue recognition, research and development expenses, leases, fair value of financial instruments, useful lives of property and equipment, income taxes, and our valuation allowance on our deferred tax assets.</us-gaap:UseOfEstimates>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjg1_a9da7040-f0ce-4df1-bb6d-727570a6b083">We have determined that our chief executive officer is the chief operating decision maker (CODM). The CODM reviews financial information presented on a consolidated basis. Resource allocation decisions are made by the CODM based on consolidated results. There are no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels or components below the consolidated unit level. As such, we have concluded that we operate as one segment.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzIzMzM_33c1901f-773d-444d-90f8-e99c4c291da3"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzI0_ebf7c6ee-4f18-4fe0-ada3-b8b770825c82">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2019, we adopted ASC 606&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) using the modified retrospective transition method applied to those contracts which were not completed as of January 1, 2019. We recognized the cumulative effect of the adoption as an adjustment to the opening balance of accumulated deficit in the current period consolidated balance sheet. Results for reporting periods beginning after January 1, 2019 are presented under ASC 606, while prior period amounts have not been adjusted and continue to be reported in accordance with our historic accounting (ASC 605). ASC 606 applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine the appropriate amount of revenue to be recognized for arrangements that we determine are within the scope of ASC 606, we perform the following five steps (the five-step model): (i) identify the contract(s) with our customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when or as each performance obligation is satisfied. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is primarily generated through grants from government-sponsored and private organizations, product sales and collaboration arrangements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Grant Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have contracts with Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS); the U.S. government&#x2019;s Defense Advanced Research Projects Agency (DARPA); the Bill &amp;amp; Melinda Gates Foundation (Gates Foundation) and other government-sponsored and private organizations for research and development related activities that provide for payments for reimbursed costs, which may include overhead and general and administrative costs as well as a related profit margin. We recognize revenue from these contracts as we perform services under these arrangements when the funding is committed. Associated expenses are recognized when incurred as research and development expense. Revenues and related expenses are presented gross in the consolidated statements of operations as we have determined we are the primary obligor under the arrangements relative to the research and development services we perform as lead technical expert.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Collaboration Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for a contract with a customer that is within the scope of ASC 606 using the five-step model. We account for a contract with a customer that is within the scope of ASC 606 when all of the following criteria are met: (i) the arrangement has been approved by the parties and the parties are committed to perform their respective obligations; (ii) each party&#x2019;s rights regarding the &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;goods and/or services to be transferred can be identified; (iii) the payment terms for the goods and/or services to be transferred can be identified; (iv) the arrangement has commercial substance; and (v) collection of substantially all of the consideration to which we will be entitled in exchange for the goods and/or services that will be transferred to the customer is probable. We also determine the term of the contract based on the period in which we and our customer have present and enforceable rights and obligations for purposes of identifying the performance obligations and determining the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate contracts that contain multiple promises to determine which promises are distinct. Promises are considered to be distinct and therefore, accounted for as separate performance obligations, provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer and (ii) the promise to transfer the good or service to the customer is separately identifiable from other promises in the contract.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Individual goods or services (or bundles of goods and/or services) that meet both criteria for being distinct are accounted for as separate performance obligations. Promises that are not distinct at contract inception are combined and accounted for as a single performance obligation. Options to acquire additional goods and/or services are evaluated to determine if such option provides a material right to the customer that it would not have received without entering into the contract. If so, the option is accounted for as a separate performance obligation. If not, the option is considered a marketing offer which would be accounted for as a separate contract upon the customer&#x2019;s election.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price is generally comprised of an upfront payment due at contract inception and variable consideration in the form of payments for our services and materials and milestone payments due upon the achievement of specified events. Other payments the Company could be entitled to include tiered royalties earned when customers recognize net sales of licensed products.&#160;We measure the transaction price based on the amount of consideration to which we expect to be entitled in exchange for transferring the promised goods and/or services to the customer. We utilize either the expected value method or the most likely amount method to estimate the amount of variable consideration, depending on which method is expected to better predict the amount of consideration to which we will be entitled. Amounts of variable consideration are included in the transaction price to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to arrangements that include payments for a development or regulatory milestone payment, we evaluate whether the associated event is considered probable of achievement and estimate the amount to be included in the transaction price using the most likely amount method. Milestone payments that are not within our control or the licensee, such as those dependent upon receipt of regulatory approval, are not considered to be probable of achievement until the triggering event occurs. At the end of each reporting period, we re-evaluate the probability of achievement of each milestone and any related constraint, and if necessary, adjust our estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment. For arrangements that include sales-based royalties, including milestone payments based upon the achievement of a certain level of product sales, wherein the license is deemed to be the sole or predominant item to which the payments relate, we recognize revenue upon the later of: (i) when the related sales occur or (ii) when the performance obligation to which some or all of the payment has been allocated has been satisfied (or partially satisfied). Consideration that would be received for optional goods and/or services is excluded from the transaction price at contract inception. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally allocate the transaction price to each performance obligation based on a relative standalone selling price basis. We develop assumptions that require judgment to determine the standalone selling price for each performance obligation in consideration of applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated research and development costs. However, in certain instances, we allocate variable consideration entirely to one or more performance obligation if the terms of the variable consideration relate to the satisfaction of the respective performance obligation and the amount allocated is consistent with the amount we would expect to receive for the satisfaction of the respective performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue based on the amount of the transaction price that is allocated to each respective performance obligation when or as the performance obligation is satisfied by transferring a promised good or service to the customer. For performance obligations that are satisfied at a point in time, we recognize revenue when control of the goods and/or services is transferred to the customer. For performance obligations that are satisfied over time, we recognize revenue by measuring the progress toward complete satisfaction of the performance obligation using a single method of measuring progress which depicts the performance in transferring control of the associated goods and/or services to the customer. We generally use input methods to measure the progress toward the complete satisfaction of performance obligations satisfied over time. With respect to arrangements containing a license to our intellectual property that is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from amounts allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, we utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. Significant management judgment is required in &lt;/span&gt;&lt;/div&gt;determining the level of effort required under an arrangement and the period over which we are expected to complete our performance obligations under an arrangement. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjgw_c8101d9b-05d9-4e8d-8b20-c7bd38286ed5">We consider all highly liquid investments with an original maturity of 90&#160;days or less from the date of purchase to be cash equivalents.</us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjgx_11f9b0e4-8332-46d0-b621-d766eb2e0729">Restricted cash is composed of amounts held on deposit related to our lease arrangements. The funds are maintained in money market accounts and are recorded at fair value. We classify our restricted cash as either current or non-current based on the terms of the underlying lease arrangement.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzEwNDQ1MzYwNjczNzI3_07e301d8-766f-432c-8b12-051fa91b94c8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, non-current &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash shown in the consolidated&lt;br/&gt;    statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,635,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzEwNDQ1MzYwNjczNzI3_39db6d09-5365-4bf5-8ffb-290371b66b1d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.521%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,623,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash, non-current &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash shown in the consolidated&lt;br/&gt;    statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,635,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzItMi0xLTEtNzk1MQ_514cf3a2-f62f-4ba4-acf7-32115fcf82af"
      unitRef="usd">2623850000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzItNC0xLTEtNzk1MQ_7ebe46cf-75be-42b2-9e2e-b2f28761802c"
      unitRef="usd">235876000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzMtMi0xLTEtNzk1MQ_d11d9686-ef55-4ca3-96a5-769bb566134d"
      unitRef="usd">1032000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzMtNC0xLTEtNzk1MQ_9339a6ec-2a3f-4efa-8c28-3cd683c42e0c"
      unitRef="usd">1032000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzQtMi0xLTEtNzk1MQ_a8ba823b-c07c-4a22-b718-087f537f0a0f"
      unitRef="usd">11053000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzQtNC0xLTEtNzk1MQ_54e2509b-50bc-4f7f-80b7-bda3808e49e4"
      unitRef="usd">10791000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzUtMi0xLTEtMTA2ODA_d254a136-3374-41a2-bc69-2efdb2ec5d3a"
      unitRef="usd">2635935000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo1NTJiZTYxMmE1NDc0NDBhYTU1MjQyZDNiMzkyMWEyYi90YWJsZXJhbmdlOjU1MmJlNjEyYTU0NzQ0MGFhNTUyNDJkM2IzOTIxYTJiXzUtNC0xLTEtMTA2ODI_d5ce5836-ab31-4283-80c5-6b752174ba2f"
      unitRef="usd">247699000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzA5_1ef41553-b2f3-4df5-901e-cebc9ba349a1">We invest our excess cash balances in marketable debt securities. We classify our investments in marketable debt securities as available-for-sale. We report available-for-sale investments at fair value at each balance sheet date, and include any unrealized holding gains and losses (the adjustment to fair value) in accumulated other comprehensive gain (loss), a component of stockholders&#x2019; equity. Realized gains and losses are determined using the specific-identification method, and are included in other (expense) income, net in our consolidated statements of operations. We classify our available-for-sale marketable securities as current or non-current based on each instrument&#x2019;s underlying effective maturity date and for which we have the intent and ability to hold the investment for a period of greater than 12 months. Marketable securities with maturities of less than 12&#160;months are classified as current and are included in investments in the consolidated balance sheets. Marketable securities with maturities greater than 12&#160;months for which we have the intent and ability to hold the investment for greater than 12 months are classified as non-current and are included in investments, non-current in the consolidated balance sheets.We evaluate securities for impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and our intent and ability to hold the investment to allow for an anticipated recovery in fair value. A credit-related impairment is recognized as an allowance on the balance sheet with a corresponding adjustment to earnings. Any impairment that is not credit- related is recognized in other comprehensive (loss) income, net of applicable taxes.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:DebtInstrumentTerm
      contextRef="ie1dc78c134c44ed99d6c12dca67dd5b3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE4OTE1_241ac262-d24d-4ffa-9171-3743d3b0761c">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="ie35d35ef9a724996964e8f367d178412_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE4OTc3_4c1ce54f-b6b4-451d-b969-03b3c353396d">P12M</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:DebtSecuritiesAvailableForSaleTerm
      contextRef="ib024df048b7a4866887eea7ae4717c0f_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE5MTMy_378b31ea-218c-4be4-9aa2-9719fdbaa426">P12M</us-gaap:DebtSecuritiesAvailableForSaleTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="ie1dc78c134c44ed99d6c12dca67dd5b3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE5MjIz_3804f95b-4e3c-4add-9680-a9ac6dbc482a">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjg4_0915b706-a2de-4b92-acba-84aabda69812">We have accounts receivable amounts due from our product sales and related vaccine supply agreements and our grant agreements. We also have accounts receivable amounts due from strategic collaborators as a result of manufacturing and research and development services provided under collaboration arrangements, or milestones achieved, but not yet paid. Amounts payable to us are recorded as accounts receivable when our right to consideration is unconditional. To estimate the allowance for doubtful accounts, we make judgments about the creditworthiness of our customers based on ongoing credit evaluation and historical experience.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE5OTgw_9ca38582-7471-4ffc-acb6-1df6ba6272ad"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzE5OTgw_cce69047-f928-4a5d-a512-624ec805bd04"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzIwMDQw_204167f3-4943-4778-81f3-1e1e68cd6747"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzIwMDQw_5cce395f-1868-461c-99ad-aaa1340ddc55"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzIwMDQw_a13b0573-7576-4312-a59f-93f8a1b88f94"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzA0_b770ccdc-5fb1-41bf-b135-66d1dada60ba">Financial instruments that subject us to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, marketable securities, and accounts receivable. Our investment portfolio comprises money market funds, marketable debt securities, including U.S. Treasury securities, debt securities of U.S. government agencies and corporate entities and commercial paper. Our cash management and investment policy limits investment instruments to investment-grade securities with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations. Bank accounts in the United States are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. Our primary operating accounts significantly exceed the FDIC limits.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:MajorCustomersPolicyPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzA1_55fed40b-67e9-45dd-82f1-f31e1b821b13">Our accounts receivable are generally unsecured and are from customers in different countries. We generated revenue from grants made by government-sponsored and private organizations, product sales to the U.S. Government and international government agencies, and to a lesser extent, strategic alliances in 2020. Historically, we generated revenue primarily from strategic alliances.</us-gaap:MajorCustomersPolicyPolicyTextBlock>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjk3_d3cf8238-5111-4cf9-9368-0b1b3cbdb726">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A significant portion of our revenue to date has been generated from the following entities that accounted for more than 10% of total revenue and accounts receivable for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.933%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Percentage&#160;of&#160;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years&#160;Ended&#160;December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Percentage&#160;of&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accounts&#160;Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merck&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BARDA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vertex&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AstraZeneca&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Government (excluding BARDA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;European Commission&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United Kingdom Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;South Korea Government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;* - Represents an amount of less than 10%&lt;/span&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6112e1e86f8340e6bab6155f0e0c14fe_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzItMy0xLTEtMA_551a4325-e443-4e6f-a7dd-1400ebde9b84"
      unitRef="number">0.61</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i662ae8da17484626ac7417cac28e5c33_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzItNS0xLTEtMA_c0e4bf6d-f14b-4937-b156-065698e62e80"
      unitRef="number">0.49</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5ed2d47d1bf04e3aa23981e0213f4b17_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzItOS0xLTEtMA_5ab5a32f-eb1c-4fe8-8216-055b06377cfe"
      unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i99de0fc656f94330bd58911cad710714_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzMtMS0xLTEtMA_2d383cde-1a99-400e-ba5f-3d616d882787"
      unitRef="number">0.65</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i01b7a2e27528463b8cd957d79fab92e6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzMtMy0xLTEtMA_06e7bf47-a6b4-4925-af5e-75f2f2a6e936"
      unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i28e4b001726a427395f0430b3d5fa7c3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzMtNy0xLTEtMA_0348abee-2fe0-484a-8441-7e1b254b2f4d"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3739e5568de9403ab6f1602f4947f2cf_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzMtOS0xLTEtMA_7068c07a-465a-4150-8871-9150086fb508"
      unitRef="number">0.54</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i58174bed8d7245f089be80163f527519_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzQtMy0xLTEtMA_ba688c60-3bc5-4c13-972e-d511dc56c8e2"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib97f41aa68a0406294fb319c1cc8c64f_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzQtOS0xLTEtMA_84027cdf-a4c2-4bd8-ad38-e55365fe03b1"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7f19d573adc242b8b4b58f70beb853bb_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzUtNS0xLTEtMA_7c2c15ee-af5a-45ba-b3eb-710924b20fb7"
      unitRef="number">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i16562820b2134dc09272d9b7168eea9e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzYtMS0xLTEtMTE1Mjk_b93c6506-55ab-4f51-8391-a052b72276d4"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i603a16907cb440afbec844ba69c28bce_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzctNy0xLTEtMTE1Mzg_cae620f2-6e83-4195-8bca-10bfeca67766"
      unitRef="number">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1d64ff60176946838aa93ccb8d36219f_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzgtNy0xLTEtMTY1OTM_cd853178-c22d-4207-ae43-5a6848e102ef"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icc33946b21844fddad6112c90f37042e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTpjODU2NGMxMThmZTg0ZmYzYTkyNGFiZGVkNGI2ODY5NS90YWJsZXJhbmdlOmM4NTY0YzExOGZlODRmZjNhOTI0YWJkZWQ0YjY4Njk1XzgtNy0xLTEtMTY1NjM_707c0c0b-19a2-4296-85cc-f45c2c1db1ba"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc1ODY_0922137b-4d51-4c69-b49c-ad2e590f1551">We record all derivatives on our consolidated balance sheets at fair value. The accounting for changes in the fair value of a derivative depends on whether the derivative has been designated and qualifies for hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. We may enter into derivative contracts that are intended to economically hedge certain risk, even though hedge accounting does not apply or we elect not to apply hedge accounting. Foreign currency gains or losses associated with derivatives that are not designated as hedging instruments for accounting purposes are recorded within other (expense) income, net, in our consolidated statements of operations.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjk4_b94e7fb3-7aeb-413f-a2ea-9c15893ecc04">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as risks inherent in valuation techniques, transfer restrictions and credit risk. FASB ASC Topic&#160;820,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC&#160;820), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and our assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from our independent sources. Unobservable inputs are inputs that reflect our assumptions about the inputs that market participants would use in pricing the asset or liability, and are developed based on the best information available in the circumstances. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used to value the assets and liabilities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level&#160;2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; or&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e.,&#160;supported by little or no market activity).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cash equivalents and marketable securities are reported at fair value determined using Level&#160;1 and Level&#160;2 inputs (Note&#160;6). The fair value of our foreign currency forward contracts is calculated using Level 2 inputs, which include currency spot rates, forward rates, interest rate curve and credit or non-performance risk (Note 7). We do not have any non-financial assets or liabilities that should be recognized or disclosed at fair value on a recurring basis at December 31, 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020 and 2019, we maintain letters of credit of $12.1 million and $11.8 million, respectively, related to our lease arrangements, which are secured by money market accounts in accordance with certain of our lease agreements. The amounts are recorded at fair value using Level 1 inputs and included as restricted cash in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i2d723b3d7ee4498a8404a7814a0df9d8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzMyOTg1MzUxNDIyODU_7d9582d4-5f0c-46a2-b6b9-c40a226b2b82"
      unitRef="usd">12100000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="iec2caba51ae04f34a09ef377a92c70a0_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzI0MjY4_e7738d5e-8b14-48fc-9313-6cb645c6fa4a"
      unitRef="usd">11800000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc1ODg_2fb2a03d-6a92-439c-8c1a-b0090d067482">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is recorded at the lower of cost or net realizable value, with cost determined on a first-in, first-out (FIFO) basis. We periodically review the composition of inventory in order to identify excess, obsolete, slow-moving or otherwise unsaleable items. If unsaleable items are observed and there are no alternate uses for the inventory, we will record a write-down to net realizable value in the period that the decline in value is first recognized through a charge to cost of sales. The determination of whether inventory costs will be realizable requires estimates by management. If actual market conditions are less favorable than projected by management, additional write-downs of inventory may be required.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to an initial regulatory approval for our investigational medicines, we expense costs relating to raw materials and production of inventory as research and development expense in our consolidated statements of operations, in the period incurred. When we believe regulatory approval and subsequent commercialization of our investigational medicines is probable, and we also expect future &lt;/span&gt;&lt;/div&gt;economic benefit from the sales of the investigational medicines to be realized, we will then capitalize the costs of production as inventory. Upon the authorization of distribution and use of our COVID-19 vaccine under an EUA in December 2020, we began to capitalize inventory costs associated with our COVID-19 vaccine, as it was determined that inventory costs incurred subsequent to the EUA had a probable future economic benefit.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjgy_b1b38dad-bfd0-4e39-b1b4-b24b04449459">Construction in progress includes direct costs related to the construction of various property and equipment, including leasehold improvements, and is stated at original cost. Construction in progress includes costs incurred under construction contracts including project management services, engineering services, design services and development, construction services and other construction-related fees and services. Such costs are not depreciated until the asset is completed and placed into service. Once the asset is placed into service, these capitalized costs will be allocated to certain property and equipment categories and will be depreciated over the estimated useful life of the underlying assets. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of property and equipment are described below:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.552%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&#160;Useful&#160;Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lesser&#160;of&#160;estimated&#160;useful&#160;life&#160;of&#160;improvement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or&#160;remaining life of related lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset, financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for maintenance and repairs are charged to expense as incurred. Upon retirement or sale, the cost of the assets disposed of, and the related accumulated depreciation, are removed from the accounts, and any resulting gain or loss is recorded to other (expense) income, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjc4_62dc8b62-5faf-4542-920e-4bc94ecc6092">The estimated useful lives of property and equipment are described below:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.552%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&#160;Useful&#160;Life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lesser&#160;of&#160;estimated&#160;useful&#160;life&#160;of&#160;improvement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or&#160;remaining life of related lease&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset, financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset, financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i30999b30a90f434baeec1c4aabafdfc4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2YjRiMDI4OWQ0YWI0OTVmYTg4ZDdjMDk5ZjMxMzJjZi90YWJsZXJhbmdlOjZiNGIwMjg5ZDRhYjQ5NWZhODhkN2MwOTlmMzEzMmNmXzEtMi0xLTEtMA_ef07cce0-7874-4b57-8d1a-d7ea3485f733">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6025964d375a48f6b8048f71aa7069de_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2YjRiMDI4OWQ0YWI0OTVmYTg4ZDdjMDk5ZjMxMzJjZi90YWJsZXJhbmdlOjZiNGIwMjg5ZDRhYjQ5NWZhODhkN2MwOTlmMzEzMmNmXzMtMi0xLTEtMA_0371cbd0-477f-41af-afaa-5083f3b66e1d">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5ab4195256a147e9aca2014d6016eea5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2YjRiMDI4OWQ0YWI0OTVmYTg4ZDdjMDk5ZjMxMzJjZi90YWJsZXJhbmdlOjZiNGIwMjg5ZDRhYjQ5NWZhODhkN2MwOTlmMzEzMmNmXzQtMi0xLTEtMTA2ODU_3f38df3b-0245-493c-832c-8dc3a3751b2f">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ic83f219ce3544b4fad28aa2afd18bf74_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2YjRiMDI4OWQ0YWI0OTVmYTg4ZDdjMDk5ZjMxMzJjZi90YWJsZXJhbmdlOjZiNGIwMjg5ZDRhYjQ5NWZhODhkN2MwOTlmMzEzMmNmXzQtMi0xLTEtMA_1ffa2cd4-efd7-46b5-9efb-a40ce98ddd39">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjcy_7e548fdf-18a5-4fcd-9bb6-dbf507ed47f0">We evaluate our long-lived assets, which consist of property and equipment, to determine if facts and circumstances indicate that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess the recoverability of the long-lived assets by comparing the projected future undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. If such review indicates that such cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair values based on the expected discounted future cash flows attributable to the assets or based on appraisals.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:AssetImpairmentCharges
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzEwNDQ1MzYwNzIyODE1_6fead72c-1a6b-4d04-bed5-6df835c1eb66"
      unitRef="usd">1600000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzI2Njcw_0ec45ade-4ae2-442a-892f-eb84a1dd9859"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzI2Njcw_9799924b-7cce-42a5-a139-8ec43922a9fe"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzE1_6a40b4ad-d432-469d-b415-23222dcc10de">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted ASC 842 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) on January 1, 2019 on a modified retrospective basis under which we recognized and measured leases existing at, or entered into after, the beginning of the period of adoption. We elected the optional transition approach of not adjusting our comparative period financial statements for the impacts of adoption. Therefore, we recognized the effects of applying ASC 842 as a cumulative-effect adjustment to accumulated deficit as of January 1, 2019, the effective date of this standard. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases are classified at their commencement date, which is defined as the date on which the lessor makes the underlying asset available for use by the lessee, as either operating or finance leases based on the economic substance of the agreement. We recognize lease right-of-use assets and related liabilities in our consolidated balance sheets for both operating and finance leases. Lease liabilities are measured at the lease commencement date as the present value of the future lease payments using the interest rate implicit in the &lt;/span&gt;&lt;/div&gt;lease. If the rate implicit is not readily determinable, we will utilize our incremental borrowing rate as of the lease commencement date. Lease right-of-use assets are measured as the lease liability plus initial direct costs and prepaid lease payments less lease incentives. The lease term is the non-cancelable period of the lease and includes options to extend or terminate the lease when it is reasonably certain that an option will be exercised. We recognize operating lease cost in operating expense in our consolidated statements of operations, inclusive of rent escalation provisions and rent holidays, on a straight-line basis over the respective lease term. For our finance leases, we recognize depreciation expense associated with the leased asset acquired and recognize interest expense related to the portion of the financing in our consolidated statements of operations. Additionally, we recognize tenant improvement allowances as a reduction to rent expense on a straight-line basis over the respective lease term.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc1ODk_a2a14f1d-bcbd-4429-aaa0-ca55d9da45a5">Cost of sales includes cost of raw materials, production, transportation, freight and indirect overhead costs associated with our product revenue during the period and third-party royalties on net sales of our product. Cost of sales also includes adjustments for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand.</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjg2_07733877-c748-4ee6-9702-fade07bccb97">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred in performing research and development activities, including salaries and benefits, facilities costs, overhead costs, prelaunch inventory costs, contract services, and other outside costs. The value of goods and services received from contract research organizations and contract manufacturing organizations in the reporting period are estimated based on the level of services performed, and progress in the period in cases when we have not received an invoice from the supplier. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment or facilities that are acquired or constructed for research and development activities and that have alternative future uses, in research and development projects or otherwise, should be capitalized and depreciated as tangible assets. However, the costs of equipment or facilities that are acquired or constructed and intangibles that are purchased from others for a particular research and development project and that have no alternative future uses and therefore no separate economic values are considered research and development costs and are expensed when incurred. Certain equipment and leased facilities purchased for our COVID-19 vaccine program prior to the EUA from the FDA were deemed to have no alternative use. The related acquisition costs of such equipment and lease facilities of $109.6&#160;million were charged to research and development expense for the year ended December 31, 2020. We did not recognize such expense for the years ended December 31, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i89a7968116c24dfeb8928db01baf0eb1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzM4NDgyOTA5NjM0MzY_1ae44026-0454-4b3b-b40f-f3040d75a3ee"
      unitRef="usd">109600000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0be93c00c40a4fb988eceb1c1a2692d9_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc1OTA_a22f8320-a3eb-442c-ba8b-f7c965641354"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6805eb08d3d64693bd8d92b3308b8e5a_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc1OTA_cc4878ad-f21b-40f8-a400-ee98acf16873"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <mrna:PatentCostsPolicyPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzA3_3b57408f-14fe-448b-b584-75fa56ea64e8">Costs to secure, defend and maintain patents are expensed as incurred, and are classified as selling, general and administrative expenses due to the uncertainty of future benefits.</mrna:PatentCostsPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjYz_95998690-76c9-4e5f-b643-0acee0d2fb56">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We issue stock-based awards to employees and non-employees, generally in the form of stock options and restricted stock units (RSUs). We account for our stock-based compensation awards in accordance with ASC 718,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Most of our stock-based awards have been made to employees. We measure compensation cost for equity awards at their grant-date fair value and recognize compensation expense over the requisite service period, which is generally the vesting period, on a straight-line basis. The grant date fair value of stock options is estimated using the Black-Scholes option pricing model, which requires management to make assumptions with respect to the fair value of our common stock on the grant date, including the expected term of the award, the expected volatility of our stock, calculated based on a period of time generally commensurate with the expected term of the award, risk-free interest rates and expected dividend yields of our stock. Historically, for periods prior to our IPO, the fair value of the shares of common stock and common units underlying our stock-based awards were determined on each grant date by our board of directors based on valuation estimates from management considering our most recently available independent third-party valuation of our common stock. Our board of directors also assessed and considered, with input from management, additional objective and subjective factors that we believed were relevant and which may have changed from the date of the most recent valuation through the grant date. The grant date fair value of RSUs is estimated based on the fair value of our underlying common stock. For performance-based stock awards, we recognize stock-based compensation expense over the requisite service period using the accelerated attribution method when achievement is probable. We classify stock-based compensation expense in our consolidated statement of operations in the same manner in which the award recipient&#x2019;s salary and related costs are classified or in which the award recipient&#x2019;s service payments are classified.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzQ5NDc4MDI1ODc2MDQ_4f45c5fa-8b31-4bd4-810f-969d1fcc36e5">We use an asset and liability approach to account for income taxes. We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. These differences are measured using the enacted statutory tax rates that are expected to be in effect for the years in which differences are expected to reverse. Valuation allowances are provided when the expected realization of deferred tax assets does not meet a &#x201c;more likely than not&#x201d; criterion. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss. We recognize tax benefits from uncertain tax positions if we believe the position is more likely than not to be sustained on examination by the taxing authorities based on the technical merits of the position. We make adjustments to these reserves when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. The provision for income taxes includes the effects of any reserves for tax positions that are not more likely than not to be sustained, as well as the related net interest and penalties.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzI2_c72be0eb-d842-401a-92da-cbe72119f66d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period, without consideration for common stock equivalents. Upon the closing of our IPO, all outstanding shares of our redeemable convertible preferred stock were converted into common stock. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate diluted net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding after giving consideration to the dilutive effect of restricted common stock and stock options that are outstanding during the period. We have generated a net loss in all periods presented, therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjkz_20ca9909-a887-4155-b19b-729a5523b1eb">Comprehensive loss includes net loss and other comprehensive income (loss) for the period. Other comprehensive income (loss) mainly consists of unrealized gains and losses on our investments. Total comprehensive income (loss) for all periods presented have been disclosed in the consolidated statements of comprehensive loss.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNzIx_8893231a-b6b7-4bdf-ab2f-3b262875ce35">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive gain (loss) for the years ended December 31, 2020 and 2019 are as follows (in thousands):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&#160;Gain on Available-for-Sale Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss, balance at December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive gain, balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive gain, balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="ib0ea47aa0744431696869108e3c2ba80_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2NDc1ZDhkMzRiOTA0ZjFlYmEwMzczMDlmMjI3ZDM4Ny90YWJsZXJhbmdlOjY0NzVkOGQzNGI5MDRmMWViYTAzNzMwOWYyMjdkMzg3XzEtMS0xLTEtMA_170f4a62-adb0-4df5-be2b-09dfff1bf7a5"
      unitRef="usd">-1320000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i84920da0b3254bb3a9cda664635471b7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2NDc1ZDhkMzRiOTA0ZjFlYmEwMzczMDlmMjI3ZDM4Ny90YWJsZXJhbmdlOjY0NzVkOGQzNGI5MDRmMWViYTAzNzMwOWYyMjdkMzg3XzItMS0xLTEtMA_862b3cdc-d8dc-4634-b517-38de434a8b1e"
      unitRef="usd">3124000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i388d1c703c504e9b9dab1f15168e6519_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2NDc1ZDhkMzRiOTA0ZjFlYmEwMzczMDlmMjI3ZDM4Ny90YWJsZXJhbmdlOjY0NzVkOGQzNGI5MDRmMWViYTAzNzMwOWYyMjdkMzg3XzMtMS0xLTEtMA_ae2f6198-75bf-4afe-8ebf-6ab39ce17818"
      unitRef="usd">1804000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9725be67d18a4c3bb82d57ad987d47ea_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2NDc1ZDhkMzRiOTA0ZjFlYmEwMzczMDlmMjI3ZDM4Ny90YWJsZXJhbmdlOjY0NzVkOGQzNGI5MDRmMWViYTAzNzMwOWYyMjdkMzg3XzQtMS0xLTEtMA_39dbba89-04eb-4771-b5e1-fa4e2a954922"
      unitRef="usd">1200000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ibc74a29947d5452483558254ae2b1c81_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90YWJsZTo2NDc1ZDhkMzRiOTA0ZjFlYmEwMzczMDlmMjI3ZDM4Ny90YWJsZXJhbmdlOjY0NzVkOGQzNGI5MDRmMWViYTAzNzMwOWYyMjdkMzg3XzUtMS0xLTEtMA_e0bc8f7f-63f6-4276-abfe-3d6d7c632b78"
      unitRef="usd">3004000</us-gaap:StockholdersEquity>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xMzkvZnJhZzozMWNjYWE0OThjNjY0MGFlYjQxNTFhZGZjMTIxMGE4NC90ZXh0cmVnaW9uOjMxY2NhYTQ5OGM2NjQwYWViNDE1MWFkZmMxMjEwYTg0XzUxNjY4_0e968637-88e4-4ea5-a423-898dbf0f2c96">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard changes how companies account for credit losses for most financial assets and certain other instruments. For trade receivables, loans and held-to-maturity debt securities, companies will be required to recognize an allowance for credit losses rather than reducing the carrying value of the asset. The amendments in this standard should be applied on a modified retrospective basis to all periods presented. We adopted this standard in the first quarter of 2020. Based on the composition of our investment portfolio and investment policy, the adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other&#x2014;Internal-Use Software (Topic 350): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard requires capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). We adopted this standard in the first quarter of 2020 using the prospective method. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard removes certain exceptions for investments, intra-period allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. We early adopted this standard in the second quarter of 2020. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzMzMTA_beffe83f-b78f-4407-9ca1-09344f0b472d">Grant Revenue&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, we entered into an agreement with the Defense Advanced Research Projects Agency (DARPA) for an award of up to $56.4&#160;million to fund development of a mobile manufacturing prototype leveraging our existing manufacturing technology that is capable of rapidly producing vaccines and therapeutics. As of December 31, 2020, the committed funding, net of revenue earned was $4.6&#160;million, with an additional $51.4&#160;million available if DARPA exercises additional contract options.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, we entered into an agreement with BARDA for an award of up to $483.3&#160;million to accelerate development of mRNA-1273, our vaccine candidate against COVID-19. In July 2020, we amended our agreement with BARDA to provide for an additional commitment of up to $471.6&#160;million to support late-stage clinical development of mRNA-1273, including the execution of a 30,000 participant Phase 3 study in the U.S. The amendment increased the maximum award from BARDA from $483.3&#160;million to $954.9&#160;million. Under the terms of the agreement, BARDA will fund the advancement of mRNA-1273 to FDA licensure. All contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $444.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2016, we received an award of up to $125.8&#160;million from BARDA, to help fund our Zika vaccine program. Three of the four contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $70.8&#160;million, with an additional $8.4&#160;million available if the final contract option is exercised.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2016, we entered a global health project framework agreement with the Gates Foundation to advance mRNA-based development projects for various infectious diseases, including human immunodeficiency virus (HIV). As of December 31, 2020, the available funding net of revenue earned was $11.4&#160;million, with up to an additional $80.0&#160;million available if additional follow-on projects are approved. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following tables summarize grant revenue and deferred grant revenue for and as of the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BARDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Product Sales&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, we began selling our COVID-19 vaccine to the U.S. Government and international government agencies. Under the supply agreements with these government agencies, we received or billed for upfront deposits for our future vaccine supply, which are initially recorded as deferred revenue. We recognize revenue based on the fixed price per dose when control of the product has transferred and customer acceptance has occurred, unless such acceptance provisions are deemed perfunctory. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product sales by customer geographic location was as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no product sales in 2019 and 2018. We had one commercial product, our COVID-19 vaccine, authorized for use as of December 31, 2020. &lt;/span&gt;&lt;/div&gt;As of December 31, 2020, we had deferred revenue of $3.80&#160;billion related to customer deposits, classified as current deferred revenue in our consolidated balance sheet. Timing of product manufacturing, delivery and receipt of marketing approval will determine the period in which revenue is recognized.Geographic Information &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Geographic Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in one reporting segment that primarily focuses on the discovery, development and commercialization of mRNA medicines. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue by geographic area of our customers and collaboration partners was as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our property and equipment, including financing right-of-use asset, were principally located within the United States as of December 31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <mrna:RevenueFromGrantsMaximumAward
      contextRef="i75fc0823bd854f9eba408cdefffe8ccf_D20200901-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkxNzU_80c7f035-2edd-4162-8530-7fe1948511e1"
      unitRef="usd">56400000</mrna:RevenueFromGrantsMaximumAward>
    <mrna:RevenueFromGrantsCurrentFundingCapacity
      contextRef="ie1df42e92dce49dfb7a34fa78d50f687_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzEwNDQ1MzYwNDgyNjI3_05a2babe-7098-4d3a-940b-013aabbb3f0d"
      unitRef="usd">4600000</mrna:RevenueFromGrantsCurrentFundingCapacity>
    <mrna:RevenueFromGrantsRemainingFundingCapacity
      contextRef="ie1df42e92dce49dfb7a34fa78d50f687_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyMDQ_30cbd343-d2cd-4bfa-805f-da8322b761d5"
      unitRef="usd">51400000</mrna:RevenueFromGrantsRemainingFundingCapacity>
    <mrna:RevenueFromGrantsMaximumAward
      contextRef="i013d6d10db654139a2efe361d808fc22_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyMTk_f4a89c52-0e81-4772-9014-9dd6d22cbd64"
      unitRef="usd">483300000</mrna:RevenueFromGrantsMaximumAward>
    <us-gaap:OtherCommitment
      contextRef="i131a90691cbf4509abc1ae852ebc77cc_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyMzU_71b649cd-6561-4e1c-8426-9392e25820b9"
      unitRef="usd">471600000</us-gaap:OtherCommitment>
    <mrna:RevenueFromGrantsMaximumAward
      contextRef="ieb1114d7eef04248a3529921433f9c96_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyNTE_b697a912-8444-41a6-b548-a30307404a06"
      unitRef="usd">483300000</mrna:RevenueFromGrantsMaximumAward>
    <mrna:RevenueFromGrantsMaximumAward
      contextRef="ie91dd2c660e24460ab55f89af07de6dd_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyNjc_7bb8065a-fc63-4753-8001-70a420fb4659"
      unitRef="usd">954900000</mrna:RevenueFromGrantsMaximumAward>
    <mrna:RevenueFromGrantsCurrentFundingCapacity
      contextRef="ic1cec659c0ff4e069c4d60941677a150_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyODM_ac240a34-fbd1-46dc-97a6-6c8a3e56283d"
      unitRef="usd">444300000</mrna:RevenueFromGrantsCurrentFundingCapacity>
    <mrna:RevenueFromGrantsMaximumAward
      contextRef="i8f900a7ac5af4c7da858cc85cc212124_D20160901-20160930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkyOTk_f3fd9cb9-8110-4909-af1f-fb27c24de2c0"
      unitRef="usd">125800000</mrna:RevenueFromGrantsMaximumAward>
    <mrna:RevenueFromGrantsNumberOfContractOptions
      contextRef="idba3a03acc0e45d5b9787c6de18eadbf_I20160930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkzNDU_6ada89a9-8cef-4420-937f-eea21f7f2a27"
      unitRef="contract_option">3</mrna:RevenueFromGrantsNumberOfContractOptions>
    <mrna:RevenueFromGrantsNumberOfContractOptionsExercised
      contextRef="ie67f5391576f40369296654a31490551_I20160930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkzNTg_2d508405-dc03-4ba3-b353-07e42dd4c439"
      unitRef="contract_option">4</mrna:RevenueFromGrantsNumberOfContractOptionsExercised>
    <mrna:RevenueFromGrantsCurrentFundingCapacity
      contextRef="i09c0c94594384d508f37a19a6c34c6a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkzMTc_bc902f8f-12a1-4cc5-9f45-11ba9696b3b6"
      unitRef="usd">70800000</mrna:RevenueFromGrantsCurrentFundingCapacity>
    <mrna:RevenueFromGrantsRemainingFundingCapacity
      contextRef="i09c0c94594384d508f37a19a6c34c6a0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkzMzI_3866fb55-d809-449c-8f75-8e88097a98ea"
      unitRef="usd">8400000</mrna:RevenueFromGrantsRemainingFundingCapacity>
    <mrna:RevenueFromGrantsRemainingFundingCapacity
      contextRef="i1388a9527fb94a0a94fd4c620dc0bf17_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkxNDU_5fba7297-93da-4443-bcbd-590a848536e8"
      unitRef="usd">11400000</mrna:RevenueFromGrantsRemainingFundingCapacity>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1388a9527fb94a0a94fd4c620dc0bf17_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkxNjA_a2243056-0190-458d-a52a-bf4f2de891e8"
      unitRef="usd">80000000.0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90ZXh0cmVnaW9uOjdiYTUyZGZmYzQ0NDRiMzQ5ZjA1NmI5MTdiNWU2MTgyXzk4OTU2MDQ2NTkxNDM_ec83aab5-f3b3-4493-ac87-b920edb86fc0">&lt;div style="margin-top:13pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following tables summarize grant revenue and deferred grant revenue for and as of the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BARDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our total consolidated net revenue from our strategic collaborators for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Collaboration Revenue by Strategic Collaborator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merck&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AstraZeneca&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vertex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total collaboration revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Under ASC 605&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the revenue recognized for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Combined AZ Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the revenue and contra-revenue recognized for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contra-revenue under the May 2019 Amendment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collaboration revenue under the 2015 Merck Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total contra-revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i5d3ffcdb438747aa92be0aff3569a9ea_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzItMy0xLTEtMTA3Mg_4678fba5-15f1-4607-899b-b8cde91985f0"
      unitRef="usd">521652000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4f1e8cedd3d64700b24c4e5f95a07fb2_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzItNS0xLTEtMTA3Mg_35ddbc63-edce-4853-9c0c-acd1b085e903"
      unitRef="usd">7608000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2aac197e32f541178c0c0244356b6ee8_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzItNy0xLTEtMTA3Mg_1f9cd674-e523-434b-a60f-39a4758523b3"
      unitRef="usd">6736000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i79e42df5da2b4678bbeea6e37c176ab0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzMtMy0xLTEtMTA3Mg_173fac1f-36f3-42b9-9da4-c37e02646eff"
      unitRef="usd">7253000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5b76250e8e294bbdafee9c7d09ab09aa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzMtNS0xLTEtMTA3Mg_b993f54d-1c3c-4f2d-88aa-c3b1216d20e4"
      unitRef="usd">4565000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iddc387885a1442e094e4ff923606bbf5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzMtNy0xLTEtMTA3Mg_0ba71151-8e5d-43eb-bf33-e78e1f447b16"
      unitRef="usd">5820000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia16dd0e2f0d2488eba0c73974791c3a4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzQtMS0xLTEtMzMwMA_fae0b0b3-86e0-4d22-b9cc-d608f35e8ac5"
      unitRef="usd">528905000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i998364a642404015895ef6268a8bef44_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzQtMy0xLTEtMzMwMg_ec59b749-0580-47d9-9312-0398ef80a072"
      unitRef="usd">12173000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i234df8a6bf184a26bc8d6f61ec880f13_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo4NGJmY2IxNDk2MTU0YzA3YjAyZDE5NWI1OGE5Yjg5MS90YWJsZXJhbmdlOjg0YmZjYjE0OTYxNTRjMDdiMDJkMTk1YjU4YTliODkxXzQtNS0xLTEtMzMwNA_eb1f4e01-e8e7-4964-80e8-2ed15d1732f1"
      unitRef="usd">12556000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic5e6e85bd35c473b8a7fdfa429ebf3f0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo3NmE2N2Q5ZmI5ZmI0Njg3YjQxN2M5NjhmNDdiN2NmOS90YWJsZXJhbmdlOjc2YTY3ZDlmYjlmYjQ2ODdiNDE3Yzk2OGY0N2I3Y2Y5XzItMy0xLTEtMTA3Mg_ff12dca9-5964-4c21-950e-1be2812dae57"
      unitRef="usd">5261000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i61596579e2804716ad9472fa52f24629_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTEvZnJhZzo3YmE1MmRmZmM0NDQ0YjM0OWYwNTZiOTE3YjVlNjE4Mi90YWJsZTo3NmE2N2Q5ZmI5ZmI0Njg3YjQxN2M5NjhmNDdiN2NmOS90YWJsZXJhbmdlOjc2YTY3ZDlmYjlmYjQ2ODdiNDE3Yzk2OGY0N2I3Y2Y5XzItNS0xLTEtMTA3Mg_85940617-9bd6-4977-b2dd-f0b4686665bb"
      unitRef="usd">2777000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMzczL2ZyYWc6YjcwMjJlZDZjNmIyNGEzZWExZjgzYzEyNGFmNzMxOWEvdGV4dHJlZ2lvbjpiNzAyMmVkNmM2YjI0YTNlYTFmODNjMTI0YWY3MzE5YV8xMDQ0NTM2MDQ5MDY3NQ_7f69a51b-9389-4480-8c78-975edad80d28">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product sales by customer geographic location was as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue by geographic area of our customers and collaboration partners was as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.762%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="ieaf02eddcdce45c9a3a94c51aaddfac8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMzczL2ZyYWc6YjcwMjJlZDZjNmIyNGEzZWExZjgzYzEyNGFmNzMxOWEvdGFibGU6MjQxNzA4ZDhmN2M2NDkyYjkwZWIzNzRiNDE1NzVjNWYvdGFibGVyYW5nZToyNDE3MDhkOGY3YzY0OTJiOTBlYjM3NGI0MTU3NWM1Zl8xLTItMS0xLTEwNjky_d3d41066-2d0d-4c11-a296-9b84429e3f0b"
      unitRef="usd">193630000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iacb86376d0f446bb9527bead47b3f38f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMzczL2ZyYWc6YjcwMjJlZDZjNmIyNGEzZWExZjgzYzEyNGFmNzMxOWEvdGFibGU6MjQxNzA4ZDhmN2M2NDkyYjkwZWIzNzRiNDE1NzVjNWYvdGFibGVyYW5nZToyNDE3MDhkOGY3YzY0OTJiOTBlYjM3NGI0MTU3NWM1Zl8yLTItMS0xLTEwNjky_417f599b-0c93-44b3-86e8-e15b47892c7b"
      unitRef="usd">6242000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3af31ae8238a40b6a097aa5017de8edd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMzczL2ZyYWc6YjcwMjJlZDZjNmIyNGEzZWExZjgzYzEyNGFmNzMxOWEvdGFibGU6MjQxNzA4ZDhmN2M2NDkyYjkwZWIzNzRiNDE1NzVjNWYvdGFibGVyYW5nZToyNDE3MDhkOGY3YzY0OTJiOTBlYjM3NGI0MTU3NWM1Zl8zLTItMS0xLTEwNjky_e087ee98-b8ea-4074-ad4c-d716927825f7"
      unitRef="usd">199872000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="idfe5c56714774f52b2aa95484fa4c6cb_I20201231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMzczL2ZyYWc6YjcwMjJlZDZjNmIyNGEzZWExZjgzYzEyNGFmNzMxOWEvdGV4dHJlZ2lvbjpiNzAyMmVkNmM2YjI0YTNlYTFmODNjMTI0YWY3MzE5YV8xMDQ0NTM2MDQ4OTUyMw_5b7fe099-8b87-4f98-85e4-b94db6ccf65a"
      unitRef="usd">3800000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzkwMTk1_6091c6e6-bcce-46f6-b16a-2094b9790463">Collaboration Agreements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our total consolidated net revenue from our strategic collaborators for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Collaboration Revenue by Strategic Collaborator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Merck&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;AstraZeneca&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vertex&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total collaboration revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Under ASC 605&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents changes in the balances of our receivables and contract liabilities related to our strategic collaboration agreements during the year ended December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020, we recognized the following revenue as a result of the change in the contract liability balances related to our collaboration agreements (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenue recognized in the period from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended &lt;br/&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts included in contract liabilities at the beginning of the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance obligations satisfied (or partially satisfied) in previous reporting periods &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We first allocate revenue to the individual contract liability balance outstanding at the beginning of the period until the revenue exceeds that balance. If additional consideration is received on those contracts in subsequent periods, we assume all revenue recognized in the reporting period first applies to the beginning contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Related to changes in estimated costs for our future performance obligations and estimated variable considerations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, the aggregated amount of the transaction price allocated to performance obligations under our collaboration agreements that are unsatisfied or partially unsatisfied was $327.7 million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;AstraZeneca &#x2013; Strategic Alliances in Cardiovascular and Oncology&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2013 Option Agreement and Services and Collaboration Agreement&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2013, we entered into an Option Agreement, the AZ Option Agreement, and a related Services and Collaboration Agreement, the AZ Services Agreement, with AstraZeneca, which were amended and restated in June 2018. We refer to these agreements in the forms that existed prior to the 2018 amendment and restatement as the 2013 AZ Agreements. Under the 2013 AZ Agreements, we granted AstraZeneca certain exclusive rights and licenses, and options to obtain exclusive rights to develop and commercialize potential therapeutic mRNA medicines directed at certain targets for the treatment of cardiovascular and cardiometabolic diseases and cancer, and agreed to provide related services to AstraZeneca. Pursuant to the 2013 AZ Agreements, AstraZeneca was responsible for all research, development and commercialization activities, while we provided specified research and manufacturing services during a research and evaluation period, as described below, to further AstraZeneca&#x2019;s activities pursuant to an agreed upon services plan. Under the 2013 AZ Agreements, AstraZeneca could have requested we provide additional services, at AstraZeneca&#x2019;s expense. Subject to customary &#x201c;back-up&#x201d; supply rights granted to AstraZeneca, we exclusively manufactured (or had manufactured) mRNA for all research, development and commercialization purposes under the 2013 AZ Agreements until, on a product-by-product basis, the expiration of the time period for which we are entitled to receive earn-out payments with respect to such product pursuant to the 2013 AZ Agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the effective date of the 2013 AZ Agreements, AstraZeneca acquired forty options that it may exercise to obtain exclusive rights to clinically develop and commercialize identified development candidates (and related back-up candidates) directed to specified targets that arise during the research and evaluation period. During the research and evaluation period for research candidates under the 2013 AZ Agreements, AstraZeneca could have elected to designate a limited number of research candidates as development candidates in order to continue preclinical development on such development candidates (and related back-up candidates). From such pool of development candidates designated by AstraZeneca, during a specified option exercise period, AstraZeneca could have then exercised one of its options to obtain exclusive rights to clinically develop and commercialize an identified development candidate (and related back-up candidates). If AstraZeneca did not exercise one of its options to acquire exclusive rights to clinically develop and commercialize a particular development candidate during the defined option exercise period for such development candidate, AstraZeneca&#x2019;s rights to exercise an option and other rights granted under the 2013 AZ Agreements with respect to such development candidate (and related back-up candidates) would terminate, all rights to exploit such development candidate (and related back-up candidates) would be returned to us and all data and results generated by AstraZeneca with respect to such development candidate (and related back-up candidates) would be either assigned or licensed to us. Upon the earlier of termination of the 2013 AZ Agreements for any reason and a specified anniversary of the effective date of the 2013 AZ Agreements, all exercised options, and the right to exercise any and all options if not previously exercised by AstraZeneca, would automatically terminate. On a target-by-target basis, we and AstraZeneca agreed to certain defined exclusivity obligations under the 2013 AZ Agreements with respect to the research, development and commercialization of mRNA medicines for such target.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the effective date of the 2013 AZ Agreements, AstraZeneca made upfront cash payments to us totaling $240.0 million. Under the 2013 AZ Agreements, we were entitled to receive payments that are not related to any specific program of up to $180.0 million in the aggregate for the achievement of three technical milestones relating to toxicity, delivery, and competition criteria. We achieved the toxicity and competition milestones in the year ended December&#160;31, 2015. The delivery milestone has expired. Under the 2013 AZ Agreements, AstraZeneca was obligated to pay us a $10.0 million option exercise fee with respect to each development candidate (and related back-up candidates) for which it exercised an option. In addition, upon AstraZeneca&#x2019;s exercise of each option, we were eligible to receive certain payments contingent upon the achievement of specified clinical, regulatory, and commercial events. For any product candidate optioned by AstraZeneca, we were eligible to receive, per product candidate, up to $100.0 million in payments for achievement of development milestones, up to $100.0 million payments for achievement of regulatory milestones, and up to $200.0 million payments for achievement of commercial milestones. Additionally, under the 2013 AZ Agreements, we were entitled to receive, on a product-by-product basis, earn-out payments on worldwide net sales of products ranging from a high-single digit percentage to 12%, subject to certain reductions, with an aggregate minimum floor.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We received from AstraZeneca under the 2013 AZ Agreements an option exercise payment of $10.0 million (the 2016 VEGF Exercise) in the year ended December&#160;31, 2016, and a clinical milestone payment of $30.0 million with respect to AstraZeneca&#x2019;s VEGF-A product (AZD8601) during the year ended December&#160;31, 2018, that is currently being developed in a Phase&#160;2 clinical trial. Unless earlier terminated, the 2013 AZ Agreements would have continued until the expiration of AstraZeneca&#x2019;s earn-out and contingent option exercise payment obligations for optioned product candidates. Either party had the right to terminate the 2013 AZ Agreements upon the other party&#x2019;s material breach, either in its entirety or in certain circumstances, with respect to relevant candidates, subject to a defined materiality threshold and specified notice and cure provisions. If AstraZeneca had the right to terminate the 2013 AZ Agreements for our material breach, then AstraZeneca could have elected, in lieu of terminating the 2013 AZ Agreements, in their entirety or with respect to such candidates, to have the 2013 AZ Agreements remain in effect, subject to reductions in certain payments we were eligible to receive and certain adjustments to AstraZeneca&#x2019;s obligations under the 2013 AZ Agreements. AstraZeneca had the right to terminate the 2013 AZ Agreements in full, without cause, upon 90-days&#x2019; prior notice to us.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2016 Strategic Alliance with AstraZeneca&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; IL-12&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2016, we entered into a new Strategic Drug Development Collaboration and License Agreement, which we refer to as the 2016 AZ Agreement, with AstraZeneca to discover, develop and commercialize potential mRNA medicines for the treatment of a range of cancers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the 2016 AZ Agreement, we and AstraZeneca have agreed to work together on an immuno-oncology program focused on the intratumoral delivery of a potential mRNA medicine to make the IL-12 protein.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2016 AZ Agreement initially included research activities with respect to a second discovery program. During a limited period of time, each party had an opportunity to propose additional discovery programs to be conducted under the 2016 AZ Agreement. We are responsible for conducting and funding all discovery and preclinical development activities under the 2016 AZ Agreement in accordance with an agreed upon discovery program plan for the IL-12 program and any other discovery program the parties agree to conduct under the 2016 AZ Agreement. For the IL-12 program and any other discovery program the parties agree to conduct under the 2016 AZ Agreement, during a defined election period that commenced as of the effective date of the 2016 AZ Agreement (for the IL-12 program) and otherwise will commence on initiation of any such new discovery program, AstraZeneca may elect to participate in the clinical development of a development candidate arising under the 2016 AZ Agreement from such program. If AstraZeneca so elects (as it has for the IL-12 program), AstraZeneca will lead clinical development activities worldwide and we will be responsible for certain activities, including being solely responsible for manufacturing activities, all in accordance with an agreed upon development plan. AstraZeneca will be responsible for funding all Phase&#160;1 clinical development activities (including costs associated with our manufacture of clinical materials in accordance with the development plan), and Phase&#160;2 clinical development activities (including costs associated with our manufacture of clinical materials in accordance with the development plan) up to a defined dollar threshold. We and AstraZeneca will equally share the costs of Phase&#160;2 clinical development activities in excess of such dollar threshold, all Phase 3 clinical development activities and certain other costs of late-stage clinical development activities, unless we elect not to participate in further development and commercialization activities and instead receive tiered royalties, as described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We and AstraZeneca will co-commercialize products in the U.S. in accordance with an agreed upon commercialization plan and budget, and on a product-by-product basis will equally share the U.S. profits or losses arising from such commercialization. Notwithstanding, on a product-by-product basis, prior to a specified stage of development of a given product, we have the right to elect not to participate in the further development and commercialization activities for such product. If we make such election, instead of participating in the U.S. profits and losses share with respect to such product, we are obligated to discuss future financial terms with AstraZeneca. If we are unable to agree on future financial terms within a short, defined period of time, we are entitled to receive tiered royalties at default rates set forth in the 2016 AZ Agreement, ranging from percentages in the mid-single digits to 20% on worldwide net sales of products, subject to certain reductions with an aggregate minimum floor. AstraZeneca has sole and exclusive responsibility for all ex-U.S. commercialization efforts. Unless we have elected to not to participate in further development (in which case royalties on ex-U.S. net sales will be at the default rates as described above, unless otherwise agreed by the parties), we are entitled to tiered royalties at rates ranging from 10% to 30% on ex-U.S. net sales of the products, subject to certain reductions with an aggregate minimum floor. Subject to customary &#x201c;back-up&#x201d; supply rights granted to AstraZeneca, we exclusively manufacture (or have manufactured) products for all development and commercialization purposes. We and AstraZeneca have agreed to certain defined exclusivity obligations with each other under the 2016 AZ Agreement with respect to the development and commercialization of mRNA medicines for IL-12. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, our strategic alliance under the 2016 AZ Agreement will continue on a product-by-product basis (i)&#160;until both parties cease developing and commercializing such product without the intention to resume, if we have not elected our right not to participate in further development and commercialization of such product or (ii)&#160;on a country-by-country basis, until the end of the applicable royalty term for such product in such country, if we have elected our right not to participate in further development and commercialization of such product.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Either party may terminate the 2016 AZ Agreement upon the other party&#x2019;s material breach, subject to specified notice and cure provisions. Each party may also terminate the 2016 AZ Agreement in the event the other party challenges such party&#x2019;s patent rights, subject to certain defined exceptions. AstraZeneca has the right to terminate the 2016 AZ Agreement in full or with respect to any program for scientific, technical, regulatory or commercial reasons at any time upon 90 days&#x2019; prior written notice to us. On a product-by-product basis, we have the right to terminate the 2016 AZ Agreement in certain cases if AstraZeneca has suspended or is no longer proceeding with the development or commercialization of such product for a period of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEzNTY2_b4c654c8-2a80-49cb-b78b-a61c53047d69"&gt;twelve&lt;/span&gt; consecutive months, subject to specified exceptions, including tolling for events outside of AstraZeneca&#x2019;s control. On a product-by-product basis, if the 2016 AZ Agreement is terminated with respect to a given product, AstraZeneca&#x2019;s rights in such product will terminate and, to the extent we terminated for AstraZeneca&#x2019;s breach, patent challenge or cessation of development or AstraZeneca terminated in its discretion, AstraZeneca will grant us reversion licenses and take certain other actions so as to enable us to continue developing and commercializing such product in the oncology field.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we continue developing and commercializing a given product following termination of the 2016 AZ Agreement by AstraZeneca in its discretion with respect to such product, AstraZeneca is entitled to receive a mid-single digit royalty on our worldwide net sales of such product and a high-single digit percentage of the amounts received by us from a third party in consideration of a license to such third party to exploit such product, in each case, until AstraZeneca recovers an amount equal to specified development costs incurred by AstraZeneca under the 2016 AZ Agreement with respect to such product prior to such termination. Such percentages increase by a low to mid-single digit amount to the extent such termination occurs after such product achieves a specified stage of development.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2013 Agreements with AstraZeneca, amended and restated in 2018 &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2018, we entered into an Amended and Restated Option Agreement and a related Amended and Restated Services and collaboration Agreement with AstraZeneca, or the 2018 A&amp;amp;R Agreements, which amended and restated the 2013 AZ Agreements. Under the 2018 A&amp;amp;R Agreements, we granted AstraZeneca certain exclusive rights and licenses to research, develop and commercialize potential therapeutic mRNA medicines directed at certain targets for the treatment of cardiovascular and cardiometabolic diseases and cancer, and agreed to provide related services to AstraZeneca. The activities to be performed by the parties under the 2018 A&amp;amp;R Agreements are limited to defined biological targets in the cardiovascular and cardiometabolic fields and one defined target in the cancer field.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the 2018 A&amp;amp;R Agreements, AstraZeneca is responsible for all research, development and commercialization activities and associated costs, while we provide specified research and manufacturing services during a research and evaluation period, as described below, to further AstraZeneca&#x2019;s activities conducted pursuant to an agreed upon services plan. During this research and evaluation period, these research services, and manufacturing services in excess of a specified threshold, are provided at AstraZeneca&#x2019;s expense, and manufacturing services below the specified threshold are provided at no additional expense to AstraZeneca. AstraZeneca may request we provide additional research and manufacturing services, at AstraZeneca&#x2019;s expense, following the end of the research and evaluation period. Subject to customary &#x201c;back-up&#x201d; supply rights granted to AstraZeneca, we exclusively manufacture (or have manufactured) mRNA for all research, development and commercialization purposes under the 2018 A&amp;amp;R Agreements until, on a product-by-product basis, the expiration of the time period for which we are entitled to receive earn-out payments with respect to such product pursuant to the 2018 A&amp;amp;R Agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the effective date of the 2013 AZ Agreements, and as further reflected in the 2018 A&amp;amp;R Agreements, AstraZeneca acquired &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;forty options that it may exercise to obtain exclusive rights to clinically develop and commercialize identified development candidates (and related back-up candidates) directed to specified targets that arise during the research and evaluation period. During the research and evaluation period for research candidates, AstraZeneca may elect to designate a limited number of research candidates as development candidates in order to continue preclinical development on such development candidates (and related back-up candidates). From such pool of development candidates designated by AstraZeneca, during a specified option exercise period, AstraZeneca may then exercise one of its options to obtain exclusive rights to clinically develop and commercialize an identified development candidate (and related back-up candidates) in certain fields. If AstraZeneca does not exercise one of its options to acquire exclusive rights to clinically develop and commercialize a particular development candidate during the defined option exercise period for such development candidate, AstraZeneca&#x2019;s rights to exercise an option and other rights granted under the 2018 A&amp;amp;R Agreements with respect to such development candidate (and related back-up candidates) will terminate, all rights to exploit such development candidate (and related back-up candidates) will be returned to us and all data and results generated by AstraZeneca with respect to such development candidate (and related back-up candidates) will be either assigned or licensed to us. Upon the earlier of termination of the 2018 A&amp;amp;R Agreements for any reason and a specified anniversary of the effective date of the 2013 AZ Agreements, all unexercised options, and the right to exercise any and all options if not previously exercised by AstraZeneca, will automatically terminate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a target-by-target basis, we and AstraZeneca have agreed to certain defined exclusivity obligations under the 2018 A&amp;amp;R Agreements with respect to the research, development and commercialization of mRNA medicines for such target in certain fields. In addition, we and AstraZeneca have agreed to certain defined exclusivity obligations with respect to the research, development and commercialization of mRNA medicines coding for the same polypeptide as any development candidate being developed under the 2018 A&amp;amp;R Agreements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the 2018 A&amp;amp;R Agreements will continue until the expiration of AstraZeneca&#x2019;s earn-out and contingent option exercise payment obligations for optioned product candidates. Either party may terminate the 2018 A&amp;amp;R Agreements upon the other party&#x2019;s material breach, either in its entirety or in certain circumstances, with respect to relevant candidates, subject to a defined materiality threshold and specified notice and cure provisions. If AstraZeneca has the right to terminate the 2018 A&amp;amp;R Agreements for our material breach, then AstraZeneca may elect, in lieu of terminating the 2018 A&amp;amp;R Agreements, in their entirety or with respect to such candidates, to have the 2018 A&amp;amp;R Agreements remain in effect, subject to reductions in certain payments we are eligible to receive and certain adjustments to AstraZeneca&#x2019;s obligations under the 2018 A&amp;amp;R Agreements. AstraZeneca may terminate the 2018 A&amp;amp;R Agreements in full, without cause, upon 90 days&#x2019; prior notice to us.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Treatment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Combined 2018 AZ Agreements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2013 Agreements, as amended by the 2018 A&amp;amp;R Agreements, and the 2016 AZ Agreement, referred to as the Combined 2018 AZ Agreements, are treated as a single agreement for accounting purposes as these agreements were negotiated in contemplation of each other. The Combined 2018 AZ Agreements represent a transaction with a customer and therefore is accounted for in accordance with ASC 606. We identified the following performance obligations in the Combined 2018 AZ Agreements: (i) a combined performance obligation that includes a research license, research and development pool services, and manufacturing obligations related to the 2013 AZ Agreements, as amended by the 2018 A&amp;amp;R Agreements, collectively referred to as the Combined 2018 AZ Agreement Performance Obligation, (ii) preclinical development services for IL-12, (iii) preclinical development services for an oncology development target, (iv) a combined performance obligation for a development and commercialization license and manufacturing obligations for IL-12, and (v) a material right to receive development and commercialization rights and manufacturing services for an oncology development target.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We concluded that the research license is not distinct from the research and development pool services or the manufacturing obligations related to the 2018 A&amp;amp;R Agreements, as AstraZeneca cannot fully exploit the value of the research license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Any supply requested by AstraZeneca in excess of the minimum quantities specified in the agreement are considered customer options and treated as separate contracts for accounting purposes. Further, we concluded that AstraZeneca cannot exploit the value of the development and commercialization license for IL-12 without receipt of supply as the development and commercialization license does not convey to AstraZeneca the right to manufacture and therefore combined the development and commercialization license and the manufacturing obligations for IL-12 into one performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Combined 2018 AZ Agreements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upfront payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublicense reimbursement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Toxicity milestone payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Competition milestone payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated reimbursement for IL-12 manufacturing obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize the most likely amount method to determine the amount of reimbursement for IL-12 manufacturing obligations to be received. We determined that any sales-based royalties related to IL-12 will be recognized when the related sales occur as they were determined to relate predominately to the license granted and therefore have been excluded from the transaction price. In addition, we are eligible to receive future milestones and royalties on future commercial sales for optioned product candidates under the 2018 A&amp;amp;R Agreements and future royalties under the 2016 Agreement; however, these amounts are not considered variable consideration under the Combined 2018 Agreements as we are only eligible to receive such amounts if AstraZeneca exercises its options (including certain options that are deemed to be material rights). We have concluded that the exercise of an optioned product candidate represents a separate transaction under ASC 606. We re-evaluate the transaction price at the end of each reporting period. There was&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; a $5.0&#160;million d&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ecrease to the transaction price during the year ended December 31, 2020, resulting from a change in estimate of variable consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price was allocated to the performance obligations based on the relative estimated standalone selling prices of each performance obligation. We developed the estimated standalone selling price for the licenses included in the Combined 2018 AZ Agreement Performance Obligation and the combined performance obligation for a development and commercialization license and manufacturing obligations for IL-12 primarily based on the probability-weighted present value of expected future cash flows associated with each license related to each specific program. In developing such estimate, we also considered applicable market conditions and relevant entity-specific factors, including those factors contemplated in negotiating the agreement, probability of success and the time needed to commercialize a product candidate pursuant to the associated license. We developed the estimated standalone selling price for the services and/or manufacturing and supply included in each of the performance obligation, as applicable, primarily based on the nature of the services to be performed and/or goods to be manufactured and estimates of the &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;associated costs, adjusted for a reasonable profit margin that would be expected to be realized under similar contracts. The estimated standalone selling price of the material right to receive development and commercialization rights and manufacturing services for an oncology development target was developed by estimating the amount of discount that AstraZeneca would receive when exercising the option and adjusting such amount by the likelihood that the option will be exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Combined 2018 AZ Agreements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Combined 2018 AZ Agreement performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preclinical development service - IL-12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preclinical development service - oncology development target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development and commercialization license and manufacturing obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Material right to receive development and commercialization rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, $77.5 million of the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through December 31, 2029 and $9.7 million is expected to be recognized as revenue at the earlier of expiration or modification of the Combined 2018 AZ Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure proportional performance over time using an input method based on cost incurred relative to the total estimated costs for the Combined 2018 AZ Agreement Performance Obligation and the preclinical development services for IL-12 and the other oncology target performance obligations. We recognize revenue related to the amounts allocated to the combined performance obligation for a development and commercialization license and manufacturing obligations for IL-12 based on the point in time upon which control of supply is transferred to AstraZeneca for each delivery of the associated supply.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue for the Combined 2018 AZ Agreement Performance Obligation by determining the proportion of effort incurred as a percentage of total effort we expect to expend.&#160;This ratio is applied to the transaction price allocated to this combined performance obligation. We also estimate the development plan, including expected demand from AstraZeneca, and the associated costs for this combined performance obligation, as we will satisfy this combined performance obligation as the manufacturing services are performed.&#160;Management has applied significant judgment in the process of developing our budget estimates. Any changes to these estimates will be recognized in the period in which they change as a cumulative catch up.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the revenue recognized for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Combined AZ Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenue recognized for the year ended December 31, 2020 includes the amortization of deferred revenue due to the satisfaction of our performance obligation during the period, including a cumulative catch-up adjustment of $12.5&#160;million due to changes in estimated costs for our future performance obligations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Combined AZ Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2016 VEGF Exercise&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We concluded that the 2016 VEGF Exercise should be treated as a separate transaction for accounting purposes, represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. We identified one performance obligation in this arrangement which is comprised of the exclusive license to develop and commercialize VEGF and the manufacturing of clinical supply. We concluded that the VEGF license is not distinct from the manufacturing obligations because AstraZeneca cannot fully exploit the value of the license without receipt of such supply. This is due to limitations inherent in the licenses conveyed wherein AstraZeneca does not have the contractual right to manufacture during the term of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;2016 VEGF Exercise:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Option exercise fee &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Milestone payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublicense reimbursement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated reimbursement for clinical supply&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are eligible to receive future milestones and royalties on future commercial sales under this arrangement. We utilize the most likely amount method to estimate any development and regulatory milestone payments to be received and the amount of estimated reimbursement for clinical supply. As of December 31, 2020, there were no milestones that had not been achieved included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or AstraZeneca&#x2019;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any commercial milestones and sales-based royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted and therefore have also been excluded from the transaction price. We re-evaluate the transaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur. When a milestone payment is included in the transaction price in the future, it is recognized as revenue based on the relative completion of the underlying performance obligation. There was a $2.4&#160;million increase to the transaction price during the year ended December 31, 2020, resulting from a change in estimate of variable consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total transaction price allocated to the single performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 VEGF Exercise combined performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through December 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue related to the amount of the transaction price allocated to the VEGF Exercise performance obligation based on the point in time upon which control of supply is transferred to AstraZeneca for each delivery of the associated supply.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the revenue recognized for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 VEGF Exercise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenue recognized for the year ended December 31, 2020 includes the amortization of deferred revenue due to the satisfaction of our performance obligation during the period, offset by a cumulative catch-up adjustment of $0.4&#160;million due to changes in estimated costs for our future performance obligations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 VEGF Exercise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Merck &#x2013; Strategic Alliances in Infectious Diseases and Cancer Vaccines&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2015 Strategic Alliance with Merck&#160;&#x2013; Infectious Disease&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2015, we entered into a Master Collaboration and License Agreement with Merck, which was amended in January 2016, June 2016, and May 2019, and which we refer to, as amended, as the 2015 Merck Agreement. Pursuant to the 2015 Merck Agreement, we and Merck agreed to research, develop, and commercialize potential mRNA medicines for the prevention of infections by RSV. The 2015 Merck Agreement was terminated on October 7, 2020, by mutual agreement, and the right to pursue the continued development and commercialization of product candidates and products, including RSV, reverted to us.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a part of the May 2019 amendment of the 2015 Merck Agreement, we and Merck agreed to conclude the collaboration as it relates to development of potential mRNA medicines for other viruses, including mRNA-1278 for the prevention of varicella zoster virus (VZV) infection. Pursuant to the 2015 Merck Agreement, Merck was primarily responsible for research, development, and commercialization activities and associated costs of such research and commercialization. We were responsible for designing and, at Merck's cost, manufacturing all mRNA constructs for preclinical and Phase 1 and Phase 2 clinical development purposes, and we were responsible for certain costs associated with the conduct of a Phase 1 clinical trial for a RSV vaccine product candidate (mRNA-1172). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We and Merck agreed to certain defined exclusivity obligations during the term of the 2015 Merck Agreement with respect to mRNA investigational medicines against RSV. As part of the May 2019 amendment of the 2015 Merck Agreement, we and Merck agreed to certain exceptions to the existing exclusivity obligations, pursuant to which we will no longer be restricted from researching, developing, and commercializing an mRNA investigational medicine for the prevention of a specific set of respiratory infections, including RSV, for the pediatric population.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the 2015 Merck Agreement, we received a $50.0 million upfront payment. We were eligible to receive, on a product-by-product basis, additional milestone payments upon the achievement of certain development, regulatory, and commercial milestone events, as well as royalties on Merck&#x2019;s net sales of products at rates ranging from the mid-single digits to low teens, subject to certain reductions, with an aggregate minimum floor. During the term of the agreement, we received from Merck a clinical milestone payment of $5.0 million with respect to the initiation of a Phase&#160;1 clinical trial for a Merck RSV vaccine product candidate. Concurrent with entering into the 2015 Merck Agreement, Merck made a $50.0 million equity investment in us, and concurrent with amending the 2015 Merck Agreement in January 2016, we received an upfront payment of $10.0 million from Merck.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Treatment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined that all aspects of amended 2015 Merck Agreement represent a transaction with a customer and therefore the amended 2015 Merck Agreement is accounted for in accordance with ASC 606. The four-year research period was complete as of December 31, 2018 and we recognized the total transaction price of $65.0&#160;million (the $60.0&#160;million in aggregate upfront payments and a $5.0&#160;million payment pertaining to achievement of a development milestone) in full as we concluded there were no unsatisfied performance obligations pertaining to the amended 2015 Merck Agreement. Additionally, we concluded the following customer options were marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement: (i) research services during the three-year period following the initial four-year research period during which Merck could continue to preclinically and clinically develop product candidates and (ii) clinical mRNA supply for Phase 1 and Phase 2 and/or non-cGMP mRNA supply beyond the initial four-year research period. Therefore, such options would be accounted for as a separate contract if exercised by the customer. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After completion of the initial four-year research period, and as part of the May 2019 amendment of the 2015 Merck Agreement, Merck elected to establish a new RSV vaccine product candidate and elected to conduct a Phase 1 clinical trial. We are responsible for &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;certain costs associated with the conduct of the Phase 1 clinical trial. We determined that our obligation under the May 2019 amendment to reimburse Merck for certain costs associated with the RSV vaccine Phase 1 clinical trial represents consideration payable to a customer and is accounted for as a reduction of the transaction price. The consideration amount is determined based on the most likely method and recorded as contra-revenue as costs are incurred. The one-time payment upon election by Merck to continue developing RSV is fully constrained as it is contingent upon completion of the RSV Phase 1 clinical trial and upon decisions to be made by Merck to continue development thereafter.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;2015 Merck Agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upfront payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction of reimbursements paid to Merck&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize the most likely amount method to estimate any development and regulatory milestone payments to be received. As of December 31, 2020, there were no milestones that had not been achieved included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Merck&#x2019;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We re-evaluate the transaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur. For the year ended December 31, 2020, there was a&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$7.1&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; deduction to the transaction price related to reimbursements paid to Merck for RSV vaccine Phase I clinical trial costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total transaction price allocated to the combined performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015 Merck Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the revenue and contra-revenue recognized for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contra-revenue under the May 2019 Amendment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collaboration revenue under the 2015 Merck Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total contra-revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,773)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contra-revenue recognized was related to consideration payable to Merck under the May 2019 Amendment of the 2015 Merck Agreement. Collaboration revenue recognized was pursuant to separate agreements with Merck related to the exercise of customer options to purchase clinical mRNA supply to further develop a product candidate after the initial four-year research period. Clinical mRNA supply was recognized as collaboration revenue at a point in time upon which control of supply was transferred to Merck for each delivery of the associated supply. We had no deferred revenue as of December 31, 2020 or December 31, 2019 from the amended 2015 Merck Agreement as all performance obligations under the amended 2015 Merck Agreement were completed as of December 31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 7, 2020, the 2015 Master Collaboration and License Agreement between us and Merck related to our collaboration on RSV was terminated by mutual agreement. Merck will complete the Phase 1 study and transition the program to Moderna. The termination did not have an impact to our consolidated financial statements as of and for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2016 Cancer Vaccine Strategic Alliance-Personalized mRNA Cancer Vaccines&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, we entered into a personalized mRNA cancer vaccines (PCV) Collaboration and License Agreement with Merck, which we refer to as the PCV Agreement, to develop and commercialize PCVs for individual patients using our mRNA vaccine and formulation technology. Under the strategic alliance, we identify genetic mutations present in a particular patient&#x2019;s tumor cells, synthesize mRNA for these mutations, encapsulate the mRNA in one of our proprietary LNPs and administer to each patient a unique mRNA cancer vaccine designed to specifically activate the patient&#x2019;s immune system against her or his own cancer cells.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the PCV Agreement, we are responsible for designing and researching PCVs, providing manufacturing capacity and manufacturing PCVs, and conducting Phase&#160;1 and Phase&#160;2 clinical trials for PCVs, alone and in combination with KEYTRUDA (pembrolizumab), Merck&#x2019;s anti-PD-1 therapy, all in accordance with an agreed upon development plan and budget and under the oversight of a committee comprised of equal representatives of each party. The parties have entered into a clinical quality agreement with respect to Moderna&#x2019;s manufacture and supply activities. We received an upfront payment of $200.0 million from Merck. In November 2017, we and Merck announced the achievement of a key milestone for the first-in-human dosing of a PCV (mRNA-4157) as a part of the alliance. The Phase&#160;1 open-label, dose escalation, multicenter clinical trial in the United States (KEYNOTE-603) is designed to assess the safety, tolerability and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with KEYTRUDA, in subjects with unresectable solid tumors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Until the expiration of a defined period of time following our completion of Phase 1 and Phase 2 clinical trials for PCVs under the PCV Agreement and delivery of an associated data package to Merck, Merck has the right to elect to participate in future development and commercialization of PCVs by making a $250.0 million participation payment to us. If Merck exercises its election and pays the participation payment, then the parties will equally co-fund subsequent clinical development of PCVs, with Merck primarily responsible for conducting clinical development activities under a jointly agreed development plan and budget. Each party may also conduct additional clinical trials for PCVs that are not included in the jointly agreed development plan and budget, in which case the non-conducting party will reimburse the conducting party for half of the total costs for such trials, plus interest, from its share of future profits resulting from sales of such PCVs, if any. Merck will lead worldwide commercialization of PCVs, subject to Moderna&#x2019;s option to co-promote PCVs in the United States, and the parties will equally share the profits or losses arising from worldwide commercialization. Until a PCV becomes profitable, we may elect to defer payment of our share of the commercialization and related manufacturing costs and instead reimburse Merck for such costs, plus interest, from our share of future profits resulting from sales of such PCV, if any. Subject to customary &#x201c;back-up&#x201d; supply rights granted to Merck, we will manufacture (or have manufactured) PCVs for preclinical and clinical purposes. Manufacture of PCVs for commercial purposes will be determined by the parties in accordance with the terms of the PCV Agreement. Under the PCV Agreement, we grant certain licenses to Merck to perform its collaboration activities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If Merck does not exercise its right to participate in future development and commercialization of PCVs, then Moderna will retain the exclusive right to develop and commercialize PCVs developed during the strategic alliance, subject to Merck&#x2019;s rights to receive a percentage in the high teens to the low 20s, subject to reductions of our net profits on sales of such PCVs. During a limited period following such non-exercise, Merck has the right to perform clinical studies of such PCVs in combination with KEYTRUDA, for which we agree to use reasonable efforts to supply such PCVs. During such limited period, we also have the right to perform clinical studies of PCVs in combination with KEYTRUDA, for which Merck agrees to use reasonable efforts to supply KEYTRUDA. In addition, following its non-exercise, Merck is also entitled to receive a percentage in the high teens to the low 20s, subject to reductions, of our net profits on sales of certain PCVs first developed by us following such non-exercise and reaching a specified development stage within a defined period of time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We and Merck have agreed to certain defined, limited exclusivity obligations with respect to the development and commercialization of PCVs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2018 Expansion of the Cancer Vaccine Strategic Alliance-Shared Neoepitope Cancer Vaccines&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2018, we and Merck agreed to expand our cancer vaccine strategic alliance to include the development and commercialization of our KRAS vaccine development candidate, mRNA-5671 or V941, and potentially other shared neoantigen mRNA cancer vaccines (SAVs). We preclinically developed mRNA-5671 prior to its inclusion in the cancer vaccine strategic alliance and it is comprised of a novel mRNA construct designed by us and encapsulated in one of our proprietary LNPs. The PCV Agreement was amended and restated to include the new SAV strategic alliance (PCV/SAV Agreement).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have granted Merck certain licenses and we and Merck have agreed to certain exclusivity obligations with respect to SAVs and particular SAV programs, which obligations are subject to termination or expiration upon certain triggering events. Under the PCV/SAV Agreement, Merck will be responsible for conducting Phase 1 and Phase 2 clinical trials for mRNA-5671 and for all costs associated with such activities, in accordance with a jointly agreed development plan and budget, and we will be responsible for manufacturing and supplying all mRNA-5671 required to conduct such trials and for all costs and expenses associated with such &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;manufacture and supply. Under the PCV/SAV Agreement, our budgeted commitment for PCV increased to $243.0 million. Until the expiration of a defined period of time following the completion of Phase 1 and Phase 2 clinical trials for mRNA-5671 under the PCV/SAV Agreement and our delivery of an associated data package to Merck, Merck has the right to elect to participate in future development and commercialization of mRNA-5671 by making a participation payment to us. If Merck exercises its participation rights, then the parties will equally co-fund subsequent clinical development of mRNA-5671, with Merck primarily responsible for conducting clinical development activities under a jointly agreed development plan and budget. If Merck declines to participate in future development and commercialization activities following the initial Phase 1 and Phase 2 clinical trials for mRNA-5671, then we will retain the rights to develop and commercialize mRNA-5671. If Merck elects to participate in future development and commercialization of mRNA-5671, Merck may also conduct additional clinical trials for mRNA-5671 that are not included in the jointly agreed development plan and budget, in which case we will reimburse Merck for half of the total development costs for such clinical trials, plus interest, from our share of future profits resulting from sales of mRNA-5671, if any. If Merck does conduct additional clinical trials for mRNA-5671, we will be responsible for manufacturing and supplying all mRNA-5671 required to conduct such trials. Merck will lead worldwide commercialization of mRNA-5671, subject to our option to co-promote mRNA-5671 in the United States, and the parties will equally share the operating profits or losses arising from worldwide commercialization. Until mRNA-5671 becomes profitable, we may elect to defer payment of our share of the commercialization and related manufacturing costs and instead reimburse Merck for such costs, plus interest, from our share of future profits resulting from sales of mRNA-5671, if any. Subject to &#x201c;back-up&#x201d; supply rights granted to Merck, we will manufacture (or have manufactured) mRNA-5671 and other SAVs for preclinical and clinical purposes. After Merck exercises its right to participate in future development and commercialization of mRNA-5671 and other SAVs, we will grant the applicable development and commercialization licenses and the parties are obligated to discuss responsibility for future manufacturing, giving consideration to applicable criteria.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the PCV/SAV Agreement, for a defined period of time, either party may propose that the parties conduct additional programs for the research and development of SAVs directed to different shared neoantigens. If the parties agree to conduct any such programs, then we will be responsible for conducting and funding preclinical discovery and research activities for such SAVs, and otherwise the programs would be conducted on substantially the same terms as mRNA-5671 program. If we or Merck propose a new SAV program and the other party does not agree to conduct such program, then the PCV/SAV Agreement includes provisions allowing the proposing party to proceed with such development, at the proposing party&#x2019;s expense. If Merck is the proposing party, we will be responsible for manufacturing and supplying material for such program at Merck&#x2019;s expense. In such case, the non-proposing party will have the right to opt-in to such SAV program any time before the proposing party commits to performing Good Laboratory Practice (GLP)-toxicity studies. Until the expiration of a defined period of time following our completion of Phase&#160;1 and Phase&#160;2 clinical trials for any SAV program mutually agreed by the parties under the PCV/SAV Agreement and our delivery of an associated data package to Merck, Merck has the right to elect to participate in future development and commercialization of such SAV by making a participation payment to us.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the PCV/SAV Agreement will continue on a program-by-program basis until Merck terminates its participation in such program. Following any such termination, we will retain the exclusive right to develop and commercialize PCVs or SAVs developed as a part of such program, subject to restrictions and certain limited rights retained by Merck.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the amendment of the PCV Agreement to include the development and commercialization of mRNA-5671 and potentially other SAVs, Merck made a contemporaneous equity investment in our Series H redeemable convertible preferred stock, resulting in gross proceeds of $125.0 million, of which $13.0 million was determined to be a premium and recorded to deferred revenue.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Treatment&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:2.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined that the PCV/SAV Agreement should be accounted for separately from the amended 2015 Merck Agreement, as the agreements were not negotiated in contemplation of one another and the elements within each of the agreements are not closely interrelated or interdependent on each other. The PCV/SAV Agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We identified the following performance obligations in the PCV/SAV Agreement: (i) a research license and research and development services, including manufacturing and supply of PCVs, during the proof of concept (POC) term for the PCV program, referred to as the PCV Performance Obligation, and (ii) research license and manufacturing and supply of mRNA-5671 during the POC term for the KRAS program, referred to as the KRAS Performance Obligation. We concluded that the research license is not distinct from the research and development services, including manufacturing and supply of PCVs, during the POC term for the PCV program, as Merck cannot fully exploit the value of the license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Therefore, the research license has been combined with the research and development services, including manufacturing and supply of PCVs, during the POC term for the PCV program, into a single performance obligation. Similarly, we concluded that the research license is not distinct from the manufacturing and supply of mRNA-5671 during the POC term for the KRAS program, as Merck cannot fully &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;exploit the value of the license without receipt of such supply which must be provided by us. This is due to limitations inherent in the licenses conveyed wherein Merck does not have the contractual right to manufacture during the POC term. Therefore, the research license has been combined with the manufacturing and supply of mRNA-5671, during the POC term for the KRAS program, into a single performance obligation. Conversely, we concluded that the PCV Performance Obligation and the KRAS Performance Obligation are distinct from each other because Merck can fully exploit the value of each program for its intended purpose without the promises associated with the other program. Additionally, we concluded the following customer options are marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement: (i) Merck participation election license related to future joint development and commercialization on a program-by-program basis, (ii) manufacturing and supply in support of certain SAV programs and/or the PCV program upon Merck election to not participate in future development and commercialization of that program and (iii) research and development services associated with certain SAV programs. Therefore, such options will be accounted for as a separate contract upon the customer&#x2019;s election.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-right:6.75pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;PCV/SAV Agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upfront payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium associated with the contemporaneous sale of Series H redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reimbursement for clinical supply&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We re-evaluate the transaction price at the end of each reporting period. During the year ended December 31, 2020, there was a $0.3&#160;million increase to the transaction price from a reimbursement for clinical supply.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price was allocated to the performance obligations based on the relative estimated standalone selling price of each performance obligation. We developed the estimated standalone selling price for the license included in each of the PCV Performance Obligation and the KRAS Performance Obligation primarily based on the probability-weighted present value of expected future cash flows associated with each license related to each specific program. In developing such estimate, we also considered applicable market conditions and relevant entity-specific factors, including those factors contemplated in negotiating the agreement, probability of success and the time needed to commercialize a product candidate pursuant to the associated license. We developed the estimated standalone selling price for the services and/or manufacturing and supply included in each of the PCV Performance Obligation and the KRAS Performance Obligation, as applicable, primarily based on the nature of the services to be performed and/or goods to be manufactured and estimates of the associated cost, adjusted for a reasonable profit margin that would be expected to be realized under similar contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:11.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-right:6.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;PCV/SAV Agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PCV performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;KRAS performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through December 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We will recognize revenue related to amounts allocated to the PCV Performance Obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of research and development efforts. We recognize revenue related to the amounts allocated to the KRAS Performance Obligation based on the point in time upon which control of supply is transferred to Merck for each delivery of the associated supply. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:11.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the revenue recognized for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PCV/SAV Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenue recognized during the year ended December 31, 2020 includes the amortization of deferred revenue due to the satisfaction of our performance during the period, offset by a cumulative catch-up adjustment of $3.5&#160;million due to changes in estimated costs for our future performance obligations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the balances of deferred revenue, which is classified as current or non-current in the condensed consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PCV/SAV Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vertex &#x2013; 2016 Strategic Alliance in Cystic Fibrosis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In July 2016, we entered into a Strategic Collaboration and License Agreement, with Vertex Pharmaceuticals Incorporated, and Vertex Pharmaceuticals (Europe) Limited, together, Vertex, which we refer to as the Vertex Agreement. The Vertex Agreement, which was amended in July 2019, which we refer to as the 2019 Vertex Amendment, is aimed at the discovery and development of potential mRNA medicines for the treatment of cystic fibrosis (CF) by enabling cells in the lungs of people with CF to produce functional cystic fibrosis transmembrane conductance regulator (CFTR) proteins.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Vertex Agreement, we lead discovery efforts during an initial research period that currently extends until March 2020, leveraging our Platform technology and mRNA delivery expertise along with Vertex&#x2019;s scientific experience in CF biology and the functional understanding of CFTR. Vertex is responsible for conducting development and commercialization activities for candidates and products that arise from the strategic alliance, including the costs associated with such activities. Subject to customary &#x201c;back-up&#x201d; supply rights granted to Vertex, we exclusively manufacture (or have manufactured) mRNA for preclinical, clinical and commercialization purposes. The parties established a joint steering committee to oversee and coordinate activities under the Vertex Agreement. We and Vertex have granted each other certain licenses under the Vertex Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the Vertex Agreement, we received a $20.0 million upfront payment from Vertex. In July 2019, Vertex elected to extend the initial research period by six months by making a $2.0 million payment to us pursuant to the 2019 Vertex Amendment. In March 2020, based on the promising preclinical data generated to date, Vertex extended the conduct of the initial Research Plan through the First Extended Research Term (an additional 18-month term) by making an additional payment to us. Vertex has rights to further extend the research period for two additional one-year periods by making an additional payment to us for each one-year extension. We are eligible to receive up to $55.0 million in payments for achievement of development milestones, up to $220.0 million in payments for achievement of regulatory milestones and potentially could receive an additional $3.0 million milestone payment for achievement of a regulatory milestone for second and each subsequent product under the Vertex Agreement. Vertex will also pay us tiered royalties at rates ranging from the low- to high-teens on worldwide net sales of products arising from the strategic alliance, subject to certain reductions, with an aggregate minimum floor. In connection with the strategic alliance, Vertex also made a $20.0 million equity investment in us. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the term of the Vertex Agreement, we and Vertex have agreed to certain defined exclusivity obligations under the Vertex Agreement with respect to the development and commercialization of certain mRNA medicines. Unless earlier terminated, the Vertex Agreement will continue until the expiration of all royalty terms. Vertex may terminate the Vertex Agreement for convenience upon 90&#160;days&#x2019; prior written notice, except if termination relates to a product in a country where Vertex has received marketing approval, which, in such case, Vertex must provide 180 days&#x2019; prior written notice. Either party may terminate the Vertex Agreement upon the other party&#x2019;s material breach, subject to specified notice and cure provisions. Each party may also terminate the Vertex Agreement in &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the event that the other party challenges the validity or enforceability of such party&#x2019;s patent rights, subject to certain exceptions, or if the other party becomes insolvent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Treatment&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:2.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total transaction price for the Vertex Agreement was determined to be $24.4&#160;million, comprised of the $20.0&#160;million upfront payment and $4.4&#160;million in research and development funding related to the research and development services and supply of non-cGMP mRNA. As of December 31, 2019, all performance obligations under the Vertex Agreement were completed. The 2019 Vertex Amendment represents a contract modification and is accounted for as a separate contract. As of December 31, 2020, all performance obligations under the 2019 Vertex Amendment were completed and the total transaction price of $4.5&#160;million, comprised of the $2.0&#160;million upfront payment and $2.5&#160;million in research and development funding related to the research and development services and supply of non-cGMP mRNA, was fully recognized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The First Extended Research Term represents a contract modification and is accounted for as a separate contract. Pursuant to the 2019 Vertex Amendment, we identified one performance obligation comprised of: (i) a research, development and commercialization license and (ii) research and development services, including manufacturing and supply of non-cGMP mRNA, during the 18-month First Extended Research Term. We concluded that the license is not distinct from the research and development services, including manufacturing and supply of non-cGMP mRNA. Additionally, we concluded that the following customer options are marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement: (i) Vertex&#x2019;s rights to extend the extended initial research period and (ii) clinical mRNA supply and/or non-cGMP mRNA supply beyond the extended initial research period. Therefore, such options will be accounted for as a separate contract upon the customer&#x2019;s election.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the First Extended Research Term at December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Vertex Agreement - First Extended Research Term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upfront payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize the most likely amount method to determine the amount of research and development funding to be received. As of December 31, 2020, there were no milestones included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Vertex&#x2019;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any sales-based royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted and therefore have also been excluded from the transaction price. We re-evaluate the tra&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nsaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur. There was a $8.6&#160;million increas&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e to the transaction price during the year ended December 31, 2020, resulting from a change in the estimate of variable consideration.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total transaction price allocated to the single performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Extended Research Term transaction price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020 the aggregate amount of transaction price allocated to the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through the fourth quarter of 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue related to amounts allocated to the single performance obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of the research and development efforts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the revenue recognized for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vertex First Extended Research Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vertex Agreement/2019 Amendment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The revenue recognized during the year ended December 31, 2020, includes the amortization of the deferred revenue due to the satisfaction of our performance during the period, offset by a cumulative catch-up adjustment of $0.2&#160;million due to changes in estimated costs for our future performance obligations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the balances of deferred revenue, classified as current and non-current in the condensed consolidated balance sheets based on the term of the research period for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vertex Agreement &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Balance as of December 31, 2019 represents deferred revenue related to the Vertex 2019 Amendment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vertex &#x2014;2020 Strategic Alliance in Cystic Fibrosis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, we entered into a new Strategic Collaboration and License Agreement with Vertex (Vertex 2020 Agreement). The Vertex 2020 Agreement is aimed at the discovery and development of potential medicines to treat CF by delivering gene-editing therapies to lung cells to facilitate production of functional CFTR proteins.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The three-year research period of the Vertex 2020 Agreement will initially focus on the identification and optimization of novel LNPs and mRNAs that can deliver gene-editing therapies to cells in the lungs. Following the initial three-year period, Vertex is responsible for conducting development and commercialization activities for candidates and products that arise from the strategic alliance, including the costs associated with such activities. Vertex is also obligated to pay us for research services in connection with our performance of certain activities in accordance with a jointly agreed research plan. Subject to customary &#x201c;back-up&#x201d; supply rights granted to Vertex, under the agreement, we are the exclusive manufacturer of related mRNA and LNPs for preclinical, clinical, and commercialization purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the Vertex 2020 Agreement, we received a $75.0&#160;million upfront payment from Vertex. We are eligible to receive up to $380.0&#160;million in milestone payments upon the achievement of certain development, regulatory, and commercial milestone events with respect to any products that result from the strategic alliance, and Vertex will also pay us a tiered percentage of its gross profits derived from worldwide net sales of products arising from the strategic alliance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the term of the Vertex 2020 Agreement, we and Vertex have agreed to certain defined exclusivity obligations with respect to the development and commercialization of certain mRNA medicines.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the Vertex 2020 Agreement will continue until the expiration of all payment obligations. Vertex may terminate the Vertex 2020 Agreement for convenience upon 90 days&#x2019; prior written notice, except if termination relates to a product in a country where Vertex has received marketing approval; in such case, Vertex must provide 180 days&#x2019; prior written notice. Either party may terminate the Vertex 2020 Agreement upon the other party&#x2019;s material breach, subject to specified notice and cure provisions. Each party may also terminate the Vertex 2020 Agreement in the event that the other party challenges the validity or enforceability of such party&#x2019;s patent rights, subject to certain exceptions, or if the other party becomes insolvent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Treatment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined that all aspects of the 2020 Vertex Agreement represent a transaction with a customer and therefore should be accounted for in accordance with ASC 606. We also determined that the 2020 Vertex Agreement should be accounted for separately from other Vertex Agreements as the agreements contemplate research on separate research candidates. We identified one performance obligation comprised of: (i) a research, development and commercialization license; and (ii) research and development &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;services, including manufacturing and supply of non-cGMP mRNA, performed as part of the Initial Research Plan and the Additional Research Plan (collectively, the research period). We concluded that the license is not distinct from the research and development services, including manufacturing and supply of non-cGMP mRNA used in the performance of the research services, as Vertex cannot fully exploit the value of the license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Therefore, the license has been combined with the research and development services, including manufacturing and supply of non-cGMP supply, into a single performance obligation. Additionally, we concluded the provision of clinical mRNA supply and/or non-cGMP mRNA supply provided to Vertex at their option represents a customer option and is considered a marketing offer as such options did not provide any discounts or other rights that would be considered a material right in the arrangement. Such options will be accounted for as a separate contract upon the customer&#x2019;s election.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total transaction price was determined to be $75.0&#160;million, comprised of the upfront payment. We utilize the most likely amount method to determine the amount of research and development funding to be received associated with the Additional Research Plan. Our funding estimate is based on our experience bringing research candidates to the point of nomination by our collaboration partners, including our experience with Vertex under separate transactions. We have fully constrained such amounts and will not include any expected funding in the transaction price until the scope of such services have been agreed to amongst the parties. We also utilize the most likely amount method to estimate any development and regulatory milestone payments to be received. Further, there were no milestones included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Vertex&#x2019;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any sales-based royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted, and therefore have also been excluded from the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the 2020 Vertex Agreement, the total transaction price was allocated entirely to a single performance obligation. We recognize revenue related to amounts allocated to the single performance obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of the research and development efforts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2020, we did not recognize any revenue associated with the 2020 Vertex Agreement. As of December 31, 2020, the aggregate amount of the transaction price allocated to the remaining performance obligations that are unsatisfied is $75.0&#160;million, which is expected to be recognized as revenue through the third quarter of 2023. We had deferred revenue of $75.0&#160;million as of December 31, 2020, which is classified as current and non-current in the consolidated balance sheets based on the term of the research period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Chiesi&#x2014;2020 Collaboration and License Agreement with Chiesi&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, we entered into a Collaboration and License Agreement with Chiesi Farmaceutici S.P.A. (Chiesi), which we refer to as the Chiesi Agreement. The Chiesi Agreement is aimed at the discovery and development of potential mRNA medicines for the treatment of Pulmonary Arterial Hypertension (PAH), a rare disease characterized by high blood pressure in the arteries of the lungs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Chiesi Agreement, we lead discovery efforts during a four-year research period, leveraging our Platform technology and mRNA delivery expertise along with Chiesi&#x2019;s scientific experience in PAH biology. Chiesi is responsible for conducting development and commercialization activities for candidates and products that arise from the collaboration, including the costs associated with such activities. Chiesi is also obligated to pay us for our performance of research activities during the research period in accordance with a jointly agreed research plan. Under the agreement, we are the exclusive manufacturer of related candidates and products for preclinical, clinical, and commercialization purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the Chiesi Agreement, we are entitled to receive a $25.0&#160;million upfront payment from Chiesi. Chiesi has the right to extend the initial four-year research period by &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzkz_2d953b6a-57dd-4928-80b3-3c00ab223378"&gt;one&lt;/span&gt; additional year by making an additional payment to us. We are eligible to receive up to $405.0&#160;million in aggregate milestone payments upon the achievement of certain development, regulatory and commercial milestone events, and Chiesi will also pay us tiered double-digit royalties on worldwide net sales of products arising from the collaboration, subject to certain reductions, with an aggregate minimum floor.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the term of the Chiesi Agreement, we and Chiesi have agreed to certain defined exclusivity with respect to the development and commercialization of certain mRNA medicines.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Treatment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined that all aspects of the Chiesi Agreement represent a transaction with a customer and therefore should be accounted for in accordance with ASC 606. We identified the following performance obligations in the Chiesi Agreement: (i) a research license and research and development services, including manufacturing and supply during the research period; (ii) a material right for the first product development and commercialization license; and (iii) a material right for the second product development and commercialization license. We concluded that the license is not distinct from the research and development services, including manufacturing and supply of non-cGMP mRNA, during the four-year research period, as Chiesi cannot fully exploit the value of the license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Therefore, the license has been combined with the research and development services, including manufacturing and supply of non-cGMP supply, into a single performance obligation. Additionally, we concluded the provision of clinical mRNA supply and/or non-cGMP mRNA supply beyond the four-year research period and the right to extend the research period for &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzQ1_9c8cdcb6-3511-498b-8168-a066bbb63f69"&gt;one&lt;/span&gt; additional year represent customer options and are considered marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement. Such options will be accounted for as a separate contract upon the customer's election.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Chiesi Agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upfront payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize the most likely amount method to determine the amount of research and development funding to be received associated with the research period. We also utilize the most likely amount method to estimate any development and regulatory milestone payments to be received. Further, there were no milestones included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Chiesi&#x2019;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any sales-based commercial milestone payments and royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted and therefore have also been excluded from the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price was allocated to the performance obligations based on the relative estimated standalone selling prices of each performance obligation. We developed the estimated standalone selling price for the services and manufacturing and supply included in the performance obligation, as applicable, primarily based on the nature of the services to be performed and the goods to be manufactured and estimates of the associated costs, adjusted for a reasonable profit margin that would be expected to be realized under similar contracts. We developed the estimated standalone selling prices for the licenses included in the associated performance obligations based on an analysis of our other transactions with collaboration partners and third party comparable transactions. In developing such estimates, we also considered applicable market conditions and relevant entity-specific factors, including those factors contemplated in negotiating the agreement, probability of success and the time needed to commercialize a product candidate pursuant to the associated license. The estimated standalone selling price of the material rights to receive development and commercialization rights was developed by estimating the amount of discount that Chiesi would receive when exercising the option and adjusting such amount by the likelihood that the option will be exercised.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chiesi Agreement transaction price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue related to amounts allocated to the combined research license and research and development services performance obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of the research and development efforts. We will recognize revenue associated with the material rights as revenue at the earlier of the exercise or expiry of the material rights.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2020, we recognized collaboration revenue of $0.2&#160;million from the Chiesi Agreement. We did not recognize any revenue associated with the Chiesi Agreement for the years ended December 31, 2019 and 2018. As of December 31, 2020, $17.3&#160;million of the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through the third quarter of 2024 and $25.0&#160;million is expected to be recognized as revenue at the earlier of the exercise or expiry of the material rights.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had deferred revenue of $25.0&#160;million as of December 31, 2020, classified as non-current in the consolidated balance sheets based on the term of the research period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i020daf53fdb84218b934041c4093d253_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzItMi0xLTEtMA_7ab054a5-4d80-4084-b9e3-79605041459e"
      unitRef="usd">26076000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie25766984ddb4900bc05c8dc1bcfe74d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzItNC0xLTEtMA_ca779c48-b912-44b5-8ede-a3ba67ed5119"
      unitRef="usd">36608000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57e78373a7b8469dbf68fb0f27cf0e87_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzItNi0xLTEtMA_8353f87d-5a3e-49e5-9635-dfddd05f865f"
      unitRef="usd">66082000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd3c14a44a694301afc3fd745de06dfb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzMtMi0xLTEtMA_49a51cdf-4445-4a35-9823-9aba51c4aff2"
      unitRef="usd">32624000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib00cb507390f4481b30f9a19ccb9a5ac_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzMtNC0xLTEtMA_bc2aec20-7d75-4c88-8479-4a32d27bdd6f"
      unitRef="usd">5233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16f428a3385e4f1ab1b775e48d93928f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzMtNi0xLTEtMA_73d49104-4cd2-4bc3-ba27-3dd7e44291b4"
      unitRef="usd">45993000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id39e130ad4a04ca288880a568ba61402_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzQtMi0xLTEtMA_ebacb0ed-5c06-4f4f-a037-2dbf27452888"
      unitRef="usd">15505000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e9ebd18dd5147d1b84a636c49ed2357_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzQtNC0xLTEtMA_0ad3bd15-2799-43ee-ae98-c35cedd2b175"
      unitRef="usd">6195000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ed1066cb22949e185aa0a6400e44041_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzQtNi0xLTEtMA_beb597ea-a720-49c5-857a-23f3f42cc27b"
      unitRef="usd">10437000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4c1f58ac26245b49538b03723bb287b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtMi0xLTEtODE3OA_7335fcb4-47ec-428e-92e6-97f320be8590"
      unitRef="usd">413000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e4582eea62043cc8c8a909446feda2a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtNC0xLTEtODE3OA_5d9a7349-9aac-46f5-af17-abcccf1ce1ae"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab0e4014c3ae497f8257beaa2afdf2a3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtNi0xLTEtODE3OA_a8c4b8d8-c90b-4c30-8092-ae047dd04188"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtMi0xLTEtMA_db262eeb-b254-40b3-b945-a655cd355085"
      unitRef="usd">74618000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc83b7e084b64944bd3c55a3664b6afa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtNC0xLTEtMA_a5366948-2ab9-4f8e-9820-9133200a2d54"
      unitRef="usd">48036000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e257e74e0c3417fa2d62c019e175efd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YmFiNDM5YWI3Y2U0NGFjYTgwODQyYjA4OTcyOTJlYy90YWJsZXJhbmdlOjRiYWI0MzlhYjdjZTQ0YWNhODA4NDJiMDg5NzI5MmVjXzUtNi0xLTEtMA_8f1f5872-3d61-475a-9038-55521226f5d7"
      unitRef="usd">122512000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzkwMTk3_9a43e5c8-a43a-4614-942f-215aa38286d1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents changes in the balances of our receivables and contract liabilities related to our strategic collaboration agreements during the year ended December&#160;31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(117,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020, we recognized the following revenue as a result of the change in the contract liability balances related to our collaboration agreements (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenue recognized in the period from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended &lt;br/&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts included in contract liabilities at the beginning of the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance obligations satisfied (or partially satisfied) in previous reporting periods &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We first allocate revenue to the individual contract liability balance outstanding at the beginning of the period until the revenue exceeds that balance. If additional consideration is received on those contracts in subsequent periods, we assume all revenue recognized in the reporting period first applies to the beginning contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Related to changes in estimated costs for our future performance obligations and estimated variable considerations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Combined AZ Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the revenue recognized for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 VEGF Exercise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 VEGF Exercise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the revenue recognized for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PCV/SAV Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the balances of deferred revenue, which is classified as current or non-current in the condensed consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PCV/SAV Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the revenue recognized for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vertex First Extended Research Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vertex Agreement/2019 Amendment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the balances of deferred revenue, classified as current and non-current in the condensed consolidated balance sheets based on the term of the research period for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vertex Agreement &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Balance as of December 31, 2019 represents deferred revenue related to the Vertex 2019 Amendment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activities in deferred revenue during the year ended December&#160;31, 2020 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,881,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,799,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collaboration revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,009,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,044,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i25d6ceefa0dd4987937b280087546df3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzItMi0xLTEtMA_edeabf26-6a25-4026-b347-2931ec0eb665"
      unitRef="usd">1972000</us-gaap:ContractWithCustomerAssetNet>
    <mrna:ContractWithCustomerAssetIncreaseDuringPeriod
      contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzItNC0xLTEtMA_23417dd6-e349-4371-a7d8-d154af1cc1c1"
      unitRef="usd">120821000</mrna:ContractWithCustomerAssetIncreaseDuringPeriod>
    <mrna:ContractWithCustomerAssetDecreaseDuringPeriod
      contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzItNi0xLTEtMA_744e4241-f5f4-4fbc-a8fe-7f3ef603381f"
      unitRef="usd">-117249000</mrna:ContractWithCustomerAssetDecreaseDuringPeriod>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i0ca78eb83d214ed796eefd75b65d5178_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzItOC0xLTEtMA_ad6a97b1-7820-4016-9b08-e019d6aad0a9"
      unitRef="usd">5544000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i25d6ceefa0dd4987937b280087546df3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzQtMi0xLTEtMA_4a0b84e1-5b16-4f46-a414-9319446a1a87"
      unitRef="usd">199528000</us-gaap:ContractWithCustomerLiability>
    <mrna:ContractWithCustomerLiabilityIncreaseDuringPeriod
      contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzQtNC0xLTEtMA_f3672ccc-5c62-4277-9fb6-d038daa1ac8c"
      unitRef="usd">121882000</mrna:ContractWithCustomerLiabilityIncreaseDuringPeriod>
    <mrna:ContractWithCustomerLiabilityDecreaseDuringPeriod
      contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzQtNi0xLTEtMA_fb8b2422-17dc-4b01-8e12-f6e64833cd9d"
      unitRef="usd">-81228000</mrna:ContractWithCustomerLiabilityDecreaseDuringPeriod>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i0ca78eb83d214ed796eefd75b65d5178_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTozYWFhYjM5YTFmNjg0NGE4ODM4NDk2NjcwMzBmOGQwYi90YWJsZXJhbmdlOjNhYWFiMzlhMWY2ODQ0YTg4Mzg0OTY2NzAzMGY4ZDBiXzQtOC0xLTEtMA_2f222400-7295-4055-a2dc-9e96f74c5230"
      unitRef="usd">240182000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTphOTA0Nzc1NWYwZTY0NzhmYmRiYjRhM2U1YmRiMWVlZC90YWJsZXJhbmdlOmE5MDQ3NzU1ZjBlNjQ3OGZiZGJiNGEzZTViZGIxZWVkXzEtMy0xLTEtMA_64bbf1c2-5b20-478b-8132-92d484b1c4f4"
      unitRef="usd">72863000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
      contextRef="ic80125be741e4f4a9e96e921990c314d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTphOTA0Nzc1NWYwZTY0NzhmYmRiYjRhM2U1YmRiMWVlZC90YWJsZXJhbmdlOmE5MDQ3NzU1ZjBlNjQ3OGZiZGJiNGEzZTViZGIxZWVkXzItMy0xLTEtMTMzMg_2fdbc17e-48cb-4be3-a6f7-be0eab21e1c2"
      unitRef="usd">8366000</us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i0ca78eb83d214ed796eefd75b65d5178_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExMDY_d13246de-8b18-48d9-bbe5-5b8404089eb0"
      unitRef="usd">327700000</us-gaap:RevenueRemainingPerformanceObligation>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions
      contextRef="i2866ce13b20c40499ee0ef2d3eb66afa_I20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzI4NzQ_956d9525-c802-41e8-a8ca-c8053b375ff2"
      unitRef="option">40</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
      contextRef="iae12a04f8a584ee1b88fb30da6f6e7c9_D20130301-20130331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzUwNjc_1843ed7a-c4fc-4617-ad56-6e0a851ce55e"
      unitRef="usd">240000000.0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="i2866ce13b20c40499ee0ef2d3eb66afa_I20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzUxOTI_fdff8de1-0bfd-4fac-ac62-1da0a3416a6b"
      unitRef="usd">180000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones
      contextRef="i2866ce13b20c40499ee0ef2d3eb66afa_I20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzUyMzU_6ec3460c-54c8-461b-a0a9-ffa21b586980"
      unitRef="milestone">3</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee
      contextRef="iae12a04f8a584ee1b88fb30da6f6e7c9_D20130301-20130331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzU1MTA_7484c988-4fca-459d-be32-5646fa4eb395"
      unitRef="usd">10000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="i3264926a036f49368bfd0a6e9404c012_I20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzU5NDQ_7f8614a9-f59c-4b60-a422-2c7002b156a5"
      unitRef="usd">100000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="ic0b34986f0674c9ea594d332b1f04fb7_I20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzYwMDg_d90bc314-d534-404c-9c0b-7647c7a330cb"
      unitRef="usd">100000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="id123e88b9869491798632873fce6c3a9_I20140331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzYwNzI_42637bfb-47ca-469a-ae5f-02b5005f67a6"
      unitRef="usd">200000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent
      contextRef="i4fae7e79285f4982b083cb9c1f4fbd5b_D20130301-20130331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzYzMzA_f60034c6-c68f-4540-906f-3a202a3d3d47"
      unitRef="number">0.12</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
      contextRef="i82bedeff4e8442618c0111343837f65b_D20160101-20161231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzY0ODY_0cd35816-53d4-4de4-b95c-2b315692b14a"
      unitRef="usd">10000000.0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
      contextRef="id653faf9397c4b2abf5814a5f812a2dc_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzY1ODc_ee5c02c5-b6b0-4408-b92c-59140204cbe3"
      unitRef="usd">30000000.0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod
      contextRef="iae12a04f8a584ee1b88fb30da6f6e7c9_D20130301-20130331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc3NDk_5bbb4d21-f54d-4d3f-8267-131a69bdab37">P90D</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent
      contextRef="i0ce35496660e4fd3bb2b5b20d645ce3b_D20160101-20160131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExMzA2_f5aed0a1-739a-41f5-8f29-8da57c40d927"
      unitRef="number">0.20</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent
      contextRef="i2cbf12bb2be14e679beb021ee4ab6155_D20160101-20160131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNzYz_d592b8c3-3eda-49c8-b069-209f717791e7"
      unitRef="number">0.10</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent
      contextRef="i0ce35496660e4fd3bb2b5b20d645ce3b_D20160101-20160131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNzY5_c5b90297-8700-4de3-9b10-7b43b4a30198"
      unitRef="number">0.30</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod
      contextRef="i9d91300ccece4f0cb4993ca5f2e28e76_D20160101-20160131"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEzMjk4_20042bfa-3102-4436-b669-c952ba492f9e">P90D</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions
      contextRef="i68a34211294a4d41b7ae0a74e31673b3_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzI0NDg5_3ef050b2-1a5b-476e-b2b1-00a6c1929c93"
      unitRef="option">40</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod
      contextRef="i458bfc4f6b6645b1ba08bf68c4e3c5f6_D20180601-20180630"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzI3ODEy_4d090cbd-07fb-4942-af5d-f0c4334194c5">P90D</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod>
    <us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjIwMDI_84b96845-7444-48af-a8ec-45441bc0d8ec">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Combined 2018 AZ Agreements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upfront payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublicense reimbursement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Toxicity milestone payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Competition milestone payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated reimbursement for IL-12 manufacturing obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;2016 VEGF Exercise:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Option exercise fee &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Milestone payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublicense reimbursement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated reimbursement for clinical supply&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;2015 Merck Agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upfront payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reduction of reimbursements paid to Merck&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,353)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-right:6.75pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;PCV/SAV Agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upfront payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium associated with the contemporaneous sale of Series H redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reimbursement for clinical supply&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the First Extended Research Term at December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Vertex Agreement - First Extended Research Term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upfront payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the composition of the total transaction price for the periods presented (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Chiesi Agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upfront payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i839376eae85647209c7ffae9f8bb94d6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzQtMi0xLTEtMTM4Mg_e7c6ec00-d2b1-476c-82f4-946ec343c20d"
      unitRef="usd">240000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie2c30c2931b74241a4573d9b7e0a96f5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzQtNC0xLTEtMTM4Mg_fddf8bab-d0f6-4ee8-a47a-576f37334205"
      unitRef="usd">240000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i9fce5c39376648a1885a52fda585e94e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzUtMi0xLTEtMTM4Mg_31054b81-e94b-4eec-8b81-ed9de68ed2fe"
      unitRef="usd">1000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i508d8e428eb4465394a0583607ec486d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzUtNC0xLTEtMTM4Mg_a10fdcea-632d-4da9-9a31-dfe93f89ed03"
      unitRef="usd">1000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i2a4f3ca9cebf43ce90d2496d447b9d8e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzYtMi0xLTEtMTM4Mg_d2688b12-4c0e-49ac-a24e-966f132e3786"
      unitRef="usd">60000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i9b49c52ea5674daf9ac712e3b8b21e47_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzYtNC0xLTEtMTM4Mg_50258ae2-592b-42e8-9d26-1a107cf9b48e"
      unitRef="usd">60000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i4df3ae247d504d6a89d97300985f10bc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzctMi0xLTEtMTM4Mg_ff6277e1-24da-431f-a4a3-6b95d9e626cc"
      unitRef="usd">60000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ic84bc8dd652f4aee96a5499bdf3e2474_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzctNC0xLTEtMTM4Mg_6c10155d-c8a0-41ca-a538-fe80b407a7eb"
      unitRef="usd">60000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i54988c4872c9499ca5902c5f6d9c7c25_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzgtMi0xLTEtMTM4Mg_8665dc81-a7c0-476b-9514-6d9bfcaa0768"
      unitRef="usd">35830000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6b5ed97867924e718b4bd2e71e3b5a48_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzgtNC0xLTEtMTM4Mg_1e7b5ce8-dfe2-4b97-8896-b6b026e6c150"
      unitRef="usd">40782000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i978a4c28e8214a16a5f021fa271e26f7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzktMi0xLTEtMzU5MQ_b702013e-d8cf-42e4-8877-feded3d8bea4"
      unitRef="usd">396830000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="iac8e23e6e0694998b8904230abbb17b4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTowZDI3MGJmOGM5MTY0NWNmODAyYjFlNzAwZmIzNmQ4YS90YWJsZXJhbmdlOjBkMjcwYmY4YzkxNjQ1Y2Y4MDJiMWU3MDBmYjM2ZDhhXzktNC0xLTEtMzU5Mw_662e5daa-0fc0-45de-95c7-90367f73020d"
      unitRef="usd">401782000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i2c28ae9af89f4befac5f089672e301ff_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjE5ODk_8a4ad107-1044-4074-aee7-7a076d46d24d"
      unitRef="usd">5000000.0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjIwMjA_1237366e-ac4b-42cf-bc79-a6866cf53ed5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Combined 2018 AZ Agreements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Combined 2018 AZ Agreement performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preclinical development service - IL-12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preclinical development service - oncology development target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development and commercialization license and manufacturing obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Material right to receive development and commercialization rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total transaction price allocated to the single performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 VEGF Exercise combined performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total transaction price allocated to the combined performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015 Merck Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-right:6.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;PCV/SAV Agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PCV performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;KRAS performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total transaction price allocated to the single performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Extended Research Term transaction price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.789%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Transaction Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chiesi Agreement transaction price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining unsatisfied performance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i018ccef08c534dd986a7e677e9da45b2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzQtMi0xLTEtMTQxOA_649c59dc-96bc-451e-b12e-c926fd6158ff"
      unitRef="usd">293223000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i10f35a20934941e3b6fbe7ba24038ed1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzUtMi0xLTEtMTQxOA_c366b099-c24a-4766-8d46-de275ede430e"
      unitRef="usd">8133000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i2b8c03d227d64183b38b465e3aef9678_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzYtMi0xLTEtMTQxOA_1407aa1e-fdba-4e02-92fe-ae5b8ee3ee49"
      unitRef="usd">8133000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i46fb7b59b5374455b1a475b17975fd25_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzctMi0xLTEtMTQxOA_563db2d3-d8a6-4e81-80eb-51f7670702f1"
      unitRef="usd">85750000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib6304d23321e4e298da2bcf056211316_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzgtMi0xLTEtMTQxOA_21f48021-54f6-4cd1-9e51-50857791ed03"
      unitRef="usd">1591000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i978a4c28e8214a16a5f021fa271e26f7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzktMi0xLTEtNDExMw_6004aad8-58cc-4848-9c57-2f4bfc62c65c"
      unitRef="usd">396830000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGM5YTQwNGUzOGY0NTFlOWNmZmM4Mjc4NWM5YTNkNy90YWJsZXJhbmdlOjk0YzlhNDA0ZTM4ZjQ1MWU5Y2ZmYzgyNzg1YzlhM2Q3XzEwLTItMS0xLTE0Mjk_05a22894-fc5a-4746-bc1e-414673d13fc7"
      unitRef="usd">87225000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i9441d23013f14c83988a31bdbb559231_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzA0MDM1_d6c5b40a-951b-4f9f-8099-baf26292ecf5"
      unitRef="usd">77500000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i4d71f32e33e84216807274b731bdc696_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzA0MDQx_8fcfe63a-4c01-4234-80c9-c670e88b80b8"
      unitRef="usd">9700000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7507c06b17446d99769c50840782858_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4OGZlNDI1ZDkxMmI0ZjE3YTI4NWY5NGQ1MjEyODRkOC90YWJsZXJhbmdlOjg4ZmU0MjVkOTEyYjRmMTdhMjg1Zjk0ZDUyMTI4NGQ4XzItMi0xLTEtMTUwMA_1cd26efb-5f2a-44c7-83a9-8faa3c68bdff"
      unitRef="usd">18371000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3aebca79df0b494194b5d4203b40878c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4OGZlNDI1ZDkxMmI0ZjE3YTI4NWY5NGQ1MjEyODRkOC90YWJsZXJhbmdlOjg4ZmU0MjVkOTEyYjRmMTdhMjg1Zjk0ZDUyMTI4NGQ4XzItNC0xLTEtMTUwMA_eefa6584-b80e-4081-8d21-834f17115f33"
      unitRef="usd">4650000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52cf8a74cf0b4054bf102b486d8851d3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4OGZlNDI1ZDkxMmI0ZjE3YTI4NWY5NGQ1MjEyODRkOC90YWJsZXJhbmdlOjg4ZmU0MjVkOTEyYjRmMTdhMjg1Zjk0ZDUyMTI4NGQ4XzItNi0xLTEtMTUwMA_f0e3ac72-89d5-4ffd-a194-069d2bad4446"
      unitRef="usd">45393000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="ib7507c06b17446d99769c50840782858_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjIzODk_c1d033a8-9e02-42e2-9bd9-42fd0e569fa9"
      unitRef="usd">12500000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i978a4c28e8214a16a5f021fa271e26f7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo3OTIwYTY5ZWM0NTc0MGQ1YmVkYzQyNmViZjQ3NGUyYS90YWJsZXJhbmdlOjc5MjBhNjllYzQ1NzQwZDViZWRjNDI2ZWJmNDc0ZTJhXzItMi0xLTEtMTY3MQ_660a84f8-e906-4c09-bdd5-ad18b2748d60"
      unitRef="usd">57192000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iac8e23e6e0694998b8904230abbb17b4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo3OTIwYTY5ZWM0NTc0MGQ1YmVkYzQyNmViZjQ3NGUyYS90YWJsZXJhbmdlOjc5MjBhNjllYzQ1NzQwZDViZWRjNDI2ZWJmNDc0ZTJhXzItNC0xLTEtMTY3MQ_f762728e-70b1-4f86-8b02-2cddd1884cfc"
      unitRef="usd">73669000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i96c0d1d3251a406d91ab4e10d74e2798_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzQtMi0xLTEtMTY5NA_a6af67df-9e94-42a8-a04a-467a90e74a20"
      unitRef="usd">10000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="id2b94ca2170140ac9a033fe7b05c864e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzQtNC0xLTEtMTY5NA_11616a8b-940f-459b-8672-dc36604b3ae6"
      unitRef="usd">10000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ifb5a3ddf94f642219ac0a81b3fe95f50_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzUtMi0xLTEtMTY5NA_0edb29af-d553-4fb6-b3e8-6d5945a75e85"
      unitRef="usd">30000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i15c7086629714161b7f3158a965fcc28_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzUtNC0xLTEtMTY5NA_5b3d3425-139a-4c9d-a4c3-464d322a4121"
      unitRef="usd">30000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib86c1e0cb5a249f09dfbce827ef9dbc4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzYtMi0xLTEtMTY5NA_96dbc6d8-7291-443e-8a64-3fbb024f0563"
      unitRef="usd">2250000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6b95e1b3c41e4258bc74f50fafe6fb06_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzYtNC0xLTEtMTY5NA_abd686bd-cde6-434a-9dae-8214d47512fc"
      unitRef="usd">2250000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="iadda166c80e447af92ff77e10772827a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzctMi0xLTEtMTY5NA_bba9d1be-45b3-4737-95ca-b3d4770451e4"
      unitRef="usd">18062000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="idd9e8d4a63f54baaba0b4b5ed1d455ff_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzctNC0xLTEtMTY5NA_f33ba12b-edb0-472f-8e64-ccb9baf44d80"
      unitRef="usd">15621000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="id54b6e3f162949438276b86a988013e1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzgtMi0xLTEtNDA4Ng_8993b944-c124-4e5f-b0f1-ac06f7ce1e01"
      unitRef="usd">60312000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ic177577240b14353b1e60187c3076a64_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZWY4NDNiNGFjOWM0ZjllYmQzNTAyMWRhNjg4Y2VkYy90YWJsZXJhbmdlOmJlZjg0M2I0YWM5YzRmOWViZDM1MDIxZGE2ODhjZWRjXzgtNC0xLTEtNDA4OA_6e8186d9-f307-4131-9968-d59edf9f3a87"
      unitRef="usd">57871000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="ic3d6d1acafe2472e83a08aef3a25628d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI0MDg_5ec27eb0-05cd-4876-9b1d-ff0ae0d2a717"
      unitRef="usd">2400000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="id54b6e3f162949438276b86a988013e1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZDlmNzI2MDFlYTQ0ZjdkYWQ1MzQwNjUyMTI3Yjc2Yy90YWJsZXJhbmdlOmJkOWY3MjYwMWVhNDRmN2RhZDUzNDA2NTIxMjdiNzZjXzQtMi0xLTEtNDA3MQ_3f5a80a2-8dd1-4431-a68f-3de5bc5b0202"
      unitRef="usd">60312000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i0f6399c8db0840dc9f38f108c60c920b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZDlmNzI2MDFlYTQ0ZjdkYWQ1MzQwNjUyMTI3Yjc2Yy90YWJsZXJhbmdlOmJkOWY3MjYwMWVhNDRmN2RhZDUzNDA2NTIxMjdiNzZjXzUtMi0xLTEtNDA3MQ_6067f759-6a46-4930-9ca2-5dd3e3d982ff"
      unitRef="usd">41877000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if79cc9521a4944dca9685e052deaf802_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YzMzMzU0OTA0NjI0YzM1YWNhYzRiNmJmZWQ2NDY1Ni90YWJsZXJhbmdlOjRjMzMzNTQ5MDQ2MjRjMzVhY2FjNGI2YmZlZDY0NjU2XzItMi0xLTEtMTc0Ng_c39816ea-9979-44a3-8f4b-97b522839e26"
      unitRef="usd">14253000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i356a33ce286d48cca156527df59d429c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YzMzMzU0OTA0NjI0YzM1YWNhYzRiNmJmZWQ2NDY1Ni90YWJsZXJhbmdlOjRjMzMzNTQ5MDQ2MjRjMzVhY2FjNGI2YmZlZDY0NjU2XzItNC0xLTEtMTc0Ng_ce575aca-7fbe-44b3-ba29-280178216db8"
      unitRef="usd">583000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i563f38b3693b4356b6ea8f9fe73e7167_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0YzMzMzU0OTA0NjI0YzM1YWNhYzRiNmJmZWQ2NDY1Ni90YWJsZXJhbmdlOjRjMzMzNTQ5MDQ2MjRjMzVhY2FjNGI2YmZlZDY0NjU2XzItNi0xLTEtMTc0Ng_14c2f818-13f1-47a6-97a3-9f81c2b35e64"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="if79cc9521a4944dca9685e052deaf802_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODI5MzA3_f1b3fe59-dce1-4c6b-8673-716fb4c0b71c"
      unitRef="usd">400000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ContractWithCustomerLiability
      contextRef="id54b6e3f162949438276b86a988013e1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGU5MTg2N2VlN2Y0OGU2YmI0YzU3OWM4ZTAwZWUyMC90YWJsZXJhbmdlOjk0ZTkxODY3ZWU3ZjQ4ZTZiYjRjNTc5YzhlMDBlZTIwXzItMi0xLTEtODU0Mw_91364192-d38f-4268-8e88-c9aa9c54b6d1"
      unitRef="usd">29335000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic177577240b14353b1e60187c3076a64_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo5NGU5MTg2N2VlN2Y0OGU2YmI0YzU3OWM4ZTAwZWUyMC90YWJsZXJhbmdlOjk0ZTkxODY3ZWU3ZjQ4ZTZiYjRjNTc5YzhlMDBlZTIwXzItNC0xLTEtODU0Mw_f4db2f4e-6531-498a-b111-25e3839bac87"
      unitRef="usd">41266000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ1NjQy_c8b2040f-5963-4f58-b630-75a5bd6ce0c3"
      unitRef="usd">50000000.0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibdc3067fe5e145fe9f1452bcdebc7ceb_D20150101-20190531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ1OTIx_548b8784-0d0f-4365-a8c0-170d6af4ea60"
      unitRef="usd">5000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="i6f08b25f930848c1a69931c8014c2742_D20150101-20150131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ2NTQ2_b270c62f-2706-4700-b336-5a576ce349b7"
      unitRef="usd">50000000.0</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
      contextRef="ic7359b975668474bab9835c2035fd8dd_D20160101-20160131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ2Njc5_d2e4c274-0634-4198-b29b-526a61652036"
      unitRef="usd">10000000.0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod
      contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjE_c2fb8168-0516-41a5-b60c-eb108094661c">P4Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i3e4bfb91e3734bcbac49d735fb9839a4_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI0NTQ_afbc39cd-7290-40dc-958a-638fcf5bc197"
      unitRef="usd">65000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="iae641b44702e44228c65d680d89234fb_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI0Mzk_194553ea-54d3-490b-b577-b2e694673c80"
      unitRef="usd">60000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i4a11405a9cb548088dc27731169c33c3_I20190101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI0Njk_0329c444-351d-4782-9764-8d7adf71d7e9"
      unitRef="usd">5000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod
      contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjI_66276b0b-1e37-4a3b-8589-0958faa6c306">P3Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod
      contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjM_d8370a83-42f3-4040-9599-2df15436836e">P4Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod
      contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NjM2_aed26c8a-5a16-483e-a634-2af72a164c2a">P4Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod
      contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjQ_d8658c26-2cf9-4ab3-95fb-faefc3e0bbe4">P4Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i56cc782d9cf240ab9de511487fe001b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzQtMi0xLTEtMTc3Nw_c04b0890-b99b-468c-88f0-387a513283ed"
      unitRef="usd">60000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="iaedcaef95a2f47b299253a6c24982262_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzQtNC0xLTEtMTc3Nw_74844d21-337e-4fad-a4f1-4211013eef4d"
      unitRef="usd">60000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i0212b2f2863143b0a038e34ad03323de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzUtMi0xLTEtMTc3Nw_3475474d-94e2-48bc-a053-55e85cbde80e"
      unitRef="usd">5000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ife317ed77f384b109eae0a11e402500a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzUtNC0xLTEtMTc3Nw_9e75d53a-d9d6-4b9a-875f-39df09831241"
      unitRef="usd">5000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i8b94988b255b492ab10c9199f363efe2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzYtMi0xLTEtMTc3Nw_5cc9a41c-0bbb-4f58-96a0-b3419e666728"
      unitRef="usd">12353000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i018b2aab0ed44437b6b42610898fd072_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzYtNC0xLTEtMTc3Nw_c3f1d5ba-20d8-463f-8d99-f70d9ada4e11"
      unitRef="usd">5265000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i7bfd65e4ca8b47f6a09d780605125913_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzctMi0xLTEtMzk2NA_f7871077-5d41-4833-9c07-74d6117a4268"
      unitRef="usd">52647000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i7561834c28344ed5a15e15ffa2d94708_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpkMDViY2ZjYThhZDg0Y2FlOTU0NDUwYWUwOTgxYjk0YS90YWJsZXJhbmdlOmQwNWJjZmNhOGFkODRjYWU5NTQ0NTBhZTA5ODFiOTRhXzctNC0xLTEtMzk2NQ_7af43339-2b0a-412d-b056-b3f61d5c57cf"
      unitRef="usd">59735000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwNjc2NzA2_289944ea-eb5c-485b-985f-c4eff941ee9b"
      unitRef="usd">-7100000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i7bfd65e4ca8b47f6a09d780605125913_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTphMDQwOTQzNjhiZGU0ZjU4YWQ4N2RmNGQzY2Y0YWY4My90YWJsZXJhbmdlOmEwNDA5NDM2OGJkZTRmNThhZDg3ZGY0ZDNjZjRhZjgzXzMtMi0xLTEtMTc5NA_ed5f0055-5934-4382-b123-5e420e928dd7"
      unitRef="usd">52647000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i316e60df5f6843bf9f30bdcae4453017_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTphMDQwOTQzNjhiZGU0ZjU4YWQ4N2RmNGQzY2Y0YWY4My90YWJsZXJhbmdlOmEwNDA5NDM2OGJkZTRmNThhZDg3ZGY0ZDNjZjRhZjgzXzQtMi0xLTEtMTc5NA_1ba5903c-4ad9-48b9-8285-97be78e46763"
      unitRef="usd">0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia449e79cf2a44014b2511df73272f527_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzItMi0xLTEtMTg1MA_8f0b8449-92a4-4c62-8447-56387bbaa4fb"
      unitRef="usd">-7088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i392a2394213c44f893b9b592d6e59b88_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzItNC0xLTEtMTg1MA_b54d69f1-6813-4972-89e9-bfbab6ae0f5b"
      unitRef="usd">-5265000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51ff27e4a88e4237b3e19f6822bca430_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzItNi0xLTEtMTg1MA_11d1a472-0dd7-4201-a47c-bf95e18843d1"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46a1cdfdf44f41ceb9bb274d0f145355_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzMtMi0xLTEtMTg1MA_01f8299e-beed-46b6-9235-dc7c08b89bbc"
      unitRef="usd">62000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0395a7348b444ec48cc30fa685878865_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzMtNC0xLTEtMTg1MA_2eff19b1-3c0b-4253-9b3e-7a98bc7015bf"
      unitRef="usd">492000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88da5e4006934b50a0e65f87903ba7d4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzMtNi0xLTEtMTg1MA_ce1fb200-769f-4a9b-923e-2a5efee5c62d"
      unitRef="usd">24582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1acf7d5970e4063b3ec0293575fe05c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzQtMi0xLTEtMzk0Nw_dc25485a-ff57-45e4-b34d-b2c661f319c7"
      unitRef="usd">-7026000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i624e4ab60a804616a11ab12b4aaca0b7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzQtNC0xLTEtMzk0OA_0ca49bf8-c649-40a0-9caf-535bd01a2b6c"
      unitRef="usd">-4773000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8350b0070d0a4021b617d51d1237f6e8_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo4MTZmM2YxYmYxNTY0MWQ3YWU1MTZmMzAyMWVlYzdhNC90YWJsZXJhbmdlOjgxNmYzZjFiZjE1NjQxZDdhZTUxNmYzMDIxZWVjN2E0XzQtNi0xLTEtMzk1MQ_eb866872-2f7a-4ce4-a1ca-3e5485f2ad75"
      unitRef="usd">24582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod
      contextRef="ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NTY4_4d5cea9d-714b-4e47-b955-e91300676060">P4Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
      contextRef="i16fd06682d81475283857811586f4079_D20160601-20160630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzU1MjY4_8bbeb91e-5256-45b3-990b-490921537b22"
      unitRef="usd">200000000.0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="ie3347a1fc6b94f67a83914d66ec9adbf_I20170630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzU2MDUw_369034bd-7dc2-4e7b-b027-fba6f1d97f65"
      unitRef="usd">250000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="ia0cd83a6a1924769a19a58e5f11bd212_I20180430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzYwMjEw_0ee629f9-029d-4946-8870-737499c12a93"
      unitRef="usd">243000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ic50bf5d952c24703b46068d51770fec8_D20180401-20180430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzY0NzMw_41095f84-c64f-4c12-810b-3510776459c4"
      unitRef="usd">125000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:RedemptionPremium
      contextRef="ic50bf5d952c24703b46068d51770fec8_D20180401-20180430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzY0NzQz_20cbd55e-57a7-4103-bfb8-90cdeb46310b"
      unitRef="usd">13000000.0</us-gaap:RedemptionPremium>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i0d5048c0c1ab41668db8aa8a13a9f01d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzQtMi0xLTEtMjAyNQ_91370295-c755-4ece-a3c1-4eaf1a386ffb"
      unitRef="usd">200000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ia61f19b469e44cc391bbf2ed9db3b35b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzQtNC0xLTEtMjAyNQ_e0f8daca-5bfa-41cc-8da9-aa3522d0a1e0"
      unitRef="usd">200000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i4ad30b16714046c3b761def5ad1ec930_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzUtMi0xLTEtMjAyNQ_ca471b58-194d-4f08-b3f5-b76e3b99a97f"
      unitRef="usd">13050000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ibd817774a25a4b54a5e146a36338e853_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzUtNC0xLTEtMjAyNQ_3afd543d-d892-4b5d-85c3-1ecb9166b6d8"
      unitRef="usd">13050000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i791028eb61c741c0b0bcc8de949523e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzYtMi0xLTEtMjAyNQ_b22650de-359e-46c5-933b-ef6f7c854c71"
      unitRef="usd">310000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib1c48a89440e425d8cdcde9fe46e6f1d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzYtNC0xLTEtMjAyNQ_e2d9575c-521f-482f-a029-92289866a8a7"
      unitRef="usd">0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie979852e105e4bda87e75d94f1fc565c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzctMi0xLTEtMzkyNQ_a39e1b0a-dd4d-4bea-8443-adad8b00ce7f"
      unitRef="usd">213360000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie517b85a81b14dd1be0f4552d417c47e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1NmY0MTRjYTFiOWE0ZGRlOTE1MGM4MWI4YzE2ZDM5YS90YWJsZXJhbmdlOjU2ZjQxNGNhMWI5YTRkZGU5MTUwYzgxYjhjMTZkMzlhXzctNC0xLTEtMzkyNw_ae32db7d-fbd4-416e-9036-57758a2fd446"
      unitRef="usd">213050000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="id3a8ffa0085e4794913a1deaa0b73f5d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODI5MzIx_ed4ca9d2-e033-4c87-9736-804fd502de2f"
      unitRef="usd">300000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="icf670da31cdc46a09101eb0c8678cac6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2MjdkNDk0NWFlNzY0NGI2OWQwZGM2OTE2YWQ1ZjA1Ny90YWJsZXJhbmdlOjYyN2Q0OTQ1YWU3NjQ0YjY5ZDBkYzY5MTZhZDVmMDU3XzQtMi0xLTEtODY1Nw_74091da3-35ad-46c8-bb85-9e61244b78ab"
      unitRef="usd">206356000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6260d9dece294c47adb143dbae8f22ba_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2MjdkNDk0NWFlNzY0NGI2OWQwZGM2OTE2YWQ1ZjA1Ny90YWJsZXJhbmdlOjYyN2Q0OTQ1YWU3NjQ0YjY5ZDBkYzY5MTZhZDVmMDU3XzUtMi0xLTEtODY1Nw_821c597a-69ad-4b27-b14a-a0e9320f6429"
      unitRef="usd">7004000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie979852e105e4bda87e75d94f1fc565c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2MjdkNDk0NWFlNzY0NGI2OWQwZGM2OTE2YWQ1ZjA1Ny90YWJsZXJhbmdlOjYyN2Q0OTQ1YWU3NjQ0YjY5ZDBkYzY5MTZhZDVmMDU3XzQtMi0xLTEtMTA3Nzg_dd87d5c7-0227-4ae7-875c-9c191c9698be"
      unitRef="usd">213360000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="idfe0cd89ae6041918c135184fa183ddb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2MjdkNDk0NWFlNzY0NGI2OWQwZGM2OTE2YWQ1ZjA1Ny90YWJsZXJhbmdlOjYyN2Q0OTQ1YWU3NjQ0YjY5ZDBkYzY5MTZhZDVmMDU3XzctMi0xLTEtODY3NA_22a04fa5-7960-487b-9b25-345c6954e3cf"
      unitRef="usd">51007000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i340827b3da36421394e5bd54e37ccfea_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZToxYjRjODY1ZTczMDg0MjNhYmMxMzgwNjZjMzRjMmVmYi90YWJsZXJhbmdlOjFiNGM4NjVlNzMwODQyM2FiYzEzODA2NmMzNGMyZWZiXzItMi0xLTEtMjA3MA_4df8f58e-036c-45a3-9da0-033e3f3036bf"
      unitRef="usd">33103000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf3efea2a5d54653be9c2285642a667c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZToxYjRjODY1ZTczMDg0MjNhYmMxMzgwNjZjMzRjMmVmYi90YWJsZXJhbmdlOjFiNGM4NjVlNzMwODQyM2FiYzEzODA2NmMzNGMyZWZiXzItNC0xLTEtMjA3MA_fc949897-160b-42f3-a422-b0cb70634c2f"
      unitRef="usd">41382000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i950a1adc46aa45c28b3349f86c2a031e_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZToxYjRjODY1ZTczMDg0MjNhYmMxMzgwNjZjMzRjMmVmYi90YWJsZXJhbmdlOjFiNGM4NjVlNzMwODQyM2FiYzEzODA2NmMzNGMyZWZiXzItNi0xLTEtMjA3MA_49a2a81f-3e23-46ba-bf2d-c2455391305a"
      unitRef="usd">41498000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i981f59fd40474c90ad61c969280172a6_D20201001-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NjIz_47038f29-e987-41f7-a2dc-25f4e4291328"
      unitRef="usd">3500000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i340827b3da36421394e5bd54e37ccfea_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NjIz_bdbcc70b-a674-44fa-b712-d64b32b72198"
      unitRef="usd">3500000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ie979852e105e4bda87e75d94f1fc565c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2OWIzOTRiOWU1Y2U0OTg5OWI4OTQ3MTAyMzIzYjg0MS90YWJsZXJhbmdlOjY5YjM5NGI5ZTVjZTQ5ODk5Yjg5NDcxMDIzMjNiODQxXzItMi0xLTEtMjA5MA_9c0c3c17-4ff1-404d-a808-2d6419262432"
      unitRef="usd">51007000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ie517b85a81b14dd1be0f4552d417c47e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2OWIzOTRiOWU1Y2U0OTg5OWI4OTQ3MTAyMzIzYjg0MS90YWJsZXJhbmdlOjY5YjM5NGI5ZTVjZTQ5ODk5Yjg5NDcxMDIzMjNiODQxXzItNC0xLTEtMjA5MA_43aa88fa-2be2-4e1f-bdc0-7db09686668e"
      unitRef="usd">83799000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
      contextRef="i5499e80adfa6472b9e1528ab0f94b167_D20160701-20160731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc0NTA2_bf3a7bf6-bb53-4aed-9d9d-35f040cf88b5"
      unitRef="usd">20000000.0</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected
      contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc0NjA4_565919ee-e085-43ec-be7d-350362fefe57">P6M</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc0NjIz_43eca0a6-1329-43ec-b497-9ce5844fda75"
      unitRef="usd">2000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod
      contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjU_e4d23f87-1155-4239-92fb-678c87f468a0">P18M</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods
      contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc0ODcw_1e767283-bed8-4a0e-a8e5-fec3a96b050e"
      unitRef="extension_period">2</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod
      contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NjY_f64cf570-ee60-44c2-a8ae-b9801add2f59">P1Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod
      contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3Njc_efa65cf7-19eb-43d0-9642-883ec47dc577">P1Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="i3f8781fcff4e440a97e13c637f9373b3_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc0OTk5_e5d2fafa-d7bb-4952-858b-9bfe0f353e3a"
      unitRef="usd">55000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="i42f4b3b0fa0d4f57b37d2a96d63f003c_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc1MDYz_b9089f18-80b8-47cd-9e8c-1d6f21217db0"
      unitRef="usd">220000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="i7f178b19838f48b4914e2694d3057ea7_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc1MTYz_e92a81ae-152e-4013-adcc-f7e808be483f"
      unitRef="usd">3000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc1NTc3_86c91804-a1a1-41e4-829a-506f30661da1"
      unitRef="usd">20000000.0</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod
      contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc1OTkx_65d12140-40da-49a6-bb13-9b75b1046f18">P90D</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod
      contextRef="i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzc2MTY1_b9f7d584-2da8-4d70-85ba-505de47ef7a3">P180D</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ic6a88a9c14d2404d970ffdfe239ee718_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NTcw_17810874-4669-4fe6-a0a5-6c46404c3f9a"
      unitRef="usd">24400000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="if8af61d149a74aa9bdde3e7ad4d3907f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NTg1_ca7419ea-6ccb-4486-a79f-bfe8c993df39"
      unitRef="usd">20000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ieb6bc087a0004b3e8507b5cc459cb4d5_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEwNDQ1MzYwODQ1NjAw_0b9484d5-e997-4a89-9595-ad91d672c668"
      unitRef="usd">4400000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id85fae767ef44643861725eb10c2ee6c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI3NTQ_e4950413-3159-4b39-8b57-2ad2e336da5a"
      unitRef="usd">4500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i9cfd6d8a963b437fba39ba94ab400b91_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI3MzU_31be2ac4-9df0-42f2-a396-a2ea2d96f46b"
      unitRef="usd">2000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i15c73ffb7e51425da60d278c68eae95f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI3MTY_543d6188-324f-4b4f-a496-1db1ed9f0af2"
      unitRef="usd">2500000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ia11a3663e67e45c08dd00fe0f20b964b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZDZjNTBlNzA2ZjA0YmQ2OTQ0OGJjYzBlOWJlNzgxNS90YWJsZXJhbmdlOmJkNmM1MGU3MDZmMDRiZDY5NDQ4YmNjMGU5YmU3ODE1XzQtMi0xLTEtMjEzNQ_1f175c1c-ba49-420a-849b-3c2946184040"
      unitRef="usd">4000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ifd261966c1e44f1db6dc2b1efb265428_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZDZjNTBlNzA2ZjA0YmQ2OTQ0OGJjYzBlOWJlNzgxNS90YWJsZXJhbmdlOmJkNmM1MGU3MDZmMDRiZDY5NDQ4YmNjMGU5YmU3ODE1XzUtMi0xLTEtMjEzNQ_05b5c605-f976-41ce-9bc1-d5a6f8017640"
      unitRef="usd">39798000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie02f591019054030b611751b6c248c94_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTpiZDZjNTBlNzA2ZjA0YmQ2OTQ0OGJjYzBlOWJlNzgxNS90YWJsZXJhbmdlOmJkNmM1MGU3MDZmMDRiZDY5NDQ4YmNjMGU5YmU3ODE1XzUtMi0xLTEtMzkwMg_d16bdb98-f531-42ed-a6e7-03708a6550e4"
      unitRef="usd">43798000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="id85fae767ef44643861725eb10c2ee6c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI2OTY_5f02e464-a8e4-4b69-bb43-91218cb45595"
      unitRef="usd">8600000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie02f591019054030b611751b6c248c94_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1OTI2MmQ5MDkxZmM0ZDUxYWMwOTcyODdiODMyNjU5Yy90YWJsZXJhbmdlOjU5MjYyZDkwOTFmYzRkNTFhYzA5NzI4N2I4MzI2NTljXzMtMi0xLTEtMjE3MQ_aae15ead-4247-4fae-864a-9e718ffa05d4"
      unitRef="usd">43798000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ifea86eb2da07419ea798ae719f81a8f9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1OTI2MmQ5MDkxZmM0ZDUxYWMwOTcyODdiODMyNjU5Yy90YWJsZXJhbmdlOjU5MjYyZDkwOTFmYzRkNTFhYzA5NzI4N2I4MzI2NTljXzQtMi0xLTEtMjE3MQ_c46bb53e-141b-464a-a65d-1e2654ac1ad3"
      unitRef="usd">30346000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ib894739b97434938997c5f99e78f77bd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzItMi0xLTEtMjE5NA_a0b0cc53-dd3d-4df7-8423-1192770ee2da"
      unitRef="usd">13452000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i1d7dca1d4c4c4b9686df22df24888acf_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzItNC0xLTEtMjE5NA_24acbf7a-fcaf-46a8-a081-06e3fb5364d4"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i5feaa13311494f2aad81d49c0f29adec_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzItNi0xLTEtMjE5NA_d2185e55-b02b-4525-9efd-e4f337a6c369"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i8e076d5d4a504530950dfa10765531a3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzMtMi0xLTEtMjE5NA_c77eb519-7469-4c5e-a631-80047c5754c4"
      unitRef="usd">2053000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i0acd16de5695440eb15012080a75bb86_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzMtNC0xLTEtMjE5NA_31e3ebd9-a17f-40dc-9dda-d8b5a0050656"
      unitRef="usd">6197000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i381c45f95fdc4c6cab91ea05c8184f74_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzMtNi0xLTEtMjE5NA_fdeebdee-2f37-4f4c-8e41-de624c72e983"
      unitRef="usd">10400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ie3f73020d7f8417cace85905171f5d06_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzQtMi0xLTEtMjE5NA_548f084e-5e7a-4e15-bb2d-1c3b0930c683"
      unitRef="usd">15505000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ic0d1ada6b97646e1811da4767837e43f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzQtNC0xLTEtMjE5NA_a535ba3d-f44f-490a-bc10-3f928799c068"
      unitRef="usd">6197000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if6a738901f794f2c95c70ed3d3ed65fc_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo1MTEyMjIyMzRmMzQ0ZDJhYTAzMWVhMTJhODVlZjY3Zi90YWJsZXJhbmdlOjUxMTIyMjIzNGYzNDRkMmFhMDMxZWExMmE4NWVmNjdmXzQtNi0xLTEtMjE5NA_a5828eb6-df57-4472-bc8b-d737cf16dadc"
      unitRef="usd">10400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i0798e7f1beab411290adc80b49b4a243_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZToyM2VhZTEzYjAwZWE0ZTJiODc5NTA1N2Y0MDczZmEwYS90YWJsZXJhbmdlOjIzZWFlMTNiMDBlYTRlMmI4Nzk1MDU3ZjQwNzNmYTBhXzItMi0xLTEtMjIzOA_1bede6fd-18f7-47cd-9f8c-4716b9b712e9"
      unitRef="usd">2648000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i5e5b4776d84349f68d1f905844a0195b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZToyM2VhZTEzYjAwZWE0ZTJiODc5NTA1N2Y0MDczZmEwYS90YWJsZXJhbmdlOjIzZWFlMTNiMDBlYTRlMmI4Nzk1MDU3ZjQwNzNmYTBhXzItNC0xLTEtMjIzOA_6ff8a8e9-c4ef-4c2f-b013-9ebbed3567a2"
      unitRef="usd">793000</us-gaap:ContractWithCustomerLiability>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod
      contextRef="ie80373ee84ee409397695d20d023b830_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3Njg_89f9cb28-f3c8-4163-ad54-283343b895b7">P3Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod
      contextRef="ie80373ee84ee409397695d20d023b830_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3Njk_44209c4f-33c0-4f58-80aa-b19e2d3ebd11">P3Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d3d81698c934b4a954d49e51245e401_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI1ODk_51aa1381-082f-4786-8dc7-ae4d04e75a06"
      unitRef="usd">75000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="icdbe7e517bf742fb984721f52fab2d8d_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI2MTE_39368654-6954-4aff-9ecf-c05d57fb5519"
      unitRef="usd">380000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod
      contextRef="ie80373ee84ee409397695d20d023b830_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzODM0_334b82aa-11b9-4060-be38-ffac387a2ef3">P90D</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod
      contextRef="ie80373ee84ee409397695d20d023b830_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzODQy_85e3878c-bd78-408d-b452-3d7a784b9ad1">P180D</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie80373ee84ee409397695d20d023b830_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI2MzM_21668900-10ad-4d63-a12e-2128a68a29ca"
      unitRef="usd">75000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ib95741ea249d4f97a45a3892a2351840_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI2NTQ_f743bd3c-17da-42fa-9e2d-3625c49e5352"
      unitRef="usd">75000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ib95741ea249d4f97a45a3892a2351840_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI2NzU_8c3f9e64-e1a0-4b41-a329-3f682acc6b64"
      unitRef="usd">75000000.0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod
      contextRef="i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NzA_4b1601aa-a191-45a3-a068-6a151fedd0a0">P4Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ab2427a6c084cf9af1c48d8c688b9d4_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI1Njg_5e119333-1d37-4131-bdbb-8cfa0734c293"
      unitRef="usd">25000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod
      contextRef="i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NzE_f2dd76eb-6320-439c-af69-0e411d41c7e4">P4Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="id8c83ee462da4e3dba463ddbc3ee245b_D20201201-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1Xzk4OTU2MDQ4NjI1NDI_db034bcd-f0f4-4057-b2a0-0562cb8592d6"
      unitRef="usd">405000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod
      contextRef="i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NzI_f7996d7a-816c-4505-aa79-c432052c3c97">P4Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod
      contextRef="i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDY3NzM_104ed389-1b4e-4a73-add8-9d7919c1e0eb">P4Y</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i71d5a04ae7ee4c9facb541e95a628feb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0ZjFmOGUzZTFlNWE0ZDBiOGRlM2FjNGMwZmMyZWY0Ni90YWJsZXJhbmdlOjRmMWY4ZTNlMWU1YTRkMGI4ZGUzYWM0YzBmYzJlZjQ2XzMtMi0xLTEtMjI3MA_0cba4751-fd4d-4b59-b9ad-5b09a1a6b95c"
      unitRef="usd">25000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="if8775b14ae8d42ba85896b375b513e87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0ZjFmOGUzZTFlNWE0ZDBiOGRlM2FjNGMwZmMyZWY0Ni90YWJsZXJhbmdlOjRmMWY4ZTNlMWU1YTRkMGI4ZGUzYWM0YzBmYzJlZjQ2XzQtMi0xLTEtMjI3MA_84071ce4-9da0-418b-b9c8-fb1086ff05e6"
      unitRef="usd">17496000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie6671830e11c43fa9c3834eab410c9a4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo0ZjFmOGUzZTFlNWE0ZDBiOGRlM2FjNGMwZmMyZWY0Ni90YWJsZXJhbmdlOjRmMWY4ZTNlMWU1YTRkMGI4ZGUzYWM0YzBmYzJlZjQ2XzUtMi0xLTEtMjI3MA_7e95efe8-746d-4df6-87c6-16ed5f050571"
      unitRef="usd">42496000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i7916b94daf6644a1ac5fd27053af9d56_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2YjdhZmZlZjA0ZmY0MGI4Yjc0MGRjYWM2NWNiYzhjMi90YWJsZXJhbmdlOjZiN2FmZmVmMDRmZjQwYjhiNzQwZGNhYzY1Y2JjOGMyXzQtMi0xLTEtMzE3NQ_ff291e43-e205-41d9-92dd-c2eefb25299e"
      unitRef="usd">42496000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i927d619ab07840569348f4a56e6f7fd9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90YWJsZTo2YjdhZmZlZjA0ZmY0MGI4Yjc0MGRjYWM2NWNiYzhjMi90YWJsZXJhbmdlOjZiN2FmZmVmMDRmZjQwYjhiNzQwZGNhYzY1Y2JjOGMyXzUtMi0xLTEtMzE3NQ_295e348c-3cf6-4b54-81c4-0d05686191c7"
      unitRef="usd">42293000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifed27586ee884f47a07d016946f33a60_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzQ5NDc4MDI3MDc5MzQ_d7f44cb9-7889-497a-8308-92aed4a639b7"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i485a222ab1ab4c8aac1f1cbc39e1b10a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzE5_ac3d8442-9054-446e-a60c-c75ab417eaa5"
      unitRef="usd">17300000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ifed27586ee884f47a07d016946f33a60_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzA0_eae56eaf-a75f-45d2-b4b1-3c098bd402c2"
      unitRef="usd">25000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ie6671830e11c43fa9c3834eab410c9a4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNjg3_f86349fe-f25a-4910-954b-890c5a1195b1"
      unitRef="usd">25000000.0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzIwOTA_a183301c-a3a7-4e49-bbac-f74a6305efbb">Financial Instruments and Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents and Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our cash and available-for-sale securities by significant investment category at December 31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cash and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Non-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,623,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,623,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,623,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;215,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,888,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,892,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,276,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,242,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,246,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,623,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,983,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="45" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cash and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Non-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;834,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;836,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,259,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,262,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;235,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;867,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and estimated fair value of marketable securities, by contractual maturity at December 31, 2020 and 2019 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,983,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,618,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,622,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with our investment policy, we place investments in investment grade securities with high credit quality issuers, and generally limit the amount of credit exposure to any one issuer. We evaluate securities for impairment at the end of each reporting period. We did not record any impairment charges related to our available-for-sale securities during the&#160;years ended December 31, 2020, 2019 and 2018. We did not recognize any credit losses related allowance to available-for-sale securities as of the years ended December 31, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amount of gross unrealized losses and the estimated fair value for our available-for-sale securities in an unrealized loss position by length of time the securities have been in an unrealized loss position at December 31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or More&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020 and 2019, we held 108 and 19 individual available-for-sale securities, respectively, out of our total investment portfolio that were in a continuous unrealized loss position for less than 12 months. We neither intend to sell these investments nor conclude that we are more-likely-than-not that we will have to sell them before recovery of their carrying values. We also believe that we will be able to collect both principal and interest amounts due to us at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our financial assets measured at fair value on a recurring basis as of December 31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (Note 7)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,243,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,622,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2020 and 2019, we did not have any financial liabilities measured at fair value on a recurring basis and did not have non-financial assets or liabilities measured at fair value on a recurring basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzIwODY_654374a6-7c69-4d71-becb-1edd6e4a920d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our cash and available-for-sale securities by significant investment category at December 31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cash and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Non-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,623,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,623,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,623,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;238,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;215,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;491,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,888,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,892,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,276,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;615,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,242,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,246,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,623,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,983,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;638,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="45" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cash and&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Non-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Current&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Marketable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;834,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;836,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;687,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,259,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,262,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;235,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;867,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;159,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idaa6defda34a4c4d932f1760b89de1bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItMi0xLTEtMA_9c2ccff6-5ad4-4e48-ae9c-eb686a19ac0c"
      unitRef="usd">2623849000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idaa6defda34a4c4d932f1760b89de1bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItNC0xLTEtMA_d3f73ab4-f39c-497d-8e52-402679e31a1e"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idaa6defda34a4c4d932f1760b89de1bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItNi0xLTEtMA_30fd2567-1347-414d-b03a-9423b0bb2d24"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idaa6defda34a4c4d932f1760b89de1bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItOC0xLTEtMA_bd4c3b74-50e6-4560-8108-338a2d59df62"
      unitRef="usd">2623850000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i99a06be594a943e1a989839f0ffb78dc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItMTAtMS0xLTA_88176d8b-10b5-46fe-9c3f-6f73ede25940"
      unitRef="usd">2623850000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie0f3f6d0fe374c3bb4e9274841921099_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItMTItMS0xLTA_a5356cfa-d25b-40af-801d-fcf9ad80888d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0721e19a82dc4039bc8fd234b6cb6467_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzItMTQtMS0xLTA_c27e863b-53b4-4d17-a311-96a8a7a42bf0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3f82068d4e014cd3b0ee0ee048db1dfc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtMi0xLTEtMA_08f2329b-56bb-44a5-9335-86f8c3653338"
      unitRef="usd">238774000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3f82068d4e014cd3b0ee0ee048db1dfc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtNC0xLTEtMA_8a81d7a3-0945-4711-8312-30e7efe0ec12"
      unitRef="usd">49000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3f82068d4e014cd3b0ee0ee048db1dfc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtNi0xLTEtMA_272a0be6-0245-477f-b402-ad241d8cfc2d"
      unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3f82068d4e014cd3b0ee0ee048db1dfc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtOC0xLTEtMA_b70328a6-7dcb-4a30-bcd5-6ff5a87b30af"
      unitRef="usd">238819000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id80775b1abbd4c83a0c7b6a0f1187d02_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtMTAtMS0xLTA_4496d609-dfdd-4533-a3d9-e478e78cf963"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6823e77a4aea4168b1bc6bd432b8c5f0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtMTItMS0xLTA_cb53a085-788d-4a80-9ce2-b3dbf3d3218f"
      unitRef="usd">215389000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i39aad2a193424f66b1a29c5062031f07_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzUtMTQtMS0xLTA_353cb18b-a155-43fa-89a1-475e6cfb70c0"
      unitRef="usd">23430000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i996f146052f5425ab4c0c71f5c174fa6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtMi0xLTEtMA_9103ecef-4b2b-44a2-9290-8839e6e1b4b4"
      unitRef="usd">491549000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i996f146052f5425ab4c0c71f5c174fa6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtNC0xLTEtMA_0d8cc42f-9226-4824-86ef-33a987d2bd4b"
      unitRef="usd">69000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i996f146052f5425ab4c0c71f5c174fa6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtNi0xLTEtMA_7e5e6831-478f-4a8f-953b-2b20b35a6921"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i996f146052f5425ab4c0c71f5c174fa6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtOC0xLTEtMA_16bfec90-1987-4a09-97ef-7ae750400193"
      unitRef="usd">491618000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icef0d3913fd548d9aae035caa234d06f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtMTAtMS0xLTA_80594f38-1ef7-43ff-af26-6786295f62a2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i964440db25964be9b19c02aff5c46eef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtMTItMS0xLTA_944f887b-d5f4-4a15-82ab-6ea55abbb505"
      unitRef="usd">491618000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib2120d892fa64041a731353e8cb520f7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzYtMTQtMS0xLTA_28b42ad8-820f-40d5-be49-f902fc2f1fc7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7947068ef4b140cb8095b9ed2268d8ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctMi0xLTEtMA_bdded2b1-52ce-4c70-8840-43bf64ce22f3"
      unitRef="usd">1888022000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7947068ef4b140cb8095b9ed2268d8ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctNC0xLTEtMA_830fd43d-5ccb-4d88-951c-645e6e2c5ec0"
      unitRef="usd">4294000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7947068ef4b140cb8095b9ed2268d8ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctNi0xLTEtMA_f8b3cdbf-3df1-40c0-ade6-77c6b96e8262"
      unitRef="usd">147000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7947068ef4b140cb8095b9ed2268d8ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctOC0xLTEtMA_d0e2a395-50b2-4d52-9037-cf44bf937512"
      unitRef="usd">1892169000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8f339cc94e424df7982cd710e1c8fbcf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctMTAtMS0xLTA_0581670e-4a83-42cb-8c2d-f24e5d17ad34"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie57495990d1840ab8a3259591e49318c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctMTItMS0xLTA_dddec197-3ce0-45bb-ac19-715d6a8ab81c"
      unitRef="usd">1276751000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i571622ed8ff84fac92fa646c065d9071_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzctMTQtMS0xLTA_c6584270-85de-4602-91e7-5f8e01f5ba90"
      unitRef="usd">615418000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2dee05d95adb41a4a76b2b9fe164e598_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtMi0xLTEtMA_f208d757-6428-47c8-9fdf-279b8f2a2f56"
      unitRef="usd">5242194000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2dee05d95adb41a4a76b2b9fe164e598_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtNC0xLTEtMA_003445e5-a62e-4416-82c0-ed09b6e8a722"
      unitRef="usd">4413000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2dee05d95adb41a4a76b2b9fe164e598_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtNi0xLTEtMA_f6079761-ffa9-4cee-b0aa-4ecceb033bd3"
      unitRef="usd">151000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2dee05d95adb41a4a76b2b9fe164e598_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtOC0xLTEtMA_c3e9b819-bcf6-4058-924c-84001822b483"
      unitRef="usd">5246456000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i76e8315a6df54be8bfc95f09f6f3034a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtMTAtMS0xLTA_b6982acf-dc57-48a8-a18f-de89245e0810"
      unitRef="usd">2623850000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4fcf3aa943004b48b99acf53c21041eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtMTItMS0xLTA_75c49b9e-f262-4867-ab97-174566fa6dad"
      unitRef="usd">1983758000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ide75e7fae914434e8be15fac3dd2dfa1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzgtMTQtMS0xLTA_8fd0f721-d8c1-431b-8f8e-9f0d9281447e"
      unitRef="usd">638848000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie142da5d5a7142dfae28d3de3b0a7398_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTItMS0xLTA_5e6a3269-286f-4e27-9692-8cb03a0c8693"
      unitRef="usd">225874000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie142da5d5a7142dfae28d3de3b0a7398_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTQtMS0xLTA_7b75857f-8472-4c1e-ab60-bf312778a204"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie142da5d5a7142dfae28d3de3b0a7398_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTYtMS0xLTA_7ac19ad0-81e6-4b7c-a123-da7b5cc443b3"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie142da5d5a7142dfae28d3de3b0a7398_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTgtMS0xLTA_800c3775-5c24-4db0-a757-8ec06eee3288"
      unitRef="usd">225874000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if6a6eab513bd479c8ee7b20cf6c72b5c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTEwLTEtMS0w_10586f73-09d9-4425-8f0e-3be91cb99897"
      unitRef="usd">225874000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i85f6292c70ae4905b5aa94e6b6388d63_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTEyLTEtMS0w_19e20d0c-ba13-460b-9e7b-3f3d79aaf6e5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5deec5b143314f2491823db42ac2c318_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzEyLTE0LTEtMS0w_75e9bd7b-44e6-4aea-9ef5-0e7402de561d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idf5b8160d74845bcbadcdc11cae28b39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTItMS0xLTA_30269281-ab7d-41cd-b420-ed08c1e1eda3"
      unitRef="usd">82028000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idf5b8160d74845bcbadcdc11cae28b39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTQtMS0xLTA_9ce30fe5-5f4e-4f78-abaa-7e95e612279d"
      unitRef="usd">79000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idf5b8160d74845bcbadcdc11cae28b39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTYtMS0xLTA_de5d62f9-8a90-4558-b513-8949a75ea430"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idf5b8160d74845bcbadcdc11cae28b39_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTgtMS0xLTA_d57141db-b797-4ce0-95e9-2a9dfe46e0b4"
      unitRef="usd">82101000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id8d8c21441bd4fc3927d70eb5b4e9cb0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTEwLTEtMS0w_40f0a7c2-259a-4080-8b48-dc146faa0e95"
      unitRef="usd">10002000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3e09bdef5a344ade862de02fe62cbd4f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTEyLTEtMS0w_892b7c03-ebe7-4590-b8d5-c518bbe9f94c"
      unitRef="usd">69197000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5711c49fcbec48988da71f366d87842a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE1LTE0LTEtMS0w_9f482063-0917-4035-87fa-dbb22d04cd35"
      unitRef="usd">2902000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i595f9f5c7de04040938f423373395fd2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTItMS0xLTA_ef2e430a-ff25-4357-9e93-784819b25439"
      unitRef="usd">117891000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i595f9f5c7de04040938f423373395fd2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTQtMS0xLTA_8c8a6b68-351d-4be1-aa33-c73c9d76acda"
      unitRef="usd">260000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i595f9f5c7de04040938f423373395fd2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTYtMS0xLTA_4891d88b-5e96-4570-93dc-252c8e605de2"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i595f9f5c7de04040938f423373395fd2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTgtMS0xLTA_de4d5733-da8d-4af1-b4a0-66b2aa877a85"
      unitRef="usd">118149000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib098be9e25b24dd6963f1bce92ec3842_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTEwLTEtMS0w_8b704c98-e8e9-40f6-abea-d4b471107d41"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8337e774481849ea898503604f8098ed_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTEyLTEtMS0w_9d7305a2-1258-4a8c-b61a-baba1e426094"
      unitRef="usd">110186000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8c6c58de542642c998e43061db878c5d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE2LTE0LTEtMS0w_236ecfc2-f526-4249-83f5-13bc14aaee9c"
      unitRef="usd">7963000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i56140fc5415b465091fac71874a1d04c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTItMS0xLTA_e5cc6ee1-ed12-4cfa-8de8-be625a0aa388"
      unitRef="usd">834187000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i56140fc5415b465091fac71874a1d04c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTQtMS0xLTA_aedead34-7dd0-4fec-81d2-770779666904"
      unitRef="usd">2708000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i56140fc5415b465091fac71874a1d04c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTYtMS0xLTA_edb5a0e8-0bcf-4b7b-988f-abcf73d78dda"
      unitRef="usd">32000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i56140fc5415b465091fac71874a1d04c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTgtMS0xLTA_673f8537-fc64-4763-bece-d92c03f715db"
      unitRef="usd">836863000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3679a9fffc96449eb191d1d92e564cb9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTEwLTEtMS0w_89562705-e01a-4dbb-8c73-a734871caedb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8f97faca187a40e7932e5f1ed655d0e4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTEyLTEtMS0w_0adb536a-48a5-42a0-bdd1-1e4ddf1de332"
      unitRef="usd">687741000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i33126ccd28674b319b0f542852efad14_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE3LTE0LTEtMS0w_b21c2a24-966c-476d-80fd-768c40fc48be"
      unitRef="usd">149122000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id9134c7c3c5e41aaad7c846573608b98_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTItMS0xLTA_6269556e-8519-4c36-a4ac-2b9272c963f1"
      unitRef="usd">1259980000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id9134c7c3c5e41aaad7c846573608b98_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTQtMS0xLTA_b8bcf194-a4f6-4107-bc53-6d720e441985"
      unitRef="usd">3047000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id9134c7c3c5e41aaad7c846573608b98_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTYtMS0xLTA_90146b22-391c-4f90-aafc-a8696c26d560"
      unitRef="usd">40000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id9134c7c3c5e41aaad7c846573608b98_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTgtMS0xLTA_019cf1f3-945a-4dba-a3f3-01fcc5b56ae5"
      unitRef="usd">1262987000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib0cecee608c2404fb5cd0656311e9766_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTEwLTEtMS0w_e665bfe4-279e-4ac7-b85d-8632635aa7af"
      unitRef="usd">235876000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia40c55509686422ea2a7aeb0800b0708_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTEyLTEtMS0w_539bf146-3962-4789-9c85-4c3851578ad6"
      unitRef="usd">867124000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i94845de97f3740f29eb21f83595555aa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphMDQyZDMzYjU0ODg0YjAxYWU1ODIxZjIwZTEzMDcyNC90YWJsZXJhbmdlOmEwNDJkMzNiNTQ4ODRiMDFhZTU4MjFmMjBlMTMwNzI0XzE4LTE0LTEtMS0w_b432db56-c2de-474a-9f7c-9acc9e8e5dc1"
      unitRef="usd">159987000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzIwODg_516a989c-2346-43b4-9f76-e5b4eab51ee8">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and estimated fair value of marketable securities, by contractual maturity at December 31, 2020 and 2019 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,980,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,983,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,618,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,622,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;864,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzItMi0xLTEtMA_e2f8e44d-1ed0-45f6-b00c-f951028ef0f1"
      unitRef="usd">1980963000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzItNC0xLTEtMA_6c3b4fe3-e0a9-4e3e-90c8-e6834188dd7c"
      unitRef="usd">1983758000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzMtMi0xLTEtMA_ed3df0eb-3cf3-4a23-a07f-39189c52b799"
      unitRef="usd">637382000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzMtNC0xLTEtMA_049a4b24-c1bd-41d3-80a6-344543029c78"
      unitRef="usd">638848000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzQtMi0xLTEtMA_bfc82607-b6db-4e83-a3e7-3fbd74f79e69"
      unitRef="usd">2618345000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzQtNC0xLTEtMA_909fc592-7133-45be-b23c-91c8274ec9b2"
      unitRef="usd">2622606000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzctMi0xLTEtMA_8c41e95e-e9a5-4b19-8198-ffd232e14bf0"
      unitRef="usd">864958000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzctNC0xLTEtMA_4a41786c-8177-4586-9710-4d65bf5855ef"
      unitRef="usd">867124000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzgtMi0xLTEtMA_ef055ba2-0126-4186-a03e-ee41ff65ded2"
      unitRef="usd">159148000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzgtNC0xLTEtMA_d3f53e89-72f6-472d-8e20-5cac17ce602b"
      unitRef="usd">159987000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzktMi0xLTEtMA_200e53c0-a954-4ecf-b3f0-ea697fab0e4a"
      unitRef="usd">1024106000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTphOTY4MWU3Nzc2N2M0ZmRkYjhkNjQ3YzM4MjcwNTM3Yi90YWJsZXJhbmdlOmE5NjgxZTc3NzY3YzRmZGRiOGQ2NDdjMzgyNzA1MzdiXzktNC0xLTEtMA_679700b8-1a08-4d6c-9332-653803ec6606"
      unitRef="usd">1027111000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEzMTk0MTM5NTM5NjM2_330a07db-7072-401c-a194-0ea74ec43132"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEzMTk0MTM5NTM5NjM2_a9da6f44-a7a7-4ceb-92f3-c7cfd4baf9b6"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEzMTk0MTM5NTM5NjM2_e3e1fe3e-e27f-4fdc-9d5d-a6d4b90c8ad1"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzk4OTU2MDQ2NTM1OTY_b9ac8da1-84d3-4094-854d-d0d1bc119906">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amount of gross unrealized losses and the estimated fair value for our available-for-sale securities in an unrealized loss position by length of time the securities have been in an unrealized loss position at December 31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 Months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 Months or More&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtMi0xLTEtMjM1OQ_6323ae6a-bcf4-407a-bb2f-c0b855356bce"
      unitRef="usd">4000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtNC0xLTEtMjM1OQ_a98f27b4-f333-4062-b9fb-368076a6bc9f"
      unitRef="usd">81524000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtNi0xLTEtMjM1OQ_08ea2607-4765-4d25-975a-c4332a588303"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtOC0xLTEtMjM1OQ_427b3fe2-9c11-4126-aecb-cd80e53901e9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtMTAtMS0xLTIzNTk_9aa7d831-15a1-4fbc-85ff-0065e8977e19"
      unitRef="usd">4000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i82ef8a8f960d4586b4b70315e91428ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzMtMTItMS0xLTIzNTk_0bb273c5-822c-4547-b5c8-cb051dcaddf2"
      unitRef="usd">81524000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i537052846af24b89bb148e79200f55b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtMi0xLTEtMjM1OQ_49899342-ffa1-408b-9c70-01d6add89a74"
      unitRef="usd">148000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i537052846af24b89bb148e79200f55b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtNC0xLTEtMjM1OQ_7d582ed1-a723-49bb-aa20-58faca508966"
      unitRef="usd">507016000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i537052846af24b89bb148e79200f55b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtNi0xLTEtMjM1OQ_e85a72c2-9456-47be-94c1-7131af8e0df0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i537052846af24b89bb148e79200f55b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtOC0xLTEtMjM1OQ_c17256fb-ec02-4c44-b5f2-0143d6458e57"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i537052846af24b89bb148e79200f55b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtMTAtMS0xLTIzNTk_593fcdc4-8322-442b-b2f9-fe9a8b16c7ce"
      unitRef="usd">148000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i537052846af24b89bb148e79200f55b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzUtMTItMS0xLTIzNTk_c3883dd6-c771-42f0-8372-def6e0df5e3e"
      unitRef="usd">507016000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtMi0xLTEtMjM1OQ_5fdd8c38-5e6d-4a6e-ad76-033ef56f4186"
      unitRef="usd">152000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtNC0xLTEtMjM1OQ_4afff8f2-9cdd-4331-8176-0805f84d588c"
      unitRef="usd">588540000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtNi0xLTEtMjM1OQ_fcd25fc8-af39-47d5-81f3-c135922b5eaf"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtOC0xLTEtMjM1OQ_89a6d35b-5641-475d-bca9-d02eaf644bca"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtMTAtMS0xLTIzNTk_eae80cb8-c2a9-44ef-af63-d3d21d61f658"
      unitRef="usd">152000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzYtMTItMS0xLTIzNTk_be4ae244-c497-4e03-b4aa-11803e0747b9"
      unitRef="usd">588540000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktMi0xLTEtMjM1OQ_5122b18a-d933-4eca-bac2-5538756af07a"
      unitRef="usd">6000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktNC0xLTEtMjM1OQ_2d1b206f-8989-4fab-86b4-d046f7ac4566"
      unitRef="usd">12822000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktNi0xLTEtMjM1OQ_c5d8c05b-ef3f-4814-b4d3-1b949ac85ac8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktOC0xLTEtMjM1OQ_58dda3ed-f7be-4b5e-a0de-2c876d79b5a3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktMTAtMS0xLTIzNTk_873a2967-6164-4967-847b-2419c6adc409"
      unitRef="usd">6000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ibe7c61bd076b43b49d7fba03cf8d8ca7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzktMTItMS0xLTIzNTk_bfb9e516-7025-4744-a0c3-d80f20527007"
      unitRef="usd">12822000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTItMS0xLTIzNTk_96d08c5c-99ad-4646-b641-c553f06bf6b0"
      unitRef="usd">2000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTQtMS0xLTIzNTk_0a2bd481-30fd-449c-8b5d-53de82f5ea08"
      unitRef="usd">9979000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTYtMS0xLTIzNTk_bfbcca71-0ca1-4260-8025-266741157921"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTgtMS0xLTIzNTk_1fc0cc9e-6cf5-430b-8133-6e0ca3292197"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTEwLTEtMS0yMzU5_4890a2b9-7fe2-4cc3-a1f7-66991a6b14fe"
      unitRef="usd">2000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i9ab59ae2ae3446928c5af56bfa301632_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEwLTEyLTEtMS0yMzU5_d63927b6-587a-4840-a6af-91fb0ed2e4e1"
      unitRef="usd">9979000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib1643b608a454ba48f175331a4403c94_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTItMS0xLTIzNTk_52e7b08f-21b9-4a6d-9829-7ca130f24dad"
      unitRef="usd">32000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib1643b608a454ba48f175331a4403c94_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTQtMS0xLTIzNTk_33b6d11f-15b4-46e0-bceb-a1b2a4553cf9"
      unitRef="usd">62360000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib1643b608a454ba48f175331a4403c94_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTYtMS0xLTIzNTk_d680608e-21aa-4c7b-9c07-203d24418d2f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib1643b608a454ba48f175331a4403c94_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTgtMS0xLTIzNTk_81f65b28-0b36-486e-910a-400ed78ebf2b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib1643b608a454ba48f175331a4403c94_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTEwLTEtMS0yMzU5_e9ec6d2d-36f5-4aad-8bd3-68153a1e47be"
      unitRef="usd">32000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib1643b608a454ba48f175331a4403c94_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzExLTEyLTEtMS0yMzU5_f812c66d-e6db-4d64-b4bb-5c1b8adf2b67"
      unitRef="usd">62360000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTItMS0xLTIzNTk_f57b0c33-bb35-44ea-a9f4-4773dd88d684"
      unitRef="usd">40000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTQtMS0xLTIzNTk_6cd02045-561f-4dbc-98a0-3083786acc01"
      unitRef="usd">85161000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTYtMS0xLTIzNTk_f8659439-72e7-43a7-81e6-82712e863bc8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTgtMS0xLTIzNTk_c78d97ca-38c7-4a5d-b1e6-9debd62d90f4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTEwLTEtMS0yMzU5_b2d6187f-9d48-400e-ab9f-84435c1e3b79"
      unitRef="usd">40000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3OTZmNjlmY2RlMjg0OGIwOGU0NDkyNDUyN2MyZWYxMC90YWJsZXJhbmdlOjc5NmY2OWZjZGUyODQ4YjA4ZTQ0OTI0NTI3YzJlZjEwXzEyLTEyLTEtMS0yMzU5_739a333c-4f31-47f5-a215-206421cd2252"
      unitRef="usd">85161000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEwNDQ1MzYwNDc1OTI3_a8443014-6b8b-4c46-8725-9b4f842d08b4"
      unitRef="security">108</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEwNDQ1MzYwNDc1OTMy_3e6aa3d1-00a1-40b8-856c-c7aeda3545e5"
      unitRef="security">19</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90ZXh0cmVnaW9uOjYwYzJlNTliODY3ODQzZDk5ZDc3MzVmNzgwOGY5OGYyXzEwNDQ1MzYwNDc5MTc5_bd258927-17d5-4177-a0c7-a5fe7a8e05e2">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our financial assets measured at fair value on a recurring basis as of December 31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments (Note 7)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,243,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,622,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurement Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities of U.S. government agencies and corporate entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;836,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8b335d06520e4536aa8cb118383a9e23_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzMtMi0xLTEtMTg3NDM_93e6638f-d69b-4211-acf4-de280ce704cc"
      unitRef="usd">620947000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia6ca9dac78c340bba06590609c9470cc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzMtNC0xLTEtMTg3MTc_dbe602f4-2d7e-4dc5-80bc-b8f769552ba6"
      unitRef="usd">620947000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7f78c3ac89654cd9b1f1e7b8bc2a2df3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzMtNi0xLTEtMTg3MTc_de0b1f67-70ef-45a9-bf76-65e23d479fb5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4b7c40b209f7432bad8109c7ff3676d5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzQtMi0xLTEtMTg3MTc_c4624e4f-2f67-49e0-96ec-bab401a05f7d"
      unitRef="usd">238819000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8568db59e98348d5b7ca8485856bbd75_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzQtNC0xLTEtMTg3MTc_ae80c54b-2bfd-4f62-ac2f-c9e7057ae2a7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0d25a112fd9d498c8f8fea65aa96a2b1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzQtNi0xLTEtMTg3MTc_5e16e26e-344a-49f3-b5c8-071a3aafb140"
      unitRef="usd">238819000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2cf18fd57bb2482194f59b63056872c4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzUtMi0xLTEtMTg3MTc_7b6bb1bf-6bc5-4931-a794-26865e593ff8"
      unitRef="usd">491618000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8c2ec2379a2440c98b39d472944fc58a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzUtNC0xLTEtMTg3MTc_e4bdb57c-7bae-4394-85f1-aed712ec11e7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idd8faf6c9e064166a193a079404e5f6c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzUtNi0xLTEtMTg3MTc_5fab24d3-bc64-480b-a4df-1616ec5ef87d"
      unitRef="usd">491618000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i415a12cbcecd4182b9b75a85618710ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzYtMi0xLTEtMTg3MTc_e29def4a-b0fa-40e5-92fb-ee1c14d27abd"
      unitRef="usd">1892169000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3f50ef9dcfe04ebd9ffd657cbf135f93_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzYtNC0xLTEtMTg3MTc_fba5e711-b433-40e6-b29f-22bad5d20c2f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iddd4aa81b7a24685aff1379ef5b70952_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzYtNi0xLTEtMTg3MTc_a77d7685-16bb-477e-bc53-31a42ffe5633"
      unitRef="usd">1892169000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeAssets
      contextRef="i7d497d05b06c42e4ac9fccf950c4da8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzctMi0xLTEtMTg3MTc_6597f886-7dd0-4535-bb24-b1ce01e3b9e5"
      unitRef="usd">293000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ice8d50a6d09a405c9102e4f3dd28be53_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzctNC0xLTEtMTg3MTc_816876c5-2213-4da3-807e-392c6f826895"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i435ec70bb8f44c8f98a7c85f98319563_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzctNi0xLTEtMTg3MTc_b9012653-7a35-4ab0-8cdc-b1d0d3765e61"
      unitRef="usd">293000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7d497d05b06c42e4ac9fccf950c4da8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzgtMi0xLTEtMTg3ODI_4e238b82-3482-40b6-8dab-845c0cb05546"
      unitRef="usd">3243846000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ice8d50a6d09a405c9102e4f3dd28be53_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzgtNC0xLTEtMTg3ODQ_7f744117-0325-4080-84b1-80702a040294"
      unitRef="usd">620947000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i435ec70bb8f44c8f98a7c85f98319563_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo3ZTc4ODM5Y2RjYzU0ZDM1YWUxN2MxMzdhNDVkNGVhZC90YWJsZXJhbmdlOjdlNzg4MzljZGNjNTRkMzVhZTE3YzEzN2E0NWQ0ZWFkXzgtNi0xLTEtMTg3ODY_f61b1db4-0bde-4be2-b265-bb866d2ed37d"
      unitRef="usd">2622899000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iac8874c6a20b43398d1ddc844bbce921_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzQtMi0xLTEtMTg3MjQ_464fb4f2-64f0-425b-8b97-dc70be67ae52"
      unitRef="usd">82101000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3ff0406894b54724bcaadabdc19dd9da_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzQtNC0xLTEtMTg3MjQ_abb38f19-402a-4f95-856c-2f592e2089a2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id2404bad267f4f3e822b71ad8835e7ce_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzQtNi0xLTEtMTg3MjQ_31954a4d-d487-42e6-bf34-1136055c5406"
      unitRef="usd">82101000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id2404bad267f4f3e822b71ad8835e7ce_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzQtNi0xLTEtMTg3MjQ_61779437-bd17-44b6-bf3d-668fa5fc44a0"
      unitRef="usd">82101000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a45bbb5f0fd487aa6bea47688234221_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzUtMi0xLTEtMTg3MjQ_2c234e80-c947-4f96-80a2-9b87e5788773"
      unitRef="usd">118149000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i93edb11d678e409e93fec11af2f7d699_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzUtNC0xLTEtMTg3MjQ_772a355d-523d-45ad-ba9f-41f70612180f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic32def168edf4442a4f6912414e3f4bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzUtNi0xLTEtMTg3MjQ_278e9fad-9d5a-4458-902e-ead37c235941"
      unitRef="usd">118149000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic32def168edf4442a4f6912414e3f4bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzUtNi0xLTEtMTg3MjQ_69c9fc1c-ad9b-4e8a-97e4-22931199bbe1"
      unitRef="usd">118149000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icac57ca879c546568a22b09873f17e85_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtMi0xLTEtMTg3MjQ_73d575b5-c7e5-40b6-a365-aa9306335a5e"
      unitRef="usd">836863000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iee48996722c54941b70a1cc762872f9f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNC0xLTEtMTg3MjQ_1e2fa255-af71-4958-b576-c524ff169e29"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i48df454a47ab493e9a020ee1d9e830c1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNi0xLTEtMTg3MjQ_79ed05de-551e-4055-bb1f-a2aa3db9f297"
      unitRef="usd">836863000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i48df454a47ab493e9a020ee1d9e830c1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNi0xLTEtMTg3MjQ_c3269ed8-b1c3-45a3-be6e-5c4b01b220ca"
      unitRef="usd">836863000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7803fa02ca4547a9871f8bdeb3407587_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtMi0xLTEtMTg3ODg_38cd0fe6-35ae-4360-89d4-bf45efb107ec"
      unitRef="usd">1037113000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if68a771f3e9646a3af1d44b31f4770c5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNC0xLTEtMTg3OTA_358468d9-5038-4c49-a459-f8eb9c14100a"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id4bbb095206742338a02ee9ddcc36c12_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNi0xLTEtMTg3OTI_505e1662-0449-47ec-9f33-ee960a8c681c"
      unitRef="usd">1037113000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id4bbb095206742338a02ee9ddcc36c12_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNTcvZnJhZzo2MGMyZTU5Yjg2Nzg0M2Q5OWQ3NzM1Zjc4MDhmOThmMi90YWJsZTo5NjdmMDg4ZTk1YWE0MWIwODdlNzhiM2FiNzZjNTAyZS90YWJsZXJhbmdlOjk2N2YwODhlOTVhYTQxYjA4N2U3OGIzYWI3NmM1MDJlXzYtNi0xLTEtMTg3OTI_de7b359d-4630-4cb9-9319-d5b3efa9b7dd"
      unitRef="usd">1037113000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGV4dHJlZ2lvbjoxMmMzYmJmYjk4NDg0ZmQ5YmI2Yzg5OWFlMGEyYWI4Zl8xMDQ0NTM2MDQ3MjI2OQ_c338a57c-2289-4d95-b12a-3d2221e96e4e">Derivative Financial Instruments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We transact business in various foreign currencies and have international sales and expenses denominated in foreign currencies. Therefore, we are exposed to certain risks arising from both our business operations and economic conditions. Our risk management strategy includes the use of derivative financial instruments to hedge foreign currency exchange rate fluctuations on monetary assets or liabilities denominated in foreign currencies. We do not enter into derivative financial contracts for speculative or trading purposes. We do not believe that we are exposed to more than a nominal amount of credit risk in our foreign currency hedges, as counterparties are large, global and well-capitalized financial institutions. We classify cash flows from our derivative transactions as cash flows from operating activities in our consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Balance Sheet Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our foreign currency forward contracts, primarily accounts receivable, are not designated for hedge accounting treatment. Therefore, these forward contracts are accounted for as derivatives whereby the fair value of the contracts are reported as other current assets or other current liabilities on our consolidated balance sheets, and gains and losses resulting from changes in the fair value are recorded as a component of other (expense) income, net, in our consolidated statements of operations. The gains and losses on these foreign currency forward contracts generally offset the gains and losses in the underlying foreign currency denominated assets and liabilities, which are also recorded to other (expense) income, net, in our consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross notional amount and fair value for foreign currency derivatives that are not designated as hedging instruments are accounted for as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As presented in the consolidated balance sheet within other current assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We did not have any derivative instruments as of December 31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The effect of foreign currency forward contracts not designated as hedging instruments in our consolidated statements of operations for the year ended December 31, 2020 was as follows (in thousand):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.773%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.773%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Statement of Operations Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;br/&gt; December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;There were no hedging activities for the years ended December 31, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGV4dHJlZ2lvbjoxMmMzYmJmYjk4NDg0ZmQ5YmI2Yzg5OWFlMGEyYWI4Zl8xMDQ0NTM2MDQ3MjI3MA_b54f9a37-20e2-46d1-b5f2-00e1d5b39c24">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross notional amount and fair value for foreign currency derivatives that are not designated as hedging instruments are accounted for as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As presented in the consolidated balance sheet within other current assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The effect of foreign currency forward contracts not designated as hedging instruments in our consolidated statements of operations for the year ended December 31, 2020 was as follows (in thousand):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.062%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.773%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.773%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Statement of Operations Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended&lt;br/&gt; December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other (expense) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i04c7af5cb0944a609bc48c18ac1199c8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV80LTItMS0xLTY4NDg_a39fa198-47e1-4e45-8e8d-738538537b97"
      unitRef="usd">368448000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i04c7af5cb0944a609bc48c18ac1199c8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV80LTQtMS0xLTY4NTI_e033634b-dfdd-4c8e-9d4c-a730f4923df7"
      unitRef="usd">293000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i04c7af5cb0944a609bc48c18ac1199c8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV80LTYtMS0xLTY4NTY_fe3b40d4-cbba-4fc9-9bb5-8ce68750edb1"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i79bfa2998ec14f64b6ac249d9dba29fc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV81LTItMS0xLTY4NTA_37a14af6-c8dc-4596-a6ef-770e78a9d2f3"
      unitRef="usd">368448000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i79bfa2998ec14f64b6ac249d9dba29fc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV81LTQtMS0xLTY4NTQ_f9401422-aba2-448b-a07e-36908c5fe198"
      unitRef="usd">293000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i79bfa2998ec14f64b6ac249d9dba29fc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6ZTJjYWM1YjJhMzlhNGM2ZDk2NDk4YzExMjM0MjRhNjkvdGFibGVyYW5nZTplMmNhYzViMmEzOWE0YzZkOTY0OThjMTEyMzQyNGE2OV81LTYtMS0xLTY4NTg_4f2d5ed9-39b8-4451-8842-278e87c13421"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i17d27b5a687e47f0b3b24ad613e488ba_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6NjhhYzcwZWU5MGNhNDJkYzk3NzY0NDg5NzMyZGQ1YzYvdGFibGVyYW5nZTo2OGFjNzBlZTkwY2E0MmRjOTc3NjQ0ODk3MzJkZDVjNl8zLTQtMS0xLTY4NjA_fed8dbd9-ff7a-421b-8eab-d1e818d861c2"
      unitRef="usd">293000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ia68a26c9b80a46b89ff40f182120a6bb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDA3L2ZyYWc6MTJjM2JiZmI5ODQ4NGZkOWJiNmM4OTlhZTBhMmFiOGYvdGFibGU6NjhhYzcwZWU5MGNhNDJkYzk3NzY0NDg5NzMyZGQ1YzYvdGFibGVyYW5nZTo2OGFjNzBlZTkwY2E0MmRjOTc3NjQ0ODk3MzJkZDVjNl80LTQtMS0xLTY4NjI_b073b0a2-3762-42f6-9792-13c68fe4b609"
      unitRef="usd">293000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGV4dHJlZ2lvbjo0NDQ0ZDE4NWQwOTA0ZGZiODQyYWY5ZGQ3ZTllMGRlYl8xMDQ0NTM2MDQ2NDUzMA_22a6c0f9-0f12-4551-8ee2-4f8287c43940">Inventory&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory as of December 31, 2020 consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We did not have any inventory at December 31, 2019.</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGV4dHJlZ2lvbjo0NDQ0ZDE4NWQwOTA0ZGZiODQyYWY5ZGQ3ZTllMGRlYl8xMDQ0NTM2MDQ2NDUzMQ_ae7431ac-8455-428b-b66f-a2652473fc7e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory as of December 31, 2020 consists of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGFibGU6Yzg0OTI2ODk0ZDMwNDgyNjkwZjFkMWFmYmIzZWZkZmIvdGFibGVyYW5nZTpjODQ5MjY4OTRkMzA0ODI2OTBmMWQxYWZiYjNlZmRmYl8yLTItMS0xLTYxNzc_eb0b06e0-aaca-42aa-9741-8215f617b1b0"
      unitRef="usd">36222000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGFibGU6Yzg0OTI2ODk0ZDMwNDgyNjkwZjFkMWFmYmIzZWZkZmIvdGFibGVyYW5nZTpjODQ5MjY4OTRkMzA0ODI2OTBmMWQxYWZiYjNlZmRmYl8zLTItMS0xLTYxNzc_1b29245d-4576-4487-b1f4-9f30485e18b5"
      unitRef="usd">9015000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGFibGU6Yzg0OTI2ODk0ZDMwNDgyNjkwZjFkMWFmYmIzZWZkZmIvdGFibGVyYW5nZTpjODQ5MjY4OTRkMzA0ODI2OTBmMWQxYWZiYjNlZmRmYl80LTItMS0xLTYxNzc_d631d37f-9ba5-427f-bc39-b4c0745eb1b4"
      unitRef="usd">1290000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGFibGU6Yzg0OTI2ODk0ZDMwNDgyNjkwZjFkMWFmYmIzZWZkZmIvdGFibGVyYW5nZTpjODQ5MjY4OTRkMzA0ODI2OTBmMWQxYWZiYjNlZmRmYl81LTItMS0xLTY4NjQ_edc5e85a-eded-403f-8d52-4eb5e06b6357"
      unitRef="usd">46527000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDMyL2ZyYWc6NDQ0NGQxODVkMDkwNGRmYjg0MmFmOWRkN2U5ZTBkZWIvdGV4dHJlZ2lvbjo0NDQ0ZDE4NWQwOTA0ZGZiODQyYWY5ZGQ3ZTllMGRlYl80OTQ3ODAyMzI2MDE1_a773a4f0-6323-4cd8-86cd-4bf861684b9e"
      unitRef="usd">0</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGV4dHJlZ2lvbjo1YTYzMDM2MDE5MjE0OGJkYjNjMWZhYTBjYWYyOWY2ZF8xMDQ0NTM2MDQ2NDE2OQ_6f89cf58-6c43-4170-b1bf-867e5ef89c12">Property and Equipment&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internally developed software&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset, financing&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense for the&#160;years ended December 31, 2020, 2019 and 2018 was $31.3 million, $31.0 million, $24.9 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ib5b8e9cfd6ca448aa701acdac947ae5c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8yLTItMS0xLTYxNjA_be00a7c8-a11a-40d8-b7ed-1897bbfa9638"
      unitRef="usd">120714000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="iee04f0bed89c49668441e99337b4c6e9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8yLTQtMS0xLTYxNjA_30af7de5-0e7d-4713-8755-11517548ee12"
      unitRef="usd">108257000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i40944c7d8d6941028b74d51f0012965a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8zLTItMS0xLTYxNjA_cdddfabd-00c9-4af6-afc8-f93b1231e670"
      unitRef="usd">179901000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="id7f1f6b5edb444fd9d4b39047aec17fe_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8zLTQtMS0xLTYxNjA_b0edc006-1de8-471b-a14c-90cd549c346b"
      unitRef="usd">152426000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i029097fb98da493492487f2642eaca98_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl80LTItMS0xLTYxNjA_8375bb5b-3b27-4764-a189-b6f921771653"
      unitRef="usd">4662000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i9baf6f70a62949e58d3e834369eaf15d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl80LTQtMS0xLTYxNjA_05cd9d11-e3bf-4aad-9c3f-bb35f7d1ea9b"
      unitRef="usd">3316000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ie7599583c04c4bb2b5065bb8e0fcccac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl81LTItMS0xLTYxNjA_24809d47-cd4a-4897-b2f7-7d808c2804e5"
      unitRef="usd">13398000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ibfa4e9080e444a89ba97d4bb414498ec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl81LTQtMS0xLTYxNjA_3e745ac1-cb99-4138-aac8-a2bf32fddbb1"
      unitRef="usd">11985000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ie7293e7dd6fe468bbf9ea8382a321117_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl82LTItMS0xLTYxNjA_3e409457-6816-4a5f-96a7-5a784fe88c9c"
      unitRef="usd">7020000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i2a3475829320460094cd0d1af2b0eb08_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl82LTQtMS0xLTYxNjA_0931439d-f33f-47c4-852e-3b08e519c85b"
      unitRef="usd">7020000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i931a0fc9cb324f33bb8472be6674ba39_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl83LTItMS0xLTYxNjA_425a1115-53dc-4613-9150-24cfed1d906b"
      unitRef="usd">56348000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i2f4deb71bcf6418281042297367c1bea_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl83LTQtMS0xLTYxNjA_17e80ea7-56d1-4e70-8da8-21340215dc20"
      unitRef="usd">9853000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i9127d9980c58485bb596c9f9c0fe40f2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl84LTItMS0xLTYxNjA_80fb9128-c273-491b-b9be-2adc33d43a8c"
      unitRef="usd">34507000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i6ec608e56a914901a6ad79ac5be09f26_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl84LTQtMS0xLTYxNjA_4f2b1644-0665-4f04-8da2-a1a50a163143"
      unitRef="usd">3222000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl85LTItMS0xLTY4NzU_dccb6d12-d194-4dcf-bfb4-c24ad4e695fb"
      unitRef="usd">416550000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl85LTQtMS0xLTY4Nzc_d28d3ea4-f502-4ca2-9d14-866618f30c29"
      unitRef="usd">296079000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8xMC0yLTEtMS02MTYw_02fb9f4a-576b-44fb-9b8b-68f82b26b3a4"
      unitRef="usd">119661000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8xMC00LTEtMS02MTYw_59e6c8a6-3a14-4e68-90f4-42aca464f743"
      unitRef="usd">94584000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8xMS0yLTEtMS02ODc5_40648ac3-21e2-453e-aeca-50989deee0eb"
      unitRef="usd">296889000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGFibGU6ZjQwOGViZmU1YzIwNDZjYTgxM2VkNTk4M2ZmOGIwNmYvdGFibGVyYW5nZTpmNDA4ZWJmZTVjMjA0NmNhODEzZWQ1OTgzZmY4YjA2Zl8xMS00LTEtMS02ODgx_a380ee91-6808-43d8-bf5d-5cc0bf9d1899"
      unitRef="usd">201495000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGV4dHJlZ2lvbjo1YTYzMDM2MDE5MjE0OGJkYjNjMWZhYTBjYWYyOWY2ZF8zODQ4MjkwNjk3NDUz_23ad95ee-8074-422a-850d-16a1de4be986"
      unitRef="usd">31300000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGV4dHJlZ2lvbjo1YTYzMDM2MDE5MjE0OGJkYjNjMWZhYTBjYWYyOWY2ZF8zODQ4MjkwNjk3NDU4_1d91610a-3769-412e-a436-fbd471f1f89b"
      unitRef="usd">31000000.0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDI2L2ZyYWc6NWE2MzAzNjAxOTIxNDhiZGIzYzFmYWEwY2FmMjlmNmQvdGV4dHJlZ2lvbjo1YTYzMDM2MDE5MjE0OGJkYjNjMWZhYTBjYWYyOWY2ZF8zODQ4MjkwNjk3NDYz_e61d05da-d82e-4a2d-9693-1e0200ed6238"
      unitRef="usd">24900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90ZXh0cmVnaW9uOjNmOTM1ZDRkY2JjZjQzZmQ4OTU3ZmIwNTQyNzQ3ODlhXzczMA_dece174a-c029-4f7c-9853-400e2729056c">Balance Sheet Components&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prepaid Expenses and Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Down payments to manufacturing vendors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tenant incentives receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest receivable on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical trials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation-related&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other external goods and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities - financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities - operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activities in deferred revenue during the year ended December&#160;31, 2020 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Deductions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,881,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(82,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,799,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collaboration revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,009,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,044,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90ZXh0cmVnaW9uOjNmOTM1ZDRkY2JjZjQzZmQ4OTU3ZmIwNTQyNzQ3ODlhXzczMg_8d6b1429-7e21-4a01-b47c-621de92ee6a3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Down payments to manufacturing vendors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tenant incentives receivables&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest receivable on marketable securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <mrna:OtherPrepaidExpenseManufacturing
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzItMi0xLTEtMjQwMQ_005233d6-cef9-45ba-8a4e-8dbd17ca61cb"
      unitRef="usd">216538000</mrna:OtherPrepaidExpenseManufacturing>
    <mrna:OtherPrepaidExpenseManufacturing
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzItNC0xLTEtMjQwMQ_8ee87423-5b9f-414a-9a8e-d63be4410781"
      unitRef="usd">0</mrna:OtherPrepaidExpenseManufacturing>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzItMi0xLTEtMA_cf0cb9fe-4d5f-4f18-8dcd-1f55a1e8b06f"
      unitRef="usd">15647000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzItNC0xLTEtMA_a54c672f-2b07-4d4a-aab4-b5bdd8e22c47"
      unitRef="usd">8475000</us-gaap:PrepaidExpenseCurrent>
    <mrna:TenantIncentivesReceivablesCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzMtMi0xLTEtMA_64bcd7ec-ff14-4a0c-b5f4-0d5fefb19deb"
      unitRef="usd">10242000</mrna:TenantIncentivesReceivablesCurrent>
    <mrna:TenantIncentivesReceivablesCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzMtNC0xLTEtMA_59c30384-aa2e-41f2-9d7f-a59e844f8e75"
      unitRef="usd">4093000</mrna:TenantIncentivesReceivablesCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzQtMi0xLTEtMA_87dbf73c-fc36-4447-aeca-b127a873e537"
      unitRef="usd">9725000</us-gaap:InterestReceivableCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzQtNC0xLTEtMA_950f1096-3c86-442f-a416-15fab7762499"
      unitRef="usd">6835000</us-gaap:InterestReceivableCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzUtMi0xLTEtMA_bc09e13f-60a0-4365-9a88-9edcc62915a3"
      unitRef="usd">252152000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTpiYzczNzcwMjBjOTE0OWE0ODExZDQ5ZmRjNjc5OWE2ZS90YWJsZXJhbmdlOmJjNzM3NzAyMGM5MTQ5YTQ4MTFkNDlmZGM2Nzk5YTZlXzUtNC0xLTEtMA_da4a3766-05f3-428a-a7f1-65f7c0c174ea"
      unitRef="usd">19403000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90ZXh0cmVnaW9uOjNmOTM1ZDRkY2JjZjQzZmQ4OTU3ZmIwNTQyNzQ3ODlhXzcyOA_949b79db-a3ce-43e1-94d2-23bcf8db48c1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands): &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical trials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation-related&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other external goods and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <mrna:AccruedClinicalTrials
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzItMi0xLTEtMjQ0MA_0dc8d839-4714-4877-9a92-c1066594543f"
      unitRef="usd">97249000</mrna:AccruedClinicalTrials>
    <mrna:AccruedClinicalTrials
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzItNC0xLTEtMjQ0MA_9b5071db-1071-4be5-99d4-454cb341bece"
      unitRef="usd">6291000</mrna:AccruedClinicalTrials>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzMtMi0xLTEtMjQ0MA_881d8c59-d7d6-4903-973e-a7f777e53b50"
      unitRef="usd">95247000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzMtNC0xLTEtMjQ0MA_1a8558fa-d0c6-4a35-9acd-cda75707b31c"
      unitRef="usd">27428000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <mrna:RawMaterialsAccountsPayable
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtMi0xLTEtMTcyNDU_26ec9741-3157-48b8-a31f-e07dc4b1efcc"
      unitRef="usd">78085000</mrna:RawMaterialsAccountsPayable>
    <mrna:RawMaterialsAccountsPayable
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtNC0xLTEtMTcyNDU_477faae9-037e-439d-b261-a9af367ed353"
      unitRef="usd">0</mrna:RawMaterialsAccountsPayable>
    <mrna:AccruedManufacturing
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtMi0xLTEtMTcyNTU_64e24b2c-6391-42a5-90bb-d6dd24321a97"
      unitRef="usd">53412000</mrna:AccruedManufacturing>
    <mrna:AccruedManufacturing
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtNC0xLTEtMTcyNTU_38251f21-ad18-48f6-9816-adfc2d2a6010"
      unitRef="usd">5872000</mrna:AccruedManufacturing>
    <mrna:AccruedDevelopmentOperation
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtMi0xLTEtMTcyMzI_f59ce74e-b0ab-4c12-a14a-7de882a71aba"
      unitRef="usd">29253000</mrna:AccruedDevelopmentOperation>
    <mrna:AccruedDevelopmentOperation
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtNC0xLTEtMTcyMzI_7a9b8ea5-9cb1-40d2-ba2a-4ecefc898d3d"
      unitRef="usd">2567000</mrna:AccruedDevelopmentOperation>
    <mrna:AccruedPropertyAndEquipmentCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtMi0xLTEtMjQ0MA_04423e9d-bafe-4cc2-b0dc-7417f3a260d5"
      unitRef="usd">17576000</mrna:AccruedPropertyAndEquipmentCurrent>
    <mrna:AccruedPropertyAndEquipmentCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzQtNC0xLTEtMjQ0MA_ec9a9d0b-a323-45ec-b1bf-c44fc9da0a78"
      unitRef="usd">4029000</mrna:AccruedPropertyAndEquipmentCurrent>
    <mrna:Commercial
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtMi0xLTEtMTEyNDE_166c2a3d-3a3f-47a4-ac41-28f509b3cc05"
      unitRef="usd">6922000</mrna:Commercial>
    <mrna:Commercial
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtNC0xLTEtMTEyNDE_b2d40fff-d210-46f0-9395-60b73f0c1784"
      unitRef="usd">0</mrna:Commercial>
    <mrna:AccruedExternalGoodsAndServicesCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtMi0xLTEtMjQ0MA_1712c240-94a6-4424-b5c0-6b6af4163903"
      unitRef="usd">91847000</mrna:AccruedExternalGoodsAndServicesCurrent>
    <mrna:AccruedExternalGoodsAndServicesCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzUtNC0xLTEtMjQ0MA_3d1f7a6e-ac54-4451-8cba-8f126cca26eb"
      unitRef="usd">21465000</mrna:AccruedExternalGoodsAndServicesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzYtMi0xLTEtMA_f315268d-56ce-4644-adbb-7d859665fb72"
      unitRef="usd">469591000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZToxMzYxYjFlYzMxOWI0YjQyYmU1ZGZlODAzNTdjOGYxMi90YWJsZXJhbmdlOjEzNjFiMWVjMzE5YjRiNDJiZTVkZmU4MDM1N2M4ZjEyXzYtNC0xLTEtMA_d6e70960-3b32-4323-94a6-3b9696e966e0"
      unitRef="usd">67652000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90ZXh0cmVnaW9uOjNmOTM1ZDRkY2JjZjQzZmQ4OTU3ZmIwNTQyNzQ3ODlhXzQ5NDc4MDIzMzAzNjU_dba961cd-f005-45c0-bf9c-102081e728e2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities - financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities - operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzItMi0xLTEtNjc3OA_6de914dd-7658-4f33-9fd0-a96b293a2008"
      unitRef="usd">24328000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzItNC0xLTEtNjc3OA_e1a3513a-c82e-4e7f-b5b6-211b71dc5f5a"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzMtMi0xLTEtNjc3OA_a8253707-096a-40a7-b189-caa837563e04"
      unitRef="usd">5972000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzMtNC0xLTEtNjc3OA_444722dd-70f2-421f-88aa-8957a02e216c"
      unitRef="usd">3583000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzQtMi0xLTEtNjc3OA_d03d1d3d-e40e-40af-88bf-ce94a68f9b4f"
      unitRef="usd">3365000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzQtNC0xLTEtNjc3OA_051698a2-2a02-40e9-82f6-a6078ffdcbf8"
      unitRef="usd">1480000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzUtMi0xLTEtNjkzMg_66589b30-ab83-4125-9941-b0841a8c8b43"
      unitRef="usd">33665000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTphNTkyNTUwMGZkYTA0NDNhODBlMDRiOGFjZGEwNzNlMy90YWJsZXJhbmdlOmE1OTI1NTAwZmRhMDQ0M2E4MGUwNGI4YWNkYTA3M2UzXzUtNC0xLTEtNjkzNA_82c40834-85f2-40c8-918d-aa63f7df7dcc"
      unitRef="usd">5063000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="icc80cc31c16d4bb5b781ff93fa778e3d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzItMi0xLTEtMTI1NzU_3fd49392-440e-455c-bcde-2b0ff1cb7b94"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
      contextRef="i3af31ae8238a40b6a097aa5017de8edd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzItNC0xLTEtMTI1NzU_dad31536-37fc-4f2e-8dc2-97ef84b19e8b"
      unitRef="usd">3881303000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod
      contextRef="i3af31ae8238a40b6a097aa5017de8edd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzItNi0xLTEtMTI1NzU_ae16cd40-6152-49c5-9495-58f558f94d6f"
      unitRef="usd">82134000</mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6a5ca8f57aed41fd9ba65d7a8eb8066c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzItOC0xLTEtMTQ0ODQ_25cbeea2-9f05-4bec-a889-96699f626ca4"
      unitRef="usd">3799169000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i61596579e2804716ad9472fa52f24629_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtMi0xLTEtMTcyNzM_99b18eb6-46e9-41c3-8e49-de2f4b27217d"
      unitRef="usd">2777000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
      contextRef="ia16dd0e2f0d2488eba0c73974791c3a4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtNC0xLTEtMTcyNzM_1621a114-d389-4c8a-bb64-4ab8d174253f"
      unitRef="usd">6775000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod
      contextRef="ia16dd0e2f0d2488eba0c73974791c3a4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtNi0xLTEtMTcyNzM_2dac9ed5-d947-40bf-bc0b-697d899275bd"
      unitRef="usd">4291000</mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic5e6e85bd35c473b8a7fdfa429ebf3f0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtOC0xLTEtMTcyNzM_f3e4f0fc-7dac-4baa-9b85-9da95202cdd7"
      unitRef="usd">5261000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i82530c9d21864e758383518f41158ccf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtMi0xLTEtMTI1NzU_bf7b2a53-e729-4026-8db2-03056c93ed06"
      unitRef="usd">199528000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
      contextRef="ia1bf0bccbb5d48e2b6b391bd4c6436d8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtNC0xLTEtMTI1NzU_1328be04-07e7-41e0-8030-4fcdc5b2d6a2"
      unitRef="usd">121882000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod
      contextRef="ia1bf0bccbb5d48e2b6b391bd4c6436d8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtNi0xLTEtMTI1NzU_3d615944-9e0e-433a-828c-22a494d5a483"
      unitRef="usd">81228000</mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iee1f1d3a45314f5a8987999269779a3f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzMtOC0xLTEtMTQ0ODQ_65f7e7ef-01fb-4986-94aa-3f82890fbe50"
      unitRef="usd">240182000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzQtMi0xLTEtMTQ0Nzg_a04f790f-b718-4421-ac05-5e62adcd1b1b"
      unitRef="usd">202305000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzQtNC0xLTEtMTQ0ODA_b7689082-826d-43c3-b645-276178c1d780"
      unitRef="usd">4009960000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress>
    <mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzQtNi0xLTEtMTQ0ODI_c0f0697d-10e3-4a7f-b589-4d57df385fd8"
      unitRef="usd">167653000</mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod>
    <us-gaap:ContractWithCustomerLiability
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjAvZnJhZzozZjkzNWQ0ZGNiY2Y0M2ZkODk1N2ZiMDU0Mjc0Nzg5YS90YWJsZTo5MTg1YTY1MTlkNjM0NmJhYWVjOWYwMWMyZjQ3OGYwYi90YWJsZXJhbmdlOjkxODVhNjUxOWQ2MzQ2YmFhZWM5ZjAxYzJmNDc4ZjBiXzQtOC0xLTEtMTQ0ODQ_69833246-0adc-4501-976c-eda77d436385"
      unitRef="usd">4044612000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTY3_cb47788c-ef9f-4fe6-af53-565f9196ad8e">Leases We have entered into various long-term non-cancelable lease arrangements for our facilities and equipment expiring at various times through 2032. Certain of these arrangements have free rent periods or escalating rent payment provisions, which we recognize lease cost under such arrangements on a straight-line basis over the life of the leases. We have two campuses in Massachusetts, our Cambridge facility and our Moderna Technology Center (MTC), located in Norwood. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cambridge facility&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We occupy a multi-floor building at Technology Square in Cambridge, Massachusetts with a mix of offices and research laboratory space totaling approximately 175,000 square feet. Our Cambridge facility leases have expiry ranges from 2020 to 2029.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, we entered into an amendment to our lease agreements to consolidate our Technology Square space in Cambridge, Massachusetts. This included entering into a forward-starting lease agreement starting in January 2020 to acquire approximately 50,000 square feet of additional space at 200 Technology Square. In addition, our current 200 Technology Square lease has been extended for two years to 2029. As part of the lease amendment, we completely exited our leased space of approximately 60,000 square feet at 500 Technology Square by May 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record operating lease cost for each of our operating leases on a straight-line basis from lease commencement date through the end of the lease term. Operating lease cost is recorded in operating expenses in our consolidated statements of operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Moderna Technology Center North (MTC North) &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2019, we entered into a new lease agreement for office and laboratory space of approximately 200,000 square feet, MTC North, located in Norwood, Massachusetts. The lease commenced in the second quarter of 2019 and had an initial expiration date of 2031. We have the option to extend the lease for up to four additional five-year terms. Contemporaneously, we entered into an agreement to sublease approximately 64 percent of the leased space to a third party. In May 2020, we entered into an amendment to the lease whereby we exercised an option available in the original lease to receive a tenant improvement allowance in the amount of $22.2&#160;million to be paid back over the term of the lease with interest and extend the term of the lease to 2035. In May 2020, we also amended our MTC North sublease agreement. As the result of that amendment, effective June 1, 2020, we obtained an additional, approximately 28,000 square feet, or 12 percent of the leased space in MTC North and the remainder of the space in July 2020 when the sublease expired. The lease modifications to MTC North in the second quarter of 2020 resulted in a change in lease classification, from operating to finance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Moderna Technology Center manufacturing facility (MTC South) &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August&#160;2016, we entered into a lease agreement for approximately&#160;200,000&#160;square feet of office, laboratory, and light manufacturing space, MTC South, in Norwood, Massachusetts. The lease will expire in September&#160;2032. We have the option to extend the term for&#160;two&#160;extension periods of&#160;ten years&#160;each at market-based rents. The base rent is subject to increases over the term of the lease. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Embedded Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into multiple contract manufacturing service agreements with third parties which contain embedded leases within the scope of ASC 842. As of December 31, 2020, we had lease liabilities of $24.3&#160;million related to the embedded leases. Certain embedded leases dedicated to our COVID-19 vaccine program prior to the EUA from the FDA were deemed to have no alternative use. The related right-of-use assets of $62.3&#160;million were charged to research and development expense for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating and financing lease right-of-use assets and lease liabilities as of December 31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets, operating, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets, financing, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_509b73a1-344b-43fb-b968-8722c1c25a5e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_72c4555a-bb44-4abb-b6c7-1be6c51005ca"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_2a800648-bfb3-4584-a0d1-7572b92f5809"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_5ef609f9-9865-4708-ad5f-c12a24e8246f"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These assets are real estate related assets, which include land, office and laboratory spaces.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net of accumulated depreciation. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These assets are&#160;real estate assets related to the MTC North and MTC South leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in property and equipment in the consolidated balance sheets, net of accumulated depreciation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in other current liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the lease costs for the year ended December 31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Amortization of right-of-use assets, financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interest expense for financing lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financing lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total rent expense&#160;for the&#160;year ended&#160;December&#160;31, 2018 was&#160;$19.1 million.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information relating to our leases for the year ended December 31, 2020 and 2019 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used in financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Financing cash flows used in financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease non-cash items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets reduced through lease modifications and reassessments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease non-cash items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained through lease modifications and reassessments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge to financing lease obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease terms and discount rates as of December 31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable lease agreements as of&#160;December&#160;31, 2020, were as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financing Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amounts representing interest or imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Include the optional extensions in the MTC North and MTC South lease terms which represent a total of $338.9 million un-discounted future lease payments. &lt;/span&gt;&lt;/div&gt;(2)  MTC South interest is based on an imputed interest rate of 17.2%. MTC North interest is based upon an incremental borrowing rate of 8.2%.</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTY4_0bd534ec-e25f-42b9-85bd-d1469a52158f">Leases We have entered into various long-term non-cancelable lease arrangements for our facilities and equipment expiring at various times through 2032. Certain of these arrangements have free rent periods or escalating rent payment provisions, which we recognize lease cost under such arrangements on a straight-line basis over the life of the leases. We have two campuses in Massachusetts, our Cambridge facility and our Moderna Technology Center (MTC), located in Norwood. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cambridge facility&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We occupy a multi-floor building at Technology Square in Cambridge, Massachusetts with a mix of offices and research laboratory space totaling approximately 175,000 square feet. Our Cambridge facility leases have expiry ranges from 2020 to 2029.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, we entered into an amendment to our lease agreements to consolidate our Technology Square space in Cambridge, Massachusetts. This included entering into a forward-starting lease agreement starting in January 2020 to acquire approximately 50,000 square feet of additional space at 200 Technology Square. In addition, our current 200 Technology Square lease has been extended for two years to 2029. As part of the lease amendment, we completely exited our leased space of approximately 60,000 square feet at 500 Technology Square by May 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record operating lease cost for each of our operating leases on a straight-line basis from lease commencement date through the end of the lease term. Operating lease cost is recorded in operating expenses in our consolidated statements of operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Moderna Technology Center North (MTC North) &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2019, we entered into a new lease agreement for office and laboratory space of approximately 200,000 square feet, MTC North, located in Norwood, Massachusetts. The lease commenced in the second quarter of 2019 and had an initial expiration date of 2031. We have the option to extend the lease for up to four additional five-year terms. Contemporaneously, we entered into an agreement to sublease approximately 64 percent of the leased space to a third party. In May 2020, we entered into an amendment to the lease whereby we exercised an option available in the original lease to receive a tenant improvement allowance in the amount of $22.2&#160;million to be paid back over the term of the lease with interest and extend the term of the lease to 2035. In May 2020, we also amended our MTC North sublease agreement. As the result of that amendment, effective June 1, 2020, we obtained an additional, approximately 28,000 square feet, or 12 percent of the leased space in MTC North and the remainder of the space in July 2020 when the sublease expired. The lease modifications to MTC North in the second quarter of 2020 resulted in a change in lease classification, from operating to finance.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Moderna Technology Center manufacturing facility (MTC South) &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August&#160;2016, we entered into a lease agreement for approximately&#160;200,000&#160;square feet of office, laboratory, and light manufacturing space, MTC South, in Norwood, Massachusetts. The lease will expire in September&#160;2032. We have the option to extend the term for&#160;two&#160;extension periods of&#160;ten years&#160;each at market-based rents. The base rent is subject to increases over the term of the lease. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Embedded Leases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into multiple contract manufacturing service agreements with third parties which contain embedded leases within the scope of ASC 842. As of December 31, 2020, we had lease liabilities of $24.3&#160;million related to the embedded leases. Certain embedded leases dedicated to our COVID-19 vaccine program prior to the EUA from the FDA were deemed to have no alternative use. The related right-of-use assets of $62.3&#160;million were charged to research and development expense for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating and financing lease right-of-use assets and lease liabilities as of December 31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets, operating, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets, financing, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_509b73a1-344b-43fb-b968-8722c1c25a5e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_72c4555a-bb44-4abb-b6c7-1be6c51005ca"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_2a800648-bfb3-4584-a0d1-7572b92f5809"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_5ef609f9-9865-4708-ad5f-c12a24e8246f"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These assets are real estate related assets, which include land, office and laboratory spaces.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net of accumulated depreciation. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These assets are&#160;real estate assets related to the MTC North and MTC South leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in property and equipment in the consolidated balance sheets, net of accumulated depreciation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in other current liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the lease costs for the year ended December 31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Amortization of right-of-use assets, financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interest expense for financing lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financing lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total rent expense&#160;for the&#160;year ended&#160;December&#160;31, 2018 was&#160;$19.1 million.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information relating to our leases for the year ended December 31, 2020 and 2019 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used in financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Financing cash flows used in financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease non-cash items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets reduced through lease modifications and reassessments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease non-cash items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained through lease modifications and reassessments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge to financing lease obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease terms and discount rates as of December 31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable lease agreements as of&#160;December&#160;31, 2020, were as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financing Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amounts representing interest or imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Include the optional extensions in the MTC North and MTC South lease terms which represent a total of $338.9 million un-discounted future lease payments. &lt;/span&gt;&lt;/div&gt;(2)  MTC South interest is based on an imputed interest rate of 17.2%. MTC North interest is based upon an incremental borrowing rate of 8.2%.</us-gaap:LesseeOperatingLeasesTextBlock>
    <mrna:OperatingLeaseNumberOfProperties
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzM3MA_b18c396d-82ad-4333-a0e3-8df3b4cd1854"
      unitRef="campus">2</mrna:OperatingLeaseNumberOfProperties>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="ibbcec80ae49c4b8286395ec88c10e2bf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzY3MA_700494df-0b75-4ee0-9fd9-773f1821b27b"
      unitRef="sqft">175000</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="i620a2c29a9454e86abf8ee51f8558fe7_I20190831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2Xzk5Nw_264af2fc-8aee-4a7b-8c65-f44dd0957272"
      unitRef="sqft">50000</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i620a2c29a9454e86abf8ee51f8558fe7_I20190831"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEzMTk0MTM5NTQ2MDEy_33f8770e-44bd-4427-b0f6-1ae941e0ee71">P2Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="i9c54db761b0740ec8aba56ebf889d996_I20190831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEyMTU_798c3e56-1883-46fc-ae69-c4d39d932e4c"
      unitRef="sqft">60000</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="idf6426583a4543de9fc96eca2bc03260_I20190228"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzM3MjM_3ac25506-f816-4b3e-be68-0b898fe7f8be"
      unitRef="sqft">200000</us-gaap:AreaOfRealEstateProperty>
    <mrna:LesseeOperatingLeaseNumberOfExtensionPeriods
      contextRef="idf6426583a4543de9fc96eca2bc03260_I20190228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzM5MTc_a44255ab-87c6-4eaf-bbf3-c0c9d4fbc3bc"
      unitRef="extension_period">4</mrna:LesseeOperatingLeaseNumberOfExtensionPeriods>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="idf6426583a4543de9fc96eca2bc03260_I20190228"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNTg3OTQ_e0d2324c-48de-4b56-b92f-cf9b94773335">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <mrna:LesseeOperatingLeasePercentageSubleased
      contextRef="idf6426583a4543de9fc96eca2bc03260_I20190228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQwMjA_0438d632-aad7-4798-9e74-376379af7955"
      unitRef="number">0.64</mrna:LesseeOperatingLeasePercentageSubleased>
    <us-gaap:TenantImprovements
      contextRef="i7b968f2e54364ba8ad58961ced8da02e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNjMyMzM_86ed1bea-ccc8-489b-8987-45ba6f23e2d1"
      unitRef="usd">22200000</us-gaap:TenantImprovements>
    <mrna:AreaOfRealEstatePropertyAdditionalSpace
      contextRef="i6e728091fd7b4fddbe99aa3980407db5_I20200601"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNTg3OTY_d4c2abda-1d41-482b-82a5-0dad4b75ecbc"
      unitRef="sqft">28000</mrna:AreaOfRealEstatePropertyAdditionalSpace>
    <mrna:LesseeOperatingLeasePercentageSubleased
      contextRef="i6e728091fd7b4fddbe99aa3980407db5_I20200601"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNTg4MDM_caae21e0-e6c8-4750-b372-c3507190c174"
      unitRef="number">0.12</mrna:LesseeOperatingLeasePercentageSubleased>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="i028772f3641244bba3f25ec35843b217_I20160831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzUxMzM_e4e1601b-711e-4208-898b-efb9051ddbb7"
      unitRef="sqft">200000</us-gaap:AreaOfRealEstateProperty>
    <mrna:LesseeOperatingLeaseNumberOfExtensionPeriods
      contextRef="i266a5c7f3c4d4becbe194489fb7a115a_I20160831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzU1OTg_3e87cda2-a623-4992-81dc-7637df7d2597"
      unitRef="extension_period">2</mrna:LesseeOperatingLeaseNumberOfExtensionPeriods>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i266a5c7f3c4d4becbe194489fb7a115a_I20160831"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzU2MjI_938d5de3-16f2-443f-8643-3b9d2543df3a">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseLiability
      contextRef="ib99c6b4909974f38905c833f846083b4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEwNDQ1MzYwNTAyMDk4_8406b635-bc0f-4c0c-9e33-61ec622a23ac"
      unitRef="usd">24300000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib99c6b4909974f38905c833f846083b4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEwNDQ1MzYwNTAyMDgz_75dd217f-6447-4ac3-b58f-82ed519abdd7"
      unitRef="usd">62300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <mrna:CurrentAssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTcw_6b05ed45-a859-40b0-997c-77f098295ab5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating and financing lease right-of-use assets and lease liabilities as of December 31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets, operating, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets, financing, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_509b73a1-344b-43fb-b968-8722c1c25a5e"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_72c4555a-bb44-4abb-b6c7-1be6c51005ca"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:36pt;text-indent:-22.51pt"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_2a800648-bfb3-4584-a0d1-7572b92f5809"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_5ef609f9-9865-4708-ad5f-c12a24e8246f"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total non-current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These assets are real estate related assets, which include land, office and laboratory spaces.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net of accumulated depreciation. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These assets are&#160;real estate assets related to the MTC North and MTC South leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in property and equipment in the consolidated balance sheets, net of accumulated depreciation.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in other current liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</mrna:CurrentAssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzMtMi0xLTEtMA_5c1c9e6f-0f38-4ac2-82f2-5adfa1d18e9b"
      unitRef="usd">90201000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzMtNC0xLTEtMA_f9bf1eab-143e-4b7a-88d7-a745d09fc685"
      unitRef="usd">86414000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzQtMi0xLTEtMA_6d8d962e-bf6e-40a3-b584-be6cbdd1b586"
      unitRef="usd">55045000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzQtNC0xLTEtMA_3bc2db7b-5c2f-4e45-80bc-590b5cb86873"
      unitRef="usd">9544000</us-gaap:FinanceLeaseRightOfUseAsset>
    <mrna:OperatingAndFinanceLeaseRightOfUseAsset
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzUtMi0xLTEtMA_c65b466f-a059-42e6-b5f2-32d65c7dcc96"
      unitRef="usd">145246000</mrna:OperatingAndFinanceLeaseRightOfUseAsset>
    <mrna:OperatingAndFinanceLeaseRightOfUseAsset
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzUtNC0xLTEtMA_8ea12e46-0db6-434c-93b4-e4fb4f99c819"
      unitRef="usd">95958000</mrna:OperatingAndFinanceLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMi0xLTEtMA_a61eabfb-e1b6-4000-8241-ff7c95dd0c3f"
      unitRef="usd">5972000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktNC0xLTEtMA_3ef636b2-bfb6-4eda-99b3-b9a030ead566"
      unitRef="usd">3583000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTItMS0xLTA_82ba12a2-7f5d-4c96-8c58-7bc25f1f6ea5"
      unitRef="usd">24328000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTQtMS0xLTA_44a86d75-e7e6-4221-b172-90d571ac9727"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityCurrent>
    <mrna:OperatingAndFinanceLeaseLiabilityCurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzExLTItMS0xLTE1NDgw_5035623d-c618-49ac-94fd-64a0b8a292f1"
      unitRef="usd">30300000</mrna:OperatingAndFinanceLeaseLiabilityCurrent>
    <mrna:OperatingAndFinanceLeaseLiabilityCurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzExLTQtMS0xLTE1NDgy_046fbe35-2bfa-4f53-896d-3b8642d542d2"
      unitRef="usd">3583000</mrna:OperatingAndFinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEzLTItMS0xLTA_533d7aae-ffeb-4938-a02c-0461b46b3819"
      unitRef="usd">97421000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEzLTQtMS0xLTA_efa79e73-a657-4706-b4b9-340f25982f76"
      unitRef="usd">93675000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE0LTItMS0xLTA_f0b3d557-849b-42bc-ba4c-127ae2b2feed"
      unitRef="usd">109874000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE0LTQtMS0xLTA_7215f4ef-14f7-4a13-bf82-7c918e092c98"
      unitRef="usd">38689000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <mrna:OperatingAndFinanceLeaseLiabilityNoncurrent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE1LTItMS0xLTA_0f7f4cb5-c15d-41cb-b43e-a2bec46b3cba"
      unitRef="usd">207295000</mrna:OperatingAndFinanceLeaseLiabilityNoncurrent>
    <mrna:OperatingAndFinanceLeaseLiabilityNoncurrent
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE1LTQtMS0xLTA_239801a4-c11d-47ae-b19e-e7ae61711fa5"
      unitRef="usd">132364000</mrna:OperatingAndFinanceLeaseLiabilityNoncurrent>
    <mrna:OperatingAndFinanceLeaseLiability
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE2LTItMS0xLTA_6e40f201-0f52-45cd-a7f4-4610cda82723"
      unitRef="usd">237595000</mrna:OperatingAndFinanceLeaseLiability>
    <mrna:OperatingAndFinanceLeaseLiability
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzE2LTQtMS0xLTA_9fb89f1b-cc58-4bda-8c4a-1bd8dc64849d"
      unitRef="usd">135947000</mrna:OperatingAndFinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTY0_ad0898c0-43aa-409c-a89b-5a02a5b3e27a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of the lease costs for the year ended December 31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.120%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Amortization of right-of-use assets, financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interest expense for financing lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financing lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information relating to our leases for the year ended December 31, 2020 and 2019 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows used in financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Financing cash flows used in financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease non-cash items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets reduced through lease modifications and reassessments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease non-cash items:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained through lease modifications and reassessments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge to financing lease obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease terms and discount rates as of December 31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzItMi0xLTEtMjQ4MA_626f6fc7-337f-4a16-a4f1-3e57251a1669"
      unitRef="usd">16939000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzItMi0xLTEtMA_5e96fc28-f729-4bae-8383-7d221a7d0a76"
      unitRef="usd">17015000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzQtMi0xLTEtMjQ4MA_6d2a57eb-e0a2-4a45-bc87-30abe33ddef5"
      unitRef="usd">1011000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzQtMi0xLTEtMA_7e16ba76-6578-4090-a340-ac1c77d5a5ac"
      unitRef="usd">309000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzUtMi0xLTEtMjQ4MA_1beacd86-cfa4-42c5-89dd-b60649091fbc"
      unitRef="usd">9891000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzUtMi0xLTEtMA_5fcca09e-642b-4301-b906-3b9859558ac0"
      unitRef="usd">6557000</us-gaap:FinanceLeaseInterestExpense>
    <mrna:FinanceLeaseCost
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzYtMi0xLTEtMzU3MQ_1cd8b4a3-816a-4f10-bc3e-aa8f71c51088"
      unitRef="usd">10902000</mrna:FinanceLeaseCost>
    <mrna:FinanceLeaseCost
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzYtMi0xLTEtMA_eaa0a2c1-fa99-4479-acf5-e99089a1fc79"
      unitRef="usd">6866000</mrna:FinanceLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzctMi0xLTEtODQxNw_9a24d42d-89dd-49c1-a141-e72ee0713368"
      unitRef="usd">13322000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzctNC0xLTEtODQxNw_4e4c1958-2f3b-4bd9-aa9b-bd739e3e92f5"
      unitRef="usd">0</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzgtMi0xLTEtMjQ4NA_ab7348d0-7ccb-489c-89bd-4108277b9088"
      unitRef="usd">5229000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZToxNzAwMjEzMWRjOTQ0MDI5OGNjOWIxODE4Y2NjOGM5ZC90YWJsZXJhbmdlOjE3MDAyMTMxZGM5NDQwMjk4Y2M5YjE4MThjY2M4YzlkXzgtMi0xLTEtMA_352d7f33-883b-45c3-9ac4-85045c3dca41"
      unitRef="usd">4399000</us-gaap:VariableLeaseCost>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEwMjA1_9b788a28-5d04-4723-beae-50b0a0d20daa"
      unitRef="usd">19100000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasePayments
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzMtMi0xLTEtMjUzNg_73676464-157c-48eb-8c67-ea23b468b5f5"
      unitRef="usd">15089000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzMtMi0xLTEtMA_cf400bb9-6b54-4359-afa8-8a007a77bb8d"
      unitRef="usd">16121000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzQtMi0xLTEtMjUzNg_6a85c943-2b4a-493b-8b1e-fee3a124b174"
      unitRef="usd">8523000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzQtMi0xLTEtMA_74fad7d6-a65a-4813-b2d1-ea32fca2f1c2"
      unitRef="usd">5585000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzUtMi0xLTEtODI0Nw_91d91485-6641-4826-ba09-cf0a78ac4b83"
      unitRef="usd">7519000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzUtMi0xLTEtMA_9e4b20fe-35c0-48d4-9686-2b4ace0cf6c8"
      unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <mrna:RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzgtMi0xLTEtMjU0Mg_8b3ee6dd-b90a-4b79-942c-89f0f19b51b5"
      unitRef="usd">6755000</mrna:RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments>
    <mrna:RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzgtMi0xLTEtMA_1937cb2c-6cf1-450d-a260-7db83829f15a"
      unitRef="usd">2717000</mrna:RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzktMi0xLTEtMjU0Mg_98531766-b5e5-4937-91ce-a5d42e94c6ea"
      unitRef="usd">17107000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzktMi0xLTEtMA_f9c2e688-e3f4-4941-a2d8-8bfcbae833b8"
      unitRef="usd">34014000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzEyLTItMS0xLTI1NDY_58221b5f-adc1-40ea-acf8-d7bd183325de"
      unitRef="usd">46495000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzEyLTQtMS0xLTI1NDY_484008e8-2bfc-406a-9a30-c65853ceaed5"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <mrna:LesseeFinanceLeaseExpense
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzEzLTItMS0xLTI1NDY_f105ea7e-fba6-47ec-b583-ab660bc6884d"
      unitRef="usd">1304000</mrna:LesseeFinanceLeaseExpense>
    <mrna:LesseeFinanceLeaseExpense
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo3OTNkZDI5ZjllNmU0YTBlYjE3NjMwNmZkM2ExNGI2ZC90YWJsZXJhbmdlOjc5M2RkMjlmOWU2ZTRhMGViMTc2MzA2ZmQzYTE0YjZkXzEzLTQtMS0xLTI1NDY_2d783926-967d-423f-8e4b-b67ee2418748"
      unitRef="usd">971000</mrna:LesseeFinanceLeaseExpense>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjY2E5YWVlZjczMDc0YWRhODM0NTY4ZmYxY2RkMjJhZi90YWJsZXJhbmdlOmNjYTlhZWVmNzMwNzRhZGE4MzQ1NjhmZjFjZGQyMmFmXzMtMi0xLTEtMA_d753dfca-a757-4207-8cc1-4ed23e45ba70">P11Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjY2E5YWVlZjczMDc0YWRhODM0NTY4ZmYxY2RkMjJhZi90YWJsZXJhbmdlOmNjYTlhZWVmNzMwNzRhZGE4MzQ1NjhmZjFjZGQyMmFmXzQtMi0xLTEtMA_a505a73d-f1b3-4e42-b823-d100c842a6bf">P25Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjY2E5YWVlZjczMDc0YWRhODM0NTY4ZmYxY2RkMjJhZi90YWJsZXJhbmdlOmNjYTlhZWVmNzMwNzRhZGE4MzQ1NjhmZjFjZGQyMmFmXzYtMi0xLTEtMA_40041360-0661-400d-9dc8-8768322bd24f"
      unitRef="number">0.103</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjY2E5YWVlZjczMDc0YWRhODM0NTY4ZmYxY2RkMjJhZi90YWJsZXJhbmdlOmNjYTlhZWVmNzMwNzRhZGE4MzQ1NjhmZjFjZGQyMmFmXzctMi0xLTEtMA_5870ef51-cef3-4a2a-ac41-9b8603edd01d"
      unitRef="number">0.131</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTY1_034da700-d1df-4eaf-8042-ba0e025f5d5d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable lease agreements as of&#160;December&#160;31, 2020, were as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financing Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amounts representing interest or imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Include the optional extensions in the MTC North and MTC South lease terms which represent a total of $338.9 million un-discounted future lease payments. &lt;/span&gt;&lt;/div&gt;(2)  MTC South interest is based on an imputed interest rate of 17.2%. MTC North interest is based upon an incremental borrowing rate of 8.2%.</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzExMTY2_7dd585a8-107b-4ea2-b073-25fdc22d11dc">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments under non-cancelable lease agreements as of&#160;December&#160;31, 2020, were as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financing Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less amounts representing interest or imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(379,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Include the optional extensions in the MTC North and MTC South lease terms which represent a total of $338.9 million un-discounted future lease payments. &lt;/span&gt;&lt;/div&gt;(2)  MTC South interest is based on an imputed interest rate of 17.2%. MTC North interest is based upon an incremental borrowing rate of 8.2%.</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzEtMi0xLTEtMA_f794c413-7111-43c6-aef0-d4ad83652c90"
      unitRef="usd">15492000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzEtNC0xLTEtMA_651bac77-367d-48cd-8c5a-96ec2c9a78a0"
      unitRef="usd">36579000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzItMi0xLTEtMA_5e0e5e06-76ea-4459-af55-d4724659d83f"
      unitRef="usd">15913000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzItNC0xLTEtMA_106cc30b-3025-40b0-b681-7a1c0a6c497b"
      unitRef="usd">11848000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzMtMi0xLTEtMA_7184ff25-b2c8-4b34-8baa-3eed7b1cca52"
      unitRef="usd">16008000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzMtNC0xLTEtMA_28bd2b38-fe15-4891-9c35-05e32b6f7ed3"
      unitRef="usd">12054000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzQtMi0xLTEtMA_4421f709-f147-4f4f-8726-84bc75336d1d"
      unitRef="usd">16168000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzQtNC0xLTEtMA_9b9905bb-e4cc-4442-aaa1-a5e07ceb7f2b"
      unitRef="usd">12279000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzUtMi0xLTEtMA_c4b26d4e-2690-4501-bfb8-60fd06aa3bbe"
      unitRef="usd">16567000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzUtNC0xLTEtMA_8f7fa129-38d8-400e-8948-ce2fa8b9d2be"
      unitRef="usd">12493000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzYtMi0xLTEtMA_6df6bc1b-0fd2-42b8-a76f-0dbe80084878"
      unitRef="usd">93599000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzYtNC0xLTEtMA_76ea7346-03e4-41c8-976d-bf98cb1246f5"
      unitRef="usd">428059000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzctMi0xLTEtMA_b6a28262-a913-439e-b013-f67b1f33d7fa"
      unitRef="usd">173747000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzctNC0xLTEtMA_6f5ad7dd-8a64-4d9c-abe7-dad8ab33aa8f"
      unitRef="usd">513312000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzgtMi0xLTEtMA_857c469b-7d77-4609-83c5-3193c75a68d1"
      unitRef="usd">70354000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzgtNC0xLTEtMA_5b556780-b6eb-40c9-84ff-5fc53c9041ab"
      unitRef="usd">379110000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzktMi0xLTEtMA_e4a1e01c-b982-4504-a4ce-a6814ec4ff12"
      unitRef="usd">103393000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTpjMDE2MjY3OTMxNzk0YTdiODc0NzU2NWE0ZDg3ZDg5OS90YWJsZXJhbmdlOmMwMTYyNjc5MzE3OTRhN2I4NzQ3NTY1YTRkODdkODk5XzktNC0xLTEtMA_f3465c22-4cac-4db7-8912-28aec44782fc"
      unitRef="usd">134202000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i313b37fa8a694900aaf4a540ec5403b2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzEwNjk1_14584fd2-47e5-495f-89cd-368fc7b94f3e"
      unitRef="usd">338900000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <mrna:LeasesImputedInterestRate
      contextRef="i6f36d10d97c04db1b365a25391679774_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNTg3NzE_31257760-b7e7-4896-82ff-11c61328670e"
      unitRef="number">0.172</mrna:LeasesImputedInterestRate>
    <mrna:LeasesIncrementalBorrowingRate
      contextRef="i3832eb52624b426797a221627ead873a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90ZXh0cmVnaW9uOmYxMmU4N2Q5NzA3NzQ2MWE5Mjg0NzcyNWQyMDBjNzg2XzQ5NDc4MDIzNTg3Nzg_4286be83-cde4-4121-8496-902a95b940ab"
      unitRef="number">0.082</mrna:LeasesIncrementalBorrowingRate>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzQ4MDg_46a0c4b7-fafb-4a47-97cb-d46203db1fc5">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Strategic Collaborations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our strategic collaboration agreements, we are committed to perform certain research, development, and manufacturing activities. As part of our PCV Agreement and PCV/SAV Agreement with Merck, we are committed to perform certain research, development and manufacturing activities related to PCV products through an initial Phase 2 clinical trial up to a budgeted amount of $243.0 million as of December 31, 2020 and 2019 (Note 5).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are not currently a party to any material legal proceedings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As permitted under Delaware law, we indemnify our officers, directors, and employees for certain events, occurrences while the officer, or director is, or was, serving at our request in such capacity. The term of the indemnification is for the officer&#x2019;s or director&#x2019;s lifetime.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have standard indemnification arrangements in our leases for laboratory and office space that require us to indemnify the landlord against any liability for injury, loss, accident, or damage from any claims, actions, proceedings, or costs resulting from certain acts, breaches, violations, or non-performance under our leases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into indemnification provisions under our agreements with counterparties in the ordinary course of business, typically with business partners, contractors, clinical sites and customers. Under these provisions, we generally indemnify and hold harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of our activities. These indemnification provisions generally survive termination of the underlying agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is unlimited.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through December 31, 2020 and 2019, we had not experienced any losses related to these indemnification obligations, and no material claims were outstanding. We do not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments and Purchase Orders&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we entered into a 10-year strategic collaboration agreement with Lonza Ltd. to enable larger scale manufacture for our COVID-19 vaccine and additional Moderna products in the future. This agreement was reflected in the Global Long Term Agreement entered into between Moderna and Lonza on September 4, 2020. Under the terms of the agreement, we established dedicated manufacturing suites at Lonza&#x2019;s facilities in the United States and Switzerland for the manufacture of mRNA-1273 at both sites. Certain arrangements under this strategic collaboration agreement are within the scope of lease accounting (see Note 11). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into agreements in the normal course of business with vendors and contract manufacturing organizations (CMOs) for raw materials and manufacturing services and with vendors for preclinical research studies, clinical trials and other goods or services. As of December 31, 2020, we had &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$659.5 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of non-cancelable purchase commitments related to raw materials and manufacturing agreements, including the Lonza agreement, which are expected to be paid through 2021. As of December 31, 2020, we had $27.0&#160;million of non-cancelable purchase commitments for clinical services and other goods and services which are expected to be paid through 2024. These amounts represent our minimum contractual obligations, including termination fees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to purchase commitments, we have agreements with third parties for various services, including services related to clinical operations and support and contract manufacturing, for which we are not contractually able to terminate for convenience and avoid any and all future obligations to the vendors. Certain agreements provide for termination rights subject to termination fees or wind down costs. Under such agreements, we are contractually obligated to make certain payments to vendors, mainly, to reimburse them for their unrecoverable outlays incurred prior to cancellation. At December 31, 2020, we had cancelable open purchase orders of $896.9 million in total under such agreements for our significant clinical operations and support and contract manufacturing. These amounts represent only our estimate of those items for which we had a contractual commitment to pay at December 31, 2020, assuming we would not cancel these agreements. The actual amounts we pay in the future to the vendors under such agreements may differ from the purchase order amounts.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Licenses to Patented Technology&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;26, 2017, we entered into sublicense agreements with Cellscript, LLC and its affiliate, mRNA RiboTherapeutics, Inc. to sublicense certain patent rights. Pursuant to each agreement, we are required to pay certain license fees, annual maintenance fees, minimum royalties on future net sales and milestone payments contingent on achievement of certain development, regulatory and commercial milestones for specified products, on a product-by-product basis. The development and regulatory milestone payments, up to $1.5&#160;million for therapeutic and prophylactic products and up to $0.5 million for diagnostic products will be recognized as a cost of the asset acquired upon resolution of the associated contingency and will be capitalized or expensed depending on the nature of the associated asset as of the date of recognition. Conversely, commercial milestone payments, up to $24.0 million, and royalties based on annual net sales of licensed products for therapeutic and prophylactic products will be accounted for as additional expense of the related product sales in the period in which the corresponding sales occur. In connection with these sublicense agreements, we recognized sublicense grant fees of $22.0&#160;million in 2018 and have no further obligation for additional sublicense grant fees. We recognized $6.9&#160;million of royalties associated with our product sales in 2020.&lt;/span&gt;&lt;/div&gt;Additionally, we have other in-license agreements with third parties which require us to make future development, regulatory and commercial milestone payments for specified products associated with the agreements. The achievement of these milestones was not deemed probable as of December 31, 2020.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="i1441021944924f86873ecc11207adf0d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzQ0MQ_f0e72f52-1254-472b-a4bb-29219b661094"
      unitRef="usd">243000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount
      contextRef="ib2ffbac081c347a18476291631b1325f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzQ0MQ_ff7691b1-914f-4d51-a54b-3055125b1c93"
      unitRef="usd">243000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="i62af6315d0994091a5ee85593def32e7_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEyMTQ_0d19de70-2fed-4c34-ab80-a691d38d6e8d"
      unitRef="usd">0</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="ia470ee9b9d754ceeb6681190f52793c3_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEyMTQ_107b1449-fe6d-48fe-b51e-af533a7c14f1"
      unitRef="usd">0</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3ea7b5505cee487fbf7be94bf6d55f95_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEyOTE_31ce6b42-5c69-4ee2-a1f8-73daa59059a0"
      unitRef="claim">0</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i794421bf0a8e43a3a51997f49bc8dcb8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEyOTE_412715bb-7f28-4626-828f-b61955153dc0"
      unitRef="claim">0</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i794421bf0a8e43a3a51997f49bc8dcb8_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzE0OTg_6ffdc872-6a26-4f5a-880b-26411c4edef0"
      unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i3ea7b5505cee487fbf7be94bf6d55f95_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzE0OTg_b909c474-2bed-403a-a664-ad41a16dde5d"
      unitRef="usd">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted
      contextRef="i4c7e100fa92b440a8d435619ce329b08_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNjIw_48c4b288-eb51-4a19-9962-e050d1b3c1aa"
      unitRef="usd">659500000000</us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted>
    <us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted
      contextRef="i1170ecd035af4400a71afda6f522a17b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEzNzQzODk1Mzc2NjEx_d681ed66-eb48-4a5f-b375-512b548ecd05"
      unitRef="usd">27000000.0</us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted>
    <us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted
      contextRef="i2b6cf5372b6e431587c7ba23a440fa6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzIzNDg_01e74371-e50a-4f83-96a5-66b4ed691a71"
      unitRef="usd">896900000</us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount
      contextRef="i61eb580f6c4e4674bede2f83be700c34_I20170626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNDY4_c6d83b0e-1883-42fe-a97c-88a0d38826b3"
      unitRef="usd">1500000</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount
      contextRef="i0c3c86543acc46e2b8b0c2c0de911ca5_I20170626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNDgz_f2de267d-1c5a-452d-82c1-97b765027ca7"
      unitRef="usd">500000</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount>
    <mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount
      contextRef="i7e99c6608c7941008ec26bef45112da4_I20170626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNDg3_8eceab4f-5f4b-4735-a504-7692eee900f4"
      unitRef="usd">24000000.0</mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
      contextRef="ia945c15292e84282b614fb94308ea684_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNDkw_6d30b50a-280e-45b2-8192-4b0ffa4e315c"
      unitRef="usd">22000000.0</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjYvZnJhZzo3NzVjNTVjNjdiYjg0NzUwYWYyMWUwZTJjMWRlNmE0MC90ZXh0cmVnaW9uOjc3NWM1NWM2N2JiODQ3NTBhZjIxZTBlMmMxZGU2YTQwXzEwNDQ1MzYwNDkyNTA1_5d12c637-e2d3-4e21-8810-dc3b0c4b6a26"
      unitRef="usd">6900000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzE0NjY1_b25637e5-dbe4-4d9b-8f3d-c0187f9c7668">Redeemable Convertible Preferred Stock and Common Stock&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;28, 2018 and May&#160;7,&#160;2018, the Board of Directors approved an amendment to our Certificate of Incorporation resulting in a total of 775,000,000 shares of common stock and a total of 509,352,795 shares of redeemable convertible preferred stock being authorized, respectively. Upon completion of our IPO, our authorized capital stock consists of 1,600,000,000 shares of common stock, par value $0.0001 per share, and 162,000,000 shares of preferred stock, par value $0.0001 per share, all of which shares of preferred stock are undesignated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 11, 2018, we completed our IPO, whereby we sold 26,275,993 shares of common stock at a price of $23.00 per share. The aggregate net proceeds received by us from the IPO were $563.0&#160;million, net of underwriting discounts and commissions of $33.2 million and offering expenses of $8.1 million payable by us. Upon the closing of the IPO, all of the outstanding shares of our redeemable convertible preferred stock were converted into 236,012,913 shares of the common stock. As of December&#160;31, 2020 and 2019, we did not have any convertible preferred stock issued or outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 14, 2020, we sold 26,315,790 shares of common stock at a price of $19.00 per share through a public equity offering. The aggregate net proceeds from the offering were $477.7&#160;million, net of underwriting discounts, commissions and offering expenses. In addition, the underwriters exercised their options to purchase an additional 3,947,368 shares of common stock at the public offering price less underwriting discounts, resulting in additional net proceeds of $71.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 21, 2020, we sold 17,600,000 shares of common stock at a price of $76.00 per share through a public equity offering. The aggregate net proceeds from the offering were $1.30&#160;billion, net of underwriting discounts, commissions and offering expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ica4a9c0275b4439ab3a5bc61a47582f7_I20180228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzIwNw_d46f8b64-db05-473a-abee-8fc9331f6d79"
      unitRef="shares">775000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ic8e4c8c0f7b04ed7b492b9f6c973bbd6_I20180507"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzI0OA_dc891fdb-5065-4ebb-9b0e-0c5a0cd915be"
      unitRef="shares">509352795</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if52ab1a643294862862c0ab9475e5fb5_I20181211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzQwMQ_f18b40e9-5dcc-455f-8fca-90d6c6a4c37d"
      unitRef="shares">1600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if52ab1a643294862862c0ab9475e5fb5_I20181211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzQzOA_fb6e0e00-fecd-4511-b1c4-62a514cab3f7"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="if52ab1a643294862862c0ab9475e5fb5_I20181211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzQ1Ng_e19feffd-0e9a-4bc3-85fe-df9b6e0ec738"
      unitRef="shares">162000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="if52ab1a643294862862c0ab9475e5fb5_I20181211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzQ5Ng_54cd8d63-f4cb-443f-9755-0f1bad59ebd5"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ied8820941801441bbf695baf84bd4408_D20181211-20181211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzYyNw_10340c6d-edbb-4bb6-acf4-87c993cbbc37"
      unitRef="shares">26275993</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ib0015b9f558545eb8bbce9a072884272_I20181211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzY2Nw_1dd38974-9341-45cf-81b6-37a0b56f6ab2"
      unitRef="usdPerShare">23.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ied8820941801441bbf695baf84bd4408_D20181211-20181211"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzkzNDU4NDg4OTM3Mjk_b7b35f50-0bb1-47c0-96f4-2ec81843825c"
      unitRef="usd">563000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <mrna:PaymentsOfUnderwritingDiscounts
      contextRef="ied8820941801441bbf695baf84bd4408_D20181211-20181211"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzc5NA_7cdfc18a-5752-42c2-b5c7-11634f8391cc"
      unitRef="usd">33200000</mrna:PaymentsOfUnderwritingDiscounts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ied8820941801441bbf695baf84bd4408_D20181211-20181211"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzgyMg_3e2adb67-4c67-41f6-b76e-9b63b64c123b"
      unitRef="usd">8100000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="i817a91b1df304d8db9ad7e21b92c6d5e_I20181211"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzk2NQ_b06c82bb-1903-4636-896c-72aaf5739eab"
      unitRef="shares">236012913</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwMzc_39e16fe9-d910-4766-a95e-49a5434d3548"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwMzc_543d21b7-23f0-4321-98e9-5b2188265b47"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwMzc_58849a64-2a35-46b1-a01f-c8e068bd79e6"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwMzc_68ccfc08-8869-46f3-ba0f-ff8ffe29c5f0"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwMzc_79cd806d-b62b-4eb7-bd20-04007c39b4b5"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i11303c4705d14f9e9722ef0609332f64_D20200214-20200214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzA0_d39d651c-0798-4772-87ff-92eff3e19496"
      unitRef="shares">26315790</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i8d8ab51d966d48869f4a4a2010e84ff8_I20200214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzE2_d1cdd5ad-0aa5-442e-a266-c6c577d8ba27"
      unitRef="usdPerShare">19.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i11303c4705d14f9e9722ef0609332f64_D20200214-20200214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzI0_67d1002b-5773-4508-ac59-bb01450afd15"
      unitRef="usd">477700000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="if4562f74238f400d8605ac78ea70d681_D20200214-20200214"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzQw_ce3c203a-933b-4061-9c48-c228de10aba4"
      unitRef="shares">3947368</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="if4562f74238f400d8605ac78ea70d681_D20200214-20200214"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzUx_1cdfcaca-04d8-4485-bbf6-d350f4785644"
      unitRef="usd">71800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="iafc11244cc12496099eda35772ccd636_D20200521-20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzY2_9a38f24a-0ec7-4df7-b4fb-998755886a0d"
      unitRef="shares">17600000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i55700871828341ecbb850efa2faf67d5_I20200521"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzc4_f3d69477-2292-438d-a25c-a18f7fbcd63e"
      unitRef="usdPerShare">76.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iafc11244cc12496099eda35772ccd636_D20200521-20200521"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzIvZnJhZzo2ODRjYzA3MWU0Yjc0NzUxYmE3Njc5MDUxNDM2YjE1Mi90ZXh0cmVnaW9uOjY4NGNjMDcxZTRiNzQ3NTFiYTc2NzkwNTE0MzZiMTUyXzEwNDQ1MzYwNTIxMzg2_012891b8-e103-4443-90cf-67c2ed3bafa5"
      unitRef="usd">1300000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5OTQ_5f997cdb-ce5b-40d1-8136-ddb409f4f359">Stock-Based Compensation&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2013, we adopted the 2013 Equity Incentive Plan (the 2013 Incentive Plan) and the 2013 Unit Option and Grant Plan (the 2013 Option Plan), which provided for the grant of incentive units, non-qualified unit options, and restricted and unrestricted unit awards to our employees, officers, directors, advisors, and outside consultants. Historically, we also granted restricted stock to founders, officers, directors, and advisors outside any of the Plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August&#160;2016, we adopted the 2016 Stock Option and Grant Plan (the 2016 Equity Plan), which replaced the 2013 Option Plan and the 2013 Incentive Plan. The 2016 Equity Plan and provided for the grant of incentive stock options, non-qualified stock options, restricted stock, unrestricted stock, and restricted stock units to our employees, officers, directors, consultants, and other key persons.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the IPO, we adopted the 2018 Stock Option and Incentive Plan (the 2018 Equity Plan) in November 2018. The 2018 Equity Plan became effective on the date immediately prior to the effective date of the IPO and replaced our 2016 Plan. The 2018 Equity Plan provides flexibility to our compensation committee to use various equity-based incentive awards as compensation tools to motivate our workforce. We have initially reserved 13,000,000 shares of our common stock for the issuance of awards under the 2018 Equity Plan. The 2018 Equity Plan provides that the number of shares reserved and available for issuance under the plan will &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;automatically increase each January 1, beginning on January 1, 2019, by 4% of the outstanding number of shares of our common stock on the immediately preceding December 31, or such lesser number of shares as determined by the Compensation and Talent Committee of our Board of Directors. The shares of common stock underlying any awards that are forfeited, canceled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting, satisfied without any issuance of stock, expire or are otherwise terminated (other than by exercise) under the 2018 Equity Plan and the 2016 Plan will be added back to the shares of common stock available for issuance under the 2018 Equity Plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The terms and conditions of stock-based awards are defined at the sole discretion of our Board of Directors. We issue service-based awards, vesting over a defined period of service, and performance-based awards, vesting upon achievement of defined conditions. Service based awards generally vest over a four-year period, with the first 25% of such awards vesting following twelve months of continued employment or service. The remaining awards vests in twelve quarterly installments over the following twelve quarters. Stock options granted under the 2016 Equity Plan expire ten years from the date of grant and the exercise price must be at least equal to the fair market value of common stock on the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of&#160;December 31, 2020, we had a total of&#160;64.2 million shares reserved for future issuance under our Equity Plans, of which 36.3 million shares were reserved for equity awards previously granted, and&#160;27.9 million shares were available for future grants under the 2018 Equity Plan. No additional awards will be granted under the 2016 Equity Plan as it was replaced by the 2018 Equity Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have granted options generally through the 2018 Equity Plan and 2016 Equity Plan. The following table summarizes our option activity as of December 31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number&#160;of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Price per&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Grant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Value per&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Contractual&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,536,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,036,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,888,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled/forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,627,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,057,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,976,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,461,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,596,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of common stock for those options in the money as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of options exercised was $785.7 million, $75.6 million and $5.3 million for the&#160;years ended December 31, 2020, 2019 and 2018, respectively. The aggregate intrinsic value represents the difference between the exercise price and the selling price received by option holders upon the exercise of stock options during the period. The total consideration recorded as a result of stock option exercises&#160;was approximately&#160;$179.6 million&#160;for&#160;the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Common Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have granted restricted stock unit awards generally through the 2018 Equity Plan. The following table summarizes our restricted stock unit activity during the year ended December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Grant Date Price&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;per Unit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, non-vested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(247,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled/forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, non-vested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,192,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of restricted stock units vested during the years ended December 31, 2020, 2019 and 2018, were $5.0 million, $5.5 million, and zero, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2018 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2018, we adopted the 2018 Employee Stock Purchase Plan (the ESPP), which became effective on December 5, 2018. The ESPP initially reserves and authorizes the issuance of up to a total of 810,000&#160;shares of common stock to participating employees. We will make one or more offerings, consisting of one or more purchase periods, each year to our employees to purchase shares under the ESPP. Offerings will usually begin every six months and will continue for six-month periods, referred to as offering periods. The purchase price at which shares are sold under the ESPP will be equal to 85% of the lower of the fair market value of the shares on the first business day of the offering period or the last business day of the purchase period. Employees are generally eligible to participate through payroll deductions of between 1% to 50% of their compensation and may not purchase more than 3,000 shares of common stock during each purchase period or&#160;$25,000&#160;worth of shares of common stock in any calendar year.&#160;We began our first ESPP offering on June 1, 2019. There were 251,752 shares of common stock sold at a weighted average price of $27.97 per share under the ESPP during the year ended December&#160;31, 2020. As of&#160;December&#160;31, 2020,&#160;3.6&#160;million&#160;shares were available for future issuance under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Valuation and Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation for options granted under our Equity Plans and share purchases under our ESPP is determined using the Black-Scholes option pricing model. The weighted-average assumptions used to estimate the fair value of options granted and ESPP for the&#160;years ended December 31, 2020, 2019 and 2018 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years&#160;Ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Expected term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.27 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Expected dividends&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Weighted average fair value per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* - Not applicable &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components and classification of stock-based compensation expense for the&#160;years ended December 31, 2020, 2019 and 2018 as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years&#160;Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted common stock and units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2020, 2019 and 2018, we recognized stock-based compensation expense of $9.6&#160;million, $9.8 million and $10.6 million, respectively, related to performance-based awards, including awards with vesting or commencement contingent upon the IPO, for which achievement of such performance-based condition was deemed probable. Stock-based compensation expenses related to non-employee awards were immaterial for the years ended December 31, 2020, 2019 and 2018.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, there were $226.8 million of total unrecognized compensation cost related to non-vested stock-based compensation with respect to options and restricted stock granted. That cost is expected to be recognized over a weighted-average period of 2.9 years at December 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i6c6d0348fa0f471c99e4a3d4fb593b39_I20181130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzEzNTI_3645c2e9-7c8c-4ab5-a901-4823fe21d5de"
      unitRef="shares">13000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <mrna:ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized
      contextRef="i262a8b76871743d192c168dbbc78eca7_D20181130-20181130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzE2MjE_fafc54c3-b6bb-434e-90bb-5090e3e84e74"
      unitRef="number">0.04</mrna:ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="icac42209a69c4d4faecce8d9ec2c954c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ5NDc4MDIzMzI2MTc_4f08f68e-6ee3-4931-93b9-cb819b8b17f1">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i94e125ac24d548f7bcacf7258fb26f5e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzI1OTQ_37279288-9da3-4b05-938f-81cfcfe48f15"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i94e125ac24d548f7bcacf7258fb26f5e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzI2MzA_e969417b-9893-4739-8538-b1cabad6870b">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments
      contextRef="i456564aebcd9408998fe415ad2b5746b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzI2OTk_8607e46c-ef48-45a4-9b4c-f934aaf5a964"
      unitRef="installment">12</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i94765e821a9d4db08f74e0976fc741a0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzI4MTc_1d5db3ae-3068-42d7-8af5-a4f503e50fc5">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzI5Nzc_1f330a0c-cd19-4d7b-a44b-6bba6e39a1bb"
      unitRef="shares">64200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ifce35912e3be4df98cae3575af43d851_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzMwNDk_3001fdd6-2f3d-4b4e-be92-125fc7a0fe17"
      unitRef="shares">36300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i28ea496c05f042ce8f74e96e04f6dc1c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzMxMTU_0544e75f-2dfd-43d3-a8d3-bac78c476db9"
      unitRef="shares">27900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5OTE_f2e0cb49-9a63-4bda-9a13-b0fa31c78343">The following table summarizes our option activity as of December 31, 2020 and 2019:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number&#160;of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercise&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Price per&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Grant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Date Fair&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Value per&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Remaining&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Contractual&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Intrinsic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in&#160;thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,536,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,036,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,888,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled/forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,627,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,057,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,976,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,461,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,596,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,343,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of common stock for those options in the money as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzEtMi0xLTEtMA_4d9df535-e9a7-4fec-b7ee-10a10cbcd356"
      unitRef="shares">45536915</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzEtNC0xLTEtMA_8d4e3468-9d9a-4fe0-9f3a-39f471222e16"
      unitRef="usdPerShare">13.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzEtNi0xLTEtMA_7040a493-5ad3-4bc5-9212-099d18fac90d"
      unitRef="usdPerShare">7.35</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzEtOC0xLTEtMA_4262b27f-4338-414e-8e80-a4fa368a7fff">P7Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzEtMTAtMS0xLTA_fb6f762b-19a9-4ddf-b907-b49ac4fb6931"
      unitRef="usd">286310000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzItMi0xLTEtMA_b39b38ae-c8a4-4aed-a9ea-144b60b50f0d"
      unitRef="shares">5036520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzItNC0xLTEtMA_d2cab064-1b22-4531-8873-9923ff4055e7"
      unitRef="usdPerShare">36.04</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzItNi0xLTEtMA_a0b485e2-c752-4509-b889-7c71e5774155"
      unitRef="usdPerShare">19.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzMtMi0xLTEtMA_6a87a1f9-38db-40b4-906b-5dc6992e3351"
      unitRef="shares">13888434</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzMtNC0xLTEtMA_43d054e9-0ced-4da1-8452-02eb00d6ca8e"
      unitRef="usdPerShare">12.93</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzMtNi0xLTEtMA_1ac04223-3351-4475-a3c2-6b70bb6cb835"
      unitRef="usdPerShare">6.68</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzQtMi0xLTEtMA_83d2e070-8e6b-41f9-bd99-9000b7f2558e"
      unitRef="shares">2627468</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzQtNC0xLTEtMA_50210f68-7c9a-446a-8a58-cceee92dbb68"
      unitRef="usdPerShare">18.14</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzQtNi0xLTEtMA_cd8de44d-ad67-4496-8e52-46f01fbc0137"
      unitRef="usdPerShare">10.56</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzUtMi0xLTEtMA_4200bf7a-a3cc-42a9-9e39-d59ea78aa55c"
      unitRef="shares">34057533</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzUtNC0xLTEtMA_617d4dfb-b5a1-40eb-82d0-7120211a5da7"
      unitRef="usdPerShare">17.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzUtNi0xLTEtMA_e5090bc3-5703-4bfd-a53c-7f7194ac137a"
      unitRef="usdPerShare">9.12</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzUtOC0xLTEtMA_37824f9c-1541-4ea1-8f8b-0d7edd88032d">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzUtMTAtMS0xLTA_4adb5f90-6b3d-4c67-9d66-aba120d43e3e"
      unitRef="usd">2976235000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzYtMi0xLTEtMA_7693b4d7-70b7-40ef-b8ba-97eea2165d26"
      unitRef="shares">17461374</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzYtNC0xLTEtMA_2651c160-d6ac-4fb8-a2f7-33cd81af2890"
      unitRef="usdPerShare">10.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzYtNi0xLTEtMA_59f64481-59bd-4cc4-b10d-48c7690e1c54"
      unitRef="usdPerShare">5.67</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzYtOC0xLTEtMA_4d4ce69a-c4af-463e-b14d-e1fc61c33c4d">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzYtMTAtMS0xLTA_2eee50a7-5ea7-43f9-b7d0-694ed2d10aa0"
      unitRef="usd">1632365000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzctMi0xLTEtMA_accd1682-0c68-43f2-ac9f-4b0893dfb159"
      unitRef="shares">16596159</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzctNC0xLTEtMA_e05b6976-c1a0-44fd-86cd-3db89fa87b28"
      unitRef="usdPerShare">23.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzctNi0xLTEtMA_97f4248b-ce11-4b08-b2a6-d48efc9052f1"
      unitRef="usdPerShare">12.75</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzctOC0xLTEtMA_1a50c3ae-5926-47e5-b823-c9f8557bad39">P8Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTo2NmQyM2Q2NGNhZjk0ZTdjOGNlZGY5ZGQ5ZmIzZTRhYS90YWJsZXJhbmdlOjY2ZDIzZDY0Y2FmOTRlN2M4Y2VkZjlkZDlmYjNlNGFhXzctMTAtMS0xLTA_2dd42034-7dfb-4d26-b51f-95e4980de5fc"
      unitRef="usd">1343870000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzM3MjQ_82f8d90e-698a-4748-be01-211cc89d3fa7"
      unitRef="usd">785700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzM3Mjg_8a1ec3b6-3810-4f6f-8822-6866728f3e50"
      unitRef="usd">75600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzM3NDU_adc75559-84e3-4423-9fc7-e07bbc24d9f1"
      unitRef="usd">5300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzM4ODY_9d9f1e7d-927a-4929-a0da-ab5d06289b83"
      unitRef="usd">179600000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5OTc_c145ce1b-e779-4c75-b8f8-17f9bf954902">The following table summarizes our restricted stock unit activity during the year ended December 31, 2020:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Grant Date Price&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;per Unit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, non-vested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(247,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canceled/forfeited&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, non-vested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,192,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3a2b16bb22614c61b08450535a865c3a_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzEtMS0xLTEtMA_eb4c83e8-25c6-478e-b33b-e34fea468836"
      unitRef="shares">1177249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3a2b16bb22614c61b08450535a865c3a_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzEtMy0xLTEtMA_241c7933-5b69-438d-83c2-afe295030d1e"
      unitRef="usdPerShare">19.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzItMS0xLTEtMA_443cd623-ac71-4742-9c0d-04aec89db9d3"
      unitRef="shares">1478093</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzItMy0xLTEtMA_ca70a4d1-36f4-49d5-a9f2-e7972d49e6ac"
      unitRef="usdPerShare">37.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzMtMS0xLTEtMA_d0408c5d-6db0-4dd2-89e3-677a2c4fe535"
      unitRef="shares">247349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzMtMy0xLTEtMA_6e64ec67-711d-404a-8514-3d1d510b5ae0"
      unitRef="usdPerShare">20.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzQtMS0xLTEtMA_63a37881-6e54-40c4-8eb5-7e051d54b7e8"
      unitRef="shares">215033</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i4807ee8256114040874d647a3a407087_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzQtMy0xLTEtMA_19a2a7a4-86aa-46ea-a08a-985d0876f945"
      unitRef="usdPerShare">23.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ibf4921fe189a4bb3adbffaca20a7ba53_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzYtMS0xLTEtMA_2a2dbc3a-2bd6-4297-90b5-19aa4a9f61d3"
      unitRef="shares">2192960</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ibf4921fe189a4bb3adbffaca20a7ba53_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpiMzdlYmIyYzE3MWY0OGU2YTVmYWY5MDU2N2VlMGZiNC90YWJsZXJhbmdlOmIzN2ViYjJjMTcxZjQ4ZTZhNWZhZjkwNTY3ZWUwZmI0XzYtMy0xLTEtMA_8b22bf25-2a13-4681-8e33-20e3023397cf"
      unitRef="usdPerShare">30.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:RestrictedStockExpense
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzMyOTg1MzQ4OTQyNDg_664a14c8-d403-4784-a03c-f1771a37e6b3"
      unitRef="usd">5000000.0</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzMyOTg1MzQ4OTQyNjc_98393c04-b1d8-435e-850c-4575ad70fe6d"
      unitRef="usd">5500000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzEwNDQ1MzYwNDc0ODU3_82957cff-b3e2-4bcd-b4af-06c79a1aa438"
      unitRef="usd">0</us-gaap:RestrictedStockExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i4793fdc04065442a8c634bb5b8ed5276_I20181205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ2NzI_bb24c45c-be15-4911-847d-b8f6639b5e6f"
      unitRef="shares">810000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod
      contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ5NDc4MDIzMzY3MDU_292039ae-2662-44ae-83bf-9404a5fa621f"
      unitRef="offering">1</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods
      contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ5NDc4MDIzMzY3MTM_8a98578d-43d9-454e-a5a2-42fb88d06f12"
      unitRef="purchase_period">1</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod
      contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ5MDM_3831730e-16bd-48a4-a6da-c19c08fa7935">P6M</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod
      contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQ5NDc4MDIzMzI2MTg_5ac0e71d-3979-4227-a289-abf2ac6658a4">P6M</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzUwNTU_ec0438cb-4c7a-4027-b83a-6445e3c7085d"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <mrna:ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate
      contextRef="i4793fdc04065442a8c634bb5b8ed5276_I20181205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzUyOTQ_0393b4d7-7ada-428d-826d-ce6adbbc1b31"
      unitRef="number">0.01</mrna:ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i4793fdc04065442a8c634bb5b8ed5276_I20181205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzUzMDA_76e60c88-d8d7-4aa2-b0b3-badf3a0c64be"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzUzNTY_39a91177-97dc-4fcf-9ca0-4ddf412ccb0c"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount
      contextRef="ic0d0a2d43e69424f84b26ba57b08bc7e_D20181205-20181205"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzU0MTM_1539cffc-9a00-461c-900d-1fb196fcf5be"
      unitRef="usd">25000000</mrna:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ieceb0f5d61c741e2ae79714848077fc6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzU1MzE_d7e82b6e-b5b9-487d-97d0-cdaa22274b7a"
      unitRef="shares">251752</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:SharePrice
      contextRef="ic81d102f7ca14bd6bb17285971aa99df_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzU1ODU_fba830c5-b623-4371-9294-6b89d380b404"
      unitRef="usdPerShare">27.97</us-gaap:SharePrice>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i0f14ad75477c466dafbb2d98521f49c5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzM4NDgyOTA3MDUwNTY_d6c9b5cd-43d1-4246-bd60-5c8a0aab48e5"
      unitRef="shares">3600000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5OTM_4da55583-eb47-4f06-a693-63d6b261aacc">The weighted-average assumptions used to estimate the fair value of options granted and ESPP for the&#160;years ended December 31, 2020, 2019 and 2018 are as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years&#160;Ended&#160;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Expected term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.11 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.07 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.27 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Expected dividends&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Weighted average fair value per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividends&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value per share&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________&lt;/span&gt;&lt;/div&gt;* - Not applicable</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzQtMi0xLTEtMA_57e4bfb2-6e29-4268-97df-10e1177b8a61"
      unitRef="number">0.0083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzQtNC0xLTEtMA_978b528a-79fd-4702-91f8-394d7486f651"
      unitRef="number">0.0229</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iab7b67e811134bd584fb576d6e749803_D20180101-20181231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzQtNi0xLTEtMA_e1d0b392-757d-42dd-a90b-4af9a63a4f3a"
      unitRef="number">0.0276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzUtMi0xLTEtMA_88b2f55e-6e72-44b3-acc8-ab90b5454f3b">P6Y1M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzUtNC0xLTEtMA_b4dda0ea-40c3-4b5d-b51d-ca5fdbb3d1d2">P6Y25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iab7b67e811134bd584fb576d6e749803_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzUtNi0xLTEtMA_622af53c-e729-4ef2-a8f3-d57d5a18f724">P6Y3M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzYtMi0xLTEtMA_1dab62bf-a4a3-4ea4-861f-b83567498b53"
      unitRef="number">0.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzYtNC0xLTEtMA_e58cb766-5411-44f7-be79-608162d3101b"
      unitRef="number">0.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="iab7b67e811134bd584fb576d6e749803_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzYtNi0xLTEtMA_4af8c2ab-2f14-462b-b14d-47d227e61bcb"
      unitRef="number">0.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzctMi0xLTEtMA_75ed099a-6446-4a95-ad91-0177601b45e5"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzctNC0xLTEtMA_c4d3d8c4-4ad7-4857-a7c4-6db7ba70b054"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="iab7b67e811134bd584fb576d6e749803_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzctNi0xLTEtMA_d03c1aed-9ec2-4a29-ac9e-f60a0ca310dd"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharePrice
      contextRef="ic8ea87e5e7834335be8ba996294292fd_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzgtMi0xLTEtMA_a05b6e7f-dbc0-456f-ae76-fc2421c06c6c"
      unitRef="usdPerShare">19.30</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i5bc50b13e4114cdeb9dfbcfc004a74de_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzgtNC0xLTEtMA_4a30a1ae-0c04-4a29-9d93-fb085536f835"
      unitRef="usdPerShare">11.35</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="iade5b4d11372466e90c1c179f3b5ac9f_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzgtNi0xLTEtMA_69574702-0110-4e76-b5db-fae395f084a9"
      unitRef="usdPerShare">9.33</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzExLTItMS0xLTA_6e9966a1-2609-4cbc-b46e-5ecfb1a593d3"
      unitRef="number">0.0014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzExLTQtMS0xLTA_d05f608a-012d-4cf7-97de-7fa74acfd793"
      unitRef="number">0.0195</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzEyLTItMS0xLTA_599a0f06-fa72-412c-b51d-0b63fd9bdd36">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzEyLTQtMS0xLTA_c35553d0-7b11-4d84-bf4a-a8bda65bb0a5">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzEzLTItMS0xLTA_e9472737-aaa2-440f-a3e6-bf9edf1dff02"
      unitRef="number">0.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzEzLTQtMS0xLTA_36989425-ae05-4640-864f-3c55d3dc5627"
      unitRef="number">0.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzE0LTItMS0xLTA_0b73c9dc-69da-4210-8dc2-4bef60cd7c04"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzE0LTQtMS0xLTA_86c5e530-82b5-4462-a88e-ee4d6d0f7edc"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharePrice
      contextRef="i38f16929f2a54250afa6263ffee43aa1_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzE1LTItMS0xLTA_fc3afd12-0ed8-44d9-afac-5bd314109551"
      unitRef="usdPerShare">32.18</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i7cadb2afe3df43fe8cacb9af45694889_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTpmNTI3NzAwYjVjMTE0NjNmYmNhNWFlZmY1OTQwYTNlOS90YWJsZXJhbmdlOmY1Mjc3MDBiNWMxMTQ2M2ZiY2E1YWVmZjU5NDBhM2U5XzE1LTQtMS0xLTA_ca0ae332-30cf-48f8-937d-12526479b4ca"
      unitRef="usdPerShare">5.98</us-gaap:SharePrice>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5OTk_efdfd0ce-63d4-462d-a4d3-320496341a89">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components and classification of stock-based compensation expense for the&#160;years ended December 31, 2020, 2019 and 2018 as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years&#160;Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted common stock and units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzItMS0xLTEtMA_d7f7e397-38fb-4a98-9a25-590c70c231ce"
      unitRef="usd">77748000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idfb875d2dd6444368be09ca65f957e45_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzItMy0xLTEtMA_aff02389-75ad-45cc-8852-a4a2130f658b"
      unitRef="usd">74780000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iab7b67e811134bd584fb576d6e749803_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzItNS0xLTEtMA_4aed66c3-f735-4239-8398-79d72ed6c6fa"
      unitRef="usd">63288000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifa289361628e459292558aa0cf78cd6b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzMtMS0xLTEtMA_cb371020-3730-4c69-b592-cb36be6f19f8"
      unitRef="usd">12401000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id16aba6da7f64bd394030c96c373b2de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzMtMy0xLTEtMA_5813aa1d-f1fb-4098-89a8-5d8374b2577b"
      unitRef="usd">5125000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iea322dace75d448fad9eea135238af31_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzMtNS0xLTEtMA_715a10dc-0638-4f60-9ca9-f0ae435d4107"
      unitRef="usd">9277000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3a04ef3b932f4c2984bd5d73d1ffb033_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzQtMS0xLTEtMA_1c7fb9fb-b01a-4447-b2b4-3d5451b9e111"
      unitRef="usd">2872000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i85268ae8035d4f41a5b317ce5a10ddc3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzQtMy0xLTEtMA_2a3c69d4-3ed7-46e3-8b3c-f6cc401419d0"
      unitRef="usd">1217000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1d492fe3077f4edc95bfea38191dbe14_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzQtNS0xLTEtMA_9f93b91d-46ee-478b-abfd-147357a54889"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzUtMS0xLTEtMA_1049b6f5-0375-42a2-99fd-4bba4f9fe50e"
      unitRef="usd">93021000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzUtMy0xLTEtMA_fd8c7f2f-2915-4d86-aba1-1dd3976138c3"
      unitRef="usd">81122000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzUtNS0xLTEtMA_3000e862-e684-4042-a2cf-38b1c85a6cdb"
      unitRef="usd">72565000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9b7796d6fc41467489873be3464c5281_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzYtMS0xLTEtMA_1585ed21-c09e-4edc-bb4e-62d07500fd90"
      unitRef="usd">56155000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8b394cfd73114e379da638593c59398d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzYtMy0xLTEtMA_4c5de71e-300a-4276-921d-8728f4c7b472"
      unitRef="usd">48259000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i205ef00a043d47539d12683bf81d27bf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzYtNS0xLTEtMA_cb66bf99-3473-4534-990e-ec097ba220f1"
      unitRef="usd">37659000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3d40e479571a447ab799a9e823712900_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzctMS0xLTEtMA_69d109b7-9763-4db9-a58f-63fed9c52659"
      unitRef="usd">36866000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8f343e6d4c4743d787e7ead6fa87139f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzctMy0xLTEtMA_3441d4dc-fb5d-4b47-a9e1-97f96173e26d"
      unitRef="usd">32863000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id1a3afd2d01d4284ab41f3b52d9d7bc3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzctNS0xLTEtMA_0f47ff7b-b37f-4d65-a9db-5daf5b2d9583"
      unitRef="usd">34906000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzgtMS0xLTEtMA_3d5837d7-237e-4e10-8871-f6db8733688e"
      unitRef="usd">93021000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzgtMy0xLTEtMA_d6ca70cb-2ebd-45aa-8f2c-fc92cc1c52c0"
      unitRef="usd">81122000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90YWJsZTplOTcyYzViMmQ1NWQ0Y2ZhYTQ2NGQwODIzMTEzYjg1MC90YWJsZXJhbmdlOmU5NzJjNWIyZDU1ZDRjZmFhNDY0ZDA4MjMxMTNiODUwXzgtNS0xLTEtMA_25cbda97-5de0-485f-bccd-8a2901667761"
      unitRef="usd">72565000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie37236e25e6d4e2c8a87336c27d49324_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzQzOTgwNDY1MjIwODQ_2d77c3fd-c852-42c4-a92b-1da42c410868"
      unitRef="usd">9600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i249101ed25324c3c8d67aab92ad128da_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY0MTQ_e578048e-1ca1-4215-9e9d-87e96c5a812c"
      unitRef="usd">9800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8bb1304918df480cb950ea6c29a15615_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY0MjE_4cc0f66d-dbea-40f6-936a-2e93a4ed03ba"
      unitRef="usd">10600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY3NjM_ab201763-3770-4193-bcae-7b87ca71587d"
      unitRef="usd">226800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNzgvZnJhZzo5YzkwNTljZDM2NTM0NjcyOTY2MjI0YmZlZDA1NWUwYS90ZXh0cmVnaW9uOjljOTA1OWNkMzY1MzQ2NzI5NjYyMjRiZmVkMDU1ZTBhXzY5ODA_12dba3b6-c253-4f9b-88ea-90da58a3b1f6">P2Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzU1NQ_bd1e6b22-bcbd-42cc-bfdc-e442f9e2a509">Employee Benefit PlanWe provide a retirement savings option to our eligible U.S. employees through the Moderna, Inc. 401(k)&#160;Plan (the 401(k) Plan), subject to certain limitations. As allowed under Section&#160;401(k) of the Internal Revenue Code, the 401(k) Plan allows tax deferred salary deductions for eligible employees. We match 50% up to the first 6% contributed by a participant. All matching contributions are immediately vested. Total matching contributions to the 401(k) Plan were $5.0 million, $4.2 million, $2.1 million for the&#160;years ended December 31, 2020, 2019 and 2018, respectively.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzMzOQ_8dddf746-40e5-4156-8468-59640ce272e5"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzM1OA_2ffcff76-0ce7-4e34-b0e1-8bb9ccfd4f30"
      unitRef="number">0.06</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzQ5NQ_dd4394c6-fd45-464f-bc60-3dbbe25bff86"
      unitRef="usd">5000000.0</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzQ5OQ_6a14d943-8fdc-4692-9dda-7f536ac231c6"
      unitRef="usd">4200000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODQvZnJhZzoyMWIzN2Q0NGQyZjk0ODZhYWRlMDZiMDllZjZiNjg0MS90ZXh0cmVnaW9uOjIxYjM3ZDQ0ZDJmOTQ4NmFhZGUwNmIwOWVmNmI2ODQxXzUwMw_d91d64c3-b355-42ac-8ca8-31cc93f4a6e9"
      unitRef="usd">2100000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0MjY_7b5332f2-8a6a-469a-852a-4248be27871b">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss before provision for (benefit from) income taxes for the years ended December 31, 2020, 2019 and 2018 consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(745,445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(508,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(380,473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(744,513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(514,716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(384,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for (benefit from) income taxes for the years ended December 31, 2020, 2019 and 2018 consist of the following components (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the U.S. statutory income tax rate to our effective tax rate for the years ended December 31, 2020, 2019 and 2018 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effected at statutory rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal research and development credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax rate differential&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation windfall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant components of our deferred tax assets and tax liabilities as of December 31, 2020 and 2019 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.898%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carry-forwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized licenses, research and development and start-up costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit carry-forwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease financing obligation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(823,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(470,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets, net of valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,959)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have evaluated the positive and negative evidence bearing upon the realization of our deferred tax assets, including our history of significant losses in every year since our inception and in accordance with the applicable accounting standards, have fully reserved the net deferred tax asset. We concluded that realization of our net deferred tax assets is not more-likely-than-not to be realized as of December 31, 2020. The valuation allowance increased by $352.7 million in the year ended December 31, 2020, primarily due to the increase in net operating loss carry-forwards, research and development tax credits and capitalized inventory.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a periodic basis, we reassess the valuation allowance on our deferred income tax assets, weighing positive and negative evidence to assess the recoverability of the deferred tax assets. In 2020, we reassessed the valuation allowance and considered negative evidence, including our cumulative losses over the three years ended December 31, 2020, and positive evidence, including our recent EUA for our COVID-19 vaccine. After assessing both the negative and positive evidence, we concluded that we should maintain the valuation allowance on our net operating losses and our other deferred tax assets as of December 31, 2020. The release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, our level of profitability, revenue growth, clinical program progression and expectations regarding future profitability. Our total deferred tax asset balance subject to the valuation allowance was approximately $874.1&#160;million at December 31, 2020. We will continue to monitor the need for a full or partial valuation allowance each quarter in 2021 and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, we had approximately $2.26 billion and $1.70 billion of federal and state net operating loss carry-forwards, respectively, of which $380.1 million of federal and $1.70 billion of state loss carry-forwards begin to expire in 2030. Additionally, $1.88 billion of federal net operating loss carry-forward will carry forward indefinitely. At December 31, 2020 we also had federal and state research and development credit carry-forwards of approximately $73.3 million and $26.1 million, which begin to expire in 2030 and 2032, respectively. At December 31, 2020, we also had federal orphan drug and state investment tax credit carry-forwards of approximately $2.0 million and $3.9 million which begin to expire in 2039 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Coronavirus Aid, Relief and Economic Security Act (the CARES Act) was signed into law. The CARES Act includes provisions relating to several aspects of corporate income taxes. We do not currently expect the CARES Act to have a significant impact on our provision for income taxes; however, we will continue to monitor the provisions of the CARES Act in relation to its operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Utilization of the net operating loss (NOL) and tax credit carry-forwards may be subject to a substantial annual limitation due to ownership change limitations that have occurred previously, or that could occur in the future, as provided by Section&#160;382 of the Internal Revenue Code of 1986, as amended, or Section&#160;382, as well as similar state provisions and other provisions of the Internal Revenue Code. Ownership changes may limit the amount of NOLs and tax credit carry-forwards that can be utilized annually to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section&#160;382, results from transactions that increase the ownership of 5% shareholders in the stock of a corporation by more than 50% in the aggregate over a three-year period. We may experience ownership changes in the future as a result of subsequent shifts in our stock ownership, some of which may be outside our control.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file U.S. federal income tax returns and income tax returns in various state, local and foreign jurisdictions. All tax years since the date of our incorporation remain open to examination by the major taxing jurisdictions (state and federal) to which we are subject, as carry-forward attributes generated in years past may still be adjusted upon examination by the Internal Revenue Service (IRS) or other authorities if they have or will be used in a future period. We are not currently under examination by the IRS, or any other jurisdictions, for any tax year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize, in our financial statements, the effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. A reconciliation of the beginning and ending amounts of unrecognized tax benefits during the years ended December 31, 2020 and 2019 are as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease due to prior positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to current year tax position&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease due to prior positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrecognized tax benefits may change during the next twelve months for items that arise in the ordinary course of business. We do not anticipate a material change to our unrecognized tax benefits over the next twelve months that would have an adverse effect on our consolidated operating results. We recognize interest and penalties, if applicable, related to uncertain tax positions as a component of income tax expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0MTk_15e3de63-d7a5-4d8a-94be-ea1c26ebea39">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss before provision for (benefit from) income taxes for the years ended December 31, 2020, 2019 and 2018 consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(745,445)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(508,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(380,473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(744,513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(514,716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(384,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzItMS0xLTEtMA_c275d93c-e24e-4229-91a5-822e64296d9a"
      unitRef="usd">-745445000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzItMy0xLTEtMA_b0412b53-5850-4075-a08d-11ae76d25327"
      unitRef="usd">-508595000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzItNS0xLTEtMA_5c36947d-b229-47e3-b9b1-c215881ffc8b"
      unitRef="usd">-380473000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzMtMS0xLTEtMA_aef5648e-5420-4524-9b69-cc05e58180a2"
      unitRef="usd">932000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzMtMy0xLTEtMA_7fbf65da-a41a-462f-89fb-10041f3f6c64"
      unitRef="usd">-6121000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzMtNS0xLTEtMA_edc41d70-686f-4de9-a051-b66c1b24c19a"
      unitRef="usd">-3935000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzQtMS0xLTEtMA_26450336-6f92-4a66-981a-fd4f1dfda8bf"
      unitRef="usd">-744513000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzQtMy0xLTEtMA_22d302ab-a438-43d3-83f1-cf2ef2702fc0"
      unitRef="usd">-514716000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo0OWI3NzE1NDBkOWE0ZDM5ODEzYWZjYzdmYmY1NTc0Yi90YWJsZXJhbmdlOjQ5Yjc3MTU0MGQ5YTRkMzk4MTNhZmNjN2ZiZjU1NzRiXzQtNS0xLTEtMA_67ee3c07-fc1a-4de1-94c6-f8a2ee62f22b"
      unitRef="usd">-384408000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0Mjc_227c8753-84a1-4b25-af88-f1665cb27c42">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for (benefit from) income taxes for the years ended December 31, 2020, 2019 and 2018 consist of the following components (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzMtMS0xLTEtMA_752912b2-c815-4560-a2b4-05f61e8e7592"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzMtMy0xLTEtMA_9c370d77-e05d-4207-8365-0198c93fff62"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzMtNS0xLTEtMA_65e83596-5e97-4953-8a40-fa648ccec72f"
      unitRef="usd">-26000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzQtMS0xLTEtMA_5157b2b2-c961-4d94-a946-8556a48362ae"
      unitRef="usd">32000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzQtMy0xLTEtMA_9f60fd9b-a958-48ca-8927-eea935a8a427"
      unitRef="usd">505000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzQtNS0xLTEtMA_5cfe8b32-5682-4d0c-9755-1c17c91c3245"
      unitRef="usd">352000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtMS0xLTEtMTQwNjg_e2c0c329-b6e7-48e6-83c3-7d38a7362e76"
      unitRef="usd">2519000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtMy0xLTEtMTQwNjg_85b3a6f4-4f0a-45ac-a967-e79fad109919"
      unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtNS0xLTEtMTQwNjg_f34e017e-2cab-4932-b782-67da6421e8f0"
      unitRef="usd">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtMS0xLTEtMA_fa979e2f-d195-451d-81cf-01dfe3d67081"
      unitRef="usd">2551000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtMy0xLTEtMA_025f0c7c-1eed-4ddd-9063-4fe9d5c0595a"
      unitRef="usd">505000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzUtNS0xLTEtMA_320c08ed-ad26-4b3a-9c7f-fa21f014eba0"
      unitRef="usd">326000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzctMS0xLTEtMA_45da105c-cc12-44c1-83aa-e87a526ab247"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzctMy0xLTEtMA_4ab02904-7828-4f0c-8af5-031ae418b0de"
      unitRef="usd">-1200000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzctNS0xLTEtMA_320ea633-da91-48e9-93a2-26c06d5cff80"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzgtMS0xLTEtMA_21295c57-3dab-4141-ab73-7884c2204199"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzgtMy0xLTEtMA_9aa991b9-3de3-4bc6-8977-d8fbdc3c26f2"
      unitRef="usd">-1200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzgtNS0xLTEtMA_983d126b-259e-4ea9-8dc9-b560aba6501d"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzktMS0xLTEtMA_1fd59bdb-c090-454a-ad3c-4358a9ca8382"
      unitRef="usd">2551000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzktMy0xLTEtMA_3421e31c-e97b-4f5a-a9d6-baf8ad459161"
      unitRef="usd">-695000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo5YWRlNGRiZjk0YmU0MDBmYTNiMjFjYmE4NTE2MDY0Yy90YWJsZXJhbmdlOjlhZGU0ZGJmOTRiZTQwMGZhM2IyMWNiYTg1MTYwNjRjXzktNS0xLTEtMA_da6dac03-e855-488b-a1c5-1475dacb5caf"
      unitRef="usd">326000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0MjI_159698d4-2ac3-4867-be13-7bcc93aec27f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the U.S. statutory income tax rate to our effective tax rate for the years ended December 31, 2020, 2019 and 2018 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.067%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effected at statutory rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes, net of federal benefit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible items&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal research and development credits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign tax rate differential&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation windfall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzItMS0xLTEtMA_dc169738-5d60-4711-81bf-61b4cd906b93"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzItMy0xLTEtMA_b2cf62a7-8877-4355-a77c-c9c40d630799"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzItNS0xLTEtMA_9e578dd7-4f94-41f0-8502-fc586c8b3a6d"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzMtMS0xLTEtMA_bbe64f5b-0ecf-41d2-a80c-6de5b0f8d68b"
      unitRef="number">0.036</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzMtMy0xLTEtMA_fb170e71-2dd3-4f18-b569-c1e2ad695b75"
      unitRef="number">0.079</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzMtNS0xLTEtMA_97eba8b1-7b1c-496c-89e7-be4c22af3224"
      unitRef="number">0.063</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzQtMS0xLTEtMA_51ca0238-88a3-4894-8196-c6372ab4d40a"
      unitRef="number">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzQtMy0xLTEtMA_38028cdb-b121-4d9e-a2ec-c5a129d16f4a"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzQtNS0xLTEtMA_183617fd-ea65-43c0-a4ee-2387f134555f"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzUtMS0xLTEtMA_c2e2b279-820c-45f8-8269-40e179d23f54"
      unitRef="number">-0.474</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzUtMy0xLTEtMA_f00aa521-58fe-4674-8db8-3826c5940d97"
      unitRef="number">-0.330</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzUtNS0xLTEtMA_364535e0-b02a-454f-be7d-bd12c03f4ba4"
      unitRef="number">-0.285</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzYtMS0xLTEtMA_647d0d55-6e2a-444a-baba-4af915d5f57c"
      unitRef="number">-0.038</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzYtMy0xLTEtMA_dbe93efc-3393-4e04-8fc3-b7905bb7f111"
      unitRef="number">-0.025</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzYtNS0xLTEtMA_c764f62c-6445-4fd9-8f41-ffa39b2224d1"
      unitRef="number">-0.015</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzctMS0xLTEtMA_c37ec45f-4481-4e87-922f-1a3647003dcf"
      unitRef="number">0.000</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzctMy0xLTEtMA_14fefeea-6e3e-4b30-a7e4-a8f36ab4c325"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzctNS0xLTEtMA_966735e5-17f6-424a-a7db-1ea7963f4130"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktMS0xLTEtMTM1MTA_24c931d0-85c7-4cfe-9618-cea53191ac65"
      unitRef="number">0.198</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktMy0xLTEtMTM1MTA_0a317843-5ecb-43f0-b350-4ff4f27a0ce2"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktNS0xLTEtMTM1MTA_c1a980c0-977d-4507-b00f-5c47d51ac641"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktMS0xLTEtMA_daac7b6e-97b3-4ec2-b44d-077cd4e12810"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktMy0xLTEtMA_a1677257-b4a3-48d9-8db0-32a923880eb9"
      unitRef="number">0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzktNS0xLTEtMA_2843e908-d524-4153-84f8-3f3f5497bc82"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzEwLTEtMS0xLTA_3857946d-3423-40b9-b5a1-0d647863c3a3"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzEwLTMtMS0xLTA_867d6198-8340-4db5-b783-5497f091558b"
      unitRef="number">-0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNzQ2YTkzM2RlMzU0YzI2OWY5NzJlZTQzMjI3MDYyZS90YWJsZXJhbmdlOmU3NDZhOTMzZGUzNTRjMjY5Zjk3MmVlNDMyMjcwNjJlXzEwLTUtMS0xLTA_ac2e7957-77b8-4703-868a-6a41c5dafb72"
      unitRef="number">-0.001</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0MTc_7151a503-28d4-4477-b511-173f2febb5d7">&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant components of our deferred tax assets and tax liabilities as of December 31, 2020 and 2019 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.898%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carry-forwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized licenses, research and development and start-up costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credit carry-forwards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease financing obligation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(823,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(470,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets, net of valuation allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,944)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,959)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50,677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzMtMS0xLTEtMA_554bccaf-dd74-4d65-8d7d-d25a482708b8"
      unitRef="usd">587211000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzMtMy0xLTEtMA_6bbf198d-651a-4f4f-89ac-e16f75a4785b"
      unitRef="usd">268173000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzQtMS0xLTEtMA_b0ed7622-c72b-4a71-ae50-e9f6695d0ee7"
      unitRef="usd">33089000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzQtMy0xLTEtMA_74dc740a-f073-47c5-8526-bd6e9b832c61"
      unitRef="usd">43978000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <mrna:DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzUtMS0xLTEtMA_bffb0a8d-a9d1-4d54-9c4c-0787a2a06b8a"
      unitRef="usd">13985000</mrna:DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts>
    <mrna:DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzUtMy0xLTEtMA_2e0f4c6c-5a91-44c0-89a0-07c9c58690e0"
      unitRef="usd">19891000</mrna:DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzYtMS0xLTEtMA_9b45c06d-06ad-46ed-991c-5697af107b39"
      unitRef="usd">99024000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzYtMy0xLTEtMA_c17d53cd-380d-4466-b2be-2b5850f34728"
      unitRef="usd">77222000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzctMS0xLTEtMA_e4fdfd68-2b97-4273-9e6a-31e5b50079fe"
      unitRef="usd">26962000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzctMy0xLTEtMA_3a189483-2706-4bc3-83ed-ba07d0e896d3"
      unitRef="usd">7377000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzgtMS0xLTEtMA_d08033ba-65ef-4f86-8a66-0ecdff7f83f9"
      unitRef="usd">29785000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzgtMy0xLTEtMA_e496fa18-c1f3-4e88-9408-b3780a27d7eb"
      unitRef="usd">53475000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <mrna:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzktMS0xLTEtMA_2600c713-9796-4dbb-b9e5-a54e458b8d32"
      unitRef="usd">22313000</mrna:DeferredTaxAssetsOperatingLeaseLiability>
    <mrna:DeferredTaxAssetsOperatingLeaseLiability
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzktMy0xLTEtMA_dc746f0b-e26c-4c7a-b0c9-8ad4cb011830"
      unitRef="usd">26571000</mrna:DeferredTaxAssetsOperatingLeaseLiability>
    <mrna:DeferredTaxAssetsFinancingLeaseLiability
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEwLTEtMS0xLTA_7aff939e-520e-4847-9fed-6ad6a842fd98"
      unitRef="usd">23718000</mrna:DeferredTaxAssetsFinancingLeaseLiability>
    <mrna:DeferredTaxAssetsFinancingLeaseLiability
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEwLTMtMS0xLTA_f36ea7f3-f1db-44ff-8aa0-db9326022648"
      unitRef="usd">10570000</mrna:DeferredTaxAssetsFinancingLeaseLiability>
    <mrna:DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzExLTEtMS0xLTE1NjA2_7e72c1c9-58ff-48d7-8c39-2bf451fd9fa3"
      unitRef="usd">38058000</mrna:DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts>
    <mrna:DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzExLTMtMS0xLTE1NjA4_d7a6b811-dee2-48d9-b413-159b4a93ba71"
      unitRef="usd">0</mrna:DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzExLTEtMS0xLTA_15658ca2-34eb-4832-84df-2b34c593045c"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzExLTMtMS0xLTA_fd6a1789-594a-4bdd-8985-1933435b0806"
      unitRef="usd">11000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEyLTEtMS0xLTA_bd7daa03-0721-4d23-8a78-e83f22a3b238"
      unitRef="usd">874145000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEyLTMtMS0xLTA_8898dfcd-a74e-4d3a-89a2-1c510024b08a"
      unitRef="usd">507268000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEzLTEtMS0xLTA_ecb2b8fb-c2d4-427d-8f63-8cd218898777"
      unitRef="usd">823468000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzEzLTMtMS0xLTA_c6a0e8ee-5e13-48d4-ab2d-a284d6b3bb00"
      unitRef="usd">470753000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE0LTEtMS0xLTA_f5363523-1caf-4d5f-ae6e-ac2b9d2493e2"
      unitRef="usd">50677000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE0LTMtMS0xLTA_c8a64348-b749-4e7d-ae1b-c0ef0676c884"
      unitRef="usd">36515000</us-gaap:DeferredTaxAssetsNet>
    <mrna:DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE2LTEtMS0xLTA_1ab31903-e862-4db4-81a1-8f2ec483a35e"
      unitRef="usd">11539000</mrna:DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset>
    <mrna:DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE2LTMtMS0xLTA_6cde1fe7-5292-4ea4-bed5-9086bf797f9b"
      unitRef="usd">2612000</mrna:DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset>
    <mrna:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE3LTEtMS0xLTA_b9609ed7-80c7-4f45-85cc-d43461f63326"
      unitRef="usd">20349000</mrna:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset>
    <mrna:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE3LTMtMS0xLTA_7a422a10-b65c-4cc0-9fa0-51359240a142"
      unitRef="usd">24944000</mrna:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE4LTEtMS0xLTA_3b62d28c-c7d7-44c9-93db-9c31e9423536"
      unitRef="usd">18276000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE4LTMtMS0xLTA_9f4c1468-e477-4c3a-8c09-c348c9118094"
      unitRef="usd">8959000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzIwLTEtMS0xLTE1ODg5_34af7659-4cdb-4527-87f5-c4db364296b1"
      unitRef="usd">513000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzIwLTMtMS0xLTE1ODg5_384f0f45-eed2-4ded-903c-5b2e015e835e"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE5LTEtMS0xLTA_359cb9a0-fe81-4a68-be5f-1f5ed490f262"
      unitRef="usd">50677000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzE5LTMtMS0xLTA_7b1bddb3-430b-48a3-a7ff-fbadd6a04b47"
      unitRef="usd">36515000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzIwLTEtMS0xLTA_256bff4f-8df3-461c-9aac-ca1f9e69baf4"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTo1ZDliMGIzYjg4MGI0ODRiYTFmMjg4YzFkODExYjVkNy90YWJsZXJhbmdlOjVkOWIwYjNiODgwYjQ4NGJhMWYyODhjMWQ4MTFiNWQ3XzIwLTMtMS0xLTA_33338235-8b68-4b65-ac94-04414c321d53"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzkzNg_e8750d34-a0c3-4da3-a083-231681d63a67"
      unitRef="usd">352700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzM4NDgyOTA3MTMwODg_3b5f1ab9-2d6c-4137-ac24-024a7b696022"
      unitRef="usd">874100000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ic351569ed65f40cab21d97c586306914_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzExMjU_983d0c7c-6f40-4ff0-afd4-4e882e305c23"
      unitRef="usd">2260000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i85f3c831978247f8b69404de24b90b66_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzExMzI_ce8313e7-db06-464a-ac84-ee3891ca1c48"
      unitRef="usd">1700000000</us-gaap:OperatingLossCarryforwards>
    <mrna:OperatingLossCarryforwardsSubjectToExpiration
      contextRef="ic351569ed65f40cab21d97c586306914_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzEyMTQ_20bf27d8-c4e7-4d63-a9df-b1a85d8d138e"
      unitRef="usd">380100000</mrna:OperatingLossCarryforwardsSubjectToExpiration>
    <mrna:OperatingLossCarryforwardsSubjectToExpiration
      contextRef="i85f3c831978247f8b69404de24b90b66_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzEyMzI_16c6826d-eb18-42ce-9e32-c1c380e657ae"
      unitRef="usd">1700000000</mrna:OperatingLossCarryforwardsSubjectToExpiration>
    <mrna:OperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="ic351569ed65f40cab21d97c586306914_I20201231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzEzMDM_faeef821-033f-4165-b83d-1aac95465a89"
      unitRef="usd">1880000000</mrna:OperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i5c241daa0d5241ee9eed136d8c0fd4be_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzE0ODM_b123d205-2ef9-4a02-9ab5-ba9befaab518"
      unitRef="usd">73300000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ifdad93679ee44415aefdf2bf5e771d19_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzE0OTA_33978e9b-7958-4273-a242-527eac5f9cae"
      unitRef="usd">26100000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="icee62dcd4e004b8681b4d520ee487a52_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzE2NDc_1c62b069-36df-4a99-b20f-4b97d6489628"
      unitRef="usd">2000000.0</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="i1f5c4be154334b0e874859f16c0dfa3c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzE2NTQ_0ed19675-9cbd-4187-8dd4-09a4f160b731"
      unitRef="usd">3900000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90ZXh0cmVnaW9uOjJhY2JiOTM0NTUyMjQyNmFiMDQ0MjdiYTEyNzY5MjlmXzQ0MjQ_fa926e71-a738-4d51-b168-2eaccd4de78c">A reconciliation of the beginning and ending amounts of unrecognized tax benefits during the years ended December 31, 2020 and 2019 are as follows (in&#160;thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease due to prior positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to current year tax position&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease due to prior positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase due to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i20204b229a394d9ba8b28882826012db_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzAtMS0xLTEtMA_7d51f82b-4083-4ad6-b1bd-aaf7f33710e4"
      unitRef="usd">141000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzEtMS0xLTEtMA_430cb06f-2457-4553-aa86-61aeb499367d"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzItMS0xLTEtMA_37c68bf7-828b-440b-b955-6944b0d579b6"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1191369058cf41a6aec423e2a8b9ee92_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzMtMS0xLTEtMA_0b4210c7-4f73-4b2f-ba87-5827f95c5841"
      unitRef="usd">141000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzQtMS0xLTEtMA_a6d23e58-fb61-4dbd-8aed-4c45db1767bb"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzUtMS0xLTEtMA_f8ecae22-dd5f-4028-aec5-a2cc530bcee5"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id8cfdc6a9eda493abd00093bbea4c21e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xODcvZnJhZzoyYWNiYjkzNDU1MjI0MjZhYjA0NDI3YmExMjc2OTI5Zi90YWJsZTplNTBmOTE5NmZlYzE0ZDE5ODA0MjMwZWI4YTBjM2JjNS90YWJsZXJhbmdlOmU1MGY5MTk2ZmVjMTRkMTk4MDQyMzBlYjhhMGMzYmM1XzYtMS0xLTEtMA_4f515982-e497-4bfa-99b2-97930abcea95"
      unitRef="usd">141000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90ZXh0cmVnaW9uOmMxNWVjZThlMTNmYzQ5NWM4NWQ3YzcxNWY2MGU3ODFkXzU1NQ_88ab30f8-75d4-4d46-8a4e-d7d0c38744f2">Net Loss per Share &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Loss per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2020, 2019 and 2018 are calculated as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(747,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(514,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(384,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium paid on repurchase of redeemable convertible preferred stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative dividends on redeemable convertible preferred stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(747,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(514,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(401,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381,333,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,802,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,114,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents, presented based on amounts outstanding as of December 31, 2020, 2019 and 2018 were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because their inclusion would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,057,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,536,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,821,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted common stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,192,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,250,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,714,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,478,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90ZXh0cmVnaW9uOmMxNWVjZThlMTNmYzQ5NWM4NWQ3YzcxNWY2MGU3ODFkXzU1MQ_75ee2403-5cb7-4e54-b084-725f7ad9d924">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2020, 2019 and 2018 are calculated as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(747,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(514,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(384,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium paid on repurchase of redeemable convertible preferred stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative dividends on redeemable convertible preferred stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,996)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(747,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(514,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(401,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381,333,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330,802,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,114,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzMtMS0xLTEtMA_16a439e5-93b0-4ae9-a3f8-50cddbadd462"
      unitRef="usd">-747064000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzMtMy0xLTEtMA_bcd652f1-546c-4437-86e4-2b8f6f5889e3"
      unitRef="usd">-514021000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzMtNS0xLTEtMA_48a8343d-4b19-4d8c-abf7-6b99c0ca71c7"
      unitRef="usd">-384734000</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockRedemptionPremium
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzQtMS0xLTEtMA_268cbb91-4d41-4190-9845-05b696b37afa"
      unitRef="usd">0</us-gaap:PreferredStockRedemptionPremium>
    <us-gaap:PreferredStockRedemptionPremium
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzQtMy0xLTEtMA_b4958660-761a-4194-a71c-cdfc8c073b73"
      unitRef="usd">0</us-gaap:PreferredStockRedemptionPremium>
    <us-gaap:PreferredStockRedemptionPremium
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzQtNS0xLTEtMjU2Mg_b044366c-7518-490a-9e99-5c4e38b2dae2"
      unitRef="usd">4127000</us-gaap:PreferredStockRedemptionPremium>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzUtMS0xLTEtMA_9975d903-eebe-45d9-bd59-a1b937bd42a8"
      unitRef="usd">0</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzUtMy0xLTEtMA_5ff6764f-867b-4280-869f-7edbacc65b5a"
      unitRef="usd">0</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzUtNS0xLTEtMA_cce22af2-a8fa-42fe-9d81-d7864eeafc95"
      unitRef="usd">12996000</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzYtMS0xLTEtMA_552694ba-d4de-465e-be32-fbf581f1371c"
      unitRef="usd">-747064000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzYtMy0xLTEtMA_be1481b4-47ec-4cfe-bb21-565da08c2ea6"
      unitRef="usd">-514021000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzYtNS0xLTEtMA_620c02af-7db0-4522-b999-7c9080e53121"
      unitRef="usd">-401857000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzgtMS0xLTEtMA_e51a3f45-d537-47a9-aa9f-1a9def243fb5"
      unitRef="shares">381333059</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzgtMy0xLTEtMA_aa56836b-068f-44f6-b17a-7aaffad264fc"
      unitRef="shares">330802136</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzgtNS0xLTEtMA_8bb4757d-ab32-4555-8422-c11b635151b9"
      unitRef="shares">81114183</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzktMS0xLTEtMA_0143f436-e1ab-458c-9c2c-fa1268771a6a"
      unitRef="usdPerShare">-1.96</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzktMy0xLTEtMA_a4ded046-703a-4025-acf0-0a7dd358b7f7"
      unitRef="usdPerShare">-1.55</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTpiNDJhNjhiMzIyOTI0M2MwYmNkOWMwNmRmNTRlMGI5ZS90YWJsZXJhbmdlOmI0MmE2OGIzMjI5MjQzYzBiY2Q5YzA2ZGY1NGUwYjllXzktNS0xLTEtMA_d6b68405-9e87-4c91-b75c-fad44edb7725"
      unitRef="usdPerShare">-4.95</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90ZXh0cmVnaW9uOmMxNWVjZThlMTNmYzQ5NWM4NWQ3YzcxNWY2MGU3ODFkXzU1Mw_59abd2ba-e247-4080-843b-6c55d763cb96">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents, presented based on amounts outstanding as of December 31, 2020, 2019 and 2018 were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because their inclusion would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.493%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,057,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,536,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,821,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted common stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,192,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,250,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,714,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,478,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i51dd4a3f885044ac854c50b598512881_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzMtMS0xLTEtMA_d9be035e-3813-41e7-b507-971a97b301f3"
      unitRef="shares">34057533</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i824d33d947634253bc2e12c49e671633_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzMtMy0xLTEtMA_3324bcb3-f856-43ac-a4b7-1fc775546b90"
      unitRef="shares">45536915</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3e245ef509484130ac56ee0f5b6a622b_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzMtNS0xLTEtMA_8b1cbb8d-9de2-4a8d-b18f-459b99a8491a"
      unitRef="shares">50821132</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i240d1607bdb54d38918d10a2e1bc9173_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzQtMS0xLTEtMA_71427258-bbc8-4317-b392-41069ce1a82e"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i707c59ec394d4425b93e15c1605fa977_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzQtMy0xLTEtMA_331fab28-d3a1-410d-af83-648d175c2cbf"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i224ecb912e2c48888f26b7e1cc4953dd_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzQtNS0xLTEtMA_d40347e3-6b7c-46f0-abc9-8afd1b392d4f"
      unitRef="shares">198597</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic87bc10f44de4145997be66dfd27f93c_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzUtMS0xLTEtMA_2f340b36-4ca3-498a-9bf4-8b239a6aff43"
      unitRef="shares">2192960</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie596a0c92b8647369ac2d14e1396ef36_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzUtMy0xLTEtMA_c89d2575-271c-4095-a000-91815219db6b"
      unitRef="shares">1177249</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9f5a8fda25cd4c74af63d87a7168e3ab_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzUtNS0xLTEtMA_768d0828-8198-4b03-90b7-c3bb2402575f"
      unitRef="shares">458715</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzYtMS0xLTEtMA_42985c07-0937-42bb-b66d-260baa1c376e"
      unitRef="shares">36250493</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzYtMy0xLTEtMA_9399ba72-7bf0-48c9-bf65-e7a80ff61f05"
      unitRef="shares">46714164</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xOTAvZnJhZzpjMTVlY2U4ZTEzZmM0OTVjODVkN2M3MTVmNjBlNzgxZC90YWJsZTo5Njc0ZmFjYWRjNDE0NTA1ODJkNTM3YmI5MWMyYjViYy90YWJsZXJhbmdlOjk2NzRmYWNhZGM0MTQ1MDU4MmQ1MzdiYjkxYzJiNWJjXzYtNS0xLTEtMA_4015f71d-8ab1-4179-a309-684af65b4775"
      unitRef="shares">51478444</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGV4dHJlZ2lvbjpkZGI5ZTY4OWI1MzY0YjI4YjRjYWNiYTExOGU0MzYyMl80OTQ3ODAyMzMwOTEx_7c35690c-a066-40a5-b36d-f32b6582de9b"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:Revenues
      contextRef="i69d8b71e26964171af7d0c08826cb641_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8xLTItMS0xLTY5OTM_c754d1e4-ca8f-48c6-b161-0803e0812bf2"
      unitRef="usd">764529000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i27c2ab469153406c91a205c6ac53f02f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8xLTQtMS0xLTY5OTU_9fef4c75-5159-4469-ae31-2d8ce78558f6"
      unitRef="usd">54976000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i14039f4ce16942f3a4976f3e56714742_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8xLTYtMS0xLTY5OTc_96f51e12-b2fb-47c9-b291-1d254890c2c1"
      unitRef="usd">89075000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7733c373247646ffbbaca5983877f101_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8yLTItMS0xLTY5OTk_85d858fb-e132-49eb-8480-e815c2bbf0d5"
      unitRef="usd">38866000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id776b0bb1d8b431e96ac4e765df020ad_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8yLTQtMS0xLTcwMDE_90c5f7dc-56b5-4eef-b412-e39a0f7b7587"
      unitRef="usd">5233000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibba4dc7e26f542198f1a60b6226271d0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8yLTYtMS0xLTcwMDM_7eac52f9-2599-4cdc-a5d1-f56806fee3e7"
      unitRef="usd">45993000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8zLTItMS0xLTcwMDU_8f91aba1-740f-4d6e-8fde-5d2e5ba31e70"
      unitRef="usd">803395000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i48f280fedb704fdb943f554d696b0c95_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8zLTQtMS0xLTcwMDc_6973aea5-5bf9-4184-99e1-eb98be0dae6a"
      unitRef="usd">60209000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yNDUyL2ZyYWc6ZGRiOWU2ODliNTM2NGIyOGI0Y2FjYmExMThlNDM2MjIvdGFibGU6ZTI2NTQwMWIzM2E1NDhhYmIyMGNhNTc5ZTkxZjRiMjIvdGFibGVyYW5nZTplMjY1NDAxYjMzYTU0OGFiYjIwY2E1NzllOTFmNGIyMl8zLTYtMS0xLTcwMDk_223ed062-10c1-4e07-bb26-0c869a262297"
      unitRef="usd">135068000</us-gaap:Revenues>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMDIvZnJhZzo2YTYwMjhlZTA2ZDM0OThiOWQ1MzI4MGRmNmU2ZDk3OS90ZXh0cmVnaW9uOjZhNjAyOGVlMDZkMzQ5OGI5ZDUzMjgwZGY2ZTZkOTc5XzUwNQ_88c36aec-be85-452e-97bd-f3bcf01ae1d1">Subsequent Events &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December 31, 2020, we have entered into several supply agreements with customers to provide our COVID-19 vaccine, up to 125.1&#160;million doses, and have received upfront deposits of $125.4&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, b&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ased on the initial confirmed volume, subject to modifications. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 18, 2021, the European Commission advised us that we had successfully tendered for the provision of 150&#160;million doses of our COVID-19 vaccine in 2021. This tender is subject to execution of the Purchase Agreement, which is expected shortly following an opt out period for individual Member States that expired on February 25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December 31, 2020, we have entered into additional binding purchase commitments with third-party contractual manufacturing organizations for our COVID-19 vaccine under existing agreements. We are currently committed to minimum non-cancelable purchase obligations of $314.8&#160;million related to these agreements, which are expected to be paid through 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <mrna:NumberOfDosesOfVaccineCandidate
      contextRef="i9ccdf2dca2df4aa3a9aece1c6399177d_D20210101-20210226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMDIvZnJhZzo2YTYwMjhlZTA2ZDM0OThiOWQ1MzI4MGRmNmU2ZDk3OS90ZXh0cmVnaW9uOjZhNjAyOGVlMDZkMzQ5OGI5ZDUzMjgwZGY2ZTZkOTc5XzQ5NDc4MDIzMzAxMjA_e6173906-9c09-4b68-baf2-6d9b8cfec9a0"
      unitRef="dose">125100000</mrna:NumberOfDosesOfVaccineCandidate>
    <us-gaap:SignificantSupplyCommitmentRemainingMinimumAmountCommitted
      contextRef="ia03ce25e1fdb4153b6baf85bdb6588ef_I20210226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMDIvZnJhZzo2YTYwMjhlZTA2ZDM0OThiOWQ1MzI4MGRmNmU2ZDk3OS90ZXh0cmVnaW9uOjZhNjAyOGVlMDZkMzQ5OGI5ZDUzMjgwZGY2ZTZkOTc5XzQ5NDc4MDIzMzAxMDQ_ff7f8306-485e-48d6-a330-49f4f9789b0e"
      unitRef="usd">125400000</us-gaap:SignificantSupplyCommitmentRemainingMinimumAmountCommitted>
    <mrna:NumberOfVaccineDoses
      contextRef="i9483d986200a4cdfb7e88b336fd9711b_D20210218-20210218"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMDIvZnJhZzo2YTYwMjhlZTA2ZDM0OThiOWQ1MzI4MGRmNmU2ZDk3OS90ZXh0cmVnaW9uOjZhNjAyOGVlMDZkMzQ5OGI5ZDUzMjgwZGY2ZTZkOTc5XzQ5NDc4MDIzMzIzNTY_4325f3bf-bd51-4994-8353-5b94e52e0d9a"
      unitRef="numberofdose">150000000</mrna:NumberOfVaccineDoses>
    <us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted
      contextRef="ia03ce25e1fdb4153b6baf85bdb6588ef_I20210226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8yMDIvZnJhZzo2YTYwMjhlZTA2ZDM0OThiOWQ1MzI4MGRmNmU2ZDk3OS90ZXh0cmVnaW9uOjZhNjAyOGVlMDZkMzQ5OGI5ZDUzMjgwZGY2ZTZkOTc5XzQ5NDc4MDIzMzAxMzU_ae9ac578-375e-4d2d-bd84-de8decf344af"
      unitRef="usd">314800000</us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619952580360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 16, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Moderna, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-3467528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 Technology Square<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">714-6500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MRNA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399,769,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-top:1.5pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:1.5pt;padding-left:9pt;padding-right:27pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s Definitive Proxy Statement relating to its 2021 Annual Meeting of Stockholders to be filed hereafter are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001682852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937125304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,623,850,000<span></span>
</td>
<td class="nump">$ 235,876,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Investments</a></td>
<td class="nump">1,983,758,000<span></span>
</td>
<td class="nump">867,124,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,390,560,000<span></span>
</td>
<td class="nump">5,369,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">46,527,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">252,152,000<span></span>
</td>
<td class="nump">19,403,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">1,032,000<span></span>
</td>
<td class="nump">1,032,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,297,879,000<span></span>
</td>
<td class="nump">1,128,804,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Investments, non-current</a></td>
<td class="nump">638,848,000<span></span>
</td>
<td class="nump">159,987,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">296,889,000<span></span>
</td>
<td class="nump">201,495,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, operating leases</a></td>
<td class="nump">90,201,000<span></span>
</td>
<td class="nump">86,414,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, non-current</a></td>
<td class="nump">11,053,000<span></span>
</td>
<td class="nump">10,791,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">1,880,000<span></span>
</td>
<td class="nump">1,931,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">7,336,750,000<span></span>
</td>
<td class="nump">1,589,422,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">18,359,000<span></span>
</td>
<td class="nump">7,090,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">469,591,000<span></span>
</td>
<td class="nump">67,652,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">3,867,193,000<span></span>
</td>
<td class="nump">63,310,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">33,665,000<span></span>
</td>
<td class="nump">5,063,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,388,808,000<span></span>
</td>
<td class="nump">143,115,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract with Customer, Liability, Noncurrent</a></td>
<td class="nump">177,419,000<span></span>
</td>
<td class="nump">138,995,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">97,421,000<span></span>
</td>
<td class="nump">93,675,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liabilities, non-current</a></td>
<td class="nump">109,874,000<span></span>
</td>
<td class="nump">38,689,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,853,000<span></span>
</td>
<td class="nump">138,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,775,375,000<span></span>
</td>
<td class="nump">414,612,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 162,000,000 shares authorized at December 31, 2020 and 2019; 0 shares issued or outstanding at December 31, 2020 and 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.0001; 1,600,000,000 shares authorized as of December&#160;31, 2020 and 2019; 398,787,678 and 336,536,985 shares issued and outstanding as of December&#160;31, 2020 and 2019, respectively</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">4,801,849,000<span></span>
</td>
<td class="nump">2,669,426,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive gain</a></td>
<td class="nump">3,004,000<span></span>
</td>
<td class="nump">1,804,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(2,243,518,000)<span></span>
</td>
<td class="num">(1,496,454,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">2,561,375,000<span></span>
</td>
<td class="nump">1,174,810,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 7,336,750,000<span></span>
</td>
<td class="nump">$ 1,589,422,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619945540520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">162,000,000<span></span>
</td>
<td class="nump">162,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,600,000,000<span></span>
</td>
<td class="nump">1,600,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">398,787,678<span></span>
</td>
<td class="nump">336,536,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">398,787,678<span></span>
</td>
<td class="nump">336,536,985<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619866188936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 803,395<span></span>
</td>
<td class="nump">$ 60,209<span></span>
</td>
<td class="nump">$ 135,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">7,933<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,370,339<span></span>
</td>
<td class="nump">496,309<span></span>
</td>
<td class="nump">454,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">188,267<span></span>
</td>
<td class="nump">109,620<span></span>
</td>
<td class="nump">94,252<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,566,539<span></span>
</td>
<td class="nump">605,929<span></span>
</td>
<td class="nump">548,334<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(763,144)<span></span>
</td>
<td class="num">(545,720)<span></span>
</td>
<td class="num">(413,266)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">24,715<span></span>
</td>
<td class="nump">38,530<span></span>
</td>
<td class="nump">27,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(6,084)<span></span>
</td>
<td class="num">(7,526)<span></span>
</td>
<td class="nump">1,835<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before provision for (benefit from) income taxes</a></td>
<td class="num">(744,513)<span></span>
</td>
<td class="num">(514,716)<span></span>
</td>
<td class="num">(384,408)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">2,551<span></span>
</td>
<td class="num">(695)<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(747,064)<span></span>
</td>
<td class="num">(514,021)<span></span>
</td>
<td class="num">(384,734)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Reconciliation of net loss to net loss attributable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionPremium', window );">Premium paid on repurchase of preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,127)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemablePreferredStockDividends', window );">Cumulative preferred stock dividends</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,996)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (747,064)<span></span>
</td>
<td class="num">$ (514,021)<span></span>
</td>
<td class="num">$ (401,857)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to common stockholders, basic and diluted (usd per share)</a></td>
<td class="num">$ (1.96)<span></span>
</td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (4.95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted (in shares)</a></td>
<td class="nump">381,333,059<span></span>
</td>
<td class="nump">330,802,136<span></span>
</td>
<td class="nump">81,114,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 528,905<span></span>
</td>
<td class="nump">$ 12,173<span></span>
</td>
<td class="nump">$ 12,556<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_ProductSalesMember', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">199,872<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember', window );">Collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 74,618<span></span>
</td>
<td class="nump">$ 48,036<span></span>
</td>
<td class="nump">$ 122,512<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The excess of (1) fair value of the consideration transferred to the holders of the preferred stock over (2) the carrying amount of the preferred stock in the registrant's balance sheet, during the accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27010884&amp;loc=d3e42851-122695<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemablePreferredStockDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemablePreferredStockDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_ProductSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_ProductSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619945187144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (747,064)<span></span>
</td>
<td class="num">$ (514,021)<span></span>
</td>
<td class="num">$ (384,734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on available-for-sale debt securities, net of tax of $0, $1,148 and $0, for the years ended December 31, 2020, 2019 and 2018, respectively</a></td>
<td class="nump">2,501<span></span>
</td>
<td class="nump">3,447<span></span>
</td>
<td class="num">(132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Less: amounts recognized for net realized gain included in net loss</a></td>
<td class="num">(1,301)<span></span>
</td>
<td class="num">(323)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">3,124<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (745,864)<span></span>
</td>
<td class="num">$ (510,897)<span></span>
</td>
<td class="num">$ (384,897)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619981157048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized gain (loss) on available-for-sale debt securities, tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,148<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619942907272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Series&#160;G Redeemable Convertible Preferred Stock</div></th>
<th class="th"><div>Series&#160;D Redeemable Convertible Preferred Stock</div></th>
<th class="th"><div>Series&#160;E Redeemable Convertible Preferred Stock</div></th>
<th class="th"><div>Redeemable&#160;Convertible Preferred Stock</div></th>
<th class="th">
<div>Redeemable&#160;Convertible Preferred Stock </div>
<div>Series&#160;G Redeemable Convertible Preferred Stock</div>
</th>
<th class="th">
<div>Redeemable&#160;Convertible Preferred Stock </div>
<div>Series&#160;H Redeemable Convertible Preferred Stock</div>
</th>
<th class="th">
<div>Redeemable&#160;Convertible Preferred Stock </div>
<div>Series&#160;D Redeemable Convertible Preferred Stock</div>
</th>
<th class="th">
<div>Redeemable&#160;Convertible Preferred Stock </div>
<div>Series&#160;E Redeemable Convertible Preferred Stock</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Series&#160;G Redeemable Convertible Preferred Stock</div>
</th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Series&#160;D Redeemable Convertible Preferred Stock</div>
</th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Series&#160;E Redeemable Convertible Preferred Stock</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Gain (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,686,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at beginning of period at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,176,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of redeemable convertible preferred stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,666,004<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of redeemable convertible preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 549,413<span></span>
</td>
<td class="nump">$ 111,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares', window );">Repurchase of redeemable convertible preferred stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(269,180)<span></span>
</td>
<td class="num">(544,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue', window );">Repurchase of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,009)<span></span>
</td>
<td class="num">$ (2,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (704)<span></span>
</td>
<td class="num">$ (3,355)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,009)<span></span>
</td>
<td class="num">$ (2,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ReclassificationsOfTemporaryToPermanentEquityShares', window );">Conversion of redeemable convertible preferred stock into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(508,539,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(236,012,913)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Conversion of redeemable convertible preferred stock into common stock</a></td>
<td class="nump">$ 1,833,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,833,561)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 1,833,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at end of period at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,206,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2017</a></td>
<td class="num">(551,365)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">71,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,157)<span></span>
</td>
<td class="num">$ (621,893)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Vesting of restricted common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">856,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options to purchase common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">446,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options to purchase common stock</a></td>
<td class="nump">1,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ReclassificationsOfTemporaryToPermanentEquityShares', window );">Conversion of redeemable convertible preferred stock into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508,539,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,012,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Conversion of redeemable convertible preferred stock into common stock</a></td>
<td class="nump">1,833,561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,833,561)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">1,833,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Proceeds of initial public offering, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,275,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds of initial public offering, net of issuance costs</a></td>
<td class="nump">563,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">563,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">72,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(384,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(384,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">328,798,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2018</a></td>
<td class="nump">$ 1,530,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">2,538,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,320)<span></span>
</td>
<td class="num">(1,006,627)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period (Accounting Standards Update 2014-09) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,984<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period (Accounting Standards Update 2016-02) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,790)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2019</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at end of period at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Vesting of restricted common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">621,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options to purchase common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,945,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options to purchase common stock</a></td>
<td class="nump">$ 47,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">47,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Purchase of common stock under employee stock purchase plan</a></td>
<td class="nump">2,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">81,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">3,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(514,021)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(514,021)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">336,536,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2019</a></td>
<td class="nump">$ 1,174,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">2,669,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,804<span></span>
</td>
<td class="num">(1,496,454)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at end of period at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Vesting of restricted common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options to purchase common stock (in shares)</a></td>
<td class="nump">13,888,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,888,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options to purchase common stock</a></td>
<td class="nump">$ 179,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">179,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Purchase of common stock under employee stock purchase plan</a></td>
<td class="nump">7,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Proceeds of initial public offering, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,863,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Proceeds of initial public offering, net of issuance costs</a></td>
<td class="nump">1,852,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">1,852,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">93,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(747,064)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(747,064)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">398,787,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2020</a></td>
<td class="nump">$ 2,561,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 4,801,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,004<span></span>
</td>
<td class="num">$ (2,243,518)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ReclassificationsOfTemporaryToPermanentEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassifications Of Temporary To Permanent Equity, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ReclassificationsOfTemporaryToPermanentEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_TemporaryEquityStockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Repurchased During Period, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_TemporaryEquityStockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_TemporaryEquityStockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Repurchased During Period, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_TemporaryEquityStockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=120519210&amp;loc=d3e90193-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201409Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937436744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; EQUITY (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 41,322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesGPreferredStockMember', window );">Series&#160;G Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">10,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember', window );">Series&#160;H Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 474<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesGPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesGPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936017048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (747,064)<span></span>
</td>
<td class="num">$ (514,021)<span></span>
</td>
<td class="num">$ (384,734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">93,021<span></span>
</td>
<td class="nump">81,122<span></span>
</td>
<td class="nump">72,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">31,251<span></span>
</td>
<td class="nump">31,021<span></span>
</td>
<td class="nump">24,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases', window );">Leased assets expensed</a></td>
<td class="nump">62,286<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium', window );">Amortization/accretion of investments</a></td>
<td class="nump">10,185<span></span>
</td>
<td class="num">(3,742)<span></span>
</td>
<td class="num">(1,866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(1,385,191)<span></span>
</td>
<td class="nump">7,216<span></span>
</td>
<td class="nump">832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(46,527)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(241,041)<span></span>
</td>
<td class="nump">9,751<span></span>
</td>
<td class="num">(5,289)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RightOfUseAssetOperatingLeases', window );">Right-of-use assets, operating leases</a></td>
<td class="num">(10,542)<span></span>
</td>
<td class="num">(5,664)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">11,875<span></span>
</td>
<td class="num">(23,964)<span></span>
</td>
<td class="nump">15,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">388,392<span></span>
</td>
<td class="num">(3,362)<span></span>
</td>
<td class="nump">8,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">3,842,307<span></span>
</td>
<td class="num">(44,119)<span></span>
</td>
<td class="num">(65,260)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_IncreaseDecreaseInDeferredRentCredit', window );">Deferred lease obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_OperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">11,792<span></span>
</td>
<td class="nump">12,647<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">5,989<span></span>
</td>
<td class="num">(6,169)<span></span>
</td>
<td class="nump">910<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">2,026,971<span></span>
</td>
<td class="num">(458,968)<span></span>
</td>
<td class="num">(330,865)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(2,956,295)<span></span>
</td>
<td class="num">(1,145,226)<span></span>
</td>
<td class="num">(1,227,709)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable securities</a></td>
<td class="nump">1,137,129<span></span>
</td>
<td class="nump">993,181<span></span>
</td>
<td class="nump">783,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales of marketable securities</a></td>
<td class="nump">214,686<span></span>
</td>
<td class="nump">168,654<span></span>
</td>
<td class="nump">177,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(67,448)<span></span>
</td>
<td class="num">(31,554)<span></span>
</td>
<td class="num">(105,766)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,671,928)<span></span>
</td>
<td class="num">(14,945)<span></span>
</td>
<td class="num">(373,094)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">661,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from offerings of common stock, net of issuance costs</a></td>
<td class="nump">1,852,725<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">563,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock', window );">Repurchases of redeemable convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,182)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuance of common stock under equity plans</a></td>
<td class="nump">179,643<span></span>
</td>
<td class="nump">47,259<span></span>
</td>
<td class="nump">1,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans', window );">Proceeds from purchase of common stock under employee stock purchase plan</a></td>
<td class="nump">7,040<span></span>
</td>
<td class="nump">2,891<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ChargesToFinancingLeaseLiabilities', window );">Charges to financing lease liabilities</a></td>
<td class="num">(6,215)<span></span>
</td>
<td class="nump">971<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation', window );">Reimbursement of assets under financing lease obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_PaymentsForLeaseFinancingObligation', window );">Payments on financing lease obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,175)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">2,033,193<span></span>
</td>
<td class="nump">51,121<span></span>
</td>
<td class="nump">1,226,842<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">2,388,236<span></span>
</td>
<td class="num">(422,792)<span></span>
</td>
<td class="nump">522,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of year</a></td>
<td class="nump">247,699<span></span>
</td>
<td class="nump">670,491<span></span>
</td>
<td class="nump">147,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of year</a></td>
<td class="nump">2,635,935<span></span>
</td>
<td class="nump">247,699<span></span>
</td>
<td class="nump">670,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">572<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">8,528<span></span>
</td>
<td class="nump">5,585<span></span>
</td>
<td class="nump">2,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_StockIssuanceCostsIncurredButNotYetPaid', window );">Issuance costs included in accounts payable and accrued liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment included in accounts payable and accrued liabilities</a></td>
<td class="nump">17,617<span></span>
</td>
<td class="nump">4,676<span></span>
</td>
<td class="nump">12,892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed', window );">Leasehold improvements included in prepaid and other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_LeaseFinancingObligationsIncurred', window );">Lease financing obligation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 10,089<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ChargesToFinancingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Charges To Financing Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ChargesToFinancingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_IncreaseDecreaseInDeferredRentCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Deferred Rent Credit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_IncreaseDecreaseInDeferredRentCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_LeaseFinancingObligationsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Financing Obligations Incurred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_LeaseFinancingObligationsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_LeaseholdImprovementsIncurredButNotYetReimbursed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leasehold Improvements Incurred But Not Yet Reimbursed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_LeaseholdImprovementsIncurredButNotYetReimbursed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_OperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_OperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PaymentsForLeaseFinancingObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Lease Financing Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PaymentsForLeaseFinancingObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ReimbursementOfAssetsFromLeaseFinancingObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reimbursement Of Assets From Lease Financing Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ReimbursementOfAssetsFromLeaseFinancingObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_RightOfUseAssetOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Asset Operating Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_RightOfUseAssetOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_StockIssuanceCostsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issuance Costs Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_StockIssuanceCostsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) arising from the lessor's sale of assets held- or available-for-lease under contractual arrangements classified as operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 40<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566025&amp;loc=d3e44908-112734<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire callable preferred stock which is identified as being convertible to another type of financial security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the financed defined contribution plan to acquire shares of the entity. The plan initially holds the shares in a suspense account, which is collateral for the loan. As the plan makes payment on the debt, the shares are released from the suspense account and become available to be allocated to participant accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865421656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Description of Business</a></td>
<td class="text">Organization and Description of Business<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moderna, Inc. (collectively, with its consolidated subsidiaries, any of Moderna, we, us, or the Company) was incorporated in Delaware on July&#160;22, 2016. We are the successor in interest to Moderna LLC, a limited liability company formed under the laws of the State of Delaware in 2013. Our principal executive office is located at 200 Technology Square, Cambridge,&#160;MA. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biotechnology company creating a new generation of transformative medicines based on messenger RNA (mRNA), to improve the lives of patients. mRNA medicines are designed to direct the body&#8217;s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a broad spectrum of diseases. Our platform builds on continuous advances in basic and applied mRNA science, delivery technology, and manufacturing, providing us the capability to pursue in parallel a robust pipeline of new development candidates.&#160;We are developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with our strategic collaborators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) and an Interim Order from Health Canada authorizing the Moderna COVID-19 vaccine (also referred to as mRNA-1273) in the U.S. and Canada.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have incurred significant net losses, which were $747.1 million, $514.0 million, and $384.7 million for the years ended December 31, 2020, 2019 and 2018, respectively. On February 14, 2020 and May 21, 2020, we sold 30,263,158 and 17,600,000 shares of common stock at a price of $19.00 and $76.00 per share through public equity offerings, with aggregate net proceeds from the offering of $549.5&#160;million and $1.30&#160;billion, respectively, net of underwriting discounts, commissions and offering expenses. As of December 31, 2020, we had an accumulated deficit of $2.24 billion. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had 21 mRNA development programs in our portfolio with 13 having entered the clinic. We expect to continue to incur significant expenses for the foreseeable future. If we seek to obtain regulatory approval for any of our investigational medicines, we expect to incur significant commercialization expenses. In addition, we anticipate that our expenses will increase significantly in connection with our development and commercializing our mRNA-1273 vaccine and ongoing activities to support our platform research, drug discovery and clinical development, including development of any new generations of vaccines against variants of SARS-CoV-2, infrastructure and Research Engine and Early Development Engine (which includes our Moderna Technology Center), digital infrastructure, creation of a portfolio of intellectual property, and administrative support. We may finance our future cash needs that exceed our operating costs through a combination of public or private equity offerings, structured financings and debt financings, government funding arrangements, strategic alliances and marketing, manufacturing, distribution and licensing arrangements. We may be unable to raise additional funds or enter into such other agreements on favorable terms, or at all.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash, cash equivalents, and investments as of&#160;December 31, 2020&#160;will be sufficient to enable us to fund our projected operations through at least the next 12&#160;months from the issuance of our financial statements. We are subject to numerous risks and uncertainties associated with pharmaceutical development and commercialization, and we are unable to predict the timing or amount of expenses or when or if we will be able to achieve or maintain profitability. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce our operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865424456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP). Any reference in these notes to applicable guidance is meant to refer to the authoritative accounting principles generally accepted in the United States as found in the Accounting Standard Codification (ASC) and Accounting Standards Updates (ASU) of the&#160;Financial Accounting Standards Board (FASB).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made estimates and judgments affecting the amounts reported in our consolidated financial statements and the accompanying notes. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, research and development expenses, income tax provisions, stock-based compensation, leases, derivative financial instruments, inventory, and useful lives of long-lived assets. We base our estimates on historical experience and various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The actual results that we experience may differ materially from our estimates. Significant estimates relied upon in preparing these financial statements include, among others, those related to fair value of equity awards, revenue recognition, research and development expenses, leases, fair value of financial instruments, useful lives of property and equipment, income taxes, and our valuation allowance on our deferred tax assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that our chief executive officer is the chief operating decision maker (CODM). The CODM reviews financial information presented on a consolidated basis. Resource allocation decisions are made by the CODM based on consolidated results. There are no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels or components below the consolidated unit level. As such, we have concluded that we operate as one segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019, we adopted ASC 606&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) using the modified retrospective transition method applied to those contracts which were not completed as of January 1, 2019. We recognized the cumulative effect of the adoption as an adjustment to the opening balance of accumulated deficit in the current period consolidated balance sheet. Results for reporting periods beginning after January 1, 2019 are presented under ASC 606, while prior period amounts have not been adjusted and continue to be reported in accordance with our historic accounting (ASC 605). ASC 606 applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the appropriate amount of revenue to be recognized for arrangements that we determine are within the scope of ASC 606, we perform the following five steps (the five-step model): (i) identify the contract(s) with our customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when or as each performance obligation is satisfied. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is primarily generated through grants from government-sponsored and private organizations, product sales and collaboration arrangements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Grant Revenue</span></div><div style="padding-right:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have contracts with Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS); the U.S. government&#8217;s Defense Advanced Research Projects Agency (DARPA); the Bill &amp; Melinda Gates Foundation (Gates Foundation) and other government-sponsored and private organizations for research and development related activities that provide for payments for reimbursed costs, which may include overhead and general and administrative costs as well as a related profit margin. We recognize revenue from these contracts as we perform services under these arrangements when the funding is committed. Associated expenses are recognized when incurred as research and development expense. Revenues and related expenses are presented gross in the consolidated statements of operations as we have determined we are the primary obligor under the arrangements relative to the research and development services we perform as lead technical expert.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Collaboration Revenue</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for a contract with a customer that is within the scope of ASC 606 using the five-step model. We account for a contract with a customer that is within the scope of ASC 606 when all of the following criteria are met: (i) the arrangement has been approved by the parties and the parties are committed to perform their respective obligations; (ii) each party&#8217;s rights regarding the </span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goods and/or services to be transferred can be identified; (iii) the payment terms for the goods and/or services to be transferred can be identified; (iv) the arrangement has commercial substance; and (v) collection of substantially all of the consideration to which we will be entitled in exchange for the goods and/or services that will be transferred to the customer is probable. We also determine the term of the contract based on the period in which we and our customer have present and enforceable rights and obligations for purposes of identifying the performance obligations and determining the transaction price.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate contracts that contain multiple promises to determine which promises are distinct. Promises are considered to be distinct and therefore, accounted for as separate performance obligations, provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer and (ii) the promise to transfer the good or service to the customer is separately identifiable from other promises in the contract.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual goods or services (or bundles of goods and/or services) that meet both criteria for being distinct are accounted for as separate performance obligations. Promises that are not distinct at contract inception are combined and accounted for as a single performance obligation. Options to acquire additional goods and/or services are evaluated to determine if such option provides a material right to the customer that it would not have received without entering into the contract. If so, the option is accounted for as a separate performance obligation. If not, the option is considered a marketing offer which would be accounted for as a separate contract upon the customer&#8217;s election.</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is generally comprised of an upfront payment due at contract inception and variable consideration in the form of payments for our services and materials and milestone payments due upon the achievement of specified events. Other payments the Company could be entitled to include tiered royalties earned when customers recognize net sales of licensed products.&#160;We measure the transaction price based on the amount of consideration to which we expect to be entitled in exchange for transferring the promised goods and/or services to the customer. We utilize either the expected value method or the most likely amount method to estimate the amount of variable consideration, depending on which method is expected to better predict the amount of consideration to which we will be entitled. Amounts of variable consideration are included in the transaction price to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to arrangements that include payments for a development or regulatory milestone payment, we evaluate whether the associated event is considered probable of achievement and estimate the amount to be included in the transaction price using the most likely amount method. Milestone payments that are not within our control or the licensee, such as those dependent upon receipt of regulatory approval, are not considered to be probable of achievement until the triggering event occurs. At the end of each reporting period, we re-evaluate the probability of achievement of each milestone and any related constraint, and if necessary, adjust our estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment. For arrangements that include sales-based royalties, including milestone payments based upon the achievement of a certain level of product sales, wherein the license is deemed to be the sole or predominant item to which the payments relate, we recognize revenue upon the later of: (i) when the related sales occur or (ii) when the performance obligation to which some or all of the payment has been allocated has been satisfied (or partially satisfied). Consideration that would be received for optional goods and/or services is excluded from the transaction price at contract inception. </span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allocate the transaction price to each performance obligation based on a relative standalone selling price basis. We develop assumptions that require judgment to determine the standalone selling price for each performance obligation in consideration of applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated research and development costs. However, in certain instances, we allocate variable consideration entirely to one or more performance obligation if the terms of the variable consideration relate to the satisfaction of the respective performance obligation and the amount allocated is consistent with the amount we would expect to receive for the satisfaction of the respective performance obligation.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue based on the amount of the transaction price that is allocated to each respective performance obligation when or as the performance obligation is satisfied by transferring a promised good or service to the customer. For performance obligations that are satisfied at a point in time, we recognize revenue when control of the goods and/or services is transferred to the customer. For performance obligations that are satisfied over time, we recognize revenue by measuring the progress toward complete satisfaction of the performance obligation using a single method of measuring progress which depicts the performance in transferring control of the associated goods and/or services to the customer. We generally use input methods to measure the progress toward the complete satisfaction of performance obligations satisfied over time. With respect to arrangements containing a license to our intellectual property that is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from amounts allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, we utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. Significant management judgment is required in </span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determining the level of effort required under an arrangement and the period over which we are expected to complete our performance obligations under an arrangement. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment.</span></div><div><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Product Sales </span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales are associated with our COVID-19 vaccine supply agreements with the U.S. Government and international government agencies. These agreements generally do not provide provisions for various forms of variable consideration, such as discounts, rebates or returns. We recognize revenue from product sales, using the five-step model under ASC 606, based on the fixed price per dose according to the contracts when control of the product transfers to the customer and customer acceptance has occurred, unless such acceptance provisions are deemed perfunctory. </span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments with an original maturity of 90&#160;days or less from the date of purchase to be cash equivalents.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash is composed of amounts held on deposit related to our lease arrangements. The funds are maintained in money market accounts and are recorded at fair value. We classify our restricted cash as either current or non-current based on the terms of the underlying lease arrangement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash shown in the Consolidated Statements of Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, non-current </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash shown in the consolidated<br/>    statements of cash flows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,635,935&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest our excess cash balances in marketable debt securities. We classify our investments in marketable debt securities as available-for-sale. We report available-for-sale investments at fair value at each balance sheet date, and include any unrealized holding gains and losses (the adjustment to fair value) in accumulated other comprehensive gain (loss), a component of stockholders&#8217; equity. Realized gains and losses are determined using the specific-identification method, and are included in other (expense) income, net in our consolidated statements of operations. We classify our available-for-sale marketable securities as current or non-current based on each instrument&#8217;s underlying effective maturity date and for which we have the intent and ability to hold the investment for a period of greater than 12 months. Marketable securities with maturities of less than 12&#160;months are classified as current and are included in investments in the consolidated balance sheets. Marketable securities with maturities greater than 12&#160;months for which we have the intent and ability to hold the investment for greater than 12 months are classified as non-current and are included in investments, non-current in the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate securities for impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and our intent and ability to hold the investment to allow for an anticipated recovery in fair value. A credit-related impairment is recognized as an allowance on the balance sheet with a corresponding adjustment to earnings. Any impairment that is not credit- related is recognized in other comprehensive (loss) income, net of applicable taxes. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have accounts receivable amounts due from our product sales and related vaccine supply agreements and our grant agreements. We also have accounts receivable amounts due from strategic collaborators as a result of manufacturing and research and development services provided under collaboration arrangements, or milestones achieved, but not yet paid. Amounts payable to us are recorded as accounts receivable when our right to consideration is unconditional. To estimate the allowance for doubtful accounts, we make judgments about the creditworthiness of our customers based on ongoing credit evaluation and historical experience. There was no allowance for doubtful accounts at December 31, 2020, and 2019. There was no bad debt expense for the years ended December 31, 2020, 2019 or 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that subject us to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, marketable securities, and accounts receivable. Our investment portfolio comprises money market funds, marketable debt securities, including U.S. Treasury securities, debt securities of U.S. government agencies and corporate entities and commercial paper. Our cash management and investment policy limits investment instruments to investment-grade securities with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations. Bank accounts in the United States are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. Our primary operating accounts significantly exceed the FDIC limits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable are generally unsecured and are from customers in different countries. We generated revenue from grants made by government-sponsored and private organizations, product sales to the U.S. Government and international government agencies, and to a lesser extent, strategic alliances in 2020. Historically, we generated revenue primarily from strategic alliances. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our revenue to date has been generated from the following entities that accounted for more than 10% of total revenue and accounts receivable for the periods presented:</span></div><div style="padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:50.153%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage&#160;of&#160;Revenue</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years&#160;Ended&#160;December&#160;31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage&#160;of&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accounts&#160;Receivable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government (excluding BARDA)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Commission</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom Government</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea Government</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">* - Represents an amount of less than 10%</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We record all derivatives on our consolidated balance sheets at fair value. The accounting for changes in the fair value of a derivative depends on whether the derivative has been designated and qualifies for hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. We may enter into derivative contracts that are intended to economically hedge certain risk, even though hedge accounting does not apply or we elect not to apply hedge accounting. Foreign currency gains or losses associated with derivatives that are not designated as hedging instruments for accounting purposes are recorded within other (expense) income, net, in our consolidated statements of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as risks inherent in valuation techniques, transfer restrictions and credit risk. FASB ASC Topic&#160;820,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC&#160;820), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and our assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from our independent sources. Unobservable inputs are inputs that reflect our assumptions about the inputs that market participants would use in pricing the asset or liability, and are developed based on the best information available in the circumstances. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used to value the assets and liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level&#160;2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; or</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e.,&#160;supported by little or no market activity).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash equivalents and marketable securities are reported at fair value determined using Level&#160;1 and Level&#160;2 inputs (Note&#160;6). The fair value of our foreign currency forward contracts is calculated using Level 2 inputs, which include currency spot rates, forward rates, interest rate curve and credit or non-performance risk (Note 7). We do not have any non-financial assets or liabilities that should be recognized or disclosed at fair value on a recurring basis at December 31, 2020, 2019 and 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and 2019, we maintain letters of credit of $12.1 million and $11.8 million, respectively, related to our lease arrangements, which are secured by money market accounts in accordance with certain of our lease agreements. The amounts are recorded at fair value using Level 1 inputs and included as restricted cash in our consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is recorded at the lower of cost or net realizable value, with cost determined on a first-in, first-out (FIFO) basis. We periodically review the composition of inventory in order to identify excess, obsolete, slow-moving or otherwise unsaleable items. If unsaleable items are observed and there are no alternate uses for the inventory, we will record a write-down to net realizable value in the period that the decline in value is first recognized through a charge to cost of sales. The determination of whether inventory costs will be realizable requires estimates by management. If actual market conditions are less favorable than projected by management, additional write-downs of inventory may be required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to an initial regulatory approval for our investigational medicines, we expense costs relating to raw materials and production of inventory as research and development expense in our consolidated statements of operations, in the period incurred. When we believe regulatory approval and subsequent commercialization of our investigational medicines is probable, and we also expect future </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">economic benefit from the sales of the investigational medicines to be realized, we will then capitalize the costs of production as inventory. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the authorization of distribution and use of our COVID-19 vaccine under an EUA in December 2020, we began to capitalize inventory costs associated with our COVID-19 vaccine, as it was determined that inventory costs incurred subsequent to the EUA had a probable future economic benefit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Construction in Progress</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction in progress includes direct costs related to the construction of various property and equipment, including leasehold improvements, and is stated at original cost. Construction in progress includes costs incurred under construction contracts including project management services, engineering services, design services and development, construction services and other construction-related fees and services. Such costs are not depreciated until the asset is completed and placed into service. Once the asset is placed into service, these capitalized costs will be allocated to certain property and equipment categories and will be depreciated over the estimated useful life of the underlying assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of property and equipment are described below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:48.552%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.553%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Useful&#160;Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lesser&#160;of&#160;estimated&#160;useful&#160;life&#160;of&#160;improvement</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or&#160;remaining life of related lease</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset, financing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease term</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for maintenance and repairs are charged to expense as incurred. Upon retirement or sale, the cost of the assets disposed of, and the related accumulated depreciation, are removed from the accounts, and any resulting gain or loss is recorded to other (expense) income, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our long-lived assets, which consist of property and equipment, to determine if facts and circumstances indicate that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess the recoverability of the long-lived assets by comparing the projected future undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. If such review indicates that such cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair values based on the expected discounted future cash flows attributable to the assets or based on appraisals. For the year ended December 31, 2020, we incurred $1.6&#160;million of impairment expenses. We did not record any impairment expenses for the years ended December 31,2019 and 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASC 842 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) on January 1, 2019 on a modified retrospective basis under which we recognized and measured leases existing at, or entered into after, the beginning of the period of adoption. We elected the optional transition approach of not adjusting our comparative period financial statements for the impacts of adoption. Therefore, we recognized the effects of applying ASC 842 as a cumulative-effect adjustment to accumulated deficit as of January 1, 2019, the effective date of this standard. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases are classified at their commencement date, which is defined as the date on which the lessor makes the underlying asset available for use by the lessee, as either operating or finance leases based on the economic substance of the agreement. We recognize lease right-of-use assets and related liabilities in our consolidated balance sheets for both operating and finance leases. Lease liabilities are measured at the lease commencement date as the present value of the future lease payments using the interest rate implicit in the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lease. If the rate implicit is not readily determinable, we will utilize our incremental borrowing rate as of the lease commencement date. Lease right-of-use assets are measured as the lease liability plus initial direct costs and prepaid lease payments less lease incentives. The lease term is the non-cancelable period of the lease and includes options to extend or terminate the lease when it is reasonably certain that an option will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize operating lease cost in operating expense in our consolidated statements of operations, inclusive of rent escalation provisions and rent holidays, on a straight-line basis over the respective lease term. For our finance leases, we recognize depreciation expense associated with the leased asset acquired and recognize interest expense related to the portion of the financing in our consolidated statements of operations. Additionally, we recognize tenant improvement allowances as a reduction to rent expense on a straight-line basis over the respective lease term. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales includes cost of raw materials, production, transportation, freight and indirect overhead costs associated with our product revenue during the period and third-party royalties on net sales of our product. Cost of sales also includes adjustments for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred in performing research and development activities, including salaries and benefits, facilities costs, overhead costs, prelaunch inventory costs, contract services, and other outside costs. The value of goods and services received from contract research organizations and contract manufacturing organizations in the reporting period are estimated based on the level of services performed, and progress in the period in cases when we have not received an invoice from the supplier. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment or facilities that are acquired or constructed for research and development activities and that have alternative future uses, in research and development projects or otherwise, should be capitalized and depreciated as tangible assets. However, the costs of equipment or facilities that are acquired or constructed and intangibles that are purchased from others for a particular research and development project and that have no alternative future uses and therefore no separate economic values are considered research and development costs and are expensed when incurred. Certain equipment and leased facilities purchased for our COVID-19 vaccine program prior to the EUA from the FDA were deemed to have no alternative use. The related acquisition costs of such equipment and lease facilities of $109.6&#160;million were charged to research and development expense for the year ended December 31, 2020. We did not recognize such expense for the years ended December 31, 2019 or 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patent Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to secure, defend and maintain patents are expensed as incurred, and are classified as selling, general and administrative expenses due to the uncertainty of future benefits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issue stock-based awards to employees and non-employees, generally in the form of stock options and restricted stock units (RSUs). We account for our stock-based compensation awards in accordance with ASC 718,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Most of our stock-based awards have been made to employees. We measure compensation cost for equity awards at their grant-date fair value and recognize compensation expense over the requisite service period, which is generally the vesting period, on a straight-line basis. The grant date fair value of stock options is estimated using the Black-Scholes option pricing model, which requires management to make assumptions with respect to the fair value of our common stock on the grant date, including the expected term of the award, the expected volatility of our stock, calculated based on a period of time generally commensurate with the expected term of the award, risk-free interest rates and expected dividend yields of our stock. Historically, for periods prior to our IPO, the fair value of the shares of common stock and common units underlying our stock-based awards were determined on each grant date by our board of directors based on valuation estimates from management considering our most recently available independent third-party valuation of our common stock. Our board of directors also assessed and considered, with input from management, additional objective and subjective factors that we believed were relevant and which may have changed from the date of the most recent valuation through the grant date. The grant date fair value of RSUs is estimated based on the fair value of our underlying common stock. For performance-based stock awards, we recognize stock-based compensation expense over the requisite service period using the accelerated attribution method when achievement is probable. We classify stock-based compensation expense in our consolidated statement of operations in the same manner in which the award recipient&#8217;s salary and related costs are classified or in which the award recipient&#8217;s service payments are classified.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use an asset and liability approach to account for income taxes. We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. These differences are measured using the enacted statutory tax rates that are expected to be in effect for the years in which differences are expected to reverse. Valuation allowances are provided when the expected realization of deferred tax assets does not meet a &#8220;more likely than not&#8221; criterion. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss. We recognize tax benefits from uncertain tax positions if we believe the position is more likely than not to be sustained on examination by the taxing authorities based on the technical merits of the position. We make adjustments to these reserves when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. The provision for income taxes includes the effects of any reserves for tax positions that are not more likely than not to be sustained, as well as the related net interest and penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss per Share Attributable to Common Stockholders</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period, without consideration for common stock equivalents. Upon the closing of our IPO, all outstanding shares of our redeemable convertible preferred stock were converted into common stock. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate diluted net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding after giving consideration to the dilutive effect of restricted common stock and stock options that are outstanding during the period. We have generated a net loss in all periods presented, therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss includes net loss and other comprehensive income (loss) for the period. Other comprehensive income (loss) mainly consists of unrealized gains and losses on our investments. Total comprehensive income (loss) for all periods presented have been disclosed in the consolidated statements of comprehensive loss.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive gain (loss) for the years ended December 31, 2020 and 2019 are as follows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized&#160;Gain on Available-for-Sale Debt Securities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,320)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive gain, balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive gain, balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard changes how companies account for credit losses for most financial assets and certain other instruments. For trade receivables, loans and held-to-maturity debt securities, companies will be required to recognize an allowance for credit losses rather than reducing the carrying value of the asset. The amendments in this standard should be applied on a modified retrospective basis to all periods presented. We adopted this standard in the first quarter of 2020. Based on the composition of our investment portfolio and investment policy, the adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Topic 350): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard requires capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). We adopted this standard in the first quarter of 2020 using the prospective method. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard removes certain exceptions for investments, intra-period allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. We early adopted this standard in the second quarter of 2020. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial statements and disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619864251624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Grant Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Grants</a></td>
<td class="text">Grant Revenue<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into an agreement with the Defense Advanced Research Projects Agency (DARPA) for an award of up to $56.4&#160;million to fund development of a mobile manufacturing prototype leveraging our existing manufacturing technology that is capable of rapidly producing vaccines and therapeutics. As of December 31, 2020, the committed funding, net of revenue earned was $4.6&#160;million, with an additional $51.4&#160;million available if DARPA exercises additional contract options.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we entered into an agreement with BARDA for an award of up to $483.3&#160;million to accelerate development of mRNA-1273, our vaccine candidate against COVID-19. In July 2020, we amended our agreement with BARDA to provide for an additional commitment of up to $471.6&#160;million to support late-stage clinical development of mRNA-1273, including the execution of a 30,000 participant Phase 3 study in the U.S. The amendment increased the maximum award from BARDA from $483.3&#160;million to $954.9&#160;million. Under the terms of the agreement, BARDA will fund the advancement of mRNA-1273 to FDA licensure. All contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $444.3&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2016, we received an award of up to $125.8&#160;million from BARDA, to help fund our Zika vaccine program. Three of the four contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $70.8&#160;million, with an additional $8.4&#160;million available if the final contract option is exercised.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, we entered a global health project framework agreement with the Gates Foundation to advance mRNA-based development projects for various infectious diseases, including human immunodeficiency virus (HIV). As of December 31, 2020, the available funding net of revenue earned was $11.4&#160;million, with up to an additional $80.0&#160;million available if additional follow-on projects are approved. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following tables summarize grant revenue and deferred grant revenue for and as of the periods presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total grant revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>Product Sales<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we began selling our COVID-19 vaccine to the U.S. Government and international government agencies. Under the supply agreements with these government agencies, we received or billed for upfront deposits for our future vaccine supply, which are initially recorded as deferred revenue. We recognize revenue based on the fixed price per dose when control of the product has transferred and customer acceptance has occurred, unless such acceptance provisions are deemed perfunctory. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales by customer geographic location was as follows (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no product sales in 2019 and 2018. We had one commercial product, our COVID-19 vaccine, authorized for use as of December 31, 2020. </span></div>As of December 31, 2020, we had deferred revenue of $3.80&#160;billion related to customer deposits, classified as current deferred revenue in our consolidated balance sheet. Timing of product manufacturing, delivery and receipt of marketing approval will determine the period in which revenue is recognized.Geographic Information <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in one reporting segment that primarily focuses on the discovery, development and commercialization of mRNA medicines. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue by geographic area of our customers and collaboration partners was as follows (in thousands): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,075&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our property and equipment, including financing right-of-use asset, were principally located within the United States as of December 31, 2020 and 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865666984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Sales<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Product Sales</a></td>
<td class="text">Grant Revenue<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into an agreement with the Defense Advanced Research Projects Agency (DARPA) for an award of up to $56.4&#160;million to fund development of a mobile manufacturing prototype leveraging our existing manufacturing technology that is capable of rapidly producing vaccines and therapeutics. As of December 31, 2020, the committed funding, net of revenue earned was $4.6&#160;million, with an additional $51.4&#160;million available if DARPA exercises additional contract options.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we entered into an agreement with BARDA for an award of up to $483.3&#160;million to accelerate development of mRNA-1273, our vaccine candidate against COVID-19. In July 2020, we amended our agreement with BARDA to provide for an additional commitment of up to $471.6&#160;million to support late-stage clinical development of mRNA-1273, including the execution of a 30,000 participant Phase 3 study in the U.S. The amendment increased the maximum award from BARDA from $483.3&#160;million to $954.9&#160;million. Under the terms of the agreement, BARDA will fund the advancement of mRNA-1273 to FDA licensure. All contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $444.3&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2016, we received an award of up to $125.8&#160;million from BARDA, to help fund our Zika vaccine program. Three of the four contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $70.8&#160;million, with an additional $8.4&#160;million available if the final contract option is exercised.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, we entered a global health project framework agreement with the Gates Foundation to advance mRNA-based development projects for various infectious diseases, including human immunodeficiency virus (HIV). As of December 31, 2020, the available funding net of revenue earned was $11.4&#160;million, with up to an additional $80.0&#160;million available if additional follow-on projects are approved. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following tables summarize grant revenue and deferred grant revenue for and as of the periods presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total grant revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>Product Sales<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we began selling our COVID-19 vaccine to the U.S. Government and international government agencies. Under the supply agreements with these government agencies, we received or billed for upfront deposits for our future vaccine supply, which are initially recorded as deferred revenue. We recognize revenue based on the fixed price per dose when control of the product has transferred and customer acceptance has occurred, unless such acceptance provisions are deemed perfunctory. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales by customer geographic location was as follows (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no product sales in 2019 and 2018. We had one commercial product, our COVID-19 vaccine, authorized for use as of December 31, 2020. </span></div>As of December 31, 2020, we had deferred revenue of $3.80&#160;billion related to customer deposits, classified as current deferred revenue in our consolidated balance sheet. Timing of product manufacturing, delivery and receipt of marketing approval will determine the period in which revenue is recognized.Geographic Information <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in one reporting segment that primarily focuses on the discovery, development and commercialization of mRNA medicines. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue by geographic area of our customers and collaboration partners was as follows (in thousands): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,075&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our property and equipment, including financing right-of-use asset, were principally located within the United States as of December 31, 2020 and 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865392696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Collaboration Agreements</a></td>
<td class="text">Collaboration Agreements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total consolidated net revenue from our strategic collaborators for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collaboration Revenue by Strategic Collaborator:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,618&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,036&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under ASC 605</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the balances of our receivables and contract liabilities related to our strategic collaboration agreements during the year ended December&#160;31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, we recognized the following revenue as a result of the change in the contract liability balances related to our collaboration agreements (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.305%"><tr><td style="width:1.0%"/><td style="width:65.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.706%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue recognized in the period from:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended <br/>December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in contract liabilities at the beginning of the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance obligations satisfied (or partially satisfied) in previous reporting periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">______________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We first allocate revenue to the individual contract liability balance outstanding at the beginning of the period until the revenue exceeds that balance. If additional consideration is received on those contracts in subsequent periods, we assume all revenue recognized in the reporting period first applies to the beginning contract liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Related to changes in estimated costs for our future performance obligations and estimated variable considerations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the aggregated amount of the transaction price allocated to performance obligations under our collaboration agreements that are unsatisfied or partially unsatisfied was $327.7 million. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AstraZeneca &#8211; Strategic Alliances in Cardiovascular and Oncology</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Option Agreement and Services and Collaboration Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2013, we entered into an Option Agreement, the AZ Option Agreement, and a related Services and Collaboration Agreement, the AZ Services Agreement, with AstraZeneca, which were amended and restated in June 2018. We refer to these agreements in the forms that existed prior to the 2018 amendment and restatement as the 2013 AZ Agreements. Under the 2013 AZ Agreements, we granted AstraZeneca certain exclusive rights and licenses, and options to obtain exclusive rights to develop and commercialize potential therapeutic mRNA medicines directed at certain targets for the treatment of cardiovascular and cardiometabolic diseases and cancer, and agreed to provide related services to AstraZeneca. Pursuant to the 2013 AZ Agreements, AstraZeneca was responsible for all research, development and commercialization activities, while we provided specified research and manufacturing services during a research and evaluation period, as described below, to further AstraZeneca&#8217;s activities pursuant to an agreed upon services plan. Under the 2013 AZ Agreements, AstraZeneca could have requested we provide additional services, at AstraZeneca&#8217;s expense. Subject to customary &#8220;back-up&#8221; supply rights granted to AstraZeneca, we exclusively manufactured (or had manufactured) mRNA for all research, development and commercialization purposes under the 2013 AZ Agreements until, on a product-by-product basis, the expiration of the time period for which we are entitled to receive earn-out payments with respect to such product pursuant to the 2013 AZ Agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the effective date of the 2013 AZ Agreements, AstraZeneca acquired forty options that it may exercise to obtain exclusive rights to clinically develop and commercialize identified development candidates (and related back-up candidates) directed to specified targets that arise during the research and evaluation period. During the research and evaluation period for research candidates under the 2013 AZ Agreements, AstraZeneca could have elected to designate a limited number of research candidates as development candidates in order to continue preclinical development on such development candidates (and related back-up candidates). From such pool of development candidates designated by AstraZeneca, during a specified option exercise period, AstraZeneca could have then exercised one of its options to obtain exclusive rights to clinically develop and commercialize an identified development candidate (and related back-up candidates). If AstraZeneca did not exercise one of its options to acquire exclusive rights to clinically develop and commercialize a particular development candidate during the defined option exercise period for such development candidate, AstraZeneca&#8217;s rights to exercise an option and other rights granted under the 2013 AZ Agreements with respect to such development candidate (and related back-up candidates) would terminate, all rights to exploit such development candidate (and related back-up candidates) would be returned to us and all data and results generated by AstraZeneca with respect to such development candidate (and related back-up candidates) would be either assigned or licensed to us. Upon the earlier of termination of the 2013 AZ Agreements for any reason and a specified anniversary of the effective date of the 2013 AZ Agreements, all exercised options, and the right to exercise any and all options if not previously exercised by AstraZeneca, would automatically terminate. On a target-by-target basis, we and AstraZeneca agreed to certain defined exclusivity obligations under the 2013 AZ Agreements with respect to the research, development and commercialization of mRNA medicines for such target.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the effective date of the 2013 AZ Agreements, AstraZeneca made upfront cash payments to us totaling $240.0 million. Under the 2013 AZ Agreements, we were entitled to receive payments that are not related to any specific program of up to $180.0 million in the aggregate for the achievement of three technical milestones relating to toxicity, delivery, and competition criteria. We achieved the toxicity and competition milestones in the year ended December&#160;31, 2015. The delivery milestone has expired. Under the 2013 AZ Agreements, AstraZeneca was obligated to pay us a $10.0 million option exercise fee with respect to each development candidate (and related back-up candidates) for which it exercised an option. In addition, upon AstraZeneca&#8217;s exercise of each option, we were eligible to receive certain payments contingent upon the achievement of specified clinical, regulatory, and commercial events. For any product candidate optioned by AstraZeneca, we were eligible to receive, per product candidate, up to $100.0 million in payments for achievement of development milestones, up to $100.0 million payments for achievement of regulatory milestones, and up to $200.0 million payments for achievement of commercial milestones. Additionally, under the 2013 AZ Agreements, we were entitled to receive, on a product-by-product basis, earn-out payments on worldwide net sales of products ranging from a high-single digit percentage to 12%, subject to certain reductions, with an aggregate minimum floor.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received from AstraZeneca under the 2013 AZ Agreements an option exercise payment of $10.0 million (the 2016 VEGF Exercise) in the year ended December&#160;31, 2016, and a clinical milestone payment of $30.0 million with respect to AstraZeneca&#8217;s VEGF-A product (AZD8601) during the year ended December&#160;31, 2018, that is currently being developed in a Phase&#160;2 clinical trial. Unless earlier terminated, the 2013 AZ Agreements would have continued until the expiration of AstraZeneca&#8217;s earn-out and contingent option exercise payment obligations for optioned product candidates. Either party had the right to terminate the 2013 AZ Agreements upon the other party&#8217;s material breach, either in its entirety or in certain circumstances, with respect to relevant candidates, subject to a defined materiality threshold and specified notice and cure provisions. If AstraZeneca had the right to terminate the 2013 AZ Agreements for our material breach, then AstraZeneca could have elected, in lieu of terminating the 2013 AZ Agreements, in their entirety or with respect to such candidates, to have the 2013 AZ Agreements remain in effect, subject to reductions in certain payments we were eligible to receive and certain adjustments to AstraZeneca&#8217;s obligations under the 2013 AZ Agreements. AstraZeneca had the right to terminate the 2013 AZ Agreements in full, without cause, upon 90-days&#8217; prior notice to us.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Strategic Alliance with AstraZeneca</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IL-12</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, we entered into a new Strategic Drug Development Collaboration and License Agreement, which we refer to as the 2016 AZ Agreement, with AstraZeneca to discover, develop and commercialize potential mRNA medicines for the treatment of a range of cancers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the 2016 AZ Agreement, we and AstraZeneca have agreed to work together on an immuno-oncology program focused on the intratumoral delivery of a potential mRNA medicine to make the IL-12 protein.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 AZ Agreement initially included research activities with respect to a second discovery program. During a limited period of time, each party had an opportunity to propose additional discovery programs to be conducted under the 2016 AZ Agreement. We are responsible for conducting and funding all discovery and preclinical development activities under the 2016 AZ Agreement in accordance with an agreed upon discovery program plan for the IL-12 program and any other discovery program the parties agree to conduct under the 2016 AZ Agreement. For the IL-12 program and any other discovery program the parties agree to conduct under the 2016 AZ Agreement, during a defined election period that commenced as of the effective date of the 2016 AZ Agreement (for the IL-12 program) and otherwise will commence on initiation of any such new discovery program, AstraZeneca may elect to participate in the clinical development of a development candidate arising under the 2016 AZ Agreement from such program. If AstraZeneca so elects (as it has for the IL-12 program), AstraZeneca will lead clinical development activities worldwide and we will be responsible for certain activities, including being solely responsible for manufacturing activities, all in accordance with an agreed upon development plan. AstraZeneca will be responsible for funding all Phase&#160;1 clinical development activities (including costs associated with our manufacture of clinical materials in accordance with the development plan), and Phase&#160;2 clinical development activities (including costs associated with our manufacture of clinical materials in accordance with the development plan) up to a defined dollar threshold. We and AstraZeneca will equally share the costs of Phase&#160;2 clinical development activities in excess of such dollar threshold, all Phase 3 clinical development activities and certain other costs of late-stage clinical development activities, unless we elect not to participate in further development and commercialization activities and instead receive tiered royalties, as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and AstraZeneca will co-commercialize products in the U.S. in accordance with an agreed upon commercialization plan and budget, and on a product-by-product basis will equally share the U.S. profits or losses arising from such commercialization. Notwithstanding, on a product-by-product basis, prior to a specified stage of development of a given product, we have the right to elect not to participate in the further development and commercialization activities for such product. If we make such election, instead of participating in the U.S. profits and losses share with respect to such product, we are obligated to discuss future financial terms with AstraZeneca. If we are unable to agree on future financial terms within a short, defined period of time, we are entitled to receive tiered royalties at default rates set forth in the 2016 AZ Agreement, ranging from percentages in the mid-single digits to 20% on worldwide net sales of products, subject to certain reductions with an aggregate minimum floor. AstraZeneca has sole and exclusive responsibility for all ex-U.S. commercialization efforts. Unless we have elected to not to participate in further development (in which case royalties on ex-U.S. net sales will be at the default rates as described above, unless otherwise agreed by the parties), we are entitled to tiered royalties at rates ranging from 10% to 30% on ex-U.S. net sales of the products, subject to certain reductions with an aggregate minimum floor. Subject to customary &#8220;back-up&#8221; supply rights granted to AstraZeneca, we exclusively manufacture (or have manufactured) products for all development and commercialization purposes. We and AstraZeneca have agreed to certain defined exclusivity obligations with each other under the 2016 AZ Agreement with respect to the development and commercialization of mRNA medicines for IL-12. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, our strategic alliance under the 2016 AZ Agreement will continue on a product-by-product basis (i)&#160;until both parties cease developing and commercializing such product without the intention to resume, if we have not elected our right not to participate in further development and commercialization of such product or (ii)&#160;on a country-by-country basis, until the end of the applicable royalty term for such product in such country, if we have elected our right not to participate in further development and commercialization of such product.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Either party may terminate the 2016 AZ Agreement upon the other party&#8217;s material breach, subject to specified notice and cure provisions. Each party may also terminate the 2016 AZ Agreement in the event the other party challenges such party&#8217;s patent rights, subject to certain defined exceptions. AstraZeneca has the right to terminate the 2016 AZ Agreement in full or with respect to any program for scientific, technical, regulatory or commercial reasons at any time upon 90 days&#8217; prior written notice to us. On a product-by-product basis, we have the right to terminate the 2016 AZ Agreement in certain cases if AstraZeneca has suspended or is no longer proceeding with the development or commercialization of such product for a period of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzEzNTY2_b4c654c8-2a80-49cb-b78b-a61c53047d69">twelve</span> consecutive months, subject to specified exceptions, including tolling for events outside of AstraZeneca&#8217;s control. On a product-by-product basis, if the 2016 AZ Agreement is terminated with respect to a given product, AstraZeneca&#8217;s rights in such product will terminate and, to the extent we terminated for AstraZeneca&#8217;s breach, patent challenge or cessation of development or AstraZeneca terminated in its discretion, AstraZeneca will grant us reversion licenses and take certain other actions so as to enable us to continue developing and commercializing such product in the oncology field.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we continue developing and commercializing a given product following termination of the 2016 AZ Agreement by AstraZeneca in its discretion with respect to such product, AstraZeneca is entitled to receive a mid-single digit royalty on our worldwide net sales of such product and a high-single digit percentage of the amounts received by us from a third party in consideration of a license to such third party to exploit such product, in each case, until AstraZeneca recovers an amount equal to specified development costs incurred by AstraZeneca under the 2016 AZ Agreement with respect to such product prior to such termination. Such percentages increase by a low to mid-single digit amount to the extent such termination occurs after such product achieves a specified stage of development.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2013 Agreements with AstraZeneca, amended and restated in 2018 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, we entered into an Amended and Restated Option Agreement and a related Amended and Restated Services and collaboration Agreement with AstraZeneca, or the 2018 A&amp;R Agreements, which amended and restated the 2013 AZ Agreements. Under the 2018 A&amp;R Agreements, we granted AstraZeneca certain exclusive rights and licenses to research, develop and commercialize potential therapeutic mRNA medicines directed at certain targets for the treatment of cardiovascular and cardiometabolic diseases and cancer, and agreed to provide related services to AstraZeneca. The activities to be performed by the parties under the 2018 A&amp;R Agreements are limited to defined biological targets in the cardiovascular and cardiometabolic fields and one defined target in the cancer field.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the 2018 A&amp;R Agreements, AstraZeneca is responsible for all research, development and commercialization activities and associated costs, while we provide specified research and manufacturing services during a research and evaluation period, as described below, to further AstraZeneca&#8217;s activities conducted pursuant to an agreed upon services plan. During this research and evaluation period, these research services, and manufacturing services in excess of a specified threshold, are provided at AstraZeneca&#8217;s expense, and manufacturing services below the specified threshold are provided at no additional expense to AstraZeneca. AstraZeneca may request we provide additional research and manufacturing services, at AstraZeneca&#8217;s expense, following the end of the research and evaluation period. Subject to customary &#8220;back-up&#8221; supply rights granted to AstraZeneca, we exclusively manufacture (or have manufactured) mRNA for all research, development and commercialization purposes under the 2018 A&amp;R Agreements until, on a product-by-product basis, the expiration of the time period for which we are entitled to receive earn-out payments with respect to such product pursuant to the 2018 A&amp;R Agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the effective date of the 2013 AZ Agreements, and as further reflected in the 2018 A&amp;R Agreements, AstraZeneca acquired </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forty options that it may exercise to obtain exclusive rights to clinically develop and commercialize identified development candidates (and related back-up candidates) directed to specified targets that arise during the research and evaluation period. During the research and evaluation period for research candidates, AstraZeneca may elect to designate a limited number of research candidates as development candidates in order to continue preclinical development on such development candidates (and related back-up candidates). From such pool of development candidates designated by AstraZeneca, during a specified option exercise period, AstraZeneca may then exercise one of its options to obtain exclusive rights to clinically develop and commercialize an identified development candidate (and related back-up candidates) in certain fields. If AstraZeneca does not exercise one of its options to acquire exclusive rights to clinically develop and commercialize a particular development candidate during the defined option exercise period for such development candidate, AstraZeneca&#8217;s rights to exercise an option and other rights granted under the 2018 A&amp;R Agreements with respect to such development candidate (and related back-up candidates) will terminate, all rights to exploit such development candidate (and related back-up candidates) will be returned to us and all data and results generated by AstraZeneca with respect to such development candidate (and related back-up candidates) will be either assigned or licensed to us. Upon the earlier of termination of the 2018 A&amp;R Agreements for any reason and a specified anniversary of the effective date of the 2013 AZ Agreements, all unexercised options, and the right to exercise any and all options if not previously exercised by AstraZeneca, will automatically terminate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a target-by-target basis, we and AstraZeneca have agreed to certain defined exclusivity obligations under the 2018 A&amp;R Agreements with respect to the research, development and commercialization of mRNA medicines for such target in certain fields. In addition, we and AstraZeneca have agreed to certain defined exclusivity obligations with respect to the research, development and commercialization of mRNA medicines coding for the same polypeptide as any development candidate being developed under the 2018 A&amp;R Agreements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the 2018 A&amp;R Agreements will continue until the expiration of AstraZeneca&#8217;s earn-out and contingent option exercise payment obligations for optioned product candidates. Either party may terminate the 2018 A&amp;R Agreements upon the other party&#8217;s material breach, either in its entirety or in certain circumstances, with respect to relevant candidates, subject to a defined materiality threshold and specified notice and cure provisions. If AstraZeneca has the right to terminate the 2018 A&amp;R Agreements for our material breach, then AstraZeneca may elect, in lieu of terminating the 2018 A&amp;R Agreements, in their entirety or with respect to such candidates, to have the 2018 A&amp;R Agreements remain in effect, subject to reductions in certain payments we are eligible to receive and certain adjustments to AstraZeneca&#8217;s obligations under the 2018 A&amp;R Agreements. AstraZeneca may terminate the 2018 A&amp;R Agreements in full, without cause, upon 90 days&#8217; prior notice to us.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Combined 2018 AZ Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2013 Agreements, as amended by the 2018 A&amp;R Agreements, and the 2016 AZ Agreement, referred to as the Combined 2018 AZ Agreements, are treated as a single agreement for accounting purposes as these agreements were negotiated in contemplation of each other. The Combined 2018 AZ Agreements represent a transaction with a customer and therefore is accounted for in accordance with ASC 606. We identified the following performance obligations in the Combined 2018 AZ Agreements: (i) a combined performance obligation that includes a research license, research and development pool services, and manufacturing obligations related to the 2013 AZ Agreements, as amended by the 2018 A&amp;R Agreements, collectively referred to as the Combined 2018 AZ Agreement Performance Obligation, (ii) preclinical development services for IL-12, (iii) preclinical development services for an oncology development target, (iv) a combined performance obligation for a development and commercialization license and manufacturing obligations for IL-12, and (v) a material right to receive development and commercialization rights and manufacturing services for an oncology development target.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We concluded that the research license is not distinct from the research and development pool services or the manufacturing obligations related to the 2018 A&amp;R Agreements, as AstraZeneca cannot fully exploit the value of the research license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Any supply requested by AstraZeneca in excess of the minimum quantities specified in the agreement are considered customer options and treated as separate contracts for accounting purposes. Further, we concluded that AstraZeneca cannot exploit the value of the development and commercialization license for IL-12 without receipt of supply as the development and commercialization license does not convey to AstraZeneca the right to manufacture and therefore combined the development and commercialization license and the manufacturing obligations for IL-12 into one performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Combined 2018 AZ Agreements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublicense reimbursement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Toxicity milestone payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Competition milestone payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated reimbursement for IL-12 manufacturing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,830&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,782&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the most likely amount method to determine the amount of reimbursement for IL-12 manufacturing obligations to be received. We determined that any sales-based royalties related to IL-12 will be recognized when the related sales occur as they were determined to relate predominately to the license granted and therefore have been excluded from the transaction price. In addition, we are eligible to receive future milestones and royalties on future commercial sales for optioned product candidates under the 2018 A&amp;R Agreements and future royalties under the 2016 Agreement; however, these amounts are not considered variable consideration under the Combined 2018 Agreements as we are only eligible to receive such amounts if AstraZeneca exercises its options (including certain options that are deemed to be material rights). We have concluded that the exercise of an optioned product candidate represents a separate transaction under ASC 606. We re-evaluate the transaction price at the end of each reporting period. There was</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a $5.0&#160;million d</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ecrease to the transaction price during the year ended December 31, 2020, resulting from a change in estimate of variable consideration.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was allocated to the performance obligations based on the relative estimated standalone selling prices of each performance obligation. We developed the estimated standalone selling price for the licenses included in the Combined 2018 AZ Agreement Performance Obligation and the combined performance obligation for a development and commercialization license and manufacturing obligations for IL-12 primarily based on the probability-weighted present value of expected future cash flows associated with each license related to each specific program. In developing such estimate, we also considered applicable market conditions and relevant entity-specific factors, including those factors contemplated in negotiating the agreement, probability of success and the time needed to commercialize a product candidate pursuant to the associated license. We developed the estimated standalone selling price for the services and/or manufacturing and supply included in each of the performance obligation, as applicable, primarily based on the nature of the services to be performed and/or goods to be manufactured and estimates of the </span></div><div style="padding-right:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">associated costs, adjusted for a reasonable profit margin that would be expected to be realized under similar contracts. The estimated standalone selling price of the material right to receive development and commercialization rights and manufacturing services for an oncology development target was developed by estimating the amount of discount that AstraZeneca would receive when exercising the option and adjusting such amount by the likelihood that the option will be exercised.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Combined 2018 AZ Agreements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined 2018 AZ Agreement performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical development service - IL-12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical development service - oncology development target</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and commercialization license and manufacturing obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Material right to receive development and commercialization rights</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,225&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, $77.5 million of the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through December 31, 2029 and $9.7 million is expected to be recognized as revenue at the earlier of expiration or modification of the Combined 2018 AZ Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure proportional performance over time using an input method based on cost incurred relative to the total estimated costs for the Combined 2018 AZ Agreement Performance Obligation and the preclinical development services for IL-12 and the other oncology target performance obligations. We recognize revenue related to the amounts allocated to the combined performance obligation for a development and commercialization license and manufacturing obligations for IL-12 based on the point in time upon which control of supply is transferred to AstraZeneca for each delivery of the associated supply.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue for the Combined 2018 AZ Agreement Performance Obligation by determining the proportion of effort incurred as a percentage of total effort we expect to expend.&#160;This ratio is applied to the transaction price allocated to this combined performance obligation. We also estimate the development plan, including expected demand from AstraZeneca, and the associated costs for this combined performance obligation, as we will satisfy this combined performance obligation as the manufacturing services are performed.&#160;Management has applied significant judgment in the process of developing our budget estimates. Any changes to these estimates will be recognized in the period in which they change as a cumulative catch up.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined AZ Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue recognized for the year ended December 31, 2020 includes the amortization of deferred revenue due to the satisfaction of our performance obligation during the period, including a cumulative catch-up adjustment of $12.5&#160;million due to changes in estimated costs for our future performance obligations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined AZ Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 VEGF Exercise</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We concluded that the 2016 VEGF Exercise should be treated as a separate transaction for accounting purposes, represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. We identified one performance obligation in this arrangement which is comprised of the exclusive license to develop and commercialize VEGF and the manufacturing of clinical supply. We concluded that the VEGF license is not distinct from the manufacturing obligations because AstraZeneca cannot fully exploit the value of the license without receipt of such supply. This is due to limitations inherent in the licenses conveyed wherein AstraZeneca does not have the contractual right to manufacture during the term of the agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2016 VEGF Exercise:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option exercise fee </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milestone payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublicense reimbursement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated reimbursement for clinical supply</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are eligible to receive future milestones and royalties on future commercial sales under this arrangement. We utilize the most likely amount method to estimate any development and regulatory milestone payments to be received and the amount of estimated reimbursement for clinical supply. As of December 31, 2020, there were no milestones that had not been achieved included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or AstraZeneca&#8217;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any commercial milestones and sales-based royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted and therefore have also been excluded from the transaction price. We re-evaluate the transaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur. When a milestone payment is included in the transaction price in the future, it is recognized as revenue based on the relative completion of the underlying performance obligation. There was a $2.4&#160;million increase to the transaction price during the year ended December 31, 2020, resulting from a change in estimate of variable consideration.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total transaction price allocated to the single performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise combined performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through December 31, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue related to the amount of the transaction price allocated to the VEGF Exercise performance obligation based on the point in time upon which control of supply is transferred to AstraZeneca for each delivery of the associated supply.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.986%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue recognized for the year ended December 31, 2020 includes the amortization of deferred revenue due to the satisfaction of our performance obligation during the period, offset by a cumulative catch-up adjustment of $0.4&#160;million due to changes in estimated costs for our future performance obligations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merck &#8211; Strategic Alliances in Infectious Diseases and Cancer Vaccines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2015 Strategic Alliance with Merck&#160;&#8211; Infectious Disease</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2015, we entered into a Master Collaboration and License Agreement with Merck, which was amended in January 2016, June 2016, and May 2019, and which we refer to, as amended, as the 2015 Merck Agreement. Pursuant to the 2015 Merck Agreement, we and Merck agreed to research, develop, and commercialize potential mRNA medicines for the prevention of infections by RSV. The 2015 Merck Agreement was terminated on October 7, 2020, by mutual agreement, and the right to pursue the continued development and commercialization of product candidates and products, including RSV, reverted to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a part of the May 2019 amendment of the 2015 Merck Agreement, we and Merck agreed to conclude the collaboration as it relates to development of potential mRNA medicines for other viruses, including mRNA-1278 for the prevention of varicella zoster virus (VZV) infection. Pursuant to the 2015 Merck Agreement, Merck was primarily responsible for research, development, and commercialization activities and associated costs of such research and commercialization. We were responsible for designing and, at Merck's cost, manufacturing all mRNA constructs for preclinical and Phase 1 and Phase 2 clinical development purposes, and we were responsible for certain costs associated with the conduct of a Phase 1 clinical trial for a RSV vaccine product candidate (mRNA-1172). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and Merck agreed to certain defined exclusivity obligations during the term of the 2015 Merck Agreement with respect to mRNA investigational medicines against RSV. As part of the May 2019 amendment of the 2015 Merck Agreement, we and Merck agreed to certain exceptions to the existing exclusivity obligations, pursuant to which we will no longer be restricted from researching, developing, and commercializing an mRNA investigational medicine for the prevention of a specific set of respiratory infections, including RSV, for the pediatric population.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the 2015 Merck Agreement, we received a $50.0 million upfront payment. We were eligible to receive, on a product-by-product basis, additional milestone payments upon the achievement of certain development, regulatory, and commercial milestone events, as well as royalties on Merck&#8217;s net sales of products at rates ranging from the mid-single digits to low teens, subject to certain reductions, with an aggregate minimum floor. During the term of the agreement, we received from Merck a clinical milestone payment of $5.0 million with respect to the initiation of a Phase&#160;1 clinical trial for a Merck RSV vaccine product candidate. Concurrent with entering into the 2015 Merck Agreement, Merck made a $50.0 million equity investment in us, and concurrent with amending the 2015 Merck Agreement in January 2016, we received an upfront payment of $10.0 million from Merck.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that all aspects of amended 2015 Merck Agreement represent a transaction with a customer and therefore the amended 2015 Merck Agreement is accounted for in accordance with ASC 606. The four-year research period was complete as of December 31, 2018 and we recognized the total transaction price of $65.0&#160;million (the $60.0&#160;million in aggregate upfront payments and a $5.0&#160;million payment pertaining to achievement of a development milestone) in full as we concluded there were no unsatisfied performance obligations pertaining to the amended 2015 Merck Agreement. Additionally, we concluded the following customer options were marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement: (i) research services during the three-year period following the initial four-year research period during which Merck could continue to preclinically and clinically develop product candidates and (ii) clinical mRNA supply for Phase 1 and Phase 2 and/or non-cGMP mRNA supply beyond the initial four-year research period. Therefore, such options would be accounted for as a separate contract if exercised by the customer. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After completion of the initial four-year research period, and as part of the May 2019 amendment of the 2015 Merck Agreement, Merck elected to establish a new RSV vaccine product candidate and elected to conduct a Phase 1 clinical trial. We are responsible for </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">certain costs associated with the conduct of the Phase 1 clinical trial. We determined that our obligation under the May 2019 amendment to reimburse Merck for certain costs associated with the RSV vaccine Phase 1 clinical trial represents consideration payable to a customer and is accounted for as a reduction of the transaction price. The consideration amount is determined based on the most likely method and recorded as contra-revenue as costs are incurred. The one-time payment upon election by Merck to continue developing RSV is fully constrained as it is contingent upon completion of the RSV Phase 1 clinical trial and upon decisions to be made by Merck to continue development thereafter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2015 Merck Agreement:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction of reimbursements paid to Merck</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,353)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,265)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the most likely amount method to estimate any development and regulatory milestone payments to be received. As of December 31, 2020, there were no milestones that had not been achieved included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Merck&#8217;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We re-evaluate the transaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur. For the year ended December 31, 2020, there was a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$7.1&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> deduction to the transaction price related to reimbursements paid to Merck for RSV vaccine Phase I clinical trial costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total transaction price allocated to the combined performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Merck Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue and contra-revenue recognized for the periods presented (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contra-revenue under the May 2019 Amendment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue under the 2015 Merck Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contra-revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,026)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,773)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contra-revenue recognized was related to consideration payable to Merck under the May 2019 Amendment of the 2015 Merck Agreement. Collaboration revenue recognized was pursuant to separate agreements with Merck related to the exercise of customer options to purchase clinical mRNA supply to further develop a product candidate after the initial four-year research period. Clinical mRNA supply was recognized as collaboration revenue at a point in time upon which control of supply was transferred to Merck for each delivery of the associated supply. We had no deferred revenue as of December 31, 2020 or December 31, 2019 from the amended 2015 Merck Agreement as all performance obligations under the amended 2015 Merck Agreement were completed as of December 31, 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2020, the 2015 Master Collaboration and License Agreement between us and Merck related to our collaboration on RSV was terminated by mutual agreement. Merck will complete the Phase 1 study and transition the program to Moderna. The termination did not have an impact to our consolidated financial statements as of and for the year ended December 31, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Cancer Vaccine Strategic Alliance-Personalized mRNA Cancer Vaccines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, we entered into a personalized mRNA cancer vaccines (PCV) Collaboration and License Agreement with Merck, which we refer to as the PCV Agreement, to develop and commercialize PCVs for individual patients using our mRNA vaccine and formulation technology. Under the strategic alliance, we identify genetic mutations present in a particular patient&#8217;s tumor cells, synthesize mRNA for these mutations, encapsulate the mRNA in one of our proprietary LNPs and administer to each patient a unique mRNA cancer vaccine designed to specifically activate the patient&#8217;s immune system against her or his own cancer cells.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the PCV Agreement, we are responsible for designing and researching PCVs, providing manufacturing capacity and manufacturing PCVs, and conducting Phase&#160;1 and Phase&#160;2 clinical trials for PCVs, alone and in combination with KEYTRUDA (pembrolizumab), Merck&#8217;s anti-PD-1 therapy, all in accordance with an agreed upon development plan and budget and under the oversight of a committee comprised of equal representatives of each party. The parties have entered into a clinical quality agreement with respect to Moderna&#8217;s manufacture and supply activities. We received an upfront payment of $200.0 million from Merck. In November 2017, we and Merck announced the achievement of a key milestone for the first-in-human dosing of a PCV (mRNA-4157) as a part of the alliance. The Phase&#160;1 open-label, dose escalation, multicenter clinical trial in the United States (KEYNOTE-603) is designed to assess the safety, tolerability and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with KEYTRUDA, in subjects with unresectable solid tumors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the expiration of a defined period of time following our completion of Phase 1 and Phase 2 clinical trials for PCVs under the PCV Agreement and delivery of an associated data package to Merck, Merck has the right to elect to participate in future development and commercialization of PCVs by making a $250.0 million participation payment to us. If Merck exercises its election and pays the participation payment, then the parties will equally co-fund subsequent clinical development of PCVs, with Merck primarily responsible for conducting clinical development activities under a jointly agreed development plan and budget. Each party may also conduct additional clinical trials for PCVs that are not included in the jointly agreed development plan and budget, in which case the non-conducting party will reimburse the conducting party for half of the total costs for such trials, plus interest, from its share of future profits resulting from sales of such PCVs, if any. Merck will lead worldwide commercialization of PCVs, subject to Moderna&#8217;s option to co-promote PCVs in the United States, and the parties will equally share the profits or losses arising from worldwide commercialization. Until a PCV becomes profitable, we may elect to defer payment of our share of the commercialization and related manufacturing costs and instead reimburse Merck for such costs, plus interest, from our share of future profits resulting from sales of such PCV, if any. Subject to customary &#8220;back-up&#8221; supply rights granted to Merck, we will manufacture (or have manufactured) PCVs for preclinical and clinical purposes. Manufacture of PCVs for commercial purposes will be determined by the parties in accordance with the terms of the PCV Agreement. Under the PCV Agreement, we grant certain licenses to Merck to perform its collaboration activities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Merck does not exercise its right to participate in future development and commercialization of PCVs, then Moderna will retain the exclusive right to develop and commercialize PCVs developed during the strategic alliance, subject to Merck&#8217;s rights to receive a percentage in the high teens to the low 20s, subject to reductions of our net profits on sales of such PCVs. During a limited period following such non-exercise, Merck has the right to perform clinical studies of such PCVs in combination with KEYTRUDA, for which we agree to use reasonable efforts to supply such PCVs. During such limited period, we also have the right to perform clinical studies of PCVs in combination with KEYTRUDA, for which Merck agrees to use reasonable efforts to supply KEYTRUDA. In addition, following its non-exercise, Merck is also entitled to receive a percentage in the high teens to the low 20s, subject to reductions, of our net profits on sales of certain PCVs first developed by us following such non-exercise and reaching a specified development stage within a defined period of time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and Merck have agreed to certain defined, limited exclusivity obligations with respect to the development and commercialization of PCVs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Expansion of the Cancer Vaccine Strategic Alliance-Shared Neoepitope Cancer Vaccines</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2018, we and Merck agreed to expand our cancer vaccine strategic alliance to include the development and commercialization of our KRAS vaccine development candidate, mRNA-5671 or V941, and potentially other shared neoantigen mRNA cancer vaccines (SAVs). We preclinically developed mRNA-5671 prior to its inclusion in the cancer vaccine strategic alliance and it is comprised of a novel mRNA construct designed by us and encapsulated in one of our proprietary LNPs. The PCV Agreement was amended and restated to include the new SAV strategic alliance (PCV/SAV Agreement).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted Merck certain licenses and we and Merck have agreed to certain exclusivity obligations with respect to SAVs and particular SAV programs, which obligations are subject to termination or expiration upon certain triggering events. Under the PCV/SAV Agreement, Merck will be responsible for conducting Phase 1 and Phase 2 clinical trials for mRNA-5671 and for all costs associated with such activities, in accordance with a jointly agreed development plan and budget, and we will be responsible for manufacturing and supplying all mRNA-5671 required to conduct such trials and for all costs and expenses associated with such </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacture and supply. Under the PCV/SAV Agreement, our budgeted commitment for PCV increased to $243.0 million. Until the expiration of a defined period of time following the completion of Phase 1 and Phase 2 clinical trials for mRNA-5671 under the PCV/SAV Agreement and our delivery of an associated data package to Merck, Merck has the right to elect to participate in future development and commercialization of mRNA-5671 by making a participation payment to us. If Merck exercises its participation rights, then the parties will equally co-fund subsequent clinical development of mRNA-5671, with Merck primarily responsible for conducting clinical development activities under a jointly agreed development plan and budget. If Merck declines to participate in future development and commercialization activities following the initial Phase 1 and Phase 2 clinical trials for mRNA-5671, then we will retain the rights to develop and commercialize mRNA-5671. If Merck elects to participate in future development and commercialization of mRNA-5671, Merck may also conduct additional clinical trials for mRNA-5671 that are not included in the jointly agreed development plan and budget, in which case we will reimburse Merck for half of the total development costs for such clinical trials, plus interest, from our share of future profits resulting from sales of mRNA-5671, if any. If Merck does conduct additional clinical trials for mRNA-5671, we will be responsible for manufacturing and supplying all mRNA-5671 required to conduct such trials. Merck will lead worldwide commercialization of mRNA-5671, subject to our option to co-promote mRNA-5671 in the United States, and the parties will equally share the operating profits or losses arising from worldwide commercialization. Until mRNA-5671 becomes profitable, we may elect to defer payment of our share of the commercialization and related manufacturing costs and instead reimburse Merck for such costs, plus interest, from our share of future profits resulting from sales of mRNA-5671, if any. Subject to &#8220;back-up&#8221; supply rights granted to Merck, we will manufacture (or have manufactured) mRNA-5671 and other SAVs for preclinical and clinical purposes. After Merck exercises its right to participate in future development and commercialization of mRNA-5671 and other SAVs, we will grant the applicable development and commercialization licenses and the parties are obligated to discuss responsibility for future manufacturing, giving consideration to applicable criteria.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the PCV/SAV Agreement, for a defined period of time, either party may propose that the parties conduct additional programs for the research and development of SAVs directed to different shared neoantigens. If the parties agree to conduct any such programs, then we will be responsible for conducting and funding preclinical discovery and research activities for such SAVs, and otherwise the programs would be conducted on substantially the same terms as mRNA-5671 program. If we or Merck propose a new SAV program and the other party does not agree to conduct such program, then the PCV/SAV Agreement includes provisions allowing the proposing party to proceed with such development, at the proposing party&#8217;s expense. If Merck is the proposing party, we will be responsible for manufacturing and supplying material for such program at Merck&#8217;s expense. In such case, the non-proposing party will have the right to opt-in to such SAV program any time before the proposing party commits to performing Good Laboratory Practice (GLP)-toxicity studies. Until the expiration of a defined period of time following our completion of Phase&#160;1 and Phase&#160;2 clinical trials for any SAV program mutually agreed by the parties under the PCV/SAV Agreement and our delivery of an associated data package to Merck, Merck has the right to elect to participate in future development and commercialization of such SAV by making a participation payment to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the PCV/SAV Agreement will continue on a program-by-program basis until Merck terminates its participation in such program. Following any such termination, we will retain the exclusive right to develop and commercialize PCVs or SAVs developed as a part of such program, subject to restrictions and certain limited rights retained by Merck.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the amendment of the PCV Agreement to include the development and commercialization of mRNA-5671 and potentially other SAVs, Merck made a contemporaneous equity investment in our Series H redeemable convertible preferred stock, resulting in gross proceeds of $125.0 million, of which $13.0 million was determined to be a premium and recorded to deferred revenue.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div style="padding-left:2.25pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that the PCV/SAV Agreement should be accounted for separately from the amended 2015 Merck Agreement, as the agreements were not negotiated in contemplation of one another and the elements within each of the agreements are not closely interrelated or interdependent on each other. The PCV/SAV Agreement represents a transaction with a customer and therefore is accounted for in accordance with ASC 606. </span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the following performance obligations in the PCV/SAV Agreement: (i) a research license and research and development services, including manufacturing and supply of PCVs, during the proof of concept (POC) term for the PCV program, referred to as the PCV Performance Obligation, and (ii) research license and manufacturing and supply of mRNA-5671 during the POC term for the KRAS program, referred to as the KRAS Performance Obligation. We concluded that the research license is not distinct from the research and development services, including manufacturing and supply of PCVs, during the POC term for the PCV program, as Merck cannot fully exploit the value of the license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Therefore, the research license has been combined with the research and development services, including manufacturing and supply of PCVs, during the POC term for the PCV program, into a single performance obligation. Similarly, we concluded that the research license is not distinct from the manufacturing and supply of mRNA-5671 during the POC term for the KRAS program, as Merck cannot fully </span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exploit the value of the license without receipt of such supply which must be provided by us. This is due to limitations inherent in the licenses conveyed wherein Merck does not have the contractual right to manufacture during the POC term. Therefore, the research license has been combined with the manufacturing and supply of mRNA-5671, during the POC term for the KRAS program, into a single performance obligation. Conversely, we concluded that the PCV Performance Obligation and the KRAS Performance Obligation are distinct from each other because Merck can fully exploit the value of each program for its intended purpose without the promises associated with the other program. Additionally, we concluded the following customer options are marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement: (i) Merck participation election license related to future joint development and commercialization on a program-by-program basis, (ii) manufacturing and supply in support of certain SAV programs and/or the PCV program upon Merck election to not participate in future development and commercialization of that program and (iii) research and development services associated with certain SAV programs. Therefore, such options will be accounted for as a separate contract upon the customer&#8217;s election.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-right:6.75pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">PCV/SAV Agreement:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium associated with the contemporaneous sale of Series H redeemable convertible preferred stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursement for clinical supply</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,360&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We re-evaluate the transaction price at the end of each reporting period. During the year ended December 31, 2020, there was a $0.3&#160;million increase to the transaction price from a reimbursement for clinical supply.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was allocated to the performance obligations based on the relative estimated standalone selling price of each performance obligation. We developed the estimated standalone selling price for the license included in each of the PCV Performance Obligation and the KRAS Performance Obligation primarily based on the probability-weighted present value of expected future cash flows associated with each license related to each specific program. In developing such estimate, we also considered applicable market conditions and relevant entity-specific factors, including those factors contemplated in negotiating the agreement, probability of success and the time needed to commercialize a product candidate pursuant to the associated license. We developed the estimated standalone selling price for the services and/or manufacturing and supply included in each of the PCV Performance Obligation and the KRAS Performance Obligation, as applicable, primarily based on the nature of the services to be performed and/or goods to be manufactured and estimates of the associated cost, adjusted for a reasonable profit margin that would be expected to be realized under similar contracts.</span></div><div style="padding-right:11.25pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-right:6.75pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">PCV/SAV Agreement:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KRAS performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,007&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through December 31, 2024.</span></div><div style="padding-right:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will recognize revenue related to amounts allocated to the PCV Performance Obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of research and development efforts. We recognize revenue related to the amounts allocated to the KRAS Performance Obligation based on the point in time upon which control of supply is transferred to Merck for each delivery of the associated supply. </span></div><div style="padding-right:11.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.986%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV/SAV Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue recognized during the year ended December 31, 2020 includes the amortization of deferred revenue due to the satisfaction of our performance during the period, offset by a cumulative catch-up adjustment of $3.5&#160;million due to changes in estimated costs for our future performance obligations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue, which is classified as current or non-current in the condensed consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV/SAV Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-right:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vertex &#8211; 2016 Strategic Alliance in Cystic Fibrosis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In July 2016, we entered into a Strategic Collaboration and License Agreement, with Vertex Pharmaceuticals Incorporated, and Vertex Pharmaceuticals (Europe) Limited, together, Vertex, which we refer to as the Vertex Agreement. The Vertex Agreement, which was amended in July 2019, which we refer to as the 2019 Vertex Amendment, is aimed at the discovery and development of potential mRNA medicines for the treatment of cystic fibrosis (CF) by enabling cells in the lungs of people with CF to produce functional cystic fibrosis transmembrane conductance regulator (CFTR) proteins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Vertex Agreement, we lead discovery efforts during an initial research period that currently extends until March 2020, leveraging our Platform technology and mRNA delivery expertise along with Vertex&#8217;s scientific experience in CF biology and the functional understanding of CFTR. Vertex is responsible for conducting development and commercialization activities for candidates and products that arise from the strategic alliance, including the costs associated with such activities. Subject to customary &#8220;back-up&#8221; supply rights granted to Vertex, we exclusively manufacture (or have manufactured) mRNA for preclinical, clinical and commercialization purposes. The parties established a joint steering committee to oversee and coordinate activities under the Vertex Agreement. We and Vertex have granted each other certain licenses under the Vertex Agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Vertex Agreement, we received a $20.0 million upfront payment from Vertex. In July 2019, Vertex elected to extend the initial research period by six months by making a $2.0 million payment to us pursuant to the 2019 Vertex Amendment. In March 2020, based on the promising preclinical data generated to date, Vertex extended the conduct of the initial Research Plan through the First Extended Research Term (an additional 18-month term) by making an additional payment to us. Vertex has rights to further extend the research period for two additional one-year periods by making an additional payment to us for each one-year extension. We are eligible to receive up to $55.0 million in payments for achievement of development milestones, up to $220.0 million in payments for achievement of regulatory milestones and potentially could receive an additional $3.0 million milestone payment for achievement of a regulatory milestone for second and each subsequent product under the Vertex Agreement. Vertex will also pay us tiered royalties at rates ranging from the low- to high-teens on worldwide net sales of products arising from the strategic alliance, subject to certain reductions, with an aggregate minimum floor. In connection with the strategic alliance, Vertex also made a $20.0 million equity investment in us. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Vertex Agreement, we and Vertex have agreed to certain defined exclusivity obligations under the Vertex Agreement with respect to the development and commercialization of certain mRNA medicines. Unless earlier terminated, the Vertex Agreement will continue until the expiration of all royalty terms. Vertex may terminate the Vertex Agreement for convenience upon 90&#160;days&#8217; prior written notice, except if termination relates to a product in a country where Vertex has received marketing approval, which, in such case, Vertex must provide 180 days&#8217; prior written notice. Either party may terminate the Vertex Agreement upon the other party&#8217;s material breach, subject to specified notice and cure provisions. Each party may also terminate the Vertex Agreement in </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the event that the other party challenges the validity or enforceability of such party&#8217;s patent rights, subject to certain exceptions, or if the other party becomes insolvent.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div style="padding-right:2.25pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total transaction price for the Vertex Agreement was determined to be $24.4&#160;million, comprised of the $20.0&#160;million upfront payment and $4.4&#160;million in research and development funding related to the research and development services and supply of non-cGMP mRNA. As of December 31, 2019, all performance obligations under the Vertex Agreement were completed. The 2019 Vertex Amendment represents a contract modification and is accounted for as a separate contract. As of December 31, 2020, all performance obligations under the 2019 Vertex Amendment were completed and the total transaction price of $4.5&#160;million, comprised of the $2.0&#160;million upfront payment and $2.5&#160;million in research and development funding related to the research and development services and supply of non-cGMP mRNA, was fully recognized.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Extended Research Term represents a contract modification and is accounted for as a separate contract. Pursuant to the 2019 Vertex Amendment, we identified one performance obligation comprised of: (i) a research, development and commercialization license and (ii) research and development services, including manufacturing and supply of non-cGMP mRNA, during the 18-month First Extended Research Term. We concluded that the license is not distinct from the research and development services, including manufacturing and supply of non-cGMP mRNA. Additionally, we concluded that the following customer options are marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement: (i) Vertex&#8217;s rights to extend the extended initial research period and (ii) clinical mRNA supply and/or non-cGMP mRNA supply beyond the extended initial research period. Therefore, such options will be accounted for as a separate contract upon the customer&#8217;s election.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the First Extended Research Term at December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:84.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Vertex Agreement - First Extended Research Term:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,798&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the most likely amount method to determine the amount of research and development funding to be received. As of December 31, 2020, there were no milestones included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Vertex&#8217;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any sales-based royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted and therefore have also been excluded from the transaction price. We re-evaluate the tra</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nsaction price at the end of each reporting period and as uncertain events are resolved or other changes in circumstances occur. There was a $8.6&#160;million increas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e to the transaction price during the year ended December 31, 2020, resulting from a change in the estimate of variable consideration.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total transaction price allocated to the single performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Extended Research Term transaction price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 the aggregate amount of transaction price allocated to the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through the fourth quarter of 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue related to amounts allocated to the single performance obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of the research and development efforts.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex First Extended Research Term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex Agreement/2019 Amendment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,505&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,197&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue recognized during the year ended December 31, 2020, includes the amortization of the deferred revenue due to the satisfaction of our performance during the period, offset by a cumulative catch-up adjustment of $0.2&#160;million due to changes in estimated costs for our future performance obligations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue, classified as current and non-current in the condensed consolidated balance sheets based on the term of the research period for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex Agreement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">____________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance as of December 31, 2019 represents deferred revenue related to the Vertex 2019 Amendment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vertex &#8212;2020 Strategic Alliance in Cystic Fibrosis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a new Strategic Collaboration and License Agreement with Vertex (Vertex 2020 Agreement). The Vertex 2020 Agreement is aimed at the discovery and development of potential medicines to treat CF by delivering gene-editing therapies to lung cells to facilitate production of functional CFTR proteins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The three-year research period of the Vertex 2020 Agreement will initially focus on the identification and optimization of novel LNPs and mRNAs that can deliver gene-editing therapies to cells in the lungs. Following the initial three-year period, Vertex is responsible for conducting development and commercialization activities for candidates and products that arise from the strategic alliance, including the costs associated with such activities. Vertex is also obligated to pay us for research services in connection with our performance of certain activities in accordance with a jointly agreed research plan. Subject to customary &#8220;back-up&#8221; supply rights granted to Vertex, under the agreement, we are the exclusive manufacturer of related mRNA and LNPs for preclinical, clinical, and commercialization purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Vertex 2020 Agreement, we received a $75.0&#160;million upfront payment from Vertex. We are eligible to receive up to $380.0&#160;million in milestone payments upon the achievement of certain development, regulatory, and commercial milestone events with respect to any products that result from the strategic alliance, and Vertex will also pay us a tiered percentage of its gross profits derived from worldwide net sales of products arising from the strategic alliance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Vertex 2020 Agreement, we and Vertex have agreed to certain defined exclusivity obligations with respect to the development and commercialization of certain mRNA medicines.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the Vertex 2020 Agreement will continue until the expiration of all payment obligations. Vertex may terminate the Vertex 2020 Agreement for convenience upon 90 days&#8217; prior written notice, except if termination relates to a product in a country where Vertex has received marketing approval; in such case, Vertex must provide 180 days&#8217; prior written notice. Either party may terminate the Vertex 2020 Agreement upon the other party&#8217;s material breach, subject to specified notice and cure provisions. Each party may also terminate the Vertex 2020 Agreement in the event that the other party challenges the validity or enforceability of such party&#8217;s patent rights, subject to certain exceptions, or if the other party becomes insolvent.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that all aspects of the 2020 Vertex Agreement represent a transaction with a customer and therefore should be accounted for in accordance with ASC 606. We also determined that the 2020 Vertex Agreement should be accounted for separately from other Vertex Agreements as the agreements contemplate research on separate research candidates. We identified one performance obligation comprised of: (i) a research, development and commercialization license; and (ii) research and development </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services, including manufacturing and supply of non-cGMP mRNA, performed as part of the Initial Research Plan and the Additional Research Plan (collectively, the research period). We concluded that the license is not distinct from the research and development services, including manufacturing and supply of non-cGMP mRNA used in the performance of the research services, as Vertex cannot fully exploit the value of the license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Therefore, the license has been combined with the research and development services, including manufacturing and supply of non-cGMP supply, into a single performance obligation. Additionally, we concluded the provision of clinical mRNA supply and/or non-cGMP mRNA supply provided to Vertex at their option represents a customer option and is considered a marketing offer as such options did not provide any discounts or other rights that would be considered a material right in the arrangement. Such options will be accounted for as a separate contract upon the customer&#8217;s election.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total transaction price was determined to be $75.0&#160;million, comprised of the upfront payment. We utilize the most likely amount method to determine the amount of research and development funding to be received associated with the Additional Research Plan. Our funding estimate is based on our experience bringing research candidates to the point of nomination by our collaboration partners, including our experience with Vertex under separate transactions. We have fully constrained such amounts and will not include any expected funding in the transaction price until the scope of such services have been agreed to amongst the parties. We also utilize the most likely amount method to estimate any development and regulatory milestone payments to be received. Further, there were no milestones included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Vertex&#8217;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any sales-based royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted, and therefore have also been excluded from the transaction price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the 2020 Vertex Agreement, the total transaction price was allocated entirely to a single performance obligation. We recognize revenue related to amounts allocated to the single performance obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of the research and development efforts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, we did not recognize any revenue associated with the 2020 Vertex Agreement. As of December 31, 2020, the aggregate amount of the transaction price allocated to the remaining performance obligations that are unsatisfied is $75.0&#160;million, which is expected to be recognized as revenue through the third quarter of 2023. We had deferred revenue of $75.0&#160;million as of December 31, 2020, which is classified as current and non-current in the consolidated balance sheets based on the term of the research period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Chiesi&#8212;2020 Collaboration and License Agreement with Chiesi</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into a Collaboration and License Agreement with Chiesi Farmaceutici S.P.A. (Chiesi), which we refer to as the Chiesi Agreement. The Chiesi Agreement is aimed at the discovery and development of potential mRNA medicines for the treatment of Pulmonary Arterial Hypertension (PAH), a rare disease characterized by high blood pressure in the arteries of the lungs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Chiesi Agreement, we lead discovery efforts during a four-year research period, leveraging our Platform technology and mRNA delivery expertise along with Chiesi&#8217;s scientific experience in PAH biology. Chiesi is responsible for conducting development and commercialization activities for candidates and products that arise from the collaboration, including the costs associated with such activities. Chiesi is also obligated to pay us for our performance of research activities during the research period in accordance with a jointly agreed research plan. Under the agreement, we are the exclusive manufacturer of related candidates and products for preclinical, clinical, and commercialization purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Chiesi Agreement, we are entitled to receive a $25.0&#160;million upfront payment from Chiesi. Chiesi has the right to extend the initial four-year research period by <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzkz_2d953b6a-57dd-4928-80b3-3c00ab223378">one</span> additional year by making an additional payment to us. We are eligible to receive up to $405.0&#160;million in aggregate milestone payments upon the achievement of certain development, regulatory and commercial milestone events, and Chiesi will also pay us tiered double-digit royalties on worldwide net sales of products arising from the collaboration, subject to certain reductions, with an aggregate minimum floor.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the term of the Chiesi Agreement, we and Chiesi have agreed to certain defined exclusivity with respect to the development and commercialization of certain mRNA medicines.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Treatment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that all aspects of the Chiesi Agreement represent a transaction with a customer and therefore should be accounted for in accordance with ASC 606. We identified the following performance obligations in the Chiesi Agreement: (i) a research license and research and development services, including manufacturing and supply during the research period; (ii) a material right for the first product development and commercialization license; and (iii) a material right for the second product development and commercialization license. We concluded that the license is not distinct from the research and development services, including manufacturing and supply of non-cGMP mRNA, during the four-year research period, as Chiesi cannot fully exploit the value of the license without receipt of such services and supply. Our services and supply involve specialized expertise, particularly as it relates to mRNA technology that is not available in the marketplace. Therefore, the license has been combined with the research and development services, including manufacturing and supply of non-cGMP supply, into a single performance obligation. Additionally, we concluded the provision of clinical mRNA supply and/or non-cGMP mRNA supply beyond the four-year research period and the right to extend the research period for <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNDUvZnJhZzo1NmMxN2IyMDNiOTE0ZWU5YjQxODFiZDY2ZGRmZDJkNS90ZXh0cmVnaW9uOjU2YzE3YjIwM2I5MTRlZTliNDE4MWJkNjZkZGZkMmQ1XzExNTQ0ODcyMzAzNzQ1_9c8cdcb6-3511-498b-8168-a066bbb63f69">one</span> additional year represent customer options and are considered marketing offers as such options did not provide any discounts or other rights that would be considered a material right in the arrangement. Such options will be accounted for as a separate contract upon the customer's election.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:84.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chiesi Agreement:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,496&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize the most likely amount method to determine the amount of research and development funding to be received associated with the research period. We also utilize the most likely amount method to estimate any development and regulatory milestone payments to be received. Further, there were no milestones included in the transaction price. We considered the stage of development and the risks associated with the remaining development required to achieve each milestone, as well as whether the achievement of the milestone is outside of our or Chiesi&#8217;s control. The outstanding milestone payments were fully constrained, as a result of the uncertainty whether any of the milestones would be achieved. We determined that any sales-based commercial milestone payments and royalties will be recognized when the related sales occur as they were determined to relate predominantly to the license granted and therefore have also been excluded from the transaction price.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price was allocated to the performance obligations based on the relative estimated standalone selling prices of each performance obligation. We developed the estimated standalone selling price for the services and manufacturing and supply included in the performance obligation, as applicable, primarily based on the nature of the services to be performed and the goods to be manufactured and estimates of the associated costs, adjusted for a reasonable profit margin that would be expected to be realized under similar contracts. We developed the estimated standalone selling prices for the licenses included in the associated performance obligations based on an analysis of our other transactions with collaboration partners and third party comparable transactions. In developing such estimates, we also considered applicable market conditions and relevant entity-specific factors, including those factors contemplated in negotiating the agreement, probability of success and the time needed to commercialize a product candidate pursuant to the associated license. The estimated standalone selling price of the material rights to receive development and commercialization rights was developed by estimating the amount of discount that Chiesi would receive when exercising the option and adjusting such amount by the likelihood that the option will be exercised.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chiesi Agreement transaction price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue related to amounts allocated to the combined research license and research and development services performance obligation over time as the underlying services are performed using a proportional performance model. We measure proportional performance using an input method based on the costs incurred relative to the total estimated costs of the research and development efforts. We will recognize revenue associated with the material rights as revenue at the earlier of the exercise or expiry of the material rights.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, we recognized collaboration revenue of $0.2&#160;million from the Chiesi Agreement. We did not recognize any revenue associated with the Chiesi Agreement for the years ended December 31, 2019 and 2018. As of December 31, 2020, $17.3&#160;million of the remaining performance obligations that are unsatisfied is expected to be recognized as revenue through the third quarter of 2024 and $25.0&#160;million is expected to be recognized as revenue at the earlier of the exercise or expiry of the material rights.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had deferred revenue of $25.0&#160;million as of December 31, 2020, classified as non-current in the consolidated balance sheets based on the term of the research period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI http://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865423896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Financial Instruments and Fair Value Measurements</a></td>
<td class="text">Financial Instruments and Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents and Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our cash and available-for-sale securities by significant investment category at December 31, 2020 and 2019 (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,623,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,623,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,623,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,888,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,892,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,276,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,242,194&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246,456&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,623,850&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,983,758&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="45" style="padding:0 1pt"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">834,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">836,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,259,980&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,047&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,262,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,876&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">867,124&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and estimated fair value of marketable securities, by contractual maturity at December 31, 2020 and 2019 are as follows (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,983,758&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,618,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,622,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,148&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,987&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024,106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027,111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with our investment policy, we place investments in investment grade securities with high credit quality issuers, and generally limit the amount of credit exposure to any one issuer. We evaluate securities for impairment at the end of each reporting period. We did not record any impairment charges related to our available-for-sale securities during the&#160;years ended December 31, 2020, 2019 and 2018. We did not recognize any credit losses related allowance to available-for-sale securities as of the years ended December 31, 2020 and 2019. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amount of gross unrealized losses and the estimated fair value for our available-for-sale securities in an unrealized loss position by length of time the securities have been in an unrealized loss position at December 31, 2020 and 2019 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2019:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 and 2019, we held 108 and 19 individual available-for-sale securities, respectively, out of our total investment portfolio that were in a continuous unrealized loss position for less than 12 months. We neither intend to sell these investments nor conclude that we are more-likely-than-not that we will have to sell them before recovery of their carrying values. We also believe that we will be able to collect both principal and interest amounts due to us at maturity.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our financial assets measured at fair value on a recurring basis as of December 31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement Using</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (Note 7)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,243,846&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,622,899&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement Using</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2020 and 2019, we did not have any financial liabilities measured at fair value on a recurring basis and did not have non-financial assets or liabilities measured at fair value on a recurring basis.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865672856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We transact business in various foreign currencies and have international sales and expenses denominated in foreign currencies. Therefore, we are exposed to certain risks arising from both our business operations and economic conditions. Our risk management strategy includes the use of derivative financial instruments to hedge foreign currency exchange rate fluctuations on monetary assets or liabilities denominated in foreign currencies. We do not enter into derivative financial contracts for speculative or trading purposes. We do not believe that we are exposed to more than a nominal amount of credit risk in our foreign currency hedges, as counterparties are large, global and well-capitalized financial institutions. We classify cash flows from our derivative transactions as cash flows from operating activities in our consolidated statements of cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency forward contracts, primarily accounts receivable, are not designated for hedge accounting treatment. Therefore, these forward contracts are accounted for as derivatives whereby the fair value of the contracts are reported as other current assets or other current liabilities on our consolidated balance sheets, and gains and losses resulting from changes in the fair value are recorded as a component of other (expense) income, net, in our consolidated statements of operations. The gains and losses on these foreign currency forward contracts generally offset the gains and losses in the underlying foreign currency denominated assets and liabilities, which are also recorded to other (expense) income, net, in our consolidated statements of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross notional amount and fair value for foreign currency derivatives that are not designated as hedging instruments are accounted for as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">_________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As presented in the consolidated balance sheet within other current assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We did not have any derivative instruments as of December 31, 2019. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The effect of foreign currency forward contracts not designated as hedging instruments in our consolidated statements of operations for the year ended December 31, 2020 was as follows (in thousand):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:56.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.773%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.773%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Statement of Operations Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended<br/> December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no hedging activities for the years ended December 31, 2019 and 2018.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619864305512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text">Inventory<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of December 31, 2020 consists of the following (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:60.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>We did not have any inventory at December 31, 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619863932648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, financing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,495&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense for the&#160;years ended December 31, 2020, 2019 and 2018 was $31.3 million, $31.0 million, $24.9 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865363704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Other Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prepaid Expenses and Other Current Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Down payments to manufacturing vendors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant incentives receivables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable on marketable securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"><tr><td style="width:1.0%"/><td style="width:73.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.119%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation-related</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external goods and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,652&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Current Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"><tr><td style="width:1.0%"/><td style="width:73.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.119%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities - financing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities - operating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,665&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,063&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activities in deferred revenue during the year ended December&#160;31, 2020 (in thousands): </span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,881,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,799,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,305&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,009,960&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,653)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,044,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619938020200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases We have entered into various long-term non-cancelable lease arrangements for our facilities and equipment expiring at various times through 2032. Certain of these arrangements have free rent periods or escalating rent payment provisions, which we recognize lease cost under such arrangements on a straight-line basis over the life of the leases. We have two campuses in Massachusetts, our Cambridge facility and our Moderna Technology Center (MTC), located in Norwood. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cambridge facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We occupy a multi-floor building at Technology Square in Cambridge, Massachusetts with a mix of offices and research laboratory space totaling approximately 175,000 square feet. Our Cambridge facility leases have expiry ranges from 2020 to 2029.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we entered into an amendment to our lease agreements to consolidate our Technology Square space in Cambridge, Massachusetts. This included entering into a forward-starting lease agreement starting in January 2020 to acquire approximately 50,000 square feet of additional space at 200 Technology Square. In addition, our current 200 Technology Square lease has been extended for two years to 2029. As part of the lease amendment, we completely exited our leased space of approximately 60,000 square feet at 500 Technology Square by May 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record operating lease cost for each of our operating leases on a straight-line basis from lease commencement date through the end of the lease term. Operating lease cost is recorded in operating expenses in our consolidated statements of operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finance Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moderna Technology Center North (MTC North) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we entered into a new lease agreement for office and laboratory space of approximately 200,000 square feet, MTC North, located in Norwood, Massachusetts. The lease commenced in the second quarter of 2019 and had an initial expiration date of 2031. We have the option to extend the lease for up to four additional five-year terms. Contemporaneously, we entered into an agreement to sublease approximately 64 percent of the leased space to a third party. In May 2020, we entered into an amendment to the lease whereby we exercised an option available in the original lease to receive a tenant improvement allowance in the amount of $22.2&#160;million to be paid back over the term of the lease with interest and extend the term of the lease to 2035. In May 2020, we also amended our MTC North sublease agreement. As the result of that amendment, effective June 1, 2020, we obtained an additional, approximately 28,000 square feet, or 12 percent of the leased space in MTC North and the remainder of the space in July 2020 when the sublease expired. The lease modifications to MTC North in the second quarter of 2020 resulted in a change in lease classification, from operating to finance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moderna Technology Center manufacturing facility (MTC South) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August&#160;2016, we entered into a lease agreement for approximately&#160;200,000&#160;square feet of office, laboratory, and light manufacturing space, MTC South, in Norwood, Massachusetts. The lease will expire in September&#160;2032. We have the option to extend the term for&#160;two&#160;extension periods of&#160;ten years&#160;each at market-based rents. The base rent is subject to increases over the term of the lease. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Embedded Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into multiple contract manufacturing service agreements with third parties which contain embedded leases within the scope of ASC 842. As of December 31, 2020, we had lease liabilities of $24.3&#160;million related to the embedded leases. Certain embedded leases dedicated to our COVID-19 vaccine program prior to the EUA from the FDA were deemed to have no alternative use. The related right-of-use assets of $62.3&#160;million were charged to research and development expense for the year ended December 31, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating and financing lease right-of-use assets and lease liabilities as of December 31, 2020 and 2019 were as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, operating, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, financing, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,958&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_509b73a1-344b-43fb-b968-8722c1c25a5e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_72c4555a-bb44-4abb-b6c7-1be6c51005ca"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_2a800648-bfb3-4584-a0d1-7572b92f5809"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_5ef609f9-9865-4708-ad5f-c12a24e8246f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current lease liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,595&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are real estate related assets, which include land, office and laboratory spaces.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net of accumulated depreciation. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are&#160;real estate assets related to the MTC North and MTC South leases. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in property and equipment in the consolidated balance sheets, net of accumulated depreciation.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in other current liabilities in the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the lease costs for the year ended December 31, 2020 and 2019 were as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"><tr><td style="width:1.0%"/><td style="width:72.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.119%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of right-of-use assets, financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense for financing lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financing lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,322&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total rent expense&#160;for the&#160;year ended&#160;December&#160;31, 2018 was&#160;$19.1 million.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information relating to our leases for the year ended December 31, 2020 and 2019 was as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used in operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used in financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Financing cash flows used in financing leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,519)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease non-cash items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets reduced through lease modifications and reassessments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease non-cash items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained through lease modifications and reassessments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge to financing lease obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease terms and discount rates as of December 31, 2020 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable lease agreements as of&#160;December&#160;31, 2020, were as follows (in&#160;thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amounts representing interest or imputed interest </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Include the optional extensions in the MTC North and MTC South lease terms which represent a total of $338.9 million un-discounted future lease payments. </span></div>(2)  MTC South interest is based on an imputed interest rate of 17.2%. MTC North interest is based upon an incremental borrowing rate of 8.2%.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases We have entered into various long-term non-cancelable lease arrangements for our facilities and equipment expiring at various times through 2032. Certain of these arrangements have free rent periods or escalating rent payment provisions, which we recognize lease cost under such arrangements on a straight-line basis over the life of the leases. We have two campuses in Massachusetts, our Cambridge facility and our Moderna Technology Center (MTC), located in Norwood. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cambridge facility</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We occupy a multi-floor building at Technology Square in Cambridge, Massachusetts with a mix of offices and research laboratory space totaling approximately 175,000 square feet. Our Cambridge facility leases have expiry ranges from 2020 to 2029.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, we entered into an amendment to our lease agreements to consolidate our Technology Square space in Cambridge, Massachusetts. This included entering into a forward-starting lease agreement starting in January 2020 to acquire approximately 50,000 square feet of additional space at 200 Technology Square. In addition, our current 200 Technology Square lease has been extended for two years to 2029. As part of the lease amendment, we completely exited our leased space of approximately 60,000 square feet at 500 Technology Square by May 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record operating lease cost for each of our operating leases on a straight-line basis from lease commencement date through the end of the lease term. Operating lease cost is recorded in operating expenses in our consolidated statements of operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finance Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moderna Technology Center North (MTC North) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we entered into a new lease agreement for office and laboratory space of approximately 200,000 square feet, MTC North, located in Norwood, Massachusetts. The lease commenced in the second quarter of 2019 and had an initial expiration date of 2031. We have the option to extend the lease for up to four additional five-year terms. Contemporaneously, we entered into an agreement to sublease approximately 64 percent of the leased space to a third party. In May 2020, we entered into an amendment to the lease whereby we exercised an option available in the original lease to receive a tenant improvement allowance in the amount of $22.2&#160;million to be paid back over the term of the lease with interest and extend the term of the lease to 2035. In May 2020, we also amended our MTC North sublease agreement. As the result of that amendment, effective June 1, 2020, we obtained an additional, approximately 28,000 square feet, or 12 percent of the leased space in MTC North and the remainder of the space in July 2020 when the sublease expired. The lease modifications to MTC North in the second quarter of 2020 resulted in a change in lease classification, from operating to finance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moderna Technology Center manufacturing facility (MTC South) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August&#160;2016, we entered into a lease agreement for approximately&#160;200,000&#160;square feet of office, laboratory, and light manufacturing space, MTC South, in Norwood, Massachusetts. The lease will expire in September&#160;2032. We have the option to extend the term for&#160;two&#160;extension periods of&#160;ten years&#160;each at market-based rents. The base rent is subject to increases over the term of the lease. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Embedded Leases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into multiple contract manufacturing service agreements with third parties which contain embedded leases within the scope of ASC 842. As of December 31, 2020, we had lease liabilities of $24.3&#160;million related to the embedded leases. Certain embedded leases dedicated to our COVID-19 vaccine program prior to the EUA from the FDA were deemed to have no alternative use. The related right-of-use assets of $62.3&#160;million were charged to research and development expense for the year ended December 31, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating and financing lease right-of-use assets and lease liabilities as of December 31, 2020 and 2019 were as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, operating, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, financing, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,958&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_509b73a1-344b-43fb-b968-8722c1c25a5e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_72c4555a-bb44-4abb-b6c7-1be6c51005ca"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_2a800648-bfb3-4584-a0d1-7572b92f5809"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_5ef609f9-9865-4708-ad5f-c12a24e8246f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current lease liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,595&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are real estate related assets, which include land, office and laboratory spaces.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net of accumulated depreciation. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are&#160;real estate assets related to the MTC North and MTC South leases. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in property and equipment in the consolidated balance sheets, net of accumulated depreciation.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in other current liabilities in the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the lease costs for the year ended December 31, 2020 and 2019 were as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"><tr><td style="width:1.0%"/><td style="width:72.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.119%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of right-of-use assets, financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense for financing lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financing lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,322&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total rent expense&#160;for the&#160;year ended&#160;December&#160;31, 2018 was&#160;$19.1 million.&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information relating to our leases for the year ended December 31, 2020 and 2019 was as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used in operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used in financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Financing cash flows used in financing leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,519)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease non-cash items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets reduced through lease modifications and reassessments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease non-cash items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained through lease modifications and reassessments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge to financing lease obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease terms and discount rates as of December 31, 2020 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable lease agreements as of&#160;December&#160;31, 2020, were as follows (in&#160;thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amounts representing interest or imputed interest </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Include the optional extensions in the MTC North and MTC South lease terms which represent a total of $338.9 million un-discounted future lease payments. </span></div>(2)  MTC South interest is based on an imputed interest rate of 17.2%. MTC North interest is based upon an incremental borrowing rate of 8.2%.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865874072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Collaborations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our strategic collaboration agreements, we are committed to perform certain research, development, and manufacturing activities. As part of our PCV Agreement and PCV/SAV Agreement with Merck, we are committed to perform certain research, development and manufacturing activities related to PCV products through an initial Phase 2 clinical trial up to a budgeted amount of $243.0 million as of December 31, 2020 and 2019 (Note 5).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently a party to any material legal proceedings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Obligations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted under Delaware law, we indemnify our officers, directors, and employees for certain events, occurrences while the officer, or director is, or was, serving at our request in such capacity. The term of the indemnification is for the officer&#8217;s or director&#8217;s lifetime.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have standard indemnification arrangements in our leases for laboratory and office space that require us to indemnify the landlord against any liability for injury, loss, accident, or damage from any claims, actions, proceedings, or costs resulting from certain acts, breaches, violations, or non-performance under our leases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into indemnification provisions under our agreements with counterparties in the ordinary course of business, typically with business partners, contractors, clinical sites and customers. Under these provisions, we generally indemnify and hold harmless the indemnified party for losses suffered or incurred by the indemnified party as a result of our activities. These indemnification provisions generally survive termination of the underlying agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is unlimited.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through December 31, 2020 and 2019, we had not experienced any losses related to these indemnification obligations, and no material claims were outstanding. We do not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves were established.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments and Purchase Orders</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we entered into a 10-year strategic collaboration agreement with Lonza Ltd. to enable larger scale manufacture for our COVID-19 vaccine and additional Moderna products in the future. This agreement was reflected in the Global Long Term Agreement entered into between Moderna and Lonza on September 4, 2020. Under the terms of the agreement, we established dedicated manufacturing suites at Lonza&#8217;s facilities in the United States and Switzerland for the manufacture of mRNA-1273 at both sites. Certain arrangements under this strategic collaboration agreement are within the scope of lease accounting (see Note 11). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into agreements in the normal course of business with vendors and contract manufacturing organizations (CMOs) for raw materials and manufacturing services and with vendors for preclinical research studies, clinical trials and other goods or services. As of December 31, 2020, we had </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$659.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of non-cancelable purchase commitments related to raw materials and manufacturing agreements, including the Lonza agreement, which are expected to be paid through 2021. As of December 31, 2020, we had $27.0&#160;million of non-cancelable purchase commitments for clinical services and other goods and services which are expected to be paid through 2024. These amounts represent our minimum contractual obligations, including termination fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to purchase commitments, we have agreements with third parties for various services, including services related to clinical operations and support and contract manufacturing, for which we are not contractually able to terminate for convenience and avoid any and all future obligations to the vendors. Certain agreements provide for termination rights subject to termination fees or wind down costs. Under such agreements, we are contractually obligated to make certain payments to vendors, mainly, to reimburse them for their unrecoverable outlays incurred prior to cancellation. At December 31, 2020, we had cancelable open purchase orders of $896.9 million in total under such agreements for our significant clinical operations and support and contract manufacturing. These amounts represent only our estimate of those items for which we had a contractual commitment to pay at December 31, 2020, assuming we would not cancel these agreements. The actual amounts we pay in the future to the vendors under such agreements may differ from the purchase order amounts.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licenses to Patented Technology</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;26, 2017, we entered into sublicense agreements with Cellscript, LLC and its affiliate, mRNA RiboTherapeutics, Inc. to sublicense certain patent rights. Pursuant to each agreement, we are required to pay certain license fees, annual maintenance fees, minimum royalties on future net sales and milestone payments contingent on achievement of certain development, regulatory and commercial milestones for specified products, on a product-by-product basis. The development and regulatory milestone payments, up to $1.5&#160;million for therapeutic and prophylactic products and up to $0.5 million for diagnostic products will be recognized as a cost of the asset acquired upon resolution of the associated contingency and will be capitalized or expensed depending on the nature of the associated asset as of the date of recognition. Conversely, commercial milestone payments, up to $24.0 million, and royalties based on annual net sales of licensed products for therapeutic and prophylactic products will be accounted for as additional expense of the related product sales in the period in which the corresponding sales occur. In connection with these sublicense agreements, we recognized sublicense grant fees of $22.0&#160;million in 2018 and have no further obligation for additional sublicense grant fees. We recognized $6.9&#160;million of royalties associated with our product sales in 2020.</span></div>Additionally, we have other in-license agreements with third parties which require us to make future development, regulatory and commercial milestone payments for specified products associated with the agreements. The achievement of these milestones was not deemed probable as of December 31, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865379832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock and Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Redeemable Convertible Preferred Stock and Common Stock</a></td>
<td class="text">Redeemable Convertible Preferred Stock and Common Stock<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;28, 2018 and May&#160;7,&#160;2018, the Board of Directors approved an amendment to our Certificate of Incorporation resulting in a total of 775,000,000 shares of common stock and a total of 509,352,795 shares of redeemable convertible preferred stock being authorized, respectively. Upon completion of our IPO, our authorized capital stock consists of 1,600,000,000 shares of common stock, par value $0.0001 per share, and 162,000,000 shares of preferred stock, par value $0.0001 per share, all of which shares of preferred stock are undesignated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2018, we completed our IPO, whereby we sold 26,275,993 shares of common stock at a price of $23.00 per share. The aggregate net proceeds received by us from the IPO were $563.0&#160;million, net of underwriting discounts and commissions of $33.2 million and offering expenses of $8.1 million payable by us. Upon the closing of the IPO, all of the outstanding shares of our redeemable convertible preferred stock were converted into 236,012,913 shares of the common stock. As of December&#160;31, 2020 and 2019, we did not have any convertible preferred stock issued or outstanding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, we sold 26,315,790 shares of common stock at a price of $19.00 per share through a public equity offering. The aggregate net proceeds from the offering were $477.7&#160;million, net of underwriting discounts, commissions and offering expenses. In addition, the underwriters exercised their options to purchase an additional 3,947,368 shares of common stock at the public offering price less underwriting discounts, resulting in additional net proceeds of $71.8&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 21, 2020, we sold 17,600,000 shares of common stock at a price of $76.00 per share through a public equity offering. The aggregate net proceeds from the offering were $1.30&#160;billion, net of underwriting discounts, commissions and offering expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619863913064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2013, we adopted the 2013 Equity Incentive Plan (the 2013 Incentive Plan) and the 2013 Unit Option and Grant Plan (the 2013 Option Plan), which provided for the grant of incentive units, non-qualified unit options, and restricted and unrestricted unit awards to our employees, officers, directors, advisors, and outside consultants. Historically, we also granted restricted stock to founders, officers, directors, and advisors outside any of the Plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August&#160;2016, we adopted the 2016 Stock Option and Grant Plan (the 2016 Equity Plan), which replaced the 2013 Option Plan and the 2013 Incentive Plan. The 2016 Equity Plan and provided for the grant of incentive stock options, non-qualified stock options, restricted stock, unrestricted stock, and restricted stock units to our employees, officers, directors, consultants, and other key persons.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the IPO, we adopted the 2018 Stock Option and Incentive Plan (the 2018 Equity Plan) in November 2018. The 2018 Equity Plan became effective on the date immediately prior to the effective date of the IPO and replaced our 2016 Plan. The 2018 Equity Plan provides flexibility to our compensation committee to use various equity-based incentive awards as compensation tools to motivate our workforce. We have initially reserved 13,000,000 shares of our common stock for the issuance of awards under the 2018 Equity Plan. The 2018 Equity Plan provides that the number of shares reserved and available for issuance under the plan will </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">automatically increase each January 1, beginning on January 1, 2019, by 4% of the outstanding number of shares of our common stock on the immediately preceding December 31, or such lesser number of shares as determined by the Compensation and Talent Committee of our Board of Directors. The shares of common stock underlying any awards that are forfeited, canceled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting, satisfied without any issuance of stock, expire or are otherwise terminated (other than by exercise) under the 2018 Equity Plan and the 2016 Plan will be added back to the shares of common stock available for issuance under the 2018 Equity Plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms and conditions of stock-based awards are defined at the sole discretion of our Board of Directors. We issue service-based awards, vesting over a defined period of service, and performance-based awards, vesting upon achievement of defined conditions. Service based awards generally vest over a four-year period, with the first 25% of such awards vesting following twelve months of continued employment or service. The remaining awards vests in twelve quarterly installments over the following twelve quarters. Stock options granted under the 2016 Equity Plan expire ten years from the date of grant and the exercise price must be at least equal to the fair market value of common stock on the grant date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;December 31, 2020, we had a total of&#160;64.2 million shares reserved for future issuance under our Equity Plans, of which 36.3 million shares were reserved for equity awards previously granted, and&#160;27.9 million shares were available for future grants under the 2018 Equity Plan. No additional awards will be granted under the 2016 Equity Plan as it was replaced by the 2018 Equity Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted options generally through the 2018 Equity Plan and 2016 Equity Plan. The following table summarizes our option activity as of December 31, 2020 and 2019:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price per</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Share</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value per</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Share</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Term</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in&#160;thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,536,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,036,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,888,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/forfeited</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,627,468)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,057,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,461,374&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,596,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of common stock for those options in the money as of December 31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options exercised was $785.7 million, $75.6 million and $5.3 million for the&#160;years ended December 31, 2020, 2019 and 2018, respectively. The aggregate intrinsic value represents the difference between the exercise price and the selling price received by option holders upon the exercise of stock options during the period. The total consideration recorded as a result of stock option exercises&#160;was approximately&#160;$179.6 million&#160;for&#160;the year ended December 31, 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Common Stock Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted restricted stock unit awards generally through the 2018 Equity Plan. The following table summarizes our restricted stock unit activity during the year ended December 31, 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:72.335%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">per Unit</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, non-vested at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.01&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215,033)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, non-vested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of restricted stock units vested during the years ended December 31, 2020, 2019 and 2018, were $5.0 million, $5.5 million, and zero, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2018 Employee Stock Purchase Plan</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we adopted the 2018 Employee Stock Purchase Plan (the ESPP), which became effective on December 5, 2018. The ESPP initially reserves and authorizes the issuance of up to a total of 810,000&#160;shares of common stock to participating employees. We will make one or more offerings, consisting of one or more purchase periods, each year to our employees to purchase shares under the ESPP. Offerings will usually begin every six months and will continue for six-month periods, referred to as offering periods. The purchase price at which shares are sold under the ESPP will be equal to 85% of the lower of the fair market value of the shares on the first business day of the offering period or the last business day of the purchase period. Employees are generally eligible to participate through payroll deductions of between 1% to 50% of their compensation and may not purchase more than 3,000 shares of common stock during each purchase period or&#160;$25,000&#160;worth of shares of common stock in any calendar year.&#160;We began our first ESPP offering on June 1, 2019. There were 251,752 shares of common stock sold at a weighted average price of $27.97 per share under the ESPP during the year ended December&#160;31, 2020. As of&#160;December&#160;31, 2020,&#160;3.6&#160;million&#160;shares were available for future issuance under the ESPP.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation and Stock-Based Compensation Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation for options granted under our Equity Plans and share purchases under our ESPP is determined using the Black-Scholes option pricing model. The weighted-average assumptions used to estimate the fair value of options granted and ESPP for the&#160;years ended December 31, 2020, 2019 and 2018 are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.986%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years&#160;Ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Risk-free interest rate</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Expected term</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.11 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.27 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Expected volatility</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Expected dividends</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Weighted average fair value per share</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value per share</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* - Not applicable </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components and classification of stock-based compensation expense for the&#160;years ended December 31, 2020, 2019 and 2018 as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years&#160;Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted common stock and units</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,155&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,259&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,659&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,021&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,565&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, we recognized stock-based compensation expense of $9.6&#160;million, $9.8 million and $10.6 million, respectively, related to performance-based awards, including awards with vesting or commencement contingent upon the IPO, for which achievement of such performance-based condition was deemed probable. Stock-based compensation expenses related to non-employee awards were immaterial for the years ended December 31, 2020, 2019 and 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there were $226.8 million of total unrecognized compensation cost related to non-vested stock-based compensation with respect to options and restricted stock granted. That cost is expected to be recognized over a weighted-average period of 2.9 years at December 31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937050504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plan</a></td>
<td class="text">Employee Benefit PlanWe provide a retirement savings option to our eligible U.S. employees through the Moderna, Inc. 401(k)&#160;Plan (the 401(k) Plan), subject to certain limitations. As allowed under Section&#160;401(k) of the Internal Revenue Code, the 401(k) Plan allows tax deferred salary deductions for eligible employees. We match 50% up to the first 6% contributed by a participant. All matching contributions are immediately vested. Total matching contributions to the 401(k) Plan were $5.0 million, $4.2 million, $2.1 million for the&#160;years ended December 31, 2020, 2019 and 2018, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619863938600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before provision for (benefit from) income taxes for the years ended December 31, 2020, 2019 and 2018 consist of the following (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:67.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(745,445)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(508,595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380,473)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744,513)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,716)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384,408)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for (benefit from) income taxes for the years ended December 31, 2020, 2019 and 2018 consist of the following components (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:67.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,200)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the U.S. statutory income tax rate to our effective tax rate for the years ended December 31, 2020, 2019 and 2018 are as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:67.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effected at statutory rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes, net of federal benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research and development credits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation windfall</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of our deferred tax assets and tax liabilities as of December 31, 2020 and 2019 are as follows (in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:77.898%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.055%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carry-forwards</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized licenses, research and development and start-up costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carry-forwards</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease financing obligation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,268&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(470,753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets, net of valuation allowance</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,677&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,515&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing right-of-use assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,539)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,944)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,959)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,677)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,515)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have evaluated the positive and negative evidence bearing upon the realization of our deferred tax assets, including our history of significant losses in every year since our inception and in accordance with the applicable accounting standards, have fully reserved the net deferred tax asset. We concluded that realization of our net deferred tax assets is not more-likely-than-not to be realized as of December 31, 2020. The valuation allowance increased by $352.7 million in the year ended December 31, 2020, primarily due to the increase in net operating loss carry-forwards, research and development tax credits and capitalized inventory.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a periodic basis, we reassess the valuation allowance on our deferred income tax assets, weighing positive and negative evidence to assess the recoverability of the deferred tax assets. In 2020, we reassessed the valuation allowance and considered negative evidence, including our cumulative losses over the three years ended December 31, 2020, and positive evidence, including our recent EUA for our COVID-19 vaccine. After assessing both the negative and positive evidence, we concluded that we should maintain the valuation allowance on our net operating losses and our other deferred tax assets as of December 31, 2020. The release of the valuation allowance, as well as the exact timing and the amount of such release, continue to be subject to, among other things, our level of profitability, revenue growth, clinical program progression and expectations regarding future profitability. Our total deferred tax asset balance subject to the valuation allowance was approximately $874.1&#160;million at December 31, 2020. We will continue to monitor the need for a full or partial valuation allowance each quarter in 2021 and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, we had approximately $2.26 billion and $1.70 billion of federal and state net operating loss carry-forwards, respectively, of which $380.1 million of federal and $1.70 billion of state loss carry-forwards begin to expire in 2030. Additionally, $1.88 billion of federal net operating loss carry-forward will carry forward indefinitely. At December 31, 2020 we also had federal and state research and development credit carry-forwards of approximately $73.3 million and $26.1 million, which begin to expire in 2030 and 2032, respectively. At December 31, 2020, we also had federal orphan drug and state investment tax credit carry-forwards of approximately $2.0 million and $3.9 million which begin to expire in 2039 and 2021, respectively.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Coronavirus Aid, Relief and Economic Security Act (the CARES Act) was signed into law. The CARES Act includes provisions relating to several aspects of corporate income taxes. We do not currently expect the CARES Act to have a significant impact on our provision for income taxes; however, we will continue to monitor the provisions of the CARES Act in relation to its operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the net operating loss (NOL) and tax credit carry-forwards may be subject to a substantial annual limitation due to ownership change limitations that have occurred previously, or that could occur in the future, as provided by Section&#160;382 of the Internal Revenue Code of 1986, as amended, or Section&#160;382, as well as similar state provisions and other provisions of the Internal Revenue Code. Ownership changes may limit the amount of NOLs and tax credit carry-forwards that can be utilized annually to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section&#160;382, results from transactions that increase the ownership of 5% shareholders in the stock of a corporation by more than 50% in the aggregate over a three-year period. We may experience ownership changes in the future as a result of subsequent shifts in our stock ownership, some of which may be outside our control.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file U.S. federal income tax returns and income tax returns in various state, local and foreign jurisdictions. All tax years since the date of our incorporation remain open to examination by the major taxing jurisdictions (state and federal) to which we are subject, as carry-forward attributes generated in years past may still be adjusted upon examination by the Internal Revenue Service (IRS) or other authorities if they have or will be used in a future period. We are not currently under examination by the IRS, or any other jurisdictions, for any tax year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize, in our financial statements, the effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. A reconciliation of the beginning and ending amounts of unrecognized tax benefits during the years ended December 31, 2020 and 2019 are as follows (in&#160;thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to prior positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year tax position</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to prior positions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrecognized tax benefits may change during the next twelve months for items that arise in the ordinary course of business. We do not anticipate a material change to our unrecognized tax benefits over the next twelve months that would have an adverse effect on our consolidated operating results. We recognize interest and penalties, if applicable, related to uncertain tax positions as a component of income tax expense.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865666984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss per Share</a></td>
<td class="text">Net Loss per Share <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss per Share Attributable to Common Stockholders</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2020, 2019 and 2018 are calculated as follows (in thousands, except share and per share data):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:61.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747,064)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,021)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium paid on repurchase of redeemable convertible preferred stock</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative dividends on redeemable convertible preferred stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747,064)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,021)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(401,857)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381,333,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,802,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,114,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.96)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.95)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents, presented based on amounts outstanding as of December 31, 2020, 2019 and 2018 were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because their inclusion would have been anti-dilutive:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.493%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,057,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,536,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,821,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted common stock units</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,250,493&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,714,164&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,478,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619864031496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Geographic Information</a></td>
<td class="text">Grant Revenue<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, we entered into an agreement with the Defense Advanced Research Projects Agency (DARPA) for an award of up to $56.4&#160;million to fund development of a mobile manufacturing prototype leveraging our existing manufacturing technology that is capable of rapidly producing vaccines and therapeutics. As of December 31, 2020, the committed funding, net of revenue earned was $4.6&#160;million, with an additional $51.4&#160;million available if DARPA exercises additional contract options.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we entered into an agreement with BARDA for an award of up to $483.3&#160;million to accelerate development of mRNA-1273, our vaccine candidate against COVID-19. In July 2020, we amended our agreement with BARDA to provide for an additional commitment of up to $471.6&#160;million to support late-stage clinical development of mRNA-1273, including the execution of a 30,000 participant Phase 3 study in the U.S. The amendment increased the maximum award from BARDA from $483.3&#160;million to $954.9&#160;million. Under the terms of the agreement, BARDA will fund the advancement of mRNA-1273 to FDA licensure. All contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $444.3&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2016, we received an award of up to $125.8&#160;million from BARDA, to help fund our Zika vaccine program. Three of the four contract options have been exercised. As of December 31, 2020, the remaining available funding net of revenue earned was $70.8&#160;million, with an additional $8.4&#160;million available if the final contract option is exercised.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2016, we entered a global health project framework agreement with the Gates Foundation to advance mRNA-based development projects for various infectious diseases, including human immunodeficiency virus (HIV). As of December 31, 2020, the available funding net of revenue earned was $11.4&#160;million, with up to an additional $80.0&#160;million available if additional follow-on projects are approved. </span></div><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following tables summarize grant revenue and deferred grant revenue for and as of the periods presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total grant revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>Product Sales<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we began selling our COVID-19 vaccine to the U.S. Government and international government agencies. Under the supply agreements with these government agencies, we received or billed for upfront deposits for our future vaccine supply, which are initially recorded as deferred revenue. We recognize revenue based on the fixed price per dose when control of the product has transferred and customer acceptance has occurred, unless such acceptance provisions are deemed perfunctory. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales by customer geographic location was as follows (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no product sales in 2019 and 2018. We had one commercial product, our COVID-19 vaccine, authorized for use as of December 31, 2020. </span></div>As of December 31, 2020, we had deferred revenue of $3.80&#160;billion related to customer deposits, classified as current deferred revenue in our consolidated balance sheet. Timing of product manufacturing, delivery and receipt of marketing approval will determine the period in which revenue is recognized.Geographic Information <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in one reporting segment that primarily focuses on the discovery, development and commercialization of mRNA medicines. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue by geographic area of our customers and collaboration partners was as follows (in thousands): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,075&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our property and equipment, including financing right-of-use asset, were principally located within the United States as of December 31, 2020 and 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865372424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">Subsequent Events <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December 31, 2020, we have entered into several supply agreements with customers to provide our COVID-19 vaccine, up to 125.1&#160;million doses, and have received upfront deposits of $125.4&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, b</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ased on the initial confirmed volume, subject to modifications. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 18, 2021, the European Commission advised us that we had successfully tendered for the provision of 150&#160;million doses of our COVID-19 vaccine in 2021. This tender is subject to execution of the Purchase Agreement, which is expected shortly following an opt out period for individual Member States that expired on February 25, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December 31, 2020, we have entered into additional binding purchase commitments with third-party contractual manufacturing organizations for our COVID-19 vaccine under existing agreements. We are currently committed to minimum non-cancelable purchase obligations of $314.8&#160;million related to these agreements, which are expected to be paid through 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619952674440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Our consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP). Any reference in these notes to applicable guidance is meant to refer to the authoritative accounting principles generally accepted in the United States as found in the Accounting Standard Codification (ASC) and Accounting Standards Updates (ASU) of the&#160;Financial Accounting Standards Board (FASB).The consolidated financial statements include the Company and its subsidiaries.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">All intercompany transactions and balances have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">We have made estimates and judgments affecting the amounts reported in our consolidated financial statements and the accompanying notes. On an ongoing basis, we evaluate our estimates, including critical accounting policies or estimates related to revenue recognition, research and development expenses, income tax provisions, stock-based compensation, leases, derivative financial instruments, inventory, and useful lives of long-lived assets. We base our estimates on historical experience and various relevant assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The actual results that we experience may differ materially from our estimates. Significant estimates relied upon in preparing these financial statements include, among others, those related to fair value of equity awards, revenue recognition, research and development expenses, leases, fair value of financial instruments, useful lives of property and equipment, income taxes, and our valuation allowance on our deferred tax assets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">We have determined that our chief executive officer is the chief operating decision maker (CODM). The CODM reviews financial information presented on a consolidated basis. Resource allocation decisions are made by the CODM based on consolidated results. There are no segment managers who are held accountable by the CODM for operations, operating results, and planning for levels or components below the consolidated unit level. As such, we have concluded that we operate as one segment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2019, we adopted ASC 606&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) using the modified retrospective transition method applied to those contracts which were not completed as of January 1, 2019. We recognized the cumulative effect of the adoption as an adjustment to the opening balance of accumulated deficit in the current period consolidated balance sheet. Results for reporting periods beginning after January 1, 2019 are presented under ASC 606, while prior period amounts have not been adjusted and continue to be reported in accordance with our historic accounting (ASC 605). ASC 606 applies to all contracts with customers, except for contracts that are within the scope of other standards, such as leases, insurance, collaboration arrangements and financial instruments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the appropriate amount of revenue to be recognized for arrangements that we determine are within the scope of ASC 606, we perform the following five steps (the five-step model): (i) identify the contract(s) with our customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when or as each performance obligation is satisfied. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is primarily generated through grants from government-sponsored and private organizations, product sales and collaboration arrangements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Grant Revenue</span></div><div style="padding-right:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have contracts with Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS); the U.S. government&#8217;s Defense Advanced Research Projects Agency (DARPA); the Bill &amp; Melinda Gates Foundation (Gates Foundation) and other government-sponsored and private organizations for research and development related activities that provide for payments for reimbursed costs, which may include overhead and general and administrative costs as well as a related profit margin. We recognize revenue from these contracts as we perform services under these arrangements when the funding is committed. Associated expenses are recognized when incurred as research and development expense. Revenues and related expenses are presented gross in the consolidated statements of operations as we have determined we are the primary obligor under the arrangements relative to the research and development services we perform as lead technical expert.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Collaboration Revenue</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for a contract with a customer that is within the scope of ASC 606 using the five-step model. We account for a contract with a customer that is within the scope of ASC 606 when all of the following criteria are met: (i) the arrangement has been approved by the parties and the parties are committed to perform their respective obligations; (ii) each party&#8217;s rights regarding the </span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goods and/or services to be transferred can be identified; (iii) the payment terms for the goods and/or services to be transferred can be identified; (iv) the arrangement has commercial substance; and (v) collection of substantially all of the consideration to which we will be entitled in exchange for the goods and/or services that will be transferred to the customer is probable. We also determine the term of the contract based on the period in which we and our customer have present and enforceable rights and obligations for purposes of identifying the performance obligations and determining the transaction price.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate contracts that contain multiple promises to determine which promises are distinct. Promises are considered to be distinct and therefore, accounted for as separate performance obligations, provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer and (ii) the promise to transfer the good or service to the customer is separately identifiable from other promises in the contract.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual goods or services (or bundles of goods and/or services) that meet both criteria for being distinct are accounted for as separate performance obligations. Promises that are not distinct at contract inception are combined and accounted for as a single performance obligation. Options to acquire additional goods and/or services are evaluated to determine if such option provides a material right to the customer that it would not have received without entering into the contract. If so, the option is accounted for as a separate performance obligation. If not, the option is considered a marketing offer which would be accounted for as a separate contract upon the customer&#8217;s election.</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is generally comprised of an upfront payment due at contract inception and variable consideration in the form of payments for our services and materials and milestone payments due upon the achievement of specified events. Other payments the Company could be entitled to include tiered royalties earned when customers recognize net sales of licensed products.&#160;We measure the transaction price based on the amount of consideration to which we expect to be entitled in exchange for transferring the promised goods and/or services to the customer. We utilize either the expected value method or the most likely amount method to estimate the amount of variable consideration, depending on which method is expected to better predict the amount of consideration to which we will be entitled. Amounts of variable consideration are included in the transaction price to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to arrangements that include payments for a development or regulatory milestone payment, we evaluate whether the associated event is considered probable of achievement and estimate the amount to be included in the transaction price using the most likely amount method. Milestone payments that are not within our control or the licensee, such as those dependent upon receipt of regulatory approval, are not considered to be probable of achievement until the triggering event occurs. At the end of each reporting period, we re-evaluate the probability of achievement of each milestone and any related constraint, and if necessary, adjust our estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment. For arrangements that include sales-based royalties, including milestone payments based upon the achievement of a certain level of product sales, wherein the license is deemed to be the sole or predominant item to which the payments relate, we recognize revenue upon the later of: (i) when the related sales occur or (ii) when the performance obligation to which some or all of the payment has been allocated has been satisfied (or partially satisfied). Consideration that would be received for optional goods and/or services is excluded from the transaction price at contract inception. </span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally allocate the transaction price to each performance obligation based on a relative standalone selling price basis. We develop assumptions that require judgment to determine the standalone selling price for each performance obligation in consideration of applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated research and development costs. However, in certain instances, we allocate variable consideration entirely to one or more performance obligation if the terms of the variable consideration relate to the satisfaction of the respective performance obligation and the amount allocated is consistent with the amount we would expect to receive for the satisfaction of the respective performance obligation.</span></div><div style="padding-right:9pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue based on the amount of the transaction price that is allocated to each respective performance obligation when or as the performance obligation is satisfied by transferring a promised good or service to the customer. For performance obligations that are satisfied at a point in time, we recognize revenue when control of the goods and/or services is transferred to the customer. For performance obligations that are satisfied over time, we recognize revenue by measuring the progress toward complete satisfaction of the performance obligation using a single method of measuring progress which depicts the performance in transferring control of the associated goods and/or services to the customer. We generally use input methods to measure the progress toward the complete satisfaction of performance obligations satisfied over time. With respect to arrangements containing a license to our intellectual property that is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from amounts allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. For licenses that are bundled with other promises, we utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. Significant management judgment is required in </span></div>determining the level of effort required under an arrangement and the period over which we are expected to complete our performance obligations under an arrangement. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenue and net loss in the period of adjustment.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents</a></td>
<td class="text">We consider all highly liquid investments with an original maturity of 90&#160;days or less from the date of purchase to be cash equivalents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text">Restricted cash is composed of amounts held on deposit related to our lease arrangements. The funds are maintained in money market accounts and are recorded at fair value. We classify our restricted cash as either current or non-current based on the terms of the underlying lease arrangement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Investments</a></td>
<td class="text">We invest our excess cash balances in marketable debt securities. We classify our investments in marketable debt securities as available-for-sale. We report available-for-sale investments at fair value at each balance sheet date, and include any unrealized holding gains and losses (the adjustment to fair value) in accumulated other comprehensive gain (loss), a component of stockholders&#8217; equity. Realized gains and losses are determined using the specific-identification method, and are included in other (expense) income, net in our consolidated statements of operations. We classify our available-for-sale marketable securities as current or non-current based on each instrument&#8217;s underlying effective maturity date and for which we have the intent and ability to hold the investment for a period of greater than 12 months. Marketable securities with maturities of less than 12&#160;months are classified as current and are included in investments in the consolidated balance sheets. Marketable securities with maturities greater than 12&#160;months for which we have the intent and ability to hold the investment for greater than 12 months are classified as non-current and are included in investments, non-current in the consolidated balance sheets.We evaluate securities for impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and our intent and ability to hold the investment to allow for an anticipated recovery in fair value. A credit-related impairment is recognized as an allowance on the balance sheet with a corresponding adjustment to earnings. Any impairment that is not credit- related is recognized in other comprehensive (loss) income, net of applicable taxes.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text">We have accounts receivable amounts due from our product sales and related vaccine supply agreements and our grant agreements. We also have accounts receivable amounts due from strategic collaborators as a result of manufacturing and research and development services provided under collaboration arrangements, or milestones achieved, but not yet paid. Amounts payable to us are recorded as accounts receivable when our right to consideration is unconditional. To estimate the allowance for doubtful accounts, we make judgments about the creditworthiness of our customers based on ongoing credit evaluation and historical experience.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text">Financial instruments that subject us to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, marketable securities, and accounts receivable. Our investment portfolio comprises money market funds, marketable debt securities, including U.S. Treasury securities, debt securities of U.S. government agencies and corporate entities and commercial paper. Our cash management and investment policy limits investment instruments to investment-grade securities with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations. Bank accounts in the United States are insured by the Federal Deposit Insurance Corporation (FDIC) up to $250,000. Our primary operating accounts significantly exceed the FDIC limits.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorCustomersPolicyPolicyTextBlock', window );">Significant Customers</a></td>
<td class="text">Our accounts receivable are generally unsecured and are from customers in different countries. We generated revenue from grants made by government-sponsored and private organizations, product sales to the U.S. Government and international government agencies, and to a lesser extent, strategic alliances in 2020. Historically, we generated revenue primarily from strategic alliances.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text">We record all derivatives on our consolidated balance sheets at fair value. The accounting for changes in the fair value of a derivative depends on whether the derivative has been designated and qualifies for hedge accounting. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. We may enter into derivative contracts that are intended to economically hedge certain risk, even though hedge accounting does not apply or we elect not to apply hedge accounting. Foreign currency gains or losses associated with derivatives that are not designated as hedging instruments for accounting purposes are recorded within other (expense) income, net, in our consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as risks inherent in valuation techniques, transfer restrictions and credit risk. FASB ASC Topic&#160;820,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC&#160;820), establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and our assumptions (unobservable inputs). Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from our independent sources. Unobservable inputs are inputs that reflect our assumptions about the inputs that market participants would use in pricing the asset or liability, and are developed based on the best information available in the circumstances. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used to value the assets and liabilities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level&#160;2: Quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; or</span></div><div style="padding-left:54pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e.,&#160;supported by little or no market activity).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash equivalents and marketable securities are reported at fair value determined using Level&#160;1 and Level&#160;2 inputs (Note&#160;6). The fair value of our foreign currency forward contracts is calculated using Level 2 inputs, which include currency spot rates, forward rates, interest rate curve and credit or non-performance risk (Note 7). We do not have any non-financial assets or liabilities that should be recognized or disclosed at fair value on a recurring basis at December 31, 2020, 2019 and 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and 2019, we maintain letters of credit of $12.1 million and $11.8 million, respectively, related to our lease arrangements, which are secured by money market accounts in accordance with certain of our lease agreements. The amounts are recorded at fair value using Level 1 inputs and included as restricted cash in our consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is recorded at the lower of cost or net realizable value, with cost determined on a first-in, first-out (FIFO) basis. We periodically review the composition of inventory in order to identify excess, obsolete, slow-moving or otherwise unsaleable items. If unsaleable items are observed and there are no alternate uses for the inventory, we will record a write-down to net realizable value in the period that the decline in value is first recognized through a charge to cost of sales. The determination of whether inventory costs will be realizable requires estimates by management. If actual market conditions are less favorable than projected by management, additional write-downs of inventory may be required.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to an initial regulatory approval for our investigational medicines, we expense costs relating to raw materials and production of inventory as research and development expense in our consolidated statements of operations, in the period incurred. When we believe regulatory approval and subsequent commercialization of our investigational medicines is probable, and we also expect future </span></div>economic benefit from the sales of the investigational medicines to be realized, we will then capitalize the costs of production as inventory. Upon the authorization of distribution and use of our COVID-19 vaccine under an EUA in December 2020, we began to capitalize inventory costs associated with our COVID-19 vaccine, as it was determined that inventory costs incurred subsequent to the EUA had a probable future economic benefit.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Construction in Progress and Property and Equipment</a></td>
<td class="text">Construction in progress includes direct costs related to the construction of various property and equipment, including leasehold improvements, and is stated at original cost. Construction in progress includes costs incurred under construction contracts including project management services, engineering services, design services and development, construction services and other construction-related fees and services. Such costs are not depreciated until the asset is completed and placed into service. Once the asset is placed into service, these capitalized costs will be allocated to certain property and equipment categories and will be depreciated over the estimated useful life of the underlying assets. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of property and equipment are described below:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:48.552%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.553%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Useful&#160;Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lesser&#160;of&#160;estimated&#160;useful&#160;life&#160;of&#160;improvement</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or&#160;remaining life of related lease</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset, financing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease term</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for maintenance and repairs are charged to expense as incurred. Upon retirement or sale, the cost of the assets disposed of, and the related accumulated depreciation, are removed from the accounts, and any resulting gain or loss is recorded to other (expense) income, net.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">We evaluate our long-lived assets, which consist of property and equipment, to determine if facts and circumstances indicate that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess the recoverability of the long-lived assets by comparing the projected future undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. If such review indicates that such cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair values based on the expected discounted future cash flows attributable to the assets or based on appraisals.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted ASC 842 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) on January 1, 2019 on a modified retrospective basis under which we recognized and measured leases existing at, or entered into after, the beginning of the period of adoption. We elected the optional transition approach of not adjusting our comparative period financial statements for the impacts of adoption. Therefore, we recognized the effects of applying ASC 842 as a cumulative-effect adjustment to accumulated deficit as of January 1, 2019, the effective date of this standard. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases are classified at their commencement date, which is defined as the date on which the lessor makes the underlying asset available for use by the lessee, as either operating or finance leases based on the economic substance of the agreement. We recognize lease right-of-use assets and related liabilities in our consolidated balance sheets for both operating and finance leases. Lease liabilities are measured at the lease commencement date as the present value of the future lease payments using the interest rate implicit in the </span></div>lease. If the rate implicit is not readily determinable, we will utilize our incremental borrowing rate as of the lease commencement date. Lease right-of-use assets are measured as the lease liability plus initial direct costs and prepaid lease payments less lease incentives. The lease term is the non-cancelable period of the lease and includes options to extend or terminate the lease when it is reasonably certain that an option will be exercised. We recognize operating lease cost in operating expense in our consolidated statements of operations, inclusive of rent escalation provisions and rent holidays, on a straight-line basis over the respective lease term. For our finance leases, we recognize depreciation expense associated with the leased asset acquired and recognize interest expense related to the portion of the financing in our consolidated statements of operations. Additionally, we recognize tenant improvement allowances as a reduction to rent expense on a straight-line basis over the respective lease term.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text">Cost of sales includes cost of raw materials, production, transportation, freight and indirect overhead costs associated with our product revenue during the period and third-party royalties on net sales of our product. Cost of sales also includes adjustments for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses consist of costs incurred in performing research and development activities, including salaries and benefits, facilities costs, overhead costs, prelaunch inventory costs, contract services, and other outside costs. The value of goods and services received from contract research organizations and contract manufacturing organizations in the reporting period are estimated based on the level of services performed, and progress in the period in cases when we have not received an invoice from the supplier. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment or facilities that are acquired or constructed for research and development activities and that have alternative future uses, in research and development projects or otherwise, should be capitalized and depreciated as tangible assets. However, the costs of equipment or facilities that are acquired or constructed and intangibles that are purchased from others for a particular research and development project and that have no alternative future uses and therefore no separate economic values are considered research and development costs and are expensed when incurred. Certain equipment and leased facilities purchased for our COVID-19 vaccine program prior to the EUA from the FDA were deemed to have no alternative use. The related acquisition costs of such equipment and lease facilities of $109.6&#160;million were charged to research and development expense for the year ended December 31, 2020. We did not recognize such expense for the years ended December 31, 2019 or 2018.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_PatentCostsPolicyPolicyTextBlock', window );">Patent Costs</a></td>
<td class="text">Costs to secure, defend and maintain patents are expensed as incurred, and are classified as selling, general and administrative expenses due to the uncertainty of future benefits.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issue stock-based awards to employees and non-employees, generally in the form of stock options and restricted stock units (RSUs). We account for our stock-based compensation awards in accordance with ASC 718,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Compensation&#8212;Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Most of our stock-based awards have been made to employees. We measure compensation cost for equity awards at their grant-date fair value and recognize compensation expense over the requisite service period, which is generally the vesting period, on a straight-line basis. The grant date fair value of stock options is estimated using the Black-Scholes option pricing model, which requires management to make assumptions with respect to the fair value of our common stock on the grant date, including the expected term of the award, the expected volatility of our stock, calculated based on a period of time generally commensurate with the expected term of the award, risk-free interest rates and expected dividend yields of our stock. Historically, for periods prior to our IPO, the fair value of the shares of common stock and common units underlying our stock-based awards were determined on each grant date by our board of directors based on valuation estimates from management considering our most recently available independent third-party valuation of our common stock. Our board of directors also assessed and considered, with input from management, additional objective and subjective factors that we believed were relevant and which may have changed from the date of the most recent valuation through the grant date. The grant date fair value of RSUs is estimated based on the fair value of our underlying common stock. For performance-based stock awards, we recognize stock-based compensation expense over the requisite service period using the accelerated attribution method when achievement is probable. We classify stock-based compensation expense in our consolidated statement of operations in the same manner in which the award recipient&#8217;s salary and related costs are classified or in which the award recipient&#8217;s service payments are classified.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">We use an asset and liability approach to account for income taxes. We recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. These differences are measured using the enacted statutory tax rates that are expected to be in effect for the years in which differences are expected to reverse. Valuation allowances are provided when the expected realization of deferred tax assets does not meet a &#8220;more likely than not&#8221; criterion. We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans and estimates. Should the actual amounts differ from our estimates, the amount of our valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to our tax provision in a period in which such estimates are changed, which in turn would affect net income or loss. We recognize tax benefits from uncertain tax positions if we believe the position is more likely than not to be sustained on examination by the taxing authorities based on the technical merits of the position. We make adjustments to these reserves when facts and circumstances change, such as the closing of a tax audit or the refinement of an estimate. The provision for income taxes includes the effects of any reserves for tax positions that are not more likely than not to be sustained, as well as the related net interest and penalties.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share Attributable to Common Stockholders</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding for the period, without consideration for common stock equivalents. Upon the closing of our IPO, all outstanding shares of our redeemable convertible preferred stock were converted into common stock. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate diluted net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding after giving consideration to the dilutive effect of restricted common stock and stock options that are outstanding during the period. We have generated a net loss in all periods presented, therefore the basic and diluted net loss per share attributable to common stockholders are the same as the inclusion of the potentially dilutive securities would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive loss includes net loss and other comprehensive income (loss) for the period. Other comprehensive income (loss) mainly consists of unrealized gains and losses on our investments. Total comprehensive income (loss) for all periods presented have been disclosed in the consolidated statements of comprehensive loss.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standards/Recently Issued Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard changes how companies account for credit losses for most financial assets and certain other instruments. For trade receivables, loans and held-to-maturity debt securities, companies will be required to recognize an allowance for credit losses rather than reducing the carrying value of the asset. The amendments in this standard should be applied on a modified retrospective basis to all periods presented. We adopted this standard in the first quarter of 2020. Based on the composition of our investment portfolio and investment policy, the adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other&#8212;Internal-Use Software (Topic 350): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard requires capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). We adopted this standard in the first quarter of 2020 using the prospective method. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard removes certain exceptions for investments, intra-period allocations and interim calculations, and adds guidance to reduce complexity in accounting for income taxes. We early adopted this standard in the second quarter of 2020. The adoption of this standard did not have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, we believe that the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial statements and disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PatentCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Patent Costs, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PatentCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorCustomersPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorCustomersPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937469288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Reconciliation of Cash and Cash Equivalents</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, non-current </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash shown in the consolidated<br/>    statements of cash flows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,635,935&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Reconciliation of Restricted Cash</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents and restricted cash in the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.521%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, non-current </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash shown in the consolidated<br/>    statements of cash flows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,635,935&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Entities that Accounted for More than 10% of Total Revenue and Accounts Receivable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our revenue to date has been generated from the following entities that accounted for more than 10% of total revenue and accounts receivable for the periods presented:</span></div><div style="padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:50.153%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.813%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage&#160;of&#160;Revenue</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years&#160;Ended&#160;December&#160;31,</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Percentage&#160;of&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accounts&#160;Receivable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Government (excluding BARDA)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Commission</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom Government</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea Government</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">* - Represents an amount of less than 10%</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Estimated Useful Lives of Property and Equipment</a></td>
<td class="text">The estimated useful lives of property and equipment are described below:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:48.552%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.553%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Useful&#160;Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lesser&#160;of&#160;estimated&#160;useful&#160;life&#160;of&#160;improvement</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or&#160;remaining life of related lease</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset, financing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease term</span></td></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, financing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,495&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive gain (loss) for the years ended December 31, 2020 and 2019 are as follows (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized&#160;Gain on Available-for-Sale Debt Securities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss, balance at December 31, 2018</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,320)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive gain, balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive gain, balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865389816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Grant Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following tables summarize grant revenue and deferred grant revenue for and as of the periods presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total grant revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total consolidated net revenue from our strategic collaborators for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collaboration Revenue by Strategic Collaborator:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,618&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,036&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under ASC 605</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined AZ Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue and contra-revenue recognized for the periods presented (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contra-revenue under the May 2019 Amendment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue under the 2015 Merck Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contra-revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,026)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,773)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865321432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Sales (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales by customer geographic location was as follows (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue by geographic area of our customers and collaboration partners was as follows (in thousands): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,075&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937676712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following tables summarize grant revenue and deferred grant revenue for and as of the periods presented (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BARDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521,652&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other grant revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total grant revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our total consolidated net revenue from our strategic collaborators for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Collaboration Revenue by Strategic Collaborator:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merck</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,082&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,437&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,618&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,036&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,512&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under ASC 605</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined AZ Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue and contra-revenue recognized for the periods presented (in thousands):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contra-revenue under the May 2019 Amendment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,088)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,265)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue under the 2015 Merck Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contra-revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,026)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,773)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Changes in Balances of Receivables and Contract Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the balances of our receivables and contract liabilities related to our strategic collaboration agreements during the year ended December&#160;31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, we recognized the following revenue as a result of the change in the contract liability balances related to our collaboration agreements (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.305%"><tr><td style="width:1.0%"/><td style="width:65.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.706%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue recognized in the period from:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended <br/>December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in contract liabilities at the beginning of the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance obligations satisfied (or partially satisfied) in previous reporting periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">______________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We first allocate revenue to the individual contract liability balance outstanding at the beginning of the period until the revenue exceeds that balance. If additional consideration is received on those contracts in subsequent periods, we assume all revenue recognized in the reporting period first applies to the beginning contract liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Related to changes in estimated costs for our future performance obligations and estimated variable considerations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined AZ Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.986%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.986%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV/SAV Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue, which is classified as current or non-current in the condensed consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV/SAV Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex First Extended Research Term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex Agreement/2019 Amendment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,505&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,197&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue, classified as current and non-current in the condensed consolidated balance sheets based on the term of the research period for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex Agreement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">____________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance as of December 31, 2019 represents deferred revenue related to the Vertex 2019 Amendment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activities in deferred revenue during the year ended December&#160;31, 2020 (in thousands): </span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,881,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,799,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,305&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,009,960&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,653)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,044,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock', window );">Summary of Composition of the Total Transaction</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Combined 2018 AZ Agreements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublicense reimbursement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Toxicity milestone payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Competition milestone payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated reimbursement for IL-12 manufacturing obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,830&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,782&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.652%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2016 VEGF Exercise:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Option exercise fee </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milestone payment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublicense reimbursement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated reimbursement for clinical supply</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">2015 Merck Agreement:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reduction of reimbursements paid to Merck</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,353)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,265)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,647&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-right:6.75pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">PCV/SAV Agreement:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium associated with the contemporaneous sale of Series H redeemable convertible preferred stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reimbursement for clinical supply</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,360&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,050&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the First Extended Research Term at December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:84.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Vertex Agreement - First Extended Research Term:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,798&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the composition of the total transaction price for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:84.435%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chiesi Agreement:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upfront payment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,496&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Summary of Total Transaction Price to the Identified Performance Obligations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Combined 2018 AZ Agreements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined 2018 AZ Agreement performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical development service - IL-12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical development service - oncology development target</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and commercialization license and manufacturing obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Material right to receive development and commercialization rights</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,225&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total transaction price allocated to the single performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise combined performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total transaction price allocated to the combined performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Merck Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the allocation of the total transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-right:6.75pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">PCV/SAV Agreement:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV performance obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KRAS performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,360&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,007&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total transaction price allocated to the single performance obligation under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Extended Research Term transaction price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the transaction price to the identified performance obligations under the arrangement, and the amount of the transaction price unsatisfied as of December 31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Transaction Price</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chiesi Agreement transaction price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,496&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining unsatisfied performance obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42567-110969<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937421688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Summary of Cash and Available-for-Sale Securities by Significant Investment Category</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our cash and available-for-sale securities by significant investment category at December 31, 2020 and 2019 (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.212%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,623,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,623,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,623,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">238,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,888,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,892,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,276,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">615,418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,242,194&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246,456&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,623,850&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,983,758&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">638,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="45" style="padding:0 1pt"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cash</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Equivalents</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Non-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Current</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Marketable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available-for-sale:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">834,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">836,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,259,980&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,047&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,262,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,876&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">867,124&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">159,987&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Amortized Cost and Estimated Fair Value of Marketable Securities, by Contractual Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and estimated fair value of marketable securities, by contractual maturity at December 31, 2020 and 2019 are as follows (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,980,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,983,758&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637,382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638,848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,618,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,622,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in one year or less</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867,124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,148&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,987&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024,106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027,111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock', window );">Schedule of Unrealized Loss on Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amount of gross unrealized losses and the estimated fair value for our available-for-sale securities in an unrealized loss position by length of time the securities have been in an unrealized loss position at December 31, 2020 and 2019 (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 Months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December 31, 2019:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Financial Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our financial assets measured at fair value on a recurring basis as of December 31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement Using</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments (Note 7)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,243,846&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,622,899&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurement Using</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities of U.S. government agencies and corporate entities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619866093480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule Of Foreign Currency Derivatives</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross notional amount and fair value for foreign currency derivatives that are not designated as hedging instruments are accounted for as follows (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,448&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">_________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As presented in the consolidated balance sheet within other current assets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The effect of foreign currency forward contracts not designated as hedging instruments in our consolidated statements of operations for the year ended December 31, 2020 was as follows (in thousand):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:56.062%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.773%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.773%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Statement of Operations Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended<br/> December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865884632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of December 31, 2020 consists of the following (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:60.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619866071800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text">The estimated useful lives of property and equipment are described below:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:48.552%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.553%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated&#160;Useful&#160;Life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lesser&#160;of&#160;estimated&#160;useful&#160;life&#160;of&#160;improvement</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or&#160;remaining life of related lease</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset, financing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease term</span></td></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,257&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internally developed software</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset, financing</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,079&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,661)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94,584)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,889&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,495&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865513912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Down payments to manufacturing vendors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant incentives receivables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable on marketable securities</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,403&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands): </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"><tr><td style="width:1.0%"/><td style="width:73.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.119%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation-related</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external goods and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469,591&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,652&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Current Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities, as of December 31, 2020 and 2019 consists of the following (in&#160;thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"><tr><td style="width:1.0%"/><td style="width:73.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.119%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities - financing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities - operating</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,665&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,063&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Deferred Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents changes in the balances of our receivables and contract liabilities related to our strategic collaboration agreements during the year ended December&#160;31, 2020 (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, we recognized the following revenue as a result of the change in the contract liability balances related to our collaboration agreements (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.305%"><tr><td style="width:1.0%"/><td style="width:65.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.706%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue recognized in the period from:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended <br/>December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts included in contract liabilities at the beginning of the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance obligations satisfied (or partially satisfied) in previous reporting periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">______________</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We first allocate revenue to the individual contract liability balance outstanding at the beginning of the period until the revenue exceeds that balance. If additional consideration is received on those contracts in subsequent periods, we assume all revenue recognized in the reporting period first applies to the beginning contract liability.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Related to changes in estimated costs for our future performance obligations and estimated variable considerations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Combined AZ Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,192&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.986%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue at period end, which is classified as current or non-current in the consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 VEGF Exercise</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,266&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.986%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV/SAV Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue, which is classified as current or non-current in the condensed consolidated balance sheets based on the period the services are expected to be performed or control of the supply is expected to be transferred for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.066%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PCV/SAV Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the revenue recognized for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex First Extended Research Term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex Agreement/2019 Amendment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,505&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,197&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the balances of deferred revenue, classified as current and non-current in the condensed consolidated balance sheets based on the term of the research period for the periods presented (in thousands):</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.927%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vertex Agreement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">____________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Balance as of December 31, 2019 represents deferred revenue related to the Vertex 2019 Amendment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activities in deferred revenue during the year ended December&#160;31, 2020 (in thousands): </span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,881,303&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,799,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,305&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,009,960&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,653)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,044,612&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937136424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock', window );">Assets and Lease Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating and financing lease right-of-use assets and lease liabilities as of December 31, 2020 and 2019 were as follows (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, operating, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, financing, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) (4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,544&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,246&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,958&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_509b73a1-344b-43fb-b968-8722c1c25a5e"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzktMC0xLTEtMTk1OTc_72c4555a-bb44-4abb-b6c7-1be6c51005ca"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:-22.51pt"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_2a800648-bfb3-4584-a0d1-7572b92f5809"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmFjN2YzY2U4NDY1YjQzMzBhMzBmMGZjOWY0Mjc5YzIwL3NlYzphYzdmM2NlODQ2NWI0MzMwYTMwZjBmYzlmNDI3OWMyMF8xNjMvZnJhZzpmMTJlODdkOTcwNzc0NjFhOTI4NDc3MjVkMjAwYzc4Ni90YWJsZTo4NzI1ZTYzMDBjMWU0MDEyYWQxZjZmZGMwYjRiODBjZC90YWJsZXJhbmdlOjg3MjVlNjMwMGMxZTQwMTJhZDFmNmZkYzBiNGI4MGNkXzEwLTAtMS0xLTE2OTYw_5ef609f9-9865-4708-ad5f-c12a24e8246f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current lease liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,583&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease liabilities, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,295&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,595&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,947&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are real estate related assets, which include land, office and laboratory spaces.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net of accumulated depreciation. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are&#160;real estate assets related to the MTC North and MTC South leases. </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in property and equipment in the consolidated balance sheets, net of accumulated depreciation.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in other current liabilities in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of the lease costs for the year ended December 31, 2020 and 2019 were as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.888%"><tr><td style="width:1.0%"/><td style="width:72.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.119%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.120%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of right-of-use assets, financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense for financing lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financing lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,902&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,322&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information relating to our leases for the year ended December 31, 2020 and 2019 was as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used in operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows used in financing leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Financing cash flows used in financing leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,519)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease non-cash items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets reduced through lease modifications and reassessments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,717&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease non-cash items:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained through lease modifications and reassessments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge to financing lease obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease terms and discount rates as of December 31, 2020 were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining lease term:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable lease agreements as of&#160;December&#160;31, 2020, were as follows (in&#160;thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amounts representing interest or imputed interest </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Include the optional extensions in the MTC North and MTC South lease terms which represent a total of $338.9 million un-discounted future lease payments. </span></div>(2)  MTC South interest is based on an imputed interest rate of 17.2%. MTC North interest is based upon an incremental borrowing rate of 8.2%.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating Lease Maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments under non-cancelable lease agreements as of&#160;December&#160;31, 2020, were as follows (in&#160;thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.442%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,579&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less amounts representing interest or imputed interest </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(379,110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,393&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Include the optional extensions in the MTC North and MTC South lease terms which represent a total of $338.9 million un-discounted future lease payments. </span></div>(2)  MTC South interest is based on an imputed interest rate of 17.2%. MTC North interest is based upon an incremental borrowing rate of 8.2%.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937372536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock', window );">Options Activity</a></td>
<td class="text">The following table summarizes our option activity as of December 31, 2020 and 2019:<div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Options</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Price per</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Share</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Grant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date Fair</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value per</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Share</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Remaining</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Contractual</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Term</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Intrinsic</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline"> (1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in&#160;thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,536,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,036,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,888,434)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/forfeited</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,627,468)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,057,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,976,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,461,374&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,596,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,343,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of common stock for those options in the money as of December 31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Restricted Common Stock Units Activity</a></td>
<td class="text">The following table summarizes our restricted stock unit activity during the year ended December 31, 2020:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:72.335%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">per Unit</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, non-vested at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.01&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled/forfeited</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215,033)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, non-vested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192,960&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted</a></td>
<td class="text">The weighted-average assumptions used to estimate the fair value of options granted and ESPP for the&#160;years ended December 31, 2020, 2019 and 2018 are as follows:<div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.986%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years&#160;Ended&#160;December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Risk-free interest rate</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Expected term</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.11 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.07 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.27 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Expected volatility</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Expected dividends</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Weighted average fair value per share</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividends</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value per share</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________</span></div>* - Not applicable<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components and classification of stock-based compensation expense for the&#160;years ended December 31, 2020, 2019 and 2018 as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years&#160;Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,748&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,780&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted common stock and units</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,021&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,155&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,259&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,659&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,021&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,122&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,565&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937880536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Loss Before Provision For (Benefit From) Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before provision for (benefit from) income taxes for the years ended December 31, 2020, 2019 and 2018 consist of the following (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:67.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(745,445)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(508,595)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(380,473)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744,513)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,716)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384,408)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision For (Benefit From) Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for (benefit from) income taxes for the years ended December 31, 2020, 2019 and 2018 consist of the following components (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:67.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,200)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(695)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of U.S. Statutory Income Tax Rate to Effective Tax Rate</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the U.S. statutory income tax rate to our effective tax rate for the years ended December 31, 2020, 2019 and 2018 are as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:67.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.067%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effected at statutory rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes, net of federal benefit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal research and development credits</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign tax rate differential</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation windfall</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Significant Components of Deferred Tax Assets and Tax Liabilities</a></td>
<td class="text"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant components of our deferred tax assets and tax liabilities as of December 31, 2020 and 2019 are as follows (in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:77.898%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.055%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carry-forwards</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,978&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized licenses, research and development and start-up costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carry-forwards</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease financing obligation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gross deferred tax assets</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,268&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(470,753)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets, net of valuation allowance</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,677&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,515&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing right-of-use assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,539)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,612)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating right-of-use assets</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,944)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,959)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50,677)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,515)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text">A reconciliation of the beginning and ending amounts of unrecognized tax benefits during the years ended December 31, 2020 and 2019 are as follows (in&#160;thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to prior positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year tax position</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease due to prior positions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase due to current year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937862120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic and Diluted Net Loss per Share Attributable to Common Stockholders</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2020, 2019 and 2018 are calculated as follows (in thousands, except share and per share data):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:61.208%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.002%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747,064)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,021)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium paid on repurchase of redeemable convertible preferred stock</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative dividends on redeemable convertible preferred stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(747,064)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514,021)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(401,857)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381,333,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,802,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,114,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.96)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.55)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.95)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents, presented based on amounts outstanding as of December 31, 2020, 2019 and 2018 were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because their inclusion would have been anti-dilutive:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.493%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.860%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,057,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,536,915&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,821,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted common stock</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted common stock units</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,192,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177,249&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,250,493&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,714,164&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,478,444&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619866001720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product sales by customer geographic location was as follows (in thousands): </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,630&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue by geographic area of our customers and collaboration partners was as follows (in thousands): </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,075&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803,395&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,068&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936104504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 21, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 14, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>program</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Operating losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 747,064<span></span>
</td>
<td class="nump">$ 514,021<span></span>
</td>
<td class="nump">$ 384,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares of common stock issued (in shares) | shares</a></td>
<td class="nump">17,600,000<span></span>
</td>
<td class="nump">30,263,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (usd per share) | $ / shares</a></td>
<td class="nump">$ 76.00<span></span>
</td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate net proceeds from the offering</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 549,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,243,518<span></span>
</td>
<td class="nump">$ 1,496,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_NumberOfDevelopmentProgram', window );">Development programs | program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_NumberOfDevelopmentProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Development Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_NumberOfDevelopmentProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619939880920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Accounting Policies Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment expenses</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,370,339,000<span></span>
</td>
<td class="nump">496,309,000<span></span>
</td>
<td class="nump">454,082,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mrna_EquipmentAndLeasedFacilitiesMember', window );">Equipment and Leased Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 109,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Marketable securities maturity term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTerm', window );">Marketable securities maturity term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit</a></td>
<td class="nump">$ 12,100,000<span></span>
</td>
<td class="nump">$ 11,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mrna_EquipmentAndLeasedFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mrna_EquipmentAndLeasedFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937013400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,623,850<span></span>
</td>
<td class="nump">$ 235,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">1,032<span></span>
</td>
<td class="nump">1,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, non-current</a></td>
<td class="nump">11,053<span></span>
</td>
<td class="nump">10,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows</a></td>
<td class="nump">$ 2,635,935<span></span>
</td>
<td class="nump">$ 247,699<span></span>
</td>
<td class="nump">$ 670,491<span></span>
</td>
<td class="nump">$ 147,608<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936783640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Significant Customers (Details) - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue | Merck</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue | BARDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue | Vertex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue | AstraZeneca</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue | U.S. Government (excluding BARDA)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Merck</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | BARDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">54.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Vertex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | European Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | United Kingdom Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | South Korea Government</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_MerckMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_MerckMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_VertexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_VertexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_AstraZenecaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_AstraZenecaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_USGovermentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_USGovermentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_EuropeanCommissionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_EuropeanCommissionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_UnitedKingdomGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_UnitedKingdomGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_SouthKoreaGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_SouthKoreaGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936742632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Property and Equipment and Software Capitalization (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated&#160;Useful&#160;Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated&#160;Useful&#160;Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated&#160;Useful&#160;Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentOtherTypesMember', window );">Furniture, fixtures and other</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated&#160;Useful&#160;Life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentOtherTypesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentOtherTypesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619938178664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Components of Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="nump">$ 1,174,810<span></span>
</td>
<td class="nump">$ 1,530,241<span></span>
</td>
<td class="num">$ (551,365)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">3,124<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="nump">2,561,375<span></span>
</td>
<td class="nump">1,174,810<span></span>
</td>
<td class="nump">1,530,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized&#160;Gain on Available-for-Sale Debt Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period</a></td>
<td class="nump">1,804<span></span>
</td>
<td class="num">(1,320)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">3,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period</a></td>
<td class="nump">$ 3,004<span></span>
</td>
<td class="nump">$ 1,804<span></span>
</td>
<td class="num">$ (1,320)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619934581000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Grant Revenue (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2016 </div>
<div>USD ($) </div>
<div>contract_option</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsNumberOfContractOptions', window );">Number of contract options | contract_option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 803,395<span></span>
</td>
<td class="nump">$ 60,209<span></span>
</td>
<td class="nump">$ 135,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,044,612<span></span>
</td>
<td class="nump">202,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">528,905<span></span>
</td>
<td class="nump">12,173<span></span>
</td>
<td class="nump">12,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,261<span></span>
</td>
<td class="nump">2,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember', window );">BARDA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsMaximumAward', window );">Award amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 483,300<span></span>
</td>
<td class="nump">$ 125,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Other Commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 471,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsCurrentFundingCapacity', window );">Amount committed for funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">444,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsNumberOfContractOptionsExercised', window );">Number of contract options exercised | contract_option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember', window );">BARDA | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsMaximumAward', window );">Award amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember', window );">BARDA | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsMaximumAward', window );">Award amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">954,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember', window );">BARDA | Contract options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsRemainingFundingCapacity', window );">Available funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsCurrentFundingCapacity', window );">Amount committed for funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember', window );">BARDA | Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521,652<span></span>
</td>
<td class="nump">7,608<span></span>
</td>
<td class="nump">6,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=mrna_DefenseAdvancedResearchProjectsAgencyMember', window );">DARPA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsMaximumAward', window );">Award amount</a></td>
<td class="nump">$ 56,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=mrna_DefenseAdvancedResearchProjectsAgencyMember', window );">DARPA | Contract options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsRemainingFundingCapacity', window );">Available funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsCurrentFundingCapacity', window );">Amount committed for funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=mrna_TheBillAndMelindaGatesFoundationMember', window );">The Bill&#160;&amp; Melinda Gates Foundation | Initial project</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RevenueFromGrantsRemainingFundingCapacity', window );">Available funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=mrna_OtherGrantRevenueMember', window );">Other Grant Revenue | Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,253<span></span>
</td>
<td class="nump">$ 4,565<span></span>
</td>
<td class="nump">$ 5,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_RevenueFromGrantsCurrentFundingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Grants, Current Funding Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_RevenueFromGrantsCurrentFundingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_RevenueFromGrantsMaximumAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Grants, Maximum Award</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_RevenueFromGrantsMaximumAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_RevenueFromGrantsNumberOfContractOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Grants, Number Of Contract Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_RevenueFromGrantsNumberOfContractOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_RevenueFromGrantsNumberOfContractOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Grants, Number Of Contract Options Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_RevenueFromGrantsNumberOfContractOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_RevenueFromGrantsRemainingFundingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Grants, Remaining Funding Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_RevenueFromGrantsRemainingFundingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_ContractOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_ContractOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_DefenseAdvancedResearchProjectsAgencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_DefenseAdvancedResearchProjectsAgencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_TheBillAndMelindaGatesFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_TheBillAndMelindaGatesFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_InitialProjectMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_InitialProjectMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mrna_OtherGrantRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mrna_OtherGrantRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619945853176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Sales (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 803,395<span></span>
</td>
<td class="nump">$ 60,209<span></span>
</td>
<td class="nump">$ 135,068<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">3,867,193<span></span>
</td>
<td class="nump">63,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_ProductSalesMember', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">199,872<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CustomerDepositsMember', window );">Customer deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">764,529<span></span>
</td>
<td class="nump">54,976<span></span>
</td>
<td class="nump">89,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">193,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">38,866<span></span>
</td>
<td class="nump">$ 5,233<span></span>
</td>
<td class="nump">$ 45,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of world | Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 6,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_ProductSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_ProductSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_CustomerDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_CustomerDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936956984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - Summary of Total Consolidated Net Revenues from Strategic Collaborators (Details) - Collaboration Revenue by Strategic Collaborator - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">$ 74,618<span></span>
</td>
<td class="nump">$ 48,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">Balance without adoption of ASC 605</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">Merck</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">26,076<span></span>
</td>
<td class="nump">36,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">Merck | Balance without adoption of ASC 605</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,082<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">AstraZeneca</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">32,624<span></span>
</td>
<td class="nump">5,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">AstraZeneca | Balance without adoption of ASC 605</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">Vertex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">15,505<span></span>
</td>
<td class="nump">6,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">Vertex | Balance without adoption of ASC 605</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">$ 413<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">Other | Balance without adoption of ASC 605</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis=us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mrna_MerckMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mrna_MerckMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mrna_AstraZenecaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mrna_AstraZenecaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mrna_VertexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mrna_VertexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mrna_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mrna_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936739464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - Changes in Balances of Receivables and Contract Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward', window );"><strong>Contract Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">$ 202,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">4,044,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">87,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">Collaboration Revenue by Strategic Collaborator</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ChangeInContractwithCustomerAssetRollForward', window );"><strong>Contract Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Beginning balance</a></td>
<td class="nump">1,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ContractWithCustomerAssetIncreaseDuringPeriod', window );">Additions</a></td>
<td class="nump">120,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ContractWithCustomerAssetDecreaseDuringPeriod', window );">Deductions</a></td>
<td class="num">(117,249)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Ending balance</a></td>
<td class="nump">5,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward', window );"><strong>Contract Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">199,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod', window );">Additions</a></td>
<td class="nump">121,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod', window );">Deductions</a></td>
<td class="num">(81,228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">240,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amounts included in contract liabilities at the beginning of the period</a></td>
<td class="nump">72,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized', window );">Performance obligations satisfied (or partially satisfied) in previous reporting periods</a></td>
<td class="nump">8,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 327,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change In Contract with Customer Liability, NonCurrent [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ChangeInContractwithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change In Contract with Customer Asset [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ChangeInContractwithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ContractWithCustomerAssetDecreaseDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer Asset Decrease During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ContractWithCustomerAssetDecreaseDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ContractWithCustomerAssetIncreaseDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer Asset Increase During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ContractWithCustomerAssetIncreaseDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer Liability Decrease During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer Liability Increase During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140620058322392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Revenue - Remaining Performance Obligation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember', window );">Collaboration Revenue by Strategic Collaborator</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">327,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">396,830<span></span>
</td>
<td class="nump">$ 401,782<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 77,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance period</a></td>
<td class="text">8 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 9,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance period</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member', window );">VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 60,312<span></span>
</td>
<td class="nump">57,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member', window );">VEGF Exercise 2016 | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 41,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance period</a></td>
<td class="text">4 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 213,360<span></span>
</td>
<td class="nump">213,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 51,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance period</a></td>
<td class="text">3 years 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember', window );">Vertex Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember', window );">Vertex Agreement | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Performance period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2028-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619942328504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - AstraZeneca - Strategic Alliances in Cardiovascular and Oncology (Details)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jan. 31, 2016</div></th>
<th class="th">
<div>Mar. 31, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>option</div>
</th>
<th class="th">
<div>Mar. 31, 2014 </div>
<div>USD ($) </div>
<div>option </div>
<div>milestone</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,009,960,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember', window );">2013 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions', window );">Number of options to develop candidates | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Estimated arrangement consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones', window );">Number of milestones | milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee', window );">Option exercise fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod', window );">Termination period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember', window );">2013 AZ Agreements | VEGF-A product (AZD8601)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember', window );">2013 AZ Agreements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent', window );">Earn-out payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember', window );">2013 AZ Agreements | Development Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Estimated arrangement consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember', window );">2013 AZ Agreements | Regulatory Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Estimated arrangement consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember', window );">2013 AZ Agreements | Commercial Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Estimated arrangement consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member', window );">VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2016StrategicAllianceWithAstraZenecaIL12Member', window );">2016 AZ Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod', window );">Termination period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod', window );">Suspension period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2016StrategicAllianceWithAstraZenecaIL12Member', window );">2016 AZ Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent', window );">Tiered royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2016StrategicAllianceWithAstraZenecaIL12Member', window );">2016 AZ Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent', window );">Tiered royalties at default rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent', window );">Tiered royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember', window );">2018 A&amp;R Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions', window );">Number of options to develop candidates | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod', window );">Termination period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_VariableConsiderationMember', window );">Estimated reimbursement for clinical supply | VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Earnout Payment, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Number Of Milestones</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Number Of Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Option Exercise Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Product Suspension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Royalty Payment, Default Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Royalty Payment, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Termination Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in measure of progress which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_VEGFAProductAZD8601Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_VEGFAProductAZD8601Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_DevelopmentMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_DevelopmentMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_RegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_RegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_CommercialMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_CommercialMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2016StrategicAllianceWithAstraZenecaIL12Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_A2016StrategicAllianceWithAstraZenecaIL12Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_VariableConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_VariableConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619935329320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - Composition of the Total Transaction Price (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">396,830<span></span>
</td>
<td class="nump">$ 401,782<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements | Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">240,000<span></span>
</td>
<td class="nump">240,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements | Sublicense reimbursement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements | Milestone payment | Toxicity milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements | Milestone payment | Competition milestone payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements | Estimated Reimbursement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 35,830<span></span>
</td>
<td class="nump">$ 40,782<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_SublicenseReimbursementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_SublicenseReimbursementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_MilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_MilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_ToxicityMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_ToxicityMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_CompetitionMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_CompetitionMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_EstimatedReimbursementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_EstimatedReimbursementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937784664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - Total Transaction Price to the Identified Performance Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">396,830<span></span>
</td>
<td class="nump">$ 401,782<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_PerformanceObligationAxis=mrna_Combined2018AZAgreementPerformanceObligationMember', window );">Combined 2018 AZ Agreement performance obligation | Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">293,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_PerformanceObligationAxis=mrna_IL12PerformanceObligationMember', window );">Preclinical development service - IL-12 | Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">8,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_PerformanceObligationAxis=mrna_OncologyDevelopmentTargetPerformanceObligationMember', window );">Preclinical development service - oncology development target | Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">8,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_PerformanceObligationAxis=mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member', window );">Development and commercialization license and manufacturing obligation | Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">85,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_PerformanceObligationAxis=mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember', window );">Material right to receive development and commercialization rights | Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 1,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PerformanceObligationAxis=mrna_Combined2018AZAgreementPerformanceObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PerformanceObligationAxis=mrna_Combined2018AZAgreementPerformanceObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PerformanceObligationAxis=mrna_IL12PerformanceObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PerformanceObligationAxis=mrna_IL12PerformanceObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PerformanceObligationAxis=mrna_OncologyDevelopmentTargetPerformanceObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PerformanceObligationAxis=mrna_OncologyDevelopmentTargetPerformanceObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PerformanceObligationAxis=mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PerformanceObligationAxis=mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PerformanceObligationAxis=mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PerformanceObligationAxis=mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619958900168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - Revenue Recognized (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="num">$ (7,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember', window );">Collaboration revenue | Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">18,371<span></span>
</td>
<td class="nump">$ 4,650<span></span>
</td>
<td class="nump">$ 45,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619864215832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 4,044,612<span></span>
</td>
<td class="nump">$ 202,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember', window );">Combined 2018 AZ Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 57,192<span></span>
</td>
<td class="nump">$ 73,669<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Combined2018AZAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937378504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - VEGF Total Transaction Price (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member', window );">VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">60,312<span></span>
</td>
<td class="nump">$ 57,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_OptionExerciseFeeMember', window );">Option exercise fee | VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_MilestonePaymentsMember', window );">Milestone payment | VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_SublicenseReimbursementMember', window );">Sublicense reimbursement | VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">2,250<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_VariableConsiderationMember', window );">Estimated reimbursement for clinical supply | VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 18,062<span></span>
</td>
<td class="nump">$ 15,621<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_OptionExerciseFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_OptionExerciseFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_MilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_MilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_SublicenseReimbursementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_SublicenseReimbursementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_VariableConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_VariableConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937838008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - Total Transaction Price Allocated to the Single Identified Performance Obligation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member', window );">VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">60,312<span></span>
</td>
<td class="nump">$ 57,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member', window );">VEGF Exercise 2016 | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 41,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619935943464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - VEGF Revenue Recognized (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member', window );">VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">$ 14,253<span></span>
</td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619864054888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - VEGF Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">$ 4,044,612<span></span>
</td>
<td class="nump">$ 202,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member', window );">VEGF Exercise 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with Customer, Liability</a></td>
<td class="nump">$ 29,335<span></span>
</td>
<td class="nump">$ 41,266<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VEGFExercise2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619940919992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - Merck &#8211; Strategic Alliances in Infectious Diseases and Cancer Vaccines (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">53 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 21, 2020</div></th>
<th class="th"><div>Feb. 14, 2020</div></th>
<th class="th"><div>Apr. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jan. 31, 2016</div></th>
<th class="th"><div>Jan. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,842,307<span></span>
</td>
<td class="num">$ (44,119)<span></span>
</td>
<td class="num">$ (65,260)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="nump">87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate net proceeds from the offering</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 549,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,044,612<span></span>
</td>
<td class="nump">4,044,612<span></span>
</td>
<td class="nump">202,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,009,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember', window );">Collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,182<span></span>
</td>
<td class="nump">240,182<span></span>
</td>
<td class="nump">199,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member', window );">Merck agreement 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod', window );">Initial research period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,647<span></span>
</td>
<td class="nump">52,647<span></span>
</td>
<td class="nump">59,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod', window );">Performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,353<span></span>
</td>
<td class="nump">5,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member', window );">Merck agreement 2015 | Collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">492<span></span>
</td>
<td class="nump">24,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_SeparateAgreementsWithMerckMember', window );">Separate agreements with Merck | Collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,026)<span></span>
</td>
<td class="num">(4,773)<span></span>
</td>
<td class="nump">24,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember', window );">PCV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Estimated arrangement consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember', window );">PCV Agreement | Series&#160;H Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate net proceeds from the offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedemptionPremium', window );">Premium recorded to deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember', window );">PCV Agreement | PCV products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Estimated arrangement consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 243,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243,000<span></span>
</td>
<td class="nump">243,000<span></span>
</td>
<td class="nump">243,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213,360<span></span>
</td>
<td class="nump">213,360<span></span>
</td>
<td class="nump">213,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,007<span></span>
</td>
<td class="nump">51,007<span></span>
</td>
<td class="nump">83,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement | Collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,103<span></span>
</td>
<td class="nump">41,382<span></span>
</td>
<td class="nump">$ 41,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember', window );">Upfront payment | Merck agreement 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember', window );">Upfront payment | PCVSAV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_MilestonePaymentsMember', window );">Milestone payment | Merck agreement 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from contract with customer, excluding assessed tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember', window );">Premium associated with the contemporaneous sale of Series H redeemable convertible preferred stock | PCVSAV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,050<span></span>
</td>
<td class="nump">13,050<span></span>
</td>
<td class="nump">13,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentResearchAndDevelopmentMember', window );">Upfront Payment, Research And Development | Merck agreement 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_PerformanceObligationAxis=mrna_PCVPerformanceObligationMember', window );">PCV Performance Obligation | PCVSAV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,356<span></span>
</td>
<td class="nump">206,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_PerformanceObligationAxis=mrna_KRASPerformanceObligationMember', window );">KRAS Performance Obligation | PCVSAV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,004<span></span>
</td>
<td class="nump">$ 7,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Performance Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Research Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in measure of progress which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedemptionPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The excess of the (1) fair value of consideration transferred to the holders of a security in excess of (2) the carrying amount of the security reported on the registrant's balance sheet, which will be deducted from net earnings to derive net earnings available to common shareholders. This amount is generally an adjustment considered in the computation of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedemptionPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_SeparateAgreementsWithMerckMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_SeparateAgreementsWithMerckMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_PersonalizedMRNACancerVaccinesProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_PersonalizedMRNACancerVaccinesProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_MilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_MilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PerformanceObligationAxis=mrna_PCVPerformanceObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PerformanceObligationAxis=mrna_PCVPerformanceObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PerformanceObligationAxis=mrna_KRASPerformanceObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PerformanceObligationAxis=mrna_KRASPerformanceObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937373160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - MERCK Composition of the Total Transaction Price (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Decrease to the transaction price</a></td>
<td class="nump">7,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member', window );">Merck agreement 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">52,647<span></span>
</td>
<td class="nump">$ 59,735<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Decrease to the transaction price</a></td>
<td class="num">(12,353)<span></span>
</td>
<td class="num">(5,265)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member', window );">Merck agreement 2015 | Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member', window );">Merck agreement 2015 | Upfront Payment, Research And Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619935543720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - MERCK Total Transaction Price to the Identified Performance Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member', window );">Merck agreement 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">52,647<span></span>
</td>
<td class="nump">$ 59,735<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member', window );">Merck agreement 2015 | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619945548264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - MERCK Revenue and Contra-Revenue Recognized (Details) - Collaboration revenue - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember', window );">Contra-revenue under the May 2019 Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="num">$ (7,088)<span></span>
</td>
<td class="num">$ (5,265)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember', window );">Collaboration revenue under the 2015 Merck Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">492<span></span>
</td>
<td class="nump">24,582<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember', window );">Separate agreements with Merck</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="num">$ (7,026)<span></span>
</td>
<td class="num">$ (4,773)<span></span>
</td>
<td class="nump">$ 24,582<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckMay2019AgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckMay2019AgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_MerckAgreement2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_SeparateAgreementsWithMerckMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_SeparateAgreementsWithMerckMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619952517992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - PCV/SAV Composition of the Total Transaction Price (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">213,360<span></span>
</td>
<td class="nump">$ 213,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement | Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement | Premium associated with the contemporaneous sale of Series H redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">13,050<span></span>
</td>
<td class="nump">13,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement | Reimbursement for clinical supply</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 310<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ClinicalSupplyReimbursementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ClinicalSupplyReimbursementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619862878376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - PCV/SAV Total Transaction Price to the Identified Performance Obligations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="num">(7,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">213,360<span></span>
</td>
<td class="nump">$ 213,050<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">51,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement | PCV Performance Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">206,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement | KRAS Performance Obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">7,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement | Reimbursement for clinical supply</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PerformanceObligationAxis=mrna_PCVPerformanceObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PerformanceObligationAxis=mrna_PCVPerformanceObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PerformanceObligationAxis=mrna_KRASPerformanceObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PerformanceObligationAxis=mrna_KRASPerformanceObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ClinicalSupplyReimbursementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ClinicalSupplyReimbursementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937527224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - PCV/SAV Revenue Recognized (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember', window );">Collaboration revenue | PCVSAV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">$ 33,103<span></span>
</td>
<td class="nump">$ 41,382<span></span>
</td>
<td class="nump">$ 41,498<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619864084824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - PCV/SAV Balances of Deferred Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 4,044,612<span></span>
</td>
<td class="nump">$ 202,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember', window );">PCVSAV Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 51,007<span></span>
</td>
<td class="nump">$ 83,799<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PCVSAVAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619866148344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - Vertex &#8211; 2016 Strategic Alliance in Cystic Fibrosis (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2019 </div>
<div>USD ($) </div>
<div>extension_period</div>
</th>
<th class="th">
<div>Jul. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87,225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,867,193,000<span></span>
</td>
<td class="nump">$ 63,310,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,009,960,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember', window );">Vertex Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected', window );">Research extension period elected</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod', window );">Payment received, research extension period</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods', window );">Number of extension periods | extension_period</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod', window );">Research extension period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Proceeds from equity investment</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod', window );">Termination period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod', window );">Termination period upon marketing approval</a></td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Increase to the transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember', window );">Vertex Agreement | Development Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Estimated arrangement consideration</a></td>
<td class="nump">$ 55,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember', window );">Vertex Agreement | Regulatory Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Estimated arrangement consideration</a></td>
<td class="nump">220,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember', window );">Vertex Agreement | Regulatory Milestones, Subsequent Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Estimated arrangement consideration</a></td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember', window );">Vertex Agreement | Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="nump">20,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember', window );">Vertex Agreement | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Marketing Approval, Termination Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Number Of Extension Periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Payment Received, Research Extension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Research Extension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Research Extension Period Elected</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Termination Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in measure of progress which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_DevelopmentMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_DevelopmentMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_RegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_RegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_RegulatoryMilestonesSubsequentProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis=mrna_RegulatoryMilestonesSubsequentProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ResearchAndDevelopmentFundingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ResearchAndDevelopmentFundingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619960302536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - VERTEX Composition of the Total Transaction Price (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember', window );">Vertex First Extended Research Term</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">43,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember', window );">Vertex First Extended Research Term | Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember', window );">Vertex First Extended Research Term | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 39,798<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ResearchAndDevelopmentFundingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ResearchAndDevelopmentFundingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619864200056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - VERTEX Total Transaction Price to the Identified Performance Obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember', window );">Vertex First Extended Research Term</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">43,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember', window );">Vertex First Extended Research Term | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 30,346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936882968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - VERTEX Revenue Recognized (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember', window );">Vertex First Extended Research Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 13,452<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexAgreement2019AgreementMember', window );">Vertex Agreement/2019 Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">2,053<span></span>
</td>
<td class="nump">6,197<span></span>
</td>
<td class="nump">10,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexAgreementsMember', window );">Vertex Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 15,505<span></span>
</td>
<td class="nump">$ 6,197<span></span>
</td>
<td class="nump">$ 10,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexFirstMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexAgreement2019AgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexAgreement2019AgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619864007864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - VERTEX Balances of Deferred Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 4,044,612<span></span>
</td>
<td class="nump">$ 202,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexAgreements1Member', window );">Vertex Agreements 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 2,648<span></span>
</td>
<td class="nump">$ 793<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexAgreements1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_VertexAgreements1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937848888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - Vertex 2020 Strategic Alliance in Cystic Fibrosis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 3,867,193<span></span>
</td>
<td class="nump">$ 63,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Vertex2020AgreementMember', window );">Vertex 2020 Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod', window );">Initial research period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod', window );">Written notice period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod', window );">Termination period</a></td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Vertex2020AgreementMember', window );">Vertex 2020 Agreement | Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Vertex2020AgreementMember', window );">Vertex 2020 Agreement | Certain Development Regulatory And Commercial Milestone Events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amounts included in contract liabilities at the beginning of the period</a></td>
<td class="nump">$ 380,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Marketing Approval, Termination Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Research Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Termination Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Vertex2020AgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_Vertex2020AgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619867046776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreements - Chiesi Agreement Composition of the Total Transaction Price (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="nump">$ 87,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract with Customer, Liability, Noncurrent</a></td>
<td class="nump">$ 177,419<span></span>
</td>
<td class="nump">177,419<span></span>
</td>
<td class="nump">$ 138,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember', window );">Chiesi agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod', window );">Initial research period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected', window );">Research extension period elected</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod', window );">Research extension period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 42,496<span></span>
</td>
<td class="nump">$ 42,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amounts included in contract liabilities at the beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Contract with Customer, Liability, Noncurrent</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember', window );">Chiesi agreement | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">17,300<span></span>
</td>
<td class="nump">17,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember', window );">Chiesi agreement | Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember', window );">Chiesi agreement | Certain Development Regulatory And Commercial Milestone Events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Amounts included in contract liabilities at the beginning of the period</a></td>
<td class="nump">$ 405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Research Extension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Research Extension Period Elected</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Research Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619938147048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Collaboration Agreements - Chiesi Agreement Total Transaction Price to the Identified Performance Obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 87,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember', window );">Chiesi agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">42,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember', window );">Chiesi agreement | Upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember', window );">Chiesi agreement | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">17,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember', window );">Chiesi agreement | Chiesi Agreement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">42,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember', window );">Chiesi agreement | Remaining unsatisfied performance obligation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 42,293<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_ChiesiAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_UpfrontPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ResearchAndDevelopmentFundingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ResearchAndDevelopmentFundingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ChiesiAgreementTransactionPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_ChiesiAgreementTransactionPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_RemainingUnsatisfiedPerformanceObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=mrna_RemainingUnsatisfiedPerformanceObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619942271400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Summary of Cash and Available-for-Sale Securities by Significant Investment Category (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 2,618,345<span></span>
</td>
<td class="nump">$ 1,024,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">5,242,194<span></span>
</td>
<td class="nump">1,259,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">4,413<span></span>
</td>
<td class="nump">3,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">5,246,456<span></span>
</td>
<td class="nump">1,262,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">2,623,850<span></span>
</td>
<td class="nump">235,876<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Current Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">1,983,758<span></span>
</td>
<td class="nump">867,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Non- Current Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">638,848<span></span>
</td>
<td class="nump">159,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">2,623,849<span></span>
</td>
<td class="nump">225,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">2,623,850<span></span>
</td>
<td class="nump">225,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents | Level 1 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">2,623,850<span></span>
</td>
<td class="nump">225,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents | Level 1 | Current Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and Cash Equivalents | Level 1 | Non- Current Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">238,774<span></span>
</td>
<td class="nump">82,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">238,819<span></span>
</td>
<td class="nump">82,101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Level 2 | Current Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">215,389<span></span>
</td>
<td class="nump">69,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Level 2 | Non- Current Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">23,430<span></span>
</td>
<td class="nump">2,902<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">491,549<span></span>
</td>
<td class="nump">117,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">491,618<span></span>
</td>
<td class="nump">118,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities | Level 2 | Current Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">491,618<span></span>
</td>
<td class="nump">110,186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities | Level 2 | Non- Current Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember', window );">Debt securities of U.S. government agencies and corporate entities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,888,022<span></span>
</td>
<td class="nump">834,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">4,294<span></span>
</td>
<td class="nump">2,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(147)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">1,892,169<span></span>
</td>
<td class="nump">836,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember', window );">Debt securities of U.S. government agencies and corporate entities | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember', window );">Debt securities of U.S. government agencies and corporate entities | Level 2 | Current Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">1,276,751<span></span>
</td>
<td class="nump">687,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember', window );">Debt securities of U.S. government agencies and corporate entities | Level 2 | Non- Current Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair&#160;Value</a></td>
<td class="nump">$ 615,418<span></span>
</td>
<td class="nump">$ 149,122<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mrna_CurrentMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mrna_CurrentMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mrna_NoncurrentMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mrna_NoncurrentMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619863981640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Amortized Cost and Estimated Fair Value of Marketable Securities, by Contractual Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less</a></td>
<td class="nump">$ 1,980,963<span></span>
</td>
<td class="nump">$ 864,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">637,382<span></span>
</td>
<td class="nump">159,148<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">2,618,345<span></span>
</td>
<td class="nump">1,024,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">1,983,758<span></span>
</td>
<td class="nump">867,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">638,848<span></span>
</td>
<td class="nump">159,987<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 2,622,606<span></span>
</td>
<td class="nump">$ 1,027,111<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120252992&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140620058306120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Unrealized Loss Position (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Gross Unrealized Losses, Less than 12 months</a></td>
<td class="num">$ (152)<span></span>
</td>
<td class="num">$ (40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Estimated Fair Value, Less than 12 months</a></td>
<td class="nump">588,540<span></span>
</td>
<td class="nump">85,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Gross Unrealized Losses, 12 months or more</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Estimated Fair Value, 12 months or more</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Gross Unrealized Losses, Total</a></td>
<td class="num">(152)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Estimated Fair Value, Total</a></td>
<td class="nump">588,540<span></span>
</td>
<td class="nump">85,161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Gross Unrealized Losses, Less than 12 months</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Estimated Fair Value, Less than 12 months</a></td>
<td class="nump">81,524<span></span>
</td>
<td class="nump">12,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Gross Unrealized Losses, 12 months or more</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Estimated Fair Value, 12 months or more</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Gross Unrealized Losses, Total</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Estimated Fair Value, Total</a></td>
<td class="nump">81,524<span></span>
</td>
<td class="nump">12,822<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Gross Unrealized Losses, Less than 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Estimated Fair Value, Less than 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Gross Unrealized Losses, 12 months or more</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Estimated Fair Value, 12 months or more</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Gross Unrealized Losses, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Estimated Fair Value, Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,979<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember', window );">Debt securities of U.S. government agencies and corporate entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Gross Unrealized Losses, Less than 12 months</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Estimated Fair Value, Less than 12 months</a></td>
<td class="nump">507,016<span></span>
</td>
<td class="nump">62,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Gross Unrealized Losses, 12 months or more</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Estimated Fair Value, 12 months or more</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Gross Unrealized Losses, Total</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Estimated Fair Value, Total</a></td>
<td class="nump">$ 507,016<span></span>
</td>
<td class="nump">$ 62,360<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937526424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Impairment charges related to marketable securities | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of AFS securities | security</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121582814&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619935059944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Fair Value Measurements - Financial Assets Measured At Fair Value On a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">$ 5,246,456<span></span>
</td>
<td class="nump">$ 1,262,987<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">238,819<span></span>
</td>
<td class="nump">82,101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">491,618<span></span>
</td>
<td class="nump">118,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember', window );">Debt securities of U.S. government agencies and corporate entities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">1,892,169<span></span>
</td>
<td class="nump">836,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">3,243,846<span></span>
</td>
<td class="nump">1,037,113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">620,947<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative instruments</a></td>
<td class="nump">293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure</a></td>
<td class="nump">2,622,899<span></span>
</td>
<td class="nump">1,037,113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">620,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Money market funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">620,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Money market funds | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">238,819<span></span>
</td>
<td class="nump">82,101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Certificates of deposit | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Certificates of deposit | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">238,819<span></span>
</td>
<td class="nump">82,101<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">491,618<span></span>
</td>
<td class="nump">118,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | U.S. treasury securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | U.S. treasury securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">491,618<span></span>
</td>
<td class="nump">118,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Debt securities of U.S. government agencies and corporate entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">1,892,169<span></span>
</td>
<td class="nump">836,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Debt securities of U.S. government agencies and corporate entities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value recurring | Debt securities of U.S. government agencies and corporate entities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">AFS</a></td>
<td class="nump">$ 1,892,169<span></span>
</td>
<td class="nump">$ 836,863<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619938134408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Balance Sheet Hedges (Details) - Not Designated as Hedging Instrument<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 368,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Fair value, asset</a></td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Fair value, liability</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Foreign currency forward contracts</a></td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">368,448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Fair value, asset</a></td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Fair value, liability</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency forward contracts | Other (expense) income, net</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Foreign currency forward contracts</a></td>
<td class="nump">$ 293<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998896-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619934899608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 36,222,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in progress</a></td>
<td class="nump">9,015,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">1,290,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 46,527,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936956040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">$ 416,550<span></span>
</td>
<td class="nump">$ 296,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less: Accumulated depreciation</a></td>
<td class="num">(119,661)<span></span>
</td>
<td class="num">(94,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">296,889<span></span>
</td>
<td class="nump">201,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">31,251<span></span>
</td>
<td class="nump">31,021<span></span>
</td>
<td class="nump">$ 24,862<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">120,714<span></span>
</td>
<td class="nump">108,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">179,901<span></span>
</td>
<td class="nump">152,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentOtherTypesMember', window );">Furniture, fixtures and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">4,662<span></span>
</td>
<td class="nump">3,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">13,398<span></span>
</td>
<td class="nump">11,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">7,020<span></span>
</td>
<td class="nump">7,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mrna_FinancingRightOfUseAssetMember', window );">Right-of-use asset, financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">56,348<span></span>
</td>
<td class="nump">9,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Property and equipment, gross</a></td>
<td class="nump">$ 34,507<span></span>
</td>
<td class="nump">$ 3,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentOtherTypesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentOtherTypesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=mrna_FinancingRightOfUseAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=mrna_FinancingRightOfUseAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937433944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_OtherPrepaidExpenseManufacturing', window );">Down payments to manufacturing vendors</a></td>
<td class="nump">$ 216,538<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">15,647<span></span>
</td>
<td class="nump">8,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_TenantIncentivesReceivablesCurrent', window );">Tenant incentives receivables</a></td>
<td class="nump">10,242<span></span>
</td>
<td class="nump">4,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Interest receivable on marketable securities</a></td>
<td class="nump">9,725<span></span>
</td>
<td class="nump">6,835<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 252,152<span></span>
</td>
<td class="nump">$ 19,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_OtherPrepaidExpenseManufacturing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Prepaid Expense, Manufacturing</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_OtherPrepaidExpenseManufacturing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_TenantIncentivesReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tenant Incentives Receivables, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_TenantIncentivesReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619943533240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Components - Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_AccruedClinicalTrials', window );">Clinical trials</a></td>
<td class="nump">$ 97,249<span></span>
</td>
<td class="nump">$ 6,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation-related</a></td>
<td class="nump">95,247<span></span>
</td>
<td class="nump">27,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RawMaterialsAccountsPayable', window );">Raw materials</a></td>
<td class="nump">78,085<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_AccruedManufacturing', window );">Manufacturing</a></td>
<td class="nump">53,412<span></span>
</td>
<td class="nump">5,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_AccruedDevelopmentOperation', window );">Development operations</a></td>
<td class="nump">29,253<span></span>
</td>
<td class="nump">2,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_AccruedPropertyAndEquipmentCurrent', window );">Property and equipment</a></td>
<td class="nump">17,576<span></span>
</td>
<td class="nump">4,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_Commercial', window );">Commercial</a></td>
<td class="nump">6,922<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_AccruedExternalGoodsAndServicesCurrent', window );">Other external goods and services</a></td>
<td class="nump">91,847<span></span>
</td>
<td class="nump">21,465<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 469,591<span></span>
</td>
<td class="nump">$ 67,652<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_AccruedClinicalTrials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Clinical Trials</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_AccruedClinicalTrials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_AccruedDevelopmentOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Development Operation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_AccruedDevelopmentOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_AccruedExternalGoodsAndServicesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued External Goods And Services, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_AccruedExternalGoodsAndServicesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_AccruedManufacturing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Manufacturing</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_AccruedManufacturing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_AccruedPropertyAndEquipmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Property And Equipment, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_AccruedPropertyAndEquipmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_Commercial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_Commercial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_RawMaterialsAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Raw Materials, Accounts Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_RawMaterialsAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619865501112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Components - Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Lease liabilities - financing</a></td>
<td class="nump">$ 24,328<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities - operating</a></td>
<td class="nump">5,972<span></span>
</td>
<td class="nump">3,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">3,365<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 33,665<span></span>
</td>
<td class="nump">$ 5,063<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937378504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Components - Deferred Revenue (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward', window );"><strong>Change In Contract With Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">$ 202,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="nump">4,009,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod', window );">Deductions</a></td>
<td class="num">(167,653)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">4,044,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_ProductSalesMember', window );">Product sales</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward', window );"><strong>Change In Contract With Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="nump">3,881,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod', window );">Deductions</a></td>
<td class="num">(82,134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">3,799,169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward', window );"><strong>Change In Contract With Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">2,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="nump">6,775<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod', window );">Deductions</a></td>
<td class="num">(4,291)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">5,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember', window );">Collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward', window );"><strong>Change In Contract With Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">199,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress', window );">Additions</a></td>
<td class="nump">121,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod', window );">Deductions</a></td>
<td class="num">(81,228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">$ 240,182<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change In Contract with Customer Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Deductions During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in measure of progress which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_ProductSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_ProductSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mrna_CollaborationArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619935210248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>campus</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 01, 2020 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Feb. 28, 2019 </div>
<div>ft&#178; </div>
<div>extension_period</div>
</th>
<th class="th">
<div>Aug. 31, 2016 </div>
<div>ft&#178; </div>
<div>extension_period</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_OperatingLeaseNumberOfProperties', window );">Number of campuses | campus</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">$ 103,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, operating leases</a></td>
<td class="nump">90,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Amounts representing interest or imputed interest, operating lease</a></td>
<td class="nump">70,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Amounts representing interest or imputed interest, finance lease</a></td>
<td class="nump">379,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=mrna_EmbeddedLeasesMember', window );">Embedded Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">24,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, operating leases</a></td>
<td class="nump">$ 62,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mrna_CambridgeMassachusettsMember', window );">Cambridge Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space (in sqft) | ft&#178;</a></td>
<td class="nump">175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mrna_CambridgeMassachusettsMember', window );">Cambridge Leases | 200&#160;Technology Square</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space (in sqft) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mrna_CambridgeMassachusettsMember', window );">Cambridge Leases | 500&#160;Technology Square</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space (in sqft) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mrna_NorwoodMassachusettsMember', window );">Norwood Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space (in sqft) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods', window );">Number of extension periods | extension_period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_LesseeOperatingLeasePercentageSubleased', window );">Percentage subleased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant improvements</a></td>
<td class="nump">$ 22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mrna_NorwoodMassachusettsMember', window );">Norwood Leases | Office, laboratory, and light manufacturing space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space (in sqft) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Amounts representing interest or imputed interest, finance lease</a></td>
<td class="nump">$ 338,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mrna_NorwoodMassachusettsMember', window );">Norwood Leases | MTC North [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_LesseeOperatingLeasePercentageSubleased', window );">Percentage subleased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_AreaOfRealEstatePropertyAdditionalSpace', window );">Additional space (in sqft) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_LeasesIncrementalBorrowingRate', window );">Incremental borrowing rate</a></td>
<td class="nump">8.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=mrna_NorwoodMassachusettsMember', window );">Norwood Leases | MTC South</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_LeasesImputedInterestRate', window );">Imputed interest rate</a></td>
<td class="nump">17.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_AreaOfRealEstatePropertyAdditionalSpace">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area Of Real Estate Property, Additional Space</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_AreaOfRealEstatePropertyAdditionalSpace</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_LeasesImputedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases, Imputed Interest Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_LeasesImputedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_LeasesIncrementalBorrowingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases, Incremental Borrowing Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_LeasesIncrementalBorrowingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_LesseeOperatingLeaseNumberOfExtensionPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Extension Periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_LesseeOperatingLeaseNumberOfExtensionPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_LesseeOperatingLeasePercentageSubleased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Percentage Subleased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_LesseeOperatingLeasePercentageSubleased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_OperatingLeaseNumberOfProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Number Of Properties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_OperatingLeaseNumberOfProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=mrna_EmbeddedLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=mrna_EmbeddedLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mrna_CambridgeMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mrna_CambridgeMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=mrna_TwoHundredTechnologySquareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=mrna_TwoHundredTechnologySquareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=mrna_FiveHundredTechnologySquareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=mrna_FiveHundredTechnologySquareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mrna_NorwoodMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mrna_NorwoodMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=mrna_OfficeLaboratoryAndLightManufacturingSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=mrna_OfficeLaboratoryAndLightManufacturingSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=mrna_MTCNorthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=mrna_MTCNorthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=mrna_MTCSouthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=mrna_MTCSouthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>187
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619981128776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, operating, net</a></td>
<td class="nump">$ 90,201<span></span>
</td>
<td class="nump">$ 86,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Right-of-use assets, financing, net</a></td>
<td class="nump">55,045<span></span>
</td>
<td class="nump">9,544<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_OperatingAndFinanceLeaseRightOfUseAsset', window );">Total</a></td>
<td class="nump">145,246<span></span>
</td>
<td class="nump">95,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">5,972<span></span>
</td>
<td class="nump">3,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Financing lease liabilities</a></td>
<td class="nump">24,328<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_OperatingAndFinanceLeaseLiabilityCurrent', window );">Total current liabilities</a></td>
<td class="nump">30,300<span></span>
</td>
<td class="nump">3,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">97,421<span></span>
</td>
<td class="nump">93,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Financing lease liabilities, non-current</a></td>
<td class="nump">109,874<span></span>
</td>
<td class="nump">38,689<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent', window );">Total non-current lease liabilities</a></td>
<td class="nump">207,295<span></span>
</td>
<td class="nump">132,364<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_OperatingAndFinanceLeaseLiability', window );">Total</a></td>
<td class="nump">$ 237,595<span></span>
</td>
<td class="nump">$ 135,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherLiabilitiesCurrent<span></span>
</td>
<td class="text">us-gaap:OtherLiabilitiesCurrent<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:OtherLiabilitiesCurrent<span></span>
</td>
<td class="text">us-gaap:OtherLiabilitiesCurrent<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization<span></span>
</td>
<td class="text">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_OperatingAndFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_OperatingAndFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_OperatingAndFinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_OperatingAndFinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_OperatingAndFinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_OperatingAndFinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_OperatingAndFinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Finance Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_OperatingAndFinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>188
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937834616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 16,939<span></span>
</td>
<td class="nump">$ 17,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets, financing leases</a></td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest expense for financing lease liabilities</a></td>
<td class="nump">9,891<span></span>
</td>
<td class="nump">6,557<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_FinanceLeaseCost', window );">Total financing lease costs</a></td>
<td class="nump">10,902<span></span>
</td>
<td class="nump">6,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short term lease costs</a></td>
<td class="nump">13,322<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">5,229<span></span>
</td>
<td class="nump">4,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows used in operating leases</a></td>
<td class="num">(15,089)<span></span>
</td>
<td class="num">(16,121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows used in financing leases</a></td>
<td class="num">(8,523)<span></span>
</td>
<td class="num">(5,585)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows used in financing leases</a></td>
<td class="num">(7,519)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments', window );">Right-of-use assets reduced through lease modifications and reassessments</a></td>
<td class="nump">6,755<span></span>
</td>
<td class="nump">2,717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">17,107<span></span>
</td>
<td class="nump">34,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained through lease modifications and reassessments</a></td>
<td class="nump">46,495<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_LesseeFinanceLeaseExpense', window );">Charge to financing lease obligation</a></td>
<td class="nump">$ 1,304<span></span>
</td>
<td class="nump">$ 971<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases, remaining lease term</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases, remaining lease term</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases, discount rate</a></td>
<td class="nump">10.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases, discount rate</a></td>
<td class="nump">13.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_LesseeFinanceLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Finance Lease, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_LesseeFinanceLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-Of-Use Assets Reduced Through Lease Modifications And Reassessments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937197064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Minimum Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 15,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">15,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">16,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">16,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">16,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">93,599<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">173,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less amounts representing interest or imputed interest</a></td>
<td class="num">(70,354)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">103,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">36,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">11,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">12,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">12,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">12,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">428,059<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">513,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less amounts representing interest or imputed interest</a></td>
<td class="num">(379,110)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 134,202<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>190
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619958962888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Strategic Collaborations (Details) - PCV Agreement - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Budgeted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember', window );">PCV products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount', window );">Budgeted amount</a></td>
<td class="nump">$ 243.0<span></span>
</td>
<td class="nump">$ 243.0<span></span>
</td>
<td class="nump">$ 243.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_PersonalizedMRNACancerVaccinesProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_PersonalizedMRNACancerVaccinesProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>191
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619867047736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Indemnification Obligations (Details) - Indemnifications<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Losses related to indemnification obligations</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of claims outstanding | claim</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Reserves established</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_IndemnificationGuaranteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>192
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619864063560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Purchase Commitments and Purchase Orders (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=mrna_SupplyAndManufacturingAgreementsMember', window );">Supply and manufacturing agreements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems', window );"><strong>Purchase Commitment, Excluding Long-term Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted', window );">Contractual commitment to pay</a></td>
<td class="nump">$ 659,500.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=mrna_ClinicalServicesMember', window );">Clinical services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems', window );"><strong>Purchase Commitment, Excluding Long-term Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted', window );">Contractual commitment to pay</a></td>
<td class="nump">27.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=mrna_ClinicalOperationsAndSupportCommitmentMember', window );">Clinical operations and support commitments</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems', window );"><strong>Purchase Commitment, Excluding Long-term Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted', window );">Contractual commitment to pay</a></td>
<td class="nump">$ 896.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=mrna_SupplyAndManufacturingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=mrna_SupplyAndManufacturingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=mrna_ClinicalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=mrna_ClinicalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=mrna_ClinicalOperationsAndSupportCommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis=mrna_ClinicalOperationsAndSupportCommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>193
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936544888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Licenses to Patented Technology (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jun. 26, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount', window );">Commercial milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Consideration paid</a></td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_SublicenseAgreementTermsMember', window );">Sublicense agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross', window );">Expenses associated with license agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_TherapeuticAndProphylacticProductsMember', window );">Therapeutic and prophylactic products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount', window );">Development and regulatory milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_DiagnosticProductsMember', window );">Diagnostic products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount', window );">Development and regulatory milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Commercial Milestones, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Development And Regulatory Milestones, Maximum Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23221-108380<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_SublicenseAgreementTermsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=mrna_SublicenseAgreementTermsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_TherapeuticAndProphylacticProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_TherapeuticAndProphylacticProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_DiagnosticProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=mrna_DiagnosticProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>194
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619866242632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock and Common Stock - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 21, 2020</div></th>
<th class="th"><div>Feb. 14, 2020</div></th>
<th class="th"><div>Dec. 11, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>May 07, 2018</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000,000<span></span>
</td>
<td class="nump">1,600,000,000<span></span>
</td>
<td class="nump">1,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">775,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">509,352,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,000,000<span></span>
</td>
<td class="nump">162,000,000<span></span>
</td>
<td class="nump">162,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares of common stock issued (in shares)</a></td>
<td class="nump">17,600,000<span></span>
</td>
<td class="nump">30,263,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (usd per share)</a></td>
<td class="nump">$ 76.00<span></span>
</td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,852,725<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 563,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares of common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,275,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_PaymentsOfUnderwritingDiscounts', window );">Underwriting discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 563,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Preferred stock converted into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,012,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=mrna_PublicEquityOfferingMember', window );">Public Equity Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares of common stock issued (in shares)</a></td>
<td class="nump">17,600,000<span></span>
</td>
<td class="nump">26,315,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (usd per share)</a></td>
<td class="nump">$ 76.00<span></span>
</td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from public offering</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 477,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Underwriting Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares of common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,947,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_PaymentsOfUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments Of Underwriting Discounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_PaymentsOfUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=mrna_PublicEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=mrna_PublicEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>195
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936429944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 05, 2018 </div>
<div>USD ($) </div>
<div>purchase_period </div>
<div>offering </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>installment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Aggregate number of shares authorized for issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised (less than for the year ended December 31, 2017)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 785,700<span></span>
</td>
<td class="nump">$ 75,600<span></span>
</td>
<td class="nump">$ 5,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Consideration for options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockExpense', window );">Restricted stock unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,021<span></span>
</td>
<td class="nump">81,122<span></span>
</td>
<td class="nump">72,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to non-vested stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 226,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period of cost expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mrna_ServiceBasedAwardsMember', window );">Service-based awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mrna_ServiceBasedAwardsMember', window );">Service-based awards | Twelve months of continued employment or service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mrna_ServiceBasedAwardsMember', window );">Service-based awards | Following twelve quarters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments', window );">Number of installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Aggregate number of shares authorized for issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77,748<span></span>
</td>
<td class="nump">74,780<span></span>
</td>
<td class="nump">63,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,872<span></span>
</td>
<td class="nump">1,217<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-based awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,600<span></span>
</td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="nump">$ 10,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mrna_StockOptionAndIncentivePlan2018Member', window );">2018 Equity Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Aggregate number of shares authorized for issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized', window );">Annual percentage increase of shares reserved and available for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grant (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mrna_StockOptionAndGrantPlan2016Member', window );">2016 Equity Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mrna_EmployeeStockPurchasePlan2018Member', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Share available for future issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=mrna_EmployeeStockPurchasePlan2018Member', window );">ESPP | Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Aggregate number of shares authorized for issuance (in shares) | shares</a></td>
<td class="nump">810,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod', window );">Offering period | offering</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods', window );">Purchase period | purchase_period</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price at which shares are sold, percent</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate', window );">Minimum percentage of compensation through payroll deductions</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum percentage of compensation through payroll deductions</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum shares to be purchased during purchase period (in shares) | shares</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount', window );">Maximum value of shares to be purchased during purchase period</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase of common stock under employee stock purchase plan (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Weighted average fair value per share (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod', window );">Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod', window );">Share-Based Compensation Arrangement By Share-Based Payment Award, Consecutive Offering Period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period, Number Of Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Consecutive Offering Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Maximum Employee Subscription Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Consecutive Offering Periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Annual Percentage Of Additional Shares Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Minimum Employee Subscription Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mrna_ServiceBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mrna_ServiceBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mrna_StockOptionAndIncentivePlan2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mrna_StockOptionAndIncentivePlan2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mrna_StockOptionAndGrantPlan2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mrna_StockOptionAndGrantPlan2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mrna_EmployeeStockPurchasePlan2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mrna_EmployeeStockPurchasePlan2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>196
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140620029866696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Options Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number&#160;of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">45,536,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">5,036,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(13,888,434)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled/forfeited (in shares)</a></td>
<td class="num">(2,627,468)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">34,057,533<span></span>
</td>
<td class="nump">45,536,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (usd per share)</a></td>
<td class="nump">$ 13.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (usd per share)</a></td>
<td class="nump">36.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (usd per share)</a></td>
<td class="nump">12.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled/forfeited (usd per share)</a></td>
<td class="nump">18.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (usd per share)</a></td>
<td class="nump">17.14<span></span>
</td>
<td class="nump">$ 13.82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (usd per share)</a></td>
<td class="nump">7.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share)</a></td>
<td class="nump">19.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue', window );">Exercised (usd per share)</a></td>
<td class="nump">6.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue', window );">Cancelled/forfeited (usd per share)</a></td>
<td class="nump">10.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue', window );">Outstanding at end of period (usd per share)</a></td>
<td class="nump">$ 9.12<span></span>
</td>
<td class="nump">$ 7.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Outstanding and Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number&#160;of Options, Exercisable (in shares)</a></td>
<td class="nump">17,461,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price per Share, Exercisable (usd per share)</a></td>
<td class="nump">$ 10.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue', window );">Weighted- Average Grant Date Fair Value per Share, Exercisable (usd per share)</a></td>
<td class="nump">$ 5.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted- Average Remaining Contractual Term, Outstanding</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted- Average Remaining Contractual Term, Exercisable</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding</a></td>
<td class="nump">$ 2,976,235<span></span>
</td>
<td class="nump">$ 286,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable</a></td>
<td class="nump">$ 1,632,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract', window );"><strong>Vested and expected to vest</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number&#160;of Options (in shares)</a></td>
<td class="nump">16,596,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price per Share (usd per share)</a></td>
<td class="nump">$ 23.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue', window );">Weighted- Average Grant Date Fair Value per Share</a></td>
<td class="nump">$ 12.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted- Average Remaining Contractual Term</a></td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value</a></td>
<td class="nump">$ 1,343,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested And Expected To Vest, Outstanding, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>197
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619960290280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Restricted Common Stock and Common Stock Units Activity (Details) - Restricted Common Stock Units<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares/Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, non-vested at beginning of period (in shares) | shares</a></td>
<td class="nump">1,177,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Issued (in shares) | shares</a></td>
<td class="nump">1,478,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(247,349)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled/forfeited (in shares) | shares</a></td>
<td class="num">(215,033)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, non-vested at end of period (in shares) | shares</a></td>
<td class="nump">2,192,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date per Share/Unit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, non-vested at beginning of period (usd per share) | $ / shares</a></td>
<td class="nump">$ 19.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Issued (usd per share) | $ / shares</a></td>
<td class="nump">37.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (usd per share) | $ / shares</a></td>
<td class="nump">20.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancelled/forfeited (usd per share) | $ / shares</a></td>
<td class="nump">23.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding, non-vested at end of period (usd per share) | $ / shares</a></td>
<td class="nump">$ 30.85<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>198
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619942814488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.83%<span></span>
</td>
<td class="nump">2.29%<span></span>
</td>
<td class="nump">2.76%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 years 1 month 9 days<span></span>
</td>
<td class="text">6 years 25 days<span></span>
</td>
<td class="text">6 years 3 months 7 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Weighted average fair value per share (usd per share)</a></td>
<td class="nump">$ 19.30<span></span>
</td>
<td class="nump">$ 11.35<span></span>
</td>
<td class="nump">$ 9.33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.14%<span></span>
</td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">54.00%<span></span>
</td>
<td class="nump">53.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividends</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Weighted average fair value per share (usd per share)</a></td>
<td class="nump">$ 32.18<span></span>
</td>
<td class="nump">$ 5.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>199
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937494984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 93,021<span></span>
</td>
<td class="nump">$ 81,122<span></span>
</td>
<td class="nump">$ 72,565<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">56,155<span></span>
</td>
<td class="nump">48,259<span></span>
</td>
<td class="nump">37,659<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">36,866<span></span>
</td>
<td class="nump">32,863<span></span>
</td>
<td class="nump">34,906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">77,748<span></span>
</td>
<td class="nump">74,780<span></span>
</td>
<td class="nump">63,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=mrna_RestrictedStockAndRestrictedStockUnitsRSUMember', window );">Restricted common stock and units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">12,401<span></span>
</td>
<td class="nump">5,125<span></span>
</td>
<td class="nump">9,277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 2,872<span></span>
</td>
<td class="nump">$ 1,217<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=mrna_RestrictedStockAndRestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=mrna_RestrictedStockAndRestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>200
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936546264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Percent of match</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Percent contributed by participant</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total matching contributions</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>201
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937463320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Loss Before Provision For (Benefit From) Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">$ (745,445)<span></span>
</td>
<td class="num">$ (508,595)<span></span>
</td>
<td class="num">$ (380,473)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">932<span></span>
</td>
<td class="num">(6,121)<span></span>
</td>
<td class="num">(3,935)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before provision for (benefit from) income taxes</a></td>
<td class="num">$ (744,513)<span></span>
</td>
<td class="num">$ (514,716)<span></span>
</td>
<td class="num">$ (384,408)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>202
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619937760904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Provision For (Benefit From) Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">2,519<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">2,551<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,200)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,200)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for (benefit from) income taxes</a></td>
<td class="nump">$ 2,551<span></span>
</td>
<td class="num">$ (695)<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>203
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619935543720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of U.S. Statutory Income Tax Rate to Effective Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax effected at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal benefit</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">7.90%<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Non-deductible items</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(47.40%)<span></span>
</td>
<td class="num">(33.00%)<span></span>
</td>
<td class="num">(28.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Federal research and development credits</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign tax rate differential</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Stock compensation windfall</a></td>
<td class="nump">19.80%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="nump">(0.00%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>204
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936571784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Significant Components of Deferred Tax Assets and Tax Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carry-forwards</a></td>
<td class="nump">$ 587,211<span></span>
</td>
<td class="nump">$ 268,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">33,089<span></span>
</td>
<td class="nump">43,978<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts', window );">Capitalized licenses, research and development and start-up costs</a></td>
<td class="nump">13,985<span></span>
</td>
<td class="nump">19,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carry-forwards</a></td>
<td class="nump">99,024<span></span>
</td>
<td class="nump">77,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">26,962<span></span>
</td>
<td class="nump">7,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">29,785<span></span>
</td>
<td class="nump">53,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_DeferredTaxAssetsOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">22,313<span></span>
</td>
<td class="nump">26,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_DeferredTaxAssetsFinancingLeaseLiability', window );">Lease financing obligation</a></td>
<td class="nump">23,718<span></span>
</td>
<td class="nump">10,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts', window );">Capitalized inventory</a></td>
<td class="nump">38,058<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">874,145<span></span>
</td>
<td class="nump">507,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(823,468)<span></span>
</td>
<td class="num">(470,753)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets, net of valuation allowance</a></td>
<td class="nump">50,677<span></span>
</td>
<td class="nump">36,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset', window );">Financing right-of-use assets</a></td>
<td class="num">(11,539)<span></span>
</td>
<td class="num">(2,612)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset', window );">Operating right-of-use assets</a></td>
<td class="num">(20,349)<span></span>
</td>
<td class="num">(24,944)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="num">(18,276)<span></span>
</td>
<td class="num">(8,959)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(513)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(50,677)<span></span>
</td>
<td class="num">(36,515)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Capitalized Licenses, Research And Development, And Start-Up Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Deferred Expense, Capitalized Inventory Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_DeferredTaxAssetsFinancingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Financing Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_DeferredTaxAssetsFinancingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_DeferredTaxAssetsOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_DeferredTaxAssetsOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Finance Lease Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Lease Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>205
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936850840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 352,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">352,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">874,145<span></span>
</td>
<td class="nump">$ 507,268<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">2,260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_OperatingLossCarryforwardsSubjectToExpiration', window );">Net operating losses that begin to expire in 2030</a></td>
<td class="nump">380,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_OperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating losses that will carry-forward indefinitely</a></td>
<td class="nump">1,880,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry-forwards</a></td>
<td class="nump">73,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_OperatingLossCarryforwardsSubjectToExpiration', window );">Net operating losses that begin to expire in 2030</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry-forwards</a></td>
<td class="nump">26,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Federal Orphan Drug</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry-forwards</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Investment tax credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carry-forwards</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_OperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Not Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_OperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_OperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_OperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=mrna_FederalOrphanDrugMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=mrna_FederalOrphanDrugMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_InvestmentCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_InvestmentCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>206
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936130568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits Roll Forward (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance as of beginning of period</a></td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease due to prior positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase due to current year tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance as of end of period</a></td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>207
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936062680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share - Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (747,064)<span></span>
</td>
<td class="num">$ (514,021)<span></span>
</td>
<td class="num">$ (384,734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionPremium', window );">Premium paid on repurchase of preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,127)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemablePreferredStockDividends', window );">Cumulative dividends on redeemable convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12,996)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (747,064)<span></span>
</td>
<td class="num">$ (514,021)<span></span>
</td>
<td class="num">$ (401,857)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted (in shares)</a></td>
<td class="nump">381,333,059<span></span>
</td>
<td class="nump">330,802,136<span></span>
</td>
<td class="nump">81,114,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to common stockholders, basic and diluted (usd per share)</a></td>
<td class="num">$ (1.96)<span></span>
</td>
<td class="num">$ (1.55)<span></span>
</td>
<td class="num">$ (4.95)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The excess of (1) fair value of the consideration transferred to the holders of the preferred stock over (2) the carrying amount of the preferred stock in the registrant's balance sheet, during the accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27010884&amp;loc=d3e42851-122695<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemablePreferredStockDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemablePreferredStockDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>208
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619862849016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share - Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities (in shares)</a></td>
<td class="nump">36,250,493<span></span>
</td>
<td class="nump">46,714,164<span></span>
</td>
<td class="nump">51,478,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities (in shares)</a></td>
<td class="nump">34,057,533<span></span>
</td>
<td class="nump">45,536,915<span></span>
</td>
<td class="nump">50,821,132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">198,597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted common stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities (in shares)</a></td>
<td class="nump">2,192,960<span></span>
</td>
<td class="nump">1,177,249<span></span>
</td>
<td class="nump">458,715<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>209
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619936882968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Geographic Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 803,395<span></span>
</td>
<td class="nump">$ 60,209<span></span>
</td>
<td class="nump">$ 135,068<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">764,529<span></span>
</td>
<td class="nump">54,976<span></span>
</td>
<td class="nump">89,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 38,866<span></span>
</td>
<td class="nump">$ 5,233<span></span>
</td>
<td class="nump">$ 45,993<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>210
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140619864218792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event<br> dose in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 18, 2021 </div>
<div>numberOfDose</div>
</th>
<th class="th">
<div>Feb. 26, 2021 </div>
<div>USD ($) </div>
<div>dose</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_NumberOfDosesOfVaccineCandidate', window );">Number of doses of vaccine candidate | dose</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted', window );">Supply commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mrna_NumberOfVaccineDoses', window );">Number of vaccine doses | numberOfDose</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted', window );">Contractual commitment to pay</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 314.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_NumberOfDosesOfVaccineCandidate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Doses Of Vaccine Candidate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_NumberOfDosesOfVaccineCandidate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mrna_NumberOfVaccineDoses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Vaccine Doses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mrna_NumberOfVaccineDoses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mrna_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor amount as of the balance sheet date that the entity must expend to satisfy the terms of disclosed arrangements (excluding long-term commitments) in which the entity must commit resources to supply goods or services to one or more customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a)(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>211
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%W;[>]OM!KB)5#S*@I%!%,3[__0E2\110-\Z$4"R /(FP#[U!"<+<.H&M+.
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M/(*T6P'@_5((]7Y3+=">X4__ 5!+ P04    " #+@UI2-\-M0I(#   -"@
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M,83/?WQG9RR*BI&X'W]7@QZLYBP,UY^7HW\H%\\7<^]G["R)_AF.\\G1@7L
MQNS!GT?Y,'GZR*H%T6*\((FR\G_P5&&M Q#,LSR95L;<@VD8+W[Z/ZI K!E
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M?%5O\2)/9N4W>>Z3/$^FY>.$^9Q)"@#__4.2Y,L7Q9>#5E^8//X?4$L#!!0
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MX-2PI;[M;A>T_N#=>JBS&IX@CE #;$[P$Q"L]PX4 +P\7#(%#< PVU:PH8Z
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M5P>!3B1K5T *%!@0UXKPD%7XOO8@4QK\%L?7B#G$1Y&OM0UA[0I-" :LW>L
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MG+K$;(+/H&,/="XZ;G %CM1O_)C#><#DZ=&%C$#:59XQ)H*'CQM^0Q(I0<P
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MD'%?>U(EA2D9;4GX,[#5&+=! ['SY% ;'R'Z8D>1%;+D\!C(ZMH"K+EH&@Y
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M4*,G- ]$;XOHQ1H:CP_QAX]5;33U'#(X$ATZ.T7G43P)YSV !WP#>IJ+HFI
M(?K]*K_QGL3@W,;PDI(')#M8U[3N_X?&+#K$<EI2YL\IBO=>GA 0$LLCMZE
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M#-KO6"=9Z\<G+ &?PA> Y*U$OFX.X)#=A!BM>X*H0N?X?+$_UQ\QGY KUHJ
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MO-DTP,/9T\G5B++@!@#W,)A8Q?ZOR#XF)L'P3G.M#B3!G41]!\CT<=DU,DO
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MZ6,8=D 5JG85":(0@ O5^=[&?#@ IGQ$+\=JEF,4/V%[6]MRL/(+:YQ.A=
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M9P5$6%^S4_R FZ.\8%9AT]J)H$8Y9W_"I\A:R;EZU!$SF%RN(.S:&VMD 8J
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MGRQ"MX-U6WZZF$25Y\8?BY[3O\@I@;\%6ZKR;,?-*0;_-0+G^QY5A[VG[:5
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MQBDR8'$]3RZ&T^4XQ,> 'PHW;N\,H9(5T5,P;HIYD@5!J#'W@4'RYQDO4>M
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M=IB0PG*)D508KX#]N=9N^^$/V VYT[\!4$L#!!0    ( ,N#6E('RQP #@P
M &(\   9    >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;.U;:8\<MQ']*\1&
M"7:!WMGI:XZ-)&"ULF 9EBUH91M!$ 2<;LX,H^[FN(\]_.OSJL@^YM!(<KX%
MHP_:;C99K/-5%8EY_F#*3]5:J5H\YEE1O3A;U_7F^NJJ2M8JE]7(;%2!+TM3
MYK+&:[FZJC:EDBDORK.K8#R>7.52%V<OG_/8^_+E<]/4F2[4^U)439[+\NF5
MRLS#BS/_K!WXH%?KF@:N7C[?R)6Z4_4OF_<EWJXZ*JG.55%I4XA2+5^<W?C7
MKV*:SQ-^U>JA&CP+DF1AS"=Z>9N^.!L30RI324T4)/[<JUN5940(;/SN:)YU
M6]+"X7-+_0W+#ED6LE*W)OM-I_7ZQ=GL3*1J*9NL_F >OE=.'F8P,5G%_XL'
M.]?'Y*2I:I.[Q> @UX7]*Q^='@8+9N//+ C<@H#YMALQEZ]E+5\^+\V#*&DV
MJ-$#B\JKP9PNR"AW=8FO&NOJES\JB%0]OZI!BT:N$K?NE5T7?&:='XAWIJC7
ME?BN2%6Z3> *3'2<!"TGKX*C%%^K9"1"WQ/!.!@?H1=VDH5,+SPJF?CGS:*J
M2QC_7T=H1AW-B&E&WZRMH^LHLJZKC4S4BS.$3J7*>W76,OB;$FMYKX0J:E6J
M5.BB-N)>EMHTE<A,L;K$>"X*4UPFLDA4)A>9$ADM%K(L9;%2")*Z$HA089I2
M+&6B,UUKT)9%*M3OC=[0#*$>-[K4Q4K(NMN@1H3A_W5IFM4:J@^#D;A598UP
M%F:)#VIW&V9V62J%F 31C0*AM!+87%6)S&1-.]A/\HGWW93F7E,45YYX6.MD
M+1YH<6)6A?ZC%24Q52T:^!(A!J9L[4GA*\B,%&.7I%T*18T/]Y@/)D6FE\HQ
M; E6HTZS]8,1B<PW#:D;<KV35263-5[K&BR1SFYEOBAUNE*M]IY8=_3IG0%/
MA10?5;(N3&963U 0V4J<O_MX>^'!1HFLV7#B)U,^&)..Q,]0B]6$L_*!#<">
M29)F@ZU$#A#1E\O,0(V+1F>I,]-@T[O?&UDJVJ6CY6V+ NBHUT1,/Y(JS'*I
M$^<$Y'2RA%KA/0:<F?))L$.*VM0RX]TVL-.C!M"I[$GXT]@;C\= 2=YU"7R!
M5(<U9?7MO)A\[$FP[>"2I<DYGK$-_9V/Q-M"W#0K !O>_;E'KK#E^1*FAM%3
M]AR\DPF<LZ_@=-8?,)[ G4RF4[#+<_8U9>4[HJ^1^+C6Y!%)U@##+!^D"LL(
M!=2#+-/+JI8EVW*'#]%]P"8_R *[/G72R@1Q!RZVU1J/=[5*EI)IJBE'R<PQ
M+4D[XWV96'WM;.NY25-RL!V<[SA>RTHLE"I@G5H17#-64%@\P2NJWC@W%8*V
MK+<"J3<'&RLQ^293+(QZU.3WG852QSU)M"7U9%]J2!@?Y'CQ!"-9-7($$TZ4
MV*0+J %<D!0*YF1O!Q<[DX[@!CMF2RF'<(FU*+M3BX:D D4H,-0&@?$PO@?L
M@*[EUH)!SPV" F6,!1^V6>^[*3E1W<+<LEV$">*-+@CO6P3Y/ X!=1#WA$;V
M\8*\Y(U:E,XA#X:9*% Q[3HTIQ"&#4:-/;#8LRR\;M>T"+*6D4/8>" &U8XE
M>#IIO((VP0;1)CFQ.PG#K*UE2E"A"X0"PH9AA_5F3<A30W^0 T#.;'@"I+=Q
M,+ J"=YLZ-.2##0(R"6*QDL*$[8\^+U%V:/R#113*&30[.DPAG4ZQ7O5+)RF
MM\,BHNR9T*2ABZ4=,L-*]5K#^RDHGSCXV]CX,G#VPCVL,0MQ12L>L:&F/631
MZD/>2VV+"J=V4^J5)MF=QQMR:P4]$#\*3@E7SRFI6P%EALJ>/=6ME[EIK$S/
M@F 4(!]EF5/\0D$6G2(*DT]]\N8"9RO*.)-I%@^!Q65,;[+]Z0Q@8;RO(9E5
MQJK% 57GFP.CM*9B_".BV!3YV&X!H!H H%HN%?<1XH<&8.*J5=[*+*AHLIKM
M_<?;#9C9?KS ]U!.'W,%*EHZQJ530ZFHZ4IM8'"XM'-_:#*7B&!Z%TJMM!PI
M*AW&76Y2C9AWL -=]GL="410MWJR\2I%LJ:D3\\NG#,$>D?8LYC;@R+%FD6X
MT1%LRY%646C4#2?FKN1@L+M#DVG!KJ\H)H>@[A#,?1''^A+*&P"A9X&1\LD.
M;ZQ]"W[,F/=UH/> X'!&H05W:@-T64!R6XM_$;\X&-ITSN/<+W=E^9)"UN5Y
MSI62&"\_J?IRP1Y&U8/CB 9LZ8Y4!H_Y#WR=MD.%5+J$^MF0'8GOP'9*<7:L
ML>%"%P4$Y4!NRW:UB-Z(TT]?[#$6]#A(?8WM(H@$]2FJW=AE?5K0.FX"AR,^
M;^YNQ2P*.,3QBF;3:CD<AC E%6N53,M%VT0QCD6CL,.Q$CT8>;T#V9WM^_YI
MER\\ZJ1=R5W'S[^^?7V)C'8ODX2*$[CDJI0Y_FJRJ*7_W2\W-G;HY<WK&W *
M7TE)/4R)E5S SQ&*"")&IX8,\I%!PO):<@5DEI<-14(%-[2"38*!8$P885RN
M+.6N:R"?3]6]RDS725)!8_T.NW!^M""[I]EAL41T;-#WI=,ASCC&]@PA#YN.
M9W-AP/Q+ZH0I)57BG+T 21HSJHOK TMYV0UO>BT^['/B]8#EH6*JQ;E_(<Z#
M"_%,S,<>5N-A-O$B/SJ\NA/6K0ZQ.KH0,9JK*!9S+XXB\9$Z,-#QH]@+H@F1
MCKUY/!,_]K)?BUM;YU_OE9Y##9W'Q!E63P/\#;UX%KHR\O/S@\@+@YGXVU]F
M@1_\W7'3=A7[2\*Q%P(H+>V?Z%#B*QCS[/&%(SJ?>E'@BWGH3:;Q,?ZVE_GC
MN3>;1B*<>9/9W#$ZG+#/;#">>L$\%GX8>.&D5W403KT8XU!Z"&U%4_%O^X_M
M^]$>>CA7+"F(J,3D0KT+J-;"%HI<#XE$40#LCY30@ =RGY]<XX?^'XC(!%.U
M09FE.5F.V%..\N&&=[!HNTKH<E$'3>1\;]M^%]$!P('5W&E'?U+DT'.K3UG(
MC(L\/FNLK#\?%R'>WLN 9-^O#LWTY>TLF%'O:8JV5>K+/^J^JJ\"H_\9*PXU
M?A7YT<2;AW-ZF'IC?]^K>=ZUN,EA'/V'[50@PP'P\W81LD*9.?9]1-X<^G0E
M\1"!=Q%UJ%J$S-P7$R^.I\[[=V=W$HR]^9A@8^+-)A-QMP:G-LWOS N!%S2O
M18Q?9:D'9Y+M/(!90 H!O,S;:"V_+7GX,_$ $SWSYR._35(C<==L4$"0GQ)0
MR6HMEK @G,A>4709VA69W?'$-WN(K/Z$@]P20]SC<)7)K=#@C E$<C#3E+82
MA0OLV6R(I)UX%:7TG6,%)]4S@!;RR6Q^P8\3SP\ 8D=I['G8^<R+ TI.,7 =
M<=N[[U>M!IKZV+[UB-T@L6?7H*-1VQY.M#!9VE#KWQZ^'&I-[$DF+:@J6QM.
MO&D<B\";^M.#5+NFC,JQ1]>A\"G'D2R*$/;'4Q%&"+NH.X;Y>E&Z3;]-E@AU
M!')2J\1;KL/Z-JGGU2S0?UA']Y&,(R14']4V<4*)"26Z7+7M8;^*CR]L):=1
M%E.'#@T<*:MV$/*0QW\XL,=>(0"%^JX!V=(ETG/LQE\/.3I$8(PJ]:^[R_T0
ML(#1!KV#HLLQG3<M6KF[A\I=*1R^/>E[C,_HP/MBFGBCZ=)#_(,09>_0GXJ)
M/I(&@Z!-E2/"-IISI0: GLYI.*#!N1]"9]XLFM%02,EE/)X)/_#&<41#$0WY
M$QX*[,*8AN+)E(:B>4CY$NZUI!X:A58,"([H["%NH?@SZO*GH3=%/103S/L!
MF*ZJ#L5*Q;=7A3OS=JD(T:3S36// =S8^11E8HQBXSR<SCW?']NJ^;U=CGXG
M:]1!\.-$A*TA :6:"#5V( :UF2LH!OTPG_ZYMK<K)8[602X4;.76R42'6ZP9
M:HO"<#::=WU14URV,4-GY];?MA4W$D>N%^/N>C'^D]>+1]>=KA=/UXNGZ\73
M]>+I>O%TO7BZ7CQ=+YZN%T_7BZ?KQ=/UXNEZ\72]>+I>/%TOGJX73]>+I^O%
MT_7BZ7KQ=+UXNEX\72^>KA=/UXNGZ\7_@^O%J\'O/G.%<*9?MU:"*=F?@':C
MW0]H;^SO1OOI]M>W[X &&@)F:HFEX]$T/K/50_M2FPW_BG1AZMKD_+A6$LY/
M$_!]:4S=OM &W<^*7_X74$L#!!0    ( ,N#6E(G; ,[L H  #\<   9
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M7HS"C>CI=M?29BD67;72)$K6KFO8ST?SXZ/)(1K86@YSH)LH;5TOD)&^O-G
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M: &>+QT.5?F"% S?#,_^!U!+ P04    " #+@UI2F0&,SXX$   1#   &0
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MZ[:SI6TCZQ5(<B47)Q1;9=DXB**(/V!+06:\FG>,;9_"@<<XF@7I. FRV?C
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M8^7<#T!LXL>S1SBGDZ?>)$[ ?22"A/8M_"#$,8GC.O06R<P+(8GCBQWC(*F
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MA+&_3;,W=;GEWX-=E75=YGRY41(E#BW \U59UNT-'=#]0/#-_P!02P,$%
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M>U4J*ROH]O>_S;,T^^[@ZC2#VNP+ >M.QU.13[/.XAE,M.A6M]^_& ]Z16!
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MM6(2[Y&89H/*?*V*QE(]O (.G/*VJT_OK^GVC).?^C@NPY"EDKL L]V:6'0
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M4$@+\'YEC&]OB$'WKYO7_P%02P,$%     @ RX-:4@A-W*D>!   V0D  !D
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M*N+PQ.KOG+!C/+'*D6Y-7&*T<I)9PJ;^[5@; #DR5"P9'2D:HH'R#HEEH R
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M.=%EE,"1:#K]BR>BTT?M0AA5E)'HMT$CFTT3U[-,' $93JD3?0C%.WH_Q+Q
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MQ#KRI^YT00Y+[F.R1#]"WW/R;]W$ #>9'_?'Y&+K1X4.G$:H:_>6!6(E<V<
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M/R^SCSS*+PBN7S1%Y=Z\_RR[!X;<@9HW18'P-07R,!_NT!&8Y[G"?"ME)OJ
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MKP5>*=!=TS#UM$(N=W-OY!T6KNMM9>Q"L)BU;(LW:.[:*T6S8$ IZP:%KJ4
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MR;.>-@;M,A4J#\AA! X3'^$(=U. H]K@E[VF;@D"L<#X8@,:"5WBCUSB0AP
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M)S&2>%4_7]8=([?NR7 NC9&%:VX$7PIE"3"_DK".IF,%=&_(%_\ 4$L#!!0
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MO1E=,.#UPEK?3T* H=LOOP%02P,$%     @ RX-:4M*5ZM-J @  ( 4  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S8N>&ULA51-;]LP#/TKA-%#"P2UHR3]
M")( 3;MB/0PHVFX]##LH-F,+E45/DIOVWX^2$R\#VNP2BQ+?XZ/"I]F&[(NK
M$#V\U=JX>5)YWTS3U.45UM*=4H.&3]9D:^DYM&7J&HNRB*!:IR++SM):*I,L
M9G'OWBYFU'JM#-Y;<&U=2_N^1$V;>3),=AL/JJQ\V$@7LT:6^(C^>W-O.4I[
MED+5:)PB Q;7\^1J.%V.0WY,^*%PX_;6$#I9$;V$X*Z8)UD0A!IS'Q@D?U[Q
M&K4.1"SC]Y8SZ4L&X/YZQWX;>^=>5M+A->EG5?AJGEPD4.!:MMH_T.8K;ON9
M!+Z<M(N_L.ER1R*!O'6>ZBV8%=3*=%_YMKV'/<!%]@E ; $BZNX*194WTLO%
MS-(&;,AFMK"(K48TBU,F_"F/WO*I8IQ?W)E7-)[L.QP_R95&=S)+/?.&TS3?
M<BP[#O$)QU# -S*^<O#%%%C\2Y"RH%Z5V*E:BH.,-YB?PF@X )&)[ #?J.]R
M%/E&_^WR1KE<DVLMPL^KE?.6Q^+7@0KCOL(X5AA_4N&1W5*T&H'6T%<;P'5K
M+:\_NM.#?,&+4]?('.<)F\VA?<5DKPWI0B&^)JQ7:/NK@IS8+L['4U\AK$FS
M[90IX5@9WJ'625.XD^D'V >YX<GR:)74#HY@=#800L SNPH8W%@J68F#RT$V
MG,"M,HK'KH"2J' P'(C+#)[(2\W).YE',#X;3,0Y?'3#Z=[4UFC+Z$W'+;3&
M=P/<[_;VO^JF_F]Z]W9\D[94QH'&-4.ST_-) K;S8Q=X:J('5N3947%9\1.&
M-B3P^9K([X)0H'\4%W\ 4$L#!!0    ( ,N#6E(::7GOEP,  !L(   9
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MEE8*<RR&XV@_;83F5K9K![B2+6]+NJL=M*;$>J%6+SJ\X3O%_FF]4XP/0:T
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M(XGQ\9@=J5#%'N>#^5@DDK$I-LUQ^%V+B:VL2$A1BCB8,?$GV$8L4&<%1L'
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M&>C^PMJ_V';M+HFWK<4KIVNN\(ZO- W [XNVM9L76F#\K\'I?U!+ P04
M" #+@UI2RQIH3*D&  #X$@  &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6S%6%EOXS80_BN$NUO8@&+KM*0T"1!G$W2!/8(<+8JB#[1$V<1*HDI2.?;7
M=X8Z;">.-KM%T1>+DH8SW\Q\,T/KZ%[(+VK-F"8/15ZJX]%:Z^IP-E/)FA54
M347%2GB3"5E0#;=R-5.59#0UFXI\YMKV?%907HY.CLRS2WER)&J=\Y)=2J+J
MHJ#R<<%R<7\\<D;=@RN^6FM\,#LYJNB*73-]6UU*N)OU6E)>L%)Q41+)LN/1
MJ7.XB%#>"/S&V;W:6A/T9"G$%[QYGQZ/; 3$<I9HU$#A<L?.6)ZC(H#Q=ZMS
MU)O$C=OK3ON%\1U\65+%SD3^.T_U^G@4C4C*,EKG^DK<_\I:?P+4EXA<F5]R
MW\K:(Y+42HNBW0P("EXV5_K0QN$U&]QV@VMP-X8,RG=4TY,C*>Z)1&G0A@OC
MJMD-X'B)2;G6$MYRV*=/WI>)*!BYH0],D?$-7>9,38YF&E2CP"QIU2P:->X+
M:AR7?!2E7BMR7J8LW54P TP],+<#MG '-;YCR91XCD5<V[4']'F]HY[1YWW3
M4?*.JR07JI:,_'FZ5%H"-?X:,.'W)GQCPG_!Q >A%%DPJ!1&+J6XXX:Y0!XR
M7K"295R3"RF*"=D.^KY8O\+,LC%3]68R-+-LS63&#&_,:)-;?*_7C#PR*A5A
MF"4",6;%DLD^SOCKQ(26*2XBD@BH/J6)R,S>3.10Q+Q<D3$OX8FH%8BJR2'Y
MPV@]WZ^U46H4WI9<@\BUIAHPO2'CT \LWP\FN [LR KB9NU%MN6'W@3#!Y55
MDMASR7AN.:XS@;=6[('<CT7"6/6MP/$:JXYOA<Z\M>I;OAU-!L@0]&0(!K/T
MKP@PJ!K[]*&J:,*.1]"(%9-W;'1RL_[_V "**U&R4JL?)L99+24H."07+&62
MYI"-GW^*7,?]96<U=B%1ACT$^!#8 ?$"M^>("TF->^GN>B,TZ$L: R@3.,U.
M=PZ0,@;/TXW=;M?8L6"P39YH25OY;XA]#QD;0.#:O*$^PAK@W[SGWWR0?U<,
MTI7PG%,S_2!GM]/KJ8E=K85\W.(@N<)X:D'.LXR9*=D_W4?.8;O(0_G,-O+%
MV%>]_4T8B&SMBUH2UF/HW_P062GT!*I:DJK7$Q$];S" (-5;@ T6UYG:Y.V3
M2T-(DU"+E,Q42-;RJ<N]-YV#9#B-X7<^]>#WDR@/ $T-WL+4)= 8"Z@?>QI-
MX*5CQ#M6O25G:UJN0*@D=S2OF[A2=(V6"2-C/YSZN&WL>5/;+-QH&N"BXS4V
M"BJ3M8E0RN[@.%856! )T)E#Y7K3"#V:!L8Z_G9EU2<BY1 8K"(."FWC.N!U
M)UO7:RV2+Z8AP,&M@0DM(LT *W%B8V+CU&;U&?(K48F'2D#7ELKSYXS8"+88
M8"B\'2B:L"^:<)"\U^ NSWA"(2YGFZ8&Z>P:A>''J5(,'F,D\?8#ITL@N^;[
MF_F@R9>;N=K"DNQ@P3+I&Q'&A&[PX&V^P8,E8- _)7Q;)_&3.GG6OU\HE7?/
MS1^23\C\"MBF<2CD.)P3*N7C 13P/94I=KL@"BW7P7[GSB/+";V&,0=XLDYW
M>>-YEAW%Q(=A'\* H!6'ULJ_@EC.$Y#"8GN1U7@/I2OU05V!6@7A<4!1%  +
MK2AV3.(:ZC\%&<>6[?HD!*"N2TZ31-9@DSU4QB;@MN*Y2T++"\--'"38+FOH
M#[$5@I' @]-+0#YOHL' P9W,N*[E.1ZJ"T*'?##O,UY"/:.\6.9\U<3!]>!\
M$A''!D%[)PZ\!*.F-WF190=17U!-.75W$.YF+*TDYF0?=:+0MQP?<-O@]3P"
M. H2NK?51(#'GT.3@J9C6V$ A?AD-F[T]MUPGZ; MN800@\"X 2[C-J*$TSF
M/B@2_V(=B.R@5JQ#/G8<*_!B@.-:<P<:QB;F>\5A4GB^$?>MV(>F><$?L--W
MVB++#>&,,8ZL. "QMC&9P^(+1X&G)3=N',-CJG%M8@IC7]3WG7$&NEC4=['H
M.T<_3L\%6_&RQ+A@;< @Q.5I(>JVJ]R6.+:AYWQMNUQ[9%7D"GH##@,LCWT-
M;A#-_@9W^L(98;D#DC4@Z09DO0T2([GL0*:U1-EOGA->W?D6-#<TW=M!H1[?
M$,=W\+DTI9O6Y@A320ZGE4HHCFZI/JUPVMJ1ZXZCB-4XTFWI=PS;C_\;Z^IU
MYB&,C?O[V#K;^AI1,+DRWUQ@%& 2FP\3_=/^L\YI\S5C(]Y\$_I()?!!0??,
M8*L]#>&/D6R^LS0W6E3FV\92:"T*LUPS"B<>%(#WF1"ZNT$#_<>NDW\ 4$L#
M!!0    ( ,N#6E(5I_'$2@0  )(*   9    >&PO=V]R:W-H965T<R]S:&5E
M=#0R+GAM;*U6:V_;-A3]*Q=:,<2 &KTMR;,-Y%5LP%H$2;=B&/:!EJXM(I*H
MDE2<_OM=4K;RF.,%W;Y()$6><^Y3G&^%O%,5HH:'IF[5PJFT[F:>IXH*&Z9.
M18<M?5D+V3!-4[GQ5">1E?904WNA[T^]AO'66<[MVK5<SD6O:][BM035-PV3
MW\ZQ%MN%$SC[A1N^J;19\);SCFWP%O5OW;6DF3>BE+S!5G'1@L3UPCD+9N>)
MV6\W_,YQJYZ,P5BR$N+.3'XI%XYO!&&-A38(C%[W>(%U;8!(QM<=IC-2FH-/
MQWOT#]9VLF7%%%Z(^@LO=;5P,@=*7+.^UC=B^S/N[+$""U$K^X3M;J_O0-$K
M+9K=85+0\'9XLX>=']YR(-P="*WN@<BJO&2:+>=2;$&:W81F!M94>YK$\=8$
MY59+^LKIG%Y^HKC_*I2"#B7<5DPBG'QFJQK59.YI(C#;O&('=CZ A:^ !2%\
M%*VN%%RU)9;/ 3Q2-LH+]_+.PZ.(EUB<0A2X$/JA?P0O&LV-+%[T"MX5DRUO
M-PJN1W/_/%LI+2D[_CJ"'X_XL<6/7\$_9XH7P-H2+GG=:RSA@(//M)9\U6OC
M9M "+D334(+>:E'<5:(N4:I#OG\K<[EC;HFYWC,KR\Q>,!<#LWK"#%3HH"N$
M;\AHAB:00&' 9D4P^U"89Y!;.AID8, +5A=]S0PU,S U%;R"$]X2G.@5[54N
MX$.!G=[+H>./XDK*W\D,_K"\5X=Y!UI+^:EO4#(MY,SZV%KZ#D[2.'7]:3PQ
MXR2(73\,[#C*8C>-:/U:8L/[!CK&2["=I>ME45%E@UC3K$1J>\8_A6CO46IN
MQM3PUBCIX^ K^/&'+ S"G\;W2>P&83J!B[XQ+J!&0V&XYR6Y3PTDWP<;A&Z>
M3R>/%KXE@D>\$/N!FR4D]!);0>UD\-\7V[M,W$@9M>(1U<1%0:_H$X7Q^Q+*
M-5WS16I&6>!&4>3Z20Y1Y+N9'[I!- 5:#DAMD$6/%O]G,C([.#5.M(,D&1QQ
MFB>3(P6?C 6?'"V[I[4+5U][?L]J;#4E\$-1]R:'UU(T<+&K#?,CHBS[1W,8
MV]&APC^JP/RU9ZIC!2X<2B>%\AZ=Y6<JX*$"J=L]<Q3@HT@7[(G62#&_-EL/
MK!&],8#^X$J3'PT U;-1_6]=8(L4)7QFN.DDQ7/C_Z?^1*>XH.KB)+&P76>%
M!:-<-5^YI'728>\.6]'7)524W+0%R<)6\_=6!=7I[&B3&>(J.J-=042%E*1N
M$D40)_2:NGF00$+Y&U+B1B'<(/U*>&'$///YR[H.\LQ-\O35_7W+*0)4$SG5
M_]0'0D]3-XQSXLW<E$B).R3B."<I4UJAHIG&D 1NG&9N',=P*+>])_<$:IX;
M>QM21$T!'ZX,X^IXX3H;[AF/VX?;VD<F-YQ<4N.:COJG*26I'&Y PT2+SMXZ
M5D+3'<8.*[HTHC0;Z/M:"+V?&(+Q&KK\&U!+ P04    " #+@UI2DP$FF>,"
M  ! !@  &0   'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6R-56UOFS 0_BLG
MM ^MA J!0*!*(J4OV_JA4I2VFZ9I'PQ< JJQF6V:]M_O# G-MC:J%,'9OGON
M>>XX9[J5ZE&7B :>:R[TS"F-:<X]3^<EUDR?R08%G:REJIFAI=IXNE'(BBZH
MYE[@^[%7LTHX\VFWMU3SJ6P-KP0N%>BVKIEZN4 NMS-GY.PW5M6F-';#FT\;
MML$[- _-4M'*&U"*JD:A*RE X7KF+$;G%V/KWSE\JW"K#VRP2C(I'^WBII@Y
MOB6$''-C$1B]GO 2.;= 1./W#M,94MK 0WN/_KG33EHRIO%2\N]58<J9DSA0
MX)JUW*SD]BON]$06+Y=<=T_8]KY1X$#>:B/K73 QJ"O1O]GSK@X' 8G_3D"P
M"P@ZWGVBCN45,VP^57(+RGH3FC4ZJ5TTD:N$;<J=471:49R9?T&Y4:PIJQQN
M1-]C6ZR3>Y9QU*=3SU 2Z^KE.\"+'C!X!W 4P*T4IM1P+0HL_@;PB-U ,=A3
MO B.(EYA?@;AR(7 #_PC>.$@.>SPPG?P5OB$HD58*UG#)7%5]&E0V4T)EUW!
M4<'/1::[_5]'$HZ'A.,NX?@C":^?#2K!^)!+0_8"!VU8T&SIM^I^-(D=WG/=
ML!QG#DVG1O6$SGRI9-&2.,VHF39/OA>X>4W(9=XW?<LTT&\M.8VJAI-*@"EE
MJYDH].DY_$"F^J8"M03KC&#V;8$'41DZN#/,4*9/,$I#-PY]6*$V(-=V-GD!
ML1N, [B7AO1;G]1-)ONUVE6)6!Z08U0-&R];-9 GEJ( ^O(YRZ3JN3=,&6&/
M/B!"OZLB\$>I?23_Z9G$8S<*4K*BL9M.8C*2U/4GT3\*P\1-XA@B-PA#&$=N
MFH:#WL0/W3"-R(I]-_ MV"B,7#].X*VOS#N8:E*]Z>XN3;I;8?H!'W:'ZW'1
MWPJO[OW=>LO4IA(:.*XIU#^;1 ZH_K[J%T8VW1V124,E[LR2KGA4UH'.UU*:
M_<(F&/XTYG\ 4$L#!!0    ( ,N#6E*9OY5:9 ,  -8)   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0T+GAM;)5636_;.!#]*X300P($T;>L%+:!Q%ZC/10U
MZJ9[6.R!EL8R$8G4DE3<%OOC=R@I\H<D(ZN#1%+S'M\,9TA.#T*^J#V )C^+
MG*N9M=>Z_&C;*ME#0=6]*('CGYV0!=78E9FM2@DTK4%%;GN.$]D%9=R:3^NQ
MM9Q/1:5SQF$MB:J*@LI?3Y"+P\QRK;>!;RS;:S-@SZ<ES6 #^KE<2^S9'4O*
M"N"*"4XD[&;6H_MQ%1O[VN '@X,Z:1/CR5:(%]/YG,XLQPB"'!)M&"A^7F$!
M>6Z(4,8_+:?536F I^TW]E7M._JRI0H6(O^3I7H_LV*+I+"C5:Z_B<,G:/T)
M#5\B<E6_R:&U=2R25$J+H@6C@H+QYDM_MG$X ?C1",!K =XE8#("\%N ?P'P
MXA% T *"2X [ @A;0/A>0-0"HCKV3;#J2"^IIO.I% <BC36RF4:]7#4: \RX
M2:R-EOB7(4[/O\J,<O:;-LO,4[($E4A6UGVQ(T^50H12Y&8)FK)<W9(/Q"9J
M3R4HPCAYYDRK.QS$]O>]J!22J*FM49N9P4Y:'4^-#F]$QQ?ZBWCN'?$<SWG>
M+,G-A]OC/,U[@'1QG70%VWOB!O^7=7F==0G)/?'/M9929)(6 V1_O)O,?6C)
M!EA6[V>)!UELS(LN.;PN.;R:UG]'<MR1A>!*Y"P]YLH:XP=<T[=D63%.><)H
M3C8X"+C_:$7^>MPJ+7$'^?N*(K]3Y->*@C%%)4B<CF<D%TH-KU[#$-8,9E]]
MG4^"B1,%4_OU=%WZ9J$;.)Y[;K;JF_EQ,/&/;&=^!)T?P54_-DW]8,P24108
M/2STY(4PI2I(R0W64I.=M^1?,IJG3\T<T8DV=Q(YYCEW8M$W]!TO\MTP'G8C
M[-P(K[JQEBP!@FO2B"0WE4J/72/^6&Y##H3]I8HNI/=-W(=AT5$G.KHJ^C'+
M)&28GX3CP8V5FP"DBNRD*(C> R[*#B2FV)#@J*_&'PIXWRX,'L(3LS/EDT[Y
MY+KR)*F**D?IJ3D]6<+T4 %,>I-[7N"';GQ1 7T[-WB(@G DM^-.97Q5Y1)>
M\;Y2FNHG[;ZH,!/&M\AEW$O/DS)L--@G1YRY\7RA,F-<D1QV"'+N)^B&;&X1
M34>+LC[UMD+C&5HW]WCQ FD,\/]."/W6,0=I=Y6;_P=02P,$%     @ RX-:
M4HQD-*HF!   :1   !D   !X;"]W;W)K<VAE971S+W-H965T-#4N>&ULS5C;
M;N,V$/T5PNC#+K"-1,KQ96$;L.,-&B )@@2[?2CZ0$MCFX@D>DDJS@+]^ XI
M1?)%9HRB#\E#(M$SAV<N/D-FM)7J6:\!#'G-TER/.VMC-E^#0,=KR+B^D!O(
M\9.E5!DW^*I6@=XHX(ESRM* A6$OR+C(.Y.16WM0DY$L3"IR>%!$%UG&U:\9
MI'([[M#.V\*C6*V-70@FHPU?P1.8[YL'A6]!C9*(#'(M9$X4+,>=*?TZ9\PZ
M.(L? K9ZYYG84!92/MN7FV3<"2TC2"$V%H+CGQ>X@C2U2,CC9P7:J?>TCKO/
M;^C7+G@,9L$U7,GT3Y&8];@SZ) $EKQ(S:/<_@%50)<6+Y:I=K_)MK(-.R0N
MM)%9Y8P,,I&7?_EKE8@=!S8XX< J!W;H0$\X1)5#=*Y#MW+HNLR4H;@\S+GA
MDY&26Z*L-:+9!Y=,YXWAB]S6_<DH_%2@GYD\E?4F<DF>Q"H72Q'SW)!I',LB
M-R)?D0>9BEB )K^WKMYSI;BM'?DT!\-%JC^/ H/,+'X05RQF)0MV@@5EY$[F
M9JW)MSR!9!\@P)#JN-A;7#/F19Q#?$$B^H6PD(7?G^;DTV^?-:RP8TT+O:NS
MP>BP FM!F9^/,FA%V8LTJBL8.=CH!&Q;4?Z:+K11^)WZV[-!M]Z@ZS;HGMC@
MOL@6H&R'H-K86N-.52HU^8><SNJLQ.TY7"M +Q,Z"EY:J%S65"Z]5*8IZA3/
M8R"H>"21Q<(LBQ3%PZ5 MW$H 2]W.(0UA[+V/HL]EKV:9<_+<L83E)Z%(?"*
M\JRAC5;O*#6'M-ZUF/?.)=ZOB?>]K73-A2(_>%K %S+5&K"^/$_(K> +D0IC
M.^L.N"X4) 0U^Q'B0BG;#M;J7N:J7IAQ+; -;W$#<F,@T[Y&'-3T!MZ\WF0;
M)&B;[2VSK14?''==+[0_!PD^MCM,L,]B+X)A'<'0&\$C:. J7KN$)?""8W=S
MZLLS/ XCZH=1-#R.Y-BT.^Q%X;'EO,7RLAL.V*[E7F0T; 9)Z(WMV\]"N&#*
MGL$^P2ZYYG'5.9[ZTYUA13]B@U+6$&3_6X$KJ-WO+PV'K:U:F?IZM07M5$F;
MR4(C;S1W(A=9D?DRTPP1VOV0I6M&"_7/EKE5;)'CW"Q<%QM066O9_#!XE,G<
M4<9'JIDDU#]*[KAZQE/5(@6<LYB ,E%XW+6/OTYS]*.>Q;$9&K3_#L?7][JD
M47@Z^)!=T@@X]2OX?RV('_6<@K!&B9E?B6^M[A"*9[/=C/B@&P%F'U* 62/
MS"_ MV"P!MJ>5F,D(5J5E[4H+Z-MPMMF20?[EB738.<.EH%:N;NL)NY@6EY;
MZM7ZOCQUM\2#]1G>H\M;;P-37L*Q]U8H4"2%)4*&%WVDI<I[;?EBY,;=]!;2
MX+W1/:Z!)Z"L 7Z^E-*\O=@-ZO\N3/X%4$L#!!0    ( ,N#6E(YCGD#X0(
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M>L.!V.4YX;^N:<;V4PM:AXW;=+V1>L.>3;9D31=4WFUON%K9M98DS6DA4E8
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M.AG-XT:-@I1K ?5^Q9@\++2!>KB<_0%02P,$%     @ RX-:4K4=G=89!
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M0=_SH]IJ+]*PCC3LC'1",ZKKI.=6Z>Y4B"9\8\+5<S.>3U'DA1WUB.JG1)=
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M=AO@_58I>YXX@O9_Q_PK4$L#!!0    ( ,N#6E+E6$+Y5 0  -08   9
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M8S0&KUYC?SD DU]PG/YZW^[6FF<@Z9U.,^D94GIVROV 6VL?O./.LN[6FF>
MZ=F!V6I-N6HPTKRF^(:POOW2W+1WG-!XL>$B9XBN3J .IH%J=,4F3:-M<<^D
M=>?E&Z#ZIW/Y[ANP^G:POJKS\H]O@J+*UJN[]Y1675"LLD?\0C76FT3FCY'*
MO>5K!)/LX?G!_BMX,8,5^^?PXGW^DH QG[^S<(OYBJHY$9&E<N6<]U6T/'\-
M(-^0+,V>$2^8E"S.OJX)5NV^/D#]OF1,[C:T@_)EC/%_4$L#!!0    ( ,N#
M6E+:_P61A ,  $X/   9    >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;,U7
MVX[;-A#]%4+(0P*D*Y'R10YL QN[10,TB+&7!&C1!UH>6T0D427I]2[0C\^0
MTDIR[)4W[0:P'V1>9D9GSA$YY'@GU5>= !ARGZ6YGGB),<4[W]=Q AG7%[*
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MH.P&7%]*:1Y/[#S5S,^3?P!02P,$%     @ RX-:4LSA <,$ P  EPD  !D
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M"&9#AK# 5[ZTW)!CA73,'$_OR$ 61B$UQ$@R F4W%L$+.3<9*$V^?\6HY-1
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M6,Q5C::=_1%S5<YI\A_$3#9.,9H$\>.S;IM9%(>/#SM_K96UWQ%G3,UXH8F
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M EZ"&RZ\3^"G'X8(PE^!!+DI7P8>&(=AX$8>3T 0@6FTR';M-@&3(.%RUR7
MC7QPJ2P$^.AZGKQB GZ>\-0-PN07.?"'NPGX^<=?P(]J@#]7$BL1R5D_E?-1
M7O6]W/??=KZC%M]OW"> X N '.08T)=V]%M^_PI T@J?V.'CC7@%L*/@<&B
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MTAC0][D0>CLQ#NI&<?0'4$L#!!0    ( ,N#6E+=3IG^30,  . +   9
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M ;2>2FGN)_:2UU[JAW\ 4$L#!!0    ( ,N#6E*[WO_HK0,  /P.   9
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MV&E._P*4QH#.%T+H[<(X:/\N@[]02P,$%     @ RX-:4BMN;BF! @  ;08
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M)!&;(VJ*_$-.*'N+>H"V'UF/!XUHTZ=4^[_XRXY%R0&Q;,XR\DWM^GTM10"
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M48HYD5>\0*9'$BYRHK0IEJXL!)+8.N69&WA>U\T)94XXM'T3$0[Y2F64X42
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MC5 WK,WO *4-,/N5$/II8CO.\(/)_P)02P,$%     @ RX-:4G1N&V3+ P
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ML P7 N0Z3:EXOL2$;R8.<;8/;E@4*_/ G8YS&N$MJOM\(?3(K5!"EF(F&<]
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MV4 #B*)%+0:*Y[8M7'*EFTQ[&^NV'H59H.=7G*OMP'2:U1^%Z5]02P,$%
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MIAKV*SN'>MOV,^8[F@F0D*WR"P9C%8!?=D(O)Y(=\LW$-9.2I?GAGN -X=I
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M\6,![;,O\JN*'/90&'L?'@EE>_4@8A0-R>#=0/#8-05;V]&%MW3!(1"B+G(
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M850TX3!#T^"D@\RJ:%F*B9$+UR9,I<&FPPU3;/- V0WX?2:E64\L0=4X#OX
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M3#"Y,6#9O0]=H$7C6FPKM&E8-ZS,DPK2)ICUG1#Z/;!=.SS2V1]02P,$%
M  @ RX-:4D4JS?5)!   ,Q(  !D   !X;"]W;W)K<VAE971S+W-H965T.#<N
M>&ULO5C+;MLX%/T5PNBB!9)(I-Z!;2"Q6TR %C":Z<QB, M&HFVA$NF2E)W,
MUP]%R:(LRXI;I-[8)'7OY>&YY.%CO&/\NU@3(L%SGE$Q&:VEW-Q:EHC7),?B
MAFT(55^6C.=8JBI?66+#"4ZT4YY9R+9]*\<I'4W'NFW!IV-6R"RE9,&!*/(<
M\Y=[DK'=9 1'^X:OZ6HMRP9K.M[@%7DD\MMFP57-:J(D:4ZH2!D%G"PGHSMX
M.T=AZ: M_DK)3K3*H!S*$V/?R\I#,AG9)2*2D5B6(;#ZVY(9R;(RDL+QHPXZ
M:OHL'=OE??1/>O!J,$]8D!G+_DX3N9Z,PA%(R!(7F?S*=G^0>D!>&2]FF="_
M8%?9>LHX+H1D>>VL$.0IK?[Q<TU$RP'Z)QQ0[8"Z#NX)!Z=V<,YU<&L'5S-3
M#47S,,<23\><[0 OK56TLJ#)U-YJ^"DM\_XHN?J:*C\Y77 UA;A\ 9@FX../
M(MVHI$KP?DXD3C/Q 5R#;X]S\/[=!_ .I!3\N6:%4+9B;$G5?1G$BNNN[JNN
MT(FN( )?&)5K 3[2A"2' 2R%NP&/]N#OT6#$.8EO@ .O +*1W0-H=K8[C'K<
MY^>[AP.C<9I4.#J>\THJKL BPRH'AQGYY[,R!P^2Y.+?@<[<IC-7=^:>DW>R
M[^4*K#@3O;FMPGDZ7"DFVZD+?<]3M&_;C!^;H<BW@Z@Q.T#K-6B]0;2?B1"W
MX"Z.B[S(L"2)6MI*YN(4E^+1![>*Y[=P7$,8^3[LX.VQBUPO=/OQ^@U>_Y?8
MI43V@?6/0"C2PC#J8.TQLZ$;>?U8@P9K,(AUWF)2X\4YXS+][R2UP1$,!R*O
M2VR?E8TZ5O/@>+JXH8_Z1Q0V(PJ'9PM^8AQ+QE\,]P-+)FK"1K]_?4+;"+/]
MMBNTCM>F'"([@&XG,WUV=HB\H)]UV-I*X"NK5&W :Y8E(,TWG&U)"5@,D8%,
M:'0![HT20^>-N7>..0VBR.ZNBCX[#[G(/\&]D7,XK.>?"DY367!R!9;I<UD0
M&CR3:\*'.#$2#+T+I, H*/PU"3V=@F-Y=/V6E-0).+9R''B*?J.A<%A$9RS?
M%))P@U3C%FPI=YB3(4:,JL'P @DP:@>C-TY =#RW'2<*NQGH,8-1>&(70T8O
MT;!>/E#%/\59]J(.!UMUH=F0LQ* C+XA^/L3@(SF(?2V":CCM9D-],'X@/_7
MK [1&LE$PY*I;XS7;'E=" *P$$262D0QC5.Z&N+#2!QR+T"_T3LT?.;\>?J/
MSY*>[[C=^=]CIF:_<X)_HY=H6"]GC K)B^HVK2YJ:@->J4U@:/M%1MY0< 'J
MC=*AX0/<SU,?'ITC'=>S@R[U/68(=4^;5NLVG1.^TJ\2 L2LH+*ZFS:MS<O'
MG;[O=]KOX>V\>K\P8:KGE"^8KU(J0$:6*J1]$RA(O'JAJ"J2;?2=_8E)R7)=
M7!.<$%X:J.]+QN2^4G;0O!--_P=02P,$%     @ RX-:4J>W<MGO @  F0<
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M2!. SU="Z-W"C.?V-)[\!5!+ P04    " #+@UI2I]N*J$\#  #!"0  &0
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MW1:*PC >AH];^-@)_YE)7%BTH_LD'ICCQ$<]4%LJFD?1,.B\!9T[01]RM4V
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MM5A;<YLX%/XK&F]G)YE) $G<W'4\DSAMMP_=9I)>GA60;:: O)(<)_]^)<!
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M8+?N*#/*-\75K0 1V^>RO,>K9^OKX>OB4O3-_ U\ORHO>1LQY9WS%\+5B4&
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M%%C<L(J4ZLZ*\0)+M>5K6U2<X-0$%;F-'">P"TQ+:S8QU^[Y;,(V,J<EN>=
M;(H"\[<YR=EV:D%K=^&!KC.I+]BS2877Y)'(G]4]5SN[94EI04I!60DX64VM
M6_AY"6,=8!"_*-F*O3704IX8>]:;;^G4<G1&)">)U!18?;V0!<ESS:3R^-.0
M6NTS=>#^>L?^Q8A78IZP( N6_T-3F4VMR (I6>%-+A_8]BMI!/F:+V&Y,)]@
MVV ="R0;(5G1!*L,"EK6W_BU*<1>  Q.!* F /4#O!,!;A/@OC? :P(\4YE:
MBJG#$DL\FW"V!5RC%9M>F&*::"6?EMKW1\G57:KBY.Q1LN3Y>JXJEX(%*]3K
M)+ QY!J<O'7WJM<$?%P2B6DN/BGPS\<E^/CA$_@ : E^9&PC<)F*B2U5COI)
M=M+D,Z_S02?R@0A\9Z7,!+@K4Y(>$MA*7*L0[13.T2CCDB0WP(57 #G(.9+0
MXMWA,#X2OGQ_>#2BQFW]<@V?>\JO#'-R_61,N<=OZA<HP2WGN%P3O;[:F9,"
M57^PP!65.*?_D?0*W!9LH]#__J4HP3=)"O%[)"&O3<@S"7FC+U"=4++_EI Z
MD6.O0,WH&T;=F%YFL>L@.+%?]GT9HB(($3I$+8>H$/F!WZ(.1/FM*']4U ,1
M!/,D,T5,R8MJCY4N[TB]@I8ZN P#PS:A\.P&UHS!7M'] /I^S\ ARHN0'_<,
M'*+<,-A#'8B*6E'1N"AUD-!R?076I"0<YZ:8.%4-E K)L3YK1DH7MT^)+\-+
MZ'3MW#F[FPWE@05!% 0].X_!4!2X/3^/P;S8"8X;"O<.*CBJ[.]*ZQ!C54(=
M%[H0X[J^#MWS&^<.2AV&H1?UC3L"\\+(Z1LWA 7*X.B$<=T! <=/"-5,):>)
MK(452I+06DUI-R65HY9V'1OZ%V)IU^EA<'Y+@X$)$'E._VP\ O,A\ON.#E$Q
M"L,3AG8'!AP_,>Z**F=OA#0^5AMU4BJ1H,IQ.5:XKGG#Z$*\[#H]C,_O93SX
M;X*B$/6M'*(@@F'?RB'*Z?EH[TT!!>%K,TT)E:TJ2/UWN;W:3FRW9D[I79_K
M2<Y,%QU-/09^QWQ-2P%RLE*4SDVH\N'U9%5O)*O,K/'$I)I<S#)3TRCA&J#N
MKQB3NXU^0#O?SOX'4$L#!!0    ( ,N#6E+BQQ2"BP(  ,H&   :    >&PO
M=V]R:W-H965T<R]S:&5E=#$P-BYX;6R-56U/VS 0_BM6Q"20MN:E20<HC40I
MT_8!J8*Q?9CVP4TNC85C9_:5PK^?[:2AL#;KE\0O]SSWW)U]3C=2/>H* ,ES
MS86>>A5B<^G[.J^@IGHD&Q!FIY2JIFBF:N7K1@$M'*CF?A0$$[^F3'A9ZM86
M*DOE&CD3L%!$K^N:JI<9<+F9>J&W7;ACJPKM@I^E#5W!/>!#LU!FYO<L!:M!
M:"8%45!.O:OP<CZQ]L[@!X.-WAD3&\E2RD<[^59,O< * @XY6@9J?D]P#9Q;
M(B/C3\?I]2XM<'>\9?_B8C>Q+*F&:\E_L@*KJ7?ND0)*NN9X)S=?H8LGL7RY
MY-I]R::U328>R=<:9=V!C8*:B?9/G[L\[ #"0X"H T3O ?$!P+@#C(\%Q!T@
M=IEI0W%YF%.D6:KDABAK;=CLP"73H4WX3-BRWZ,RN\S@,+NI&RY? ,@,!)0,
MR8)304[G@)1Q?48^D8?[.3D].2,GA ERRS@WY=*IC\:YI?#SSM&L=10=<!1&
MY%8*K#2Y$044;PE\H[J7'FVESZ)!QCGD(S(./Y(HB((]@JZ/AH<7>^#SX^'G
M ]&,^T*,'=_X -\=(%-@+A1N2Z')KZNE1F6NQN\!!W'O('8.X@,.%J!RRRY+
M<WXPK_:5<)@A"49!\&% 2M)+28Z2DIL#H=ARC5"0Y0MIJ$*6LX8*W"=NF'/R
M'VV37MMDD.>[1,K;##&Q>I5XZ-2W;(ECLSWV*4M2_VGW&+86%SL6\2AZ:S/_
MUR8:A;U-&XB_<\MK4"O7+;51N!;8WII^M6_(5ZX/O5N?F4;=]M57FK;+WU*U
M8D(3#J6A#$:?35RJ[9SM!&7C>LE2HNE,;EB9QP:4-3#[I92XG5@'_?.5_050
M2P,$%     @ RX-:4A>D__', @  ?@<  !H   !X;"]W;W)K<VAE971S+W-H
M965T,3 W+GAM;(U576^;,!3]*Q;J0RNMY9LD51*I*:M6:96BIMT>ICTX< E6
MP6:V2;)_/]L0EC*2]07\<<^]Y_CZ7D]WC+^)'$"B?5E0,;-R*:M;VQ9)#B46
M-ZP"JG8RQDLLU91O;%%QP*D!E87M.4YDEYA0:SXU:TL^G[):%H3"DB-1ER7F
MOQ=0L-W,<JW#PC/9Y%(OV/-IA3>P OE:+;F:V9V7E)1 !6$4<<AFUIU[&T?:
MWAA\([ 31V.DE:P9>].3QW1F.9H0%)!([0&KWQ;NH2BT(T7C5^O3ZD)JX/'X
MX/W!:%=:UEC /2N^DU3F,VMLH10R7!?RF>V^0*LGU/X25@CS1;O6UK%04@O)
MRA:L&)2$-G^\;\_A".!&)P!>"_#Z@. $P&\!_D<!00L(S,DT4LPYQ%CB^92S
M'>+:6GG3 W.8!JWD$ZK3OI)<[1*%D_-'FK 2T O>@T#7Z"L3 BU 72= 2\ZV
MQ*17G3"Z7 "%C$CTP%EYA=[A+F.0F!3B2GEX7<7H\N(*72!"T4O.:H%I*J:V
M5&1U2#MIB2T:8MX)8JZ'GAB5N4"?:0KI>P>V4ME)]0Y2%]Y9CS$D-\AW/R'/
M\9P!0O<?AKN3 7C\<?CXC!J_2YQO_/G_31R*B4@*)FJ5LQ]W:R&Y*J:?9T($
M78C A A.A'BE1$**5A)+&,Q@ P\-7/>7[?QZ%(1!$$[M[?'!#MB%SCB<].SB
M 3M_[ 0CO[-[IR/L=(1G=:CKJ\J?#BEH@-%1Q(GO]=C_:W,=N9[;XSY@Y4_\
M<)AYU#&/SC(WY;ANRK'JRC'3Y;ANRS$SY4B:VR!U.0[IC(8R%82NW],Z8!>Z
MP<B->FH'[/QQ$#CCGE[[J#.5P#>FPPN4L)K*IG*[U>X1N3.]L[>^4(]+\Q;\
M==.\3$^8;P@5J(!,N71N1HH5;[I],Y&L,OUOS:3JIF:8JP<2N#90^QEC\C#1
M ;HG=_X'4$L#!!0    ( ,N#6E))%4\O$ ,  &,*   :    >&PO=V]R:W-H
M965T<R]S:&5E=#$P."YX;6R=5EUOVC 4_2M6M(=6&LT7"5 !4H%5ZT,E5-KM
MV20W)&IB,]M ]^]G.R&%Q*1H+Q [YQR?>^WXWO&!LG>> @CT4>2$3ZQ4B.V]
M;?,HA0+S.[H%(M\DE!58R"';V'S+ ,>:5.2VYSBA7>",6-.QGENRZ9CN1)X1
M6#+$=T6!V=\9Y/0PL5SK./&2;5*A)NSI>(LWL +QMETR.;)KE3@K@/",$L0@
MF5@/[OW"U02-^)7!@9\\(Q7*FM)W-7B*)Y:C'$$.D5 26/[M80YYKI2DCS^5
MJ%6OJ8BGST?U1QV\#&:-.<QI_CN+13JQAA:*(<&[7+S0PT^H @J47D1SKG_1
MH<(Z%HIV7-"B(DL'14;*?_Q1)>*$X(87"%Y%\)J$_@6"7Q'\:PG]BM#7F2E#
MT7E88(&G8T8/B"FT5%,/.IF:+<//B-KWE6#R;29Y8OI$(EH >L4?P%$/+1G=
M9WI/95;1S0P())E CXP6M^@,>[, @;.<WTK6VVJ!;K[=HF\H(^@UI3N.2<S'
MMI &U3)V5)F9E6:\"V9<#SU3(E*.?I 8XG,!6T96A^<=PYMYG8H+B.Z0[WY'
MGN,Y!D/SJ^GNR$!?7$\?=D3CUYOE:SW_@MY\QQ@0<=\AU:^E^EJJ?T'J$6)@
M.#?M44D,-%%=&_NIS-S^-&E?(A9M1,\+:\R9XZ!V''0Z7@DLP.2WI(4G:_E>
MPW ;$CA!P[)!)O#,EL/:<MB=9,KDO4-,IL/6:EZ@CMB9[3:HF><NQ)GE06UY
MT&GYE0J<RXM''S23\8'!>. VC+=![7RW,?ZE(S*LS0\[OX\%)""-QUT?R*C6
M&OWO!S+Z:EOF;43/E96XD8$NG3//KO-YFSM7;%]<Y<%X SM?NC= 3/8[E<[]
MGU0C]PK_V[H*):H*K:LJE.@JE)552*@J9 S0;=T]AA-J0/7"4?.,&E#M0VJ?
M5-\"V$9W,1Q%=$=$6:GJV;I3>M#]06-^ICHH7=4_9<KVZQFS348XRB&1DL[=
M0#IB94=3#@3=ZAJ_ID)V#/HQE5T@, 60[Q-*Q7&@%JC[RND_4$L#!!0    (
M ,N#6E) LAZ1M ,  $(.   :    >&PO=V]R:W-H965T<R]S:&5E=#$P.2YX
M;6R=5UMOVS84_BN$@ (9T.KJ^%+8!I*HQ?K0+DC6[6'8 RT=640HTB/I./WW
M(RE9MEN*2OMBBQ2_CSS?N>AP>>#B2=8 "KTTE,E54"NU>Q]%LJBAP3+D.V#Z
M3<5%@Y4>BFTD=P)P:4$-C=(XGD8-)BQ8+^W<O5@O^5Y1PN!>(+EO&BR^W0+E
MAU60!,>)![*ME9F(ULL=WL(CJ*^[>Z%'4<]2D@:8))PA =4JN$G>YTEJ ';%
M7P0.\NP9&5,VG#^9P:=R%<3F1$"A4(8"Z[]GN -*#9,^QW\=:=#O:8#GST?V
MC]9X;<P&2[CC]&]2JGH5S -40H7W5#WPP^_0&71M^ I.I?U%AVYM'*!B+Q5O
M.K ^04-8^X]?.B'. ,ET )!V@/1[P&0 D'6 [+6 20>86&5:4ZP..59XO13\
M@(19K=G,@Q73HK7YA!F_/RJAWQ*-4^M/K. -H#_Q"TCT#CU P5E!*,'6*[Q"
M7\/'$#TJK/:*BV_HM!X]8 5(<?2AJL!Z[S1[E8/"A,K?EI'2AS1;145WH-OV
M0.G @9(4?>9,U1)]8"64EP21MJXW,3V:>)MZ&7,H0I0E;U$:I['C0'>OAB<+
M!SQ_/7SNL2;K'999OFS482@GLJ!<[@6@?VXV4@F=1/]ZMICT6TSL%I.!+0PW
M6*="B;!"LO>^T,YUN=3/ER9A'+]Q*?^+N/SG<1="7/="7'N)3-CK$#>Y\18Q
M781U/E10@L 4;8!!191+#3]I%D[=8OAALW#AUL(/FX:95XII+\74R_.%LW<Z
M'?<ZT3<4$%'02)?M?I:K.)S';UQ5X<X/3 9$R_VP>"009KWU,R_/78W95EO-
MT#.F^[8V8JJ_F9@5SH3PTUU-9N%D0(<19)89DUS(? 29SL/K'Y 7:LQ[->9>
MJH]="@B0@$51(\Q*_:U]UDW$3K<$"A4"2J*<\>%GSDQXN%3QPU)CF4L2/RSY
M$7:AQZ+78^'7@PO=7C!3*&R%1"71U5-H)0BF+A'\=(Z@;47PPW1NI0.1\0O
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M?K;3C<+1F4X'+9# "F0!*Y 28J(QQ5PIT$?;(.@9#X,!'0Q;XTUQ!KW$#+V
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M5%JGJEFW#]4^.' !5+ SVR2=M!\_VQ":%Y)5E?HEV.:>Y^X>+N<;KBE[XCF
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M;8+9+X30V\#.A^[O(/T'4$L#!!0    ( ,N#6E)).:GU4@(  %X,   -
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " #+@UI2F5R<(Q &  "<)P  $P
M            @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M ,N#6E+:D4#P@08  ,49   8              " @0T(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " #+@UI2]/J/XJ@&  "!&P  &
M            @('$#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ RX-:4L43"4G? @  NPD  !@              ("!HA4  'AL+W=O
M<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( ,N#6E+&6.E2Z04  ,\7
M   8              " @;<8  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q0
M2P$"% ,4    " #+@UI2-\-M0I(#   -"@  &               @('6'@
M>&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ RX-:4FM FN>4
M @  ] 4  !@              ("!GB(  'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;%!+ 0(4 Q0    ( ,N#6E)(G^63T@D  #PY   8              "
M@6@E  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #+@UI2
M0(E/7I "   A!@  &               @(%P+P  >&PO=V]R:W-H965T<R]S
M:&5E=#@N>&UL4$L! A0#%     @ RX-:4O.R>[98"0  8BH  !@
M     ("!-C(  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    (
M ,N#6E)6._R'/@D  $X4   9              " @<0[  !X;"]W;W)K<VAE
M971S+W-H965T,3 N>&UL4$L! A0#%     @ RX-:4H40+SOR*   LX0  !D
M             ("!.44  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"
M% ,4    " #+@UI2@A^D,#@(  #/$P  &0              @(%B;@  >&PO
M=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( ,N#6E*39 DX.0@
M -83   9              " @=%V  !X;"]W;W)K<VAE971S+W-H965T,3,N
M>&UL4$L! A0#%     @ RX-:4H_<!+;9'@  9H4  !D              ("!
M07\  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " #+@UI2
MY4-GE#D(  !%&0  &0              @(%1G@  >&PO=V]R:W-H965T<R]S
M:&5E=#$U+GAM;%!+ 0(4 Q0    ( ,N#6E*MJ5[&A@4   H/   9
M      " @<&F  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%
M  @ RX-:4H\#9;A4 @  # 4  !D              ("!?JP  'AL+W=O<FMS
M:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #+@UI2/B]%&4\#   9!P
M&0              @($)KP  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+
M 0(4 Q0    ( ,N#6E(K!V+CJ00  / *   9              " @8^R  !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ RX-:4@?+'  .
M#   8CP  !D              ("!;[<  'AL+W=O<FMS:&5E=',O<VAE970R
M,"YX;6Q02P$"% ,4    " #+@UI2)VP#.[ *   _'   &0
M@(&TPP  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( ,N#
M6E*9 8S/C@0  !$,   9              " @9O.  !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&UL4$L! A0#%     @ RX-:4N7[[X7I#0  +"@  !D
M         ("!8-,  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
M    " #+@UI2^S>IA1,#  "K!@  &0              @(& X0  >&PO=V]R
M:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( ,N#6E)R@,"7\ P  ($C
M   9              " @<KD  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL
M4$L! A0#%     @ RX-:4@A-W*D>!   V0D  !D              ("!\?$
M 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " #+@UI2)AV;
M;CT(  #H$P  &0              @(%&]@  >&PO=V]R:W-H965T<R]S:&5E
M=#(W+GAM;%!+ 0(4 Q0    ( ,N#6E)@?%VUM ,  "L(   9
M  " @;K^  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @
MRX-:4LM/CN#%+   RY@  !D              ("!I0(! 'AL+W=O<FMS:&5E
M=',O<VAE970R.2YX;6Q02P$"% ,4    " #+@UI2,;4Q#'L&   @$P  &0
M            @(&A+P$ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4
M Q0    ( ,N#6E+<:G&<]@,  (4)   9              " @5,V 0!X;"]W
M;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ RX-:4HC=#M7? @
M-P8  !D              ("!@#H! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX
M;6Q02P$"% ,4    " #+@UI27W<N>0D+   S+0  &0              @(&6
M/0$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( ,N#6E+:
MLKQYV 8  $\6   9              " @=9( 0!X;"]W;W)K<VAE971S+W-H
M965T,S0N>&UL4$L! A0#%     @ RX-:4M<1:LMD P  ^0<  !D
M     ("!Y4\! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,N#6E(&Q\/+9@8  $$0   9              "
M@7%I 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ RX-:
M4LL::$RI!@  ^!(  !D              ("!#G ! 'AL+W=O<FMS:&5E=',O
M<VAE970T,2YX;6Q02P$"% ,4    " #+@UI2%:?QQ$H$  "2"@  &0
M        @('N=@$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0
M   ( ,N#6E*3 2:9XP(  $ &   9              " @6][ 0!X;"]W;W)K
M<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ RX-:4IF_E5ID P  U@D
M !D              ("!B7X! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q0
M2P$"% ,4    " #+@UI2C&0TJB8$  !I$   &0              @($D@@$
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( ,N#6E(YCGD#
MX0(  "\(   9              " @8&& 0!X;"]W;W)K<VAE971S+W-H965T
M-#8N>&UL4$L! A0#%     @ RX-:4DAD??;_ P  @10  !D
M ("!F8D! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " #+
M@UI2M9IG!- "  !9"0  &0              @('/C0$ >&PO=V]R:W-H965T
M<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( ,N#6E*;44RD>0,  -,*   9
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M970U,RYX;6Q02P$"% ,4    " #+@UI2Y5A"^50$  #4&   &0
M    @($<I@$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    (
M ,N#6E*8'!MA-@8  )@A   9              " @:>J 0!X;"]W;W)K<VAE
M971S+W-H965T-34N>&UL4$L! A0#%     @ RX-:4MK_!9&$ P  3@\  !D
M             ("!%+$! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"
M% ,4    " #+@UI2Q*>7VHT#  !+#P  &0              @('/M $ >&PO
M=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    ( ,N#6E+,X0'#! ,
M )<)   9              " @9.X 0!X;"]W;W)K<VAE971S+W-H965T-3@N
M>&UL4$L! A0#%     @ RX-:4O8X+_^@ @  J 8  !D              ("!
MSKL! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " #+@UI2
MQBWK$4T#   L#0  &0              @(&EO@$ >&PO=V]R:W-H965T<R]S
M:&5E=#8P+GAM;%!+ 0(4 Q0    ( ,N#6E)NJI!NQ0(  &0(   9
M      " @2G" 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%
M  @ RX-:4HP)NQJ5 @  2@8  !D              ("!)<4! 'AL+W=O<FMS
M:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " #+@UI2/8P) :4"  "N!@
M&0              @('QQP$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+
M 0(4 Q0    ( ,N#6E*J)WF&5P@  *TQ   9              " @<W* 0!X
M;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ RX-:4B1M*V9Z
M P  <PP  !D              ("!6],! 'AL+W=O<FMS:&5E=',O<VAE970V
M-2YX;6Q02P$"% ,4    " #+@UI2":U*.M4"  #P"   &0
M@($,UP$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( ,N#
M6E(!\0=8+ ,  #0*   9              " @1C: 0!X;"]W;W)K<VAE971S
M+W-H965T-C<N>&UL4$L! A0#%     @ RX-:4MU.F?Y- P  X L  !D
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M=#<R+GAM;%!+ 0(4 Q0    ( ,N#6E(VV;<ZS (  !\)   9
M  " @>'O 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @
MRX-:4A^J.?^P @  Y <  !D              ("!Y/(! 'AL+W=O<FMS:&5E
M=',O<VAE970W-"YX;6Q02P$"% ,4    " #+@UI2IZJMYP<#  ##"0  &0
M            @('+]0$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4
M Q0    ( ,N#6E+_:90D?P(  &P&   9              " @0GY 0!X;"]W
M;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ RX-:4G1N&V3+ P
M@ T  !D              ("!O_L! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX
M;6Q02P$"% ,4    " #+@UI2-[]+^GT$  "H$@  &0              @('!
M_P$ >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( ,N#6E+C
M3W >%@,  #0,   9              " @74$ @!X;"]W;W)K<VAE971S+W-H
M965T-SDN>&UL4$L! A0#%     @ RX-:4C$,9FLE!P  *RX  !D
M     ("!P@<" 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,N#6E*T+VS(%0,  $0*   9              "
M@8\? @!X;"]W;W)K<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ RX-:
M4FCC?X X @  L 4  !D              ("!VR(" 'AL+W=O<FMS:&5E=',O
M<VAE970X-BYX;6Q02P$"% ,4    " #+@UI212K-]4D$   S$@  &0
M        @(%*)0( >&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0
M   ( ,N#6E*GMW+9[P(  )D'   9              " @<HI @!X;"]W;W)K
M<VAE971S+W-H965T.#@N>&UL4$L! A0#%     @ RX-:4J?;BJA/ P  P0D
M !D              ("!\"P" 'AL+W=O<FMS:&5E=',O<VAE970X.2YX;6Q0
M2P$"% ,4    " #+@UI2.:\]O9,"  "G!@  &0              @(%V, (
M>&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+ 0(4 Q0    ( ,N#6E*6HYO.
MH@,  !4.   9              " @4 S @!X;"]W;W)K<VAE971S+W-H965T
M.3$N>&UL4$L! A0#%     @ RX-:4F(QZ]?'!0  %1L  !D
M ("!&3<" 'AL+W=O<FMS:&5E=',O<VAE970Y,BYX;6Q02P$"% ,4    " #+
M@UI2L.157N(#  #(#@  &0              @($7/0( >&PO=V]R:W-H965T
M<R]S:&5E=#DS+GAM;%!+ 0(4 Q0    ( ,N#6E+YA;1!6 0  &T0   9
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M970Y."YX;6Q02P$"% ,4    " #+@UI2"(BO]U$#  #+"@  &0
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M,3 S+GAM;%!+ 0(4 Q0    ( ,N#6E) Z5$["P0  $P1   :
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M,3 X+GAM;%!+ 0(4 Q0    ( ,N#6E) LAZ1M ,  $(.   :
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M,3$S+GAM;%!+ 0(4 Q0    ( ,N#6E*T1W5P0@,  *,+   :
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M;"]S='EL97,N>&UL4$L! A0#%     @ RX-:4I>*NQS     $P(   L
M         ( !:)P" %]R96QS+RYR96QS4$L! A0#%     @ RX-:4AZCE$^#
M!P  )4P   \              ( !49T" 'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( ,N#6E+),"%3. ,  !=$   :              "  0&E @!X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,N#6E*\;2HCC (
M &-!   3              "  7&H @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@    !\ 'P +"(  "ZK @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>212
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>213
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>214
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>471</ContextCount>
  <ElementCount>558</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>154</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>19</UnitCount>
  <MyReports>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060007 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070008 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS??? EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS??? EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Organization and Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/OrganizationandDescriptionofBusiness</Role>
      <ShortName>Organization and Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210031002 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210111003 - Disclosure - Grant Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/GrantRevenue</Role>
      <ShortName>Grant Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210141004 - Disclosure - Product Sales</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/ProductSales</Role>
      <ShortName>Product Sales</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210171005 - Disclosure - Collaboration Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreements</Role>
      <ShortName>Collaboration Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210471006 - Disclosure - Financial Instruments and Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements</Role>
      <ShortName>Financial Instruments and Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210541007 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210571008 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210601009 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210631010 - Disclosure - Other Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/OtherBalanceSheetComponents</Role>
      <ShortName>Other Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210691011 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210751012 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210801013 - Disclosure - Redeemable Convertible Preferred Stock and Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock</Role>
      <ShortName>Redeemable Convertible Preferred Stock and Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210821014 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210891015 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/EmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210911016 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210991017 - Disclosure - Net Loss per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/NetLossperShare</Role>
      <ShortName>Net Loss per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>211031018 - Disclosure - Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/GeographicInformation</Role>
      <ShortName>Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>211061019 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230123002 - Disclosure - Grant Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/GrantRevenueTables</Role>
      <ShortName>Grant Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/GrantRevenue</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230153003 - Disclosure - Product Sales (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/ProductSalesTables</Role>
      <ShortName>Product Sales (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/ProductSales</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230183004 - Disclosure - Collaboration Agreements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsTables</Role>
      <ShortName>Collaboration Agreements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/CollaborationAgreements</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230483005 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables</Role>
      <ShortName>Financial Instruments and Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230553006 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230583007 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/Inventory</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230613008 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/PropertyandEquipment</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230643009 - Disclosure - Other Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/OtherBalanceSheetComponentsTables</Role>
      <ShortName>Other Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/OtherBalanceSheetComponents</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230703010 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/Leases</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230833011 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/StockBasedCompensation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230923012 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/IncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>231003013 - Disclosure - Net Loss per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/NetLossperShareTables</Role>
      <ShortName>Net Loss per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/NetLossperShare</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>231043014 - Disclosure - Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/GeographicInformationTables</Role>
      <ShortName>Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/GeographicInformation</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>240024001 - Disclosure - Organization and Description of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails</Role>
      <ShortName>Organization and Description of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/OrganizationandDescriptionofBusiness</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>240064002 - Disclosure - Summary of Significant Accounting Policies - Accounting Policies Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Accounting Policies Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>240074003 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>240084004 - Disclosure - Summary of Significant Accounting Policies - Significant Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Significant Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240094005 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment and Software Capitalization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Property and Equipment and Software Capitalization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240104006 - Disclosure - Summary of Significant Accounting Policies - Components of Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Components of Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240134007 - Disclosure - Grant Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/GrantRevenueDetails</Role>
      <ShortName>Grant Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/GrantRevenueTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240164008 - Disclosure - Product Sales (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/ProductSalesDetails</Role>
      <ShortName>Product Sales (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/ProductSalesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240194009 - Disclosure - Collaboration Agreements - Summary of Total Consolidated Net Revenues from Strategic Collaborators (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails</Role>
      <ShortName>Collaboration Agreements - Summary of Total Consolidated Net Revenues from Strategic Collaborators (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240204010 - Disclosure - Collaboration Agreements - Changes in Balances of Receivables and Contract Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails</Role>
      <ShortName>Collaboration Agreements - Changes in Balances of Receivables and Contract Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240214011 - Disclosure - Collaboration Revenue - Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails</Role>
      <ShortName>Collaboration Revenue - Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240224012 - Disclosure - Collaboration Agreements - AstraZeneca - Strategic Alliances in Cardiovascular and Oncology (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails</Role>
      <ShortName>Collaboration Agreements - AstraZeneca - Strategic Alliances in Cardiovascular and Oncology (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240234013 - Disclosure - Collaboration Agreements - Composition of the Total Transaction Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails</Role>
      <ShortName>Collaboration Agreements - Composition of the Total Transaction Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240244014 - Disclosure - Collaboration Agreements - Total Transaction Price to the Identified Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails</Role>
      <ShortName>Collaboration Agreements - Total Transaction Price to the Identified Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240254015 - Disclosure - Collaboration Agreements - Revenue Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails</Role>
      <ShortName>Collaboration Agreements - Revenue Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240264016 - Disclosure - Collaboration Agreements - Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails</Role>
      <ShortName>Collaboration Agreements - Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240274017 - Disclosure - Collaboration Agreements - VEGF Total Transaction Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails</Role>
      <ShortName>Collaboration Agreements - VEGF Total Transaction Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240284018 - Disclosure - Collaboration Agreements - Total Transaction Price Allocated to the Single Identified Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails</Role>
      <ShortName>Collaboration Agreements - Total Transaction Price Allocated to the Single Identified Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240294019 - Disclosure - Collaboration Agreements - VEGF Revenue Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails</Role>
      <ShortName>Collaboration Agreements - VEGF Revenue Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240304020 - Disclosure - Collaboration Agreements - VEGF Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails</Role>
      <ShortName>Collaboration Agreements - VEGF Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240314021 - Disclosure - Collaboration Agreements - Merck ??? Strategic Alliances in Infectious Diseases and Cancer Vaccines (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails</Role>
      <ShortName>Collaboration Agreements - Merck ??? Strategic Alliances in Infectious Diseases and Cancer Vaccines (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240324022 - Disclosure - Collaboration Agreements - MERCK Composition of the Total Transaction Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails</Role>
      <ShortName>Collaboration Agreements - MERCK Composition of the Total Transaction Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240334023 - Disclosure - Collaboration Agreements - MERCK Total Transaction Price to the Identified Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails</Role>
      <ShortName>Collaboration Agreements - MERCK Total Transaction Price to the Identified Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240344024 - Disclosure - Collaboration Agreements - MERCK Revenue and Contra-Revenue Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails</Role>
      <ShortName>Collaboration Agreements - MERCK Revenue and Contra-Revenue Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240354025 - Disclosure - Collaboration Agreements - PCV/SAV Composition of the Total Transaction Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails</Role>
      <ShortName>Collaboration Agreements - PCV/SAV Composition of the Total Transaction Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240364026 - Disclosure - Collaboration Agreements - PCV/SAV Total Transaction Price to the Identified Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails</Role>
      <ShortName>Collaboration Agreements - PCV/SAV Total Transaction Price to the Identified Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240374027 - Disclosure - Collaboration Agreements - PCV/SAV Revenue Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails</Role>
      <ShortName>Collaboration Agreements - PCV/SAV Revenue Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240384028 - Disclosure - Collaboration Agreements - PCV/SAV Balances of Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails</Role>
      <ShortName>Collaboration Agreements - PCV/SAV Balances of Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240394029 - Disclosure - Collaboration Agreements - Vertex ??? 2016 Strategic Alliance in Cystic Fibrosis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails</Role>
      <ShortName>Collaboration Agreements - Vertex ??? 2016 Strategic Alliance in Cystic Fibrosis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240404030 - Disclosure - Collaboration Agreements - VERTEX Composition of the Total Transaction Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails</Role>
      <ShortName>Collaboration Agreements - VERTEX Composition of the Total Transaction Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240414031 - Disclosure - Collaboration Agreements - VERTEX Total Transaction Price to the Identified Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails</Role>
      <ShortName>Collaboration Agreements - VERTEX Total Transaction Price to the Identified Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240424032 - Disclosure - Collaboration Agreements - VERTEX Revenue Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails</Role>
      <ShortName>Collaboration Agreements - VERTEX Revenue Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240434033 - Disclosure - Collaboration Agreements - VERTEX Balances of Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails</Role>
      <ShortName>Collaboration Agreements - VERTEX Balances of Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240444034 - Disclosure - Collaboration Agreements - Vertex 2020 Strategic Alliance in Cystic Fibrosis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails</Role>
      <ShortName>Collaboration Agreements - Vertex 2020 Strategic Alliance in Cystic Fibrosis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240454035 - Disclosure - Collaboration Agreements - Chiesi Agreement Composition of the Total Transaction Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails</Role>
      <ShortName>Collaboration Agreements - Chiesi Agreement Composition of the Total Transaction Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240464036 - Disclosure - Collaboration Agreements - Chiesi Agreement Total Transaction Price to the Identified Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails</Role>
      <ShortName>Collaboration Agreements - Chiesi Agreement Total Transaction Price to the Identified Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240494037 - Disclosure - Financial Instruments and Fair Value Measurements - Summary of Cash and Available-for-Sale Securities by Significant Investment Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Summary of Cash and Available-for-Sale Securities by Significant Investment Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240504038 - Disclosure - Financial Instruments and Fair Value Measurements - Amortized Cost and Estimated Fair Value of Marketable Securities, by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Amortized Cost and Estimated Fair Value of Marketable Securities, by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240514039 - Disclosure - Financial Instruments and Fair Value Measurements - Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240524040 - Disclosure - Financial Instruments and Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240534041 - Disclosure - Financial Instruments and Fair Value Measurements - Financial Assets Measured At Fair Value On a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails</Role>
      <ShortName>Financial Instruments and Fair Value Measurements - Financial Assets Measured At Fair Value On a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240564042 - Disclosure - Derivative Financial Instruments - Balance Sheet Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails</Role>
      <ShortName>Derivative Financial Instruments - Balance Sheet Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240594043 - Disclosure - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/InventoryDetails</Role>
      <ShortName>Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/InventoryTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240624044 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240654045 - Disclosure - Other Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Other Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240664046 - Disclosure - Other Balance Sheet Components - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails</Role>
      <ShortName>Other Balance Sheet Components - Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240674047 - Disclosure - Other Balance Sheet Components - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Balance Sheet Components - Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240684048 - Disclosure - Other Balance Sheet Components - Deferred Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails</Role>
      <ShortName>Other Balance Sheet Components - Deferred Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240714049 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240724050 - Disclosure - Leases - Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240734051 - Disclosure - Leases - Lease Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/LeasesLeaseCostsDetails</Role>
      <ShortName>Leases - Lease Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240744052 - Disclosure - Leases - Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails</Role>
      <ShortName>Leases - Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240764053 - Disclosure - Commitments and Contingencies - Strategic Collaborations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails</Role>
      <ShortName>Commitments and Contingencies - Strategic Collaborations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240774054 - Disclosure - Commitments and Contingencies - Indemnification Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails</Role>
      <ShortName>Commitments and Contingencies - Indemnification Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240784055 - Disclosure - Commitments and Contingencies - Purchase Commitments and Purchase Orders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails</Role>
      <ShortName>Commitments and Contingencies - Purchase Commitments and Purchase Orders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240794056 - Disclosure - Commitments and Contingencies - Licenses to Patented Technology (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails</Role>
      <ShortName>Commitments and Contingencies - Licenses to Patented Technology (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240814057 - Disclosure - Redeemable Convertible Preferred Stock and Common Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock and Common Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240844058 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240854059 - Disclosure - Stock-Based Compensation - Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240864060 - Disclosure - Stock-Based Compensation - Restricted Common Stock and Common Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Restricted Common Stock and Common Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240874061 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails</Role>
      <ShortName>Stock-Based Compensation - Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240884062 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240904063 - Disclosure - Employee Benefit Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/EmployeeBenefitPlanDetails</Role>
      <ShortName>Employee Benefit Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/EmployeeBenefitPlan</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240934064 - Disclosure - Income Taxes - Loss Before Provision For (Benefit From) Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Loss Before Provision For (Benefit From) Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240944065 - Disclosure - Income Taxes - Provision For (Benefit From) Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Provision For (Benefit From) Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240954066 - Disclosure - Income Taxes - Reconciliation of U.S. Statutory Income Tax Rate to Effective Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails</Role>
      <ShortName>Income Taxes - Reconciliation of U.S. Statutory Income Tax Rate to Effective Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240964067 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets and Tax Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Significant Components of Deferred Tax Assets and Tax Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240974068 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>240984069 - Disclosure - Income Taxes - Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails</Role>
      <ShortName>Income Taxes - Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>241014070 - Disclosure - Net Loss per Share - Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails</Role>
      <ShortName>Net Loss per Share - Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>241024071 - Disclosure - Net Loss per Share - Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss per Share - Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>241054072 - Disclosure - Geographic Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/GeographicInformationDetails</Role>
      <ShortName>Geographic Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/GeographicInformationTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="mrna-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>241074073 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.modernatx.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.modernatx.com/role/SubsequentEvent</ParentRole>
      <Position>116</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="mrna-20201231.htm">mrna-20201231.htm</File>
    <File>a2312020consentforincorpra.htm</File>
    <File>exhibit1017moderna.htm</File>
    <File>exhibit1027supplycontrac.htm</File>
    <File>exhibit21subsidiaries1.htm</File>
    <File>exhibit31112312020.htm</File>
    <File>exhibit31212312020.htm</File>
    <File>exhibit32112312020.htm</File>
    <File>exhibit32212312020.htm</File>
    <File>exhibit4312312020.htm</File>
    <File>mrna-20201231.xsd</File>
    <File>mrna-20201231_cal.xml</File>
    <File>mrna-20201231_def.xml</File>
    <File>mrna-20201231_lab.xml</File>
    <File>mrna-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mrna-20201231_g1.jpg</File>
    <File>mrna-20201231_g10.jpg</File>
    <File>mrna-20201231_g11.jpg</File>
    <File>mrna-20201231_g12.jpg</File>
    <File>mrna-20201231_g13.jpg</File>
    <File>mrna-20201231_g14.jpg</File>
    <File>mrna-20201231_g15.jpg</File>
    <File>mrna-20201231_g16.jpg</File>
    <File>mrna-20201231_g17.jpg</File>
    <File>mrna-20201231_g18.jpg</File>
    <File>mrna-20201231_g19.jpg</File>
    <File>mrna-20201231_g2.jpg</File>
    <File>mrna-20201231_g20.jpg</File>
    <File>mrna-20201231_g21.jpg</File>
    <File>mrna-20201231_g22.jpg</File>
    <File>mrna-20201231_g23.jpg</File>
    <File>mrna-20201231_g24.jpg</File>
    <File>mrna-20201231_g25.jpg</File>
    <File>mrna-20201231_g26.jpg</File>
    <File>mrna-20201231_g27.jpg</File>
    <File>mrna-20201231_g28.jpg</File>
    <File>mrna-20201231_g29.jpg</File>
    <File>mrna-20201231_g3.jpg</File>
    <File>mrna-20201231_g30.jpg</File>
    <File>mrna-20201231_g31.jpg</File>
    <File>mrna-20201231_g32.jpg</File>
    <File>mrna-20201231_g33.jpg</File>
    <File>mrna-20201231_g34.jpg</File>
    <File>mrna-20201231_g35.jpg</File>
    <File>mrna-20201231_g36.jpg</File>
    <File>mrna-20201231_g37.jpg</File>
    <File>mrna-20201231_g38.jpg</File>
    <File>mrna-20201231_g39.jpg</File>
    <File>mrna-20201231_g4.jpg</File>
    <File>mrna-20201231_g40.jpg</File>
    <File>mrna-20201231_g41.jpg</File>
    <File>mrna-20201231_g42.gif</File>
    <File>mrna-20201231_g43.gif</File>
    <File>mrna-20201231_g44.gif</File>
    <File>mrna-20201231_g45.jpg</File>
    <File>mrna-20201231_g46.jpg</File>
    <File>mrna-20201231_g5.jpg</File>
    <File>mrna-20201231_g6.jpg</File>
    <File>mrna-20201231_g7.jpg</File>
    <File>mrna-20201231_g8.jpg</File>
    <File>mrna-20201231_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>217
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mrna-20201231.htm": {
   "axisCustom": 2,
   "axisStandard": 36,
   "contextCount": 471,
   "dts": {
    "calculationLink": {
     "local": [
      "mrna-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mrna-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "mrna-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mrna-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mrna-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mrna-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 824,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 12,
    "http://www.modernatx.com/20201231": 3,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 19
   },
   "keyCustom": 90,
   "keyStandard": 468,
   "memberCustom": 89,
   "memberStandard": 58,
   "nsprefix": "mrna",
   "nsuri": "http://www.modernatx.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover",
     "role": "http://www.modernatx.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Organization and Description of Business",
     "role": "http://www.modernatx.com/role/OrganizationandDescriptionofBusiness",
     "shortName": "Organization and Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "if52ab1a643294862862c0ab9475e5fb5_I20181211",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240814057 - Disclosure - Redeemable Convertible Preferred Stock and Common Stock - Narrative (Details)",
     "role": "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails",
     "shortName": "Redeemable Convertible Preferred Stock and Common Stock - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "if52ab1a643294862862c0ab9475e5fb5_I20181211",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240844058 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "role": "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i1191369058cf41a6aec423e2a8b9ee92_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854059 - Disclosure - Stock-Based Compensation - Options Activity (Details)",
     "role": "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails",
     "shortName": "Stock-Based Compensation - Options Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i3a2b16bb22614c61b08450535a865c3a_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864060 - Disclosure - Stock-Based Compensation - Restricted Common Stock and Common Stock Units Activity (Details)",
     "role": "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails",
     "shortName": "Stock-Based Compensation - Restricted Common Stock and Common Stock Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i3a2b16bb22614c61b08450535a865c3a_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874061 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted (Details)",
     "role": "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails",
     "shortName": "Stock-Based Compensation - Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i55c91b83beab4426a8bbb4d09f62bfa0_D20200101-20201231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884062 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details)",
     "role": "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Compensation - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i9b7796d6fc41467489873be3464c5281_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240904063 - Disclosure - Employee Benefit Plan (Details)",
     "role": "http://www.modernatx.com/role/EmployeeBenefitPlanDetails",
     "shortName": "Employee Benefit Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240934064 - Disclosure - Income Taxes - Loss Before Provision For (Benefit From) Income Taxes (Details)",
     "role": "http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails",
     "shortName": "Income Taxes - Loss Before Provision For (Benefit From) Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944065 - Disclosure - Income Taxes - Provision For (Benefit From) Income Taxes (Details)",
     "role": "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails",
     "shortName": "Income Taxes - Provision For (Benefit From) Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954066 - Disclosure - Income Taxes - Reconciliation of U.S. Statutory Income Tax Rate to Effective Tax Rate (Details)",
     "role": "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails",
     "shortName": "Income Taxes - Reconciliation of U.S. Statutory Income Tax Rate to Effective Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210031002 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240964067 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets and Tax Liabilities (Details)",
     "role": "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails",
     "shortName": "Income Taxes - Significant Components of Deferred Tax Assets and Tax Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974068 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ic351569ed65f40cab21d97c586306914_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i1191369058cf41a6aec423e2a8b9ee92_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240984069 - Disclosure - Income Taxes - Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits Roll Forward (Details)",
     "role": "http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails",
     "shortName": "Income Taxes - Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits Roll Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i20204b229a394d9ba8b28882826012db_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241014070 - Disclosure - Net Loss per Share - Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details)",
     "role": "http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails",
     "shortName": "Net Loss per Share - Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241024071 - Disclosure - Net Loss per Share - Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details)",
     "role": "http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails",
     "shortName": "Net Loss per Share - Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241054072 - Disclosure - Geographic Information (Details)",
     "role": "http://www.modernatx.com/role/GeographicInformationDetails",
     "shortName": "Geographic Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i9ccdf2dca2df4aa3a9aece1c6399177d_D20210101-20210226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mrna:NumberOfDosesOfVaccineCandidate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "dose",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241074073 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.modernatx.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i9ccdf2dca2df4aa3a9aece1c6399177d_D20210101-20210226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mrna:NumberOfDosesOfVaccineCandidate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "dose",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210111003 - Disclosure - Grant Revenue",
     "role": "http://www.modernatx.com/role/GrantRevenue",
     "shortName": "Grant Revenue",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210141004 - Disclosure - Product Sales",
     "role": "http://www.modernatx.com/role/ProductSales",
     "shortName": "Product Sales",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210171005 - Disclosure - Collaboration Agreements",
     "role": "http://www.modernatx.com/role/CollaborationAgreements",
     "shortName": "Collaboration Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210471006 - Disclosure - Financial Instruments and Fair Value Measurements",
     "role": "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements",
     "shortName": "Financial Instruments and Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210541007 - Disclosure - Derivative Financial Instruments",
     "role": "http://www.modernatx.com/role/DerivativeFinancialInstruments",
     "shortName": "Derivative Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210571008 - Disclosure - Inventory",
     "role": "http://www.modernatx.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210601009 - Disclosure - Property and Equipment",
     "role": "http://www.modernatx.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210631010 - Disclosure - Other Balance Sheet Components",
     "role": "http://www.modernatx.com/role/OtherBalanceSheetComponents",
     "shortName": "Other Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210691011 - Disclosure - Leases",
     "role": "http://www.modernatx.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210751012 - Disclosure - Commitments and Contingencies",
     "role": "http://www.modernatx.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210801013 - Disclosure - Redeemable Convertible Preferred Stock and Common Stock",
     "role": "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock",
     "shortName": "Redeemable Convertible Preferred Stock and Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210821014 - Disclosure - Stock-Based Compensation",
     "role": "http://www.modernatx.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210891015 - Disclosure - Employee Benefit Plan",
     "role": "http://www.modernatx.com/role/EmployeeBenefitPlan",
     "shortName": "Employee Benefit Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210911016 - Disclosure - Income Taxes",
     "role": "http://www.modernatx.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210991017 - Disclosure - Net Loss per Share",
     "role": "http://www.modernatx.com/role/NetLossperShare",
     "shortName": "Net Loss per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211031018 - Disclosure - Geographic Information",
     "role": "http://www.modernatx.com/role/GeographicInformation",
     "shortName": "Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211061019 - Disclosure - Subsequent Event",
     "role": "http://www.modernatx.com/role/SubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230123002 - Disclosure - Grant Revenue (Tables)",
     "role": "http://www.modernatx.com/role/GrantRevenueTables",
     "shortName": "Grant Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230153003 - Disclosure - Product Sales (Tables)",
     "role": "http://www.modernatx.com/role/ProductSalesTables",
     "shortName": "Product Sales (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230183004 - Disclosure - Collaboration Agreements (Tables)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsTables",
     "shortName": "Collaboration Agreements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230483005 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)",
     "role": "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables",
     "shortName": "Financial Instruments and Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230553006 - Disclosure - Derivative Financial Instruments (Tables)",
     "role": "http://www.modernatx.com/role/DerivativeFinancialInstrumentsTables",
     "shortName": "Derivative Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230583007 - Disclosure - Inventory (Tables)",
     "role": "http://www.modernatx.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230613008 - Disclosure - Property and Equipment (Tables)",
     "role": "http://www.modernatx.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230643009 - Disclosure - Other Balance Sheet Components (Tables)",
     "role": "http://www.modernatx.com/role/OtherBalanceSheetComponentsTables",
     "shortName": "Other Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mrna:CurrentAssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230703010 - Disclosure - Leases (Tables)",
     "role": "http://www.modernatx.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "mrna:CurrentAssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230833011 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.modernatx.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230923012 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.modernatx.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231003013 - Disclosure - Net Loss per Share (Tables)",
     "role": "http://www.modernatx.com/role/NetLossperShareTables",
     "shortName": "Net Loss per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231043014 - Disclosure - Geographic Information (Tables)",
     "role": "http://www.modernatx.com/role/GeographicInformationTables",
     "shortName": "Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240024001 - Disclosure - Organization and Description of Business (Details)",
     "role": "http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails",
     "shortName": "Organization and Description of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mrna:NumberOfDevelopmentProgram",
      "reportCount": 1,
      "unique": true,
      "unitRef": "program",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064002 - Disclosure - Summary of Significant Accounting Policies - Accounting Policies Narrative (Details)",
     "role": "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Accounting Policies Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074003 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)",
     "role": "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Summary of Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6112e1e86f8340e6bab6155f0e0c14fe_D20190101-20191231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084004 - Disclosure - Summary of Significant Accounting Policies - Significant Customers (Details)",
     "role": "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails",
     "shortName": "Summary of Significant Accounting Policies - Significant Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6112e1e86f8340e6bab6155f0e0c14fe_D20190101-20191231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i30999b30a90f434baeec1c4aabafdfc4_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094005 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment and Software Capitalization (Details)",
     "role": "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails",
     "shortName": "Summary of Significant Accounting Policies - Property and Equipment and Software Capitalization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i30999b30a90f434baeec1c4aabafdfc4_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i1191369058cf41a6aec423e2a8b9ee92_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104006 - Disclosure - Summary of Significant Accounting Policies - Components of Accumulated Other Comprehensive Loss (Details)",
     "role": "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Summary of Significant Accounting Policies - Components of Accumulated Other Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i9725be67d18a4c3bb82d57ad987d47ea_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "role": "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "idba3a03acc0e45d5b9787c6de18eadbf_I20160930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mrna:RevenueFromGrantsNumberOfContractOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contract_option",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240134007 - Disclosure - Grant Revenue (Details)",
     "role": "http://www.modernatx.com/role/GrantRevenueDetails",
     "shortName": "Grant Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "idba3a03acc0e45d5b9787c6de18eadbf_I20160930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mrna:RevenueFromGrantsNumberOfContractOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contract_option",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240164008 - Disclosure - Product Sales (Details)",
     "role": "http://www.modernatx.com/role/ProductSalesDetails",
     "shortName": "Product Sales (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "idfe5c56714774f52b2aa95484fa4c6cb_I20201231",
      "decimals": "-7",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ic80125be741e4f4a9e96e921990c314d_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194009 - Disclosure - Collaboration Agreements - Summary of Total Consolidated Net Revenues from Strategic Collaborators (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails",
     "shortName": "Collaboration Agreements - Summary of Total Consolidated Net Revenues from Strategic Collaborators (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ic80125be741e4f4a9e96e921990c314d_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i1191369058cf41a6aec423e2a8b9ee92_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204010 - Disclosure - Collaboration Agreements - Changes in Balances of Receivables and Contract Liabilities (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails",
     "shortName": "Collaboration Agreements - Changes in Balances of Receivables and Contract Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i25d6ceefa0dd4987937b280087546df3_I20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240214011 - Disclosure - Collaboration Revenue - Remaining Performance Obligation (Details)",
     "role": "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails",
     "shortName": "Collaboration Revenue - Remaining Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i9441d23013f14c83988a31bdbb559231_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224012 - Disclosure - Collaboration Agreements - AstraZeneca - Strategic Alliances in Cardiovascular and Oncology (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
     "shortName": "Collaboration Agreements - AstraZeneca - Strategic Alliances in Cardiovascular and Oncology (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i2866ce13b20c40499ee0ef2d3eb66afa_I20140331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "option",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234013 - Disclosure - Collaboration Agreements - Composition of the Total Transaction Price (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
     "shortName": "Collaboration Agreements - Composition of the Total Transaction Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i839376eae85647209c7ffae9f8bb94d6_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244014 - Disclosure - Collaboration Agreements - Total Transaction Price to the Identified Performance Obligations (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
     "shortName": "Collaboration Agreements - Total Transaction Price to the Identified Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i018ccef08c534dd986a7e677e9da45b2_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240254015 - Disclosure - Collaboration Agreements - Revenue Recognized (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
     "shortName": "Collaboration Agreements - Revenue Recognized (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ib7507c06b17446d99769c50840782858_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264016 - Disclosure - Collaboration Agreements - Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails",
     "shortName": "Collaboration Agreements - Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i978a4c28e8214a16a5f021fa271e26f7_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)",
     "role": "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274017 - Disclosure - Collaboration Agreements - VEGF Total Transaction Price (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails",
     "shortName": "Collaboration Agreements - VEGF Total Transaction Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i96c0d1d3251a406d91ab4e10d74e2798_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240284018 - Disclosure - Collaboration Agreements - Total Transaction Price Allocated to the Single Identified Performance Obligation (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails",
     "shortName": "Collaboration Agreements - Total Transaction Price Allocated to the Single Identified Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "if79cc9521a4944dca9685e052deaf802_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294019 - Disclosure - Collaboration Agreements - VEGF Revenue Recognized (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails",
     "shortName": "Collaboration Agreements - VEGF Revenue Recognized (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "if79cc9521a4944dca9685e052deaf802_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304020 - Disclosure - Collaboration Agreements - VEGF Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details) (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails",
     "shortName": "Collaboration Agreements - VEGF Deferred Revenue which is Classified as Current or Non-Current in the Balance Sheets (Details) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id54b6e3f162949438276b86a988013e1_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314021 - Disclosure - Collaboration Agreements - Merck \u2013 Strategic Alliances in Infectious Diseases and Cancer Vaccines (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
     "shortName": "Collaboration Agreements - Merck \u2013 Strategic Alliances in Infectious Diseases and Cancer Vaccines (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ifdc4e94646c4466093dce917a6fc5e18_D20150101-20190531",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324022 - Disclosure - Collaboration Agreements - MERCK Composition of the Total Transaction Price (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
     "shortName": "Collaboration Agreements - MERCK Composition of the Total Transaction Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334023 - Disclosure - Collaboration Agreements - MERCK Total Transaction Price to the Identified Performance Obligations (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
     "shortName": "Collaboration Agreements - MERCK Total Transaction Price to the Identified Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i316e60df5f6843bf9f30bdcae4453017_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ia449e79cf2a44014b2511df73272f527_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344024 - Disclosure - Collaboration Agreements - MERCK Revenue and Contra-Revenue Recognized (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
     "shortName": "Collaboration Agreements - MERCK Revenue and Contra-Revenue Recognized (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ia449e79cf2a44014b2511df73272f527_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354025 - Disclosure - Collaboration Agreements - PCV/SAV Composition of the Total Transaction Price (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
     "shortName": "Collaboration Agreements - PCV/SAV Composition of the Total Transaction Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364026 - Disclosure - Collaboration Agreements - PCV/SAV Total Transaction Price to the Identified Performance Obligations (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
     "shortName": "Collaboration Agreements - PCV/SAV Total Transaction Price to the Identified Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id3a8ffa0085e4794913a1deaa0b73f5d_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "iae26ac15cf594fc4a4c729775db551d1_I20171231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060007 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS\u2019 EQUITY",
     "role": "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "iae26ac15cf594fc4a4c729775db551d1_I20171231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i340827b3da36421394e5bd54e37ccfea_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374027 - Disclosure - Collaboration Agreements - PCV/SAV Revenue Recognized (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails",
     "shortName": "Collaboration Agreements - PCV/SAV Revenue Recognized (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240384028 - Disclosure - Collaboration Agreements - PCV/SAV Balances of Deferred Revenue (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails",
     "shortName": "Collaboration Agreements - PCV/SAV Balances of Deferred Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240394029 - Disclosure - Collaboration Agreements - Vertex \u2013 2016 Strategic Alliance in Cystic Fibrosis (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
     "shortName": "Collaboration Agreements - Vertex \u2013 2016 Strategic Alliance in Cystic Fibrosis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i87ddb061c8af41b8a41e6c31b9c1b6ca_D20190701-20190731",
      "decimals": null,
      "lang": "en-US",
      "name": "mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404030 - Disclosure - Collaboration Agreements - VERTEX Composition of the Total Transaction Price (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
     "shortName": "Collaboration Agreements - VERTEX Composition of the Total Transaction Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ia11a3663e67e45c08dd00fe0f20b964b_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414031 - Disclosure - Collaboration Agreements - VERTEX Total Transaction Price to the Identified Performance Obligations (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
     "shortName": "Collaboration Agreements - VERTEX Total Transaction Price to the Identified Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ifea86eb2da07419ea798ae719f81a8f9_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ib894739b97434938997c5f99e78f77bd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424032 - Disclosure - Collaboration Agreements - VERTEX Revenue Recognized (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails",
     "shortName": "Collaboration Agreements - VERTEX Revenue Recognized (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ib894739b97434938997c5f99e78f77bd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240434033 - Disclosure - Collaboration Agreements - VERTEX Balances of Deferred Revenue (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails",
     "shortName": "Collaboration Agreements - VERTEX Balances of Deferred Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i0798e7f1beab411290adc80b49b4a243_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444034 - Disclosure - Collaboration Agreements - Vertex 2020 Strategic Alliance in Cystic Fibrosis (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails",
     "shortName": "Collaboration Agreements - Vertex 2020 Strategic Alliance in Cystic Fibrosis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ie80373ee84ee409397695d20d023b830_D20201201-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454035 - Disclosure - Collaboration Agreements - Chiesi Agreement Composition of the Total Transaction Price (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
     "shortName": "Collaboration Agreements - Chiesi Agreement Composition of the Total Transaction Price (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i2055b9c162b043d0bd8bfc878eb467d5_D20201201-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464036 - Disclosure - Collaboration Agreements - Chiesi Agreement Total Transaction Price to the Identified Performance Obligations (Details)",
     "role": "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
     "shortName": "Collaboration Agreements - Chiesi Agreement Total Transaction Price to the Identified Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "if8775b14ae8d42ba85896b375b513e87_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i5518761bd5764a98bd1c1d394aa48408_D20180101-20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070008 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS\u2019 EQUITY (Parenthetical)",
     "role": "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS\u2019 EQUITY (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i859a2b8a071243a4aab797a9e567cab2_D20180101-20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494037 - Disclosure - Financial Instruments and Fair Value Measurements - Summary of Cash and Available-for-Sale Securities by Significant Investment Category (Details)",
     "role": "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Summary of Cash and Available-for-Sale Securities by Significant Investment Category (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i2dee05d95adb41a4a76b2b9fe164e598_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504038 - Disclosure - Financial Instruments and Fair Value Measurements - Amortized Cost and Estimated Fair Value of Marketable Securities, by Contractual Maturity (Details)",
     "role": "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Amortized Cost and Estimated Fair Value of Marketable Securities, by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514039 - Disclosure - Financial Instruments and Fair Value Measurements - Unrealized Loss Position (Details)",
     "role": "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524040 - Disclosure - Financial Instruments and Fair Value Measurements - Narrative (Details)",
     "role": "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i2dee05d95adb41a4a76b2b9fe164e598_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534041 - Disclosure - Financial Instruments and Fair Value Measurements - Financial Assets Measured At Fair Value On a Recurring Basis (Details)",
     "role": "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
     "shortName": "Financial Instruments and Fair Value Measurements - Financial Assets Measured At Fair Value On a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i7d497d05b06c42e4ac9fccf950c4da8f_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i79bfa2998ec14f64b6ac249d9dba29fc_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240564042 - Disclosure - Derivative Financial Instruments - Balance Sheet Hedges (Details)",
     "role": "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails",
     "shortName": "Derivative Financial Instruments - Balance Sheet Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i79bfa2998ec14f64b6ac249d9dba29fc_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594043 - Disclosure - Inventory (Details)",
     "role": "http://www.modernatx.com/role/InventoryDetails",
     "shortName": "Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624044 - Disclosure - Property and Equipment (Details)",
     "role": "http://www.modernatx.com/role/PropertyandEquipmentDetails",
     "shortName": "Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "mrna:OtherPrepaidExpenseManufacturing",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654045 - Disclosure - Other Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Other Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "mrna:OtherPrepaidExpenseManufacturing",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "mrna:AccruedClinicalTrials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664046 - Disclosure - Other Balance Sheet Components - Accrued Liabilities (Details)",
     "role": "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails",
     "shortName": "Other Balance Sheet Components - Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "mrna:AccruedClinicalTrials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100080009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mrna:CurrentAssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674047 - Disclosure - Other Balance Sheet Components - Other Current Liabilities (Details)",
     "role": "http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails",
     "shortName": "Other Balance Sheet Components - Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherSundryLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i1191369058cf41a6aec423e2a8b9ee92_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684048 - Disclosure - Other Balance Sheet Components - Deferred Revenue (Details)",
     "role": "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails",
     "shortName": "Other Balance Sheet Components - Deferred Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "mrna:ContractWithCustomerLiabilityDeductionsDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mrna:OperatingLeaseNumberOfProperties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "campus",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714049 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.modernatx.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mrna:OperatingLeaseNumberOfProperties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "campus",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mrna:CurrentAssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724050 - Disclosure - Leases - Balance Sheet Information (Details)",
     "role": "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails",
     "shortName": "Leases - Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mrna:CurrentAssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240734051 - Disclosure - Leases - Lease Costs (Details)",
     "role": "http://www.modernatx.com/role/LeasesLeaseCostsDetails",
     "shortName": "Leases - Lease Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i6660b9e0b7bb4aecad76079a0dd7cffb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744052 - Disclosure - Leases - Minimum Lease Payments (Details)",
     "role": "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails",
     "shortName": "Leases - Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "id8cfdc6a9eda493abd00093bbea4c21e_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "ie3347a1fc6b94f67a83914d66ec9adbf_I20170630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764053 - Disclosure - Commitments and Contingencies - Strategic Collaborations (Details)",
     "role": "http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails",
     "shortName": "Commitments and Contingencies - Strategic Collaborations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i62af6315d0994091a5ee85593def32e7_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyLossInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240774054 - Disclosure - Commitments and Contingencies - Indemnification Obligations (Details)",
     "role": "http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails",
     "shortName": "Commitments and Contingencies - Indemnification Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i62af6315d0994091a5ee85593def32e7_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyLossInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i4c7e100fa92b440a8d435619ce329b08_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240784055 - Disclosure - Commitments and Contingencies - Purchase Commitments and Purchase Orders (Details)",
     "role": "http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails",
     "shortName": "Commitments and Contingencies - Purchase Commitments and Purchase Orders (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i4c7e100fa92b440a8d435619ce329b08_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i7e99c6608c7941008ec26bef45112da4_I20170626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794056 - Disclosure - Commitments and Contingencies - Licenses to Patented Technology (Details)",
     "role": "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails",
     "shortName": "Commitments and Contingencies - Licenses to Patented Technology (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mrna-20201231.htm",
      "contextRef": "i7e99c6608c7941008ec26bef45112da4_I20170626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "mrna:ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 154,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GeographicInformationDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r645",
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r645",
      "r646",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mrna_A2013OptionAgreementAndServicesAndCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2013 Option Agreement And Services And Collaboration Agreement [Member]",
        "label": "2013 Option Agreement And Services And Collaboration Agreement [Member]",
        "terseLabel": "2013 AZ Agreements"
       }
      }
     },
     "localname": "A2013OptionAgreementAndServicesAndCollaborationAgreementMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_A2016StrategicAllianceWithAstraZenecaIL12Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Strategic Alliance With AstraZeneca \u2013 IL12 [Member]",
        "label": "2016 Strategic Alliance With AstraZeneca \u2013 IL12 [Member]",
        "terseLabel": "2016 AZ Agreement"
       }
      }
     },
     "localname": "A2016StrategicAllianceWithAstraZenecaIL12Member",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_AccruedClinicalTrials": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Clinical Trials",
        "label": "Accrued Clinical Trials",
        "terseLabel": "Clinical trials"
       }
      }
     },
     "localname": "AccruedClinicalTrials",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_AccruedDevelopmentOperation": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Development Operation",
        "label": "Accrued Development Operation",
        "terseLabel": "Development operations"
       }
      }
     },
     "localname": "AccruedDevelopmentOperation",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_AccruedExternalGoodsAndServicesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued External Goods And Services, Current",
        "label": "Accrued External Goods And Services, Current",
        "terseLabel": "Other external goods and services"
       }
      }
     },
     "localname": "AccruedExternalGoodsAndServicesCurrent",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_AccruedManufacturing": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Manufacturing",
        "label": "Accrued Manufacturing",
        "terseLabel": "Manufacturing"
       }
      }
     },
     "localname": "AccruedManufacturing",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_AccruedPropertyAndEquipmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Property And Equipment, Current",
        "label": "Accrued Property And Equipment, Current",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "AccruedPropertyAndEquipmentCurrent",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_AdditionalNumberOfVaccineDoses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Number Of Vaccine Doses",
        "label": "Additional Number Of Vaccine Doses",
        "terseLabel": "Additional number of doses"
       }
      }
     },
     "localname": "AdditionalNumberOfVaccineDoses",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended And Restated Option Agreement Related Amended And Restated Services And Collaboration Agreement With AstraZeneca [Member]",
        "label": "Amended And Restated Option Agreement Related Amended And Restated Services And Collaboration Agreement With AstraZeneca [Member]",
        "terseLabel": "2018 A&amp;R Agreements"
       }
      }
     },
     "localname": "AmendedAndRestatedOptionAgreementRelatedAmendedAndRestatedServicesAndCollaborationAgreementWithAstraZenecaMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_AreaOfRealEstatePropertyAdditionalSpace": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area Of Real Estate Property, Additional Space",
        "label": "Area Of Real Estate Property, Additional Space",
        "terseLabel": "Additional space (in sqft)"
       }
      }
     },
     "localname": "AreaOfRealEstatePropertyAdditionalSpace",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "mrna_AstraZenecaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AstraZeneca [Member]",
        "label": "AstraZeneca [Member]",
        "terseLabel": "AstraZeneca"
       }
      }
     },
     "localname": "AstraZenecaMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biomedical Advanced Research And Development Authority [Member]",
        "label": "Biomedical Advanced Research And Development Authority [Member]",
        "terseLabel": "BARDA"
       }
      }
     },
     "localname": "BiomedicalAdvancedResearchAndDevelopmentAuthorityMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_CambridgeMassachusettsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cambridge, Massachusetts [Member]",
        "label": "Cambridge, Massachusetts [Member]",
        "terseLabel": "Cambridge Leases"
       }
      }
     },
     "localname": "CambridgeMassachusettsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain Development Regulatory And Commercial Milestone Events",
        "label": "Certain Development Regulatory And Commercial Milestone Events [Member]",
        "terseLabel": "Certain Development Regulatory And Commercial Milestone Events"
       }
      }
     },
     "localname": "CertainDevelopmentRegulatoryAndCommercialMilestoneEventsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ChangeInContractWithCustomerLiabilityCurrentRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract with Customer Liability, Current",
        "label": "Change In Contract with Customer Liability, Current [Roll Forward]",
        "verboseLabel": "Change In Contract With Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityCurrentRollForward",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mrna_ChangeInContractWithCustomerLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract With Customer Liability",
        "label": "Change in Contract With Customer Liability [Line Items]",
        "terseLabel": "Change In Contract With Customer, Liability [Line Items]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityLineItems",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mrna_ChangeInContractWithCustomerLiabilityNonCurrentRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract with Customer Liability, NonCurrent [Roll Forward]",
        "label": "Change In Contract with Customer Liability, NonCurrent [Roll Forward]",
        "terseLabel": "Contract Liabilities:"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityNonCurrentRollForward",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mrna_ChangeInContractWithCustomerLiabilityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract With Customer, Liability",
        "label": "Change In Contract With Customer, Liability [Table]",
        "terseLabel": "Change in Contract With Customer Liability [Table]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityTable",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mrna_ChangeInContractwithCustomerAssetRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Contract with Customer Asset [Roll Forward]",
        "label": "Change In Contract with Customer Asset [Roll Forward]",
        "terseLabel": "Contract Assets:"
       }
      }
     },
     "localname": "ChangeInContractwithCustomerAssetRollForward",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mrna_ChargesToFinancingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charges To Financing Lease Liabilities",
        "label": "Charges To Financing Lease Liabilities",
        "terseLabel": "Charges to financing lease liabilities"
       }
      }
     },
     "localname": "ChargesToFinancingLeaseLiabilities",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ChiesiAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chiesi Agreement",
        "label": "Chiesi Agreement [Member]",
        "terseLabel": "Chiesi agreement"
       }
      }
     },
     "localname": "ChiesiAgreementMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ChiesiAgreementTransactionPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chiesi Agreement Transaction Price",
        "label": "Chiesi Agreement Transaction Price [Member]",
        "terseLabel": "Chiesi Agreement transaction price"
       }
      }
     },
     "localname": "ChiesiAgreementTransactionPriceMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ClinicalOperationsAndSupportCommitmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical Operations And Support Commitment [Member]",
        "label": "Clinical Operations And Support Commitment [Member]",
        "terseLabel": "Clinical operations and support commitments"
       }
      }
     },
     "localname": "ClinicalOperationsAndSupportCommitmentMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ClinicalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical Services",
        "label": "Clinical Services [Member]",
        "terseLabel": "Clinical services"
       }
      }
     },
     "localname": "ClinicalServicesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ClinicalSupplyReimbursementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical Supply Reimbursement",
        "label": "Clinical Supply Reimbursement [Member]",
        "terseLabel": "Reimbursement for clinical supply"
       }
      }
     },
     "localname": "ClinicalSupplyReimbursementMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_CollaborationArrangementIncludingArrangementsWithAffiliateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Arrangement Including Arrangements With Affiliate [Member]",
        "label": "Collaboration Arrangement Including Arrangements With Affiliate [Member]",
        "terseLabel": "Collaboration Revenue by Strategic Collaborator"
       }
      }
     },
     "localname": "CollaborationArrangementIncludingArrangementsWithAffiliateMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_CollaborationArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Arrangement [Member]",
        "label": "Collaboration Arrangement [Member]",
        "terseLabel": "Collaboration revenue"
       }
      }
     },
     "localname": "CollaborationArrangementMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_Combined2018AZAgreementPerformanceObligationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Combined 2018 AZ Agreement Performance Obligation [Member]",
        "label": "Combined 2018 AZ Agreement Performance Obligation [Member]",
        "terseLabel": "Combined 2018 AZ Agreement performance obligation"
       }
      }
     },
     "localname": "Combined2018AZAgreementPerformanceObligationMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_Combined2018AZAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Combined 2018 AZ Agreements [Member]",
        "label": "Combined 2018 AZ Agreements [Member]",
        "terseLabel": "Combined 2018 AZ Agreements"
       }
      }
     },
     "localname": "Combined2018AZAgreementsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_Commercial": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial",
        "label": "Commercial",
        "terseLabel": "Commercial"
       }
      }
     },
     "localname": "Commercial",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_CommercialMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Milestones [Member]",
        "label": "Commercial Milestones [Member]",
        "terseLabel": "Commercial Milestones"
       }
      }
     },
     "localname": "CommercialMilestonesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_CompetitionMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Competition Milestones [Member]",
        "label": "Competition Milestones [Member]",
        "terseLabel": "Competition milestone payment"
       }
      }
     },
     "localname": "CompetitionMilestonesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ContractOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Options",
        "label": "Contract Options [Member]",
        "terseLabel": "Contract options"
       }
      }
     },
     "localname": "ContractOptionsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ContractWithCustomerAssetDecreaseDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer Asset Decrease During Period",
        "label": "Contract With Customer Asset Decrease During Period",
        "terseLabel": "Deductions"
       }
      }
     },
     "localname": "ContractWithCustomerAssetDecreaseDuringPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ContractWithCustomerAssetIncreaseDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer Asset Increase During Period",
        "label": "Contract With Customer Asset Increase During Period",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "ContractWithCustomerAssetIncreaseDuringPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ContractWithCustomerLiabilityDecreaseDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer Liability Decrease During Period",
        "label": "Contract With Customer Liability Decrease During Period",
        "terseLabel": "Deductions"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityDecreaseDuringPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ContractWithCustomerLiabilityDeductionsDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Deductions During Period",
        "label": "Contract With Customer, Liability, Deductions During Period",
        "negatedTerseLabel": "Deductions"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityDeductionsDuringPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ContractWithCustomerLiabilityIncreaseDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer Liability Increase During Period",
        "label": "Contract With Customer Liability Increase During Period",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseDuringPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_CurrentAssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Current Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Assets and Lease Liabilities"
       }
      }
     },
     "localname": "CurrentAssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mrna_CurrentMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Marketable Securities [Member]",
        "label": "Current Marketable Securities [Member]",
        "terseLabel": "Current Marketable Securities"
       }
      }
     },
     "localname": "CurrentMarketableSecuritiesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_CustomerDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Deposits",
        "label": "Customer Deposits [Member]",
        "terseLabel": "Customer deposits"
       }
      }
     },
     "localname": "CustomerDepositsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_DefenseAdvancedResearchProjectsAgencyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defense Advanced Research Projects Agency [Member]",
        "label": "Defense Advanced Research Projects Agency [Member]",
        "terseLabel": "DARPA"
       }
      }
     },
     "localname": "DefenseAdvancedResearchProjectsAgencyMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Capitalized Licenses, Research And Development, And Start-Up Costs",
        "label": "Deferred Tax Assets, Capitalized Licenses, Research And Development, And Start-Up Costs",
        "terseLabel": "Capitalized licenses, research and development and start-up costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalizedLicensesResearchAndDevelopmentAndStartUpCosts",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Deferred Expense, Capitalized Inventory Costs",
        "label": "Deferred Tax Assets, Deferred Expense, Capitalized Inventory Costs",
        "terseLabel": "Capitalized inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredExpenseCapitalizedInventoryCosts",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_DeferredTaxAssetsFinancingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Financing Lease, Liability",
        "label": "Deferred Tax Assets, Financing Lease, Liability",
        "terseLabel": "Lease financing obligation"
       }
      }
     },
     "localname": "DeferredTaxAssetsFinancingLeaseLiability",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_DeferredTaxAssetsOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease, Liability",
        "label": "Deferred Tax Assets, Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiability",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Finance Lease Right Of Use Asset",
        "label": "Deferred Tax Liabilities, Finance Lease Right Of Use Asset",
        "negatedTerseLabel": "Financing right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesFinanceLeaseRightOfUseAsset",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Operating Lease Right Of Use Asset",
        "label": "Deferred Tax Liabilities, Operating Lease Right Of Use Asset",
        "negatedLabel": "Operating right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development And Commercialization License And Manufacturing Obligations For IL12 [Member]",
        "label": "Development And Commercialization License And Manufacturing Obligations For IL12 [Member]",
        "terseLabel": "Development and commercialization license and manufacturing obligation"
       }
      }
     },
     "localname": "DevelopmentAndCommercializationLicenseAndManufacturingObligationsForIL12Member",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development And Commercialization Rights And Manufacturing Services For An Oncology Development Target [Member]",
        "label": "Development And Commercialization Rights And Manufacturing Services For An Oncology Development Target [Member]",
        "terseLabel": "Material right to receive development and commercialization rights"
       }
      }
     },
     "localname": "DevelopmentAndCommercializationRightsAndManufacturingServicesForAnOncologyDevelopmentTargetMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_DevelopmentMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Milestones [Member]",
        "label": "Development Milestones [Member]",
        "terseLabel": "Development Milestones"
       }
      }
     },
     "localname": "DevelopmentMilestonesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_DiagnosticProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Products [Member]",
        "label": "Diagnostic Products [Member]",
        "terseLabel": "Diagnostic products"
       }
      }
     },
     "localname": "DiagnosticProductsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_EmbeddedLeasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Embedded Leases",
        "label": "Embedded Leases [Member]",
        "terseLabel": "Embedded Leases"
       }
      }
     },
     "localname": "EmbeddedLeasesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_EmployeeStockPurchasePlan2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan 2018 [Member]",
        "label": "Employee Stock Purchase Plan 2018 [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlan2018Member",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_EquipmentAndLeasedFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment And Leased Facilities",
        "label": "Equipment And Leased Facilities [Member]",
        "terseLabel": "Equipment and Leased Facilities"
       }
      }
     },
     "localname": "EquipmentAndLeasedFacilitiesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_EstimatedReimbursementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated Reimbursement [Member]",
        "label": "Estimated Reimbursement [Member]",
        "terseLabel": "Estimated Reimbursement"
       }
      }
     },
     "localname": "EstimatedReimbursementMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_EuropeanCommissionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Commission",
        "label": "European Commission [Member]",
        "terseLabel": "European Commission"
       }
      }
     },
     "localname": "EuropeanCommissionMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_FederalOrphanDrugMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Orphan Drug [Member]",
        "label": "Federal Orphan Drug [Member]",
        "terseLabel": "Federal Orphan Drug"
       }
      }
     },
     "localname": "FederalOrphanDrugMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Cost",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total financing lease costs"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_FinancingRightOfUseAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing, Right-Of-Use Asset [Member]",
        "label": "Financing, Right-Of-Use Asset [Member]",
        "terseLabel": "Right-of-use asset, financing"
       }
      }
     },
     "localname": "FinancingRightOfUseAssetMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_FiveHundredTechnologySquareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Hundred\u00a0Technology Square [Member]",
        "label": "Five Hundred\u00a0Technology Square [Member]",
        "terseLabel": "500\u00a0Technology Square"
       }
      }
     },
     "localname": "FiveHundredTechnologySquareMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_IL12PerformanceObligationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IL12 Performance Obligation [Member]",
        "label": "IL12 Performance Obligation [Member]",
        "terseLabel": "Preclinical development service - IL-12"
       }
      }
     },
     "localname": "IL12PerformanceObligationMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_IncreaseDecreaseInDeferredRentCredit": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Deferred Rent Credit",
        "label": "Increase (Decrease) In Deferred Rent Credit",
        "terseLabel": "Deferred lease obligation"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRentCredit",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_InitialProjectMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Project [Member]",
        "label": "Initial Project [Member]",
        "terseLabel": "Initial project"
       }
      }
     },
     "localname": "InitialProjectMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_KRASPerformanceObligationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "KRAS Performance Obligation [Member]",
        "label": "KRAS Performance Obligation [Member]",
        "terseLabel": "KRAS Performance Obligation"
       }
      }
     },
     "localname": "KRASPerformanceObligationMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_LeaseFinancingObligationsIncurred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Financing Obligations Incurred",
        "label": "Lease Financing Obligations Incurred",
        "terseLabel": "Lease financing obligation"
       }
      }
     },
     "localname": "LeaseFinancingObligationsIncurred",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_LeaseholdImprovementsIncurredButNotYetReimbursed": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leasehold Improvements Incurred But Not Yet Reimbursed",
        "label": "Leasehold Improvements Incurred But Not Yet Reimbursed",
        "terseLabel": "Leasehold improvements included in prepaid and other current assets"
       }
      }
     },
     "localname": "LeaseholdImprovementsIncurredButNotYetReimbursed",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_LeasesImputedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Imputed Interest Rate",
        "label": "Leases, Imputed Interest Rate",
        "terseLabel": "Imputed interest rate"
       }
      }
     },
     "localname": "LeasesImputedInterestRate",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mrna_LeasesIncrementalBorrowingRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Incremental Borrowing Rate",
        "label": "Leases, Incremental Borrowing Rate",
        "terseLabel": "Incremental borrowing rate"
       }
      }
     },
     "localname": "LeasesIncrementalBorrowingRate",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mrna_LesseeFinanceLeaseExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Finance Lease, Expense",
        "label": "Lessee, Finance Lease, Expense",
        "terseLabel": "Charge to financing lease obligation"
       }
      }
     },
     "localname": "LesseeFinanceLeaseExpense",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_LesseeOperatingLeaseNumberOfExtensionPeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Number Of Extension Periods",
        "label": "Lessee, Operating Lease, Number Of Extension Periods",
        "terseLabel": "Number of extension periods"
       }
      }
     },
     "localname": "LesseeOperatingLeaseNumberOfExtensionPeriods",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_LesseeOperatingLeasePercentageSubleased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Percentage Subleased",
        "label": "Lessee, Operating Lease, Percentage Subleased",
        "terseLabel": "Percentage subleased"
       }
      }
     },
     "localname": "LesseeOperatingLeasePercentageSubleased",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mrna_MTCNorthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MTC North",
        "label": "MTC North [Member]",
        "terseLabel": "MTC North [Member]"
       }
      }
     },
     "localname": "MTCNorthMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_MTCSouthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MTC South",
        "label": "MTC South [Member]",
        "terseLabel": "MTC South"
       }
      }
     },
     "localname": "MTCSouthMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_MerckAgreement2015Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merck Agreement 2015 [Member]",
        "label": "Merck Agreement 2015 [Member]",
        "terseLabel": "Collaboration revenue under the 2015 Merck Agreement",
        "verboseLabel": "Merck agreement 2015"
       }
      }
     },
     "localname": "MerckAgreement2015Member",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_MerckMay2019AgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merck May2019 Agreement",
        "label": "Merck May2019 Agreement [Member]",
        "terseLabel": "Contra-revenue under the May 2019 Amendment"
       }
      }
     },
     "localname": "MerckMay2019AgreementMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_MerckMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merck [Member]",
        "label": "Merck [Member]",
        "terseLabel": "Merck"
       }
      }
     },
     "localname": "MerckMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_MilestonePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payments [Member]",
        "label": "Milestone Payments [Member]",
        "terseLabel": "Milestone payment"
       }
      }
     },
     "localname": "MilestonePaymentsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_NoncurrentMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent Marketable Securities [Member]",
        "label": "Noncurrent Marketable Securities [Member]",
        "terseLabel": "Non- Current Marketable Securities"
       }
      }
     },
     "localname": "NoncurrentMarketableSecuritiesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_NorwoodMassachusettsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Norwood, Massachusetts",
        "label": "Norwood, Massachusetts [Member]",
        "terseLabel": "Norwood Leases"
       }
      }
     },
     "localname": "NorwoodMassachusettsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_NumberOfDevelopmentProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Development Program",
        "label": "Number Of Development Program",
        "terseLabel": "Development programs"
       }
      }
     },
     "localname": "NumberOfDevelopmentProgram",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_NumberOfDosesOfVaccineCandidate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Doses Of Vaccine Candidate",
        "label": "Number Of Doses Of Vaccine Candidate",
        "terseLabel": "Number of doses of vaccine candidate"
       }
      }
     },
     "localname": "NumberOfDosesOfVaccineCandidate",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_NumberOfVaccineDoses": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Vaccine Doses",
        "label": "Number Of Vaccine Doses",
        "terseLabel": "Number of vaccine doses"
       }
      }
     },
     "localname": "NumberOfVaccineDoses",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_OfficeLaboratoryAndLightManufacturingSpaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office, Laboratory, And Light Manufacturing Space [Member]",
        "label": "Office, Laboratory, And Light Manufacturing Space [Member]",
        "terseLabel": "Office, laboratory, and light manufacturing space"
       }
      }
     },
     "localname": "OfficeLaboratoryAndLightManufacturingSpaceMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_OncologyDevelopmentTargetPerformanceObligationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oncology Development Target Performance Obligation [Member]",
        "label": "Oncology Development Target Performance Obligation [Member]",
        "terseLabel": "Preclinical development service - oncology development target"
       }
      }
     },
     "localname": "OncologyDevelopmentTargetPerformanceObligationMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_OperatingAndFinanceLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability",
        "label": "Operating And Finance Lease, Liability",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiability",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_OperatingAndFinanceLeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Current",
        "label": "Operating And Finance Lease, Liability, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityCurrent",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_OperatingAndFinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "mrna_OperatingAndFinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Liability, Noncurrent",
        "label": "Operating And Finance Lease, Liability, Noncurrent",
        "totalLabel": "Total non-current lease liabilities"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_OperatingAndFinanceLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Finance Lease, Right-Of-Use Asset",
        "label": "Operating And Finance Lease, Right-Of-Use Asset",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingAndFinanceLeaseRightOfUseAsset",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_OperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Liabilities",
        "label": "Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilities",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_OperatingLeaseNumberOfProperties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Number Of Properties",
        "label": "Operating Lease, Number Of Properties",
        "terseLabel": "Number of campuses"
       }
      }
     },
     "localname": "OperatingLeaseNumberOfProperties",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_OperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Not Subject To Expiration",
        "label": "Operating Loss Carryforwards, Not Subject To Expiration",
        "terseLabel": "Net operating losses that will carry-forward indefinitely"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_OperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Subject To Expiration",
        "label": "Operating Loss Carryforwards, Subject To Expiration",
        "terseLabel": "Net operating losses that begin to expire in 2030"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_OptionExerciseFeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option Exercise Fee [Member]",
        "label": "Option Exercise Fee [Member]",
        "terseLabel": "Option exercise fee"
       }
      }
     },
     "localname": "OptionExerciseFeeMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_OtherGrantRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Grant Revenue",
        "label": "Other Grant Revenue [Member]",
        "terseLabel": "Other Grant Revenue"
       }
      }
     },
     "localname": "OtherGrantRevenueMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other",
        "label": "Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_OtherPrepaidExpenseManufacturing": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Prepaid Expense, Manufacturing",
        "label": "Other Prepaid Expense, Manufacturing",
        "terseLabel": "Down payments to manufacturing vendors"
       }
      }
     },
     "localname": "OtherPrepaidExpenseManufacturing",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_PCVPerformanceObligationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCV Performance Obligation [Member]",
        "label": "PCV Performance Obligation [Member]",
        "terseLabel": "PCV Performance Obligation"
       }
      }
     },
     "localname": "PCVPerformanceObligationMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_PCVSAVAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCVSAV Agreement [Member]",
        "label": "PCVSAV Agreement [Member]",
        "terseLabel": "PCVSAV Agreement"
       }
      }
     },
     "localname": "PCVSAVAgreementMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_PatentCostsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent Costs, Policy [Policy Text Block]",
        "label": "Patent Costs, Policy [Policy Text Block]",
        "terseLabel": "Patent Costs"
       }
      }
     },
     "localname": "PatentCostsPolicyPolicyTextBlock",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mrna_PaymentsForLeaseFinancingObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Lease Financing Obligation",
        "label": "Payments For Lease Financing Obligation",
        "negatedTerseLabel": "Payments on financing lease obligation"
       }
      }
     },
     "localname": "PaymentsForLeaseFinancingObligation",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_PaymentsOfUnderwritingDiscounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments Of Underwriting Discounts",
        "label": "Payments Of Underwriting Discounts",
        "terseLabel": "Underwriting discounts"
       }
      }
     },
     "localname": "PaymentsOfUnderwritingDiscounts",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_PerformanceObligationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Obligation [Axis]",
        "label": "Performance Obligation [Axis]",
        "terseLabel": "Performance Obligation [Axis]"
       }
      }
     },
     "localname": "PerformanceObligationAxis",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mrna_PerformanceObligationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Performance Obligation [Axis]",
        "label": "Performance Obligation [Domain]",
        "terseLabel": "Performance Obligation [Domain]"
       }
      }
     },
     "localname": "PerformanceObligationDomain",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Personalized MRNA Cancer Vaccines (PCV) Collaboration And License Agreement With Merck Sharp\u00a0And Dohme Corp [Member]",
        "label": "Personalized MRNA Cancer Vaccines (PCV) Collaboration And License Agreement With Merck Sharp\u00a0And Dohme Corp [Member]",
        "terseLabel": "PCV Agreement"
       }
      }
     },
     "localname": "PersonalizedMRNACancerVaccinesPCVCollaborationAndLicenseAgreementWithMerckSharpAndDohmeCorpMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_PersonalizedMRNACancerVaccinesProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Personalized MRNA Cancer Vaccines Products [Member]",
        "label": "Personalized MRNA Cancer Vaccines Products [Member]",
        "terseLabel": "PCV products"
       }
      }
     },
     "localname": "PersonalizedMRNACancerVaccinesProductsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ProductSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Sales",
        "label": "Product Sales [Member]",
        "terseLabel": "Product sales"
       }
      }
     },
     "localname": "ProductSalesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_PublicEquityOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Equity Offering [Member]",
        "label": "Public Equity Offering [Member]",
        "terseLabel": "Public Equity Offering"
       }
      }
     },
     "localname": "PublicEquityOfferingMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_RawMaterialsAccountsPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Raw Materials, Accounts Payable",
        "label": "Raw Materials, Accounts Payable",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "RawMaterialsAccountsPayable",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ReclassificationsOfTemporaryToPermanentEquityShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassifications Of Temporary To Permanent Equity, Shares",
        "label": "Reclassifications Of Temporary To Permanent Equity, Shares",
        "negatedLabel": "Conversion of redeemable convertible preferred stock into common stock (in shares)",
        "netLabel": "Conversion of redeemable convertible preferred stock into common stock (in shares)"
       }
      }
     },
     "localname": "ReclassificationsOfTemporaryToPermanentEquityShares",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "mrna_RegulatoryMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory Milestones [Member]",
        "label": "Regulatory Milestones [Member]",
        "terseLabel": "Regulatory Milestones"
       }
      }
     },
     "localname": "RegulatoryMilestonesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_RegulatoryMilestonesSubsequentProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory Milestones, Subsequent Products [Member]",
        "label": "Regulatory Milestones, Subsequent Products [Member]",
        "terseLabel": "Regulatory Milestones, Subsequent Products"
       }
      }
     },
     "localname": "RegulatoryMilestonesSubsequentProductsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ReimbursementOfAssetsFromLeaseFinancingObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reimbursement Of Assets From Lease Financing Obligation",
        "label": "Reimbursement Of Assets From Lease Financing Obligation",
        "terseLabel": "Reimbursement of assets under financing lease obligation"
       }
      }
     },
     "localname": "ReimbursementOfAssetsFromLeaseFinancingObligation",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_RemainingUnsatisfiedPerformanceObligationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining Unsatisfied Performance Obligation",
        "label": "Remaining Unsatisfied Performance Obligation [Member]",
        "terseLabel": "Remaining unsatisfied performance obligation"
       }
      }
     },
     "localname": "RemainingUnsatisfiedPerformanceObligationMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Commercial Milestones, Maximum Amount",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Commercial Milestones, Maximum Amount",
        "terseLabel": "Commercial milestone payments"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCommercialMilestonesMaximumAmount",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Development And Regulatory Milestones, Maximum Amount",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Development And Regulatory Milestones, Maximum Amount",
        "terseLabel": "Development and regulatory milestone payments"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersDevelopmentAndRegulatoryMilestonesMaximumAmount",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Earnout Payment, Percent",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Earnout Payment, Percent",
        "terseLabel": "Earn-out payments"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersEarnoutPaymentPercent",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Marketing Approval, Termination Period",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Marketing Approval, Termination Period",
        "terseLabel": "Termination period upon marketing approval",
        "verboseLabel": "Written notice period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersMarketingApprovalTerminationPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Maximum Amount",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Maximum Amount",
        "terseLabel": "Estimated arrangement consideration",
        "verboseLabel": "Budgeted amount"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumAmount",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Milestone [Axis]",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Milestone [Axis]",
        "terseLabel": "Research And Development Arrangement, Contract To Perform For Others, Milestone [Axis]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneAxis",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Research And Development Arrangement, Contract To Perform For Others, Milestone [Axis]",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Milestone [Domain]",
        "terseLabel": "Research And Development Arrangement, Contract To Perform For Others, Milestone [Domain]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersMilestoneDomain",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Number Of Extension Periods",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Number Of Extension Periods",
        "terseLabel": "Number of extension periods"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfExtensionPeriods",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Number Of Milestones",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Number Of Milestones",
        "terseLabel": "Number of milestones"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfMilestones",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Number Of Options",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Number Of Options",
        "terseLabel": "Number of options to develop candidates"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersNumberOfOptions",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Option Exercise Fee",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Option Exercise Fee",
        "terseLabel": "Option exercise fee"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersOptionExerciseFee",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Payment Received, Research Extension Period",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Payment Received, Research Extension Period",
        "terseLabel": "Payment received, research extension period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersPaymentReceivedResearchExtensionPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Performance Period",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Performance Period",
        "terseLabel": "Performance period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersPerformancePeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Product Suspension Period",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Product Suspension Period",
        "terseLabel": "Suspension period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersProductSuspensionPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Research Extension Period",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Research Extension Period",
        "terseLabel": "Research extension period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Research Extension Period Elected",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Research Extension Period Elected",
        "terseLabel": "Research extension period elected"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersResearchExtensionPeriodElected",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Research Period",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Research Period",
        "terseLabel": "Initial research period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersResearchPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Royalty Payment, Default Percent",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Royalty Payment, Default Percent",
        "terseLabel": "Tiered royalties at default rate"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentDefaultPercent",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Royalty Payment, Percent",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Royalty Payment, Percent",
        "terseLabel": "Tiered royalties"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersRoyaltyPaymentPercent",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mrna_ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Termination Period",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Termination Period",
        "terseLabel": "Termination period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTerminationPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mrna_ResearchAndDevelopmentFundingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Funding [Member]",
        "label": "Research And Development Funding [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentFundingMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_RestrictedStockAndRestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock And Restricted Stock Units (RSUs) [Member]",
        "label": "Restricted Stock And Restricted Stock Units (RSU) [Member]",
        "terseLabel": "Restricted common stock and units"
       }
      }
     },
     "localname": "RestrictedStockAndRestrictedStockUnitsRSUMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_RevenueFromGrantsCurrentFundingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Grants, Current Funding Capacity",
        "label": "Revenue From Grants, Current Funding Capacity",
        "terseLabel": "Amount committed for funding"
       }
      }
     },
     "localname": "RevenueFromGrantsCurrentFundingCapacity",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_RevenueFromGrantsMaximumAward": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Grants, Maximum Award",
        "label": "Revenue From Grants, Maximum Award",
        "terseLabel": "Award amount"
       }
      }
     },
     "localname": "RevenueFromGrantsMaximumAward",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_RevenueFromGrantsNumberOfContractOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Grants, Number Of Contract Options",
        "label": "Revenue From Grants, Number Of Contract Options",
        "terseLabel": "Number of contract options"
       }
      }
     },
     "localname": "RevenueFromGrantsNumberOfContractOptions",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_RevenueFromGrantsNumberOfContractOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Grants, Number Of Contract Options Exercised",
        "label": "Revenue From Grants, Number Of Contract Options Exercised",
        "terseLabel": "Number of contract options exercised"
       }
      }
     },
     "localname": "RevenueFromGrantsNumberOfContractOptionsExercised",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_RevenueFromGrantsRemainingFundingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Grants, Remaining Funding Capacity",
        "label": "Revenue From Grants, Remaining Funding Capacity",
        "terseLabel": "Available funding"
       }
      }
     },
     "localname": "RevenueFromGrantsRemainingFundingCapacity",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_RightOfUseAssetOperatingLeases": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right Of Use Asset Operating Leases",
        "label": "Right Of Use Asset Operating Leases",
        "negatedTerseLabel": "Right-of-use assets, operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetOperatingLeases",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-Of-Use Assets Reduced Through Lease Modifications And Reassessments",
        "label": "Right-Of-Use Assets Reduced Through Lease Modifications And Reassessments",
        "terseLabel": "Right-of-use assets reduced through lease modifications and reassessments"
       }
      }
     },
     "localname": "RightOfUseAssetsReducedThroughLeaseModificationsAndReassessments",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_SeparateAgreementsWithMerckMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate Agreements With Merck [Member]",
        "label": "Separate Agreements With Merck [Member]",
        "terseLabel": "Separate agreements with Merck"
       }
      }
     },
     "localname": "SeparateAgreementsWithMerckMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ServiceBasedAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service-Based Awards [Member]",
        "label": "Service-Based Awards [Member]",
        "terseLabel": "Service-based awards"
       }
      }
     },
     "localname": "ServiceBasedAwardsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period, Number Of Installments",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period, Number Of Installments",
        "terseLabel": "Number of installments"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriodNumberOfInstallments",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Consecutive Offering Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Consecutive Offering Period",
        "terseLabel": "Share-Based Compensation Arrangement By Share-Based Payment Award, Consecutive Offering Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardConsecutiveOfferingPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Maximum Employee Subscription Amount",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Maximum Employee Subscription Amount",
        "terseLabel": "Maximum value of shares to be purchased during purchase period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Consecutive Offering Periods",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Consecutive Offering Period",
        "terseLabel": "Offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutiveOfferingPeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Purchase Periods",
        "terseLabel": "Purchase period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPurchasePeriods",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercisable, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted- Average Grant Date Fair Value per Share, Exercisable (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Exercised (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period, Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Forfeitures In Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancelled/forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding at end of period (usd per share)",
        "periodStartLabel": "Outstanding at beginning of period (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested And Expected To Vest, Outstanding, Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Vested And Expected To Vest, Outstanding, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted- Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mrna_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Period",
        "terseLabel": "Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Annual Percentage Of Additional Shares Authorized",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Annual Percentage Of Additional Shares Authorized",
        "terseLabel": "Annual percentage increase of shares reserved and available for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardAnnualPercentageOfAdditionalSharesAuthorized",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Minimum Employee Subscription Rate",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Minimum Employee Subscription Rate",
        "terseLabel": "Minimum percentage of compensation through payroll deductions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardMinimumEmployeeSubscriptionRate",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mrna_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value [Roll Forward]",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value [Roll Forward]",
        "terseLabel": "Weighted Average Grant Date Fair Value per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mrna_SouthKoreaGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "South Korea Government",
        "label": "South Korea Government [Member]",
        "terseLabel": "South Korea Government"
       }
      }
     },
     "localname": "SouthKoreaGovernmentMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_StockIssuanceCostsIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issuance Costs Incurred But Not Yet Paid",
        "label": "Stock Issuance Costs Incurred But Not Yet Paid",
        "terseLabel": "Issuance costs included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "StockIssuanceCostsIncurredButNotYetPaid",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_StockOptionAndGrantPlan2016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option And Grant Plan 2016 [Member]",
        "label": "Stock Option And Grant Plan 2016 [Member]",
        "terseLabel": "2016 Equity Plan"
       }
      }
     },
     "localname": "StockOptionAndGrantPlan2016Member",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_StockOptionAndIncentivePlan2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option And Incentive Plan 2018 [Member]",
        "label": "Stock Option And Incentive Plan 2018 [Member]",
        "terseLabel": "2018 Equity Plan"
       }
      }
     },
     "localname": "StockOptionAndIncentivePlan2018Member",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Collaboration And License Agreement, With Vertex Pharmaceuticals Incorporated, And Vertex Pharmaceuticals (Europe) Limited [Member]",
        "label": "Strategic Collaboration And License Agreement, With Vertex Pharmaceuticals Incorporated, And Vertex Pharmaceuticals (Europe) Limited [Member]",
        "terseLabel": "Vertex Agreement"
       }
      }
     },
     "localname": "StrategicCollaborationAndLicenseAgreementWithVertexPharmaceuticalsIncorporatedAndVertexPharmaceuticalsEuropeLimitedMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_SublicenseAgreementTermsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sublicense Agreement Terms [Member]",
        "label": "Sublicense Agreement Terms [Member]",
        "terseLabel": "Sublicense agreement"
       }
      }
     },
     "localname": "SublicenseAgreementTermsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_SublicenseReimbursementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sublicense Reimbursement",
        "label": "Sublicense Reimbursement [Member]",
        "terseLabel": "Sublicense reimbursement"
       }
      }
     },
     "localname": "SublicenseReimbursementMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_SupplyAndManufacturingAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supply And Manufacturing Agreements",
        "label": "Supply And Manufacturing Agreements [Member]",
        "terseLabel": "Supply and manufacturing agreements"
       }
      }
     },
     "localname": "SupplyAndManufacturingAgreementsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of redeemable convertible preferred stock, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "mrna_TemporaryEquityStockRepurchasedDuringPeriodShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Repurchased During Period, Shares",
        "label": "Temporary Equity, Stock Repurchased During Period, Shares",
        "negatedLabel": "Repurchase of redeemable convertible preferred stock (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockRepurchasedDuringPeriodShares",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "mrna_TemporaryEquityStockRepurchasedDuringPeriodValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Repurchased During Period, Value",
        "label": "Temporary Equity, Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of redeemable convertible preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityStockRepurchasedDuringPeriodValue",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_TenantIncentivesReceivablesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tenant Incentives Receivables, Current",
        "label": "Tenant Incentives Receivables, Current",
        "terseLabel": "Tenant incentives receivables"
       }
      }
     },
     "localname": "TenantIncentivesReceivablesCurrent",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mrna_TheBillAndMelindaGatesFoundationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Bill\u00a0And Melinda Gates Foundation [Member]",
        "label": "The Bill\u00a0And Melinda Gates Foundation [Member]",
        "terseLabel": "The Bill\u00a0&amp; Melinda Gates Foundation"
       }
      }
     },
     "localname": "TheBillAndMelindaGatesFoundationMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_TherapeuticAndProphylacticProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Therapeutic And Prophylactic Products [Member]",
        "label": "Therapeutic And Prophylactic Products [Member]",
        "terseLabel": "Therapeutic and prophylactic products"
       }
      }
     },
     "localname": "TherapeuticAndProphylacticProductsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_ToxicityMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Toxicity Milestones [Member]",
        "label": "Toxicity Milestones [Member]",
        "terseLabel": "Toxicity milestone payment"
       }
      }
     },
     "localname": "ToxicityMilestonesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_TwoHundredTechnologySquareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Hundred\u00a0Technology Square",
        "label": "Two Hundred\u00a0Technology Square [Member]",
        "terseLabel": "200\u00a0Technology Square"
       }
      }
     },
     "localname": "TwoHundredTechnologySquareMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_USGovermentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Goverment",
        "label": "US Goverment [Member]",
        "terseLabel": "U.S. Government (excluding BARDA)"
       }
      }
     },
     "localname": "USGovermentMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_USGovernmentAgenciesAndCorporateDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Government Agencies And Corporate Debt Securities [Member]",
        "label": "US Government Agencies And Corporate Debt Securities [Member]",
        "terseLabel": "Debt securities of U.S. government agencies and corporate entities"
       }
      }
     },
     "localname": "USGovernmentAgenciesAndCorporateDebtSecuritiesMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_UnitedKingdomGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United Kingdom Government",
        "label": "United Kingdom Government [Member]",
        "terseLabel": "United Kingdom Government"
       }
      }
     },
     "localname": "UnitedKingdomGovernmentMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_UpfrontPaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront Payment [Member]",
        "label": "Upfront Payment [Member]",
        "terseLabel": "Upfront payment"
       }
      }
     },
     "localname": "UpfrontPaymentMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront Payment, Premium Associated With Contemporaneous Sale Of Preferred Stock [Member]",
        "label": "Upfront Payment, Premium Associated With Contemporaneous Sale Of Preferred Stock [Member]",
        "terseLabel": "Premium associated with the contemporaneous sale of Series H redeemable convertible preferred stock"
       }
      }
     },
     "localname": "UpfrontPaymentPremiumAssociatedWithContemporaneousSaleOfPreferredStockMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_UpfrontPaymentResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront Payment, Research And Development [Member]",
        "label": "Upfront Payment, Research And Development [Member]",
        "terseLabel": "Upfront Payment, Research And Development"
       }
      }
     },
     "localname": "UpfrontPaymentResearchAndDevelopmentMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_VEGFAProductAZD8601Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VEGF-A Product (AZD8601) [Member]",
        "label": "VEGF-A Product (AZD8601) [Member]",
        "terseLabel": "VEGF-A product (AZD8601)"
       }
      }
     },
     "localname": "VEGFAProductAZD8601Member",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_VEGFExercise2016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VEGF Exercise 2016 [Member]",
        "label": "VEGF Exercise 2016 [Member]",
        "terseLabel": "VEGF Exercise 2016"
       }
      }
     },
     "localname": "VEGFExercise2016Member",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_VariableConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Consideration [Member]",
        "label": "Variable Consideration [Member]",
        "terseLabel": "Estimated reimbursement for clinical supply"
       }
      }
     },
     "localname": "VariableConsiderationMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_Vertex2020AgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertex 2020 Agreement",
        "label": "Vertex 2020 Agreement [Member]",
        "terseLabel": "Vertex 2020 Agreement"
       }
      }
     },
     "localname": "Vertex2020AgreementMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_VertexAgreement2019AgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertex Agreement2019 Agreement",
        "label": "Vertex Agreement2019 Agreement [Member]",
        "terseLabel": "Vertex Agreement/2019 Amendment"
       }
      }
     },
     "localname": "VertexAgreement2019AgreementMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_VertexAgreements1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertex Agreements 1",
        "label": "Vertex Agreements 1 [Member]",
        "terseLabel": "Vertex Agreements 1"
       }
      }
     },
     "localname": "VertexAgreements1Member",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_VertexAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertex Agreements",
        "label": "Vertex Agreements [Member]",
        "terseLabel": "Vertex Agreements"
       }
      }
     },
     "localname": "VertexAgreementsMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_VertexFirstMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertex First",
        "label": "Vertex First [Member]",
        "terseLabel": "Vertex First Extended Research Term"
       }
      }
     },
     "localname": "VertexFirstMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mrna_VertexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vertex [Member]",
        "label": "Vertex [Member]",
        "terseLabel": "Vertex"
       }
      }
     },
     "localname": "VertexMember",
     "nsuri": "http://www.modernatx.com/20201231",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r58",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r127",
      "r135",
      "r237",
      "r392",
      "r393",
      "r394",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r127",
      "r135",
      "r237",
      "r392",
      "r393",
      "r394",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r127",
      "r135",
      "r237",
      "r392",
      "r393",
      "r394",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r201",
      "r317",
      "r323",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r351",
      "r352",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r563",
      "r606",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r351",
      "r352",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r563",
      "r606",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r201",
      "r317",
      "r323",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r197",
      "r317",
      "r321",
      "r564",
      "r605",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r197",
      "r317",
      "r321",
      "r564",
      "r605",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r332",
      "r351",
      "r352",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r563",
      "r606",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r332",
      "r351",
      "r352",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r563",
      "r606",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Axis]",
        "terseLabel": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r198",
      "r199",
      "r317",
      "r322",
      "r608",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GeographicInformationDetails",
      "http://www.modernatx.com/role/LeasesNarrativeDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r198",
      "r199",
      "r317",
      "r322",
      "r608",
      "r625",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GeographicInformationDetails",
      "http://www.modernatx.com/role/LeasesNarrativeDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r539",
      "r541",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201409Member": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).",
        "label": "Accounting Standards Update 2014-09 [Member]",
        "terseLabel": "Accounting Standards Update 2014-09"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201409Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r23",
      "r202",
      "r203"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r61",
      "r62",
      "r63",
      "r68",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized\u00a0Gain on Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r65",
      "r67",
      "r68",
      "r596",
      "r618",
      "r622"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive gain"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r64",
      "r68",
      "r71",
      "r124",
      "r125",
      "r126",
      "r455",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Gain (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r24",
      "r395"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r392",
      "r393",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r432",
      "r433",
      "r434",
      "r435",
      "r565",
      "r566",
      "r567",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r354",
      "r356",
      "r398",
      "r399"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r356",
      "r384",
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Compensation costs",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r30",
      "r208",
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of a real estate property.",
        "label": "Area of Real Estate Property",
        "terseLabel": "Area of office space (in sqft)"
       }
      }
     },
     "localname": "AreaOfRealEstateProperty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r104",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment expenses"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r117",
      "r180",
      "r189",
      "r195",
      "r233",
      "r451",
      "r456",
      "r495",
      "r575",
      "r593"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r54",
      "r117",
      "r233",
      "r451",
      "r456",
      "r495"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Assets, Fair Value Disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r219"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r216",
      "r247"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r222"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r220",
      "r222",
      "r586"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r220",
      "r223",
      "r587"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r220",
      "r221",
      "r585"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsAmortizedCostandEstimatedFairValueofMarketableSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r212",
      "r217",
      "r247",
      "r579"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair\u00a0Value",
        "verboseLabel": "AFS"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r214",
      "r247"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r214",
      "r247"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-sale, Noncurrent",
        "terseLabel": "Investments, non-current"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r357",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails",
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails",
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r465",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Calculated under guidance for revenue recognition in effect prior to change to new guidance for revenue from contract with customer when using transition method for cumulative effect in period including initial date of application.",
        "label": "Calculated under Revenue Guidance in Effect before Topic 606 [Member]",
        "terseLabel": "Balance without adoption of ASC 605"
       }
      }
     },
     "localname": "CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r109",
      "r110",
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property and equipment included in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis": {
     "auth_ref": [
      "r568",
      "r569",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by project.",
        "label": "Project [Axis]",
        "terseLabel": "Project [Axis]"
       }
      }
     },
     "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r39",
      "r106"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r13",
      "r107",
      "r113",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r107",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.",
        "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r100",
      "r106",
      "r112"
     ],
     "calculation": {
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of year",
        "totalLabel": "Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r100",
      "r496"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Non-cash investing and financing activities"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r115",
      "r117",
      "r142",
      "r143",
      "r144",
      "r147",
      "r149",
      "r158",
      "r159",
      "r160",
      "r233",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r48",
      "r273",
      "r580",
      "r600"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Share available for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r124",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r22",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.0001; 1,600,000,000 shares authorized as of December\u00a031, 2020 and 2019; 398,787,678 and 336,536,985 shares issued and outstanding as of December\u00a031, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r74",
      "r76",
      "r77",
      "r81",
      "r582",
      "r603"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r168",
      "r169",
      "r201",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r168",
      "r169",
      "r201",
      "r492",
      "r493",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r168",
      "r169",
      "r201",
      "r492",
      "r493",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r163",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r168",
      "r169",
      "r201",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r166",
      "r168",
      "r169",
      "r170",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r168",
      "r169",
      "r201",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Changes in Balances of Receivables and Contract Liabilities",
        "verboseLabel": "Schedule of Deferred Revenue"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsTables",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r293",
      "r295",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerBasisOfPricingAxis": {
     "auth_ref": [
      "r317",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by basis of pricing for contract representing right to consideration in exchange for good or service transferred to customer.",
        "label": "Contract with Customer, Basis of Pricing [Axis]",
        "terseLabel": "Contract with Customer, Basis of Pricing [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerBasisOfPricingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerBasisOfPricingDomain": {
     "auth_ref": [
      "r317",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of pricing for contract with customer. Includes, but is not limited to, fixed-price and time-and-materials contracts.",
        "label": "Contract with Customer, Basis of Pricing [Domain]",
        "terseLabel": "Contract with Customer, Basis of Pricing [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerBasisOfPricingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r293",
      "r294",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "netLabel": "Contract with Customer, Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Deferred revenue",
        "verboseLabel": "Contract with customer, liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized": {
     "auth_ref": [
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized arising from contract liability from change in timeframe for performance obligation to be satisfied.",
        "label": "Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized",
        "terseLabel": "Performance obligations satisfied (or partially satisfied) in previous reporting periods"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.",
        "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price",
        "negatedTerseLabel": "Decrease to the transaction price",
        "terseLabel": "Increase to the transaction price"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in measure of progress which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Measure of Progress",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r293",
      "r294",
      "r318"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r293",
      "r294",
      "r318"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Contract with Customer, Liability, Noncurrent"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Amounts included in contract liabilities at the beginning of the period",
        "verboseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r20",
      "r21",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Preferred stock converted into common stock (in shares)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r85",
      "r564"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r118",
      "r428",
      "r438"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r428"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r118",
      "r428",
      "r438",
      "r440"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r118",
      "r428",
      "r438"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r167",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r230",
      "r252",
      "r255"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "negatedLabel": "Gross Unrealized Losses, 12 months or more"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r230",
      "r252"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "verboseLabel": "Estimated Fair Value, 12 months or more"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r230",
      "r252",
      "r255"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "negatedTerseLabel": "Gross Unrealized Losses, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r230",
      "r252"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "terseLabel": "Estimated Fair Value, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTerm": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Debt Securities, Available-for-sale, Term",
        "terseLabel": "Marketable securities maturity term"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r226",
      "r248",
      "r255"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "negatedTotalLabel": "Gross Unrealized Losses, Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r227",
      "r249"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "totalLabel": "Estimated Fair Value, Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r228",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of AFS securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r118",
      "r429",
      "r438"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r104",
      "r118",
      "r429",
      "r438",
      "r439",
      "r440"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r17",
      "r18",
      "r418",
      "r576",
      "r592"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total gross deferred tax assets",
        "verboseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails",
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets, net of valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carry-forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r424",
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credit carry-forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Fixed assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsandTaxLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Total matching contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/EmployeeBenefitPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Percent of match"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/EmployeeBenefitPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Percent contributed by participant"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/EmployeeBenefitPlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r104",
      "r178"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.modernatx.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r56",
      "r57",
      "r491"
     ],
     "calculation": {
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative instruments"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r466",
      "r467",
      "r472",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivatives and hedging activities.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as an asset.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value",
        "terseLabel": "Fair value, asset"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r468"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of derivative instrument not designated as hedging instrument and classified as a liability.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value",
        "terseLabel": "Fair value, liability"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r460",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r122",
      "r459",
      "r461",
      "r463",
      "r464",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GeographicInformationDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r317",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GeographicInformationDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsTables",
      "http://www.modernatx.com/role/GrantRevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share attributable to common stockholders, basic and diluted (usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r150",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r409"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r409",
      "r442"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Tax effected at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r409",
      "r442"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r409",
      "r442"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "Stock compensation windfall"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r409",
      "r442"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Foreign tax rate differential"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r409",
      "r442"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "terseLabel": "Non-deductible items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r409",
      "r442"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r409",
      "r442"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r409",
      "r442"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "Federal research and development credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationofUSStatutoryIncomeTaxRatetoEffectiveTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Compensation-related"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation cost related to non-vested stock-based compensation"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period of cost expected to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP",
        "verboseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails",
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Options",
        "verboseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails",
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails",
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r129",
      "r137",
      "r139",
      "r157",
      "r237",
      "r288",
      "r291",
      "r392",
      "r393",
      "r394",
      "r434",
      "r435",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r503",
      "r613",
      "r614",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r482",
      "r483",
      "r484",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r333",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r347",
      "r483",
      "r536",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r482",
      "r483",
      "r485",
      "r486",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r333",
      "r335",
      "r340",
      "r347",
      "r483",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1",
        "verboseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r333",
      "r335",
      "r340",
      "r347",
      "r483",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r333",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r347",
      "r536",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r482",
      "r483",
      "r485",
      "r486",
      "r487",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r488",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair value recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r511",
      "r518",
      "r528"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "mrna_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest expense for financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r513",
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "negatedTerseLabel": "Operating cash flows used in financing leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Financing Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r509",
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "mrna_OperatingAndFinanceLeaseLiabilityCurrent",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Financing lease liabilities",
        "verboseLabel": "Lease liabilities - financing"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "mrna_OperatingAndFinanceLeaseLiabilityNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Financing lease liabilities, non-current",
        "verboseLabel": "Financing lease liabilities, non-current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less amounts representing interest or imputed interest",
        "terseLabel": "Amounts representing interest or imputed interest, finance lease"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails",
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r512",
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Financing cash flows used in financing leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r508"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "mrna_OperatingAndFinanceLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Right-of-use assets, financing, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r511",
      "r518",
      "r528"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "mrna_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets, financing leases"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r525",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases, discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r524",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases, remaining lease term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r224",
      "r225",
      "r241",
      "r243",
      "r244",
      "r245",
      "r246",
      "r251",
      "r253",
      "r254",
      "r255",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r333",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfLeasedAssetsNetOperatingLeases": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net gain (loss) arising from the lessor's sale of assets held- or available-for-lease under contractual arrangements classified as operating leases.",
        "label": "Gain (Loss) on Sale of Leased Assets, Net, Operating Leases",
        "negatedTerseLabel": "Leased assets expensed"
       }
      }
     },
     "localname": "GainLossOnSaleOfLeasedAssetsNetOperatingLeases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrantMember": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award of money not required to be repaid.",
        "label": "Grant [Member]",
        "terseLabel": "Grant revenue"
       }
      }
     },
     "localname": "GrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsDeferredRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r463",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r262",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r120",
      "r441"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r120",
      "r441"
     ],
     "calculation": {
      "http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r120",
      "r180",
      "r188",
      "r191",
      "r194",
      "r196"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before provision for (benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/IncomeTaxesLossBeforeProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails",
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails",
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r410",
      "r416",
      "r423",
      "r436",
      "r443",
      "r445",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r118",
      "r138",
      "r139",
      "r179",
      "r408",
      "r437",
      "r444",
      "r604"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for (benefit from) income taxes",
        "totalLabel": "Total provision for (benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r78",
      "r113",
      "r406",
      "r407",
      "r416",
      "r417",
      "r422",
      "r430",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndemnificationGuaranteeMember": {
     "auth_ref": [
      "r282",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.",
        "label": "Indemnification Agreement [Member]",
        "terseLabel": "Indemnifications"
       }
      }
     },
     "localname": "IndemnificationGuaranteeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Axis]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Axis]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effect of transition method for cumulative effect in initial period of application.",
        "label": "Initial Application Period Cumulative Effect Transition [Domain]",
        "terseLabel": "Initial Application Period Cumulative Effect Transition [Domain]"
       }
      }
     },
     "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r99",
      "r101",
      "r108"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivableCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Interest Receivable, Current",
        "terseLabel": "Interest receivable on marketable securities"
       }
      }
     },
     "localname": "InterestReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r31",
      "r258"
     ],
     "calculation": {
      "http://www.modernatx.com/role/InventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r51"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/InventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r12",
      "r52",
      "r113",
      "r156",
      "r256",
      "r257",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r33",
      "r258"
     ],
     "calculation": {
      "http://www.modernatx.com/role/InventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r32",
      "r258"
     ],
     "calculation": {
      "http://www.modernatx.com/role/InventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentCreditMember": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment tax credit carryforwards arising from certain qualifying capital expenditures including, but not limited to, rehabilitation, energy, advanced coal project and gasification project.",
        "label": "Investment Tax Credit Carryforward [Member]",
        "terseLabel": "Investment tax credit"
       }
      }
     },
     "localname": "InvestmentCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r87",
      "r177"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.",
        "label": "Investment Income, Net, Amortization of Discount and Premium",
        "negatedTerseLabel": "Amortization/accretion of investments"
       }
      }
     },
     "localname": "InvestmentIncomeNetAmortizationOfDiscountAndPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Amortized Cost and Estimated Fair Value of Marketable Securities, by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r232",
      "r573",
      "r589",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Financial Instruments and Fair Value Measurements"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Operating Lease Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r527"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less amounts representing interest or imputed interest",
        "verboseLabel": "Amounts representing interest or imputed interest, operating lease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails",
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Extension term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r44",
      "r117",
      "r190",
      "r233",
      "r452",
      "r456",
      "r457",
      "r495"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r29",
      "r117",
      "r233",
      "r495",
      "r578",
      "r598"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r46",
      "r117",
      "r233",
      "r452",
      "r456",
      "r457",
      "r495"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r283",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r283",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Reserves established"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Losses related to indemnification obligations"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r277",
      "r278",
      "r279",
      "r280",
      "r283",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of claims outstanding"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesIndemnificationObligationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MajorCustomersPolicyPolicyTextBlock": {
     "auth_ref": [
      "r166",
      "r168",
      "r169",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for major customers. Major customers are those that the loss of such customers would have a material adverse effect on the entity.",
        "label": "Major Customers, Policy [Policy Text Block]",
        "terseLabel": "Significant Customers"
       }
      }
     },
     "localname": "MajorCustomersPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r100",
      "r102",
      "r105"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r72",
      "r75",
      "r80",
      "r105",
      "r117",
      "r128",
      "r133",
      "r134",
      "r135",
      "r136",
      "r138",
      "r139",
      "r145",
      "r180",
      "r188",
      "r191",
      "r194",
      "r196",
      "r233",
      "r495",
      "r581",
      "r602"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "negatedLabel": "Operating losses",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails",
      "http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r140",
      "r141",
      "r146",
      "r149",
      "r180",
      "r188",
      "r191",
      "r194",
      "r196"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Reconciliation of net loss to net loss attributable to common stockholders:",
        "verboseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r135",
      "r153",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r432",
      "r433",
      "r434",
      "r435",
      "r565",
      "r566",
      "r567",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Standards/Recently Issued Accounting Standards Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Rest of world"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GeographicInformationDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GeographicInformationDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r180",
      "r188",
      "r191",
      "r194",
      "r196"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r519",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Lease liabilities",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesMinimumLeasePaymentsDetails",
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "mrna_OperatingAndFinanceLeaseLiability",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Lease liabilities - operating"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "mrna_OperatingAndFinanceLeaseLiabilityNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current",
        "verboseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r514",
      "r522"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "negatedTerseLabel": "Operating cash flows used in operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r508"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "mrna_OperatingAndFinanceLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets, operating leases",
        "verboseLabel": "Right-of-use assets, operating, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/LeasesBalanceSheetInformationDetails",
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r525",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases, discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r524",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases, remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r1",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Description of Business"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OrganizationandDescriptionofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Other Commitment"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": {
     "auth_ref": [
      "r60",
      "r65",
      "r470",
      "r474",
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax",
        "terseLabel": "Foreign currency forward contracts"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r73",
      "r76",
      "r449",
      "r450",
      "r454"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Total other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r65",
      "r69",
      "r70",
      "r231"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTerseLabel": "Less: amounts recognized for net realized gain included in net loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r61",
      "r65"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized gain (loss) on available-for-sale debt securities, net of tax of $0, $1,148 and $0, for the years ended December 31, 2020, 2019 and 2018, respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r62",
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Unrealized gain (loss) on available-for-sale debt securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r45"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other (expense) income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other operating income (expense).",
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other (expense) income, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsBalanceSheetHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r45",
      "r286"
     ],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [
      "r215"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings",
        "terseLabel": "Impairment charges related to marketable securities"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Underwriting Option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire callable preferred stock which is identified as being convertible to another type of financial security.",
        "label": "Payments for Repurchase of Redeemable Convertible Preferred Stock",
        "negatedTerseLabel": "Repurchases of redeemable convertible preferred stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Issuance costs",
        "verboseLabel": "Offering expenses"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r90",
      "r92",
      "r213"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.",
        "label": "Payments to Acquire in Process Research and Development",
        "terseLabel": "Consideration paid"
       }
      }
     },
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r332",
      "r334",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefit Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/EmployeeBenefitPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance-based awards"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r357",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "verboseLabel": "Redeemable\u00a0Convertible Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockRedemptionPremium": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The excess of (1) fair value of the consideration transferred to the holders of the preferred stock over (2) the carrying amount of the preferred stock in the registrant's balance sheet, during the accounting period.",
        "label": "Preferred Stock Redemption Premium",
        "negatedTerseLabel": "Premium paid on repurchase of preferred stock"
       }
      }
     },
     "localname": "PreferredStockRedemptionPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value; 162,000,000 shares authorized at December 31, 2020 and 2019; 0 shares issued or outstanding at December 31, 2020 and 2019"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r37",
      "r38"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r5",
      "r7",
      "r260",
      "r261"
     ],
     "calculation": {
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from offerings of common stock, net of issuance costs",
        "verboseLabel": "Proceeds from public offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.",
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Proceeds from equity investment"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r90",
      "r91",
      "r213"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the financed defined contribution plan to acquire shares of the entity. The plan initially holds the shares in a suspense account, which is collateral for the loan. As the plan makes payment on the debt, the shares are released from the suspense account and become available to be allocated to participant accounts.",
        "label": "Proceeds from Repayment of Loans by Employee Stock Ownership Plans",
        "terseLabel": "Proceeds from purchase of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r90",
      "r91",
      "r213"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r95",
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Consideration for options exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuance of common stock under equity plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProjectMember": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Planned program of work.",
        "label": "Project [Domain]",
        "terseLabel": "Project [Domain]"
       }
      }
     },
     "localname": "ProjectMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r265",
      "r511",
      "r518"
     ],
     "calculation": {
      "http://www.modernatx.com/role/PropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedTerseLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r55",
      "r266",
      "r518"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/PropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r14",
      "r264",
      "r508"
     ],
     "calculation": {
      "http://www.modernatx.com/role/PropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r41",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r269",
      "r628",
      "r629",
      "r630"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOtherTypesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Property, Plant and Equipment, Other Types [Member]",
        "terseLabel": "Furniture, fixtures and other"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOtherTypesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r40",
      "r113",
      "r266",
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Construction in Progress and Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r14",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Estimated Useful Lives of Property and Equipment",
        "verboseLabel": "Schedule of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentTables",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r14",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "verboseLabel": "Estimated\u00a0Useful\u00a0Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r83",
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expense"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentAxis": {
     "auth_ref": [
      "r16",
      "r577",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by arrangement, in which the entity has agreed to expend funds to procure goods or services from one or more suppliers.",
        "label": "Purchase Commitment, Excluding Long-term Commitment [Axis]",
        "terseLabel": "Purchase Commitment, Excluding Long-term Commitment [Axis]"
       }
      }
     },
     "localname": "PurchaseCommitmentExcludingLongtermCommitmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentDomain": {
     "auth_ref": [
      "r16",
      "r577",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item is intended to be populated, by the entity, with Members identifying each purchase commitment about which information required or determined to be disclosed is being provided. If only one such commitment exists, this item may be used to capture such information; if multiple commitments exist, this item is the dimensional default, which will aggregate such information, as appropriate.",
        "label": "Purchase Commitment, Excluding Long-term Commitment [Domain]",
        "terseLabel": "Purchase Commitment, Excluding Long-term Commitment [Domain]"
       }
      }
     },
     "localname": "PurchaseCommitmentExcludingLongtermCommitmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Purchase Commitment, Excluding Long-term Commitment [Line Items]",
        "terseLabel": "Purchase Commitment, Excluding Long-term Commitment [Line Items]"
       }
      }
     },
     "localname": "PurchaseCommitmentExcludingLongtermCommitmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PurchaseCommitmentExcludingLongtermCommitmentTable": {
     "auth_ref": [
      "r16",
      "r577",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required or determined to be disclosed about arrangements in which the entity has agreed to expend funds to procure goods or services from one or more suppliers. Such disclosure may include identification of the goods or services to be purchased, identity of the seller, pricing, effects on pricing for failing to reach minimum quantities required to be purchased (such as penalties), cancellation rights, and termination provisions.",
        "label": "Purchase Commitment, Excluding Long-term Commitment [Table]",
        "terseLabel": "Purchase Commitment, Excluding Long-term Commitment [Table]"
       }
      }
     },
     "localname": "PurchaseCommitmentExcludingLongtermCommitmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted": {
     "auth_ref": [
      "r16",
      "r577",
      "r594"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount to be expended to satisfy the terms of arrangements in which the entity has agreed to expend funds to procure goods or services, excluding long-term purchase commitments or unconditional purchase obligations.",
        "label": "Purchase Commitment, Remaining Minimum Amount Committed",
        "terseLabel": "Contractual commitment to pay"
       }
      }
     },
     "localname": "PurchaseCommitmentRemainingMinimumAmountCommitted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesPurchaseCommitmentsandPurchaseOrdersDetails",
      "http://www.modernatx.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": {
     "auth_ref": [
      "r287",
      "r480"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.",
        "label": "Reclassifications of Temporary to Permanent Equity",
        "terseLabel": "Conversion of redeemable convertible preferred stock into common stock",
        "verboseLabel": "Conversion of redeemable convertible preferred stock into common stock"
       }
      }
     },
     "localname": "ReclassificationsOfTemporaryToPermanentEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemablePreferredStockDividends": {
     "auth_ref": [
      "r141",
      "r288",
      "r291"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.",
        "label": "Redeemable Preferred Stock Dividends",
        "negatedLabel": "Cumulative preferred stock dividends",
        "negatedTerseLabel": "Cumulative dividends on redeemable convertible preferred stock"
       }
      }
     },
     "localname": "RedeemablePreferredStockDividends",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedemptionPremium": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The excess of the (1) fair value of consideration transferred to the holders of a security in excess of (2) the carrying amount of the security reported on the registrant's balance sheet, which will be deducted from net earnings to derive net earnings available to common shareholders. This amount is generally an adjustment considered in the computation of earnings per share.",
        "label": "Redemption Premium",
        "terseLabel": "Premium recorded to deferred revenue"
       }
      }
     },
     "localname": "RedemptionPremium",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]",
        "terseLabel": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross": {
     "auth_ref": [
      "r402",
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross",
        "terseLabel": "Expenses associated with license agreements"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r401",
      "r640"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r113",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "terseLabel": "Collaboration Agreements"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r2",
      "r13",
      "r112"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r9",
      "r15",
      "r112",
      "r626"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash, non-current"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesReconciliationofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockExpense": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.",
        "label": "Restricted Stock or Unit Expense",
        "terseLabel": "Restricted stock unit"
       }
      }
     },
     "localname": "RestrictedStockExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted common stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted common stock units",
        "verboseLabel": "Restricted Common Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails",
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r25",
      "r291",
      "r395",
      "r597",
      "r617",
      "r622"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r129",
      "r137",
      "r139",
      "r237",
      "r392",
      "r393",
      "r394",
      "r434",
      "r435",
      "r613",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r175",
      "r176",
      "r187",
      "r192",
      "r193",
      "r197",
      "r198",
      "r201",
      "r316",
      "r317",
      "r564"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue from contract with customer, excluding assessed tax",
        "verboseLabel": "Total collaboration revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsSummaryofTotalConsolidatedNetRevenuesfromStrategicCollaboratorsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r168",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesSignificantCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r306",
      "r307",
      "r320",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "netLabel": "Geographic Information",
        "terseLabel": "Grants",
        "verboseLabel": "Product Sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GeographicInformation",
      "http://www.modernatx.com/role/GrantRevenue",
      "http://www.modernatx.com/role/ProductSales"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/GeographicInformationTables",
      "http://www.modernatx.com/role/ProductSalesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Remaining performance obligations",
        "verboseLabel": "Remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Performance period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPriceAllocatedtotheSingleIdentifiedPerformanceObligationDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationRevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]",
        "terseLabel": "Summary of Total Transaction Price to the Identified Performance Obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r79",
      "r117",
      "r175",
      "r176",
      "r187",
      "r192",
      "r193",
      "r197",
      "r198",
      "r201",
      "r233",
      "r495",
      "r583"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/GeographicInformationDetails",
      "http://www.modernatx.com/role/GrantRevenueDetails",
      "http://www.modernatx.com/role/ProductSalesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r523",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained through lease modifications and reassessments"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r523",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Aggregate net proceeds from the offering"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Shares of common stock issued (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price per share (usd per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OrganizationandDescriptionofBusinessDetails",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r68",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareCommonStockEquivalentsExcludedfromCalculationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Reconciliation of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments.",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Summary of Cash and Available-for-Sale Securities by Significant Investment Category"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsChangesinBalancesofReceivablesandContractLiabilitiesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2020StrategicAllianceinCysticFibrosisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Provision For (Benefit From) Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Significant Components of Deferred Tax Assets and Tax Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Basic and Diluted Net Loss per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/NetLossperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of U.S. Statutory Income Tax Rate to Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r356",
      "r383",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r356",
      "r383",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Loss Before Provision For (Benefit From) Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r12",
      "r34",
      "r35",
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Restricted Common Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r471",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Schedule Of Foreign Currency Derivatives"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.",
        "label": "Schedule of Principal Transactions Revenue [Table Text Block]",
        "terseLabel": "Summary of Composition of the Total Transaction"
       }
      }
     },
     "localname": "ScheduleOfPrincipalTransactionsRevenueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r41",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "auth_ref": [
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.",
        "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "terseLabel": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CollaborationAgreementsAstraZenecaStrategicAlliancesinCardiovascularandOncologyDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsChiesiAgreementTotalTransactionPricetotheIdentifiedPerformanceObligationsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKCompositionoftheTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMERCKRevenueandContraRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsPCVSAVRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFDeferredRevenuewhichisClassifiedasCurrentorNonCurrentintheBalanceSheetsDetailsDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVEGFTotalTransactionPriceDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXBalancesofDeferredRevenueDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVERTEXRevenueRecognizedDetails",
      "http://www.modernatx.com/role/CollaborationAgreementsVertex2016StrategicAllianceinCysticFibrosisDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesLicensestoPatentedTechnologyDetails",
      "http://www.modernatx.com/role/CommitmentsandContingenciesStrategicCollaborationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r13",
      "r112",
      "r574",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Reconciliation of Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r357",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails",
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Weighted-Average Assumptions Used to Estimate the Fair Value of Options Granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).",
        "label": "Schedule of Unrealized Loss on Investments [Table Text Block]",
        "terseLabel": "Schedule of Unrealized Loss on Investments"
       }
      }
     },
     "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r415",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r166",
      "r168",
      "r169",
      "r170",
      "r492",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Entities that Accounted for More than 10% of Total Revenue and Accounts Receivable"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesDPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series D preferred stock or outstanding series D preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series D Preferred Stock [Member]",
        "terseLabel": "Series\u00a0D Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesDPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesEPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series E preferred stock or outstanding series E preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series E Preferred Stock [Member]",
        "terseLabel": "Series\u00a0E Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesEPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesGPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series G preferred stock or outstanding series G preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series G Preferred Stock [Member]",
        "terseLabel": "Series\u00a0G Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesGPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesHPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series H preferred stock or outstanding series H preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series H Preferred Stock [Member]",
        "terseLabel": "Series\u00a0H Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesHPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Cancelled/forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancelled/forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Issued (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, non-vested at end of period (in shares)",
        "periodStartLabel": "Outstanding, non-vested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares/Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding, non-vested at end of period (usd per share)",
        "periodStartLabel": "Outstanding, non-vested at beginning of period (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date per Share/Unit"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividends"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails",
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum percentage of compensation through payroll deductions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum shares to be purchased during purchase period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Aggregate number of shares authorized for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for future grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Outstanding and Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Number\u00a0of Options, Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price per Share, Exercisable (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised (less than for the year ended December 31, 2017)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Cancelled/forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r364",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number\u00a0of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at end of period (usd per share)",
        "periodStartLabel": "Outstanding at beginning of period (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]",
        "terseLabel": "Vested and expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]",
        "terseLabel": "Options Activity"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Number\u00a0of Options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price per Share (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r355",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.modernatx.com/role/StockBasedCompensationRestrictedCommonStockandCommonStockUnitsActivityDetails",
      "http://www.modernatx.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails",
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled/forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Twelve months of continued employment or service"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Following twelve quarters"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r113",
      "r357",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Weighted average fair value per share (usd per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r378",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationWeightedAverageAssumptionsUsedtoEstimatetheFairValueofOptionsGrantedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- Average Remaining Contractual Term, Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- Average Remaining Contractual Term, Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted- Average Remaining Contractual Term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price at which shares are sold, percent"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r520",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short term lease costs"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantSupplyCommitmentRemainingMinimumAmountCommitted": {
     "auth_ref": [
      "r48",
      "r580",
      "r599"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor amount as of the balance sheet date that the entity must expend to satisfy the terms of disclosed arrangements (excluding long-term commitments) in which the entity must commit resources to supply goods or services to one or more customers.",
        "label": "Supply Commitment, Remaining Minimum Amount Committed",
        "terseLabel": "Supply commitment"
       }
      }
     },
     "localname": "SignificantSupplyCommitmentRemainingMinimumAmountCommitted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Internally developed software"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/PropertyandEquipmentDetails",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPropertyandEquipmentandSoftwareCapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r115",
      "r117",
      "r142",
      "r143",
      "r144",
      "r147",
      "r149",
      "r158",
      "r159",
      "r160",
      "r233",
      "r288",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical",
      "http://www.modernatx.com/role/CollaborationAgreementsMerckStrategicAlliancesinInfectiousDiseasesandCancerVaccinesDetails",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r50",
      "r124",
      "r125",
      "r126",
      "r129",
      "r137",
      "r139",
      "r157",
      "r237",
      "r288",
      "r291",
      "r392",
      "r393",
      "r394",
      "r434",
      "r435",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r503",
      "r613",
      "r614",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r157",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Purchase of common stock under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Proceeds of initial public offering, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r288",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Vesting of restricted common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r291",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of options to purchase common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/StockBasedCompensationOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Purchase of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r21",
      "r22",
      "r288",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Proceeds of initial public offering, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r50",
      "r288",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of options to purchase common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r22",
      "r27",
      "r28",
      "r117",
      "r210",
      "r233",
      "r495"
     ],
     "calculation": {
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesComponentsofAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r116",
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock and Common Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r504",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r504",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r504",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r504",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r530",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Other Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/OtherBalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carry-forwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Redeemable convertible preferred stock, shares authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Redeemable convertible preferred stock, shares issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Redeemable convertible preferred stock, shares outstanding"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY",
      "http://www.modernatx.com/role/RedeemableConvertiblePreferredStockandCommonStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of redeemable convertible preferred stock, net of issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TenantImprovements": {
     "auth_ref": [
      "r601"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.",
        "label": "Tenant Improvements",
        "terseLabel": "Tenant improvements"
       }
      }
     },
     "localname": "TenantImprovements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r224",
      "r225",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r432",
      "r433",
      "r434",
      "r435",
      "r565",
      "r566",
      "r567",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r333",
      "r347",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. treasury securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsFinancialAssetsMeasuredAtFairValueOnaRecurringBasisDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsSummaryofCashandAvailableforSaleSecuritiesbySignificantInvestmentCategoryDetails",
      "http://www.modernatx.com/role/FinancialInstrumentsandFairValueMeasurementsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r405",
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance as of end of period",
        "periodStartLabel": "Balance as of beginning of period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Decrease due to prior positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase due to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesReconciliationoftheBeginningandEndingAmountsofUnrecognizedTaxBenefitsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r161",
      "r162",
      "r164",
      "r165",
      "r171",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r521",
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/LeasesLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "verboseLabel": "Weighted average common shares used in net loss per share attributable to common stockholders, basic and diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.modernatx.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.modernatx.com/role/NetLossperShareBasicandDilutedNetLossperShareAttributabletoCommonStockholdersDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 19
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=27010884&loc=d3e42851-122695"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27198-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27337-111563"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27357-111563"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922890-210455"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121548805&loc=d3e10037-110241"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121596127&loc=d3e13051-110250"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=120519210&loc=d3e90193-114008"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121566025&loc=d3e44908-112734"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(a)(32))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6806780-109447"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=SL120269850-112803"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a)(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "730",
   "Topic": "985",
   "URI": "http://asc.fasb.org/subtopic&trid=2197926"
  },
  "r642": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r643": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r644": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r645": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r646": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r647": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r648": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r649": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r650": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>218
<FILENAME>0001682852-21-000006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001682852-21-000006-xbrl.zip
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MO&\L?$IUJ; WL]SO!6=CK%_=JO>__?\ 4$L#!!0    ( ,N#6E(!JCJ8#AP
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M=,]Q%/''6QGD<ABHZ@Q,YT#<2L<9/9?F*->U"KTY3C^;:.3:B:))AG,AO0_
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MKERDL$<:-CM\M@_Y0]I.+5Z;J.4ALP9SC\2OD<="#G'B)@&<"M9MW33I$2S
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M<.>; 4UX#?[/!_4T]$U^*RF3E>MOG?@5NFB(9)OUO#0?C?"N(HPTCNH4[ZL
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MHTJ2U46J#H@8Q*0)85",C'&=EE7]I/!I3:?(!$%F]-H%KVJ=<M*]?BN_=V]
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MZ(E#KP/_AWB:F&1*B08JKHS=_ZJL0M,5TT9=7@[)?--/D6;"JDFRG=*2 9M
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M_Q&S@H\KYPT<:QY@QAMZZX!Y2:T@W! 9(4M\ LC%JJJ8!)1\:3>[FXF8$ %
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M_Q%0./H=H7#T&E#H_!%0./X=H7#\&Z' ]]DD)GXC]_\"$$Y>!(3VBX!P\AI
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MKS9JQY6Z1S@.ZP7Z6@>QL&*RRHAWA=(S$8'BFK(4/9=DW%9ZX=EUXU]:&9
MJT(XV.9TQL7B.2= 'R?"AG 07#9[H*TSFQL]D3,\TVI*^K20&T+CCM8?GZ.Y
MS#C[.%:V TV@&Z<:-W V'ODJ\)<DB.?:\RO'Z^D:'_):2VZR4F2^,5M52*S#
M&,<+YL3V.2*08G,!6IBJ!1R.NNZTF&W1UV"!S7C*#ENPM)B6:42#] I?6-51
MPV8? ^(0 T0:F,U' K,'A;:<A8B.[J*=A$2[F8Q5B4";2-,72B\SN;%2P 1)
M^3YB[A&N27!+MHO<RN)SCF?[Z^#X'""_#8Z>@,KDXO6W%!$O%^251JW2KJ N
M5]7A==A*K8T]_^1NP;4$B&@SX>["1#T)&B^V0DD))\-A83(G86!QV(AL]->.
M+YFDIVN[%XUFG;%3TG5@8*T%D6I'077:\[D; C^M9LSQ_&52SH8$:J5.H:LM
M95J*7NO9FY]@F01,ZSOW<KH;D,JZ"MC%@9U3[^"L B;W3$2?UD S;5<Q3TID
MT>Z-'%FZNTU1J3_G9PR:8/W[CI(NTT#FX,6:(\?4;]:TET_9RY2O =*S4-)&
M02%Z";E@IT_<&?Z<<WJJ.%*SSJR,_UQ=^N&2_'\1^_K-?4@2I"GZN#?;.,&6
M7QIJ.@4"I"QZ?S7^&T_ZK(H77+N]39\Y:/8].AMBYP%@X')?QASKB8K:6D=<
M[PM=L![.FO %G%[P, X?_-D3IHWL7'$Q6MCP7_+-:(^P#C[&F%>K"P-<D.D
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MD<[Y6L;,@*P4G69SX1L.2\U=Y*BV*<&%7*Q$=6V:E7J9$9 *1C"FVB*=,V&
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MN2MA;+9VNA-8$/">=-V*O2E*T[*QZMUT)<%S+267I/5AG2A=)T$6Z,#00HZ
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MR[_[E5_NQ\6@\RO^O)K<7/_X_P%02P,$%     @ RX-:4K[:;D+/ P  $B$
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M4^LF.QK;Y;EX6R!_;Z'S#U!+ P04    " #+@UI2BYN,L7D(  !I)P  %@
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MJ^RXW:"$[R/2W%JILG2-HURQ2IME9G$/8'*"([05XC,2.%+(7=0>2?CGC.R
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M2[EI\H5O!.MK^<5"?SLY_!]02P,$%     @ RX-:4O#]!S0-$@  ,UD  !4
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M@>=NE)@R<]N<&><,'0?K!@-CCG4PSM>95W98+;1+2_[\"SC)^_E%:WPQBSO
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MQ1M9IO(G\;VQ4_R1,VH,%J^E^Z0J\4J7J#SWP-2V?OF([K:07?E.B.OHK*F
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MI%]<&JIWME)%BR%#,I2JBQK(U2CQKBFY!W/F/:+(9W^7VRO#^?S!HX?;5[.
MVT<[48;_*LZOJWG3;?2MGP'4TC*SDDM&%0].WOK8] G:G>-U__RN?RI'S_C%
M(&\/AX.VH#.?)GZ_">'Q3]ITR8K*H8M9S<FI:M,XQAK8!TR<E-',0,EKYWK
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MQ-.?[S^_R9%1^>FJR=DU6=]Q]>DQ3<[:+8V/3_G^>')V^WM:_.?O:?%;5BV
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M!JUJ'[HR=#"G>?UX9*M37+'DRF+W4L%:BW<AIZJMJ[@FTXNW[\,WI+Y3UUZ
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M4&F=\JYK1Z B@6AJ>4/*A];[)8H!8,92<K8^ZS[4 ^F4)UL[ BG(@:K+0B(
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M02L34X#B=)4G:="['FQ>_B)X?I+PB8_'P_+X]&PR?G491_5D))50=?7)<4D
M,*^ND2RJ9N6R#K4'*5W=AFJ1D:Y!A:$FC(4 +:"!&&KKV\>4"7L0Z7X15']X
M\%S;MN/[,L8P4?4UB @T",@N%LO1@O7(5'4?FBSV";A%KAT'A^BBS0HRI&22
M4]XE48:JYIQIU53@_?'IV?F,)WU3@ZD2,*JH6%P811EN&-J\,FB -OFS8N/K
M3F%:Z&@R:#F4XBN#CRG5UAW91D/6:*U[4$[_BV!Z.JZSUS3AG3;!/^[3>!)
M(+@H:!D%7HF8ST65EO::5&N LV+CZ8Z!6FA^LB9Q19B3-5"M%=<$P23VK:D>
M65R1$37/PKC*T1B]>#)X<3S;K\^FO#V=<F_&5(7"*>B4JV\U9:)68 P&ZT/6
MB7NP\ZO;4"UR5&D3"F)4V;4"J2DY]!DK9B5^2]4>5+CX0CDQG[[/;9;W\4@^
M^F+"T[Z$5IZS5Y&=)]2 2I.G$I"R2ZQ08N,5&5;+PVJ1&=U9AE2V.FO?U+E+
M(>I:T58*(;+M<!@\G<P:3D4>_/[D*4]>#?*']N[JK:<T[$UDZ\EEBM4%X@*Z
M%HF9O"N!(J>H?)<+]'4$BT66^C3.JHS%Z.B!17C;:)V.%;1V,><.9ZC_!1;W
MQ\,AI98CVQ80)Y.V -PC=<VLJRZ6P%D-U5'$&!#1> SB8FR'BP)U$)>O&R_O
M^AUE.CT[GWZZV]'E>]=G^+->1^_;)_VWSGYWLO/9Y/OVQN><Z>8\5*L8&14Q
M8(8D:'J+3EZ)62LVJ>.$>9=1\HA%5M#9\2#3\$/6T&F:#,H+WJ7IE/+QN2CZ
MWBQS>:/(9(.$X("CIU0CL],U.A<K7^66J[A&T'S6E9\P#1],V^5%FF[G?'YZ
M/FPY'SM\-N$\F%N0'9[FR>"L_;I?K^7L!W=W\'K\[_-1F7 YX'P\&@_'+RZ>
M_O><)G^5BO2UCD#%!06$V4%)P>ND B@9T)3(>18*191 T6_(<WOD>3AX]?_9
M>_/FMHVL7_BKH#S/?6Y<16JP+_;<5"F2[&@FDAPM\2O_XVJ@&R)L$.  I&3Z
MT[_GG.X&0(I:[$@B*7%JDM@D 32ZS[[\CEAOZN&I[]H^6'78UN)P$:5)!&XK
ML^/$=&S?5-1CV^$Z4L]A65V5)7\RG8 '8_?M\ $.)H@C/TQM :?BNS$+&??"
MR+<2P4..70CKK:Z?^F >-*@3V*$9@5L:Q&[*>2RBB#$G"DW7#'BL1A69OOE2
M#N;)I.W!Z0XL;SQX9$(Q_4Y!Y]^JB F#P$Z!?2T;4?? *;/!X':\T'5B6V84
M+7]=%?,J$\I1FH)/^8?T(LMJ"G?Z X/]!ZR8I"P93["#Z&3$DL?5TOZ#:6G;
MQY!8D#J)R]U8)+&P(M<-HS0.F&7)DL4714JK<C!Q%"5^[$9F% 5NZH21Z26A
MXZ2ABZ<1K\'D)*HYU(T/$Y:?BFK8.9L]N(YSP>EGZZ*B'<N)G2 %H\F/X&Q,
MQE*7>>@<P;] ]J[NJ6PD[XJ1D@_ZFULFCX+$!#?;BAW?8[;G1)8?1$'@KD';
MS+K3%)A])^7D,<R^Y7?R.*%CB]BS?=N-P0\'DF*V;?EV(!@/ V<=V@V? 7D]
MDE>Q?/*R7&QP05LQLMTT](&D1))8EFT&C*<F7UU%J,V38U$+Q"J \^U4P'72
M0MIT.2T_B"HMJ^&[LJ)2[OI:Y0_\H"X+EF??!3\X/MS>844BJK]8DF2%J#_L
M_#6;>D+5E6!/ZO9%)>A9'S,DDRKY>C)@U0B75 Z& J%V'JIM=8>-LK%<X4Y9
MC^NC]*R@5A"N*#<3]=ZW))^ 2?:N*H?;0R#=[#LM^+>IINZC"O[T123C^[^\
MS,>MBX$7VVD:L\0,K<1QP04*W<"W024[5FPYMK?"2>D-73\[NG[(PA>;I4#$
M'@=_TC4CBWE"A)X7.5RD8"@$:V .-'YE6==(PV#O2U"RWZ:'#.Q_<92V'\]!
MONP77 P+"> --WL_8< .8_$(OL+R53-S U.(*(YXX+F)$+'OAY85F:EG!Y&3
M.'C4\%=YU*LMR];GJ#$_<\^CGN?J'SOJMB0D9]GPAHH0_.J'RS@<P8+8\TPO
M0>S0((W3(!:1&Z<^][PT\E;?I%MM<GDDK!_7M:TX-5DH7(<YS+.B*$C=*$Y"
MGL1KT+.R+H?VD#@!22 LTTQ99,>N"T?'7<?SK2@1CAVI1J/5YK0/$[ P*;P[
M'&9CO%C:6'!:?Y3%Q5A4P_:KCDUU,AF-<HS=S83M&G-Q7;P$RP(5FW#3\5@*
M!VBRP&(I9SZH6)M90?Q\#W GSPH,P:CJRG4Y,#OVD]1S O@OB$G+"X,DB)GM
M,#B]E/GK@,SQ-P],@6*5!6+X(AN"&]1>L";'Z%LB]D(S]1-7N-CL)[BPT]")
M16":X+"3M@M,W_97]1@?SUT]!0^>C<1DG"5PPOC+P30'"9LE3^*J!EC=8/L/
M4=V0.$GH>V#-)(GK"SL.8S.Q$Y.+R+(2YKWD0][-V$4!MUR[0PT$YK-],TP"
MA$8R0Y'8?BQ2U[,LF[,GY-QE[0"68">69T>V"%T[!$UDN6D<N0[L!?-#RO=9
MH7;+PU7610\98CR9Q/E<T! +!1Z!KF?<]?#^[GKX8)&9A+DL2DP[\,#L=R(6
M@[L6)[[%"'8@E75;X5.4Q/X8$X0/5GN:@)>:A(F9!K'I"JQS!!<H GT>!4X<
M<U_M@&<&*[<#7M\,'F 'P$5@L<5\%UP]-_1M^']B,I #@2>\5!9Y(O=;C\[]
M/[H#P 76@_27\3"T3= "(.Q<UXKCU(^\F*6A&W,PQT,I"'$'^D^U%3\K"$%X
MU1G/6#7%QLNC]&1<)G- L/L?CAY=E,V<S)VBS'H(41;#?GK N9X7>JXGP$;#
MV<_,#.P0M%M@/QT9K]O9/0I/A5; (BNV>.J8+@]Y'#$>"-N*(SOQN2?6X#AT
MH<=.SNIZX7&@NUH6],5#90^?%1%8EF,ZB1N8'@?3,A)18-LB-7TS<AP[]75%
MF6VY??V'E:6&F\]%YF;):D3,"/"3TE0\SN"&^5P>G)-[OUS>S$__AI@-><AB
MS^*1[W,W#/TH=<&&!*HQP8E(4Q4IWISD_?EM_G#^CBGG>CY8[:[MA*EKFCST
M38\E ;AS@<G]T'H>_-9 ZU^*:CO/2XH7'E'5VW/D.)9B%9OK)@G\.P+9&0G.
M'"\(["3AON.K0_5L62B!?UC#0UVB$/7Z]CT+(F9^^C>.U/,"TPP#1!]S7$LD
M<1QZIDB9G;+4#[CNJ]N<Y \)T>[A_)V0/MBGIN.&*3-3-[ 2X#>7.=P%5SAR
M8HGE!Y8KF#:K>CB(8'7(AC-!+3P?*2.W"[Y?)/B42X&_Q+=Y;'O2ZCOF0R3-
M?)N%<> #ZP2NPRWP)6#[.'AZH.,2%BA''8ZFOSFC'Q.$\Z=TA]/>_>G?BC\F
MKFV;$?,C;/=+F4@2$?)()'82>6ZR1D6 VU>LXO.A9)F3_HW5@M/WCQQ$7DYY
M7^0*R_9PHA?W0&P&,9QJ&MA>F,:VGX*K_\(.\=Y/^TO46$TT!X([8)5\&,)+
MPR6RDID65K$"MN6H>"Y5HDWI(.F$/,?5+BX@[/Q W^O>983@%'F^RT2<\,@U
MPR@*4^%:'N-V[ 6NOT[CH'Z28DZORH>BV9<LY@+?$Z%ML8B[/#9!TKG"C (_
M30+78N8:D=&=QL=[K%Y4AH?_2*33S%0:CO)R*D1G!<^1?-)$.%YDV<*)A<O3
M*$P8?!!@O9[#0\]:_8*O99[?X]3@A8*YD9^87FJZ-AB>R-&1CR/-?)Y8*XR]
MNDI>Q./ &C [MOPXMFW?<A,$? M=S_0<CX6^ESAK@-)^ [<<@P:OLF0L.!W4
M&1@M]?')V;K4B8=F($ '>KYEN2884X'+?3=@#G/- /ZV1CIPV>>S?(T4IVYD
M6ZFPPHBY<>PP'J<I2YAMLB!FGK/ZXF_99_@HHL\-(B?E"7"7[[FNS<+$=PBE
M/13<LP-?9\Y-;\V.9<90>"BC<H$&G'F.KE)_JDBGW3>]GR."QADN5;Q\L2>L
MO_UA-S@QN<EL[CK"CUR$2'!CVP<^#T"WQDD@=)43QM$W!+9"!':]MJHEL3MK
MJ]J?_F1H9J3>[[/\_6*BG/O1#].F2$1LIA[W+?2EA<U$$ 66&Z*]$:2)O_YV
MQ0N@S>58,4EH<<NTTR!AEAMS\!FL ,X4R(>Q*.(KC/7^,BGF46PF,[5<AN@"
M09"XOL]9"JXCC^"@+#!RDS7H%'^F!^-Y263%V _'8C!F?1;&<>QR,TI].T[7
M*FCZLL.7/(W#P.,V!W_?=1T_Q+E>"?,1AR$0KK=&&!ZK<I!/AM Q6TX6![$?
MB-"R+' KN1=B84O@<U\$;A2:SAIU?:W,02ZG=RL4+ R$)P(<8>YXL0ACL'AP
MM+D=V>D* ]X1G"%VYLESP[]^% B=*OCVI:C8Q5WY[;6@D,?1IW'BF;'E"->R
MW(2+&"S<.$D3TW19X'*QNG'QEW;H#QAU9UQX8#2!P YLL&Y%9"968@51ZL0>
M2Z)41P0WA[[T0P\?, -FN@)..'+LU$WL")L1/1XXW$K3V'2<9V8Y/T>;&;;1
M#YD H\KC;NI:S(L=*TB$QRR3\[7"O5O^$2['6G;"U/(C.TIMYKFV9[*4^;;O
MI*E <#/V3*HV_JX0_MMB?E7,JR!A/+99*AR>NDXJPH0E<<2PKRIRPS!:7?/J
MY1SW QI6*;/#R/$MWPZ%ZP&;VYX7,F8F:1 F?*TJ0Q?59<[EP;<+_H*J&[CE
MLYCYG 6I#Z:3$[DF#G?V$R=P8IN+]56^JW2VR]'*@CFVS5DB C"LL%.+1T(P
MR_%L)V2I8ZUO#&NESG8I82V+NY$-"A@3OZ[@2>3%*9QW""S*8V&M$RK5"AC-
M2SG"* Z"R.=^FK@6@B+BO'8G%H[KNXEG-VWHZZ!6]XND'(H&"N2/4N+[7JLW
M6X ^MO<->S&>2ZO.K&,;@SI-4AXXEN4*)X@X\YW0BYP$_HE"OD:Z==4/>#D*
MUC8]D9HF,UV'NX'G1-RR_=")T]#B=A"G:R2$5_Z ER*BX5A-X0:1%UC,=0,6
M!U'$(A':3F#9D;E.>?E['?![48!CFN/H+#[,B@S,*89M$<]92*<.UGIR-W&Q
M63X( X&CUOR4A8'E1.ES$])+/>+EB&EN,8>EW.8F6,UVZ++8M3 I9/.(!W&R
M3KG\-3CBI0AJL*YLQQ>VAYPL["0$[G4</[$#\),<>QV&<M[A#BE 7IQE19W,
MS[)YV'8C."+!;0_.#.'$N1\P%D<V \LJY&R-A/%J'.-R!&X8QY9CPEF&/'5#
M,XDCSQ0,N#%BEN=;WAH)W!4YQN643CD>'%<DN.^EKIFPV+9PZK$7^H[I1]8:
MC#*7ZO*4?=N>C =EE8WGYA'MPK<(RK]33HIQ-5V3]%OHI2 :'2L*0ML-TC#V
M(]=TN;#=.#)CWU__<SE1 WS1OLG_/:FRFF?).M6?);9K<<9,[L$?A(B$X);C
M<T10YVXLUO^$?HQS[OU8>.!.)7@VWF%5-041B^)W<1!B34@AY8Q'CA\ ";@N
MXNF(E*=VG'HB""QN1:M/"@]W)AOYH#6K$+[-$W!53-.-0S^T8A=$A4D#')EG
MKSY1/-8)/0154G;PG>#H!!]5HP$K=JO)8^-J/MB(NM1+0$-8GNLX;FR*,'!#
M+THM/S%YRIPU0%M99=)HUW@)Z@M?3/YR38C#LSAWF9.&H6>Z+DM"S\5"=R\*
M/?"/URIEN UWX%D^P<#4B4B #.:G:R%,VV1,\:VC=(]5159<U.!X22"WZ>(;
MO,BN,W #N.-PA%YS7-MSXL06EIVXD? #RW?6JH+V69+%DJIRP2/T1.J9D1NZ
MEF.RQ/.%,%,O]IEOV_$ZA6&>)UDL):QCNR:W?#.(>>R!W @Q3&>9#$1&G$16
ML%8M$T]!%G-59<]1@01FD'B12)S(Y2YHD#ARP )-@$J\E$5!L%$@2R2))=6V
MV*Y(8D3B!$,BA/^EMA\'PDK K/ <SC?*8YDDL:16ZB!.+#-U72Y<R_6B*(B%
M[_.4VT$:.6L%0[\$DGC.;03"BWQF)I$=A[X;.'[$$IM;KK"<R!>IG+ZS42!+
M)HWE*)(H]5B8<F9["7>3P&6I[_ P8."9AL)A&R]D)4AC*0K%CW@8!Y:P_<AW
MK<!B:<#-Q Q#VT]B^&0-% IV]37E6.]%>5&QT2!+6"X/-9'IL3=G)\]+WMM!
M8K/8]2/+<US3![^1V::7^"SQG-2TUZ%J<NDGMQQQ;+FF$Z5N(BS$-TT=YN)L
M!D=X?F"Y@6NO@3A>_LDM15H&@>-@6Z;M!K[KIVD<LX1Y4>B$09#">:V_M-0J
M\+ LSIYE?2,/ C\VX]@"O><ZE@"C.7%%X'L<A*;)UJ$C:'6.<#GR$[C.Y4D@
M<&:7:UM1F%K,-V/?MGT[L+BY_O+S*8_PJ01I@]/,RUHL!F?&;_35]T9DCI*$
MIS9/F,U3ES&'14R :DU\)XJL(""&MBTMDRT3J&35J*$[JU3\=P(7[5W"OZ[7
MO,[]X)'ELW5_^6SA$&';?P#F9J:38!.!E?+8!=,V]F.6AE[,8]\+0R%1DC>G
M>-_"A[F#^4F@_V*":RG3FUE7_N(HW?TI%G9#AT>A#Z83<X&;XT"$8>PX?LJC
MP+)BQ<(V""#]A\WAWY>%[;X5WIN%VY_>EX7_F7U[4XFZG%2)J.5?!X)Q6CS/
M+G_]%_Q+<782I,#;H>M[8'DY)G/,U$P3\(3L($IL\S-JZ?::>CS-X?B&6=$?
M$&;/&]?>"KS1^.U5QL>#-Y9I_I]7]--?_U6/6/'KO^+JGW #^6=YG^9N-_^D
M^RA67<#3XG(\+H=O_!%.>!RS.!?Z!W%9P8OUDS+/V:@6;_0?WO*L'N5L"NR5
M9X7HTT5O+T4U1I7>9WEV4;P9EZ-VY5NF7/T8MFG,]?W5UUOTU3_'_/IW4;@5
MF3=_;6Y9S7?_I'M7^@=J#SWY5MR M>,V_+]7SJNYUU/O;X_&1EWF&3?^8=+_
MWHX8YUEQ\<8T++I+^YA_TAO_Y'[#QKQQMEPX6*0HM5LX#$Q4K^1]] 6PYK)Z
MHY>3 @GV4S;,\NF;_WL*K%@;A^+*."Z'K/B_O9H5=;\&HDWE#^OLNWAC.? 4
M^NN5W(X [D-'IK;'LG%SSP[W3_=VC9/3[=.]D_LLW]RRO15:_\G>SMGQ_NG^
MWHFQ?;AK[/U_.[]O'[[?,W:.#@[V3T[VCP[O]U+.D[Q4=*]W^LCJ 1#?N"QZ
MQNZ.89N>&]V?D]_>[[T>A]NW(C_\&6;W_"W3M>_%[#]R6]<",1K^B RYG\"P
MK@D,]3UN^O4OM32Q1]]0GG3/H\)SG]_18<9Y+IZ<^$C:OCLZ/FB(36W:$^Y'
M+M*5VHY_@9(ORN)P,H3+$T/9 L<BQ82"#ZYX),PXB&,7/#'& ]\,(F9R'B1I
MNA"ISB@86FI<9&]VRV0R5(;3*Q6Q<?Z:QKOEY1_V\>6Y<S#A7_8N/[V/OAP-
MWWTYM,^_G]MG[N'NN77^Y<_O!]]_&\ _PX/WG[X<?3PW#[XDWOGW_:L_G,/\
M_/MH</Z=#P_LP_QH]T_[\..^>?#]X.K\].#JTY??AN??\^'A[KYS]/%@>O N
M_/:'_6EZ_C'QST_WOQ]^V?:.3O/L8/?".MQ]]_7\XYYU='KP[< ^S@^_' [.
MA^_@_LDE?_\NB]^?^8?#,^_3E_WIP>GV]/#CG^;A[J>OA\-]^]#><P^'[[Y^
M^G(V/?BX/STZW5;7_ 7/\HI/IZ7]Z30?'GS9_W:PNV]]VH5KAW_:YU_.G?/3
M"_O\X_'P\'3_V_F7?0_6>/7'Z=[XX,3\!O_U#G<OOGUF<9HXS$SZ.+NU[P8\
MZL=@7O>=B',1>R$B<K_ZU3+[_R%3K3W%7V?H>[%67RQ>G2UO5L!:6QY^H@BZ
M7TG*"<EF6(+F^.6 55^-HT*\OJ8O[KV>C_ B^#+U#2L)YU;B+ES)@_,--<".
MX6H0%>#<O(G+,H]9GI?CN/RVB*VVBV+"\F,Q*JOQ6K+77R[__=_Y)SN_C+^,
M!@=?#NR#W:_>T<?]JZ/=,_/@X_'@_/3,._B^]_W3^S/[P'Z7G7_\Z\NA%<)]
MOSJ'IV?NP>F?4_SG,XXT#NS([W/N^WV7,=8'%Y3U(]_#B%+(19B\^O5__Q$%
MKO_V)FYY6//.O!<9_>\_+-]\>_W?C[*F><I>S&/;AX=GVW\8QWL?CHY/C0]G
MQR=GVX>GQNF1 ;;H*1B<AN481\>&Y?W"7QM'[XS3W_>,CIG:F*C;.Z?XM14Y
M[OULU. I3-3[;<*[LC+& V&D60UZVI@*5AG@1@MN/";CO^$81H8[#CB;XC-%
ML8CS/Y#_OB>]^A?-^LGWSSX3GA_Y:3^US+3O"BOJ,SL$21 E29#@U!G/>5QQ
M/7-JLR>V,ZG@#,?OB(K.X4 WAT:'QMS(\5W'[*=F"O(ZL'@_# *G'WJPS1'W
M6!2FKW[=%8D,SF&>8E9F]PP\BAOMGN6')^XG9HZ.-W;,:06KS[#&:V/+G/YI
M?HZ%;:9IE/33,#'[;L3!C#'! 0ALVV6!E[I!&BE;QGT:6^9^M'R3*7-ZO'UX
MLD^&P]/8%"O"V]J$&#?T;<C NY%6Y=#X;(Q+^->JO\5..1QF-29&C'=9+HQ#
M2@Z]>7@SJ!4,>Y01P:?)A[UH@7!A?4Z=4%A>$/83TV)]UPGL/K,LNV^'IL )
MEUXJ$LR!67TG##SGWDKQ)@J[(]2_Z+)L>&'450**MBI8<ZB?+ZRM+Z.+5P;+
MQS=]-9O2<,/1M[>S(0D,/\P'9'$%\FL5F+4M>_3MU3]OU_S6[4'P^V<X[KC1
M@W&H/>]#+F;11V?%8W%!J(?%&(?%OFQV=#[[(?.99X*'8=HNL&/B]\'5 .:S
MXB",O3!(/6#'@Y(+(/B>L5\D6S]CIYI;3T)C]],"O^Q]8\G8P.,WRM1H"<)@
MM7$R$@FFVKF1%<;^N#9V!JR"I5Z/T=TSI[,@XNC)=/%3)7J\<"MTK)])]#CV
M5A#=+R/S0[>UMBS3>?C;XFJCA\@?W9+RD"<UO]GR\)^<G!\GZ3'O]-18#SBJ
MRDL4I;,A 2E2$=6E F^'>ENH>E!!?^V W%A+"2N3)0>[^U>'7[Z:A\-][]S^
M!/<]FQY\N3#/AP??CDYY?OC]J_7IRYE[/MR;3Y9<'7S9MH].,4&2?_DT/#</
M3_>G1[O'V?GW/>_0/G..3O\:'IX.LO._,%FRK9,E5P=_?K82$9L@>OLXZJ'O
MIJ[HQSRT^[[%(OA#DH2>A?&$G%VQ2MR:+KF=O&?J)3:<<+?M<,J^[:M:+ FN
MO,8V_5.3^'Y#XH?;G^W0BJ,T 0<@3##.B5Z $WG]4)AFZC O8E'ZZM<0[!#7
M#X +[LX)KITPOQ;!(A+^A<2G =[V$;C;E='%P$)C94;4TL^J"U9DW^GOKU\$
M[]^P<?O')X9"::F,62XU#LNMUXM(9LYALVXK0ON)C?O9G_X\02\JR&A.9:7B
M,4\CL+<YKT1=J__\ 0NP-L+Z+F']O;5'\+YG<QYG:1Y^/\!K\X./\!G>:W<;
M_GYQ=?#]W9?S[Q?P3I]RS(P<YJ$)SW2.X/N#[_O6P>[Y]\^>X&'@>&[?MP.P
M;A+7[D=.(OJ6Q3S;-H4?N?&K7^%DC5.1# H@Q(NI<?+?R6VFSNJ%&Y^4O'?@
MCT<5''*Q(>XE$G=B?T[<P+;]).ESX?E@W(BPSU+7[0>>'S'78V%H^:]^W6'#
MN,KXQ36"[CUJ0OY^SIRB*;)#CJH/\,NL2#9>W#()Z^OT<VJED6,G7M\R R L
MTPWZL9=Z<-")FSI>; .MO?KU@-4U2P:36HS']>W2\EF;B,L5QQ]*8++\4S;:
MA#_NR3@=W_#B<^"F8>KX3C^R_ 3+W^(^"WR.5D(LN,M=!W;U5].VG.A)W<+'
M*6R^IW>C2 M=P \5".1LQ')C[YM(""_&.$K!UQ'ULAW <3E:TOX MQG(;@O<
MO+NJA64=S<+W6U)^XA$%%9J*VY5@:RN:'BSWY7TV/>:Y(G3Z,0-IXZ:V!X(F
M]/H1=T)$N+1MK$WQK6!>S+Q^S((!@C[_,"B+3<' P>G7[Y]-VW; 28S[#@N#
MONN8<3^*P&E,!'.XGY@I$\ZK7P,+'$K/_*DB.G,K7"'F;].1__N/T+:"MS4X
MPKD8(46H@A7*P^83E,T&,O.<Y/OI5[VC:$!G,3'(],:6K85/+NYE'V&#CV94
MM%VB$MP83:IZ@FG<<6G +RCR9]F_Q*]1:V+QTG8R?O,S;_>C[;EO%]WKR=*]
MD;]E><Y/I7O=+<<,'CPO:SE;P)X/WRX8;OG!2TOWRK5QD:@4P)M) 32#OWKU
MZVDVSJFB08 /:"0Y.(,_8 ^N^\M7C.3AR708E_DO/V0*K_FKZT(6.G;Q+1FP
MX@(^*(RK00:?M!+RV6;-'M$<4ZIF:MDQ\==:FF/2GS_:Q74<#CY].;@Z_'C^
M_?#]&?SS;_#CX0V&X*4/SYR#+WO?X7[S_KQ[\!X^M]\-#[YO@\]_8'XZ/3#Q
M]X=?DNFGX:?LTVD"YMK!U1&NL2UG^':T_1GVE$6^8_;!D@,#SA9@9KNAVT],
M+[1X'/F<I[(TMT2Z*9.O/6/$*N.2Y1-A_ ]!4EA8;6S4@[]7[_#2:5G)2"DB
M-X1\#T+>ZQ)RG,!FFU;23WWA]]W(YGT66F$_Y!["O:6F8\6O?CTX/MS>T.C?
MS%*@%KN>H-"R>$_IN+4MX'UJ,MZ?(6,_=MPX<?H@=^.^*T HQU%@]E/.G#1U
M MOS7;"GP%\Z9#5G_S4(:]K 9G4Q-O[X8^=O-.C_O).UALZG[!@"#_1BQ@-=
M>D_T85F(GZMFMK:\#?C4SX-/K1XM[Q<<:Z2$$4^-9"" S8>(29%):JW:ROBL
M-IAQ)?*\_[4HKV"9@M5 1AR^J"<8D6*UP46:%;)P_G@"].&:GJ;[#L\ "VP9
M]+\ELL"CIP(_PE;]!W?J1&W4/NW36FJK!POFFJ![(LY8DO2=Q _[KLF]?FP'
M43_FL6-YPG8CP5_]>BZN):\-@WI$O1^5FP_35[Q,4CTL?YA3'N:EFZ;<!P^8
MKJ?\*\HQ?/+?28;J'K1\BAVD%75YUXMCSPX6Z#9_HV[@U@[86JH !!9;#;*Z
MY[.WJXSEC]+1_<B;L'@QSUKW_57FDV+,*NIZKNJ7K?.LSSZ+F;!#J^^G5@0Z
MS['ZH2?2/@M%FD8><TTK0#%_I\I[^)253 F:WGS**KK6LVB[G9[%K,#R^C>6
MM7J2^VH@J&]B3GS_8KTV!F"BHLSF!LOS1G!W)7HLU _@GK-"?$9X=XQ9'8E
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M5C^PXS[!\X].?QM\HI$-Y^[1[E?K:/??7P].?_MZ\/ZOX='[?6S]FR]%H5;
M3U_^] [>O\LQR7?XY<(]0OMP^.>W@_=_7L%]W?,OQ]FYU44Z.IL>?/\ZWR/K
MP=J&N+;#W3^Q[Q7V _;I],PY_/COP>'W3]FYC;VR\.Y_S??(_NE]QB+#B*5!
MWTLBL^]:<=1G<1KW4\$LC_L<=!5[]>L?BS7;-=MT8?#UT?OJUHP/M^>W\<FM
M6O-&JW9S5K.;=+C(AMR<U\J>U\E-IO/C@T3<"',NM1ZM[+=)#4NNUS-Z_M1:
M[[S5>E\NYK7>MT/[X/OA^T_#@^]_#<YA/8??OYI'[_?,3Z>?LL./9_;1Q\/L
M$(L[K7FMM^]]]B+$ W1%G\=FT'=]-^FSB/.^8P66YP?X97HGPGJ' ^]I0SX!
M#-:*_W3])<S>8G][Z?)%K^L]+6M'KFHC9^Z2,]]FY,SW@_DH+SSGP#S_O@W_
M[%U]@GOA$+=S+#[?A?N\/X=K+ISS+Q?FP34$FGWGL^.9S E9U+>=T.V[KNV
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M%.1;QBG5>H"B'((ZUN,$VEO75 JM:L(S:F@:E>#VJ<:G0B2@YUD%$@!,"&
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M\4-5CG U8L. Z\N _@MB0.>9,> ?XH+EF+%(!($@;?AP??DP>D%\Z#XS/CR
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MC8!^&1X?;O<M.W!>TPGB82!U-A/0#1HO#D))RJ@*I(BT?]D%F-WU&'Z;JD^
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MS+PFW7(B+6[YK3:\9+HXIA)<;7UAP$E?N6&$!]5.3421B+Y$N 092L 0H?2
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MHY^D/J2<>??3U(!' I^0RX1.P;47N\:JN.2;]V5+]4[?LG,S[0+*(9GG1S
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M;AS12N0(I^90*6]P# B\=RQ<;'P.T9=9]A/Q$,XT1^C<+,Y%AF+C[.3D6 .
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M<9: ](EOZ^9)71J&=WK4O!G6E84%J2J7H4CX<F[E-\$3M$<>U""7AWZ>S:_
M)QJ^D'#LTE#/(3<C=9-(;EZ!->M>QNC:/)8Y#=N66XV,RRVZ)JKE+600.;62
M*D:*Q^WK/=_RJVEHKF4*3BFH"UFO\K<4^,A'__67/!T>CG>'V='>P?[YWN[N
M=KJ[/=X>#U^,]W8.7PQWMO_WSM[1T5\>ZPW>VNC+;_#G7SXD9Z=G;W\Z??_V
M*:PX"3NOPAASJ3[+S$.P"#O;@SWU?Z)@O84X,A4UJY<$^#04[ZU]+O"8/&)%
MO%?G>RCVEK$%.X<K>^R'==4(!F)GSQD9Y6,<[&(X7 R&#Z:>D0I;L(F]/;<
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M1N8ZP-:@Z2!OY-#*O5;Q,/65YPM=H45%2VJCHD51^@MN]FCFV$L$(B"O<4T
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M5.S1!(C:19+3I/!N*])SH#E'"G=@\:60"1?.QO2\0G_ '+<FD^+4,>D.[OL
M"IEMWI#;#>016?--9=Y<0W%)?C#?FT4]'<VHQW@X+)T.CM[GQQ5DNM9V>0]?
MZBK]O^Q]:W/;5K;E7T&E;Z>DNB0C4I)MQ76[2I:56--^E:VDI_O++9 $*<0@
MP "$9.;#_/;9SW/V 4%*<FR+BG5K)FV;)![GL<]^K+V6KB@"%=*:P@2PL>4$
MHFT]'JY=,0;<C>;/5UCM\[1?K_7@6I],^?9@KH</,-?M=1&RQ05%)F3V9Z1'
MRVU8>!7F^N..(62;RZ@-W%)U)=&XC*],*QDW,PC@G*R ?I:N&KYH6",=*P4<
MKJ>[#?V^'GQ.$'H-KVX44-T"Y\>">:O7%->P]:)M5]J:Z/8S-V4,")D<]:/]
M>]R: 4Z5O$709C'0MLSYIX.O#Q%XO;='?^X??@+RNK,"O4X<X'HME_S&_:);
M9=]E(?HW6-Z4)WV?S!?,NXU-]](Y+MTEHM?F19#Z[>>F$P*0AJ96S>WEFI8[
MWQJ5Y&6193/.>/#T#=9,'SL^83_+QEZ6#4^/E"T?YXXJF*^"%@AC6;$ PC5C
M.@ETPIKO+J]Z3_;(]5 :@O)ORFVM65?XD>P4ML:'#_GW;<V_7Y\Z]&DOV"T.
M;],?F(Q0:_BXDFG:=-JZ\,Z[['E-'#CT9Y6J#Q=7QZRN=L3'0PGTZZZB-:EE
MLX#D!T@B)-I?C63"EJ^?[;;EZXNI#[;\V]F%-['E_0%5+_J?TXH_6-MML[8:
M]NJI;0_M6TPUMW9R(G%ETK?%W_WLH? )EVG] :-^_EOA<=B2%[^6FMZ'MQU-
MKY;=(7P7_B[1;5?H;#+\#I6@45XN%2*Q, 2+0J6Y6],)-)5W!HY<X&;%YR8%
M@8L87< OD2+5-GW<B86GQJWW;GEK82QON?<@N+>>G+_TWF_-_KB)>D,L/;Q8
MVI@S7SOQ(Q)A$1:I;K>45K("/#@8=7/LSE(K+E<0K!2U<JU-GU2AI\FHHOZC
M[L$>J?\PC&[*2HR^Y(13*4F=<72^G,,Q%\V2A);N)$G&PWCTP2<\?WI^K!42
M& 5,F.9X>]9/U%G6%Q)!/ZK*57PO)'[M%I/N7/;,SFGQ=K#K;DAU%KP'2?BE
MX^ZKN!Q=8 :FSRNVJH<H>R4RDCJ"IK>8\@]$N(F7H8[H89DF$])N*D8U]Q\W
MM1PDNQN/+O#?M(%7:!*T^./)E9Z0'M9*184GL&(YT\R#2WY 17O\UPF<,ZD4
MA4BO/D-F>:1&F-;P3:X?ORY0->N8_?/K! HY1R;C'?+FR)R0)-10&%$HB\='
MUSBM1C5+13C:-1PRR@)3;H^7M4I Q?7B JF'B;CJV%@-IVR  SV>\IE,"IPC
MV S$K6Z#$=%HC(E'DS0/.&%TUZ;@9NK&I_.*F/&?Q649_4JL90V*J/Z3HWLL
M=GSZS'->54GR(5"@H8J'V6J.4([JO! S%7D]RI*"B"'RL5>S$#EK_ W>X'YU
MIP=3[C60X44Z0HS=U&:TTHR1: T+O8I13FYJ+!ZQ$-X\*; @-10VH8NB&(LH
MG]IZ@Y!>SB6&9R $&;F:)<91@0)_3#.1D>".[M01+-;PWH=P;_S>DZ._6VX]
M4KFS]!6[P=E-<\GULH9(Y]IE87X.HS=R-(5$6HJ.MXP"?BE\Q'YW "="EA&"
M@S!_-[P/TRWB"8B)]C7?QP-@G)!IC@E7PW2&]%Q7N@\488WGN7(STZ-TZ/<H
M^H5?NRA0TMK2#:*&2(8>7U36<R1I[(7[H(T^HKG9:$.A#'GB9*U5:"U;SN87
M2'Z-XGXE>VA@WDG[B)]MY/1)P(P7PF0BHH&,M.'#K,[BLM-X-D;NK-OFS+02
M/+D/LI3CPNA>D>8355SA$F5!>!!T0U<>RU.YYWCN13FX4WA_QO\H1HMEP9OJ
MK[@_P6\2<6J?MYKPONU%[R7EQ:1&_,9X(&=+& 2W8W+D+P2/B983D8?!^(Z6
M(Y'E$0%MHA7'3Y56?"?)Z7637?^V(;,^P2\L8;GPZ<.==J;S?4PI35_\,'TI
M__/#='XP$'Z9738H*%Z-"Y5-#9/LVXEBRI44QJ DW4',=("UP,G&=Z6;Z$5(
MS!#VR$P2CL]4PD6*9T-!WP0"??1E]!OG"QA4<.1.W@UV.QX##/9KZ%$["T>S
M;E[(:(4SLVF6U!^*T7+A.<QW7KP\WHU&$,57T=F9W[\-,4-Y8/2($^([%Q9V
M\P1T7TK2FV$14*:^!N+<X&4(ZOO,MXHU,T8TVAU[<>3%P5&E>YC7BND''J#I
MQLOI QJL)C[D,U?! _M5E^#&QR.Q2:+XVZ4K.MK["5/5!U/?DP<10B*5!Y')
M*V4FNO+3&3J]L+F6A+,6=)%',IH3[=:TG=\N".C1 PCH+ETV8]X;3.B6R+4I
M+4FE=Z)#)F)I6)XD?A)H%N8A":\< >3!X%'C>*J+L7HU:L^?H3&'__^2SV&T
M@+K9\1#U.B?LNJ0E0N7IFDWI%<]A3S= @=5IGC*6GE6P K$KBG8)4>#0@Y8S
MOI&/4J4#?'.87H0&1I94W73D->'G+3T7UYG2X+AR/.S8S+%"Q1[MO'[QMMJE
MMT$0"($L<31H"F-'%\K!+YY5B7"]7XM_,)*]E.F$0Y\DLZNFI".',"M^>$><
M,_YXK:_$9R.NB\#!8E\RR*Z1.N"6!4<WC8=_C)ZK P?^_&6:7&W)>]PR&EX3
MW.RL!&V[U\;!3MGE.A^?\-6PUZ<),[OA20;.N^JAATXRN_=;MDHVCF6LB'8;
M)G-\7*G*HG,ZP9"@4FM6IV,($4QO U:L860N)1&&P1OF5&.B%>6]B;\$4[@$
M@RF1<)E(FY?7X<0LEA?EQ _Y^Z+-B3L2+HS**5@B(D-8LB:$CY4R,I@CS.?"
M60[G^=A H:KF8NGO=0>'?T?U>0I'=T5#0N2 ,>PN$ZK[LS;1:GI S'O,ZV.P
M!Z] N;P6BR0>-P8'%9+BHW1%Q5'-B&TA/ :VU4FL'%.LLV"U.(QSR"(7KGI&
M!]-8Q<@X[\C7Q]"7>U40:,\ /<K14B,&%T_3&;?)4"!%-AB]TH1"+!15"BY8
M5S7E-#1-4F(Q!<;HF7/SZ>T*&*\+>.O\(X5[C6! SU:NV>$FKD=%A5EVCM(<
MS335#N74(9>;;ZMWZ[G;PI:K$LQW+Q+7A$+/2>MJ)/+DJ%()@2H<WS20'$6*
MB/K;E00.CAW;E4V9C'U8-'#^2.<,'JP8T5<H/X"=D!2$Y+@J_(Z @<$-45+"
M%Y9-M9Q!X#%3@3;*NUXL*S@&XYP)LEE[(JOI<A6GNLLB!J^(T@MP(H_AO;%3
M"K[0X;Z0CHS>Z$(LE&LH*F!=YF9]IZX/% U;2HX.2J-R<F1T412,EG2)%PJP
MP3'";I-[8N5<1H)ZDFCUM^4FU#>B!"*J;U')Q#D:& 92=!YG!?LD94)*TO@U
M<D(W'3=A50&F0/V\;!EP_:,ZF9'E@/LZ25<YD'C=J+2M].!JO#O^K;Z,28P5
MO4]4Z,8T/S^WYC0R <7Q\UO8.*RS=*Q6;M/"?_S$)0.;?9)QH^P*7[-,[*8(
MJ3)N8CEI!?8?@27N12^**U[&OB,)9@S+)J1;BPW'DBL8)>XZTN^%33WXII(D
MDTF-9:/%F$<*<]UAT4D:>+3\ZE,4$K5?B*1;4U0<#'#2=N.UGG7COJL\QGH%
MFWA"BWK=0XA;[Y_%$2;'2RHX21]PDE_$) 2@P8EV5O!2/QB B77U ;85)BAH
M96E^IC:>BG=!1+;ZR"AN1U[#(IA:D@6\\<;BG4ILUR82N(?%C.O2SAN3MYIP
MEHPRS<5J0I?RR?_"BB^=IF,L7*92>Z2$?YGBX25.83J;9]*E*^:AX1&3)).1
M&MJ4[:9X,&7G*ZZHKQ?_USVC2X7[H^Y%,9Y^2'.$.O4?/ZWD\K/8%CFS98<?
M#C%](>9!*T$WK8NU$46'Q*<"0S(3(9DR<LO(E;I17IVFX12!3<<55HW5"6_<
M_<E>]^B(S&P>5^)131/<;G$).PI&0GST&).(=-'CB92F;SB##4>6W1A7PT$N
M!^SG?5:7'\!M;)F(<XC8%R2XWO"G>WPI<"2R\17:))Y?N'],A1HL3BQ@N<'>
MU39*>.:N&0(;8VW9!EX3<#];R65AQ?G'Z V+H=F$UI:\S^VEB7#BS-J.?=L^
MKEBWU)V('T,=V-]0VWR;0G5@%;=M'7SV%&?@A" DQU7*[.*:U>@3F,1GB_Z!
MFP Q$$FH_\P5'U6 YFA2@6!UA<^3XJZTQ2E-52XN:C.M18A,Z$1NX7<(+\5:
M8^W/B+_3@ERC#"=^MC\G*$E+B5GM>@I*.C9?&[QH:LM23<I!X[#T_(/[ZF%;
MXMC7R\*'[9A'Q&PR.8LO;R*,2.&G"GOC8<I?)F"7TY93K-"*O#9-D=8WFPEJ
MFY'N.,5M?8T;26Z3"P@?<"I])84MC8>8YOXC"0EJ)+AW1:Q:P+TNBF]).U>K
MVP"'8+T+V7#Y5H$8LES*9,*!\XUQ,B@V7?+9)F<G1'W3;EGC2%X4=;:R^ FG
M)C$EO0>ZV_.ZK.J$726DTDD6"L,RG7D8*(D8M47F.+0A)KSA+,=4!DX6.>^-
MX])#!II@(1&M%AWJ>)8$"] 74Y+110XF<KK$_;;!<ED.AW5$+5R8L IV6J78
M2 D4LB&A2V<55%JZ11P61//W]9R+X:KF4ZW >*TP'GF_#Z73&Y9.'S^43K?2
MO_Q+RF@WQ*83*]_*VD1M54T<(^?Z;/!X#):F[12Z%W[F:Z\ ]RS.AC^,C' S
M,P&AN)8S@G%;FM,/%D.=AJXQ,0CG)F@T&6P78[H/<Y3MO3T-URC-+YF[IX7L
MC>=BQ^;6=C&[]2S\V.:^]%LKXEJ8+9U?X%&$FF,%L?",X?0]?-R+WHD<.#(6
M4H$+740LZ1/NC'LFX$5A*6#YAW6K&L<7UY@V%-BE>JWRR#]'.V?3GW>C."2?
M<F5D:378T.<+KL(4;.2BF,-L:]]9XQ!(9].H*D?PY3*/N\B%T!_L]_]W.GC<
M^VT^_2Z*L\7:SQJ'V,&3^<>G<D\YH@[AKEAB0[,B=Z:'X(_%8A\\WIM_1-M^
MN[-SW9%V\Y_]!C%0.EE^N:-PK=FZI7%VBL28(OLT3V,K7GMC1F!%(7A%&_;&
MJ \?AGT6[,5=C.%U(_: D5EWA'[*A]^N/_YDO3^.CYN._^>[-!X]GNR/DB<'
MCPZ'!_O[>_'^WF1O,CJ:' P>'XT&>_][L/?=9W#B#P:]QX?WSH]O'+:R%HZ^
M0%/WX$8>_MMW;]Z^^/?+XY/SLY/HU^.3D[/7I^]_C'Y^^>;9\<OHQ>GQR_,7
M$7SIYW?'K]YOB1>*V8:P'0W))L%8I 7#!A +LLP0A#)24U7Y!B;TJ4I"S6BF
MR^0A,(\Y'B/X$IU'KD60K8JE,.&3'G(0^?H^0AA<WR)[<5/X!0*"XB%V3Q<E
M]@5@SK"*GAV_>W[<B9X?OWL+__/Z[ 6C=)ZE HY\A0WFXSCZF>"./R':,[;9
M)>8;8]<9!N+X[/E[%5*%CX@L"BWCSMGQKV>[^%J36AA]JWJ.XZ5YP6D9SRIZ
M9LHY<1M'?#\:\/Z3?HB;/M"3H_U[VG)WEINUXEHQ9:$H$5@\ON0">JP, Y*6
MQQ\$XS&"R4['U#E<K/62MF2D-HX+O1459ZRKH)U!A)AR> (> 418/34966F#
M X>#RGM+#\*$NWT0=GDT"TDTQ+PS!'(SM! D5CQA]CN<"R//&Z9[?ZYAW\8"
M?<48>?]I]'Z9CTOL"D. "CLHT7F!G&E)QS!)6T>)W]1=V4-%)<5+!5?+1==_
M1"N#-:ZOXG),"T,AD&8!X5V&&(6FLV%=XH!QVC(,NO^K/SCL[;G..F5M6T&E
MTG-:I$4OR @17$O_HHEFUF6&X4FIAK,0ZDLFMLO\:M5ZSCYB<OYUD>1NI7?7
MK'3]!>S\3IC$&28+1D0ZA SE>=T-UH#+46W]A\&>>KN8SZ!A'B<(51IS]Q_7
M^W',I1"IS\"1?%JI=D%S^,SK^=\$0#'RJ1UI'T-?FOZZ]C3FU+?_GIJ">M&I
M)P>DIV!JQ;C41JU%XJM9*^2)N,4NXS1#5^:N[?_-\I/K[/]?!7;^+R3Q9F-/
MK^I<$IA]V/R'W)%*I9%%&TM]A<DMU_%X+RA)SP,CSD!QH07'79WC_B/#0Q_+
M#IUD\64*_P(&))%6:S"5"ZH7,2./8Q"GK51>)!5&F_$H_KUV^HATVY\*1!AW
MHE^F,;I?\%'_""DV9-/PU=A>(&B%;J%4$GSY_M'AH =6NBQDNMBS)+;>JIY.
M.<I&G#M!W17Q0E7-*8&5X*T854.W1< .3'(BM<3C!%O'9T7U>YW";R[!L*%?
MB7M\@EYBKS%\<+8@#TG.*#<!UL-IJ5>H/)\'7QJL;"T0MY2IC@GI-DRX5"R,
M&_XH1#Q4E7RL^4\\4 +;I[SHN-@R^J,;.!L6%*<(] #-28PDV=B?[1UJXY3.
M6,%#EW%UT='NX-_J?$1=]%CG=5C3 "QP!=Y"B[/"F'K,*%,?+YP+",XGG%<Z
M*HM1,K^(N?<@3Z[ ><SA!J^"3W 3#5-D$ADG5 E?@83C+ ]SK.,0">",NSUC
MCAC()^JL@,40@88%:BRPEH4YY8AO)(MI7:1_U&5"&#OP,) &I<9/TTIJ*[#.
MX@P=6CRDX=R926?Z& [625K-HA\PB5YR/P)<J1/"R$-TKEY4:&P4V^Z>4R*?
M>U%J.4,+O_>XHZ;?+)1Z07D21P#@>W2)8C>6^D %XSJN"-OM?F+5,)^5\1]I
MYHZ2JD!4 )L'<SFAGJ&>#%A'F=>T^->+-^@194Q^A)";:%X/X6#3J#R!GTZI
MPX0P#S9<)002 4+)B>U%SWG1$]("%57&'7NB+9)<;#UX_OA6 68PV 6RV]1-
MI[&KU!.WLA3JV!/%S<0L*UK-8++9>T6ZHBQ.7-S>YNFW7G\K^_;6N!D7:<:'
M2UXK@0F/+D8@8W+LC99'3-U7]9P37L0FI;/5['?P; N%A]0X)],%&.;$,M$0
M[V($;XT#F$HTJ=$4.&_H3W:B:R+QV\C@'GT11,7]3,9N6]#RET'M'C,]FBD>
MM83P5GVKC&$OH_76[-:&E-6]<".%$1/Y^B=@Y9A:&/N<L Y(S$R.=X3R*'3.
M8!^?-%[,I$^L47^3X]?D.V+W4W2 X)ZP=IQ#S]%*>U;0Y%DZCI=*!!1#F*9:
MYSCK9ND'[;Y"/L&=7U^^K5@W2<'!E6_Q:3R[<!8M?#O//,@9(2 "ULT8 0\.
MPF!2*_2@=![-TY'I+T@I53<$%^_JMB'&)NN\%NKP9 /4X4D;U&%P=/AI4(?'
M@R;4X=K:\CU)SSB( D;%6[*?/PV'(/7T$(G =HIH*WV&KS5AA^F.4M!"@8A'
M7PDDI5KCE5#=EFG-*VH"LMD2B9D (\8A>B*R$9%2\UZ8U>><T'2)<<UJCL,4
MZ2?1^"+5 K4[MS*O,B:B$VBY=38"2F32M0E5F 1V^D](H/XHH&'M:"/D94*L
M>IH4(G1[D7?U[[2C)$W4B_Z9P.V&OW&_AEL_2JM+)(,/;/-?AX7\&,+PJ@H9
MGML6"W$C!(LEC@;X3GM'3TDDP+*C6DDDOZ;"T@?#+@=/$'LH4,F.H^SR]"%6
MV@L)@25A6E>K5,Z-S]J%$L(#6O;4T_NUGOJ'=[Z>X!%NLIY634QC:JOU2^1>
M9"#>UV3& I$Q2KE*SQ=3-Z,!Q_,KKBZT*A; AJ.#']'VP]ZQXF1^6 HG48;>
M.!(JP*@1T-ANCYV^T^WH1/OFST89BS?SP"M\[ HM*]&+5OPV1MH38=%60QF<
M=E3S7'#R578O> -7L!V674((BS5GN2^5.#4Z)70G(]#%DJ]N[T:K^QK_T/8M
MW>'W8J7XV;S27CW3 K0B:BU$X6NT6"$2(D8 6$,)MT\.B7PEHX#*@0IPD"C_
M[,[8YF2H($0O^L_9/W_U(.UU,O0AFAQN\S:C2M0[QX[A9"WX*#C'JM'.VW>O
MSP_W.."B#'\>?FOGU6O4WVWH>C<\$FQD(/@(N#^<[O2/&#Z]ZY5R+92PY9SV
MQ;JU%FC!1FV&]<NMCKMS"[[[1_3SJ_.*N^YH]''/,^BA(=U;\$#&4F:!1TTR
M%V<CRU2L'.KP)#$32HVDH4U/!,U]&KI>E6ED=NBDFWP4CA8S47X)=C:WQ=&#
M#XNB,L0$4H:EEVL @6/M=9 =0T/AQ (=>181?90^\FD\>):Y,$?VHF.0U9)B
M?Z#409@&X0WD'UY8K"@;PIQJ2)# VQY_ER+=*AN#AYSQC1?VP=Y#SOCN@([D
MI;XX\[T>@MGT_;$'T??Q;/Y4C/SAXX-[BG]4917* :O79),<+G?IF[]P8(@D
MI/_41?]IGA="HXR,X$DBF"T8OX0]!0%P@*%-QXYO&7Z49 ZWFU3W Z_@%D$G
MBMO@HP05/O[US%GC:Q'&'<8+!,,AO';H:J/;N0B\63<9/*H<K(P3\"!2JO[R
MT;,#4T6Y#?I62-,AG U#N#I6 0))+_A9MZ_-?^@[[0Q?'P^1^_6XD2KS^3;<
M$TI?X//@#CA'_(HI!TW\S*8;'L^_6+1]J".&<SR4CX_L/@SY+O05\-FBFF%W
MT30I9S1EK(RK;?@\0MU),:(OXIL(EE=$<MQ.IKE@913-1HV59+(QT:_/7@AS
MH:A+.&849F;@W/T"*=Y*]^SWPN7_%Q$B8T!%3L$TS==4AEBA@2@W_#H@6BH=
M3TUVDOM1)1[_+CPC#9X';FWF)<0U9_%[[#J8I$DVUHXF9D.#,2HH;5OG&&:0
MGD5[LP$R:\!"^9" DPV1":U.-5/JZQ&6]!+Y+"CPUQI*N!RWS5JU5P1N>8YM
M+8YSXWK%EQ2R8#9]$CZE"GF(1](EOF(J'9)D!QLZ=M&F*WJIXP4_4 \\RW)L
M4E$Y*D_;,R)%D>, U[W_Q&&Z15'&LV2%/2P9YROHLO >DM7H][S<BA53">_B
MOY/#0'H*)5RV."8LFR:O[A\@H:6-V7!_R+AK/CK:8WDM?FPPTO"EG %Y8PX3
MJ : E&-T+ZI]PMU^P &4*$/:#R&"6$B:G(&,K)V"C\7X108IC0H$R-.SP$./
MRWJ*/#(P_/6"MF1 #"S,C<0B F>%<K$9PL6?\($&^ [PK(BTPDE=D$07?/&_
M#A\->H^BH0P<MS5A+Q%&5'.J[.1$?=HQ6!K3/"F^"TV5:S$7#F&#C</3I< "
MPK NQTFN@BDQHX4=*ZG9GI74'E96UF=OLOS:34.O(=Z\:)8E!_W#^^TU&X]
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MW+F0SKZK SHMBRNPMOH;KB]6J)SPUSSWWPJ-R"0AVJQ[0?WWY\Y;Z\5V6MP
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M^8(%:4-7RTPZ(G'=T33UHG^MR]IUQ/._T2(6VR3&WVL0J,,A-%WP3S7&K+7
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M<IKUY)1JN]B(ZLH8),,P$78A47VJ*E)&.LM#A=!.&-(4G-.3J5C54*'-L)I
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MDO^)JU:[WL&C/*)C?,FOY%XT,X/#V1IP3N?)ZH-'IDW4R+NUGO!,;7B#\T;
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M,;5&$9X*5A>K'XKM,%BM4#&)(4S^LK['#HW&%"->B614PA"5Q49@R^(IL7#
MKHN265).K3Z[;ZV*RQGGV2Q [ *9Z8BQ!-:1GB^8CW=D*Z.84**UR-B:LB%N
M-0XWJ)'LHB@7BI12R34^M)-162-U%VTQ1HZF\%2+K<.OK#<3)8Q1,:-#.,QW
M4!>QV(.KBX0Y-K%5#XQ(R3S0CIE:EZGG_E^;%PE6:D?Q28Q\GE=)=X(<QX[(
MR'*MA6N<,RF?O=7C:R<=UU78[\/R^4FZ] 4F#)Z-X(8;+?X"V& =3G(/!#"
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M5+)0/AJ3@BJ4T,V7T%CN(U@[U%=*0G*KYRZO(BS=S=(_@G44)DJ;81>< _P
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M@9%_.*?QY+ZYU:? &P77;ML_6,<.QRU\6](+@B\1@(=U_1H/<D^6KZZKP>,
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MX]!#J>X ?40W&B4E'<#3\/DX^+A,<>5>)B-/NNBXKI71RCF ]2A+:LH 2$8
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M=I-P@-W4_"859#T15X<&A:N+AD8'?@44*C>E5>XTW;NF-=65A+^^S1  ?49
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M*LN(O00S4^B5PA-5$%[A:SD2[,A&^,E&5%SI))VU&52:90G;';,(>XFPKL]
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M9O;:8.4Y4D7T9TU'%\?RSPPVF)O<\\X2@)>>UP*IE& ^$7SKH&IU?;"A2(S
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M:$ME:8##1D1K<"IL3,Y152FQ*05 Y4"C_7M0C9RWY),VZ [4TH::.&V%)JY
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MA2M5N"J"&-NDLKEQ'&?C'$NLP,8%<S7MF =W@C?Q:)1$P:L0V^_"OZ^S$M3
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MV"Z^3/)L"@:@>,!5M!B';^0ZSP:%,W3$J7YA.*Q*ZD>!2K58"ZOUHBQ79 ?
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M/8M:;A.H;'78^GR%+!Q[$WR\$;@0(M!9V;9:RD$V19DOV=7VGR>^3K#- G7
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M01F/SFZ0HZ(+LJ+*.R+('VYV*O3\*4" 3EZR:*:7ZD/96@/3,//$^]W@<%<
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M&YDP0=]'D<I; [)UJO'N-FVX@/2'</E0KF'JRD)^6TT(LHT=Q.$ZRFRQ."8
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MV+38)%9VGF43JQ3I&T%.]O>PW[L\<8ZY*2$]A2MO(\S,18$V7>F;MD^\X?+
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MH$0/0=&^YPG\+;:U2K+02;>T74TY!,[BPP#*BZ<<*LJ^EM3()CPT9HXR6;+
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MUAOT]T["L.O8Z#=S9@1;<W1PI0K 0(&2,8^KN7,)9<2*,1#P;<5 .L*0F>B
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M]%10CF96>\E;Q9:X0 E?[RD;/39F+A<0E$K\,/5ZH_(B(M+<5VIJ=VYYY\E
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M%?0H-PY*6@I'V2M:3U3*39NK%3J#,QW6ZJ9C_>#E+\2BW#O=+XX\JKMW0"/
M(X$VCX[P]YUFUZ?U.%@91<Z^[B]_Y?^^_"6;G(7#]EO9+E"(\5_YFG@13KHV
M+SF2=Q:^FP?A7W["J?>G6G"YA-B)/1T$MO,/"B_P%*BJE'*N%VJ8V,D7O*E1
M95KK2=+6\4XD0Q'KA.$XC%+9B$!(KB-"G7*[RI9,0#C!2)4HSVO_];9M_2WB
MY(&CL?.7O037OW6?T=4I@%\VRGT9G!Z"%'XXS5?R\&P2/,J+B3#84GUG^LGP
M+_E<7*G11Y*54SOZWFNY4K0TX=IP8J9_7>V>RDZ&AQ#YU")*+:\,<2%W7$-;
M.$EX"18'E"A*)N42YF)+&GY' #=$BEV7"QV>>WDV$ VWN6H)[(WQSF3[8']H
M4?8V*V[,X5<2&&EV)"F#I$ND:^>;OS!4&3R+@IE@\7!==2AQ1"QAL?6(5A8?
M?EDC<#P8YBN*KJ2F;A?,3$H"&3E+4\_+*^WJB1H'&"K1D"''Z_^Q]Z[+;5O9
MUNBKL,[79Y==!:EM)^ET[_Q2G*1W=L>)*Y?=5><?1((28A+@!D#+[*?_UASS
MLN8"%BC9D1/I-*NKTI9$XK(N<\W+F&.()=;&61*][!I>UP:J-436Y%'99H/+
M<8,JF0RR+RC8Y"'4>?%%(J-77K$##%C>=+[E*V#339^4J!V('U[<*QYK[W@I
M/NB2L(+0%HU=DHK>(]M!/C@2C.U;&M%H+#B8,&+*ROCW*? HZ-JT^FFU6E08
M1K@[))CY.QB1F%/#^3'3VJW-_2R?0L@B!BA)-.+?W+CKE!IPS>B[N WXR%13
M!8 >I;_1&ZJ==:9C(CCBR0L]=-\#9?J+L%:0<=:SO0R[1[MBYTQH!(1Q/_V>
MSADT4*;?J)MU5RJ]<N4MAZW6KMULSJ1O.#OY4G@*%GW4JJX/C%0@S#)V08X<
M4O/<B^_:YE_EXKMA=>ZL4V1;<7"G&4,(NQP;7$?WSMSQ9? >-K"[J*732MM0
M&O\,=K/PJVP=EN49"=[TUZ-QG'. <LV04M?(OKT"E.NV7WR#[JK_^#\O/OGD
M"RK_AU_]&.*)X/R<7YRC(/!CN%TA>91EC7:L#W]^%_TQW8'2IW-Z(SILL@ZP
MU>&=T&-8$DC68,V]$C_M@G$;/>+,1[^!,8C35P47#K (Z9=->$35_*G2+W^8
M/SMJH4APT8I<'KU]=U4VZN$6">LUU6#;YLS]:O3AZ"BOY>1*V3?@$O!1 )5G
M5LP#"VLEPN.4+@INTI(..GJAGG%WO ]E98TV([7OU !OBK:3[C7A.@1_ A$R
MAJTHT!+_W Q&]DMC4X:C^%KY]V6;">"]Y7> @8U>@E>.D-:YQ9X"C0$L^MP3
M*(^-:6+NN7Z&D%19[A,KKZ5ICIZAFK,7/H:*Y-X)D+T7TLUXK4@5:LM#):A(
MQ''+3)E5N]NXD\O4VOHW(&ZY:;O-ZB:L=ZD-2G:+\ W^L1D:3?/+!'?.TD88
M0E?>./C[R#T+HRD'YKP]$S!NY+@S3V!S,/T::W*[!K.$G-5JB3B51^>JPHS1
MD<O/(<\ P,>"*8:)U'Y0VPZ,_QDYWH=T)X:GPGO+8P6?@VR,7(]3L[:T49GK
MC:Z[!Y0Z'-2-Z/U)Z^7Q^Z7@U'TO#I)_"/1,CCO^2;1O6\G-6:E\J+=C(00.
MH@!V>8\(*G&J;L1[B?%F DUQ:[^$B.BHQ;?7!@NEMV"I-<LII]O5(+\<_?.'
M)J?*EQ<_2D2/L'(O<?ERWY,":A>['OG)KZO-CD86X\BIZ=RS)C(3,=E<&*\K
MLQU(K!>OH'&0JZ4GSRQ[BDUY8:Y@0S2T?=G%7L&' B"#ET:[] \"D.'^TCQ#
M:MQAG56RWY-N9L(2C1B@D[6G([VM!C;U2'\<E%F+3HR!/.R'[C5/6P#*1O*Q
M,"BCL.G2=^LNS&2P.4>%IB*3'FP8-?J8T]N9RJ9TA\% J'$ T#,2%1>.IYC.
ME#X<T>5*\%>Q;;=-M9GTJ/6!D^QXJ CO@^5:"ND8ZZ :-Q-IEW#@'5YBXI66
MY'L%)Z2,.D3>2PK7OB G_?^KPJ8KB\7?-^6[]J=MV)7_H('^\T]A/-?!#_WO
M]KHA\HC_"$[&%_I307IKY=OR'1[L]3K,6??G+^OV>\*<<KUL]$M[+"+\P2&;
M9"]_N<AZT<[Q"D8V^!LM8KXG*5SRZU_PN5_^\=1[:G+#4:]@Y=\ZYE6<OD6D
M0 @^275#DW+J=W"HB^<GU,6#-8@_<T(5Z]_,!"1PQ4Z,K02G98 .!/*V8U?:
MPL14EFMB8[1T[&Y1,*V.F%3-9 D%U< \JLV*5"8(2P=4.F\^49V6.CN1-^T&
MEDR&,DRYYN,)'UY7-_P3B(U5'I/B5KYG[YZ"--RJIN;6WLZRL(R3+X5BC:G\
M0;:/PP+?G*V/$3+W57+L\O@D42,_ ?=3AH@)=?9&76\R4YR_X+0ZU?CY4[NV
MW?0\-NQ,H;G7!F<^KW.^^$ZND.7A&F(W0!3-XQC<:&6BKPZ"D7%N'+85*C:.
MZ  5'Q71B;2;L>E7HWC<BX,P]0[#6U]7Y=MZHR(ZB)W#B&PJ -@GV7HW!YZ<
MHXY)Q26E.0GNTL\EASUM13,%BE ::6U,1!2-V!D[>H(J07A,=Y8 6[CI69.[
M.4=?7\;**-3W^1C\KY]]82CV%%-\EYB@0LI8<N!/O\*:,7$J7('!5:U$00FM
M0UP"TVS,;&E\.LCL6XWZ)V^2/+S&F+P(JB0.KQ/B"[?<-!5+7<;]^C B7 W>
MGDKL)LYX*CL;MBEH9'K7D_] UL'[@B\JM;4MU\MRA1:MBVGMJKC;AK^M,D:+
M@4H%I .@*<Q1MH^7I^2M4EW.M.2@9<B',@VWM2?XI )TH8<6BD[<76<)XP5.
M U6,R14E,6E:4W3DR"FEH9Q9?,U517WPBC/*I[G(8D3]N%7;5[T!NL9.!<Y)
MV8I*79%42M'TQG7J*J:QK!*M^4$G8R:0R'%Z&#D(9.S<@8_0V9><2:UA6O>F
MK%=XKWPUUI5'WHED0:F:#9JV'.6!B$0JOUNP--DIL'RA7 0&-JJ?FBR&;($,
ME3!]1XBFLG=PB1U%.45%,TN4@I;5B.:JN2S8VLJ]F@J***%$YI)WWS1/E-"/
MS"1+/0\899G]=2D97KX-U\2'JV[+1Q*G.@QB, \<=8>0N;FS!?PJGT%\#!;D
MHC=X*;8D'Y:%JTHR!H)3(;1"..V(K#!AFJ%G\J>_??;I^=\66U%VB24^;GJI
M092L.L"K9..0NE^COJ:HIO$G7U\3U_(+3CC@WY^,=,_[I,#ETKR4FOSV^Z\2
MV9$)9L*^Y^<5S;\D*W(<0X']#]H902_L8Z$HS6QC%*E3KZOXQ939?@S_B%_7
M\>X3-\7EME1JCZMA]'I6DQ#$"M76]P3FX?TECG P-N!X)O%DE'2D+H6R46;S
M1A.7(2 S5E!VN_-O[^'#W.*5LM&QV-F*"<5W>^2NA&2%T)1[[F<;S?KXU'($
MI1,\@=/XG$>])/Q!X?M6'G@46_B?F7H\GX6TMY(#!Q_A0)(^\QY0$.;IEE;!
M9=E33P1R67U$&0K3,9C%$U8F.=JCZ4Z.77'RIWA"=0"[2;@Y&Q>.*_16_AMI
MW/+A2;'(QRLM%;GS&1(QL)S^Y!P++^K8ZJ)=1MVZTL)9'\RJ"I1X1)EFAT>U
ME,L-)=*%W8>&S>B9H,W=--(98&7>NV'IQ#_LJW@]8]MB9G^VSN&5SA<_D4_A
M[LM+GQ=?SVWHGBM=<C#MV_JJWD2R*12WZ<[EYO O=ANV;4-I!F47"L:/I5F)
M:(K<VGHMP+BPX,$;I7-,"FA&Y9@-?JD!'6*,*K$@!B%=_F$SLN*YX)T?AZ>2
MA.^L4IB%1?]R,6_%+ G'ZG7+*A=P)F>&N4%4WZ$N_AYRI&9DP/&[<<U:\_6,
M&$CM%.3!'%#AX7<#NP";S8Q<=(U651RE6((E(^-&5RX,;Z'(ZALN,8%Y!:RE
MAAH?-RRHB361GBN4'%?,<48>2#G_@+\T+%);&6D6PP)\E$Y9'(WT#-1R"):W
MO0Q+XBTO5!H1=O9(R8T><NKTS4VO\N]NJ A'ITP25 7O0O6ZF:$/UU$^EDB)
M8DG3<'H.HJ0C208$UJ.>Y.05'9!V$D<5$;K"M,IG+"U@4>KH+1.P"Z!;,Z'6
M%)SZVUA;_K@<$N4*N$#VULJS!\_$!EL969 ;GAD;N7[80^YW#K:G0THV0E:W
M!LS4'.$2@J(K2\\A1_*Z9G);:Q?$-AP[IGQ<4W-D@V^6+O>A#8S&P\?R]F![
M2_L"V)YAT>TAPC+-NX]1ZP]DPF]-'M\^O69RFZ;=PT1/)OS6>2:&9=5WQ]%K
M62<*0O3K%-N7@_@%-]=*TA"?K ]?ZQ'Y@D/EQEI\I;5V4]B'BY@SYGY3?B61
M%=QN]TT;S&X-Q!1>TR>!PF/OMS3%$75D*VWVY<DD.'#G*-)UA1U9JQ*<]TR@
MLU)=ZO#BK2N&\Q!&?E%W!S:NI.$5W"VX%\3,D;Y;(>2%@Y(7C<J,]""GTGHL
MK;\XE=;_2(NDF\PDR,0DT+)-#!0U_ERV(2*A%A\T1@K1ZTW9)%%#*GLF : X
M. 35*KAVJ+Q0"&XUA'O+F<MU.)L(^MEQ"AX8RR:*4D01-FF=EWKT[&'8B4 A
M&[\/V/H9.< I'3ZB,#N><PY-DG-SQVYTJ/Q!1TZJ81GJ]=HC#Z=WA]L;(RFY
MLJ&YYBZL\F;6$"\Y)^=>^6&4D^3QG+;A!"-_E(&T^]Y0TT@DZF$73RT:R6E9
M7;X>411.1,:.7BRCMI'DI' *A$7EL!>TC3HK6&FC&H@VSA?_4X*S@AF A :*
MW?S>7L/K05]JEA.N-.MGMKEY/H]D%,@S<9B1<QGCXA1B;).IIOWITC/QB22[
M TR*>39 ?0CL 3=6C\8>0*P,\5IV5?M6!%*#RT )A5Y(S-^24 =T2<,"*'&P
M7FZH05T_ANV@>'?=R:(_K%Z3SD]ALW\9AN6:0CBN$-+T<%H>!B[VSFJ#E5B=
MZ)+&8<J,H\?505J<'Z-<]%MJXHK.L#RW-7RPVQVFGBB1FZ'TKK<97SPMZXP8
M0&;7[C3^=O#_6X<C@C@I9T>ER [(>-:=L[5VM>=J!J)F+F8*$$$G]];%Y&$&
M;I6$P+R9N$:9-U4BYOFE09NG XHU#)X]2]F$33[S2,STBO,B5>6K)J\2GH :
M9:[WP1Y1WF++0)MOUXG/[B-XWB"Y:Y7"2IM2"TQ"N^F:RN=1CQGKM3^]+CQN
M2Z,P)6^Y-02;B;Z<8^Q2'";*T(M"5Z4R3X-2'W[YW45PBU%T,]^> E)W(LXF
MDI3U8]2\;\MDE.66L[!C/-)EVI\I<:@S>HP3C_V_UJ8YA8T7!(MY6+CQ]\>K
M6$4Y!8J7JW)G'5S'V!FX-H#SC6-U& 9_6&2OP. &BI"L25BL3Z1"'O&Q2&NA
M("6A5J68,T?CTE?Q0FIUY/D>RB3=RM:K(/FCXTX4T-&QX$A_OQ.8/0DX!].^
MX,,[QK^3,66GKX3,&TF$5H.  9O%/_?A#"\6+Z^#/QSL1Y]R#5PCJ!5>CR)_
M<?U['YV<PJA?]9#1FA6^ 6^'V5QI8W6^"I*DF6EJN2D\RHN#6Q615B?53<:S
M,DZ6LIA]TF&_"ON;E8S%5Z&$5TL"(NX,-#?E9]@0RC\S%5?.<L0C+C)+<#4-
MN0 RCNEB'X_"9 BK=SL(UH:OCO='OZO?5'QMZD--#G.]+,<PDO2U,B_9]1U5
M7RYKKE>'MV:(X6KQ_1D!19#GX]^&J1]W:;.$.9_;"&V;:A]N:,6#(9CLKH^%
MJ6WY:]L)%LG>(LF"$]8VK+I1A\.7Y\_#_SZ7MS' 2G:UNK/B'^'[X=F9'R7X
M[X37";/VE_-/S];M1C2CM5B1?W2Y(#W )Y\]EP=8/)G>]J<VG$*+BW473K>G
M[!LI1D'AG-'4U4YP3[!?O JZ:HOIVC?$4=9PM4&Q8(K!)&";! S![Z?BJU"Z
M8CE>DAF_JAE&0MZ*>1!",7=E:T#\K%%"#HE:+Y:6(.)3#>"N6F]4A2RN+EF7
M.FCR<D[*1<J.TN:3.7G8.CA9#QQ#"7T"'KYV\ARW'AMWK(=0Z;+@HT^8\7#_
M%!:E)V)2;R 7.'B#@Q6G3"G3-PH<![D=/6X_X+!441Z _=V1B;'#W5P);]56
MO3\H^4S?<H.T_ F9PL@H$Y[GUTHA+-Q((&]8DP/P8)"C'U!\<;[NKARN;\I#
MFF:F:5950(#;Z6!#%*&!G&OBC25!\)40-+ZGN# V*SZ21(J6";(+E)R!+;QD
MA8XJYE&]^43<%9D*,*,'EQ]J=50L&"7OW<=2*(Q\@1WR&$QGG?_T//GE'W)7
M-M3]KN)V&#Y7*#97J3<UO&QNM0N=(@EJU]AR%3>*5^!/YHWZ9DG8A.&P(TM<
M"**!EXOT]3>0HR:04L\A6*TD8K37Y!R2/-Z0KD[/.#87_7C=/%::M)H0.6%T
MW&RJU5654@\10J"]45 )G"2V?SPU' A3C![=N;%!$BM$V\&9O%3 TKV+TI&Q
M2IN4?T81GL- C6@!$T(!:1>F- (RQ)6$MC0HHG\EO$P<;$8FM#9)DLHZJU+1
M, N^M0 _C],*(Z%Z![?%0PB*D^8TO5^2<5S3CKSS&?!(+(NL[VO9][JJ 3M&
M@5H1+2:#O&\L*M^"+LC)C3-Y*Q)]+,4;P1[DRM?E5=/VJGQ9^*P'/7_+,<BF
M7E=GS&%5P:&27= G@)&>\U=#POPD!!2%)0Z$$L>H]LO- (F/X-3U&=_:HT[T
MQ5U69)X-D]IIL,OH3/+4F+ZR'UZU?5/I=1D7PV I<FK)[Z]$6H.^!5S?YD #
M(+Q><3";EBG,A!B0U92!/A^4\,1O#*DOV^[4_4AF9M-:1_,%QU'L#R-TVI1+
MQ:'1PXMK.F8[GA$;+K%'*O9NJ5SH#6*]3L]T1>+8VG+#[J472LE>,:&(0&;R
M-'X\I>R QS EX3)AWPX:B6,0MPS)0W&ECN[BG^IP40H]A<=R3S0VX3%>T33#
MJ%WPNGGR]:N+I]CLML@3")8#5J4DM=X%X_,[7.FHU;C3=9GXA^D&QHN\4-:"
M<&8RU_>&>RJW8?E>2_>HQ5E(WB*7T!!U^69CI36!C_%VP_6JIEK7@I\$4\)@
M\BK6M<,9"<;AAB@3PR^N$05\=4.7:P9CA$*L25OWA"V(V()/3MB"/](LN+($
M%Z8I'S>PB>>M$8[ N^W37@"<1SXS@K]SVP<=$?#M+\MA>>U+>^K!$>GN-><H
M-.D"=+M6>=DZ*S0^809R6CH4+-,K4L&0CV+ZOOJ6 @(RST&K>LGS&S0O&#8J
M5E#Q,''X)6NU=AR($QGC>)/S*$@P/V@<Z[RERC,[%V'@#E7925=<PSYO\/#A
MCG#(&X=KR"5%]148WK>DP:,G1=Z(0@5M;,G2A*.L1I_"8+(I%H^8THZ]MY_F
M3L=$AHQ)A)6IY5S0QR$04"1CW.][Y&6XA$[.$3K?TD>2TVT\<DD*T_#7(TS:
M6+)=<Y4<BRH)-.0EJRU)DW6$HS,_*W=+ :'ID<M31,^.)GY&Y]M*H\?!@:A1
M<+KFHA]'-;H#%PK[D;LEJ]4><'0-.-;6!NC>G58ET6LZ+&>=X*S3;[K-6QQS
M\5Q?8C#:X"08M LL9N;<(3MF;I^CDGXHKM9[9JU&--?6->S)G[Q1E%X>%MLR
MKC3+R"[W9.DVPA[LR!Y\.WG,_0&(])9IGI(.,R44V=1O: )7TJ@V)C4.F[*.
M'(G&,O5 IN+H\?9W8[[R:5UY/UVP(VK9R'S%@5>:+)X9[H35!L>"=<'0MU;A
M)%U2<@7383\9]X@V1JT-M,JTEUNC(>_HK3BKCF;'?1.34)ZK(9^\@-BMT2P'
MX]-2B3"L0WPO=L(1*0&;WZ^$\.%U)+TUW;[/GGG=OL43^KR(FN2_)LHE3YF*
MK+=;^1&4%W3I1"83,QQZ?@AUO*RC-@Z4O>?[CQAWBVJ9%UV*QIOO^2$)4$+"
M.^*#Q"WJ^;USR\0NQQPS+/5R;-RM4<.>(^E2Y=0+LEO:IP?$(3\?1ORPV"([
M%:$3+0$643D.'_WO$"#3R?&"6EJ>T7]?ASN@UVOQ)?T?0CDHX*P6+%0X<,<^
M6"V./#MH?-^%>9)CP'<R.RR?2]&RX:\CFVHI]3@N37$.0C.Q_XH?]Z<O%Y@I
M-MH0J=J;WAWT5YLRA(EON1LB&-?=#E0+_8$,(-V5VEDV56QO ;&HD*S38C->
M4;+FY?(-->K$?BMHLH9K/X[\WM\SRQ.-T(PK\JW0'1L23?=.^5GS^T$!K/O>
MT^7$-)M]3:MMLTDT^7V.5>G;];2#5]! CH/!W]53,2#16 M$=^Y#DD,<4EU.
M9M8!8.N@) Y&Q!H;'-)&[D3]R'A[CO2%6B)K^NZ%XRC75M!"_0BY9]IZFF-Y
M.I+X+CB/BB:1M<N;SDW%8UCU"5C<=49[/EJO*^",^!%6)U:$CAJ[(QZ!U TD
MHH-N&#6O^_!7D>3T &>1=W^<GF38_I@IW9[<^CB% DK= &L8]YWB CT8O?*(
M9MCI*J@+PYEX >]N2'=.C<5"&GV$3WS*1^:. \W UBFO)C+-_<!Z#3%)EQ#E
MN.0\5CT7=*V#4]1K, *(^W&3^2&@0-"]YOGB[^Z=Q6-,VY7#0YHDC"R0&<9W
M2SYK')!=3&0XA8]"1L\O)TC77M>7[-4I'E3>AX,HF-\C\+X85N1KDY;4=XO8
MF#(FD-34@KE 4<3"MYJ<1'\OOQ#&AV@%)5X&#FS"?^?BRCE&C41HP!%M3&11
M& GRZ.S3T<@L;:?.A#%QQPCU+Y!$6C=F<A6NRLF$;*J'1G.-(0DG#I3D>6<+
M0:-DWT@E5(%"E[+V<0(+-&#$/>U4L))FZ#'1FUO5HV7%+%<4O),_%)%$*$15
MIC,RHD.V2U;^\$S@";ZG11 &81NLS^1P\2^JL;W\X@^B ,?<V*@7A-?PT0VH
M1K573-P381L+2UA26^2HK;MR*[Z?E'N\T_)0T@WOF?E1[=&2 VVUQU8#E7 Q
MP_8IQ4WKF&N[,,4,F-.M_5#&Y%;X@/!/$?D?CLBLH1)#WZ<#!+>7-6\Y'.%F
M)19Z0&*8!=7 *B-I0[>+^PA4)HUDXL9HK%# "73%!)/"K8I9H?9-+FZ,&2GE
M[>L)EIC@5+!J?T$XT!IX7-N*61R/"O%RC<8+J"$].I.$&(F>UT:L%>9WI,QY
MU IIGV3E@H=^Q/WM;\K2:@>2Z]'K99IC09Z]#<0?9.^Z_4X]"9W+\;[R,LFO
MG+C'N-W3$:R/-IYMLL5/]>#YX8K8W J(Z++;"_,<T&,-':!,6^D_MT(\74PX
M@-('BDHM!=J$#LK#H]QSTCTJXM9B/78L_ZGB)I228QB,%5ER'WH:W IV! 5X
M%H8Q^+U,LP@P9 U45 A6=NV&=&5(H)HI&PM.!,');Y>EL3]HFF#LJDJFQB)-
MNX\G705QB5D#02$3$*BD]K_TDK+;Y+@(UP5 2$A=YJ2""M]K6_;TK$ZA.)WT
M5^A,<) =I#R=NA&QY<$;*<:+\,@:FYCY0M:Z=$G+),5%Y">U3]=AC\R=[9ND
MEX/W5<$99+<,A6IOBCQ7&KP,U; 6+T<KE0#/;3 5_4AX[7]9!43Q>BI4@3GT
MV:,G*M5"%&;!P'4'7CA<=7[J1LT8K-@@ -SIR(34&ZM);2IY6T!>>>(%U A>
M1$J2&KTY[S(:6LD!J8$1)WN)BKBD40TD-:'Y-![ Z?Q;\%QH\2]:O?Q!&*=2
MDS[1G#'R=10<I2>5;&L5Y-.7':?RN.>5_-X!T K>-XF,'TK&:=#%_G+!ZW)=
M$HPZ/.2?PX]-VX@D+!KW&")E13U7PSOA7QS^Y=,3_N4!.BC/GWV"&'RM+12<
M32V'Z]DCPSA4R7@(DP!H/-TQ+'_UO5#<-RNRA-[F .,=?W0HD_[0#]56\S-R
M33REM LS?W+R9>MC0;=$V/FB*F&: ^QBI;C^/WNP])VY,$;UM2)O$PG%4%'T
M9[#L574V=12R%!UR)"Y2/DYY[GB>JGIU;HR\VD+$NX_#?SX<Y#'\'Q]1MALK
M^9\F[$01T% +),.Q5V.F7 Q!?VVN^I1/.M$21-(MG*=</J'+R/E(O?/[+6U[
M^CT?">06<-[;B7;TU_7.RQ:,78D;4*,>&.09BTQIWE>37U&\M3!95595I5N1
M3*BC2TX(XD>,V;3JJ=[W9U?K4_D+R_T3AB;;]>LZG?,-TJHMI\_]:OF/<#I3
M6 'ZO# D.W/V??X#DM^4>DW*I[/K4J(EUUE(T86!?9&)DJEY*\0,5BPN<]E6
M=0S.%R]3=W=^:I1%>U-K)1#^K23?G4^3T4R/P:ZZ)^I,HG0=%0YC H^+CE)(
MKSM[']0&JQJKFI/SW!XT]]AM-]H:.5CXVIG/WMH9'"3X:$UM9L[@?\Y.6=;Q
M([N<>'8C^Y<=R[3BA??1;A8]OT:8$5>V&J^_#(-M;!2;?QW=21-V0FK *SO:
M'#AS79W4.<$Y$8X1 Y0L#-E(9O]'PI\8B(PH-!1V]D>6XPS\#1F<B!''+H\F
MUD1*90O$LE-*HNS.I A?3TO&&<8/I)0^R!RPL_YK6S=6E7DTR<5I#DG'$A0(
M'%$+%8_.$M=1**B/8=.X6BLQ*PU<C&DM%;(@'GA "M !@_9N23[):"?J\Z8T
MY9BQ#9^4TF+K9?RSC;;@O +8#)KIJ[B275VHBH]%Y&5$3D#&4*2AN3'6RUTX
MT)2KM_7$\Z,JL+B#I3KM#678+]%S.K#@+F<[5_LN@;":.VT&21Y,]*M%H$E2
MM,#HL70CLU#P=.<Z?=<:A'LD8#0,8+3CZEJL&$I-W6,FP4U0C2=$0FP5*9'#
MAJEG<'!-A#Y&QJH$!+?OQ7(QIP3[Q<*MM.^E_*-,?-(TSN77C-7/Y%:GOF]&
M:6RT" TD6&3R\&F!U4#-,9E-[."&8:1%0X"9H5V^>33F9<P6H:2Z$YW4UDL2
M:J?2KE8L:9\O0 AW6<S#PM$3G#QUNU$'<$1/JY+'>EK").=!*RAC2Y(]:)G7
M6P[;2 #M\UX<:6IKL^P/WM4@)"N)Q&Q3Y2@D4.[*2P+H2#:CW):EU[ARZP)G
M9:-G).^PER9#RK]N#A^TE/Z@=9:O$OY(;0\^L3 I@:&,S1@ 2"D#P$@$7WJ$
M/Y#7_  ]MH&Z%H91IT'*<EX(8QDU7JCX3N&-#YDDC&&Y#.:J%R9\WUSJV #(
MDR[[PA 0*&6PI9,MP$0"<G?0,]KZAN&/E,OM6MJ'R04KJ;09PFA)FUHV/>U'
MI C7*?>%8Z%>N3TLY"H,27!@\]84_O"0_/M5*;*,BV\^Y&NS/1R#YX0??4>@
M$KMZQX0 )E?@13_DC$IW>K1'CJ%\O/W=J0H%$O_%1W%HB,;@K3LV$CT@F3!
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M%JJMEXZ+PU79R'8 _-09K_DFW7HP<CE)V<"28R%S8XIDE87W^0C[G]04-5G
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MS+ID<H6QO%JV3;L],)CWYKK=5(^#R>NKO0)6 9-M][TA4-&;UQ(%-X%/:XG
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MTF(Q(YG[@2#D[6Y(/Z=%I5&'$)5]2N:%P9T/! =KTK<*[\(@B=H7[%-W@]2
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M5]M%/*% J"+DL.0C"(E::DI8\KI9$:"C+_N20T+_M4&V/'/?RV:6GY%F<S9
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MXG8J%#L[AUQKC*L=N8,P,8N]+@'V%NGDX(L-M^$F(%H<GA\I&/#D9 7V4Z_
M$EAH S[X3/V?<2[]S*Y0!9:AJ8.UW4:+U169RF$((^693L@KUI]JRSFGQ%"M
M#/,W89&ZLE9WUNW6_(5"SF_*@T87F<+7H,P=:,VPP\>4RQM"^^SBV,#3A,@'
MOC6C9[AETEH@:$WN?<&-&(Z.B0NW;@.WKL]+"T"H85FH[C2M9RO.H=L?1<R
MF7*1M[S-F;@E.(QUD_,T;$M)_(='2W SH+_@6:S9-UX\(BYS MD1*GDR.L"D
MVL=@_B"#2+Q/+52NA,B!9S2,:]^N3#>;R*8>)$S8P#@.I#'CHSY=QQB>A(!O
MRX0R?7A],)&LG&J N>4<-6\@MT1D\29T^;XZND2+3_F$N83<:;26%4P?8C5C
M9];JF>HX"*L4%&@3DCV6]8E&"7I&ZHVF"2HMPQ^Z#N<I[/8M<)[I@(<;>2]%
M*7'8@(<M+ _^GNO^-UQ _?)20'U:R,,066IBT =H@J=4N.O )S=C.RC(IH^V
MXI5'6+6<VU-73G/7-[M2ZJ[G,)4S9W+^Q<ECZF*F(@5W^9$AL\?9E.&'\/62
M<A"(U U'&D8,!O=)ZBSW$+R 9\99=;88EBZ*^_F@W5.Z.N'SY:-23$\A1\+]
M;1@"AL;<4@J%K(OB5ZQ5FWV2J$3G!L:^^"P.WU<4B+GFZ)S(839E#U\6(7.7
M/E#&E T7^Y@J,F:/=&LMJ9 O7!9A;HJ<P3P(PV=]8')E]3*27)M#VU(DTO'$
MNW!.ZRY8\[WGDVHK>#>07G#A$:+"Z %RU0^_]0#%?KWZAA4#(Z>;0C;8,&O?
M#8)50R@ B=0YQ5C203)0%2>X^Q-UHD@]$O@&&,,FR98DAP0'=D%5P VZ2>J9
M1&<[P1>QLMYB#A"W))_NELY7SF>"T@'U)7YG$LRF5(#)EY6(#LKI<["$FY7G
ML9O"LF.E2^BEI7(?ZZOA=,5(ELZ^$MM:V#,YED _-E%$7#AIZP(OPX$=D(%-
M>S@"^0\ D*7LM(9PFCIZ+84,Z$+C'@O7;=A.FZ:J-V$.ZVV$\J'W$3IP+-'/
M,*)\%F 2"M<%D1\SI]I0)=&]6.CKU==VDN51WK/,0M1%==-W]RA/&3X ?J"5
M,,>*8:]^J>F'<D85D7HS.Y7IF8>^/_G0(W6T+P'0<2<W+ES% \@L69B%=E2X
M*3K*[SVU$4]2NH'.A>: S.#LZ>R I;F0-+^E>N"H);P4'I/N',ZA:B_-VA^I
M09BI@3E2;+OV*IBBBHDI7,I.YKD$E!5A&YA[PULAS"M21A&C9]A$F+P>F1B1
MR1+A="_WY0UC3Z9+1^KC3:F+:>70=)ZH9GAMB_KIM6UL+1 N-S&UKCO,$Q<A
M.M-1$\6D&>NR?0?/M%'L@-R=^ICC>V/KZF4]/)I\FZ,/HHX./7;<P;<^+M$(
M$7C2DUDI;V@WC9O.E#OBS!"L$.,>-SFX.M= 1; X0S7\6Z[;NMR\"X?XU&ZO
M>.!W^']??52,:\6\2QT=]9]23#7O9F0AHW$\&JMP3"T4[ 8H^ECVC]4NA9!I
M71T[[A%B&.6LV K\T<1U!3G[VC'ZJ0-@U8=E+TFIGS!0&VMH$U*G)L,N3G<Y
M'42NI^:==8PA^"0%5F)TU)0;AYWSSR5ME=147-_1YH S\(J\+\$5P_=H6.+\
MJ32M6.4_CC6O5R\7!\7RGLNH3[NP=$3IW#G*\8O_];$.:S<[N*+=Q(.S-!2&
MM(1E0UF,B[OT> 0>=V7=.&3CO&PL6<_+H#_:H$L>@8\(2LH-P]3#B7D9Y\?C
MXA)\!*QL''2DD OGY="%(*VY#/6C#77*M$D<D@TDM(+7M '0%DE_0]\R:?%@
MBBI<5\50K%9P!XGB<%JC1@@>Y;U06VK=FS .0*#<-=M+T/2HLQD<O'?HKY;(
MF+7:3:AI^BPRRB\'9#@E_09B"F%9/N]IGN$GKC@<>! _L48)"47Q4QFN]ZRG
M0GJS!DE+P"IZ+F#T!L 90S91G_C"T 8=[EU5A^T+',,<<"><,,/8-57K_H H
MD_##EGEFG6^?OWEZS87@/&:8MGGS2//.TWP_E=DZTQ3HAYU926FN&C=@%6>U
ML&/T0?-2,7LJ%8^[%@OGQ"F*X=X@2?YM9Y4UDEFZZ9!%=LY78-BT\*^RWP[<
M90A@V>O5*_=@!F9R+*A(K@IP,=J[M"5-?*8D;5,X 0 <?37>@BA5U6)AQE\\
M[F5A^EMDUP?Z;45%#])[>M]#'6G;#95#*0.7B(QNQUE#8+'&:D/F13@.OJN'
MB?H$VRU53:9ZN"6*?Z%%@6P3E/8W,C_/8B7^4!VP%.NH>,/X;PP%E1F5P@$<
M$"N;6@ZA!.1YS^USUQR?R Z&F=T!7'*C_7K1[Z]7KS$'?^B&H5Y+SU)"(VQI
M7WX$_QJ:[H$Z0?QLB.+8AQDNWU5M0[*I(^]%S1:GCY, P78TFE!X:BEU,X)R
M2G4;=A?L/VAS((W3L!,;>,DK!(C5*IKF=!N#F0. <+@.=_O:-\!?TM:#J14:
M'E)=!;=891UGW;X\TH+AC'42"J7'D?/R>O46Y8E7#4)8=LD4Q5TN=9O,=VD'
M>6Z9X(A1'\V>7GBQZ^[#SOH3L@,9-^ "H'LH@.[W%P#=TW+XI.W;I!I\_ACV
MM"Q_Q9"F<%7JP@#N78;-;>L;C!P2JH9@TL+:O66H+;I]35Y$0+G^1@:J<1X8
M!!?Q5[.:W;,X-H/1_^+S%W_F[D9NZ4%D HZ1]'9G6J%-7.'[;@M#L/K)*#=>
MX99&:_C]3Z^PK?[O77_?==OP=>A;V-R&0V3D_IH\5@8IFT92D488)/0T126"
MLTWWUZN?;VMN\ ,$^(U4O4R@(MQ%Z1T9^>,<1+CONNX<F4BR'.K1I!."<X7E
M$A,W*.1S:\^Q18UNOVB,%$Y7A.E2K[03F94%9S(9UE3&]R.5@!9[DC?DLJZ#
M+]XZX,J97KP5JZN&64N['R=P0)_#FOY9NXEAQJNMOA"H"+>;KC]TB"$J(U$:
M:I8B?MSP#++TK7<8#0OY!_JI--B(>1$5R['3AL^*@4)4;7?1N$(<@V=6[0_L
MF)$$DO+HZ%/A'02[29V-2[C@_#Z-M%.D)<V6NFV5&CM0]E5)' 7R'M[HVCL5
M] /LR@>KF*#[&32%D,%L%S9!ZR!NZG DTZ>G 35N F!9F\8MM(8S3Y.:[<X9
M8U%;/\,5R#9!.KSY9@B1'!5M";M198$WQS4X:1N$7J[ (8 62V(N<*8!0S=W
M2DBA-5?SA0+A.CKNT.SQ*(;%46[>$4&IR'N7X<Q"IL7[VPI-YAI*]B.V>M.+
M%WI'U)SOI=>0X6)(O&BX%-_>I&P. @5P(VYMY,IY9^],?-!VV3SU1 2+-5M3
M/'#$BERK(-_(E^H$K9YGZ< 1\8803IM]NGZYWL=L3C')F+3!%9S&Y]Y. P$#
M.9%+(R6+.BQ POL;8S:!V VV^"B9P/\Q2F74K4_8U!FS8F+^' R4,:PV*S:[
M)Y8EDR;8,=B-A_"MD2S,@4&XY*PTW<:P&3<5])<?;FM+3_FMY<YO VR0<24@
MGE C@[5#-$[5"/M".+6@)U#O5ZBW)@SOYK#5PB?* %5" ,)JV/13/7KA)%=\
MHF5!M%Z0S2#B5AQL@."&LT\S7LVQ8)<JGH08)9%A+!#6P'.,@S'?<M@B8Q@1
MZ-XS.7N^AJBD88J#,>CUSFL[+-+?N'GAL7"_XLEG'L,AB1N>RIYY_TPZ<Q5+
M;PRWR@ 0)>Y93]#92>\,YV,,HR05>T$.N0K^:7;O+FOI"1$>'%=E8Q;V+-K[
MS#,4<WOUVC94;L,'Z.'M(4E#^64VI$]EZLYR[85A"2]Y(V>#+%KBFW?]UD8P
M/$.=N\X!=;X*BXOC->U1HN!;!O]OU7?=?E6U=W7?M?1CO'T-Y+SMMI'$.IE"
M;(4@6G8Y=Y#6CGC_\/FWT.E&M0!QE+4[.\SP?=>_\U8FAPD[@8/_UIQ$&:UM
M14IGS'_&P1\5WA@ZJ\+SXZJJ\47F%N.$9^>7MFMK6\A8)DT($:^H8%N.6?;!
MLZ;SJ2SL#]!IB'K'3S=VB\F"9+(TC>-1*;($Q(U&',Z>+A*/8TQ$( ,@\_NQ
M!8%SI]E>$6,Y<$>&!]A(XQQ,I&H=GCR\N)L"E@9EF!E7_V3.B[,PV=FJ$W_K
M]*Q$4^$:^QTI/!*AB='P_.#?P4C5[5F? %UE.-N]/F>GBR?#-0#1'E<<.K98
M1$V(Q8CKU8_&9"1QP@-7(O@;B E9'Z-<2DV9'A*FH;X@1/CP9\JJ@C3%< 54
MURXDDS2K!CW05VJ@8Y_#X7"/FO,3RG**F9M7V17>.U<P0Z9V0NFW')">%?YW
MB3'527UDZ^@0FW+]UEM]$7ZV/_KMR392WP%=T59]?:>  !#I">J=D8@ T"K2
MB@@A,V96P%.()GX#6'LX(1V]9UI)[2$Q24RUTP"S^"SVN!R1L%!R(WYRG*$*
M.>AD2M6_R)+[,Q0@HO=7!I7%**P3;;PXLI\W*.B:=<UW&5F7(NW9+;1H>E\/
M[SMEO^$:V1\N-;(GXS:]^$.V1G968)UHN!!8DR&?S?J<<OJ?ZT!]<]9C7I#F
M=@2')V-$:X^+6NG=>T;M2BMGY_"+6#N*PL6A0GI'3.E'@,]@Z/=3<U.FE9QO
MOG]9N&CGING681!NJ[(!40'7H25$5M*GXR?&[)K1)5-S)QG-8=3Q4&#&<SA7
MYC)30/\CG3N<%>C+ Z87LJ8Z0[  _I!;X)#<IQX>FRYP:Z2WF@J5NW!5)$U3
MOTRJ:/-R%D)[!B+@2Q]G/PV(YHV(WF'>-INNWQJP>+:R),'NUQ3)52[B03AW
MQO%QK%8/=T/Z1BQB2'Y%B76-$%IS- HN#QO)U:-FX/XJI8&+?"!KNE@8H>O5
MVZ[3MC()K7$X7![0@5["JA0/(*'04C)!DX;(Q\M\^BNW-FTRDF!@?N4[@-2V
MD1?A.;"@]:LA!]9GV[%%C)<7DQ?.7T+X#+DI"RM*$F=<>N4_.L)?G/1M=5>7
M4;=>=I]=FBL>;>BU (@UKU0\[3+2C]G&DE!]^^2'JN1Y-/(J;>82)L[+K#S^
M^H^GIQR87]4\QVBG4(+\Z!/JR,W:UL#*3I8*^*DO,_6(; NV,93$V]5"NHB\
ME@F_]TZR,O(P=EB%7#6=<=C"*01^TF7.'FW.?!G+/$-%^]B$*FL)MU)NE#C'
MQ86N$9#=-_ PQ7?0N/(R?[_6GHME-B_C_(BGT,P:=7W^Q$E] NZ$NDS&K[+H
M&:N#;",F-</LYV7T=^S/H>B<\#UP(-UUM:M!N/"&;:##/Z$L&A0B$,?)>9?%
M$(AJ-L1@<>E0_C4V(_*DVCJPU%3OX1C/(J4'1.F0 Q/6N:9QI*G;;C-9^HFK
M14"ABCFXOWWWTIK3J&D32_->8!WR<HT>V2TSTZ'&\U!S"@IN7VX1M,34:=]^
M_5(@69B1M7]89I;Z\^M*16CGR5]K/A,Z@$+5CUB9P!#\+5:ZM$.M#K]WV6L'
MVV?W_5G,[@\+[&+' QB=QHO/'(!D2@S7',BZ\HQF)C&A&*R4B0%G(];[9$@
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M]%:X>Q$_)^QR5"? B17Y%9KW(BG:L!G-T:OX?>!J81JF.R40T>%6J"A:DH2
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MMO7"O>)3Z[UX_SX;F#.(M!'\+VT4Y[#_DC/DA@SL\N)&<[M&&,\] CO5!J"
M<0E, Z2PT>_M/*3S/IQ^S<CJ!N=M"?;07Z]>20RX9-"\J\!U3)1S2JEQQ+.6
MH%(UTI[([)ZT-F^2(=,=H+Z"9NT7K?*'=#11VZ"D^(8)C@2Z393+'6Y)XE<+
MOV"@U$*>5W)40=L-8#P1=RR&@>M2!S@RRDTU$?,5IN_J\,Z;VS9,P<W1J?0M
M-7V=&2)2UU@VN,]AF?Q</6;B#809*I%A[;'YO23F%L*&F?\K2K%G+ LN)CHB
M@\^R[R#J)Y)NZ.T*ZX TGV#?HJ*YQ-G+!0YMZK<@.FI'HK(&X1GEO*4$E--5
MI?-C_L!&#)#Y4O8IJN 83P;_=>U)#$F'-EI89OQ/KM\!SJ6*N&(CSVCF!<(W
M$>99WW;=UDOE ;IO-,G:H0Z+K%P2K05V@*'F.T>ILB*Q*:PU+CM+U!!/T.#>
M5L)S9NE8]>WG76W<KJQ4"HNP:8@5L(7 D0#-'A?&3!'\0!G#W\ J@53-II9/
M@@Q#!>OO6.G;#$WAJ$'P>@S=)2'CTM1V%7IC%Q(2EC =9;]5,%IX;]?K+;^7
M-MCM%!;=D3UHG :WB%5ND\1L%^)AK/$#]8DPN=!!W**C<QK3J2\NEE66%$"=
M-YK[97HZ"#BU-2,QXUQ>OF>3(HP9/D=L7AAZ>RG*& $);14E!$X=+#0FM/F%
M.."T@=(48]GWT)A"7H777#</R'5&[<J[KI=WGI[-40'>'2X+<9D4 )Z4U$ZY
M7$B\@+E!:L]U:7O.]'KH7JL?TK30V:X;]T30Q%5B/B^@C$C7XZTJ_ 1>S!,^
MON]Z/.X(QTP_ _Z YGB U,H6;%W?(1(&ELAV'TSMX.!ND&"IFJT$"-C9G'J6
MKJTV]P(U*9./M_,6UT2*O7<OJFZJHSK TP66V8(K=PH_^UP698;>2NI^U=GM
MZQ0645&Q0$5@VYT4E("S,L+/KL-QEV_3%Y$>87ET]<7X@>#LZC;3'AF!7FO0
M-+69AP?'Q)9*G 'TZ9DX9MI,L!":'#Z#2#=.-!@Q3I.>23R_V"Y#3@E5ZSNE
MN!J'7*RQRL?BW0RT80D1N]Y)W[N71T#?8M,=5(H=6_L)K:B ;9?V2N7=/6@
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M.'2S5CA19Q^9Z^-G;O$I^X20L;J!7CB ]-]T\(XS#@#LF!W&V<MC9P0JD:;
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M_CX%:P%Y.KPV5_#QF^]7\I#D(1S6(!&[G055A0C,NL@#=VXDZX=ZD8A9SW(
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M&IP ;' YM[#(P\^O+':LF6AZT:4-SZ4A!YS>Z@/0Y",]-)';%9Q"@WY[*#/
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M%(XI[HWES#A\%E&N>GM_)).[TK!5:D3ES^&?NRLE.+9&<4WJ?3=V9-AVN%$
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MA252,PD#3A23,,,B\XFR@2I\(K*@)_>*@S@Z52*;QN)>6+_C0Y)Q&+1C77[
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M!L[<CR=\4AHD<O>RLN1Q[M8YQ<'%N>*LGW.3SG;[_I887,1JM-^7!\6_ET*
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M#&"7EFEV'5@D;[WI;/N;ZI1X,N:SFGLDH65L0_LZ+5>8X61N>&I=JVG2>2K
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MF=FNKS@(Q"F22+T#"37)Q*9C(Y4C>C<Y%R5IWHV3>11RKU(@5Q%3;B=M4R/
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M.Z3ONHWD$TH?QD(C5'XEVN<<&FU.JIVZN#85G?QI0H:(K1>N=?S^P^:XY;2
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M<D=0<)IQ!],2H+40&XK@\P*Z+G>3(JX%&)58N&45_U4N5[ <6 7*PK^I?/Z
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M7E[U^N1AD^D2M/ZG+>/KJ?0 *DW\T>A)$^A[K?^^7 V&,;.-.+9K2?25:##
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M_M;7S9:,XF^X^^Q*].GC(#>JR'&078-M1"M*$_)2+>BDB=?/M+HWI+\!FM[
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M[ 8PD)C*)7_8K>$\W$\1B%\2,%P\YDH/"; 0GINJ/R+B2>-R+P1*C,)(OU,
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M?:>6M )R@&[2#5SW)\;1*A9R4+6//7M1-RUC5..Z_+9&Z;>?(EN//'2D'1*
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MJ['I.C!"!D2D61)ZX,*U/IW=R!P7@'S,Q'RDS6$(G_[Q4X#Z;%Y-6]J:X4S
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M)I-D&<R-5UM9DFSF\-,L#.>M.J*ISIP[">ND?[%FOW8[B@HU!]X[_20;FYQ
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M#H&MX3R.Y-2,_+/S<__LH=Z"7=!-CL7X>6XD/A^>^5?CGL#/EL!7YT/_?/1
M#\5S)/ 1TG!TMA]'X!&J+P]+-#XF]>7O:=YH;_$%4XX?+O;VZO9Y<7$^\4>G
MI]\]6O+BPT6>V8B#2TT]5N*>G9[Y%^-A3]SG2-SQZ,(_'?<G]TA=+:=]\L5G
MN5J8RL-CB[.\T:8CTAOD04&5SU+1][K\\:E_,7K2<L"'R::]&U)[I=+DTC][
MVFA]3Z4': "CB7\Y.MM> ?@:*;37B^_%Y/R)J'/,]_L&Q>;X[O>WU"U-8B6^
MEX3%TZ=-[%<JG?O#R]VMDJ_*\-BSR\<_&^\@EWH"/7DX\?3T2>/P1TJD_5[M
MHZLG.D+'?+4_*].=(@K3<)%J[W+J3HQ=WUYH'U2,-WSGM/U\8!'EEXNQ[OGF
M.3WUST:3G77B@W%9'G8 ?<_!AA'Z=G8W>'KB'@%QQ^,K_^+JHB?N<6HK/>;Z
M$R5&[&/%[[ZH+G*\=M38/SL;]7;481/IQ?G5#A[LGCQ/'0GRQZ</A#?[JHBT
M7U_$Z?D.FEGOC'A$$(<#2GC\-2R\.,T[DARW5-29OM]/@"'F:8D]Z77BGV?2
M''\OK$?<H,,^92\N3B_\X?D.(9Q'WZ$]I\GW9Z4_*SLXO8;C47]6^K/2GY7[
M?(B3B3\\?;#W__C/2N]D?,9.QK\4 ?"DJMV.O> L9!9B]J_,^:__9YK]Y:]5
M;?V>U^@39C^9ZV?86&F5A]_K?[R<1_DJ#M;?1PE-G%YJL6I>WD7SX@87-!C2
MHM28DO'EYP']5*,E_W9V/K@<G7?^/!R,.G_;-.SEX&K8_>NF43?_=GIUVL_U
MB.8ZWFK4>]P ]\KBJ\:C+<*63^#3B*#+F@2Z:)5 _Q,&6>[]F,S#N?=#. N7
MTS!C\3L9^9V._N>_+Z]O@N0Z],;#T95WFP_P/RYW<1O=NR_._;^#VG'8FX:[
MM07/;+7@KVWC+A_CL#W'O>&3V+/5 [:N[R*V&:F8^H=]3F>.74IA']1B8MN
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MX3@L? ,\7(XWK!=% GEA&ZUO^5MZ/%-^65WN^,FVF\O^Y?QTO]6HYQ)P6=5
MT%(B#G.K7$H+HF]--_2UVZ8G!VZX=L0@F2F'4*'C O5MIG+FE4I2NZU&[39*
M04_4]3!\EK+V-<\-!JZ"#Y(E!!UTZZ6@&75#^^6%RH.95W@@6$Z5!Z)>V+I^
M?[4+\FS:>O8:%V0%;42';5V0YS;?OK4+"NS&<V[H6:Q=>);.&&[I6!HPSG5^
MA=+V*+M?6.D@'-H99N<+V@ 7I<(:3[EDQRN,R%RTM I&R.\H')\L]G6U"VP[
MP V\T17NS>P \6B$BC9.2G<N-O-08>,L2]#3E0)8<(VLI2*/S<,$VL.XKK6
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MS)9Q0&PK\0FE4I+ 3R3QK2!.K"2@<:"2#ML)3 AI]L7B^U)"Z=%]]]9M%M,
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M%)8HV0R)U&U=5P=83#C4B6*'$RI]B$1BFD D$DL24L:B6,0Q=SE$(J[)6)_
MA(9*R/Z%(8/Y[LI\6W60*."^M"SBQB'8,(M#B#QL3D"OX@B\;F!3^]E+S[18
MG^ZM]Z4,TE^BFMT$'LMGYIX:=\4]1"6#1[NM1^L@@B5!&'O2=R$"\6*\5R=)
MY#&'V('C!Y8G&'/"9R^IZ09(8+$K./?>4-;LL&[RA,W^'J*9P>QW8/8M5%/!
MW9#9C#@>100>A6KJV412SPUD8$G7![.WJ6O:]JT3D?LR^KX46'IT\GQQMV>
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MX^_ #;@7> D)6!@2*D.+!+[K$I^)4 K7CJ+0OGK57:-1-\L,!XW:>XT*91*
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M ;TU<NUP7JF_%GP/H$J#!>_*@IO(@UI>' 5NC#5KW'6A@H11XH-!)Q&W19R
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M(HA9 BHM@L!*;%>YHJ!R1<'@BA["%1UWPR*:""$<ZA!*U3'2V"<\2 2Q R'
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M@+B]X:^ +.N?]3_M[8T/$FQ3I*-4[2 B3?VD3&V,6=;\S&>S/(WF,QZ-)'X
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MF^T^'">45*ZRDKU6@D%%2DLCI9*]5O9!D5*14I%2D5*1TM)+:1IKFADO<3"
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M,5U$YMA2Z477B)8F(7,)^/-6NJ?=BX.+3UONHG5R@-/G\=Y^BQS\U;KX].:
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M%EMT_4*1TC)(J195)LNW#Y;5'U*]N3<D[RL^]\47,I4OY-VX+R0Z&2-A#N&
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M/YMCRL_[\+^S=K\]"!]"[^^V"T-;X7UPW2^=ZBJ5V5"L@ZFL W?'I<:X]BR
M0U@+0" Y1SJ&B"AE0DALG.)R;5VS)J8EI;DVG%"2'9="3.6 71TIU=2G5@[8
MVAVP-]UOG.,D?N*0S_V,P7*,%-:0SEM+J)(>VQAK>,"^I-3(O<%AZ%6>MUXX
M3/!H_QT:[4[Z=[@>U34PWTOZ8PD6%2DM@91*^F/9!T5*14I/(B5=I+0$4IJ[
M2>>\ILI0&CU6(&@PT0/CVD@!@3L?YVG25>KHYK@VNE,IHW]T^_W=,-B+^^;[
MVVXOW_+&8-!KV[.!L<=AO_LVF7F=0;'8IK+8OB2+K74S8<(K2QAC2&DK$,0
MR#*B42"680#@EE5#YY.\:Y0P41!?>'E%I%135UOAY>?FY9N>M*"34+G3B*O
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MU%U;IVSFX9#%45I;_,ZS14/![W/@=ZR80PDG06N$H^9)M] 4*4(H(I9*)[S
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M:+><R?J3SF]8O<ZV!K!Q*I^+D5[9UXT>V)OPXC[F43[JL/"7-I.6 XX 06.
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MN1CXS-UB+S[@%P/:/ ,$4(G)21NIK#P#9:Y<(33E!YJ&?A1I1D&\1(E.-0W
MC$XD%[02*]1GI/ZC2VC[AZ^O06#O@*".C*W.<SC')8 /=E!8JT>K_<DQ&C=N
MW W]>8^._CZQH^/W] #']G'WR^'Q^Y.4><Q/$DHBIA+"(AZ2-(DY$2:($AH*
M#9H;T*(WI%$P],/5BCN67JY'&5$(&@?SN=!:LU"'J12)YDQZ-(DU2]**,D+J
M% [\HZ>,NZ6,C_*$\21)_$22( X4H%1,21JD,8DH PEE>.B%H2O4X7E#4(E7
M*<-M/MJ8 /WC'#5IV 7TNG!TT$AK?EXJN][HPF[6$@$IZ@>Q45Z2,L4\%:=
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MN5,+[;WX!ZI"523HS!DZZU^\9H1UW.?$!OK;R'VKIQK,/:U_[> C7#%1O%#
MRLK"IPM:W7WWT@6MKKFT'+R?VIAEO.S]LRI+P"FC31K/^AM_S?%53U_OOOOU
MV<[ED/S].DW%\$'T>%(S_<VIF8\HR7*MH+Y2\"X!3BJ\U'BIBCP#,EZ!F.=A
M(*1A7I3JD*O[7(7U,[P2(FU^]-6@6+ETNIE)SN*%W[II33NKO'G;FO:"GM%+
M4WCVEY,85M$HI8GG*P;ZM0;]6LN(I$(QX<6"*:Z7I>.N]8\"[]=)2K/V9+2R
M/?G(^9ML&+S08-!J3!N;U&EILKL55V#XO>F UU1W,<T#L.55.<O&*-BV9!;W
MJ<G"DAR99D$>)X]Y)S0- R\P"?$BCQ/&A"0B""E)4^J)1 1QK%<2:?^N4DC&
M'+!4URMHF>OC7)U6"JBQ>5M5EH]S=I6@ *(WV_%9_FV*K$L*6U/]PD8< UG6
MQQ25BPJ/8C[ST=QF=.+923W [I&#Q#-[].EUU<[*D+9NX6965JVJ'56?-;JX
M"BUS,,5G=5R .UIPCO#60UA[]>QKT0DWXU]<EIV-"QBZ^$7BTB%Q;G!UY44<
M5>EI2EMG/*K'[=K@V4<QK_SHZ*N=X*&5<SW.2VWFHS9I<I1C!4Z7]64;.UBW
M*+YR<6G0W7>6P8 *NR@X],+F#]JGXD&+=9OJ$:RL:Q(Q'T]K]RV?X9HW+F9T
M.@[P?"JO?,!-QJW,"CD?P]XB_%I?(J[>?.2.<-RIBSU-LKF;UD WUM/Y";>G
M0UHBG\^J',6BN' YA*.YF[*;9W5"T'1Y=,-$HPA(!T>GLI$]Z..VZX5U+3O7
M?PD+(Y&X7,D5>T)3C[*>:V=]T!$*9@6:-;B216:-%?>\[@KO++AO%L@+<S;G
M4]1UJL8<1<4UI;Y4C1DB5Z$O&<=MUS,O=9=>#<\*MS+6R^P.=#"]697#[R;F
MFC87'[Z!/)?I<7W?SBZ'Z.H0 A?/<;'URXQ&^;ES^4^J0\TZ+1"8JB+MGT-2
MO].6R@?[DRIYNG<[H2/:K<I;*SYZKU-'AI_Z)SQ5//:81XPG->C)QB="1(K$
M- YCCT?"2X)-,EQI/-/,;.Y\<SAXEFFS4NJ@0$^.!5W[<WNTC'$V*-(0J.&J
MIR^/]@Z>.?S$/Q%I,GU>+F!$0]N(>.A_=24!^*)"8&7 #I[>6U"V,%#Y;^J7
M.D^7U43$A3/L\)U-D8&%YU4X;L=6Z$H<#,J*XX '^"D@*4BBW/YVID>-0\R*
MLNX;4#*UQU7#SGI4;W$X9@^_\%N\OCH!RPLK[_.)17,0G/FY6]CN6#$BRMU@
M8P7Q<+I-WH4KJV9.M4ARK]?H"-N</N,F>@NQ59T800 0B7&"YSF(&3U9R=VK
M0J^.ZN6J.+O<HLBKNV;C?1C_P4D02$R1-22V&3*,*9)ZH)CK-)5,TM17/'CR
M HAF36J,6\,5";@MH8+7%(%O*]7D;:N:7.\PZQ8%436VUZ#@H:,.M^#O;';V
M<@[*,[RQETB'7_>]$RU,+",-PLCX257."<B7@$49QUY"0YG09;>DB)D1L08R
MCWTP0Z,T"5@4*9U$5'B!D,L2[/YT'3 [?^<3E^?J<F)=X)[*[0'%[KN7@\B+
M%JMEWC5GK1_YTYJUK(%2$W#ICH1J&BYO><R7CO#98%[63H.Q/;"Q<GM6Y'7X
MO?/H6508C#48/6WE&WNPE+O*E_7,VBH6:/FAW!W9PCXVLFEY'ZUY7%E$7^LH
M5!?$CF_6UJ=1%XVR^VVMD])&ZZN/<Q<V51]P@4R>.,?$J Y76A?27QU9U1T8
MT;3,U;(BY)Y0GFD]LPJ1M4=1IRAJE;BZ$16*T\SI'/809'F.]=%@I74Y\[RB
M65OU8X0_9Q@*Z$92^VZLYH&+:'VF;KI:59%0;5"NM?Y;+\_RP2,JF+6KH>M]
M>>J&$.(IHQM,M:WN8'$TZFXJ/DC6Y#JT$8_3F5V.]J+&XL>KJS4N)>R)#1MS
MMGY];#=TP7^PD:.F,E Y+[BMH-36_[&;W0DVM'-?:_H^C"C]X[S5_QU)8^0S
M;+[5))OXM-I54&]NPQXV/KJ['K4VVCYUTP:T!*>1SAJWC\G1U+<*LPU_G>EI
M.7AJ?X'/!#\C+NC1L^>#I]DSD*]87LM<U JTW?RGY;.6V&HZ^06N7[ZA>K/C
MSK;4=,.2U?/LK7#OXF)U3A9< C)>]OE9;:5LN*@&AV]^-=+84WALL^[-?M2Q
M@D"VF@/YKG\DFFWH6"P12A\&76*(0SU)&#VLVY@7Z+"K0L(M,KNHT=/"AH!;
M>=9&'9-RBO!95/!4QS3GG0J0Y; J!#>#U1E5[NO-K+XU"W<MB>]JNX*Q5DWI
MN45[O.K)B]]PY0:50K QU*!NXV2+=%\=/GEO$<ZU6=R5$+]FN4W1P%@-5S&O
MDPG@"H"V'LZJ"-KL8O#TU]VW>UB*D ]@1LZU48G\(U?TL?JT6Y89BI#9X)TM
M%XA"%B'Q315W,[&U_ESZ =*C1B'WYNVS+B#:.)P]O'Y6YS]4]=+PQG_/86W@
MZ<7G#$\LG_[[W^^>_=+>UQ)\4^5P3QMTU*Z9\!L7?%T.=EWEMZ=[NV_?[%:/
M^Q4#C?\W'T]_&1Q@+3_%![]9__1KC*JI0F:6OWG6Z1]]/=ZK-)<-SN;:A=W-
M.T'!XDH4VM#AP91?.)'CGE0WN7-Y#G7Q,G3.UV?^.+XSS=V@JK"B=0D7+E$"
M(/5<PY*@:M>,QT5(#UQ$\:*JV,!5':2^H(3:IS5BKJRWLSD9P=R$KABUP&YE
M7I4\D94NI70V0PC?;</4F]!QE+,=R6R?T)1XX^65GOV=&@D<Q=937GA^JS2>
M@CK>%56=ZK#M,45N%@+!R\9[U?$YGK<E7AW*7SC)!9O:GALMK$T=YE3+T8T3
M:Y:YL_1.P5.N%F9[U#7;7 O\FOAWU6W;+!!>+@B_&Q8,][ P5Y:V=<:'TV(;
M;JVJ2C1JHX.>K+Q,B^W8K$M:JDM#N;D76;Y&8Z@20:VZC"?:>/SH_.%ZYM3C
M)?8!_BLK\\WF.*)I66G"(("RM@9K^QD3S&KHL<DLK;*>%9VL^*X26ZG:3BF%
M![5%>.VV(Q.?8DG6:LU6PR(73O'6A4D^XDA(VD=";HJ$O#*R<=GE*)(D,2D+
MA/99+,+$TZ&1<2137X5I0#?%(U[MJEQ\CZ]UD$H6&QH(Y@O%/2U,X.O8"P43
M+%S?.?6^(?(T1V\2 ,*_;$'L2IHZ)X"K[NV.X"4,#;ZJ#&LP,FMSV>'(A7.)
M8>9DDY7]0X_^O![6VFP\&\MIHTQ:Z[FN;.]T^>J"F8O6Z."I[)97P0'5_L,F
M%0]',ALYWY;^(L]P#%?-RWI%JON[TZM4F$8"6%LW%TC_3G!@!>0EIP/\W1FL
MDR3-:6?E6$"O'0RO&7L=4-&\R*IAE3KG8C$F-A_/<EZ%T?:FCF/":MWS B#3
MQ7+4CI0:Q3<Y-)Q>YN907[OB%7G("MA5>D83C;;DF\2/F'@YGH]FF.V >S_.
M2L<([:Z[76Q^JPJ= [K(V0X:=>W7-?$ZRA+M=4UE=8WE$(:U0E)[\$H@5:SJ
M/MNXB75Y^.K N=4M&HIRG.J*WS>)NL@.@Y83!CJSMB+"*-H'Y]9[-<M/M?W:
M>>SLGT5UXM_QXC8Q6Y]Y-JJS3A>&8%F]P1VW,/:BBN/6#FD-"]:+@245*N!Q
MY2/:(+%F-Y:\=3NW<W3B7Z_D^/V4G$=?B<)H.0>"70!\"A\$6!I53MU:E'SF
MMGJL->!9CO[]6J%%&A6ZJK!4T7.AKT_$'6Y9B 9LGSIK(;6IF%YKP,+:J]9A
ML/QB/D#U?[3IQ3N#HSI6$C.X_SO/BH5:!.N%!KZV1@ZUB B9J6H53"L M:R)
MXZA#$!V&KQ"WLS! %N7SD;)SMX*@Z0R '(BAE5;!M7Z'2?V(FL QO[S,A]7Y
M5NU?7K<DE^^&?1",8/E)'0SC;34(5X:B%FAV]&(-!73>VFRDC:SLKD)CB^A*
M(?A6V<-VPH<F?8[7GD!DW;PZ/!$M,JL_8.D56"_ .3R&K!0W-=>;&*,*#;;@
MN*@X5;!H#47;NZ7CK+/--1HJMS4_'-%6GS) B5D^T>U=.(1F&ZL2"+6S%,U/
M=TAL>[!@4+A#Z/KF;JZ/K"FG4>)<M1Z7%)19JBOR"SZRIJ_FQ:1VI36'C1V7
M']: <T<'&&EMJY$X)R$>*G3:G8PUQQ9?&XZ#%G2W]LQMLR+:UAFZ5!NMU<Q&
M/7/8IS;KWETFL>KG?):-<**5V,;?W<NUJB)_J_/W2OL=Y^4,%N(32LYJ)M4%
M6!&D"GE>FN=Z L+0=^S+8EF_5F2K9P'U-J.PBS";68G<UMCXEE5<5N=W!KO5
M,??&00U<7Z@J\*XB\8WG>_K+S-H]%>1V5/M*^BP4B$+W<5':,^3E*;3A!TLA
MV];/B]- (,\EUIQJ',=M79.+E:HF^/LFOG5Y</J_<]<1!_6P$4B&QZO78'!7
M[>6R\GOEN+O&CP60XXM%K8IN>;$5A%O,68$];-BMLW46WI8D9$-1-K*DQ45K
MT:WA-X<95Y-P-P1G TOO# Y6@7I!K:K<F%66SZS(1S5.5%BIVZ@+%[73]&)R
M:&_5DFD5@;!2G&W8O&C%[-FT+!AI,JJFG)V>5A4Y[;I:]L&JG Y!M*W9Z1R8
MRP$V53,ETFQ8A:ZB*9UCEH64?4Z[[:Y5TD5SR((3@$W(D!)L.BJVT<)V=]SF
M]=A FX5LDMH!@&=:Z+Q8-:=MIKY;W28LJ3TD*E03;MVBB^0S>4;FTR:/JJ-L
MN62N!H!PD'6KH)J**K<#3KYY(S:.6A<A4K.,E9Y5!E0C=[MI6FN4 7?U)G4
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M6E?]:_6D!>=2#;]J\Z&SC1[8&?P[/T>%;FAG60$21@=6F8_GNMWG#9H83K!
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ME"C*%&'&<)+ZL4_ +@U4(+PX\O&PEBXK"0.[KD"[!VL)TQ9[J*@IJYILN%*
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M'F$)PTH^S">Q]@4-F: &^SO3+>D.^_-!:P\63[( \$&'890HG3(OX"(R0%M
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M>)E1,3?+7E#XXIP7JN.UA8T!-4#.1];;V!G H'Y5[1$ HWXT5[I]6#D%R5+
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MI_X!^E_W]B^.]MZ?Q"H-$ZH8"8TG"8LX)2(2*9',XZ#:""H2+,%-=U8CZ@=
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M\.O2)9:3%/"6<XOPO-]Z@79VC$TYNH#PV/5?1LZUKGJ/J<RQ\#3(ZLK(H-<
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MG>\<]F(T#(O;_M:VHTCIL"C!V>J-AH.A.@_OY[:X&H+S=B?^H7J2^PY>&K@
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MF[=?4BN:V]HR[CZL]%2P7*M[FLJK\)6["D*]T87O]Z(Z#4['H4;2VF$O)-O
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M;M<,Q&2FRD&MSBMIN73C"ZO2!&45BC@:XW,X/\3>ER428EOO0G&/1>Z1$(K
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MG=?U*XVD*&/KB]+>UU;MRA9-(FPBK@P'+DS9DUKBL-&I96OZQL817%FF6MI
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M>>-,QFUN,H:=R^"SSHRAG!"/# [H>:'=G77;//US5]WV21?J^SJ>;X$79#8
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M'$P&UL& -#B;,:9 .*3.,YL'Y;2F/J=ZB35HFA=J-J0V:J=W$8]@A74@I@:
MD5D:%$?2<N<8U\XRS]?B\=-IQ+8NCI#53,'H9Z#@Q7K.2F>::YX9K[$7DC@A
MX,1_(W1TDGEZ276T?%RFO\S405MZ_81WJE\7(8MXE/BMWNZ\3U:QS<["DI4Q
MH#N:LY85JKS.6!=-#!$ >[!#^C(W9&%\)C2\(JLJDHFB/*['$G4Q/6B2OA<S
MUDJ]I**[BKEPT#G0].)1K;YQ24]BX.?M>K*XD=/=:7*3END,=R2B](KG)H9;
MA9S!)D.5P)+P8#%R) 3A'I):<!VZ?)<U_I7M[7\B.]L?V.[I.[J[_^$H,,T1
MPS2CF(-Z8*G.E.4R(\:30*GP)A'9+F *?$CM0+O<"P_*HZ"649E;0[4UFAD+
M"J[5> F-R!K^'TLT=JX^'5%L S&.9=KG*!*^DPRF!30$$@SQ6N3L_V?O39O:
M2+)PX;^B(.*-MR="R>2^]-P@PMW8OIX80=N-VP-?B%Q!6$B,%KOAU]_,JM**
M6 0"2I ]XVZ#5%59F><\9S^'F^4)[NO5#1"S@H1@A&>(8N8TAPX+:;GTVBL6
M,G$\-W$<'!XS2AQ'4@*":8BX$?^E:20.Y SR3@6H T[$<0=N/+MJT"SLW#!*
MB2G33M$;425Y<%>UQ;I5C\6R[1N*[W_ZR YE_7-1B7)3T]<Y$?%KXY?V/XK\
MC?(-FO>(?5;EKL6GO[3CY7=2PFS9\K0VN$S5O85$9MIVCPL6;MWY(GLS[EO1
M1=Q-'8CC!<<=[_:&J;A]&-<SG.9V/,T+1*5QDF'5N2P.:,GBI@UG;:4L-7JE
M_[%(1)W&SGHA^'XJ]B[]FN,ON781BYC$RW3WLBS?+^87IR[ A>MR7*"1'ONS
MR 0SQ7(&\9I^4<8["7L47QUW4M#3H%=)*PLU]]/"CYF"CTDITTVEF1/2F11'
M%5'T:B/CI_\<]\H=;^;X,^,O>_=\2F$>]'UD@2)59V;/BI"[\??BOVFL:'P^
MDW<ORE%3UO!CFRA+!!VGW"%!%$4>IJQE"954''N.*;[FP,>68&PM]Q93IZBB
M%"LAF75*2D]%S9LH)P"J(E!C+?4N-^FM@!M)^OHP@0WO4*S4=K37'M*@6-)M
M2N[71G>USPA[6-OC6WO^XNU(Z'7K^7O]JQO1;'6F&7^CZ,;_D,Z_-6FP>O_@
M$ISI3S7U%(%;(>/7>W1D?7O->J^!Z)OKW/MUWD;.?7MS2\LG;6FI$=*$<^*Y
M\)19*)V#,!4<86@4IV8-?7M7\ZEL=FO+B_C[H[.]@]\Z>U?O\-'9.WAX_AGO
M'WR&^Q__?79X]5MG_]N_XV<G?^\MMK8\C_<Y;Z'6QZ^DM7MTWMK]DI[!]G8_
MT\/SO;/X>W9X_I7L[[Y/!8@S_7O?7^U]/D8!"6:1!493!2B&&DBJ#" 6*\J1
MI)#"K1W:C(2W.9TM5\'Z4/RS*M:_*)M^N<'H?Q#H+[S_C3H#7FT/E\+\1B->
M<)@CQ;E%GM* G.'.8H-\,)@SBF5&O%HBWM=%Q(/,,,LA T$)#BBR'BAC$7!,
M\Y FW?&$>$0UQ>,G+RX'E^<!MH<IL2_*C0?)E_*"JFOE+2'QB%QOE%PCA5S*
MBNUCM^;5" $/4T\/E$HR&(4$&HZB_I1*-C"55M$L!.HN!*Z^_VR='#O$C3-*
M@L (BFJO=T!S+P D DK-&8.>1K67K$,(K)&1WN!DWF^^,1JV._&*PIU^WAL,
M&YWV]]3!5Q?%\HUS/SSME5WIQMG'XSF\HW&;@3L"Q&6N\KCLZY:<J6%1*E9D
M/W5[LST+VN/P6!5]NA80&(?XQF&KLEQ:G_C%!AOC7*I^>_#]>H?D,NA70</<
M=?U45=LOH]Q5E7M9N#Y993,%BG[Z5) ^2$5O17BMV*GYHOABGR>U\.VX%Z-A
M6O9X0'&OOQA+JT8TEFEMZ=OCGM37BO 'Y>:5\?.T'7&C4KIXLPQBQ9,:=2:+
M&'6KVH;AY62]*4JXN,;!-#!8O8HKMGLV&[WH4AVO+0KF0=GT<%J$/XZKS<Q^
MC@_L5MM=9@]4I?;6COI5-_G+\F7FD][+KZ?^B:Z7ZJ:*GN)5 'P<SQVW9*[.
MN@SU527"J>3*>-\M2X(324VBO<N)JN^!_Z$[HW&%5OS6F'=G&?9&[?2Y.'DA
M0%9%D5/D-9YG0:E]?Y%&9Z?ND]-HJQY,Z: LL"GCRY%44A&+FT:*9X;*VG;?
MCLX'PVKD:3JS*JA:#@VH;3IBGG3\;&E(4<\X/&8!8A\/-?7RHX :KH QE "%
M,)+64,84V]J1V_S.-"3;]WJPC/&>B[\F0^6O!Z/O.<>^6>'OI'V(KGAJ+-7&
MLYH3Q_[0_781/AX+-;V6C *K3%3"/ R>(IH*@HA1CB.OE.8$*[^842 M4LQ
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MU ,849'K^3:&D>LMLK-;8DU</!/[<]!C310##!H<I3+#0$$B@ V4FJ"(8*G
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ML25HS8Z^#'CK SPX 3S!O#(N(ARER9FGO8Z %QB 7E"(G6<<N8T#O,>VA=^
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MP@Q@G*((D,P!8[4"#N((C9S2^%,&R R0KQ @Z^=,S#'?];@,%V*^7GL)K9'
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ML .$IPBDU@Y(XPC@$C&BD4\3XK,%OUG<NTD6? Y=/!&;SX<N@D38<NZ Y\X
MZG@JLS<&,(N,U"X*:RYJ:*B_A4J*EYXA6[[\M:ZCN7/Z8[>FWD)B%14/11%
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M=+)>&RFX#\:11*)RVGEJ:4CWY%&W'16HX.FYX*D]!T\1P\I)A12."7%A#7(
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M)YHZXY2P6N0Z.02G5 %B60%QYYK7$JD),7&+'$ZY;5@4R-#D4(S$$QZHL@X
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M*U' I=+.!6NGCSH(;&7 QG(LO"$8=#2Q$*AV43S1NZAT]HDZ.^]%:"*UDEZ
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M1"8QAF !);;:2TU\)0T?11I"5(X)$Q"7#(,I=0891@P*PK&8K'$JA%\Y(>_
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M._IG8VT+-UL-"C]9XW"#;N;='" [0GE$J08J%8Q CE"+6 "M(\"G(H]CL@1
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M$XDBC"/)X2GP2_D\N\:6,Z&))LQ$KI,UE%&KA<02BV@,GF?7K^A]YN2BVOX
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M.A_ 5I9PFR3R.GC$A9'(RIB04C@J;4V@B2W,O7Z5(V*76E1A9X6=[P@[JS!
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MG[FNJF,%^X7"+M=:!^U,S'SG)'<$*L:1=7$\D*P>IW80  [MH #IN7'4+M^
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MUK4XUSC=<"\B=G_W3]Y0Q&Z\H3XVV\"JY$U!NYL"=E>,W.18S ,L':9:*9J
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M:E1<^>Q5KT%*B<$_P$XYQ\%EL$%)K(S%(2B?DMM;RU$83,#3GX9CKF8M%%[
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MV(,A@7EH$](XVX@61TQ%$D&$V2:,PHF O1(FY6ZRDCJKHY&**D;@_Z)>:T6
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M?]]8D:UFP8WS/_$P0V>_YX$8 /:^B!WSKVJOZ?:&+7_:[X..=,X!X?/V=5[
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MK+!C^WTDS\/;AMO.LM%I ^C'\")$?J^V*J_G>T5VCFRX/K9RU8*0U"8P%T3
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M*MP:BS,C.R+>[_ZY]0$1 WN']S#",I<Y]:8^F+'=@]GLVDD(MO;F5(Z#[&"
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M7  8)2<CCABC%'U V9..'/$<26H%X1Y80RKQ#5A^<G7]3W*.3Y[&6T[*/AL
MC,EM@P$SBT]V#@\B,2FF%!#@@$7<>8:T2!&%9(I8>,4T8("D=T& F2UG94#@
ML@@T.'!5% 2(@N ^Z" 92MP[! 9#0D8)@7 BS@9AH@OB;CC0*:RT<B!=*QTE
M12;G".:L2OM2"B"!>3CV(A%268;K52VHPIQR &K$FLZ.8C^Z\_SN(!?-6@P;
MP4;6%!N>PRJ<$^>2-,+9I+G+O5ET%7+)TH\>#I)_@.#OIJ(>524,^*,,:FLP
M.,T=3/;Z,&G5N-^PGNR?@UE',./8RX!B -[.G9/(^L215MX8YAU@*.R75*Z#
MW;UNYC2&O=:J&Y8DJESQ[[;PW#6(Z4 U!=AR0FC!170:!@.XCA75FE-%[XR8
M4_+P>QY0@Y'P)'GM0V#:*(X,XP2XD@?*3$  F++8"9FD=136GFW,VRC'$%G[
ML@\/^S$?HBB!ZKJZ8DX'][']HRJ2=SJ8)$D#I%25"18)D#T01!8+D-5/\"N,
M.,-&3F7<35,$?'4B8D\N/-\O=C[D9SGDNWO;;/O;]P.G'!-)8(2= TE2'B,C
M 45H])IHSC3-H5@AYU5COA026R_B X!1\NW/^NWB-ARU\QN,XS'M055S<,'(
M_U-(4$F]&<57=].7J0?Y,'J.-RP\7NQL'B@?DB?:(J$$19QZBISP"A$B63[U
M8HCWN<_CG"9(DUK=54G96$[FU@DK*RD0LS'W>BL:H4I)\WC# G%XOGUXP"*U
MP4F%N,\_2)(H-Y)$8+<Q)[DGE)6F6'.X^D@>3NQY<1N6G:;V )9<I$YO4/(!
MTVCG&9/Z4IYV4L1KBLI41:'OY(HLVUC]@5$Z_V+D6!-E<RW[D!CF8+4X8X.*
ME#A#@9F)N!S/X?@)YOD0*F:<YZS.>'S;U/@[W?ETX+ L#4T1,9@A+IE$VDB/
M%+4V"<5,S(W:*)/KF-!U0V[DQE56W(0?SY[ZKW;!^05H0WM1<XL0&(XT6&C@
M\L3*W)N<9AW3SL1HZ%+JMLT-BU2"](9%Y^/9]H4_ .$@,D6#@B$8")$$L\J(
MB+BQ@C,>F.#ZAFIMS:*NXJ+"R@5 984H2["HC!)D=(XX.$KRR0WAN%IT40,L
M9O#2FA@L-\RZ@#$VS+EHN:<D+J4*W]Q%W9UL?,W*:@V:*<%@L4P U(,18S%)
MR.N(I79!F2A?CKHV*SM96:F]3QYKI'4N[RL30\[BA%+28#M0X\6-93-73&<;
M("Z+JHP/&LN G*0N9QPHY +%"'.,E6?&<2?N5B_S'B\,ZW(NN:O(#69!NRQ5
MJQ1;F)0)?B%1@5'26(OPJ2HD]_#[$\(P\UQA$0A/)AI%:4Q8@KHPFN2H#SDE
M'(U^:?S^CZY#XX3VO:V?VQ>;^" P$Z0@'F%E--!519%6*2$#BY58)(8;6:(
MC(AU91;([7IP%$ ';9T@P4@9> ;QQ"VW *\X:@XH7H'M7,%IH@ +2L)'>A"(
M#T'8@+"UP(0XC<A2L%Z\]$*IH)VEP'&)N3DF,&G8V3HIQV1:L>QB8X?=C4&#
M<91@[-Y;.%3P0-QI0@6/)&%;^$"J0&#"'0)Y8H@+X&;6"X.<PP3^LBD0V+P!
M@S;4@V(%ZY<"!7.]Q>4TXNA(U_JDG5*^5BZI%7_F<Q^#4F\_5_7JG8S+F8VK
M_-CN]*&P!3.&N) T*3 +=(*].&B)A?5*1ZMP+A/8[([/+[&?S@Y\9)[FHNP
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ME5F6J(T<BK_V^B6GY2U+W,_MO2\'6' >E4B(A@02QP)#5H=<'L(K[8$7!F?
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MG1C^D:J^TF_4R?0V2=.OHS5O>-.]8/'3-&^2S#*E-4$R"C @L>=(1R>0BE@
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MX+@78N<)VZ?,M]2FVW6-UW\30/*X>JWIIP+&&@]6"*$9BHXKQ!.6R$K#D&1
M/JD$VNG];#\50S4S7 ;)A.6.,&U3!&(5N('=S3L_KY_*B":C$4VVDX4 L:K"
M2'$P+$WAYK3>G97H++I%0._=GJ\XY^V@[O0RN*47RUP,O'TB9GM")0^FL?>"
M2"Z%-DHJ1ZC#,>%(61IAYF/T;H&=9@-7N\VBS5LDWA#R;HU+%NVR<K_>+3=V
M6<$;1K-FL(\TV.?J7W/M1XEXF;UNKFWBTLS?G>9O/T-]A?H?,]Y?8UX_U[1.
MG6*][N3LG,.SJSWE-Y[\7_"!W]C$W= @IYFX&R=.+Z+!RRKX"E-W0PTSLSKU
MRVKSYI=;JI8MXTS]':ZQ- %N!KGP()^HP-^+T8R* 5S]^;D]^(Y2/Y8.[#&?
MK&[UP>1\@ (UY<'NGHLDA#?$:>:B=9Q3:;5SC@=LDJ0N67Q+R)0O+5MD7%9B
MRB&41>-7D(RM6C!>1VY277;B>&=OB^U<;)[M?_OSV_;>1_C.SO'^\<[1SE^_
M=KX>[Y/=O4]P;QC+'[-E)_8)C)MM?_A7>^>O[9_;>Y_H-OW:WJ<?R?Y??QY_
M_?9%['R YZ1?1*GZU1Z7G1 J<I<<13+2G&LL=8Z])D1PS(DH3EM)UM[A#;TB
M?2>>0W_^^R[$L,&<!V!.2$XK$6@(DG/.I'81&V^E2"8+Z&UE"QK,67W,V7D_
MQARCM!-46Z1,"H@K3)$A22-F>%!<RR0%8 [=H _NH=A@3H,YUV&.=<I)%34A
MA'$7A.;)"26#C(H;C=DMA3(:S'D!F#/A.9$$[)BA2 D%F ,[#;(&.\1M,E8R
MRQ/+.68;ZKI$CS>'.8T?YV[6:DY(*'6_<@A^-9P\-RS!ZDG=32D(][)%YYQ7
MS4'GI9T7G(?7(R'8 QD@#3K? 9V_3%NA6CN:A(A@A:I<W,'E9HA>(^MR554N
M )W=VCNY0<B5PZXEG^!>9*E1N*L*=R]#K%&XEZ%P4R88@&BP..:SO)XA[D1
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M\W9]'ZMQ=&>]UHW#;-!/8WZN30)!%T^$>_;(NZ!V>L59?!O<G>O+<7Y?'!3
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M1OCK0][$C\<9\XJ6=S?0F^O1ZE)RV(*69TT@B ?!D?'<(ZRTLM1BZ;3=V"(
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M4/#Q47"N"84BG"HJ-'+.:Y";""A;S  >$BR-C\1J&DNUR)?!\@HK+TSTS/#
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MM3?()2E05!9(($F2<$Z E2"T\#JYIM=+@9T".VM7*;# SE/ SHRRQ#$129&
MM'79&:P,L@P;)'76D87C2HG<5*7.E:YS_GQ@YQ:)^/GOS!BM[JBBOQ^DYF?7
M445^UJO$?-0\KQ]C&!8TX>1-XE093_$!Y8)NS"41/RPH7,G@JM*^B=ZL_>?2
M%,<3P"&Y&(SV5'/N&7$F6TZ(B=*+9#$>XP7\)H;MS.6"2ZT)$499#@ DC#0$
M3C/0NKWAQO*-K3>Q]Z5OCP];OO:V.T:'_+9KEOAJ@O5W2B%<'?J/A_*@"UX]
M\55K"!3G;[$%,\OR/GZ+L*!WF/^3U0OX%&N]X]BWPYBK\]]\ML0OG9C1>9FJ
M]-OF;W/'"\S!YR/F!/!B$+M7>M),2L_N5N,%S/@P'M1@5<Z,T^;.Q]/_TL^G
M^Y^\_/SF?6OWTT>ZN]-N >;3YINWI[MOWN)]"F="Y_7?C;W#=G.G01M';[^%
M-W_R\/]^;W^F[6_NZ/CKYUR/96^?[WYZ"YB_C_>/WO+]H_=PEC1;^WNO_]Y]
M\Q'&L7_::&LXB]ZQW9WMTSRN7;AVH#P3TF"/+)82<6P%<@QTWL2HDT+3$(W;
MV.IUXQ7XK_7C<:^?5[8VV>_:\- .:\=]V+ ^T!YLEA\-@/B -'(EAM :^!X@
M\VD==O5;;/>.JQ_ELA#9FQW[O@7,<W9> *+SOKE=Z\30\D"'@\W:[JA?\X>M
MF&KQ;Q 8LN  MZ66C_T:4+;]DE\%]XPI-.=>5L^.WVP;<&)R,;6ZMIM?E M#
M5-34];&J9Y&)M3IL[*3.10O>V>@-AGDL^:<P,?CE,?STX@WU6@^FEBM- #/"
MLT8)5@=DF>Z7>O7R_+M,PKG !.K8KWFUTJCK)\/KQUJ[-ZY* 2N7;_:]/JQJ
M9K##:,/_1K8_S-4L6N,E_ @<!O=^&.;Y;"Z*F%9@+$WR,7'&0V0&-$SOA16@
M?1K8^">M3-(#) 42JZ"QYDYK7RX $Y;-3C<%* R.]KQ$8SIJMZWKC3>G=@R+
MU\V73NS_W]Z7-K>-)(G^%83F[8:]2]*X" +M74?(DNS6CG58DKO'_N(H  41
M-DAP % R_>M?9E;AXB&1NDB)F)APBR2.JJR\SQ1[DXA.)ZGRBJ 9CV%]?OKZ
M#V4USIM# I#\,ASFBHQ%)LF&=03I:AU37:[#Q&J_]7KZP[?N,#I@>C2+?:3%
M+O?8AVNI\6)[DGSE#%C*P1![%U5;'3U2:Y)M["_1=#%INI@\ <C6TL5DK=[
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M;PIVE7_[25F"<LG;;L+9SS8+8+5_L.B:3=*=-_5ZN'#8KD)P>O-KJB.DBCS
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MABH582ED72[*YIW5\Q$:\WEB)9X5$N;-QK-:*S !#%EAH"K/&\"#H'.K![R
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M_S(@K,LIJ2.:(LD D*QP3&L>6-&^Z(A-A/SJ46\G>VO(T?BOAAZ?-SW*]9A
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M%_X=.FY='\8H*QMI*@1I?4!>T5)N/>$7JO'98LSZAH$8V%YSEXL(K/EQP:
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M/@W4V9;IW0>X'=\-AD@G\\\H[7+A!#D<K0_Y:?3E:N!3-?C]\OSTH%\\O@*
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MD/_ZXQG^&8[)*>.+$?]M\8<_W0P<_3">#^?S?(??7_YY&60##/#'#$8)TO(
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M3ZD/V$[ECL/M5_)WY]O.9!U,\97[OS""Z*]-Z,%PV,U?T&YTZ">I&U_X:9$
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MN5#7$AM*<: 1,CB@W(HFO0Z> ]9DXH^^P)P"\S%S8I7UERV!LLWEN+?(V?O
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MT#<4-CI&M&>>2!MPW3PKDI)!EU%P"Z[)>?0@LJ>A/W4):A#-65,H)Q*X$-D
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M4JP(VK+$D0@6M%94GZR_G"9,M&=D!\QT8D@;;21N68XF+H/#UX1'QET0WM"
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M0&/66N4)*WW!@<E@=)?*KGTD?KW^R/5Y7T>TM3NI;MK]E1D7A..9J.A9:;1
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M27'<6+AI,M=O ZS]7PCWJXLK,@F:T=DB=KBAP"ZC+LE(%H.E)-'@T59S#JU
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M&:IT]]! 4;>#-J $]\L)]NNJR%V/?5HJLK7@&T0 []WA/'H[R4M!8HPH!V>
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MY.YZZ1- %%_0SWB%4C@=G9=/O>$)+.Z+/HWF4GDS&L]:(4Q>?/^$#YGYK#E
M,HISDLHD*<G1/0@Q6$*1$9<=,]0WVK4KH-]5K' 76G=+\?MFO\F.O?$BRA+F
M;G671;3L1E!E%;MI3; #+:JGQUNJP-[JL_',1>T\,1$M*"F%N.Q.*SQPQF6T
M5#>98;['>OQ 0X-#4>-UF*\?[CT+:)(E3ID]^N_KVN3KQK0VE&Z$RBM+I$4)
ME2F3Q-.@-8,HJ>I8K7KO<W;AA/7.W*B-V&NW^_O'ZU_?O/Z&5M%@ @AOT0,A
M2EPGI(R6.B"DH#.Q*24"+/FL'&@KNFG"W9__Y#2@@IBKSV9\^8^/1_^X4L8%
M(A=*72LCD,N4NEDB-->19&4X9*E"7)ZSO&H\XUT?_^1XWU[(M>L'[IB850@8
MIG>#B"?Q=8.^<L5TV0[Q_1>/?D^$BVF90CUY.XRC\7GYAY#PW]WY.Z\OQJ-S
M>(=>$?[2?-4F!<EU:7N>N"<R4DM<$)D8!<P88;65W8I8=K:$)Z>^CT-9*F:J
MKKSVYU($F:4EVCC<J3UNTM9J0QS5',6K(HM=+E\>7<;4#J,@5;CH;8QY%U!/
M+4MJ+:(ZY<IL(N7>LJ28#-ERGP@#RHFD6:(U9RC!O^'747MIJC6[W_,LJ?K,
MKR/<O<N28CKJ@ (AP7I&I$J4.+3O262*L2B2T,MC$ X\2VHM-NL.WUF#BGV\
MB?\X]>/I*US/9;M.*X!&BPXD+9Z$L@HMNY )CT8)K7)(J4DWMKK+>(+&S1[H
MPTJS>4]R $^6LEX;9P&>L-WF 2XO=RD3T(!EUI71'Q;/59.L4C2;D'R@V0FF
M-\\$Q <_YP(^YP(^YP(^YP(^YP(^J^ES+N!S+N !Z^YS+N!S+N#C=!2?<P&?
M<P&?<P&?<P&?@AX_YP(^YP(>9DK%<R[@<R[@<R[@4^3].1?P.1?P$:OOXU"6
MYUS @XR"/.<"[EE"V',NX',NX,Z8?\X%?,X%W)M<P%XF_1Y-T/KZ;QA"]%=V
MV-$IKJ4,DAT,7_IQ&HR^^DF9>8QK3L>E@^GH\_?ZTWZW1=)PXF]5(2TW8G/:
MLE"&HTLKG5169!E4SMQ1X-'R55-_M\6TL_CT]74M%P'?PV )]]:6"8>&!*DU
M@00L64DC+,\-W'EX^EV52;]; /C]HFPPQ_GXO*C#Y$3[B+M)U 2=KM*;$1=L
MA4<OGUH%5%J;9;<VF?4P/2H'=C-M_.&TV!&;M8.T6RSC-_]M<'9Q=G0VNAA.
M3X24*N,Y1ZCWFDCF <TR"(1198P)5CO9+:Q;"]&S0O; 9&USN,);]=O@%";3
MT1 F)S;&P+R4A&:#+Y97GEAJ@'"E+><0LW:VKVWR&M:S8O;%:>T ]Q8KN=SK
M%_<T;P#*;#0:55+$A#(MV$=.O%*X+IZM8-PP]'%;*^<M5,^ZV1.C%0/+VR[D
MM1\/1Q?3]_Y[^3W\:<3_X'LF*(I5$FD2_D%U+A=)^%5RP#173#G=6CWO1/:L
MHCTR6W&DTK:+^03CL\'07R>,GRBOA+$Y$&HU)>A(1Q)0E"A<$QE+CCG?? >]
MA>I9/7MB]+9JJEVIYH?1=W\Z_3Y_SUY=WA$L7C=ILZ+.4J(R1\G2:(G/3)&L
M@F<V,@N*M=;2^P ^*VS_/-_67;T?NGNU&"X43<D3:D0@$FPD3@1%H@F!&^EY
M],U/_SN1/6MKC\S>5E.S*S6=W_=\O)B<7UX<SD\,QSTX9SF!'&A9#B5!:$<
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M>-E>3K#YF=E/3&9F4//DC572.&=XY#;)X#.6DNQ(X>8!1D8M ><EX+P$G)>
M\Q)P?L' 7 +.2\#Y]*X$2\!Y"3@O ><EX/P:<+P$G)> \Q)PG@7WLRY@WXSN
M :-K3SZF<9>M;LO;B7E9DYB17!4EZ)\0?;#..2&*L2B"]$]UV-K[P!ETUQ)*
MIBRMHUL\DI,:O *L=_SHA.%2"&[8W"9E#1VRZC4?6V..C)&^D@P<E.6)]HBH
MP1KA652>7O"6@;Y7,/&\#R*'F'C>QZ+S[L-E;48E6((LL58L&%5;GDOP63)K
M4<?,FK3=?J5]N(X!ZD16/ZW@EK0Q1GI+P=E0QYN2[EV@+V42VEOZ;6S5]_ %
M![>F0EZ3 %<?!,PV(-!E$4N JV%DH!>*FD0&#H' ;/',/,\ATY79,=J25"H:
M7$[U+BU$]LPHG1OQD6:+XU$"7-/#N(_E1PIP):FBR@G!VL)(*8K.J$)G5 DQ
M"5DT7=_+<S&,4PQP];%4AP!7'S5/'^ :=M9?F^A8&QD;A]9&4.Q.7(X[Y$)A
MC)E;E74FKU,R5Z247EJ-[*FX7!MI9Q#44UISJ5,$07L^*!L9(!8/V043#;-*
MX,D&]9Z>*6B3Y9;9"-QP1?N45!!2YL"Y%_3]%+0;K2?J2Y_\V =E_28_]K'2
MO$-RR3&A5490,07Z)6CPM0>(%8&<M"R5]4U&+KW2D-PQD)S(ZJ<5D@LQ&Z-1
M I,LUV%"&7SQ&41)21NFDY5I9B?/287D>B&O#>>L!P)F&\+HLH@E)->2K-,'
M16TX9P= 8+9X]HFS&!R'K%2=B"P]!&X3>(]%TSU=H9Q;IN0D0G+3P[B/Y4<*
MR2E$S20IQ9HD09F0P!6T$'TRZ$UFV;#G B<G&)+K9:D.(;D^:IXV)/<+R?[O
M]Z2AR_QA%=^<GZ]J<&6[NOCIHN1*J+_:_D!KPVW>XD5Z6_]P\R^,D=S^!L&W
M(:1I&&8;7%F[HR1=T-Y:0H_2R@N/#G- ;E AP[1_E.00<LT@=):849FK0*\)
MG6A*AEJ^P2S47HI):$WO4J,"Q>E#9S]=Q$TUT _YYK\_73P=IDDBH/:TN?@B
M$JB4([A@)43Z)6DG55#80E<]Y7Q1!\)A2-SU'5I:LEUI9R_:GE.<]BCI@-$.
M1<>;4B1\'868D*,6GM.]=R%B3@7 UA9M<-/Z;;...:=ME?FG[?;JNMQO\QYK
M7.;=?Z[J:^)E0*]E 6&O&7]*@./,@P@Y*(6)FS;1K>=%>X40&]A>>SNA''CY
M.4(_=W^5OK]:IS.OA"'WW0*/2=$JB@9O##GRT7!F1 XQQ$[WI<%$>D5HF]"6
M#Q$YP%"A+HT>T$HFE=00G2$A!3. T6AP3#FZ4'++8J.B\9DVZ9C'83J@U1Y"
M2TVUV7VSF-MW1*JH0Y0(W%<_0/,"3C('V?!8BI7:\&XC*(>4ZA7!;EJ+/H2F
MG@J:O^#?JT]7G]Y\6E]=7)XAJJQK ,WX+(%\50:A<BR9%:5D46**S6'YG40+
M)$>PY$,XFJ8,I;=7GZ[.:4/_*[_%R_CQS\]OTO_2S]3E_;&^/0C>?JPK_NGB
MW?9R]0DOR=_=;:IVECG:G%( @;7WB(X,7'&!U%V252Q&\H5'YSD-L[97!/NY
M(N;A2V&/YEQ=W]O>7Z[CO[\;QOE[CIF6EGZ]^$;B,^7JJ-7DH!1/(I:,$)A(
MD(N2ULG,PNZ5:"!:51\I7R%0VUGQ(>3<\9>AE#]]OGD#\J?5U:<SD=$5R044
MF0PH3[]@(A?:RD1OAG3XX(@?ZN*S(\DKA,YQUG@(#]^62!R%R*DH!RQ6X9P7
M4*GG((M();E GD234."2Z6AEI4="RD<G-@8[N'_)N+W:Y#KX>OUAD[?;,QVC
MLMYP*%;5(8(L@M-.@E.A8)'T?K3I^MUN20MZI\+'(] _.ITR(*DU.AYCD1HX
M2PEJH1GXS WHX@3Z$&4Q32XSKY1$?Y0#.(W5IR;17\<G'@W+WK:>B]D%SH!G
MY<G1]1H\XPK0,)<SD]IFTRETM/<1)T!=[V7O]>!Z'YK\^'CG^KM^EL_+]3B]
MO \NIF"!#VF09VU\A#;'M#8RSYU6M65Z*22?I).8&U8G<SB#@1FSVP]A+E;>
MPY&>PLA]E#BX<=_^ZU'1;HFV6,BGDG6[8E'7H?*U#8ZQX%WR,O'(G=?=[/OD
M<\9SCX<UQKJ-)@>DH5V+]C^_OWG_E&PL*V90D2\DR!=2KGAP61I(.FFNA0T\
M/\LX[O*@4S#SD+ILP/1Z[-;U#]RNMO7ZM(J5EE;WL1AS,59CW;T$25FI:!$=
M.20QLB)]<JY)[6XW\5ZIQ]?0A@,RP+I+>?NJ=9&S9<%A5T&GJ2EL8>S>>#K"
M4I/L8;?RJL)+[58,W"3:Q+.EO;:VYT&AN7,J1\'8Z2'JF>J^.0&JCX&&]FS_
M_$RZN;C\#;_4_?KV="XLHJ?5@>6T&2L1.: .$2+)(Z7FP2K7R=-Y[-/'#_*V
M,<1Z2"T.[<O^LCK/M-"+?"O2]DXFY%9GEL!&F4%)50 C>=H^ITK%4HQUO(GN
M>< I&G<(7;9];6_SI6^VVW5<U4F*U\JH <Y/G]?DC.7UU?8F,4\_>=/QZCI#
M?W?I<MZG$#U$97QM!4?W+5/(Z@IM"2(X;[MUR!M2JE-$TF16&[JTX?N%/'X-
MN!73)D/7.UF@$%9(3"0Q;6V977Q2F*22J5ODN_LS3Q\Z@VF\287!$'T34.<4
M49#HGM<V-LF1XR4#&!DJOKG,:6XM9$^JC= Q-_/Q$3 O&'_3TJ'+(I8V0D-G
ML@]%49/^*X= 8+9MA*)"%KED0&OAM>&_AE!D I:]C\D4R^S<FB.<1!NAZ6'<
MQ_)#WW:N.XO<-QHAQU#?NCI19)V%8I"]$Z L:<1S+2&1P^-ET#&HU.TZN^<)
M+XJ1=JBUUD.K>NAHQOO\&6M;F:^]9JJC?2WJG<]+BTO.,S#&QYHWC!#HG2'O
MI:C@=12Z([_FV4>].D0,J_P&M(OM^@+/ZU"]7W[_YYOOVPK]]O9?WS<KND@_
MKR+MW%]7<[^8]Q]Q\[GJ>/WQ4WZ[WGR^F]SHG>0HZ)[-"WG"/.7*H&0@M&&J
MH+32=VM6UES45P?->1E_Z" +R?_^S;_N9;W;ART]-&1ZV=AUE5:]W2/=SM *
M>N<\+R[Y;G!\[.-?'X2.5O* =\^CBUSO(M4WN2OIA4G%0_%*$78KBS<I4DQ@
M! 5./B3O%M8=2J)7&A:9SJHS:O)POXB[%[;#,GH18(>3;0*^[#3H&!J?1YAV
M:+=PP.5D6Y?C:T-62U?OK P$)R58:[64A@4ONOE_<T?H4US?DP)H'XL.#<QO
MTS5W8MTEE$VV1LLHP%AC2"[OP3OZ72U2U$&KS$4WU^Z)AXQ,+IW*:NL&*A\Z
MJO%[_E"K^]:;+P_$BC+;)!0'GVB%JE@-R&C!(E?NB'+&NJX-W_8]XQ4"82"%
M#[TEO%U_^E1[=^/Y [%2"9B,EZ"SR+14NI$$IP3P$'.=O(LH0B<<['_&*\3!
M0 H?\+Z_W5S6;I;I*E[^NGF?-W^MXNU$3\=DG7E%%UE&N!2N0+#U7LISS-PY
MPW:#3X_F6^CSO\FUT%>[>99] KS2*]L@]ABPC]DW\FQ)$;<2;>]F!W<0JD>2
MN0]8'DHS[NUI&$,]M/I 6A[PJ'A:."-+#() [K@CM[JP"*%H!"Z#MB9%EGB7
M=DAS-/V>:\F(EN^CW.&=@V\CV%]WO=OSRC$32XH!#-;%>N\ ?;10')?,"N=2
MP8X.PE//&<])&- 2ZS9J;-#]_BU^7EW>I#'>KK>7VU_+GQ>?-^N_<B)5T*EY
MN<K;FX;I.=5FUV\^K>E[_^]Z,?_X<OLS7W[=T._^-\?+Z]= &4V^JU%01'*@
MDJSSF.EW.@EG7"E9-FI/-/Q:7JD3,A=T-&B >2O*W9RB#L*T),E])\U$]6U3
MV_AA:_TC#=1F/L,W0@E=!ZE)NJ!Y:T %I.M?$1X,'1)""\U2;M*C? 2T/%>[
M-FNP]+'+R&R06[_B[M"/SF9?O8<2:,E,:T C+1@ET92DF'&=>_)T?NKX"?8C
MK-.#:W&X:AOX4^\O\?+F6#['[?:V'>DUS)DG!\]$$D>%.A[:14"I P2'(10Z
MH*5OTS9VGT2OW+<9QE(-NA%_*\_MY:.+1$TK]!^(-(VO,I#-=KW<813>HM#^
MH61&N:31:I#"(IV6RA/DBX"L+7J1HO-%OF0(/.. C(: /GIN8/GW>4.NU'\_
M6GX9-4\J6P918J8C+B@(N3+."EJ.C F_2ST?Z"39+],$=8]'FFSW-!A(WQ,/
MLWWW^]O_>;O^]'F]O7[&NM!A^<>://;=EOL-1M?V?G;+0;7'*6)G+"V3/*0D
M2_!**)T32N6C=T:I:%'(W1C?$5+,8 @M#T7&Y"1((\F!EN1 .U<),Y)YQ1A7
MN$L F+S.ZN>AAM!V&W;E+:=K!6G(UG'J*@@!(<4$/C$OC#2URV ;#9WNB+(^
MJ#ML1%D?J[4(M(\P1B6%.GZ-6Z"U,%!X/<!="E!T A96F)2X#-YY,;">&V):
M>+G#A0*\%YB90"BZD/MO2@ OBP3C"W.A( NRR;WHE?9I/P;8$UE]ZC[MPY9E
M*PPI!PQ@A/7U4H(0@I(06.+,V)!9-#-STTZJ2TDOY#7I4M(' ;/MZM!E$4N7
MDJ'W\4-1U*2]PR$0F"V>L?",G"&X$LFA"H&#=SF E#K8K*15L4G?YAGC>)0N
M)=/#N(_E1^M2$DP0F:ZW4)(GK]Y'#T$:!*.,0A1*1=ZQZ>:)=2GI9:U.74KZ
MJ'JD^,(C78653TQYKP$#TW3AJ[U4:M*DEBTHRTC*C&.%"$ZRK_PQ?F$#&T[9
M5[Z+G$M?^2&-?7 ;\ ,L-65?>9N<C?1N018UELM<HMW;:4@A&%/H\!>I203^
M%/K*CP*H/@8:I:^\N$[A*@.1U6XZPBGP*1HP3,L0?10Q'])H>O9=?WL9XMF^
M\GVT.'3-<I\VQ(YIS^GH)V>.W5!!:+4&T 463)2^Y$.&"+S0QL\#06 PC>]]
MW\>C2#R:@[]<DQOW4Z(?6I553H]F$;>->!/'"]2:3#&PRG88%L[KE"27/H6D
MG/$H#3>:[O(B<FV#?))A<;QH([ &WOW].<?+G/Y8?:(?^;6\I^]NRXW 7],J
M2EC#4J972%6.-*/7U&$P0/=*S@J22MH,UAYN">-0,*P.A95,MVNG:_.,&,'S
MG,%%)12/6O$VV;[94C F0>!A1(P^MFL0*#E:5S?W?..$"IPS,*+6&;@@R(WF
M#J1G,18EZ=<PRS=UY%SSRP'FL#8_K6QSS%(;+<BA,Y5<;72AE;,$S'-E<LS,
MR$9H?\'9YBE0UR33W,?ZL\W,=5G$DFENF*+KA:(V@P0.@,!L\2PK.\];#U:*
MVA6?W"B,GH%(FKOD"HMV;F.*3B+3/#V,^UA^M$RS\0J-D0IX4:06Z<@S4[4H
MLY!+'WF]UW?K&WAJF>9>UNJ4:>ZCZCE>H-Y?XN;RASK7H;Y/EJ%4CDNPO$A:
M#?DX3I@,T0?R<DS0*9197J2^6\:K]C$GP\/>[/8+"B6?[>S5,P@FG_'YAY-W
MU;834-;!QUQ"2B)K98Q!YXK (J-Q.A"@VP:42;@EI+R$E)>0\A)27D+*2TAY
M"2DO(>43<O>7D/(24EY"RDM(^37@> DI+R'E):3<+:0\7M#MU@W"BW2CKWNW
M**X_7-0VH8UHFIV?VSI\=I@"=F-D6#*+WC%TF7P^%9@W,=&.(PT&B_S)&%EG
M"6;0TJJ8F#'S0ANJJ;W[48*+AH.)D=,_V84XMW-MZ.!7;<;\&&/\IEESK0W9
M;C/]D_[ O\^<,=QK&8%>_-HJ*23 D.@]H9M"5(9;G5H&(OK(^J*V\,,0N2?R
MT,RB+;HB#]CR-SL75#+@$B?-*3H T3,-Q1I6C*-#RW092]4;FZ^TS\\Q0)W(
MZE.'R?:.!S)!*?I70%*<@>(8P2E;0'.1@G?T;^J287C5$]7ZX."YB6I][#'>
M.*T.0KVVB6J]#-5MKM8!6AX- L*+K*P)P.JT!*5J)PFNKL>"THW-1FO*T),7
MYSI1;7C+]U'NR!/5/-VTF>(:I*\YJ6@$G;6TPY4L9=8\"&/E<[?7%S11K9<E
M>DQ4ZZ/&)LG@(4*"+J8@&4=RV-&0<AROJ4D'.J+GR%4J96GO-S-'8SH$-.CR
M,DRDLLLBE@Q9P]1"+Q0U22T< H'99LB<*28%$4$K]'2V8(: UH"7KM:LI^1;
MD<1FB^-1,F0S@'$/RS?)D/V"7\C/\_=A^+O.&T:B=SR"D8GD*D55#YDPI*Q4
MHF#4NS2:IY)DCS_D1059#[79@SS9  H?N@?._OR=2:S0X\%959L/*DEN="BT
MW"220&<4Z];>Z-12I<=!X%A5#[T1O,^?<5,+)>YS<37R?X/6VRZ43$0;F 6;
MZ&:ED&[-B%R \%:8Z$V.PG8"PK./>G6(&%;YTY:N_/;V7^_?_&NB25$'/+QA
M/OU85>PFU5WD+A5/_HI1.F$(/G.K(I-9Y>+COJ3Z 6+,IL0D&6L31ZPS[!&4
M% E"LA*RB(@*,9G<*%CQLDI,A+4B>5)1MI&\6#2U2UKVY,I:G90/@:LFS7=/
MO\2D#P(/*S'I8[OYEI@DJR//+-:.C73X><? <:]!J,2"##S[J&;YIK[4$I/F
MP!S6YE/GSH>-&HAZ!&- *(G\/;JD<;JJD:MNA(O!2N_H_S.+UDP?1)\"=4T"
MZ'VL/]N 8Y=%+ 'TAI''7BAJ$GD\! *SQ7.)/CFC%83():CL%2#C!EPI7DAG
M+?=SVY)/(H ^/8S[6'[HN-G-Y7HWDDL7<Z<T\V!\)2 DRP!3LH#74YVE<!F[
MQ<H>_?B7&A_K9:?UH$IN<&_J.!3!9>UD;5C.HTJ@N*'70WCZ4I7(, 4;59,*
M@7F/Q9F!*]C ?@W($IU[\7>1<QF),Z2Q#YU@<HBE&GA=G>7-6N@2N )3V?IT
MM%MPZ#+$B(P%$C;K)LR$4QB),PJ@^AAH:/_GT6$NA39A)YR#$C2"*BP 6LX!
M?8Y2",9<Q$[NSPL;B=/+$,^.Q.FCQ:'I -\+]-LF?UI=?7JSW:[C"NE$OM9$
MC<]]^KPF'S"OK[;OL;(CZ2=+WFQR>G^YOD]>>I>Y\-&!9)Q> ID+^)@M&"FD
M<DZ99+I56P\IU>G#:$2K#4YGI^^N(IZ_O_K\^?S+[WGU*5QMMM\Z_]Q+[8(0
M(!RWH! M!)<5R!0Y1KI/9-]M$-.SCSI%H RKWSD0#N8T=VDHB9I3$]I.7C+*
M)2.X]=$XY84-UC'4QF?A$D/GG^8KG-#H)>^LDB6YNHDJ>I>L!&^M Z37,VM$
M$2;L_S@C$@,A1.M$^Q<Z9FI)%@.,QH-&9:P516?>*()[ZB2&/@@\L$]F#]N-
M%(S[>85A=;ZZ_/+VZM/5.8GY5WZ+E_'CGY_?I/^EGZF;S1_KV^6]_5A#F3]=
MO-M>KCZ1L_1KV=U[:B\E)@0**"[2D9B-@)"U 8\ZJWS=63J.=0\>>&VO%MQS
MPTV3[-H@H=9Z%PU><6"B1C**81 4)M!<96\DEYE-QS [17Y/\SU[6)N?%K^'
M)57[516(TGM0%AUX'32]PLA<85H%N13)-DKJ]$)=$WY/'^O/E@_191$+OZ<A
M,:(7BIH0(PZ!P&SQ' 5SSFL-D>5:'>4*^,(B)-HF!&T*CO,F[;EFC.-1^#W3
MP[B/Y<?A]X0BT CA@5O+R3>+&5SM8B8R&IF$L$;L8/$U\'MZV>EY?D\?)4_'
M[]'&1>=R E=L(5_=<PC&62@J&DLZ2"*(A=\S@2O8P'Y3\GNZR+GP>X8T]J%T
MC$,L-26_IR#Z(JR%[#V]9(P.>"Q> YU44GD?4?!T>H@:AM\S"J#Z&*B!__/H
MWGU[1C-I3;$6(=BD045?QV-Q ]I@DJ*$))!W=82>>,Z,<_"]C+-NH]FAV3__
M\_N;]T_)EJ*.(8< THA CAZ)Y4OAY)EQLHW3T>5N5G_F0:=H]B%U.P'M)LD4
M?;! _[6TWZ$&GPT"6L&8$LR'CDU 7C+MYF#;#ZO? ;W1FPWI,51>GW(Y:N5,
M<6!0TRFG% ,7K0'N5(G.*Y:P&]EJ[R->X3UE0)T_1((<'@EWG+,.<CU^#^F#
MB2GN$D,:Y%D;'Z'-P5V\)^1S/%A?NY%I+A&48ZXVZ5<0BJ7-CG8]$G.>5M[C
MWT]AY#Y*'-E_IPN*%;E(,#K6>4^)CC*>!60;+(M>9:,Z%RK.PI$;UA@]_/4^
MFAS;7^=1D_M@-0B;JD^)A&H=%!3G:+W!<X;F9?GK[<P\I"[GR.9Y?XF;RQ]J
ML[F;^B3NK=$2A"^5Y$];'29:ER#()E,RLK+CV<V$U?/=,EZA]S@#/#Q$MWIY
MM/^SG<OT'(C_9_P%4/]W%;=#_L^L>%(8TR$595()5D15?##2,).8;DS^)^D6
M^O]"_U_H_PO]?Z'_+_3_A?Z_T/\7^O]"_U_H_Z=^&U[H_PO]?Z'_+_3_UX#C
MA?Z_T/\7^O^((86%_O]R7,&%_G]"9.V%_K_0_Q?Z_T+_'\TC6NC_"_U_H?\O
M]/^%_K_0_Q?Z_T+_7^C_"_U_H?_/WW]?Z/\+_7_^]/\1"=+W'DY<?[A8_;^<
M6K4[W_N@YE3F;DO<X2>S)$U4RL54MW5!YLLF:4OOK1.N6/XT/WGO(R?+E/Y\
M3QPJPD21B@>N[?7UA -JKX!;[3 RLH$I,TN4_CPPT?A'VB@>N\Z]^SN>7Z4:
MO-MN,_V3_L"_SPS7TBE9YZHHNG-IR4A?6)--3ECGDS=>-V2V]9'U164&#T/D
M'BI;,XLVR!R^CQ]SNJIS58[)JUY?+%&6Y&D[ FXB)\T9A"!E!NF2QB"RB:9)
M;'ZX)8S'O)P8J!-9?6K>Y79S>?;;9IVNXN6OF_=Y\]<JYMO42(S!DLLET610
MQC((*4FPD5Y-1!^U[K*MTN=_ UOZ:A>R^P28*J0T%0[6 ]ICP%OH-_)L21&W
M$FWO<Z7/"]4CJ]T'+ ^E&3?<-(RA'EI]("V/!@'A?$3RN4&S4E.HHH /18$6
M 76,.5F67ZCI]\2@1K1\'^4.GDWZ[@+U==>[G]Y<+..N@$W7HWOIER"2K2%T
MI$4GCT(^=R'M\)SQ7.8!+;%NH\8&ONXP'%.9D',?21MT(P<5:3DH<ZV3DJ@M
MDZA4$S?W19=;3.QH3(> !C2\80BP71:QE%P,?7T[%$5-N.J'0&"V)1>H7?$A
M&C"Y!M&%]#6G$8%.EJ 3U\;F1C6?L\7Q*"47T\.XC^7'*;DHUF/A#H%90SIA
M/(!+*  #"[9P5I3KYBZ>5,E%+SL]7W+11\E[G<D1DUO_P/.:I-NNRP^W ZQO
MP\6MDES//K!YLJO?DG>27MQG5I)6162Z'H1Z-T"&)08EHG1V][+1]]$S2'XE
M%W1TGA"<ZA7:)E:KU0H$5-QRQGS1C7K(3)_\>K*9Q9D3O"X^TD613A95:*N@
M&ZF%8JTA[S^%P)IT>GM2JA>U[QZ&LEXM1WI9:=ZI*^Z3=(@(*+0%%:RG.Z5%
MB&@\DH-CM>(M\/9*4U?'0'(BJT^=NAK6:?=.&RV8A&2#!.63 .^\!BNPA*AR
M*6)NEZ63BF'U0EZ3&%8?!,SVSM]E$4L,J^'EOQ>*FES^#X' ;/%LLZ_M1QTD
MGCTY5#:!,W3#Y=P);YB(S*M7AN-18EC3P[B/Y<>)866TRCJK("A3&V08<NZY
MR\ L!H&*R1S"ZXMA];+3\S&L/DJ>-H;UK[PA=Y9L:]Z3EB[SAU5\<WZ^JC&6
MU<7;+]O+5?QQ%3;K[6H[?#SK@(<WC&T=JXJ=.)?(.D:)3&#P2AF.5D>;6<Z*
M2^\Q[(MS'2#&#&)>FCG.0W*0>3"@(N>TU7('I5B72T8GRMRRYT?'O*XW@",$
MN/NK[RIPZK%(/[!:)[I:UDK/,^.C*9$N$W2*!5*I4N!16I#2YE2*MGR7D+!G
MIVXFXHO:[0_#ZG>;_3QLW81!TY_@CM&XS)($8VI/MI@S>.LCH$\^%9E1J2Z<
MN:5D85"<CF71H9W5(Q3V&WZI/_![I@/RKYH/>O1-.^-".!YI85X(45NY&7#"
M2@A&9/HS8UQXUH\91]17!-<9VG[HEA9'K.Z?5]5LOY:=Y6S/)--2*X[ E**+
M+7,,,.D".0BIC%$28[?F-PV$6] [KGV';KPQO)-SECG=?%*,X#.SI-O((* S
MH+FS-F<L*C??>I>]=@[6W3NN:WRP_H)_KSY=?7KS:7UU<4D*#8*6H2%'3@YX
M1EJ.404<6N^MY('STAJBWTFT ',$2SZ$HS[V*O7;9DV.<]I6S_NG[?;JNH'#
MYCW6_.*[_UQ5?D51=-TK(4!0@H.R)='NSNG50<92XIA,:)*E?5ZT5P2Z1O9Z
MB"@SU0;W1]Y\6EU<1Q=O=VH3C=<Z^5K;16Z%X8K>"A<@NV05RXPGBZTWN0=2
MO2+,36O1A]"TTYV]FW_GRQI^^/QYL_X+SQ^N3$JG68H9 J^=UP4F\BJ,@)00
MDY7&%]TM3]54S 6\4]G\(9K=.!,BM8M1)LQ0@V6U/T, '[0'PXH)+%F1S>N:
M$#F/2.> 5GL(+?\29D-ZC8)[8\$F4MU-WT"?)1CN=:;_669'ZZ%^ K,A)X;U
MW!#S2,#_N(:! T0B;H\-%7.]\!DH,9.:L](0@F60D86<;*('=VL-/)A(KPBO
M$]KR$4@VF5AQ_]H]Z+AWEKAQ6!0'SGFI##,%/HH"+@09<RA*IR8S&ON)^8K@
M.((='X%=DQ$\W^SVFPVI[ P9XR7*#%F:""22!+SNX9&9I*U:HMR]OH]RP%\+
MMT#L>)L] JR#4SF#NQ&_9-Q>;7*=0[#^L,G;[5EV.I6D)#A3)"BK(@0C/;B<
MN<PE9>;LK/W-!TM:0#P5/AZ!_L&)H09U/2(%+Y)#B$R0HTR72?)*>(2DA=1H
MHS&YR3'_2NL(CP'T1%8_K3K":#@7FA5 [@0HEJZ98 B%6=1<:^ZP43OBI8ZP
M-_*:U!'V0<!LZZZZ+&*I(QQZ'S\416WF-A\ @=GBF4MAN%<)&+(,2NE<>XI+
MLF;DT>O,DUWJ"$\2QGTL/S0U^[X,Z?N"I8OT\RJ2&?)]Z5*]0]Q4+_WV$3>?
M,.:KRSIJ;OO315QO/M>_F!/]O4=_YMW59OTY_[SZM*(?NIN^K1%S\0Y$3 P4
M]P4<4P4*%Z7XR(7';A4PDRWA1=TH#\7;^L6!I4$)3<=AO2YDXX7(8*T+H%P0
M$#!$VG2SQ6BBC7JT#DCS&=4^$]>Y@0T;](GM/".TBYS+N/8AC7WH=.U#+-7
M2^TL+[=::,<3<%L3QY$;P"0L2(<*L\XBE2:.Z+2(&F9<^RB ZF.@H?W%/S^3
M;BXN;TNS;D]GF[6UW'O@R9% HCCPR7'PGM&YS94IJAOU]+%/G_&<YEZ&6 ^I
MQ:$'/#Y^,O]X=5'+2.]ZMS+44ND$4L94F=(>G/2\]A",&*WR&H\A;7[WL%,T
M^M ZGE&5[B^K\TPJN[BY47.1LE VTM4BTXU:<+I?%!F "9V2,SJQT*V3\E 2
MO5+/=SJKSJAL\7X1=Z]OAV7T&B\^G&P33".?!AU#X_,(T\YQ$[U=#HM1>V,<
M.%=J8+*>!9[\@6"9ECXZ0>[D22#TJ4GJ)P70/A8=&IC?R'XOUO;6ZS"*KBMH
MZ$;F9*;#Q10Z7)2%J(5'J:/AOIMG]\1#1A[=/975U@U4/KRS_Z$R?]:;+P_$
M\D$RE0*"%%B[Q%A);PFS8)RBRZS7.77V\?<]XQ4"82"%#W]6/13K_578YO]<
MD5[N)LW="HK>)<Q20C:) "N3 :=(Y*J2H&J?%28.1L:^IRY8&<XH>X/5X[2B
M?/?['^_^O[?K3Y_7V^N'K OI[8_U)9[O5JXT:$79_^$M6U$>J8J=5I2>%^^D
M3EIA5)80H5 55"XJ<FV"4'M;4?878X0*S'=_?[YNFO?'ZA/]R*_E/7UW6VYD
M^?F>0YB]R38I#H;K JID#C[5P8)6HBW>%AWC9&6:G98P3CFK<-+G+&I(L1+4
M*TO7Y^* ,51*).U0-QF1,=MRUDD0>%A1:Q_;M>L:>;BN;H<F()="* <R!D;^
MC79 QZ*@<S!)-%X&]-,A\%GQQR-6OQQ@#FOSTZ)6L\ 5+54!SW56LF:UK0Q/
MX'C,463CLFMT+KU@:O44J&M"J^YC_=G24+LL8J%5[P'RZ"AJPD<]! *SQ7,(
MV>5(VT+0N5Z1!2TFH@:55$3Z*C#>I+IKQC@>A58]/8S[6'[HT-H-L?7'U69[
MQ^[0.I?BZ_@\DTB&3">34\:0>J*6-5(3=V<H[(F?/?CHETI#[F6?]6#*G8X>
MK&W00L1:]%B0''*+X!43X*6WTI40F6UR%YHW/7@&[E\#^TU)#>XBYT(-'M+8
MAS(Y#['4E-1@Q4@D*2V4X"PHIFNM%&% !N&PV%0*;S(6Y!2HP:, JH^!1J$&
M9VZ+\2F!SW7V#:\-FQVG]0NIG":=1,5.D1K<RQ#/4H/[:'$*:K!$H7E@"8HJ
MK#K[M%J' B0K3%FI=##'3+-Z*=3@@XT^M([WOMHCYGH?S21>KND6\%.BGUJ5
M54Z/^GHM9A$.)%'SK/# 2MM)%6<671+!.&>8HCW%<84QLE#IQ-&P^'2J^'C9
M9I,_%L6SH@V]J'0WI ,9:SFIIOLGYSH*+G(0HH4?\]+RQTF6&!$E.$'K42@-
M./H6Z,#H]U&@MM/EV5]T_K@/ @_+'_>QW7SSQT);IE4N@+[X&MFQM!X"C,HB
M*716.]ZH6=$KS1\W!^:P-C^M_'%B46<?,AA?1X-YSZ&20"&[X)*4*9@\MT&[
M)Y,_[H6Z)OGC/M:?;;ZMRR*6_''#Q%LO%#5)O!T"@=GBN1C+ H]T'II:/%2<
MAR"5@L(-=R&DF$UX93@>)7\\/8S[6+Y]_EB99%WF=#)))FM^RP &DD9RNLUG
M[Y&';I4Y)Y,_[F6?I_/'?90[Q[O2^TO<7/Z ES>O3K;)&#01?&#DPAOA(!@4
M=?)'0.7)NP_SC&Y\MXQ7[4Y.AH<Y5 D='6@\VTG#SR%V?,9?0/1X5W$[\6,6
MI+?>9ZNT43$6QQ/C&B7!*CM,H7'\F*1;(LA+!'F)("\1Y"6"O$20EPCR$D$^
M(9=_B2 O$>0E@KQ$D%\#CI<(\A)!7B+(#^Y*(\;8'DQ);46ZW/N@YM&P;DO<
M#7'%1,Y:";[4CAO,^NJX%1F3]1SI7O-TB&OO(R<[A[Y>R[*4-DAF0898IWY$
M#4X7)+![7XS1LK2*6!TO_,B#G^ED,$%[!YBBK'-=$9QD#)2Q]>S(F>?1.N"?
MW.#G/C@\<O!S'SLV"& -V/Z96\[)79&T$DDG%4\"0BD9;/&T1R698VX21GVE
M,TJ/P>A$5C^M,!9Z)5B6@? 8$BB'M9&B\&!0,R8X&IOG=EA-'\::"GE-0EE]
M$##;JW^712RAK(8Q@%XH:A(#. 0"L\5S]#XZ:S,P)15M"W35=2%E*#$Q?MW'
M6,UM=/1)A+*FAW$?R[</91D>LN,L08[*@ I*@A=! B/W/@L6+ KU7-3BM$)9
MO>SS="BKCW*'+C:_D>8^K$+F\O=?W(H7T1FL\3K':H-+$S@@^2I@4T1/;KM6
M^MF(5<=GO5(P#*;^-AO!UZ#;W= L5"XYPT"G*I*GY89 <MD<C0\Q"9WY(8@8
MO0G]/%%PB)KG0"/]!Y[7#/YV77[()6\V.=U&B%J%NI]]8/.0=[\E[S:29URI
MVA@@)*:4B($'YI K3Y8.QMBG0]_//GH&(7!A6!%1*4B^5#?*)MJ[,KT6J*1W
M64;^2D/@9SDZ*4K2D(6E=SLZ3YI1"0P=^"G1+W)W M ($>\7M?$>AK)> >Y>
M5IIW/!ME#+8(2:++ZF,66HE4A!#G?*(-AWYM,BG]E<:SCX'D1%8_K7AV%LEJ
MEQA@#I$,( +Y8I%#EL(:@Y%EOM R&\:S>R&O23R[#P)F&__KLH@EGMTP$-@+
M14T"@8= 8,9X9D5[:4$SP>O\- 6(QH)DJ:AB5!9.OC(<CQ+/G@.,NUM^I#"6
M<E)Q5>,UL610PG/PPB,(K9S/!H4-W>;]GE88JY>E.H2Q^JBY<7A[R^]"[J(&
M6>JL+YGI8L>XA. 2K1&-XMH8UK5_ZIX'O'K;'Z+HB9NH7J^@6O@]Z>DR?UC%
M-^?GJQIC6UV\_;*]7,4?5V&SWJY:]$OM__"6L<TC5;$3YS2!18="2Z:YD@:#
M1.MCC$:@]$6(O7'._F(<&[*[E^.O_,VKLZ67ZI_KB[CGC[\IL?\F!& \"T$(
M!SS06Z0\%D*^#V L^6HI<1>Q$:=UN$4TZ&/=:4>Z^ZOT_=4ZG7FIO4]!0P[.
MU%'RY+TXI2&:*"2!2ZH0.^W6@XDT14_LB;#9H6]V:YNVJW7_D?3\6 CXW=_Q
M_*KV G^SW6;Z)_V!?Y]QQ4UP@8[$8 4=CMH#:FW!*FV+%J$8UG*T9A]97R$^
MQ[)L@[MU7Y9]-+XX\L\85B<M<@?.(*N3R(V.3EE76)N39=[5$K.!8$-[[LWS
MCW](_X*;?^?+^B9]_KQ9_X7G?^3-I]7%M1-WN\DSYJ0D5P^X<:3$E,C[+^CH
M3B$,]]EJ;V3K@_MY,5\A4F=F^X>HEE.A^N%":.^/(?D"NC!;)\#00A #'0XA
M>,UB%KNIT^%!O&!V:LL^A*@:IZ%7G2.N?')@D12D4%APR"TP'9@U7F>G2D.O
M<VX-O2:'83OK/828;NI9OKW:;$@U9P$M1H82;+0)5$@6D(E"_H?VK,CL=<#1
M_<E;X5XQP :WW4-\F>$82@.H[88Y((7*S%H.&J^;X&6ZBT6A(;'B32+OP;DF
M(P^'7\I8C*79('9B-)P8@\DH6;CQ$$*.]&8+#TYF!MER8PPOR&*37?E$&$S3
M(+ -DZD'$N;+_.BPB(7)U)("T@=%;2@@!T!@MGAVVL602X LT($R6D--<X)$
M5(J;%+19*G-/$L9]+-^&R52AL5LFR(1F+(@$@DXGDJHXH-LE RV2+3;*$I7I
MP6AYY!$OE=/2RUX/.2W'*KM!\K+C /3BZ/(73 8F0ZT<%9E>FIIF$)ED--RQ
M-%J>Z*%XBXO8RI8#YHBZ2WG7X;&#G"W=O*Z"3N/)M3!V;SP=8:F1<M^/SWKW
MROA@&(CH25[E!.VY10*S181D>8ALM"CE>(AZQJ>:$Z#Z&&AHO^C/SZ2;B\O?
M\,LWI[2+F8G $0RG'5D).O-=9A+( RA9\9AM[M:XXK%/GR(PW<(0ZR&U.#1]
M^RUY8+2B;YR_W_.'J_/Z5[[0(?UV_8ET$%=X_LOJ/)-&+O*[O[YAGEOED3MR
MSB)S$I0S!4@U 1*W*(LU\D$3QST .$Z.4X3*B):9EA;^]N,J;U?W7]/"/J^W
MUT];%[II/#IC:WA^^#%2-"2*#Z:<'<:XRZ$4.JH"3T9%[Y$%9W0120MG633[
M&./'R#.;26?UMJJ5""""4:!($718)PXETBOIK2W*^\D2_DTGG0U,,2;586$J
M0I:\LCH=!Z=,!!>=08Z.EU Z;?\OF#8^$2X;D<;[6'0FI'&5K$=#6O,I<E"\
MYE-CU1JSY)1GQIDU#=_F>9/&)T;G6'8=^K8SP OUKAZXVWLJW+OS:Q6?F91D
M$D'7QML)E.<< B/GC*7H(W?96B_&VC(?%_'5@71&%I\1^7S/JLZ2M,%*6H34
M:&KCG0).DZXQE8@291"2303@!;D3V'A 9GD_XJ=7,11/&F(E1E Y>_ 6R561
M%H/.'(5J-(1LEK3=>9WT ]JN 2^\9_E0-HJ$#;1E:^UH!Y>NLM@1,KDB444M
MO6M2ECCW<K"90*ZA-<<FC->DZ"WON!3!HRH&C%46E*[]B;DT@,K8FFWG0C4)
M4G24;T';@/9KP!L?: !P(DVXR"-$S^L0P(2T@("UE,<PCSX9/MTA>XJCQIN?
MO</:_+08X06ED76<6K*"UFLR V2% P979-3"(+-MT/Z"&>%3H*X)"[R/]6?+
MFNVRB(4%O@?(HZ.HS8SF R P6SP[V@A*= **QUKD;CRXPFL\V$HG/2^HFU L
M9XSC45C@T\.XC^6'CO_OI+EO.15"8M'!T1&E#*,CJG(J7#3@4B3_W@FK7+?8
M_:,?_V+9WWWLM!Y4R=,QOQTS2BJZV.7D2,JD%7@?$5@H4F*.,ILFW?[GS?R>
M@2O8P'Y3LKV[R+FPO8<T]J'DW$,L-27;.PGMM5,>3/$.E(L!G,X.DE#!H0TB
MBXEJ5^;/]AX%4'T,- K;.SN%)7@#+-(OBJL (9"!$WT/.7>%\6XC*E\8V[N7
M(9YE>_?1XMS8WJD(Y@.'D$A@15] ,-("DO?')&<:D^[F_YXJV_M@J(QHF297
M_2/]OO>7N+G\ 2]O[IX1HW$J))"Y;J]1Q]HLM+:OM8IC;6CM8XNC:=AEO&(G
M?$(\[*6CS+V6X6PGZ3Q5-</97>W'(^JZ%6::>H9=!>U6-$B1643)7+1*:.<+
MZJR]"R(5E6-I4-% $BTU#4M-PU+3,%-:XU+3L-0T+#4-\V*X+S4-+VH+76H:
MEIJ&DT#N4M.PU#0L-0U+3<,+@=Q2T[#4-,P$;4M-PUQ"94M-PU+3L-0TO)H<
MVE+3L-0T+#4-2TW#:\#Q4M.PU#0L-0V-,I!+3</+=@67FH838J O-0U+3<-2
MT[#4-#3Q?I::AJ6F8390F4--PQ2L[T<IPY=KNF/\E.B/5V65TZ->Y+9Y6_OC
M11N/&SZP&G?HXC&%HJ0(D?&@@K6A&,XYLHQTWBDO.M+%CQ=RLH#4U_R,9;%F
MBQT([C/=2.ABY!FS8)@S=/_UTEO1PFT:0OAQ>#F:G".=50'+M:Q#P",$7V-(
M=0?,6MALTJOBY8R,NL,8.7VLUB#L\G4.WC%!J>OH@?4Q9AD\V!@M*.,07# "
M,A<Y9R5*+DV($\,M8;RT]<30G,CJIY6TQFQC,(4N%"ALC;HBA%QY)Z)(*S7C
M4I:9G4C3)ZVG0EZ3Q'4?!,PVT==E$4OBNF'&KQ>*FF3\#H' ;/%<YX*S+!5(
M=!Y4<A8"*@Y<.T[+TXZE)J3A&>-XE,3U]##N8_EQ$M>R2.?1,##>D(^6=8&0
M.(+F*7CO$X9= OMK2%SWLM/SB>L^2IXN<4VK*IABAHPU_)P%!U]$!H[<2HN%
M!=4D?C'OQ/5,W,$&-IPR>=U%SB5Y/:2Q#\TU'F*I*9/7,3N&6=(1I1F]9"@]
M^" TJ* TFIA$#/GT$#5,\GH40/4QT"C):Z&M,YS.>9<4DD"HP*$)$#@OOD1?
M$NLV??N%):][&>+9Y'4?+0Z=O'[\9/[QZJ(VCKB5K](O'-,!BHJF$C,L.,,2
M8.:&9QN,C\=T5_CN8:=H]*%UW/AZLYM,O)602Q:8-A&,+064)9^<4$L>F3;>
M:L90RG3(=>?QQYTB#H;7\_"=+6[367^29)5 NB]Y?"NKBRJ7D#VPI.EV)BT!
M5FH!NBADQ2%/W';<&7H]^!31T5+W(_4D_'%U0:*N\/RGB^WEYNJ:KH 7Z4=<
M;?Z%YU>$<-Q>;6YH#(=03'I]_A \D<,7M$/V\*@"O;>>,XZ*!8V<,T$ONC'1
M2*[TV:%+:VBAZYMW<SO=/F5L:SVVN!V;T<O%R3K51$H%DUVR,3.GK=0ENXB]
M;/9PF0TM]_[JTR?<?%F7M[C]2#_TYB]<G5<!:#-YC^?Y?8Y7&])PWH8O[U<?
M+E9E%?'B\J>+O_+V\CH<@Y?YPWKSY0@ZV*3RCHVFM@K?P:7E#(V2=- 0,!-G
MOG!G-,JL9-'2JEZX'%SRH1@K]X+\N"O(5Y:$8"S%6!)D[NB$=4D#7;<MI.@L
M^L Q(;8EI720\MCPS>XC?LCA\NMCWGQ:;RYK!Y:WZ^WEM4-RED42+#@!)FJZ
M2K"@P&..4'B6VGDGHM8MM-)7T/&=N';HV@WI-#5:@SS',_+&>/6I\J9S^J_-
M>KO]\V*3\;PNX+]([?^H>T6NS25U3I6>%"!6ZI*R6H*/U0%V=(GUTFBCFM3O
M#2+]*X9C _,VB&,?NHB?Z:NOBQ#<U^N9@&*K&D/A$"R]:,SZC,46CJQ)JFX0
MZ1>,#FG>!EF\_4KZ?CEG)B3OM5<@6:3;N\X, L8 1@83C,4:YQD#AOL$?$U(
M&\1(#3IV[KP!.U+?),:#T-EQY4&FE&K/1ZQ$80G*HV=%<V:S:H&C#K*-1;@>
M#SA#&V0NE.E'+HPW%;ETO!>C,WB;Z,!/W(!#37LK1I.2%CJH)IV[]L@S%8]E
M<+.OAU=_ W_K.C]1\F;[YB*]SYN_KJ/<OY;'H@N5_[5]_(_N"OD[K*4E:V7(
MQ4S#;!D$)>N9F7CNL%5*6*=\ JLLTIHDK:D(.BV\D9X;C6B:=.J</UR?H<W,
M'JU]+-N"E(7;R@>H_WGWGZO57W20?"T\+YE;)U@"4<C;5%$)NL34F6,H50J.
M:5Z:%'L^)=3X%X+IS+W+SQK*5BT(RGES>1V3OZP*^"%?CPZ[%2UD)XH-M0FW
MK-6G7($OU>F-SJ'WR+UL$AY_0J;7C**!+-5@,_KS_1^;ZYS0EZ]N[ET/#,FE
M0Q=!^ZPKG4%!D,X#$Q%MY$EFT>0 W"_2*X;00'8:FC7TY_O_6O^5-Q?7A_R'
M3 O/V^OV*IO/M7O%3B3OKK##H,TL&ZA%'*"D(I? 20_6),D-LI+R3D'Y/NKH
M 4]_A1@:QU(-HF#W:>M_?+G_[7^O\J8R*K_\7/F4UXZEX E-*@%*21P4XPY<
M=@6DNY[*R51B3;*>W<0[V=#%\,9I$)5_E/GP4-[;MZN+L"U#%;VDG2@6T<#L
M^Y#5S&8-'*E^0D=M=7'&@ DUGRJ%J*62!FRE_0LO;&)->JK, &#/10_FAJ\^
MIFJ)JY\N/E]=;J\UP&^/9\.S#SDFR"+7[5MG0"X":,FXUSX@\B8E\4_(-+Y[
MU=":^W!SI"D:Q (>$TW<-<@TCF5G MC$/2@3(I!71U\*QS7JJ$MI0GMX0J;7
MAI)#3-%@+_D'GM=Z@O<?<[[\N?YT57G=39FP+$0;H607ZGHU72$)PB%+GK@L
MQ<8FQ]$^@4[59Q[$  TN6H_)=?LJ=)&LI4N\7[1I_-]A3-@!%T?H?Z2MXU;"
M6MW":\</GWRLG0X]2<@0M$U19!ZRS4VHGV,CXQG'=6Q@]%'[V%DL93&;S#08
M+@JH: V@40%XYC[;HA4/34+'\\IB#66\/CFI/IH?O!OZS:3.7W#S[WQ9S\H'
M\42/N4B1R.O)E547BP4G44&)VG".RDK1K>/]LX]Z\=9NH-&AB\>_#F=]0D!M
M$N?">TBN=G!'08"TB@&ZXC4+BF?I.IF\R]-.P^J#ZW5O7'6Z&N#OZF#HA]YM
M+U>?*L7[_J?7Y;'5AR]WY=A7>/X+7M9OCU6KV$3FL>L5VRM^IV8QE,!YC#D:
MIQ3'C$PC4\$PY@-3R?6J66QM@H:(_[YLX;=* :A[Q3C0??KA8V.PARIV"V"=
M9P:#\B(RQ8UVA6LF,X\9A1>>]0+3TV*,6<V:G?-&%/)G47)0J63 1$=%S([3
MD2YD#$W8UJ-6LSX=7*GOY^KB:GVUQRP_Y^WVCX]XP<4O]),?MV>JN"A-2"#)
MZZ$#L,[2S)%#2D97CRCYTJ1EV;#+F'NQ31]D]JN9:&KP!B'V85?S35%;_;$S
MQG0H)3KP/M01C4Z!UYB!G,1BE(^>BR9!^J:K6L ]!AP:!'>.6]S=HG[=_+R^
M^'"3'%,L>@G2UW9(G#EPW@80A1DG P;MFU0\#KN,!<U-#-Z ]#/L:G;?32>X
M%C$82'3)!B7H^NT*Z=EX8:22,3G;A%O==%4+N,> P^B5PH\OZ4P(S9+P!:2U
MM5-=DA 4_8ZG2,=+,$;N,G#'@/#CPKY>9 Y@O(> 4U, ;O>=R2IXB4;02^)I
M"3)+<$H'"#H(BYXEG9JD# >0?8'C<*9]B$X]1N.$K&G+3K1/&T<^B5(Q@W.B
M #=(.O.B>#9!Y&#&C1/:8:J_0>;>.$$@0XZURE72]4TQCH1_QT%+(ZTP='FS
M35+?+[!Q0B^S=VR<T$?]<Z] [[*6I7'"(8T3>J&D92GZ(2:>.VRC=;+P4+/=
MN8 *5H$/ 4&ZK'(QV?O=R1"O!:X'-DZ8#5K[6+8%Y>R),FKC2\9"2L'JG2CG
M MW";21%61:YLH[%)LVP3K?@O9>Q>Q2\][%4@S3.$X746CA6BD9ZL1+Y(TXD
M0!,]"%5$EDXIW88%?[(%[\= :" [#3X+Z9 R:J>9%\IGX!))#RZ2'E+D$$W6
M22OK75@*W@?$T#B6FB&K[I^XH:6M_LHCT8H>/&]L)M'3"]XA#^D<I51&\Z*Y
MBF@<>LQ:%T%W4,O0]R(//;7TAA:^_]DWVVVNK._K/TIO+N]_^M<+_+W">D,O
MW76#\9&P<(1D8Z-F*"7N3@U1&GTA;SVZH+1&QYA JRV724>K4B]\'2'CF,RU
MF&E[]@9IPU2T87I3BUM<AJP%RYG9&'232/ZD<QCV=@W&VB/=^P0Y^]K"R23P
MIC"0F%6R:),,35+#I]+:N0^:#F[MW,=(37ADF]5?UR?'S9M]ED+@B9G:EK@6
M!2MC:=&)04@% X^D$=>DY=^N(*<,CJ.4WF*@P;44]UOY#ZMMS5W0!G\FO10B
M2)(D>%6I,PR\S!&"35K[Y)S232ZA>R4Z95@,8X;1&4PWZ1/-I+2I&$"%G!8N
M"Z"O=R27+,L!64AF26,.MH$,:Y#9I#&_MMOYQOO\<9/_<T57YB_7\6?KC4+O
M$D0EZX BK<#%Y,"1'D.6QJ!M$M#O(-N<TYN]X+"_N=H@9AFIX=6]@+?!FRXB
MCMU/;4?&R;NH#6/?#BVNAC#.1#C2CI>8T(''4C-@PI"CQAD8S;Q6WD7GF[C(
MD^&G>Y.TR>#3QR9C]=N[CX?<A7.]50*3AQQ4 F6\ )=9!$?:T!:91=>$Z=5%
MN'GTP#K*JEWZZAUCDA:-TO;DV&747&5$H$L@^?M&DUB!Q-)!2=29D\A-2E1>
M(&WK*+]F /4WN&X-FK'JLI:%MG4(;:L72EH280XQ\=QI6\XJ>J%3 E'3JTJ9
M2LD0"DP(4ON(J;1I)CI_N!Y(VYH-6OM8M@%*?UE?Y"\W33E^O+I(][WE&0IF
M@P4F4IVPR#.X4DL&?$S<FZA":<+8>ER<%\Z2Z&7B]>#V&7FZC?-*L^@D,*7(
M2>7: R)Y()E+Z81ETFNVD/W&PL]0EAIWNHU0+FLI-?"@Z'ILE ;:G 58+!Q+
M"2K'9;K-6! :R$ZSF&Y3N[U9S0(44\<X*6GI+HT:#&-69N%2RCM^U$+V.P9#
MXUAJNNDVQ27">&*0=?"@4I+@I8PD:K1,,2NX:1O#>K'3;09*P QEG)80ZM35
MOHNPRW2;P<U^U/210VPV^70;G5!E4?N]F"IT-A*"#1H\0\?1"ZW:= 2? <"&
MF6XS'K[ZF&KDZ38E6L7KZ4]G,CD#AAGPQAN(IL@HO&>:MQWK]O*FV_2R9H_I
M-GU,,?)T&UZTB-$AQ. RJ& 28&022D24VAJ&.-H,I!<RW69HE!QBBKU[R;#%
M,U]YGX_=.@XIB7CF$X<H9>@C]&Y_7%DD2QJ35$KQK$*2D:.55KC,3>%GW<4?
M5-/7#GD#?=]^;GNM/[: '=U[JQ3J8$W$J##*(%C)23O/4P[!E6=T_W I@UK@
MVT;U_YW3AWQ,7="ACVIOIX[+W.U1+FSAGC&CM%2>U=9%ULC"K(I*JF"?,=W^
MAPY5*O#-P]Y<I/J,U<6'-Y'^Z*;"X9ZX_ W=-=C$K/$:C(H6:&6U7Z[0P+R3
M22F1&6O4=?,(J8>KKOCGNH(+S]]\6E]=7)YAG<\G2X0H-:N#D^G08\E"<LG:
MZ(MGH8DWN4^@\9V$\="TO_KB"*,T+<7Y1B,DX@]YN_IP45N:O=G>:N=;E=6B
M@6_J\,YHR]!U*B X7J.642(@;2>0-!?9%<6Q-"+B#R'^ZP3B: 9OTIWYD%7\
MO,*P.E]=?OEV);6GNB@J@TB9K@*:+G;H,8 6M"!C,H^J42/0H9:PP+>YX1L0
M[GZ]_)@W;]>?/F_RQQHZJRLB#R_7%I)?5_GN[WA^E>JPET^?UQ>T%OJAFB?,
M/^2;__XCE_4FOTG_>[6]O#/#'_CW69 L,\P6>.T7H9S)X 33]#MM0Z68*MXD
MN=MV6:\)ZC,"2).FS?WU>I/3<H&TQVP$-"2]<ES0T1,=U'Z)DH=<4AC/U^@B
M\5BE@#/;E0<WYEP*!A];[>^K[;^O\Q:>?'9AT((+GH-2+(&+B!"<UHE%9JT:
M[<IY)]1T&>I18-$!C >9IZG?>C>,K3)";H/2761KF9Q^2KAI<M'#F7(O1@:R
MP]A843'ZR+,&NH6).AV';F(N93#!.%DT9L3&A^!8&'DFG3P-1/JHOT7.F#PZ
MNNZ0[_<1+S[<"WB7A$+.Z1 7Y-F%VMW%%O"R)-!)%9/(T>-M1EL\*=64GONQ
M!MQ-  ZF_08!O9L[POM+N@K75^'G;\>P"VV9BL%#BLZ 2KRV_8FJMHZ,.IOD
M31O?Y F97I=K,I1Q&H0C]HAVUZ2[@W M79,GI9O&-QG,EMTP<H0A&AQ 3PO)
MI4HA.P?6YAI:L!)"+75FR6=G2\UL-.'K3H"29[R3:4#21_\-P'$=N/J5-F.2
MJ89AJZCO_OY,*LNW9V0.G,DZM4F[5%N/A0"A& '9L8RB-J 5I5EP\BG)QO=2
M!K3D8_'#P<S0P%6Y/6OO0O=W[T4I.0K')*#@]8 MM6B4DY#9:^O)C4JA"9WM
M<7%>EX,R@$D:Q(H?2G5'#>\@5TNW9)]@TW@D0QCO63P<H?D&1\U>^;PQ*00F
M@ 490 4EP0=1("9->ZJ)0J0F;6C'1<0SWL>8@.BC\ 9 ^.?Z(MVG@&^/-Q(G
MA, 19*PB63*8BTZ#8PR#U-H7WL0-?426\?V*80RU'E;+>YV(82G//UW\1:?E
M>O/E$&+GU[\\!%5SCR@[Y,O(K=(VV!(\*NF9$^@EDTD&E[DJ\>Q1H0[5RN%,
MY-V/&%1#'?C%.55NJE92**6<J^U#).DG*Y>P>,[/GA#P4&T=P1%^\!F#ZJL3
MJ]<6D460-@NM++.!9UZ81XS66N'+V5,B]M38;YLU^;>77_ BO?O/U>KS=:KU
M *T]^CE#:.YY 7>TQR-R](9YZ:U"QGRAG4V8F HJ4B$_>T[4 31X^,OZQ*>U
MTF:'5SBQH#BZ$K(JBHX<+Z)*)0CZ.NL2]:,Z/?IM?NQ#CWBQG_JX5KKM\KI'
M+15GUA3O2*NL$':5('U[Q5V)(CRJW&&(^G>?_-LY7ER^^>;C?[YGF,A@2(MT
M_2U%)U YU7JK%,%D:3CMWL4KV\(?>UZT8[W/O4^@W]]42^2?*Q?K]]6'CY>_
MEC^W-SWX;ZE97\='_Y _;W)<W;CJ%^G-I_7F<O7_KK\\PQ)B-I9#?75 "54G
M$"<%PA1+BA.9:3&J]H9;V_C>\<!HW?63YX:'!L&[ Y?8<7&Z^,1XKMMN,K0X
M;<!KYR!AL(+K'&-ITF^]Z:H6F#?#0(.(PJ&+*Y=YTW&%TJ R0@O0AI:IN.00
MC/20HY+D&24TJ4F3B/9+6Z#>%@U-YJU\%8U^?YX?DY'181.=<N C9Z"82W4<
MC*PD89NT]09M$R>DBW GA[G!+=(@-?-U_,Q>9=QDI8QQM)]C +I$15 IL-KO
M7$#Q,B0GE->Q"6&QJX!CD?0;8Z:)/>9"O-^[I']\J=2^Z^0&RL@T@1]2XK0N
M(PHX(RSD.BF9%Y=*FR[V'62;*I7<!A-=#\@#;3.F1_<-+[2+B"TSRAUDG":Y
M/+A]N^+G2.-,A",EHG(,'6"1NHI*M_,8.&@AN46MM35-QO5,AI]G4M%S@$\?
MFS2 S;U(=XE3[T+1*$%$:^L8F$0^'(F3M7="2AYEFY-J1XX9N<V'VFH]G*(;
M1,JN[X4?U^?IIT^?-^N_;CJ3W7681\,\:@G:8YU0A7764-3 ,[.9&VUB;G*?
M>D*FT\/#4 88\RBY)F]>=XN^%11=\!F#!U>L (4<(3!5>\Q9(74H)N<F]?R=
M)3P]W+0Q3H/03:W]O[K,F]V-C]"KE4P<BD)1B5X%D(D$TF7-9=!6N"91]#WR
MG!Y"AE!\BZ#,NES^7]SD'VIKRO6W@A67E=&1CD(G:[<II<%+%>@H+"H)RYP6
M32;.[)7H]# QC/(?HD(=-<?AMF??Q8>= /5=)8!P+.8ZDI"V,CH&:2L+*DF0
MT2!GQ>J$.]>5/1,;GG[.Z5A[:*4^M+<^_E2X+AR(5<$_79 B/FSR=GN_0\FB
M/*I:"JU 6>G NR@@T_]<+)$5;))Z>DJHTT''X"9X" _3@CA[[=A\V\KSOJO0
M032IISYN")I49W%W.6@I!"T2BLJ4R F#"=GD(K)/#E7.9QT%'TZ[A[/\GO_0
MQIKNP/DC))-W[(RKB(_:>\5,1!YC5+0,U$_I^VCJWQ.?_=LF?\95NBV*V^)%
MNNFY=;79U,QNW<J/:1$\T),;V^]@)>QR#VG'"H9)1)D4=QB$=8Y)(9*.P3OQ
ME)$/5,=P2'@3X^8JI[L^@:NC6D,?])S&5NZXP!V;"G36<9LCUUEI+SR/=)N5
M=--U6?+PI$T[+74X"WX+F.9F?.9AC6W99ZD[!G7!!^1%^)2*LH$\C)2%CT4)
MJTL2_BF#=E_T<%;](9=,#TR_TV7JXBJWL>:>AS2V8I>E[5B/3*:<TBYS9I1B
MVMN")CKE0Y(ENR?/T3V/.^)*^?:Z^\U/%W?];_[/ZO+CVZOMY?I3WMPW7/WY
M*ZLA99G)6[[I<:V2(S^:<PF^=D'(2A@M6*<K9K_G'G5K[O2HVU?B]_7Y^8_K
M#5W]TQEMCEA*1DAT)E8JEP>/V8!C+AI1I!&(PZWUH0#CW:1:(^&[^_88YFB0
M 'I2W#,N H^.,>"&>5 RD'"Q)JML4M:HA,XTZ=;UI%1S!-"QAGUX-Q_(*@WR
M0L\HXII-6AN;X67\^.?GK\U]_UC?[N]W&KV=AG1-_;D./IP9)730M>-,K+1J
M(SQ@8@Z2%*78&-&G)E4X[9;TVL$Z'AX&S%W=J/*I9?V0TTWD;/O#U69U\>&W
MO%FMTQG=1$JL)+4L61UD&@4X6SSPG))3,>0@NPT7/N#A)XRT4>S1(-?U]#8>
M$4,2U<M@M0&H-PI<H>T)O;;7M'K#V<2':PN7](;.68+7F:X(X%,D#2"K^6FO
MR#*">6,,ZMVQR<=XH:.PJ.?G;O97]=1LZNWFLB8^ZLO\Z^9F7OD-_T[Q'$OF
MFMX.43O JPA>*0^B(%J&@IR>+B\+??XW+PI]M?N2[!-@;'YT4R.O!U3V@ [F
M-_)\'5>?[X;/=Q&J!_NY#Q(>2C,NSWD80SVT^D!:'@T"QL2,4@J0@=X>%1V=
MF(F\"!:9]Z:D6'27(7%S-/T>BO*(EN^CW $M?KW1W4KU'L_O:6O&!*LBK4WF
M7%M5BP"!60FI9*N3\=P[U\E!>/C9XWG* VI\/9RZ&H21_FN#]U0BE6,,:,CI
M%KPN"R.@5AJLSH9Q)0+C31JH?B/#2[;PL2H=^MU\2Y<W#.O-35WP9E-=DF^(
M8TX[;[%.E68^@0JQ>K""5JRTU=:%($3HYL@_^9R7;-&AU;@WTC$LX>::FGY0
M/NOV;PZ1I'I,B-V\H6'68$XV2:<"DA)5\MK'2*])P2S.'HISD"8.Y\%\]_>'
MTTH'=DO!H#$S11!-2J6"0LIBH@[D'BCCR]D^T0[2T#]QL[F.]1V1"]WS2<-I
M[6DA=X>&9X_(M#<!E2HVU'KVVN O%2$8ECO]/?C,8ZMRMMM\T[/AA[R-F]7G
MV]7>1@VR3*5X'T#[0)L%'0W@>"G@HK="%,6$;Q(F?T:NHXZ9^V;@UQ__SZNZ
M*]X7!:\R>;S"V1)I<RR^%@!++@$3#W4:',O%L4BN3J>#YKDGC4_U'-+>WQTZ
M@RJU@=OX9I/QU_)[QO-WV]IE_H[S>L8Y9IOI..0B7!>M&,"8(LA*RQ.V!)F;
M^)#[!#H-3 RJ]@:9Q9LU?P_:W_-%_K]X_D?>?#HKE:Q7/$+&ZB291)<<2Y=>
MR0Q33#EK3)/&V<_(=5K@&-((0^?D'I/M;E=[5T_N&DRYR?ULSP2O0]6\A*Q\
M[=&%#+PFISU(F9DA]Y!YV>G Z//4T\!"6V4/F&G;*RC)%>EVA1_R^ROR;>D[
MZ2Q(3=<HNK'1/<V!(O\7'&;:[)S2QK-L4X@' ^*1!YXX%HY5\8!E9'?K_R-?
MX,7EMZ749SPS;V/Y_]O[LN:V<F3-]_DOF,&^O$R$RU75XXFJLL.NZHEY8B2
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MN/K.5[UT(/0KZ[XWA/>E#!/^MJC1'$^^DU1^J_DJO\/HID":S?L*S3/<[AQ
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M=WL55X(MLEA@J$M8[)90DF)*)VGH&XVRB7>R'WFO#F<-M+:F@J!S ^F[XY?
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M<7QU]>MX4O_3(!EAK(Z%8=)T%!B=2=#DF"I0M5ME 7)4+TK01[%Y@:&E?M=
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M ,^T=IY!I+W468N:<Z_0O-BU^(P6X"6L@ M<S0?!]UDMX<<1A]V"\#S7WJ!
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MK]/T/U[P/4:%[XA8@G ?,@ZPTO?'0?];PVZ#NH,&5G7807PMUO*2G*A 1"Z
M!>USS::B+<71ER""0N!*ZKC/IG\96MQ@6?:OQ$.DUK/R5G*/;L>$9>4C),W
MAU"[(]'N4GN *EYT" I*W*NWQUYJ7$O!Z4[L3KH8]RG(LV87KO^TWJ",IMA[
MVN!>;VN7#W@XLRN)?M*H@.0\2H51"R\ +6(JV3F.,FFY(=%OK_?V9(DOIH]N
M,#.NY@^B[]Z7CYC&GT?#_R(C8UZ5_78\G4WO(]XQ)ZX(P4R!$P3@8EG(P)FT
MHM;,.(BER62^GOGH'+Y>O GS>D*6*AQHB*H(2[M_J599)%\,HC;,D^6.UB41
MVR0_[D?>Z=V@<Z+Q2<"[?Q6VR)N[\Q#ZD=W"6R#'T',IZ 0RM35*2(Y%9POC
M,B5K>>&\T9RL%MR<ZK[PDL![?EA<YD5B%IH8\)$YL/46GY-]Q9UAIN3 7;5"
ML$F4\L(N$L\&BNUEL@<HY[G<Q^S#TX]+Q2/*9 _!RDG*9(]0]',!<4@2M"-P
MF:(\K7->:J<T2]9.%B!,#KF<IYGXQ8#WL#+92\/N(?H][:4B"BUD;;,M:]*=
MTC58)B71B85K%X@X^^-2L;'"][]4/$!;/;I"-8BT6K1++&\OXX448^*%%EV]
MT-+DIK& Y+85!Z5DM#'HE63:I[&J8U[\B@'47$^MMZ9;DB2*%'1@,J)DNB3%
M0M%$G/"($F,.IDD>]LN]J.YM.SI"0PT*6-Z-TOB:"(+97"*_+;VH^=G/?:YS
M.PS3+F6F?4'F#4@6(O B=2#"F_1FVD+3#W>T;\6=#E/+!;0/<2V]S*W4G<==
M[$V7^V&D@R(:'%O;B0P!3; N,,5#[:Z9-0,=Z&"-",9G1Z=LDQ'%9T#)#K_L
M/" Y1/YMNA(A/? +G<,_XS>\&G^M-"[O,VY/4.[(%\7(!/!$6ZGQ+'!0S <3
M?5#)<=D$(GO0=GJ;IT=M/FTUU*LJ&EPP_0-'.($KHO!-OB91D[%.W'_#QT2:
M$F24P3)$[VC%D/\'1=:IKZ*(+&V4T"1Y<R_J7A)B^E?'QAVFWS226QOO)V*@
M#&?5 S@F/V3=8_I(_-A)WFKKI@2N.J;*I:)E<.2_>/(K JH"T<4RV$%H=^EU
M2++9\K1&LMPG249@MC+EZ',RVOOHE<G<$H"=%UIKN4ZD:\@^4+*+I?HG_(U'
MB?+A?^]#=AO)61&6ET"2"@F5SKHX%X/FABOZD'L3LQUL(.QXZ<S=JZXR6CZD
M9TFM(VU%7LZ0B+((!"JCA5->@7'"E +>$KYPL)7(XZ7VVW@Z_0G+N):1C[\-
MJU7ZZWBR1/"O=' \^-L.*[KC&WO61V>F5Y2GM<A(1UF1EFM!FX/Q)6KO#'J;
M.3P">T?VC]?TJ?1[-JWVHTL7?928DTHZZ$P6D$7IM4XF^2STXX5X8@W6J-(H
M#:^&<V-M7/[Z5"VX&[*/O]_]5>T),AO_4@JF:G8M/^E'L]W?W[/&>Q;("A*,
MLH6CSCQDJ[/-P7I$$U-2X!WW;M!*-,<CY-/P\VA8A@E&LQJ:'(]JP'M<?L:"
MDPEF^ILWTRG.IC"JW_\VA%B[*@W[6OJ=7]\S/OH5QPH\; %E44?R<$'3$\$;
MK534D)U3R<"@D6".1\<?,%DX8_UH^\GC>M;>=G)7M(%"N$)O+3Z0?PH.#&W>
M'I(PH@[CD8-M#^X6@7C_%>OC1I_KT?Z6GOV]+"8=/<B5+%QQ<J93+6"M+G7*
M+,B2626M*$5.KVN2U[<';5T#,+5+U=T%R+]AE' 5UF^_U,NW=Z,WU^.;T6S
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M:'HKYBFF__EY_.U_+9^XT//RAU4UW[_U=%9AC^(?=Y)= R/PC_'HK^EME8D
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M\V,+" K\"R8*[0N?W]:Z75TD7I13S%P<?0>XXW]GLL2QI*?4H/1AF4)94;E
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M PU-- (+W:$A*RXE+2ZE:(EU5JB,$D1&7$KV&XT?,']' X6V1*&\5/\RP_Q
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M@HN;;>#O4-U4Y16A?\!T^RVF/](=HVJ*PJK(;P<1#_I#7/U!\-],R]3+"8/
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M<E*5?8+P!?FT_90^0S461XZ(^3,=UX>&]5E<X-]T7+0I-HJ>J:99TSM*_Y;
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M6$&=F0@ N,C2_@$(R0K_M$F$$"6/)DDF4#7R0XB<*[VIDD;5):6^YFY&:FC
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M,#(EC#(DDTCXL 1=&"B+4322!C0U87?Q,.">0^K];;GI5^M=2N:66E2]:I;
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MDI>;J?5B3>YF=)Y4$[VRFMEZ\;#Z&ARXQ.I;_"4S_R6>AT%UOV]CQUXV 9I
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M5V2$:LPHNO9(3(^.^9]FZ22.<JKBD8(-G0*S>0<QDDMMYG);.V-^<U=XQ>E
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M9$7.3;-O9DI0/%&B5I6V-CRMX%KS?)1+''O]?PMZT%DY D(1K4B)2Q#ZA#G
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M="_4#C>(;H'TF62GHC20/+*:F%&G\J"72,][[GS:[ES^.[Y@V!KVF+JM_Y@
M! X(#33/X=46SRAZ&93IVO+6FV9OU_A]'*_D:WCZXK9F% 4%;]H#UTA%NL9/
M8R]M,=E1(NF96P()7]8_O=TRSO*4TC2DU/B5U@<>I@C!A2_YQEG73QZTX31J
M=VC,' +FXPKZ4/Y7(]T]>9#3X!3_J%5;5[@FG[6".-57JY2*G*6CV,K@*_;U
M,KZRF4-1!^:!^J,OX"D_?E ;CTY2]U*_)*WTL3$6T>/58'[0DSC!E=)BV+,
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MAMA+SQPX%$(&5UJ;$BSM:-G.I)Y;:#T=D(D)^*!CP"R&V R%7ZB':\\?M?>
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M8O#:,+QR!P5@W8CG(T-V*XD46)L;.^)?2H?T]_-]Z[F<YF>H#P.+*$X#@[\
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MRW"6DT,.0>7#^A[,N2G=3:6B$_%.OKQ(2IK@5T_9FEGUF:>[+4:8PPKI';Z
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MC3+5E[Y3,AWEQV?97T6_]F!5H%/%F? .*[/,BW;U\\+ZVO1=(/MD'6]S>("
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M7D8@]/-#[;U@*<EUIFH-I/OU((+65_F8(N8M.3'EVJF@76Y#S!!_-"5H-B,
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M']WBG';<$-Y7_E&Y_YO8*+<9N)I")BDE]CQ%C(>=OOZ8J.3,><-V\>E#_L=
M1PN(UZZZ'Y_EWUEY(WX4O$PZ(R:K/+?8;<82M^ECQQ8YEHX?:OT*;5#S,5N
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M=OH(1T9K-\Z<$1E?F^O-<$81705?JM-\&=DX4.UU[@Y@U4/GO*PV^ Y&*@J
MH7(H(*1F+/U@Y7?6;W]-E=2-RW;'PV]_,J77F(HPLO_JG73YFB->]WG[%Z^9
M^G>?3[$0>\J;54Y:3W'4$E_L\+N[F+RP^O/%RGB"%"VFY^2]_,A.%CF#6?S+
M^B35>;$5PAWXX(D]I.T*QP?T)G;A:W*'1V/CR]IP_/0XO'YAWZ=PB8%>9JX9
MH;&&8J,=^KJS@L*?VQ\C_,=]7#^PD3UYI,@6Q!H@70)T<S):-7#W=@1=L%"4
M.I0>^5J50""+NQV02$R].2>*=PI1>.R)U(;LREB='P?<\;CM5S'&!-L%?)5F
M94A6'^^7N7$VS1;.Y#?-BE40UTUK6&+&I-1X$4/?29+5BH1:CTEB82+,-N!'
MO7IW_'")\%*CW5SCH.-93OJ !HE-USB#7J^8+=8?&ZJLIZ4$1V'>&QN9\6R^
MBO.K<Z=GC9%U8F'S-#K#;Y)35H:.U4PCJ[JQ39A5;8BFD.Q=$' /"L#;R62>
MNIFV+.QF4VGT.QYT47_2X&[-&=FYGHD%./[/ R[C_A3(2%C+=_4N.9[6^8+F
M*5]]F(.B(IBDKI8 *X,L>MJ)0[,J\F7POEV'3W66.)P&'V<B><M;J_.60@7Q
M7+I5'Y*7<MZ0:I0<EL"_^Z%4\/!YD!=,._!"\KLDX7[)9ONLR00."6*ZSU]L
MHM5*9NZUY\ +N%QRCL#M>3X4)"#HJVJ5^DOH?,;Z':4.]D/\&M);$N"Z+'9=
M.C2V;;8VQ\=KS= RV5NZ$E/X*MC,#4822.\4R49F@HSOC63J_T8=_[-4?UB^
M[B#)G7KU"\>C$XY?"5Z.B@DMM!B3!P>PFH8H7':#=Y'/.&R%?V:_!9X /.A&
M_T_GD081-N<[$XZI/>"WIE;UI>3V5C<1QYVBU=E+U_H<K'R- 9*"'D3>+X#C
MK' P69U:A]4?G 'OEMC7!O>NK"E@O5//;P%[9\OI2 FT?&4&.D>M?841-%&?
M4  CTO4Y B=B$R'B&=]=#=J?AG3AUC2&&;])E/(MFKYX*41CF^1#PG>4D79X
MRA(F;1YV'R8ZB(Q,S+Z3*%;>C<:-J>DF[J+A1O"O.8V'TJTQS@H!-TQ3[2R[
M!#[8^27V%Z0&!<GO(77=(^<,XF^[<>MS$IL(4OS&%FE<F7("G@S_$^>Q_A$\
M-O6 -03Y"I7$\ADBPH+S=D-A,08K]A\5Y79$-P3[W_[V*ZNUS&#\5*X%$SIX
ML(H",&^X$23QGTJNS>GM()R]$@W"GOY7=$L:'(AN=GX&^TJ1X@<1L-;HM97]
M%IA\9%IA__4B@X"@5ZMNCNV5?[3X3+:TFA.?##1N2INL!M.M\[3(G]]_>)D#
MH9R .-&8^%#;8BQ$KP'MGQ*8>X>/62U\FRVE>RD56Q77^BG;)M<6!=21HX#N
MIQ6>/GW,F/.M## BT9X39-J3)Y<.-L8M4IKS#SE$FL/^!-95S25U@NM60MK9
M/<'0]K)<HV4-FECQA[5?0J/PQ*Z__O RY:8[C8^Q>3!S*MZW8UY=A@)ZA!A]
M5;2P[:[\QD-:+:'%^[#$.V@F"E!O/?[]_"%_^O>R/(Y'KP9 EA@8F4[=654=
MD:T4"+[5BLA/Z=&J8G_8^D=;#?-*%Q2+%G?Z9TRZ^FD;+<HN7*L,UC.!B?.=
M#KLLPIYK)25X8-GA6/5YD-,!4\FY;N.C;Z'%C\>_OGO-K9D\Z?L167>O=J&9
MQ6M\!])[>@U5B<OL-M:#U8/36HR\:!8T1ZHDW-GBQV?S^SX(Y1/%9L0/1,S'
M&Y6D/GGXUP$H"A#$GIX[L/K-J+PW<E)/8/[G8&S,N?9,[OKZC>]C!$[?44#:
M?%BKK-,'M[VF4D&VH,.UD7CAY:>BQ9\QXE,DZ :,@!KXRMJIORBB[R+H[ AO
M3PX38547,/M:<XX>CWIS&IQB%67P_M/;BH >UIBXUK7R^US5IX6%K&9ZY4#1
M!Z&NHD[!ZTCL>17F5@N0O\PWV <P1BQ_G%;@SK3CW#Q'CL#&J9"Y_3IV<CC-
MS7"KHY#::"9V;9^+R$,UF^84<UXY;$HLG6ENUC69PO .*Q1 #TH8=AO'\]3O
MT=Y9QLCJ*B[<N8J)I6YBW[_='V=4G7PNTQIX(F7#G>&"=H8=CK#L8N::J","
MJ=P[\L]MB+O&X0^KXAZ!MGILK6]L56_6LK[&\;WNOA.<:'7.'2CQ=#6</CL0
M5.9-;;::,GG6ZX8VD9"P9-W^J.XVR?\AR!S?G]73^_"0@6-&,TDPU;+$7GC%
M]-=Y$AY''&CAX',MI^ZK1VR#^G12=#C+'=9:H=[S/>DLU"M[<[&%]G*LLUA[
M1A)YJ:7HO0GA[G&TEL2+7KB-W<4<&1,X6KDWKO#V[#NNS&N=FHE:/QHC/S0W
M#;UC/D_'P[48F2$Z%SGH<F9>'Q<VC7CQCQL+.$WDF8"\UN2- _2/'@K0B2RL
MJ:N>?9MF_'7F\R@]7V(GU8>$:;M3\1/)L#N2W79A^&AJ</LH2'8KZ$Y8K6QW
M8J5>YIHZ#52T 01W^'KHD$HS"H]CU\F(7O,A@WON'DR<T=;><OT^D./9]>=-
M,V#210$U-FHIG)A"RSW*$I]HS[-)<E)A T$,O8F>GIX#"M*G'@2V5^;G&2SV
MAE_)JV@;')>?U=/02<DE]SR]UK050)!/=U]0B_[N<067+A24R4R65<>*T)IM
MZG/$EC1;:UE24 2:,R.5WH?#Y@/\67;J(8(-19X>,(WS$MG;9A.5TA$"OQQ]
MT%>K0)E:T^$"C?WRYSXNE&EG)!$K5?I1<@^13Z!Z"7[%*GDF.RGT9\MMKDX?
M26Y>5OSRP,^C8K/UGZ"5.LQEVL;8+5.'S0>>WE=EQRB@WXRENF9.^=-B=.PK
MW+4V6ASAJ@^JCUD\9%7*7DW["]HV%_8*R-\7)9S#]LU"YYO)/Q=?)D)6NJLQ
MDRVMI#@QNI?>4WTAFY@?-*_5+"[RI.F#$+?!%H7P>\KV6(@=920]<G?+I V-
M?G%8VY5NJ'O$*5NXWV;QK'N]97P?M[6:%79&4$'E/VKT/J7&R,Q3LI.&!M+J
M^D O^.#CXE-,0>D24251!_F3WBMMG/F_'33\;P[P_V]#'O7[?P!02P,$%
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M2^,1T0,@X,(X/_H&T2]]#EAK+Q<M6J_>/P^3?]*;'B#>458.F13W8'!-8ZF
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MIW<Y0U%B(@VY_ GSIC1@J,[T)^" :>W-M T+DBN%S$STP\?$' X>OPU_>AL
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MK1=@;I%%^0 -/TXNWBVJ]%T_#"SX,];='WJZMUY-A'583K^@Y**[S'[*M_!
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M#1I2\L4-^9@"ZCXX1=+]@;C2L9A*Q$F-@76ME^B>W^<0IC:9E0MCBS%IR(;
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MV>ENL9EDW"6A3,ZG_$21=?J].!UY=LD#-&!WUI)7$1M\F,:,-F\E7P>@-CL
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MU#/@7*0/MQ\_]_&;W( @(V_>(R\D36/J(8]>2<JO\?)TH>Z!RMD]B0N!R7N
M2&C0!^\F6HZXBB_'A.ZP5_*S7G='G\;&\!7=V6NN%MXZR%Q)_VT.7=9@'H%?
MB^F=RAKT=$*@[C:O'7^. %1JGX0RN8PEJ0HOWZ@V.[/3YO\]LR7YIJ%HMS%W
M4[VS81J<GC];QU,,H633GDO6O0II6UB2I_Q!VJLHB/?N#"_R9%_OW!/E7V),
MW]PN]2#.'W[X*EF-0/[L!T^+G-'D=?_\'=,?)F3&N_SM6YCIM17TW--@-MF]
M@L]7P-N]*-7E+LF*634)F^EKN/BX "Q'I->/M!;J1'@/V.W0G9=5&"T:&?5
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M[M9@EY]A9>5]:;-H/0E] M0UA,#7]#-UGP R'3-_G:11XO<F%@O9"<8BH0P
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MUDS]B@"F;UFT*DDK.'B&5TB+CCNW-2C@R(-816.* ]2JT=@!BCQ#R:%,B;7
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MKY+-8M>K?>NKWQ&V8+K8]=INI3<JICZ?2LE9>MXO$F?.R29&:<QR;]BK*%2
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M9.+>T?>T?;,2[) 55N0Z+=K:.X9&/?.S1T@6;9)&6L9VJ/J/K#C 7COTBV>
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M8F_8U2J=?*)C0LB%=9G$SX++X<&:-I$JBVN^'Y*&.:Y[,YE+>TS^,,R"]QQ
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MC>\$ (J!4<1ZZD.NBTW1D^T+W=*J1B8BMV:8'W \R3?7VLR)HZ(U!$GUDPT
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MV^0L<_1&3YKV6](HFVAZ@87#EI/>CO]'"%AZ>X@]H$_UWB IEV,')W:W@"%
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MH/0>>F\&$EI"ZA>?\YQSWO><[XYQ[]WPQ\[(REJSS]^<:RWZ&'T6.&%L8&0
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M66-#7"$AKW8GM/>L<<C@&"G$C0#R1\Y EV5J&7$D$#D%[D)QEG\Y:+P.ER5
MG-;VLA75W)9T\+]#S!ITN/8N,M(/./D$=9"V@[QTY43',O63E^5EQXZ9Z??3
ML/?O"_08YC+0P<A3EB$"I,$)JD\(U^['(^?K>Q5\K*GW]\'3XGN2C; D"F,@
M'8B16B%5,OP@D@YDL:? ]LQH:Q^/S.\@<I<T.#LH;BG37J/?S1JGXHH(17-T
MX%;FYNO8T4TTU8\1+YD$NG<RDU8U0<B@1QDPS+VE2R]_AS2LNS#2$!W0I;HE
M,,P';$!+ DR6L:(%TV(,IK-A:IV)4CIKOT-T*@\:5^E (/)M-G)/"8E")@,0
MV#(UXQQO>S]#(JX1W9C)@FGMN+*1S/^*.Z?-U+ 6V^\P#7'H!H:Y:NA8HAGF
M7<[(U$/HS;*] D9JHP/"0.Q*]W:[<<C>;V2]]MHVPUI]/FAS$?O]:9\9'D(Z
M4=#Y5W21B.C>=OINAM)DV#[$;1F;> @YHL;PJJ)9.F )(N<<W'J"?&)&6IWY
MU<=<EKZB)OLAIYQ R(5=ZHF2"F88OX4B:84.^"%M(8Q@+;!P133@^V<ZT/QM
ML&*TAQ&M!MZYYA'5&)%HBY&D2T>A)$L%7B9,OSXOD]FM@;D1A4-5[5N*W;'0
MI-DE26MHB]PEK*/_PE:$L#;ZV8H:OOJ;-ZRPI4C7_Y.DCRG?]V0@_H[,=Y:G
M0<^>7@:L"T<5\)JT:^FT2SLM=" GX:G:2,_AM.NM$07N3N/?]PLCDM[*C0N2
M;G6M]"02/"<&*6X)ZF1[\#<8:CIC>A<8__W1ROYJV(KYX'3*?#L33/:.Y9/!
M:,4JA<EI>\UQ(2O#^_!93K.@G;A7XG(X9+26?,FXT+TAV,<OM:Y."5.$:\O\
MIQ;+N@S%X&MVEOGKQIV:0?:F8[NO?M_='KV0_QC\,D%3Q*?@ D.'#=W.1$6C
MK_T(]?LI_-P8R2\0B5=6MRX]<C332L.\UJND81MW@H(R@WJ,S@X(L3YY+!+Y
M+/*"ZD*<>["-W<$/K:1V+E@>MSKY.AWX!IO;9<0XC-Z*].9$UNX^H8A9I/@R
MGR7W*>I\;,9\;D+[I$'KU0]<N &'NG'0YE@H/D0;TF D&;.$_C/^CU$L-$JU
MDQ3#]A1\1BUJ!WK2'TIU\F]PW\:H\4STHX @;D=I\N4I-Q3T-QJWZ*Z&DUJ:
M6K0-Z_ _(Q^>0,V5%A6K3TS<Z@XRPYH6BH'W'Q&CU).QAGVE?,X<.<O.<L6]
MA,AC&[VB(RO-,"800)30'\@:4CF:5?4EE@FF'ID34_V\[?''O5X+B$J+3)WU
MX &281G SD,ADY/Y7>!T!F9P@WM^WJJW*IVTK;S4A+?]:L+-4;#TQIG;7C$*
M_##]CI:N6J2.F'L,CI'0 H02YC[/\;BA(@7G-P=?^"!7LK%O'FK&! 1!7^[)
M'_>:/]@KVN28OI/&7Q5N]9P9^+'HK])ON((U#\4V;@0%!X_0NF^HIFDTI!6)
MF"(=;X_A/:47XG&-19YS6U$:'#J'1LXFWZ\:<?(]'U%8':3O<V7[[0ZY[GGF
MU>'? Q@[E0H41.C048Z/0?Z?:*<&'B'T<^W=TDK3.?,*')AX]U/C)<N-<Z.+
MY9VY]\J$T^<4HT./?TX%L_LS%1(#=97@7*W6DA-R!'YKB.\$Z%I(_PY%1:W(
M#!D8"L8A2X0$BB!_O8;:'ER:F/M:XWKS[<T/.355W#9VR>KA.GCLEF,(;F8!
M'4$)+ 1'++W<:=%1JC(=U1$<E3CA^)$E5?=#!61-TB55_(-\WPAD>\;9N=I.
M2$*HDU"2(]/M>&[UQ8*YK_X4-^0A&\9%W/CNH0Z0;;"-[O+';4M![<;D7VX:
MHY'GZXT"77P+W.(['GVI'- +D+AH/4/0C>:(:?BQX6!IB%BD3OCI,+QHJ*Y:
MU#GOTVE4Q3,GB].Z.X5KM+Z"GTY>$CZG&3DT&]^;@OYVC]RZ2\,1BL[&UQ=0
M)T(&UV@J^MQM3EY.5^]=GWV2/S'>U'40SM734E!7E!5?G\L8TK]&4_YIK0DE
M>!(F!H?(?<P*2>(><5(7GTUL7$_H8?(^LFW)J@HGW?IY>B>3X-D7%$P>=/;=
M?XM\,B4R.#']E,=._G'."4;$;5A-ZYJZYW/ZRI.,Z6') ;$<QH2I@T/!_<H1
MG8R00# K*!AY>J;FZ[.2A;.\DH58K E?$JOJ/;/ZX.!!["+X811C#(0QYI6S
MIAWC-:Z@C#'<Y++.H,RV)9.U:(B;;1>7ZL7%?'7LC9A>3!Z#\N%= J% *Z(G
MCN Y,TAQ99:/NLQ_X9J,CK\8&,-[<,Z34DWM\MO-7NM- 3^9"0D!UVNO&TG"
M%-!/IK@*B'VL-\?M*F6NR]SHG\#D5%4\2V$$,T*T1O#P*V>=ZTA&X-+6UJD2
MR_GP-10;MR4R.+IQA7G<[N S(T2PP4HD;)HJ]%^]\<=:?([H04[5Z*YM;1GV
M(%;13UK*&'.SG<8Y'R+Z%P 76$>O(&>O5YKC/&A&TQ_:P2$,>)BGU']%K(IO
M(5.L'E($?[#9$UQB?;N?HN#M[HG9T-]&+*%V<D(^.Y\J@B=<,[ ,/[>$?EFC
M)8MGMU.,R!#*V/.B6'^VMRG(('%XP,O./)5\D*)TFE6-=1-XCQ7\R 4IM9N_
MU_L<AJ<2D;L^YMZ+E*LX:N6;ML"[N.F)GON-STT"G>!Y1NQ?11\^Z[!29XNW
M5WNE W)<=61IL/$/]%2%VMD+[DY]2C4N$09I!I6?O:K6."E*![@7WW YFNT-
MA(*ZWOT3%]YO:G<#AYQ:6Z/QCI^"55W36M/9\.VHJ0+,O F6U#V:_\JTI/1O
M.G#R)9SV$TH]FU!=[S#O1KDD]5'C=EZAGK?W<92IIU0M5 F"^:2'RJA=$5QN
M-"66D'WA$BVV<>V9'.-ZG]8SE+]^,3'QE!L9+KT=G%F!,LR;X_CTY9M,?!2'
MZ+/$MB"BJ+C$2>G?][JK9^8-?!)B5\8;Q>A /)(1P<ONH'>9K+/(!=1EVH/Z
M]'T/8G\6Q8]HE[-.LIH+LZRI?CUSNW_Q[GF_B;R;XK(W8W[^D#)B\9F-K5KW
MGJ@>)*_IX'?W=(971O,T5%QN9%=<K]PLC=#_ W48!0<R61L]*MW'P.5EHL?W
M(R,^2.-(02&RW2R!G>0U#9 9S+W):4MG$;G7#W[[S[K7RNOCW2+R&M>6 ,,M
M;GVUJTF902?^R13LP$'<_C1N\]TGN,"U 5C:^IP_]D%7]ZG@3D2YQ-258W)>
MF".O?AT^?/CW/M]N9L1NL2F;0>7@N5-V'B*2_".X4F]1M^U/T3M-@/6OF:H'
M#5F]>.CL5@2LJMC5JZ3,J^J=9WZRWC-1CE,'WL.Y<R'&U1K6 VGB66ZE-E7=
MX70 4T(9A2KQ'_(17/0K%;8O;3"H3YU##NT4^M2;WBX)$6"\#_S1/.\X>&$=
M1+ CW?)@"1P()=V8SIPSA8M@+W)IF*$F\5BL0T<V0_/6#,W?3UF@:2\QD H=
MD'L)%W&GD?1V% L*][/G#V]+4G<CEG0R,HV!)=HIA#2NILV3']/;FF;K4-4H
M6=D0F292K'ZQ]<WU%UJ/.-4M-'S3=I*'0L]2CEFH'-G248"+*T$F2G+,YX^Q
MLM%L#2ZDOF;#GQW72"AQG.$XOEBPE0N2861M<][CE32267V(MEF5DYR[V3M7
M,AW(]#W:;X' #SB,;DSN9(8C^;5.XS7;A*F]+U7(VG94_O[I(Y.?\<@25J.3
MP(^FY^Q?6,6KUCQI=3H1).M7[N *@1:0$.4ZWJOX,]%X9,?BFXE1'HH3;[3,
M]^92D8'#YS&15]\EF=V;J"F[G@K]",T%J#C1_BXVMJ4UL9N'#DQHQJEX$V_?
M3':N>AW\FT*VV[M0<.Z:=0/O7C!8ISNTX*LCLMCL'VV2LPSL2P<VT_ ><>%H
M?F4K-@CQURA>7L8$R0-_@EG1BGY@R*&@!T6$]LW#*E>G#^$?W15_Y"]2HO2
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M9^];^.!FZ:')ZR_W-7WZ<]=@(NWX'Q-W5#M57V)4Q8ARO:^"$MQ!1Q%'B^G
MP^IGO-ULX[N!9VG=->6^+$E*QK9"IS#/<C!"1\_S%DGS^G$6?**<&Q2 $+WG
MOJG4J3V7%WQ6*ZUS3^XH#-5@1%LEL4,C6Q6?PSIG81%T "+E@CB!KZ%(0[D^
M>TV895ZOK3KFIEV_D_Y<S,G@1U*% *O&=NO[11[#LU6A9Y$_DD-H%!!)7?:+
MQB'4*].S]D_RC?P%,-F:[<PUN\5'_[0Z_IG2?E<^76B4<T])T1!_%^#M+<H_
M@JEZOV.\PAZ?V_6KE00<I<@OP\8]FC#G,H^'2B*,:G'[Z07PB/9CP?,B1A(5
M,=)?RU&Q>C#F6OO""[E>3>*V5V^8.M"!Y^\0UX9WN5YH@,,J/5ELAEWP3PKX
M,_W]\R8NO55H8<9+.(DC/O+J;[)&5 684^[@.'1$\ ZQD9]T]SUB. 7/*9.=
M'Z1<'NG<SXKFR+(2_+X6;3TP8-&RM&X7#"'JEW6CFV[F651B;RA,?%5#>.+8
MKA(CQ./G&R2L4#APJX>=3,)H&^9\O\^M,_/R;WL[_;E8+G9QB;'O?49RT?IM
M>UO$;@^V@$7]-LPX>[T5XPN(,]<G,9SYK3C))\M=3G1 :TG3J&=4BWT_\]"Z
M^7J&\&!NK/RK9,]YT-J)RFN4USXLG) &N^%*;<U6E,IR<O&8G7N:"Z9>C3\@
M_MR77R_>%TLP"X+T'.V]C4W&1^W[[0(<XVH24;M!+XJZ.">4[GAEN>5ZG_FJ
M42S/\L9 (VS-S*.P?E'G_BYXH!$.9J?XDS7M30-PKQ_@H<^=3J\0O4L<WHS\
M'*(#+E-U9Q5=I7Z%//GJ;)V/D":NS$&CRR=C^.>#M3U,=1R+YJ9N2W@6K7T5
M121.U/QJ_*544"'\NM9:D&QKEB9&*L.?STQ<'4M"7:I%U44F7YBEX<W6Y8S*
M3MUQ/FL%R$HF8DT""1+_;%4D0/=@NRK-YCOM>:5$N]:9:E"8T/G*XK7*K:-0
MT^/-6E[-;N?O7KLY%?"(9]:_154CC4 .+GSA^8YM!D8],MJKH=":B<,X7AB:
M'X!YE53.'!ES&U"IEYN03)FWX5V0>,G]'N1.DNM;Y@E"_ YD!*?1LV(U/3,!
M-&A62[B7/98.7*(H4P^7##GZ1?QR'!I%16$OBBV(,/+PVM]MNA#]/W!L0_/5
M"NK5IWG]/[U6A;8A@Z/ FX=N-"NICBDH8?3@M5T<D9#ZI_W*+..5?>*CTODG
M<4N&->:?/:N&JNV ]YSY^6'4Z\C-N*5K8$;>KI_YU<<FED,'FG6Y7BN6G2]1
M3JI&W>&FI*\)]9U"O.&X<O$ Y6Q]9]0\\ >B;169I_&_^]77K64OQLE5=1&L
M+RI[1(#^ZK":^'/'=+QM.*[P/[I "7]U@3[)O)8O?.&JU;8JFT(P%YR\5"0R
M$;:6>/OT/[I +F53R+^:(FQB\XKAC@ ^.@'I1=1K(=7=U0GN5A6R0^/Y>C?L
MM6:^QC5O>"0GZ@]6<;'_FHC[,#?U8+/%;2&[0P8ZT%""' 7W(6V=,_%[7/WH
M/"<YY<4MF;+:YENRIM,W34D@5<0-XJ'Y8#"7K?1+'15B^T_:V13)CL^]_!^?
MAN1KG6A7291[W"1PNGHV6ERC4QD=F\;QJ#KC @X<=0; %Z\2A!&?P3//']HS
MP*%\/R* FN7[T-/3*7<2BOU65>LFD2)YD\?O"4@S[+TL-E8?UN(M-9*Y_--3
M*C>ZY*V+G$W0GIPA)>9^H=Z[[2G$#.5BSQ><):+&SA^)ZXC5PVO.;T8*GR_"
M)738Q%SY-2V,5U82#=9_' ^BP =SJ 6[5'GY>3! )+<(2M:/.H(2UOE6:$%V
M0@;RXR7HA6E% MMV7L1F#;GC8"2CQ\.-NH9L4MFW$F@QIPQ0SP7J1)&M$!(C
MBAG*^/TX%\U#4(E;26.&7%I\[T^7Z0\@3'.(KR"JR9_&W=_,TK:[YLY"NXWR
MAK7 ><3P_#"KP4=[,JJ%VUL* U9;X\_*M$;0+L@7:=V8;NFG?L'R+SMW=FMC
M7CPEO7R:U0UJ=,B<1O\"8R3&J1MT($'[ZKKSG2:%L(8@AK7)#CCH+]5L">3!
M%^E A4)*0E:].IZE@R;,E"2I.GV*P=$BUU[ 5?/7O@@U8DM6D:?\_%Y^N7!<
M"A</W%U(27NQ!AY'TX14IDV#?*$X%LP0E$]MVV.O?$/@I"')V\3D[5W4&+.1
M\@-]RPXKUH<[?#U$D-7P'E>-2=','2-6ZU35GV)5Q>VMN7EZ7DIJ-S6<T+;S
M$J.-VJX7BU"X@N<(FQ,L-%V-MO9,>2["V<@A$%',EIJNY38/%88'MU804[_7
MB'/6ACDVO):1KK6I']ZY4\Z*](]T&,.,=;WW2[8R=E=U(X&)]ZU<NW*='F0T
M@"@7UW_Z"[SO^.481NH;O:C<?Z\C*)EAG^0<TH 1#:78CHIMB24JZ2$T!U\M
M!OZCD_??^P&7D1BEA>LVE2:>@<*#)K538@W4_%A%6 ;^W;7;U15>C$29=OW#
MYYLO)4228OVT_#V"= 1=-:ZE.59)")X^:>3CY2^4(_=V_/&([[FOZIOK-D=9
M$_L8))BO/K%M@2-Z\]V%H[^4IT#+)]Q\S]CDQE?]_-+ ^KSHAVS39>DJ3SAM
M>\N(:#V[6J]^/NM(@HEK]I>J-WJ!@4=JGFPG8^?CS9^:GY;)NB@"7-'ZP%(T
M0A&-L*LD(O-M-P;,O(,?/3]4AWHVEP8? KX:)IA(O-1:"?;2-E/I\#@)GZ.P
M%"+=(%[=U *N]_Y<\2DSB. 75R_HWCT :KH@>M'6N40NB[@[.,?(8-[NQXFV
M!M/."?6?;_1_^+4:?<,WH:M _8>87$%K[P%/&7HF[ ]8N* VVKN3VQ17XWL=
M61GRZ;Q$STB'-.9S 6D-S,Z(!@=<Y!(Z\'6 93D3L]#Z9H)RA<B28]\X,'TY
MPL+/<*KFG&J-($O<VTWOII6\P)4V&&9'#T4'PA,_PH.OCDS<J:GR<,MQ.&68
M?E7P0<#=UN974,VNG:8M>S;LVME,7.]^ O%>R1KI4J6M:1*JL*8&M6UAEUDI
M8S"[9-CBDN0<S3F\EGF,XC#;>W05?0)QR:-(]S.11#!6VK ^V57DKS X\8/
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M3/S*$[MW3Z4"D^U_:_/QQG>RK1>!7>C R[2XEBWA,4>WB_"7ZR9,@8J1BN#
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M-I_QB;Q!RKG>X$,?'BA_&5J[45&88#S,DSFG(ADG)XQLIW)>K2;U/J=8\RR
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M0MX_'>!RV"%D4[8UJ 0T3DS%M=-BP)U?EB&H29O\K/QT-\DTR7A $29_;:'
MP.((Y;@W SOL#KQ9'[686;=.@'R"VGZL;TQQN3/RA)VY@KL)>%@2V$%18VL6
M$<07$<-L^O85NZDE<S'&8S)[Y_:_0U9N(YUGXAQ/,M+/C( #T=+<;?0&GF_7
MI^-,N*]HXJ66"Q9*/-?4[6.S(JQ4<K_ 49<#>_+4#>0PE0-#ZME3B=K#_W-+
M):T<_9X.-(#]GHCO1L>L0,C-0?M\2_P^T/_<5TF<':4D-FBBMTK1N_FV,BS)
MU(+=U3T8TYAMI[(AR#PZU_21=(+U]N)8>1CKQ(W?_"&9<FSJ8ES:@8\[OC<>
M^C(\C=?24KZ*=\<<3QYN:]5X_@G"/UJM#W]ED$BS^?3#1)9=QZ"8; ^U,^*,
MR)W<$(C/^Y%@U7^___;RL?RKWYR#JZ.C+.J:/"<CP/)W1ZL0FE90@/A8TKP9
M/8Z[?_F=C37!HTGN56[P"W/:CS7(E75KHATLT VWT/)X7?A1D/[ZG:L5-M?"
M64TKG3VE7F<L\DORZ$J7^#IJ$>/GNDV^!XP->Y:TK'N[I2RO6T5AK9D-)YPU
MX[:4N$2"9N,[5-:&OQ,7FDD&$;,?;KJ17/(2NGV/MWR^\"E,^AW/5I.HV"<V
M\22F\9(A>>5W:1<'B>'WB>VKR/M3RL>U>K[4<8\K/S!81* ORX?]4&>+'MF6
MV<F=?8*U1[<=OQHBT$2B9;DM?AY!N0S-]G!.G@N.NQ'$8L6[.*!GECR5LPPC
MGL56=6<V[=5G'*L]5Z5@O$X:65L,+]GLSV>!8[*&DXI/L2X<C8]^!G5T<+@R
MLOU,V3D)W*HMWX2\UR!PJX\.N&2&[Q/ 3AI^:><$;A[<J]^:44M3>QB;()Z\
M>WR@;/S!;$C+!"92;[SG9L/OF6NH TDT4[#-B'&>P60&MGJ*>B?>\8K$E0=Q
M'VD7C<0FF6X\B-L"S8OGYX5;=YDEA?1C$J0<"I9 @=^"T]Z<BEWG]KZXD_-]
M(NYMD"5FDTN=ZX/X!>2K8(O6'*PE#AQ14Z6=C%B<]=-N3&(Z-#QTKB@R!UQO
M28@H+)*L#_L)FX$PR!7,QAK\(((V!&IJBR2MMF>6Q!A(+E;SAU85=3<$W"B;
M,GKSL^>[') F\@0-7[1@M3VZ),;F[O(I3J$6%/(-6>G*%!7 ]N'T3DX'J%56
M?!U4V8I8Q?'536I_NF7UE]B-SL15Z3>12R;6KG!D;#(7,VC0H ,G]GCM'9KN
MOCF:(^U&.[UF82^'=62;<9R>CPJ'5OS<CD,%!]]D.?WMZ=6GW8*:$#R7\354
MQ,][^Z^&$L8T(T0SW._P(=[2S D0F/MI*TRH.2&]INXC)^Q&OW/%R*:B7:O:
MR<KLTW(:5_B:-YOFF,3,]!Q8'+ZO,*ALY\)SN=\9"OGDQ::/W2OX6O;^/6=$
MS4#^1?,Q3)[-[8#,Q=1%77__8P:U:9=VR@Q T[P'I1]=WP?VOR\2G)2%\09Z
M--&!.Q_0&#[)KD9+2LYFQK"!],5B.-?W4,GHX] 6%&?^'=_]GS(,5-B7-"J@
M]KL;ET""O(5#3 >7)YN,\DVD$CGAW\-'&KSXH+(Z# 88HHPI^S/G5$/W/3E>
M=X_+TMN0XHCN"E&Y:A#W9459H]#KVXK$AR6<(U>5D2+$T2LW#P]7X)4'3M&!
MI[^<07F2F1P(6(&IX(".\GKZE<L.3L;E#:#(6S%HV_U#5CN9S_J>D 8ES?<+
MX6(B-0,5I!+%KR6K&$H:0P<U%4>1_.[(A1?2=""O'=()JLS/PN>T-/(->)ZK
M]YR=LK4L'C.\BI$*'Q60N>_S]=>JTPZS5Q.KTZ!_4$EF;./Y#RK2.OPXLU=.
M_HRDD M/,4PFBS6ZU(F%T 'A7?1)N/%$:ZAY;1TJ7 (^)O5-+J9K+FD[=X]E
MNT0^F&]P=^:4X0[K;>IB[;F@C,< 56:??^!2PD'!0?Z36SU%0UE'AEO,$ZW1
MM;-[FW,RBJB.9#N$/?'90V$%PG>L;OR50Y7=0<TKNP_U2!8,_'!-^RD,J_@2
M>N+<X]:*\V]2Y<""C +:L>91\3Z\%O3XR7Y>N('(,T+<3L[8L-TMI#+Z6BP8
MR\%!T^(5(+J8(]<L,Q<#V6E#T\Q5[R8L0H(-)@$Z$!D7 <MA$5I'),AA,['Z
MN$R+=ZRAVOU9$NIV=;0>R)"A -_Z43H LHB=L"8-"6 \,S[^2+W]QCZ+35[9
M>&&/UV<>_ $YJT@'$KA@B3\1VOIKM\&)>:3W4V5MF2P;WA\'*2YSY'D;0WY2
M+F=0'*0T3>S&P+;2R.CCGB.S;:=@BQY)([3C1+8[UV?@$BTUCWKJW"H+A1IQ
M6S4J/3.A73-'2Z-,Z, 1G72/LTK"'2'EH.CKE5 >E#X%0Q7T<1ZD ZG)C K%
MZRJ2C.""# L+*=N]*CW77L#[YNU2Q=V8%7D.I1.+LJPGW]PXTAT(;3HNTF++
M&GHZ1.![BHZ FTHP40I55555,RU1][C\XJO%\,XF"9;W5IX/]Q_C&B,_]OIG
MF<Y_$WFUP/'&K5$:'5T^>]=E1@R)"K*6)@M1Y$="3]C!"ZX/M6?YB^<5F<$3
MIRNP5M9R+^0-#A..UZ5KS7JWP6Y4GY8VS<TF5*::G4U\4/%]"6U9[!C^4+9]
MQ")_?HHP?,/\MNW&:LB9FL>!OQ"K^&<4O>F7J/#\J),&08S@4<1GW8-D1,.)
M#<-UK=5:,?+MB&Y1Y/<$D;GI][H_+CDXT0%FE^S4_W4V\2:;AS[O32;[FM:M
M QX8?A0!)JG+%Y5>ZDBK2BF?]30V.?9#T4(].P8SK?_X\]GK1=]GXXR!#;[<
MG=SF,M@\>,[Q&-EOG7:^'_E 4=2>J'LWSEP8$17@+?D)_;#\,OG6:\&[-:FU
M3*/+DCZ #BES(Y<"3D84T(%#%XB1 ;/(\0B[P<_*WV(,-EH[R +=,4A_3]%,
MY=B5H4]\YI/50;*EOT0#\<H+?E5VV!WTU1SV9)"4Y&1&ISRZ=A<V+M[;AH'^
M[L5MMK0'^3>FEXRO?;$+O/#C"%GCGF<G^X62I2,$SE;A??G\Q-\#2]8B7'B0
M6=[CF>.T4W?@$7.PL+TBA?.5WH5N(S5'G0).!I9[Z3>+<IS,8!*#2Y1X&2W8
MJ6.7F4=OLI](@7VM/N$I?8[ME/>:S5",<6+2>W]8_HS$ZWRY&*%@C0ICA]LS
M$7JA9Q.[S.*#N!@BN69Z=G"[;!HVKU. R1DLX]D?=U1)M@9"]U6OPG=/W<+]
MX[;>'<\<#2<I*?BW[",8L\K>[=)0Z+Q.IG&P<H8/HIB1@;CW][,5B:1,&@NE
M"/O7,6<+F9=KN>/B5L@113S('&MA.! (VU;4HT HLHK_<9;]"D=,[O;HHF/F
M-'CN>I6;5G5SV0Q#6],ZPUK(]=%5.4WHGB>-C%PU>,IM:Z9AEAR,Y*8#[(]B
MI#'9!]::=L2XFBKC/\J2_?KGXMYFS>['PY/*Z=9+T$9T:PBD2J'%:#]0QXI<
M0(PK&/CPWX?* 6<%Z410%]H/R;U+,C]F5$DI)L3A0998L_\\P\9ZL3+3/7W)
M?@[YBDRV',_=25QRC/BS//>?*WPS^K3*?UYE9Q:I3OQI_XD.?#9C,"(^+%DB
MG40'SNR"6Y'-"3M46^3H-49R"3=2(S',RZ^/Y8R;5NZ!P$>:!(WWYX-$CSGK
MK9H_%%CJ_76I_B<4Q4"4_>AW'UEO)_8@DQF*TZ$-=0J;5;9LESZ>:0UI^/3?
MEQ>O#WB"Y*AS%,A0L/DEH\7.[;(I<&N(3M)_7U_T&@C)."='[:= !M=,CAE5
M-5J1.XAQ90,?_NL"XYF87/(MM-R*.T/CA/V"2T8KD.TR),.*3/[CF//'(Z6V
M9N=<K+?*\* M+G=$C'3*S)E=&IZAM_/HX3C"Z%]-ZLSUB5579AE;L[/@Y-!5
MFL0: R(KISLWEY'::1(;NT4?__=-1CKPJX^YV&@%W-7 A@<AW85R=[*[&,O3
M@0W+T?^Y^>O*$DM4^7-U\48O5.,?./S_&D<<S1= $>4V<''\GGRGBOR/O2.*
M"?/,^^_N2;J^WA#!^ELQ78VO ;PS/(8W$HC%%VIPXGFR1I)'[MTO/QUP^=UE
MP%]GB*F_Y/,#-QT"; &\ %6E ]]UZZ4?SBN.[WZ72>\1GGXG>ERHTSIM7=,G
MD.UIHOJ"&-NC453G EQA\WS2FL;$P8-%GC3G7+4W'\L=U;G>0^(:=8^]M_Y!
M!W 6Z&AK%.@I16&N!-R":>MR%]ZK'/T_I7QY-)3O__?TL1=-MFS#*$+6R!+)
M)"&$[#+)GIWLVS D2[*4-7M"&%MCS[X.8FS#R-CWD&4H!F,\4]_G>Y[S?/[Z
M/>?YXSKWN<]]SG6N]W*]K]?K7/?[93)@I]#+U&[=\-#$\%IL[ ,;^6]W4.K<
MIL\4)8WRU#XU0R<Q)=D:.BSK0EHI!;_;)-0G"P\5$KB=,U(^URZ> R);62?L
M,1CE.%&;K[>#LV],,06X]%R^<VF2(M&_Q"V$RLFE,:>0)KIR;@E_J6S>,EET
MY=T.]TC.0GPH<\S868;W=WB5%9X;E8L8$"B\4798_WY*4K*L,#D_U?R;8223
MS<X_<CZ5/HWXU09DRCD ^7LF.!>-:WPV_>7%K6V4TAY$DOL!;%:^TKI"TC*C
M:S&QQCM0S&(F1#[MY2 AD1GME:Z54^H9^ZQP!X6-1VCNX.8K$EH(;1?\P:@,
M<,3/[7)%"U=((CM7T)F4FA%_:KOGCQ6O^0THLJU;A%7 7.+^Q#CSG\9\# ZY
M/CH1M65^R;^3*RB ?:.QZ5AR5IYQ8Q_ISAMAV0"6A*W=4B)05GBH$P6N]'CP
MTSR>^%X^6'<ZJ9N<)P+,,I6]]23\B]R#<P#O>LS^C6@?_E6A(KA(B#%$K6ME
MI',T@I,5H9["W[(N5H.#;?V2[\9_KK41C=+?NUH3'EN7Z\/P_8S;E&18CG?N
M\MV7.$Q6&(IYZ2G#K;!V2P%^11]B-E^+][YM#I!&FRNNU3VQQ:P^:76Z2A5_
MYU*L/.3E.P9U]^5B\8CF<(U)/B9EEFD[C( ^976 LBECUTVN]$ $K#<FUU&#
M^.0T]WAF?K-A$][5/4]\J7L.>'1HIV41G7,9>U72?DE;UD2\K4D.43X.I[-T
MMC?&>@>#'SMO#8R_&B["T<?:\*3SA9&+Q9O*FDO3\G;CBB)^Q676CAQ@5<?L
M;JDR%\3%1*VDKX#5\:L<_S18@(D2>W4MG^=--W@XFT<KC0-LY'QQ+IM1_:K)
M*49<YJ;<"(](EX@5(TP\CZ>F=@\L]SA$75RXPBLJ3UXO0J%:2]N.JTTWB+P'
MGQ=5_J@_\6TIZO4KF@FNF&IXFN_[_?M6^/Q>J3$6^6'Z6NLIG ON?SKYEB"X
M.)?Y:4/6[/$^H?-N1#;OP<^Y?1QX#H6)$KY5C%!2<PLC&1QPCF-@\O9^SI0C
MFVU7MA]VSG9JR+3;'13:7@B_V?&@*0O<4'"U75HGFTH@_]X]FLB>M:H\NLG.
M0H&4L9QAQ(3W[Y B1'E9B'?XVC;1E20]69NP+0G,Y((2ANM; C0W(A@+$KK!
MC.]H"]*<H6QW-)H3&QQT!S5FV$IT/WB@M0.L2K[7H" LA"EBF$^6HQZZJ?^)
MSOP,<?K@=>\\;T3Q(?G$R X>)L975EA/]D2D?7MR9IN@GX.]57K4>G(.X I,
M"!07L[GR*,2]$1[7HE2[!K'#W_RZSX>/BHXZ>7"?9[EK+[D_:HBA:0 L!+[F
MEDG2:3:T<,"'J]!9L&P6Z-1]9^-A 4OD-G'MJ<UFP@-RO[YOXLB?4B&%2! S
MB1&_B;IG%\9/-^#[71/7:F,[H]9.\PG3F*V'QL@42- N>-G=HCS J*)VV0)9
M,% V(W7\0#N)H.8#XX"566H=5<G95 QG%BJX,_GO#'%%WH;.B(KX_VS;BWON
MYN'6\4SHJ9+U\: EO R0,G0S2.A7!A'>!\>QIO5$%+?MT1QKY^1QE\$=DF'?
M.\EV!IUB,K 0>1KTR)^7H,G!$([)UAM0V,/6 Y=*_JJGG^,%&C$[(2C?HHS8
M,+6S0D\$M!06M5:I58>O[^8J?>O-*9O=J,LKHF47S%29%3&.%'K)(@X^C;VO
MF#%7P3Q5DXPYSGE!$:W4I&/$<[7 !4=PKS=74(HJFC5#(2OD@G^#8>< _R#,
M:FVLVCD@*(]$KM"<^R6*P<O'8E8IS9(O%GN:\V"E/59KVJO%O%T=!@=W2"S'
M":RBY/,-%L!:WAVWT/>"4?WEJG50-GJEC\\ROV\%>?<=G)/8%=/U';)F$7@/
MLJT9[&A(+OQ>9XR;C&8H&]V6$7(>QTG-865-AG9;NW9S#7:?VT.ZYT&F?7BY
M4,X%%$9@*RC]*?1;["/-7+YW[=L&Q,<7XU7%$KK/ 1Q]HR@ED#E8UCM6LD48
M81O[[1(SV\7\51NBQ'Z.XRF=GP6!!3X(J2WVB= ELIJ< ][=DW&U.<B"S=+@
MZ]M:9+5,2:.TQXUR^%SWP /V$ G_.EUQ78(1KH_Y1NGR\!.385]52E9V(35;
M\#[ZT8L%C)N2)"&1%?I&B<T_&J'.GVGE,!O]].%#JDW3W ^7"Z6Z8IYW!D^2
MJ, 'X,,*\+$P? '11@S;],2A6()WFR%Q+2$UVL[L$</H(UU\?1&V-8A0<JKJ
MG]^)A-:VA=>ZWB!N+'D$NU07Y#RBUW3A?S?5*:>.8N/G_/FK+197B\ITJ/:G
MZ#'1?\S*,"@[\B$] RSW\OK]?VQ6^TD2[X@SQE4=X[&L6J40Z9?Z2Z*L+D:/
MKQNLO=(F[02'F)R.W7M =G!]=/:\-YPK,-@A!BO%M1N\3'3=^ETICR2,^HBU
MU(5P^V,ADJ[X-IU8U@-EU,]^U SL^#2=HX<?#J)_65W?-<\-3$)/G\4EA4ND
MQ=*<3ATC)]W18\C#VZ2,>Q+;BC+;?F1^/G .>'^/5<SF]''^&FJ"=/O/_; I
M\4<O>IXP370>FEZV?:+U<G<A@0M6<E.XD1FII->!&O-J@D@<??'035J.B)EY
M#:?S'[W8A[<G,4Z_:E9ODZ?8>;\?/E(_@$VP,O@"=[(\&:\OG_P12-53YLQ^
M.A\,CVO[(_Q@UKM:/[=Q1H:4G =8PG+!8Z3(#Q[1<-@[^H'%Z2]L\,';^R_9
MV-UW$B]\!N(HNJH>E.%,8JSFF91N[*UNOF_Y9ID@$0GVCQ_H7TJP,CDV/0?4
MWKKGK+ZK_DG%F2,"B#Y2_Q.R_-K:N-3'.^< 4W*BDJM"^3E@FWLQ3DX[QZ@*
M3[FO3#D6W?:EDB9]]8OYQV.+@-;]A*4GNII1B_#>+=UH;<0E.- ).SJEQ>MW
M17HZ6D60RR0?\"!WR:K&=D)1QHY&#]7/WJLP4/0FDHDU&:%SJ&5>/V$N$E ]
M<95<%*+0Y(T2=#HF4^8L;3H[3Q@F8*5YI%XYK[YV#.SDN!$)V"W2O,)Q32I2
M+)[U/@X]:G$QX!.$7<7C\"EU>NG'U+L!__07?2N$'0E1_'-'2.W9WWHO,QBD
M9M_QOI[,(6F4929)R0.J8.JVE>R-^?\C?./T'^&;/\U<\+_-7"(EE:!)HLQ2
M,*3=S]FK]))V_>&83N*+7[.\#MC'M]^O!B2DL0_-_/H(M/A/TW*K^#G@59S_
M%DI!;+WSC*8KX[&?K)Q90=J1@48 I:ZG55S45+ZZI<;WG55DV.N.(=7@5"1Z
MK?]-Z 81?!9XG':8<_:6[RR?).!OTGT4(M(\-O36#:GB?+&BW=A",EO9X !4
M+'^/A=X$F3R1K\+&6;O]K;)EKLYW>G#?RTF7,:Q468VXB:T]PACY;QRHUQ-O
MCD"[(/3-<M9X1691Q@%1SSN>5?)SRWP)S;V%OFP6^"VYTS@BHAJJ>*6'4Q,1
M8V3T $!]BTII3;YU6/P%I8NBR^')9)J^6\&JW,3,5L?B<GB709>*@ZIJX WK
M[K]MGO^E/^.2O7*I'[*\P1WG@,F">/FZW'E@,SQ\YA1K;TIH6]Z$$X#[1?4G
M*R?@#:/\>/<:[=/%W#2(8#TV9Q2]+K@;^1(>OK%[']C\7\V=@K^:.T:-\:XE
MZ6%G9!1/TU#"'^\NUA:B %X@8_H12C)=*+7X6+P-GZ@_W3X'Y'':>J"1\! %
M.!GK5SZNC[?ALK94\B4!#Q-: *;_:BL&S3F3"/8)?R;"/)=OQ;#M1OK6WU7*
M^77AWK]ZF!!TRYE.:Y8A=B2@QZZ6!VCN8?H'QAKR<NJQH0+_HH#CMWKE$C]\
MN% #)W^-7LYT[.[:!2\<G8Q0OO\O!5S[#P44;O9 'Z;#8;<C^J=^%TE[!92<
M+F:!%TZ"1BAV__7_+]D%5ISD!?B0+8EJT>#W"G!/[U7YDRR C+]Z1Y_-SLB$
MJ2*.B):ZL[:/88X/)T!.?@WXK^$('X#9;>00C%!%_)L ]L2[DSD0['88$6P1
MZ/(>?1C=!KL=V=O_Z^@CS:R9LBPVD7W%I7CF!QW*<9M3Q6F#4YC7($(O5%B>
M+]-AL&L72+9JE+QLB?0P+MV]H&#'F1S#[+'QU&G2/7*H7L*%34.VX,WP;&5W
MT+Q] C- -F'A\&2L!_3=Y;$2G@2$EU]_PW<.2"AIF[78TB'3?9*,.5_FMA0Y
M)DX'U5N[.@YK!P9'?S2M:,X!ST/YR037&#)O0?9)(KS4O="H(=Z*?;"=N$4$
M;P,#8>_1R+;_'?;[E*E("U-V07/\HTQS3S5E4+P(5V?KI1&B^"23(Z=Y:];8
M79&S;-](0):M7X^+"FA.T]J2>I3(,V]F5^;%FL1\X11% @86WN1?RHGM- V4
M$58K6\C*KZYJ_!7TZ?_6U7K(EXEVGZ=?@--,SD7&NRLH#@(M%DKDY'7#X?LZ
MO\X!)]O_T5_0V+.'[%7\^IF5J["5>QJ0&@/8+OX4 Q 1Z>$$$_D;&>8R#R-K
M'%]M9[-(JAG37P;2O+M3_N<FZ!SP&MZ]D'0.H#,DHY1Q20@!L?X;2-#<;G8M
M<'1>9I!6]G"].YBXL?!LETHQCYVAWO&2O+S\,?7M YNQTLL'G<;U<_RUV.<!
M6--_2(N:QVY]_+1HU,_B#)W7%.^S%IY07=TC8_QI#KQA,-EOO&1224 ,X(T2
MWGJW,3BE^<Z)5K/I01^-!%=KZ]&E.7X'E3+7U%UH%\R1KS@I<3:#9=2E^-BS
M;J.R#JXI^S@8:O$$E5C>5R)\O&RB@L3+EN9/F5>^W7YQD&<BX?XY+[9.?CIU
MZ'9.\\0HF6<R5Q+1>N> !239HKG17WV_S,6Q*+[&N_[=3KZ(%: = -AN] UP
MT"([WS/)(XRM.899?/ZP_:D^56CAB\%+UJY7=N;S0C<NSS_CQ/WUT6D8^8$@
MI\KW/SYJ*23(Z8PVJY9L&;<Y0%LT]-Q8=[B7;VA=Z3!]5[36"[*DOP!-OK#6
M*L,CND?*M9-^+H&QEK*8)H,K=TQG272?XEBF:>(B!2NWE'Q[?\7K'SR"O D$
MS7PR@K.&XXWL43R7D/CR\C*Y2E'XB^0!T+OM&:G8N*,P"F%TWPKHBC)KVWU0
MPXBB#C5D423A'$#UYAS08\P6WON&J/Q9UX,<S/A<>:VORPPV12*"J?PVC'<S
M[\:JR=ZKFK&UG/R4H\P:OC!/_=0?K)LQA-*PC7D*6SOP_8TK';W/T1F;99N5
MJ"%]P8#$2/;ACB")J7@?OLF>2S3R/)DKKW @\49RP+P*U6W<N<2.$SL>[_6=
M/@8(N5$(#P[JW@_]U5^I7V'3G0- XL6Z,6@/+U?1OO=-T!0PKX9>6@HD0/"]
MQM9(+.-]>G<@(3OT'!!3H6@/V:<GFQ!3UL8"]<]_-&J?"&$W50T2VA=-/>Q@
MNNEFL1HCY6>_YDD#VG=N,:+-,[2ZW\ZJ:SR6AQ73ISNB?/HIBQ7EIWZ]KRW2
MD.*G-L CA%7I&IXZ"52R+")?\>D2]QAN V&C4?>JP[,]99WWB)+G=X4B9,EG
M8ZGX'+!G2K9+;<P4)KR'*D(XX2+SX$Z),K,3RV8R@X0[5.F6"5["H?+3^\4_
M::Y*P]_P@+ U \$/[CU\BIMAN5)7R)*J?2WD"56ZWANKON5WZN4 3YS=4;2$
MHHHB32_GPU03X*'KO8]5:AD!2TQ<R59-8(%1S/R]TL*_Z71,0_;LP3G LON/
M N%=W;WYU^Z*>I^=4LVJ9IP^HHMQA:T?:5-ORI7>BM/A5/QZ'+I)(\A>(N,>
MQP,<];$I,M^L2,KC<7EC?[<#<%L:,""5%R]SH(<1;[>#CHQ0F\06XI7>,I0]
M\<=HQ1]JV*3GM2$-T0C-R#75"U5/^4357:>5MZ!FP9%MI=]5_)R7")_KLOWX
MP[64WP6_A2LD62#W)A/R<^A\M(+"7@C69[M6V-@P"E-$@18J:6B*.-C+(=0"
MV>!(ES3-1KFZ.ZY)MP!)+?4,'P$-KET. '')L-@GU.9S:4L,LD/0S%QVZ/3T
M_8B5#',%&<,G4AIW]P"L$8MW*QF=I<S-!I:U9793-00?E?U:M71-/[B4"-UE
MQ\E:*K#QY"LE^+BE^>YW"-Z\GNR>QU[AU=4&]-ZEW]+?]*T:.NAW22UX9$A$
M%.?S"PE&3W+PT]<!9APNM.TE$'+YSP&=1CSPGW^3U@S;4N[X_/JK6:)788^=
M6]6E Z4LRM&O=*O1[7>L!M@@G;=T;C^O?.96NX=E"#)H:6F<J#R:@14CKI\#
MU&-1H\T>B:\C[/R&/#VGAAXL_--["'R3K4P.8(640@(A5?W/ME./:5N\MD=*
MD-[W_S9$MV(</[]MYA2-,R\HMN:ZYM]_+Y1_,IC%F5Z#DZ$X5#CAOHA@-XF;
M/$/&$)=]:T-UA,!3VT</6+/5X'Z\=O(/7CY:OL.QS!OJF<.HQ#]9XV]*0*&T
M"(S76^*'=0Q 7JY4KQ+;D_N/H0T=Y7E_BYPNJSH94O+^S2+UKN<@\LR^7+7.
M6W&:SB6X ''QSH#760 ZHV>A (H1@,+%J8] L3$95S]]/.5>4;QW/3*KU]VF
M6E?/0Z:S+/%QA);G)TFNF]PJS!C6<7@G9"FX_:\OU<]4F,E;%(%S[YQ5&C:M
MGMAQ_\V@8E3;$(#=<:RKWE'3CR]F-07,V-I2Z64)L4Z-T*3[MQYU<UZ<AB9P
M;HS,]8OJZ)_J&.GR/FKULI6CYV-BI=F5"B-GH&MJ2YGCWIR9?^?-[<_F_;QC
M([;!ESP($\-L_I>G44EJ$KMNK9U?^IE-/\9V]X3QV OK[%V^,$RAZ.E5^=$!
MZ1^D\:J3@\=T:<:OCX7IZ5L>%@"U1CL < L >$)S+[AHZT0[MEY.22*&R\'$
MJ\G1L?V$^HS*J_7BN*)ZI<QL\YSTV$HSL[:TI.G&8ECM 3 9_35J5Y9%O*T3
MRMT3J(0LZD<X^AE[/'_FN*_+$6MNEL+4D[NDWQX*O]B^-]F5#>D\Z=KT/="^
M,3 M5NUF.J$9&@X1#C\'B$Z^>DEG#1#U!/S-1@_(7HIZ[BFUX#F 59W(1Q(4
M!1)OZ*W QZ4@).%&A! %6T<KIP6MOQM& YK6O"]7K7L]0GSHY\^7=T#(I1@<
MF24(_<_&[6;U?,'HYGL(1RG-$76XLUBI9BA3V$@)+\^RS&KC^D_,)\*K -N6
MUJ#00SKKJ\ZF!71U0OD'U LA+JIDB,1YJ"#$L3P'.LN43J GZB>@?'&Q/8F.
M.U>[>Z/'-.@7*+NH# T;K.H=^6-7;,.-(/9-&\]/9ILUL1G:OYLS7'^7R9;R
MIQF_V%]:$$J)EOS*)L%UA8O7UO+78>/-Z.--\-1S;<@S:,$DEU[,J4'DLE[J
MDB3S62+D7LZ,\"N0]KKPG6]"M+0<[$K]"Q:79_SME9V=O_*E[@0--&TT?](4
M&?;@[S%17'S\81AFW^(MK0_X%"/T_SPJKQ/*\5"+/8LW$JXUQ37V7\9JV"8K
M,/H!3-"4IYH!D@I9?%>*J%):K?-9MVKC2@ER723>\;+?# 8/,#XBIWR9T-*!
M1ZNIEU5@\>TI*Q0=FT(4?;L09S%.=+[$XK:VV.H[:3\F#5K5VH,;<14WNI)H
M@12O*BZ [-W1]4B"+K[T,>&K1UGOYPU<1%9@4$5_Y36A-,;JOI@?\+F(_;L,
M+?T4!9F+NQ$5-W*>PF3R!_B/KA^:!-&^25RP9T**#,3F?CCH7ZN1;KN\808Z
MJM[ V66_GJP*F-0WFRYP5<PB[A@RH/M7#M"W%$N7_+:OS -]'OW$=!X=V*VH
MR.RXYB=947BK,[3H!.*GL2W,VOC0<9B$7SFWH'[557S?VM#A_+?L0_'=%$]/
M(/E8&%,!?3_@,^G5;N<,]C8LT31<9G\P!FW:W5=4%&"^E?^V%,H8LUXHXMGU
M7MSB-,")9)_N"&87EY&@[BUCD!I:LYL0\SY.'2(JBH#V'[1Z/GK"-KT.,*$0
MC_W*CN81)/PN\-<U&Q=UEXXS>U1FMV_;'''-X:UK] (%;TAU]U=A:M/<QH*$
MA_48T6T;QBY'2LGXMR"GC[">Q@MG2[KC:_GC-5!NLZ$U[ Y6_N-7M7@C/JJ4
M2"#?^UZ/8=:AH*@D[5-M!VQ]JJM2FG^&3^=L[SIJ]%N_ETL7.CK9AN>6&I8)
MUI-RGUR/\P@GT]T\M UXL?*(G\C[XF'(,)N<Q3DZ'KE'W6[?5FI<V)PM5XP&
MP)0.9NZ1J##GPNF. MH<<-6G!5>;U/4*C96L=<5U&?<N$@^F621_>B-0N\!7
M(;C!79SV("Q5M#='0U2#?U]#(&GZP:>Q1$\3]>'4<T!=@0%1\^M>$5'X',#E
M'OG]F8LVQ.>(%U1;N5<$@<.+0)-5_EN]GOZZG7499;)(T7I]5<Z*$KDIZ_#
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MKC+'&'/M8/Y@E@%J74T=30 '!P?0QKX S#R@#N#AXO[SQC9\[)N F(  'Y^
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M--Z6-E['QIL.O%ODC,  ?2<0<-]5259)U@K#G[P7'9D458$I7>]OUJGXM3&
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M/#??&?C4[%1KYZYLDDSX.FGUGD?GT'E@3H<+Q.&K$Y2Q@ZT* C9"$C1'2V.
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MV+WNN;;#.VEL%Y]&ACN!=XO2J.(5PTA?1FI(HF7S9&FW.>?LW6;&-%LA/F%
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M8$FKW)E3O#7:7KMH)BW-[0[$"EI@<::%D[']H)+KY+G:(0T&:*P<@-KG)5C
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MD+R&\LZ90;<\C>4W06Y3$#639'&W:O[FIO15!5=!B-7]0IH?2=KC;FE$85B
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MR&357&SK:ZJA>;X8_N1CXS]-VC^R[X?S"E:[;WL-(WE7[;I"R&,]OJ "GG?
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M>4)VUZE>?)UE+K?E]W"C21 )+[S1>G!&CG0F/.SVVKU>&TL%R(QX)_/WK:<
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M((458;!QP[.40!:F@R)-B?I,;B? \B83+5&-3HI4NK2&\5N[L"IQ"@@XZE(
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M';FXX;+GJQ"L3D/;]^2C#K'X 05-I&J8K&*DX74 3'GN/!5D?:;B>BJ2KU2
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MOZE7S-Z-)BQB-"_W>UZ^BITX@8?OGY!=,0ZA#,?&-,?MHR4F]>9)NP3@X7\
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M&2&+/EV8Q[NT;Y;]%0(8H+Q[MMQ!-*,P<=2TN\-8>;6VDFM.XL2IEF1IVYR
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MDH=S 2<9]8$73R+"<*P".\"8XWGA]$UO41OA2EBX!R<NR:*Q%O_^SN6.V36
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M=V]I;.#3@-@-%WL7U]_\KBGNU-:@ ";?C*$C!T=XERJ;R.X@-NQT+]])]-8
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M/HLM1\?Y'W*&%[708C$8JLXO-'/;Z%ELXI"(B.+K50M.W![U-:"M>&KG=Y
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M:+R97F3CE4QI[$MC&;V0^J6DYNMJJH_S 5<U[QF-X[)&$]F&%D.GGAH]SS-
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MO><I.'G'5!Q:9SG2O6Z;):?3^#K>K,C"ZV4W,S6TOV6:;_957-::RUO/<&S
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MT>[U5/VIV/"IML>R9W[$S_/>3&/.>P*XY'54Q1LTZ;C3&O=>N!&4]:H?_QE
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M66NSWD6EM>#U:")A8KFR5H/R^.OG*F,>09 ]8K4FLU*-?ZVS^[WN5XIB^NZ
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M)>#:_(U8P:'=A2 Z=QLD:S\CPXP]TJ6T?*7/^\<Z-EQXM8*IH[V526@9/!Q
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M,V[7'_/=-*G@Z18@N4 6GG2[<IL. VH X?81#ZZ;7%Y50)HF&&9YA<7RKV>
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MV]S@/'#JJ@W-J)U-P<55A=@T1FB_5843;3Z8<WEO#K=EXK.--L# _-)@9*_
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MIVGB9UEN-.C4K'#%$L8.Z(D;MS#)#9'6M;J3YXMIVUL96Y5RR5UYE'Q5\/\
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ML=,#(.??&/QKCM0@M-%N!JNJ2VL-U&WV:.9%!?RV(VHY )//OC-13:Y;+?\
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M)(\?>P.#GN>#2UNG/2V@]/LBZ7!-<>'[[3]1GNKK4(;HB+4IK9(V&>CQ8)X
MP-W<"J%Y<7$<-M;Z3)!?_8)O)U/,*^>Q9<$KR%4_WN>GY5'9,VFZ1>V-OI\9
MU:SN)UT^-+HL),C+%2_INY!XXP*U[&S"I>6\T-N9;Q4DN3N^:Y8H%F+@#@C.
M!@G.0>*WE[K<G^GWV[6[=?0S6J2_K^OZZEK4-'TAXX8[BQ@G2W@=%25-^V/A
MF" \XX!XR3Q6/X<BMKSS=2T^>:&SU:,AD\K]^F<E'W'F-0N<(1P35F^\+Z?<
M:+%IJ7,^F6<$*Q0O;R^3/$N0,+*<L-V-I[\]:=J]O!INDWMQIV^UU&Y12)(X
M?.N)F0#_ )9DY=@O7\2:B,ER\JDVW]W]=?D5)._,TK(FN[<Z9X,N((KZ=S9H
MI>^8F2XVHV6.0.7*Y&,>F:9J$_\ PE5E8#2KBZM!$8=0W*K*TT74JW0988&W
MI4=A9+?3Z7J]XEUIVI6Z2L;%9=D<K-PSO&I.XXQ@DG&?6K:7$7B+3=/OHKR:
MSMEE:62UGA*-<(JM\K9^Z V']]HJ?A=^J>_G^NP]T26_BE9I+RRDLY+&_P!S
M)9QWCA?M.U=Q,>"?D&<$TS2_$=W<Z5:W5]H]S'=&407-I@,(MI.7 /WD]QUR
M*FTE=,UZ:WUBU*3F1/+CNL$_+G!"Y^[D@Y]:DOH-.TF]EUN:VDN+Q(/LP>'<
MQV;L\*.ISWQ4>Y?EY=?U[;E+FMS<VGZ#+6.75EB\00?;(8I[=0-'N&6+;N;.
MY^#M8#M^'%9%O?6EU-:W"WFK1'3;EK5[>:)\SL[;5:1 IRF>C#\:NV.OVCQZ
M5!+<W$5WJ@>>"WEA,4FU?F*MUP0.N>M/UVQU"WN["_M7OY$<FTECLYT41HX(
M,Y# Y*<8']*:TERR5NWXK_-7)>JNM3,MM.?^U$73+FQU*WMY[AKF:_<W%Q:7
M1 V"+LH&3E3R >*L"R>Q\6?;+F.*<7]L+4M;VQW[TRQ+OG&P] ",YQ6CJD=Y
MH]C=7&FM9W++&K*UT?)!<8W22N!@<<DXZT/YVH:<NG:AJ<5OJ>H0F-;FV?RR
M6(SNBSZ#'Y4<S>M]'IY]PY5M;4=:3-=?8KN'3C& <1>;\DL,; !\@C(Z 8]J
MRK*ZN(]2TI-56ST2ZO-2DB^R1*)1?@(Q4!QR#M4MSV7!Z\:;Z!#:ZAIT\PN+
MB_TZ)XHKAG8LRNH#E@#AR=H/(X/2JMKJ&J-XPEL7M;EK2"%;NWEMHR(Y<Y5H
MY&/5@<$#T-*-G>W;^K;][[?YC=U:YZ/IT?DZ?:IG.V)5S@#. .PZ5\L?M9:7
M/??$[PR8H616TUXC=",OC,P..G8@=>H:OJBR!6R@#!E81KD-U''?WKR[XU&W
MN+W0K>:5H\3>8=K[2!G@\?,><# XYYSC%>3BH>TIN-ST<-/V=121\ZZ7X9U&
M%52ZE4Q[/.8R%3NS@$<_[0Q]>:[_ $GX?RWMFMS-]GU(HF8XUCP''(^;/'3'
M(.<[CWQ6ZUKI>F[@T4<_F%7BA@'FNW)S\I.<YYSGJ,]JM7&N66EVI2W.8Y'.
M]8@6WRE<ABOX9Y.*X:>'A#6HSOJ8BI*R@B^^@6MOX?N+= &&TD_PESCGGW]?
M05Y;?6<FFO!' P_>384*Y8@'([CG S]>@%=4WB>Y@6"9@D$+\*DYP/\ @)]\
MD?U%&APGQ!J4MV)(I&7 &\+E!NSD@>V>GJ>:BO*-9Q4%9E4%.E=S=T8FEZ4V
MDZ+?F2+?/J1\@36_R\#G@]LL!SGG!^E7O"D+&XDMY[0F=$#OL CW+G:<J.P(
M)JYK49N+Z0R2>58+'B%43 4 YR#_ 'LG/X^U:-NHNHX[A#MN3'C<BD$!AUY[
M#KSTJ(0]Y+L7.I[K?<U9M)B5@63+(NU&5MK;1T'7Z>G4U9U"[^P6NS8AGV@M
M$=Q/S<#/H.O-;6BI%'<0R73>9Y<6_P MN3D=.>^??TK*\1&+43<7",2^W+8&
MW'/8XY'MR*]>4>2#:5KGE1ESR2;.6-\]W-MF9?,=@AC7(XR3LSV/'_CM6;EX
M9)]I6,6V[:V5Y!P<,3^7]*NR""2PGFF58C 6V21-RYQP,?Y[U3T'[)KC^9,H
ME! )7!&",%"">#D^G>N&*YFM;MG6VHIO:QMZ7:1K;A6"M&N JXSR/Z8Q5#Q!
M>J9?*CE$,V#AP &52<9Y!X'/!%6]:N1I\<K$N0H.TH,8;U_^O7%W%_<M?;SM
M>5>,;2"0I.> .>V?TKIK5%32@CFITW4?,SM;::XU&TDAN&\]UVA)&;A@.ASC
MMTKC/%&ER->QQ+)##*B;E!&5;D##9^IZ'DY.#6U;ZU+#&%MO*>[_ (@Q9E1#
MSN)'IZ?7'2HH]4M+QI=.5EMI)'+1R9!+L#DL,^G']*J7)6BE?44>:G)NQYIX
MBMM6CLQ8;D:+:?DA. &QG\L^QZ#UKV?]F+2TTOX9F5(S&]U?3R.#WPVW/Z9_
M&O'?%D\NFQS6[DNG[SRT".V]> QP#Q@D$8]#7T9\(K#^S_AGX<A\MXB;17*2
M?>!8D\_G6%&-JC]#>O*]-'8^::^=/VOO%&CZ)XH^&]K=W-M9ZU<W%Q)8W$VD
MB_=40(9Q&&PJ$H<$D@X)Q7T4J_,/K7#_ !2UYUU6W\.P>'(M<N=0TJ\N(C--
M&@8Q&(>0 ?FRXDR". 4Y(R*Z*\>:FTSGP\N6HF?)_BCX]^#OB3H&A:7X2TD:
M);ZMJ#6VBZK-8-.DBHA%R!" %AP 0IDRN1D9K)T?PC!\2_A[XBTWQ'!)X-\/
M^'F-O)?W5S'8*ZI]R[B$6%!=P&' !Q@C%:7A_0Y=!DU#7_&VL2>"=+OYK>TL
MO#NO>59W,#,6#)N0NI8GE2W!SC/6M_XI?#_3]+^ NM?#OPC<R^(=>N&BFEO]
M=MA>/-'(Y8(\>5\W$;-@#IC/45X$H3E:=2WW_P"1[\91BN2GJ_3_ #*?PY\:
M^+7OO#?@O2?"$GCKPY8:%=3?\)'>7 F:>Z3YXFD7[IE=P%5R<#=QQDUC> ?%
M$VM?%;Q!X0M['0O#&K6KVTFH0Z5(L=W<WTZ S)=HOR@H<1[U8[MI]:Z_7=-U
M/X$>%-,OQXDT72+"33(]/M=!F<6HGU)CB)OM*?,BL $$8' 'M5?PWX1NIO$:
M+K&H>'/#WB34-#+S):F6YN+34#G!\]8_+=4W!@&.[(YJY>TE&,)ZO[O/^OD1
M'DC*4X.R^_R-QO!,?P/^+>FZI!_PB6F76M/'%/J%R\L=Y<!028XE5"K,?N#S
M#T)(Z5CZ*UIHOB[QU83ZEJ6K7OVI=:U&"]\R=;""X("")BNTH /NJ3C!--\8
M_#_QGX-\/^&]$B\2Z'XA\46_V6UOM5U=B@<C(>7 Z3$<JG7G-=5HGQBC\#Z+
MJ?AAK3Q=?WGA^:SL;N\N],-S+?-<$K%*LT2[9!CEL8V X.*TC%7<))I1Z=_Z
MT,I3T4T[M_A_6I)KVEVWQHUKQ#X#UWP_?^'O#L>F+;6WB:&X2+[9YJ_,HPV\
M,@7!)P"3C%4AH\WPCO/#OA[P1;ZEXOT>2UAL7N-0O46QTU8%VLP&/,:21222
M 1N"CBLWX/>!-"\573V'A;6?$7@_PSX>O]134],N]QCU*60XD(>XS)L1CN1U
M.!C K9\*VNA_!?3YM#T^WU&3PSX;L_/,^H,\]Q=R,[.(X96;$LA^8%!SD@#T
MK33E4EI?J9J]^5ZV.ET3Q"NL?$G5= N/#MSI>B_V0LJZU=2QAKR8N8G4VOWP
MJ<_,W48'>NET?X.^#M+\3+XIMTL8_$*Z9%IDE]%&%<VJ'*1[=WRIN' QV R<
M5YQ\5/%$VM>$X=0\,2W7AC5-6N+=FOH-&EU%[=2$:6.YC*AH2R_+D@C)#'%<
MM#=>'1\2O&T?AC4;6P^+EUH\ O+R99[NSB4+^Y(4XC95!&=G.0,]Z['*%-N.
MCL<_+*:3U5ST_P ;:1?:7XA@E\,#3K"%A+?ZQ-=:8<:B%3:B"9#E9 <')#$@
M8%6OBMK-GX6\,^$=0N+"^W":".>/3K5Y[@Q3$+(@53\N6=6+D':%/UK7L?$.
MGZ58Z+_;^JV4FK76W[/;[Q%]IF107*C))Y!(09QQFHM8\<:DJVLDFC6^KVL\
MZI([;56WA(),IR>0N.@YYIRY.73=BCSW]#@?#NJZ7X@^(E[IFG^(+'4_#VFB
M.&[TM@JW-E.9"6:9PQRI7 "@ G&:6X\;>*_$WC[Q!IL'@.Z\/Z3:J+&R\3M<
MP%KSH$D2'KY>"6^;&-H!%<<_QA\'^%OA[XB^+W@30[.ST"[U!K7Q%J>DZ:[:
ME>7$<BQH848;=@&_+GKQ@<YKO?$WCOPQX0T&SU:?75?P^VFQZA+?7K!7AC;&
M/-3[X8@YQCC!%<ZY:=/?UW7](VUJ3_+8\7LK/Q%XLTG7?%-CJ=SXAT3PYI]Q
M8WB2Z&UKKMUJ <[#"I*H5 /7I@9ZGCJOV;K?PY9>$=(LFU>U^(ND74MQ=7&M
M^)9=TMM<*^ D(QM#+\X.,$-C!P*NW?PSU/XJ^"_#<?CCQ"([T77_  DMG?>$
MDEBM9[5)%-K&[OT9U<$IU.#TQ4,ENE]\7M)\%V%]'IEO<6$]WY+:4_V:20MD
M/]H4A58?-F,CYMPKB<'3FN6.OYG9&:J1M)Z?D=7\.Y+?2=3U75-)UV^O89;R
M9(HYK7RHX!&0IB' X8\Y.=QR0<5VGQI\87?AW1_#VKV/B+1="TYIUN=0DUI"
MR-9@?.L9! 5RS(H8\9-?/L7A5O!.J>%?"VN>)_$GBYK34;C5$\1V9-I:;EY\
MFYYPT0!*A3UQGBNN^,6O>!-<\-Z?X&T[6U@\5:G?2Z;9WT<B2W#RH$N9(XWP
MZ* 2!M8 #;QV-;T9.-*2CTM_2,*L;U(N74V]#DT#QM\2O#_C^XLO[-\111)I
M_EWUWY=R(\ES$8@Q7><*V,9VYHKE?@[\,O".L7^HSZQI&F^&_BKJ5U_;*6K7
MGVLPR*IB6\&<88@D< #YN,T5K3JSC%-1O<SG3A*5G*UC[8->>>)=1N+_ %&:
MW=V6&-]JQJV!]37HE<+XPTP6^J"Z5!LG3GTWCO\ 7%?04;<VIX52]M#":U15
M&%8D 8QR/PJ6/Y8]F&W'@BGPQ[MWIG.W'-/\D+D.1N'.X'!KKOW.<2%8V^5^
M$[L>E/E#-(%( '<_UIP4N0%/X=<U*J]B.?K4-E%5HU^Z1@8R::H1I)"&RR<,
MI/Y5:VA6&0<8XYI@01KDG+'@\=:7,.PP+NR< <9(%,4X#;F+#/!X'7VITC#[
MG3C/'-1-DDG)S[8XJB>I-D(AWL3M(/R]!P>M.4?+G./2H8Y#R,=#C'2I=VT<
M$C)[=*GKJ5T(K@B*,$=1WQG%-\MHQ!$ "0NYY,9P6R3]>H%-O'DEC81@-NQW
M[5) OEPH ,A1C([U=_=)ZCXXV7ASN8\L5X!SUJ099=N2V.-Q))IVTM@' ]<]
M13?E&%!R >IK.Y3(/,.XQX&T\DMT_.O1=-A%O86\8X"H!^E<!'&99(4'S;F"
M!1VS7HJKM4*. !@5E5>Q=/J<YX[TN'6-+@MY_,V+.LH\MB,.N2I..H!YP>.*
MYO2=)MK>X>ZNY6%Q-&L<DD^"92N=IQ]T$UTGCI;AM/M'M86GF2X5A'YOEJ1@
M@[CW&#G'M7#:=8Z+(JSRN;BRNKK$-M?J61+H,V'4-R&SP#T -7"_):^GE_7]
M6)E;FO8=J4>GW.IQQ6T6F7-Y?H!=QW#!FFM5)R0!PV#CK6QKC:=]JTO2RMQ#
M/(HF182RJ0G8XX QV[US^M:7HVCZIHIGTE;:RLV"V-S;,P,<KG'E;5&=ISDD
M\5K6VM3SWDJQR6]QI-M$(=R.SSI,&P58<\8]>?PJY+2,HW_K[_+02>K3M_7]
M,@7Q#]M^UW!O&@@TJ>5+E3 55T /<C)QUR/2HH[[0-:\4:9)'=F74YK,SV@R
MX4PDYWE>G8X+8[BI=*MK[2[B[L;R_CNX%7SK6XF;?<,IR7#K@#:,A1[53TO3
M[74M:NMT6HRQR+%<QZE,5CB8!F"PH!@C8">#P0<]:M*$>9WMII;S^7];$^\[
M?K_7];EWP[<6EKK6IV3V,.EW<ETTJ*\Z%[M3@>>JYR Q&WZCZTEQ?:]IEGF:
M"'4+V:3R(3:QDI"S9P\F3]P<9QSS21:;ID,D.GVRVMV8PLPBG8.T<>_(D5NI
M^;'?J*7Q5?:9'9QS:C&\UI;R?:"RS",K(IQ&#EADLYVCL2:-)322O?\ KOU[
M7'JHN[M8EN&BU#2]+M=3T]=1DO'5)OLR>9!%(OS!B3T&X<>E4_$DUYJZ[O#<
M-I=W_G>7)>WBG9 !\DNQNOF!21QCOSQBDAF&H^+KE'AN+61=.4P[S(JLDARQ
M=<85@3C&<\$]JUF\+36MC=76E3FUF>WCMHO.=I((RF0KB,G.>>><G HNJ<EW
M\]M?Z06<T_Z>AEWL,\\T%A8S-#=BW(@U^<Q2,0&4,@5N68X).!@ #)YJY-I]
M[K*W6FB]:"TCCC4WUO,/M(FW98$ 84%0OUW&J5Y-:WU[::%>W-M>:ZD!NECD
M@94=@,JV1R@# ' .<51T^WDLM/6QOY=0%S?336UU<0VZ13W<Q4G[5N7A551C
M/H!WJ^71='Z?CZ:>GXD\VO=?UI_6IVEYI]S8Z>Q-TML%R1,8UV[0#QC^H]*K
M>&_#9TK34U.[UAM1O+J-7GD!*I*P4@>6N<)D=<#FJ#:@VCZ=IMIY-QJ&GP?N
M)[V:5?W4849E8M]X'U'_ .N/3[>Y,9U#45D$:S231)#<;X8(TR$,8'.'3#;3
MT)Q7/ROE=W^6OZ_UZ&O,N9&OING:M_9TPFG@U&^3S"DRQ>4I!)**>O3@$CKB
ML>%H=:6RL-4U5=-UK8M_.MC,QA(C.& <\;,]03FH=%U[776WL8KA=1@"K=75
MS<6K6X-O([8V$<;E48*D5KV]C97%@LMHJR64BR#R8@/+FW?>R.AR<C\ZIITV
M^;\/^&_"Q*]]*WXF>QW3W^GWT-SK>C7SF7[1,D;6JPD9\K Y*<=QSFFZO;W<
MTQCLI]/^V8233$N+4E8%  D&1ZC..F*T=-CMH;."UTZ0:>UD\>^T6-7")@_N
MFSTSZCGBK>EZMJ<TE\;BU6W$4NRWEW+(TB8^]@#Y?I4N;3NNG];>?6W0:C=6
M_K^O4@C^UWUU;&WN9DCMY&$MNJ!DGXQU[ 'G/U%95U:S^'9H)HS>2:;;W"-%
MI>G[O,$C,0[.2V63Y\X/ Q5JUDFTN\MK*SBMHQ-(\USY+^2$+DMY@3^(LV<X
MJU_:FN7DENJ:5;(PF4/)<7.&";\9&!R<<@4E>+5MODOZ_,':2UW.VTBSBT_2
M+*U@5E@@@2*-6<N0JJ ,L223@=2237S)^U0IF^)7AN+SC%OL63Y20VTRY)!Z
M8R%!'?\ "OJ&T&+2$#^XO\J\J^//PWB\96^G7[2R1R6?F0X7IM<=>H(P1GKS
MT->3BZ<JU-Q6YZ.&FJ=1-['BMAJ&HL98HDCE*HD"%E&$< !PF>0"#GD\$#UQ
M5N>Z>1HU01RQJ4CD383@8QC)Z#IG/I7I-AX7MH=.ALX3$3MV[HB0>?X\9]_>
MLN2VN;6\GMIK6W6(,J>?\V]DQG'L>>G2N"6&E%*[.^->,I:(Y[6M67Q5-;1Q
M0^2T V;RH900,G&,$=/7G%;.DQK:K*MG&@FN5#S2,<'=CHH/'IGZ8K"NXT^T
M2O%'NCD7<%4<+@=SD^@)Z=SZUV'PPM(+JZ<W4R7$\JL258CH.V>G(Q6=.,I5
M=]32HU&GIL9%QIEY:[MY&7"Y,AW GT /]?2M^Q\/VU];BYF!@X$A?=AN.2#C
MJ.O6LWQ UJ)0)&G'E/Q$PZEC@_-WY^N,U8L+J:ULR61MI38I<X9\'^7)].E=
M-*T9M2U1SU&Y03CHR[)>2VA=%Q,%Q@^8.A/3I67=:A*RM&()!*1M"<!N21N!
M]".PSCI58WQ,J1HK-"Z^<6!&(VP,@^O3]14>IZ?YUPC6?)49CD)(QUX)QPO3
M!ISJ3DM"80C'<+C3Y;:Z-H&F=@?,?<=JCU'MWZ?UKH])\.MI]C-);$\9N&D\
MS)49P%P>,?RK M0]B(V+[MN5?SGVF-^W'4CMCWKN;>\N)])\^QA:5)K=/FV<
MNKD<*"1SP/SKLPM.+=VM3EQ$Y6LMC@OMTWB"399+*ZY!&YB2"#Q^&1WHT.ZM
MM-6\_M&=O[15MD;KDH-QSSVR><>E*IDTVZOHK/=%*TF%1L[67G&#CCJ21^-4
MX-/&JR-;RB6ZCD=S+(D10?+\NP'CDDGIZ=>E<+;YKVU.M*/+:^A@R0/)<1R6
MVYU>4NS(Q0]>XST_/K5Z;P=?6UC')')Y0D=3$BR .AY]>>X)'O4>J:;=:7%+
M]@ :),([MR>.R\=> #VK#OKN^M547#-++'^^8N"LF /N=\D8//<G%8KE@[3-
MM9?"RQ>WSS:?-IMSY8\H%/*@QN#C!X(Z#KTY/-?57ANT73?#^F6B#:D-M&@'
M/91ZU\6^(+6YOHFO[2*>?;B.0*WEH%)!(R/0X)_/UK[.T&X>71K-I>)?)3=S
MGG:,\]^<\UWX>2E?Y'#B(N-C77#,.!7@G[6G@ZWUK3]#UJ+4IM$U#23-)/J5
MO'YCI8X5YX\=<.T<0^4$Y KWB!PT@KY]_;"\&ZMXDM_!UUI.JW6G&.]>SN8X
M6E6*6"90)#(8U)&U5+*<J V,FKQ%O8RNKDX6_MHV=CA8_!<7Q?\  6@^+-/G
MBN_#1*WDJZC8B1M24*0@"3 %&#8()&<@#O6C\=M#T7Q9:^%M6TSQ7=Z#<>%8
M!.;2S=5;=(F(OM49^\@/)4D9P<5YKJT/Q0TGX7ZQH$&C+K>GZ'=VQ\/P?VI*
MTDVG+_K)IY,'=, 6(&3GL.F?:?">@^$[Y=6O+;Q+#+=V4%NNK7EU9QV_V<B-
MG42R, 7PA [[<'H3BO)C%:QA'1VW9[$F]'4>W9'&_!>\D^*=M<^'-1OE\0^(
M?#\PBU/5+S2'LX?M$9R)8XV'/4;63\Q6)I7P9L/@3\3-1UV?Q%?WNHZ_J:HD
MD32LD4Q7Y5"C.P8/4G'K4OPQ^*>KWFH>/M8\$>()/'DD-]#;0Z-):BSM;1 1
ME89V7,X*EI Y)!QVSFM'3_AKK^CZU=^,/"%E)JFN^+;^"?5M,O\ 5UC:TC52
M'G2+!_>8"DJI^;CI42A%VT?-_P ,.,I+JN7_ (<X[XG>%_%VO?#.:;Q#H'AC
M2-?AUEM2@NM226?3HEBEREQN.")?+R<YP#7H6AZI\5_BE>^&-:\%^+M+M/"M
MCJ,<UR]N!-#?V.U0R[L!5?.\X4G@ Y[5D?$:/XH?$JQUWP;KEEJ?A[PM/:,I
MUN1HFG6177:RQLI#1L,@[SD<CO5ZQ\1:>WP?UCPQI$6J7-[H.FB+6= TV%4^
MT(\0XC*JH9BH'*8 W&JC-RFY.3[V>^G_  Q,H*,$E%=K]#L[7Q]X9OOB3-X1
MO+6WU&\UF"?[--! \UJ;<, 5EEQL#;NB@\]LUR.I:7IGB'5I-*\3V\=W#H4L
M.I&W>-BZ3H_[AH>BN0V21G@#.*P_V<K[PO\ #/X5:=K5MI5Q9:7:6$L]IX9$
MGVS4%E5BSH65FR5R0%ZY(],5H_VAHGB;XM)>>,K>'6+22&+5M$T5K!X)]*<@
M)-,\V[$C$N $.,8/I3<E+EYW:SV%&+C?E5[K?_AQO@W]H'Q;K/AG3YO"5C'J
M-Y>>(C:7=EJ5L=.G@TX.R/-''(Y,CI\OS#AO2N+\87&K?\)UKEKX5\066B_%
MDV\,MU;7TKW8BA$NY7> C:-R,?X>K#KP:O>'<^)-8\5_$SPGHC1^.[%I=,\,
MZ7XR@6R6T@1@)7+1N3(DA^8.Z@KC&><U:\7>#_$.G?&+6_B+IWA#6[S7YK2Q
ML[ZYC626UF3"[C;H/OD$ 9.,#GUJ:EY0C)N]NVI5.W/**5K]]"32_A&;OX@^
M'[7Q-X>T72-&L66]\/:A/*8)8;V0NTBPQ$XQU(4')/4"O5/B[XPL/!?P_P!6
M2ZU*QLEBMV$OB#5X=UN&8[0'C!&4R0" <FN1\7>#[6\'@[2&DT/5K7PBZ73V
MM]<O<7FFSJ&8-N#<2@OD;_X>W2N!L8?!WQ<L_&FD>)9[/6+/Q#KR0W0TN:9?
MWZE$ACDP24DX7=MPO-7&:IITEU_K]0E!U+5&>[:#X/TO0_@/I.F:%%8VEA;Q
MQW$UOI,(6#!Y.V/)P,G.,]^]>$_#^VT3QI^T)XLT&2'P_=ZHFGP&.+3;T2:A
M<Q(WS)<*1Y:JA8D#=NXZ&NN^)W_"X?"?B)_#?@[1[V#2+RPBL=,UW3L7<4,Y
M&2]U;GD*@41YS_%T-</KWA*\\ V.IMXML#\.]"MKNWU1O$&@E8FUF95WW(GC
M12Z1^9U!.2/:BKRRESSCMN*GSQCRP>Y[?\5O%GPQUKP1=>"_&.IOH?ATQK8-
MJ,LWDPHPPJ+YBMN7)QUP3FL?X)>'_'_AO6-=?Q-8V.L:&6DAT]='+8AME 7]
MZS$[I-H!P/7K7FG@W0K#0?&EWIUSX8T^\\*:ZL>K/XB)207=V0#$J0-R[E57
M:W')%9WB#QOXA\<_$1M&T^RU3PIX)M;&>TUK3]3@>.[2>6,;W%T&*HHCX)C.
MT$=^M1[9.U2IH_ZT_P""7[%J\*>J_#U-.'P3X>U+Q[X[T.S=]>OM:,-QXHT?
M5M4:..PT^1&42QIC@$%00N,]L8%=]XV^!_AJ]^%::'H=Y_8^BQVT']FWNESM
M%<!P"%/0,$7:@R')=20:YC2? "ZE\%=+U;P7K4GB#2;>W,=G<6FI*U]K<<1(
M6"6Y8_,H?/#''R]*[KQQ)JNF_LK6FHKI\]WJFFQ?;EL !=788;MB*BLHE9=W
M*YP54U=./NSBX]-&S.;7NRYEOLCF/A-X%T7Q!IMQK6JWEC'\2;. :5?:K]D:
M W%M&Q8>6CN3LS@@]R/3 HKQ32=(L?&'B.TM;";7O!6M:Y:P:G>7L6DDF[6!
M,O:S(Y*Q%_X5SG'<T5QWYXIR5OO.NSA)J/Z'Z<U4U/3X]3LWAD'NI]&[&K=%
M?6;:H^5/+FA>SN'MY1MEC?#<?K[BI1,<D<$,?O9P :ZWQ3I NK8W,2@S1C)_
MVE_^M7)HP^53UX.%YQ7=&7.KG*X\K)8]N]&<8.>U:=K8B:UN)O-&Z(9V[>#[
MUD1K() P90G8 =15CS-I*@[3T.#^E2RACR*V!M+'UIJ LWS#'?IC'I1(_F*Q
MB R..?7WJ/!C7#-@K\OY]>:8A[1A5W [FS]X57DW!1M R3D]C5B/,JKZ=,]L
M5;CT>ZOMI@BW+G!9C@"FM-P>NQE,NW8S#D>G-31G<V>W<UJ6.@2ZA,\3?Z,(
MN&=E!.?3%8<3[7V#>65B"<'!P>M&XB9EPV <-[\\>]30X9E4ML_VCQ_2H22&
MQC QZ^M/9MN&5@<]5^E+=#N3ML5F"MGKAE& :@R&96S^M,63</EX/YU(R[(]
MS+L7.122L-M%K1=MUJ]JF,E7W'CICFN]KC?!4)>_N)6_Y9I@<=R?_K5V585?
MBL:4]KG.>-KR*UL;-)+U;*2:Y6.)F .]B"=H!ZD@&N+O+6:RUJ>2-)(#<SP9
MEG!F20@'*!/X./XC78>/[XZ;I=I-]CDO!]J12(@I,>?^6AR1@#J37-:TUSI\
MD.J1M;QV8R=0GF#%VB5?E*$=<&M*=[)+K_7];D3W]!FI37,<%R_]HR/:*WF
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M/(P17BO@#7O&?A"Z\0^-M+TNW\<W6L:P7^PV5]*89H?-,;.WG-MC=<2"15
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MGMUP?IFG)-*NJM\QA) 4QJRE @'RCD@<G_Z^<5):1"&Q2"W.+EMZ%XL?(=V
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MU0NME>2*C /,J@0A<'Y#@YR<\G'&,<5AOX@O+V2*:VA\MI/E:*$X^0\*V>F
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M<V"/\/2MC/8?NVL!N.<8(&,CWI&X0A6VL!]?TJ/:L>[!PW'2G9VY')'8CM3
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MXO=GOUWJ,5G"9)'"J!G!')^E<EXQ^)B>$=,MYGL)+F\NI!%;VJL 6)!))/H
M,FFWI76/$!C:Y\DPC:"5Z#J<BN9\=^#K/QII<^E2W+VDV\2V%[&P)B=<C(]5
M(8@KZ$UQT?9^TC[7X>IT5.?E?)N6?!/QR_X23Q/_ &%J%A!97,\#W-E<VMR)
MX+A%)W#<!PPP<K[&NIU;QM<V-C%+!IKW,^_;+"#]U>[*?XAT_.O&?A9\'8?
M.L/=37^^QL)))[2SCBD:/S)00S!G]/3IR/2O8K6ROQ;S&.(&.8G."&P2FW<O
MH#P<#WKKQGU:%:^'UC_7_ .?#^VE3:JZ,R+CXD>(;?3?MP\->=;APK>3*7=0
M1PV .1GKCD5J>$_'.IZW"+C4M"FTB"4*MNLAS+(_.X;>P!Z'O3I/MD=F((H(
M;8X DF5U4H ?[N?3/YT6TUI9SF\O;N260(QC6($K&I."0?7^E<\JD'%I02\]
M?\S:,9)IN3_ X;PK\?-:U[Q7#87?A,:7I=QJ+V,%VUV)))%"G#[%'!W#!!/
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MC*4'9G5A8QG5C&:NCYK\7?\ !5!O"/C:?PW-\*+N:YCE$:NNL@;P3P0/L_\
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MK3PQIU[H,#S)9L;A6C=PN#\LB.."V%P1BI/#OQIO/^$EFL;PS/\ 9I(_M/\
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M[_R/IN^MX[$L]LL7V&7B1E.0K>G7CVK'FOK?3]LVIWL=K8\LTD[8'!X ]3Z
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M@_"OSO\ A[^T=XM\>>/+31[S1$2QDG:-UC4YC7'\3'M7Z,?$:%=:2=X-5AG
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M:/CC]IS]G_Q)X_D4V:E+JSED=K>4[5:,XY#?2L;]G_X+7G@?2;]+^\1]6O\
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M[/P7<7:_:+6RU57FM9!E;@%2"N<_*"0#QFM#X&^#+&QTO4M30M'+K<LDK0P
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M:\4:KHGB:SO;&^FMKL3*#*KG+ L 0WJ#[U_0!\+88XOASX><1J'DLH2[#O\
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M1D%)\<]#T# >[L'$PL/"PJ,@Q">D^'\][GL 4ER@#ZT$ XT%0"=%PR!%NQ\
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MH$CVNG&.:*<.2XW2A\R@JD+Q+ [-^LLT/(IR&&QECT<?Q% O"O.. TGH*A3
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M[;/8M.MH%4@74^*D-./C*C[YIK1\KI?F6SH12-#P5Z]_SL]MH4&NIJ2\;-G
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M0<8K+4@);DPPR4=-+H+L#MVGB)]6$?P\CJDK$QC2A)B;XF&*UQC62/W-@PR
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ME7:N;>6NXJ OI6 OMTC4XL^VW /HJ(55035BE3E>M_(.S0W599#=Q,38J(!
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MP8S\D)]#KY+--&?^ZZ;L_X_ =+_T?P%02P,$%     @ RX-:4OD2\VO<SP
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MK0-D21@,_]#3,+C_J(-F(M<P_G[WA"SWVK6_Z]1Q?T _^=OQW_ZB?J"F@3L
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M*<EGB=766Q+T8%;Z%<D@;K,%]M^A%+'/MP'W)"(#5Q&)*" \YY]JEN*R*@H
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MT3O>>G\_^ ;$&^^MERAU&^YS#<VM1/C0#?@?7OSAA +.W[WX WT(XZ]V 7_
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MN=D?JO4BZ;VE8TO/H6352/'$O(X,5IA7'E0DK*;VH3-]G?^R52!#+ *_\:;
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MI)OOFX_<%GU-CK+LB'PD:T_%8\5PR&.V^ZK23W?>VP?FKS,1C;3RM/[;K+<
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MX ;D\*/7WBP2"OCEA<IF2LN-S/8,LN8+1GT^G5.=Z#OW1EX<*K]\#IA&N29
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M[\ H%C7RH8P?U&6&WO$R@E[WWNF+/<WDS[R-^_0(-/GBYTYL#)^_8JF#UV*
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M[_W5&OX^!IF;SE3&1ZBX3<G:\K)OY2($,1*4RF6\;%"EE2Z68:A%2::K43W
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M4@3^9'SL:[R9G=YZ-:)*EXN/#ML=I&",'<)\NCC!*%K->$(6B'35F1QKTOC
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M^Q$U>YUN?>1L%LYF?SFX]HE]:A#=/ZK0=J2":MSIEE> ]US8G&</$>O+X;A
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M?I/AX/B,-4/""2%W7"UH1*0GQKQIJL9)1Q1<0U*O0EXV6+8I^KJ;.,^SG;(
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M\NP%2E?C/$ZY!"#B\0]:<J+N"1"<*%9(0/V]H'O'T>N<$<<4.WEH, 092YO
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M[5"\2DC*O310^:C/0DOZ-U.S@UN[N3\SWN]$MUAB%P&TG]7[ =Y$?P'!EPY
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MKI8(OPI#RHW]2'.;J)3(I!]*<K)&QCI9?]"*,5(%Q=??*%&4.W]>4<7G!F0
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M\-VA?EV?A0>;,,(*!WPAS#8'^.O/:Z/3VI&X!;J0?H&FRU320N>?VRZ+"U=
MWYKYL!GDF#*B/]O3+N'U@X Y36NTJ.G^IRSD@6>.^QK-?R#SF2,?XP+.")P-
MK%*^"(2X,FX@VG.@[X>_FXF)FCR\W8[/.3?FN<;RNNN&?,+6KR.]R#IPZTA5
M-/D#69TQ\7WF(+^A%ZH"./.^_4@S5N-*-4RV5]&O5-+C WUY>@G4KQ(D,P:?
MFPG?AVZ0#X+S%_<ZB&X.N1;FX&'SET._X1G/2S5(@'(-,O^<NU]XPB@/:D*/
MB)^)#M4D(CY!&\K<&Q5'T_^T=YAPMWLR&N:A7%.16L96>3M;J9W\>,0O\LQV
M8*YOV5(89(V(_ TZ[AA=$1 OVMEF4+7K4*&MMR4P(CCQ,4-QVGX[/E>ENUS6
M;&;;1L)\BF!BVL36S::#8QTOVPSG9=!&%WM]F=3S>F=HT.%<Q2MGGB?PR+YU
M LSFW(D(W_S:]&PEAH56]5\U+,E>C9=C'\NR=J/6K^(:)CJ5$\X=7JR0 'I0
MAID==F+3LO6"^_*1/;O!BY;_N+2F_X_T=F!RR<'V]EETVR,8MO[=4(7N.:RC
M@*@%6[:FL"Z*')E9?.WEBHJ=H4=!__G]01G?>F0/I22FC?P9="AUP+4LM'__
M\%C.;Q!K!]Z^,3VI-I_:3$O#XL3;U!DZEV+T?;IOFJ6+E#(S<].K\ND5C_;Y
MV.6[TRLT_\T!M4;:U(-<\X9:U!>;L_<:;(LL?![[89RY+_6MN!U>&(B@35?1
M(1(?0H6U#&-KT&#3#:5T8FH3_TC!L PIJ/>5<ZIU8ZV+%2_+TMJYZV[;VM@0
M@@O5(3^+,B)B< '>I2VJ&_E-J<)>SG5(H6LR?6#54$RL"ZN(&0Y?KB+R;! S
M'!YC!',#2CKR[7Y%F>7>&%'ZNH:I:WTF-_#4*B61=<OJQ2-+/I5#Y+36)M@0
M$99/6]HYFQP<FNL%_5C8)9.4ZG+71+ORBNM=9(P,Z:;;X;O_<BKY?T@9D^=5
M5PS0W8:O.D!!UIELBL?IHP">+CAHI\8.F PL]ZP[V_=R->AE?R#/I7"H<D3_
MUZT6QRB$ .4Z6X1Z?4R1<MYIGW?TL*K&EM;* -ZS,!#2"^&[(/;:T);Y_#G0
MT@;K KQGQYY5OT-$!7-V4*,Z(V;[S">+O^/YW_?M@4^R]>TNGK>6M4I1R9_4
MT'2>^.8PM ]9K7.$52/X9MQ.\VR,YF,"U/KS*P 7I/6Z'8^H9(*;Z3D8.MU9
M>R&KU""//WOVD Z"77JK_E.HL!W!N[7\%1JH,JVG/(6;H1.+,UJEY/KK"46D
MJ_HE"S24CT6<LM16"GO5G"T3K)M>2$#+L2-8_?G>?B^G/;A$31"5)DQ[HY_R
M_,IFRL]OPP1QC N4Q&:>4.BJ ^PW*,)N+,V:YS?H6&U,2(GC@QQ#7:>J![E8
MPV1AQREU$YRT].-^S6SL=>_P??EAX@U\!>!]<\0K .Y#A;X/4DS(#7#%WZ_C
M4'^_B<1D"TO?B2NO/\[Q70$$=YQ#M._^!D4/$<C#EAOK>]*-:5$UB*\-Y7V+
MM"-E4@EZ4NKMVSSIFR05&RQO48I8R=-0!#;C=#[[V/(^.,IB2(?7XH?H]H^P
M*LI&IG\V);H=TGC=VK-4Y>()/68T$N'R(@ UQUCG7?%V]6E<C(:,E/?G5&P9
MSZ%0A)]768\5,,\331[*C%- 0B=R[0&-<@\[1&>I+;E,?UKMENH"R;#=<0DV
M\4Q[?CO47XX)Z=1F7Q5ND@5ZR,8%'CN!Q?D\$+-2@HWY:+5V#]IH0!.F7U2V
M(GV-NULV_LTSJ7EUB?!<->]3!&N)B'V1SSK"; F+T2:Y&Z>S/KF;$[K7+4D+
MRW$N;LRJD!A^#->-[:N\'/>+..!^U#"N'Q7\TTLD&MK6(%57X//W*\1%'SML
M=+[1%PS47.A+UJ;*)2@AK7V&ZP=V("J4&RVRV4^E'WV"8S57!<BY\EXN<DMJ
MD>94NI.B)P]IV"V/>W7RT$<J(QO?VER-C_=:KS$I?<9I*)M2/#G^!S-_.(=P
M_"GSOJ](.A>5ZJAF^XLV-+@OAR9HMS0+J_TR6%NTP,FUIZ7N/* ,I4,98F!.
M2LBS0T4^''$@^S''PCWYG/4."5B%CJ% Q'02?0(KCW\;,?X1-B'TTEHAMD6.
M*9W%G75:OI\BN:L*Q$M&Z;-S2HJ M#8<'94=O&=4-K3RAV2"MM%"7.?)O6ZG
M1"_I<X\7CLP>S@-X?.D7CP"%5D 80]QC'3V2T3EA_[;I?7:QN\7@O7?Q8#%6
MPIQM^+C+M8>@"A](QJ:XS2PT)0]H:]65!<+R"6&M.ZEIP5VO%(LSD,6L)Z^L
MW2:ZS=);CBW7W[O/N'!<;?7+\E7P?WLD]#\4QRV<CM_-@H="L77+9O]&;?7_
MDWZ/_QU02P,$%     @ RX-:4@W_7B7GP@$ F^(! !4   !M<FYA+3(P,C Q
M,C,Q7V<R,"YJ<&?LO'=45$^W*'C(*$F1'%6B1$5R%)4D$B4W43)-@^1,(PA(
M3@(* B))8DO..2I)4I-SSMW$!IKNQ^_>>3/?][OOSIV9M=Z;F;6^ZK/_.-55
MNVKGO>N<;NP4=@FX\TI111' P<$!S&\^ '86> '@X>+^==TT_)N+@)B  !^?
MX#81$2$QZ6U24I+;)"1DY)1WR,CODI.0W*&Y<_<>%34U-2D%+1T-%1TE%375
M7TAP\&[FX!/<(B"X145&0D;U?[MAVX"[Q+C/"  \G(< [ET<O+LXV"Z %0!P
M"'#^K0'_6\/!O=DC(1'QK=LD-P.J[P"X.'AXN/AX?^WZYMN F^\!_+L$E ^>
MR!/>T[(@>NA")?0^(9N8[7EY.[7V"(+]Z5O7X%NW:6CIZ!DX.+FX'_$(BXB*
MB4M(OGBIH*BDK/+JC8ZNGKZ!H9&EE;6-K9V]@YN[AZ>7MX]OR(?0L/"/$9&)
M29^24U(_?TG[GI.;EU_PH["HHK*JNJ:VKKZAH[.KNZ>W[]?OT;'Q"?CDU/3,
M\LKJVOK&YM;V#O+H^.3T[!QU<?D773@W=/[W]C^DZ^X-7;CX^'CX1'_1A8/K
M]=> N_@$#YX04LIK$5FXW'LH])Z8ZGE"=GG[+;:GV@CJMZXCMVG8A9<YD'^1
M]F^4_5\C+/C_$67_.V'_!UTS "D>SHWP\.X"<L#UF^^1W,"_X%_P_Q+@RDG*
M'<(VE3)8SR>/2QIX+I0W1*2WL$!+:P:+.W31;*AB*^>31(S&/XWB7B>W?#,4
M=[5[,;*I='V*WA6(E'CQ>?PX!W.)<?<9P0(!4,G^[[&:_T+U+U3_0O4O5/]"
M];\<5>A5Q\W,V]S??\3_?R#*_/\2L@,1WV_8&'3#Q/_E(,V[8K8OAP5N'_;,
MI(:W+C-@_ERQIF(2SK  ;R J 7/XR25F:G>F/@X%T;A,@AX58H$9\$"K_9/&
M5>A'^>UTYVO.R$:SCV8D56JLF'L?9SNR$''V:<9W?N7NFD*&+U\/5IZ;-2<D
MJDV['.'40@(KE7A_;2\CAIIIUK4?S:L<'A2<I1HZI@90;);H!71YN'R>6G;A
M>9PCP2O>:ST$;XK+96A*@\_L.$([':#CZ5@@60,SIH06+;A6:;W0P0+[(IN^
MD^TF3Q61A,T%693&_43A^Z%#!1[7G[]QFV<:/6]Q$7HB@#/4]MA'>+N%<-K>
MUP136H3Z4EKU.;";H^KLC 4\]\+UEM*,M4FN^8%Q9CC^DFV>=9/DJ$/F62U2
M<F8Q;<Q/:N^=]&'TISQ:7;_:5H3[>O-I=4F]4<NDFG/VEAEB)NN4$PNLO\$"
M53=V1';#'6UGC*[<E9KY+&:X 6Q?;N>5%C[5I#B#OG27_*#95#X4Y53QS5H@
MFRHDH^U>(A%;0I\!FC&B"@3Q-#&6383?G7\:\#5FDG#M&3R'8E+Z\*2W7XN4
MB'Q\)@OD+./L!S*M\10I3D<F<\(,'6='4U*J#P_FC78P#<8GB_\@(#LL$#:.
M!0K%L !/UG5^?7_6],%PEZGTY)YP?_V)G[B'!!^$[>I1"M7,^R"?O&17=9=J
MZ=Z#9W3#1!X(>.\+Q%F6'PR,!:;%+C_=,S:<B>),>UA>KLF> .(Q>=]S-_RY
M<G%>"N(4S#WFY3EZW%)871EP;_:%M*)7C[A?/=RX"'-:R'%0E5DJ4&ITYG3E
MY(L%_D%BPO\H2N.4<D3<<\P0=$\Q<67-^^VD#F^ 4WN:BI4N:2@7CL$!&YB7
M)T@6*<'$%2=]*\^;$SPH[1VUG[8?O4LP$6709*=B7!YI,L#T:.F 6$.33)<4
M]J!+-87*Y,HTT-277Z\DVA3:72?>D.Q"DNQ1S>LQ8LISJ/2]428'P_@&D[N(
M+H*>I<DM5\OMJ&&!WP58P![V"-':08WD"G._=@>S*&9VH'8H22"+;T61%Y&R
MJ 7CN[&?AWV;L "N #M"N.&T&GUDHN3L['(FL==%PO-[V87>7KJGW>*8;@*$
M,C@MX(.%9PNH/!\Z6_!;@"\V7%5/)VG(KC+$G\47>O0/(D91CGE^1E=RK6IC
M2KG_J7ZOIZ5V,"I+ZU*$.OHKU@9R7;E[/IWNMT*^I \?0/XF<=*1\<*7:1.Q
M[;S1OA.R%]U"]C4,)[Y-\>T!F^T!!6JW8K)C/DON?2;4EF]?(&;;>"Z>O6Z(
M&RY7X5E]H[8;\^?3)P&^^-XA47EOIIN>:Z2G8HS1(!#$:"=Y9L=7_S\3FZE;
M(9H$9$((;E3SVO>-%I4,N#)LSDI)=_KZ\$>2ST5RW/D[I<".A?HK\1V&QR&>
MV>SR'N+"_86')2PS!/;>E)UL3XYSR)+G0R5ZZ21^8(:7!VD%+IWEN!8'?><F
M-J7MD@+'K ,*94L],;NM8 <OZ#]:V60#6A@)0_-IX&^W/+AB/8/.2@^?0,4&
MIROT-9JK;*7<QIK]=9%FR_8H"S^PX[F7%^5K*SU0LTQI>540/9U4;F3;&K5_
M;#35Y,1BI08Z08X<.CN,^=1O2AZ0:ETE=.E=@L\_R [S<2@5B#E7@B-B/3)6
M*B.G R':Z'@G>%@L8I=Z>A]JHJ'^/9+WN/+,_/_$K>,-8<31+G]: )3Z6)?L
M@ZIQ9[XRY\1VMC&VF#5*85=Q=JEOLQ_36UR5J)>Q .+H,$SN!!?IC,&9P0)'
M:JP([<.+!Y*TU]'QT&W^B4#[R8GU:0]2-0+M[UZ-._YEEI\G._7=MZO! N';
MMFCIQN6X:Z )A 6"/%O124I_[S"[@Y9#>65K(!:[9&61H)VG=I<>>PPF9>EY
M&LQ-YU[:Q7)/59@B(S]^R$J(Z-N.GLBZ[<]0CFI>F=V5P]G! I9CR=]4O:45
MR\Z'CM[I*-DR#6R5D-M,_<#1GKV%V\@">A]SD)%JMCN^9I@BJE>I'T!1#5U>
M7R2%;A&L+*+Q;A1M[<;,_M9Q0?OB.E[:LE2#H]*A@3P]4*011J%@Z^/V.-&O
MCTU(*'_JBV=%L.[G][WB?<.\8(2@CC/131@*:UZ^QM\1/:<U<DHO-JVBI1UI
MZS;)>1O&T4^H2ZD<VG<AOY+8?W1>B8:6#3@_'J#916 :LURAG?TM=%C@#TEW
M*XKHQJ_]$OX//2)(@?(K"52Z J+YH%0&_OF\AD;T,@\3SC3*N*NJTG?W]:IM
MBOQ<;E&C4!C!)SV-[L,/^G*$30J<(86H<(4)CQ_$M'J^JL82-;]YR\X2J5XD
M6W14WAUZ5A0+"DI?CX)<8@&3$:&!\C_&HRJ"&KN5L@@L$)[J_P0+?*.-@B+(
M)[% (G@+&BIW3[@UF@5G%&V2(^\%R=^1=4ZF/N)YW6(,N^=T>X!H()R.*U@V
M&?7%K)3UYS Z;3@8NG^%!53+>(<&A2[IC'C<87ZS"-OL%,O=E6)QG9E)M-8A
ME9:"?_M)NP*5)L[_*GA^O:Q <AX*W"S]7X"Q0'71O-V"S*BY"Y]G:MELF9Z>
M^>(C7*$L#QW_5C'C++5QG'D=KWLDWNS)[WDB#=[#ZYE!*X>A[L7AM2:J5XK[
MZF/.^2\G7U-D3Q&_.7U8'P!:G4CLY</KO(SLV=%I7H/_(5?*4=;8X*[;&U;X
M<[IU&N(:53GX/@C*(__P3N?],":6I<N[)Z5&B&$BM'D- I[)1Q[CX6VD&%]=
M.E]Y-W/V=<A8M2<<RBC]]"E^2^+A2\O%-]5V21@,:0%&YM72R,*(L5*4M%&B
MB1U<TEQ-T^'U,]%STB+]2J+7B,<:?VR_ZIL5]$I[TOQR;3_0XZ"L..%_GW2Q
M\3GJOV;+?PW^O%>O1!=C%A[*9ME@@5&[XFAD:A1,VF4E:M[S4OQA4Z.UK:J'
M=31$,P=(].4^-(/NF.(BAJH#.#:RE^<Y,4>OG>OJRR-5& &<%&OV)4 VN!C:
M48:PO;XM28LAL< "*^"3 2YJBY\G]L]U0)\>YOB5_;ZI$A)0GA;+&"GZB"[=
M,$X>:IM-L.P1>.-3VD76O3E_,[B@])LRL#Y-"BT>Z(,\M. 7XW6:U>UOI$0+
MN=3X=]I"%AIXY6*#S4AVX3-EJ8394!^9A*HJ;^6*,$;_T.C]!&.<GL?J/G/J
MZH$U6"#49&GXDLI=$$US$]>Z;C*KVXWM62?<6V8H_G L$%&RV>7C.&JFYP"?
M+DNI76O:B[%_I^?Q2CNQI_O8S72[-4(*"VRKG34ZS60QS*)]D>R2,=4G"09S
M<[,[%3L[QR^Q@'"%TGKR??$+W%7 ' G_(M:UM2]+LXVA*??[<D#XPT,J-9,Z
MEKV-+O3QGHD767?LPIP7K!*ZK._]%!/*3((%"'YB :3PWWAFCP5*OGB,&=B4
MC,V[-[?L5D#'O^Z,:O<4#*1-R-:T+OY.JC]B8JVR_<@VH:^5^FK$Z>![:ZIF
MC?VWU&L&%2J^]\ G:V76[KIHA!+=9NI*\EK::QHQ(]FX'^D*F5*\4?TV"?N4
MVJH\CP*B<=[J#^C-^.K/MB**F^BQP//84"P0/ 5%W;C9OVU1*4)HRE_<IB6P
M=>/:Z2I4_=;0CK_WVOG6Y2P62-#;MX8D($%H&SBKDJC<V[%1Q=&<D;13/:VG
MH)Z=&Z;WJV5_@N%S[[AE/LE:&8Z@E7T<MC:_S?!2,G0N@G^A@* R(-]3*SIQ
MX/>7'?_JUPF# ;_^+J@<#+57B-R6UI]6!(@""]PS>A$I=.FZ$4M?L'OM:03Y
MOF?Y)NC8]Z?[9DR4&LAV$[5SNJ@_GW5KJ_5.-82H?68S#&(DMS=ODN-S_D@@
ME#SPQ5>R3IP*\F?[)@18H)??5FO$>8]C3#A!Y#JO.6/H6\(K 78#SPNUK*<.
M%?L8:KQQ]][IK/^211HW6TK<3*%?.)]W+K@0K">0Q1]Z]&*ZDZ'4"62X7Y9U
M(=QRUI!%Y2!')Z)ZK2BC+2.F4C$9.$&VUM#<7"[V5(7UN6HE#ZZ/!<,/IPLF
MG7CTVZ;R";+KL/?9]F,-<Q$QS55?OA0\CQW8?V 1I'*[Y,Z]C.JS+#3/(2'T
M3TXV=*F&%<,9A])=(,4"V4K/L4"[HQQ:3>-R,!64NC,TZSQ66^ T?[-5K<I,
M)^>RGO.6X8##G85#&"B+:AYM-2FPY\S?E"ZN,!B:F6D5P23)41D6\^EPN8)0
M@^W/[1!C5)X'S)1_;X8FA/G*A']]<*K\V/1 @>YZ*>'+\\P\39Y$5X6 QO]*
M9KHL7/TKATQ/KR83KVGG7M?1BO^HMX[16+NJ/9IH;3Z1942&=Y6^Z&%0S,IM
M3D[YDC?UB_W/C$&$*%%@@9!4O RULM:4_F3K/R9;)G+_3'^M^[Q OT)Y[+!&
M97#'D/1>;4V$98RKBK@N0)JH,3X9E;[I[1](*6Y$]95? (+.P/AF:71^Y8_^
M_91^%>DQH<3M:E<*%SVJT*J.TKF)=A:7YEH*%OVK,++.%1W$7N;]T1PDW@_K
M4:.S!YYMT<$/Y^NBW4:#Q+B_1P+<N3;$>9]#-854MG@%59!Z$;"^B+Q=&H:D
MY@:3HAD3]KQLU^>O<)..GNCA-# 7C :)V/TUJ:@AL]#V^_8Y[67H' V-:)]U
MYLZ.0BQW/&F*S5O<(*FTC:J;((XW*;VX=\CH[:9YY.F393U1NC;=W,'I6=^S
M::VU8X#SZQMY2V1A@0-<LD/]C+;FO!A_&,(+^EU!O/XB/.:GM[4TM70(O/3/
M7_&4Z!?T/R2#-SD?52-&6?U&J2W962]5/<SP_.G#.U.AU-*"X)5=C1J4T\ZE
M%'BJ:3/JUH/I5M<[G?;F<ZS+L*;?'/W!&S63LO=$XT2?IC9'M>"@<L#+P\1@
MS-W)$T.10U*'HTY/A-%"E%2ZW^<*2H.\)WTYZS9Z>HKXEOF\#0BY_4?9WC2S
M1F/N6 !H3@GU@5K_Z+0OV*U4$+@R?Y=Z3U(B38S+[?[=Z$U&/U^RS;VK94$"
M5.SQ\PEA/]Z+)K;ELU8D2[:'FW??Y#V3NP -0MS^=N=Z4"'[_8OTC-C'9DBI
M)6@0AG;17V627UK(_P5AC&@,=4&XH)/ BJIU8Y1_V88$?L$&P1NA.[GQ7DMZ
MB;"PHKV51=$6#9U4,Z6MEW8K]KR%'/WGI8P!,OJ%O^6O+/E;(TL\/B'\J&N0
MD,U(_[ )5X-AHD_F\VL(JHS9\OTJCS*6S573J!5!PBTCC<@FIH7[X])R8 _;
MO'DRP_UO=W\/;&]V1;2\8'S"6V%P!)!E7O]&2R*&0]%WG5=(LD(O4VJ+P"P\
M68I8X(/IV>6^H'!="I7WT@O*'/JI7\GV;.]T!/O45?8?H&R7PU&6>3M&!R%^
MA?VY* K-B0=C'A#M0TCS@&]$C$Y17R. '_:2^-:O-J?G&YUO*J-9SA8GAR<Q
MQ!<NU )Y(M5G)T<G-ZF\3WB,G,.@4L\",>3ASJ11E%:J>LT8AUV3BFN::=_/
M_)<_GQ5O2 8Q^C5X/,"1]EGL@4:P(FI;.,&! I@AS"_,F/?B7B T8WT_@JWG
MNOCKWK \O"4=WFJ[&+; B"2*.55Q+)E4'SNL H,@7#KUXU;!Q ?[B8:BZ0I^
M8?'ECU@./[$VURV]D29!4"R'Y06LR%#R"VQJ3:PAJ7NR<J =;V@*\I2\G'X>
M@+R=J*G?-BC*/;[1!><Y8(T*2>>@FGD'BC@+V)_BL4"*F+%OM"Z7-?IFT>OO
M*NT]Q0*<E4M95X$WB<QN)#IKO,1Z3(2Q6&*L/W-!+^SE'"/XT?WH6 JV'S X
MQ90M1LVV7>[L&@OD35+'^F#V69&"O]*ML@Z%L  )>N3?TMTG9\M_F4VF-VPU
M+'3I.G!7N:EJW+J^=K;Y6ZQ0N"LA'4?[5F>U%1;H?(6RQ/A[.%\=TV(!)A@G
M:AT+<*C>%$TUK)</)?O& YEW:\0B(&31,^E5=X9 &F$JNB^+ZZF6O1UMXRSA
MK8+=MM.?GHC8CU1&6\$7G!83CI.?? [5U@K[-6LY)[><]U=^+RM9>WT1A05B
MM6[J<][EN OD1.OA@!G:M4E #M@=LV/35Q-=WE=;G.HH>6W\:^S@_9A7/P;9
M:_3!F[4+XG%F\<TA;-7VR]IUI-K5TYBIV:]6'F7.^^AYT/SB53[4I-L33>&+
M!<*2$;UHU,[B^88@1D()+0P+D]OLU<,"K4^@R-^(OD!6[^#-YPQ51B8#-8,>
M9X\C2*K"U+/<R;]<N%T?2,+]9>GA @PB4:]:$G*%>'A $GQO#M_W2OE=>N6B
M0D1CRFHQ6P%^5 V!1'^@B-&_JJ8L9A &W7T3@+G_MK0IGLO2M>\0?5[6RW&+
M2&H*OD0CY6*&S- ()@HWW=P_IW3N4Z>T8P=)&@DU>6//.SAEWR.#H0RI78:Y
M7JI8 (=VLIP7VG?)BF'0[V0]7BV&+GYN1:VS_FU1WG90.PM;K/<W")Z.8?Z<
M9?1T'SUR$L]9O&](QA[4/O-)4B"OT%CI3&%L,W;&#QQJ]5DJ6.FW4JTK3RN<
M=+8""[3Y\6)>7)[QUBX%B"Q!HQKDXJKMW:]E9R[I<X*&C#:$=6?H]5EY,UT[
MJ[VHC_7W)K  V\3Y=<B-OHR4ZX]6GW_A%"J3(B[66]@[>^=A;90J?7[["!:Y
MR"RW;("*7%3%=&%&CTOU-@>OS)*C&\OF')T/;"4.38O-># 3T"/-JL,K@EXL
MD),/J_F-.$&*)ZL7-53*MC[HT.I9U>5!-CE>P?JV;JQ#;D<'"_R.PP(..1B&
M54R>!OH'%C@KNEBH$=$@N4G"R*.*!]GY(<5\@[@]70T7SN6UN(\EMH/!>RQO
M@J)4.J%B&-MMRF5T/C^7:@!ML\#DX33+\HT*NF ![0*,#O1*EQ4QR7K* UU7
MP@+5^B&JWQSBMUUV7.UK7;8K1,>;[.B>]_Z1?:Q!U*SBL1QCT[, 7]E4::FM
M;7P 64^9GK#A^O9<D5%VO+7BZ*:81YM=1%T1W6A#UDTIC9N*!=C]8&B1WNM7
M61<W:K^O ^TTAHX78H%D5LR$J5P^6@1)</:S 3+X84:A'S3HGC7S[A?@'D,B
M*E0O3:%>S>@OA<1/NM"35,,4?\SY,C/4L?2!O/'3G9&0L9;'?I02/S!#_<Y.
MNN>MQT*8[E_.3@J+*ZD7F;_^<^(^0#M$BM,9TT?R3*]CIP?<Y@(RT'6?F:AM
M>J@VRTMYY<(O)R;#/,A\]HW&U"LC)3ZD/FD(R#;IP+L[&];.)CTA72D0BSR:
M/SQ/YHOCBD6 9E=2#O,W;Q3I'Z@RH>U<G.'%W&NEG;*#(N*NP_=-;2^59OT'
M&RUMKUH,ACQ78;X7>LWWS@)N*OWF;]#97DS2+\.W%27,DM1<= Y)?BT+^71[
MX0(Y'XKUJ$I6Z45*:E4NLFRT%*@OD!?$6@I4.,.HXYX:.7(T5\ *V2O>B+T2
M=*N0E*Y>_&&"IOE3G(GPP"^P!S?F.(90NL9%R]\$"P04N;/3ZB!X\2"0$PO4
MFEWS1+:8HYP146I(I<YT+$!E*E_BT&K3!+8O=:=_^'3FY<,Y3KL,E4\T]R&D
MGX&OF2[\6=_7Z-5!D?WK4;U<'K*ZMDX)M1M8@'_8XS^L([=<A;Z+!9ZUWH$N
M2;.B?5ML68FJOPA#]^T.2LS4);5W^N4^+U';-R50\&)JH8R^T&J0EUSE]5GX
MRB"% OQTD&<4\AS#^"@[8OUIYP;P M^N]S.Y9[A:'V-P9ZF 38!.G5?X]_V!
M0YC^6&"&W)M%Z-^6BT-!Y/"A?P2[6%$41%B !99U((N[0RMYNIZ?46S?,U$M
M437XY& M@05C=V0D?+U(VO3(=B:TCM1!1O L<-)#E5D NJ_&,KJJ79UYM/![
MQU[[;7PYY<'UM"YOL(^3DOH'K8$;[=)'>0C8<K8X5P8T95P9+EIN:?QMU1P,
MHT8[ZPD)D@B#UW[CJ(HWLU#:M? 4AHS^07!16YJ0PYF7'JT&DRO;:S8Z_1"W
MKVN.LF9E![T4/:RD!^A[I"OG!B.;X_S6RDXG_7[?G2 9J9ZW*WZ\D[Q'_XY"
MFWO#I@H%OE\LH%P+1<H)-KI7US2P:D$[[5%LF/>!]V^\FK<<ZI05,1-(C 6^
MF7V40[!08&3,A%\@O/2<<6=110$O7I>7-T3:EV8W)(]LWJVAUZWQL?@U-&Y+
M.B5.F'*U--1L\7W.M*K&=0$$>N'GEMO-5CUWY]6S6$5&SW@O@>?E%G56MR4^
M8X&)3-;F^LPS5.9Y[68!>+O^I!8MFA4LMT6[0H$F"L$"<7\%NH*EN$L"U,T=
MSA(66)TXAMS4-0&J&G!^82_XB1C<NB5$(UT=5'-<:IV*XQ4<XAK\S/+NN^8=
M&Q27?VW#!Z4N2;KJL0.]CAUT<UNP5+YK,>%KJ2\5N0>ZW$0<H4P#6:?.X7L9
M"RW.ZV,P]6N*G+]KWW]0!WPL$$KD+\V[$5#Q="4'ED%JAW)T)DD4VYMMC+^J
MQ9^>RR1TA^*>-C;NRTKQOU =YW.:60>]J4W1J 15UPUT:(^$,2J2/X^?9G13
M>OI06J:SHG'#UZQX&^8,\JJLZ1W)^AO73:_-OM[8E_0MBR5K1-W/9C"RR [I
M0#G<Z.ZX=U ?QUUR[S8QJ1CIUTN*D<C< W^S>];>3"V9+&4$4AIIYYC]U)V.
M2.Y\?^X;JP?^.VBV>FL]OUY^1D"E]9\"F<W=0AMQ77K.']N7ZV4%TO$=5I0]
M40\,'UI),4H96)&&A%SH8IH8D*V18F:(]ZA@,J67XR\9NL?YK(/7H^1);W^C
MS]W\8))S^TG=)OTFP%P;&\AAX/V8Q#IZ1_(F!Y8B_OI(%PMD)DJL"+,NR(8#
MDS$J6."6?H_]A[K8*S4]*=MT?P:= /FIG/-4KG+VT%+6FUJ2S*Q[][H2%K$^
M>F!LK&3OT363Y$%+:[8'=64)LI1-/K@SDZN%$QHK/AGTN*B(: V@3K>),#CF
MYUIR^OKSX<YES$$1$;KQY4V-4\72P5V>@#EFV'8,I/%653<&H6Q5-3RKE.0B
MS-6<[6391J1?LV/Z)DJJY>GZKU,\DO#8;6.G\6WSP=I'H #9(7!Z84Y-;827
M=,5/7:T#:"H\?E@2<1@L+;%"1O?+YYM]JEFS]4!*0M+[V*?1XV*+^/[2NK&I
M9XL4?;[,HNL?H-$:]11CU-4(SV4/04+Z/X=OO+A)I4ZNP56).%5?;:<TB8;.
M%_!NW&HC?$*X!EPWQ@&K,GCI]GYNT,XU,5;B4=A9V?E-\.TI-KL3D#)F('HV
M*49DW9+MU+N7JC%F/OSDAI&O%[.>^^IGJSACE$Y@3U!1B'P9\+Y19A3IG9U1
MV*5:;A/(X95<F!9:\'I:Z?YI7W[&AXEAHS2K,*&#=\V2MH@?>X=O6V(R*;MX
MJ<Q_ZQ23?PL9]#]?YG?=[+FWW4('KP870V2L[;Y?*5]?)$N()B7=N'&=(-WA
M!;Q8WRM,:EYGKM'%G:K8QB_] ^OS$1*_+'^=H E,UQR-OT<^^OAOA?+_9.#=
M(%:*\&?.ZUW^C.:XKEVY)6W"?[IX%A=V(%@J:)%R/!![*JB;0F?*K8P%#%0+
M/PJ,!&F,G6@2#611.&(>#B/?;TQZ0._(2_M6(QLJ3'B059/E."W#41$"H?FC
MI"#_S_Y+;8>K?CJFM BSJ T4%/%CAR$\IK7ZU,10*8+Y5.HD3<J%#$ZC('@5
M^BM&E?NY>H?Z?FZ O)FT0>!H0]Y9==XVFT:,,Q=2M#!7@\W>RQYR!K:JMXOV
M(CI7>_0X?XFYH?9W<_R &=%6H,2(AR"12;_+RFY/NBG<??XYO^+&@7=86M0[
M?B/EM;<YGSZ6=!%".C<<(]?<YUE7%),0,[UJ8_M-^OF?_<6643G!0U*?T^BQ
M0!63<:BFK/Y=2RC]=,R<?HXWZ]G75DQ_Y3C:GC##LF 1)>&O8<\?[:K4HMQ/
M\D/6%M+E%/J)_%VO!,P*!2X&IYT'N9-I=-7 SXSV][]ZB7G6E%<HD=3-KP<-
M=%'CXR6-L^8!_NVK9((K>AFKI>!7:DK=\ 6@=KRLY9<'=4UQX1PM&&0;35A3
M%[F\LN"$F_4D1[_/HJUW/(MB_U35#&_K"=A+G[:AP?"E0)G@ V4;']&8GI=*
M'OK#FF6=$NTB?[1>*[+&2JL*AJ YBG8?V^O/K)V]$T[8;G#D%^GN/-%1T%1A
M3Q@2IY<IWF069=9MHBATJ"E'I6VN!%87;M>F-9]($A:8EX.BIN2KWF^$RKE0
M*7SZ(6'1_-G\:X"2WUF(K7B5'7RWWYDC7[N/E?61.3&[+7T[]0K+W>MO(L[T
M\HA9]<J*<@W*W7OS@A\A:6)68ZN5I*F@9_[93WT<TJ/>K=[_\S0*!<U#RR-J
MNYJ=KK3'JB/\V5Q@NY"\J>VW!G0FTM'(8<]&%W8A@?68J<^?]MFMPA@7*SFP
M0 P7TJGZNI7BX\JH4Y4?;]WJ9';+=?>R/3XR0J"A[L++1Y7)-O@C$5<I(JO[
MVM;T^HLM*LH%\C9MSE?FX!O_:DQW[1>*]"J( ,C^J"?0\<B'VFPIKD=-?X4V
M0J"J/^.%/)(_VE>AYKM''%D'LATB'=U>LD[H\S[A&5DG7FR1>"Y1Y8@"59=_
M)Q8@($;$-JYJA##PQX57J2F9-L=UW1DXF['.3:7D>SNS1LL3%/^M(OJDG\((
M?<$*8+ABE3JS:&["L;D4#"-F5O5)O_[#(->'O+T<JN%[M,F=U/HSO]58X^"!
MI*BK E3L9I=H VU7%"1P7;K^U,#Q%+\A^1TA_)/ !IWN4M8R2[)(:R@6L%.5
M<3DM#N!:L6+H[Z@9_*$$^<'?^;)NECZ>K%N1D%9\I=5TJRQNOQ ZG.MVX\"5
M,(&5R"M%A%GO(KG:C\'<+3-*X?IJ3D$_CHS,;!*3)^Q)CW09?[$?3>\XX*-\
MD$,RT@9<88$/^(.JP#@.-;0=#QP'F[-G:UD,G3\7//?I 9\]C(3.:B]./X"^
M[76V&^[C9;V-^6-D6NU28FB'!2A+1?P^IMR"+56/4_I8:N+F*!.N?.,)NM76
M=O*C2@,?[8<8-_I@I!B"9'T5I_GV/,+2%DI<;_GU"^Z/!74-XU.1*P(%P7_;
MNMS>#;9A>" _%N@(065@@9>KW:THMH:;K,;CTNN*88NAX(87-HO$]FE#Z5ZY
M#IH!E8.5+>^STV0FDRH.%('H0GPK5V*1?6%]SJ="F4)I!=QYMFXPHI1.(JWQ
M:)B'^?=(WAZ9H+\>%J\MQIH=Z52W7EE@@>]L936[*Z(?X!4E1DE$ECG74[GT
M=Z"E&-;E:S^;>L%_&DC>>K?;DL?"I2[S9?6GVM/$:XWX0B.=8IWUG<5=C.U/
ML9@3QO1Z*\FTCI^HFRG^?=;7^_7WG8P?K)%^%267M$+JHD56]G&9+;OT4XT^
MN R[%)?."9F^$!Z1?JCTMI\.WZ>.C:"7?BD6_+1#CNPATO-]WF^GY9]^45%Y
M]ET4;.^IY!%0GZJX[\$R&J^(.AIY,V07_&1<#?,:QFS&2[-3>FW6HZ0FAC][
M?@V)=AJ2Z/;H\=YVG=!9N3R<AT9B 7O(^+3DP9B6V>3PP#91%P5%60%_W_@;
M*Q8>#%SWSBM2^%ZVBEGJ(;D*6:VX^*^5$GN,+&(A*2 G&9YBX719DJA&W=3V
M(.MST&]<E>VQ8 HGC2<NB)2.(9+PK"[*DI091\G<WS7TN(\>BQ8>2Y@KKP:Y
M2C"M2 V';/Q9S-J'(&?GIN49 [)8WAH'O4AH7>?-:AP* )M!/K<O3O>V7-_(
M.OVJ-=RUOIS$5/<:O-@W-NKOD_O"(EO>Y8<H_PGC[*.$G/C0M.>S^@42C#Y,
M[K_R=P(E1SC+QP\?-MF3G461I[(DK-6)'G'.E8M/5T'X1+^N-]R&62),&1MK
M:@+<NY\Z3#*\OF]X0(Y\ -GS0G];763RV$_.1PN"=V5D&+4-J@,49\"-4H)<
MKM(N!U>C3A>&-37 F[%$7EJ^=@7Y,3-H8ES J9%'2Y?97; K;)MC;@LF;;F\
MK[%"%"5"-'ZGW0?"Y/ETOEL*]!2'[J'!N).YZ%="[7KZWE>R;-Z;SR>%87>[
M+0)K*1?4S!&AM=[GQ"L\%[^#'KM</XT\DN0=2K$WTOS*I-\TZW?:FG6>T:(D
MU:V67U+=N@H]EK$]<\ ""3M7F/8*Z-94\;;11?'?>ZZYPN36C)L-#ZT7VRY^
MPI*A#JT7W$9>U\&K6&!D3']"]PBVKX\%.$C4L<!/8^BEI,.U(!L6\#>-OB:Z
ML:>UM\WTJR);DGGPN!7!\$S*<I;[%3];1W,:[\W.OW"K^\(ID/WJY6]OEIQ2
MXVJ4&-E9=O9VS<S L8-1[!>64G95BT]AN*$?\94-UU9QGD>ON3Z:Q +X>:/^
MN[.[5\7\#/QB5PIY61J/W&6A@K_M2*)E5Z_1YB%I5[<_?Y5145JL-"J5T=?=
M"4P"T7\HYC;-49,JE?[J6Q P7>Z#9.SL6-0<3]R:)QFD7%15P\GV.+**SE<1
MG_[IR Z1Z+\>T7+(Y$'LG\<QFJ5VI_:JM(PO-22I5,:N2+!I2MB#>*@*Y-=3
MQ;<C2[' ;7+G_1AMXE/>]'G97_MO:1D"T\;ZV=08ZIRYY7Y'4O"!QH!-J@9H
MFVC*MB/LM-T:REDLFDSE,D.OE?'P&"]EH4Z/99J>B<6EJR6/65>I=FGT:"\U
MRVU 0R#82<1TOD$XZ^A$!=RP,Y37PN&M-\/,\J38H+PZ3D>)AL$?J=CB[OU1
M8 U_;8G29YA]-4FOMU>6.MRH<7)IDM\<OC0"<12&-];4':VD_[[%]R'WM6O.
M?9<A#2=PTF@@P8Y10=CR. TXKLK8<- /5\EJ&%(AC4[4B*=4;)]IU'!,2"M;
MO+V7@@4Z9][!G3G'/<#$U7AD+2E6!CGN-C/$27S3QJ[9[UP-%1UTF5@*=0+>
M7!U<0NIY*5*O1G2M)^14:S!#LS"1[+$9M.(('_II0:Y7 ]AL^Q("S^"NJVY*
M4TW<F^O!4Z)7P;/Z\K@M-CPRJBM0^H^(X&U4Q+<)I%OAMJ1'B:1^ O<3%;RR
M4_Y:&P _F)Q<XP6<6Y;,GH$?_J.A)L?#S4E:CK/4$2'/LO:@)J/=AL=0_7%V
MG^.1XF.0%T+:(97F80>&V"2M0^JS1<V[!Y'>M1=K327JQ.;/[M\;<WZENN-@
M/'?HMYB_?7; C05L'QW[J3C[G<R_FH6X]>Z.R-DN7O#.$%TW0;>EDWV'E]0V
M\KY'78'Z(]!7]H?\]'QTLTU:2>_99\N98JGB/SM-LXDH_=.AD&G8PV;)*8??
MZ<W?#\^?CO>\M5MY;)#\2K_*&EK_[P="[U$&?QT(K4.K:='QK?>@LS!,LH(9
M.UH056J+&%QJ#GE9GV08K.?B RZ2:?(BUL?E_1@IV1=T?+0G>[V[ZSP3A5$V
MBVC=OS&*5]]A03L<]5?.A!;;*Q615<6\W8/S)K!*%K@,6!^5<5.UWU:<[31S
MJ&Z=<!;1;\KD?I"LMS"5P)6XU^XCM/XS- COAPA8^_I[;OV8NY\4A,$U+;
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M[D#]U>^S.OD*H@%"RDMRO"\0^<,IF5E _)02__BF2PEHTH;ZQG;\68AW3<Y
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MJK$F#T,=V#GPE4Y%7WOEE7OFW@>/O$+Z. _EMQ'^"8<T P(]$)1IYB<;NJW
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M]4.)_=+Z?4T3?%^T_5J^RQGW1MT*1DU0,8O:%)KJM5_&/P+LU(89J8O]:>'
M"/<RC]M>H6A7Z-L,S5B3=U6EUA$Y+XNCGA72!*#H7ERY$_.ND2LU*>)[/ ):
MGH:#N>6@?%SPST?_7:#+4E$^!*>=;W0/W]Z>;H$MW,WOF^S>&V4Q'A/_JS3W
MIKC:W1%SU^>B>]'61S"K<+1HJ[3!HXC].=KWGY7,Y,SQKB#5M/54W(ZZI*9S
M;V5)$0]6[6\.I;/+$*RG57BB83O=T'/VW0XD]W_K+C(6\@C8U1Z'PD'_M!<!
M*3U4JCT"LNQNXR_:P^]NH#Z2^"49DE6>/VU3FV-#VF6.2H-TS&&48-QPM%=0
M?) SM+L)GG7_\H;[ >MI<NO6CX!0US6I&^)ST!WI/]V")KSOR=E%'>%,!H;A
M2<XI))-G<MVS:2XK2V.N8M?)?XX88@-X>S>_X8IF1+4?_^>'Q_\UWGOCW%J-
ME56!OCFWTL*.-EJ,<9#G_VX(DX\ '5;H6+W4?Y]1Q<?[+.AFA37M)>(1D'NJ
M/0V"ET.8'P$?VJ.?[ 4)1694%2#9>V!*FYX>HKCI%NXT'D!'*RJ')C2JMP8Q
M07(;.MICK#-YHK9X&K/+<0;:1..])ONJ&ADN2@[-)93_M#UQON[\IRRT#V(!
M-[SJ!8;!!L+/Y^U7VUI/(4U<Z:D\U>:N2<5 &8GF]7;31T 8!Z+C_KGXDWD&
M$CX"$!FWGZ*TFLZ;'%]M5&=PA9&7:YT4M]<KGDMR_EM5:BU:W/$1\![X]/=6
M/SX"[BS;)[+C-'Q6#O+M[Y[6KQ,8#?V72CS2=.R)DO]5?UH>)/[3N\@K:@MS
M4M!O]C*A_% XX?K*OQ1R'LAJ^A\!YT1/'O6 ]I0L^\%';"Q;[Q^:+5=&:._0
MD W_4K#^7TY,1 5:GMYP)O<(0/F_F _M_\_3>5+(_E[J)9+O'CTJ(ED[N=E6
M6M96<?U$4-ZO_4]L!>LJE(A[^;^>^]2.\9_PYT6 0M,ZM?P)IM?''=W'\*7S
ME9P%B@V84W>OARH/WXD3BYN]:?M1"5%=M2?L]Z3@A_6E+3".GZBK5CD*3 XU
MJGSH&.KQX/6RB[<%7)L]C8=,DD-WV5I(KR**@_M\08H:VDWI_<S&688IMW1'
M"+?G7A<5\.;Y7A+0GT;)!")0>&<Z7>&/LV<D/F&*T#QW18;=R"O:W&:2L6X.
M<O7]=AD.$*()S[BE?""J"!9/B;ZEO *70[OE28_4H;^E1<Z>('P%W&_L$@R4
M1KJNC>%*5_29Y#,X@V?5EO=5!^F'&GB'>.A?';Y#<ZXU]E6K/(9X;G"'",U2
MX!WNK?Z^DZ-JCI8N EJ5[ITZ1C*>3JR_B(T8EBVKM")G$^YS@V(_<$$=_/_"
MXB,@,NB7EF4_O0A\[7V6PL9Q1MKF>(\V8W--TM#@W>T1?]M?>#'W@."Q4"OK
M$PSX8O)P;GA[8X)>;0_!AELXW8W@NQV NOM)P,-S!%=;.5@O+(1QZJ*%^_!>
M=EVL:%WHE05N-WXG[?YD @J=F? ("586O_\H%+^\%A2IY[>=\Q0#\&T(O":&
M3GT/8M4ZN\"^/M6#[J@+OX&CXFE>-[C/W,NC.YO#>P7O4\\Y'3OSM6<ORDQW
M5&>X.8],FEKD-QN_##*H_!E*DAJ*KOVVD2\:GWLQ%GZ#'OGZ[]H4_T6J!,$^
M^Y*P''NO_58,\8>7;QD \C 7C'T<[YTPJ)4$X<,KK$< *K)!J6H6(O2BS-D[
MERY))I6,P?5-R5N8ZE1K]!<';9I<%5+QCGXC@78$\+!FO>1VC& 1[,\,;\]S
MY#-8LLZ:U_;PY $2%BM@>!AN,#A\>($K&@2<]K$?;Y\L<_A$Q/<QB=@AAXZ*
M=K0UK0]44Q[E3ZF/Q.L6=8\+7ELH4U[>T%)G"-.UGY!)[*["'J,GDAFN!YQT
M$A]^^J7!0@8P5GD-)M6!QWVO<-#_#=/YH?%]?2G4ZGV GX^3W =VVRACR J"
M7:X6"=VX52QA\1^S0+_TSR[&%)?AD^9FN(R=FNU8^%X6X'M!O--!VRI!?!EL
M5?P[\U>-9WUKY\YA32!5^,.S97W?YP*^:U(1F[,0>ML&^^_JRLS -NJ[N4[*
M\)KR6=H3+4=7F:K=OPU V\W:K. ;FBS$RY/^26"AK=YA5TYL10$>=75B;!6+
M:NUSQO<BG<Q-#.>7ITY2>2X@<LDW>&%2N!><MIQ9#IWU-;HOM$?]B1*7-%Z8
M2A!-D"_LPY3:VXQG&E"ZCW&39/N,A-13W!UZ7V%(351#N%<-Q;K!['JMDV+T
MQ>E!A;&ZPXV:,BHM7S<1R8%S /',-=HH<5#VOAYU072=0AVY0+3UCHD3^G%(
M5P9J)YGQT'@EE<5D8)R?U$ [7;)BC:(U8RHY0YS"MA?/#H8Z*M:/N./Q_H+Z
M4Y\HP%,$G&?N^HO,O/1NG<S-4!29-6QNJFN-0&6LW1T:?!,\%3Q%@\% @UG>
M/[G:$>%0I_1QGV^O/I4BG[X=S%Z4RXII>H6_\'$\$*/1'[1C1^"<',3^T#_C
M: 5WSLZB<9IV\'3-RMP:DZP[QEYAO;D G<T$X&N:?HS%-_M(J:D=\-,)0).R
M#B)O?V'D-6P4W2M)-D4W49=M1DIK;25C%?V",L1=BYW-&#OE]1> <]1E&L0L
M$ G]5, 78Q9C=O= A#+FY7KK#1&S;&>VEU1RUR@;WM/O:TE0)I<.Z*%'BPM(
MCF/O;X7D]#X"2)*!H._XYT?\M\=?%O](84R#%P1&C!9D)ATNL.;1!#VJ^"?E
M?=\$*7D] KH,N0YZ?P@VSCKFL#-VI$.%3:X<RF4)I$J= +D>RZR_^*9>(\%Y
M.BN#KB;;.F7=_-H\_9[>A7T*@/I/IVUM0.6ZF7$9:\O_E]:5\7><\2\? =UV
MXHSW14\X9O)UB/2E-R2')>:3Z5F]MY%CJO2U;X.]2#\+:GEV4QOENE"X^/MU
MJ5>[HOY%U*,5:V=D4T<I5)1^^[K>]#@)>$O,U+@XYDBI#<_@5D_WY^V)10;D
M7)QZ-W,K-@U:"J[/$BCD];S&+52;7%2^F5L&B!6S)\.E^H!8=_))QU)XMDJ^
MC,5R'-&,M7\)J=)/M]Z_X4(N@.T370K0T69U_WMNH?+L![X"(;77I&+<OW-!
MJ_?U_)/=7>TE^Z!<'R/3]<'/<#&H7LEX%<1(BGK!',-]RC,=J6C($+%M]>'.
M]B7ZP]3G+G)^3E6.ULO$&M"4TX"WY&LENQVO=DEHV/ZZXU!J!!_I.?Q"73#H
M:DO^$SM5PK5%%Q/DC49Q!HR@ /708NX+"C8_?/=C_*<PB[BM/0M<:#3,(0H)
MTFE7='=!4Z(SE2<?8PQ%%<]Y=Y_3JKX!HKSCK)T\F9GHRU42ZB,YL"?T;@Z6
M=AHC66_)X<DTG#,P_]RT0;02OBR)+-L8P]B[$B7I*+<5FKW!N>@[VB[ZV6-O
M8^;S53!H!EC=GXQN/-3#&\#K@E%^,Z"&I"[83YV=<>EL$*+(ZXBD;VP@M2=O
M:5^Q)]H*4T$7^UO47;09RBPP/[#!#8!05DH2Q9W<LJU\K I;U<G5)N4DXOUC
M%O&,>+AE,*$0TW7.-('&^2D%P-Z<#*2I'&1(#(;WZ-&&@/1F7\<QF#&>ET38
MN_0XF9_F"ZOQ?@I.D/$="]N8>@T_3J,I$VZ>)IEA;/G*HLJP\.*R$X!=KPP@
M[KKC@^/UZ'=@V-9X22G'W^+U"E5X0_!WI#F[!\_"=3&\AII?F74'!@G&)!I]
M__S>" ^AW4\A%^7.B:7^5ZJ>ZZ(#XT!=D: BS%WWT,'\/6==[XMU+%U %U>[
M*3IL\.^9$4+WB4W<IX6Z79=Q!#,0&"Z!A+[.2UKT]2;_=MUKU^X\?,N"N@.D
M.O"4(N%P(Q,'%MB25.KMGQH8Z-H\$,SF8EI>NKXS(VA+.#-?XG*M?AW'DY@\
M"*&'?X5[M*P= 7M'R@_2\&UN4E(K>)'2^E9-9^UCQ(TJ=N_8*O6SZYW'E.9'
M_*)M_.S]XRYG\0W>\,A:&[S%%@V.>YB6(,&ZE%2__W9DBE1U+S5$IM_)E1F6
MOMVC$)]YP)U)_SFQQF4:.ZQ;3I5V'?#[6CLYZH:R&XK/#Z( @>9M"E2B3ON%
M+1OKI\Y+RB0UX]3I8KL7/X:FQ*AA%]*S@/-+]4'8TC8;G.J]BORQSH4Z>C8G
MF*BF9:UIO.RXUTQ[@8\ -]^_+Z;_8[?X#'A$[?AK"6('?^,5K +W3S>[CR["
M%XHMI6^MYMZ&K:)Y9S_[;(7N"1!"%_>&]N(=>CVP><VJ5+7#6S.F.R+Y1=Q&
M!,4L**8/_35_$ QMF2]1?<9$XU#&6/J-_AIW8'%*^S>GE3=S'U9\0(>5Q3AM
M;W"?[(>FF#VTZ!S .2V8!O0WX^;F:U 4>PJR:$-!DNI.&,$<N5Y+.K&GQ;O$
MV,*CLJ5-1Q@<N._']XY\A:*==A&B#*?*>-Y8XRAX,^3]1*682*/8OVXEDCVW
MV\(/P^AB1D?-.&L3NG1N_0MQ!1=:(ZPSM(+MUQ%/0,RR#"-NX5;LL(]$((;%
ME4D?L($N,D8<OQX/0^]?QFI'<&5Y2X4*D)\/<U+LB\UQ%@2MW/.>#$'?DB^&
M:G2A2\9XB7V4(FZGNY.>:B>%:%96SKJU,6O#0\*/]+:3[1F@U@V"IGX).?+;
MY-5#H0WUXZD&5( PMT< EI35D7;G(X!4X+NOZA3'B3B?[:S]6B;&<+J=_RQ+
MZHX3&[&_29U'\FG5*)_1$8@-N3"0<10?_WSI:+3A/O27CC4A2K[M&)A=8.HP
M;ATG+JUECHU7H<&VQ$XL#BR]NA(K+EUTIP@_;VA.N3L#Y_1*P6"0JW@.DOZ)
M"],&_-[>4K%7(=?/CI=2%[U_XN67[)S$4/12 *,K:+5[G>EE_P)Y4S$I906/
M#F*:AX3WY21*5C8M-4Q+F@+67&.R/EV#M1L?)C)[R:IX;(5<(D[LN;DIMM;C
MV0S]+="$V=X-# ?P)+@:/0#)?3V%2^9I:7LGPZ?IE5WJ5K* !\TG97%"O11]
M%<$"(WJ4V4E[HH&\2A25E@W? AM3#NJZL#$VWM1 A!"\H.=W*A/EA_9E[C;;
M! M]V,TA6L5]E2(>MVU2T8#+/=TGO)D[>>20-+KVKKHQ^4^=>N*6/,HURGF7
M*<JN0@6^O9 *@JDU5=066*CH=D#=RL.UAV?G/-MP5C&I18&T88ME9)A\*"_U
M)[Y8,"L:^J+_A<)VZ63W9.LFJZ@=>T9 R;<';@06Y<_ S?YSP!B35!KZMA>U
MR8LN &_#@'D@]LV#/J6$$<M:<U55G,Y6D'S7W 01C0US=D NE=M*<@*N:%;(
M TYFIR1@@E\_<_"D?"W:[<Q WC F]NPMVB5: OK/\NS3&;$#W;)\P[]_8BG+
MY8<2@_C.!:Z)18>QHBYK#Z>,OI==/S"?N]NQ#ZS2T-38#(D>N3U\6KC605:
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MYK)YT) DH\\T<NG!$VT?HL#-_:5_NC1E%7DZ46<ZF'NU?["5E@ ]H!]6*[_
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M$'MG.P>H#U&R01IV]SSO#S=_&XU6RTQ^: .#?6(;61R*!B7/_5[$H2T0PVM
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MQ?SE5>+[)Y)^6S>0*$D^!'=%F*_HP]DPI!IL%>A:P]5X+) 1;\JYP>RYO#X
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M"-L,?.'@(JN6K01" B]&XG;]5;*_^'^I'];<$*OP,73,%JE)I*<.?I_W4H)
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M^QNA%3+BEQ\NSA4_U>]^? 2<K_4EGH8_ EZ=/DQ0/P+20;=?VHL>$ \ZL..
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MZ58&A#HZN;*@XR(S>%88(_Q>G!N.C<\S/-W'2_!"\2W0VM7(*XI77#Z-\7Z
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MZ7#>(WZ-CAG"-(.7IR^GS\!T#K6 G+B ]EIFN4F)\RSUXX*RVG5[$#L-&<@
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M#2L)#&>H5C:87M?&/A/<+>E,L/.,?ZFBHF;4T;H:&685)!RLQ$*5'MXV)FO
MXG5M4"L8*4,&SM9OG-V;3_U9ZMWFD;U;1*JQ==C2;6]U>U>M<:QQK-PTOT)/
MOR_7472+^^G .F D@ _)6[[5G>L\*IKY?G) F#-K1'CJ@CGQA>,UP3EC O3[
MYM\M^O)X[!L5&(;@-*=BP_E4  7P'B@Y*QC"!6QZ;33)$(X/I5CX7C=#7%F;
M1[$!#'&3_0ZOAMV9!4$S9_0N#I1);KUU6.NYB6 %GP#GO-FJ21%.&D%#MX]F
M1["9I"]J,2\^[9SD?<J?%Z D7/(C:KZP&RN=6R&:BB782^H7*,%&^. -6%^F
MF<DO3]P9%>?[D;-[SS^YQX&5++"?)YA0D76H(]& !\=542BX$!EP( /7_WU3
M/%$:LVAJ+F#MP2%W\A/MN[>\!L>!3E5&JHNT8520UO%3>";1HCE$OJV4C[@X
M _F#.EF?'+9;6'6$:")'2G1G1J[4?/1EOQ4HO[Y0/&9D]'ZJ;=1,_6M'DX4R
M8"3%%5XF%B+\CEYYT>W3!8<]1VGMFB@GJ/?W[CL[-VX46$3?Y_;82"0#G*C%
MZ)!#/%JKQFXO5_6A1=G#EE*[1H4"7$)CTS50)=3=46M3"+*; F["BKT>;"T0
M:UN 25 7+=S65Q6^%?@G#2*]T?)ON-WI\L28(* FP?:][:/S2"D71D34N>2)
MY3VLGV ".D78'7)C>F-4;)2A:0R\OV#&.A"8_FG3U-U 3MND8GCQR-DIJT9K
M]D*NI1%M%=\*C=)K'+8BN1?M9L0CC;">9,#0++^T-*/B8VYM\H-@'SO.?PHA
M]\R&,>)%I?[U;"D]-RXFPO:!+J2PS#!OUIN).6QBV[0^'EK/$ISZ18\XU0U.
M<\1ZCTXTEJP@X0?R<)=>;)WAZ,W;SA+9\'Y"0N/O-YBHM:I=4,@.]=0 -?&W
M\&S9:$,@[3GX<DGG'PO8I'.)><&?[$]WE.'36@C$JOD+E^)W^>$TM/_P1@*\
MS+O*DQHUL(C9[XX/+'X-/E "A^5A0\&>0:L$$ADX+$^\H>^/*W!KGE6"SZ**
M&K@,J'Y>^B )Z$Y>\L#XCN"]D ==27Y+$3F2_/;IYO6(DQRKC]A6.@8"1[,D
MYJT6LE1IL9=^VR8SLD\EZR7:G0PT=%KMI$PXH2>M:V:XLNDN)&5=;2D&O,%&
M_7)KYH?X2&Q"#:5__^9G,T0W8ZD^KKTK\.F9K-A/ZMN=J#6>LLO%*H7/I?#W
M6DOCVR'4!+E%*=EM5BFF@Q_(W=:G ]UU"],<\E.E*0@Q20(O";7"4IG4L;M)
MLDW;) /7')S*.% 8BRR/):*"CV4-:_4PXN0AF)NMF[WIVG4.9/"_'0N<S(:2
M8[SYK #%SSR1*[I]S_/O<Q[3=6W#&1J%L\P"$@1-#5!<-VUS,FIC8_)Z#]>G
M8M6Q?#).,GJ9#:QI*BYNU#] 8AT%5[B?CJBV&J@4<.7X3&,H.T#T_O5:H<Z+
M?N(7 ]UO1>C!;%4(SLOW=\JC_S:EYSPU]RXS1&',1]):!;*%9WFPQM_^!CQ5
M@M@R$ES/D63@(RYB1LJ?YOS"P7W"W=V",(E:NT_(@VL:,&\S(:O1\6RXR:%&
ME#OHO::.(WB)*TK9@U]]MM77#8L<(0-P[XO !QK(;UI$Y-DE^LH50J=FVFT<
M$)[,WFT/"%=5\F&&TM!X+R]:RM()Y]3#;3W>L8W2-W%'\/'/?Q>0CT[MR,"5
M-0+7 :+=@J;VW+PD= ;YU$L^)[#++\1YW]DIE#AG9&VVB'DS2;!C,N_<D./Z
MYJ,3X.H["J_ SANE$G4<7LO],SI)23J7G40\L45ZY?Y +YXVR6]'/XTT*,BR
MU)W8$0V>]_%B86VK]._>D$[I)@.?"X_TEY5'WJ9I:Z26S2MA66?*[)KOC1QW
M'7$@36P'7HZ2,#W8GDV<8:?*8_:\SD=TJT7GZ#/_/U6K#15]\#;!?/NY;>GB
MF/O;,)OS6M)GK!6V)$WD1?GP\K0-C+5VPT2E+S"O@&"/U1E#-K"RR4TFZ;3.
M\;%4X"_U%$8Q,<(7Y,YKO$[+5R/EUBRRWU)EQW^0XIR4( ,W'F<5N63;.5G+
M"93!O<!CM[-U8VX,%I0'.+^*._8X?P)I^!Q($8\MP/<6$*[7^>PTGZ)ZA-91
M;:7RIUV&.@...XF:AOLD'ZC 7_F2(:H28G(IC+#%8#DM'DHR=YA]2K,Q.'M0
M&CW0A=;^K.AXY;TR)$0,T)^U"[#P@,?PR_!?U*KFA><KKKAI1-:&.!.+S9.2
M./; (ZPGOF)E(HHNJ1"7JCD<W9N:<-2@ !Y\*!<R3(1E'I<?;#*6Q0G.!^U$
MJ1<4V$_XRM6EG*S)>)\SR")^;L&IVB06'DSB*FN8^#,N<C,BH_ZU7'S-LF$5
M^MJ4B?9)48R(;O.6DS.S7R#%SU*XLV[I-XX\K\PS?O3?QM]KKC@=)62_=8?E
MXQC8R<U_<_M\?"5&7XL,Z'6/E&S*WZX<W0N<?G]H+QVCY^'N=0<^S4I?SZ19
MM1P<\S3-=O 1VF:CVA+Q?5S,K]>0G[8G-WI!/,Z$GGO,)NTW$*!6ZN3,%-$#
M12O^2C+Z_M[&,NZ*_!X\Q]&(1BNF"QL@C5)JX-6+]))^^\_/N/>4G"EK98W.
M-VIA<NP+FF^//4S=SJO(@ ^>*H9$8TIT#YW$4G!*#4X].8P-8,3:;Q0[\%?-
M>@1-7-]=M AC^FLD(<Z.:JOCF-\6;+ Y0F6P$:J' [DDP,'.'IOT<)KY&U]9
M2M,<U%M0^VS%L/R:FO )VG#&">ZO5CJT &5Y 7=IN*2ON]-RPWR3Z1D94,UO
M5?DG5X9E63)O] UOH<EOJJQ',8"1VD\>3C>M4JWSI4=),TR#RC6I%B@6'T_K
M4QCI&.$."K0O.&AN6&IOZ#!:^M-!!OH$-5]3@-0XMP(_Q>1X\%+[C5OR$@+W
M-]D^OW<-7^N05UIO.(XF P%)R<Z&N& ;9V\'T?PWDQY:"-O*53WBZ4;6F8%J
M(T.^=Z9!'<9\*/&!ETKV3(7QO5&?K?5C E_!B#N,]?:X8S&_-?(S_!8L\CQ^
M#.%F9'?^;G0DO 9AB0/S^__!C[W;#(Y"'$$B5D<@_/Z_=W<S*C\^".(,8>RB
M_U<ECP'];SIFJ>DPQX;R__"+^3#H2=KB[..&L7VKBFK+,SN1X"MXD-Z.5"E-
M\P/O3UW=/0<6<4/3$I1FXU^[;\N]UFXD Y86F0D#!'FJZH=NG=";/G+LS0&$
M!'3L+"ZT8\8R6/2D:;PLHZ*&E4FQ%ZS$:GQ^*661V0QCVS$8_SQ<FPH74+]5
M$T9*D"8#HXP7P@'>!^?+%?U[NON-'0?DU7%D;T&C9BE\<!YWE>,D&E*?==3M
M8.2F8>AQ[B  PMV<T3Y+.37"O3[%)I$NNS6##MAB_T88:4I?GKQ[)+>S[G]4
MHVN.3_=S/RD-_X3MI!WD1=HGK&T9Q']#&%ZX.)$'F>&=&)7(*OBU*6*145/T
M.&A.L>\"FW1Z(.K*WS8'JL:E71R;XL93#=J]RY;<?0-SB,&+Y^(8RC#FF%]M
M4]%H8@$B\^/FY&;*'SM9<PQD-<KVP#8DM3BJ*\.UN9UD0G%&5/)LICL(C/_;
M)&EB)Q[A>'\571Q7<YH6\\3.?M!<I_VO1\?Y$>G%L>52'!D8L2[SC'9K0U.O
MFNO(*BX5Y4P0E";D(<,[H:=6BJ/@!5FBU*"/$NV@#$U843A"SJ@ZS"%N)['G
MPO&]7*7B*6ZH&.!+P73'%,O>@]U)X&RZH.=>.?$IIY3%<T &I$<8I(W*'R[X
MDE^@&[72T^B\# -?WE@[V1$=55TP*/EAUNO&LZA#.7E8"F^QN(%RU'*F]T;
M<-$8\6ZGQNZ\]AG.4ZS\^ES"@=='P5+DQZ4R!FESW,=0O%@A2VO>0]+U;D^L
M<^\8_JJ@R'@)-/UV?+M5VJI@M$;9J35Q87_7URD\0_DJ/ZT!VX/!)TX#=L<Z
M/UR]:2^Q#'5MM,8:TP0)3S26+4FT6^*T9!46/:J#!C3IN\YRQY9OTX09,#,
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MP)RBX]U.QN.M@)[]5UM,\[FIASV/SV+F0X3K!A>A1ZC%(5/B/B'I>,!+$\Y
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MC4G+G[.JA"_\J-77M[12<6!."[#[\&!B]>6W4/Z,OA3WOK3H-1^F:"6.,>2
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M@H%O'R[0*WJ!FDV1W1U"F7C1W>8W\V;>'QWK>G7:EAW?(ZR:GX=^+"VX]QC
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M7A;#[?[ ^\B;<9#=K%/N%F*P&^JO%IPC]HU#(DX828 Y\0'4*B_]LC-H3F(
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MNQ>M:(OZWN <CMHS$\][3Y  _.:B"XZ11G5OA;/W>F-+HQD8/.E"P3=B/3>
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MD1>9!Y;[%QQM@RP_.V/KOE<[.U<%:S5&GAZ+9L EG?/ $U<HP)<2AY/,&9<
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M=!6=7^0^S6=^[E Z-=49FJX1:>Z2BZR87@Z$F>;;#'FE_M"BCK(\;&97 ^]
MQ&3DJ_J0%2RAA 7H#PY(K^?;8V44X%U/!^B5MF\J]Q?J^G9N$T86"]6X3?-E
M%ZBFGU-QKC9D5 H?NM'^)KJ.1%IV=R#-!?T=DM$:>+/CCXQN/BPY+=$J0=R'
M'!4[+72ZI:2TR+0^W"M% =Y7\@I"%7U\3HMSVE*8@U_Y+UBPVMO:/ CB$9(
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M;OS?SK1[^,"+4G_MS%QI[_Q:BT2X/M>H,NJZ/%U^0]7AG%M6QMCY$ $:/BN
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MU+.K%9J<B8Q:/(?IE/=67#\XZ_G02X:NE)PW&;Q"-A?$#M<"B.M6X_#FGGT
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M^W][2Y[_+_]?_B\%'37]?P!02P,$%     @ RX-:4C]/4[#D$P$ L80! !4
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ME'\'DVC$SFX:S/6;S&T0N#[QR6"-ZXB C5PB%%WJPJ)CMV@B2=]QMTJ9MS'
MZ8S2(54Y[OV)OSU!#L->R)!5!$5IH6JXR1VO1/,H&0P;9,C=O3-(/B6UHR>5
MMT?I$\B8!;.9?<W'A^M<*'$6[<@4B6Q/%G>C;##KH)V9U1)E>SAGSL;1.K49
M5\_#@Z+"DM]$8."Q*EHYIBH)IJL-2?WIDM<I?P@DQ>N<!X1HI /5DLHP9EW)
M8(8 ,>C]CN.W)BS?[95>F[AW.Q0/5XH^>T/WY=QQ_"/P>=EU&!MTMR-U.D>+
MMSS_H_G,K42 UU#KT>@UBL#G[0I"ZS<X6 W4@;]M_F38-((N^,"3"-3'$@&=
MX188*1&D8:0\&$ >7B<"JSXF@WN_)Y+#2#(" )7L!IW=PEO/JXK.LR-]^1HF
MM!]"F6>XW[-1G+L8OP#M)1>[Z?Q]24-TN?A GQ8?T(0!;YP*!:LH%J]/4(4_
MPUX:LR1-5^]H-S$Z*1;P*%Z0P<PG&.$R!;AG"I./[1.![[D:P1#<^[S5S(NI
MG!ZB])(&(S;CY>CJB GE%#4[Y--W9Q7&TD01""H%N. XTD;7MQW&\@%C Y_7
M/V=_9;Y55D%V??/)X^%E!*QA53JP/S&.56(AR VQ7#Q#C^MF3\2@YENBRW2+
M'92(0!1_Q4/7]Z_K[<I5>NFV!AN7[T<%_E!UL\Q%;T^8H0?Q@I:@.NS95V7Z
MSH4XKI%VG:)'DY.RFV\V[FS5U3!7W(Q[SH,./?0)(NM$;/@NR.#"9EB=3=H=
MN7[.8N) YWGO1(L]7''-6G$:F,(>^A^[/SR&;8S,T[O/WYEA&B)M#VC6@V:^
MKEU0(O$=P0F+FCIT7O)CJ30],L/&>BH.1?A#%!%PB*6$ALYWOU&YEP)ADJ%U
M%FI?SVD>3_1U<NT3+/\RL!-B]L;S\4,%_7>VRYT.WPF3 1S? A1@;;IY/WV:
ME,0'@D^CBQP*N!7V(]]['05MYJJ?*,;Q2%"W\F2^ND$U"&(G4*]G4<UJ)1.(
MP%V4A[^I?*+^.![L([%17GM>\$$BL*0%!%%92ELVHR$_4&A8>!.Y&#M!>DS2
MS_?"FWRL:G]G.")%\Q.U],&C+\OJ;_U'!OT6<C)M#_)/L^=PTVXYI)#NCI#U
ME]1COBN(O:/D(14. E[K*-PC>\-3)>?^V=Q]N!-K-><!.>.,IW=E[.#E/[A+
M04K?!W+7.TL@E%^X0[UL[0QV:\X"5 KB_8!?JSKK/;*_:50? @9A.Y  +MCW
M_@+8Z@./@&]9I.YE4@CU?R0%\(.W_]9YLI6]/Z8%8F[[^RQZ.ZR:")#]T+?"
M*NF:=$SPUN8=;V4YNLJ%6\M4L(N*A5S[0L[8F(Y.65Z1;5W-JO#%-7[.9!Z5
M ;'8R_FTY!>MF7IV-&P5)!\@F%O!26=,^;/CI]L:K997)Y&\V/L'">-^NMDX
M90T,/$Q%)\>>"Q(BMN=\6]\,A4#49<I:)W6X]1@-O3)(!N(4V>3"L9-W1OPD
M,>#?$B8-I: @\ZP'HP<::5>BMW*3[H#!7UL-0K^R/MOOEB%+Q&P?V*("+CF:
MED?-7,'$AGAFJ)U6#V[,GG>\2MG?V991&M>1_>-HX>4U?2"=QP*#W,B:C_;I
MMFP9DR4%(TZB3W/,>NA*'5:M6%P@>>=Z2H0<36L87]V@T]S"J!_MB;&?+&;Z
MH+G$G,31DQLV9D3K2(S#P\J9 C&^?66OMC$IW%.]]ZM;0MG47'H5F@ALZLSI
MT^%.NI4VQW.Q[ -]YN,KHPLC,NU/+B>-&JIMIK"/A-!\/](12&@'>;&2+68Q
MPFP@Y_$W*L9J!. XLW8?OBP_C]G-#%^3NV);+IH/YY+(PQFNW>0YKW&N7+,#
M1+^M0HF]BK^T<#6E?7C20I-^?Z;]^:<[D_KIV8IQ3H\_,]3SBJ["7R-K#T/Q
M(*OYZ2OS[988F_@BQ\1U+D>H&BUG/D+++<U+I]JN+?K#DJ;A#8#,DFEA,)IV
M03(FN-NDM@J:^H6[R/P1+ES\_=;F/$V+>1M';N3R/>BY+I]:J1M*V[%9E"T@
MJ#P:$:KR9,X?TJ'O6@SILV6#AW^(N2J9K3Y]T/>\N/2B8!%WB!YVA ,,-OE&
M!#@#Y/$*8RT<TSAI-#*D)EIBT!BE'R894_F$:4+G4U'(F("@F-\<2Q#0?1&[
MV_F[P&3;H]H@45+9$D)O)@D[JAU7CH_)#VX3@=0Q(O!LT)1$5F3(=D]9#6Y0
M>H$I RX,8F/G-1+1=JX"(T_K)<7[]R+KG>>B:7NO2$G=^OBYI[=;H.SYV+0?
M"RY7OA49KF02856IJ\?M*B6:QLEM5Q=TQV[QM[D%D6XJJCAA\A8LZE4 E0,?
M^;BG9.C,-2RKY<5AEZ=O/ 99U,\1QDV<&\ONB'!8)1^=/#Y??S:CG-!)4,$0
M@1!)SZO;>&4U^),GIX6^:$?GW[1*)B:MKF@&NURC4KF^WJ7/)AE)X/<[_PW/
M7?P(KXQQ:0:'U8CVN-PWQ-Z_H?&VHG8S>>8^^^,7#T+7KFDYD5G PV .KB$(
M+D08X9*]&CN6%<RZ?WIY;S+,I?RIDGIC[_GPY5N,[[H=HJX"()=JLJ^:)^=P
MQRMW:YL1XTU"*H=<'ES5/EX''V/6-Q(VOW;RLHIH-JX\O3$W5S%?W'W"C)MQ
M9;.PJW"TO)"@X'$'2^?3L/:;DX38CX/M&%=)GA=:CW/)%2]&;:UEU5QXLZVB
M7NQP_OOZ.5Y4^\VYT;,<P;1?@6<**:<F5%G-A'Z]V1KP&^[/SCDPVW6P(Y@!
MB6::752OVO0]=!U,RQ+EQ3:>I@(K-8/?8=VI5]Z7669 VA"KA:O=)D'<O&;]
M*895#XQ](Q_\2([V A[5!D$Y>P9<@D]XH;,=:FR?QBZ-^BDZES@8V]X;:9+T
M+!;S:=YLF6Z=#W:A%J&E^Z3 6U(ZC'20I/WA:&H]5:O4=]L1,T(X/VX4PA_P
M \'WF,_UN/3P9'8#Y?^!,)OJ#V\7OZ"?>=*5"@K;R[@N9CQR,U3'66UUP>*C
M0*\[167!W-E;'\D_R9#-I4INM,,=9L\Y$_CUY\%T=A.7/]>9^?H;$NZZ%"8S
M?V[E"7C$*.KD7)RWPC,/ATX>@+&(0#]>7SAD%A>PMJ ;0AMM<K-B]'5#<AI/
M'H7W/&V@E*9(/THE\.X %M:5QNL[-]@^2#?9#B4A$<.:U\2;L0[L!T1<O_R[
M-)I:K7W*!SXF9MBL!:%6(A#^:;U%!(%Q#:/J\'^I0-%VO*GQOO!+MM%R<)^U
M-T?Q C-]O6(WQT7. /[3E.70A;/(N1Z\%AI&+9%"7QT"8<'%R]T=[BAG5J1O
MTA7E[<!_"FPZHT^9O'Y@ Z/&:2Y(XXJ]<["2KT+>.2?J9Y@.NWE*T,HM3GVY
M5R)!$Y^IZ;!7,CC1B Y!8%GF&<-DZ<D[QN%EXL'VJ5UODX<<D@EWJ!-N+TLC
M$F)Z^S1TSOOR6&7@\D\,H2;=QJ3D3QW1'[]8A^TOCTB.GU)GG_06ESMJTV!F
M?K!Y]) N?8<]4,WBUW>Z\ _@Q_ C949RV.0A(<[<Y-=V9(.-" @]F7,]"2 "
MP[01P&G _PO?)I-5@E.XKR\*]P?X$('V<A*$YV02 9P^(T$;_LTW"W>8<MJ.
M+^DE2. ?U.",T-^WGR'D$0B)I[6UT]729 E??847=LFG/)Y@]MV,K#0BFO(K
M%;#OOG#0L'3,6_=1E]3Z99.<VQA*B/ E F@5\)%(+,YS"KQW?Y8(G"--UFN$
MZCV!0.MZNE0EU1\,TGS[VA&@9D=X,(MSG.4@ M_D26"'9(%A)XZ1^YHR!*/#
MK"PBT'&G!YD*P=$J2OY>U@/8[PTH1Q"X#KO >_0D%-[NF,6_C/VC5-A:C/T$
M&(J<YW\&Z9?$4RPBT:CG1&!('X87(@'O98,_*-_P)[W :+B?%1&X,<U(P.L2
M@6X[(O# 76_HI)W ?T4=/TP$/NOI$'B]&$]9#XE &Q2V8P3"K-?!?A8B"2SM
M1""AI(P$FLW8V%-R#_ )5IX(\.;^46F2X9N@)O#_ASJ.^M&?F%E"')-K P1'
MQ-#5=7$:+J5>\*3$P,Y':0(HJMU5RV:LUWP^O W.T.U[N;ZYN=Z=K:9V,_L=
M7;+5#TW0.[Z%GHYG[S;D^#D>M<]DCOOB\0U3QV(@5NN'&[SFGB(M2^"(U8)&
M^Y5A5,MDEO ?W)C[>]T\=P)0,Q)2UV-UAHRDVZJEKX-B4\%)\G]8M6;7?XH7
M52+ Q,)/L(?-B?WG5\Z>"!0K%MJ=SA.!L/!XF P2PY) !$(M2*ND3IH(DPG"
M)VGBE;9 QU>WB<!K4D%<+%Z'_7GY_^#Q4X-^9<UM1ES8^PN[.B0.^I\/;/ 8
MSTAU .;_K)I&,U#0P04$!M$.!^&5^51\/^+MZ:/6_3PL@H:<RN]$[_A_V):P
M,3KIB]%7%2'9\9WKRQH3O:O&I^2>3PQ.Y-W\L0;U[U@VN\=;DH?@3T:;S'*F
M)Q629Q:T&I+E01UEES]2[<BBESGU)$7='K[[H6.3,;2O"#Z_=+26UJJWI5R0
MZG "XH:U?X2M%1&!I68B,/W@=SVC+0@GS.%'$^-\9!EY^X1US6;_^YTM";@.
M1\<[3B.CB^D>0JH![]5(FV/ZP@78,24.1K)QA0@LC*VB<592'</1=JV7Q8UF
M;[=WN8UK!<%55-;DA1N5U6L\&^I[_W?SCI.0U1XW2W@5 "+EFC?)B?L@S$0
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M"NK70E-<\:\]2HG =SD([)CD1Z\=M:8_2F[\!R1?:<(**8S*9*,X1_+5ZHA
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MX!-/$*8+LJ\ 6Y(F @@#0K4U:/>$5.!32+M$T)H0$^R;/$&?D7#WJ"#BV(S
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MX^?F-]/Z<$C$1O3!TI V8^80 3!W$.1H#N++I+B]5/,Z(YM+=!EL@N'"D>S
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M:.16M2R</9(Z<P6*)(J&.@_6>.;7?2D20U%O15T0N4LP!()BF0!0UE&O(&;
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M_M(%_H'S^JL1DF6UBUZ*Z(BPS*J(IKK;O<Z'?!K2C<L>H7<Y:20:7H6ZA%.
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M\COIAJC>(Z.4.Z#B32*,DJ6*HG0O[_S"UD$]IJT.$(N]$0Z#0O&0FPD/N7'
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M=O-I]%&:$W3H'I#"T 9W+OMK; ]_HW$5_X-MJ4.69YK"0>=+2.-X+5'H^?2
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M3[\7?M+*OTO[^@?I_[L*ANUX@\=$;I"V21A&@^F?:?M/LN+[]@&TDGJ"D'!
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MI-0SJ#B=^,/8UIAYFB"X>5NE <1N]A_<^>&HZV@9E,W";55#6N5/+F7MSW!
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M)2<"#V$_*N>?U5 #W<#P;7=M@I?M/+UB3(\]^E(X\^-PP/=5_;Y6G-B91AS
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M4_+MJ!L'5.E2XKP06A<?AZ_&#]4P9>F:Z50+P@4T=^!=ECO,FR\./NO7.S>
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M5[/TF!R'$H)D4)$V\ZP9,&(A$+%V[[1&>2JC>?$2!Z=:0$S"<YDEW.XM8ZK
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MI,7\*5:G6LK FD_%<R1\5GFJ>B>E^P)'(FGO(3S[$E/#9\I6=X)6!CX&7L4
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M-M1CV^MZ6.,[HPZ\>'90DOOK_U=E'9U@ #_H7#$ '[F+5(F_O+P(FDV:7L4
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M,]@/O B0G+]0FE:.Y_&SH C?\BP&(UWN[>IZP3,N66J #4><XVJ[&^_MUON
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MD@5Y60S9.+T 8/+6Z7STUL, WNF<5V, DQQ^051UR7<BW<7+M-1GTB][ CO
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M?2A-LYY$VQ<,Y)/5S;Z'_O%L1C*]22(LK#@BS?>M<3@&X._\?:"@ 6PYC+9
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MT/Y4&<>3&  \'O+SJX0N=86C(@Q@=4 :=>GV_\>:UHRH1R7N3D68] X5VT_
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M9V&W-+>^UR6YV6PJG+)&VYZ'][;ND?J>_XBD1[$RX,0!IIU4:.E)TCE(PAT
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M)CNR%1DWA!=P/$X%]>?@KZ5R1-M%3XVW$!4SH?VAHA=MTG_T+;_X>XYP6V'
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M\K_$,@SCANF[7-BT:U66J+45RJ+S3/H]9QZXT<4W/<YPOWU [FO(':X+)@'
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M84FNS?,T(WU4:GL"R^'*2AX%<Z8=?_B8H_\"[26@F]TI.Q>O[^[$2]/E7O8
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M'+?ZR[;>SZ.ROJKYCW[C+V<_V66_V4"9B>@UL%'FS2IY#B\K/')]46X+!CE
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M2F.!W^9BENHCIU<;*UB#487](^:8S]=QBSRE#>:5@M0\V1/?K[M"V*<CFA4
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M2.6W>=J 7P_DBFL4@(;LW]M)U((MCBSCV<_( HI7[2_F!,O<) 3%)'4L9X>
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M.BJF]D&EX821X*GD%VL>]S\3F(WDOU?D)\&XBOL8Q-<13AF1U&]-C-O,A<?
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MY%*G_DTQ(0UC_49-P'5>L,IS8EBS!$:J^DI6K,L21 !QXE.44^(S3(QX)>T
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MVHHVABVUV'5J^;TSX*#M(!B_??@=DFRO99GZHF1AW_ F6]G,66JAN^^P"/C
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M12CW= /AU\8F)!CD_D899B8T\#WQZ4L8.O"@'D,['Y^YOK'!9K*'C'O%W8!
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M@*O2](Z['RSUQ:)#["O $JU^,.IQ"$SWHWC0$2,9Y?7^%1%ON&K8\3GQ"Z.
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M:]I7M8)<#@O@@U4,,,K0:D+9@A!'WBLIAL04P@05Y"I*F/#$-7%;HIWA'63
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M4OW>Y6!PAOVW]&+$6H*Q5J:B<E58:LA-__^<82/0L;X*B2+-!_:7NN$5?#@
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M+=;@0J<M):0(%6</T[V2093B=%71$_*$5ED'XGAXA\G\C?E\'5=U@;=KW!\
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MVO5Y#)(27>Z+PU<]KNS^C7DIS;9, >!=_1T,<<T3TLR"_LV%Q7QW'S >T05
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M=V=-#E_,/UHK>%<.X&(&.5,%2_[SH W5DUD7CS.!VT_C_P7L%V_RR-_^/D,
MB$C%2R>JOI?+KLI0<6D)!*#,%C^\C?X>I7'9PW8._-RPL<!W@ODX>5Q/EL1
M0;8$[&SGG%B2AJ:R;%@:,J+9F+:0FR&<F<\\YO'N;'&NU-$4ZWJNVOS:FN@D
MF!]B%939Q<,WX]&HO^I7#B8JN;J<$+_Q^?P7J)^ ,3LET5,_6\J-7<A/1]A3
M7S_KW6 W"C-D,13*1_MQL]F1_;B$R08RP'VVFZ$3YL8G>CWE0\8[5VQ/9?>
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ME@!:%K3BY[Q)ND\Z_U]@5$#>XQI#_X[--P]A1CTQ:2A;HD>!:189.3>")\A
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M:F2IE@5Y_R!JO60^)L/D-;%E2NCAC?6M]*Q06+W\P'"<%)58/%KRUJ2T[G1
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M :-V;VYT!OZTJ91N_;2E;7VJ:JF;(J;'G^EF,^O=KTQ5TQ645(:T^EKP]X5
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M:'\D%4HMF;$K%Y%,;\!79L/71SDG"'>U]XCZ!=-[06$,/[&F5DHW7.A_BWN
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M.98'[AP6%"UC=%N4@F.&H[.0"EX2\?+XFI)=B3&EX-XFI@DC)0]Z2RB^VU_
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MO4#7^&;D7O< SBPBA3W)$D"M7(2IYRU[-LLV0\-+?[Q$U_.BI%0H#WFCZ=?
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MQ5\>?DD\[V39Y$,C@#<IM"M55)B#Z^2X41.-PDM\MXL5%<2O \8.U80>_0%
M(SC1:%L-:GM]7ZF]+T"3UZF?R>G\4D"OASI-,=7?1_+JLP5C;4\9R9IR;K>
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MOB1Y54,*)'L3$E;N-3$O!F9F4NJ.,4^:^]EL852.W12RV%[5.H8U!V_.AQN
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M%4OYL5EMO[FZ5!N4J?PO*/=_)^U_3]4[H)OT5V]Z1F:/:)?]TLP7P:!":NQ
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M%B83-PB]C2POW/,RDOH#J.W93OY?(UNLPS#.IG38R^! E:3SU^<-N#.JR%@
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M*C+0S$!?&94K@"8M+KM+-J6 <;$R\4(O+LM'*0;A0V1V$M$3F'K>$P<O(W*
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M.]5&''XL9S?Y?:_\]N4>G16*<%0OXWW<TE%HOAT<\>8/;3FBI1UY+Q;0HL
M3:ZES//+^L,*U1_(.W?W8]30XS&K-K:;OF2Z=@H_N2 ZR#&*Q()'.6>GK[\1
MW3\[_3!80F UU:Z:,=" 14>_H#$KXR:5%A2&[I2B4\Y_S3#+&-DT1!["]/[B
M#$\]:LRIC(@ELK_<SKH#F[?VEL!PK-;T*.NQ>M; ?NVO/"TDPN+!^FC/*(5.
M;X5:?G:R"??9-@^CGQL9Z.*CW%WE5?D5@B_8> *P_+BFVX<Q7RF84I#G#ZRK
M9CR2^&6WYG!(RYFRRX)9L'&_ZF1.>OK-V *_*CL RXT?+6%T0K:Q5QLF-5CI
M'( %E+-^^]LQG)SEA%^E9^MPR9BA^LD+T<1NZ-@;HY?CSR>/.D&Y,RN#:.&*
M= HM'+^DA$B$_BYEE709W@W+D)5M]&5 XK[SR5GV?+2\ Z:DD3(P H&6!7<"
M+0,C 5$]G*#5V!M39^LQ0$O$"&KHM4.YZ9+:UWYT#JG6W).87\^O.7RANYK=
M[Z(C405T-\YSGDDIW0$U*N"7SKM3@B;NPM,C?%5J*!P<M-41W:P?I&9&!;P_
MZ'0T9JS*'_#$X.KE5A6 YMS>%G0 (I!#.L^9K>8]\M=0UA+-,,J,-:ARSM2,
MH=>P-*7J:]7#34FB0N'BI3JUBLX*)N$VG*/7&J8ZEI.TJ/Y];53^!$#^%])0
MK7]M;E3C%O&TYO6G]+>OBTH';0,%^<C8GN:1WWJ=S3%^; -X/7GYZW$*HUZ.
MWQ7%/Q%?;TFEX$20 F%K5EFF^ ;?*T?WL)X?%13^GVSA%+-(G@DUV,_9E9<5
M=EMH@"+?P;3<\,M%?._RPG'OZNKC,"'#2J3T>OECJ -I5XZ1#/,6L>EK>=(7
MM2\T*<.Y)3'IN!%!=#8,(O; $$6CVAT _?SL9@PY7<M 6:[A.2Y;7\L*YS?W
MZ(<_KJRS-*P7*-UL;:#6TJ +K2G3N7<1%]2O4F%Q&!M,2%L"^2@9/S(J#1(B
M;G*6+>Z 7&M)4+I^ZC>61#& QQ+X4= &E75RI(EDL+T#0(G2T9TE:F@ZH_CV
M'Y"94RN#>TFFP*35LC0*%3A9Z*#ME$'DP2*R&&?Q>TX]=[,.5XTV4Q*Z@>$V
M!XKZG7#^2#\")$G\.=VV?#G:%"+#=:1/MUJ$:=%6[ZD]C=N.9Q09BKM(8H.Y
M=. X<I+7+*D_B[=>D=H,T00,\']"NCC)P*[6/NRW^?XD9R9&#H,ET&4/4JW%
MC]WP1:U)-LMP]T]8)Q/RY +2>!@=,Y6]T(+WF U)B45$=4<M3#S)?5E;+[B
M;N%Q]B"J^QYKB?EG8X==Z.YM<'9AP+2VA/DO-Q+;Y1!(W00$R'$JUC-X1>T5
M%"\TE5&.L0_-V 5&7E@6Z=*$B1N0C^0CTU?"Y!^7R14)SSPQS\E,<HZ-X^&.
M'8?J6PWIE9O.]<_JS93?6"+QXXJ[$3?"(+HC]9V2 Q/AYJE9TU8^$2Q*L<';
MS@K0R-0\5)1I6GY(8GWI5$+:*2<=>8(NG';D&@*,%+G?3EN5X58P>!_*GX]W
M:#:/+HV<ABG2N6^44S,$LN/LD/R9OP?D0S59NH><G#8F8'3L1=D/2"7=AU W
M8Y&%M53)#Z=[,ARK5,<2'PG2]/?PJAPV&QYH_ZK/_Y7W<QS:TY"8WXSI^@U:
MI>_JTBV#5PP>K_?BJ*YY7A=:QL!)H<*Q@;],1J\&!71&B^TY,C'M7$Y-TK\'
MK\3>,+M>Z16_^\W?:P@[^X847JTN=\C73\I5'ET_7:&Z.!58QRY+'E?U@<^
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ME[UW'53W^1O></4FJ:Q*T7-Q'BM+))+@B'+ &Z(_,,9')FZL -G4EP(AR<2
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MHS(=/>BCF33Q;'IZ#U9M4^<21%J?MZ3(KZI<.U;"@=E0&3P\#W)5_'ET[J2
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M=/W*_P>/0-]PX)YJX6NGU,U6Z#CWF@BX]+.Q_L_!U]^Y?MC>:-I9T*W3J\1
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M%$L%:WX3O#ZL\O5VP];)/'=;_BF3^SW_W6FB*N?T^3?MU(D=DJ7>Z!.;O.F
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M"S'89'@SM(-5A>1= ,\-K>=-3DX2[HK,$<588%G5^)EX84A?A,\E;IJPC[&
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MH\S@_<,.9;I8[T<XT!.O^?-**HJ=Q4+-:4TL/.O/7-6$$ FQ^!8KM-;V/<\
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M&OUI<G-V4UFF@S,5E,"8.L;+]!4O3<O ;40A0W$[6?;%I)+73FVEG]S6\/9
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MUSE551QJB/2?=A?E)(;LGA>7N_M**:<Y.A&;=WA<%6)%'C$VQ P+1Y) RB0
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M"$7Z,KC*JZV/CI&XH1-J:<\#'_S)2;KVHI:#55(\Q6,7[<N+)E<D_>.EN=M
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M0SQ=P! *=#/O9GL*[=7S&8H=B&U3=L<G?U=(7#1"&:?SX8FOWLSC3/PTU[G
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MIU FO7NA"N4"DM>5GX?7:-%D5^%B@2-*--_9?U3[H:KT(ZK5L@^49#N%?[G
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M#O]90@$;&B[%\U)A6M4G#.&[2B /I?5,GD!'Q_1442)GG1#I__YX4!J-J(?
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MY7>A0&:CE,W1SAV-$6IFA<2QO,R%:=S?+K<ET>[I#-,-#SU?*G8#]I> (B]
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M%W8%D]O!5VVS'^9_TL?*)*UD>!BD:A#)[K>M_I==JWC_(ONSXA_?R[^9ZP\
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M\G<56>?.YE'XSS9M@)C^DM#^ZUF)];9<Z#P<I6ZSP8Z,2!M!?1LR"P>=J#\
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MMS>:+E.R2WXT65TF6X7QQV#4O 2SQ>F=_B'\GH)=N6FZS8(T<OK*H=5R/'2
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MB?\MVRTM-D[=H1 9+LX5C?$F<H2.JS$F?"T(.VXXI[K:P62A@JW!^N\S^@"
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M"7X7W"%.JB@#_[C_!&RQ0/"W%TY-R,JJ(Q\9RAB[-6RZ@;^'1I.5! AWM$\
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M=#N#O.0.CKXG>XXK4%K_L$8C;+_??@R-<W]'QYAWX2:N-+W>2#V[V,GQ6$B
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MK3VQ_T_BT1^6"-\&Z7(I[&*<!M),?&^@H^'T7_UGS)=SBGDM I@7CZCLD:/
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M8L"OVS#7_)"V=./Z%NU!MGQV<5M6G9DY+S8R'S'1"GY@*'J2$4@>OQG6(M8
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MT$C!5\,*7^:B+$]/EXF;#)S:7%AA(=88%*'?*!=KE>]*N2WM<:XX2J VV4%
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M:E.VX"0%44S@KQ)7RM<3FDLW+41V:<N)TMQ_>=E2<NR*I54AR(%RPVB<.96
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M OL'_J$!(NW=G8Q)FPRQJC)L#X$E"90]UVC<O;[*.4,)1NJ\(<E7F,$$S@Y
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M*>->A5/+6L82V>V_D*2#I#O/NAE.@_2N#<<7_;^H%OKMS_%XGY9IST031;(
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MTPO:OSC_FPN*%,Z6^,AXBJ2R;SN[;4]SMF[Z+/M4<,'?'Y.+OL'.E,@N3[]
M3,/(E3H&^[A(D;:'0B2=)2I!&]H6,*0?/XF2B\L>&.2B3B'*&P$L"8CL#CF3
M*51XK^31L[8-!^<_$\8]&J/#/B[XEQ4[6/9-L;.+W/63J0BG#CGIFQJ?J]#5
MKY)K!>UQS]6SKRB]UV3Z]B@$YS%C;$D^)J629,-,@7RFXO?BOF1(J/:MK$E=
M7<0H9AC13_(_6(JW*B^WYD03SC7(TK)/%''$1H6GWEU4F(>0N".[\[?>,HQC
M%S('F6UA4SI0S:NA9,>]S_3GGKIOO&R.BE4^(ZI2T ]3!\?Y-)""PXFK#OU4
M*)%C/]=J6IN2!6\7&*E3>AS5A\&6?\04"]%?Q!>$4N;9IH2]XN=I[P-7*\3U
MFLKKCWM8"Z(EZG,-QLD7%Q^4_VK3,?IDD:&]SA9!:O,#*RBZKKV^;?'<]U/1
M_(]!U]F;4L__^E.+D>7[>]/(5L+.\K<RMF#JP8)L&>)F?V1,P)@+F&QW(QOC
MUMYS="HD9)X.J@$CJ]+?<7B'4"HIZWZBS.P(IG9<3YTL-4P<.6O_9F/9('.[
M.OD!_<;NRK]G?:?W8(9=C127X]C?%T^=^V^"&I[9_/QMSD#OY IPE7 'WM5M
MM!SI=NM=_."L'Y"M59@I8FMH8&(1+:?$W4D43Q %'8KLK@_32Y47D508(,O&
M+Y5S+9 4;4!+BL  :VB?L?-Y,$V0^WY"2[];5?EP:XNV(>EOS8E,)4[23VRN
M9:]K3RFHJ;NF;.[94A)?7DMI$%BUMP=&)_W$;'(/^7_WREU/*LQ_045S?\A\
M0V1%>-+T"J%6^.3]3<DIZ#/JJFO'Z.ZG"V6<XR>4:-5KZ<RS,FT/E3=B+S7R
MPU:=%C$(D^Z!79P:&[?SEG?)@PC\+G'C+CSQW"#$A*ST^:Z+H.SYI]9)5[HE
M@0#M1ZG176[&T;.C(A,*5;DM@CI/EKWAZVM%4* .LR>T;KIJ"$HX1&_#-)J=
M>*5]J@[2\: PBFQ$,UJL2SL8B%?GIIM*K9,%M*?V3 <(4CSXYC.1W-391,ZE
M?6[N+Z=Z'8==2SI3\E^G+8 2+F=*L89]?4?L'3JK[<;GYYV_>7[A=3HC149\
M=2LQG!L!\XR&L^5C1&5]65\KT,_&^3N76)_V*&G'*O1Q)YM/EOE24N\5OAR(
MK^4R_CE\ENYR>CCB8B&G:HHV"=X$23I2B^6A3Z 4*!8L*@TU!M!BOB>5&<T6
MU$X-4NEYQQ@-QU52P9_ W6&14 T=3I7S=>)(E]A5NTBW4R#0$&@PN.H[S_H<
MHD)\?>R5%G6T':4SVW#IL$G$8[$YQR6!$W.^S^:4Z65 J6Y9;FL0^XL)K3V>
M*@>"?YO'QO-*%1:J@"/>MG-"6:I65&"Q;4HK7-?;?WK=F'<(+2:2W[TILXXC
M([ZC-4K[YMP<D%TD>$(?8A_[5G&U;OLK;6]!1O#7,@B.CMD.F8*5:/ 3R4(,
M/9*D\R^\8Y 7#U"*(U XGM)2??!;8I@T<S^?[HE\]32#@;.31:8LA:3'&%46
MTC &&L$GHR.C 2_E DZS'U6PL;N0&?K:VEA=%\K@R4_QL;GELQ 2/2 K#3@+
MQ:YW!=)0D(,<)3VIH]X=@%5J)ZQ\Y=NB4KQ@FD0ZS\$?Z\J$KAK'C*>Z*KG?
M!ZZ+++-/K6M;3K J\"_@DO";! A6YH\>/O61:9>Z1]:/;0IO"]R&D3RY=R;V
M&VEC+\N=W,E[A*B%Z9R!VX>O.6Q2<?T#7S<K1L;$Z_<W?YA/E./DCA6^T6DT
MI<0 5+573.@\0]VIGGGNZT:JU@FW7Y:I,[FO4!E\4KEPKKQ*L'"2'"B"FQ2/
M._X0]B2W,N&[6VV84MKU;OVHZPD1^A]29"?_KR?!<60^#1_-4-9ZF0ZA.%S/
MA+@ZC"V0IC4U']4:%%Z85'V53,\JX>.UL>O#KK>+>ZQ+])Q'M*/;0K/L DWM
MI!#CL^9SN(KY_$4))R<*M?3]Z-C5TO:\F*HU\S-\L=S$O7L@MY_NFG*D.WH\
MUUP\K>-[?0EB!$*8G(B"4AI\ @*@G25Y.\]V/-]X.]'7T/]!>-"AD"-0SZ/D
M)-EH;-VW0#'2 ]=H]?O2)D5TA^]@'+\$B]-YFD,);<$TKG!)/_[L./J^"_)K
M"(7OIPJT,VY!1W\W)2\;S!L&BD\HV]B7^F[*-5-.[S;,G5P@%,V7]B")UX8U
M,++S .JIVDN,.(,>2$B>!;W_8R1.YXR?1/$.2::ESS!J_/E=*7=M\?F+J#N^
M!A?"8(RH%J4ZJ63W)$<O\5-06K&=3^@&ZJ+.NC8D2AKR(NMZEZ\X0H=(B>2%
MA=N._S:#C8))GAH/++_4AB+6/'-&6CE-.U5.H'[<2/ZGIM3('1A4(,OWWXSK
MXG_S'$&[!H%_$NWDS)\MY2.>PZN"?UZ9J6/5_:>]# H:?>*K.0[2X1,3M?<L
M1!=%[:@JP;[I7]M@1S3( I:V2R15X[.M:'*?H[P1_&H;4Z=(GY&&6!V'X[_/
MC5[F)M0S:2>9S].?WK"^@N.PM.>\;_8O&YU0XGK]*]2+>ZLR?^H0_[94U2QI
MV>NFYHOYQQ48T5GTVV79:'*/)#GW4 4M-XFILS)A_U_3[!:-^@6AK^,2.!XX
M68_T>;_H(>-8[.C#3N[;>S@(9R@]>CVOXOI'7O2M"O5RM/ZSMB;*TA[:8HU.
M] XP4*?IQ#"XLS:6.DEFO=TN@Q=H^'#OE"R%.0YN'N3(MC6#])OAJC!Z'_=)
MY 3LJ<%\6[D1U:I2PNVVY]8I6B$CD%DG-7AWL+,QJ2*VGV,<RV- PO@;*S##
MU$M_NJ92!Y)D 6="?USGY&R46_E[A69L*=4*>[?O'C#]KRT:F-VB9.51 ]MI
M0"@N].^!2J] E@X7UV3U<#KZO'=L!8$9+R@\O/'3?3?]0QHP$BYPE$1^>SP:
MCDMF>L(S41W(Q=(#[K2,RQ\*)S3VX1J1?I)FX\29AE_.K3CE(P>ZZ2R#]J]Q
MEV#^O&1DCQV* /R]MWJ_7@*S]\"/L;O^F=\>6Q+D*?= 53F8\>!N O'SL/8H
M=C3W7^W7XO^MVN__%]?_4SY <?\C2=9TSL8L//@_*]!IS7 2:$I^+EPPI8*8
M&/8MW#VHUCI+EH@A=Y(5:T/!_*S8A2VW'59]T"E$*EA05Q,V@-/=B%TRJIB-
M/4"=VJ+$<P\TN]H-YFB#TGT1MO[S%-8"%M&+O(<Z^YK[^FGA=%9]B[*BZI@1
M%1.+?+TK/&Q"USD\@<)5ZL:F!368K'15>Y]4 #7)7\^P_$OH7+BES2I\N;[E
M+%IH#DL5[^C_4@=1\.)5[YV/VG6O)73^+<YI#ENC9=:5$MX7*E+$42%3)'E+
ME0LG;:@_5B"TB<[ZIRN2EZ1--$^DPTK!+^>_!W9R9>Z!=^Z:ZAC$5_YU9<XQ
M1+IW?[6T9GS+?,/SL42^OI1H?DJ-*F>B@3$R_D#!*=BL9>8H$VX+>NTLU-C1
M#JS[/(7X\/>[ZX]"P/@BSZ/0H[3YW9=&.T><XXK\&B02 5,QWJAIK@%HE%^_
MC-+\UH $_!X@3VKDC%I^2O='/L2%ZG&BAU+\N:^5U@DKU\9M?516!3-HC9I$
M5#6 [D:&W*HU[=3IQ9<!K>.6D).&59C&'N]2F\"OI8]VA14Y:R:F;-ODSP["
M>+@8FR5VQOT?8\\F[J<>W0/ A;5GV"3J4:J)O'J\CKH'6Q].Q]<=AY\!W/9/
MWSN/O?I#E<;DH$*#T5#-J5@Q:Q5^A>:VW4)91CD@6K3*&,U1L=6!XJ0_X:/8
M)OM8N/9;#/R.JE.O+6#X'L E"+IAO/U:+"/75,Z4I+*V&495G-E]NW8 NR,_
MH@XQQ;T'0NN.!(V-^S8O F6[J\/(%"DD: ,[OSP+_*G)NG?)</P%K0F[[07#
MMSG/J,P9>E@B9AB!C\*=%897B;8Z>J*]++A_]*#;7_95+IQ(5J%,>0%<+*;_
M2[N4":2M!<_&4:!_SJ%-."J4_6AO$V'QPJ-W*JC',#=91!_O>>9M,0A6!((9
M4D;D<6EV/PEI X0_L^..0\RFJF"/E><%YK 7C]W&*NR2_D9")WMJRV@.E\K'
M0>JFHE6=RJQ-]X"PT\;O&DM,W*33LC=PVA!?J= +/[Q;>Y7:G; EZQ3]6A7B
M)U@'IR#34:44#OIGA724/-S+#4B3@M(&DC#<3ZN$O <'3$ ;XOUW;\*/ YOE
ML0$$!2).LFX"/]<XM"NQ20T!?QZQ+:\OI4)K=OMJKU,D^S0R[5QM0?PS<@@W
MOZ<,YGU+?6<E>4T&U@BN?/".PFIA-I:6U?)&0W+TQ9K7*ZN-R3DYLL_UJEPL
M3K4@TQ^CW $7P.6^YF2+HV9?Y8AN=3M)4+M*J*\-%#BN]OXY>/E^.\9=M6B_
M]"^)G7-_^6/V[3DXA>>D/-7O!%^;0EXU,A8>+GM-%B&C(:EY@ZJ?<BH =,;6
M4'=Q4^XY)9?]^"4<&@:GI2TSAI8.;%2L9-J_KN.<PS,R$J^CPP$^140HAPJ2
M":YFN3'&DSDZY\N=T.%'H?'"GLJWY6'VDL>'*G\O*U^RC&IQBP#"_U[",2]]
M4QW8]:U*3Q3HT.F$!+.?&*T*A#BU>J_@2\LVPS17Q VXD\+[6'8/'E$7_W98
M11*++./MDMR1SL1U^5O1,>F>KP?M<)\06+P.X/KZD.,<"#ZZG/NJ0;;#ZP_Z
MRP5:Y)=B!>4EI#RSK*D^@W+\EO_4BQ,C#_S&GK\W$6VZ;NO)LCY[Z>I^:G$C
MU4J@T=K\QR6\]O#Y]H(21LB(:5"?%$$-A_8=T6_J1^TT!'CO0U10:T,_7XF6
M];ME3 @\R?>B*_ZKH7O'?8%#C7\1<3#(7FT[]R'0OBK16POWN%&\]/T-Z!!&
MU99]$7ZC6&2PPZ\[B")1J):G&P3-^<.P,=[13>O.O"?86ULS+ZC/6Z'4M I'
M_BRJM1$D'1L-.:+Y.%.VK/,AX@%=T[T(B7-X=P /5I%"D8DV<;R1O]L5Q"I'
M(T5[(BM_KJ^<=O/E[]EBK<U)"3-<0[N.XO%ALJ-7K&/;]^*MHUV=4R3V-?]K
M[@K+E"JX,.=&*C"5RH_@UW%_3MA53$:=H3YU.M]B%'SRNNV[^W7]ZQ](6Y1*
M3V\5_<:+NC#2DVZ$H$M?R"T3NF'QXD#QY;73FY"ANYMR[QM,XT^"T3*AALI^
M/7)8=LG)\?K?K5+JY009,>X!%B#>RXFBJ@6R5L#O/3E'DB0W%\&C(FE1TE4<
MQA7.'[MJ^8(ZITP;E%;D,&[O[NTFR[7CQ1/=D>GP*JXY[)L90:&=+8A<1@J=
MIT2,QRW5L. VTMJ9W/.#(BOD("[ISKIB'%-IA'9*/4ZLV]2"J5/DTYU<44-]
MQ"0AF(E.<D)66'V? L/L:VSBIW[L;8V?/:(:\6Z"&2<9W]#6YN ,N1&C=]--
M#BMHV\>71I76%D%G5P'_9)H59V3L!\2D>YOI\8@=KHZ4LEJ$0MR_X=__K Y@
MN"JIE@W1^?'?:<^L!=%27+PQEPYI+9-=3#X*%HW@>3VNUC9X7H$B P/SOL45
M:R<T\5:J*5J*'@[XZW)"><\8C<D1@I,OYR**VR.XF&W1$MLC+1Q>($3>Z5$^
M'NC;TK/-A3,MVM'N;(TXE'V&O!%<G\LC\BE='O$B#[)SKFZZ8S0#!VJI53DD
M-6!M:S",T?+&PYY/R&K7SM"U)B($-R]]:N1T GEAQ+N,=\^,W-^.YY,\^[7V
MSFT]P,3!, ) =_Z6;ZUM7(4CIEA0JG<E5I$_^./1J+:9>3]U(F!L0"R9:-8U
MNYGFYD(YS0XN:Z(HW4+*VUA@99$DNY!&NR<L9)64_$;#52)ETRXG9'OE+7BH
M-2$+V'PZ$TACYVO5"/10K[IU,R3"G_E6K_Z=C(%^S1'V_"I>4ZYG39>I7V$4
MU2N_ </9TU'$;3PW='0^YC# <[J=E+S35OG'-OZC(S&8NI'ZU:FR,2+%&;._
MF,P35$!O2]L+G"C[XBQO_ZJ4YM\#-+K%A0HZNI/[Y(%"R%R>+9%!O"T44M<S
M)W_ G\NCH['!-(W6D>#D+)LP3]O#B?-:DRAV_QD,M#4D2EU<1ES_'<45M)YP
M6V)<)9$A;NT1/FQ+[RJN,\KCSPLC@K8QL+/P*ZPC5!82Z&Q.?[.<6?]4*E41
MN)+A/S_R03.(77<SU Y*(;BMX_LVRV[V08!LB)OHJX(1D*HP/ZP^2R?VQ6P*
ME$R"AA+;H'>;<K35OY-*>AS:S?I"3V7Y^VZP>&Y^<=+!8]+2$0H!92R,<5I#
MJ9UR<"7&*5G^NV?,6G&/^@85)+Z4>C:_3"Q?>N=*(%!Q_J;OC"$HN139GN+D
MX'K2\]3 V#R-?JO-L/3'T:+B4V)$/F>FP0\OJFF0=?$.X>OA3D,U,.Y"M;/+
MGY*]M4P*#Z/P]@E.KSD2"?C#>VM+Y^UZPL$A/L'H.0L.D"JG'BVK&^ZP)V2O
MJ?7?9,N1WTVXU(G T(BYVE3*H9ZE5W ?KMB1@%A_U3%":D[VP#-7!1] ]6/1
M.QTK?>$'CD^&%?<3LS?'P=:-KUN#6LZ58$/3:$'6@Q1!1BPCBJ45KQVX0C&E
M'#J2F\3(2)^U:TC86_5"6_U3WK^.4C,"\OX6$VG./+S)T@_JI3FPWYC\5G9T
M5GK<5:1/L!3^;E8%KI 8A3<L+2V81*VS\H]+C-4SH;^M?MYE=UXCLK0XE+7"
M$W\5@8KAB^&3)=4A19_5ULNRXUZ=[J4?8S".PUZ!T5J9E *CV.B,##4>(AF:
M CV)Z9I?_V:J;<??[$H1>83+E%,I^PW_<WX:BFS<ARTW)DQHX#Z_ "D0/DGF
M6T=U+\,JE2DHU-<)@\:T#B^U_^II&,RW3HGW3UO6Z4[5??*0NI-2JGK/,10Z
M5F":;:V:M6ID\FIW()2!\7I#_/66X;2&LHP 2=)YUNYF#.1TJ=,Z"^]H@>$B
MWT#KNO\MZP.D[.(W3%R>8WA&(HB!W2F(Q'70+U_1-Y>$.$S(HK'ND(M5%*LO
ME F:PH70C[$*:RL;*C7K_^3#SN:$)+26$)?.AFCLY-!D"1]UA;X5]>T_.X15
M LG<KPAD8T0M'I#=KCK/PA"=U"JQ=C(U*]=#ZC-H=HHI(QJ]'CI+XKS<_"1T
MX];C<&(076I\#]C>9HH)6W^"0/>D8HO/P(^F-HM-[1&&(QL%H<-KUT=!#9<S
M=_9"13&+N$JT<EE+GH Z^O2&)!U5;W)J,.IJZ=KKYU:,4X?OD)F;UHGRHW_0
MVBL!^C91T"GJ"4$[BZD=,-])>J5Y L.&NFM;36VD_E%VL58(PI"F FY4A<H6
M)M&%=^4=6O*8.UK#?>7QTK0#$K/S[(/2;^UJ>,N5+=2/0<=E$+2 .M6!.H8O
M:05U,=0'?4U?[A@C@ ;>5Y55H43K=T36<P1K(1IS;5,EUS(:,H';Z:$=V640
ME,=2FXV-)WM&1M&OSS'\;WA/P:"\$?/%]^V]2U(1R<^?NOHUW@-]1$TCD'%,
M7XJ>C@:#)"%:_ DK$^2E]C6<C!$M.1496#B_$_>IPN+$ MN5C"[K^Q=BHA"\
M$@Q?34725 &Y412FZJ3DUE)N356(VL?!AG#SV J2CJ:SDC01U07G/K+MAY1R
MR_)#2<_(]MQ%R)H>$9 _,^K 0F%BJ(286NJ!"*V\B*6_8Y^LDWW!>X#T>'S@
M3GD\;W0/>-#@]1U)K.A-.ZD_9O-7\QF=X;.#GJ.QXD;6BZT:?]WZU[BD*_#,
MQ#"_NA,UNFAA@6 "_=!J:WTY2=+H/$#%>Y7JE#XU6FY=S]]771/&>%SR,SA8
ML1."L$?LIOHE/$HZ)HY+QWPB)/ZYLVU$/<%T*C?!PO0[A2#=^]6O.@JUOJ26
M)Q8U0=3%5E%N"K@9WI#-7"5]B[C^N-YJ 3T=(*NW8#.[M<&W6-F.=SYA9JUW
MS]>F@(MQL^SUS[936FA3TGQZT@>X6KV;QO:5H=W\X(CH\**A-RYYT^FN MXU
MY3-6LM;E6A/5FQ/1GH_BBZR2U:6N A!7,0<R9[Z?FR\,#>?EL]I8D_O/YQS,
M;&P7@]U&F=!Y*)"&2CUZU6&XCC?#5@NSYSWV)]IU^-9#2I8D6I]2PJ1^(?S_
M8*HYO$N."[<@J#SE*' _#($1FNZ@FMU9%I0V:MYB32K>A.J'636&6ZK,&\4W
MO<KJ/U';C+&#__,@4;]-XJQ-BRX:Z5V<CU4K>@6DI0Z+4TR1KQ0YR'J3-3SK
MCE,;3]?-XE/24KHDU.U5>"/1/1FL<*6)=LB76"I99O(L*<%HKN_VSF!L.^C.
MNRSIZ4*72_W.+^.A].1'8']NN9SWCDZFYGC)F($;Z=)LMFCL'*,[*(G3,E2+
M^]WWTM@I":2)]5Q^9LBX=;&=5W)#6NIFWY[;VOHBPZ:$1@RK="HPHJ+I79$D
M6+L];-"EPO 4M -:1R7S&6YIUM4(9FXRJ9D=@&Y*OU=:84!"^FGA-*WM#5,K
M)\Y6^A:C @+NV[*)I^0?Q)U:,RV]>W\]NO/@93(/!E%]3/4 ^!(M-<O1F7\%
M\S!IZT^S%.M0PCN+=!Y!W[]H=?C*8_=2Z!XP8'W*^YM7&?<LC2J"KOEYW=G>
M!\BED\# )2"(9"GS?SDIUV$9(62<Z?>#!7O]B2W:#!%11]H&@8A-RO+0J(2A
M0:'2^SG%?P4'@R^_< !$1(EYJ>&.[TAYKME'/-B+@#IG.//<3MR2L:@&6WY.
M%W=X\)VE3GO3:E($$*9H7O.I-1;"'5/>S40=+4R6E\GW/L,RN@GOXXL[OM>:
M4R]F<O0K=#+YG.:E"1,.(VH@=G@.Y$PR&G4Z<@!Z'<"SB6+MOVE*]@GTHL=Q
MRHAN_X=B<+JHWNK("?T7H<MM\V(LN(('6MY-J4)*U)_ETJ1BAS?A;#/F+A)S
M-U-OE]1L=<!/,L9>;^C:9YRMHWJ(*80X(CV8!G,"FJ"@M]6'?"*-#)8?E5)7
M)'MO=[)OA9 O1\<5OM'%:YB82EI178<CP'<GE6#@PI)')J;?PAKX[%RVKZF#
M2^G<IYF26]]HD*_16!HR56A_"X!1ZIW!/ 08Y!Y@$&9;.C'\TXN8ISZ7MB27
MVF=I7GEU&V.I/_[&%]T<A<$BK_#NZ@($NS5*T;J9>@W")<*AP%!98!WLR!LA
MVW*QZE0N'I8%"="VA==@ LX6B( B5&X;8I7U+6J\_'C=G.P\ML(>7ZB.9,%%
M<XGOCN@#(O#9^VQ< 7R6;F7N<H2GKE/>D2!T2*(.:K/O@-/^_BE"?@=3=9A(
M413@<2#TLRH:>%?_YW*JO\_V>%7B1RJP6-XF;1JI]KG7Z: "XG%,PR8ACFEW
M(@^%.SIMRB%K*U8RD-.^Y%Y0=PUCHSXO7%F6@^CFJ/B;DB!.Z(#%<[FC*C-2
ML\0W!+_D7\5,]N*2WK2\3P(STC/UJB%?S==GY&/UD4&LX4QV=]154]:\DMB'
ML3>UGFS+*=N&HBBQC,)JCJ[%US"GDRP.IB;QA5-DC!WHU=72\:I"^\A[=@OL
MOW 9LK3?:FJ#%2?&!U6K#BVLA<$_7C5F!/5]Z??,*L3FXP\IL9_[\&%IEKV<
M="5&IV8[!$9<A_3$)R:R(RJ(;]_3B$HXW&/)3%[%751=P3X7K>ST&:'_ OC\
M"LKZWM!4/+?Z,O$-3W9\,XUYPH4Z1CK*:2P<.J28RNQ"IV=:^L3MK,]G<K.L
M/LM^\K%*+8/RNI!DUABX4XE2:EGSPY 38QJIX (XZ"JB<I#,M9/PM^UVYQJX
M=1SMOWD-G'QH!EV47:K/_XY\>Z,HH6:?E0J,QDJ'<^)/&9LH7/\-M4NS/>_<
MWS<4G:%4WZ&EN<UD'\[J.0\.5-9.M5]B[[AR_WZR=:<?#"90M0,1(V_SUHNG
M6H-H)+BS1 D<M5,MO8ZZ Y:A/ J^4A] %YD=B<;YBR=.W[;3S[.5#;^>;PAD
M61.JM)#Q>,LP*M\>)+Z)>(,3XUOL!.-5@L!..3H#A1$UG*U\A3MZ6+YIKWFT
M9AHJ_]FPT63^<V:)9'FW$$4:D!CI\6N>8C>$O;M!"^'^,9FVGMWQ5]7#+AE*
M$RLT%X(N7D>?EJ(@5;H8B?=O*A518A2Y?[71?"]=N#!326E!(G*81^$O2=B6
MEPSA!YTKKYL1HVS'T;JIP]RV$^OIN?>!6[&(4@GAB7(G"\T9]H-)2@G5:ZDX
M7NC'C8%]5)W3S2&-Z&VFI[@+&V73^0B@/?.5TW%-R\;B?#+@[R&:T\W55.W/
MPPIPW4:Y9]&%CM52(!7WU?1?/=0YX64R+SWS%,?LV&2QX46>:GNS/ONF7;Y%
M+(*A\RI=G5?CO[I!Z?_4#70<ZWS%7LDI&7U(^6P9*L:R;$I &T^GWTLD%7LN
MQT3_SPB/%U)<3;-3 <+*:ZBJKQF+=P&3W0.9_R)[1O-:56#XX[X7_TY'%WHH
M_MD:%.0< 792%UY#Y3;;)2U).Q>?K*T;/"$1/P6QTQW,]G"]IF9R3OE;OD]]
M;83G0>>(_:?\Q<&-VJO);!SRMSN9#GPG<WM]0Y3-#5L)=T0!U8>MTOC1J_,4
MOB7Y] 2+4@I;RQTKAI_Q$RVG?\4<.;G1*<^NO'F#Y8O PC0L'.*1"EWWB,;6
MM8 S5YI(O\OO8G,'3?=^ZTA$H[?&R4^ "]&?%V>W!N\^H#MWI]VJ+HOC@L:&
MF .2,%N4_A?SQ##)XO)W\R;\_$KZSS M$FH]LJU2"UQRML^K']-6-<3 WI)9
MD%%+SU6@9'L32E2\-RLJ)Z1;Q%]UMA(H;\9%^^24VOW50Y+53]-7S_\-[B45
MV)K\.J/RZMA!</J;#?M:5>]L/^D5PBZ:V%PN!BSG3L<"-ZE*$MSMX=^Q;@A:
MU\_TI*2+)9-((3)2;>IH&C*9D[=N7!$]Y.Z X.E,N@VLPIFW?WCIF8^,Q->@
M'X3%<;L,%1B7-[5JY,\/5!VN+J;[%;G>]-CY)<C?<$2)9X? R)"KR)?.HED-
M<I:C"QP*8]-XN@7RE.5<]19A4/'2;.W/@!-%@YD-Z0@1YMF7]@9N,JL/U*NA
MYPU;&MO-EH;&[! UMK28U2D%XX2+<<QFIO(1*4I#H_QKRIY:XGN@9Y/&YAX@
MV(!%"_>TQKY.7;]\IC\_OQ7L);*V'*4[N/7 65*@ R[/%6GF(J?7H "LFHVI
MNA$!$[?!K7V^&S/S)*=8OO#[RT1+5]5QVJBFL15=H@\1Y45A9. =8&S*(W:?
MWXRM8G]"SF_HTW?TTRV) EMM%S>P,V&!K/N$ 9SOY7]2*/7&<4>."KR3N?S)
M!)1RY4TLD:<@BEY;]E'$/[.H4I^ZQ)E3EJ2&D3??JH>+2>.W]U6G'$U[:5^V
MI.Z/Z7V.'7_R&<2^SJOF/(!Q#UC'G<:]< S RIO:VZR)"C^D;W6_T<0$_ $B
MYVHV#X=K).P;0\++ML919_K/ 1"+]"P?X$<Q0Z;^9O2SGQMRUY-8ZB67Z5F=
MVF>ZN]HU559&D<5FUK^K!;'@[#HFTMIUDSG/%H<K<P3)UK.R(:EUJ#1Z.Y9]
M#[W7<F1@D-*K'^Q\!?%(R@SU7S5R@Q(\++?\@I-$.!'%>;G%G47J( 5O#/20
M70.5E3,G2WL)AZ:%)WX9]P"CL@55(A)&RG^'7Q6QSV&-6#WV,/M6E" :X][+
MZE/E49;A+,1O5^_:_^4>,*(/D4B25<KM*RMFU$I=_ :A5^H7SS^]9085,:Q&
M/0WU<]6W1#_M+YPO'R)]WJS(Z!F-$]N?<+/-P4%;$[29TNV6/<3[CDA:Y8BH
ML,IUPC \7\=DR2[JPY7EWT*LSXA':S;.1')J9*7"SG4NI8JTL)J PS+%YTRW
M#E)YJ>^14W[5;(KISIY 0"WH)7AV_7^:V\A499_)U<CU[Y"1/AWT>6H+BO3
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M5!Z P*O*?E%"&*&D&^6T;YZ0\6HZG?: #KJ8*U,,.,@S-_2UO3\@O<68LG%
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M@!];&( A*S_HH%<1.R296 H;7-P/%T6 :.'4$#OR%2)U'Z8>H29-T+>S<H=
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M3<ROLPQ%34,I ]VNQK8]2:;BG=VX0X;QXT83W6\VW49":60?ZZH+/;/.7NA
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MN..Y*;+LJOT(_S^ ;E"R>\D$YF'1_RR6%RVIRN+NJOV]C4Q^Y!]-=FT6NWO
M>2+\:OK4(#,"I#. C.FDHXN.C0PCL.^M,];=3\&J]'FK_;?6-GKW@=I(JS=2
M$> 2.8*RFR3HALZ!S+GBR/&SE6[3*T/5$(YN070MASSO/MWVZKZ]-IP'1N,T
MFD]$U>$JRA<Z-G7] (%=Y3;NP,C[70#TGW_.@*A55>;H.MW \=NEKZ'ZFJC
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MU?Y=#JSD:!M6<3/L.2QDN'6=D=INHGM-Z4C,<!U?[%RDZ>-^TH4Y=6QE*CU
MGY@1B,"I6;&HA>I^# N\&4:U88P"X)%!VAK6]$Y[?;'!TU''.4L78_(XB:_<
MGP_-S!M^14V5Z\-$=,P#>24^RGTU)W_[.S89DV=&?=1H2CN!;-6:',(9'XAX
M&2'7I^0U)02P$V'0O56:66K!DJE#:>M/?IXI4-GBH=!2ZNO?DGTL,>W_*..7
M'9F48N,*@RA)B:)<Z8[?O+F2Y,L?5.N)WIK0?"*8!\&< E^F/O=TT]A.'F3K
M")DYWA&GEVC%_:PABHLH Y0Z?HSPV^'R+!]ERM3:?^P$B0!TIIEGUO,H$^>[
M\2ZRGMT#J9SRR^+,$4:J4CO 51Y@=XLCLKOA]D1 H(4XRU:^YPXSCRC29.:\
MQIUZ?@T[V GSH8+>>TU%9X5J]T\TE"P%4RB/ Q9)-QYK.;0/DRYZ]Q;4 QID
MB:482>2RG?D NJX2R8+YL*5"G8J3J!:W'^03$@S]#U2PO%2EQCFZ;Y*<W6VA
M_A_SH3P"8.ND SA2RRC0W\I_C(+P+C,5P7>@L+91_6EN'EX*(]H^U(O5'V'5
MZ"!](03M)[&% ]$X?^;0 &OC'>.K?*(]:6)"<>P"]8_V=^@D?M9=P;=F4C.T
MGSYMM*K\JE-NN&,WTX$\,6[*)T+LQ5CSA*%0#8DK-V-;K%=_=2A;0_KT (5=
M_PAHW7&^?)>F-S<5;][19'"=UP@25NI\G4U3I*3NO8'1MRF??RLX&T:N/X.L
M2W^>QEO'0"$[+#IA(*'5!JNH_>3%HF/W6X-DK$K3@Z(3TV125L)#QWG@$TV$
M(4%[%!\;AJF"'6G"C@J\NI)"/K:32+^I(J-5T-G'VR'E$ S>@JEYG5[KX#8(
MYP3_NGFHM#;6^&[HLE^ CS$5)DM$1)P\'"<ZZ,'LF(66<?"[$RO!*HRQCM'%
MG=:MP_AAX&\9$-$^5EVWTKV9^/BHLV0..?GY1K_K(%<JF0-O4]-D,XS=^=O*
MTUK+45#T*S";[(N>,T3KK-W\,')*CB$GD!,KY@90.*3*G*27L(DG'?:T300?
M%P5OT29[=IBE948%I;NEO9PL4K_=H6*[=;9NC-KD^S.06*HYT!DWHH]Q1B?*
MMVC7RZ&&9Q%-#.&(#U/ZS^;<=Q<VPU/=<%FL@H'HV,\ID01?!I@GLW!:C<IJ
MJ!+!>_7"!!"UI,S!NX$66)4P"O:6P6<C0O?2\1Y JCQTA[&L=0]+_\H[N*A.
M]*EFZ42+[9@MSCS46[U[]*;OFSNAKV,\VXON-N!%OQH2KNF%TP2#>M0-SZE'
M,)IG:HI7T2R(#I-IYK4\$,-JL#SC[NTQ^E)7JU+=UV8:B\/'Z>RS,A;K@2RL
MAW217I"?W0-G,[LC4VA%ZW+M]06-2=4W?E>N8O0GT49Y0F%EQ$AGKY=NJQEV
MZ;[X#[!V7QFV.R>JQ5=:S. AZ'3I!OE&W"L%H\M&^1A'Z6;=D?E?*VJHU],Y
MHK%C_OP#/YJC4+%#RV)/L96INM83G3%$A7QT+0)7*6\D^J9"23)57O1CUKBZ
MH;K]& X/EZSPT@LT#M$J _D//[:.L[<B2S1>MYQ$W\SR_A">*UYB*7W8['C8
MC>]Q2] 06)%U#Y!^M?:T%KG0%]M;[U)!CPG*TB3\,YEJ^$+%'>VX7"NL&2PT
M*-518V$N(]'/.'QU#T2\J&V\L6@>LDE\N/)5X-?[:8/%"1Q-D6/UO5 !=5-N
M+4\R<[LX<\-F\2)[4Q "&.K&)HU7Y&.O1%E-?5!<9]'S>T=&M#6U9QQ8_F7'
MS^@8+VIRF96Q)X$C;X0 -<K$H5QLVAOP7=6#JM&]QC;WU4R["_*L*"VAO-^7
MNY)8]1,U)!U!6A8KK#>RH20J(A \"BC[8IG+?RN:E-5&U\51W\K!7]Y0<\VT
M#C=5IE\DQ\JD4[A]G/<+@])A>K+'"R&I!)_VL_HJ<T$$\(Y+L-)3C#A$1<2H
M^V R8\%ZT KS^:\X'5(5Q5D_7B(E"GV1)G.:ZZ.^=-[W@&>#$,:KLF48I5D0
M3F-S+.O=GB@DQ1QN-OG@&5D=?UW>"L<#]#:FHM40%=T; ?P256P]/EZ:)GI"
M-K$R%_'/IJL!*Y(F5@<VI2<@X,^_[CI'3.Q[VY)J6)!O3$>KJNU5DO$V)K(]
M-WY1:-EN4J6;.E%>^6<;WH81XJD/<M ;F],61'TS8K' &'\/2.]9AK$/-(R^
M:J'!KJ/++G.FG?;#.D.DT$U^L'7DV,?[4Y#*^@<4K^80+?G\3Q*:-_KNW00V
M*JYD+VG7.(9JRITIS/%B$MTFC;!!C >[N7QU:(QBV0=[EI[E$U*HW9C43*D\
M%F4G9X@*A,0C\H*PZ:*0/!F.0GW.W$R)+ZZVOY6Y2_A$ ;XYIS3O&'Q;KA*V
M:+\HGY2Q1$I&+'#!GFY)FF.RW_+WZLUP_W:W,:QM@2J@-6R7M:=RV3!_'\-Y
M;1M3%Y%UP]AM.4D!C)$N]#Q]052F[KS@5C_QQ5V 4<Y8 M,K219TN@=M<>O;
MO5PFG[I0"P_E:#-P_5WI7L+Y[%WJMY.3@5V?2RQC.&;$QLR^/@?4I&)G63F=
MB3'R :);^.'2N@A?AF."370HN0%-2*US.?FY8R"N8,N0[XN1:!V<79<O"?[L
M V>ENK(X0FSF/ZURZW;#W9Y"([-Q3TRL$GNB@P7#9<EG@YR^J?J?1^9NU^]'
MG/Q@NP9@\E& E@OJ'EB0&0OI>2+X:DQ%]XH@E^^KTG'%TE TR3!+SBC@Z.RY
MZW7H)A\4^& [_G,G6OO2*$XHXZKZ>O)$%D1KP!E0OSIT4..U^:'OZ^_$5X9W
M+IR?X&[ZKX_["5XN,>,P(B78]0)F59;L8MX3E3+="0'J0IY*_YLR34%1^1GV
MVARZJ"BNW;;1Z!IB8+ES/A]M(YEN9*??B+OO5%O=,+5V?/!915_\":Z@+*5X
M8:9K>*8(_H))+%7TS^M9$C3S=7*M1YY%=F7(/AOS7>,M.\:$CZEH)OC"/]+C
M0+W1]@#$!?JKK)A?\ A;]$9%N[N7+LYHJNT>+^GOI[YP==C+D,=!7T]A+CIO
M]"&:\IRP?'QE-LMVOQNGUG_=1\K,\>Q3+#_&^KY<4AN4\61T6K>;]<+6N_N*
MX(N*CJH8"".A< GVF(P\U/%AG<D:;*/V=!!I"C99<_2F -E5;^/8LT;5S56E
M3K*/3-:Z,9@)$MW*WL)>9,KZ^%R>:"G-N==:U'O=%-T#--.3ON$(3HJZYGK
M493T &_;9]32T&!LAG O7&LSC-A%.%<DO@]LY#6C0!37E:HRZ[0L\H_+\@ /
M;]&06U3VRZ0=+\RU6I*(<M V3B-)ED8X]35O,>I;$TPQT<;;3-EA\)H\:KKB
M5F]%+P^S[Y#6>K$.FH6&J%DYZ;/$%.F0*7W8 L.Q$W8&X$(W05E.(DL668.J
M8_< MPZ)%8YJH*>;6U&*3:)WX8=5:H=KG:<N')4YOM+K+*H'9A-;!-&_TN/T
M8U-<PJDS0\H" P..-$M4G<EBG_GCR?SXFT%F<_1;9RNXP'->_B#MV\G%.T-W
M45/F_RZZP6F9FJ>Y7?_-SLCM;(I1E\V\BZ+6VF!FBCVS=.,9VGPA E-YEG;S
MFRSI*L$H2(?(-:%HN/[Y?[9BRS^#.,+*)0 ^#DFXV>JR2JIC>+J5ZM^:L%AW
M\E2A=, NZ&:XOH]?J B.9B.D\=5\.?*"-K6E.<3[B8 -_R4@>+E9:0BM[R!G
MJE?W(3G*L'CKNP_DD[K4^$J.6DKF\?1UL=MVWIXFAD&X-E'EG CX_B^!(1,>
MV2N=:G38*/"N]D:N7N$E,_D]\.B]9"C1]/2/(K*^2BPVZVR!%.9=$C5?8$AD
MOLO"4K@1U2S?<3RI8JISQU)EX/]89S[,(5,L?-O."I(C;?J_@=%8\4X8-=K_
MIBY,3J9\,+3+2?*=3RQIR[CU5 ?'K@16/J]633S-F8V#!07A3'_+>/;^T-VV
M+NA@)[-)9SFX=/_WN1QIWN7K5?D[,7@=JAWJ<YO_1VAN;4 /1-*/Q'K6"GU?
M[XMZ&>LM8Q1O1])5<[HD:A+Y4WJS:NLYL8975Z'_6BS>9'UYRME9;]T@G0C9
MDCLU3T5YX0ED,OXQC.$$VA9YE%__[9#'4(NHXA?H]L&>V:ZJCHF;V+IO+_L3
M.?!/?Z$> <K )TJ)$/:!81:?MSN9ZI\^(&T%-#D4&2^*K I/A!:@>T$;#@VY
MXC-:A$I?PR"Z6IG+M"D+0JH<6Y(6"B2S;Z+.7\W$?A94=/.A.V9;E*<[,F:/
M7^AU;;'^^/3%<QV\'>W\YWP_%J #DXH>(&]1H^? 7PU<(3E.-!S\>JH=^2HA
M=2"*]<?C'S;UW_R>5JIV]IFL3^!:'+[G/CO*0$D.6*\]DKT!^CM>S= 1&=);
MKEXO+VE&%"R-:!'4A<O'6;Z:;H99M)6C=A7IO^Y^290]WVIC>J@$@[M],EU
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M8UFIKUK[F;$6HJIU%I?E'#Z7ICS%_OE8;)2?7)\E4S)@>&B/AKBB'S-5G-+
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MRZQHRW0BH H1GUBS';0B\)D!C50P!:D [>1 2>IWOG@F:-Z>_<.VZ:(?9MS
M<]LU+)Y.@_ZE.8G'0'_JR;*C\DDLK^G:)\ %"3:=43@[:!XRTA2W+WFOW$XI
MKI417DRM\(I?=7(*+)16O/F9)[9.C-\\5E]T%@_).G?E_3SF#7AS0]3\R'DO
MTD\OKG@0JB/)D'3MR!R=ZR8/-*HL&8F;$'ELZ22D(_="W=_#2^^D]E>J_3J:
MC=^X>_; U"9KR3^*L&&TF'.(MQ+GG;N6\ZU*^C>B;(^X=UP:!WOF/;(@+%8?
M3#3/CFJQX#0C9QYZ/,1)LJH9_B@H=)D)'D@3'8*&TE72"V--?- W^MT.0!)W
MS,NT29*XGTU!Y=26TUK?ZT\+.$532NAB-=X!V$CMR/\93L'NCXT:G-1^OP[#
MMB84?34#OU"2V&9UVE!N".[9!B<9,[F&)?'V[053[9"9\.RL5-D'B-+?BR"<
MBZU6\%LD_T*J]Z'Y4Z8-]<UW-LE>K(KL)077*M+D9OR]IQ:_F0/VC4\BVL^.
M,[>/-OU<Y=P?F#]K, 6A -B8N=5J=SKT"I]M,S68[6COK1^ OIUS[X(S^>="
MQ$BT%X4R+30W0;JG_:H!"%6Z0**Y!2$-T]4WMYA0<'&W%[5.G U2!OP-TZ.I
M.G)7%0MN#22FA-.!2S?)B*YVDNW[*[H1N;MEXP'1UD2HTF) W98DA>.R/[F,
M/!-6*;]]#-UI6=%+UWIY($6'O4\ #S<3AR;MG\I:V15!\EY*U9_QXIF-8QGX
MNZ;X;B[>W+1TT/>/E7V^!YQ'*"=]Q>^R,0D(ZD?[AEU\KA)[D)\EBEWWE5ZH
MB@TM#'_<7C8A(_DZP__(VJ%]#L7O5XW]%BTEY>+Q(MUK)_'+QQ23\/ 9C=K?
MMK\4WXI<!3K*FKJEPH.^):1N:?9J$G\!,06O=-VZ3 [B.:_-KDDR$H,210\Z
MFUPVAUGJ.O+L%-"9L_HFIU.E$B/L N=H[8]-&,ZYD6P3V/]#:',">^;G!CM1
M584<=%\A^S%E5E:T"-I7I'J\+R< W6Q"_45"\CEHS5/H)*35=/W5TYEQLZ L
MCJ$F&FJRJO^RZ;B4&JP^O/RD:>5X%L)/?)W](2$JG<REY(H2?*:\@$UON.@A
ML #I*1M%(Q>I1;=ZL:_?D]5.39?5R^-9^02L,=: 8U%5#3YVK1)M]$%=A!+(
M3&;'23G*A?4+%X:^O* ;>3E.JWB.F&[AO!G-2]/EPX8[!HK^3)(CX%D\+&HM
M<V",-93DPH^VW/P\I1E \^-EJCM\8X4EXK6?QRR2JMX^P4S^]S>]'$8Y.F1J
M1E9U\P&2CIB#U4)NKL.BRR-8/#3/U%YY'JIPB87119E)2Q-K$=&4ZNWQNCIY
MQ"S(D&4M8\%VM/;9JSVZDB5?\AN&N.UD[8F]UO*>)HQ?Y/*SK%&Q"%T/$Z<\
MH4T=+4EV@]LLJ$VOK[7MI4;ZFH9_TM.<SS:M0^?T3*4S(?NXICL0Z%JAWBNN
M.M_/,F:?] ;%S^&7"6*]@ XIOOU@&%"9L"^O(+^_0Z^)Q$G,%).[%](*4K'U
M4M;];FP3VLC?;G.^IQV*^NGL'7(@^/9K,@UJ<U0^ _!2VH=KO$:@Y,3JJJX<
M]J)%5<C%5.R%SK;_2\OMG*9Z/H[#-W(8PC4?4"[ZT?.B4!U+D(> 'IW-K!Y_
M#,-]:?E-$]JB$CU7"$'Z,562QY9O!7<09+SB7*?K /:5OS+\Q>+9D..MQ44>
M>J>%U3R2C6-J9Y"W.,^F+75MX(K;4$2<ZQ,097>N*U@8!N5.N4_1LGJ[L17%
M-;.X^L\5 '^H9QDC?C#.,%>(EMCD F^0%%:O'^:=DHV!,#>$:@D4H'F1UOVN
M?UWS>N&U8]7GX-OU,F<9*-DHLAT*"C]#]F7^=G%!O!7Y6M,KQ@8&41/3K$X1
MIK]D*G69;,*T"9Q4(Y.2YL@BAWJ[P?_ +/7??:GZ$BQTUQYAX5X7<>]'+W=O
MW9-ESP,MD1'I:(KU[-.VXO9/<O&@=@E79I+@]VFN/ ZO*)P;MFJ#M<3!T\@:
M )QL?&N9LPWS>5B-A75D_$59T:62]+IM<1ZG5-9EO.*;"V 4O;0^F91=;4OZ
M[\L\9.;M56MM;IB_-='7?P)@NF^)GX!61[WT:9_MWX6S?2:9^]PQ+D9Y/HYB
M)&137E"):1CR^OH[.6)D&4SE">X#_:**S[K9,7*D7S^/1T0(>0VW>N/"Z@M_
M!%3>C"*!/= .S14\U$Q'L*AAHHE\W+,;LBHT3#]?AN<":K*9IC;-*7S8=D:Y
M>XH8YW*Z8Y:\_52QR^MN9,&IYO83_% V*Z18B[6I^A9"-2-#@X&7,BD,@S<X
M3X F^%SCN* E*M;6-O<'9<N90@U.)SI4IGE0;4UR(Z:0EAM)64,P)"E7^14A
M;,B< 5+ I,1O%.%\M?$\&736169R6LQV3%WY?5 XD+_7^3X$*EEH'6L=?HPI
MCZO\@LY,TH=KVI^UVE;MHRR*,'9JKDFI3ZNY5'5SD!@LA5L?[X'3^5;S\;^U
MV-"4O4;_ M3T275#27L(K\X&3.D0W4\P]M^D"T15]YJ"<J*"3?%<KRRN7NN+
MQX,EBK@.9^!+\4U<31=RM@7-,).FR$&2]*#E 2X$255H94E)D::J/]XGI#W5
M)1:8W8$]32_'7?E! TXGMW]PKTS5A),M-#<LM.,3IQ^75CJ'-*9K'3^=!<:>
M1LV"_H&KLX<W6Z?/E$Z@[;V,7MLPX!R6O7]F<)RE%T/O*=$ 6QO5_O!/7-AH
M+%N 2SPN[TK9Y]<.^9W/C&A0QD+9:K ')VN]T@1:&KC[CYZ !37D1^\G@.FW
M!=V$?NFB&.N6B E.&V4TDUR!#K4')36N AEV.N8WI4G:*5:M=7S'-Z_Q&GH<
M5_;$(OZ%(8P-L[^IP$B?5)E;6*BTS(ZF%Y&G4K_56)R@AXQ$%EQ#0%TAZ/YT
M)3/3'/L$4-3\/WR&D1J/B8+EW5AQ#AQQ3M9U.:R+*M\LD)79/&7OQ/Z)'W9I
M>0M6'$3PF"*[YA^5H RVPK>;6OEEGZ,]SOVK>-%%K.OB>:%<C9/4]0&@(!.Z
M^G.:6BNDB#QR)[D(:TKS<,JC=X.4!3CXM;K*ZZ0N;;P1+[JJT.>'R>B*0'I3
MV=CZ$ *KJVOS.3VYG1<U>:IQSGOZFJ0WCMLR\PV/]!MX,MS.R"8NCH_]P^QT
M!<$OTE]Y].+-Y2B$9O(12Q/1TCDB- @$S<I3(^M^L3 M9OQ^K$&RRPX?>487
MI[,6+4!W=U2"9%\!5=9UUK%^8UC]%W?_L#T_Z\9F3O=K<18C24PILKJ^UD;*
MGHS*XW\"M&("?1OI:S3P59ZSB.U[IKH 4O9O)#%I!R:JHDT=D$ Q/]?543EE
M<?/>Y7T7CUO^D__3G^MKVL$"?/M ^0X3TMRDTMV&C:V5J [1JDI=%2=??,^Q
M&[Z:VBA&7)])/5%FSJ'L1B(K6$$'*1?41&SJYNKB?J,%!CIS,'[S'9YZ!"LS
M\CT!7O\\2T=1U1:Z12?HK*B-M)V^A<=/A$-]OC1]%U4?9+%*SV*\BH=GR8<H
MC-G6N,3HAPQE>60,4KQ#5OHW[(+T1ED816 (IR8+*IF_RWNK3ABU'=O7897/
MVCM1N*>G*4%;G-:Y#?TYO_DP_04!G\4$?NLX^?T19SW1N",CF+M;;.S=@VWI
MUZ(M+6KQPKF'M'CV)>)O,8%$)SS3S>OV;BD7%_QT5A9H+>'H:S^ ,8GDNUX"
MO<Z'-"[(,K7! Y=6$7)F5E%!=ED_WEC1,;<9UP5,KU&*)X$S4:"#:'7=GR;N
M[-EB+HP$9%BV2I):S2K,5: [N-UMF6GNW-COG&4D!Q6U1!$\[[QUS0%EB)3(
MO7?=M#B(KO4DBGLVS3])9\U>D@M@#DZ777H5(/^Y8K8\[3.]:1/URU?X:36C
MY\V)U3SS.W'$:8EP5@WY?N#LPT"<AYTTRBH9I8$& <'$@K14]X)A(\@C5@4G
M&[F,RU9MEC4@_65MFFV)T9(!&HE!3&>F6::4&L9=+G?[1!GO5&T*/0TKH<VG
MC:_UF" *T.UE\[#J)$\I*S.E=:.L'#&FQQ<1!X$\M 8]Z2#LDF)Z43.M1:3;
M5?6;DGG??-L2_9NK*H]*"[M#7-B&ED<!TK D3SHA-HD.;6)RSE=4R$C!=K0E
M4E$$"5P3,S=;-=SMWS )4II+CKB'QU68>:,(Z"N]F3A$3% K9B.\>ZIP^G'4
M9 +^"=</9F4L<"_D6YO[J1YLTV;KGNG[*!_35KP=@VL]6-0BR[U=+P,;FB'>
M@P=\G-"Z^=1]$=/_WIY:EC):&113RB7_J^N,=[V$TS50F:(3*F7A_O[+.0'C
M%Z,_IDS*JY;(O3S)% ULY1^TDJH-WH%:8BJ22I\ 'Q-02+ZUL^JB0;<%BA)7
MZ+IQR_"H.K(><2"C.;6&D]PN4T92I4E1HP*X:-N!JU8_W7,=VD^B&!E=LKN(
M_SG&\@WS_+Y6\KB@_F*W$ ,+K<-L*4M.0B G#BI)X/R?>1C]\C(1ELO9*-M?
M\.AO2G!%4&>C2##:KJQ.@@;;4I]VN4H4N1QU+EK4;\\-M3U)OZM7U\,M3 K/
MKORW$/[X%87SJ.:WQ/K=L*%N3OWBLP!J<A$^B]2I(GOZ)%(W=RIPBLQ2E Z;
MWQL5JWK":Z3AK737;PA-LV4_"H[;4;3YP=J6*?-69MXL\MIL.H\H=G/1[TAZ
MB7I*:M.D?7 *,T).G]E@!4KOE]^^R6+QA'AM*-'WF(>58\<Q=CZ;K -1)#9J
MME4=WA\+'<9X_/:&L;KYNF>_NA/J.X:;-$2X)5,-'!&!$I6D-">Y+R=S<(6K
M/Z3TGQE;V7_Q80RP#N1#9HI.RYFW$AIN:K"X&SK2R1J:VD=5K1T]+#N*FG3D
M:*""<,H9PD#';[1+A1[IAQV>@-/-I+M6X];AZ+E=+CUN[/QB^APJR.'KA6[8
MB+F:^U6W7H"93H+B[IF;J5KN&=T3(.B#AZ2N,44[;JLXGE=U[A^38TY?;'F[
MU0/E6"I0!J-STB<$9/VI>Y='5=#/)!&TZ?*!7#<:33 W<YHT'XM;=2A[\SD>
M^X-5 -4_%SB*X.+A7!T# ^*MZF!=9>U8%,KI\O^07#) 2,,-MV6TJI=9;"<O
M'(GV?-V?D@S\&E7J/U/XF(6ENDO&8I7SR[41.V^GV6\H$II\L]ZF"<1=>56M
MG,^68TP F@/H&A/P<MLO"\X>5[V'/>Q9 ]!ITYG4-",/!ZN^7^@=J1[^?9>8
MC: ,JU%TNV*/X@ZFM]&9R4S2BA!V%9P"IOL7M!+!&CI;3%A,Z?X^7)HN+YQZ
MY=N;FJ()>EPO;7PPN%/M:L&E1[RM)CV@K9RH1.716%F,?9+:S&2*@^;O(0W8
MOB87Y$IR)G[VQ6+T=0E*N/R+M2PQ>0.HH>4B1.;I)?AB ""$^8F6J2]?5Y)Q
M_UE?7C31FH%T!-&%"II@I;TW=<$^892SH.Q(+YT'%/)8OR8K/65JC-#JU&CP
M*/\P7NWW/+$.D@W#+\530 638--$(J5/NY8U-?\B<9Z7_K%5N/B7SA-EFPV2
M$G$OF-;714J]OE"]WZN/<B^-T/!/]]G+" 8! O?[(O2DNZRSQHN]SHS"1!.6
M*!/+^:V_(<HU<>LJW;3$U(2.!]$)[?H\C3I^XYD,?R%7MWPYZ+6US>H;'1+[
M"%*-)MG5";:6 AOB=*!$1/D)*&_"E&">6Y'Q)NN)*U*'+'?U9Q6(E>(;[3_.
M=XLW-$0#GA[1A*",M]'YX&)J+]V-#(W50X%N=KJ&IN!QD?-!,L;_<LABK:!J
M@?BTC(W\YI/N"-E3,;:LTTL(O]8:&]IG)P[A+R68_C7WAR:0+IAC3.63"O*_
MF'?"?S'OO>GP6''BRX*YO:MY;YNZ41GDRG[<(N+")1FZNJ.8P4W9SJUX2]NV
M@));EZCNS.,:8P7WWKO]$HQ1I =+9+AF4M?@5WH^;<Q<RD8M))!XUC14S;GW
M0 Q+HY:Y=-!R=&[.IW)V]=N[R/=M(M9P&4='\CP<;FC5NYYMDUD59+V:8;LH
M1Y)N#DK.7#N4T_9B,.W'TX]9)4M$K'EQ,@=9C)4W&Y">VMU_"AX2OJ;O+DH;
M<E(USPOD%VJVY\,.VI EEGSU,WS7\1%24I=@U#F2"X/XVU0 HCKQ<XIUZ UW
M(+V 653=T14_7'6OB3PZ.D]/OTPJ&,M)YY$AM9XO9;,ML7ZX8Z%-R'F!'ZYQ
M,3DYE;XR:+,O,_"+%MN7;ASY01)SI.SQ:VQ35M-KSCR?CQM9XP5E/I)=]"/G
MAZ-[UVYQ+Z%DIE1/0 #))QLMUV(H?4(?%.SB,,(I"L/U]N7Q)+2BD3:U3 F6
MYT"%F(3[ #+V' U!IAPM^L&NLL#GRT*A,FO='TQ%_Z84<L//EJV,^'>BY=X<
MTS30^<A8ZZ?I5%!9FBMSTM\->)( %59ELRM])O7-P;I(/5..\1>7I>H2R;@U
M3N_<9S\G-N'N:=I<@,E%ZO7UNK$N%DMA.]J6R(GE49\MZ!$L:V%/0$NEOY]@
ML^R KBRVQA/@;D*3Y,^XK^<Q23W+5LZJ? U=L2JV@4HE5DF\3;)M.QNW8.G=
MMR;7.UOOF>P'6\Y4[5#H_3+PFC:*+P)?UW^#\[[2F_]V3LC@M@;[2RV'[R<6
MYJL7]!_*/X^+K'$A4GNK&T[?=G6.U%;6A0@'?QF&M*<NF^M,5K-KJL9UK6+V
MIW7/2S7;@G?[1T"N6$\ E27*E^)]P=^9<24SSF5"K;L"= _ =EDWS3");,I\
MIT,?U>H=B>M8,_].@95_Z/H'+2/-8"FZF%YJM UMVIQ/+QDO^G^^D1ZK@Y>Q
MNU:JWT1+ 4(.2_6T(HZJ_R+:E];.3;_SH:W90A$DN84(>^7QHQ==KW %GH"D
MZ,/>2YYB,>);HV]FN=6_6S[(/P&>,E^&_-[HX:>Y4)2RCKU2 MO;SJ40;]Y7
MH5F6.W Z6:(P/=36-9A61P_P>\EQ<=CWO61:3D-;9,^J,X .E3F?96L:?SZ0
M*]J/M2IIWL@TMPM#E8+MC1?4-O"IE 434\&D$H"5)/<\Y$79D_9C,FDWU2YK
M,59$)C,33&^2K1S5-E<)&"&1>PL@'1PCM*8D9I).%UE>"(.%?&8'_7MWWR%;
M0QV+]73[*F$NV&Q+!'+(\0B2:I7?_Y(U+$VLM'.KD#M/"U G88PDXM0J!MCH
M%X73KM"")6M2M-:<M^$!Y\]&R5<@>L!8"4D^]'+2FN4XJ>]:5-;)[[7[?3'W
M;S8E?E"*CZ/[\!,@DD;E@V84&]XSA->(0BVC#A?#NV@F3:/SJS46.:^7Z'OU
M?A3GM'1J@"&,9Z[<7^GY=]"2T]_*6I&!C#?]F*UB-)OM,BUWAEB+J4RR73[;
MPIV;+>LD&V;)T? E5S(*\4O*M%2E1X>'T(J<PI4:&\-'"%,]"-XE)[GR(\>-
MG)%++%G4Q\B]^?H)A[O=]M^NP4+*D1GNAY=\KY3/"O9N$UN+<3)LMF6K_;LQ
MGP!VIBD\X#LZ*FZ,57BE?A'F:RHO $U.]XV[MF)C*[C1]GY.9S/$21ND^ 1<
M%J$8_1@+^?I%G\F)O0NGR^W>JC,: [GX+VRK8?H+V^2XSGEZ'"$V*FC[^:6L
M=_/PB7F\]*PV7@>,.J3MO(F-IN@IM,W*0<=[)9(UWT1S?ZX:?1_Y94*2Q$DW
MM?BS&TM ]0;[43/;?;M(KECYZKBZMW#D]%MP>J+&;60F6,+_;]$AY-E,FSC$
M?RXK$-EX1.9SW4"VP=X^'(JI[O )[RH6N8>=3Q@['Z,_I*#D,N<Z$7\4ST.6
M8Y)HSG,1W_^WJ?9:$SNRO#"7L:_ 0+_;A3C:,LX2IA$KB8(@^<K>:T_2BP?&
M X^I !BKC/[;JC2)GXAU/@5RON#$<H>:X':22!'MQA:I@)#4M&Q2#;MF@BTF
MRU%U^X+92[(]WT2F N,5O(A^N['=.KN)?K:#K"9$^XVR(I)1O)'':>FC&"_H
M\OP)J.)1K#/1S])6E<(?LL3['^/]_\<OIRS\MLU41-IC"_T3,*KD,=.1=4/?
M!'JH>P+&8$81I_J/<A5A;0=_[!]09S*\B9^ N/]S=J3V9SCS%^1X[O\[G.#?
M-4R_+P]P2>&I($GA)2#U$V"VOT820?<<$]<TQQ:C^\J_)R57E$;H^Y#KIC2[
MG51JK =SK)'\:MM^$#3BIQ<W31@H4J4X47_] ^F^".D]Z_(^>YA0!XPE0TG&
MK!!+5/%<<07>V+NE96I"9M.A$,.)[YD*-7-T$1+(7-3/OFOCE<N6*LE.)HE,
M1O5)XE^':<<S7#P!F&TJ_3ZHZBRL3&$ZJPR>Z$J:%3Q"8.SG>9T4$@'Q6E;8
MUL-Q)<KE[Y"%A&I:0H8B>9<7$L)C<^78=?$A#<.LG.N4-1)CQ^[G]ZKI)(#K
MEA96;.:@_.!O^<W(2 <'ZZ#R$%LP>X)]G(H3A?2_%8XL@@ +LF4KK=BFQ]-J
M&-124Z&OPOP3ZTXTWB5SO/I"+XOCNF[+SN/5:,VS[E.7HYS\W?G$^]>=> 1U
M51_=4)JW)'KK:[T+3QYQWLNEJ@G$J8$ C,MA'^;37%5#KC6_4#K6FG[[31R?
M37J0W@EEB*=5R\1%J1C[M=KWC8?"]L?$A.^>3T#/VD-JYHLQ&<I/8U1L')!E
M4;?3XQK*GL;C.;Z/C^.(@'6X3N1#)I(==&];+O962B^KAC>;'I$#302DK&,_
M^#OZ5S+2GM/7@$S(0?;?O<6+<(>N#Y[;&\8&/P'SB8#/&Q*X@6D6]&/MR^?J
MW[XIUVMK4H]\M$0V4\YR_>@8GN*E3A"LR\<H 1RG EEV6[3367A?># %<?2D
MX&JL@(!5S/R-&P[;NIMK7ITNOOZ0@,!ZF0I*KWS@[5SY9\Q"5+)SY1B%;9EJ
M)*YS\\)L=+W.*Z^OD>F)9),'FL?"L&I08@9B@]S*1GBE^GU&QN.#X[$8&C1\
M0?:(J-)^ #JAU0*YBD8$N9WLM LF+I5MLTH\ 00$_'9N#9WLUYK8<Y=8!V*4
M?(]C*WC&ZVZ0K5\U:7[!%P(D1/C*_8[\ZW+*Y2\UO+ A+>"AN<!_Q@=R13;P
MZ?$E&N,ULBSUY9H6T%H:C-R]5/9DV/\)D)LLQ$WZ9_4<;0C[I?*7Z:) $3(^
M4(2DUKA+:1%=[<D3$&H6-SUB?E?!K=-!6R?'? S+]WH"PEBI6J+L/EA?S81^
MB/W51Q?)3KMR#ZY =)]DSA@@J$$A-6F?L6]YF@RLP!1N=+_8-!B/AIJ3&9JW
M6U;6_GYD<H\O2GUC'V>+A!J&!1G_$] :<+^+?'TXMZXK3+@.5U_KWBR;]QZ8
M3PH>)UM[3J\C?K45<E?F-3,&P^RG$6 A]OQT:DQZ+YFZT1EGV<KQRV#%W?>4
M3=:H2D)6]\VN-!<\]0Y+81)ZF<$[_CBNS#N]CY=)C'%*^\X,%$KCSXIIVT6S
M3A 9E]-<H1>(,.0LJFN'+0ML:A9=VQ@B6*/_V3(/NK>$:HET7YTV-DW69'VL
M14M=9+& 8Y?-;=CG V8'J4E9J\,,&C,5.Y8VME1>84V4"=CI+S<O4";7VP3O
M/V^P2JYK1]3BX%E_#SM:(#AYDUCO[],W,XLS%.<9;_SA<7Y9%&0Q+HQE14]R
M3'@;/#'^EDXZ9+^]_A[)![S-CNR/@=SZ! 0Y;6G9$ZM:D1-6:)\]>$/ZW.\$
MDB@2G ;81CP'[T4(AX\WFSE)FQ-K _+L'-N-U6>UF[U?MDY[$Y8NNU-V:\$L
M'$9E/+!?7X5K8J#LZIBZO@TYF>&[X[X7-@Y=P<]./:+DDQ[%M[=#P<Z+M[A6
MS>HBZ'6(%)JI?YQ:IGSL3NL$O;+-[4K5[*N<))9A!3.V,SQ,T^%X,+,<\US-
M!>83'DG*'$S=MTGZ$O:)5B0(?Y@YMKX;['\?Y'U[PY5Z"OL.OX3SWLDT4S+[
ME<:3Y;IH4VQ )K6+?(>-7Y6W6*R&U2P923Q2CS+P$G:GT8MQ;0T^ <@JTEX)
M)@:^Q51MU=6M:J2>A^88 K1MY^4F[;>P>^8G )(JM2R_U\H8<L>YZ?>L@8B]
M?C*C1!1JY&LE,Z^JF70@\^"9V2,5?L6?\EG_VJSD\@D(OH= F; B^(_HHE9<
M302(N/N2=@T%8D<[[IDP>*Q;->Y.BLJISW]^[5?I),:K]LC4/0L\AC?GRXF]
MTO_#NJ;3R85&KG-NY'(GYJU)^?R1<G%E8>TRHNZ./H.XX^$<Y3QV-Y?U2(S\
M8!R\6C&OOX[B+8:H=+/%3KN X!Q5U@/W4%X_[R? L--^#&\4X\>'*KLD<)B>
M5_'BH/ X64WT1X77GNGQ6MQP0K53\UJ3[-U?I%!ME?C!8':Q7F(6Y4\ @X@_
M?38#$-]>D=]F8AS")6?OL]$<.F6T-3_0.41.K7[72ZE%ZK?ZXD ,&Z&T;G5O
M>X*8MQ9Z NHNDL%62:IA? Q$ CO\/3Z/B6$;@Z2#H$KW0BE[!N-1TSO-9LB-
MY;?DJ-\:D:<KL8LS"ANLW-X<#S_SXWC.:K(():]J#W]N<;ZE5(_;6>JVM*[[
M.7UKV7[SO(^BQU\$UD'!4GUZ_>WBMV=7K&V1?IC$3H)=Y/?;4N0V53W7.OJQ
M'S>1:\TD)^_G+'0$T:O784@#LN'C]G E?LJ;-7J4HBNM!41E10Y,'K#5:JK5
MSP[X43Z1R3C._018:GXP9D:DM#VX,/Y]I*)\M;X!:$ULQT6A01BVQ0 5J%0%
M!<VPES5:-AMS^D28NK[/E&&F5G@R:KI$!CMV4<A^R';D!<#\01C&Q<#?:\1(
MDF<=51TK]FJ8\D=#/Z7\9\-2B'QB"6_V,_W?FF>\?<:./)^]86F^(L50,0J>
M.ZT]%#4$R$>4<YJ0W2"::ZJE^E86W./[XD"ZM\OW==O2'X-V\M_U:/83/!?V
M/5 V0_VUK##H!(MH!TN.C%.X <ZPE'?(JE"AX<NEF+6U6'_1$->U^UV4%L1:
MK@^D)_-]%9;_^3!-1<$3D.%W06VH?3A8]%"]5A&CS.L6]P>C\B]>'AZFK.&V
M>M]E]1[O,P^6D%=6>P_A$V!6[G6EV<AHL0Y&]IM4QO/W:R%7?O1GVFB@6/#*
MG=]_2;%&W/<$V/K?5VO9PC=J@SZ'(4NWH.'M\>%]^LZ\$=A)>U;$LM8(<6QH
MT#T?9?&2>&R9SM:Q@?/SBY1$9UEY89==:[>ZTX9.(0<<:Y?2;^@UZ'_#;TUQ
MY'W)US!;N"N;_<*ZV,/#$34T1K>VYPC:PA1>_89+.G_&)#:N<02GP#).(PBK
M;S]4L)H,$W#:L>SK-(D1*!CFU.\9EST@>:]EXL_TS$5!* Q9RADOVI/I%WV9
M'$E?OJ$DXWX9YPM I>X4+6AKM#[8YXQ/O,;?CTSS2C-6OBI8O0/5E,3&0>99
MEV.9R4,B<I;8WR[2\?<WT.*WQ89%1X3T24;6_.4P\C5\K_!/KL_D6V+3#^2+
M9CHO[V2!..8^4?0GH.-C#246PD+A)*MKY87UK71EGCA%%NM#I *-0)2$71(]
MTVD=!A7ZCH@@3B[(TG@^]\]*=5:8L% ^HOKQ-2'$ 'O48"]I&HXM;JC9TNN!
M&\Q7S(_QS2ADHRW@"<!Y9!0C[/;%'?<6VY*(*!TT _MS!(2U(NY)"LO]'5R-
M"5LQ'J=;21M.$D3?37A+6A39G-<(;'DIA-55-5!H!-#9EI4XY1*CI%Z^#VE[
M>2]R4OK'-9/DI"Z]22O,TC"G5I?\#Z$3?##.PYRAPA-A<E7^! 1^1?#]R<*I
M/2;SYO.1%&L;A9M.;DUL-G/I$WU6IPLB[H\U8(H3-:=D8^=*O08A&& ]MGX;
MVH=/@+W/NM WGV++F?'=\15YN:2=0=E-&>?%PQ2\S+QBACBK%4,Q1.>5\T,V
MR!(&X;+VPVGA6H^(B/IX&7=VT)5\F%\S*-NAA9ONG3\W:>H]AT)$3#LN2N>N
M?!7_$/WUQR.U_KWRI"B-N^>TSH1&Y0Q=G(N4*^;S:#G3/P34;K2ER)V1YF5^
M'52LMK[=I]*;:'Q_E'@YW1<KUS<AV0P@P]SQUN:'LO)#ZH=T4;I.W_PX^Y<K
M-]Z.V\^(>I3O<<SDYU<-3MJZ#Y3#5ZH[3I^ D"7XZSNIAN8P-^2KB3P[<J[%
MO-#!K"MGHS=/ .H:8G@=$K:">:]4Y#YAU'J*GH->8[N:M*;0U+OY84%Z;()%
M>4/G"?C%DFQ[A^7^PR")O2SU5]W2J,QFH".\I>U $[0:!SJ3NC=Y DR0GH!Q
M2ZLKE/B_W[O=OFNJ<C<$,A]T.:2EI77.,K%HP!]%$V7'IL#%L28&Q"DK:EWN
M]"J'9=7)]!PC9!Y?'"2W8B,LLNMX0'B]K[0:Z<XV'([0:2'?IE90@FXDU_PZ
MVD)7*'RIO/5.D@-Y4"<NBMD*FJ?N][X[+G([*]IF?Q$0RF. -'$TMNY6E+>M
MIOGA?_WMW.$9T@%W^PB1/#4.MD@UKJ;SL_#J&_H1FX="6A#V* T3<G7I_*+]
M2>3N*@1QG>\[F(6ZH.^QTD62+B$BI!1\MC&4=+9;W"F_\0MSI,OD*(8CUE@0
M(;2* Z>]^^#N2TF$:-XP+SR!N\@&326%_<PK>DU(+$XCQ2(NJL;_!1YIM\,S
MXM>A6^97!?7%TY\KZ;3B&<D^YVZT' IGE2 8<4?*N^<R"F[%?ZB_BFKE./FX
MZ!CZI0=T0E):1 ;S]V7Q5GB(?138-<;QY=AG=R_]\T@;(Y6'**44MM&A>COR
M$D4P#/],VX$Z? /D.[.#T^,W)W-5@G@ YW5LB/AU7!_DRY_K<;_&<HM*?V>?
MPMJQ8_THT29U<9EA8YNT]VWIV:3\X&@K^CJ(;$+,U,BJ:6FJ@]F/3,4BX.\Q
MNW&^F=F:.9P[/;\*1]RX%-T+G^Q$V)&JM)HV-Y^*_NQ(4ZB.Q'?X88157;2Q
M30>P<W9>^J[+A'..=4W4FZHA/<A6C, 0="^@%;./[Q:#)-WI)DQ8IY*$#6)$
M @1NX10)F;L8]UHG%G#\.^(]AWOQB4=6:\HW+0)@%G#)'#CS:P1),QIJ+TN5
M=U"HX>Y^^Z\-XHKR%LK3%%_61]BY^_F'>A]!K&&2]7V"<TENKI_\IGO]<KC!
M?G.EH-H/6M6^PWYX6N?V<<)\19Q'>]O/R'H1QUCA-]57SR=30)]7<!>6%M\]
M')75559CWYB_<J=(&WRLL6D_?3_WES1EU1C#?=;N()B66:_L6D!F/Q7M>93?
MR#G3:7/6M$C:05_A^-,ZU\J259I<H_EPE'MKG;H=*M^QI%6$/M(H4]R+Q=WJ
M&_*89^3+F+-NH3L1R$2I8D?J;P_:+/XMAQ4$W?=W;1C>5NPJ;VW=:?F<T%I,
M<>[='UW^5HC>%\WX-3*G(HABZKD*N$<%H/-)8*1SCBE0'AK?<^ 61CHA_-LV
M<H2YP!L0/&_[J4?*UF+*^4-N6U8S,1K[5! GOUF8RBMQX-@&MSD]O/Y$>V.G
MR\^_K08MJ\,^*IG@]I"DF<:RE4[#\,CT[>>W)UBY30DWP9>^>>%W/40;X7BR
MB6IO57!5@&P3?Y'2<]@C9B))]RGMJO<5AEV-G5T"MY\?%D].Q!- \1[2DS:A
MPN37H2&,M7XG\G*AV\V(.^ZX(]FS&YI?&(1-I* ?8,5K@9,I-\= ] 0D94Y=
M$!ZFK8)(O'D0GS*I3BNZ^KTEUPY^(P\<]4R#[5F_AA)0<OA_^;CZJF@$%-@R
M\8@)+9 I]!WQI9RC&R<\-:Q3K")X I*%!B[:PK4)M=I.E/5WJEFJLI#U<VT.
MMFK+P QKO^I\JF6T, (1RCV4I$^ G3TA^%H4]31JI_-]T*UM?TV$:M0"7+T.
M:3](-V]>$E]+2FR 4YE^I4L9VW>LK=(WLU6@"I'A<@KNF':BFBISZ:"5C:U&
M:K:)DQUHI+*/5HP,U"@'?WN U(#FP2H(1I/W?]IPW8T_GJ0T-SQ'S\$S=^1]
M K(\V"MW(ITG\/=;V1'J=^:(XS]-;2$N%7@(IF.Y*5O3ZJ:0P2@%Z7W-7U)U
MXAVKT>+;R0JAM\J/A"^RNB!S$$U$V)I^&*O:06=]\C0T=GM^)*8_4:2^EP9?
MI*IVR^]$:27LD0E1><)G,'5O7&X(ODT0I<T<%TJK0YNFMK7N0 =6N1K__6&?
M?Q*R9ASJ9Y$U"^LUPCZ-6DJ__3F[?[Y0D$&K1"+YMI+*M&3U:-F#_.#-XW-.
MOPUR;VG0OG7#WX8M)%A>A//L[YU+>7LAPDYI>Q^13F;"4KT62AM1]:;+)+M_
MZDEQ1]#^_"[@NO3ZY4LAP-?L]ZF?^$,>R"R#C3+4M8W0Q8]PM]) AGQ]__70
M2:[0)Q34H5T3AJV!U<!.P(4<<O]&$,\^:H7\[3OL"*=P:+08'Q\JI!?EK"(;
MM/K3^,P"] IT1/D$%&)99R:C3#T^NY>';&#\L<=R'^#7FCT@8'1DP72J5+@V
M%?/RWV_W8:ZUPGV&/9!WPNF8>D.ZRE:Y$87Q^'QC#7P<?&L@"(NBJ7D"Q"H;
M5-04]UFJ-@G%NZ0EKT,^/C /RW1!%M1'N"B_WV+)?UR'V^,*7&[OEZ^#Q*W3
M;T42AWJL;'/C)*=^N)0[KU'DKT--UBI"CH4=/Q.DK/=#OUGS.OB_9G1RRL7N
M).IUUO]?S'U55!Q1NV7CP=TM!'=W:2)8@ #!W8*[.XT$"=9(@. $UQ#<:=PM
MN+L$=VB@:8;\]]Y9,V_S. _U4+U6UZH^I[]=>]?YSM[I];\*W=_I&0PXD8C:
M4[_P4MYT:10 0K"F!W)[(D^#JPRAEPT",)G"H>(VY9&+2^_PG5MS..\Q6^_E
M#U.K5U/$Y NA#$^LD:$JC2TA0H^:\TM?I"*)N*>)+3)LDT*<^8-U?A\N%4R?
MP(?8:5Q2OW-)/FA-CJ/*XOI*CWK,"9(7O)&D44[;+/C.?! U'YN6__D0?W#W
M[0NEM!4]XSQQV5>A8KB^HN*^*GT[09^@](I;$--!\KV!4C72M,L.G$AW?7F]
M7+!MA$4]M.ZZ:.7 ,S7Q&W-CG#820II;GPH6_G+18+Y.TF-)+@:RD)V.(^]>
M'U730?O;/BF1.4&,*'PY"S(B^=;95$97WN1#J>1HJTT=!\>4+<6T4P:M%6$A
MU( G:_)FG1JHF7ATOL!\ZF?8<D@:#UKCQZ6*Y:%Z%9'*RO9F<%WBH \,Y;5L
M))59K4=TUD?J\N(ECMZ8NK@>L DZL>?\"<W'IX)^R[-=1-*;O,-+2C*EVD'Z
M& ]SI5?NM?YS]Q!\CN8-F6PT"&3JEY9CSA:FY*>-'L?38]3 3:2K2C; 1-T\
M9Y5C;-N[SVM%3$@W!WI$,4<4IYX8DCI;B:($,BLQOSK*7%D0%%'(F1$3OFB/
MSV'##\949P4HE4W__$)*S$>RBP>RY:A,G;@W#>M_H$<K/529F43BOK:35/OS
MR_1*5X26EW9P^OAZ1!D(M&J,HXHAT=R!"W)V#]^>_FZ*^RRE91J/.U5K?YWU
M3K2W4:PB$7R_EU 6*H^M*VSO\!5U "5<UHX)FUGM435E6]-3=?$R/X9%:K9:
M=SX]>8;?Q]FF9J7D!3PS9N4VE61CM=K;[&10'(J:F>ND:2>8BO]-]U%UY*Y;
M9J! DH&< WFB+HF 4<4 X@_LQN2],,,MZQ?D18J7A\7*CU:76M)I8"5^ I14
M.E6>?:]O^S-*&EH=W*<T3/[Q-Q8N,LUWA(_KAK];FDG.5PH2LZ.:16&^FGNJ
MPV_)T4H$J81^+S\#RJ)$:N?-@C]?R;^BKVZ,DCYP(@#>)0. 62IC5H=ZBH=8
MKSI:&M3Z!PU8X+KE6@U;<ZMO"!2XUK>3&WD?TDW49@2T(4U7P#JNC4] +\PP
MI&NXQT\GW,5-^;NV#%EA^47S4V49D& OC^7<BH%B)@H7$:ZK;78&5RUCYZ.]
M4/7;T!R.1/CJ8 %JE>!GP8Y'V2]^(/H_:HVT R)/;.N?5,@JPBZTTAB[NZCV
M%,A.*.G-)W:E*6!SC//1=8_Z18VC-8.5=9'3$G&SC6,"973<8>JK)0B_E?>[
M$^VM[[!.7,)IU3Z[*>GBQQ'/=H3G0J9S9WY>%F,-96X:5%T*=/ZN8>=%"*8O
M0<T:4YUV5^1D=FGX2L_39:; O,Q4=25-?IN.'9LUU!1'M4+C/T36&EA4)UKA
M4[>JI1_2HWVY-?Z.L>7B9*C2>C9%4,OA&( 2B<0\%T_$S<'M6#3J&ZW_O@M_
M &]BJW?V[\P 1;FX?*=)K3GS>G!4J&J;'26(EW.WV7Y##F/G*3!96WFFZJS@
MZ?:' QT<EGCU#/#?"F*<J9?];?&AIKG%DGR4=U=NYD_QNJ$1+[^.8('WYK\^
M713CO=J=^;J_19?IMWCW_<(@/<#D7BVWA$*1SJA9^HG6VRY-E.J;3L&"5_3T
M"?-1I4]@TU:O!8=&CXG$9K@&@AEYXAY1BM Z9=#P6NXLJX1DT9#S='NF SOU
MJ(X5\SPUNS0 %0VQ]D:9\8;)P-A@^379(B8*VLI%.F!2$^.GA@D.@%A.9[IH
MIC*%A9NAQF21FTR4?KJDZ$",0>_35JVR>"-*H3\\.7\,8&*S1JBOD&)SYLB5
M]6D#D]C@,>;J?NX9(!@W5CD4<,E805+F<I4XVB/I?:9/-8DJOFK';T 4WD]I
M_:(E=5V8CN$8=B]%9;A#,L HBVK;\;-4_R"A?(6?Q3P,H_ ;,*C4X93DD"@9
M"<4TGOICSN DLE[X3YQ4>ZO,ADZ7RU*&]/*BHY$RA09Q]L%IN*\BF2;L2B]S
MRI$RB#EI4A7Q2EX'$>$UX51J^@2\Z_>CT](HY:F7$\[I6&CF.7IG+C:.G=3C
MV]\SCB1^&18IF@-CB?Q@ QH0Q>1>G$W0['\2[7-- #PH[P.H1U..&VH*^#U]
M2)UAM9_[J;C/R W;-9V!:<63J)\RB@ZUKM!:9[&[01.,8=) ,%2K7&B6<ZAS
M DDP&:?23W(RQH9?#L?9(F'66=)%;V4*B8(ZT"^C-TJ2[<*<,SSERP+@9J_!
MIT!$+=&9A<PT_@78?/+31?/338B^M_T9 ]!CE0(VK@=/=%,>R,-WK0)D'\R*
MQ6E4\9ZD$>M%*Y8?*Q68\9=TY=A<T@J^(YP-Z$G;N&G<B'+GAP5V$?%]5)%R
MPP/<;%<:EOFF5#H4=#,T)YEEHQ(E@MA,9(J? ;8D8Q=UZ.!6Q\K,)P5X\L\S
MW73C2,YZ'_+7"D%JK7[][W+ZZUF0WJC@RS8:O=,U_KC8OQL4]N2B5^::FQ#Z
MUT_]2_+K?TX=^>6\G87_%@C[#__Z\F6&2F.,XEE$(LU,_C.CH)_1"KB+.!9D
M_=K(4U>US,=#&R]2[MD0O]#])H0QBA?&QBM-+.B LZZ'T8C--?NW!$I^,U"I
M4/CW-EU"AM-LL?6,5]3R(;UID<TS4TB$P;)4?W&MH&M_!JM\32!,3>4*6/F:
M8]5G33$@9^3*SR=M^4%+IB.U?(C5KU+?;/_)L,T65:H ]'&U0GR"0(*TTHDD
MU<=YV-G0O#O'.4#R+Y*-MFUPX@+9T*&M>"EC',%D+U-2#>D24(S3(M%:<S=B
MT&U.LBL2)B.E0,+ =5SRSY&$J-.B5>D"2<*.*&N6JHDV#NVR]+\ZWK 2?3'*
M'<IUC93,0@[)"_H]\T-L_V=_?Q"_@X1,L;&!#YXA1^(^@K3$D\A>W6%]1XZ=
M95]N0S@J/?( V6<0G98UHF"X@.L117FC%N#+3')JF?65+3\[4[Z;=9#) 'J_
MSU%ZNQU"0V,</4<2,=D5HZCY3>XK06S)JK8VPQ5]MAN28U*O^:B&\GKI(1&R
MO;)#%1_J7_9F<;I7,1\75"5M.:D.F4C@4SH?TNZ5&*[O:)]\ 7]*:KES8DMW
MMG]].G[BG;XHM1,[,JJM;249GR*'WG]FLK?ZRX(D6\O=]M:J>&)'7(%A=3N*
M;^":N%@&\-;.O3&>HZSFM=-F H;PCJTO&WN&>VOP9CQ!W'^:'J( 7C\*&\(I
MV_G'I&H%UG$.'@RR+=J;=$'[^;SF#W-9@/>WWO _^QOWK9Y6S,73A8IC:DUU
M[>E_!;RZ7XD\+75C^L%Z<W:UFW-?.58N;?&4NG!"1#E)5G(<WY9J.*CR9WH)
MHMPLUC;R<1"L"#G3?[4 /P/T,HI71WS0?2H9ZNPW.&+0Z>>C -D^_I%&RK%,
M?[*J8ZIO$6L%5LV.5%M8E@QN?X,F="/53R[G&@4S/+8XA?K-B>83*G(W2NXC
MI2*H61$VG@'USX"3;_GPD73J[_B+7,U;)VKDQW4]3(/;,53D1::#2N> W<C7
M^"%R^\Q1P(U\6AH)!?^K]UM_W<4]1?4EN3\UZDS_'8_;"="9VX<177*^!=G:
M#3D)9RBX9PA5<V;ZB,N+W%XA0^+LCB!0YKL^IY &$!H,^/. ]($[ F8;?^];
MV7ZAZ#?2&I,U3GUNJ=Z%H+#$P\,;-:)UX@H&MR$] U!XH/.;U.](9^OM:$EU
M6"E/!!7)\AG=QA?I-$P",!V1)J^KIG."@)0PUD=E?XGZ"ZT$V^@WS8WMTZ>S
M1OJLG2CYS%0Q>)H1JG* '5S&IT:(N0C$V@G7YB$GM$(@"S@@-&\R! *>HJS6
MLCLI4!.ET#7P)>)(F<(T8Q\QX(/K^$#++/T^IZT XP^I"O,<>6]1DSP$DF1<
M*(7FZ#8UR709=@C'6<N+36G-!RAZ@_$U\=PUR1#;<&]7H(]>CY(P[/:Y.K_(
MW NAGRXT.85I>%*+9"D^0MD_S>4D8AS9L^M/6F3C! I='7]Q%8#:I@=5=M@O
MH^$8L1<@.*%3[&TV;NV/CHQ-<2<N&;1=X204']P.O \=??HSLPJ+"!,PX#,@
M) YF, DS+UBU:SGVS0Z['<Q0JW_$HBL,];Y"C&_&TA:A[V"_I>A^6->H;FBO
M2^/BY*+7_9G.GYQ AEB!Z_QV8MLX[!E #K&25-\D[7X&A'5PMQ*0P0R+%3SX
M>+;6#'>WC1TF%3!-KN+AR0^ZSP#D56C?,P!3_-:[YL_I_I4'&'WH*9G%/$4(
MNNJX<"QDR?L,,%!6TF__,5%X^DO0,[.RL+!%%D=BY)O*&)3[(RSA(@=&I+]=
M%+V-[:72<,&9J+]D/(%L]Y1LOZ"9\!WK^] &3OW#34")3/$[A@P?Y!-$ 0Z%
MZ\ZJ_6= ;PPC=*B,&L)N=YG)\R+#0KORO-[)-8)ZAJ4DGP&3?RQ>AB+:&/ZF
M7H ;RGK7_\2T^Z6M_8]'2<^7'I\B-D1)?OSW#_-'53!Z,> 3HCWHG!S8_<_8
M.R06)GPN *DU@E09V_@ZQ$&*AQR>TD!4Z%0G[$I19EBH.GRDP]?;7N=[<5HM
MP6N!@R_5\@O\^-E;Z_)++07WM[J:\I*#0,N;'BO[:F&4^(TX68T8JG,5MXNC
M[=2(9X!5581P!]<%N@]=[%>2!N?ML=8FDX\?TC:LD),6-<$B?8$6H"X.RP[P
M;68:IW! VC7[3V^BB]V(R!#027'J_7SC,Z#+^/6,?@\0:R\:=/O1R)BQG[]Q
MG!4]6NI1RSY0P$U*/W@#B _<*,HA;S,N57H@^6F^,2:02%\W?;R5=7N[RC'<
MV]@2]H"Q6P>!LJ#U/[(W%71<&.C=U AM6Y79W)Y0!GQ\\Z*N@WY7.;V,A86_
M E1\(\/!<[F?E.)3['9S58HBM;ZNY@>A#KU@*G7@""4:COQPRDJ6Y\7M"V30
MGK/W0.JJNB7U/\4M*[7-,=;9"!A^"3-'Z=SCJ_DE+VM"7)T0XBV0Z&"TX0RJ
MUC[QVGP&+/$KMDXS3E7"1+<=I.@X5V.;.8E'=0%CZ$X9UF8(L@R_=G=KTQ_"
M(:(@"R<H\S.@#Q("I)00W'9XKW,^(Q:8P_'-Q\[)3WQ, )>0'H5&=OJN]?>N
MVP J1+9<?FTI<71^VDE?E3#VLTR04.#X&P-S2?ZHJ=Q]-*KLV9V<>JL^&S@F
M?**#Y\(P_U6]HM];)[.>K$9^OCY*7,.*1WB43?A^*'P.<JX6R[W14>^U28ND
MJP=-[4NIW%U;-201TN)>XR,*Y0AM0D:1()!GDWHS!]GX":*Y*9_/]-ZMH&=(
M;JR9KC2/13@&>NJ [[X))CW2^*,;+^EOUQ=]JYAP?I# 5R@[(F3/$=))^$Z\
M.L]-GY<R+FTI*1,X A66.S<.M3<_GP]W7P4JU,;Z)UB8V]*_ ]#O=6^"#1(5
M1!FR[3@M*H?_T*;1O@)NE.;@PSC+]'NV1_Q4**Q'.Y4%G.5L?*,/PWFJ&X M
M(^.\31Y5,\ ($%X=;E0']K2$^F;&]8R[@RR0C_R[20P5'\]A10$QFP\ROC$%
M?-GX7.49 -5-CTO:,@[SI0Y_$:K123A5UHF%E775R0P&&QNH6$(-?U+6<$28
MVK5OR9\R_9T>!;VY7U!']Y=->E;ES:A72H.OW<<C&Z:IFMU5;?$@<% ;L43F
M+'NQ)2=N$:M0J<,"98L5U7P.S!YZL7&V^-AM97P17G@K3QWC.1=?E>;F]9I\
MD>#+E^LA!I;!(>)S.3!PH\*+8FPSX@/4B\C7W]Y3H<06O#<H^;$_EWN:\Z;,
M55X+^(E]&&AK=:&<VIE#?)B-V>['C7^@5:S:N$PQS* 3Z:.:CTC)&S'0P;ZO
MLK@/Q[#8,":W;>B@NC#ZQAS,Y5B COUH^%0VM,, 8' M^V,5G(@1=YS7L3#S
M-<GFLD+HPHB<U"F9%X%:!4V"*L;S3#91#P4\"ERXNKV"AFUQQQF1GN?$"F;X
MK>/8\0NFS-9&,2E^(XJ4MU#UB7^S+7)_=(.S6:#SA2>O[>>G6?,@%=-T&!YT
M=L-0;@-W (QGS>-4TS)YPROY-;AFA)Q=L#5TY?@+4.]I$*JV?60<!<*6X-TZ
MDLRC-E<)/\Z[CEU\ZPTO6_[^#&A51_OS?8+CJ;2#WSMG0Z5SG<"[TF+ZY(81
MW::8%3SJ5/>Q2R/HT_1O1W^J\XA08S9X'Z0^9X!V"7.[(W7S1+]7:!KJ.8=>
MCZTA5Z2?[_.J5?,],K)CPI81CG/O;0EHHW*=J&.VTIM_<[=N,6Y.>*Y*E2KV
M[$<NVF08(6U!Z,6U,921M-M\$Q*F=P?FVESVV!*'U.KQ<\-:EA,+7^ZNGET>
M]\E53Z]91XS674W&#8(OL&K<2XL+4RZ$>IYB2@9>*3<U5+=D+9J';&Y9Q,FR
M54AKO3Y'WZI[#56_37W!GI_*FR!"6QIRJ&&1SB&M:7+E_@5.89IIPDQ\]YJ@
M:3*R"ST!KHB!*7ABR0I&M+^=%9['937K'B!+M7_LI:=A1C^A-/!"8RX.;X&+
M9W#TM*T)9)CM9+U3I,WFB5>W)S;#99>%ZQ7'5!DM"Y\"!4'K<#6RR7$7F<23
MSZ.Z/]^Y;.6C./3<3DPHA[@]+MK#P\[91/4V28Y00 6_7R,"@Z?=K3'>17=)
MY?.UZ,3",^!VZ@_$%I-R3&RKRQ^X32U&)SB>67.?H$+R+NVG&4*G&8+Z\*F1
MOFA5@>>ODV798Y,&T8'"0)87,)=P%'P%M(,@<08[K674-6G^-7UDZ&OT<\:=
MP;EY5/?"FGZ-MQ*0N<_8@#IXO5?&]5>94,NHMG#M\%..Y2S#[Q@LXC@>UP"W
M>+M/@NQD6'V#5-4# O5?XG66VPL+G(?$5UIBR+\\CJG/.@F=G<@$CN$UHCV9
M_C@%GE-#YBHFA8C49!#95FWG/+7QNR1'7<:85V4E,C,QZN4U%5'9T*EQ6*T1
M13E-TVH9U 8#=-^6$K\K 9C@!&%\F8R.-!+B( Y'EV4#(8II.@#EZJ?NGK+(
M%9_VK"R9KP2P&M_<1XZD&,18?'KUHDO 8945O\(&EKA.F=#HBC)S=F/@@M4Z
MJ>PON%)TJ3<\MT(C[.A)/W,AC]W2-YL_7]2$6=Q>V$:[[JH+GB'>JC^9DPDC
MT=9E1-JS,,S-,? LJ3K+GW88G:J(R0V.G*P6O27J#"@;H6ZS$_]FB8'4$H/H
MEZE1?%4FYECY5&1,XJ5UF!_>%//:J5BT? 8AR[S,P&B%R$%L:PD_9VU4(S!M
MS'K6+O;CU&S4A <6A]@W!@R0NOK &Z7@;0MWQ_>L@P)?Q:**EI0+DGQJWN\-
M98:RDPY,$O89%*$HMC,-PV42]^985V61Y(,RK0IUPLE.MM$).*S;B64!,+:&
M?#LW#XK"]LU:^!6'Z;<'J\+WA0=\!Z=GG$]]V\( I766!UP]0+-[TA )YZ[\
MEXFU1+YM6J4H=\PWW7G:N@S_^;5P<A'8X<>"1M+^B_C%WH:-#<7]2[E?JY"Y
M(*YY09\M3D/'=$H''"W5!0+Y%6$(%>YXBUYYB6U*B\8;_>84(F8D+X8GP)$\
MND.Z+N>V33[^1PT2&8<NE2);O>*BP[GT-F7&@@Y7UBYQ^?T+8M<?^.\]L'O$
M^CA<B41,8M#5_P:P&=7-RL28:K <=?:)!9%3\7:_BB7A\:'3P B@4]6A<94\
ML$9BUSB_UFOO'I(<FY0ANS2/9PO4F3C2XY%.F2Q0BY$-Q>!3H8U5GRV:R=>@
M<,<;'C@3&)>F#3I2+&3*JTZ9L0C.O)8G"@(2S@5Q&O[3LIG]3'!"%D80E880
M[]I TYH*5L&U3AX;VI;"F/ZO '\+!\$_C2'CMUZKC;R]O//D1U/QU"@6QMY1
MF.()B,NKALJK#IN<X-X-K4HA!0+&_][3'B3;+S\;54,".'',7YA2Y),.V_&(
M1=,R#_Z8R!%%3B;V4#I8MA2>9%,N^\WK59KJ[EL&$S@1@H0VODH.UX<D:L_?
M(L4*%".4]$&#/3;JDZ&J.@<-+?86G";R1-F>6%:'?K/I@$JKHJ6#^T?!.E7'
MH]U<\H?9=)9<+,4QQ,N';3\[836Y)1%>&B#^_$5EI/FEJ?Q=788&U[ZH>?#,
MXZS#Q\/#6;PEG?JC!E?D<C+C4N!^5$#,//_[EL-5AQR)-T,0L%NP/*: FI*"
MEJR'>F(Q6I2)5(F!W5) Y4 "YXZ"D+-JX^O'V8=(/6DFODAS@KN 4!>8-:+>
M-P?3V+L*WO)G@#?+F*+NTEQ4RZA:_YTPR=]B!NE'+S^:%W6;U_1UY=V?BBIT
M4S"?A".M4JBF>P#)_/O@O'HMA#B=6@*%\FN$#-/<Y86AO;/L/<<I@V$#\,&#
M5C*1*HKXX%E!&G9E+\\ .&,TLM4*_D!L;X4DD7WS(B@I]?5K[;5\+,FP?G=/
MQ#RA&#=F.=+CE!WBVN#]A$7F8BRE5.*D$(XJ%'H]EF)9#,'*%"DG&M_O^1#J
MQVQP'-1#V/X3.TR,I7T[3^#C8O">_AG@84!XKXI\@]<25LB+KCHH5K29,YPE
MP.I"*/=ZF*>+G/Y>$Y,;YZ#%?\VAO<"&V7(GX7KB(V"J;*QH<<B9BV(.-1/O
M0R499\+D/GFY@"J"AJ =90;T#^=9]@#RJ?4DP3K8%J)J].EVKD:1B-/M34QD
M?)#^52[R[WH_<8THQ6]<::#=@J85$)O';E=M?:(I4=)W\LLMP]&U3DUJ6E5(
MQYKC];99Z&G*=UY@./OG()[K5;O/,UP ,?%E_7U4A=VE'CBB+&A";Z5B^1F
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M7;(!S553$Z^@EM-=V:13U^+XT892JYR3VR@-,212.SLYKG;;X$7<KISSI!<
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MAVK'!5\2V<\@1!0E:?;0P0)4:G!TI0=[8<C2VJ%!)CFRN>UC4C:*X[3FNQ@
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M7#9M.'HH_?ST#YR$KO$R=/&LED>](50:,*X>H&$'(_1R8C,BZ.:,^-!/-JM
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M[5:E?.N#>(Q46JBFQH:%;^9&4$&*I9VG04?9+))]&\'Y77):K'^S167N0JT
MSO* ?(N"71#H%P1S=7.&B /-=$/!\Y-66G10]UO]?Z*J5T[96RRL'TKGQ)T:
M,NC<EE\SQ[R<8]7;*\X&L!L 1.EL /7MP"(5Q^!+AL)V55CROUTO&OVG)(98
MG-:;>#Z7CA -P:1O1.Y=Z5#RRV_0?-@WMV8-+7.L.V.[:'"^CTM? RR1+22
MI9F+,&A8A+@6!: _QK[;"19+[N;$M&+ $9Y$#OJ-+]1UD,*?V]Z??"X6:CCX
M$S0J8N3V<":^QMUF\[=X*WGKITF?Y @W:P.>E1.A(WR@)\6C?Q<<)T5B/_C[
M?@S#E?X;BG^+(<-HW&@,?C%@&MV?/2YT=:BW4Q]C3Z& [7?!%"]#Y(G?]!;G
MFJSO=U4V.<N'XGQ9UO?E CA=V40,]X4@^RK\H%%S#"='_7B7>I.*R7UC26TT
MWNULCW%H7S-M%IT5H3( 7^MBA',4A2#T-D1FD"P^GV6AR15"'^4*# M63NG
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MS9L+R,KB8PK%4;P/HTJC!PK@I6!CA6S--N3D&$'>GX8.91/1&P6+HSG^,WE
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M<<3(L3\AE OA';(U<Q^^%OR:=F$Y?YHJ@$&80<04BL-TAL-<F&+\,Q3"ICI
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MR-PFC:GH9<30R6W\J&%N\!-\@"NF@BV'CO,^ U]@0&-TEQ^ Q.X:I/Q[<Q1
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MQ-RL]6<DL5C\)0WIK8ZCHG+MK!I],6Z_4"-KM/5?.WLI>C]9(.<218A09K%
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M3>P;E]QIN"=+>V#V.4Z^G1UHE<F0K9%H?:O7BFKL\KQ>T@RWBE0Q2E^62&A
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MF*V^;%- /^W'R!1,YY#O$ '2[_I8O+-@\\F&2YES???>:#;DA7BQ>5NL>EB
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MK_"XK"WHO[Z[8TI?O1BCV0S$'!D@I?H8A2BN:C^')&[7U_2_1IJ<1PIS2()
M&[],\9&X/M>!'6(H18WFIA:$>_5]ISMK^%;D)V&R>.(W=KMRF,#N_429WLWY
MXV.$_: _6;!>*](O+M09DC-OJ M[$>D-I+4PCE:3(;"6_D*"\Q?<5DO.W?K&
M@;\;&21#;#\@ EN8V(!&BK#-5'8PVA1^I7<326MO<W ;7B3GO#SLY_'!@F.(
M[FO11LC#J_QJ!*PGG4NJ,W3N!3&LS$Y7R\E[]L<P)^.(^1I_0AEAHACE@-QF
MYT:AV9FA/RYT?B7[]H.CF1M*;!,6(OO<MEK?^Q]C<PJVIEVIUC=BE6L0:-J
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M4K%!>N/WW(J%6?QP2(-S0=?5\FB(^'A[6?+(I.;M/S'.N #K?R>I0IO2Y1X
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M#?S,2[#>-OD@*>Z+9L*IIH*L)QE[SF9<TLMZ6:IF7:]N""^5]T@.S,T?-CO
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M75W4U E"L4,P;HN8 :I/"1PU]*9MG$OY5K@EEB9E1TJH-!Q;JXZY[-7DOI'
M/V\ZW[A^_),7PQW.+;FI8:*>%.KZ6KH.8!B(VD5^<3SK-I#/UC?U$O.CRV3U
M*(^@>:0NM7$;G9JM'B#>Y9NA)DNLT&*NL@W/56BLE\_,O13/B/IPPPSP:S"$
M(3_W6::2S#6?[08M9D$HTIXM'_=+M&=5 8#[)[Z&HQA[I?HF=T]F%?<'FE.S
ML*U<N+Q.?BJ-Q7"5A.CK9,)]0":XDY^H($$R HL=,Z^DZ!TFAQ(JAW6R=QK/
MKH[)!!(V=(7E8('OL%=6T_XDH9>0$:]Q)[D,<^@XB>)K,1=P1%^8G(.2;![F
M>H+O/L@5]5.2H9,C*R<J4I9*-L6NV..:ZPB05(DD$%41 #[:$#JJ?4R^^.[]
MZ7-J]6HQDO^/Q]&']Y"_U:,DX2=6V7)NQ%4TI;+.-19)\S$X>D!:V@BPLZ%>
M2K3Y'I?+7N;5H2B.%G:3&L8-?G@J"I8=1C1G\+%2#HHE&>>HU&39FUZ-^(GX
MJ?C3R<IW:B(>A*33:4'$WD2%SL-'K][C,DW^8[]QKZ[YR:64%7"F!PX8A+N^
MHH *A-L8,#9D.&OX1*Z!\CQGOAVOXH7IA1DU>O\7G&M!Q O"4K:T)<0_XQS5
M<!1,@ZB82'('BC'I33M=;8X)PV3PYQP7<W R(/:CGU.Z$2239DY9E] SS-A[
MRURI@!K6PU.-)\"JC84_D-I&F6+9H:B;9B3ZH(0(0*!4N(%K8\J>@)?H?<>O
MN/7=]33+/\__<DN5?4Q%WS2L^E,%BX>1]*]1@*EH(@\G.A[4>5Z+9%/DX%#
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ML>E2G8V=RW8\TN_Z.WW!PBXS ZH-\"+;GL8QA^/R]ROS-\^ZTNC"M)R.TI!
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M+)#&%%E54R]<4'*D/4P7/MCV"SYYX.X>A!=H]]6950%@?5%'X$2U,$M"-D^
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MVM3KJC_"CBDXQF@F-U0#S..^V\5]%#RF@K0?8</:]!V"CNG&T"8'GKEC*>O
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M\4_T#V12++>^.B<V^Q/R%@T%*S)X+[RIE$2, H\'<4[O;9=2_5CIX<!/ZL4
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MP(_Z"%6R*-0I,8OVXBB=?D6J:?,#5B^SG2"(A[&2- GC=;QT$+VC#.BM:?%
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M%79_X7 4S?0$*(@UA+/4??<IZ2& 5'5[>I():M746\3!\(CV3<_J M VMIX
M!*KHK[9-$E3)W\))3^W&9H&VV'Z?62TM+:!]:%C:>6:P!+1]0P[G&MQ6 S)^
M(&J ;=E[V]+V$2CLE%']_G/#OC%5Q]$)+RS9T;LG.?F9'Y D=W!VC.V DEP:
M0$2BQILZELKFB#UO5-[M-X%<> A/!4YT6(I!VH@]V?<&>%UKDDQ0:_(C"[CD
M)B_E>I><.N4)@'[;Y8R]=^S7NC22"R.0\01*$83<@7%[QU%@(&3)LU#%=U?)
M'K'/F#<PX-@H$W)FJM^\Y.2474\UQ_3,E1C,.X::'8'K5A#J:6]75X] :L?<
M"XF.D3EEC0=W![^??'%+LCVO60/!%%3\'"-:+;B]L4"%':< T!8GD35Y;)%/
MS/R1W2#9C0C =*PM3!%FGVVK1$U!2OSA"<!.3+_Z_*^4D+F&K:DR\WV,1,0\
M<"QW22.R&V_F;G>^4YQNEFYE[CMF WTY%#7N\;P1X3FY_TRUG/=^MW1\UIQU
MW$"7A;\:? ),V"]K2V(Q88@!\O/.>?QMB$7W5&',N<L_YC'F.41&607A6G@=
M^9X&UF&\;?3\2\NR+ZY8L>Q)X3]U=HBBBU4,JY(VIX^S^Q;4:#2X0095TD2_
M_FTA_/]A_)?6I;JE\_]S<]./]>3B<3E1K.E9_[T3X?]A(*^OP1B> /#DM:4P
M1!\I\ JJ7M%:\K_ZL) "@RDGY)]9D)DPGC-DK#\!< X,=LO<ZL%.$.25%:6U
MKBCN(&@EU>"+#FIQ-OC'^2> K7.T+GE6A#P'WZO>@E2S]._^+JHI-%F=]+^N
M!BUZ ^6?*=,;V(FB/IQSBL.'@M.S(*9C7:T3)/_,X<J?2T50/PW:8A:(>$VJ
M?O,OKY?A_*/1FXV=^ZH[V4HQ<'L-<U=A_[)JQ7K'.B3=%>?3P<Q]';L6B S4
M^03@<=X8/TK<6,69Y>#K$7\W QB^^Y)?32.M!%_3&0M$];X,H#W3E)P ?O&0
MX&I@-2-H>+PB <;:SSIM*.I]=(TIS 7H<HF&Y)D+Z\Y.NF8.2VUP<26)F!AD
M2KF><<$9 ^ZAW:,FSC@FKYN5A3? _A3I($QF(=/;$,$C5(]V"EB4$R?M)%S1
M_ _%.7) $=9HFG^U<%UK&\WC6JN8R+RMMB<[_[AN3<+4_1S%LOY+:HJOW;F!
M'];G)2,YNUR%+@.DB\^!2R7]6]WBR(C>AA2G[-)$? Q?/31NFO[P6ZP_20>N
M^_>@"+;=YM>C]I;.%/*,&>YT\3E("2[;QP"<[R&FF+#+7G)('^2;,E\I)UU*
M(GL!Q'Z5=O6+YOY,E7C>36G)>#+_P6CEV6[&/>T,\)FW IXI\V$*@K4YTH,8
M^6@NNCN,!S<CLCD;&;'DKSOG.18@>F9<T;V&MK]$54YJV/^P*/$$,&3>63L7
MNL?"F9V<G8JDTV HO=M>^$<Y^>-_IVG3X..P;>I]8<YUK%['2FY6+*/\=52]
M*M^J<+%$RX*!#YQKE6^ASJ-31'EAH5],;.?.]W'44)IRRD*_*+[Z+JMRX"HO
MOOBEW:+,'F^^M;O%@YQ,_K=UW>B@27'!Q ]G1N>];Q6/U1$CX2H8_=%-3X#V
M(%,87H5"_. 6W\7I,;"D;BWZB W9BE518AFT[$6'B$H:_/;82R;O="52Z;A9
MA?>EWN"Q#W*4>S8')/0I<,9;Z]W5L]D)2#+K7J%^IL^=:*/7K*86\V#$6#NE
M*C:<=F*&8=%9;4T!U/I92/,)$.! $^ZG[>MA,8SB/YL_RD^X:"7WSO>S9RPO
M:NK".A-E@JJ9T5Y<T#L;$/:5>Z&]KB2]$-YR?P38BZ;K^UJ#V$O?=^U\L*+S
M^1X@D1-X$'/_GD?\W;3C((.*SR7ZSKB*L!_.E59Q-E0-JJ#-]]>?L;=CJ7I:
M_O*JX^6OTU/QPX-8'BS0]0B([/:AXU1W7)@FHE7J7-$X\T#>LBE!=]6S<)5
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MW)E)(K0MT^P20UUX0N8J\^;X]*%<R[9*4<#8C4K@^*8-LE?-"0<?4;M6U)A
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MTZC8@W\CVCRNL)@Q%^80.@=]PNIC<V[=<K&B:X5AO9J9U.0YS_0*1AM1[24
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M=H'D4JWE.S_?XV7=PPC97GTMS1&M L@XZ52>O.]]<3%PD12J=L[]-[3_IU[
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MK=^+@[ZXT*]HSP'PY7WF,["[,KW["'CJ>?UA*EX= ULNS_$K5"I6SLPO#.-
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MSR\Y)FM<W% DGE<@ZK>;$0K$T=-N=WT5XA)G/DRE:ZRZ&L#OTF%/WO5S5 E
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M9Q4ISNI2;?$WF++-,,PDU YN,F35P#A#=?\2G5O3O,RMJ/WD.[[PH7IXM6A
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M*/ " )?D_M7,#P#.YJKL#SYY(=*^NPFA8HY8]?'FB;$Z9)9($^9<=]S2;E+
MZ"]>*%OG ^!+T4;C:=8X=RYUAWF4PQFJ/I,091V2Y^UI!=]O]#9,,XUARP3"
MP'F&^8I.%%6'*>JA7O;N +^:=FV=W&#JW]T;Z/VRHI!\*=)?T;WCLJLDT@H\
M[>0R;(I4'HNFTCN_G(G7%4 V+\C=B,HZ-*FQ_=EF$=-><:_G%D";?I==CS'A
M$2?A_R^<Q% 7,B7?1?J^]5N6S*[J.'I9?J*5L1R\+HQ27.<IQLU4\:C!R]8%
M+AKDP<EHK#[N X !RU(- ZC\^U  ?Y3O5A.Q1,1#@,D,)KFWD9]>T.UD) 8E
M_:5P W:/&\J)O:*L"[9(K.+;!V:\K.-TG5Y9+)7C ;N3RF(@O'^C^<R\M/JG
M1G:C'F-#YPF>-1W3T4;M2 [YJ]&FX"^Q/$<#VR<EI1WJL8XXH&F-KZ'[ J*C
MU7IBL4)@<,+;DWE^_RESO-R_2?"T1EL8_WQ);5V@"W^XTZET#U3,N'8G'TVE
MC\"ITC1"([4(@&XM'^:AN489<65G3S3-!N49!L@U5>PIQ@JD",HH[W1A/<Y$
MV$CO,B2\SX&T\\O& 1VDZ$* S\*JSW 2$--;F9W-^E[%O_@5SCA,1]?'JV\N
MN<*\YE2DVY'18CYNXJ),%Y#G1G@>%_5BB^I3WS]9''\> *W!!J6I]\XV>D$$
MK\T6IU_WAWZY>U+&"K+Z1\9C2*F=C/:I/$P>8#?57@OW]&E@PN.K8EKHVV$3
ME[A>[C05G)AWB4C$HVBM'RC:B/DG(D-:78J:HP^@H>!K VE,DB+<)Y7UP*M"
MATQ,^W-KR+GIL7)ADAJTQY%%<>:B-5R6N"GO:MJYVBN6,J^+G.&A_[D8!N@R
MO&(X?8QF77-V)4=AO13VPS]))9++:$:G^/]<$&:SWY2V(UY@P/JH[RW1'P %
M%%B;14U1Q@N*#J.<3P PVVBG:S776SX3ATW:T'(E9]-TN- #H+A,&9,R(7L$
MZYL<*!-*/F(0M68%GR'3G:_NL)UQ=H_0YD98#Y.C!5D5VV@)X47E<C9[;FZD
M/2=N=]&;2BSRB(.,FYV6VPLJA'_!&X*^T3HXI$1@QF-@.L6TR,/Z?V,IFF@:
MT/\QMV2&N=CAXVV@^ ]85&G*,M/TANWY_*NYQGW[:@VV(BT!6Y'6M(/06KUF
M"=OH$*IEDB[BK-(6[DYW78W?#=(IGOX,_(>TU @9.DL,0^WNL4;27U0F;-TD
MYXQY9K/7AGV0QF<\H89F.^/RPV$S_SZNLOF-7:F^IT+>0@_Z*6AY9AX'N\XS
M)P50D*>W./<GVW#A>]%MO7+.[M%%2=H$15KUD08 ^"-D1*;MN=I-)D%R;1%J
M8?H2:3>$*, V%F3V7LG(KH4264<L-13,]IMDG%)MT"G#&1%L&WQ,W7(<2J"(
M7HT?&R2RN(<59:5:;MTG[:*>D<_ Z?*E(.5?[]@) E_3Y+AE[E[!C:SJ:^7R
M&=!'XR;F\PS?:X^ID+,5MFM0 8@FVS_SNZA?L.N5E/@^PD 3OU//3Z,(&SZE
MX^'AVO:$/9WFICEG1J+^ @2O\TNT1H0.]3MRD(GS.N-R2E;!+K<9G_S5E=:'
M+EISIQH_@%L9O0V]0HNYPG#T[!N*GPX7<0JQ,N4X\A]M753TD[]8[.]1QX%/
M?T?C;+ 96L7*/OH@4:Q'X_3& [AZUT5T4_8)[[Y_!$<0QO3"'-"Z "Q_[Q*9
MU]7C\'Q3W6+$\MN[@Y3QS \A(Z>B>VXIG$MZKDO!D']KQG#?_DK"#!Z5U_V5
MV(G4GR$4J\O6T=ZHB1Q&DNDZ]?[L+:+Y(D6EH=).CJ9[*U<[F4SXBS_5BS4F
M'LK@:#U>*(67@X<-N"QNS&RS<>0_LZ\F&]2W 'B;M/#)A:!HG07PDPZ96!AZ
M4]]&0:"_H@==2B/PO^FHZON4[D43UP^K3]@=K7H2'JSIA_1.R09BW;D,ZS0U
MAO4NR6W9568./GURC_6Q(CP%\;;.2V.S?;_'/>CZDIQ@!Y%WF6F[&2)04]_
MFV8?C*9Q92S; W%@'$07JZ0R_11'S1!_V9^_:*0WF^D=NAX ><>(-;K]X?VD
MNB9<>>DM4Z!Z"M]8](9ZZSE6B(R8FOWIAHY@>EEM0,<Y/S)4=VE9](/3QL8Z
M!O]T*]RPFF7%19*L.)A*&7"97<4%"M';2$/PE5H%<JY3O?6]'@!&0)A;;)XM
M<>"L@),+?MUB1>"Q)T^+V5#DY0@4Q/"O',=^*+DX&C:W:B.ARW&?E!@D0:$]
M,0='&6UK[6\A<?<N7I9GP8?3&Q>&E-"K@S$6'@#![_+DBN6:$21Z[^MO-"E!
MV\MBQ@W?HT+=8U[:/0!8$9I\]XIF0CU[5K2VAB[/U^FU@>OJA</GU+OQ7PL]
M1A4F[$&!<@9YX:OQ3]. $/EUYNL(YV5G2J .Y)SB[7K?L^J7O][B&,%8D%.E
M8CU9"!K[2J(BN^UB.4S359]C<GC]=I[2S/3>M.D=D<T Y\6!C9JH'<:0+^?J
M$E32&GD-Z4WI-L..+^%WZ!CBIH'UH9<@+J]S^<92=6H(U!4:OIIAERBNV;#Z
MG04_ #P#'P"Z:^</ /\EK@3)O5PJOMZ;0V63XP7(K@$6;']]S>K8O'&B[*OC
M>-.KNT1@&9>\RM*G4^;4/ET?7Z;OQ[[+_1I/6D&ZW MVRX>]T')V8\B?:7P-
M'+43MQ9_'!"'/%CST\$<[#&YGUGM37P  %&\0APM4LTG+M=LE0>*WD2)GXIZ
MK!\ )%SEC!J5*0HNL.04)A'Z19O7R[US7T2_#PMTP3U-;Z  0(5T7\<B>\MT
MX> #P. !</O4RZ\&VME_[9!W\FEEW7EPK/QC.*ITR'J&^T]^^YF5CUGAR*P*
M35S[7"YL<M+] 7"<NJ<:7#,N\$3Y 4#N?A#NJ^&[-P$Y("$,.QAOYK0Q?XVQ
M%>XG'W0SK;%]0+WV/?S;IXD#'./H:N"=Y[=[ML>)&G_BTZ6T)0#O7*:S3AI)
M=D=#V#-KM]]1!]OJ^(V@7C9VI"C@O_G/<A#U!X#$5(S+B4T?38+D%!<Y?> 2
M)F1*2^!Q\;]W:^G<^E5[R#BY>4G>);>-6+?Y+OYCZ?46-7(R6VBGUR-8]XZ:
MX3W/337QINP#@-"/VJKME/3$89X:LAAB.>LG7PK5/?5PW6XQ-LD0#;&'Q.H:
M0X_\;31GVI'I,PN5D_I(WY#W]_JLN>O<M3QW4>_UVH)2N)&I[.F*B8VES2@"
M=;\?;<?P9HH\:#][!X\HMW2*<([#[0ZV1'S_W-W+:?/> [8UOCWQ;C;PR;2)
M'F4;]@5S7RI]*O&MD56"*GA%E-SKZD"G?OQ6U6&+)N6944U&84DU9,S6[JGO
M5$R*))BS-MCM9+[W\XVVPXNZ41MO4S#R*7.C@E&0 [W8HM(?&6CU[*>O=5ON
M5P>ZTX]68<L(4"BRYHO<:Q7N6ZU$N_>>7/KB_J9H$V[XZB2C#":D,84'U]#1
M%0#[MY=ZE_$BS<\<S-59K@\M@*/,+5O D%;ZK[2EN?4/@(K49#.<8W/&\S)V
M,)YEBK=][=@^Y_SMF-X+V!!>A0/5'2N'SYY-5MF66$EM@T2"4\WVJ8J>((SX
MJ+QRT\HK=WLLB_(!@!2R\R64>M<M\8W#(Z^@TU=5'[C?Y '=.[W".0T7+BL!
M?WD6A*VP*#%SGV0[I_8 \*4TVC3,D3+?4PR.I%]>5<Q^7/J1DD)]HIT0X9GC
MN=2O]Q>ZFH]K>">*+635N8=J8XIUNA$E06HI2ED<,"V8*8)E?HZKF47$MZ2L
MT]JM:C]"G$5R=?M_CU ;<MZ^1XT4G62Y+D(^3)J,W2GDETA1=(\EAGAH;_0P
MX#!@]'^:8 G*$,\/FXZP^IU2I/@G)Y4L)"\\CXUBW6/0U2=X%3BKBSH]EEMW
M(.]A"LQP/<!FCAJAC^ [Q3%&/\O(;B&[C+WF8RX[I@027C/*1H K[3.;:\</
M'/.EPG^:Z=]O=54[.W?3RXG=#E/,J+WJUBRAJ35SKQ/[1<V%@_\U@R98@$+
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M;']70K2SMP!%]A(:3_EO9D5I'@LV +_Y<#M>)CH];W[YJ_'*H*V[H!%E4((
M?X$!^1U"-:T<6&G<6[_?[E&*";ZN,;TPLL]I*]J\,,+=>0 \X["8$:,CG;6I
M+(I] '3MM]N++P%5,I8SQ8#8,\WL_*^_SNWK*O)IU\5]IHX(*KJ;"CB2)6Z)
MKT([@&A6I*)(41-CHR"O9Y'RN\BP3V1J9O/D;1>_B<@? #42:@=&[_46^EQ(
M!\E*8W[V/UJ+/R<HM7K2)=):<@J]5L04,YI(]D"2.&']%WNOL[7O%,#:19Y1
M/RY DNRPG:6,Y -(>7!B*4>3@)=06 "@V)CH]K8*71:35%0-KHPY7Q2[P(&'
M;X%Y6;A1KUU9?U&$@3$,D"VG?O,\:)AK5>7P*K_/L=JT0C@3N\N'.=&<9W=8
M=Z#0L:FZQF*&?+F&)7ES>RL31]\ W[DI0.2\Z)U%2D0@7)EX4EF;&[2BC)&7
M.!A>N4$L'S:]L\!N:L=^!%F@<NK/SR[]&*R/!TC<7%#"]K5F;M!(-ND8_)S[
M#'?<%F>KP*(% ';[Y]-D!MM+9NT9%_J7G^VIZ5C1!AEBWG$SC%/FFZ(%M%_F
M<PPRNZ>MEP'0U_F23J*\_! 6U",B^=4!DVO^I&M0)I?PM'7R4-88#-=1:UJ"
M5Y*,2ZE-=,+D@,?(QD)JW][[LJ=8+."WL?_S896:(/>EZV&>?",^<\\*[NN&
MD[/WUR;X<]):ZC.S?H>=E&N\7ORE$CN7"(_UY_Y$?7WT8F.M]#O.B)2IN?GV
M9AFJ+3E8U8LK<";"4:0B2LSM!,/@>KTDU/Z[52LMW-EN/_IDMQZVYO-YYS71
MS<CDUHP$R,9"_T1C8N@ 53QSF&LSR59Q7 %7FTR[N%A&O^,(M&/RD5H+?0#\
MO&/'I27BX5S.?M_ZE<[I_% 26ZL+&.SLD46OZ38N)O!1R-":U+$P)_89V#-J
M-RVC?=='ZCK*PC._;W64L-NU[8E.^JQ)[>&"6X+:[@+&A;A_P0G[6L$=2#.T
MX,_;%& P!W1]J>-53J#CJ4G)\_/MN(4-&-_Q44AM5#A-1]5$?!F_MC;M]P'R
M ^#:TO=KV$>\.;_D$A_UZ;:J&FW8/DFT/9=3,'Y&&7+5>_T46=#12E9Y;/3U
MH*8)%Y.GE_<@6E=&7"<26^X!L.>:[^'0Y274=4]$)]%C4EUGJ"M'A1U?.<AS
M"'D Z.79Z2UTN=%?F\G%"2_28E/?L5OVMG-,R#A0>YIJ1[M9,!"/Q"XA:/OO
M^ID>>RR$XX[F_;NG9TRRT%V5*0) CO_Y\^83;M@24]@KEUI?7VM_A6&)>64-
MO215,T/IU?%DJSR=V;H];\LU^]1XSSO$E)GUZ^>-$;/1B&=/.P'W0S*6=SL8
MFL7#)J!QAV=P$NXKLH] )!%4M^K[9G8A*)AJ\#ELI BA!=?,%ZBMM.GUV29Z
MRCV9 FA"3FK9O9ZOK--><E@E)<795; ^'4#G'\,U!7N]FJ^\GMB(,8Y(GWW!
M.F N#%#&X@3??FAU4"S\X/@3>\0O=PHQ]+U[SO;J">;G-YON<\6%?2Q[X9KI
M #7X-"<W5\K2R\^_&OKGVIV.PFD:WJQ7_ U>*I/G>KYZ%G,$P5K7%/UJ%Q1<
ML/QY*R>J@VR2ER)BL7+(%$ ER%CV#ZVH]L>5:"B/BLYLUR?B1'3;#QNG2I!R
M146=:4<$S)9W8:%KP^7VVX3P^4T4/UJ.!B7M<FVB=R%J-..%MJ/L%6BJL0!:
M1$N796?/)4=]_\N4N"@3/_Z=VE1;]1\2.R[[W$_1_X3'7*?4VO#I2\;R0S"$
M[JKCJ('Q\MJLH#2BYM^8@I\)W6QCF[GMAZ=%7H>EE+PKFM.';/2X$3RZ12=]
M,K5!TF':WG76+DR+Y\J8..K5.E^D#]%>"C_9XG+9#9]*R;'(FK4Z=0B<YO<;
MGHS*$O!*2M:[%?PM;TKY,_3) )3#XJQ$(+W("JX5Q]A5*&<9X*A"_OQLY@ZI
ML6-BF?7>BD93)? @'.;W\EM%X6S+W2=2A(TR,3,I&CB"*[V@/!4MU"S%-BTA
M^8JF5K943T2U>3U-^1EER=NK"!$R*?1WL[EYJ:=L;,,JK=.E-7\H1;\'R]%F
M [11DLI8 R#M' MWW+"_I^5*1:-H=MV/:F3/O'O3_.K+X!%<+]@0]()4;%V!
MXCTJ$G03M#C[KTY0/8 OXSYO;,JHL=J2J+%E7?OVQFOH^>-H)P5?VU/GAE&M
MA(-D*S-WB@'DB4_QOX7QO0Y:$F*#\DB2 L@_$N"9CMV,\5*:+O T$.$B:;(<
M5N=I/:<=8\6*G6GD='Y"R735<7_5'K>FV_ ._7R6KN<8*\/A,B.6,E5ZKR0N
MKQC8J>?1=^+Y2^Z.!T5A/V6NX*KW5<<<8\O4(!-%3I#G+* 72OU1<+K2 FV9
MZP&@[XBSI[F_ED*%O@"Y3'892D7W"X0Y"<.#-U@/R2ULK76B?N/9E?7-9>J\
M=Y9JNF8R^'OV%<B?\4%I4R<P_$ *!/LH.NU67BNP^2M[%^[T'L+[(0MPU2%0
MI#SHZ8!A++<>CN1[#$<JLO])#*(@&9A=7Q>"$(_KCF-VJ?LK * Z^2QZP,D&
MY/3!;N-3P M_^;-=2=)L#FL*<K9(],)V\OEO<Y:F[Z.[]W-Q5&(+Z*Q#$G,5
M3?[QK,7_WO7'5%CE6C,=@W>?7X=C2\=LTOY0&TH0=>JG4:1]-3/7:,COWF@M
MA[O+$8<&\[$(F_KJ&4H0\#Z)-C M_*H',#0L?Z41N3Y8-3&M?7V_'UN(L\.7
M,OD7MK5K]C$\7YG@*L^N@GMN.SV7Y1WRUA 7ZJ9\71,B:J4K@P'RM.6Y7B?W
M;W!SHXAH&A7]MO8FP43=]8A$!P''9C<!)5%S;D:WP:S']SJHL6.%QRGFOA6^
M7I7&>D6^$DXO12>, 5"=EKH*L:O%S^$_TZ^#(-OX@X%OYOP%$)%Y.;J():.Y
MF%SUG:Q^8+2 \?0X+=5[96G&<'?@S'2)]?*<A"JA\)MF6'(^2\ ^*_IB2[-F
M=.FKS$B!%=9\(]^"_8-+,"OD3L+='15/%$]WKKEA32;#_V>EMQX -?I5/D'R
M3B%*-<ISDCGPK1^B,]?D!+RJA8@XS)VNYK"Q<'&6';",M@.&,J8T\\WD,;RT
MIOF28$;)+E*^V+:=U!E5),ZV;SM,DV 0+BV_+2SQHYEU0)B\W_Y%_>*F;)7=
MROY'IP]8"98K;T\;>W.ND_S9:'U51Q 0+OQZ9A\+6V=V8#^-WK#$LG*$ZA93
M,ODAWB*?5#G,SA@7#@\CN#C]C0>H')8B+*7</R#GZ1Y_WB %J+P0WE-]OK)>
M9CZ_FQCJR@Q33]# D5#M+6Q[-Q,F:76FG3A'>+"5;6%@Z.W!RX-I0D6UF[9^
M1@$?EG("Q70>$!BZ^OM4'N+#>@-BS[212P6%.C\C^R VB8P2)KX=!_XN=R5O
M1Q227RRZ/7<2V:ELL/43IC!)P32SA-/4]JX7Z;VQK[_QJ1.M/N2%IEN3DI,J
M 1 V;/,]-&Z;:_-O^!39GQ-65@(SP+K3F01Q:V7LHT^_5X*^K.".P<#?*,J&
MI>M.I.>G^35WZUFQ<[?\B2RWBJQI]+VBT>4LI%#[JA2/@-T=EO?HRG_ WP8T
MB!AWHT"_,>&:G:>+JQ:NFE3,@G/0USD%US:0"?.SK" ^Z*@<527PPWF9DG5*
MG^_EXK 8\P3+E3$OD&H]#;E>"] 7B/UIP[M@KI"JS3"Z&,8['%549F_=<C&A
MT[7%V0SG3,/\@N[7G/$##9RG/%5KDM>;QVG/M>ES$(G).3%Y6>)^1ON-5#HB
MBX/7!-K<VINWE41-PU7I6=2_YLNE1]7>[TE;=-X!F&X3P!2:GB'C5]&7 I4,
M2D?B$Q<6W>1BR4R5FB1U7R7L<3E5YBG_.>^U7A;XD4$YGI,DSY&S1.0Y0(VT
MH"@9!I@+A9S_X8KHFN.(S3@E73]EH<@'* .H*&#%V@9&MI3(H#^LMQU/29=#
M=S4/5@6/0>8R/PH[/(FT;U, %<6SHX5ZWU::8P>J8T_\Y>@SINAC\N3R&9\X
ME'/K- W]P=A]Q!QE]):/4VU#M'2K5]^*-^<J.-WTTU#NG:#X3VB>O8O.52O#
MQ/E-<_*AAMD#(,,:7V@#+9.0R+KV,L\NOQ?4D/Q)U5'(#?QFJ93=0;E+F%$L
MD)#V#4-,[&LU=%&]PJ-_=(P7*QL=WA:<,M DIH@4SP6'60M6V!^]8#?A)+.S
M;]B3).,?*_G"E14EQ1('V?K)<4>6I_L+Q,._3R23-A_BE_X H%E"J?L/P8\O
M:EMNFL^XF&"@(%!N ,Q!?G*K2B!O.GW2JLPV9CTA3O3LQH0BR^3YB6XOG#>T
MH&]D59+ZDAR-[FK>/;/J5MCVKM>WFS@3N*[6SJ2M_J%_?'V+ITCC#HWE9C)M
M;/@5D0VEG=?VK>2\[J[+PHNZZ;3TT*- &8':X7<"FRU-:!PGW1#)0YRS7,R%
M":9DAO#FR,I,Q-\C_Y"MDL79^>5>TBWR9+1^+6KJ?,S*#W&]]$(Z3\_-1'!.
MBJ^0BOD%U0>:NQ)#!PNOS0L"E]BUNQU[*Z5;2 7P<%9>)E8J"I16=@C]V33K
M'("+0LI9T:8OQW3?5[ZAZ:$Y?T^%GK?UTS6*<,%J!F8)TVQH$KL+EU6[H!8I
M0TJJ*CRAO"DGW-__<H(S^-,O^=[Z@%P-G?UKK+!!5K@"*Y"-<HYX?2[9?(94
MDG#(BKQE6H@#9SU SM?7(7^^YHKW6[9AJ8NR5>-F1A&^@@.7BM)"8_Q=M>2S
M]&D!CB$*R4<TAEXXNU?W.K[KG0TX8V^ +:(&VEX9-5T0BYA*) ;9OEYGF #7
ME)E0D0+$*11%7W&IJ.MIPPWWH7C=4^!*-_88@=E8&<. _']D?MNOP3B:T":G
M%-]!OJI^D9(XHW?6H$N4Z,.)T9%;*Q.<Y@]E"B:1IOCP2Q@8H3PEYI@A2<FG
MRY%[.B$KB[&#HUMAP=7NYMB9<)RK4C[YIE9K+K><3.&D2Z_D 6!I-#^R^$76
MZ6)$I,3NA+3;&:1VL-EVK7:IMH\C96'C37!X]:QSC>_*1/LMVO5&2HNA@]-)
M(.LA@>.?YB[AQ9IROWA?/R:]JI!_ GK=;WS%&R<N^?:QM[+6%+Y[AX3,RS8W
ML3GJ9[T'OY6RW$W4$G)'F4T5S.:.8)I+WGEM:#$\ ,@XXYWG?WC] *XK0D*G
MQRULJJ&-_@\ 7?'P6[2%87[WD\0$J5 <36? '2*][1O_7E$WCV$7J, _JP\,
MT5US:';[5/0B;ZHTKCC-?ZP"!X7,K3S)3_X4YV!QZ;[;\,E@.</JEOH2/^>W
M?=FGEB]=8@H<BE/ZINJ47@*1&?-E!R]"VYJ+^6YF&!\ ^,S$<N"CV<?W)<=W
MW:RU*5*JK;$V0IK B0%P>Y&W;S'+Y:5(T2US0C.EH05:CQBF?NS))0&2_-GP
M== 3^H7W%3 T9W;TI_X!HO8<_G2N2;>3BP5%]><RZ'J&Q>*$$CM8<:(S]HJ$
MXXM?=@&8A']3=5C,&D>UX^L9><N/6[1QJU/]0>NRSW@=8%?I!9QUS9*(J#7W
M&%  Y9:@RV_ \JIF8E^CMVN"F'<L.(_;3*+=KJ[2.!%H(>1X<S._^16K>C=*
MMTF_ZGI=29/%AR$C5Y#XM. !T.E9 !V5?0 <K3X \,33'H?A#>F5%!:ASMMJ
ML+JSR]?O/)'=4>FEXLA][BLY+-C50R.=;O^BCD>&_O/'(;G1R3.9:MC'UPJ#
MZJUU'G3I%(U)"R5^QMD3KJEVS()ZIF8+SD-#VK#N:9D[%AKHW<57%"KJ./]Q
MU,__.6H;JI9^Q-=_)Y^7XX.QAB?/:8G@;TA#!TIC],:/N3$UN70_!^>:O.$>
MBIQ<OE8Z/[K9!=Y?/0"FB^'+I*ZWK^HUD^#'/0G@?M5+EWT<+;QFQ^Q^E*T_
M8!1.&U4NJN$+448-PTEOR!9BY]\_+G8HTLM)^^G=V\H4BNBJOICT2*75"_+U
M$XS'S"^CZ $0!0T&6TBTVUAYU8YD,8,F6&JB@'[&.+O3-3?E[U"4THE-#G-9
MG/=C];!!\H(UIJ]4R="CKX_3YO?+UW^7>8KC8.,/YP))FV+%BZ ;\S(M6$%H
M#147P8 -3FKZ_%V"&/),BW9-JOC\G]88^/787W-QG;#T<NONU;$MVXCY6V<9
M=W%14IQ%SN9?C V@P_(\+%I?=\,K*UN?>WXW5+<:"@Q=2S4YP=AW^IFRM782
MNE+#6G\7 3:1:/?BYG?1Q_!1@*S*14V10W7+'FWUM0F/B@-+?%2K?-"-"7+B
MDFR?/6=<I#A;H<M+O0NW%N/>(DD!>$T$+G/D/'FAY$3^!=J*<UX\X:.8((:!
M'S1_E?L 8"JX\ P>0XA-T>GI5H^9:#4E#A(Y9J(KF.P:.CV.0(/X].-=Y$U,
M\4L?%T]N[>Q/\TXLP#)PR1"7EW1\A9X-M>">X/)1\_N7=UZ:"6\OA"L8'&BL
M"?TI*>@#(->3T.,?B,\XQA0+BYA6<=<:OKH&G=L_D]<-JU@?  %JA!OXTY:/
M]I%E^-(F%U'AR/5/77.*P8)P:-+V:5GW>+.%2QQ]8HE<9*M!&FS,$MGFB7LN
M^NU\\'M_>1Y)2S?8Z52.XE.M@L8#("$9^;)"(+%]F80KZ1O_@323X2&UW!WB
MHJ(3_(U,&C/%K3MJ,K$A @=QWA+^>IA@5Z#,1-E<?8( +^DF-U&T>I\G++:O
M&]_._+NW8[6^2\,DEAIR&@1%:S8#(P=E38YN!W/!_2DMQ/OK:Z%\C=N*W^]W
M8<A_<F+#ECY5&&_V1?#?>OP9JDS/$29%A_PFJ@T"]GSW+/]B9;Q'[VCZ>?<H
M'*J[8W*?XF;X 3G\P_IUO(PMT7::V@-@%7:^9^C@8V:%^SS^](>O""]4'NQT
MUU$4Q]*MQW1;]?(!X,]3K':G6OUE%69U/H=S)C#V^%+E'7/"GOD)!R0Y:HJL
MXH _I 1"T'R M8^)S!I^:@("ZMTF?' JHW%;'MH6;>UBL>;UJ^&;[!X"_0%P
ML<>G?I)M/5:L_\<34<#>^N$C"KUIZ@$0S)>?C[YHR!:%]%!Y %1-T/;!<,^7
M+PSI4HQ%:,>TG5!WZ6"\O,'Q5(S1E9,?TXZX=G8Y(?_<B28]NN<P"#6"%#K*
M))$EAS)OP?5Q.,:"W7EZ2/14WGWXR6Z"0#N" &MR-1\ I\3'M2T-#P#SM[/B
MJ'V36H.\\22?4?[J!\"76(03B+-0/^Z.IZL!LD)9QW \&G%!8#M^84L?_M&C
M3V(##V$/MC(B_8 ;) /_YE6;M@]- N8IIZX71'&'4IYXRHS3\J^#C[:*IZ Q
M#+]SB#N-Z(V>*B4[U5Q8':I )'I*I)<OO4_L1@B^6]A"C 37A1\ K6^*5:_/
MUNQSTNH*A3Y'"D=[00G5$U&47 6HNL.[H#L^!$?.1+[E_9%'YN\]N\=_W6)B
MO]=BV(GUO%J:[N0FN BZ^F['"_HZ,<+NGSXF]UR/B\U<I'LY$03-(_^^VOUR
MOJV%<U[AX'ZN$J=3W-K6?I)CX@]#S.@9A<25+LS?)W("17'510=&2=P9,'70
MO>?K;;]$D;-<9,H<.RBNNTUGRMQ_!M[)ECLOKZ3O)_$BG(DM]^M0I5LU=BCL
MO@< IT,M]D579] #0)(Y[]2ML&O#ZM$P?(_;%!_=&^3)H//@Q$@ -?1D&_PK
M#O6L+KC@)/^:;9S#U6ZL+ZK#!'F5O;P2DM"V]WX\"FGEOO( 6$\JHX4&-9(+
M#Z=9H!K%8A\ .[8VX 6W)OI\\9D#]C*2[P;LD  9")_W^NDG;:'E&DB8Z8@
M+3LW<AOOT4?XFK?0$X?0 X/RDTV)KQ+&7RUG\.G6M9)/V#X IO2*H8V/ML?
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M1:92 1LHCPS/4)H</M13#SZ1=4CHO/:J]8_A:SFZ^@\.4\L<M=]?7*O=OO.
MKG'64,+59'+VNK&\19;QV;VZ^XXP[I>;Q8G5$+7'?1%M%A"2:V<=YO&X6_?V
MYT& [E_B!+X/@!41)%[W\0.@EYC> _N-E5WI4GO,L>U1XK &?8 ICB72N+E
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MPFS)'+-JI'\&,%<XT@_.!@-_4=0PM3N;SQRW1NH0SETU8^,\25%>%O]YUS8
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MLA/)0L_G^,X"!^6H^10\4V)I &S_5LRNHUD_3L,Y.QIR2O4,Z$Q^P>>1"SO
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M4Z]L1+;WMK$7>39,O,[;>HU]<+_+X!$L2QG^RJ-.R\;5GU1NZF(A=_'N4!A
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M3V'*E'LU+>0BX"5A$F_^&\0V2<O[1\C9L2,$['O"4ASV#'B+&41I75EC^)-
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M>K(SP)LDQ4'XM2]8^[-$:M#VY?H8DM!%-W%1\I;C_<S*FKA;078J?SP)7D0
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MX$]7,?PR\062LU."K=Y\8V!%27K=_WXFDL S,Z%GNDD6+:PH-#3%2+5RQ+9
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MS2-GSMD$>U.<KQ",@L [W-#4D6)5&DM\=CQKRMU,KO';M<E9/HDU%./(%^*
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M!]$'>U,YQ?1YO(EY4Q%'2R=UU4JCYF7OBY6A])WG7[_>3'LIH:],:?[T&T8
MU7\Z#1<R91KJ3P5+WTXQ3 GL_,SK>M-2H^) %$W%MDO!QLXDA;H;<IWP7TJC
MV!;\SPQ>BM\0P+GBY?^D\&JV_T_L7U10101 A0#^3?\E94?C.O6_A%X2Y,:0
M3W+&_TV&*;\LC)D@-_$_E5X(=+YQV02HM-4*EU>"WUA9+$FE!PD+K:!2]$V,
MJUCA*1U0::B.![UX05^=$F>=&\LU5B3> (F2![0S0D:F**=-$E\[Z8J_$+ST
MCQO=#@'&"V:#/6G&K:F4L3<L\<IA3ZQTU>,9QQ0.J=I\A@K]P1A,)8+#F%+O
MHCZWMK\<) 9\9 :)OX-9RP?_(:O7I# -S#K?BK,__=CX^P%-HVR*I@GR=6[8
MEI"4(POKWKA8/PVK64BSL:5N8<%DY@P\*JU+D8Z?KR2=M]#-$GCR65NZ3723
M]T[M$E!C,Q1[/J!;R1(#WWO:Y>?1!K/2#*-J<]4$=K'8AQE1(Y?F= V,1VO#
M/_.@C;VBU]K4BGQ'GT';IDZ(G.B,J2=\5E2*B=.9PR;TH3#;LC2W*,5T:=9N
MZ]5$C7!OVK$P@55S=7!MBK3\T(7]7@67NM]7_,^5K57,B2KG!(H@.VQNK$W"
M*V1_#JNPRX6HD4)+U.<$GM3.L$"#/.9J3%\N"JX=93S/'@5%(1'A0<SD3 'O
MC<(5J]<+/I].S+34+I<\A416TB=="^5UP?/)J>9ZZ10C)1R6--ST-1],S/S?
ME$_97O'(U4QX_GC!;4MY&U(N#G)-0WUTH'#DJWZ;-+ W#@UY+IC99IX.Z^6=
M:)A]*WK%X.1FKM]YWI>Q;"K5EB >JW"47^6GS0'L-XTR-J7ER/DT]J.<%1WR
MZ2N.7C#]R9Q/O6+I8;U-L58( >B3;F9QEI]FEL>:;+(%*;7F%_YZ##&Y>%7T
M?KGZ.+@EC5-9<MB2AI 1&A5B!= B00Q$'+8I$W@)7=4=I/+_%C6%IT^=J@>)
MY!W;K%6(QIYFT7N^Q<.:JD(BY2I;W!T(X:F<_?PE=2"K@'7_PK?V^-7*X!L*
M-_Q;2@K_0VA"LS"1.['\\G3O;U?I#(/QCG1ABA(P\6283]VT++LMX=*R8GU!
MPZ_9R$4$D"Y<.:0(J[*AO;G)E+/>"0R[$XTR__*,I[?% GDJ,8"K#7/3OQ?E
M5H,AMN$RNI+QN$HYN@-U.<(N:6:H(HNU*HKEHW*L&0^@H0BC3O 6[$O1#1IA
MQ9-;G?#G3-?4FI)J7WJA+8$D6%?P(;;Z1>J;'Y*,W>U$+SL"PPPE5D+F*"EY
M/@7062#%GL>O2Q-S?2OKE^R1G,6[$X>01A85:7[].A'KC_>RJ)ZG?R,K[@3.
M&6>=-K>PC!GXW65^-)ZR$G+9SUGX?CG-%RL"*NGRIYHDJ.:5G(*LU-#CL'B*
M7_Y3F5!>+<"MWM3P_$E6S1A=GYH"F-RS. 9-#=F=U,G7 B>N4-O*716[PI"Z
M2&O;IRGIP6HDT=K1VKYBYVBY/[5%B4F@8"J44L+F]0)[(-'[?767^_X_Q(I<
M([)JJN<<H<_LVUS2, E>$7Z"=' $JD6&\-I_TAOR>SMS4B(JGD4XE7IK4\0B
MT-]6DI.O6*RUL$1(W1C"ZUW(K5B:#>CK'9.4O>!%2<CT+)FS//=T7I:(<C?(
M\G6<*%5_5O5<<&,]-W:".Z:>P7ET?<*?8<% S/=IPC-42$HHW;EN-]<J&T>T
MO?S "[J^G\2!XA@%+/@20(Z>J!WC"BMEEY:QCSF60#<@!2C[L]!%=YD%2756
MF?[*<SVH)Y-L-MOW(Y?G<ON]K+?$BP!2*EX),2& ,*NQ)R\2U^ZM24JK!AGB
M5,)%(D^Q2YOM-<PRN8IJZ6.Y9G:8SH=V;S$FB=I&#2Z1=+;_O/[X^DST# '@
M2K]5$0)R;Z<33"JS&+Z,8-9,$[Y/\ 6XM%%9.<+J"D*3"Z1AWW5"!DX-Q7:>
MFGTS1S*3S[K?G,C-J1K/_&:N[CPN3<0!')A$]V+?]>,+K1C176EL2E<T)(XD
MS!"9P"_2:/P9Z;#2OD9ZX6C?D%-,GI0,#\T,,O02F5&%"U2&M)):OT(5?_K5
MOX %[16([65Q>2,7>PB@([E<71-)0FJWGV#:Y"3Q?3AQQ%X_'1PC+8SG<J\+
M-7-O;-&-^73>4_8-$WK%Z54YDNMD]TTV9PE_!"NT#[@Y'+90>J*74/QGD3^O
M*C^%VH:C^%TI>9IYPM0#7?22N#7Y;;94-,_2$?!@V=<AKJ$:\RG2 LFJN23;
MUI,!TLXV</9PFLM3B*>$)(6C'A_@/SRU&2TK#N!+*DUH*D&T3^R,E5BW.YFZ
MA?34#T)V+-]&L+9-MIJJH.](IZ&+8.B*0FC<'N/7KM2A<:8+$D_3C[]O9;%"
M[R=MLQ*DOBJ^ZKB]+[BONUM3JQHK,=.B*=VU:XH=DTRM?\4J%,_O5YVK[738
M5YNQ ))M_#K63VI("U, J7QAI[GHJHEUE[>M\,Q!1WOW(P5<;"6Q.*Z+YL0>
MM!913#5)W60FK6\L?C#B@+ZII',0ZSY!>'R2$=_6K^:@(&"!W!7%0*\]]RZ\
MJ!>YX+F]HN7'SW=+]3P8U 8MR5:ZQX*K*M_[ZX/-(G@7EB-*#]498-PY6E)4
M0>/X4_\"6N11./;RF"D3+&3:N>>WA,XGS8[\GN1I[<UJU+ZSK-;]^66%#5"%
M*H&(IY2U/\S^() V#;,U:X@/$NW)I4BA^U*L9##,V5SOP;AP8##^'?,N(3?]
M0%/G%YO \,]YH[#&44;H2VP$4%*UCX265#G\U/KWZQ4Y!%"HS7UVU99_2.61
M*VM=52.;3E6T*-%M1G3W)60FC0CBN3',-& 6(IMFHAKT-+L<^B5D%I4%U>GY
MQYJQHL09*NRD$PQVE4EDVN)/7Y8W BG=><W4@=3\?*NJF3#.(96'#)./6UW?
MT(S_](!U*H79FJ]^M]2R5%5T/-M.MRV^'!;+V3NU]&[*C1]T9>O3O=S7+/B)
M "P2V\L6BG,\EXB2(L94B.S,7(+G<8<<V/*33.[,RGU67PZR='&Q2*9NFAE'
M=-1:4VJ<R0=%<$?S5<J&_@ISDIRM1I:HV+48?=\"8M<\HXX-.20].@9A%3F6
M2,-CTNUY&FK#3;$*WP4A!6$+9F3EH)$Q:\CKX%(Y*&*$&H_(U]]Y31_0ICW=
MJ@OAPCA_Q[I'Z"\OK08N9Q"<LPLKLG50^,,:I.#K5^WESV['SYVSK$>T716V
M_9ZZ?O=T7W,]B,^C0YRXZVM&&N"G'E>L8W6CDE?6%#1#ZESOU 67#&G,65Q:
M7 QL:.!VNF(NHR5OPQ![#<=,_.'VN&)+GNR\V;WBR>A9L?8H%YA<;G4S48?Y
MXS.<$W[R1'Y<.I.#IYL#/VE;>S5O;Z2/#[V^+QL%K7TYG$S-!NP;/2V& ^:(
M.D*C+XN:A70:6IIPDNDW5EXX<T#U_/"+U4^N0+K/6RWKPI&7^7M0./H9U,ED
M=2LFA._5.WIZ(Y.UX,C%G1SN.$40J8J>93+"EV <]9/+0Y+O%W:VQ5OV?P9"
M%'<L_1O<\JT+14VKXH:%W:(#6'QY\^T8CO_@:VP\W45)@Z 87Q00$$_')F*C
MO>+<'\?3Y,R'?0QV9VS9QWY@)Z2(1P 8$QS;C)%DOQP7]LL"PRAK%4_R,.AC
M$$ P(X,FTP%Z87+:@X#UH.V5K;5:DT6Q:4-3BD%D1^+J*6!^7C(J L7>:'U9
MEG!K/)%A)[O":_D4 ;B8P#V*FT,_%4MK:1Z9&7KL2?(UL2_IO5+ BX1$3')&
MDY>7>$0='MWYL(^"P(,@GOC$0TBT0:P/V>EDVQLR9TU;KP>OQ9[YQ\#,$7OP
M+\J1GP<?B]QW&S9?5\1>M(Q% !T7M!01L;^!!^EB8_M;=\S;LBO62["_(-/,
MDJS7]0)C_?;_8.\MH^+ZOFW!(H20$ ()+D$2W!V"5B!!"H*[D^#N+H4$""X)
M$-S=I?#@4#C!H?""0' *+: HFM__=H^^[_9]W3WZW=>?7HVQ]ABG/M0XI_;:
M>\VUUYEK;K6"!0U\OJH_A%/NJJ]>QAOA@4[N_IKM'TJ8=+[8]SH=UN)A3\+:
MZ_NR7XI]@'NPE-IHIP1=D]24LOKWR0G?P"N\M#?FFN YAK3V(EBTI*T?FG<F
M9;$1)OYER^;W "XF1TD?NM\"0-@;_A%3ZPW_)_/R$./6A[N*[>O"1@CLP%*B
MVS4WK]-8N+@@*DJX))LOJV<X7P8([+;2=!V^';'=PV<L9'+FN08>!X6BNF_F
MO4WS%JT1]$[Z ]]"<')P\7/^LG%9RV1W4];NSYQ4XJ]?0LH^'Q7$#O"A>.)X
M'N)6SS\MB[5SK<!/SNVY*[Y+<1:129A/'.OO85QKW&'YO"#^44N8HH];[%@
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MU\0F[UF[3C0#:4_>5Z=U6AE'K]55U9XLZ9T<?T,IKO]2>L;^)W*5BE;6EY_
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M?]T*@,SS:3]'J V(9G*N_AV,8,=[KT5+JC7@O">#O6] 'EU44^^VDMFY<0_
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M E,MJ9W)^S,\DR>"YQFCOD(2=6R51\";ZW-BJ/4]H(9KH&WND2/ND@[NIOM
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M^$')N*E=1H",<A_.^82P18R9#%ZT$!O+(.WYVY;JR#1F!':0NZ]*6V$LH5A
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MF->S9:4E#PF$XX+$K+,=T<X=U>71#>)3\(JYC9[BG[MNJPN0O<F 6$D\YCW
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M9L84/.M+,_\:)EPU:>"D*?E%HAF;.&#5ZR@WUBK=SX79W%'%YFL ^=2F?\\
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M 61P<GQ^V,([Y,^07S*E_3.<9O(J3:\;BX"OU+2WFW)=I@<J\Y>?VP?XFL?
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MOOFQ^$S8<*['E\M>1I$XINJ8Q(R,/]U[(3C1U=H/?R((7U'V7K)&M:*3]J=
MF@7?*_WF+\6Q&*\SX^KO 3JU:L%QK)W^8+HQFHV!HIQLD9E;;$<T8]FB@5?4
MQFJM8^GNO*>/.(KCIZ.=!4^-Q'CQ>?6GQ$]SRA%TH ;1V>_Q;RUH5'B!!EID
MT57A]0ZDG_9Z++VR;8G5QH2F90*"T/V=#5OW &H_%L_"_272?AAK,8P^1JIR
MBRGT)_.ZH"0N-GDWV4K0>6: 'KA;N,J!]BXOZ8W%J[$"0UENHU#>:(S+Y5)D
MD'&I^S6>1+35O VEN/+?Y71",:U7\D65U@$;#YM?AF_0_UP^UK_?C]G2$/>
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MJ8LUJ'J^H__9!R#]"CO1B)@#6\_73MR\V+8J!Y^DMLV6JCXQ&W LEA5\617
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MU[\>[<Z:8:*W9P^J+9'WBTMG?KW3RM@#X1YO?;SS6?KF#3H_^8P&FAHV]K_
MOK"[_%O16]Y;T9M)],_EK[\8(N5Q5C+FBI!U W8)$Z:X).DW%#8A3-O&?PU^
M?'E7I3NMHEV[4O((<'/^;QFJ_O^08>YH(4A FI7C8+L3/ZJTG,$DUUBK!"&.
M]J?T"BJ_!\8H%@AU[P6@0TIPUNN OF[((N':W/>DPWFN-BNS7.J,Y&$QWTQ&
MO:LM"^KSB(B-%J[>OJL3.#@3@K+G9D@*>Q?9##:KAM7T=',Z/_]L3'%3Q6J.
M]KR9P'FZ3G?TZFOV[TE!^! 2E]W3,P><HV?I%N/3J'T#E,5>N0T\ .8ZT01>
M$?\F.<7^%SI?=_58! ;;5LPB/FP8Z'C+PQBZ(TQG7"6'&*WU&\($C1OJWBP=
M.]8'K=GN1L/Z#ILV2[V0.*3K]N%7\5?,'4D^S8YC[ 8HPNRV'!9$F\P[KEFC
MG6)I\(;L98_ =:5(_B;2UUX^68:+XMF%T6NN*C?11N3@#NK+)G:(OQC_)(.K
M2"3T!]6Q*<42??PL1D3ZEW'Y&ZJ[JU84V/6A$<QB#=0;J;5A?[A8-.])U=6<
M%/*]AEQ[@RG9F?Z$7@CB:*Y?R>_9&</:<HPY"ZJ^:C!9;_LSM&&+S-J/+UP?
MNGC;%IF&^5&IF(\-XD9Z#D8\HY9KF'H S%I4-USIV4^(EY?$%3TE[&V)0-?3
M]C=:^)N0 '!-WU%8;1H5//<!P+KN7$7+V1/8+HMC^V3G]E/BS_-S2BS1($\B
M)Y1]#)\_IW7K:4&G[NM7(6NK^(O)MM0R=4_?ESD=.^EL.2\OA_/1:HKB"+FC
MK8'@#">(B%6:MH/S3P_ ^,G!<"NW-Y-1:-NINA$17%H;)I6]-@'%VJJ<J>Y;
M9* ]A"\_Y6$(/OL#6J&@W&@"8_@.M]70'N;#DGL20#C\+7S=-$1ST+B=)/DF
MY4J]DC*8O6R.M"RIJ>N-DYCYUJG-'FA1[8KUT:<06X:>5N)9\LX'X-D%J4;%
M].]EAC2!+WO4C:@3E6\X8EB8G+HPZ4H6Y?'.3^"N;?=:H!</P.H)<C3UE/R*
M#VY_&GN5,>5:("8PLM$6^HUJ9 ?NKM)49S.GPTDCVFC/NVZ2R+WY'&>H!O;Z
MZ '(VV/HRN^D>39MIK)-2"K_+C\%O)>W6EV4EKIVT@_]<!\!^A(IO^8>6@,-
M7242F(9I==\[&E@T1$G%L*M'!\J&?,;MW\(?\0.HM2+BW;0F4#:,2$#;W(9H
M#P!4&'P1MI& Q,E\ )BFKGP>/QD 7Q3-MMCWT5:>1-6<P%FT@EI?+^C-IS^Q
MNH+UB9:ZH*^55E>D2$>D_YZ%+*9?Z</F^L;":+%KQK 7YT>,UYM"8N[+RKYS
M9(RA169 DD,7+[(6N,4&H2/I\R=(U2#8-;+Y$GS_1E=K3\#;YD[4=RA-!&Y_
M9^^M"4\OU9O/#_*6M"^0-F84DM@Q$=AN'FC@B;NA][[;2%[&6KC/!%D\ '[@
M6LQNRN8W/AOREK[,>X)EE:W^/I0MP13+$K*;+W\%66'BH>%WH[Z!)B-D[_!]
MQT&599!"#\C: ] S%*DD,[D><V7 [K701(]Z%&[!*\$#T#9+B*XYAUT^  M>
M5SRP&_BV/:QO3;'&)A<^%UA@Y1Y5T>?4R4-IRDCR=AS#Q1LM<K%*_R0LZ[ZQ
M50!N=][Q#1J$H%W#?ZT2^F?E0+/.\0:"&UF)5SI\F%'F7,F]! M3&K=H0':
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MW>313J/]#*.2@'OEH5 ^WI[W:;D'PND)YGJ$H;GS/H]G*+LX3$1!\TP?P>0
M5$,[9RD3]+W&PI-FW$7=2'3IZE4;'4AA.L?R"<"2[<W-*O>'0+Z04\_32C/-
M?*G)=9>*-_T3\SHEM?A^QM]E8VVETSNA\_[K+!?U$R A?_/%$T";T/8) -!2
MC3<G(",_JQUKFBHS:?[V4*55AVW_.+V+!,TJ6[@5F^D=M+CKV</ X>9E\<03
M'^J=4VY8N8UIB\$4D>WR)H)H;B"Z4#18H#IM'-Z[,-@>/X-0Z 78?.?0 ^CL
MTGW\9G"4&9S8]GI,-=.T%67**EJT+"W)LUZ7[U'J]3&%[L]'DLRR>ME;QWR1
MVEJD6-4H^ZH->+C+8(]\&$(#= HJ,:D26J'9N,T'#"1//<O[+5TTD(\H(6RH
MN,)>AX6]""];Z^QFTIG<6#$?L?\[_^%T$F;R8/3<K(RB=+<3>7Q.)=%7H>_P
MQ !D/VI'&<I$.&J\,?::4"HJ:R2T80_YS,^P$7(4;]V5-)X5VEUW\[_LF_ZK
M_.>25_.U<==L2N[%2Y'&8:'_CJ-/?!MR6JV4H-4X=1G<NH2P<!<C3,(4W;@O
MM@ZG>-4W*G6MP6C.E2NF-?;>EE?#I<&=+YD,>0WT/:FLQ;%9*5"&558D" =-
MFK6HX! T#PJTV%Z9GY248=V(K-TBCV0,MLP5U?&_H<N_4M3-K#U] ASUYA-Z
MT9GQZ'UEX?RA=3'(5+5SR:CC9*WA$JHUN3LZ!6',EF8=T6;PML*1'1D&C4$9
M._@2KGN_7VH^'$.5?[S>F74P7YFI+?:]12KP-GL@/'7X/;+$1\>W\ZAV_@2X
MUC@I=K-.0DY'_RE_W\I2"]SZD; XCT*75</[7[,%D5\4=I/KN;Q\!L5_3TB,
MR+HLI,MY*:3IKA1"MF+_Y:_'/_^7=>__@RJ*:LGL/^JF?*HC%@)G54+D-]"!
M[4G>"UQANX>9M,C-;U/N&2+5'AF'GP!KA0(4U^F,A_-E0QLC4#[+^\<'6%QH
MF#OEX>]#3A7:  ^3;)>9KJ7=V;/E3Q"^,N4-H?#\Z-O0A4(L>2V>""$.%]U?
ML^@6[FZS!(,WI4R30XY/ /<H7"@.NM[NLP=1[^]HD>NGVCK)0X+,2@X'P@F?
MNT\J4[?^>EX]O5M0>DP)\7N_&D<3*(H6(]8>Y[O[@53T[=(B/G[5HM8P:0M$
M2GLKSJ^H8%]2$$$BI*"<=@9D!D8R4Y5Y*0951+$QJO9U\K(:3.]H B(\&)RV
M1>9I6J!.(EPX5#?KLHC=VXEXPG%I54E= QGYW>A*6/%=%D1/18.;9JPW:L36
M.;=RHIX[0?:<:#M'[ AOHQ\J?_NAS"/;NBC+A,Q>.)GMH//XD7$"PK4^3-M#
M[-(RP9K=4K\K1<(.%%,<2-=G2-%8PA@FOI370@H7XG51;'=6T-#6D71U!V):
MZJ<94%S24GRXIN6,L=9;/-DM9QIK,V-%LE"5?EFUM"<:B7>2A9(>QO@.J!AZ
M]2I7<D.2RC&&!RYN:O.=X"NA'YPSJY.:X*SBE15-,R>[)>U1TM(:QB;)/+VB
M[*E8'?4BK\DT],GC\'<1(O+RO<D65IF@LVO%>T5YNSFFY=[2<2T3/QB+BTEO
MC"NQY?7@HLFA,^/6@'C%[HHOU^\)L])?=&7NW<N"8P^HYM4'/'L6V][%P? 3
MDK#]2-G97!LLV%0:5LRJV,Q\B62*ZZA5LG@;ANR>C&B+ BJW.P)>PMK*:S,O
MILF8)X!D2^CU=,,2T99L]HOG_N#0B*-$81P5T#Y;Z-#!;(Z9L&AD/=YX:QC8
M_C( ,U/_X\["^R(=X&.VP)MR;>;F4?M<_M2B^>\?L-)OXGYB%E(6QVO.E:FX
M!>!..48KQ_DSH@4J1HF7JD[5\LN0]5@,'OP\8J9XDY-DC%(DV%](72OJ2I8-
ME77AZ]G*"N%BO$(B<VQI^@Z2.<Z_+*MO]\;SX-F883-S?@+LZ5EQQQ9&R@D*
M@]QA\#**X?%UI(FSXZ+V7FRW 1FW&$N&,ZPSR-1$D4L?7 WOZ7;(=D(U=[\[
M_% %+\"F=##3-C^=FL?OI;A.:&9^.#EOM)YH 7T\0TQ=M^3C?V0Y9SR0Y)/$
M'ET5E_,$<RYJ+%IR-6:+XNV0,=P^KF&B+$F:W]B;J[+5_:::W,"Q% H(0;TC
MHZ=>;K=( XNZI@>VF5HCN<0<,4<,W6N-V*3/8W]7\.2A-P*&X.WI!;8C4=6B
M<S6HEXXF@U8SKNV6O(:)(95EFW6MU?$BNWERB0]+XANZR2 ,0^4D&&C=2 SX
M(?T,#_KBK+E30S6\]?5MMLA,.<7DH?5A&K!6BX1: ?OGRF(0BLU[WO(>Z?=E
M'E3KR#CK[%4+?6.CP+%5\"0HP#,=4Y]*2CHY^X&X\LZ:2"]?@R?T-J[5;+FW
M8%SN][*(IU5L.WD,#1$:@_FC-M=;!R_X]?7#F^==K"#J[TX ."(542/;1C4]
M_['0U0=;$ULK9F<@^V]I)KO7\42] YZVD>C.M?X;%B*.&0._##L&R6'BES20
M0T=6LX_:$X):5?65W2+53M!+'B$L'==E@G@<U\"U0,%@I+M8[7"PCNJIL\*Y
M]<FAVAFGOO)]83LPUBMNKTK0[;VVLB(2)K/01N]( 9]ZP)=1W3;8JS]I'J;N
MB(OZII=H7"O^T&3[W_YAT');Q'\^_BY6K?1Y:IL+54J@H^47TO-F&:#W>YK0
MGS@B@I$X(KE%A%MB_<$!-'DT:LT*+"P[6<M3[:@TR9;:]'+LO-VSY<IV*\;L
M Y^5S:X=0B'TW]H6G74?7-(/=+Y@?N[Q2M]T=XW8^J%0[WW!YTI]4S0A*4D=
MIR/)N/>6:B,;$"-5-IQ$="'/H<IO8JB/-OV&"VVJQWRXVN&[<9&&7U-&&G9B
MUB;KS6P3##2$4C,L7ZVB<!,7L=>J:L?OG@.IE\SBS[:-,I,L"2. 8E3:&Z6(
MTUVLDR5".R]*V2U0['<BFP]'DG[$O5?_=J43KF)NB?O=)R?6=RI6Y4.?2U/7
M!Y<$E'?5&-[+P$W5?9-#QHT[B#N4;U=_7X1K.8PI22"&K9^2N13K@=*E=TTW
MWHMN.JO59>W[B5K_V]Z/GL67;3#DA37I%72OD3U'ET"N&4?-"#&$K_Y;WR*Q
MO%\C4\V%/JP$"R;+]+8]O(?R(#6-IQAP76L_LF9>/N*17'1;H,7*4':BF:MO
M1OL5^?93I_E!ZC4><P7>9"]Q8@L>%]:L]AN]HK\E,!J=4NTJ:/SF517K3E8J
M:I.&?CN]IDNB];8T]6!^1?*&V5IQT.D:Z:WD-1+7TO.6UJGWWS_B?DQI_D9(
M%@P,[3HM#[^T)IY+;B&&\?<E!"D/0$S&?YR#L#4=*5'.6>=/8#+>ZPF/8?7I
M]_3%.6?Y/=:HM\1KI=;6&NMW7E>Y2:Z1;2=V\.GZ'\K1'W.>US2J2_&U\VUL
MWL>D@-3A$7]G7%US'TMC-FY$^622^VF[@=E*2<%AZW_FS:C0\3$JJKH5BW'D
M\O);EO.!=F4EQ^<^RXDQ9^R_ L\;M#=ICP=2>18&K Z:P!\^+"6  AR$4&][
MU[Q)/]?-$.2A;N^9.+5J15QN!M[#FS<:QAVJ_H\.PEBGT+/-QX('\EDA^?II
M>0[P^PR9GU=K-\_+3(?XS#AV UU 9X]@?'GA\BT&$68V_99L)=X79JL@XP@W
MNK(7/4 2 ?K5YD)FEG)J2 LXJ*Y2EBWJ_G54!O1UDB1/A97SI6J\J6Y-@G]M
M<:Z?NM5E5B_*S3B";/>?$Z#;[;M"SEE.=%/_&Y^!?3M"LN] *6(+&[/2WG'E
MDY/2FN;W5F4[D3/S>$O4D^^4Y?<ERYFF06:C2&8W,FB,!?L,& (':K@4]]9&
MH%PN F:_X4.W);P>%];UG4 /5]KHO)5O+3U>O7:M6CGN&!&WK[53:9(6X4-W
M(-H;1ZB_ZHJYJ[WBNY\ TQUP9L^^EJ,X[<%$PRMO<]E7DC94%I8JU","._4R
MV2M!M)=Y6<N%S_/&+W3P]"2DI@W?K-\[9[G;W7S1*OP\?]SWN4.(2J6B$?!V
MTEANC]98D9;ZS;@6$VYL8ZI$]/P^!HU54M@?I4RS8L+&T]!GR^*7=AHG4D>F
M+3^2!\M"!X:0IJ*5!YF?QTGP8Z@Y7U_10'M<H A]']5,\;Y&:A[8@&OK:L@I
M/BIB0H8#09EL<RI&(PL"EG_,AY :V(U_2HJ[]P?S+2]]!.;=*-ZK:J^VA::]
M.;L@O"P^7"I8G(DM3Z CRP!"0$NT>%_8->:<3+1%\89=.M=I?%<E\*XB/I!'
M]QC4"^NH_G40OEB.A[X*^@?!&K);U6>PB?]O@C73)\1>XVF$9[3?KTIIYF>5
M0MV+U2DB)3.%DX/)33 D'HK '6UW6#7_IGU3$VJVSYVT>$"7%>MH;LS,X_CV
M;Y>/-*9P9CP*QC$^^/^>*7F89E\*$%B\;*YRS7N1XC]K7FAP!Z=";RXCU>25
MBY\3.4X=6F2;B%7FE5C,&3U,\OM\29?4*<HTAHWS6T2S!1IIB1+,(/H#Y3CE
MB9A6W");'"_5GO*APX*GH)9P@#-)I3&3[+J,6@9:L >C$<GRMSR+^I$/#;%.
MC'H 1"3XJMQ838L2<=+0#VEE(\/@3KQ"83Q'A-:OA%4N6#L['/2@S_KY]>HJ
M>*_Y^FF=E.<QUV*5KRP5F,F&RXQ4'5ZBD?=O%^^ZG1^8'L9/?BQ^L$*<O!2J
M@<NVY?F]&B,#INFF-31@\O2Y*B+VJN&BEV*.VR1W=,U&R;XJ)3:<Q=8L,#.2
M\%TET$,Z$,8LLC](\JP)?&]-(8Z$X!P.+M6,_)0HDLV8N3M@AZYHB?0E1I>M
M1(\5M@I3@K-[KV Z(S'WER;"2[>),8 R2C; UE<4@!N#:#I']=).2(6*'*BE
M,"Y,A'_//-?X6FM_<@1N-($X> J*Q=%M,>/:T@9U_M%D?2]T^"8P59PL4TS&
M5.ZER@5G^^#'TR/][*'>(4$7VM#XZ"4#A2&GHO 8L_@;9$?"&'8ILN^%P!$?
MZCQQ/JGCHM]&O%9\BKO/?A"AE0)'^ V>SLC0[V+ZAB2;7JH1O2Y/##KX;J4I
MSF1+Q4&H5'7PR,<@<B]RXGJYI<?\@2> *#:1_1. .>0%,  @B2N)9D%BCHW[
M5=D%H$0<M""0HOY*8/&J@9H.Z+.=6W\!B;L8,M:!J5%X:\3X,/[V+!]\ DB_
MNTN__$7B5<LY4<)6$VD3ROZ%0XGY*J<)<HXS<^B(J/J]"+.0*UN8L.TTMF3R
MSNF:(.$%[P4^$^L!>*:N@)JNGQ>7$9$(B6K>!UZ82 #%D =;R^H\5Q(^A30<
M@]XX@#8B.QI?8DZO&,U?IKXV< +$\BH&%[9/!^]#!9DLK<53;@PP1K%[@?'C
M0)/1G?"AV44!]QA;>%A& FZQJ^[#+MN$#WY!7@+E(O*7;)?%S6S<><_*NO*_
M[IPD*;O?\%=\DH\9L@%<9<"AXB'XJ%PB<=8F6ZS+\%WO:K;;O?UYJ2S6NQ.N
M$@<P,1>BG+QL%&@."U#GS_(;$LIP*.;F.3.7<QT+.K_PT4;9632I_:*L68#4
M)J45OB%P+P<GK"<)V(S,2F;2-TWC[E-!^#+I/]IBLN=%6C6^[6HY#NE](\V!
M8YNR[L.T9#-@GEKFF\^Y8L[=OK.4.L'! _IH_CB_37*OR)1\PKJA_EC=M'CK
M?LTTC=IW16_277-]^L'W@M-H11#JJ[K/.!AM8DG=\_[M*XZJMXN]NXPBWRU3
M.#HQ%L+ -?TI)W.O3W\5IM91<4_,$<VWR-8:SYG/JE[ /29R04@W4_W2H3NE
M9F.(2GRU1T-KKZ62>"^&$C *P9U)TT6J35N!:5LL+-D1O4HC:E[P)?-+HJ[P
M,JAWT>\&*D8YX?!Z"DV,NV0=T3Z# C8!,.6OI(:B1A1Q@1](7Y5,G?;$D01T
MAXN&C XA Z/7:Z8_%@#T, "X< H[XI60GX.".>Q]+DR[R,7FF;@,/D6( %*$
M9[Q[HU(E2G)B=<@;#X) KDL>&46299.'$A2;FC?>4'\KW[1_V'VA%E[8WGY%
M6H2JJ6B>0[253%M2@GF.)VB@:ZY1XKR-JLTZ'(P-W8D"B%]FH"<--K5.XV_%
MK$BK4RCZ,B6@-+><C3 J%*_L8YG5#0MVXH7;_J*&_8#C.V9 !;PA\;%#$'=U
MQ0LH27A=UY=-9-QCGA=7)E+"<<?VI:BMF]J0_IYX[& V"9"=9Z%R7W="+AVP
MPTHDYQ58_H< H83UNQ>]*Y8^"I+J+-&%F4$+GY^!MJ386:?1%?9V@K\J'$WB
M%V8GE]/$Q!\FR=)+6_*.@B/1V?1K)RA/PHXW9G)J6R1#?()UD3A'[>,B!P6A
MVCJ8\/U!$J#%H9H+XK<T\S[X3KU'&"15G+N@JUG\6'=FM=1D&4RN.UBJ4R(H
MTJ7*?8..7A;K[*"TVB>7Y85$,H:X9;#BXB>M&1_(S'*]6=C[LQ(K:-="@YN5
MN)K^H_!;66MSR^ZN/]EZHRG#'4V^H61)'&XGK6-=:"8;"V+_9'NP51CF=#KC
MC&GJ)0Z/-_!A>",H-2NW<FT1O/,[8EG3A&CO(4+:UIITBA6W@#HBD$@S,P?-
M*/>JY9QCX7-L40I.1 IQC"E50TAV/%<\]WX9'-)I04D-U)*//7ZLA*&7FNY
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M5CI6+B;EG@!M!T^ KO$A*.:/HR= />?*_2N-)\#*UA. &/0/M7706NH#\Q-
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M"W0EF/6COQ"_^\"TL0CGXXZ/V,IKS-05&^-*G72???U](KU[&2%^?43PW(P
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M5C2^83U+A(6Z8Z$_"WC[^DEY,UY].Z%LJU=?U3_C$6-0O:3,RPI\\P.\)8R
M![9>8^9;/M7Z$6/VXQB=,Z#"TT+?AZU,@-; U<F*16#O9^J"CH+P-=ET51'>
M1U\?1 1#<SD+12U@Y>)\.]+IL8+:HPME^=[IHL@W_'U;6QZ%?5_Q25RXMQT#
MIQ5^HJ%?AOH;,#NI[B8T>CGECM*LA3Z?K\&#!W*+XC5"(/&?N!.XH:!00P#/
M9!*@SJ6_!'@K66;8I+8V;IV(W'/W>A#FX65<7T1_G%D+&&8734LS0!C=$<:A
M7\R(#K\6+&(,ZV/&Y;P0?R6(%HGK54MMQQ1,1,A7T6?T'C&C:=*2-55C?9[^
MMPOB)W3P2,&GNIMW2[W;(@R?$WMVY]X]=(LXYVGH5B4GN^PP3@X1=<N22*)]
MI1+]1(HG!LB-EJ9"X%<+1^RQ/1$./BI9K08;0=@ZVI8B/H(G<@4Q>4LB6(7C
M>PX790NU=;C?X<U]?Z@>_B:'UE%[VBQN0Y.NV-)@XVQY(57X@& UHU)9J/N[
MZ6UN< IV?)(D?!;4,6=*0-(LOT<]1TY0;=6+=)@S>0[=/)\FF[0(R"?J]/()
M4$RXL9*T6EL>W#OH3:$>Y?T:GN"<)"ES[9&@*QV'^@D0XIC;/474'O>C%_X)
M\"N2@&JRU($!8S:Y"F\D5NLVQ.SKFQ^>"]X[Z:!RV8&&J;/X[/6PK9J*4.<T
MD8# 96[7-^?]Y8JUM[1K3P#D^=R=B-HY>=OTJH\+RBU58COW=(A9D-NEC%NQ
MI4./UVNW>EIZ2Y^37QBTCE_P3 <+39>X>F]-6=^A3HV>[OPBM5;2K;5PQMZM
M:UB&F6&R\,6(V8!>]^9:<M>>CJZ!\>6 ..:%O4D2/Q"O%KT^/ '@7LXF'NC0
MG8F#<X:O-F_>[5 *'/IZKU*]N!^W6/WY%7RD$=X77:[J],H?]M([5S/,NSNA
M'RESS"5Y(S_40V[8VO )\%OEZ%=DK] S\IP%':\W6H!05O;MB5BTXU*.]7O=
MT^V? +-<B[M>>(W-X>@<TE^1GP )8166Z_?G/&V5J/X'VO'II]LKIGREBTE!
MC_Q= F'>T$W2X2< O+Y@D6>.6;&HFJ LQX0'EPEIN]\\,A=C-Z_IT>2PD5"X
MUZ;W*25CX\3#BX+%M7(:L%18>8)E2/Z#=N#T#9SF@?91;FIKNE7\=86X)3P:
MDUR&J/PA$GQ>F:OR-V,Q\)H,JX@W]_S4FY3GSNR1#+Y<[DIQQQ LU@EEI%E8
MA/\_)%L54KP'^A,@.KLW_>HV_9[DZF!Z$_3">]/T;.?1BQ86).AVI1>ATBZ*
MJTCXOS<=Q?]4@1/7>0)$D64_ 70F_D@[K_Q)IA.-(WO_\+R_?I"ZC'"'";N!
M']TEGP 921?>OV]@GR1!!^>RCPATX*[/?]V9&KS[WQ;<[-?NEB3SZR8#X1^>
MQMI<X=;\4PU2'5VIFRZ?%\)1ZT\A='31S;/_F:OE[@B,\WRAPPS5U;Q;>>E(
M,")07.Q\#SMEA0W?JW*_U0E_Q"Q<<TL;Y>^0AI[INE?VPCIN-"%OUC6].,@R
M8AQWML,QTD^)[XU;%1Z_TS);;JC9=@@F[^S3 *',GIKJJTN[XO?[SF<U@NE8
M^@DINBN$%<]]4G-K\T\V&HZHKDQ&>(+#N5N29PFH$1B%0A3TT5QM<ZG]0&ZB
M]V;V0!C?-"M4[[_24?O 8?7-"7= %=I[("GQYP(9>6-^, 7MD?Z*!.CP%_C$
M_44?R[+5M_^,=!$T&)R">031.?JMY25>[9V6:0H&O->[ L5) >1]_S@0G__]
M&OJ?R*GR!D3\P&JR;OU2^P"'LK?8C*ZDGN0%DZ@/76\K1_1)K[V.)\'A2;'T
M&M>TU\JK*>+)(XO<GZ,_50NT?T,77'OXSDYT:L^0563A!\T/<=X<B8W,& MF
ML_MYQSE9,K*&^+Y &D:]=8 IW25IO%G*'O)"NM69[/1Z53>S(7Q?5P;D2*OH
M*E.BO#<,C[V\Q%M:6!0L&:0V00/IFN]XD:V#$ =-0U66>U5:ZNHOSQ\Z%KVH
M9[:8CY$B/"1NI<DRSQ@EJ\:P+:EFUBV"@L%+"WBT0U2/*6B^![VY!B[9JY8[
M@;6RF!U<O.6'M193E5 E6[QS0V, XLNTC!C0$@C<0'\A1*^-(W8 0A>K*+=M
M5= .:@,H X-'OMXZ%V@#/L_PQ#N_,RC_2:N\<4I3*+D;F#.\Z[  PC0[-6TR
MI%R0K1Y@N'$BU08[T0I,6EV&L>*:59LFI>AX1JR0>.ZFWVK+ZC-<UV0Z2ON
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M9B,IT@O85]HDR#=Z"$V1!,)%+GO4K!\H?F($P92:K9\YL)HV[U'^FJ5EP E
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M/3CI&?,]EG?^W1!"NIJD0=@60S>,<K.M;2/VYB,_%SG]X%O&(GBC:&H]_^T
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MHW]T,/2G;JHC<_3R"+$S69%<LX]W.83N@&>PE6!1W@2!V_>*=34[^J?ITUN
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M>F-Y%>1C>3@0OX45Y;C^)PG%!1NS71&88@_W!7FP)_/J+P]W%MU_=+-AAI-
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M(_'][D4B'0S?D20]VA77=(6=PM4NZ5 AUV4/WK02F%\#WEX#2 [LSK[78V=
MH"&<Q@AHU?H(\P]GA S^O\X(G1B9^D4W:]!Y?.+1RVO ?/&WR7(&E;;0=:^G
M\ZQ3'L D]_;[K.1Y!@K+5HL7A3=/R[5!GFVKH[7\$%Q&1S)YNW:6/LPOY#=>
MFR7NM A"/52\T27=5XP:"9/F)U$9? \#56OW?V!!Z\$3?[15*(VKON=4WM;8
MZXR_I/^M.TNQ+@=:5#L?X,>"+J<7F>WF?TVY/6OTJMZNYC0>J#%K3P+3@P-O
M^KKB%?#OB9YTV[@;[N_XB/6MF>^,GE#5&I9'/QF:J;SD$MV20^M0"QI^91N5
MX@NKZ>IPG_T#7&M0N=3,SQ_(Q%E< Q1W]E@[*[Z<>"ZV1 U!Q"&*LT6=<@G!
M.J<%E9-GJ=_:Q?P6_OHH6 -TA!!<674K2\PN%J:7%'M&O.Z!"K\8MQH&Q1B@
M=)YE$YVSM^&X39ZLY5\,J9S;8QZ@:"^O:*WWL7RNBP-.?^H>*?"TBU:>Q^YK
MK+W\O#H?U)V6%4F3P6(P;XHXA)$03T%6[81]8CM2M8'!EVIO@H2'NV+_=-3%
MCI'LMC"L1_*%I3F$K/]XZ6J:LRCS(?TK/@L)OAB%]I/4JT3=]KLGIQ.^0J4V
MX4.OK-K=;"BN;AXRTOZH5&-AZNM5]:4=H=1NPT>U_935692HW2B89Z>TT'-O
MO:DGQU!9]*LN(U.QX#W7_3O"O[62W&SK(32?K9WH/D,I6D\4O9@M$BAW3D8W
MN)AJQ=Z;G$56T$<?!EFQ]-N?71SD$N4/LUF /P '6KETS2YS.UA_S&$:RI3@
M2="S6)BRT7'XR<7C]H!19%,# 8Y3OJQ>VYGG>" ;3T:G-T^3WBCN_DZ)AFH]
M:WEJ^TC+WMKRETIT-(I>TZ@N^;S4@6)F'0EZ(KSSZI576FX%:'5T<]C%A)SE
M/IK=2#IV=4__Q_1&Z>IF7"80O0.*YN?WQ<]-IXANO[=B<KK'.!+0=)"LY1O[
M*W:D>;<_8=D>S*>_DMDQ77,G^_O=PX>\C#@ 16=M 3X4G45BB'F&$GS1)QVJ
M)1GU1#^;.4D(-PSO*GQX8T#2*S)=-(:/Y7!B^L '/ M7Z]CAP+J.@K]8"OD'
ME7)5:X5*Z'%W*9T)JUD]P@'Y'&ZH]+4SD.1@8G8=%-KE*>FX\,2=:6X =G+S
MPB;.;1P][ QTJRR#5-"FZ<?F3P$F387O.*LFD@].H/LU=6WH;N2*[M>:@XWD
MWO/'J6T0GNDM*%*UV#U]/7KY\I@L30NCQW1+ SHENF.\=R;3@&YS!!+L&#.I
ML'@KL$61@F7"$,;65]8VE;:0JMC8O#CPL7+=E;0<]AJP''\"LT;F.NV[0OZ?
MPL.U_RT\O/WLUC4@41[)@6V_!NSX=?L]R^(]^$=1HK<V?,$4S['0D_5<=%"O
M8":I'1/&O?*248D=\BAVY"=:*_<'""[:E?S5S-/RXRPKG=RW&,@]RIGSSF9G
M.^3DNP;@WJE8^&$9K8?+IASNU<]R@_G2^NZ#]Q8 <@U8X!_3:X R:[P&*)FS
MO/CN5J[+*BW/!&*=M\$P:G'8GML+AXI[UKNF["8\BE&H-E+J]'9(W@S6SVN^
MH51#9(D"[JL;7LJ7YXTI9T[VXL]$[^0L+%4AXGYJQ0=<DMU0ZASU['ILR,_W
ME(OB[4CV^%1<7M,\:^@U0*.Q,IG_TY_[^RLL_.)5N<ZQN<[7 /+Q=;1=MD%?
MQ\J$7;$]#!TX](O>"+!41M%#K]>*S10G0T%*$R;H-DAGS^T?<8.SG-$Z7GK:
M%4]ZNTO!V(M$Q?%2>Y9EC*2#;@56#FX3,.2K7DFS2B/)]!XA,JG ^.'R*Y0-
M@H =ETNWF9U75^Y:.&X;CG8I.7.$G1C).SMG[VE7]RR?58=PH;\#.YM^:+G;
MZK! ?*&C:0!PY#7@T=,W#$GAZOG? XG+A;%IGT#5]BU*O/ /?F\9=.<8"Y^U
M?/\'J!J(Q5;6G+-8+':P9?H$LS="0[V]?Z^2BX/H@2M&K":*:T<C^TXJ#884
MG2F?B820.BKV(&-T7%7>8KI/P9KDKT'>0RR!3M:,4731'$83]:I'I+?XX\Q"
M8L%O)L-\E5__%53#;T#5R="ZOSU4^LR,#A(O#.J*YG5$JZHNW.N$][Z?C"K(
MOVJ6 N._Q'!> V)/3F8^MY/NJ$,*VE$$7"*0"&'9)Q#Z/3Z>;!1Y3V[^S53O
MWI#JQ3:)IC\X.T(''XKT?6;W-_J[4BX:.C\^>'2R-&^%<;&3K91D&CH'DOGR
M'_F=A.I2W-@F'2X6S(O2IO_ 5<R_X"I$!A@MU).FVXB^6E,*]ZQ/6V#7=DB'
MV]PE0M0?EV6KU)*C5'KI;P:WI/*&5]?^E5>-VLBF^<'C^7O(MSEN HI.NQ(*
MOS %^%D-KD^ZHI;UPD$_="<R#9IACAP"HPQ="&Q"OC#5T7Y;@]J8_"^P55;"
M>LG)L/:F)+8UZJA\ZM%?7@7^*Z^^91MUJ3R"H-;UK@& SXG9.\8",>]YS5LB
M)E[+$L^97"9>Z%BN\4CX@I#GG3-()^-QOF^MQB;0DQ$0B56D;9I'%X@91A)/
MOD&M<^7<^7*) <66^/ZR\EQX+QA]X5"-$:B/#SM\-/W0]##TG[#:U(/*^/X7
M5FO^#5;9-,9;"N8KT5&Q/=$_?@V@9W.'H(3KM:SG:=9S+>LQ4/916#+5J"_?
MC9:G>7<-J&N_%-X;DV0QQ&9WX#A7LI+MZ&(FA *S7: PJNUKP U?;\C\6Z1W
MZA]KUJ*?$5Q2_Y:)4'D*H.Z0\^]G)#G# ![VW7<3JG@3?_/F16Q=KHPR^W6I
M!DT..35B=O5+V9,LN;=L>,P2-*:7\8$SF54#%6YD.8+Q<7)2"FPV@E_==#2F
M=2TT_$D ^(#/E%\!F82 6_ZO2!2IY+F5+)B#F)YFDMS?<26%">V*WDVO)Y8=
M:Y?J?5P^(YGE5HJM'JRJ\N_H/<SSW482W-<?\VI3].HF:[C 5+AO+TH4T%%M
M=B%#CGBB!YG;7ZB"7GUST:2F?;&!_UW3PR-.M].J(<DLRKDQ6G,2\\:T:&1L
M8<C2C2&V[Y<YBI*XE2V<[-,1O[1:PI 3H$@$S#)Y2EI>O;CD585XH?D)[-G]
M43!,O00?OX,H*Z^7S&E#CC[/^X!V&/ J.MO=26CRN1;7#_J)HTT'=EDOG:QC
MVEMH_ A \S_H1A DZGJ1CK>]2?H=]_P20",FN^]P&//U'^<O\F5E@B6TWD%I
M /VG!:4'CZJU=<WD@QA_9--)YODS.3M23?%0CI=4UFLYQ]DR&/&.=-<;+'23
M0KSNX5],IT4.I!R(81";MP+NJ<U.9=3<XI%RLW7X^C1#E]^[ZS7'\>V\O*&A
M^(0O%N !8CK,;T"T>,.TA]":N2MCXFG19?"YJK1DORVO!4>V_#T*L,VG_.9T
MR(*]^AQ%<YW1!BZ(RLK_F4UY07_+JHSC/=Q]T@<0QNF%<FR6W5FUW=D7W.0U
M0+R>?%EH<D?[*=Y7[^6O"P%5,4[GK"^U" )B&E]T&^7H3BMP9E)OK+GE9N)_
M7&[&EZS1]*!&+?]"#MR)[J&]S749$0%3KI]DM:C7EC%/*&7EQRIT ]AS\V!%
M!A="W_"L0<TNC9>(4NU)C%"^310S@]LQD0+C']:=#&B(S90Z:9"XL8%LQ?'6
M;77=2_.,IWCZW;K"%[Q!$L/?56]?Q6>9R<&Y;*M/[0UWBO#TEE;D88\^?(F3
MS&=4O1VB-2U\*T__6Y3@B&L-VU/=1"RAQMBIW;!:WM7['T\BV$6^W1D$$Y#,
M9))XO_^Y\*/\^TRU/F9ND;]#$K%0ID$P7A,J\/@;D5;?Z*9*)LFV6HU!+,OR
M6_81\6J6Y0NK$BW=S^E<7D/C^C#&KHVF3"*H=^UK2E#%YYL5*#Q>*^74Z^S>
MOSU+!<YL"=WZ^*NN0<E]E'O<$3%)1R6(=U^*:3A&GK8_D^ ;L_R\NM1#YA@
M&]CM[:A4Z,SV ;E$]Q VS4:A=XT?I#A^LQ3[4,(Y]?20;WB%R:S-6VR^K=>
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M/*RO37CD\RS!1G+C?B$W;B""5'2-JVG<EZC02/:GF&Y-I$.;Y41HW-67K]>
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M-AZ"!M&.TC$TUB](!9N]+-LRJ2[C]7'LLSPM=[)LZ8<OO58M)37Y/Q_G@=S
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M@+R;S</U@4CA*,O9J!8=WY(Z,,,DZ6)_'_!3'%P<:*D'HM8PYH(OKM:8E)"
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MH@A#%RDAGJ@*UM"7W/FMZD_OV^^  Z'W23N<2/IK?M(?)!:PFW;/_@6C'<$
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MBN%A1Y,QF!CITSX['D  F7H4Y:=W5R!*'D4@.C$K&I=/7)+N(+; M3EO5#2
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MI\A>Y2=]_<I@0;P-2?5-:O)B<G/_!Q88NVT(<UCW%PTX:EE.3J49?SCE"]E
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MDVOF9Y";#O</6I6DKE*FC9N='*'F]M3)8 [#N=1\HZ3_2'')?#61>Z&9U9<
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M6""LJC P"$QJ/+>^W.M%]HEF/KY[V_CZZ&(%G=MNQ.1)_:%YDA^@\5!#=]R
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MP<;6UV*VT;:P6ZBGCX>2WI?/5_NQQLY T,>RWI;Z'#?P8OY_NYV-A&(();$
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MC H=KAG=7:^SF.#5$R<<AQ:,+=5;/-,TMHE<D]P>9%2P=FRV42YW.5*@]_X
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M"E,XO[]8A+2MFX [?='>Y^.$U5_C@Z>&W\Y)]"_)?FX7JGP?F7-X\U;<B8V
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MT)FZ<^;)\N69&,-%C&$-QO"$_B YY;NZJ\&82(]AJ<MN36ASEJ-33X?O@]
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M;1Y4[?@C1(?(%NPGI,4N@%C)(0^1\8RU.IZC>MS*[N!%Q2[-B411LRC<!@\
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M]"SMZIR*6,#XK^Q 6R^,RA08#O$QQ]:+"J4>P+4X9#_KBM?0ND*RV.&V3/;
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MQ/WW'H5;.6 .O?6Y"&CD_K4M\P[H'8JTBY(&@UN4C6G4K&9Q=8U(O8F6VB$
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MFHL#\E'V92V7I$CBT8^WY&\##D[%<P?4GZL6LZ2ZLF*K%_9[Q06G?UN\H2<
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MNU\=LS*;9ON0H!X:-FD+^[G.2P8ZI /,N$ON.U9H!-=K<^QOSR7?'JA@M1L
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M@N>>$!6ZB_FS;;X>.,3YX)J%@*VFWM2LN1WP@CQ]JAZ7K\"BW0F*NS5(FN8
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MB]3_//EQ@7V)N]RXB_5^31QE^UW_KY(+LPO7:3_9\OW8 /+LU+M-]FWLG_U
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MIVS; (,QBYA_\3ZE_"MT\>^9MEES;XB2CX<1=W" 3J%<Z/0"MF=R6V"MN9(
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MLBZBOTC$H$YX_..G?39Y;J)W?X8/"[C]"C6X7NY7T1.%E+):6$P<B"7^.7K
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MJ=8L,)KF+>GDT,$' F>IG(F8?4*%@5-;75U[;N(6I,O4Q:U@<,(>6>+PS<H
MT>7G<E3H'R #&P.##@Z6,*68T(^E&3Y$*W\%$5#I4VNK,<?WJY$&K7SQ)X]?
M2!B![[BJ_PG=:Q*#P$4D?I(&<9GQZ'<4.CMRI/*/V=FFX@"N;VB8LC(4Q%/
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ME*C29ZU";WV/"QZFKM\Y]0./)TGY@; $E5V\@\&$+54/N0*#7!FT#&1H?Q=
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M_B6D)*W 1APKD"9= /UF^@$L&PNW1Q&!=F:N)UDZUOC-; T8=OT>S.7RU_7
M1,&Y#]"7)L?N1* .:K#%W)SH@Y ,0M JOJE673\:.,Y?+D7EI U/'VDXS.E.
M(W+ L>RS_NN<$U\1+LIXWMW4J,(M/:Q BE3^!D&?U!(^G'SPX/8[\Z I3_[B
M_)UMSC4BT/3K?I+FA O=2;SJ]=3?SZ "5O577WUMXM@J2M_?*W;&8,_*_*&O
MP08ITH*+C6""[(E4Z"F'SNR%?!RI"1X-]877>4Q-GIS@^O5@*O_8B0/>91^R
MG!'A"GXS_/ *JT4@I<.P"FQ.;")Y&24B/3W>F$?C@;" _=1#_2!4/LGH?%3
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MG8S:\U'G!.D'R[LL3GE6Y8]O?Q?MC.:?_,CW[LFOWTSDJ15&NA)$8%H%77$
M;9F?CED4:S-F4QT2<!9D&GC/>-)Q?$.F[X/7?CGB>R]OWFT)MMC:$W;=<9>S
M%JP+]/<SL"7H'#<,/MZQ/?;]0O:?*('[OSO]^W)DB[)LT.[X7"A2#7]S;/8_
M/C=:%\65DQ'"V^<?\FK8XC.S<*=IHL%[< H@8"TVXB0/J,C?P0^I_*O-50E9
M_8"'"\Q_/<%M1HDKS-$5?1[37!(JARIR"WP=^_Y>%G1]\>EA,")Q_@%)@.QD
MQ[98H6VS F/1*BWWBB4/68^#Y&4+;Y)13+"<EOP  . =U7:L16L790Y.+.Z5
M:+;7JJ"7#Y@/PZ)G!]:^8ELX['Q52BX\NO4/'P17G]?;[:,/>^C3(Y(N[U0K
M2O:W NC_!FW_?QJ1+?K21U##V##H\3TR%W,GIX=:K5ULW_O6X1^N7.1L)U<U
M\3< (1LZQ^&)O1)8\)2Z"F$_ 0%"\2,"!0.(P,I/]PD"@@00ALIT'5XG)^N$
MS3W6-(C:\K1+*+;*?5%7\7B3C/YVT.4VY,Y%KMLR>N;EJ?5),K:P80+-AH'O
MSVIFS^SQ_(_AM1\)?;?F=_8;:TZ:>TX8IS5TLI8SS _E8QNT,_7<E]JGMPH.
MGBB95==6D;O4WKJ0KG;I"O7ABL^0/U\:"MXZ"VJMRS+X7EUNRRRZOV;8CEZZ
M&=MRIM]DP1_P9^[RTY7CDIP0B40=M:<KJC,]!VX!QP,<\M0F_2*IZ1=V(LX9
MKIM3\MBF<[E2BM_R?^)YH(WC6.#@:[DALR)VP\8S\W:XP-VO+R(OW_Q06/OM
M R4+SV<UCFW/$(F48A_RJ+?K,LMTP76ZX7:!V)G^["US;?,X\2^E WZ?^^J_
M%[X#E'C$_PC%Z#9P+<I(-;L>A4M:E\#76WM]GESY,_C\XXN+NRQ <O1KBM>Q
MN?+L?\:;_+KA3M\/Q%I3F-L3DQ,#&X^GA4>:SA95'(3E87-F9]]+/'=7G$9U
ME1=3>-10;Q,?.M=,Z\WB>A-*/O,[?M*EH2![5@YD8KMB$E-#V)-T/DI<=Q-/
M45QH"O;(8]D5,6P4'?M1;B#R*[F+\+OII'NWN_NTY$^7ZHCS[%5G<7[JC3FM
M#NXG56\AF(<[S3Y+SR(550LCOI_?=[17:'EV?[&KA9]NEV")'CN==$HKQ\=*
MSY]Z]V.(@!\$QU<U*HP7TALR?%%;?G@,Y><*NFE(9U\NQ7&3"%SK-4MKK"T?
M3Y&G5=UKD>,*&?&EL=*1_)RZ_Z9^M#@J@#\#^9 -NSCOY3"Y8'8>LBVMD3'I
MCE3#<N;!:;N>&!H9^-7-1)*1_4N'\_8S2"C75[%'3:YZ"Z+*%5!-^4R9(CO3
M_>UT35?>SCR__@M;-"_$U-*";%Y./BZV9W9743V8N4:":JHB.>G  T;<?>Z[
ME#RFZ5R?+D9?N1666IE/:OK3IO3N8M,T%+0-S]<B=M6+L6\Z)_]7EI/*M1!Q
M<IK'VC/M591LWY9Y(H[=NQ8)\<NV4="[H],6^:6:^IE?5=BQ3ZGTW1[H-)/?
M2EYP2(X9U% 40HB<T,K;LOC2H^*2%I1X" -QMO5GS?J".7(L5ZY OGY.^1E)
MR1W]25)'+426<6..9XQ[]'U3DGSJ8O7,L[@EJX2__3U:XB'EP8Y2?+F5EYDP
M=TJK--T!I=Y <U+^8DK4;$B?47:0&60KN7+Q7=["K4M!<[X'*Q-<>3CF0;@(
MN4Q.OEO.=+V=K4+5C>]HW;E:S@06SIQZF_N:UK./5KZM0!F;&+/#LX-J%Y >
M_"<RMQ]MIQS._N2.L^LXDR;[?3!)97(1\V>DTT"O)IC>6/%PQM#R!_(\8'*B
M>"(2IXA1\Z(MF'N \O))TC9J[(A>X._*)\]1<]F?@)OTBF<&K7Z-Z5H86T5G
MSO=[G!J[S4.K>YRLAD-:ESCB%9$]9[Z*BBH3E0Y-5S$QEDN*6,8EJ(4M?4JT
M07_L3%M M0P1F)*&^59.3BR'BV3*'D<HN3D7E"&QVELL<MOZ+Q.CLBR6/O1"
M=M^L5I7XJT!?VR17G:R/MJ5\WV;'59V\-O1MT)7[&R2+1DXW3&DY2&6*<*7%
MS16HV*>.(42J*]_$S4^7"4N<0? %654G"!'$S[]1.O7+%^,(8Z_=GSVPN/UT
M)<8@L7*U*I[2*Y@:/[;5?\QHV0*]Z@(+8:9T$O?A:6LIL^!:_T';36=R6D?G
M^/AME6'L4OG+WQ&L_%6?3!]__^0\^W*X3('YBS<(>B!HA+V<3"-*?\W.GL7W
MC<F6FOG^,3SO-L;G)QT%$F-=O.+_9ZJAU^O')XN09X";Q&+U.SL*CLM7F@OG
M.%%[:8O&O!Q2KZH-;?7J>$],9W^<\HQ7V)[;![N[1B@J8,>\$$,>OE _S!_[
MQ 'AE"K_*5_X^> *3@25JX!:RV=*=_ 1+>>O/XM\.KYTLYH\UO)LLHI.2H&B
MEEUG(+2!+]?]<.YVOHI(,8[MB^[@3Z>*Z YC2K8@9:Z+]#'C%1OPTC6WQA-9
MKRB#+O "$2 I.7^[\'.C_@*;]R\['D9=R0S@NA3K]MBBY=;UIRQ_A )4ED'
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MW'8U*]V7I6VGO#^*1A" ""Q7-GN_:1A\;P@AV?^:>4*96P+66:/E/*U91Z0
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M#NU.Y%D2 ?<A^*=1?RD0E1X>:=LHC[?P*3PW/=/N]GY:A2'T#D$@4"3]GOW
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MF!RN0RE\.K.F5D\W5<W\)YTQQGKY 4[%4J82??6DY,F":9_6#-9?XCQDUW9
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M*CSQK/7Q[SE6Y(:T$U*:H\0N=.7*G<#\"-=PS_"IT/=Z#8\7K.^0H'M"CO5
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M)=PX"VM:X(G498[G#Y8)Y]KP[\5^[8O'Q2\U3E0Y5R6/"[9?6Y\+N_V-'TA
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M=M7 M [QO+ATK\K)W/.9R@V@VUV\NZ53CBLQGE^8Y5AW1QMK0P3:WD%;S8D
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M?&&,J7:F1U6)/KEY KMF2#X;8P*O-SGQ1\(?#PS63FK;AD&_)J>BSV*X1'S
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M<[7\3B_$=4R2O'\U_S1L58Z]3:>J_]@WQ,K!2Z@F&GX_-/<- N]3456JA#C
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MM@/[8SG*ZA )H9)F"S,/]^AV,D9U&&Q:HNM>/<ZYV]D;1Q31RIKBTX+"7HE
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MUI-RZ/HD?VT)\!_O9--&YKTA438P_Q>6'R.W"A3D\,B2CQ'7/*OE)GW%[K>
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M40&1/Q^K$V1" 77UWUR%SF\8QC(]7+P(:KI #@H2UDO1#0&-90T2 4W7+8X
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M#SG7-7I;0C?*ZGPJI0L2'_#QG/]L"0:'WC9>P>C46+T=J-_]F43M9B6_\)+
MHS!PENVB(OLR5P_%6A(;>I4/6C8#=0;Z!R\@DM359J, 7V@K7VD*,H<,D?G"
MV9%W+@J(K^J64!:7$[S-GLDOR@<-77$U4!I6!F1]))*3,EU$+GU4HWS.:([Y
M1CV,':6!MSSDVD,-2#B19[?L;B8XY,@[DW32[@(^0/O2/+CVQ^>NRA>H]-RL
MT($= N-PZH7<QNJ(/0_^2W)9N: 8$ZD7(L(5;LNPIC!MYBV..=2I7;DJ2^0I
M%6G )O?=MPS?"FLE_)T;>-5\5()FR<*'),&DL'H?WQ!4,M0G2^2@7KI\#K@
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MEX+;18*J33?&F>+FV,1SGH1L=?(=^A1>3"Y5J^H+V5 5QI:K_D2$\( BE"^
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M:'?QP-S.(&1R8+S"LS-6H:;H(W,!KB=[CG&+W+2%&.,3^X,JT%7Y$G_0V_*
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MOVB \C_Q_R *U46+V+5OR'=Q^Y1DH6@^S"(4'\_1+3*?E!PFD_G;FZQYZ90
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M*.!YJASOC.Z<"@9PG+9J&Z,8+X7:$=J\HXF ]P=$?[DR+#"XA A\%]-H:#)
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M'$/^?TR.)0%'##5Z0%GOB6GYPQ\6.WF].T-__X5+<=6/5!<2=-E(Y*8L;/)
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MDW[9C@=F:$IF\$>KQ[U<;<6&UMIC+?[O!T]U$BXT*U[D3I<;]$,.C;.;FE-
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M]%J.@RR@B1'DKN',9!8CRQ+DB,NOYQPHBM_"'"#WN<21&!(1FZ<!I>KLX8>
MV$DH/I/8$C']F(?QY?(?%6 5"8@)6=$Y,Y4J"6UP1V]CHYY2%%5]5H)N+G@-
MJYL;3*^"00R$ [I2MDQ=NJ;G)6$X87I@8'SBH[.+FFJ8>=Y>9#RPHC(#]="U
MKICDD@28N\DJY%6+M_A_2? 95@*?'T[EXROQ9U&VT5Q34_YYM'@0?P';UCEZ
M#?#D&4356D0CK56PRIC@3<S<ZK5.<G2]UT12E.\3.+SXPIH?M)@H&+0"I_X6
M3H3+\79ZG"9=YAXV M"5[E79JE1!U?DR D;QZC46<3#I0 00Y^ E;5>;ZX[Z
M2W*6_BT)$O^5 0(W*(0)\.5"PAN0()?,?/#(B5]E=A$\;!4FKY!G,=FH!NIO
MJ A[O)RGQ<*? Z>L58U1F))38@0LA(J^.S,U/M$%8+R63;Q.?;*BN/10<H18
M!R <S3$3IHC9 -PV;'PP$>*#6)%,[N&+L?#&8=!^A$Q?=9#M,$@K,<R!OP!K
M,;TA3$ZI$NX(J9SD$L7C+U27Y!L$R57&JV"OW=A6ELA* L)A8O(* *Q0'?H/
MEY1_*9O\Q^C)CESDHD!^IG74;'UZ"3YEQ![^=Y1JV(27@[\G(E1\F8#O3)=&
M36Q#ZZ+W,6&W=7D")A-OZAG^WU51]$-K3%;_VVHE(#V7^T'_75"X13ZM(TV.
MGB,I19SH@Z%_-_WZ7QZF'G$=I^Y!"S/N;.O);UF7EJ=V-X7Z'CD8\Z0D<K.T
M,R-[3!V!@S+B=I&'JF]M6/'9:V9<N9:.9+>%_)-&Z]+5M4;.K28:7 K7Z[Y/
MMGN:7(Z5+YUH'%9_&F^G?<?QY PF8J2[%B$\KV% K_<KU[M$G_MBRM_G_.,F
M7N'ZEJX/4::<Q0:OUKP(C'['RP+*JPXZ0\ZH)N;"L*CK(T:H-JIL"GMAW>0/
MS_HN& _(;FU;'Y0ET(U#1=Q:BE#D>K=1GJIU5T#C#'2,MT*WO'_Z"G"%E9XT
M )^FNFQK);N*MJW)47(O?-ZYMQQI?=ZN@C)\+]Q&3Y6OZCR>1#5GU*7L=N6P
ML_CC6PNUCM1CGM=U,UC[NVHIKI3CIKUCJ1PC</S4SLLO%,ST96*6NWYZXTA^
MH8]_S/E%Q)@Z\2'M!M>&HU"?F$,I.<2J4>#M1<Q#0A1RVF3G.5X1X1#76NWI
MT(]Z+,4XP_%>'!OV4 ?_BJ<F=:YG3LV_5;=% H514?EB5!5.%.QV.;KL(9MI
M=M#XG884_\GHW\*!U!&:-1619 2%KE\J>A6?74/.%92&0UTC](AY<EP"&OLQ
M2<C<_LTEM_7_H&R:LCN+P9*A]HEN?&]RR9,S%=1)MNKLBV>L[^DZ[OPYE%R.
M6M!:&2IC7="IFL+L7C00H)H%>^OP/A-I>%<SV<&4/^TM;'&[#ET!8B\VY=UF
MEX[5A=OVLFTJPHO='IX]5K&!U6$L0MH2";_W>L9! B]"0W[X*Z,X9T^_==18
MU>LTU>X4VP"\BS&^0YM*&Q\W[SQOTY^1?7Z 3KN^B#>2L38AVZ(K@",PSIPW
M>MIZ#&M)J^D:J=0DCTL>:J[AH:.L$\0[LU7%&=> #HZ\ J[1'L:U#U3#ZF0;
M/%X1>04X-U;U4@,*EEEX7]!D1>$'AC8)(63\9D/2=(,XFP?T206SQ\&+,K8D
MKYT(T3,_IDP"_!M_>%!?V!\X^0A09>(;',=:?@KH7',=]ZROW>^^Q#UR:%7?
M<2B#E7AL*;S(7QNBZ"B8BHLZ2CNP.!+)=_F>O__!Z6,,C?4]J&.OR4*7A>>M
MWB9GR2FZC*)[ER07RE7:5561_4]CB 0R5J<QR(]/@E1(I $B#J72_N2.U]=!
MRB+ B,__J[C(S]'_%+2I).S[^BS<J-RN@#B]/>H+7QW_=7$MF/ CA>IG%Y&7
MI,<"^A>(<V+?(@]E"0R[175RKPNLH(TE4K(]ZY&%FC) Y/MBE-L!WD)8U7O'
MMMP'=Z''[B>I<;TY8]N,C@9GIJ-8>4@SMDU+E6;Y-Q&BMGEJHO6:C/MO\BX'
M,CQ9 NM/RFMCZ+[/^;NKO-+2_B@"+9\4'^N\YT'<[E60NGNFU2RL.V.D*VGW
M:'3^95J(2MX[WJ)6H:^E&HLY9:$K6N-K+6^WA/R(_6;\V':I0]CH:G>G>V'V
M>XELM&\PBE1+,[FV77$7*P?E33YOE^SN+NR$V%?-W=](/!6.L^9B'>DUD?)B
MI-2)>@O$>F ULA^J7L2@YUD[\Q<5O;6-[GN,:89W"?WT#E?)?>FN87&2G@YG
MV03Q41"Y+(A4AT14&CWQPV00[E*'<P</G8-RNBA'D5U^HS$C>;:;N)^[:2.4
M.!O&]^+$F_@VN+=S1^Q;YO/G[K >T%HG9CRO"W03GB)Y+\Y>]D3E^ J 'Y5G
M^Y'[:.S6=,P1%=0L"!E2ZK:F1YI];U0.WXPAO25U2#OM9"A6>(D1^1*9L%"U
M>U$86BG@2R"][&]1D,(>K4WZ5?D%7L"TBQ&?S\.]L?=^U)?3=PO/N49B=Z[_
ML1]I?YM7U>@\8GQK-3&BJ4]@ER*L'I5 ]Y2J\F32>GO!F^(*V.(^$_>0Z+@"
MJJ3;RA^NHPUYDA;D>]\<T,=.EQ2].^ZA[QCH^QTI9+/5<FQP!1 +/_>Y,WIN
M \.9S S(E:5M"OX]0"\I!0H(O5B(?;'B/WFF7!5R.'),^41//$8>5G 26@&G
M?A73+^UU*G'XI2IXX/#M<2!)(\=7ZD.;>S%(U:.D3_GDA?1WBX9\</8>O_-1
MW1U0QOA1K:_G'QO*6NAY6VT%U6H]>.GRR;47R_=7]'''V5L?KN,7)?)YUJ<)
M_84H<2Z>U-QO#(D4X?!-'56]B]B)-:?N<K:+9!\;AK;,<:*=]D]V9UHI=L7Z
M>MMD5(Z)RNS"4]]7BOR_OFJ^O\Y+A=UXG%"J*UU\G*N%L;AG_1@N3\>1:Y(B
M;TDT[!F46C3O:Y-2&7NWB<4KY)O15.""?\>6UYQD15/SX(%-XH2=#:KU4\H4
M'WY9Y'KM7A#+G7Z (6S;#^+CO5O8:L"NU+*G/^8XM?$0<H]<SX6)I:3V)U$@
MR:I(E>5F8=ZY6Y0,QI9]2Y!UT>9%Q$ QJOJ$/@1Z0LJD]H/TF9HR-2_*X^@<
MG*L\LGE)?,YSB7YHP&E0R5XD3QS+MJP'(Z8I4,*F2,,2[>=ZG<_84<WPPLJW
MA^3\P40'K)&%,Z<^<>D=YXM^UYW)NVVOCCI[A,'KY5P>G_E^E-G3_MY*>(WE
MK/!^Z?W3"X^R7VWN7FR9.= (2TN&T/*@2L\Z#$C>7$!Z)IRBYOSV)<D>@;IB
MR17P59W;D_V[[(LI^AU6<49LF5!&  0'L'=+XJQ'-ZX7R@K><[#X71N1<&K<
M$6[&@Y3$#0G.;T$F1OL??9@K.C?_=),<)'7N1$TZ?-W!F]QH9JU/DMV]Z%@<
M[WJ;,_76IU/:D91(IMVNAZ'*Y^-U,+KU.FIQX"M,$C]G10FX @H_>FVVS!<2
M9L+KB2_"JZ^ 4WF8ZFY=<Z=WII:'I5K%Z#ZE@!8Z_J.0^*0 4F>,P Q&4'?T
ME:1]([.2X;VK?_@C:H)MBP8JQB9)#S,]9Y.GN7R]^Q1,*(? OJCW?M>![Q-E
MU&5<OL^'/>Q+-<L%["M :<A_G66D,F]8\?9ITF+AUIT%ZD"OG9#*J/M][B0K
M]<LL'4UU,;($8>[WT4FZ?_Q#J7=5E(.H0'MTITRIFGLXA[])"VN'['(3;X]3
MW&_Z*3I^H/BM4>(2WZ2PM]1C:<'N/?%RGVO-2ZG58YW\ +'S/M^ A;F 2YS=
M@0#U;X^:R=!&K\]$)E:";<PM:DF_>I*360K)/TS#S#K'A:W=8CCG#FDC.=:C
MCIIJKZ /I"N8T(QI1A_"02\]^696 +%.CL & <^RNU^-=E5VWE]R[M&]$N@I
M62,4?,=8#OOX9JG:@@&;+99?U&.Y%5LPQHC[\IO_+1^1Q?((*L[+J<JH-^A&
MYDV6TG*\E,=IOS^SE(8LFSZB':O#0^)XK9Z#4UN%J:/F+^,6R7V9A]%OJD9R
MJN5+/#0ILSV69\CO\>L7QV2\=\*L\*\L]7-MO<2DEKP_)B]2+CXGV<7=P@3K
MI682K_^1IX59VECU4K?'&31OK.MNT"AB[)%'JO7)']Q5ZTMD7:/+#+Y%N6A7
M-CW4'HO[45'QMKI3<7GH]P+V& /R5,V.M37*GRH!['YK8UX,2I#TI48&-5AW
M\4*VU$<@OYK]X$ZCM(?(,EKIY"G>K-+2M,9GCUP-&Q>[0DF'A2G:K@33EB:1
M'=DQX2623*ZU,%5;NMVFCC13.V^UJMUSAA@BGZE@JN],T=8(J627'"N4M],U
M[" TWE[%/%W:*^W>S-$A""?XPO%WJY^>DKOJS2L5A=-Q:DT8V$I_$5+1-?TU
MOMMKD7G:L#!2-9+)4*3(!/A4[GXYL_@U^O[^5TDSC">MB?$A/O.C>N674@$%
M\6FW%\D_"">44 <=\#][."?XA++P?+_1F.+B\=AD0L^*S(#G(VZ6'V"ON#"6
MI?J1O-_[-YK;.LEO445;VMFI;8?.5T#6I/YQXI;_<N450 =<B&2C\.(,1VGO
M][G6PPIM#(1\JK#1[H55M RJ^TR*"\>N@^2&HR85(G]6H6<]415=$NJZ<WHZ
M5T WL=AK^[')HMY,QZ9K2%9ZS@ZU_,,,8G#;Z+K$\43Q&<O#OC%27:Q[I<Q\
MH5E2QG!7SQ0;#7C4#21D,C^[ D"&_KH9O?*1Z)^O-<0]93",IVDP%/O+1U,9
M4*B^.!V4>D:E)>@!0THXVL*TI.,^ASG.,.A[MC96W ^#*9<^-DDI&M"7/D ^
MLQW#]:B+K*N*?UJJ#E)1DW+DF843)>!G7UE%\\U[3Y9"P+RGYW2X]GZHF&U
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M;\]H_^6>3I1?3/],?2/Z"M#J.2PP>-Z/@AVB=+<5Q9=JDOTT#^\.$IMT52D
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MWJH&^DM 7)G\=G;P!KRXLSYMC%;M5\-^IP1RJ@[2RCQ?\3M7IE\WHQU20)_
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MC:TU[UT*I#UZ!?UF;Y>?$XU3"BH3.7MP*7MF?!*]A_Y:<J8C(2,F1M52_E.
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MGG@?O"NB3$* =X#')ZW"ZQK]<'HA-F@@FBC-I6) H_IMAW+PZLJYH/-R@TM
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M1=$R9X>3V_!T=V8V#[U#$O(D<H#WV? M[P2B3^PUIU^1^U-/+5(-;RVA6G
MG$LJU'?&=)SL&@DIU$X/M>_<3&522GDN&#51J<4YHN,OU"3#F:\<N(Z5U9C:
MFTS1E;X6$^2B97SP9ER7N*BB9\?B &J0-7A]^LXR<)?48UEFCQ0JSDY<LDEM
M 4S\(4'C9A(QRT#D M'L:W$VX8 05JUJF'"$3U.8R7V2B:2-?!"Z2SB0Q'QE
MO<*F@..-' 8//SR=)J PF+B?"Q JK[&'JX 3DY#ZY#,#/!T**W;<?R!&38U+
M:&:0"A3?OUG4Z&\V47?'_@-02P,$%     @ RX-:4MTA-MA2V   ,P0! !4
M  !M<FYA+3(P,C Q,C,Q7V<R,RYJ<&?,O'=84^^V+AH$!$&*] XJ1:6I5&FQ
M 2("4J1#5$!*!*2$&HB@TI$FH"!$.DB)=&D)'9$2.M()O9-0)Q"2RV_=7<Y9
M^][GK'W.>IZSOLR1/V;+''.T]_U*R'_(LR#FQQI:&B *"@K0\[,/B#P!>@"B
M/'?NK^VL49UMU+34U%14U'0T-.=I+])=O$A/1T_/P,C"S,!XB9&>GIF#^1(K
M&SL[^T4F3BX.-BX6-G:VOVY"07EV#17U!6KJ"VP,] QL_^U&;@1=HCUWEQI$
M27$%=.X2!>4E"G(K2! $HJ"F^%L#_5NC.'?VC.=I:"_0T9^=4,D,.D=!27F.
MBO*OISX[&G!V'$1UB9KE\JU[YUGU7]!<<6.['12707OU?FD3NT$_7ECFI7OP
M!3H.3BYN'A%1L6O7;\C*R2LHWE%Z\%!=0_.1UF-#HV?&)J9FYC:V=J_L'1R=
M/#QA7MX^OG[OWG\("0T+CXA/^)28E/SY2TIF5G9.;EY^P?>R\HK*JNJ?-;7-
M+:UM[1V_.G\/# X-CXS^&1O'S<TO+"XMKZRN$79V]_8/#H&CX[_THCC3\]_;
M_Z=>E\[T.D=%14E%\Y=>%.>\_SKA$A7UY5OG6>[IT[QP8[UR.XB6[7Y<1FG3
MA:LR!GCVE^[]=!S"LC@1PE^J_4VS?TRQX/\MS?Y#L?_4:QQTD9+BS'B4ET!@
MT*EA9L0UT#\F+8218K=O@%BK4EKJC:FQU5'.F^52L_Q77AEHNL5>HW2/F%>[
M"&220>U(.KAXR1J*+^5C1EZ;VYM^T3:IKOC[!^QC?13J;$__N>*[W+8=ECS#
MM(Q7,KM'-6]%$,F-!J<AXZ][;]EU$!BRV%<\0?J6':U8'H46)&@=+68E-6_.
M\ZQPJC(ZZT;7C?PN:BQW.S0&#]GDQR%YX.?(H _EM$F#]RVNNXH&OX+<OBKP
M0./1O)<&F"=9^%/VP4<R*.;H]B<+-^U-!PSJR]J>"1).#]1PMF]_.-:,GNLO
M(8+M"PJUJ$N^K=GN-#5Z5+]E9/ #77XKM, SH.\&+YM\/Y385V%HK.[>9'K+
M,)AB5?-SW8$++R&M9BG;)A\E#RC/DT%<P-QZ6RE0WF0(J$G*&/GKR&ME3QV<
MO%'\["_XNT'T8_BAUNEQJ'&= YL!!WW45_L@[;O4[#L=$0B7<%E4A/5U/#B4
MQ.I3WIX2&FIG6K+4'R7USCV8ESH(M(S)<8";G);(N8*(H!^$GWB.K&R?5&.,
ME51+2RWATJ]RF1?F!N]Q;@EMCY-EV48*QJ>]O2#^XHF[[JK#)&,31-!> SM^
MJ_3D8>" -3^0F &7KL4O!R\38L(D+9Y6UD7,043'J87!GY5C-<177,>J.R L
M*AXX51V2F(^JRM62/Y!.1YYFO41?EKTO% N41\;A'J*C^_;VAZJT+B.0D>_K
MVYHE^CIF[%W4S]MT:6ERSJF_NL'%P6^B$A'W,3-E0,)GLLG]S6VW%!B(35_]
MW\3:^>0^W.7':7H@UXS/H.&@2R546\LFO/CUF+&&U!M:R3;1@4DG*=U?>RDW
M0H(*\\)D^16,/LI'*$\X;!DKK&4,W:29?(5Z)CM8SG$<J7XK1_!V <.5J VL
MW#*$2B5@GBF,1ZW28UZ0NF>VL$Y'%ZIMX8MTJZDV?/_9_V9VI3.<#+KK)T[$
M0/KV(L2; V7@\!$U/J(GH#-;K-;<NZY+@"U4C2:S<NQ>ILLF?IY7\4;!)BE
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M0E_]\@<V_;O4_TKB3@:Q818^ QA2XR'R6&0]OP0RETQ,$.0D@_X([))!#QM
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M1M"99G5ZY&M\A,<BX4K.TT7*!98GQATA@9=]O-NMZ:L(+I'?'YSYQ-SDE&8
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MC<F'7^-<1+X'7=$3\BFSS\M ].$&R8A"XJ.R4<,6NIG;KCJ5:!.?UH6.MA4
M; C"FG/XVZ3:?,]R(,P$$VTF)1%?U^7&SR#BEG5/5<YJ!>&ZR36K.]\$9OSY
MC"E&W=VG4:, CSTG,]")UT6J__I8AF>E=\WQDX([MW[2%<B+4?7-;M2H!=R]
MJ1].W[X<@B2L-9?R \MQ'<)<5.)#5(('5\#NC!K/V'ISKS?KU6J/Y\532%#=
MA^,)I@M\ADZ;<AJ\\VNYRQ4+/VK>+S2:08-PY.<TUA;/MD;LJY"S.A]H:G6C
M.9,U,^>J1V<>WGR,9#Y7.3/HE;P1B,ND=^R]UB7Y+6BKPM-#JC^LX/P$ZEUN
M%2O.OZZIRF57JKS.4'=G!QN-.+U.%V]YE01+[@P13AV"6:IK%06_^5S^HHUN
M(EA(L(*R:PK^U&*&RW@2#D'LTQC,J[NCU_1_&#@E)M@:"&T-]B09/7+X5G@]
M&#VXARW8L[%I.C-J'"<ZME4-7?1$>1?EQ%R^'=#3#1%:H9^N)PFX7(YK[(E>
MVRD=(&]V-6?L)?X,,1X(U/"V52 7Q,Y/*9R8U.&9P.C[],M\W$<MRSL[(1I5
MM)1=EY^"T/&MO\&LNZ',TG25X-Q/%!$Y4D\,?:3X$.1A5*+K3K'X(GC76ZI8
MT@XL.X>A& 5 D%K.P6"B?TQW,=$]J%,@ZS5:*):0'%Q]5_IM&RQ%^W=]QI=?
M!QQ5O.<TQB C,[0TSP<6D#3SD<)M*&EMW]X">"=%XP9L2-C.*C=5VV1?PE?/
M9IT2ZZ^0J^G?+FT]&TF\Q_K6IJ<*&;B'^JK7.6W6<G3WGXP9;M]<]L+D18O)
M\9GP1S%;L'7P?3=O;7EO]&0RIM7TI-9%:83L1/<5#16T)C14@!O;WJ+U24DU
M%5/PE")_F_3-$L^WT6J@/E!P7UY;G3-!CWMT:4 UR8WH3X-^SVP^\(2?"Y[V
MHD.W#J"[E9_I..B6-,!+[Q%6/@3=#-QSW3H$Q4)!/M@X_\FS*W-B9*5,MKC$
MH1-9R4729\H^&QC4KDG">I=4*.@;PS[)V4\IZ0&MS>/QC8Q4&]I+@\4C4O7U
M6#+ /*BJ78B]A@B,.03-(+CRR1)-UF3/777)6^_@!E1G6/O"_<ON1SZBU#KH
MQH$H55O^SB'(Y*3FRU9W&5EDD1XZUNCH XI#'=G-]>+JQT<RRVDB(5<;RCH7
MFY8T)W9YFCY\ Z0H>97D,U7IJ]KDU,2#^&!IKS1]63OQ'+F$F)4[W_>X&;4J
M4:^>)$K?:R":D^#^V.G3A)/C6D2+:D_\GM+&I:;,C,ITTQ;</1OT(2A_]A"4
MOK;65^P\)$(Y!(W*% [I;5]1AQ"P_ #O@F2\NEL>H-3?TRI$MDWVY,V0S17.
M_1J56">U'Z,='3K;D^].;Y?RP58K1X1,<+Y2J'-G#*J[W.XA=C5< ^=Q)5BJ
M"L@DG;T'5 :#_C(+1<K]Q 6+?!(](Y@2I/::@U;#W!0E^I(!I.OI"F51R)A!
MGE(L[Z+$NQ&BX?UJ;++S;9X7UKZ*IH#VA]EC@L;"<WE:H6)SAZ"04,DC*.!=
M=< 2AE@.:M>;=0M_JFK6^,RJ[A%JD<56*UGG,>&T\IO?\TK.VG/6/7V2EU#(
MAWY"!G>K05E[';D ZRZ!9G^>WM^3753MZJ,?1MQ,_79E;B*\@OY%4Y!L'OU]
MPG? L[.QZU5:; A<*Z X=0R^>+YXRV^'\?BY6GE5<_3EJ/'++TIR0>PO3!+>
MK.VU'((8L9 &9C-OK.-?$N$D>JM>+-#4>986#/@3C_R-2Z!DM/I51)%+4@?;
M!J90\*G_E4^"=2(M')7H8^1S<TIU9.>U;<*L/6&]\-6NC*!ES*@:U>;>I8%.
MXYFJ@<7N&+Y;IAYB62KH>D_WZ:U!&(^+S+3%%..(D*J#_7-JS+96)*)Z,'Q>
MZYPA,;;<VHKL'R,B>MQU[D(S]=;'VX%Y=T 6;0LJ_"JK#SG\<M)TG5>(,]"L
MG+06)I'&_$.0IQCJZ.BRPK&DI:Y#$)>ZY!%.Q:+.*61HG<;K.!*E]GWU?751
MU#NP[.!6D\^"S^P>;,293TUF71Q3UR;]D#N#YZAZNC=MT?+^KM=B.]GS<<^4
M 5J!;+X6^9>VZURS"8=6G ]5V-6G<5)!1NO^59=?<:5QZI4+[Q?><V;MSD%I
M%T=VY<[&VP9L3N.IO^V8C72U"0195WY_ZQ4/[/L'>EE.4;G9:PTWXEM_K/^,
M=0\R5\3,4&=Q U(H3MJUU.WV+%' OP1(&#/)F%<0^%(Z7XQ_G#5'=))BK',]
MN< I3;SV?NLT.M?Y-0"E3-?$C"V&=6ER!\B=\7%QSV_7PKGT$,S5U:@B@/G-
MUA&S(YAK[(G<D4II&H5?+W8];LAR_5Q2GNSPEW.H-U=5BM5%<V:!&4H663EN
MJ28=KT_:2&\%CSF^8SZ]Z+0M*W9W][[^H[TN=YZ&G+1[SDL>UE)[_FZD-6>9
M/.K6 0TW5E6+#=CP,=:]T?Y_]=&L'$+:Y0.$C!^D+U;PK OZO1_=C0U"Q=0=
M:[?'-*0ZL';4PBJ27@Q-L=@B \K],_#@B]5.[_DDP8Q>CK>CW3<(^J(L,]RK
M**Y6/AWRY;GNZ^HZ1 [V?N??DM3BCU/71I5NG_),"6,-C!D<#F$$W-KQ;!C(
MB9^;1<N3@6_?S*[<G_V(3;74I'5[#[U%M-Q11JIME .%=/]]O\MF27'P34#Q
MU_+VAA[UQM-6>9PF_RI/UC$;<75=7X:9@%]%*OJ6^L&O$#RJS@D!97)?#T'6
MHQCTU%*[CMY8P6CYL\=N3#59VJ)BE=<--+TZCG]ZC[0:)2/7]@MA?3B#NK2C
M0'7LM\HQW%V?,45[CFF",1(/+_066;MBY&_+2O) D@Y!'0*(R!H6L;&=C%.=
M]ZU[1O2*)9,,>L5V)4HT-[4RL2R'H*Q9/%Y^KP&.!F9HV-(L&;+P4#3"#1\A
M<&)HH'#9RFBCL5(DWBN12WGBMOZO"7S"U!&SGB(ICU&?;!Z"#*PRR4VZS:2A
M+GS$T:&7+I=HKOV8:L/[T-I'MM?-ZT75O/>KWT]3%#%D)HKWF*88K+VG,ZU5
MENR'"BK\[%09:S0^R><N5-#]%->O(N9\7;+\(OS*UA&7"#X$[:3&I'7)J2SO
M66\W[6=AH.IPAUM  [FC#<LF,^$XZN,'Y0)BGY[PR^XJD]D82NWYP+V:!N:0
MJ6BV.[IXG+VEKC]6;V-2)]7L_'1;/B7>D%-X;/?-_CQ%(>L,8)\#D^S4E, I
M[&09/>@T-_0-]O:6>]M9$F[Z@';QP^\M15 AAU]NV]8(5%\[@L'0OQ"/)10.
M'K!"SL)=ZTC=#;X%RF$TFR), PLE4\W@VHU]$ U=[^!MJT8UHYFUD)77AHB]
M/IF"CTA4S$!^''XF-=ZE]9+C0_B9SI2V\XFK4--)N3B:<![\!JDUGS#K-^)9
MDWF3YR7QY,)SE,[7A ^4HJ3F9[MTK$WLJS<.63T1 $N/IB+@2)9JPW.H/\@'
M3)^F4U#77$P J^M/>.*/%U]M;%![4\QG-Y=,J3*M)Z/:!*UIPNQ07EU*"J)^
M]-3[=D$Z4YQSBY\6&\()R0Y7(A]?/0I\YT0G/E2K!J=,MH1X6'4?';U^E1#C
MNEJ#7A6AB?ZA*7R'0$^'&HIA94^UMKK T =7'! <.&IK_04:V/S _O+]@V\^
MY8YR@?*S!:CR_*# &32BN>]JU1L_(^M1,H9.1Y%Z,F"E1K6M!W5ETN[V9D@3
MDNZXU;BKBL^V%^^[_=?7;,!KT))'-O"SD8;UB07TMO'-&EB>?=*3"'^+0Y#X
M)]KER312G?9!IKH<<9-G>J <*.U,4T)AQS$& XN[@UV=]RM [=_C0!JKGA07
M !% PL]O1!>L1%=;-FPK"FM#'M9G?JDH/!B=03";KI];F J1-4FB)KLM_;B^
MZCQ+9[XLM^E'3UQ1,-;];PA+_@4F%0GT*$<A"$SU&!(JR@?+ B1LW:JM&L?X
M<.D(5JY%;M9>"]]P6X1&XZO=A\*:Y>F20!WU%K"Q*2\MY9Y7U2%453<;<^JA
M9>S9$5V(TD&L<4L3RLL8RD@3!92+@3[\_2; @'H3MJT_Z=/++;LCQSL3>::2
M7T>FZ82:_L_GVF@,C<F3* 5A6KX/5&U,'H(ZC=MY*"M]6K+\#L*6YH#V3OEU
MGX;,W4KL_VL]^%N)JHWN'U('/QG^;B?>G_Y'7D<(P37&X C)2*AQ*E$T>V78
MC0?O_'M30:S?\#Z3U+90:-BFC6X NAMU>K7U<CV)Y>F+E#'X \<B*!$J=\"M
MO(_:] 7+!>Z4_-OU:?]A]>AX$8EQ=<&CZ%]U,N5R6]'4)[$(O1N$>[M"Q?,D
M(Y!?C7D:X-EC-9A+54?'+-7'8SIR!P*63KV12R_I%,Z\^HG8@&6&/R!+%%/E
M5S2O-C1%T[19>673CI\XQ7R=9<OGYZ6O'#XYS1HA%V'Q6,?J!0CFZ(6>YIVZ
MBWVZQ>NT6?-L<!#EETN6[-+B<L%7"T?&?6B*AFLKMC0C?W]L$IYUH_SH)YY^
M%%G6A4&[.&)"Q$A#:^0<&!K2%"/S?$5-*=4IU-(@\>A<_#;O@/L(L_WE_J!#
M57>Q@ZF^OCK"A8_U^)<7R0G?TF^X_K-2Y2[X$Q(ZC&9'HII6D;_60=BZL^![
MO%S[%[ZBI2[WOC9^L\7GCXZ@&9&/&QGJCI5)MYXOC&^6(]C<$X88D//\UKV"
M<E07C7VEGIU,_18A.F2<]0HWB<(,1>S@N>%LD\]\(6<L 2<.I=.YV/%J"E11
MC#5:26LQ@S-LMT)R/NTEYA $AIO^M<1@"1<^T5(;X:,6K-9N_I(B6#05ZB(.
M/U:WV%[ ?JSXI8=[N0SZ6P6J?*UFPK-DN$'A [K\$&0C0,WPS)T)NE9ZD$47
M6CFS:H7O'#H#H W)'BW$6#>8V:IV;/_'A,GS< Q2+%7RNG3 NBW!]E(V396$
M6-LDSCZ 5I-]1,Z04K//&G@32E>+%CX:QGT?.KFEGA/0AV8:;;'OL)48I=EE
M3[NIRJP%)J3!LAQX[[_/BUWAR'\ZG?2H23836TX[N+LVYK\*',4@ 0*^O? [
MP"LL>XT*^G9T"1"Q0G2LK1W;B;67KOH\>TSC#**F\YB-^W/$.4V)IXA3--XB
M6$8G[X6Y[A&8]MZ/UZ3$#QM??@>5?5^KF/(R][NSI$4J7/#1XE(<\._8HXN,
M-XL3@\_IBD\FE_!-T8J/7?V,%N1V5-'@<-54A+O^)7'?*AC#P>:J>7D<LWH(
M6J.J"2OI)W[)X-^Z&W?R2D$#>&K)P!,#RR!JQ?IJ:&KQP%),B,0^P3R'T3)[
MIM[0*(V'!M(]<<DVREU#QP'P D\&@5P&BZ]9JGV[HGHO.W\EVE-V/OQNHN:]
M>0:_SS]*7"IL?T%W]^F\,S?MG1;=,76SA7V'H% <38NL64K<Y)#(+H,Y[;6;
M1]S6*73EZA+[P-#AI"05MEL -SD$)=D?\1(JPQSB9QKZTL$[N#,1=0ZN3+:I
MGU@@.W9'E\ZYI"LUA?@5Y)YSYFR."WL/?E.5X&7:^AL>'N@929?@3==[,3F\
M[&_KK5-DDW9Z48GXH>NEUWNG$K.1\G3(IODYSY)@0:AWY4_HWTVYCO]M2]@_
M:=N;L2A.N1#PT/RKZMJ(>;=6T9J1@FT#D4?/-[_U(XF"NH%LWEGR.)IRMD$V
M!Z=B(V:CD*T@@Q+%VM#\;%_[KR)99;[=BH3_<7=Z13VX_!'@_:GUPD09A:5)
M6)7X WS57W8G_MUSM;A0J'0;.7*!(RR$%= CMF*([DR=5IHYD^[!'PH2*08W
M(1<*?GNC/V57+\0Y*+6,CS$;LX5?(SNVU,AY><DF^R1V"*0ZV[. /K#G94W,
M8ZO3UNH^'(+:,4!0*:P(%GE_O$R:T(#4Q<D5*-7Z@QPXGWT]]F:'E?UB(;FW
M)4UR-L#&>N"W?H(A5GG9'5[ABV#1%%5$Q;8JX&$9CZX\594MYT@1WPE]4OUJ
M)O<,AUWR/BX;8%G@#:-+& 4Q1?H6>58\F[ ->BYPG5-PHW42M*ZBHJ&"/C:>
MT25RNOK@PVZ\5KN\FS*OP&QS:NK>=- 0*SE OUR^"XEG_+YNF_>D00XT T/W
MH'B:O2_C5Z?C&H=>'C&#@2#C8?"=NFLG$4EBHA<_U'?3 U0&+Y]#7:YJR6G=
M9:'+6-/FPOM4ZQ 8P%L<L#VBY1SY-:AI-4)WPX(NJ0)%;)(:<,E76F55>R=@
M/'EEWEU:X]H]R+04H3-+2>0LE,="^/<ABO')[9J!0Y!ZW<+1L:5XIV]A7V"Y
M%,IY"4L1= $( 7(&%M1%\>N!I$_5&-"B))E-OP5_D$LU1@Y@_>ZY];3RP%5'
MGI FD:2%'A2I<AU#%;8?3#:H_BA7V"__Q<8CB?!8:C'KM+U$@&)5#"6&MW$3
M;X,K./"W=3*B)IA5K\_H87=_B33DT$=;A0!_<A.Q(G$!Q1L<,<>R"EFC6K\>
M3"7S'?,3-%VWZ1%+W]/BA%N1$*]HXN[$8/-.,YY&[N$'[H&.K,D;_,8BUYJS
M/CFUPB)[)J',]"MPEU@K4BVV[-%JM56FTF"/;A;!]QP/E3GZ9L!CA_F-QTR*
M X _(2V*SKR,8#SBE>XGMRU&FE72%HS'% "C;^EWT\1JY,L,DHA7_+@^I*Q;
MZLYQ8I^NCCG[KN:C@^=J9>^,^FV/_5K>WVG81;X($0?LB1')$KF$8*<9<TP\
MK?@NV_:M0]"LKWHQY4)CX/["?#X&%]>J"5L@2KS+A3ZUY1I7H%J?NI?M2JER
M]>=,E?'Z7L\*8KSH!'IOWKR:7J-Z,A91_$T*T_*>ZY%^95REJ4GGL=50*Y][
MD]C=0Q#3#SVSNKK]D QX[,0/?(T_+1',<PC"%1T%>['F/EIQZ7)1FOPVP(^Y
MN5V%#(=4O1C]\;NW'"+:-WH\KE= B&GQTB&_A7SY=0B*4OBY%#.X-?QV=/'F
M9Z4OY[X?U[L?-,K0W@Q>0,:DUW5PDRAA!/RZ''MPNI'Z(YVG-C&O==BF5K<#
M39;]\+P[R(@]D5-A;3@]W:SKHD\F'?HCGPQL.X__,J^G?X9NZ3T^!*&/..E;
MM%OA[YKB9VA0:(3S)Q0I<A;Q),#V7DCWG ?^VA?JU"ZE8(4'S[NK%?$1)N+)
M9(-XTB'D=<E:7KS]BN-^]8J&U'K?Q7H+ &7[$6A9@# NMYYN)>51?MTZ>2HW
M8^U96>B5DB]3/YDD8ZBB'8UN/^G@,6EQWR1#:XL/SO?B'AY/TJ@O9[[TZ/@?
M6XO^JRW5USJS^$?A=CFS+@(_,MU+7?P-JX+4/K]*U&\-AYQL]2(ST<Y&SM=6
MPO;,!&Q+";T62T[Q)4.,.LM\[KDD[ETV.)AZFQ8"O,'R-^OD 8BN6EN.875P
M0+Y8HTM\R%29S)<BX8FW7@(1;5UW#,;C JMVOR?_1#XD#='.YLX71FYR;6S?
MPI*E5[SK;,8+&J,.[)VF$9Q0O9^_-)"1.TWNRG=K(MK;)Z^>XYG\R:4R[//0
M^!/W/)XA1&[5]LI!=JLL<'O5/,QF1,'>1>,5Y7.VNW_AD(=ER#;#H-M/J]'-
M)+E<\VMC[RJ*I#+(0QT(9IK1F-T8S9)PH-5I=J5W2<^S:*;L,S+.XU@D-'#Y
M8A'^><5DSS$"_H46N_J%QIB?K<PC/I5%,YA\_)0[MSI@7:*D&K9L2.1X@66G
M/20<2-Z:: ;GX5U4[P3X\53-O$SM/QC?$9G &T."_R+GV=SDF>&? Y,VT@@:
M(CB#D1IJL-Q=#$26Q5"_TZN[-53O>)7F_U?CB#/^8U.>>UWIB8*HI3_V)034
M_;$O+^]/G[D.)I\E=&$[K\-E]WB3+3.9K.HF<SDO:KK]99SZ3_:-;S@[6S=R
M(80L<]#S@B/RQ(B^^@-'I4**V0P]0GF_Z>#!QG?S_']SER,W]WB$H&5FR%:V
M'< ,2FV Q.PE?J5=(]^JVI@ZR%2%YTI*A^NMZ/X./DZ7 L*(3!T(KE6KIFG,
M[JMMO6,OA6/#HZY\[AV2:-CDH-V:U)0,^:)Y<=*WNRYH$]^6 6O&3&>?6I#,
M,E([MMC*!HP0!I@H?N,T;A^/;HPWVZA>%6O7N]-2J4,MFD,+SA'S!^F+)%%!
M[/ID+2SBMX/!A:M>VTMCTRU,E ='4(TZ"U=*VGLX(KVY,? ]RBE+8R TCIGB
M"3RP93H$94.-#D'8"Z7:0LIK1R];S(]5Z!!4"*%U!3DZ_PP!C\&O/9:N*;WX
M3(:!]TQ[D[ED<=?3O[+E_[(.]O_/3"858[4XEI4#4[-5I[].WQJ#7%LZ%2-O
M\(OY*(Q)Z]J<,J2DD2=+71;>K:T/Q@I)%0(Y_-^C-[G;I&,QWJ^TYIC0W'OY
MB^\%4O(FZ^[W>+G+OTFZ9"K?F'7J_"[W_ABYKM,,RT:_1#.H!_Q)HFV_!C,(
MG]?&H..^!>Y1@[EV,2=4=(_1GS"I]):ANM]@T5J?I[58%O%TYF$*_BNB!WQZ
M0Q$B#!,EF+U(#TG)'CH7:9[@E$$UO7((LOKRZ8SV@N<BU,*\#USIF: .J8!5
M]S3R1M-D"&#&69=2-X5 K8@GS);B1OW75*@K>G=Q$[L3:M,R%#T%]P#K>F-=
M[D2[_\UMLAWP^\#K0Q#[#U*@^$L\PM.-TGA)1F)(S*AI+Y/=JZY0.!#G_0@?
MAR7P;2N  0.S 13U'G@-6WM1S'9[D>\ O&E/KDCZ]Z6>BDMM-!)2@KSY3NK;
M!9Q3OALNYKQ5ZIM&C%;'LJX,Q:W7O#T$+42\4,<2>+O6/7L0)W?QW*Y7+'N*
M+0Y*^PQ]'*/VO9@>O>S<5=^& )YD:PMRW:<6O:XTTK1>L9[PY'@HG^X60]W+
M3CIFV[G]$!376/<J1,"U]>Q'TEIZF7*K5U!1RM>>']UG7W_8Z79=>ADB#8MM
M0[!XT/AY7U5LV&<Z0S'J7"_5A]Q;2M:D4EK/ &/$D_$$&7L#$BIRS'S,XX>W
M]]7: '[AX4N@4I *: +/WD$V[P"S;]+X7>;W9PR:G5W$4D>^=,! \V%(@G#I
M5RU[099RK3;5%1MKB.MZT0:+NA&_:+_MC0NMK_*^BBA2I0!/4U)=1X#TKMOI
M'2JJ5I\H]>KRS+TK7K;]NN<BSOV)"4.5H3BM<SNHEUAV12R_FYMT>DC:Z92<
M%TX&'+JZ>Y(Q@/^=@QRZX"KT+$;K+-P&<$/#931E2+3:TF)79:8UJY9WH/B1
MT&V#.'>[=:AER"2>67$H'G%\=_,TS&O]@7GS5049V.*%_4?*8@S+4 G8'L7Q
MH*A5PA9V <&I1]J\CVQG4@VN"9WFW7_H)?]:)^X"N>?.H.8.2G[,,]E(>741
M$^]C_ @]]"/=!=&VG_7N$,1(':$)LBW%^VH= ]0ZIYTC*D0NKL,-B*61J<$&
MYCFW^."5:#M<?G"*K1Q5S9+F5FEC HZ5;%]]%BNPG AX*.G>.,EW1:/1GGN=
M>T0SYH =MH%_>W2WW_VOO]L>>$X)4E#YSVIZ&V[=-X?98_O6_YO;U8!6!$:"
MB6Z"2!"2+78@&9;3)P-9\_($/U&CX:^%830W('R[Z#O_MLE!)S_/65T3\8O#
MO87I$2>074.1]$O8RH\-'PT5LB:2OA=+W[+\/ T1PN6YFAM/+>\]^(SP/W=W
M/>$>2*)5#A E)W<<@CC@#,06\$-EK6?CSN_FS_34GQEAY+^^D&AT#!_2,8]H
MOT[4U%HDRAV<*%TNV<^@G!>$JQ&UOSVZI46>1!<4!46?.&>L;_<GQQ,G;!Z8
MUHPHS&3>I!-DGI7GNCAEZ83?8A!+_GD"QA-)A<'/3]#LT#^K@.I[E9@Q'IY(
MTZSY -ZF-C&]'M("TZKM0;%+;6,WRLL^B-'?+.V4?2K_[8?C<6?TLM%#1VSE
M=]I5$F^/' _,LPU<;99-%C6KB9C":!=VQKNXI(@S>BG/2G.(^8I.YVQF#17[
MW6,KQ^WGKLB]U,(HAX>H _CN+&'2TF9/Q/<XMIN7;KV>N[UP\.3,29#Z8UPU
M;A!?95LS';-*X@CUQY[,C>ON6/=;YITQV)G!N0>?M39X7O2+7]+OX&:#5C3X
MK (TO%' -7!H>M$RWSHHR)K%O#Z+:$:MS+GX'07G"%R50I&7XA4@D5G<6#(X
M2M:^YHA2?AF]LR"I\3)A#0)BSYLT@9>LI^O:3..NX\.Q@C7@&%QZ*\K>I>3I
MK\&DSW(^F1YC:SACJ;C<E-X3UN_/!)G0'@$C>? +F-'1E;Y#D/4D)H ^4/"T
M\>Y-Z])>4"]SW@N04*KD\?JAJ<V.P-K2"B"7B(ZQLY&S()NTUS8^N#)K5WB+
MXW458NPV8W6@1X]K!Q#N=0*UGDVJH-!OT0<;AW<%W36=1/NI!E\[&<:\;GBM
MFA'W"4RY0?M/9UMLRK_C31Z8O4\M=E^JHJ9L_DC3F=#DI-F/M%YQ4=X3\&W9
M>%>TG";C6.PB\-[VX<2;A:2$!M'"\V$OI1[\09\(@W8HMXP?@EPYD+QS/$%F
M\=([5&UI:GSE.(]HO>;<O9/'>A01Q'/@&A" ('K6?J.I*:&F_&W]D^J:* %&
M31ZWK\4M*'CR]3="?M%PKZU&WP1IK=+>_43]W0S<Z)\^82L!B"5?X(A\#EA*
M5B615J=G6V/YX]OWC637]+W'V5HT5BLKO+NM>"-]>Q5$B2?JG*K'"4UCS?M*
M1++W8LI2ZO=Y<[U_CXK4BWX**,Z!WYA47%<VY+VYI(M:VX,^C7VR\:U_Z_V6
M?$3CLACG[<%OEU]"ALV[L<RM,C#O-LT+ $JI,$"Q?E+6P4TB@><)7N';^^"Q
M;3FKQ[[8:FFD9"1=:L,?;MMW\H<D6#H+$TL5 \ ==+E*LN!JH$96$>G;Y6Z<
M,=/74]<9-*1" 1E2V .@5K%GC';CE[K9:%&BCM:F__>7-[-@N[OHHE9&.&\]
MH.56TJ%9*)+CZ6!^4J5O_5/7 [%-]>OSZQSMG$8BT?E6RUY?=/1K*U^QZMWT
MLE8POG__7](2V :N^8$D<C"&C)TFEH,7/"-#P*[3 \VJP07)BJ5&7JI<W+>*
MBMI"G_M5LVNX;0;2U@_*0KB!)EV@>H&#ZVD6 YASW;=WI__5N,(RE^$Z6WFF
M9?;%YWU5)U:8 N.Y+91SL#0F /K+*1&02/,<_V5(L6LD$U>SY$=I7F2UV^0#
M2IKT?8W:M&>_N9UFWI"2..>0.!!\#"H3TAO"2Z[ D.6(RET0'L *<KR-Z.5^
M(B',ZT(S_9$A4M6FV4-Q5\9=:EIY[@@M<+M?V]7Z9AY))0 H4F2[%G^-O@*"
MWX7!:LPNT\.^SBW:[KCN3WR3KUC"5$5WS$#>GH)1.?(JJ6=MAK3=]G%E9%E
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MTW\1^/P5@)9PZUX!I!\="V;9DN&;FF+6<*<IGD62:I.H<%C_''COUH)P +H
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MBO?J= ,VP:HUVYZ,(SPLQ^Q.8#!=@Q(O^=]Q&?_XT'%1Q;,[\\6NC3\Q))R
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M;26I)/7,S17[;0L.@HFV),9P[E*3Q.B^4J+Q5)-M+S;=*+<8,">CH9/-P44
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M67C(>.FZUH'K_R'NO<.:[+KTT2@J*FJ0WJ."TD&E28V-)B(B50)$I8,0 8$
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M&)%7?^IZQ><1"<*<E3<C?L;&+K']VY%+ZNR?B# 6ATD@B?8U?PDG:O?M=\-
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MN130[%V=**!, 4]% Q#/!JE>><N)2MW;:90X]>H8L[JQB>MGR\AO#XHY"/Y
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MIU<P5ATR6-*B6%=4:;8?.-ZH6*7P@;7S.T]1VS<B"'5+GTP.E'V<9%-8<5#
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M=,CRC?M@6+>G!?G**D;&?7^0!"A%CO(S+S)!HJ_T@-B;K2?X,.D62,I[_;P
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M87?$.G$[<_9?QNG@XJI@'&"1\.N]6#-"[].[D,2.'5-!_53QB2AEVY*'D-\
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M2-092Z)P;[K,MZ;%R++N?IX\R(IY:\2"1]E>5G+]>&F >=7LLOS[>_$Z/@-
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M- DK-4:OB"ZL7:/B Y41P@6&1R%*-@1*!&O4D23GPTN/GW/GV;(.R']/Y)J
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ML11#>DI1NC*.$I8#&PG8"P> T6P=['0:$L%_\ZC;@I/RL6G4$5X]_O8(M",
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MDD[#[ZZ;:."$5 )V,#X 1AH]K1TIYJV-U6[#KOF6XI 1X3OJQ !&IQ:V9^Z
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MYTN28ZXC30BP8NTP?O_C,S)8Q^A$[L\:(TG,>/8(EZ09B_'W+.66[/ /?H$
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MPC&<(]L B*DB?+UE\["%_9UI[ ?;SA\X#VY-MXG"\65?H_P\ @4#78=%SSA
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M@(3T>LH2U+$)MB^W.P&UQ<"KMJ\&4X$#RFWMMZPF,6M*2]L9U,GP0[LJWY#
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M^VI@*H!I9>*(_MXT3BL_#-P::/H]T>^@B;?*<#O+^++EQ9O2T#NF#9.$8A3
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M:G2F#WEQ&W\B4W]:6+?I$RG)=N@1OZ  )NZR87(=)!Y,&U-K-+PL;:>Z7=E
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M_[B $J-X_WF@HXI=S8G2IWB3X8^JU>:LNTI%$RA B+#UI_!!4SYNK&,UKZW
M)_:AY/.T$Z<AV=\HP-5^G?_NJJS7<T#R\E"+PP3:&'M H$Q5%KV>858:563"
M@ S%UOXG#:]VQ9^>2A$0]_T+?R;7@:L"69 @M1VZUGI<F!U$24,OWVJVM>E9
M! IPD./HLA3OXY&-I6Q+^3'X6^ZGAT2U$1O1 TB&\@X\A1';5^QT 5/GCZ1U
M+9FI@,,%GN7-CW-"NYM2PK+],W)NIA;80X%2J'+'S>\GZPIW],T-8JS$FT9Q
MWR%3M!]2O_95'L3 &63N87<Q2=N\0./9'\+0R]BQ.&7FWH!UKE(*BO8 C;&*
M"D/A-.N-PTD[G;#6#_8I5ZO;3D=:0]R==KZKKJPWV63TN>O%6V5T4_&*@=N_
M)Q-CANSXE0I434MN'CF2&F<%L>:YW:()%=D6B)9&;M0);_'>!]^FZMI]R=^&
M(<*O:M=ZP+AZ?;>OEIUNM=[:N8MQ1'^<&I.+U]L,H4'C$UA^,/%QTN/84J1(
M9;/3/U%-^8+G7IV2@LPGG*O0]7RU_TNR(]2UA>5(JH1_=?B.!'Y9":7#MG&1
MWC&^#=T4 >XM?9%IB-G_CAXIX_#D;V(:UYP&XAW>W4\2$RP/>[L(ZU[**C$\
M9CTM!6=\--GS#'I0\\^RG+";9WUZ3, XZ_/F"NMY>J$"WNRS3$9Z&Y(PTHW!
M<X+$75^0VE+>OPE4R>0P?_)GE&@?Z.)7IH]?ZGEUUN#,[7:8U RI[ IYXB@*
MZVH.&7G#)6V4 48!]J:5/]@23N-@NOW4;&K HDU;SR!1^#JA*VN& F3&X__U
M.[=UTGP3D,UVB4&JIOITU,F6&_'^/_CJN_%@L:4:ME$8'LQW(,44?H01_]H&
MF6EY"%)01,+.GK9 (KZ&*$!$RW7MK<;&U=WF%$."5J/*%[TNX,T^1.Q>J/'/
MH79^Z]1#W-5=Q['S<@O!S7;ZVE.'4/(&*3.IFE'8(*;O6@7=K5Y'@WN,65;;
MM"]A45I*2W&C2:Q42R;P81W1?IO5ZYY)>+I:4@EJ6)(46SDV'W?,$[E/"+Q%
M_$ .TM*TI/6(H0 Q;N; Q57N#I^,4<2@MIWI?!.D$W>KXF2,%%%V!^F2ZF%!
M 4R[OEVP-L?4A=V66AWM8_*TT;U75Y-QIZ/_5U-T7+;<@/\I>0*5: K-L3#>
MU(* 71MK&VN!%%(81M2SN][_S)2FV]'VK.9:4\2_QLNV[[)6#?)Q%"=1+RN[
MLPO1(Y3%']@XE!\QC1YCNOOB$MU[L^[_,Y+<%+?NC?WXZAW3<,+M90E"A.(9
M[?IU<0]/^G<3/83XY\<!6N3,2EJ>%H8X74CTX/XADA0M<A-$OF^,/^V_4/KE
MF<&:9<(+X64JZ/LQ /*L<XB&WYA]8YQX=>E 81/_]9>LC]/$5RA S;&#YW>!
M]+;\QGV\/$P5&0MRU@J?L8+<OE(CIMHAL7JG5E,3HQ!JP)\/V/1'U'2?92<O
M'Z)?<7$KBGL)U!$N1-?'@4$\Y+BOX2H],'7K-_I-\YZ$ TE2(E.IN[/ZBP=8
MYPZN=R@ 0E]QA=K;6UB6.N(O\9;_<]'.3M'==M4Y"6#YH_ LB=;T";?4J%T+
MP^PF2,S6LT7:Z_5C0_ D\AQ1="NW-9?B0U,OQ:A;+UY2_:9=3V)4[,_]@+ ,
M\&\[SI7@SYQYDF,?,94[NM\%)+0K?I#^FJ.35[KQFF[Q+!0ZVGCEDA^H*5/L
M/6G*WD2_2B-':LZE28J67S?>>4=!,JVSK);YL#QW [B&WB%A(9L@$FODZ\EC
MF++V/A<G%X*'X^)2%?CCQSK:D."09]V6U(_L4<'H2.%PMT3J>>N1BIV'49[E
M'W(EHM=5KQIG?*7/#'1?GQM]/%ML6O"B?#5=/S;P]\"K,0O^RQ-D,_?.05O1
MK+DPI\S7\"R/XX? ]7D$3EU"OF[-W0\4H"@EC.YOU52;<?\<0@$&FSXR-?#Q
M-"62QB4@T_Q*^+LULG<-G]N79E.%\-"8O+VYYKL\U]7S3-9F;@+%<7JU^%Y[
MXP\4YAONNVVF"NUIJM-VE07PU%6%4'WJK]!&3D+&*&J?N1.9'+9,<?!I7YL0
M^9@60VP(,N71QCTJ"9+21$X5\%;R3'ZTQ9L@VS)1'"*FPG\3_D$=*G5],HQ>
M]"&3Z"SXT]E<P1F_<M/D[BSCU&A&N;?=O1T!"F#9\AH/@<_VFD@V)69XUSSN
M,Y8J?X^IPCJ(=G\1M,B)'6Y\?T\C?_ANH+1EF--4.V0#^O(<'"I;=S$GF>8I
M,B@R,.G  $7O56KT'V[[95E-$RU?*)B>O5CUYH0#CN=CEJI-<0&M^,?&I"J"
M4_N4A- *+LHUAQ#&QAFCCKICY$R_@@-: CM15.',KZ'P6409FB[E7F [PXJ-
MLD_!OC\#B$Q_?[&<,JE*L,</NCY4;,#'%902H&TKOZUU_M@*((W=8CRX-#^?
M'L;]3;"6&(K)% \_T<2**MV6UW!\Q/;5V,'8(23R?-T/1[Z8LZMR72,_%)/9
MS2A=^K,(_AF_,&[MN?\2;FWJ4^2$1NL)$IWGWL7+YD,4^:J?0L)]/^3?6BSV
MN16;UIPB"YF5A<Z.YM=>Z&J/ )/6XYGQ-&G1C#VK]#,_15=8N/_0S&@ID&[=
MJ[TGT?@HT?#KF=8=W/&.*W-O*A+G;AA)9AEY+ '.UEL"'>I_R;(M[BL6*CUG
MOFRHXHYD\E")C-XB=/X8%X5E6D\ B\Y_)#PSNF[:B.P".YELKA$*-?FWLWJ]
M7%RV.7&S.5L.44)S<"-N%O@@.\O'HX7GGS(#.\3GVA+6B<2-=4YYYL]:8;9T
M>&$SF9!OA?#N2&;93OG*^S[KE'_@RUV9YO85S7C:9<QW%(!$PF1=&>NYP!((
MVX:68LJBJ;YACFMQHP-FV1[_)\T#*H-KJOLU<N1KYX\L*.Q*-LZ/I:A(%V2D
MVY#HXV5+73<_]CX5^^T+64=(0#R!) ?6YHVFP0_\N:I\JYU0/"<E1 )AKBQN
M\&V$>3MT,?NCV1EW_<JU'$VZY9DX%/@6IG#B**97E0>/5JKEE#&@TC87I<%2
M>#R4.NQ+Y>1BTK 1^EO@4A]5M>DSS25%MYS^JY6]H"LA]CYQ&<YSQ>A(\<AA
M/][E/2.RX)1GO3KG;6CHS_F\:(BVZO[Q_1YB$RMZ9Z!V;TSR>830P#JOFMR6
M.";4\4?)SJ_JA$%+X"DM 3;,/<Y347_I8?S5&M3[ ^4G[*=S3$44 ,</!3C[
MUZ) Q7@V&/ 022Y'A@(\7TVC+AU+5@LU]+V&4DGM3>7&##0;.A:S[FEWRD_.
M:OHS5G(THP#?Y=35SCWK].D,HE  ,>O3S H40-J]V+\<'^ARCP*$8D2 :/X<
M.K$_: UC&0O+?N:9,*UXL37*8:?<[$658VJS%#.-$86PDF NVT/*KFC0J2%)
M48#;3U>R#ZM<<S@H@(51Q^](#63'1L 6<(.S/H-2Q,Y->-E926C*\J)/U\C[
MWIJT:V/4V;QK7:\:5,*DH^E+XL1ZOT9\Z/ROA^_; 2MXVZGG%9'M#QI-*$ E
M' JIH%W7W=%W(*JWAG?#,1/A'$:D@9K^7/MJHQY5LE.O(^6G@PGT#[7#XU
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MCK1H<V\ZG;1)=?"H6O5Y5 @O,N#+$.,^S4\4N?_ MK8[#7F7&_'[S#)"  7
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M7XE2O+,ESV[D'F1B3A&-GK:]B]SU%99Y@Q(M(K/:1"2RQ+SGE1-R7WA!0H_
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M53\;^U7AJ^)"KCCHSZ;+0O2:<6]K@;22@F(TW6"%%@> AJ*&A\^D.Q:&W,Z
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MWQM/MY#O%7*, *UBR/ZDZG1!PI,\FOM""K;;J6=,%;TJU<PLA&H!Z'NB3#-
M,@DO-\K5_45PSU*/_2<=C?>WJ0KR*SN,;N_1,'^Y#&)0(X:,Q4YO$14.7)6;
M6*N[PA&ZTSO+Y3B,DLX?#M,1VZ((2I/S5I59ZYZ,BC49)"3POM*@QZWFTJ]U
MYW<S=]$R\,55)+[MQDEHEDH[K$/^LDS '99BMO@)!T=<H>L>H09*3C5<[.AI
M^[SXT -'4"K/%FM!%3T8=S#0=%U- B?V!&\\_IZ=U0*CVDGB#?(5'5Y:C]2
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M@T,Y_BXWDQVZP%L:J"]B2SN^4!E[\7>+,%CXJ+=3C,FAGV<K<V.&(9XPI]3
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M,3;8JK>"9K6C>9% +4'@2P4\4-SJPW2C"Q.ONO*0"B\P:X@=C<<J8_7/NW
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M/%I.0 LX-LF.E@#^Q_['_L?^&RR[)M/5=>%="T\<\^L<<< Q%*Q$DCRN8$^
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MG>L0<@MZ5ISZ\$HK3=9MWMU2:/%1,*R[!C;Z!+=$GKC','3?2!O@^<-L:8_
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MDXTR.LZB ! Y47\*T#XEV(\ZXR]V&]?^;@[,\IU*4Z=6TI,G[$99'K?X-.B
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M*R'[IX^UA$@)KR1-&K$>BAZ@NC>Y2<:^@:I!=5)(GX#@XN( \L<VGE7[R\3
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M>!<BYB*TL^/B);O:" W#CA'52S<&$,76JA^6=FH:&AW%RXC5(LH1PZP[7ZR
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MA!9#X?+Y&Y;/B@IGU[W!EH'%E5=/\B?7\#:ED97J(JSAC&W7&9FU:*/&<H-
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MI;U)*XILUD5?*W8=.@6$<_X$WL_J>]A_1MD%3W/)[5PC3<\MY#U3^FR*( 6
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MQS)?7BG%MA +79CU 2:$%MRJ,>'E!]@9K$'F) ?N%! I_C,ZQW.K !,K:/8
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M]8EF8FG*'G,*^#[<2>(GZ.#&=8,-QY[@P:^\[">,;_&;V,&X"P<U#Z"WC=V
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MX /I1$2:@&/H@?$@YW.>5B9F[2XJ:(%N.T.!I_8!R6U5F:G/I2!FR#XA*J"
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M5AT$?@$4E X&OC2;M686R:P*<!_0@ZLRF;&Y/RX'Z$3''6?9Y18*N?"6<-2
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M[JP'_:E'CP12)@-BV1(V03;-EZAZ?".(+F9QG%D\[58^UL+Q !ATNE%2YWG
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M=]SXXK===O)KN -O_=*[[V&?PUWTG;.O%CZF7/F$QW]]\H)?81[W[:M?")]
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MT]=)_8F@:&=E>)^56RE435!_S(+FIKD4*!OUANM=P7Q^!$DY-XPKZPQ]P=<
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MIFQ(5&H+*G8& -C&:3R6*AMW:I2^$07M30E; 3J^FX\YD*]A$0@BP9NX0R.
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MP<?1(%,8@M;)+7<-W.MVH)G&7QQ07 QG#!!KYN8/UTR?SSD1#%<895O6/GL
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MS_-#)/RVO*P>P#F ;80Q"L4)%E^P3>G0?V(5H'L_5"8]4^=.)9*_9&.DVHZ
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M%/Y$Y0>S3HR$_0+B'Y>M4191B'J2N9DPK:+8;#-&?3)&<EK8B\U?;BQA9O1
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M4/%45@'346P]H=PW3ORP6+T,/E[6P,T;1P)I2D/,V+0IMJR Z HJ_+]&13Q
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M3FI[5Q7\(Y ?.ZRARF1G/V[Z("HO-IFG^61=-T?B$DSNH;2)=N;OD,(HD10
M!+UHSTVV)"7\*<< ?L00.'FWF5GZ9#:45_<;QY*-B=_?4A2D9R?!31 XQ)W4
M>E*(;A*-F=:);#G^.IAS[-M\*(92Y$>18_'U"YQS#C4RRO5Q<>?*JRU_2[P6
MT>]B=0W"O;YOJXR2%J^'\VB:P0IO31@=@YG&0 -K?:DWWCPHG2/H+2<[Q (!
MB++7--&_U[PP;,@IT !5NP#= N1-Y*Q'-$FS,DAH8T.$OXG8W9JL'DN[575L
MM/:HVIGU?>O=3(F?;-S9.LFK?&DDC.5;V%"+U0>;!VT<<&K.\R&_.BO:[<4,
M%HDHV6P>GL-:'&TB@O+4-NS&)G@QV,;@,* CR$H(2>FVKX/?#EQ[?"IV^'YM
M+#^=7>+7U;I?AH]V-@0'4;^[<@VCCFY'$SE\&FH+6JX7(@*QE@2)QE+#I,WL
MGRPO0VY>"RR[E"@CN%O: <F5#F1CI;".&J&'/V?3N.9SLP1$>97D>8=]_PD-
M?<.")ES,VC5+ZQ:M[XRL'9X=?XKGQQPX)<^\XOO^+Z!(U:_T8UG)KW E#^*Q
MAX]Y.#JEZ4MUI8!5=D&N4L?'%1Y=:E@-GT!0W++EZN_*P<Q=L%%=X[I#:FO>
MRVLG#P(3%AJZ69O"2U=GFN&6S'S"G=6D>-YP1++<VKD^ I\P@7LRN+GYJ2(<
M=BC;<N/#^]XE.-;\M62-7:W5E5&%Q<,'DT\M]E"'9R$&43Y^774SE)R'FZ33
M_H';*[GMD\B+D>2O=2=5#*+E1PTQ3,UP.%G$K0&KC8T:U^+_^;F+B:K-OSN$
MD>U"T/D@,V3]SN[=-"*$MK6@3SW4+CH$WZJ2^=_QS-T*7('IN7U>^V0!-[(A
M-+6L-1UOY[1/^J#\P!I?#!X\WBGFFN@E)W*V! 44$%,"7F^:._?[H(H)PG*4
M2Y (@@3].43/X.FCA*0R?9M,IXE2.?%CY+QHGN"&1R(EC5<"J"D41)!IK>0U
M[<F,5J3/N4PG4"Q8!78<JTZ[^:NYND!)K><WKWNI/1\4K56VI4@H)J( I33J
MY0==U4<,J6,U@@,3\V];DITK#8*,VIME#*L.#V24>' =8%1\L 0+A(E2AO04
M[_].MIK-Y'_E>!'DLP%VJ<3&)RQ!$04!(>UQXM'EN$R#1DV+!S!C,VOO:DE)
MMDY!A:\W>V0X"J^>?%!:_J(6N4#C7N$8=7>_&3SGUSY!\;-@\3 UL,=J.R'E
M^,/BI9FJ6+43YXMO_B"+'JI]V[F\'L9P>MKQI-=?OJOWKY;!5NVC%BAQDJZA
M%)=Z0/#GFXJ&X&K$S2%'7KLH5UNTN6WF25G]W@I]$^5U2>74I+?SNRJ0[F5/
M8LSUXGL=&>V'QK_>\(/@SSAW"AJS[HAG+51N&6*G G#[4=SU=0>#E@=3-7U
MODDW&]VHX$'N*:\A&;6FIKU=N!;=BD?"8M@T4),%;EGZA)'(*OGHYL<K5PHR
MY"0#@=84B[4ZT>+T51QQZ&-43M%7)9J'DJY*=.:NYB%$.DVWO2[9O@95PA)5
M+U?.(=E%$FFQ<?-F%E]3TP*=-(F!?&'>!N?&$76Q2F)/'"TP'F*F3-F"4WWL
M3]YYN-[)=#QY,A[+?YJB%$#F:0E9YKKAUP "5!#67=SSVC@>T9B9_0MX46T?
MKJRM>G#NQV?Y,ZMOTX%2,D>,>"HEU#X(_.*.<M>6!*[=S/(_\7<Y*;:,5[G/
MEQ-DM )B>8 OG^G)EM'_) 50,A,6_$A!$9-A,)#P?SE#]$3=: !=X/_<D,\8
MG&W2G0VS&(LVV7%553(:5+%G.SHN?TM]M3DI$M@;P%UUM/]5)4?O>H6U]=S/
MITDV[PO7L151@2+ MP3!%HNH")]],7\N<K0U!=44US3!.>D%A0N@(-J<6>-@
M<2@+W*#5.[/D3#?!T<,PK'@U CZ'\57+:E4E[[E+L^ZL<OSB[BQA-]L4D,K^
M[>;V==]G,3'%H#KS$*1^OG;/PNT%*8^T) ._9H;[,.7HI^77ED/2<'=S[9JF
M/U<Z.(* 6CZANU<M?N6GK-=<9*QM.#43'H__K/P."@UO:?*:3O??E@D,]:H_
MME+3")T?V1A]WWX,G7EY9L%9IC;FF9<^?KMCX\X"G_^'S+V,KB^H>B#OZ2'1
M6T,"D:R*->GJVRF4<M/'&MX]-:U3./&VPF3WWG"]US$2=AUY94RWZ7>NV4\6
MZ7IN?*'@AYQX9?,%;<L2JGK<A<+<T7E#4WIJF;1CAOH<&3<M*-!OI:(Q;5DH
MQ /[JOIJ^SN'R*3-%:9'>O6(-S]O@^8"%_(I7.6+]O!XQ[WG1)BKDZ58P?/?
M00VK;R?RS%BUZ$Z721M^D4ZM(U..TIV6V_F5UYUN^-0XC?W).\F_BOJ):NCY
M,[38WL2[!P:#4ZK3K- IWK=3D)4IBO<"2_]>OY?8'M&WK'GI+06&AP3A'-Y\
MQ+-T^KC",R94\VIE?<*3C&N5(U]*R<>)Y3VZ"1MA[$:Y7)*8XN(,^;ZP')5H
MWB@>(,VNHC"G-\$D7OD?L?15DL;'^];]WJ(_'\C96WSL$!DZ??+JWD^.MZ==
M-B^[EC8$.S*ZS44;>*KJEJ3[R/Q^10OJ.N_723N7IU.UU^BB-NU1%B[DD>GN
M9?6+B&;-[4P$C@"7-(,RN(OR9"I*@$ 0!H/7FHQQ(+XH)V1Z)Z.TOF $;B1?
MM6-OP<'J,^+JG(7,>RFX;FA&$CP3:#%5Y:UH66WDTGYZ?+/[EEP)-%R58RBA
M12 ,+80N)\V-AF$KG"S8P Q0L(0(>M*2^T-^_Y-'X)';C'P'1U+ZV;*?EYJ*
M0P831D^N'HO[+V37[X;3%=]N6G5"M9CQ G<Y5W5(RJ,QDE S#KD3@3!"=#@!
M"<>&<W)$O];FKA4OT6+=-X?'VM3;N"8)2S9]^]\.1TT]HFSB;JVGO=%P@^J\
MW(097JJ2WEI/&Y=3L^'MHL3?6<D"I7&V@YAJD;?0WC[7\WW][P[_;.-+%]'S
MD2V"E]1Z,NI9V(5_4VF7T1B8MH'D690-^Z_[O2!?64@?/EF30/2<88F $(K3
M"\?G!#3$(*]:P1')_V@QY=O9U ^Q[P)=>U(8S(%T<Y!I=7SG?=&R0&Q(F]\,
M&HUY_DC,@/7/U'K#-3FJQ8V.^EH^&248UHW;:I*'Z6K'\^2Y_=3!7);\498I
M;_C#,3WVX#"H2^6S-'!@ST0F>;S\K.7;YRGE@>"O5@$'CRTNU0\N/#E_XW_D
M=MP<XO*IS;'T>4'4;O\(24'LXT*UL0T^G3C^[BVN]:CYH7/"4)K8)G#]VAMX
M*2'W8J**I*L91!;7OM!6*1>I3&B[7I.=LTHTA7UVG#())WH7YW2D^R%U%LTQ
MKSO26=3>O)M]>3N_P>3ZAS=A'Q[9*=X?/-J8:YSOETQUFF*Y]LU!7\0)KA"T
M9C_7M&89*"23).28.+Z@<?4Z,K.HX$'Q&[_13I? #^#8X>KJE?Z3V=OUY_\"
M<%T!&,_E:17CE@BJ'W5G=*%Z.6?JL+4.)DZX11#7^X1O^IF^I]-<6U^3B&%]
M8J? RUDZU]. .AN#W+G50$W"SF=1!1S#+JGD@!SV$<68B8K\ZJ$_/"W*3K%M
M**(#UE@AVY1[MMQZ=!^&O#T81KST.FHP#\W1U#7-7=/<QP-R@(@*9B2-CQU?
M4DPLBM1X].*'USWJZ:@OHW8LG1&I7VYP6?4,K#Y(I&ZS+7!F=#A%;>Q99&65
MI-S*S*SF19;FNBMS:N/_=!QU?847JIZ1)R-$:;HNJE+4H8\-7+9&_=77R2UJ
M50>Y#T+?@)T=I,6JJ<[_90EQJOG+=76W9-/J,T5H/> #>S>WH;DR.R_>XN>?
MV]Z0VXN_S^DQ")R[&!%(6T5]E;2T(JIEW533%\R!G+GINS2K_$[F*,'S(>G:
M_%3V4@Q1Y+BT85&  E3NLX?MH>EI=[2#7A//H?Q4+S<)YN'/0'R=#(5;)])Y
M_Y=>%&'JG&@N?\*ND!<XRS?H?R/CUF9Z]82N.45PYZL;'%T>&OH3:?&A]F?D
MGPB3'>H/S$3RYA4?T X$#L2!_K)()NY_OP[ZPW"$(@M<<XYFI5J';_-)P)F;
M:]]@XZ64:JF0"0HFITYNS/)Q6)UPB;C]J\?/VJFGS-N,PP(^5_GS(!8QF1)[
M"]5USVQ[L4*>]-8WY?=;GB>;E"1,+#AFGD3+M!<73H4(O'HX8\=IZ+KQ+^"#
MCG>%@GE2?;-)@8N$6<@=>"9G4O-Q&9>LGVC5(?%2W,'!UZG!Z'>/IT$9HH'&
MAF&:?:N6[C-X<>P44DZR6GMO!=(/D@RQS)-S)<F6$2)',>+VJ@;:F PYTB5B
MWU#X4!\\^:L3;OW69E^@&^0H_*:H7)NQ2( JU452ID2UL$68G=494ZXQ6=NV
M.'?J@XQ,5YZXN [3[A!$0C'-ON$047&AXF?%P)D9K<JX?DP0K;SRBE;%L_1V
M!#=!6L^DJT4(K0=7MRP-'N*BXKOEWT1)VL[H.*2_9V'TK?2V\/&L5)UN3:<2
M?D<_&F41@*A3L*';C#C42F9OLGC<Z/&JOJMEB]BP1T)!E _I3B]V29O6,9/L
MIC@5@MM];^,-!!:>\<]I98MVOC(03)0\[GB2-CO3A/=^KINT(IC8#E\?0B$Y
M&(H^]MT.S.[V-UX+_L(K\BW4\G>(D(7)G<H\Y/2=[?D9RU5@P^2SN37W_:C/
MU<QXV)!M"!CT(G?62!=_;LY3X6&"76"-P.XG?;V&/66OY5JPSEKL-CY3-1!M
ME##&5@7.O>)5FR/T&^ F;KB8U/_V(%4R!?+:8BFW6ZC9K:Q05<'O4,@X_VD6
MPGDMS#&A1NIFF<"([BCK$,(5'FF5:_["(P3S]R@0U[8.76)0&<AX1%-ZB 5)
M7J!Y0@*/ID3QV$CVBYV6_P@Y7GWR8>LR="?DCU%XAB%R8*#T2<N].^:MQUM8
M9.6G=!/E2L=IX5"%0TU7FSPWC?>FDAWM/E6V/LUB*Q[B*!:4A,3>3Z8.)Y+X
M)^W:#S9CQ;84.UES8U:]P@^IHYX-9'Y'Q[8&3DH&MUR"V5JQ_*2W0RH+J&*"
M4.->7NC=&;C8X=]'X/<N[!Q$-: ZBO;:YB<.[K1)N^4CWZL,I+_]WO.RB>3=
M,+:K+SJ@<^5Z97*..JOQ-RB7Z]Q8S$U=O!@TO1=U3[[MEKR!S@0^MKFR*;HT
M1-2GW*KBWJLG\W$'\W$RAD7KKMEXQP]23JI+X-\)OW@5;+_7;E9J],)1]1^"
ME2KAF$&KA3C%4>&#[F9#B.9945E0L)4BV&SP2&!(LC_5:N8[BCC=E'0>P.,D
MZT+#]-$(0_(^N7[XPZJ[_\UGE<3HG9M&7FFYA"%72>&X7'<5BG2\Y&$YJ1^L
M^NKALB6/+"C9&/SCDP(H_CQ$K3<)0SBK*G&J4R2 G&I@3&[C:4VT89AZL3;V
M^?JUT< N;8\>RP3LT<@(=!YHQ\8@'MF]7LNQ7E3\C !HT=2%?/'TI7[*#<NT
M&JL(^F@<:<F:@7< F8;>69N\'C9XL> >0E2M%2\\%\"D- _>_&+X':HGZ7_[
M$:6;?5^_IZ&D>%MOZH*_OI+JNQ^]Z/YH'<:NOIJ3PYZX!#BDKZFSY4W*_%
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M*F_R_$/0*9:BMKX1*.J'N:R7:SG#93:L.'1'^D*!)$0,2 P*9(GAI\;3ZU*
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MN/EIMO/G7N3 ]5U]JP/M5JRS(&@FV-,7;LMI*H]"K?RH+0EC.Y#E.K])9?^
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M>630- _X%P!^4OQ$F1?*L79>;S]@AD>0IM^.-U4KK#41 %<V+C?JU'5Y-1!
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M5-<DX*%_P8(9=C5(9$5P<J7FRE@[&+7IZJ+2=\?MK,4!U(=!2K$<8##2# M
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MJ)Y\S#>0V'M-@[)9Z13=@4S)D2$9QL3+:LUDO]TGX94;%#;EU,X"8@GDV,=
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MJ]@IUT]U";\74CG?Z.B$CM$N^>-5/PJY+FBFUF#% $"T8:7D#$FS+6;T-96
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MPD <X-V'^:@VP:02S4=A]\?S _6V7T\B]:;NV.8:QOP+@)PO7A3XZO3]LV4
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M$C$[8U?:!:71;].08FA'7IM%:&Q'BU\N+[:UXXPC:6?,;H6XQQ'_E_)J+@"
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M%]>.F$]%8HQ?:6S$&;SA#<,_ B@!C46I$5@/ZV7V>H?RS?!ZMQ;'4"UTW,'
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M\#4,,<BO-M<GW1FBQ?*4C6TU[Q>P(G0T\?X&6/-;:@0Q4; H&/*_*"Y1]EA
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MWYMD>LX3IZ83?8+:\JE1E@J%'^+U!OH\2H;Z!$X?J%9O=0JQ6@8WE3?'1:G
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M@4KDUZ<N'<;O+[JW*]O=^99:/)I)]>XZ#D;REH;K&_$.^WTM AFOB03'Q;$
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M@5\C#=/$W?Y?LOM?[2@?THTZ -W4CG1KLG/UH/=.%M(.M3AM@8C-/Y/\,I8
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M%"*KP[V;P<\ U<VY]\MX"W7 *)/1Y*FVM!]@'3L(PD"E&]NZ8-@LCR,A=.;
M;D+7[11W!.2W(Q55$JVVMM)^_6F2)S,M7.)N!K[#L>TMLF9PW3&DG6*#=YGX
M,'0@93IE_:4/JV==BX;:1?.+PPT/:B*\W/ \U[922YC%#.&OKWJ59(P-VW17
M]+T_Z%IM,>8]I=>L8*+>=I(F1U^2 X^$L07I9S93V)J&SCL,L@\=@ES@817+
M+9Y8DBF4&.6BGO=V$WZ.XLG_&>5?Y=F0VJHHXCG^:_O5.+'RY338N@)BV@,D
M*"']OQN>NERFPNO=)FY;G8OH$<NK3(?.-+NXJ=\5MM'&),#U2V3%_8!EHXH(
MC5NZLWU8,98P3$O7<"KXS$"D/ V""%9/E"_6^;YL]P7 Z\BDV2.AF:6\-K-@
M;&9Z5G'F@ROO,F?Y<SOT[67X7X?&@TOL"7]')6_A%\PI7E]D1YN3F[*Y2!*&
MB31?7"5V!I_^_@ 1]O(>?=H[0VD&KMV%:T^V:[!E]PI $ND!4:CBA5R6/1 +
M81>Y$A+Q"\_"Q!>I;2V*?!;%7<0B8NRD W_COG>@)L 9=0)QV==1!,;Q_;I1
MH5:*5=>T^I&@L-3^ !>.ZIZ85Q]@H=,1\ZA]"QQ43'A/<S/A\@F+/7)0Y%=W
M?2F=3J!6/^",L?16A(@"V89TI@7P7<4U)#%-3"@,-#;^-;X;4[TT>JXTRZFX
MN$?;H^E3"UZ6JEIMFU)HZEB>7"0/08$S+3V=F)Q!S\/"95C2U5]$K2GGVQ&C
MU3AAWCJHC'ZSDFB['Q*+;!%@Z[-THF0F#E"+D2DGJ<6"ON\K!L]^K(@/S3'5
MIS.Q]ED1U:$1RWZ04_8558,.[+OGB>2(/?=TB1[U])02C?1B>$EO<IL>!7_%
M#768Y0CY,-O1Q)5DIZ) QSJ#0"2!4S$RDAF"K=I.XD]!IT.REV1'_!=?8-?I
MVN@4"X!BT$3#4AD5L1NW$(/.4*6^GFA@_"EVC9YB P=J^U/_+0M[*!N.ZU]<
M$)J*Z-RI;78"$'1@@ CKV#(VO%)5V_V'6_;6_@)(BF2N8/K2[:-C7*(TCX&7
MHU(#U4:(_@:-CAK6[F9(?(-ZI6%^ZEJ/OQ@6P<Y"Q'3-.2JGNA/P3>FTEVC\
M,CH1U+2K"H._CIOSN!QU9^G%H&M_:(OUX3CIS*-DQ&_L\SL'%UJ N T@Y*=
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MM-!-!SLPW*?MJ\+5A,+9PG42EUI2IB4]1FX?[ZFT(*D\>M(C49=-T<9%E/S
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M;74[\U+"PV]8Y$'@,Q_>^(%_HV386+(S WXNSQ<JQ:BPOGGZV%9*Z-<Z7+N
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MK@6R"EYT2K8=C)&O]#L.0BTR@ 6$F$6=<S D-]4 \%J#3D*@UIE>G^ZFAN.
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MCO<4OT^@);K%I$H;(X)MN:9JI_DC),5L'N4F2G'E:I@7GW=>LTP6 ,+T=D$
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M'*X,&&$2M^8V>I*HZ<K?;QUI>EXFX(9?5/,(.LY3_>T<Y:,;YZI]<$_4[D[
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MB)N]#PH/9NKH3<'J+86>G"OP"0/6\_8F3HY/CE/V%CJ"23];U86C]K^TAZ=
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M8WG=V^XYI))KY^G5V8NUU:&(5XEE+=V50!=/WXW17&^0;=M0W7:\7]?^+E0
M?>R*2!G->VAZI3]IVT<(ZMJXTMX_MB)=M\6Z8B2W3*>9W!1-F4&I3NM=EH3Z
M+!BOJ4?I5'[#C+U60N3.RKB(;C3G"Q^;0-M]\*:HA_(7OT_QJ/QXK?2)],*X
M=K@7A$O3)/_4BNG6MO=:H-ZSM3R4&]SHE &LN0CKM; 7$$>GE-Z0:8&(/>2[
M0 G7]=WLM7B"O0F,JWT)P+(P43\VX10):ZUTRJ>D-=#BO#D)++.R+?*I<JKQ
MOQVLMKSC\Y#M1ZP&\X^D5W?,0=FVW<Z5OQU7RS=<-\WYC!G?[C00WFUD&GF]
MF?-<W?\UT6Q!&'U7^O/)$6J2"WU_I6 3PK.HFO[RJ+^X*+>70/WJ9]O$@KD5
M(Z=RC*,NJKJ)6]?%</5:2YSY>^K((L/%#U5_ !$'](/CB_!8UK,[IQE29@CE
MHZK*B3MQM_&L2[BC)#]<H]V$%O[4X$Z&+(_)XVA)1F+;=4F=%<.GW1)-0>>A
M5\=SP9_&/)62&8FZT(76L:=#2GI2O6]7[DO*S9VXI6-QU\8#)(:6#=V*"Q-9
M"?,/L-6NWJTQ$A4T^DIWQWBT0_13:GM82V5VPFR*9,F[ZCE1]3T!3UU>ER[X
MUD9:E_OJF<AO^AK5FG[]P __G:/<.Z\P=.K[L+*UA3=TT>7NO(EY\6L1A;)7
MN!+H%QN7X26@BS<072D%?.#G8HPPF_9,T!,XXMK\U#YH0!7]_4Z62R]HH%=J
MYU7V0B1O4SW\#X#LT93U(M MF4/H$\>\FH"D&RTZ3JBX=LV,F&&5L20=PR>#
M'5N-R9$9.9L:9P@1.-4+G"('?IPS?44#%C6A*J7MM&+N9BD/?&FP<G5F]4XN
M6LQ\;E6K-.K'ODS!-\2LUW>Q8P)MYA@,-K )"VZD$RGH692Z!&^L<\LCH5_M
MP+$3-]G.7G](66WV\M^A\M#U8+^S/*%V+/ST;_J!8$Y2O-/<O]82?T-EDL;-
MVMMC;J8%IW PAK]$9LE/95F[3F'1-?T2A]LQLOV@%&-4/!R+8CD=7ZUEXC$?
MJ!/N]9:4'7#]CIBWHN,U[)S3F_&;%.A+7;^QB'0NX6]P&_QPT.[5YP:WSU=N
MXEPPJADS6P\4(S<^:R4B,FP=;@QK"RJ7]T,Y? 0;UV[M%(=T%U8=?,4%A9-:
M^U3*YCV-#$M@ E $KA"LP8K[9W\7*R4"A_? $83L<'C&<#XNO$S7X&U03;_V
MRNRO05CV ;</QSUD!["&TT.AJ*N'8>_CRXR6]'E;>S<PA%(%&RVK/BGC&:7D
M5V7C:1EAEBCKAMU2]3F86N;Q-_\4%#)*24UCE-=PZG2<A1G9XV:FM961>9^U
MA8F3EB\SU)#!=;WU[QS2A >6P6DLZ@EXZ;8^ J[^A@82DLM-4CR?R_@872@]
M"71<+WIQ20#[(9-E_4;[DV>WN#?/-#X%9+-,^)'1]+><+3OO.E&;]Y%:RQ-X
M#_D-A$G *C>U60F8WPPVL^GST8X>5(2X9%_O5FAGD>B ^^EG68IW75_.FL=]
MP9RM*O_(,A[W5&ZH_J*'X(3.4H"Y?;G3RS)HW.[."8[V&@F^U!?-I-^]TEN3
M\&.F,E(W*(,WWGC>NB-L?Q- V\4RKGN?:LPV,KXW8<PC/_ZF"^VGH"NZ!=W6
MC<*!)GB#6K\:6L-J\2?3)3'AFFB?EP0MW2]9"H;P@ &8FWM.=B8 3.^/.F_@
MNJVWO[1L:0+88>J!17S5X*.AA%*SYD:&"^#V%+E3'W[>N,H1I11-6D:0YF&8
M>E$:D(LE&(&\JI$AO*,3+<1FJ0-*OE.RL2%>OBK>>NY*"IFUDV"N%T2MS3*2
M"OS!L$C_8S?A3'72(4@)#X9!$7W6.(X"1 :U/XF2%8OS+Q0#@T"Z3:5[1K8D
M $(^P^;^N)I6PA7GBR+K><DR\=O+TW$;.V)76YHIW+TAR:TH6+SJ/J^N61K"
M2'98Z%'&7%>ZD%B/HV,J;7@T^ZN;.WQ^R1GSS7P(N <N-_QGO 4"D1NS=E_8
M][/PT,&@+E^UC43Q^"J*E'+.>&M<NB_S7.O2@JE^+9]AG^[3GYGYTF&QSQBY
MX;?IYBPJ^\>K)=(-4U+YOK.;A90W/29TU!M]9IWQ1(I?Q4G80A.V[4@#-4YJ
M#ZFU!?;/C.<B1TE#(ON\[7+SCTOPW_;/;L-/FPV?9*T]U=VW:+=]KIW/#4V[
M-1A_L_HK#XQ;8>^#/MP?I:M%F%Y1V/8WH-X_ UU""97,,:V^_)BST'QO%S2<
M2JJ2'E@(HQJ6->ML238Y63>L?7GWQJ]@#'_MA?9-TS%.X\2#N)2L<_-MJ$<O
MKNBZ<.48['CO<3B :SK1+\1(A/SC 69<4BRGY/(:LL8VVY]]PA'CFI\N&:_(
MN@:'ZL?N2NUZG(<#U13YG!KM>V92\DQ=9D*$OLRX@31S%G1_(9AGC&][304^
M\? JBY'*4!) :%0NHDH1;#%F"L&?E08J1:/+!Q!C#8PDZ"8Q.3BIIB10[(6P
M9KR8]8LT >V4"VR7@L5-U)>8B<V'$OXGWJ=,4<>%=%L$9MH4XN5V8$9O_VPN
M</[A'P#OP]N5BIP6HZ8L_I>]Q1$Y*=.!3QX& ZQF7OLQ38I&4W=MF1.[</ L
M#NI'Z\/8+FC:*],QX3Z_*S6=4&YBC^UCPF4UOC$_Z&UCY^P]Q OWGMVBN9L,
M<9X/!K(HLTW;'^',8XWGSGD/,F8*Z,WF_$4<2U\&7GHY^,2SCLJ<5=*$D_*C
M*:-.F)68:7E*WP))UR<!Y2'JJ:%&?03)-7;(-U8\N='#XMR(XV 5J_S\F^H@
M?1E'.%9])$*(^0/(1&8(!];B)6E+(E/JW4"BLSZ)KSLW=?S'GNBMWOK^!X!_
M9QY2&&G_-@+UJ3[CJ-F6UU/O ;U9)IS+X^FQ21HP4Z2X/=HDS[O^;EWZXDKP
M3Z^J-X?7WUV[>Y\'P@+Y Y!9LEPZB.EZ-FW%_U.Z9%TZ[*;R'7_:TY2SCW\
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M=W.\O_S92;L4*&9%#Z03 UXV30 *8%FC:"3=9GP!K*$O\4)L@;+5-_52<@)
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ME6570-.FHJ:O2H'1-.N=<J5_ 5/5D&6/.X6-7@4P3GEA%=LVJTP1DUAKT4C
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M.?X"^CG1M+T"-]TH@+5=(K*GEL,S^Q6M\D+["*E:!SX9%R%"Y!'=O>Y8<SM
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MS1=1=#<!O.4_[2A$'#]O3#Y#$ LAZB =G_M'[D[:*';'!J\<;T5T"8PL[Q]
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M]M[#3GGQU#S?N_J-C# YS9SC3XJGL<@1\Y4#JXS6U$Z3*-:?J*TJT;PA]NC
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M#I2Y4XHOWQ18T33. ?[O)06@#P?( FY%L8FZW7LSX7(W(!B:?7R7QZ,T>T
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M 8+#<J/O61'FI_M]^]9"H(MZS%A?%_D8=EJS/\E8'=ZNP;1?&"]L\*WP%J,
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M98L%393-'KFN%WGV/X X$]JS<'^,-(/0BIAS+Y%JXG!WV]DJ;K$V()5\S1H
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M\K&E?9LU8AF:+MY;=HEH^ZHBY!>3AP_Q$(.<U.<K3X5\F(OZD.G? .>K>;)
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M- !\GA=_S1%>'+7\.-2CK&];>$7RZ>#+;R@T$&J?<CDA+'H8+&*/9 XZH:3
M[=;/\NG2'##YEA=)06H0UNFDN0WWSW4\G-K@8C)?81\(<**B_RFGZFYWL\[L
M3WW%W[_*&>VA4];G-VWAM(5D1-86,I>>$OPJJ3^A[W"2Y54&^("MU(5>D7'
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M+GY3KH;>VSFTVB[E^W1%>!L-@\3K(4\@?^]R(9.5*F+J5B9=E^1#'V,.FQ]
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MXF=*YZAUU0?6B7XZPO&L8G?W>B,Y8U+Y9=)+!A*F[CI$I<AHP"67H 17G1\
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M.3_NU@LY4)B*&W4#".2-^&_C4>I50>J,2] (H+ ZX_\,NZ+2(0%!5$E .AP
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M\UVKGN=#MIC/EG">OP#>.K.K8L-0$["/3<+%U[H9G"X<XJ@X=>MQOB]]9(L
M-A:(*O\+$!VU6]DGL:$.U)?$T>+'(J66"ES*3"\-E(QIJO$7V0Y&,I$'I",,
MIC>O2WI5>5OQ\=I/!*<<@>)2II'MF=[<.3R1(&'.*FV-) ;J]O)05%(%#ZDO
M(J[P@[VTS(.2<7VW5";>&V[)*@IK^G#E$9V?Z_(7CTT+\[^PU"\D=O^8Y!)L
M:&:ZXQCW6[CNA>?&1I_#PWN<[SYD",MP&^_I&)F]HFTJ)IV2)4<\_I+X<2%Q
M@!"^QZ^JM7W$ON-6L] B>3!@DXAK>O_RI<+D W2*[;G_1GOIDLT['A;X\I(,
M.:E:+# &J% 8Z=1\WBMCSB09'%;C?">NCSJH8J9AS&Z3I^C9RR'-_IN32$56
M6V)Y_I]0=Y$J9PM#\KB5?C.SPT]:(8D5653[X:8]SA/!.#4>R2FBF\C^J@\D
MJINIBF--C4O16V:'*DLA:I3;/ALCR_C9)/C,&L#<P= [(3>IN ==,R[45GT\
MJ!X/!^_@^(/W^Q,4AK!]#0*&*3//4,<]J*B4,M.4%E.4<$3B,)40_-UDI-^<
MW]P11X&%##A"%C)%+/>2N12!N0M;:R3B= _4WY&_"B_D*'5LG4V,7L,S2S^L
M4H7S.0]);'20Z>Y[K 4V_P4\IN@].'4U^0U(84QA1(4RI@  )'4 NE"2(O*T
M(FD'3I,"'R>X6!A6K4 &K[:_^C0+/<4WZNDU<PI6W*_?;IVDJ@!Y?%]O8V]K
MHVW:'0GYE%6@TC_;@<&*6&,LAS-XD"BZ/(+O)&T;]VZJOK.C!KN:B67V']7W
MDE:&WRDE^.>;-$;W183&O $,2FJ*G*^8_2O</V?J%Z\YZ\X!&*]BC.=O2HCL
M,!#H(.D?<GX<B/[N\.=B9_#H&%DW'HF_87H.[&ASI<.V*^B:TS8M6A.HWUC2
MJKM&\AP4//S [R),GF(PU-^.C!"NIC)1SQ&!F!IWKOQB)!&V<$?E;QS6+Z1V
MM9CV-5PM>*.6!$83.1$IZ2F7^U)ES"4-T"5;*&18&<"QPPRK4*NOL/874GS6
M;^ D8U1>?7FS4 OQ<A2JU Q:='5564.M]NB:"/C."-OV-^18B8.UBMT\[=29
MV,>-K1MNTV='RM53;5FYG8!2,&5M-@+EHD[XOIM[[L5K^?Q5Q(U&23?Q5G2L
M9)%::!3 R$WC5I^:)>03;&4]3]N@_>!&5>F?B3A%FHH!L*0;E/G[+8OJ*.ND
M]#!ZWS9Z%G"M5%L#J8W==<4J/.H;13:."3NO@78AD885.- -U^AC)LYE[\P/
MF6(D>[BLF5J\J0"B+V3)?&ZP6I@Q]T@T-T3:"JKP:YX/@[7/HX=61YSE,!G,
M%+"6T*-).M7#&3^*<GY"A7I^'TLT-8,M%8C./^D',@!$36@52/U:*#K)P%ZC
M@"D?PKC0&@X!K89@.WQ^,V7K/#JBHIX/:-Z\!/VD=^<4YU6F!(1JEDJ#=3&S
M!IH6:+LQ*R9U^M%&&5C=6O6GIT%ZMX7:IU1FFAI/W<,DDF3S2_4C-Y'U6GU0
M9J>!HGB/G[0=V$*L:);\*0%&*\,L<TP]IZ,\3.;$\BJ!BA-U*E*H5X_B-GWE
M*:Z!2^3<AC)'#6R*#29%<_FY_P#0C];M5E#^ 67VCA)R?[&_WSGE:1VU"YEU
MJT58+^O%\=V&38 .>624QGL@KZ</9PR+(XK.;_TSSXP%SZ3\H>:[AZU15FYD
M_88*:\@(@=?#9*;,_1FL'I1H:OU [SSR9C[1\2&';BI=83\LN#FT4%MC38IG
M\672YPU07'Q[JW]BS]MO_++2F$Z"T>TEL\U*7S$0OR,SM<X1NXG2$.&+(I:7
MY[]2T?_937EH0P&^ %H8$Z=5"TJK!6&6P6.R_LMH@?5KMY;R:R8@3]LR5X>E
M[3AR:;-UQ-\ZQ\./<\0X/P\O<T#T2I75?V'6W9PHV=<7/@M^>'Q,Z7=E,I:>
M!-O(,@2:7L.Y^&6XK *C-_!RB6-!N-N- 0;\E!T5(?CE3@,%3G7%*9WYO.]7
M+3MY;Y(&OI8V(ZS!FLRH*QWLW<Z'U?>@:X$L2>@5:1GP#EQ=O'^AM$#RH\K]
M.N?A<]A,,ZU21]L?T#J[>Z8:?5_O?B#=E+G9VWM#('W[@9N/3&CN-:<,0R!:
M(9AG7";+9^RZ+^V>XP/E6D2V/1$R!XB.ZG)"L[RU@>"V:*N6.<JPR8MNY*S=
M+O)JQ+^D(J'9U]<DW+M:5%OLPS/CTI,[/7._S[@W#'U8I1]_$AS7>LQKAK11
MQ0P);;CE<17WLCX1&P9E3^AJOP:U;Q^]AJP965O:38!)[# SGCDU&6;EGY>G
MEX]^-1]!XX/CQ!-';]UYK21RL%K5[+\?2RB(?=;Q^Y%_KKWCH9#1\]^-\HJO
M O-W6W9AK@_6N@O 8M5SO>7ZL;=+%'HYI JQ. @57,@/E7BZ4U%I*,2:A/ZB
M0'#\O?PS4=E/"^;^DXK2Y?P'OVX@OB>];LK.KUF.[=!*.><4&4 ($<YWKK2B
MJW?4"N=LK2O1CF9!G3:RBX('DZ:"7]NXH(J:A%Y^ <R2&XGV.+F,QO[,6%1V
M?E48J5[2I!6LZUSYOM/IF>AHH!LG";61ZX_=>9,*M((_(Z1BZ-?)D8=C&WB.
MKTA'(ZU4MP 4,FH3#YO:;-T]**]^#I\8Y@#R" ! 7/Q<.BN>NY,<_0).J?S<
M<HO#[QU[]-.'P.=4X5S\B9);+T0.?S(7D-1S+>QV5^3J,K-^:V94])>TS)*F
M?2>H[UH9T3N!"+#QMA!TS-+E\!6OK6U9 %&&_$&XP3.QL?$N5N3S*80X_^(Z
MD;8(!1V=H '847&14Y'R:T;ZOL(@=UE]:K1WA1#/ 0E/F*HB9PNWPT)JZR75
MK 2[RP:S]'%.N,I!,?,\:HDM6GSDGIMA]7JC,$+Q$^\F;OI,E;QR$6OB.AA"
M^0J%I8(PI* PY-C_H@8J0_6/00&<-T//5-E)I5'+UI\M!,U49!6%,C<B'F0R
M8"3NU(NHS]FG7!;-RHR\EED&M[Z.(9+,F[0[FU:(%V?!5>IC WR_%]4%=+29
MQ[/NZ_O>8%C- F<>+<+B=8A8GHA#_,9A,UTN10@E.PDVCOINXTI3O*X)^X0Z
MT4<KGJ5N,?\R"5EF_@N_J!]MOA8K\M\!2[L):Y7_9(1C 7.X@9L'8FRW#;F?
M:[UB@.YHJW<J0IROZ,LEB6F[E,Y^)L?JJ:LPEPNDN% OZZK@R%0?; 3>4G*L
M]T\K61AQ$^=%:5>&7D>T/'DA7$3EEKJT9.3PFPCEH'AJU@88^&Y:89'\Y$_=
MG+2K",(MY7@N?<VNSYWY>$F&Y.2QNWX!."/@MV(,-'05'B.0IV'*N>Q7RF'S
MJ94 ED&6<?JYP9L$7N$\K*@@VAUYQL!P-RM7+C-X @WSX MIGH]97)8.4REU
MA '%I)NYPCQ[U4G+OM4^-^QYF;;>WCY6R]F@_'B,1::KHVKZ!,KQH:8E;0"F
M_1_L >^>1? ="\.YAOGLA(2;GK6+4-/)$4Q@EG\!O@%6U@76QAG+)C;Y3T5%
M0)8<# !2D[GF[N;N_C=E?P%?9.7^ H8]+@\'3TK,KF*#.E&>S5?]QU]\SZ8*
MKFSD%*^RUMX>F(;X;CU8^']).GG85W74RG5?"P1E3[1.[2=X*?>\XD8WWH+Q
MI/ R0XE.=PUFB1XR?P&,C@9>XQH/]!*N1ECN*J'.W\L2M9V:K!O?^DU;S@QF
M]QWV2#[!#8LX)'/=/>7X]3GBA/6KM*4\YMKSO.?K;-#X<.MT8F#TK8OHH/2*
M,9\K(>:QA'OGOL&IX8,%KTWL_20_$(4$PL9]LT^_M5O#]7XR;82L_!)=NYA8
M17."6^'X@YX9!\7TDON1(K+,/Y/%6K?&5V/W*7UK".73C[UM&U"PT>8 DZMO
M+X;EIW?&AUJ77JWR;"4;YKIH $7>P4?OR;_;'/Y6&3??[0ZQ3$[M>+'W;$I#
M>1AA!N$=CFL.3&A%8P5\LQ_QXT?95[FN^\&2?IL^/I""QE'V"Z"\^,P$2TU\
M(PWQ3""O<Z3EITGP?GKKR^WKP=;$L..MHY:&CH,1U;JVS7SG_%._H19S#V%8
M^DZ63RQ-^-,MQ[>ZG)DAPT?0I(U+TO$_R.UR405%]S_%U/%H(:-#!\J_ &^'
MA8"ZUX;$-L]^P[5?CPJ US,(1SF/.V'#;RXN/(:U5[W%-2NBNV)I?D:4W;Q\
M2] V<+S8"IBQ_7&ZK]S:@L34Z'W;M-_)N)BH\<'&>QO-"YV$4,A=0[T%Y8>;
M+2R;P80?XMZ549)<#S;8SZD==^G&<$\0<)9KLRH&8I0%XVNULMPDXS*K YB+
MZ/%<LLOJPE_ 3F=F4L&K9@[K47SEXTZJSYCO.S/.G<(=@<YSK_(UE"E.X,TV
ML_V/]TIL&S)*ZH^>)&7E^5T\OSCUF(WFGE@WM/1G?;A#B%QPC\[\499@Z>6\
MIW;^*B7P.5-<M[O2E;V(QEB;Z*9Q^NY6A\V>YO/"]_Q?N/#;M%ZZ!V=2+=4C
M"@C_DD'TUM!JR=VN#^Q2A&IEMO?[ ?@/IE7$>&/#_*3#:A51KFG!"\P%^N+Q
MKW#4_!>EYB$FK(]RA$S57T#_RHU$PI9\B)_>6-:MQ95NC,/"PM7S]=!=X>Q+
M^B$7M;D<F]=5?CF/]+Q>'[\D>+81!N^E>2AX^ZYK3JU-R&0@9G<EZF_.CXI/
M/VM]F-O:-9/,NI8[WANHR/:6ZYNWBPZFS5ULZ4P/_7/3S*J[P.8Y%S 1CGZ"
M$2KI[!WG=?5NQ&^#3':DV\&&R[CT9 LN TTN48KL"K<J=K=9*>^:I3;']69O
MJ.NH]5IV[_^O:DT?,J&_@-Q>X;\ H=F_@!4MKC;K1UM!60D-LJ^?U(?^>\!]
MKC5:('[N38OR4_MFE@>[BK94X7??\]EM,,P'AZ6L]@0AZ9_@][E&]'4?%^E1
M!E>?L1T+",BD!)\4@1S&3SFK*SMP$.Z%=]/'KC079-V8<@22F>Z208V3;K!\
M>S(1T.N=,+W2WCOG30SQ3EN:FW)N"D76'".G$=A&8K#A<I_OZE,I?MUO*C($
M3WQ4MKJ-&P:()ZBK&Q-<=2 ,$1@ "LL#H%"5$A[WLX<KTY;6[)ON/-X,J<M$
M;W$_A>9!34,I?KY5N;A=UNV?,+68-"JNLI'! :>TC58G2P:#2 RK9%"%H.<U
MW0 IX4&5E3EIC"7#T39L7:E4X]1>:NS5Y\FU4V\'(!UNJN=_<?*645%X7]0P
M($I)AY*"Y "#D@(C2,,,/90PA)12 PXIC4@WP] M,\#0W:%TBW0CW2#=^/S^
MZ_W\KO6LY_/]=L[9^^Q][CWW#0=+A\^3VVC"^3*%2+EXS]0LB2<N;F4S&!>Z
M7?J3/)&SLE[]FEQ@0QTCS/8S%D9SM""58P,I"=>HPQM7>_U#RSHIE41J@%0L
MI"/Q;@,?M_'6]9')HE7S^\)HJB43R6\_'?N"J+<D1^7&#,FH@JN;)F@7D.2=
M]28W#(6\^86*;]TJN UG2KNO8_IKTO9[4:U-%X_CYE669U"!_BCP;UY<O=#5
M=[Q_BJ[?98*>3+YM86=]T5++):F[%N1-W21[>4O"@G-26_SD.QN=<TJJL!N@
M-Z]7,'56V;4N9#"&BD+2@XJXM5-3A:%<**+IL=!0->>UD&0MU5/K@3BHWAP-
MNL!*C*8L_%"+%[1/UFO.^"+=+&7NV4S=[6CBA3B>L?)G@LH/5'CC;5V.7GOL
MCU*D&ZZY].&):P_IB&13/Q*E:OX-W0[(HA^4R:V@8H&5LW2JOM3J0L,W)^O\
MS<F 7-N-)HF>RP/#.2K"93'C =!Y;*;:XD]^'"-;VP=(SN@HPG7:>/O;:^[#
MV@RO-].!7WIDCL:U=0Z6_X%W?3(N82/^)\$'7SXO[X*S^2[7&36+Q7Q-066V
M=?YX%*"?7MK^8\@D C2L Y?>)XS$$^$H!4!?"B%S-VFQ,G!A?@XL[\QAG,P5
MZLG O'\0RWB[S84K ^YB'57N'/J0B/D=&SY+MLU.#C.#T_Y#N<><*UZB>-A&
M$):/\S*N T*].(?!4T9P.,113YQ+X@[7R6AKO: *E+T+7X;?9X)B O36V7PQ
M\OY <UN.^*H?K)25+-TL:;AR:V*W]K9=AW.]=CV[8/9]*$17,M:<X=%6^V[O
M4%+C]&OSI4P$YSO+9T\<JP:6LJB'DP4\A<7,\X]OZNF/#H2**K''#[J%>6XF
MDC22G$:%;]4NXV]LRL]^QZ[<P34M!2M3_KP^\32(MY;@O&*:_MH.G3)/@KX#
M->HMAT7>S"8ZL%6P"^0U7Q,=/"JZDT\2[6?R"#X!_6:,=/&,5E3?5QE$.$RM
M4Z :)!2%V539?NO$=R0^Y\,:)+;=N]5K6QPFW9U-)[Z"I4<E6T;F7?\.;HYK
M=7P#;^H BVY_R9-[*+R[^8?#=//E6_#H0+(!ZM0D8]]6JIR7XRI%U/CS)@(
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M1+]?"1-W1_%5%RSN)L-RCC!D5<$ZU#CU0FL@80$#L3@N\N]Z644!=@M52P2
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M'#?&?,)0[3;A>>1C#F(CUOS"[A=J:VQC9 Y5P/S7*Z;0N81@Z-1W*A2&W0T
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M ^=DP=D C_[:(*2W(DXIR%D5#VP&F*V819X!: \ED1B%Q(WK S=6CY")"E#
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M25K5V(,Y\J-OB18@DM-?[0JMAJ&4?"1JV#<.T[J6:BI%1#9#K96U']D)=8(
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M)TQ^^J#L/A^]@<CA*%+1 F@10[Y"D#F$6NP6A%*$[+J!^&K8:(!H6*(9BWU
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M=JD7EVTB5,X_27EI8/^8LSF>34/\= /M:<I8:[,&:.!JL4&7\0P(12;D;6D
M.XQG:IU)L5.UKIV[T8D[3CO !YVTUU$TQE89UG1(712#AE G$ZU:<++5CJU
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M@VJT/$<'1"J\VBHS":Z\>ISJ6%5X;6FM4&TN,0P"I<E'H0/S)_(GZB;0U)4
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M_ 5 C<R)$%O,FA9:]=*D7NGE/OU>)-4[;0F?6R?(*AL]0%YZW?V_L2;[(;Q
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M5O]JR6)J!%(8[63FJ?C24OU7T!"ZX=0^[&0=B!S3VWK57OOBE5LY>&G[8.7
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M^AQ1)0TKF^.QU$;0#<)+),@P[LC&"ZA5&\[M-0A#HNM6?ZCU0.A0B\T6!'X
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M75^4[GCTO!*!2MS74GA*2K]@_BU]>H-!#67JK:U-$))S)!/P*$T'+1_:&\A
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M3)WE*I'2"8I5$ZEDC)J5<<2 ($29)J3DXB.PEO_ 2 H)B])I8=W7^WI_K])
MSSL:WUL*@7]YH<;7]0-*31UQZXI2/9'[W^=6\:3:OCH9/%8@*V$H . "8 +\
M+_Q9_FF"I7Z!I63,WE1J)\#]Y&GDAK^&8?FJ=L*9IMU+CMI1GMW-Z<-!O]GD
M^<UJZU::I\YUE!>.C_"M;>MIIVPY3GT=.MUQ[FIQ1;GZ3K G&&GCJYK0@+C+
MK$^_O2^OXL_1Z/\T*S"D87J5:\4DW?771SK[4_H(VL6TC 83KDK;=E61;KGF
MSP[%+9AEB?R9W3=FT-C82HO@7KW2-SGO_1+5,FRQ#HS]3DX,$NQFVY"<=[_F
M'_#69O9+F&ON*R_,!/O,^OU\0;A"X$D?1==.PJ>6&ZF=!36RV3;V7Y,6;F9L
M.47 @_,&+OR</K- MGY/X_CSJS]S=R;WHOJ2C\U5]7R6'+_SK65P=C*6"17Z
MZI"XN7;BO*=WUJ,%H=1ZX2 572<HM'AQF'1"A;#(KJFJ'ID?U:3@MJ8RP_9N
M+#(+GQWUGY"&X9YW32173>J)V-:,2B#=UM>+%,4IA AH9?'/NQE<)E:YF!&<
M;*YC^GK.=OQBD+!Y>:HE>3X,A/6&HN3G\53PM[E0YAS(),[1/<0Y1@[:+"$G
MV1<>BKKF6E<.:#L2)P/\<';]XYQB8IUXL.T!B;S2F$O?O#Z>U;T6$1X5I/FB
M%7U:I.S%745LDHQ%(($01[L'L#0 A-;$-"&M,"_)"9%W3\+DQ3KEEJRK'?TQ
M3LN)KA:>F9S<V+8)M^6!Y3B6FKKWL42[^LR[BDHII14IYQ&S?M(W-,AX:FR*
MW\I?T3G]-8J9W=P8J*A)?(REK9K6W/5LG2@V/3AD@.RRS9JK%,(WHJ[OC7YL
MBZ=?L\%05 \'3U=/"U&.N"+Z5\KN9BQ7KFJS5/7J<6QUR4-6<U65EA[<+E4\
M?ZC9-R:H20-H,-W)6JZX/(4R!J!/M7&3)<CKQ\9P [%*Y.A<>J^B&*H("&6"
M\7P06231(6&H@$7B3LL?/K:CF\N\:_6*?S]L*K]=-#%0=T'GA>%J7?"T)#F"
MB#[ :X(7$QL!(A0M6'T[.CXGR9@GA")*J3;HB2/(U??)Q7;^1,L+Y+C;?$@]
MX[%-<F02M@ T):T*I\C0"AP>5\Q#ATTT.MZF!&\E7<XN\+?4#UUS'SUI"'Y:
MQCS;* )OID6PO?5WUH8H[5JU(628-,.EY."-$46J)M2B$+@<7+F#FXIXUMU,
MUJ",###'S/391W!;I=E'@4M. 5)'SL#;NY=_!8:8Z@WQZ&AN>J,X/%ND1-P)
MX#$0O<(T7A1G.)?K-H7HL98[)#!M3935X;&O<NI[VNM8>P-"$)ABUR85]I)!
M(7_L=U5FW9JTI6>CEPP;0U[<YP$C-%</?F.[NR!AS&,%JWUHOI.0PS'?[I;T
M!KU=NJFJ:6+;P?#_8D0YX3($QA1)VCM&XYJ7F9<BH\92E'A#Q':MQ.<3*)\'
M-Y(CJB:0-E>X-W7J8)5P%M"$8@/""#&(($-$($%@Y@TX,8=>A D!R^K:A2!#
MI O+J* *S2@H351-%RA\]LV1Y-%)<"B3MY88"=@("J>&PE.P)0D6KA&:D3(S
M; G'C-N@-_A&:)OGE0.FQBQ24E 7NZX)G*]9_$B*7EJ%VR?D]:<OO>O7UK<5
M$=R6/GD[*K,* GFB8)VM9PY(#&9HN\H9)/(V_*$SO9R>7'[P/E5V"A,"Z>N*
M_20-H*%(?:J%/S%D^P"?F)!"EM"56(J8]9(U0>E [C]:13Y<E&.0\SV6=R26
M68+[0&0(/'SOVWK)YJB;,GZFF;I1:X1M)K1LV8G?:;25IBV%GB8?*LYVMUV7
M(> /-TLC7NV8C^=GB]&Z,'(E^U=$B$5.*CJY'=8%7:365KY8U)"\G=H0]:1"
MO^BLSO]CU@[>UV"7HS V'14/K=[B?FQ6PLB@HE/_FF4VHZ2=[L.ZP>^6RS&P
M60RQ8Z;.F[G8[>'LS4\JKD(^)L.S!\ON?61A5'HJ\W[[W\EGCJGM!^?F#7&R
M,8[ZXDQY=N$^]C)U-?#1^=?6*C+N,3K ?M.4K0'_I@=L#E X,N\;AS%^SK.=
M@=C-II\/$+50AEB,1K?<C38I=*LMBL!1+N 2$O,3)T>*XZ?%\1?QM6G#-RCJ
M-RC657CD&+E=6A 5'ZBA>0/F49&A"2OVF=5"!QPK%E]KX!M4&S;B^V8%?)!C
MM4@)D/L6%D50'RLCP>(^68:,B<J&CP@^-W+/6(3MF&G^^>\4/LYHB: ^N="+
M-46_\5A\:??=;..E^^)T,WN??&4$-U-.,O(!EO2K%/%AQ8K2+W)N_PP)R693
MR\RTJJX^E/D>3!4RG1!S J&N)6'"XU@M?Z=L8ZTOX(I<%3H>^#[BU7:N_]'K
M'4;Y8_CL_<^P4ITOW8LYN@Y_51C((.X@H+&17)PC))=$1\Z@.!P4R#R-<92/
ME8-TJ$"BF7O6R^68M/N#8,_8__8\<RU\%M1VX">B!3'BAAJKI;^V%430SLHA
MY,&GN'=43U03 N-"SY)7^OL/D*9J<78"97^^+,YH6Q0(SW!?DM7/#LG)$*:U
M($52-HJF/+T(7M!EMF>^%M0ZF/GSV.C 03GD0$(G55*,5L^&5<S,, UW1D$J
MGI#6M?:TS"E\.AF/,Q3 "?<!D"/A 8"'F(=.'8EA9POJNN8&)IV/FG=R:G*8
M33)/P9!'^?)Q"V H,5&/.T8/>AS!Q-?PP]9$S\#X[0.(GBA:-HYOOMS2T3AQ
M\UBL-# 63PKI"GT238\W0=9&'NH%"!16412$,%2@WX70I2_8N!OQTQT9RM7X
M[]]AFE[I\.MJ2I!I^)0QA4W45F/V9P63.S+R?W$EG;=9B(RW]L0*:,JUN!:U
MN;P6V(KG81H[31A%&>A*6,8OF!J:&KWQM1[.2CH_B[65)J5_(-^HS(U6FE%D
MZ.-]_%E$4R$N>WX"O":ELJ'7;JHJPN.D9TVP7*E8HV"7D=&F'3B2AVX)>]KL
M4RU=^/8@.7YI.XU:M^+PQ5_VHSN-OYJ2I!4,-&+X[230]7[_TFN)TZ5"&<)?
M9%<\<A,A*;2\_?=9[IF(N0^&:6SIJVZM$M<5==,8J9Z0*!B41H!9T@#>:T 7
M/RP12V>%%)P,1.A5S^(@VOG;5/]S-L*30CRL8H74!"^X"/.A!)L+1T(>8[NQ
M4J.0>.R*X[LDJ_G$< J55^BTM!\'[P9J8ELU!>C :LXY(N;A*-^69CWS+.'=
MK;; 69\3'1+-(<TA (!W2=3C2&:9NNV7KMZ!!')!/B20K*X^+H+29B0,S0(^
M)EG^FBS*%?+9<$)I#Q2YA"VN7]KG4TM'N-RG<SR'27:.'[J"D1!>M-O[S"\C
MY>_\CK!9*<R"/[A;>;Z,Z&K;?V&2-GI@*< 7?:(8T_4/\"2[T?<C5S#>V"%C
M>45"=:?B:[]U$N0NW8_R^?#)+9.M]-RXR+,;MNFIJ1Z0U8A:EN[KRV]VI5^9
MC@'ZBQ$2-;7WV"6A?X!+S2@=_TF*^"+%.%=1( UU13PJXAE]9<K )$S\SZY7
MY (6YROL:XN GFZL$K8T6+9R3.WR>R *Q\W ?J7IIK!A,W]!B^&&UR27M]%V
MBV4NLYO>]>8N1QDYC?6.1#4VH2XU_L<6[YS3/Y_CF.)H9TQ\W[^E*:UU[HGB
MI4[=.!DS%&LJZ&CSO-SGZ][REEC9A.U/8[@=YUZ7^PWTIC.-I]10#G48TFXL
M^1)M/!;("%'BG%E1"X$NA,QH[^^$B%JE&'<]MXLJQ6V-Q-"8LA&R0SO"@5@1
M-V0[:/B2SPQ1[52]Y.NJJ;<#DW;4^ &,O[6&JW+N4R,<NNH7?8*_H+''7)K'
M(M-"/O#BL;*>%0^W.,2MKMNST<41LN>[)\%U!E82Y-_J59IB^LT^/P/6NTJ"
MR-_X>@)_O:J@X9]LFVUK*\[2>,:+(CX%E;3Y*B?_-"0RKY@6.WCI>/]Q9)_W
M8L@8B_:YW-I]WKTJQ,5L-$RE"X_'<&[J#PGY)1E<=8Z1EY[$V;>@ U52.XIH
MWEP,&8A,.JF*ZXP\/#/6R=N^S,TU/M7H\)>-/ \6Y6A03OA;O?0^,[RL9L"7
M3\8L/D$G.X"=\1,['W*[JM1>R57.6-?)NW-F;FT%>7]Y,Z:QW#^&HV_/L!-]
M%)MJ-EY>'L>\"#;DV B^T:F<.?F=8-]%%5E^M: )@22M>/?1E3SMYQ>X&C6O
MMO%$T$D\-*USE5#O8SHPUG74RCYS-\=YN7.3["^L-RNED6,:SQ72)]7GDSE5
MJJO-&V<G"S)J%,I^QJ=A>CELP%!X#S$,S*,CD3^=/XTQY9PDV4>:#\6:=U9]
MU@>I+;<DNRPW$3L@*5B2VPZVB":KOA$_4EJ6Z\S^GRO%H_0;?:%7,U:>5E3U
M5 ;I?ZUM!NV:Q&N+(W-.)-H.NE6)5<"LS'GD"5.OTCSXNW,>[A!XLDEF?; 7
M4M-B%0N7G/RF"@V$1UR7^3'G));(IG(@@H(C;3S?4J &UGIRJ9#%EOO(00=>
MZIHA'].:JK!&*A)951 G<_@!9[HBK&,H@#;JZ5($RI$S%,D-XD0BREQ)&% R
MGT\X]'H'2N(%FK8_5NLR-M>W*)0(<A?8;OY@;6/D?Y49#R3#4&X\;=  06 $
MKMFYY4V".UYH_)#;(,']^,C<9 9CJR<M6&/3=N;>MD.8-!8'/F,C90TDQQ!7
M2_R^MQLV,'(GE#G'AH^+YZ#M;K=[F?>AE8@1:2@]*5/9>V^0S$ER7AJ-7]KY
M3PPP#ZB]KIX>_7W4S*B>LYA3.TT544IOBDE@XH%2H%=!QS*<^,6B''K=&F78
M-!-CGQO&O6\-6GJMS<_<OPCH712PR-ED?YBV2UR?"Z)O/S@1%^EK33GX, *^
MO\/O0/QA?%.6^,(BSGZ[:SA?('FQ(V5^#UN1C0,?N7DT/V\^\7SI;_C8>D:P
MO[/%-B3 .^H 5_7[K?$;-?GBZ?TF4>]73:YFL[OH@,#JN8[-[QL75MS-PQA]
M9<WWGUZS:/G] <*$I8FT^''9_L_8A<8]\B*M4M;?\(T;"L1_%OBRE2@S^L'8
MJ_GI]G3/Y_=O$$)XY-2RL<_M>E%,Z17.$XZ-=<T,$$/<-A2&$8W/16XJ+:HV
M=E+J&0=]F6*VO\V8#K;#+%MU''J-'ZV4GC>+*Y,H4<;;B&S2C'D(>'AO:^HB
M=S OEC)B:\IP#;4[Y$I]MZO)]9G/+X,*0!%)_9_TS_U@AFMB5]:@%2J<HTLC
MI[I_G_C&:H&TVE>A*(I)T6.&(*_?_DJ_/=M!X%9%SKVRLO*?1KM]7V31WUE>
MW>1C#SJESP)-T:T\)HI.+&GM;SP\VM3R@[!SDHL5VZHZX.L.ELAS>]U]-.+H
MEB?1/=[^^H5RE%K?^9+2QOD 37F!-!-*\EX7[.AU^:S,9R,,GX_U7AV+YC!V
M,5M %AXN86,.W)3^IO;$WYJD.55D\'R3-."9N$OB.G]Z15EV'B9^+'+\7K<%
MMIA&Y#J9#7GV-&C2U;6EG#.=QL._H60E5[J(T?.[OP]?7\//^Q[";=.#P(5Z
M)WL!6ARY1KH(<+"N"C62%<+9;CM4%EE!/-YJ3@..#V0\WP*J)S&UV^B69O"7
MXA)L)_W[FN8O2HPJ:9E^L93\-?&_F0AQ<.(]SF%:J+H.L*3W8;3\"?]5O!OF
M83Z<=VOH5>5^-Z*F("UX1]IF/^)TSUY,S3W)#*5*_ ?(; F"()!B:Q*1D[.#
M$GZ)QTY%)UN3ZS'\,P(<(D_/(T^*Y"L'"D=*31C,[K)\'2-+27.AYO92@1_L
M!OUGL_'>Y277!_IJZ3O96&RLJWMRONSJ-<A- >Z4U$X&YOG?4$QIH'M:!QA!
M<D];S[CTGI^_Y%V[?J926-D0,#LTA^CAKJ[) 46EAZ>)E:**DM+=TR?A:I\L
M++[F'[<=>((G.JK3UFQ%YZW5U*S5^%3LQMH7@AO%)^_TJ/.OETCEL%!9AL1P
MI^3;GM]CP:ZM\OO>X[F&/?<?O^7Z#S49GU(V#]97";;?1\+-7?IVWDB__F6K
M,IU0+KCQD%O[U -K&!CNAU?]HD3[:$B1\R !>XPI;^[=D;HYY@Q60,O[0__F
MS.I-E-0>UB,->W?I"W%\R/]#VEL&M>$ WZ*A6 L%"BVT>"D$".[N%$FPXL7=
M"32A:-$6=P($=W=W*\5=@@=I<:>X%;B_^][_?7D?[I?[<6=G=G9F=W;.F3FS
MI_DPI"C25#$ZV$ :"'9] 7%GTL^L//E]IY+Y4E2UTN=#9[NAW"7NQ+:7RTAS
MYT' [:6KNZ<$KZY%9M=@<Q-0)B=ZINRFGIR@SX?TP4E/6P==]_;3H4+*/PG*
M,TJ$=Q.%_ %%\HIWE(;Q4NJQ/DQ[C/IB:#852_J=@\=PNF8E/NEF1-TA-'/&
MDY%5NZ,4)F>TLJ5$Z1A+X@X42S)^P\\"H\U^,11"I=="C 9,^T*_D'N&VG^[
M->&8"=D4"P[Q/]9C&BCR[XPU7VY#ZO571HOCDPUR5I#H87-;5(2.EVS'GJD3
MGS#*3L^]JNFR,$J[.&:@-M]2@)#2,\XJ)8JT4@TU',\J(7Y1^[9<&_CL.IB8
M  ?T'BB0..BC1O2AV_L#!NF7AT7D94EG9)ZDU%^/9ZJVF/2[PQB /IUZ;)WW
M3DRCQ]1M,:$>SC4SI7KAW(<%36F@3[(5(M_Q%"%H6$.1^7/1 EM]M:7G(F,<
M#/QM,ZJBLK+=[0$W0'XK,++<3$/%F_D4?XL\B A)Q=;X/5]P]9OFM>:R&Z9+
MI40%L"A1M#/!L>%?W]EO5]WIK'\&0J+_4M;]CK5\OA;Q+?R_OXRR'W@D+ZPF
M*KMN)2]N'_9/&_WO?+>R;E@WN\[\4OR^(?4QU_'W7)\ N;YWVT\ #YJ6KF45
MC N?"]PG0$K3WM&C%(OD"OH(8_X!X[3A7N8QK(/%Z_6=TA==8B_E/R^9@KX$
M7&)<]%ZF>UM3A0GC:(JP*[ 4BC>ZI*Y"&L9X1XJ/A@R@H\W5&<!"[2TZ.T<@
M@*B6/X>03J4YH0(?$EO/3J>H_P9/*Q$H%024.I3>E???L)D%2NK+V^YS<^9'
M$>67.MJ).3C.:<?#[S;[MNP=6UI4>_KW;F1:Q^UOOK.83LOCJ0^54?LGK5B!
M/D,)"][;QQSV6V=F+5Q(#M%D-E\3;74*7C+M7<_@.!L=U.'LA%U>M1=W:0J;
MIZFJI2TMSLJ4A_'2=CQH&\G9I)#Q;;^.;J/1,/&,%S&EZ+C_F!G6 ;H3N*/Q
MZ@S:*PKDRF2-'TP?Z[Z-H;/4^KNY8)VR"OZV_Y:TK;IVE#=B3V?15R9A<5&B
MN:9 !0[THF+_:!<LY8@QUZ5IHLNI(*GZT@;5^7K?^D"RK&,SFFK@+-VL710[
M ]GO5EC865EHOJT8QB)B+L'(C)7]72NSE;R?!*DP&D+GX]Q!?N8\(YGF\VG(
M/98[6B"NYS/G<U@/;?'9]J9>N3Y^B1ZPWRY6.H)S:""<+</P<QQR8T+X>7T#
M$DEE)RGK"=M^"[Y(4E-P6N8T05;J N$0@;1(P^(6S4H^=956;Q742Q/=<O2E
M[O%YMP(R831S^ [M1=691-;8>H_09NDW](#UM'N:3N.?92J]#"H?$2_A$!*4
M&/OF['@^,G+I198QILN7G]OU_=PI(NQGYD1%WM<H<4:_2^)!_F1"_(3-JUHR
MU"N'+"<1"J9MJT5E'* C<XXD>1R+RU$.@\]/2-@+,/V^C^I._MYXYLP)Q=R&
M_6P1Q 8TLA)HL0;B2[)V"A-P%:$&KO28.(.M=#00%PPUT&O@%3DGRJ^PW"Q&
M>9DRXLR7K-<;1=:?61]A/9@2M?/.*EK=V2%!,4HW7A,<$&\QQ[W<!DH(9FA8
MOM/>9H)5WYXX+%6PEZG9Z#HE_<&;?S?.H3+R@@7"265[/GI7!<[[/H4.VGT"
MD+!T1&DW_?A<?BJ@]E)'08GGG&BP,M_J17Z,NHU"@FH4#7_]OFC!4I]YVWLN
M"]F*M&_J/&%_-XN/>%*(,TTKZCNVV<=WE"AKTLN-XK-85,#;J-*\0H+"3!!+
M876%PVC3>%H3TQA$_32OTF<_Y>I3@E("0-RO[&C>Q7IH)) U@#B+-[?U_J%K
M=N:@%;4@C/PM75Z.VRO:Y7>W=$R'C>5B1J.]:FM2&J.P3+W?Z,MD,Q(+%T94
M)S>]*HXBD_T01U#C<8B[$\9L5>1K!H'75$Z['0'N+W]WV&QU*5]NK8@?9T?M
MJ:F0%\,-O_QRXM#.=;U1GW%J(UQK'R:9*VF"\I6PV$ ><!(G[E3N!&-6ME V
M/:9JAONPQW==UNVL3X"AC1&_?Q4F3P :$[.9)\#D/=&?MD<!Z4/?)..X/'=/
MK=M!]%J:BKC?W&IWT1,@?@#Y!+C5[WH4Z^Q^ L@>2@:?W"QBUMY![W0B5K:T
MK2V@5\>CUO^5G;IX IQYG*T] 5AUGP #20N2NSXA?U>> )1<QWZ[;U%'.OR>
MO+1!\?UU/S!N:PP3X\&((:Z!T=9AM"8(S//.#IH?7ZN5[9.ZWS2!NI;>NXJ2
MSW,.+A1I<TM?W_)2^99YKE6T"BY86%%E[,IU^^8EFL2WO][Q3IAEJ"&8W6O:
M]B[V8O9>6!+\Z'-Q^<MPX0N-4_&W1(\FW E&K;S4RF6GT@'@@*F^WAS/6=FK
MHH4 ,[HY@R\!VW08!@17\[WWT?%G(O=+(K/Z;<SS#8S3OO5>\/N,M.D&_;.A
M*K.I"7E)V2KIU1_"K43%G&K-3P#&>3B[FW"L^53^EEB,1;Q6>'JJJ'K%J]86
MKD4[YXI"S87.HTG77SFYND"@0ER0I-T2<OI^U^:@DN"C().2>96_4X95@4#B
MARK*2\WN%-+E7T;ZK[?FIV<'8ZN)8+(?&4@=";A$Z"Y0@W9G745JV>WAWUT$
M^,D>HWQX1H+8@["!BKHOS6QA19I=+B2Y[4%\YTJ+_<8RL=5D" #5Z[O=80O0
MW<3CV#:VU(:;GIOPOFSR^4&K +6E2E4OS8@/WX33Z=4RC+IZGBC:"1F_WM6S
M\ASO$UJ*^;+A"9!GYT,I>3;QH.BWQ7!9DBU158^1+6'J^]\&W'$I'&$] 8Z3
MGP!;/%G9HM('U_NO]Y+VJGZZ/6;[J%I#<G.A.W9_RP7B @W@;UFMRX+_E2Z_
MCC[M$@Y"KWT.]A4T@HN[?A,=3&/DLV2?">CM^I@9WF'@HRIN<+HV6[9?%?+Y
MRR-E3SRIZ\71G9\2W,!V_3GGA-P8$^^Y]M>Y/$5=IN8-KD*Z$NYU?7!M$.FM
MHU28D<EG0-B#[AY\K61@=@T5,V7#N>DP#KJ Z>WEJI6OJ7\Z)2MYOY.^YV*4
MLC9I(41 IN" ,Z=";83'O,$Y'DIA$+F ?IOBT1^X(66W,X/:"^K.JKOU_Z^9
MK+T@&P1,X<-?00:SSPI,I[CT5O&>@A@[3AQ;^,4+_7(1277JSO$6*5@-(DO4
M\48@/*<6N+'92T6KIJ^X:"/L7N_@<.0C/4^>7'M)97,4C8NMM0/QX9\Z?J0U
M'ZJJ<:8PS1O86^  T7F.1U_I[_9_KX(JW84V7A,T!G?ORY DG-Q^DUHSE$5H
M9;_!4[UG?O5-2\.-WBD<C >^E\:RQ6&)] +RUM*::Z<76?I3:0=>%QS&?O.'
M:-<*XMY^)(6B?,(FPSZYIIQGL9W\>0*PGZ<1T>_@YPJZP[^UKS&\=3M<@W:T
MV6HTKW%O\I_[@N,7LL3Z\5]Z9@V?_<AO)NX*?OCZ#-_ 4JL>'?[#05PU$8M7
MV^3#MRX MIROAG>A0A^J WQ\T'A/[:]NPJV9FPOYHU+%00JEZ'[9  +AFA8T
MCIQAFAG_5-1M)\ P;/GK@":<2"-Y#1$O^7^<8 N^WLBLZI.HF1!@N(8L(*9-
M(L\UR(T?8KC6J>U\2IEU':(2Z8Q*P;@6DU& \4CS #*E9E)85'PT: ORV2#\
M/$&:HX"0747@>.,$^#[&[" [^Z%\.ON#Z\5;XB-M"TF6ZFJ;END5N 4OX3O(
M]7/9B@)GNI^3XG@:0208:[T4$)(QC#=%=<.,$YYDGS?XM8L-NELX%FL/"QB<
M-P/[H\.>P^S?NY/4O\=LA30N!#,@E)%T UY:B;>.7$L9KCYE)O8D@DPU]27V
MDJ98&8#@W&WL3:N12H-QKA#DP+<IR[YC_6=@]D(E%5"O8\[,,\%=K^]\SU+X
M_S*"\%-PJ!H:NA):N%-\5(ZEZ1I$@A*<I,3Y7FI64P,6"/T)_3%^ ZX)+$T_
MEG/MZK@3+"O5M>LOPI+(_9<O> VGK-X#V6M'OXK%YN(EWJG,:+F+4C<P/S_A
MW]Z):HY!\.:S,R=&FLW/N?998E7^:282A R'T9M]6.Q7/[EI=?)R(!]!$AJ%
M4OW\#=D8D$"V2#)]N25+43:D#2W;$OJ6@3_,!-[,E#*P4FBRE.VUZ'/M>^9=
M1M"$K;_7/=E5,/Z250AO!U$X0!MZSDEGF:+$*12W$VD?KE^C[$;2#91.GM!2
M]JG\38IF\FO5^(JK1A\B-E-433;\@G49&U>0DJEI !H3[>\I0Q8(4A8($LG-
M^!XJ UYF:K''K+)=OA]?PKA,N/$]V:;&/=G%ALFL2M^&=N<F$5DX:- P-9A@
M%C6(EZC3?Q$4_7J03:5_KG4?Q9[PKU9/6JE VM@B@I50P$!<1B/NZ'1-2DA@
M#4EA5QB+O MRB_5?D@**5P0>>EV@"Y<P(-_3H+/5PT9?&4K8W8%=PC]C$X!.
MS(Z"+S!=.G_:8H/M")'+L/SKIE.F#F:-)8WXVN]:HM^UFV0TO.XOL'N__X41
M<<7ZGSB8V<OFS##5@+\606.]QZYPX0*X9QB_:,MIBT6)LGH[^"PT#6^QNX,R
MSY0]"$4VYN!&R?M<WOJ:W-?G%*&;N%"C\-]ZL*UYL5C$$J24G@/UA1"V%T.\
ML<SA*\VN%UYC'VW[B]U18R3J]W(&GH7C&2'Y)X<51GG>*+7F$H/?): :\V$+
M>SSH-:+ XV7T_.FXKOK@@@[]8,.G*?+R'O+B-EE53R>5*C*N%,3#QX$>:-GV
M_F:)^AKX!<BS@"&?N+HNL&(,G6H/@_(OS-FVK$>)WX5Y!6?\I,G@H"Y*8/7$
MCSM<^5GMOJY(*_HIQ1$2[YHDKP\QB?H00QOY)_H.X_:;,+?@Z7R-6,ENT7P'
M+&_!J<1/==O=E4 7GZPFM71HV;LQCX.DA0S&OY0UO%?@ZNW)J73/>TF5?!&W
M=\"0^[M)7&%%7_E!;3-RRM!"]!4RV#@[(Q3BJ\JOF:4G2 ?<@:9M_1H3!=&!
M;U^0:($__FAJ_S=PD$%8-.8@SMYH4.=L@6;SA<1&:F0,@U31D,1 T*V#VU(^
MT_A\KVNJ.!\R:"W-:7--L*QI/LWW1_UJ7!U:.28R=UU#PY&M>?I1'E_"X.R-
M9;I=^-U]I,"W-:Z"$>2&QU:9]O&0JY)A2<,T60'(GL%[;>X;@QMA[HPME,7.
M0+/I/OX:8=)Z0'2<T9FY$V$%_J<G">$]8853"Q+#&F%#+:]8"[MKTKR1+L]=
M"<2Y26%4L2O><N7,Y'-J!6Q<&6$&X\#W)%+SD3*O6_B=EN#IJ6"@#KJ; 0G]
M*_^OQI.61R+EYB#YP<ZEB,<%<28JY!F-KVXV5#$:6'WOYCES.:I&?6HNX<D"
MC>28(_W8NI-Z?,.2Z]T"0>R))&-6&4?Q#N\N=DH/G&89W#@S3-+'<S6?%$C2
M$ZX+_CDQYADVPBIT4E-PQ[.)C8K;GAF-U=QNW4_$F-8NV1R4-<O<5G+0V/0,
M4S/O5H16S_4IG6 AW '0HS4I@S,#,THN%+0(7MD_C9Q:SFM-K)6B1+A+G&>S
MB2&>K4#K*R877V %)L:^D,&[ H)8_K79XMST:T8"-?5D24A75M$.A.\=\Y9D
M G3#W228H("8CLL.NB+S6\>&!0KOUJ!"17UWDUU_/$<Z(Y&33G_%)X 7V?2G
M^6^6)1QL[*"SV->M1&:452T&!"'!_@[((#YTF5E"Q;3@$77Q.9G T;%N_=')
M)$%T(]FKAL;8WZH;OK.@VII30+5X^!YJ0(I'A*R^94<@X9_#"^IN,Y4G %"A
M$%WLC))R>%M&PZW+Y>6]]2BA_!&2Z!RX-)(-/C[6T9-)V'PWX&Q]_!Y_OQB=
M\/T;F)+ZZCW,(LP1-4P3UX)3*JV<\EFNDVB$F]Z?6C][%;-O.7Q)O<LO=BOR
MCHD:1/WZ%:DCSN^7>[O?&VE<?S7,7+L+5JFL._8P_,R?B\ J?'U:5BYW)#-+
MJEQB&]F:UK\1U*A!!<T(P(-$M['S[M27I7[E\LP@PG3ZD4T-H!F#1\I*46!N
MIP5L?_ [8KQK0Z U]*0O[N4'G0P(Y?T\VL%[2!:DWE=@;TY?K=9WJ6-I7'0E
ME>2XTM0E_?^GFV(XFKG +&%:K#3K)Y'->M;71%V51N*B(E9\W$*HQ&, O0#B
M&1"R!U4P>[[0!X,7I8A1E?[.'0.@VL^CO6TAYU-Y@R2IMH.)5,"+Q@UI*W5:
M,Z7%)BT!==#!GT+3VU %"1\%W]+THPDJV,6?;676*?><-17O'U:]R/3'<FLR
M[2P7R0^:R*CS!93&GXEJ\YK&97M+^0U)Y?PYQ<B+EAAQ$-<&3+AR-5XGB[W^
M_(BGVR;%@";/MU!2T>03%7&XU^..LO-<2&Z,AO"#+K&.2YK0!95:K)!!;.7*
M2552+-^8 YDFRTK4SH@O0XF[HE<M_G%O'.G-?@1HS&T4T7Q;T91EVKV50G\W
M<G=TV;'G-_\$R%;]<!'CQO$?@3%2"5)*9W6@B4J7C>>]_S?USIIBU<B3,5?N
M04?RV?"T*$J;T-7C5I[JV,=?:;>ITC!HL!CVFT2+?WXNF.#RX4*X+ZFSV>9!
MNH;#.F+@52E/I<$ZA1-OGX/'?FKJ]%TGLC^+8F!GHYP[44/CD3$(G'2FY:8R
M7S!$(,&0YV/!7]S8KFJ/XBK^*S(U2JMCZ!?VB'CG/H-THL8^+(KSJ,/,"(9%
MG /YM453ZNKY/Z6;[&@UEC.8WUQ)C=XBJ"!QH#O[>:U%I5+5)LA95-;;"!-A
M4!2AZ:D?EH_O@X9IM8^,GH\2ERKVEG=_6/MUC ^WABDI7A]SB4UUFCZ5LV :
M)EEU;D[6&?P3512/@"9W NAYYEU^P=72[+M]QI:6Z22S+X)MTQ,S.S.,Q!>K
ME]C[%OO2>SN2Z]%Z%TF,:U1#ZG;?#6$-3,4*L:VM8B3GF-JS#E^_JUJEZ3?)
MB<CI6VGP<A5:^@Z>O2:1V#5.K=_QY&>^*Y6O^3E5I=;N?+EV%W]:H%MV?A#_
MZD(P *YL4]OY_/<R4Y1>&O&R^(ZQ.V73X' .XR*?'JNMTT>PFTM5P9C_OJ5W
MF[+0",LL:4D;[>NT1+%8)VZ!MKVB@_E9>;-]I51?9);ZC([LI5Y/\LUH#8W%
MQDS?0*EP3\P&O_S!Q.TKN_W2S-HX73^*:;[A&]?=-&-+7L8WX$\,+\CU6P29
MK$_ZFZ_B\I-X^,'C;G>1/LH=IEZ(B[V+W9WP&,5'Q /C-B'LA-[E\*[8,]IY
MR'/&@#(544I.8K^6O(G+7C.TW4J@G!HZ6.:\O3/JN1AGP43HT&2]87?V2TPV
M5]NS+LU/?<9'OKEN#A?%A,*MI+I^M=-8?:+U3L!S;V<6F^"UQ^BQ=.&@)WU$
M<:V8DF!1E!')BZ$O!B)>EZU*3F#E;SC(B[#.;TZ"I2?A1<\-70=PM$?DIY9/
MBOU*GP ZAOB7I'>*7S+91Z:YEXEFU-B6-,X9Z<$*D1U&25/\Z; @9:^T%U=:
M\/)DMN[6Y.^;;S^P7FRZ,Q>PSG_8W*&L#O<0#"-1$3#C+)NH\C-Z3/<MZHSR
M>#UU.0W7$78/>S-B2.OZ+-M,KPBXE2+)8-:\]:CG5 HF%WWC439459\Z _H[
M?:C?1Z?*1]:$(WAL&+303Z4C Q*:37X])TXT7S2)BS=Q>0N[Q!D0;FW"J>^W
M/G^+\QG&**H4.C.UN:@BP(4LJ4':=<KO4#@=3[-YJOU2%74AZ]@:AO8GA"2D
M6S>0;:R[Z#9@#Z\PN\;/[LQVQJ"ZIK.B?;.UF@L<%G?$3]?(NGK:G6,AGOO!
MMVJ)-70(QMS;P3-[QXJ:?R14HJ!X++GJBRM6)6CS0&82>D5T6$"[+^TSL7QM
M3LX[M<*8)0$%JGFO^J2#MABVED(Y4>&;"^T$V K3/G8&_11YAQH9>F'.(N%B
MIB6A6?)&V+''7"1O1#RLRTY.4[-"5EO5UVIL\=*[HZ"<%6*J*FF3-^=73&1X
M_=C>\G;&:K/LFZ%!8K7 7RKSN=QH^G^:X(0BQ.;HK_?# 3&3"R-R8E[%7[0N
M-EGT403BF\SEE(7IE<+"-AHJ0 BMLLC6NY>N6B?SD-J$RZV.[.K8IBFR[H6R
M,&-$ XBM&YI<7E$XG>AVJ"4-^+H&EVKQ-).HQ<N?FQ[N3"!+8'P)YLJMLL*F
MY1\H;)^6!;_'7* RWO06=9+*-72:/INCG^:$]5FH <^6/2+J8ZP/#K%BCH)*
M1=D*)0Z6L:B'T'[/^*34O\5.;W"I)!Y>E?VY#;7B:$XR,H@1;E%2KJ%NRI?X
M P$OOE!_@97IG\$J95S46M'U?27C8SP'_K"^?MRFHAD'V83]B!T"Q:JO49GQ
M$]I,[],])1* <B:J*[X7SY#DG@SXW]SW^2AW"F4+HU=-@D7 0*_ G]Q9=!/%
M/CV+TH30*)GAFGE]01-N-:U3\ETXN)Z.J&QX4]]PL/1!:]A4(;H(X<26S4W8
M8)5__&8I(X'&LRE!0!I*^+J9@<%)HP0<'/@J=[IFZ ,)FVFEV<G2!^" 5OS6
MT5H=QJ^]P[4JU=0WTGZ1TU;$>D'?\'?6:^AXTDR'DJ@Q+H!@R-P'1=.V6BWY
MX171URAMEITX[$2^RX1/:97%@;W/54A!Q O@YWAZ*P[JZAIS#5FDS B?(KU\
MI%3A$C!PH3O\P HE9 AV,^!:'XW;(KA/,^.5K='7GSA+0*<1 8B,:+]0_5S
M:!$%"(HZ^:*J,5VRZ<@)%>)GEWJJ"G\!-XDM&X-$K2-L$T_S*E1!K%"S.897
M^C(R87J.U%>4^P*H;E+@D@H%!ZAPYHP$-0S%GIO\XTK0K($W&0*AX #B+6.[
M%<'FS?Z4RDCP_(-Z/N.V/J+PN@5[RF.YY0^R!5-HCH=IO+,:C)T+GKHV@N$Q
M^.-L8K*4J0+S"L#X48WG#G9SDP>J0$58$TEB8SVS8SX['C8+)&#AQ^1^;!T9
ME2);Z%_S_A!JAH0:TN"\6H2WHEU"#B"C8PFC\3'!DG1<AV5ZJ: (&23^ :GT
M:5MD6J8MCYQP /&I!_W/)X#E$Z6[&^)%:2FV?PQ9;RGLG;-LF=:\K]F:R,>T
M%T[*"6<#[J8:LTM+KQ;T,)@A"AJJ^PS)"#W25B3/?)V60O0X.6'B'E&2)HO5
M:!':"4]*(:$QMW;U#.]:5Z/+/]\;#S=GWE]KG;,_=Y.;)=6!N2[,P>F_"YDO
M'?I!'MH0MS4 I6._[<XFVL.C9%DSSTQ++>O-#&!4CQ>-YOJ59]&"(\<(N:>,
M4C"\R*\71(\F,3#4D7?<$5SK+N :468KNA96I]A@MVB6;$]U=KW37 D\^,/P
M[.T*CG(" _6_MPLU1XJ3;S<7=64]0\]V?D5\T&@SKV'4?"D.- B\JD95 IU9
MFP-JI?==*;/)#@ 4S] E^DLP]I8MH<(YY,HAH:<#B([0C=6RJD;!)T:VT?_?
ME9\])7F&Y+[#W@3%(!SDKM1QD=6;6,N.A;<TO]%;?XF[CX>7%D'Q^D4D_@M]
M9*(0E;I^]&:197233E=XTF%505K.WPR9"4E+%Y3F0K!4-->EPKAVRLD?%^T(
MR/C!%\IEA=/\_J_S_'Z8M/VPD?C/%S\#VS<]Z>;0+!J?&@#Q+;LYRI0E,:%C
M2@_($XWTON]WQ3LG4HN92I(?-CY[,-JD6UQT1;2XROXX4Z#8\;CBC&T+32$$
M%O.19SB!@4/67,_C&+$4Q+)U#E+G\],35IKBK!-9?)B\?M\-W[V\P$S@'TA?
M&6IT-RPMACE:G9J030JG;R>XGAO8W<#A@0T<;=2]&2G$5YO<9.._&!:Y#64/
M:QNU$C.-1JZ.6L'KIKFKLD4Y)V77.2;%U)OEK &>,I:JJB$8:&V8&H.ZXB_>
MH8:X1:VP^&*Z82\CCL^S#BH5<)2FB$LU6AJV*3 %F6GR71G]<'I(R&ZM^ ![
M4! GNGO1N1':67ZF>YHVKE#55=N=%=(O+.#Y05E,55N)[( 7-DP9I)V,<*:_
M LX*Z.A ,(YTYK;0;GL3O0RK\J5>D0\Y585^A:MR[A$GPI0"FY&9#;"-+0X8
M(4EY8PQA]=>8Y)+.CNK&@0-+0^T?]0NS(YD7@M^3/9ECT9%Y+^RA<M,-/GV?
MX@7F@9=MNWYQ/E3*E\N5VO&)7F9]YOVU+2,PC\6$%*TS['_*ZOL1G1)1!,($
M3DHX.^^M4HA7*^V["S.4TOZU(@H<W=G;?($^/4; L9'>F_T[6Q\;;C&B?9L)
MXWQQ)Y<K3\Y 1P^E9*&N'WG\45;N-X\@?/H=&OH1;A$JFQAN_9+G?<DI(7^<
MVS@T<IH^:!YBJWCNJ;I7_;"_TTT_%AQ14+,7&";H#S/W2?(:N$OU$KJ@#?S3
M4E3<^>G!V(2^^Y]23/4PBY)RFN3(;V#HM*5:1=_^ ER9I1DZZB@NX/7G%W2V
M '&=GM]8Z3HR=U0ZM&T7:5C+1Q_892>ZYSE&/BN ]>@Y)"8K^CZ+HO(_&)/"
MA661[()\3481/H94BS&Q:F@^M*'Y!"E8+*5B=#]VW:1W)8#-ZL47Z%^DB,(5
M5'Q,O.;_Q'RD<LRTV"F"0XPYK*]I!@[K*+Q]!^A#GKFIT<%*)Y/?*'\V&-<,
MA\H9:\$3\EUUC: 9@VC#Z<$^N:$I:Y?KA"Y;Y[V OF63?L/L3H/AND)A)^RM
M<?K WY\)>H^E[2.H1YW_BHJVY_Z@,^:G?!E<'D.>'!JU-!S&T1W<?E/>/K''
M7[%?GI_APJ.SN?*BKLO8N1!?(OW/'=)EAD\]4JTU):+O)X[HUTXK%U;_43M-
M[HW^XLBRX/08$@M.EFXKONZBV*KT1;O51^L)3O$OMT-#+-.!$Y-5<P:373.\
MG+4;JB_'X.'1GWYH"YQV"FR]5!]58&S-J0*I1!5*7-C->\P>?'FUKO//XPH_
M%<70VH@)UD=!UYI<IX7#9-0GZ*T?=+P&+HIVB:(TAWQS/7$IULNMQQVJ;5ER
MY\5%06-.GZ$%H@:A?Q8NA'5;W@R.=2[&;K"]^YL&XP"[(F-\:S,&#;33<C^H
MJH9N)^$]3L6@<&<('5Y'Y,&KWG\IF%/C_,OF#MKZ1Y<N^<9WV.R,KD(OT$"Y
MB+K_U?YL*\-*9>>'-P"#,'5%D;S2.B9(PQZ/VV:-B-_^ZQEG_+NWO]-#,H6?
M &+#YJ=(4:OHGM9A2]T5ZRO'D>&*WQ8S%1]+^@\*Q@WUR%R65 ^KL_UK&\I,
M%5= \LN>^7^YP?^-#?X$2/:S1>]5]1OZ]).OX+ZW2H^MU-5N;U5VH>@^>YY"
M0",L%X=>UR&7-]+U(\NX$YGGP0,IRUGYH>M>#6=:)=8^FRW4+P,S9MA;5@S5
MR8F[:3\P"V_L2^X697K.S^Q(F!KG\2JS3G.X_VIW#H(5S$3BL^1V3&Q9>4L]
M2@M<1VP:38K&&^N5B@=Z5LTK!?Y22)^Q"G(PFL#1M0 )Y$\7S?XLRY#+KY9(
M]I&[2_A] D[7_C;FF]-"$A_9C*8QM$4Y'W<ZR2(.B]YB^P"IQ0WMYCT)+L/L
M?#^^X]Z$N+)72%.'ZL>/)&Q@CS%]=  WR:7T'>I>I3\FWG(X]=,+<FTKBU0J
M]Q!4R@PW(_K:WY/L4U@KK7]'O1\UEXW5;8;M?\5!X&6<_5PS="VK7>&^(K_1
M$-T+WQ*:<XG<6"PD]U-+-">' HV5(C9O'B(-O*A":-H"^Q+%5_C+WYH$6>C:
MF0";DGT*2IKT];40TKB&"2AMO7=$=_D$@#5;=@+O&D@QJ(&=-DX[U9(#X =;
MLF)DB7_?T/@$^'+2F2//IB%@1YUBPU.;EWD?;J=.K$3XT6T]'U?L0NCB>Y B
M)$S-9G<Z_]"="5:C&_J5FI-M<V:N2P2H?-]"< 4LW9^<&&TO*'Y/O>::3Y?_
MNG5V)O!81BVX4G$^C0*FU!Y\&N:\9NYLGM-D\)$L7W^@.HZ_ 1>_LGF$.YFK
MO9;DF?:REI;;KB #>I0/J9J?LY,2.5++(()^R;6TXGF=KJ1<B[)C@0T8ZD$H
MH2^P$(H ^Q_2'@\>/@/O76AYFJ+^S EW5+&83,^M2FKBC:^'1V %:/8G0A5:
M_,:0%FLZ9H<K]6A[NV"4$]ZG7*V#+NU;U]K/+=/Z(H;;0;-PC2^Y"'C2V3)B
M.[>OP=!^HDJL;J%^)._"B;>TO4AX^(6\=ORC0:KAF'R42"??<%!Z6US9CCZ:
M_\/8?=I@GTE8 W88&7X$Z^:CD[CC(K&^%M[(BU>_7GI4-8]$0-"'JB/RC[_1
M[+87.G-)RHB@!M7/A;M[^H*(^(E55]=*?O&!1O2TW?OZI:\)[%7!H%81G:C-
M_/.^V;EV5::MU:9:?.5*:[6@/XD-D]#B P>FOF'&+F?^JWW+9:5R^+/2,1Z[
M06U4T-6RFX,3S>K/X?:^EIUONC(G;1G-)\1=^346ZD5-S/+QG5MO]>0:,X*<
M7\R%ZVKV_.GK2KT^F:E,<E[9<;9#.RUO.:VL4=@3B#K9P>$E_!'>P\;Y&0:H
MO81;0RJO,I&VCV^? /UR/Y"\5KGV711N2W99%N8AK#(T5JVI0U;;/9DN2AJ)
MVZ! ]ED&#R;5@R9QX.[NY9+U/X-Y]K),)O[>BN$-PZO_& [6;7J"C1P<GL2:
M@!;MR'-:IJM#[T.A;<29!R[]\8'+12!#56W$EA*2^]J7C42)(HUXSR:Y0_4W
MF5XG]U[ -7!IJ[[Z^$Q1I:>O?,J$Z!V2KBY6]^6<MZ,Q08K1F7FSSG)(0:.!
M%-181LG;M^9LOK!UPZAHV1UL&'C8U]T&Y206_-ROD=>G/G6ERT)3<2[INVL4
MK:_BKK'<P=KDN?'<;L9&N)^J?1H)8NX>9FDH@X.9%%2BUCE+JDI?XB:4KI]G
MJDB*]^H-4@SPILO, WJ*X>%DOLY;Y8>VFC_6DX\BKK^.Q3,H>"C%< >'&SP_
M?TTGT;$_@7H<8R\]>6 B@*Q!2W^AT]K6U5W@!4L;)XQI6@-LJC%?FK:NRG+]
M#J!Y!I2BNOA)A1LT3DX*]NH90,KTV1AV5D-MB[ +W'[OVU__1G@>V\)O>5]-
MV)B/S8O&]O97;"P,%CNAM_V(#.>6Q,=>,%)F^_$K@G0&"CMU5T6^^>[=Q]5U
M[EZ*B$Y7T'LM'PVA1$#Y?TL.5FB:Y)H_ZV=@'^A>'*%2ES?XC?O75VA=>F.U
MSTBM^I9*3#6M.!(4W42.2.7O^0;/9(8\AZK8L1NIF!>Q%;$_1H48?6TH&8'9
M::6+]9"\HHP=46M\DQ@HMD0MI4\$)R.ISED.(N@^Q=4*>CD2\?Z(1ME]$"MV
M9*Q5"GS$9 E2,,VKN?^*I0GZN7O^UH+C:,2&/'+15B8"*L" B] I *GUFO76
M-VF]T= !Z*GV^/@O\65:J92'+.FS1,(Q7;\FGAZ8UD,0O5_CEM>_:Q1EPJQ4
M!WW,WH,&WA3$XNQDST)2B!M/K2(66K :<S]\7R*5F0(1JG@9F=4:3&E(:Q)/
M6RE $SF+632TW/Z"Q)5=?Y,*Q;3FTT]7 ;E=R HBW8XMU-Z\/29WPG?EFJQI
MT8P93!TY+JFY1J#M)8XF5" ;,I/1\.-7GIP1GD0Q\5;.JN43!(,U]7J3XW+0
M=D'V_<U?T%U>0]G(VEV#;%IN%B@8R(K-$ 4>R"04+SZXAKZ]9*]3;SI7I>%/
MZ4DE0BJELNMP_NB=ZJ3:@K0/$/?_966.^_NHNO%2@6*@[I$3WM'N:TPM'EX<
M*<3*_&QFJM<P&16EJQ)8=)!E5]F?J0X%JR4?B9111+QI7*]B'DCERXO(U5+Z
M>\4?8B'Y2@R]IUJV1WT$-5(KF/WL5@ 7*(*=]Q\U"3)/] [K,F38]+4;OW&R
M<B<13NXK,KN]46>CZXNE^D)FL?@NV)[$OWI*<_VU17M^!0@;])[=S"@OT H(
M8AFR.A WLM$M0:$SREXGT,'39WZ5Z(2U[T7T,.ZN@C2-722;GP!73#>$M4+;
MT?""/FTE!^V"!(H9T6U/)[6$7OG9A5@MS)B*QFO,Q<Z=<P>CD;D*EI4$\[85
MB?C$@DD'UVG8E%Z+EP/_\Q:Q;[EI7'Z%RUFIJY?XLAEW5NOH58/!F]GM?&.9
M?P)B5/*^_*D--M%#52F)RR,503$<^VQV?G2V;_+I%B(^*P>_NE<Z-3HP*I@I
ML)\//4%?Y][Z##%]GJXHI^%#E/;@K<=42RI3LV^;J+G"]Z.S)NT:4B7/[LI4
M#[5'N#. >GP%E"Z%.EM ,0?F_)C2@S+1!9"MEH6JL4CC+Z0FU,2 //%8&NJL
M+,F5=X3-%M?4?#&O%G;7WO:7ZL"PQNTUH7Y_!*'7M-:_S_#TU!ZLX@2^%%6%
MT**Y!.AR%3M]FT\3Y6MIJD&740?RY#%H9 NAOJ+--GEY98# .'QQ!:P4;OV:
MR!.D/RWS;?A;J*@3Q@>!. UG&AR\RZC]&-R+H#W)%!\-F\0J??-_1M_;XO(H
M$U>T68%=]8DX(7@]Z88+,:DE>M96KB:?J5Q#)/2&I.VA1@5,E/&??J0-T;UK
M44JT]OYZ)[Y5M81SEZ*\*:F3F?X@=2I8Q,'2R],R^^Y2'HS[YJ=0YOIZ1VBC
M&FR<7FJ>[(P:Z1@>BH1-7OS+4 HM6CL;/3MWHLO$;K&OTOEBI[ M3**3<UR/
M9GA,[:Q=TQI7ONOXNU;@^W6T5"B/(&.DN>KUV4G1X;<8C^ )VACW2-.I/9>2
M-^3_TF6N)> Q0J,E5B8]7@(*[(4;>G3-\.5@I)8CYZK[#/![!<5/T2^?X$;!
MN \5%(.)CPT/XJ+O%$]J+J:7]^0_[J'<8W=8S][K(A@'8Y,C@2 ,MMI7T[@?
M\QVHG<_?YAVPQX3,N3;1/U002=-^__Q8\K>H[')3DFWGCUWG3R%]?G!BTV[O
M_&^OP"P0,FQO.=@(='JHLU+D,H<NQ-.^]"GL>F:H+RQ](;41X6PBJ4>C>'F-
M_8[I[>]EEU2X'_<"K)>JC-1"H+IELY0JXG5V><4O!UVR*SE]X^%Y,U>W\(5+
M0B6[P=TODG3L>:JI'$?7[EA(QI$8Y!KGZY/^<<-0+J!RA,F'Z8]N$17S?0;L
M@PD:"BZ.I;)1O-MNQU(LU&A'008"-\?UJ)O+BL1V(*1N8-NBTC.(K3>#D2%D
MQ9;!-P4<NOXO)@:VU)&(\FFD5Q<X?PG/LGA6REI7OMU7%3B(O:A):\_G=A\*
MD<GP5)32F)'"]!D2)6QML<8G?:OM/MD7)#;G2/?6T(K'(A%4(#2%T5L@!SH^
M8NIUXE,1"Y8!OVL4Y)AZ"[<MM33(;LQ?Z'C&B[A/D8(F)B4LZJ=;59,$4<_$
MQF)0$H2#6D])+1X;7\VN:<X(X*\O3Q_+*SD53ST! ,J.OEP1),F-Q^KROWQ=
MJT=JBUH7OS23%<F/!\8^4W!J;NU[ G R[=ZI-XY<3___C4(U_\<H5$+FP='"
MMTPB;DVO4^&N]I2I(%/CTGEW8D[RY7JZ\W[9F]\BN#PT"G\.\W *>T#J:7*]
M!Y]R&WUEHTSU^"V$N#79#R@5XQFE8@_!'!BZQ5U+4C:S WAGG$6TA3;9:R;>
MW?MY*=7M/R)/]<AUGTOU_%T%9F1JJO7WNR2M:FV3^PVWA'D?Q!O<%JYK C_-
M;8Z\FT+K)^"XE=YY[60&=%E3SM#FH5,OMKQ_3^15J:=P?M#YP_W6^RB&Y2Q2
M+(^]IF\/6Y9(,EX\@M^9(BB,K:!'F+\$UA5@JX@IVYF<58__:S5"'.-._Z)J
MV#C MV3^7] O*C-<O.%C+B*E=P65E&8.9,/C%@CN@Y<1*:<&+:Y;)248<(=<
MX67"HX":]SYT/D*/1<L6E^P%6PZ=_!=/@/V)@,_K2LJ0TB6FTDK0P$VK+^38
MA.3.4/B=P1OR1X^(9-?0@67EV=;FOL3.04433Q!FJE^#=*!URC4*%;17;2C+
M/ 9=OSNYV((REI%D-PX>YLW*E&TFC-;Y$HB!$:E5H463U)Y@@D:=S'5!"LSF
MSNH:M4^+707'7_L>&.'*QA\NV1T&A)]Y*,3:S%BXN]9[1Y (3FR4ZTN/%-=Z
M^_ +HCZ$[VF85"44JV]5RJHDI3J;2MAZ<%XEPB=4_PE&_"6:<9Z4K%J0_,3!
MGQ/EOY4@]!9'T]AB^3IIHP:E@"_1[TRH$-%KI7>1')9EZL!JA6K<3&S3V%P8
MMLK&V7O ?F#SRNTY[O!]D'XP/\VOQ-ZN*G$7M?#.P4?-(NY/;N+#FH_:M\3L
MM)/X&LV5*T?R!S;#RH?#V$//IVC>N%O5T6A.R)GB/0'L-0E&SM?R!(N5;7#Z
MX,HH^I3,+YA3W/]4HR<^M"7,2-C]VE)RX]<6TXM?<V*S3M@(5[*D>\&B\_-U
MMBC&6U07UMD)+8QOW/KW.'#S/MTO&J;?NFB8T?_9S<$&3/TU<7RD\ONC-MB&
MI2%Q6,TELO$3XO>*K ]>FAXM6XK:BSN!WL>2SD(A]Y O6:K+3;VWJ]B424Z[
MNT)/ )RA,A_Q<W;J?XZR8AO!A;S2'PIS@;U-L^*[Q*N'E0GG,$SE9E3V@\^6
M_&S^LI?UK]6K#C'75^46HDCV<Z.F'T$37F)C_!SZ71%)*3I%TI5M\+=9(7 M
M'X2'!/.H)V>1FBI7XL['WS2OP\]9E:+$:<.KY:GM9E@[" 4VM)@UR((87DEC
M$5?Y.:Y03Y^E6UZ-82)<3<ZN_/Y2&XWIY&:-9MUD+3G@ECA:C3X!\!MS0\QN
MC'IX3%<LYGQ! 7Y@[C**IF7J2M\ ^+NS9?$($+0/!&+!-%Y<\U)W58.8+&[P
M.VL"R9?2A@5-9W(,'^;FV8K3U./MM.FIB[XB42WH>>#GOFFEB(AN5(=UVW0E
MSJB7]J6[TO@KTA_;%=S!YYV\;QH2_DR_>6=^VVSWW)VE)\-DM[QD!V $0R(W
MJH?>7]=M29Q,W#DLE8D,'=Z/%16M'HJH+G=>2CPT)>2PH2+L4P2*UV8H.:[S
M5[_6=!2E6S$VPR[<)&9.U7"@O26BF/-&#VG:HKNR2Q]WE&G?FNP_ 7(J-]1,
MMPV"GHLG^E/WM*U5[L\V8*^ZY."9GW-?%O@O^KBA?: "[U:7)G)N.HJDS.\C
MU+I.OSUT=O^Y;\4D-3+X:M)W<O4$0/U+Q2125)5..Z,E/95G_Q9NWK3<-J@E
MYF>4M -?"0JUX%P=^JCU&=TY:% J81&FQ(Z%. AD>.8&_BO)=5>G.4WY>ODK
MLEWIJ"&)_XWYYM_2\@PN%93  40BI-C=H4T^9*".QB&J(=%.SK"Y<\(9C]JG
M]"'SV+Q]\.! 6')VE9\W<M57I#9KII,[7CO-0 >P5 YBF;=P84S-T9PF&[86
MLL)!9*_GB0E:_BMI><QV?QB MN2X[1[+]?U[P?<W#Q;NW5&BWJ ])N_5I3UO
M$%VDPDK@#8G!JCZ$LK5I%,!++E#^ILT#[TR;G2G_\$=-_UD@Y)0-7I]E!SE]
M:*/M+UU'S<@2-FL=#,<\HR#1J=6IQ4L ,QQ,OCU9F5G+S#VO.$# XX^@L_]V
M?HS#6P2%+1CW'RS;]".5'4;3Y0;:GP"]RW&_J&JB^T:$)I#5Z?$Q+N5P<R1:
MYZ9?5Y,E=96%@2<?',3<BRS@!B;2W4P4$-;G-P<68YS]QUXEY6,J!%&/N<X$
M/CR=Y<N^,9 Q0T-]TW:5_8E@T%E9)E>8L]6'(:T+/=[/DL PE9 U P2!B]"E
M98D&3=R-A1I;B903+>I^MVK(6W)_6W?FVS[K >;[RXV#3 $FJT!8IWP[I FP
MGDG0?YRSH&-0-["0 =>/AC)HK^C+13=_VK6GZVNKAMC/ Y\ &0#YQ^(G )C3
M0**T,]LW12([,]3'!)95X/3Y8O:7)Q'IQEOAKG<#FV@<-IY%PRPCA'YO_J!M
MK3>CI2@;4WRAKIMJ )UCA;UGY8 &*A23S"^YZ$C2[^341_()<!GWE^@)H"B.
M<3$KWY>OK^_1%)]6WQJE:]S7E\8F2%I&*6_.LQ*XG<>'5E%P,JROZ,UAAGPB
MK080U..RBM/[B+BHJ=)JF)1P5HIVRO>=*6O.T]Y$/&AUEY96Y%H*"=X4]#%L
MS$F6"_#,.#CZO?7\NR')AFLN/WR0+;QR*7LGZ/-1W-Y'5JAI;A[#:_[W*DW9
MQ5'PC,5J>K63^A]FJI'74?"WJ6X]_!,4O77+SGP;>GH-5RITG#6.I7T+<O:-
MU8W[U 'DT ";?WV2=O=/ +^(O2? $Z \QM_O3GJ78/$N]P'(X0.%ZV+?M5X,
M[?-^N( ='*"P*"'1=#O#(LRW4-(Y>NN+6X3005P-N);<&D6NE1;QIKZ:@2O8
MB:F!AR#2_='HO:VX\Y3"OO2!0?R-V\:!VN6+;A]%+]_?ADMY".X8I<<LH?&F
MF&I?I;&]9]@^52Q&/W]YS&ID(PWCR#["C(0O91#W7 6Z+S@3 RY%_T\RX/\)
MJ/R'G@ [7,.20Y=^UW$*E3HQMZN%%FQ1J_..IO^E*4K_N3'D#2-Z>"B/(>U-
M:-GB8_ *RR&,10VN%G#E$ I7:L7X_EJ8N2[V,G*I0=LW02Z,D/>7?)\!C['G
MEC>+DH]VTQ>-=@ %QJI6 )DH I^'P=.4EI%5;H^0)#L6B<9R)U&K]\?5D,+:
MQ3,;TFHD.<L=#M92/&.DRY< H*U [")G4CJ/#P^_;;'U 9,$9&_>-(XW/B0Z
MZE76/S,P#+X?UGCQ24&S1@&VG'\AL8*-*Y\*14ZBV',*TQ1EH7R!C4NO1+!R
M7F" %&G^6Q\L^^/@Z549K7X5*W4"=JQWB6/U(^'&.RTH+F;)5H0;^B>T^>H$
MH4U/4_;>E_)%LHFPB*<EJZ>;!BF+19^#QI#K%E:B6Z)C7&/W>R+K6DRYS?:"
M$N[/ _O9$+/>:TB:!1O?" LKB "(S%!.?!6WK$624[/PS!U%'/,,(KC@W'A/
M</5W#=WXX+8FQ=O365F#W!2")-(I7]\BU'%L_1,%*J<#%]@#>V"6-UCL!O=B
MA/Z>DV]P#5C9<5\98L(7]+_]7* >%CS&-)=TE^(QF1EM"5^V==<L$37"]]S_
M&WL_YJ^00',L6WXI>IQ(5$^M_ZZ1H_)[^ )W=LZMAB9Y%YMBZMWF\-=C+9WS
MD?T&4M:?C@E1_@  'S>)89W7O<J':*CW6[S$<R+5T,,&+&_Q8)%/Y]"@'YT/
M>Y]$HQJO:GX3T%[^D9@K0J'?962LK;L(TR.X',55&UX48W ]^HPB-&VM0?H1
MTN_^G),U.&I\\W*NV=@W8M=L"'00E/A<AG>1TL=W6*&>.:2WY:N6VHTG,_>P
M-4K(T;_9G,C@&Q5<#<:WL*@A(:O"QJRL+W)K)L)2H_D20PJ[M^6R-/?  <J9
MOD*$8/?B>3"WN<[0K"Z25'A?4U%+\&?Z?YTDWY;X68"%R$4HR'8.H5V:*0E+
M*3#F6&U#ATY<YTD06CI[FF7H7"GJ/)^ >SY,E K)/M4Y%0:(F?V96 --2(NL
MTWI.8T_ETK,[D@BAT38:V=%L\1U@?YA,TF9SX["B!+,>;LX]T6(V-64B-7S6
M:+DJ^4SLD@$;8XOD]53O46UK#&;SFA2[%I*.D8?6I;[S0)U\D8.U8RL*(8EZ
M$YLKIJ6ZBLI^&SWWZOQ8I(JS:<S$$_ME3N,CQ\^$(*S#S(W.';_E23P] ^?Z
MD<-F+528TJ"&%^ZK>IJ57R%?*)EIS99]U;-)!ALJ8_"6'*X(9**41T/*M]LQ
M'>?KB!/!\71;G3',?#W/-1(J2P#4&.>X>TL,50:TZII9RPI>Q@+;,.BH0-2@
M;,?DWW2,!>73E8_])AK>,SDW"P^6P8FU.M,90.KL/"FW\SEC*KT-,3^AZ(L6
M#8][KO"CR**$I((RTK&INRP847LV3NFZX><Y?8AHOL"8/5)UB%Z*)I2G*JL'
MODRBG.3K'',6=L5_&J 1&6D0MSDRG#.!A*A]&QQ][4,<F/\8S?>1H#7*LRF9
M4FGI+AP.0?(+_/&27#-^ E3U:O@&MZD*('?$,V]:?;*X!R1+KH$+YSME+Q6"
MJC4>:K_8UE/Y@8W%SGI7E38]+^N@^,P0# S'D0+_XR&--%_*[,R,O#U:U&.2
MVI2$B7.GW?&G*&]A@[JQ$#['TK.^*Y,9"%G=345Y=)YK_,S^D6T.6O?@GM2D
M_(0^G3Y&[F+SI.BED^Q+0>F^R2^EPN,"&_8_//4@T]S+I0I(2*+IN )!&G]5
MB[UA8")G<WS7X E\3LGEL0;N9/"C:T.X?67<UYUI=2M"]%CQS,/A=X&X'H7<
M[D L*6;24F5FB(/>UBC[(.$\1(,J[C5_=Y(D8T6>A@'XUA-67,%CDD8GY1G[
M*8CP=T9'UW8E8FZCX:A#,T\;M5R?PY1!+W2#1%WX$4M<(6U,<N(#=\SUBDQ*
M'CYR'A"-2):D2T;^?7 M3]0_)]-(.]@M=1^5%=*EK:0.&?:TD^;V]>-*T=E0
M8E%+#>7(QL8J<Q)$^+ ^ 3Y=TE3!NVB@A/.-^_Q$=7U_M_")+TJ:W"3OU&B(
MV(>? $'67"9OMI-*FQ\RZP0?.&_$O2WV7/"'=H WPK@L8UE#C>7YS7&,R&,Q
MVW>R'$G/=(K#>\O6U62_8='MC<=UP30Z^-QPZBQYB'\9WEK_2=XRTGT#1\\/
MQN'_=F(BMV8T1#/(!.=MBQ*]^\GK@#?WK DO14O),H%)UU\4KODWH(4!HT:"
MR2E#K7T?HY.*K\<."MSC#&K?Z-/(.$\'?SW^E!@;O_7C-^%.5;3_Q^: E%HV
MPX0G0.)9I_Y&XFOJZM41S2&IM?4CM3:?H>M=?#.HFEG2AJ*>S2AA3K^:[5>^
M J!*50>VL7["<_J<O8UL$K%&2PYEOO9U&B4PD:>9(BR_,]&-O>G-]^AU##3T
MBEZ*SG..WKN-L&.I"6"5O3Z\\K6H0=+CN* \D6#H*K,5HZ4?1:7HZM2:7R$W
M3:613N#FCZ>O2%E :SI)4$L!029]0^*19).\D7E#]JR3P8,5VNK\)_O=%AV/
M 1TA.QV'J\&W_..E)M!R#,$UK9._%6)#>GK ?>^;Z"\WR:].@FM.:V_NKR=I
MQ3LS:NK-);([I/_B[J*KJE/V*</W7_V^,:BJ*VX>N3F6MG1W-.JLK/PL=7QD
M?$\B)8(Q,;F2?K,<,.$!](G0AG.R?G$\SKC^P @W+Q7*D(V5H&/?IO31R#!4
M7]9Z]GR?M!F=D>?WQ@>'1R3&>'3P;[*U]Y0%=WWLORGR9G.9X1F90)V$QD4,
M!H( "<J#=%.##/Z;LO!EKZ$Y%L2>S"SI)[0]O1WSB:]F'5#^A13D&O*)2C_T
M/9.4D"U12B975_& I!W3[&S03#<>18?D>HW&J;7L?><U@9<Y>UXM+Z?P*=;K
M3C1 )./+QB/<.*:$*NG1R,L7M>>99#$>CAX[O-!S!-J=4WY2*A>+^FF@6L""
M8:NK5?+^_OD\UP99V8&IMMQ'ED%8]D?'$L488N2"%8O>L7X;)41SN8%ZZ)1)
MBMF'L+FGV.P/]59C??VMH_AF<WYLDG?!FX)?W]T7,J)7ON+NC%UXW^EZZ5U"
MX[T*+K;V36:(2HYI+RW^@W$I\'"[=KL^[YP?OXGAWAQ96]QEABGENCP;5.-7
MZ/>Y8W8VW,[ E*#&#\.5D"7'LK%OE77VKYUXH"J\ F-'ESX7=G<"=\J#'C8Q
M#Q"OZ3M_WD07-S.2'U%<R>1/ !JXA)+ U'R0H=*6^>>3PI&105>6ALP5%TU-
M4F/+%NG"^U#W.LO#ST%OMEBZDDQ5TM@O68VENBKGISIT#V<&].(0H2K:':"'
MW,CH289A-R4HMD3>_&]%15IGZ8RU\U<?AC*4[Q8790(N:BYS9YIZ.#Z?8@>^
M S/#K&X=&DI=V9E&9.[=H074L[7R*ZJ-)G;Z2=D1O#N"\S$T6\)-AVUW1%T#
M%LKQ1GW")@1P,EOSVOO!J BE@%%#^^64H/BE48&S2KDR;*=G_@T,7QF(!YK3
MIN4JW_"8$%_1__1&]1J>_DIFDH3);7-;# @_4AHA=5=G1BJXRGYW8),XVA]M
M#9RE5=;T6^8L(+G7SC*"6'@KQ(+GEA"BSX=YPA/@MC]O!^X2[[8V:$L5ID_V
MK<+N]/H](>.<^=ZH*-TDZ[FO?%GK!_$U_V13%IJ:!F\Z[T)86K)B+1)OY(F9
M@(C-W5=4829GXT(+1'0686Z;SGJI03YK630X8/7_Q=E;!;7AA=^B5"F40HL6
M+T[0XDY;G.!! @0I7B2AN$MQ#P3W(B%8<-<6AT"A. 0I[E#<Z?W]SYGS<N<\
MW+G[>3]\^YMO9LWZ9NVU5MU2=V13OMH4$\F8)%QKQ.Y;&$G%_$51_#&@E;.O
MYOJ3%=[7Y,;*EF0N4%: 1G'2YC<7&X1A1OA3RV;H5*#/Z;YD-QA9P?B-<S^%
M9)8ILGPEZ*0^_W2KZ7[=^1(8G;CBGW+/8[3B6Y"^AC'OITY/$H@SLB#Y_"#P
M2CGL;+XM,8E)!_W,4=1R0AGX219?VYM$>VI:C-DH+Q*\O[Z>X.F2[%_0$25&
MN%H4GO7U@_:U.E2 HNEA>J@6R+/U_GKN&6[N>S%;%7D!&CN5O2_*2G8G NTK
M1 SVMJ9<2.B=<N1?WQ<!!\]/B6B-;VYNI/_ZR?>J-;+^,4'RW9T*E$7<\LZ9
MS1ZZ#?E20B+YOKP.+:5NMF]JVWEAIL[PH^=Y-L2*Z'W-Y*!G/)STX2=->OQ#
M98,+EW_5!]FZ060N:%+=I<E<H':&-/,IH=KJZV8"$<I+C$/<[VJM9Y]D#QXO
M/?AU*L&[^C\4/RT>Z_RRMR/+81G&J& 34G/>SJB"KNI6.FF7C;LT<5."UAWZ
M*C]1Z=S,V[Z5N:+L[#3FW+4?+0Q NVG/]M;(&0D\AUZ:-6]5A5-@VCP+"T8_
M<I7X%?@%1>($^2HT[%*Y6\DHKBJ^Z"AL,M'X<.'SD&14J:+!N!D<;'5C,5Q;
M)RLS'+4 FXCA=1IHB!.EUN:2,5$S>XR?4L^,NR6PUHR-=?N D3$B(R@XKMWK
M@D_AXJS3Y9C=H+\--3G[20-_D@P<.H=D1L18Z%Y]#S]U+IQ7X>%<9YLNYQ L
M5G_$%SF@H]O S-Q8X2CIY;5W.#:C:.@D;=MIA15&K[?E[L('SKYJZ2H.T.55
M^<[GE/ ]0/[.+U1T9_"6_4'&GP[&17S=RJM:=KZ5<#^4L(\N='.QY[@O<OGC
M9V>?9D^]*?$E\O6;QS1B;[*\9 :OM8VCUO4'\>:T]&$TE9E^EMD(I& "MAIL
M_*,@+(2Q@ ]EHM!F4&@@93VF'%]DMUE!"MM$G/A>?ZMD><'N](%N Z>8\.#&
M3E<OE/F7X,0@GE?#HI+43QX&3B7-IX\??Z/>5R_!'T]",@#^8T!X0! .$/3\
M!XXXSO- TJ02%HY'RIH D,XC($*AY[7W:X7 O!3#N F']Q,._./$6-6:D(8)
MM>\.2<+SCS5#F%_]#UL 4+='IJ@F4+901[5\8:#&^,M;I+CC>S0'$+@OQ/<(
MUKW!7GX#NS_\K!8/ L[KI8RE4FRBV8%Z*TJ*:57QI!T]=X C*7?:YR%\\LML
MJM%?2LL=\0=J;"R4G")/WA!;^0I/SG$7\S%\M4R5,#XV',?*^4VQOY8K44T%
MLUH.7=64<\[H\FW>+E<XR_+/D,D#']4/6)RI<]8]]O$5P<Z5$ED:3/?XI=64
M?^Y+?(?D6QM(I4U=!DW-!F)X1%-I.4P_S1-N%07J%R)M0>3_DZX,1'PG36:1
MM6)1EOA?1A/'8T%*NO53@R#./S*!H=G3$5KZ4<D)!R!]Z"/%DQWU'\*6Y^3@
M9/O*LH[4..FU8NV4]P8J-=%XP*Y96_EI,$T3DODZ J0GX8Y;,@TUD]O6Z7Z;
M[T-;"FN1GZJ_7>EM.X_M2651-IQ.8F[X[00#I!7O7U$?@F%;)6QRQ1&+\B*@
M@Y4>Z#S0O6*C5$6-AW,:JM,PZ8:T&@0F[=L:_T2R,%6S<X ]-%Z!37"^1I6H
MQ(UOUO1X 3_R5E.I)+ZU]<D-+>'I#5D;?#)OJ+@^]N8N5:"O^GF:Q[M:&%[R
MIF\90PFQI1(WCAX$3H;*WE?6?&;Y]/%'9L?B>8-DUOYM;:;9[EAIQNFFVK=V
MJF[HU *T0UM@PV01L_#$ 1G+QPLT0/,B%D17CT_-*\&2EI 1?_'@<O!^PE%B
MX3O2JP+Y".;!#O-@<_E.NOT__X')!$XWWM\GE>BILPPZ<Y5O:AB\T(ZR+8+$
M[Z;%8$SL@D#S)!.?/7"@Q-_1BHN:5(]*=^<RQ >%X;U5:0LZA6GU7Q=SQ5;K
MD75Y$2.O)H$I(LQ( *W.1^KMOT]@O FMB!Y_\^/;77*L*T.(J;P=]3@6Y!,\
M7)6ZZ/K.!X@@]J!%&KNS:4H80G3'>P706SWHL.2\ E:+@W[[X:_Q85T+()D4
M=-P/MUF2/X2!' >[AZMW!W)7#5J2O?6G[Y=D]Z_1!TO+WGBT.X?4\$;@\5-W
M#/SO;73=NEX26A_"-(CG;51RU(\7%QBF=>6"B+6%XCABUR^2B?/Q(\6GC]V>
M8C[R8W4&:]W;'8SG)T7P/\6?NED32_O&=6'Y9WAHVM=0=8<A(9?/:$<_?BR8
M#OD@_6&^T/D\0'M9HRLT5,!WN3"'V9$6E/HL@,_VX4/[IXKJLTB@CO#$%:+K
ML:4#/-@MKKNB$6Q*IBVM>U;K*DWRA;_CPWTE3.M[[8\3+"1*U8,E5+AB?BB:
M[\;WLYZJ3":^G,&C&%2T@]UI*;(%,R1C''A"!^UEL04 7JI#[0T+,)- K*+B
M0U2N,B<OLLRH9.0AGV?WE%?;X.&1F6JO\#.JDS6BM5^"97YM79OQUK6[G.9&
M&V)^O4^?C7X53*N*>4YEU1]<(=[>P"4AE-3!\7;(:)8+GCQ:=%G."YPRJ6Z>
MF%J>=/PFYC+UH)O.@6'M_0_%8[]VF/?O7K_D&Z2O:QTZ6;!/./4U037$U8=T
M]V/ULX8_KDZ&S3L+VKSIKA<%-"^J:\P[V(Y'I-T,G4-V'L"3)('WCG["4GRG
M6T4]Q_=Q3,G.=&1./6]'Z4#8S=D^;5;=Y"*^J.-?IBEKPS,VGCJYW;R,'C]B
M)>I[18=2.;0K((GPB I#->TFYAT%UW\X%QV=*_1CH[>#6P&7'M'GK9 L/VOA
MJVRW<X8S])E0;ZZ"":QWNUWBV'%/@^+F_:B7>VT*3=<VS8;70FW@U_,4SSX/
MWOB%0.=N*\<$[0.&NB%5QWBOK_'SC.XU(D,C]6:E',4S,[*&F2[&R6+=M^\7
M7'!SI0AN1O^T[3YG2SY6^X<C9G["3\,IWI>!J9X;U5\1Y)5B!F$0O2XU%$S$
M%6XFWG2?C,A?/*EU*5-J1@_QKI0D]RNS]6R-CFF/'Z%^N=R@;UI7>6 K2V(;
M<6)=33ZY#L=M(L(]NQ7'4?8Q+I/A1!:D%_4ZB0;^9+XMNYQ>3OK<L?-PEKYQ
M'QVW,K470V<%S!G*]^R-U%IJM"$W$[5GMBNYNEE:O_QKT6*IJ?<R9FG3+V(L
MQE-I9]>N69]>4JT<&0WV[;G<2;PK@,,GS,C!_$N(#<CEU.A"TRH\:5UH<-F_
MX$?,9(4NIJJ/YD#+TG?B'G(/<OI0QGJE(KW2B1*0COXZC[06<KO+-NU/OO/
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MZHN?SJ5W\1^M2E2\\5F*N :(L[TBIB<GF/O,6>Z93IA$Q]D^&478N=6_$UM
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MAVYY-+E7G53PS$ PU1_W?=]E*I><N6HZ/Q6<2D"]G5'VD"'EK5EA":SMM +
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M"?D$6CRD"8MN0H0VK)+CZX46QG]Z^MH5]Z?5AY?W'P-L*F<H^)QYG]]88/Q
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MF'KW4RU)<YUGR"[E)[DI<\4<D8(U,)_%N%<*/<)51+U[B%L 8S^;5).,FC"
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MY:C,QR[6CRJM!VGS(ZPQ?YUI3*L4^P6S$K>O'K5^RS]#6)U./]GNW7NPF-G
M/,675/I'BJ:OB$#>-K<^15O6!@=V>)FZ>4DALOPEKOWQ"S)U[_PUN4$MB<B\
MZ,TB"B!'Z!9G(CK>FT>Y-<FG-H%&HPUE^ A5\!] VS"1BG0EUD]64;?GX;R;
MUF#!)6OILHYZ:;ZFA,<(2?O_Z1/&G1Y54G..^+.6@N&#T1.Q// '\K2$OA\"
M\_Z79.,)D.&SW)!!U90N!FD'H_YXZW'2^=[1):D9<P>:"\5A%8#^"D)AA9KL
MH1"5OL<%;7)OK"$]SD)#BQF;82)D+U0[>NR@B9:[@1RT[NE*>_^:C25M,F:C
MZ&*^6 H>"AFR5!)2<O0>]G&$F0>+_ !WFIF2'AE_K6V5%56@'12L-GN<;]EJ
M[H%\)3H ?C'()\S H+<VR^G0-0Z<^@=(MK^@3&W2;UP%RDMM4M?]-%0/8ZER
MV)^7_2!"\B2GWCYD#,_%(D;-89*KWFWO^-<QBY3<#\5?XRQ&#8W!VTB3+5HE
MN.06^Y/Q-+N;?= I+&JXLRDN0Q<1A&E(IP9  H])NY7*\?U\O/ _M&JA<Y+0
MI.RP\HP))Z$5Y@.H(XD-KXY,,:J&_*LOX[$Z8YX0 05;=O_$4@[_ WL,<>IS
M>'1!6\2I8S[=!Y0T<0PS12LVK:GS0][0#_>J/$W.BE'];XW/T+)LVR4M!=T'
M4VQE<W>(!5CJ36<I+P31@G*$&465@L@T2"&(HDZ#=/*OB$(_0O]=A<1#7YKX
MO]E/3OFL,O$RS2)HO?)I4\D.ZZ2_H:WR%QZ5FWIH\'.#S'G= 7DHP4J7**(C
M&/W%0GGJUG+EV$HOHBIS$O>(@^DJN](VY+;-D-_VJ/N7CF)+96G%'V(='&:H
M9PB:D56C&55EXUQ?D21J7,GTPH]!I7ZD,8CTP/$[BW >=JZ%^T"(-)I+S5YG
M4;TARL76U,M<SC!H%49] -?D+W5[7\^VIUV".:^[>1LX.ZCMFZ/]\@'W* S2
MLWL:FKIOJ:-^LB".XS/8<:[2=5]/2.>L[B?(0[_6?'3\P4!.=>R*(\'ML"&'
M.\# ]>'4IS_=C*RW5)O?//FU<L9S&+1$.%MG?!XS:-0TW,#;SW2$,I]YK4FY
M8Q[9=Y@EXGH]ENVP.9%7]?R.+2BX*+VDJI:&2LL6!*1H\.FT3T)F8?$J:@:;
MG[7L.JQ4WOE3<LK/_F1H!8GK."U-[YA;K1?Z8B1DJ#VW<C1E[%LN=Z<W>"#!
M L[ST1?YDR(4_ UQ)A5P]JFN<9-!?#\GLE_BB#LCVV,IV5SVP*21DQ\4$%,$
M"=J5*VBY!$LMFC8'XC(9A@<@XL HXU_%6^-TOR[+MN>V-Z,D[:]TNJY^SC&P
MM+3-+KXTN?^T4N1G=,R]U":2 \V'@(:JT[\1@T0U1$_H<Q!G/')O!NJJ0<OC
M'B.FAJ%*4+T0C^17,#OHQVJ&<9/?12:@#H_#ZN?_3>HTV\4C,%,_.\KE*);%
MO1 +'[K\)(\^!S]6C#WW:><<B]E"6ESU5J[^EU[C<9X H\WS:QRG3R>T]62W
M;A BW";G./9$8\@CET40X33T+EU0"THSY;&3,-%O/SR<4%[CR'(_5Q6H:,L.
MUXPV\9DAV7A6<3A:&]*J@X MF9,RQW20ZF1NFM< RV901/\ O R<?0_>&02T
MMREG@,5CNB)#N<_B1\$Y;E&K/7N1A[@$)-K7'J1EL8VTWE#4]T1T&.5AEO4-
M/Y5BNE56LT^#)J"8MR3+&V/YE1=,>3$V7FQ&$P6D6@NRGS9]LE8U5"UK V*=
M-?=SB.@28Z$P,Z=U$D?XV4ZNM"JNRYNBYYBI,3U>^ZA#BHLQ=5#O?O'K[%3)
M^7=,T*)VP)?F,-4=I$]@UMZ)>:)97D[^X7X&RW[P:,N56>6%$H.T'D<C;8'X
M:-+L,Y>ID"OM"[$4Y!4"*'$>D]FPCZJ%R,WZ7"V%8FG\)JYFU\;5KO#H7V[?
MP\-$[)_2D.$_'0L(A9@Q#\[^E4[!?PP#&!81_\G7>E@W1JL_PU\ZEJNW5=6;
MM!!LI(L&X8T*EZA8B"$0$:O28RD%L?*<$14X,D6E*L5DT7KAT3/&LZ"@V[KS
MJ[R<(]SW/C^W>USK-!V78J(MU5]ARG(.#;6,,R>?;=*9=CV=3_V)4BGJ!TW1
M&T6[VE'4<[,+NHI:(<IZ% P6'M/3/I>Q'K.D"^5V4F?C7-;K)?^-KA'*E2D3
M.VIB)G:A-4(N3+Q$!8\?K6N3C&]AET]5[D%D(K&C,E_B^?N?OB4M[*_96?S2
MOG$KMSIF;BR\ZA.3W_XQXP>XF62/*+-HYO7\2N(N3*SDI4]+*0J8_UABF*%7
MJ%@;[?*S +.6Q_CH_+J/_]S-S[H,LMWIN\,-(1=E-()/@6&;QQ#)>>Y*"Z0%
M>XG/!753FC96Z*__.31:;[.[QB$D 5L9JDLL;.(PU=1K:&9/<_DQRO/>@G?\
M*J8K>#  7?\T\^\83UC3LE4NK+R$P;?[VT2(\XS_T2[0U\PO[C<'+="*? @&
M*[/ )(L%I];244W<;_P#+!7\D%KRT/(8Z C\-K<FMG$[^)3.R$5S"ISR>\$V
MZ4NCBOVU1^XPS\9X93:_6"68IW7AA([>+->YT[R1X=/R<2M0S91L4:7'T8>A
M@.(^#Z2-17B,HKF8\@TM.J2,ZI_L)<]QY9J+(_/TJCHP=,=0YQ6X.5HZU=]4
M%UFZO9[FZ5;)V3XCEK:=]/R/T\%.=H>YF/(JW^B5<$0[-K^,CS38\\&=#YUQ
MD/N9_EK+F%!L5F['_L=LP8)X%K G7VG+5P[0_.'!F%(PF&)4NGM1_ $WGZ0-
M2FVH3OME$HWAUZ3V;EG4CO'^B=_*99"4#NB/7TN72L4KZL-:%&]S'5,5I ID
M*%663_%2ZD)Z;\UK[/LK%(74>$"0F)],SW@?W4A%;=FDS<+^BV=R7A',E2-U
M)HJT3B%4948=I/YURIZ[":?(#5*NXOB$7)1[MIEG<&5G2_4'][8=4[$]_9-D
MT/$?_I)"WZ/71LZU!W[5"P9;OB2>:#Z;JIQME_BK=.XV+_?'S14WLGFO!!?4
M&B%&-+H-481\* 4RT FQ'B%013KI1]HB?.@:7U@C(?09W9!H.FX*EJ.K)RA)
M-H,:.C6(R?$5\=<:<N"ELF-;9W)'*]B^"02(4O/Z2)Q,/I=_C'K-N;R\0WZM
M&J&/-%4/M/L4*KJYJK)^:!.<[=;P.#5^QKY1H,:-3QGE C5,_[4L._: 5+:G
M$XAJ^KTUW$5@TR4:I;5P;KG+-;M8S&2SVC;WK?R0*[K&,RS3Y45+1?N(<' 7
M:\P#B"^A:\2K2>"RO=?Z$.*F3IQL>_&AU(+!++6!_'<W#+C>AW/"'@05U_=P
M.RZTG?<\.EPQ?_>S$/QUV3E@JQ("873*T"7%^2S2X,M?Y'>13S6[Q95))K3G
M.YEFBPI>5V0<#D?NFQK$\_Q1M/]3"317,<OHDRCB\*&(DD[\O.*F)1-AP#)C
M"*6 +CC65L>#!\'#AU04'-1&;0;0)%ENL4R#<KHZ%&0E;='XT>?-J**!J-:6
M]JB0^2(%)Z-AVR:$NJQJ>#1D8T4[5#FW+,1Y>X5MB-G^NU?Y*^88VX?]9 Y/
M$(^4 T)UV63SBBQ]U^H:MPSKJ8PA3Y1ZA]O<CI+=?7^XMVF-$+[O;8:4LHK2
M=L=5EPBSCNPQEBEFE!KH&07KN(8IQI1]%]K,2%&XXW*.2UKF+ \9A%@5=[[C
MVCPD 2#PI,G;7KU9>=]QH[Z@3,]]5'.DB=89YN-^9N^HJ63+@][9!EK>'5P%
M7L'N3<0;;L;^=G7Z,RLO/V3XHR#$_5-S 93R;:)FXST?$;6E;#:<=/Y: !).
MHB&KUFSFXY&Y9<\C9R&'=$7?#I[^\'DZ6W!K+B%]F[T>=FP0XJTFLO1_X.((
M-B\Q]G_*,0?S[M+ZIRP:B/H98Y0;M."KR4N*&1S6=NF$S_.>TC9)>9/I:BSV
M7=EK552'U]8^P,1)8&$V2Q]BL)9S0S:6'S]]N$R>MZSG)H1#&V&VQ*JYOSHW
M1%IY6-1*HM1 XI.&]*B-ZR/E.DO?N7LFRU<MKCGG>^<ZPJ/F]P4"Y\%-ZNY;
M+S;G]W3_ZNS-X5_SV#^/]/'K_GLS=8\U HMK&[QSGAA\'?TSV#Y>J?_O/P!]
M27]C8*D$J][&_$S5099^9.UEKY409::]AG=ZY^E-GL]7 S1(.2_ ZEMYG).*
M'@._L&7S#8#RU_$%[_*5S[%;_MP,2,1GT;0PM\"I(?5WF/1_,N.MK!Q%S9]D
MIE!8;I"8Q.7=N:NQVQQM]&J8P+:DX<\HT*R%3_X&37*7:?\#$"'4C?M[>\ [
MECU/L&(W:_\ P4D_X4Z5O^7<M\N'^STTOL4(17D-KUAI6.!*YG^WM2U^\4B6
M\][6AZS5U=:O>,FE[?1L7/T#5!\MQ@[JZ=X]C=M*)#:,N)<-X_K#_'%!59EZ
M]!^@IT-NS;EO=_=1@!-7\= _P/R5^*LOA0+G[19YHQ9I[]^]>K@QW>1FM04R
MTM(M7C=[8^N/$^73%_L'X!LM\_&HZG0$F0]R*ZZ\$RO$,OLU9@8_K9>:TYGI
M>KM=EM;'>>429U!<*U -1]$:5!MA-1:_2FW4N'HGX:YB.4\FI8QI$,6U$JU8
M/9,7^\L:MN<_=PFFAR1W8Q+=]RU&F3=9S#>7'0/4!#R59L@#A<BR!#>;]36@
MYML2;VS:F[TVBZGIH'62P,OTK1A8_RLR'V/]@\!JKXP^(QS/E?[@^F_W*$LZ
M PW.#,,P6A]QO0.I3(^,+@,<SV[^2Z;EG\8J'[YP(D:^LUB<GWQ>N:$F9('_
MG!+9<N Q,H9YK0A%<*7"4+P=_89""X^RT_/]='=2-JP'$+3MG"ZELVX,1V2>
M,U8=3MU7=ANOM5CDFHO: H\RS6'($(H/VJSG,WL'X>2?_JI%_NV+L[-D UMH
M?1'(#6-L1%N3*24.-C75?!B,7$IH7X(]\Q@4B;K54.?,LZ]>\;F^#O7]LUPE
M"=)HZ2'I9%_I"[P\LP?IHS&3US\9(OY_7ZSYOZ3 44(6_E1V6AG[)HFTJ-Z;
MJC4[,2P$Z0NH5+.>!FC( M8LE! "&]_M';3.'G;D$+Z0E.[@>9+0M.Z'Q^.L
M"$V@[KDDYH'F^!PM,<.X8*IE.68(5&M4)9$W2!V"C&B7+DV!:&]\KX#U &;<
ME?2#YUR7E32'/KW.PAH<'/G6E^N:^*"8+R[R/D[#2G*TQ/JU&L:HY_A:HS_!
M 4#R5JPB922G-T0W!<#RI9 M8]ZT-NK#!!."%@R#!&=L&)/H&^3U M4-4K'&
M?3$VLWG=JAN> UEIQ(DR [YFJ<#1>K'P3'NI9;#$]7!\G+,T7"#Q6R,(0&Z7
MJJQCVCZ?&[B]?[@)Q/CUO)D#L_>RJUM]65P+*-XH(#)H34\AOCA?4&;V)N#(
M!I(9@0UX%IXU!:RQ42Y[2_T*JM_-@RI81]W*D1U)&9+61/D:&BX<%HOFJI8-
M*U4&\'73E-T.?*!&L5*F']($,@]%")I3+<6->ZPW3#@><:'+Z.&/FK!^7.C6
M'(ANY'$PX'\_!\@'MLV<BX]$XLCT4O[6.@PNZBHJZBY.R"R[4BWZ^%;D#2W#
M,<S^-+.8'H/QRE3WMQYL?X!N(XUA/2#0\7<JVT)@Q62PVCMQ+JPZ@#0U KS&
ME,XG4N,D,J5.:AKR]+GD4HNK-*$7%?QPQ_?F,D5L9O'] Y%_@,3;LLNQ:F&#
MGVRBX#%E!^R1CC,IJG.CKI.V=Q^/ -X9I&'\$=3<D6S0GBC-, 9-8P*W?+K>
M\U+T!9'J'PM@/UFSUH1LX:MNXN.QX@ G512JUU@\N;)?@!3 /P#UF?9G@+B1
MO0.*)7^>&Q&R8QE:OV'UX9=0U!7!_MLA>V6\>Z$3U<UP<6,:$R!'?4M%N!S.
M V]EB0USS&1F_-OM ]62HH[;J.[*!]7P5,$?!?OWVN%^KO]!&#20[ *DSJN^
MGW>I;D:RXOV; >]G$YXZ)[[AM)NX-+RW?^"H-]ST\3<EC2MTB^6)EX]XI_D1
MKW&&'"O%72G!Q>Z#R>!O$V[0YZ M\O"3J^2L,ZGTY[O]5J]WUN1!/M1Y%C[*
MB&5NI5&+\+*(WB# 85E*[3U^R$;=_9HUWB#/,04;NE J1>[7"3$/44MM2RTI
MZ]$)X^X#$$SQ*P1!4_M5@966"A.93"W/>*\%$,F<;8NO*QH 36U39W2C1=8<
M<63&@=W]N#[+&"V\\;[*MNK#G+E5YL3?E_0X<>@H4Q)F#\&_@2J'>S!)H2_H
M4YWP7K;<4!W6;]?JKG>V4"_#(3Y-,=EP111,V/3OX_00+8]><+)#<'+J3INI
M5,7O.BU5Z=2=9_QOR5+:781]S=&_"\K&P(<E-AW-#F6N#NFT[3HJ*16J\CY]
M64X7#Z0;]>&OP_1,@Z"".:3554N^\\+?CPT"T!>"YMGXMLJ1(,W1A%.ZO,]
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M7*I?N0:W[$9MK:DY24&DNCI'G&QF.SQC9^XP&7H6CV;"AC =HK?F!_&,5Z^
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M>T0#Q)V1,D_%:42ODX;'BSRLUVZ3C^1*NN% ;#_8%+%Q285)6[*M>%[?<9Z
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M(1;H P@B5'"6CE<=/,KG'+*!K[BE):6103#>2+<3OEZ,RWH?$."'LJJQ:B%
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MM\78H6)-Z%N*YGP>HIK8C[/N73ESB6_>+!S!Y;[]%9@:L+?VPBE4C_Z3R&W
M"VOSJ<6%+RZ K,LQOEH3_3J:"_*GONLL)H!)1/H_D-SEM>8NZ&NQMYS[T7N4
M;G?P3XU$2(?V0]'O=XH4H@&CN<4M9&VQGGMH67!@=K EW=[>UA1\"HNJ%_$G
M(S5QPZ(^RZ:OH1<3Y->4Z2S=WF3@-G_/EVU*9=-*;ZC:RC&N\6#WG.\(\V Q
MM$@W^3QX_Y?4 #AOT:(BZ_Q"#=;A"S%OY 4?Z_=5;AM9:I;L$-@=S=( A]PI
M'DD>S?M,E_ 8839A):,UY2;)GQVL]A]T'B*=TF8!F"Z24VH!U'3PK7O/:_\
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M3FM^!&TL'O=S9]0,%>#.GXR4)/H.Y9D[T#RUQUF21ET3A!)Q$VU2^2<X0M+
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MCG4HJS$7N T>M\>'[A%CDYWC6N5Y'(K+NHD;5+95[KK%PI3=Z1XK^R,[*<:
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M&-=4'CS0*P<2@?P-T$Q_.I.XF9]E9,./"5L)HHVAPZ"F;0HF)+H!\!=%I-^
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M1XR1Q5TS5FQ8?E [>89J8ZL=B669XU3T<0(HP) )7[0'E[)1RW]<F+X\&(@
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M'Z7)&;5J6M_K3N)PTM)M$8^*\W\5MW*#+MT76M%IC"A,N%WH^&=N="0 I[A
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MWZ-/ &JMA[7QZ\/S8 U1L8FUG-5VEP47FX[V_[AN%&%O]I9&M?KQX#*G^0D
M^C>=479G^02(W'U7[%(57S*I:1B+_^XLE2GQSFXS.U?'#P7)'MEH!J*C[S/
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M,Y5#:_Q0!D0R=JS>[3B,^ ?X1EA#,\#,O+@E6B$"^5JS^F4I>U)KS$_&;YK
MR>2S0_ 79-J_.YC/&?:8M]*N4]#B_-^_W&?'*K!T574#Z[,<"_JSV$=JA4;I
MV*=K,Y^@J%&HY](\<%15$-U?W20 =P 1M,0]^YE]JD Y['6%\=?P#\UJB,=B
MNQX6'#PFJA1W+\ AWXA=I9R)N>2:@K3EM*[L?(V^^JQ$'\91RO;7+P;U-"?
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M 48BMM$0%J_B+T/[6D$N01]=#W:7<&VX@&NOK2\15S](UK]%VE)=BE$99E.
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M0(AE8X?[4X5IVO-%TCD!%]0$>T:,\TLNMK)@CX4VYQZ<YRD2UB>V0"WIR_P
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M,6SK\6+G:E&U@%!L^2VKH^'"@%\^R^45XR]6-2;Q:!/7<_Z>\TFFX0C_<I]
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MH?%=L_\'R-VV$^Y?V/.LRF!QI-N^^Y[ADSB;FV@QK799#1_=EDJV:!17>?.
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MG12+OB_L"A\>/G[I(OH<I^*,69:5[2HYF%9,Y&5"3;M4]#-"Z!4I3SO,LW;
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M4(LO\&&3NNESU-'V!>TT!Z\S[QH\@5KJM:T7&?C@7JIQL=7Q>=HO_QD;#YQ
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M])%#3P7QOK%BY$8AWF[8+@0.X%3\OU-""!% T * R1D/SXN.@.ZD[.7<R9B
M1=3JTI)B ;HNU]2)&.,BROY-H*F0M$9#M'.ZRYVY3Y48_ K?M#74.WR]%&,F
MO^56.IY1V[RY!KK+%Y260 MF_8!^RZEC![BQ6 T'^Y)L1T,1&N_*!FDSKP+&
M.</*16N;&Q_X>PO&A>>8V9?:GY$,O?BDE"/$K[[8')R7#>,[X'MSE=+Y+B<
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MLLIR?W+LM/FV<O0XA@]KX>M)4,0*677@6=2&U@JY#MZ;#ZPS"7$TD*8Q*E'
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MQ(E.>^2$SC^-(K3%44S'T!I(" 1[C$FF"-DE_E*Z;B6\R!U,T-O^[/193)'
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MK%%X IFAA(17O&5^ZF[-1J$(=>%R=USP(B),F2 Y>_ ),BG)38&UU7F2G"1
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M&G%,J0^0O>%G2? #/"_CUA@926\!_%6O*Y&O.9DVHH! T=; 1<^2;Q1"03T
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MAR19+KE,T[=X#O&4424&O3P+5.IH-_=QQ?3Y)WMJ3(NR*-=S(2JY8DGAHN=
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M)U9N=_2B52ZGZ'I>@>,,"$?%*<2/<E6S3=0>PD P%FA"%M0.3"-#!<XT6-;
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M**N$W2[Y/IS>.$IY*,4"8OL9\,\,3T 20V@G;^L35SIO#O-(&4]^;5*XT/V
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M JBWO)@C^AH]>5NZ!IF3_ON8/62E9_]*V-'G5KM>&OYG>]<EPQMZ+_[XQVG
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MU(NYL!VRL6T*_H?A\P=L66"-#(Q \CN?Z\.VZ/KN $CV_G KJ VYSH&\='C
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MA'M(!$(;I[GK@_\KA07(PQM#@^,! -+P$B8:RO1HC"URQG:[L-1Y^)23(MK
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MP&98I_JTWVC2C8]V@(93ZQL/EW1;V%GG_$V_2M&1?.0[?/GC+O!]W3$MKW7
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M?,-RL@\D(["1H.44ED-H2.S:JD88[UK:C>&23T6<E;-UMXE.3(N[R-9Z/26
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M3N=6_0#O_%Z9?7%4UF%F!YYKZ,K3&HNTMIYO-I.B9'NO>!(/$ "Z?@/0XFR
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MP[J2YCICD24@#OH3Y!/\+?'U,9<F&HD8)6+A)?+SN@2Q;JS)H= S;HR'ZNS
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M^&V+?G8+&H[NMY;LA#"I>K<HCR+VXI>^RD*"#^1+-+L?G[8AB<3MXR.GQD=
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MNRH7:R9Y_J&;;CC]OM@EA\75G*]SBHK)(U9JDTQDF$6^RD([]$8(O99Z2?V
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MS\7WP@[B>,OGOO#IA9U,ORHLG\9\M.5)V?O)(CX">(_74[SN=,>2?KO(-1'
M@[S$FD;84W-WP>N2W7T.?_@;K*/U!2P)D>V7\5J%)SJ&@;0G?R] :43S3@>9
MZ1G8O^1C*'/6M#R@!3]"Y^2?>KW*(\WKC&$H7,HQ+VSW)U21V-5&H(Y$?I0:
M!/WOU[._;F</3^^DA*]JUF,EOCR1ZUQ?J!3^ 7/,F] Q-XS\WECTA;BA6#4N
M3O+D3%'I4 Q/R4SH[-WT+;M?>T$D*IS/R\-5XSGR8)7E('LB?%MB*/"NI4W!
M0<JDI''E<.IT0*G"<4K#L "549MM54^HH*U.WD[IU99XT[QSS;46>L1/<Y7X
M<]MECA[C]+OS9OUJ *EOI1/?9_'K#>./&,I-KOG\#ZA9\@\F.MP#GV76^FS1
M Z9*HU?[5W>5Q^*\)@UST?;+IAN)B8;_;+E*;"8^,L\)94I;W_J</MZ^MMA:
MGVYU_-V<A?:<-/,PW:ZY,U-UT_ ).&MTHD1<\G&/E3DNM.=/\GUJ-@6E#8\U
MGC4^4R5_$;$;N[;,E"#<&],PJ#A 6J!LK)<%OTB/16,Y(5/U((D'>3Z[BUH;
MZ\83&X5"_>@_'KDSGANG)?9JPY?/YURU2M>AML!UB&Y!$CQ/]?^MKX#/+<\H
MCW,A=,%2%(C.C3W_GQ(T92,=(IUDX)[<UKN8ET7'/-:<*NJDQ6B=*5+A)(VZ
M?WJK#^_LVK7\3!LWOW^!=685D[%9LGU<H47PW-Y %O[F)3+:Z?%<]T,P_T:K
MY!@.*S/<S6Y!.PURR\3TBTK7)7Z5./KL\4U8X#W [99U%^ZQRM T= _(O0>\
M<>+F'])08-(M&O\:6RB@]MGN.Z?_Y.XV^V7P_Y?8-$'YU=@]($H)%+B6>7L/
M6&E:W6E/X-<?BV(<ZCI%WP.HA\GN 2^]LJ^364S$JF;^MR?CU56!SY.N -1=
M^&7I&+.*WW?Q#NGR(NR/VEH\D8^/U[X+[I!IA*X]E0.1]1>;H#Y]_32NZJ1P
M1@D2&H]IJ&N(%S7OD"ZX!]C6_LZFM[C+$&/9#N^4;MPXJN?A(<8[$PBZ2O_Q
M-^6U@R=C9&0DL=]QR=591@:#S<I+<<8,D5J:!($4U41ZX\0;%%Z5F9H&FJ5B
M;WKG8=:M64#IX5$ >$>^)W+\5T!6Z^LC*H0?DN+T'M SIEGH:%;=9U#3Q]H8
MS\532FUH@S_9P5=Q-Z8Z]L7_6[7LI(RV:69;C6F&=+-T44!^6^CM0_.[4J_I
M-*E7+H?H_HA&;%$ Z<H.2K!+!G_>:JIZQ]4)UN6FQP,^-F6_?/[R/76J-_:[
M"Y&17_TSD9,H*;N[,:;_@IS+$ WXEDZ4_]$J0]G)L^(UA\7F*1F"Q1GS!J98
M.;.G_/TY8_HGH2'7$:GGTJ<1CHH6$H?*,+8ZD7I.X)?3T!Q1A5/1TX\[&K\/
M[T(J;U9%EVY,[@'?'T\$9C;N?KL'G/S]47,XM<@Q> \@NH7U_V?HZG<-_!%(
M<6E]#_@T>Y.<)-6.BHWI_F-_6#X"N0?HRJB8:7WOV?EXVM<CD*W7("-Y%,O?
M<U=X2^GJ#'KWR^SM/-DCT>>-:#*8]1N=U"$N_0>H1E4;H;@LQ;(H_"<B\J.%
MK+0V,BCG4HTI_HE-E)/"5?*5[ZJ,7$!X*[,;$T<1EX8:8CY!8Z E?^=QRA%%
M;E1[JL$HS'A4KF,7*'3SAJ2W;FQ<UUPJA7W@\AS]]J%% /H_3[^CD4IU]JM&
M?^[J^<<([VGFY6W3[ZWO?2Q&7+D&1=JS&SR/3JW@_.-KR)2&V]=O)FLR/K2Q
MU 6M.D%U6ID$!Z OE!^:"&2_S]8++(TK#U0QGCQ[>3H9?$5YJKT5E9!S,D6U
MO5&:++"HM:9NN_G=NG=,@+@L=H2FNL:ZQ2=VA]C.Z&-W$81K,+5<*=6!AC=(
MNN9_1=#N-I<KYBN%]>_]X^(=3MZJ00Z'FU*6\5HNH%LA'N9AAXKU_N]3X'A-
MDVI5\'2S\MO'>;]D#PCCFH*3-J_YT_RUJV=OVE)./*[GQ\\:^KD,7!*=6TXR
MLP>E4;,._^CMASK&@;=.@I#_9=?N-I._!\@U (O.Q?Q97KIE1EMNU%WPN3)N
M:^+\$,S+6L$=/^U!KV+'* 8Q!1AH931/4"[:[82A!*L/NPIKI4HZGW>SGU10
M7YU>4&ML6FJ;QFC@7(8J=4E^[FAOFVT[?Q=MRW^ZVL)!>SJ>_<&#N,\K*454
M^UENIR ).]];JYK!:\XZ$FAT6[KK[*<9A90K$\2SYQ$D;13'WDQT&_K:[J9G
MMV8J/D91;G&@W3<9F<U3&:4A2>64?Z9_;4V!F6MW6E-&#&QU8^;69^U8=YT.
M7[MA^68PQ_NQA&5DU%<-G;=>5_JKSHEG;(/,F0WC%$D"-SZUR'_ENV65F6)!
MF+",&)5.1C&+(4I+Z9KWA2';3R4,#?4WBI<%7ZERN^WP5@X[(1=7LM7WC0::
M3Q/O2+>5CE.L[DX/%,6&J2IYVR,-7FY&2OOME.=K_6X"V_L@S=#UF,()DWH3
MQ1W_ 8^U"9UB=5M,+GZ4BXY-].?'X\.1$\PZ9W0P9W-OOQ/,68NMO:^X>SH&
MU+17R.&J_JX_Q\#J$O'KV#0%9QM.]=3S,1W;.PGFP;DK7_T6X]C-2>3'HLD^
M+EC 'FN#HKR09N2RDU"T*_*UP\W=R=-A)IS+Q(CJ^,D-)OAUF;&)B\9CZCNP
MQV*B6U*W9 30IEW=\(!J>PEX1OCC<A&F$&KAI6[.$N\U.9^W02KE\]GIK>UK
M*A7(+2(E&1SM\0>4#*3B=;7F=IQ07S27,$[7%?,35^+63O+B=H&LIT$T.+LG
M)BML[@%_FEJ>HOVJ=\(G_5GRYP]55&$^8_J"I>V.S?I59CYNX3']*?KY[^D2
M>/QAG^'KT9'?Q>\!;&MBO_M#"O\=X@V?Z+%[G2,Y-"UK/_"(5;,/P/T)-C_(
MB6/NBF<71H@UN+$'/).E^D[CTT^$]SYF[H@LZ/,+39C3_$/1WO*2:HH14PV'
M)KE#-]]8ZQC2/*>IPXIVJVJ=R-D(EE7/1Y):=^H!+U5))0V/33CU+2;G/,[#
MU0^NF ;2Z6U53+'J7NJ"6%?A@71*K43UV%B$N[M3>.2!$>S*/;.S1<P:.)&W
M/<N)J=HKUXJL,?JG!DD3*W*!98(QN"3AAOT7QBGYH03T ?*:S-XDH<^"\N0]
MMS$M!=MJD/7O(FC^H*+QT4*;M]#L8DS<7P.=02*%;TFD?Z!UL>?CBS$_#)3_
MLG$Q.MK$J378KJ,F?ZIWUFI@OZII=:NLTBD6*Q:,J[TT*A'M>Z>W3D/W3@4B
M&)T,HE-$_S>MY^P3[1-)MTV_C5O#C+1;1Z[C<_5NQ8?2Q:#K2TOJ$7E2^9:%
MPQ0%X>]^X'-Z<3>"_T;%Z>9.#MA/J\PGADN55B0W.PIE"[\ZXL72SMMR]D$H
M5<1$>Y8/Q6Z*?KOKM4UKG:Z)B7^$P7_.E08F3VB-_(KR:G[#1J<^!$-X\\&2
M==C%ID$FPZ4G]P"R!DIXPDX&5\IHM@%#+.;V28VO@]N.K"TWDT'9FHP&XQ?M
MQ XB_?@=@>LR9_;B:IB".UT":BJ,X7,0='P8R)0B=REQ]B9WO)4@V_!M)?KQ
MGEO<,.JN9$_Z[I;4*;T73E#II-;*4VZBLYQ<?#,6QM+.-[Z/-:/)1IO_7\CA
M4FJC9+>]I*=R2=/8L=_00U%K6^'WE+E]EU<ES82!:F$X\MA#3%J7S#K1]";Z
M6XT#,,HGHMCQ#R;+IM4E@<[Q*T_[[+X1L4^/FU:QNI&](Y_.MJ'T5'6>:BB3
M4<_K/_< R:M[@/>B^)"[Z61);%)2]SHBIX)327W5:2T9LTJWT.BA\Q4I9&Y'
MZ5>^R:249^IT6IHT/^WS^BQ[,"O[Z%*PG<+M07*;=\_80DJ83D1U-<[>H+YZ
M+008*L4GC,B34\J<@2]*(\=W/E1^JN@?\^ZJ<,^V@&O@M#>; XO46X_;/5K'
MYZ;.R+%*#!B;/>Z$Q(WH=1NM5OOL@X%DQ9>97-4V#-L,;-AUNPK?,ZT1NLV2
M+),>S=&.O=K/:R3ZA%!&P0P]J:B2X;G79++I]<VT0@VC<]Z*IYWO@\+)9_9;
MA=&_38TR3CPK>VB7E=$X2%/]3^P29/0L._4N\,PY5>1C?M.FI:HKWVO7AH-Y
MA.A/U11RK).9S[,P430']?B\6 !+\SW LA(D1>;FG"[3$U<:=0 Y7?HQ,PQ<
M8ADK6F[)[1<K<;!^=0XI-)]5[WX5N87'*>+5&"".&DAJYNECDQI$8- W]FZM
MQ?.2)F1IL-A8Z?V!I,JN;!Z*H1ZBBW.7"V>Y/5A AZ=<^^YJV22<]QZP:NON
MXZ0S63"ONZ_85T\+:XR,,=:.]9NT$Y0&7]FYZM,-YZX%6*]%W7GT-710A4:[
M(.R;9X]M&]J)\X)VGQ6[V/GZXA+GC;X-N+Q:Z8%IO<"G& Q\\_'QXX]SI_2\
M\JT^J\U%Z@D71M%>'DUMW5O(CY2SIA^=VC[!U7^=_A[G9A#.>-[XN#AF=WBR
M?K"\9UD3^[P=Z52A\6C.B9\5=P_@OV:_\3EYO?;UN8D7]S'+'[V@J?0 I0WG
M]Z85__(G/Q(=G6FPS5G0%EI&6HE.UI^*$PWT&I+R[@L93!TS(<D^V%!.Y]FK
M?BA"+HN$Q@<_:)$H.L]TJM5UULK#CBB[#M!6\);-[7^<:$>;O3EWYC'9Q76=
M$<J?HITH0F??N33:=Z27%ZF5"--!(\M?EAYJ!]H'?F*87"1WZ)8;O$OPPGRD
M%P#7!C+$U4IXB26K:==HXFIIT\SAR9,SRE^8K!4)V$E:ZO;0^3G)Z.XS!NG=
M@IHSFGWHA%M!WIS)MHA_Z'A[&?/WI3>EOKKU%FL5_0F1,==0I/M'#\E8G7Y!
M+5<O+A'/ YH)^]&!F7=XV48^Z#][1OF)+DW?T?25_9?\9 5]^/ ZG5Y5O9F]
MJ"1;+9'Z@W^U,/^ZFX+NE(X0T43AJ9/NY.(S8Y\15%;*<,5&NZK3PC^PHOH:
M.Y=PMW")/5C_9;I71I2&BU;\A.[2J)&^J9:IOEP#J@F=23^<MY(W_%K;WI%K
M+U?\1H)H]XES[A2+K;WM5$HR2!'(9.7-U)QR"(O9%8PNAX"[50K3[8H+JVS+
MM V$1+=L_N\*+9NO_N/:2O#_*+2T+ZI1-XJ;;?JD@1(:T_>&/B@SBS^8-3.K
M#1S)$4XOF1(>E!-A=V,P5X52GE2A9.'^N<!RD@%;Y//?!S.<9&-R@%/Q'VO$
MF?!"!MA($XX'DXAF@MLZ8L8D=>K+0E#LB^I!*@13-:/B)0.TU&!S<^PD@96W
M>7*\LD*A1"S!E*P468^<44+?/S)N>ZM2F/B%@PVW8S2. 4PB@L=1W3"LJOWD
M(YPI@_"XIYH=^@WQ'BDX()!F)^F181[&X)A"9TOH6&AHRT9:A[/%^Y\>00#
M#%X)5/0V0//LEQ6:+8HL&<N@61:G/EYC9@L".;:;@R\@SS<ZJ41F9IB_NK0A
MX ?L[L"FWA]QT[ 9C>HTJL& [C82Z I#[?<]D=^\G;S@!Y+O%EU5;"<2"\J"
M1)@\.!PAP7(E!+U(X=<;ZI6AYM3&<UT@RM4>;[Y&<GOM;Z3M,\H*7QS!7.JW
M?9JL07"N2+&=>*%'_!Q='&NQ&,2ZOD[]MCQTCS[[I8"_G"H?;]\'OU\MG45D
M8ZJ6CM>>4[SZ$2J\5H]T?T291KRVSN,.,+*:Z3/NJX1S'2: 1B*Z#BJK\*H
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M8S&->H8\2X$6E[XDIAR&I9L=]5^(QIH47'?W\MYE$VB_32GH2.T'OHN?9:7
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M^;#L'K ],RZ*OEWQ^A9GV3+^,J@7/L"S>/X6$5*VL"@L^!K&67D-?3''\^Y
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MM(R_CW=[NV3<201YM*^1J#.L5W%=P=_T^N_!A9>7I(E?\-X](-13C3]8J^0
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M6(W4.OU,K2Y:4_F6$WR6A]:OILM!.13DB1?PN0TX2FEL)1)N$1X]_]D41U_
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M?*1R&+&_5H9P.S=<.7)];K%E!&H\,#Z'UAUY.56_]#%]=J8G9^ :)2Z_H9=
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M?%<M6:>S)_-&9W^4;&)2;W1&H:S<RD$F\A4E&+FNI']HF&%@=)SI?8&?7!O
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M0HVA8V4A)PAV(,@$@7_!8?<-)Y_:,]05NJFV#"H^E,1W>R+VU4<DE).I-][
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MLEK\^?2ZYME>[%6$"T^-'B28H0=7,4%(*8$%ITUT$_G>0IQN@(V*3<H[<Q&
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MK\Z,G+]V99!XAF&""0,4N5U#N:1^1 (M2Z-BN+FZ/$_&Q<*.J?"]*MF N)?
MUHE)&"!A&>86:^:[2=T3%>]/O9(!43 #9[CBL%EIE>^GE868&'^I$0MP2&$2
MNW0<_<#=3/87])K=*+2W#A&DUBOMJNXXJ94(1AQ?:;^9$S]%=]]BX; D/C5E
MZYZ^./QPPJ^IO7C@&@^_E'8<2F?<X@S83&C&L^HXS7L6^1807P%50JE5G&@>
MSX31%8BDS\5#-GD22UE7QUB$AE[O]T80BD=O.S/QCS)@A1-G.S*QXS*(#TBQ
ML&'_)&B.9?L!C9R?)?W[SX/T6I/BQEQ!UMYE3:.50,GYDTELCD)Y\!*Y$GL6
M(#/4/5F?D=@8BA"MSJ80.E#2BYMB8;M*(=..HI+G:?(\+S0W"6V\"=BF-<#I
MR;Q6^-W-")TE7I</1Y$4]=?%!^_MS:G*6FW-[&O:/?Z2D*YVC_66BHA$W01$
M4&5H4+A2NOE^;N07 WZ"1[-[N?07+G$T?Q><VR^)J5B#@-7*%VD"7-6\T Z2
M[+'O&3,Y^1<7OGA[\I@HS6(+^,AWL,?T 2"67U=YUPJ>D=*TT3%R)78&?^JM
M"5V-;^A+'J2SK&AXTMB!Q,)2U-CV<QLB9Y#Z;D!#S/%9KBI\CH7X\T=K9C<R
MFDD-%"ZX/HF.)LP$$'M0@OH1R!AE;^C&U5."X:^J(W&-*: ;931*6!>F>*;;
M"[2O^1WZ2^IE\ZJFJN5CG5]Q6"1%OU7<*AAU,I!%PY[MO4TZC,8A;#,P_'.J
MK @ X5?;A*=#R8[R3Q^118_S>5KN8NP'$R7$<&LHCA<,-R00&;)Q7^OA6(WW
MC'K-]-@=^O#03Q>4PJ _)4,-_&!]KG'#.+F(#EGB<YIB?PR4EJ>??=GE*XP(
MJS.VM.H%__I"5)0Y*/4[F!U8)$%2(!N"+X<,TA8$)ALIP()R_T KCT6^(4R4
ME#AQ=Y1WBS[8/&+Y3C!@E1K-**LZ%+MN\%;V>S/#]N'CIO'S<^)B<\-45TW3
M$\C6_/2O^!U0XX]4$4Z;3!F81I+ Q'"N/3 9B@4(^CB/)5>\G4EPV;LU[VCL
M27D5[E0209"[3GI54U#O.^_.8 2WW2'2S&&\W,2.7*UJY<VK>5OMQREIPW7U
MLISFA&SAX-BJ92?M1&?J<\?/6D'Z3#DH60EK1FI4"!?9R'M:G_RV'^J#MNI(
M.TVP=!B=%2$_@E(VG0R0HSCU6)"\K[;TRKYFX,0 <?P*FKR[)A-FI-&OK^?I
M2B!0Q"P40C-:;8AVS-DNZ_DD9B585W.]/E2%K. UX%:4Q?VN#2-_09I4WLE@
M=VBD.4Z,<-&H6Y"BQVYZ%_F^K+4L.7F_D4.4<HY!-:)N=R,E0I04WE1)04!Z
MMCP$IK.^QBKB&:[>8]16<,H@F%.U,A>*>3R08<X@Q:7LCOND^-[ZYQ-.3XZ?
M-+%C]4&J<4)])M(_9%T\)#]H652O&OB5\A</6FVP=@X:6M;.N'3Y9"VMU-!X
M,.DV/ J_[!-^-7 3/JG#B5:".$E:+OII_X;,*&E54C!4\0L=Q^[2!]5-'KAA
M'P0S\D'T;"PUJXP':CV8Y)7]ZU^4#['KZ<Y['$![K-$^0-VJ"&E[T:ST\UL1
MTL1!R*:%HH>8*[>LBL@:,6C-H52Y'PRT$S%U"TWCX7P<\C:XR']$%=<BDDI-
MKZ8>O[D/4AX $X&NJ1L*?[;3_PO2]VF1^^$HYKE EEOP5>S#>[;$!D7*1Q/E
MU7]I?55%8 <*:?.O7DZ4T/SY-B%E%"- /=H@FT)I:*1G'QE]HQ[\-J9+U]"P
M2UNA>AN76Z_O<LE$O(PS2+5[" FN#Z!.M\F?= BJ&G\] *A=O>E@8?C"/FL+
MK(W59%WUJO#5<5>,HWPN5X6*,(X]GVAFA]A[E:&,HG0WE(U"@.)*,XR4]A,#
MFI[QW<(*@J)FD#G\-;((X(!#175OR-TMG(6^;3 M^-9NYW[C );$947_A(YV
MT2-90%QGP=B,IPYSG1"5]E&X_8Q<1-V'@P%EJ/9'F.M4^@M1(R?M65/F R!C
M6]1KM[EF8C16T+#*I6KXOAO'L[HOL.(6E:GJV(J'Y!5+TPXC3?GT^0,)7/QU
MUGB2R)[^25$C6;-H"H"*9K@5IP#-K[G5L9KBL Z]VNZPH+5%\?P8:2K*'0$U
M#\ZE>BJ91?!? I,$!?OG>7T5G_C^*B%'X/X[!<NF ?/EGLCN=]^21A/VC096
M@289(5\S]G,!R_*%9"\?E:YL^5L*)"%_EML9C:K9)R!^31H;J9M +.?7ZA[=
MBH)ED[D0Y@LZ]F;X.<TYG:])X)U2\Z[S_*D+Y!94GO)[,*529;9<WL^%%HWR
MQX(48U.NV9MJU("5]C/=#43FGU76YLBLO\]4_8X'\V3R7YMY^S9AHOZ =;T%
M87)[,U9#V#,>>)OFA&:$6PNSP^9][EHJ0^TN)R+_[HDTU-8C[>SC9NMG-?9/
MTJK@-A0A%*OQN$HG(-S=A0^URPJ&&<UG\U$IK(OR)ZC4SA^HWD)BI=>B3&=D
M.W&)^L; MF7.LL\;>X1XFK2P>MB%IT"42#B7?KT@DSN[NC,:?+X<,+R$K-ZN
MR6QU-&N\ZK 5\>OC=DU6">Y9-34;( VK5:9*]XZM4!:8:U2YJS]C&_V:H[V7
M+OHTH1;GUZQ(S'56RP97-W@<F3P(%(^/(9^,]K8\X=41A#LD.]D5S574GQZH
MX*<2-E9YR34/_Y)"+V]D#U32+.76T 5)S)RQW[TQ#M4K.HU36[:MUL:PW^MG
MVDUPT>UI:I$/*:*75G;W9\Q<BZLD@Z)&.V;.R!,H9(HF')^9S*KJ2+/1G[=B
MH;0ZT&X^TRHACCC?V,1]+G>_N?I.JQ\JH]5S&8_SF68@H3SZ7\./IN=]'BVX
MR8<.=\\2OQ*5(\P>GL'WV3UQ3RP[++L&*AKTU&P*[)?;6H*GMN@"701V9"LK
MQ#W^8H-M/0\EVS3'2DO[!([M<QH0#4W1]#?B)0XD/@3VKNF_.[^0 T@>@1Y)
M_04 <-:Q<Z;I_^]=$O^7+8A(824L_YGPP0;2Q@)"/_:\\'GQ,42U=^K3V-'W
M,\U33YYQO6)^&S%_$GF%E\<-T0N=V E:FW).>(.K ]:.LN$?$XB?OZG6T5>4
M&XR/'>XG8B@<3"&;(LINF?CL2[M[E<D.&5UVU"BDANH/"EDI1 =:C?EQWD<_
M &3-BHUH_:]4KBW*N&4U9]+)?MA^&&M5$K=.UG2>V-F@:/;*XFIJ%2G<-?H+
MV\RG^ANQ2/=1$G1-:/-GZ(D!M^ /:V.TD8F3;#]IDZ6Q*A&PKB=0+Z\!ECWM
M4/8R&.W=YA#)M,^0N%'H^;LV/G0MA"[@RB)OT:]GOM($?<M:,59<H2 VR69X
M/$+-QD+..CL)[;^-N3,,2+V@8[Y=G :+DG4^ (@]2<_2'38XF<Q=[#93!Z;K
MQA8JVHQ@Y:WDEE>5_+7)3CNMJ=7(M27EHE5/!L9!T60QG<>6T\V)I(J@X&D%
MUM+C(A(+%F.WJYAW+8S=+J1,37^<6LP#(N;;HIM;]CVY]2=-[G,JIE_"+ C$
MML*:27?=>TO'-YAH-VO$<>#;;';UM4FMB;>#,5JV'.!S]IM]R5ZYUIBXT\,=
M2IYB+^&*134RSPB+V6FEZTY5/OJ:XL3/4)9DW72\!P"#.J.;XO.N&JO^G@9N
M>W9W!"5WH3))/O+T4,MMN@KN7H,6I)A/7ELI,0ZF$PQYL\C QMZ+2DE63VIA
M8SXJ%>-Q0_. !:=3M-Z*JW-9O6XY%KPPTA<$"JJ4-J5355&+C/[OHD/HXF_@
M_ "8H9,66T>KA!6N0?[>=N%'4FE:G/D*(9GGQ;).D^BC_5U?M@!U:ML4%UE[
MKI>0FR(V(.A%3C[+W5Q?Y\[D]0/@E&I2\O1B)[N05=@%TY XA6&-,EZ2B-*D
M4G[^ (A;$>&?IJ:A7)\9??;^W97@I"1=RCUUU./NNE=K9$PEW2[/*/\%[$]8
M?LWSU;-8,6.W^'YCH.D@W@C-3S$H'9]9:Z!X  2I!G;X;ST W"NS#&.C,+1E
MFDBE%KO36.W VX/>UD&NC0? 4,&X;1M&W:=3@_*"XC+MOP%KR@+J.U?'!LRN
M6 ,#+RN;KJO6E:=.\Y!\$'^V!T!OW??.@2S6^PV%&34'@?]O[<.A":@WS6/Z
M$Y"RY6/=M>PXDR7^F?/O/5Z4O#]'YDO"A@2:#I7?X-5\S_PU,J_<!#SDU#RL
M\P/'0B-JL:/W&%7TP>@0--=JQX4Y/0$Y_G"]ZY]I[+C9BS:#8'@D?-#2XYG/
M2L9-FI([3<#H:/M(1%B40*MP8&BKC1#<D$\*<NORBCS<?!9L%UE6P^F82/$U
M[^N<-CME4X.FMA$0ECSX(SQQ'@^[VS\@'#Q-%O6NCBZ46-,TN#A Y& ^U<Z=
M_,/+RTHU4$"JP/+_X.TMXZ+PNK7A044%!)$4D,XA!:4;)&:0&DH80DIR0)"0
M5KIC&+IQ!A@Z9VC^THUTS #2#4I*^MSW4^<]Y_U\GOUM?]R_M?9::U][K>N:
M>)^@XU_!'"&!8QDU,CV8#C50*N_;SH# SY;4/(4S%QS7T40F$SCX,HD'$F@9
MRI\/5."X?!0E+;9:P2GP9NNYHKC*"/>;]3^JO+59H(;GF&0/-4JDK]:%Z9E6
M7G$%WJL<OYF#B_HD88*EE:QO'$$-P,22FWB*)F#(]MQ;F:VY>*.D3VGBZ_H7
MV6V9J].?6_33]ZG?]$D<T3A"8,L]>RB9D[$%==_AUTU/F4.E)EH,MW4_GIK$
M=2Y>\'FA^+(G(3D#G$R!;]8('_,>0X,1>&N@EN:H%J2L\)9^.S=L0>JI;?A8
MW?<N35H@!+*572QG[H//H4!L##W&/N\D?AEK394J;=>/<<@@SJ2@;@SN6O\Z
M+BT@O."ZPOBP4Z3#V\376GW?46@9WKN>-F+X%["@ENIRD3+D=5!>F#?5_LW(
MG75\#!O@Y^KLP\10:GS^_#ZWMIK8;X8[B.AZG_J): N?]FE60,<L_7T3=R^=
M[<2AJ"/85 49QU%M(A*!YH9%$H-N;PF^\&Y(1FAI2;L"J[Z;.^IG\H%(-%A3
MYSEWR+DD:E,[,\ 78.SYUYM\Q%6'WSAN9\0H0;)76JQP?<'=X;.XA>B (E9E
M900X2'I#H47MJ*/Q@\GCT@,+I=PSB\=OM'S'Q9=.4:;%T Y]H%VA-JQ4U<(+
M]G 5(2O'P>(O+O0FA KS='([7M$(R]'T%8^[A8CQ=ZYK!?4[<:I]=^-MD'IF
M1Q\V>Z>_26<WY/W0J:!I,P5!:\280J=Y13)<)2EFGO<#/PZ;E=%T7IUAIBQ%
ML=2!U@]!'"D^5#G L@'YR2!]S\H])S?\?HNT&;H(G]9$+S4#D]+2D)@/<4\N
MCERAGSU*FUQ^9&F>V:@=)\$<OX"(E8X5?O>\1WER9C+5D$O>[]S(,/[EY!-)
M6 ",];(6@8-A;-2-E2 Y<+E'^ M2U;VJEL9=]-I25G*11HW@>DF:N[P9AC%-
M;;)%+,L:-WE3E#D1ZI15) A!T;Y&XE%O4J"%JC:S#PZZ_C]18?@OP*)#SX7O
M5/JJY:MJK]#EMZD$UDZ*1EQP=7V[0/F:>J#I<^\FV3H=9[T$Z[%W2IZIK1C.
ML=0UIV-V 4R>#QR2/=WB,+B?0_$.XWM1Y=\_Y_M(A>\:L7IFSI 9 @^U)C08
M<U_K)"]%N27[J(PW= =IMSJ-^HC+G*B55T%>5IM*(YI629VY)8;B'0MGQU=3
M7HXX)I:EK4F_U.XW<\P5,=S=T(+7OO!Z4VSF49 GL[.8I9N/.#-IYJN+HS)\
M;5 IQ+L"KY#VD^>0N3[Q4]MTV?Z6CZ5U%%\<6(R5D0"#7R09KMYN4=-<%G]:
MRJY!4=NV-!\G;WTMLH@X_ N8VWX<$+$HG_='ZTL?YG\.D]Q__G\T .__7P'
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MODMW<J,*N,'GGA',CBD38XNL[S>UYP=>Z%)(PY% X)Q7?9>BADF4O)7";B&
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MSC'^*4]!158$X\\4B8)?R$24'\%X_5=!F(-GO41B=1IY"E("%R=!41\&P.2
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MY">/3J.F,J_=(-C2'=M&9"TJQ@O[8/I%"D6# 4A#*&HSH&=O>_(R_7]?/PX
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MC&3IMF))$K1(C!_+R+Y,%CA$J;BVYY/$_'NXU>/'$Z^QC<'J!/IH:KZ/ -@
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M(BB+EUI <P=0I?$N5#6I_V4Y>0?H\1+S)U43VH5<O; Z'[LL6A:!!)KS4-:
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MXFY=ZB"RL -C4(:''8AF=XP9I@J(5S4NK!,AT16<GC?P*G<@Y7U50/OK.6K
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M#HX>45C][/.7#B"I7,NW_ T-SX>*,\:W(+HTS# )_XS6+*NMFQI.&*IBX6W
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MYNAW0FN=*KZE>AHU$C1<3^O \-PX?;GKQI*ZGM<*-9;:93W.@01*].JN-AO
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M*3RNS?!9RQ5:K^L0TR.PX6I&= Z;!SM *Q$_=324I& !9!B,5#6EC,OG(7S
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M5M=DW8/<?5A8C*G-=W/SH4AVCGZ>#ZDP_M[33"S% =?TM:>=L;85+X9Z_]'
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M*OZBCTL+%!X%<JR;CU/S' NVZTQ@S,'7('.\>!K72/^9 !M"5"\\&6O2ZHU
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MV6I^.VRD.;:@ABT^T/!LIF1E0+"@-XW0/C^N"5I*PDFYEEOM/43'3QM\,K]
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MNUR4'6LXM\X%^PE;0_Z7:^M^U"+]8%%79J_JR^J=FR>38[] $:_B 2@SH3G
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MP)JGG*9=/+)1/B\M-MJ4I-*4%F37[Y9O+VCZ2LWX9VB'I5UCJ*<8V'=[?OQ
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MEZCI.-'L-9$?TZ1O16F<I.4M3NV(BBH9**Y!BO2W @-->1TO4F9S)C/>CJ#
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M8%M#13P%UFNI1.\R,>B\'>?),T%5>8K;+C"L;M:[ S@JUAX65;3YKD=2')B
M!CD=7_PAZ:'M^:^0NYG=%J,?+ ^_1TY8]1.50J,-_T>>':G4WHZY-'?&+%]$
M7M<X[6/SHH-M1?2;$N)+]5U-/ V]B;,%CWUS;/@D/02;4C0)#FF\(N#G]11V
MS2NL57TZ ^SLD"_F5%:Y)R%G9DM(-!Y]0P=WWTH)E^KF9,1'=%]N-D>4HZ.J
M1"E[VC*K)$4CJ$H*0^[UBNFRS>:Z<VXT8E"9-:VIIJCTE=[%\U]/?NU6DD[O
MB[8ZEWFI(@G^IN1Q/'2-LJ*).B-Z*'K:DJJ9'K4DJS5^'_QCDW2EJ:+;95>3
MQ50%P=;4/Y7V[.3_X[^:_D]8P>&C*Y/8==Z&SJT%QIAQA/O#8-UIGK\E\CX)
MT^7=Y7Z((0NV2 GTSW[-9@BUX"'Y^*C"UP3%!J/Y<?[1U %FT[X[@ UTO/W=
M)QOLB-)ZMOO C;]-/--ZHU YAZMT4[T[5' T]CPJ4NE].%NTL1C CA7_/?-I
MNPY3='F&?QVH?_/O:F00"]1G_?1-T1^I\EN;$]TKR;<ZW.(G]/Y621[M!3SJ
MDO4WXK@T5>QH%TH\GP9QO)!LN'S:*)$+UG<(-CS2+EY,WDAC</(<'HC;'C?W
M[;9R72LJ3$_I)IT9HNJ:KLQ+&7LP(37)\>?MJ\O*DWZ'@98Z^%KE_$<LK>[K
M>)95'_3K3[&/-M"9P;JAJ^<X)9A3N;E-:C?F5-8*(K=BF2VG.N@G/R<\.]&!
MJQ.#0\/<99K$7R3&'W#KG]Q<-E_V_>6&XCBOR"[];@10;VB<??2C][-[C49%
MU 1E_'^(,#+$847(1@:;!QK.F-TPC^KM]*>DHQ\_24!;#Y$5E;2R]K<_HWD,
M:8FZT;B%-]P!QJ1BBB6+<\"99PGGBG> D \FCXO2SDOO (+M(PW[DJO7$RRA
MWWO(#RKU!:>G28<JZ;\\[JCO,?Z7%2VTSO#&P[(6;;/-WG'@/*7]/NN3+>--
M,3?E7SJW8Z'-5?Q$Y/C:24LOG@]:J$+.,[RFWM>;^ZF7_A^+X!'"5*;WUK2X
M/;8;?:'1^"NTI):-]B='P50/'YIZ<,7S5+.:9M,S$>_TX<%-SLN"T/W7EX]3
MDOX:LA1+!BH2?+.9T]-F8>T3/KR*/P#IF83TP:83\ACD^-BKLC_HB.+J<_B:
M1OQ?OR(O;";"U$X8XM ASIQF+(Q5ZBKMJ%;&*-TGDU*3U'&^@Y/<FB;'MTHG
MQ,Q'DP+,2C;9Q@AW*,K$/7SD0VWOG]$5:(6;MC_=J>PXB4TST,91+Y00*+$E
MQ(V%[-,JWV14&B?[V@']FB]A=X!,DW8]K-A6[+_,P7$A2:-?+2'!<?]T,/ _
MPSV[8_%=T3Z3*F:J=7P6"DEZI6=O4TA$I^[]L'?R2L:95.BG<[!@0=Q,/*?F
M=X 5WA...\!@Y;K4=?XYLC#QPN-FXYC UJ/RU+<M#FM\0GL,BS]\4CZTE'0D
MI=X"'?4=X>W(SN"-.NQ\\LO2]O#3$%4P@_LIN-S4#<IY*.95L5WZDYB;8VRN
M-$!L0\DWB44O?:#YV4A+R=\V%%KI2R/=-Q^R8-#H/$O:)N/$=&#&K)_FR8>M
MC@TX1<]%C.P-Q@>7I*+/U%<&;*HFIQ'C#'O;)SS@+"P(C/_PCT,J)>YHCUZ-
MQZ;A7+222.J!O$]/(2I0LX9'5>1LQC^AH7U;->W(Z_5F\*.5%X+J!9<JXAO*
MJZ!$Y,$0E<I0.JZ<J![#[H>Z8DQ,ZD75%D4>%==66I+^E\)>,%GX_L93M9L3
MI9+9?+=3"$J_ ZC%D*R8%S\&XILWM[8K(_C:9;U]/IR8%=[PBPW-9*;!#8S
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MZ>KJC\W(EY1&I<+_&1U:*<DF5\V+)=4T+6AAC:;KR-C 0+ F4]:)%B_T"\'
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MMT>TO#1HK82Z#0ALJ$UZI&J</ +,,\+P=1KM7$^6N3)8$LQM^&^+?:L\K!7
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M#DD+;OMR9K@4[@ZUWB7*#SO4N.R]!7(^.[FM)76DZ ^5_GSAP/F,;&R@-MV
M0F?*R&V:C[7H9E)5[N? W2=&7K!CU1STRQ,Y(#[NDM/*Q^F\14?2A77]#2&#
MU\BW#J]9@<K";'^33$"X^(94:J[%$-8]G;I_SI;DQP>)7UK+IU.%QBS9*QOP
M,%V=4!H:VVVD*6K20NS8.$%QL \S.I&69TY-]W*",)\34-/UR^P:S,\?,QM
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M!>R>L@GZY\[?[I]MMJ@*K]@P59S$GP8PTI/</0+6?[5_U'I0EWRBI[4ZT6%
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M7UV<%&T62S\I$W80AW3DU"#%+E%"#X@3H#BM FK(FKQEWR?=%8J]%?M>^>R
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M^J2I6*GD@N<$B^JB!C]XY\N0'3WV%&>YH/4YR(X^90F[44C61'1>Y[%#?<_
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M^A8P2_'GS#VU".LW[TAM:++OMXT]C#WKO=@HE-9VM QD_!/!CH"K5I Y-['
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MPB)(RZ<,#=+F)[0&ZDNRX6:62>HI9,1-Z>0&SH:RKK"DUOYPW-[Z2!*9QB/
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MG* .!2L*;N3,-3Y04Z5RT4[K;_O;^W<N"/,+2D9SD/T**'W]KTMZYUB&_X8
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MD<OY_;-YJT' TY7&HI'IL$7G$!9(:=Z9VB[G8HD^=L6FC7[:,%=80!]$L[Z
M7=QEIV=@9FSC7:*O[DSC/\28 #DM'Z=MJBO.H&T=G+[6L//"T.QRO? 1J\JR
MKG%LR,M2V3"H,8NDU;#PE#V>(^:_@"QIAN0 )O63HC,AG_>KGJ.]Y*A\Y!/7
MV(6:/ANGF3Z!9_W%;]>%TU^QN'VHJ9J&EN=O5\+C$Y\Q:2],"!UIC*V76NDZ
M0%P0OGYFD17Z[A]R_Y2ZGJL1ZLGUE(@I)NJ>?:$J09.EQ^6:3%#P]^H;@BDR
M0T="O)U%9GFIIC?-C'A<T(PUJU:@Z$[)2'[Y-V-IW=T%.N;,*_MR&ID[8=Y0
M_2:%#\NXIW),WV8Z2.:)\Y9U4ZG.EK<EJH,$J#C[./$M4-'BD1+=K5WW 1S4
M%4%O7]BJ>\V5%=\@X7*>9(/-BH904A;'[C3'D"PYM9]5$\W%7J%%C .4+:9;
MUH32@-2YI@,IJ>^5B-*02<&;[+,>S:%+8=^XT7YCJF';$ZTK?567$U&C%C=Z
MM:"UZ3>]A7]!^V*?9BE^AN7B^ZG*#'V$N"7!870Z23R$RD/DD0!(XZQ\5HC.
MI6K\/,:J>)52W<NJ)2U)A-/+H&29.CO6"3A QADY%CU=IDE4;<:9*QX0L:;E
MRWB:"I%59KU,K6L.\[K7.G"X*PICQ2JK)TOW5SFG_B,?FZ]SJ%CB10I<A$"3
M]<;CVP5:Y3U]36-4'V  5"E_1Y6/WY@H#6PMO#$J2]F)/F&W$&*D=2>3TC^J
M,1"7H?[/]XJGZFVRREQBOR%ZIJ:IMFS'U)"?9^@5<R.5IV8U+^N\&SJB6UC$
MGKW,\ZQYN[LZ@'8-WUN@S$3@5END!;NK@U6 ED::.=P'^BG\WH=/?K*KP$ Y
MKB/^9KPVZ2-_\!MW:)?3^661HS943M!] I&*L&-H=)S/[>=&($A/5<)O L[\
MU0>%\V),M>9G*13NAA$<#6N68#J6X:;>SL003:YX30V.C\3]-7V?J[8&!TP$
M8:SC%2I7$3D:PR4:'_9K!Q,%/,QU12 =4U#WS/KZ6DBQLI[#N4K&C<:2+#65
M7.*4DAJ9<(QAPMJ5:_XNSIEZ_0&'QZS#;[6\0;7*F3X%V4D$Z]]DC8ZXN#^X
MJOI\")%OR0\Z<OD+F/?2P!D04EBC%5O]XCZ58C:]F1QR@OR"C%U!_JM_H-6,
MFC6][E\L\YI\9I/X[A6>V_J$9D_BZ^Z)Y-Z,NT(H&V.!;@BC!0. E4E($*6-
M7*X=1.>>@>MO1&M,\0_F!'1*E2*FSWV#]<_*VX\\^)YZGE#YQU7ASP43F+K-
M9ED[J/\R0Z:,ZUJEQ,9.V%A_]E73<Y0#566Y5B%&:_JE&S'^7(*MZ_F_SN [
M]TK!Y.8K Q=O.R:KKP??]?L% SWI4]D^+2'/[[REG,/0&YH<3.UNP\^H>S[W
MG91HU8X?K0X8Z0H*%7+(5<MI>GV_8*T;*QBPD)[UFM:I'6 <8IC1#TSH:59G
M.^6WHJ:38ZG9WI'S+6B[T5YIJ"!;N5'_:MW*-="4WG0P]M6RA]A:572XMDPN
MN%V>JK2;D8<N647^P<C0TTJD18>HY.X1B\,1Y8/_K#'[/>CF%=M 5SJB_8^!
M?=EDUM<S7(/4$S?="J[>W:,FSYG/3@=UO_JI(RB.3X4K]Q(E7_^D2UXM:8D6
M@D3V21Y<]T?1=@7?ZC&K4AE6)#:ZU*/@Z:4'D!YTS* Y#2A2Y%PC_8+%^&2/
M4YIU:Q.=9+"]2_37$QCI2 O^F;QZ-MTM99X$X6&;YKM6$L*]'(V:#>QIZ2"-
M^08K^HS2OQ,HTJ%QM :5JBB_5U546#LH@<^ *IFR\S?5"A?J;$N+/@^ FBSW
M#?Z4Q,/4'"M>MQN0,#QBD>CX;M**?)3H]<!);5;P(AVPW6.-^YL*$8X(-],3
M#BE?/_[D2,ESCFUPTD@A:0/1&Q\"V-*]])OO9&#$E2!>=*FHL.-SVXUN(2[S
M=UW"Y CZA][9WX,]_>WA@FV[W*-P)C>-"D'&P3&U:B=(1]9ZJO?BC6\M7R%S
M3\ZZQWV%F #(,IVYQ!)E^^QNPF9R/)6T[H@LYP9?T)I,)Y%T?*_.A#,('L1
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M<%;-GGF%(^T+[YT(S8MYO5CE@V0DDTJ-).DP*S:WS*8X=%0O?";[)0&@$SA
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ML#!>8BW#/*49ZN%Q>:Q$2##V6B>:=EKY67U_DZ&;-CBN/]J?+ Z<XW>F4%[
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MTG9FX^GM"L*COY[5OH/MCP#EF'03E)8_O5DD':N7X!A5E*$;>!QG*V(2<$T
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MJ:J=VN2Q3H>"+8&@'MGH]"4 7 S+FS0E1-?.R[FF?[KEWJ@/)Z=KG_D0I*#
MKR\Y<O_KYV13)JNJGV&SC+:Q\W@>$5%+,E'-D/Q9VO7DQ."[!L) VY/B091F
MJM94PT"*N13S:"D/@GHX$<E#!7+I?,SP4R;%LUC:HEPHF&ZQ'59S03 3 9DF
M*L$1>8V(($(!MSVY8HP_][]%$K[U>N#S'KU+V%#[1'0_\>%<Z'=XT?,4>3^"
MQ<^Z]ZTVA@<J*Y#HWPL%D?@.@5.BDN'"*PXWL<H,Z@\1R4L2"64:]5/^2V F
MJV:1\?&-T;?7'.II=0EV!_8EL13B\%"LBLX9"AL[@:C)6N)R22M2B,#N>F;G
MD<9M;O"X;?2IZ<)0--+/^N-.K;U?5YZMG:MDB=&Z?G&'AP&CN4]47[4#_^^P
MCI#(.MW[&<ZE?C#\BHZ6,+:EMB>Q,Z_E PG#0=FD):GS1GSX?ST[^X@%R.X9
MLU/,EQ%C6W$DO,:B3!*A>=7/HQI?S-C/DA8VJQ6CDA9.$2=XN=+<]=.-P0?J
MUU;;<@9;N%#U>=WEQX8;[N0P%3S:_6@0[HANXG.(;MAP^[J"%*'V%(04(KBR
MS"KM.013^IX)IX]9MM=@>=5;R0PDBJN\^!>',$/$U["G1!*!*Y497IV9,'91
MS_I%&:EI<65Z0+L*L->U#\R1?NQOR(HVDOD.2C\++MKV5\#]=N+@%!EJ/=FZ
M03FV';7H<<BM!_+B32-FS[)O0X('/>$8W-.N%>4IR;DO+";>38<(;(AYY$\W
MYN?;!U&*41>0*+(QKFI3?Z.VS._\;1O8>;U0AN)13@^$S1QH36=0R6F1=]<:
M&NTI7:Y-)1YX--"SO^1, )ELS%)B?"LQ[;5+3XUZ8#,<CUT8TWN_,:, A+ 1
M[^\[N=R,_L@CN!<5=']X5>_M0;41/8&9IK59_2[6F8W#F2)C2R8S:OFD6.M]
M/ <9D*X0W_39JE]<Z=3#)NWO1X/A>:DR$%RDXHKAK^'\$\#:,C1WCN[1H[K>
M98:5[4')J<J\IHG2ADCD2]AK/_) "BE&#P4NS5$\H)55T1<SQ#-!HB]7P+@:
M*MMBXXDE>3:ILTEH5:@P97:SH*ZTCTG^!O&.G2!KF";!.)+)ZJ_3?$^:&"X[
MMY-.A7_C3RQH[6U<%C[GCQJHS^;J3#Y*-"GZQOFP1/=6Y%>\_X9V7< 6KYNR
MG.\9< ??NH\MHD:H0*?" 6C[5E]D1CVO,J3$! _!2F-6*P#@J53? 8GB!!!<
M:NUSPOD+*U7E]V_[N+'4%B[DNXD5&VHFS/0IX!OU+)RE?W/H2?IXW-2K,HSE
MK6'HU+2YPETW%Q30Y3N 4&X*BC"Q]@99E^GK^G%^23S-0Y]IS;>6A]PZ13J.
MO%P]JV38E.WC]'I]]Z6//*Z.^&HC4?]W7'=:,&X1N -)9'7V<M,#8:!TES[#
M[VWM=,\4ZDFH-6^7+B2C /\P&+R7=.6RC"C;&;OYQQ7CJ1/J9#M-X4HSMTW5
MKS1N7.JAY/:ESB"8;GM>3&ZO[@F0ACI?+/@ED]+P$,7CQRX>@%Q3/<X<G*;Q
M*[A6GG'\@"\-Y]C'YCR^JI13HQ7X'UHX0]<ZN(7:@8&6?@A[@W-04XOQ+3M.
M;HH%GA!?)B\"(U7823W#RCEMP%#I96*"#VAV5)358?;6J8.+J?=A^.7G'?=+
MCE03[8&*A 1:)J&ZI!["/!@UR$AMOJ7S5Y&ZZVKFX__&QUL%M<%%[]ZI RU0
M**ZE$%R*.[10++@[%"L-@5#<H<5=@@0MQ1V*!J=H<$O0($6"2W&'\Y[OS#=S
M+OYS]NS+/7O?[+76LV8]\X.H7QBKWC%SQQ*I']7O. @IBGC7"]SR=NL6.ZE[
MF>@'S7)-<7%[2"9,] Y: SD^LAI1^>\K*CT-3 IJFAX06\BX0YR(^<EKN65F
M[TMG$!:/=YBT)Q=<__PC:;W*.E#N--=H=$F/WB3%*(#RA14&/>%O-N+W\EIH
M0QBP?:U(R(; 30RK-%%'LB_#Y+RQ1YSW<A1T^.T5E&V Y0ZK<'+'$G)VJ&BP
MZY]Y'^&L&3(CS"K*CDQSD4\T;!SD3S+E-9G**Z"+\U;9-%,:V3P6QCDYEZ2G
MVKQ_E:9NFH9C4:=ODS230,I//\R19HVSSSP-<-B4R-ZW-8;UA,I^]>6;2;<7
MKQ_I6MC;T3)JT5$MSZ_.._"TZHX<C3K2'NU@/_2R0JLK/0/F-CD[:3BFS6>R
M+I"TWP(IV>83>Y$O])H*$,ZWTA[W2-.K;4MZBPOUS?LWOWCW$8B3!P#9]SZA
M!\#0??\#@.Y[+[D9WFW8)>FO]W>'@0\ GJ.L1\5>^D#F-<X??33Z<HZ#K=4)
MAL(?XRP,?''U^=:70#[]<?AKCQ#*E3EKU_*&AVZ2^3R#U.6>]UBTF"JY8)ET
M[U3I31G3?U%]X02J"BJT;6Q^,@ MW_4S#?MK6MVP""X:7,0DC%WJM;/H1F9.
M!IH=.X/BMH.V5;?,UB:SWYCS#U;))XR8_:K,J,4J<&1&L(GLX7XK0DU83)3G
M<<V><VO4^P@ICPGE_DD3G9YG=Z@3Z<"+AK*.WFV:?L(D9?O;[L4EW9O/'U\4
MK"$:^Z@&Y&DF8J@0+YVP"$B:KTEII=8:F[)@U-BE!&<I*OP.![V@Z$EQVQR1
M]J3$[1^Z3Z34$6ARM*ZP_JQD,T]:*?KB/2H"AR%TM'_OD41&+/O^><UZ]\U"
MJ;FX9 6[)QQ\Z9^N,R]>6EC#_JJ*'I:;XFPORXNT%H'5E>!;BXS4BU?FU]>,
M%TZ(%!,U8!S+K:^T8']1YP+#'""IONSJ]*,(#I9^L!^ FM(YFD1KHRD%=%(&
MO)I.I2=&>L3=6U>Y &=VS!-J4D!)DXMF-P>"-D.4YLKUP+MMGV71Q%P/?6_E
MZ2-^<J!>O4MO:Y7&\?0DIV=+O)%R1>("ZJA:V1@GZJW?>7"_PU7$@H=PXX)C
M>ZEKIG6CFC3HG6N2^3Y/_G>^L[M1JZW"KAV3,S)/'H&1RO'5S(_UH]A_2T0?
M)7<_77UE3R/-S!X5+RXFU\-Y9'?0RUJ\%/D &%;R%L5<!^;J$]^"O9NR9Y6:
MFMOT6FF'_VDR.)FH4UL+<RF"QX=BVB)PYA)I8V&PD,9SB20"U *H0=VT/M.4
MN_-^_NK?]1 -"_F-N1J]022(ITIT.;QH690-+_>T)>D+;#59(G5WC"_J5IUP
M**6.22ADB(B'L61IG6"I!_K\#_ZWW'JFQD5E=")DBU=';][D"[S$,OAG[HI:
MUA^3_-(F+0OCR:FU*QN!?HBQ<Y[1:M-/84?2_AWP2X\-/ HCH_W=C:2L/DQ,
MP_::3,=+!VE954J9R'5(,GA?!68LVY2P ]OHZR])O_5 N0IQ0,8K<H1]TIQ;
M\VW>&,BJ25-"<_;\^LLD;\Z%D#+$, $,Y(]R5-,)J\7IS+P%62M38]/=R\?\
M.V22$:M*%P)5 S$!H9NM2G -22)'A@= '\6Z$<T7*FHNMD<@%C:M0!UW=D5,
M\?2L=B_(_&5TXJDSXHRR*W-;(AVR486&5/JBOTCE>/%K!&I34GPB9!7^K88D
M*=&4! !*/B6NS)C0"IKE+8UF:\Z,MKH(.9IFN K2O4'$5I=]_E55I8Y_Z^;U
M\5E-?7E1;)I>[>H,TGBDSV'.D2&IA6'_MI#J\&WS259^<)';:US,9[>*NEJA
ME[!?=05@\0(E/*4=83SJH.K9F,ZIQVZ=P6M;2>LB94ESBTT<L9/9'P%,)!+Y
MY,0? *Y25$D?=$N?P[<M!AK"G(\W*34,C7G3Y:(W?K$,'QYX#6YD?V)9=V_.
MOZC $R>Z1>^SQ7S8+\5I<ZZ5,^BX;#%HT97<Q(:XG$]R^K;%=IXIQ9$)>XF[
M*6+VICG2&R>_)T'>?EC#7F@=+)3;/AUX\RA"K<]]PVCW,Y(-W+4\HO!%I8Y=
M1U_H0$FF!0TCA-X)QIB"51Z)&8W/DZQ%@JAE=.HK['!E7L?K%+"!W@+9GCBK
M?Q",I^"H&;9<M=S=J<'SH:S(@;)S<N#4F.W9?U^=##4Q-'JM(\RV@'^]HPMH
M[>4=3D+JGGT2E_M$@#.8%,*F$N:C_*,FF2E?1$.8;C&L\>NDUX_!ALKFG]2Z
M9QJ6,UVV =P"\AK=;.SB%:8QW_&F*TLU%T&22BP?9&O*?01:L^C_F4R(]&HK
MJ:<.@Y*4LQB621OWBJP1_^*>YDB6/'&N7&N8*+P,]!PDPZ@*K95Z?77 ,1["
M!2T::1$7Z20]S6'_%M,/ *BK6N/0%H0Q5J[,NGJ>2_7*0C[(]4Z555*R[BNY
M??UAD@@,) %I)3NV8V#"V[$2SYGVX\0'(!N^5:E[ZEGK'E=27[H[!D^DI$8/
M\:_WRW\0R@?$=, RU1A1+,9U.[,IJ6XG]!'/-KHB,6E<7%Z<YT_IL%"MQ/%X
M#ZIDW2(BK:\?--@T\$ _\)0 @3BS@80R.%//Z@10;'LV#?-JZ^<-P3GB60C)
M$@#4?8*H_1D/WT*H:>PQ*-VOB-*- ?11&_HK!_Q2!E8'2Z;[%2@9IO/'.K^W
M^O:;Z"67R5<.S]>[_2>T\:N@P$AR9IFE^'Q2)KJE?03U?C',D"2/S98U0:>A
MFC+Y&]?TB=5&Q;S7[+[\G+\3F$OPK6^_/EC=!R*/"10+)*CK?N\3_;&?8P<V
MJNH9=:,K@3!-1>/4[]7-PX)S.;CD;((;,7),5Y&*1I&Q?P$ ]J-G7L^.>2]C
M!G55SP877?D6)/Q+;I2LXY6,(^P;>MQA+W1%5A])/M^4WWKQU?E58X)-ZK$E
MI69JO.6P Y=RM!F8F^(X';2@[&QXL&\DD_3X!W4VK19Y2IU0,E<O$$<1J&P4
MJ!4O 4I2!. 35[Y\;Y59F\ [SZI^BRZ^-ZYHG$RYG@Y=Q%,"82P:^N%<?D6=
MU>=!E=VJ"#M!OGSM,S]?\O(^;454E+^ZY;L"V<Z256U^-O")[6VMI4H(8ZN
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M+NZKS*S.S%(U/G7H9RL?<OA-677>,VC%WE> )TGDH36X$(^R^O7<3=$HR?O
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MK"MGO"RVN37)AW?#E%.X%GYWFR5X2$9Q"Y&NZRWE#S3??+/SX@$0./< ('X
MK*%2'P ]AY>[5X1'ZO?\M8Y'X&/IC:C+Y0'_7'_AZXKC[.@'@,-5 ,?<B7D!
MIF-UAC[=/!-;AJTTR[U#'8@GN.SI1WK>B&%I=B9*)1AC?B]D2PU#\QW6M5<;
MW9CVHACJ?)Q?))MKFIR4[HB]W?TYKX2 \4HSVN_N])X]&I+4L/E9]]4+DUW"
M&^*=!$DL\;RC*>D?6!GVEKWRW;LA6!6EZ)$(E.+GH(CXJ'#\LI*+!%05W2'
MT0;25SDT<3EZXUI5-FZ?VW_WM9$Z[=NAI@1+3^L9LJ;=!6=#3;2[B8?<3=G!
M,3>#_U=0  '3^!Q#E C^Z#&0KR*E)V5ZODL']L*%DDU.R7JBO'ZX_9<G"ZJ0
M+Q.5?941):).[#;5%Y=PW. 7]9GD!)C#JAGTV%T;K-<;$GC;$ZSPN?$:75?
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MKT0GE&H[A8NQN;+"CN-=YUDUZHHR'S&(Y5A4* @L>EXWCTGV0P<9Z)/]+N1
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MIYR$&PA)_'ZI$^%7W]HP*?2JMR#XQ$D)1X/:HS$_CL058[0F[N1:3<[F_@
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M9/LCSX87+4V$?3_(.M<9K-I>C7[<@C\_%JF;Z<*R^[S+GMI[&60HM+VGR[E
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MEY9/6<-T,"5?LC5T/H:.VZC*.20$^=.[;LMN5KX 2M0\AI'+..1H!X_3YD6
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MEYE=?S:BN20]XS%7%VD6,Z)JH2)GENP."C-46Q5:FPC2ZN+]/)A.V#-*3&3
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M_<YG1Y@?.*DQT>'5]<YLJI+&RVUJT$4914OT9\;S_$=#KABR:=,@FE,^W7*
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MTT)MY7N&H$F1>33]<4<OHH<3D9Q/.@_-]R"9$<PW2JPJA+U<9=4CS*R@]-:
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M-\7ZLL4SSQ-W2, S[R=V?(=TO\MBMU_J_BG-X^5>E38H\2HPJ6'LFG5@IS0
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M57U\^&M1<O@4TZM059-75 H2Q4MV>L!/AC%+QDXV=9>_,??@' [&GU4>XA2
MK@\T*/L"7/IV#/GZ P*_?E1#B=*A]%W;0!$4CJ/SD;XO:6L@<0_)U*"<S"(T
M/(_('I42(?Y%)Y8/S+$] 3HD_ 9,\AAZR>@!U2#=HDVWFC9PS""H1-:OR3G%
M9D>_>$=SI#IAW5O?8M<MI>PI"R<#4L])04L[U?6,U![QDI]V*]IG4Z 3'DG_
M\-E(_9,^J/@W+2M@DA@W>ZHW>1)K7R2U<W\NN ' +E==]?$1AWRVU8&#+A6E
M[NMNP"K/Z_&JV%OO'E/+S.7TD2YA(\B#*!NO/EJK>GK&VN:RC/?8=)Z*VH[;
MZ3.Z$#1>I'=MLI0<:RK7L[ 4Z]GAUGOMG6&BJ^A(KEZL%V9M1!1K(_3&M-C*
M0!U1F<%*9F?37$**<@22-I+?0[(IO6Z;_$=^YA^AV&X):1(> P;YM5S!Z%R>
M@ J]C8D:4[,8I+Y[PI&[LQY,4#\K13,='4&ZU;O'UU,E(__%.[NVZE/Y_8IP
MGZ (+G?Q@G]7%H_1I]E*;@]5/.K=JD/8F[$">5B1B7(5=DO0G42^59:N Y/5
MF; 4;RYO;IURX/=!L>]]<VWONR\4E6=MD]PTJ=>-_(D_>,94GSWJW3E4-*L
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MH,SL3$;PMH_EYIL?[N_H"VO^(+Y_W-I]F\V1\B">;_I65$C<>663TM%Q_/U
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MOVF[0/4WBWA/\P"<0:;@B>8]!KIX>PWZ)%$_(HKW]M.SR!*&_S]ZRG\;;++
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MUHZV^IW<JZ8!2L_E2TS+NCGH.2YLL1EBO^N.84FU)$,<H-=6_"U_R_#51Q(
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MVAK\366.IZ>8H*V>L^=0CIC)YV*FNE@$Z/\A[:V#V@#>=M'46UI*BQ8OQ:%
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M_G'8).EK%8EN='FY1K;3) ^LC<B"]9LH20$,-A,^NGK.D@?(T9 SLJEUFA-
MJ_N2HCP-3"3]K2 0@\)#E4WOCV*/'+$/3@Y/Y@*=Q'GS*S8R ,M[.JN;539T
M\W.6"<V5_A,;I#&\;M54_F4!C7EKG+^C:$"9%L'AV?Z 166$@3C8P[J;--6>
MM5YI.]+M'I"UIH]^9Z >43?/O7^E\L5;R)O;T:IP?^;1Z?[OI&Y0@5#BRY.U
M:.-O&MS/OW='.AO6C]4AUMD?L@_I,=71"-V9<3XT4'>4_>1G_.W:,[YC3 I1
MSQY=2YS)WHYF6AXBM6#W" '"%,8Y!\/G3_X5K@CXU-P#=!ITHH\4!SV>9\D
M[,W>,#7XTI3C>0QUC_3.Y9T\!\G>T8-=2HXG%W-!ADHHT'Z4( 6KZ-_<[GM
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M X9@O=8W")ZH%E866OL,FAP3XK$3KA-R=K*U0U!&%)+"^)0_H48TS82X Y:
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ME>6O+M50,) $(:60V2/YG_>>SQ:]CW#7B=5)67/GS<) 4N#ZN=O[6S+]8^[
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M2/!&KPG[!Y[O?4MI^417%A'ED,S-W=34EA;R^,'9UE!Q@GJXKN\ CD<-H\B
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M_=3!P_LQZ3'G8!!?;,$H_:)+A9. *2KS-<-)U[4D3<0GO'N TMR+OH68R[#
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M*N:3L#KYYE..N"<27;0G-B<%@""N@5D[VM=;F_1M=: 'O'!$0_H^*%O0O+7
MSZK\ 4]WN8AQ<FGA&N$BI1+OZ[G:M)@WTH9B$@D.J;!?6W'84GO .PTW7C&,
M=)JX__>,)8 *+JH9M]72(>N5/''<8)P 1DYK*\ORWNV5VQ5CID=K?#*X,EQ_
MV&<8@V-S&5E_/&*769R_W$KJ-. RR;CI/':3*==V2C_+2]=#NGM^6Q*$JTM(
MJB9SD?CJRC$]X!DM5V0$E53R8B<6!9IV/$<3?SE6F1?E[;'YZ?N^-]A;:'&<
M_UC_6\$PGPI]?N#EJ]TXF' @A_^1X14:<2R8<E1AG&W6_Z%62G844E(>EZC3
MFCZ8E:67F280E=! %JJ0*_]!:N,MK1HM.3D'-+1,,L!@PPMQ!.O11VSFE5,5
MJD& 2>]#0)$&ZLSKA!V0:;%KES[5I05$W394>$O*5XYF:R,?OH[;<O\..EH<
M&*(V=7/W0&X66"902EQWK? ^ C>VF+W;GS$+C=WUYGT[Y1>9RO2CS:E&,3YW
M^E?3*@F<**2D<.H?$^)73>WUA9*T9;X8O;-%B?R6 .6;2_XOY4%=GC!Y2<M\
M0PG.$[1JQ/+4[*1J^EG\P>J=.8M3"GZ FD"GP4BE6\:22%HPR&!2PO_@?61M
M9AQY$O><P;2<:Z)!)#P2!%).@]&CUNM9O>*VGM$I6.5>SIUTHDZ"2R0IM2T/
MNG3SIW9<NN%)Y:29Q2[\ZBV-XO*#!,T--?D>#J+-U[" 2JUT9+Q&:GL6,-EI
M:DOZ__WVZ7]7_(IRZZL@-FP^)X+VBHKK:YF*B)&L">XHX?<P]Y6668J'P5N\
M&$6-W=??]N!P-LZW>:N7H3U^33M^Y1G 9%K+*31L:1W8^ -UZ; <OV9Z\]@5
MFK0$Q&@07S%6,!CT!^C(](K-PGALW[07W= GF5AH1<5:-NJMNAFHVCBO7Z;&
MMOZIZ73TW/>OK_0*)5UVM^;;EX3XN6["1H&7G(@J4I=4 %""5R:/LFKPD$=\
M(JS=8O??),$'/#!I<P]33VG9QPTSZ^G7Y;K_?#=?:3S3TC%Q<79Y$8_=#5TG
MXW3,BF9N#J.@UE363FR4 B;/+#2*;BX>Z$V6%604X7L=H3L:7W9X&OHX9/2?
MALI8PK,#=@1&A08_MCHZ@[2+U*&2+<VO+=?%Z4R><M,)57%GU_I*A^5*X?,8
M/8,0-:_V1R=/09P7;<<+:U'WEE/8UG@'#+[!7W.E90/'7<[GH!M%KF]^QQA)
M5_;??RL\7C(.T=>SXFM)0/&627/$\M60_5)*/>5$U=4D4P<L9W]=H X2Q3[7
M*V4>/(EQXDQ?+-8L_L6C7(KR6D0W@JHMH;-E'XTP B[G Z8;A7Y(&;GKGQLN
MFEO&J<30$+T?Z)P[2[UF\AK6[^W?OS"# HU%$_:*0W,(ZQ1%3CH=FJ9L^E7C
M:0W&%UKO\C6+Q[DNBA9[M2!E27ZDT-2_LA<1AE7 +1ZNM*UB5R/_VH'V(=<0
M6R-E3;+0-M;DC0 MCG.*6>M!JA.Z_\PM>$>U@ID,FD;JW]?R-,VDG=* -"TX
M'6 ]]A/;9X[G:9V^%6:<^B-EGGQ^Q/C7RFT8&UD30Z$QH&RMA%UBR]_(1398
M@TS9IBGIAXT3?'Z\@S6UU#=I<RRS 6;Q@AA<Y@=F',.&Z\R%"NI *D/_2[:A
MMLW1-;M4OV&J/*,8?EG3'7ZM7(ZQ$2TUI?+]>!XU>)O;+^$BD;PB7,_U>TV"
M_I;=:$_B;+*TTO&?(/P^\P19:%P ]9.$J.G&K5S0XSDBKN9/35,+HE&\Z3]Y
M33) <(W*HG2?3FH^OQ?LJ2C?O8)IKF#IL^5=DF2<)L]8&=ST;=$2D2AC0/S4
M#S37UHS.%R_34Y[Q560"I_5FP7WM4.P;P93)4Q50!LA P6 >&SI>,&D24CE2
M*E& =2C*AJ\D>UO(.Y[/J9<9/KT+;5!<S[8^-TXT@7)6TW])<F,@REJGNG5$
M2CV?1M7L ZRB!U9O;%IL1!T!Z_4E>7GI('^<FS/M(GHY>OU3S-MYD=,_'=U+
MNTT3\)RC8L*8Q;]0SB%9>-"PFB-" XUA^YT5-$Y#(G"![^R7N.7X/B?"<9W4
M9;$?K:M=?*Q<*L(^(V*L+IR^T:D;O66:F[6L_I,_6W/HGWTV;+WJO]2#@@!+
MG75WUGE@A<8'Y9KB*L6$!*9 #[O'/NKJ'N7-%6P[V<&[8RR2=JX/>"6-QZBB
M75H,[^AI=O;YHJKP@7H)-CUDA>I$O&@?R.]1T5Q_:CA* N@RR++J?,#[U>8[
MM2O=/&E2ZZI-Z]LA$D7XI9P?Z 5K2RZ6X(K+3(DA3&$>4;-08NUM=N?L=ZRL
MHU7I%2$B#WU%X8\0M943&>Z201]3G<.WE%-_:M@5*J$2 #7S&_V(9I=/\WB0
MRMNLZ^,[T'E@2K_VEN;&8/:XD\'>MHNC#1]NSJC+E^)092R,C4@N'%\*GB,R
M=^4%Z-\WW8B_WCWCN7Z\#8L9I<\I]5_NL/-=% 9N%HV&3CE]"\T;*1T=/B=M
M(Y<Q_^*FLLXT8(L)?WZ%/&_]<?&TLY-(BPJ1%+MFB#%$V[)0"5 K>=>^[7L'
M2SV><P8TI3LT?,+#PQ.Y7<[Y=8/HW>3^193P38SI<4CT?KO, UX"-!"E3*3$
MP' \,K&S9:OG^B_- CC@ 2^X+\BVPZL-1LS34#*^F1&X6A#OW$LIW!7T/T7F
M\AXS@+C&0HM-VKIN?/IFM IG<]'-\K.NN3O%Z^OO_;W)9\M^OW<Q<P]XB@%Z
MVTAF]3(A2LCDN>'_/!Y:-^%$1\^"N,X2="QG_MMZ]W>LDN7 ]),1BC9N'89I
M!RTKF.YEC&L[0TY/-??X+OSG\3XP17BT+4 $5\^]TJ4C6\RZZC%^ "NIBV9/
M>B7*(\59%\]KX&[2)HWT$(^(XE1\F5D43LVD XACM7KRKH #%:0M]PZ5O.54
M*MHVX:3C<H_<*11(POJF"M>,E..W'P'#)>M7#Z=5,DXPHMK606E2ON6NX_C&
M\0</>%_OC3U:43.JG -G*)_!*HN&ZLVDEBE_29GR]YNHF'1U?FP"FT"<]JD&
M!%E2&X#L#6G_BDR1E&R2B:[K^M4"H]%OZ=,JNJ4D=G2K7JGV+=_/"QC&<9BU
MK4B HSA]^RID30T+PTT;*CC3AG]DWIQ+4&Q7U@!%(SVZ+7HWJ_72!A".C@<:
MG* &J:N@,1ZF=]S^K6/V$T%@$S.OWR?NH++&ZAX33[_%AHL8FL/@,:!P*:C#
M\J3FK"S:^$Z[B#KO+W5.=?4& C_T=3W2DDN[\]1F2BTET-A_5,)YJNR=T]G7
M=6,D5^ 05'IOF'4ERR@B/M-%%,!P"9/)1[>LN/^U4&3A>G3C3W:ZFXN6W8O"
M\*1%N^3FR+;+\BT^QMNW99TL_1*/)>T > S]6U769-SMS>&!148*4DC0Z/NY
MLQBWY*Q1X,3G),YR@V/] [V AOCSOL##T,)EC6AC5 404GBV@O9/^9>P*#C)
M5DQTVA!%ZN3,V%>>:]#!09;\OBPG,\RJ?S@C%/>A???X :\!P-&P5Q0L/C<O
MG+# Z[ ANB_/FJ0/\2G:OOQ8I4.^#.'"Z!=RVIYRKLL9M5<K;Z^%^["6ORBL
M&!0:XIJ5>))9(E0XKM=7F%A4"L#H=PFWT!OWO.CWE!N1_*WQ1HWG?Q -4#PO
M7(]9G!R$>WY+T&ANW3+4:?OB,%_>BV_66ED*EI7]'*W]-[1?+?_S<28(' K6
M6U_X6CYE;6! /D.Z[:C,LOPV31]1/:)8FY)AF O.3XM /!4"^G>ERVDL3L)H
M(.F[,P#1?6PAJ7=KA>,#GLWO;712D387AKQY,+'Z]:C!><Q?Z6='50'JH9,@
M:VEDQ+GU*3<7-QMXJBI;DPA4E$=[.I@GEF;0W$:UZKAHC Q>QY4\N1-N4TG>
M;#H/'QE<; 5%L>YF?;RI?@:4F&22^K^%2]U3 ZQ.B@ ]"XSINBL-B8:W<5!7
M.=; "98AR7G4#HNJ;2>Y-1MKW9[H25D+$;;^5,/'X0M3@3"*+,5T:N*OU:UM
M,W82&HM-B0[!B!&43NO=@GB%-_Y2:RXU*(EC,\BHO27TV M_HR%565;.M5_O
M%%;G(R8R0T%>4_13X 5!V=?R&H5O?1UEB1$&/XO-XS\,?6!ZE]M'9W\1!5C4
MW@5G)/*TJD2Q 7E6HAC;OI"#7W<@%'@3RZ2W^(QNR[]\H..(7?N+:4^*WZQQ
M]<,=*/DWY^7#+ >B:;]51*Z7#(6&-TX8-=Q)+@4(L*$5#%OI("G*#0ZNYATN
MZPOY+GI1]/12YE7E=:7Q7E4EO1-)JNV7NY0I_"\,0RM+^)'.OK8^8<H#=<9B
MTS,4_/E+9"JFF2:E8=S,,H^:5C0L_<)CH<FI3:] =$]X>>9RYX53#I:B!EK8
M@7'YFB0_C_IH*OC+;%I\]_2@'/K@Y?>!M3C#& =QQT"14-UQN:P/C2W9:N=[
MQDW'J:TIJ)&5V/373%7/JT.;3\U.*5IR(ZC^<#K8NP_;BT;QX/[*#FJ\=M/K
M(>E=-@6M! ^;=GARBH/*\@TG5[N545='C2GT @#C#6%14LM<7L"K JT[F_@S
MC\(-CO7"%#J.1]8ECZ8.JQ*TR?$7D+T<X&U21+ZD7)7%U__/@>0CH3AJ1,".
M^L'%1=;G+KX[HD;V3]_P8DGC:O#^I_+_W3%X$2_98[:QILAH!,&M\!^%TIQK
M=>",9:^-:S\"XN('<:C3F14>PTN"4MA1M<C%N^)B>%+<+6_VP,IN,_9E!&%#
M4P8</1NBR;%Y\WL ID<@^AV#SHP+ +Z.G67O1V,W.S?+P<\;QL=6H2(62)#^
M8QGPELDS4ZY8RUHFS,L\_[IPD@J*V,0] I6>P#9Z.#1LY,#BM<>WW5"%OL/:
MN8PO&!^EF/9U\77BSMZ&PF91Q@\S&HN]"7S<S8(D%OJ:<BVS2")Q=>9^8W7&
M.<'?"S&#(E6ZY9=Q'*;]"^G&6DQJ#MK27]C9_XG%YK[SF,W.?AR%;+H1H4^#
M3P@[;?$Q%U%3Y.KH*9Y,Q']+)'TT>RFVOP_RUXMNB^H*,EC$N"YDJZF8-@O<
MH6@1,B.57#H=+(S#GD>2&ZP%9;4J/R?[AV6S24N)3SH@SUHG HFLO^K^-W<Y
MDV)J(5_MP!$(?G?C]1[S#!P<[,.1WDC%+I8BP-1=B'[%&&*0J$%J< Q3M1&?
MSW!@4EL^]$Q\^>[H]GI=R%D=G1MK__@$H/(U&B=(;2%[::HA=IOUDYRQQEXC
M3CTMY$,M0Y54_3J//%%V;VXCCZIU(5$([I"]_)L:_O(L(H %SF#U.^U\2G_.
M;"CLJVX!P'6H/7E1D4@X'S/\H43Z,SXM/J<S?1_4/KEH"DK9P;NF5-TKR6WN
M1I_F](/*^RWZ?C?6.1W %1:-%G#4VX)^+A;?,TB>62N;2[Y4;%8_FF$ W$3'
MZB(/>V\[%&1%^M0F9#-'Y:X3U[U:4E(+,IE)E:'Z'X._K(F\O*E@D=USX&TZ
M1<:&6A59[W*51E^4-VKPX.P/WBL .YBF35H.( MK^!)H[%%>F_UQWF&"Q[Z>
MG-4#GC8]O=60.9MP:]8T>J8>BG\@63I$K+;PV7,J \VYE$ZQD- M=$Q/;CSU
M@O:KNRG)/^B/_M5)7&XT@YQ30F^11>-]!65:Q?19]CN_K?93Z 4K"EJW3T$=
M4_DM;*47%Y-YC2C8C(<G[%1CX6\Z)V''%N.<8;=AG@9UDNW:7<14L%%KGK:V
M#"Z+NM730&J?F?^P%5WY0D$%B#U L_4T:G(F7&-3U9]U "MUMRU:Z[RD*H']
MR0TYKNX<LLN,Q!,I&U>6'<4A4BE+>DBRA9.GE'W-&YU@RLA:QU:D&@DPPPI&
M:J9P!7O$80_HBS0P3;SIY6F(_42Q,Q$K)L4@6K=?29&\66\(UQAI;I&E_@@]
M9&EN\LKBF;C!&)]3Q!1>J U>[%=UT1JLUN@GPQ-N:D*<) 96J%1 WLR1E!2F
MX3OUF617BO9M(SP06VE;6D5][U&91]DS6%C#8R;DCN37#:<]?#YQLLJ(JNQ#
M!0W)T=)E'\NNB$!OM_>?KW/)8YP.[?:+D&-J@>G^*1L9.DYS9_X3'KHM%=,+
MWA</>*_!@1H"Y8X+=%;Z+HN&#L<OV-[T'$O2<6;?0P.E8@Q%H.9FTUEAB8EO
M*OMRW$+;2W83>#7+$=-7E7UD.M$=#WAYOQP\[W@Z&-(Y3/YN,BYTYG[>G1>!
M[.>N()<.IZGY@XIEVRJ7^3NEJ@7_UPG=KTR97#CY0P+WF,F_^U 9IM>M#QGF
MN*DB2H2.<P;7JB7U/"^CW$D8-RA%0O7$4*FEKCFN?@-JMS^*L&\" SC-='NI
M[NBL+V\C/R8B.&/U3M[1>^G&-A:[#DTJC.-#._K*O32YHO6>+ID^?=E%\@$B
MSQW3KR<, %'1#SNS]N,<)<,%3;?G8['Q9KJ&81?MM@N&YK4F&(Z23<O-9*OZ
M]Q*D3H'.H4SCPOIU27:\91GUWZ/F&^/3\OMFXQ'(+I>TZ4O]5._Q_0NB^-]5
MH@]XD7"@U/.HSZDNHS/@C(.HRY>[]SK6Y[N;5\7%T=?> QO4Q)XGVI&\@S\@
M[W&=*F"LBUZ)2$E6TYV\3H[?BW+WM=^J\\+';-UR<A>45SEA&WNDK$,1$&/-
MN:R>KS*@-:J%#]]$Z<EF.P*D+H/RZ672W1=7R/?O?VB.L=\^X,URNO2%S7B:
MN?M^7R!:[/WU[AG./+?18T^.]5IBZ980>Q=2^(#7W9'?;K2@#)#7=O_W);)I
M3VD8-((B?;Y#L6,+^"9_&7?K^V.IO6NERQ'@RM=R&A-E>:49PLHF9I$U2H3%
MI>UAOGTB",M$[>-90/-_0+VVUTIQ:<<H(4;2U9MX2J%@="SXRH[_-_P&V#<P
M9!7_!=:JH.0#E]S'S!5OQH^^OB"AKECCLZ)\P(N0+D:-VL76LC''+80E)8ZP
M@SQW\AM4(=@@5[?)4\\'O!>[?QA3H?'5WZ('T'5-B]P_!LJK,A4^0\E%$\Q>
ME!S.4Y3RKQ9<[GGN'RQ;52)O:<K+SF*&56,$ MH5^=_/W18A.[[+BG(+B@@Q
M/?O^1'2(E$!G@]G8>Z9[2ODH3N%H2(^H0H*6+#JN=89N, L$ZC_V.MN.EGVU
MN%:SO7:0+2QN.&N#^](M>$$4/7Y\^P^T;;T?/(5W8,7P]6YR\'A6C/51O?J!
MS".>D!A2SR/OJ%N!E/&S!'3S/96<&:,%LB6"N5N';MWCJE/(&F5]_S)%4'.;
M&R70T-=9$;?X]%\YP=>GCZIY-.0XOWW)FJ@F^B@&</M3M*%4\R/P1-A16M6A
MI1'8NXWSS *<W3S@/;H%WQ^[+5_*9"$,NI(8Y4-DG_P1?W6C0CWJWO]*-KM+
M^Y8/T-#C=)_76;9]]3?1.Y%T((@0/Y8EBG,;"=0!KD5 W!:K]:O99^;;?P &
MS(,+0PI_BJ\Y84I@)UASGU2HCVICUN5O5YU;D>V(B&,7ZM]FDKU7?5%'.[/3
M#;-+/(8T+5]\7N065_(4"/_'>\G4X ; S0C1!7IL<T'&6M?*0:-7O<H@<69+
M=4[N:'^WE F[J&:V'>.D  5ODEC T3DCVW'( EM:@/ JE8V'K,QZ9E.WTAP<
M]U0[@5(W[]>@K[]C^$XXZ3<.@U@;=;UXYX)O3@:)+MYQW>7,Y(\+AY%W!'?O
M?/AR9#[<R0>0^W[NYL^6VXA1O8U39<:[TU:^M;]-V;Z1<C2])9%.([Z?W]YT
MU>9* NWYI] B8_HLFR;P-9'LIO#,7.Y)7(@UULTGGP1N/N4W[6)U3GDN]0<\
MGD+LQ@?@FWC *Z"4L./H6*=.F3[ ^D8,?.O.0?MKS<B3\/8=^SIRE:1%<4T8
MLN/C*VD*AZ7SY&KWP8%K(:0>YA)TA<-K#,_7=?8V3RBGY,?>=U8>#RP\Z='R
M_3ATYWD=U7X>U*]MJV;F]/-V^SK.3L;(D X4V,9CS,HNU.QQ%.@L7\_(P;,E
M:_7[]%593\OPD6G[:&<"H>ET0-+/Q3:2<KFIA)DN/G=9OC/OLX@?MTG?;Q]E
M&+M5@7>\IHFUO:"?X:+N.@O.3N*C^72C5YN:QZ3C+HK$;Z$9.4QON=.B,.&U
MZ6:!/ --E8#!YGI>'_6;B,<NJI.:.^']#*4X]XP.:M^NWP!?@W/L]D05L7;&
M<23DOX!0.V\RW'LF8ODU/]?T6LA4;"%TYEG":?(K: R,0$F][M?N0%166[1V
MMV."BFZ6.5>WVKBL['5QP(<._XZ<TV>3S\:+"YWDU&9C6&RD?<*V HO<;YKJ
METS-&/8L1&>B,VC7.^7L7MX"N9.ABNYOAR*HX?%CHVH04@)$>8I=5$.+U+#$
M%O>').*<.[G[;W-])4N/-BLNIS'%"\7CQ>S7Q@/UW. I>H8/O0GM'D-&]/XW
MF@?OUH9'E5R3!FH\+?2&P;N1>YNK+=1FIJ5Q& ;P#6P!'N&NYR0D/EA.KA(-
M_1VD3U+15_6'FD0J0#C@T1%-!Q-FW3#1^ZGY3KU@0]$Z$&Y%50/OG.DA"#8>
MI'/5CBG$N65%;,I.1^FI#\ %:@+^U&6X@MI\ \^;JX#WK'2GR0*:B7\8O[F6
M^I.4V!57@SUPQ>2+UW[GRMN%$CHTO@F_N:,5Z[96)(2N+A06H=-Z+:\LM(*H
M^VW&C55M2(T=31V2ZHR-W IJ.8%#7M)JK67JMI&)+7E7PA](YH(?\-(PG^26
M,3(/>!LVPXW1&3A-S%D\YGO OTX^#?]_WFUZ^FG3Q>(!CWXA^.Z/X0.>[[3D
MI-/M8?F.."I0Z,-48HESP9? ]\1MS&:.D<??]FQPL<N>@G>=)M/SE1T1P!L.
M.8N%@/2J&"'*)]_I U#)V(0W36F5XF&6LXJ:]D\5R"C&1M <)Q1?))_YX*LS
MSR+89W06]_C='*(Q#7&"-!C'S0Z)KX<\A:6#V]7?$]HT"?%)^D!Z[RN;0,!M
MYKG.GVXT9;FI32]$RW_W?!K,AO!;]H5.K$L6+T-TTQ1Y2B]36I=\U-]QZNX4
MN@#3'L4 ROKW(2&1?AQ4K:D^+IH^PG&\IJF?$PN+0*R=6(%?,5\39NORP+\?
M$42))7QCX&+6"L?_>D'!:S($8Y&1Z1_/+5- AC_;R&-JHL%7Q\.3R98L>84=
M;AQ,&S;H00MF;+N6,FF6ER)$:KO1VWP+0 $N\,5%\[><#;+M]UH(>48O+K11
MHS8M9IH'4I+[MF-@?)RE^> >(FN2_#S S\/U,%8>6[*D;_.3@,_>L<YDJ\PE
M+RWIL+2Q@TX]B7(8S$4LUE:S''TQ8/3,93]ZT<.QY?,TL9!B!!H.>&+MBV8P
M,?5YX8,$CP)D2B%5K2AZA+K..[T\SW&6NG_F+F*==!=YSG*57)(3CMN[]B#
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M^$N4:&M*:TOQIN>&[T8<Z191XI1 F1B5DK=,NP?JXW@7,8+Z5-T)K5-^-.S
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MV216N,J!3ZX;/N3OKAV]Z^ZI.DEXNOO3P%EQG,J> V:V?]]#GO)D,=W==--
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M?Z7.00%RS\/"\A\IDX">IWQ*00#HB<3O5$WQ4"N%#>AD9Z_-97E!E^;\&J]
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M#>B0$1%PB:-RYTC.Z#_2YE63JBCN43]D++NV$G)))*7A'"Z56V;!ZC,/6&N
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M8_DUO[X==#!-L<0J[<GDTXUM^)[9Y!;IZA11]"7URPUO*QX==L[6-Z-U LG
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MH5IJ4.<O"^U#@4!\7\RS<"8=W>+:0/4PQ4-6L=J99RCRAJ8[;_2O\MA5/\X
M?=]JKUNX$^AOKP]ZIS@U.!C0O.)]^&'.8X_H9=)N3(LE_LM!#27OH7=6XA'7
M*Y]@"L7$=*%(_<X@'%73XRVOY<O;P@X_"7V(\\AB!/-\JM,<O5M"$8$KV[LL
M@^3Y,N<0"8F V9W>OCDHK( (PD;6_"GIU+%GSQSCL>1+_[#-X7_/"H5Z<VXX
M_HB43'^5S F5S?'%>] ]L-5 ::_I]3W2H7UF_N.1?Z O0D&].SO#%5>@"5.9
MTL;LF-CM,E]@50C%%(;J(7[V&KUZ^("8@07IZ[%#_QM_3L\61R>/M=SXK8.&
M-$9'KND<778N=NY4L_(ARR4V-Y&<]OCKZMC DU[BU8GL+(V%@ HKS),D-Z>)
MQI\JY,O#?EU+:(V[R2TQ_C6YOU^,;GEMMXU\\YIT]'#"T$_^)7K:-G,53+.;
M\.T&<-AQNT@@:3LW\<FX"MI-<_74&=\<1XD+;Q^ 2*3TX%=<=)G::*&D0CW3
MK&W5T:]U !/4JO.K.R<7HFOJ)L!!N6ZG"L#4]J;[1WU1>!E58X^:/GY/96-M
M]J#$T3\&6>7K8+!C_:=?6FE#1X,/UX8<\]^+OA&Y+6P@<\^)BRFQX*HJ5'?G
M-H *?<$$J$OXEZN'K!)2/A[%J?]>=JGTX=)Y+2BMMU0A(VY;DYJ#^K>OMS$1
M%->E.H8IDYJ:7,H+P3U&8;.-T]XWNWX<"8/J7LU*9E:$[CGJWS>B1UR7+Z3M
MMOFNG#R%5P%;XC1!>.$66+D^2G]W&\IY;OVF36BZM]VCC3VO+:FU2692!F>G
MG&H\4'BHQ# @P:&*3J\W0*F_R2U+X".K;:]/'  OZ1$C]IL>L5H%IJE/73'N
M\'%/(A:8;'=#DR^2CIC!(7,M(VT9 P&4C="E$8*^$&_W9(>#>(LWL/N,&V<4
M,(-H:!JI3E"<<3 Q,RC)%8YDW-FEE6I)!_6FDVBFQPX+/9Z9)HMIY6PXEG!L
MKA^_D0GY/3%CT7HA,[<JQ=@6# _1-KF?[45@:<6[55\XJAK6[/B+66@VPZL?
M9Q149Y^##CJ$T]*;ZA8K,PVR#/I$X:$!RBK@A^WL+?TS*W&C4TM,]-LUX:MH
M4SUT22T[0;0C/Q<]Y6>]IC\C0^:^N7NDZ<' NR&DO] 25@,O^N-WZD;OQYS3
M=!7O8)3!>UBU--O?6ZBU?))Z@LV" %);IU*WNT_>&>F1<*DD\^^/HN;#V$2O
M*NKVO1HV7%R,IS<$!1KW5>D&0/S11@,ZBU3;T 88M.C<1.:#E_E%5?S"MU\.
M.3-6^$K36&NJ; 2OZ8N3QHU_&T"DT$ [ADY;CGP?UW4%>\Q,4_L['[H88D1\
M$6"E-MWVW?I[NYT" 1ASG+ L!?W,J4,B"2CHVS&3Q;$M"KBO_:S3#]3.8)QB
M?3-PR+[@K=X1_=:(#RJ?[\T;$RM3 ?$*B#_?F&B:Q@@9P/1QJWJ^G%Z-1['Z
M'R:C\[Z4%,H%I%_\)0HW+ ZE'XKYK.].#9 /ZXTB3PG$"B>OSTP.]CD4GMXM
M-DG0(^[1+48H)<Y&2M-W7&2C)E<1.+.QC\+K=$+T2>LI^I3PGK%5)"$Z&MF,
M3RJT:/3K'=\R"5'W[+ER5.+XMHR<._'A'6A2?)'-,S7?+P<P6*Q(@E7?^%_R
M=M$?(OWCER*,XS_-TO4(O+QP_ @MJDG)3[%Z1F#+!_BQL!#%?6F\BMX]0<TC
M-[=EF.HZ;V8\_A+5@X%YQ^67<0N "]ZX!4N+V\@QK,I<WEI.9B"?]'XWW7:N
MV4GTL4*<7P&2>_A=MR!I?U?3[1Z_GRR)A35H*)QA?A7TAA@$"H!IW+2\.1&Y
MO$("0WA]>&]WV#KF5J2Z:T+F.D_X6P]O0V0;H2!3+^,K@6*@7B7SVKSA[ZS"
M 90JN#ZOFNG9<_$%^LO@@6I*!)!';>B(+E97,'YL^@K5()21D%MU\QDB,+?A
M<R05431^D5$<3Z?.L[H@5G(]"CXUF S8+I;9M1^_C* ]2=/_*%C*MOJ,&K97
M5AVKAST3S"[+4)E-VW,35$V]K6$J\BLNGB,*85[F827&FNA1X8VY)!SI^RGU
M>=FC1LTQ'2VU\6FFT76P'5^WU#L$J;+I.'KFC( B\039X!V>N=&YR>D4C!4>
M8^T-7%HYYR7Q3X!Z\=VT!.9OR #/AA&C6V=M(^6G-UD&I6,24U"YD37/2S\"
M"FO57:[C /X"$N$SU?,]XNK>GI2-NXP:ME7Z(2K'R;LJA%:CO:"FZN7"VH_U
M)1&?DE-OLR#RC;>58(SRD#1@38IWD4]\YMG^5K52LZ/(;EJ)N+?!WD=4YH/D
MNG4LIW,P&V] 6VT;G0HNBG72HC"X\% "BAZ'';EY#I4;"%Z*;:(DLCT#IX#J
M#M M)^/<8LE#=8EGLXVKP\5SX51!'X__$G5)UWP[8-PU*&]G=L;&6TVPUT)]
M?.)M_"(+ 8# 54/4A^T8VHF:YW>G@".\/^G :\VX65"N?4AJ[C\NQD.5QR,9
MDZP!T&PQUN#MV)6E/ZOCLAYZWJ;!AU?8?;[L#BWC_;&]SLE&--DK]'9S#C&V
MRH!';K+J^2_SF+6PXTSL+S1W:A;R=4Q*PY'*SY,^%<4>X>_MZ>UI":QJ;2L5
M4XG?#H*ZFF=\'4J< :^6QX\0/L"= -%^MG&CZ?>EZ9NRY35RRP*7!BLM+&C<
M3/(BP6+%?*IN+YEP.K.0VLV!?*2 7'3KT776_Y>R4OD'-!=3;N"8OT3X>\.$
M%NQV$.L%L-!UHDT(2W/V3*\%[6)>+]J$E!#>,Z[;>R-M1(!AZ-,E4C%9V6LR
MZM<Z<2.Z^KI&'&(*\)8$MV&'= HHI&QWB'%5$?Q53N2DCN-#^JX3HHXY9JUF
M64$%/JN;7S/5WCIWW7XPVB;4ZF!-GYEFG2&<O K'4MN*"V=I9@IZ!J%*#W*O
MQB76%L9F';,TT :(\,:?7\]GVMS'761[*/[LE8"X5BB7B@K%NU7TX2IY\LW'
MLEM:_]?[PSU3*;T*H:X7>;ZE0J-UMS+)'W^_45573,C M9!?<%E\4$QP32\W
M[DBDP"LKL_F)**IJDI;^PNJ..Y5OTWQ(+ERM#'%)&2NI_LQKNN'17C@UPN J
M39:J97V^VPC!>ON=.J\2'&N+M*R.P0 >4@KEW>Z51FF[<:GXY><VB+))-N%]
M_RS3R&U\@G/O@#3ZB*(,91+7HJI2"[K^AA*IB8FK7M2?:#Y/X^Z;A2C.>55V
M&^>$K!_/JI*'!DY!C'FOW?SXD$T397C'B9%Q&H##TL\/$0>/**9638U(1/<I
M+*_@0BP5WIA:%@/]'11^%DN29^4#8E>&UE'G,1_1,7+_^I4G=ZQY/7FDQ!B\
MZ)$*UC,_3=/4]!XWAEK\N3DMM?/AO-:%XGPO4U'B>=X+A"]_B2"G9P9C:G$'
M.1O)H4UD,<P)UE2240-B8TE_C'=Z 5_&:C?MS&LN]UWXG]J4Z4E+L5+UL$P;
M=\$N$9KR!R\^\\#SZ8X]=V;'9MV'71Y?:@P)+[C52Z=MOSCI?;.J55#\C&+8
M,IU*\@/ M@@5]J&MT2@R$<5_F$0W;!S:_-XBCV2\(K<KC$!I')KF>'F_7GC;
M=.SY_WM<F<B:$.WLI"2/%DD)2$*DKVDYV<1# /[S3$C"Y/*$=O[DJK!^M*Q;
M#T!;IT4,HD4>"W''S<@]>6+?9_MM;&XNM4J@<I6*:^K!O)MJ>VMYG,Y^E?X)
MC8Q #O>^[>9WM\XVN4-A@RW06"0OP#@T0K6UZ2>A,IA$89)5.QI%)Q0L"Y$L
M]U&_RX]2R\$GXK(RA'C"'M(^L_611:+0E::,+F]*]9M4L()I01_;R"O=RN:+
ME\<GX16Y3-E/KMVV:)*..K2%)97\WF>:"JC%AE+[(_^<\+M]U5L&]B3=73K]
MH=V) VMS,O&IJY9"TAAJ4HK" &I^8.UO8]._@*;L)M,@U$\-HZ*6[8A\GPE'
ML,\1%<)AGBF[*UOU7V@QYCR:+@S5$T'?L+2Z"L_)E\_0?E_D$(;U$;R7@P 9
MR6:_<5L,XCN]#E*%Y]N;7BB-WK>QS6.93#2O8_MVI2O<]8=KF:\_E6^M_?\)
MC+T6V6*%832S;0_,]>+*LJB\Q$Q%'#)##\_.GPBR37>:*WV\XI^RVZ'ULL+L
MYUQXTH('DJ<[ &WJYJ&:Q:- O5+]_9:X_R)7.GYU-4_EV7(^/T%X=(Y%9H7>
MR!^* (]46^U3EX>^]Q15 V4B?H2E&[P4*%\P2Y;;ZOD(T6?/>*ZMF_]NX/6'
M(NKO%H[<S4,/\E2+KH=*]==;8@;T.N_7C621/IGD<7 ^G_@/:E3(EYL/AYH"
M[D,=3':&O^VBH+;><?(5E1<2L5QZX!'U*#,WJRNU*K?,QHQO<DCV^J/];N-H
M7>HT#K0L$@?1+QAL^TOD9?4'[HOH/+#\P8\<)Q@X@G[_N< &DF^]@_FEP0X9
MN/E[6B_9^6$V@]][M]L5>ZD;0L4NR,O7U%(BS%. )HG1#]HMV4_43-E+2I6]
M^,R<0S6+QGI.2@/.N=!AR4:7[3QOD2)>=$'JW5[-!@1?;[=+T#G%N 7;D;1/
MUC)MN#3^LLC PFYT<?3]!?=C$P>_9-/0]Z6\$0RPM0\QPB6&?.R:&<I?"G2U
M_G@[-M %,4::U7.!RD2;BW-=)C3LU0!#!,4\L)NI,_S,HCP!!_Y^6XCA3C]T
M5D(,\J]5_J._G(I9>8QW?NQ@*X_N71M0\.9;;\*'LOC==RP"?[CX@LSTBFQK
MZY).JT*[C&T"YW)*=31 0+0ID_L).&.LHSE.NGC%CL"]UZ'O=#2V7S*LO+H=
M+U>)_4CN0T/W$VE/^>?@(^^DBE[/&YN"O.>J4;IH)CA<L4[=1NFQ>3I3',.G
M&F9MQV.Z(#;@P#C&%#EP4?O3"'O54-YO=16>!_86\#4@!)=9&7P/_G?0J46'
M;EBWGNK,GV^CC BL+_',/^G=EQF\=1Q=^QDC@P2*5Z&&U(9>(/<0:,C&K\N6
M4\?&&VFXR1_$P+JT@<&_([[=Y5],N//O#L:D4IT%I0#]_4^H^JZ_B3WSDQ8=
M_M N_IUIB+]H62ODX0LH?TJ?GC,MF^*'"';L0/ _I6GTI)JS3W(B?;P Q2VR
MR#'?8$I,H&IV5563Y.K-@IVD:,-E3)+.S_;]NKQ-08&8E#T>3/)KK-_CNB?3
M2+YWT4L7C&."?=;T$7FZ>AUF,2+>",3 ^:%[,QTRZWPD$$.N&OVPMCL!.S)%
M!D]K]JDXOK7:;9R;$7%T0P6M+V[M],(-N!1W(W]TB@]/S*+VIG;WQPR,C0G^
M=NM*6__Y[I%J=L= )%>+,;SV&E/..T6(&=HY) 5DZ1]?6\=B!45 W+C*1K!5
M77S=O2YD,,XLA@IQ+=7KW"8R]0.](Z_-9#1^Z3Y9X)WC\<)(BYCX>=Q-[VU\
MJZ;;M&ZRFYY2X@;:KB2+?S57XJQ#\>':+:.O8CVDQ1+]-.'-F+/P7IG*DG6Y
M9(CS_B<RYOO[-T&>A[$%F^R*W@X@4#DKW;Q5$D=C<;%\ K"P?5<Y?FXHYSKX
MH5;1R:1WM7DM;P!%"N<<]=AI(>W<UVZL.Y?VCD.'2MB^;RAUBGZ17CHOXZE[
M6W?/[FWW)X0"\V6"V5I6F4^E-.E^%&D_@B]OZ6*X^70(3>A-3C6K];RHNXBD
M78X:[XH.S'M=_=&E[F5JH_)Y=*M5F7A@8##Y5!4&M]5!&S+T\7@L#4IWZ7B<
MK5?+'=+7X<T]=JKEG ,.F2U2'1 HO\]XE97F)P4MSZ<_]?N6\V.N5'SBV;JZ
MVR2=&1!-@!JL0P.[,.CY+T75%K#]+.0@1V=3!,L(AQD64523$VL)_=DPXF+=
MN)P$^&>H-N$N]PM;^+VCQG<(EB($N^I[;=?X<9Z$\@ZU>;5])F^OJCRE4@.@
M9VJN-J:\-8TK#I$0 1V#FW<H/0'%(48"4K50;#>TZYSI63ZI;6(^>M"? 2<K
MB\6-!\[+%@RIP8S5T2[W%X#-I>J,A$Z_,\F83=@8S/$@_/6*9(!3O'37^J0!
MFOEE:>]JTV!D8X7N\\/ ;/+RALE\HLA-T^95GE)E/[[;3<BI>HMSB[7=J*)P
MXYRW]4N3^,?\:*I'/Z5B4KER1F&F@(O/(:X36Q,$C6*-M>+=*;&AI54 &J#2
M/L7C(*IW&;>"O!$Q/!++M_7+E4J_+=0WK#4N6A[4,51V7['EU=TKIGG"F/P/
M((#D OQ:EYVG\M>A05_J M+DR^A1R .M-8>F"4NL^92&\RSGSW!X:<N%=VEV
M_<4M+/Q&\1"<FZ4I1$?),$OJZ^H-G?T4MAPW1OO,0BA%#)3;%<F?EWQ.]L^#
M%T6 .O23576>TQN9$[+^HQ#BSDQX#\9]"KWO/?;OI2ZK(]4A+T0F;U.*J="/
MA2E+4Q#);'\R.GATPJ+_^NZPX)L)=K^[A]VZ@<H7#SF1?Y[C(K\>221VB#Z0
MOPS.NXQ8N>@([1\"+9MB'.<T QISIA,&"=<HP-G1Q6T2L*/47"-B<X%Y=659
M#95N2UN92F8;(M#0%B^E CY$R\1VE8&A_%2M&-R)*$B_Y"_1.6^72!T>9%@S
M=SQB >04^5-(S%8>9TY9O7-MUGX<Y/8O"Y+K=H-0%[=UM]9;$K 24=98,6=&
M"N5!CZ@7!]CMEC? @4)G4N&(,N/T3%CD!B3P,VF;9>U$^*V<JPTG)N^U\=SQ
MT20>APEY_+*HOKQ79J8:^7(JS@DEHI]+PJ6]OO&72,7<?DLDF=_\T5*P?GD!
M-+M:VMN+0\D%8G9T[/:R^[G#MP$AE\:2>9?7W98ZAN !I=1_U _I@0!4OKW+
M&&&2@!NP^(F.5AF]FEZ_HI4!50F]&"?\>05#T/>.WB8/RYU0]1N&/'7M?3/^
MJ]XBU9UYZ?7MP%J;L)YKB+YUFZKY%17N5XK0Y<VSB9D>,C:61D.MN#7TY0>>
MCX)G*)^&,3C4!/'"T[FI-<2>4P/_D;.TY;>L3DJ5#/\^BW_T2C;G5U_'I(/+
M^[HVIHFE>RO>U(E?<Z0"FNI)]?4B3PZS3*#E0L[:F*@CKB?05.%_)*<\$-:R
MR+:*-B2&:PX-8@\-G/X7>-%SMR?AC@?8YT<C#,&=,,A0^2^#N^9R+0Z>,><K
M/)#MW]5HZRN:E?/V%,\X/^*;U*NW>&'ADI@=52X;0C:R?[C$RV4,CE(= *M_
M&YL?)]2ZFT[N_BX-A2QM;R"YD723Z4^:8W*I4*!_#G87CZDO?,8UV7[C3;J,
MG,64L]V7X04J_0)B^JYAYXGV8_+DVTL3O?"UR()^;&T(N7,3YE'T"MN7H@CL
MF>I_P5%N1W)C!<54FN*7@(%S@ZSFF.:L> (*%("Y7I#UR6Y3.-0@_^(6K!)O
MO6,M'-BBMF:9/%!3?M'GU>A4T[BL-=Z;@<?;7$Q&MMM(K8FR*E<M-+'@=D;_
M7>QJ/-K==+3A0H_)$74E%L1ECMA5[W5^G')F4?U92>HR9B66C&$Y .\>]7)E
MSZQK(MWV!7 QZTUMA3T_[5^BB:W&U3=^I)-]V3$VI7]6PFH%'AD0/-M_;0B>
M[9E^[?=0',=8J[W=#<YT7_RJVU+24=JT^!2PUV'FRNNQ7G(+6L[,%6[H+GG9
M:WM83#WO!L-BJH1KR_> 5S2LS\L^K*3(IWWHX.I6-4Y[M[K^DS2,DD?TU^YE
MT(<JQ1T,O/2P3%R/KW5S+LT6C'2_+=B.?8MLV:UBUN:\##+L:[(0,\%:K]K.
MVNIZ"U@')U^9?UB&]?LEC+TXVS#U1"Z?-WMM5S/@NN5\7M6"=$]U>PQ'<QBG
MWG;]SX_+M#PD?)\"[U*@U]F2KYHG) ?"Z+Z34;5<.(>(M$+W%M!+-[NH1EKR
M>./!?YO?,T.Q Z_!CT\+JK;(\>FI$P<\5C#%KO0C.K_"ILW%LBPC*A$:P\:,
ML/T@OC^5FVZ=D=%1I"';"E3P.%<E'6_G%S88_03F*Z7P>@-G7HZ-+3ZEN" .
M]L9CV:\R^(]'#)DUN4O$*?XM*:]@CXB4K."V)%O"7)R=U1J8\L.EI%I'SFY6
M>F/_5]AE.-W3;>9<V7/U(GIQ.26WK6K8=4##Z4Y0F\;\T+ C6.,9O7Z=)-B"
M3SL.VL;G@7JKLXSK:8'<\Q(#^QF]^D3:V2B4_,<6TW[["*+D0EXY.G$[=I)E
M7=YXCMKDUYOG[S-$^O6[7ET69UWA>"!.K[M9+X:&>(KI2Q:0[KKY'>HG[>+%
M5[3M(H5\7XN5,C&V9HP0Z$TI2]<M^$Q7QG7;?5SA6J70*G-)%,7[;F&T]2OS
MVOYL]>6$4_7\Y,;PB_Y"MK$^[8IHNCM5RR')F[\9%?\2)=N2=N1!K7EB"S,:
M9L"@K)YL&4?C@57K/VX??Q6+?N=RD&J!RL9]C'HBJV,,'EL2#TM&=WTE8\K\
M/0,QP] <8 )[J5^:9890J0D-FA(,/O^#6Z@\,NS;F3$SEZ""LK%G<$/?^/L>
MCC=<"*GQ#3(*@W.-20D$\?A"PN0H>F"%[GIBH&=V?YGO@[YT)B]GRW7,(6X]
M(PCJJ%0:UK%)8 ;NFC9)0*Y2'<^K^]V]2[B3+8B?41^?A/T8Q-S)VOG4?$+Z
M]LI'F'@M)Q$(;,7M.CVD+"KE\ZO3L@AH32R> Q@L_ _6WC*HS39:&TV%8@5:
MM$7;XEXHKL5)\.":8D4#Q1U:2G$-[D6#>W!ID5+<W8H$B@6W!#F\[[?WGOWM
M\YV9,W/.G_QX[EERKW6M:ZTG\\Q]8YNT;(L7H-)C-KE+MO<0K((7!1>Z_D+M
MR&BKQ3M ,=$[J%? J)K9O$7YP4(9([PF1[%%@%3+T1BHF11K.]4,CD]+\'_B
M1K X74QU!55VQ0A \YE/$EM))5U,-G*NS ?-3+2VT+>"O;0(_J)$JU="/32:
M,%!63>9<LT^:):ZA>IX#*:8E-B'VR2Z8N"+9=]D5PQ2VPX69R7H6\E+I#H W
MK!92D'\#1](EIJ^DTV@2Q#MN(A#S^6?>:3H"G+HAN,:9E @'1+Q*LS1)@E?Q
MYZ,.9N\")##G:MM!]JSBY&W_/JFYEGE".2M!A<P.2"MEKVY4UE,CQ!:X_WY?
M6BL?;:YDKC^97IHX)^CLO)FQ?=C;Y&'Y DVN> /<):S\VS%1F:2S#!M\G3>^
M<,AGH->LIN%7..XH@&1;FC2QJ6LJO(*S_#)6+^ZYI ]E_;.>7>: !,)-.:K5
M0G,:\B3*[P#*&PLZF<JZ^:U'[%XC:38]'/%S>S--IVF6N1,R"GDA(?# W,IQ
MC*%G@[+^Y<64G_ZDN..D2 5\!>697EBSF[&Q UM](<W56K]**?VLGP=(OM<F
MN]!M?A@MT&-S.(MB?'H]_P;AZ/-:!L$"SO(+ZM*,9LF*L#R+^@%"NVWU*A<V
M50P-;$)LQF147OK,6"!/_7+1RS0#-=^738>\[/><\W)'(XI55?H*>;\GLHGA
M$&NMV0:.QA)_>ZU*$#PVR>^K)W/I[0GGVFMK]==+7&X@<N[6#! \C_?4UQ$-
MRW&]E@JM-4&/ZOLP5UL=40>:*<B)4,=MOMAGE6EDM. 5O/V&K:V7<+.+:AN@
M)P0NNC7O+G4ACXOFR_SG46IKPG)EQ; D;&<==+X8,>%J+N:;2MV\[T,JK%>>
MSRND-<+SM9_7OP5J? CC8&M&G^X3LZO0U'-!EX\[:MS\AI_/=/G5O<M5J"W[
M,_V=RR*(OY$19P=NM' 5E4]66JER/NNC^J4NM&-7:P'[5B<X3>MB9%'19IN(
M?6Z<0;;<PO$V1GY<VR&T9XCCF&YM];K!J285[OP(M+\$?HK#^,"$JH%U2H7*
MQQU(;V!95$V]$07NP$HGK8P\Z6:O4=6/EH'EYN<R1'Z;SA=:$Q&:@#*]B=_D
M\V9Q$&#6\W>>P6+S?AK 0S?_?0X:?BS -^ ,\6>X1-D;\GR4R8#'^M.>S[EQ
M#CA5Y52S &=O_>P;_*=Z%5M!"/*% J>7^@,%/4Y/EZ8Z7MHJJJM;_D6Y7V)=
MEWU/9&5>)L5NM',CZ+=9JY;M) L2?=(ZZYBS<8H"[-61[#DA[.OH^D5V7C)K
M?/S&RG9A.UK' OZ,!7H%P&7(_/RHF"'K\X.RR)HWLYV2>B>STP2Q2Y;$_M[*
M/0GU$QK?L1I#C Q"%95J$O=%KWRR'V?6+<(TK*@T^*D<$7]""$D^;0@O6Z4(
MS,<]5*H_Z%EB ^(T-_/:=8:)LG9!2!.)O!NV)PPY>GZQ2N#LGHTD34+]]B0L
M8X:AK&[TAE4BS>012PIG_N<Q57CT"LG"QM7SFNDT"95/QFY@PWW8YJMK;A4N
M40A]WM% EQB*92LQI42S.OP8YC?UI)!7@V&X(8]]HX$JENQ#L#7M!GLA!U+4
MDYU9:$4M1-B6[[@6:J6,2?NH\7,J[2)ZO;WQT[5W'E5!0Z<9>%17OJS"=&4J
M%=^,5  V@6,41F;G-1X\+@B>!)YGNHY-V,&06KFGU(E^!7)Q&X/QTWNDQ8Y(
M3QP9/R,GSC4VF^H#IY7.KXJSF*GRL5$46-NH[HQHL(9KAL5[.%6<+%%W=G\1
M>:KL;4")STSJ 7B,,UERXL'<0].U/V[ V<F>IHHGOD]RPKT1)A<-W'6&T0UM
MZ#O2K@_LLZM <[JPQD>?W*PED=DO\!&@[>MAY3>9\G6_?K4[)&USG277)W!O
MTI&0O/_=IG1;KSI<LBNT*ER>P;13YN*9PH3W"VBI]R,ZV&[+8J5TR*#O\_SK
MNF<#E:0,?%_F1>473$(^Z;6#T!H97$99;U7089<;1 ;=#QV/9./W^&<KUO?$
M$1;^MW"D(-'<>1Z4^P)[]PY0#KD.=9)$.7#> <(,_#4_W62G@"\^^7>@I^X
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M2>LL\J+KY[9CTXF299^M9CA[RH:%EU-&RN;-\6+DW+Y]HY8A<$Z40.X_),:
MDE+KM9OMM(3]7B.I3O ",DXYYV53-ADB)<A*PBY!.1"J2L:*R\#PV4T+W&=!
M^II"+S\=A<W!++IU!5O12'Q-C*3CD0(C&U:0 TG?I0M CH.Z=M%D'%@T,<:J
M>A4O<1:"C,U@CHUG"[@CV#(U*Y!LQG<6Q&L-\?RO;93G0(_9E+L+>@"[F<,
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MD8Z0Z*A/6/+2*<FNUE>A9S8$QRR.AU8B$*E%+C.LF@&/2+JH+:C=T-,W'GF
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M63:IBF%UYP>%\(S#/![8@3W.[1B%>YGLHQ9B+PWY&YA/Y2*4-6/,]-W:WB2
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MS_HH836\+=T6S2@DR!O(W5A 6V#1U"P==OZ9/STAM;_!;)(6G_9: 7K^5X3
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M]?N54B^/LIQTNL%W=Z&)$Y1$'/#SH>1DJG93###&B"K/WT3^85B0WS?T'7G
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MK_6!)W?7Q7!"Y_>F15^/:_2G[V^9+'<(Z25<0=)6(H(*YVD#ZC!?HM0/FEO
MA<5^:5(1#[O6L3V21.: )>,KC)#WD'/;SQ=Y=+F;)EX(YSRBG*;?Q-32%CU%
M%ETY%81%7A_G^V7*9N2 S)^*8U#>YQC$XM!^NEP'\74>Q0*'Q0V^I!F_SP7-
M\Z;9BSPNUC6\QJ;D$A,5>/ /NTW*+INM#H*P:/Z:S)"3\AQA)ODU]2IJLQIV
M=FETB$XT/*=MTF"_TU&M1C\^(*IDHCW[J1^OXVA4R>2'4J>XC#O #.K=%XU*
MO-.)SYH?7*V=['E@!E-=LDV\I**/2S),N#,FTP7['\*N+YC$+D6%J;D-3_U8
M _0]3JC:YDQ:+C5=35+%DEVMDY\H^#$.0#4HTREPSA[M4.Z_I-65.!;SDGV\
M<;4>SZC?0F9[\D@(Q5> _:9'G;D?J/2TOB)+=?Y8T,=Z;M]39](H>;%!MA2C
MN;]? /$JEW9QBVO)T/A[0=1M;+;<SUY_ 51$M?2I3^Z^4J19PW*T_@J>"*<Z
M?QS=0]#IMIYVFSMI2X+XOXC[RJ XG&_+B1 ""9 0)#@$" [!@P=(<'<G6 @R
MP.!.$MQM<-<!!I<9G!#<76=@@KO#((/L[_]VO^S6>V^E7M5^[.JNKN[JVZ?/
M/76JKVU<W97%KXO6]?\N,!+KB&DKQ9_&)Y@\L6 \R(SSMG?7!P@0-#VBWY^+
M0;:)Y+SY/2^VI_9?HRS^6T/:QMI8T5!\==G>=K>LQ-G>OOR]</*[/X%X2?U)
MK(I#='@?NO!*%=2W 1/U22:?QLOGIM_;92V^CWS\;8NF.-/8H0R+PS7--RFY
MS]%5@KW/0:2VAA5.[LI>%/3.5^ 733P/>>O\@=LE/V\3IR+.7<"\9<)([+QL
M\>UD3U7J(%#]YYP>NU)]1;DWIW26P2#H*<O>T&6*66Q//7#Z\5HWJDR!1#5]
M*M"/K@"<PS^WNW: AZ;P"C/3&\518^'V[MW+8[ED'-!WNW;9MQ8&TRV@8?\P
M<#-K(2 LR*NJL:&HD*X^;O$5^"SO^1_1&BT9H80LRR>?I'E5Q+J\\(F^D_E1
MD(QT^FG863%>-\!F-$@(4[)+6DL3G^WF+> Q#;FI%_(9V[ER-3TM7/LH8YNH
M+55/4>W TMEX-.Q#7N*DWT'\P<H4J;=@*429RN*SJ6G2@FC2W$^'*N6;* ED
M.KRCTDA._@.6[R6I0%P18QGRO(?]!P?QTL6MYZ/VH4>DLU;9'/TWS\0J3KP>
M5TANB[#(C,[T*AY"Z=5,J]R$P[K7HW&CKXWU>3; N;A-?*31],X1G<DSF=FO
M_U9E*Q^E%K8=$&AKK*^G)?XE+VY<'L!B6S#X[M7F#D/!$+A@R@*);0S'#J^X
M5[@[JA\4BO7<&XJ/G9!S<>2^L>U+6110]:E.-6B1V3)K;K:K"?F@VD2U[T^\
M3<T?'_>?1-$S1+IM5$SQ8" MM*JEH"GP?>UR]B*E#^Z0\$YYI6@_[]]!X/SD
MJH)9#UTO4B&N/N$YO2&'<8OYON,\.,\;[^,@1W%Z#]\L"R11!CIKOVL_I%H2
M9&T. H$M$Z/R9\AM_D[I\8URG$D\'SV'ITUKSXJ9V?SVNBMPH_2PL.)13DIY
M:S7:JSER$GU7OE6H4M?G>&^\!1H8JU"IK6>MV6 Q)T1A]OJYA*QG2%+DW3BZ
M+X?4[XG[OJQV.MUM_(+480\1]*)F^W8T^F14_&V]_" ;.XBZ!T#F5*= ^<@#
MH#>B#^E0Z:I59,4JK^#!0/E]-J#3RPBE5L^'KJM.>_5UXDP&[YEHL,'&E243
MI9:*=._N^.)2[5!C$6?S#9F"Z)ZM1[&T]7!":KC* T#BQM!JCXJQ\6"4H/1\
M5X4WFGF&]!C"N;!><VE#RDZH"KE[=5TPG:U_* B[+SBA'R??Z6$>2Q/Q,'1K
M<^"B_F+J@RL/'XJ",,[9:[+UUI7;QG)W5;$Y&QDR5D2"I/U464H;DAL2#10G
MBJ43!L&AY"#<VU*17X^>$OQP$P;*Q*J+<981PDOA3&0R"M'\Z=_OBB=MSQ?O
M^-L<(M8==CA[%-Y$EEN11MCD2U9@,_R[4&'V /B4LSOJ\P#PUZ:Y@3/-Z19>
M5?I?+KKJ^@ON6']I&.8/^<\!YY4>0GNJC^=@'[J["O'?$>"E[XP1.%G:X>2;
M1YSN]O(D%FHZ-KYUOYR6()LBYB<9_";-3#W=EQ>T'E1J*U:B8#6D]5$%B\:6
M4A\QKZKL;%;0P3Y#ZA7+PWU[Z+HNDEMH+NJ[9,BZO12CS&A9BNTX]8XU6N,1
MX!S'<,V_S9=_" [W%T 5/!9Z+92S9LV(NHB,M]25U5M2 Q5',;C3D)"<?YYA
MD;:H.>)Z<D1OM/V]O(NY['+50N<JC.XDF?//T!1%%HC1]HS2?]0%JH$49]6P
M\"W3P4%S=1PP&04[O/NUYR_RQY&NF#A$4*<8\91O__M.($?B6HN+F1=AR.ZN
MI+Y"V-7/61/BIMX$^0)+3A5$.=5+59&I;\QG$<9^2_M$)8$;HF;*P">5._:W
M];I2O@*'&J.8BV.$]/BBEQ!]0@.<Q(97V:L7%DJ4>D\7:7E:49X R6C-1.KH
M?RN5P/VB2<"'Z>"V]-#-KD<S_JP5.,-M[7BTZ[>\G),!'%=N63!*P'34YJP>
M!'BPG]Y@SA\ Z_N7=LG-6^7LFG:!FI,VFQW99[J5/57KY52-#;>Z1QTKA96H
M\YT=DV=.#X"]&,O(IZL@*@/6OTGYPE5; CZ*OZ_%'@!!G2Y'S%0YGNYN"I3D
M>]Z&Q?05C7 \5]/UOW?3]QBC #<?BBZ&,0O_W-O3%(7M0U==Q273"X'\):ZE
MP#Y%6\4595%^4OKC#38U_W>%10Z*WYIT:?\N/X52K/&3>MF58\VH*?L-,2DD
M-3K\61AB^M9@B,7VM$CRD9W:0N$YJVS:D<\LJF81PIK=4.5.Z<?C>=JWY4L"
M]&W:$$QLT]UL_UMIX#QYWM,TB:Y4OW3J0=16GSBT=U^;&8PJU$0U0>T\TL^*
M'>853-J:4_.HJ=R49-_HRAMO5O2NS'VVY"C1KHF,8)%2R'+[G&#D]ADZPW53
MI7E(.89JO=IX :JZJ3&90S'%;@]V;'3L8/) H$D@2:V>JB:T8S %5V3N4%T;
M4QVD;1K\C?I(Y<HZE*>=OJ>K/C, FS+-?/#+Y;O3AG)*Q:T6=Y_!:$-KUJ?S
M;B\)<<EB("WH%_H&,)VV@MH#S+<^ZZ[J6V/+E Z^#.=#K2IV'V*?)?WKBLVC
M3#'%S=FSZZS.-@G5A0QO((.5GH$61'2)--Q;<;5QEACT*\J)$>W!3T.A;RW,
MZM+"PKF&_!*I4JWY\]/AE!!5+:A?\1#;(49<@G;7IR% 4V)C,?\@47%3V[I$
M2]NEK[%K08#EE_X<YWNLP&]),,;I9AZC.N:?-\#P(R#2F4-4#\BSK2Y2>Z6G
MTUUJ2'W@,+S!:5?WRR\^=DZSNOK"#HMD!:/G)[$HZUDQ)$H0CZRLCXO(\]'F
M#-9,VW=_%YTRI!BSF.V5F_1>*ZS$1JR3X:-L2)_!81]2?C5_USWEW9:5>[E2
MV!!:3ZG4R?XK![!Y^W1I20EVXMC$XBY2!OSNAL]T+<Z"L*AY:F=O65P65<"8
M3L(F8%B&)UUN&/L/5I2N-E#!=LEL\HOPQJJC+4W,;VQ=E'XV"+&_3Z^KK]@J
M9CO>[K<K99QF3[.5I*9:J^LJ.9EM,H;C?TP5RHLQT8Q<^:E^ H:#U[N]S#?0
M \4_=G_%M[X?K[R&[@K@,>>9F4X] .@-<L)])-QI)(8V/N6)I*V\CDC/%;'<
M5$R;+U.N.\R7"[L9#C_\&-T:K!CU1PM&%@/ DU$@# (\ CP.;/^PH17QNW<S
M?Z3D]'U\>AD+[\N&!C;R;G9KR?D4CO+Q)2LV^2=N' M31,@/A#FOX!3"?UP:
M[*X3Y='L^G.J^J1!]*8J4OU\>N^)O\VT*R9][G?^^).P8+75_0$PV&/3.YO$
MMY&L-@:>PA.X'] /LVPE\B>&Y,UR>ASU)2"-@.T\-RD(Z6 A%\6TR;9PM7[7
M[S#O.>;!JL#7!SP(U1SG9O*6 EV9[QVGY8R2"@I+[Z0BP+CA.\WA**,A@1FH
M.IPR@7]S5_YE3+8X35,%F)A=>-=((<- HY[9OK"43DY#-4Q-9T5:X>4SC]P/
M'MR%2C\ZB%(U,J69F?I@;]K=/#3GH$R5V7$"S<MR?7H>:D6%CT4X=CM!QMX!
M0.V!'XO/::Y_?L*$5+7TYCIZ[W&$WXGSX_:P(%/*JBCDZ1TM#9GCIHFG?G^L
M<D(M=OTD_LQY^M03M9^$KVR K2WR#CH2)8#IX>KQE](B%,X.+(9P67QAL8X_
M(3-^X]EE>=!LR<_*92/BRZCQ%DB%@W"2P[ANI'PM.>Z55>1R3(97)&C#.M-.
MC'6V@#\5J%BQ2W;62F6[<5&9W>ZZC)<9-B$3RVN5'"S YS2#&M.?GJB]1A.#
M$O_$VW=?S3O@O?XSO+]\P"8[W"C(%AK[28[GP)XHJ"0/IJ$CMZ#P_:"#&IW_
MP9_R3=+<I>[<?!MC$>BOP.?^^3).WEYBA^F4QXBT_B96\JR4A>LL&N>BHB(0
MLT5;,^QEL*AFC6:G3S0HJ]2H3V.W _</VQ3B]/>Z08U(:M]S=$?)=_-2L)RS
M*\12?T%\-3O1ROQT8\CO(J&H%6["I@Y2$$FBFO8KW'/[7E(=:S8&A\ =B:"<
MLT*[%(.#'3NV#%:_ ![D47]4RLL];8DM&>.%*4TO/B<;B'>S6 Q+S,,$0::I
MWQ.]WBIL-/HJO]O'9C^B9%\#DPI6/EG4QG]QKT"@4MFT40ID*D&6 O 8U@AB
M%)A(#*!V*\HQIZ",$F;#)I4O85_W83G<LTR+@E8.R7=ERFZV]M2'-",@V.B=
MJ+>=1A-9 "=/QKFZ[V::;:5H*4VFW2_/&[O@YN3K%\E%,"W<[VQ4T+Z(S@-F
M?V^*!B7+8%=6EXW?$HZ2X(X/[9R*BFTS=Z;Z^;J,$N'P<S*2'.KU4(&/1S1_
M*1TI0!M*[6YDXG*3!(%AB(M?K&!))&0L2O+DR6_0AICPO>46Z/)K>U5Y'S7.
M.Z7V]ZWM=/HHIHVFQSA+V@U?HOQ3CU9CDS0JK/)H79<@BTQ7_!5*=+<93K$^
M/7>FDEYV&0P7E,I]1!' [<8DK33E5\5;2-BFY-?%WY@#U5;W/X:L$MLD.1XA
MU<D0=5'*+)%JDQ[)SU$_<-7B0B9?!?T %]$RLBA\>L0B-\\ $'AB()Z0*@C^
MN#M&FSYSAR,]I4[5>)K+,<T#E\95M[JJ;"YLV RJ:I#72!"0HSUJ%!T1*#(T
M2AQLY"6!1GS@:R[/KZX@(8*!,$22H"M"M07$8FC"O%GW.6: P:X^I$+^Z^JP
MS2*?[]D/<"E5(2'^%C#LY.GK1I$]CUBD9-N>%3%1804=$W#2UQU]U"C<LTL_
M/Z&J;EF_[S.=-^64_P]33?1#3YC&?L_]RU@DCXO=_5BBHF(7E,R2$'6VV>RY
MVZHOO>F-W_PJ=P#CAOWHR;!4?!,HR(-F(]>=*\!+XSG#O?$%BQH]N^)71UR?
M7()GEFS#LNO8YH02N_+3!?I$'8^-UYOLYWBU[L!P^&EZ!="QN3J'^/K[T2,6
M*GFQ'_B0X@:CEK?L,I8[BYG>&?6;^D$?>;S?Q*R%*5\<8GR5%)Q%?L$:CKWM
MUZ B#P F(UW_NV'VSE-T*^GBT$^OJ!R:T&90)EGP*X!RL<'J85%5W@*J*RS4
MD&ID["ZO\]H;6+'0PNXP-EU]?1(@!!.P9D\B]509YMDY"&%$+L!)X34?["AM
MDW'5.V3N-9XHR1I@+T9K0^I(M9)\3"3DVX4=N^\"Z>T#3VXS< W"-3+CUL8J
M/E\E^<<)R(O)'\P.<L[:ZW!4/NXNTWB$U]@-? !<+//*74;#GRNTM=^IZ*%U
M9ZT'4[H^:\73?;I.9&!V;'KT)QZV?- _W55#//-- \Q3T<FJ3W&W02AWBW!<
M@X:I_@2QUXKOV=RNN6 PN]KH^$N 6-D\HXB#\-.?4_LB/C(UMOE%QWXH\*'?
M Z )4AC<P?C(>(5%_O)BWJ^@<A%L]'PAH/'I+U\!Q%6#3\0C>;6=E4/AR$=:
M6O* @S6X<H-MA%I*BP>;'L!'Z]/>M<HBN"JWIS[2-N>UA+<B1>PK*GF)BU*&
M[:F5^$CPQP$<Y?*GS D/  ]CM*+#ZP,T&KB&WAD<-D;8O6>U=8G=?S>[,(1\
M_-)3Y6-BL\]/+)'$XXO;]&C&#,59B[6NFAC[S@$:FOR>2E\Y:E]9\\!J;+]E
M>[R8>W'RGD'4JHRXH NK,X2)2E>;\)VD6*_QB*98'KT;,>."?5.M7\L3.%SO
MS'!  )67V)N"=1:FKFF;';NP"KJ55YP;1X)PCE6=Z?O=NI;03ZX;*%.PF':9
MHCF[F:])'W]R8>E&X-"\=5#:F@5<>GV@DIJI1@(J[K*%6_>.QS8Q2K[ZET2,
M8=&$$!=AI\0)NH@]W=$'@.T7)Q8*'^]=V)4D1G=15!^=C343[*M?:/5DZMMW
M>ZV:50\U=WH<!*0Z$6US=$^014#BU\'MR0I=2/4(6.]@ );JW]-D9K-C_"U&
MH 3=/ ^ ^Z_]]^U%5E?<Y[&$?D62VJ;7I*[H!\!?,MH#-'6HG^[8E3]H5;7^
M.83>)5FTZG9.YB8)$R,^Z7Y[D_T 6#&9=!FJ/QO)4Y7E$=&-C=F?@LTB?(@W
M]1V;,'RV6\^+]NX[1S'Z6R-KV,Y6EJ<$ID%ES:R^ D\">+XB$.VH;\M+%HH=
M=6</ #.AC-4Q+)CP9(>L]#N%$ RG6]W@TT/W0UOZUZ&;AX@K9 K-\G6X1L=L
M*="!;55GQN'Y42!.#3T<:=7/PQ [2)2E^N)$H$=&EU&,<4:";HO&K0L)-S;(
M!,DN%Y67*HB)0?0G&#]KG.J(M8DM%G)YY#A-YV.=L[\2O QX5O ;5^I6@BDF
MF T753)=]9VSR*2K!*/&Q>CW3QKA "YA.R0'?VU. G9<N$U-O@@7B3:8&G_Q
M^Y;*K]L65$+RZ;QN!S&%?+M 6AHC%QAGC.9_S_E&Y;Q_'*5W+TWL)%*+# [J
MEZ/V4GJ;094M:R-\8-5VB*G/RDH?"F[-7&([\-_WHS[;_]:!O]3J(*KD,M"A
M5DKL9EK:GG,\&,/9^ZI(&EIC;.P"/PK&^U'8RZ;GGEQKV 7YJAPYB&AB9#W>
MW/:6[6FZCIY<KT*-E+5K8R8]&^Z)+-B.5F ET58EJR8>6VP]ZVGV+=YYW^I3
M3BF7!I*O@9$B"6#MB8^[J*@_KRH6KI/J%]],L*/WVK/K;!8// 6:OJU= B<D
MO:WZVI/\-G&1FWOTWHV020'2H(I(>35M\0,6:JN+TXSZ%GT1%BEZ!=65Z?TD
M-P7R3\SB8PZM=J;3PED*[G^O[>_?KM"8DGDOM NL4=8)S-;&U.912$6!FV!#
M<5L[#%PHY&[(7QIG=]6%*IJL!>15]C,+6,./_\H:G.1/R%U(.(!I)\6&,6IP
MLKVFA@,Y2+2 ZL"?%&M=8<;6YYH,USRBJ8E6DHHJV:C&NAD)3[L64A$'-H%?
MPP61C;#(J.\3A&_L1_NMZ\B\Q%76<#YC!@X$:QXI< KA9]-'ZH7BL''(2H5?
M91E6-C;8"A3(;74+:C+9??T_7>.C I0:UQ5.Z/T#H.8!<"GP #!2=CP-:(TJ
M2&TA>0#T]@H] #+)8R_%Q5O>^KX8CT%+X)X3-/?W_Z>STMXF]>E5L?]=H*'^
M5JTK03GP]ZVF)M5%5W70F0.<M7DUO2>K<!HUL?!AN/\-&8L_0R^%5RU)4/PH
MPH/*9**JH>G[^Q5H'3]S1Q%_+X>VO.64S:9;1N\$_ AA?)?C"JO<YB=!,I'V
MB+/50&1).PMG9:+-R73,?GQ[_C?;T6 FK;JK;"U&Q8A/=\WH(FJNE@AJL,'[
M  C<]1+.9L:FRU5(J&?S&A\OP8^EW[N/WUWJ@ ILE$XU=AD3M1IJ7^9QSO1T
MWBU8GKHFV/CK>75NX!]M%)\)Y(FT"7D#%UH3-PKZ$E2)BBC3': OIZ**]D5]
M)/[:08TZ?N1UM78[LEL:6_MG[[^7*<Z#UZ6NYM0/?<S?67_N20(RWP7O]ZO^
M@V@4D+'4HP$%P[K,/>&Q7(%E*/PZM<'",\J&HM2,H3:ZYS(%BRM"E#6%93U;
M]?H!T'KM\W$?TR%0581L)T%DE6T>P(T^-JZ?_*G@AXDJ[KZ(:@+/ZZZB3]EX
M61D@%]"HTVT5"]'$L(HO+,\PKZLUK/.?#.JBVZ(<TZ#I.3'L*1ETUIO*F&+!
M]HR.OPXPJ^?PPQ&?V2U,G9Z$=&$*4>P$=>)>3,J>WU.W.R$HW!]/^T^I4:CK
MBD&9*"N4Y-1^Q'N;@./_WE^%S6,8+;0!KW4'E'Y^TGX_VO(#,/=>PV:"O$>=
MAH?\B-8#BXC-\?$G;-#TP83!("?T%<O,?Q!=KX83XS]$?6:W%.+7]NG'DB&+
M8YB/$T06P][&"TF#8"MM\)V*ZCKWK4Z2N9$#>IMO9B)<&N/?/JX;$1"T#5)+
M17ZS#"+?/6>.GCP<@0M(I>\*XH=M'5 +;QHB*A6OH[EDV/MRJH-5AKRZ6%@)
M'7:=PO )B<F3@L3$.'*:-9G:+59^)TX7&XK)_D"['!S,%J1#CS X.OU[OD#M
M][)CENXI7DH7 8KO9CM/4P3FCVJ-M'[+GQS&U<":XNO>EK&3NC]]WP">X:>'
MU<*("-\@4.2\RJV%V4$?;S2W6J:N!X7'$M@89(1M4[-CJ7#K6*=Y\:Q>V<R)
M>D<$2R&1TGBUEOJEG#*P?CW?UX;3>=O\7P"E>U3P%WYB]%?T'H(<GEP:;E+5
M1;D(*\,%E=4  MO8 _>.EB[*]JI3T_ZT0^>ZF3:@31]06:4WV8X":>%\ZF6P
M1@'4.70N:N6TXWI]$B([D!P0T=G%8U] _FL7E7W^GB;PL?.B!AA6M-P\63 K
MB2M_'3I;2#VND<3XN:*#=$' T'OGWL4IY?TOSL9FH89.$&0UI=1"IVUL"SN+
MQ/N-X@- Y7R.X["F#>MM#R/SC@6CW"A(6V5-V5.@=$&H4D4/F>U<5=J:2*W8
M&,/B$ZYV3_W'+G(^-3).I@P8=,T<;,HC#-%5\>9Y19BR)OH.[Z>DTQNX1^M%
M5A9_U< ^2"/=J/6\\%WRBR2)\,NI)/^)W0< FX1R!EQCCU3[NH!MMC[%>O5>
M>Z!")5_#=]0@7#=]V!+51GQKHSVS:"-8I@>GL;QM<&/]*]W6]CG-SAG%.; I
MM"'"$&=\.IBMF,R+Z\Y([84#P"(ZC/.5MEN <^9.B\Q]6[,:0K6P-K>SZ)(I
MMC#VE!- ;BY'Q&-.'<WA,!MV1/;6"U9A(%:,'B-1VYPPIR&)W66Z<[8XY?OI
MT@D'X<CDD]X/488X=="UFZW7;8514I6B1A&'\D_:C=M5"E_,9;,B\W 2WGZE
MGLV0^O1DT0 OQ0[!#A6V<S"N5*E4;3B^+JF5IS_SJ?0>*[OM72YJNU"!9&^R
MSI1H&]0\>P"DV!(7ZN#67D($P)4*&MU&FR(D]HG"N\;9TE^K10?FW FMY9Q^
MJ?8VE!-#W @?M\!0QEE>VK1@B_DD@C?P_.J:!&>_?<]80O;/Z"]1W997[M5#
MP"?7/H19#P#Q(L/A#9E7(:_D.5=D0BRM&7KF^_6D)O]&FU$2U= 6EK+99Z]V
M[="\_EZ2D""<]SF^D>&MUC8_=]8I">LDF[U!65O$_,L/D4\;A'IH&6@9A/"5
M%&7)%3[-BPM0K\SY<:D4[I%721:O3?7,:JC[YY1XE(UZ63.:#IK-$V31^;QB
MJ<G P568:7KA]@:52(6+0[-3<H!#)5.=E.'4N[_=LB@#\5%HQP1(C(>*X--O
M#&7/-7%Q]%;K?;X>B 1;QMV#6"A*;6.C-5D5=W3-831YN!07%)[]1E-5Z[V:
M ;49UTNDH[;)S4B)%$J?>VW*&N2;D+WU9+L#+^P4A_@)D).]VW;U@LX2U/9S
MZ<O1A"%<%/37"]-'8H-/+"HJ#=)UDTD*$$RZ9YH['P7==!W-6,1->GY=>RL=
M2898[^+<J:R*OHA>RYJ>Z;7C%W+X/-95[<^K2,J]X/H X%8WR]F7I#V!B)B>
M5(ZN[4=LF.I.CA#Y$GY^ -S*#O?K()!I_4TF-HN5#X _=/TN%'UQ*J@73JOR
M26(QOT4DS14!,6T%Q8L!@A2>-BMOVY$H..;%D-$"7TKWO'P/1XV"@?#B\]DH
M6E:CY\#;K9$^$,&?-%:-@30Q>SD@PW5E$@<%I/%)!9NV3X^N)<)NWD1;@;SW
M%CI,J !"+M+O,P:NZRS73L7^SGI=];,H5"UZZ0!(7X(U'1T8AHO,/AW-)[70
M$Q5WM;--B]W7DTF=RR*1UM 7\8\/?;7[2!Q'75+7MMF3*DQXG47+8I>51U38
M?V><A)@6\P!P^63 (TPU!O<+O;C@QJI] &Q,3>(JKIG-75T QH2QM$,> &*&
MC_5%HM>[8VY"[L?A%!H)_N,>D[EAH[^/+\?7(JJNQ:=+%=SY2E\&T=$W0H<T
M(\WH:-W$TEN'O_*:7_D+JA+O/P 8C0O+Y36IJ[JYB0<U7>I\]")5,TE/#^K)
M\L-I(9N6[DE,-R27KE!_*LP<D\3CL3XET^=5%>TO9O7*[@(OP!F^,#N2:\/R
M<AG' 4A?7GWJ],=;.GC2L_:VCG$Z/#H6>4R/7VZ%HFY/N=E;@UB.=B%XAE]%
M5E(6H]A>XU#=+^)S ' <..X3VHAGCC(;[C^WS6?20%35_O%!>16KWUX:2=L\
M "KUG^A_HRP@UN>+^TDR+._&O;>09L/8M8@@/C&.@Q/O*UI;YEE7G<H+\RM9
M?8X1;="Q2(0>,BJO7$^5%ROM#B*%V\9:+%(7>DN>+-63J<AF:\G^4%3Q].G'
MENXPKX]T2;'4]G<+'?V>7:FZ$F$2_V;\0\3= X!F]-!9,+'1N0.OXIK9S*+*
MIA%V+;#T/2:CF+<CI^L+V]D5;7Z+Y7T1.M/+M(E]?6?I1^)%'V69_-LJFO$^
M#W.L$)7]J'S;F ? BY70>YVB%,F]ZJC*-D'T[I4@X^W"8%;\I2[B+!TZSRLW
MRONBH32S@+7=O\270VLU@=9<K<ND-]MRUOB+AG=\BS)/1:P4_OIF^6+HZ6I3
MB['51;[V"35+U=5R$K =12Q=G[K<K=+OS$)&%/<7<3Y"D5X:_=D%<B-%_F0>
M,,L3?&VVRM>2)!YZ'E'9]9Y^^C&Y%(4COB(0!LZ#37B_"J(#,#Z7>B-'""ZB
M_XK]B;_/^_U9SLA=L5&/Q33)EN,,S;WC P"3HKYM<]GN>$#9(W_Q%.7THH<(
M?+$DU_*"/@]AF9[<N8>.5NWOZ#D+^+[)Q92]4BI_U+OQ- O.4FNC\&1?/N2'
MZA9YK,SIYG5'O0ONZS&^+(2(['?POC?L7%9[J7'>O12(%X;ZY^)F:)YJ_AW?
ME.IV@;'*[K YCN?[OJ9NZ_XY5:I>"S1-?5)ZS=96<WW?.1P\XB).CMZPK;<V
MQ][Y^N2Z+P&S]"]$ERULHOZG%W=]5#CG>"A[\B;HZ3 D>YLV.TN)5 W\RZ\0
M6$X5+37@NW? H8Z?)AC^C12\W8M6]8Y(?"[M9:/0XD%MY,[ \?E1-45)["-8
M?DRQ1-C73_OKQ\ZZ&V6]EM@D/ZJ_=@_D %@4'DD/5Z8/JJP='HP#IU#-$AG[
MJ@OHQ*6WZS%TI^.IK9&<CU@> .O%0J[%&MYQ*0SW%$93-MAYZCMH'_Z!V,W)
MWD7_D/9958]ZJVMAG-'G5VB7D'4-K4]??%^$+,+T)5Q9VS7T05B&^X(ZB$-1
MR=GMP7-M*YP>]];PT&<A(@(5K D%G E+A1!G4RV+TPR\4'DYSMJ*V,8]7T[!
MR_S[!!X>J ^VX+5G!4#BH)*89C2.XA]H,0QX\_53"YMQ/P@]CYI'B.0L@1AB
MEV8O_N$SK+F>/:6;&P*1X>\FYK7'U^1JX#6NY77&NF\LWAND2S+.'!;"%K%U
MJ0PT&U&@WFF43H%<'\K36\\X\V7PU2^JL T5)K)]N[?JITMQE"BZ?BD"FT2;
MKS^2B@CL51.6AW.9(5;13M_W1MS.C*Y3\B@C=2AG3%Y=S\=P*#VW?#N1;G]0
MF\FBD*W3=;]8%6MQ>#RKHKPY:L31^Y9!Z/*I9Q8<35"G)V@4=8=EHZ8G0H/7
M*O, Z"K67]72^H2CTWTT)[-[3%_U.&2 ]JA#U095&8U.XF2<E'SZ"*Y*0U-W
M=K7[#L3\:5\DN^/K-E_1D\=7\H@^!\@"_ +OPWNLHGEIQQMY=EI,9 GK94X0
M]='R1*_12\J_==\_'PQ+2;TUK"HY.JX>@JK3.E8OL6!#6OR^/*OK[T3!&J<]
M(]^\2P??9G-[7HGC"^%L[R< )*8XL'+=Z1'M!4D-F04''[R#.[FEP4V$C][$
MB,AE170<PR0-@F-^1*>9&\9>QK=WU;D<'B][)J.ZAN]P4D7._B:0H?Q_/>XB
M0<;'?/:RVU?RGI]BIS28K@P'JLB$!+/_'/>(OCEH7QQ@2] .;I)0?DFU@\[E
M_3#-5K-GWSY\L$;"[V>(*_*Z\6Q#%202?]LUCKF(/?D'J.TP+XW6S^SK6X:_
M9-T;$B4*25^[-Q&-19:UG[E-O+/W?@!\#*S&>#@OCPQP26&4/K.-6O3I2>LE
M<V.)(>CZH":UJ "?J6*%[^=,/8#8X>?9%([+X+OZ&T"U,\GG^%8AM3P!;\CQ
M37-JMLB%8LT*X])-SH:KF*^;=F2 =]5LCU[P;<?[5-4</WO)$P5[1H&%W>?4
MA@YY=37'.U/:!K#:"#1NM.."BB>-N%;*Y?RKL]&6 V2 7)'CB=MM\U R&^,G
M/6!?IE@NU0  (/"OJAMK[3=FJ306:I:$?>B&+P5_8]NG611EN@EQG 3G'R&*
MMRIK/&CKOGMC-[;ZI#03K279Q<Q3Z;XW>@_8JT:*,'+B]2.Z$!4J=T7!=@>L
M2AI.-B_CS]+PN;$=RI0RDF]'?C)9TA5G'NG+(?%N=M8@8,N[SWF@CZ/" \],
M['02YP(2@P6Z@*$F*+;!PUUOGPNJH=B50/1X>VV=?C"?S#45>*H=M5A?68W?
MY?;Z#)\Y^B[C@GI)Q0X5S*5GW'->$\@0()LZJ+/TFZ_'#IC52MC^5Q=VST#C
MD-2&H1'R,OP[B &]AJ=\B6OI,$:!NS[[!0XY CLXBQS0??,F^NX\NT:]KX^C
M%'HL_".-6\+5CW<+\ZAR[Y555^_Y325]A=QY5GS(T*N:L0M70WT/@*#I>ZY5
MD\X!SM_X%KC;(+OWH;$N[F4&\$OWQIBE>G\N,JZOZRD6>"?FE3-JRS"<W37G
M18.I R06?7661.15P3X3_;YUNPZMQV%P4CUV TUH4\?&V2L S?>I*Z21.&@0
M\]:WDKKN6*[?(D&0VE<N\@!#O(Z^I!DH-82*ZS#//=.A71VB>!EB9"XK=2<]
MBCZX_3L4Z'_0##S:*QT!^4W?6>8Y:4YS0864^)_44/NR<-^_.:#S0]#4J7B5
MK^(^ '3O"?7:^W)HW\S;BQ8E"&?%P4+^$CBLJ;X^B6K[%<R<VZS369RG0!%_
M5R'.T]9RSBG\PUT>=6KK.;ZFO4MD7:F^S'NY6WC^ &AP;WL E$7<+0X8!:YR
M$U:D11V=O?I65TTS^<6-PL?[DL'G^8R**#F=% ,_K,>':DSJ^3T'E:2G\,(Q
M"/N^Q/%66!=.:Z+0X;1]HLT%\F([0=QTO"]B2>7$<B!H?5),G6MSR+:SE7JM
M,Z,KI%5Z-<EA>EV*%MSUH!NK4,QJ.WV)G>V72O!18&D/&^E&,Q0[9>+GXX)P
MO_)T+P7UJ#-C8'-5@ML1BK6R5 ;@+$O',6)OS<[&JSHQXDY$S&_JU@8W4B'>
MY:>0$Z8X"QT!+4&\;BD*BO,G)EQ5J :#A@$#@UON2XO]D1MC_>8/4<[#B^2[
M$;O%MXW<AM:@6B2B:4M\CMKDD*VJSB^T&L_5I4FH>6!Z&#0+^*]3Z?Z?E#W9
M]ES3XS<$__ KBP? (?"^,1VU_@#P(I/E_E=5BN@HEW\ B9_FT-?/_<,5:=Z_
M^<1HW/Y3G]B_?G1]-)!I&NA\S\+V<AWWO2.+:3SY']; 4^A!R6$NBXKVNN?(
M@<N$ W=Y>MH%*=U\IU\X*',7$8X\F@?Z5*[4[IDU E.L[+1?IJ\V]LJO,+=S
MVT!ZJ%0N:P[$9&'(1<$6D@L*OQEY*856\C*O7H7*!&7^11OM87SK\W-%LGJ1
M99?5YTM_:%A7ZP>S!E.M+(P'%;P, 051)L-FOZ/$16X=A->%7VF_+\I*8APK
MO%$=$8-X1[EF=,4DNG1J=ZP8!=0Q'0O<[Z.L&)E^7;T8X9K"OZP>W3R:H%Q<
M*B 3D3BI*-].0<F#8GUL<>@74H]P;L+S\X96.J33>ZN\'%=] X-1_54#)QE/
M@6?8Y*,G;+BW!23U9@H'"=->H"4%.'#=$V(RU@&9VMT?["U^U0))+XA* %NV
M3)5]O\YP7!(.+!(D#G!L*YEPT-DPZ!DD5 9!QN\"!?2S7,8@43(R7W2'4R^9
M+:H+_U15=#<MQR>?#E0->^')E$$W[.F0WW\M$JZV(KQ%2B-ML%3D#*::[SR@
MIXX0^(%U*$SF/N$\,=&]#6/#;NB^H9.L$ ?6J)0=SY#8Q4"%=8$GWL7DRGYA
MC3TN$KCG&:[J&G\XE;7APG#9,.CSFS@S#J7*D@N\/B\NR(Z.RCM1I5ZC3=Y*
MZD0ZRR"!=BE(H#%/M%@;U'!V1GM\0:'/YV\@O*(Y<H"S9!&HJENO,KM5 (-R
M/2O;U[4O'UJ&O*2 #O!N9_^ZT[VVFR6/-'38/]IO:=B2D];]8KOFQ>:Q=BLD
MO[F:95Z3]'K"&_.<9-QL45LEU%K?C"RM <U_JI_VS%6(HVC[=&4H"DX_$$U7
M%$S7S2)O($<;7Z6B\J9!T&$5U$0JDUZ@_"W=L[B% ,*!A'LC'183DDH9II3Y
MI@:*JVV.O^N6*W7]WQC?I-:['.05P%I)#$!D5G,L59A(M/.BTJR)%?C#/!"P
MC[^>0\Q\E;@R5URFA;7T[]P(++!S"%;(=5C' -1\T+&EN2E4"2.^?D6G?:SY
MSO"+PC;N9)#CZB=LX.SY9>7M:]>#E7])?U\Q!.KH%%9#2M#/^46&DCQ2_<=!
MK-/E#L(U5..+<45N5&=D.EUE'L=;A@B&!T :NP\IXBY$]"Z(T&NCO+MDPVNJ
M_ICJ*6O&6_FP!1M3;Y'#WFM5;H8<4E(VR)$[2;U Q0:QR5PD-]2JN5*PNRS"
MZ%;PA 6'(4U@E*Q,74Q>R_GUTZQ;@J0.1*4!G BG"YA7/#XE)ZTL(&)H4U^$
M!\O9S,-YQ*PZ_ZQ.GOVG20G>HUU?-S+J+][=W3'+5O.C @G0H4;B/0"S+.CO
M>D]A]*7#BT<+,=%MI9(G&#>*+_IQ4_VZ<+<S]N-,ZN7!Y!>*[M^,XSBBK E^
M(0+\=DAU''BQ:T1^+JX-LR=6/]TG(%6OF-PQWRII>MMCK7OQS87/@,-AJPR>
MAZ@PZBAOX=23>NT,SC%7)$5L=T^J*&T9Y5\-E]QY.. 99ML1OEOASL)7L?*!
MK2G/-UNT#UMKC@>W-I0RF8,/<_U\VMVT#PR\C1L4R+^5;!Z#6Q)&9+?\%FBL
MO337=3+,DRIS]YC_W)^1%#FJ!E7HV1&SM%HX[WIIP/[.:&84%H2R[>YLJU.C
M=V/XOEO7:OM2;$5'+^UJY,)F;1.*U?&?]&"?0Z4T_DK@]JX8[/ U4S&F<GR[
M$*3@T!$H.$'N=WWL1,.@G2=BT&DJY1F*I;TL[HVL5.,ES?6.RJ:01%G3<)<)
M:'/8;#LEO4M7 *7EU$^?>*^^9*$O(=Q#HL4KK6;,YEC^;Z0*I\=)# ]L&=0E
MY8;)(8]E;=40H+B?XT\3IT\N\9;1316<"8MU19[,TB28-UY#XR4MT/#%ZX#U
M.85S D%U1\& D@MQ0<X]-PX-Q*@SK'BQ/IEC"5SD(HQ4]RW3[?7/%-UZVS2:
M=JV7\Z+<HJ(\/.'1/.1$GUG754;!5Q]H8H-:U;0DRC[[OD.VM#%].!/%JS/K
M>+DXX,'N8]!_L9764<HA'D$JH,JYV +MY9T=T$%^E!CZHWB54*G[K95?H5?P
MC89A+"Z1\':YY$_B,+556')!3\0DF5G(U-^0='O&YW(8[)C6^Z46=R!4)[_
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MR\ <;D>F^[$??W1:>,SQR8&Q[3]YMV-/I>BAX0,@TMO9+T[+!'7 O];IHY2
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ML[T)P0K5QO\@[C.11BU19 C,(3C__*:](/?U^]&:C:*PE8&JDEMVZ8C]%)*
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M_4M#17XM MXYX*3%[FZ"]:*&K (YG27YI8)#;*-4VQD;5@A2Q>2/1(2L.=E
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MA?HW/S5$[6IJ/.'FU<;G]A;*GATM+ $Q:8W"*W\*=5- ;!BS^RT4[_4)W@.
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M!@JEU:-]D;_\O\NC>@EB?9$]I>&Y/ET+UU)S<"J)2X?ZJRYW8,"E!896JX&
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MO'Z1HW?G'DHK<1T#=Z^T6I7]KP$(UY]G#[TZ;M)3%'O\DO=M)39.0:N6A#4
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M/DH(H:@Y@&$8SKZF]U*Q?*QQ$TM<4\U7"NIF+X6XG6'W_7ZW[(F".Y.P=XY
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M%;YHO3^5%=<)5D3\=LKO2CP;C<ZL="C*UYI\+&^V62BJ*S=KSEP/OYG(6B'
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M'H367!"ZA9*.2@3UT3_>>XSPR[%,P#2_"'6#X&T<SJ-\!%"\LZ(\"IL!:,)
M;Z_CTE#OKLS;EV"Q9^ ?B,H=?XN>GB((YF;3"XPC[&>.M[YI:,"A<S?:7$KR
MF]?W.B8X$S[U(3>!TPE32.&5 "M0<.^@>+C9);R7P!VNFDA\#> 1Q:8R>G8=
M+L^TB!'A.7DJAC!20+D O/&*1%6;K_>4M'0("]V)P9W1*PQG5I*__TT4(V([
M]UV>^82KFRCFWQMVN<M7B.*O1%BGA%]ZB4LN-!#>IK!.WQ9KHOK%1-YCA+W%
M(_#1WR*@18WG=-=W$6+4&$)/1>HHO'8ODJU&2=JE ??PN#Q I45-D,*FMS&+
MO>_<'EJS+:>A'N@%C+' F#Z8BF]G]IGU>BPSD-'[\@=&;-252'+5*:X!H$!H
M1?3Z!M\])KI2M 5BZS=N5V.74^\=&1/=>WS+B_+RL'Q9JJ08L>OZ5N@(]&.O
MZ?H),'EM"4$S]+=<%DFXKO=816,^.CV]VM<(**<(I#S-S[\(D)D_+E683$:?
M].V<N2<+**%LC8I>1.\XG[J^9,29K.@O,@A0+W1$RT\V$IRE7LJT_:]Z[8\5
M@HG^8HGJ=0[KB['@SEZ_;DE$&]ITWG\G.O _7.8OT4N(>-<C;]WV4'=H<7BL
M?!!,QI(2;QE$5>#U<3GG\TQ?T<[5CU2HQX$GP!+\P?&R<^CQC"O:HD[EKF7#
M:]\K[7KOLVL[>BT&0^(,&"=-M<:DOB<2+#ND5+N@@]=;0-$F.JN\Q%I2,%VM
M_Q,)Y(8VQJLECUU%^^]$]1LB2=P?1O_5V^UK_B Y8-;^$\FQP^8FNXT2OS]M
M&GG(^_,$:$YY MPH%E^24\1?<=3[.<V9==C7BXR3_^I<9#U&I<8\ 4+N_)5K
M%CA,4%+_&_N_L?\;^_]S["!"43M**S^]_*ULA(6;HAAG8@MALLIT;KSPHAZ(
MJ!X+G807[9O]JD+]+N)SNC;O5:;Y@+9FVY*!V/82?G3KNO8\\_!UO:?6)9<R
MUV"%/D'J-S9.Z&0A^(%K<DUF^85A6*NN@"ZL)K+ VW#DC6J\9(/!]XS?0P](
M^N-3\XCVIELM65?M5_/[B+4X%I2!?6^\&/8MSW3"#)X-K 8&#V-SEFW8VI=D
ME[][Z;'R)LKDH?)WZ/F;>TTKOB*Y+=:'+9XUD/);%K\.%>6F4X3^+Z,\TW"K
M3QQ4^T^  NXLNFO0RS)AQ/X]:D]ALE1Y+=6VQ./BL6JH7(_Z7'K,H*WZ5T%R
M819SIAM%&<@G!TLJ*99 *B9P01;U8C8]MJ:?LRJ7G*1*._FG\[TB\KVQZ4D>
M=-3?2B$&[P*C/K,?'O;(OC&W*(WBSH^?0M5<T7)7S)97Z5<=CR Y%N2*2GX<
MPJ5LH&M<O$YR?5+1W0*$B=?-B_&%X+^TI4* 66',XFO:0TG_:>XGP.VU_P!'
M?7^Y!<]M1-H<R1HBNB=P*5UP%LFZ,2]$K= W4+RD=9_.+,LHM(79GZ$BN?MR
MEE0CND]0 I,W7EE!<2*^E'*M25ZUOVWN7]N<F0V5+PD-%HAGL@6WY%F:^8X^
M-//!B%0[FRD2*H-?(VOI:$0)FL;ZC*?1(0**^D;Y?NO7M.0DK3H*]A.U!BUU
MQ,[J?FH[S4Y^27L'MG9-@Y\S6MJ)8"0.-7+\M7)^0ETTL.B-5P4W$7)]]'!>
MDDJH7N&P*PAXFT7VAZ1\,5E0%7+<QVIXY57BA 0C-SS_NG' MO8(NJ!54)OA
MP-<I0X_*7]T=_6VB2TKG\*^^'? RL/[I7X:Z0=@*8M=*;/^O??3"(XKRFR=1
MQXB*MAMP$(\+96,U3879N [22$#N)Y2KYI>-_BZDVV!-U7L?3 LM#OVI9YKB
MS[C.#7+] KG]966[8OHWV_F/%_%'*6V>QC]$$DUH;,D9WXLE$Z:L6)0REN=!
M;I5M2TY^B?O9(V_*FG-:LD_V&-U71]@6-FQ9QJHN-H+[D^(%B\%U/OO[! >=
MSI"CK=^P>!S)U;BF)6\%*,QUC>W;XM$OS?%A:QTV<52$U]RB"&>FDRF8G1YC
M5.H7"T),_)1OBK2J(.D$"?"$F4,,DWFH/,:4@>CNU.#PK7)>W8PY>A2X,YTC
M!8';<7"S];;RT*^;L=R.J-1.:VFP9M!V16A\WD ASIA^RUNVS-6_<-_+_?KU
M\>PEN_H(CJ30_/LF2Y>3OF(&Q)69B)1YRNY9BE61+B5N[2*YZ)7+5W05[I"R
MT^\,$ D5)CK#::S\ 8D4[>0W&V5G+,S4!&* X/7_I!' JZ$&).(&@%371=%H
MSS(;R8P43B$CN]9),Z[.*I5(.E9NRL8T8!)AMJL^(=S2B)6MV\NMN-G?HFZK
M)TU-6<\ BVR[=JR-98R]+^8?7]?RD\$L &V^BGF_SCQ'$*Z*LSRSO$/XUA'-
M2D\.5,$Q7RCE$D3W0[]]61TY"_%;ROQR"EEP*Z=]9 BO+7Z^W7A1'45#9<-2
M:H-OW'5%.L!S^Q#>+6D^DO#*FJ ^'@)\^;K<-\RB3VL_<1#")@.TB[&H=7-U
M]T_EMJ.(';]7W)=>:^87:&EVJS5EQG..[Y-[#Q-(&F-^LY7_IH=VH-^Q,97*
M361H3BJ<3);IA-+,[Z$3TJEOUU PM>CS-](9Z=%I4_K3:2.V,?MUWVX0L;X\
M+DP99IL\4>K4W09*^*CLN3T<HT*HDNTP1XM.&"/H/7"\%V,DA!_=27ID+9!,
M6"6RY.^NJ'41Z(,:./8W5,F*"]S)$BH3,)T7"G:-%M-40*2;FY(0\M"+?#HC
M@/&<OFKH3#OKZ VE$**E2<,XS.:C2,%[XQE73U3PLQGW8WQ@K?#UXYO:,RV7
M'%=5LUQO#YL8K\>T65*+A-N'GX23S328H6P4+*&"Z:,$J;&9]Z.\D;3L*S.R
MIYP&[8[,,89TM$8%0BW80G@K@A)^#Z,NLPB.]:R7"^EL)(K"ZX+\O(3]:E+O
M3WV)7:K5X8G?J_B3S&RT@?=3!&KY>'F6E+T0'M]EA48V>A1BFUVF<A %A:=+
M?2"SJ>V3_-GP$/*9;O3<9\W/0C$6KM=8B/DBOH#LSLP5J[E,YSCYQV)_S[KT
MTB'OR2S*RX9$&"/AJ ^E/106S;]DIS@?QI/KQI.CN;BP6Y37F$10,3C/6L P
M=E]V<'5@_T5#BOE35(-T0?ASZEI"'*7 J[B5:A\?!93?48TS5Z'$B@Y!0JUW
M(AK<><I!P(4<%S0M4,[W3('QB&<7JPF WX163N8C@6&O-U<M:QV?;("H__R6
M679YX+>P+EH?=3;,&#J(R/GKK&SWKL'0BJ&HVQ/GX8.$!BT/*W7\6OV@Q@P=
M71TR5MC*4BU,12!^@<'>HD%1N1@64I!^J)5&7W[_^BJY^*]QRGF)O=#68H&L
M-L#TAL@5/N;;+<VY6/W,S:RXIT%&4\DWOQ('B4J9K[_U-@\?=2PN:67=4I0:
MSG_X9IU7  QT,.\;GEDLJK732$O;)HGG$:_Z.Z+[,G'XZ@C'''*$MU&T&.^L
M9="6[,)Y^S>OP;70T)/;*R$9G/^E#T8MV@-5D;Y_&;5/'GZVI[04QF$.H[@(
MR4IG9H[W\47M[4Q)O?T]=#7T8+BHYRT+:>,/KL]E7\=8*O-J9!\9L377#Q^D
M-1?2NYN24ZMHB7MK?\MM4(ED(AUNA0C[/#H._XKM\WG+^1H'0WKB0T.U]1=&
MI&3T;)>+^"N:QEB>*X" 3?3FYOZRH0V39P%]3F7A-^0AO*<+KUCKK%KK#7K&
M(6W]F\6LG*QBXR:4JSJ:O^,A[;4+./#E[R< ']'%,[M)?/F8Z(VSW1KT4#[
M_E>I15<U,6-+J['(-JE K$KXC6^^&A'?KA5&X$FQ$>#TV@\,<C2JG7I8S9J,
MYSD!WCQN5]H -#0WJ@\.$8A;;L:NP,:,K]VS-=4(_Q^9UPA$(Z2X@)28/H2
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M3 ZCY_<:_?1K%U0'G;?;M-5=H%7X>Z:;Z].]Y8U&A+U^ R%FGUV.5U9.U!.
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MXE&;]$C M;!P,+QR;SY($Q*_8]D\G,OD%^?=RFBLFJ&T^CEGYGDD9ARO]W6
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M"H85J7O>_VS+21"'=?XH[V#^^L(K< /^1G!,5&S@U1^2(:1ZDMEKLP_XGMI
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M^0#>-@G%DP2!A>\^+AC67%S[[_J"WYN,7*3YVUA.=95L$Q->/0'V_J#1L"?
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M;:64 69G*CJG-V8 #H@UJV% =FQ+)_/=<*I.J/FIHMD#R2VJ=IS7*8U=1>-
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M,2O1J4!0:M]&U/.'Z_OXZ<]AYE)5A6710<U+$#RS-Z_BS8JXY""L^#(*B_@
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M,\XFJRM6=8%DXQ)(U9$1ZMZ8S;HO:<A=Z"(Q>^/B>H&YNN-.*QQP4AD,OX3
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M!Z[SX=1,UF&9DD#P*(KK_S=5K?^/!C9NO"</*5HXU,#B$M]222F708^N:=]
M)QYWYZOLL91Q7T )I=J(=^P%BV/5G)UA%[>![?QO+X4EO0RZU"WXMH#$L@MZ
M(0< ).KYDR]4]VZLD9,K_"!'7\V*)P^LO8[%QL#<#'MXU_8@$+D<JA4S/G_A
M1IU5L4,U+QFL3O&RPJR)](.O- U0\U<MMW 3A=!^.59Y,BBNRW CD=D;)[3W
M_A@I,3?99,'QKKMV%,YQ[Q>&/42@^CTG[%%[",L<@1!_;Z6'Q^*0POK+_Z5K
MW\QWEXR:[1YN([B$35_9F,6H <VT@-;K*XA0"5]]/OV5)Q5Q9Q_57.YYRD3
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MZ#)W?_<[S9'MS\*!W;H1TTZ+D")#R^04"?2L>%2'[)4R%(NKJF[NW9_QK9+
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M>2H':K3>AA->)0Z+3_Y]!/R<D 4'/@)* J1HFH=1L]-&4H\ S\Y+Q_LBNT?
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M=@=T]JYSB"=26%#-HQ\/:(T"[K(->:?YG\?9=YTZ\WBGG-473Q@K]>U1NS%
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M)V<P8$,!JLL.+1V,Q1+GQ0)(V*&Z:P.!_C*Q[B>V*!=59*J:/SH?%G/S_KX
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MFL3V.]9RB?Q++IL0;2\-'2RIW(< _U]SWQ76Y-*V^]($85%$RA(,16#105%
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M35B8%Q9!M]CQZ4IZ4YR=-KD;^2I 2S0;M3<MD#-OL!M*.YXHY:5O !9-&K=
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M[W2L($%-NY,E4BK\Y5+:,:,92 96*B#>'OGH\UB5F/1YN.^FI)@7<*;'F!>
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MB$+C0T?L'T3A'L6H5@+Q*7<C<H>210B):$4*L9"I0 _N[$PO.D[W\!?"O?2
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MM1"FC^ELHOYK*->DSOPO4$L#!!0    ( ,R#6E)XVFZU!1\" !/# P 5
M;7)N82TR,#(P,3(S,5]G,C<N:G!G[+P'6%3+LBB\AJA$)2I9$!"0G$% )8N
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MH"3@(G!7H$I@_C#O8</#P8>S#O<([A54$G03O"=8([@J)"QD)10F5"HT+GQ
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M;Z"=6'G;VT6GWO;J_$K)0'($^\5>ZV 7<NI;UYX&^'0%JS%!\^]*'YN>M3P
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M)8G8Z6R)KVL7^E0+2JZP%KIM.(A=;EHV6FH:%;P<Q5OLK99_;</'\$Y\BK[
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M,24DZ[VW2G;-FDK.#9RC=@.ODBZ966<&> ZCJ"K5]D&9;<3##O6[RD81<]
M.?IPZSR\E ";NJUJDS7,G+M1S,.U?J5(46KGI*^,_"DK%LM^@GM*/ 4'F!LH
ME,N=KF2MJI32B=P>'B @Y3ZFCL0%9[IH$\,*R?XE@K*/!6-X1=;&!GQME1F]
ML])"65KC3^M?-1:JD["742R4_B %1.OG7/+ZAW%06[NVB.); WOEQ24^1^BP
MV]6C7S7DY/P^+Q'PP<'GW]2:W+B\[UE&6KK/=8Y F0@&S>> =W':^X/ C#\)
M_U["WW<$2-3YS$_4@FT<(VE1&JMA%,E%OH]$*Y\%J;Z5V=W\YS,B"*,=%W%/
M-;N91BUUEE81%=$!UXL>SA5/-2;1S,(Z7-MV3P"K/];_ZSO;8:0 5$TZ*A9:
M3Y<PQDF];6<-\^NI<EW;F63<6+ ^GIO=BPO*AN%<E#O&'/R.=)@AX3-MM:?-
ML^D+ODVQAQY-\D/=\(ME9IP QIPL4C?ZV*AND%7TDTM/:%NI:%_O\'#+/N$%
M%A4^)L=QCK;QU!@.US/BTA)FWCB(5X <B ^T?M_BS&?A$RSV*HZ0WM,@X[DN
MQM1Y,-F^]N17C)7V$V.A (Q5^Z]@K-])R*4'C( 1BJ':V([O"Y$&H;13>9?Y
MAH?+3G]:4+100&HOS 5V5)14S\Z'%+F?YQKTE!LHUR/$2#!\,U&6@T5FW'58
M8)0J%+O5)7?3]BH0C<IXG ;L4J*S2/LLM7H!G0"]2.X7'W0_8#KN$JE35L'#
M4X0[9S30:#>O8&O&N$I@U2_>T+=.80YMU,@I,K^B."ICEBN;^?Y94-%2)O"V
MX_@8!(77_=1(%>N )R<%O\M:5-%_>]#=K=129Z?!76OII-'<(-GQ^3,H:SG:
MW+G^:WY[5[IAGQ5'PY0U\D#:=79[N2NMWG3.R[[!1#D:9#UA*2&Q<9MNXPII
M7^$Z*\M-(-A5WS*NS\VO*& 09HV[B44R/@N6K,(A%WD"'%0[>Z^)!3.]B7QX
M,B)\0T?11TS[U3RP=)5T1$WD7EG*C"A57Y0&.0PU!KD:A_]Q!K:M#!,'X)?(
MEBAU-0;,8R*@?P!-_)/PQR/\M0' @S#2>\K#1LHH\?4P#<*^W6\*KXY?O-GV
MFGJCUS"K"*D]/3@8^'YPX/!=-G1T9LO2C6<Y=^:LF18+-V>A+?<E[_&:WV<V
M=EZNOF-8L,Y/\G5"62"H'Y=@H30(KPC*U-EK=83UO(>=1[Z'2^5MHF0G=MWA
MF= %4C\1&]<@K'CNP54VIPHASAN "Z>7Q%<BO;I'-L6';>"Y326E"?R72+;P
MY6%2:P*KXT1A*"-_:%+'1%I0'HL/WT[LW?OQ<@E@KMJW8QM9;3E*@RR.>B3B
MNVB0.3)VA0;!(0#AMT?%H832Y()4HF!<J4$/3$-%5]I[G4(N6)DZVV+?<7K3
M <]'4T4HR.7\&!J$0VPCT<W";D:<KH3L_Z+SJ4#Q*N_6QEZ[49F(B?.R07A;
M>H*WCT@41V13GT*(]/Y'$NL8'E$P6SY-4.K?C%?I];3HC:8$*AN]SA6C0<RW
M]ACU"J\GYC2KVQ+*E4JM"F\_EW:2MU PBWQP/U7HS!W W'Y[]?L8")X10F_/
M0J>Y:!"_TD$4.1NTW76^8W]MUA2U5Z'C"ACWJ1TZ,I38H/^?;3XR?]N.@5TA
M*)\M)#4MOZ&_JT/&6%K_H):F<[&SV@7N+.XYBY.A,I>%KH141)A=.2,-[GK?
M05I0N/))0AZO"%KNW9^HAYRUV+VJ\_1VY]SR)0<)QP)R<A(BCROX8>)QG7>7
M2H.0'S12"X740S>*>T^YSG.!N]41QNSXD"/K[XCE99:E%JH>Y^>&/-L"LF)+
M&>(7D:.2"V&U_8JK#[%$O>K-YF6YE,SW61/"W5W1H_M-5XN]K"H3%@CZ2& 2
M+^G"44QB7-/!#U;0@="KVZ*["G-\S=1%&L3316<G[L7BRH3QR-)$\!C9<8_B
M?H##KZ7;L\2805J'*F_,%%8W'F7 ?P4!</+V*HID1^&E&K Z>MGQ^[ )4'U*
M=LRGU\2#W2=HD"Y^FVWH6F7[<6]%<^ZB9;*^>'Q"7-W!0JZ@T,<A^4CM)T=W
MC&;7_TCFX4_"'X;P-TT!.L47\5-C%#PYQ=U"G+^L^B1%?"FA8:2K6Z5<_$ A
M57 SCSPZ[&W-?7VMV-%"5'NN1DNGMUASM>Z@DL2RMO #?>Y,]@6"U>W5?NHY
MCHWS&5).FQVN'F]&\!!QC0FIMF7-44/?[K%Z<3D/&L2M8E.[1W%89P^*\"I.
M&][J#WH8MFB#Z8KKMG-1 W%;,_Y'!BHB:F]!Y?L1:@B^P9C:\//L(=%J;,H,
M>+X;K !+1:SUTR %'8 Q9CZ=0&Q9PTU\O>U$V+>VD2HF@N90.775@TVREY4N
MYT=N:L:W2VG9_F:J:KPA&8'"G-Z'(SXQL@/S9]W[_7OH6OP;;7_3$:29BM[(
M@?;_]UU><QJD&327OJUYXU#RZ1)YL,IHD/T/) %_$O[_3/C[P];_SH(3+27*
M!NS7?+M-(0VRHP-^VA\\I5&=#ET-A)&=\C9HD+KF9?X%&D1JP92\\\\.J/Q)
M^)/P?_W4VW]&.Q[]C78@_I=VT/V==D!C#.MHD.H%T^#_:*KD3\*?A'^-\->3
M"/)*.]4ER,>VN<,#>[[ES\FB3Q<ERV,(Y!87^/$!^S+)TA*7;2G%/(1H9/['
M-WX)L0DWKD4,K&)^'JWQH5JA5_-186Q1>*2Q#NJFE4#5V:X7UB-YIZ.J''$Z
M9\MQP456X5*21<2+1FOIF/JE *=Y/;WK )QJ"3<>^MC;V8*)A3DOE^90M5&<
M/-5Z*#[46R#6=KRKD#,ZNX@*-G34J2YBZ,K9<I5J^/Q]8B@^S%!-\-#)KIE,
M03[]A]<H+^$@JES_L#(VPT3IW5YQ1VJ/?:%!;JU$#53RG2C!04_YUJOMX)_(
MR ?5C>\$FIV6\H[DT#<+NA#"*4.Y#FY(2_-3)+DV;&F0JB"/!AJD<VL NH)R
M!R%L*_['#1JDG5PAI;IBN+7*-(VP7C[=O[CRO;R]B[@U5/4Z%M..R.T.KFNU
M(=-E.PXV?W4+".BY]7"P\L&6UBE>I^?]&M:K&NH-4'#SC?S[^?7?SXE&T" 5
M7_[?=F;]+UYX;\>=YS\:SO])^-\0<E7"T.W\I*<4L1$&_?N3HFWL,8/N+5!=
M*7'^PM5!@PPSA!+^0_HE%>GR$E]M=?/UQTV1WZ,+Z3]A S^7 N\*P[.AXDO7
M4TFZY5DE%@\I/^8"EI?R,2F)=7:Y!)TRM^"[\8V3U\AN%XU&ZI&'#A^VC3#H
MF N*?'4U(K@3%()<T7_JKZZ(SCRU9<\9(DFN#0Y/6&RU-]?4ATXC?2@C989)
MV#6!A^-W)IN63WV1E+PJ5G0FL4706ZFZ&IC9-6%8FPW)Q+1(#M&)NH5^NS&Y
M]2Y%>ET_\UP01ON)_ZG3Z@8573WBY_:GGA<__WS?)4#,9[>?;EP(K/5KL'C.
MK.CB>"PJ):-QW/&"V[QM L^-X.QW*O+&08UJ0K42@DET%PO$>6X</ =.XJ/G
M'PP[_$>KMO5>H&I:I8S@U1%$CF[HA1(7PT]%E*HEB69$S(UY/9;%4FVGM^SB
MCA8NBX^8=<[TS#@,F^ME'*Z_KA??&YH$-OLI1E)5QIJ-RVF0N(PF5S&+?,<S
MSC2(GJVBX>GE%?A4X\25EHF*!8L^'9:+SB*B9PJ[ X*0-P65#D,O6#\]1\1P
M7XT4L]9[?QX0XKS@S\9O)>TIE5+7MQ!?I5()AJ\K*\B82R/RWFW;<)VST02-
M-AQ2";[50<(\U[PS;_JJ4)>E*2MK/'T_O?T9\^,_S1"O)RXPI952MTB14H"6
M-4QY/4(8V'G"0BT?;#H34C0>:=%%'M9E4A?B2WU2LW.0'>3U9ASU"6PU'#V5
M74'EV+'C!\QVD%;5W?4,NJ*%'14EN )\::5M03Z>$&?.&9V^L%A_HABIC+A@
MA=S_@)A?0>]_6[A(1C7T[?N),& 2<1TUZ!!<Q@]4JW'0V-5/LBG0C[-!4X.X
M[JOW);0ZL7"F$Q^#V.9*!)V*\T])^W+X6R_:F1Z[+"XC'$(  _I^PA'HAX:I
MM<V[MDK.["I,82GIC28.CW>C;>Q))SUM>33D#._K*K9=_-3"RAORB)7!C"/\
M YBJ[.GX_8F'&=)_Y1UHD!?U!_Z[3>?_:V35L@S=V_D/IVC_)/P=X1<5HB8=
ML/J+>R&#^ODD.\K5L<%3;T0")5YTA!,ZBPH1<CB;4L9[$=;F<Y(A90(=DPWJ
MJE^NV)1GWTC3RYJ/5503WMS$%DQ*]E=\8[=*SXR8R8S4G8[ R@MW210V-I!5
M.$/E:9!SH!)\84LQ<S*7DST=]":;\T9%X:?),ZX'P2$@841%-#"$)2G\,E\Q
MU1 E4+IM[+798#%I'W=@ F^R<GPWH'IR_B;9^/(WVV5<XTPV\[RU2)^1"2.W
M-[?/!Q-KH_ 'WU1=*6 :Z](_3)'IT&UH4$T-M2@YU$L(1%A5F"R2SYHEUC.N
MQ]-.Z7$Q\^FV)8.I*UNL2)L&@^;QR* [61@'9KVN@"?)&?')\AA%^@UW 'V=
M(TU0FJ2,40+4@:9M?+/40#N\P6V>5!)E;#*_(&"HWQ>-:5!C'UO8"[Z8*W]?
MY:(\O;KR@PAGF8.]6(;;_%? ZMIS8-Z_!L6=/Z.U<82DXQ)TGJ=?O$4(OWL8
M+WIR+VFM%#EC,U^Q@QSG3M-L[;,;L/:80,Q4*N3+QS4\N'*NX9Q6@Z[<=&H<
MP+_\J#J5,$^E#?X)O(9'_"QEV**BH:PD@GU^.$(H1V#2?ETX/[C=+F=)4CBT
MX?2CLQ^\LYE"O>^:/I[/FI()Z3F"<%X.8/H#B.!_E/!KR:JQ^ K10 &^;]BX
MI6Y>68>,(3BO<]RJL<#<@:WLAQNF(P4:9&=JN*F#!; 7G8'F,.RY<\GB[OE.
M"-2/,^%D*R\!C^GL-#VU2O.5H.*,]@I9&1,[C%%U9IA5SH852S*#AGD 3^:<
M"<>G7A?@XR]^%J=GEZ-^,.!'^18[=HY1S<S#B"M69N[\9!RUJ6&$Q7C<O42I
MD\)$Q.]J*KG=)DK-+&EO]X]#4T#SUPO.X$<(I>;'P"8- I.R[]X*^\*E+[UQ
M9+)2TOVJH J;<!P[WVQ;>K>;$^;AE*;P_H^)(0PO2](._YRJC<I[GE 5/S2S
MAM .JJY_8D:13V=E5)X'_Y[?P$0&.=IT@Z^+Y.QZ@C6R7 )$,5]^'V*?ST+]
M3?G$MC%UGOC?=]_0O^Z^(9EFYGYVYON_G#,[;-@]XHE8F\D2AU:)^]K3($YB
M^5DB<-0G\1-.-,C1#@L:!$>6LYE \\2WT" 'AS:QY2SX0Q((KN%OG6U"PXKV
MN#-T%3L/?']P;:  N]1JX;%,+2':K+/N":P8^A9W>\ K^7>OKO!541FPDZW2
MKQ0SUMA[AN^(R:_H:!PT.FXU&=>;W9"DZUNQHZWSZZ)AI>QH$%$:9*J?4E[:
M_FT!$6/,@?\VO346I[13WU-#@R0;K2_RC^.,)+X2F9I19^>KBCZF>O<Z===]
MSTJX6R56Z7:\ .#9BA/>?@O?"$]="-J<6VK86YFO'AXL._UY@=!-X11_25VU
M8^L,4LP[<9-RWDF]T]1*8G/]"AIA*'>RR5-0-N H^P+A& AZ\XRJJ';&+3/8
M:C.XRA2Y'WV)R<FC;)!4M5$J*JJENF7A+*?BV^:<)^:10$S*7M1K*V7LK982
ML^K2,?@A&^,U*N+F\QCL8GC[[X4D6V-Z[.>BM<1Y+)TN(46L0_=.(PQ)Q6,>
M=HH_%ZV&RH--:55Y90LL6O;PW>:'-W64)(Q88B;BNK,;$K.ASLM!&3([OCH>
M$7-4W$IU^ @-,J:<OA28'S3J?@  @(=&Q!V)U*$6CC!H*/40SNJZH&:US$&B
MC>6/"%0Q>'[M'OX/9(=^!R%ITN99O<E"H49._F&IH/02TU<2896:'XK7>05&
MK!WHW^K[)X 9@56#9:,:0CQVN"IE2'^#1PKIO@U[BKBYABO2XI_,:H$;]I99
M"[E6!JRS1KIB+$)EG\E?&0D%'+(3ZZ\?L_]J9O/)U=8<P:PFR?Z([D-RL\G\
M7'ID;')LB7>:=9;UI<R7V?6SLSEY 1?.'+T$JJ_GB-=- #!74 4I3LL&BP(:
MTV1$LIM_D:/PJFR!]&$=KRTJS-F4P^?*)TU=#$'KET_[:P&&W"_]WTVS&DZ#
MK)8LSQ$&89$T"%VU>(NFQC-;=)"KT6QB\KU&+D)5VF",9W!4%N;X+V%U<D69
MVJ>>$+=:$H,YYX&W/*1!_E;SNRRH9^^.L:)=/>1(R+4=?@GLX],?EG/]JT5R
ML.<[),(U]X:Q-G."96[&/ Q^L=R!Z=:A%SZKW51<U]<, &]@R/\?)"_^OT'X
M:S&@G@\-4M/@=7&9?8=J'&^VKF]A8EU(0OM*H@VC"$[AGW@[Y'L,:V7DL:5!
MSZT0'/2Z 2X#H4_>?;%JW;BK^09D9/$R#?*&A+IC28.$ES:W3LL5W7"\B_=G
MHT'>?[5CWZG[GIC59"%2ITR(3<]_NATY7-/ :Z6CXYN0EQ>+B29,-?1I']7"
MJ,<#JV[\F#_(F$=*A%(YH!D?MQ:&JYC E<AHTH<UQ2SL=02U-;VWGN#N5H,;
M*"KRV-\V2XS7\^=2.G1/V('G:T[ $4"N>I64;C/<EC$S>T ?[O3AD8:6E@;O
M<PT-#6GF2#>_]U,<:F>E+5PN08Y= U>C=X8TA*KYX'63PCD73^Z!T;LCS'=*
MVTY-E!;&.5IEZ)JMB2^8.AG"E3]V2I$7[?I],ST<)BW/3L8QO_)VG8_-Y;">
MM[1L<@40+PF(X_CHWNM/D%YYK!,7UO*/J.C'9R]Y]=;VNC :Y6A.*O/DV0,(
M(&]@]"[&5^RC^@^K0@:N%NZ8F;6:B_*"8P!'RGAOU:G0JTK3/Y<^:'7R5HW_
M1=4ZEC=!UU-^V8]YN3^3\0!8&).3\+NS:7'_-)OVESTM'GM0CWZ#?^Y\1$I:
M#_2ZM-F_:V 70'@#JXJ^F>>RNZR&/4J]?4H1CZ)H?C/%MWE651HCYGMW^T:
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MK]7U7,!\Z'Y=3N<=H]F\)40X#;+Z?@D=F];QS*6A@:5B7C3H82(!=KK:?"6
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M7U%.7-J+*B6?S\&=1_0OV2T5EBH=U.5E_/'%='Q-2[5?O85:\S M("?D81:
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M?3] 6ME IR_%0178/U$JY%7UBG?B(,4'RNS:B, J&94N^*I-E)[K;NE1\^F
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M 8KWR.;^5)">D9\>KJBD?43SIIP4\O1WMM \1!:K/_!.V7_7E?0;"']HH7$
MW95]E[]"36T-%@:]XL3>NHZ11[R09JL7L\WIM]5^[#Z^8GM%3\RJI4C^<J+'
MH3OJ)B8F-@>(D _'8H1W(ZJ25D;C+Z>@GV]K?T<&)91_8(G_:KE Z? ,K!T,
M*6A85OI:9KVA:;SI/IO>K.;!,)F5EG6V)22?#32C1J%3&!(?EC5TZ+TWK 7^
MBL9YYXKXE7=$G]T>GTSE<M?5^?PWLA?S#:O';E<V"]C]@I>HD]A6LT&%W>[^
M#+;D9]R,HESPP56C^ZMB\VHN>ML&3AEZN4PZ?A'K6!UG"80^6\.A9")#N099
M!^.=S@8WF6QXZ*1N'B]A*+MSEDFLF?YLZSD% .8-M!)5O(67DV892?52$L[F
MPRFML]F;/@DOQQ/J*Q.WT3C[G!&/>3=1<[@$SL6YFT=^QZ&=X69<LF%.I:>G
M9:N2&!@T*N(G\6K/=B+L^3]JP(YSB?.(AA'Z!W'2?55S['V$H86LFY<H_9T:
M9IL]<(-FE8B3>:\?:3#H["G(9619ZYD%/OE95I5/HQ18R,1H_2TTI"H0[B+;
M3A=[A\0GPT%7ZF;QQ#E0WRPSXMJ3$$DK^4B<3RP?.P>:+?SRQ]EC1W,L&\RM
MK29#AR<3U %.7_[''==_,E$439X\@/U@@LR?])-#@%/#.LD=V@X(0]@4B^U!
MN5*Y[/^4LZ1,@^(%ZZR?'L2[$LVZXAGM2;:+-0N$!2Q.-&P,;XKBT/=8SM_7
MK2D?-S.[24XN>RX^Q23LRWT]M58*&QG;CN*,C$PISN$0#F]FX06]$N,8^U:*
M)JP#D2G6^C6G$CV1U$+;'COTA7=G>JFC:P@GB?-)ZAG^PG56]%@3;DAR.RB6
M/RS^A$%$S%N++$ROC$H41EOA<DSE"0Y  U[=9)H-Q#=1Y* L7K+/5^Q0&_ZI
MJ*^W3^B;>IO/5Z<.5!WV<8TA69]L*\?4=PY4.QREU3,9*ZA4"/K::";A_/EY
MOY+XHQ*-:^"<IW=&ZTC#E^,&_:2N??X9&7NIS/V$KFH8NB0>Z7C:3.-]115/
ME<VQ?FR5.??^Q:=9V9CF+X[',]1FN455\O+::H"S$7;+:!ZNCOB,XOBVK)1>
M+KK:,';;-F 4M\_C^=1!/]/*/K\Z)M-:(H/&T>[KM'KWH*I&73N##)\&/_T;
MA<IH-C B=G8!&@"EDQ*<N[6?-!780(6$&D%1-R8:"FA@7SQE4RJK<IP^M%T>
MD U_<L.(KUA @X%!R"_E>B9]KUPW\:S1X_0C !PT\_D#1UTH6"$\6]^<;G([
M6RDE2U(F].-I'%=(\M]^B#*Z;FEKNY:[G?"S;KY%^[K!##7&79,2%]ZGR#L;
M=^D"C+5TH:\!L)431&,;QH/(H7U5ZI^J3DW)8E9VN\5/_\":.!?@%PHJ1LF*
MI6>&F]H#L!;6+DUP)BDHL\.6R_D>%7("L^]QT\CKGUE+@%5>4:J7$FL6E6)1
M>U,YKASM2S>^CFC ZD4*ZI9PQ:^&O?AMI[S7U$DP^(H/ZJ@P+?T5>;:H1J5#
M-S+,RYHY<5[I8&#@<]$8>CWG<2<AF]2WC_S1V6X45JU=M@=]1OJ 2Y!G]+"3
MZ'RZ8M=;+(;DJDZ-S17W]UC1F]^]-=LMDB!S199/*40!6F5%60U7E[V8$@O<
MS/!YP(+AAKZ_B?(PD>*C0OAA[Y[;>^AIKYX\$T' X8I6+^7>[?P:.D1/:(OK
M_USW12O2>A0U>J("OP@'KD0M8-*)42&" (K"<9&^B@;B<83&RDHW1U>DAY:=
MK8AL@:= >:-AQ\(-5*TK.\S4_F/YA%+ 4G##M&,T82LMH^$V@UI02]#"+SIU
MK9R5NXI)A(><3?FX_B2(>-7TL:6F 6,N*26WC_"BB7R,1G>YQ3.7,X?WB\\L
MIN9D:9SOU3!?*NT3>%_VBS7GU59!;N"X2^=<23<)'G@3\3<X*"N%DV1-/%SA
M2F'[\9PIN,J3)[=*7_Q5K;#IAV-UD[>P:PQ&JDIRUNPQ3DJG@Z$1PUN+Q@ D
MN%M($EK#EU AU58D"!72(TI8HD*&YGZM&Z(5)^6AU_00$-A6* 7X\)T[@)1(
MEVJEZ &P)!]ECQTGNZW33$C5C7N)"R)'O60]E]%!U0QE*/O^T=MQKW,;YUS'
MIFM_/,U+SL^(UM+SS-&-U!D]]O (Z!1)+?Z=>(7_04*]JH10D;*FZK5Z9:73
M49V"\6PJ=0'RIDZ$DY_ -/'"5YVMZ$BFN9G=YK%MHN#09BO'VFI!.RY^EU5N
M.UJXZ^G"Y@<K;@=]DTO"NKR?=2JECTD%734+.V[R0%,3 ESC_PC('D^0&?$:
M3*U2+Q"/S]_4%'<J$LOU6@FK&_98O)6K^69T7U;PC-N)\!=?6#4T?WXX^2,,
M5 <U$HCU"N^GH4?0K=S5Z<=K'B)G&<0>]EAMO]-:.O:+T?P)CG'P)0N,MIB;
M."G;$1' B3=F4"$K1@?0M,N1@-P?>"A+A2A>B ?,-\2O;'"OS1BQIGL)2N;5
M@U/Z*>"ND&GX ?A:;6J*V"JV0N]K@R!N_&\LZG0QZ4\7=?NS19DHL#D!*S1@
M@7;_\6FMD[#_\C2!MW_Y-,O.Z7%2UU.*'6 0.!E=7]A3,/1'THW&UP-60,5Y
MUUNN7GTLF:B;\2_FJ)"O5G[8":DI B9XQ;?QL[N+1U)SNN1@9=G?]BYI!)*V
MGN%)/HN,_<^41VT$+G#JB'-R'0N7[=T&7G4"S LN\RR>7<$0_ E[I\:1^0?
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MRPS/H6M1=YW 01>HOYG)_?\/PF0KH!-E75SG-CTIS[RBW 85C2*^>7]:7BW
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M0YS3F:^M=BOM9].UPY"=!J1;ZY&?%*^4YH)C&-$3K; )TZ3-55\$%;*0Z0K
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M@BM-3DL+,)"WL7E,7J<E\S^^R-]VZD<1!U]13!/:+QUHE"2GKD%WEHP72(#
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M9N.3W_/B;+FIGH\;7^S6V528OG53KKZ=Z5[IB#\S#(Q-^G]B$'&2#:)OLE5
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M<3MS,+:F!_[O*UM*5@,),/9[6@.VX+\F-7R5_+5% GBOF!U02/2P!.00^$X
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MOUEA]*.\QML?BVS<K9=]+OO/![6FG>$C;WFYR<^TS9N&) "LD:R_]WX2!9(
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M9'.V;_U6H7:,+'?\(/-C.?*<R$<T@+)?;OW'L.6_5DF_1%CEJF\CN?]=XC-
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M(F<D5.PV!@3BOSKP-+V;NY/S(JP_\O,28^<S./<+=D;V^&L@!J!L7)DO *C
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MK1'L"7A_D]W<HV[US6<\0 ]$F#B44KLT+*SU:GA>79'T*::[]*N7[(W2J9%
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MF)V=TZVIN?23H_!G@;5-9G96=FZPN(^!LK+U.Z'Q\>$GIW-<LHH8V4$@$!5
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M[4:(WEAOUM3>7&I#N_V,8^];*KJPHFLBG?>E=IT_HR.D5_L@\P X-Z9;/R?
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MK?@'W30V"^]--)M)TE8@/0'Z,Q_$5 </ 'N'F47A=;H923I&O2P(SQ*"FZ)
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M*>K6L>L!(:;-FY$K\OK<<_/:@5')9:>:8+\T:,?^#L=QNY!UB^_D*& W.XW
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MQQ]%8&!BI50!$=/Y#;1G.%,_= >@7676U#7S.!"PEH&QXY<<XGVX?:]^OC<
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M9>Y0-4N$O=M14J]1]GJ^PJVGKFJ,K'596KMGZV4KAP(A_-U(XU^4TU)".(#
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MT_BM])/4'*;\TY[J)VTWY[< %'OM"Y0D718$:^ *90JQ(+K(:<E%#$! "NJ
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M=9L9Z!GI9[WRJK)K^9:U.&)TF%E4A_U=WY-Q0[W61V!<L?&^>B _05Q@B2
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M-K.[%6)Y!T<!@^:0J)K(@\;RE_#9# H/@ZZ:Q-J07@+L>Y$1 .Z%_.[?NDM
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MVK^1^3BN)^?UJG]3>#.?K@3Y,+-6N++F;)/^W*XH"JJY-52JG27M2T2-TLX
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ME+)K8KZI^1+-E;5_UERXA'?;?GOARR>;!W(C0^Y]M>UC8GQ3Z2[C6;\#")Z
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MJ8#I9(*V>1@]HI0$]&ZL+AP@O8/^>Z+[TB23_BF5\OWV@P4&">8A^H;*,7F
MV-@>6QI;@G*S*F @(7^!-\K4(FAF:;13%F2MN0+(3+DQ/7#Y=+G_@@I[R3R?
MOY2.OWV1(N/PLYGZ?E>WEPIJV"RD9!)"N2#,>771[V7UA?MN6RW$QA&MH%0
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MOW.N/Q]:NB;-=S%!66DD$Y,(?TQR<6"OOF%@QTQ94J#>_39]=D4N-]6S!HL
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ME>Q>ETM:_W"2V#<9O8W(K+J"ZRU]TY<S$[#IB+M!X:=CBIF@\,CG^;?[\MX
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MXL?W:^2\#U_K<O%W/^P!A[7VG-7ZFM1\=VIK_M7<C. #!I71Q]792@UC3E<
M[XHT)F]U.9,PV[0?0U.DS7X#9T6.3G#$:%&OCIGA=?9+-*]SI#L:J^,RGB4%
MBI(RM]T*8U&Q89J@1QA6&FS^GVX>OL-Y,4&=2VM,$%V#AS5=RJ>==8C4OQJ>
M" %W;/S(GV&TSLSP]R\!S$CGV&^2T>I%_0$G3L"3, PQ.!"&-E18K;:QG^&;
MJ6":F]Q7-%V2)L$$P8=66!SV!$"M_C:($KW"^*2PP@2]5L*P"-W"OW6D#3"
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MOQ[_7/Z5UE_IQ1#&[-GH6T*U<2=U48ONG(/@V9WS[7EZN7?!SC/L>%;+L9M
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M32I#(V(9'Z+1"I,7#/5%5&LQW7*<TE*]T&=:G[9?VKN]OI _A J\?.5I6R2
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MM>Q;DT0"G/YZO3!@C);6W^>II#.:%G(#XMG[1%T,*ETL5_RM>?;5#F>\>XL
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M]GL2#YF7X<V_2T',BP&P$D($TWI8+!2-%*3?Z&>,1VZ*;#'HT XF:'*[EN7
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MY0F0?+/NTK/ 4W(0&648;/XK"7=%WK<4*TM7SBHDT@K\7"8(1*KVVUH:O\V
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M@Y'#S9(;H\"\*6%.N(J(B_%^VC[@K]S\._YM]YN&"@X:-<U%-YBX:S)*B:C
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M'S!4UJLD"!$Q8ZIABL\=QEZ)?BLC7=&8F".P[( 6,+ XF>A&0;#@=*S50KW
M27Q'A9BRVCO1:'>ONNH^X!0NJ<RBDT2#JTP.=&P@"\8HZ<$.XPZS,ERUS:J]
M:?RCC22;/JVN!UQWT5[WVNZLC3+SYHI"I-VY%7;&[9VGL#[6SOQ-J&Y 4MX"
M92RW47: [Z[US8Y>L[@?^:8/J-J0]Z$IAZLS-,OWNL@3IDG2[ZM"4:6F>]13
M))DAR!YG]CG&F?5!76DJ*[3IL2\EV9 ?\UB0RT.X@ZOS.2X014<%#5&4!!8?
M\QM[CO6<P+3#P$EER=H'7/1J:,Q-.+Q"$7:!0\IXK4KAL-_GA@H_1MK2DC5T
M'2HM?"IZ/!.*B@J75MFD<BFY:BN89_:LCI3Z.KT+7QV?ZWN51_ C3*NZXSZ0
MI?W2GTOM,@F7-4=HSD ,%9LDT"!(4+)D8 O'>T I]ZO)U%"T8F*-%IS@#&9Z
MOO-E;""6RH2K!%I4%&>Y[5O\*)X WECKF1Q93*"N#2-P8'LELO!B.A[VVBBV
M&!603')BFRT):-W80P)T$F)G-I.BXVFL2MIP-+>:D"(E'(]TVS(VX18S5@D+
M):Z*%>9D'76EM(&-PX3<RB*52.?ECH8P4V#B86Z+#18[3^ER52:D5LS+(Y=?
M]=-*U!;EI-72.K"79[P@9K-J'HS'>3KT@!&A81V,2+0<S+,E$7DV.*R3F=_G
M1,WM[NRP0K7(LC1S4A@C<$&MO2!3$1DT0KD5"8$Z6J7M"()R+&+5-6VN1Q+A
M"VE"*\!\4E-=LJI@)6$ZB.>[&+ +#I*&!5N<:@+6?"3D8P%=SF+0BA,8!G"M
M;EFFD.HC; RIZY:><\/1..KWNIXH+%&;A%/;K"M8*&)ZS5F[:!,HM+AMLRIG
M;^9S "^"5=#;\KPE19LRG(5"A(/I%+2XD0S/Q[B@=/OU=H(GAMHV3#SK1XC=
M1XF257*F-/<!]6(>F%"H8CX^,SU<%::%9.9,K.@9.25U0J11'R>8G(CK@:"K
M'0(?:1UH+6BNQX%L6-+>1JFGZ2CUULH^(*S/"1&") CJP\)L(4U!S42TX7CD
M,VF-JNR"CD$='>"QOI@Q]D@8#T0<J B!G"^AF25/O';0K\0)2[8R>A^P'DS%
MB%:].40"2@T)T$*DU[45! X:]%!SF1@8SJ=%0?!.BVU17=MV$V6U;J-C%M#7
M8D6D ,()?36#RYVGN&0])9Q4G-DK H7\8;T(%C49R+"O.?$FG3I4A^DI=-=<
MKH@A/9?K$=612(7GS<TVT[?21LRWJ >EF93O##OF'65)D V_Y.O-QETD;E0O
M,:.-HCPG8X.>S0"Y&(:NJ8M6F*,9&7'P9CTQ2K,=0YME)'10BDD25Y.WNR8/
M4:X7UTD7,)8BD_)R5,T*4<M\?>ZL%9X=+0NRC$B-YM5ASP?:'L?'P[KDN:B_
M720&D./N8(Y;$SP8,_@^(-W+-RW,&BQ7HB+F+;U3(\A(VN:( I3:D**3510J
M4J0'/I!.!:0A'",/C(<YEW.4/#5J=UE!R_ZV,^(Y<A^0V%:5D?IL"J*ZY.."
M#/(HT&?-<"XW)E9 8@02HJA#1*HM^])L5*W'%.Y9)$CZS7P]*+J>Y+B0LBZ4
M\5'#=@2T"OU !G"RTX9L/XXZ(;\EE[4U-SP B"MOM* V_7!3=T0&BN%< ,@X
MM&8\K-EAG6@QOX&##H:'S"YB^ZS7<KI^ULS)/*?0AAA/PJ'J.(ICRC4ZM[TU
MC&A8+A;M"=Y)5X2$>+ P*4=M93#.DR8J-;P%C[-ZG:R#?4!K)'6!M411'7T[
MCY QI\U R?;&(@E7<J*D0V@#%080!KA/\JTY6/;S8HVW_(H%5PM^1"%5%QY+
M+BG.6SL[A+!Y6R= ?35'B&%>Y\NT30[<^1:B4*JS;AAE6R<MM>#[97>!)& -
M O76JH/ +X""U,# %^?SUMPBZ%4![@-Z<%4F<R;W)^6P/]4PQS&[[%(FEIX)
M1PTX%TJ='$QK*LQEDJT0'!6[)C[*:G1FK<DES!CC<K4.(16A=H/B(<,YRP!=
M<Y!G@>M&:W$6E/E,83&Y5H-E>S022V0J)1HKZ3RR!*N)KZY67FGX=8=:R,.D
M5Q'*5JSZ@=?:!\3A.&*=5DWJ+C?NP:V!2!1Q.LV[O3FT#A%N"=1066C";%AD
MT5;8;+8"Z6S=!.T%*+>)N4$MNMZ40IV9,=L'G- $!UDS;N9:^@!<R<8(*(VU
M-*GE0=OJZG SD@DQ%7W-\"K$4)F5L02AC5Q)K$@MLV:BPA;V.)P'PDK?,0?5
MG*][*SG3.F[>@SJ:4E# .L4(&E!&VH@'-E-3:VW H;P&ME3HI51@TU5NI5B>
M5& -%[V>/V/*C.(GIK^K85+'13TQ>V&"VJJC;J93<-A?S =ZBY@CDS#N]3>3
MFH$ CZWK$<TK2$%5<(JKTECI*2TPF"?6<A9%65J&NWA8C 1X86:>JD1%(()Q
M@LY)PS9@AS>(,IE@HP*<R8/AU-,G-+V<%>NELDA&DRD3FNE2GXC6;&.;O5&)
M ;OP-7>D"4FS VYO1<><RDI6-T'5UN%I.@1:X*#TI>5H.J0SH =4+B7A?I X
M@MZ->W46KT.VX<I=RY-1*SUJ-@F!%6JX$"PZ%>7!AK<*,?!DREG%S&P3"[A(
M(-RJT_9[T4S+:Z+O^<.TXF5D5*+]B)EW7:/@C;Z"-[/&SI=M,K?6^=+!UKQI
MKPO-@9LJXVHDMBB$)00@J0VC:B]J*;=62@<,N84LCA!)X;I^OIHJC-B(%662
M,M80JO8!9VX3!#6("/0F7!741 =<DYK4 NN)^ (=4Q831I:H*IQ<6J <++;^
MN.MK QL/29(1\E&OA?!9NUXC#+[CV%@Q8,-MIF['[(16=(Y<4-UX*SI1MARU
MD"&4,HB!!42U;8@/80$%O(J*?EO4Q0EB&/4@69J%UO?'OMQ9[<RF@ )1FM>I
M5>#3W+<)@>HZ!8 OR:E0N"PF\F. J%<MC2UZ7-<$+2T4 (7+%EV7IL?=]0A;
MSF0 &.5ZN1WO T8J;G%62U@E6[_&(&DT+#HFW(>(L.%!37].V_::%-9S(T$'
M:\K%!943++C/H@;$ME;+SJ03NDM-VG3G"KNCQ,M::C?4)IVJF*HRMDYE=3:C
M8VEATS%@U>M&%(^-"%HWT2B0=+,3J;0PHE8#VL,I(2H8;^TQ,".-I=7.;)96
MK(%NU\HZ66< 53PC.HU*F2W0U%"@;*VT6KS;,EB$IYCYFJ:ROC?:>EK'%+LA
MN&U;F%?@,#Y6[-[D:,1.$V^!%;.6K\]2-C"KB=$4Z(=8O=W893+JIOAP <1:
M"Q?XN)K@7=SPRJ"R^W.\#3MLUDVD&3@0VQ(9MW?\4&DE2[VMM=464_!Y*VR4
M?S]K1;)0% ,:Z-91F97;@H)[:9>?PB:*ZZJK^($=R5Y&%@NWOY7T:LCAMJT,
M]@%YA9EX$*8HJ[3?3.=5$(:9MI)II>%R(.]4L($-;+O+ZH(#]S*-7*LZ(^)Y
MR='80F/=:5LLY\T,VJJ7PUT-(SM,N:@@PPG&=<.IDPBH#=98D$:9..O2'+>
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MN+,>#F8>->8)B0APL\5O@FR6FWWEZ$(05<SC.+,XRJU\M(5A 3#L=*.DSO.
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MMC*=F@R9R#T>7K"2.EPCQJHLIF7!@YHF*X;5I8<J($V\1H;' XHN"Z:_)@F
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M@0_N?36L/5M19R[AL<D=2]^8QRUH9):(B#I'=L9NI;DBAG1U,C,(Y]QL7&[
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MI3T\]QZ,\=RUJ"I/6%:CEHDDGMQI!M#[T;9F&9[$H$9'N3+(6;YB2>N@-/\
MF.E]1Q_A'MY%\I4J\K?&S92Q)#*\62R?'N18'%Y&S9HFG4BLC-7(Z6W9[?NV
M@A0[]I^P?EKNK>U\PR<VE*6VFH];C.W<DJ4Q[D)X*CXIIH^EOGSL+V_\DP5J
M+=NWOK;G2N"G;O68.J:T_P V[;Q:DN#BTZ'F%YOXUD(<M#R^".S%68U8LX^)
ML1T;5'*TR*^2Q]AVK6C4.2A+H)I(Y45E5BCG8']26=<ML[-B5+BCJA+.JX.F
M3BXTK1X4X8'\^MUX=O>0W6ZMZ[+EHN06#B_O)/.,U)2:;7>JLU5&.>'O$_&/
M(.=EN7[&3SF N9RSAN.XR</@;U@Q8>3*_FW)9:%FQ-%%#7@DF2O7DKF1U$<C
M;=R-Y.[GO/\ 3_U.XDH25)24?PUHHU>*<FXIM4TU;/>V$.6KG/Z'9P=V$M4(
M.>6NE7/2L'&$5.2C+5KHDZ<>LLQPC <3P.#K\;XW0QT"\FY+B,Q+1B269:U>
MP;>,J7+\OMV1]3)@*9W8D2=NSDF5B^OEUV6[WB_5--PM6YVUA2KA23CUUDZ\
M<N$53HYM8M\OY>_T*E%7+]ZU=E5MM*Y6$9.N5(+2G@DWDYNO)G&.0YS)^<N0
M8+/XFJDF3:W@L-DII'8<;Q.'LV,GCK^^.$OUN$OU%>/)5F VF99B\;55.NF[
M<O2WGZBVW2QJC."H]2:4DE5KO-Z=-,6W15KCQV+>WAR[])>C%RW6B=NXVUHD
MI2A)NB?<24]5<$HZFU2JWIR/P1BLU/EX\MXIE%FQ"8+'(\31QS3F,L)/J\5;
MJ6(\W'-(Y.[1UX[6^Y91T)/><EWNF<YQC-Y-O1)=K3PITUT]#>(CR_S'RS7;
MA:G*TLU%*Y"2Z5%IUKT*.KI2P.5\I]ND\?N08CF6(2E%;GIO!GS=Q>2K2*T9
MK_ZY$LD@MK-(4]MH5="H/N.Q(&Z.RO-Z7<C.Q3!T:EU.J='U.-*]'3RSYCMJ
M:X6I6]TFU*-4X+@UIDM2XIQDY4Z7DM86N.YCQES'C6.S..IV)N.31YG&956G
MM3Y46,J+%I;N5ORNEDU&KI# "L0@B)4K\SN_&MNMANI[B[*<X*.I5;EI2KJ4
M:\<NOAV^B]X^:;*WLK$+=N\YZ9:4HN;DUH<FJ*BQ7!*E>SU.X7)&_&\Y4^M2
M6*_R'B-XM,L4%JE%DK]1+$]Q '83&M1]I6"QLL:(@^9>XSF$:;^W>BW*7@W6
MN-:0=$LL*NO:W7 RY1-RY7>VTZ1@MS83>5-5Q:I//'3'354=$DJ-5.<?N6BH
M_G]JKEA+^>1<FM5L>(JX19^/9O'TLA8EKR2,L*K!95-ED<L9%;8[,%'=RFL^
M7VI+2U*WICTU6#3Z,4WV)<3R?,.FWSB_;DYQ<+VN?11]Y./3W915.$G)Y&Q/
M"''UY1Y$X53K\INYC%U\S1ROT-N+,5\A5Q7&X+.<-7*Q6X%QS5$R-"K5*P2R
MQ2FQT^3J?$^8_-9<N\F;MNSX6YNI6XR=%64YQ4M+6+?AZY)_NYL^7_(WR[;Y
MW\T>716Y_4;';RE?E!:GIA:MRE#6G6*BKWAP:Z99(]5J4UN>)GN4OH9/=D5(
M38CLLT*G:.5WA C1I!U[06[?QU^/S^F0UQD$-(VJ%/"QXC'U7B^E:NE""I=,
ML0::2O5I2%X%A8!#[J1LQ'0$;$@(8NQ3^NS%"GC,C4^FM"S:NV:-BM2R-R\#
M)-)1M6=C?,78%=D!C3Y54[   1=/*X6CR2QQVI#G)LG:_P!<O698<W?Q]<^P
M]J))<I?>:K60Q-M''$WMJ6"  _*)QH#)(:0BMVKAM79FM+$HKS6"U2LL0(VJ
MUE"1Q-(3N['N9B/75 UI4LE!=NV;F:GO06&'TF.^BH5:F/0,3_+DB@:_8E(Z
M%I)F7\%&@%*\.67(W9K5ZG+C'6-<?1@Q\D-JN0B>[);OO>F6TSR=W:JPQ!5V
MZDZ ;UGY"^3MB[!AH,,H846JV[UK)S$, DEM):52K6#+N2B-+VGIW'UT53%N
MHG'>S3YN>D^"6'"10*\><?*UVEL6"JDP1XF*&29(U+$>X\B'I_#MMO<:]1!&
M#&8K'9V6U1XU'#=RT4TN1Y!4JXN%=U=',%Z8V8LE++:D4-M'%(K,.YR"-].(
M%5&.K9]Q'C[S9/(TUDL9):EV2BE:N62*O+D'!HPR%D/; C>X?XBNQ#%QZP(M
M;P=7D:P29ASG,C6$4.&;+6ID6O"ONM8BPBSM5K%Q'N;!B5CL0'ZD%A7K [>C
MMF8<A)F<BH>!Z]?"FQ3CQCNJLTEA:ZU4N6+(0[DM,ZJ!N%&V@%OI\H<I]0<C
M7&)6N47&)CB++621O8FR;W9 \:@'MC2"/;?JS: MMIFWNU#0LXNOCUW-];=&
MW<NS?-TCJ/#D:,%;=/[;K-L?[)T(-KMKD*9:A6Q^*H3XB15?)92UDV@FK?S'
M#PU<?'4F>Q*(D!5F=$+. =@"=,:]12S(26ZV3H-CN-+D9+;"&]F#:QM),=54
MJ"9GE:3)6F[>JQQ1,IVZLN@(K(X3C&-S-3.MQ,Y',Y'(5X3DZ6*7(6*,Q 5,
MA9DD;_48(0@#3(.Y=2BK6F(%L[1P]7(4N19'^\%JS7FBKT:6.DSV0K?4E)62
M3\DQ9EK%@JL6EDC[!L.YOX=5]($N5RX.K^497/<CR> K5;2B&I5RUC&0Y2S,
M8VCK7*]+:Y?]OLW]M6[0O=W KOJ.G$&07IXHHZU^7+KBZ$#+/8DE-.*&S&X'
MMQ3V+T;"O"Q/7L[)#Z!AJ@+\=^]!4;#Y6M15IX+$UDT5R0M4"I9H:I^K@B@>
M<,I68B4!?13ON!!_.)C#**S1)8,;B!YT>2%9>T^VTL<<D3O&&VW 921Z$: 8
MY&QE:M6)L;CX,M<:6**2*2Z,771&5O=LF9X;SJB,!LBK(YW^.Q.@'D\:.JNU
M=+,D#B:!'$9*SJK*LD;R=(G"N1W#J 3^[0'-'F82X[.W<[!7N7)<3@>.YJI0
MIUS<FN7Z&6SJ2!*I@E]P)5[%;MW*=P< $ G[5\A7(7>7W=G<I1WGB^&J"IDZ
MXN/OH\3\[_.*S=V_.]MS.SJU+;1P7WG"Y)O-4PC/VIM42KJWD7F/!6.-3Y#)
MSQ8JNJQ6;^/IBW#G;-DQE5JNE*Q\JRS-Z]TJLH&_:1T^;0Y7:M2K<[^G*KK%
M+AP5>QJG:?4][GU_<6]-E*TY/O-1<9MY/&K2QXIMTXK(T5%R[G'DFJ\/&X[O
M'<=/,L%S(5XI:DE#W##5C^ISEF&-*;F6="-@7(9 -QN6SE>:;MN<812K1+%)
M5>;PR3P4>FF537"Q%I7U;G=E*256\)2=%DJ.B;56Y4Q6K.C.1<2LXS@&4:_R
M[(7;BN*]"*M=M9#%?FW9W(C1V_93(6JTZ S/81H_>CE4!QV.<5&5RQ.=UMQ=
M=*KA3[KZ77/'A0R<[=G=0A824E37*F*;^**S2TKNNBK6N-*&:9CA&$Y#6IYG
M#9RG@962)CFZ=%/R[*RB!0+\">YAXTN+&[+(-HY86+1RQHZE1L@H;F*OVEHO
M4QP[RX8_;DS3==S9S>UOR\7;5P2D]$J8U7#K:I5=1C=SA_E'LL28KFDO(0U:
M-!8/)<KBQ<%>425JUB*N]RM*:TP$D98]L97<$. 3A+;7XSBVHRI6C^%JN;IC
MZTZ]1LAO-M.W)1E**E2JPFI4::6K!T3QHU14S9@6>X;RK"U:N2Y%#!E#8O5)
M;&42W/?DI6Z\-L)%W*\4#5IK$BDR30/,)88NR5 '5]<]M>5Z-V4G**X<$^#R
M67[39:W=B6WGM[=N,+CREC5K)QQDZ5S=.AKB=8\+R8SO&<A<>J]F3,86KE;&
M*6&&RSY'#/3>>*J %,MAXQLL9)&Z=.T]VKN'"?A;EX)3<77A5-8]C69=I&Y;
M_4;)8MVU-4XZ7&6'&KBZZ?1TD-Y)XOD^635IJ5"M]!?L5.10)D9/9M15C"!+
M2->)+,%F.Y9II(4<LC1L$9>I&L]A<2VRMW&U.$G"2_A?"G5AZ^HU<VL2EOG>
MM)2M7(JY!].I9.O75_W>LV+X!Q]E>03V9\)3PL5/ 7XTJUJ$^.*26[^)2%S5
MDM65KHT%*3L"B-&W9E78G7P_YB;BV^6;>Q&<IN5_5CP48R6']_'/AD?9_P D
MME=7/MYO)VH6XPVBAW>+G<A+'H_+P6''/,ZDHW*E^JYHRV?9A+U18FAM1OW1
M(%]V*7(P@W%&X(F_F(Y!ZMUU]1'Z5+,1=QUVIMC<M!F8Z<AHV+D-RK>?ZN!$
M,T=N6H?92V!(K.G:G;W#Y0"-$4I3JY.GCI89<F<ODMK+Q7+U:M4A]U^YJ\+P
M8V" )5A/:O\ :E*[DL3H"W&+G8J#G-38JYDMY61<55MX^EVA?Y,)-R[DIF8L
M/FD^4==NSIN6/',"6#EY'-'8?D5/#TI#*/HX,3=MW^V'8]PMS6J5)3,#MMV*
M5(Z]/315X@>P,]^G(,ACC56Q[\,M"X]6T7K,SQ 617DL5&%B'JR!Y%"ML2>N
MF9'@(8V&I32;&X_$C$T*+B.NE>M4I4)?>!GE:A!5<%$65SWEHX]W)([O756&
M!@\2%XQD^/V&R..X_!>2+'VI!;FFH92"K)<[O:F6&]D8E6Y*IBV;L9M@ ?0C
M<J< 2>)CHU)<A0KY.YD;=>>.>^M[(37K%5KB&:O'VR,8ZD+Q#=(T5%[>NWQT
M0%<;5M4Q=CM9F?+6)K,UJ+ZN*C#]#!+\M>I%%1KUR:T03HTA=V.Y+?@0&.'J
M<AKW+,V=Y!2R L1[5,5C\3'C:M0(X+S++-;OY&V^VP):14&Y^7?8@J\1@2E,
M97WKQR#8_P"G-@C&I32S[RU #LUZ6=^Q[#G8[1HJIZ;MZ@!6)KQM65G@JQTE
M$/T<T5J:6U,2I,YLUWIPQ5@C[! DLO<!N>W?8 1N-:."Y=QM3CT^*I5S[HOK
M#C*N/O6)6!D^EAJVFMN_4EGDAC!(]3TW E3,PLK7^GG*F$RFR!'],I#=HA9C
M()/>;U "$;>I&@(RE7QV.R%NM!)D);V0[\C8:U8RV0B6,2LBI'/:>>E0CC,O
M;' C1_*-PIV)T!9"*=',VDFS\TMW,K'/5PEZ_2[8(:D9CD?$45BAM"$]6E.\
MF[=2>@V<02OM,MV.=K\RQO"T*8XBF*\DH/N&RK&M]<TZQ@@@3>WV]>W?KJ,Q
M;X"$,&7_ #&:Q8R-4XX!DJXZO0,<H! VEN7YK4S32;[["..%0.A[O74Q,0M?
MG9OU%I#%1XL!7O36FMS7Y#W.'@J5HEAKPCL"D2O*_4D>WTW9C7 "MQKT4M5L
M?0IVC-.D5Z:S=>B]>F S&:+VZ%UKDB$_+$3&"3_&.NL\L@(9:6>E&EZCA'S.
M0[XZJ1UY:%:>."9_GDDM7IH E6(]6"%W).X0]2*P1V?I82*>EGKW'I<[DZ,D
M-?&FIC1D[U:1I3,DM=9"(*7M2+WF=FC"$#YM^T:CIF"1R=>G+!!D;U:_+^5A
MLA'4K/=FD]Y(P_:^-QTSQ92Q$5_EH4FV?JG4[F@IF?HUJQ7;^8FPM*A/#;L6
M1=AQM>1 ?;6OD)[*;)5E>0 KW1L6V&_P,8*S=V9ITY\3F9J4#SQ6?K*$-&P;
ME1/<#5T.0J7(%AL,0?<5.[8?*1OOIGD!IR>AE,IC)\?C[&'KP7(+-7)G,4;.
M0@EHSQ&*>%8:]_'@>Y$[!BSD=I]/B,E*<)*<'2:=4^AHPG"%V#MW4I6Y)IIY
M-/!IKBFCCOE/",A3.7X\MBCG,Q@\+2ORW;T0M5.5\/OSYI,5<R%2-WG&;HV\
M79@F6,NLGMB5%'O"(?IKR;YIAS78V[E^.BL_#E3#1=48U<7EHN1:E1THZQ;:
MCJ?X+^9_R_N^6^<7MOM)J[_*\:.K'Q+$I7'%35=7BVIQ<:QJI149I*4W;7GW
MY<\89;C$U+G> P5BC@5:"E6DF]V%\?G;T*9%8:B2JTGY94BQR;3ENUVE183(
M!(4^Q7N[-S=PL*4);F,)+!I\53#^RZK-454JGTF^7[FQL+F\<+D=C.Y!TDFL
M6G55?1XBTRRE5T;H=J>(,G'S#@]G&Y6G71>6\<_O&8ZW\Q%L7J=7'9)U][VO
M:*F:M(@W!1V?YCL#KX_S=SM7-OS6VJ782C%KL;G&G3]Y/JIAB?+_ "[&WN+.
M]Y!=:=BY"4HRRP:5N5>C#0TJX-RQP3+^>F7*\/X[EI8'FNSXGD%&+OC6Q-:,
M;QMC!,Y4K/8:.J77N]6=R-MSKJY/_)W>YVT<(K1*G0Z.M%T5=.JB1Y_F!_J-
MALM[*KFU<AJ><DFM-6\W2+>/3)\3SR\/\U?@GE'-RTL-DLU9S$V?XOBFCM+2
MOX[*?WGIVH^06+DLD)^C%3$V4G0C^=%:V9>W<#D_3[G<6K$$N\JQN1;HG@]5
M725*3BFFDVLUB>C^LV6TW&[N2?=>F=F:57'O)P:58UK;DTXMJ+3<98-G8V2^
MZ;A]*S%B/(GC?D6#S*Q103VJZX/,CZ:0.IO8W(36DLRT9 AV((F5V Z[,ZZ?
M])WEB7AVKLH1K7'X?]UMO'"NA5SHLC>N?\OW,?&W.WMW+B5,/CZ,-48J.&-%
M<=,E)YFS^(\UX-F<2+'CWS%B,;BBB2IBL^U&]8Q;JH66NT&7R&/NPUT_MJ#O
M[Q+&5M]C+]N_*2>]VCO7<M=MM:NMZ8M:NU+##2J&.UO;6W%QY9S&.VL9^%>C
M%Z.E+7*+T=.EOO5>MU('RQ1XIYE\;YK%09GCN<Y7@R][B>1QF0I)6OY9!]-1
M>OO>D@B%HW6J3Q23;P/)WDK'(C--MM]SLKT;BM7/TDTVTU5Q:B^-%BLTTDI1
M;CFFEEO=YL^:[6=G]197,;<DHRC+3&Y&4H\'*3HVTI1;;A)*7PN+ES+XHR&;
MP7AC)9_.67DC1)K?%YW5(K$5<4Z5'#)$>YY%2I?B5:Y;=D1%[1VJNODVVLP5
MGPEC:G5T?1+O->FK?IH?"]YNKOZAWI/3?MZ8ZEGJA2,7VJD57JJ;$X=RCG'D
M?%<=N\FJ5,;PCC4CY*A!$&AFSV9$L_T^0E2XS^]CJ9L,:_=LLC,CJ7*[MJA8
ML6[\]Q87_<7%27[V%&HK[L'2N+;;2==*3?5+<[J]M[>TWDE^CLR<HK#NUEJ3
MF_OW$GIJE&*3:HYMI=8\;XT,C)BN,YJ*:&#/ULQROD^)Q_?)E<GQ+ I4K0<>
MF2M''.J7LKF:D=@+_,EKB2L#VDN/J[SWS_<;'82W6Q>F:N1LPGG24E*4YPS5
M=,&D_NN2FJ2::^_?E%Y0V/.N=0V/-HZ[,K,]S=MY:H0E"%JU<I1M.=Q2DOO*
M#M2U04D^HL'/!R#"SU)N,Y;C6/'?2CQUZ.'$RR5=AUK18NX9ZD)!VV_EGU W
M'77YW6*RP/VR7<>;%R8ZYB<'2RV'I8^2Q2BL6:%NFSS2/,9K6/DR\4DETQSE
MC[KJZ%]OXATT70@Q]@S0A2YCJ>0OY&;'V E^;)6KERR+,B*=O?M?RNSM3^&#
M:%&!  ;NT0'.-,,0L4AEGRMNM*TEMK$U*2Y7^KDDEABGAHP58Z\2J"L0,:DH
MGJQ!.J"^C#/ ]I+.4DR$CR^ZD4D5*'Z*%A\D,:58(I&3<'YI2['\= 6X]<P'
MN-E9L;)&U@_E\6/K6H7AJ@MVBY/9MSK9L."-^R.)5V/\6_1CQ!6M)E7NWTMU
M:,..C,*XV>"[/8N6@4[IWMUGI5X:@5SVJ%DE)V).PVW QO+<AFX_3M^W@%KR
MR9*+&X""2U4B@S%JPD]JU>,=#ZJ>M3Q].M/<F4I]1)! X1/<(77J<EY5=YSS
M&WL+34%)U<GCIBLW3#%X*-6DY-5:56OCGFOS%8\K<CO<XOQ=R4$E""=-<W@E
M6C=$JRE1-J$9:8RE2+TOS*1.,\9L0YF\(,6TMLY?)L_Y92L9/-3Y'.6IKL<T
M]NWCXNZQ9M>P+#E9;4,'<_\ I1^E?+VUV^WC:L[9+5:MQ4:XM1@HP<D\(MR:
MC'5IQTRGAD_P;YRYAO-]<W&ZW[EHW%Z;GIJDYW7.ZHM-RG&,8N<U!2P<[=O'
MXEY]8KRCQW*>0>497DEU6Q\]JK6XUD786J7%?RNY#<Q4R*FPK1>]"K62I [H
M_GV0DCYA&=N,9PUIQBTGCAEC5]+K5URIV'UE*%ZY<MW':DIR3<:IJ6?=HN*2
M5%3.K2JVSOG#<GLYV"/-K4B?DV!DHC(C%2I83D_$K$CPS.D?L1K/)7,[RM'V
M!89EW1@LH&OCNXV4-J_TSG_V%Y2<&\K=U)-4=<$Z)5K5K.NFK^:[3FMS?Q_7
M*W3F^UE%7%&E;UAMQDG&B3<6W)JB49*J:U46EO,_C?%7>+Y3/M"_(N+U,3G>
M58R[CG@IW^.T\5C;-X[O/:K):K44:6)4=&E[9.UE[E<GJM<RLON\QBH;FU2+
M;JY.3PPI^+BLJXXIJG!?Y'N/CY--W=C?;N12:4(P2K22;7Y=71O&E4TI1>KA
MS@_#K7D^.K$\&'XM2XOAXJ6:L8_&ME+O(,CD\G>NU1>4VL?7NY4_5&O#($1E
MKQQQR&;MC*Y[39W(JY=N7$E)ZG&E8IOTUKTTHGP1AS'F%BYX&WL6G*5N*C&=
M=,Y)=-%2E:TK5I9RHCH_%_;5Y4XDC2<4Y_'ATOX>I;DJSU/RH)%5@BEOR7*5
MR3,8_&T*%AUBCLGV;DL;$&! C#6G;[VU%R3EII.BT*J;=:1IBG)TQ<=2_>RK
MOW?++\E%PCK4K6I^*],HI):I:L'&VF\%-QE^Y\34GD*>3NXG%2<Z.%R0XM3C
MY1?Y/BK.1FPN9J001V7Q?U<.#J25<M#4LSB0K$U19(7C2<-,#KO\>\I*Z[-R
M.BY*+?=^&DHN255)QKIE335T3HZ(\C]'MW"6WCNK,_$LQG&/?7?U1FK;>EP5
MQ1UP4M;2;<=2U,WC@/)>&EK#%19SCE^;)UK3UO9S]=[<-K(?3W:M:E(*HBAJ
M5K&+5A'(BRRE9'(#OLNN_LHRO1O.JFI+"F$HQJFVJU<G&;55@NZLECT;/FLX
M;:>V24H.$N\Y-.$Y:9**EI<8Q4[<71XOOMJLE39/@R.3#9C+X>]'1LV<O4OY
MRA;I.)CCJU'(THLKB))WF]UZ]C(9N.W$HAC"RR3DL_>H3Z6^;?*=G:YA9YUL
MXN'CQ4+B:IJG%=V>5*N/=>/W5QJ?JK^FSS%S*_R?<^5>9S5W]+)W;+4M2A;G
M*D[56ZTC-ZHUBOCDJM)4Z*GEJ17Z0EEG6W/':BJPI)<,,B+[,EAY:T+&H3%V
MKM+*NZ=Q"L.\@_3Y^G3'\DU#'\CQU_)\NM4OJA]'C.-2W*%6A=M2(8&=:RUT
MOWY.Z4$!I&5)"OI\HU,*YC@.;0R%+,QY._RFA1X_V_31X67'U*OOVY4[8WFS
M-JX\TDHDZI'$D6_H=_BXUK@/>2UEKR6ZLJVL?!BT687H[,$S6YI7 6J*MH7(
M*]54D.[]\4Q<?*.T_-J^X#3(S<A6]0BQ5+%2T'D1LG<OWK,,\,(DVDCI4Z].
M83SF+JK/*B=W0_CJ8@MRMK,UK-(8C U\H9F]JU<M96'%Q48&8$L2*=^W8'R[
ME$C]=OVE3KP XR$-1K&,GFQ'YG:AM]E.PM6G-+BS. )[HL6Y(C4B5$'>8V,C
M  *K'8:H&>7BQ,%_$92[4O6[\-D4L9]'%D[GL2708Y9Y*=,O6BA2(DRV)4"Q
MH.K#H-1TS!/% 71R7[D#  22*A[]M^^-6$<A&W3N![?AMN=4##*/!! ERWE6
MQ-.C-':M6#/3K5I(D.WL79[D3K'5D=AW=K1L3L.[;H0'A<21QS0SQ^TW9-[J
M]LD<D!7OW1PW8%=2"&&XV_KT C=7(-&@QTU.";WD]R2[6GM1BO\ -[H2&"U3
M8S'IVDN%'7<'0">3?*I5)PU?'V;I= J9.Y9I51&3_,<RU:-^9G5?X5[ "3U8
M;=78!CDVNUJ$-^+ PY_.5HXEBK59:53MGE"K9>O>RDD?TM53N?5I"NP[2=1^
MT%V5JT+^)#9[#19*.!(;TF+-1<P5MQ)N$KP&$BU+$[E5(0=WKL ='2F('-OZ
M1J,-JVMNO7J&OD!%"]R"6)JX$D<4U?'2=]E4;HT!$D;D %6V&J"^3*X^#&_F
M]JRM+'"LMN2SD$DQXA@=596L174@FK/\P!215<,=B-^FG6".>Q'RC"K/Q[/3
M4H;C P9C'UZT\ABCE*S+ N1K30[2!2O?V$KZJ=QJ9K "MSZ[(84CC>9I1VYH
MXTJYF:"+*U]D=4FG$5:6O7GF958#8B,/ZJ0.W3A@"RJ,O#A#!#D\?G\[6#PR
M7K*+C:<UOW>]A9@QR7#4]B"0;1J"S;#<CN+!C3K!(X]<A]'6_-S1?)*&:PV/
M2=*:R%G"_3"T\DX"PL%)8[D[G8 ["]I"S*UJEFE+]9BX\Q' #9CH/7J67FFA
M1C&*\=YXZPLG<A"SH 3_ ! : ;5I#DL/)^9X>WBHI89HIL7-)7GM+552O:!A
MK-M"98A\J1.7^&V_33@46Q4M>WC(!7HW<;56(U8*ENO+CK,,$ ]B,+"66>NH
M11V'Y6 V/31 0P^6QV<H2/B)[_T\):DMJS1R-2821QA?=A;-TXVNF/<'W=I4
M9A\Q8[C43KD"['6:D]>UCZ&8&2MXQGHW+;RU[=FO=V;=;HKI#!]3$W\485-B
M-B!J@3Q,=V"A:JRY].0Y."2P&MV8:%;V9F4^Q5L5L3%"D4<3#KN/<(WZ^FT0
M+\'!GH*TO]X<CC\A<EG:2,XW'RT*U6 H@%91-;MRV.QPQ]QBI(.Q'3<E7B"8
M=$D4I(JNC#9D=0RL/P*L""-4A"X^QD)Z-WZWCXQWLM8AIXT7:-MKM6-"(2WL
M]M*J;7\(C+LJ@_,PZ[3$IU/(:EU98A]+<:M(.^%I$=8[*#NC2<*)3$P)!ZJ2
M/7;7GGHE*=V&VKJD]>>:$]EGZ5S+#'*"P,8EV +*5((Z$$=0- 41X;T,T#F"
MUV.4D+57-4R*Y>,=DK.DIB*CN[7/S#?Y=QJ MK"TL4E66P9K4:;_ %8HM7K
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M =R!,F,B PQRR1L(C&DQ(EE0]G:LI,P<22*>OS;[GUWT A/%=-%X*MR.._\
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M OQ$E*SAYZ6$S\F2>I]7CSF)+468LPY#9V9[$S;P6+%664$QD!  %V &VG#
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MMJ]-.ZK.\MKXG"BN0]">,>JM7UT,:\B\:J\CX-R6O@*M6MD8*]6Y+'DJ=/\
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M*2>A)]0  R,N;_.$A6EC?R+Z8N]\Y"Q^9?5?-M"F.&/^G]O?;YC8]-SMOTT
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M2FWJ<7JGQ!X7CP3O=2VER6RT>.M9*I_J]&IO#)/^2<<L!9+GUE] (Q8 7YF
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MCINVU8VJQ<=6J<W5?%)4:BE6D6U26.GH\;?\\MV+KG9ORW>^=4IZ=%JTJ/\
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M?0O\ !(3O81HC$E8P=S&U+/.\311* >Z)%@D25MM]^YXP-OCOT 965BB9<I
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M;EE)2/=MQM42K50G8M*T]J*9V7U[8T<D:@+)8WCOPV56].LB-%)M;CCQ]*-
M"99*K31F664] 0DA&QZJ-MP'$\GMHME#"40;RR3VWKUXZK;/+/NL<T3NBH"O
M<!TW^903N*,LB'[8;]1,4Q@1Y3>R,SK#4K%.Z2>$QQ.K!HM]V[XP%^)!T E?
M,0CJ9:*3#1^TJLV5OP^Y[5.9.OTCK+"ZFQ[@ 'N@$';9M] *N5R5:&_C):T<
MG4PW;6,FLN( 7645XFEI3J9-OD?=E(ZA6!&@'W>;=4O7DFK&9#[<LE9XIXCN
M1W&K=B1U8;>CI_1J@6C_ -&F[,Q[%^9U[';Y1\SIVIV,?B-AL?@-"%DL9GA>
M/OF@,BE>^)U29.OJCCO"L1\= -UDBZT9I%B=U>&"/ZUC<GKK$ 9U<.EE9=@Q
M[@Q<;=W=OZ )U):]=_RTR5(9D[FKU5R#6K<E?^(SRI82.QW$D[_Z0;?VM (0
MV:T=R?$V),3')8$LU7'5V!L257]PS36Z[*H F.Y)[>UCW#<G4!6K-#6N28P2
MTUV7W:M&E0GA-6 ]S%K4R2RUMY&!(^6'KT ).@+FEM5[I%J9[4%MC'3JT\5/
MV5T7L[WOWO>LQ=WS="Q@5@3LIV)  L5FK<5O?GFJ3,(*^/ITJL56FFP+3V9V
MWF)38^CJ#OL$)VV >3RR1S552M:G$CLLCP-66&NO:/YMKWYX79-SL!&)'WZ]
MNPW% SN_65YELTZMO)32#V5K_75Z="JFZ]TLH<J[%CU[A'/(.H  Z& <S01^
M_!>D+*U9) Y:]:AJQ1-&YDE:LKBG/(IZ!I$!522&&VQ M:*A.\&5_D3F&$O7
MMM-W01PN"SS1-W- O=&3O(!N5Z;[:H*M/)=J)/B;--A*W\NS*CVJQC5V21D2
M">N9CNIVVD4'\= *V(7EC'MM EE-C#8EK>^L+G97D2(RQL&*$@?/TWZ[CH0,
M=SW),'@\0US-\IQG%8%8PKF>2S4,/&'A*K-*HR[8^L6;NV#;=GS;@$$;[;.W
MO[F6C;PG<GT1BY/U),-I9NAJ#(_<OXIPF-NROG^1<@7'M)",I@>+9+.U<B-]
MEMT<SA<4_%71W?MB#31E]@>Q@>X]T>3[W_FJ%OJG.,9?W*Z_5$QUQX8_3IR,
M)3[H,ADL4+_$_&>>EIK#-*V0YWEH<,\<49?OM3P\2QG-ZT2KMWB.Q/1WC&S-
M$>@WKEFTM_YG<*O1"#]OB.T_2HR[&35)Y+Z>BIBS<\\Y<ZP\\.(S^-X9C;8D
MBARF QE>+,PJY+2M4SO+;7D6O;!5]HYAB8>P[A>TKNM__$]I=R$[DNF4FU_=
MC&W3^_(=]\:?3TF/?W$Y#R;$M!D?+/)<W&2T$DXY#F<I3>:*4_4?58RKFL=Q
M"[.LFX*R8K9&]5V^762YG&U_E;5NWT-1C5=DFI7%_P#$)HKFV_IZO8/>,>,.
M+8;%V8<9/2RN7A%R"S?K1TL%4FR)DED$63QG#TQ-/LBE95DC9"Y"[GY^NN>]
MS'=[C\V;E3\3<O;)R:]!5"*R1GF P$&*JQM/2P:Y1NYK-G#XE,="68[A(_<E
MLVW5!T[Y)69_4[>@Y97;LU2<FUULRHB<L00V(9(;%>*U$P!:"9(Y(Y"A#H&2
M4&,[.H(W]"-]8 BZD4^5QDU;/X6I2CE:2NV+%N/)UY*2%1"9F6M6A'NJ/FB
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M<,6U2NNG<U5H=<^//&^,X976ZSPY#-V*_M27XQ_(K5IF25ZF/)"LT+NBEYF
M>8J.B1K'$GTWYB\R[SG]Y.YW-I%]V%?;+@WT84BL%5MM_J/R3Y$Y;Y-VK5JE
MWF5Q)3NM4P_##BHUQ>-9O%T2C&.Q+0N,B+2DJPN74O+:AELHL8ZLJ013U2[O
MZ F10OKLWH?C1\Z&^0CNQUK$V&K8V3*N(Q$<A)+5K/\ S$#FQ/5K6;)$<.Y4
M!3W, -U![@ TR;7J]*M;@PE?.YFO[:I#'/5HI%),JBW-!;OEWKP;IZ+WR,.T
M;'J0*)YJK2N8F*?-<?3-/2->^N)AKU\K(N05/;_U-;@K0SR0&=@KL(]UW.P]
M-1Y8@OR&8HX[$0Y?+)=QD*_32_2%9)K\=B798J35L/+<%N?O?M,<;31DC?J!
MOJUPJR,7L7Z+8=\C<LRXN@]069K-MI,7-4@=0Y:<S^U+3E4'8ANUU/3H=7AU
M& A8G@S>$EL8O.-0K6H#)#G*'TDGM01MO+/#)>@L5#&41@7*D*"2"" 0S6 '
MV,$2X^DL%^3*0K6A6/(RSPV9;R*BA;4EBND<$TDP'<6154D] - .9Q,89A6:
M);!BD$#3J[PK-V'VFF2-XW>(/MW!64D>A&J"RJ+0KPBZ\$EL(/?>K%)#7:3^
MT88I99Y$3\ SL?VZ 3L]:,QL4Q<(K.\M"'VK'U+K&7:K#]5]-#,9'':AD]M2
M2.[M&^T!"P5H>3X-Z>?XY)CJ<S^T<-?EJ2L:U=T-=Y!C;$T$2L4&T8<]H&QZ
M:9K$99$EBJ5&C2%#'8Q<31K/+!!6AAAJ1E Q#6(8ZS]R+,Y)#-VR,?F(Z@D@
M)XNACJF/EJ8A9JM=I;:F7>Q)8^I[VBFL>]D1/+8E61/E=_<5NT;;KMH!/%2U
M6J6<;0RT^0LXMY:-J[;D%RU%>(,I%J3LBBEGA,@)1=@HV78:(%,+!D*U"6M<
MSXY#DHY9^^]+4H4UBD.ZQUFIXQ(DCC@9""&+2$]V[>@! DL;'DHZP&6GI6+I
M>0M)CZL].L(RQ]J-8K%R]*61-NYB^S-U"J.FL<3!NO8)8LYHQV3FTQ<<IMS?
M1QXN2W-&E'<>P+,UN*!I+9&_>514_#15XD+L=-D+D$QRN,BQS&62..L+L>0,
MM;8!9)V2"**-I=R#&#( /[1WT2J"S'1Q""Q3CPLV&JQ,T4<8&-@BL(P96FJK
MBKMAH5*@=7$4@W'3?TV NQ>+QN'BEIXRDM.(R>_*560^_-*-FEDL2L\MF;9!
MW,S,=MAOHL!F1\EK 0\CB@:&Q)GYZWR2QX[*W(Z]9E4$/>BK3X[&QN(AN&DB
M[B=SN6ZS"O6,:=1I#S/Y2?@&:K8GBL%C/^1<UAILCC<;E\_/C.#<5Q(GCQ*<
MAY-7@GB:U';ONR5*L<4UF[/#*$>!$>:/YSY)\C;[SCNY.$G9Y79E%7;NER>-
M7HMQ6$IZ4VZM1BJ.358J7U)\UOFURCY8\O@KD%N>?[F$W8L:U"/=HO$O3=7;
MM:I**I&4[DJQA%Z9RAP!:\9\XY-G<GS*;EB<L\ASN<GD,S'%%!+:N0UYF_+H
M2N4@2M@\=CU>**E6B>&M6WW7>1N[]J>75Y:\G\FM\DVNU=GEK^*4\9SDZ+Q+
MC4,9RE2C>E+",$HQ27\K_.MSSS\R_,][S5S#?K<\\6,86THV[4%JEX%J+NUC
M:A#56,=;:<IW'*4Y-Z1^YSE%,8[A<"'LR]V5\M86QW&W%B&H7E*"9RKB%,C<
M16BV[20I.Q1=?(N1QEM]X]+[D=2PP3223PZWH=>I]+/A?FR=K><MCKC6[-6W
MCC)-N4HT?0H^+&F6*Z$)<5^Y?"^)OMNQ6&HWL%R;G&=FY"E?BL]MLC4X_#=Y
MOS1K&;Y7%4$<N-BBQM*"6+'RV(GNBW7=%2-IIC\6W^SO<V\PW+UJMN%O<23N
MI4I&,+;S>#;DY4=*JC3;26GY[RGFFV\O>3;.VO.-Z[>VD6K$I)ZISNW8XI=Z
M*5N-MRC6C3BU&+;<N>X.-^=/-=#$YCDO)<E-QNJD,>)DY7D9TJ8BM'7%6&_A
M>*1C'XB-&H)VR21R0664=LI+]P'NV;%JQ>G?V%B/ZFXVW<G@VY.K:44Y).M5
M&D$^%$?$MSN=QNMM;VO-]W/]%9BHJS;JU%022BY3E&+<4J.5;K5,:NJ.T?$O
MV[9_C^ M0<3@-/)9/'7Y/[^\GJP3R27["_\ %=:I4 Q5N7!TF<2,\5:..VL2
M[;-+[D/%S'GNSV:C:O78W-Q&7>C%5[6TGIKP47-./&K3U>IR7RGS'F4I[C;;
M>=C:3BW"<VHIU^%)R3FU3O.XK34^%$UIZ-XKQ7A_ANA!17Z[GG/+%@2R?3UJ
MTV2L9?*RO.\U>"65,=QV*W,DLQ=Y4D:&*1@7C@[(OC^[WW,O,4G*L=IRA)XM
MM1TQSU-+5<:JE11TIN*HG.LOF/+N5<C\FPC#3/F/F.36$8Q<]<W5*"D]%E.D
MI5E)3E&,Y5E&W2&:<GY=:J8S*4^1\.QF4KP418RT"YRI;P-&I854B_O%E<QC
M,=C\)]06=4]_Y9.W^6SD[#S=EL;'C0O[3=SM-RI%N#C<DUGX<(3E*Y3"NG%5
M[R1[G,^;;I;:[M>8\NM;A*W6Y&-V,K48O+QKERW"%JN-->#IW7+AY 76\J^/
MN8Y_+>,>)YW$<2R5H6(,>V/RG(,0T,R-=F:K5LP8R_0-6Q=DA+35TC=E+!9!
M[4H^RY65=DY1I&Y6DG)1TW'EXFB-RL7*G"2=,&J))?1EO<O;049J4[+58*#G
MJLQ;;\+Q)V:34:NM82C7O1=6W+I'Q/YUKYK!7N4<KIX<<C\;WOKL_B(J<DJW
M,=%7 LK^2V7MW4DR->22N(MY#'8,;J>\1@<>_P!EKL3VUNY*,;L'%N+:<9YQ
MRQSHZ<558IL]/E/-7;W=K?7K5NY.Q<4U&:3C.WE+/!UCJC7[LM,E1I4U]Y?Y
MCC.1><\E8\4\7N\'QY&*K87$P\>JX"QF,E5I![_([7'<E72IC$M69_9]MXX1
M*E9)91[LS+KI\K;;=;#R]^GY_>G.<IR=-7B.,>"4HN3:5*X-:6Z)Y'%Y^WW+
M^;^<GO/*&VM6[4+<4Y:?"4YXZI.W-02;U:7J3U):FL6;4X(?,_$L;R'DV MW
M8*LLQR^>X7DLB2G-+\_N1W<A2N5KCS8_DTHCW<F53D7,:S DI)KR?,G*_+_,
M]YM]QMHZ-S&+MU4.[HBDXUA)*FEX1FE@M2HTE3Y)Y'\P><>0\MWFSWTU=V-R
MXKR3NO7XLFU.EV+==:QG;<N]+0TXMNNT8,IF<[Q2#,X6KPC&8_EE&W)O7R(H
M9B6:U4>M;N7S2*207,!/.DEJ(J[QO&89AU8:^&[R_L=E=E"_=G&];FE6=--8
MNNE.6'>2:3J\,5DF?:/+-MS?FNVA/:;>U/:WK3;5K5XC4HTUM6\?Y;DI2C18
M]V6;3W!XVI\QY#A$QF%XKE+7?%!C,OF:].D<!%! 8DBRV,LY2S0I7N1Q0TA!
M&(I)(ZSR?4/NH"2? //'F_DO)E'<;:]:W6^4]5NW":<HUJW&XU73;>JK3[TO
M@2I62^X/E3\M?-/FB4MGOMMN>7\H\/1>O7;3C"2BTHRLJ2CXEY:-*:K"W7Q)
M.M(2[&XWX@XSB\D.39;\PY!R.1TMQ6LU)4$6&L-\\@Q.-Q4-3$TYVW"RSJDD
MTH78R%3MKZ%YYYQYQS[;0V6Y<+>RA3N6TTI4RUN4I2E3@F]*>*BG0_87E+Y8
M^6/)^^N<UV*NW^:W*KQ;SC*4%+XE;C"$(0U92DHZVL')INN:\EMXFEBHLOG\
MC?PF/QT]:[.:]VU5D:4D1Q4[7Y3))8N1M-* T,;.DC#8]R^OQ1TI5GV(A[)<
MH9/"_F"9*:AC9ZZV_P R#'&R0U4(E:9WOPHU6(HGS%U7Y#OT'73@!UC+]#(T
M*UW&W8LA1EC(@NPS+8CG6%FA=_?4E9&62-@Q_P X'56(%186U6DDQT]6=RLB
M0RAQ/6$Z@J!(8'W94D_B4$'X;C0@C8?)P8\O6@IY'*)'$!"\\N*I6)BZ+*WO
M&+*S58E4LP';,W3;KOOI[RBLQ<TW>:FMJ=(#,U&!X9?=L1Q^X*]>6Y]'"S-*
M.U'D]I=]BW:-]@(V*]>?#6+F8P<E>816#+AJD\6:LRP %1$!%'#!/-.N_P#+
M4LNQV[CN0)PQ R>I0SG'XDLT<UQ['P]MA*4-B;!WH8:@9D4I@KONQ0=O40]P
M.X&Z@@:<!D3TZ16:#H;%BK!+7!-B.62K9BB[0Q?WI.V:"0(.K'9UZ^AU0<_>
M2*^(RO\ <VWC[#YC'1T.:\?6\\DF7[S>HXO(SV'LVWE:]#[.$</(&9 A)[E5
M25^U/E/NW:YON-O&5-=B,LZ5T7(I*O3W\.G)5R/SM_4=RZ.Y\M;+>RBY>%NK
MD,%72KMBY)NG0O"Q?!8MI*JXQN^3.8\7M-P#-4,AR?)598\=B(:60:MC+%@P
MQ6\?#=QM*K5FSCVCVK \YFGFEVB!,KJS_H.Y#86(_KHQTPD\9:=3CP23=7"/
M9@L4V?BJW=YON;G^DW)^)=BN[!2\.,TG5MQ6F-R:>/>Q>#BJMFJN/<!\C^:L
MUF,EE,W8Q-/&7+D5N*\M^H[24#>FO8S!X&O%76ZV+7'R0R3SG^5(T49=RP4>
M9?NV7<A.2E/;W'\3?=2K&*23PQ<EC3%5E5TH>YL[&YA:NPC*%K>65\$5_,<M
M,Y-N2QP4'@I8/3"D=29N^QXTX_X:/*DXC1;+YC&<5IY6M;L2_4V,G))C)G@@
MJ0+[56*C7LU)3![*(S?4R([L O;T<O<;D)\PTM.CBH_A4&\%UO!R73E142T<
MWUVKEOE&N,DI*<IY:Y7%'O2Q::B]2@_PMU;EJD\<\&TJ_E7@$_&Y,!2RO]VP
M(+>%SEJ)US$\CSVH\CA'M58XH^ZO:"V8+$H>&;O=)#%*L46JSO8[>RUOGJVT
MIO3)1JE%TDE/'K:32=:8HV[CETMYN8_Z6M&^MVH^)"4],G.+<9.VVDONJ4DY
M*CE@^"RGEGVQXVY13(R<-N\9DJ(ON/QIZV1+5X(_95+.*Q<T]FZPAC 4QQN4
M&QWW[AK7"_R:]/1M[OA3?16*?]^.CUI/H9MN[;S'MK?B;W;_ *BTEQI-JG7;
MDKM.-$W'I1J3-?;343C>4N<>O\I_-8\7=R%6V[8ZR+%>CM;DBR&(P<;9^ECT
M>LP<6X8T95'<&'5L]Q_INAJ[-J<&J3G%I*2Q5).*B_0S7M(\Y\75MK:E;N1:
ME;M3C*3@\)5@IRFLGC)8.CZ#(OM;Y,:N-GEN,]NKQ7EE%J3*HL/4IYNK%!?%
M8A1*H:*Y,_:#L1)^!VUNE&>ZVVXVM532M+ZZ52;Z-23KP3ZCGC.UL-[M-\DU
M-3>M<:5TMI9UTR:IQ<>MG3'D_!<?L\%JMG,O=HUL9E[7$X\O@'9[.3PO(TCO
M5J]>*O1OLS;M 'C6%O:,<FQ"@G7'R^_=>]N0A%_S;*FXM.L)Q>A]>.+KQ[K9
MZ'.MK87*K-V=R--ON96E)-:;EN:\6/"F&"<?N]](QCQKXLH8C/\ #\AB\QD+
M>#_O9@UK5K]4TFK3TTNY^*&>+:HKVI9\5N56M7:)B/<!)"Z\GS[S6.W\J;VP
M[<8[B5F*JLZ2N0MMX4HN_3/%56*/D_R;\O3WGS%Y7NHWKD]I;W,IZ9-Z5*%F
M[=2QKJE_+;I1:71MIM'>E1,H)[K7K%"2JTP_+H:E2Q#/!  =_K;,UVQ':F<D
M?Z.*%5V_M;]/RJ?T4'^A"&KV\W+EK->;#UZN&@3:')2919+EV4A"IAQL%5UA
MKK\P8RSJY.VR;:F->HI6G''5R%RM5P/T%>7_ %J?*Q+BH:V0MR>V6_E5K+9"
M6<=[!Y)H4ZKT+ @ZH(S'W,36Y#D\1CL/E(K<_P#QCE<J,9:BQ+V7 =8FR5GL
MBGLNLW<JP]Z#<]00P$PK0<!"ID,'C>2W,0,IG,AF\EV69JLQS.3HXZ)E>2&)
M1!7DPV%C9&+#?VF9>WN)'9I55IQ' ?UJ<-7.SRS\ER%NY<CFGKX*U>H)5JU0
MZJ9*6.K5J]F2*$$*9)&EZG<G<Z<0.(*6:7,6KMG.1S8EXPE/"0XJ"O\ 3-L@
M,T^1>>Q:M2$ACL!$GS?P]-,:]0*B'/G-F9KN,3CRUPJ4EI6&RDMHKLSRW6M"
MO'"KG<!8B2!L?QTQKU 5+YPY58Q5Q2X14):T;]R3*RR&([(M#\NCJ0(LY_B^
MID)0?P@G87&O4!B.ZEG1%0XKM!D4:;)\CKOAJL?NCO*1V(A87*W92WJ3%L.[
M<$_-M..0"U])C\U%:J\9M7LIDX4K6\QCZ>,1H*<+KVKD<A=N49&A0@$1H97(
M4;*=AIQR C<IX!.38^Y9AR<V<E@:.DZ#D-O'00QJX9Y8JYFP.//5MI)5C9B>
MA).F%>L!EDQ%++8[*Y/+Y6K+(ZT:&/BR>2BQEFR0[ R8NDZP6YBK'<S*Z@ =
M.@T=,P.<H]6I?H7[_)9,367^1%C);6)IX_(V7+=9I+=4WYYOG4*D<Z+\H^4[
MG<P/;*Y!;U:PN2I5<5%&RVJ<U!GLV9W)$;)DFR$<5>-=P GT[,3O\W4 7W 2
MR@Y TV.&%?#QU_J>[+292.[--]("G\O'15):Z?4R M\\K]J;#Y&W.T=> )&P
MUE8]ZD4$TW?&.RQ8DJQ^V742M[L=:VW>D>Y5>S9F !*@[BD,=SS+2MT;U3B$
MG(LI*QA6[6CPT,V/AB964SW\E8K311EI246/OZAO3IO&4?7L=B7RF-REK'/:
MR4+?2TK206+ IJ_N,9'"=U>LF\AWD8 [D=>G2]8(KE-#C_=3SG(+&46OC'18
M:M2UF6J33M('B:7$8DN^0F5EZ QONHV8%1J.F; \S#8^UBX,I>S&2P6+J^W?
ML3"Q-@&>(@!(<D;4%>_60LX!BWA<L0K#?IIU@>32Q9/'UKU/,VL;3+1W/K:T
M=%!8JKW$Q3?G&/MI'5F!W+*L<FP!5P/6@6DL/D:#RX'(XTR.W;!>DA.7H*T4
MP2PKPT\CCVF8!&3I.G8_4[[%2[""&6ES\4%=,'4Q=NU(X2Q-D[EFC5K1A=VG
M6&M5O3V69N@C[D_:^HZ\"EMVSG*.(6:OC8,[FE2)6IU;*8BG-,Q E=;%Z2TU
M>O&-SU]QSMZ=>C&G6!>W3K7Z4#9?$TK\U41WUI-%!DD@R$4#C>C)=AKJTZ&1
MXXY2L+$-U[02-4$)G\=AN08"&;E6#O35H5BNR8:-;U^Y%8.R+$U3 23M>FB+
M[;)[JKU.^P)U'1K$#H_093C:2-^;\=QJ5EE[0;7'LE0IX]R>V14,=FE#[-?J
MI[3[1]!OIP!(QY/'3X@Y:.VPQ:U9+9N;3I_J==6>6;>5!8*&.(GN [F7YE/4
M'5X Z,@KU,1?*01XZK!=3?V*]*9LG:L(P)FEGCD;O@B]P[]T9V+;]PZ[^:>B
M+V)&IWHI'L!:U@E13J8BS9LSS]H5I;-JL;!$4?<#O[487^TQ&J4,@\U6:M-"
MU]XC(5>AC:->8VI7)W>U8G3MKPC<$GOB)/\ :^&@'=RQ+6BCEBJ7;;&15->F
M*AE(96_TAMSUXEC4^I#@[@==M] *-![TD$[R68O;7N%99A''WL!O[XA)$S)Z
M;%VC_8?70%TL:3JC=7,3^[&%GEBC:6/<*)3$=G0/ZA@P!&^VX&A!*U6$Z1R>
MTDMBN1-7CDL3Q5Q878HTAB5@P1AT)C8CX#KH40]O'9FJGO+CLG'%+NP AO5(
M[L*LC[!NY>^%G(Z[,-_@=!D.XF2="KF.9X9.R1A$R1B>, L8UD,FW;W?!FV.
MXWW!T!97LK.9XE%CO@=D>2:E9J1LQ9]A ;$4:V$0+_&A92-CN=]0"=.=W::N
MR7G-5RC7+=>.NEERS$_3A%A]R.,= P0*0!U8[DT@M"7$MA&CLA5=72>9J[12
MB1=RE=89#*B0=H!]Q$))W!;J= ,J;68;$]:2M:%5'[DR-Z]6F:U+(5 C@@B>
M22.($[ ,(^HZ+UZP"B!*ER8NJ0Q6WC[;%C(RR2V+;%NVO!5G[DB15W[0CC\
MFW75 T6K]#DS/#7QM>O>?MGLO)8ER=JS(&D6) T8CCC#@G;O8;#?8?" ??\
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MF8K_ * L]@5!("?_ ":%W'\6VJ!I;BDOX[^9%?K2E!,:E6_]':+J"15:]3G
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M<B-#)31D=S)$SQQ@J"JJR@Q=1>TE:-@6<9-#B\[4S-^FLE.3)3FE<5<DL2R
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MV012,[DCY@3H@.,'CL1CJ-O!X.I=Q56E++ 6:O?B)GL1B1[5.YE(Y/S$@O\
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ME)7*-F*^ 1@Y.%@QMS(RJR!9-DRENU0A*.S]GS10L%!/RG8 S'B#JA&>_4<
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M=[$B1LVP'>>T , *9S)XG!STLKF,U9H0DM2K8]6+U[MF8,>X4JU6:]<L(@W
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M-6M1S?'X:B4,I@<?+$L$>.03<?O5:U:7LCKHN.FBFHP2)$ %C=-XCMT!(TX
M>86QC+.-B&'G>:C7,M**9GM3/W57:"3_ %B]WSVF21"#(Q?O8'J>NA!E6R=;
M-4;]3CW(:EJ_CW2A8R?M5\D*UQ0AD:Q7JO1J2V&0'HA2-7/\.P*ZE:Y%)&G.
M/:^A;)U,AE*L 6TR>S$YF  ,LU*"1VK(TA'R[] =M]7W@,5'EXJH7-6\=<N=
MQ_F8RA8Q]<1] JF*SD<B[R=-RP9 =]@HVZNTA?5-V:IOE:5*&SW.6JTKDF2K
ME4?NA*V+>/Q;-(P4$@Q*%;^T=M] 6XVS<O4UFR&+EQ,\C2*U"S8IVY4C#%4:
M26C-8JDRIU*J[ ;[;G0%^.I4L?66GC\=!BZD+ND56M!6K0!0W^DBAJ$Q*DOJ
M-P&_$ Z OBN1S6K-58K:O5$?N2RT[,-60RKW!:UF6)(;90?Q&,L%)V)WW&@(
MW$+CZ$EG"U\E>OW*Q^MM_F5ZWD;D8NL6C[I[)98X=A\D2%51?11ON2Z"B6+%
M/'Y&]C9.36,ME;1;)_EN2O8Q[M*H7[-Z="E6I2PXY7<*&9&&^P[M] +8JOE*
MD]T9?/0962U,9J-6''5\8E"J"^T4:+8M6;1V(#2.YW*] .N@)&NM\36VM35'
MKM(OT,5>M-%-#$%(?ZNQ);F2S)(VQ'9%"$'3YO70A&XVWR"S=N)DL+2QF.B+
MK3G3,&_=N$2*(Y)*D>/@@J1-%N2/?D8-L-B-SIB47%G+-EY*K8RNN'6J)$RW
MYEO9EMEE!JC%BE\L:@D^X9_A_#UU<?08-U&=6Y5AS-S%4\%?K%PU^[EH\9'4
MQ%BS((V;NO,T37KLGN#<HDAW!W/RG9Q(/:&(I8V>]9JBV9LE,L]M[61R-_N=
M/<[!"M^W92I$GN$".$)&!T V V4H!I5PT=/-W\N<GG;4V5CCB6A9NV)\-CXZ
MZ1[BC2CC6K4>4IW%Y"SEF8*0&8%3&H$[MBG5SN/:[R>.@T\35J''I+6,JQY.
MQ*S(9^R>,Y*[."RK&D4BHI'\)).G$#Y8<O\ FTD[WJ?Y,*PCAQR4)!<-IC&S
MVI\BUPH53M*K&L(&S;DD@:8UZ@,I_P"]39J%:PX_!QU AL2SMD;6:L'MWDCA
MKQK3HTQW'97:6?H-RO7M#&O4,!\\^5_-(J\="J<1],TEC(R7V2TMDEA'7KXY
M*<BRJ-@6=YHP W0$C8L?0"MVQ=@GI)2Q;7A9G6*Y9^JK58J%9""9I?=8V;#?
M.>R..-MR#N4W!(%98Z]:XER/&M-;O&&C8NUXJWNQ5HA--$;<TLL4OT<3LVP7
MO(=^B]=] 0N2EXYCL_BK-^6X,WDV-'%Q1RYR[$>BQR,,?5:QCJ,6TP]R=XXT
MZ[L_3<,*]8QH5S=O$XC)XS+YCDMK&0[/1IX=K<$..R-N;O0RM4CJF_?M(LR@
M+[C11[*P0-\QC:6+9&7YJ&_'D*M^?F,?'\'"85>@E+$PR7; <R%+&6RQM@12
MA0OMPQ1/V[_,2=QB\ZUP,?>2MZ/,2V\7)C+N/KT$F=\M'9I36[%NN1&84H3Q
M7*\=5^C[LRR ]P('RD-<2#BZ<H'J#')0:,SK]>UV6PCK5&W<*B00R*]A^NQ=
ME5=O1M^F230'I'S*P53MW*6)V95(!(7Y3OW,HW&X]-_AK(A&Y*A0L&K=LX>#
M+6\9*9L<#7HRVZTLI1))*4U^2".N_: S$2(2$'J0!H4B>35L#''7SN:Q=O)O
MBF!IQ5*>0RDT<LLD; QXVD)HGD,D:_S'39=NK :CIFPJ\#GS[LVD_P"3?AO(
MC??$8["^4/'V2RT%J?Z2:6ME+TF"Q@>K))]/-:X_R;-4,H4D5_:&.=QL5[A]
MF_*)V'YYVUJ[9G>NW+5^%M1JZ2=J=7)+%Q=O7!]&K4\$SZ&_J4CN_P#\TN^W
M&WW-O;;>QN-K<O2FTJVX[BWI49/!3C>=JY&N?AZ5WI(\ZN=?<%P;&SSF+#9K
MEXA%H12J0^\X]V"<%.1STH4ANQ@%)*_O(\;'?M/RZ_;>TY%S.U;JUX2PJHJ$
M<%1I*DDVX]=%58-YG\H]_P";.17K^E/QY-O2YNY*C=4W+5%QBI+\.IT?>C%X
M&D,3YT\E<TYA+4X9A\4./XNK&;-/-5KL4$'U,3_20YK,XO\ /9Z^5N3QLE6O
M46>1TBDG9#7BL/7QO>!M:;>[%SYA<=5"$DVEQDV],5%<:K!M13DVJY;:6[YC
MJW>WFK?)[22=VY!J+;RA&,=<Y3>.FDG5)SE&$5*F<2X[BO(^WB/DW@E3)\RR
M7*ZW+:MFW0H7^*8+BLV R-')XSBN2;*VLDMNSS:K3LV[<]'%V+#Y3Z91)&K=
MWEI;ZYSJW+=Z8[%6)^'#5JK<BX)N2TQJU"345WE%)M/,]Z4N4V/*]V/+]<^;
M2W=OQKC@X:;,XW&HVWKG2+NPBYR3@Y.24HTHCG+GU_SGX;O97Q3X=SWDJ3QO
MY!H2/6X5A./S\XQ\*#O?*8O"UK/'^1S<=DB6,N_Y<U266)@\A=QWC7S#E7*M
MMNX<X<79OVY*6N%8I--4<J*BQIG1/%8F_D_F#S%O.7W?+4)K<[2_!P\*YIG*
M49)UC'4]3:2>57%)/#,=\3^]_P P^-LM2X[RWB6.@CQ$E:ERW$_W1@X/Y#>B
ML92!IUR^.CA@RE="9(TMTD2T!V&2'N,R\N\L;;FEMW]MINWDZTE<N::O'+7W
M*YY4Z$D=G*]SO>17H[7?:[&U:HY0M6%.D6UB_#I<4?AQ>I4=6Y5,T\C_ 'G>
M(<WRBO:RESR!R_C4U+ZK'KR3BT%"3AEB2E3@O8;,8NB8^%67GFEE*Y"M:L]Z
M*T4I"QQ23]')=U9V6V\#>[9;:\W64HJ4X2H^ZW-N3731O2LTTW1<_F;8WN8[
M[]5RS?2WVV22A&;C;N1U1[ZC:BH1=75-J*N-=UJ22D^:/*OW1<AY U1>'Y";
M@G%L6\4]:Q3^B7+6Y$"QT)ENF*=<:]>0J]3Z/LL06!')#*)8XV'H<QO6=Q8=
MN4G':OXFG34OPUSH\FEC+*M&T_'Y/8W&SW:O6[<9[^-=":U*#7WM+PU1S3E6
M,,94JDU$^'_MF\C>=,CB+?'*W&\.>36,M/%R3R+>R>%6X</3FOY*W8L0X+/9
MVS:DK4Y61YH%$S1/W2+VLP\K?3L<HY;'?VMO6WJ45&,5&6."=&JXNBRJZK ]
M_E5G=>9>=2Y5N=YIO:)3E.4W.'=59*JE3!-O/2DGC@>HWVT_:1PGQ9@[7.O)
MDW&^99B:REO"Y2U0=,!C,1')%^77Z%3*-*\]G)V=I:TLL<<SQ-"?:BE8Q)YF
M]YOS"XX\NVD7#=_\S1C)2_Z:EFE!+OR5*RU8N$4W[/+/+G)K"GSGF$U=Y<J>
M#XF$'#)790Q3=UO^7&6IJ#A@KDY1CPW]Z6=K87S,V1QN*CPKXG"T,]'AZE=:
M,E.-GER6.2:F@7Z+(9"G%';FB*HT<UI@P[MV/RK:;EV>6697)RO3MPDW*NK5
MIDTTI<5%Q<(NK3BE3"B/@',-E'<<\W,+-J.VMWKD%&VHZ5!2A%Q<HJFF4HRC
M<G&B:E*2>*;>2>9O&W+\IR'%^3O&^/RU^]RB"C7S>)XLUF;DU+D5.A].EW&U
M\7[ES(M)2HK4FAK=\Z3UE[8Y1*_M[Y;FULXRW4I4V4DI.5<JT2E_"U3+*E6J
M-M:+>QO\RN6]A;@WS2$G&,*5<J:FX+HG%ZJ5>-:)II*6W_$WD;EEG\JXWSZ2
M[QSD]CCJVN*<H$AK'D.*NP0Q6ZUQ*[QL)+U9XA8@)'=(1+"R.8HZVV=AQ>B]
M&%ZU*6I8+%QQ[%<MMU=*5BZZ:*==%K=QFG=VLKFVOPAHE1RK%3[M:X2E9NI:
M<6Z37QZG:ID7-;_+XI\/#R:/%8KBV+S6.IQ8C%Y:5\QR&Q<K7;#9BC--C;$,
MRUZ^.G226TBBG--"QBF=T#^CL96E?<>70E/>7;<GXLTO#MTIW9)2KQ345\='
M22TO3XG-H[B6UC/G5RW:Y;M[MM*Q:D_&O:DZW(RE!Q^ZU*<JNW55MMRCK]'_
M +1>6QTL3F_#UWZ.AD.&9?/Y+$4+.0LC)6^-Y[)QY^I/AJEN"497 XZQG9:[
MV8K3_2L(H7C3N77X;^</)]UL_..XYMX<ERW?:+EN=.ZYZ%&ZFTDE-W(3FXX-
M*2=*.I_6C^F7S/L.:?++:>7'?A+GG*O$LW;6JLXVW=E<L22;<G:5JY;MQGBF
MX--U32ZQPD5*JV0HX[CTF#IUKCD2K4Q]&ED[$G_>BU4AJ6&LR#= &EFBB]SI
MVE@-Q]4(_10UP=;C^.O9;'XBM;BN-*MS*3SU\S,EB>3<*3F,BDE:W*.XGVXY
MW*[D]HW.BIP M6JXFCF[,J6[TN5RJR,\-C(Y*Y7CB@$4CQ5JDLTF/QZHLB-V
MHB,0P]1IQ!2M)3Q^7EIW>3M<RF3]RQ2PUZYBH)8:H:1@N.QU6"I9FABCA(,C
M^ZQ[&)8?-IQ!(0U[\>1O6K.4$V/G6M'0QJTX8%HLJ*L[R7.^2>[+9GZKO[:H
MI"A2?F-!6!<O^86VLRX[\J[(Q1A@@L_F'N;+[LENS)8^F*;[A42+?J"6Z;%C
MZ /5,IDD#)&(AV>TZR,TC[@^Y[D9B18NT[;;,_</7;TT!!.L^.RT$.)XS5-7
M)R2VLSF8;%#'K#,7W+SUTC:]DK<Y8MOV]N_\3@G4X@;S0X>ER6"Q#QJ>?-9*
M +8SU3%1&.K64&,"[EYC"J=PBV]J-GE(V)38@Z85ZQP)"Y;IT,E1#5,E8NY3
M>G')4I7[E:O#"Z.\EV>)'HXV!6F![I&C,A_A[NT@ /9(42TMY[-E0L(JBL)6
M^C+S3IV3&NJ_/9+$(&)("GT^.J#1'.Z&*\;VJO(H[K4N+YWD#KD\;/*(J?'^
M09"M=NP\EPEE3%-0_-<G52"W39VIV+%A)0B-[WO?;'D'S%N]UNH<@W<XN+MN
M-IRI5T:I9E7"4=.IP=-<::8NE%'\W?.7R/RWE_+[GG'EMNY&ZKZGN(PKIBY)
MUW,4L83UJ"N*OA7*ZI1U:G/G?C?%[>-\M\IFP5B-8.29:AF,-AYXI(9(\IE^
M0WLC4,T(@+K3Q[0323O$DL4=3;KO'(!]Y5A9Y4WN?AMVG"<DTTX1CC3'!UFX
M13HY22RJC\C.-_=>85'E[6N]N%<MPDFG&Y.YAJ5*N*5M7)N*DHP;571FZN;7
ML=B>&<^R.3LPXZ@^1C:#\PN5H8ZG*(#!'?CHWBP:Q#'D*@[ VSR2+(B)V%%/
MB;:<K>[VTD\86ZMQ3QM.NBL>$FI4HJYQJ]53Y5O[<;O+=_!I*-R^E&,I12C?
MC3Q=,WG",H:JNGPS26BB/-0\^QM/GW,.3<7XS9O9?/S0XOB%JW/;II4GL2U)
MLAE1A:X2WE[.9M54C2M/[/9#)*3N[+V>W=6\GO87;,E;LQ5'J5?$K3"E4TE3
M/!^BI\5VTN76>67;.Y@[^ZFZK3)I65&O><J-2;;I3&-,*U:IU#Q+C67Y]%F:
M7(_&?'(,[+1J6;L(O8R<9?'O(O;]7.U;ZO'6H9PH%>=W[MPRR$"01Y;O<V;#
MB]]"WH>&K/MPTMX<<:==<#'EVRW6\4H\JN7E>BJZ*J*X4K+4EBWAA7!U22J:
M1\@\"\>\&S>/PK<'Y3)RF^28\$O)(X*+BU.\,"RS5[&<CKR>XI%:*O" T8[V
M^0QLV6WC8GW]HY3MO)MR4/0Y*M>E8TR=#5O7NK2\+F,8VKT<U&,'<?6U%T2Z
M'@I5K'5BR3PO$</PS&QIR2E]%A\MSBA>L8Y,KE.28F-1CHZEZ&>M0BP5;(WL
M*D,UJ8HM@/+7C149PQ7=#;WXW)W;%'W:JTJ*LL]2<NE+!-4SGG2O-/>[2Y9M
M[;=UBO$47?=9:;=&E%QB\5&3JVG6E+>5:=*T_(G&.."?&\,I)G<Q5L1X7BN1
MF@&%XR%DJQ&O8BQCVI;D5)+<1GD><%(XJXE)0!2?'YQ-;3E<N9\[N+:[%6W*
M5NM;LI5:C#52B<EW4DDWJ:HU@?*/+%A\Q\P1Y!Y5LRYAS6=Z-N%Y+38A!I.=
MUPU-M6W6<G)M+3%U3HWV5QG#XKBV!A@KVEFB=?S')9JV\:3YG(VTC>YF\C.2
MJ-9ON Q]$1>U$"HJJ/RAS#F&ZYGNI;W=RU7I>I)91BN$8K!+@C^CO)>2\O\
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MA"0I(S=GIN!O -,I;QV.R6+L2XN[=R5XOC:MFAC)KKU8&9))C:M1I[6/J=S
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MFJ/';A$0_C6.1#N""3H"2K68;E>*U6?W()T$D3]CIWH?1NV14< _#<#5 L2
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M:0'U ^&MB=55 =8Z6_-3AER=.O0NN&,U2K=?(PP_,>Q1;>G0,K%-BVT8"MN
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MFV)'R@=20.NJ"LMR"*@U^T)JL$=86YUD1Q/ BH)722.N9',L8Z,J=Q)&PWT
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M"23N3L6 *X],DE?;*V*-FV9)#[F/IV*-=8B?Y4?M6;^0D:15_B?O 8^BC3M
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M0P&,A-6Y:LP9&UA+,2R%8XJMFU3DBMQ"2:=5:-'5F?9=SZ&.E,<@/8YJ^?Q
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MV[;D4OR:YQI* P\F)AB^I!R;Y."Y8D^C!7=*$56Q57ZEQN TC]J]#VMZ:8\
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M.W8$;==P O>;()5<XR&G8N[QB..]9GI52"ZB5WFKU+\P*1DLJB,][ *64'N
M%TQD6%)_I$L6XE4I#')'NKR=J2B&Q.L("JI.Y(4LH]-^F@(GD%'$RUX\GDL
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M ;8'#83&09.EA\&V#A:W+#8D2#Z.3(O[:DWH;4<K6IXQ[Q5)&96#*>T ;$S
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M94L"1]BG;'%V $'NWW '1#ICLS65PF*RA@<^T[K!?K07$4$]I_F=CH2-]B&
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M%^XPT\]^X?E>.IFI9\8\:H69A+8LPTIN2Y.*N#(0V*R)MW./6GAD "^[CQZ
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MD;=V4MN= (+E,(V>;'+EX),VM+9L0F1+O%75_>:Q)C4E,<<K=R_S73O"; $
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M>W^YVVSG<G24M$[ENRW:MUI<NRDE.=RY*,7*$>ZX1UOT\Q$(H^]BZV$&)QE
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M?=B=7M(26@&%=K5I;D61H5X(#++!"@M"ZMRFR]ON6(FK0I 95)!BWD&W]HZ
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MQ/\ %ML  IB(\TD-C\]LXVQ9>Y.];\LJV*T$- B,5X)19L69)[*D,7D!13W
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MKNHZ[D]-B(67Y+D-=):6/BR5Y71$B>S'2BC$NRS3-9DCG>*%%ZD(DCD= IT
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M[Q.W<7V C [B1MOJ,IQ_X"_4/^S3[H?+7,/!7@?SE@_(7EG@&'Y!G^8\,Q^
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MS03,Q$89B =7+?\ 5MON59F]O:L)5N0D[45"-*R;A'OP:6+<8IQXT53=SO\
MT#>;)[BW'>;C=R>FU<@MQ<E<N-TC&-V?\NZI2P2E.49Y1JZ'$-7[./!%7CS7
M)O+OE<>0VK6'HXSB&%XGR;CG',[!99HA<SOT&-P')Z=-XPOMU,_0F()5I5D!
M9>JZ_,][F$I<IA#_ $M3K"=Q.#E%T:K&5)JF7P+TX-\FWAY%VO)H6_,5V[_K
M\K>F[;L25U0FJIZ90U6G7!_F.C=*1HTL6YSCO)^;H\:H9'+\$?F_!LW#R#@\
MM+)F+E/-^14VKXV$_P#)KGZ^&E7'P<:R.1L96]!?L8FB5!CM33)'!/Z.YYAS
MBYN-OLUM?#WRDYZFU*RTH2BZ-.+Q<E5?$EBHRH>-LN4>7+.SW?,I[_QN5NW&
MWX<8N&Y3E=A.-8N,HX*#I*OARE2+E&HQX'C.?>9\/R//VO-7-N&<@6YG>'YS
MA6 CQV&EX6L5R2&QQZ]D<*N)SE^'*T(X7LRQV*]?(Q$;H8P$7M_T^'.-O'_5
M6Y3A+O6UW81FNK%RIFG*333JDDSS/]7N^7-W/_0%&W:N0[EZ7?NSM2R[V$85
MI22A"+4HN,FW$IXX^TRGQK,RY7FF2X_R6A7K/6QN"; 07\9!W]H>]9@SBV<7
M/9C@0QQ++3F2N)#+$8[*0SQ=%SDUB^U'<2E+;Q^XN[%_Q4=6EP2:72F<=CS#
MNMHI3VD(1W<UC<EWY1Z7!26F+?&34I?A<3LO@OAT9?'"#B7&*D?&)0RI8R]^
MY#Q>RB2R,8Z52891LA&DK-V-#5>LK#82*5V'-O=WR'D]RDX6UNU3NVX1<UAA
M5]U1PI@Y:J<#MY=L/-?F.RW:N7I<OE7OWKLU:EBZZ5WG+&N,8.%:K4G4Z&PG
MBKC?&?I\USJ_C<Q)2FB;&8^2EV8>I<.T=;Z3'R-:M9O+AV*5_E_B8>W )>UM
M?'-]YCWW,D]IRNW*U!KO23K-I9UE@K<*8RQRK6>FJ/F7*?)G*N3-<PY_=MW[
MD6M$7&EM2>2C!N4KMRN$,,6UIMZZ,SI.8X[+8N3*V^+91N*F5U3)Y&#%+!/6
MB4JN3&,M7EO#%S=8XW,0D?<$1^VP?7D?Z7?V^Y6VM;BW_J-%W(N=4W]S4HZ=
M:S:K1?BU*A\D_P!>VN\V,M[N-G>_T74_YDU;TRBLKGARFI^&\DW'4^$=#4CD
MOE'#;5#R!F_(_BRG4I\<YC%Q_B^9K<ABFQE*3D=>V8I<KP^%*]B7-O0XVADG
MKGVJB151VR*-D;YGR^].S9CL.9R5S>5E<:A*LHPBOBNM*D7-O1B]<I*#IC.2
M^L^;[6UN=U/G'(H2M<M:C8C*[%QA.Y)U<+$6ZSC:BO$HEX<8.XM5%;MO<_C?
M%U<EYJ\5\39S!A>'U,ASN^C]TBW[].K)QWB&/G:,%ULG,9.7((6V5VQS,?X3
MKZC^<W.?T?E.5E2_[OF.Z5NF7\JW_-N-=6KPH-?ADT\'0_2/]+_E=<S^9$-T
MX?\ XMY+L)7JO%._>?@6%+K4'N+B;^]!-8JJ]')L7+-EJV3.7RL<%:!HEP\,
ME6/%S2-W]UFTHJ&Y/* P"@S"->W?MZG7Y*XG](@NU<E+=ISP9@8_'P$-<II1
MK2S7F[CV(;UII!6A8D!@D7>1OLZD@B 4LKF&O5/I)<;%C5!:]]3!:GO2G<[1
M5/:L5Z\ (VW=_<V_S#JX@<S/;6:JM>O!+ [N+DTMIX'KQ!"4:"%:T_U4KR;#
MM+1 +N>[< $!K<=XKE!X<.]Z25W@ER$;8^/\LK'M9WF>S8BMR1R$]$@20DJ>
M[;IN!'YX4JTF/RLG&K/(<C4F:#'FA2Q]F_1-D*99XI\C9I04XS[2AG]U3\/0
MG4?33$$5R:GAA/A^0Y>KR2Q9ISU8:&.Q$F7L&.X[O:C-G'X2=J\C))'L\DA:
M$]BJ6((#'3-A=!/9F.C+5@GR-^[C:\$T=@FKD;6,DF949A5F:G+%8F5@-S$I
MW8KMU&X)]8'UJ[6J5Q>LVZU*E&!)8L76%>)8G4A.Z:>6!*Q]QEW+@_AL"=Q0
M1>4CS.4@H2\:SN-Q]>4B>>X^-&9^KJ2(CP-0D2_6K('&Y[B) P8$;;;-'7@!
MQD9LG/CY?[MV</)DU:%4ER7OV*"J77WC-'CY8YR_M=Q0!E'=MN=M'7@!XQE5
M(VD$;6!$JR21H54L>TR>V&9W2-G&X4L?AN3MHZE21B'())!'%;_(_P [MTI0
M]&)8\<;->21E#3UY\E/6BKA.T,[*_?LO0,0!K"K,N!AO*Y$O8\MF<3)E:U3:
MU^7BO-D/<F"]H44H0RW''<0 RL.I/IN=8MLIB7(L_;EP[2Y$9#'XZ***W/[5
MZ]AYXHT4,*\\N.L5["K\W:T0<AF^78]!J:G0M$0J^1;US#/?1K-+#M P_-)7
MEQ@A@7^69TGOQPO$H]%D(V)Z@[ZQU2%#*,3S'(Y>@LU&>8UIH2D&0@*RG;L
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M)G_G?Z6:'<#H&Z= &G)XL94N8_-YOE>6PF/ADKTH<;6R2X[&7[TDD\J"S[$
MR%N>9!M[:S! D1/;_$28)O(S(B4LB^<&(QU>19[3/^7QUKT4@7VH+%G(0R&O
M$Q/K&8Y#OMW#0%]Y,I;^@?#Y&A4K-(LUN::D^1>S5  =0.*_A&CCHM'=JP0F
M92=Y6$H ((4Z DV,@:/L5&4L1*6D9&1.UB&C41N)&[P!L2@V)._38T$;E+.5
MK+6&)Q4.3DEG5)_J,DN-AJP$J'G:3Z6Y+*R@DA$C.^WJ.FH!+,O],E?(0X";
M/7ZTIBIQ55QBW*PM;">6.UD[5.*M"1$HD*R;G9>A W "6>L8R+%K8S6,FR$"
MS5)5Q\.,FS=@WED62JL=.I#:,DT,Z@J^W8K#?N'KH!AR.7#_ )90S.=OY?#X
M^E-5O-#7LY"C))-)[;05<C6QA:U:]N3;> %E[P=P=M *V[]#)X2KF?SW(<:Q
MBR);DN3QUL*[PI(T(@O+R''/)5K3R;;$+$[CM*OVL-P)*]]1DL=%+ALS7H)/
M[-E<I%7KY..2BR&0M4,DHJ?SE*E96$J!=_E.X( LORY*WC._C=W$M;D*K'=O
M)+=H]BDK-((Z,\)EE!'0!U4'U_#3L I8.9K8<FLE++9N.O$H$KR8FC:M;HDT
MI*KD9*L(W9PG\P] O=U[A04$=V3%(<K2Q]_))'[[TZO6DUI"6CCK2Y  _(=@
M)'5#OUV7TU +6(8;F.(RN.AL*85GL8YXX\BGNQ 3")$DB"6)8Y%'80HW8#;X
M: 2M5:F:Q8BOU[L%69$EEJ_46J%I53YQ%,<;9CE(('S1]Y5AT(/IIF#">7^0
M.#\5X/E.3\SS=O@W%:!%27)987^.WY/;5'B@Q<$B19J:U=5&CACAC^KE(;VU
MW .I*48JLL$#SQYA]SGF'SAD*O!O >'Y)P?B^0DBQ>.Y ]&UF?*_,AVA8QQO
M%K]=8PT5J%25L,T]^0$2JZ,70<=S<-X0P7M!7$> _$7@GZO*^<>1V\MSB5GM
MY'QMPG,8_.<]M6WWLSMY.\F71D\'PU9' ,]6NN3R(]P]T%=@3KF C3\^^9/+
M39'QE]J'C.UC>.*K5<IA/$$$F$P:PA1VMY)\R9BQ^:Y^Q/#V=ZW,DU6;MVCA
MCZ)H#H3Q?^F1S#D\57+_ ' >5K&*J3@2MX]\0*<>L:, Z097G68JRWK1/1+$
M->D$.S>U8V8, /0_Q7]I7V[>'T1>!>)^+8[*01H'Y+DL><_RJ9V7>67^].?;
M)9I&G?YY%AFCB[O1  H '1J0)%[4*QOL1VIVJS*@11L&;YNWH.F^@%?I8X/>
MG*M\_:TFV[$]JA1VKN?\F@%_HXV>.1DW:/N*-LP*]X ;8 +Z@?'0"BP"16^5
MUV9D/<"C;J=MQ\WH?4'0%WL#N"['<J6WV/;L"!L6WV!^;T]= (2Q+"C2/W%%
M.Y.S,1WM^&Q.P+?T#0%6K]?3T_P_$: 9>PEB-'['4=_>H<&-@R$[$C=21O\
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MB 2J#IN?7IU OMS9"O0,E6G'DLBL<86LMA:%>:9BJR,9YA8:O74DL>DKA1L
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M"+H #OU) =78LQ+:I&A=H5**.7R"3T)KERRH9>V&I,MZK!3#+OW.\<Q]-@-
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MX;#Q7,/A,;8QU:E:[YA+5OQPV;-J-)9)X+EX$Y(D;!Y4>0!AVD[@@%18(#?
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M!47>7:O#."#DU^Q3>Q+5P=)1?Y/F3:WR=Z:T).Q6R$X=YLG?6L\ENV[&6*,
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M]*,MD9($4ON)B%ZDC;3CF!^(<P,P]F7)TUPGL+%7QD>/*VWLL%[I[.2DMN'
M?<)''"FX(W)(.[&O4!P_YK^9Q=GY>,.*K&<O]2<FUTNP18@.VJE58]B22SEM
MQL!UU<:]0+&GROYK'73'5#B/IO<FR;Y)TM+9)D K0XM<?(LRCM4F1K$8 8[
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MNX[]O30"4E?H=M@=CL2-QO\  G;H>N@&*UI!&HF*M)U[B@V4G<GY0?\ @[:
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M)'DV"[GH.IZ=/70A64V%@<PI#+9$9,<<LKUX))@ORJ\R0VI(8V;U81N0/@=
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M(3NF27&8F6"&EDK*UU@I0-7JXV!:D!]B!)[DP81QQ]R1_&)\T>]WL.:WX_\
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M[QQXJX]QRG8I<=X=QZ;E-G)1-F9DO2R9JYC/HZEHBM47ZB&A#9FZK%J=N/\
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M'#53,Q;]1LM%N_63-)-5- PPBO E>5;B6 TGU#S6FM-#)"R]H1%A1E()+'<
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MLY'$1.Q@MQFY414>Q7/W3Y"\^0\./ESS'>4-M5>#?FWHA**I"%[]Q+N0N/\
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M'R!1L-M_Q- I.UR*G,T$=>W?2"1H8G=Z5:Q85"8XVD[;KUHI'V!;:0J#OL=
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MT^_7K8*CX+MTU2"QBO&^)OK(ACQ7*?0BG_.:R7W^H:\;!_EA.@C$0Z]2Q]
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M;*SPQ+U(0)*WH-_CH0;9&.5\=%8GPE7,9*J(+$6/22JZ)>8+%*].YDDKI&L
ME<B4JCF,'9>X]NA1',8ZCF,.J9["+DTC$5U\.#'<[K4:-VPH)'K5[+H9"!WD
M1D]3TZZ KE,5C,WBH(LK3O1U8/I\B*5>S?J6H):\3/'"ZX*VLEEX.XCV4:6-
MG4=H8A3H!6.2/D&*8P/FL3'88*DLE:SA\JBP3(S%8,C66U76;VRN[QJS(Q(V
MW#:R2XDR)6%HVB7VI1,B;Q>Y[@E):%C%('D!/=(LB$-OU# []=9$*S"5HI1
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MPV "-"6K)5N8_&9J._<H//5LV);4.3M4K\G?(J9"**2,I)"SC^2WM_( .@T
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M:;#_ #CH!MC;.8ENW*]G U\5B8/<%&T,I#8M7']\@,<;5J&"I#(F\FYL,^Y
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MGZ6)#U/9'WM_G#0@I:&2-BE]%)1CJ"1SD1:AL2V'BV7VTI&*>&.*0MOW-('
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MR5ZG:B  ,O'(6)) "].RA2#N/C]1JORJ]/0>:7^UIJH^]+[<&"J&?[8*_<P
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MO3J-4UD1CJ]*[B;6.K8>]Q[''ZBG%!'%%A)6BE4^Y:H)C; LT@SR'M9A#+W
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M9@JE8V=3(1\H8@.X4=6"]-_V[=- 0DT?MJYEE!!=BK-VH%#D=J _';T!]=]
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MXHTENWVLKA5/:JNN^VYW]-4/ DE974.K!E8!E92&5E8;AE(W!!!Z'5,"NA"
MS4V4JM5FPO'ZV9O32""6>SD*V+AI5 P9FFM-!;N.K=Y[4BADZ[D[=-SKP*2$
MV,QUNS3OV\=0L7Z(8T[<U6">S2:4#W?H[4L7O0!]AN4*]VW70AC?*8N/UK&+
MS.7Q>5RU^G81,17QM;+9*1+(?W1(M"FYHHZL QEF51\JCNZ*!&4D,_F<#C*5
M6SG\DV)ADL02UE-VW2M3V8]I5K)#CYDM7=M_YD $B..C*1HVN('EJJV7AH6*
MV5RF.A#1W **UH&NPR1AD@N)D*%BQ%$5;<JOLR@]"1Z:I!U=6T4A:K<KTECL
M12VY+-4V1)23N,\$1^JJK6FEZ;2M[BH ?D)(( 2O_F<L$1PTV-CE>16>>_%8
MM0"L48]T4-6Q5::1V[=B954#<]?30"EXY-*,AQL=&QDPL0B2]-8I47<N@F:2
M2O!?L1*L99E4*Y+ *2 2P=@&F0^JCH1WEPU;+YJG%&T%.*>O"!9F,*6A3R%]
M(Q!$HW;N(5F1/3?8:>\HG8JPY;$PR<APE>:2#;(/B6]O+K%:K"1HA"3%%':G
M"GY/D'S-M^W3AB!:Y'3R.+67*4[4=;VHKL]&3W39B:-1-[$\.,FG^IDB;HT2
M-*CL-AW=-,P66'J9C#S232Y3&4I8GDEF[[^ R,$$#%WE+GZ7(405CW)/8W9Z
M[;Z9H"^/:G)BH#1LV33-9A!;LSVY[0B 91.]C*F:U*Z[;AYBY.VYW&G "%;>
MQA0N$S4-R1H9(JN:M>WF8FF61D>:=:EBC'::.0,"J21@$;= -M.& '-%;D5!
M(K%Z#*9&"-H[%I85HPSVU!;9J\+VOI%W8 KN[*O7J?4!*!LW%CII+D>.N91?
M?>&O2:Q2IR;$_3P-8LFW*K$#YI.S;<]$Z=6(',$EQZ"2WJ445UJY>>A5M"Y$
M)>TDUXK=B"@LW=Z=S)&NY_#KH0:PQG-8@PYG%-26]!)%;Q,]B&P\<+LR>S/-
M2D: M)$ 6$;LHWVW.F>91*KBL7#A7Q5?'/AL6(9X/HZ;-C)(X"6#RQ2XJPD\
M#S#=^]768D[G9B=**E 1_%K."R.!:'C$M^'%P26J$%F:+(I867;ODLU9LY%)
M/;4//W)*PEC+ CKVE1%2F )K%FO'6^BAR;Y67''Z2U8GLU[-T6$ 9EO&LD2)
M9[6!*]B'8CIJH#N*U6GDGAAL033565+,44T<DE=W'<J3HC%HF91N P!(T(4J
MBTL*B[)7EL=TA9JL,D$/:9&,2K'+/8?N2(@,W=\S D!0>T +CN^;N(/7Y=E(
MV78=&W9NX[[]>G[M ,4]ZZMVOD,?"E-^^ND<TT=OZVO(KI-]36$1ACBD0[=A
M>3N4D,!Z$",P4Z_S\?4XU:P&*H!8Z+RPXVE4M!F9F^AQ]*S+/7B7U_FQQ$]W
MION 11QB./8; QV8\31CIFY)[MN</+-;M2@,%>S<LR36K!C#GL[W8+N=MM]$
MDL@0G&Q@,=DLMAL;D\YE,DKK8RDN2M9S+0UW4E4KC(VDDQ-6<>Z=X8W65@/F
M4A1VQ4R!(U\ABJ><LXE\_)=S&0/UB8B>Q!-+0K)&S*L%2K7C:G4]OKW2[LYV
MW9B>MPKU@D4;V\E9$V62031UQ6Q)6G&:VP(>;N ^MG>RX.W<W8 -@N^YT(16
M*;E39O+_ )U-@8L.&=<'1QZVI<G)6650E_(V)Y$C1BGRF..,KWM_%\N[L:XE
M):O+E7NW$M4Z,&.C[5HSPWY[-VT>A=[-5J%>"F@!V 6:8DC<[:*OH,6Z=I^=
M1]['AWRMYL_VBORKXR^WSG%'Q7YIO>7>-\B\2<VLQO'CN.^0?'_V_<;\B\5G
MM&M!9-2K<SG%XJ\D_P!/:2!9S*]>PJM#)YER,I;IJ.$JX>HW1:5NKR.V/NK\
M.?[0[^IO/Q7[2?/OVX>./  >0.&_->/\'R?!7O('D7C5;CO$N!<ON8.%JV+Y
MMSOFL/D3GL_-:F'BMO9AQ7%X5@-IE8X_W8(_I]DX[J]W)))?3Z8&*=N.*9ZS
M_>S^B4O-?TD?&'V+?;9FJ-OR3]N>3X[Y)XAE>23?D%3RYSS&U.=OSVEDK$UV
MW2XLW/\ *^2LQ>H)/++4HW/I*\TZ5T:S'ON;>MA6X9KVF,9]_4\F>1_VQ\!_
MVA;_ )$</^F=4\5\1\ ^*[& S7C:]YO\C+AZG)N#>*>46<O2Y%C,'D,!S[+8
M;DM26#)6Z]6]B>-Y#.(75X\A $%F+1!;K3X-*+IZOIU&;\/XCNK_ &?W]/C[
MTOT\?.GW1\0^Y#Q;)PWQOY6Q'$IN"<_Q_D_PUF\;S;,^),[S:CBZ\G#N+\_Y
M)SVI%G^->0K>4@]ZE#'56FT=IDE,:-LVUJY:DU-8/K7 QN24DJ$!^EI^FE][
M/VU_J^_=#]T_FOPPG"/ OD,_<W_=#GDGDGQ%GTS \B>8L+RCAP/&^+<^S?,,
M;^<8.J\_^M8^#V"OMS>W(0A6;-R%]SDNZZ]'2)2BX)+,]XOU+?MJYQ]W_P!C
MWW#_ &Y^.[^%Q_+?)/!9:O'GSLLM2E;Y#Q[+XGE_',7-D$66/&ULQF^/P5)[
M$D4BPPSL^P[=]=%Z#G;<%FT:X-1E5GSQ?H8^/?UCOLV\A\-^T?R;]HU#AWV@
MV_*7/_(/E[R)R9.-2<NP5S-^-+6'QE?B_+,=Y/? YW -S+C>'E>.AB<I<8/*
M!.L#_P OFVZOVVH./<KB;+CA+%/$S/\ 2[_35^^7[:OU?_N8^Z3R]X';C/@G
MR5;^Y6'BO.E\G^'LT+M7R-YBP_*N*W6XSQKGV;YC57(8"D\_MSXZ%X2!'-[4
MA[=+-JY"^YR7==>CI$I1<$EF1/ZH'Z47WJ^+OOYPGZG?Z8=2'DWD3*9V/EW-
M/&T-C"P9S!<Y7C[\9Y7FL74Y5:H8#E/!_)?&Y9XLQC7MQY%+=NS],LD=A!37
MK-Q7?&LYB$HN.F1QGYV^TW]:+]8_S9X6I_?+XJXW]J7ACQS;GQK28G%6L-B,
M/4SMC%R<OY'QOQI+SCR3Y%YKSK-XW&0UZUB8QX6&:)(6L4EDD[]<X7[\EXJT
MQ7TZRIP@N[BSU2_7_P#T[_/OW)_:[]H'B+[/O&QYSCO!/))\18PN3\B^-^$#
M"</H\!QG$N+239'RAR[AT67OL,='7[*\TU@G=GC&^^MNYMRG"*AP^G$UVYI2
M;D=>^9_TU9ONP_1M^W_[)_,%K'>*_+_B_P"V[[:H<1G<K<QV<Q?C+SUXB\4<
M>XO:AR>0P&1R&'RF&FG;*8"_:HSW(C0R$T]0S.(2V<K6NPK<L))+UI&*GIN.
M2RJ>$W@UO]I6^P_PS-]FOB[[;N.>2>!8M,SB/%WE!:_$_(D_",'FI[5B*SX]
MYQC/)F PE3"+=R$EZA'RK&69J/N",Q0PQK7CT1_56XZ(JJ^GTQ-C\&3U-XGM
M7^BO]@?WC_9SXHYAS#[M_.O-/(GE_P I28"I0\3\F\Q<Q\C\ \,\/PQOW)%K
M&3,Y;C&6\A\@R%\?66*'N5*M6O%'6MR"6S[G3M[5RW&LW63X5R-=R49/NK ]
MV/;C+B4HGN!2@D[1WA"=RH?;N"D_#TUTFH^(CR9QB7[$?]J0\;\\S&-LQ>/?
MNEY7#R'BKI]&3FKOW&>/>0>)[L,=J]/7I5K5?[@)9V*M-$R5_:+;)*I;SFO"
MWB?"7UX>\Z5WK-.*^GN/M5Y'A\-DZB7LSC+>37#PV;T%&L]V6:1Q$LCQ)CZ5
MA(LC:<0A8T<2?,=EV[COZ#2>9SH^"O\ 5*_02^^KR%]\?GOS!]I_@!.:>#/+
M_(X_+E#*6O*GA#A=CCW*.>4:_(/)''\C@N9^1>,Y: XSGEK(RP_3U9:WT<\*
M1R2,K[>;>VUQW'*"[KQS1TPNQ44I/%'VS_:I]O\ QO[8OM9\(?;OQ>W[.%\4
M>+N+<1DS%+>H^4R=#&0S<FY+_K=>-Z]CDN?FMWYBT4;+)98]J'T]"$%""@N"
M.=NLJGS*?[0K^F1][OWY_<CX-\G?:9X9K^7>!<5\!P\0SG)(/*GAKB->KR"/
MR!S/-M22#R#Y#XG?OJ,7E()38KQ2U_G[?<[U95X]U9N79J4%54Z4;K4XQ34L
MZFI:UO\ VP6[%[].S7MP][Q^]6F_2VGB]R-BDB>Y$SIWQN"&&^X/0ZG_ '_T
MTE_[?Z5/8']+^A^LYEN"?=UBOU1JD%[,Y/BO!,=]MU*S;^UNA!:OWL5Y7J^2
M8)+GVW13)662:7C0[\XO:/\ V5('U1&^S^HI+QL^&77T&N?AX:/3]&<!_P"S
MO?IH_?#]AOF#[DN8_=)X,;QMA><>*N,X#A\R>2_#_,WSN<Q?*9<I:QJ0^/\
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M_&22!L.H#7#T\?BS9Q6*P?Y11K.LPD@K4ZU&Y/8'=*\"P3&>69.T"1Y(UWZ
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M<2+#*\2"258W,,18*LDBJ2B%CT568 ;_  T K71Y8H);,*1V!&K,FZR&&1T
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MB.*"TR"Z\KAA&2(T>(2S2,".G3N/H?366"55D#8V!\4^4>0I",#X\Y[R'O5
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M>RX<0RR02;!@%EB/;(GS ;E6Z$C<;Z N,]=;$55Y56Q,CR10G?O=(_XV'38
M?MZG0"<TU7%QSVK5J1(9)0Q,S-(L;,H41P(B%@I[=]@#UWT X$:R2I:6:8J8
M0JQK*?IW5MV60Q?PER&_B_#;0"2R5<E#((9W9(K!B=X'DA9)ZTBLRAAVE@K
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M/91Z_P!5@\E!'#(H5JY[8;=(,(]A\J-V'T .F8+8,+%3PHPE&]DZD:0RPQ9
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M(W 0;RRAI.I ;J0;Q ]GFBJY"![676NMM!4IXN9Z$,5FT&+M)"TD0OV+15@
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MLHPE",[PI*;!!7<A$=EC[W(_8!N=OVZS22R!E&'\><ZYC44X3Q_S;.QS /\
M3X?C6;RLS@;.B]N'K6_=]P;$*K,&!'KOK1=W>UL_G7;</XI)>]E49/),VW@O
MM+^XWE554Q_B+F..692B#-)0XA/&J^A']X[^)-?HO3N[3K@N<_Y/:^+<0?96
M7^%,R5JX^#-P8']._P"XB]%'#;AXAQX!2ON9_ECW)5_C/=)+@Z'(GD;I_P +
MU'[=O/N>;>46_A=R?9'_ -IQ,U8N/H-H0?IM9VC6]_F?FKAW%X>UP;=?"VLG
M$K!9=F[\KE.+1,1M&2-P!W-_FCNXWYQM3=-MMKDWVI>Y2,OT[XM(8+]LOV9<
M*45_(OW?8;(WHF;WX,-RKQWB+V[,WMHV+A'*KD*[.H&ZEF"L=_BN4><>9=S_
M )3E\Z=+A<:]?=0\*TLY>X71OTSN,; 7N?>2YHP#VTL5Y5N0%N\=G^OX7#<7
MPLG<'/3WRFT9#=>C9^%YWO\ W;5A=;M+V2E*7L%-NNE^L73[B_LTX^H7B'VD
M9[/.@'9/RSCWCX56/\AAVR<FYCR++!U21_F:HNTB  ['N5_H7F6]CN>80AU1
ME<K_ +L(Q]I==E91%:WW_9C#PM!P/[;O'/!H5!2%Y.7M9;L;L[O<Q/'.!\?K
MQ#Y/X5NN&&QW&VVB\G6[F.\WMZX^J'URN2_PCQJ?#%(Q++??I]R.4W2M:\:<
M<B/\+8/A.6GNIN(R0]GD?,<[3F*NK ,*D8*MU7?8CKM^4.26_B5^;_>FJ>J,
M(OVLCO3ZC6.5^Z#[C<V77)>9>6&!MPL&*I<2XP(U)W[4M<4XU@\@?P[FF9]C
MZ^FW?;Y!R2U\&UMUZW.7LG*2]ACXEQ\37$_D/R1<GAM7_)ODW)6JUB.W3LY3
MR+S3*34+<#B6"UCGR&<L_ET]>=1)&T'MF.0!EV8 Z[([#80@X0L6(Q:HZ6X*
MJ>:=%CZ3'5+I9W8&A@L+!'6=6M&:Q)+#7(@#H$#/9G50@FE&P7<EFV_ :^I#
MTS#H<AQ;#<HN4(KF7N<CR\T'U=96Y#FHJB3D301NJK:Q6$J0QR]X!]D)"=S\
MFVI55ZP9%)=QU+,1U;.:1+^6B5<?AK%NHA=:BRO-+0JA$M2,X),C%G'R[#;;
M;5!7)7*5&Q1L7L_'B(09D^DL6,56JY)Y%0*)7O5WMEZ^VZB"6+<L>_N&VP$L
M[I&I=V5%&V[.P51N0!N20!N3H!I,<C];4$"TOR[LL&^TS3_6^YV#Z5:B(GL%
M"^_N%VW ]!\= 5GGM):I0PTC/6G-@W+AL11)12*+NA_DMO-:DM3$* H"JH9F
M8;*K 0.6KU,=D8,W4XC+G,W9[:9R%&+#I<J5U  ]^[D[M*2&L48](N_<C9@-
MP= 7YFA@$R6-S>1P\V2RE=XZ>-G@QE[+24F,CRK*B5X;%?'=C.6-AQ'ML!W[
MA1H"1NUJ_P!=C[\]O)(]9I8JU*I9N+4L2V%[&DMT:?\ WN]I.H]X/%#MW[*=
MVT 9"#:>ID9LU:QE'&B:6W61\?#C[@8(%;(SVJDMA(JX!($<L0)/S$[;: ID
MX;$AJV$SDN&I5'>>Z88<:WUB?((HIK62KVXZU53W=_8BR-N-G78]P$B6DD->
M2O) 8&8O,Q5I#+ T+^W].Z2*B,961NXAP4! &Y# !*\U]:['&Q5)K?<@1+T\
MU:OVEA[C-)!6M2=RIOL O4^I&@&69MW*-2.S2PDV>NK/%''4JST:SQ^[NLE@
MV,A/!'%%&OKL68[CIMN0 EFI*\%*'(VL#/F[-*6&>K2ITZ=_(06F91[M,VY:
M\,4D)ZF02)L!N#H1NA'<KQF)R&/BN9J#.3UL:PL#'X:?,FQ8EF:*)(Y*&!F]
M[(,CD ='6,%CN%+'59@(Y7%U^68^A>M9+E6!H0K+;L8ZM8DP$UA%.Y7+JL'Y
MFBQ+$2$26/HVY!.Q $I<]N7"1R4\W/@JD<%><98K5>6&A"JNQE?/5[42"2 ?
M-),C,-^X]= 6M:'(<-,_%^0U(WE+5X,Y5AJYB&*2%PL[Q1^XE.>3H0">Z,$[
M]I'33L YO)FH<0T>)EHW,U'#72*?,^[7I6)5>);,]I<="7C+P][*L: =^PZ+
MU "[MDX<:76*G?RR5P?9227&TK-H ;HLKKD9JL#-\2)6 ^!]-4#2U'/8PP.4
MPM/*71%#+-B()*]JK)<1E8+7L96.E"RQ/\P>18R -P-]@8"KP0Y#!O!FL-"*
M\M1A;PK)%DXQ%%NR5ECBC,5APL:E513L^P7<@'0%E&M1OX&&DF-N8;'35&J)
MC/YF'N5*J%H4B7\NLI-2[HT!7VY%<*1OL=P 'J5:F.QAJ)-+5I5:DB?4SW9Y
M9J\"1L7GDOWI9IR\2[L9)'8C;<G5!!X3(XS,8BW!Q;.2W/I_=K)F+!N9=8[D
MJLXE6Q?=8\@(F;?M20QKT7Y1L-3L _X__+J2UI>1?WENU[,J7KI_+D>&P=B:
MIK8V.*&FL*@;1L"XWW).@)*BEZ.K$N2L5;5T>X9IZ=26C6;NE=HUBK36[\L8
MBB*J296+%2W3?M%!= MB2!EOI6+L\P*0=\D!@,C^RK>\JEG]GM[^@'=OMTT!
M'8:YFKBV7S&%APH24)3B7+1Y.S/%L>^6RL%2*M4Z[=JK+,3UW[=AO 2R111*
MRQ1I&KO)(XC41AI)6+RR'L WDD=B6;U)._KJ@@<1DH,DEJC5QW(*-:HC5TNY
M2E<QWODEXR:;Y%DR4S*!W"1HP-B"&)Z:@$N-M@X1D,;AKMZ\U.V[Y":Y<RV3
M/UDI*2*,EDGGCD=3 0T<4A6,CJH)Z@/,7'5IV;E(YRSELF2MJS%?O59;=>!R
M?9"X^G%4KTZP]S8%8$+[CN9MAL!?C#9KO-3RF9IY+(.[V8XH*L./>"HP54C6
MF+5J9XT<'^8S$G?;X: I0BSZ9#)29.[BY\:[H,36I4;%>U!&"Q<WK$UVPD\A
M&P^1%!(WZ;]H8@LJ2\BDREM;E+$U<)'WI3DBOVK64M,K#LGF@-*O4J0NF_R"
M25P?CH Q[78<A;QZ8&MC<)5B0T;\-RL#<G?M:5$Q5:N/I84[C\[R!F8?P;$'
M0%_YU&MV_5FHY*K5QM8V;.8MUXZV([%C$KK#:EG66P8XR2[)&8T[2&8'IH#R
MF^T;.6,ES?RU]QUP.MG$8WR[YGIR62Q^ES67GEX7XVJF1F[HACN3\DQLE=%8
M,JPCM].GER>J3ETL'17Z9'"_SWRYYP\L6H>^MQ3"<;\4<<LL%:-K.2D_O7R]
M(P0?;L5)*F/0L.I28CTZ:Q![:1I+_+]KL'\Q/<+;G>+^WV[?V_PWZ: GH5Z=
M/Z/PZ_Y-AH"4J)*(U]XHTO4L8P0F[,>T+OUV5=AO\?70$C$)_J-NV(5O;&S;
ML96?<[KMT"J /V[Z D&%C^1].(OFL)[_ +G=N*P#&0Q[?]MWVVWZ== 28#=K
M% O?VD(&W"]VW3NV!(7?\- /44[ ?$^OX;_'^@: O@]\F59HXT42D0&-V<O#
ML.UI 47LDWWW W&@')]T/$L:QF+YS.S,P<;+_+$:A2&+.>NY&P'QT 6OJ5JS
MO3C26V(V->.0A4:3^SW$L@V_>0/VZ 6KB1H:TEJ-%M"%/="@$1S.B^^D;;M\
MO>-NAZ@: HBRR^^EF&'VO=VA 8R^Y" A#2HZ!5?W-^@WZ;: 49+/NP",0BO_
M #/J._N]T;(/9]D+\G\>_=O\/30#GL'[?\/Z- 6/'T9T53+V$)OT!.VZJ6V+
M!2WKH!CCCD):B29*&&O;+/W0PL2JJ'(3J7E'<5ZG9B/\F@*K)=-V:)ZT:45A
M1HK/O;RR3$CN0P[;HBC?J?V;;[] +K,EF,1?35UG+31K*'E$0CA)_F2@E6[V
M4>BCUT HZ;=SHH+D;D= 6(!V!;0#2(22PQ-:AC2?8,R*PE6*0@@]DA5=R ?7
M8: "#N00.W8;'?J3N=^FVP &VW7_ ": B;7UR3U8ZL-=JI9A::1BCQ1@+V&%
M5Z;[;]-CZ;=/70%ELS)!(]>$3SHOR1%UB#G?^$NW1?Z= -"&**SH$D[58KN&
M[&8 N@?^T%/3<>NV@(Q@\@E$T*H!(ZHO>LHEAZ=LA 4!._\ S3OMMH"+G]X3
MK&L6\!C):7O4%7!)10GJP('7]^@(FVCHC&"-&<L/E)$:G=ANQ('P&^@(FR@Z
MG8;@$#IUV/PW]1Z_XM >+_ZH/##C.2^ ?,:5A!)9R>=\/\EG39O?@ST$O(N&
M5BXW[5K9+'9%]B3W&78;$=0.4/O M6+>)\-^>L4DDF6R/"/'G-[%B&:6E++S
MCQ'EY?'7)Y6FK,D]&S=AX@EYY(NUB;8D'5B=5/2T^A@]9>-W\3DL)C;&#DMR
M8NSB\=?Q]F<7IO>HY2I'>I31W[_O"^S5YE+,)92I.S'?IKVDTU59&L5H6*C+
M?P]+*O<R&+ CN36'%NS4L7EDLU_JB%BB9PK=PC';VQA1L 1J@<8F"Q6JF"WE
MYLU:BFD$]R>&A7D5V[9!7]C'5ZT,2Q1N-@P:38[LQWT \@6PJ$69899.]RK0
M0/701EB8T*26;3%T7HS=P#'J%'IH02J_7]UOZT5 GU3_ $/TIF+&EV)[9MB8
M +:[^X,$W3;8CX@"CH$DL"K*%( 8]NS@J#NO:Q8 $[=0#N/PZZ$(FE?L3Y"_
M3;"7Z-6J?Y>3LMCUJ9&5W/N&I#7NS7"O7<O+%'O_ )12S&VJS7LM1K8>[CQ6
ML">>[+CTI4,G:M#NFGJ3!@]Z4%-I9"G4[?,= ,\%1PF+O9FEC[=RSDGEK7LL
M+^1R&0G4VDE^E8-=EECBB9$;9(ME4;;@?+H&*T'K4<KD,=-R&?)9*_*^5AQ=
MR:D9L908^VD-6O5KP21T$=2$>7N9MNK,P)("M8S5<I83(<ABLO>+/C,,8:%/
MZ:LC,=XE'?D;TJJNSR%^SH=D70A,H)09?<>-U,F\(2)HS'%V(.R5FEE$LGN!
MCW (.T@=NX)(#4-DOS%U:.B,2*:F.433MD7OF4]Z/ :ZUHJ:0 ;,)'=G/\*@
M=0&$-S*G.6*']WS7PRUS8&?;(T=K=P^P/IX\7#[EP;JS;RR%!_+]#N- -+-A
ML?G((<=Q.>S)EVB?*Y^JN*J5H8X]H>^_/)83(7)X(HQVI[;;KL%/J *+P8K$
M8C*3Y"M2N-D<Y)[=NX),C?';&6E F>Q-/!0K(S[*J]B^BJ-E  A)_0I]<;[6
M+K.(A#'6^KF2C&O]IA2C9*\LKGKWR*[KZ*5'30$%F<;"<A4R^1Y3E<5CZKUT
MCQD62J8G$V+/N,1];,(([MMK!*J(C.$/;L%.YT!-WPR^Q9;*-C:M60RV_EI"
M*S&1VK%8GN0S>Q"'.Y*%'/IW#0%N0BNW*+)B<C%C[$WLO%D#43(HD/N(\AB@
M:>&)VF@!5&)95+=W:VVQ 7N?6^P?R_Z46>^+8W/=, C]Q?>)$!$C/[6_:-P.
M[;<[: B.029&I%7NX7C=;D.42988TGO5,6:M:0,9IOK[,%B1$&VW9&C,Q/IM
MOH!;)E(JD&4L8!LMDJ21O!4HQT;=Z">9HO>6A:R,F/B54=06?OB+*@.V^PT
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M#;KH!OA9,9!+D,14S<N7OT9UGR,5S)+D+])[: Q13*"#5B98MTC"J!U('74
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M4IC4I)AZ=+.LMGD,C7<Q$!CN/W+N.CC5*47?8DQ-%*\%^<]J-),S/-MU_A4
M"\03#SP1/%%)-%').S+!&\B(\S*O<RQ(Q#2,J]2!OL-"$68<\<T)A>QB8!(.
MTT?H+$F3GL%&WE_,/KHJ]=$D*[+[$FZ@CH3NK&O44HTW(#FHX4I8L<?$#-->
M>_9.4>P4;LCAH+1%=$67;=FF.Z;D;'Y=,:]0)<1QJ[R*B*\G;[CA0'D[!LG>
MP&[=HZ#?T&A"(;'8RMF5RD>($N5OQFM-ED@CDEKUX8DVBEL2R"2O7D$:@)&-
MG8;D;]=.LHAE,MBL9D\7%:K7Y\E?]VO1-+%Y&^$C+Q"=IIZL$M:G$&=2S2LF
MR]?X02 +\Q<PF.L8NWE\@:4QL/5QL;7[L$=JS83M:/\ +Z\ZP7Y%C!V,D<GM
M D@KN=V &^9>O0O4LQD^6?D6)K+[3X^S/B*.-O6F+E'LW;L'U9;M;;VDF13V
M [?Q=Q]>0)&W7REBUCY:.5KT\?$QDO5QCEMV<@AV,<<-Y[:Q4X2/XB()&;?H
MRZ DI!(5VB9$?N3YI(VE7M#J9!V+)$>YH]P#W?*2#L=MB(1>7DSR1P?D-7$6
M9FE'U!R]^Y2CC@!!8P"GC<@TTKC< ,8POK\WIICP*-<O/8IBA;K\<?.Y1I$K
M!JC4(#15T8S3O=R$L+PU%8D;)WN>[^$]=&!+DLF-AJT;.3P-[/M7OP3TJE#$
MOF)ZUZ-7>&V(P/:KF @@3.R*K$=0=1TX@7SF1Q-3$"WG7LTJ4K5>Z)1=^L,[
M,L\500XDRVYY2\>SQ1]X<!@0R[[UM)58+LG]%>QU6]9RM[#XZ-JV0DF2U)@S
M)$P5H8,A+8CKW*D+M(O?&6A?N^5OBN@)&::&2DU@733@,8F^M!@C]J($.9>Z
MY%+ L;(.I92.T[CX'0@VM2V[U&.; Y#&)[Y5TOSP/E*AK$-W20)5O4UF?I\I
M]WL^)WVV+L ZE:T:G=1-:S9*Q>V]B5HJTF[())&>O%.P_E]S*%78ML-P#N &
M^3GOUL=+-1QBYC((L9BH"U#1BGF#IN3:M!T@CC/S=W:[#;H"='D4B,A&EK"T
MK7(N+5\Q?@>*R,/4@I9HU;WS /2FR:TJXDA0[&4F+;KL?3><,02K2QW<5]3?
MQ]^K&8#:FQTJB;(1B'>7VFAP]BZ+$Y[ 1'"\I8[  MTU2$=?EHYOC<MF\V;P
MM">#W['6[ALQ!!#+W,CI7(O0&=8]C&O\QT?MVW.VF:*7=M&_QCLH96_B\=)C
MS'!ES+8KWZE6(=AL_49B-K$<BQQG^9,"=OF_ Z9H%,39J9+!&#CV<EN"&NU*
MOG+'=E)'L+'L+KRSB*')-W'O[E/M,>@Z=-3-8 ?X5Q]#' V;7D%FJTD-O(C\
MO222<2N62:'&1PU*[0[]@4(" H[MVW)J Y<Y&.@[1I3M9-8':.(R34J4MG8E
M(VE[+TT$);8%NUS\=O@!!OB_S6?')_>"MC8[\GN&>KCI9K=-$[B8HQ-;A@>:
M3LV[SV*O=T&X&Y*O$I7&37[-5CDL9%BY!+)%'4CNQWU-9541R/)'!!%&S[D&
M,=P4 ?,=]A48-\!M0,&0HVJ8Q-_$44>>C%%*D>,:Q7[=FL45H6OJJE=RY"EA
M!+N"0H&Q+,@[QM>E2K#'4(9H*]!OIU29+FV[*M@F.Q<!>XA][K(KR+W[J6[E
M8 !2L\*%Z4<EB22HD0E><6)&;W5+*3:E7LGD8#<A6/;\0!L- -,?:I">SC%S
MD>4R,$DMBQ!+9QS7ZD4LI*125:$-4PUX.X(A>/N( [F9MR74"W&)8JRV:M_.
M+EK<CM:AA>"C4GJ4R518Q!4"/+"CL![C@DD[;Z 5H#->_?;*28LU6F7\KBH1
M6UGBK@R=_P!?8L3-'8F8%-O;CB5=CZ[C9CQ ZKO=9[ M5ZL,:R[5'KVY;+S0
M]H_F6(Y*51:LO=T[%:8;=>[X: :4;M^S<R,%G#6<=5J2I'2O6+5"9<JI[_<F
M@KT[-B:M$G:"/>".P8?*""  C5S1MY:YBTP^;BBIH6?+VJ25<3/('5/8IRSV
M$MVGW)/<D)B(4GOV*]RN- 0N%@XKB\]D<?BX\@^<EB67)6;(Y'E-X^DJ)-F\
ME]940GN';'[X)VV"].DPK3B,27QN,AQ^1N,^;RF1N7U-D4\EDHYDK5HY%1FH
M8^&.O#! KR*I<(3N0"W7K<NTC> I%$*N<E>SR.>9\A"5H<>L/BH:\*0A'EGI
MPQU(LG9D41,69I74*S;CH",>)B2JI<%N21K$#4C"BQ55JNMA)PQ+S/<-IDDC
M=3L$$*[;;]QT(*H)_>E+F+V.V+V%57$P<=_O&5BQ1E;=>T  C8[D[C;)+B!L
M9[WY@M<45./^F,K9$VT#"SWA5JK2$9D8%-V,A8 =!L?AD"'0QT>020X[B<B_
MF86?+\DK18BG7=T20Q"VYLQ9/(SJVR](G[>_UZ-M..0),8S'0Y)LK%BZ[9.X
MB5;.32&M]6M:*,E$EL2,D_TP,:KV)W?,02NVY%ZP-'BHT<U#:FN9=[F6CDHU
MJ?U&4M8M!"HM2R+0@#XVE($B -B14/\ 9#[N0TX@DIFAKV$LV+QA241TH:\T
MT$59K$DC,IC#(LLEN?HH!=ALORJ"6)H&LU>_^:5[1S*UL8J>U^5+3JAKEEQ)
MLTU^=I9B!N"L<2QGY>I(WT 65SK9*F:<^)BPZH3D$LU;D^2E?=]DIR17*U6N
MA';\SK*?7Y?34QKU 4N/EQ9HICX,:]-I=\E/<MVH[,,(9/EHU(*4L5B612WS
M231!"!T;<[7$%+B6J\B6,7C*%JU9G@BO2V+1QSK44$-,9XL?>EM/ O1(B%!W
MV[E'73L RS$E*I:QUMN/6LUDFF^GIS4,;4L6:2,1[DTF0NR5:]"NGN;GNF1F
MZ]H;8[1^T"V8-" T;UVKD;<E:R$IQ8^ME+Q%B?;:6>GCUDB*1^UN)IU]N$^C
M*6ZF![8J)//4M//=C^B,L@KU[,\,$[2(H_UN"NP^L$07Y$;N7<GH3MJ@LO6*
M]>LEVUDABJE>2.Q/8G>I6@>(@J*]N3(0L((9&D&_:8I0P ##J" [@G@M00V:
MTT5BM8BCGKV()$E@G@E02130RQEHY8I8V#*RDA@=QH"RRMIX=J4]>"<M&5EL
MUI+D/MAU,J^S#;I.6DBW"M[FRL02& [2 UR4EZ.M(V.KU;5L%!'!=N34*[*7
M7W"]J"CD98RL>Y4"%NX@ E0=Q&9(QK.W<A3J1STL)/FKG>BBI4MX^O[)=6$L
MS6LG8I*(4&Z[J&D._P#!L3M@RK%F.9N&O;QT=C*X9,@]58[PQAKULE)#<2(G
MMJK,%ADLPL[*CCM)Z[$;ZQ>148[E;<9Q,UV_6R%:#Z?WIZHBFFR$:_*WM>SB
MGM3/-OT*Q,Y/I^.HRLQFW9AO8I[K/9I4IZDLTDMM+.(L5:_ML99)OJ5K6:+0
MH"W<W84 [@=MCK (PF"K#;PT*XF[D6J2P2K4R%B:W;O,KE^VXEC-I:DM?,W=
M$\BR1,NW:#'L-1&1B56K%9KV*U'+_G$M&:2I;M26(+<L=Q5#-%:^C6"%)8PP
M[HU5-O38'?4H" DX]>>&6#ZJ&[D84?O9@L""63OEKK-#"97@C"LH^+%1OU)U
MC1Y%(BKPC(RUHOS5*K73WF?Z$3?2_P"D<QB+ZAC,>V+M!)]6W( '332Q4\N?
MOKX#?PO+N.9FU3J5J^8P-JC4^EL2V#.F%R,K?4VA-5JFO;>'+1!HU]R-0HV=
MCN=?5'S VNG?6=Q^.U3TQ;^J2/[-_P#II>:'?^7G._+$W6>QYS&\NJ&ZV]N*
M7137MKDNFLG7"AV1]B8M\J\"\?CGI[+QG)9OCRW39CF>TT.5N9".-JRKW5%I
M8[(UHU#,2XZC80 H0->_Z_+?)5YW_+UF+?>MRG!^B3:]2:1^*_Z]?+L>0_U,
M\ZW-J*AMN9[?9;R*2IC/;6[-V76Y7[%V3?3)]!VOQWCZ'WZU;"V\75J2E(VF
MIP4JUEF9FDDJ0)+[Y3NZEGBC#;]-^NOEJ2/QN9;Q_ X^":[4H06Q*EEY;LD]
M?)F.2RW8'[<A>C,-E@-OECD8*/@-5*I*F;XGC'T<EJ0379S;L&PRVK,L\<&X
MV$-2)S[=:NF_15 _:3K)(E2:P'&+U">]/>S=[+26Y%DCKSQ4Z]/'PAI#%#2K
MUH$D52#VL\DDC/VCKON3DD2IFE3'3+:;NGB,+1+[-58>V965OYLSS&9C*I+*
M  B!?B23K)(QK@2M:GD5O3-,U%<6(D%:*..=K[3_ ,LO)/,TJUTB7Y@$6-B=
MP>X=5UDEB2J](X@^NCORUEQ].#$15PT-M+C?536W=6>(8Y*2PPUT4L6D,Y9G
MVV3;=M9$K4CX9IXL[9K5.+R5Z\P6;(<B>3%5H+DHC3VECCKS3Y.]*JGMWECC
M"]I&^VV\XY MI1XS%YFS0H8;(1V,F#D<CEEJ6'H2R@.$%G*69");!ZA8T+E>
M[<A0=].(&_\ ZCU?EZ@#)2<CO469B)<[9QT%.%  '1I9,%CRXBZ *CNQWVW?
M=F%>L<.H</%3Q^>ALV\[E9+>7$U?'8>:UOCA[*QO,U6A5K1KW0IV]TDI<KW?
MQ;G3B!9,?E$SDN2L\CG?%L@AIX!*-"O5CE=%5I)[ICEOW)2REE >-5)]"-]U
M'6O "]BMEWRE:S'F*U7#Q(JSXT8M9+=NPSD ME);I2*%MU 1*X???Y^HV8UZ
M@2(:S]0ZM# *@B0QSBQ(UAIRS!XWJFJL21*FQ#B9BQ)':-MS00UJYF:^7J5,
M?QV*SC+)63)9J3*5*2U22X?LH+!8MWIE1%]?;4E@.[8$B8@F99#$T/;7EF::
M5(6:$1?R4[9']Z=I)(]H(^TCIW-W, %.^J0CI\%AILQ5S\^/BFS%2!J=2\ZR
M2R5H9/<+B%2S0PLP=@9 H;9B.[8[:E%6O$HPSMC#XZ[BLEE<IDJKI))5H8^I
M;R0KWK,Y4$RXK&!GRDB @*)$D2/??8$[Z.F; \S-O'8SZ7)Y;/+A:->1HRMF
MY1HT+D\B%XXIY+,8FEE58F*1QR+W==PVW0\,P+9".Y/]%-4R\6,J13)/>8U(
M+$ERMNA6O'8LRB&FDO4,_MR,01VE2-R!3(KFY'H?DUC$P0&8MD9,C4MW7>KL
MI5:"5;M%%F?K\[NRJ-CVG1UX EM4A&9.2S7B6S0Q*Y6\KK%%']15IF)'[@\K
MV[ )CA0$[A%=SOT4]=&4D&9E3N]MG;Y04C9-_F(#$-*T2E4WW.^Q('0;]- ,
M[^,J9-8$MBP5K6$M1K7O7J0,T895][Z*Q7^IAV<[QR=\9/4J2!H"$YA)AH<4
MD^>S]WCV.@N0226J.4FQ$UIU$G91-FKVW7CG&[&.!ED8)OOL#J.E,0A^G(<"
M,;7RCY:E6QT]=+$-N_96BC5F4E)G-]H)%5E7?=P"1UULA;G<_+BY=B;!B.;\
MC<42G$^,YUQBLSR1R-<5#R.%ZG:2ZUHL7?A4S2%E[7+NJKW?(WPZ8<NWUSX+
M4_2J>^A##N0>>>*4J(7!Y*KD\D&B622:AD(*?9VDSRQ5Y&@L.Y8;)&TB#KUD
MZ=>R'(N8SSBH]K^RHJC'+/W,82"JHK82YDKJPCN,DBXBK-8"G?M51FY*\+/M
M_:E903ZD=>RWY:W+_,G%=B;^P51B&3^Z+,)!)+CN*4A(J[K!+8GNLS'8=BNL
MN,#@$^I"=.NWPUUP\LVU^9<D^Q)>^I*FO<UYUYGRK&?2Y2CBZM:5EFDQQHU+
MB!X9.^'W%LK:20_(#VDD?-L>H&W9#R]R^/QJ4NUOZJ"IC%WRCSK.T#5M9_-4
MJLL:Q&I3MSX=DAB("1@8FQ7]J,J@^52 5Z$;$C77#E/+X96H^E5]]15F*VLY
MF,M7"6,QEW  C26>:Q]2@B/;N&O(\N[ $=Y!)#$@[G?79#;V+:I;C%=B)4AX
MK1N562ED99>S^2+4DDEPAU([R6F?:9MM^NY /[MM;%&*R2!,83CG)L^CT^.X
MW+<DR,6\3''8FSDY%G8H56:KB8"5V]Y-EV#$,O7<[G"Y>LV56[.,5UM+WA)O
M(VWQS[8ON+S=515\4\WGL."T=C+<>L\9JR%U#Q=KYI:$?T^S#9P2".N^N"YS
MKE5GX]Q:KU24O\-3-6YO),VYQS[!/N>R\"_GG%^+\>DD8MMD.5XJ:)8MB8_<
M7%39F82;KU':".X= 0VW!<\U<GMY3E/^&+_XJ&2L7'P-Q8W]-/R"(C-RKR7P
M+"5U_P!/-C8,WF8HT+2*"6R-3C<9[C[8^8J-W(_LCNX)^<]I6EBS=D^O2O<Y
M&?Z>7%H?/]F/VT<3B:/R%]U''XT10DE?'Y/AG%K)4LH*PUKN>Y':&R2+OVHW
M:/F/R^F*\P\ZW'^4V$_2IR7K48CP;:^*1#0XC]+WA*BE=\HYWFLU<!5QZ9'E
M60FF4&-V[)>'\;PD!';+U*S+\=OF4[;5_P"<;I5M[>-J/32*_P <F_8*;=<6
MQ2GYZ_3]X<OTW#/MRYWR]X>QH)LQPS(9C&S$=C[')^1.27GE'?" V\;C?N#?
MQ'NO^B>;MQ_F-Y:MKJN)/U0BO>-=E91;^G62,?W]8/CVT7C+[1\%QQ4[?IK]
MW.\/X]'%V*L<9.,XW@+%E!'[49Z2J0J; = 1?_#[U['?<PE/I2C.7ME)(OC)
M?#%(QG,_J$_<ME/<CQ'&/#W%('!]N;V.5\ER4199 .YK5_%8]B@=3M[)'>F^
MY4E-=%KR9R6WC=N;FX_[$5[FR._<?0C5&7^Z_P"[7/33?7>;8\/0D#JE'A_
M.*8.2+O>79QD[\&=R)=8Y J_.%':#L6W8]]KRWR"RZK;:W^_.3]B<5[#%W+C
MXFM,QY \M\D#IR;S7Y@ST$A)>G8Y]FL;0;<D_P#>#CTN&IK_ !$;A =CMZ
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MY>Z)VJ4?RS&/D+-0VE_G3-)\L%" I& \KO&-CMOUVU:%+<[7QT+5L_?.8?\
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M\$[78(*<3IOW.8Y7WVVVZZ8@6R/YQM6&(&-!,Z_5R9%K1$=;^T:T-909IS\
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MSWY_JC>H145CMRQT@ET6Y+-- OMVK"I7BCJ2RMO_ "E>7M4 EMSL 'P
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M_7>] !+9>1=X4K(6F_A8LTC=OS#;8[[Z 8-EK7YW'B(\'E9*IA,L^<VIQXJ
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M@=@1LQGN+5E88Z8OW*\..GB=@EBU>,!CK3RE8U2-9W8-8E6/_-5D0*02#T+
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M2%"-^K';J BD^7?*/$:%2'#QQ'_79;S-?L6" 5$%"*L\*5EZ@O).KD^B;==
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M3\V^YWV.A!*$6X;<[7<C6DAL/VX^G'5%5HD 7=9)I+5B2[/_ ,)1$NQ_@]-
M. ESZMG,]8T# %2L*DHMK:[]VF:Z;IA> Q]!&*ZL&Z]Y'30%HDN_6F/Z:L,>
M*_<+?UDGU;6BX'LBB*?M>P(]R9#8#=VP"$;L &%-?I\I>KUL *%1U%J;,(<9
M#%D[DI5V"5ZLTE^61#(W?)8CB^8'M[@>XBB-/"XG#9&:UC,$D=K-332Y7*UU
MJ]X=5:</?FLVDO2QSR_*BPI* YW8*N[:4HP-JZ8/'<CFA27*R9S+0RVI%FFS
M^0I)6[B^RF5K&%Q<8,':B#V2>T*H.^QF%>L#R:UBJV?J0V,T8\K>IO#0PCY!
M46:*,O/-;AQB%6GD A;>9P_:JD*1\V]X]8$\AEL5CLI6.1Y31Q@>!H8\-;N8
M>JER>5P8[.]M!D7E0#M18I%0[G=6.VP#V6+,-E:TD-S'QX5*[BU4>C/+D9[1
M,@1XKPO1UZ\" H>TP.Q(;KU':]Q"0)F]U0%C]CVW+N782B7N3VU6,1E#&5[M
MR6!!VV!ZZ :6)+<-FHE2A%/#9E?\PM-:2LU2..(>W+[7LR/=>0J$"@KV@=3M
MH"+R-_\ +\K22KQK(Y.WD?;KSY2C7H)!2JK+U_,+UJU6E$46Y<1H)"=N@W(!
M%&V97&5LWA\B_&LAFLP0].G?HT8K Q-=W[99I[=RS5J48R+#;D-[K)W  CIJ
M//K!,W*U-K5"Y9L7(I8)O9JQPY+(5:T\T_14L4JMF*K?("D@3)(JC<]-MQ2#
M;+-2JS4\CDL])B:E9RHKRWJ6/Q]R=R#']5+-$EB9EV^6-9E1OBIT*+Y:.V\4
M$E?+KAH:]E+%Z<UJLYGIQJX>K[EPF"HLC,"9.UF 78;;[Z,%MW\YGGQ<F(M8
MF+'F7W<F]NM9NSV*A$;1)C&K7*L$3RKW#W']Q1N&"G8AG8!_8:TOL_2PUYNZ
MQ$MCZBS)6]JJ=_>FA]NI;]^Q&-NV)O;5_C(OQ$&68FNUJJSX[$+FKL<T?LU6
MMUJ/MAPR26!:LJZQ^W&QW[06(.P'KH4B.00T8DQ^;M<3?D68I211T(J52A>O
M4)Y=IC+!9R$M2*M##-"-Y@RLIV('PU'T\02.5_+Y<:EW+T)I(:)KY05#6>];
MKVJVTL0CKX\VS/:AD/;M$9%8[@%E.YRX8F#=66Y2Q0.*6_>MWL=1B^ENO+&]
MW'VMBR&&O-%$L=\-+)(J-!VB1F/85W^71Y$$,S[62PJSQ9^YQRI*(+396 5*
M5A:I'?[;MF*DJU!*&&Y9%<;;>FX)Y#B.)I9<GB4EP&;HI[RJ8LR((,O7>*-B
MD\D2P6JM1Y2R$=VYC1@=T/H&:P TMR9UL'%_=F[ALOE1[<1R&:E>/'R]FZV9
MY$PD!#RAQL(D]M1\6&W5C3#,=HO=L<AI8-9JV/I9W/I%762I7LG#4)YW9%L2
M0RW&O/!!"&+!69F8+MN"=,:=8P]!8D^3&$^LS6&@M92$-8_*,1)'>_F!V%>*
MM8R(HQ/86-AW.?;4'?8[>K&F.8%9E&2P4ISN'=1+6>>YA8Y5R$Q$#F>.J&JE
M4LV'$2[HA9"Y[ 6'4N&(XX"$!ASV$DCN8O-8"FP]HTYITQ=_Z6OVD>V^!R4T
M]6NZIV]@DCD* @J%/5F@.ZKT\QA^RC)D:U.>O+4AF,.1Q60A6,-7$L(OPU[L
M4B%-TD92&V##N!W+- 4@J&'&''T\C9::"!ZJ9&U,,E=CL=A_GV7L%A/85V#%
M6 7X;!=AIP QQ)F.-N5J?)8.0Y6N\T<E^ZN.F2M=[>R."W2P:8Z.&*%DZQCL
MD/7=MSN)7"E<2-DSCH\A%2@CREJM<OJK?4V:E5Z5:1V=F40UI+-MXTC0A>LC
M%MN[IOL(8#W0"-FM6MP25KE>&U6E7:6O8A2Q#*H(8*\,BND@# '8@]1K-($=
MCFAGQ11L/9P]55LUQC)H:L<JUD9X]XZ^,L6HTCG0%D52'V/\(/35!%\27"KC
M[$&#X]=X[12PRF&YAYL)+<D9%[[8AG6.[*6&R^Y*%<]OX :BIP#+N/KA*[9?
M$X/\U1JMJ0W[EPYFV#?F+I*(,KG?JDOS0&+=A&\L:$C<==M%3) <X,T:SW<3
M%R"QGLC4E$N0-Z]4M7ZK3@%(IX:4-6O37M&ZQB*/8$';8C1 DJ<4T,EI9\G)
M>DDE]U(9(Z<2THFW[(8DK01S&,_YTK2,=O75 VQ*<@4VFSEG#RAI3]%%B:5V
MN88 3M]58N7[/U,K @?)%$!MOUWV$5>(%:;YAK-O\P@QD%,$"B*=NU;LNH=P
M9+9GI4XHB\?:>Q _8=QW-T.KB"E%KJV;==\54H8Z!NVG/#<626WOV[R&C%4C
MCJQ[?C*S;C^';KH!#%T*&,MY"MCN/)B899%MS9"M!BJ]7*V9^Z25NVI9:_)/
M"SD,T\,8^"%AJ+ #3'5<3@LC-C,7B<C$^4EERMZZD%V:@;+KVM)9R-N5HC8D
M$841QLS  ;J!MHJ)T0):"M!3MV)/J;LDV2?W/:LV[5BO%["G=*=>1VKTD D^
M8(%[^F^^PVH)#0A'E+29#WY<C$E!X5@@QWTT<;M;9BQF>X\KR2ED&RQHB;;;
MGNT*6A<Q^:NS2XT8050$A$%HY5KW>N[O8-@5$JB/<=HB9R=CW =-,:]0$VFS
M1RR0I1QXPBPEIKTF0G_,7G*,5C@QR43 (TD #.]@$@G9>G5C7J!<\]F'*058
M,/*]2U%)/=S"ST(J\$L:LL,$E<SC(6;$G:!N(O;52/GW!  AC#@Z?*DDAXW:
MDS>0KDV>0P89FKP0=C@16LW*J1J7%<+[4;.X^7=0"#J85ZQP)J[?I4[>.AL&
M[]1>DEK4UK5,G:@+'VC(;9I035*R*.W:6P45>NS#YM4"=VSC*=_'2WLC]+9M
M.^/QU22_)!%=GF*DJE 2K%<L* -F*,8P>FV^H"V?&Y";,5<@F>NU\?7B[7PD
M-7'&K;F/NAI;-J:I+>V(==E21 "@(/4Z<06Y*MGI[V,DQF5HT,?#,'RE:?%O
M=M7HE=6,%>S]=7CJ"1 5[O;9E)[MSMVECP!+2B<^W[#1+M*AE]U'DW@&_N+&
M$DC[96]%8[@>I!]-4$-F9\W6,1P.%I9*U.#'+9O9%<;7K(I'89GCJ7+<Z=2>
MU$Z;:CKP&'$6N)9_+H[4N*I97,5*Z315$DBCB-_L3WDI7+T6]=#(#VNP4]H&
M_73W@;Y#$T,YCJC\DP=2[)4_U_\ +).W*0PVUA<%(UEBAAN2!'*CNC[23T_'
M2B>8[!:7'T<]C*L.2QMB"J3%8&,LR?3M&8@RPQ6X<?;>O*B*=_:9WC![21W*
M-F8-8?<5A4SO@GRKC2@91PC-WU0;#YL-4;+Q]G3HRO0!7;KN.FQVUY?/+7C<
MGW,/_=2?]U:OJ/MKY#<UER;YS>6=]%Z6^<;>U7JOS5A^RXZ\*9X'CA]@]M<%
M]U.%K*RJO)>(\PP8W< RB&A'R+L7ND4R,/[O]VP#G92=NA8?6/DZ?@^88Q_Z
MEN<?9J_X3^JG]:VT_P!9_IQW6ZHW^@YGL=QTTU7'M:O!T_S-*MK%TK5T?O9!
M<K7X9VQUVI9,4DM9IJ\L=N*"W&H[HIA#*![D1<%HRRML?AOK[C/XHB="0O4,
M0R-?)VZ_?#/900HOU(W8+-!6=E@*;@%=^[8?CH"L9R<-!WG6I>R21RLL5424
M:L\H[C#"K6);CPAN@+DMUZ[?#0!!)<DQPDR./A2XT$CSXVG:6_&7'<5K0VK<
M&,CF>10!NZ1H&.V_:.X@,J@?.X:2'-X.3&1W8YZMC$7+%6PYJ/O&%F?'SS0!
M9X3U0.2H.QU,UB#&*/(^'5\1/BQ+'Q#&5E>I5AM7*. L/%)[CR2XZO%?&3K%
MF+-WM'%*?+UE3!SL%STX%%K: J44=W=W]^)6W-V=@>+60H'B,+A#<6>PP2DZ
M.&UQ&)S!!W<9]OUE]\,_F\U^O$]R[Y<K.2<Y><[$4(97.RD" 2$DO$!,UE4T
M6(=>E&X=R_-,\42QM<7BKM2D0._G]8ZU(9-L<Y[$8[>;C;0@C>0L>%3;1T&$
MA2C[18*EUV;KOR/'P%4Y53?SMGPL^8I*V<OCYI:4@\GV?T6.='(KL&SS2E_'
MG+M,HB3O*XKPUO4,WW]W,-H#U\>>1EV2_BB8CS:Q'N)S=-.]L#WHW_*$05VT
M^6J\GI!6I$ +0_T7D=O7I^[:8-*KXQ9X3(CK\@U+L(LP#=KST#V%019#"HK9
M.(''XK'QY^0B! J!6$1-CB).E#R=>Z]FW4J(Z9+"ME>&\R.3<F9: ;>_*(VM
MH#![S&;FHRPQK:9%#OA^^9>.V4GOTA?)H;J5H((,XS&8N9O$ Z@,WQGDJ=J<
M$E?[F$Y[@H@_7@?-3'5+<R24R'>B-+ -)IJV+&&UQ(9FO"V=C5#\2<;9B>8Q
MBJ8I!/"I\1@SE.;\5.R-^@>$KGE. @,94JF?GW"/^:O.# RW13%/-KO)]C F
MV-8K\'WK*' \U,E8?P'(K'/!/I9;2<U7Y\1W%TSE4C^I<?HI=25#VJ#+^C !
MTV4Q]^CVL7''[OD,T +95V^+JC(S#6N<U][F7K^>.K%&]]]1!*\%CAX_!<:Z
MWYG5G\U.&K7=\7J=%\P4G- \=K4;WM6A3>ET>'Y0;XWP7I/1>BLTS,G[UA:
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MQ[ML!??6]G*#"FY6;VIW0P7]? >$$R7N>:%=/+N^<7>]K[EPX0@HNQ^[+?L
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M]P=&XNWS1NRG)6=A)58]W1IPQ:>;QW +'W+%>+:#GV07(USQLN3IT^=']Z-
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MLW M90VPCK$.J#/;>;\MAMDCR;_!/N2U/C5QWF=\.C8W#2G2?EN[Y[(K7B^
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MW"='^L0H-_?OE\!M=PJ[H(&=$-0M$U0^87,Z3Q@C=M@LL*8@77ML66?2+E_
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M:CV<70T]RT]=3VNT@52*$'T^2(Q6=\[D[CEY?G=?5JZJ1*2VZ?0 ,;=ZH?=
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M!E/W5W3#66;M,K['0WI>S@['HS2H %V*SU1A<)6/:-=!T].9IIGV,!RT3KO
MJR])I&CY [&.?"H#J)UM_* SR/Y$^X9!=5Q D2V=9-=/S,H8=J703,O*O;GN
M\.P\.JAGPXL>M?FYKY.G&W[%YHE$'G!-N\)TW>-279OO]":DW(93/3?Z.5'
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M4M=/_Q?RLB%.\Z*B8*G/MOE=M]H- T4\+*EG16QME]CS;_$6C)CZ UO-1--
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MF2H)9$M$?\3V%O5]D'; 7Y+B1/]9!I?F9H_LZO]DK=4U;K>*>=[*.C?&Z#8
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M%%XG=(FZ+B=B39F_/ "+Q5/[:_4R:*.*<ANJEFZEZEM+.84[*!S&M[JD#/Q
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MA! U*ON+%<>ZY1>5. LQ16K-K[U0?/!&5\+#?Z)Q%[O/"@0:8J6D10&!M)5
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M.1P[&IY>'^_8OWD&VZ3<OD>D*W^ME).7T4L[DY?2X?'%SUSN#T71O%IIPQ_
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MLX?S+HYY+E5;4M* 8C1 T'.EAPQM]:LXRPCU44>E'2GY\?KS>N[-22VY;N&
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M8RS(>7C]J2,4^Q8MYZ?%\>J^1)#?5>UYB#F3>L):&\E$\'H8HN#86RAW0=V
M+J/#GF5@:5>8U-J*8_?BEK&_Q=L6K=B&(0CL%;U8B%7N/S\<2C )5H,DOWL%
M.$:>S/B/V;3PQH*GFBZ>^^-TNC?E@QA^/B$\^/8^:#A8>FC @IEC=A_<)4>5
M4#,$/EUL<+HG26TN6[3K7 T[.X?62Q_ALX1K>6J/Q)0E97Y(/IP0]*3F[KIV
MG#!8-RQ_>%.:01SEA46(J;?B]#0XV(O*_^SO]OO/*Z!2XV_.G@:;#6%?9'O;
M6K3,Y1+OH]8?_TSC+,@36E9;T>3$QJ\1):TJM XUB))4%HFTLWU+IL(.=NL>
M;W3?IR2-TH>P+JLAS /8!FR[TN,'^<J)A9-[+F+)\8AYD0<^KA' OC"L]R-J
ML_.MPE!"N Q&_=JGX.^O@*;K=T]I<> Z6J6+8SV#?M.=4Y'<CS^!Z@($"I]E
MOB)X0A@&=0AR':1O33(_/9\>X5P,__;C0 IJOUFN:CF?GPHF(_KOT.S%L_AA
M+RF%IK_.@3:^ 5*A$Z$>Y GF2KMI%#R\'&Y#W<B]I/Y&CJ90QY%]_;>#<3^*
MLWQM__KXMIS3"%83W24#0^7IH&<=KX#.HM;@4Z\3^+7&I?VJVZWJN$16]&4R
MIO_9B,BE4'NK@JD=BI!BUKX B<3S3AYK,E^%>XVZ1ZADOFTV09GC=&L>Z8&H
MG]U.DH6"+6O:$,V_ ^E9C2P/.K'GDI7'A6>_#C;N?<W[HH2#EPU_BUP)O50*
M*=5)T3/.;7W687<3H[Z.M92!W48Q*O+5Z D/F@KHFY/41\WCC,PR.L)]H5]]
M)_S: ZAN%EW8FMK_O1.#*SC4=NQ#G^W: C;04V7]\L*BSY!1BUH)P1]@HS5#
M9V8K?>G^0M?,&WZ3T+C8T"R]FA')DI='HXT3NE*96WN<9A#+85KT14/&MEXR
M,2I(8+$#*#DF]\ZS\Q6 S0>4-DC>HD-,7K_,92+ F::92F6T2T\M=P'P9JZ:
MWZTZS$0MM_>*7NBH@2=MQ8LF?;"K[W+;DFF/X)=S$?@FO&% BE*\XM<+4&0/
MQK)R<#.-\?.88T!?Y2(3N\\@S4KC&[SN;DGEF#\@KXE;V)6YAB^=_]86XMYJ
MPI22FR!4_5]VNC<<9I#!O,+XQF1X38$_4A#4.V[>\/"V_OW?EI[%:-8PM;]I
M2JVE<<H,'Q(R78> /YV1V&1Q+E,T"19'X?V]GHL"'CSBE%>':SUHL7'#=A77
MGG*X?@!D&YZ";VZ]":5NC,$JLR-VESN"QCV83BMJ+@:C*OM7D]C])(?D%,"$
MA!;;CUW8JJ:T.Y=XG<EEX8L>'K=0 HN.;-@?Z,)S?GX;%[P(C:_^!,+0:Y?$
M);1ER7X6.^C)!<";$%X(0+8_=%JNH!FMX]2%L+NRC&[0.?PH'$?6\+3Q_T(D
M-]/Z\XN5#(85ZELH\SV.$RQR]'><"3^**O/"*T"XM#AFPS8"NWEQ]&2SS2$B
M>KGP#U8*08KM'!YI5 U8CH<A47MO%]*"N7^F]0XA]T'M;WA0W/#7*B15O-H*
MY"38J+P<>*RMT0'Y-&;6NFJYJ>'TQ/YIV#%%$"QUR?X*$/TKTW.88E9,97-^
M+9"V:'A:#FHLVS7]PI^II>"<JQ.YH8QIN.^!>=1QO!8&^$>J\_8H9RA[J\4H
M\?ACQE?Z7Y+QD@XEY<X##F/U>@FCY%<TFV0X*EQQ3;@_^)2-,VI";"WL>DR\
MX71 =[FGRM8R>F4G^=4^1O$2-/@>Y=N2=T8)WM_+X$+;S6FR60XG:-EC2N<P
M%KLFU+@:&GRGF[>*$UT1>#GAB135%H/OR*FWX3?6)"43F"63!'Q8QHH%I7PF
M^2A+^PR&QXKJZR L\1_VQ@)SR5SHBMS:Z$DFOM;ULT<ES;R^F1*+!/*;;8@E
M:!S^]N;^#.;O9$D+,O91XV&;2P9G"7PT)_($+]CJ1T,6=.?:F)(S@$08".#W
M1FD96F%(V$^KEGU/EPY6YM%49F(V]>$9T5C!PO%XS%%.J >U/D((,#16O?6V
MT?B%!0+$O?+W\23D0#! ":MLJ\%FS2A20&ZWJIFVYE"0B&O8V=S"*J9N!/DW
ME9GAAGYJ552M]Y)?XHAE*!7?Q#>M&,X >KI\P^=<WLAL":8WZI@7J[<Z,L1X
MU[(DU($X]+EPL(L?G )$%TTF*1)N6W>O,3S)"=6^FX(+J>AX].MXAA[U,R=<
M,HH8@KA24D\$1#Z3>A*JXGM^6X$@DP@#PN<^I%(5^Z*+>Q>^"$LI.DFG1/A
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MP9UXGIIJ92RBBTN*\H^L@ ;N!1R9I#XP&=I5:<^FT_V"JA2$J.+EGK;M913
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MI)3F\U+HK\L/:6K4 ]A*\<#O_.L,20)R[>_]0"@-UPLH2.B&>^9^HWKDX5A
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M?!4I'\92Y6!4Z[-33^Y *[I@SI4Z%K_21?@&X(-17S^P]-[D7;7X2KWYV(@
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M\O2?TNK$S WM<MJNW9V1-ZNU;D&=N/HU*O-=C2\6,FD0)Z"2M/C+UYG]IU?
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MH,Q1RJ[ @N^^Q(K7@D4:-5#0YH>N2U\%&8]ITSZ5%L5JQ:UU7207@[L"32[
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M*E3\D')9PW)&)<=YB:FA<<L\=N#T6?Y[K4&J+;I *^4DG6EW1PG<IT7W*_!
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M36,IB<J@C0_C[6O7+$^5#L<52& TT/N[?\MG9NDG-[.@0FD 3[U%D\^H!3U
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MN@>-*(3-1B>7N#FO<3*=@[.J:]!QDU.[PZ3)#C@GZG<KG?"+X]NZ/2B-V$6
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MY^_NQ$7)[\&!)] AE',A@1O,)R]HU!A'ZNOKX+$02TV&@)*;:%%XPZL_/T#
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M(51&S*82S?Q@<FV<RJ!1 J\RH(+7!#N.Z\;[AB/3H6 J>RUJ4@/S <&_^U[
M)[KYL7L7Q/3S*Y'_V>M[.0(O7SW./P36>\_FFJF=5#AY-H'C@D5Z&7AL3JO$
M>Q>)";.(-%S?\1:2;K]45C*.WU#M9"Q#S ?[!YMS]O4SY [>@\>?9SDQK*2P
MX-<\5@1RF<X\%UY?.V?N/[+\S$>@]FU(.S.$7'M5VJD_G)KE.P)N4O>9*-6T
M(TAI&NH&>174Q!(AW.A7[WF_-#$W'+S+55:?8??\;Y3-KM7K;N>?- \TP=3
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M@?+C#HQMAP*BQO[]Y0?.1-K84._B,-DYCK^4O@);VY1H69$-[7ZVUXG6FO\
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MJD>E(1S?:J8-QOJ%1%"CJU*QM#)VTLB.\]U]]"]OTZU%]EO&.6Z\W!H)>"I
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MK.? NC4/\'LO ETI?JJ ;_GW-TS:F91I/F3FR*$-1IGB8IC-B/FN2HCT'QJ
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MZ,E.V,],;3KN^'*-)$S^3$2_[ E.!#QB!FG8NI= HJHA:* 4+L05P0C,<N8
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MH+$<F5.:?%L+N-!!+[B<>=V2HN'^]1&'JXGSUA?PIC@LU/<WC\VX/^ZA59W
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M.RR5J[,'N5*"U<)+D18J1=Y+\BM%65#<KMWG0J_?\+J\X-M3I;(OB<+J28]
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MM."3H"8>=E@]86^:9%@IJ?*ZCXS<:SM09ISTR\G3#WBHBM[:38?=)6CG_C^
M#\_FG.F\H*/;IU[WT(I&OFI:N$3B_@N\D=]X'9!WV76%AI0EN!-55W\[;NI<
M!")>:8R1OOCQ\D\R7XAG*UNE$[Q+U+NM+QZ2VW339IWZV!2<]:>)Y8#>7<@?
MF(VE+JCVPO>9N24>2=G*B63"KK_76\4/1OB_^C3NP_\;.<A?H2.BAND/9E0*
MIK<BC>:S#K8(5:24YEO\NG>%@I.>X_@ME0NKB/US][40].)^XZ1G9W=*60'.
MV0(A*7 !)A.2-D73.-E'P/NK3O^&::O-L:5%CU;FNGFGD#P*'A>R(5)$&4M
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M,!^_V@[YUK?JN$^ ZF2W5'6/BX&RQ_85UT;C&FR_J2N,+Y\>>DHJJ(8JC?F
MAE[$9%:QM993QA8:8B6-T:VOW+G:<\!4IFBWCU%OQ!DWX'@*;YG8"$>!T<S#
MPN?VYZJ7M-(/!GN%^;KW-79Q>TYL#MC.MA,MOUQD6G3/^/=Q&/Y<RU\]#@?W
M"*XR,#X#CLMS3E-4\N72Y!-&UBI3R\ES'+>[!F'-M;S>XT23"-"ZR\C@?(>9
M2<E\X%Q[)P=YN<VHE?@Y@2C+2$C[X[BW1HMT*!DJGE3G3>)$ETU&CWA:CO\\
MJ\U2/<L6+40QWK^8N]3?=RR)8KUI](\:OX!&DP@# W5.Z&1'F=Q8#\V4;8 V
M8$\_S[69$R87)]T+_5SS;YR$6X[@C$F<@UM4N(9Z?P73WKCNV.U-X/W5ZG70
MUF:'A7L5,A0L[51H\^OM6)?+Z 9>?C'1D90C3$O,P>*)&+F?54TT4\_<E:RR
M)8AM.NQNN)VTM][OFUQ2@:(OW/M+D7)S(8FVILGH#:J"JG_U7A*<FD*X=];M
MO AS[#^=(<-]*:7,C2%9B=_AP"+GXF#3ZR+'=4G_N8AAT-W^!!\IQ5CLWL]Q
MU$U3*87%&*(4KG\X8Z)6(O<Q)0<=K1&3_C/<\W#^C=7\H$+KWU11YS<X^&/_
ML0"T&7A: V>8)2#R%,/%CK4I-K.#X"?R^'/;MX0+)-I!6SUJ2?C&=+X)6KO
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MA"UGL6J98)WT)FGS(BN*I'F8V%DI>7SY5G:[[H=?* ";QH1;K^IFPH-'0Y'
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M'VABG91GNL_,^PERR4G^_:?.S]*+TV62YZ3FX977'THHQRU!02KS[<4U0Y'
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MN_D=H[16:SULD'/L$LVDU(O\J[[CTG^:^.%,",8EHNS6<>?[69I@@+4:QF+
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M%1@-(RAA\P#O2)_,3=;"P_,29/%]@<*/M%Z>M).0U<]%;T@UH?[2Y^T4L3.
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MIX-_0_+R5=%(K1M\(?BS?D':XYH_SY^W@U?B/RVNO"PS! 98+^ZVN9/2SPS
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M7^I>XX>3DJ61U$*K3DU3 /NE\6FZ(>#6YZ..]ISY79A1X(HCOJ<USWSES^8
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M#F_TRU@ ^R=."R8UUHBW#]^PN^'0]^ O_B["?RI3) IJ/^!>%TRO]59+H4Q
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M82Z9_/TVT&TWN&MM^R&OYY3I^[/J<9N6VED)T@>]:C\?[QD.ZP]<BPR'.65
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M9A4=)3N^\FF)+H8P8^SHL;N*?'Q/ V1;Z17_BK?YS&XPW;^  %<!^>*-T])
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MRA\[Z];=(U3G6/$<W7?S#D$-BASM_:VQ^4I0!" J\B)&O96]$5P H..UA]*
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M(R72TFE[Z4A."IG5'UNQ]^RL[&8NDX\W=O2FF,59SB^]QCZDHB^@GIPM@+I
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M4UX:&M@8S0C]G8G#\G#@*AX$JO%M_+VKK?K%)9'1<[DQ(CI<TL>9)9]?)57
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MK#-^"F!-GL]W-VE=_B/,_G:AHT%XJ8'54G">SYZ](FN_9E945P6_'%$6[]7
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M_U1 KW#=-<&!]B()?$F[F/@<@K@&4)EU7JTD"W$8"+,?IW29$K/B5)*L+LR
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M3:T 5RD%(1D=$Y;H)2 21S;E4PK*^7[3@=_H2@X_.7ZR2M+G_6G&0XQ<N?N
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M7O*6B,YY'^:7\EQE%HK0,M5#UCU'-AA1@@(?;<12!AV[^M(4]4HT1UA@XXK
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MTX;R_BGO-=T-\T@N<S/<P2.O[66+UWG2AZC:QOHQD4"Q7(&.'."F)_.7=I=
M_"]F"O\ 0N?.PBJH*N:?_.YK^SV5*LC5+JAL%=[$.THZCKOY&(]:K_3GNOC!
M="P.)6_M/7$R@Y>1&7S,D[JWOG@WR]F\8OYU ]9M'9ZF[H=QV=WC/ZL&9V7)
M(Y_[I4)?[,AHC]]AH,(.G&<F$*-:4(;B7[7^^ R\=B*OEE0G1)]7]M&>_/)A
MQ:FPQ)S+EO3+V^1G.KEGE<F%(/)BF2FIL*;;/R>[7(MC35D-*5._/SFHXK45
MM=E+.Z?O:<>:WCBD]H015]VSYHJ&[8GF,=PJZEQ__SZ\IDFT-DH8T+! 592#
MQT/^P]^<I#2\PJ&N(,H-G$HT0490D9X\@T]QGP>7#C7K$06?VTU*&T.6W51K
M4AL:=*]SNLY_I0FY,SZT/42@*A6@*+4DCJZLD[IA#FO_VTCC!W[$D.X7%KE;
M\L*54(FKV@"O=,.Q"9M[&V1/XOR*Q>GDF9"=<_JYF2H?=.0.WTO6NKVQ6#BK
M+S.__107V]VP\"'IN>MHJ14&M=09I,=Z/E1%6B$"4AMG.RPS+2!6($_2EQ_W
M.G*.:ZI<8ZT""9*:O;YZ.>*(N%#S1G=G%Q^+;=#DIXDBV@9;7-[K_3EXAG$Y
M&X:I.B?]$5Q9O3U5[&F_;Q:8973YW3LG59QZ[!([8+'8QL5K8UVXZ(LLA#JG
M2F\"L&@T33N/IKIVI1-D\'2/S5UQZGI95@="<K0UAJ>]*&W_ 48SH>WKT<?'
M'=+?1YZ&" Z6"_TF+OS!;5W&]]57N?X." KWU@9BJRZ\!%]-D2,H*VNJ#7KT
M+_Y4ZQR>?X"7PU75$A>G%Z?67NR*TO$GU7E?#5XY604[_^"SE.7Z_1C8-?2R
M?#JASFXL4C*Q#@$\OD^<GEY(ZKPX=??+#A- ;594'!J2Q4QJ$PGK)9(2RNE_
MU*JID7Y9$PYXNS--GJO:\K\**/E_"%:/RTGZ.]VZTL,\'YN7Q[>Y=?WSY]YS
MJ?6NRM0P/[]4NC8\DO3R/66OG<=N.6Q6BM7ZU/58-1@:^.#?1:PY$:R;DS_Y
M+!Z;P=S]-=@-ANI5&IQ3-("*[G73PEUJ2:U>5*138.N$16]V>("1JQO#Y_6\
M^&8%%D]$-0U&IZN=F2-FYFB+=%6\NC]6P]QDY,P<M\?>&!8 L_H;=CH T^N<
M+0".B<'PB?DA'9!,^/B:M/"N%Q7^Y/7R )<VHDJM((2S<95Z.7J[(XD?LB(+
M3*_#*QZ](,2\3_")QRK</Z).R5^!N+^V6F>G6(:]14\AJAG?#W">Z!X?>YRB
M'L@>G04Z1P;!&-I5I?3-<G4:LP/%BM'O(L]OQO\!!*1Z_%(NQCT6?O-B7&><
M&K8O#V/JK;DR>Z[K\?0[%.H.3-/Z%.]NL._D%LCX)0Q_>#%EJ]8"VF^E'7G;
MM4!),&9,MPZ"2]DNY@F8.JXZB7YM,+)M;%1X"!HMLD;1ANXT(CT1Z<5"*XKI
M,%'N0%ORBCES4O\Y'96=\HP\X/CMQ87USDUAK\K%43X=O^L) D6]Y0;R(VN1
MU #MT7CH? &S;;S]YJ8Q><,N+^#&M_S,NNWIL:$[)AZ],%M&SG+NFO#H:A5L
MN>6?QW=^)F'R.->K<AF72^VUG,96U7RN^%D[%Y;Z_%ZZ)]^8W(J6>73<Y;>"
M@3@SY?=91WUO5PG>N+PT.&_$VH:;^X7#:7V7B.M :/WB+/AKA>=\H6V]7J).
MFH8YGO>81N)(2/\=^? '0E:T;^Z,Z?DTPU+IW)7PN3[G#O$-M=&X_F$\9L<I
MJP"PI-VH-K?_$=1/*8 <'& V$$! Y37!4(8[TTI.C0"=[*?_K,^L 5H^99+=
M_"> QMU"LZU'=_>\7/T\/#1_Q_G5=S4F"8'3M#,JN$"XVQE;[9#! J53P83Y
M5O>X7\P-BD&8.7/;V8U_-\=LK,&W"3)*,#H>'I-"8]GWKSTGG*?1D@WYH]>O
MI_V<.^[#ILM=3/(@BV^5T#+<6.;APZ>'Y8W.\1?TMG]TGEBJ3VL1KDIJ$ \G
MUZEQ8(V"2L_3V]*:(FZE&3?"'0AD,,?36+Q(I \HK-1OSPQ+&_<X^A37M$B!
M@D9IJ'M2_551&6:/;C($7"F"=M?/XXF[[L?YVA8D+]).X4.)X\:>"8R5F9X>
MKD.F>+I]V0'Q 6[#]W:[.U><Q6.MKO_Q.)0=4H_T^Q!QA[3KK((ZVQ0-O^.(
M3=WRL,YT $%^/K_1Z.8HA?_)GV_0T-[0B(%A.N;42HMT E;&9HQW[S4*O:'&
M-*;JU2R.M/P$/UDG:R^"1%S.(ZLR?O)GV+3R$O'VT$HLML-JFARG]$YK)$+Z
MK,<0?9QN-T')0G[=DYY^W$@8JYL9VO9CQU+\@%\%Q7Y%R[83Z9\>[?KJ$:OV
M&_8Q:P*A'U:,Q<4&A8WJ&2/")D]&_/$):CXL(R'2*F+&1 O-_\GSZ Z9,Q^8
M(A_4"KCAHR;S6T99V!4&I*2L-:V>:=DX5OG;)M(M]8I$37N_3JVNA-FUU4=_
M2KPMMR2G+JI1*%]ZZ[&VTH#F?X^3NIR?Z+%R^N[FE=86F51D"!'9'>O8+G_\
MV[ILSHN?62P!+]ZE(]]O%9Z4VU3AXFB;N)F :OX!HGP\G]F9$8-7W*YW7W^=
MK*^/<3=$3>::SW7N.,71#6"++)$,?77/#*;_*4Y.''EBWW VL:Y7R-=1]/[S
MEZ39D1!F=K1V!WX5_E45(3<@QXAM,W7O1$TO@HU%=."*JFY]Q\WCZPD7M>N8
MH*,J_F6:1Z88F]!?2#W+<,O*^1.DS\V/>]-_R*!N;"VC;O:&8:V <\B D6U;
M0:6,Y"P[R[.=%G>DJ6.LK<9LB^*XEU,R+F]MZ0M]_K8AQJCE>2O9VG?(B-DB
MEH6<2&;N V;[:_ !DM,X,0]IYHAL9:;1+F_E5A%(HJQFEZC-Z(2*^6H\+^>.
M.[8EE-E=,@MC+[UE*MG#;EDB:MNJYG#Z9"J]&.F?'7=.P'PA*6.V*_[B=7.O
MU3,/^S>?>,(X^+ TKA$H5I[3&JJG'%&@4FN?.I@&]7-$:W:3%),>UTC:H<<7
M+.B"0JYYU\%0;T6#/].YDZ["BC53D&SV=9@;S9U0S>&1XKT]MQC'Z%45[V[[
M*5UD0UJ/F80^].PW/F[R9BROC"0A6!QB95],=PK7]EJ-GQOFTH*%M;1^SN\@
M3.UHRY==0.8M'; R2Z:>'G6(<PP)E+D1ZB=^@J3/*\Z;(H?SN LA7KY+WQ61
M=49YR[]7892.!=OZI+Z>Y0NFWA!G4QT/EUMVZ%TWI:0/JMHY]4R9AXE(2:)Q
M8*Y99P@?F/.U9EF-\@[D[JHOF8&V;M#1VW370V70$3KUU%:!:QR?H@$1AXMS
MZ'>"UAPOI3QDE?X!5 W\J$)#)GW]YB,GAX;@R^24'!"OM+;#.7WMWJTE??VX
M"N,U'2#L-O!H/\SC09=G7C[@*)>7^O>UXP=1.R4A/([#*GMEU&NF#)</K+"W
MS9S!-'*WB8'4;=.)8<:W#$2+3#U<:XW^YWLD9]&(/@2I<D5RUD5P1,#T6".3
MD\NVE]0%';@*?] HN2Z&QT.60H>L\G/_<3[3 V!BO$%^$N[Y=/+PV-Z 3^/$
MV_TD,##S::.S8"_DD1]L4'9BW]ZMBVZ<X#$A@E'.CD;127I8SO\/4)90BH]2
M'R>*&8P\#'S1@./EE9\_V3P W[H0P+/XG[P+R+*U?+E$9TC1:$N^/+2@>_]?
MS,J\7WQ?8:^5<\ A>W5=J)?_TC;V:3.JJ50.ICU>0K+T[O_.;/=2X,H<Z?</
MP/8/X*?3:FN(!US2(W5_IWBW[-;C]US?Z8,C-8R6?E2M%Z-KV+;"_AU?/:)0
M)5UCT6&Y]GK]& PUP_G[I!#ENGHL%-(T*1493V;A=]2Q"5:OE"V@R M0,U,)
M%0\3SW'W[)6!4QN-R @SG@B,7F69<5!8/#^OGS!ILB'Q?U59T)QC?[HB2OK
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MACG=*![+)ZZDUN<;<Z__&8>)%.M6-3"(*]A-$"T7^=.^#8IY_$(_4@&52EN
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M@ 4&XSLD_,"#?C'1'QPP8CL,^8)0>INY76%@]5IKP7]Z;"#$>/6#*RQJ;'J
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M0KR6N9.YPZ+X,8KONWFK/BFA'@#P2DX(OJ)>.QN\[C*D49ZP_/*MA[KN!M/
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M1#^4L"RC%IGT]GA=)[-BO=:V- XH/%2P'6L-E0G[/9#P/]A[RZ"XNK;?LY,
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M,(@+\9K&!2]46+-B=\,-"6%\ JZ69^O_UI%=/"MAB?31XOI24$XD1AE<XZ9
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M?<B!OC'BO9ZV=EI=>B,3,;)3\C;"PG0-(?R;X-:C-W_9R0M?25)] IE"%<X
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M7B6UZ6(MC._=RHLR&MT:)".HLG"=.EJ$?QHRRCE:;E#'"G";H%Q!JGO1308
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M)Y:#3R3K;?(K[4T&?E:*3D$JT80BARA#@XZ]XO>O@# !=I3HC#CQVJ/%^F<
M\7 ^.KU_1.?N]!X;IQF:$*:;#_N@:<H254(AI3>-1-<(0T)>Z4 7+FXLR8&E
MH68W'']1N\Z/!;?PY2"?:CEMWXJ!?3<NG[7X5Y6S=Y/BG(F=;*D!K+,;<;PF
M+&1P=P$-:D42R)\H?*PP9;OW\05P_*]DI!05-8/C7]A?\CX@;8@'; ?-4Z7A
M=(,RAU.Y9#[9R1P2Y[-N]<RCT;W26D'I.@LB;0V7P'3.4C4ZYV)9KBFP=H/
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MJXNK"B50B)=B@ =L:4E/GV]F^D L%I-:D<O(F37W&W*85>C'?IS\W>S<)[=
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M6;@&9J@?\WX5^K4SL[=)OVBH/5EX?!QD7/6:/V#DNY0%R^Y7-;KNG2[WE0=
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M+'Q'7SG$QS#&6=,5+GSD+$E-6U1@P)JS1TL=<W9I@48)64GXI.AQIN5NLR2
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MX7-# GZPCG!E]2-L6!4V::I[@50N.DZ<GG!2YR]%9KTV,+I06,T[06T=>T"
M](^L;_$^T[ BXLNP-R8P/[?*R\&/)MWQ];A>Z^JNPV"\[8R I+H%Z[/D:,<
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MM.0[TJYH.GI1NG?=E^$3UY4*]I.<453):\%/I%&##@Y)T.1_IXQ!C6"Z\5\
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M 2PK.WQ1-I'H>7-H_K'. T\_]+L?/8ZM?/!OMA4EFXOFF ? J1;\ 7"T1_\
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MCIRG4_$BSB?"NS9$W8N7)9@;5FG6;YC9?&EW7C'NN2']W029*I,-HWE9.!X
M/'E==)BCX"B(+Y[KQUTC,%(V4H-4!?4K" Y'^O%O,B@^L9KR0FP6,2ZYUBZA
M6B&[GB__64^N-WHN)S"\H_,JX^6<YW]I33Y47AZA2VGXQ$CW4?F'6@#Q>ZQJ
MA;3_KL - [ON#D]47[MWET>.Q\'89>Q1EG#O)$'#%TQP/ R5MIFCQ[=>,OY)
M=)>GH!#./-R&VR&NCC<;YKZC(Q?LN2].DNM1] !P#K Z[4*M,OT87^"N%E2]
MD'X Z'3O>LD+R+220._]D29C'47>#X"W =Z='?,6ZD%&WITM"^7*E>R^GM]<
MU1>ZA1WO"YC+M?GA\M[_?+I?SF6HN/4!0/HO*$D7'(,UV057,PSZ=;-@^<!&
MZ5K(J O*G&) D-V&81S_O%^M;SG?^*18++?Z$)[Y+Y_BE33S/F*K;;J>^EZP
M7-ZK4=,+J9#_"PG=9LYA*!V'\ $E,#4"ONY4DC/M[K?%AZ-!N6."ID$&S56'
M1CR,O^+'_J%8CK6;]O.:+8F.!\#YT3H_W\U9:?=(D)/0.(LH)6L5"3^<9ZTU
M7NU%7%HD76XIHY>(]><7"9^F;!PQUK:MI=RP[G)0JZ?;=_-T<NOHEQ"^KN#;
M]H*AQ)PNVRO(=Y]%S*$C2#I<JU6V9,AZ44-K:[NIU4T+[;D^^@"HT;TN_-_D
M'/%-84_4V.O=@MR-/XJGAU*QJ=E&<D[7#P/KA. ,+D6@OO<X16X\AGED8N:-
M 7?S"S!:[=-%O3@#D.<?J";5ZF.8,^L5SU']0>P SJA'1O(.R*/1;G?>"]_:
MR\P1E=BBCKLE\0"X4W4?IZ]Q9[OXYNCUF2AAA?ADY#;#">D<K+V^1GS1&!CN
MR0RY$OZ'ZI>V_0EN^+0"'8>W=;:]BYM@ZIO\Q-MW?=]FN7Z-I)A6S@2IYH-A
MIG0Z(DS2QP,&;.W,SARCDK)O)./.YH<_]TR,X;^6?S+XLDNT[>3NQUK#$N)L
M3!W2EO+/-*X3AU:O T^L1NP#1^_M84Z6GOOG4YW6PW/;=ODYA">]A^)G0B<%
M62UM:(]T;#A#("ZQ6[HYWG&0!ZJ5W*Z8FB5VU]OQBDD%WZ1IZ6C!^GE(V&N.
MC?9QF9/0O3?V3L]J\)KNZL H\ <4\W586-KB:\VLP^##ZSW3/:19,]W]OL?!
M5_:=7-CNSW[V.\.N<]=U=-"(:KK/I5M+FVB9B;FU%+HJW:VQHM>ZPU?.)AJU
MT)GY#4"ZV)>"U.E%M&X3AZ=Z<YXK,%N:G<-Y[R,AWY=LMB0I#_KU+Z^B! SW
MK*EV5\+<C284Z/AGFH_:F3 =70YPU$PJ-QPR8 U4^O*I-6A,/-(>"6.4<WK;
MW!ON9NUS0NC;5>#!>Z>G6N][37J?>:&GU[RYUV0>U.++Y+"T"WYYN'[&=CT2
M.E10?H&\R+C5^9?XHLK!/)L=)GEOF8G28+Z12+CCK@C(J#5QV!YH&TS\,H[6
MP]@X3IRGH7$KPD-%^EL0O+DJM%O\Q/-P;&O8KW)L9G!BEE>T7U2=W7#&F,@D
M@D0'(?][&U' $KR=?O4O!%U(KO3F84:'VMT$EG]MEKTLH5ULI9_E&S.N7LRM
MTE)!.1T@=G(=5YYW(?ZA+F_1\*+Y ;1,Q?]!VWMX-?FU_9XH*J ""M*;] [2
M.XA*;])[;](E2"]11) ::NB@5.F]]QH@%*5# @$2.@02I$,XS^\YL]YWO6?6
MG)DS<^8?V.N^U]K[VM?ZWI_[<TVA[O (LS5.\Q0FK--/2,3,3!7FW2_.)12Z
M.!Z_5DO]G:@6GWM]ED#CZ(9/HK35=<Y17':')V%K8;,JA",8:%@/)6K/2S^E
MNZ6\:;\\\CR77?R%]<K88U@YS1 D]6;KJ$.8QE-LGH<$[,(578[@$:PNMVZA
MS;?_VH;HGH@:B>,I@:\25CT-E, $*X/A$Q+6( >^5IP.9-64[WU:3&U,P+*K
M40=-Q90PMT?HP-AE]T".R:WR<% Z=2<[U1_V@987%^+ QV%>(4F7(*S,N!<4
M^*J9#&:9:QE[[+FUX/O@#D_$*Y2=IC+G)_N3^;TTF!]JYY-1E\B>S;_9W;Q
MTAF1PRG.JZBU'GTWB<YD>63K^;ULR LNR&B=!E(?LKTAE4!Y9!_'*+YD*JR0
MLLW!HIAL>![>XM1;!E&?JX@6+=_;"**IC F,3[SED)_//WWR\RH+X[9JB('
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M_8HKX3ZK?K%,K &X0K/ "+2HG*5D=2EN<# #&"S-_EER-F^L-YPJ<Q)SNQ0
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M#,^0Q7@8;#=,0BZ;:[\>M[]I8I2KQ\Z%.DA3>LRK._-1&WM9):9KN6L8BVJ
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M0LQY4-GX]TUH92K?MAP8O'X.DT"K\_ ,F,=*7C7-C>2V16S#KC4HDH0]FB\
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MIE41*HN06:CHE-U1(]<W8MUM]34LV6G)AD/9T=M 3W5SX)T? =\CPMTC*WE
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M93B2CR,>H4K?"83I9;BBLL?7D6-G\BL[%H&AIYIS.C'HO;WDG 8FM1?#.XJ
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M.TUN--%A,>JYVG!NQ(>/GW_NH,6";$I;94)Z<?EV\.!,95I7%L^;"%=/B&W
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M251+CK#W]ZAN=*"0XT>A&C%_2>:*BB)YQ^G<YCI4'K0R5+Q86E%IYO1YL^&
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MI.V@KY&,GU@=A-2-\Q["+!<P"8?E4!5XBV=TX@=!JII"0R9> KD'\P[#3/!
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M\2/$%\+ H+!5AZ+,KMJ:O?]67LMCMQ+P+4W&19?O8U" 4V#+>T)T:N1 E[W
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MU_>T>;;1:(19$051LJS*76Y_VYM4[AF"2A6Q-BOY8/G6LM38Z>.E#>(L<0+
M'//L=V<!Z*/Z$VI!)18DRAHK)PK><1JZ-2K\(3J@"83.-VT=,MH2EWI2U<BG
M^D R:62FN>K6A6OB?R*](<X.!U:G@))=WC'#<D-+/H4.1(3S*L>2[6KRE-3>
MB&#JP%1JO^<?[,HI@'I'U-GM)O"'(Z) 0?7R(8/7AO\6ZGE667O#=O4AU'4(
M185#GCZ(.1J*Y%HVT>HHR!?HZ]2_FGL&^!C"I?BP^C*ZX+1F<\.OBE"EPNPR
MTSYW^\C\IRY2>\XU?#]@V,.?&HZ1NT$.G^'*HIEA31X;@:X2__I4/L8  +Q1
M4VW>$.NP<@Z*#5C4:/)ISQ+$6<SE8.JNUI-C'J5WV_H(+)?;@\HAH[]/)BO.
M (54H&WX.M+*\ZVG/^ &A/9AVW'Q2.'PV^.[Q!27P3YGGI;$2*/9(N>Z>FIX
M36 L+1U!9$3%5@X$9!-X>7G^QD,7M+\I?U2^_8C#CYI78 "FI8]/.+"'CYT&
M1951+GQ$\ VHH'O$K7W8%PY=KU,;3.PG9B&Q"IQO+O%OJG-XTFS+#C>DJ1H.
M^XOCO^^= ;3?N%'VWC)1AV// .GOJ,^0ZZ,3ZB9G@ N2#HB<*WZ(%?L[T6O%
M!=I^@T%;?R2T[I?5J,NMPHP2\E1(-E^I^DL70WI"UTE7!]4+IQ<#[E,?4Y2C
MX,?TQ _']$\\J>.O0GQ?VN+M'PY9]1G7]2EJ_"WJRYBZJB@2F]GK(F:9R#,-
M<NA!IW,E3]1))GLOSA**6K\T;/4'I&L[3&]J\S7Y#*^&207QO-X9X3UM"8M7
M^12!&OR)#%%,D'=2&@7R=4$8T/]:78L9^%S>UL5Y$B:8X!,"TENG]T_F]3DR
ML0'[^KW]YX.FQ.#6IM-$3O4)I?3QWQ &'$S,>V?RTY$X^2;>P=6>XV"4G^Q+
MUCZ(9,2I.1Z$JW0[DO*8[O66GMB@*%VI"UT]BTX1])O>(%ZQC&8+F)JON, 7
MWG0+J9\(_NJ%%<X*W[KKVTWFK8^,>"W<BRU (%"OL</50V[@:8HVJOT7\N5B
M0^($DGLY 8(;K0]>4'*X1NTQ+=X!*J(.S)WP&4*^7D[Q&[78S>&8$4<"UBEU
M8PH9?MDI!]H]M0RL\T=P>DT$0$D<!9X<0=2/FVU78PZVO#CK=HR.MLGGVH@]
M.,-SQ. /O2>QHWF>?S// *PD9.RK$+\1T&I-ZZ<^2WT5ZY)[ _V#)"V!Y;KW
M;Q!MUY5:YOJ<)0K]QNYQ04<9,6 O90.;%N%YZ ]=V7Q=";O*MSE%@AUF7'4K
M2,3.0^KW,T#=;5PB'82769(+Q\ZP%PE5B41M/8T-8,I=1?HO/, %4JX_F\F"
MB.+?LGV*+_-1HD8A1 ?4'#'#\?,_:@>RLVC^C$?F^ANW:@O>X 46J<7&QVW$
MEE6P2EC,&:"$*5U%_;I1CN]._<XE:@FDX&J':"@(-&+T!=MZL[M\%=OU]US<
M8M_?:R^E+U;Y2P\_S2U=MGH0^'L+XX57<_# IU+ZM*2WNW@6DA7GP&#VC@"H
MT0R(I#['1&;H)_'DBV-Y]POZU? '"@KNCF%3'J3C+"M<FDJJ?U.91CQ,N@"5
M>+'OU0/<\Z2JYB;YOD&#3T7GG*E"BS18@_^15O7Q4D%5L,_I:7RLGZ>!M^^:
M#!/Y$7OL1(CC\7=P'I: D*H]OAR3K);N49GNB%.?WQS-C1BW^9I!T$Q.HOZV
MRI':;(?[>#3:3NYYHNK?I +%K3;DM,D2)VB9L Y*2T)1/)2:J;9S<O253_H1
M??A5TOF[/]B^!X3&V;<DVMD;:,*3(8&)\[>YLXM** XFRJP[B80ZT6&!MJ4P
M;@^%P!6EOXDYSD(!Y2O[[XJOMX8IYFE)QG=CXF2A<K>MXR0UHS+5J@^.L](V
MP%"?=0LO5LJL6(G \6V*5#CK\YI^(#64%O6/EO5#/+T\5YGR&DY#.IK@]C9.
M.'=Q>&9QWH8WQ![)H*];CJX3%+2:UUOP)#(137-'+7I#NT[.C]R._7NOEC]/
MX5/*/*5M__:TO]:*^YT_GV76A^(RB*Z&)ZF5$IT*]L]#/N!G6BKR=O[.Q=*>
MNV>? 4K):JL.P9]M]I#5^1OVG.)M.TDTG79\6]N=)CC9A]+B]:#AIC=YFEF@
MN3<)4=PU0;"/4S6NC=A[()2.XP'VH+_RYHG1<RI"=53-E0/'TW25H]?FOX<I
MD1-[VB0CT(?-O -T._I+GPZI-YDE)<C^/>'7%A[CJ@'_*.F1L-D'M.-XL/22
M6\)]BUW7<^W\[_YGSHYD22:?,\"5TR"=8![P[I1":D]@NG"R,X'[!*1WI%%S
M[N7/+T.]5T$!Y_SI&!$DYTJ"2\[8EL.6M(WGJ&+1VAG 451[R/RG:B "W2MA
MVA+L:FNO\56GZ&5&S* -HW%&[\4MK1ZD*WQ@W(%[>K-D2MM1,F%G\BCS&M?X
M: .*8K04=YU%NOS/ $:-*AAO%^FK=2*6(E7CO7%>:EN9QF"I,./ W*]NM/5P
MESBH''\:_HIFFS]/5TZ7/T]0RRXS?M@]EB K.L=W<7#F":OON?955](F,S=L
M1]U*N'[3^3E<[2_X*R($UK-' %@8YV$G.>[_#+_\QL7(]VT0C?^=>D1%?,*-
MY$/I::].QM.^DU8@/JY9VO8 Q5O+]Y&OF'*LSB_Q6+FBA]$U6OY"V<NP_!93
MNU*\^^E7"W%M4?!$G(\#W8GO#8/F6B>(IO_)2GZB:ZF^2OGUGHF5;P6R:<*U
MYUXVT7G*-L*3#54KMLK2$UW^CMN54;6"L2.:V!%%:.Q-W!F <S'Q_I?G#?O:
MDO1S?]B5Z6.Y0)A:T[87"/.LZ[N/3Y@1,UAO0^])5X^\1,@/G,2P1YVLD7;K
MYAG@/D0P-K"NY[:O!+,^O0P[2U4B]L;RYE15##REN2[#N99;]GW*=T9(49ID
MVM,_,FZUT:*_"A0QXTK3\8:7;'('FR7,*Y3R+%>D<]+S\26XG!8I7P$?M-1Q
M93]FD#58>KJ$24=H+ IZ2V'26/L'Q0]]B;^T1OM;BE>5U$O-7>RZQ04TC-V1
MVL302*:ICK8O_FEH$"IT6NDIMC_<,JW%>)'>D;C;.49$/IC#@5;%$:WGQ&X*
M&GQ^$MJ;7#9KKAKMN+OY.VR8?[G6I<C.N#%L^C[;&4"(QRQLP/&M99S]2VL(
M?:;:C^<IC"9Y2D(BVBK[?6/JK0&&/3<(_JK-*RV4/CB]A:DA04_N$!E=][NI
MM2HR-4OL :]J7J8N;W\E7%0*_=T*.2U6RG]$^. _E8IH//A!I*JZ9;_4P.!S
MR/QT[VHL0\2N!UC]O*WK,9;;?-$H\-[,T4GYZ>8;N6CL@\6Z]<TK1A]89@C
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M_^]/>\U""MS6*F2H]@X )\1=)-%J.KKL"=(]L(<XC$Y?^O=WJT1SP#!I87<
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MU-/Z5B@C6B4B#W=<<W4VQ<;Z,..&\.+\',73I^ ==P>PCET"+D^4T82>BC$
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M=7GL'U1T!R#T9TH]H5& D:/D].LWD<ILPYZ)Z!YO_Q^X51AF[JIQOW&>"&K
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M^1X>DUWC2?8\W.JAB0[Q]_C".AY5)BI65U39:(SEH(N]VS95?.4IY>!XW^B
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M<=*K@A0+VL#U>DV)ZM]MWMTNSW?TV"(9K-BASQ_(_ADTK3WJ7Y5G[\ _6]9
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MH5V;KVGS&%OR-35'=CT/$$- HMD_G<C($NM@_2RK&V_M9EGIUH#D^>-Y,%5
M9_Z;"$B@X <O 6OR0#9:#/%R8YZG"]^C[K2UIS.LXQH_7[QBOY'=-\K;>9NT
M0;U)EUI5LCW6_<(*DS@B"[2G[1UAF0CN;$_]C,!NMG/C2'E(^.X 1.$RT;6X
M+,O-I7<32PJE@VY4.=M'J9)VB7$4S,J5M>R!BROEI$U;N$&#'6X'KLH"92#Y
M>MJS+?:ANDF))J+7M,INPMTF  UDO(XAB9&7+(6-Q2MVF^>^#$+I!K8C]B R
MCV@;OGRFSM3;<>%?;?K1;9-N'ZR0FW/BH=R98?_4OZX/*^I;BX"=LB2^6PQ.
M9'$PZ-",*HPZ^8M1<R;> C$:\A'LVZE<S7_37YFQ4 Z G^@_=[<!Y9%'KRMP
M4WR6_NI<4%31)3Y3:^L4ZM6=%Q&:TMQQJ-[I:=V1Q39FF@B0H^T+B<BU_'>*
M7+!0\1!HS_48X]1IVGZO^K]-Z0C]K  QR#,UQ_Z*5E1*+<I]%JN)Z0L2A,1T
MNVG\9%#&_OK,P9?TI5.3(!8CFW '8.:N=(-3]#18-?0-[IR\CIUM);D#Q,4>
M[^*#7=22/O&>??RYF+9L 3_31$T7]=S+6(/6.MYW\N]P3\:<<&ZA=X!^3$R^
MT^:@0H\G/7;GWQFO_8Y%_,/YU0I#ZLR4UVI=20^P44^7+_$ZPL63__T\2XU_
M$>FY.U=<C;XU;1E\F\L])I;!_]S!M"F::K+ ,UKID"4.6*U&'/Z>P 1%; QQ
M9WWG%9,G&5CZZU::.XT.,MMTTZ*OS*6@-(SNV*17HQ^Q?.-%@A:$#BGC0=Y0
M:J(NG$MN)=;F3"M('Y[.KEV2A1HC?GL!M?N%1%UJ.:1!9C)1B:WO&?-;(2'S
MN\8+!NH1RAT5 9.\-#3"&R^"H)L+>$3B<^^WEVHSX8S#]7A$8AWJE$D!3_@Z
M#S5H.D/( B/\YLCWF)>6Z7?/_4\3-HU1<^@V%ZO)6"]$D]]E::W><JY *<#7
ME]!R*Z#M=8HCYH4*7#<,TZ;A\FK-'R;AR^0.[$?G%9PS+$W2NY$^D8[=/+O5
MZ(-(1ZVU4@3LS52J;5 =T/?&"\0L0!ZN>E"MS%*?T PD[DDE=\;!"/:4^H2Q
M[PXCH\U]W0,2S="B,'@ORWNE_NL(0*-;\YX4X>\BJD<1>2_\%TG?<W9),%3"
MCF\@ZAL.J&'QN=GT>>4MEG8\^XH3@FXL).F$^]^;W('9][!'&N^C8FD//C(&
M3=@7+012(R9LF_Y4TED[KR<24"799HW,MZ&00UZ ?U3J#FMH![57;)LN4I[=
M*+F@!8]CDPL8B"_&E.\ B]*=A*)RT%:]*65BJ$0^0(G<=?_XG2Z02>WK_+3!
M5KB6*HND=C-M[Z96RX.^G^3:J$O(]"3SEZKH DN#[E)@&-T=0/$FJ311-<[Y
MGK9/EG0/^1<\PCO:SC<(J>4BVE(A*7M]7*%*\DOJX=_(R19'REHVGC:&ODK[
MKY\UY8!_*HQ+R,>><9[1NK"3J#TSRV'Z.R7TS]=SIC9',LI>;\;T!M9''^\
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M?XSO&#L%_ $7EYC(J(O8W\6D6&SO/OCXE><-X-_%"7@ H/U"L_^GA.ZS?A3
MH#7@">94LK7#E%3\<(R!S.FN6\*>DQM!J/'6>C"TL:I6_ZYF?F>?N-4EF&='
M!=!G;KQ#K#KB'F_\#5+^TY_=JI$P)<I&<?-5=?[[CU"Y]]Q?CWAX$F?8U/K#
MVO&L(U/^)!YG.1-./I8_ED2<Z%LJN26%:P36NE-VO#$"5?JUC$D 'F4O)Y_G
M$!MV;\(/E>QW2J*W%65T%KC ]J<EPU7.9:A3<YX#9I&UFGT/_R#[;T=MK+MU
M&]"S9YCP@0BPZGE_HQH\LXHS/ZJTBK-U\D.)"DS%QMK<)*6GHZI"$\H^\D'5
M:!E\]Q2;.E=$BSQE<6#)&9POR4P()3B*5$LUOC0H2S9KRODIN'NA?Z8E_*K)
MM;/C]$#QO=S0I(%7/\IL<ERF$T=6\O\>-J>1JM;IAT<$S]\3:EH5^5UM-RWD
MO)6#:Z0FV<1O!QJ;U3=!GQ1\^_YUV5,FW2/"[Q\BV4\YWP2HNMW&K\>?K+-V
M&YL8#-;8WBR8TMTZRA?ZW#?$NF[9P/ACH>"CF?DUCE+/.'AH(#E6 J=BWC@[
MI9#C8Q,.4Q<_/&.^\Y0B$4X%K-'F=KB<9E,!>>?+K=GK>8M?=2P4=FS,1UT'
M1;&^$Z(;S!;_.U=ADMFLO<KS*BZ[:5C)CQ/@C=?.Z1M+%Q1ZT3%A/G6K6]((
M^[>[O#7X>;B6T9](2?/DZT83"I3=\ AXNRJR9\7G^++RC?<_*;P)LN_)#YJ@
M5("A??%WY%+.CY "KUW!I]YN&2=KIK"L$BL84[9=UMOMP&SIL<?,R;\!ZX':
MAXXX*/::I/8.1_/\2\&_Y)+W0@M3@MK>;.<].G/73'ONMX)+Z'[IR.L-G=OP
MC.X+4.[)-X9-UEF+_(P2FW(*-Q(E=[YD&H+@8^2WOA=]JP_]X"I8)GM;0_78
M':.+F.UP:OPFM PUL)I#HZX.33=%Q>@.+UJ)_"*6,-8="^9E/Y2A/,#/]]6:
MM5FIC*KJ=0PS^[AXQ[[H'@\^1!.WG- > T'$J!ADT[EL3N.VPDUZT<E!L_0=
M>GJ\]\RG2_71%4#72J:>"W>&*#4JQ>B7<P1^8 PZR<O"%_JQ_\^DL)*:3,OX
M7SY!'(SNSC5@[\EW+/B0J67IV]M0"L]?CTHGDDT;9<'/0L)T)?J %4C&'F7\
M"9Q=H6.R%T$,[CZ\:"O>>D>9_';)"0:\#(@>,KH.CNM*I)14>/)(BJX)YCI&
MZB5\^+8H2%E;NR_W<)L[USR]^ 4BI<(7?1XM>=TGTK!,=S&P=>=)GB*D46.V
M+,5>S?8X]'K+H)8(P[6=&06/W7G#L0<13W2@=L2MKS\6@UUOK0V#F+Z3;([O
M6&%HUF2(&8+#,,W$C+U6 05OG,0'%3^N\!L0O G@9BO_1RP \."F]R=^YB=>
MV40&LT8N-?L>OV%EA#^727'%>R3"V &**:INWI$YD\\W"360Z$EGC4;,$]_(
M-PA=1H^W;"E:.']_'7P>_+QG,E&"-LJ1[NC&E$8XGZLC"FH')2]=H#SZ(O#=
M:>>!=RK<%.;*G3CMIQ7]YR%ZN:-)=Y7%&U&M\Z0;7CW.1Q%] Z,TSM&>'%5B
M;&]_P4M/8&>R/.BQ_'O3%$2$I1^FXT>H*^K16"YV@T.4/L7Q(^9X6_'!%#K;
M^^N=N1C08:/6AT@Z .9D#\]M5G1)5+L_]WN%B^2]Q<*J'U3 ""FX*%;H3YRF
MW:JT!J=<S/71[8?I@P.)I'XGM@TXMCJK#)%PR';S'[=Z6<5BB4+PTYPS82.X
M>U[-.K]3-(!'O*WYSF"5D(@]L$V4H7MQ A9&E63-A9;)>X)YQGQDC*Y?P50$
M."PT_QP^RG4=<QGAVQ)#.1J?0K3?X:5"U3Y':UK@]FGK?/3-8'274A)RH;0O
M0A[\Q_%.E]PD>LB['RI>TLC/7RQL4-<9<BD ,QOR][K4'-";)U-T(Y^^4#@B
MQH%2L%S'=TY>E* E&\IT6QQ[5WSYYV_Z,O3#:([F1D171YX&HUW/O,UU?>K5
M0H[/Z!/]6I"G(RL%3C-5>W4M,]7SX9IG_L#N?-1#6ERDT[L PI>K:[%7/MN,
M[L!N'BF7H^Y@HUN9:2L,''<0YR8%[7+'SV::IWE>/6Z6C1PC$&W7PDL3J0 /
M?/H-37_0T&WLX.V0?XSJQTT*YZ98B,4S\RWDHK>-'T)HE_<*1^G89Y_VJK%4
MQ>R%2I?4[=<7.U/38(=30P8O?FAY^7FXY@,1R<77+HM,7V)H9$O+IP)X_(<H
M:EIH!;&0*9T[>C_L,B\;_P$ :,YH'U4;UW]GK0HF4P'+E+7D&(Y?E^7CZ6(:
MM)Z:![/UY_A5/L3]L854'(-C3X,%T^)J2Q]^A12"N3EZ*LV^^0R7T>E?SIA(
MF:4 <9/A;(EU2"L9F1V-.R73YLRNPG!N=JOF^(F^;T<<=7RJ'^7CWWPO/(L>
MHM,7%99G=Q3N*!JOMG^Y)ESA1.;XP$0;]'WT>7'8$;#-\[9-U#4SVUMSG^2?
M"10*"W]$=C^4Z"BQ"N [T:2[\$_P19P=95U[_.[)S/G6!AQ/?WPD$F\N(S/T
MZG\^K_(VA?B'"L"[DM_^L]:UX\M4P&?:!/EUO\:4BDW9N+!6<C4(1@\,0R%M
MK^1LE,IFGFA?6E%]7.Y%,3U=!1:88VW!P(_O1;8UE[>D-4X_F'UH3Q1(:"==
M>3F13= 1+-G8Y#"*I (T,5/: P[?P4('1)J^(L_W.UW FR\BHW(1=A0B0<*
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M[=UZT(F+JPQ#?>H=9>"!I9A'O'=^B@@9H(EM]\8-OR&$3/]-!U$2A+<F4ZB
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M<URH]Z3A=GUZI27X&T1II,XM]%4L%<!FASE__ITQF\'\"D,>P9"&?C[#YJV
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M\J8T4_<E,!5@CC[TH0+(T>M@BD/D$!40G]U$24=J'-57%HH1,\Y8*/D8)TH
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M8-G$_[G3<0]D^WK,UP*:[6!)3X 8G'@CAGN@$CW/^ .QB*ZI9).M>7!6Z.4
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M-031-./@>72RXIEJI,&T:.SR>JA[.E 9?^DWDP-(@(]W)$XB)O]^">X/==]
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ML$^K,,UZ<+/4BEIP@<3K.*+,R+H*?=O3PHHAVZ,66:?Q4KJSJ5B7GQR1JXW
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MCHN1@5'RT3ES387=BJ+D+5DB1:0?PT-&<BV9B\3N!!W"C]EC-8F#V^8M8+;
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MGKJJ2#ZZ65;/>P&P0+AI[W/8%5(EOB:;X1)%3]_&YH;P1<Q%,<-F]&GVX]G
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M5Z48-'_JS<?7VW:.N5+TY@W6@NKN_[/#%UK6?QYQMADI"T7.OF./(/%N3EX
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MI4\#V^BC 1H%>A62GRK+29P5N*N(JLG3/*_WN+I 3J]J\%EO7/&70U"JNZI
M2[SB=Q7;)X]\+P-_/NKL*8VHU&8J#64^W_@XG,H"\ZEN**[@JT^Q6<1).736
M.?]>= \R]A]=U>IKC1=_KS#82G$'ERM/+SIJ0M)AA7'PP\9%^M$1:KL-8 GY
M8UK:K:D/XE5[5@("_3Y G8*3MH QJ7T7=3[E15)NR"DG$-VN>ZW_Y1SH*$U'
MTDZ]ZJ';&$.UY&N>.6:,$<$6A4E:?](3G-OV2\N##!!]WP TZ\J-<!_"E. D
M>79?C&E].^P#,R:T)T+C<4)2%FIQH.M_Z@;O-,LK?ZQ:'+-U*I#;XK0!!CH+
M3F/M$P9D5&;;79S07$V::,+OBS:Y"&%]Z5#*^<RS\K*O\<]PQ<9_C/!<+^K\
MWJ['2#5RN6SX/%A>:3M]J*'7\X]JR9(_"75P]O%&7"B\YHP,6)GZ)TV,#(#I
M/J 20!A@+&;:9K!]K23S#.M<^4Z:8;YZ,B#FG9KUE!NU1-]*)V/_$#+/@Q:\
M(MR8"'.-SSZ80[GT4<Y,G]5_$$F/7;?:B=WH^-I*>BPJ:/F"B6N_>5:'QXX8
MBU KMX[@"D!@,AW:[G5=?UX8G/Y)CM=RR@JI;0,M!6[6U)P\_ZE FYU=D:?-
M@EJ=0-ZY)AC;:-GBB:KC# S[<G',#R?41^'8<2O7TPZ%[)*")1&^G0,>W0I&
M2<<A(O/1?S@: GADZPP<3[:5'WL[O/]""]<IOW Q^\]/&3U;7W?L]'T?3&Z(
MF%DLU;DVAV8<O1KY;LEM]\>4*5"6</_@H#(H_*/9+\U!;UM[YZ@HAJ<WW%J6
MX'';_7.4E2@<J&(6#'/T8>/8^?.FBB$-LV!67"&5/5HBNCAD:Q<@89>R>S<B
MM8BWEH6Z*&0JJ,W)NL#$NHP]S%^B^0 6[[%E6WY!<W"V ^SPI*;X0>PQDOPF
M-///0^,:(Q^CW&?*_PX_N8I6:F\]K@-]V:E08-84T4]69="%V? \+POO6V_P
MSBKHCLN7'?,Y7@AX&P]OTF^*3;%925;URCY:1AHIU=0.H<+=SVP>.NRZ5=_5
M*W6]S!+^Q_SC+[P(E.UV^F-3JRZ4)B08F>.$P]HYJ[F47?&OQH/E)<@=5:^U
MUPB'OE_>I5*,8H>Y^DRW10(9;]L]4Q0FJ;8+N%K4W7.86_)/^)*C^EY2"K*L
MTV8%EA/U)5H<91K:@:(UOE<+43NN4E#C@-1_9@8%&0RS4%"YS&]>BQ_Y^EOG
MP^ '%G<<2+V>TG:KD+%VJ:YOY<(5.R*(KSR;.+PH)II"YC"/:W!.QL>J99K^
M;(.NY/6N[(MF:QLF-ID?CD7'\\]8G&[ZC\('8707%L+;I]/:'0LB,3CE^(-#
M[@S?+GGLP(#M@(-&O&*"\E9'PM+8:&*=.92D:POP!%!G]IMF'?7HJN=_Z$RA
M4PJ^4U"NE$_[2E\?P%?^A5Y?61% ]64VST\]R(OO%@6;V2"J =M%0KF>D@'>
MRYW_0C0;9K<4!-]]ROAW[46B@+%TE&0S30-?6GROS 5!5TE_1I5-;Z]D32RL
MA'%9Q!Y>MS;BP7 A6SRTK;GZ69&J&K7089__&&*)G7L#%^)]$/:6)-C13I0P
MJ2RI7CGQJ]@_<\$VY;0%$RVGB[N3PO1(4IA:,J"0K@KR-\8N^#H9X&CS'W>,
M,67 >@[>$66?H\?H^^#K)"G?WSZE=P9(Q^'+IZBSO"[%Z\"H6^&44D[S(>UV
MJOG.X\,"SBQ@ZM[/W5IOQ)O EG3?GW%?_BOG<RF-)0EK.!NN'?U[N[&ZT)TI
M>#D>-;=%DK,O84Q^DYO_T/GA6<Y#TD (2;<2]T'KR&2(^HAW9ZJ1@0Q@NO'I
MYZO7A_>-^2FKN)N]*1._*:0Y_"TOK/"I.YYWJ>11X1O\85]WT"$/4'!*,QXP
M'%*+$@2S?*U[N#[@AJ(=1F9*_>DI_'K[6V5#"NA7R<^.<_/4N<N:T.+UOUMX
M9NZXE]_?8Y9^O#KQ)08:WNA7D7G']#)H:60RX=7%TGKHTS>?O$&]7!KP418J
M)V]G2>-9]YWAB7II#EC661D]E@/=SSEPA,P,F+4%GPN8)OY,4P(Q<H5[3*V)
M)Z?2/U!EHZUSE.6[&%0IB!7^0*(_UJ[5)GP!.#&:S&Q\'KZ9T-8?\[?PTN&R
M:/MYZ?!<_OPS4OY5GUO\6!,H@EHB]/1M>>O [:11ZPGK?ZDG6X]9( ;EODSZ
ML^%_(K9@/\B LM*YAUR+=!3@4*,):4GMMS+Q786*D_\RBIV@@2.9=)QS76]U
MI,F 7X^WI:?[AO@E(B)YW[R8'6I>#E;T.2:6%SGQ2?X[NX=<0Z16C7L4W[,W
M?*QZ33XI=NH65TCM,Z8<_"5U75*LQR=_U8MOKA5/;7K<6VWPC+'(ZKS;HB]>
MQVL?X@-1)C._=J5S!N:OG[$Y>31V'1Y;?]B')9VFJ<8,O_5N2EM[.377*N#
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M+/ELY'"D%;YWNS#>3FU6OBTS9ZW?+GIT>&71HF0I>.:TX%*]\B*,#/CT(N>
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ME2=U<^"9;ST/)YA&B=-A-?6KW$5BP;]V/O'<EAT-BB&H$'7) /4:T?,NR%0
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M\VS\6.314G5?1M)=&]3-?*_O00%7)PEB'*T=\L(KR6U+D7<?VV+]^E)"A@R
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M\NZ .6@AF3LSK48;[B2FG\#I_X]R_A*T1R<=_LC\V^@;K5#VIU8/2;B#,4$
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MP>L7+8,O%G8,Z_$5-G%35%9BU5:5B;TE373W"NDI2Q%<5%.57_X[OI>AM9J
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M[/QLY=MF[I",^U7G@5^P<,OW/I(:!L_C6HY'B7*; GA&!YQ&5W%DRR(3._?
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M;7-VY[<\V"\W7\4'?BS#L@[Q(C+LH!Y#PE2.Z-?7Q6*-Q9?-Q6G'5"<[TV3
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MY&'V!\)4&I3./((CK7 ?BMP>Q_H,N?U)4H@8-C-L':[-^Q/D\V=DV"[?BV3
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M>7,TPT_NFVTR&CB/S3[TY?7OI, %XJ.O!"Q]X)4"Q];WGT^I-#)./E8/^/&
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M!]Z"C3RD:Q_5="=E9<D7FGVO37W%M9D8P#C,L\CB*NK2OI-RT>K1^<XX7C_
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M KXS_P';_ZUZO<0A]N1)J-L)\,*[6."N8-V1L"609Y,T5[YO\=IWOIH!<*#
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MRV+:>II8!7@4&'S;]8A 7A4OOK ;? 2OD#M-9MLLC%*A0!H(3=5HX4D'^^C
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M^AWE@-#Q<17]<2_BN".IVPK4\-KDR$D,,39H:&;?C9;Q^JPZB-,'\1NU/)N
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MSDPNCXB&2\T0*_APA&L6_W)BHP#K^L50G,6N^<IJ_!(F34*)DP1Z4EBB49;
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M\U144X9,.\V#[PL;=+J$S9+]529.HHT.G([/Q]L:B$Y\IW'T@9ON_6=CAZX
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M3'BU;8E@D[0#S+ZZ \^YR-Z\V P3%LZS>_@#BCJG01&AL:=H"W>?F&8C'@;
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M8\RXW')-L&CG(V THC)%JYQ6[O?+!?D]6%&7TRT B"Z-&_Z^FLGD0>S6Q!)
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M=ZTQ#JJH4#W46(L2.5_G:]_%@2@ T@\ IP2'4\HI.5PLC386X0N-A/C!:O:
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MP?I#!.<N<</H&8@ X[XMJ%VX3^;E,'0]#.5Y);:W+<*$_W-%?2T%EO+@3OI
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M\;> .+/N416[2Y[ZC,*800Q4'3=3T7,W1OD%:,L:N?Q8:8$C^Z\(D,5W@-^
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MR3B\AGJ*[DIM1SZC:TNLYCZ%OU&?V5=7'=NS%MC&;5]EU9:='H%<]J[*UI8
ML,V4Z9,#RL8OUX#YWTXUFBP"2_O3N#&KP]X)W/C(:>D8JVL6Y"^2+HI[]L/:
M1U#C@APT:GU1[2L3-%U_]V<J'Q_;@64J]4%QE8'B-G/(G5-M$U]<0#S*B>KI
MYQ);=NBX.=*[UH"_G.?UK=)\WO+@TG()0+D(@&C")(SS,6QWY@KL&1S]=:O&
MA(=BQRS+E;7!5*H7XP6C#L3A=(2]^TU[ACN<1Y_$,GQFTO8"U5(RAQJ7QYV.
M-"W.(65_.5F<7/)WJ=1;=\:MM@FVQ*6]4TN]ZKSY&,I2Q6N*020XQIVE)QI'
MM^6EVFXK_K!/%"LA+>]2!$Z)'@JB%B"+]OO[$JXI[>$!DY=NMKN>1>)VH5-@
MR_V'BZYS_B-M.D.NT^+L?/VYN+]J>[.>)H5ATSGQ=QW[KLA:NA>O7P-+2]L%
MZV(M*/@\I[.4(^?]C)R^.WIM+,$GQF:EN/),;!*GM63\*P,;I-^ML#'A-:\!
MRGG\/GRB>.0R&PBFG.[&>@W8@/DCUJ_\;FY(!BSDRAU5DMTN=GAP,F5IBRV?
MSO5"6LM+O5QV$^^;)O0.-+\2:QO,-HKF60HK2I)ZG'6ZA^>QC##00J<9";%J
MODU=.?1:L!P!/4S3MW1@XPQM2M,$:<._.0?:DKA5'YPZ_^57+?Q<0,3!E/Z5
M*0++YHS/LZV_!I0Q[LKDE4*BKMP&S]_/(T*N(!G+W@</CBJ%UTH&81?GC,*8
M#:6Q'N9A'^/)M(O>"B=ZS4&7V<HW;YJF]I3)O%:1HJV;0970>XV'<;SGRS,S
M?Y3OJC0O+7C7FO2TO@_ 7P6@\:.B"R7$>"FPFK\0#>Q,>-C;[X)EP%1KRT4/
MWGW%L#:=-5>2#'TU99QZT^TNMTUF[A1HE\J/?B4T=4AT[8['@:C>E4W]7-%:
M@^Z2AIGJ$I-$EO-";H/]#*+WA#5]0P_O$J26^\@!'92#1WCG';SO7K@MUR^)
M6A59\0Y\]+6P>RWQ1A"H[UG3+W*$ZU2Y^8X*?Y5]0_6\K.;P^9#'MZ\O-IHN
MBL>E)4M8&F=ZRMY)_#!3O=UE5O:SH;&(X:NPV73-D*D6KA#_XCQO 8*<R6@Z
M8\>]VPR47LZN& ED^X49UFGS&H&X0@2\B\1N2+?9-57;SK ,>".S"@/M@.]^
M2?/1&/QF<;G#?"S$3.@^%3$1J>+F.O9(*J&FD50!Y?1P,S I6M8:^[K\*8"W
M+7Q$!: <S0K-$B4Q6VIP,"O.)2#!>V80;.4O%(FA!J9L+4FO,+0\S&RCC-R8
MO60E9TS(I8V 1LI#\_($C[XF>>&*9@?BY['HZ2ZMA,"TB=BR-Z1I^M7'^NX;
MF0B!D<W45A4%P7;#GL4E4KR&9,CR-6 L/2Q@U^>9I "*2RCA@C0[)MM*V)N?
M_8M_PZ\C@OIZ"U\XYE+TZ6RY_B_:Z :0>HW3X0F'[V2%BDN:IX+NG[C!HXUA
MT7$OX-/X6R^K[MV*QK:Q4OMZG2!((B6UUMIGZM%9P6N$[>V :>^@_9V9+\(Z
ML*U8_^>)R[.L6:.?AE^[GHN+J^RU)XB/7,F,CJ?=_':?!9;5=;^C,76=YE;E
M_)91C-*5\ZL%PTJK-^G4U+E?(U=*E+1WP="_9^X!_.!!8"Z[W]7$*!O_NBD%
MKAJGBM'+6:D9KO0F3/.%'U-K=?H[#!^U..1@E/Q+[B>NS U7TZ2Z1%L.JY?/
M\2NTDCX/4X*NEK&KQ"WM^%%.M#-2C90.,9O/J\;ID<O7ZM?(%;!:?B]+EJ@_
M23V^!J1);P:IC0(NX+]8:W#[&VP.UP#>O*5 M0MVYC6SS&N Y]7,>CQG^#4@
MVCN>G0A1%L#(UC%90ZC1%'*;/^-"I^8@2]),X4%6SJ=;1DE3>J&#*ORE=:^3
ME+05)+S!Z ,T33H!VNX=],$_IA^<@6\^K]\?BG7[1;8VBJZA*+M@Y.]?EIYV
M7AB\!OA]P#2W;#TY,#P2L6N-R00QI.]ZZG=$$#%*54VO^B^AIS4)KYV*4^^Y
M1S+KQ:SJ,11(<XL3LND2+\<)52H$K[.@F6N VOF^VQ[XJ@IVXC<D% *\?VD=
ML.IS#1A%>;:7H^+\I];=-XPI]RO0(E"2PV)F5:'.\]7#MB?<R=)KWKC5&VJQ
M+BUL9DGWN@\EWSUT;(C!MD^!PG*.AL<A&[B*LS-0EI>-OA'L[7(J@W43OZO!
M9+(BU[2CRV5BP#Q^T!OR%VB>I&,40BYZLOE"\5/X7\JKJ"<S@X<$8%*7#SF%
M?PD6V:M'W1*3AHG]I9<@*P=<?Q<KXKBRI]Y AZ(>]T*0*%1D'I0T+NC'E6E2
MFYPD.94CQG]4/7G5]:1X!'+9B%_#C^)S\5A\_+G7/BX3,RHU?K3$*<0H='B/
MA061O^*/ZQ=G4_7.N[$F+L1IU*4X6)LAFPXW?)>:K:K P.6^]N7%#]'C]&2_
M8:]!?)/3&I]+KF+IM/YX4XD<G^?DCU\*(/P<_G<@O+TDB*(S8/0O8S0?W'(;
MI5G8,O:BV8! U6C.4;$?"7P]F(7H=8:/YVUOE!%,TD:"MPW"UH+$WOT>H72;
M\2.>5[:(E-Z"M,UK^36E.'^?TM(9A496A(P)M!10:6J;3CSYQ;VK=^:T9L3N
MA8+D?L $S1\D7(BRU:[GD>#A0XA#X_K^J^Y@-8WZ%C6^=3:'?F^P,"+7:9WU
M8:<MLYG6A1R+R_<Q+1I1B'7>BP4D7B6S;[%9]^FWH?"/]C53L^Y&R$&^GH:W
M)WJ,NP'<_H%?@GS]ZP\0^R1W-]J"XGJTCLSN;+$F]$K+M4=4VEFZ7<7$KS5=
M S@J^GG6E-\*0]+66*%LV/SHUG#X 5.8R[,W[*;=?E*;<ZI;?3G 9UT9.%4X
M(Q#IF^M ,A46K6<9:(4+ %<<SAC\-!@,XT?7?B,VR++1T9A,4B228;];Q&NY
M42(9<XBQ\1&HC5MEDLSCAC=', T>28G)T9$V"J4^5;BQC%Z#*2"<% <7B\KW
M4O3,9ET7EN;C:0^4*X3,<"K15@@F9V%FPV.A1$RV?KM]">6JZ^T:GEP]SKJB
M:/-G52 Z-/%3(9;D1N1N^JF>H(23 "SPY(?9SQ58,UR298(M/*]RY'Q_H>H%
M[;E;+]/23?4XA.31:UO4XPQVHQ=/QQ%2\_5-LUA)EYGDF?:UJN>AR=7HW:PK
MX:%Q0NQFQ7)DHO>4#]G&P 5GXI9_=*+6TL.AT4?28)W(2@\QO&(L<3V[OJ.B
M#=BVO+W KI;!6<K@LI<O]_%$A6JN1*7V'^TJI2)WVD[-;%K=JMM6^6_SP^EX
M?OL#  [OOJ_O+%IKHIP"1C]"=A=K0:?_E&D)7UG%2BYKKX.9WSRHB;6=ESIW
MA/1TU3M.+/XN4%5%5C[+KR-/]@_ ,Y;$*R-_3WQSO%AH?ZZ\VF9<%(A8OB<^
MM[#X6P?C#^HBKS_R"*L9*[RO]FU<0<6"H0Y:"N1%UG@E0A)DHEUQF/]:I9_6
M]BF"DCWK1W\/@!H'F;W)!<')3ALRN# ()$T>0>"I[*%7A5<FJHV/&#K"'HV!
M^MM0/C*%@1,_#M!. SLW04[E.^3]N(=_<?$=#=0VU+,;7DW(VM$(N1_F5CQ2
MJS6EE%N(K?B+2LJ#?[SXV.=)RF^OMC]+K&9RF5P9',:HV_FQ7 ]J-7G0!#K]
M<P/I5.DG4^N$?TMHU5$%?(Y_TE:6?54:/VP4D)IR\(,]?NVRX5D_S?=<,2S:
MPP0/RA"\!L!=7Y3<(\VQLJ7>B5VD< KA/CP!RE?=H:M_/Y?0XCBLSX->H(;G
MMN41%?-Q$5,2?_CTA6@AE+&4A1V)>U%AWMCU<TS2?C$\>/;T_(XGE\?L?F/*
M:4B5Q)$,>VO*&6U=]3H5=!>&+$,I33SE=Y1#^YDN'^R ?"_CSECV&_$OX_3Y
MM3^+"+#:AYUPKT&7R=5OY#/K0_F?]46U=D::=$KUY 1KG2><N9.LKL>W@KUP
MET1QI;DV:HYEO$8?59?@3H?XKZWY;<_W9$B@+F\>1:$L,+.!'2]=3HC[]Q[%
M+\-/D#!]]UD"9RG'_K=\H3^%Y@"2WU3![,#@DTF'?-JI?65^_'?JT8P?2.??
M4A*7UX![W=7?2MG3V:F;\ZVGND</7D0Z;SC_EN9K[!#!DZMU:W[.U_7CNQ41
M@.4V9YRY*IS0F?A)K%3WK;]D0TH6_"-Q^W VSJJ#OIZK;2@#>C#K-"\*604B
M_;V0 6]>Q>W<5X*E+YP"OZF<_56EH5XFK2^-"L@6H!IMR% B]I7=\J\E^BS=
M=\*2J/?DD8F-W0&7-'_&RD,1C8D#\W[10$H:V?:.4^;@CZIXU6H9&\C2HE3=
M8KZSGRHB"%E+[M3 2RXLO&>Z=AP.7,J%>YQL[Q:2 77=D? 23UPUHI34W^O*
MW;V8@Y[+GM9KUC=YMWTUX.5S?2*>*OY8O9]E+/LS'V4(U<V?&WBV H1)1.+-
M2FGP\<M^T!.2F@\L!V51K+C/-%J->"(0$<'$6)T_26SA3+1F3^KMQ#U*ZRRD
M20<+53#I-4 WCJNYT_WY3;V 1HY]',T^<S8OY5P(F>PIJ;,TRPDJ:*Z4U%(A
M%NI'E2!#7H8<:S>?X*![Y/F1W7SKD O2K@IW7[@&F'[-RV]P(#[?[:858+70
MOX1JJJWMJ'XM9W%4M<MDX@W9AG'YGIZPCQ6]%=>5RK]T)N*\%$5>ON0-<>SH
M_\RX[)L0LMUX#6C7S)9U97<2X0Z(+#MAOXMGUB!>X7>F(&_:GW14.#D]AQ3Q
M?1'4K&B7 9M/?;B)>!'QJBVFO8!DHL9,A<#<E?.(]5,M:D;I(_&[\+PFJ%KW
MI<AVT1W&VZ5%&7NBDSZAA V^Q1T "AO7G+<]GG] ]?\B+N 6 _F,C+Z6N2KN
M#R7C9" FG_%?)(%]LVXE#I-_;T\\ ^*CW:W]?=N=V)58KZ3C@, ^4Z!K^>EW
MX$H!I7(@<[CR]WHYX2E++Y?#/T$EA.JH/KE6K3O_YL%AP*PA.-2V")(!TA3C
M3JX\;J?R2$P)$Q.= @B$_R;D@")ZR*]FL5T>!"$X7P,$4?5.UG7/#.@^GODI
MHMJ](";X?QRRH$Z6ED_^MIX>'^P,:%N5.".3\CJ_BWO!6T+K_8GB-QA#-%-]
M#5C;;5>A,/L_G1!ZF]N5E:*Z9&^O9%EH\8;$5!@W\H>B\BJ7][B>LA\&:TT&
MCKPO8WGY3;7(PO 9_.PY<+&5?!F _Z0/U;JQ@_B? Q0H]AK-[H<BC(8V(5-]
M5CP][Z&^>P-DWIPF$0><7T1M.7CCYC*"B;BH]/NTDF)UK#N["++'!X^/)+%-
MJ)AY!/MJY]<VY0S5I.D!:TY09>):"*6(!*-6T\V&$F#KR*TTK7TG']>$0.RS
M/\MM*)>JP29.0(?+@AYK>-+7^TY*X.F#T7ID'?+LJ= UP"&J73UF K-P.E/%
M5)HQEKQI,_VZ1-$BZY!]A2 E3!]U#0 F]-N48#]TC-]1@#U8M ACWU<6.BS%
MY_5X_J'^D=./U$GF+2%QL&AJX%=7W'/R/)-#]Q?.AT-1%[2TO^/:HZ&0;HB*
MSYD7'2RTZX;B ^<W@Q_]#6/6G\,H>&;4_0(0;'O#4IRAM"W);]7R-7:KU,/0
M$K(,&]%% D>"#NNL3K$CE-HM)JNSW[TA/HQI?JF]4Z8'KNU Q#<1.7!BV@L7
MH*]+OP%!]T,_>GK N-[2E%4+!KOBVUU.-Q+NT]^X2X9P78  GW6O.$J5NFH)
M09..U21JR)9,?%7Z?RYHT3Z!)JPQ%%L.)I6T>A3.*CZ3.$EJ (WJ8G7,3M8.
MKP%V6T)>&A-6#I[8I]J1JT%Z$^.R6EW=9+"C=$>CX4WTVXFED8U*93].^YZ\
M[<=^]]@400N7C1NCV(Q=AS1FRZ30Y1\*-58.]GU\]T]:K@$6SRM5$^_OR>IR
MYP[7=MZV@FVD3M$J[-MRV']?HGRFI/%YZG&*>AH-</!BT#@O:JQ"+GXM^GX-
MAVO%S;"5V==D.DN.J4O]6YF@R2@KNEG(7E=W=2W,=>HS7QP\@0=Q'ZPPYI'K
MA+8X<Q3:EVQE5Y-9S54.Q<38-.GR$?1A/^DX:D<O6I_L>%\#;DKL=3;-W$U=
MR^,_G6M3K .2Y'OO,DAY&LT?B&:H7>B";YO]Q1+T39X*;/5#.8@G]LFN><J<
M1[4;/O+JKM1!>>W#]<&>B,=**IB?5J@FW;ZU.X\D/.AS$^6CJ?&O[3WVG!I9
M GZZ=_'MX,P<7C8N\>LJVY<S>.JH,^CX\J@# $1_ $ PE>>7F*];-6:'^'GB
MQPZYK1ZR).]YOWW8Z:F;ATE&4_GJ<#K<*_DJ3\FJT<WT7HCS#KUO\F]BC_*-
M7<]4:\QCVVZVY\F4FFWOAQ>BO&<8;%Y/-@6(R6L-7(42%XS98TYYFYBQOOFU
M2;[]"7\Y_*,\X1':SA7GB=68F>#/A]L@ZJ3K7]+T@)-3K?DMN5>7)+N"!M1(
MH4R17*=;(A=GPL%>3YS5!@P>-IQ,D]1>BNG><CE+I>W/<AIBH32+:4J/]K$Y
MMYIM@^I->\W.&<-B<6GXFNV3U[:@^PH,QKJ%Q'+LK]8]DG1)G"^L03\3<'BI
M&]W%4!%DA92#;M5<?)9]S';&-4!]EAF @I@0'>$NX>9/C2M./?&/Q5#<7:OB
MW,!?KOR/15^&C%K9;3Z%^3NU\Z\];$@8M#RZ,UOXI=#V,1^79A^F.2>*TY11
M6,D8 ;G/M8J:=D$IHAIS%2I0GN"B]W.(OS(K0EPOKN P\K.DWE"5E;-:AW_A
M6@+0195]2$Q(X&W L+PAZ,J!\3,TM2O 7?AV_#,[*K^I$+.-X1^CC(%;%@VM
M=MVOK02IN+X&)MB+_NJ%]:4HGF2+7[[$HR\@#P8E"RZ= M9'3]K=S1PFC'LP
MCM.RH],7+(ALE]VUK<]^1PB*]<QX4=(I9^W!4KKW3?C+LUL#7/>JU :&H%Y&
M:4-N%]BC7664:B[?7=VE]?*]A?-5G_HS'RRFUQ]^B?-YWA=H>,R=WL(=AXO
MZ,6Q=+5D]; FU3"OL^:EZ2Z;BJS,QA/#^./>A1N)+2D/B+$Y,Y7U5 AD3WI8
MQKX8YDQ.<+%\OCD>?@%7S[ZK^G- 4"B"9MP5S4V!2LERTD)O&3\%!8V""TKF
MS^;/HGQ*4MNP09H'+33,YZ-4$1E'TC?-^O5- W[5BPV7$\S8V>$(>W/^-;[9
M=;!NPTJ5C6W:!.BUPT'S#FI.7[<(I"<$4K02EY ;"[>9342L&3O'-4LS5#R4
M/MSU3N@SV]L\'KV++]]\)EFR/U";"QIV27A\O$?7N3'Z>!DFNE1#N?5S??T,
M@A%DAS#&]-BZ?F-^Z;"*B3E)?2!P"MRTDQ %@70O^& L23#ZM*]3CPS*Q\7<
M6\Q^3'Y?'+2&5)O(IT)^O[J_%LSRG)"13:V00_ !?<=YK\4.QB)Q'T21-LB2
MZLN3+;,3\#6@T6Q9GN]8BCN5S7LU.R'E&E"O@=WR(F&H8! 3XNLXIM9@T,G$
MKN4=0=<)_,?Z\>QK%48O!^V4-D+>=GGEP/TB4P/ITM.KFC;N9>U-SDP[ZAM+
M%[7-MA1V^;=BCU<2.+VWGL0.'BYIK#D_\*,1$>PU8M@.Z]*J<+LI,6'%()G.
MWFYJ*,K[I4Z[P?2MB<98BG^RDRMCY:N-%LO55I1&T5;\^UQI$QSFL&2)'4FS
MD[4*H9C>G-N#(J\!R/0%A=L;"_&.5/=6?*YZKP',/@IDL82U][7BE;!UG3JH
MV&)C>1\3F[<5'6^J#2H4C?UUX 1KL!'91R9!/KD[D",X'P$%1'M3\63B;)S<
ME\8!\+7:3&:H,\:_YNM'X] &'])DB^-[_FOKJFK4$D<))R)%':Z\(EVYQ90:
M4&R#./^W"Z>?]:HZA./ S1BW50^Q]+VM@2NA?O#^G<!\XYFH]Z6VYW.X#ZRZ
MDJV4=XR+W@MW. 9\.Y16)E.FWZBE*BH:\&[M)^$4]?JIIIKOLL]-F8V]RM]E
MI\ZMNHG3L EO0&*S$DY@*S"TV^7OP*JJN$$7M% \0GLMD_6 8U,T_6Y"CY7M
M.M-4A"<UFT%);1N&XU751%,I:/=-W#"_FU1/V1,EU>@W.HVZ%:3LWQ+X,-<
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M8CPFPKR\67G2<5 B5*& Q9^F@#DE_R;7OA82!JX_VY]0>GJG_AFZX_($-9F
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MO:S66B'PC>P:K,Y4S#T6Q[@H6E9Y0F7M:B.$1E:'?I6-*SX"TJ0+*MB)5"[
M*=7$2B(G&HM]4?194HHX"YPLSAOWXG XEQI#<\^P18[WC/\(*1G_ 4;^^(A-
MBUM)TE:9;[B&N6%UR ">$.V $]8+C;U#8\_T,&%CIJAQWF#>X-!) =8':X.>
M%(1]1U:(>=TDC-#$3B0>L4'ZVM:EUZ7'" NPME>]:*N.;T>/WMW@%HUOG)#
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M;Y6$^7YK\MP\S\$%I*"K]$"-S6+M/^I2F3/^T#7P<-;<\N5R:-PRIX0#YQ5
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M3;X*YAUL"S9V-'7<?Z9*M@X4L,4Z@J,DS2]C*>-NIWKQWTNM>VE(ZU?/.!=
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M.86^B7R1U:,]>KEIYOE@]>I-AS>,3O"8QC$E'K)/2_EG!'&9^,?&R)R:4&X
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M-TO;(;[*B_M8)=QH*CMLWB)[IAW#(VN2E*U^.IU/OA&+7["I(^$MI1HZ$//
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MU*$")AW-<O[6-5)=XN_SSLIOH:2X 0B9E*I[?387M=2KV6RND.?68@'*0(-
M-E;O,O%97E1!:R-=_DL^?R^U^G)$UZT@QU#BT2!@VG&6Z#=6S*>!3L;<#T>T
M M! :>HAV/@1$VG?:F=D0M?KAJ<3J!1N4<&JEF)/ZR+]3_Z:'0W%S:4724?X
M9S5C5QJ0>"LEO(JT=8Y<SP5ETK'H@G%$>W6O'/_ZHDH A&354T_K7G^M!2^<
MX[FI#SB:;;5]Z&O0FP?)G=,K'R<J*1[8IQ88L I#'_>T(OSC>O+D+*E9SZ%7
M1OA]0L7BO34@! 2!EH)0H,0@VEQO]#J0"@M&7WR"^DH9)V ?ZZ"&Y)X];@X\
M6%A+VW.J]7GA4\06)M-D__U(?OC#!4_FPA]&3ZOD6!]M29C2SQJUEX0O2[[6
M0;F.H-)<$3P3Y#)T$H;+_NU\[>$U> -XF_NNO10]MG[G@J-O&7W,N!:T]U6H
MREX<?,\YT3OA2&R]RJHM?M#&.8I5@F^N:GS#U;<)W-V\%W5'1MP@"+5^P*][
ME0FIZ I=\K .!96.I?X;(S< ZK#:2_J+N$[$-5/O=6K288[HT#M;:1UP(H>1
MM!I/_UJ@DW'J>L$O^Y-2#IT[2>9<Y-Q10K9QE9)ZE5V,I_D^GF*Z9.FJ6B1S
MUI.T:-8S21P[;GBK4W =^"ZT_(#WM&%C42H^);!\6,'\.(KDDV\.ZW!Q:?+
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MF<B++Q>N%XQ-Q07(PO($<O6:5D$!7XAVN*]V9_/>O]!_)I7KVXE'=<B&1!=
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MPOQK[,"L6 UF%F%GF_XY9<(.E>$VQBK&POZ1K QUL2J247N.+ZK6[,:(W+O
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M-[9!S:%M%1FJ6@\S2C78O+F'R0^3QO8N.T %)G4:KS]-B?W/1I)"OG6!P?7
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M98XL_8X\4R)9E##P!=@,*TFW;- #W)+ L]"2H$[.7)GH;@[A'+ZN+@2>)O\
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M[9!^CY\&DQM.2W >P&UNEKZJ>I=O-#CVT;15MN(TWGES'GIE:4YS96ST1OJ
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MYU]B5./JD?ET@5:[VYAXA3C_8&ON4)6C8 VH??0FITMQ'#6!P0][LBE%=+]
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M$N$[6W=BR^-I6"\.XC)Y)AFF_AQ^4@@'X<X!?? 8HKQ;9, #<A"1-HY*^AP
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M&,V"$0O7V,XG. R3[Q(!Z)F'@.5H :RR_."@QVB1KEV0L,!H*A.#TB+OPL:
MK;A7JS['_YKI\MB?79#]&%LDU!*N2NV^O^)9%[JV;.O0*S.?/_!3:/"R*L)5
M_9P\K]RQ8?SE!O:7V7P_U)W+*<G\:73</;*0%>&K5^27 +ERZ76>$ET5)N O
M,>I?9(7;0"GP:N?%4M?LS5JGQ*ND8ZB&'J-8LF^^,QFML(Z65HU,$*T8:=;V
MM=_*J0 /XU6(@.#6=SB6;(K$6WPRS7Y'OREE*H*5X8>?&0@;A.@;&5E^A'8F
MC$KM97:U%+4A67F]O8+T+&MA8S/Z@DU$ .X%M<)K_H(O]W6?RD8M67S8RO T
M&5XTC?'Y#=KKPQGEZ9H$WC\<_X7XW;6]L5&,)Q\F D@;OTR5Y6X0S=$3I6.8
MO((W33% !-[^D1M!7L'?'ZJ478YX5R_270.EF]TPB?TLGE.9O]&HM7VCR7B.
M""Q*SQN8:VK63#DOC#^O#3F=TN:A^ICVQ*WLZ_710>FZ=E+!Q$)C$N-H.0E-
MC;G=,2'Y84!5B2M4T\)OD:R5UZGG\*$F_/+@YU!D^4;=^L&F5=1[K4,;OF0"
M'1'@78=L\,A'O(R$#L*CI3ZN>BA<G"JZ!C=44VR6'QTB@>[>!J4\HH>WF0AD
M)3S):]TC,+IQ.WP&6](.%[)MN2.##$6R0:W632S;H'GSM7&I=8*"GS@[BYBU
M7F9G.O7C2+R6O<Q'*IYW%MXO(-C?W3P3@<;>/D?C![0N-%4++<'6P9S0?B5<
M+<FUMRS/I7XC\HP^X%DQV1&HG"A>-JLQ:4USC9VC0=D/,S^X'V?)3-WQN,\/
MD81QCY8C2O4<>[>^X:>E.%+$O\&'PIAT3;G_ZWN@_UHHLW"U2Q*A>/=ROW2]
M*=&BYA8,15A:CM_@F_[W==D:.]GR]#7JJQ^:W(<-@FZ)DDHG>$344@J:Q';,
M97LXA"?LIP0BNM/Z2_T;QS4$DN9!GSDE:[4DAGK)/]QI-<H;?<3+@1-"[H4%
M<Q"!#FW!<7E^9!9O9XOS(N70S[0 P?>&;UJ+30PDF>)>L-R.E+6^__SAU;/;
M?[>NIDY[$2*4I&:\_.AE5OR%=_T"6.9]T/8>9ASYI_1,$^(4/]X;(+J'$C-Z
MRG%?LQOD)O*ZI),GV(.-OB]89!/*! 7S4F\N*YG*(A3[97^S/C<$6[M_/7G]
MO."NUJSOJ]#8)<1*#IY1__N#QBBH,YP.?*S(-G[X45Z^<6QQ.M)6O:YYU3[J
M^CO-I(J"EG<WG/E & "\YP>5Z$+5_!QDM/!9":G/(-@*PGV9VMTJXTUJW3\S
MF-8>9G;R[GORTA.!;<H\$M'R38$8HP=P(WTS/.%C_M>"D%D>;&O<5A_ZB[<_
M!):[6.U2^!]W6<9ELT[!G?8BIUAJG/3FYJ8W,B!WJY)]3'^^*WH9&\WW4SA.
M\I;_XRI_$F::(XC 2I.?".%[0!\A?GQK2?NJ1[$IK2"K-RG>#FMS,,51F;V6
MM>5;##TK9G.SLYP?06NQ6_)@*?MY 2-]PD[ D9]0/!R5\ROX)LZQW=@$A3"O
ML5@PF-A:$S[B0\G-G?H/;HVT_?+^E9RR*+,A<*Z?1*I\/LW]/4K%C(+7I:5;
M,^=$'%&YT7:5^97K3HK5:7(FHA[":9]F6_D""S.]^Q04QB<V=-.WR429V\I:
M1[#A8UY!@<C*X4S8/+AA1F4"T_>FG1<]!CYX)G>#9W0;QIPO<,&XJ\/@)-P?
M6(;;PF,S&A.@C:WW8,92#[+#]U._$68XBC_'0 -MUL?.DWZO"E:G7- -O:'\
MYYX;U5[]\F)-7\3*+P+S;&:6#&I@:=[<U'0$FCN[?NRY@9Y_EG;3U/CZ^\<7
M.65ZK?7(/<HT=+>ER/Y]G]IH (Y^ 3VY"XJ"'U.3BKC"PK\\$J)_IL%87MQ#
M!*A+?TP<1>X)6:H[0^33<Q,:LRAJSLV,9N)14G9RG;&?J7,&X/*(Y>*WBA*0
MU[@]3R01H.LK>P+A+%5,89BQ9;UV\Y-3.HWL]1GK,YJY!M 4W;V,,W'V?$.#
M,M2-2\N7BV:TI@_4TC%&AUJ']@IV%>F>F_WPE2H(+Q&H]C0DF 3Y!DNA+?$"
M.;834F>P[1P&Q]E,G4EFV>WYN-&GS3PV$O7*O>K#S"GE90_0R=!^,QR("+S^
M4XFO.\7>QK@;"&K^'J:U,"("A2.G#F,/%D_7XZT[@J6(P/OD'9/@7/!Y,DKK
MH=,FAZGB>69M@W$F^<\P;+4&P-XE0N'M99'=G,#A)T%@T*G9Y A"8'6BI':&
MBC>C,[&NO>N%9@F2K#.YRP+V5P<,)KEU*'#C),5ZQ],PV-\4RTL<G<^PKL/3
MKYUI28H] H ]=07SY*C?IGZ<>DM=6I:1&P%1NU&[/B_DPCX^JL+<^[R_*'Z&
M_6:&2K3PQ+<?*Q0&Y )) 8!(-YX*%2?;G5,O&S^K,^'B?1F)GDJ_4%^Q)7QB
MW^+3H1? KAJ</]56AEH0&?1_U10E%&)P2T!/V-:;_R*=W_7XR?WB[:["W]/!
MXXM</86I;36SYFIN;.&"CV*:/Y9\7_*XSQ/2+*)1EH+P/;T707^S;"QZDPBH
M!EFI,!F]_.=08/Y#N(ZS1RE8HU1S4.5N'$'A"HKL.Y6'I- O*3"(MGM7H+=:
MX^&"R,X78H.IY^7IZAO::%_-JPOYEVV+VYQ-BI-@*3G=/_PW7RJ3)<8K+9W?
M=A(F1^U-GV'%QN1Y,?9]Z?M^WRQ:762.O+!GTH._-=[8UC6T'#S[\.#KC3_\
MP-*['RO1I[($YN.8.@LOVDC?L>MG#>V"U1'/WP>Z)O1_/#<QE(+($(&D4(P]
MH6L*?NI8#7M2=9OI5B=+= ,,[CG2A2S5#_M26;YY5OL79 O@$G*A/S0[9MPB
MD98G+LBAYRH/B<!LVZ\X5@(1R.E,P%FT<XX3+.FZROT4^A9<H%H9"_/!C=>E
MF_$"TNLI1FJB:6-G1*# VT,+(GEV1 3X'RIC6%)18,'6T:.'"B9#+6;&<P*C
M.3B&)!'5IB'/)40(1 F"0%AP5,?HNYU$&>?6M>*%(BM"T4ZD[8295ZSC<9ZH
M2_#7,<?.1YX\Y6Y$X()C^@XE^J/ND'0+O!C/>T#C%..W.$Z@/<F.4O%?Q*;W
M7*,D*-9!:7 -S%LRZ=[BG^2(@,^5]Z4GPR .$-+;V!$N$27_$&5YM=&W?6P!
M17$LRU+DD!)8&ZU0$#R5#9\,G56!F 00@>P^*Y0.;1?*Y;;FE5U81;Z/X4'=
M;+^8'9L<2OW'*P55_RI6K$OM1P@CVJ+<M\PIHSV_PJ&!(VZ^MQ0J-OZIH"$N
MQS$Q_I=Q\KMW0]X$;MP[9 +KRT'?7%S,T\F=7+VQ06M_KD$V;M\=(=>':X4>
MB[7FW4:6M? NUO GJ93A7A.BL9>I&T;+:4NNAZXKE1[;ZDI/$]X'UI2SBX\<
M*O!%"U<.?_A/APIJ9GL>W-X,??:@[>U$U(SHT(#_].'T9T)JZ7]SH,N2/+BK
MD=?^_"O<\=O]V0'9EAU\LZ4Q[+,]3R]TJOT$1KH\OV?L&LZ_*=YK<&?NK4:9
M>NZB3D=) ,6M 1JQ;/B1/Y)N1ZI/BL'H)&CND-%R1.EZ#@7(U@_/?J:-2]"/
MZ VHG"0"$6/#IQI_HJ@L,SO<UP3:^P8WY0;M2Y@/?> DQMK588DEGP(=^N08
M$RA>+=;)]IA!:;)R2TF5JNO(4=G";<S'>MP@\JR:E&(9YEYN9/@4VKI[N^3.
M:[)^$FVPE:G)I;X<KJVJQHRA3'^<RB5VZ4O%9R)PBQ0.=T#@3\F=!-:O&.O&
M5# 5M\1S"(]8D=^*X?=-0X<;Y+_4"2?'W=Z)S*.A(M3A^A_4*B%]9[X0,8Q;
M-Q$@<]S(W\P(2GM7I(4MWPI,<Q?L_CG(9>I3RO9\;R*A;5ND]3S'&6),!&IS
MPIQWO<L%$&/]_-'GE1G(UW&F5%R):0F2?+2B^-]SS?V[WM+%ANY]!L4_ML<<
MCQOQH*61UWFMQTL+Y:@$>@?)S?8;D]MN8YHQF0Y?:L?CJF.[/$4?QK!;^B#9
M[G_O#4#DZBL\]<1^T'^*(,%TZ+^;98+1G7^1MT)O=<Q$6^)@/19\Z#^5U@5S
M3J(0A<" 0E$^VP/!##;?)R\>WBY_&E8S^WPET6+1@O9,U4__\9BW)B^OQ9;L
M Y65AAQTC(YK.T=ZM\QI+"NC:&*7X&?A,18&H1\#CP8_=-10 #Z\%UWP$F4X
M[U9=9):]&2)WDCTW;<M\PK4XE8>=1XYOW\[9M$:]JB(ZZN#6#U0;7ZL^]B6&
M]:T ^@6!'6U87P9FY; 9M]CT!+<8#&<%NKM[>CX<\O@U0@T2F1,<^"/UNY+S
M2\=C2KDS-[PB)KW;+>)4+"*T[MNYB9_K;E$:MXR?=8JZL[AU@X"6E&;M2))H
M2U.2/.4S^K9'=XC 4@D1V'\-983NDJAEL>;3TS*X(GRI. 8S!+4G I&#PKA@
M..5C1Z6W8"SF,LBQ;D3HF/)<A,3\TRQWC-;% &;T;3Q[!'(O!NXT[_:=P-TP
ML2M1^.!9'C@U].S!V+*FYF!C#/^?2XZ(8VLV>F%ND;TR7-'Q,LN[)6X0]D.Z
M>897D%LWPD3E8SA+LE=Y40_#+O]NP@?J#.Q7OX$F+AJ9"J&!9OY@Q%J,)6*P
M=,/63\/Z@$N1@ZDM/R5I=7+>>]8\_IM&/6:A$F.)?)9Q=-C.\JUIW/M%2.^O
M6?.".VK<42=F/2,? \+[S5OI,T[SX'?EO<]>6SKQLM9I^2JU38)JZHPSICI!
MAR]N",93?+Z&_?G(FOZLY\>RHT7JJ:^EK#*[,BO4VBA[%F]B:2[7NM>0#M>4
M/9HS2+23$[V3U(><%+P_T"]<M",$%V_4?8.K/YD3^8@I#OD+)L[$<XOGH3:X
M9.VYF>"24KC=MFNTP8^#&T%E/)*J;RH*S741Q7G?2B=2;]WJV#J':O'FN'KR
M4&&*2;3%:?R(RO)OM,7H^=CT\?9\5DWW[[]H2[0Z,,QN+%*>=WCTTV^\ XI.
M"DI_/KX+KX%H%+NZ@%Z\6*SUD56YO>+_H7V2EIW_OJ%>5<FFGT1O#DFQ7&="
M#/J7HHNYLJ8]2=%GD/$527'JUG7R^[:OJJIB1O4^.ZE,%M1M?H-BVW*T<E3'
M?$:S%"")9T*. :SQBD(0"TQXW/(UW;U\3%"WOLG,D.O4L>';6^]^^S])>2UX
MU2#\,>VS'(WSRE9%B7:6H;(N7Y1(D.KP[L "&QY49;:Q(ZD3Y,94TL\UVG/+
MQDYWS49\.:3Y9FLYE@)G^\7/]0Q%TY:_GGU]%%-AOG$7ZKC0)2!QT2.N6E)-
MY(_#P(=AU<6<5;O^OD]1A957*O4]X)I2:2-5"8/[;D/=<IK,3UG&C1#56&Y2
MO9?]Y9_: /]6]&_&:C'V]H2TI JRE:[]BE<Z9CH5)H]$1W0L7L.QFK5,'J8C
M%.>]?,VDCR/K.2>R&FY3^JUEC7[DXPN__H$)>,0\.ZKRS)JM7,4XLO>.8?17
M715FE;!_'*#BT3E[#*'XBIM>,M=\VA"J-BY]5FB,0L"DFG;M&[2Z?N[_1J9^
MDA576KI;98GEQ$$K( KGV1#92_E5-VNMRTR5*QS1D=1VO2(?]0Q#'\8O<7^J
M?3?(V[5^]0 ^/4+0VD-&G$>?6A*25,RJ4A1:2M(:H+G=ZUU;M\M,I@D.AT^%
M\UKB?_U'0 >3/L_+3W-[W]*JZ^?6;2'.('_[%!3F+32^5\4X9-YAK\%O:^;Q
M_?Y<;H1<QV%9"-:2;]A?OB?"QGG!.K9LR9O_UW/*-9?T3GC$,15-CL3V+13;
ME]1.A8ECECV^<%?S@H/!S_9RP^ ]G0@X;5U.N")'Q*-?*Q,TJ>2,%TW2\A7.
M.HMY^08?MF9>NJ_7Q_[].PI^C\ (T9W$.Q8X</2V83BQ*1/U@=.&FIDY- ZA
M9S2K/S]*N$(28WPV)9G"Y,NR*3<K_P=WFH.]"8-)8A$[_IB;)[_Y-#!")E_M
MK=^2SUH.C32>BD.OGC/!AD>FUXY!O(I"ECDG7CB$!$$UPK"!",S@\.!=O\#S
MOCOF2^D+VYZ&N"]!"NB1/@N."2+@ (N*L4=QW]Z!54K9U-%9=/]!)CW,0LG+
M_C3BOV[/_J=MJE46:9'I2+MS#U,^6!\F_]&+G^?W]^E,Q]KX^R/U@:F06_%4
MG\8ABT,2Y[<^T_:YG0B:K)U_)0*CF%'T'D% 41B3'C:[&K]P"&8!$P'MX[ L
M^+ZM.!&X5@?Q(8&Q015TEO:<EYN'9'QT($HHM/61HFE@0^:C5H60GQ>_/@RZ
M^5Y585?K0NGNU-K.X+&L(!&@7.$EAZ]DD:HQ*S$=TE>R,B\:D:,?$C3F++$,
M)),.D>[F1_?R:?%L 1(_2%2;YM]-8,)$<<@E6E;(X_KQ2HA<J>,IO_$(]WE5
MV?!6H+U/YMNDZ[JH5[K33W_$%CR\<"T@"S)[9@**6FD=W6YEQ4BZ7?,+WYQR
M2._\B5&Z5%)Y5N=6G^FO59'MG%CV#1__YJV(#)IL#D*!8X%?<7&3@.VM3LIK
ME/"+'4UG0CQJS<WF-83)Z"B3P,T%$&'V5V7,S"\")OW3MV>];N+N(K_YRVOX
MHBJ5==YOM,3G!_'U2\R^NLGY,:9,V$W\1:+LJS57CWF=HE^4?Z=*M22QN@X2
MYUKI)MPD^0WI.+734H\, $\H7:9E3*?O <[I3&O\Z#Z_X_N,AAS!;>KH@AJV
M,3]M[3LT!(5KP3I^LDK-N$KT2&] Q8QX9O%F><7<9I3,)]</RM1@BIZN635V
MP3'F^)NV7717\SZG78*_;(6^P6:38P0P= (Q6LW> C8V3[J-ED<Z%Z-]>:]9
M(?(R#-,U)J04E)]ET#,PF 3J,[E\?J,<J<'_^1(!,Y*5B4)7#TXQU!RO28VO
MF@KL538WNM=HS\Z=^W;-T=AR?&Q=IGRI7QP1MN;_TN$D=6]W6GA@I][F>+.]
M!:VS#5X*HNQ9I*[+"K@EK]U^_>M$O4BS0)*I93-SOC(;??\H=1)7")7;VEO@
M='C1K!U]K=N0A[\Y<)Y%E7X&O$_6(JG-(M+ZIKAFJ+.1K*&!"K^*7D0Q0$PP
MC1U91EH8FP#-.4>.%)8 L(J;?"+;Z]J7XS>B3K /KRW=N:S.!OOJ*H9J;4R[
M@M+XDOI4@RN:W5R]XR+/E_C)H7>Y3^F3<WG,#5H/38_.CB9.?NY%@O\<%&%P
M.173BF"9$YN5Q::=@38$;PC&I[9%/2EZ"5^^%X;_GKR936/Q5=C1U2MW,S0M
MC>Q\P4)Q-OUJ5F7J3GNA/<5\ 6;>9#A&0/\Q<DSE'^9GFF F]_Z,KH\DPB*\
MDDHIARAKSSG6$08'6N6R"IX\_]T6P>&AD<J#I$+!^PI0V$9^C.?:7MPB0\6>
M(KU36@NJ* PE)OMB=(8(/$W2VF9R,NP;>K_$GONJPF#"9JGTZN8/$E&JUHF1
MFC?M;+]=UR!K!\YA=#I-T1*,Q72CI4<-K/BO/X9.#R-#/]P!)Q*!D'0(62B*
MY*(Q8JX#$KA2/*C$M#!3B%;>Z%X/><?GMY(CC"$!;&<V4Y3;-U C4<'D.,D6
MU7+TENY4JY"U+P@;1/CD[X(-TY>*D0*3M[B]^"0H$#Y_@#1H@BFS<C [(OG#
M@_%9JN.&NC[AT5K3\R)5Y?:^=OB,5('JKZ'F/ V$RG-?Q86\II$K^%?HA#AI
M\B)CIZU+#>7-A^9/;XG67^0IFK'5N$N8FN/I1MB;,=]ZD2]N4NT>[-17D1%(
M2K\OJ?^[TP2#&-YPKQS6#3W'C*D<M]*-?<G:V;DO7@)<H0G6!O*\2Q(T>,7Q
MA:ZN .GL*+MM]MS:2+XDX/D;A;>\86ZC^@.P(1>-U019Z7H2J2_Y\A_A7A48
M)=Y<CO/ME$UOX8V0:#4(+GSNV&+[D\ZLYAZ%;URQ5X+'+;%PJZPFKD1S,:,)
M^I7Q7;V[-Q+S7N4)73[IZ)U2H(4[ ?A]''@I@=)/XHRURW>Q3J(7%I;4)>H^
MX^?;.W8S_8I@%)V*2 ?6G^QZW->!KJ\[EGGUN TW;RM4PJ7U;!9H/*CN9BFF
M<^MY0\,$@5NSU))6T&1#STL<?>+$'UE],#VPJLSV75!M/6';$@;.V.LT?^)T
MBBU%?:.BI=LT"8Y"77.@K=]\X*R?$N+(2?Y37G+O^QP=%_4ORC82G2'[5S/Z
M_V8^XV^0Z0FE;PTJ@HBA%6M10X[B.1ICKV1E0:\;'5?I0\A>Q?23RRF^9?!C
M/JD^NXM_C3Z.;77'! 0)+ZB?%G>W\79C/32<!T(&S'V$-7S680W;W,7)X;WN
MEL7!-QIK6GY)WY<6L6QT'#-]FB[3KJRS]N1YA(Z8DOW B@N0_!D [_=A'=%H
MG!L2GL"AF'S)N:(>#(ZJ$J^H@DQ&]^X;Q;KN=W8JQ68E;WL>7/N6\NZ8G08D
MT8D4L=I:G'V1*LUMD+&F@ZX-#G3P'AW ^&UZWY7BW]73ZM_*F\4GM"FR$H'^
MGQ W(E#%04E(UK*8M)2'"*)'(L5 #O#H1D9<\8[JO?R82<)(',7,>>H #>TN
M-D15S>+H4 $B*6_&Z)K<TM@&^K<X/-78O4<S@H*1;3T(RA0-2$C&QK!S%OCJ
MWDFC!&GHTB*U,&M=01(HL0K#ELKA4N::"QR<UU3!-LFI5FVZ;YV9V4:>]N'>
MH?>,)MOIP3STZ/9F:1(TD9N*EY:/B,U%<<6=S7UCZ$X1S<^65+B5JG>O36W0
M:]GE*) (?$H\$_=KZ>HE I<.=TQU/LCK+SK1].=DW 3WYX!I^L"EIW2!B K$
M#\NOT+='1""L,5ODES>WQ<*69C.O<WW]"ZOFY::,*8WGR?%?K1#L0*?G4%"@
M!KOMI) 1E;8!<U8%P804FL\.0_[M.$N[^_F7X.M^O$B)'BH%S[X'EI'#616X
MH$/AE7&OJ0E1;W^+):;QA?O+C@QK8BWBNC8, S3/K'G5C 9Y&_D= G3"QHT1
M=;24N+(ACLZAPP3Z!2VNFI-CS"-N:]69?O84=0V]8-65UV\5E+'6Z'(_':3)
MHQF:9B2L83,CODAJD<%<R1W*.^.ZFB-9)_!%X(>QN'')]7LL%Q'E"$YT@E:,
M!EHLM8ZVH-5IGVZ&NSMY9G\%#^._Q[B5C)">?OX_ 78_V$[4,HP!(GN>@]>$
MX?1<!*4#;9Z+';FG-,?%"T3?;?.\I?<T7F/FD9XZ; 0^G?]XM/TN1!83GX :
MDM72W"'O2JA2X7@R:FZF09'8&"-ZQZ?\]<M+P8[L5RZZ,I_JGJF 8Y!$X%W[
M@V:P9OG7&;'M0)?7!U==&S^XN3WAUMBF@'">W84HH,_AG8L\N(55:5F$WL">
M\OA2_=>TY:' .-#UUU*OR>RLDM^-"V6L_'37-@ZX+V'/TKPJ)!(XHSH%=W';
M#&)F?9RM$I]9MBS7]'BH_:70D$Q%WE$=Q^3TPO!\T*5C++\+ZW+?VZ.$B[@A
M"%OR='M^\:SIAM8;T;B:V715^Z:?>899OW>_ ZD=7+2PPQQ>\XT'J>U1RP\=
MO+*T?>E-G S/XG-*[J[S^_RYI8/'?%BKZOUP08T_'Q<RTIU#K\AF_I(JD<%A
MIDY4O%*PX<T@EJ[+IJPR]KA79.K(Y6:?Q;BKU/G3X6N/.Y'4GB9SO0+Q*@K*
MM]CX:KI&PQ3M-;6"326VE%%OFOSTUKRDOITXPRNIO+L7<,%G';XD.&=K/#.(
M'1Y;] LROOVC>[6P0>!M4G+2\P_Q_B=L:5+!72C><)!,MH3\2Z3!EI5 N/G3
MCB K'[GF6*C[2(;<S!BD&F&-7&1PS!8=0TW4Q?R&5:P(/DG,:?F.3'RW:JZM
M9 B$7+[.L>E3FC\*VSK%ZX"OQ:2R++OP8 *ESYVGROOC?\DK6:%<I"4.-_!G
M/H(T+\I[-]_\V'RC.['"_.HR_T7#.(\,(O!^-V^B -$J*VIH,@N(7_^8Z%)2
M%GOQ(_#T*Y=H&94$$&'Y81$-CQ&#:#&M5VM:EYK<T1R262=3J,U^]U: 63[5
M6]#8XTHQ^\/]$>C(Z;:W85=/!Z)KBZ:\(BBP:FSZ1(%&%ON!Q/#U0>=AA]#S
M!R93H.U H:PS>9RKMLXGSQ*X@O^$."THRX8P;<&%88TFL,8]?%;W2[S.OK4.
MC*R06K C O7?^>@OLG4(IO;+S?1Q32;\'D?NQBSMO6VGFZB0"N0&O9CR*@>7
M;V6J/*SR*,RW%\(U?!7PFM.6E*MT,M3#>AEBUMR@]3_2-8.RB8"OY8,BACI!
M'9:=?D&!MM7 *L/S^<.6Q>8M'E$T**+5OSB&EWX]C6,UK^$PFC!O2]]H9]ZU
M:C4=?KGO4M,BSH"#E*""W<AQR\_'<RV_%?A]D*FV/C1,G%I5 %YB)6R6F3<F
MC,SE#9QT5V+;%D8,CA_"/G[6E^\CL/A&RPOMXQ#?$:6N\$!C=*9,)3C!,$S7
M-25')5R%:W683,$WE'#=#XRB^)RNR(40]2[)=4FFDIM<8"&LQ&3]Z&KY>C'
M2,DL(5:1 :?99Y2XZ'0J)5;^^)O5Y/;\CO1ER@+?YZFIE-K,$4H;)F?/Q"SC
M:6A;O2UQ5- S#XO'QVE]YBK^"?@;1( .SWO@Y];SRZ^H)\#1XFX,PW)-X5%+
MN.Z>Z+WJHWP":ZPBUXF\/W+(]/MJ,#;7G>W;V,B9)3C4H[O]^ +CSF:0MB?A
M8LJY+!'X;IYY<K.U*[,]HM@H!M>^V O&+'>9*$1T<ZMI__(.>OA\PF9\>;S"
M[(F+3;5*G#E2HKY]_(9 4L KC$5S_I8)-%+JM_0U\=-9O:]9OBK>]I*#3#&;
M504ABN&MQSV\^^YP6M"V&8)4Q@6GFKPR+39YJFM)?:RQPX)UW,RXXAS@S:1K
M\=+J?WCC^U_)<TN96<[0M?-,^L:]IO-%RC]KXS"D/D)A>1[4'9 3YN:"%RIU
M;#%LG=5JZZU^C4B+H*822!1(K#8T'_RP%+OV^=7;X$"_,]04#"G&-ZB'7MQI
M=EO.>N:4=@?:*6==L)$TM]@C-N&NGG@Y5 8=__,^_VK'# WRU,"2VY'$:G>0
MYZ\OC0=3XJ_43>PL>O%<K\UVX(NK>8.D:,QH#> Z0XP3 5I1O+D]\J-1'T=V
M<ADN;#[;4>KA+3$Q?DJV>*DD#:YWYW^<DW3("P&O":,DPF2VQ"2$"LW:/3,<
M5<;-^2*J AF.>6S[K/%-MY$GOMJ5@?G =#7!Y^!#>*N^UGE1^PW(P_,,),8P
M<\G<;=FG5=ZV=%WMV9C=/;/9EWV>OJOJ![-*DL/\QJ]C?] KLU]2?Z4$S/[K
M=H1E-KR&"/3"F2%^)%H?X40*C)AVMBW>J](B;F%)QGUY6W;Z4J/BE8PQ[_XH
M79DQ4=-I4;66/R(_O/T/H[3X$YQF;I<_<F_6;FJ!#9E8-/4E+/'Q]CFVM([F
M/A"V7,Q\>D4@AMIY=R RW_,>%T"IIP6Y=R8F$U>&V\)&OL/KV(1V9V!+'1T+
M6]$[< ;S!;;5&-SBZH=EJ^M1]T:89Y7IN4"U*87@%Z%G^<]/S:K"3'Z+=HS'
M0%M,)4Z#- @:\">#\%J)'16KY9&9S+Z&<;Y98]S7QU(-S@D98WS1K?'R/X[A
M0B&YJIZ6+HB^Q:\+H;GF?@F]&955B;:,[9^0,3\$C%GO2IW*ZZO_<-]/\V>/
M?Y FC;UF&YE_%#!6L##<UVF;6,Y!.S/XZ4"35#M!*_^:2/><DF=\]%>#@P2I
M$7A'WL'SL(K-\F"UH <NC[V:1L[N)C*M$=HP"VV;K0=+\RD<Z9W8NI8P<3%7
MB2/CPG"E5"_PV=L!M3=*?%5XP;9L7MHY/P^"?8X^>KYCK#!-.3U#T #L'[5K
M<2GJ(Q$(]-M1/T OK%C-: 1M!)?O/PP0SONT_N^>[/=3Z]7AG/:#HOY$%/GE
M:/^2&KD\E#MOEL,(GM']IMKZDIF_[J7LQ1BRGP4@2<#@;CC__%8?01H"J<?I
M5VZ<:FXIDHU6B7\YTTCO71!/4#N193Z?L'B1("&"6-'-:56??<0!K4V(K+=D
MAO"->8O9=V';.=N2P"6$(5L;[',=#C/UQ'DU5R(@+R)Y>X"^_Y4 NU I"NYL
MR>'7V*'(@EX="?^KTQS?JSG[KM3,3WN!?6]"[//>A;*!^ *I01Y6\L#(90'1
MN!PEG *&41^7G#=89J:"C*D4^Q@C9MVI>(.C)^ZWH:T5O#\RO]2,F>RM'&<4
M\[H4V<D)$:  X1(QBFYO+1GD)8/I)"&RMF.S!,8UC& )OZQ,TM+&&60)0G+T
MH#TL82?X'>+OS0/P2I,8V:,Z%QVC\QQ[%[F722//HS?1489WQ*;DE!F39*EK
M\/D":X5O<M!:3($@"K\6N=6X9PATJZY_F7&" (//&G^XY;[(!!%P=5%^1HIW
MNQPF;E7.P(C4G=PZS<@NPDGQHZMK^10+GA, 6 ++2T)JJFX2AY8'5>*@70':
M.2AN1?XB)]\WO[O355>9*.U2A.T.F,K7A"(Z5C@P95;KY\',^:#@X:W!)W#9
M8]Y<(N"\;-4I(1HG?';+8,K0=U2H;:>MQ3F@_1O:NLN"'_,BF+\MV8(P%<-W
M2ZQ5H]2TC^X&^6T5[L[>Z 435X/GG*[JTG.C*@&;=^-F3',^]]+'N-Y&7%UN
M54&?%TT*(EKE O_AP4\V6AGOV'XP!/AN6J)T0?L.>4B-,!OUI1=8*5WA4H<^
MX5*1>PGHQ6XR_[*;H;!I(M"I@'I=T6\OD(EL-6!W%+/]SE"R:71!A=>?B4Z+
M"##B5!5\C"5VQ#F?(BJ98LR?,@\*RW]<L9#_\?%=,VTUA;$(5;L >C@=M2-V
MN&,Q)"'&GMI9??O'ID=5?('D@VSE4FK:ZZ%F4&QQI"(;OJ7+W*^X<_#8VR%O
ML<089N7.0;OXA0AD5\<M60=P2:6F--0=F1,!V,C^[;B II>E/7@BH-K@>+0^
MM=D7&?P;SE/5RHM..^@ZOF.Z$2S=E,0:/_\3QC7(]0.%FGD4QNY[?>"';OI%
M.K_Y*4+'@OQDJ_N9G%^P@O6SIJ]-HVK8)XP:Y&K<\ZVW66Y9"UB]M9Q/NG*2
M[WQJE #M4,4_!*-T+N/ ?6DFV!SQ3V#GC8MWTQ-AD'[^KB?K5^G(600CE]YH
MW(>IG'_P"G+5>:O("KV*PU(EW&:YMS&3EKQF,MO/7U<DR-^?SO\3J/8UGXW&
MO+-@?E!/!.J*V45ZU+3J\4$ZO]Q_B_-6)EG=-7:VOWEK&#(Q/\?@Z&GRRTU3
MWVD_0&-K=O.V2"C)RV"]+4(<\%#^22MN5XALB4"%VG$&Y[LKEL<&!2"+5+'&
M7K<KTMT^,^$%"]RMGO4NK4IN-S]O+T3;&= 2 4"4UMIBKZ%X<A:A\_-$-NWU
M3-O] ]BN- B>^@VR[7.HSY=Z,\XF;DK]MZNA_@>U$JG3N?V0OST+-*5(X:=W
MK)=C,/:J&1W>?,\M^05ZJ.-KFA'A\$=.2Q/H:)KKS?TEHYY%#L4+$+?Z\QH(
MO6<!1!4C%'48]'C*1;VWY=N&"W-][2S5X',^-S'YO4.SE"=JOJO ,\1ZEG]"
M-&AE.9@'^KL91@36SV^WPVX.WS5^.A:@C<XX3CU<=5-KF13+N%.J+6DIQ8N&
MUVFQKF"RDRLAH ]!&_5;H,,;NVY6CF(IT#:^'->F0S%^DW&\4G$/M'#1U,GP
M'G6?)XF^,"8\'U 'A9G!%"8)%W!">A."$Q6':>B%ZEOS-TN1WZ*DOGWBG%)K
MM#D(3KK$,XGRM+KM^IDWO;5]S:[]A"-P\.?A;9&?4"0S[A/2PDN'[3>N933
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MIY@F.P==EVK9HQ##XC7U!A> KJ?CXQ*XDW>:C":J+HYP^X,DR+W.T+KBO;]
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MA""*$<@H?F-I]I#Y>;7ZJHA5>I:YB_,7/;6-N!3<Z3^7"B 0SM,\MW1(B4-
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M=+7RN]6UU"6J"SC/&:PW8V_.:F829]%B]0*1\D;/!AG]Q=?5*^K#B#?MW2\
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MUW2BY"#!'6L^IHQT]#G;ACN2R6T>LSN<B6/H3:_!V?H J\4+0!B#7TC%8JH
M:$DRM7!JZX6F&S-D4@GW$=Q[E9]#N5?D(]5'X,>8-]!IZ)(%,PY2-2)GL0C9
M!C*9;C(9KNBX21REDO"+*JU^H9-,LIB,<TOHDNZ7/D6=B77ZN1+\H7XNI?<N
M $E^B0E*]T][:9R!QYN-KRUDU+LF!S HB-)BC3]S;,&M4D;%(@F[O'XT[6PI
M]T[Q(1KWQ[,2?)FOWH2$B5\ 3F[BGZXV;TG&>M,-4<% B?<)=U+>PO0P0S(Y
MNU^G^+,7N"NN)7$BG]@9DF)XY(O>3PYD-N4VQ1TU6;:5QI@W+34@#HM8+>CH
MJD:D/GX?.U"5XQ<M5VGY=$Y6 .6H$A_]>[?PCTF<_W3P_6IRI(I4QZ@N4E8L
MK8]Z1--L%Y-KYD.KC\'T'\7COUME\!DXVJS6&$XG1)5'Q6U4K0*K&,+1S#ZJ
M"[%A$J!(/YAI:9#UOAZN'ZKDN2:F473'@$2VH;7&13+CK4@* /]J #>88(2E
M*^YHVJG-OKG^14_^!NB#%.25EUUK7DKO.N"M]!Q5(SS:YPK,#!AJ'=LYD*53
MTKEJN?S41&_*L[DM;+571;U?WSTHT-L]Z*0,D[S4G\436RE-I(:9_R;2P$3G
M"GA"X=RP)S_&<FK"%GC-3'SC^U[[4>2N:OM3*L%S_M%9D)+Y(#]!/7O6,>6#
MLT1BC^_;SGAQF]**1^2@JWRKP! $I4< %4X:6Y*78V)^ 7":=TPY;XAQR4NK
MX^KXY?2-<8(JB?/LJ\T[;4T1D!K,&&N4MX ,E<%596XPI.#*G%_#N_(FIB7:
MRW^U/X!%=K_XQ5@VJ,1T8H^[C74-*U%@]2EJLQ3 =)8A%D<T(\]DBZ(EU5_6
MZ_U*-BHT\?K9J35?S\A9^?6P1&9(+[] RL6A]U">0*>^^":^HS-9BLM4K['R
MV!!<M#'=LU5[X+VMY.AV :"06"15R^9CK!$T5+^5.V9.\X=O!S*5JEHW)F?Q
MM1H)3"W<F*,;]XQ6$!DMV=X]C,PG7>9\"&+"4DW*;*D,P>7G^J@^['JLR*3/
M1;*VGSX)YC?[J<14OWRLE^#,N[V E*^80Y=BU2@NTS7Y:S9 2NC"^PN Q6'A
M_(?+A--N-"&R/C*?^ >TKY <^S@DC^[5F]IH#2>6$<<_J?YS.@AI6837K 8"
M*!$)N0,?,,TML.9)MPUPM7>_AIR+7@_^1&2/.((6Y;]VMJNM39'U]WG1S3GT
MPT"9A.MS!@!@SXUV;+3.(W;#[V.&TS07S7 8C/[H2U23<A5A!]T_C^$]=6DD
MV'(]C<BMTG _*7HZL!;;M[2[M]*D?[N%*(<9:)>7U%)M13\8@FGE=3T*VCWT
M_U.R9 *X]LUG(K!9-,W^,<<8"OH+87>YF[F$$1,0X[\5\Z-^GF]>;:B$/,AY
MZ$P_AM;N4)[E_LN)>/JN049+<-<? MR2L:%P^XY'=.095H2 FB1[^:S$2>:,
M38V[7EKH.!TS+<#I+P _[9=XSJ-*+P#97I]8$I=REQG63\0JACPU+=PU*T:^
M\YBE,O_46[J9L-O-G&]KM:UXHWB<!#-/?)1N#<&8$<H<]\^;GK-52Y'_R@=M
MI64Z-+-2OSHJ.7WO]-8]PA6.;ORK]3KR_]+/0/W63;E;)V;_Y^<N^$]U<]\N
M9\=HV,0Q:6EI7 ]5]W'3I>AZ7L*;^U^,6TG4)M[#G,NL#SC;8U=+OXC""BI,
M=:,UXCZD)T MYQ <RXC8.4Y4Y#)5^XZ<K(YCP::,30EN.]B-,OV.?OQ-3D:S
M;R3O*-^2G;KB'/%NV3Z0EFJF]%C<B)2W&^?Q[0 .9=KOV(*9,I*J3R2!VCJF
MA&W\[6^;P] 4[TG^RD;M]1>U01Y;%AHG.SNY]@^OI#=\D01HLO"JUSO%+BT?
ME7>X+M3[.WZKEH$9_0YSR?H4;I,JR&44^M+@R35E8UEZP87":]?/"L:1N("'
M&I248&>_1JJ$#ML)WAFSF(Y%$=WVH9QN;1K-DY<)J(:=PD._J9\#(PIL>+#1
MR+P>&M,?ZYM?SR<QV_%!3Z,=<$40+ T@=Y\ *YH3P'.\T%B*[W62,4D'K3LE
M:G65W\=$PUJ>54'*@SQRM7I,?EU[2%&9\,/T3+OV/+7I3%;G##$-:^+8V?>%
MV)ZIS$O]VG=?.T<>9QCUH>UW"7U-Z!(PC\#DX8L<[507:O7&;=211$%)Y -1
MF5"5>[QM[!$M26<=FFY+RI$J@W-S9+J5TLQ&B::G^HR"R9HX/0$#]2JE^VF)
M7-7O))DACN.@1=XS$,X+>0$@FY]H&-BA0G7C!JI\/^^C^U:V]ZMA<Z[I]=Z]
MJ\MK!1)B+O![>,LENPQY-E:%U5IHM$A*SZL S5;#"OP(!!.R.<:R82DXDJD[
M1*'\H"$2RY^I?P% \.Z&!BP51?.I)I@,5OI3:)AD6VC/=1DE;3([O.LM6X@K
MMA8KLR+C[;ZCR_E![/55C633Y!@&Q;%5%.8X='7L6Z/#89&TY\;0W.[XV^ D
MW^ X!RY>\\_QTI_H=-?N="1#'!5*B'5I.M=#&Y<IP7,*6V?+=K +P)D9Q*=>
M_?>A\HCX#I5^M9@406MQZ+CR^2UJMLGG[]A7R .[O&8\K@&-\?9+L;1*"P+D
MY@2%I"&=BD?"&_O39IVDCQ]P>TRHK;L\[O-0D,:DH?ECB-*'D<XJLF82R<_5
M)8I2)6H:>LMBW&CM>Z-H40]TUU#]%X!Z9M(O]FJQ[7[FEO3EL2I#0QW%\V>V
MT^8U*6:,<C]T!5#3:SO/@S\U1%^Y17*=<YOU;7NK 8=.LL$%H/C+00TLF5I5
MO#C:<.K#4KRI9/%\BM!J\=E,+)$F6ATTA@>VZ_K!QO3LB?C:UW!Q1&M'.&C<
MQ[_]12QDNROA O!D%NPJU&#(VOC>U&%*[IBJX',I1ZI1DD2HS@'+[; )T[)X
M!+_*G")9_9?D_OM*C45%Z6ZOCZI1PY4G+HNSYXFTJ/T'%L15C9/=^]SDORPH
M.U+)"@E)(J4\XG[MIT!K2Q"%W;G>^5U1T**#0Q&Q>MH<=23FP/#SZZF+\ XH
M*(M(WQ0,/G<I%&B$CU[[L7.ZIQO;644<+D&T&N(0VSL@(G53F2]R"NB:L(-T
M.A!9#4CMGEQ]?=(P+^NUE]S;U:=<W%\SYL=A[C@% [L[$T<C^$Y8!4!O.QI"
MA=\K<).]]VO[9 >_%3;1J#"P=P$(9/G<='("_"L4OV]G@*"7H^$H1+1:9')&
MO>%(>!$.))[P4SA,XZ?;4.^%H:?FR[((;U]F]XTV0W]H*<V,R>;5LV>#68F>
M]RF^ZVX.]21L$%^1R'V8*DT&)=FXLI,^[2E:!W0,L4(5??L+G0DB7S=OR-(Y
MR\WUK9YG;AW7?TN] TJXT_XX#M:I8(.\M/AG^%X%$:W8&PEQ$EH9)\[T1\SM
MWRZ>>S;8ARI-6BP[ 2?Y()??^?@O)>:]_S7%'K]2PN1?F[C,8S<">VIH@1+1
MK<^,BJNQ?SN^6!V+.$\X+UZ@(LL]X_:_ /"*UYQ)C.^6T<H6)_>%K;WNF3.C
M$@3-IJ_WG@QW "O&PX]<@3ZN8$BHL**SQ*$U9-ACGEH)1\9.3IKJ*-;!4IX>
M*/8,HW3@8@BS*BJE8)'+/L\:&CB=.2%LHEU5HJ7>Y:;5+OM+GL_5O?U3W^@\
M<?8@XD# ?;$AJ<ZHC#MXL5@A0.-1EH7DG"L-Q+C-F]H8U=@>]W2-WD@LV%!=
MD2ST[4D4!^H"<&O>-0(]P)HSPL9TQO#9=0'KE<,Z67]I8V;#UGNX_^T]2C3U
M=XE[>)[?[DL7@/49!(;G,LJQ!2O[?K*\,J;<%3+>6X>JJ@F>-K?!YF;Q&?>M
MOBMR8N/ Y8BZZ/7_MGKR,CO^W3B!W:]G8SIKI.KAGL+T:J0K7LW.!]V+BT:[
MIORF/X /G WPN<R+'</MYN<&>ZG6""13KXP.DWL@:W%_/,!?-!<N $Q<7>'T
M\T9U9P(-#Z=H)&OJ2VWWNVWJ;K2@?V5J%;(R+?S++;*:R+$N&8XZ+X=VIHSC
M3$+TQ;=?R_U9I;@73B_V2JGHT:>*+U?TPJZB]U^LQA[ $2M X^^H3*(VZ'O<
MC+[%F+B==96!3<($.,7!C[2]]K"83<O:$E4VDIVB/+*SO6M5%S+%7K[M8P,E
M2_'BOW_=Y % _3[Y-" >=-<10B?@(?_6F<%\T*7JL8UN3D>!U&3Q[H-I1E]!
M3C-?ILNYMZ*S(>=X:@)KY9#F(/1B+P#WY;3,$%<A,-")6.EO.#L>T3[U(4G&
M+A,%UHUJ>"6EUT#2;^#^CE)^*[,T''[U$G7=_8J/7-H03_=723E_O>+369 O
MW\Y4/'93E_UY>9X(4MI;-,3MQ\[4O$H[DI%^N0UN,W?=A^?2+M-T2U6?T,8/
MDYI$&'AM9G*0/^\_<<Y.SRJB"0UFW.]$($_8Z#737HGQ"Z&*%/.\*E<WMOA.
M3S)2E7T[VI$,]]\-?D5A#$?ZX(,S'9S''_F]_&?X?RX"8?777EOQ%C)^@0W1
MBJGC!B*I9[;8'8@4-:@("1DKXFA]^*[Y-WX>H)T5&57P==B0HD"@RG!W]UKL
M5^/0L;3DV5-)/U:Z-H0C3#/6>/\"L,B"R3X%Q]7O *>/1;2Y9X_EFLI$MZ?[
M=TX&F/U_UZVWV\0T]RU245;&4^.JJK'\_?>9[Z4'?]?_=8(KO0_7,WMW-2'N
M). /PO3=K.8%X$KRGYBUB(.)!ETLEU6-%-N5(;E%G[O7J["/XBS'_=[S)5<]
MC=\6;&5G5#>$"-_@+QV1LUKN=2L(2%Y<\7Z=%+2-6/*_=7,7Y/MYE0ODD:9\
MUG&7II&H^,-5/G7_['<&;\K0T 6@V9:HBE#VD>HHC6"3&82S5LV.![I4ABMT
M<C8V5HU3+Y?7S9,9_VXW4G\EF_OK@PI<C?B4TU5("O<*'[0<RX"_;A_ .Z]?
M'VFB:=;;!S:K,90TELT+^VP[_]CB0]M9)=?/@QLSU1< H^0RS]),+[F<]!>^
M46]'&?H>'CBE[ WF3 >@O10B,R/X/I[>^;>Z<\#S(CF33#QHD3PY@QT3DKP<
MS;ML-"Q^XN%LQQD_21ST)W^@ E;5>U'SYM:1[L\MRQ9+Z3,+1X4KH^@K^#"8
MUJCKH0[I5&/5;,=:\J.8#=L8GZDKU(;6C3G4^0";>!G/KU1(.8L"&!M&Y[V"
MD$_&/,X'[\O5U39/-X&'DXTK5T3-^NZ;""%KS-9$FU[_) %M=G'(!?1!/J>,
MMS5-(ML4'K]OG>J*(HK(I32NI7I_9^X]"_?8\M\*CC!3.^+>[PD/HP[8Z?"*
MBD/%#M?]XXL==G1#K'9Y37TJ(N&:,]^)6V5TE2+/K:\5+)2!=_UO86(G+@#M
M#PYPUL.[AZDF5;*1)E62$>-6@3-J+NN)U$Q/B@Y(%>ME%3GOWOK!-EWJ-/0G
MQ1SU<0.54O'MA0#_5<943O+ [:+.M[Y_^-:0D];&(X(7 &MPQ8^8Y:?U5<,2
M*I5C>VR/BV&=-75\#VKXFU4F9DP>=S%^G]DHR&^*&#C<EX_P\2OOY3.*.#98
M'!5P5M@[':]0\#A/+R7>WT)2HWE_#"\UU1X@C4>-;M>(N!9,FZN[N_PD27@@
M7B;'TSM3\]EFF?%TH!U.-T0PQ/8N[A9 OV\A;<<\Y$V/.%&C)1RW@BMQNFS
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M=G*>"*>?(ES%QV']A&YOX\.9-AQ2NG#!XP#S*=,K*R=H\&ELPJ[_^2YT]P)
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M4V()K@ $S3+7:@EX!%SSX<*M+:(R?*%7 &K0S)"G72Y0U?7X>%6AG\H*4 F
MI[?P_)] R,9GI!$97.Y%BXEK91BS_.4E!S$7W285=[\X1@1-1S0*)S6$A;]Z
M_-/M@?_OCWX;+O\W$:K$%6&U60.C84[&$;1O)]\CH4W,M"/5^]VN45 H=94J
MKQN1_6GB9Y(^(M\;',1+;>$U&U!!!51"$DI0H;/.E'B\9'?G0W-#)!1R_V#6
MV(G335O_9SU%6J]$Q)>!=YED_PF@G/^$38M^*&"__+\ 2.X_P@V9A 3^$X_+
M1A")R=AE+(4M=S9*?!'5](??%W8!??C!_+)W?1=XR\>%HK=*Z1RL2]*@3T1R
M@WZ% +CXGY:]EG7G9+F%LAM(@F?$((+^N,C=Q>D_._1^A$9O22[7(_Q6:_5,
M7N_S:GUDI'P?JD;)E/"NM?J_PD7Y/V\+CU*J_PKIVEB4W(P$$-L7Z.) 89UQ
M"\]FNM'8$_<\,&)DIN;.Q097A'G$<6LAO5,)&=W-I_V$C6WAK#2,*)9HJ^^J
MJ-E+IXZUNU"QU(I>P;@J]BM "721HSFTB,$B+?*V<UMU1O<(*2Q'D>4!IC?
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M*OXT&!.8\:FV;Q(\BI"Y2*E7!F6UG\9*?YL387+*KX2CV+$2?GC-!T:(D,/
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MLLQZF-BYG<AVE^MS;<@9/L(28<I:GV[XH;*&]O[/8:&O*B;%RN$\IWX#'#:
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M>XCZ][X=MPDNT:J@ VXF$>C#O5%5ME%V.)VBUF!^9)*$2FI;^A25_]A>>)<
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M9/;4Q1J5,KNH0=<W"_*4IH>;L>.0I,H/N=6/@U\T P)?_&M7^I_E_(7/12S
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M89%-@GT:EF5?*JI>I"Z3D]7TDURCV-3.R^GL:\I/1;![]__Z_OMW-R!KZ#\
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MOVZR1(S/LQIW2EY[6!4#@C<'/DS>4+N8PE1/;.81:G#L&B9X=N;8\_X@.>^
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M%6]5 R66KC_B,*VW7:NS,(N+"G=?/L5J/+^LHQ*5^&%H-9NYNZMCE[E+W&Y
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MD6L4+,E,V]!HZA?[F<].9+_"6VYE!;^E0Z=F.MG6=;P/JW7< ]X_8I?$A'T
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MIZ^&PP-5>4PS- + QP#/2]W81N:5^:"]A*\%18^I)G-! 3DNBQ)=!7W;;IE
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M:!'1IS[O8O!KH"X-Z4B=!6*OU%HU+_R "2XZ7L8-NA!E7J^UYE&'I@Z1!&&
M&S?D ^O(L"4*Y1$$X;BML>8F_CM#Z=(C:U)'0[T6JV BVXD _HZ_9A=&3*G/
M7(KY#!+^F3S+=.Q)-:L1JWNE+SXDY#N:[[TG@V#I3NM EUX9R%,<++;B-I\
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M_^@,=X<^;H8: BO/+2-E@;OM8CW([4IA34X/C#*<5-6\$D*(D/A@ L4$6I(
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MK!\A*Q,BP_;:H"?]0\8BJZZ^R[J"7H^<)EE"53',X^S-#NKH-Z#((WWNQ6_
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M*Q.7?I6KH$%P9G=1D55F3.#]5@NC/A#/_O]>'J%9^\_**.YK_)NO\,[](B"
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M==ZK6K%OCBT3D-4 %9D5I7I.0B:3[2)WNS S_"=T@2A;.QTW?CT!4*.(KJN
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MR'0^BDCH+EE3\)S-U8H5A3VDBUY(!=-XSO<YM2HB'TQ()2@B U.[,<MP__/
M$:X-5J]Q:NTR</FAQQ=P0W?FFU9>ORKX4&&TY!XAGJ+8[I$7-K63[F ^:/.
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MG]Q'QZ"'.A"_K%5S89E1D,7<;IB0\YJQ!EW%+]ZVC+=\Z5ZSOM8<[XVA&.K
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MCE[0W4U%<(+4FN2RSL9R450X42N>U.[P!B1N6XE%O:R7TI'J2P+/'DY8-_9
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M6\![&^#A%9]" :-1;UVXCD!5KUJ?LO8/,2*;=.J HP#5 X^B<K6J1%5AL_'
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ML4MY=MMMI6ZH^YF1E$-LZE".PI8H=T3KBWE("_"<$&<E28&+=/S]BB58/7_
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M1W.#[BF[WJE X([&A3!"ZQ@WLKKCFWC02%V>+!U<P=C"\*SR[X&8+/^'02<
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MRKVRI/DG)[<8K"ID&@Y30WX0V/"4?P'E8/ 2).R+S>N:@^C[=S#AS-7&9DR
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M<TZ(WRW\I[4QCY^1Z?% H-TY"9Q)VQUIID&G\O4MI8V"SW<5=27;)[7(89E
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MH&6Y:@^>V"\_RS&8N>EHZ:PO'1FI@K8"+RJ!_&GN.3X""Z4@2]>E/ZV #M%
MUN>>477U5+V9D(N(BO$4VF=I.OYL1E$/A%]"C *1YG89W$8G3U2=U6U##TLL
MSP2573V#X2[U'/JO^VF^AL(0'0;#':Z^TAMFVK:$C"PPWHK*MB1&7$YLUR_L
M>+-/GG]BGP!R\*"TP97:ZZ0G9@7A3 7\3"<GE"\0Q3\/GQ'L]*']3.3?]![
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MCAO9G!/Q:B1%6M-E?\R^WGUN>6VX& #,=VGKFC$.$0UI[('UKKSPQR#C%03
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MZG%GJ.I\,_2QJ(%FX2A_A4:_,)>,6UYW1ZCE'JO,J\[8==>2O,FXR11^<#:
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MAMSJ/98F^L+6X(ZQ,X"Y(,'/_Q[+>K']^#T[D;?!JOX+P1#RY8JU39;1PZ#
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M_>_L*Y+HWI8W_Z8*./S##L&QE]K0 Z52%J)_BG7)5[MIP^T-C+%?EC#A'PH
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M$G[?*\RCG!H.P2K)IY\C<W<QW-LH_(,;6P]); S'4:#F/ZUF*]9)*5'%105
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M&G MT1*6/V?^(0O3J?]^@XGU&,^.RP6-J^"TGG-J+W[^Z#-;D2*8Y\#EI%%
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M1@4>E^)U2^HXD792.G %QLJ0>Y72QW2MYUW:X!@ J'WO&FDX1=]B'=(%"MB
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M)3BT4 @0W (DP8-+\>+_W_.\SWOFG/F?\^W,^73MF?O^<L^^9NZ]]EY[K5O
MNTY(SBV@:H&C\_I>V"U@JEWTYMWYG:JA6T#J/WA@;S;HRMO7]S+ -N*OG^-?
MOZ+5,<;)C#YZ*5^543I"+<!V*31X7Y/'<=]$0C")_5BZJ+TWH\PX2]X#>,!
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M2_UB&+LS85>G7OE;P$BL'&)L@_?F\FSRN:RLW\EP4O6TYR'4D7OL5GS$JV!
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MX]^9ZY#/_^!!P+V?!DWG8?#P0AVYO1-ZR$299FME]H)-0^7RQA)UV;OF!U.
M'RN:]14*/T(X&@ *Z7;^$Z:[&>.J;>INXO\@J\W7"\VD[]DTL^I-*BX8*15]
M!<>ZU<4_?P[(%*JRU0)A3)U[<W!GF8T.38XS8^U"?]RDN;?!8S@L@<W!Y&K:
MR0%5WZ&5_[?T6>JP/:.'ZM[&1/FS_!D4%%+N[;B"^#-CZX;[I!U+<N:JSY]
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M(<H\GD^!P[O.P2NL::AF7J^O8>6,>II[?&[4ZZR1.I/2$HK/HKE;A*M1=5/
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M7KX6J$I:0^87"0F1_ 9I.)R844I[BOA!I/OCL(%FBYWXQTS']5F^^1[5CD3
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MQZQN 9.FWGON?!$:81M=*.O&%2\N80E[6_RN/JU)"\HIMK)#O@--7/PF;1)
MFD0=4A2'-TME591WN%]<;%/N?M$Y9AAAP,V5TAL^Y3Z+UW6L^:I=605=/\;+
MF@P3-M%^B][%P9^K1>")B*P&')Y0J.<08=,\3!\#G;Y[$S[+>Y-8/XYU<S14
MH9%-0KY[LIIISF!/./Q&+[X$$]A[*"SP>!H,[3ZTLB;O%&KL[WKY%B;'S]+[
M0"GY>FO[ZP"L&Q#ZJH+,!F&!"!T=](1SR# :#C7&=UC^^O=A$] Z%4G:CF$U
M=*?S[9J7\K#^#5KNR4CX9',8/M<Q!\?L)?LKH 7Y.1);0C.;E4"V1/JSQO5&
M\^I2LY5FZM)YB8(%-LU^..G\HM,4!Z]\J;[*OSV1=K5MEH]Z^&IJ2W0.=R)9
MFXSXSB;;RBP8D6[]L_1'#'$]TT\>U$:64C0\BA;%*(-_?FLP=#L:B%W4G-1_
MXNR.3_F94U(WEL1 L+EDQO0WY]4@A*T,J8(NYJ$XMKN##INS>Y3$]GF+#C(1
M3;QH#&$R#CX)'*#]B7B:>%>AS7,Y(/V*BW+(-V]N.K%,UO/U%\.(\(\3J>*!
M%Y,12K5DB9L_)G+0EXXF@XOOI^  QY6=(G(]%+LK=Y;04I%,U;*C/*3X([WQ
MAM#F>A$C3<[O0B/CBX<MCDC-HHW2!XGMT[XJGI*_",):DFUZ)IM_B,/N,&M\
M\G.DUOSR7&\\B2L[V&S*,,KKS1P,SLWZSBZ_B/@]S94FT?0K4\GZL^N<%H0\
MV4W?V<T%LV@.=Q^$<XLM?K3H'8'4H_)6P0M"2<70_/@UH96BCA+# MEO+V")
M&]H SLTQ5B;QHY6J.X.3K>COX6NI Y,?CQQD?*"/)[:9E V8BDCB%7-'.,?H
MZ@^EMQ)@S:$7%"I*]Z,?C=[U?+F]M#L=U7'S\(-K=?3S8IKK4>B7HBW*EQUB
M8QFTR:LOFSZ3#XD_E>KTEA4ZG2HC9E?@X@2;J$@J310PDO@'=E!XO1E"=^7.
MC&I3?7MY*!Y;S^@C:.TJK;9-][C>B&J[350$".I-_HV"=#&_-5>/J<F;22'3
MIH^YY+H9UT]BB27"@'XG&,^,T6..FW82O.;UAA5&,*<+K&3/.'GUZB88,'Z)
MU';:(+6FT]:7&J]V1L0(/88"9XZ^_)I\I*4E"0^C:( S>H51[[IJFAJKMFHN
MNE1\Q;P:L:R=73/E%:-HU<O#@)/B3*753/9K/W59<)U%%N''7@)[!M96Y,^N
M0JEMAXQ;:&4]E;:2GF$.X3.VKU_<O]Y?VO()<@S'5]4FEI0BJ0>/J?Y6 00=
M/KIH>X[Q"M8-_G68J?(:E[XTZ5$7=_!$+*BJ-WKO:+)$TW=TOG@VKGC=%/F:
M(3-9YJQ5$[=T*)%ZY+3:B3H5O%E^RPMN2_&>\24W,_W^9STXN^3Y=MWE+>"+
M9:%C?[V1L+O4\A-=T?K<YG,O\V3C?9?[\'>. @_9B.&W .BCT3]56[%S1?(S
M+E<3DQ>%^W0"-G-.-4A&0=UF4R@J6ZO"GA?DWV!\.*!2#Y8YJKL%:,D(0@(3
M5F.^C(H'.C5Y9=SD9KQV5F[RJ$"(NLN"*CP4<P3Z!X[7D83:-9$FCC,Q$XJX
MJP6W RMG!K_&%" OO56_V_=4\#RMU_& ^O(2N#ECG@<2YEJW^D:WY.- W(K2
MQXD/+5\K'%&7T<G; S+\PK-M=6S5OW+@*_WL2UJA8GBCLV>)1=&\RJAX2_5A
MGG9*SXG.G5C'"6F;JXPM6DTIY#4&6K>=5F.9O::#RJ":!YID+CV!%LRKN1XP
MV+Y8R=1VUHA,K_(ZHE7XXZ3DI; S^\K&+W  B_817D:[ZCI*?KBKP^;V1E[,
MK<V2.X2E9'8TJPF8L;3&D?6NJ@SJLK8J,"!A]K9+%#-FVYO#=@OP#ZV4.HPV
M.+=HD+Y>K\+HKUL2GC"^PB?[*^OMU@DM!YV5)T99XZB+6P*AXJ]Z]LF[&SEG
M;=KR##*OG",1C%D6!I8/;P&6<<N$%OL1>.&B0 O.X99; +&C^:(X2':B5!/3
MMHO'-6:VD*$F\(3[;E7D+C >(<X*\\%Z?%^]1KVV%B3/=DV&ZVJW\]QV#1U6
MBN3E34M6I=JGR&?E]O2U6G5,TR0'-Z@TB?5P-FC@,!WK M%U"2Z__2*3>] O
M8$?"5WZ!G[J<[U-A(3\'E6B;':.>D5)G+T\GOCJ@YFB0*57=C.J <YT#LWUJ
M)6E#5I)Y"M/SU>TF0#2^,N6W 'EAS*!$IM90A%8V=8^*0*2&0%22SC^/U06G
MHQF"WVQKUD[LB&(&V^;HK=>24V@@1614F.BFKQ\1TU\?O8Q[/VF@Z#&^9[\0
ME"IPE#WE+8$W/*I,!4D$KLSU:6I9^\AW26WMU!>XL6+MTX9<)X*SAPFR#8\L
M P:*)"-J9$1T9LEW:].<MH^TZ)^4L,E2(;Y;VS/'JQR_O)3W(>6_:)_)7+\:
MG,TJ&YG>,DE(7A1MV%O4[GR+:E6K^V"R+)Y2LN7.,S$,-MN+<UQ=/O^1XR!5
M,DUX1E\G1Q31\; ,5L[^7ZR_?YDS'3@?9<;0F"=1\/S4;8C]_:Q*B5#Z@:*I
M9&\2FDZGS$O\EYZ#V^)VKHDY\F[SR8-B+C/GEFT3]IA$1>[Z07<=+M6BDEZ5
M]Z:?(:R^QPF%P<6>\2 V!OWT.M%A#BGN@"^&_?]+I[142]516UN_ *ZB0B 4
MER6K*,TIR26:N@>,V(X5I-I6L;:*^UCQ?JEOX\>CAPT%\ ];40[) M\<A86Y
M^^->U1=%^-:/LHIOEB;]=/M#H9HV6FH@AZ_Q@6BP2&+,:]^QWGFO/+E9-6_\
MY=Z2'K<]#R_K_>0P)DI)$H?5LL?_Z>4:%Z=J_$M].]I2X$,99;\D>L]CJJYF
M?@J798/R-I4.RGI_1':*V[GDK\,FA<VI#"R;L/5DD9(@7^>:<^CZ94W3Y2RS
MOJ_-4DI;0SYNJ9-4ZEU?EVE?, 7N>TI8YNSH,V$4[EACN _'KR,V77%<[1-B
M Q2_#.-=^KCCN#E_E_^M5+=IJOU=K%&"JK7H-^>]FU^DF0[%IG :T\%3TK1X
M2$<^<LI^A>4E,;U7UE9^P*D\R<'B=I]QS-3C>X=)NV_4V4'M<RZ>8%N)SSC:
M!$V52,?:Q>?K22U>'#']0"U+H_*90&MRMFC*_D@.^WI@NOEAGF3#@SC' G>K
MF'@G. <7(X)1DV?LY!D.Q'>>T%Z1,8<K;51!")>;"*<(2'I >&&2O5]?6U]"
M!#04'9%&T) F_3 ;H U\/.Z3< P;)GK5H4Z9H5BL89]Y//&04F.M%5;Z/22,
M<SPI]F7CBM0M0/HR.,4NZBRG(0"!RZG#S"J3O!_P[MG(%2/>7-0UAD8W(/JI
M-DJT[\XU=W+\+C\N(&V!RO1E=(I8^V76_?$5YC@<<#0:5GZ]\@!,KI<P+C2F
M/,48X3]SWCYQ8_;+$U<IU'S$  +]Z=VJ68ETYGJMW^!0<K@2V\XIWO2ZX*^T
M]JE!@EF-22:&#>CB?B:L%NZUG1!]]=N)F>IK8FO2'NML;MX'2:_YVE>(!K:U
M/9+: ?%)%<>3'*$3C:Q51CY%N.<+.:I+*<MH'N,QCK4,WP%E+3;.:5WC7AZ^
M==(44]/M'-&V;>G&M?(T$7HNIQ7NP^3XY(H5C*5*Q-.$LL1/L"B*[(1T%S2X
M8&Y0T1IQ1H,!O2++G>$O?O766?+';M>V%+Y2??K2)RE/3_C(OZEMIT3SJ?@\
MQ/A^T8?8=38@ IM=T0YTWNU _[XYZXYY45-N.!XC6@!3^<YJ!:LU"0N_K$D&
MG[FTS^P58H)$#0N7@0E!INL"5V)*/F"$7ZKHUJ$3'V] S6%RC6?.D^'0F +_
M,C(:U1(&<]>@Z*#F'&[/6(ZKA2W'_+UJ9^'6JYRR_D?**D#0^2H^XZ&Q/=4Z
MJ#IZ)9:% M9Z"U (5(?$Y*,[3'=J(4^HW6SFNH\/$I.H_ UAAH<KE;6@^A"X
MO0:9_1^3P:0'@(*X@N('K,HOO]T5NO_LYU>N/Y;'X[H/)1,AM34[-&CN@_7?
M:#?T_6;WUQ"]ZUAD]^5"92??=I/+7, 9W+IF7&1-AI'490)WZ;A%,#,R0E#4
M,>Z<33P_4I*ME[%;&!1F,3M_;.6M1LLZ4(V-9$ >J0(OFUN?O^8US%K>!X<Y
M]RU*.3<AX\)RFXX<S$^G267'-<^>[YD-=>AM+S!W&!['A$U>!)Z5[HCSLCM7
M+V+-AU+ 0A.G3UU'8NGPD@(Z(8LK\?(E"EIPB_$;PW,F_%[G>* #=+OXQ"3F
M"#QQ%J#)\L<:%?9:$IIWEM',89&YG _C%8A*"'9,UO*R.Y&]0#[XL]+;&2$,
MP_<%:>Q9&DYN9FS+A&]6B5]6:?9;;F'Z0)L8C*3!2$S#672H*J/^O.RZ-HYV
MTS7G3.],JJ",?!N8.JXG\R[[&W#TRJG(_51\Y>UUZ*6%HV#-FZU8%3Y#;"IB
M.UA+6Q1Z)D&/(S+-C_3*188Q[NS/IJ0?>MX"1" NS+9)PG[7Y=Y-.K5#H5H]
M:8J=K\5ZW?=^!TD$+E]0>&>#9J 9=$$'$FK[X/BR-B.=;.'+7-&FRJNP3?W.
ML82_?R.20TC@)>R:9XD_XB^4[U8S$@5JQ0*UX6JM<DXL#C_F!K_%7B.I^<2J
MI@H;8K1 \EJ3:3*NHNW1)*]QSLWSJZR<'*.O<,\^N!,%OG-7$9(YO0>7&TAJ
M8.UW%>)SE2C#GK,'9+I1^1M]I4K&11,_EXB0#<T)U!L9"=<E8'WUUHHQ-!.>
M#!+D[\\.<)963EK3R6RV3GNP\#*3J(NA93C^S9MOQ<4-SQKUC<)[BX+!K(\T
M/U/V-W+%&R=T2<C/7V-T2&?<"'9.Q<2?P?#?O!Z+P"JUF?U1JLVX%VQ:4R2"
M7XI'XW,K8L3Z@7*ZP$7?._72:7[J$6)41RUH0HD</Z?<_?XNTUKS>%-"E;:&
MKICSEOFK,,4'TI=JDMF/HW-?M2+O&_24\;SG,=K Q?18]8(_EAOBL]&?:H%&
MSW9/(P4?(5!65&3*Q!^""0LM%5VT-<*5:-)W8/KL%PW_M<!+$H,C66N%S'YH
MO7%VR9X =^\2!_$-OMVQ0'K[;.3CNVN'FX6\,L]5*/P11FY6+%F"!,KN4<ZC
MI8I9M/G;=9M3B%N X%"5NP?Q3)/<8U7$=34&<]7)OUI0S$]UE)[_J/=U4K2@
M6]JVK4ZN(=,[#^A!I1#K,%L.;?RU^@NZYPR6]GYZJ%JJ@;DGH+/G;DXSOJ,+
M'W4&O)#1EN<#)MHPHJ?D;N\>O+?*SO[FX9=8_AW*8:GFP;>EN4^T/CE-68=K
MM^#';MY(C4_DX%/T6P+US'XF7)U]0I T(#8,T@A'EEKN^NK'\H/FU_S)F'M2
MW,IG^:K,2L#'MX"Y=ESWG^%'-)9 ><1X:+';5(G9Q0O+9J.IWTU/JT@2V=Y1
M3L)5L=;^:@<LG@W[TZ23>3?P4F_(.>J!>V:R/*S_BZ4R28N^;@@SW6^PLC/[
M$:DJX9U$U\UWFS2:T2GUPU"OS*!;@$WK%M\MH,:M5>8Z'A%TQ5O7BYI#2K:J
M7;J4!15?E[Y/H&U5'X!TS:5O-HM$F3(?EQ? 7ID<G(_)?2ZPJXZICW[WDKSR
M[ZR?X7J*_?&9V12J W<ZQXVV/"OR/+CNQV OYG$=MP!PVZ[7["R^I-@#C :J
M_MDS#.2*&H@60/G5([.H]^#<RDZ42?E[6FO][(?]4P1B0HJ60 FC?>:FP"&/
MQ'4@89,(M]$YK\*-12]+B;<DX]OOU!_R'II$*+D"G8?@#17$TO<\\@BHBD=J
M&R"ZLN[!Y4;?&TIE;+(^^RZ<'N%:ROT\6A\^_.6"7:&Y[TB_MW0+Z-V7:&[1
M[B+_BI_0G6,"%2F_%+%KH;*F; G-:Y=Z[\" A:Y(L1;$'/1EQZPW)FUP?R2Z
MQQ&NS6+W,?K9+0!DAE-L8W#X>T^+HU>D.;K G@URDX?+\S*CO_3:<*:EUMAD
M3'$8J<$XO;(!-D"S1%#"?W,&7-?JHZ#DX^LZ GP"/ <YA$SPBN%$KIT @@%I
M\R/N\<V_(*^*6X 7)$9H(XF+#?> ;:ZDY/PL,] 6*M?_ GYST!+5.*8']%?7
ME%@NHX%'"Y4F*\OR!;O(_99:&+AL/!%M,V+UIHRY!?07U;72'Y(HF^]6/D'#
M]UYOJ-0-.*L7>NV;9$:3?%"R_EEW&*A+RL3$]/1J$==W"U"'DN*#- ]7DX\D
MH"V1NAXP.'F;.3V4O [<W Y1'KTA/&\^.BJ'SI-M9@@B<%0"Y6[R1WIEFMP;
M;<I<O?Q:R.>*RLH>,BG-R3.'?MTSE.^<JMML;40&EH0*XT;#A^"7"+0A&"PX
M8?U01*U_F-AS@T-%._[7AT <XC=\RM7]!F1$>ZQ/&%!TV'OFNH+?Q205-76E
M@.UAFEN*5JO:HO_:N2[R'#3._Y/=FK,LM,Z1]&M89O[";_LX.R4V66A/YMG1
MPT![T4KN:<DNTR_ST@L+9JQ-*;RO1S[/K!R($-+ 4U%3&L0^L"#EJN&6#F-$
MX!A^J)W,MI#AFTDQ7Y!$1J>W6PI&VM+^TE;@8*A>%]'R8Q4XY?7U"^<^-2^K
M&Y[_Z\K$<Y9L(F?/,L?=8@[XG2NARZ]'O]WA^-VHK4.[C5O SL19SBT@(%W+
MI#IX5V::<;9QX/MB8AM^RDW+W'^LM .J>.&&OEFARURMHFM^-7&FB3X.B]P7
MW43+<^T%+\;_8EZ4,0GBDG?O#;L02'IF\>\1%S%PSQ=9Z\$]35NY ^(3CDP@
M40F.'N@)UECU?GAW-MZU,1QF,1#\>O:9)NMX(XHIA6Z,Y)MX@9A/MM[K&H>_
MTT@GOE=@RXOA]W7VNY?GK^_[W\'J71I3+=M4<0J_3Q)SU1H[$V#R=I",37>]
M,_XQY/?ASR> +SH)O]=<>*#MGB<Z5WYJ_<M'?B=5DUX21J9H,6CMG(79'X[&
M,ZL&AAZ7>E2-266YTOV':J*G"0)ZS8\X:"3RU?.+#HA)XJ;(P=*FX@(<G/HQ
M8>S5>\+$EOWK*YJX#\!Q^KC?D8)^K$?K9DVB"#.='?E8^]=K5C\@K*?WBGT8
M"BK>!8/>RF70).HG=81)QB6$"0F*(MUHAQ"&R4^O)%%D66F\?PH:[7OXFMH/
M)UR:!ZR2J#E;S;BC9</.72_Q3BFLPKJPD("]7%HG:EM8=0J/:&''F@*W1V([
M6N,BTZ,>M_7S"!.P\J375<(+@RVWT]OUDI"K&&C$?>H+2(W%Q;-_"&/MC\]Q
M2S8CA3L0ZIAP:0>N0-I^)=#J9&8FC%?M<$F+R1^)Z XAJYZM_]^;4CRX\^/D
M<+W\_[BQ/;QWXC=M:9DN88Z0I3R#[B/.0#HHK[?3[4V-;0,@Y_,@\'SA<T^0
M/,??&M-->P2,I?^&-!D;*^V$S=X)E*G^/I(B[W$TYJI^Y%IG+45SY(URWYY<
MWS.XJMQF72?N6MN^\2_+A9S>N*6Z^011CH-<OXR'."1O7;CHS1^7CX_4)PEH
MD/"6E@'%I3BS2QM.A=U#E7\=*>Q@U/CN(BRX.0[5!VX!/%(&$JNY:-:SY[F0
MXBTS[?R>;3HR4NWZ!U9Q@O]4>PG"BBG<F;7]4X@MS*Y3,@;B+68]O NN_>T>
M,.UI]W2.,>"<%U[O6)C[B&!?=+G^LD2)4VN5^'V86?=0+>@77A$#XER)>SL-
MO/G4DM._\^CC6D$[>ZU5", W?DUPOX8EOFK 29Q/9\OE%D 0JAUV),5\"U >
M\TTR<W-%BEVQ[Y0Q()WW5 KXV+ H:9;N"")=;E7&JZ5).$CV26O":6.Z(8%F
MRTH)C>-9V6ZKRTOGM;+6D1CZ,8T@(/YRY(,7[&J(N7DG('FE,40X,N;O7ME(
MDS:CL]0T?441<)$"H[40S?_(&$;*4 205)*6X2)]Z;F:\CWG;0"V;%=S7YRG
M0!01@*DR/PT7;HZ>/>/SL50U.V &X?J7L?GR;ASKO%-D$W:@9'&?8@):@SOY
MGQU("QGD-ZHAB76H"?;K486*2NDCQ49%A\NH6:N^5MXC/N[?^>P54-:&Y+UR
MA4^43UMQ+?Y0\EW"37&>;C0U2TC80(MC05O\Z%R>D4%>4(3-3<ISZ#&BU<.M
MK4=KYPS5G4Q[<:SRX6^%%(GOY\M>EIFOM.IE7Z1UHE\6N /3R22IK[[4PFX!
MW;8H@AMKZNO,$*F"("['S2UAK:&ZOJP(-N- [3-JY>WWC1T4AV/7:Q@S59>
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M][[:.$<^1;'97]]J[CCJ55NW/,3K_TR9G/MOT.=@-C^O@/WWO_^D"W%Y?U#
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M0,@YRW\+G(Y*^RN"IH2IZ]X\0;9>;^M#\L0Q[XD2XDK4;)-X*H,1BXFQ&&'
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MXPR.M]SN!WOG"^-=:M^(NRHJ[+Y/2N&C*E@0+Z@\EE*B5]P;H"-^ 7005)K
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M>W>B(_=%Y_]$5SK7/W===6&8Z/[F3WK'#J?'WQV6#Z'+FYX.K=81/UL%Z_&
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M\"/6"BO"D$F$!B-G7(RI/W/Q^>"QZD=48X^[Q,LK?!SY+Y*BGAHN6M"VLIL
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MYHN<%MW/[Q,JCRJOH:7AHB,76\PT?R1$>WX7;3IIA4Z&8*'QAB>Z/S#"*#M
M4VDA(5R5&>[B$H ?CA0= MXZCX4R-/OT\$SAW*(NC7WP/IIJBGI=3I_RR3!W
M3LY4.+D1$U5N^MD19]$M]&;5\E-1@:*U[??7(-U()V_1B[.UIDB?<DAA&/;$
M<!2ZQ_'.3Y8<;W>3YH!0)@RKY2@33(UB("G=@L9\;")!\2=8)[<,<DC;_9^&
ME)&/,$Y#E<C4:KII1%5&9VO;KTI6F?KYHW$]Y0N\^!*)TOL"ONG\_(/SP0FF
MN61@L?NZJ?)V;*D[O!3KG#USA:)&HVB9--C,I-&D.<;I^)D/7-\L63@X87X:
M)C>-;6R >X/CSY75,#$R<B5ZC/QL*\ZKET>"N#T.P2WXLR2+V+ZS(G7.==%P
M3/L-R7=T2-+5$@JML!-"P&*Q'866E[TO5T;&\727A!>6]$:9^\HU#@/8VY9L
M=E]#C1>R4DO5I#J0DU.,2BH,"C(,Z3"&,]X!<',&VD\$5L]2FO^1KJN?F?;6
M,.L[WD<^XM;-*;'T3[Q$I$.HUD7[M)9%KV"2 P_Y^RNA2^4-EYXG>4X)!'>"
M8'.$H%JK@"TB)T&7Q2C& \)9]0 <X")N1=?$;?XI@\QF"(*<<LH%86AMCGVK
MG[IW.U(DGKR!-S2>@W)%/"D6AZ6$7OG=R+9I<@Z9+@7 /&($#AGWI@P$=@6D
MP4IAB54N-1,999>.E\^+&]T)-DVN](?]WQX1D'/,MI^4>S_0QOKP']\#.^NP
M<WV9T52S)X282[HB[8N]8H6Q.EU6;:\GYUG2'/R,/'W-2"TM.AVL*8$V%$*U
M?C\#7C%.=1UKJD$G+-3QJH8U*F*O,@W!5M/3)=H7ZE>>M>4YM9QX'K]$%KLP
MQO^CUH4"+M QHGM?BV!4C1;*YPZLAQZ&:'X6AS$"B*B\9UBMMF%%<<6TLZ^V
M+/!?_;I/3+S/3XCMR,?#^06J_?$$9+C49*F(+;3DK+K[?D1P*]QI1P5Y.MZB
M(&'3;M)] 61M-%O'ZBF;]O^Q:?NT*:A(9=Z7Y56Z2>VCNO7=GCN^N!<\ @'J
M%.$<*]$Z>PE3#2' ^?_D08ES8<\%<?U/G&EQYG?4%[K#S=&<=T/>TYPF\:=;
M2XHJ<\\C,GWXWK@]Q+0>!(;VHMQ <<K4C/]</3#E4+%J&(E)=U_E-S@\@R8&
M2W1@P4K5!\V)IHR<W;/X"+*#%)7D%!O/>\7Q1,3M0KKS34_/]%O'FN'P";5G
M&M<&-VM&V(:]=\:>R[4(D<Y$Q0=/AWK=\U194LM\5 2X-I"Z'O%#%C>0]DT.
M^@\ RE]L]1O;M/ !F@OLNBP9F:7=]%3%3'.JU]=SNQD,!!8^7-OO+T'3LX_5
MFFC_QD//H\K6C7_SX.;H?KCJ&=>@_G:B':731SRX^Z#I0<+&#AWAL"N5?U"[
M<_N**7_PS[]^!/D-#X.ZHWEE.4R?< &@Z4#FW167"\JAH58!SY&E)![20&MI
M('LUTWE";O-NUOX+@%DH;D9H;];!>30#W5%=*&X+;!SA.GD>=V.$.:IC43*W
M=S")-E7B:HYP<%D%G_E1*D$\=ZR#GR5)KE,AR\6=&:JJ1VFF=KZ:F'P$P/<_
MVHIAJ+\+B,.A&]2PFQ? X%@JI<_2';)\Q#@M2:$OMO;6)*%Q[['*X)BND\<U
M3N[9O]WN!4!_+<K<4A71TYTS6V,D4T[6%;UQBD!"'6\NZO(R/I=DIUV_E05-
MP\H2@!+%$K=QH^V\LN'A?9= TO'_ZA.C)MY4^@X=-KA0$7:Q>;=UN+<8T)A,
M'IT(DK=^YI9SFB4S@2\PVDLF)HRX#NXSNJMT*,_4SNDW_:X6L885KMY01C9%
MQ)7/1%$MC*ID+&V8:"!:3_B<<.M0L5+E/6EM@A%X^W<J*79W!T'1GQJX8\82
M-XRZI;^IAD.\423*FWY_G@K7&[V<.C&8<BHJ2)5+25.Q=[QZ[$'IHUK53<B[
M>%?ZK4YL45"*.V^[/HA^<Y@Q>7OS\T2.;+K8HNR];,,IM0A8SY?]R>KIK+@#
ME)78UO2,-I]AT][>X.?2[+(_!"_B;0Y(U._L8TEVVI0 3<\DSMDWLW\2"WTC
M>+[QFGK<65EIA8.)1;'6(!YQM:=4F\*S?J!D7/S7LQ#Q>,".X$WN./O]V&C7
M+-VP6IY$OJV^AXA,2:[!+SHT'MG2QO?L.CO&,%K/P?E4]\C=6 P<*9"W']*+
MXIV2M=[+S>$W)1Y;L5YXQ(X[-+:[P9YKX&O)!1=<_=-#TF>Z6%AQ@*J&RLY'
M@K?>C(&O89H31S=/%]0"5TY !>S2B=BC34QS_G2;_J@(J4C'3DOIZ)%4&2PL
M23A#"_T_!1S\9^8#YH8RJ_[W;!;4'4<_L_HE=B)M&]TCEV3.8TW@>2)I),8;
M0O($3KT0@HYZ&FE+.9UH0'R<UC*!OM^=PS&FIQW97,8.V943)PU"Q-*-;731
MA !GX/ WD[+56G _2F-DC^[Y;-5TK$/,VAO4B4(_:?H#!W*M&4=%60[]HPEV
M:Z&CQB'QHFMV/(65!QJ:Y%4]0?1OH83H<G!7/U5K2HP[^N_:9YBZ)HZ5\0<I
M',@QRI1ZR.*1)IUO&L-3_A.;CF\!4RI90OX=S6G?T0:84"&FH\<FKM+U=>D7
MQ,Q[V'>V06CU!TIF@8!'Z>5/UCGHBB5"*)6!7S.D Q8+1AJ$4TT"^_MML]D$
M;5]O+90?S T$$=19;Q;5EA,\Y0=,#9>57IT W3V$15_MDQ6] )#5K!\?8[U$
MI^=Z>MA=Z]NIX5W]C5MG[47S$=+7OJLXU6V['HJ3-5D=5Q0B607_%FE?'RF/
M1+^_ "11%ET";I4>IKXYAK\ZP&DEV=Z4AO12F1KU9EI:B4>6"XG%U,;DQWYS
M7?;7+X2PFE.T)N::VL]#$*8=0'%?7N48-:3ECQ], J^I_3ID*"Q>%]XZ?#UG
M,S<FLQYW,UQY'EBZMG98MS43)-!P7F8W+45\F/Q(.9?<)Y,^/2LFAE>D+<0[
M^P)0#&)V@*OE3>Z#F#A!>A,UO#L^1SX*']E[;5+(A?%F!DDI'+(K*A,3%^.[
MY_-ODR<7=7C.]N9Z:\GNZG0C*/K[>[A^I44&JUK\'M[[UG2)78Z+<-1C&-:3
MNLOI>-3 #L2+>:58;&E_E',#Q[';7*\AC:602XI>PE%O\BDV% OW&HN#UO^5
M3OUP$Y/]2E_Z0S<CMM9Y'WW$AI24^F561H/6IKRO.]]KVVH-I2&E+"C2DCTJ
MB+6WPA]2X,2L(RV[646 W:<14*SXR:];<ZO-&Z%((4UXG#4U$)'TS @W+/EQ
M>IP[/=W [:+X\5,.(FK.S*:O<;#FDZ"%HY>)*.7%/^0T_/$_L*EMN[ZC3X7)
M^NQ.U^<92@@56AAK93130AN)80BZSD)&YEP#9M\,:R<QM8H,\2C<1<)J,5P0
M@$&!"?F5]8-* O9%O5E:'2DGB>!< TA')\WB<6;ASE$M,+ZX#KVRK1&KTK#W
M#\20IK.))>[(6> 6>L1ERWE\PP_,\AET]*IP-&$8LOO<,IQ%XK^A45&OY3!-
MV ^2_8;YCA07U1^>T48]J&!=/,#B<CE8)]E0>]YF6BMK)38>.SLF$>(,C!J7
M ZTW3"AED(A+9N]'$MRH-55^9"MQ*%L<8J 1YS+^HY]A&5IT\2D[#,],.UW9
M4:A9_,E\9XVSD%R5T:""LRY^'Q0\GNQ=P+L\JE2KDMK/D9*\=ZYIW[,5DI.S
M@",E]\<<.)>]Q,H5L[BY:-;K7I</S <&59,>2*N&:^_F%M0V,7W85LS"$W2U
M=$FX6_ ;9J_H:S(A[!9$Y96^,V$V'===-G) Z=>K&7"9\VAY%UC=B1A'A8 :
MXG.BDAU4+@0S_FSD;;OR&7U(^3UD4QV5N/A-5BH_"T\V^CI>"<^[;G_-8U*-
M[B]#R(QNMP/'](:[M]?C5](>)V>3=VA^)=S5^8&9KQ6IVJI>=2[O":!4PJ.R
MS.=TWD$@WL<Z+X"24%S-D.8CGA9,#8XEU^Q?J/F1/B5Q/X*NSF@4F#6"3[/+
MOO1Y6\FB*86-9YF+(G0BJT('I_7&H=*SD*F8PE>)1:TZ(ZSE$G220C^FE,)>
M7VDP3Z<N=8K-:J#0'E0JBWZL2 ].*$@1[UO7 1U];I..2MWGH=+B%@\['T<,
MJ(PS4OCBSBGYM-3FE?\;*[D>1? ]QE< &LS)95YSR 8X1G @LWBQ@/,I.<ZT
M2,ETN,6@93LKBK"DWEBS(<J5M5BLOL\9Y<D\D)E&CKU:'TC]#9=[_*"0TXL'
MV9LDQ:/*N2BBHR8^4P'581)J(,AGQ*8)40 +SX*%YW8%^70VW0]R"/+9)3+)
M(6@'5+N%K\7!J)-N^S+D[O;(OQ@(K>XB>2"01AVEHLGJVUQ(<)W??(JPY:<S
MV1 *IB)] DSPET!^@I*HU%WT-9R_&-U7O&%$2Q L'Q[+2NKNN*&_*E9%<HW<
MC$!A&8& #68W,CP1.4DCT]=%%-+"//=_!4A)O5JBZ:J,&JYVF 8J6'18"-_A
MV29YQL=LI(2@TDC.K8!(Q"L%LN.?IJF9=*;%0!BA!'B65D??@8P]@SJT%JP'
M#9C'-\M3/WLNW! \@4DA\<->_IV]-]M!=$;0Y4:[88WE!0,=#W],)?U5.2\?
M;29@Y:P7_+S+O2&3Y1GLN/=@4]+P9Z#,\_? F4KFG^CBD6M)E?8M]F3#AJ?,
M54*D\?G@E_WF\I9TI^.JPB1KN.5$(0M$-0GC0IK<^2;_@.!:IX]/I'\#MD%V
MUN"P>3!SKCWD@M5;)8#")*<DW:J#7$W[KC*>?$-/-,F-07 C_ (8: M)Q+H\
M&CU M24?_6IT$*&2].3LHS A"J%T7S2+?NB=,VU!,)\7K_<_?=P>>/L"F/PZ
MT]SX/@O7;A..Q(FVJRDCWG%V.2)BGB7^Z\ D9CA8M0#T!79I"0EDS6Z]K6-\
MV_^-0OH\^LO=QV$1'26'AMZ:R\L70'-XM8I^(XVBA6L3/T.AH&BA4- %8D#$
M+=V%H_]:WTJM@/PR(NZPAWN)T]HDM7^VC50FJ5JNO.G)LMJ ]:/1TI$3[L$I
MF\:=_$@ +W?BHJY=;P*%[9<'1;IR4'Y1@"%)?6J&'D2!JLX(FF!I1792%R?B
M:WMZ<S67VX=-Q2JZL9GFDQ5$WJ:I:/AQ^)%RR_'8K'WD>M_+ "(_J?\"L.QL
M3D/,'!?:(>#^7^:R[%N--,W+RIVO()LN&E.^O<&_&"/9KQOZE-')_](W=K'I
MD=!DV3&0WV["""M@A.DZ)PKT;C=I"FTO -,DXV;_@;J1*.5T?1@) XGD#?>B
M^58]5Z1>^7 3"%,UEUKNF^A"S/C%A\I:R ?#@T+I59N6O2V*?U^E59V'*&:A
MRPI]==K0.[T"\K<!RY7NRBZHY/:S6-I^G@A(D0P*Z^9 ?L?TQ99[*12LE[D3
M.:?3\"B06I;C3,X9NQ^D!2VN3"W!^B^.&YXB#['/IK][?[3_.EEEIDX;Z9&5
M9E,O#96AD\7QKVQ1\(6V:A:8[[9J0B;@AA>""J-Z'U\ &L!!G(.P%X"TC_H!
MPI#'W;C0/<WX!4 W[<+/QW]5V9B%[]AG*!%;[]_BA?.'&5K&N"X84N]&_V]V
M^-,S*%+WW)IFM(ZNGIYN%J:[P]$K/#KF%+KIF9%XA!^W)1MZP4DV?5GV"A(F
M*2?]DS9N8GZ:I+7$CIZ!FA5L<(M@F_UT\\!:Z>$@<R=YW-]GJ(5;(Z3TJ8?-
M]=??A_*P0X$7P \*1WRW.:JI?RL6_A;]WT?>+4=1;TL_UQ]3GFP3*1POE0HX
M]]DVTG)_[[8W@!&4:U'BTND9Z3 T>(@=<V9E.&E^V_.NW8^;)#9&TRR+^M-'
M?. "%G!_9,YCG<\PHOW_D%#^1Q0IC"&K$Q;R$Q*^"26PF5\J-Y)<A&+,2/U-
MP.1@Z-%KZ,EGI#.RU/&H0Q?^%(D.B"T2+:CGW$K04DI49UU<:\1BNROYK@JC
M@KR)B8EJ,_'KOII1M *K_DJ/+_/^!TT8M6V5:@HT_/]R\PQP;M8YU%B82UL>
M7#6K6=QH%=AQ:1J.MJU'Y$A]=Y$8F((U#&O%&M="80T;DX&T5C\(7'2B&((I
MUCPNKE>K99HV,MK^3<_B;=>E+G*?G<#)6WD699-3I3[6=^;0PZ6^?A!T0[>F
M>A/(./-Y;;#1?:?AMW-4Y3Z]=FX;A?:=R7%7^_&^YV"CP/;EL7ZG(F.*F'ZE
MC8/],4^]BREO.Z?HT,;XJ@[;Y'I1%CUX!A'4@R(IRC'5V0(= #[*7PPJ:G(V
M*UP>'+>W+)S-U3S8<:0#0?*>P?O;DH_&8' &-F'^Y2:>L=#U=WJ:5+2?.C1+
M9GQ%3); ARZC<'<1LK<DLGW[(35CWWWFKJG.R^#>Z?]^1^:FY+FI5Z:D'>%R
M0?6P8L1N@/_=N7J\.Q,H334)OM43$Y,0*L_^ZTK<[MVC3LW$>Q6=5NUC[^IE
MN]IO(5:U'2'6];IY'!BKMG#)G_COOB!Y22+QR/G[K82T)OX-V&1BH$!: (!@
M(8,D0ZOB/W808=3#G@<8+FQJ,6KJS-BT1=K_#[OCXH304T/<HG&>O7[7U9-N
M?Y5SQK5.C]A6#3.A?IVBOR9[^/>YVG1H=9Y /G_0*_P$7(L99Q>@5?0(CF=&
MLZU(KY[-+=+%!LZ\4&:FOR&U8/Z!5=/STI.7(X[,HQ<M;9F&@_9[JU%UF5&$
MYTFI7%#C)B-^<2'9?Q;Z9Q'K.Z<AP6*;QZ-,-R'6VBHP')LK7>/K&#DL@H'6
ME':JCU)&-2G!<: @P7>,?7GG:&QTQ7&AK]BK;+'+-=JA-1CI7JO-L3& -.Y+
M_3 6MI4IY*A@-K"!W-[921)2B\_/R]: 7CV-]_B_77P!4,ONRGM29.ZY>2LZ
M \=8N&Q#Z#IW$J'EW'/Y'_NM#:?)VK.H@"[V3@.S?Y3DC/NRF+V \FZPRMM6
M'E$_ =<C]IL/,YQENKXLMFL(F)/IXEKX9)T=KQN3:G73;LFBM-OW><5-&XW$
M&^=#C<W%*G!MDLT2)NR"L8KY@U&:HC!'1$1-<@"TV:9Y*0]5]T EDF*99*;K
M!H7GV=EWG_6"8:"=K]U66'JH3:^C;6RZR?;!>MIA*Y$?V9VX NI+58O/U%2H
M]SK1<X Q+3/Y%JW>6STOB5@]_G[JL6DYV2%_XK*>% B17[X\1+B998*[GN2-
MXO!L^6?_C6QA'0'JJ9 9.AVN6<:/N?J?Q!N_N^/]L_13.@-;W%QC4R)QD"KJ
M'"><PO1OSA7I"R"]YCFL3JD%.=?L!E+[-HVKQ%[(=-^N,P_L&6 EN7CB<MF8
M-"L^MAU>)RDQ83LQB9KI6?8]ZFG$ZFQZ2^'S "6SR35+/97;A= LE'O3H&GM
M+V/:9TZQM- ^$VE2@2HRDVO'ZI6,J_:3+3/1!TI+-&_O]RTK5ES4G#+7#I/E
MF6,:C*\[J&@&"_K$)Y9J%_'WGT'OYP"J*FQSH$'H7_$2S?B$_EUTN^P70'%6
ME6A\<U:&[G";\T7!B"CU(7DV$LJDO&Q2R)(;IY;)/Y>@SK3EK.B#K>:;D=5*
ME9:F%"=,3ZEWGKCS K@8S5%"%U-+?'L&'(RJLF1S5VDREN$A2B/C8W:IS\):
M("_@2")!7/<M5<@CCDC$SS/#D@^O93X!67+'8O^Z1^QVT@_*G(,HE:,+2O>%
M3.[:W0UK*?/.C423V\3[A+)8^5(,(_S:W)V'&^F7O@RE5@_4I5KQ.PY6![;#
M$BZ$G(;6GK*?CP5<1X'M23Z.0\1>?0M&>BG0S1#5GG!TDS$"_+QH)]3TFI^1
M-/RB9!A;VM01N\O@A8(OJVJ>_G!,*G0,<:=A_I3?%OL F$.%36BB7BQ*>V?2
M!/H5-MV-FK/HU@M M6_J8NOF!7#Z$+ZJ;>R34):S%\WY F#2R=I#[?5,M[_Q
M+0U/K$W*630(D5X9_<"TCGK>5=D!D3U/5^7,:YF*W1:#XN$WU.2T)6YV0^.+
M\$+PH-_?6$'1[Z^]V_1K&QU+2PKJ0/I5UE+-<[D[0\BA]R5_7)IJE*I*"_<$
M<A_'D.M'%6CB!95E9RI3_Z'.;#=Y'4:'K8CM*!@2/_J2/O3]1WVLN9]"T-/<
M_];3/?RAMXLNNM1VO;AU)8[X]5V61YHKS2 ]-O!N6]O>^6WI@-E0M'Y&X!KZ
MN(4CVC^\'J$ 0>2MTJ7O45?>6,7CX:X6M (K:Y_/G>IG3[ UV=5V.I%9B\T+
M@/*N=9IF\EGG2B]RBFW])Z*K=7.(B&>_CZ1=L]RG9ULWR_T-;\$ LD-2Y@4
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M=YCE%)O.*!3]G$2&K*Z2_EH.'SCJ7+^\205+CCJ3[8RO_L'\=ORT?F UH]N
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MDL8URQO?UU)&RD3P$08P2/WNX,Z4#SYUI .'T58U=/XZJLJINL6K*LMF!^:
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MR-A:0'EL+Z758>_%&*[FI&%)*R^%)'@H*.IRR+)EE]*6SM,XAF*+EK1RO)U
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MS+AW@=]?M)V(T3? -A9<$<6HP.$(>LZH&',ZXT>0]3E=IW35G6<+$_R8.)G
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MY[ U%/ >^S_W+G;_3L[)X4;9U8];P/O8'_MM9WL/$8,+*;,:F(5-_\#Y+,7
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M]#(^K=9H2BNP^\Q@**H3\C.\? >1>F]  -_:13GS>Z6W>;;"VWH^:]OW_5Q
M.2(_E96*)P\C#U1[7QCT,5#V;*!9<^74Y=6"YA[>2LN!FNW,8Y]S+C +'GQC
M.9#C5&J41;[VZ:!!<,IB,"IM7HAC?ZB50:.BA[FX3&7[XV+N!OYG/[!&CU=T
MTBS<S+MRBWEFJ5@Y,-+9SA,._6;;&$3QE>-^3]'L&:-DQXNHF+P3S_9"VBH!
MT%H%79'2V!%SD,=7W:97'*4(IB=9KS2F#$FX3&K?M9_.FJN2WKQ)&[DI"ERY
M!8S]RC\^;R;\NQ+D[[ZD6M$O8 ]*@R2BJ9^[2Y.Y[QDE+)BMV&('(AXLL\\8
MN_-OV%2^5D6WEL268 M;N ?"GOI_M>J[1@MGYS5E<.Z_GRN:G[T%J%9T>CS6
M6, LSEGKV,HW,A?PMO8-8PFZ_ 3)YX OVG.Y;KB=Z56GXX26-[?A]E#)V, *
M&0'LD'A/7%/!5F5>V)#[4)>QD!SUL?>N[8'74+X4*HUFIL9:"Y/#ZJSLDS!A
M??\85<]^2;[=MK]B4-B&66,('_=#+8EJ'-,5$18@.7EI*A_$*2^1"[*OEHW4
M<X_"JVU/-C$\21[CMX!83;\@.I>>F,#F6P"[)RD>&3R>O>(GIQ%5NR.Y>+V)
MF1/VXL6(D@9ZT:E&\,L.ZORY!;A/A'@_,I^@),M9S]>Z@O^6VT/< C2#OUZ+
M\HV49[QD_+>R;3A>C,ZWV3][M:V];7'=-\\-ZN*\,N<4I3_N87YSP(96J04&
MKPZ'W *\^"\]KE2VJF&!=L&6LM\9DKSW.>&H.5OQU:[XA,DE3S&V9\";/035
MBS3:@Z?3C)T'UG__HRHD4?+A]43[UL@!8V'7[$G6]U/HUL)L-L1X<AJ&=^Y:
MPPC"3VFE[C4L!@^"X<(?;T2\6JUFR7OMHV"M"[Q#TKAQJK"J0QUZ((B3:$LG
MY((D<^TF=:RVM;N?1,+F(>5\P3%42O2\ "R@2%MF4%2"\NB2/;CL3C[B4$R/
M59R7L[D3_G]ZV$PY%%$_(C_MIDT3\G2$4Q?<<# F,D-K^A]&Z'S,D3[=HVT9
M>.<?<,5M5UBRY9V!B7>FKC,K^(D2WCS,=*0UOH,)'?J!8%575>=QU66;C"_\
M,7T=\X.NVC>-;2N/7W?N$/MZGXKW[R*S,^>"&B?\]:8!Z2+T7L&F7A5@ 73G
MBO&(Y93F7O/!T;ELS;?_+2[N'QPBNWUO^.8 'UU5&S,/RR9LZFDR<]X+R+)P
M_;@9Q)8UUQ$!CN*RSJ$T:P0SJ$*/<X&'U.I?S:*," _WT6XSNX?[[/!8<8GW
MIJ.@+<=$3O>NOK_**2(A6FE14!@9%$C?BU84K>-Z*?[4QHR,8<0Z9D)!"TCF
M:U],P8'H,1"/9;G NV7S[7O(=!N"&]E7KWFGKT@CI]SWG?;+*YOX=C[-T/MD
MIX53&"!?:3-WS]<WK9*S_7[#W*5B0R1Y@)_WV0$32JQ3^(O;N;4VVQ+J&$-]
MEP[U-E)RPCK!ZX+5/\R-=71H8A=^;H@8+FAFJB1[_KIPYU@TXW@7<99URM^!
M/37LX^/H?1')87Y1LOB@--X0>QY7$RI%F7$+*+P^)NI^_A-;T78+*)I4<D_^
MU4CL>WQP[=7:$6%;ET^]FI!%Y_.LZ,=$GGZO,-'[7!HWD8HNRAWZ(1[)A'+A
MOZ?77DDE(ESYM#GY:=.ZRP.AAF[)4P5]XT4[RY=#?,86/\A5Y0QWRV%OJM>^
M9)5[23<Z@#I5%%@_/B@@]1U#?_WS=K,NTZ=@XC-MGX)AY:+DL\&XTFURDYW.
MB1.N>H(L5F+=#O-2$U.]0A#!*\@CENWR^T4T4)7BHM@6S^7*%H.\E)PR9J[W
MJ\*_28.9C?#$-MDR1-IT\H:\095E[^TC^.Q)7Y-DU--L*>NIO_V+74:>NY9_
M*WR=%%O^B%ERD^+T6]$=T \J_<$K;HHH ^Y;P/!4J9 <V9U9I<><0)4%R>?E
M/ELC&L)CU>FS2:$GN5SC&BK\$;D%UTEBGV2'OIWDO0U+_,%9.'V#1P"U:N-W
MRI)C?9W3!F9<R^@#Q%T/#HK_>/"3_OPK!W5LX&DSH-52S@FVC_U@+WQ.\T-9
M, 7Q%!BI$* FR4!#K#5I4D&=$1MT.?T!E$!>. ]4+HAY-&ZJXTE$X[/-31'Y
MQ^'&O/J"A-0U$[ZKI[H) 8?S4<-&>KTHKUPX3$; I5DT1^G*'8<;#XH0S*);
M_;^E4Z:DYXZL,4=\/N95?YU%(0XCE(F[.)8(&Y_"56.[W&<$O4AWC2C^3L%7
MS%'EZ>Z2:0W81J58$[U5SO*G\@ICVBN>( @( HR+3&H=B73H.FS^5MN8#CMZ
M)BBPS@]/J^(T5&RX<C]9<D6%$FD_HB00KP?V__W^U5 -7:[LQ)Z02*&)D@Y9
M(O$F9BLCM<7 #OS31,*GVD-^X@<SH_?,'9?6*5D"ZE=3G@2__E5C+^9H_05H
M8:NQU:(, MY1"V*=V;7A8UXW53"SD%=S(]1F@HVHK:S'EA35>KV#._O48?5N
M]EL.2QF]9AJ5Z45"+]R9;<_!,\/V%&OM5)QU+6/'!CF;!3[3L9)JL$E&LIAQ
M5H>YN''>@-+J4\4OMJX3S?Z:H1QOA]0DMQ\!YX)-)3[GCK5*F>^)S$4[*A:Z
MJH0V>[MU.8Y/?ZME-"7K.>)KF N\80Q>KSL]6.X!7D0/P.W8;LRK!ON;??GV
MJXY=WBA_@9#D?.Z-LZBL8"0OTR]@;F_ZPD:XXJF@H%RDH?GQ#K+,+XV%0K37
M/GC]^53L?:^0";_G[?L$CCF25_==(OZE30^.^C-:2',X?R2[ZX=2/63>0[+-
MESLY6PCT%R,LU3;^(BUF,BU8PR6K*@(N1!W?CI<-Z*.,N;C9W[VHS*H/8H/L
MJ,NH=!Z5Y?%]/2]RJ6(C;?UB2;1\7089#';BBC4Z??DJR@YZBC./NOMK\@9/
M69V->8 2B+,4_#H<\]E"NT.!G3%*Z0GWH+5*#XXGS(#2]+&]V#-9DX[PTO>Y
MV]AA5%0U94)NGV5WS+-V+AX8BS"A-D1*HV9)I_UY$RU0=\)SQ3/_2=]_RL(X
M$O%-Q!N4B!(4&PL?GD\)FO:]!_]20";3/M<2,-IUK'8O^)17&5+R7]2CB[]K
M_K<=$%W]"421]1\J@%4U?U9E)EF;$THBOA3_MW/0'/A]KQ'<#8/.]&>/X/8]
MWN'4*/ N3'WH3U^<==_!X[^'-4](^8,(C&OU;;]-V?P,Y&G!H5;F3*TY!OU+
MUZ]JU_ERUS0;T3L+0LE[L L6/F/')Y&".JOI*W"UT\*DE.)+L4$YYF.7- ;=
M15_U\J,>Q^:?XCSQGGV1NE]R5ZP"6)/2(6-1;GZB/BXLX\&M#=/WW[C80H]F
MU$.K?<,;,9 HW8C[BB,*'*M5E?+)GMN2N>'"_S$OBG'F1;LWO0!NHO98IG]A
M7)^^6XSHH"!+O#_[+^-Z$/86H'$+$"S?"9L>Q'-Z[MFIC3BD2$A ML".PODF
MNC=CF1M.RVV)@6.K?,+KNOYSY4V?*N(D!"M3HYO.IPW5WMLN6=6IU$J#-)M.
MP/&2'^\5/\\]<:[&UQRQK_#)/"S8/2W?1&3S:70<'_Z$C@78SR=XENM,'\OQ
MW *V>M:(R[")0XN6VU(3Q?.B#0)0LN"!H010-_9G72Y[J:;!I)@'M)5)U*#3
M*+D)'Y+E7-#I>7$ZX!^-F^)D\O+B17\PRLY,Y&2UCU=:EA:1A,AK'<FE!71,
M2R]/%DU=]37V-6V383E4?TDSQSY>Z+EORD*>#'(N1]T"FENB#H_Z&7E;6J/Z
M;S1F+6<]HTT.?_K/<KS- L_2VZ7R%#?6:.HD/X^$"$2:1>+"?NZB!KJ>P=!.
MKP=9+\S4:W>G5&,6U\4*T\'N5+^O3]=5E\LB2#*E'9>M'O4LJS%ZJ''3-^LY
M%-//[Z^-.[J5&BQ!:](RVYKK;&90IU1 <Q>J3TFYI3=K2R!)1)0H,\4M0.#C
M'^TT-YZJ)%ZVQ5B)&A^W\17K87!IR_AC_2*ZV>N&\$\89ZZK(KH(OK,TZVD)
M+IC^]L&5?^8IWC?K, F]X*ZSF,C<1?^XY/VHI(,YPS39@-FXE=1CS,5.SY'L
MBJ"JX(=%]+ &TLBKR?VQ>QE<*NHEZ,5+NMB:Y5 A'M@RWQDSH2$0#J?GNJ.1
M?@9='F"P@_D)=$>V%N7H;TK20?YN)+/1!=-RRCU%?-[].]8X_.>G^^2]5]6+
MNV*L5!;@_!<U=S6CW@02/?)%N&WYAM,^5FBAC _@I-?5[% N]L$UXA9<>0K/
M(LW\X'"'%%3 +Z)G@EP_8.3K=QM2V+M,Z+2JN!4[:8[4Q/NC5[;3ME0<X4V+
M.]!QM;17<HDK?/66[??YD1?$#R)WI^T>(-Z"+42U$8DEJRH^?VD,B^@:\\M'
MI_A*6_;I4JGJUY[J/U]94O]*)&!;/Y8F0*<]CJS_=@8W)"E@;"H7/P!$)NFE
M%-;KJHF1DK=9)+0T?P[R?#B52[3]"YBG#J#PI'"[\)6_IR^</R',ZL6AQ"B=
M&-/K]:[KA_<<[I,J9,%#'5T&+KNOR$>:B4*H[$LX>G6,CQ%R"4PI0J2CK)/I
MPU1HMS\ERSPXMI+0_RQ0+^#7X_P.G"-S!IPSB.WQ 1C26'O9'ZMIA)+\"[GZ
MN0^_,F4K.)3DC2,S6OTF*V7S\9!12#<X,*!-\DC2O\']LAYIW9RZ^>'_8FFN
M8'[O@]=$+G\';X8&W0(FXVKJUWK^V0]_D<6PW+S=TG%.EQN\\H3N<L:&2MIO
MP*W/310W9'EV,=6@L_]B1?#Q21C;B2AWXFXCW_C%H&I,[:LJU ".B=FO*%3@
M%A"D($<KA+^HQU3';9<=)_97;[KMSI)88-HLH/T5*:>=#M0$JJ=\6TZ\CZM<
ME M[-1+<EU-3$@[S<@LC^U_8\!85KLC&=:KCOX[< H[_X;NKCF!\7_DM ">;
M>PMPV);8. G\MWA5O70%17V^.3R#P+-QET-]?R]'O)O=<1X6KQG&8(\_0.'&
M7\ P]+U?HOT;MEW[YT/I%\[>7%7*=:NC'O!H4(;$NY&A51L<[<"9H0ZR8@$,
M1HB;O3?&O>A24DXG3T"(,]CM\1>;+>UN^-#.SLH5&EH=XBOW)8^\:2L7-/ ,
MO0)#6;.M;?TU25UO SXWT)_WYB[NI0Y&3C[ TFO,6;Y-,@E'H!Z7JSKT?KMH
M1'#006I7M$3H7]9+]]VD"L&QQG;EH34PL<@YCW?F3?:A"VT_&3)N%HQK?0QY
MK^)<N_]Z FVG7ZV4FY;'_/I47TM]QE358Z*M\_P[9E+B=/I B)$L(5C5C!@E
M8>=$/WZF$H^&##2WS#/L" 4$^WC?O>D0]'Y)_/E"]^$@%):ZE#*3[51O?:&I
M[]L$]),T@6S)J$/7))O=G]&CU+H&CO0L$=R=IR.3)4^&\H\G3I@6Z*.[=F=0
MN]:!M<["N_FO.W>U>8WU%^GHE+&V+394_D/5Q8;<H1O/?CJ+4>4.^TZSOB&^
MC\I=*S $IULE&N;JC/&69A%>DBUG(1NF"YW[-'8]G*\9UITJ5H32%O=3<=,#
M_I7A+;,I'P2OPCJ2,_=<B##J63+\W+5]Z)()#&_O-QJ90AX#H_>QM-,I;(D=
MX(RZDT029U-.12<9J4!!J1_'N+D1P[*HAL?MCJ(+M7NE1,-BYBZPX/IY.(S?
MR&!TS<D2/L#!58<]S>S#9#P3O^&ZAG.BWGS%.,^;ZX&D;5,*QWZIUS]Q_Y0J
M\@I/' UV-./(-DL+OF#-Q 5OAB].W_B6_#/@@79C@1N,. /^%K!JX33];V/D
MQE2]R^H6D&RNR7P+L+]6APJ5RVTNH5RJL"Z"9X7.+W;XA>L:QLLEYH;JH0V8
MKVPDHBN/F#[)/WQO.GV:>AF$S3L/5%E/'>>_!; FME9>/\7/W0)&1-S^^1S?
MM9WX+0 *SYT)=J-/AL5=2V=E9@Z?M<?\&*BF_]9N+D3_O8<BIFO0'5[D&K=Q
M_<O*2!?D%@U&_*H%H^^4F=T" MT?CYM"1*KK9%SY5<!O56US7ZD0V$CQHW5U
M@82U0Y6&@1=[&PV+.)GG:'2P%$_HK"W-AE]#76!TZ'=G,$]'8T LAL/S].Z^
M:Y.SJ%PL]K04-@[ZKO[4+,(FR*FTS+?4IX5VZS[X$*B31)=,$1A F @MG!01
M$[K,%)VF6G2^;"_"VAU]K=3XA39OEOF) ;>1^Y(J!IGQ9[J06IVWR5-$N&5
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MC4)&I_I=-EWORJ8"T%J^41C#QLUI+L^=\*"5:]Q,&2$IF9!)KS4*]GTW%,,
M]O*-5K-!/I$8J_.-;OO2,'9)!S3(*GA%_XC )_+".BZ1M<*<YE>^QS/(J+DQ
MRVZ)ZN+]Y%<)\J<[>,>[NTP5*EM8=?(*JP9/-98?!LWA'A3<[R49)$>%=)'Z
M[F7*+V>EQ75#]%<")BF2MWK,B66SYA9I/EW\G<Y*_EIO11_0,WD3N<CZW?G^
MY^+MWP<$CB=XF>3"O^Q>RY4R9)7M!0;D2@%M61TF;=CW88?D%5E9DHX=VK+2
MCN8//D"Y@*J&/QPKPS>1*Y!&Q9%C?>Y8MO!OTX7A"@_O[4]5&Z&,'>J9$E1_
MQRJ:N\@JU'6"#>-:@OJG+4<=5!\#$P)S/N]NX+=-!]M"/_X ?FJJWYK6I'%C
M681\2YH*7<GY-J%Z[SU2^D%8$B>E0D+NF:KVVH^=2P<6=04I"U.P%KTGJ\.E
M,%VI\T<O!V6$BGPQ T?$93A-EV4#!7"LBDB514-N&FO2$&HY'H-"L"*9LEC,
M3QS*^1SDFN8"GB?%?207KHG0*+< O/(BRY6T]SS/\OK40J)DQ;)!GG#GL865
M8B>$?*[1WU.#_FMZB<3741E)UWNS'9T3I711[#HZ"IZ3'.\G*W?N88T]WM5E
MOCDCZJ=5,+FI7%!_8,%E\OM %?CO7\0V95=V (NLGDSP#ZJ:I7N1F/T29YSB
MTA\PX"/Q@@P*F9W9V<ST[VT-NT;E_#@S>.+YNEN7X56B8S_3:X +W4A9GZ[&
MJH$(@IFW"6CW1OMQ]+8?D*J#_<6:?ET<WP;TR=Q<8'O$U/>PO_-N99_X6!JF
MV@\QKHQ3TCYB5)UE8A(*:M">JI:(SMJ[>.KC^'S")?8U.HDQ5/U]NY\)9)\+
MOOV]$- B1XJ<,]+Z-#O\.C/!)(%?/]DVZ+*>M88-NSBP;: &I%X7"+G9FE[.
M]RD:8**>Y^9:^CVE=Z* I(9JF.AI*0,S$MRT%KR%1^S];7N%H(,UM-"Q\43H
M(L5W4 6U[1^K%:L9TX5!R!]XI-N\\I9GE%-RLEJF[&.HZC=*P9QN"QM@0)/.
MZ$XX>1&?2W^<YK0+3Z).T?&X3/V_^S'4*_FI\":'J9:,3]8'P]YR7>11[X6O
MI-]N@OXM  1ZO!Y@IAC,>, ]B@J>>CLX]>,6L(8)M<FL?!,7V+,>&CAQ?/'<
MHJP4:>Y](*Q9%!JP)H$ZC',R(043>PN-R_>WU01(5K,>G>M5[=*Y/<G5%,_Y
MP@1!,+P)&E-;PXE$B&Y6:!P+W)]:U)T^>C5NEOG(R*!]GTCA&#NBP8UF;7ZL
MG>ED)XIU81(?&UNAZ%-C^GPIK:3$Z6&"&,#&G^D]W3- L9/1E40:L&8%$Z70
M1TP]5_4H)5IS?/Q_&*S_1=U;!L45;&O#)"0A0( $#>XN"01W"3:X.P37&=R=
MX 1W=V<@Z. $'=QMF &"N[OFR[GGO?7=^]4Y7]T?;[U5[]Y_5M7N[KV[NG?W
M\ZS5:ZU_$<.C1;<GJI$&KR(ZD E?0;"3ZT>JD[K6Y[@*<ZF^Q%%- :)#_7**
MLLK?-BU,/5'?_[XCX5BS@@XGWZ9O9D-[-)ZIWTD6K<E.%M-T55OMGQJS "U:
M;9U_!NP=TOC:H_[O O9J@K719O[NW?QP=X@6#DRA=>CF$U=2\[6@Q8LX4ZA2
MIF.[?A%O>)./W\1'WSWWS*NI[0)).RO<B_)]1E'5X&$ ^[8;1E'%!#4[_3G\
M6B[)WF(K=*Z-."9E^I"FXT+Y&HX6 ]&'<L/)70)"-V"F[5KL\].YF<W-%R-L
M>*^UH(J*3B#I!*7TV:[(;Y@W JW^6[JO0H!D+SAF?%?U^EQYX3QWE'T(%F(A
M-!/<($A-A3E'34CQZP$(+4MR_A"2QEK?#JL?KB$O7X==K.W&%S)!MX^1(RKK
M/T?D!XQ#)T?>?9[&#M4Q+^E1GE'@CDLJ0L)^$Z U2)9P]8[70GW->M"&A'_R
M="$FUU$A6YC4=83"S%'K$5I"DZV4,MU9C:;-_^3OE;8(5OAP]0[>@MYW^-!F
M&3U[S-UT2&AL_:H*!N) JM<WH/X:>K1@F4PJ'1D[7OC L$:X4<I!91N19U!P
M@SDP>P*,URHO-\4>4U^A3F!=X#?M4>B1\T\RS*8)YLXTF.4V<#0*8JZQ'F]>
MSV6YJJ=CBVU^PFA/9GU%GY.W5YT1X*G5<)Q-5CJ2:PY9 9\?::7)*T+&[(?]
M: +G0V*,K1DI@?Q+#:KX"<GYHHPT[S$8-:1-::6L-,_L\"ZPO[9_QY./.N8,
M@!1) =2/5D8GYQ19K^$R7[YQ\MX-DBJ4JJZ+J^H+>VXXSG/S#7/.$<U$@2Q4
M(.Y)AK51D>L=%6ILQ-F*\&J52;"?[AI..8-O8?F41/' U1P:H'F!=ZA_3C]X
MR553B!+VO/83O&!=Z80PZ4ZG)8="+86#+'#I-;I,D];U%(827JA8O:#,PU)%
M0]+M^#Q87(I396XD^]/UOX= ^(<H:'!$/!U&<90X1]^QJL('G[,8.5Q&;-R@
MT[;94AGCV-T(DJHYV9%38--MV9M!WD)FFWZ(*;A 7C+2GH+]]M V2'Q:2 Z<
MU*WIV6;BW+SW//V.G&?]N_P>Z4_P"MD;;K+OE+8R@3@8Z1;-OT52EJGT-2Y@
M7V!X ]QB.W2?1,_7ODYF>YR#8X1U6N;7I!+L&]P9_S:Q.J%1/?PD4V"/5TA4
MYY8)N4'0K36<.\!2!4KLCM8ZIL1![\_GZQA46("USR84*0LO9;6&*T^P/KL4
MQ[3@ Q9YYP$&H5WW:5[LQS7.3TO L#(>,P.$_@//"0'HM C8/T'MC:^H%6ZQ
M6"E^A<F27M5(B:5GKU+ER3*('<]$NK[J'(R0^N$Q$F/DYF3BE"I(2F-6 -]6
M_+'?N>;[H:WC>'4&= 2;<'XN5+V!^-2!#JN>1I56?T!M+ 1,^NWPP1#+5['U
MO" \^W'6P[Z!;P@5JL/1\&TX^78UA__B^^+R_LU:@/)64L6!\F^$U4JCB-1B
M<KS'//./C:BX=%OHV0-7O-,DS!P[U08B%5".:@7NF39D<7V5S%!$RB5XT#J%
M[_$^5\;OV UYEKFE\_SA[0F]G9OS^Q.-W06#>_C3P6)4Z(4<E*-6Z*%JM-)^
M 5F@9\H]8>YXQR'[)0O,@:J?A\"TG;8N14[?AU$*I.PB'Z-9K'YL<-EP&7X\
M,9/8BKD%P5];480?/P_<L+:DLBXB*DF.PN+-5]X],.H#>]P&R_E(N[@B0H%P
MASJA/J<M1XTFF"-HLQGC9R_WMI$#92QN/MU!X8>HJ,XP:?NNRX<3X>4;Z98.
MQ+V"^U[*-6GJB>^XPH';=8+BYZI*ZY.%D>AAA:4UX2DBEDVQ"#.%:9?TVJH%
M/=:CM"]T7><<E%*J5)!8=-7M@3TU$E); HGI527A@8>*Q7<\_L;N1RO;8JO;
ML@@BQT5W.6&=",#/H_%54[<#-@6+H<\()<+TA.5#+.T+[G,-G]L(ZSJ.>^JF
M5.JJIS6'X()< 3 @TG;=53 RY$DX^^3:LUD@C'G::(Z<Z<C6Q)V>*C5I:-&@
MKS=GHLHC>=I$S[K;)M?1GZ9N%1&+S>(1?XS-,F7_\I5;>B*';N:%UD1WEM'E
MUE<E:J5E+[(<-XV]D [?-J"]VUE;Y$FOA\#HZO&)V_4,!":\"7(A6#/V=C;K
M=UR>K#?1S(9T%YEYXAYPM7*"%YIE6BC;,MDMFV>8+6AX!+>$IGF7E-*;8 !6
MS6IPML[2:J&%'!Q2N'+O9:"P6DFFX;="XN_+$@^)9'LA/&=5R^QA[%-DC;46
MLZ6VK:00_K15S(/?:1K'4!5#3Z)$"L*U)E-KYH9,2[P.V_V#9'69NBI_+O5[
MW0KNO8WE@VB7&F677<WL:.516.S[0N(WY)H=7X^V$[(%TBO^.9IJ_OGA^FR;
MIJDN<B["PY"8I/.$67 %3B[>I:HM0"]0U[%RE3Q10QJUL6@.?=ESW67;9$G4
M[4Y T_L'B2435/O-,W1O--5SHO:H+GPX+4* /-:KO3?3%',)IBZ%&U*8T9N0
M%6.X)IA03#R)()M_(N8P7.X@NYF9W@<]:9]77I]N/.R91;>K.*!>5TI&Z/6B
M;U'+^+]S9\KE\+*3/F%E;&Z\( F4U'?D7?<X<$KZV\TRGJC)]Z";(A&[SJQ$
M[W"%1'<!P @IPK=JM<V0D+7*!F3%(=3;ZI,C$2@0/YB6Y;=ACD Q*1\HK=#G
MJTU+6<U8,@BA,B1:5ZXN@Z)!4R/Y%]J5I/S5JF\01_3.$.BL *2MZ<HMHB4%
MW L_]"<_TMV(!(K7X!_DL'ND)IMI?10(Y&$=KJO<FD!MJE9WVUAB&:M+)8S"
M9]==<::-HME%)&LYQG"X5,X1IZ[8%[.=N1>V=R; ]YH[1M;")SKXW0L?MQ&P
ME.S,7+/ZD^1YJ8U#?%\.>/BB+H(Y'LX@*S72@A%(9W!F+3^/T$TI2=W6KVWA
M;;J*8NQOY?EU\[(-EP&3-F>SQGA12B=Y(.3N1Y8W>:M!H02C;H:7O$PU'_FV
M!$"B ,?^%?@\F58LJ2P(BXA6L]"F(3)R.R'65A !5SQPMQX]7R"@ZUKZE&*7
M<( YP\0F/DI,FS%TEU1V1M0RT*)[M.LU@@^;Q=]9=@T:U-&S,8RAGQ'JY.UN
MIBM*]K:]S2G_'11MDF&U^EC*]YC 1",QYE8_JA>(9G)"M1VTFGZ+;EUK<.)<
MS6 KZ<HB_2/$)1K WZ 4[2R,-?>H*C@5[5+(?NP)LWPSX&35]KU)UFN':W'@
M?%P@P?"L*@:0R$@U9=RH<\%'B.OI=L53>( I9Z1G!DX18YUR=N:2]>)4\+(I
MO_;25KG)L'X2DK;X@R2P2A ]VB(]>HAM/P;?[$";(+9SII5U!4H[]C&8L&U2
ML^=6CEV&Z9UG4(=):Q&=.4GGQ'Q*Z1KM7%(^/Z^8CLE)OEX\NX>U/XR#!T,2
M&Y/-9NIN:D8IN2$6"G<Z=<LIH6^$VSXZ-EL%/43>^2?)R8J_F**D>2D,_-V]
MYJ3"H/H'R5?)&QJ;F!*5$M;9>#6S\;]-"?17M!+R:3GXUR4$BZZ4EZ1KO'W#
M3LPST(H0;N/;6ZF,<A170]WGC9 /MG&B.BR_VN_LHI'V0.O[0U."@FUIFDRV
M@1-,%37&:X9+AFJQEFZRS"X^E?5XM@EK0A@57+^8F,AT1$)*EATQSYZW?&+N
MC2IWX0;+Y]^<ND6DH;%STK3[9B,K4$)'7=_=97UD.7L'NU[#3BG78+D?PXIY
M?*ZU?!=]2)B1K+K@8?[XI_JS.R5JD ]9W:F >3_M033M-2,I=UT)P*W0CMX4
M\;P#422!UJ\9_22G<+AKOA%I.3K=%ID2_8=N2&3MUILO%FM*U.%N\1^*HG:A
M+"ADA0&34H#LT<CYRB_HK\A#OG,CS._7Y9C'^P/AGXMX,A2>^%_RZ5,G>>6-
M,@DR5?UCE>3@WDS^P.W>TY6+CPC>BZ'/#:FL4[,>NZ4J-;.IJ26=OU#0D-OL
M1I_)PV;V\P0LAB=^WWKX)J$ 8=J/)$*Y$J(V8>X+N6FMWVZ33#0?K=2J3^IB
MA$ &1?4O5X+X/",>:X_>M.YN=U)U=FR#A^$N+"<7"@R?;C.4GL%&91LY^LVY
M?J$;]S9K7>G'X\?'+R>U4-[VUS[]K!>6JEWVO8(^]@]&(N>!4VKI9@LXIW#>
M9.$5^[$W16]ZNAUH44?<,-OBLYV[2S)()ZT8A:P1*MM1<"^EOEFPAY*Y(E%2
M&IJ%RZG.E<_U,R0HMCJ/E\=G752864H>!_NG_^((O63:@_@,?%?PA]&P,QNU
MOYT25BR%BO5&._*1'1\>#1JZ?;>QI[1VOO"%=!_[V:@VT$[D#K"JMDZ'^4<&
M5X[-OO9=VQCHU"*N4CN6'H2N*34?XI5AS>@IV.B#3"O%_:4/P>NJM=;?7I21
M3)P4MI0(1*&BK&E_L,N6*EST6YK.'J%D1%'FG3\M+P[#QQ8Q.JJBQ9_^693-
M%XNFO6 R=5;ESHB?K2+SRE?_F;..>[ /G8E>69@<K9[\FQ;ER=-5Q1:S<D/A
M-.I.WGPM8@9#L28TRU6PX>;\6I6.P):72/E<>..!P:;E_!Z!SLC$_WVX\3I3
M@MH0V=#+\:D+:%W0,/-BDV]>9C;(P[H&Z]M]Y1O()TB98N1.'LH*,V$9,W3Y
M6C/L[&,"L5ZXDNQ"T9DLO^TA565$NPS'4@8@LB6!UWD2RSV62$BG1,&D7K0O
M#N;R'C/XO51[+ :G2$F4.KK=YY*YV6+D&Q<DVW6QC3*\=CE-MJH8$I=U:?)*
MP%PA9T* +J<6+096GZ;[QU%U20")+!,3*G]@'HGK6OE"3-BR=F-YP[HO7"*0
M -\K"1MOFU[5A?QW52!T2=+V5C[UEW-<7GX918QN$-9AF29O' MWX:STA_(9
M0_*"6NT*:]5391)9I!=]N:Z\:!6O6D,8+LO(*Z&A.<O,O(2^O/'GNGK9 *FB
MVWWIL' 4P,)I\E>S4YE)!^30[P%X@C; >'/L#-6 5S'\+Z61#R>#/.<6 KGD
M!Q=.O(>J=/<67;2$\64C3?G &88"J8NLA*PQ-J*)-AV_HAV#UA-PWY_$,T+>
M(T*]&H%]NQLV#T/*%$0+>+2R3(5)LV;E-!G\6,^ -I:P&7R#+HY6TU%P<FVH
MH3NS ]OM5W<B1U"T8V:,--6KM'U5J!I6F.EN'/(W&RR4[VC),>RPH\JQD:MZ
M<_!DON[O_B8XY5>(7M[G66UE"FD+$@9';7$]$T[MVDGXAXVZ)7'58!I:"JLW
MR<NZD=!R27I)&\*B@X%:*U7I7X-&TW,.5M254FA#3-3B":EOODM4!VC)8Y=8
MW<O$5_*ISB\O"0:3I;ZS.J'8Q0+ 73>+=O-475@?.&MJUPH#E6^%+,L<<^33
M#F6D?_NFK$B_]SLH0U=Z+R.(MV:D:1-=N):208BZ<UIN(8!/-X!#W=RM(JT9
MS*S@HBJC/.L1+4VT*)>B/R Y-?M[6EM?:[XW-P(E<#*@*(=1U?64JL-Z3OU*
M"@ HVUP\UW\G7/R26"WB_&I31A;SPY43.=I&2O()-2WSBI/8H'=E8#<"K"Y/
M]U]3//U'TJCA>?S_Y?FLH?(Y^;][/ILZ-880V,@P:Q"__,_\ZYMEU<:4ZL/1
M$?1I56Y<BRVJ8BI:O^;^RWDF=7EZ\;F(TH':]/], )Y  NW\6?I/3VND_\DY
M'_UR"K#N3[R2OQN2QU1G6YSWCY6;Q="+V,/Q7ZNEL+,!U<Y*D&N[\N,B(9EA
MPVM\^J7/-(QN<-U+5?FM8=_&71S#=Q<[J4QUO&;)!GCQW769H5HN;>MP@R:5
MQ>Q6[W0^N!1;.N,%Z^UR$S_VL72NT2^T\T->WT8+\6XT]=3'DO?)X%\96Q];
M.C6<,_0G).:7$V$L<B9-V_T0C]+1SOZ63XJ=1J6X+5XCYYD)?5G?V09I<AJ'
MVU<MD_G7F%1UI244+AN6L',3@M6IAZN\-HXKJ)L#4%]0!R"].,83!;]8:#G(
M47-KM!$[2,GYAO'VAV([WVFU)^_'B>A@1&LUSGL4Y3M1Q5)%1L_:WL#GLZJ!
MBB>I?I(%E@&[NVW:>!."^7=1;&KF+=K50,RXW0CG\$/IE)[99$_5=+D.("^*
M&HB6B42T.IHNPPW#083B 1Z]22S2XED-,\LH.0E;V5Q:\:!5*' 13@(T&A3F
M?RW_\(D[_=V(965LTKGKAA$I_X"BH$KW'#]Y,5D/Y+?]"4@[^=IG4W[$\35?
MH(6ET4;U26SM1['F3LP0J+WV8[A3EB,%=SEF:]+>I.B-22HGCCM_]SS=]H)X
MR(M2[[6EL7H.D*$T9"C">!A+[QR,-BV4<+\V)\>P1XJ?&15\,!^_R5LSD(3'
MN+0A*'M G,@P#TWV-(!0]YS$+M7$L6E?/<]1HJM[,KC1#$YP_]ST5$'(DLJH
MR.A]XBP(B<8-^9!?PT7DXLXW!<;H6'R^VU[$PR%8X0*T+_%/]NG#0D>CYEKJ
M"[ _U>HI&6PSFXJ;<0L[( $2[L-G&KZH;=0"?$O+--^%0I-U*5;/VAK0MU(V
M!_TPQF&TY8XTW!YD8;JJ"?A+@8!)%UU\-/67@7B["EP:IOG7MJ+_<ZSU3NY[
MRC5P@:!Z/SQ30O-N?'G.09PD(%/-D<Q@2 WNR P<%$?3OT@H*F>R5Q8C82:-
M7@@9>[4T!CT2'VOY!(#6$@_0\]T@+,F'Z^AI%.O%?6=3YLZ5$:V(5:C\'':*
M&6]JRI)602KI:U&W+!Y,LH?M6-RN;JT]YRE>2X>;;"V\RY8.=Y;Y.1MS;+94
MX@:9OM=?:!_HU,ZKH_&+TA(DB^7EF !H"82JPPGBH?FR]*,MY#VILYZSMC:^
M4@)W6\7M?G2J9,.T.CN#(&:05,_%'@%NOO&OB 06ZX$_2,(V\P71'VA5VL/0
M$MX7VS >+Z1$=IW.P'4Q#3Q=:HI)<T$353/ \F8IR#96MP6OVK0B:KJT^S$'
MP?,$,-4TUK/Y+BS@3GLBIAI%'#,'U=1GS-IO[C;'$C^;LZ:8S$7N!-D.MIR[
MG>DWO!&KI\8S[,[MAHOO/(11%IK365O$,8+MDU"=DK3G._"\GR.M O"3M:N[
M%8REKK'$$MM_$GP4UJ(W'$<ICS>#9A()#E87W]8M6LA;QI=+3*T"V>KV49&2
MFI>ZR55J(FQB8G8B^^__W0 Z</,HV9E;G',/LVU\<W*GHC'E,%QE3]TXL3@S
MH0VD52TRB4;@^5EPF+Y?TRT,#B8#NVP8EM:M0.T@";W)=O""7)H6XL/MTD_S
M'J:S]W:0FA*H8^ 5;L492_P9=K'-FJ&-FNXT5+"&\?A_IPDW,-D47W^!L&N=
MD(1&WXY0*&?#I%W<^70(8D#5AJDGIHN]-/*)+#FV/<0J/_]E;=$<:9K7KM]7
M]Q.+<];ORW:50 [<5HA=HER37KFUPA<_*!V>B&FG)+\+[EBHJ"L#TSM9B:K$
MV:7RG\EDAIDI.63KG JG0Z2.(ZTU"/N@S$/>&M=VT,31VBUIK_T8=CA<H/7
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M*:W483A0L2-^G&)3VMS/,OY5F&:5D?RB"VHCJ<K%ONLS)>$/'^9FZ#BZ6A\
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M;PUH;.4HZH82HE<?#,+?O,&@QH?IRX$^C^!K1)L*J,61B!#!TSQS3)W&[+Z
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M5-*X!+U[![Z3UR,F"B1$%;M >6M 4]V4\^1R>;ZW6RR<75"9TZAY^%!^>21
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M:[ LKEM6IFS(?I,-F#SC3T 2T4*[*FR5PE8OBBM*>'M&KJA13&Y.7\ZH=9.
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MUB$;>K5_6X+V9868#I%W@(&&N#DZ.;:+PINUC>Q"YW&&/G PA>) O6?PCG?
M?NQ$8'7,-=T_I4I4?V9V@=STA? 0IGFCMI;2#)GF-8]$^45)FX2DUXMU/QS3
M*TU$>[D4UARKJ"*(!!/\0ZNU)_+^?649O^?6)P6\*TS:%I0$Q6014'M-B6F"
M[P^O6.RMHEN(JK%C?XU,]ZO+S7/8P-I$9_/!%W$I;)_5G5QF.@N#'G!UH;\]
M8)OLD61H]52CO0C<U=S9/<U.W_*Z:FN'33DTCV#==, &H6?]'/<_"2!I.LQ@
MJA3T3S7B<0KWWQ.EXZT8N?N+EN^*^"[< ?1CAI9L5?F]41U0I./*&;J R'@#
M#.IA-CNLPE,.89R?=+39QG>5[;0^.M7\@M%Z*,VGHI0%YS'^7-A8LCNT*ZY+
M.>PQAK5']M8MU40>],K;L,?'-+^BDZU2,:#ENXE_%6]'#9P^#VXE@8MF2U&A
MCMA:*50.Q[$2XU$369IRX0=$6(_L_1VD<PY";6OZC<NL*)&*96:S?[9Y\O?'
M[/5^>WJB!F'!DD1ICRR00!\2Y&>.A5"BXU_Y.>S+63<MS^4DO"]8LUY;C?44
MSF W_\3KV4_OWL<JUAIQQ54*P6;ED^:6E6+0?]S,B]B_%!5]!=.SVW]/P'N@
MVPWDB\JT.&3VIK#Y,W\ER/Q?2;+8EM0B=>%<TD^C[?WD>6RM0[ -@D-JZ#!3
M5)A4B,1 ^7[<//:W_GO%">')XE#0*=8GX [@;_SGRU!&\G5<TL[.AFIHST$3
M$KCC5U6ZC[ARY_!JI(]IB_$HQXC*"2:MD1>ET\B'FGM0U=&@<AL=V\UT(_W/
MAD2KW3A"W1IZH?@:>(<?(TA[A)ZA_6*)5HE[H$9\JEP^F@7R,$@3VO$=O'N<
MD0^[82,#5 \(EZV_49Y:O!0/29F+M<ZX \Q3USX5YMB<PV+[-Z)DDN:R@\X,
MW0*XQ<,"S/N?Z&!+*[*/7[HD)$#9Q73P",(N CE/4D^'6QMV--UZ,M@U;*_+
M:K/$+S1A_L\K+Y8&B8^02;B;0"JM.@CB*.E57>\.E?L=@$>B8&A!\Y?4,")M
MH> WHV5CZ["E79OX'R;*K-;F: \0D[%+U!:S4DIXS4*JS..&6:I&41I^FT?V
MQ&NE,D\'%&X/T&Y^E*H9L;"] BHO^C=%I/F*[$S;L8>-MVH'$CU-&$E'85V,
M:S9D2K]?U5%?5!'))F['+5#[Q]H381<GR:7DO/%M+"8$_622B\Y6!K_E(D$M
M?'K!V&Y;4NB-1A3I ACK#QN5F)TZVB_<@LZJ<S_V\#]H2,_)4@QW#I5:DDRV
M_)!%\4DTGE$HQ:P_G*FHYBT_EI-$;& /I5$8)_.-[KAJVD?N-SG]RC#;;V"T
MN,")#8[_8GK0$,Q,E2U$+K(15$Z616$S*7 NL&>3O;LR8^D>"R,?W(OG\S6P
MC LA7&YD7NX8XF,(_[/?:M,HU\C5ZE,H@*$V@FD["^):VHQW_-5@7*%:'53G
MK*4C%8E%HDEM3#S'S#G>%S0\(J?[P5,YVMN4:5AAOR%D3 27L)&^3 QQ,.2Q
M;)>Z3;X(\X(GQR+2-N:C(S)@SY.P0G5B5=FP=%$^;:&UY068=:<&K-]/D>7:
MQ8GY^('EJ(N?7JPD;P(.5+_U.6['PGIOC'.<:R(Z&J%&93$MTJ6QR:# 0X:4
M-MB9=/_($L&0&O<Y6!4NZN#QV<:W*LVE_ X@+RSAOM<E\=BI2,W%]^7I3!<N
M0[3;XU7S-<6?:G0S5,5R(-B!2-0Y7MA<F.B*:8+WR>!\1MT1#V5@G*&QFR"1
MP,ZK_%XGMS+P<[%.3^F(-M/KF-U%I:T%K"B26HH-4>^JKIMD05(0SU11'[3:
MX%2D?YOMEW8S?J&TZ=LSCKS.4*T1RL\"]; URZEGN'2Q"2L@.5/7)\F,+//O
M #+0<_T;'=;G(SQE*3!8F=2*I]5WW/&.YJ(.2PT:&;U'(XB^7;6WW.KP%[=J
MFDE^C<J HLZ4HG_U>>VOF.H.K!;M!VTKU[C7=!NVUJ?D+9BBKNH)TK&7@I>#
M/OF>SZO3<N#)=P!["V1#]L+1&;\U=:.]_O=C] _?J'7A]4]9]WY%_.HQ0Q\E
MFQ0_[,:ZM!@X?,:6)U*@B7E3]Y*^;=\!*N0+DL\\+=HR7F)>[QRTZ03,M7X2
MMT4VF'0?^<5KK"RC<X(ZXGW27E'V6Z(YO1GB*N,R^KCCW%/L&]$\'I$94\T9
MTFP;HE2$3MT>CI=PW_"<6,CP.8YREL6J&=0YH 0.;<I@^^++ML@)HXDX<5LP
M6ZW6#_<)=6PS EM#6XE6PDJ_KB9UAH0I?2(,/@TXL5E2Q32'S=P!U(W5:)8Y
M6VM]OGO@+.S>-!CS(;8:ONZ',. ;CJG4_DDPX-*Q3QNPZ'\@$;'KZ,VW-QWI
M?CDI 8;5SWO$K;[OV1NANBV:AS42IC5Z]F2=22(-*Y=3."*O^F*P)(RJ\ZW;
M2(97K>]KN[_1Z[69$(_BCG_\Y2:.$CUO4N*=EY')4(_8IKJJYE&A66VV.O4X
M_7#PP[D8VWS%N_A\/7!#PL"1N<G@6.\?1&VT;, 8**RW898\0^:O%U69\]:^
M53MW9?CKR6X[]P BYQ\^<[.,9?#NW)ZQW)TQZ["CJ\OGJWW&PU9KL&(NX@&)
M9=<@ZVTVO>"J%,@=.[$%L[KPSU5?E7ZF38N.P')<EC6_^ F1+-K#/_$0G)?[
MA;W6X>5*7Y!<"SAIJ2) GP/]HWQ&2^J602X*-?9D.+!-AGWG!B>HH,>6A)SH
MHTGA9YKNY8#LK)D#X6)=EX4LGUA/1\>EK.O]LJ7&\#ZD[[W..P!;AP=4/T0X
M%O1WT,RQIN;UTVC?CK,#NA[*QJ)"M/.$P233V;P)C,I%*=?;?6=@=NF4P</A
M .*?88@3KW&\(++'WS%I'P3G42WRH.%I9P<.\WH7.JX(E _+RGYOM$<OK^@X
MUF.+6PCL5\(!NN<0'9*1\/Z*>M)']#+JK'6I#7L9<<ET$#)IXAFS::'0ZLD[
M=X8KW6[V3=L8K^0Q=M0GS0Q0<:M9F.D]4B3FCE"&5>#L!+O7)#\[,'/B3/GP
MYSP^U!E/O,SQE&]H7L"(SP?:@W71B&D.090:5@EA$&#XV^BO\<&5:\HRV<N<
M#3Z3U]C4?0[/WH+U>! YX4[H_@N04O(FE1*QZ;<QRN,=<@SYW(@?Y?%2;/[F
M'6!/#H^A69]P77+DK&$>6WR[/[G1_)7;=7_LN$)U-V(-UQ>6X]9FM&7XE(=]
MFOT9.GB@']5,[+FQ]VU<LOG2QF?$(1 N;[4(:\M_Y<LJFX%4@<U'9S3^P@XP
MCY@.^;YL@WBZD&6J]Z+:U&,4'=:\R#>O1(\=*3/=F!>_:LR"06($N\G_QYJX
MBN_^C&_E/T=_N$7;K4=<QZFQ\TJTB^Y;08I=<#[U;Q(T [<[X^/72H+#P#?
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MW>?5.&2JO-Q7 L7O^7U* O,-^DFNOSVU_5C)"JY]ZN/V*6S 6(.*!I2$T!G
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MWN=4%AKL3WX4/Y&V'A:D);G>YV0!"K5?I8<P+19ALM8JT^\I/OX$1I2L'PT
M=/O0'22C7D,LB7&;C;WZ(;;D#OB ,[7L,:^>8TY@"IV60Q\#<.U'8Q<$.2]%
MP*9,H'B_I%)=<!M+4O05PQUY:GR8B"P@HA-K$PG8>AFN>X>3ZX5E 41: P@+
M64K4@+R\P2+&N?7Q^<9(X$HN,2%'BG-\W5G&&(O5@NFWVP)).C\+5$OTO-KG
ME]^H04V^MA-+%NMG?>LE]DT$7;7%Y134\J2<D7@MP"7\.?F2&&)[+'33K#-%
MO_MTS_I&58)V^82$!Q>M\9CN2F!(3A0!%CIH',A*6OTDK4)8+&;9>;!KHN?[
MEG]2\5E^MM"2&'AP1&\;1F'K*JZ7#.-0^9202YK,_"F9.48VX7WN)^+[IH2<
M_V7"?@_^4)X9S,& >YJ86_XXJZG8:Q8EO:\:#T(]%3]T[>-Q-08.NABL$WY/
MGVE8NZ=6)BR+>YW._UGE>1I ,X>WN+PP(>D\=F&(%ICN:N)V6LE:*DH=T3WC
MXR:2/9/4XE>#<IV]EN/SDEIZX)3)%O42( !]9/5*S<Z@.W,A-JR%UL'(.>=-
M&'%+%<&)\%1!47;.]Q,AQ?=S<Q<4%><!X0%/ZOO<)#^-<+S2O>3.O@'W,@%K
MR6([I @SU'>O'DT^G[SW%)JXR7:L$G0JUD+E%*T_M:M/E S3'JV^CGB3XVA3
M[(5=^>#%OR3_,=YZOC3#0Q&C^^43EM5]*&EO!&XJQ9O/MOM81]1I=:3_6,R#
MU:S[]@\-/]N)E-/!U;:]V;7WQV;1T54@GZ39C'W/VJH'=1Q?2S3Y?A1DU,*&
MIQD)$UX;7^GTD@P)%:$IDM71GUW54P5=G5UQZ787"Z.""B:B'[ 0.3CI!B$\
MW#1V#HK8LWD(0%7F>8/\*\(-HD,O#J#L"/^0V+_PXEF/.ZBM1Y"L]+,C3@*$
M=:UN[9=[JW?Q13;PVWI&G,5"<O_'_TOXU^7K9>5T%8H"EMF+0 GKMUH@Z:@9
M4#^X;)#NF+F>/*) -9*'J:92.*,! ;"/)W)63(42J=K[0I^MDN0=[-PH^D\B
MORW_OD[H:>G=H^2A'9&B<GJ?[E!!97\Q6C/QQ\Y\9\%/TZCKZ8V,H(.HREA-
M4<D:\^G7_.G\28>B4A^^1#^3\R&4^_+'A?8;T-+E_CH/S HEA5%Q]2H_?(9@
MK4#P#>MZUN"Y*O8;12V:J%EXNBR02["SJ7XHAB]ON_(&G';1\/V8.SN)U8./
M125\/@2[Z\3EB9WK1AS-908[ KYFI&%;"UKZN @1-78NE!3NF59LZN>#HBTH
MQZH*S(\; -?0\Z(_8,N%J.MZ)_?NJQ\+ +)6\4^(I3L<F\%E]2[%0;F88LW&
M,!P8N\G.>::YV'6BZ*Q_I,*9I'''5::.N?&E03!*9.2IQT9/?;C26?F58_#L
MV.-3&D7RY:P1Q"%+QP>)F(,Z\8,.3WX:GHT<2_(]K'KDEC -E+9.5?Y)P83[
M4P-EAT@N59X'+.KDLRGZ95^,92G.@WDNBPLN\_ESE 9K._D+')O%#>+2%(H5
M ?10WZ%^,^MCYI7H81^ZIW5Q@KI@2(Q)*3@I?T:?=U?B/D_S/]VR_^%L+"LL
MH.0N]X8Q*IF+Z1TIF.">JZ7E \,]4VH[$/%6C@"$-UK7J':HZB+''W5UAP,)
MG&'!F_HDPY$$@S(% ,0Y'?P_+.=H!^X%?Q FU'8V,F/X31U[>4A[S!QI9/8<
M=X! SXDFM#J&_\GU'4Z*V_LZP?HFM\ &QIF^+]T#A,&L 1>7/Z9:ZV)^E^MN
MI4/;\":&N-:JPBIT^@CI' 1G\M[?+ 3G!==WH(*-3MKU-PE'>8EI\H"^KPL+
M/I,FFDDG)8[$ZX/6R&'RQP8<:8Q_V@[N3Y35F4TM-=B<\(D@3_Q62@4'J+O:
MN'L&L&"><F8X_QNT^KI8Y(KVJI+)#*&:HM\&[4-VX%842=XUX69'VJWSB:WO
MD&]C-O??K9:9^=0T,2/@^+>^7"V^?7"E]-M+RN.K#>P<N71:75^&?VR,S<#+
M9E4DG6"KI$LSG/DX6%A92M/(Z:3KC/&?,L2XU(BW8G56QOX_WF(24#3 909$
MQ"O>!>JP13K9OO,.<\E*7&)<.V/#ONOEIACJ*FTTXWE:G8"V@7$8<;(K,>-N
MS:+^W/P1=6DW=NH$$]WA"&NW?CIA+$F9MC4?E;"SBV<_#4_]ZAXXV /FLH@D
MH=62LW>W)%WM5WG'3'!_HNT<2V]S9;L0T-$8>#0&\J$;^NG58K/'-093:%X"
M&63H;^XYUYILI5Y@VD\\L^@@DR=DA2\GEN9&":ZI2G#S,X;V(#O&J#.9FDMA
MK'<RT@=6U8B6H4-+Y8'(N;OZJ\2(<),1:ZE+8)_>&B#_9?Q/G\#M-[M&3>M\
MW%HI:SP%PWL.W86$59B@<PF%^8./#=Z:S6V](#I:5*^<:SWZ"(3*2#.QM:3,
M=+IFY1%^_<MXMGBK*1/(ZW5&$\2L*N=AH^P JT!,)W&%".XAZ$W-E2N/D!RH
M.DS[>4[(!G5:0/+Q2RQCLF5+0;VA9/[&>/%SQ^Z95A\ZW!><+9*A;$@2]'X:
M46AV**?<6X\XO4,]+/J&[<JC\=#E#*T;..P*;UPXT[7A.G\YX0%:'<GO!4TX
M-CP&)#@W5B0-V.P=G&X"HQVB5G'D3N@CB+1HO*OO<(QN._WO<)HM)<QK KLL
M*>?<$H6SB=8WKTSCK #Q( ^JRY=&)\9E:AC^\O=3#O'$M/VUC_*)TF(;?^KH
M9==,YSY>/'PR:S[%5)V)D;##&'I=\*!=1*,)G-&/IN*P=#N;*4I(T3L<,9 _
M:\_99Z(Q5Y]\ES=)T+5;VV[9W][4$%SUQC VPJ:#XN9*C$3OXE70R5E'JY'T
M&2BKU^JL>_U"8>$%"FEF*4"EUAK\"B'Y9:[5D#F"W(FH#=34&RE69.[@9,_8
M38:[85BPR;LS@D(L>6,DZC0.D*J-7]^CT+&KV X/BI'YEG7D' (JHU\DWYI!
MARQRP0UOD4HE'P[<@HV",F"=ZVNFFH,^>4D,1/U#=S@E%!-3#Q?1BK[\TG^$
M%\KI)9K,N%-SZU>OX(FV4#LN 70#QH5]<=\.M]4E0,U+: 3*]*0\6L*@SUIP
M#=2O@S)2HHL\F\,0N[:M@(3B EIL,%\5?;W*&/WT5(, 7]3!%_OHGY?O5ZS;
M +8U!.<QU@8_KVS5$1M4S!<[D(>].N0);P]+_\MJ(!6Q.8]?SW_\88JVGO-]
M5A-].COQBIJ_XMFZ&@#*W#CL<_!="2JRJ;,-4J>/EQTD"-& <<AX-5N%N;_G
M5Y_Y=2CT&D.VL-;G23LNBW9V7T#,J_H2B40O+&4)L+6: ATBCI7!22D_B[CL
M#/;3M./= 6.-9BH9 !@'^Q,'JIO#_-_ #.<Q[^:-(ZISP^,['&K>(REMLP<V
MI4?9Z6Y R($?MZ@^6 A*T[UO/&QD&+&@D#!$3O/E>44,_T=V5,Z%X9.L4=TV
M?CH(#YG@O%E5X)@8$:/*@\!LE3*Y=-&#4N8G4D>-34"HBU&[D%^RJ\,7D+)#
M!ORZ"1KDSG\/2EB\5F2M^YICB;""5CY9%$8AF:#!JY"7J=$9V00%0#*X.[W:
M#,J319Q*-P"5O(NVU*&<-C?W3[RWE#M,\^3YN1V<\US:7-.3X.O</42%<ZPJ
M.V7X;=JC7@GDNW6600M.WI1 29=WR#?PM =?=%C">FTW4\MKR&?<XT[X%M)#
MN>#3==.Y)*O-!GGP=A'A/T="W@)QC>=9DZE[9R\-U?)'3R=:%YEB!7R0ZG%^
M,21#/CV\)!5S+QR%F6)1+QY"C=)-P6'9[ %TZ3I3<B3%N7]0-2T+LSZ8HK[F
M^3VW#\IICV88_7T?("YZ5_/ZMA;+#0 ]JSLDDNL+K\31-CRRKVIRM9UATB:5
M_'BH&P1JI&;P3<M[.52VG%<7<V?$I4V,3.:ZH82 B*H_.Z&56"]C<(MJ]/C>
M+8!D73BEDKO/38I*63,%=G[U#B[L;.=WWN'F;KJYT+*Y<I#"'8_FNRY:/,UY
MT[S:>+,&YFHDIZ3:\FWJ3697:F3<S]3\S&':_/3[;FX+;>>@?FF[A']-7[-C
MXZ^A]QGI(-@"><D<K:ZZ&U]IQJ'%*3%&*CW,MMI;L58D.B'_5+[1)1NUM"]B
MP+-]@I87.SYZ1S1DAQS3I:5_$X[EHD@A7WM.I:QZ?T]BC-/V*TPJJ8 K@(E5
MV8]317IWJA5*\?V4&(3DQ,>@^8<:J7V#8A(LH6?DI\T;M$W/YV:'RN(X:.8%
MC&.D4>#/+##!:P="X2L>9IC# \.9VM6!"*:>9-'UZ +-CX_%2_YW$+VJ-*?J
MU7,Q,F?Z=<7^/<B*=JSKZ(K00J-7[)IUY4K!DL^HQR/G>NRPE!VX*[6V$-.Q
MK"9L0-9H8(#UVNK$?)2J#.<5?A(>(@"I ?J1KU../!/Z693]OJ(Y@DKGFRU8
M9R)-%&X_]M#;''EPOE][ VE=I':56GS2=T7;N7X -U33.7&&J,AYQ73U&A3'
M.Z9^JTR2UM]@JWIO#>$&L6)-*486O*(D-*J,?YIPE1FSW$)\>4^X_0N94HQ^
M#Y1+!+\HRN@6!GCU0S]9UR"\!0,=>#XL#&]E=\$&#94>OQS1F<SY%$'#\$IR
M=GH'K, V@?^H?:=YWC.V VG,SV;3.]<BVF:8KVJNXF>P?<!F-4+5++1HO?2F
M?5OXF#E5A,ON=;.)FAV5>B\I\\8OZJ\GIH1#MJ>VUS^V1RZ='G8(33](P%62
MY-S)&&-0J00\W8-^ZN^X*IF[P[$^476XCEOT)IKR3D._GP)MRM1?$$U;EH9]
M10KSVZAW>40G'\N7]0R:C@^EH(%1S*XY\1Q.$=$/GU ]R&41-XRF3_BS:D8O
MO*#8,&CN&;1:$"=IR+%17+Y5W28K4?R#5QA5M'UPT(0V6V-XX=QL 1T6VN$C
M2$)JQYDQBY(P"R^OZ(X,:ZH$'2M+Z6>,L9\&IBP!8%QB5@\-7YYX:)N6%F91
M/#G33U]+YTR;*%@8?BS1=RZ WWNR;WK.;.1>IDL!\,M^ZZ+*[L-.W)4RJ5??
M(/R@:+9K1R4IJ7DQA)E0<XZ)A66X?+1415O'0$Q+/$%2P4%59RH$XD[3EOV'
MRJID9SH()T 16^'U2!Q:@A-']0V@1?6BF![DV%2Z <LBT:RFG[?/#A-XQK5W
M2BM*'!SFBJ,-')OJK.^Q%!2\K!3-KQ":DAOZ[9&G#H5,,U^]A;_/G[R\D2ZM
M?.CV)D<G@E")5CQ&,GA&CB"W!/&IDO707I-?B.J%ZAMB)FRY$+ [D,-068E5
M%C*50RNZLS98,H=62&K\UEXAZ_F3&*GAYZ-M-)] LZW3%'NL\E%)G![5%7\^
M6Z<?32A86 ('"JX4M9[.+:P8#2ML7%Q+#\[',N..TU=%[ J5%SS>F)GY'O(-
MLGNT*2G50,J?GF87?ZX%<Y_[6"8TWZ>GQVYA\HTH3/GL*BZ":O!!9!;)VW6<
MJ16-^Q\%*PA^)C/G/,-C]O^]85+N6&/32PWVRWIWQ"[N-*8.>6"@-%V:4Y@J
M"U!2@4Q%K@TG%K]0)7L!-5H7.LZ3LM(ZGCK V4[,DXP0CUU+JAQKK ]C>$CX
MCDZ&>,ZD4O$>FY+2CM(XCB<]P>QS!>G%=\J&SSP9[GENC.;5I[6J?9RL)WRK
MQ=3M2#RG<$2U__<-&I$XA &/<HJ:A;!IW^OAC V>GLFTCUH]:1I6OE_H_>+0
M^#( LN@^944K5E]$O03^HCLYTP9.=D=<9W]Z!#,Y6<?9NG(<"83-5U&H-."0
M?AR*GUL>2E:%O"^RV=,!V9M\:V"$L=/T9GK.O:MZ43RC;RK1HU$V@@&O3-;,
M;:)8$$0AQ,U045H<&M7T *=U+XW2Z-!X[EG5ZOZ#^-NOJ_L_V'&O34Q"9"(U
M!#SK26&2P7M.QDR[E3?:P>]D3FZ&-UIO)P/O<#Q$\OZA/G%=("TAH0DTNYU-
MCG(*%X?\I%JF#J PXOWDPF)344?1([I7D1-%GB;B.51C=O&/9->EUX)7X/5Y
MM3 (A#0!1I*T'3_UW6-N86V*QVC$O<!.B$7>767C1?Q_JC_^6_.3_QDAB*2<
MZ_];"I?XCP.@;HUX G'HWG%W9RC\0X0XP-EILM#I7%GS%6DV\YPUE'V"127S
M4U/J_[SSR;]QS).\(]K5/\PO7WI_2)M*WAB?NTPL%[V/ -I,(LQ-DA++W \5
M."SR1K@B#,\U4S1IZO(W#*T'IA0\QF*R.ET L*P%/CR6;@'VE=='0O5A0<96
M484\&V*F)DP5A&S"X\P/VU>?=Y6V_HI.*O%0J?QR+CWG_-D&@=H_Z]^.=&GH
MC'']2-86T/AKI?;+T8*F-@<C(N.^CK(X>,ULNJ0DMC?0_I_$C3XB9U>X]V%B
M.UK\ N7X=-.T^>><7<[SZ2FG1H" >G_OLM4HCV@:;]V]L>>.#$PPHCP62?'D
M5;2#C/;0ZZ^_@__8UBJHS"]M'M'!DHS.S9_U3WZ:)X09&S"<UCBJMEE7.+YT
METV<O/?VL>[TVQT$)-IT<PVB=B,P5[C-]H18O) T=*<OMOA,^U4"G%FL+-!Q
M99B^2M.N_6M?GF %YYPFD>>;SZ4Z.H(K\"D3G,FDPBR?;<_9D)9_$)_-N-(#
M'Z>JWNI"@#-);L!C$OMRIYIDD[>YI(\!6-LQT/N3>>A7["S:0B+>0LM<H4ZP
MMT*,U&?(7*.6X=:.7"[ETH&=0&Z8':E5&,;R-D2^$6ZJ)Y@U1H=<&^>MYQX2
MJ 2H^X\)$]PP-R*8C+?N<*0_5+2>E0&JUBB=$[]]@WJR.7*?41,6)L&JQ<5%
MAUSQ3>#?CHJM>D&_?A,> EQTQ;T6VI!71]96(UX21HBWLRS02DX3LA9.FE'"
M_.FTAVUZ*8R8XN;V[*2'7#".%6Z$@J- 1A^+5;_4XGS,[OP5O.Z0:-J%:&'T
M9-A .WW5NSQ(<NZ3P=9->18XO)NZ3!7T4,E=H!)1?Z^P)%:HIU?[(E%><&;4
MO"YKPUL?M;B&K -<-;_D1KS.UA!Q&71YX38IVSQ9_"NC"TKS7F<<LL/3::RD
M$S+._A9MQW;-G9)A(*6YZ+I+?RB"]YS1)8BS'C7E:H\\2=R:+_I@[)D;G]_E
M+2D.=-9A=P.S'K-L^^*(&NHWIK=1 O=/J>W_PI.]!LF2]Y&M$OHM$C*> <)F
M4#MRT%BWQ:ZLZ4GE.&W/,50<?T9:/S)06:5A1XK][[W1S?8PH>[?8XY2ZOYX
M2\F*=H^P4,=XMQ2JY^4+L(.1NK8!W]5[EG+U+I+.!@&7'Q5ET5X8@Y#XTO<-
M$]:]^Q/ B0#U920:=.ZCC36 CV.]=F(B\C61@Y;.[.HD;[TD2X; $2CFY]/)
MSSO+I_CK_Q.5X3$/TT>RD)-S=V%_Y /L7A\3YF.4>BOZ#D>@_4.,+&3VN?1F
MO1JX:C/EI==<1'>Z&4^*;2&\4)R --3389'2H]PSU(FL[P)\2I=J/32 [86#
M;VG45R(^K?W:KZDI,;"+CZTC>ZI0<VOA#[6[?/0L_-O<QC$/<1>4DM&!N3'B
M7I(.C*2"T+?LT64&$-.L=W*B?R("/SYH#,*-^3[@[-6B'CO@W/QFL39#WC?Z
MXP-%;0B>NS6N4,E9H;0U.X')L[YT4I+\O-P*D#)<Q*#<R=T3A+B@Z2#M$;:B
MJU/PHHT [3/>X?PL51--/6@P?)1DIDNHG-)I[+X^5<YV,V>P"M0D(?3U4.7L
MGW1WFAVE9(D?V5V !_;,^\M\A@)F$I7:%HY%3$"HBA9'ZOI\CK6*0+6!_@*Q
M1PJU@A%OM>]P;+F'P01[;FSD,V99]<A*XH18F<VK]B3Q%5]TX*)NZ]((4M3X
M!Y_K\8&V86BTO/5::;@Y]TL\ B6B@-E$:6=)<N;'=SBQ]'LGP9$SYO30G.X@
MWG-.^&:.B,#612Q(2^G_Q)="NJTC ]@7MF><+)A8M/ A&>:ZQ>4.YS?G@' 5
MH_X?[F6Q[P=@&ZE$DU_4L"C9S(^97;$O^*EHP]S5IM^[<VK/L&PJW>\G6@Z&
MF]=*#?%QMZ"B7>Q<1) )R\-CC2BRYI=/B+@9?-76C>294L4+6THXO:ECQ]]'
M<5*5,!.#S@!-HYBKKPVOCVHDYA#^%2_Z2:P%0C?) 9C9Q87M&9$64@?'MOE"
MUA%-75VKZEV_J5)%K6FBDW^&?YTIE0(4.>F(_>,?-6AJ@EF,&6OWTF\X"VMO
MJ(M>I>86ECF)KID'ST7)9/)OZ7KLT4KQR# P/RB'R6#,7P=T?"Z^!#@E4E6J
M7:RE:"*,+8NK\GF>FT[(# :CD9DBIE9C+==B&49>33;(4!^VGTDU.[?P\L3
M$^E8 .0.A^(PV*^CN)EG=)&^<\ENUYR\J-KF7ZHPY,XOLC\YZJARH[WNZ_N5
MAW3.H_A'@AT^)Q(5^1CRA6C4NGG=<.^12Y?7%67(8!&PEFN,*06#Z %]?$C?
MG;J7:)U[:25;>P]W5P=R02SM6PS:X.79VO4M?KFAY4@SNUD0,'9=K3QJ.@BU
MOS(?U&0X;+?T'7,:/YO?DFH9H( F.PT,0[F"QQ+4K<*6!<M47@<-MXE(\-5Z
M"2U6/JQ7MN7*ZFU6U "W-4G8I)&X!\X/6"DF)C9O]!06GSRQE2[,GW)QVYFY
M]T15Z\1@-?E6Q'=J&)4C[/M91G^$7?5)HM%4Y3?UB>9;A^91\\W$%;G;Y%OC
M2WJ;XSN<06ISWH,\/"Q3+/_P:C*=(6EALLQKP13)X/50'X1K5J#6U:]_33CZ
M3/K=[W<XBRS>U'<XQ?>1P3>F%PJX:'_V'=:=&0RRB,(YE6?G+ )U92C5OS]F
M.2?BR:=>\)W/%%V](48W:!G;D6.%BK'N6[%Y4_>(IS8(HJ//TCT<R,(_?J4*
M;OAXZ7L "#SGA007>D^CG 7VT]]#+ ]<?:CF#V##!FL)!4J+9R*/$=>+$[%=
MV4B;R.JCO7: F%M(8+="_7 $676*D5,)<6 ;;1NSQ!,,KU+V@NTY/JIRX?Q)
MAC<O:G/95B*K"57U]>V@M]A0X-S+".H'W6#:SLS%$]KVWK,,/-MEF[X"HR)4
MO(LC<?:X&C0'\EUR?>S*<9'H#J<#/B'U^1PW9G%BP;6(U_8EX1T.4F,^*9AC
M,3.+[XW9,B_?T2;8%DK",CJ;$7M87_;5MFN@R:0Z]1?+9;4Q..31'4ZPEDAA
MQ >*#K7;5>38PX-#:W_W)9=YK]WW>P=F.\Y+N!$'A#-P'V#_5.+'I>105$U_
MDQ"4*VIM=IOO]>.OG$F]UO)X@>)<Q(QMQOQ/S+V7)T\6*0);#A#S=-J8T]Y'
MG:"#OD:UZ >]+*[R*"*)1K%15@\ =>2KP:^5RW9HUGVL^>O.:)94$AMTEJ>@
M7/HW&7W:BK.F13M'J7R+MI&S.YR%/N?Y1^<+5T)UZ[4>4O7S,0W?D?<%OV7!
MZC;..0GW!#MK)&Q-/:*AYA5/>1S)&'M4 EAZPAJ3TN\?#6T+11\^VG4>O?".
M]OFMT2=EXOTY^/S*;0/+ZXGJ0A_:SO:@#J7(,QKV'M:#O-U<1UM7*830[A25
M4.I/C'U!6,Q,DF]T>+<> ['U#;D__>%8 [$>]@CILC5/BNV4DFHI7$SA?2/,
MG;W>XH6YMG,]7Z9H^AEG3-<'DE#.P%3R50A,R0CHO1PV7OG>T-F<S^ I1"Z@
M>M\HN#CG#L?4ZL_GX-]W.-Y/[G!*]SQ*B-"W"=@!"?GAMC<VKB[>J* 1+-V>
MB]<OEU&FM"WJZ!"KM%/LQA<K]P/A(0,FRNOVAQLMTCSA) ;7>,IQY("MD4"B
MQGLA%#+%+U[6.=N5:E;=X3C[6U%<VED)7S4]=?>ZCP23Y\6M<"N@1V[J?B#6
MM'1TZ5"N$7&50DV,[#Q-!"A"HL85"PZ&H+Z2_R=9T$*E\<>GB*PL'LG73/41
MV8E\9P6*H :X P%@C)NP\"%3)#-N285V4M:K#-M"5/Y,3C9F'G.-=*OE7 (D
MFK.T$%EFQ=T;H0JXF'">H%6^].%CE/OVQ05)"]4*NXS<]8>I&I3J1-X +*;^
M[J&MC'@]@Y&(V8JS[(51(]LCRW,K"HWSI1L9[1F"-L4H!E/LY):*?N4^O(9!
MC)Q#3_>5+! ,:J-]NSME(AF2GY#&342%HSD@]7SK32WU=)DD*^_+.HJ4 X]U
M1*0R%!<$>!GX,R4]>Z_=GL^O?96T&@_,R,[.S/QUG/H^<NY:YY3-B%*7=[&<
MW+Z.LMH4\$"I$<BL;#IZZ(9HSTEJ5K518[K8X!7:5-(-229/$=5@/*=19>LZ
M."\K<H#T6&?<3P&"RC)F,\0!,70J(\>+\'_:&XU!*85?D@Q5]#YMWMO^P.C
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M=77Q#@=8-A3CU51_19H=\<.7?GUNF#B-UIQ\KG#?^QEJ,UV51\U#N?@.QYO
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M U2^-Z(R6"XX+-N"!;NA9C+^,!U*=UI+E;B>&3.)MWIEH#TFUTS.]EXG .7
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MYA1CF&7PB_. ?.7=F>^75#*"FA+N\(^C\:A H#"AZ)+%$G1!S6:8+-FYZ!^
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MXMD[F>?MES/4M;#-L>)+_EO%!=U>BIC)'*\T4#NC'I4N33ML621[S!1@$AP
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MIH2C*!RV4R59JX(:]\M*V5 3L-S2'DH'4^ +"7&&6,"32KVX[#.#74\;M*^
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MCM&DU8TFC-/$UX%0&CH64MSZM/,3V1ZJFTFQ\GH0&$:E5=ME&4R+LJI%+8'
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M'IFPWEBB0,-"D(;1<*CV^OK@;#[^*NI Y/DH?'^S=2^>)^"$=%'I<TL&U3T
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M.4!_)D.KG<>CJ[6VM0;54(>;@DA^%?24M$.\6<*^NR:_UV:4X67\@+[6_/8
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M+I>]6K+=+UCWF;J?@V&]"IYE6I@Y3]XI9Q/^*B[V9<LG<BC??J01)=  JZ_
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M]V201A76<[(E?Q]-O2"S5@N!88!BU*BC4^V&56BLL3]G UPP549!)A9 !35
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M435?;+LET/6'/7&#V.4,!AD:^8UQXX\WXON40_R\8?^+MK>,BNO;TGXK(81
M @0(D* A0)!" @&"$R!XL,(]6* *"G<-'JP@N!.D\()@A;N[%%ZXN[OE_G/.
MZ=OG[7'&O=W]=G_=8X\UUA[[P_JMYYGSF:=).+@_6;9_1A(?7%Q.I!*'^;30
M_G7S"G86-IWGG__^&R!%?0Y^0MONR%-2S_V:+,_#8C2 .?Q+_<\JH=7H_"V3
M]"_WA(_]MI<,C-OSR9[<8N5<DC=Z$04)JXSJ=]ANR(I.YO97M!DHU.(Z3#26
M5*L.<-\[GY<OE3.;1/T&O.>#VO(1$EM.S2(,)?Z>Q@]4(\(>KC22V3@L^BI
M5$37GF@3^H!)-2!2HT3L.7^*>A)$S 6 51$)+/JRD<E, -T$$?>R');$:VU+
M$?-4G!9A- /EI9DFIQ1B8NB?QBV/#^7KPB3^)S';/T\KXBW1>\+( TU&!KCT
M:T:,G*P0U2?\[D#5-:R?Z[9NKYZ]FW4:17WQS]4W \DLRPC33:CUJID@YXL:
M@5JEI5Q_&]=)S;F$V341GS@BB_T$A(VAA$TCP_S:Y0@1%C62C$UOMU9+_J/'
M=N[A6-JW;Z+#$&RZ<,ELG][*VB"Z^:#Q_'?_HA8[LX8N0(6'#O77OE_L&O6'
MY;:J^O)'YPVG/L":/O.3EHL[YV2+IR%\,ZUEV\H][/_-<:,_C<RN&*:FC2U;
M2[LY%OG/QR!^?PG"("\;X;N?6RZ/:&?H<Z/JL6*CF<TY$:T0G%F=RWP:>BZ
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M>K@7=#T-096.*C^@VUP*1S6JAYSU9'LMK%*SK>X(68!1-"03NJ6@?5_'Y-^
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MT>@82G#PGFZJV,Z2@([5\M1DY'6W6_,-B%S'2LJV+M*2&!.0,Y8-5&62$6Z
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M)K9?[?TZM&6FS<9\J ARM<A?E5E1:U<>&Q+L@)1"V@P:#J@;4YX)VRWSJKO
MT@^(NMK:TBI96!4%&Q1U;INJ9FFY[?L(>)JJA>(']PFIQ'#>M/I%-ICHQ@KF
M/J_.QS.(C%I^&#N:F<JEK'0GLD:U3F[-O[3AH-)%OVN;/OUX:,-@3DJA9TQ8
M:3^-7B/(/L0)P1=S6.!D$<M<,!\'+<GXNXL^\QL@7_O'7#\Y^XL/BRJYW5G_
M9KS7*Z+.)K?(/2Q(N*K3OUN?U-\$L3V9>%:VD^]\X.XU<SF?6[T6&B)LD;$[
MNYH]4=2\!S2*GJNR/W?'7$=?%??M1A^5AX_I#-#O2-S0BLTID%>-QOQ"TK]=
M$H*+\/!'Y<SYD:E8;&E*>+_T6A(V9$M$+4AL73$U=,\ZN.6KS,>E7]@ZE#R+
MCGA9?B=S%^7Q(SZQOKD>-7&^KT=N3<R3W3 M5MGU./WN7GH\IV'W92Z"D_D>
M'LJ:SZ0H+?UQ2UIQ#EMZD1! ]LAG:<F@E>W,660Z1$7":$=:#OS@CQZO3W?W
MM5*SP%QC" QD @*.EJ[O8HI]8R4495$99'Y=V[2!Z66E22'T3SZ.,&&@EQ4I
M7=.XI8GM5* . 8[$!,7!@*VE+A#?ELI78P>VBFTJ&9 C*D1::?AX58J@>P()
M\9#[+ON<2XPPK63_&SY&R;<5[2*0G ]$I?NK0(#VD>PI1N)-4#R;JMR\:(.\
M=@-_D!5># 0_;DA)L&5KF,K$7,QB=VK.Z+,7AO<[<L%\3<F7-Y@XXM7C*525
MIU>FSV=$ES+H'S'HDZ7*+!D\2*<S3@+_!KR_40SOX\JE^PU(3.T<?0KEFM90
M%C<7U;@( 1&J=:FTAQP*Z2G2LO^KHDRZDTOU]W_+.OP'YT&D@6KD#__C$$^:
M?O<='"<VU4AUA"9A$4MUFAA\-MZNLK3&/T"%F>=MFB-;RU2J(5T0_Z]B]5]E
M>S)8@[5GM]&I9/=TCEMW@QDE;7K<Q0G%JEYTMORG5'YQTP_;.=6*0UQ-R7X#
MG.& 'V>.?OH>3:1Y2]'+PAUB-8_^OJA1Z=2DD2,=]2MT:'=4-CW3IG@ )3\A
M'.# H.=:V%I+K^J@K%I"M*^:\.] MA+/5I)DH%[K4#52<N$F6>NIYS:I.;5#
M3K*"R=0IQKU]0I23]@BHYX7@FJA$ZY#MVFTO%MO2,2<J_T.F),I_74X/@0:1
M1+0#AF^XE1[=/IBHE?(IU,CO(GXMA1.YT@-FA576+K<^C^3+MU#&QC[?MD
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MWEG^"PO'UX#CDFM T03K>L4,E\LCL5\-RJ_\71_- /L62'OK+9Q,A'&^&?B
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MG=5$:+;DR,,6E KVAS'7=G_P@\I&J*'-;+0B@U&XK_),I'^4A<<0%"G%VNB
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MS*WQO, !=FA''^H;,J;"T_4/?I. I:]>7#-,7/QC!>);=MV.5Q^QDM7[G3M
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M^IE!45MV/];;3EM_=3DH=![N%"-@@P/KT1U-.@=9.1%C_%WAL A>\0?WH/G
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MU/BEB5!YH:9#/A[G(K2&_EC!?)O*H@$;-\TR@<O4M@[ZCLS.>&!&+KM/4Q]
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M)2XQ\(7:RJF+-'ACOL&T*BVMB&^#6=@UC.*!>Z]AE-[>:RX-EIEH[7NZ7W0
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M>P*?#CK#OE;.T1.SL^!RGE;NC5:KI%'=FE:FA7VU2E3N<B_531N=U"BR?ME
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MS*"EO!EX,:C_9X(C89!T HHA(0G5\,7XJLXHGF3T:?/K!S;&9X\)BK2Z$QP
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M?6 YD$"XP8#2MGS/-<+.='#+K_^(6R"<NL.FV59.["C5)CWL_8*Q:G3H ('
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M0"D\L[&1U)1K;!3XIQ=>T4Y?N8'E<JY'Y"PQ92]KW3(IM5*)YDF9Y$&DHJ6
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M:&6@Q.J@\8_[$\S^S7,UZI^#BRV!#,6OMP 853>U2$A2C-+@?9C0QVX$ WU
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M[&J\C-R891%N%QG2LW 8WG=<0"4KT''SH1M=5CZMG:Y+%=+8#0=NQE]2P7]
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MOQOBG<I8^-QKYJPW@3>4@9>.C%K.QFN$(HD-O ,I'6L:DIBW$QR<2=P3M<I
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MZ;TS=FLZ:5DN7'/-%)GJTL3L+SBKS'I<IC?O+CC9O^A[,1O%-3-S&SK/V*/
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MFB.M5&L-&TE0:11;5Z_Y&R -# Z8TBM]5[XAU5$53BMN;3?6O#!'M,UC9"9
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M-W/FW)FY=6:NS-Q_Z\>NVE5O[=KOL]9ZQ.<..\U/^!&4W<M!,4GU(7$0E0V
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MZ,3%US'K)*B-[@O/=^9=/SCY"Z%.%>X2L=G$BTB@"=LDKPU^EF@68:9Z+9_
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M@/<U<4R6-VTMWCO.YIM^Z9[@^J(R*/:O0CQ8&OE2-RSH01TH[3-^_MXH\5N
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MH5'+UQF16&PV)Q'K'@8W/7'5-@V+'ZQG-G6A=8N0,,8GHS6=V?0]GMV+T!=
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MD4T6WJ N#ES[<N.A_J7L*B;:7Z7RX#O/E^$JG^H]C<T%5B#S@V([V\+!#E9
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M+Z(F%[]U/&"").2-+(:RS8R]ZH ":[;U,J=%8F _]ZK]6%><(45GZR9>@3>
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M\<KIF.3 O16XG5&N]*QR1S-[H /Y?LA"& JAQYQ!#++#8[X+7(L-1XVVZ-\
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M/'Q4V85B'E=ON,67V!^*FR$L^YL2;8=3JZ$![M>$WT8E"$]+WU(WFS0N9=P
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M!Y=&4\XF$R0-\_JR)'1#<X[B/G:-FXA@:P]YV1R?*UV->]O08A-0OU:'-Q$
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M-CA8(&APAP0G0 CNE@0/$-Q=AX'@;@$"!!@&"Q \P9V@@[L3W >'X#:##C#
MYOUJI?;_OZW]=T_UJ;IUN^^M?OIVGWZ>ON=I\6D#\$)%05D!@(:&AM&!T0$
M/"T#W@,PT-'_4_X9YK^"A8.%A8F)A8N-_0P''Q<?'P\7#X^ D.0% 2$Q(1[>
M"XH7Q*1DY.3D^$245!1D5"1DY&3_>0D:QK]G,+&>8V$])R/ (R#[_VQ/70!B
M', 6NBD&&A, G1@-@QCMJ0_ " "@8:']EP'^=T-#_]?'9]@XSW'Q_C5H> %
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M?EY(+>^J*3?ZF]D!'^WXNZ8\@.S_K^N#>ZM]X8^3E RD+L1 =MDHY5CC\R=
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M3-F'KZTA\G#@[)ENQMO#6@ 9'_;<._"_06\('M2KG6,F,323\V&\^?E=]('
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M*(.6L(G-W!B6YOCQKP=0XA^=>[\<EMX%LX0B%[(7>ZZOA1$JRP5*<X9U60D
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M0Y[R"V_"8RJ1C7*3ZN="=<T'VN/[RM*>"UN!8B5OG1*ZMJ=KEKSW8N[*^Y\
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MX3<<&7T]3B])_B?UT@O'?"87!UUEL!BYJ=)OY:$J[CQ6CO2.MEP)Z'3D\",
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M5W7YKJO4$[7:PE'>B?/?UAX!A,/K]OZJ1V)I"_#M; ^GEXTP4-3QV484H @
MX+8W+H#(VCG:)";&\OU'G,[R3;!K.F^*6%N6>+JZ?T>)ZK3#N_WG2AHBXT?V
M8.6^WE_MSVJ/@-:F?YM)<H9V_-B5:I\)4/@0#VF1Q%WGC:G5:$2\H(V_#_H.
MSN-*CT"!&I!<XW:T/&!XN&BV/)1]FC/G%/ ,P&DW=V.7X [:[/H'-7_8<R"
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MQ-<V.= @N:V*M45]3_6Y[0*SD#UY*B+W?VCZ]O]K:OS_FW ?Y_\+4$L#!!0
M   ( ,R#6E*])]S4<R@  *@O   5    ;7)N82TR,#(P,3(S,5]G,S$N:G!G
M[7IG5)/=MNY+D]Y[[T6J @&I$140$2E*%Z(@ D9 >H!  .F]J"@*"-)["S7T
M+B!*+U(2$)%F@@BA)9?OW%/VWN>[>^]S[OESQ[AKO'.,C,PW,W.N]<QGS56(
ML\05@.F6GH$>0$)"0M9.U@X Q 7@.D!&2OK'<][(SQ\**@H*<G(*&DK*"U1T
M-'1TM#2TM/0,+$ST#,P,M+1,'$S,K&SL[.QTC)Q<'&Q<+&SL;'\8(2$[_PTY
M!34%!34;/2T]VW^Y$3L!9BK@%XDT&8D(0,I,0L9,0NP%! & A(+D7QKPKXV$
M]-S'"Y14U#2TYR\@F0!2$C(R4G*R/[P^UP:?ZP%R9@H6X<LZ%UA-'U**>+(I
MAJ7F4HE>J^EB-_N"%5-R\ JGIN'@Y.+F$9>0E+HHK0Q24;VBIG[]AJZ>_DV#
M6W?OF5M86EG;.#YR>NSLXOK$V\?7SQ\6$/@\(C(J.B8V+BW]Q<M7&:_?9.9]
MR"\H+"HN*:VMJT<V-#8UMW3W]/;U#PP.?1R?F)R:GIF=FT=C5M>^K7_?^+&)
MV_NU__O@$']T_$=<)  9R;^U/XV+^3PN4G)R,G+*/^(B(?7_XP5F<@KARQ=8
M=$PI'WJRBBB&4;%=2\VMZ:(653+#LCMX?:'A$%-&B^/^".U?(OOG @O_;T7V
M[X']1USS !T9R?G@D3$#8.#L;EZ<%-GW8,?^I4N-9_G:8C"/.SARD4\SG2K'
ME2_=RM6O.SH'B1U>/DKZ(;"2TW+-T$/(?:# $<Z,8^S]>0&NA;/(\41G(0;L
MM<:1,>^;ZF8TS3UD6:^+48N,0OW7]-KMIRF'77K"!R0+@BD#5@3IGO"\RBU>
MA'D8-$^":.\Z!OB"$HSE1IL_/4S]^&UU[30_=>Q61YZ+NG.4SVS]F>"=^O%R
M$:ZDZ7Z**#&N 9KW))W\K2:4HP3JLZ)V^=.K#5-%7T)(Q'L#[4M\/WS-P!64
MNC4WI@Q()WY.".W<NZ)5]H$(1';A9@B)NX*G\K)$ #]E>")"! 8[< J$CPHQ
M1&"_>6MQ@ZR3"*"?P7V)P(>@:") &P\F@/1/Y1F3.O8]GIVK/)V)0'_9LM1[
M1K+_9$\0VZ2M3@2^M/6<J_IRB !/%3PO5).1P$DY #E6;4)@F^J(P.H]1/<*
M?HL(Z!V>:S@0IT_:]N( +!A_7Y ?L;&$)@+=F#$BD&AZ_N_/5ZO.>+^>JZR)
M *[T\*/4_W?O_T7WCGZ:X!=Q/8;5S:BFLQP1*SF,:_[#U2"E2!.#*WMM%#[V
MP%EN=-(I);J#I2AZ:124I;)@RK&^K19CQ#)4Y]?USKW_F5+2RPW"%2*0*M,K
M>,#8=.Z(&T2&, ;9NQK"@YBM*T3\D/4A^;U_>&F^]$W!S><J4_)=7L8/LW\+
M"8<*K?$<_3K(_[)_YMW;#H2=0IQ7[/RXY2OWV[PM)BJJGKY/$R539344&!KL
M[\[_!E_1N=#FB-:+=D8G1[7SC,N"&G!R68D)%KC-GR+-K31-OQ0[Y*GY*%;H
M2#K?,]3&G7<6U5DJ8@V"SR "3IR]B./[OW=_HP5K%4[CB0 +$=C.PR<3 </L
MMJ50&JF\?UX^->$NO'4MMW6]:]\C\.%9 ;KA\=&B7@ 9@10A_:5*"V<9XU.A
M@"F*>K5WO#2U6M>R]/A9KNK3N308]_SL6 $0R,[>!7N+&8N4VP_6N_(;-)G/
ML4NG[JU4\S&UIXB6<*"G/LW8W1%K4;82K'W1Y\QO%_9<K&[ &33>NI9V/30X
MT._';4;;/-23$XQXP6$_F+ZS(;.M]K7-A23THU"E9F&NWME!014#?B(P5^64
M3Z++]C9J^Y'S>.AEN"<1$+&, 6\+GG_(FV^W/,ON6 L]528"-<ZWB<"XU=9F
M,A]B\"6&\83R*V*CH>HE$7"N.A("TX.WK2? ^Z_4@<T.MRR0+[U,]R@XVF?1
M;%K-F=)L4I-J24XE:<EB=GK.B@OUE6_X.:%<@2(RR+*;UUJVG0OO0.T#13"B
M_)C)"FWF>6]6X-%FI 81CCE2:7<UO#SM#4_L8,AV 7UT%<<</L/XLV^BN/QH
M>6!?XN]OY>W/XDAO6(P+!72E6H!2M.$#G5RR6K8K4ZA7"!JXC(=*A7?E&$,.
MF]DFYZL*J/*X-'JX>UGYQB511Z^FKC432F==-A/*B)#!CCV%4T,B4!N/ 9_)
M!QX&8I/G. FZ1" 6<6 *UR<"!6/V/Z]2L)G^<W(]@'31QICVE7DJ-[6>="=S
M$M6:H.<]#TW#PA_'4]GI6F,9Q?87781G!V#<8T(/?':A!H2M8"FR9/S=RY"H
M%JW1T9&TNH4W!=GK9M_3#,1?[Q/,HW-A2G?PL1AJ3=?2^8"4NE+7AMU+%32/
M9&L5O ;$R&;E'L$LG''ZX2@Y-*^E4QP4U#3E=#U9?O9R;\#V.'/RX77+FNLT
MMMVI-^+Y7'+-V1Y(\0$4EWCIRU6P1Y>O\WDZ"MA(T1Z9]9#[?9$UZ:_10TF+
MA%)^IDF+N_H07]?=L"0]OD39RQD;C429"SBAXKS*BZK(&31^W8.K8LHJ+'L.
ME^#,13'*GS\OSM6Y0=0LI74&OGJ&,Z@+/MDL"\?'/R7PIN!;!N'3N. <T^="
MP7FS[\@(QZRIFXI29'E8^S9P[*E"T9-&CA^N<E]#/-)Y,VCRLU K?EVG4$J+
MZH;T58XPK\^Y37:*6RS,@SU"@A\ZSO:AE.COR0E+E%^4%REO-TW_YI(SNQAS
M@1?&Q7 CK;H_.$-L:A@2%?CM,$D695RVY;<.BWN%K(L,?V]R-9&OP>_=Z1S?
M\5VR:MS ::R]$!&H#AX@Q#\Y@AP$$H$T,NP$H2]+B0@8.%:5:OZCC/A!LJ_:
M=Q%.ZRB17(K_;E"3O7#+5:'"-TNO[W&T8:H?F?"+DCWJKY>^,J;L79(IQ+YK
MX5OBG1B+6J_-N<9,XBSQ5F3(W9%?13&-ZMARE @@3=V,,9P1W]KQ#]'@6'7Y
M9/:)&RT_XX4F(CB3W!98=!2YOD8 H?[8HZ-+JN?90R\@C-['B;UJF%9O:'-S
M _W.?E/,VTHE<"7BR:NUAZ2A:E* 8_J8#;#G$8>HIXS7YCO5P[<^CG<L=K7G
MP >V7YQX.CWU<G0H#>VI]%-\YA#(:H5))B2,P^7//J",)*)7:TKQ'C:XQ9]1
MOZ$R4I8]!REGE1B-MU3RAHH<2>#%^B1JKJ-;S^X8' SG1+9SH'!WRC R62(:
M%1#SB:C48.4] Y'[UN$#@RYS<6S#';R(F./,UA4B0+IA3S*Q7OM9>6,?+YDQ
M]A:JA*I]>H]NM[>.*29.\0X[&P/ 1H)9KI&OD&A;$>1_8O;C,/!V1K;FS"Y/
M]YFYNUR\71W7&LU-AN8N(#4E +2O!=/?/F?K\W*HM^-$JEWT?%2^5_F_)SUG
M]W]&&#1Z(7MFJ',RM#\D L=TYAX8SA@G+!&(^G[">FYS:2,XNYNI==[@;2CI
MX8 ]C&N]NET('S7<8W\%B_R]_=8Q:AZ_K9/A=4/'W++9L9.]! UA7+)_0H\Q
M"B;=G+AH"-7\]E08W*EUGPBPAI"%W:;K"!>@G]3D1ZLY3.VD+9MF>XU&,RQ9
MF11SA>MS70&PC--M#'$7 5-=-L#<R-(0.:.\$$^[88$91]-YZ?6&=IXDZ4^:
MMTB1*?2$<$_ 10L*LPIL:6UU'1;\.<23S0S$TFU>F%[ERO[[TZWO;_TD\-HM
M'.79\UWPOJWE1R)0-W.:(AB5<R#[(^?8D!_PS:G/Z'G+=0I!)]H/KU1&X]2G
M#VQGIK;=\\97%)Y]61!3>E-%LVY4XT;3+%LVU!T:W(&&TT*QAU?CP/3Z*Y.&
M]\RQI\:\$MD:UPK!*9$;*O#V=PZHC(/ZS]OR<O#+5?8PI":%1+1LHPD^<^L6
M<M)MFP%_9Y5OA%M,#*@2U$&!/\Y6W</KYKMF,G:?%SNN\RI-2Q+C%?4;C@W3
M-DX9.\5,#G9#>RF+>DO RC,ILLH_BO]N\"/($2=!_'Q:T\4)$C*T@MK^^]"@
MVM5<%C$6=<ZJW_ZEU.AWY9/&XVI-2@QO!PM>;]ABDF6)VIW]73GW;"E7V&%;
MI(_OJC9+2T:? /TY<"*>BCTRD$/MV&"41E2^+3"3S:W]V&Y6[FQS7)D-$8=M
M*O ,R3;,^[ZH&2C*^]W"?%G;53+OU0:EB5(_=%I:QM:JO"*O,1P4194BHO><
MY!X= *9YE?*W4\S__0#[0Y 1*A;J8ST_F9] &&<&.'B,UI:@\L^UD:#JE&ZJ
MN"4)DD</"B(JR\N^N:TT@;8[Z']76/9F ]B#DHJ-,?2.S5[_Q4J?Y@O3#7XF
MM]B'YO4/O3PG)-G[X0%XEAP^N?IXPV26I0T>W]9Z?^SL>\;@ISN\F@*/K]_@
MZBT=0;UPME?E^:G)CN[')D?L5[!7ZL[5A#W\96[-%O99NNZR.5DH[66 )/TJ
MKX^I+O"G@UCUGPNW_7])FK\GY@&^M%;R#HUIZUR[YS"Q9+W"0 1T)J?B,*>&
MSN0=+"A!F1[>01%43RVI'C/5]P7)7\HD01B5*HGDE3.=BD*8+VW$"2CGA9+H
M'2(@+7WR?:]+JTQRY6?H3TTR=&P%B#/<<&Z7Q]DEH'O'G,8J[-V#G/Z</"+0
MYXF9 S4<[;N)+RW<@: S/5IE"2M><8@ET-?/Y\67R=_*!<F_/W3!IJO)1RPH
M'2+PX"3YC&-JKV/[-Q$0HT07G<6K.Q/2!J[R"^ZTE;@>LR='@#)PC <,S87W
MV_I?0'2-()_>#9-*7W=_G)BY4B<B;!9BF?&,]I7 #-:B2[DJ8HFU)HEP<I>C
MQ<<$-%W$%/=MD1,:$*/(%$7N1AZ60'IU-"!YQ[40/W\$%R P-!E>?-#<E%J9
MH3]1M6X0\3#54;56I/]3O&+)54,-(8?X5U4W\:P>)?-P7NPC]2E40V:MJP5F
MG;IBI=$G_<'@Y:Z3>B+@>X5?BJP ][@.' V7*W_2T!+<7^'KY"S7J\(18P_-
MN"%;(Y)D>!E@]+:GQOH?Y#5/:G-MA4C@(P9!]*H6/$Z?TM'+=)NN 0_600_Y
M^\J.TG;5%IOU1I@_>2>_1^X(@\XXB,#MM/7=(04A&'U?Q Y%KTX8[X?4.Z91
M7EQ>]*;8JN?;IU(9QFR-G#.'42JH20]N&\RW-% B[4MS;JK2*V3-FP9" G(G
M+%M^2Q)8QB1D$"C+3>$TJ&KQ6N,E39:(H'ZG9=[0P5E1Z4XFF$A[U'\9DO>\
MA]>NB[WE,8JS?>0H.\L/[#ZYE5NY^65#78Y0(.LAZY>BN</G*-MU[QWCQU A
M[$"L',KZ0U^)C:ZFQ=XK&GG1V0%*\E4M19F/!#E8]7WX->QA]/Z/>=IU1C?0
M./W2S2;I:'>UKVRL.RFNRS0_D6-\,)7I[FZ/;3F1+]FT\;.?MMZ\KG&H\8S@
M>OAJ[7M!H%_\RB)G#ZZ[P<:'6NQ&==9GS8+D)8?OZV*':H47HC(*;5U:W)"1
M[Z[QVL*FI3[[F5RV*,[[:UYB'WRRS,1KB$_-Q>N?"*Q[E\X;^;6$WPR7>B7/
MIYC>]*[>,8P(R%'F#NA4@3YN!#ZWOM,P$[YTG6Y<?UW6HW['H9DW],J5P;&*
M:YG^C=<+K0)3UKY_,;(+M"O[$5)RE+%1*;/2$8,TYH3+8I<:*^Y?]RYYHA+O
M*]/%^.)Y@&PIIV1>BE*V9[92G'O)ZJB^,1Z9B[^F)<)=#N+7#OH^F3AG&?]1
MV/J&+<.NO;P_(VIY<3VX/,!1M:X1XR9+;VY?R&_],0?T>V*Q;2<(XF$Y^_5_
MH#;<NANZT>&V8VOPV0W.7V)0L<FC$%>Q*Z9.Z]H"RB[Q]'SFU&C*QO15,4?K
M]0 R!=O^F B\F$'"F2=VZG,B0EAJZMZ:-#4B)W)##4L50</L=N6/+J=%K DV
MW4+XO.RJRB0"K@HQG*_ S/+U1JIV^-829.3,@@*D,X2M?M+-QU,<)2P<\"@F
M-=(B@\P;XYV>0',<A);E:" "=*>7&FQ&VH5KW;2YA:;<1:SR6Q-?* X.YEY+
MH[H"D&RHFU#:_H^MBSRU%5^>FI?;XO7F7NN(Q&=9W+LRY\[([%QW4P^\2&^I
MZ89C-<)*=V;4?!WV]*DX<$%'OKZUFN>^02T6XJL:A@)KQQ<.>Q>_3+>9?'1B
MOO\\%97$A*B-CQ0T#@26D/7A_8M"#5%7A'4BDT T'S8HC/XMO>P],&=0NQK\
MEQ4M^3$KJ!NG64-[VFZG;6^W19A)R9*EU_?1;?U%@<+6LUN?^ V-6NJ;+%SD
M16#YY@[Y9:14Y$SZE,5JY:O:SF*OEK\A)K?+HGT<;WFE/7ER#-$=6:W8J<"<
MHH:5+3,((ZD[>%8T->V0;-U\P)Z!<J*H4EV-@R%+((%]D^UN1GUXC@_7"'C*
M$W3IL$,LLWVFKMK4W->@\L&$_%IMTD4/%DX7QS<?]3ZQ[=!=%2/U3",YMLQR
M ?/*L:+E8U<56'4YLK3+N(+<5+HR,=:+0WN8V&?<:P^3@$ZQ7V&99B5<&@8+
MQ1LK6QCAL5NJ4WK#0?7S$R$)B-B.M144_?GT8&=)!*[75_[LY4RQVFBLO6_,
MQWRD\.LC6G]1:Q1VA+^+0<0+B$V@K#$[-K^Z4Q8&9%6R!;\4N10E+1GEQU::
M/O=P*+:V_,9[]3=H0O]$]51M_AQRV,G =TE4KDB-V,HUM4W_6]LZA_P:ELK\
MEB.K_+R;.U]\ZK10-YY=NB=L4^<5\712)+]J5-+=6:JH?7.KSK'#F7=0/H02
M?U$X6\U>2Y["5Y^\A.;*E8TG_$&$.TK=X .%)Y!C]?EL\...J-2%?!/8G?&)
M!\).]6E6XELYOV/0R1";^)X.4K?3BSB>@=YC1(QO@)O;TV]U=@IF+6DX\T="
M#4-B7H.*-5APZT_#M-H((4Q]PUCC$(\A<\8P<TS?M?STS!(GJ8JUK)>3!<NU
M^F[_8"*%W(.M$FY4,2%FM5>)@"X27G6BA1@BP;L2 8=/;XA ?LU,P)[S!_S
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M8YD=F</MFFF4] $*C@19?D%>:+\Y1=\-6.DWZ,DV":V%3:-Z5A#;?9BJ2"+
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M2Z!/6N^*\K%99BP>16&CR:^D-T%+@(1=E?PTIFV[DD)0>G$ A*PYK#WTX]O
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M]B9Q"VHW51N=\D0)RR_(*ORC;A%9K>H;TW6??NPI?N.P%SV<)>WP&@OHF!8
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MRBDW?42[H>R;$]UY%YLGV[0?^!00V\11M<ZK%?HRNND!EWFC6TE1NG/K^XD
MVH.R@-S< PBQ.K\:X'T)TX5%#1N/P$_?[3'ZV]#T@*,%6*+(+R)F<=/'%Z>-
M[!WVD;=B;_,HR/?34&H:1F&HWA (B=X?5DH]2NP+[CB/TT*%*$O;J3C]+?!J
MOOO7,(/8+M?5P4^UZ]TFR>E37W5PME/4D_(!5Q\9,R7ULM;L>]UO&HY^W3_1
M7N+625U9Q=KJR:.Y+<B>MGN*3 5?SP<\R9#0:<@1!7LDNU<A5_:3*((]V+/B
M8&>BXXS=H=*,+5';ZX)'TK?@LL&E_.4.ZXQ%NUYQZ((OCJ*/TFUI_5:-\TA7
MXG]O]>E-WH,3Y^.E%0<*7'=I+T8I3%5 X3Z\=LWCLNVC%2BQ;/C:MI"GXZ(Q
MZR!=ZN@DG0_ X<*E#E%T=UC'^48)@1%"PZ>'.RNBZDO!-&JC<+4*Q633X!C$
MSKN?!COM&2*P T /&=>XI8G;G+T!S+^[*'?=\HR0N7&="(GA0ZWV#X#[^J&5
M$?5K"]G3#B3E0DH(>"[.92(94D4PH90DZUV@CY/F$WY2U,L7AD5M*($M]S5"
MJ!]Y5$XQ'^$#4]_LYG.'4K8W+U&V^UP4K3A7.\ZE1MQT<!1B2R"*)@AN2]ND
MX:;#+JE^/K$GB+@=) G-9E1AKMZ."-F_5.E6_[JM61G[-F9!$1K_SFX0S7(B
MHWC^KH\T/<I<W4D[]4%C]]1;VR:K]XR=99AL+SRJOP=5T1!FF6N?VD<!(95(
M-'FE_PAF1Z$17\)%LG5?]'4S.97&:,PB;F&)4=HI&OM%@-='H%CWU$SOS8/T
MV1S-XBNF"D7OQ(2(/JWL'LE@EVCR,4C JX.),O*^>IU7K2.KI->CZ:V;Q\5G
M9:3\#!B/)YI;3Q(IVY\9/,]%@Y"KN0K678*V,JI4-<+.=A/>RJ2ZO(\?%%KN
M(%,%7K DZFB4K@I2*S(/]L>=;N4FMKR&CD1=DP&H"T%4P1>JT,VFD1)R$@*W
M>B5^]NB#_".Q)?9=S2J-/FB]<1*Z%(B$<@(-_?W".OHDA>FVB>6L315)T?<)
M49T/C[9>_['$'FK1[!LH(ZWD2_7F?U%V"UZ;&SH7V"!JP_6^?6^90QG%(OE7
M27&=,#Y/*#>=P<'QMUT6*1<;;UE376^6P9A.V_H3]B 7_P(4!J.I2V20Q=%D
MC;A .='2("5.^V$%7-^/NO@MF12AIH>8- ,0Y_0/4@4*?%35IDQEZ='CK*4R
MUR%\EBR\YY40XJV%G.J6;B92OAMNOT;@L0A&)-X0J*'^F0;,;5IKJ"^B(U3N
M-B2K-<OY#M5@K'O?,=C#**4ZSCX4V+YO32.EZ&=8QXL* [WRT_J,F?Z_&E7S
MGA5[@M>L4O6N3IX(_06J5?QN40).7+UO2Y*WZJ>\UJ,P.TZ*U7X)!=L+A[![
M"9*^7EH2M^GS"'\<O93HH/Z+J"$%/Q,.=K;:A.2OZ<D"PDL6<F9U6=:35;NK
MYV.(#%EI\8OZ>]5,&8NP1(6?1V_RYGLT;G=$GS_QK_5^44]>]3/LZ%X;!H5#
M8B)5[<U.>H?KT)GJFQ54A/3]^^$M&9<^O\'*,IN6$X<(*G<Y<U2J)P:L]&8;
M1Q?"$>K5'PO3'1T'O>2?_'[F[]9LS,QLH!MN]S7R(B!''MJ./0;5,PJJ<Q:(
M&_:FK05SEC;%B@*WHTE"[QZV!,SSAYM0+>93H'!,3.,=I"6"0]2':TU%O,M0
M/NJ&@:O@!W!4X=Y@/M?. F&S[,.:8W YI%?7<>+F9,&4K^H,NF[&[)?TS4.W
MJYJ,E_0*$_<1\3"(#C>EXP^1 "/>T,A2#EU%(-@)DDGTL*OY%^X<%?2A7D.Z
MH,+HG@LHJ]&<K@,\)<U;0B9S:_QKI\Y?\N'-VL\=!9[2MIB^ZF=SRO4 3C9)
MU(!JVUH"EQ!NF.A&NFY_SA-]I5_)/W!T5;;J(G@-P4<+HV@\HZD5PJ?^;2B4
MP(5$PAT++ ]"A7L]H^HBP8F_:,Z'=H#4B:%@W8-"O*94X)D"3T41=3/7UR\V
M#?!\%@)#FI\PN*B1,5%3(I N2"S)F1"#,M0K*"!<^(SM;GF9?F"4;MBT<3;@
MX@K+>*[;B9.54#UZ$RF'#+D_H2C3TL&DRC3Y/E7\YO*5NQE^O"DK8B'YW,5T
M7III+5"SH*O42^0QY[!+BQFSX#6^3=%0^LH@R3OUOOH\<'0(0R(Z]02HSM6Q
M:CEP@I#7Z3.&TMP76H:;W-5?<K;68+.N59L#+.'H( JVI\8[C/\8%(>HV'2K
MSQRR299N+= O^J1]5K,:$S0?BS^#DJ($D.-Z6.EBWB[G)X.<77R,";#Z>TC9
M1#/#&/N==OU.EWJ&/9^I3;9%#!,2TIU=DJQVHVYRK_QBU=D1HF"V@WV^^R61
M4S,&NOZ.XZ@("A^:VR2%$+]I%4LR8&VYG[&<@5%RUT 0*$MJ"UES+%1T#S8!
MSZUW7NFY&K? ZHD%P1BUCF^\=MSJ?E"P;$^P#A.S9<KJ=/9=6IA*]:69+_C<
M/&HS)[M5.2$]S-I,$:J]A*'S&5TO@RY>!*]N,]">4F"]21$VSH)V'(&X':7W
MK0F;/QMO\383]5GO@X=O4Z";PI1C$%DC'E^CJA#D&\1LBSQK^BC!]U[DSO6O
MH)?<]V0Z4 #ZORTE26U*5)4>#:\*@\440Q-UDM%VTL-4A=M5R@=")3)ZRAGK
M]FA0)"N0UA9 63^$=;M<G!#M]H.2]CA#[KC!.:)\V!Z+O+NJ@:(F@@X_)E[,
MY[(BQ_4R @\7UO$\YH5K(M_:R^ZH=;P5S+ER/=2OO7/[_GP<U!/!3C.@X/:+
M%A*F^D1P]2X>^QQ/*]M7??5LTMV\5LJ6$D,V19>23LX/?SI(U\V"N+O-Y2Q7
M:'CWVT.O_$8.O_O]U]PV87J1(V%QW0IWR!5AVS1Y."8><C:;Y, TV BWOZWN
M;IUVD3W90SB?^_8HWKNU').0AE2" 1'E2-^])X\FJ[9DVAKSM.6";%"#J 9M
M@WXFV6?H)Q;<O:3E7*:#.)P5]V]2KZ"@B&)=F'5/:>&U>=S=K>OZTLSK+B$4
M)<,VX#VE>LD#DRT50(8(#I7:DY1'?C8FB&A^@!D1-/>J=2DN[XMIEL_VO2B^
M;^FY9;_--?8WXPU;^E6OI[,9Z]W/RZMGV,V*@L(MV/L=K>+WV#<%K2D_'?7>
MJ04*]@G]<&BX?C/'K)^L7+^3X8);./D>R?-LJUJ3)!3ISIK ZE/Y+2'A\[;"
MUM-+FE([U2_;@BAQ)^W*23/0>(&"JA=5FG F3 5UA3]]?&656(AK3SP&!4G<
MHLXJA.$W6JD3O1!^);5VI=XKJQ:ZN9651^W]R4Z#]B4V0^P>P(20*L/6%*D]
M]<U8Y:_-]@)3OQBO>^P15T-+YKP%6B*:FUJ:8TE<T'"5%RYA3^$GPT BVT*N
MX?YSH(R[O_GGLYM))B_:-,?K4M+<%(E-2R,_4M\1L_K8JSF])?2 2Y!$V?:,
MA?J6&Q4I%6\9;9P9CPBD'9K]P-RV/L1=O<P]$QX\Y:=0[L;[EKDG#ZON;WTR
M-AD6;>2>T'&ENKZ_7.AZ_#%H;@73C]?1N3Z.[E&B>2:996YV0)02)*TXM;-F
M?OXM7PZ5WOFU4A1(I8E2T#35XIS%^8VH0',\&.WI//T6\J6EB:VW-IE&F)?%
MJS(<!&87O;IBI)/E9\)1R/K3BT\N8Q2<YYU:1,X1U07?_>:SC+%.LHHQ*W3R
MNH?Y7)3X4X);?'TGZ][D^=:CI$CA%/?E-0OUF0$VA)P\9OE"[9>%4EWD_:DR
M@ <%15"'R*_0',+<)P<#&#KC&![9?T_:K(QI/@9EO@C ]D?I?0 ,J>$6 (Y"
ML*!6V&X7V+O$/N3?3>0(MZ_^VKF$\P)VR.[1E.W.%DP2SGQ22RU9QC:3F1L_
M=D?<3.WOD=^_ OH0GF&!ET0"''T<'W\KFAPC]:*&?QT5W<F0@!<W42SJ(@>/
M0<*VG&@S:F8&T\!,X*&SP/BC^O$5H3D%VLA'+5H;ER=X"\8)+)E399_M;O,4
M?54G16RP:=6/E[(UG>)/]<^#/V6/KWIO]C#M<4+_O:4'7TQ*S^-U(J5EWLSQ
M MQ>[^][JN.Y91H#T#+O10<+<PV_V'3_EN$*R&OS4-O-VH 5="10YN_$<O-_
M!ZI-?2S=:[.L&C/EPA]K_N!P\;C L)IZ$3R[K=:N;956T()O:$B[J^Q0?$^2
M-\K/ZJ:#6A*K[X>&]/TY[83F5('7AOA1#YD."ZI'U"XT'MNXLH^.?\)[=V*3
M)I-U?GQ)1M;_$JAV5W/$I*F:D[J5%E2%L@8*3JS=G7RDB6,C\:&%S+9=0U.6
M=<P/_Y\1<4-0/PHK) 44F0Y;%Q!QZ0H/1W@M^^6A/N9TO-69J%+3UE;FR=MB
MO8%?HPV>VE[2>;33AX(<WD9&"E#W4DM*@9(>1V(E2]SY&#0WT"S3&&.5I10
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MSP^)0Z>IBBT<0OBWGA#PC#OQIQ?G<.[7EMF*"YK/7VM>N1JX!++[+=O?+C
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M@^I*,!T7E/KZ*"L)EC7A^7.KYP^^4ODR8[:$XZCGN[\K:SQ)E2LYJFL+(F/
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M>,4B%F97?#*/H%0BRH !\SSS'.T3]NIL%,EOB9?\\\7W[#G"UT*N-CMSRLI
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ML&:32ED6,=\?0+PU+GP)==>A&+#H3%49RN:>U2,Z?Q&%<_#D]4==W<6P>KI
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MG"A04^D/K?[Q;7YDHR4A1/0TN5@GU;-LN4=1!1-CU""3,>W\)I:;[:NF:7X
M.S=3,U6.K(R'A@H&YSKB;:0J:H84C"=)F/RM<_SB3TLG$3+$]=&6+BC8P.T<
M2:(Z\X&^YZ+(1]X5M>UR;#1 .G3:-2&[H.&?W'Q7;WBH$6;M)JWTGR^[>%Z\
MPFEP0M.JT@X!.8E09VE)G"M:%]"Z7B-FPB7WYA53_W7O\K9HH)F$"U7!1=IS
M#V&NE%T?7 Z(U1.*[(].N_>+8Z N$_F2=J9Z%"-0JN\HC27&,;A/\;>P+I>T
MQ5$D'W-C  \WT_P>N!+TTATC1H"R&Q2:>*/.K(#' UXCG9]A**'N+)]_")M#
MHJ!?H,WH&(UR5!$YPK0A[4];_X4/2=,DPGF))1W[ZK64.RPH!)C,AS<-J0_.
M<<0;!9; %?.Y;BN49[]XP,;&JW5?$+IV.+O.UT2[0#Q,S6\1](A6D*@?&G87
M\DZ0FFE&GM 97F;D1PP<M*M/Y&NV,S)N(-*!W=:DY<W]OO$XDQO'_^PGY/0V
M!K"TH,/K^5K1)WOQO1P3C2.I*E%B[<)A)Y^X=?W8XQGJORJL3I5)8*4#33XP
MAGW]8G!8YY;_7O0*9K#*AB.N(2AHE9DF$/$-0BR#X)EI/2@:1V\M'7#Q!SN[
M30<?4FI]V@(M2\VN"H-;/%X%<Y,+W7+:T58&XO7R39/+>Q:;;Q=#AA[R>/8^
M:J^V[J=QDCUND';KYN1@5I!:GY(':QM/DZYWB7O&2D\,-,A*,[?+TX$GN/#=
M8"X2)+S,N[C,VX-C2GXZQXV]63HQY =SO]=X X@'<9:(BL4<\YQ=-[T5;GP*
MYECM[' GEL.SENWX-2%]U;'^JP+3(GUN&,4/OUQX]6ZX.)SZ#LI:F'D<RY8\
M&KUE '%$10S"[;>:UPMZO+L:;6%)[;OA'?4LFI7+V<.KC#<CB#N)N8SC$B,M
M52?3.&]6T'IL$BZN;P:I'5 &J8Y$=/.T%HDEW*?L\;C!!E73VT-ES^I4Y+R8
M@%BCS_8=EC>]%!GJE:]]5..\]^=O5I)$/]07?"R^<MQ@..8(Z%&2B?:J \&/
M46O0F /CL(BH[?N-O*<X1Q:$V[7. A>_G-8WW':59N[1$:+UZC"1S7)<-4PC
M,)"CO.-)W%C_CC2C?#&A)T_G8WU+-YAH7;C3-"%RFHB7;O^4HENH?,:DK5:%
MU7'(Q3!^O/*Z?84NX,\2"7$$A6,E2=[3Y[!]OZ9L36HM+?HG-6SL;A>>6X@4
M*1W;L*^0R+IDI5KPK68=G%H!9_*,!345?GRIE0$9\_O&018S(68L5]*!Q\L'
MA;LM'$$YM?(]ZQ.5DT[5W@?()BC[,O),-4KPQM.9B?K&/%_U),TT@W,F/+[;
MY9U_E2K?KBG9Y0/Y$[OOX(U'\HW?ZVN^).''!Z8=>M\RP,E&U:F=44S-&Y'V
M<O4D7G3^;1_-!F2EG79C5TNM3"S3^>+]SQI. XWV#.@IV1C+_.8WS4S<>)W1
MM"*BWKQ:>SMM>IWPM59 G*![=BM[Q^/JX7L$,W[F^*H.?\0-HS)E:P_ENY0G
M<2JU'F-Y+U[<6@NTS#>[*NI%Q,VRA.J<F9Z&PI&F*:[J9J67[*=-!G^>AS8(
M-KPX$W!JA!Q'+&S&\91MO]6ZX2;Q,\!N.R#L<_SUS*<W4J5$]*M]_T)FQ6\S
M)XT9H@O6[20SA#![>D'UBM9<U#G66L#W\H:Y AUP0AZ9H2H/8%B\\OQIX(%7
M,3PN-CVUCN+A!BSGPDU5E^\S@LR"0NS9R6YY*VF")NF+"B6)1::!Y[)AG_64
MQ&K%'6(M10IH;3C6[;A[!KB:@?(!-\EMZ"\Y^Q\=S^;(9@;?H*Y[IZ29.Q".
ME O4*Z29& G2Z;*/*NFU; G^W/<PS^VYK]Q3>8@GA8P.U ?=PX/#?9 B<(_6
MP;&+(PCMHVGC7FT+=Z6G?+^L"XO*53+(;E50&Q6ITE"F?B?$O=0]U_EIV%;$
M]8O76OV1H4A&S4RSD"3BZQP*IR9G7/8I++MA\^DGG5#[\Z6WK'<Z&2DK_]>6
M&,?&R5LVI&?6WE'%J\^UL;G\[[&]+\H;'F""3K8'+*HH_IK!)T3X& O2N@P;
M#+8#T=6_/!H31Z9P]9],CE L:QFO1W\..0;%C[: .%T%%TOR?BKZ\&-*\+ 7
MQ':?-N9;GY[_U.2R-6U'C]$!*Y)I4Q +'O+*NTP-?+(X^LJ.R/6%V!&E]K./
M%LIU7NCI>4UCDSZ^O(20P3>8LI"=C/K6SN@[%4[HNW&&4&4_@!:LA_Z?%Z[\
MO8D:4.XA+@P%7T0(#E>)B"13K)Y$;XY<L3EY(?'R\[BU7V(DGCD-T]!@"7(M
MH74CQL>#22W$)1!_<OL<EUVK>$7/)]^D^W,P499::\KQ:& ?M0L]3*$JXA7#
ML3R-)(^7WD5:?D\%_B@X13F^>S+=:O#PEA1_.9(@FD""?H-6\U;/X8Y3M: "
M+NGC6FI,J#OQO^1D.L2N:#?*K49+,R_@PB&5,]%:7@XDL18P9UYRL^!,O"!_
M=UJ$MX6;SO3Y4T4I2(YO'2*5MJ.MR)<Z"F0G]:8.K(B+1GH+!S[.,' __<%0
M>\9$^ZDG7EE!<FL9C)S"LI+I ,$R3I7=1%$4H1'S7:U/#PV[Y"KG\[M"JQR8
M8\[XC71"1=B+$3U:%6,URJL+JE/#ZTK+>E!*B3:]L0KJ#X7C@V#32Q] P&%!
M%31*H[QQ=I>8)QB?@U=),A]5.>3\HVDT-A1[EA-W<^<[2QE<+Y-R!7&C\O M
MU0L/(NMFRS_>:Y4K&AL[K)  N=O9Z#S2FCWMU8%N+/H >F^)CXBB _@2+0D"
M>JT)*_J%F+D\:+\?$_D'=',BBW;V,28H^"3"(&+7GYQ.7*>*::ZH"PZZ"@:-
M3]U\U*B?I<2ZY7B+&7*19\^<FVD3&JTE0.)J@E3QA2*\/L(E33F7ZYU>\QDU
MA&L6?7QS.^"CN]B%T]H5&=\K#].H'I^">P)V4G_RUN@H#&%,IF43]/UOW,PS
M^&I3>?J2GO]R!L60\7)CFAE2"T9RF'.,B$>8X@N)"JC<I7LN'-;=7L*C?)=^
MYBF_>OTR)CDV:S1A!<FBHV!%!561C3QF>1IB#$FGH.R^FK]N^O$2O,X^N>MW
M_'=6?.K>.C<3<68]#"^T2&[$RRFRK7#<*(+O]B-4RZQ:9CL?W@7_E-5@QRD$
ME:R;@I9JL$)]VX>2G4H\^7$8W_[SL4!1COZ2G"@D7(<[IFT WNC-"B8;S)O*
M5-\[H[S>IM10*YK*$/_-![7?0.!)!!<9G]..WW6[UR(J0?%]Y_&[G98(>EL8
M[!7R34MPQY1L3I.B ^$99$?"HWR.#\NBO)FFF'I.R7-9'YC4?DNAKD4?7(H&
MB) )5GQM9+ 47+-I5U1TT*10M3927J'<@5/V68B-PHR2P+=U>R:"QQBD7=D6
MX6$3)/-GK?S#)D;^Y'NELVG02^:VJ!2VO=:@/5T D3,'?HWDT!(KIEXF)\Z^
M5QBU)$E&Y.CGNF)%ZK/TW,__NL1I$A+JM%F^@3^-)C6WIM.DAC%.><OV9SXG
M373V;VL3"+<*F:/$$P.*M4NFI#^ DIY1>4A&!*=6CXAZ7"15R(FA))KVOMC"
M1,4JO\86E/">*E6235K@?^&W72[5AJO<:+%IO-%N+QS39.:Z-WV>)!Q0'9$@
MN'AQY.)Q%I>.+9Z4(T?0/'N.W$R):N\]P:^GO_UP_Y/VX]L3+0%PUP2JA0YH
MD'&FA]FTL\T4;2J$N$KV":\HA'=13#9'>Q+V?&DN'A>S9DD394&]C+M%!Q'Y
M6D4OD$M(LY,3:IFY\$K=\';CH0Q=1_\C#Q>N_0!V>EV;^FA\U%NDWU19Q5.P
MZ3.FK"XSH(W'F(:1N,D7$AM)#1QNPP:/&HHGC\NM64LS$S9$$/+D=Q_(#7-Q
MY6&S,^1;I1C_9V4.Q1+S9OK,S\8[SE>P9\._E6#ER>!2>ZH0V29_!0=25*4<
M\C;_R)[3'>'M,A\4%SO:TO+Z80 X ]OR\:7.^2&D$SA:5.$PXU'_3H?4D&J<
MLKU@P;O<&7N9.LJI;/GY]_ MI20A[<#1TN"?.-;>,*HN09'#>)85=\S4G\TW
M2K*X-)/2E6?+A3EB?E7[8LMH7]4=EE<(#[(709$'$4"^@EX.<&D84-$<RQ]R
MUVH]<NQ)4Q97<F^^_^DZ(E_[*/0436?9$QZ4:4:2B@S[D\Z'XE>_\X?%UZO]
MQG=TC?,'4#K&@+C71@= -%FX)L$D#%] >A[1[+F4$1]WK,73UJ;^P[DYIW.W
M>JXM?EW%C3FUU4>L[1'@3\)'P/RNT^*B,L8\CL>YF\-Y%^K=Q8K_H:P5KQ&A
M+9#(F2J3]X3>,V19*,N20].>H*;AGJ>1K.'*M0L<"5Z;%)]RH5DZL(8KA3O9
M$'=#".#P/8W8#+VB/6."B\]F#2O_B_XNME,&6TH)*46B.WMNW$RSN*-8$7A"
MTXPH36GUH#QKI%ZOS@<F^?[%$XNMX3OAEUG$6$8R*>:(RYGM(\'@)\0+-,7X
M'B>/JF6-PE\^FD>^L1.5FK+VCL:G;C#$:ZL;48I04$>1A*\V!435UP\I>G"Z
ML1H,NP_8_)!/TO60M8KH['EN>F^G/+U=E)\<4D0>G=UHR00?F;:==.9-_K5B
M+PK[:K%R?H7[<M $OV=V]4X0-Q-)-(%RA7J5Y/0=&ENO5Y&G^V&5=I9T<L2;
M8O'5ZGRFR^DSG[6.Z%TI3[Y*'&U!"R(09#M"G,<W4WR04'/]_1'UNT;^;/'B
M,K%X@WV01[OJ3JMJ_Q,]"Z'4\!/:K0!"8A82ONF*K#F>/]ME\\,#PX(_O$:U
M_GQ]8D"N.-TY=N[E#<Y?N^B&U7=$:#/D%%63XD<5LV:/C_;(5[:MSKMVN\=
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M;J$Y<H]] I'<HRU71/2(KK+9&$/B%]/=2JQZBW7=GHH.7!G.M_7I#$V,;AM
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M^K49QJHI09_&>NQ/*E/%^U@$*,+DT6;!GP&[J1\1EV/P0_C'0V*U,2SK:5]
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M'=;^,OT+;31E9$O',SJPJ"2PJC3/-XD7D)/BXEVO1"*\J#%ZJJ8Y&-PD'V.
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MJO[J!<-C!7J&$.==<?%^2*DL<F8:1"%#FF.7V*#;VZ$T&B<))<U $*9[%4O
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M_V#093ZGQPO"ZNW%NC"9RCR%M-QO+^#@C34&@N5ITRUA2%CO)C3GZ\D&RQZ
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MDMW;A2\=.+?T HSN1S9HCR#__LI;9HK.4V3?QUE&;.^'QN+.M7F<>6P<HS*
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M#SW[7ZK>_/LK/X.LZ8DBZX:&U31G#%WM'6##O!G5O=-T/LWNN-B;/,L(@/"
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M*.X 9G[QOAOMXM!7=P"$SF$RZN1:]7CJ)281060EZ]D\5@,\I1.I48LS=>5
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M>Q@0Z7D'()]W$-N[,GG70$G$-(S"$>>^ Q!_7FU7<%E(11)@1<T[0I)U:N\
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M]OHXY)/7?O/X:9I2OZ/(H)L;N.D3&#]TB"9ZZ[+)YJ6L[65&V0I8 R(Q*=[
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M.SZ6"$U6@DC[V#"=/!Q;Z=1O06BB8FQC^:)48]S1\->T-QW:?&D(#\W]9["
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M==9"=J;.DG!E >*=(LL7;G#V>\)CJ(K$Y$LU#OX=0("U@,8%[]]<!XP:$Z3
M!Q/]<[&C&G5J!,L8M#&OHOUM9U.J9L6J@Q\DE\Z_E7&/02V>6$8RO?8-Z+@I
M^+%OP26+VT46O&?K^*AY2YB=S;%T+RDO9M.#=NYV@.Y?)HCX G\:[B-AY=FR
M%9O_A5.K]CEP<Y-ZO$%)D:WD#D#,U1V(2@C\$-BM<\\DG/YFZURZ+"&O5>\
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M?F%F"EUA;(U,8R&'AXFHSNF6H;66A=D!R)C/SD>2=D9Y_+9U$[FR];/,E=F
M&,Y@E2.N8(4&P6>3,9$:9.G);A<D+RIO4!B,EZ!X[:BVC1>TASE!;>7F3'2O
MFM2GN+H-75IOZSY?"!'#9Y&2C5E['F?0I3:&5B<ZRZBM&?*GA*M715PX%7)
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M1VI].%#I%;ZG.VCK"Y%?U<_-B]ZW[W_*\D,?$QPT9"T/.410_LF-3MB?C)=
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MDS')^A<R&WZ&EZ3#M@ !WH4!Z,'EW&_WUU 2?X/)'[?YYSA-+QH-61B(=A"
M-.#M=]"C4+=;VU"UNP-^5H4WS;_DBP.HSJOXD"5,(^)O[/D-[!C&S!$]2 P7
M9=.L\%1$"*BJYES[@[NRL%*]=ZLI-5=_4N%JJX@WZ4,1)Q\E)4;EF60%=+7&
M+L$<$X[YSC-^G*BPLGPPNP0FA( $;$;,=;X2F.>E'*G/H+U@/?1N&T.6+DG0
M=1]P"+*W?%"4(W':)*\OE?ZPF/C/W!1 %A!TI.@U',;/I-"BS=VST ;A7A P
M91TO>?-%FL'TVR#>9U0?F56&L;X$1FKC@/3&7J1(8U"&'$?2K, T 1_@4A[
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M>1_')L8'T0IWO1?!PK',G<2'6"BW.WR5 D@4I.B).5K@3'40Z"-4@8",5V^
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MS8/[R&=KE /*7DFU)7M@I8:W<-&YXMN<C&)\NUIV@##-. )Q^ YM?\XY<-)
MM%S4T"%2(;,2C9Q>Q05H+?)OSL5<;_25(_ @1J(];)F'$42:6%\QRA'20&\Q
MEY3E[9-3<F  ^&6&WK>5);78)?7(J[VE\N!F"&TFVA";G0IDZ"I3PBM:+VZ
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M_#3(OCQ>,I(I1@M<5. 59CW:>/Y3L^<  _T%NXD?MW'K9@;=BJ47Z-YF$/#
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MH!C_?@]0^&K,Y[F %ASV4 /1KU&DE+V1%V %KW92VI?Y2^S\I@[Q]\QO=&"
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M2JYTE(NY6F6=M09^/8,_SWU=&=%3Y73H *8\.LZSLD88F\$3:M2^#\<EULQ
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M3 'F&!+4ET>"H<!L9XKSSPD5-PA-!F&XYK_>WCJ8F^#9 CMW& QL96[A)>
MX)9H?3THE/N3A@5+ NKH"AP06!T/"[P'DL)".H(A&&<Z%D,P0R!\K34L8&!+
M)RLF2B1<>N/#%;#]@ P C<GV=(+#>-X6 E,[D8\X2@(Y<FU\/.U0>F".GA/6
MTD%?#&*XB'_K)Y&!Y\)%"&\*TW3I/+8S$8/WY#DXFW#<R6".CQE.9*F! _BR
M+?4A/D*^*<V<2'$W$P>TOE;>(A1=WYD-H^ L_6R\^ *DGBX.X(C3L##SL 8S
M3#&_J ,@$%]=H$B/+3;O"%NZ/8#G[HQTUV4R^3@\'4/CF""Y=B0\P-8<+!1;
M2!\S#)UK9<L5F6K@Q"::Y&W%8MDZ<;%P"  #I"VA+X*MN[Z%+\H3X&%C)[;*
MW@2!-8Q$AYC:@$5>#)$Y!T7GVKC;4P6^4&>V+A_BZ(WQY3"9/B0HR)PDU@RX
MK:<>SI[$(IKBS)>V^PA@#M8&*D;*-DP R@\'(>KY0''>3"8;#?>"<KFZ=G@=
M78J](]\*B7#TA#/(0@>B)<01!?=!6B M3%%.>(X(];M5^>5&_YSQ VW#T0<R
MO;WYO@[ZWK;N" [:WHOD2\=B<4P]1U.TC1F+[PZDFSA 3'PQ'E:_;_=A-'"Z
M7BRD.8H/UW6P15&(3 ^J&95!]1(K) ++%5J0*#2>#Y.)@?-%.F1;:YJEO1Z&
M0("P!;986Z0-6L 7]TU@!K;V6-H5T14')0@2P 2$8]D /3W,3,RX<&>:4%?7
M%^,I9'!%) @<8(XCL7STA% LWY.*H_ M.?8B!X8]WT27XR>. ZP)#$]WJ(^Y
M[Q(4L03S;>&6)'>Z2#P:GO]CIS%,7S.>G@7#U@YJB_"TQGGBV6!S,R:&0+1$
M@2WP'%\@2(\!!_&Y'M;Z%, O;$,!6-MPO= F ![?U\86;LV@4P1V)IZ.WN)X
MT,'1G"Y&A4X.%#V,LY\&%HP7VD*A]B0<$T#T(#KP=<R@-F0Z#N".M6-2E[;N
MO2WX-@(_IH.I*8))M1&#.Q-W/P</75VL!95/]#2'XYABJ^U)!*+]^&0>#.3,
MP.F:6X"X0H3(7L_*QTL#!L9S6  =-L:3BOT%./%"D=C,((D@EB?=TYKMSF&(
M8P=KD+4]AHHF C2P"+8CVAW!!ICI>W@)*&@A2@Q_>0PF#4[3X"+I"#3*V1H*
MM^:9PI<0K+@./YXS3V1GS\.@1'^%E0IMR:6R[#DL)L[!BRYVE>90/R\3$(7E
MMV0/'6@V(#N2 X].8Y P8''$#6?J,$7>8OR$83H(V#@RF*>#LJ%12 X." R7
M[, 7B+BF)!\]E 7#&^-LY6MJZ>"$%T?J+- O*.(']6)9(;&Z?D@- <D,[@P@
M8I&Z^E8,*!= )Z-\1;Y\. B&9%(T/(!<.L=<U]T/1202.$2HA[Z[ "9PMG3W
ML'34QV'M"82E8ZO.!&^:M34>)6+J6V,LJ28Z! P90[#\#V<B+0 HK+V-+DO7
M'L+APTA0=P+'B8NS!R"6%-L.3^#3S/0\,$0O2PR+ =5G4WG.<!+2WIE/$4?%
M)GP;(LI9)+8Z?C2&+\\'A+!S9#L@V.*A=.3 O8D4;[Z7C3O1D^($Q"RUT,R$
MP.6 &5B$C0G2TLH&A. @&#32S\J94+ZW@ ,4X;!>.#.0/4_\F#*1WCBQVL+I
M#!-'=SK4 O/S%9+0$F,+A1!_L27H<'!<7QV<N1741VPS-;A0)Y*G"(R!D,6Q
M$I4I=DXV%""/XFM)0J*LF;X.<#L+6SL3&-W!@\SVML>" 98_ :G8 !'M*4L'
M> AF5#L0@TP4(;$^%'<,U@9(0).]<0Q+ @-OHLM&_G;0F4=!BMT2U%<?S;(
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MRR)_'QS<-^JYY<SXIZI50>YY8Z:1?+LA]_51^WQ3=(]5II;=WHSP^60GHZ2
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M>[A2ER4/)IQP(]U?-9SU0BUW8#"R0SVU5BTYUL6\N>,(U7P":Z 6)6@Z821
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M^',<NS6K;9ZRUO2-?]GD%3=E,SPXMD!;F3D@K3^\[=F=MZ^0Z[7U]W&?_H!
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MZ);6=].>0L^W[H1G#5-$9C7/W!]\B]DU''6!8>S^^HQ#7O\:OT<'K.(R4_O
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M.D*NF+I]BYX<.N9SPKKYC5VZT8ZO%JI*\>ZWTOR">M0+<J+KGSK)48:9K,N
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M\8F'#//BDX!>EZW^RE#QJZNGJU!\1M5:KU[Y9U_]I(W?><!3PU[A<N^IQYG
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M;@TLPFG+$<*66L[JRG<S08WE5%?NI/9Y<[W#W[E'LD9AM_\EZ\4(-IL[83K
M7>_0BC1:RWHI<&9H*!G0FIZ''.#= .)_E;+<ZE@B_WE7JL#]);DJV<N;U;JB
M2< O2;(VSW)AV%7R&4LR]68G=]@ WK(-S+[F0$^'WID3UD(K06^SLGP!8BN=
M+&UF&G>QA1LPRRC@B;"V2,TLB[2F-GKD/X1?_"*-"5%AY6?0)A*E^_6O6F&(
M]'.KY]QUB%-95*5I8?X9EOVNDJ4<J12@V$SI.,M0=A59N0_=M_ZOHF)G<%-Q
M\>F#_Q"LO4G#(9'7;33?@1G?E;#R*,,!%01+%\Z.@6TT/^5\O(L7R[+NU'![
MVDIUKOI!L75'8+G5$NR[$NS^7^%NZ;2<-6Z&DCKF06O<KZ"43YX"9&3OLR6S
M923L/U":(R/OUDM]EJ.*$(S@D&WR,EVA_PX1W0&U1"Q$INLX./!<R=6MKNZ\
M[VO@F3I/2D*6N^]B*-8Z'0&,CA+2/8(UJ'A9[YUSNU//BCJ$_6,<^"%ZK'AI
M\PZ]PW/J'LV&KR2^JQ:%;9I+QF46'>U7F_!;W+@X8:FT9K4X@XD@(K]M#%F4
MQ,TC^QR/%E-62\45!Z:X>/I=!TO'YI.<9F]>8]$&B&*0!;G0_2@9OBZUO,K]
MBD9W[5]%VFP:Q1PSW8\?VD]N::]\2&?-%A Z 5^VS!#[HF8;5X)SSF\O8BR^
M"9 =R[)>O,:/1 Q;XS<[:+%WED:K</9H#BJ:.D030X*7TP-T.&]Y4Z3&F;,&
M$,O3DC7G^E:F9(,HE955/WM&_KH<F4'@:"5B[8A.;P W0(E:=;-_0IH7%W2_
MC672!Y*K'MUSN7#Z8ME0!RMN:@V,*'WQ?+ 66<HDJ.N@Q$]?7CB872<731O9
MYZPX'/:(@]$WR;__;@+ 1JR[E:?7Y4;P.)AX7P04U;B-7Y*284G'6<M\Y4P/
M:+_QWEV>>"S.48Y/PRT_9Z>?7_OA8.D673]X*I22'VJM_@_ATC+RCQN'WX'7
MO=CTT:DS/__B%@^K,ZLR?<7)74=AI_*X.MIN!-1[Y^,"E.+^4[DCAY*@$QMB
M]X8E (RSN&).*PJMV )%JT8/[L#I_WZM9(SI#'O'9ZXXQ6E233V B6>Q60!C
M^ZS#V=@=G%/5)C&()4JHK/PV#.?6/<J!\W4[@Y_-VY<6[6=F:8INF"H<8O>S
MR=7+*AW6T(K80DD9'*C*,GGV%Z9)-Q0IEG:ZX_6\>;_:\=DS,;"IJ_WF:C&,
M3R*&0.(Z!DU8 >48@46.3"9W'0E=YB_*08$"N'<?9S,)-Q@'V#[Z=2CM8 ,&
M;@4IFXQCHM:LPC,377E*GJUQ3O3Z\$5S@VX/2Y)9C!8C2-EH;45E0OEJ9@6B
MZWZ;R;UX"!G8,@I@(Q:1M3/7D0DC4-I]=4.+8=/O)][.BW9?<DE3_6&0*W/J
MG$01:H&+Q@=Q/*:ZXIM*+!Z9"-@H]H[/\\N>'(5DKMG?^FX'YRD@E>8?8S[V
M^U >N:I=,Z5$R(:+KUP=[S1DGSG<D3M_L^&-BB25)\/I2\SXJ61YTDTC^KX^
M]2R=Q$XXPX("BR;UN^6&@-5?#!/^39W)"@#TF9=_A1X5R7K>I1WKYR'.%C/7
MF%0QHK6%KJ>W"5;QG"!9D'S8NZD^6RPG6UR#RROU1\2CZ[3\^4]W\@@\6M0B
M(@024.DXCZ">]_L-IS?WU?&X-1/VVLCFW3J8*"31B>@J,JA\R:AU\PT.75)
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MO-[<FFZFV"3CCM.%&)X/\2VY">D*T5)_=)>5X>CD:%$#&"KTGH^.1TXGPIR
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M^'&PL.ELD0>%\5OB+^(NKE"LU%K^ 'K,HWXL4ZG939-Y=]?ZFC-\8UH=9_S
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M/\!K%X_""6Y_V"7<=>=;&6?1W'2&7PEH);4*AF*=+AC\MOSQ#^%X[]KAG=?
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M$O>283!LZ)/O?MZ@O0SU$*E6*M"<59MC.B/ T6LRC])I/G%W&,Z6RZ)BZ%N
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M2SS^$(LHZ:79'?BCK^@S?+X&$@^=4C0#(TV.!!EQTEC,06=*7(#M'+4UHD#
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MUOB]EYPQNO3A>#P<,1^8 O<> U,:W([,-_>/,55A(2V5OE,6U8AUK$]H\RG
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MXCH ](XA@=$.J]'-0H=)?!VTKMD8Z.+-4LA5ML5[?!7L9(%KPB.S8>E0V5X
M^EA/RN34A]*]X,&E#]3,#E<T#.]XH=Y*$B?F.F.,C*I<5&NT%,D*[@G&36L%
MG\1+Z*)H'I%KR1;G>X)"2[<L(4($-NQ;2DE[3]B[2'9LT?*"EQ[5G,.ZAG?A
M>7T@,"O,MIT,]!OGN C0/D09!5[7Y<B",T-<P)MBLS.V\,;<5WF=EW,0@,9
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M% ^X>\[P4>'F<5*%^E H"1U:^"0J5_NRQD!:2"-& \/00:I&1D< OJF--P>
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M-:(R(0MQ:V\B6T9].\7[<MWA(7I;(FBD<"-NTW0  !A@J]7)],D-[.[J]DB
M8K3*N@P/EB1^BSI:Q$DIWIUF'_$FI%:U2D*W;:WX[;92*KZ_;<,A^\7:0U50
MYHT"C6G4 I3D*1-<T^[(5T-FJ %S.?N3VG"QSK!AP4/V(EY3"KE&ZQ$9WT%K
M)Y[9B@YODX("2I[+ V[!)$>G<.?IHK]G#4_?H^M-U;)'749&C"\*/MI.;*'@
MZZCJ;/#*EFT/E(:35T4%5@$L$*L;<E@?U$I3KB.Y5>QIP&T>1T4TK;(C8(,B
M=5&1,$>@W:XD-&Z_!/9MM<1]/F%I_XRHUVLRK;='7.Z"N,Z"FX/-AD +,Y_C
MN1DVX3*H@Z$X<QN\7'X;K$SCQ)8W&H.L";"YGOGUZ^Z[F+O;HFY8V$NT]F3/
MV)Z#H-AFB EO-J8X(/,>#K=[9W^<\,A%CQ)$^J.@*"N:Q34HD 7H))[L4R[Z
M^':2]Z%FW>"<-AZIVD2FI@6-<3P2S"J?H]"VRT+0UG*8FL+J0NJ%?9J3@?&*
M.:GZ-LKQC8M8*U^53PYAIZ3:>Y6ZNB%8R]85HET S"S81,M-$1MM&Z19-UM*
M ^5(%?>KH;%U:"A2:,+R\U!KXP@4.T]39P,-^!.'R,.^0UE2O:G-$:[KNX<V
M:P%*R+%C87WNFWH+#>>L;VG(=Z^1S9]6[DK<HOWQN+(JA!(<""GM;6HJW(ZQ
M0-PS%N"KG?/;"!WM)-;@D><6)&\#!7*R2S4JX@4/Y1F+7T.X'2#.H"P:BAIQ
MU\D$*H6Q'N$'2ZD(/'&+!%G"Q;"W+S>6 W DT[GS#'+D5R'O]6 K\M>2TC".
M+=)%M9U\TF! K=*S=-GC:Z\<9]K+.8"I"X!ND"@R@PC>8CQRNBT1+&E+LF3H
M%\L KPA[C4,_+LC>H,S%MRN]=52X(A.8D0L.2<^'9#;9_38JB#':2O0&TF4Q
M6344 *+5["$W/6P\_MJ51XP&L\3DY.&D2NUZC<M8O)DL7_A8^WVO?;DEX"]_
M))&41-R+"^;;/D:5;#;HO.A-S$E-,D&]JVYA**<B\9FT3!]$BVOA5M>:XJ]"
MNJ]"%13ZV\*X8W9P:&MA&/J.N6IDA272<YR<2RP)5,C3KEH-G8!-S]75@GH;
M=1" "\%0)U +>HB%JS.)"K;MK.10X&_(H5$(WR63,='CQCGN%A,"'!04) TD
MQ[",*(T$A J.$,/Q78['N7534L?KI3:/!X&$H[[7LCTBE4C,W/1P>V;B<5W:
MLE"@LK#CI9S\3>_FOK*O%^I$Y8).-,?=:FQL\.+"Z:6+$J 1-URGV+K&&S(1
MEY%ZC"4M';2AA0^,LX !LX3!^50J&4B\G.M5-N;NB'FBQ LCR]J1""L.+"M^
MD8,/X[JB6;50,*;BAI$B!+#K!#A;;RL7,1K6-XQQN@J*R6^E*K,.M^312]D+
MEUE>:\0UN^2W^+F/!&;PU0//G;P<#.41.AF1D=)/6]-_XN6VTOZ&E"Q#.KMO
M9[#8N(UK2RF2"6(8 J?MK(8#O2%\:"7 -TO!Z>34;_>%<%9&:]$K[2J,S5S@
M&\B;_4 Y5/JL%49EB#N"K;RLE]7(2C*LP#8:A/7#XC-ZH48S8W*JXK&E$"-E
MY$5!G;CC MHWB5(B73=36R2F9&Y ?:<>1MS/4?2(U1684>"4T!&XWKV"0%[9
M/[^YKS=N61_UDBY2&': GUJ!TC7Q8UO.VC2%-SBKAUNKG E7I--X;\IC,V%2
M#3,&7%IA=V34OG2[RLYCIM.&H\A[N744?92NE^3' MNQFCG\GN !/6E#7"<;
M/"$'AY9'V5N4TE 1O^I6O7X(^2S.]V.2<L<+RY(5.EK",!%IDBX9D:ZU;.(2
MP]34JJI1CX,4NMD+;7:W!-Q_<B^WI?N\<;6:+O"<"*0T=;:V2,"LG\NSO-F=
MP+[R3OLUI5S\/;%HS!H8L63;',AM:Y 4H"(D-!$GF:VEO)@(_S%8JL_I46'E
M*YXDK+C>HJO6#R/Y,/#[T?)P#10!5L6\>@_<;;A=LKAK[*V,';:-9T?U?JU?
M</XBR@#@W=1&)!71PS2#,0W ,7T_RG3A(*NIBUH HZGKM=) P'4]6FG_"F\[
M(@GEDVUV4]?)0;=?:YY]M:J;VM2J(.Q/&[2!)Y,CM9J@5GN_9F!O=F88.$4Y
M<@5*L/3450]1!APYH,ZT>]P/618"M2RJ3+A9G3J9+_T;RPV&KP$,;'8UY31^
MZRZQ"4LH[<2415&836&L-DTSK>JJ/Y5'0U'8S98+O?I@--,2[H6\7.+OO)\(
MFTO=6YZR'\((/E@Q+"6TL[7R?D5YNTAF\2'T9*&'VO3<-JX^#@BTLE<]GK#5
M!L]Z?L672L/@%<GA"-PV/<_?T!>%"&MW)5\.QPLH@3CB@B75B/X8F:?JV(0R
M)A]H75%\H*G( !+A'5/O%A26A-V",GJF6-.>E8'NMN&]6Y BKY&4IX#%5[+1
M\CN\+K9@V<.@!E^[?F4<6E,](L%8+VC3F%)7YD%+<M/+!A;JHF;QWH$.:6BO
MIBNDW=8<>AR>Y*$)!M_9(:?NA*TFN.6/-EO.K:WCPT%<G\UMAR*C%=LU6&3X
MZG*&9[.)=-%&H96VFB+#(%K#4&^YGNVY*"XUZ+DO>27)V;T(JE>VKLGLU&6F
M5T<X#KB>:!90"3@+LD9TVT<J1%=1";?7X<*+0D-<E-&F?@L!:F]MZ].2NJMG
MH5KB0KX!O$,9.I1Y3J!L)9K> LK A@YZIO&U"^1J8H7((V.C6&WSE&RN-[C!
MZ:70..DM+I.P[)/7\"@>KKUVRH6@6D#;)1&<G::6J\0T!52>&<IV=052SN)Y
MZ-M$-!B;4D%%GR[MOF_TJ5N=Q\UM45=J,X++Z,4&%@AYV?%VA*WII#PXG>%#
M]1$(HIF!196RY&['[IC3B-(2W9+I,8^PTI# K;P@U-U>E6JM?IRG@+R-59S.
M;.L$1T!9-#L&CI87"!B[RD/FKA1S)'2#:L<34.N?Z)06K-BA</4PP_Q^2LVZ
M3H,!B&Z9%-%EO.*[\L(L&L*7D'"LU1$H3Q ?6EYP1'JUD8950<' XADNZK&>
MC5G$B4'FEOR2Z)H] M-&O@HQ*<!N@#-)+NW5X$Q?5>:T[ Z;+>26N&==A63&
MKQ5^=288N,BVPA\BPF4:L)?853OYAD\.G;=$[ZCSCO6XFHS;FL,QKUP\T$94
MOUKI4'F"C<:)Y723&*PN:RAV+(0]*=J)7Q.C8F7-?@@L8O?$@SF)XT5&!<ZW
MA_':DTI!$-6G=#"=W5F7&$+7?#OKN=6YLB4FTQ>HFJFK8MO T7I);YRL<K6M
M311)A\6$%NM6INED$Q_DV_IAJQZ,_FII*%\MD:5"VL6!1PU8$D"W0HE&@)B9
M<C+=@2H+@%G^*OH.&QA+%#)>CJCD^CZGOSY6FP6LM<DKD:'A*XRC*3W4CBGA
MHT=AP60'K3A(FI^H)^U\VI]%?3 5.3\CHM:(@8"G1)@!9+E!O=N:@YT?#U%G
M;.(:=Z)@H.8,"V<2T8ED6E%IP-9YKK>UAOIB3ZWKAKOP/+G>Y09K8M7^(O
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M;H*?R-X15= 6PP-_1O?*11=S8QB!?2%6^:Y821"@]P*'K.YVR!L&N>0C6?D
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MO--@>8V<Y*ABM,\_U=[9OD1-D\;<^,"R1L\6O*P0[[87!1ZS/&(8)"E!WX;
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M_48"994?AL1IVI<8ME_<_&J7<3J22P?.3++)I^GCP85R-6V^I\+;*+BB[WU
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M8LD6'YG84H5V;DI1?A_XW,E<(A]F^7&4_%D>H*^=EUE135J^<*'Y:3_2,6.
M-]G/?6$>--]&)>DN\DCT8GG*N!GB_,N+I.J.O7I1X,C6W1-A7,8Y5C'34HC#
M*T>,!.,?I8-71=54?SO2N KEL'J35G,2@ 17QE'S"3BYLE Y)5I(\0LX#5Z$
MXT_-](>KURQ9HQHR8+.5%OH2(9X1L58W2$( =']DCC9<T?*<H=?J:M$$NCWU
MKD]A"E=D2QQBU:L8 .^F)GWD%]_6VW 8I<>FM<R6^IUSDV]2G,@VZ3"LUI?A
MEI;JZ1;LZGD.Q[-S%I)E='IVB@%TYL?!P62U*<)S^S49_:,5DA_%10CV<5,L
M@K%F&P<+1T@F'92#@3Q.>1%;]U^+# 6@V2RSG:3D,]2V$A*KHI9WCL1F?Q'V
M5[H,-I![_/T:U(K;4L#3)3\2$:;.\Q6]ERP#5_T%/C\YUR_0$*]W'[?!*# &
M\0PC)0*#0'2D-^U1#02U;,Y#^]1V6GYR;44?7>=VXRV/*Q?(@[/>B.BP16_$
M%B<"O8-J%SLM\\\+H]PCTMKN'(LYRH2+E(WH?84(]*2/\_--853#MZI;,X\S
MDJOF!N\[7Z., GC86G.CR<B2+G(".9RXVEK>36,^.'6](<2:^L8/GVW)" BV
MDPT2MU?+=&$NB2A.'J9DI\RAH*"0ZZA#P M=K3ZTKZ9[.[_0K_)VEUA48Y#T
MGH<?5'J$1;:V\DRAI[D!JBG&^4!^:9QG4"@XNKP:4\@,QL=N16*' UX7:\?"
M/AFE;HU%NIJNR$W90Z0#/31?K>7DK?#;!Z#BDD?-"E2$&&.SA'"B&9<W\D-J
MXWTC>&]SUM273(_TBW.+V[EE-$0.B_VVR+8+6?T[Z! [WH,+OQ@CN_WRS=,6
M1IW_W,,"_ KLET$@OCOX-5@N+L63K8&BT-]O]Q>!BBL;!Z_2R;7]UV'8B'2"
M+:]OM##V&PM=#1U*^(5MH/>2@_TA'%7:Z^1L,@Y'=#9=4.S<;PNOHN)L;!L9
M02+.0\E/A-BLHEU#74[NJYHD8N5'?'+,\:.<]YGV%7X!MFV_?!C*?R/T,R=G
M"68Z436*6Y$X!\YP_>M+ V_\]J3@C.AET<OE &>-+X*,D90,4@S]@H-AGH/O
MDB?%EX*;Y]@O]#Q;FI5BZ+>[@B-Z!VI H9OML3CJG#J^?C+K2K4?FK:J8B3&
MA&F,.I**Z39$MQ\\BS.3;U [9=DAX)7=T>RVW-0*N-:8J7K^[S@L#FA]1Q$1
M%_X:<CD.,A9S_N_-.(=.E@]?;'*'B'(RN;SZU*1"F,&H\?U"^ ;VRP]4: 29
M9[1R=V.=5R8Z1X]A611"P6T'7\ JT9_ZG$/,&2IO3[:SBDG>D?D^ &/L=6"V
MRR/Y_I]\E"4%:+TL7+@FTPR#5.A8:!-5?0.\."?UZN?QO%IJK Y!2-Z\.L)E
MA3\=:F$.>RXLZ''VA@=6$$W1#Q1?''6&EFSBD\@5\A%Q0CG''ZT^FM4-G=MO
M$"YD]0=Q;[[,2]V=YGSC@!30<5YVA!H \TS7<A$8G8S0J:;'9@U'X%BCL8O;
MW+6X@[&;VE-^P\I&.-40-I817XTA;THYY[YQ^-KODCR:\*1("#A"#;+_%%#%
M</R$.%F0F:-M9LY=XF@+IM#QYAQ&;64O8VCB')MFK5IF>(X=C$%%1E<4ZWZ*
M]2U(]2U(F]K9OWS.LO$9^/F#7R6FP[L_$0PI.U'MAW$"Q$8='0:#0K]<?EU2
MC 9&/QZ$.,41X.+:8!O_I/]DWD+W+#@DA-\(VI1!245@>N]!121E<2%ZT=-R
M[,!?R@35X6NXK4M\<2Y')NQX1D+M@^(44!>0G(O)(COK,T[0#_FC*H W<VAE
M$>*Q#$.'*4MD,D2FA@E[[+9]>A(DHDTY0]'R>PL+'O='L54O#_;P%_\HCB4]
MB'B1##?[R*[DU#@UG8O<=7@!3SRX^*&+B<+JQZ^T6R.WWEUY 1DKY@Q;%!+L
M=-I$U.I?C[D8QK(!4VQC<_,BT/(*=]%K%#D)DHQK<9A3&M4N>/5/@->G>@D#
M;@*Y:"%4:7X\Q,3O5- ;$\.QGFW3^F,XWQ44)<(U\.MOPR*FQFTMBSR[T^HK
M@FEJ,HQ.+@!,EC"#E@%PR$1- L>EH*W\4^ $;G]['(05LD>E@!QR'T9]O \(
M[;MW%Q^V]IL)#JJ)>! <D2-"0YLR>ZS6_1HNI[VST0#;45F^-.[]<WBB32ZA
MD_*E?(9KFU- /$+O@UP>Y9LOU?F_N=I,/YA:X_6N_FK)TR1(X#]?]H[M<<^-
ML]:AV$A;-W#UF42T3)IW9&]C)6W&??!RL1=OD5^VJ4*M#PL74+)SV!.PF)P)
MFX/U74(:@E;&#3C1ES+'8)9I(6M>_#_1Q!N6!LJ,/;*:KAHSS&6XF5$PU-@$
M_W%ALCRT3%FQ:7_W,$:<+5A_1#.\X?)Q^EA"KE-7T<'K+X+=2XG!_D8H^3.(
MOP+<(MHBY5>:*??=+PJ2+#OJ#(41PULFHH?>S?0_DW0,WNP6_[I;$W,+7I+8
MYL".J&/*WJP@%4G,ALADE5G*^""XE&GQ7,9DD?'R_,[ 0N>TP@.96\N(X-)>
MBG)].$OBW'J=YLF23@!$ J<^:SGM>';3YC: 1<2[@^-KP;SJBYK'TR(J:L%Y
M:@OP Q=#63_6/6!#)D4 7:O60F_L!CHP)>)J;M9 2WZ_MVMN,K#^)?(U3H]#
MR1RZJ$-$[A%9V3*MY]5P\IJE/LR'P]_=O'A80\%'4Z(K=B\W_>DILD+6L"\V
M\<A9&U"8<(#7(:-S=(A37E:.KJB^0I#^ 5V5()U!<$ SO?R?);R2=(0@WY)T
MA#O>DG14XEN=^K]AS/J0DZF1Q[\%LJCBV\T.JWG>G>N?/'WO;?#V; @*"K>4
M-V18W_26\[%; ^"N@#F46S$2?X8OF4_DD_5<XI$P)]_A=!!XF3TTA$>Y8:J7
MZ:O%LWW"_5'D'?P7X>.'G]G'[4&2O"@ SOKW.5'R6\&=95/]6 I]T(!/)XIU
MV-\(V;T-MQM@M4Q6F[.!'7T?A4F;4,<*.2#]R0-7.IH?T?]36 A0NI"[X--2
MW@P,5K=?8^9(ZBWFPOA8HPK_2%^$)_SV9<X"!J@9.TC\7?MAQ[S=?@O/?UPZ
MNW,!Z)L-^=2QD/=MIZ9UY7@'##,!F9B$YDY^6] C6=E>R)R6=/TYK5#% ?HU
M[$U\)<G^25N'R$U!C(]#&J]]85I#]9#4B"(2".23K5S@7PFK9 =C?>_6T%MR
MY,QR[%F9^VHI\( :6E@RS=?9FTJCF&U2@_=-#T>]-+,08\OVDOQQ85!K,#$+
M,OWEC>[&HG"SFGE)GAASQ R1/CCK@Z2&@"XJ8-PJA9'#^2;I[I6-[V&[$+ K
M6*W:NP4% 8(<&\Y@48-.;1M'-!:AD87O-.%5$KJG"ZKZ*GHX%;E^<2Q=HR3]
M.#HZYI;D$K[[5@5R+>NSS+5>12Q?:]/Q(%HZBRH<@;>:&ZRE24E$(R(1/I0)
MV4.(N?)DB)ZK)_%F."W7.?6-I9.9<(CA+JBKD=_D36(X$[06[D+\=!8D;C C
MFJH?+E.M.")!S**8WKV/(4M<Q.ZY4]507$964UM>0<U'C"\%H[FGAL0U]"S7
MJ3#N^X"-OI,Q=G9F9LV:B]8RC6$7H>HF^B8#WEKM1B$W,SG%O>$MLL*M+U]M
MT+*V);O9QJ]X@WX@QU/NQT!MG1*Q+WCSN#TK.C .K&5W3V0=U56:9V7UC\T2
MJ9SV<L^>^4?18:E4GWZ5&OP0FGO*L%+FWPIU# J:D#M/RF,0$ZF>4?NX@7TS
M\^7P9X7N=MLK9\'!J/F)[]?Y3Z<UNWHRF"GQ?Q%LI#R<4; 4M&4LQ^T\N>#N
M0T&:4-Y\R\*OM>\PDQZ#<[L4\>;KN8Q(_<ZH>'=$Q3P'<!'@;MT27UU!</TN
M(8B.V5/SN@I)?L0ZGB.0,6>/MPEE!(9?E)>/])@48[(O[LY68#1'1_WT$4UY
MS;M@A(3XD9<&D>R=9O*V[^SVGR\OF+K<!VJ50C-,2?K:3XW+SDV%02<@/A#.
MQ:@W&7(3+*YH6&0=6B]T=OC).S=B]"\"H=C [5=2\=E2,.8[00#G4KZ9)=O^
MC<9)SS][N@';H/SX>\B<L&J6TH)";,0W!U&M1E)1D\7*HW2EM'B)HLGT;7']
MP1V1X<__J+#JXT:_YC4U%==-:IR,NDRIQ$3OUP\2FK> ;W_.6_/F+'OLO&Y[
M-\Q^H^49:%$X5+I?I"QY"Z-.A6V"(/N[/$IFF$M&99.8MS]F-E9\\IS*A9).
M!6]DX[%PG[**)'2I2+9X]XOHM\FN=G/*V,O[;Y6![6-""FYUU07+EQQXB;Q%
M_/B_&VBLGL1FG6""+EE/D6=,O>LN?+-,U9XHEUI=8K[%;A>8DYK^CR6 MN8:
MW'RH#MK2S6['#WOBN9WFLK\(UJ.*7&+T5B))?Q&('U5%_B+PO:I:'];I3G")
MD6S(J<K^T=#Z,KH_U"T07\2S%0A=<UD0]I@;<,YDDT'.FU T"F+G>5[CM2!H
M_XN0,\LTK4PYQK[UWZ,#,GM[]S+Q6O9U_NDRK?]$VA+U%Z$,,?D09IG,B.0_
M5A75 ._WM4>++.XZF""H?#'0=-LH-S21*5*?K&%Q9<\=X+A9A'A1QS\9[NLJ
M*!D9.%9G^B@O#R&!28SBO?8[N<-$XL#VN#,C+YSL("(/N".-5V%-YF^V[VT^
M3L"2BH90$EQ62XU5,4A\JIQ/S\&9(44O>G9')SO!O]YG"9G24MAE6=Z5-Z@=
MB[F"E:1*4#H=X(L/XF3DHYWRG\XP%;!]>S!?S#;2QS-2!LK&?7F;J("3-GR)
MPFNY\PS%;BUDXFAG?R KPCL!<4V3H\Y_VHP.YG_ :^U[E SMX4:G>J ,; K7
M]2U>I(MK"X>!'Q_@^:2/DV_K7!C%WUE$CWA,63QF3_I-O,W?TR&QMA*$V/2Z
M##ULRRR_8?6S1=4=4I$PHX_&-TG+1D3"M3\<CIV\>Z5&>*BK/M0TMB_SLS;U
MI?VAYAN>,--6[720Z[*8_#B?B3MR]L':"=*.]NFLJ'8%HON1[^X'\]AD^5R$
M9$NNC#&9_!8]>IEA\W2/5>]D8BO1[P? *.QW!8[4RE* GK5LZ5ZD8CON.HV/
M/HBAY[IT?.OVZ_$(M.YP+5VZ7?#2\J>J=AS?2*U#'+'6;(=-1>9C$X.N\N<B
MXT1EY_SGT:BHGQ(;.O5;5-T+8H67@A>W(=4I8)(:'9JN6?*,IL[G7J_L^U33
M,.!29#+AO7C;C^%6P8RXK)PZ&!5S4]T>71DA6<=%YJ-1>&27X).8I.@?Q+$G
MZ)6OMB'U9=Q"3V[W2WCS(@-!QR$SP? ;TVX@7D;J]X:]_3+!P9$?,MY2=_'4
MJ5](N:0I[%F0.=4FC$+(ME75N*< +[W7FO8VWWM+5F \O$I8:I0ZFA)=B0JD
M&+P^PZ>)3"'/;=3G(16?]U]=3K<&@6=?X'J?'QUO;C0E58]-*-7.J\]T"*(_
M5%?%1,S4$G_,%';P^XR4<WXFK<*;P]34J?;Y(0%44TVL-.KD\ 1!ZI=*! \?
MO^^2L!@.K[C81IA=^:?^CPG\D7W\>3CM^S(?TV9:>AISF87C<H!S@VXLN1VK
M:^/<A?1<I(:<D2[9O%!E/BA2?D5*<(5:5LPG9<B[1ZPB0,<Y<T/&'=KJG8+#
M2Q;M=',?!Z3CF+0_<G2D'C/YA$-+_<0X)8<@=C*$H5S]@EBR_!>A=C6H\%1\
MZ?[;^H#2\MD"B^OC7P17=.#"#YQ!TJ\0U@$,X#BU@JK6[GY1UZU)B]7J1[W.
MDZ>YSM:%!1JOM]S9LT]_,JWN[":FSU<&#4S[;P\W? &H/:^"I3]BJ2FO5C3=
M&P>260I0#R'$=H$27P^LK,M-]VR,-Z>6-*%_$8"0'+;@>_ZA[I\9VZOW^.F[
M;']L7L05KIZJ;WJ+RM?_J?MG/(<U83KYUS,.!?R/&V*XVQ3L!6@VN02K4M4W
MTV"]4#6_KY19<ED =\"$8NF0VLQ8_\PVY@)RO1[P;3)_*PJ'KV>PZ2J"Y?N8
M\"1V/\LY$F3\);74X.R;MJ3*A<-$FZU(9HI^;(V!_O$4[J;6;VP(-!ZKU=4L
M=MMOY[6TYH>$9%2PW63%IF+J[!XXCPOC#OXSMMY_@E;,IY[MNZ ">C>X&@5@
MB-CH"+1&CVZLE+(A/1\; "?2F<,)="=A7962234J2AX,B<\*%O59P55_<E3>
MTD?A3/O&[;H/&36B($]]=_\M,)L$N_\HV7FI8_V+>;+41M>>K5)71VWJO."/
MC<,$%A;?G\EGE7]"KC@;K2<>C_BO;_4O&WK3WQ9>Z2)DLB]B8_(.^#O9M.HU
MS4]P,C$[" T-/M6]OH55N[*Y.%"8@ 0(B1S3=EG*J*D'4]?X281R+8!H=+JG
M=V,<JOUD W'A++-B4:)7NZ_K<A_DGRIK "8:31G?J#R[EO1Q!5S#843;1T"+
MCEK)\X)<+!=G?+[]4"B*/M8PKSL0JOE!=UL7K>;V]UN$< ]>/*+ F"_U+_\/
MR5E#M0IYB;)_\YX/EYA?U0BD62M##2[B)\2AS0NL,5I)0OQP=">JH'V'I!)[
M5,;*2-?>7N.*Q^"R6QLTP%J]9>4U74FOIL(;?S5.+49>@_F=G"[2A9.;,%>!
M8Y.ABS+?S/6F37C"[CVX.61(%WY4 0#HR @BA>[*&$-EWY<"MWG A;($9^<A
MP^'N2&=DGQ4G!?G)9^6HWG;FJ,K+X?,H(-;)7\]6O]U3#N77CN1.4BN'_9;Q
M%+KU:\VW))M=&7A]DR-%P<AS-[)UAR1TT3.5,$-MG7#//L5H2613G,+C,;?>
M3$;#KO)-@S(I\5U/]\6^#-FEPTD'X.A_0-2-FTF*=_E5?MSS6&<NW7/.8>#3
M#CBZ-UX&.SLOF="4.-[CT+ W=2!5N=#Y.N)4$IVFZJSCD^(:VL\=S-]&!^CB
M&'"<C7)\?9?:)423BRL_,I0LNTQ*5R@K.>/&O^PJU9#*<G7#F)S1@)S3H$Y_
M1.7P0HJ:H%8S@%MXR\66D;ROPZH\KLC#Q5K\A26'9U=^:H]F<I[&<_%H(M;T
MO_U3[?_/R.SG#7GJ.%/\1; ]ORR_0X^(S&CPCW,]R7!5$IE7[3J_!\FON/^Z
M';!B!D_WNU0/Q;2>E^4T$I:^2UST^&6Y.(DM9/.. .?K/H.;+/> CR!3]/?
M1F'?Z\/;\W<RZ22>\H>#9J>C_ A:Y VFZ7B!K;S14*/&9F)\@E%X+??%D!.7
MQSC^GG*F+7[I9O6U%1TVW^'=O+9F)3IH>@UWW2FQ:_WP,[/.T6.CRB\UIY>L
M3P7\RVY.?&[B@]!;_CG;1MTZ0),_;3$]:N2S35;'.5T]P-S]P*;G:&$<7X!
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MSKN.[HFT-;^A@[36@P?."DQ %EAE-!_58+GP!GZ7H37&4)9ZL[RVH5HGX=W
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M!@<T[ER7MM95.50,E1Y;+0-V*./Q5O1O,4Z2?KMR<2&,IKGK#+U3QM O#!K
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M[@&');39_T%F9?B..81J8^ETO*N5W5FH><7+C]AQW'_4VD$;;47K(DV+547
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MJ;M+4I\>DAP$]QK_$PA>)2#.A1B)&6%ZKS3,4O[*XR^ RX(B<BD-L')0_3Q
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MS;9GOTB;:WW/8%[LJ0JNA)^53:"J3FK8P-<X2C3A DOCB>@F=53"P+N05P2
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M$)CN,1\,T3';!8%_S*DJ+R((0W.C.OJZIRUQTJYU7-Y6Q%?0^(H(ASZB\7]
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M$T%+$(4@\>,L@DN32XT-R*?U3M>+D',(JFA\>52<]=%=6D#2->NJ\/'"G7D
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M9&M,F91AZE"EC<%9;3S(1+/4+ V:M$4% G,&5?H@@%BJ[4WY*$T3EQ5RQ(X
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MU=DL$["N%XJ:"G48KC'HYP-Q@MH97N)Z=C.1[<P/J4ZJ +VT\=)@@5$/H<X
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M(K)>KXLM(5<C5:%/3<08C^J#'!UU"YT ]ATD2+@Y7Q'3#F^T2$022$]HY .
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M2;6N&=HI,IW/O]!L<4$K^/."]UV[XH%7C1??5LB1_/&59(CIK^=O,042A1&
MI<-O-P+K>RYA;%Y$^ ELI"ZQB[F&K@,+*PLN*3\TYZ\->EL0JV=-'18(*3:S
M_D"=I4@49S%#4IM&$Z?);)8M'6?>%,O?,S4+O/8(+_]4>TX_GTXSB!>%5GRA
M%SMQ'%M@<"^R]:47QU)O$*EZ)9&MU)#H@!#KJ3C9M:OK'8X%Q;\ [[MC,7T/
M8('D?.)L38W]M^Y)O:;LW5,7K6Q+C_U?\0V]2?8/G0&#.GTY5R8LV8[DD$#"
M3$:R#[%T7.AU46HF>E&_*X>D=R0T_!K/A816?=DT5PS43_JN#7H> I]1O==N
MQ*!=^^*-A633 A:!$#D./@&IEG&W_'@CT(O,]B@._';G&<(^IJO3T;-<D+%.
ML[X38PT_32NO@1D\PS-0H=1705!@X9K8XJ <-:IZ:'Q0 \.&J/GU6SJ$Y1_F
M5<W0S'A&)3A%Q,Q2G2,.ABT5ZQ%)&?G[R2->=GE0:U"L4AL4[NA65-LLS'"7
M+F0E!G68%K [+6U%0%W&W#(;U.9+P/+7]6-PM_-SFRVH[[6@ZTY)X:S]D7V5
MD!-J[:>W6#C([Q-/,YNTZ88SJ/+V2-D*OWZ?1W&;D=+0!O)/<,7+"7O,2^'!
M];E@!A[P;.Z5;">L9ZM:-!E227[#7+),02_Q508$Z$X]=8Z;S70<(3<V:YK$
MSB.;=+&">Y 65[#/;B_I\2??U"> TP:?87K9&A6XV4*3PQK<P[<R.2;%9EBZ
MN,4ETK]AR5RW7OL8+[.B,(,N*)9XLW+6;HF<]W%(RV4MB*_ YC$D:]Y]'!PC
M-S_V_#B"/,G6_\.:N^19=,JCG3[/MPWYC^M1*6R5G+3",YA=06>?WLFXM.0?
M/M6S2AUYL:?@4<$D,.&QMW">0=UINZTARUL_OOT9LY-+P5>^NFH*=9K).II<
MON7S1*+D8T;9WS73>2C9\2RS&&K6KYV4+-Q37>+K\Q71'3K-"*1@GZDJY>JV
M"L@TO*?"DG36DG>[)_[K:SL2!*['C+'@/O\QNR<;"UC'#('@WMLQTCD<,D+Q
M/<Y4AG^.^1[%!^TG0KY79M4B2))AHMO:[3W)O_J%5D/R;K=WWQ#CK=FW!I+W
M !P[O^7H']?69N=?1(GJR(9O%?>;"&;OG'<#:TFX/BKY<$Q;_?.8.IXA;><Q
MOQ"6\,#VDC-?D=Y /I; W_5^&LY'CF7!^Q9KZ @2LFO'VB*?\O6$[_'/+D6N
M'GDDG%@@[RJ9A>C&_?-:;G<)+W)%/I\RW1[<)#P$%[,;I4F_.]>@V#&^A]#]
M.OT>4 -&7)J=WS(N..Q0W" )6W<0&^]]/!ER7&^A=[WVHE>TC7V FR["G3B$
MJPQ7!<5-^#W@SKIMY>L1_-W-W,R?#$C.W4]\Q+Q6\M@48$0A$4AA*+90>/>I
MC&)>9694$VM6MVJ!Q_$H5Y1WH;BM>93Y'I I7'H/T*Q+:K!' Y?E4/O7[V&(
M+\@Q\4YM*Q?M5,RZ4<48'+N<=@"[;ZZ&"<D?5=ZMG3;IE9#B6DZ\R"W\$OTC
M5M:61GWLQ[<UCP6MI=)+1N'=K:9Q\JCLV-"ZOM@?NCOE)?N&2QR;YW;3I^(5
M02>%*K/I"]9U+H5^T4O4B6?,X'+% DK5K; !?G==]46C>OB6G4G;.+:H=_W0
M&QG<MWHNN,"@Q($DKW1;@5(W <L<,LZ-V9AKF?G^'\;3R"7T[R$L)L]UO[]-
M+< M &JF1K47^.>6"VBSUYVG"B=+(*8M]:3R";FZS+QD1GXU8XP=YBNPJ$BN
MD':;N%=92N%>*DBIEUP W4?IQM?G[(#V,;-3!.9YX6S3(RRR!:BKID5DJM8D
MR1ID/A0_<G3/(G@G)!)XDZU3%:7P_,N325? -*\JY30,@WFB9KM"D=QD_'K!
M4Z0JDEM2\IUXND<=RRN]F(XY3-AL_@OHH>VRQ69[_(E[H)UYW%6I=.R9:8<R
MB79F\O(2$@M%[#AU8);.,G!ZDV@1DVK8])F>!_$@I]4&UAR;_!LB'K"$V(L4
M;IS.-28HS_D/KL62J8JDA4@F1%4V%Z$#W+,L=SH[FR62"P*3(F-*!)QM093=
M^9>$>0W]O104&S:BN>$._']D)N>;4?UV9-,WWPIAR'Z5<9"8>RS\48CV[3<D
M/L(H^NO UU.[GZ4&2U$H+Y6()Z%51M_Y(5T21CQHTB>GK4_ DN:JBA,,8XY1
MG1;4V>ANG#;XR77A%F697.Z5VRWIG8K7,5+,1_33D0'X:%#KHIXRJ/CA#C[%
MY$>V!,N/,FOU8\[J^$E.AIP<1X-#U-LW0K_GU_,-BX:YZK2)PQ^E3(*E?YK$
MK(,_W:1@,P!M,T!N(QGQVI9%22GDZ:YLM7 "__;9D;K7]<K/4DDC?P6HE8WA
M<D@;H>8,4+]=&/9"$'',_0SY,%.@4W?"= =]PZ718B'"L"U&XG/A],FO68MR
M2?]MMR*'6.^!R;*OB,0.#FRP@QZ#>\6Q;<KJKKEO"#M<]S;051NSRJ[QMEF)
M/W3V%>]<W]K.P.N@G!A%V2[:SB1BRK!>4'HQ7_J'7VI!CS (O'*!$]RX-K%Z
MN7[,"3P4H0-1:]8&!E)TW.<>2[7:9MMXPUL.1Z\J%T9C)6VO-FG(H:_QQ^MT
MG7)XC.,X6-^S21TQDKPUU(PUV ?K<DM5QT&A0-6<L5(YJ*9ZK:,P'ZV.>E/4
MGX:V^#V FOBX3<+7NXAD)T?P]&QT*H3KS+_N<I9%(H87!I_R%Z[@WYB=@L/\
M PSXSNKAL2DQ4G^Z/L.3!H4\:BL!ZP=-XC?&%5]G*+Z(5M5=$+[K56F@GG]Z
M$>(F,2]041_;9&O (+$L\,Z6/MZ604FCM$/C%?ZZ?FO6]34.ARM3ZLS[6A&5
MYKV/"*(GUCPRG[&0JQ>H0_L?,5'YT9!(,&G>=L.DR%J%%^A.UF:X+ENN/)=?
MIPQ-ZWV8>%Q-BH,X^(SV"))=+/C[Y*0,967LR/J1[W>0: !:H/E'4DZ5MWX5
M^Q=2G%@7U"6L#?:U]G]7,@S;G+NC97_]L>1=^%8GL,-Y\_)=,\8WE:(VE#;P
M=W*BDN]L&N<WM+F$-]B_D^&0F>)FY$RSSM;,+[(>?>AI=E>K^NA$H;.P,-42
MWXE>^@GYDG3 #<Y=QW=_G,PG:XZ!'8:O @_)Y%R;'>7)TJT6]I7N 3R?Y\SA
M5=H["FL?;G4L<6'C;+BQ4OU58GMXEOOM[#M,J&.,/T7^S'F(>@_ _ITB"#G)
MA1?Q9.%-!=[97OTQN/S!X,+LB@>#MS31>O-61[^?OWAWOCAUAO=D,_&"@OGZ
M#N<B^![P=5L!;K\5'#;8QG2&3.(OCNUU3G'PMZQA3WIW&IZIK"S;J"1,2.=E
M_-?$?&?J3SKQ^5$'[AZ2L%;*ZV7B^!6/.9XGI_]B[*5'6M?)2>0#M"Z6H<3?
M0>P!:+W$I0_6]@FG/%C;_YCBP5@('/8X;V/+_B;W/RR2!==0ZC!+:SLHZO:"
M]D<(X(J;!Q7\9RY(P'6\3OR*Q0W/TZ/]JD.E&% =Q=>KU?*B(@LO<SOM@U%-
M$X/%^G7*/:(PEJG4ZBJ8.97EX<6'X.EO8CPOH;]")I><=X$BKAN ?F*;F \.
M?[>)Z-5/)K:&9G<1(SIQZ:DS 5@'(0B7X(L5W:=@TE!_0_HAWS28U]&3N4^K
MT6XR<P*5/(^7AOUR*<*WQ[KB)89R^545T&4U: 62[P&RG)27L7;,(^I9P[(W
M#C%.<FTHI#(>RR+AS9@.&4Z+7K8DUGLA,DU&>3_=:0]EMI@DPV@0B3"/6>[E
M^::,E\WC/9EI:H'Q<FG:$:8#^GD3VHXH?83!:>%>4KO91$[=&&2^05?9*1^N
M8?&L]:J.S>L;E7##R1?S[]@N*+ZT>!B:&2=Y59$W5YRT.+011C"#3>X4V9@5
MBWIV(-UX!4Q?"9\O.:KM]"GSGA+CP@R=OH\(LW>YV9;J0L[S)LX\"0?MSU\/
M+%Q/S\.J-#N'/134_>E>'W2&0FR%M/22#QE;#8-Z@?CT3"4#M$O58U)!+XF$
MRO4_S4)\)JP/>Y_]WF5-Z%E#X"P>:C<(B="?SNI'Z(4GBV*XC'9RKGK(KNL=
MCAX<#*;90YI]6MY$2!($3G0TZOZ^YGQ2<2N=?SHUQ_ N5O$0#VZ5//QCL]X_
M*\0%8?[,I>K'N0V_ZV KN2U8)S]T["6?K45MB\C3%GG/E,5,Q>5.$8K;'3DE
M6PSC(%(BXC(=2,"#*4,D*G4099(4/S'4B.&FJ7!_CR2S)#I!BM"FHJ4T%T$6
MUTJOHHN.%)X96X]3+S&\5!K2ITYMI6=FJ+I766A;544?+<E3EADABJRSUV,V
MUX*1:ZT/\NGHWQ,A\$^&4(7ZO5VL2!\E1Z6]E'=\,,2^^& DM-0E)B&^0/V5
MT4?)#%N-49T*<OY@&X_D_A67_7 GKW)XSB7AE#8/OZJ%U@WWL' GSYJ'[(;>
M7F 4HVL%I-<Q]""($6=GXQ$IWZE(UR=DH%JN,/?)]LN5\1LINOZ"6D<_5D-+
M9[^&>16_LOT?(7K0-006UPPKCH0(D9/&L&4L>N)-@>#@@1+/X5(6AG%6.&.)
MBM KHY\P>YL9)+"H]ZV]TOB,D(/^(1,6?H9KY[+2:8)I IUY;.<<+!.73:N\
M9K1I.6?I=],DW+2!V:\Q7Z$V\P&3D@WM1Y,+1>(^MEN_7_<67 0IQBMX+)SH
MM(XL7]J#0=Z:".>\2KVC_;!TN^1PRIR_G-,;,N!(G'YX04]B(Z 46NI!4U@@
M7TS9'D0SI_ '$Y$'3"#_BDDV!<X5DJZ7[L/@'^\8I[DTT[CN/7C'G<T?,KU[
ML("S',<F]E,3_:K*XKU[6\FOY/0K]V>V@X9?:69H&FSWGY;M[+$G7[/P)GGK
M1N.[;:3X"<',ZN1>7AAWZG)G"[&I'24BV-OY,E2,LS#5:HS3DXF+C=L7-^$Z
M?RCK,2>H]H<G01<I?WBR=,A>"69Q,>LU/9CBNL%EDRV/^PN4&])K^QKXQ!(;
M(\[J U%6_F+LI>M?[HE^<(\803]MLZ//W^Z94<G\XY[,IG_CGD"ZVNX'4' >
M0&$ A1=O\6N\GDY\%]^I913\[%E&^-\.<K+7^-M!;'\<Q([C61Y)&LXQW2(\
M:-7.N1;13Y:WZ7ICK%"G:Q^S4(7F+)M$-=PBUD4A)_0)^$AGI+"&%Q6D.=US
M1-3\]8@>9),)HF?)2(XIMN"Q,Z$U;2[J?WY5\#3)*O(4.)? ^=45Y"^<8$;7
MB7]I$OQS(*3$=9)/?<@]:-"Z7+$I!A^OFUB-$9,PZ"4304;D6H[&,$Q$N02>
M2.*FN79LE5QQ+2R(=+M,\:WF8X5;UAPHU"XF><K77:#73X-B]@VXEXQB$ Z'
M)9!&T]I.B[TCFP(>PW"*YPN\;T5C<T4=$-^JD+^;HEWY,%%D3T&9;96ROB'(
M@J!*FT=-HA$'OX8^'<7[F[, 284L.<FP7R7T=[L!V6(]ZD8FZS.AF+9;G=D
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MIR=FWWC6M&+@O1*;LKJ2'3C\.22 5,3J'N"VW<7;BXBS"$[ETLP[.V>"F$U
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MYZ!IX*R!WJ.[6<.CT'M,E)RW08OUH[Y_(>43=FMA=8)/.Z1@H<E%O+MQ4(E
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MV5MC-\%SGS\GZ'016F$24&WUM=&M]\U!54T%]#JH'K;$5 ?G7:%V_3>+N5=
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MWV9,51@ $Q/4"*AR73Q&+U)Y, 3*9M60]58?/-FOWQ4!_<\ $V_;V:"X8T#
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M[)K;?*HH52X<"1Q6M=#GB9F+I:)@T&GAXK8?F7<W4WKE_LX5@X-5-P O1,I
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M4I,K"U59-U"F<E8E"7&D=B<I6B&MJV-R8XM5=?3%P/VDC!_[AB)!RZ&\N(.
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M:DL2+$=.P!TY\)_4'Q<(Q Q*$ Q4*S>M3L4L8ZINYW1+DDR;;MHVUG<=&_!
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MM?IAL-L(J;!/RKF>G<>=0;SI4=U:BO!J?$6/<-&"9W&4UR= E$MS#%$=.3;
MR66MVE*1C->#JXT  S8R3(/H*3C:EY'!^ :(J)1]6U1@$6S&ACFT#OE,N?%M
MPC3B-M_:._'7Z-?W3DHVH*H#;FA#?&A#*J@2>5R)ITI6_2L>CJ 4B([":*@
M J6./Y.I9H976:' X@DPD_8;<NFB+USD0#W0J98#_@I",FH/5B*A$MAKJET@
MF*D.,E5IY1HJC&**$0+[3:&I8B$0;P8&L5 >[)35ANTO5775I6HDFS+>4S-
M$P-5(1/7F5:>-4I8KV8V8)(3<R-N R'E *UDV&P@CYM.)Y !TEDZ;-<4-,T
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M"KAN-ZBB/CK7 3&)Q7T[DE(9J#,\6/"B' 3Z,4EQ!BL$@@+!00S"I&&%5SG
MYUJ23S?T\5NFZO FH K8F(5Y,(<Y/ C!?8*!,$#S;%6P01_-D\FD,0!+EF_+
MT4Z[:,I@1,4B<,ST]>/J::($.&K+A/WI9Q' SZ18%=!P16PI#F8"!0#N]G@.
M[PSW&=L@'@^0JBUBR: KCD9(^VC@6Y8O,P*A>"$/5FW/KF"R8O;!DI]/*!R(
M4\/&_6H5L  ':((%V1 )$J@3(E'(B18XW']5>7#%3CN!@8B9;'">YD#<M])'
M$ SDY\P9 U=_<G U9P5W7W$*5'$T3ZF23JLYWG+\-/5L;75'2P,_X&SHBO;5
MU9TM_1'M6__3X=(50ISO.%T*?EW_I-;VF4+_:\<G6<5>[?')\6/BLZ7*4.*<
ML;;D6VULE:+5&0W%T2@1(.)!(AP:*AV.!# \3,#Q.(H&@U%D50G=NF)^[<!P
MD(/PV<'@;#0 0.AL!%JU<KNENEW)4<(U97C:]8><&_ZJ;:4NF36EZOO+2H_Y
M?Z'L#SH]_%W*KO9T]/^1LJ/EL7*BQY?'-UQA]Q5'@3-2;W@8F-4&R@K/BFG-
MV=TY8Q@<F 6-O\:^5E"?,P9#$+Z:DHZI^>-FM)YBM+_F@<,^AF?8OWY^-R+5
MOF-.2-.=[4.2FY6:BF\$1Y.,##?VK6)2:FI&?T6%U157_-8%I=8Q).?;Q<-3
M_W/&<I9B3AM>KEK!4YSA;PFPKJ,-#S#SHX_3T%D!:-6*E5;3:K6UX0'X?Y^O
M7G48FJ&,%)&&XYSENNIW.N-J%)\9:1G5_UK[8>/_WZ@N5[^N_,@Y5SK!N'.N
MZB4K_88Q)'=<3/O[T&N/:%\R5SU7_E511AHN)^D[2B.&5-%7=R)]E86SFI&L
M'"#;E=Q*/>&T.M;W#O%KQ\EGUX:U1[:)C?!ZVDC,M'$Y8]^J.YHSZ'N6]FJ'
MLONW?FEB=MOHU'[ ,OQVP^$5[4//R'6& YHV<QKWE6NNIL'J7/3;U7(=U]!,
M9>@M0P ::OD]8^B85<>7F6F9+7<X!'\<K9HC6?7^=[=:X<1SQK[NQ=^N1BN.
MZ3M]M*Y4]':G^1\&LN)J/WA68+]_-PD@*(8$D2"!?7?;'U>;:;5==OQ7/5;%
MP]6#R$_3]E]-&X(A&!PB0J'@#YFV'U)[M=.V$LV_ P._>[&.:G[MQXZ&OZ$$
MKO@1I3W6\0%@Y<\QK?"*_^/73YW\U,E/G?S4R4^=_-3)3YW\U,E/G?S4R4^=
M_-3)3YW\GW>RSK]_KU<99O7=L3WW^/+9"='A+_[^3Z^AD/]5QL0O_SAAHRD3
MH8GG3IJXT80U-IHX::.)7]XU8>J$B1/66&/2\#>)5[ZFK+W6.I,F_VS-B6OX
MY=2&$R9.7F.-B1,FKSMYK377FCQIPII^V5H3UI@X9>V--\&[&_UBT\TVWT*<
M?]VC3[+"O&NVW'['T!E+ECH=[ZEE8SOL!.?YT[G#3EMLGWR7+VO;82^K]C5Q
MC2F3?K:V+]<O+OC#FKC&I$EKKKW>J*=A\:2-)J^Y_<]^ 8?SDGW56E,V]@X[
M^?3%3VRRV>9C 2S$"Z?]_M%-"_-N?_(O'TR/%*][:H<=9>?P(S]TSWOLY<Z=
M=WWYS(3U)OD];C1IHPE[3GCQE0G[KS?QT-B^?W]NXT'H\L=W65Q_L_?LE)NO
M/N,2::?[3TC?^^9=YWU^TV67_G+&[<N.^D?FDNI?'KZ\JFRS[@%++CZ9(8\_
M]^WSBT_F)'GA/T\Y.+9PZ>E_VO.= V]=>K1WR**#F&N:]Q678^LRG>5?7#GC
MD@_66;;)YQLNG3[W;X>F7GIL;J,^1YORRR?6._V$0G2+G9[:!+KHOE,VGWCL
M[!W_B+4V64O?6;?WOOGL&S]Z]KZ#"VN2!]S0R(%OK7?[>_=T^:+!WE:[\=A#
M]QW\=8W=GIA\UQTSWWOSW/T_GGGV/W<_[?477KEQ^H/_ -:Y=NR432ZY?OJE
M^^W]JPM>N:Y_P06IJTY__VST^=NV[5QSRV*>IF?N>^4QZQYQ\L=[+60^1:[?
M^[HO)USP\N,;O;]7X)"-3WYFT:_FJ>#4"YZ_<Z<3)YRR^Q/GU\ -O2?5BV<L
MC0NI!SJ_>/R@S7+-H[$#'W[PP:</]VT'_6S"'[>8-&[&_^+RSH,.NT#^_/B+
M7C_UN5L^773'CN_%+WXFNJ7UZ.6G[[SC"=MN/O.H!U_13ZHF&X4IU;NF;)G<
M(W7"=% ^?*LWD^W7]YKUZ/Y0\Y GUWX0?>\:Z1?O'G]'?!G]FW(]/?>M?^YQ
M!?G!U,47/'P;./6R\TY;?MC:=_\L\>!UIS[]ZWO7ONV):X^1/SYPWJ^V.:,[
MZ>4__VK=@^E]=.7*S2_\^VM_>?2B2;>?]N'R::?>^XJ[\#?/3KV9/F#JQM?-
M>^CZ"];8XN+(TOUW>63KRE%[/7SZ!M<^V.F9+Q]_U'7510?MC8MGWQ[X9>CD
M$W\]_Y#-F'W><8!GEBX]@G]C\7L7)="/=MLW]<XG6\^=__&YA9MW';OVK/*Y
MD;^5MKIJT?WG//F*^M[CYE\/_]?5RXY9?Z_ZO/*TV]:?LVOYHC]<\MZ56^GW
M3-SL_=.>7WCMK6?WCYMR^Z__!QM_=3EYQ^7Q=W=XYL3V\D->V_'P>XY]9Y\+
MGKG]?YJ^E9?;@_- :>H3!RPXY<L)N\S8;'>A_-Y.3TWYWUQC=#EQ[0-//F#*
MQ^<_]]F"3U/[7_7RC4LU;%'X?_2Z\<LI]*O'+4LLGOK&JU].N)]>\\1-G[HI
MM?A_]^CA962_Z?O>,>?B?^RY\Q<%<49OX>)G,I=O^+_.WO!RC5]\.O;Q1N\E
M;OATS^7S;J_<W5GX6'/_(_YGQ_ O-YQ_W^:+3FS,>?B^+R><>OJZ4X$KO%/T
MR<.2C=Y_[ITU\]USMYU^[A7&'QCQU#N"+T]:=O =W!J?[G_6/2=^]-I+ZQS[
MR!$3Q[Z<\-1V^"N5R>2-L\X_>.M _N-WG[[&/'3)DM"9>SPA7_GF)^\<\N4$
M]ND]/[SS^=O^>=0?;WKS;^"]QR[=+JM]\G#EQO[::^WP[IU3;CEM^HW+_GS7
M6\_/??W2,U^_:F"]>^HZ &X?=/F'%TUZ*&A^.2%SS/7:C<]>=$?6*]WZ[ Z+
M]OE[?_ZKU(+5ROZ7O?#X1^!=MEB;J6U[V*LWUQ^YYN5/D.?V?2EUI!/;[8DI
M@9<N-^G!_+G)M9S7;CQPSI0#\]"%>PWX'=>Z6;[QO2?6O?7$P&>_.>C'>\/$
MO>??-N_8+RY:=$%G4V7I0\]ZKS]\-&[^J;O=VQ]-Y6O;7OF;W>5E9X79O687
MR$W%8Z%KUCKA>?/G1UY[P\>_N73!E>LTKWOFG<,O/)B;O]LA-^SSQ5H''[8\
MM.]S3TU9Y_ #HMX]EV)WW31OESM^__GOSWLHO%;N[*,W_.S#TRU]ZNSEM>*]
M4^:N-^.P>.2SCVK3BD>$LF<=4\06WO"KK:Z^Y?&]W_K@G>R?^X49R' VC[PU
M><N1!^3?/SCWV06+Q _WT:\]2YRVTK>\2<^\\KM#/CQ$ONW>M6=-Q#[X\6YT
M.+:DU7RF?,>\HT]W<]>T?WOF<:<_0\Y:>&N[_/P)?[Z6:8=RVYQU\5U_/GR?
MJSXZXY;B2U].*&Z\QOP/_G:Z=D/]+YE]K'EC3^]U[)<33G_XHO->/''7MZZK
MO?.BIMWZR-HGGW+)L0\4V^N-W;O[0^B<RXW[YVJ_F/7YU7.?_?F<]1>/,6]M
M'7\BM>:GC[KWS+C;9(0GG[]BX6U;GZ0MG'/)QQL><--!5[R[:7+2HF)KPZ*T
M]OV7::W@6G7MO,N>??_MY=//IQ9ONLMM%__NP\*2&1/V'M /+)Y_#7#I/S\Z
M?,IF1_2W.7/#LU!GTU_QCWYXS9-SP-JEN6/6/T!_X'ZG=VJMO^?%;YSR3N!]
MR7[J\4^W^(5[M>;]?NJ;)Y]PU=2-538!MJY]^[?'U4ZXX.A/U3</7/-7&RPY
M_-W;WVYLG+GOF+&CCP/VV>NL_8Z[:>'-\P_:YO)3GW]_22TX7WR=W>K!(Z#K
MUK[DJ%WR=U[0^A,:?&K':;==N>O+QVX;?&ZWS[FMBLGRQ]C5?WB%FK[HHO=C
M8X^<TIW![W/CX3MV7VT]>-;G?]KC'?>W#QW^\?Q%S^<6/,ON]M">4_[PSP\/
M$=K_VO[(GR\^G#CJGIUN!=ZJ;A;YY_5'"Q\^/NFH>^NW*!O-?YO<<,81_=]
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M-+XUV652TA+O2@]XTS&TN$8H;(1HD6WZ9O5R[-=DG%^VFTJ$%6U-ZWNH I+
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M&R_#.=TC^ZH,<8RD;.5*M1DRS?\_FP8HT:M(RZ9C\QO :OS\??4S</=$:'4
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M-I(^CN0Y"16Y 2A5+I[:UMT 'D^"48=^1V=3/KTSM9?.]E<4D_.X4(S-$[K
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M1$0!DX)Z#H&Q8;\\W G6B!0A"4 <<PI"U5,0?+NBSAT41<CGFJ&O25JN"8T
M LG.U,V!BSVZ=B[<VT=,_KW"PP)8N5'R$C\WNZ<66VO<YTS[EM+LL%=)7!#%
M6]3V=!/6P4#'YV"VD3X))KT*#RU%K8C<>Y^+J7H)?ZK UCNR.[OE<RKO5SBV
M>8C*/]78XP[<E';G9#9D=3%_NC(9:(WDTG$HYAP++.RD/A09RPU-8!CBC=_;
MZR&#GRV2>ZCDB:GV,X;GRO-P9.HW4&6$5BW.Q$HA0FLC+2Y<7H#3K#9ZF2FG
M=!I,3A+K5U+5[M;8)<M?[!Y:='0595<O7V?J/VDA<W[;$5L8U:RB&G1;,)<
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M %N#++Z$TA>8^;DV'\=)^[=\Y=8,=Z]&4?W'AT.T-X!3SXO_1C(ZQ_C+FYJ
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MV>W87&>^ XOG7M=E ]ZF"M9/G^C(N!+L%XU?-HNYT'5'+^&.,+=OG&W45-Z
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M3KA8NLG^?.BG ?B[%Q/-&>()F?&G<:(_ZIAI,RFVU"LQRI$@T\J"]'NA [T
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M2H6!DS%\D4:(?!.#TDB:MF]&4>FILL*.:O19T)];:9/)=K14X;D(R/4*UAM
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MV'?ESD\Z\#EF98[,RKW0P8JX%2)N[:$+:'"^AYR'(0#"SB/0[> 5>4_*R9S
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MW$&PP79@KN&#<M#[6WZ)85Q&Q0VK\ZM>98R(,E!(G_49<D-[?9ZPA0VX&R[
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MSX,-7%H7HR*\CW54)+"G0ZV7=YRNIT8JJ;:5LN[<M/Z$<G:E5S1:H!>3R$@
M"**MN;EAMV-5XPS4EVR^!XP-O )W^\,8JI/RR(:XJ3H#EKX'+&A]*"A>/.A\
M85KL'N[=U&ZY8--PFI2H K58] V+4H=1;RA>#OYC@9>LA3W2QL6$0+ $6 YF
MS-Y2="WL'+6^/AY3@D*WTTT4;#1M!0;1*EEN&BV1Y,566]1:/4TB^: <RL*(
M 5O1"8@)X)W5LR"TKP4[<L"SJ]U>(3LN0U8D)>$HLTP!'5@K/:"2$2>>,)LE
M)LW#+6?PD1.LZ-GN6&"\=B57];R-1\/9CJ0:;+OOJ_NV;7W! /(&5]O"4*19
M9X8[-AY@1E6S'C4VHAT:H@S0CIHI5#HRLN><@R>5#H$F9\'QO'.@58E?*\E4
MV*Q@1,VM49M[^SDYLR7>X9FQ)MK!*I_J.P%<*27;&R_6(R<$6 _S@H2?6/3!
M3R'3@ NK/=(C $.2M[,)Y,'@7-0'*2CW,D-JFFB#H<#03J@%T.=%<EW)0SG<
M>BRW\M$5B:ZM?MULL&G4'*(B,\INPA@?>@,#)4)XM0H@@8E-3ULN&+QL80>C
MB)2-=3G @%TQ*A _*%2\*AS? E82UWE1:VBPX]T),JX/&GL-4'D.0+W=7FB6
M.<MPZXX]4OM5UNSG@5P+T&#/V)UY<BF4CFP:CR& V8_;34L#',"1X&0E^ASF
M!SQYB,&2:@"[_6 A.Q.7F"-JU<Q6OK&420*)Y4"@F]#6QCO<L3<QUT0N/:X
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MS6J,-OQH#&T.,8?:DM<,63.CVHB4H9I6OLL*6S&1.RV^&6T(MVP(N9'1#,6
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M8><1A5ILDD3!A,-UT<^-23CO4WR&Y\PXGX-FN5@Z6W\W;N9L)T59MH',M77
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ML3"@<6)$L#\<F#6:\6PEJK$VT%<J'X;81%7M)!/B]<QC],/9.4#I>^"XQCS
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MZKB2JZF;^^#S%ZC63.\/CQ<FYA'O,>\WW]*-XVQWO]F&L6E'#Y !7;.3=X^
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M8F81F+(8,N:[%QT#[1S_?'UYG?+"T/1"&0^K9:FL4[+93:*)X]@P;CL/3#3
MH9WRM1[[H,CK=3G='VD+L!*O.-A(MAKNL+#(]T4V;'*)\ D08YT_[/[)6"!M
MSLC'S]3+,,.*GJF0@.VWSJ+O^T_X(^=+%&\RMA:Q6SK91QX*^-$32YRPV4N/
MMU2X9O07R20-="=,K%GF^PV9BX7MN=:O6L1(@=)F NVS;/S'#BO>+6;,=%-L
M;JIM+[:9OV'3KY/-'F-_R;#B+S^)M52I_6WS)J'IJ*"99C\7&)V/T[Z=H37_
M9^$5NG>T)JL#:1$_1#0#"<$0C5)-/VN.\BB0T*1-6ZB?7&W.+^+WE]<P(K2/
MG/RN4M#Y;ONH_FS!/Y]</G0Q1O\WFXO(QXN7=/%P1^MJW_5-$U#/U(UZ8*=O
M3Y4)$J[=<#I"FDN.7 ]A.!)-GW&.9T^A7HM=D/_PE9#C&BWO6ZG=']C/2(G%
MW> E8X%>M<1O+ (9,7L)JTC<\ <"I5'DYA,@=+>VS=WF"X8';+5D?\0/IK(I
M=S!'FOU#\U8??_/C%S>QNRFEZ.@ROO*HK&K2;NHG@$*LYLX.>"EVQ&D(YX,*
MR8V\$@>T>ZAV2^T.=G'^!*CH1BC")&R:;U4G8K<S+R,D"PY-J!>%]DTHXW(&
M)E%P2Y$Y08-1-WO6:=32A"- RQ#O\E4L_>.N5\3B.]:577J&ML$T[^73WF]1
M=C@&IKJV'3ZZBB)SND2=?/P$0WP%<QYB%]CTU:XGV\QY=TK%"E4WI<2&!H9Q
MZM[0W"KU_="[ ^O7N+XT4"*XW1$1!-:E;\3O4= KVF-_3QU-9V-[S3V[7;W5
M!4#UO]YP/SL0O(0X.;.'7QJ_OL*EA:[G762Y^#D40H0&?OP:D/AYRGPYXN&]
MLRWD4VEA(.KFE!S)C-7+LF.KM>%&[?\SI1&;35.QJ&]E^5<_</\AP.JH?M+!
MS:S#Z6P'Y[->TXH(HXX5^,MI3FU/@:[7L;%3_G$ N8>D7[I&+=8++4]QAH;7
MV7E%)+_RL#0R$*76S25/@-?-K[V05/D:G,"S)X!,B9%==Q'OYY[;OH*%N](L
MH+]]'4>V?+6*8-\7H1XIW#*T//>*,:DI1P'*SU-=K]4[RQN*)XR/=^R"^G4]
M"V2.FJ^Q@F:=(*A@][ECW!T!Z-E)3U>$?&YS5LWU"&?<+1J9/C&B-J?=NEOI
M5N#@ 3)'J$PA6*>G+$H>LXJRX)P@AQP<F#XT%<Q2Z%")M6ZGK##Z,V7/O1M9
M^:$CL>[@I :CY0ZGT"D/"=L]@1Y2^&1%SX+Q][L^IWEO3V?IT,O.KXI-!SS(
M;Z%F73[?P;8*OY5[EDGK1UYX3IX<GZ$H0.]=.>N@(!)"-[I;M%;C@*&!0L>5
MJ1H7U-(?-(78L.C>GIR#[?@"%V<<SD&\38N==[#%4ESH)-D!A635NA!<YB@Y
MKG-CVM3JXI%B<FBHW?2@R9;0A:"#9/TKTSQZQ+A/\MC.A^*9\KWB&0R23";8
MU_QS&*1NPV(. 6V[OA:_B_G5*'.A7U#)]EJ$LO=8^(IEZ,W-9P192;3/RQZ#
M@@D$:<#&%/4=Z?G',?.]D/IA]S2]M@L*K#!;CULFK#-F7SR]UYG<(>JLK=?>
M,>O&'O?W=[?)@U7>0;.$)Z#!:%,U3]'%UR_/GA^MR98AW_KS9H3RX73U@! Y
MQ7VB% K]G#E/ )8%^RZRTQCW50X"?6!,?.O4+GX:7<^N5*(4F'#5>;>'54J2
MZ*OT$8#2^%&B0CAT)U#!+8*3EWT,F9WB[]YY+]<VOS'GUZ&Y^+;XG3GW35$T
MS"/6\ 7!_KA3#'=O^;2=OQH?'8=AQJB)TS9%Z^FAGE=XG) WDN^K#[(Q*;I;
M7+''OR==64>-_[@B5[WH+BQ$/#OE)-NJ4A$JUIVKRTD\#>)@/.1.RA"DI["-
M_U0_7-AN-5$O=)U92AG-T<[#KD?272CAF,:&UR3,5;+Y'2/54EU&T;^%(M84
M#)]6EG@.!IEQ4JYSMN' 0^U+=I ED4:'IF*<!<\H11?@"B=\4!+W57 /0@TL
M1!A%![9[(Y*KOT.!"7[6J5XG1:/\5?AC3 ==L),:Q!M![OFW3 &HLX&!:I7L
MUQ0LB-W]&9R8G=3U6M29'MR^1_/=JIDC.?8@>= ^&X65FX-7^*E!/&[F OQ,
M))G'(_*RS>(@[L]%0H;XQU )@)!<F%C7D/OIX>(&V#S0+'MDTI_?/-0F\B>D
M\\<5;7SGV>RP//.TV#%@=$C;*W?OUV49^."/E"[07QDJS\=;;E@VW'Q!PE[3
MXYMD8-JUH_?'("=*>C9@3='T01#VX.0)FW=E:W;6VO#CWU?N>@S4I8+$@)R9
M%8YG#SR9"20*-GC<IYKH/9J-JL12OBA ?VQLDS%MF*3*4'/)D<88S9O$OW)W
MR;;-6\+W\49Z''L>>%U[Z:3FNSX!=%P?@<YM%[ZYA=\,+(P#:"Y?T-]2Y?DP
MLSP$?L7*#,C>S^[-7H0WEH%D5#%>&BM2'^D)TJ1\-2EB1N=X@2V4<J6?#W\"
MC+:L^X-A)^>PD[7/G7B)%(QSJ>NRRKB'5WY/ ,UC"<N#_6\^'./S,)YRQPL<
M_< CKLT8?;,F8P[^%Z%W5S?BZ7D"2AKAAK3Z543<KKF5]IU*6][.LP$=L#IX
MW;$H8J/'.4SW+GBZZ_. V,: =VF!\8G2ZWMU_ %&XG1#CM4]G4"A5_OG]E><
M7)KEEZ-?M[_[XTVVM[82Q8S!V%+/RS>0KFVG]E0Q9,_%:M(,A;YO*:RM*MQ1
MEDX&K'7@TEXPJ/T1.%GW2;5(5:_ST5V)HEP^5%[3C0D*Z%KAD*G4Q94'B>21
MG6W+5PV-BW,T,+$IG[^CXI'I9^ :1#.@6B[C34CX>8T4/"#.^^=&#,Z]YB*H
MT4)SM8,YNX/YSN(3 -N""/Q%$'$J>?4$N*I])/XR(BKZYS;D/Z2GXG^5GO+?
MB8_$)KK](_)/(N5?V":UJ@Y6IX+U!W/C_A 6Y\/J*.W0WW>VG;!C_DC9+M=*
M*<J/9E=> 'O^==7:KD>2KQL[(TKP9+*];@=^/@'\'0-'UDN3/+WZ+K$H-P0>
M9-+79BOLQKE:(+[ V@^M4'OO(M$FN&KUH ;T):BI]E +(GM<W@^U4ZF&^Y@5
M5.!NE[:';_GC93[\"#.C4-X6R.!OC\9\4%"9E";";!@9C[,J6B<'@2&\K>64
M_08CUJZ7C.[K*CVA3G'H$._HR6UP'D+CS3XX=\?S\D$BH#/GX4$>]0YZH?]8
M*&R&$9C8'8+KG!F0K^I-^-^(97D*D"\H(D2JT915=ZHEG5]CUY$.[6V36CG7
MC<OWO23:5FN,N1,UMEQ(>$F^C)_)EX:WKL9^27S@ZC:IU6]'4O<ZC!_5"^"'
M.X[6T* 7*T$A*$X.HHG4ICY](C,<O!S5*J%7J@E5VKLCH*5,ZV4F \RP:!JG
M0;ME(%^XL[R>ZG],(E^MZT&\]V\870)W>U3^\Y_][Z?\_PZ(=]\KMT27,^M-
MU5:3:X&Z\LW92X_4KJL?6&YUBNXOSS=&?1<G=[O^$$/_\19'9UV\8D@"NL?'
M"^E7L1E,/]VF"O&(# Q)3F2I^>*0T5WX+LAI2D^V);=T3[$RN% ?K+JXG.5=
M7QN8<3?+OKL]E68OZPF0K)M-0]W1G -4K=&L/"%,@;P:9:AK_E8PQ.%74C!H
M+S>OL)J:&?/K+4C)NHLNLK'+_99*HPJO"-&NJEB@_2J V+I"L&+) ?BQ=+.X
M48)R^*LDYM?RCG 1/N_Z0$*\C7H.47RR6TJ[ETK$/,4:Y5,.%H=-1EV>J1JU
MLE*;A$9QTLTC2]RP<A4G3!>+;5D2'C*BYG(\"WGKI'+[%<WJ2M__])%O,)O;
M>GM*OST!P$^ YL#3CL%_FC F7_#V+6&#V-_4_9=H,DGL]+T\,=%UL"[F1'A5
MPX^T;;6Z;6,5;P4O@:(;XU3B#Z+(Q\G)0/;'SF[%+8D8C6OG(02+RW"%!5%&
M-WW.<A>RL-+5?MRH6$N2Z!7?I>>.@<#GLY=<P:8'*V0]HV%]SN=KL4R(R66%
MHB,KU2> 9(E$27(F0!1^"-Y^W,7<^.LIZE?]NM:? /2MTF^(Y-XWX.0SN;D<
M:+^5D0B4>9M(6KJ0Y&^\_IA4[CL3X+O^:+0XZ?L$H/Q8$?X%CL@%/ESF/.(5
M68MGGCXH!X''-[2R[VXC,*X7]VH?%-PZ<9X C/[_49,9YRR5N5SH,HR&QTK)
MH.ZWWXR93;^2<$/%?GW[PVU1CBXI:OOUW"-$9/D%;L"+ 9AR..GXH,/.QJBA
M>FK?)0O.R<WC-^OLA7&OH@L5_IEP@4J2Y ^&J.?;Q@X#QZ^5I2A05$8I2)_!
M0(J#8P$*A3 ZTSCYE'39\6.'2A N%ZK;LPL93[1;9J8WB@9O7E3RG=%-Y!?;
M1IW*V*"\H8>W=A6[!,?Q6Z:_J.9MF2K)Y9.V=V5U5Z=G55$=T.^_S&G6C1J#
MB =3N+T-O20,_QPIA4N*- 8Z'8ERQL53E)I#5(7VTF7F]B! AYF )%:?=_O8
M#%QS) .H<5\-/O4#ESXIC,9*O"I!%-,Z*:02#EEU1[-C*2S,1J@E)3/N7ZA=
M!IL<_XL;9SG96 K]]##O(?GG#:GQJI_BO**G)"K"\ ;W@+KG('[CU'%'UW/I
M_W'N&[.K5->+&(_&B,Y_<>Y3V]%-*VL@6V#)5.E;UP$[[)85_F9V!R-P43ZF
M6DLQL_%"8K6S[WIS54250N.T\.6,7%H2=%YDF>4-<SP/O_W$:T18_4)/4^A.
M X<'F,3:*5 @U519H_AQ(KDYH,I1T;6!;>C?7;FO(,X3O]O*9:,(UT%PE@D-
M,;5,6J2S:<,$75^MOL%2EMAQT[*/ITRU".:0$;SDTK)=VLZ9T;W:J3PP'RYS
M"%M%4:Q9DZ0< >[X-\9Z'7FHA?2UITI"F^QJ:L1\/PNU!+4]6VU)"!G^>DC]
MIE0A2IDC2Z$$.V%;.[_:R$G'TP19*H])VPK9GCTJ?O7N+SD)_3OD1*QB8=E'
M)S;($H(24L?YX=%,[1<Z*$O,M$2%);[MZ^ R"^]GNR6[N#YFRU^BKCOM8Z6$
M]"7$.$H$7K_8P"H]# 5FM>X5%Z_6*YHS"]ET*JT=9-&D&A?12&UIX\<@-3SA
M*E3O3$JR>-+[TC,FM@]I\ME3W\:_7XH_>']/@.&"]<=$$HS#^E@#@M_82XC%
M]ON_#>T(D,S7-I/7QFQ:A"#CJ#[Y: U62J1<"^[K17L;%7(G'2Y,!_"/WM)O
MEZY8'"JK#X^SS7K$35U5ET>K_BV_8WHE5S5[[)4-[[=KBO'4N$.+NWOU$ETM
MU$X4<,2U\W[+?JUS>VUJ?+OK2<COS!?^6L90D[ _:M(+5D#CE477HO(R4;$0
M9B;M*=B?))9Y'&-@ >LMV]$[F&I]%Q0#.[;UD@IU6;,G]Q+Y//-LXU "<@<5
MOZ=]WWN\$7JDX8GL./JO_:-O&SOP?%G(WD;9WR_289[L:79Z>*R;DMQM?57:
M&$!5KN'E-83 ^G&O[^.E7'E^*XX1O?1"L6,]VB"W7L_A[-T;+OTTE'*2>+M<
M'MK3O1H2O/-LDO+@YAOS_/%B[/<;,^>@1/3]4\B6NIS$(X3B"<"9"YPO/)U4
M;@11\6M&FU=Q+HFXA OX@%7O!\).8]';OC421;-1A&GCY3UJF0%@49"X[%#2
MR5\=1(I31>]E:Q2Q8]6&&E"['[<4]V?/E]\'9'Q##\0X,LK&HAM7+,F(I]+:
MYF4\EDAS8E1KO([KXKM***95HSTT2RAV4$:R!C*M;V])E)T,;09$.$?BLY'
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M!70%/@'<6/*Z.=$)M,4'-"T&8FIW\SK,M?%6K,T==#*P$(OC38R!0!:MY*+
MM1EPUWUS%]Q;W>9>4BL/=N$U5PYY5_YOGD_XC='590C]JV%]49O4\[VH*.>\
M2U7;I(7(<Y&CR=X;M7<1 6&8!,LO*%@C34_N19"!=356ZK\CQ4 -<_=Q1V1]
M3OG<EY3"]DT8SZ80)R9J&P"%36^O\W.S'_=23-QJ+V6/$X[L2.=%V3F:?"M,
M8I [C.FW($38+O&2G3]KVDMJ3UV_UK*!S_QHTB_%P[D,LVENT/3?QEP5S'KY
MMSOBJL9L;^%VF7Q@2I.OGO@_+PGJ?L^>$-ZL5;]TP&RGX++[2P<,(LO#A"XN
MHWEK#;/KZ4UITD*GQAD)*7H6LO8_I3GM#5.V%*2)BXI_-$6%B^4Y>:X^D$4X
M]IC]<K=O(P^)#JI%?3TZ$R%J7DO2,!J$SF;XQCH^08Q >-:8"H=/WS25U]$_
M[' FX&CVLG0_@F.BUBK<$0/S'E,1HS^W5*??^#5/\J_?LNJM0ZMQU&.VGZQH
M8&!P(?,-[$C.NIDFMSK5V"@LWU 6]V]J&PS;'>BG0!MLZ6O4YHRSR'7GWY!:
MU 1;"J1KT.-/+;Y32X*>>:A#W;1SO=3SF55\1@/;%?I:H6!SWC4K\#J%>CI\
M=A8\;E U\"E?G3_02P+U+FDW\&>>6T?;36Y%]+$$ZD&A4_H2DO[S=)9;O=7A
M'$! *-\'C9GZE?%7;&Y*Z^(,;5!9;72Z>'KT^SKV4@W"Y(;4%^7-)?CF*U[5
MIK',HAZKH'L9+]I5GT>,:ZP90A8ADM][*F,?O]2[4N7(^(4\X&W)1JSDQ-/L
M/O;\+6J9E&:_GK^*&,JMJS\1>;CN8+@EKE(W5[5YXH(\(*UIF;+SR1H;U0D1
MXF@T-4I[\$FR&6NUT%H1!./1[.8;S4P5'7U50@6"+Q&7C]U=1&)]EHJFW>:Z
M>!=JNJ(Q;I-T.KA";?K"XB"]]3!Y6+%;.,*X5!BJ%UG4IEYZ^=OXL[+*][ZC
MC?E6KBU:(V5CY3?QHJD^S^IN4 0>.SL8(+B9/LB<PIX>_\4%Y!.@%==HYC;(
M^)Y1\/+-NR_[2NL]-B3=/U'X2F\>*A0?X(DMKLRLDT6<1G9)G<."=)P.*X)Q
M(#M*J[*;P.P;#\D(3\]'Q?P;)-7LM/J]UZUZR^/M9"#F# _E^$U L29D#UYN
MU'*3BICX[=^BB0Q-BEW%2ML+17]_/#9#ST] (AI2<C%!ZW*ZK_K>1Z@:DMXN
ML]IK<<FL/2!*\QT_PT:B6)1*(/K'OE,'K,?_ZY$GO&5H'P+"_6N6+R#N+6L]
MJ[CY^GTC.=])/2KGD;BRR1:5/@HARM51AWQF\53GF?D%OX+D@BU/"-7:CU5"
M7,XP9R+JOKQJ@]FEJPI)OS;Q+^(DQFY'+%V2!YJ*>TJ#I?<P9DO^RF-.M[ME
MGTO%'XF(?84VL2? ;@'.10LU%N7Z3F;C$N/%R+V&KM$QVA- 1.IPZZ4-YLU?
MV)K)<ON0W(C%E_ZJA3$)9R>@6! U+0?R^$T.<(/QN=Y]/7/VY)D]NCCC@?U]
MQ&&8GJ\%%[50*F\RD79S]V?=#)Y"%Q^;KYT[ABDM:<'<'13QR"*ZQ+CZ::I,
M[Q^;V$B%H;K57/';)X!Y'+ 5NAK;%ZC:V5W8ACANCS/NR6&_NYRWKQN5CND/
MP5U\FY.E;)I!L(F:M..Z%I-+?YK\&ZT:(42NDL+']/IAB062%FH<S>0V,AST
MV?^O[#_.[KP^]ER-OK[UO:(8,A^:=38?7;1HNTZVZ  &4W2,BZ-,&S%CKGGV
MCI>F87YT/TQ$2_N%VLQ"L!1+>V5B(XLCL.V+A ;2.RC/Z%9#-;N&^OUUO:Q.
M)>4M>%@JU_PC*[I>>.'R5JQAS@$TRP3?$Y3+> =)\_/<!]8'I3%OR2)7R2/S
M?W&K/&?"#U36TM8FBV^T5AU(:&WS 0A0%DZ..@>LVSO/Q4KA;JD?5S'\E3__
M'_2QO)GC(]Q$]%IULB<D9-?+_4Q2EWS)#V,:M/9**-P_,7@DB<DQ731U"M2&
M3SW@_7 D+CY$"W5JG<E"<NU?1$'M'^T"6V*+S6M1_R&I_XFNY1=_F42CU.PQ
M9_,)T-TJ>;Y1O$N1??H@$PH>[]$HZ8PHTXX-5+FFVC",W?1!UU[NP9TK$_5;
MNV1Q^.O3_KUMKA>B9^_/U%.%]UV=>Q9BO^B'@VKN(U5#*Y>[PL\PKCB35#W<
M0&7-FI:Y^X#64O.J$"X^$XH2]N*RWA5;CW)J@G[=;NE+(:,J]S (7-0I*#G:
MJU;&\Z#%^303(4@/7Z?;<A,>Z$A/J-.Q[0WU4,:5/)8799LP<_)KQ)%]_EG<
MN6/CUHHSWI(@?<ODD)'8AEK2V/]JZ8XU_'6="\V0BZ)VRS9PJ*:O]!)NS/IK
M@"MRU-QB9SU&<)T,['['K=&4&=HHZLQ=V?Q7</)T3[3SKE76$N161\8*1TMK
M8D&<?[ITKZB5",!W8]J+1*^NR\9;1.]]8CERX+]E(;<7Y '=IO[$134A\Q6=
M0]+SMM'.H,;9PLBW,/L04!M/@;:-/!7 K[3B:Q08W8*YT6J0@LR^L$-XGIU;
M"[[B== '?! 7B9,H?O'8PGC0:BI8/+$_M\!1>,A074>0/Y*-SM>;/&-EE>Q#
M9^"L'&KMY][NZ[8W%/L.*R&\GA@L^7I$8&8F#?T!!1]#JTCC?'^"&-U"6BV(
MED&$(HWFT)6Q7?C2X6JKC0<UIB^AY/JVY?@ST4S/ \LZH2:[[UT_*'<-%_V1
M \%@3G,FJ5!P?+=_1;P2Z+%&?B,V0?Z/U"2((;]]JW\K@'O/:DCPSS.WQ:CK
M$&A< ,.I4 3*5*#L]LK@V8Z:A_#&)-BP\:C#)I5>&V0CAYUU[^<AB*/VPY[,
M$@BL<C]QAD.UD]S@BV4;:ZU4N#Z92"0</-SA/.F\[(S!MZ!,<*%_[;XIV::F
M?X^%P?J/?4AEZWV;$I$J%*E?#1_<8:RAEKN*<M'?5+B15(*9%D'OWN.$3XO=
M2U1SC FZ_1D/NR?+/42[8LUHZ)]&D^00?CY@#90S:DZCYD.%8SA3>T'F_)(V
MNG]23&[/GA^(>"S!N^\\C%,W30\8W6H2C4)4BQ'VFFB+(J4<(DWVHU+- M'E
M2]IOJFGE4/"5WV8:-L@I#.:2-@U'E>PT"KS]8+(66W8R>R06.S3G3?4]#WXB
M836M!7L"P-TN]W-%ZGNZT7MF._2+VV=?((%="TBX2U?4WC>&EMI,GOQE$;F6
MXM_!5]U.@Y4B)PG;MNY&7=^\6I^=[5)XG2\Q28[?H"*!\ =QR*5^:,T3P*"5
M"EX=BS2>N\#[1_>%Q=</<OER]Y##GKC:93WYO=!='6FV8=9[B[3?>GN+CKH[
MM@_V0ZC <IRCC[R%'_$=/K3/K,^!%"#ALJ/K/X^E$;KV@:,235")JNK4[=40
M'"V1XM:^:X[EQ6'^Y[+>\[J@6W^3_(C71;_OI3N:RWXB.VH'?<1L^8M^.^F$
MYFA+1GU+?]:EKB'R##J7TPV'EEJ'(2[@/>JFD\ZQSC^1U1$YVW-FY'T5.B*
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M>(&T426//X$BRWR!T-;[V./RAR? ^NYM;$Y4X#<01I=)NSU:1"C* FI,55=
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M;"&6M#W'45YH)ZOGL?/JN7W-#=Z>]0)(+;I:6_:*S#Q-V8L\# 6IS;Q'D2/
M;.YU=G2'PC(&M..MN&0_+X6?5!":<1$:&4L4R65D0NYF:F@2'JG+PF.A^IQH
MQ$'VW8;^P.G*4:#@Q<"^'KZ'L5OA$>-()?2FF_Z3Z)[+CJ'L@PKY7A +S5P<
M"Z<2B]18:$(%<PU-$*,8Q=",I.K8&5+,VK=@Q+4#=4]^6Q&3KV%I(<U(P:CD
M9ER0S.D8L60B1P/)M?OGYY0&766WF^6')O7G]DKX4WED*<MF-IVC'9KUD05/
M@9N'DW9SW&^K?3=$L^E[9G:U[Y=2.I89^_*@G<'QA.L=D%"D]J="]8-T$97R
M#&E$/_EG[[C?\/EIQ[NC>[I/:^W%O_U OM8O@!D+N@&^Q\Q+ZG_?B']*6 C/
MS35XK7T.'_D1\BKIVO[_-6'^-07SLC^0"*CPO0#>T/X*T.$>=1;';$=\PD^C
M_;J=%HKOL;.1\CC!$MO&(:?H:6-.\L<,.%.7/R+#GL_T-3/\YO+[)7P/8\]/
M?$K%ESCC!9"F'ARPU5HY]3BEF4(H,:SAU3S6QT:I3!SWTZ*D%W'L]\!JPW&Z
M"B)MYZ)CX26X2#G#5[;">0???;^:A+B'J+_2!;:]5BW@?B'X @@SJ] WT+CZ
MA'F;HII^E,GU&S]'YY@34ZG<HA+%!6<$)XT):!+3S6/P1DUMXH2PZDVU0NDT
M(<$;;N.#M'BRL,9SK!U)XU5_W[R&%P")YZWW#'(Q$M']T>[RHZ(*9'L/4CN#
MJAWX_7#7*A'>/?8*_=NF@E9'0G5D_&<QFH];G0X>91P*QOII,!*CB!*&.A'M
MYX>XPGTA(VT;RH'=CT!*&M?S>3*<<TFY]Z%:-_ O4G,]=9W4H_+1F#D%M@V#
MV6[DBOMAV_1=DPP]P.L-49GG+BL"+ %4DH!_L2O7/W<$\ +P&"MY2/HCU*^?
M/+PE2+4WRS_> =)MSIK'DHO1\$E$6KP_ \S*HJ[WTIGEAU+TG'86*82] &RB
M6AD<(:2%LV2TEX6FE+RB)<I^ZLB.9R2J K'-E>NS;H\CUKV3=.];=,_FM\+\
M9:3Y2*TD(MLIDM3-I1YJMTL4:9)XSZ>)LK,GB3))"Z_R*7D'O$ZV3_>*]T]N
MK[1GKGBYCKA7)&)P9.W'GH%XCK4KQW'/F7R3S=':69Y&Q1QX#T!+<=]P:-E/
M3Q82N&Z77?\K#+D</HJ6_A7R69C+I15Y9:4!$V6$P,#YVG#% ^;N]._;)]P.
M#XPO^0YM2NJ[_.?8G5>.Y=*46/3GK#+28GGGF>S2UC\99$$]4$&7, *1Y+JZ
M$,I\G[@DN&8BE&K6M#J+0:5<[Q$Z0#M/>VHC;]M.\EN"^FT')ZD1V\**IOKS
M<C%;NA=?DTQ=<IZUO36PIZ#O.A4KV?)X=\.WE*OJ%B-W2J.&V\_H@LICE]-7
MQ7R_[@7 $L.G_-T#[ I#ZE!UE:+#;.XA[<RJ;M-O_VY-7YC(Y41^Z)8[$M>U
M!476L<J4B#L.1GN\=X>-W/E!1:O6BE2@R$6BD,T%+]_AR0ADBV<-GM/H;VDJ
MIUAZ'P918T4_T?JMSS6BC65CX>%A&@J1'WV5:YR@XN]Q9=@QEM96'KI,D6'8
MU(AJ?<2K=7^[HMP0C@LKD'+&*1/VIBV0SM%G8!=-V"DO4*XNMI4FUU[NE#91
MT?7";G\PSVD;7W**(YCP\6FYO_NX!II44M!X ;02EY^44,!/.O<%L\-&/55#
M_+BG/%X 1+M/QE"DM-ZRZX4HQZ;2>:.$L7:CE<)W:P)P*1E6 62FW\O9RK*@
M;@A\NF&7J#GSWFZE'1.VV;CV1[%1VT_20>G3K;PK+;3D$=9X04H1,7%?  Q5
MU6;[L"G$<U^0A=@N)PLB[(K;I"@S>]X"4=ZL!&Y)&B3?9@C#BAR\8^$U^?;5
M:_9^)Z?W]@?%3-T8BP(:DZWD=7,G'31D.<>T7BHU="**L3^;L6_HU*PPL6M2
MV#"GV$1#JRDQZ_%8$UGZ]99'^U0<8:-' #3(Y8'PE6  LGP8Z(;OL?\8(I1N
M7?B?S1@S":X0M-D'NXV'0WBOQ>TW4,W6"C&"*SPG8C/N7@!6>]@\;>ZQ@^)(
M9:J/]\Y)PAEL26Z=-\V?Y.=%?#+22YQVS=711RGY]4,'+6MA#BC;!.C-\6T/
M6?G$FQ!%7YAG9K''5V2?3YN*7+%7[Q.=FI?UM71M\IJM?F)'MXN[#,TB",S\
M8"BE(>CYKO,)]T XN;ED+D5V"'8"GN6OZ879N1U!8>OMXG8.N4:?LL;V>_WU
M[C"TJ(J.=7@E9]L_H!Y$?,J]Y/8G\HW0N"3JH"6;WM#&*Q%+KE%+>^<DQQR_
M->8N*[>;3Z8*%NC5J>C7RY5+T3K")1X,UF#HZ>=(VG7^9JK"$KTX6=\?#V8D
M=[<?<;]N12P]9V?7^& <$YI4^Y0QK0E;\,:3?Y?KK%&ZU%[I,DKGU$R>.GU3
M"6,J26S5BFXV[_X2:D3DUK.0@[E)/'$E9+=SC>[KG7#R AB">&6C[3F'QU7R
M6-BX?6?_@WN?0,PNS+JB&MUO&X"\*9URF%!-*I],99_+'Y8XPN*/UI1ET QE
MI#($'$A3G.Q(4V1M)6_4#,$_RK-G1/N<XV6OB[_'O!CR7"8/Q95\3X]\1Q;*
MO1'=S,K)X<]NQSEK\=/U7,UI0T+5*ACHXBMK0LJ(FRXFS38Z5I20?FG*TEH3
M2IA(.<L.TX%92EP&/^?#J8PEB[@FRA7_>E%22)5$9$SFJ.-D<Y8G:O(:\CJ8
MAO$V_*,!_O4UJA/;BYJX!QCH2I)4.G'5Y7LWZ\01:++)C'1C^TFCH;!C+UL^
MS\S'FQN21=YC/EOWVTO8E5!@.6'S_*/$U1'ZKR&;/GDAQTQ-L//"&85&A'AH
M&1>^P'*$?AZM-_B UT0D7!OKS_!2VR .V#*Z'EAO]N4\Z(1JRVU1S?;_1DL2
M-R285^)J*R^ Z\3+>NW"M:?*6$_*W[APX_H'DR/?,$8BQNEO=%YW]0PQ>@8)
M1^E^B^[P, MZ3E04& QER=[\SNXDYL&W_WYM&+,:<1FYV_>7SS/!/?'!*G0
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MLNXE*OQ3(\(DA^BFI&H^6F!2%W'J]4Y.CXQ)_[0<7&I6X%G^_O6_*%IS^6^
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M<=/B6ZYD8%;\WNL5HYX!$J[*:_2[N9#)#0$P4$Y*S2^SRGI(4$5'?;/=*/3
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M$\43N1F294F^X/ET>O)-@RFD;WIH%8?)XHS7&AHCK:#(@>[FQ>#-R>#?7^0
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M@N.B.WPO.&<IO?QYCO );Z;2#4Z_/F6"J7+R@^Q#YZ?-+O4B&6$C.TIO:_J
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M7R0Y'(OW, Y_IC61C,S;YJS\AZ9E^@^MAXWP]$8[Q_H/T3#E0G9^K6KLU]V
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M59'T=SN.[%'YJ<F\92Y--)LV_=&0/IUNX6H'WIT_WZ%;B*1&9L)>#L9:@3L
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M&X$TK?B^#VR1#.N'"G/S/#)OM3IS*H6/WDY8\9+;J&UR*J.?V&SB8X9#]9.
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M\!$4,6A-^88 ]"N,(/QJF<"\WPY;+G;$[IZI,<.JOGZ*'V;W1LD3%I!\,=[
M4:O.D:QRJ\@W)6%HZ1^3QU@KU''J'J\O/,[I'G6@N.(3BR^C]P8\'Y4P#W_O
M(H7MB /Y:/$5\K'0=F].;J !9DN!^>UU6UHZP/)_54!6HQ70FTF>QUB>ZRO'
MH0:^VO[%>/"990)ZDI1BA^1EPO.2.9S"_V&GUEQLQZH4% Q@ =*/8,:2DV.;
M6[SN><]#!+3 WT"0AF(RB*S>EA1^B5[67+ WTKLM67)\.W?;\=3IOTK@7A/U
M VC5..OMN6X":0Y_OLHPK;B]&L*Q$UU%L1&_]A9B^I_Z]*D4!0]5)N#<36I
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MO-:&\3R>C\OK[5:YBA!1PS$,H)Y/HL'$SM<D\:9SAK0O!^FK8^WWF9LK[;?
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MH;:'GERNA&>SRZ6"7.TL=3>Y6_%<K[P]Q//WYS*C]6'O>"Q3"^7U7A#KAS%
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M+:VA0EA!V %#L79+[2*U/JYD90*I.0>/GY /,]>[V^"*NHP_9'41SV?.7'-
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M:*3*[0N]O=T_)7P++R+/J88=KD0.ITT(<N'%Q1WVBN,&,AT(1T7=/XWI;&-
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M).] 6I-UW!P=F6#_&6-<-?=ER!D_MB"F3W(1*<\;1&,Z5<H WGB1'_E0+D,
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M]9XSTE[-+R<LV9%RW?W@/\"S1B,8LA%#9$,JN.PT\N3<"_1-Z:U&0M[M[^I
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MYG^$BA3P.TJ_%VAPK"(=2@NNMBS@0E56L)X\$@;W+YI7<PF4D-2_,ZI&3WL
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M?'_#RBPJ/,.1WRMU2^7N'6JW(<#?4AV6>LT<B5S.90)CP5BMZW,CP2O+,7A
MXQ#3>TT(0+@Y%9"!)31)NW)"N=.M>+;=;ST-,<*]4_&3FOSEU]6$D18UQU5*
MLB,=[N 7/],.-7;?Q*[?^N)VJN&[(V_2A>.]RH>#5JE89"+_ZL_&K4:?GYZ\
M2W^\2$56E5P?+^H%Z$9_FUV(#BJ)34Y:P0,QX-MPD< 5@2&1$V/L@CWXTY3I
M\5L(>>/% ZWN;QJV9Q]_7<S>?;#*G$WUVT%@K14+Y0H<;;[\A_!KXH&ZT7]O
M"7 ^%GFFKWJ=$X/MFE)C%>^O?+->X>L&D>JC+/6$>'LNNM+)7LRQK,D"S3HC
M[BI$RQP"._W_,I<"&ZUT2S ]S.8^)6KI)M8<Q8I5>#QZO*M0$[V%MG*Q-]E8
M1VMR*>F;G3^#,[6U'D&SZ/# 'NGW0"ZK #$//UG+_/6R#$O0<_^PVT,&IO.:
MW&_X#9P51Z/' L;26P7'3:H=G?,#T86X:UH^ZJM_R2,4B/VQ'L"'&UIBN?1=
M]C=4;\$.,=82;5&=>*;3&VN[/@^].=;3_9F6]+62NK^!E?G%$VQPCS(35J+"
M09FX/M$_@,>RC,+J7>4CTUO<C]KG^QN5;LN?E(HQR],4R.FGE8!K^; 6QT>9
MG$,";YG?FWH]I/.(?.;)K\[G]7:M^'O9@D.3 ^SB0B9@",)XR8,^((_A0GWE
MH*F?C%S$ V\["S2+[E+D.1[$QY1JB--[L_"VF./H\4 OZ%SD.O!_*JC  PPO
M0#\#(^%>J+@0&=(>FB=3TM6"\NH+@W[<Z4"KZ);,@Z_ PI&&GL"V62_AIQQ#
MREMJ:;RMZ3IHO=[B;CF<?<@PYKD8V:=-%H5:C>@6I6U#=V]CO?V:R<S>?MPU
MY0UI14=UXX';&:;84@3_N-02+=*>29I+M:YVT%G;&NZL1!\KZCOLN!.)UD>F
MXM26B /W_'[B@=\V%7[E@X+^W\Q^ZM:4-;L49M@.VR8CZC^VH0IO:K@;MG+?
M(]J73I[@8JB/-U!GV,IB_,_4QAC.-"_,L -/Q@+M#IG-L9HHF4@I%WJA?O_F
MCJ;)N>USAKPS^Z."Y>8//6+!1Z%]? F0DF3,R/X]C'+'*NHD8V7.W[HKDV[L
MW4HC;F8"!E[VF;!-^7.J06Q?4)M,84X![TUJ %SE 3^7O>&1LH"1  :F@;=5
M%K/R@TU6U;R%-P<:%(1GTY9V&Y;7;KBE;YJ?.&-(TNIZ=; 8#.F34>!IBH2^
MM9>D@RRR7F*NIN'TK?6A50CZL9]C5@B2HNY]>4&YN>03PZ>3QYA77C+#\_ ;
MLAT<,S-PP&\#H8<-0Y_07^7!K10-T",=K=054ON/%W=5,BPP@]+O/WFC%OD'
MQ<SD$[EHN:-S?'DR) E.7#Y><KDL@\EGMKSKD2D%#$4NQT-6F(.#[V_=]\8>
MKU73FE[)$@($YK7$?_NJJQH:3+D;[?+LB40_6#VYX5W$5[PEL!X%GA/I+FU"
MQ/BC:SWQP!W>O/SM<^]8)$J;(.GI"P[9@T)3/. FJ4VGF!#B3LA[:T$%9/+O
M2A2N/W&+1TOVY](E]LLR3IR+PV.'W1ZZ/W*5XTYB'NHJ<@O\O,K/K]3J_<QV
M(Z&O;;O5$<Q@E_K^.E\.W::TUL\PJ\<FY_8)9["/20TZ1NAM1+.WO?J\%HOZ
MH/SYOY#.##Q@?4B C6I7YL:>*;?F+=B+[@;2> D9ZCHF Y9F33VT-IO)3H6D
M2$3\OXJ.?X6RRU6Y(C$*S J=.PEL^EWC5V8\IX;9_UY0K.V<'67^1I-2X$]'
M=.3Y0X3\55GKNY'PI>K6'OV;6!$5K/T;U( ^8SAJ3"3S7"O=/'>%@Y'@)K'.
MO>'WLE)_K_+TIGYF)#]JX$<X]&@_G5F[\3[Z-]$_-5^&900Q'DCJPF;A@9=*
M$F>LIS_0D!MXH \%T\<#/SG2+F-<7R/DP:AKC67C_U83=_@%#TS'70UHG;0X
MG!QU# Q5CF<]SW(%V6H_DXC=%%1!_6Q=X</P7=U*!6%%Z_$ JJ1$KKW7#!MW
MXH\^[+T (2%/FS'6#GDJ]GRXL?0C#6D)7F;U$U>]I99JY\5@N4/#B(H'4O>[
M[RO;.@F]V3B6[A-ODHNE8[(J>/S4DVOP\_SGPM9F-FWA;_7V7N/;X)L."%YT
M8?"QDO!IA[OO5$JE634>L)\+L34B)!0:=K,L#R[>,4L<]*)DU;V;PT:42C.P
M82MW\6F5 U=[M+1?>Z%XJ8;M0XE00+"//>'C99RBVH5][G<9CU+Y1M8^N-\D
MO1,3#&P@,M"WHXJP'NVLMY-+EKZ9/*^J#%W<.=Z4Z"\B!"L>J>X:AGV#.,F+
M1QG$E"Z4X@%"BSGRCR^<*'J2'=S++/OZ:38V"FVG_CA").$5C6N06I'+, 09
M'I@Y?84'LONL3JUN73S# [_\EBNNXKQ!YQ3)AUX%H-/()9%?:X-X8,T@]?US
M/# V<QV$%F%?_HWJ_ _#)!6FA=VU1A^BF,(N>90*6I%>,>)XX)G.@II!9,\L
M<=5W3BJ^)1]?ZE<!.^LC-UHT$-Q7WQ%R4(<YU*?KK'EI@F%:^1ME?CA!V]N]
M2.VDP?:HZZ'L+/*IXGC+%U$+!M(<*Q7E3*P2QD\?VXP.>X2Y-*ZREV:-*9F'
MTS4D]<T,5H19L;M'&TV'6M!,(;BQ#<JLT%X4:=1J,*HP.'OTTLF_T"'5YSPV
MS$.ZY?N96WNEH+ *V8\!5G%&4+/]G3_I%YHG_AB32SX(\:54::\OY;R)\<&]
MYMJQ.;U(K2F-1]#]V2^Y#$]-N-=>GG;#C%9'[D"CVA"2V. 52_-52!?[VV%_
MTZ% MY6*FVT1KTL8"M/(K. ?G4X$?S*)?8CDG?=]FTTUJJNQZ-BBO$/NEU*=
M:9K&U:A.,2I&1 J@M127,=VP\17]F71]"BSC86<%1L*RI8%U4)E[_&]H5:W.
M@*X!^^S!MX[ _)J/)S]379$ <T6AO1WAAAT>>$5%9M:Y<F&N3[M[<NY55EO[
MO=YVX]%N13Y3G!]+ X]XX3ZMUJ#U7+)3"U 4Z( 'PA89QR\AZ,!N;P3KZ#[<
MP ?#I1ZZ:A[:P=V2)MTO#5_Q^=G!WR[;$:<*T9_^']==_RT8?EU/@TF8HL$/
MG:(=:HC2_$>C=';C ^(V9F:M=2/0AVRJ;V"'N#FNE8HV/!!M18N>CD&P8S.Z
M KAJ;2;@2H&%INV2;^W5VF!!?^Z+_!&GB<WW8ST?FWK;4!MJ$K'L2RT6^<3Y
MH8;W5UIQ>3>(P.4[+!W:>1=5V-'W=]8)-2'98FSOO;3[QS<\=,S$XBR)4?T/
MK0RQUEF"[YY_90 )5MRNDP>1O[5Z+]42<3=X'B3_08DD,G)J07 _-^ANAVP\
MY\'K7N"E35+27\6)&L D",N$TZ=#!5Y].!Y9<UPL:8>1XP&^" P8U_;>]DBJ
M/1*[A0>B\(!3PM\TT 7"&@]8@4^%N!:+<B,/E9_\0]S^>P900715'+BFA#;!
M]39379$\/FU:SL-AS-?/0"_2KGTR3_BX& \4_,R-%("?B?ZG*A#I>,"A@N+R
MV92B?C8$2G;X?+QF5U=ZO;Q<DJJ29V_\UOZ,>9HP?7S5([Z;]!\W/BWU"&P_
M/E,[^8666@J'^2[K&E^3\\P[F-00H3*1=_F_+PU1K_+GI(Y[1#A-)X)X/A-[
M;<K>]E[^H\(Q>J%@ABT?69X.7<4T0UHC+AM9]VNUG^GDI5GTO.5_?$NQ*B,Y
MP$B.\"-$'(J<ZY2OZ &%G[MT47U<%,<PA&,H:T^^E4'UM9K\="897?/\<_+2
MU.X$5=V0EB_U^SA#Z1>V%_4=NZ2*5?L.]>A)-RIKLJ_;98@ML"^/>6K5-;@G
MNJ)JI,X?E=CU(]9QHQA!9.482(.X#_7HS&3'5$1?2C==@N>LS;#AGEL5?(Z.
MOF097A&96D&^*@IUYO; BAWA,4?Q4*FI^=R"OM ^_*D9K3"W[W-!;D#+77^@
MG33++'.#SLU%\*'FIR8&6LT/ PG1T:<,9V>@CF]J'8%4<-_"G6L%+A.I*&"-
MR50R-*QKKDO''1J-&=^4&>Z+F=;>V']+=O,>%9$P/^'AK)0C\UI-S*'3Z"%X
M==;,B 1&<1D,EKF#0<(%_HUTJH@51-!@^\?5T<G?\Y8A- ,H@2&!QW'M,K;Z
M*08KFW%6Z:A':>V<HRFC*X(6T;E[?7-UB.2K'Y*''+T8@16IQ9QR.PDL)8[+
M+G=$IWZ<)\X@UK+J5>;:H$&J:_RR!IR!97F-</<!_W^;_\GXRR&HY,&I0 H8
MY-K<>'W&.%]N]ZYN2V:5-5&N>-5-S@_RD0)_3D_,KN)6L*,7RE!0S_EICWXT
M]<[YY(>FQMC>[B/N>Z<_.P2XJ$5)GSGF8@LN^"]%L7PK6*^1.P&C(&9%N?PA
MU[IB'Z_5^V22I:7MRJ;ZW *@C@^*(C@RK\)+X8R3:JRA2*1G2X#"8(=4PY[G
MZ .'$X*^B+L*H6>PMM\_][@AJED3+0JOQO>?&._;@SXW.\T^_!)*0OVQC>L[
M:4& >^\%*^P.%E,,)>VR8L'V8=AZY?T<F1AI=DZM[LG0F@VP5X^$6VD1:K1/
M<6KA8''"5QD![-#Q59-]%M1(*,>]*1P_UF&N(\!URDO')9Q)G'E&S/31JYQ.
MW[ -%AS06PL$-!E ^ ,[X9[@<R$P:RNZV@4G912XG(7>,1,Z[=6GL,*F6F'4
M"\,4W=P*9BRA44_]YI*#9//(R.LW7(&^;160Q?3_/^-(:*N3SBX5$TP#W9T]
M#O?*P4;VK]2TB)^#2#I+9QR$S02JA+H2R[E!;X;_WDU^0;]F,E_[9Z3[,"B+
M$7$/IO+;JT4 11I:$R/2V50\Z1DED'5[P.U!8WWBC6HMX>>R754<#+Z]!8 /
MI-HEU D.0NMWG.L6U%7:TU/_ZF%_/R1XT DO/T00\;PF3HO,1?]X?CL98[)/
MLRIRPQY<4Q$I)"7R"7F[$$72$&)=WYQY)17SWL@<(JQ%!&GFWQ6L[#U%^'DO
MU+QM5;UDLZ\PQ;[MH:+;D7Y?UQ2I/KF1Y3#U6VLNEJQG>%U#5!FS#9&&/<?8
M]EK*]"A+C,&5<G:9D,E3)85]R[N["N1RDJ:"R=87CZV>[/$\W!OW_>K<H;E^
M^HMTLL;@?^W'R7^%15;WR!F/LN0UU14ZQ(6_WQ5(PC;B >["GJP3XI9K^4VE
MPF& !XAPUQQ9 GO]Z:77]<XX2Y=](71]9Q8'C@J;MW)06_1BMJ_8+,%%\DAX
MUSSD+">#:'/=M7#>QJ=<!W?K"@_PVJ+S<&V[>""/HZK5^?"##X1!F1B;>"TJ
MIA+,L'A SVBB3+C,B<LQ8XE';_=UMXZHC2"#QVG04^(X@DLPNK4-3'9)@Q:.
M*][>OQWC)ND^LIE[E>OQQG5L</Y:!(7$U:E4\%]] ;]S;(T$U9S&PN]YH#.T
MT<8%SI9P?13/5(H:UUP BF#0@9LOQ +4G/3;Y'M ;V"U5&I0H"T>H%3#D#\:
MK\4#S$N]5WE% S^V?^L(-?<3DKM]_G6S616TN+!K55F(&\8#%)(MUD:30G#"
ME8F625;>YH2:F2]R,=*\],5&'7C D^*OG"3!UH,!SM!G+*8VHG)$)OV02JK+
MS_I(#UR_[B$N*A91$G1S_U4LL[5I3LQ#;K<B(R-" ) '!-;U9\)PC_GVY?#
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M%,_ZWWPP-Q\0ZBJB$\UW<>=RPK;?.04(Y_G+9;J6F!3%EJ]>'%_I'=FMA4Y
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M;<RZA;O!IGO#7=?&A9K7Y(&SD+:I\_OCG]Y_:MTZH1::'!K)>I A[4'1*OO
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M_0;HY^7M;.R(L Y $[R96"-K&HI$X$,9>GB.GE"/[\/PM8:3$ 00!.]E;X%
M,'GV=@XL!W.J+YQC: 7R#W"DF.N1/:&>9("OI^,W0( -T OA3&7;!N#07B@"
M%$!!& 5*B  $B@?@V6,%<%^HN3$'1#>T! I]&%QS.QK!ETXVYM"QV$!" )Z-
MLB:Q:+;H '\AA/8-T%G !V'% 8Z_;7QL2"(",]";BB,[!C$$/B1#$1</<L"P
M1 A?"MD.:^PM,@QPM#&B!3G!( XV>#B1A491":!O@! AP-];PA:8&_LSJ12
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M_4/U^6>;;X#_1=D_;7Y:*?\^O("?3/[WX?UT"?@WXOU4;?Z->/\)RI\V;!1
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M?;]Y7&%"$%&%(K&O@]#'D\UEFCD(V7S1/L _X/@-SE*),5GJ9HCI3.'/7G%
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MG4W=M[GCTN-]GF]9H )_(\:92&M$[%6#+FVECN@W8NW03=&]L3O9.RU 4:1
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MDH]3&NJSFX2HV^WRDFEB7F)+:773(RCQZ88;1R8[F_D<^\O]!<;%Z_L'LTX
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MR-KNW9^0&%27R,C*'B??[7Z0WIMM#=5"-KPPN;G'%Q _0)9^-UJK]_1X&Z$
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M00Y#T-:U8IBLL4,O)Y_&^*,E1:)<%:7.;G9"EV+R0HKH(F)M@=U\)=Y[C7E
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M5YE7Z?-W!Z;19[6S<M0Y#Z=[]%U_[F$HR<$Z+G:O;+Z_"]5WT^9@EGM*3'>
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MKC1JJTM8-H' %U/",[[9\Q4\\V*6="WP"(&1NF[8&%;W-$7J,H^961S6>FB
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MA#5H"1(7E@4VS1%^IDML*(Y+#C<&4UTV$PJ?&0B#3#AL8]WS.Y>GN43'YUL
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M@T^[S][2GF9<+%_^H!:_FFU.3W<EF'LH6-B?4\4K%'E)R_9TBU9&)OL-8K>
ML#J>.%?*5_X48-58PEEDO:-7(?)_,?>>84VN6[MHG$Y%5&0""M*5*B(@O9.I
M(ATB1.D0Z5("TGMB03I$>B<BO?=>HM*D]]!!>N\M"2DG.N=:Y_K6V?LZW]YK
M[>N<YU?>]QG/&/<HN<=X\@.PIZ;7 K:>01_$<33SJS5&S;4ZE-5?>40"Y+D[
MWGVZKGTOP/9RQ-Z>08WJ8RI*-1W%V(0,/E4?2CZ.=47%I^MW[^[YD 'Q;B$G
M+W0:SHS/Z747U 71=M?8PV[F@9G5>^4BLS[O/L9%"5Q3Y;LO&/HX.#:&D^.A
MV*N@8X]B#^WOBO:)?4R-S:IA'U)U!'/\ W(G839.N;GG0J8?]H.'J9A3;IM<
M9M8/];.KX'[^^[T9L(-G?N><6/;]*$'U0A>-^JMJ*HTSAG%3BB8^-#2JF9,Q
M&J4]KXJ$I]\Y=T]+3-OIW/;7D,D2.]=YIN(NKTFQ6($\!OC',3CH/!\;_K*9
M*'YKL&"!N_/Y4D@(A#$O:G@I4-'>0&3('5@ ^RCV6AVAMFK9[Y4EOW?QEK+6
M=#:?U>T,QH9,U8Z='4F9IM*(4>5:<.9Z3W-$J@[P49221L/9C!4QV%U3H2UX
M:\\6,Y#5..'-99V^B'F6S46X*D*W:'M#Z?/)3??7?$M 'D6?B3[%R.W)^S'W
M)JSDPS,VKJH]/Z@:HE55PW2H"N;8C/9*"_DEX/+/,P%G7? "9,-#ZO_AXX5%
M[Q@4N#:7J$+\SN0'2<<VGH,:@!64P_)K+8[$D5W$]MLL7S1RI9D\-8PDT1=Y
M=S17YHFF!C)Q\OFSF;*F34VL>84?<\M?^5'A26>7+,*Q7A"7A4OV26T;>)>4
M1L^ZIX[D030\2[-BLYA+4-!D=_N$!HFV&X!#-LZ3Y8&US^QY2ME]6;!<_E/O
MP0;RVZ[+46=V5)I6&&^+9NJS7V_U@IIW\3%PCT]':IES9S!55.,S;W),/9=3
MSJLIDI77R+MAY%VTMFC&WGL4Q_QLGGBL-\*/%4M/W'E4E&ZS6,D0W( 1($R]
M-Q#W\ET]^RYY9G=^(;\H'=M\2$68:OEB9\_;XN3W'NY16L:4W+-_I$P6IR);
M-N!P3PAJ*<6_AWB4D6W/ZQ$?E3;JDVV?P)>9SJN#R+9;!G[M_K+=2 +<&9\M
M^FG<?QY[N67'K"C=8M[SUR%[WJ0?WCW+_O(FI2U"VY=S2@=@2.*-\7F&TXMD
MKW%PC"S$#S)!I6EYMD$"_-CQ/X"_%!=/"%F+OD("'%<"_?3M^2)+V>%<\,LV
M>V'48EEGA\K[UC!,V9&*+Y83(TH6\,ZBEH_",R);'HC':JSCSW!_":"U5^6)
M?[^/Z?4E_"5,AM-N:AF'O:7YX<:C)V!O5:=;ZQ)Q]$62"@W?F#>V?1Y\=TGQ
MD MD53T6*^918DH^C\-&8_T.+.Y4^_2SB<>;1[0LSKD4,O5FY^3%+X;8[QLT
M!_GRB%J7-#/;CDJ\4PA1TU'E>&^@DL:>=9S+.I=B5KA_;TROYO4M/:OHB6DC
MD_F^$A=% \='TC4Z$$4ID.J[GC#K^[>M.AD?Q\;HJ'R38>JY-#FC/S0M^S -
M6:\=_<,[[MN\ZYT6=)+QC):2XG(<<[1I;>@T'7]Z'/<*,T)N6D#^;NNNN_U#
M\?BIX88MW0-<.E2I]-O"<,%D![*I/DX"6O+$[UR>>"V^5O<&4/AT$EP(=N!6
M"1].-:B9TK0334RCLLKWT+OEA:VLV&)9';E>UEF1DD!_LI-#%VMBON)YM]TK
MLJ?B_84]ZWKA,YALZ=U8F7,DZYB :11M8KQ3GMAIY?#M'*? ']6>5",.W"VK
MZCM^[ZR*)J]%&1+ />9&.]D=-^LJ;HT2>.?\YZ\H]O)FOH,C?&!*84&=-GR.
M T9_-K[ >V5']?*[E)ND%KKSZ<XQA.8TNY@/U-;F.CW&O1W7O!%169DO[-]8
M5.S.8V7$C9=9%6<QZ-6;5'DKK[&$'O-\D36S.IC+K&,#KK 7$8J,%L%E%&%8
M;T5U-U54<L],(<-D1?F#<NO6PNQQLDV>]V+HT_08DBX#:34%7#AM:O>Y)<-0
M5[G@>N 0B8\E8YCEM:*'FFV]&-\;B,Q+\]X26<OIZ6,^3M&2QHGC!CTC"RN8
M?E5?H[(LL[BH:;6):D0Z.EN3H>"I\P9;*2N4.WZ!CUK,UCU]$NVN_&Y>P=F2
M!/C=8B^2DER(MCO@X 4?:VM_V2M%B:WG_ \2DBW7+* <7P7GM#R>#-13"=Z]
M=$.X1 <G8:+2?('I:^'Z3&).TWQBTD+CDS\^?'PNR4?W0R;)]8[AR$1-S&/>
M4<-OSDD?+9GMQ!Y$EU*M]@XNZKX72[8!]PY*,="Z>5#&61B$9JX99'<PF%T>
MI];R3)^>';?0?>%81;#L[I[H0[?ME7H'",0V)1@]'HRC]<GF>>8=MU=:@=>#
MK34RN!Q21+E(;37Q5?!?U[HL'6(I59-9W?EJO9_F:829LQEEF$;;DIS68['\
M%775)X^D-J-5H,*EJ'9Y_Q#^#FANS"&$=MDQ<%K:LF\H_YX0WSWAM+R1^QV[
M(BH45C)=$_?+(H<$?29,'JA2>N%MG@6%QVY.>0 =MO+'9(J%Y5T_VAE".6/,
MXK""C1F=]X1]-E.2=)#1;=?-:^1?B.44WS;VO5)SP/$4Y%##8GNHG=?U=,;2
MM53S1M[8DV\E,J.&+S2K<GLK[0H8NI_2WTVQ\:C5]U<;_@R&*F7;UJG".'QU
MU,P?SUF-9D4OZL:(2*V[JS0C U\V.L^ZK1JI'/#J+I]@'=G:Q5.JA3,,T??O
M9]Q=/YB2F'_7]<0A)#WD$5<#PR<>=YFF,U/^P+T9CQCZ"7<PU^C2I)6UK6%H
MH:TX(N<PYU*QFR2;?]:#V?#$<:'H%)'U3!%@'IT,,NRUWW(O\??.>5:ZHMR,
MHQA1#!V[GYMXS/_KQ\S]4^,*$F!4FXC[87\O:0A[E""$N0EOJ6/JENOL-T;]
M^+7!FXCM2<!?!<X;4UD>L4N[D !OE<^WWI))>$T0LG^/!/!_3:;  ]V^> @N
M%#AO<GZA*-?$CQTI/4R65#H_0KV4ZP2OR9!%YV&>VQ2)FWYKZL1+S'O]A#='
MK*#4#?B73'_L?!F;1?Y1&MF\$TKV]&*ONX)K-@GP6\39&NR+=V3I)2AE "Q8
M&$$"3#6>7NSC7<1C!U/PO_UM+>,H0Q+S.[R%O&4@PRY#!W]#!HAZ^=/7_]Z&
MZ#\V8NVIV=/XD%\L?B+Z%878@1_"+?B]B9^^RX"!;SI^.D3VUV]#@WCQEQ-H
MD/!1MBCF^B_@!O_-(Z+[IZG?!%LR_GK4=/?";_81+S#\"@IO_E$A&1WD[T"X
M6Y, @+"_ E%P?'1SO@!;^>W$W"A\AA"4/F0\$#J]RYR^:<]\6[IJ0XLK-N;$
MRNJUK?F#\(AK?-;*N'<\[AJ*YR\01PF\RXSGBP&\*F=(:1?8(V3+/2K..;^5
M+NQE&.:3&,+[;X$WY &EWQCYT68O].)_%5U5_2E:)H9!*;ARD=LSN;%>!(4<
M)?&2F_8B\0N3'RBU"WCG9^\%C"RBL<<:%I;WZ>JY73L%FVL90R2H H)+JUH+
MU2-%7HDUWFK+M]T:@^8_/;G>D!BR:8N1K^.4JFE0C.G8&)[I"E;7V5Y5\S!Y
MOYVM6%7FQ,<'C9<=5A,3"^!6XQ"G26)0=)-#T;=B>V,.J7YV=-7<MG]^IE)X
M0"&AQ5?VK&MYE":K)QQQ@SPW4+=6F)4LZ;W32=P!%]'&6FO6J4/O:R=QA?>V
M>:7K4BJ75%=SH7/O1S_M"7^0:IO2>*LG,"YW6&E90C^,30W^ZM#X$4&'ZL[(
MOE/ =CYYTD[LY>;C4-.)*XJ.C7+CR@INH*'Q^YUK9+$MU^C%Q,IQ?5NBO>SF
M%9V7>C(A" X1SAYK5VJZ\B[YDKSI<M>,)-SUGI/??=W%,!6Y-;)[%5LW'D[6
M'-G;6FK5*4\L:EY=]Y>GF#+75'A@<Z.Q^"N?]B-$&_A%W_<HOGLQ I."F(KG
M:FY]8USAP];(1_Z/: 9'%C'6:MD)28\'U)@'#_4U>/AZWDM/[/1%Q@J47NV0
MOJO9JY;HVBJJ[>G!S:5D$B+RTW"EZV1%& GPIPV!@>7\-\V?W]261X@6J<O(
MD*,T_N7;YTMO;#'_L9=AQE"3%!YK9B KS[1ZO6^$^;**LW7VDRKQ6T,XC19^
M-P$U;1+ *'>,1G1PY, "):4#?U]Y-D8".-P#/5F[ ?HN^NN!XO]OG_^L88G,
M1LLJF?C+LVJS@]"BHL=OASBD$CY!L2O=_J#.J]]%N;?6Q\6-A#[&;XLM?7PE
MKL G(I_58$^IF1Q%VRE>INCS'7XUZCY8D$FSPB KZ)@+6C,)K4F&4HD-TTYK
M2L1FU$P_5KT'K>(*N?>85E%1T>3*&^\WK:?T5$\JRZXO&:YH=GO>GO"":;ZW
MA#Z.SG,UR>CALQXTEJ0UI\UNCVTXIZ"LO1(^6,E-XP.P\%'7,C.&C]5%IH\[
MZ'=\VP]VO3,D#)7O4;\\@;176'VDFK[)[*(6"8W)4;(TH;6$/*- .=DV6[24
MJ4-M:U]O%BU=;=A/$$D>$^+\%L<RZNQ@;]/J(YXF7R7^H"_)F<WZB4F'J@%M
M>/@='H'E\U8_V&YTQR'*9CM9SE1;O4.<V#4I@:5OR3"\J6:;Z+5T'<VC<=,C
MXWZ$P"3-_&-*ZKMMR2&/A+RIVM.4NWJ9:<:-)"H&9HW9Q3\-.'^_W9Y</J_3
MU%$@N+[)S!G8';7]?6S\D&9S.3;SE%7&(PI0C!*651=\<0A!L!E/Q(8H1TQ/
MCCOVJTV\0$TT-+LC%,['JFBSRC)EL& +9?_C[.%CK81G"S3187DFETQ,W+FM
MW 7D[E7'B?_!\6(,_<V*9F%\_,_(&95GGY4=HJ=IS)5L!6H"HKCOJ=+X7*%(
M"P>^TNM_NP6^@SN6?DCPJ"<!=,N"MAX4(PW?\U;#2D6 <%_U'87V*/8GZQ>?
M'M2&-Z2$RIP0;',+'/B%-^I9<PQ>$=I3SO0DL)<:GWWN+J^L^AC;R+?\M1C!
MRJH2\J#L'4:EM]5M^:88]@75G'"47F=MYZ%:V'WFJ?P0\;;*W+K $_\TORR:
MK'$V![YK4$LE)5OM-Z-RKDLM+8NK%1_R3ER3[IJ]B$>?GCRKL.\L71YK]+Z3
M,]'ZEN\TR>C6@'[^)-?X$P[8DX*M \*%;B=_JL)ZWF+':H7Y3N:NLJU:#C47
M$<NNTK*2RA*O+-T9L.%CYZ3J^(^F6Q-;=AQ&]D9:M)/.'>@_6MYWVP2?2-'[
MOC%^,FDPH_G^!4)G -5?<RMM3OW)1;KT1CGG)C4+X1]Z@P4Y]H'09(["^DSP
MM5VS3D-];T-O\,&W3=WZQIH^;TZ+Y"T*.3E7"ZUY@ZS>$W$J#EEWS(CG8;JW
M%Q&H,7U?0X*/N> YG'5$#5=G_1M(;3']<P+J9(\[->@C?LV>%7JD':IFJFS&
MDY\J%Q.3\6#B6VJ^CD!1H\M&FE4+;MX@^7DUG^JFV>FFH/!F'V>Y9_SP5PZ3
M\KA#=J["[M,G:$]J_:\Q3MK\/$E4[G^D0J\4F FM5,I^C-&^%_N.!-#YD^O.
M?^MWR;_7#?:[G>N'4]=Z]7@*WOM&+(^>>A$?*=NRUKLGB'D^1);4%)0''_#E
M/W-XJ>J<D*+-I#O5BQA\*37#2]%Z4B.@'?#R]I@$>_ SD6,?#2?V-^U6\D:T
MW-]3SY^]['A\.W*ZDEMJ,X3+1+>:_=M+D4\ P,W\U9#EE5+LREUFN.'RK637
M6/%;*L5:-ASUD[<#!XK?,M;PK7N$JZV.FR<4&D0&#PDN5O,XJ*0QNLAU)(6.
MOMY4K6NJ\&NO>MK4G=H3X@MY&$(#8C8PC?N<5%?N>\6!-M8C+^H=QZJ[(G?-
M>P@T[.&R!/)4:1#V5B]1N;1]/(X]NI07>,%(%"O'VW=QEOJ1RU1!=\MF85AJ
M,L+V!2>:0ZJ9KO)F3XBA9O[#E3OEASH+?9'9$@LT45&,?#QJ:AJ9VER+%JF!
M/@\\>9UYXX6Y\RND:9('&V^ -1KW!:A43OEYCOS5%_,&WXM@=)37Z8KN[IU!
M8# UXVK\? W[P3-["O"L/Q;+YS)^!)N MS\J8@6YGZTM9_= ^L[-2(!;E\O<
MY<?GD=$) G#)G2#\<Z:OH__F^;'%(C",\03_O-X>V[(-7/R$IEAK\#TZ!*^4
MKIZ7D0"A[_55=]/Q^%CL/_8OSLJ3+1R.'_G_LD#Q+]+4;F2#N62#9W\99-O8
M&^@"Q:-2=EN)]ZE>RH^0S2/)YF=_FO_BFXL"<BL8$IT:J3%YXF\7O2+/1;<P
M^;^T0]KO%C&AY ?G(7\=^(#78?KF_B_/XG\_HR1W?CY_\<UH07$K&,&<IJ]A
MLL3?G#WQAZGYU9"CPW"@8G]A-Q!']@2*13D(+7XD>T)U0O9DFARKG[8H&IBW
MR)[4KA+*4*%/]!EAI34KCO&3;HVR%Q<1]]<TK8%E(MN& XK;7K>D:Q@Y=*Q4
M\Z*D"RA#"VN*8DVKC<22W#)1<Q\RH'*;FD6*FZ 7#<*]V0+!6S%M@KY*'Y>N
MU^'-E^CU.,?2C6S!Y7VG65X@9GY1D OL?H.[T)^% Y#0M >G1&DJF"K+&7Y<
M9._L3Z0\C"<>QBZ<I-?:ENZ+ Y( ##]?>V\=B%5V'K3;'*JN=:XV)L"(;#YX
MS0<PJ2*BJAP&/^ZR-]\Z  G)1G32(+MXD>S)JR;G&,0O73 IAW^HGV_M@X0<
M^0YT4B&Z.--)@%]2WH4'"D[>F(5R+)?K_)%Q#PI.+0[C[=OS0CY,)*<EZ^@'
M:N_OMSSQ0!9Z(%>)']$^R7-O82W UNDMYD<YEMMU[:^#<DQ&/_ *+Q]:C1RH
MK0VLUO_"F6STXP#OE$E4-<;^Y2/9&5#?/I!YG02(UE. B_<V$@;)[H!2?L D
MATB O_6??Y([P2 EOV(Q\\KXZ/HC;(G5_.Z;([U%O_F+!\T(+/?13Z-P,BYR
M'"3+R>=:?IYSVEM8S<]&=)P"EQ,&D'VN @2\W)A891O6\_9 Z6+"0.E?KTXP
MR098S*P2/AI[0M:,0H4<C2_:6APT1) 5;_VE^&?X@,QY\]$0!91X;^W9_D\1
MFY##13XDI%T("4E>-3C?1_P,%MD9+]1?8I5G/\@8D61?) [@7"W^,/LDF[VO
MJZ5MV!:*)2>&0_6U\=7Z>!B>S>ZGPW@\=)&HZG=.#LS _/N^YWZ=/V4TUN97
M&W_)).O_$D@E"[C\% "KLT<T0;I$D?#D7;)Q[X*?>-!W28 #'M<],FH@C%I<
M.QN)C$@%D860?PG]&"9'K#($R^-Z=&3R4^1GFF 2SD"N?AC,OIX,;^V]NA][
M4,^](!*@+65@H,_U 0$C-X;)D1O:]2)*" .YYF#_\*-=9II\]K^\:D.3]9>3
M]1\=_0T!QE.#88\(!W5)DC'\C!*YR,1KR:F<4,3'>&/) 4>B*-)1-_V&81(T
M_U3US8^<%7V\ P=,M0G_5T1^U73'-][E?Z+ZF;A0J^EQB,U)5UZ_%[#/[UMY
M=3[ZY?+,HX;&"-:33]/2-$;E&N_"[GWTIT2?&X-&16C(!9&J=*NZ6J+N>=P/
M.>I51Y;C42^PY5*37%U!@G#)<9U&=Q)-3;:JF>"=B'N&H[%)-%%_D$-K#<>@
MO^%CZL_)>.$M?Q=(\0<LK^O9D7$W">#_5X4P34"B/8'D,BX]&_R?R-CUHF2'
ML(20&>MT2-/7KA)Z%?7X,Q:QRB2'0R:H@-CTJ5:%*\0V9UCUL>YB=+30HS]"
MJFWFE),9^Z@YG!\8EHBS";<*NEK$EH6H!FD_:2O<#*T+T4Z.31P[V4#0O--!
MY$<_,]$@YRO7R(^E<^D%Q:'6VMEJ8QP11RXR3>@^D"D/2$:($I_YB5!OT9[\
MK1U[1':,@"U9@;<$):/HC/S8D1$:[%VRR/GD7;WS=?)75+F/=PG\?ZOB_2L5
M.=3+:0-[?9[\A.-?J<A[L6K0:4FW:=J\\AN8_C'Y^E@MYQ9KJX698['IW?N>
M]'&M4'KJ@YLVQFX=<A-GKGM"499OFXUMX1&@RVK;DS@0%EZB.U=29DV;HP^N
M]FI1LA<N NU.-G2>!^JD>V]69PAR*AW=A1;S&=*G44NK&-Y4M#5\KFL=QZWH
MK](S:"FU-NH$RNQ,6U@B 3IV4*D@',,<>*'=!3+D2@)(X!5\-C]CW#Q%KN%P
M;+9PZT%MA6P?=S8Y$H"*( G%;^9M1QXC;_#&$,.0V-I\X[-1U&95@K Z#G??
MX)=PKH\3F_S7;\HD0.04"2!3(LO<O-8:M,)+ GQS!*:\IF>SP/OG>WZI1L_D
M%L&7'<3IGLT>^P'KNYJA\(T;&K L']]X\?:!UVA$X!D4^#5.LY&WF4\&$KR\
M"),U/B !*IU)@*SQ".!I5!?BJYO0RI5E$D#?_SW1;Q&8 T6E@HF!G@AL830Q
M DF\@-/T&B$!;%D2\0R/B<^"<*W;[$=K- 11*'[A_YC8Q7U\G]0PG*#H\A*%
MT?WV4_#;WX)./P7/PN$D '\T.7K$BU.=2<HL*T*M86\.86J$2Q,=>:&'N,)!
MR*W&$_8LXH7.F%$X2%@Y14B^%8UBW9T"!G$TG$)\YMQRZ;IZ\1+U:R2 ]3FH
M%_(HH;6H7A<R/O)=:'ON!O5)Y@:2!*!Y#1\Y1?77 P>USDD 41?4D"1[7Q-U
MKQ-B97_+\3G#R<G%IR3 R" )8*B01&9"!@H"T!Z_07QW-HY-B2.&U!&A6T"1
M&_()K27U:I#Q48>$4Z< $J"86H,$P(2])R*KB6XDP"/?+7P?^0NK. .7V >*
M:,DFM)9Z*Y+%RWM(@-Q%.!J>4[DP(\=[O%-ZE)?>L9=XL( %K:<@5N<H5L&=
M7'@I:MXP'.XS']SFSBWE_/24@:#7KU$C-:C^?!+@L>P\?JB+K'L /XV&634Y
M"@5=6IZ$0UX\$2*L7]+>U,LU[8<'$E-JB.X:IR"?<Z]($$X0OCI7>22\I.HG
M!>(A%W -)7SO\7T2P( M'10DWTH":$[#I7()5_>D#A:]A=;)U[84+_:D4D;U
MA5;O^Y!Q]!_72 "?NWJX]F.BG_0<)\YZ&ML&STA;8I/3XR8P _$4;[%IS@$M
M+,K13PG^5L:0\Z&07^6GP#)/]S/!B\ACV482H,\/<>PPO\]&L>K?/HQQUE).
M.#G)MCG\^()8)GO#3[J$%V<Z3U;\F76:Z+ ,S+0F =[@KO4.A*]:/_UP:-PG
M+QM<[48GLK4AF&7 D)E_%8YF?TD"(*40&RE.:[=( #(@HMTRZM>Y6?:(F]1=
M3Y _YY(7Y^L]^!-,>?,#F-@+\I@01!Z$Q'L+SX9^C3T'>)LM%/<-.+G=Z^V]
M)?<DH.27?WGUJ]T"3;#WR$1 )F*4'_5??9H1M_=/$S]^C3YO,0/C,#46$H#<
M<4KG+_Z<D/RH.V"-A\_(5;E:'P?#_-6J8:(G\__$\>7O.019@H^5)@'(#0+2
M0D'FT54,D#KFI,,$>(OZ(76?ZWW"/IF6R4/,$J8?3513> E,W@7_LBM>2T9L
M#^=F?\C>Y\GW2RQY^L>QVLIU)0L5#TE:OR_9WVV#4LWYG,-X7BXW!8[F9,;T
MUVF*.#T(D>_&Y&^-$B[\:KR7M+<]I(%UKM/%<8D'>G&#J[U6-S&GTI#/$ES=
M^"<T'^Z>;>6;=\,"^>/I:5D_YDN(X'F:K76(_*^L<IZ%BH^WRY0-I$1L8!^X
M;)&';_:V1?> 3;\9)U"710(D9?<+D9?JY2BV;@X9W2F(DIQ]B]=B^II_Y-P,
MY(XT@3DU7L2DBK\'KR[YP-19&O#S'A0'4O:7<_LZCO'QTN[DFP/UXFLT%>@O
M_7L_];=?*.+\6[Z1/)Y3'/QI?^%O=42GZ8N83^)O_K9& DCNO,4_8_KR-QIX
MRND7XCVJEPJ.DKG+Y3VHOO.7\)N7R]@EF4<.]5?FR>,[,/2B/O4_;,%^V:+X
M"XHG>?2G7GR#OOA_U++_*AROAF_\.PP7CU;GO8EJ>')8R!5(CL.-W+Z6(WP<
MEAP7<EVU+9!O:2G^:UC^0W+@!TB D%9]&:3$^<"AWLKXZCFY0.D"R]P5H&?(
MY=*>TKXSX,],;/I-[P&[(#\S _^9B5%L[1P\&D7.S R9R<BIR#]R:B(!N&'D
MW)#Y@(R" ORO*(JA_.HN.JLKGO2I+U:,J%J?[*\73@Y.4QT&W5KA6NZ//LS[
M(VY2W\N6F_9:>7RTBEJL=?7]I#1PX18V>EEHN;*'_0O]-R+G'W9^72X,AP8K
MB!_7S. T;_./N+]#NFSB@6\$/N"5+N?V)MR%<Z?K$P'D&]AM)J2(\0=\O+<%
MYK<)2-O+_X^.GHI^QK+RK9JW+@8)6O=$'VDOMH5U[@0>)^FP&1I:RWF E6>V
M]J0^J^F8QMW['C9\.3_BDUQ&4YLT-U2_6ZP=Q;PO[<+XM*-MF<%:P$F/TA8Z
M>;5HK$ (GCO-(X+X\J0L*;"V06P[F 1@M&5J#'O-^T;&HN<(C"IU1U2)R.7R
MQM!NV4+E(JCH7Y17O#H8[>91AV8W](E?<HK<M+>;-(IX#!U+GH&I5W U/79]
M\]</,.-BR4%Z2RD7[TV-ZM,+O:@X>N6\=3BSRZJH5%$4VL)QIY:>JGI(PC6[
M-7S6V#(C^\%@;*=#</#'Z#L37_Y7?N?Y7UH*+WJ@O%/ON?-:V((.5$@ <.G8
M0S;H6>D2NPXN"UX$S[LX][^O_&*N>TY#]@A^=3[YFG3N!WZZG@J6SS4Y#5_C
M0YFK]6(,!MSQ ?D*-,K1J_)\.9/@RW&U J,QUG%9X2U\/I73TKY/1M-MWG1!
M!.6,MN,[V7$L(R=EH$:\KII]KDJ:Q00N;N-,5FMY6TLHJ1/J K%5FX,?URUM
M6"'@F&ZCS@Z9FJZ#/:G6/I61:>3=#CN=DO)RC8*;QBV1='8ZL<Z%>G*Q[@?@
MV<'@1.<1(;54<3^S-8E.=6*5*--:XL'KX9/Y!\ONMK.-[]K-U+3O:[!8BZQX
M^1=P<-40):#9:L=^U]2BX;\ULZ7G:*;/=]BNXBMV+&:-OM4,ZQ?UBVX[O!DM
MFO>STM5H\(<4YP7CK_".AH]-S5=W4V\/#!&^FUQ!088&NQST91:GEXY\UTI/
MQ0F"*SSD\4&@Z@R^@E=DNV/7,,+=IZ7JUY(/3A^MV]=9#.Y3/P9W%#CS&2!Q
M1WJ@PO'\M$+W'I<H)HMD\'X):J^:2 &_/& %+%VM70*V9]Y#?!:WTJ91_)HW
M-CF26\59[V S0G">:A1#VXQLGFP*%X]S]AG:F'2HX'E[B&=/]RZ/1R*N/T=V
MENYOXA"0Q=<]-3P"D>T<H,"G;-'5[[@80,&F+,^C[C3"J-\85#AYGB*GK'M$
M#YISS_DC),[U$3%L4H@/%IA4XW"%X(;CK#PA0D00;AX?H'V.WB(!BKJ(F_ (
MO<&OA&R@V$,L;HWZHQ+(W&LK/3(@,[N$.ZLAZE@])#(N<P07^"0Y-9<[TCUG
M20P>Y+3D/&U56;MEW@G\T7GP\)HF_YL>;OBN/XVNI3_+!T$W,$B'8U.3 U28
ME+#UB3PN"L^WSS2AA:Z/O#HSY ?F6$"&-^>#EBK@[1M RD1B/S*CY 'F_'')
MBI[A]#=M/&749F4RZ.M@=+0U9S.PI%+8K77.%W<\$'9K::'8!F,-?)(=4^M1
M0P(P^*)A,AKPW^'7Z.#/;=QFM1!\BH%1Y_0F, >V0\$TU$SG5CF5*?*MVCJD
M0-9YQH]G+^?</CMWFL8(AHR?3V9A'V.)IR9,*Y3O)B426,V^?3<=S"$!UN/8
MJYE IB7EK/GJ8@E/=CD+7 MD8 73& 7:6TK3U9ZH\Q9X)MRM%PTD9KGCHW-<
MCGSA!W7$;!A-Z?G\=FO8@U5:--0 K?'F@/UIMCP;%W),//M;Y.:UH7V/O._@
MF.I*K-^Y7-TA>&GDR'8U!+^?[.I5?;C6:6=T1 +<) &N;6L6<PT3UY#L^0D9
MM<^=9T1Q62H?-9D00R<R8::FO#'36O7"$)"?WQ!Y"BW=\-AJGMR5T3W!-_,>
MKV.S'G-');F) -\0+BM!BN 7/B[DV.NXU:J^B+FIX==L%MGS!A;-10) <*@A
M!CE9A%\#XT-%XG47#;9FGP30]K5T@=:,A&O,"10+ZTCES80Q!F/&51L5M-5@
M5YC*YD*<UO$'CVQ6&0*8.!H\"D.@&0RMJOG74#T0A++2M'>7#+C]1/3/7@6$
M!UW%M?R8,%4W6TC!E#Q7' T)4*"0 P%_6NSJ?HJR"?7Q)>RJ.5BP][U"=YVM
MM'8D&8<O[U(]NG^MXF&XH)]_1/E*?@NFY4O'JG(,;?3CL:D/A?<;[HVM!N2E
MGWC.>?]NV=W;/+)S/C)#S/")*)]8S9H.G)R3]*T?6<'I%].7D$=$@1@R8*1D
M_'@3+&MC9:[L+%*P>QLZMW7KL[3FF(U3+<)IM(N.SHO<OD$2FGYR8\4V)QFS
MJ?ZA?O_U+PG#[H7W9 "PNHM)0%4_R"@!HMPZ/GQQ:F2G\9P.T[Z?A:,-(U 7
M_"G_Y=\C^O_PDL*B/Q;&H-6[U$:57EG)WSQ"8F^Z;S[%K0T!2RZR/8W="J*J
MVTEQB$IXGEOZ6"C/278=USZ(TN^]_)3^J@&')'6;ZR9.Y@YBX9AAC$B>;+(N
M[OT;8"X\)KJR6#8D7;NQ,E<;@!-A]7IV[U3T)"*JUSI2_!VWV61452QQW6NE
MZ4-[[$9V.X;6(KE!E-$ZC>7\ZW&GT-WR:5Q"Z^*1S93.0R?S<O3K/I1%LKD<
M+*U8:D_>ILO/50;,T@L-F@;!+"9W*SUX>6,T9%.T3$J3??Q-@/:AO),G_#0^
MRBI'N@=,4P=T)74I9>7^>R9/71\LW5P_2+?@S-C;V,1>EZ!4#\_ILEX8[U%E
MR5NUMESBGLC<50\1X#L^"EN2CEQKKUHQ%Z@--3U0W>^RZR@W..N,R)$O-^'5
M3PKL/RLY@[?O>XMNBY?85MNO(IAT1[*F%!1NC4]*H&764QG9Z")G]1II"M9O
M5>@@=U7+S,I9O^_RGK)VF0G0];)_R1E;%P$J/W43.9M;W.Z?6_4ZAPKO[$//
M:-@KNQ"LMF)57O8KH=C"[>0!33FQ-!XY>."NHTWXG)ZSWZ2K61)VPW=JZ-4I
ML:;!:)H>X1197J3QK*73>KC/XU(8V[5US'=#F*@(DZB(>J_T8 A4*(.8$86[
M'OS]>[5]R@_)5(G3Z1M*Z<9#:!X9]-BI8>5."/Y@09B.CF:O24^X9OET;'9[
M9[5=07C!;J"F!F'9N8J\G1028JYCCSO!H-:CKNLYEVT,RXBPR Z$L<<8PY!A
MXP3J38*V^<P!"7!I^O+18F?6N!^0H?0$GKL?=GD-@7$WV=]3>.#SPI;=-&3C
MY[_(Q2WV)=CZN8Y\=>VL*V[2/R[8"UI$CN&0X^><A<+"PR;!B<C+0![4PC&L
M=)1@BK(,N/&;)KQUG5@* N'_9/D]F00(&E0F!FW"E_[XM7, ST,=?1(V4KLB
M^A':_Y[)PFI\435R9$-HBRY?FP:OW1?D7#<]W5?;O.'D;VV!8?$6-N]A,ZXN
MSERB 7Y#QR<W,L3:Z=RIOV2S7T*W6P7!ZAI+9N;^ +[]7<@7MK[Z4"DF6D3O
MO*&-F#@,5YM-^+!T>!*J:7/^LW=8'#_L8LJFZ5/^[=!-9].?LN/C @$4,.G!
M"^;8.KEB;-&X%RTVN^-LB6^ 7S<82?^MF@2@23[&DSWX?:RCL;1HT(2:.QJ%
MCU6F/E$H*+H)?ZZ, Y6-0S;QSAA#3HQP+B[!=6<60N@E 5K]^+^F"9WZ>B-\
MY+GB\1P*R*+<=*'1*[NIVD1^V\#* W)7'_I ]W6>*"J_PWX#.9G0ZQ5++\^3
M@!3!E=;!D,?,/-_)$G<A./66'C;#/N'Q<S(*M@)@@<3QEH(]J ,>IIPQ53/-
MJ0[EKB H<D4KCYRH!#<@/SEWG L:'%E53<TSCM%/H:.RS3D4;@B6,C7UBM@Y
M"%'G(J-6&*E2U7Q\[!+[U<LJJE(/]<,@-V05[=S/3 UH"(H$, ?G1JH'BK++
MU7>&63.2)>GL/#PNA^5Y2/6AZ4BV6_#90-#:_F:G=(FZ5?N.R.Y9O6V836",
M7Y* C&Y<D;VHZ#Z"O6]QU^2+ NOH_KF&<F<.+BYRJ'?LVITIQM]UGD1(.\ZX
M<UP6-N O%VQ&+$:HN.?<+#WUOO']HZH#<G_HU'YP7K6F)>;T@P=C4Y)L@N=*
M3U./:;ED,/;UL)\-_96D8FNX(;HK1@V++S_B'$-J>[)]]N3:$_;._[I3W5G=
MJ2"L"7.H05SIBC?GF9]"\VG:=*TF]<MGKWSZ+W1'W<X5JZ3&(0(,"*>@E&A>
M)* YPD>1X2I;0Y8PI+K=L3NQ]MO%"$2T3V-@>_3-])$=R9#+ZLI;<ETT_$,G
M&F&E6[>OYR<D?YPR,6N3&>XIT)T*404>JY,[L5#>Q8E_IRG\1]?%(9[GKQRD
M>8RV.R*[-1U;SD-L<X8A5^.KD[BY+H*-MMM4O7Y8" @^1I=>R2W.OH>N5 AX
M]CE9TUZ<_4MV0NXF[X^'+-D\?&8"3Q4(:SJYU$U+^:W&N3+'(@>SFY]M@=6<
MXFXD@.%+"=GKHHQ5%:VVME5XRD=N0EO(,1W$9A).@Z+JWP%/P>BIKAT--ER:
MO.3 G\P_M5'-($ZO/9T L=&S8/T>\T,K]%!W-#AZL2EGYG'P<%;>]TXC[\JI
M0V:-1JI3&>M)ZTX[R^Q% :/A _%JJ,&&>)5&6]MQ8H+"M&O=I*/SGD1"C3R:
M'WW<;&T^5FUC.%7):FYNSL,CQSW&$.OG-*E@9/0U(JJ$J:9YB6CURC8WT5$.
MJA># #ZL)BH#6\!#0AM,:JD%Y:]#P(R/BAI'DQP2NO:,"0PK_AR[MU>\G(IA
M S/61]#*CH8?+96OII=K*H5]%.TC3T<VA\41Z?4<*$5_WA-@Y(E00+IL+,Y]
MUT'J>"#4;43 +3AUM"2*3AVT-2R.\TCC7:GF<7!5<F&@GDVL8O915S*-KXH1
MT7\=PP1V&0S(7W<U=P>"JVP:EVI,C-SE6:S4;16MNJ98S\-26TT0W*]RA?1'
M(%=71K O3I^2 #6Y*Z6:YLVFR]OX)B4CQQIGB:4<][-^8,"Y=<L63-U]V,9N
M?DP/TO9<_7*(I<GSGHWUA"4IJY$VJ_Z@*7B!\MA]7)8Y=L#9#RY;G59"3.Z,
M@+(*J)ZA_9&W]Y$.:F-M>V>I6HN2S.JV>T7$XLQ983S=$EN;SW=AV:O<^7:@
MXB_BL#7A+*0M#3)#A/DX_P-YN"T ;3)&P-?.]>!?YYQ>X1I9?2R+W/!"K'Z5
MV$7_&"'316E"+K]^L<W&[O&6*O*L$I]'4,"81;8]"?"7I\ AGYE+2QQWL=.K
M(YSMO.H,Q.>I,S]5.4J1 .]6WGMUKNBQYRZ2 -FX=ZWU2X3!QA]S?OKXY*5C
MO"F*>I18.DK/VLF^3VYTG'.=5KIX>5H(FEBZ=4W!I/J >"U"5)<$"&.+,1DI
M;2.6%I]KC[L*8\GZVTD ]1/@T2<I2O&5C6-X-@Z)Z;CX)@:RCU- H7&H]3<_
MN,:1N4/$A$T28"GQ'ZV.!#CZ0CY.(I,.D+S1>>%+5RG&AP$'L2$ 6*XGLLJ<
MJ#(R0$";#%E$]JT_2FJJ0$_ILQV^)(7YIBQ72[$UY)1W5Q0%^KX0?U$5Q8HT
M,Y-Y="IYHT*64F?.[7LX>FV;^1%3PS&GCK]DY;ED_)HD1B*Q!NMZR!S6_GIG
MPZ!&(QY)9<\*D_&M3K&ED5F0;YTQAM-5]C0,I+"QQC-I5EA7M=NJ=2(,B.QP
M%;0U:Z9<@U\]GU<EB-UZ&S-6?YD$:'Q7Q1R1GW*UV,I(///)L?YV[%FY(!%\
M36+;85J44[5 S,J+C;^B!>5SX910<3Q@:[JX*[,T,"^=GZLIH)DFP*3U +P@
M;2UCU<?6Y[R$Y$V>A#GA.K=XMEK.)!:\U"$,MN:H6L-YUU?I22+*X18A6P@6
MO)#7$=8^$AW8WW3S7UGA0OOD\R=5#D-W+R=<:;A[BN,>91\]/EZO2MCDSX?K
M7RZN0$2;E92X<:<&L_K45=W5ZM3Q9PN):DBJ@$6FK8R<4/J#/EU'LDRXU=H[
MLB30&%A7<O'([C*\YX:](ZY\],_3B;59AYHPC ^:S%^YCO]WZ.L_N"ZG#WAJ
M\7W(WUPU?;KZ.#)/)D_HSG3PFE;VCO2'N1FM /BVI;KOC\UHSMT+>9NW)U("
M=1[8U+D?4[J-CA1"'9YW<HAN)F/\B0)A&YP;BXR%PTIQ4LA'@&BI?D;-,)'H
M@"'4PZ&ID_#TL2[7TNT0UBM1K)5D6G\GF+V?A,RZK/]O@K](U_]:0];:W--+
MT#_RQ4IBI/+U'[//9CHT\N@RSS+0YQ_]Z7N#]VJ"#+RK[ZZR/3:&JAKJ?*X^
M,A:BFS$V=61(G5Z<=38*]78Q[V)"#RVQ![2U&=:$A.D.T1>UM:FCV@]3$92H
M]FYGZ0HH^8)P!.;F5=?U S[0(+/]%GU(8F)B4I"!J;8W?$_AC^53H]P(<*EH
MFL0'GYUV%R.3>-6@KU8C[J]%9;QL7QW*6=]_;F\WQ__*@T.V_[%%,ATW"9 $
MJ_*O.J/(G73Q9+?I@)( KQ2Q:Z 4UZJ1TAV.\A*-%P?AQXAX#EBQ[4K8O"_A
MX<G ASV-YS_.4S8<SN,M>IB.O]:=POJAPTF\WYP-8;8C&WW5R7J6SFNI4DJC
MUO3RL2I*PDE,?W3]6>[/,_N^S>3Z9NZ]E*<9]YJYYA75!8/&:FECW/ I;_>V
MXXJ@TO4IBF[AY6AX:_ !$<<)\=/8>D &N-V-S75M5U2N<3X'?D7:+,C+C[#>
ME9!W#M&(B9":WI9!AE;Q"4HL@O(9:1*>YR%^B# >[SW<=?;7T"W>GY/1("_X
M12K"M.#U=(TH.ZLB#$@UY*7'1)IE);@<6,<&!"E%JX5G$CQD$H)(@%@1#L*3
MVY+\4TV.FS:"XZ>,N;-,P_"OI_#WPNR45L9P8,MTF\4,;)R]\P0UZPM_H('7
M9YEQZ1;RU+T*MB*62&/2X. SA1 O! EP_R%TS8F< IA*%V)>"Y5Y@E)>L?)U
MM+%":@HLHQIF@:"@#?/#.PQ@U:SASYAG%2(B),"?W\,MO$^=1<FMW&A6GF%&
M-G]$/\UB_L9E36<??U;@X$]2-QD@D_KK/=XY,A/[*;Q].7-P-*YBLN]T&Y^\
M%Y3O3G VFW&0.8XLK&&=*_+0M,7Y,$".K^%:\JHMO_JYHF4$;_88$1_X:#KC
M8$(XR!@N\\-WLB(\D %'QBQWD9U,]7C()A"__Q>W^\ S"*XD0/N%+ZK_9/3;
M-T!0]0AER9T<L:]YX9/AZ9'JT5:CP8F1,7L&[AR"2^OOMC9$6'<0S$W++O[R
MQ3QSV/TBF.@"5LYFDG;+T3/%/UL.NT.SBW @TI CSJ3\YUZ_M95-F-UU'45C
M7;&:3,OZX@R5]\$6#@TJVO71EO?,1@4-,PO;'&N8(,F'/LF&SGPZ(^4M43CJ
M&0*A:]QI^MRV3ZQ*R02MDKSC,76"+<W:\I=IYZ?O>;5EJ&@OO&3Z&5<Y34@I
M2\6CO3HEBOKEFWD$ZOH(.^Z(!-,8>TUGM(_AU ;=%'-@ZJ51.84,Q60/[:0=
MH]N6'>J5NW=$QL)"W"E/0HM,*4M4+6X?QIO&&[EWT<I3W%U3%<A&%<U%X5BG
MTF.V+7B&.;UGL'PYT%6U-E/W@QRF$YP4JCXDQ0CK61,7BM\YX1R+7#BA\Q2;
MT=BI8S(R]K4SM&Z6$XB?52@!A;?IHKX7NR<EH>7S5][\/PF&NI5#F^FYHB5Y
M68V&(P8M+6'O.>\PO1<=^\/QXW8W W-!A8A.I$QP=X-:,^_@<$#^L]%,7!ZG
M\HY"'I4\M>VJS[=V,>]LA_J3[PH1G]6^Y]1\97>*T#/WWYY0!D$FBM6$E&T%
M6*__GM N:FPO_L[U8%J)]V[+< Q[Z0<9NE#.]9GOCF[>[T4YN?)ZROVO#V<S
M9%U^_F]2YG]B7;S:[\'#7+QYRSW)M#4GV#I+R78L)::(74W3M-CHPF?C^N'K
M+;10'E6A\$PUE=YW5RU90B:F"Q;T W.RJ@H+H^;>2UDCO'C:]=JEZ3U47F<,
M/A8YOO=Q4U7>A^^$YO2C4S&D8VK&FV;'-7<25;^>H):=:9AO)F.MMHY+F-JI
MW!#!S"['^R0EF.-HP[DY_@C\&)C\F!E:Q4U5$Q#]1\"=D'N/_XCFRJ94=>,0
M>O0']9U_W]U;LCT@/B@[RK2BMSHTTY8UC0_4&\436BWX,NG!24*PH^EB>6KH
M[/,N$,,NN:KCF-"UZ>;@0''?,:'JEIZ]E.651M>>5D_6DZI^&?N:/MNM$@T:
M\5##D:48AGCWI.J-Z '_8Q)@]V*#K%K54CU*DO>;GDIP<]5 ) HG5UDTQ2''
M%]/'I*A;DW7_&F](_RZ%NI2O$U59GWLEK;R.A.YH[J&QEKKJCOK]]REM9AM5
MW1^?3O7ZYNVH[ ];3E_A$!6@WMW3\']VG")?X2JK4;TD-Z6TQ+!3DW"F,<>Y
MG'2J9+C8M91MY#R==K1! N1A/C>9KL:@#K>D7& ]SB!XC^C1QDZJ1[.<>#P!
M/;,\8G#(V59;;4KMMF9WBYIG?Z$5G$9=-UG+:UPHT?=TZ/?:CYL-"6V<Q]<]
M[6<QAVUZOJK9Y+M!J2&1S)'I5N.N4UAGC6G[5\WR(\-P8  Q(#?"%6+9JF._
MVI'<NL[+Z"'ZW;V66=M=;?"5*#=7SP_@&Q/^[SNU-"77XVH7Y.$/O+Y-0^/]
MZ'(,#5'A<)NOZQ]K9CEYGP5=^[%>E6U% FS01*8O8@X[DOB-E#LXX!\F6XV&
MW;-Z0=_<7KO<':\?;Q"%8'7$_!U;08\L!ZHFYDV<QP_=B)=&;JQY@L::44*0
M!8O#@CMYX8/C(/0>9(M8@,@KW_4JCF@83H89$,7G*3@;2M6-CI4/A+VKM<,:
MJTO(;2L:0KP?*-Z\6'-0$DL0:8'68M<TH?CK,B:VM+&*$+VA=0+DN"6OS=//
M(T;&/5"Y=JZW3:.'-<[8-#V?!% ,PY$ EOJ2S)21Y8N-"[-;0PBU8C+7DP?Y
M14*&0PO_L$]KLW%<[7NVG]> :P2A\0W".Q:[*<3#@3(_Q;2G[<<<B?.>!(?
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M[9D;M**[<DU0$S3G<AO^<?Q1[A=:N6=I5%O$F+BH9"LD?YX+YZZRGTV&$B$
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MM+\XW,R.&;L[<B6DZ 1JYLB:/?JZ(<Q*[T9&PV9A;1RX+!8@NW:R(4J$K]0
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M" +EI!$Q@=1PR#9FT>)V*6)H/C9 5:G.G5</.(SC5;MVP>BA.U+EO.?R5.\
M3U6V9M@XO:)[%XL<VXBXR^6+"?E, N2$G!B8EUV]II#3"JF.Q47Z)J"7N*7L
MX)R># \FLH_S$VL)5B3PG-M:%U/M=X@-3VD/J0#X%GP#6/U2TM;,X> 65Y\.
M:5?L/K:?V.6TJ]L75BNB2\(](P!HTEI;=%L$_U@2'4U8(=U;KQ/76=G'XTR=
M<8^7BU^_,D9$"'(R,9N6\5O[ORL"FZG@4W"B:))<"ZW_N+_AEC%;/T_->A9D
M,9.BL9%B@&:,MKR@>)W4YR)W5R DR('!*<9)/84[^*.-K5MKW'NIA42@ UJ-
M\& L[WS568G6C2SZCF&>6/NVXK\2%>"M*B.W:9*]OBI1C],D8LKW=%9HMAAJ
M-AY"N,^6NB*(F5T(4/4 X!J1XXPWUFA''+#ZH#W+$WPZ)5A-F(=]1LFB*4H<
MX+)(KP/1.$N"#PDG)<I:#25Q06=_AW[).*D^ +**0LQ^&[+>F?7%D24_CA:%
MWWMD805T#ZP<EDH^\O[TC_4F8+?7%+&7I)$/ "!Y)<[@(_F4@.VQSK9?M157
ME0/O0+R"WH^HHIH=YQ8^99LW?T<EN=5+>$8CJ8<P#-)6Z^PJ^/1=@TZM;K&F
M<3,:T42,17\8!-[D!G [@.&=RTJ[MP(0D5LNA8SY:AA?;I*8=N0'E_Z: Y;?
M&J"!A+5H;YI(%0_&H]&;O.ZVR#4?Q<90"[S_^Q$K3P.X<A1^//8 P!/EO3CI
M_?6?E9'8E-YK^MZV6KA^3XS^Q<P*Y^5U&0$ZW IC3?Y5G_$_]*W[N^_4"3&L
M\H$_W83ZW?R9+M6" ?_N\=++EIA/L8<R]PF3JM,'5_]6N)/9."QWVAW/='TN
M..II@QGX&"G1OCX,7AO7UXB;@<SP.0[$P\SZ*H2\[%-/>^;<QDRI/<9,7E,Q
ME ZX@NQ; B/V[@7W,Y$%U2^I<T/0:_$9"7+G[$GKNC-\".XJ'&"XN_[VR]TG
M3G):^>KIU'';^HSB.[M4*4,**:Y>\?FSR,[5*G"=AV1O@V%K\9^!K&0P38S3
MG-6H7@&'.)!OB_IS>NRX[.V5II&ASL3BGU<8U2O%&<?4Z/T1]^VK^YG%AD@U
M(Q-+1VLBSF*(U2 O32-V\CBV'LH5,Y:?H_3]].6L[1*M. ]PGL[ AN("AA4L
M!2>@0V%-COEBU8;O^1^4LJ;'374F+UC/K^^K^- :#,:(?)<FY>[$6G&)K0H@
M82*C!0">5&#)_+-=E>\/@*^BV2=RJ5$XK'<M15<$]\'9'^O;'@#!HXP/@"'D
M ^""N[3R<M2,U\3+D^R>D/=UVR]2N0> H!^,G/3P?@4<T*=Q,S3ZT^1?YOQM
M.)2^MV[_5P ;$RU?%?0-C+ =A3H[*PU&E>)*D\4M,SY6ABU ,I?%IDE)=%<I
MC2%;3%8>A-.L__3,R=E6;:+23-8?/"99NUQL6O!'<A[WMDY.5%UM"5TZ<-.>
MXDP,KR#NR__Z9X+7CE KSISBZ3/WG+8AK$ ,2PL#2SV[5V$-K6.-LNQ5&7[5
MO3X<N+8JS%E+TGJ6Q!P-W3(JFW&;+LLH2#,9<G3%Z45.MPR%)@8-#+ .II $
M5&M1?<L0++C?7TST'@5O+/V]+<0YM#VGCI%TS]XOG-R W^_Z^*O&[T,A-VUK
MOF0'S\=C-F>O796-&EI8-BU?K_<:[" +9UX[5ZTA9*\\3LM<%()4M]:<"6\D
M69:Z>A%2I,6!(X=QGF+;43JW_C.]##;SFRA=,IWUJ;-19M()R!.8V2%<UO&>
M<WG)9Z#QFQIB+(6R\4N_W*P5'^WQRHIS3T_G<Q/T[K)BV-'QZ8D_U*)M57CA
M+ELJ=4^\='KQOM!3.H7.VD-]9#'&KRX:,N.ZV7;0:G<.)2^$;A@*I:+0545#
M8_>J( _G7K6<?@UNFFE^,0')]_Y;O3.<*H-G*GXN.R4U_?$*&'^< ETIH0+)
M4U*B)+%:PR&(53:>3-Z\J"OD)K/7Z9#U?+9LNZB'5<WM4AU9&P#E5;@Y6Q4/
MF)8:W9=N4O_5:_?;>[C6T7,\W[O*MEM4*FCK&$.GE=S;.+?5/*3'ZOP]"7XB
M4UD_2O?V?_)^Z]63X<A;M*EU]L:CH=AKL;U/K^DWA#KNB+<>G3H)M9%Y$T8)
MQSO<WKS=X"T=L:R*BL4>Y*P+<;OGS5[U*$P25TNV0+-H*+A+&D+S/)@2)?%E
M4P]"(H]SMVPNC@VWB+,4EFU$F2+Q!.*6F4W-_$J:SH.XE$=I^K@VY+K_%NUQ
M,ZE;8.&E#!M!Z.7/DK(H$E]'%&7&/U8%O0UDON;.7C\[#0\8> "8!HQ*B[^S
M?0#(+CP .O;OS>:>WY]]HG1X ."F))MM/(D)\&JV>X0G@:A7*Y&*DWXK^@#8
MXMZ2\);?_W76]F;?C96F_H*5;X#/F "KFPUD,BS+_K/3Z2?WM%GDFO:.H06U
MPFI7#=)GH*.?V$I),\ZC\'= TG-</Z2 __O-1?'V:CPSW7ZVZS+1D4>,@GVN
MN,!"C\( FS85VS#?=?X3MD*7A6UU>QMYEQ'9U[F"%A%=%BI!?]QQCZDW@=8=
M%7DD6P']92Y*\IWHC-S%K-\C1H36=0KI6X:<H=</ *+^S&!1SE#)#/TW WES
M/.+%1LZ%[*C\GXEV;\>R3!=-CH>'ZR-C]OP=KK2\)T^*8'X1I=5S39R)(FVD
M5Z+):Q[GH*%P#^2YH:M(!TKRF;RV^I"2FO)%B)' YM*LR&FHB8YN#6%<C1EK
M[3$&=/71>P0B$T?IFR*&D87<Z+@0=0;#Z7AKDST+:XQ#%?8R55K"19!6$CWE
M*.HDBYA/1]R(TM(851_0W(<TE<+.JKBO4=266_)COQ\ 8P>Q*,&"Q3UMQTTC
MSL\[BZR""->.ZH[LN>;D@>)JU:R2]V31+Z_;L.5R'9AK\R6QAON.C?1=F>1)
M?7])YSX -K])!UTG;"?Z1)S$900N-5:\FO/5_V*VKU;ZWMTLU9'+'VC&W_8B
M.M1FR@V)O$1@IA5LC,;S55! [)U=KXR_KVA@(J.]MZP1?OZ3MV#T1$4AYH[^
MZ_K\ @XL42W2.KXA:FW,"%'(V43^T7Y-H]KI"9M*A3!-4&-M6A/QS(\7%UM*
MG?N2([1O379X9/>I(W6.=H&ZD7LM*W;OD^7:R?N0Z!I_=9!MA#4H*:A^NGZ$
M&.A'7KUO(Y5"-&2@K(47VBRJV9DCG$ZJN_D\!R6,)2R<( E-)FNH)6.'< D+
M+5-RE'KX=8U^_:@K1DH'KJ]YKA_N:!)T[2">LI>.?6#\4:-2+2A<S2/G1\M*
M?C9\OUSI.'+P>?_)LSD*K,+IQ94Y6+DH18*E4T&IRAYI"G,ONSW;F,E084]K
MPDOG?>K2!.3[ZEK[RF4-Q2X;XA7::_ZLCR+\IYM;J/5[S0H/O9C1M]SQH?LE
MDNTUCB<.7$5F&]-P1];JRSE3I;A5$!YTJ5O%OXEZET)%E5WMO8C2_O[+VQ/F
M?RE5<6SX &"]7;\OVGR%1Y#\^3I6HB)?8Z %9W!0-8]^52$YINUG1?OE/@%+
M4R]DKU,L8YE9U]HNCI<<59RZTMP 7AH.6B OK[&ZL[;6M8SQ:225I4P9(1NL
M"6XF.K&Z%I\QEALSR(I(:O#>#N^8(ZR<:Z#0L0)CI.3_3@_Q;6HNF,Q-Z:F6
M2@;:J_A3$2XEP['97[K!;3OQKP%B/^_8[^F/I>/F?4-NLO7L56&)8E3A5",S
MGX\KPLFC6]^#XIP<'[O6\Y;.?7 F-;_-G+T\D(S=>#W)K(.Z0ZIR%>_L\1?F
M*;K''1WSQ&[H]D,QC*G^AJDD=>3>2N$[&:&F3B/<ZLTUA2EF(1L77N&C?5N?
M])+G@-*^VD;QZ]/#<GU\=E%R&/87J)BI';SJL8^HBM%37G@1W#:5@..VKQZ\
MI32Z2*P+OBDC[N%F[EHB0'EL94V28W$F6)U-?P&29!4.5'GN5 >-3?Z*FW8@
M,@BVM0:B1RSY3: P*U;;9/GG:4<*HS@X 8,GW_QM_6R/QS=-*QJ[&QB_N:1$
M+DQBS30.VEO.MK;W0:@+\YA&LOM+<S1[^_X4@T+-P5]<+4AEP(]B$.(4@;@I
M@WE1:9.C;4-F0X%P4XM7>W7)I6L]1Y7KSJ]%UKWCK(329@!=OZU VO$(,#L?
MQM!M=B0VQG(:$S>0M M$G^L1L[S=G7P%)]#3[.(1_%*SX^IMN+O,N3,DK>BP
M<$\.=KQ??]V1IQ*I:PXWW!U].^3121^WV.]J(H[MEEKF9@UG@ZUV.3:Z,PI@
MTW<&W/)K 'F/ 3/2R\+)J02CD@^ D]4[&M[CKRT/@,PRTL=8WLU@/\\,6O]S
M8Y9-J?RM%89+W79)OO!M(+7Q[_N:86"Y90V0U#O006+7QCMM'#-HGY$52*!B
ME%62['[B0A'_J''K4X<+(_J@W\"N!5ER- )T50AJ_G6L>YQY$KBV95UQGNDA
MWK_DG?%W$/962'YR7#]9"&]C+)^7N6F6GZ&OLM!&AV)<XC-RD)710'AW\G>A
M]C?.J_#.%N&1[((0OX -8@KKGLS:U1CV))M+==Z4Y55-E""7#+%NMS])ZOPZ
M/Z8BWQSFE!;-86Q0G=MX$S?_9U<Q]J>7=_67FIAEK2R;5J7;V./+=JIUN8.M
M37%#6Q<+D6=H!:I7L^3B#>B$O&Q]GA+H<)!A_14^8Y:)[H)@I]70>?[;HP(B
M1N(8K.T3YV[^ *$**1X.[W?;"\_?=GA9EM;FN"AX6(A X5.C<W"M-]8@SO!X
M^E;TAE?B7[9BSB4HKZAB^'D-P_W>T2N<E,DVA<&!T>B;BP\NEC&4I.N*^ZV2
MBVJUW0=\)GG5+B\7<]*IM3#X<*,L;4?';&"PV_QN-3;^Z_K-ET.;'MS]/$"8
MW?MI5AM'J-R6PK;#%@'LZNN1\Q!O^JW?[^2^NG6IX'4%W%/4\"(Y+:$PWHB
M!):_-G)IVIM6'!*N,.QT!LV<TE,WTK!*V&B</.# ^_ IU7F$"=/DSWXU#;%U
MN#+R=O4N/O(-,;JG\K%-:ZR+N]78P&+]64SLS@*%8G7:,@ZSVK"5]!XUJ;!Y
M.L1;?I[XO/*-G3 Y%4C0^6C>X;WW.PAC]/VGYM 3MAFG?0711_W*OM<9 ]GT
M0[]!&"ZW$QR$*\,PU]\A#RG1Q]?,(?KND7+^[T%&H)XHZ)^@(;TIQ3>UE?_%
M/)1T"0L@2E=UZP9?7OHF9#<'%^BE)K/Z1@J[BY!O=/X4S UC=,12]M3*WI[_
MFH#TYOL91VOBM?: ISHGNKEK[6[%EEC2UCV+);60L2A]1R%;LI3&)A5Q^@!0
M\*5=_G$=6/F;7\\V.O(./-3E!?Z[X]!UTYI_]:7K4JY:UW#1?1GIXZP/6@5>
M,UIMUE3O)*,HW/-T1Q(Y4=SDY[YO$S2Z()OM<F):,$9].1%,">]<;'9KX/5@
MS[7F3L]ZK:CZX &^AO> ]7"*;QJ?T<X!9UJ;<OWZL%+M>A0AH=BHD1ESWEEZ
M\.Y*H='*1]\9 LB>>';H+!A%?J3M$..BD(V[7I?E?#S/P"OJGCHAIE>+N"^U
M\X;N!1:WC;H%Y_OZ>)4KP])^"\$9G>3K+!YGJ/H:]HX=@Y3SRY^7*"M3?OA8
MP*"2+R]O8QI_+KYRTGWBMY*W&".)G@0[UJT<U==I"HX:N_(9SY:11G0M0^ZH
MQPWU&&R:HN*)B07(-9;T/\L_ "+7[I3FS)SK1U^7CT)ASGR.VE[A*(FD5/A$
M54!IC,VD *&(G23(J4!3_N35"EAQ=S#!_23<')]94;MP>]BXYP9;5MYJ0Y8J
M7/KK^ ZOPGN8CR5?W<W^H;'W6:%J!O65A86%K=FN7WS1NF*Z[*6:3T?O"N2L
M=5+<]++57CLI5K#71/"^.A]S:6A1<Y 5R4!U/?7,Z7<H1LI*/'CVSA0<[?LT
MRTC60<84GQO!(+[&SF3U73:/96BTJ)>?-ZCGV[G5_='%U1+HK=_E3KOEB:I[
MQ)6'GQPK*!:/]WBD;6!G;>%@.S;O/'#A=/!X>1%Y&KXC4+X=7VMWB&X37IUI
M/_Y[K2TH =L,80X81U3/<,(\GZ#%8"><;ZR]5=!$EF4;.3.&:5$)3X.N7Z#G
M$UHS<<;1-_J+:ZO^OR75]F.<E2^ V[#6=;KTLXI(VA-OQSK$/(-- Z-[W2#M
M@I;%O!V-Z)U_.RSQU+?*^X!WZ_=?1X>0>[/I0I5]U'@,*@S-8"?N-[N]]#D-
M,X-874A.E\K&JLXNJAIPK)"PE[-W8'=>L9&T"AL9-6\2IG6_6037EDL\$ZEU
M3U[196IY>1=^P%I"'?NS6=_F0+@U:0^8D>VCS\+66;<XC^RT5U?N 2'+&N9[
MD+U 9 #8M(J&^[JF#!I:O=<JTU"Y#WVW= "4K+*WNH97ZH$34!&&D"ZY+P>L
M*F:#Q#><;G",&7F$#VN\T0S7BG":/L3\DH?=\GU$?W-E>(R ).;%\11:6@R)
M!#'R]Q>OQ#)4'^&SI1]H4H9%*VGIQ)=)1?F<8(1=?::;3R.GG3A#UH5O>( +
M4;7S,\S5Z!,3E*KFF65 4[O] ND:+Y^)#8L%RW2M807D3'Q"0[6>5^5\.<\'
MVN?BNU^(@1J+[->GR8OKL4KR:TQF%JYP&3:\';8 YZO*#LEV=175+WF4?P6P
M1?:_[ !**PS@*<6?=\W/%LY8='(&\S8T*>2Q4$=9WQ_'A12TIF7$1-C3'6CH
M&2?&'"MG,KRM.3#8-"[J<I_F3B%T1Y'4HE2NRMRHF@/$L_%;<VGQ]TGE[Y*Z
M; NWYW<*0 JMT88=1-J9FDCZSK^O99T$7UU\O1W?"'U3YW0Z<1O:[AZ"%V>7
MAJ:J+/^58\)B91R/^#9OI'QU[G*.!5&QI.2KM4KJ-+-(-%'J9GK*=Q*YK#CL
MB9^]UFT"5(&O7<I>0TL;JH9HX,3'5'1F('G$CY@AJ;/VRHI.:^4$=3$86&HV
M:EMK[S0$MJWQMN1*IHA/U8AR+?E\^LJIJ,^^.MH7+JE^(G2)H*SO#W8P+N@H
ML9&E1.I63O9I*[]'LCRU3@M_H4FN<F_LQ'Z+/ ZQ=!X764SWH)UQ 6;Z/=G7
MH;HUXRCO/2%-P7YIA.A4NQF:XY^_3G-8M%N_;"-_EOVWAK.G1IT9,G)"Y"&0
M6#PY2T,O]'KA+V;OR,\?7P#Z,=<YE^A.<E,UK)S0[7*?'%OL/UWWL(9V<ZK'
M)T:_>[J&FRPP<_5E>IR/>SQ='!BMF9.WSR:813!];%&^'*80^9N1"W=KFD@S
M.R(=<]\?;$\^G1P.K<ALSJ=EQV7XKB\_4:L],2!'JM;;9\:KI ;-3<HUG9FY
MUYU_3"4R[VJP4S0N#$>RRXVES.>^&6A>7)&G;VUN0;7JS+4@OF2VT=\6]VJO
M=7P- V4A^KF,$B?ZU> +ZZ=:JF'A)G^"JO4_,)WAC%MO655/A1W4WGK.@[?H
MK+L:!X<:$XS4:W?Q%"%%KW(%?T;U]5W'$7QZT3(T\DYVG94*Y30O;$FRK\91
M\B4U02>0$W>;7E-G'3?1G9TS=4@<FYE?^[/4 T KXK@QGFGH^]=ZQJ&7RUP[
M>S5D_2(%S><A^LAC3JYLB<'U"8E]&S60.<%4B?VU@5Z_2;2%0S;TK&RD5>"<
MB&"=7NE1BU_F13JYT^IB!JCZY\ 7A+Y@9?U\HP+9J!&,C+',GOB SS:FCUW1
M:ALTW&D0R:TN.$'I.GN\A)FV>B?^^BL D,?+0$(L1NR.EE"VZ<#?9E8-VB6=
M2LT_H(CI=<RVLU->T&Q[MN$F%:+LV#<X]OCDG3OF.*>P8=!K>/3EGDZF?R]7
M'_^UHZ&5JQ8HQ=7VJTF5H28SF?S4CK0UC8E6>3'K*]NQ1),/[[WIK<GW4XA=
MN)0?SUJR=J)ZE+U-( E&&:8KY84I*@[,"0RNO^!$C/%4AG<LC1>$?]\\ZP<
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MPJRB@\IE564U]1"NA>YY W^"NE&:(R#SRGE<R=34>4GBO+RS+,^(MT_<ML:
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M9OI>FWQ:9,$XX81N<^#W$.-\RTD9&4@Q,LFZ;[3[<.-?9_KW+E%Y)PD\#6M
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MP/_\UI-R;JE\]5HV,'3C@?MA?7@;6!L$]$FW2FT!Y&!&HI3=-/N%MPR<) V
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MFN-&**MUN:8ZV$[[%<M^8_*:_&X&W:LC'$+&<F<VV76,!!AL]/EMLG1^N^3
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M[9)_")P]/0^::(,<4!U&>S;*4PL*;LLQQZM%.VE)HN[^V<#?H]NYU@JNC6B
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MU^>I';CR76DZ%;GP_<6%KE39'S*4T+]<!/&  >78&@G[4SPLHTGP!-XSI?E
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M?=DLVPSO6>DD&?^;GE8JDO) H%G%WE!R?*NYL/YF<;.\RSL4D%N:H?Z5013
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M4KB@P+_#V^OS&JJ;3WMTO9&/,TA6F[XIN9+UARR%]=W1@>]QQ(2HM#+Y> !
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M_707^/R80R"O*<&D1F"??GM"&V[W]'R%H:-N(%_37?"+^J9,T[JUWAOO9TP
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M;&5!H?1F415Z7X7D4SGZC/LDPX_13ZFJG:1T37K*Z 9PW@=(0-)T"4V;?0?
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M1NQ*YE:ZM&?T@$M9);K65H<C!+A3RY>)1R3+<_4$Z#1I8UW(MTP\_GV,WA@
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M<JX)A.@#9F=R/<P\6/I/=P7]LAP:DG%7UCJI7P6S[CIFQ#UH&.3CHFEK'-C
MV.DQJS=D0[Q*-@!!#3_*RU?[G+[$"&$T:C\Q*WO$N'*"WZK\Q"'6QEV]KY^]
MRYUOJRUJ&[7=-Z^,%H]8UT?Z>!%9O2W/#L"':>O.*O9;6: RU+NLO?0N=$';
MV!52+$L/GO%#SB,9QCVMUY @XB9/;O1F'1MV1IN(I_LG5L3KQ7;%_KOUM,.W
MD^(*8#/[S6X7@+$-#Y-J!!=IV- BLPG'1/U3P4$$NU.LZ6I"]5*[(I>.@4JP
MO6C2N+IK%;#/?@CR?"A!T7G=J8*)! -Y? ;C40V[1H:*#25C[.-#YF:3+.F_
MS4V+Y[JT7R.A9909YDIX:5M0JCY:NUHA,A/-M[H&(%*%"5I5,DYW?Y+G<64:
M$4P"UZ">D3=H'J5,Z@6>I:[<R-%4AW![L8*K\V8E/I$ :&:-!AXID\GKX"=Y
M[U#G:4<H*"$M0:5TK @FXGE 9"!GE]@W/H$6U.E284UM]"%0"/\NQ'[=O8J5
MN9,Q>' W35A3OA0A!IV75"8(9EX'@F4*"HKS_F+[QXDEG+^**<-O)ABY*YH_
M+VUZ5*8[18M&#.2;9S_X68)PC<252DVOT!+(/!L1,QC0*35T=NL39G1P2E0!
MO/N__%!F <$.+HO56\]JB?'.J++=$-.C H2R7 BI=<V7Q!%^>L;:4^E&YWS=
MR@*F?S<"KH,B-JHN!5A469G#OI^D3Y@$6V:N7XW.K;.5(^8O9I"WC 3?D8^-
MKY#:;!>@25Z".5\RGUI)%[.T/S@!'MF9U*RK  (F/"$.=F3"A/]IG,0LPS1-
M2[;^'%P,<X]8C.#5JJG.%CX?JFUJS+E49C<U48=J271$R/DGTLI#F @*1+[C
M_(>1!F/_'D[Z<[L!TJ&PK$G98@^8N+U M,#HI_;T&8'<@GBL:&EKOP=@Z+/Z
M-]L(_FGRT4A+@US]#'EW5TAIS Z!02ZDK<%>GPJ7WR%!TXJ0J7C?/&PP)4@(
MT*0T;[QL DR#1EB2K00]#@YY8+RLVU+'UM"'K!*X2'(=F%_,':X$OE2%#P(&
MQ !!]8V)WLOLEPH<E-?/EO9MO@FX<[_DS-L_>"#>K-Q[X#ULYHO?[R,] U9_
M]&3$:LN;R$I$R*!V'=0=(M)>,L-K@4UGX3,L31\69BJ:]YI2L%VEU'V5]/,_
MM.5E)UM;BU_74*LV[/3.=))^U'"!*B%G#\-QM:GYKL>1;<%U5:"\\O@612VG
M"U_)?' -_(8G9\9V4] -,(0Q05MG\Z3A$//;=$.C\@H)R>?YE.%/Z[XQ:<B<
M!;[QU.W.5%,9$DPPF@8<M_CC:)\;[##\==S(5=W'WU\#-"^KP: KO<;WV=#I
M8-L"O]*8 _52O4V-CB'@%-H0?EH&4 FJO],G)GY,=9(RG2Z, #; 4NLS?91&
MU^_-G9P>:B!5>=]T<1\4MB4ACF5;F%YW#A@>V=#C)7TT>:!)Z>"(USP4S+B+
M,-.QG@91V-LI@D-,1IJZ3]"D+R\HY&/GYIAIV*2IUGOKRA*ULUT\!?VY8T4@
MQ/5(])0]357LLGE+W&N765^SMDGG0P@R8Y#LW*1C>8AZD!U;#9#W0>HZD?1Y
M4=*FL)5>,I?N\*J:LH@AYW\E8C]7Y_YCQ9B%B*OI?5YS^D?Y6<PD=;HW2,>Z
M-<MU.6<90J$8M2C6U>LSE-'-/)($O8H46;37$[!N2F(!*15\4T6>!&H-IW91
MB3;\[4@U_(*DI$<1]](V/\^/E-H]SFE_N*YW>MYXMQ:M^.:268_%\7+9=S7U
MD6Y&VA7FFS.O"$-BYTX,WQL>DSIF3'R_^R@&B[:KO\:US#PRKWL3JP;9U< 7
M&^;O/PY5M#OQ;MG+]3GFXC:ICB$02:6)8GZD=9$.Q WUH9 .J6G*,K%A VT-
MJXVI+8QOW+&K]:*#20EJ#V4OX#<[:/?TJU&BN(-1RL0E71O>4R?DF&2<4']2
MH*6E9R8]7\6"]3QGQO2,%#)*.0/"$I]E.1F8.4DA0>N(Q7MOJ>Y<4;;V5FSI
M^;X6A$1* E]#2\&0K$]HP? &V:U:B!(A*Z)SZJ= 3B>Z72T5L]1GQVYV5F<+
M31;,:N-5M6H[U&EE.(T7YZ3==*X$)UP>\NE*ROH*'_J#V*>0CEE3BY-">YD,
MF\ALCTF>N]E<(<LQXL1&A-K,,;%8T@:H1"RN#GS10(A9 7$SH8XQ@>K$E?,F
M0< <_BCL)0\JADO:3MA"6+] C6,\HKZ4CUE"YY;BKX%HTZ:.^04HZ,OB)&]@
M:J5]0]0"6T/$I8+">\JN0P9DT+KO6&5[86J=."\I\BJ'S[,%U;RX/@>IQ2ZZ
M"EIGFM8E\6I<"U=E3#I%5"P[H%A12DP=;1E77<TBWJ/8GI.@1E3,QZ3A%%FN
M[ */C#N?7.;J&JC;PH)Z4:ZZPRZ%82+YFHH8D4+L;5&CN9V;6"-15-""F>N1
MIV2;X7#CF-/,9.PXL:",8$'OCN#!I$HN=8S1F&;'G;3%OM8XYH)=O'Y5,O]O
MZ:P4.=M 7HZE/N$DICJ>!0I@3[$HXY,)02/ CB60TW^BH4*%EP'F#:WZC/*%
ME)56'5W@:DP>"]"7UT#R;=-_I[BD/]<,SJ9X4>Y4YER6FTM-U+8HIC/-.?5-
ME^(8.9[?V?N+SI=H$SD#=+DX;M\":00T3#"S6+0S"U_L%4BA9K5;M UE?K[W
MG??-"4)BD#[PJ'=8I-A!B%T< "P47:>^/IS$IE)8E((T:XSVSE3BPD:MC*A3
MNU'R'YI<;YP*/NB8R]0SE(UVW'_TSJ89GC.(78-Y!\L;58EUQJ+D]@L,3?T:
M^(PV! +M7\"S3 =Q4W4P.STGQTW76F=+/SLTFHJ:P(Y(\9,%-LXP*:^<#%/_
M8/B]>T[U27#D'YRZSNK6U)BU*U<'AM.FQDR>6PMM-\CHPI6'6T"(=!'_+)NT
M@.+%U5UJ>H.UU+@0LAVX%=EAG 5;ZWAOU<QDNA^#:JV83^S)=/"V>[[1K.GI
MB2VCCZN1-D66T;%O]1A]6D]-8(/6.COFLL'KN;FQDIY6_0[92PYLD/4_.'R
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M*VT9!'OO(9W#H>_V,XMC1[@^#,< X07&CS\L,CA90,\LU+DVN',L/!K^X @
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MW&ZLCL\>X]R0RV[6KN1N_,&I_X.SO=?WEK[SM;*,Z4FJWJ_B6(QH,FC(?)U
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ME;U]P&'^!$GFS [F4Z_@SCA?C2&T?VG%XLO+Q&.T&*/TLH)MM:)JUZBXA#7
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MD&8F2[FT=4DHW2>,@]+).Z7I6):POYMHLE[?2=&/DRUM2#:;L2CFYRBW.1A
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MXF=*R)WJBIN/IYT>+M%$,O4_)PD3R #@9:242T-!NM'LF-D?!62:$<0\G$J
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M9</?:!ASGMFOJ[8CX_6J6:)R'/CZ_1?7%N^,M=;%]ZP:C.^X#.:ZO*=CLPR
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MOA"GAF5QZL2)ZD"GFWO(-%R[IV9Y9?FXL*YET?@QGZ9NG6;U1S?KN.*%P24
M;T+S*$O%XZZ&=)L/6-QD"WP@?KO<74WTC(>0USNX&>4V/W$%53D"P*PIJL:K
M"5WL(_O5U22DU6.@\O[TG[*QD[4D/IU!@$+"-<N-K@>E_X_O^?_K.GL;>A9D
M>+K!<UK(H/9E[H\Q)#6GG]W>EECW[+KRC]KGQ7.&)[D.]K_/&>+5)KDG_PJ=
MU+UX0K")^Y.H./W.&7)/'E[\SU,=E\)FB_] EW9E*_&<H3?FN'/NG]N+>Q</
M4P\7-PK>!G $?';+D_%@I015%.WYCJ16;@J6.8@I8!O'JOEZ,K'>ONJLO,"$
M*_:K32'!9;N_?KG+-01@93>-/YHG???3S>L3DY@3GJDGB)N[$F6:8^9/A&<*
M BY+"@*E/+D@>10P9WT3T=JIR^F6/SNK@.MB3=&!JYNW6:6<&D);3^';4N9_
MZD6H??E]_=5VZY8/V0XZYIP<*X=4D4]Y@.7"K'/YKHQ$GS-@*(Q5Z?/+B$Y3
M8^&*9<3A"$92E"!1;R::^>U-<4I;8F'$MMI6W9"R\K. J8T/NAX(P/9?U$!\
M-C*(L7?C)%JI@#I@.^B2:F0;/>4GEOF43'HUHRTJUE4U+8;+@'?:0-T81WCT
M[^>L_5IN 1S"?YOW/SEVM=*:N;Q:46'B 9ACBAOIP]<RBHBAAK;[I9-=C- 8
M\WZ0QZ.5P+LD-UW4/\H2 :(;FGGB>>*,2O"^[OH,H,AX\BB0L'/?8G8M.'G*
M,3-%4<+?'67\=J:5@S-Z/7RT_@)2\6OC<<H;MX=*,<$2_1(?M[3>CTQ*O@V$
M65,1HG7IH&1Q/OVC\4F>O;]+&YIF(T@?OQRNO1Y5L<Y"W>HHJ9,M\J@I+EM^
MRFRRT!OP_DQUPO*(5";68(9:G2[-AU/ I<!U-1<H,'H8;U?2ZZ0H#--)0V?9
M9"ML%35,4\3GJGZ$)(Q\\F7Y#_7]93H!GMQ3_/S'H(/^0/O?KUBK+GQ33#B3
MSV;[([BJ<X86=Y6+3\X9E$)JSQDN#)XS_'8_N)1J-])HJ.WEWGX?/5E6^JW2
M&:OX->^;[SVM0MRE#^J&Z-PT;%3-SO/^>LT!H0V&_%P##W&N-?1S\ZYVRYY:
MRN.R>?-Z(Z!9_-B@(VGK,98I$XZ.]H'H=!:5WTTJ\/ 4J'6G4F$U";CA'OX*
M\<W3ZIR-*Q<KNQ=%G>9W7+]+K;Z[)<FYU^3+.SCRHZ;Z6\6;"J:HRK[>$M9;
M>P_S\V+=^ 5JF?[^\.N$0@*&T"Z11[S1:2] D'@.TO(,?<NAO< S/H:"MJJJ
M_H3-;QR!IPQ"HCWOT,/SM/F//KE[O)HO?Q/8@K@^6[]Z,D#J*.4 -<TDF[P*
M(7\B<9P.#46OS;UR!<RT'#O;AOSUNQ6>LYQ<TZS47S6BWUI^&!0R_UZD(D\O
M\1ABSE=>&6-M#D([$N+?++=$[S4KQS3#/7!PGF$;G]  HMP@$2.T9Y:9BS30
M%Y-4%4QI D"#.^,@1F'T3U)HI?QY 8_:=)BHH #%SK//J-04=<W5IT8XTJ#)
M7<8Q:8D&EM[9E:2LA.+Z#0]:2"/NC>G1U+7C]XV!?72QZ4$P,1@6N,S,-(N7
M._)>Y!$#V340TQM.0>O<ZG6XH/+;G\:@!P&]DA%<@KQ\7"'6?<G, $A[P"HY
M!&*0(P/Q>+YHX\?8]GM%_XTZ,T?K]_+?=BT--2HZB7_=9=?)M;XU^R#=2E*T
M=<R^TDE\=X?'^+NJUT["NU4#<MMD2,Y*)?QD\D8COJYF*@8Q,CU,'N2&<5I$
M.U)&7Q(JXBLS @V7Y"7&N'ZDUS0.^B0'='AF0:8BB9);$Q E#8-<=N%Y5"Y-
M7W4<@>."[OUJEQ4_)'\RZ-YF4: 046\*TH5?:F1XV<>/^1ZI.LS>&K<>\0D_
M*AG"M&GS&.K;E6Z>4+XV5]"X:XZ"POTX\1PR8WW7\;G;3&Z.M0Z5VTXY+?1;
ME9-</ED=%;)1@^C X*;I8XF\^>:GZZ*5$7&3 =]>  W3*@% $C;+4 ^>Q?BR
M&0;EK6;9!E<8^!8C'PQT3]MIFJ4,V#V==#SZ:%ZM>$GR[Q#II[/WL,HTH1M?
M.!;B\]7"!#9B\.S[X,4]_8_ ')HG4-PA=5#P:H=-XOT$,D9BOKRRXN51:@?@
M(($%%[RW.B$S?NB??2Q&80>3,T,*!V?RKC4CL"3OY2V#E_N&E1_IC#-C">-L
MV$X53P\U].Y2XA.D9IEC.E1(\Y,7B./)$LK)\F65NH&2WH.1Z'9/[3H/8<$Y
M/EJ]<@2EW[QNXC0G')I0W'2O8P,H W8?%8:5&(KN8K: HL:4(R]W?_AT=.\\
M/QF6N&TZU?QH9SV8*MF$;UP'6 O60Z)]8KUK$6F4GQ =>I9YBS]FRYZ_QX+
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MOMK!5BF-WY54,B'UC;5*!(5OW:(-*:07/&RAJ)'"QI5Q1>FW7P4X[0UC8,D
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M::9>R$H*B8J6"X?H/,SYJYEMSH?C4[M]7R4)XF\FD+?I34E>]?#)QG-.K4@
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MTXO)-V@GPV&^^)\'/_P'U/(?79;)F?HBR@B)@6$LL2B*A%^<C)8IETYTMH=
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MLA!?J--[*:UY:O)._QXUZSOLLK)GW9QF\1ND\#;0J.S\I V:OGHUR;6>_ 1
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M/6CO*C=M>4$"+$;T3E=_TXD5F>^O-P0S\?0Q1ZX#GL(T(V*$\,[6GU%?8C1
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MZ]]0 NJ!O/DR)S:+:@E[AG\:*(1Q]<"]-.Y7]FXRB?,QR^<QQ>L-9$WV,)*
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M0\,*Q-IPN_W-_%%-*:^Z5D9];C*T"GT=+<[T"J;"CZ$&"/5P8NL9%;&L3T.
MIQF)YG*QEXS4FFDXL].L[B\,XOLF'N<E(K4NS*#Q(BR(:^47]9\^]H/" >""
MO@,.-%"+2^ER 'IV.&,_^GVI?-0&BQ4>GW%2K^* NQ5J:*OT''6O[+Z\=PG
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M\KG4D40\@#0Q"UHIN)#O()KB@(_;<051JT!6,*])^Z0BFF+K-*VY>4HHRZI
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M8L1S[HJNG%-C)'M:-!BM_N#!]@9':&9PLS4B_AW5)-9!VM!%--7@E5_W?C2
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M//\/5C+X4W[TE@^"'<ZY>0E@)\F=YP0&O2MQ6!B6:5AR-_J #/JZ=$-8,FI
MFYSYV9J556:XN4B8"F*^)!RW;S&TO0KB<+P$T/'K=5K#7YUG7@)>H[G (MB-
M7@1'(Q%BC,T+L3%K':_:F1WY/C&S=X!UW7N9Z+.QR!M'&S B]DB$XAH&GO>?
M8OIO]NHE8'<7-X Q0<(XW.P%\-E1)*-5?GXZ+0QZ]S[KZ-U443VSM_.VM4(,
MI+)22"0.<4%_#P:NQ(*B%1Q8B%)(%%-X^98Y(?NTTHVUO#[\MUE0W(M$D?0!
M=1]4&,C\1@TU9G9@+$:04Y&^$D@)7M#!&^]6:0>M3.P_"8R_H[WWO"P\G<H=
M_J\KOO?/OT.LOA%UNNVEH5$^L!B2595RS,Y] 3']#AND]/C]_>L+1?0!+D&I
M!J\>H[?R^ X=^"_4MDY/(KS]C%^./<.];L4@8D/YQM6U@)&-[T:R6NK;TE&O
M;:QVBZ+73>[0$CX8S!C/FS&\,:">9[,8MJ=OG6R$)83R16($.E?K)9)">?N#
MG9..^3UZVSR:)O\Z[J#:N2FJ;\<5@Y\QB.YY/!?P)F@2^[#[P"6K303S<7OG
M.^2%ZJQB"0Y>'R+U@&"1U18U)5LZ(LKZ9MPF[H48(8=Z24M3T&7<@0T,'+"7
M)$:=28>.%= TX_7J"NX0PQF Y<0(WK^@AL^3G@AHR%O)G[B=2OX6R&_%B4^_
M 2';!'M\4R46$354"L[:K"$Y8]2&.N1AQI+HW*VI'4[JB_;>%RT"DW2 8Y04
M\M]/C(PF;#RP!,6K04$9<YI,D#IED0441G,U4;A#_AK^:D'__A51W633WS63
M+7*AZH=]I].=)SNE&&B\AL24/XR5N.P-=)TQGX$#\06E7^?=VJK67D:+V_"6
M8U^>R%.Z L08#AL! $&K<8>;<V!9.QPZ3H.9Q#Y-\L:&/)&J%C3#4\<V1LW*
MLIZ9%E U)3TW0BCOLFB*M0?0I5/UROWCF+WDW'T)X%%$4VY>J.+XKML2D?VJ
M#@F%2'MVXT=/Q9I-AYR]P2G^LLLNN^F8'W6?:I/9UW[[M)!O\4A=]7M9;=1K
MG=W]CWY\AVX0MO/M9&_P6N)I)_Y\;2"CPO8^C6UJPGM>T]!G7&8 ,GN\)B7[
M2JAD_#9V=E>X&LQS8COK!V4D^O80K#]&:DY[*0QY><O*>#TV%)O92[_3FQ7I
MQC'WL,;*ACXY@>"(_UF]:A*9=5(@W)[Q9$:A4__IN!?LA^8]3!V\8/[US3#&
MGZF5M\W(?3P87H;=<XLG[A-"9A&U5Y6<=@8N_@?-?@1D Z>?^E*58NU"CUPE
M#M8-"Z0XOMNL6P84TQ1?1_6_[V\1']Y8@BM [*="N=Q"R2>.4AAEX_QE.;9O
M%6NQY8;5&P5PU"\&U?0K#Z>(,@ &*5*YPJK(-J<L?O T[P9A"YF(T(&V_DK<
MSYGE,<P:K@'_%(G5$C*3ZU,Z QX]]S*(?O6VGMZ[@XW5-PD8Y]#H' N1PCC$
MPF_CQI M$(N52P#YJ+\3-$@"WA1HP:FT:!O$',3T]4;AS;T#T37!5][A+>1_
M3J5^%Z(F!^#">9B-/D]GY&E_)>8(!PM7'UR?]"X >.^_LI+_(/3WNZXGM_GJ
M-7SMU&I#"J%CTA_*M*TAC2-$+ OAG@4G-85_WIHY&4P'QYCG_K:A\<0Z]735
MM56T!'(C,_4T^<,T(HHZ?+N@/!U/*TG.;41O[#[Y/-'[221R&U;SY>NVLVEC
M#L_J$,L7=["-T.]:)UN6,"[F@;D__Y% J]"L+DT:8KB]RI(M=X0QHC%K9C/0
M\\>C*%OGYF$3Q5(K 1G<3J@,KJ#QB[%"UJ^MK*=6ZK_.B3,&\_2R+8QIFH*?
M<K-C0OFA/1P:_.Z(IKVD;R2NVF@U+8S:NUM2N]6NM)3"9W[W!R\!@;R9=_1N
M2QU5FAR ZG?A/]H].TH/LBE>O)&;+<C$!<9> E;R3K>(^O?'2?]\ PO>;\]#
MSF@(S/K3DE2=LD,^I7/Y&TE0*%@DP[+%6Y_3>)0KGE1WO.8232IQM6+[)^VT
MB?KIGLNU!S>*PNC^M;\)!/9+0(I)"I1@T6%T"2AV++F2YFG$[5X0$_05E'V[
M@&,&U@&J0OJ\3G/8G%20[^?!D%/Z_W[UQF<NS2$'BGMDDBS([ 5UEZ7\\Q0\
M9I.M.WNLMJ1O/OF[,^TSO#6=V]KPJ_:;O;YG6>IK6KMVST+I$)A+P$(19^U9
MJ2Z;Q0U*-E/-_ZX)JFT)7,=/0+PF(9*"_6A>_=)E%^7<]CN;IV1IXO'K*#%=
MR8>BK^?1*A2_9>_Y'DG?<(QCN4+]C%QT]=;>&\ 0X5I'\Y-+0,97W,EY7&[A
M1;:EQ;=?__7MBI+?VZ30;$)6>M=?JIH'"\Z]>TS/'E?6_/*N'VMQOZ4_[WA,
MN2)6D$$!R(.&/,$W)I?AW_6A:O(P(>8_:3QJI/V>&;7\KHO 3 0D/-+O=K5\
MK:33S+>1>X(Z@$5!#RS@"I> .6>32\"D<2D@N/H_$0G<PZ\27N!2^M%1%Y*X
M]$V4<PQ,L24 ZFF]^:8#!_H(ZPB9,)0:^R&?,0J)N:J#-)-%$#5B&@;*M@@Q
M*K2-U)W:/>:<E/QEZMC&8@!;DY-O8F]:(95%@&'CJ!ODO#HXYQB2O$*&RRE'
M7LFHR$Z0M,=J5([O)];/KUXWN12%J<OJGG^$UEYPDA1Q@20Q>"!)&"X:TROH
M>4:%;O(H"(+D%WCO'6XX!JR?M0[<90'G$6PN >]3^NW%9Q$8B3,082R1!,+N
MUY]'!F:<9_/7A10&YBH'(5[_)#'F76P[%@9=/6(2R]E=2'QP(4:4'4#)P"X!
M-!OQD'NB"\9^MR!'4PVM!O)S/[Y,"M45%__^Z]4>\2DUJ%.98#.!P!3(:K"[
MG7:<_!H-@I;;;)O[A&2M#Z^_^PM[40#,:3*B2*^9&9-07[EFW@F/!_S-P#CL
MR&*@]#I%"\3C(VB\>3 PQH-TKWA^VYI";WG(,4BLP(</=N/.P[T<44IS1=MF
MZS]'A7.KF+V,51CSLF2TNAPH[#C/1AE*;@L.7MJY=2SE>X>>^.QB3]GEM=QW
MRW U+9E@BXZK$3.MA CC!6)JQ/>14"X44?ZAJ@?/4_#;,P/E4^.&-SGJK1Z[
M$V#*AI8,5Z&ZVP:'W#<9G>8O?JAZ96! 406\WV=JJ#)6\B'$>/^V]X82U6_-
M-Q,,GA5]4>;46XVZR0V@NRN*^O,9J$;,QS6=]0N(X ;B.]1J=#%CG.# 75.K
M9;NYO 6KZCTS"IP)($O"SY%-AFXPD4=\@S>\"[>_4[\2,.YU?2"8*0HO9=LY
MM=>8M_2TE^=61]?2(Q%#!CF#&F$M/@Y\%$7^]Z_K+Y4%':^&!T8(.B\@@<[4
MB YF$PI&=HJOIOQM1O7<*QGOJ(F,C_A(?^_JIEW\7A(A+K;JAF-[HQI"C^$,
MA\AB1RX!;"[+=+B]-*S[H92]N[GJ,^9EVQQ!2+1A)CF<0)8G]CNQP+WZZA&(
M 4%:_TX=+!UXM3OT1B,.$;L^$1T7<EY:RO]@9FO>R?6%QI-1>NE:]0Q/SS4?
M*2J]OSY?<(<8VT(&DNAGXE/#Z8Y=N@EZQ"ZWS(HC-,1?/=J\U6HUC8/#]57^
M',V"A"[*<>$PF)*-#(-RV#G#VGS%16=C+P&QQE<'.N(C MIT<G=/H3HW?ZVO
MY1*@_^ZL/[^O6Z\W+_V&53[[QP*MW5 1B,Q56)_U%3(=(W9!WZ$]HM6&E7\%
MG0\U9MM^8A=&EEH\!E#*7LB0'XZ?D@_B 3@H3^A((2X;++F:$G-5AR7.)$G2
M"XC&D.(=WDM /?37[F[3[J%^_B5 X*S^PQEQ-P.#X%<7Q>85 DG/B>XKS_#V
M^<!$65FQ%-U6W,/9VXMV2X#7N6@K0XT1;U?IJ +=%BJS'^T!7EH._E<!)XH=
MFX==L.Y'@%@ZZ)7@6:CLI +G]IGT@3>Q#3Y:P+V.;L1(<P3-88?7P>'!ALL:
M_$[H6$"N*K&^UUJ][4>P1JE/Z3;C5<YE<#5=LK-V#\B^_5'1YI4KNX'E:J(Q
M0.^.M!#L!XUWZ574?=2@^',AAP_<Y:R&:,_"9!OY;X+HD%]T@_PQ-C#&GL.0
MZJ].$3]WEU?I/G.F_9QQ)KM+ 2S[\Y^%Y =>J9,SBJ1<Z?X4J=C+XU\RFZ[C
MU5[BGT2?:;H4RT4^T[ =2TS"PKC!;T_T8WJ6R:]>^4_4IM?HT24 A9L[CQT@
M U/-D]T)FB#C'#E1]E*G _Q=M3SOS+M_GDV2QT?;46NUN(^4;TR1U#RQ":];
M&R=+ LW 'U=_M)(/_>"BEM 5?S [:WY('RN:J7-S\$M$2S<W]^\ Q;_GSA@@
MCR6X5MW8^Q) <8RK4L4^DDG?A7@6.TDPMAA4KGDR<7DQ4&EM5(>&V1B*9>'5
M:X/NU%W#[S'6U@X.;J?\*R[Q^R@U0@WQW=DMHJN_ X_;=<6ID;99O4G3U_ V
MNVXC,:</E)31=O,6=[F' -WX,T(5KFSG,*34%=64AC6Y[LX3U3$[\A5L\5!Y
MEMD*F:*Z9=JJK9T7;5EH2QX9!G0I@OL1,\_ $"6B;PG8QC1ZH3?T=F0OCS))
M+*TLZNAK6_J8(< +T6;^ZG9/*_+ZH%#$787]^,)F9R0TJA)SPK$L@H=8PY,$
MXWA,Z%T]P4T\1JD<%]O2<%O^H+5HX,BDT%5,-NF5KG@*$OSPGB>]#L!+0(\9
M)@&,"1SO':-MR_NI14>MS0T"/Y56!3P"ZOR5.F,FCG07T)[7JTMAZ<> J,W<
M1Z7E2U;6VI/M?:6*D^R-!R-\^8D7CS8D?V?X_,V6)%A@);)74A(+J64](3KJ
MJC$1ZEJ.; @WBYLPMCP!;M/:[K&L+9\I)JE#90R:=/T$*<BFKH)7?C39\11:
M3-PVP!M?%&(^[I68W-P;IC3T=,IPHV*\>:?Y8XEGE_ C&E#%FU$O]BR3Q)[7
MRWLR4 JT\LU'PR#&G0_'6<G;[CN.ZAIW/,V+J5::Z_XBNLY]BN"VY\D(3V/@
MZDR,(Z:0N=Y%D'7GI=)LFS_NX (M#1*;Z#( Y _W%9\-OE4A]P_1=RA8_<Z5
MV-;\O;=_S']:@>#C;JA[Y-HPDOAA^I>I+OM&%IL%:)5WG]UROFN9?;PAQ&VS
MI'=\FZ>A+5C$\5M#P&26RHY9:&=E-E$*3]^'N-XA6PK.L,;U)V#.><TG,8BZ
M,ZIVQ?-NUAO/ZXJM>BJB[IDM%-S;AM^].8'L>-(LX@H*5F[O[%PX] M1O?X#
M-ARLRV9J2_DO-^"C[@,E!7-VGZEX*^Z"'+)ZZ"TZ6SHGCFSR1MZ!,\03T_6B
MG@*N1P3[VH32X*=A*=(U,IY^G=Y&EF('J'N^#PIZ]%95S'*>?3_AWQY&>(QQ
MN/'(=H%B YC!1E8STC4=RI!Z-\*=^5N-!7_RH<%UBV)E@N"_/@C^.V"8%0X:
MYR]XW6I,HQAC[-CS9$"BKVE&O#[=4(]L^>L,UFG .R=\]:M*S?SS;;V(WO:W
M]S@[>?]NOMOT#U%HD\RQ']"Z(G8L6O^3]4'J3#>' []E@4M K?S32\#$-MVQ
M]=^-9REZEX#HFE]8#:$6&RA11U'"^6+&I_%BZ972'GJ ^V](9^4?LZ['9(,#
M?.N%TJOX_OYI49J%=(N_]+IL3^3^(_G\CQPKN#K(H@?Q5PK- ]V1+[L$;'Z=
M"+MG'O\33WE\D5>\N+B9ZSHCNPKH>R5I"9E,E>MLL64H")$:"Q4D6>/UDSIT
M*UQ/!  9#^HGCJDFO6$V%A'>$J8,;W\+ ;[WEM\]ULA<TJ>T87G@_\7+<C](
M%]3:@!YR.UK,%LO/V?(SU7WSP<?ZI,^8:KC_0NV6&_+L"9L/FP5E4U#D7?-^
MM41_F!*N<)>ZRJWMO+2IO$VCL$S^];M(OK!OX04@<- ]:NKJ=ZVU32\-FV,S
MIG;8XXJ(0(-?C2$VILU-#FJFJ88B=1$5X8/V=RG64EH)['U/\H,,[PX/GD(D
MY*6*M4MN_GJ;8:TT.>MY;]KK%/VR/VKUWO7>R2&F[ J==]+NG3,B;ZE\<E'E
MQ4WQK ]]Q%X=W_S\K'&6=V%9(Z#RZ]I9R<1A(#3"(>W@:\J9+?'$% <*(]F&
M<KN^=;F0G>5%-KT9P&HWR]DJ9 Q0'%0TH;[7=T>C?FS!6D19ZEKWDPMY%1$L
MX$>7 &3;7J'/9W<-KBNJ6LUKD=*3F_D#>_%SR\B*T/,G[:%1MT9_HDS@-;8F
M+=CS\4O :QMC40P,":.1Z52H!2OWLKCCEWB?\VRFNY8>Y 1"/N?$#DKN':T7
MXR5W$,Y864YPC%U(*%C0$A\:B9V)\OP06_@P>9X#$/A6[.RV>%O-:G>?:5H/
MT<IOZ=TJ*'HWE-,67*^-P)VOM. #"K%YYP]NK$^L-^<[FKJ^$W;E_\K"M7X?
M!7_VN>6L+.4\]>(6&-8=R..9G>)?F>3>X\"L>/X:C<QMW$G<+W,S/TWZ;?QU
M<,=D2%II6TP%%"1ALD=W:C. IOZ,CTGIX%SU!#W-UL(K1W]-HUR4^YOP[L6-
M7L)3&4R;DC#_H[?)\<@6]8N<,[D_<B0R.-'LFX.MF[7G].@Y=DNN/ *+<D_8
MA#GFBM#.B]UY0*=<Y1923KYQ5;+ JY9XQ$[UF1J8LL,8Z@XC'G Y31\CRSL"
MOV\&(!"='TS:P>D/=;QX5:@V5/[ZV!^>R4#T6V?AUVNRL?G6](7L8.T+;_IM
M9=B-:UO8.:Q:8L98(5DT],Q-WZV+J'_&3K3!G&TZ]_I:$\\5H$PHL/>#&,M)
M$9>JE?BK:JBK)Z,^9*]I%7TWB?.3A6G)Q4@HW7BH,#C&MGF\(0"WWNKZNMF>
M/<,PJBKK='&XXAU/6J.8W$-'#UGA9QN)CZD"!\:H9(I=*\'PDV?XFO8R&Y==
M[Q*P<[>RA?E$-7J?OR:SNE1'NHK"X*M.W;U/SP?G5]3UJZT60X?@K,0$+&].
MA_?J0A*]\<0NK^ZLU^ZM1CO[ ,N7*9X-M5^MUY_P1T0 O,(U!0:J(<+3'B1M
M?P=R,-R;2E\FGR-'*8/ UCZ9?C?A8VESLW0EQ;"8TV*K'IF.,(KQM>7%CU.9
M% PT6H/_^]0^5>9*OL=VGU=8EMVC/Z4_-R5>-%#)+ZEON*V"N1X#NJAS+2'W
MIM1O8<<B"RD53=BW434%IS*56""SVS^5=GV^E?::A-BXC2JX1\"%TU3*&G4W
M2V^9T&TOD\=P?%-),XBQX<R;$SRFCQOK'2];7+1T8\H>T..Q1NM3S%8K&$<5
M8+D2AB36DS3%YPZ/-GJA40?@$7O<;)Q"OBOI'K:0*2^J#G%V9[$7MRA2A3.^
MSM*F)->+EA*EBF/:>25@9'S^J08"*D79_EE6F:Z"/&];FXWU;FR*X^%_LHZ5
MO6FYYVGAIBXBQRH2415!$PN)L"2W69&,[0"%E!$3="8:\GV1N?"$\B!K> )6
M:EY6IOHK.*WXA93QG8XG^K4?!H3M'VDWK=R3X7_T$XO9Q;9'&+W_^2==5[KE
MK@KW8)\/FB&4$PA8 J=8(*;7\<"X#L. [-RO%0I&=+7)8M$WBN+ R6+WN9Y8
MKN4GR+UT]S8B0C$AU^W;9H[V&3<Y>*;'?7TJK.?Z^'O[%GRSTY[)>WD],I',
MT!10P[IS$#O/C+;A=-/'QB_'D!J\N.JL+^P%2=\6-ZL5U];Z%CT5TA<&DR]L
M \I9#'OJVQW5'AP)U@O&-Z)Y2"RQ6Z<ES:B]O'*WMNMN)W+_O,MP#O%QYT>6
M=[UVBN*N#;,)?#"'A_78G#L.^! G>RXDH'3$M ;$CGMK0;_:H$SU_6IIF^*7
M)8;7.TJYE$#!F,P#.>=N0;IUHM-*"&</G&L&/EJV2<@VO-5W7K1HNV3WH]^D
ML9U*E^%UT"M_^I@[/M^9--7-.NY)(A&):'IU*4PA)S&OKY"9)Z 3G]^W#O.]
MU]!FVOS1T,?78P]GD]UZ<)^6YXOMG;+!*F 5R8/86$52G%8G*W71$&C$,Y5A
M1UT;P,4=""4?3=V2$P''N\DZ#4%\&,/NNQ0K M 51!>('<*?,I@PH!I:S[^&
M@<]XUQQ178Q/?P4%&]883T)^ XK74/'7OD4!+/SQY)CW&NIXDS#%"MGE49)X
M)1S&)\7UXNVHZ[VFGK=*B;8<@V-+Y)T <$'GF35X#"G 0TRJW@(!C]*<<<MG
M.W#1V\3P^3(=OJ=4M4\]E)O35%6L'NKXS&>,)*!906[>'$1H]R6 M<,58W+-
M%2Z$BPFOD=GQ*NN<9:Q>6YSYG% 6S1X^.Y*L]7T_S:K)0!OWY=2;*_0'1Z@,
MSKL_!0A'W&N LN[!I]6W/:H\3.9O[7XO#ASK:_'R&6%!=>BL9B.].;:6N8G=
MN$M -T>HW,0+?-(QLJ\TGV?9AC<A(;7 _X=UK&<6H:[5.5=%*^\\,(NM+A[P
M!^'NS>5NG8*$)JBNIU5L\:B"+;KR7F:8=( UX9U^.4,H_7WA>-1BY?&U3?Q)
M4L#MBSF.W)/W_MX\8(?[*;WV3)Y/)I$%?.W)YR_S[*:=VVP\OY5"?;SJ5".E
M2#_8YQUO,@]-@HL)W@UXAVYHK !YRXP];PJ/^H2#V_@"XY:5:+2ZQ'[>2 2-
MZ.\#4>KDR!SB^)G&?#]<!B^0W/8[=6MB,S<Q5S#Z<[.RTFEG::\>VKSI\*-D
M;FS<NIX.[1-V+K$78:K>UT@O\)DG _1CT1>W<069Q8M(S/0L=NHHQ-IH3H9M
M,4@- !9Q$MI0X0_G!Q.L_Q:NI+PGO:BY&$?M]QH'KUJV3W+V-)TR</(TI9VG
MIH\2RG*B.HOE'WS[+/-7[&Q7B/Z@AGKR/Q<)[^%9M[8&KH1BW)Y'34EM9XQ1
M6SI]^0MY]3LT'RNK'+.%PK236_K\%#.QHT\.=7%-M>6;,[>^N7%D^=K:6'[I
M;DECKM.[-Q<&X@&0ZHAV(3AO4^([S%F*8 J*_N)Z8'W*F6O.<2 P*&6YC6OH
M2>*\%-J5][NO0Z6J=_9YH?N:]T%'Z?RZ<\ B@_.][4/*JSK'OXEF]$/'I89.
M!%_EK$ ?::!D]R!)F>YO^I!(L6MY95YI&CVS^(:XBIC2UKEV4]IZ<[RAZ.W!
M0>YB27%#OL2SQ]0_$#C32T#,[(7J>9J&L#71%VDA((PW^V$=TMFA:A=IBS;B
MV3*O4Q72E1F^5I]ZE\QPUW9V5Q:8H,$1.LGAP.Y7""!F8R62OH&I#KNC!Y!*
M17LV:OWM-K$E6=(1M: E5ZHWG 5A@K4W/@-'C4$8="]L/AG=8YTT@ 0Q$]<:
M"]_+$26,3!@7JH]R7U=)I+_@'ZY\<0M_F_&&F)=Y/WAX6Y#Q0CST9YOL'#72
MFQE\ .6 "-7A[GMB%EZ$<.15]K'5?MP+>U&W<-*5XYO,I+9Z]"T>\'=YC&#1
MBE?N1D?:\\Z0?+"7 -IEHJ1V_?>.>EQ65=-,\(?:;H_D;(/QMC&>!FJ7NUR!
M%R=\8SN95-G /I/X5(417ZACC6$9\F9*:@<'8=R6K!#+\#F$%O;E0L)50V2V
M@[K:]8)MVG%<7<?':\@YY":')1IWULK-&_U@0XCO)4(5]/)<N8\'V@>-?5-3
MR1 ,B_82;^F8>.4KG6UQNTWW#?N'M$QDY:=/6::1T^!OY@1_GM_>2^@+=')!
M)U3TR"-2QG*GF%.V6H_#?7'F$L#0N7^CV:7S$M Y7(4N ]>O>$=Y@MQAK"1U
MO&)#4P$_L9 <C.AI:_P035\MY=!,UXQV^O"VSB!"9:%<[1DS&/88M]^_SW'Q
MLVTM.Q*N\K/Y0K EU<8%<?UY@E/UP(GP%)N/MQ(H9:]94EW^&;HI,,:+Y(.3
M-"9FKO3=(=9W*;\A(O6D4B>J^!87FE2$,8=D]F_-=-\IQ_BGT)-"B<9?W:(G
M%FQP9?$*@S6A(X$\0WRIP^%-J@5WY"-4H^U[+6:?R[OTQW<[%N^^V7\&V]="
M-#ZR$_2O<IJV'PWU-$_\HCQAI'_Q<.=EIF226-*,P2*5Q=/4KB.A$[;3OP],
MF(BK!+FT/9(L53&>?B4W_42 ?]%YNN-NOA%*GF_,JV-=]/#&;P'NE'$'(%P$
M[(LMBY+N,,(8VZ.MQ[TYY>QLE/3>59(/?_]C%B9TS,X=;29]2S$>.8;ZE5&7
M:UY_8?5_D/9><4U$7[]W%!5$! 'I)2HH':1))Z+2I4LO41 1$$(G0" H5:J"
M@H 4I==(#3WT7J1(KZ'WA!I(._R?YYQS\;[GXBT7<SFS/S.SUOK]OK/W7H,H
M!_%E+XAJ&]H9I1PVL8U,II &4(>NB[=!N]9_R("1FS8I-@YX"3*@MP%V"4WE
M/NUDP(N'GI=,]C40C!V[1#.GVP3G$5)$GH&50Z?8E?<V,IBU=F>31]@2EXV$
MN<\Y,5V=<B >&N+(Y&@=:AK14L\7'G07JOUJK&3F]G/COU7G"#['U2\#Z]=M
MNP/NT)K'L^X8<4I3?H)F^ ZEFJR93!R@UYO[SWW'!F##J1-*-E'\B,>5'63
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MEK%'K4^"&$?W&EF*" RI1&DJQ KJ"7N5_.\KU!]INAY1]-/@:U:(3B?H7V3
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M3?<7TW[J(/25G*#GN0WZ&(9Q,IN8SSVJOK]$.&6A=A$_IG>B%^]QO&(LZE6
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M$>U9JT%8\%P2CJO>_?OBTEB*3IO4VCC7Q.OPWA4N4/:\,XUQ8(4!K'+=+BE
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MLB0,BKRK;'@ARTHWH[E-5J7T04;"&I_>^ZNMV/\UY=W_YP'9GO@W4$L#!!0
M   ( ,R#6E(5!'2(VR,! &I6 0 5    ;7)N82TR,#(P,3(S,5]G-#$N:G!G
M[+P)W"Q961\\PS ,#!@<04 4N=R!02UF:NNJKKHP%WJK[NI:NI;NVER2VO>N
MO;JJ(Q@BJ("@(HL+DBC(X (1PJ*"$0W!?0-<D(@H:G!%0#&81+YZW[X#L]QA
MB>3[Y?M]],S[WGY/G?.<Y7F>__-_3E6=3_S>)]Y_S1>O*9JZYMIKK[UF-?QW
MS2?^Z!M>']1U?@D$]]5MII-9[FUVEH*=F8/P;1!XS5.>VN6F';OU!<OUP_WM
M%S_TEI^]>"%T;K^H8AS$Y3,W"%?'TI6/_-8^QC;I7'SJY:=TE[HT3]W:O-"E
MR;ZZU-U^\5SVI>'[63%X\<)YE3J^_>+D[,(%C1,NS++2O8#=AMYJ0S!\ <=O
M@T<8CL-/NH! , )"P__XK?#H$H9?0L87KGPN7KYQ^/V4TO$N27/J2G?#7[=?
MO#*MP^%PVP&]+2M]$"9)\DP,@MPZU+BUZO>UV=VZKVX^";E3SMRM[#+,ZS#;
M7SC[V[2RIK[]XL4;+]SE<^K(L3_93]Z4R7DOC@VZB9NZ^[H:EA &/RG\3+YC
M7_*R,C7KRV:>)Z%MGO4"YEE5G_I\"OBI&G=O5H=UXEZ^VQC.1SM)ZKN7WGDA
M"<\&>2DQ]_[M%[M;'=<SFZ2^>%DP?1>%R*> ITKW$ G>6^;YF.[9_=F0G$\M
MU#]C8*6;FV%Y\?(V:"YL[/H"-#K3-W$!1B]A\"6,O+#DMK="8PBZY>9N\N1E
M:>9!:%^H^]R]=($-]^Z%66"6]?G%\U\H?B$8!"9GE\HF<:L+!W>P*SL8^G.=
M"W5V ;H-P6[[5(-MX%[PLB3)#N'>'[X-BKM@#BWRTJT&+5X(]Q?JH8J3V<V9
M5B]=^-JMV]744._"I S-A-M^_9.>=(^R6Z=9XESMPE#VJ9YO_9P_GZ/6KJ*A
M4]WY52Y\CK8_N.\GC?^JV'$?C99TZG_ZACX8IO[=_69H=XD;@,,Q:W-NUN[E
M,Q.Y%89NA4;;,T-!+L'D8"27(.@IX+WJWE-.YH1>_UE)^53->\B8E>Y0>A\R
MB+O*N$O-J\G(RFV6)9=/($@G25/5Y5GIA9F,7_@J-=P[V:'ZZKN(NM+@'K(&
MYTFMO1DFU>?HB6?_Y&99N=O!H6Z_*+E5UI2V>_%>#:[T=*:]2X?0J8/+"(:?
MC^LN19^N4>"&?E!?AM&[M+I2]NF:70'#M;!8?JK=O1#RWNW"=,"YRR 9@:/)
M1)1C8RWYD^G$7TSDR92>3.;@6)Q4NV70.DOR:"[) SWG&FXR&8EQPD\ :'+^
MF4Z&^F>?Q>3<92?B6>/A(TZF(#":S&,JMI!U,EEN3PT\T)K0PT5?7$PGN\74
MWU%3/UY.17T]._C+J>^S\TG&S X9<RYP/IUP\\GA[$><3T;"8D)LYE-N2TW%
M[:([6,NNLE<=X7WRY[!830\V/Y] ^M"#O@QV$B5EY]?.!=ZM\N?X Q+#1$5_
M$@[3G1P6TFG*$UJ:B)PT3&TQ,<]GOYJ<S4Y<3#[U$:G)@5X.R[*:3>)A>L,U
MGY[?L]Z5-9S,AMD.ZV+3,S%CA\NSH8/YQ!=G0]FP(H.@/3<HBY.&]:=HB>Y$
M9;%<((O0UA<[+E\&TT[MQ%"8G@O<U:N ZXR0F$F]WRX2\2AMXX+I=528\3MQ
M'^.;(Q\X.V.UG4,-3:\S;CT+?"-8#TM7R)!2\PHS+?L1*"S.!<*;+61H*I68
M*MPY6D*J!A+D9EI7EHJU.BK!SMX9N5H^]E8PX*&;1:";JY!.F7#4\U$&S&),
M5I+<U5/C7&!A[=>(N\>8*&?4-,?#O"B:JC3Q-I.&]1VF3\^GXF NHKZ8#09A
MG:U9L)A/9PN9VRVHG<0'M&]TOK'HSP5FUNI <2MI)/,S2EF'=KLXKN?2W ],
M>=>KH3YF9U-4D'EWO? [9Q<?_/,IKR.#6H9.[% [E"@VQT/OY^<"(4 X!FLY
MKKGM#A.DQ-%5);<T"G8U6$J,U,E,-2^M)=Q8R&>:_KE 8)ZL537!0B/-&WMO
MX%Y<;.+<-/<%DQ8%WM=E ;2@.1C:_,PB%F<F-B<FY&Y4$"EQ ./ QF$L:&O-
M.FG94H\F%J?F"F*-OB^9G-+F,K!?TX>U*HMES^S#?#<59X4!:%Y/M"##FOMR
ML<D.-6TI?;53:MP,PP+-E^<"RUIE6*CA:-!00DYQ(YURPK)2/O=?8GH2:-:Z
M*>45D&M$$%9CP[6/1=174S7MI0#584$2MV$AJRB6 -+8+VA2D>1#9$5T7$G#
M.M/*?"91HQH8N2>SJ9M6A JFR,(1 0#RV$1-UU-+68C,%.2FB89WI+I8-\*.
M:D%O10X@OI_5G"(J-6#NXR46<I5;,I-,;T_@L*:$%9W)C&LT.SMD1EF2,PX,
M&CF<S8JT\E*T/ZYMI"[X;0TW++Y<CJIL;TNU0-D$*'&B%QTQ-T7Z,7 N<,/4
M,F +S$Y,N:9&%GJ-S><V51:4MXTG>K(JT$,UB09K%8*PL$;%F-K-2Q2<3 ^D
M!&*!T1*3&+$5"6&:<X&=,GSKE&EO)@=876W! LHYPNI+>PZ!\JQ+1-AL\<1L
M,D1K"4*1TK/JR%5_G0L<OFW3AG4GDZ.<+^;5;#PU02\L\D]J3P=+-P+,<0-4
MF+.!.VN)!'M2=E&@+,"-$$H'EFI#%-"B$SA,^M1>QV,*6:;P<A\LQ7TTRA?6
M*L3!B+!JU\)(OFH9"@'3)5]+5;(P-=L69;HG,$61 "*.)*G7%6QS@J]MF52B
MB=I+8[HY9 (S;H\!($-.-R^(?5*,5=6(R9DH'<30PCLP(YBJU!8.#9-4HL&3
M19BW!RP_QIVX.6D9<-H^5!D1727HK@SYT;ID((&/%Y6]8W%OC0>+FEY,ZF"Y
M]$8%2'63%4OMK'FI82S>6,UHE90[-F2E<7>:\@:E5I&L.M&B$B76)S++/]KB
M?@7ABVE#=\H2QPH-\W"^,)LTX&U-C:F2I\?NV$Z1 &KPJ&7I=M'@4FV?"SQ.
M6&(]BDIE8C)YCK%$!J@>!W="06*8LX?&>.*YM2ZG9)/K>2HV14/%ZF0BP?I4
MF=,;8U0Y.-,J]JQESP5ZG(>-V*RIS" '#[-PQ,*.X$#&B!WQM!PQ^T7G1@2;
M'^=]%(NQL^U9II\JE*D!YLS5QYYJ3<<3%<Q4&SP7.$;0U!P7?9:MF7*Q7ZY!
MI:1HKRYF,G4HCN8H::62W%OYAJK7K.NJ*NO/9&C;,0ROF6WI!;["73&P<X$R
M[H&3M;SI0,P?#U:/;1"$R:-/BRMR>5Q/IZPNABIO3-B^S_N)F5@G3Z%795B8
MYQ[%4H63L\4"V>?X'BZF5!S/);GPI5[,%Q%#(X4B2$U'<(JDGKF&U(PW4$O/
M+=1FM,6<4L\%FHPD]G%V<$Q_;''9ABFM=NL(+1W,'17:$7)5AAN),L1>9ID\
MD^!%R!S(PSPL"K*=@,@(LMHF$]06Y$_, 0 I93:"RBT;[%07#F-UH[#!I&?$
MM7[LY6U.YBHZ[125:JT M25Z%5/KY2@LYZC@48HXF>PFF3#1BTH^X2&%&(M8
MV6\->.?''C>GE*RV=AMMP4P1@:XH2I9G##Q@V8"R<[A9,H)(2B1/;4%IK0"+
MB3>KK '+$,JY4RGHKC:CNA66D6G#]>:H.;D3#,,M9_,^= .SW<T6,* 3=IG$
MA1AI_)%3(X[@JI9:00O+<1 )TT?6F;Y.B+W3E+&18Q4$P*;+6\F8&3,BY:]H
M4D9YL3;!BB<'1:P6;%D@T90[<(?Y8:[OLY1'/55)J"'FV1("\>+)EXOMIC)A
M051T7U=S)8IEB8HC?1/Y7%28OC_V_8A2B:'_0L,Q&R5KH^O5;;=F!B#K."-#
M$BWBN4K*J-,:TO!JTVK4SFUI9B--S7VWF/GK,41MP](],XZY!N3J9M^QK"N'
M2QY1>95>%\=E&.FK8D#JS0E<<Z<\><I$:.<4>%RJ&K@SJ+#0STVR\0<WW$5M
M"^@;",0VZ(8IW%8B(GTAR]UP+1E(JYS$(<; 9M#,V7Z)>M0IT,/WPO(1!JA"
MTI-$ZZ4UM@\:6HWK,::::$M;S,@/*$-01C6M=U/(]$>-"1T*4FX%[EQ@F_1]
M2LY(6#W61K-=XT,/U!)=TQW3$ZJ^++IXXQ%[+_>5*=JT.%6H$;ZG<B17ZS&3
MQ$39(01DE^QJ?>*'<A33QP4S GH78#+K:"Q'\+)K]80]XI:%\N-% 9ITF-3M
M3O*<48A[V\3=N2DP=GIR*77$&MNNY@2@]?SJ7."(BP?-RKQ!(W-Z-*</^&*A
M3)?;:=W)L[FDZ;M-IP1I82HFO@?T:@TP,ZRJ66?LDD%6A7*[R?!X9X4I>EK#
MP@]"QL(D9I)PY&@"RF.!*O+1$(J/P49JUM@R6)'>MI$VM0FS)JX)AHD>ZK%/
M"&([)?C:GFQ:1.Z V;8[%QCI()[K!FTPO(P00& :IA:MJ* 1AY 41D#EZ@#/
M%3U\V.OG^H=!<+(*PD'3>M^#>$17RG9%:6<73UH^J^$N63 =G G(^B$"=6?:
MS@Q>KC5XMMW"W!Y.UP.63<-X-M7*(3H,K((W5QFJ P-L1 .>@O"PMJ<08&UI
MRX5X3'#QP)1";E-08MTM1;1S0I!BR(E*;1-5HW58;%#=G$O=T9;VK!\M>533
M&F.;E"6J%S$?E2=^F!P!F]Q!^!*3QLCL6'NJ/P76+A=WUCA@$B_EPK6?-F6\
MA5)UPQG;%20C4RFMAS1J%0P>(8)=OXWR9(#R<X%WA_?CL:>;O0RX+9> %MJD
M*-_9$.DRQR:S4I<KAGB_C4R5*(I9S?#<:!4$"N7J8!\0#7X*4H5-@H*M#2'(
MWA!QB!P"D<CI+!N<1N]'A4X9@1J1R^ERJL0KS,*-3-D7)+AR4>?(\R8ZY]8K
ME9=8ICBAS08<)WHOT=# I65E9<U*#G/XRK"0#1F'<VW')#2V53,EVD6E'!P8
MWV,E<@:E4 5CIL;!E2\ 0T254< YH8VFF "]4?0Z.)#H:)Z:1UA>;@&7!01&
M _KI8*3F&7[J7:Z3VZ,Q!&UD#S19(!!U8VTFOD>0--J7JT8^!7IAO&?AS2%8
M-1'8A(9GBPW(6;+.[X@4C\R^FRG Q$6GE,ME](@3W/R Z?;.W&:\PD[3:+,N
M6Q)5!)Y+S@76><W7ZU(1DWH]7Q(S=H!U9I91&YA+)KZ_@XRL7V"S@6BEH!O:
M,3QXH@]B3;_E,2NL!Y!4V% =A2EH;TZ&;4MBDSL#=>^X, (99E^G0N$J7F0@
MH X%<[:+)Q'N="X1:?AQ[*OF@1"D[9"F;>A1L^W7%!]IK<9V_6D-%6;,EP1+
ML1,2!4.Z\U2-+RP+]@IT*?A+C&"(9E6X(%(I%CS8'CIX'1:Q+%AP8:?&_3E:
MZW%LJ^W);((A99)YEH$-5(<F.UE;K]=D)9LSW8^AC;44.(CJ!DK#2W 7TXV5
ME-J 6GREC^AQP<C+3)!R;<6W9)B?LH!CRDF=Q+6LA6Z@B!9[L?,.H3AJN;T.
M3N:ZMR!56Y)S=A%7!B;US%)J%QP3<?ZRLPI,HGG*"<0#TD'[[4DI"C$"=*PL
M)ARD5W%M!;-=LH6@>,[%(:5)C;=V(J3WQ2%S CQ\,F;<O-<S,5J,;3ZVNY8F
M-QJ3",>M<QJAP2\3*%!$L]6W9F1U2Z.O^&ZA6;YOAZ$\#>$)2@V4TQRME[:
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M96I;^PH#KFLP W+$0H 0;_FNAE7C)'!4JALD&@WL8Q='J@I'&(-)7:]FV#2
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M+-I]8K2_\AD76MXF?$:P)I?;M;*$+*K]RNDUEU\5:4<F\$@]-0P\Q[!3)\)
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M#5M'DV]$IY*:_:#6A+^>%5::]^MAE3/SSV1(.GF,(4F])BN;-&Q8S"#I6:C
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MJ93#0SC#B/).;[9N*XZGI4$45I%S[%P&+O1/#\VSG1H9+-MAE3@B"BLJ9KF
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MI>=9I%"P/G?QQL)NHBOEVSKTP@^H8U'%%N6G@ ^N17"OFZ4C-D8^PP/L #?
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MU9&7F\'YH82.$C.AFUM1R,O\&@EVD"CHA] )QQ.[DN[-36V#'SSG++8SSCL
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M2H[^ SAX!@U&X0X<42>4QQ"A\ 1LK?8HQ0$^>*.FGB\K_5^Q-2!9T0Z< I;
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M\THJ_9RV-7A4?Z+:&Q/:$*^>\874MKGZ20CB/P1Y"XUY8+G=I4YBZ=Q1XB@
M%:CJNR>@EL:+LW95BFF.6/06> /9:Q*!$<[72:V6RXY@'.%INN,;SL@0U[R/
M6$JJO6;#:?I9X-"CM1M[)911&8.;3(AM[JLG#!',.X"L5M<HD1U!'"W5J_$W
MD3N)84Q:BE6XJBA',(/&]2B"K(AL\@N \K&?,A% 7+X;OABN= U[(.7]H;\&
M^_S!:+T'Z("(2PW_0P*E4\28>I%(98;UQHMX54U]VAHL&3[_)K1^O 4E9#;M
M!#["YG>/S'LT!@\V2O7BW%>"Q\L<:E)/[G&X!7J295*CNRAY+K<'N[.XMC="
M3HFC4^:MUWDOFK:Y:8I2M'4K;@L?+OIA\V,/CZZ9W%D1^0O>:#98KS\1E2*K
M*R0LN=F!30L689+] *$*\2?=)*AFLOF5$P4GQ!O%]>;5J,V#,X,Q^/?3O^EH
M2X_@9/Z$&U\D<W7XO:5DV!QCI1EJVOBP<[.D*!X1SH4KG[@@_$,YO3,V+N'4
M8B'FEH_C;5?533[V+D=.'([,CV+F4$,JVJ4!N/O0W@/7]4"S(V24;F/+3(Q*
MW5&4EP,32I&G]2;D4$_)WPHE18(2R&4T3Z]+8!M#TI4-(#OW?65XY6OO0;UI
MD<?2G!-JY *D77II#L?N8V')J4K#O:MM^U%X,_J]V'8,X0X]S&C_ORKNOU!C
M?R;;T(T>*3"8_0:RMY[:;K,7/."K=HOHDH@R%E"V!'GY)9W'*BPJRKRLC2A)
MT0__1>$FKP83**B/OG+G,]*4ZG][H4]=\=,7ENY;P!G>21/SM/K;XIPN^W>%
MN^YE#R17IO**N/;ZNUW&$FM]$5R6Q3'@BN*LC+ 4[S6" 70AW:^Z?XM%__?,
MDOSJ_VVB=]7SLV%@9N%HYP>E*ZO.\:2-&#OVE_,_ASV2SF%K:#O&(A>HT7J[
M52(XR]?W._&49@4,8][*:';([C1G=T=O<1JANC9*]M8(62%]D"+;.!?W2_^)
M+^YBH=DK67"7AJ%*SZ"JL+28* )%X6V.^0&IXH< ^87,%VYMNM,%8_G?#_&Z
M)+3&.ZYQB]\,&1TT[C>Z*VE;)5.8_4BTX(QFK+-!C=7\(/@*)?>60@@>]]O4
MQT#X99GV]>:\OHIZ[NKA1*V)1IR1+PBWY8V?(5)?2UN/*1Y]@D2NQB%_0?O7
MUQEF7+?VKM\'XTC'UG:W^H(&KV7Y^5.:OFK+4NW*&H(_/K>(W@7%5_Q7T17V
M7S5^]Q&WQOTN?_7.Z<A)VFC>=@C^#K]ZUFE57..H>C%\X[8Y.F>5?J!?S_I/
M3/5DXW2$,JF*O":?J/%'F:FBO+1-O&OLALVZN+/+TNR95HHSS?Y+R_M[!$%B
MM^+[)%;K*+5>4,)*2[@"4JE%>7T_*9"$,D9-Y<=C,T/8F#T([;]1Q':.,'P9
M\1AR>WM4NRA';?=[6#%\\EHTW_ _!SU\7_70F!NT-? -_[&+J>^W1$,^7L+=
M8BAP:%O[HON<I"9D]-1(^U G\VQL6_,.V W-GQ)>M7D3UG/<V"QMOBB76K#W
M^^;E<&A?8<'?:VA=>SI!%,H?X2_LA$+[5NJ]_X;:6_<*5FO+#GN9_=?T7&ML
M["GH"&FP"<HP3\IQ?J&;=V@.]2KN<GF*51]-?)ODF9!7]"&C)'C]''JJ^(7,
M^U0E;82NNZ9KN1A(=WA<>46\!-;105%*91F!];X[TNRWRC[%S2_&OSF^>KPQ
M*-Y\!V!4QG%[/+BIK7)(YB1REYBYWD/$X^-B=? @M9L<Y?\T*)2C9X_IT%M1
M3/?%9U]-#1&IBK'Z" ^)U>EL,R(1ZT6B]'?"K6)912UR,+Y*;!M>+T33[ID+
M8*I+.Q&ARW"$#L?5= Z^ _H+]:Q7@.[%W8LW:Y59C*/*^J=-(&]([--*H1D'
MQQC/\"Z[XD]'+GPZ2B^(& 6ZKUJH'"5"^%R"%U.2J^W]=F3?.X"=J9U88UR:
MU*I!9@03N39@1."G>[!(,16T9D"=.]D;2MD)2Q>_&=MOX0K--MFGH'U&T]^+
MPCM1OR,A/W"KO:0-:9@Z=+J6&:KW9M)@D^=Z%;@FQ7Z,*@;GA/_4)PRM.S@Z
M4V\F##+8,']KT9O^<V;I7?K# <1BF&P>9JK5L3?WJ3GT(]+=IM9:*D-"7[B_
MN#[>%')N[GWJGU/5!.(,+ J,^/FAO%\VDI1P&.#<G<14B8$WL4OAO(O\2"/,
MC>8L@9A6Q<BD_YS'625O#FWY0563Y^+<S+7[JQ/T')T0R4KL?23! 2S1W+\P
MY+J@AOY.G_K^V&@ZE!2#9*:,WBNO]35D?!CT0N5Y>A67N0+"Y> =D(2Y8,<'
MZOM+>BR.8[P#K![D#J%SE9;59PXS!?L)^4E:OOE ^T2G/5.(O<W[\):41_X0
M&*!3OCX1OZ@@_/=0;L;UX]&\MW=5Z2Y0XNF&DA>;V#B$YX,;<[JY$,5IRNSF
M6\:UGG[<VO0FM:U/A$Q<=\+7!'Z;>C4INS1<MCE7"[YC ?WXC&+]#D#:9\]
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MQR=Q0%B>*8BW-%? P+GG2J+;#L^ QC5W0OR2IB;&)AQ4=\?ZW&*'Y9"?&Y5
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MHJ?99]GVE/D7A#O#<R!U ]=X,4DYFU%.D,:(F?(;*NC5;[1J9SQOB"W+>W$
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M_@&HL?4 YZWC%%@@-[;9KUWLU94 '1 SO1XE6+)E9UV#G=1,< 0%S.,JS:[
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M:Y;,#MU9S5OQS%>D)A:QZ:3L92.GH?Q'':SV5IY3_-D$[)9NC2A8PW$]Z)D
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MS5V_L=SA3C;5B@0RHGS5U2J%AE?\K'$/SS%0Z^^.ZF*\DY(B#4)VGR$2V1Q
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M&M/.[['4-HDQD)6I,$3S#@?OW=9Z<5\J]4R9$DA[GT(F)42M0LDKD"KT> 0
MY+L!$O1]'J/Z&6F.Q6P) +@3.^@L/H3!X"_QTT[E(-+&,DIE.A%XAO;/;]TU
ME*0CI"W:U7MWON4L(E4NQN"3$-?ASBO*LYB@<B7<0\9=[5U#O;2/HRHKPM&F
MLL;G;DT]4?=>7\;G)6VDB!_JNJ;J]3K/.\ 8GJ[(/+GX0(R5#OXZX+;'9$T0
M)D#'V#P0L?B, KQG.2PF5<OAKE2VXBE ,8B#^BP"Q<7O_AS[ 6!?6\.HED@/
MJ<V;D/-8XY'DFOO,AKQ(:24&?)=G2VKL-YZ)W',#TBQ)1JRP53SE1(%(3#\
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MS9H"YBWFC="68^J6:HVI[KV.;_'J,^B' D-F<@<+-UCSP;P8P"XZ 5CKT8/
MY)%#^]H9S,^8\,U;$&2F^%$CZY=UV )&ONH%3JF:E$7<J.G'5O7FQ2XXZ7DG
M.)MJB5%>-=51IDSEJ'!NV[RB!?LH/C'&#/!CL"(M.S+L*D8I7F&!)DBN6LE)
MBAF45S2RQB*/N3D\A;<J2=!*&D"B-PPO(:Y.@I3K^5)>(282!*!<<5(*DCGX
MDNPZAJTSM =2AR2.ST-3ID) K[#2J@<)DR%04PXY X"S:-7;@F W>J\36*1;
M.#I;R,9XCS!C]'!Z>KZ(UE[QF#<A+4>E5-OXVST,],E0_>?<&:>ZNHF(!;+5
MJZ'&:WC*C_P4!OH4)DJ6?3L:*+FN1B;0F+(VO'B06B@Q!U]!H2"C>',I<DI(
M2!ZC>P#CW18IC(1J8D8H0T'E=A,:$&W(#Q7T^RICH+6NHS3\6*XWG&EQB3RQ
M&8PDHH*++,!/KG.0V)$R.B8F4CB'(2S$* 0MLH(ECJ4Q7Y]!:=2HY_Q];:K&
MN@UIN40JZY#-N=Z.5\'ZR&[@O:+([ A:G5TH'UT7TOC1'*M*_H;V2P'&++G!
M!>9G:OY0PUZOS>;\2QV,NV[[AUIW<#>A_)F VZ'.%O#2P.WPWFLIFZ1< &77
MQSD$;#Q;8<N=2^!KDT>1ZG?(1C*A;41ZC.LO:M)W2)\69@6GD2=-U4)M'WF^
M8M)(G4B'CI1KYWXTN5US_I/J%4AL*B6@'[B6#X%[WK5\<^3O_A(6'9O#K#("
M$G,=WF #DCJ&N+KAFW95./(U2G[%!60D? "(Z$F 2<;1:D'4)NRX[J$ :N5=
M'23.;G]D<2T/UHV)M$XG.)<XB3G5!4;[VW2+HB:8]#*54R;[SBQO_)7"!GEH
M""L'N.O(LYOB7%3^#D8UKNT$+1AX<$NM>UKF A;UE*$GQ)_A(Q F#!I'DZ7-
M5ZMI4!,9AIRX;:PO<(YMA$XC%!3'\L,OQU;N:7\1F<4NCANUZ>&FZ(B6LXP_
M:OJ[)-A.[KP*EINF^TM*2-S*.F$<:_."#0+!7I9NVJ''L4KKJXZN[EBO4CYH
MCDD$)JH6FTEG)HWJX,_+1?)H.G!Z7TI>KN.!_8)!11.>)JV-!V_OK!Q+1'CH
M*]_#I.)OP",M!I(KO2W)8O/?CA>LY=ELOMT, STMWG4Z#-UUK]U] -[1:(:R
MG(LK7+[)E7B4V-"V,1N[@YS\ABNEY4ILW9JD=46/+CQJ4S!B;T4E>N*^3Y"#
M"+--9J1;K?,5CU=GV*6&-J/.FCF2LF^'E00S!">D<IG*#U+ /$V4K&)Q;)BX
M#),_^FDY6G$J7,39]<=+$129V@HJQ<H+ 75DZCG"NJ@^RL2Q$NB,JL@16)4D
M/4-UPHB&=]T=+Q^ F=$-F8:Y,C5XM.)@-0S4Y')HBQ0((72H>30026!@3R0/
M-TVAM$KVALVF2+ ,5QUD7P]1"@U%QK/_NOWKX;"Z:U?=]Y9AA6?_O'$'I0.;
MDJ'B>9P3GU!UIV;NPE$7'M-*.IB,@1:1-"\U+ZE-U"155=9*F3'7@I$>)DQB
MQ_'(-88IN3V+X\/7(<ZVY_-<>8+:W[]0)8N=M6/P>%BF:!.;FY.F@X7);<W$
MHN[.856<QQ06@2O38;)SG$C*IH7D0J@86@ ET<)=I>3F[WZ\5EP#--$G8!JS
MB20.RGYOI#1<_>CZG[8L"BH9L'9<B<?[,$5%[ / 6OLR[5JGMZ_Z)%;\:,)!
MJPRI)C>9A8G AZUF@RX?+R_ZEFW%$8W;/'9=H'(3U(!,>V$; BJCN5@%LK4.
MF;M)! L^LK6]0A U=8X2!_M\_=?D],0_4A(9K=E)T$\F(Y\@)Y<?XDL##"=D
MX:C4BUBCW-@>0(G29SSBD-VY--BZJGF"+'5ZS!H8@:.B>$^:O&/SP%I;]@M=
M=G-'=S^+ZNU>M31J*"& '%#NA5_KUSD,-58O]GI(<KQ_CS_@</\P=R[N]QL5
M+XN+XUVG7%#:7H;XYS'H(OH*_'1AHH1;%I3UE?*3-*S%U<29.";AZ(D$64K%
MDS09VPI18X0D4:7&_!#1 G)*""/G3P^72RZYN;]Y_+E_+I$N4M@[JJQ'*,1!
MS]#P0]@O8,0HP,(0]:,4K,X)&4NS5?\)!%8RU:7E2?@J!PI_O:L?5 W53?-N
MSU^E ^MSK,;EMX#8$FYG7Y KY5%:;%@JEU,&4+ZW"L!K4'!P_%Y2%,S,W[5=
M.FS>-7U@&'>6Y5.R->N-1L6@:\+GA. Z<_9)CN]QB&NE))O(Q2DYST2)U0>T
MEL2J0ALO:8I-*M?&_2R+;Z8$KJ2G//>:,%HE<[5B?"]CNU8>345O$&X2S1M$
M1YQ()Z2?\!+F%B02!'R[UJ4MR;Z\;[/6<F"2**R/ 6FNT">2W6BJX!3%[K?R
M%DJ\T&B7?*4DWU S#ESB;/)<&<=5&25(;&9E<+-VT (-,G]E89UKJZQ01%J>
M/0+IMT9P\RMF8JNZKKA7?SDM3Y0X'^?9[\2E1;-[PZ5N)X*O0XO!2:UC77%;
MKZ^W1F6SYL5.&&Q&K37(,$H8*?8LXW>*&W#KZ>4%^$M2UKQD9Z_E0"!F:3;*
MTW^JSULE=Z<C*:TI1#T6A;"B.U.1+K8FFARG\C>SD@NKX]65;5\E'U_+&K%S
M(,9AARRCAF$9AW$>1YW_ %RN/UR^=\S;G@_9EV9Q]E99T^!19C89MA+KPSSA
M-6)7P8HM%U!GS8$UP>M1^R@]XB'\.$NF-[B?J@5]3)B'YG3S2UEDBJ4HF?H2
MOOG:S?'SM4,\F5PS,]CU-^GU#<:R]-OLI[AQD]6WE!YF#14\Z JGLLK4Z&TP
M[)C A=<KPL]G+$Y:6!45JNTQVR)HS"BVBV81NT29&"=5WK6"E\OX?<XDWAQ=
M+B^3<[NT-_0Q,&A:VN)RNB_&59KLK8/$88VK[4]45LHOV19=UH31Y_"LY1'=
MVC+.O.V$4AM67+3A_/GI8C1H>R9WQN;#?46V&D]7T)S4@+?%1C[WI-^VZZ:&
M:P/(B6G',L71CB^B&J>DYM/0S33YKG!BOD#O'QOEG(8].(_:+S:C21M+*$48
ML>"D2@SQU[(M]"\+D4"2PJ!E]-%8Y5Y/2>HMD@>9*)2?Q#+&K=_0E8$LU_8W
MC-K4-X3V<@>KR-C;L&BM(5)'6]_1UK!"Y-.XJ11,6*,S!@.#Z+HX3<%U%<FY
MJ@D"DB9!%P]/]Y=Q133Z5T!JNO)/GC5.(>RST[@XOVQ3U3L>A\FE*2TK?B1H
MSD -1/9)3($&BF0IDS$T5Z(?7='V$R5Z:Z@/9163I8JWJ2)V\UB[/@#Q[?C!
MR8O>6=1H"%)-^391 LM'22CU3(,\CBZ6,5W4,F#J4VP\ QTHC=:48??Z)4Z.
MSB^PT>X1ZE1ZZ4W<1#(EGX/#9'9NW^KC,DJ;<ZGVDKS/8OK6,M!'6& W=.<S
MY+[_+JEL<4U29P 38( LLL84FVD&6$6,6#)"7LVYL1UEC@E33T1QC<,+Z5K#
MF7-[\"/T#C>F";H"HILF]0.UT"WX5,$+%60O*\:B^;9RSLW=S?C[G]@G<.R^
M6<*F2DG+$Z6AC4B,FE!H$\EEW"NH.A+^):6]W^7Y:'BFNV5F78X%_X?R])A:
M=W=;8VL7/V^#Q(J,C$Z3AH;"FW&Y,'!=*W,,9JU.\0QD\3%R"=D"C"*3,%VA
M+'8(1C#^)51Y^HSL0B-!B3/!?)P@00XM6-^[789ZL;>4N-6I8Y"-[W[L=YBT
MD+9YC0^0'MARHO6;WL&L/*4.Q3YFI<179.)L;_\AON>!,*FKFNY_L87.X;WO
M'<G_[.S$,T[39K":>_7S#"K,0ZG444XTV)'A18C%JZCOH+]1\(>-??#PEFZL
M\OF,M,&6R6\F8YPD(6/S(9=V_+;D]_9];0L> Z6+'P65",&U4X_3+]$=T<MT
M1LCYW"*?R8#4V8CFCLC>4$(G S\7Z&KV;(EP-,5@YK  6$I!A3VQ*+S ^)&\
M9]#4OP3%$*=(;APV5,R*K5HHP34@#UR5)?4QL.@3F>P;"!(M:B^<\W78)G-P
MD"G02>9S6)8FQ00^]M$(W/+=Z2F?F."<U)<4$G=9J6W56WC:($5))3K;N]9O
MX.M3SX]_SB:WZEVEP<B %+]R,N+T@;#! 4>\]I>SD>PE9O^X)JWM<--L#_L?
M37?YE@'5J'+Q2R(>QQ/W#>8GIFPGGF1V_4)2Q#0G/Q)AJRN\13;< 3@ZK/DU
M#$KB\F4YG9]M/E&3L,0J'7>3CX[>&[]_ ,H4IVXT;_X7U0^ MJ*FJ7\VQA*T
MD"X&&>&.VVR<<4#9JC-FI>T!14 ,? H4-!R=Q?]3W%<%Q0$MVT*"!W</[NZ$
M3' ;G$$'M^!N">[N@VMP=QL@N [N-D@2W-U)\LXY[]U3[U:].G7_WF?_]>Y:
MW;UVU]ZKD_8O;U@V(KAJF?IL)^Q1Y6XP.<+E'&3'1MQ1W].VC^[U7NM.QYO+
M(T7K?M/,LR."1>E%FTO':J:!91F1;H]!+ S2#+<'*3SDBL.85MEZ SQHDKC>
M33N&N?\&I,Y?A&JUSY&A7\A?>^&4H&\-$+F>'5"A .L,SXN3'ZV\V?A"L19B
MN2NFWAY;.1<+-O:$%HS8 Z&%\ROV!)-P5G]WURNJ=N-OT<ZY:BBT//_9#+U2
MZ,),(@GE2_C[!F1^_;EB[#A]3@2:3W/EP'2;Z6NFAFQ]:?5)>[?9C")MHD:\
MP;2AK_AET\3_+YWM_ZZ<D$/7%0EOO5VO:0#'!02OSNFN*D]%82=B=OG$*L()
MF\4%L):"?4'S=(;KRVPRW_97".UN)?>16I%/C5V"=ER^7_B@N18(:BV;5#J6
M&RU;CC"GZ5:BFKD98MU1ECD5GZI^B81J.UU5S8ZT7FL[U&--<87A=XAUG;CG
MIMH!60:WXM=,K]Y6]XB/<<E#\PUS7VA>'XS3KG7)_YN;-["_"$.#TXM[R4=9
M+B8$-EX%CDY?U9")A%E%_Z@G\81RG/Q*CU9-D!O8NDWAVR^2ID0#:['Z?_90
M3Q.18+K!I\;-*=H+2[H4HSS81<<X_7J2=[2E75DL8(2*C?FF,B+SVM*8!G2;
M+Y>6<?$6'A:_T>*$?U#^D%2N]WC\:Z>EV)7<'$<O $*H:'YO X4Q[.86^&SJ
MJ?^7=^ _R]6F[9Z.(A4.]Y**]M5T B?8.?)OCN]'2 X'CT&XWYNICRC=;'R4
MDZ?01^D,2K 5,0&T!V4\_;BNI7'_#.!KX.6+&\X'K=('JFYC748Y!Y%M3\\9
MGF;Q,L@44; @R9N<01+I'Q'-H@K+#9R,P9J$^W2!QLM5VCL[J>Y'I1PZ^GLP
M^N@]V$S3P@V]6S?]3]?_Z^7L=TE_L<>C^K\(4>9N8 P/) SND<NM.4OMA_L9
MP7YAU8^>[!54M:#<Z6S2'[]^[>L%X-^3,"K1L;_CN4Z5G^2X&3!S<W^/B?D7
M 8]TYO)G^7O,>O5'0]M_@XA;X _T57'B_D'FV7KU7A8L4V7M\:!-,GEO,+]F
M>22^Q<9I@)S]7/:=L[M'/;XVNN&@P#=S912WY9.C[;':"VBK4G6*2V_C!S5B
M'Q;7V0J-]4[O\\"M 5+8B+V"C%!'N'#F'%;0</$E-$=C6C41I4VNZ(R5=#4G
MSLL/O'N[SZ!BHUFV_F!-- V\UQT%-P(A6")60TW?_PUPK<C:!S%0QDS9@UJ/
M <^/B0V;&)WM3C8(=@"DE2D&C!<SK:X58$Q\3U+6]E!ZQEBE Q:X9J@[VT,T
M;_JC9JI5+$?LFD+-NQ$4@!17VWZD,KUX('(9*-HT?_EC(+NF,[NJHRQ**0#2
M@WMFI5:5R1;ME_H-EI_?-LL\S *J5)\?8UJFTSK<0Z<@R"U5F(ZX?8_XQ.+*
M.,HL]L/O3:-R6LQ_S,E,V3IP'7GR/;@) 6:KRTW0ML?%DDNK OHR$=:!,1*<
M;= DF]R28/V147/5#!6Q+W0N:%&:998-48K#9XYX9(!35G-VB8J07<13@+&3
MD#U]/7-KV0F>VE'YLN:H=KM9&;?DO6Z?82L6>YYMT&/+'PAK([K^]J3%^GO$
M%Y;[,"WT*L;9%69(_""T8KFCL_@C?(K5GM(@3G.K)KQRPL7:16OV-,R:B6=@
MH+%V#>,?5&D 5TWF1[PFHP0KT *(2"+V7QVY*&6<7KU-=MXV+#J&E<(>G=X]
M2=$(OJI/$52JR )!=Z\N"JO 1Y8:9IW'9\3 F*M*9 BYIU=!0)(=C%(U$WJG
MNOT#A-:R&0M4D6^O" LN R[<A"$U4D.<.*J6BY]2)&RE!!+CKY30PT]-ER/>
M,^@YGL@L=O-JCU=2S!-NFFN[NS2C:&-[:>['=^_R/KU3KLP!$C9S.;IQ[S)@
M.G)9^37- P[H.%!>I9!LI5F10I-<=. #X;$*!SR9/ND,;D=A8(XF]5WB+^/Z
ME,&ER<K1&[[<$G;FM%-@D-%&9'/,K'I[L%3MZ?Q=4?L%3@I'^?\^LWVZ6$0)
M!$@B1>^5YDZ;+43Y(V^<9E0XK@M(L2A +G!>PF4JL5^XQGH6F6J&C<RBH#='
MKC>NB1^!:"]C0('62B4IHY5*X;=6]2VL71)^ZLMGY3J5TE;IKHGZPM6OE><P
MHE?M%)L1ES83DU(N*.5AH;RA.HZF2:^*0[O&IV8,QPDZ; L-#4%)?6=$I<O@
MZ."H4.@;&QN2@E<H$4Y+#P /5RUBMAQIEM$T8ZM_NT%09$3X3,H3)+85!<5;
M8W S'0]1Q ^T2I4W N*=.5^M:'$[U,D@S:70)WUHHR[%& AQE2.D)\@W%3"S
MX/9]0 #/D7C_$ZS$'1!#008VB0AFOI;JS-32V;"J''H^V^]6$1*_LMP@<W2:
MX5E+4_0Q3<0<RJ5T(% 93RL&*%]2BJR4%"'9P8%NT;8B)IEJ_V ^NI!SV)A;
M, 7#<7H (P/065T#9XA4FAV:5&!\L<8@O.:?\L (@4O\HH^\'&FP'<"7 D'B
MK!T.J/]D&;ACD""TZS3G+O.E[ :MI-]RGCMA,=:H"@MPUHUV,-FYZ 4Q.8(M
MN>ST\PG:V3]^8P;[@I(5XP2&V$(T2,3_]<?S@[W9REV7FW4LOCMVL$ M&&7(
M":+(SZ'?81 U!M!P/$KOX9+(DIHK4RZ5T"2T2<1#GQ&6/6V*PU7H:A->%A63
M0GV$3VB%AR^): MV\T)+O&S=@)RG-)K!,,1QO!H:*;06@H5<,]]5[]IWOLN7
ML49@ 14E#^A2W7(8:Z?Q#G!-N1W+L-(G0V G<DUCT8F%S,I&8*,#STZGO<3+
ME:'D7 *\!6#%39 S[=,+4DY>Z!G]X5/;'J9G7QMKPJL -[MPK[ 7:#W8_3,6
MVPE;HRA1[;5AY27':=8GJF.<\IYA9]BM^*/-VLM74HS&O&6#1(7W^5\K+3SK
M<;#P[LN95Q[DEH6$/-@,-[>,29@<[.R<9!06.5S<7,&VZ+B%"I(6 & K,Z&4
M6Q"_"@\"]G 1AQN1Y8H74#;VI/*6S2\<>CT/Y0P'ZNVQXE8*4/"4G! VUAD#
M+28YZ'B0<GE(:>S-T;RHG+_(/C6=1,D.&D]5Y;!]2M<UT9OSAAHN\T&7HN=Z
M1QCB#UH! JR ;J#@4$KWF^(%4CM&VS1B B$Z')9-)!\:D0VN:2J\!-TKM!IL
M\D5I0CD""HNH87T"TF^+DW-C"^8ZGYE*]JM$[N1PMU:CV:3B-+\>Q#5)T2?P
M3$69T_T!EKD\TAL7,%U#%P53E?#;CWYI/:]0V^/?%:_9S![U;VH*Y.C5F.'B
ME\W!1:Y.S%C>;K77T(T-<+Z3Q)4M1 +/AG Z&\RV=G]=ONOV%ZX].:D].>H.
M?*'[_1]+^/?#S 4TR*+.'3UQ!6.LKXI))8F,"CLZ.1M*O\+%&_7Z14U/,]DZ
MJPS7!JTYO0W:F'IQS=;$ ]4H>;J(;$O>%APERXIBU? QU=]>NV_K7Q$\9@P3
M\DVM'#.43"K;N7S81,UNP;YWLO5P!^)A.R.^3BN=Q8T+_# /S7S+)ON*_MD1
MZ&G\I5/REI5;4.Z<J%M@5T$Y"*WK)UOW].%)T:BS5W^)+XR>IB!2V#B3[*0'
M(NU_S_VS2TQ*.%;0WR^CD.[,JW;5,=@QAM*/;#TJNZM,DJB%V+5#^,YRTA\Z
MBH]5D69D+:AD/%X2=[>CW0:C]O=3(F."GZ/WC?7=;#=2?<KYX2F,.D'3>,8E
M&4'7DU\R7L:OT#*7]BRW+MIJ)JQ+X)H,)*>=,75?_%Q<(,=45=THKUN55ABE
MD_B23.J7526.J^XC=XM,A2WO^/IP<D/V^+HL>K3R!LMDHH*&=<<)CWAL^&*U
M]NKP)MN:H0I7YF$U8SSJ2\S;W@P"^/+PC(V+K8NFV5\$.T$VF5W--)EJ3L42
M0(#*:TBNR/\A;3'(/NE%&%L*?FNGJIIR;?")A!)-IHA,>$VW?B-IK\5LBF),
MXTB60=XFU:R@+#B?RBBEQ ',W33'*3"TP] L&$Y?#]M.5N?J\_7\L CE5N4,
MU]<V8NJ$[K,M/S6::C%T(EW18]3E2;#3N>OJ-E5=O<L]MP*ZA[9&MG?AI: S
MOV!U@N>3LV2B_V"+O+ JC*SU;R3?4#V<N^YML[]M<Z+.=XCMJ0V"ZP[FL?4[
M&2FPP#"STF'!TW5Z($_1&36-!31H<>Z-DUA5\N!YY,0?7KE1A^=P2_FBM;6^
MO*>[,P[)^'-#35$W_M#);=X@-^^1T3+LZ=6=F30'+1(3!\#=X =4L^D?K!E&
M?M<1[PT4Q_(RE2*%%.TQ^J\W_G%E00R_"3W3NKQ-.UJ&,X%LH+>4^MKVEG+9
MQ0Q%#O'M;2,U='&86/UK\)?1F8#5QUL#I<6\XSS?S SIWC["DAP3 = I2O\1
M27;,:$OQ;>^GCV.4>(#6/HI?<ZR^YB\CIJ?VE9=E\Q!^X<8J,Z<&#F_/LSD6
M2KK/ZD+;8R$HF_(JWR-_?R+^LTCXP][Q#3\A91+6X4#J7JBF>3,H7-2'9EB.
M8SD=2S+<ANZCW5TIG; YWO-C%S4A5\ _<\[8PX)3/4N6+20];.%Z[AZB6W%7
M+Q8W#ID5>B>6YS2O5ED::05==VXWA]*1-@O0&+X6+DFUHDS)Y?OB!R"[K2;_
MEFG]Z.]JE3?RXO;TU%[V">"7P-?<GN-<@UJ)8'[O+=]N<I+^\-;S"8>*^D:T
M[A!XSHG7.7W ^EL;FPLMNDWY>HG3NA"D?7:E+Q-__SMNHLRICN6SDPV6$)]*
MVQA58R^H35(<\Z#LX]4*XM+=2IDNGM?N.;$B48IQ<F#BZ@KBO6==&U,/$QM6
MD2RF4YA1J6O/1=1OA[I)@B2KZ2:,M!_+[[2*CNFXEO"T31-3-27>$T I'"&S
M<7E7N=C0[;=536.YP<,W06;XQMUA2ER0U%%:U72/KT4MR1RI"F00/4=FOHF2
M5O#8IB^+ZTO/D#11L/4(HDG#!V@[_[B"I&[<SD)? H=O0EZ "3WDVLMUVVG3
MI)S ?=##H#2LV+I7=NLYWX(]9)VVWO"82<DQ1<5H*<%IWJ;4^)<&X_!.8T=T
M"G@R@RDIOBQ@#]FCL:_0/:YU:M@,QSER=*;CU>MHUD.'_U]K1<KA7\]#([V=
M-=B/@(6_!J)7*;^.\8Z!OH@.]/> E-/D'8Q_\07B))9$Z4(\#KK]<CO)#2 (
M85G@^6U]+SYEEH%)CB:ROO[1%M\=TKWM/?AAD8?_3:-ME0ZCB9(5%=:[[NH
MU?UO;K)*I''<.3*G$V;JN[O DY<4]0AZ;ONL'A[R%"Q]N"ED$K>P_@=Z*K@6
M&\O.2'MF0-,5$N>DJN;4W>E%1KJQ0\77Q"J[LX$'*S<1U*D3^ETN1$>P--V
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M6PIDMR]Z_]S&UM;U4TLV8?J'8AJ$S(2^AG:3UQPZ/:EF!.-8WM?BVO!>X(U
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MWN-XSRF=_D]Z>^S?M?\%4$L#!!0    ( ,R#6E)GH.'3, L! $H, 0 5
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M\N:H#C!6Y;NK![!5_^P<$M"@U:7-_2CXJ$$%WP"M1D%0XU"SYFQZ#^8H!)%
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MHFXP%*D<90N$Q)7COI#-06P!6-!!;T7&JW5]Y*:;2+$?,5]]) *P:@2=]<S
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M<Q)V#9BD4V_Q7V0^ IBH!'H7Y##]N))F;1]6]Y:+P:U*PDMR3\Q"UXIVS8#
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M6D5F"OS=^\ZG ^E=\M$MZ><)5(^U+[RO>CT$62G^X7CQ:"I63ORSVZBR?XF
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MU=.(?OSP7A%6O=_Y5Q%5^+$8X& (L3V\O E!@=#'GRZ#YH]Z.(VN"O5'3#3
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M,]@K7SX,7 F$DZ#D^I79U$MOOUV]]N/+RGWL^(H(!2DC)8^G?I C<J-(1F,
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M1$R\O,6%86F(8JT-4'THA?Q:[-5^([/^4I?LKC+;_:0+\E"8U)Y<;D6QI;3
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M;8VUWQ.Z@ZWW_OWL3KZ$8/A!!(:* *5\)CK)5YF5TZ?G:_DF O;K^P"0\96
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M^EX8U/9DY"5L<4A@ ,$_!*.?D3KFK@/9//"#")*1?E6=F1"Z&BZB"XO7,RI
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M\D#Q%4$&8)F!(AR?Y *_C"=-GFQ#]"EYI==HMO>'!=E_K]\&$,"T&:_"JK:
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M;W0_831N9S1^KH-XP9C*_67?"K'V7WZH@])0&U=D!9H^I@D>+I\7%E1*VP2
M1TU.6UQI(T#9* ]>D+\]*.'*' \U,D%E0.@#4.596Z/TPHN50+%V!7GP+3)*
M<6NTS#L:RDHE;AVNW#8/TF #<L6"%''_FGL_^>,Y0\5W6Y-&%(F<W@/S7%M8
M:0GIRD_#0C_P2B95.<QQ?%"BX]I^E5-HN\ONU=D+N=/>Z(F?/KY!*6]'A-_-
MPUU".P(S.X(?=81.=/P^8D, S%0\FT(DF^6^\?DVXRN9G59MG0GO.A-W.Z]F
M=@HNPQ0 )@6LR <ZZG=;M?,[>(ZPILU^9][Y;K*PR8V3S,XXI6YUO*:_>X?3
M(]O,:^V>5(@E +VFU'6GM].2T5G_N[/QG8G2/IOG<M7684=(Z&769E *#R@O
MJYE(6\$9O4?#@0+2?:-*?6L4:0$[@ _/?ILYV6RCQ"(Z6$M#_EH!+OJ4:>_/
MUCF6<PAUCD)NW0$'R#<!7>5C >O7W&TM3ZI7B!:=?!.MA>D/6K^=L3_[KO_G
M[XM=9/X.+L>MER!UO=).H6?+Z)23L.?B(_O 9@ZWMQW.9XSLOY6^<Q89G!7I
MG]7@N'M-=?,JQ]Z ..N@F$AG3SG,$M,MNP>K=Q\L(0RJ3/8H) ZJA0V68+K5
M)P<5$GO4(UFU?0'_W^R=O5WU)T0VFU]L"LO=2LLH=0 Z1QRT61ZR91W&+PZ=
M3ART61RRH0WI]T%R)H;O9YZKC^2P>0MO_=WU(9)5)6S8-FM0L73$9G(PBC9X
M262T_EK/>1C4IHFMC670,I#O%J+IR$%6U<[@2X7TT.ZY-&YV]A$ Y!ESFLUQ
M"2H>2RJ,>4,\U5P%_,]ZOT?P+(-49J WK^37-6.RR]6;60+0R*J/#'XVQN6V
M@KOZOY*.2EJS4Y]6A$UP.XK2JM14F_DUO %6*GLDZBJTDCUN'(!=8P=*FH!K
MTN7!QC=VZ.(BX!HVU_#HZMASG]X5D5G.:[,63L\X!\,RR4\UIN6#!C:RIGLY
MISM.)E#WSPR^CF2E7&.U49\1Q+!1KLW84$%*Z,R5L)GCQ%']Q-%O'C-SM"&+
M/VQ4^G#K[RJ<\LC9/UU*D:P6?4.CZ@QU&FR.,"O8/RN(GCGZWQXZ.?NK'O;;
M8XZ/#=JXC&)F8T[;'48 (YE*(SGOYOZHSXJIS%RIG_VES"9AS< TS-@LOL")
MSDDTP'@:AA)8.[<T1\+.-'<,@D*1NI%S7#^ BU27T^)=Q %_;HL#$K\)Y)HI
M6'CX0/Z8[0\>?/J_),P06LL#P LM"&P[-)<IL]6&K4":78-7T'&BL_3)4_-2
MVPSREM&4%'("-<*GPT(YZHUO#2-<__0ZUSHA5@=Z=*()Z,#!O<C3*^H\L] [
M_*>@?^CGU]R??-L")>@@N[JR[40)?%EMES5<:VA@)HIC.*J4[Z&18DJN8_MT
M\ 0'FM;T>;]ID*WI6'UQ5&41#4RO_'F&/CND18%\-6 (TH;F;LU]55X2ZQ^R
MS'JACEWZ\&E)/XS1&,FJP)AC\6PGA+5OJG0J?)K]N3?SLF'FX._,+Q'&^;X9
MU\09Q/69T<@9B["NZ-WACU(][>X=IF' *''I[=3,O]+9(U'&0?^RI=4,5\2,
M:]_0.\)[]-\N]8:.F\Y\%3ZGYY.M/;P]1"B\7CU\RG@I30F.QC(>GFI98XC^
MS*'T5A.OQXHLS%L/CN60."&"O;<MEC313Y5EA&F@&)7=P?O-1_DWL6_.O;13
M_J/OF]Y?J!OZ],)[5=K/=4\QM0MVQN_O<#C,$BRZ=)L1)?X#*!0^SL<%/,!P
MF!R@.VKH+'\49_<&7N^7<CS_^#0JG)?UE&]::2"RK.WUN^#S1G]H0&X%<&MZ
MGGUD*_?)EJC(H)=!;Q0+\[['+*OJTHKUTH7Z9_>GEWG+AA<^+?$US)EFL>W]
M80^80'6R=')]0HFQS7WUF$.PS?%$S+J6@C+7YWY,[0J&,_03V134A]3"V]LS
MSVG?6OIN/<-ILR0WM7LH\AX,9]R_\4GDT^PH;>458TYLLNKR"UZ3:!L8)[A+
ME>TXD<1ST_CN#?-<=H!D>,M\)BBA\8!F(RB%E6(C2G$S /1&'((&>O?S*V,A
M_ RN+\L@/U4<O0QVI1<K+PO>GP0;MS?R5PIYZ, O(K"YP3VL%;JR>G%+OB:Q
M?$/N<?PU\ W_S,%ZM#KS,YL<KO%A77Y?-N79WF1U]G=#WB+#=N_FHD1Z-*XI
MS!M=?Y+R(FHK.'/;1JCS%7W^5]M14?9'B3\=HME=EWMWOY4.?RA;NC>]=/'D
MV^\_WWZ4@NO]$*D]E:;IE>?WMKG/+KE?_.1U\LUSYEM%Q,Y#L<XQK_;Q"&#3
MDPUUCB&@N@-A>__#>JE,['W9^R5+5HX_M-&SK+OPL(ZH$\X@3AJX1 1T);]Z
M#MH4&Z&I>#(WPT/;SMAZ%<T" EM4=H:OTG'D%Z\6\+$A.FSE;-,,Q*%9YFNV
MM*_DKR)ORT$>*;<5#FXZQ_UZL'#IX%9Y3K6C@?<G/@258X\.4",ATV'& GC@
M C)'W-]>X<O"=LO!<[5_,POG'F^WC'SWYA"XTBFMKON8P!"9G@\HO?!H:EQ0
M]$>.T<<_&MBC6A%6- +&+NW*6,8E45F;[(-HWA04JDZBRG46H^2,Z*G"QW\2
MR&+%Y.B!%^;\4GPEG H\%&[+L,I9$KKTO[/9/\N"].ZM=T<2"GD;/08$GA^L
MG:^2"!PDC#MNO\C1>HQ;G39O>H U_Q&M;S6@5I578)OW1/HNSNUYB^I=U%*!
MX=H[53XXA.;^^O,2C,?<E8B))#.Q13%%"F#YE_38^;=D:8\:/V<AI=$"A%(:
M"QF"!J3-EQL!"(#6=<5CK]!3$A& 0)=ZA1OD.K?0I*OG-#05MB6"J06(X HR
M5B(?B_809T+\^*P:^'[Q9\S6;+7M Z^RB-213(7U$CHPF P.'&Z^<'[[*^'H
ME1H/C?K^[[5C'O2D.)& O?[G^[>/'Y]^N/GOKP">[1R$16L?"^-V/(G$;7*I
M V2D@#MKV8; ,W8B>T 70W5TJZ)!-5:Q*:>#Y;0?'H= "=!QW>P9=&)Z78(&
M.>1)[BPQ]/-#4S.Q\-)9(O+S\^;B4"+,WESB8EC4<QD)^^7AE*+\N?)TUH6
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MF2\_R,+*/N^AG5#G[9*WMQ0A7]^]+W8UO0_X*Q""U^8#=FHK,YAM+74S\4_
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M'3+/P>OS\/ .B2AYD7*=GW."R2%WB[HY*TW02$;*94 9ULV Z(/#4PPY-J#
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MDTV=(!+5*:1>=44LQ=X[#:HKX,.:$)A"\;H^S[^G3KS\QA'JPWJ9*J,NUA@
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M.#C*6PLP2IKF&([JO<=16-K6]HFCP)?1=![D"X9>M/RV06INRBVJ7(-9,CA
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MLDZ<Q%+UV4ZB/-I1\D:YNY?9SK9\)G,?I#]&.+@RSU'$<%0FS57^[C+C^KC
M^OK0)@<XRIKV#6*)+0#0:^8J!K@\II#'.U""(1L\$!YLZL%IVHF;N'55$Y.E
MJC+6U 0I#D?CCKJHY:A)6J.Y Y0?M0%^M #YT(]E,7$Y_DCP)-C=W,$FV"9
M5^\>Y2KI#U582$GTAP;+XWK1 ?B=-*Q4F!PW7?,RH! !0C!:3[IWBJAS5'JO
MWHM2TUP5 XS!?Z#E>Q #R*,_RJC/OOR=>&0Q"?SZ"?"5&L>][-C&D-L@QOHW
MO&!X&0:M-YV/"5Q5'R7+KIPJHR:HT;(@.4&OAYJX?<-7S;8N<3RI_EK*3>"E
M0-BY'F]8XTPP1NB$-'Y:DT+?&)!R%N(/Q=/5T>SD=46A!0C8V**H="=C?%QX
M4X>T'Z4YD,P.O! Q]>2VZ&=H#UD;6B\GVJ*P!J@!Z9$]-/UXJ&<0/[I:.R&W
M%IA15NRW!;A6 CTL KX[O'?:(KJ.QF@CT0K:THQOV_S1$LAB2@4^"TM;R_-B
M3G=*H+B^$CIU3!7,G\7\KKFQ5*S.4<X.-Z/27.!S2UH"GA..K#QK_A[SFS">
ML2[&J42>8VM"L]-D>"<V#;Y?OT:9,&!-B*=(4#*C\;#1QO?55'$R!%*I*=9$
M/SS!'3">^:HJ8WC6+USY<52;F1:)XS8"'E *D3-\J)]2W2NZ#74OBA70_$OO
M*:;.D*D#^C-IP#3!0T?]1GLJM@03J6H'D*^J/3O@8P4\0K=)H;UYE<T:GB8Y
M !NEUT?QXC_6CG;7.!/I(J';XGX>43X;-NU\@Z?.^NJG01K;8O60)Q:$$AJK
M]FSV"\,T%#ZLIMJK1R5H47PEB0$/X2$/(S"1<?F7)="3@+>C^'Y%%0X&.'!?
M'-1BN2%67)VD @FM4/;,"E &2Z&A?A=KU&BH,1(@#/C1[ZZFGH,[B:/;.\)+
MD*Z>QR_IS_0IH/GL;&JG>_+\7L./]\H9L?Z(C2\$3WPS-=DM'T'YMP#K<,9R
M4. 58D);O5<BAZ,RHY+*,7DVJ=7#G&A-1^"^<KOF_$1W4^E&W)O?WYZ4NEXT
MZ9ZEJ:,2UF-=K#-,=6?/=Q_QUR_/J"UMK.EO_%6>=6,=#-TF=RCMP"#JWCIY
MZ#=8R_C8GX]$2)!L3@TN)0J8=U+W@@IG>R3]EG9_9S33T%?UQ0C #2EC311X
M__'WXH9TB0/;?O3OKAP?:BQ>*[JO7M#DJQWNNZ^VA7%U[:W)WF=Y+S@YY_D=
M*5-A']A9UK-1K(">:66W'%Q0[\A'P6MS7:B7P=+:@]4JRJ+:UF,=B2C0,00_
M^#K.5C.J??Q=9-$7XU-/8.FP:T@M8<^ME49Y:W$UW7  /C)PVC\M03*4)A[3
M?LYLG;_*:DX=34-0"FZZ(<@8 IU@'@*Z6.D8'/"DDKP-EK<,1XP=X.?6^EVS
M4<E/WU/^!4KU^T>(GTBH'P!:EYC#ZZ"J7TNC@HP8$-:I\.2:]G_7'5<4BC(\
MLQ=N@7X&U2?;E ;,8DU.#;3=\BFHKDT>=]=U]*UZ_/^W=J/_[3[)0[2.>KQ]
MNSWM^_3ZO<;AZR--7YMH1;^LSZIQ$@&'_^7-3F9YO0^:U.N;L0"OZA\;CV?F
MY >M(\K]9FY\ &#%](&QQU\%9=6,'YO'GBQ?DF3CX ':%@WQY5GN#&M1OR?Q
M#\AC$NF80=8 R(OHS1SJ< O"FR@P*$5S,!>W;M75#<GKA];@"XGLH<9"_N?#
MTQK0,D5 5F>44*W+]9._/S1275+6?^@.I^@GOXS96:.0V1D!NT7?4==TST-'
M9=HY@L768BS>VV?EK\+SAHY?8HXYVVX=ZI1X(V^+\%E_CBWA?7-^TBA -!-@
M[F1V/MUL/Z]^\JB\K5EY:PC6_JH 0UA8ZJT(V7X_]YH(Z"&RA,.\*:0)C!@D
MG8\VJ'&J_5AI 9W@:>.V2RX -2';^X!H"-+;Y\H%5!:?:VL%=/IFHHM^=CWB
M_^K,^@Z*$_-MSSXV/;BC:)+?'YRWJ8UE.(R9,^[(<XJW!J?1$S#7<*+E_W"
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MEY?[9-+COZG:B!X"9&SV#W1D<J(EK-%,C]4CN^ -K0+N%Y.2+/+%7BFB[4
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M!(M/8"Z<_Q'9J:Q/>N!R4%5^<Q85QI:RGUYJ8O'N_5 _A^/?/U6R.J+YO\(
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M^>3QC3&%MFVHL?//'UF\+D1X1E49%;/GKC<4_'CV07AF9_DLKTENXRWA9A@
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MTK<+38 V,1D@.0S]AO#L.<*0@O\U08BJO0^3]W/KTW:MB9PDU^]EKA72%!*
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M2W"ZC$Y97LR[%2O>6*(G,PYE&!_=HZ F+K&Q>,[Z1#!R0!KGLPS.T[EBQ5+
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M3)JM0*A*3[5FX#*DX(J4L/90@3HCMX.2@?8FU.-P4 +"I6JG?R-DT.:(BYF
MM',VT+8;LNC2OVJEKRK.KBQN*%V3AY,=:+[9;^_SZD<Y!'V6&^S/P8!%P4)8
M?CS(9(K+;"R)Q[$]I**SF4MRT9RY9_Z]*<NIU;:9S9J:[IF9;-*:SM_4&9R&
M*W*?-="L%2KCQ685>YEJY/TFN4_*XY6M#:_!1QPXE6N\ >[99^D@R- &TH-H
MV8_W.M:1+W@%9N=&QM@J[G25]TE5OLCE?[9>GK# ?[N@XO:F\62CP/]VPLD"
MP5A^=M+HBT:!=,[*B:.*%#N.9-G*Y[D5K]B$+6*$+0C(MU)CWTQ,\NR$\R(J
M\^(J?7F%EW@A:7"3CEQ@(%>X7.!^?D3*\D^3MR;(4K<B<QRJI&*L)JZRTFWT
M5:AI7)-)LHWIMN[XZ;7*)5W3VB03!M+]Y^TF_WT?Z9,"V$<O1> F.C,[HOW!
M#2(*?MC'7O&LX+>LMZQF&@C^G6M7UF@K_"9]+D+AL4SZ1=I*&20I[=V*65ML
M#AQ@.]?7GD;$:9L!R-&GC^^B.\K+_.'@Q?&7A6@-IB$CI@CZL8BR<(.)HF<=
MP;,7]LLA/+LI,]?1"030AK[VK6SM2I?%NPJ+*/8T^66+93=Q @%@/D09NM2L
M+5BL;5JL"J M1=/>14ROX,!WFQ81BN!R4I)\PU02,$W7P_BN*_43_/+;A>EW
M."""B/AD#B$0(+$]M1&F\>D!=SEB9MQZL[EFX2P$B!J8&+PQXYJ0]'=H^L^?
M:9N.5 B39%3>@YVF*4@R/';V\DG<Y2MAV)^95O06D/S)F;^3,TR+EYF9ZN1#
M8&H-%H%$*U@,R@%O[8!/1=+<+R.YYN279WBV9H/G9_YJC3'6SOW;O)S:*Z$:
M OLD._,-/O-9 .TF.R5F:-,(R97O2;6]WIAZ,3=DO4BJT(:A)DW*7:RRRKRP
MO$5JBK%!<7[87U/6D%%!&Z*PQ=UX.,^K]KK&5IU; !<CTP?W?ZP+FZS(G3__
M:(+90#GXJ<8K(D^;_NN!/7.N.:/#6Q?FQC-3#^=5+6RD?]^7E9E(*0%8**!)
M(1K2]&3OF0[[4:ZB>^=3SL7RTLPP(+72=1(6EVE92[_:*R]0WNGD2\>P#&SW
MMJR*MC@\+MTZ-K(/ZG2M[-)+;&;?0>Y7MSP=M]N_M>B8;.OX7*Z@9_%UF(-C
M9&(9[::LKG=+4_ZC:UN+O(<. ^QRK)!%8XFE,.4692_T8,0PV\_[:!"()J5&
M9SE&-X"?NWKAV*QGC"@T&A4' O0-O:IR*M') +(!*'L]P<'K1$]U1"L6N^[;
M)B2#,:N.8XRI]&E@[NA22O)20BU@+VY_(Q.@3UL*5:0S5$X/)3JAJ2@-=T>N
MHUYT2.IM,NADRYI/1*2L+L7X G&4!<Z;%XS^(ID#<"\F,Z/) )*4>E]Y:<A%
M5G@N54Y?@PD;W]K.:_5:OG.0N[P49 />#IFF0HDNP^";?YVEEI$./LER6JXD
M#@*2A=7A>F)SHW]Z;]##)2_[*[=EGG*]82[)[Z$A9/*P=%LN\NR!#D6D[-[G
M+74F7:N?Y7;R%E\4YOA:N,(8G5\$KDPNNG'RBMB(68R1+DWREX1:96JE@3>I
M #P$O"J3W5J*=@#!+"QS=Q+8JIT;F[9*Y__D[8DS5 ]\LH^^?:B5$I.[\"5M
M(P05'F_#+8 "],$X JH;]_;ZY&0(6C$3!,<W*-?3 7C:V@8AE1X4(\=>B&A3
M9R:Y_RHO0U- 2,-;;5^TX,4/826K&]34J9,6A"?(1(3<CIF"'*:RXY>U$5J%
M8D9!H9,"7:O#BFXC:,>.PK07_.^L.IOR;RW>4'[:?S+\6*X+3HQG(KF-)3NE
MGSDT\2\&&C8_I@E.U5.[KH*N8X6NV^RR4[]DW0SE.R<RU^@]N0Y 'V*\X(&K
MW<>N]=YW!1CS/X8;XL&98@YTSN]LV(ZX@U@]QGS B4Z!VVU+<#6%8"H@[0>&
M2@$,:0 Q"6#' E$-&PJ6',P-P&=\;C0/R$Y&,?  8P8 "X\9G&<2WF#'%&*F
MX ="0I;?)P!1;:!\$4IANH-]QR@#>^5G)TA'!.E&.Y 8S_KUC\K,*)ZCLH#-
MM3;/30@5A!Z"2MD9S&H/-(XV("4HQ&A1G0DH_VBE>6RB"(JYH7L%?J:K[;!!
MRE,F\+3^#P5.!8RRYTE!5/>L#.NUCDE_HK:M'SQ*?H 6D/[-QG#0W'["GF%%
MHS'9V]/H$;&^' (47(Q49.1)Z62TU-3N?"(IY#43AW;PS:?8OUS7:-'A]V)Y
MZO/$_JJGX$8,A]%FFHR]=EO$\%71'Q,>#CO)0F(WG%,38_HBP1$Z$/W[&PA)
MFXHG2#'@09@-([*!XX]MVH$OA/$,62RQ4YN?+>:0>1"9AR2#@]Y.N%#PCWXJ
M':L?*(?F$"3SDD%-(;#R3JY^B[/3JW:9<H[4K<=_*P$T/C4?H4"_#+*34M-^
M[:KGCGS1=OQ)M#-]D[(BQP2GYOY>-0,PS,P40#3+,O9YT9%%(QN0%Q+S^943
MG:Q,?%B#,TQ-P?-'YGE:M4?*#V$:[-K+=I AQ()CS(S#_ WO6_E75HW-ZX9,
MPSK-[D]#)?!PZ+",^^)8E%T1L4=OXFIT8K?U;=4;ALH,LV#TW:NIR[B1!:-;
ML"^/OVG\5]>=1F).^=W46AZO\;1WQ$[AT5YG>,I%[PC\TTB>2XG='QZA6U*Z
M][Y=Q&1\^J 9?/YZMPMR?V_X0.DAXU\3NCY8'DUJDTEM/V6TC(F"RD>7T[6Y
MHY=!.DKNT[L9'&3+)PZ+1_3Q1I+KLU.78#QY2"=B/@@PS@(!B6D!(7G3@&.:
M(GB3"&$>982-HH3:B]2X6G](-J%Y?$O"S-FO!<VW@6S$JI0T0%C]JRJBE)F&
M3G6E.YJ1R&7F0=W$^KU\"Z!#;!#Q ,;Z%;P!5#EB5)T.5C0%M_\Z(MKV=ZT"
MZT7Z"WZ?@ZEAE&56"SR&\_788##E;=,=M4[9\S V0<V#HG%7F!L=/8]KU/27
M.&Y9P6=!3Q(U'+1U;>Q!V.>P$3COB7=/@V9+OTMP?] G2SFJ@1SUO.CZ!S^U
MSSR\EHE?A8V_&XP4,9%12X5H OB*'51%CZ*^>3!N+(,5,+!-%U0(0CM04M=7
M0_*<KNU2W,<XOWE]O.%KOCNY[]RQ[<VLEAJ 5K[/O<>>ZD2@YH:?K=3]W T^
MZ^#?_#"3;Q2MC?& @_;GLBRO'RE7 Q-'C*]H@6GR>Q'-=;FL%/!H^#U7?,C$
M&)J_/Q4\>9X1D^JSD)*^P\V-#3#,*?M/Z8NB&1N#3_*F+!HUY!C7/+V\R<V6
MG^TZ%!WW]QG'S<XT:I&H]KL''GN5W&E'<I>3NXWT+U%2GP7%E\C/R+H^GO G
M4.T>,RQ%OPMI>]9^@\OQL#=ZP&XI]%,1Y^W48W/;->\O%UO--X(I2/BP0N%/
MZ\N NJF=JD/@M,_I?=0MCO4K?>:9_"SQ%?%@1,F1U@TT3^B-=)+O+^^2BUF6
M<[^J.'A"/QH"(I[@]1U;-'9[L.4G#@&6'VP(O+0%I%',I-0"19!I%IPFXN;"
M;A6--Z,/N8.,'\MKITW)O41]GS^\_A2%1$-0T?+ 3H?+ O4L!AU$C$\5>AOY
MGR],+94._9G__M'3M4.* <#@A!))26/EB=\_H4V2[Y<E"4E'U(.1):GA3ENZ
M0DY(?Q#O!T;B3^0I@>DACBNTY9AZN>=%YB5"Y@A',*3AXYO3C=L-[G9F+F--
MWJAEU!B\F.+[96"HI>$>:JO^:?URD8K9CYH@\&%11B*-E21%>ZJ5#D==E+P*
MWJ0PMCQI5IB"I00!T0VWQVI",:;?!!*_,J/0 /0J&CY;1:; 3Z4S87A6$8,$
M$E:1A.H']8&;.%$M_UFR1IJH<9[LM6/Q\0)IQX[ W6.)R9(+5^>;KGW;,@+X
MC1052=1/,^EHIQ "L4WO*=,Z^[^^5#PL$0WH0<'9+$.ZVYRB9[BR(_)()JL8
M8QL1 H,C!6BF3D12")#*8"-\P2)DX^HTG ?'F!9RSC^!]SR] [[-4PAX< G2
MEF"5 $N*%C[/($"&P"XEW10-P8(LU<:]Z1SZRQ3H *5,J#%O"P38AY (M<-O
M]$<)EZ*N"58DLO;_L$A#!C T69$-9G)1#-?5SH?IQT-X!I&MP7]O13ZXJ"$
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M&>D%"WPU@A5 Q0T:*^9#0YB*&]-_6-_EAQC?G'4N!>URR>\<<]U_\\YI-;C
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M-A,B[*%U8U$H\% $<A /P5&$H<>M+QAS)#%PCT =42HT(^06@>W:LM0F#T;
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M.'L05=MJ4SY:S)T%=BPIK@E&[N$:7"3#U^&E]TNA(B &2P ?WF$H+JH$SL$
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M5WBIPV%#.P)P@E 6+&5BC_39*"5-1,HSP@0]6DAFF6:>B2:#XXW 3P)$+H?
M ')>4((%U<0W C<0=.%0!!R  P%#FG$@IYP((# !!-FI X$'!:0$EV<,J=,!
MAI]!,!2"\5E  E>NP<84!YPB<,X "&Q0  L<*&H04Q,0MQ $$K P@#H5E.#!
M/!JB2NA11_GS&((J(0 9_Z0&5=#-" I(R< 7ZA5IW&OPR9>?0P8PP(T'!57
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M+.4$"AA. M?&@->P,=84K[C%+X[QC&L\9!L>$05\=11Y4  23#S; -QQ#@8
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MKNG)*)=<,,2PA$5!6'B/.WD(#;?K/ZM!0%9)5D8>.?/6&_3J)ST'7[R^V]!
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MZ\_JN[*BJ:=\G0^/4)6@.%>_KC<;QS/A/"9O?C[IAHCHKK"O&U.DN4]X"S+
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M1X<TB+24"-((@LG_][_GGGON[GWOC<_GGGONU3>\IJKF.@;) 04" /HG% 0
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M\)GI[3TSVESN'3V+W!SM71[=7":UU&X>;-:2RL\N',[.+@B1A,W-@]'E&20
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MVIP[Z0FZA4_CV0,KR#$*@GG%H30&GI\!1O&3IW&TI3 ;$!J@K$8A^;8$ ?3
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MP0)ZKD*=(/M*U_#%\W8O2[7"%VUJKVYF"#-,[]&LQFOX/_GBIB99UZJ@O-
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M?4]&MW,TPV/6/+7?TN4&#15=?X%ZO&C'!WRDS^2?'UB-F!,$MW"5Z3DS&^C
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M(4><_<N^B&05QW7%(:QJ)YE%1JA!OYB$D0*@3JICDQR; CD_>W*1*X/M\(]
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MNO0L[$TV,]2[P]/_[61V#UPCI&N(;AC%X!JR5O_C0J7=\RJWD5 _-,]O'#]
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M59&3.HC,L#^T\C"8\7V71/H)A=^ZQE#3/64PP^IJXA=NCC.[QF9GXOC*4W,
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M&U6LS7;W4)UL*K#"-)2,2U!>#0 Q%H8#D' YH.-41$4V8DR1IU_\Q7IS%*/
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MPLC,D-)/SNW>G;@WI;#4U(VZQ")4J[+LYL<F#4:N7TWR+0B.E#^X9,5/\B:
M+T\=XH'7LMQ'XR[I\MM#V*B8)@I+#N(N+PBV3U/PM)5D57[P'!:8E#)KW_]G
MEJ$IR=P[=M2?URZS*@L<?BW?]>(S?-A<.>*8G#3!G19P08E]_>),N!QCKV2S
M1O+I=GW:'4)5:&Q86P;WAI?@F,#KJ/D95OF!D>FEUU?I2^H\.K\,6Z/,R;.^
MO0#_CKQ=5KCGF=_B+[(-^LES@-BU9E[I5@;-I[)PS%8PY6>==NOT: 0]/I?S
MG*HW8]N+;N F$05 !JB-M$'+/JX8VX9*?L6H5\6D[[QC71'ZP'A:S-?XJ7P
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MMMKY'^0+T>_=3'&STE:Z&8*[5GQ>@.'_3N 55%:9L>%B&^>1#6DT3G$!2[F
M&^Y@PWE 44@*7Z(8OX9F.)T,U(+21_2DIL7T(W/X"G- A%2D'UML!:/$10?.
M6'_3.*QO#:O)DZOL=--OP_])$C\]+"<2;ZP:HT!T.3;4"O[P'=K.X5-MA'H4
MI[?=TW7RT[AL3H%H6D(;1:=%@4YA><0R8$?@DPW,HYJ1F&*2_"P5J60*HYH*
MXPH6+NVG,I9.EU5"'[.@[ES(V X]S*7 W\,&-2M>TYE\)2E[@ 6.YMEKZ8K8
M^HED$YT.(PM2D=(42T!J64J4('1\ " A<XO6+&#]?"Z-F"P)Z:M)XE)$--(%
MW(:QCK=,Q;")H9&I)2..H?*Z4PD!F[4B6&XR9OI:/3[MK9>BR#>\A#!H,^)D
MZ*ZR/QW:O@-U2 "[TV&C!B93W\4\K%U.RE\UP*:9Z!V8K"]&[P;NME$M !2#
M8++]]8!_V^6.0Z*UN_EN>F:KHH"I$HZTE!?&@FX':#VS@+L3$ -<@<[Y:QKG
MDOYYB?R'.^Y36803Q1W'6Y,C;G!]'?KJQ!(J$Q>H3RK;H8 CDR#0)@3B\47'
M"X$X'/9L,4RKY.QTL% )IHU9PC\=7&*@(H\!CMD2ZD.38OUSA2.(F"J(UV"L
MWH]+EE5%CAI:Z&"M4&%076?9HY_X6V"B'4?H5ZO$5JU 68/'DG@ME5L>S0VX
MIR3TTD9.1N/2YPNQ3Q;44@PX\E&9K7RR=Q/!5J$^?M,%XYZACXI4U (4E#M<
MY:<559CX=HT+Z(@;[@"JIO_8I^=AAW+*#N?HWQVUF="//(D [%A0_Z5S)2Z7
MYMU%?E<Z"C<U[O_3$!/# $(+RC)A581!(HJ3\X-953"D]]("+5F*D6&6:)+0
MLH;8=+@PTPVV2<"6N0<8IAT+6](FS,:([5HO[J@/-T%'PS+6&M,>1(G++H$&
MZ'S]3#C-4L IRKIB*;5BQW*T$DH!*L8(141,Y.?*?")-D$A#[ZX(3BL;!3*-
M=,B7R\8PKPP"ZN$H;S%'](YV8P.N]UV+)#S'WU8TB<^, *1K:.&X=-@(1NGR
M2[P%G6])V62W"EAE'L3,N2I\%WX^H.&7> !FZ'?+$-Q>6ZY?CS]3(^NI(1Y6
MXQAHUZ)Q$_>E%;.% 9ZS*V^7BDKEH%6'^:; @,HFQO@59G^N3T9$'.";.0!C
MM=J,1Y8J12J6I#+8U5,UY_1%B\HBDPIB8E5YX&@ZW!^X=\SH]O/OE_G]-/<(
M1EP"XI>M0,L._"#1>0VAXG[8(XX%7<,>V%*2=RJRE*R!MKD9E0 HCJ]%QN:U
M* U-E;N.7JGGAAO!KWU$)T/<2K[CSSRC7.Y*F'B&Y_^!I+3R&4Y%\$) #Z H
M(Q:TDF,_F>H?F]N.AC^45U LDQ2&><*QO'L7O1RIWVH#.X,T^;O/].KQ]5&4
M9DSZQR]?G@F63\-KM"ESL&*3Z8<H.8"<;NYO11QA6!9-OV 8=L4A'[S-%]YE
M<=UNN0T@\,4.4^\<IGSL8.YCSA8,<X3T:_!HNH [D$73%/DHSW>YXX9:NIPC
M2*XG'X]6ZCII2Z0]3':>LVZS 8=%'!NFFCR_FY90CQN'UQ/BQ:$JDJWK6"10
M7IR,-V1!@^N@QCQ)4S;^>UGY8UY+B%*?W4);_3K)WU!I58346%A\QQ",9@E0
MZ (59E9?P94UL](DJ6[;C%)$+P#BL$I+-,,K[XJ!A$!3(+- Z:5@::RO=)3+
M(TT4\.(/X;,>;HXC-$/O]TH%JW!/#UWT4*;# KD!]8'%8G'$A^L12C17[]Q+
M^Y%*B:G#=A$"]\>IP?E(;KJUW4YZ5' MA3!</W-M0SQJR24,V5R< "+M?T\3
M75I&>JK$6RUPI0L:Q<P?&"O0OOO98\#@38[0%@S_Y1?_&*&KI-KAIXO':.-#
M@V3\")RXM]01L#-^S%[(62OFJIZ?N_M 3>!#-*?\B X62!:Y]8UJY_#D>"3G
MN9F71A<(TRA\&R6)7,$O<0CI1>CL.+_Z;X93RGS]/ C-_6PT"]R3=NQN!YBR
MPV_U@/HO#D=ZS]4#FQNW%AY.EX?-4N,N/_S9:_NSI/D;H:A]F?1#RN1D:..O
M#+G6>F@ S1%G:*LJ@MMHQ6*X^60 ==/F1#O&L5?9\H>/WER4\&S'TY?/I34O
MIASI[8WYRL6?4]*%(EL)B'Z"40LSG\D"[[-]4#=V3H\D&^PF0+^2P2_U#HCR
M*)@EP3=<: LP^P8CA*$WREZ8<)MU?5DD(LD#G>.>=.<*?FYCDHX\.:DF:3!=
MG(^SY"D=.U3#F; O.?=]\,)KS,5,L?7+V%!L9Q2%S__/O6L[ZE1?9),2?V$K
MGV4E'Y=3SF@U?19X]<AF1<IOX8=WGT^L#QLT2_#)R$??AT1SFE4Q!]#_IOQ9
MX-O!<D[W:Z_FZY)H? \OC1*CSB9H:&[0B<%[G3Y%?!4<L/X/A@L^CAD 0N[H
MK$P!\(@C@CM <R[F@T3,O>$ --QHQE# 'V/QXO>M^:+F$AY57MSJ92Z8X?O&
M\=_+KU^T;VV0]J=^QQ;+3PW_E<C..R\R VSZ"E);(14[Z>>JK,,%ERHU-/.'
MTJ_4,<1RFO+T"<.:DZ?88N]J\CK2#E7&B78;SZ_MTKT^9!;2\4C/&V/TK(OV
MAGUP.7Q!T7^:2M^X%W1C*/XCF#':R+@[D"S=T^)_\5N?PWO!KC\/E PO)]%[
MP<\2.O%U6E0CVY:?\=XI#Y^OO^JH%9B-/Q]BHZ>'.R[:"K(!0)]BH)#6-V=_
M7U!SM_O5)RM+$_C%:RF;'AF5E'V6YTM(-_"2:%P,TR)J0 ?XYM+=SDX98VE)
M(4^F Z) R%],.),.FX%D*$LOI:)%507/XM8-9CR9'A-5I#9,=OW=?8/('*\,
M#,4P!1&9H^HCZ5\NTF,)CK^"[/PIP]E,M9S.MAF\ARSJB->,"W7,;:Y<$#U"
M^6$ELJ0Q\N?/+8:O-0GS+CD+PR^&&K,5T D(_]_,O?A36,RQN&PS0+*C4V8+
MB)L:M2CQ4(XX3:&]_&/;*/F^*[+&C+SA(7(DVYLB=\*^PW!J2YT$KF1!*X![
M?N/@F0AD"WU X:Y$5#K4D)N1TB5'!HR,=),8EPU904I,08H:'L0^!A\K 1L5
MRIV^O2'6@M/3U%18$AW0U=Q:PB&WRW6-U.!4:3AP\5\[AO+VJ/_'G5?N,/^'
M#OSTOHA?*$-,L9; NC_0\&0!_XQS>_]G3EO+S97LV;J@7$\Z=I6T#+S]T)?F
M)J01=;&T4N"M@:RSH5DUXVJ?[L4 [H7!)\EF]\>/);X;\P Z I"6/,NP5KX$
M /7C :2$=4(^L=]?08K>]VW]=,QE"L_JQ8U%PF,/17"R "I,MFAT4]#W>MN6
M#I3!NK]LA/LT*.OE NB^DWA5E-!YS%NK0^2\Z_I'+$B6(]0_E7JLJ,UL[;YX
MR^^@%#&V. "-8(U<S[%1>7VJM#*O K/<<:CF/O:TGT+P[T'PFNC9*SXFIO.J
M4ZM7?3;&=E!^M ,]"?A@2_B:X\M-TF4]DDI4NSV9LJ.V+I8 DIUCPCWJ!)H>
MF0(L]ZTG'_>SO\J,M7H987JZ5%GGP;)%=# 96F#7(6);":3S8P#\B K&K$1!
MI)"30M 8Z,7(,,X3;)=Y( #@UU;G-7 !:X!(8KWK]'T'ADF;W0Y<F'EO7ZP1
M-%FS<)8-RR2(4("=G&"HPER6"*$I()F@0"(99V!Z Y]FB1]TDJD2D!!)(W/'
M#F/ 82 &IW2.?'CNXZ%V4XL3L^(K:^ S;_*G&N_$VRG*B%7Z"RQ[*OCPV# A
MQ2/S.WX#"?!6Y-1\9 #86,.G88% %P&^* 8TSWA;@,=!\ZR]EP:\X)A,>R8?
M+S9HM?1HU-6[0_$PERH[#F*F\IW'&\2S"MPIN[AB<>5]2C1%ZD];QVQ&N-AL
M%.W\NZ\#"0H_\,00J O<$*H6;IB0& ^;U.HJ.,*"4LSB7"T)DJY!_\"GZR]*
MN?T[<QZ S"+ELVY#?&N(DE*^"C@&O5=<YWP$*Z&NM/1DL@S]8H-2WLPK_FI$
M]\O33;_Q$6J/"^X)1PS.;Z]B:K))2W59ABFQ0C##IJBQQOWY+ZBNC"06"ZW\
M3MA/N0>=P9)F)&U$JK%] R/M2F->;MRJV[$]D>%PWML/YKP!@![/:6MR[+2?
MN4<YZHY79>C,\86P! V_703(+_Q?9@'3GG%?$X;!^GZUV7S 7IO947_!>R4Q
M,T+WA0<ZH?<1] ?VR+=T0ONRW6)L&!/N?+ZZNO'W2]>G$XB!"/HC7:D.9V6%
MK,9I$TH#\'ZD-D9\B]>C6Y5!P6[,JQT@7U*>(RNH5^[T>Y8%V=8^OJUR5X-?
MN]\1*>(Y92:P7E[%A%+(8X%]$#WS]@,<[9/.:AP2T\4JN#XP6R%4:(^><3G<
M\D3R0=V@DV2R4;DC01@D[J].9DYA]&!_)?L@C(F/J4HQJU9W_'(0-1GN.%57
M2.*!5#\$X[ZJ[J_ _'TW)V'?%EG?)5:1^10W 6TW!<@_^5O^( VW\0NK:*UW
M<K3^F)FR1<:K_$4O"[CBSI*=N1G)+,&KH3,_ 5=?(J:4UQ"EW)5?$2B\1+%7
MIR<(GY#I"Y-IS6)!18NKG_;D^ET^[*VQ)I6J>3+UY8B4:)*^VWM=>UVF231^
M<=2-F;%KF>R\\4=RP"YOW#(U'16FUX6A9(7=_*X[+NS<QZ]"W7OL/]M;:MCJ
M:8Y1CO[YTH#L-M/RE>)WA%[2I"6]T!B:)!Y7X<5W,*)VUO[%]@*XMBL+JI-"
M\(<IW(WSK&87>UR]M/UP_;_U.]Z0&]%%<86-K"3',.496W[7OMN;MC$PZ,*^
M-;FUOM85 X&14T(CFD,1R0><L/W>QC7=K2*^(+-&EQC%]B:( 0ON4WGTH;XY
M"8[@1_+8.#.?9_@S%'[&F\-8.[L9W!/M2@W'D'E7Q@[_K_ MZL/VZ7O-:Z!F
MHK.\P9\1Q]*J:LUS6PI#\L1#'X=%OUG2X>T^:2[&_W/3RPK*5Q=&5F(T"Q "
M;('_T>U!S#N ,15P6F/T$/:)/^'^SD;:ST-I2BF<6T'7!]0ZM0)D/L4,?PQ)
MDJ\^.;IT=>^.[$5+Q34CN6Q-5YA&!LBX\$M"%@$$KE>]G0R! (GY9LFI4V9(
MQ][4PYU#6 ]'M.7JR6<?H7&Y%?IT3QEA43QM9!^,T+<YVFQ6Z[YH 9^/C)#.
M516#>M,,/)>G:4KY$_28W"Q@P-],G,C&=1:#@\A-R2>BLG&F;.AA#Z6#3OZ9
M:Z0I0$/ZD[ _IE]CTT5H.L>Z.'AYY'P@Y%8HBY5*)N D/$4<JD:ME3^%(Q-3
M<F@4!\85-*N8\L) ?/T(1J%!:P05:)9@+7M&GF<<8J46.[W1F92B0EPY=WL>
MYQJ7P%'?9;25GA70Z 9[EV @&N%[**$)1TVI$C'1 E!::CC'_*&DK5LWW[W\
M?PKA)JD>6]']9;\!'NA&!,Z^W$T;1P6A_MY\@SG?;OWCW]EJ<9UTNZOW9& -
M-,"15@B9924X[%/Z0=\(AQGFOJ!%O*\ZA0N6$5_!/]9O,48SK5$C!'"0@)G+
MD5LSR2_]S?-&[J#14XX?"?H$E<R&N- ,?[>L^ 3I3[/Z[QA-7DA[T=2C(H;\
MM*W__\]NAIZ6'^9?"S[ZQZ=@%ZM(3'.Q\;G479RQIS"XDB'NNUQQBE@9"V.'
MNKVDEF2I6^GA'HA$QH;E,NO6#_B[N3E]US2 MSHAJ4MO<[3SK%H.<6LJA-4R
M)JWA3:B6 Y] 8^+08>?YPD2/P0%&'!@ ':[RLK#SW5K4?2X2P%Z_X1]3?LWA
M2W6VOFV,+"O1Y[HKIO.JS@7A_SY>F_)ZG*G:AB:EI(@WV7"/^:GNR^>:!,UK
MX[Q2'-Z=Q9- 9&/F=>R0?H\,U=8KAB2D(B. K+]>D;3S.Q_TQ'O$HLZU8X1T
M^)W+FHWDE=33P>;YPH@573*K#^T;Z?S+S+55.3>HC2?_/&':3"HWW:6I,-$X
M_<GNH6WA_B0+6!J?%5,B\N94,D5432J5X"<[N>)X&X$/LLT8L9Y@.)>!0>?>
M69S&8D!'+ZVRF+EI!\0&'&.8M)SNOS\,8-P,Z_S*>"_]1ALL-Z- ]X</(6]
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M1>\^+.$(DFU%-(K-;BZ0]\]TPF4=DGZ!V%#ONOM5&H<MY%Y5"G%>">+%#?!
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MPE6?#\#N&#CT*C()4OEX/<.AZSO1%4WTEOLZ ^\8H,UQQK*'VYN;S6 JHD;
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M(]HO5,) /MY&+^IAO7GS[0@_>"=)QQF=587#/)6# /!5!+R=$: %2HWN68M
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M@&Q\_ZLK-D+YM@=R-T'NFB,=+23,99W-/E[>\A4SD$GBNCI=%Y3:=V+)_((
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M='G?EVYFD/<J0H57)-' @XZK<[-7PZWB]O$$+?EO^@ /F_A.%#>N%NOF6IP
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MQ9C+)U<I49MF\=;44PKVV-[VS_GU]TK4<%6L9K$#)NK]KZ7*(AJ C1Q42@E
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M/OL4336C :HX4,[;R'5NI=(D6I6EFQ8(KR48U56U1\S">H"^$RF23X$W0U"
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M^+71I"8CU)F,C%R#QU;I24]0&D?%<,4RB1C20O^36@'HP0 Q\$ ,8JC',:K
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MS@.=.W*+2D:MUC@FI,["SE3&JFYUXQ;67VMM93QVQCM-5CO&,F#-4)S0_\T
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M&^/"/!!QZF2%-%D2G+JN<\:K(Q&.KAR ,8#$6N'";*A 7HD& P.$)A@AA(4
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M'$K"&YG4JS <,'5G$AUL_-:+Y8DQ)E)]=#P#D:M  ZX/J9C JF$5JU#BT_
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MT1BILC\[JD3^ONO6/0*R<D)F,Y@5FKB(43<L;ZG7FA;+4EW:?Z([;>E8+;%
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MET;XFJ<__'B1K8H(N%(^I=M);9M/OX^E^O)D3T!.T_=.W\-^49IA3U>6=+!
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MGH]>V=2>7K_IZYOL/WJ!*@^\:QQXI!WZ\8=L?S]NO]<M@#63WK[18R,+V4M
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M;61#3,)3\ 'G$-<76+R-W:\Z%/USN6/GY-:Z1J>+^XX--9@]#]X2;W[/WUH
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M"=Y+ 8RY(("YWIM:_0U3<;/_3]WQAB@@.J03J<.5A8 W[,0Y%*YYIOX;?Q_
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M)(HT+E[-+7FW]&[TQ9_D,_%^X!M@D!T _OUR96\]>),3@K5K 2JZM%838F5
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M-Y[_C%[(91=&VS28FWXNAGV"$F0;E X']=X-6Z2G$I2;>F,"X\NV-3L=3(K
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M<KFV)#7;S:^(H[]&TG4TB>;.VHV[=',X#H.KK4=/:8;*6$=H)#9_139!@Z8
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MGO;BI/ZL_)_2RL><<3CC>/3=7<C98'&>5<3K ):<Y?^:<). ^NQCQDY''>2
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M9^2 ](VR)$2"V=?;U.*R;@!]2WTOA<\8NZMT>&*H#NO*IB]=]DH0.V\G(H+
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M=.4(>CY#]YR&!Y#FU!G!@#I= 7U_T;"K)7\)F8V2<;>7_]4=NO'0X4:$6O;
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M<Q93Z%\/G&S^^T$J!/SBOTMS63S_7</[?U0R_/_ZP0O@R3] ^,-3^6C%C!^
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M^#Y!+\ATW8608"9JI_!:DSV!^?@GRX_1J"< L=VE=AQP"M(EO@.J_E'B1P@
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MI#R0&VFPH=3[J6SP\GL22&Y.!D)^!I?*RJBZ?([D!F0\*N5I0Q6$%'M?7YH
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M6P-;3M _3/XZ5!$SBQ>&"+6%Z@<4NCI9RDSEF/./3%Y]T8;IC<3=T5%@GX<
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MW4KFWQ@EZ*/>AO D?9L;L#=E_@5;O_PTFP\^0G];Y],*LZ=B.5XZ,KKN?8>
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MVT#SD-KUHU%R=Y<]/7D5+KZ_$?@X"W!KGSG(J!)F<@72 IGM\&KQ=HM56:"
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M@\]XC]H,KVB]M,?AEV>.<!>U"=DX=X+T#WV=8_*:D7'4;*"0@FG+?2/>NGK
MDA@@T.U!P G[XJ6:6M3K'JA[I-Z>E"B__T>NETO9YK&DY=[ $%4A$>-4^FXE
MK@$@@G8-/8@G^W%VPL='1F?1J9SW?Y"+$P+TN;$+.0JZIS(^O#Y7:A5F$.,0
M?JY[B^"=NEGWQ)00W+7J$HY?KJ$IT_<P$@WW.Z! C*=TCAT0U^B]VTL]I:4&
M2K3+B^L]63^\<CS7_;]G7*DW\6P)VG<+!.(! 6'M.%E]P1"6Q"OX0M'@ORCL
M%D:3KKCK;,I33L\2&+AP<J65]!"Y],Y-DMAT&]"D'=U-,GN$\18SFXX1,%1?
MR!33P9!+-C![EGY\U]D!N2_596D/#S?^T7#-?&VF02ZXNPYU>_[7IT$F=Q(-
MXH! Z!MR#(-CW2AFE..0_9/MFUUM@@A%3'5DS>U<W>6\AC4OP9MKMF[S7.VX
M!JP%L$DSH,LQBIBRK+Z=L[MWQ6[ D3JS/>HQ5#NJHUN[QNVWJNY_S3UKA*@B
M<LQ2N"#OP-'N%^ 8S&QA$^\PFM6I+4C<==B#)J&H[]F$X92'#0'$^!N2M/U9
M_0Y&?)68$/?W-0+LC 5.PL8F:9T\LDY]PH@U/(G^B@=K2T=@!9$I!/2'O G'
M,[?**' 7GZK##4'*)RT__[QUR[S6Q'EDO@4\KCH[WPP778(+TC5]2A=G-"B'
M&\0F5A\V.%1,+=:73U=+/Q3#>;\/U73J=!F_ENA^YCG>)\S3%\*&N;XZWL62
MFI,4"^I]X,SLTG-8!TQ2.\+%JJNNRG=4N/![1_TG>94#R=U<G]<UN4"*Y\:4
M09#=U/X&ACJ A1%+.=_XA8NO3QJ8G$2>HT92^#.P(O.(EN#B,Q&(XQK%'/ O
M=RL&N]4X ^'B=$'&$\.#Z.[<O;#95(R4X6&?,!U'K]B&L'(?M)RN6=VR,++^
M)]XGWQ46\FBY_(.$WM79#48018DNK$0]0X'':7]@.+5(O>IKL")J$L$BP+[)
M#O%^),)Q.$8^NZ=<_;#8H%Y#8$/<E4]9YX7,TV!?7 LI=;-VK583N@3/$O*5
M.7A4V<8.B ]Q5,UNPF7D&Z<;9[+IS#$LW]OZTBZUFUCI_,ICE=$@PWTL%S("
M0&T %HMPB#/N&G(@SW*^&_8S/.&,)&[)2>I,^,>IK<QG6*W(00XJ23\A':#
M7PY_Q^R#N:5$X_<V8"(H$::6F'99+=S %;/,3EEMBO9,58E14<%6HAO?Z.63
MT?P[(#V%Z^>3V;L;.Q<WS$&J4%NR2?3&4MLK1([ P*H_SWVMZ07*QV_[8X)5
M3I2;*[//ITP$MS0)]#7IT(7]A%NS_)YF=AWCMBQ_&+BZ9SJ.TUMR/FN;DZ9G
MM0/*E<"L]F$%_[2(!HK]^Y\+_OZRY-4++DQ5]0YHBQ++9/# _OXR*^$WY#?D
M-^0WY#?D?PUI!V(I"()7*RO$B2 6MR=QMH7:*[@@ZJMU4I_=D70X8]C:Y )T
ML_Q)[]\2O*FL^QV'RBPV'6],/#B)O&(:9CF-B[QU(RXEQ'-NM/#.4[39,\^*
M,7W]Q?!.=6SV.&K\N^?)'Y9_= *?SZMLF9O!TJ;IJ2NYU9PD.$V5V:-#7:='
M N4O@""+=KR/5Q!?W96B6R[J1+OT3'GIZ%E9+?@3#-E^!P0<P=[%>$/X'=!?
MX96Y\??G[_NG:M =L"U>ZCAJ3$R]GH*#]0'CEYQ!)I\G16XE?2!@)Z3GBI-A
M/E8/F7+ .(7W<L;<Y=$-20V>;I7K?F*!HO5>+P.+AJS'E,OP]UP/5I%S.S!\
MR.)+9%(M-J (>/!I,5*1"CDF/91\._3^*)#>?,3DEB7F#'GT@4.HT1%[^OGG
MCF3GJ7IE%2<+5=>%Y<F:C4K8<V1VQX$>PR1G'+_$0)YNSY?2["26(DM#W$XG
M%8YODUCQ*2N<BK[50;9JUF0.[X D&TX5=,PHL^+UA "KAECUESZ5?%LO(1^.
MSW$.N[62749P9W!_'Z<GH'V@9AE0/BYW?6I)LEWR^07_P[2!\=L)"Z+?<#(S
M9<P''X]=$-___3;YA,=*A^]V]\;C=4QTI>,AR#()QD1=WP'ASJ;\_651?D/,
MN!SSZ^ .:+X30ONE_/>71WR5]_Q'H+O_Q1"V5">GTV;1TP(YA0)\@S]_;WW_
M:UNI[W9GZ@N?@26IE1(_#Y\]*SF+*R'))T:'G\:!(A'SN0]SR;980&FS!:HS
MZ<K(^U5^@ZH6=9U@%&D]'FN#]Y<Z#%NM7^\(G:V<ZCJ6JRCT\#5LI0/7?>#$
M5*]&S_7>Q'(I!&W FC[^*U)T*XKRF+G?G!Q2G.U&9J<&#@4\B3XTU.!24EA9
MLFS9B'MBCYFTT5X;;<<!:IMTD9@Y9C%+GN'OH4*;9,6QM3+RS8X2R5X&T:8S
M?IV8Z4=V4]^98A17[6#;>]Y=#=]J?Z5HT991LF[$.NYKN>J2GZH_G(5B'(*P
M]?,K*8GZ/K.K;-YKR,0N0[7!XRZ&T(VZB1IZ:%_Q\#<YDWGX<?IN OH^3(M!
MT_ZM6ARY'D90:4R$_33D?QO!FM4KO6N3N30:/)TIS'J;+TM?6,,023=@HD@6
M#24J^FSY!1,-RT:^OK::Z9C;6@;#TZ5'FC( 799>G !>+WUJ8KS >"])'SWJ
M.:@O5]C8=G2%XTM7AL@.:%(,:\>PFG7.=A[5FD^C'2=MZ@7C& IKF%$-@Z^_
M/@4UF>)J;'= =W"'=D #31ZXASARD&>>4K8;S9#YI:]C].,0W>VU>&^17WGM
M'','E+65THDC7UT%5.9)UF6Z]^AR%-5V@<9>06\X_Z_@ .7N3E'2'U.Y%]VU
MMV/( 4RNIRS" H!SWUU<Z"KO*2'+]AVK#T-TZ_DWHF$:[$ G8@''@3(@@]O\
M9%!ZY*46*>.HXB(=^Y_U-VW?/+S=>OXUKA"R%,#F7N\1[E6=1K-1WRQ=QS&4
MOD$6,7&2,^\K?):)S"^JI/&U-2@N^P=:#,6:H-$P3(L%S)OAQ!1*$4?I?^C_
M0MCGAR#*UGS[W,5X-]8=O-4%MT:Q)%S,S5_(AM+5"4YJZKMGE'F?'/# R$&#
MP.#@#[#-;W:+EJ(_/&55*+::09?^\.ZJ/H0-< A&BQDX?VA-%FYIND-)]PE[
M]AR[( OOG)_K(K$>=!\=Y4[.3)B$,Q)_6(DB[Q"/=\:4^Y*=%FV#KNV3O=GD
MK&5LJB8==/3K=+%T\BI=^ .3RX:2>Q9H*T#=8+PI^\40-R>3?H6-Y(C4#AUJ
M>(]['Q_3J8ATR#<]Q^')-IWK/Z6L5[KQ.J$3K11H<Z%\MO#$8ME\ 'HR(,)U
M.CQ@9'-H0E:,G*X_[%; [;V2AYG&1Y9'P(NUZQTG.$2LX3FY^?=%K$]S_"_:
M[XP5_\G-;IW "GNX=BNVHWP9;YN.+AT[,U=NWM:<4;=VAH#EMY]NT,%[&!\Z
M^</HH(565$/5O,^-TOL@NU^2@8$!/OZ;8<$OK<_?_YYAS//JA7N:%8AM!O<D
M-WD"VH;?3_>E>,:0'[>?LR,WYL9A#Y&I10*OWE<Y/#D_*]NAV8MN\!*EZ<8\
M41.3/]H^4FJ5=<OZNY^+\8KSC-D'U9 :TA#]2N=#?SUPYG7O@9(>[D_.W7HG
M'4PR+:=LIK==1W_>F5]FQ7T<4,9+V V,6/GF Y19"!',;R%=R+*'FO*SQE69
M1VY1Y@.C3X_I/>)OOEZI.FBH@6D)@P7L@!)U^0N1$.=^E"1'VW+"9.OVH>Y;
MLV3Q+^^U=%9OCT5JND:R:('%>M%A=&=&-5K3^Q639TB]@=T'<X"I3#G\&2SZ
MML:87T'@8^ /RX/2>XK,5Z?&+EFBEU'RC"<8+_C=-VJP?4QNI%O;S=+JJ07'
MX]9?YXI[C\(U>S]H8@OGG->CU_2'+Q;Q2#RT<"1Y3&8;O\>11DB(!;<?)^3E
MYF[25&X5)^= ^'*RIS>_#QO":>&J,Y\V8?S5*6-S3)X26H#OT:4F!;)XNY5
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M_?.XFIVT/)\Q]VD,\E<CU++O5X^?N/$@H;JJ*NI@=4UMG,*M]@11ZZNW7H-
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MKDN#F)I7^2WC0VSX6'?.O03?$H>+@,W,*@0BK!H6D+N_NM@(;?)@(O&ME[S
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M[2)U,Q]VY<N46]SA8[C2%8+4SS_##5HN3MA/#LX)P[_73F"/%,VKU16\L;A
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MCMX3XE'PUO=^5M+#0??7_?-<'Z/-[Z-SJ29W,<0J6$UR\E@^:76Y=AXC<>^
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MPP;>"@VQ#GIR/$D83S=D \.M2#DV(* #8QG9,0PX ##*R<&H1 1#O9+C-6-
MM"_#LH4E,,P&[.PYPB/R?F<#\L4LE1F.*_]@ \4EPQC*#@Z I4V\8 -=4-8@
M;#U$A9<-=)X88@/II_]FF,,JKFQ [-IV=T;,\(@?'N3BI,V]_C4<'[N()SX>
MJ5Y@/E\/_6@5;+:.,=49PY XB.2#W3+)W,$&2!J^G.]6]& N0R8YDS&YPQ(+
MR)_=#6J0%/^,]C:WVANM)JUX1Z9?XS_+6ZR^3XGKD]-._/\["_#[&^TM8?ZJ
M(,Q?QG#BR\-T3>&)3R#K$050%N")H1; 2"MSE%.96V:.G%$!* P<O(G]&_7\
M_\@ _E?DE\NAO+QAVP_/G6C)IQ4/]YG^J?LYS""6_T6N[YBW,1P3BIM5 RU?
M(I#)Q/S;(=_A"DM4]8EVQ?K<<:,WNYUDT^X]O<YG[3GV3]W_;Z#[O\HO"$-Q
M@8*:AA5-F !+I?#,1Z?:(!\%-Q"@-X>%E[/2Y]_B07O.-*@OJ8@O=C0,*$*&
MW2*4;MY!"R!M61'4:IRD8PRIQ=7#RSU!ALNO7Y /B)#FPOU3[__!]?Z_(K_3
M?XL^6G-_$>MKV/\T]+C4_U/O_]'U_E?Y/>(0XP&6P*#V+P0ATTYI_MLHSFXM
MH<V%)8^A^7-D@*1 69+G,8R 5A>:!!/+XD9F$FDO8LF0!$\)_!.+P(KN'$_P
MVKC+A7%BXF$W@R/Q;Y5Y@4".N/ZI]?_ 6B_@Y,LN8AS0\// !UA"N.G-L8NP
M>W^K=CSM$_/)=I$F;MH%:GOM,Y0P)3)WH?W.:DBD/RGU^->[C5#M@5W:L3V
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M(NI<8)4H9\K>6U3-HZ#UR\ 6"SNR(R=;.CU<UUV?2XAQV-O@\")5^WZZ6N#
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M9Y4XS-\#3II++<I=GW'[TH%\=>+T>TDQ83,5'0?;D2I#9971HZ-CMV7/#W<
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M1ME<&#E.:M*T"4_>P%? P 3^SQ 7AV,Z;R Y!^/:00]&IZ&#*01!T MR7.,
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M5HUW2[.Z#*>4\-R3]Y;RZH*)?B6JC!R;YLN-B2MS%\Z>.1 ^=LA_AFT%NL<
M'/PY[H@2/V.S$RG-'8.*MCKXEGK- A&]&+X)',=B]<;-.$^3C?Z1.[KN+]WW
M6TH4^";;7*$],@5IVV8\1I$[O+.S#3+60GZ$:[+ U:<38BRD%JKQ:2OX73D/
M8DO:\E9;4M:#=W\];*E:<>3B1\-!S$<H#UJ6D<]T'>5J<4<M=D=Q_]!@R?Y
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M2,^6RTZI;*C'.RW>E]I4.AWP2B$[S2767O4.O@)[&SJ3QG3D)&Y#J-)9S$J
M6HR2(_=ZM 04*!$FSU23AD/?M&7:=\I4C>N:_KKAS"SGHR*G;+O)=.<UDBY7
M:(Z!9"9P4C&Z -RYE=Y';,'N 9*(),6BJ4':R_/UT#KO)5ZU%'&4SESJY_&!
M_*2S0HKEU:W?04#<I(E4LBYBB;[;D"!\&L8X:R6(/N8Z8B&#$O9:]59W:C!.
MPTK8 FC6!]^7'?-WB;]?W49U49%$W1DAKM!YNC1S@)-6_U+:.XGJ'\-V(<A8
M'$19T+1>FKK$K?8$;KQ4\_SH8!T66N,< GLJ6R"3I5O[*?H$ML8GC4H&U-;8
MDI/,(OI\'UYR@2M#]U_918)WZ\:U'V'L?I43+IWK<K@3862!_E2=5/[S@SVZ
M:N:33):\)8E'ERVNWK?5UT4 -,I6^EA[/,\-4D'%;#W*]J<JFAQ;WYB?K/)9
MY<KDFJ2J'$^U3KE;,7KVKI#"UC:D8Z=>;P>\4;0+]P0NW7YTIKV(FI:T#3G@
M^M.@C!A_F=X0KS<=D',/BQE86/XQ+J>?H7G[0N_<C>3Z];3E?NK:$P]0DC5$
ML"7*B(C@DMNP>M'N(/4.<NW*]VYAA=QPZN>4LJ7JWE.^0:J-UU?L(?F1:KDQ
M5_O6H"0^YA-.%H&2!:WV;DRUT$:EZ@H#?-2U^.4-1]Y.<WS(_1^>"54&K"OK
M9DOQ=N\KCD%<PS43EE]!H5CB-=BUM>@L[BB\NA?/.LS6_&)VD)&I2SIP3NY.
M"55135ZP+U:[ZE?SA%(P;WG.Q)ZY1NHZSPL;PM*4T40C@^\RIXA F5>4IT0D
ME.BC?)E8SDNDF>/KA5&%[@+E\7<K53=:9K[T,[7J4^P%KKH1Y3^CL(]P=)\T
M0/5&NW$[IP2CAOGZ!2#,P1(W@(T4 2+(7V\VW@M%&&=[D+M(OHY^<F8UGWWU
MOS4E>WT6>]:W[YBM:"':GZY*J!YF2Y<1R8V;:3?B[8!@1AFE=1LBTFI/D__W
M5;M.5\PR3/CGL^87U(.>SZHR9Z6N\YU-?C[X2GD_"DM3*V'!0"#/ UV%%/K$
M "+F\,N3OK1AL8#J%V?"5BRV%@?DA]KX\DUMGB00 TOMI[0V;A+,L/YK\2K,
M3A!L-@ R=R^4,O.L7C>.L!>SCX0VH#<F:D_9^[U;NC?K&/D@2,VKJCN\,EBG
M]5UQ>9[CXR<I'1R15Z([K\DGHD_2!;J'IY"TWB<,:>))IQ9_)'W)N[FAX>L&
ML"HN.^G8)*0GR#-]*.ZJXMVN8*(L?F?;4/X[,+H-87KY("@U.MOC=R7_^37H
MTP@286$&.0JCA.F"2_TE0U&$<R/:Q0#R'5%QM@JKV(K47YB45W%-?^3]_FY1
MUI1;+*B(X.)<A44LW08>E?L@(JW.G4:??[S+YV"FX@4I;YVY'-]#W_:3/VA*
MY(@F0^Q?[<9\(].==K:6;.QR!@Y/]J0)H2\#NM2DEZ;G &SEXM9P\E]SN>_U
ME=^O!97DLMQ7F?=K;HM[I5.[_'[<?21IJE6Y4T_>&[7$/ 1^,&";3&Y# H66
MIL+@\=#=61<9@1'%]4/9;?65WX1LA8?S]_$HSW!^,Y,G!Z%B!$H[J%EMX23=
MN?P J"+8[J6Z$X"@KW4_L4BAX@&;>D0/(ZX:H8P*T\IIK,U4N1:D&=\0'ZQ_
M+NDNU?6(%4>:1B8-4J%L"3RUL5-T-YLW]SR![MQ#2%CW:2@K7ZCQ4/3LY"J\
M1.J^FQ",&FBH)1/]RL0T54["I4B2CY65XEDFW($"_IVUW/44<RMF%?U=;B1-
MYY G61%5']8KZNM+\[8O:Q^_\_PP9T;F<$MSJH8"9A'64LL'50=S@A';@;6+
M^P5+]T*F;4/J^I81#&R7%+Z$K?>>'M=("1(?62Z>_+NKS7X-;?G#X%9-C]2@
MP^'GQE+!^D9?,]7S5Z&D".82)P-[G>/<Z>&_<IE!MJ8?9/06&J;%O6.?&K5"
M!)N=33G4UMLE_.'\(?2?D[I#$^V7\ZFB1#RIDBL41B]BDCGI88I0US&,(OL$
M0Q'7*PH%7&_]&C-\\XZ6.&,_RIW<[=O2G/3PQ_J1F\?Z)'A/MQ1>X!G"$D?A
MPEPH D9W,L&HWFX7''UG9E6,=J"_?7"SY2A.WL>CEY2G8I,EUN;R1)7?DO@-
MA1_-8^\\9BC#["RZ([ /F*/5:<X* 49RI24,K2[QJ8#&!S'!P\$*'D_O.1RR
MZ=;7/&2JS_-(XL?D5W*C0,_P"G*:=ZN/ DNM.AJ6ENAF5+"/;M3VVN=PIVU$
MI5.#S9;TZ<L]Q1>\?(P$Y0/)[XZ?4L*R+###,-%MR!W1**X6,,1X]W&1*P<,
M,DX!92P1/V'$6P#AI.%?Z.&TA_/SQ1=WC]LZHM\R5HMM9S/MH,1M"*6"4*W>
MJ<(*Y_98J'$RVV5N%8@!34A&KU!^FU5GWB77H]R][QLC4VY\^[?WM=UYS/#>
MM3GC.&7;E]%,@97SH)SH!^/R;-JT%.P)019M*1#'EJ0*Z\W8T']E!?)YP>TE
MY'5"E^SZE6Z\S;BZ+_:R381FPB>+PYR76$H+E&YO-=>REEJ@S:F@,#;[G)5Z
M@HH"E"3HN.BP)L>4ED\6/=0JC=7 PC1ATS<Y-->D%6/17_T_SZ1;002NO49;
M?H7=&@9.C+D!OK2%Y%DH*/G]?2.ICD>=?*.]OK[3;A\I/V(F*/RR;_K/M%NR
M7ZUNIW/" UR',W "0<,N3Q=ZR:!U&444D>=S@YRC*@FY\.HFN0A2ML6B6<[[
M#QF/^#\%YWS^<AN>8,'?P'D"&HJ0 ^:BQN[\I2 M:F/?6C24'O<=*#O__%KM
M*/JB;W"085O]I[68V#LZ.@V=7OCGFC5'[2!#+%6V41:S')SNO]#P'<D.7 C&
MTF>(6*% ,.=#N].-6+#]B[M#V\;]:].#S5Q'!1H"))X&*'YUD)FY)? [2.+\
M*6@"C!XYS,X;WJDN=T0NC9N>>.0_2ZB!D?"_6*$%?P3[C[5<XY#SUA+_7P>/
M\.K+LD6[C$6C8]^T+ZJ.O!T1$#QT[$9P07(QKZB+C;4C^).SDUT8Q>J).VA;
MOU?35N4^KTM^LEW+:YTJ-ZT^R#\3Z<A*S'4=-7B)=<RWF0QMB9PQ?:H1'!#!
MVR]1\:!2BU<F4LSUR*L]8<*FSE_K_M6]=.V4S_=\YJ&5A$B([M,.//9Q .6G
MG&Y)B;YXWAHBD5RQ>'Y\O\T>E2B-6Z_VK8F@;#L+1.HS^SHM9,;JR@\_[=<^
M&?3TKDK38K<R!(>I+_J_1W+)."\<5YX05^B[CWMFT, BU+*U27JU>;Y(I/N>
MYNTCO(I63F-_$;*A0ZZ]\OD!7XJ9FV("]A)_72\2!;Y\18J@/+N41,?BTJBZ
M(E<"PA\/"GF?'%)./KX8_HK/$),(T52T!9M'@LT].N4K_U_-73^J3(V/N_!8
M2[CP^25JT&[=3/%6/-M\[./5!U&FB47484' D\AT+ 4<NCPPN7?6997(3K5V
M8B_^7B^'J&Y-Q/ZW"QRLZ.1X]/&@P[BX.GF=D[)E 26)O5\/NF4W^1^$\*?=
MNV_H@^5#J<UWOYDSQ0DL7$"(*=O]]1^;,S[RZBJ/AG>';P/"-1$2M^8TMD:2
M;J^.\T4>R_LVM-]7XM%^Q9!-SUW)J7>=J]3*2@.:O\:07*O+B!&(N['J#4U/
M;J1:FU_.?KPK4JX@$5)"W88(HT(Z']S^/2M)Y^0\OYE\UB. ^63?6><+DA"^
M]<JZ\Z?V+\J%XRJGVU]63%F%(8_PVAT]))+*,ZQI*9 N#$8*Q!5317460I"R
M4ZO?H1#.;2UCBCC'YI9:>]6ZF[V_GCP[(&OJ=CCX9=%HW7]7\H,\LME3X2$=
M;V9.11PH1?E;UHQ5)5<=;'Q?;^?2HE ;=&JW_8^"TG<CIR3,K*C(?:CFGM!A
M*=2]KDL-]JZ7&\<#1T-%3AYSV\5KJO3ZK=="7M#<3']$&5'+?? 7R2!#2T:5
MU-^F9^%*^M2D0$WX[>AL#7'[6I>BY3-6.O)W2&^6.4HU<D9$[.U72/H]T!%E
MGF+["HCHXDJ.';"FM\?ZETYW.^<&7+N=WOU\*?84A%WQ4X+'TVUD(VU_0-:M
M9F9NT$/_>_E'=725W:]G8YL'.N*4NB]8Q+]V*%&+54N[/7&\0CL\Z$[IX3V6
MIP[(\)R-,IGC4]3\^M\>M[I(+XO]6W5AT&L";7PM(K*TUNCE_9";F0ZW/>63
M[W0\5><SM?LL4 +?*:6H?$RS8[^M\H@UY.*75E/024(+<_;TS['^91[Q_E(3
M1F_V77OV,_\V1,]9=;-\ PM&7-=D8W/.8VJ51>_\^6=#Y5[NT\7.80=5<S.>
M\JYDW@\L<+P%>O+; NGA2D_;UY\Q>H/^&CFC]M?W?3EA<_JCL^99TW>V)C<5
M!4L1)X^FT'3T@@YTRSG6<[([5S[4M3[V2[S\^>['CCA9Q1[WUX\T;SW8'4M-
MT3.7[O+0*<7Y[^DVRC$:E+ SSX;PT26:)^)? UD.^58,J0P$UN]NRQWMM:")
M*R6R ON2]UQ+%U6I]WC]2,NY:$':2+#$:R%\U*/;][BGV5Y?*_G=R;$J? C-
MC-^7Q$;?@F.7/ TRP +IKV'YSF*+&/GW3>/:?$+R_Y9'?C4*X'-^W#FW293$
M_#_%)S7E4TR=6YJBUA=[96_6AT>ZWTC0/]US-K-XO?B-<L94QFPI>.^(!R+Q
MM*"CW@>Z'QB6%OJ9\$8Z+(7E:.P.B;/9I60;[/#Z]P/=>(./=7#1 *D&J;M'
MIW2TJR:.%"DE5D#X?N^X\I(Q*1SWIK-A*SO96*QXY-,3,\O.?OEX6\B&7YBK
M0+GFGA^7_AL<=C^<CV%KE2\US&J,FQF6#;^9[KTP?#ZO7PXE,:^9*=9DV4]1
M^EL(3J"+-^.T$O($:6ZV%]ZE-NT3W;7_06*8!,]%JR^AL'T+&;_;Y4>"#%@F
M(3](5V:TSZO9J^]]Q9-I3PDS=)WLF!6L82BT'ZNE8[)%\";=6\4>:$2(<N^Q
MT=AOJ+^&E=80*XN79=^^$[$AOONR9J18!L/[=:6H<21GK0QBWWF7I5FE+V87
M2^U?HW!6M>.!I7WY =C K#/ "5G;7="!=^=/2=:ER-O1N?E2::\67">,TD%[
M!%*N%"4_T"R'B):X@U:/VP1ATL"N7FO/'2F-S%L3J.B8#!D]DV$;5TCTN%C&
M#L!+2OY-R2GS/_KRC7M/,-+LY@E*P;&%0V)1;\NB]E"B+XR<DMRH4C_[I>YW
MZ$/1<XVU=8VG<I@-Z6^#NXM>5Y3SV+ZO!!/EO@^-4:L"]<V/#R=>TE"]=\0O
M3 6T4Y3I);FC\:]1"(?X,_35-,0UOSLM5VMK&J^\3O8WN>0"^9'547G)A5\8
MT3DKPU!MJ 62NG*DUWQ-\OK7 D<O(G4WO[PWE?]V]>OST!6+R*DPC>5KD4EA
M88TO:?PTX12B9T7TXQ=A'1MORE_M]=B&Q+%-:4/'-YPE?AMY9#^-D=4Q%+J4
MIZ;\PT]A?_#&F[HVK7,C!D#=2VG'J,\3_#/\]6^U%(+QKRL>0;8N;;CPFT=T
MM4,93B](L"=U6N8V(]/N5<B5"[?Z!92S[UHJKYMK>K;I.XY+J1+&*"\L]08A
M><J=)\!L]N-N5[5"8L%_1WC\^;$ZCD]GD*[K^[C%"9J^8D]]M^5<]AXBF)2N
MVOK:O"Q=()G'G'3-N"9<5=5ZW302<2O*5ER$%[3BJ0U)0S!X(W+"\V*+&Z29
MU<.[1I[FR:;KV15?K>0C[KIK^>;(J[TDF[1B%/9<O/67T!:$O.F-:61  &^/
MA /GZV7($29O(2@18LUTJ5H!@6PM:HNPGFRIWI 4[F;ZVTRE=\3_2EN5&RZ[
M]!9(Z$G&[:PKIS==&:UWO>I.]<N=N+!8-;[[R'.^=U^'+2^SK:EIPBB"8Y!T
M3X%2]5?MZ6C#TJ);6=UVO\]^4%%9<"M_M2=TQ=AI9/GZZ$;^GJ"@5Z?2/6?.
MB)N,A^X%Y^'4);DU,'W0\L5*4?F6->-!,97*C81Z^_23+RJ#[MI8_E!Z#::/
M_=\7FL/^Q>+?*C^;.:?6J-<M/Y#.R_?.=J!#7._$CZWQ\?.G^"W?+#RXV5@V
M5+QT,E0Z/%?LZ8>&YM@;J9=W,N0^\Q0P>5B5+3#E')-/WLSU$ZZO;[UNHK-"
MVY/Q2F9OA0E$! +:]+_F.H]+^\NR_G+;2OMK0MY=0EV2(PFRXL::GQ\WQUY/
M  =U],'>O$1((<UY+PK>ZQ$PT@H'K>?ZZ:,"Z;9K@)EGO V)DIS\M\>CNKIZ
M3)LV5C=C4K5"/95.W'5-W%!1\M)=R(:DS@[T>(3C'JH>\)GJTB<-S7N:5>\^
MUE^?^R!KTQ.A]R,D3J4)C-2=%+N7U [Z,?I<OO5D70MBR?3I='# ?=Y!B4K.
MA.NN8\Q#);6U=6,KA]Z_KT_=<S!9]5CGXPN&?#R71"!\C_CM04(&SEF,,JCL
M_D<]Y2*NZ/UM2)8[ -V&^/&=WX:,BEE#P#-LN:!MB,8YSKMMR,Y?N,Y9DVM_
M,3M_%):2UY\.D]:XL["-?^:8;<A_V^K_'/_;0X F^I\5DV'_LRJOBP#N?V%@
M-XKH_\H9_^71_W/\[X__GR+>JWL;(H_9Y_&9V0B71A]7J&YR5\F"-^Q[*[)'
MF;!+Z>O8),V_!PH<=%OY2QM^4G"(X92QPP?S'9V]6UKJ]5#9DLGWSJTVR:-,
M5!*W"F3Z[Z%_E5R98R2)O,[.;VR+)(<W--+0.(GY^Q,.3D]KV >ZFXQ#\:ND
MB6GS5>X<4YTKC2="M[0QDB#5BIO9AB05_<<9? \.N MG2VAQ8\E[L51GT!8'
M;-DFNO^U'OOT6BR,7I:V#7F"QV]#+H!GXUU88,SVXQ2Y;<$$CJ#ZYN V)!T6
M0* ^8(MM0U[W4>'L(T$$H)E-X! (E%:"5!TA20[?.3Q%"M)R&@DU[:O+[YET
M/3\[_,997C+B\8WOXI8?]A=7YD),-$5(C/^\%;@&VQ\P9D@S,<#+MV@H@*=.
MA[9%GFD^YD/J_VCF=\-&P>Q.L=X':O9C1<0B8/L8..[[TX16F)SI8>6@@U'+
MBEAYE\A91N?*!)/ES=J/Y8BC3!K?<I;:+"35)>]LW5XA;7+D=MY3![V+LM!8
MVH9(A>)CL WG2(ZK6>^^EY3@DX/>SM7D.G](C[6Z^R8AC[>;E^A2ZB#>L1_F
M!/N?@^8&6NQ!'P"R6-;H\Z,8$?9A^G)>:4N5UWW7G-_A%8^$S#*/4U6L^9^G
M0?C@E[8A73N+0@OA&T>!B]N0O:#P!_*\/#O8LIQ"V4'I??*(*P'^^.ZLV]_K
M1F;:5@%8*C##.NF2*H[Z6.8'>[#D'-MO36YOKF16LQS!D)FDI'&D8'NW(50K
M,'I[1O[SU"1M^#_]6L15D-Z&\(,_*HSHQ $7^[8AW9,#VY W.Z>MRA^"U_DQ
M_'8;XO.!S(W)8OW<AGR$UI'I;9@]VY 17SJ>*V%$9GN'TIWYQP7#$'KV$@ER
M)U2N7GZ:'+5G<<\:/ Y.IQ" (VX<H7:)';H/XZH1 KG2O^728BWD4!&=I.;7
M8"*7+*GZDM)X)-/DO+S AX]FDX/!%M89/\87S':?-(E76T-$-M0W(",)'[;:
MI8;_?%LLN?)+1O;:TPNU$9OXR#7)>L*!/UE<$1/@&LL9H;0?\*4AIT+FC%-;
MH0P]I!A"VD4]MO5:^8SU6\L2(-+EZU 6R=HDRC^+97)HMU5.4-G!*6@-C))/
M:,B-(5 *8=7J76323.=UF;3$.M6'".?8&@/.A4/7VAKF7QSNOJ>9-:@V\;NS
M:1LR(YB-#21/']&'./>(BD$$%[%4H4G$GS0B1A<8VX;L2N40N&9@5*FU\_W>
M3+^"&1WKH@U//U@E?2V8[&HN+=.;7@P\34^?ZE5KT73>OR#(OE@.4WZ8X3]7
MMJ+!F&<6;D.BXV'^H("W9*3U;,$[L&*+LUKT^7BV!G58&K[0@%'E=M0VLWS>
MF-3E'3_97E';\7R@SN.>L9:&Y%8/ \', !19)X=>HR[2!)*.7KP\X9N!-J=6
MR=NU382EV)A(HJ>5JVL2(YM&CWV\D>'KYSC@'4?%#6%)^93)QP1_)'!TGGT@
MB6+;96Y>%2JZ!R74D^>4)=0POWYUI"S%?:;RXTR$?H'[\V?KC@^0R_V, U=
MBT0_PP9@(6SWYQ-,6)22%'2O*WWN)*^V^"(OV?S2HK&()](U>=Y4#V+QG5,
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MHUBRC@P4G5FDEQA!LQE:?S*VZ)(QU\ *R(7/M=K<J,Q<?^-(;6=Q=^.V*_T
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MWB!7,O4R-^HVOF^E,*;WZ5<OU=61C%AA\D[%=7CEO\7WN>O1M%CGV>*<3*[
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M5YL=C8R8O6Y[<8RJU>9SB\L7O=\Y_\VMXK0;82D,,4!UD2UM119CZZ_=A_E
M9[6H:CET[$)F=XV("^ WH,0'Y)7U%7D,'TS3"LZ;ZO^6I4LI/);K0<^]Y)[9
MAG_,NPSR/F]27 <OYTTD;)9@@7_S"?_6GO)U'LIX^^'T@U?EPDY&FT9-X01>
MM*!BK\_LP>PK?'<E4Q@A3MS=.(:Z!R</CY@ED>$KX=$+R'NNY^<]7]7(ICF.
M]-YNS/333@ZO<%[2=]W[K6G'(>]TM;9[T5ZVW0>_O&@CI)N;-&QWIO732T7L
M@/E4A4X[CK;;TNL1GT+,U3Z3_"YPI]OKLXGS\H>RSGLFL0>B2Y/3PO2+KQ6>
M4>Y;SV-+1C%7.85<&6S7=L<D/Q(QL_=)5%S' ?8>^L<79%(20HAM%9'[M[,U
M=EBQ7<+U^*]0VPE;@=0/3I+O#Z0;'^Z#W,'20,>P\P5@2I=E>@$6+$_T8<"*
MJI>LM /HHX9 K3ZQK5_,N?4@KV^N?GB)2CTQD\]W,T[XUAKKW5#PNZ^[7S!D
MN;M9"R &).!K[F']L$085Y"U,"+DCY!6F5 &W*AW1&X-.+9/X86<SQ*NX>!X
M7Y9P7<+)^$6?71;Z>R=]4013KAE[[R2!C,/13V(_3S-1G%(S^VN4M;VNW-%Y
M>892U?.?<FDW1EZY?0F\G<Y.&FW;=0JYYX?:"4G;/\H=]=O9<N@P0"< G(4D
M)_9;*]!&21H32VWZF[;Z=Z/9N?);7;)RLQ=!2*I-LP+W*+E3+?;$)MF*O><7
M%9:*#:&=80IQ7A&N#R,I?FFA[?QZ:6:[X&F_.8%0B:5:^-?!?=FDX%M-YTGK
M[]JJI=\_T.W'&M,7V3*S"XC^H)'40F%.+HR<"Y5$ARW [IL?;Z%O09+,="*I
M<^H7Q4O:KPZ;36.\&[E!YUR4\8UWR@\*C*Q7"X*+Y0]+(PD<  W;4^Z.I3JV
M/7WYBP6=UW/\V_V?ET)M6E:]42&?D507:9='8D.=WKQ78.0,7(-?9V;\%J31
MBD8CCR239-&FE*K3>D0GATDV3CR0/L-?)UB[:)G_T$1%3:'<W!/8]+K]E9<$
M\R, .B,KR8PVKN!D#;BS+ U_1!)V_R@4:G]ZGD&X'REOIU95\M.NW2Y=QXM/
ML#37FC8%;2.,V,Z[B)9[+>#8>S:ILBN!\_R,35H?2U/]+D8.6/3 C\+3&Y"*
M:C7J\<CJ4T9+541.]DY\>N.C@*KOK1G&?#)=CLBAM338FU(:E&&__2.0+7>*
M5+_6\]9QE30 ;109Z!># $:FQ[U:IMDZ?BBJ:7%39]ABLFK;.>8JZGGZ@R,1
M_#\1@-8 [2 +MMTD"70X6>ET*-.8P4Q>R%1 WYI &P>088)+K?=O+AOE5%?Y
M1$;J?!&XD!L0P'?T:;*J@W/CHYO&PK$Q<0MKL_)]QE"\:"UK/_<C3C@"*H,:
MZ.;NKF-8I>3TSAO&2,X3/ZY'4_ INS(^K-KD?YX]/R0<UB?WN,FF]23^&Q2_
MR=ZS/$V&LT%K=(73S#7$]"@I3_V>#=#5;G>C+_^\/.XM=Z%V>>""!,)LE?=%
MLX#@/?GTXL4 NX[V,\P9SB.0E1,1S")XW&7NM"NA$TJ\0Q[HL85RQ;<@J:UZ
M*>.V[5,&R<HY2A&ZC*H5"5N%PN#SE(D++0]4G\)3,+,$O-X (9U$#W3*;/=@
MA:)J++"*RTT/?A#-W\KF^788-#8P+)ZX+=]Z0S'K,I/8=S=]1WO0HN;K8YW\
M$U Z2-UF<YAUP(%*[J"Y.*<0(^MLE,P(6D#<7\$7G(;O$;)YFL=R]51+WRL!
MU3Q^G\>G);@FMQ^F<S^]:0DNS9V&B1L@) $;LE(BW03D?PMZ*6C3J.H1<K+9
M597QB!/Z1.][-K-SMCK%WO$EN7N+UJM*<JT5XM.*+[_#26&[?,PUV<?K !76
M+NZDSH*68(<BRH_YF.Y9017;Y_)1_<V;6IGUA)9<Y\V=R></ZWR2:%@_60T:
M4VF6Q7;#D7H<6]J)@F3O*64^!ZS$T@F^T!0L'XS"9WYT@BU#+*A)V#AF>"=U
M]LXOOBQ3 ?44NV^MKY:*<JU5YJ6$>9A;D)5MJW9@#!N(R(1*P[RV(,E;$,%0
M<T7V5< T.M#,C2([-6Z/;ZYK3?;!$^K:G:E'>U21\N*,LTO?!UHLET%40RZ3
M:=PDT&UA1*6/JP=4+[-%&('OTC_%%7EX.TFP(.A@3AS6GZ 81 *1-+D0RX=6
M-5/Q*Q'2":+B$LT$6@U,2ECG*PUF T"^B:I5Q7@/'54(9BX+&3]6F0=M5C/[
M H"E]W %\QAK]L#=!9VC5BF;Y,7DE88M"$T>(!OG75YR.M*'%+^UW<JXK*Q%
M>PBB\(E_&$J'8XD?]#Y;<45Z #N6G7%7R)W^1B4)P-U0$6Y-GQM^)FFQ8_#H
M^S 5]\&]$C6.1Y)5%Y6-%A75TPCD9LQA((S>0]ZDG6#P,R$,3!;=C7I_7JE^
MHD-E#G@U9)X<57%&OO]GJ33+MB_[W/>C$3_Y\]^TA[6^%\Q9A"? %#MVVVQ!
M=L4M&QU!N] 7W%VX(W\S$J."6X?4G V/6PR%S;2&?JEO*Q?:)_^4+_;D\/7M
M=L\80[02CBN2 ^P,0#*<>K*'S3/I'P2NI;K>+;0.N5X;5-:=\-[?0>'=6_N
MN;1+_$LU-'Z6GQM:#V!0Q&:@%/58IWZ2-#J@Q"/(R%,AQT4NIC"GR$U_P*B\
M;$[@55 0TG",;T9XS$:+=N6 1QZ5\'F\?PLBV0YZ WYM=,A3ZA:D>V^[;$T
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MV!:R&?'S.!6<$.0/F(Y99;R&]! !VBU:.)H(+-&#?+4(!AX)/XVS(@)!^9A
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MIV]FG^7V8_R*U9H9G^0;%!%C"Y?G,+/F'N)VGK\ZU$E;$]C>9KS?8H&SZBO
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ML*^C4UCA,B(P^P"&-/8Q) (?RA";$%LBT)K?M@277&5$I*3EP/)'P/AC]XE
M Q=!Y=// S\2@>!*+&D-)5O8=#V*"$3J1_>I# O 9&EWO7F)P'MU&/8XK'V/
M%FL;'0[9D:@@4*W#L$.@312(";$$M<<Q_WB*-@]SR'?88K_XF !_\N-96RU2
M"Q5]P$EJ\JD=,;:$X&$BT.A+ZJM8,PBLLS,H/'4A$0@X@A#$3<'*((-"W!IX
M:"V-X,]/!*;IB #7GW$OXX=W(8=UL:0&F0>,.P:>\Z;$B;>UP _9C(@ Q1X"
M9Q/]1YL]\ R^9A7;GT@G^F?8X?$<(O!<!1?]Z%\!H/VOK(:#TJ,+] ANH)4]
MDF<WWA"!S9.D)G[M9Q1^,EMW=D=[-VRJ!XDW_?+C(>DT AEH2Q[V X+>WR P
MT0J 07LYK*HC0&,+8\U,Q_VOO-5C*9][DG^!*LVL]L@5GK*4%W6Y%-+\.!0=
MD5@F21D4@-!E2)N,1D73KKK57_ZZ@S=L51**VZTV;IJCJ^)0XF]<;F3P"#0J
MVQP.^6B#ZC]?4 "=JWK7P&MS*=[<'_7<]AT61 2XG1LYB,",AB412*>/C@)M
MJ<C9CQ&X*](.+ZZN;'P?)RCOT1TN?EKNMF]M:ZV7P%?(N1;:B!*!)@5H+3@G
MX-:5BP^SQU(+>DXOYI!Y[*\:5_Q /^TW]&L#P@[4S&S5<"J[PZ!@$1NQ0:Z@
MP I]AJG)WC^)><X/BI.(P+]?P)?_&P4\_L\$_/#/"3CM'PFXOMCHX!LLO^JO
M J+UGQ0M#GVP9_"7AQ;]:J[Y8S9] L>^3CQL_A"2;:XKOE?10 3"]1 LM;0T
M5<=/],]SV]K6/'M]Z=T-;O(HQ3,%\DDH\0-GB(=?PP'IG-0MA'VS@>#I*+P,
M6'=Y[\??76E;D/-^-?]-KLIL<_#!Y<R$ZH*"C3[0G4UI>)2?O-^WT9[ F74-
M9"IMV.3)G>7(VL.@9C_SVCQ55V4YH.#DEQX';W.P6<6$?9:?CH\)$7A=/*MU
M1#U)"KO]HB[7AP/9R1S18=/L^:<2S5<$C:4'S5U240C31:NILMZ6>#.5L(ZH
M#D$A6,'#S'\+/5/:'WH"?_B-9*J_ECB$_WHN73 C(;]E]Y8TY\R?EJ_Y_\^Y
M+?"GZ%#Y26.U?F$*ORKX/^U, O\=$QG0Z,9,K9. 9)C/--A_3>B37V4$J#T,
M,TJ"!K( \R "0^,I^;XZOYBJL(A/A-FL*\VHO+RT"7^Y_M[DKL=$H3#T05[7
M/28+BR^-HZ?:I]?EI7H';R/$84^2B0#R)E:#'8>"'&J(^\69U8=0Z.A:.VNN
M.A\@HS[77M5-S#-0W6K5UJFX-6:K5;DM' 4ZSXQ6"+?9'!.:S/7I*N]35;W!
M0-WS;>7$ _-ZE2KXNPVP=72HOC.SIHVL.!%(=1AMUB<"G'K@0B_)]2Q"31,[
MC'IJ.[C^*7RTTEV@<:CA9IVAC4[</JHP&OU=9D9P@#9YL.D>G.\F4X5 .48K
M)W<9LMD/HD,L6=CCR"M(#+G D*H^MTFPQB V::9((*(2M2'W\7'/?WTHMD'[
M '781O+KJXD6CIH(O%N&_3K_R3^8K[*G1_[+0\MDBH3B1? .,XE"<MB"%P0G
M%M)L?\C"1DJ;ZT0 .P'ZXUJN"V^T?]OY'JS LQ=/,4CZY]1!:@))DA<Q;(1@
MTEX-LC""I,K/BWEF,< L'H$7FV&;#*!53F<BH.@*WI0D6)+JRI]L[/MY,5-K
M9="( >V/9YXI*/^W^YO]-Q/C_F:BQ31H%&E:-E0XC9$*( *:<4V=CNS>W*&@
MV:;-!M=6T>5ET^-\1<]N:S[/UVS[EK40%[4&8K0T\,)\+!:-2^S[4K8ONC-B
MY!2\=MN6LLWT:MFF<) KM1/FX73IG37MSN*+NBK9!OZQ#;WB52?Q77Y)*EMP
M$7PV8BYL=6J#%-/+MURQ431O;,VL^^/[7T.\P7#G.YIWKII SFG-1/#PK,3U
MIHI/C::UR61UED4.U<>< @NZ;1:\H'6:GCN:]J5X\GOZZ'^%'&\ML*]J<?XD
M#^--"9-^<%2>HX2KH9T]L[A?O[4?Y6^$_PV!_E_>4?D])N_Z]'^G\NA_D_2_
M!PEBLQ],&O?CC>._,N?R_V2.U-50<V% A& ]TM\:).;4_D:EWC]76]J/C7_=
MZ->=T_Z\9/Y#&_\;'O_!D'_D<<+/^_Q-JT;_M;&Y)D.[KC6;<G69]7!E2O\%
M*%$V5$]$I?C&-=]-O[C=7O]:$]M9Q.GEP_7$SXIN0>7@!X_4/Z<97^.*HI&"
M]]A)K4.<_;IR"(+U_LO5LT1 G1L>-)-<017\X?3@Q4Z!,4VF+GP(,OGH>MNL
MS>/KKL8S&5WP_&IK^VUYQ6]7XN6!;I_HV8W1&M/:X:L7-QN"D7<C.UH<N;WG
MW]#.-*(55R,L4?WU%4EX#2)0;;M]N9; U/ 8$W>EI]:S"FJ[3CKZVO?E5'H<
M1TS8Y04Y5&C\;,OJXU>WY84)K$HSDO@SD:2SV8T(X.RBL=:TH5,[(I($LC'2
M"5N]K2ZP U\KH/SQU8YCT0V(8;E%0L *;-H>UTO:*O@5EC13B0LVS8$@ FP9
M/Z]6VQ\&_OP)M#T#QIZFW8V6)AV3U6E84DX1)84(.E.!"_:U?0I+:4\Z7Y?^
MU6IPL?3HO^T<0BBVU'I&(N(TY"\GNO^0S>'_8C,#HFL'\1,VX#]ZL-K-EW$D
M0/;K=S2>OR<"!MMIAU2Y1, ?\:> YB-T-/SR/8UI/O!_%LP#/]FXX@T>M9SA
M*&B<&\ZHA1PLBF<JPC!#]P]1\7C^*Z;WG]M,-H&=KLJI);=D%Y-"AI=@.9%&
M7G]-N"62?GFQPDA3IR7.SBSB]0L)M\^+[Z7L9!\=Z:=#($K9W\9-QL$)]L>A
MW%&PH ?T6G,""VG?*CC=PS%MG=:X!3@,ZT\$+@F'2A&!M[YMA' ;G ;XPQF:
MJV4R5SID?5'@?*S^M>:G#WG.F/),0F41MU%+'HA0A%6WZ?>G)I?ZV=@<_!Y>
MYGSRPFOWM$(RWC8)%CDIYL9MRT:YKS<*6LE$42G[D>F+MP[%VN5#0N:DS?+5
M5KDJ207]V"SDD#H-=R*$"(1F$)CM(V%+$K!-5A#A4J67@/ ZNR4.GS#9_J-(
MM70D E05K8@=-C"6FI8(T*G@KDZQDH+_&8D/,3!.V6%'&Y\10=+4YZ-O/WH0
MT7^V/A^AKQ76.^*[]J.X?#<.:UK'P/$G>@GD2D2@6?NGW8SE&6!6L^#%M?J]
M7SJW[V"TFP>*$$CJ@\D^D!IBOI\V*^(,@XQ*]1X<"=>%_*A!9:.Q)O6DBNW]
M"$GQ5C!L&&D^]G?S!4+2T_:B1 E^G1N/?U3(/;-_L/;GV>BEK+_F+*G]^)WY
M7=]_VOZ?F"_Z%\WO^J?F9QRIL! !L,7^IU_(A4$Q ZW7)"#:4=.6WSOMSX.P
M2R?J--#1K1]FA=3$4F[V0<5/,29*7^1NNSRIVCC'?LPKE6PQV\^N:'$Z#?<&
MSTP8@RTEP/6%NAW#&4^J0W/%R@97D#-Y1P8M'<MI>HFS?EPXY7*L=W:CX*NR
MH2&D2", K6H]Q3T]?2;J^2XG=FVU"6;=NYO*?FA,!-:OX&G%F[6H E,,O>';
M\CA=-9W,18Z^SA5(*648G-O<GJ<L#':ZY:099=6S.0)$O8>$W<BLUB$UZ._8
MX;(?IDK<_9Y_U)O@D=@]]2ZE#7>U]_=B!6W6R)&:%L424H;X2LHNC,B^W]3[
MHUT?^6MZ_#.$POX9H3_TK/(;H0D_$VKYCPC-^0\$WW^!L^!2Q[3M/8@W+:E+
M?>I.@MOG]W S_'$_?5IET%]4>_2_Y";D*B/B%WJG?J+7YR=Z5?X!FD7?<%X8
MU_S<^)7)39I\\6H2D%,78>K;>?QM(JW*$[H)DZW%XHAW:3H^U['%E,TG$ON-
M[(M7KKU_E5X^Y]I#Q;_'_02D';$=?7.A_AD^&3;G54,$X*? .T]<=[)7\!J7
M6W1;T%PZ106'SWC4]#*SA'K?P>RC#WAD>/'!Z42@[QRJ<7<_9'V;"'#GW"("
MGP8AAY>\L I5);2S/M$K&S2P.=(19Z^Q<YHOO1:Y>S8];(=4D^&D-Q?>3;-I
MG?>8NE]?43R8]9I#5+/_^-.5Q4[H9[4JK*[.26F.-KGG+D&2VB,N4^W;F,H5
M@_/\#VJ<W-0$RH^X/8,85_JQ5 V3ETR.;2!9U[=://.4<DR794I?%>)LOF=T
M1S]"7F7[.KV[I/S41PNKE(<5;6%=8W6+*3#&>FN]R]!4M]6WZG@NR11S3YB2
MBRO[NF''BYFB,E.5%!6Y)KU\5A$[>NME8?<'ZU"O5$]EVZ5Z:A1.[4RL-2MG
M5EX+R^C60T,UD=P&*1Y%8#HP6DG[H8>MP6!FE8;FE;WE]13SE,?E[M=E)5KT
M (ZLI'F61E[_U+AH[AK.DA;TP&M7QEG;E5*$7RN4L0_65(5YC)  ;X:O0J &
MS=E31PJ0:Q?;S^C;.3AX[AZ_7X #G_$#8003@Y,*LW-SY&L=:Z^9#8^\ZZB>
ML&.Y>8/,RSE&=VUQR(A ]J*$75((+2ZDTY>#$8O=J9&N%G"R/X9]/:9.&$A"
MCA9XV37RCIEV:-,TB=9X&IMS'#J;P,+JR;!)2 76S?*/Y:Q!N,-QNW7+$VF7
M5_7:3T<Y^#T]GGQ6AK/TBBXK0N!K3[:M?PY?DZY^[5J949;[DF<68XWO-.C<
MLI<W9-+#6:_TDS(-ZOZWCAC@+IG@ T!$!9)E002>FL*>DDX._&O8&A&0)%TV
M6V,=VXXUG5,1=FVR7K-E2A'Q2VLY81^T3<]IFHZ*(^QURABT=5PI&+0514;2
M\B#D1& N$LM+:"B''5[DPZ))&K-OG=JCJ"7ICE:E@0@<</F=(FE.*(T0JJX@
M!?O"AJG ^]N#=Y10H[!.1 Q.DU0D"1_!B( =6, J/0Q;<O04?)JDQ(#HQ_AD
M'&^.1^)1<Y'+D9!S\[ ;IUUXQLI=BKJNG(OA_ V^&2#^"S[-&*305*C["523
M3'W2K%;P5^Q]B)H9H7-(S$30:*S$R53ZO 2*PDDDJR;9PG.NGG&YGA%5Z-HM
M8#C(]55\^36_BXG-@HJJT/SMB4O2>F3N18 93?\I]FF0!NRLL0<8#8L00S!C
MC]0PF89QGP(U!P0W>K*N&)_;ZB(=)'D/&IZY]'(=!R8+V63TO*SG[=\=Z-E>
M>;.MKR/YINJ#U=&7,2W__)8VOR?]J^ZV[!))1S+8D'OE [=&BP*S;4;?')L9
M4$+4;\&SE5+>1MN1/6,_IO*A\;B>2A"!>I7S4O'@1A&\%$'];1D%>Y2Z:EQ]
M)./[GN8Q2("^P7D@9Q:B9#,IWR]G/P,5;I&![B/#;27#3K':TS4C=8M= )$U
M>NIY POUN#5*T'7T;B_],H2U]ES^DE*S(6=XOB$VV.2N0#CNFQ'DYHI^E\E\
M^?4O/&KFJZA(GI#T0JB?=[*!WX6>*\Y7\N-,G!4@Z-6B%&_;U>)VS2-1CSQ:
M>NM$ 5-K(=>/#S5AQV/&95OF;]_@_G37^=5M><\6AVIA_UUJ6%/J10Q%29-@
MJ>BSBNM5C[D.OFM+ )5R@<DQC;.\88?O7*%<:'B$PCEDGBW3E@&(>MR )+W\
MA2EGLK) =K^UF.??EA3WBRB;RD>%&TGEMZG0D7[8#H>W?A6BO^C^W7[A>"C&
M:$(@I>!&YUFC"S3' KPP],@F_.NZW2T9!YQR=!RO>S>_E-,1@GF#W6+Y>U9]
MVP784SC]2P4D/N<]Z"P^;1VT&472/2QG]BF^1F+6;=*Q9O+S#JU_=7D5FD.R
MN7]5AB8R'?)%4'M\!94-?.:"?INZV"EQ_GD5^GRR"_P]O-8URQ1[J,5L?=B+
M-)*_CEJ_OI+P2NUR\?FM:K%CND]]YJ^=G"WW,]P2?IEZ;:!695.X*4899GWY
MHVOAS>_>4N_T5./5GEA<OM9UCP,)Q'Y[LBNN$WG^JD51"O[,IO2P<\0;:XT)
MI]<U\UA[%@D$17U^T:(D;P.8 3G;B3C=+OBAJJSLR >U90PMU7AFV2-"EU(E
MU2.:?$@/\MRD;09;]<6JUO7+:3+ENPS?,[%"I;IHB.0Z%:D'5-XP2'5@.+(<
M]5'$4"$-$:'B<!I2XK?>VUPET)46A^L=W;#UN&JVK17'5>06 'JM=;Y51-D)
M<7J@<>H83O>]C2'\Y9IXRM,MZ\(<Z&6TW;.UPD21?*YK]S3>242=;(J?C;+\
MIE-7[5X_J=RFT&VAV6.HJ3(1$.A#6-_P2R286J9Z)$S;%:/QE#I#A:Z^M,UZ
MH^9Y-J?2)P^V#.UXE%2S]*DJZ5H=ORR=XG2&:-KZ72K;[/7'&8!+_5@-OL">
M#%]71&M85E;5T+YZ0-CQ?.3@U!A200X604E<2>;_XN2JD!.\?<;T\>W,8A/.
MJ.'ZQ /K^>5*;67&9M]0_4G0)S#N=8HM :E#!)9"!:8/CY![E$3@]6^?-WC"
M,/4J\Y-<L/8$PE3TBJ\H[V'YH?X\J&7C0(!3C)3 )C8(T5YXXUB\D:_ 5O3,
M/BXNFA7VS6Z?"*C4N2U D-&YFZ8L, 2*"-"N1*F'\<'3P!D!87SO5;Z"3OM=
M,/1(G6JQA4U'4U[O]Y%WS37Z;!43,'#KWE7<XH7OTNP@1V/EU*0\G,M0EJV\
M*-*/I:)_W= V/]^*(BA3>W%#];:3K[S_\O"[38A><?_]-@2TIJ+T2"M(N/#]
M]MRIA8Y6^>(BK^+& Q4Y;]T-?QG]%^+\<C<(EV(UH(:3DY+]0F6=K66?XS7G
M5)^XKCR -L5N/\'K#^JXFI^LJ-O8 HOFAP3K&[&%?3B1+"UMJ%\A,OREM,[;
M3F>HGL)6!H;CVC)<J;Y<]KAP12"K$98U\>Y]%#KT]&>.YU&GY,@C$8IZ.?C4
MW8^X6]7<AALA=ANS#[/JC+RW]+6B!.V]@_DD  .:Q33S:,-A.94/W[#V#?'0
M/*P$5:<6JR'$U C[>%C ZA+YB=N"S?4 6^:2"#/6R:.7TJ/B=FP;@DG,J/!N
M3]-8RZ4]*GDS:\=CX,2UI&0:.B1[N3=-%6/F1^UP#<2[A<?;73-ETH.(AB2L
M^WZA^U+*SF3;Q1G:YX<](6A^'Q7[_*7$O;<5UT<I^XI&YVJ+'.AN-[;/!O:<
MG!Y:31NI:"XGI8$RUOA !82]_=X['UEJ EZ1V<KIS&,' _X><O:C.<N^'0XF
MVB P>9']PK#+%!T/(DQ0^"DK3WOE2R:)VP((P/["N>B;]64#FK.^5\'L)MCR
M3B.LA76.Q%&[Z^W2>!/C$TI;I<=TS2_3( -$OS3P6F4%9Q*$.,KKV^3O<G>;
M9U'V,O):.^'TYC]7:$Z.UH<DC>&8!PH)Y["4S>7,7N*]H:[4>M<P$.,:I!.K
M[JT*NB#D,T&YEM8;M%]:G'FGH^IF;.$,J]2NZ'6F-LWAG(&-3._@\M*R5]?!
ME_5#*QB5R1<ZA<]WN[,*O]R!.J/3D%_8#/N?72T%,^ _[[7:!@4H1VE\<E=A
MX;WR89_3@=$H+?XC%MG"*H]J(@)A$@XKPTX3IAX]1C56]&B6Q1>5"F97_2S:
MI%D8LDX;5Y3'(XJ"OK8]?=4BQ:]@*<E6.14G/3I1/@2+04[YD&$TX>%B0B>^
M&:Q\MG7 I[<>MOKN?6Z6MMP^R<XWA_D:\229>15!MJO)UEA=$2:$4T1/V*L-
ML(I5^5X^R+&PC+EW58(LN5(NIHUK"N4#QG A9?P2-IN:MHT")J5Q\K",21.C
M'I:=Y<O7G[FWJK,7B=QH=?(X414);KB.%9X6;I$@ B]BE5%/TXZNG=\Q0I0*
MVEP-9NDY045_XSR!WGM0AF%M7'>G_LC:N5IZP2RO*<7Z8[U5RU5(U"X[&T*3
MGI"HX)<>)O %K$^J1)[+P_9(;5-L\&;"T:\?],3K+Z2M11,!7FJT\'X18B?>
M!B\(S^A$!.!A[80G& &"REE2@>Y(!/HS?>J.;&!%FR%'%; >UH/X^D1\&1CE
MH80?0RQ2^W1"OM:2VI!+U1 PGC]M41@$^Z(<2@0J8#MO&"K;#.5MAM_E].;;
MZ,5+K' NK#P(X#&/J+FFNUC!K=_?H4[G%/M9I:&)/I?GI$!%L7Z8C'[VRB0+
MUA,M?_^(37=(O%M)^_F+ZNK^83HH^SLD'W6\K/?N'.<!^1L,[0O6MI;[RZP\
M3=@8VFY[B62YV4NS8%?G]D6N,7F!@"B%.,L2=91F_N7:=VMF3F%8BWP=]Q)M
M=^N]B@/C17[;F]O(T>PT7XJXR7>>4$]I;<;:KR)JE^^>&+IP+K8-%58"#L I
M0>F_2 3FMK!)18C%._$)JMX3T<_E)ENY*X/2'[;*EQ2')\KM!C27]^<(2?:]
M'>$*DU\UM#^U6KX_O.>T-/I"/P%X"YT<5N1^?N9U?D0R66Q4',=4\*ZO0J-P
M46G^JBT+P.\L7E, C8D)OD >,S <.L-7PR->-%JH.(TY);%<)]FW]'2/0:\P
M^L5NMT[SQ,A2==!\CE1EP+!*=%2M?U3KA_Y:<)[MI,UR(G3AO5FCHRUY9XET
MJUN4:&#$;F/&6)]:A7CVX1K/BV93_OON\:/V2_>Z.8?ZEOTX(A^CN(9<NJU,
M1XPV;I55'#SRH3^##M:5\2NK<]W,WD!Z(4)B'P[L)G5RJ/?9\9B(=+V<C8GI
M?2WYA-GD^:?I63E]GCMMM'?OBGA]K]VI#_F@PMLR')#,E0,1@L*[ME>DY?2B
MXM"%$./(*<U^>!E#!'JT?V+^M-?T*WXA'W >Q-A8$9H]J25?\RQ1JG B432E
M\M&)!XL1G+LCZ\M"[''#AVN>JU0FF4,2 V,JN6G=/%8VDZ AL<LO7>4E-NY:
M.YDS.\@982)F'1996-H^YC%F\K+&+ 1J*GQLS>+O2^"Y-;#6G![&WXE^,H"=
M7?%+:B1D@_=5MN#7\#G@N7#;OWVTL[P)RXW&]^'RN\#6O0>71HG T3 1.-3F
M@,G/(S8&86V@+L)D+ZFE#".%@!,I!!YNUC%H0[ZV;2[]\H5$_.BZW+EI6P[]
M6X.U*O IC1Q2M_>8RO>M@):S*,VE"$XR%DIN\[0[,39'2,*IH5KPQTDKUC)\
M\ >SXVGF*$/&(QWVN5OW61Y')2_Z3W%UICY6%^>0E82RJ2^#12=S8F>N:.O:
M,W8EJ94F:>1!>%>_3EO!;V/]-Z/VD8=Q;PR94O)MRIV^*3L+=I+?8;H]KOY=
MN:'A-(P5O5-(^0!EJ#S@LEJGG %4EOK/CR7/2K%;4L*SH"IL-^O MBP"GCO2
M&&E382K(RG;@PK(%(L<IB-%GR2O)9)P$@J6);][0F=C&.0GL*[)XB]8'9Z)4
MEVQFL;S-VN-*=H<G/L;>.14E4?)*U#]BFI%$P$Y[8>KE"!=GC84HJVF,2$VD
MQ'IV5TO/Y!N]O33T7O#&@[*AT@E3V21;?EY5Z/HF1@K(OU,@%9[V=K8R;Z^>
M'F5?0+%>'_Y1ZXGB8T>.@DC.$XJRS[G8.7TC+7?S)*V_\&07+FV41?I]"/WL
M& B=TI#-=Q?Q_=@&H(P1U.)Z6%*[=>I>>?4U/+Q]BR*?".32;8A^)TR#KSI&
MR>P5;)/:QH^"D^Q#37#(#HO#=136QCP2J;[WL=1M'=Y5->\QZE/8[Y6YM[1W
M#?:B;[30:+G"/;Y"DFDOMA?ZC"S5:O:I@?]RI7]0;YTN*,NU51N:N3>^G77J
M=H\ZBCZ,+U_T]%'&GCFI^A)X3P3J2%DRBUZ_:7=?9:V-U#SJ*Q(!KU\_G7DQ
M2[M_'O;2[PX^NFGC@&V(I"=[THV7R]LD@V/Q [C\[4L(S44B<)_W*.= ?T'9
M,YFE#G;DOJL0TA+Y";9'! BC#-K*?LDP^2 &[1O,8AY"=JZVY^VSK00S4\52
M+59BXLG>.G@"L5,Y2J9$8,:$<[O):\>6$JG)^V#3;DZUZ%E!RU#7)R@+[)K$
M^L1= R\G+]3SI>V'8RO#.C;7RGI28S]4!M&PS/9V47(E6[)'J<+-^EVJY, S
M?' Y88RPV@!.RO+HEEO)"DTD^QTG[<(QV;?D$9+<S^_2:L7VG-N+@2Y;UJW#
M+I<GM..I@I-](Y4[\U\/.6WS%*T82NV7D.KE20\IFVIPJ)Q6!F,(<D_2EE7)
M2;62BHLZW+^2W8Z<Y[-CFDV"$E8_?Y4(;(:'6T,9L.'KX"?;'*U37++[Z+NB
M4=>3C_0S)CR2D)-R X1+UH:N^*@0?(ZOO:O5X9N 49: -]ML4M/%MY_1Q=8^
M<6T-"=D5(F^J1C6%"V-52\?:=[(&"6.NU$VAZ9X,R?1:0/%%M5;'U-U.P<YS
MI^U.B?/XLM:G]OP(_24D5^>*OBX/]W*-34J":%[Z6O552(TS&QK1U D%/4#Q
M#I;9G[89&%DN$3'4=%[D/G?B'J?N6)-PU_G%B&B;^4RL]L>5;GR.<Q[6_E:(
M=NI]:P:4Z<T['S#5C&/[M&R^H?);S@HL*TS57MA2$^,6^T6LW\K)6A15_4WS
MIC.[O)1A&[6R.5B=7J0A=6N2Y M#ZT?Z0[P8]E[Q)E7:GES[5U+K$78-N^..
M<'W&P'SIJ@K>)VE7DR#SV"2TU2-1=ODK5Y+-SV]+5)5A"WW+!OJX@LJP2O#N
M&6I;]92"G>V,(,F*A-@7%2^-WO 4]X5P1:4X]F>!*7"*$OE9HP:=.2N?;/BY
M7TV-&!_$=WQTO/BTH4'GML?*#19I\@$?R(PF;4LUJMF>MJUP>=A<SUL@2>BV
M==O(_'45SCEKLH9Y!X6<*&GDI@SV/KJ^F+I@="(J)W<E$3J4-4YX5#GPR-)E
M*^X30]RC3,GN _*8G+UX\8'%(SW3C:NDC@H&Z6C5XNJ8?:CS_[7WW5%-KMV>
M45!$%+ @("4> 5&JBO22@PBA"!$0D!H5D29-I)<H""B]""@M(M)$0'HG]"(E
M0H!0I)?028"$D(1DPOG.=^_]//?.=V=FS5TS:^:/=RW,>M_]/,_>O[V?O9_R
M$[&YG^*.T>[3S>8Q_U*V/VW]"B?<*@YN'><:$4"@I!NNZR[HN'W^R3W(J<Q
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M,662!C!6>?"IL1#5>)%XK@W&OJNKNXC]V7'ZPIK^\&X#_P'K^RIVKI:RZS2
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MG N5*]RG4B9*;C!7/YO/)*F*@E=,-YQ;*O3Z3$\<'JR0]%XYH#K=+PTZ,6J
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MY]"H';!?6[@/:_V-B*8&[L(H)Y(/>7/'WNE3RY]">QL7@#C6Y\"%9#KJ(FF
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M) =ONTZ0I_!1UB,#2 N"+77HWW<!B=Z?Q'L*!YO)OPPF7:IZP-K=739/XAG
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M[@'813(03 96M"I@9K.;(FA0C;E=PU0!<K@S(;&Z4OJ4T)6G&E0C-O0"++1
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MCK &#8T>.'M @X>J.T)[2G\.R)698JL-=@A&T<NK8>C2#")UBZR3HUY>USG
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ML)I0,G!"B1,!#H/=CF6XVV9L'+7.\^9!#)_5ATW6]_\E)8N=%UN2T0AM98;
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MOLAYT55Y>[;3>0*Q9:M8J :J$+@$%JO">TAPIW@12S'(1P@V\A>S/&9HD55
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M_II=(C^KJ\L0HI<G[OY8\CS'NM6^M+@G:^QUH5#+RDA]A7!/SIR7/OJ&VKG
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M$@AKB"CWJ(O] RL!<'L7YF$PXB[&Y>.T0[P>7L,[U,BXWAAQ#S=N?D+SY1'
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MD8./*C.;2,3TXU-2_H9YN[SN3"S+?;1M*!]Y^Z&<@7@H?9GW"8B9"E[#,H:
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M<?OMN7$'G:>(>KM%PYR@#V$#&ZAR6+A,/L>JN55AE.(YJK.'^^_[N=;E%W]
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MZ7)#9X9%_8AL9-LB64+U-=>OFW;3'4G[8U@W4FL["JQH-)G?,0F.HX@7KIV
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MI*(Y*X-]]P>3/"8N3_?^1--+#,H@IW?1 7FA&F"">),AU()L+ZP)((MEXA8
MT(Z==X5Z/;.3BHC2W)O79RWL5-H?2"&Y&C7'6Z1^-_)-S$#1/?OO4 ?ZU0\F
M[E#>L14$7]8%(79(HGADDE2()#QB@2VA;%-AH\RJJRRS>_3A3]YZ,<&K#HS<
M4L';7FY!A,*F>TG1_.E1L0C9H@2F]DQG8<-?=S^ML]ZJI$EN%6>):)[4NZY?
M=;I/BE.4!\!Q3NN^D#Y^)AOME^\Z._5]\@1$5.IBW"'6K%X-X:4H 2EHA'O$
M B2A5('(TU,#U^J 23A=LY-X9^I$N^7]H[+C[N&#4T?[LU%V \ON$VS=R@Z
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M\:G*(+"4S MHWC56.&!Z)_+.B%:^JQT$_F&7G:=$B- 6BCK%+0P65Y-Y$%5
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M^>H2'>)[$GJ4S#EW/(9KF<KSMP$3=4ZA7LDD"_K93*=@3;(4_<3.Z.GMN\8
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M)UF\J5QAY4)H/C$:-]2C!GY=@7*7;/=H7.9Y^#HI-.#$U];OC%E!7R',!S2
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MJS:/QZ_ LWM=J&,4H-.145%QH+=I[L>[^UA6_%.C@X,6\$5+.&%^U<,Z0PN
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M8OY QLC\ ?^+S3+%-P2.#GQO=ZE@V^E7#I,9B\W&DI&38IM\E=_23^+K]Q7
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M]9T";EJ*=:YGVK#G_EX]8T_07_3BDR='7XC\(C8%7D0&LN^#=1_<J$53,I6
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M8 (C#9&B[F2R)]"@X&DOF1+C;R@<3^7!GQ#<(5TQ4+V:A),2FK3A!H:*\/E
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M$+4:'8A8"R8)%#5!JJMU)OWF:':JT;)D93=GSO.(^>SX3X*!/UH]OH;$]^@
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MFG+L%M3S4M,P:AT+3I&:+-/"[Q%E+C+JZ#GOT$H/U[#'W@1*6%B0@+]^TJ<
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ME:14K^1._:I/>IN':SH/)QY9VV9)M20D3?NR"I/PQ,4PB13@UOO.Z0\D]A(
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MOGZKRLFE78#+)U%O+W^34RBO)?'GM?_['/6_3Z,)FIT&N9R[SCJWSV5<Y ]
M)>5Z?:R5[RT(6:ER4(;0B[*0Z/9I?IN8&\E,:<L-9.^\7K3C^9-26G0MLXU
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MX#^1AC@&HF]UK@RRL0^4&9<6?5(_51>!DQT,X",C7 *P-V=RC'LN 34WEZG
M0B_Q3ET*B!!1^"T<I-/=S)S+P3F\<C&-;;AJ4B28XJ.'V'K\0:!U9^_6N=I_
M>2[[_Y36B5MK;_)=R0Q<1DJJ.Z'O5@@FZF9YSR>9L\]JK.ZZD#+Z\:2T74D@
MSXX;08XEGKYP>3=LUB"F^RE'!(11W8MS(2Z.^G&T4MMOXD'<)0#H.%Y]\0G^
M<"5QMKR[@T'*_[,KW+H\J'AQY^/;![HV8:U"(W&D++?OZY(H99#V37_2IQSN
MN(;!C<:#V:^0"X$+0L8FDL/<9[KB<T?+S2WYDRUTK;4D;SJ2D'P87%W]^SYK
M/0[/!>S+?K_$\A5ET8!LL;#>^3CLB6#1*<E[^9 E^8;8YDD&Q1NKX'+N65XO
M1(U]#C">R$2@QL>O+,\)HR/>EVS8X,][;MQ(J%<[6/S"9I\?^X4LZ^4E(+7R
M)!*:@\@)LH-<LR1(XD$KR_2.1NC)9]7?#'P 7D%B=@*K%H-:<G:O/F@=HMMX
M8@"GBICU,'C0E2;[VKG,VJJ\LDGPR7=H?KC9VSN(NIU.S:Y;0/B1]>ATD>0G
ME1RZ/1$?5.XT?Q)Z^/MA]_P#F+]YHT8R1D>[&[T@XIWKAN1N<=>$8X7S\H*5
M%(^;\< @W *JK:TJW(.[.$;*OWO*<T# .68O)R*N ;MZ,_1BS7S%9D89!;F:
M<FZOHHE#G7]6\YWS*TD5\N)V7W\1NV-0M"+PA>]F4Z^6NL=/>>G#%!:2@Z!N
M\4@B!"][_M@1PM9*CW+%ZWJZ,LZ*IB+R%Q9%9!F;HWYX_IYBOBZCXE)%Q4%O
M"J((O(Y?Z(/>K")*$?0F;V,O#MF*D$@BMTG8J"TUG6P_,F[75V[K2966.0E4
MWT %=&L1+H?//)<FV.."8MM!^#<@'IAX3\W%]TN >LRF\U[EF\6]QRX[G-H2
MM3(/G7F=Z8V(Y'B[/A[)BS+"<YQ.3Q9-&];[BTQ$NE=XY>$ 7T7P#R!O"$P;
M^+MO-"&OO3HO&"R!#8H(% X<:!?#]::A7"-'<)1=EKSMSIJ/LWX>O7+2-N/E
M_[&Z0E\& ^R0\6AQ1W:"@I<DL*!0L !LJ#N6(1]GULMV(EE76%'ZG4+HC["7
M>R>)&%+0>^P:'<H],.MJ]HV/E?'0"OAM/&TN+*A;!CHWOS7BH;S6D)&\8Y<Y
M".\?+CYY!:1L>Q78&T0#?XY=1B[)M.&R4BZ2JK:)M](O 3M_T'>CP\I27H\K
MEBBF6TIF@5,.E?^KTS'^Q]PM^7O2Y\H$]\)"NVF5[5 GD15*T!5D<8%LNE)R
MWL^&:]JTCYON_4BQ,:AM/-6^IS"3M0$%!MXCCB]S$C@PT&@>]@8L*)S ?;=U
M\K#SG4!38^-2 G5G/Q<Z*KE3@Q' H UZ-:X"XH5M(SNNM]\@SJ2?=+<Q_Y %
M,7I:6*LG/JU)^'D@1Y\?'BQS\"/IK]HBACVM2I6U&(=$I76;(3C@]_&_4-G
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MG'T[V:W/;T6)=64TIH,\Z V$Q)Y(/W:XO<RR*2EUUAX;Y!ZZR]@_V?JMCU?
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M;>Y$!;&@$1KI)>IJ,&LP<!9ZMO[I?-W+F!OG+*,(#=5>&AUZ5A(AG$P:>$B
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MX7F@[T7UVSFVY*IR^R&^YFKD_FDM ^-);F2@^_\\!Y>]CCH6\?L=I@I1L^G
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MH&9^8.U+< T( ,,,HA]!;*P&H[8-B_^2P"2,B&[20?1BYC%D.[!M7U6 [)T
M_.4B&V!Y<!V<:*S]ALNK%$K570,7M$K\,_%!+**%2(1267/I (8/1%%@D@[P
MHQ3C<_BJZK6@Y"LB;B\V?6- -02UZC2?CP:G9DYJ#F<B6I#D;3IP(=<4=#<:
M[.5C+9@6(60[<58Z\'(=L34%HTG&__O7)I#>H;:D-5JD02;XR15#!T1R:0+N
MG=@=&1%WF@ :]-B#6&"7E284_@0DJS:$2DZC Q&Y>[Z7QF,(5A00A]>7"\!3
MV;K3@8["/U&MJ],,?B9,(G:X#>E D S8.![=.W%B>H5LB8% YYXY8<A6H)&D
M(N@?E?=PUS2H3'-".@37S'(GD(OFZ,X[!C?45.*?<PU6PF0#% 9T= )4^]U=
MH02C^;IXW!V^%9 6N F%FAL.XN?OUKN3;6'@'OAU/$41S(';@@GBN_IP(8I"
M:7S.NON..TWHI^W1AGLG=,4U]H:CS958<0;R-@G1WK. (!:NC\M]JC*!2='X
M=GTK42^JW5;3=JFG<#6*Y+MX4)5I%9YR;(D.D*->NW@,6#O0@0-C/U%"_T1)
M&T2)UY"B\M,!LCAW&O\FN*<^P]W__86!W7M#"DR)HDVZUXEE("L:$\%%1Y%J
MNXL\V[#[(&Y3$]J4Y!>8>V<6?CB#F3H4!>J/!4MED&B;(-$2'QC\9Z1GTN$C
M@UVL3&XG9E.\B0[TA9?(-M9W0BHAG5AA<K_=,.C?&_-H!"YM#1^80^-S]EEM
MZ!+>7!Y1B1WYPN+15PXEQ(,:>Y[^)((^2%"2M_+BU0)<N-T"!?LC!B+JR%\V
M\!;+>_=U\M:].ACA;$74!I3LL +B+@$>XK(M>'8(L1,/>EX/O+"OP0N['[NK
M+D#Y^3>I2B75E["R [;&77)TX$/V=7V_',JI+1 X'B\\" =H;/Q>7:,UI3,4
MZ^WPG;56_#I8RR>9@6B<K4#.@=8*5M"!DGDZ\&K_^M[?F=[;E:0$H.I#$&3=
MT\.KXS!WBO3CZ3,:G>,%%5\M:=SMB'2^Z3AQ#R=[Q*HQJ$KNA_9_ F]@+27K
M/XT^2V )%E)8\K2@H&RG8G[H75%#D F,30A[?V=1,78LL#*J\=_3L(>=(KF=
M &/Z$5OPP\<G"6\(U&?C+_4ME^)PC$9\GQ6F$#+L5JTZ/8_1FH>]_>[F.R&=
MT'6AH9^MT>H>\IM;2F?@WV*#[WC?;F;FT1-'S;AZ%U,4R.G3XT9DD^LD[?C(
MO"I,>4WOE6,7NP2*'R\Y2_C %)]?B)J=H:[=><*JXSOESDC&F-<,9F\U#_/"
M6U;Q)CK"F-Y9SMN$3:/<@VT5;K!C#L\OKJS&:PA?9>WH8=@0^S8C$IBU9:U<
M+-@C92)?<?CX\9A4N3) Q"VGT/9'72!J*>^=-O*SR6GE4D,#X!UWH603K(8L
M]@Y;,#9^,M1#%E7D;'<BW#+)J5JX6$XSL<)87>WL:]-T_;F\I\$F5H^3B?=L
M:HA!U0@G0JR)V<"MOJH3MAR"F8O]@=E*3RVJ@]TY#B=U5'362WDX;M<P X&F
M;\G)O_1N*$B9-=2NNJLZ3> ^:L<$S//)I:=)W+(_\Z+BH<X-;PFK%P'#8*QG
M>$"B7.U1O0EIM::)$U6;FH;5ZES[(IH^0BM.$C*\PSU6<WT=(\^14@^,!;GD
MY/^K7E%LLY/M/ROGP/G]W2,%A8)Z='G<N9C1["G'$/Z6D" G:7VL7KUT,/NK
M -."ZDA\:\NL9LMUY*ZMBYO$27.=1=?=CP8JV9K61TC3K;@W$4WBO_86PRP&
M3E-A%X?X.M2O^J=4#2@LY\5R)-2/'KE5*^$8DSC4D-LY(4R"M'?[6P_+4U20
M<SL.K2^=3,1(@M4^^S,&?(3BHN)KI8Q44J4/IHYE.08'JNH']#L0-6WC([ES
M)^!!%L1-?)OUL"#.-R'ZE*MLLCT_6ZO#)W6$TQ&/X,D$5I9:4Y5)?$R5&3/9
M=K%.I\AMN>%$?HZ@GMB\D.8SDAW.V(>CWGCMTA =>*#K<^#MT4.,2@R;G ^W
M("(!4NZ$X>%?7GF>3.4;[;M_>NSMI8XIG^I02<N8JHK3A=:?=*_=,0:4DPF)
M<"9S&&]@'8)Y@8]RE#:0;>+.]JNXRR\NA NUNXKIJZVS\N3XHH:0F^^VPEC#
M:?O(X>;$Y<B"!3O^VJ0.'(1MZI.Y5T[7?=47YTS>_S+%H=#0NW+KE\EQ4R:=
M^E[5=S >IW+\]>VI"0,OQN\X$U_EN,N5AZ.*-2P&'BD9Z+'D#I\U?@-WN29F
M,+O8LK.L)1J0J[:=)RWYD$OE:=?T1),N2;T%$Z%N $//X_+'<W$/+CM='L-Q
MU!:OP*R:GEV,<;,7[#NK?/U9ULS1F!"+0VXE[F$[B]F:??E#9U6*%L2//>T0
MQ$7#7UT/PE*?%[ZR?DP*-:N[S;'5G*"H%2'UP^_WNFGV).T(W*^S,U7\0,U
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M)I$<K3V:QH)I=S@S&CS84M 2-WYE7F(5'DN.2U=M_-??C?31_P-02P,$%
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M<(@IJS=C$%C2=1^YX&HU#T7+M\^@7MX_%QPM:88,^)<D-H^"/ISZ[W)$5M9
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M@T"'$F02O*(?0G).0@9ZE: +F:T1VNG48&-YD8FP;OY0FN:M-IL:IY$WJ6,
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M'^<WQO-^W<_R8_&1Z5)')I[9^%)*K5GTBMG*;-'7D;=/I.SH$_F9['3=+B*
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M6 A^W_$O8-BD/O[?%&/Z'LBM 8:T$)\,GBU$6[AHL"JGW'PXU?%7W.]/<LA
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M43.*-C\*PA;V4"]?EU\GCJ,WTF"G/D&NR)$T0#%,=2QX/#P3X#?[T0+:-7&
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M+&AE*E]S#_.8UOXKC 5AB:/3)%4^[2/3:08T1^M\<4UUG18='/3POSOPD/,
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MQ:1;=@Q8[<J.%]#G .*Q+3Q;_P )5KEM>0;-*M9 658Y6S;DR,GE!L [0F,
M XZ=LU4:B@EW"5/G;['UA=:7I?C2P$TLBQ/L'VA,;3RH8*X/;!!KRWP_\.==
M\!^----O?O=Z)>73&1MWGW"NR'!#,.$ 'X#BL;0O&_B8^)=<LHY+FXT>P1@7
MN$,J11KD+('QSE?X>^/6NK^%OB+Q-KVM01:LC6,MG<1Q11R@!+I2H*."/F7
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M(HN7Z@\9(\M/HGA4[E_Y7MQ342P\$:<RX3$,"$TA"AB%:9)ZRC=&' =1XI%
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M'IC][N/+M]?K=9'1354XXG-^0W0IB0]B_5'JQ.+Y<ODF+_28L@@D#QEE#/+
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M$FHF.DYH&EEEGC*D:SZ-X0>=Y<+IF;&3C4U[).R<S0<GOL[>,$P9;D4I=#F
MZQ5_)1[%,J_#B'<9"MK%O\_YC2AD7MRK.=_']5?UA;[+5N+M6MR7"YK&,0HI
M@U'H<XB04"+B"P\*$J$DXIR3T"K=C M0<].;UJ;*!^I8U<U.<K5;1U_GH#&M
MRCQ2&P>^:/- 99_EUK^3?C;3MJE[;V09G*[CK)73)=,N1=8)KDGUV"633Z7;
MZ;,'[/Y?T/Y[4OPNUKKPWX.:[CV2Y6=1W&>K3I3T@OO2P]S#,"$I@R@(,:1I
MBJ"/8TR4]'N,F8<ECPIU;B-"!Z NXJX/'6P>U,_WK26 -*98[&*/V]E)& @>
M<UT?@&.(1$I59\=!E0LH\!'F89HN'D5!\Y^KN[N0Q^OPOQ7Z"/X*K/)UQD33
MY[/IV_[!?5[]-=60?VTTY'_>#?EOMD/^%=B:#%J;KT#WF[^95_];!+',YCV8
M*,YE%N^#73C,)%W4&S$S+H+I@FHF87(O[F::%H>M%[P392G$1S5V$=U,==CX
M5JS$M[JIA9^PD/+ AWX<IQ!%DD)"$JPF"4E$(N[)R+?*CW6FO;GY=*^_JP&^
MU%^S:NW>;HI^CEJSV;=#PD8>96NDNG).@[7.%* S6E5P*W%T-UDV),;E//A<
MDY-.<0WM?SI[-;UMVHEIDROU5C"1/0K>/FG[^34^38I)&#-!H<=4!ZGY"H$T
M01RJWZ=(1![GB=%!HVG@SDW,VN3(10/[2OW4.$)BJW-3SF(,>WW<F8S[OOPI
M9C/MRW"[?1FVS]T->E-.:0Q?AFFF->Y?BI]J:N/BY9AL?F/75V/-<0Q1_!3S
M'#M&7<UU+%L=6N"\CG*Z45^-SJZTS;3TXH<^LE<ER_&C-*9IR-5T)R80)5&L
M%T1UC@[E7Z" AUYJ%4-AT.;L7(4&LI("#;JN?MG"O@(:]J#T12;TF\V+'),Z
M]MPH7]W!=_JU!I_5[ZM<)M?*$5\[3SUDP8O;0NKGFYVXK+HQ#X=%ULUO':9"
MK^\?EOD/(:I4#TT2P40$GI!$0D\(I3HAIS"E!$$LTB3QF4Q0+,SV8GI:F=\F
M2@NR3N@#'MI" 0_J*CMM.49J)(B'0D]12;2>TXC %*48QHC%01P(R5%L(^47
M4CK)DM6GFYO+B3,3X0OI&%ETMZ]6G1G'79$T _-=:NNQ9B;5TAX[GVIGWZ7#
MM/)ZN<R_Z=Q>RE%\E6_H6FZ6UTT@>NTKZE#TYLSJ@@B.L)]&4#*N5-37&2K]
M6,#8CQ/&TI"%26KSP5NU/C<IV(*O0I=X W\;QF^G$G;]8*8?H[$[LK*T&,$.
MY!789_ME(7BVK@YFJOEV;8$[Y1E$G$M-L@,PJ5H-XN:IC@U[R-!DO"R_5XI)
MUM4,^5U>IZUL\C(E)$B(# 6D::+KXT8A3'$L]<(WHR012M="NYR[/:W-3<%J
ML&"+%K1P!V;,ZJ?:3+2<$3BR2%W W8"$MP:<N,UKV]?@Q.EK#6P_S%)K<I.[
M/?UM?H]FE:U\M1'_*4CQ^5N^8-RCB6 (RM"3$*5)JF:>.(2()306-"4LL5(8
MR_;GICGJC0LNW^GO(WSXSK\C&I\K$J"3/VB= RJJ\XQ70%L E GC!@<8<#=V
ML$ ?A&</'C#@QR28P.0Q T\]:K74%1%4]R__SZ;(2IXQK9KM"EKJ8R\0">28
M*D\)QSY,U7P0!MS'.-*1ZZE5H:HS[<U-MRJXEL<>SS!J)E0.>1I9F"JD=5T=
MC15TP8ZP/F1(C-/SD&>:G/94I)G]!V<C#6\;IB(?Q/HE*;_>%/ECQ@5_\>.O
MI>!O5TVFSM7=+JO*-2VKK<J%0#%*2"BAE"F%**2>FGTE6/E+*!)^$DIL5P'/
M'L+<M&8+%9"!26@&=(.9&HU+[L@"I< #C1ZT\'6!^U^T!2!;_1'L:-]9 ;ZT
M=CA4KN$DNA2S 2@FU;?A+#V5O N>-#3G5EU'XS/Y7NU#E^TOZHGI(B&(,L]#
M, K"!**(<)ARE$+A$8E"/TQQ8#4G/-/>W/2M10<*\2A6&^NTB/WDF@F90\I&
M5JTM6PIJ'=907H'M+VNX+O-L&?'B-ME6?Y,39]PRLO\P[9;9;0,+">>%R.Y6
MK[^S*LEL&^75S".$"&*)TQA&-%(S,Z+F:#C!*50S,B](/!91/[(J(=S7VMRT
MI $+JC1 NNJMK)/JZL)&%6Q+SZF?:C-M<4;@R,K2<M<"W46NNI^M&7'BM&QP
M;X/3%@PVL?V@5+#134/7L$FIGEBN/^M]METZ)A%AF00\A)+@2 ?T,*CNCR!/
MA0RQH"QA5DIRHIVY:4BS?JJ!VBY-'^?1= GZ8G9&7VK>$@.^5"C'2>YYA@FW
M"\?'FYIX@;C7WL.%X/[+)]C(4ET@%BF.O<A7TQ:*40R1H!122I5&Q&'B^2SP
M2&14WF0P@KD)AWK'PA$WLRK21]C.LJ5REAM:VHAGVM+J\O=LFUH5B/EN:W4Y
MNFAC:^]!PY2N.@%33\L^Y'7"T-5Z@=*8H% @&'&$(>*8PI11KN9./I<\BHCO
M6>7A.]K*W!2K @E6^0HV  &I$-NIV'%"S93J8II&5J.:H7:=90?1G=;T,N!2
M3XXW-*EF]-KZ5!?Z+QYX)$UU[@?5W=7A)TP2(B1!T.>1@"B-(IA&GH"$<"_E
MG!(OLHI?[CY\;E^ZQ@8TN&%'R;JTF7W80\D8^7LVYL'^,-@1@YV>^NH^?]KC
M74<L.SC'=>R:@>5RGY3HK6KQ7F_67_-"%T=9^(AA$B0<!CZC.O2$P13%&"8R
M201F+,&1U3FC,^W-[4N^-:S67M=D!V1KB&6]VS.]8*8"#KD=61B.U/BN";P^
M3Z!]:5HS6IQ6FSW3Y+0%9,WL/Z@):WC;P)(F&KM>5M7A+[=9^7NUOK*0J<^I
M\A @B1)]+IW%^JRH@'[L^TA@*GB*K0J8'&UF;BJSAQ)HF,V2GZ7G<()4,_6X
MG*J116, 2_:%0WI)<%HFY'A+TQ8%Z;7VH 1(_]4##T%64XX%\H,P5G-_&)*4
MJ-E!0'3A(@:3&,O08Y&@5'WW^9HLS;[[^K%6W_GVX2,.>[J-0;/^AB:S+]G>
M^)&_W.M^B^T/">X9Z/3T7_WD:8_U[5ES<%YO_Z_#OK+WY+_SHJV(VQ0G>UHA
M#R5IB+ ,8*J&68@2[,$T5 PE,>4(H= +N55%0H,VYS8.?\KN5IG,F$X,LT5N
M]Z&:,&WV%3OF;^1/O$*[(VV:PH06%+D4"9-F)U40"QZ>RHO-K0,R9U:SAA>D
M%/QE?O\@5F7E/'2R9KWXL;NDV7ZXUC%$'Q_TA>5OHEP+KE/5?'\03/WX.=>_
M^KA9EVNRXMGJ[F\BN_NJKU&3<W(G_J*>O'Y%UN(-R8K?R'(C%AA)*3C#.LU5
M I$^1Y,B$L,P31GV8R8Y,LIZ-1>#YJ::+6 (&LB@P@PT:*!1@PJV3L!93_,M
MTB[.@&Z3+)TS@#FCL: R%5:V@BX?W52-X,4/T+VN3<Q8L:+WHRM>KD#-3)7T
ML>5&YW;4OU97[?BY BU#_6_A3_;N620%G0%<FW=PHK2A/^6[:)=A=$8=WYN#
M= XXI\M2.@=KG_A\L\,UP*&\5F]56$.YOBM$A5B!^22*QXR)4OWX,E^JJ_-Z
MF6I[31-$'B:!'WA(0IQ46;1\'U+BQ5"@)!9<2,83\R)@EV&9FQNGC0'7_P6V
M, UGOBZZQ<#%FH[LD;VCBN?:D!W7U:#2VE+]8\^:SH5GCP<X[QP+'V2Z3IK(
M?1B[L^Q&>C?T]@[2%S8QW?CJAHN]H='1(P?F !DZ+M?;LV]7Y;JHOHBR"N7Z
M_)6LFA'[@PY<T(/VATWU/1,OD$+OM:1QH,9 B=5HJ!-+\D"0U),^I;ZWJ*ME
M?%J38FVVW#L9?AN5>&K%B*&+7?=?QWC6D %9 RKNLM5*QU;GLJV?^4NV:F)&
M_FB9V&2RUR01*:4!2:#T=(9A$0>0,A[#- D2$2,4,1DVK\GK%?_I7Y+6AF=Y
M180:0WZJE\-L"V.6W3W)XA?M7W"@[8(#/;;@4%L/.N;7]4O 6A&P6X[8<J!^
MK%APF-]GZHYSFBEH,O#3YAR:ND\.LA=-#F#(^@#GF7XF6=;/^BA_(XQE*_$J
M+T6Y0$1Z@F ?HE@?/$%"#6I4UX6.)29>A"+,C1(>&;0UM_G]#BU857#UB,,U
M4INI9#^])O-X9Z2-';2RXZM&"CY*T& %K]SR9C/%=L;?1%/H"WBTG!T;,=,_
M^^U_Q(2S6R-;]F>O9K<,T-2751:$MZLV#\+?LO77-F1@>W;PG6KI[5K<EXL@
M25B$,(<BDDIC8QQ#FDH)612$:80H1[XTUEB[MN>FN35ZY<GMTGMH [9Q,IUS
MMN"+M@)49M@L[EEVCH%"CT?YR(K=L)V=8GMRLBUD?3S2)Y)Y<_(=R?TPQGKE
MW_*1TPT'PVS=&QX&/F+PZ8Z#1M2T("L_RILBJ_+^Z<.-<< 3#X<^3*4OE#<>
M"YBF7J(K$Q*!)..8"LO3'@;-SFZ0:+^7;_M#0X5<.^D-]D&'20U[PFP]QSV_
M8X\(CJ@=<H[$@BG'YTI,6I[ZG(D%&T?.G=C</3#-7Y605.SEP\A$V<F(L<W6
MBQ!&.$P1)'$<0:0D#&(I&8QBCS*NO-_$L\OY9]STW)1KE[6W F^;[L^<<C-Y
M&H?(D26J 7TD[TZ#^PHHX*/D0K;GRVF20//6I\T8:,W*0?I ^R<,W#/>T%+\
M?:,>^OI1_6=;:!A%222YFGQCK"MKL91#$G .J4 QX=+C/K?*M7&BG;G)T0XF
MJ' .K^9\BEC#;:_+Z1I[DVH(4_:[2/T\.-WS.='4M#LT_?8>[*><N7S@@=K5
M.N/9<K/.'L4GP39%I3VOO[/EA@O^1H'6NS>;>CG@HWQ-"AV:4-Z(HMZ\^7'\
M 74.GR1D4GH4RA2K69H@,20(,Y@D,@DCP:D76LW71L0Z-VWJ(@4[J(/4:<PN
M-E.XF73<V#M P_K,_CCS^&PZ/2,](MQI#UZ/S_O!:>X)FAQ:JU5OP=<.JJ Z
M[K')^[)K9%LUR&<\DE$,HY2K"7"82.59"EU'@WN>AX)44JLD+>9-STW5.\AU
M70BZKDIP-?$[>XIQ=O9V::>8"?<X5(^LPPY9'E#_U98PM\5@C5N?N#*L+2N'
M96*MG^ HT51=OUS_M(@3E/I<9YO",H:(!@G$(F0PP"3%E"4I%E9I:'O:FIMR
M[4&MEL*;NNX:[(59ISH,&^\KN.!M_,V$)_FGKKJD39/RPH"J4;-4=9I[WE15
MAW:?S5=UY!8'T3#?.ML25;*>VWRY?%-7PED0XJ5,1#Z,)5,S9DXQ3$D:P(3[
MDDN?4^[Y@V-A^EJ>H=[4.W%U/J,_7Q!TT4MXO^",2N/8\G,82[2WJUDS"[YH
M]*"!?TEL2R_-%T2VN*)[VK@61[1?%N)B0IU5@$OO Y\OO,7$SM[@%J,'#-#^
M3JFYSL9.=[_G5I]]_RC_6HJJW85,?.%A*J&D7@ 1B@*((QY 7U+!/!1C2=/%
M2MP1?9+><!RP1F'T6:7U9W6 98KMXT+CA;F$FU)8Y4<<V"L&H\0X)#]#V<H.
M^BNPM]L,*@MT.+:RH=:Q45FW&#1&97^BD6.$7K ;/@:3V#N&V#]UNH%DL,5[
MH\GPIPRL!K9K9$$3Z25A("!5<P.( IY ',8>C*E'$IF(*)6I32+<SK.MI@23
M9<-=[@!:EO/JL&:VS#"0BY'%^IT! ?8UM0Y-=5HMJ_/X:>M@'=IU4.'JR"4#
M7+WZ:.+K[Z)@62G>"-%D0Y$L3% J$/02+X(HH0FD41A!S##B(4EC]04;S^A/
M-#*WR7N3 $4T.('L*?]FSJ2!$^: GY&_WH::%B)0&(>DZ#G%D87+Y("KB1RC
M09S9N3YGR.AU<$[=.YT;<P;]GK-R[MI+=X/K(NH?Q/KZ/B_6V3^:G>E76<GR
M394?YZ80]]GF?H%XD! ?(1@F:I:+(NQ!DI 8RD@DF',/2>I;3'4O@#+3^6X7
M]J^$L4)4WT$N0;;;#1NZ06S>3[8[Q6YIGWK+&-3PKX RX IT3=#$MT94.\J-
M&6-L'EMS.,XNLCF,9]I.MN;I]+ZR_:,F3MRUS8>IYI";^SH31IM4\[=\J1ZC
MSP'<*G5:\ @Q% 4!Q'XD(9*^!ZFG9H6(A4& <>)Q'%H%=(^/>6X^[#9C[^,6
MYD3)E2SZV4R:9]9[(TNY@X1*G23T'<NO=EF<=\8#;?T,$BG9=]4L4BA9P/XY
MDB?9]X.SM$D#FAZX_MA7$_RO*]Z,F(*__L[4I6H\5?]:>#&+_$BY^Q)AJ?,#
M"GW(B$+*T]3'(HQ83!>/HJ"YZ:@T"(>-4G71C.KF;W3.MD(\J,>JWM0[7)G"
MK?ZU5AT#,AWAJU2G_=T5R%N;P5(;;;D0.JC[(L[\@(<A%#3B$.F<6#@)$>2>
M##B1<2PB.6"V-EX?3C]?T[8 8MN;4W2>X7KWV-_3V"OC%7Y=@*'].@X/R7;-
M +4=H#;$X6+Z)3PZ778?!&3:!?I+N#I8RK_H81=,Y^CYX9JZJH]P*^Y)ID]Y
MM,$K&[)4ZG;O+]0 2\+ DY"G0JA97Z1F?8)1&&+B^9(F$GOVL[Y9F#:WR>%A
M":LM=-#!#C3X ;/&67!N,[F<!> 9C40.YJ!/JPB1;A6AM5D5H0$OY; 9ZZSZ
MW_G$=A[633__G8?=?=/D>2$<YD#HXTR=4TR/)%OJ.MEO\N(368J_K@I!EMD_
M!'^7E^5-7E8Y.Q<X]&/NX0!RGP<0)<*#J>02TIAB%A#"J+_;.S./_AF"9<AD
M;()HH;\4"B/8008:LPZFJQJW&Y0'=9'9\#D:XU-%CM)UYTCE%=A: &5>P%+9
M</6T$T!KA[M!Z!(670X7@W!,*NR7,/54@B]ZUH 0JVW\]Y-PRB;V)<*<QGX4
MPDBHSD%1B"%!)((LPM)G?IJ(P#Q7>W];<YN/W![$PU\!V5I@$59TAN%^27/,
MV\C*M05Z50=4PX\2;@.JAX1DG>'.(C++'8<3!6A=R*5=J)89.[T16V<>,5W@
MEIDM>_%;AK<,/?Q^?Y_5<455];)J]5JHYD2IXR"6>;DI=ED6 XY9I#078L:1
M$MS4@QAQ!H.0DC@5/DN84:'T0:W/38([X*NY^AY\L,,_.+>'7=^8>9^C,3ZR
M>+LD>\"1^@&DN3UD;P-@XF/W [@Y/(@_Y"$#\_BVF^9O5P]JZO]./(JEWPS9
M***4>Q1!+-7\&B$2JTFV/HPO?.RA(,8$6:6OZVEK;FI680.^98+>'BYC+ GG
MRCE/0Q]#1%@*TS0.H&!!$*8\\!.>V.W^.V)SFCU^YWR:Z;LCCL9VQ;?A5E>@
M!GH%&L(<.H\6G#A-6]S3W+1YBL_;?9"8V."6H><%6*%W9U^)^G_?KG0@[DKU
MG#Z>YQ&&9400I(GD$(5*@FD4IC#B+)&$\B!"-H?@C1J=:4Q)B] R^+2?7S/Q
MN)RNJ6+W:WS@EQ;I'W59F0Y8EQ'Z!IRXC<7O:W#BJ'L#VP_CZTUN&E*XD;%B
MHR,YE#NT(LN_Y#DO.\6W7VZ*0C6SP#[QI/ %C&/J0T0I@Y0C#S(/"8_1%"7<
M_/BE69MS\^7J6K"B 0WN-.IJUE0VN&WJ$IJQ;K!0Z)[+D66F 0Q:Q*""#!1F
MT(*^ @UL]XS:5'QTSNQ4E1]=,&Q9 ]**J_Y:D&:/FK FI)5M^[4A[6X=Y@/>
MBE*HF[Z^TFYE_E!MT*]XG<]8%)]RN?Y&"K&;\>O\B%5ZQ$6$!4_2)(!^[*N)
M.8W5Q#SE J8X14$@P@1%5H%N@Y',3>I?YDME5]ZDG+R^*X08<$AT>,>8.9:3
MT#WR:-#:H!,,;ZVX:A8C:T- :\G>@N0H63XO9M2ERSH<S*3N[,6</75U+W_@
M& %$]?+I)M^4QS?D=<RT+JWN!^_5E5_UY#L*14HQ#$@H(")ZS2X(8QC[,9.>
MSV,9A ,FWVY1SG2V?C+HJ#H:LE8& #\ ]Y4)+D.0K#O93*B?H<]F%+:TL^]D
M!-.3CGW?W[&.PYJ&\C]=P),UPAF%0@UEURY(:G K$^<>J)/MOUV5ZZ*:"9;5
MHH)&UH33?LBK1 J"=[/^,BICCWH<$NV=(U]'J4;J)RF)ET0B)(;9K)\'_MR<
M^P\;O?"NLY!41I:__G65V;KV$[\ 9L/,?+MUY&'(P3&1IJI)AP-0K_=58]+V
M$,F6"/7CD]?(>2KJY^W66:0U&&;!SY'AX*+><9;LX#(4 _8;GH3;E;>";YB:
M57PM\LW=U^JHZ?N<9S)C=8D4-?6[%3H4MRPK? L4\)#B5$)!$@E1DGB0L)"I
MUPZG41IYJ2#F.Q&7HIG;V'88P*Q/T%<V*26KC*I3':C)4\>L:KVEZ!IFL?)^
M<8\:['),V4]CKW@=1/:6H#$'-/8T":KW+*J6[V^?JXLLMDVF[*J)-E3&[S*[
MW197%/?NPUS<R'0[-*[XV-N[<?;085-,'2]4#^++9?Y-9T#OI$>O$+7%-YK<
M)*GG28_Y'*8I"G7%"PFQ3R24C#,6""\@S*HZI"V N0V%VW"6; 4>6UL :8VQ
MF^]9]X;9C&U,CD<>QK;0P1:[WL/IE%ZXKL]/'0DKNG*>*F8HD2YG.=88)IVG
M#&7HZ4QC\'.&R>"->E^_JG=F%\M>%^W5:6GRU9T2DOO=GU[E^FCY@HHHXC@(
MH$ Q@TH($:2^KZ8)-/%H@"+*(Z,#C!=@F)L8MB: '5"=AK&Q F@SH+:C\W?P
MI3;%\GC-D XS$\N1NV%DO1RE!ZQU\@(.74KE$!B3JN4%/#T5S$L>-4PSKSFO
M-CW(\H9D_.WJ)7G(UF39G'CP!8WB1/@0)0&"B!(?XA C*'V4X"1)/=]G-NK8
MV]K<=' '%FBT4)<7K/':J5P_Q69ZYHRXD97K*6?9EK,13I48D>)2BOH;G%1T
MC&Q_*B]F-PT\U-<IO?6V2;.IT_RL2K'P*4+8"R3D%.N"6=2#-(DBZ*7(4_^*
M$<963E9/6W,3D18>$#4^(/-BER:B65\=7%^KCW0S87%$Y<BRLE>,3T\3&U(;
MI X/JIVGP^E!M9[FICVH=M[N@X-J!K<,V//YD!??\IR_)V5)V->-FB.NRV:H
MQ'' $:$("AJ&$.DM'<*D@#(. Z+^$/@B,-[-.=W.W"2D05J__#8K^3U4&FRC
MN"%H9&%H0%Z!/9A#4LGTD&6QH>&&M(FV*HZ3YVC?X3P3O3L*/;=/MU=PWH:]
M70"#RX>>VG@4J\TN&^*-*)0;<:_E]R-=9G>D+B_6Y%3,[M4E'^4G]=M2$J;_
M]FE-BO4KLA;7W[-RP2EB'I=,.6$TA<HU2R'Q9 K#1 8XBK"(>6QWE,,EO+G)
M;V/=52>S:\= L+.P4ZND-K**]^F8>04J0X&V%'S1MEJNESE^#\P\Q.?KW;$W
MUY^E8P><,QF#?[>'3YPBG/A$RACL'AY3&:65 >[U;Z)8B^_;4VIJV$VW_VC<
MG=!CG*"00$R9KX:'0 T/*!$0DP@%(0UI'"?&;O;Y]N:F]S7BW4&^7S5F<*U^
MY/=VQXP-N#;PP]TR./9.[Q/R:N[:?PWQRPU(M/#/W9(YD9_>3ZHC?]V<F5Z_
MW> QT_GOYC;M^?$6MPU/^:@U/6>_U_'@G0SHBX2$R)/2@S&12,DO54*,TQ12
MG\=!P+TX2B/;#(^G&IN;]M980:G!7H&RCI7/=WC!+]FJ^?4?[3,YGJ3<S!%V
M1>3($MQP^*GFL$:Z5[3";5;&<XRX3L)XLKW)<RZ>L_Q8BL6S]PQ.[97?B\_D
M^Y&LI$DB(D0CQ6<H(HC2(('$1P0F074B+,2>L,H8V]/6W.2DAEH%F#E(!MM'
MLIF".*)N9 $9S-J0S%[G^'"<U^MD<U-G]3IG]Y&<7F=O&7+"ILF?<+WBW10*
MN[- ;>&5SWDS9WV3%]6QG_)]MA1JH%Z))C KB97?0G *?8&5WQ((I3/8QY"D
M2*1IP#S/(NN7.UQSTZ36LBK@OV-;]_SAU;9V%/B<MXM2^K1@?<Y0#>=;(RTC
M[UQWNL'\]7FZ<O2UP_])O6AS8N=9>G.BB7;;"U60AO,N=K0N/%(W])_O<=?<
MA"=]G'.T?^;'_>,'#.!'5Y*KW1W5A1PE<0P3$?@0^52-QPQ+B.,X2M*$QKZ@
MQN/QR6;F-KP>W\&QVFT[PZO!D.>$K9%'L/&)LAA5G! VT2 QC#@[>3_+1Z]:
MG[Y[.O$]:\&>EIZ_>FB:MB)[5 ][%)VL!1_R]2M19G<KG:'LNOP/P>^RU5WG
M@FWYZNOU-AO[PB=,RB#%D!-,( K3 .)(>A"E3'"?1Y@0JV59=]#F)L%5:8''
MNK1 &]EJF4K=8;^9K<P\3V^,+/$[H_9RU2BSP,XN0$K06-:]Z@ILC;L"9 UV
M]2)<IEIS3;K;-&O.T$V<8LTUJX?IU9RW,'#9^^9C6X<R$B2A/(%12&*(6!1
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ML.X5P/P'%.NEG-G2L-:V(F-/N6/H9A(3.73LYW8!M_W7H%)FLXFAI<=5/&F
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MR8Z_ 9^55.JA+%XSTV+VZ-N%_7GO2+68\5QWM@#ON(P, ^?@45]K)7CS'*V
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MJ\T]4H6W*13B6(-\^VVSWMU_ X_LAS%K":22.V'_XDER@\V]&S].848'IM8
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MA2J6,41QIB%-2 PSA64D,\ZBS*OG3,=X4^.O.FU@=7_>V7 &5NL5%!VUN[U
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M@HBY,;<JPNCA FYW/CFWFHQ;E9F1=G7'3'U08+4Y+4MN47*EY]=?@(M$;10
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MN5*Q(3.1YWD:!$CNVQ(>A+($8BZW\2B+0Q$RCB-JE"$W/-W47M*MM*!2XMZ
MJA88X*W$X">Y)S4_/>^UVP"OMYN[@]/S6[]#\JY!LI$5[(1U&=NK XK;2-[!
M&4>.V]71_CA*5^NIZXY/[_&/6VD:KROYE^YG[<&*.J>5?W9E?+N M%J0=])A
M8?T/O%]6ZQD*,L$3&D+$E*6 2 H+1(5<G80G@N)4Z+6 ]BGDU/BL7EQ(E*B
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MB2UK4:9F&M?AOX95M^S708^SQT'7^W'PQ8HX-Z"3O<YE4FPJV5H1=*/9]M=
MZ78#=ISOL/#7U5@[K0QF+\VXI<.N1NVHMMCU(UY;<^?T&?#M:J5J3=;)6>]>
M=Y_YAE_5SVZW]29F-,"TR(L0!D%((*(9AI@F(2Q$BL( XU0PK>-<YY)-S2+O
M5W@Y>]_3UPZ0U[T/MAJ"VU[U%]/V8,Z678_3WV0Q?1]-C[N.5Y3N<82YGTH^
MUPKW1H5]'&%ZOLZ/JPG,,VCO5UC5 [M[?2++^:P@,4Z0P+ (5((<2F)8A/*?
M,:-!D)$PQ2S6S9G=&WEJO-P*!QKI]+-B]^$:YL.K0/#,9YKZ&V6ZGM3UBMS6
M_?%&RV8]J48_?_7T!ZS+;V^>-G4"0IT>KU[_%7^4#+ ]J57QV\WV6["0840"
M6&11#%%".<28$TBS+ H#(=*"YX85N;4GG]H+W).]+0RQ)WUW;_&34N!G.[O)
M:&TTW5U/B'MF"[=@VU2L-D;-<1%K_?G'KFMMC,R)4M?F8UC5%Y0^;;F[)Y>V
M386ILG.^K4K*V[",&*=9DA8(!KDJ+)@A!DD6Y5!DF?P!26FFYUGJ3SDU9FN$
M[@5NK'=B@V<EMU%U/!W0A\G+#Y2>*>L(Q9[$H!;9)J9(#TZC>H..81VMY. E
M>)V5&S0 Z$+%09V1QBPZ:*#90=U!DR<MJ/I68I?>K57TS$-);^?S4C5<_5NY
M?KQ5)9O^BR\XQ9]_#:,NNC/&>5 4F;ID"2 JH@+B*",P#!@C85*0/$RT2=MP
M\JG1MY(>W/[7[M4PH!=3W#5XVR.:GAF\!G(K.>A$!TIVT!,>_.N_Y%$8_CM0
M6MB0NBGJ!O3N$?V1B-[3*IAM I8P#FX'IF..MS%8:KNW1=B.87>*H:+(5"4_
M-?[[3;66+L.JCB)0C9\+@5)."@+3(D,0T9"J#C9$[A6IP!F.!,_RV7.=GGZW
MQJNUWMG%T)0FK]'AQ/[>I%T;!H+G:C7,3B,&,1:AH"F/$DA%3"%*5:^V$ F8
MAFE&(YKBF-,6XX\+]A8(=]/ZP[=M;.$>7+VC'5=P^?:+6C'!GXK .T';P+(;
M@(6TD>H(A3]KFE=MX-^O."O7=64/=V<Z.G"Y/,,9G&_4,QL=S0_/:+2>L>/N
M[_R%+S;\.W_"I6*G;WPE%_U)K?[7;?D;E5&FN@3?ET\J5%C<R9]6HO$Y#MJW
M))1(PL<,JL!=2459 /,H8S"*8DH+GM,LT_(%/,DW-7?A;O/TA%>OZEZY*<]X
M?$ZQ7M9M?#XS:>V5HE27R3L,P%?;&D6N%UZ/)M]P.3TS:ZO9#=CJ=F:=;D"G
M'V@4K(,*>BIZ;?+C:0%<<K5K$4>E=T_X'NX(OJ:QK$XC7Z)'7*<</Y5U=>^/
M/^A\HPRR7Y>+!TFD3[M?-1=F04P2E*(4)J'<'1"CTF0E@L @"7E*64YC8A1"
M9B["U+:"3@.PDU-11:L$4%I I4;O]W87FQ:KI4?N?M? ,W_[@-^\)HXU@D[K
MY)A+,6[M'&N4CNKIV(]DQY3U%>O=9L%6KR=Z6?."X3R)"(R20))BF*2P8$$*
MXSQD 19QEB9:9?6T9IL:_]7"FC'9,)IZI.4,(\_\U 1>-()Z;A&N!8E+PAF>
M<%1NT=+]D$;T'K)DC-4#7I3_TU9I653+><FZFB[?Y!>LNP/X*MHV9'A^)W_"
M]YL$D1R1@H<IC$+Y'\0#!(M0%?LM@B!+<Q$7A5$9+B=238Z!>DJITDT]M>I<
MG;YBRFG;J@9VNNDT)?*XSIJ<-_;J^>;&D1;.G$E= NV4<9T(-BXSN\3RB,&=
M#FX3'G?BB+?;2UX_+^A*U8/_L%DUOKXJ),[#@B<D#2&A.):4CC'$&%&89'&&
M,(L0%EJEV^VFGQIWWS)6&IR"6F*N$7'A%<FQ;H?^UK\=VEJ;KZ"3'S0*7"KS
M[@)RDV@ZG]"/%5GG> D,P^UL$1P.O3,>=<0P/%N-]T/RK$>QK WVCTWYK+Z-
M;4P2BG/&LI3#,!8,(A%ED,0(0U+('0&E(2%986+>'XP_-;*7PR]7ZGO\"G@G
MJ6&=KP, ]>SF*V#QS-Q;R1S&7EW0VFG=K8,IQBVN=5J_HPI:9SYFV]RWRZSX
M) 4Z58?K'1?+U:Y<%Z\^R7^6#XM9*K(L0A)$E"=<ONPYAWF2$XC"@$8I3WA(
MC'QY>U&FQ@NM6&94<,5*Z+'&./AZ)IC]'"_U$H&=)F"G"B"U+KW"@>J(\M+"
M6+1IOA93MZV;K:49N9WSM:@=MWB^>D3;ML]WCWP^WW9[CEDL5&% )F+)B:C
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M7GY5W:#E^<6U \KH1;Z,PQ6O]<#@H[WDEQ7LO_(:G[ZB+L>7Y6+9Q*TN'IJ
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M8:'1'<<UPDR-7WNN9M.<J<3S_IVQK2MNL4RF;KM?\,=S\?LW],KN;34!.U7
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MW:I\D?O>"^^UU9"$T@:RWU+YJZ:'?%G1^;+:R"_0K^6"?U[SIVI&HZ+(0EK
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M1@JO-_MJF<7*7\1A, C^_-/C1;=?U& O;/WRIRWK24EZY=4OWR1:?"5]R?H
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M5HCD AB#94C./3M>$9(+TN^5(+GT63OS<ANQO-^TYXL4?K-:R:_(+(H%SD5
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MF!Q*10RAX+=0Q-F11BX3,:3M:9&(P:O=_3-M>O"[!7^KC^YI(GFJ.[+3(I<
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MQ+89U(H[1VB._56/8?'UFV)KP)L!$ M,HKM\>5V!Y*AQ;2,V>)! "=Y&P0>
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M0-6]'YT)2D'ZT@T._#+]Z4RPN-BGSNAF!\NWZ]3>;-F;_)BZJSI:R!*10I1
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M'+SC34Q@=KMM3ES"6V^<' MW\GB3-)+'.= '9.>%]H/JH*/ZQB'&\V7[P>+
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MSKG N$Q!QA71P23)E45?0%#B6)8<E5F:Y#9L-SS<U+CM2%K+[F%7H#7C+'^
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M&'U2F8L8HU+<#3@=4]\MCW*C1+5MK.H'V3EB=2[8<EZQG^V?NP\OY8FZ'1/
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M+-SJX]%^O1U4KR;M#>*,:^7>CMN)X>OAD:Y)),KD5N_):06]$I$LB5- <88
M+$6L6)9PD#"*:0$9+NPJZ%T::&H4NI73-M_C HYF!.<#G<#LM15QG IXUQ#Q
MFZ)Q8:R1TS&&-3Y-O;ARO7-:F=IL?R4_NE94K\5"R&H]4]^]S+", =<[7DCS
M#!#:N$@SFA19F:7"JG70A7&FQ@?;-E#-LOR*ME+^_]5=6X_;.+)^WU_!QSF
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M> '37LF/0J7]WQQ@V#YNOGR9?[];R+^SQ<:>VS='6'=/*]4VIM\5RV9"*E'
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M)C<HV PD'6=*!Q+NR!"I%O!H@6%-=PI2:)$\A6::;&"A5]Z<YWD#AA0=2W8
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MGL+L @IOS^+)-+TZF8?5)&'6&"PY06%-O#;@;/ 0LPZ<0G!/)F\P)%Q[\&9
MZ#CGN9\HN\ ! ?BTEAO.T]_??R*Q+8_/5O4Z8LWE3HR3];9E %ETKMP(<HJB
M!8Y>.),U9VJX6KW'*-D,*1WG1 <6=B?729;?:U8Q/_OVKE*"LX0?\.OJ&7WX
M[Q-#'!C+"]CDU@>!2 YVT: +U^B(+:&'R(1M3-!F0.HX<]I&]"/CZ8@XRI6K
M5R?AXT1FHXC&##K'6K\J./C",B1E-)IL0A1#Q#(W'KH9+CK.FNXNPDYLR:OI
M,H63_\"P>$7O+"?!JR)8%!1XB0@JD8?M9*U_%R(5Z3*!>(@BO@<>O]F-Q8YS
MI$.(M2MDG-^]/&="V21#(:'HZ.MA &9P/*IZ-I"RD1Q#&,(O>9" S=#1<6)T
M&-'VX< 2&XMP\GJ6\>N_X[=)\4BJE!RTTR02[BDH1\MHVY.I%"\-BN$N#MQZ
M^&:XZ#XSNH](QZ[E/$_N?[=ZEY>U%5,>68F$YEJ08BDZ<[4@Q2@*V:2+/@R2
M+G_H^9LAH^,LZ2""'1D<KU-9')WE*7WB:+7"Y;D"U@Z39RIY8R.P&"GX8DF
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M[YIHH=$02<!JP8^B^!(B$QFR)&TK^E^W.<][@)YQTTR-L#.$['N T/<+$>L
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M%S#.2\.SL=(WJW+X 6UC9[T:@VUH[?0%N#O;OC<Y:V5I[?"P[B"AP2OA@*O
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M3^;K@4\7PIJ0LJO'SX%K@618DX*00FU>Z,FO2S'Y-IF21ZD:UR:U =1P:N@
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MP-ZML;T2X\4UIRL9<AZ,3)&#RO4$0\<,L20/WD2;I'8!79.YG9N3.&[3F>Z
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M'7C(HTD7?!3#,6!@H&UM75D*"45F!]Q+Q8/5C&&3>UH/$=3MQ=;A(+2C]#M
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M^7]B6BV//N(L?;NZSF502U,@>F5 $4_@T$E %2)M\R*YF#<"UQ8/[;']\<Z
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M2HRU4;P<5")C5%()$$+7AK&N@!-D7F4TKDB1#!--[KQ<HV%T>.RKT?DPXNT
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M-91?RV^B@]JK%#+]3\5HI%9+;D;X;"!;:A:$3AFXRW1V36:&YT&#<E$IFZS
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MZFPJ_.%J<U,+36N>^)B-E5F $:A!&57HPM;6AE)GXZ+6/'1K1-QKV6G>X\/
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M-)_B)&A8RCTX$=:*[.D\:).ARVUJDW?T)#RLSLI'$BE-!M-\6ST!>D%G4$^
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M9L6;'()PKDFCT_&/,DL!/02/3SMA)^'Z#-2%D=PA1LG"C8<8,9&21G:"D\@
M+3?&\!)8:C+A[:B<L=- L(U3M@<>EGT)[MG<3KL4L432U((#9;2&R)(C$SDH
MQ4V.VGQ/L&[JE.V#NB9.V3X0F(=[K6+J898F$YJQ*#(($AMTBN+ :Z*C%MD6
MFV1)RKRD<C^_Q&+1-I377[O8_G_VOJRYK1Q)]Q=E7.S+H\OEZG%$N>RP73TQ
M3XK$9G-:(CVDY"K/K[\)BMHH4>)RP .ZIZ/;+<DRD<N'1":0RZ&"[\!L;MFK
MOC@=,)@,3(::]"LR;5#!@8E,/!GN6&H2,)S".(K.3O\&&CT)G-ZT/O?*^& 8
MB.B)+^4$[;\B@=DB0K(\4#@Q#E)[.*1;@&/OT10[:&KL@_;)00HN9B8"1S"<
M-J@2='"XS"30,5*RXC';O%U1RBF/IMA%B2^.IMA%HF-#XC6Y "2!>]['Q_RE
M3AJ>S7^0O7\]NR"9Q0F>OYN<9Y+@-+_Y?N\5URJ/W)%W$)F3H)PI0*(,D+A%
M6:R1CTKT-X#G,#I.9:#%OC [HI:Z."4/=D#NWD.,9V3TA0,>D@(21('@? !C
M<\&4N(O8*+5_.";&+<7JSC,<"1UCF^H#@L6;?TH_G\S2F9?:>PH+(0=GZ(#B
M 9Q3&J*)0E+H*%78SFH/1M+8?L)8D'IY:E%K_79@[U?E&[^17IXZ2M_\'<^O
MZN2F5XM%IO^FS_CW&5?<!!<48+ "%#$,J+4%J[0M6H1B6,L)+[O0.K9S,C*V
MCZ7E 5,.CE=W&(TOKH:D6)/C(J=(P2 #I[ V95+6E:-=2!U8=]C,_>@&P UU
M>\*NQ3N<_RM?UGW[[=M\]AW//^?YQ62ZA,?J.&(4=4@?(W#C2.@I20@%'9"?
M9[C/5GLC6[L;+Y.Y%<K53XORSG PJC4_5!:/6:=S*H9$0;\NS-89I<0Z8J"#
M+ 2O6<QBO?QQ^"VP'^+U_R&^B9;[\;M?Z'-<I_DIGQQ8)($J%!8<<@M,!V:-
MU]FITM#3'J!?M?EI(=Q.D_U[TZ^OYE5'9P%M3:Z38*--H$*R@$P4\K.T9T5F
MK\/1GLK6B=L*GO:GA^?@>AS,>!XIN?SUUTE>3&Z_?SV[^#9;3.KOS J=)4_V
M"A\^R_P0*IJFFP\FGN/DG5LC=$2F0?A4IREF!8ZP"T6J*'*RSOAC5F/U-<4S
M*>]=Y!&BYW6>4T) %;!Z0X9Y],GP1I/??OHIGKO@KM$4SUVTVX6'.T0V9T%I
M9&T=E:P@5DUF=#(5#AA<D5$+@\P><;^?4D[Y&+!KDD>^"P9.&_CW$TM)T"4Z
M <5CO; Q'ESA'!2WTDG/"^IC%EC]^^61[X2Z-GGD.T!@[%OL-3=RE?PB)!8=
M'-D.91C9CIK\XJ(!EZ+2U@FKG'C)H=[\\2>+LGUU/!M4X!V8RBV321TS2BIE
M(2='7"6MP/N(P$*1$G.4V31I8'<*N>,=G/(-M'@2V%QMX22TUTYY,,4["@UB
M *>S@R14<&B#R&*DRH8>#N,6X-@W7WP738U]H#Z9W9R=PA*\ 1;I#\55@! (
M&8E^AIR[POAVPR]..%]\)R6^F"^^BT3'AL2AF<BI".8#AY#J.%GZ!H*1%I#<
M#R8YTYCT=L[8OT.^^-XP.Z*6.C@E!YZ^'3$:IT("F>LQ$'6L26<UA=(JCKX(
MX<<;T#OL3/;>YU ?=N\S&BI^ACUQ]_)7BXNU$@%$,!0>EE*'GB0.)8J0O+6%
ME-3E?OA]I_J)9JE=/\->V \-8SLKPV74$Y]8F(J0):^)R(Z#4R:"BXY<-'2\
MA+*5W_*35$R,!:@V]1*[:+<?V[Y3)KU*UJ,A*?L4Z\U>3=^(5<K,.ATRX\PV
M&E!Q8O42(R/[6#H^Z?S:FW_ZIJ9[+&[S+]^<+Y5R9E*2201=IPHE4)Y3(,-,
M 9:BC]QE:]?S,]H9ZZ=)/''GO _C/8#V?P('94T*9TG:8"4Q+36:VO^U@-.D
M&TPEHD09Q'I3S*.!_\3=\"Y1OY.^^_%=7LA4]BJ&XDFBK,0(*F</OF8Z.6DQ
MZ,Q1J/&2R,8MF^C+/QE0CQV <\<*OVP4,1?H:-':T4DC72WW0,CD<$45M?2N
M20UR@^K-9B42G<"UH69[QVW-]%^EV)<B>%3%@+'*@M)U_#67!E 96SL(<J&:
MW.1M2=^XU1*G@-0]=?EO5"YQMK8OQRJ8(#IZ+9E8%]%MT<3_:ZS')XFZG!&Y
M;Q/]]:1,<GIRUS68N# X:<?4]L""'*QJYMDKJ[LRAB)93)I#TC'0X>H2H',1
MI!&),42>1:-T^JWHZVAHKO4Q9AD\V!C)QAN'X((1D+G(.2M1<FER7O\\0W.'
M1V3#Z;F[J+L#KW.8%'?,Y*X8\F-8K4=6W"*0]T)NC2C22LVXE(W*RT^^N&8L
MZ#4IL-D%!Z<-_GN9]W5( ,M2@43G025G*<Y4'+AVG,2@'4N-NIC]7X'-[JAK
M4F"S"P3&?JYXNMY#%ND\&@;&FPPJZP(4[")HGH+W/F%8OP;[=RNPV4G'+Q?8
M["+P#DSEEMGW)(6"*6;(6+.@L^#@B\C D5MIL;"@FE35GT*!32<G?0--G@0^
M5]LX9L<PRSJCNK9W0NG!!Z%!!:71Q"1B:#)&[Z<JLMD)'/L6V>RBJ;$/U2=+
M0H2VSG Z+%Q22 R@ H<F0."\^!)]26R[#LTG7&2SDQ)?+++91:)C0^)I(__;
MU;1F?*WXJ25ICND 1453B]4L.,,28.:&9QN,CX<D.3U8[$3*9?8&S-#R'AL_
MZ]?%:S?%*XZX9(%I$\'84D!9<BAIAY!CH(VWFC&4,NWCMS^]W-A-A%MC:'B9
MCXVBVY?0/XF3^LRYZ57A=NR-RB5D#RQI"DMDG3PNM0!=%++BD"=NM[1(.RT\
M=N/>]M:IG1XZ<+\'F7IO6:P)&@X$]\2S"!D\(S$;YHQ'Y:6WQVS)MA/QO4QW
M.=5+Y/U0T 7RM\FAT\PHG54!R[6L?3$C!%^[ =42X*R%S2:U@?90N9 ]WL[M
M"9J]LB!WT>" =1E#)^O\-ID28Q,\?SM=7,ZOEHD).$V_X63^3SR_(A<'%U?S
MZX2%?3(U=OK\8=(M]F=IH)R)M]/O>7&Y_/Q?<[@D(+_YGZO)Y8]/.5[-)Y?D
M4MX^4KLL8C'10U"6O :'$;PK$DHI)A.46%1-[,#V)!YJ#^^M]':Z6NMZK$ ]
M7AZM.DVK-@?D:]^40A&-DT4\GU6M?28=_4*?_Z\SJ7ADV=:P+=(&+(D\(F0!
MN% 9"Q;RRIMX!ZT8&M?J-L+LNFWM @W=9D[N8KF6WEESD[Q:Y?B&^2GVCF^>
M,;* -G*"40@$+2$ LW7 4>@L6,DQ-YDS>3SS?&\.)"Z^UO_5E;[C>;YN*?_I
MZVQ^68=BW"-IJ9N[K>=-T,I3<& MTM:KK2Q#0DT!@\F:Q80F-3'$AY-^,B9W
M%QQNSF4[BH8[",'N,?+Z'!>+9>KL+S]NXH8K/'^'EU7$/VHCF#5>I<I1N<Q!
MQ\Q Y>3 E1)!H'<D!E.$EHVW_,Y$CWN5?R0<'TVK'2#X;L_^.9UG/*_U2[_/
M%HOWT\V;-(6(3' %Q<<$RDH&@2E>&QHIPR2&5)H\9.]!Z[B78T>WNVUTV!5,
M;WVX:P^=9'I3WD3B7/EUZ?WT8Q7QG!SYY67Z&O.QN!*8RZ"3J9TN6,V ,@:D
MT,%(Y54(3?(F!^5BW'>+HT/[V'K_*4*W3U<7%SC_,5LZ9/1+K[[CY+S*I,SF
MG\@ON]-6^/%I\F5*)UW$Z>6=<E_3 ?=E-O]Q0 75J/0>/YQL*_+C!Z;*V&(D
MT^"<"'7/:/!T1$ *EGE%&XG.BM,.3.O'W_O4&WW]=JVOZ[>I0*;*<>5!II1J
M)P*LM_RR#C+SK&C.;)OP? O:3B:TW 5)Z^? T#KJP*5YPJA<MQ'W41:C,WA+
ML8-*W(!#+:!@-"EI.JI4D_K&#?2,"Z_!]3X;7@D=8&F9+D0K+V]9\OS[,G&$
M?*8GSJU:5[!X^J]6F29*">N43V"51>)=$N]%6$C>2,^-1C1-+/Z03(R+VD%0
M->M$Q1W N[I2]87FX8WB369EYM8)ED"46GT;E8!@:WMEE"H%QS0O31XVGR-J
M7/B-!Y7UA/NA]-8#!O/\<NFK7U:!_9J7_3)6K(3L1+&A-OB1-4.#*_#%:6+*
M.?0>N9=M9@AOIFG<B]I^$#B0UCH X)^?/L^7<>8]W_IFX(+DTJ&+H'W6-3=4
M09#. Q.Q7KPDF463$WLS2>/>NW8#OX%T-G8J]Y^?_C'[GN?3I2/S)9.@KC,F
M9O-OM==,?NBEWY29&K2990.UI!245.3V..G!FB2Y05927NL^LJD&:8_5Q[T<
M'1U_Q]%:!T;Q]@KNEQ^W7_['),]K6N>/WVM2Y]+Q%KR^')< I20.BG$'+KL"
MTHG,(C*5F&YA(+<C;]RSNGF(/;R*>@+>_;O?Q_S=%&]HJXLS!DQ "ORD$+6"
MWX"MQ8/""YM8DTY,.U$Y<LS< ":;D#BXSGH"Y-OIMZO+Q5)B?&74#<\^Y)@@
MBURWK\Z 7 30DG&O?4#D3=X[GZ&I$[ -CX1-F#M0+:,.7'B.&7$SA= XEIT)
M8!/WH$R@2-YF^E8XKE%'74J3W+QG:!KW7!T78_NHI0,K]@N>U^J73U]SOOR]
M_G955K7[3%@6HHU0L@M5/IK")=HP(4N>N"S%QB8GZ":"Q@UP6_ML@ZBA4SBM
M-ER0,O':3\DG'VM5E2=.&(*V*8K,0[:YR4#NS22->R0.H_(M<+2'_#M TK-7
MV1289Y.9!L-% 16M 30J ,_<9UNTXJ')_5N_3Q!#*7Z7!X5=M##^_*K7UXW8
M[TJ2'EW%>,Q%BD0'=HZ9^"D6G$0%)6K#.2HKQ7:3LE]<:EQ':6"L-)#NV/>O
M=WW[GV%(F\2Y\!Z2J].>41#\K6* KGC-@N)9NJW@LLUJX[H_+1 SN(P[.+3N
MLF?77<0[SGZ_K60G"E*,A<)17E_!7-(4CEH+*3J+/G!,V.05<R<JQ[W8;^UW
MMU-8!VA<9VE-F!>S^66M7'@]6UPND[?/LDB"!2? D$T&1?L+R&J3(TK;3-,&
M%%$WN;7?E=!>VG@/CIG9$16X/T#K-(MC #3&JXNK<[S,Z1_SV6)Q5VOS#SIX
M?JGYW;F.4=4YU<X? 6+M"J*LEN!C[=;DN.%>&FU4D\!R$.I[Z5,[,I0;J+I_
M [R1Z5I+=L>TX+[V(1-0;!5[J"6ZEC8ULSYCL85CFVX8@U#?2[.L7O&]OZIW
MQ[>_QO<T?ZF$?&X&\SN^'TKAS%!TX+57(%D- 75F$# &,#*88"S6?HK'0/(F
M L?U=<<#ZR *^RGJ]Q[X5/1+;Q:7DXNZ6VY_>U:>"E?#D\7JQZGA:T+S\>OX
MVHO^^+5\OG"FE.2@%6>@)!/@A4N@C<X^HHPZM&YDU;B6[WE3LE+'>K!R*Q\=
M,"B6/;A8*& G>P)!BPPDF<Q*D5JW21,[B.J3J?_;!7V['1%#ZK5#/WT3L[5G
M\&3Z?IK_*^/\ >=G,3GM;-1@;>U"(@P2[]H"9P&UY9ISWJ0HYG#2QX7S$7&V
M)\('4OH)P?Q5H36)X<]?Y[.K+U]_FWQ?\OY0!V>2&1=CT.!4+2>2EL)PY35P
M$HC,PNEDFC2E&92+<:]?^@?_\%#H<!^\>*TJ94QH:QFI"+3/E9<4:U% 1#\,
MDOLD99M!0DWNQ9M=MO2#YD$5VN$]^2;)WK7LN9&J,80LJXBSS"(HKARX)#7D
M("(7";5JT]M@;XI/IM_=,9SKP_39H:7=RL>ZY?HL98_6100KL%8L>P2T6"^B
M6"R1,]J]3=+H#R/[-!SJ [$UA#.]GZ)/"-:;O*<[QBVS:(4(D$*I\VQY 6^%
MJD//@K<\IM0FB7\P#D[#@1X'[,.J_X1P_VDR_7*>[_=L/<NH1$Z(8())H$PA
M1P]=Q:4)0J%*W![ED7Y[DD_#F1X'V0<J>#"7>LRGHH=ON!]JGXN:%7F<-Y_G
M%S_^X\T.PAC^%>;5^?ER2-#]']WV0N4F1ZP]H64VM!ND!,\T(Y1F);U3(MHF
M =!VY!VCDV+6@NOD'1AGR;=2%.8Z)PIP@TBQKBB>-;F\.*5.BD,A:)\NBKOH
MIP,?8%.K-8$,.=8K%1E=K1-'<(KLOY9&6F&,\K9)2<[)=E'<2>];=E'<10D=
M8&G0MBW1.EEXJ.4'N8 *5H$/ 4&ZK'(QV?OU$=S_UT6Q :I:=E'<1<4=P/NY
M7FC&EXR%A(BI9%#.!7#%1A*L99$K6T=M-:E@/+"#W6GT4-P)*#MTL-M%:QT
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MSA:7Z.='Q%L/1^-@NM\.4WLHH@-4+:^CWG_+M8UGO7:JK+WY^UN>+O+**.?
MF:SMB;5+-0,@! J8C(#L6$91)TJ)T@)9+U+6);KV0<%3#1X'4TD'&%N9^)MK
MSIL]6$J.PC$)*'BUZZ76A'-B*GMM/9WY*31YTWV:G+&+4\8X'0=03)?P6FU"
M;TP*@0E@009004GP012(2=/^-%&(U"1?<1-!XQJL(93](G[VD'P'"/IC-DVW
M;S K&TODAQ X@HR5!4N:=M%I<(QAD%K[PILX5$_0TAMN]E'R;%B)=P":?4SV
M[[<9=<$F9HW70/$N;3LMZP0XH8&,N4Q*B4P4]W+/_WLO2?Z]W*VV47-7F/YC
M5M6*YZ\N9E?3RS/,/F19(D19WTJ2)'^6)0NI>K+1%\]"D\JZ303U<CW6'!,;
MT7B @KH"VCT)OI@*L4PEOM> ^4PJKXNH[>YX[1D0)=+&YA35:RZR*XIC.=YK
MZ<[DG]Z%W- @/IKR3Q;ROT\P3,XGES_N<U['QXJB,HB4*?[7S !Z#* %"<"8
MS*-J- 1L*!9.+]H>$_H'@Z #^"]OM5[/+FC]KWFZ6$J@WFQ=CRRYD<J;O^/Y
M5<JI_N)L2KS3+]7.0OG7?/W_O^0RF^=7Z;^O;OJ63]-G_/LL2)89DG?'@ZT7
M;B:#$TS35]J&V@!5\29)1FW9.CV'>YAMTA%8NLV#K+W[I[3G?NR3V7CWCX?)
M5=Q S("S+Y:?_D06%Q9?%%.>8CLM@;XBQY<+ ^0.<QYS,J+-6?@,38>_]#WZ
MZ+L<7F>5Y\E;(.B2HZ]5A!"YAB(3;2\>H[1-7-[GB!K[)688=#Q^YQM(#?V;
MD/V+;-8_8F!STK!TYCG86).$R%*!S)9@$PK2 8$:/-><<9FE;]/'JJ%1N:M
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M(<ZQ<?'';/[7;):>8B.PDLD1ET ',;%!T1^@8/2MQA)\-&CD=L-T-J\Q7D%
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MM]DYPGFXG_2[P]&/^NW;*<76DUDZXPFM**K6F@7:$L59<"QR2#J4@$5'KH\
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M[8M4O#39OO4,+9U?G(X*NP.T-2+@KA;+R><JMYL1)-DX&3E!(&HD*RD(@;M
MQX?UC&>AD]IEW !]Z -XT:\VH?7H6]_*I(!#@L/#Q=\#9M90CS+PR'@ K^IN
MGI (ZI9^\-Q+#$P*%7=Q3+NC9LRS[PB-;>K\ /&-K/6-8MF: 9]EG0*J(#CO
M:X<U ;^^VI6L*.]E*'&GCL*=]/\L!2,CX1 ]SH<4:@<!RP"-R=(680)%9]X&
M":HN'0]8&!3K BIMB?LFE8H3S;IIUS?217GCQ  X9\C?W2,\N&SX/+WZCQ\7
M6$<8(^%G^3DL<<)01RME >-(%HI[2N0M>A#%1J.MI4"RW;[=EIQUGK8.#-6A
M+*4);GHQI/BZ0.(N KF;$KX:V%\7=\M,9R=ZAU42I">N#'FTXCBW2=B&;PV;
ML-1YZGT"TQD?*;W8S%!.Y%82_YI?T,=<3)=_K=R(U3QQ[PK4[35UYVHB37$!
M'DT2LF#$D>KSQ_-VIIV^'1Y  V#GK9K3A^GW:<997@G$B: --PQ$THEB:RUK
M#U( IUT(-N2"N?]8[CG.SK19MF-3.A@WO1C2S9)"55_E!12 )5 VR4LB"4</
MAML<=-!,YW8]Y+OOK^ROC7- :.ZOB3-;A//\[U9+FEWAX$V-.WU;RV[%_=GM
MHPW1"$: 30&"K(O3F"0'IHR$D)+.+A1*5GD+7]!+&^+=#2$NOI-%;G$-%ZN/
MI)]]*I\QS;_,IO^/B%KU%:\HO:G2R9P=$]R#TO6%HT\6HC4%F$C)&%88\VUR
MVA;<G'5[XCZHWMZ>.!8V.H@6-A9@<$6TNP@VF'I,L0R160VZ9,]L=<W8I+NF
MRU;%T5#Q\OZ;/534 ;Z:=(KX)(*R!"-=I".1LE)?F!M0D<(LKK//99RY@F?>
MMK@7MD[1MKB/HCL ^PO-;\@5%W7FF:CQOU2U2T$(XHN2"64],=-DN_+?J6UQ
M+[#LWK:XA^9&A.!J _O&]AX2T<O[?$**,;%"!E[;Y%3B$3PEM93<AE(RFNB5
M>BU-.^2+.[]!.17XFNNL-Y=XRX) GKSR("(*4"5)\$41,]PA"HS9ZR9EJ4/;
M:,>[A1C5#1Z@K2[&^?PT2_-+8H'RQRJO?Z[C\U6$PURN\U U*)LR*%<0G*Y;
MJ6-@12A/K#9Y4O\"3;TTW_:2[@REO@Z<WQ96;@W5H_;&>I#,UY$864%0GMQY
MQ*!=MN3;FVR6>Y&J<>/"P72_&Z8.4$0'J*+X (F K^3Z/^!WO)A_JSRM*]"W
M3IM92MDP @\LD15J!YX%"<[KZ+Q,EHDFV-J!MBX1=@@2GJ[.'%0M'2#M'SC#
M1;@@CM[ER^EL6HNNR^EW?,R4+EY$X0T@.DO626E2**+NB.*%9V&B"$WNU7>B
M;MS3M1W:AE=-!W@;)@2YO[R-.3$90P(9+*<PI!CP.3 0AM?%H3;$TF3TQL!\
M]-+<WDN$."9,.K"2-6>8GV=\[0$F*D19N G@2GU*$(N'$"E\<DI)-#;QV.8Q
MQV[DC1L%C(J@S>N=X=4Y8!H^= _)K>1_H/.K3)>U=G%(<\AS'S-,U\>K! [4
MSO$(:;7HMYPN5D'"_8WXW2VWM5'([ 44 D$]QCU$YC6@CT6E(KR*3:YE]Z#Q
M6*?V*WW/S;>LILS]2O:UN/NZM2ZN[K_V=]+"#_3O_V,2)?=,)XJ?F";3DX'2
MPF@3&!$9.L^BX;&%; XE>%S'UPIUFT[M).KLME'N&1]R1"/<"Y_6S.6U;&3;
M!X.A9#KV# /I:_NEM@&B,Q**C!FM%"ZS)CNO3^CY/I#,9_7,GRT7TWA=O[%J
M8*V4Q<]A238]^_+HSW&1B)9/9?6'$Y)"L<5PT!)KCVK@$%@6($76,E(P7=H(
MZ6C*S\<7[H/#35]X6@5WD*!L8?CG\.?T\OKRW6QV'2X>_N$5L7OK@]:<3XI3
M*)QV4$I4H'+B$+G/D+1(@G2!="J<$-/[T#YNR6ED5#=3<K^XKKG@?7XX"8FQ
MH$L!KF+=[A8BA)2)QRAMR=Z%I)LT!^]$W;BEI)&Q>82BN@TU;RK,OX<_\:#8
M\N$_'R:8W$K00-'CW><_@QD?G"K.1LAF-2:]C@%B)0,R;:4+)DC1Y";B!9J&
MN4)^]-'WR9(TQ"[/#'@RN5X@R/JZ4X/.N<0DK8JL21_L2T3U<+UW/#J>OT >
M0 WGX$A6%?ICW<GZ0P9W*L\1=P+7DH2)VCD..=-)I#(:\"5S8#Y;Y61P9J<)
M:SVYEON+G9LO^0'+?('W7TC_N5I.$QW4/]+O3[_,5J*_A[TK.J88&.28U6H@
M.'AF$%B2)AD5*#EI\[KT.+K[=5#[8&S[8Z;VRNP@%+]GM\:4\UGME;QEG=A=
M7YJL"UJ;K"86$O$*+"93G_0J\"EJ8%HF"OQ8]MBD-^8(FGOH8FB)V;9*[ JO
M'TO!5#LU[OBL0P9J6C)+TXOI2JD;O$J*4**3&I)*OO+*("*3H.M.AN Y3[')
M%<<Q1(^;:+9';&,U=@79#VL"B,EW5U>XO*)3Y)_3$.NLF>DZ(KMG4VOE-?U
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MGM.I5B)0B!8A4(SF@B.MY"9CB1KR-"[^QX3JO$_<=&M"#Z;G<:\Q!Q7!<LM
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MX76U6-ZLD*Y&<7]BA(O5E;40%NN,2C!U3KTJ'L%I2EF<E%@8&FEWFHU%7_(
M4_2K33R]2,6X3FHX)<^'EOC8L+GQI ]96-_[:*E="E&!K;/WE"\.G"5V)&K,
M-=CT:I<0?C?8;*-B'-@,J-WYT*(>$2^I%FP7?TW^^&VB!=H0* /A0A#%E@S'
M::+8!QF"UC[*YU:'7-VBXPK3__PR__Z_UI]X Y#U+S;Q<?^M(X)A&-7-CY)C
M!_'++_/9'U>WNWKKU!\1&%A?"_<I^_I>Q8(N@L>,CEG69F['/0WC1"?# ^)8
M\7: C"TG[/U-DU;*!HP21% ("CTA7=92 N=*>Y19^":O*E\C;-P(=_# I(D^
M.L#7FOZK20I<E9P\2"4TJ!PS.&XBZ&ATR(6IJ%L67?L,9 ]4Z_/UP?UDW&VQ
M[[?K>(7_>4V?]9'86AY2W]O\B&%*>B\2-E 5;^,[[A^V:IF,5RQ!*GZ5*F<(
MP5O(Q2210]0L-JE>;2/HZ+=4&Y][7[&NLRUU\ 1B2=!56A=P3!8ZDH7S"2,Z
MWL11;*5HY!<>0R#BR0NG0:1_+B[DF%&*VSZJB4MI.M!P*Y"D=*+(8$ ;27EQ
M-@J\"$A 0I<3-S;9)G=^)W(M-S$9*FY",8;"^VPI+*^#3SF=E)IAL+JPF/DI
MF.S@R>0@.'C%H>PO\PY"U4T>Z)_=U(V2B,EI#\:4VDE?"@01?.U^MB+JY-AI
MH+.FIROT'*#H5Y!SB-3[!,^ZL*!0,V^2 HK,.2A&8HJ13E27,9H<4L3$3P2?
M'A[Y#:+OUS%T@/#[0]&ZI.1XUG6''PFD3MC44H.S08%T)4;.F8YM!EL]2TUW
MZ#E$TR_CYP"Q]X>=^]*"]5%*J1T859<)6)' >\,!M4:#6HBDFMQ/;R-HY&<H
MC0^PP^0^(GYJSG/7J?%A?H57G\J_0DK$Q_LZ\2J')4Z\%<S%E,"FU9/4R"!:
MQ\!XB@N]U?S):N.GJ=0N7]25=SE0E?-&<NW!QTR_S*:E3NQ?_G;][=O%7W4X
MT719KU0^X^7-EKB?Z<?+Z\N;9R(W?UYG60F;M<+Z0"O$.K@WYSKZ,H'A=.J3
MP=DLVY1U#B:Y*S]U'!9/K+]>O-G:W%;&-T$7F4-.26VP%& &1@PH*8$5X9(O
M14KC]G)A#S]]W+? [?S6P1(<&P+O<EZM,@T7S[)"V0;+R6@H%-S5*SH-WD4Z
M_[,@@=&?L4UOM 4,+W_/N+.)AX?%@%+MX#3[]7J1OH8KW-T)2@PR2T_^SZ6Z
M%E>KNB"7@4@I>.^\CZ7)"_"]*=T)>/HL@'<:;;6_RUC_0?TA$AO_^W_\?U!+
M 0(4 Q0    ( ,N#6E)6*,KXYP,  %H4   >              "  0    !A
M,C,Q,C R,&-O;G-E;G1F;W)I;F-O<G!R82YH=&U02P$"% ,4    " #+@UI2
M :HZF X<  "QP@  %@              @ $C!   97AH:6)I=#$P,3=M;V1E
M<FYA+FAT;5!+ 0(4 Q0    ( ,N#6E('P##8!SX  (7]   <
M  "  64@  !E>&AI8FET,3 R-W-U<'!L>6-O;G1R86,N:'1M4$L! A0#%
M  @ RX-:4K[:;D+/ P  $B$  !H              ( !IEX  &5X:&EB:70R
M,7-U8G-I9&EA<FEE<S$N:'1M4$L! A0#%     @ RX-:4HN;C+%Y"   :2<
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M;F$M,C R,#$R,S$N:'1M4$L! A0#%     @ RX-:4O9%6[I7(P  \KH! !$
M             ( !&C ( &UR;F$M,C R,#$R,S$N>'-D4$L! A0#%     @
MRX-:4IL=^:U(-P  -V\" !4              ( !H%,( &UR;F$M,C R,#$R
M,S%?8V%L+GAM;%!+ 0(4 Q0    ( ,N#6E+GRJY[A=   +)Q"@ 5
M      "  1N+" !M<FYA+3(P,C Q,C,Q7V1E9BYX;6Q02P$"% ,4    " #+
M@UI2 F/ )Q",  "U^0  %               @ '36PD ;7)N82TR,#(P,3(S
M,5]G,2YJ<&=02P$"% ,4    " #+@UI2;%^5#!4V  #G/@  %0
M    @ $5Z D ;7)N82TR,#(P,3(S,5]G,3 N:G!G4$L! A0#%     @ RX-:
M4IY^:<%D-@  _3X  !4              ( !71X* &UR;F$M,C R,#$R,S%?
M9S$Q+FIP9U!+ 0(4 Q0    ( ,N#6E+ Z=IFGQ@  !@=   5
M  "  ?14"@!M<FYA+3(P,C Q,C,Q7V<Q,BYJ<&=02P$"% ,4    " #+@UI2
MZI^L[/4Z   Q/P  %0              @ '&;0H ;7)N82TR,#(P,3(S,5]G
M,3,N:G!G4$L! A0#%     @ RX-:4JV=*\?#:   47   !4
M ( ![J@* &UR;F$M,C R,#$R,S%?9S$T+FIP9U!+ 0(4 Q0    ( ,N#6E)C
M+#XV65\  'IC   5              "  >01"P!M<FYA+3(P,C Q,C,Q7V<Q
M-2YJ<&=02P$"% ,4    " #+@UI2L27F[UMU  "J?0  %0
M@ %P<0L ;7)N82TR,#(P,3(S,5]G,38N:G!G4$L! A0#%     @ RX-:4O[L
M-3S;:@  =FX  !4              ( !_N8+ &UR;F$M,C R,#$R,S%?9S$W
M+FIP9U!+ 0(4 Q0    ( ,N#6E)>N>1@3O,  (#T   5              "
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M &UR;F$M,C R,#$R,S%?9S(S+FIP9U!+ 0(4 Q0    ( ,N#6E+0!VUP=*\
M (VQ   5              "  <9!' !M<FYA+3(P,C Q,C,Q7V<R-"YJ<&=0
M2P$"% ,4    " #+@UI2;.(!A'9\  !DDP  %0              @ %M\1P
M;7)N82TR,#(P,3(S,5]G,C4N:G!G4$L! A0#%     @ RX-:4FH]6&U; 0L
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M+3(P,C Q,C,Q7V<S,"YJ<&=02P$"% ,4    " #,@UI2O2?<U',H  "H+P
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M,#(P,3(S,5]G,S0N:G!G4$L! A0#%     @ S(-:4HD3),FFSP  _A(! !4
M             ( !M3$_ &UR;F$M,C R,#$R,S%?9S,U+FIP9U!+ 0(4 Q0
M   ( ,R#6E*XB('0&JD   KJ   5              "  8X!0 !M<FYA+3(P
M,C Q,C,Q7V<S-BYJ<&=02P$"% ,4    " #,@UI2#P#3W:.K  #PX0  %0
M            @ ';JD  ;7)N82TR,#(P,3(S,5]G,S<N:G!G4$L! A0#%
M  @ S(-:4K4B8RN-80$ CPD" !4              ( !L59! &UR;F$M,C R
M,#$R,S%?9S,X+FIP9U!+ 0(4 Q0    ( ,R#6E+0/_8MDT0  !5+   5
M          "  7&X0@!M<FYA+3(P,C Q,C,Q7V<S.2YJ<&=02P$"% ,4
M" #,@UI2F07TSU?, @"X1@, %               @ $W_4( ;7)N82TR,#(P
M,3(S,5]G-"YJ<&=02P$"% ,4    " #,@UI2$\,A7]F5  #FG   %0
M        @ ' R44 ;7)N82TR,#(P,3(S,5]G-# N:G!G4$L! A0#%     @
MS(-:4A4$=(C;(P$ :E8! !4              ( !S%]& &UR;F$M,C R,#$R
M,S%?9S0Q+FIP9U!+ 0(4 Q0    ( ,R#6E)GH.'3, L! $H, 0 5
M      "  =J#1P!M<FYA+3(P,C Q,C,Q7V<T,BYG:6902P$"% ,4    " #,
M@UI2IY/ BGTX  #+.   %0              @ $]CT@ ;7)N82TR,#(P,3(S
M,5]G-#,N9VEF4$L! A0#%     @ S(-:4DTYR31 YP  5>@  !4
M     ( ![<=( &UR;F$M,C R,#$R,S%?9S0T+F=I9E!+ 0(4 Q0    ( ,R#
M6E((?^(I#D,  !YS   5              "  6"O20!M<FYA+3(P,C Q,C,Q
M7V<T-2YJ<&=02P$"% ,4    " #,@UI2/U(WYG?+ 0"I6@( %0
M    @ &A\DD ;7)N82TR,#(P,3(S,5]G-#8N:G!G4$L! A0#%     @ S(-:
M4FSZ4>ZT=0  6YT  !0              ( !2[Y+ &UR;F$M,C R,#$R,S%?
M9S4N:G!G4$L! A0#%     @ S(-:4F5V!AO'@0$ S^ ! !0
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52P4&     #T /0  $   01%1

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
